data_2rod_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2rod _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.536 0.42 0 N-CA-C 111.987 0.366 . . . . 1.37 111.987 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -57.95 -41.49 82.93 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.291 -0.413 . . . . 1.16 111.872 179.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 44.5 tp -57.29 -43.26 83.0 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.585 -0.279 . . . . 0.77 111.722 -179.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -66.5 -48.91 68.31 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 112.075 0.398 . . . . 0.46 112.075 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 6.6 mtp180 -59.3 -52.08 67.19 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 112.409 0.522 . . . . 1.01 112.409 -179.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 35.9 mm-40 -57.46 -45.68 84.5 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.129 0.49 . . . . 0.53 110.719 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 20.3 m -64.18 -48.51 75.68 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.69 -0.686 . . . . 0.34 111.383 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.609 ' HA ' HG22 ' A' ' 276' ' ' THR . 17.3 tp -58.12 -48.59 79.74 Favored 'General case' 0 C--O 1.225 -0.235 0 CA-C-N 116.326 -0.397 . . . . 1.15 111.498 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -55.96 -50.47 70.69 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 111.781 0.289 . . . . 1.08 111.781 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . 0.512 HG12 ' HA2' ' A' ' 187' ' ' GLY . 57.1 mt -62.56 -50.1 81.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 CA-C-N 116.331 -0.395 . . . . 1.07 111.918 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.508 HD11 HG23 ' A' ' 276' ' ' THR . 77.4 mt -62.86 -47.33 93.33 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 C-N-CA 121.297 -0.161 . . . . 1.12 111.214 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 19.4 m -58.2 -42.01 85.23 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.101 0.477 . . . . 0.37 109.989 178.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . 0.534 ' O ' ' HB2' ' A' ' 169' ' ' GLU . 1.1 mmp_? -66.75 -48.77 68.09 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.119 -0.491 . . . . 0.48 111.308 178.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' TYR . . . . . 0.824 ' CE1' ' HA ' ' A' ' 195' ' ' ARG . 66.0 t80 -60.39 -51.99 67.15 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 112.9 0.704 . . . . 0.44 112.9 -179.206 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 10.9 mp -62.4 -45.07 94.79 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 120.961 -0.296 . . . . 1.14 111.782 -178.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 1.4 mmt85 -65.06 -40.38 94.63 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 120.551 0.215 . . . . 0.72 111.263 179.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . 0.534 ' HB2' ' O ' ' A' ' 165' ' ' ARG . 0.6 OUTLIER -60.35 -53.99 50.98 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 120.999 0.428 . . . . 0.4 111.499 179.544 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . 0.454 ' HB3' ' CE ' ' A' ' 257' ' ' LYS . 9.0 mm-40 -61.82 -32.44 72.75 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.708 -0.678 . . . . 0.76 112.348 -179.377 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . 0.561 ' O ' ' HG2' ' A' ' 260' ' ' LYS . . . . . . . . 0 CA--C 1.534 0.327 0 N-CA-C 112.165 0.431 . . . . 1.04 112.165 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . 0.57 ' O ' ' HA3' ' A' ' 187' ' ' GLY . . . . . . . . 0 CA--C 1.536 0.433 0 CA-C-O 121.175 0.512 . . . . 0.9 112.069 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -73.79 -69.48 1.39 Allowed Glycine 0 CA--C 1.523 0.539 0 C-N-CA 120.707 -0.758 . . . . 0.38 112.718 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -68.31 -54.94 14.05 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.654 0.264 . . . . 0.49 111.355 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -66.84 -40.92 88.12 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.382 -0.372 . . . . 1.07 111.247 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . 0.57 ' HA3' ' O ' ' A' ' 183' ' ' ALA . . . -60.39 -47.01 93.24 Favored Glycine 0 C--O 1.222 -0.601 0 C-N-CA 121.0 -0.619 . . . . 0.34 113.848 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 20.2 mtp180 -69.19 -40.79 77.85 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 117.634 0.717 . . . . 1.5 112.012 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 32.6 ttt180 -66.57 -46.1 77.16 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-O 121.364 0.602 . . . . 0.46 110.359 179.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . 0.436 ' HB1' HD13 ' A' ' 162' ' ' ILE . . . -74.88 -40.2 61.09 Favored 'General case' 0 C--O 1.221 -0.442 0 CA-C-N 115.621 -0.718 . . . . 0.74 112.598 -179.111 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 29.4 tp -63.76 -41.02 98.06 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 118.517 0.599 . . . . 1.05 111.021 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -64.81 -42.96 94.59 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 121.168 0.508 . . . . 0.42 110.508 179.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' THR . . . . . 0.477 HG22 ' HA ' ' A' ' 297' ' ' VAL . 43.4 m -71.7 -45.71 61.01 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.0 -0.546 . . . . 0.46 111.491 179.618 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 24.3 tp -60.37 -31.98 70.86 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.292 -0.413 . . . . 1.06 111.292 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . 0.824 ' HA ' ' CE1' ' A' ' 166' ' ' TYR . 6.3 ttm105 -70.74 -51.2 28.85 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.59 -0.522 . . . . 0.49 109.59 178.588 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.67 -46.18 91.34 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.507 -0.77 . . . . 0.63 111.624 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . 0.405 ' O ' HG21 ' A' ' 201' ' ' VAL . 94.2 t -72.71 -48.02 47.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.516 -0.311 . . . . 0.98 111.536 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -56.43 -40.82 87.09 Favored Glycine 0 C--N 1.335 0.522 0 CA-C-N 116.335 -0.393 . . . . 0.27 112.818 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -68.32 -47.69 66.89 Favored 'General case' 0 CA--C 1.527 0.076 0 N-CA-C 110.319 -0.252 . . . . 0.39 110.319 178.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -57.75 -42.62 94.52 Favored Glycine 0 CA--C 1.524 0.633 0 C-N-CA 120.942 -0.647 . . . . 0.28 113.006 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . 0.695 HG13 HG21 ' B' ' 34' ' ' VAL . 74.8 t -65.36 -52.0 57.34 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 N-CA-C 112.2 0.444 . . . . 0.46 112.2 179.635 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' GLN . . . . . 0.463 ' HB3' ' HB2' ' A' ' 250' ' ' SER . 10.0 pt20 -71.17 -33.13 69.71 Favored 'General case' 0 C--O 1.222 -0.369 0 N-CA-C 113.043 0.757 . . . . 0.48 113.043 -178.163 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -71.6 -37.53 70.94 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 118.377 0.535 . . . . 0.7 110.9 179.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 9.3 m-80 -66.82 -51.09 59.78 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.893 0.378 . . . . 0.67 110.827 178.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' HIS . . . . . 0.46 ' O ' ' HD2' ' A' ' 209' ' ' PHE . 50.0 m-70 -96.59 32.75 1.96 Allowed 'General case' 0 CA--C 1.537 0.446 0 O-C-N 122.331 -0.231 . . . . 0.6 110.82 179.083 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -55.75 -43.12 76.35 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 112.894 0.701 . . . . 0.48 112.894 -178.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 32.7 p -60.25 -42.2 94.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.131 0.491 . . . . 1.14 111.265 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -68.45 -42.44 78.79 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.863 -0.608 . . . . 1.1 110.253 178.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 209' ' ' PHE . . . . . 0.46 ' HD2' ' O ' ' A' ' 205' ' ' HIS . 18.1 m-85 -62.44 -49.08 76.85 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.034 -0.53 . . . . 1.34 110.424 179.256 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 65.0 mt-30 -61.78 -39.86 93.15 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.178 -0.465 . . . . 0.78 110.907 179.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -58.0 -46.39 92.61 Favored Glycine 0 C--N 1.335 0.503 0 N-CA-C 111.009 -0.837 . . . . 0.34 111.009 178.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 212' ' ' MET . . . . . 0.567 ' SD ' ' HA ' ' B' ' 23' ' ' PHE . 76.2 mtm -70.91 -35.69 72.38 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 120.759 0.314 . . . . 1.12 110.695 178.372 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 16.2 tp -60.85 -40.49 93.06 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.043 0.449 . . . . 1.16 110.754 179.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 79.4 mtp180 -77.34 -27.14 52.67 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.115 -0.493 . . . . 0.84 110.557 178.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 7.6 mmtp -75.94 -31.86 59.29 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.86 -0.609 . . . . 1.12 110.837 178.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 26.7 mt -69.08 137.21 53.33 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.047 -0.524 . . . . 1.13 112.397 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -101.78 19.88 17.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.968 -0.56 . . . . 0.49 110.392 178.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 218' ' ' ILE . . . . . 0.521 HG12 ' HB3' ' A' ' 223' ' ' ASP . 16.7 mt -62.73 118.88 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 N-CA-C 113.155 0.798 . . . . 1.06 113.155 -178.348 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . 0.57 ' HG2' HE22 ' A' ' 264' ' ' GLN . 3.3 ttpp -150.41 -16.76 0.24 Allowed 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 115.369 -0.832 . . . . 0.62 112.761 179.132 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -128.85 -178.9 4.8 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 112.872 0.693 . . . . 0.53 112.872 -178.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . 0.48 ' O ' HG23 ' A' ' 224' ' ' VAL . 0.8 OUTLIER -69.13 -22.43 63.96 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.643 -0.708 . . . . 0.5 111.772 -179.702 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -70.6 -26.29 74.33 Favored Glycine 0 CA--C 1.524 0.647 0 C-N-CA 120.834 -0.698 . . . . 0.34 113.313 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 223' ' ' ASP . . . . . 0.521 ' HB3' HG12 ' A' ' 218' ' ' ILE . 59.9 m-20 -65.17 -29.38 70.21 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 113.074 0.768 . . . . 0.39 113.074 -179.107 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . 0.551 ' HB ' HG22 ' A' ' 274' ' ' THR . 6.4 m -53.78 -27.9 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 N-CA-C 112.895 0.702 . . . . 0.86 112.895 -179.313 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . 0.417 ' O ' ' HD3' ' A' ' 229' ' ' ARG . 33.5 mtmm -60.16 -44.15 95.24 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.297 0.57 . . . . 1.06 110.334 178.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 17.6 m -72.3 -39.67 68.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.806 -0.633 . . . . 0.61 110.861 179.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 227' ' ' PHE . . . . . 0.459 ' CE1' HG12 ' A' ' 275' ' ' ILE . 17.1 t80 -60.9 -48.21 82.87 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.212 -0.449 . . . . 0.71 110.785 179.708 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 228' ' ' SER . . . . . 0.664 ' HB2' HG13 ' A' ' 278' ' ' VAL . 13.7 p -62.73 -39.15 93.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.205 -0.452 . . . . 0.64 110.267 178.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 229' ' ' ARG . . . . . 0.417 ' HD3' ' O ' ' A' ' 225' ' ' LYS . 4.1 mpt_? -64.85 -46.07 83.45 Favored 'General case' 0 C--O 1.227 -0.123 0 CA-C-N 116.103 -0.499 . . . . 0.75 110.541 178.688 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . 0.446 HG12 ' HA ' ' B' ' 24' ' ' ALA . 43.0 t -59.2 -44.88 92.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 CA-C-O 120.944 0.402 . . . . 0.91 110.321 178.168 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 231' ' ' MET . . . . . 0.581 ' HG2' HD23 ' A' ' 248' ' ' LEU . 30.4 mtm -57.54 -52.39 65.6 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.155 -0.475 . . . . 1.0 111.621 179.362 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 232' ' ' VAL . . . . . 0.506 HG11 HG21 ' A' ' 282' ' ' THR . 21.9 m -67.82 -31.84 53.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 C-N-CA 120.9 -0.32 . . . . 1.1 111.091 179.444 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 5.6 t-80 -59.82 -32.07 70.31 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.366 -0.379 . . . . 0.68 111.347 179.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . 0.517 HG13 ' HA ' ' B' ' 28' ' ' ARG . 78.8 t -58.61 -30.21 41.09 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 CA-C-O 120.79 0.328 . . . . 1.06 111.606 179.105 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 235' ' ' PHE . . . . . 0.472 ' CD1' ' HA ' ' A' ' 240' ' ' THR . 67.9 m-85 -102.58 23.7 11.56 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 111.882 0.327 . . . . 0.71 111.882 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 7.6 tptp -62.81 -24.8 67.94 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 113.062 0.764 . . . . 1.45 113.062 -178.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -81.73 -9.63 59.59 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.863 0.363 . . . . 0.51 111.527 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 93.23 2.55 65.95 Favored Glycine 0 CA--C 1.522 0.518 0 C-N-CA 120.822 -0.704 . . . . 0.58 113.388 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 11.9 t -96.77 95.51 4.74 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-O 120.994 0.426 . . . . 0.97 111.379 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 240' ' ' THR . . . . . 0.472 ' HA ' ' CD1' ' A' ' 235' ' ' PHE . 0.6 OUTLIER -82.8 70.52 9.8 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.827 0.677 . . . . 1.48 112.827 -179.781 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . 0.415 ' HB2' ' HD2' ' A' ' 244' ' ' ARG . 20.6 m-20 -83.89 140.0 32.26 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.916 0.388 . . . . 0.43 111.641 179.448 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 242' ' ' TRP . . . . . . . . . . . . . 54.1 m95 -51.09 -43.46 61.07 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.951 -0.568 . . . . 0.47 112.432 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -54.33 -35.2 55.19 Favored Glycine 0 C--N 1.339 0.708 0 C-N-CA 121.407 -0.425 . . . . 0.27 112.931 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 244' ' ' ARG . . . . . 0.415 ' HD2' ' HB2' ' A' ' 241' ' ' ASN . 24.4 mtt180 -73.99 -43.06 59.35 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.126 0.489 . . . . 0.41 109.769 178.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 48.2 mt -60.32 -50.22 81.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-N 115.709 -0.678 . . . . 0.77 111.101 179.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 31.4 m -65.86 -34.32 69.52 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 C-N-CA 121.03 -0.268 . . . . 0.9 111.497 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 40.3 m -58.06 -40.65 81.53 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.076 0.465 . . . . 1.06 110.015 178.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 248' ' ' LEU . . . . . 0.581 HD23 ' HG2' ' A' ' 231' ' ' MET . 80.7 mt -66.12 -32.31 73.69 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.023 -0.535 . . . . 1.07 111.102 178.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 19.3 mt -74.5 -42.62 49.22 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 CA-C-N 116.216 -0.447 . . . . 1.14 109.818 178.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 250' ' ' SER . . . . . 0.463 ' HB2' ' HB3' ' A' ' 202' ' ' GLN . 51.3 p -64.89 -30.4 71.4 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 109.502 -0.555 . . . . 0.79 109.502 177.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 251' ' ' PHE . . . . . . . . . . . . . 18.6 t80 -70.52 -43.97 68.53 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 108.584 -0.895 . . . . 0.69 108.584 177.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -59.18 -47.0 92.94 Favored Glycine 0 C--N 1.336 0.531 0 N-CA-C 110.767 -0.933 . . . . 0.29 110.767 177.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 253' ' ' ALA . . . . . 0.439 ' O ' ' HG3' ' A' ' 257' ' ' LYS . . . -59.5 -39.72 84.71 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 120.655 0.264 . . . . 0.56 110.691 177.369 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -61.94 -41.78 98.35 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 121.052 0.453 . . . . 0.82 110.55 178.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 59.5 t -72.04 -37.72 61.33 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-N 116.184 -0.462 . . . . 1.08 110.025 178.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -56.69 -42.88 79.87 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.028 0.442 . . . . 0.97 109.907 177.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 257' ' ' LYS . . . . . 0.454 ' CE ' ' HB3' ' A' ' 170' ' ' GLN . 93.0 mttt -64.7 -42.94 94.93 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 115.846 -0.616 . . . . 1.19 110.117 177.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 40.3 t60 -59.19 -42.79 91.72 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.292 -0.413 . . . . 0.8 110.66 178.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 95.7 mt -69.86 -42.62 73.3 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 116.392 -0.367 . . . . 1.15 111.149 179.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 260' ' ' LYS . . . . . 0.561 ' HG2' ' O ' ' A' ' 171' ' ' ALA . 2.1 tptp -64.94 -35.95 82.81 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.705 0.288 . . . . 0.78 111.311 179.239 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 63.0 m -59.69 -28.96 67.75 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.262 -0.427 . . . . 0.6 111.301 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 24.2 m -107.32 16.27 7.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-N 116.382 -0.372 . . . . 1.22 111.071 178.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 55.61 52.47 11.0 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 112.769 0.655 . . . . 1.17 112.769 179.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 264' ' ' GLN . . . . . 0.57 HE22 ' HG2' ' A' ' 219' ' ' LYS . 7.3 mt-30 -117.98 37.74 3.88 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 120.769 0.318 . . . . 0.67 111.462 179.413 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 265' ' ' GLU . . . . . 0.511 ' HA ' HD12 ' A' ' 268' ' ' ILE . 1.2 mp0 -48.06 -31.75 5.87 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 112.716 0.636 . . . . 0.59 112.716 179.39 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -55.57 -22.42 21.84 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 122.847 0.459 . . . . 1.53 111.974 179.276 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -100.43 -17.89 16.97 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 120.79 0.328 . . . . 0.65 110.986 178.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 268' ' ' ILE . . . . . 0.511 HD12 ' HA ' ' A' ' 265' ' ' GLU . 66.5 mt -67.77 -45.71 83.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-N 116.416 -0.356 . . . . 1.05 111.107 179.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 269' ' ' GLU . . . . . 0.664 ' HB2' ' HD3' ' A' ' 270' ' ' PRO . 0.5 OUTLIER -55.74 -56.58 28.41 Favored Pre-proline 0 CA--C 1.545 0.774 0 CA-C-N 116.296 -0.411 . . . . 0.37 111.21 179.332 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 270' ' ' PRO . . . . . 0.664 ' HD3' ' HB2' ' A' ' 269' ' ' GLU . 31.2 Cg_exo -61.33 -32.19 89.45 Favored 'Trans proline' 0 C--N 1.361 1.213 0 C-N-CA 122.23 1.953 . . . . 0.32 112.101 178.428 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 271' ' ' LEU . . . . . 0.422 ' O ' HG13 ' A' ' 275' ' ' ILE . 46.8 tp -66.62 -54.76 19.88 Favored 'General case' 0 C--O 1.226 -0.135 0 CA-C-N 116.406 -0.361 . . . . 1.17 110.14 178.682 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -56.98 -37.82 72.16 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 120.852 0.358 . . . . 0.4 110.628 178.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 273' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -64.26 -51.48 63.39 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.028 -0.533 . . . . 0.49 110.134 178.04 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 274' ' ' THR . . . . . 0.551 HG22 ' HB ' ' A' ' 224' ' ' VAL . 31.1 m -59.82 -42.67 94.04 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.292 -0.413 . . . . 0.99 110.595 179.173 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 275' ' ' ILE . . . . . 0.464 ' HA ' ' HE1' ' A' ' 231' ' ' MET . 96.5 mt -57.98 -54.3 33.89 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.105 0 CA-C-N 116.165 -0.471 . . . . 1.02 110.603 179.15 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 276' ' ' THR . . . . . 0.609 HG22 ' HA ' ' A' ' 160' ' ' LEU . 32.5 m -60.71 -49.88 75.71 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.253 -0.43 . . . . 1.12 111.441 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 277' ' ' ASP . . . . . 0.585 ' O ' ' HB2' ' A' ' 281' ' ' ARG . 17.0 t0 -56.28 -61.04 2.67 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.946 -0.57 . . . . 0.4 112.104 -179.425 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 278' ' ' VAL . . . . . 0.664 HG13 ' HB2' ' A' ' 228' ' ' SER . 66.4 t -61.25 -46.24 97.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 112.304 0.483 . . . . 1.07 112.304 -178.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 279' ' ' LEU . . . . . 0.486 HD11 ' HZ3' ' A' ' 283' ' ' LYS . 14.0 tp -54.7 -47.58 73.52 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 111.635 0.235 . . . . 0.97 111.635 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 84.0 t -77.38 -41.05 29.66 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 N-CA-C 111.803 0.297 . . . . 0.95 111.803 -179.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 281' ' ' ARG . . . . . 0.585 ' HB2' ' O ' ' A' ' 277' ' ' ASP . 2.5 ttt180 -53.7 -42.73 68.31 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 112.616 0.598 . . . . 1.03 112.616 -179.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 282' ' ' THR . . . . . 0.506 HG21 HG11 ' A' ' 232' ' ' VAL . 15.2 t -84.41 0.39 49.64 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 112.843 0.683 . . . . 1.05 112.843 -179.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . 0.488 ' HG3' HG22 ' A' ' 282' ' ' THR . 34.6 mtmm -141.02 40.76 1.8 Allowed 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 120.877 0.37 . . . . 0.71 111.546 -179.586 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 284' ' ' ARG . . . . . 0.43 HH11 ' HD3' ' A' ' 284' ' ' ARG . 13.2 ttm180 -63.21 -60.65 3.13 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 112.714 0.635 . . . . 0.77 112.714 -178.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 285' ' ' ASP . . . . . 0.416 ' HA ' HG12 ' A' ' 288' ' ' VAL . 35.8 t70 -58.71 -45.48 89.47 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.366 -0.379 . . . . 0.51 111.895 -179.471 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 286' ' ' TRP . . . . . . . . . . . . . 4.1 t90 -59.62 -44.95 93.27 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 120.571 0.224 . . . . 0.57 111.25 -179.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -68.84 -44.52 73.25 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 112.072 0.397 . . . . 1.0 112.072 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 288' ' ' VAL . . . . . 0.416 HG12 ' HA ' ' A' ' 285' ' ' ASP . 6.2 p -66.2 -34.5 70.63 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 O-C-N 122.207 -0.308 . . . . 0.91 111.645 -179.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 31.9 mttp -76.31 -26.87 56.26 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-O 120.766 0.317 . . . . 1.05 111.398 179.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 1.7 tp-100 -91.04 24.95 2.61 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 112.563 0.579 . . . . 0.97 112.563 -179.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 53.6 mtp180 62.99 12.65 6.05 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 112.505 0.557 . . . . 0.53 112.505 179.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 64.64 -131.86 37.67 Favored Glycine 0 CA--C 1.522 0.487 0 C-N-CA 121.235 -0.507 . . . . 0.38 113.241 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 293' ' ' TRP . . . . . 0.428 ' HB3' ' HB2' ' A' ' 190' ' ' ALA . 86.3 m95 -67.67 -21.21 65.36 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 111.903 0.334 . . . . 0.59 111.903 -179.695 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 294' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -62.85 -48.54 78.62 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 121.175 0.512 . . . . 0.47 110.098 177.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -69.78 -33.62 71.2 Favored Glycine 0 C--N 1.332 0.329 0 C-N-CA 120.657 -0.783 . . . . 0.32 111.614 178.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 296' ' ' PHE . . . . . 0.417 ' HB3' ' HA ' ' A' ' 293' ' ' TRP . 1.6 t80 -60.52 -50.94 71.53 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.674 -0.263 . . . . 0.36 111.615 179.108 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 297' ' ' VAL . . . . . 0.477 ' HA ' HG22 ' A' ' 193' ' ' THR . 28.8 m -63.94 -43.25 97.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 N-CA-C 111.836 0.31 . . . . 0.72 111.836 -178.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -58.64 -41.67 86.53 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 112.197 0.443 . . . . 0.64 112.197 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 299' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -58.69 -45.46 89.43 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 120.907 0.385 . . . . 0.56 111.875 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 300' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 . . . . . 0 CA--C 1.535 0.395 0 N-CA-C 112.556 0.576 . . . . 0.48 112.556 -179.145 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 . . . . . 0 N--CA 1.453 -0.312 0 N-CA-C 109.477 -0.564 . . . . 0.77 109.477 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 23' ' ' PHE . . . . . 0.567 ' HA ' ' SD ' ' A' ' 212' ' ' MET . 0.4 OUTLIER -61.9 -41.41 97.86 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.322 0.582 . . . . 0.45 109.848 179.019 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 24' ' ' ALA . . . . . 0.501 ' O ' ' HB2' ' B' ' 28' ' ' ARG . . . -59.09 -43.83 91.85 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.249 -0.887 . . . . 0.97 111.126 179.425 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -72.42 -46.8 53.47 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 116.191 -0.459 . . . . 0.49 110.751 179.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -58.01 -54.31 48.42 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 115.96 -0.564 . . . . 0.44 110.778 179.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 98.8 mt -59.34 -37.86 78.91 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.596 -0.275 . . . . 1.12 110.863 179.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 28' ' ' ARG . . . . . 0.517 ' HA ' HG13 ' A' ' 234' ' ' VAL . 0.9 OUTLIER -61.32 -52.72 63.52 Favored 'General case' 0 CA--C 1.528 0.106 0 N-CA-C 109.9 -0.407 . . . . 0.54 109.9 178.736 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -59.82 -43.24 94.62 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.372 -0.377 . . . . 0.7 110.654 178.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 96.1 mt -58.75 -49.31 83.21 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 CA-C-N 116.345 -0.389 . . . . 1.09 110.172 178.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -55.32 -45.38 83.39 Favored Glycine 0 CA--C 1.52 0.404 0 CA-C-N 116.306 -0.407 . . . . 0.28 112.931 179.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -59.19 -49.61 77.19 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 121.087 0.47 . . . . 0.36 110.68 179.143 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 5.4 ttmm -64.01 -45.59 88.28 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 115.927 -0.578 . . . . 1.76 110.847 179.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 34' ' ' VAL . . . . . 0.695 HG21 HG13 ' A' ' 201' ' ' VAL . 5.3 t -58.56 -49.68 81.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 CA-C-O 120.958 0.409 . . . . 1.02 110.659 179.127 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -57.95 -43.65 86.51 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.971 -0.559 . . . . 0.7 110.601 178.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 36' ' ' CYS . . . . . . . . . . . . . 74.3 m -68.22 -25.93 65.46 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 120.942 0.401 . . . . 0.44 111.175 179.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 45.8 m -80.13 -35.47 36.65 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 116.115 -0.493 . . . . 0.88 111.953 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 38' ' ' TRP . . . . . . . . . . . . . 85.0 m95 -84.83 -30.47 24.5 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.039 0.385 . . . . 0.63 112.039 -179.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 16.9 p . . . . . 0 N--CA 1.466 0.33 0 CA-C-O 120.767 0.318 . . . . 0.41 110.673 179.248 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . 0.523 ' HA ' ' HB3' ' A' ' 156' ' ' TYR . 2.6 m-20 . . . . . 0 CA--C 1.537 0.462 0 N-CA-C 113.73 1.011 . . . . 0.74 113.73 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . 0.425 ' HA ' ' HE ' ' A' ' 157' ' ' ARG . 11.2 t0 -52.58 -44.47 65.93 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 120.973 0.416 . . . . 0.49 111.27 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 44.4 tp -85.26 -33.36 22.19 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.142 0.496 . . . . 1.12 110.22 178.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . 0.523 ' HB3' ' HA ' ' A' ' 153' ' ' ASP . 55.6 t80 -61.21 -45.73 93.37 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 115.637 -0.71 . . . . 0.56 112.336 -179.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . 0.44 HH11 ' HD2' ' A' ' 157' ' ' ARG . 20.4 ptt85 -59.4 -44.37 92.81 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 120.785 0.326 . . . . 0.63 110.993 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 10.3 mt-30 -65.17 -44.19 89.3 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-O 120.86 0.362 . . . . 0.53 110.223 178.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' SER . . . . . 0.518 ' HA ' ' CZ2' ' A' ' 293' ' ' TRP . 17.0 m -61.63 -49.43 76.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.965 -0.562 . . . . 0.43 111.129 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.59 HD22 ' HA ' ' A' ' 273' ' ' GLU . 0.2 OUTLIER -59.47 -44.12 93.09 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.349 -0.387 . . . . 1.36 110.879 179.375 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -66.9 -53.59 30.54 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 112.037 0.384 . . . . 0.46 112.037 -179.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 79.4 mt -61.22 -51.09 77.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 N-CA-C 112.28 0.474 . . . . 1.04 112.28 -179.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 59.2 mt -60.27 -51.42 73.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 N-CA-C 112.297 0.48 . . . . 0.61 112.297 -178.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 90.6 p -57.7 -35.84 71.18 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.575 0.226 . . . . 1.21 111.227 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . 0.417 HH11 ' HD2' ' A' ' 165' ' ' ARG . 0.0 OUTLIER -72.28 -51.1 22.41 Favored 'General case' 0 C--O 1.226 -0.157 0 C-N-CA 120.954 -0.298 . . . . 1.97 111.096 179.091 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' TYR . . . . . 0.784 ' HE1' ' HA ' ' A' ' 195' ' ' ARG . 60.1 t80 -59.7 -46.12 90.05 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 120.648 0.261 . . . . 0.4 111.244 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 5.2 mp -60.63 -45.47 93.94 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 116.354 -0.385 . . . . 1.07 111.175 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 12.2 ttm105 -71.99 -34.68 69.11 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 121.021 -0.272 . . . . 0.63 110.907 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -63.74 -52.63 59.6 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 120.752 0.31 . . . . 1.14 110.354 178.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . 0.4 ' O ' ' HE2' ' A' ' 257' ' ' LYS . 6.6 mm-40 -65.56 -26.51 67.9 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.902 0.382 . . . . 1.21 111.508 179.267 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.375 -0.375 . . . . 0.56 111.955 179.344 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . 0.453 ' O ' ' HA3' ' A' ' 187' ' ' GLY . . . . . . . . 0 N--CA 1.455 -0.208 0 CA-C-O 121.126 0.489 . . . . 0.62 111.05 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -78.7 -71.73 1.22 Allowed Glycine 0 CA--C 1.522 0.512 0 C-N-CA 120.118 -1.039 . . . . 0.59 112.887 -179.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -72.1 -48.49 43.56 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 120.96 0.409 . . . . 1.09 110.731 179.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -65.11 -34.42 78.36 Favored 'General case' 0 C--O 1.224 -0.237 0 CA-C-N 115.889 -0.596 . . . . 0.94 110.27 178.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . 0.453 ' HA3' ' O ' ' A' ' 183' ' ' ALA . . . -65.71 -40.9 96.02 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.67 -0.776 . . . . 0.42 111.66 178.597 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . 0.408 HH11 ' HD2' ' A' ' 188' ' ' ARG . 11.2 mmt180 -63.98 -54.29 36.76 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.753 0.311 . . . . 1.84 110.962 179.123 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 3.0 ttp180 -60.24 -42.85 96.15 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 115.882 -0.599 . . . . 2.47 110.942 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . 0.535 ' HA ' ' CG1' ' A' ' 297' ' ' VAL . . . -64.26 -46.32 84.26 Favored 'General case' 0 C--O 1.222 -0.391 0 CA-C-N 116.391 -0.368 . . . . 0.97 110.681 179.055 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 15.7 tp -61.38 -37.36 83.1 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.722 0.296 . . . . 1.28 110.779 179.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' GLU . . . . . 0.601 ' OE2' ' HD3' ' A' ' 196' ' ' ARG . 4.0 tm-20 -63.01 -53.2 57.69 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 121.402 0.62 . . . . 1.04 110.84 178.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' THR . . . . . 0.494 HG22 ' HA ' ' A' ' 297' ' ' VAL . 98.0 m -70.21 -41.24 73.91 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.475 -0.784 . . . . 1.12 111.699 -178.578 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 11.3 tp -61.24 -42.39 98.53 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.281 -0.418 . . . . 1.08 111.433 179.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . 0.784 ' HA ' ' HE1' ' A' ' 166' ' ' TYR . 13.0 ttm-85 -65.6 -41.17 93.06 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 121.189 0.518 . . . . 1.4 109.867 178.614 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . 0.601 ' HD3' ' OE2' ' A' ' 192' ' ' GLU . 8.1 mtp-105 -63.32 -57.0 11.82 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.708 -0.678 . . . . 0.39 111.592 179.574 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 58.2 t -68.59 -40.13 81.43 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-N 116.397 -0.365 . . . . 0.92 111.962 -179.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . 0.537 ' HA3' ' OH ' ' A' ' 166' ' ' TYR . . . -59.15 -47.15 92.18 Favored Glycine 0 C--N 1.33 0.244 0 C-N-CA 121.475 -0.393 . . . . 0.26 112.751 -179.52 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -75.66 -26.35 57.6 Favored 'General case' 0 C--O 1.223 -0.316 0 N-CA-C 110.026 -0.361 . . . . 0.43 110.026 178.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -63.13 -47.02 91.86 Favored Glycine 0 C--N 1.336 0.568 0 N-CA-C 110.929 -0.868 . . . . 0.25 110.929 177.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 61.0 t -69.18 -39.57 79.45 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-O 121.017 0.437 . . . . 0.97 110.021 177.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -67.08 -41.48 86.26 Favored 'General case' 0 C--O 1.219 -0.504 0 CA-C-N 115.71 -0.677 . . . . 0.82 112.024 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.88 -46.47 84.76 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.934 0.397 . . . . 0.46 110.298 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 32.6 m-80 -68.16 -46.82 69.73 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 115.987 -0.551 . . . . 0.57 112.107 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 86.3 m-70 -102.71 30.63 4.58 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 113.556 0.947 . . . . 0.45 113.556 -178.132 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -62.53 -36.21 81.89 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 121.011 0.434 . . . . 0.42 111.216 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 32.7 p -68.86 -39.8 79.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.085 0.469 . . . . 1.76 110.521 178.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -67.05 -40.76 87.21 Favored 'General case' 0 N--CA 1.456 -0.126 0 CA-C-N 115.887 -0.597 . . . . 0.39 110.085 178.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 11.8 m-30 -65.89 -39.59 90.77 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.991 -0.55 . . . . 0.52 110.22 178.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -67.04 -47.67 70.65 Favored 'General case' 0 N--CA 1.46 0.052 0 CA-C-N 116.354 -0.385 . . . . 0.89 110.362 178.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -58.59 -42.62 96.2 Favored Glycine 0 C--N 1.337 0.595 0 N-CA-C 111.0 -0.84 . . . . 0.31 111.0 178.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 30.6 ttm -64.16 -46.04 85.78 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.688 -0.486 . . . . 1.04 109.688 178.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . 0.464 ' HA ' HD12 ' A' ' 216' ' ' LEU . 6.7 tp -59.62 -41.39 90.28 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.806 -0.634 . . . . 1.23 111.112 179.002 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 214' ' ' ARG . . . . . 0.536 ' HD3' ' O ' ' A' ' 214' ' ' ARG . 0.0 OUTLIER -65.0 -32.07 73.61 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.238 -0.437 . . . . 0.91 110.553 179.268 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 56.4 mtpt -89.0 -0.99 57.89 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.253 -0.43 . . . . 1.31 110.781 178.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . 0.64 ' HB3' HG22 ' A' ' 218' ' ' ILE . 10.1 mt -92.26 134.28 35.04 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 121.175 0.512 . . . . 1.4 111.226 179.598 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -99.38 29.16 4.12 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 115.824 -0.625 . . . . 0.45 110.401 178.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 218' ' ' ILE . . . . . 0.64 HG22 ' HB3' ' A' ' 216' ' ' LEU . 2.3 tt -66.91 114.62 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 N-CA-C 113.061 0.763 . . . . 1.1 113.061 -178.603 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 10.0 ptpp? -161.27 4.69 0.06 Allowed 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 115.474 -0.785 . . . . 0.5 112.645 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -154.29 -175.96 5.65 Favored 'General case' 0 C--O 1.218 -0.567 0 O-C-N 121.747 -0.595 . . . . 0.59 112.555 -178.249 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -61.59 -20.84 63.76 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 112.599 0.592 . . . . 0.48 112.599 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -67.71 -42.95 86.34 Favored Glycine 0 CA--C 1.531 1.04 0 N-CA-C 114.708 0.643 . . . . 0.42 114.708 -179.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 223' ' ' ASP . . . . . 0.474 ' OD1' HG13 ' A' ' 218' ' ' ILE . 0.1 OUTLIER -65.51 -31.86 73.15 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 117.621 0.711 . . . . 0.38 112.05 -179.098 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 12.1 t -58.37 -42.35 83.76 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 CA-C-O 121.429 0.633 . . . . 1.08 110.337 178.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 35.2 mmtm -67.91 -41.52 82.56 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.783 -0.644 . . . . 0.6 109.689 178.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 226' ' ' SER . . . . . 0.553 ' O ' HG21 ' A' ' 230' ' ' VAL . 20.6 t -61.19 -38.95 88.38 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.506 -0.77 . . . . 0.65 110.07 178.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 227' ' ' PHE . . . . . 0.419 ' HE1' ' CD2' ' A' ' 251' ' ' PHE . 49.7 t80 -59.47 -43.22 93.3 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.45 -0.795 . . . . 0.57 110.423 178.295 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 228' ' ' SER . . . . . 0.951 ' HB2' HG22 ' A' ' 278' ' ' VAL . 9.6 p -65.16 -31.97 73.42 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.057 -0.519 . . . . 0.49 110.074 178.127 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 22.2 ttp-105 -67.84 -36.24 79.99 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 109.561 -0.533 . . . . 0.7 109.561 178.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . 0.553 HG21 ' O ' ' A' ' 226' ' ' SER . 26.3 t -59.99 -45.41 95.4 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 N-CA-C 109.138 -0.69 . . . . 1.02 109.138 177.345 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 231' ' ' MET . . . . . 0.767 ' HG3' HD11 ' A' ' 248' ' ' LEU . 29.0 ttm -56.08 -53.26 59.09 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 114.822 -1.081 . . . . 1.0 111.786 179.205 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 34.2 m -66.09 -31.12 52.25 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-O 120.563 0.22 . . . . 0.51 111.419 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 44.3 t-80 -69.38 -42.27 75.4 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.987 0.423 . . . . 0.64 110.383 178.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . 0.513 HG13 ' HA ' ' B' ' 28' ' ' ARG . 44.9 t -58.17 -43.99 86.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-N 116.192 -0.458 . . . . 1.1 110.749 178.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 235' ' ' PHE . . . . . 0.481 ' CD2' ' HA ' ' A' ' 240' ' ' THR . 96.2 m-85 -94.43 23.38 5.26 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 116.088 -0.505 . . . . 0.52 112.017 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -65.14 -13.47 58.21 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 112.028 0.381 . . . . 1.32 112.028 -179.373 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -83.37 -17.09 43.5 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.641 0.258 . . . . 0.41 111.324 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 97.15 -7.69 64.51 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 120.81 -0.71 . . . . 0.46 114.034 179.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 4.5 p -97.73 116.09 39.38 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 CA-C-O 121.337 0.589 . . . . 1.19 111.576 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 240' ' ' THR . . . . . 0.481 ' HA ' ' CD2' ' A' ' 235' ' ' PHE . 25.4 m -88.39 84.63 6.81 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.048 0.452 . . . . 1.25 111.875 -179.57 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . 0.537 ' HB2' ' HD2' ' A' ' 244' ' ' ARG . 92.0 m-20 -76.04 135.45 39.94 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.205 -0.452 . . . . 0.54 111.141 179.277 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 242' ' ' TRP . . . . . 0.595 ' HB3' ' CZ ' ' A' ' 300' ' ' PHE . 5.1 m95 -60.33 -37.88 82.01 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.911 0.386 . . . . 0.53 111.282 179.342 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . 0.48 ' HA3' ' N ' ' B' ' 35' ' ' TYR . . . -64.58 -29.95 76.57 Favored Glycine 0 CA--C 1.52 0.378 0 C-N-CA 121.072 -0.585 . . . . 0.32 112.376 178.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 244' ' ' ARG . . . . . 0.54 ' HA ' ' HA3' ' B' ' 31' ' ' GLY . 79.5 mtt180 -69.28 -44.53 71.65 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.86 -0.422 . . . . 0.39 109.86 178.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . 0.507 ' O ' HG12 ' A' ' 249' ' ' ILE . 69.7 mt -61.21 -53.84 43.45 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 CA-C-N 115.542 -0.754 . . . . 0.56 111.435 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 19.0 m -60.6 -34.84 60.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 C-N-CA 120.89 -0.324 . . . . 0.87 111.335 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 53.0 m -62.36 -44.68 95.9 Favored 'General case' 0 N--CA 1.463 0.179 0 N-CA-C 109.985 -0.376 . . . . 1.0 109.985 178.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 248' ' ' LEU . . . . . 0.767 HD11 ' HG3' ' A' ' 231' ' ' MET . 91.5 mt -65.8 -39.76 91.25 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.213 -0.448 . . . . 0.82 110.561 178.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 249' ' ' ILE . . . . . 0.507 HG12 ' O ' ' A' ' 245' ' ' ILE . 26.7 mm -65.67 -43.88 93.66 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 CA-C-O 121.119 0.485 . . . . 1.01 109.837 178.144 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 35.5 t -60.46 -45.97 91.79 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.788 -0.642 . . . . 0.32 109.383 178.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 251' ' ' PHE . . . . . 0.425 ' CD2' HD12 ' B' ' 27' ' ' LEU . 22.0 t80 -63.58 -39.4 94.28 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 115.687 -0.688 . . . . 0.43 110.115 178.144 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -56.99 -42.69 93.01 Favored Glycine 0 C--N 1.335 0.503 0 N-CA-C 111.419 -0.672 . . . . 0.27 111.419 177.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -69.21 -31.33 69.84 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 120.827 0.346 . . . . 0.43 110.521 177.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -70.93 -47.58 58.27 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 116.247 -0.433 . . . . 0.66 111.378 179.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 19.1 m -64.64 -35.62 75.26 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 C-N-CA 120.725 -0.39 . . . . 0.6 110.159 178.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -66.04 -32.33 73.74 Favored 'General case' 0 N--CA 1.456 -0.146 0 N-CA-C 109.257 -0.645 . . . . 0.62 109.257 177.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 257' ' ' LYS . . . . . 0.4 ' HE2' ' O ' ' A' ' 170' ' ' GLN . 24.5 ttmt -63.66 -40.03 95.82 Favored 'General case' 0 CA--C 1.528 0.108 0 CA-C-N 115.493 -0.776 . . . . 1.54 109.085 177.615 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 75.4 t60 -66.09 -44.86 83.17 Favored 'General case' 0 C--O 1.231 0.085 0 CA-C-N 115.93 -0.577 . . . . 0.5 109.539 177.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 97.4 mt -60.14 -47.33 86.35 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 115.8 -0.636 . . . . 1.13 110.33 178.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 260' ' ' LYS . . . . . 0.429 ' HA ' ' OE1' ' A' ' 265' ' ' GLU . 0.7 OUTLIER -62.96 -33.8 76.16 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.277 -0.419 . . . . 0.64 110.742 178.998 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 72.4 m -60.23 -29.46 68.77 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 120.858 0.361 . . . . 0.51 110.836 179.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 262' ' ' VAL . . . . . 0.407 HG22 ' HG3' ' A' ' 264' ' ' GLN . 6.1 m -109.95 17.97 7.14 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-O 120.951 0.405 . . . . 1.2 110.662 178.509 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 58.05 50.33 10.28 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 115.528 -0.76 . . . . 0.66 113.036 179.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 264' ' ' GLN . . . . . 0.407 ' HG3' HG22 ' A' ' 262' ' ' VAL . 22.6 mt-30 -110.99 36.49 3.13 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 120.953 0.406 . . . . 0.44 110.931 178.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 265' ' ' GLU . . . . . 0.512 ' HA ' HD12 ' A' ' 268' ' ' ILE . 0.9 OUTLIER -51.36 -33.48 29.9 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 112.823 0.675 . . . . 0.53 112.823 -179.804 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 24.9 p -59.12 -20.25 51.95 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 111.793 0.294 . . . . 1.52 111.793 179.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -93.35 -23.49 18.43 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 121.063 0.459 . . . . 0.79 110.838 178.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 268' ' ' ILE . . . . . 0.512 HD12 ' HA ' ' A' ' 265' ' ' GLU . 73.0 mt -67.62 -42.17 86.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 CA-C-N 116.243 -0.435 . . . . 1.03 110.889 179.382 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 269' ' ' GLU . . . . . 0.791 ' HB2' ' HD3' ' A' ' 270' ' ' PRO . 58.2 mm-40 -54.77 -56.41 27.67 Favored Pre-proline 0 CA--C 1.544 0.74 0 CA-C-N 116.006 -0.543 . . . . 0.58 111.789 179.539 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 270' ' ' PRO . . . . . 0.791 ' HD3' ' HB2' ' A' ' 269' ' ' GLU . 22.7 Cg_exo -66.81 -28.15 43.47 Favored 'Trans proline' 0 C--N 1.358 1.068 0 C-N-CA 122.181 1.921 . . . . 0.77 111.79 178.205 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 271' ' ' LEU . . . . . 0.494 ' O ' HG22 ' A' ' 275' ' ' ILE . 32.7 tp -62.91 -50.4 71.01 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.366 -0.379 . . . . 1.06 110.278 178.686 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -60.69 -34.0 73.69 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 121.336 0.589 . . . . 0.52 110.602 178.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 273' ' ' GLU . . . . . 0.59 ' HA ' HD22 ' A' ' 160' ' ' LEU . 34.9 tt0 -71.85 -40.9 68.68 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.566 -0.743 . . . . 0.93 109.478 178.065 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 274' ' ' THR . . . . . . . . . . . . . 93.2 m -66.54 -50.62 62.57 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.792 -0.64 . . . . 0.46 111.663 179.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 275' ' ' ILE . . . . . 0.581 HG13 ' HE1' ' A' ' 231' ' ' MET . 13.6 tt -58.94 -49.67 82.31 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-N 116.816 -0.174 . . . . 1.05 111.125 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 13.2 m -62.06 -47.65 83.73 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.795 0.331 . . . . 0.44 111.037 179.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 277' ' ' ASP . . . . . 0.527 ' HB2' ' O ' ' A' ' 273' ' ' GLU . 4.4 t70 -53.31 -55.36 25.36 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 115.998 -0.546 . . . . 0.46 111.193 179.575 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 278' ' ' VAL . . . . . 0.951 HG22 ' HB2' ' A' ' 228' ' ' SER . 84.0 t -64.37 -40.53 89.38 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 CA-C-N 116.405 -0.361 . . . . 0.63 111.375 179.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 25.2 tp -62.73 -38.93 92.44 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.831 0.348 . . . . 0.88 111.644 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 91.5 t -82.73 -41.71 17.65 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 N-CA-C 112.249 0.463 . . . . 0.73 112.249 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 55.3 mtp180 -69.28 -28.02 65.93 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 112.959 0.725 . . . . 0.72 112.959 -178.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 282' ' ' THR . . . . . . . . . . . . . 82.0 p -93.67 -12.38 29.46 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 112.485 0.55 . . . . 0.68 112.485 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 4.4 mptp? -129.17 34.44 4.41 Favored 'General case' 0 C--N 1.33 -0.259 0 O-C-N 122.321 -0.237 . . . . 0.83 111.423 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 41.4 ttt180 -50.75 -53.07 34.69 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 116.291 -0.413 . . . . 1.25 111.867 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -59.27 -52.15 66.89 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 116.292 -0.413 . . . . 0.71 111.863 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 286' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -62.18 -42.74 99.56 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.492 0.553 . . . . 0.72 112.492 -179.04 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 287' ' ' LEU . . . . . 0.423 HD13 ' HA2' ' A' ' 292' ' ' GLY . 2.1 mm? -66.51 -49.77 65.45 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 111.719 0.266 . . . . 1.12 111.719 -179.516 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 5.5 p -65.56 -31.18 52.68 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-O 120.785 0.326 . . . . 0.74 111.261 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 11.8 ttmt -74.91 -30.69 61.35 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 120.79 0.328 . . . . 1.72 111.302 179.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.89 9.05 43.02 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 112.341 0.497 . . . . 0.65 112.341 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 291' ' ' ARG . . . . . 0.464 ' HB3' ' HB2' ' A' ' 294' ' ' ASP . 0.0 OUTLIER 62.57 24.87 14.82 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 112.767 0.654 . . . . 0.95 112.767 179.013 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 292' ' ' GLY . . . . . 0.423 ' HA2' HD13 ' A' ' 287' ' ' LEU . . . 56.07 -115.32 5.95 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 115.27 0.868 . . . . 0.47 115.27 178.533 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 293' ' ' TRP . . . . . 0.564 ' O ' HG23 ' A' ' 297' ' ' VAL . 88.8 m95 -65.83 -41.22 92.04 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 112.713 0.635 . . . . 0.88 112.713 -178.322 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 294' ' ' ASP . . . . . 0.464 ' HB2' ' HB3' ' A' ' 291' ' ' ARG . 27.6 m-20 -52.35 -49.67 63.86 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.086 0.47 . . . . 0.4 111.253 179.568 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -71.71 -33.74 63.21 Favored Glycine 0 CA--C 1.521 0.436 0 C-N-CA 120.84 -0.695 . . . . 0.29 112.598 179.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 296' ' ' PHE . . . . . 0.427 ' HB2' ' CH2' ' A' ' 242' ' ' TRP . 0.9 OUTLIER -66.77 -47.39 72.34 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 120.733 0.302 . . . . 0.4 111.759 179.893 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 297' ' ' VAL . . . . . 0.564 HG23 ' O ' ' A' ' 293' ' ' TRP . 23.7 m -68.06 -40.89 83.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 112.477 0.547 . . . . 1.08 112.477 -178.556 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 298' ' ' GLU . . . . . 0.436 ' HA ' ' OE1' ' A' ' 298' ' ' GLU . 0.0 OUTLIER -71.55 -30.21 65.63 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 120.538 -0.465 . . . . 0.61 112.079 -179.509 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 299' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -69.19 -41.97 76.43 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.83 0.348 . . . . 0.53 110.539 178.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 300' ' ' PHE . . . . . 0.595 ' CZ ' ' HB3' ' A' ' 242' ' ' TRP . 81.8 m-85 . . . . . 0 CA--C 1.539 0.542 0 N-CA-C 112.647 0.61 . . . . 0.48 112.647 -179.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 . . . . . 0 CA--C 1.53 0.199 0 CA-C-O 120.49 0.186 . . . . 0.55 111.285 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 23' ' ' PHE . . . . . 0.552 ' CE1' HG22 ' A' ' 230' ' ' VAL . 0.2 OUTLIER -60.38 -32.93 71.76 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 121.057 0.456 . . . . 0.44 110.528 179.549 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 24' ' ' ALA . . . . . 0.535 ' N ' ' HD1' ' B' ' 23' ' ' PHE . . . -72.8 -37.49 67.54 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 115.733 -0.667 . . . . 0.82 110.252 179.362 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.3 -42.59 99.07 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 109.674 -0.491 . . . . 0.99 109.674 178.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 26' ' ' GLN . . . . . 0.41 ' O ' HG13 ' B' ' 30' ' ' ILE . 0.1 OUTLIER -64.29 -54.44 33.18 Favored 'General case' 0 C--O 1.227 -0.125 0 CA-C-N 115.692 -0.685 . . . . 0.36 110.518 178.473 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . 0.471 HD11 HG13 ' A' ' 230' ' ' VAL . 48.9 mt -57.6 -35.23 70.15 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.855 0.36 . . . . 1.07 110.746 179.102 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 28' ' ' ARG . . . . . 0.513 ' HA ' HG13 ' A' ' 234' ' ' VAL . 65.5 ttt180 -60.86 -54.41 45.47 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 109.371 -0.603 . . . . 0.76 109.371 177.59 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -61.48 -41.14 96.81 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.725 -0.671 . . . . 1.25 111.18 178.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . 0.412 ' O ' HG22 ' B' ' 34' ' ' VAL . 95.6 mt -63.7 -44.05 98.27 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 N-CA-C 110.054 -0.35 . . . . 1.01 110.054 178.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . 0.54 ' HA3' ' HA ' ' A' ' 244' ' ' ARG . . . -60.68 -46.97 93.42 Favored Glycine 0 C--N 1.333 0.372 0 C-N-CA 120.645 -0.788 . . . . 0.28 111.674 178.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 85.0 m-20 -60.4 -36.93 79.27 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 121.196 0.522 . . . . 0.69 110.133 178.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 16.2 tppt? -68.05 -50.47 55.04 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 115.752 -0.658 . . . . 1.31 110.47 178.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 34' ' ' VAL . . . . . 0.412 HG22 ' O ' ' B' ' 30' ' ' ILE . 77.0 t -59.66 -42.26 87.87 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-O 120.943 0.402 . . . . 0.76 111.067 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 35' ' ' TYR . . . . . 0.48 ' N ' ' HA3' ' A' ' 243' ' ' GLY . 0.1 OUTLIER -57.9 -45.74 85.99 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 121.258 0.552 . . . . 1.04 109.907 178.479 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 36' ' ' CYS . . . . . . . . . . . . . 5.9 t -70.69 -26.09 63.26 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 115.905 -0.589 . . . . 0.6 111.17 179.114 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 37.3 m -71.61 -40.52 69.75 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 112.755 0.65 . . . . 0.65 112.755 -179.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 38' ' ' TRP . . . . . . . . . . . . . 99.3 m95 -85.64 -35.0 21.22 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.222 0.453 . . . . 0.51 112.222 -178.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 65.4 p . . . . . 0 N--CA 1.468 0.455 0 N-CA-C 111.644 0.238 . . . . 1.04 111.644 179.754 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 45.1 m-20 . . . . . 0 N--CA 1.468 0.433 0 N-CA-C 112.022 0.378 . . . . 1.15 112.022 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -71.09 -45.05 64.45 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 120.892 0.377 . . . . 1.77 111.207 178.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 41.3 tp -69.92 -32.98 71.56 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-N 116.387 -0.37 . . . . 1.31 111.824 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -55.55 -50.44 70.03 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 113.174 0.805 . . . . 0.56 113.174 -179.445 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 60.0 mtp85 -54.63 -51.91 63.9 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 112.882 0.697 . . . . 0.69 112.882 -178.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . 0.49 ' HG3' ' CB ' ' A' ' 183' ' ' ALA . 4.9 tt0 -66.9 -43.84 82.33 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.082 -0.508 . . . . 0.72 111.193 -179.24 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 31.1 m -61.57 -47.57 84.88 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.856 -0.611 . . . . 0.31 111.101 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.726 HD12 ' HG3' ' A' ' 273' ' ' GLU . 27.9 tp -59.52 -47.82 84.03 Favored 'General case' 0 C--O 1.222 -0.373 0 CA-C-N 115.913 -0.585 . . . . 1.19 111.517 -179.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -58.5 -50.41 73.86 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 120.601 0.239 . . . . 0.56 111.521 -179.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . 0.41 HD12 ' HB1' ' A' ' 190' ' ' ALA . 52.2 mt -58.05 -52.07 62.93 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-N 116.541 -0.299 . . . . 1.12 111.565 179.51 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.493 HD12 HG23 ' A' ' 276' ' ' THR . 88.2 mt -67.31 -54.86 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 N-CA-C 112.787 0.662 . . . . 0.97 112.787 -179.323 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 6.7 t -53.52 -41.23 66.15 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 120.775 0.322 . . . . 0.29 111.302 -178.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . 0.488 ' HD2' ' HA ' ' A' ' 165' ' ' ARG . 3.6 tpt180 -71.92 -45.93 59.4 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 120.344 -0.542 . . . . 0.79 110.775 179.28 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' TYR . . . . . 0.675 ' HE1' ' HA ' ' A' ' 195' ' ' ARG . 65.4 t80 -57.92 -49.33 77.13 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 111.561 0.208 . . . . 0.36 111.561 179.11 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 6.4 mp -60.82 -42.73 98.27 Favored 'General case' 0 C--O 1.226 -0.141 0 CA-C-N 116.717 -0.22 . . . . 0.97 110.566 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 1.9 ttt180 -65.28 -43.72 90.31 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 121.176 0.513 . . . . 0.7 110.457 178.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -60.44 -54.56 44.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.34 -0.846 . . . . 0.45 110.337 178.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 23.4 mm-40 -63.77 -35.8 81.79 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.09 -0.505 . . . . 0.38 111.085 179.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.342 0 CA-C-O 121.083 0.468 . . . . 0.59 111.496 179.186 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . 0.518 ' O ' ' HA3' ' A' ' 187' ' ' GLY . . . . . . . . 0 CA--C 1.531 0.216 0 CA-C-O 121.26 0.553 . . . . 0.43 110.642 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -78.55 -71.06 1.26 Allowed Glycine 0 CA--C 1.527 0.823 0 N-CA-C 115.16 0.824 . . . . 0.46 115.16 -178.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -68.49 -57.81 5.26 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 112.774 0.657 . . . . 0.61 112.774 -177.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . 0.481 ' HB3' ' OE1' ' A' ' 158' ' ' GLN . . . -72.08 -34.11 68.43 Favored 'General case' 0 C--O 1.221 -0.426 0 C-N-CA 120.466 -0.494 . . . . 1.09 110.265 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . 0.518 ' HA3' ' O ' ' A' ' 183' ' ' ALA . . . -62.14 -43.66 98.83 Favored Glycine 0 CA--C 1.52 0.393 0 C-N-CA 120.828 -0.701 . . . . 0.35 112.601 179.166 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 3.0 tmt_? -62.38 -53.78 49.96 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.84 0.32 . . . . 0.68 110.601 179.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' ARG . . . . . 0.491 ' O ' ' HG2' ' A' ' 192' ' ' GLU . 47.6 mtm180 -63.4 -44.22 95.3 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.233 -0.44 . . . . 0.54 111.933 -179.472 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . 0.51 ' HB2' ' HB3' ' A' ' 293' ' ' TRP . . . -68.47 -45.48 72.33 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.179 0.437 . . . . 1.05 112.179 -179.206 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' LEU . . . . . 0.449 ' CD1' ' HB2' ' A' ' 166' ' ' TYR . 27.3 tp -65.91 -38.36 88.49 Favored 'General case' 0 N--CA 1.463 0.177 0 C-N-CA 120.411 -0.516 . . . . 1.17 111.813 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' GLU . . . . . 0.491 ' HG2' ' O ' ' A' ' 189' ' ' ARG . 9.3 pt-20 -66.61 -36.73 83.31 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 120.433 -0.507 . . . . 0.72 110.549 179.52 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' THR . . . . . 0.607 HG21 ' HA ' ' A' ' 297' ' ' VAL . 20.7 m -73.73 -46.75 44.02 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.129 -0.487 . . . . 0.84 110.247 179.512 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 14.6 tp -60.74 -38.35 84.83 Favored 'General case' 0 N--CA 1.457 -0.125 0 CA-C-N 115.75 -0.659 . . . . 1.09 110.261 179.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . 0.675 ' HA ' ' HE1' ' A' ' 166' ' ' TYR . 46.2 ttm105 -61.85 -51.15 69.4 Favored 'General case' 0 C--O 1.223 -0.293 0 CA-C-N 116.072 -0.513 . . . . 0.38 111.07 178.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 7.3 tpm_? -69.16 -53.03 22.21 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 112.828 0.677 . . . . 0.57 112.828 -179.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . 0.438 HG23 ' HB3' ' A' ' 300' ' ' PHE . 46.5 t -63.72 -50.63 77.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 N-CA-C 112.028 0.381 . . . . 0.92 112.028 -178.505 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -57.78 -50.35 66.31 Favored Glycine 0 C--N 1.333 0.402 0 C-N-CA 120.976 -0.631 . . . . 0.26 111.976 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -54.28 -40.74 68.12 Favored 'General case' 0 CA--C 1.526 0.054 0 N-CA-C 109.992 -0.373 . . . . 0.41 109.992 178.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -63.2 -50.68 60.98 Favored Glycine 0 CA--C 1.522 0.525 0 C-N-CA 120.831 -0.699 . . . . 0.35 111.85 178.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 60.2 t -60.25 -42.28 89.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-O 120.837 0.351 . . . . 0.97 110.995 178.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' GLN . . . . . 0.643 ' HG3' ' HB3' ' A' ' 250' ' ' SER . 25.8 mt-30 -66.91 -42.4 85.51 Favored 'General case' 0 C--O 1.223 -0.314 0 CA-C-N 116.033 -0.53 . . . . 0.45 112.088 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' ARG . . . . . 0.496 ' HD3' ' OE1' ' A' ' 206' ' ' GLU . 0.0 OUTLIER -70.35 -37.49 74.65 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.814 0.34 . . . . 0.35 110.493 179.476 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 16.1 m-80 -67.88 -47.73 68.05 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-O 121.15 0.5 . . . . 1.13 110.489 178.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 86.9 m-70 -101.04 35.88 2.11 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.183 -0.462 . . . . 0.57 111.328 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . 0.512 ' HG3' ' CZ ' ' A' ' 254' ' ' PHE . 2.6 tt0 -57.49 -48.84 78.16 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.274 -0.421 . . . . 0.47 111.562 -179.538 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 45.9 p -64.95 -39.39 93.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.334 -0.394 . . . . 1.05 111.646 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -61.19 -43.27 99.15 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 121.138 0.494 . . . . 0.55 110.483 179.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' PHE . . . . . 0.504 ' O ' ' HG ' ' A' ' 213' ' ' LEU . 21.9 m-85 -74.52 -39.1 62.59 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.949 -0.569 . . . . 0.53 110.295 179.147 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -60.09 -46.1 90.72 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.151 -0.477 . . . . 1.12 110.277 178.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -63.69 -39.22 97.3 Favored Glycine 0 C--N 1.335 0.516 0 N-CA-C 111.031 -0.827 . . . . 0.35 111.031 177.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 212' ' ' MET . . . . . 0.635 ' HA ' ' HE2' ' A' ' 215' ' ' LYS . 9.9 tpp -62.12 -40.4 95.77 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 109.718 -0.475 . . . . 1.07 109.718 178.182 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . 0.504 ' HG ' ' O ' ' A' ' 209' ' ' PHE . 40.7 mt -59.09 -41.29 87.73 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.372 -0.376 . . . . 1.0 111.169 178.663 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.74 -44.6 96.47 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.086 -0.506 . . . . 1.23 110.886 179.459 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 215' ' ' LYS . . . . . 0.635 ' HE2' ' HA ' ' A' ' 212' ' ' MET . 32.8 mtmt -73.13 -33.59 65.61 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 116.222 -0.444 . . . . 1.07 111.798 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . 0.44 ' HB3' HG12 ' A' ' 218' ' ' ILE . 35.9 mt -65.32 143.48 57.74 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 121.254 0.55 . . . . 1.22 112.465 -179.602 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 217' ' ' ASP . . . . . 0.424 ' O ' ' HG3' ' A' ' 219' ' ' LYS . 0.3 OUTLIER -112.45 33.23 5.05 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.798 -0.637 . . . . 0.48 110.719 179.523 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 218' ' ' ILE . . . . . 0.44 HG12 ' HB3' ' A' ' 216' ' ' LEU . 27.5 mm -66.1 112.43 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 CA-C-N 116.549 -0.296 . . . . 1.16 111.29 -179.658 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . 0.424 ' HG3' ' O ' ' A' ' 217' ' ' ASP . 21.2 mtmm -134.33 -43.57 0.78 Allowed 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 112.15 0.426 . . . . 0.68 112.15 -179.426 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -128.9 -176.37 3.83 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 112.737 0.643 . . . . 0.69 112.737 -177.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . 0.562 ' O ' HG21 ' A' ' 224' ' ' VAL . 1.2 mp0 -61.37 -22.31 64.85 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 112.743 0.646 . . . . 0.72 112.743 -179.055 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -70.19 -27.25 73.13 Favored Glycine 0 CA--C 1.524 0.61 0 C-N-CA 120.402 -0.904 . . . . 0.36 112.999 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -70.12 -31.29 68.76 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 112.779 0.659 . . . . 0.4 112.779 -179.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . 0.562 HG21 ' O ' ' A' ' 221' ' ' GLU . 3.8 m -56.56 -27.37 25.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 N-CA-C 112.122 0.416 . . . . 1.07 112.122 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . 0.467 ' O ' ' HG3' ' A' ' 229' ' ' ARG . 7.9 mptt -64.93 -42.49 94.63 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.037 0.446 . . . . 1.08 110.184 178.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 226' ' ' SER . . . . . 0.65 ' HA ' ' HE ' ' A' ' 229' ' ' ARG . 31.6 m -70.71 -36.68 73.34 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.228 -0.442 . . . . 0.8 109.877 178.478 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 227' ' ' PHE . . . . . . . . . . . . . 16.5 t80 -61.94 -40.68 96.36 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.767 -0.651 . . . . 0.71 109.631 178.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 49.2 m -65.24 -38.17 89.52 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.72 -0.673 . . . . 0.51 109.954 178.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 229' ' ' ARG . . . . . 0.65 ' HE ' ' HA ' ' A' ' 226' ' ' SER . 61.3 mtm180 -59.65 -37.51 78.9 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.239 -0.437 . . . . 0.86 109.925 178.187 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . 0.517 HG21 ' CE1' ' B' ' 23' ' ' PHE . 44.4 t -59.42 -53.54 46.73 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.142 0 N-CA-C 109.311 -0.625 . . . . 1.0 109.311 177.433 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 231' ' ' MET . . . . . 0.583 ' HE3' HG22 ' A' ' 275' ' ' ILE . 1.5 ttp -56.15 -45.23 79.7 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 115.463 -0.79 . . . . 0.95 111.01 178.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 80.6 t -62.75 -42.32 95.77 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-O 120.901 0.381 . . . . 1.24 110.923 178.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 9.2 t-80 -69.85 -35.58 74.84 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 116.515 -0.311 . . . . 0.73 111.221 179.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . 0.507 HG22 ' O ' ' A' ' 230' ' ' VAL . 39.5 t -54.19 -37.01 34.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 CA-C-O 120.974 0.416 . . . . 0.98 111.48 179.351 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 235' ' ' PHE . . . . . 0.592 ' CE1' ' HA ' ' A' ' 240' ' ' THR . 72.9 m-85 -102.26 24.55 10.07 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 112.007 0.373 . . . . 0.76 112.007 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . 0.419 ' HA ' ' HD2' ' A' ' 236' ' ' LYS . 8.2 tptp -70.22 -20.63 63.08 Favored 'General case' 0 CA--C 1.537 0.462 0 O-C-N 122.241 -0.287 . . . . 1.3 111.355 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 23.8 p-10 -82.22 -8.29 59.64 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 120.789 0.328 . . . . 0.73 110.869 179.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 83.05 9.92 83.53 Favored Glycine 0 CA--C 1.522 0.475 0 C-N-CA 120.99 -0.624 . . . . 0.49 114.039 178.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 33.5 t -102.23 91.08 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.441 0.638 . . . . 1.14 111.187 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 240' ' ' THR . . . . . 0.592 ' HA ' ' CE1' ' A' ' 235' ' ' PHE . 3.1 m -80.13 73.27 6.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.875 -0.602 . . . . 1.28 111.439 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 38.3 m-20 -80.11 140.87 36.24 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.928 0.394 . . . . 0.57 111.885 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 242' ' ' TRP . . . . . 0.463 ' HB3' ' CE2' ' A' ' 300' ' ' PHE . 35.4 m95 -57.96 -40.03 79.55 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.981 -0.554 . . . . 0.59 111.367 179.538 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -61.69 -27.43 68.25 Favored Glycine 0 CA--C 1.521 0.467 0 C-N-CA 120.864 -0.684 . . . . 0.3 112.135 178.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 244' ' ' ARG . . . . . 0.54 ' HG2' ' HA3' ' B' ' 31' ' ' GLY . 71.9 mtt180 -74.81 -46.03 39.46 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 110.0 -0.37 . . . . 0.62 110.0 178.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . 0.512 HG23 HD11 ' A' ' 279' ' ' LEU . 83.7 mt -58.2 -47.33 87.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-N 115.674 -0.694 . . . . 1.02 109.899 179.046 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 83.9 t -64.82 -38.41 82.66 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-N 115.87 -0.604 . . . . 1.04 110.059 178.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 17.0 m -60.68 -41.5 95.21 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.712 0.291 . . . . 0.97 110.217 178.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 248' ' ' LEU . . . . . 0.553 HD23 HD13 ' B' ' 27' ' ' LEU . 64.3 mt -63.02 -43.89 97.47 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 121.043 0.449 . . . . 1.35 109.842 177.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 249' ' ' ILE . . . . . 0.489 HG12 ' O ' ' A' ' 245' ' ' ILE . 41.6 mm -63.01 -40.46 89.12 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 CA-C-O 121.35 0.595 . . . . 1.08 109.579 177.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 250' ' ' SER . . . . . 0.643 ' HB3' ' HG3' ' A' ' 202' ' ' GLN . 38.8 m -61.57 -47.63 84.63 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 115.243 -0.89 . . . . 0.37 109.624 178.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 251' ' ' PHE . . . . . 0.514 ' O ' HG21 ' A' ' 255' ' ' VAL . 11.1 t80 -60.81 -45.4 94.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.452 -0.795 . . . . 0.55 109.579 178.155 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -55.66 -48.07 73.65 Favored Glycine 0 C--N 1.335 0.523 0 C-N-CA 121.151 -0.547 . . . . 0.25 111.974 178.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 253' ' ' ALA . . . . . 0.54 ' O ' ' HG3' ' A' ' 257' ' ' LYS . . . -62.1 -34.69 76.8 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 120.737 0.303 . . . . 0.31 111.069 178.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 254' ' ' PHE . . . . . 0.512 ' CZ ' ' HG3' ' A' ' 206' ' ' GLU . 2.4 t80 -72.18 -41.5 66.93 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 121.08 0.467 . . . . 0.52 110.45 178.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 255' ' ' VAL . . . . . 0.514 HG21 ' O ' ' A' ' 251' ' ' PHE . 81.1 t -65.19 -36.25 77.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 N-CA-C 109.047 -0.723 . . . . 1.03 109.047 177.533 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -62.69 -36.76 83.96 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 115.544 -0.753 . . . . 0.31 109.61 178.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 257' ' ' LYS . . . . . 0.54 ' HG3' ' O ' ' A' ' 253' ' ' ALA . 54.7 mttm -60.66 -43.54 97.5 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.033 -0.531 . . . . 0.53 109.65 177.571 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 258' ' ' HIS . . . . . 0.485 ' HB2' HD12 ' A' ' 213' ' ' LEU . 34.7 t60 -57.09 -44.36 83.11 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.824 -0.626 . . . . 0.85 110.844 178.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 94.3 mt -71.04 -40.77 71.5 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 120.99 0.424 . . . . 1.23 111.404 179.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -65.85 -27.78 68.49 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 120.646 0.26 . . . . 0.6 111.481 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 51.2 m -62.84 -21.66 66.11 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 116.356 -0.384 . . . . 0.45 111.414 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 11.3 m -120.35 23.58 4.83 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-N 116.289 -0.414 . . . . 1.05 111.44 179.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 54.4 m-80 58.03 45.33 18.09 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 112.888 0.699 . . . . 1.63 112.888 179.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -109.46 37.65 2.55 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 122.176 -0.328 . . . . 0.89 111.678 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 265' ' ' GLU . . . . . 0.602 ' HA ' HD11 ' A' ' 268' ' ' ILE . 13.3 tt0 -58.04 -28.62 64.66 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 111.975 0.361 . . . . 0.74 111.975 -179.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 15.5 p -62.17 -18.68 61.69 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.189 -0.459 . . . . 0.87 111.212 179.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 267' ' ' PHE . . . . . 0.409 ' C ' ' HD2' ' A' ' 270' ' ' PRO . 90.1 m-85 -101.94 -19.0 15.42 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 121.05 0.453 . . . . 0.84 110.242 177.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 268' ' ' ILE . . . . . 0.602 HD11 ' HA ' ' A' ' 265' ' ' GLU . 78.9 mt -66.9 -43.86 89.18 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-N 115.767 -0.651 . . . . 1.1 110.599 179.605 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 269' ' ' GLU . . . . . 0.774 ' HB2' ' HD3' ' A' ' 270' ' ' PRO . 45.2 mt-10 -59.47 -57.3 27.96 Favored Pre-proline 0 CA--C 1.54 0.577 0 CA-C-N 116.271 -0.422 . . . . 0.52 110.54 178.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 270' ' ' PRO . . . . . 0.774 ' HD3' ' HB2' ' A' ' 269' ' ' GLU . 66.4 Cg_exo -54.0 -35.14 79.91 Favored 'Trans proline' 0 C--N 1.362 1.261 0 C-N-CA 122.137 1.891 . . . . 0.83 112.212 178.36 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 271' ' ' LEU . . . . . . . . . . . . . 51.1 tp -68.54 -54.57 15.85 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.312 -0.404 . . . . 1.05 110.073 178.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -57.6 -40.47 79.15 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 116.282 -0.417 . . . . 1.02 110.918 179.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 273' ' ' GLU . . . . . 0.726 ' HG3' HD12 ' A' ' 160' ' ' LEU . 0.7 OUTLIER -66.43 -44.19 83.57 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.119 -0.491 . . . . 0.33 110.302 178.499 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 274' ' ' THR . . . . . . . . . . . . . 67.5 m -61.46 -43.16 99.35 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-O 120.905 0.383 . . . . 0.93 110.195 178.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 275' ' ' ILE . . . . . 0.583 HG22 ' HE3' ' A' ' 231' ' ' MET . 96.7 mt -59.05 -53.98 40.45 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-N 115.973 -0.558 . . . . 1.08 110.696 178.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 276' ' ' THR . . . . . 0.521 HG22 ' HA ' ' A' ' 160' ' ' LEU . 49.9 m -56.76 -47.08 80.89 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.299 -0.41 . . . . 0.93 110.77 179.476 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 277' ' ' ASP . . . . . 0.599 ' O ' ' HB2' ' A' ' 281' ' ' ARG . 28.0 t70 -55.82 -59.21 5.2 Favored 'General case' 0 C--O 1.222 -0.358 0 CA-C-N 115.632 -0.713 . . . . 0.46 111.157 179.442 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 84.4 t -58.7 -36.98 63.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-O 120.905 0.383 . . . . 1.06 111.384 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 279' ' ' LEU . . . . . 0.512 HD11 HG23 ' A' ' 245' ' ' ILE . 26.3 tp -63.95 -47.19 81.45 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 116.333 -0.394 . . . . 1.32 112.024 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 60.8 t -80.89 -42.18 20.11 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 N-CA-C 112.272 0.471 . . . . 1.09 112.272 -179.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 281' ' ' ARG . . . . . 0.599 ' HB2' ' O ' ' A' ' 277' ' ' ASP . 2.7 ttt180 -56.49 -43.41 79.63 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 112.936 0.717 . . . . 1.02 112.936 -179.393 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 282' ' ' THR . . . . . . . . . . . . . 51.9 p -83.0 -23.7 33.19 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 113.143 0.794 . . . . 0.62 113.143 -179.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . 0.487 ' HZ1' ' HA ' ' A' ' 279' ' ' LEU . 1.5 mttp -118.04 39.16 3.46 Favored 'General case' 0 C--N 1.329 -0.307 0 O-C-N 122.068 -0.395 . . . . 1.03 111.905 -179.062 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 284' ' ' ARG . . . . . 0.418 HH11 ' HD3' ' A' ' 284' ' ' ARG . 31.0 ttp180 -58.65 -48.11 82.16 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.109 -0.496 . . . . 1.44 111.932 -179.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -68.41 -46.08 70.89 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 116.574 -0.285 . . . . 0.52 111.755 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 286' ' ' TRP . . . . . . . . . . . . . 1.8 t90 -61.65 -45.97 91.78 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 112.023 0.379 . . . . 0.6 112.023 -179.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -63.37 -52.25 62.49 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.15 0.426 . . . . 1.06 112.15 -179.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 6.8 p -61.8 -30.74 49.09 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 CA-C-O 120.784 0.326 . . . . 1.19 111.787 -179.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 10.6 ttmt -69.55 -38.78 77.61 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 120.971 0.415 . . . . 1.33 111.121 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 290' ' ' GLN . . . . . 0.445 ' HB3' ' HZ2' ' A' ' 242' ' ' TRP . 0.3 OUTLIER -91.6 22.45 4.05 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 112.231 0.456 . . . . 0.95 112.231 -179.44 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 8.7 mpt_? 61.67 17.61 8.83 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 112.391 0.515 . . . . 0.98 112.391 179.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 58.81 -120.27 21.67 Favored Glycine 0 CA--C 1.523 0.566 0 CA-C-O 121.436 0.464 . . . . 0.52 113.997 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 293' ' ' TRP . . . . . 0.51 ' HB3' ' HB2' ' A' ' 190' ' ' ALA . 84.9 m95 -65.44 -28.56 69.32 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.717 0.636 . . . . 0.57 112.717 -178.74 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 294' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.38 -45.24 91.99 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 121.075 0.464 . . . . 0.56 110.595 179.009 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -69.28 -30.89 71.44 Favored Glycine 0 CA--C 1.518 0.259 0 C-N-CA 120.472 -0.871 . . . . 0.33 111.252 178.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 296' ' ' PHE . . . . . 0.458 ' HB2' ' CZ3' ' A' ' 242' ' ' TRP . 2.5 t80 -69.62 -48.44 59.99 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 115.7 -0.25 . . . . 0.44 111.512 179.013 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 297' ' ' VAL . . . . . 0.607 ' HA ' HG21 ' A' ' 193' ' ' THR . 26.4 m -66.2 -33.83 66.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 N-CA-C 112.113 0.412 . . . . 1.1 112.113 -179.165 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -76.11 -33.08 59.47 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 120.624 0.25 . . . . 1.13 111.052 179.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 299' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -69.7 -38.23 76.88 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.025 0.441 . . . . 0.54 110.456 178.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 300' ' ' PHE . . . . . 0.463 ' CE2' ' HB3' ' A' ' 242' ' ' TRP . 91.2 m-85 . . . . . 0 C--N 1.329 -0.299 0 CA-C-O 121.206 0.527 . . . . 0.49 110.691 179.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 . . . . . 0 CA--C 1.533 0.311 0 N-CA-C 111.537 0.199 . . . . 0.79 111.537 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 23' ' ' PHE . . . . . 0.517 ' CE1' HG21 ' A' ' 230' ' ' VAL . 0.2 OUTLIER -62.17 -33.21 74.09 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.763 0.316 . . . . 0.53 111.634 -179.84 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 24' ' ' ALA . . . . . 0.512 ' N ' ' HD1' ' B' ' 23' ' ' PHE . . . -75.63 -36.32 60.26 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.236 0.541 . . . . 0.54 109.872 179.274 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -69.25 -43.02 74.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.618 -0.719 . . . . 0.57 110.198 178.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -60.24 -48.72 80.55 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.074 -0.512 . . . . 0.64 110.854 179.396 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . 0.553 HD13 HD23 ' A' ' 248' ' ' LEU . 89.2 mt -64.73 -33.4 75.89 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 120.92 0.391 . . . . 1.05 110.324 178.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 28' ' ' ARG . . . . . . . . . . . . . 3.6 tmt_? -64.46 -45.73 86.18 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 121.215 0.531 . . . . 1.08 109.722 177.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 33.4 mtpt -71.27 -45.19 63.72 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 115.672 -0.695 . . . . 0.72 111.647 179.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 96.7 mt -62.52 -43.44 98.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-O 120.722 0.296 . . . . 1.09 110.324 179.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . 0.54 ' HA3' ' HG2' ' A' ' 244' ' ' ARG . . . -59.72 -50.25 69.73 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.807 -0.711 . . . . 0.31 112.582 179.437 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -65.81 -32.11 73.45 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.749 0.275 . . . . 0.56 110.754 179.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.9 -52.0 58.89 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 121.097 0.475 . . . . 1.27 109.738 178.307 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 55.2 t -63.04 -45.1 99.66 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-N 115.494 -0.775 . . . . 1.07 110.53 178.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -54.98 -47.05 75.1 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 115.607 -0.724 . . . . 0.69 111.316 179.319 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 36' ' ' CYS . . . . . . . . . . . . . 73.0 m -62.45 -45.07 94.72 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 120.663 0.268 . . . . 0.52 111.303 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 13.1 m -60.4 -37.55 81.19 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 116.316 -0.402 . . . . 1.32 112.033 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 38' ' ' TRP . . . . . . . . . . . . . 93.9 m95 -87.65 -29.47 21.15 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 112.637 0.606 . . . . 0.92 112.637 -179.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 42.2 t . . . . . 0 N--CA 1.471 0.581 0 N-CA-C 111.982 0.364 . . . . 0.6 111.982 179.675 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 2.8 t70 . . . . . 0 N--CA 1.472 0.638 0 N-CA-C 113.448 0.907 . . . . 0.52 113.448 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -49.35 -51.62 33.41 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 121.038 0.447 . . . . 0.48 112.142 -179.257 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.505 HD22 ' HB3' ' A' ' 287' ' ' LEU . 44.7 tp -84.47 -40.2 18.0 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.297 -0.41 . . . . 1.48 111.664 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . 0.483 ' OH ' ' HB2' ' A' ' 281' ' ' ARG . 0.3 OUTLIER -52.04 -44.16 64.1 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 112.203 0.446 . . . . 0.47 112.203 -179.766 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 21.5 mtm180 -60.56 -51.9 67.46 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 112.145 0.424 . . . . 0.63 112.145 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 1.8 mm100 -63.27 -40.13 96.53 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 121.239 0.542 . . . . 0.67 110.401 179.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 18.4 m -64.89 -50.1 67.89 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.414 -0.812 . . . . 0.34 111.534 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -55.96 -47.89 76.8 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.405 -0.361 . . . . 1.13 111.046 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . 0.607 ' O ' ' HB2' ' A' ' 165' ' ' ARG . 1.4 mm-40 -59.37 -47.26 86.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.402 -0.363 . . . . 0.55 111.294 179.349 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . 0.524 HG12 ' HA2' ' A' ' 187' ' ' GLY . 68.4 mt -66.04 -51.88 55.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 N-CA-C 113.114 0.783 . . . . 1.07 113.114 -179.01 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.498 HD11 HG22 ' A' ' 276' ' ' THR . 56.0 mt -60.18 -54.62 32.39 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 N-CA-C 112.232 0.456 . . . . 1.06 112.232 -178.612 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 70.4 p -59.33 -37.08 76.9 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.63 0.252 . . . . 0.4 111.077 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . 0.607 ' HB2' ' O ' ' A' ' 161' ' ' GLU . 0.0 OUTLIER -68.92 -36.78 78.39 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 120.959 -0.296 . . . . 0.68 111.256 179.099 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' TYR . . . . . 0.845 ' HE1' ' HA ' ' A' ' 195' ' ' ARG . 67.5 t80 -72.32 -49.16 36.54 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 121.237 -0.185 . . . . 0.98 111.242 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.496 ' HG ' ' O ' ' A' ' 163' ' ' ILE . 38.1 mt -55.99 -41.01 74.17 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.183 0.516 . . . . 1.07 110.316 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 3.7 tpp180 -69.83 -42.99 72.91 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.554 -0.748 . . . . 0.61 110.449 178.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . 0.494 ' HB2' ' O ' ' A' ' 165' ' ' ARG . 0.4 OUTLIER -56.85 -44.05 81.74 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 116.351 -0.386 . . . . 0.53 111.939 -179.701 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 22.5 tp60 -76.28 -32.9 59.04 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 112.034 0.383 . . . . 0.55 112.034 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . 0.845 ' HA ' ' HG2' ' A' ' 257' ' ' LYS . . . . . . . . 0 CA--C 1.537 0.449 0 N-CA-C 113.072 0.768 . . . . 0.91 113.072 -179.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . 0.669 ' O ' ' HA3' ' A' ' 187' ' ' GLY . . . . . . . . 0 C--O 1.224 -0.256 0 CA-C-O 121.118 0.485 . . . . 0.59 110.561 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -79.94 -69.76 1.38 Allowed Glycine 0 CA--C 1.522 0.496 0 C-N-CA 120.953 -0.642 . . . . 0.45 113.359 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -59.79 -56.01 27.08 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 120.653 0.263 . . . . 0.64 111.535 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -67.69 -32.92 73.91 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.949 -0.389 . . . . 1.18 109.949 179.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . 0.669 ' HA3' ' O ' ' A' ' 183' ' ' ALA . . . -62.63 -48.64 80.02 Favored Glycine 0 C--O 1.224 -0.492 0 CA-C-N 115.685 -0.688 . . . . 0.46 112.97 179.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.28 -50.75 68.88 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 117.221 0.511 . . . . 2.05 110.893 179.313 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' ARG . . . . . 0.634 ' HB3' HG23 ' A' ' 297' ' ' VAL . 4.4 mtp180 -56.31 -55.15 36.96 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-O 120.971 0.415 . . . . 0.91 111.164 179.346 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . 0.415 ' O ' ' HB2' ' A' ' 194' ' ' LEU . . . -66.98 -40.67 87.46 Favored 'General case' 0 C--O 1.219 -0.51 0 N-CA-C 113.035 0.754 . . . . 0.52 113.035 -178.767 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 14.2 tp -62.45 -44.37 96.58 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 118.475 0.579 . . . . 1.27 111.529 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -67.58 -40.11 84.84 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 121.143 0.497 . . . . 1.16 110.963 179.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' THR . . . . . 0.454 ' OG1' HG13 ' A' ' 297' ' ' VAL . 20.8 m -68.52 -47.26 67.42 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.113 -0.494 . . . . 0.98 110.204 179.035 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . 0.439 HD23 HG22 ' A' ' 249' ' ' ILE . 7.9 tp -60.12 -42.17 94.17 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 115.661 -0.7 . . . . 1.1 110.468 179.26 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . 0.845 ' HA ' ' HE1' ' A' ' 166' ' ' TYR . 0.6 OUTLIER -56.03 -54.08 49.26 Favored 'General case' 0 CA--C 1.522 -0.125 0 CA-C-O 121.243 0.545 . . . . 0.48 110.377 178.268 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 10.9 mmm180 -61.53 -54.03 48.49 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.972 -1.013 . . . . 0.99 112.36 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . 0.489 ' O ' HG22 ' A' ' 201' ' ' VAL . 99.0 t -61.36 -46.31 96.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 N-CA-C 111.899 0.333 . . . . 1.12 111.899 -179.361 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . 0.524 ' HA3' ' OH ' ' A' ' 166' ' ' TYR . . . -62.24 -50.43 65.1 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 121.244 -0.503 . . . . 0.33 112.242 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . 0.462 ' HB2' ' O ' ' A' ' 195' ' ' ARG . 0.3 OUTLIER -58.27 -43.1 87.77 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 120.856 0.36 . . . . 0.47 110.117 178.846 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -61.68 -48.36 84.81 Favored Glycine 0 CA--C 1.525 0.708 0 C-N-CA 121.021 -0.609 . . . . 0.42 112.303 178.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . 0.489 HG22 ' O ' ' A' ' 197' ' ' VAL . 71.0 t -62.37 -43.18 97.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-O 120.943 0.402 . . . . 0.81 110.607 178.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' GLN . . . . . 0.547 ' HB3' ' NH2' ' A' ' 203' ' ' ARG . 68.8 mt-30 -63.41 -55.2 26.24 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.583 -0.735 . . . . 0.74 112.098 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' ARG . . . . . 0.547 ' NH2' ' HB3' ' A' ' 202' ' ' GLN . 0.0 OUTLIER -58.15 -34.41 70.25 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 112.157 0.428 . . . . 0.48 112.157 -178.822 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 17.7 m-80 -75.34 -43.79 48.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.895 0.378 . . . . 0.8 111.489 179.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' HIS . . . . . 0.462 ' CD2' HG21 ' B' ' 30' ' ' ILE . 95.2 m-70 -100.9 35.95 2.07 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.8 0.333 . . . . 0.67 111.68 -179.598 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . 0.453 ' HG2' ' HA ' ' A' ' 203' ' ' ARG . 26.9 mm-40 -55.68 -35.64 66.25 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 112.4 0.519 . . . . 0.53 112.4 -179.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 19.4 p -63.15 -52.64 61.65 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.808 0.337 . . . . 1.17 111.6 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -63.41 -40.57 97.56 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.154 -0.475 . . . . 1.11 110.919 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' PHE . . . . . 0.425 ' CE2' ' HA ' ' A' ' 202' ' ' GLN . 25.9 m-85 -68.04 -49.49 61.09 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.094 -0.503 . . . . 0.58 111.547 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -65.31 -38.91 91.65 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 121.266 -0.174 . . . . 0.58 111.021 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -59.23 -45.71 94.95 Favored Glycine 0 C--N 1.334 0.443 0 C-N-CA 120.448 -0.882 . . . . 0.31 110.991 178.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 212' ' ' MET . . . . . 0.481 ' SD ' ' HA ' ' B' ' 23' ' ' PHE . 56.9 mtm -70.62 -33.78 71.39 Favored 'General case' 0 C--O 1.223 -0.324 0 N-CA-C 110.25 -0.278 . . . . 1.15 110.25 178.196 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . 0.442 HD21 ' HA ' ' A' ' 213' ' ' LEU . 0.3 OUTLIER -65.8 -43.84 87.47 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.351 -0.386 . . . . 0.84 111.302 179.506 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 71.9 mtp180 -66.11 -38.46 88.25 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.916 0.389 . . . . 1.15 110.84 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 54.9 mtmt -91.42 11.57 23.44 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.288 -0.415 . . . . 1.09 111.287 179.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . 0.477 HD23 HD12 ' A' ' 218' ' ' ILE . 6.5 tp -79.26 99.07 6.89 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.14 0.495 . . . . 1.06 111.361 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -83.25 32.07 0.45 Allowed 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.7 -0.682 . . . . 0.43 111.191 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 218' ' ' ILE . . . . . 0.758 HG12 ' HB3' ' A' ' 223' ' ' ASP . 36.4 mt -81.1 106.74 12.64 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-O 121.069 0.461 . . . . 0.96 110.709 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 8.2 mppt? -140.92 -24.45 0.76 Allowed 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 115.696 -0.684 . . . . 0.83 111.978 -179.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -116.28 171.1 8.04 Favored 'General case' 0 CA--C 1.533 0.296 0 O-C-N 121.875 -0.516 . . . . 1.33 111.68 -179.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -58.48 -31.45 67.85 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 120.955 0.407 . . . . 0.68 111.197 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -62.45 -26.72 68.47 Favored Glycine 0 CA--C 1.524 0.627 0 CA-C-N 115.978 -0.555 . . . . 0.51 113.117 179.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 223' ' ' ASP . . . . . 0.758 ' HB3' HG12 ' A' ' 218' ' ' ILE . 55.5 m-20 -68.66 -34.11 75.15 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 117.024 0.412 . . . . 0.38 111.488 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 16.4 t -62.23 -29.41 46.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-O 121.556 0.693 . . . . 0.55 110.16 178.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 32.2 mmtm -72.67 -33.48 66.58 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 115.533 -0.758 . . . . 0.61 110.441 179.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 226' ' ' SER . . . . . 0.442 ' O ' HG22 ' A' ' 230' ' ' VAL . 33.6 t -68.13 -38.65 82.44 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.381 0.61 . . . . 1.29 109.585 178.329 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 227' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -63.54 -38.36 90.83 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 115.211 -0.904 . . . . 0.58 109.503 178.107 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 46.8 t -62.53 -37.44 86.1 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 115.442 -0.799 . . . . 0.71 109.951 178.165 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 84.3 mtp180 -63.07 -39.67 95.4 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.013 -0.539 . . . . 0.71 109.882 178.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . 0.442 HG22 ' O ' ' A' ' 226' ' ' SER . 18.2 t -59.3 -46.14 92.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-N 116.324 -0.398 . . . . 1.0 110.5 178.143 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 231' ' ' MET . . . . . 0.512 ' HE1' HG21 ' A' ' 275' ' ' ILE . 7.3 tpp -55.33 -52.2 64.28 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.933 -0.576 . . . . 0.99 110.929 179.605 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 232' ' ' VAL . . . . . 0.518 ' O ' ' HB2' ' A' ' 236' ' ' LYS . 38.2 t -66.89 -36.71 77.85 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-N 116.262 -0.426 . . . . 0.56 111.362 179.511 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 54.0 t-80 -65.48 -52.55 52.06 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 112.057 0.392 . . . . 0.79 112.057 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 97.0 t -63.98 -39.09 84.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 N-CA-C 112.078 0.399 . . . . 1.03 112.078 -179.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 235' ' ' PHE . . . . . 0.555 ' HZ ' ' HA ' ' A' ' 245' ' ' ILE . 63.0 m-85 -91.84 10.94 26.52 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.412 0.523 . . . . 0.72 112.412 -179.397 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . 0.554 ' HE2' ' HA ' ' A' ' 236' ' ' LYS . 0.3 OUTLIER -76.0 -11.43 59.95 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 111.873 0.323 . . . . 0.9 111.873 -179.807 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -69.97 -16.73 63.24 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 120.855 0.359 . . . . 0.42 111.262 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 89.28 -19.83 37.2 Favored Glycine 0 CA--C 1.521 0.442 0 C-N-CA 121.168 -0.539 . . . . 0.47 111.959 -178.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 2.4 t -80.39 112.03 17.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.048 0.452 . . . . 1.52 111.093 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 1.9 m -94.47 91.32 6.58 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.37 -0.377 . . . . 0.92 111.046 179.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -101.56 135.22 43.44 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.77 0.319 . . . . 0.51 111.389 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 242' ' ' TRP . . . . . 0.646 ' HB3' ' CZ ' ' A' ' 300' ' ' PHE . 7.2 m95 -55.0 -44.01 74.14 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 116.311 -0.404 . . . . 0.49 111.761 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -59.21 -37.02 91.2 Favored Glycine 0 CA--C 1.524 0.619 0 C-N-CA 121.086 -0.578 . . . . 0.29 112.868 179.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 63.9 mtt180 -68.46 -43.45 77.0 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 109.777 -0.453 . . . . 0.47 109.777 178.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . 0.555 ' HA ' ' HZ ' ' A' ' 235' ' ' PHE . 84.7 mt -59.99 -50.67 79.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-N 115.58 -0.736 . . . . 0.92 111.569 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . 0.403 HG22 ' O ' ' A' ' 242' ' ' TRP . 16.1 m -67.04 -28.03 41.49 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 C-N-CA 120.769 -0.373 . . . . 1.05 111.411 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 23.1 m -61.79 -48.62 79.81 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 109.754 -0.461 . . . . 1.06 109.754 178.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -60.2 -42.47 95.19 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.063 -0.517 . . . . 1.18 110.312 178.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 249' ' ' ILE . . . . . 0.439 HG22 HD23 ' A' ' 194' ' ' LEU . 43.3 mm -63.99 -44.99 97.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 CA-C-N 116.238 -0.437 . . . . 1.17 110.499 178.521 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 250' ' ' SER . . . . . 0.434 ' HB2' ' HG3' ' A' ' 202' ' ' GLN . 54.4 p -62.19 -36.61 82.44 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.816 0.341 . . . . 0.65 110.17 178.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 251' ' ' PHE . . . . . 0.435 ' CD2' HD13 ' B' ' 27' ' ' LEU . 13.2 t80 -69.71 -40.33 76.35 Favored 'General case' 0 C--O 1.232 0.142 0 N-CA-C 108.704 -0.85 . . . . 0.57 108.704 177.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -57.76 -37.32 83.41 Favored Glycine 0 C--N 1.336 0.566 0 N-CA-C 110.683 -0.967 . . . . 0.28 110.683 177.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 253' ' ' ALA . . . . . 0.434 ' O ' ' HG3' ' A' ' 257' ' ' LYS . . . -68.68 -41.33 79.4 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 120.767 0.318 . . . . 0.39 110.185 177.332 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -63.29 -44.5 94.89 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 116.236 -0.438 . . . . 0.48 110.896 178.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 255' ' ' VAL . . . . . 0.448 HG22 HD22 ' A' ' 271' ' ' LEU . 16.3 m -70.91 -26.34 27.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-O 120.819 0.342 . . . . 0.81 110.472 178.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -66.72 -39.25 87.92 Favored 'General case' 0 C--N 1.339 0.12 0 N-CA-C 108.454 -0.943 . . . . 0.46 108.454 177.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 257' ' ' LYS . . . . . 0.845 ' HG2' ' HA ' ' A' ' 171' ' ' ALA . 24.2 mtpp -65.16 -36.52 84.47 Favored 'General case' 0 C--O 1.225 -0.199 0 CA-C-N 115.351 -0.84 . . . . 0.96 109.646 177.503 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 63.6 t60 -59.54 -49.03 79.35 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 109.957 -0.386 . . . . 0.52 109.957 177.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . 0.458 HD23 HG23 ' A' ' 218' ' ' ILE . 95.9 mt -68.79 -36.08 77.82 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.038 -0.528 . . . . 1.11 110.453 178.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 5.0 tptp -67.47 -36.57 81.41 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 120.774 0.321 . . . . 0.66 111.048 179.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 35.3 t -64.89 -25.86 68.07 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.184 -0.462 . . . . 0.62 111.325 179.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 26.8 m -107.78 11.0 9.04 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 CA-C-N 116.424 -0.353 . . . . 1.14 110.968 178.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 58.98 48.23 11.13 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 113.202 0.816 . . . . 1.95 113.202 179.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 14.7 mt-30 -114.99 36.28 3.95 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.457 -0.338 . . . . 0.82 111.064 178.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 265' ' ' GLU . . . . . 0.551 ' HA ' HD12 ' A' ' 268' ' ' ILE . 1.8 pm0 -52.62 -29.21 24.81 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 112.407 0.521 . . . . 0.55 112.407 179.412 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 9.3 p -59.96 -20.19 56.23 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 120.725 0.298 . . . . 0.87 111.049 178.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 267' ' ' PHE . . . . . 0.433 ' C ' ' HD2' ' A' ' 270' ' ' PRO . 41.7 m-85 -98.01 -18.87 18.36 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 121.109 0.48 . . . . 0.71 110.181 178.425 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 268' ' ' ILE . . . . . 0.551 HD12 ' HA ' ' A' ' 265' ' ' GLU . 72.4 mt -68.58 -39.57 80.67 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 CA-C-N 115.849 -0.614 . . . . 1.12 110.4 178.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 269' ' ' GLU . . . . . 0.695 ' HB2' ' HD3' ' A' ' 270' ' ' PRO . 1.5 mm-40 -56.38 -56.94 26.39 Favored Pre-proline 0 CA--C 1.543 0.686 0 CA-C-N 116.287 -0.415 . . . . 0.49 111.036 179.27 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 270' ' ' PRO . . . . . 0.695 ' HD3' ' HB2' ' A' ' 269' ' ' GLU . 34.7 Cg_exo -61.68 -34.89 82.91 Favored 'Trans proline' 0 C--N 1.361 1.233 0 C-N-CA 121.954 1.769 . . . . 0.37 111.435 177.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 271' ' ' LEU . . . . . 0.448 HD22 HG22 ' A' ' 255' ' ' VAL . 26.8 tp -62.61 -51.07 68.75 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.182 -0.463 . . . . 1.19 110.251 178.487 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -59.09 -41.12 87.3 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 116.104 -0.498 . . . . 0.53 110.12 178.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 273' ' ' GLU . . . . . . . . . . . . . 62.2 mm-40 -63.34 -45.48 91.01 Favored 'General case' 0 C--O 1.225 -0.189 0 CA-C-N 115.761 -0.654 . . . . 1.05 109.831 177.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 274' ' ' THR . . . . . . . . . . . . . 87.5 m -62.2 -44.02 97.51 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.917 -0.583 . . . . 0.92 111.179 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 275' ' ' ILE . . . . . 0.512 HG21 ' HE1' ' A' ' 231' ' ' MET . 94.4 mt -58.66 -50.48 78.98 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 CA-C-O 120.984 0.421 . . . . 1.05 110.286 179.008 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 276' ' ' THR . . . . . 0.498 HG22 HD11 ' A' ' 163' ' ' ILE . 24.1 m -63.12 -46.17 88.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.041 -0.527 . . . . 0.57 110.669 178.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 277' ' ' ASP . . . . . 0.422 ' CG ' HH12 ' A' ' 281' ' ' ARG . 36.1 t70 -51.69 -60.72 2.84 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.309 -0.86 . . . . 0.35 112.442 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 21.8 t -66.35 -37.25 79.25 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 N-CA-C 113.058 0.762 . . . . 0.53 113.058 -178.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 32.5 tp -70.67 -48.47 54.66 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 112.855 0.687 . . . . 1.24 112.855 -178.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 58.2 t -70.73 -34.82 58.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 N-CA-C 112.595 0.591 . . . . 0.66 112.595 -178.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 281' ' ' ARG . . . . . 0.483 ' HB2' ' OH ' ' A' ' 156' ' ' TYR . 21.9 ttp-105 -72.79 -51.39 19.21 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.407 0.521 . . . . 0.46 112.407 -179.684 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 282' ' ' THR . . . . . . . . . . . . . 10.1 m -60.6 -35.34 75.89 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 112.168 0.432 . . . . 0.69 112.168 -178.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 64.9 mmtt -115.96 38.78 3.23 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 122.225 -0.297 . . . . 0.7 111.611 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 284' ' ' ARG . . . . . 0.544 ' HG3' ' H ' ' A' ' 285' ' ' ASP . 0.2 OUTLIER -62.13 -54.01 47.28 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 112.812 0.671 . . . . 0.45 112.812 -179.066 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 285' ' ' ASP . . . . . 0.544 ' H ' ' HG3' ' A' ' 284' ' ' ARG . 0.2 OUTLIER -60.27 -39.44 86.85 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 112.128 0.418 . . . . 0.52 112.128 -178.855 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 286' ' ' TRP . . . . . 0.46 ' O ' ' HB2' ' A' ' 290' ' ' GLN . 12.4 t90 -67.14 -41.58 85.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.808 0.337 . . . . 0.55 110.921 179.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 287' ' ' LEU . . . . . 0.505 ' HB3' HD22 ' A' ' 155' ' ' LEU . 2.0 mm? -70.6 -48.4 55.36 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.298 -0.41 . . . . 1.07 112.078 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 288' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 284' ' ' ARG . 26.9 m -59.88 -37.84 73.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 N-CA-C 111.901 0.334 . . . . 0.53 111.901 -179.678 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 54.1 mttp -75.52 -23.95 56.74 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-O 120.789 0.328 . . . . 0.77 111.274 179.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 290' ' ' GLN . . . . . 0.46 ' HB2' ' O ' ' A' ' 286' ' ' TRP . 1.5 tp-100 -91.06 17.58 7.84 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.604 -0.271 . . . . 0.66 111.659 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 36.0 mtp180 64.69 15.38 9.71 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 112.025 0.38 . . . . 0.57 112.025 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 63.71 -132.47 40.81 Favored Glycine 0 CA--C 1.523 0.593 0 CA-C-O 121.462 0.479 . . . . 0.42 114.01 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 293' ' ' TRP . . . . . 0.602 ' O ' HG21 ' A' ' 297' ' ' VAL . 77.4 m95 -67.05 -25.18 66.13 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.019 0.377 . . . . 0.5 112.019 -178.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 294' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -56.73 -48.38 77.89 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 109.852 -0.425 . . . . 0.78 109.852 178.324 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -68.7 -38.85 86.28 Favored Glycine 0 C--N 1.336 0.574 0 N-CA-C 111.24 -0.744 . . . . 0.37 111.24 178.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 296' ' ' PHE . . . . . 0.511 ' HB3' ' HA ' ' A' ' 293' ' ' TRP . 0.9 OUTLIER -57.74 -45.63 85.59 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 120.769 0.318 . . . . 0.5 111.064 178.498 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 297' ' ' VAL . . . . . 0.634 HG23 ' HB3' ' A' ' 189' ' ' ARG . 78.3 t -65.8 -40.41 87.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-N 116.015 -0.539 . . . . 1.14 111.269 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -66.53 -48.26 70.3 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.207 -0.451 . . . . 0.63 111.476 179.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 299' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -62.26 -51.08 69.18 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.053 0.454 . . . . 0.61 110.843 179.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 300' ' ' PHE . . . . . 0.646 ' CZ ' ' HB3' ' A' ' 242' ' ' TRP . 49.6 m-85 . . . . . 0 C--N 1.328 -0.352 0 CA-C-N 116.091 -0.504 . . . . 0.68 112.316 -179.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 22' ' ' GLU . . . . . 0.479 ' O ' ' HB2' ' B' ' 26' ' ' GLN . 1.8 mt-10 . . . . . 0 CA--C 1.529 0.14 0 N-CA-C 112.224 0.453 . . . . 1.02 112.224 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 23' ' ' PHE . . . . . 0.499 ' HD1' ' N ' ' B' ' 24' ' ' ALA . 0.1 OUTLIER -55.74 -32.17 63.17 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 112.843 0.683 . . . . 0.45 112.843 -178.924 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 24' ' ' ALA . . . . . 0.663 ' O ' ' HB2' ' B' ' 28' ' ' ARG . . . -69.95 -51.59 31.47 Favored 'General case' 0 C--N 1.322 -0.593 0 O-C-N 122.023 -0.423 . . . . 0.99 111.713 -179.019 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -74.1 -41.41 61.7 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.108 0.41 . . . . 0.68 112.108 -179.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 26' ' ' GLN . . . . . 0.479 ' HB2' ' O ' ' B' ' 22' ' ' GLU . 1.1 tp-100 -62.04 -54.92 34.75 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.326 -0.397 . . . . 0.39 111.297 -179.396 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . 0.435 HD13 ' CD2' ' A' ' 251' ' ' PHE . 70.2 mt -63.47 -37.56 87.75 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.96 -0.296 . . . . 1.01 110.58 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 28' ' ' ARG . . . . . 0.663 ' HB2' ' O ' ' B' ' 24' ' ' ALA . 0.0 OUTLIER -57.88 -57.38 13.06 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 120.694 0.283 . . . . 0.49 111.437 179.292 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 18.8 mmmt -66.48 -35.08 79.37 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.425 -0.352 . . . . 0.58 111.563 -179.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . 0.462 HG21 ' CD2' ' A' ' 205' ' ' HIS . 43.4 mt -64.15 -42.76 96.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 N-CA-C 108.946 -0.761 . . . . 1.08 108.946 177.514 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -58.88 -49.44 78.02 Favored Glycine 0 C--N 1.334 0.449 0 CA-C-N 115.961 -0.563 . . . . 0.3 112.42 178.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -55.55 -44.91 77.24 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 121.16 0.505 . . . . 0.45 110.759 178.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 33' ' ' LYS . . . . . 0.461 ' HZ2' ' HB2' ' B' ' 33' ' ' LYS . 2.2 ttmp? -65.87 -52.34 51.08 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 115.654 -0.703 . . . . 1.53 111.098 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 40.4 t -56.33 -45.37 81.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-O 121.135 0.493 . . . . 0.79 110.741 178.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -56.69 -49.66 74.44 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 115.597 -0.729 . . . . 1.12 110.447 178.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 36' ' ' CYS . . . . . . . . . . . . . 5.9 t -66.13 -34.21 77.54 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 120.825 0.345 . . . . 1.15 111.027 179.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 52.2 m -62.85 -51.79 65.65 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 112.364 0.505 . . . . 0.76 112.364 -179.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 38' ' ' TRP . . . . . . . . . . . . . 96.7 m95 -73.65 -30.38 62.9 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.345 0.498 . . . . 0.98 112.345 -179.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 23.0 t . . . . . 0 N--CA 1.467 0.407 0 N-CA-C 111.801 0.297 . . . . 1.03 111.801 -179.913 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 . . . . . 0 N--CA 1.466 0.343 0 CA-C-O 120.83 0.348 . . . . 0.59 111.278 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -57.92 -44.99 87.21 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.056 -0.52 . . . . 0.44 110.685 178.428 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 35.0 tp -76.94 -29.3 55.56 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-O 121.323 0.582 . . . . 1.13 109.955 178.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 87.8 t80 -63.89 -30.79 71.84 Favored 'General case' 0 C--O 1.223 -0.338 0 CA-C-N 115.666 -0.697 . . . . 0.43 110.369 178.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . 0.45 HH11 ' HD3' ' A' ' 157' ' ' ARG . 45.0 mtt180 -60.72 -51.91 67.36 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.028 0.442 . . . . 0.81 110.261 178.431 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 32.1 mt-30 -59.66 -43.99 93.73 Favored 'General case' 0 N--CA 1.46 0.071 0 CA-C-N 115.701 -0.681 . . . . 1.13 109.515 178.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' SER . . . . . 0.562 ' HA ' ' CZ2' ' A' ' 293' ' ' TRP . 18.5 m -60.38 -58.67 7.49 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.191 -0.913 . . . . 0.49 111.531 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.554 ' HA ' HG21 ' A' ' 276' ' ' THR . 1.4 tm? -53.98 -49.67 68.28 Favored 'General case' 0 CA--C 1.529 0.139 0 O-C-N 123.203 0.315 . . . . 1.1 110.93 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -60.06 -53.55 56.42 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 116.488 -0.324 . . . . 0.44 111.836 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . 0.461 HD12 ' HA2' ' A' ' 187' ' ' GLY . 89.7 mt -61.82 -48.75 87.17 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 N-CA-C 112.567 0.58 . . . . 1.07 112.567 -178.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.537 ' O ' ' HG ' ' A' ' 167' ' ' LEU . 80.8 mt -63.93 -52.33 58.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 N-CA-C 112.154 0.427 . . . . 1.1 112.154 -179.038 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.87 -39.78 72.01 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 120.916 0.388 . . . . 0.36 110.534 179.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . 0.518 ' HD2' ' OE2' ' A' ' 169' ' ' GLU . 0.6 OUTLIER -65.77 -52.07 53.92 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.408 -0.36 . . . . 0.63 110.537 178.457 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' TYR . . . . . 0.822 ' HE1' ' HA ' ' A' ' 195' ' ' ARG . 81.4 t80 -55.56 -47.24 76.7 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 112.447 0.536 . . . . 0.38 112.447 -179.48 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.537 ' HG ' ' O ' ' A' ' 163' ' ' ILE . 28.0 mt -64.03 -39.1 93.34 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 120.88 -0.328 . . . . 1.1 110.641 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -66.45 -38.45 87.4 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.958 0.408 . . . . 0.47 110.301 178.297 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . 0.518 ' OE2' ' HD2' ' A' ' 165' ' ' ARG . 0.4 OUTLIER -70.26 -38.35 75.1 Favored 'General case' 0 CA--C 1.528 0.111 0 CA-C-N 116.08 -0.509 . . . . 0.62 110.767 178.58 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . 0.674 ' HG2' ' HB2' ' A' ' 253' ' ' ALA . 6.1 tp60 -68.53 -42.13 78.9 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 116.37 -0.377 . . . . 0.37 110.249 178.455 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . 0.775 ' HA ' ' HG2' ' A' ' 257' ' ' LYS . . . . . . . . 0 N--CA 1.467 0.402 0 CA-C-N 115.807 -0.633 . . . . 1.09 111.977 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . 0.565 ' O ' ' HA3' ' A' ' 187' ' ' GLY . . . . . . . . 0 CA--C 1.535 0.398 0 CA-C-O 120.86 0.362 . . . . 0.42 110.406 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -79.93 -71.5 1.26 Allowed Glycine 0 CA--C 1.528 0.886 0 C-N-CA 120.833 -0.699 . . . . 0.45 114.755 -179.051 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -70.79 -55.83 7.71 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 117.203 0.501 . . . . 0.71 111.646 -178.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -65.59 -35.24 80.25 Favored 'General case' 0 C--O 1.222 -0.342 0 CA-C-N 115.979 -0.555 . . . . 0.53 110.111 178.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . 0.565 ' HA3' ' O ' ' A' ' 183' ' ' ALA . . . -66.93 -49.9 51.02 Favored Glycine 0 C--O 1.225 -0.454 0 CA-C-N 115.762 -0.653 . . . . 0.42 112.845 179.237 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 4.2 tpt180 -55.26 -46.9 76.09 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 117.174 0.487 . . . . 1.05 110.113 178.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' ARG . . . . . 0.601 ' HB3' HG12 ' A' ' 297' ' ' VAL . 50.7 mtm180 -66.9 -40.24 87.68 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.92 -0.582 . . . . 0.41 110.616 179.275 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -65.27 -40.43 93.89 Favored 'General case' 0 C--O 1.223 -0.338 0 CA-C-N 116.334 -0.394 . . . . 0.84 111.511 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 13.6 tp -64.58 -41.0 96.55 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 110.247 -0.279 . . . . 1.19 110.247 178.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 15.8 tm-20 -65.68 -50.63 64.22 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 109.732 -0.47 . . . . 0.42 109.732 178.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' THR . . . . . 0.423 HG23 ' HA ' ' A' ' 297' ' ' VAL . 8.5 m -60.05 -43.22 95.54 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.905 -0.589 . . . . 1.05 110.974 179.46 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 7.4 tp -65.59 -41.92 92.27 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 116.233 -0.44 . . . . 1.15 111.829 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . 0.822 ' HA ' ' HE1' ' A' ' 166' ' ' TYR . 8.8 tpt180 -67.35 -38.71 85.24 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.093 0.473 . . . . 0.5 110.538 179.322 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 15.2 ttm180 -67.01 -56.71 8.95 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 115.78 -0.645 . . . . 0.57 111.999 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 34.7 t -71.56 -38.59 68.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 111.95 0.352 . . . . 0.43 111.95 -178.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . 0.627 ' O ' ' HB2' ' A' ' 202' ' ' GLN . . . -62.02 -54.04 38.12 Favored Glycine 0 C--N 1.331 0.275 0 C-N-CA 121.052 -0.595 . . . . 0.29 112.793 -179.576 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.81 -38.8 92.2 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 117.045 0.422 . . . . 0.37 110.675 179.211 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -59.86 -48.63 85.13 Favored Glycine 0 CA--C 1.524 0.626 0 C-N-CA 120.744 -0.741 . . . . 0.33 112.137 178.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 73.7 t -70.46 -42.29 78.34 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-O 120.862 0.363 . . . . 0.51 110.816 178.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' GLN . . . . . 0.627 ' HB2' ' O ' ' A' ' 198' ' ' GLY . 2.1 tt0 -58.87 -53.34 59.49 Favored 'General case' 0 C--O 1.224 -0.278 0 CA-C-N 115.652 -0.704 . . . . 0.49 111.807 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' ARG . . . . . 0.503 ' HA ' ' OE1' ' A' ' 206' ' ' GLU . 0.0 OUTLIER -64.4 -35.2 80.12 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-O 120.718 0.294 . . . . 0.4 110.393 179.779 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -65.94 -49.82 66.58 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 121.027 0.441 . . . . 0.86 110.765 178.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 72.1 m-70 -100.75 36.09 2.02 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.425 -0.352 . . . . 0.65 111.47 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . 0.503 ' OE1' ' HA ' ' A' ' 203' ' ' ARG . 3.7 tp10 -55.53 -49.0 73.79 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.222 -0.444 . . . . 0.4 111.212 -179.543 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 69.4 p -62.98 -42.8 99.94 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.983 -0.553 . . . . 0.89 111.52 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -61.8 -46.11 90.95 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.018 0.437 . . . . 0.56 110.306 178.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 209' ' ' PHE . . . . . 0.604 ' HE2' ' HA ' ' A' ' 202' ' ' GLN . 16.8 m-30 -65.43 -44.11 88.35 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.98 -0.555 . . . . 0.58 110.06 179.331 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -61.23 -44.08 97.84 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.091 -0.504 . . . . 1.03 110.594 178.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -60.07 -48.58 85.43 Favored Glycine 0 C--N 1.334 0.444 0 N-CA-C 111.205 -0.758 . . . . 0.39 111.205 178.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 212' ' ' MET . . . . . 0.525 ' O ' ' HG ' ' A' ' 216' ' ' LEU . 1.2 mtp -64.31 -35.03 79.53 Favored 'General case' 0 C--O 1.224 -0.253 0 CA-C-O 120.655 0.264 . . . . 1.28 110.312 178.407 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . 0.426 HD21 ' HA ' ' A' ' 213' ' ' LEU . 0.4 OUTLIER -60.61 -47.99 83.75 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.239 -0.437 . . . . 1.19 110.004 178.473 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 73.0 mtp180 -61.97 -31.71 72.09 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.122 -0.49 . . . . 1.33 111.016 179.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -84.95 -9.09 58.43 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.12 -0.491 . . . . 1.75 111.682 179.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . 0.525 ' HG ' ' O ' ' A' ' 212' ' ' MET . 20.3 mt -82.41 142.89 31.59 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.155 0.502 . . . . 1.17 112.295 -179.531 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -102.07 5.74 40.66 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.846 -0.616 . . . . 0.66 110.212 178.403 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 218' ' ' ILE . . . . . 0.61 HG22 ' HE2' ' A' ' 267' ' ' PHE . 21.0 mm -55.33 106.93 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 CA-C-N 115.9 -0.591 . . . . 1.16 112.319 -178.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 6.1 mtmp? -143.48 -42.19 0.29 Allowed 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 112.373 0.509 . . . . 0.81 112.373 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 18.2 m-80 -124.1 -178.91 4.22 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 113.085 0.772 . . . . 1.51 113.085 -178.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . 0.572 ' O ' HG22 ' A' ' 224' ' ' VAL . 12.2 tm-20 -51.92 -37.61 53.24 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 112.867 0.691 . . . . 0.76 112.867 -179.184 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -63.83 -26.47 70.06 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 120.816 -0.707 . . . . 0.41 113.622 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 223' ' ' ASP . . . . . 0.54 ' HB3' ' HA ' ' A' ' 218' ' ' ILE . 59.0 m-20 -72.34 -31.12 65.35 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 113.322 0.86 . . . . 0.44 113.322 -178.584 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . 0.572 HG22 ' O ' ' A' ' 221' ' ' GLU . 4.8 m -55.87 -29.1 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 CA-C-O 120.833 0.349 . . . . 0.83 111.469 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 10.7 mttp -66.0 -38.71 89.16 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.152 0.501 . . . . 1.51 109.908 178.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 226' ' ' SER . . . . . 0.483 ' O ' HG21 ' A' ' 230' ' ' VAL . 1.8 t -68.74 -30.67 69.34 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 109.113 -0.699 . . . . 0.88 109.113 178.183 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 227' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -66.5 -36.67 83.3 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 109.004 -0.739 . . . . 0.86 109.004 178.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 7.1 t -62.03 -39.72 93.29 Favored 'General case' 0 N--CA 1.462 0.147 0 N-CA-C 108.992 -0.744 . . . . 0.77 108.992 176.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 229' ' ' ARG . . . . . 0.476 ' HA ' HG21 ' A' ' 232' ' ' VAL . 0.0 OUTLIER -61.07 -36.88 80.8 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-N 115.617 -0.719 . . . . 0.55 109.934 177.873 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . 0.553 HG22 ' CE1' ' B' ' 23' ' ' PHE . 29.4 t -65.99 -48.14 82.76 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-O 121.316 0.579 . . . . 1.03 109.439 177.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 231' ' ' MET . . . . . 0.515 ' SD ' HD12 ' A' ' 248' ' ' LEU . 8.1 tpp -60.34 -49.47 77.45 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 115.198 -0.91 . . . . 1.0 111.508 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 232' ' ' VAL . . . . . 0.476 HG21 ' HA ' ' A' ' 229' ' ' ARG . 33.3 m -64.66 -32.05 56.29 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 120.745 -0.382 . . . . 1.12 111.866 -179.741 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 7.3 t-80 -72.38 -47.02 52.7 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 120.899 -0.32 . . . . 0.51 110.843 178.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 70.2 t -62.32 -31.28 51.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-O 120.911 0.386 . . . . 1.04 111.571 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -97.3 4.34 50.89 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 122.224 -0.298 . . . . 0.62 111.749 179.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . 0.454 ' HB2' ' O ' ' A' ' 232' ' ' VAL . 0.3 OUTLIER -73.87 -17.83 61.0 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 112.286 0.476 . . . . 2.05 112.286 -178.989 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -70.12 -11.33 60.81 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.924 0.392 . . . . 0.43 111.244 179.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 91.1 -19.31 47.15 Favored Glycine 0 CA--C 1.519 0.33 0 C-N-CA 121.087 -0.578 . . . . 0.37 112.554 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -95.69 92.71 3.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.117 0.484 . . . . 1.13 112.109 -179.682 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 240' ' ' THR . . . . . 0.501 HG23 HD13 ' A' ' 245' ' ' ILE . 2.4 m -79.03 62.61 3.49 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.487 0.66 . . . . 0.75 110.347 178.505 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 73.2 m-20 -65.42 137.77 57.68 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.441 -0.8 . . . . 0.36 111.705 -179.059 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 242' ' ' TRP . . . . . . . . . . . . . 78.7 m95 -54.73 -38.6 67.31 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.154 -0.475 . . . . 0.49 111.188 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -58.61 -32.44 69.2 Favored Glycine 0 CA--C 1.521 0.419 0 C-N-CA 120.902 -0.666 . . . . 0.29 111.919 178.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 78.8 mtt180 -75.44 -41.95 54.58 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-O 120.943 0.401 . . . . 0.46 109.933 178.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . 0.545 ' O ' HG12 ' A' ' 249' ' ' ILE . 78.3 mt -62.14 -49.32 84.52 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-N 115.819 -0.628 . . . . 1.07 110.561 179.142 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . 0.417 HG23 ' CE2' ' A' ' 300' ' ' PHE . 48.0 t -67.48 -38.46 80.7 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 CA-C-N 116.347 -0.388 . . . . 0.89 111.047 179.317 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 19.4 m -62.2 -40.1 94.96 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 120.909 -0.316 . . . . 1.08 110.247 178.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 248' ' ' LEU . . . . . 0.515 HD12 ' SD ' ' A' ' 231' ' ' MET . 44.7 mt -65.24 -35.27 80.54 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 109.776 -0.453 . . . . 1.04 109.776 177.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 249' ' ' ILE . . . . . 0.545 HG12 ' O ' ' A' ' 245' ' ' ILE . 36.7 mm -69.41 -40.35 79.85 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 N-CA-C 109.084 -0.71 . . . . 1.19 109.084 177.442 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 14.7 m -61.67 -48.38 81.07 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.242 -0.89 . . . . 0.93 109.923 178.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 251' ' ' PHE . . . . . 0.532 ' O ' HG23 ' A' ' 255' ' ' VAL . 12.8 t80 -63.45 -45.06 92.61 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 115.648 -0.705 . . . . 0.72 109.832 178.305 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -57.79 -45.16 93.81 Favored Glycine 0 C--N 1.337 0.594 0 N-CA-C 111.181 -0.768 . . . . 0.26 111.181 178.199 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 253' ' ' ALA . . . . . 0.674 ' HB2' ' HG2' ' A' ' 170' ' ' GLN . . . -59.95 -38.56 82.82 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 122.328 0.251 . . . . 0.33 110.683 177.582 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 61.2 t80 -61.28 -40.42 94.05 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 121.147 0.499 . . . . 0.67 109.776 178.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 255' ' ' VAL . . . . . 0.532 HG23 ' O ' ' A' ' 251' ' ' PHE . 20.2 t -67.47 -40.24 84.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 CA-C-N 115.735 -0.666 . . . . 1.01 109.81 178.048 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -58.43 -41.36 84.88 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.115 0.484 . . . . 0.36 110.1 178.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 257' ' ' LYS . . . . . 0.775 ' HG2' ' HA ' ' A' ' 171' ' ' ALA . 14.4 mtpp -62.86 -45.22 93.6 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 115.76 -0.655 . . . . 1.03 110.104 177.508 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 82.6 t60 -60.6 -39.77 89.37 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 109.672 -0.492 . . . . 0.62 109.672 178.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . 0.478 HD23 ' CD2' ' A' ' 267' ' ' PHE . 4.4 mp -64.26 -50.68 67.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.856 -0.611 . . . . 1.02 110.037 178.528 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 260' ' ' LYS . . . . . 0.713 ' HG3' ' HB3' ' A' ' 171' ' ' ALA . 0.0 OUTLIER -61.57 -29.6 70.12 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.682 -0.236 . . . . 1.1 111.597 179.204 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 56.4 m -57.55 -33.05 67.71 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.041 0.448 . . . . 0.54 111.002 179.097 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 262' ' ' VAL . . . . . 0.5 HG22 ' HG3' ' A' ' 264' ' ' GLN . 26.4 m -112.12 13.63 8.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 CA-C-N 115.787 -0.642 . . . . 0.74 110.079 178.358 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 34.8 t30 58.8 47.24 12.95 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 115.079 -0.964 . . . . 0.61 113.012 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 264' ' ' GLN . . . . . 0.5 ' HG3' HG22 ' A' ' 262' ' ' VAL . 19.9 mt-30 -87.83 39.0 0.86 Allowed 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 116.523 -0.308 . . . . 1.48 111.666 179.007 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 265' ' ' GLU . . . . . 0.416 ' HA ' HD11 ' A' ' 268' ' ' ILE . 7.3 tp10 -49.34 -39.53 32.02 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 121.048 0.451 . . . . 0.46 112.051 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 3.2 p -59.34 -20.33 53.75 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.815 -0.63 . . . . 1.33 111.948 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 267' ' ' PHE . . . . . 0.61 ' HE2' HG22 ' A' ' 218' ' ' ILE . 15.7 t80 -103.57 -21.66 13.72 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 120.8 0.333 . . . . 0.67 111.011 179.38 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 268' ' ' ILE . . . . . 0.416 HD11 ' HA ' ' A' ' 265' ' ' GLU . 63.7 mt -65.39 -43.26 94.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.547 -0.297 . . . . 1.04 110.808 179.663 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 269' ' ' GLU . . . . . 0.629 ' HB3' ' HD3' ' A' ' 270' ' ' PRO . 1.8 tp10 -55.23 -58.13 16.62 Favored Pre-proline 0 CA--C 1.544 0.728 0 CA-C-N 116.332 -0.394 . . . . 0.55 111.01 179.061 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 270' ' ' PRO . . . . . 0.629 ' HD3' ' HB3' ' A' ' 269' ' ' GLU . 26.6 Cg_exo -63.64 -36.55 52.19 Favored 'Trans proline' 0 C--N 1.358 1.036 0 C-N-CA 121.725 1.617 . . . . 0.37 112.655 179.179 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 271' ' ' LEU . . . . . . . . . . . . . 52.6 tp -65.72 -54.81 22.2 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 121.147 -0.221 . . . . 1.18 111.49 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -58.16 -44.58 88.0 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-O 120.861 0.362 . . . . 0.89 111.445 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 273' ' ' GLU . . . . . 0.532 ' HG3' HD22 ' A' ' 160' ' ' LEU . 0.5 OUTLIER -66.51 -39.84 88.9 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 116.246 -0.434 . . . . 0.36 111.4 179.755 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 274' ' ' THR . . . . . 0.461 HG23 ' HB ' ' A' ' 224' ' ' VAL . 62.5 m -64.16 -45.34 88.88 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 120.718 0.294 . . . . 1.06 110.395 179.019 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 275' ' ' ILE . . . . . 0.434 HG21 ' HE1' ' A' ' 231' ' ' MET . 96.3 mt -54.12 -52.99 32.11 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 CA-C-N 116.093 -0.503 . . . . 1.1 110.622 179.147 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 276' ' ' THR . . . . . 0.554 HG21 ' HA ' ' A' ' 160' ' ' LEU . 56.8 m -56.38 -52.47 64.49 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.543 -0.298 . . . . 1.03 111.781 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 277' ' ' ASP . . . . . 0.588 ' OD1' ' HD2' ' A' ' 281' ' ' ARG . 0.4 OUTLIER -53.8 -51.66 62.77 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 112.127 0.418 . . . . 0.43 112.127 -179.364 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 27.3 t -70.05 -46.56 72.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 111.887 0.329 . . . . 0.88 111.887 -179.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 279' ' ' LEU . . . . . 0.448 HD22 HG23 ' A' ' 245' ' ' ILE . 0.4 OUTLIER -62.67 -41.24 98.98 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 113.14 0.792 . . . . 1.15 113.14 -178.757 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 280' ' ' VAL . . . . . 0.403 HG21 ' HB3' ' A' ' 159' ' ' SER . 81.4 t -87.21 -46.22 16.2 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 N-CA-C 113.768 1.025 . . . . 0.64 113.768 -178.266 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 281' ' ' ARG . . . . . 0.588 ' HD2' ' OD1' ' A' ' 277' ' ' ASP . 38.1 mtt85 -70.96 -34.9 71.89 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 114.425 1.269 . . . . 1.06 114.425 -177.122 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 282' ' ' THR . . . . . . . . . . . . . 42.0 p -61.5 -30.71 70.8 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 119.073 0.851 . . . . 1.03 111.513 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 29.9 mmtp -125.06 41.21 3.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.321 -0.399 . . . . 1.09 111.001 179.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 284' ' ' ARG . . . . . 0.516 ' HG2' ' N ' ' A' ' 285' ' ' ASP . 0.0 OUTLIER -53.34 -35.6 60.39 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 112.866 0.691 . . . . 0.54 112.866 -179.319 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 285' ' ' ASP . . . . . 0.516 ' N ' ' HG2' ' A' ' 284' ' ' ARG . 8.1 p-10 -63.04 -44.41 95.94 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-O 120.634 0.254 . . . . 0.46 111.254 -179.363 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 286' ' ' TRP . . . . . 0.76 ' HA ' ' HD2' ' A' ' 289' ' ' LYS . 0.0 OUTLIER -61.5 -34.68 75.91 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.163 0.506 . . . . 0.47 110.477 179.404 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 287' ' ' LEU . . . . . 0.437 HD13 ' HA2' ' A' ' 292' ' ' GLY . 1.7 mm? -70.13 -47.01 63.55 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.566 -0.743 . . . . 1.23 110.482 179.194 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 288' ' ' VAL . . . . . 0.501 HG22 ' O ' ' A' ' 284' ' ' ARG . 64.3 t -60.67 -33.07 53.42 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 CA-C-O 120.898 0.38 . . . . 1.5 110.858 178.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 289' ' ' LYS . . . . . 0.76 ' HD2' ' HA ' ' A' ' 286' ' ' TRP . 74.3 mttt -60.45 -42.17 95.61 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.01 -0.541 . . . . 0.71 112.213 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 290' ' ' GLN . . . . . 0.518 ' HB3' ' HA3' ' A' ' 295' ' ' GLY . 5.1 mt-30 -111.86 28.29 8.89 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 112.869 0.692 . . . . 0.52 112.869 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 291' ' ' ARG . . . . . 0.465 ' HB3' ' HB2' ' A' ' 294' ' ' ASP . 3.8 mmm180 59.09 13.91 3.18 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 112.768 0.655 . . . . 0.64 112.768 179.545 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 292' ' ' GLY . . . . . 0.437 ' HA2' HD13 ' A' ' 287' ' ' LEU . . . 75.06 -108.2 2.47 Favored Glycine 0 N--CA 1.448 -0.502 0 N-CA-C 114.361 0.504 . . . . 0.38 114.361 179.448 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 293' ' ' TRP . . . . . 0.562 ' CZ2' ' HA ' ' A' ' 159' ' ' SER . 80.5 m95 -68.42 -29.27 67.9 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.62 0.6 . . . . 0.63 112.62 -177.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 294' ' ' ASP . . . . . 0.465 ' HB2' ' HB3' ' A' ' 291' ' ' ARG . 22.0 m-20 -62.11 -44.99 95.44 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 120.57 -0.452 . . . . 0.38 109.949 178.489 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 295' ' ' GLY . . . . . 0.518 ' HA3' ' HB3' ' A' ' 290' ' ' GLN . . . -69.07 -33.85 75.04 Favored Glycine 0 C--O 1.224 -0.524 0 C-N-CA 120.809 -0.71 . . . . 0.35 111.695 178.076 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 296' ' ' PHE . . . . . 0.409 ' CD2' ' HE3' ' A' ' 293' ' ' TRP . 0.5 OUTLIER -70.51 -45.11 66.22 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 120.655 0.264 . . . . 0.44 111.232 179.111 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 297' ' ' VAL . . . . . 0.601 HG12 ' HB3' ' A' ' 189' ' ' ARG . 69.3 t -63.81 -50.65 76.77 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.117 0 CA-C-O 120.689 0.281 . . . . 0.99 110.75 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.34 -22.87 64.66 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 116.188 -0.46 . . . . 0.49 111.745 -179.605 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 299' ' ' PHE . . . . . . . . . . . . . 88.2 t80 -71.54 -36.04 70.87 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-O 120.764 0.316 . . . . 0.58 110.854 178.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 300' ' ' PHE . . . . . 0.417 ' CE2' HG23 ' A' ' 246' ' ' VAL . 79.3 m-85 . . . . . 0 C--N 1.328 -0.349 0 CA-C-O 120.79 0.329 . . . . 0.55 111.832 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 . . . . . 0 C--O 1.234 0.284 0 CA-C-O 121.039 0.447 . . . . 0.89 110.172 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 23' ' ' PHE . . . . . 0.553 ' CE1' HG22 ' A' ' 230' ' ' VAL . 0.7 OUTLIER -57.34 -37.79 73.11 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 115.706 -0.679 . . . . 0.46 111.394 179.377 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 24' ' ' ALA . . . . . 0.522 ' N ' ' HD1' ' B' ' 23' ' ' PHE . . . -65.57 -40.25 92.56 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.121 -0.491 . . . . 0.59 111.655 -179.151 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . 0.525 ' O ' ' HG3' ' B' ' 29' ' ' LYS . . . -66.15 -46.85 76.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.996 0.427 . . . . 0.93 110.218 179.175 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -62.32 -51.57 67.11 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 115.827 -0.624 . . . . 0.74 110.68 179.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 51.3 mt -57.65 -41.72 82.03 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.755 0.312 . . . . 1.21 110.339 178.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 28' ' ' ARG . . . . . . . . . . . . . 1.2 ttm180 -58.86 -50.81 72.58 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.164 -0.471 . . . . 0.96 110.434 178.133 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . 0.525 ' HG3' ' O ' ' B' ' 25' ' ' ALA . 85.3 mttt -57.82 -51.39 69.78 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.039 -0.528 . . . . 0.8 110.798 178.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 78.9 mt -58.87 -45.45 91.69 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 CA-C-N 115.878 -0.601 . . . . 1.12 110.983 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -58.67 -50.52 66.37 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.897 -0.668 . . . . 0.28 113.009 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 -68.17 -37.21 80.73 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.966 0.383 . . . . 0.37 111.527 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 21.8 ttmm -62.42 -50.5 71.27 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 120.912 0.387 . . . . 1.32 110.328 178.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 49.1 t -63.19 -47.43 92.35 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 116.097 -0.501 . . . . 0.94 110.593 178.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -58.04 -50.82 72.1 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 115.777 -0.647 . . . . 1.16 111.508 179.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 36' ' ' CYS . . . . . . . . . . . . . 13.0 t -63.14 -28.43 70.06 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 120.804 0.335 . . . . 1.07 111.839 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 89.1 m -77.64 -45.91 23.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.425 -0.352 . . . . 1.06 111.87 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 38' ' ' TRP . . . . . . . . . . . . . 97.1 m95 -80.12 -19.7 46.71 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 112.95 0.722 . . . . 0.63 112.95 -178.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 40.0 t . . . . . 0 N--CA 1.472 0.647 0 N-CA-C 112.268 0.47 . . . . 0.43 112.268 179.545 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 12.0 t0 . . . . . 0 CA--C 1.535 0.366 0 N-CA-C 112.478 0.548 . . . . 0.37 112.478 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -55.15 -56.48 19.43 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 120.95 0.405 . . . . 0.78 111.369 -179.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.22 -37.08 77.84 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.028 0.442 . . . . 1.27 110.534 179.567 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 13.6 t80 -61.62 -40.71 95.83 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 115.906 -0.588 . . . . 0.46 111.697 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 55.0 mtt-85 -65.32 -48.3 73.53 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 111.834 0.309 . . . . 0.59 111.834 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 2.7 mm-40 -62.07 -42.48 99.24 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.203 0.525 . . . . 0.44 110.303 179.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' SER . . . . . 0.46 ' HA ' ' CZ2' ' A' ' 293' ' ' TRP . 12.3 m -66.19 -54.69 22.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.756 -0.657 . . . . 0.32 111.218 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.647 ' HA ' HG23 ' A' ' 276' ' ' THR . 2.0 tm? -54.11 -46.38 72.13 Favored 'General case' 0 N--CA 1.464 0.248 0 O-C-N 123.183 0.302 . . . . 1.4 111.08 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -63.57 -54.38 37.03 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 112.067 0.395 . . . . 0.4 112.067 -179.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . 0.465 HD11 ' HA2' ' A' ' 187' ' ' GLY . 88.1 mt -59.33 -46.68 92.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 N-CA-C 111.589 0.218 . . . . 1.04 111.589 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.498 ' O ' ' HG ' ' A' ' 167' ' ' LEU . 84.2 mt -62.84 -51.23 74.62 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 C-N-CA 121.085 -0.246 . . . . 1.02 111.462 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 55.2 p -58.78 -42.29 88.65 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.586 0.231 . . . . 0.37 111.302 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . 0.417 ' O ' ' HB2' ' A' ' 169' ' ' GLU . 2.0 tpt85 -58.02 -51.64 68.81 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.855 0.359 . . . . 0.42 110.806 179.374 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' TYR . . . . . 0.468 ' O ' ' HB2' ' A' ' 170' ' ' GLN . 66.7 t80 -64.04 -49.37 72.62 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.937 -0.574 . . . . 0.44 112.065 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.498 ' HG ' ' O ' ' A' ' 163' ' ' ILE . 21.4 mt -56.17 -45.96 79.53 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 112.024 0.379 . . . . 1.08 112.024 -178.612 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 11.8 ttm105 -70.18 -44.59 68.43 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.57 0.224 . . . . 0.39 111.133 179.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . 0.417 ' HB2' ' O ' ' A' ' 165' ' ' ARG . 1.9 tt0 -61.52 -36.08 79.53 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-O 121.32 0.581 . . . . 0.7 110.564 179.347 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . 0.468 ' HB2' ' O ' ' A' ' 166' ' ' TYR . 1.8 tm0? -71.98 -47.8 49.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.76 -0.654 . . . . 0.58 110.246 178.434 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.292 0 CA-C-N 116.094 -0.503 . . . . 1.03 112.103 179.743 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . 0.532 ' O ' ' HA3' ' A' ' 187' ' ' GLY . . . . . . . . 0 CA--C 1.537 0.452 0 CA-C-O 120.784 0.326 . . . . 0.44 110.349 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -77.33 -71.47 1.2 Allowed Glycine 0 CA--C 1.525 0.688 0 C-N-CA 120.445 -0.884 . . . . 0.43 114.543 -178.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -63.43 -56.19 18.16 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 112.076 0.399 . . . . 0.51 112.076 -178.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -66.56 -44.44 82.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.373 -0.376 . . . . 1.07 110.702 179.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . 0.532 ' HA3' ' O ' ' A' ' 183' ' ' ALA . . . -57.48 -53.49 44.61 Favored Glycine 0 CA--C 1.522 0.507 0 C-N-CA 121.238 -0.506 . . . . 0.33 113.823 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . 0.437 HH11 ' HD2' ' A' ' 188' ' ' ARG . 1.6 mmp_? -61.17 -44.48 97.23 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 117.617 0.708 . . . . 0.59 112.245 -179.661 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' ARG . . . . . 0.63 ' HB3' HG12 ' A' ' 297' ' ' VAL . 49.9 mtm180 -66.93 -39.12 87.25 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 120.802 0.334 . . . . 0.5 110.745 179.429 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . 0.428 ' HA ' HG23 ' A' ' 297' ' ' VAL . . . -70.58 -34.79 72.57 Favored 'General case' 0 C--O 1.222 -0.349 0 CA-C-N 116.362 -0.381 . . . . 0.36 110.677 178.645 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' LEU . . . . . 0.463 HD22 ' HA ' ' A' ' 191' ' ' LEU . 0.2 OUTLIER -61.53 -45.4 94.34 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.823 -0.171 . . . . 1.05 111.142 179.202 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -66.79 -45.46 78.36 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 121.028 0.442 . . . . 0.35 111.125 179.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 1.3 p -65.21 -48.51 73.14 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.288 -0.415 . . . . 0.99 111.7 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . 0.462 HD21 HG22 ' A' ' 249' ' ' ILE . 19.1 tp -60.65 -35.49 76.35 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 116.406 -0.361 . . . . 1.08 111.112 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . 0.417 ' HA ' ' HE1' ' A' ' 166' ' ' TYR . 5.0 mmt180 -65.05 -44.49 88.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.917 0.389 . . . . 0.42 110.775 178.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.88 -52.43 24.86 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.149 0.426 . . . . 0.43 112.149 -179.43 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . 0.476 ' O ' HG23 ' A' ' 201' ' ' VAL . 48.1 t -69.61 -43.39 80.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 N-CA-C 112.572 0.582 . . . . 1.04 112.572 -178.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -67.14 -51.68 37.14 Favored Glycine 0 CA--C 1.521 0.409 0 C-N-CA 121.018 -0.611 . . . . 0.25 113.467 -178.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -63.87 -35.79 81.79 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 120.804 0.335 . . . . 0.29 110.378 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -59.94 -48.15 87.48 Favored Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 111.119 -0.792 . . . . 0.29 111.119 177.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . 0.476 HG23 ' O ' ' A' ' 197' ' ' VAL . 76.3 t -64.04 -40.93 90.83 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 122.217 0.207 . . . . 1.11 111.331 179.014 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' GLN . . . . . 0.489 ' HA ' ' HE2' ' A' ' 209' ' ' PHE . 31.7 tt0 -60.07 -48.07 83.24 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 116.587 -0.279 . . . . 0.42 111.5 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.33 -39.02 71.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.615 0.245 . . . . 1.71 111.255 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 18.2 m-80 -67.08 -52.22 44.64 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 111.969 0.359 . . . . 1.59 111.969 179.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 74.0 m-70 -101.47 34.91 2.43 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 112.427 0.529 . . . . 0.54 112.427 -178.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -62.9 -40.12 96.61 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 120.999 -0.28 . . . . 0.51 111.266 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 38.4 p -60.66 -43.11 98.01 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.061 0.458 . . . . 0.74 110.683 179.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 208' ' ' ALA . . . . . 0.436 ' O ' ' HG3' ' A' ' 212' ' ' MET . . . -65.99 -41.87 90.55 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.83 -0.623 . . . . 1.14 109.93 178.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 209' ' ' PHE . . . . . 0.489 ' HE2' ' HA ' ' A' ' 202' ' ' GLN . 14.4 m-30 -63.0 -42.58 99.88 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.893 -0.594 . . . . 0.62 110.112 178.66 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 210' ' ' GLN . . . . . 0.698 ' O ' ' HG2' ' A' ' 214' ' ' ARG . 31.3 mt-30 -57.79 -46.72 84.21 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.288 -0.414 . . . . 0.71 110.542 178.494 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -55.68 -46.75 81.36 Favored Glycine 0 C--N 1.339 0.711 0 C-N-CA 121.051 -0.595 . . . . 0.33 111.951 178.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 212' ' ' MET . . . . . 0.572 ' HE2' ' HB3' ' B' ' 26' ' ' GLN . 35.1 mtt -62.91 -42.68 99.87 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 109.515 -0.55 . . . . 1.39 109.515 177.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 12.7 tp -58.92 -44.53 91.31 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.744 -0.662 . . . . 0.78 111.11 179.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 214' ' ' ARG . . . . . 0.698 ' HG2' ' O ' ' A' ' 210' ' ' GLN . 22.1 mmt180 -60.65 -35.16 75.54 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 120.887 0.375 . . . . 1.35 110.945 179.439 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -94.7 12.31 28.22 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.968 0.359 . . . . 1.63 111.968 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . 0.48 ' HB3' HG12 ' A' ' 218' ' ' ILE . 12.1 mt -99.39 154.27 18.33 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.127 0.489 . . . . 1.25 111.511 179.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -105.05 17.2 24.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.9 -0.591 . . . . 1.09 111.052 179.62 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 218' ' ' ILE . . . . . 0.532 ' HA ' ' HB2' ' A' ' 223' ' ' ASP . 17.3 mm -59.33 105.93 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-N 116.417 -0.356 . . . . 1.01 111.441 -179.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . 0.431 ' HG3' ' O ' ' A' ' 218' ' ' ILE . 7.5 mtmp? -159.56 -65.64 0.08 Allowed 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.862 -0.608 . . . . 0.89 110.7 -179.301 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -104.3 -175.65 2.86 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 115.098 -0.955 . . . . 0.79 110.722 -179.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . 0.416 ' O ' HG23 ' A' ' 224' ' ' VAL . 0.5 OUTLIER -46.83 -22.37 0.3 Allowed 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 113.538 0.94 . . . . 0.8 113.538 -179.221 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . 0.564 ' HA2' ' HD2' ' A' ' 225' ' ' LYS . . . -65.92 -23.99 71.31 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 121.223 -0.513 . . . . 0.42 113.076 178.606 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 223' ' ' ASP . . . . . 0.532 ' HB2' ' HA ' ' A' ' 218' ' ' ILE . 2.9 p-10 -56.56 -45.49 81.26 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 113.478 0.918 . . . . 0.76 113.478 -178.354 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . 0.416 HG23 ' O ' ' A' ' 221' ' ' GLU . 28.9 m -59.96 -29.55 43.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-N 118.107 0.412 . . . . 0.74 111.475 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . 0.564 ' HD2' ' HA2' ' A' ' 222' ' ' GLY . 26.4 mttp -76.08 -42.76 46.34 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.549 -0.537 . . . . 1.33 109.549 178.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 94.3 p -64.5 -40.51 95.78 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.741 -0.663 . . . . 0.95 110.327 178.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 227' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -65.39 -42.63 92.44 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 109.919 -0.4 . . . . 0.65 109.919 178.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 228' ' ' SER . . . . . 0.544 ' HA ' ' HG2' ' A' ' 231' ' ' MET . 7.5 t -60.44 -43.79 96.47 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.086 -0.506 . . . . 1.11 110.423 178.595 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 229' ' ' ARG . . . . . 0.421 HH11 ' HD2' ' A' ' 229' ' ' ARG . 9.0 mmm180 -55.69 -44.36 77.3 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.243 0.544 . . . . 1.0 110.545 178.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . 0.483 ' O ' HG21 ' A' ' 234' ' ' VAL . 60.1 t -69.19 -54.32 20.69 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-N 115.877 -0.601 . . . . 1.07 111.475 179.307 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 231' ' ' MET . . . . . 0.558 ' HE3' HD21 ' A' ' 248' ' ' LEU . 10.6 ptm -59.58 -37.13 77.69 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 112.491 0.552 . . . . 1.06 112.491 -178.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 33.0 t -66.4 -41.07 88.16 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 N-CA-C 109.522 -0.547 . . . . 0.95 109.522 178.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 233' ' ' HIS . . . . . 0.488 ' HA ' ' HB2' ' A' ' 236' ' ' LYS . 2.3 t-80 -68.16 -40.18 82.4 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 116.203 -0.453 . . . . 0.55 110.44 178.473 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . 0.483 HG21 ' O ' ' A' ' 230' ' ' VAL . 69.3 t -56.99 -37.95 57.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 CA-C-O 121.057 0.456 . . . . 1.05 111.12 179.546 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 235' ' ' PHE . . . . . 0.501 ' HE2' HD23 ' A' ' 248' ' ' LEU . 93.3 m-85 -104.11 19.39 20.19 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.394 -0.366 . . . . 0.65 111.386 179.289 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . 0.488 ' HB2' ' HA ' ' A' ' 233' ' ' HIS . 1.3 tmtm? -79.81 -9.72 59.7 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 111.744 0.276 . . . . 1.81 111.744 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -70.16 -17.98 63.19 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 120.847 0.356 . . . . 0.53 111.033 179.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 96.83 -17.94 58.4 Favored Glycine 0 CA--C 1.524 0.621 0 C-N-CA 120.938 -0.649 . . . . 0.58 113.23 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 6.5 p -98.77 130.23 47.93 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-O 121.23 0.538 . . . . 1.26 111.8 -179.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 240' ' ' THR . . . . . 0.447 HG22 ' HG2' ' A' ' 283' ' ' LYS . 1.4 m -94.59 98.87 11.12 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.206 -0.452 . . . . 1.16 111.771 179.302 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -100.11 130.9 46.31 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.876 0.369 . . . . 0.57 111.208 179.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 242' ' ' TRP . . . . . . . . . . . . . 7.0 m95 -55.33 -43.76 75.22 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 116.032 -0.531 . . . . 0.62 111.146 179.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -58.01 -32.07 66.1 Favored Glycine 0 CA--C 1.519 0.329 0 CA-C-N 115.98 -0.555 . . . . 0.32 112.605 179.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 86.8 mtt180 -74.9 -36.39 62.23 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.78 -0.452 . . . . 0.46 109.78 178.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . 0.552 ' O ' HG12 ' A' ' 249' ' ' ILE . 79.1 mt -66.97 -51.36 55.46 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 CA-C-N 115.944 -0.571 . . . . 1.16 110.714 179.115 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 27.6 m -62.93 -35.9 73.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 C-N-CA 121.089 -0.244 . . . . 1.03 111.08 179.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 53.0 m -65.69 -37.77 87.39 Favored 'General case' 0 N--CA 1.463 0.187 0 N-CA-C 109.538 -0.542 . . . . 1.04 109.538 178.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 248' ' ' LEU . . . . . 0.558 HD21 ' HE3' ' A' ' 231' ' ' MET . 34.2 tp -65.32 -40.58 93.92 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 116.143 -0.481 . . . . 1.08 109.759 177.624 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 249' ' ' ILE . . . . . 0.552 HG12 ' O ' ' A' ' 245' ' ' ILE . 43.0 mm -65.9 -48.89 80.36 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 CA-C-N 116.186 -0.461 . . . . 1.09 110.101 178.533 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 31.3 t -57.07 -42.68 81.09 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.801 -0.636 . . . . 0.33 110.31 178.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 251' ' ' PHE . . . . . . . . . . . . . 32.0 t80 -64.03 -45.46 88.78 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 115.647 -0.706 . . . . 0.59 110.059 177.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -58.22 -41.28 94.76 Favored Glycine 0 C--N 1.337 0.623 0 N-CA-C 111.464 -0.655 . . . . 0.34 111.464 178.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -64.01 -42.68 97.06 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 120.773 0.32 . . . . 0.52 110.277 177.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -60.07 -40.87 91.0 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.357 0.598 . . . . 0.85 109.742 178.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 255' ' ' VAL . . . . . 0.45 ' CG1' HG23 ' A' ' 218' ' ' ILE . 79.9 t -66.54 -51.25 59.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 CA-C-N 115.682 -0.69 . . . . 1.1 109.696 177.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -54.21 -39.29 66.56 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.082 -0.508 . . . . 0.38 111.076 177.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -62.48 -42.89 99.8 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.402 -0.363 . . . . 1.26 110.667 178.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 31.3 t60 -64.61 -36.14 83.28 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.311 -0.404 . . . . 0.62 110.32 179.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 6.7 mp -74.6 -41.49 60.35 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 121.061 0.458 . . . . 0.94 110.696 178.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -62.82 -27.35 69.26 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.9 0.381 . . . . 0.57 110.666 179.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 56.4 m -59.67 -31.86 69.95 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.074 -0.512 . . . . 0.48 110.494 178.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 262' ' ' VAL . . . . . 0.417 HG22 ' HG3' ' A' ' 264' ' ' GLN . 15.7 m -110.49 16.99 7.72 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 CA-C-O 121.28 0.562 . . . . 0.81 110.192 178.29 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 25.6 t30 59.31 44.22 15.67 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 114.922 -1.035 . . . . 0.54 113.567 179.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 264' ' ' GLN . . . . . 0.417 ' HG3' HG22 ' A' ' 262' ' ' VAL . 15.0 mt-30 -91.54 36.61 0.95 Allowed 'General case' 0 N--CA 1.466 0.369 0 O-C-N 121.978 -0.452 . . . . 0.5 110.856 178.536 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 265' ' ' GLU . . . . . 0.423 ' HA ' HD11 ' A' ' 268' ' ' ILE . 6.4 mm-40 -57.94 -29.22 64.99 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 116.422 -0.354 . . . . 0.49 111.862 -179.418 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.37 -22.84 67.12 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.229 -0.441 . . . . 1.09 110.788 178.696 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 267' ' ' PHE . . . . . 0.42 ' C ' ' HD2' ' A' ' 270' ' ' PRO . 66.2 m-85 -100.01 -24.74 14.53 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.048 -0.524 . . . . 0.91 110.611 178.566 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 268' ' ' ILE . . . . . 0.423 HD11 ' HA ' ' A' ' 265' ' ' GLU . 89.3 mt -65.3 -40.9 90.03 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-N 116.11 -0.495 . . . . 1.12 111.477 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 269' ' ' GLU . . . . . 0.667 ' HB2' ' HD3' ' A' ' 270' ' ' PRO . 6.4 mm-40 -57.49 -56.47 33.81 Favored Pre-proline 0 CA--C 1.542 0.669 0 C-N-CA 120.979 -0.289 . . . . 0.68 111.111 178.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 270' ' ' PRO . . . . . 0.667 ' HD3' ' HB2' ' A' ' 269' ' ' GLU . 50.6 Cg_exo -58.04 -32.24 94.95 Favored 'Trans proline' 0 C--N 1.363 1.323 0 C-N-CA 121.843 1.695 . . . . 0.39 111.643 177.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 271' ' ' LEU . . . . . 0.444 ' O ' HG13 ' A' ' 275' ' ' ILE . 0.4 OUTLIER -66.06 -55.16 17.97 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.183 -0.462 . . . . 1.18 110.233 178.582 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -60.06 -39.12 84.91 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 115.846 -0.616 . . . . 0.44 110.951 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 273' ' ' GLU . . . . . 0.449 ' O ' ' HB2' ' A' ' 277' ' ' ASP . 26.4 tt0 -66.92 -43.41 83.38 Favored 'General case' 0 C--O 1.226 -0.18 0 CA-C-N 115.885 -0.598 . . . . 1.79 110.012 178.583 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 274' ' ' THR . . . . . . . . . . . . . 41.2 m -64.95 -44.35 89.71 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.605 -0.27 . . . . 0.92 110.927 179.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 275' ' ' ILE . . . . . 0.556 ' HA ' ' HE2' ' A' ' 231' ' ' MET . 96.5 mt -57.54 -54.97 24.09 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 CA-C-O 121.132 0.491 . . . . 0.98 110.157 179.09 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 276' ' ' THR . . . . . 0.647 HG23 ' HA ' ' A' ' 160' ' ' LEU . 24.4 m -59.25 -45.46 91.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.664 -0.698 . . . . 0.88 110.541 179.179 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 277' ' ' ASP . . . . . 0.449 ' HB2' ' O ' ' A' ' 273' ' ' GLU . 7.9 t70 -56.27 -58.35 8.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.315 -0.857 . . . . 0.33 111.723 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 95.3 t -57.7 -39.47 70.42 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-O 120.609 0.242 . . . . 0.65 110.953 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 22.3 tp -61.5 -47.92 83.42 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 120.669 0.271 . . . . 1.15 111.672 179.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 44.6 t -78.79 -23.28 12.97 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-O 121.052 0.453 . . . . 1.14 111.835 -179.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 281' ' ' ARG . . . . . 0.403 ' HB2' ' O ' ' A' ' 277' ' ' ASP . 19.3 ttm-85 -82.29 -25.8 33.66 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 121.824 -0.547 . . . . 0.56 111.949 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 282' ' ' THR . . . . . . . . . . . . . 37.7 p -98.69 -31.15 12.06 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 112.526 0.565 . . . . 0.42 112.526 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . 0.447 ' HG2' HG22 ' A' ' 240' ' ' THR . 3.3 mppt? -117.08 32.99 5.84 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 112.16 0.43 . . . . 1.61 112.16 -179.149 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 284' ' ' ARG . . . . . 0.479 ' H ' ' HG2' ' A' ' 284' ' ' ARG . 0.4 OUTLIER -56.81 -42.46 79.61 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 112.139 0.422 . . . . 0.54 112.139 179.817 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 285' ' ' ASP . . . . . 0.509 ' O ' ' HB2' ' A' ' 289' ' ' LYS . 26.0 t70 -62.19 -48.75 78.64 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.393 -0.367 . . . . 0.77 111.73 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 286' ' ' TRP . . . . . 0.505 ' CZ2' ' HG2' ' A' ' 290' ' ' GLN . 31.7 t90 -70.63 -41.42 72.22 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.018 0.377 . . . . 1.16 112.018 -179.201 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -61.27 -40.97 96.08 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 111.891 0.33 . . . . 1.28 111.891 -179.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 6.0 p -77.38 -29.69 16.87 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-O 120.75 0.309 . . . . 0.81 110.954 179.048 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 289' ' ' LYS . . . . . 0.509 ' HB2' ' O ' ' A' ' 285' ' ' ASP . 3.4 ttmm -75.36 -44.85 42.81 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 112.858 0.688 . . . . 1.22 112.858 -179.081 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 290' ' ' GLN . . . . . 0.505 ' HG2' ' CZ2' ' A' ' 286' ' ' TRP . 1.9 mp0 -84.83 29.88 0.6 Allowed 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 113.765 1.024 . . . . 0.78 113.765 -177.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 291' ' ' ARG . . . . . 0.592 ' HB3' ' HB3' ' A' ' 294' ' ' ASP . 21.5 mtm180 64.04 6.8 3.02 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 112.745 0.646 . . . . 0.62 112.745 179.318 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 59.07 -125.59 40.16 Favored Glycine 0 CA--C 1.521 0.421 0 CA-C-O 121.395 0.442 . . . . 0.4 113.573 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 293' ' ' TRP . . . . . 0.582 ' O ' HG22 ' A' ' 297' ' ' VAL . 83.8 m95 -64.9 -26.3 68.26 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.641 0.608 . . . . 0.58 112.641 -178.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 294' ' ' ASP . . . . . 0.592 ' HB3' ' HB3' ' A' ' 291' ' ' ARG . 20.0 t70 -64.32 -43.91 93.21 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 121.045 0.45 . . . . 0.54 109.934 178.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -68.38 -31.8 74.68 Favored Glycine 0 C--N 1.334 0.45 0 N-CA-C 110.609 -0.997 . . . . 0.37 110.609 177.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 296' ' ' PHE . . . . . 0.433 ' HB3' ' HA ' ' A' ' 293' ' ' TRP . 1.0 OUTLIER -67.7 -48.11 67.49 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 115.51 -0.345 . . . . 0.4 110.557 178.464 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 297' ' ' VAL . . . . . 0.63 HG12 ' HB3' ' A' ' 189' ' ' ARG . 86.0 t -61.14 -43.4 96.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-O 120.825 0.345 . . . . 1.02 110.615 179.306 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -64.51 -46.49 82.71 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.863 -0.608 . . . . 0.48 112.053 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 299' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -62.63 -35.2 78.81 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 112.31 0.485 . . . . 0.69 112.31 -179.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 300' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 . . . . . 0 C--N 1.326 -0.455 0 N-CA-C 112.284 0.476 . . . . 0.55 112.284 -179.464 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 . . . . . 0 N--CA 1.456 -0.171 0 N-CA-C 109.34 -0.615 . . . . 1.0 109.34 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 23' ' ' PHE . . . . . 0.473 ' HB3' ' HB3' ' A' ' 212' ' ' MET . 0.0 OUTLIER -56.55 -41.3 76.62 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.87 -0.605 . . . . 0.91 110.686 178.54 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.61 -49.01 78.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.064 -0.516 . . . . 0.85 110.735 179.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.78 -42.1 95.33 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.329 -0.396 . . . . 0.67 110.933 179.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 26' ' ' GLN . . . . . 0.572 ' HB3' ' HE2' ' A' ' 212' ' ' MET . 1.2 mt-30 -64.73 -49.53 70.45 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.128 -0.487 . . . . 1.42 111.351 179.531 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 61.6 mt -56.65 -36.03 69.06 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 120.815 0.34 . . . . 1.11 110.33 178.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 28' ' ' ARG . . . . . . . . . . . . . 19.4 mtp180 -62.89 -48.44 78.96 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.171 -0.468 . . . . 0.57 110.157 178.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . 0.514 ' HA ' ' HE3' ' B' ' 29' ' ' LYS . 0.0 OUTLIER -66.83 -41.81 86.83 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.319 -0.4 . . . . 0.73 111.96 -179.79 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . 0.405 ' O ' HG22 ' B' ' 34' ' ' VAL . 78.8 mt -61.65 -41.61 91.03 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 N-CA-C 109.142 -0.688 . . . . 1.07 109.142 178.027 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -61.85 -49.13 78.95 Favored Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 115.655 -0.702 . . . . 0.31 111.872 178.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -58.9 -44.23 91.19 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-O 121.117 0.484 . . . . 0.45 109.737 178.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 3.3 tmtt? -58.84 -52.61 64.98 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 115.434 -0.803 . . . . 0.58 111.137 178.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 34' ' ' VAL . . . . . 0.405 HG22 ' O ' ' B' ' 30' ' ' ILE . 58.7 t -58.87 -49.43 83.04 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 CA-C-O 120.749 0.309 . . . . 0.57 111.416 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -58.74 -43.96 90.39 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 116.307 -0.406 . . . . 0.85 111.972 -179.586 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 36' ' ' CYS . . . . . . . . . . . . . 17.8 p -73.39 -32.84 64.68 Favored 'General case' 0 N--CA 1.468 0.444 0 O-C-N 122.023 -0.423 . . . . 1.13 111.421 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 89.5 m -66.35 -39.82 89.42 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.526 -0.306 . . . . 1.03 111.365 179.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 38' ' ' TRP . . . . . . . . . . . . . 84.2 m95 -80.45 -25.05 39.13 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.981 -0.288 . . . . 0.65 111.201 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 69.2 m . . . . . 0 N--CA 1.469 0.489 0 CA-C-O 120.898 0.38 . . . . 0.48 110.71 178.139 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 15.1 t70 . . . . . 0 N--CA 1.473 0.722 0 N-CA-C 112.763 0.653 . . . . 0.91 112.763 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -67.85 -38.7 83.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.856 0.36 . . . . 0.59 110.679 179.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.418 HD11 ' HA3' ' A' ' 292' ' ' GLY . 53.8 tp -61.56 -39.4 90.97 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.732 -0.47 . . . . 1.11 109.732 178.366 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -58.17 -51.49 69.5 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.604 -0.726 . . . . 0.52 112.02 179.179 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 20.1 mtm180 -56.77 -49.66 74.61 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 112.37 0.507 . . . . 0.71 112.37 -178.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -59.04 -50.45 74.03 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 120.903 0.382 . . . . 1.19 111.007 179.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' SER . . . . . 0.451 ' HA ' ' CZ2' ' A' ' 293' ' ' TRP . 3.3 p -63.64 -45.9 88.1 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 112.278 0.473 . . . . 0.34 112.278 -179.374 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.404 HD21 ' HA ' ' A' ' 160' ' ' LEU . 0.4 OUTLIER -53.4 -49.76 66.6 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 120.774 0.321 . . . . 1.28 111.124 179.45 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -75.99 -43.17 45.63 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.873 0.694 . . . . 0.39 112.873 -179.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . 0.448 HD11 ' HB2' ' A' ' 190' ' ' ALA . 79.9 mt -62.01 -42.44 94.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 O-C-N 121.978 -0.451 . . . . 0.89 111.753 -179.292 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.676 ' O ' ' HG ' ' A' ' 167' ' ' LEU . 74.1 mt -69.06 -52.3 35.23 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 C-N-CA 121.018 -0.273 . . . . 1.1 110.768 179.043 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 54.6 p -58.03 -42.27 84.98 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 121.281 -0.167 . . . . 0.31 110.983 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . 0.423 HH11 ' HD2' ' A' ' 165' ' ' ARG . 2.0 mmt85 -55.43 -51.77 65.81 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.722 -0.217 . . . . 0.46 110.951 178.472 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' TYR . . . . . 0.836 ' CE1' ' HA ' ' A' ' 195' ' ' ARG . 72.5 t80 -60.26 -48.68 80.69 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.666 -0.243 . . . . 0.4 111.142 179.28 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.676 ' HG ' ' O ' ' A' ' 163' ' ' ILE . 18.8 mt -59.0 -44.18 91.63 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.561 -0.29 . . . . 0.86 111.484 -179.568 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . 0.52 ' HD3' ' OE2' ' A' ' 269' ' ' GLU . 25.3 mtm180 -70.47 -44.42 67.77 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 112.22 0.452 . . . . 0.55 112.22 179.671 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -62.8 -44.1 97.06 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.705 0.288 . . . . 0.48 111.168 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . 0.444 ' HG3' ' CZ ' ' A' ' 166' ' ' TYR . 6.4 mm-40 -70.48 -28.99 65.41 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.853 0.359 . . . . 0.43 110.708 178.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . 0.79 ' HA ' ' HG2' ' A' ' 257' ' ' LYS . . . . . . . . 0 CA--C 1.53 0.21 0 N-CA-C 112.522 0.564 . . . . 0.9 112.522 -179.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . 0.495 ' O ' ' HA3' ' A' ' 187' ' ' GLY . . . . . . . . 0 CA--C 1.532 0.285 0 CA-C-O 120.884 0.373 . . . . 1.06 110.247 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -78.74 -71.68 1.23 Allowed Glycine 0 CA--C 1.523 0.542 0 C-N-CA 120.647 -0.787 . . . . 0.42 113.811 -178.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -71.97 -56.14 6.2 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 120.8 0.333 . . . . 0.77 111.049 -179.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -61.52 -35.03 76.58 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.116 -0.493 . . . . 0.77 110.578 179.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . 0.495 ' HA3' ' O ' ' A' ' 183' ' ' ALA . . . -65.37 -40.46 96.43 Favored Glycine 0 C--N 1.333 0.408 0 C-N-CA 121.229 -0.51 . . . . 0.4 113.201 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . 0.443 ' HD3' ' HA ' ' A' ' 188' ' ' ARG . 15.0 mmt180 -66.52 -47.02 74.26 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 117.193 0.497 . . . . 0.79 110.552 179.656 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' ARG . . . . . 0.66 ' HB3' HG13 ' A' ' 297' ' ' VAL . 23.9 mmt180 -66.97 -39.52 87.22 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.067 -0.515 . . . . 0.77 111.204 179.678 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . 0.448 ' HB2' HD11 ' A' ' 162' ' ' ILE . . . -70.09 -40.08 75.17 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.899 -0.321 . . . . 0.65 111.136 179.095 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 16.0 tp -69.27 -44.41 71.94 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 120.777 -0.369 . . . . 1.21 111.294 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' GLU . . . . . 0.543 ' HG3' ' O ' ' A' ' 189' ' ' ARG . 0.0 OUTLIER -58.43 -37.73 75.99 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 120.597 -0.441 . . . . 0.36 110.401 179.169 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' THR . . . . . 0.555 HG22 ' HA ' ' A' ' 297' ' ' VAL . 1.1 p -76.87 -47.59 20.81 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 120.953 -0.299 . . . . 1.05 111.08 178.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . 0.445 HD13 ' HA ' ' A' ' 194' ' ' LEU . 10.3 tp -58.85 -35.36 72.82 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.737 0.303 . . . . 1.01 110.977 179.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . 0.836 ' HA ' ' CE1' ' A' ' 166' ' ' TYR . 12.6 mmt180 -68.8 -58.29 4.4 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.788 0.328 . . . . 0.45 110.348 178.393 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 20.7 ttp85 -60.77 -54.02 50.24 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 112.914 0.709 . . . . 1.03 112.914 -179.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . 0.555 ' O ' HG22 ' A' ' 201' ' ' VAL . 46.8 t -68.7 -45.1 81.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 112.051 0.389 . . . . 1.05 112.051 -179.033 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -61.7 -42.41 99.75 Favored Glycine 0 CA--C 1.521 0.444 0 C-N-CA 120.996 -0.621 . . . . 0.33 113.027 -179.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -68.39 -42.39 79.15 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 109.728 -0.471 . . . . 0.49 109.728 179.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -56.54 -48.68 74.76 Favored Glycine 0 C--N 1.336 0.547 0 C-N-CA 120.797 -0.716 . . . . 0.39 111.655 178.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . 0.555 HG22 ' O ' ' A' ' 197' ' ' VAL . 60.0 t -62.92 -42.6 97.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 CA-C-O 120.702 0.287 . . . . 0.84 111.193 178.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -63.38 -48.64 77.04 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.152 -0.476 . . . . 0.39 112.028 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 31.7 mtm180 -73.5 -35.27 65.6 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.908 -0.317 . . . . 1.06 111.739 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -63.73 -49.19 74.03 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 121.117 0.484 . . . . 1.11 110.039 178.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 79.6 m-70 -101.17 33.78 2.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.157 -0.474 . . . . 0.78 110.711 179.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -53.65 -45.71 70.32 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.89 -0.596 . . . . 0.79 112.042 -179.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -59.51 -41.89 90.97 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 120.928 0.394 . . . . 1.2 111.51 179.34 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -70.62 -50.62 35.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.23 -0.441 . . . . 0.48 111.045 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -60.26 -44.09 95.59 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 116.478 -0.328 . . . . 0.82 111.024 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -64.67 -40.89 96.2 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 110.272 -0.27 . . . . 0.96 110.272 178.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -62.3 -44.81 97.14 Favored Glycine 0 C--N 1.335 0.522 0 N-CA-C 110.746 -0.942 . . . . 0.44 110.746 178.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 212' ' ' MET . . . . . 0.518 ' O ' ' HG ' ' A' ' 216' ' ' LEU . 8.0 mtp -64.09 -42.12 97.05 Favored 'General case' 0 C--O 1.222 -0.375 0 N-CA-C 110.076 -0.342 . . . . 0.95 110.076 178.102 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . 0.42 HD21 ' HB2' ' A' ' 258' ' ' HIS . 6.8 tp -61.85 -39.16 90.87 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 120.889 0.376 . . . . 1.22 111.245 179.136 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 10.4 tpt180 -68.66 -32.52 72.43 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 116.267 -0.424 . . . . 0.97 111.32 179.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 215' ' ' LYS . . . . . 0.488 ' HZ3' ' CD ' ' B' ' 22' ' ' GLU . 99.3 mttt -89.99 -15.56 31.68 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 111.899 0.333 . . . . 0.86 111.899 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . 0.524 HD13 ' CZ ' ' A' ' 251' ' ' PHE . 13.3 mt -62.92 134.18 55.8 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 113.036 0.754 . . . . 1.27 113.036 -179.288 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -100.95 17.04 23.3 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 115.511 -0.768 . . . . 1.1 110.127 178.589 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 30.7 mm -67.88 108.24 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 CA-C-N 116.073 -0.512 . . . . 1.07 111.385 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 2.9 mtmp? -135.08 -42.6 0.73 Allowed 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 112.355 0.502 . . . . 1.36 112.355 -179.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -113.87 -178.39 3.36 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 113.184 0.809 . . . . 1.27 113.184 -177.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . 0.605 ' O ' HG22 ' A' ' 224' ' ' VAL . 8.7 tm-20 -56.52 -44.53 80.88 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 115.723 -0.671 . . . . 1.34 112.244 -179.438 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -54.02 -26.99 36.42 Favored Glycine 0 CA--C 1.527 0.807 0 C-N-CA 121.112 -0.566 . . . . 0.51 113.564 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 62.7 m-20 -68.47 -31.03 70.03 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 112.71 0.633 . . . . 0.75 112.71 -179.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . 0.605 HG22 ' O ' ' A' ' 221' ' ' GLU . 4.4 m -63.22 -28.65 45.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 CA-C-O 121.156 0.503 . . . . 1.18 111.548 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . 0.409 ' HZ1' ' CD ' ' A' ' 221' ' ' GLU . 37.6 mttm -70.0 -39.36 75.93 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-O 121.334 0.587 . . . . 1.95 110.278 179.399 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 226' ' ' SER . . . . . 0.522 ' O ' HG23 ' A' ' 230' ' ' VAL . 11.3 t -66.34 -36.03 81.88 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.896 -0.593 . . . . 0.47 109.535 178.315 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 227' ' ' PHE . . . . . . . . . . . . . 33.8 t80 -60.81 -42.55 97.87 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.184 -0.916 . . . . 0.66 110.314 178.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 228' ' ' SER . . . . . 0.404 ' HB3' HG12 ' A' ' 278' ' ' VAL . 18.8 m -59.62 -45.61 91.45 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 115.716 -0.675 . . . . 1.25 110.634 178.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 15.8 ttm105 -55.52 -43.68 75.97 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.611 -0.722 . . . . 0.46 110.799 178.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . 0.522 HG23 ' O ' ' A' ' 226' ' ' SER . 25.4 t -58.9 -49.56 82.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 CA-C-N 116.118 -0.492 . . . . 1.11 111.679 179.328 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 231' ' ' MET . . . . . 0.535 ' HA ' HD23 ' A' ' 248' ' ' LEU . 70.5 mtm -53.11 -45.74 68.42 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.351 -0.386 . . . . 1.16 111.755 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 37.7 t -68.91 -40.45 81.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-O 120.657 0.265 . . . . 0.69 110.976 178.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 39.5 t-80 -54.89 -33.09 61.63 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.038 -0.528 . . . . 0.6 111.175 179.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . 0.557 HG11 ' HA ' ' B' ' 28' ' ' ARG . 79.0 t -61.78 -30.9 49.4 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 N-CA-C 112.405 0.52 . . . . 0.91 112.405 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -93.98 23.16 5.1 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 112.432 0.53 . . . . 0.71 112.432 -179.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.58 -23.57 17.4 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 113.399 0.889 . . . . 1.25 113.399 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 237' ' ' ASP . . . . . 0.456 ' HB2' HG12 ' A' ' 239' ' ' VAL . 0.1 OUTLIER -76.67 -14.64 59.95 Favored 'General case' 0 CA--C 1.533 0.321 0 O-C-N 121.932 -0.48 . . . . 0.67 111.991 -179.688 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 88.53 12.71 64.35 Favored Glycine 0 CA--C 1.522 0.516 0 C-N-CA 120.79 -0.719 . . . . 0.67 113.488 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . 0.456 HG12 ' HB2' ' A' ' 237' ' ' ASP . 3.9 p -119.48 112.21 36.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 CA-C-O 121.533 0.682 . . . . 0.92 111.569 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 240' ' ' THR . . . . . 0.732 HG22 HD13 ' A' ' 245' ' ' ILE . 4.2 m -81.33 69.93 8.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.101 -0.499 . . . . 0.65 112.235 -179.445 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 48.2 m-20 -76.89 136.21 38.85 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 120.724 0.297 . . . . 0.96 110.976 179.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 242' ' ' TRP . . . . . 0.545 ' CZ3' ' HB2' ' A' ' 296' ' ' PHE . 68.8 m95 -53.66 -36.53 62.22 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 112.972 0.73 . . . . 0.61 112.972 -179.17 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -58.09 -34.88 74.49 Favored Glycine 0 CA--C 1.521 0.46 0 C-N-CA 120.994 -0.622 . . . . 0.38 112.894 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 244' ' ' ARG . . . . . 0.609 ' O ' ' HG ' ' A' ' 248' ' ' LEU . 28.9 mtt180 -74.37 -46.45 40.43 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.917 -0.401 . . . . 1.03 109.917 179.389 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . 0.732 HD13 HG22 ' A' ' 240' ' ' THR . 58.5 mt -55.91 -47.96 79.13 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-N 115.533 -0.758 . . . . 1.17 110.778 178.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 7.6 p -70.15 -29.01 38.01 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 120.905 -0.318 . . . . 1.11 110.852 179.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 247' ' ' THR . . . . . 0.447 HG22 HD21 ' B' ' 27' ' ' LEU . 19.8 m -65.16 -39.64 93.24 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 109.603 -0.517 . . . . 1.01 109.603 177.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 248' ' ' LEU . . . . . 0.609 ' HG ' ' O ' ' A' ' 244' ' ' ARG . 51.4 mt -63.21 -38.91 93.03 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.863 -0.608 . . . . 1.11 109.784 178.204 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 249' ' ' ILE . . . . . 0.431 HG22 HD11 ' A' ' 194' ' ' LEU . 15.6 mt -70.22 -36.9 69.66 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 N-CA-C 109.55 -0.537 . . . . 1.07 109.55 177.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 20.4 m -64.08 -40.5 96.38 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 109.255 -0.646 . . . . 0.4 109.255 178.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 251' ' ' PHE . . . . . 0.525 ' CD2' HD13 ' B' ' 27' ' ' LEU . 8.0 t80 -65.83 -40.99 92.32 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 108.644 -0.873 . . . . 0.68 108.644 176.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -62.69 -39.55 98.06 Favored Glycine 0 C--N 1.336 0.53 0 CA-C-N 115.509 -0.769 . . . . 0.3 111.576 178.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -64.75 -41.44 95.92 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 120.665 0.269 . . . . 0.4 110.517 178.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -63.09 -37.9 89.03 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.042 0.449 . . . . 0.73 110.209 178.503 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 255' ' ' VAL . . . . . 0.513 HG21 ' O ' ' A' ' 251' ' ' PHE . 59.9 t -72.97 -39.42 57.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 N-CA-C 109.83 -0.433 . . . . 1.1 109.83 178.218 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 256' ' ' ALA . . . . . 0.413 ' HB3' HD12 ' A' ' 268' ' ' ILE . . . -55.64 -43.71 76.47 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.143 0.497 . . . . 1.06 109.942 178.042 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 257' ' ' LYS . . . . . 0.79 ' HG2' ' HA ' ' A' ' 171' ' ' ALA . 93.0 mttt -62.39 -47.87 82.25 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 115.507 -0.769 . . . . 0.61 110.378 178.267 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 258' ' ' HIS . . . . . 0.42 ' HB2' HD21 ' A' ' 213' ' ' LEU . 45.3 t60 -59.45 -36.43 75.91 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.3 -0.409 . . . . 0.82 111.379 179.668 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . 0.404 ' O ' ' HB2' ' A' ' 264' ' ' GLN . 88.2 mt -77.37 -51.06 11.47 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 112.023 0.379 . . . . 1.17 112.023 179.275 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 260' ' ' LYS . . . . . 0.495 ' HD2' ' HB1' ' A' ' 171' ' ' ALA . 0.4 OUTLIER -60.81 -42.05 96.91 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 112.496 0.554 . . . . 1.28 112.496 -179.341 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 29.3 p -55.63 -27.98 52.73 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 112.35 0.5 . . . . 0.62 112.35 -179.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 262' ' ' VAL . . . . . 0.513 HG22 ' HG3' ' A' ' 264' ' ' GLN . 17.1 m -109.41 25.83 2.76 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-O 120.759 0.314 . . . . 1.22 111.594 179.361 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 58.4 m-80 55.63 47.44 20.68 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 113.219 0.822 . . . . 1.58 113.219 179.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 264' ' ' GLN . . . . . 0.513 ' HG3' HG22 ' A' ' 262' ' ' VAL . 37.3 mt-30 -103.94 39.8 1.56 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.005 0.431 . . . . 0.89 111.359 179.381 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 265' ' ' GLU . . . . . 0.791 ' HA ' HG22 ' A' ' 268' ' ' ILE . 24.2 mm-40 -50.84 -35.88 34.72 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 112.668 0.618 . . . . 0.71 112.668 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 57.1 p -67.81 -7.96 32.05 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.658 -0.246 . . . . 0.98 111.608 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -116.76 -33.45 4.8 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.525 0.194 . . . . 0.96 111.525 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 268' ' ' ILE . . . . . 0.791 HG22 ' HA ' ' A' ' 265' ' ' GLU . 6.1 tt -67.38 -43.32 87.82 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 N-CA-C 111.705 0.261 . . . . 1.11 111.705 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 269' ' ' GLU . . . . . 0.719 ' HB2' ' HD3' ' A' ' 270' ' ' PRO . 6.7 mm-40 -63.08 -56.03 31.86 Favored Pre-proline 0 CA--C 1.537 0.447 0 C-N-CA 120.851 -0.34 . . . . 0.78 110.751 179.573 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 270' ' ' PRO . . . . . 0.719 ' HD3' ' HB2' ' A' ' 269' ' ' GLU . 50.3 Cg_exo -57.0 -29.64 83.57 Favored 'Trans proline' 0 C--N 1.36 1.179 0 C-N-CA 122.0 1.8 . . . . 0.39 111.588 177.577 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 271' ' ' LEU . . . . . . . . . . . . . 19.1 tp -66.7 -51.08 60.1 Favored 'General case' 0 C--O 1.224 -0.265 0 N-CA-C 109.782 -0.451 . . . . 0.87 109.782 178.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -58.36 -34.48 70.72 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 120.942 0.401 . . . . 0.38 110.514 178.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 273' ' ' GLU . . . . . 0.595 ' OE1' ' HA ' ' A' ' 270' ' ' PRO . 68.9 mt-10 -71.21 -47.81 55.15 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 115.856 -0.611 . . . . 0.97 109.892 178.244 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 274' ' ' THR . . . . . . . . . . . . . 61.1 m -60.67 -43.11 98.05 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.889 -0.596 . . . . 1.16 110.713 179.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 275' ' ' ILE . . . . . 0.514 ' HA ' ' HE3' ' A' ' 231' ' ' MET . 96.1 mt -60.48 -54.64 32.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 115.833 -0.621 . . . . 1.0 110.386 178.589 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 26.0 m -61.17 -48.87 79.55 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.096 -0.502 . . . . 0.85 112.331 -179.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 277' ' ' ASP . . . . . 0.478 ' CG ' HH12 ' A' ' 281' ' ' ARG . 24.2 t70 -54.44 -53.26 56.58 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 120.873 0.368 . . . . 0.37 111.635 -179.676 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 278' ' ' VAL . . . . . 0.404 HG12 ' HB3' ' A' ' 228' ' ' SER . 97.8 t -68.6 -42.93 83.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.365 -0.379 . . . . 1.01 111.649 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 279' ' ' LEU . . . . . 0.422 HD13 HG22 ' A' ' 245' ' ' ILE . 40.6 tp -57.77 -43.08 85.25 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 120.601 0.239 . . . . 1.18 111.618 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 77.6 t -72.3 -53.33 19.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 120.824 -0.351 . . . . 1.12 110.737 179.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 281' ' ' ARG . . . . . 0.51 ' HA ' ' HG3' ' A' ' 284' ' ' ARG . 18.8 ttp-105 -56.44 -40.97 75.67 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 113.669 0.989 . . . . 0.66 113.669 -179.685 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 282' ' ' THR . . . . . 0.872 HG21 ' HD2' ' A' ' 283' ' ' LYS . 13.9 t -63.14 -21.63 66.32 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 113.269 0.84 . . . . 0.67 113.269 -178.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . 0.872 ' HD2' HG21 ' A' ' 282' ' ' THR . 0.4 OUTLIER -142.26 41.76 1.64 Allowed 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 112.4 0.519 . . . . 1.15 112.4 -179.736 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 284' ' ' ARG . . . . . 0.51 ' HG3' ' HA ' ' A' ' 281' ' ' ARG . 68.8 mtt180 -55.01 -47.84 74.14 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 113.035 0.754 . . . . 1.21 113.035 -178.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 285' ' ' ASP . . . . . 0.431 ' HA ' HG21 ' A' ' 288' ' ' VAL . 32.4 t70 -60.5 -39.6 88.32 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.043 0.449 . . . . 0.59 111.327 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 286' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -67.99 -37.99 82.13 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.201 0.524 . . . . 0.66 110.218 179.088 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -70.62 -48.93 52.55 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.639 -0.71 . . . . 1.13 111.638 179.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 288' ' ' VAL . . . . . 0.431 HG21 ' HA ' ' A' ' 285' ' ' ASP . 33.5 m -61.32 -33.76 57.98 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-O 120.627 0.251 . . . . 1.18 111.436 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 50.6 mttp -72.0 -26.14 62.11 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 120.854 0.359 . . . . 1.35 110.874 178.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -101.93 11.01 39.26 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 112.437 0.532 . . . . 0.87 112.437 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 291' ' ' ARG . . . . . 0.402 HH11 ' HD2' ' A' ' 291' ' ' ARG . 29.1 mtm180 62.54 20.29 11.85 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 120.716 0.293 . . . . 0.95 111.7 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 292' ' ' GLY . . . . . 0.418 ' HA3' HD11 ' A' ' 155' ' ' LEU . . . 65.07 -111.67 4.38 Favored Glycine 0 CA--C 1.525 0.662 0 C-N-CA 121.375 -0.441 . . . . 0.56 114.061 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 293' ' ' TRP . . . . . 0.589 ' O ' HG22 ' A' ' 297' ' ' VAL . 53.9 m95 -63.48 -45.89 88.68 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.857 0.688 . . . . 0.57 112.857 -178.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 294' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -50.21 -47.36 54.82 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 111.849 0.315 . . . . 0.52 111.849 -179.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -66.03 -41.19 95.31 Favored Glycine 0 CA--C 1.523 0.561 0 C-N-CA 120.582 -0.818 . . . . 0.33 112.258 178.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 296' ' ' PHE . . . . . 0.545 ' HB2' ' CZ3' ' A' ' 242' ' ' TRP . 1.6 t80 -62.37 -42.68 99.6 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.95 0.405 . . . . 0.5 111.116 179.076 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 297' ' ' VAL . . . . . 0.66 HG13 ' HB3' ' A' ' 189' ' ' ARG . 64.0 t -63.91 -47.18 91.77 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-N 116.004 -0.544 . . . . 1.05 111.807 -179.555 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -59.07 -46.16 88.96 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 112.128 0.418 . . . . 0.65 112.128 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 299' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -59.05 -27.35 65.41 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 120.976 0.417 . . . . 0.63 111.74 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 300' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 . . . . . 0 C--N 1.327 -0.378 0 CA-C-O 121.283 0.563 . . . . 0.71 111.286 179.625 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 22' ' ' GLU . . . . . 0.488 ' CD ' ' HZ3' ' A' ' 215' ' ' LYS . 23.5 tt0 . . . . . 0 C--O 1.232 0.184 0 CA-C-O 120.912 0.387 . . . . 0.81 110.406 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 23' ' ' PHE . . . . . 0.542 ' O ' ' HG ' ' B' ' 27' ' ' LEU . 4.0 p90 -63.76 -33.2 75.12 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.113 -0.494 . . . . 0.65 110.829 179.227 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -72.76 -46.47 53.21 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.256 -0.429 . . . . 1.14 111.095 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.89 -42.21 97.52 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 121.072 0.463 . . . . 0.98 110.456 179.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -59.57 -53.38 58.77 Favored 'General case' 0 N--CA 1.457 -0.105 0 CA-C-N 115.681 -0.69 . . . . 1.15 110.739 179.237 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . 0.542 ' HG ' ' O ' ' B' ' 23' ' ' PHE . 78.3 mt -56.5 -35.58 68.18 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.623 -0.262 . . . . 1.11 111.597 179.685 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 28' ' ' ARG . . . . . 0.557 ' HA ' HG11 ' A' ' 234' ' ' VAL . 0.0 OUTLIER -67.3 -47.07 71.7 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.74 0.305 . . . . 0.56 111.09 179.532 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 44.3 mtmt -67.67 -41.83 83.11 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 121.038 0.447 . . . . 1.16 110.371 178.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . 0.462 ' O ' HG21 ' B' ' 34' ' ' VAL . 97.0 mt -64.31 -40.03 87.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 CA-C-N 115.942 -0.572 . . . . 1.02 110.128 178.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -57.88 -49.95 70.07 Favored Glycine 0 C--N 1.333 0.412 0 CA-C-N 115.879 -0.6 . . . . 0.29 112.941 179.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 39.1 m-20 -68.9 -26.73 65.25 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 117.157 0.479 . . . . 0.48 110.273 178.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 33' ' ' LYS . . . . . 0.423 ' HE2' ' HA ' ' B' ' 33' ' ' LYS . 0.0 OUTLIER -67.86 -53.72 24.51 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.505 -0.316 . . . . 0.5 110.734 178.75 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 34' ' ' VAL . . . . . 0.462 HG21 ' O ' ' B' ' 30' ' ' ILE . 57.3 t -58.03 -47.24 87.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-O 121.081 0.467 . . . . 1.08 110.745 179.503 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -58.15 -46.53 85.52 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.625 -0.716 . . . . 1.13 110.138 178.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 36' ' ' CYS . . . . . . . . . . . . . 43.5 t -63.53 -46.04 87.81 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 115.881 -0.599 . . . . 0.42 111.111 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 62.3 m -61.07 -43.24 99.18 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 112.878 0.695 . . . . 0.91 112.878 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 38' ' ' TRP . . . . . . . . . . . . . 94.2 m95 -82.76 -26.3 32.01 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.696 0.628 . . . . 0.74 112.696 -178.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 8.6 t . . . . . 0 CA--C 1.533 0.308 0 CA-C-O 121.019 0.437 . . . . 0.88 110.287 178.212 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 . . . . . 0 CA--C 1.532 0.281 0 N-CA-C 112.036 0.384 . . . . 0.44 112.036 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -51.98 -52.42 50.59 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 120.747 0.308 . . . . 0.71 111.157 179.544 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 47.4 tp -59.22 -46.17 89.17 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.298 -0.41 . . . . 1.12 111.136 178.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . 0.483 ' OH ' ' HG3' ' A' ' 281' ' ' ARG . 0.1 OUTLIER -60.87 -49.27 78.14 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.413 -0.358 . . . . 0.74 111.545 179.658 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 62.3 mtp180 -62.07 -48.82 78.52 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 112.146 0.424 . . . . 0.57 112.146 -179.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 54.7 mm-40 -61.05 -46.84 89.05 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.732 0.301 . . . . 0.65 110.28 179.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' SER . . . . . 0.4 ' HA ' ' CZ2' ' A' ' 293' ' ' TRP . 16.6 m -61.73 -48.86 78.83 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.217 -0.447 . . . . 0.33 111.078 179.313 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.731 ' HA ' HG22 ' A' ' 276' ' ' THR . 2.0 tm? -56.29 -47.82 77.87 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.65 0.262 . . . . 1.26 110.561 179.487 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -64.54 -48.08 76.41 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.126 0.417 . . . . 0.64 112.126 179.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 78.5 mt -67.25 -51.36 53.91 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 N-CA-C 113.022 0.749 . . . . 1.04 113.022 -179.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.495 HD11 HG23 ' A' ' 276' ' ' THR . 80.2 mt -60.74 -49.35 84.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 O-C-N 122.279 -0.263 . . . . 1.08 111.528 -179.35 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' SER . . . . . 0.5 ' O ' ' HB2' ' A' ' 168' ' ' ARG . 3.1 t -57.99 -38.04 75.36 Favored 'General case' 0 N--CA 1.462 0.153 0 N-CA-C 110.249 -0.278 . . . . 0.83 110.249 178.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.64 -55.74 31.2 Favored 'General case' 0 C--O 1.22 -0.463 0 CA-C-N 116.563 -0.289 . . . . 0.41 110.967 179.344 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' TYR . . . . . 0.643 ' CE1' ' HA ' ' A' ' 195' ' ' ARG . 76.4 t80 -61.26 -51.94 66.81 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 112.495 0.554 . . . . 0.62 112.495 -178.8 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.487 ' HG ' ' O ' ' A' ' 163' ' ' ILE . 33.9 mt -58.76 -48.62 80.57 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 120.713 0.292 . . . . 1.14 111.761 -179.025 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . 0.5 ' HB2' ' O ' ' A' ' 164' ' ' SER . 0.7 OUTLIER -70.97 -45.05 64.77 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 112.318 0.488 . . . . 0.39 112.318 -179.689 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -60.72 -44.35 96.74 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 112.049 0.389 . . . . 0.47 112.049 -179.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -66.73 -48.42 69.26 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.935 -0.306 . . . . 1.14 111.467 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . 0.53 ' HA ' ' HG2' ' A' ' 257' ' ' LYS . . . . . . . . 0 C--N 1.329 -0.304 0 N-CA-C 112.54 0.57 . . . . 0.39 112.54 -179.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . 0.435 ' O ' ' HA3' ' A' ' 187' ' ' GLY . . . . . . . . 0 CA--C 1.535 0.386 0 CA-C-O 120.941 0.4 . . . . 0.43 111.543 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -79.13 -70.74 1.3 Allowed Glycine 0 CA--C 1.527 0.818 0 C-N-CA 120.984 -0.626 . . . . 0.38 114.396 -179.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -70.19 -57.42 4.94 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 112.48 0.548 . . . . 0.54 112.48 -178.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -62.93 -32.13 73.36 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 121.111 0.482 . . . . 1.07 110.087 179.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . 0.435 ' HA3' ' O ' ' A' ' 183' ' ' ALA . . . -72.93 -38.0 56.32 Favored Glycine 0 C--O 1.22 -0.73 0 CA-C-N 115.281 -0.872 . . . . 0.27 112.819 179.245 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 13.1 tpp180 -61.29 -46.73 89.12 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 117.532 0.666 . . . . 0.98 110.877 179.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' ARG . . . . . 0.442 ' HB3' HG12 ' A' ' 297' ' ' VAL . 49.1 mtp180 -67.13 -38.99 86.5 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.251 0.548 . . . . 0.47 110.553 178.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . 0.521 ' HA ' HG21 ' A' ' 297' ' ' VAL . . . -69.83 -38.12 76.42 Favored 'General case' 0 C--O 1.224 -0.269 0 CA-C-N 115.701 -0.681 . . . . 0.54 111.68 179.586 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 20.4 tp -65.81 -47.7 74.18 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 111.531 0.197 . . . . 1.07 111.531 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' GLU . . . . . 0.678 ' O ' ' HG2' ' A' ' 196' ' ' ARG . 5.8 tm-20 -58.62 -47.36 84.64 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 108.964 -0.754 . . . . 0.41 108.964 178.37 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 38.9 m -58.21 -52.36 65.91 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 115.755 -0.657 . . . . 0.4 110.998 178.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 26.9 tp -63.28 -38.68 92.12 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 112.916 0.71 . . . . 0.96 112.916 -179.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . 0.643 ' HA ' ' CE1' ' A' ' 166' ' ' TYR . 3.5 ttm-85 -64.97 -47.24 78.32 Favored 'General case' 0 C--N 1.333 -0.142 0 O-C-N 122.234 -0.291 . . . . 1.01 110.825 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . 0.678 ' HG2' ' O ' ' A' ' 192' ' ' GLU . 33.0 mmm-85 -66.01 -52.78 46.29 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.617 0.246 . . . . 0.56 110.836 179.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . 0.501 HG21 ' HB3' ' A' ' 300' ' ' PHE . 69.4 t -60.65 -51.77 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-N 116.464 -0.335 . . . . 1.01 111.618 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -56.54 -45.28 90.11 Favored Glycine 0 C--N 1.333 0.394 0 C-N-CA 121.389 -0.434 . . . . 0.36 113.042 -179.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . 0.414 ' HA ' ' HG2' ' A' ' 202' ' ' GLN . 33.3 m-20 -67.11 -33.69 76.01 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.658 0.266 . . . . 0.36 110.416 179.173 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -68.93 -32.88 73.9 Favored Glycine 0 CA--C 1.523 0.548 0 C-N-CA 120.72 -0.752 . . . . 0.27 112.002 178.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . 0.558 HG13 ' HA ' ' A' ' 247' ' ' THR . 92.3 t -72.82 -46.48 52.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 CA-C-O 120.687 0.28 . . . . 0.83 111.17 179.181 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' GLN . . . . . 0.414 ' HG2' ' HA ' ' A' ' 199' ' ' ASP . 11.3 pt20 -70.58 -32.5 69.91 Favored 'General case' 0 C--O 1.22 -0.48 0 CA-C-N 116.354 -0.384 . . . . 0.75 111.322 -179.697 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 23.3 ttm180 -68.95 -50.4 49.61 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.798 0.332 . . . . 3.41 110.706 178.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 18.9 m-80 -62.45 -44.46 96.35 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.269 -0.423 . . . . 0.72 111.235 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 87.9 m-70 -103.03 36.28 2.28 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 112.382 0.512 . . . . 0.55 112.382 -179.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -58.01 -42.64 85.67 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 112.613 0.597 . . . . 1.1 112.613 -179.256 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 34.0 p -61.24 -53.05 61.82 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.88 0.371 . . . . 1.19 111.709 -179.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -61.54 -43.73 98.34 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.096 -0.502 . . . . 1.11 110.61 179.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 3.3 m-30 -60.94 -52.04 66.72 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 116.107 -0.497 . . . . 0.59 111.05 179.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 20.1 mt-30 -59.97 -42.74 94.79 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 120.519 0.2 . . . . 0.89 111.249 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -61.21 -51.13 60.21 Favored Glycine 0 C--N 1.335 0.477 0 C-N-CA 120.611 -0.804 . . . . 0.37 111.993 178.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 212' ' ' MET . . . . . 0.644 ' HB3' ' HB3' ' B' ' 23' ' ' PHE . 71.2 mtm -66.34 -31.98 73.1 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 120.586 0.231 . . . . 1.1 110.991 179.344 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 10.3 tp -63.51 -41.95 98.49 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.958 0.408 . . . . 1.16 110.742 178.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 214' ' ' ARG . . . . . 0.425 HH11 ' HD3' ' A' ' 214' ' ' ARG . 39.7 mtt-85 -70.86 -31.74 68.52 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.038 -0.528 . . . . 1.19 111.04 179.414 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -72.8 -21.17 61.02 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 120.971 0.415 . . . . 1.35 111.044 178.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . 0.767 ' HB3' HG12 ' A' ' 218' ' ' ILE . 66.6 mt -72.78 135.37 45.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.02 0.438 . . . . 1.14 111.842 179.617 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -87.79 23.05 2.11 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 116.257 -0.429 . . . . 0.62 110.696 179.08 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 218' ' ' ILE . . . . . 0.767 HG12 ' HB3' ' A' ' 216' ' ' LEU . 50.6 mm -59.47 106.72 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-N 115.723 -0.671 . . . . 1.12 111.627 -179.682 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -154.97 -68.78 0.13 Allowed 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.957 -0.565 . . . . 0.82 111.55 -179.537 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -90.97 -176.48 4.65 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 115.793 -0.64 . . . . 0.76 112.579 -178.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -47.0 -22.45 0.33 Allowed 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 113.34 0.867 . . . . 1.44 113.34 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . 0.447 ' HA2' ' HD2' ' A' ' 225' ' ' LYS . . . -69.7 -22.53 76.81 Favored Glycine 0 CA--C 1.529 0.968 0 CA-C-N 116.522 -0.308 . . . . 0.49 113.134 178.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 223' ' ' ASP . . . . . 0.503 ' HB2' HG22 ' A' ' 218' ' ' ILE . 1.3 p-10 -56.31 -47.44 78.7 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 113.193 0.812 . . . . 0.8 113.193 -178.392 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 31.5 m -60.32 -32.0 49.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-O 121.001 0.429 . . . . 2.29 111.482 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . 0.447 ' HD2' ' HA2' ' A' ' 222' ' ' GLY . 36.9 mttp -76.82 -42.19 41.41 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.315 -0.624 . . . . 1.16 109.315 178.69 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 226' ' ' SER . . . . . 0.508 ' O ' ' HB3' ' A' ' 229' ' ' ARG . 19.9 m -63.16 -42.56 99.46 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 115.321 -0.854 . . . . 0.46 110.568 178.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 227' ' ' PHE . . . . . 0.578 ' O ' ' HG3' ' A' ' 231' ' ' MET . 13.8 t80 -65.39 -48.78 71.67 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.936 -0.575 . . . . 0.75 110.141 179.081 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 30.3 t -56.01 -39.09 71.39 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 109.549 -0.537 . . . . 0.94 109.549 178.211 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 229' ' ' ARG . . . . . 0.508 ' HB3' ' O ' ' A' ' 226' ' ' SER . 19.1 ttt180 -55.95 -44.54 78.53 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 115.165 -0.925 . . . . 1.01 110.23 177.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 47.6 t -68.78 -42.73 82.98 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-N 116.292 -0.413 . . . . 0.79 110.804 178.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 231' ' ' MET . . . . . 0.578 ' HG3' ' O ' ' A' ' 227' ' ' PHE . 47.8 mtp -58.14 -53.0 63.22 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 120.84 0.352 . . . . 1.12 111.492 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 34.5 m -65.58 -30.79 51.23 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 CA-C-N 116.484 -0.326 . . . . 0.49 111.558 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 42.4 t-80 -61.47 -54.79 38.76 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 111.76 0.282 . . . . 0.49 111.76 179.198 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . 0.801 ' HB ' ' HB3' ' B' ' 28' ' ' ARG . 4.0 m -66.4 -29.44 46.6 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 N-CA-C 112.224 0.453 . . . . 1.04 112.224 -178.606 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 36.4 m-85 -100.63 22.18 12.26 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 111.999 0.37 . . . . 0.67 111.999 179.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . 0.439 ' HA ' ' HD2' ' A' ' 236' ' ' LYS . 14.9 tptp -79.75 -21.36 44.55 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.87 0.366 . . . . 1.36 111.545 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 237' ' ' ASP . . . . . 0.418 ' OD1' ' N ' ' A' ' 237' ' ' ASP . 0.0 OUTLIER -69.54 -15.96 63.33 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.096 -0.502 . . . . 0.5 112.085 -179.841 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 90.92 -19.25 46.88 Favored Glycine 0 CA--C 1.521 0.439 0 C-N-CA 120.929 -0.653 . . . . 0.37 113.689 179.089 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 3.3 p -86.49 113.55 24.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.34 0.591 . . . . 0.96 110.848 179.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 59.7 m -93.63 106.25 18.23 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.088 0.471 . . . . 1.0 111.807 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . 0.522 ' HB2' ' HG3' ' A' ' 244' ' ' ARG . 94.8 m-20 -95.39 129.81 42.41 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.937 -0.574 . . . . 0.47 110.43 178.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 242' ' ' TRP . . . . . 0.602 ' HB3' ' CZ ' ' A' ' 300' ' ' PHE . 1.6 m95 -53.29 -41.93 66.09 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 120.938 0.399 . . . . 0.52 111.58 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . 0.428 ' HA3' ' N ' ' B' ' 35' ' ' TYR . . . -64.28 -28.46 73.03 Favored Glycine 0 CA--C 1.521 0.463 0 C-N-CA 120.815 -0.707 . . . . 0.3 112.852 179.139 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 244' ' ' ARG . . . . . 0.522 ' HG3' ' HB2' ' A' ' 241' ' ' ASN . 63.8 mtt180 -70.69 -39.06 73.7 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 122.47 -0.429 . . . . 0.66 110.127 179.194 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 64.0 mt -63.99 -52.28 58.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 CA-C-N 115.82 -0.627 . . . . 1.14 111.229 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 16.8 m -62.38 -35.87 71.82 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 C-N-CA 120.937 -0.305 . . . . 0.6 111.293 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 247' ' ' THR . . . . . 0.558 ' HA ' HG13 ' A' ' 201' ' ' VAL . 99.6 m -64.05 -42.4 97.06 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.076 0.465 . . . . 0.73 109.996 178.159 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 18.9 tp -65.1 -43.6 91.55 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.774 -0.648 . . . . 2.58 110.304 178.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 28.9 mt -64.66 -42.49 95.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 109.757 -0.46 . . . . 1.06 109.757 178.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 45.5 t -61.03 -38.23 85.39 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.786 -0.643 . . . . 0.44 109.842 178.084 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 251' ' ' PHE . . . . . 0.474 ' O ' HG22 ' A' ' 255' ' ' VAL . 34.1 t80 -69.88 -41.37 74.86 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.545 -0.752 . . . . 0.49 109.921 177.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -58.69 -43.93 96.03 Favored Glycine 0 C--N 1.335 0.515 0 N-CA-C 111.134 -0.786 . . . . 0.34 111.134 178.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -61.24 -40.64 94.8 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-O 120.844 0.355 . . . . 0.65 110.087 177.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -60.22 -43.44 96.02 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 116.023 -0.535 . . . . 0.87 109.793 178.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 255' ' ' VAL . . . . . 0.474 HG22 ' O ' ' A' ' 251' ' ' PHE . 64.8 t -66.26 -40.76 87.71 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-N 115.736 -0.666 . . . . 1.07 110.323 178.393 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -62.48 -45.76 91.59 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.318 -0.401 . . . . 0.43 110.155 177.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 257' ' ' LYS . . . . . 0.53 ' HG2' ' HA ' ' A' ' 171' ' ' ALA . 48.0 mtmt -58.98 -45.03 91.59 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.953 -0.567 . . . . 1.06 109.964 177.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -61.63 -34.81 76.33 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.789 -0.641 . . . . 0.44 109.903 178.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . 0.763 ' HG ' ' HB3' ' A' ' 264' ' ' GLN . 2.9 tp -72.12 -32.62 67.12 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 121.251 0.548 . . . . 0.98 110.036 178.096 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 260' ' ' LYS . . . . . 0.663 ' HE3' ' HG3' ' A' ' 265' ' ' GLU . 0.0 OUTLIER -75.4 -31.1 60.31 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 121.118 0.485 . . . . 1.24 110.4 178.069 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 26.7 t -64.07 -19.26 65.1 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.125 -0.489 . . . . 0.76 110.71 178.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 262' ' ' VAL . . . . . 0.407 HG21 ' HB2' ' A' ' 264' ' ' GLN . 31.2 m -114.14 13.81 8.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-N 116.149 -0.478 . . . . 1.14 110.613 178.311 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 6.1 t30 55.91 49.32 16.16 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 115.521 -0.763 . . . . 1.65 112.861 179.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 264' ' ' GLN . . . . . 0.763 ' HB3' ' HG ' ' A' ' 259' ' ' LEU . 4.3 tt0 -113.26 39.13 2.67 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 112.027 0.381 . . . . 1.21 112.027 -179.729 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 265' ' ' GLU . . . . . 0.663 ' HG3' ' HE3' ' A' ' 260' ' ' LYS . 26.4 mt-10 -48.54 -35.96 14.38 Favored 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 112.934 0.716 . . . . 0.52 112.934 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -56.54 -24.69 48.58 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 112.377 0.51 . . . . 1.44 112.377 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 267' ' ' PHE . . . . . 0.446 ' C ' ' HD2' ' A' ' 270' ' ' PRO . 23.3 m-85 -99.37 -16.74 18.31 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 120.974 0.416 . . . . 1.45 111.001 179.214 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 268' ' ' ILE . . . . . 0.57 HD11 ' HA ' ' A' ' 265' ' ' GLU . 67.3 mt -67.15 -43.22 88.68 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-N 116.209 -0.45 . . . . 1.07 110.564 179.251 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 269' ' ' GLU . . . . . 0.719 ' HB2' ' HD3' ' A' ' 270' ' ' PRO . 2.1 mm-40 -55.26 -56.66 26.14 Favored Pre-proline 0 CA--C 1.543 0.692 0 CA-C-N 116.295 -0.411 . . . . 0.4 111.14 179.361 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 270' ' ' PRO . . . . . 0.719 ' HD3' ' HB2' ' A' ' 269' ' ' GLU . 38.1 Cg_exo -59.61 -34.89 96.47 Favored 'Trans proline' 0 C--N 1.362 1.259 0 C-N-CA 122.253 1.969 . . . . 0.39 112.247 178.295 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 271' ' ' LEU . . . . . . . . . . . . . 43.2 tp -64.91 -51.14 63.51 Favored 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 110.128 -0.323 . . . . 0.68 110.128 178.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -59.02 -42.87 91.21 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 120.997 0.427 . . . . 1.13 110.458 178.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 273' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -63.45 -44.53 94.22 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 115.912 -0.585 . . . . 1.97 110.056 178.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 274' ' ' THR . . . . . . . . . . . . . 99.6 m -60.31 -48.4 81.9 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.236 -0.438 . . . . 1.11 110.381 178.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 275' ' ' ILE . . . . . 0.56 ' O ' ' HB2' ' A' ' 279' ' ' LEU . 95.9 mt -54.89 -47.67 75.28 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.096 0 CA-C-N 115.982 -0.554 . . . . 1.11 110.384 179.051 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 276' ' ' THR . . . . . 0.731 HG22 ' HA ' ' A' ' 160' ' ' LEU . 37.9 m -62.95 -52.06 64.5 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.247 -0.433 . . . . 0.93 111.203 179.374 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 277' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -51.94 -53.86 36.24 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.135 -0.484 . . . . 0.46 111.21 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 278' ' ' VAL . . . . . 0.564 ' O ' HG23 ' A' ' 282' ' ' THR . 60.7 t -63.32 -43.57 98.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-O 120.47 0.176 . . . . 0.98 110.883 179.291 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 279' ' ' LEU . . . . . 0.56 ' HB2' ' O ' ' A' ' 275' ' ' ILE . 0.3 OUTLIER -56.01 -47.84 77.02 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.604 -0.271 . . . . 1.2 111.313 179.967 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 57.0 t -75.38 -48.69 30.07 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 N-CA-C 111.729 0.27 . . . . 0.61 111.729 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 281' ' ' ARG . . . . . 0.483 ' HG3' ' OH ' ' A' ' 156' ' ' TYR . 31.2 mtp180 -54.69 -40.09 68.8 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 112.941 0.719 . . . . 0.64 112.941 -179.413 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 282' ' ' THR . . . . . 0.564 HG23 ' O ' ' A' ' 278' ' ' VAL . 6.9 t -91.03 4.62 51.63 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 120.191 -0.603 . . . . 0.49 112.289 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . 0.598 ' HZ3' ' HB2' ' A' ' 283' ' ' LYS . 0.0 OUTLIER -141.23 40.83 1.77 Allowed 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 120.92 0.39 . . . . 0.99 111.328 179.777 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -66.1 -62.33 1.55 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.109 0.481 . . . . 0.57 111.84 -179.274 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 285' ' ' ASP . . . . . 0.4 ' CG ' ' HZ1' ' A' ' 289' ' ' LYS . 25.2 t70 -65.32 -45.05 85.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.912 -0.585 . . . . 0.63 112.214 -179.331 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 286' ' ' TRP . . . . . 0.461 ' O ' ' HB2' ' A' ' 290' ' ' GLN . 2.2 t90 -58.12 -38.89 77.37 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 112.38 0.511 . . . . 0.69 112.38 -179.214 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 287' ' ' LEU . . . . . 0.569 HD23 ' HB3' ' A' ' 283' ' ' LYS . 1.2 mm? -70.59 -49.42 47.98 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.776 0.288 . . . . 0.91 111.776 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 9.1 p -62.83 -34.32 65.25 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-O 120.752 0.31 . . . . 1.26 111.409 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 289' ' ' LYS . . . . . 0.4 ' HZ1' ' CG ' ' A' ' 285' ' ' ASP . 43.5 mttp -75.47 -21.55 57.99 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 120.751 0.31 . . . . 1.42 111.473 178.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 290' ' ' GLN . . . . . 0.461 ' HB2' ' O ' ' A' ' 286' ' ' TRP . 0.0 OUTLIER -100.47 29.1 4.59 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 112.66 0.615 . . . . 0.79 112.66 -179.123 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 291' ' ' ARG . . . . . 0.47 ' HD2' ' HB3' ' A' ' 294' ' ' ASP . 8.1 ttm180 64.71 13.11 8.15 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 112.809 0.67 . . . . 1.07 112.809 179.076 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 65.82 -141.13 41.41 Favored Glycine 0 CA--C 1.525 0.692 0 C-N-CA 121.04 -0.6 . . . . 0.46 114.036 179.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 293' ' ' TRP . . . . . 0.621 ' O ' HG23 ' A' ' 297' ' ' VAL . 84.7 m95 -65.39 -32.22 73.74 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.29 0.478 . . . . 0.63 112.29 -179.149 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 294' ' ' ASP . . . . . 0.47 ' HB3' ' HD2' ' A' ' 291' ' ' ARG . 16.1 t70 -59.97 -37.95 81.11 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 121.102 0.477 . . . . 0.74 109.837 178.34 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -65.3 -43.2 95.56 Favored Glycine 0 C--N 1.335 0.511 0 N-CA-C 110.786 -0.926 . . . . 0.27 110.786 177.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 296' ' ' PHE . . . . . 0.494 ' HB2' ' CH2' ' A' ' 242' ' ' TRP . 0.8 OUTLIER -63.03 -46.71 86.29 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 120.88 0.371 . . . . 0.41 110.457 177.947 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 297' ' ' VAL . . . . . 0.621 HG23 ' O ' ' A' ' 293' ' ' TRP . 90.9 t -59.89 -49.27 84.56 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.395 0 CA-C-N 115.922 -0.581 . . . . 1.08 111.242 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -61.8 -46.57 88.95 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.066 0.395 . . . . 1.17 112.066 -179.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 299' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -61.84 -42.29 98.85 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 112.419 0.525 . . . . 0.6 112.419 -179.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 300' ' ' PHE . . . . . 0.602 ' CZ ' ' HB3' ' A' ' 242' ' ' TRP . 76.5 m-85 . . . . . 0 CA--C 1.537 0.454 0 N-CA-C 113.133 0.79 . . . . 0.51 113.133 -178.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.236 0.381 0 N-CA-C 109.527 -0.545 . . . . 0.47 109.527 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 23' ' ' PHE . . . . . 0.644 ' HB3' ' HB3' ' A' ' 212' ' ' MET . 0.0 OUTLIER -59.29 -43.84 92.53 Favored 'General case' 0 C--O 1.225 -0.198 0 CA-C-N 115.669 -0.696 . . . . 0.44 110.55 179.076 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.85 -43.35 77.0 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 115.968 -0.56 . . . . 0.49 111.515 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . 0.458 ' O ' ' HG3' ' B' ' 28' ' ' ARG . . . -61.08 -49.55 76.85 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 116.162 -0.472 . . . . 0.67 111.282 179.732 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 13.7 mt-30 -68.63 -42.25 78.33 Favored 'General case' 0 C--O 1.224 -0.255 0 CA-C-N 116.304 -0.407 . . . . 0.54 111.202 179.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 16.0 mt -55.53 -49.39 72.75 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.607 -0.27 . . . . 1.28 111.556 179.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 28' ' ' ARG . . . . . 0.801 ' HB3' ' HB ' ' A' ' 234' ' ' VAL . 0.0 OUTLIER -65.29 -37.04 85.95 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 120.473 -0.491 . . . . 0.78 110.519 179.267 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . 0.546 ' HA ' ' HE3' ' B' ' 29' ' ' LYS . 0.0 OUTLIER -65.71 -40.56 92.37 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 109.62 -0.511 . . . . 0.66 109.62 178.264 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 93.4 mt -63.68 -39.94 87.22 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 N-CA-C 108.51 -0.922 . . . . 0.98 108.51 176.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . 0.514 ' HA3' ' HG2' ' A' ' 244' ' ' ARG . . . -60.4 -49.55 77.31 Favored Glycine 0 C--N 1.334 0.445 0 N-CA-C 111.192 -0.763 . . . . 0.25 111.192 177.671 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -56.9 -38.11 72.36 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.165 0.507 . . . . 0.43 109.665 177.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.61 -58.5 5.59 Favored 'General case' 0 C--O 1.227 -0.108 0 CA-C-N 115.613 -0.721 . . . . 1.21 110.598 179.024 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 85.9 t -54.86 -39.52 48.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-O 121.185 0.517 . . . . 0.77 110.289 179.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 35' ' ' TYR . . . . . 0.428 ' N ' ' HA3' ' A' ' 243' ' ' GLY . 9.4 t80 -58.47 -52.49 65.43 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.557 -0.747 . . . . 0.86 110.804 178.487 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 36' ' ' CYS . . . . . 0.436 ' HA ' ' OG ' ' B' ' 39' ' ' SER . 19.9 p -70.03 -25.3 63.51 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.739 0.304 . . . . 0.94 111.033 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 30.6 m -63.71 -44.08 94.68 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.454 -0.339 . . . . 0.99 111.349 179.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 38' ' ' TRP . . . . . . . . . . . . . 95.4 m95 -85.68 -30.25 23.33 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 120.742 0.306 . . . . 0.59 111.632 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 39' ' ' SER . . . . . 0.436 ' OG ' ' HA ' ' B' ' 36' ' ' CYS . 54.7 p . . . . . 0 N--CA 1.47 0.559 0 N-CA-C 112.166 0.432 . . . . 0.66 112.166 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 . . . . . 0 CA--C 1.535 0.375 0 N-CA-C 112.197 0.443 . . . . 0.72 112.197 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -61.38 -45.32 94.86 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.765 0.317 . . . . 0.93 111.64 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 65.3 tp -61.27 -47.05 87.77 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.318 -0.401 . . . . 1.14 110.501 179.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . 0.404 ' O ' ' HB2' ' A' ' 160' ' ' LEU . 0.2 OUTLIER -66.53 -41.34 88.93 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 116.198 -0.456 . . . . 0.53 111.53 179.792 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.24 -51.94 66.83 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 112.538 0.57 . . . . 0.67 112.538 -179.411 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . 0.43 ' HA ' ' HB3' ' A' ' 183' ' ' ALA . 64.6 mt-30 -60.7 -45.55 93.79 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 120.702 0.287 . . . . 0.42 111.153 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' SER . . . . . 0.48 ' HA ' ' CZ2' ' A' ' 293' ' ' TRP . 4.0 p -62.88 -41.9 99.57 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.392 -0.367 . . . . 0.34 111.04 179.379 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.465 HD21 ' HA ' ' A' ' 273' ' ' GLU . 0.2 OUTLIER -58.14 -47.63 82.73 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 120.839 0.352 . . . . 1.24 110.306 178.887 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -64.56 -52.33 58.2 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 112.364 0.505 . . . . 0.72 112.364 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . 0.481 HG12 ' HA2' ' A' ' 187' ' ' GLY . 90.6 mt -59.05 -46.34 91.83 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 CA-C-N 116.754 -0.203 . . . . 0.94 111.348 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 86.7 mt -67.39 -41.82 86.69 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 121.135 -0.226 . . . . 0.98 110.792 178.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 33.3 t -61.0 -44.17 97.81 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.771 0.32 . . . . 0.55 110.914 179.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . 0.476 HH21 ' CD ' ' A' ' 169' ' ' GLU . 2.7 mtp180 -69.15 -52.14 31.17 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.572 -0.285 . . . . 0.99 111.697 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' TYR . . . . . 0.684 ' HE1' ' HA ' ' A' ' 195' ' ' ARG . 64.0 t80 -56.32 -45.58 80.26 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.553 0.216 . . . . 0.47 111.508 -179.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 5.6 mp -60.47 -50.08 75.01 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 121.188 -0.205 . . . . 1.06 111.22 -179.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . 0.512 ' HD2' ' OE2' ' A' ' 269' ' ' GLU . 9.3 mtp180 -66.95 -36.65 82.7 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 112.083 0.401 . . . . 1.56 112.083 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . 0.476 ' CD ' HH21 ' A' ' 165' ' ' ARG . 0.9 OUTLIER -66.12 -51.31 59.18 Favored 'General case' 0 N--CA 1.465 0.282 0 O-C-N 122.268 -0.27 . . . . 0.65 111.391 179.436 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . 0.44 ' HB2' ' HB2' ' A' ' 253' ' ' ALA . 4.4 mm-40 -64.84 -26.22 68.24 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-O 121.014 0.435 . . . . 0.87 110.323 178.545 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.156 0 CA-C-N 115.916 -0.584 . . . . 0.94 110.714 178.222 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . 0.438 ' O ' ' HA3' ' A' ' 187' ' ' GLY . . . . . . . . 0 CA--C 1.536 0.433 0 CA-C-O 121.06 0.457 . . . . 0.61 111.311 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -80.07 -70.31 1.34 Allowed Glycine 0 CA--C 1.527 0.803 0 N-CA-C 114.432 0.533 . . . . 0.42 114.432 -179.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -71.71 -55.48 7.6 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-O 121.063 0.458 . . . . 0.75 111.542 -179.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -63.51 -35.2 79.69 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.974 -0.557 . . . . 0.48 110.16 179.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . 0.61 ' O ' ' HB2' ' A' ' 191' ' ' LEU . . . -63.06 -31.8 81.94 Favored Glycine 0 C--N 1.333 0.403 0 C-N-CA 120.985 -0.626 . . . . 0.33 112.468 179.117 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 6.2 tpt180 -73.07 -57.04 4.31 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 120.635 0.255 . . . . 1.07 111.645 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' ARG . . . . . 0.54 ' HA ' ' OE1' ' A' ' 192' ' ' GLU . 0.0 OUTLIER -62.54 -41.27 98.78 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-O 121.032 0.444 . . . . 0.67 111.576 -179.266 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . 0.442 ' HB1' HD13 ' A' ' 162' ' ' ILE . . . -66.62 -37.06 84.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.362 -0.381 . . . . 0.95 110.909 179.064 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' LEU . . . . . 0.61 ' HB2' ' O ' ' A' ' 187' ' ' GLY . 0.2 OUTLIER -59.84 -41.5 91.51 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.608 0.242 . . . . 1.17 111.293 179.915 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' GLU . . . . . 0.54 ' OE1' ' HA ' ' A' ' 189' ' ' ARG . 5.3 mt-10 -67.14 -52.38 42.4 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.129 0.49 . . . . 0.51 111.422 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' THR . . . . . 0.548 HG21 ' HA ' ' A' ' 297' ' ' VAL . 4.6 m -65.12 -35.43 81.09 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.874 -0.603 . . . . 1.12 112.265 -179.059 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . 0.419 HD12 ' HA ' ' A' ' 194' ' ' LEU . 12.6 tp -69.79 -37.7 76.42 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.694 0.283 . . . . 1.14 111.048 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . 0.684 ' HA ' ' HE1' ' A' ' 166' ' ' TYR . 1.7 ttt180 -66.5 -45.47 79.49 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-O 120.979 0.419 . . . . 0.74 110.882 179.181 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 18.6 mmt85 -64.83 -56.58 12.6 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.821 -0.627 . . . . 1.18 111.959 -179.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . 0.451 ' O ' HG23 ' A' ' 201' ' ' VAL . 98.8 t -66.24 -41.65 89.54 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 CA-C-O 120.901 0.381 . . . . 1.16 111.423 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . 0.495 ' HA3' ' OH ' ' A' ' 166' ' ' TYR . . . -62.0 -52.39 50.46 Favored Glycine 0 CA--C 1.522 0.484 0 C-N-CA 121.178 -0.534 . . . . 0.31 113.494 -179.694 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -63.83 -40.14 95.88 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 117.385 0.592 . . . . 0.57 109.902 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -53.86 -44.97 71.33 Favored Glycine 0 C--N 1.337 0.599 0 C-N-CA 120.621 -0.8 . . . . 0.39 111.603 178.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . 0.547 HG13 ' HD2' ' A' ' 205' ' ' HIS . 88.9 t -72.37 -36.88 56.42 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-O 121.137 0.494 . . . . 0.51 110.949 178.582 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' GLN . . . . . 0.41 ' HA ' ' CE2' ' A' ' 209' ' ' PHE . 14.7 tt0 -64.39 -34.64 78.63 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 115.926 -0.579 . . . . 0.45 111.415 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 17.0 mmp_? -80.54 -53.75 6.29 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 112.998 0.74 . . . . 0.46 112.998 -179.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 24.1 p30 -67.33 -31.0 70.97 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 119.836 -0.745 . . . . 0.57 111.879 -179.125 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 205' ' ' HIS . . . . . 0.547 ' HD2' HG13 ' A' ' 201' ' ' VAL . 93.8 m-70 -102.31 26.86 7.28 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 121.023 -0.271 . . . . 0.61 111.25 178.54 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -53.21 -54.9 29.28 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 115.995 -0.548 . . . . 0.75 112.276 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 43.0 p -58.05 -47.12 84.1 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.078 -0.51 . . . . 1.25 111.882 -179.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -59.46 -44.61 92.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.249 -0.432 . . . . 0.61 110.285 179.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 209' ' ' PHE . . . . . 0.41 ' CE2' ' HA ' ' A' ' 202' ' ' GLN . 10.8 m-30 -63.77 -50.96 66.96 Favored 'General case' 0 C--O 1.223 -0.335 0 CA-C-N 115.973 -0.558 . . . . 0.54 110.751 179.246 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -57.41 -43.7 83.96 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 120.586 0.232 . . . . 0.9 111.553 179.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -61.21 -51.1 60.4 Favored Glycine 0 C--N 1.335 0.505 0 C-N-CA 120.821 -0.704 . . . . 0.5 112.345 179.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -68.07 -34.82 77.15 Favored 'General case' 0 CA--C 1.531 0.212 0 O-C-N 122.592 -0.358 . . . . 1.35 111.086 179.3 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 8.7 tp -59.46 -39.22 82.92 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.96 0.409 . . . . 1.25 110.709 178.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 47.6 ttp180 -71.99 -36.3 69.73 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.944 -0.571 . . . . 1.46 110.521 178.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 52.6 mtmt -73.31 -37.46 66.18 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 116.266 -0.424 . . . . 1.96 112.021 179.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . 0.709 ' HB3' HG12 ' A' ' 218' ' ' ILE . 41.0 mt -63.55 131.64 48.72 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 121.147 0.498 . . . . 1.29 112.117 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -80.4 33.69 0.3 Allowed 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.005 -0.543 . . . . 1.36 111.648 179.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 218' ' ' ILE . . . . . 0.709 HG12 ' HB3' ' A' ' 216' ' ' LEU . 30.7 mm -71.42 105.47 1.78 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.302 0 CA-C-O 120.929 0.395 . . . . 0.75 111.564 -179.172 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 2.6 ttmm -163.07 -53.69 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 115.881 -0.6 . . . . 2.26 111.218 179.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 52.8 m-20 -104.41 -178.5 3.67 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 115.935 -0.575 . . . . 0.89 111.391 -179.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -46.7 -29.42 1.88 Allowed 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 113.482 0.919 . . . . 1.38 113.482 -179.272 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -62.22 -23.59 64.38 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 121.487 -0.387 . . . . 0.53 113.971 179.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 223' ' ' ASP . . . . . 0.506 ' HB2' HG22 ' A' ' 218' ' ' ILE . 2.1 p-10 -58.61 -52.15 66.89 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 113.625 0.972 . . . . 1.11 113.625 -178.297 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 19.6 m -58.66 -38.35 70.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 N-CA-C 112.205 0.446 . . . . 1.06 112.205 -179.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 85.7 mttt -69.09 -43.58 74.25 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.059 0.457 . . . . 1.31 110.29 179.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 226' ' ' SER . . . . . 0.552 ' O ' HG23 ' A' ' 230' ' ' VAL . 20.9 m -65.66 -46.6 78.54 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.84 -0.618 . . . . 0.94 110.265 179.289 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 227' ' ' PHE . . . . . 0.613 ' O ' ' HG3' ' A' ' 231' ' ' MET . 7.2 t80 -58.23 -43.34 87.73 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.918 -0.583 . . . . 0.76 110.521 179.167 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 228' ' ' SER . . . . . 0.426 ' O ' HG23 ' A' ' 232' ' ' VAL . 67.3 m -56.58 -44.16 80.75 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.023 0.44 . . . . 0.45 109.983 178.462 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 69.7 mtp180 -63.18 -35.97 82.06 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 115.885 -0.598 . . . . 1.51 110.321 178.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . 0.698 HG21 ' HE1' ' B' ' 23' ' ' PHE . 28.4 t -63.14 -51.94 65.11 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 N-CA-C 109.601 -0.518 . . . . 0.88 109.601 177.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 231' ' ' MET . . . . . 0.613 ' HG3' ' O ' ' A' ' 227' ' ' PHE . 54.0 mtp -57.23 -43.98 83.38 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.517 -0.765 . . . . 0.54 111.102 179.58 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 232' ' ' VAL . . . . . 0.426 HG23 ' O ' ' A' ' 228' ' ' SER . 55.7 t -58.41 -40.91 80.02 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 N-CA-C 109.985 -0.376 . . . . 1.1 109.985 178.803 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 233' ' ' HIS . . . . . 0.549 ' HA ' ' HB2' ' A' ' 236' ' ' LYS . 54.9 t-80 -71.24 -39.96 71.34 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 116.048 -0.524 . . . . 0.81 111.039 178.725 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . 0.509 HG23 ' O ' ' A' ' 230' ' ' VAL . 74.0 t -57.09 -38.92 63.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-O 120.749 0.309 . . . . 1.08 111.003 179.262 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -104.79 23.7 13.03 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 116.406 -0.361 . . . . 1.1 111.176 178.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . 0.549 ' HB2' ' HA ' ' A' ' 233' ' ' HIS . 5.9 tptp -70.52 -29.95 66.58 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 114.571 1.322 . . . . 1.92 114.571 -177.331 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -69.92 -16.93 63.29 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 118.643 0.656 . . . . 1.24 112.301 -178.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 98.7 -19.67 53.43 Favored Glycine 0 CA--C 1.522 0.527 0 C-N-CA 120.877 -0.678 . . . . 0.48 113.631 179.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . 0.423 ' HB ' ' NH2' ' A' ' 244' ' ' ARG . 21.8 t -77.22 118.12 23.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 121.147 0.499 . . . . 1.13 110.788 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -95.07 100.07 11.95 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.097 0.406 . . . . 0.86 112.097 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . 0.492 ' HB2' ' HG3' ' A' ' 244' ' ' ARG . 14.9 m120 -103.88 134.51 47.06 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 110.391 -0.226 . . . . 0.63 110.391 178.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 242' ' ' TRP . . . . . 0.486 ' HB3' ' CE2' ' A' ' 300' ' ' PHE . 14.0 m95 -56.81 -27.48 59.99 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 112.127 0.417 . . . . 0.59 112.127 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -69.64 -29.57 71.27 Favored Glycine 0 CA--C 1.52 0.39 0 C-N-CA 121.186 -0.531 . . . . 0.35 112.9 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 244' ' ' ARG . . . . . 0.492 ' HG3' ' HB2' ' A' ' 241' ' ' ASN . 19.6 mtt180 -73.72 -37.15 65.22 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.297 0.57 . . . . 0.62 109.645 179.268 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . 0.675 HG21 HD23 ' A' ' 279' ' ' LEU . 83.0 mt -63.03 -51.8 67.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-N 115.446 -0.797 . . . . 1.11 110.998 179.197 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 17.4 m -66.71 -30.33 49.35 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 C-N-CA 120.795 -0.362 . . . . 0.73 111.322 179.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 17.4 m -64.07 -46.54 83.83 Favored 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 110.248 -0.278 . . . . 1.12 110.248 178.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 248' ' ' LEU . . . . . 0.416 HD13 ' HA ' ' A' ' 248' ' ' LEU . 2.5 mm? -60.82 -35.91 77.74 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 120.688 0.28 . . . . 1.19 110.769 178.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 249' ' ' ILE . . . . . 0.546 HG12 ' O ' ' A' ' 245' ' ' ILE . 35.5 mm -71.88 -47.08 57.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 CA-C-O 120.868 0.366 . . . . 1.13 110.436 178.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 39.6 t -59.59 -42.02 91.62 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 121.156 0.503 . . . . 0.37 109.708 178.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 251' ' ' PHE . . . . . 0.435 ' O ' HG21 ' A' ' 255' ' ' VAL . 8.9 t80 -65.72 -44.03 87.31 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 115.607 -0.724 . . . . 0.5 109.825 177.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -57.29 -41.63 93.08 Favored Glycine 0 C--N 1.338 0.653 0 N-CA-C 111.623 -0.591 . . . . 0.32 111.623 178.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 253' ' ' ALA . . . . . 0.44 ' HB2' ' HB2' ' A' ' 170' ' ' GLN . . . -63.83 -40.4 96.53 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 120.808 0.337 . . . . 0.52 110.513 177.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 21.9 t80 -67.51 -38.97 85.08 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-O 121.454 0.645 . . . . 0.7 109.944 178.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 255' ' ' VAL . . . . . 0.435 HG21 ' O ' ' A' ' 251' ' ' PHE . 63.5 t -65.0 -46.65 90.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.775 -0.648 . . . . 1.16 109.445 178.021 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -57.91 -36.62 72.71 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.306 -0.406 . . . . 0.35 110.195 178.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 257' ' ' LYS . . . . . 0.414 ' HG3' ' HZ2' ' A' ' 257' ' ' LYS . 23.3 ttmm -60.21 -45.09 94.37 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 115.663 -0.699 . . . . 2.57 111.45 178.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 258' ' ' HIS . . . . . 0.45 ' CE1' HD12 ' A' ' 259' ' ' LEU . 0.3 OUTLIER -65.95 -34.97 79.33 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 120.731 0.3 . . . . 0.47 111.132 179.538 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . 0.601 ' HG ' ' HB3' ' A' ' 264' ' ' GLN . 3.5 tp -76.83 -46.19 25.75 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 116.551 -0.295 . . . . 1.1 111.485 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 42.7 tttp -63.04 -27.23 69.26 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 120.608 0.242 . . . . 0.55 111.353 179.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 57.8 m -57.98 -26.74 62.73 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 121.004 0.43 . . . . 0.45 110.817 178.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 15.9 m -114.53 23.42 5.25 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 CA-C-O 121.305 0.574 . . . . 1.23 110.093 178.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 263' ' ' ASN . . . . . 0.45 ' HA ' ' OE2' ' A' ' 265' ' ' GLU . 1.7 m120 54.19 59.99 3.87 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 114.948 -1.024 . . . . 0.71 113.475 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 264' ' ' GLN . . . . . 0.601 ' HB3' ' HG ' ' A' ' 259' ' ' LEU . 5.9 mt-30 -119.86 35.61 4.79 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.238 -0.437 . . . . 0.95 110.771 178.485 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 265' ' ' GLU . . . . . 0.579 ' HA ' HG12 ' A' ' 268' ' ' ILE . 0.9 OUTLIER -59.9 -25.0 64.76 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 112.422 0.527 . . . . 0.84 112.422 -179.568 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 16.6 p -64.02 -16.69 62.21 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 120.586 0.231 . . . . 1.19 111.285 179.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 267' ' ' PHE . . . . . 0.515 ' O ' ' HD2' ' A' ' 270' ' ' PRO . 28.6 m-85 -98.96 -32.35 11.34 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 120.982 0.42 . . . . 1.34 111.333 179.082 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 268' ' ' ILE . . . . . 0.579 HG12 ' HA ' ' A' ' 265' ' ' GLU . 20.3 pt -68.07 -28.86 42.64 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 120.955 -0.298 . . . . 1.11 111.453 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 269' ' ' GLU . . . . . 0.84 ' HB2' ' HD3' ' A' ' 270' ' ' PRO . 39.0 mm-40 -57.27 -57.02 27.81 Favored Pre-proline 0 CA--C 1.546 0.82 0 N-CA-C 110.028 -0.36 . . . . 0.66 110.028 178.09 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 270' ' ' PRO . . . . . 0.84 ' HD3' ' HB2' ' A' ' 269' ' ' GLU . 32.0 Cg_exo -62.09 -30.51 82.67 Favored 'Trans proline' 0 C--N 1.362 1.287 0 C-N-CA 122.291 1.994 . . . . 0.52 111.605 177.07 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 271' ' ' LEU . . . . . . . . . . . . . 40.3 tp -64.93 -40.25 94.75 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.114 -0.494 . . . . 1.27 109.751 177.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -63.39 -40.31 96.88 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 109.096 -0.705 . . . . 1.14 109.096 177.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 273' ' ' GLU . . . . . 0.594 ' OE1' ' HA ' ' A' ' 270' ' ' PRO . 35.0 mt-10 -63.49 -41.94 98.54 Favored 'General case' 0 C--O 1.223 -0.332 0 N-CA-C 108.693 -0.854 . . . . 0.8 108.693 177.009 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 274' ' ' THR . . . . . . . . . . . . . 10.1 m -60.32 -53.19 60.63 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.387 -0.824 . . . . 0.71 110.905 178.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 275' ' ' ILE . . . . . 0.506 ' O ' ' HE2' ' A' ' 231' ' ' MET . 97.3 mt -58.09 -46.0 88.3 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-N 116.127 -0.488 . . . . 1.14 111.042 179.738 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 16.6 m -66.21 -49.51 67.03 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.337 -0.392 . . . . 0.64 111.539 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 277' ' ' ASP . . . . . 0.628 ' OD1' ' HD2' ' A' ' 281' ' ' ARG . 25.8 t0 -58.65 -56.34 23.44 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.335 -0.393 . . . . 0.59 111.975 -179.146 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 278' ' ' VAL . . . . . 0.5 HG12 ' HB2' ' A' ' 231' ' ' MET . 61.6 t -58.98 -37.76 69.55 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 120.924 -0.31 . . . . 1.1 111.237 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 279' ' ' LEU . . . . . 0.675 HD23 HG21 ' A' ' 245' ' ' ILE . 28.1 tp -65.7 -46.5 78.79 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 111.98 0.363 . . . . 1.25 111.98 179.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 66.3 t -79.62 -51.25 16.76 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 N-CA-C 112.196 0.443 . . . . 0.83 112.196 -179.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 281' ' ' ARG . . . . . 0.628 ' HD2' ' OD1' ' A' ' 277' ' ' ASP . 3.0 mtt180 -55.11 -38.43 68.15 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 113.205 0.817 . . . . 1.15 113.205 -179.184 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 282' ' ' THR . . . . . . . . . . . . . 2.7 m -82.07 -12.7 58.11 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 112.332 0.493 . . . . 1.24 112.332 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 67.8 mmtt -135.04 41.55 2.83 Favored 'General case' 0 N--CA 1.468 0.47 0 O-C-N 122.063 -0.398 . . . . 1.46 111.774 -179.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 57.3 mtp180 -55.41 -54.44 43.74 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 112.805 0.669 . . . . 0.89 112.805 -178.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 285' ' ' ASP . . . . . 0.494 ' CG ' ' HZ3' ' A' ' 289' ' ' LYS . 29.2 t70 -56.98 -46.0 82.54 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 120.924 0.392 . . . . 0.63 111.85 -179.792 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 286' ' ' TRP . . . . . 0.414 ' O ' ' HB2' ' A' ' 290' ' ' GLN . 0.8 OUTLIER -67.45 -43.1 81.91 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.029 0.381 . . . . 0.72 112.029 -179.375 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -69.13 -46.24 68.13 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 112.373 0.509 . . . . 1.14 112.373 -179.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 9.3 p -63.6 -37.11 78.75 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 121.059 -0.256 . . . . 1.21 111.588 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 289' ' ' LYS . . . . . 0.494 ' HZ3' ' CG ' ' A' ' 285' ' ' ASP . 64.9 mttt -75.03 -24.76 58.38 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 120.759 0.314 . . . . 1.38 111.301 179.236 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 290' ' ' GLN . . . . . 0.414 ' HB2' ' O ' ' A' ' 286' ' ' TRP . 0.0 OUTLIER -91.75 2.98 56.13 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 112.122 0.416 . . . . 0.59 112.122 179.907 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 291' ' ' ARG . . . . . 0.434 HH11 ' HD2' ' A' ' 291' ' ' ARG . 29.5 mtm180 64.06 17.19 10.48 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 112.493 0.553 . . . . 0.57 112.493 179.393 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 64.75 -114.58 6.91 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 114.852 0.701 . . . . 0.39 114.852 178.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 293' ' ' TRP . . . . . 0.48 ' CZ2' ' HA ' ' A' ' 159' ' ' SER . 82.2 m95 -66.26 -36.76 83.83 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 113.262 0.838 . . . . 0.59 113.262 -177.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 294' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -58.69 -47.5 84.32 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 120.826 0.346 . . . . 0.5 110.45 179.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -69.18 -27.5 73.69 Favored Glycine 0 CA--C 1.522 0.471 0 C-N-CA 120.397 -0.906 . . . . 0.31 111.481 178.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 296' ' ' PHE . . . . . 0.423 ' HB3' ' HA ' ' A' ' 293' ' ' TRP . 1.9 t80 -70.2 -48.32 57.63 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 122.561 0.345 . . . . 0.49 111.27 179.057 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 297' ' ' VAL . . . . . 0.548 ' HA ' HG21 ' A' ' 193' ' ' THR . 33.9 m -66.95 -32.62 58.81 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 CA-C-O 120.605 0.241 . . . . 0.8 111.388 -179.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -64.71 -53.54 45.67 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.791 0.329 . . . . 0.49 111.429 179.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 299' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -64.19 -33.83 76.69 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.322 -0.399 . . . . 0.75 111.952 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 300' ' ' PHE . . . . . 0.486 ' CE2' ' HB3' ' A' ' 242' ' ' TRP . 70.2 m-85 . . . . . 0 C--N 1.325 -0.463 0 N-CA-C 112.515 0.561 . . . . 0.57 112.515 -179.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 7.4 tm-20 . . . . . 0 CA--C 1.531 0.22 0 CA-C-O 120.618 0.247 . . . . 1.46 110.596 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 23' ' ' PHE . . . . . 0.698 ' HE1' HG21 ' A' ' 230' ' ' VAL . 10.7 p90 -63.09 -35.41 80.17 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.104 0.478 . . . . 0.77 110.63 179.363 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.34 -44.62 64.74 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.986 -0.552 . . . . 1.03 109.986 178.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.05 -44.72 96.97 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.923 -0.58 . . . . 0.63 110.172 177.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 1.2 tp-100 -58.59 -48.9 79.4 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 115.548 -0.751 . . . . 1.06 110.161 178.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 45.6 mt -58.75 -40.55 84.17 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.292 -0.413 . . . . 1.22 110.637 178.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.89 -51.14 70.55 Favored 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 109.736 -0.468 . . . . 0.49 109.736 178.472 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 46.9 mtpt -55.61 -45.17 77.51 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 116.25 -0.432 . . . . 1.15 110.008 178.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . 0.497 ' O ' HG21 ' B' ' 34' ' ' VAL . 95.5 mt -59.21 -44.96 93.13 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 N-CA-C 109.719 -0.474 . . . . 1.05 109.719 178.123 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . 0.461 ' HA3' ' HG2' ' A' ' 244' ' ' ARG . . . -60.4 -49.55 77.35 Favored Glycine 0 C--N 1.336 0.534 0 CA-C-N 116.028 -0.533 . . . . 0.31 112.302 178.579 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -58.77 -38.82 79.34 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.18 0.514 . . . . 0.43 110.121 178.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -68.28 -47.67 67.03 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 115.75 -0.659 . . . . 1.43 111.353 179.247 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 34' ' ' VAL . . . . . 0.497 HG21 ' O ' ' B' ' 30' ' ' ILE . 53.9 t -56.65 -50.06 75.49 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-O 120.717 0.294 . . . . 0.75 111.422 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -61.86 -38.57 88.73 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 120.881 0.372 . . . . 1.15 110.345 178.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 36' ' ' CYS . . . . . . . . . . . . . 21.4 t -68.03 -25.4 65.36 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.205 -0.452 . . . . 0.94 111.226 179.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 20.4 m -82.78 -42.14 18.31 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.189 -0.46 . . . . 1.01 111.977 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 38' ' ' TRP . . . . . . . . . . . . . 99.2 m95 -80.78 -22.9 39.69 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 112.54 0.571 . . . . 0.79 112.54 -179.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 20.3 t . . . . . 0 N--CA 1.468 0.472 0 N-CA-C 112.283 0.475 . . . . 0.76 112.283 179.888 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . 0.473 ' HA ' ' HB3' ' A' ' 156' ' ' TYR . 2.3 m-20 . . . . . 0 C--O 1.233 0.21 0 CA-C-O 120.904 0.383 . . . . 0.46 110.867 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -56.16 -37.09 69.06 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 121.368 0.604 . . . . 0.48 109.42 177.593 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 53.6 tp -83.44 -32.29 26.15 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.696 -0.684 . . . . 1.25 109.674 178.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . 0.473 ' HB3' ' HA ' ' A' ' 153' ' ' ASP . 83.3 t80 -62.18 -37.45 85.31 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 115.767 -0.651 . . . . 0.52 110.647 178.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . 0.467 ' NH2' HD21 ' A' ' 160' ' ' LEU . 0.7 OUTLIER -59.25 -44.88 92.36 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.039 0.447 . . . . 0.4 110.637 178.727 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -74.32 -35.3 63.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.253 -0.43 . . . . 0.77 110.014 178.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' SER . . . . . 0.459 ' HA ' ' NE1' ' A' ' 293' ' ' TRP . 64.8 m -59.03 -57.69 11.94 Favored 'General case' 0 CA--C 1.521 -0.144 0 CA-C-N 115.854 -0.612 . . . . 0.34 110.645 178.769 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.467 HD21 ' NH2' ' A' ' 157' ' ' ARG . 46.9 tp -62.01 -36.93 83.02 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 121.077 -0.249 . . . . 0.78 110.757 179.306 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.02 -54.11 50.78 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 120.792 0.329 . . . . 0.43 110.649 179.037 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . 0.5 HG12 ' HA2' ' A' ' 187' ' ' GLY . 54.8 mt -63.77 -45.45 97.2 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-N 116.093 -0.503 . . . . 0.95 111.381 179.631 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.451 ' O ' ' HG ' ' A' ' 167' ' ' LEU . 54.8 mt -61.33 -46.73 96.01 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 CA-C-N 116.5 -0.318 . . . . 1.01 111.243 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 31.4 t -62.34 -45.38 93.44 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.876 0.369 . . . . 0.85 110.495 178.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . 0.473 ' O ' ' HB2' ' A' ' 169' ' ' GLU . 0.0 OUTLIER -61.84 -46.13 90.8 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.2 -0.455 . . . . 0.84 111.587 -179.894 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' TYR . . . . . 0.854 ' HE1' ' HA ' ' A' ' 195' ' ' ARG . 91.6 t80 -70.36 -54.14 13.75 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 112.634 0.605 . . . . 0.99 112.634 -179.289 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.451 ' HG ' ' O ' ' A' ' 163' ' ' ILE . 29.8 mt -58.71 -49.74 76.48 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 112.516 0.561 . . . . 1.0 112.516 -177.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -66.03 -39.02 89.84 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 112.274 0.472 . . . . 1.72 112.274 -179.2 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . 0.473 ' HB2' ' O ' ' A' ' 165' ' ' ARG . 14.3 mm-40 -71.19 -47.93 54.62 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 120.56 -0.456 . . . . 0.44 111.755 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . 0.459 ' O ' ' HG3' ' A' ' 170' ' ' GLN . 0.5 OUTLIER -62.27 -28.02 69.42 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 120.918 0.39 . . . . 1.06 111.159 179.129 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . 0.418 ' HB2' ' HB2' ' A' ' 256' ' ' ALA . . . . . . . . 0 N--CA 1.465 0.279 0 N-CA-C 112.7 0.63 . . . . 1.04 112.7 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . 0.517 ' O ' ' HA3' ' A' ' 187' ' ' GLY . . . . . . . . 0 CA--C 1.536 0.416 0 CA-C-O 121.138 0.495 . . . . 0.47 111.542 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -80.43 -71.59 1.27 Allowed Glycine 0 CA--C 1.525 0.691 0 C-N-CA 120.88 -0.676 . . . . 0.39 113.986 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -66.83 -55.58 14.17 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 120.823 0.345 . . . . 0.52 111.808 -179.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -66.26 -37.04 84.53 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.265 -0.425 . . . . 0.47 110.235 179.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . 0.517 ' HA3' ' O ' ' A' ' 183' ' ' ALA . . . -64.85 -41.25 97.58 Favored Glycine 0 C--N 1.334 0.462 0 C-N-CA 120.909 -0.662 . . . . 0.29 112.667 179.282 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . 0.443 HH11 ' HD2' ' A' ' 188' ' ' ARG . 13.5 ttt180 -62.31 -53.47 54.63 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.621 0.248 . . . . 0.61 110.666 178.73 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' ARG . . . . . 0.754 ' HB3' HG13 ' A' ' 297' ' ' VAL . 73.7 mtt180 -59.63 -44.9 93.31 Favored 'General case' 0 C--O 1.228 -0.072 0 CA-C-N 116.24 -0.436 . . . . 0.55 110.98 179.549 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -69.45 -37.86 77.55 Favored 'General case' 0 C--O 1.218 -0.558 0 N-CA-C 112.817 0.673 . . . . 0.84 112.817 -178.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 18.6 tp -64.41 -49.15 72.68 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 118.178 0.444 . . . . 1.1 111.911 -179.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.4 -36.02 81.79 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.853 0.358 . . . . 0.4 111.044 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' THR . . . . . 0.487 HG21 ' HA ' ' A' ' 297' ' ' VAL . 48.2 m -73.05 -44.91 60.1 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.578 -0.283 . . . . 0.49 110.673 179.287 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . 0.427 HD22 HG23 ' A' ' 249' ' ' ILE . 14.7 tp -62.03 -36.46 81.64 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.41 -0.359 . . . . 1.03 110.531 179.181 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . 0.854 ' HA ' ' HE1' ' A' ' 166' ' ' TYR . 0.8 OUTLIER -63.96 -55.72 20.38 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.015 0.436 . . . . 0.41 110.683 178.449 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.33 -47.9 83.65 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.457 -0.792 . . . . 1.64 112.41 -179.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . 0.513 ' O ' HG21 ' A' ' 201' ' ' VAL . 83.0 t -72.82 -49.73 38.04 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 N-CA-C 111.97 0.359 . . . . 0.63 111.97 -179.461 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . 0.513 ' O ' ' HG2' ' A' ' 202' ' ' GLN . . . -57.61 -53.38 45.54 Favored Glycine 0 C--N 1.334 0.462 0 C-N-CA 121.187 -0.53 . . . . 0.33 112.498 -179.568 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . 0.537 ' HB2' ' O ' ' A' ' 195' ' ' ARG . 0.3 OUTLIER -59.17 -40.65 86.29 Favored 'General case' 0 C--O 1.224 -0.262 0 N-CA-C 109.841 -0.429 . . . . 0.72 109.841 178.783 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -62.4 -50.01 68.71 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 120.898 -0.668 . . . . 0.4 112.604 178.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . 0.513 HG21 ' O ' ' A' ' 197' ' ' VAL . 78.1 t -55.88 -52.63 47.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-O 120.743 0.306 . . . . 1.04 111.764 179.275 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' GLN . . . . . 0.529 ' HG3' ' CZ ' ' A' ' 203' ' ' ARG . 1.4 pt20 -69.53 -31.75 70.17 Favored 'General case' 0 C--O 1.221 -0.432 0 N-CA-C 112.091 0.404 . . . . 0.52 112.091 -179.382 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' ARG . . . . . 0.529 ' CZ ' ' HG3' ' A' ' 202' ' ' GLN . 0.0 OUTLIER -68.77 -43.43 75.77 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.955 0.407 . . . . 0.86 109.997 178.003 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 18.2 m-80 -66.35 -47.09 74.56 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 121.163 0.506 . . . . 0.6 110.604 178.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -97.76 36.26 1.55 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.028 -0.533 . . . . 0.71 110.216 179.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . 0.517 ' OE1' ' HA ' ' A' ' 203' ' ' ARG . 4.5 tp10 -49.72 -52.0 34.6 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 115.477 -0.783 . . . . 0.47 112.186 -178.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 64.7 p -65.66 -38.96 90.78 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.595 0.591 . . . . 1.17 112.595 -179.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -63.85 -45.51 89.17 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.066 0.46 . . . . 1.07 110.449 179.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -71.13 -42.34 69.34 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.976 -0.557 . . . . 0.62 110.475 179.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 210' ' ' GLN . . . . . 0.42 ' O ' ' HG3' ' A' ' 214' ' ' ARG . 6.7 tt0 -62.58 -45.88 90.89 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.188 -0.46 . . . . 1.01 110.852 179.243 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -59.93 -49.45 78.41 Favored Glycine 0 C--N 1.334 0.47 0 C-N-CA 120.902 -0.666 . . . . 0.34 111.82 178.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 212' ' ' MET . . . . . 0.479 ' SD ' ' HA ' ' B' ' 23' ' ' PHE . 2.0 ttp -60.91 -36.34 79.02 Favored 'General case' 0 C--O 1.224 -0.257 0 CA-C-O 120.884 0.374 . . . . 1.1 110.002 178.631 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 7.8 tp -68.1 -39.93 82.7 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.663 -0.699 . . . . 1.25 110.919 178.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 214' ' ' ARG . . . . . 0.42 ' HG3' ' O ' ' A' ' 210' ' ' GLN . 70.0 mtt-85 -57.54 -39.34 76.41 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.163 -0.471 . . . . 0.97 110.759 178.639 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 215' ' ' LYS . . . . . 0.425 ' HE3' ' HB2' ' A' ' 215' ' ' LYS . 47.2 mtmt -99.01 12.13 36.91 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.099 -0.5 . . . . 0.88 111.191 179.055 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 28.0 tp -82.41 110.41 17.53 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.948 0.404 . . . . 1.08 111.14 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 35.8 m-20 -79.43 32.74 0.24 Allowed 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 112.437 0.532 . . . . 0.59 112.437 -179.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 218' ' ' ILE . . . . . 0.447 HG22 ' HB2' ' A' ' 223' ' ' ASP . 2.7 mt -81.18 107.68 13.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 CA-C-O 121.424 0.63 . . . . 1.09 110.634 179.155 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . 0.453 ' HG2' HE22 ' A' ' 264' ' ' GLN . 0.4 OUTLIER -161.3 -39.24 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 115.252 -0.885 . . . . 0.9 111.209 179.396 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -105.11 -177.46 3.37 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.5 -0.318 . . . . 0.78 111.853 -179.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -49.53 -21.68 1.03 Allowed 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 113.677 0.992 . . . . 0.66 113.677 -179.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -69.55 -23.81 76.45 Favored Glycine 0 CA--C 1.531 1.074 0 N-CA-C 114.265 0.466 . . . . 0.47 114.265 -179.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 223' ' ' ASP . . . . . 0.447 ' HB2' HG22 ' A' ' 218' ' ' ILE . 6.5 p-10 -55.48 -56.52 19.23 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 113.711 1.004 . . . . 0.89 113.711 -177.449 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . 0.513 ' HB ' HG21 ' A' ' 274' ' ' THR . 17.2 m -61.53 -33.38 56.83 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-O 121.038 0.447 . . . . 1.07 111.672 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 48.2 mttp -70.26 -39.14 75.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.085 0.469 . . . . 1.49 110.478 179.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 226' ' ' SER . . . . . 0.649 ' O ' HG23 ' A' ' 230' ' ' VAL . 7.3 t -74.19 -44.69 52.43 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.095 -0.502 . . . . 1.44 110.652 179.113 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 227' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -57.99 -46.62 84.91 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.969 0.414 . . . . 0.56 110.853 179.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 228' ' ' SER . . . . . 0.475 ' CB ' HG23 ' A' ' 278' ' ' VAL . 16.3 p -65.78 -39.37 90.91 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.735 -0.469 . . . . 0.54 109.735 178.483 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 42.6 ttp180 -60.08 -45.39 93.06 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.198 -0.456 . . . . 1.39 110.202 177.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . 0.649 HG23 ' O ' ' A' ' 226' ' ' SER . 99.8 t -59.39 -48.0 88.66 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-N 116.017 -0.538 . . . . 0.98 110.353 178.48 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 231' ' ' MET . . . . . 0.728 ' HG3' HD11 ' A' ' 248' ' ' LEU . 29.6 ttm -55.22 -41.15 71.69 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.046 -0.524 . . . . 1.09 111.553 179.606 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 232' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 228' ' ' SER . 85.2 t -66.93 -36.1 76.32 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-O 121.037 0.446 . . . . 1.0 111.079 179.287 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 44.8 t-80 -77.2 -36.36 54.98 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 116.415 -0.357 . . . . 0.67 111.636 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . 0.436 HG23 ' O ' ' A' ' 230' ' ' VAL . 52.0 t -56.58 -39.63 63.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 CA-C-O 120.867 0.365 . . . . 1.1 111.49 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 235' ' ' PHE . . . . . 0.818 ' HE2' HD13 ' A' ' 248' ' ' LEU . 75.7 m-85 -100.29 24.25 9.03 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.031 0.382 . . . . 0.48 112.031 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 3.2 ttpp -73.1 -10.91 60.29 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 120.541 0.21 . . . . 1.09 111.489 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 22.2 p-10 -89.06 -10.38 47.66 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 120.731 0.301 . . . . 0.38 111.061 179.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 91.52 -19.23 48.92 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 114.487 0.555 . . . . 0.36 114.487 178.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . 0.539 ' HB ' ' NH2' ' A' ' 244' ' ' ARG . 17.9 t -78.78 102.81 5.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 O-C-N 122.23 -0.571 . . . . 0.51 111.305 -179.67 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 240' ' ' THR . . . . . 0.477 ' HA ' ' CE1' ' A' ' 235' ' ' PHE . 24.1 m -93.25 84.03 4.72 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.112 0.482 . . . . 0.71 111.344 -179.662 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . 0.406 ' HB2' ' HG3' ' A' ' 244' ' ' ARG . 80.5 m-20 -89.09 141.03 28.85 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.316 -0.402 . . . . 0.44 111.338 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 242' ' ' TRP . . . . . . . . . . . . . 18.9 m95 -57.93 -37.89 74.91 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.759 0.314 . . . . 0.6 111.112 179.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -60.04 -30.89 71.18 Favored Glycine 0 C--N 1.335 0.503 0 C-N-CA 120.991 -0.623 . . . . 0.26 112.047 178.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 244' ' ' ARG . . . . . 0.539 ' NH2' ' HB ' ' A' ' 239' ' ' VAL . 26.1 mtt180 -75.45 -48.06 24.43 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.969 0.414 . . . . 0.5 109.959 178.526 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . 0.526 HG22 HD12 ' A' ' 279' ' ' LEU . 73.3 mt -56.5 -44.93 81.72 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-N 115.449 -0.796 . . . . 1.03 110.625 179.53 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 9.9 p -70.94 -32.38 48.37 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-N 116.322 -0.399 . . . . 0.68 110.819 178.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 15.8 m -63.09 -38.02 89.54 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 122.293 -0.254 . . . . 1.09 110.567 179.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 248' ' ' LEU . . . . . 0.818 HD13 ' HE2' ' A' ' 235' ' ' PHE . 26.3 mt -62.83 -41.89 99.51 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 121.3 0.571 . . . . 1.16 109.799 177.657 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 249' ' ' ILE . . . . . 0.427 HG23 HD22 ' A' ' 194' ' ' LEU . 32.8 mm -68.53 -36.06 73.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 CA-C-N 115.694 -0.685 . . . . 1.1 109.571 178.197 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 40.6 t -63.3 -45.06 93.12 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 109.288 -0.634 . . . . 1.04 109.288 178.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 251' ' ' PHE . . . . . 0.445 ' O ' HG22 ' A' ' 255' ' ' VAL . 10.9 t80 -64.09 -41.02 97.46 Favored 'General case' 0 N--CA 1.456 -0.165 0 N-CA-C 108.766 -0.827 . . . . 0.51 108.766 177.636 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -57.57 -44.73 93.75 Favored Glycine 0 C--N 1.337 0.588 0 N-CA-C 110.946 -0.861 . . . . 0.28 110.946 177.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 253' ' ' ALA . . . . . 0.467 ' O ' ' HG3' ' A' ' 257' ' ' LYS . . . -63.95 -32.02 73.4 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 121.0 0.428 . . . . 0.84 110.899 177.485 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -68.8 -45.05 72.27 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 121.164 0.507 . . . . 0.87 109.634 178.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 255' ' ' VAL . . . . . 0.445 HG22 ' O ' ' A' ' 251' ' ' PHE . 59.3 t -64.22 -38.36 82.3 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-N 115.783 -0.644 . . . . 1.1 109.743 178.019 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 256' ' ' ALA . . . . . 0.418 ' HB2' ' HB2' ' A' ' 171' ' ' ALA . . . -57.99 -47.45 82.96 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 115.892 -0.595 . . . . 1.07 110.067 178.316 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 257' ' ' LYS . . . . . 0.467 ' HG3' ' O ' ' A' ' 253' ' ' ALA . 49.5 mttp -59.25 -49.13 79.04 Favored 'General case' 0 N--CA 1.462 0.137 0 N-CA-C 110.066 -0.346 . . . . 0.49 110.066 178.069 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 81.4 t60 -57.59 -45.78 84.85 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 115.81 -0.632 . . . . 0.84 111.738 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 4.9 mp -69.53 -41.89 75.4 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.449 -0.341 . . . . 1.1 111.519 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 1.3 tmtm? -67.44 -32.48 73.38 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-O 120.476 0.179 . . . . 0.62 111.177 179.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 54.2 m -63.98 -27.64 69.27 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 120.893 0.378 . . . . 0.43 111.151 179.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 29.9 m -105.89 10.96 8.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-O 121.002 0.43 . . . . 1.07 110.702 178.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 61.34 36.76 17.42 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 113.231 0.826 . . . . 0.69 113.231 179.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 264' ' ' GLN . . . . . 0.453 HE22 ' HG2' ' A' ' 219' ' ' LYS . 5.4 mt-30 -105.33 37.67 2.14 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.337 0.589 . . . . 0.92 110.22 178.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -56.65 -22.72 36.46 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 113.306 0.854 . . . . 0.56 113.306 -179.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 10.7 p -61.35 -18.75 60.13 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.556 0.217 . . . . 1.05 111.271 179.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -96.22 -22.57 17.18 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 120.837 0.351 . . . . 1.16 110.772 178.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 60.1 mt -67.18 -44.79 87.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-N 116.361 -0.382 . . . . 1.02 111.093 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 269' ' ' GLU . . . . . 0.637 ' HB2' ' HD3' ' A' ' 270' ' ' PRO . 1.0 OUTLIER -53.64 -56.38 25.52 Favored Pre-proline 0 CA--C 1.547 0.847 0 CA-C-N 116.254 -0.43 . . . . 0.61 111.643 179.706 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 270' ' ' PRO . . . . . 0.637 ' HD3' ' HB2' ' A' ' 269' ' ' GLU . 27.5 Cg_exo -64.34 -28.87 63.32 Favored 'Trans proline' 0 C--N 1.36 1.161 0 C-N-CA 122.105 1.87 . . . . 0.44 112.333 178.554 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 271' ' ' LEU . . . . . . . . . . . . . 38.3 tp -65.19 -43.21 92.36 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.4 -0.364 . . . . 1.06 110.586 178.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -58.84 -46.97 86.45 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.259 -0.428 . . . . 0.56 111.246 179.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 273' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -65.44 -42.94 91.88 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.534 -0.303 . . . . 0.68 110.403 178.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 274' ' ' THR . . . . . 0.513 HG21 ' HB ' ' A' ' 224' ' ' VAL . 85.9 m -58.86 -50.35 74.33 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.235 -0.438 . . . . 0.86 110.411 179.148 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 275' ' ' ILE . . . . . 0.478 ' HA ' ' HE3' ' A' ' 231' ' ' MET . 96.9 mt -59.44 -54.41 34.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.105 -0.498 . . . . 1.07 110.351 178.463 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 21.0 m -56.61 -52.99 62.73 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 113.105 0.78 . . . . 0.45 113.105 -179.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 277' ' ' ASP . . . . . 0.471 ' O ' ' HD2' ' A' ' 281' ' ' ARG . 0.2 OUTLIER -56.41 -53.7 54.34 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.445 0.164 . . . . 0.4 111.433 -179.212 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 278' ' ' VAL . . . . . 0.475 HG23 ' CB ' ' A' ' 228' ' ' SER . 89.3 t -60.68 -38.55 78.9 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 CA-C-O 120.796 0.331 . . . . 0.88 110.804 179.363 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 279' ' ' LEU . . . . . 0.526 HD12 HG22 ' A' ' 245' ' ' ILE . 2.4 tp -62.0 -47.08 86.39 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 116.421 -0.354 . . . . 1.42 111.881 179.527 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 61.9 t -76.56 -40.88 34.26 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 N-CA-C 112.47 0.544 . . . . 0.96 112.47 -179.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 281' ' ' ARG . . . . . 0.471 ' HD2' ' O ' ' A' ' 277' ' ' ASP . 0.0 OUTLIER -66.31 -28.5 68.73 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 112.474 0.546 . . . . 0.42 112.474 -179.356 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 282' ' ' THR . . . . . . . . . . . . . 25.3 p -85.32 -64.15 1.2 Allowed 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.063 0.459 . . . . 0.99 112.024 179.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . 0.418 ' HZ1' ' HA ' ' A' ' 279' ' ' LEU . 22.3 mtmm -88.99 40.74 0.99 Allowed 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.24 0.459 . . . . 0.79 112.24 -178.353 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 284' ' ' ARG . . . . . 0.46 ' O ' HG21 ' A' ' 288' ' ' VAL . 2.9 ptp85 -57.66 -46.17 84.57 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 112.136 0.421 . . . . 0.57 112.136 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 285' ' ' ASP . . . . . 0.422 ' O ' ' HB2' ' A' ' 289' ' ' LYS . 8.0 t70 -62.13 -51.52 67.54 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 111.87 0.322 . . . . 0.42 111.87 -179.24 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 286' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -61.83 -33.07 73.5 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.862 0.363 . . . . 0.5 111.234 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -70.81 -52.47 20.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.228 -0.442 . . . . 0.77 110.809 178.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 288' ' ' VAL . . . . . 0.46 HG21 ' O ' ' A' ' 284' ' ' ARG . 27.6 m -64.36 -30.68 50.83 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-O 120.813 0.34 . . . . 0.5 111.821 179.724 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 289' ' ' LYS . . . . . 0.422 ' HB2' ' O ' ' A' ' 285' ' ' ASP . 0.3 OUTLIER -68.36 -40.81 81.35 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 112.294 0.479 . . . . 0.87 112.294 -179.808 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 290' ' ' GLN . . . . . 0.465 ' O ' ' HA3' ' A' ' 295' ' ' GLY . 0.8 OUTLIER -96.94 30.05 2.84 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 112.867 0.692 . . . . 0.57 112.867 -178.9 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 33.1 mtm105 58.37 23.66 10.79 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 112.14 0.422 . . . . 0.46 112.14 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 69.21 -130.32 24.05 Favored Glycine 0 CA--C 1.523 0.554 0 C-N-CA 121.21 -0.519 . . . . 0.35 114.003 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 293' ' ' TRP . . . . . 0.604 ' O ' HG21 ' A' ' 297' ' ' VAL . 76.0 m95 -71.48 -29.45 64.85 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.386 0.514 . . . . 0.54 112.386 -178.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 294' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -59.72 -42.83 93.95 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 120.637 -0.425 . . . . 0.42 110.046 179.563 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 295' ' ' GLY . . . . . 0.465 ' HA3' ' O ' ' A' ' 290' ' ' GLN . . . -70.05 -38.13 73.6 Favored Glycine 0 C--N 1.336 0.556 0 N-CA-C 111.003 -0.839 . . . . 0.28 111.003 177.596 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 296' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -59.45 -37.48 78.25 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.096 0.474 . . . . 0.49 110.352 177.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 297' ' ' VAL . . . . . 0.754 HG13 ' HB3' ' A' ' 189' ' ' ARG . 71.4 t -65.71 -50.2 72.63 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-N 115.794 -0.639 . . . . 0.94 110.925 179.236 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -57.91 -41.87 83.56 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.236 -0.438 . . . . 0.54 111.395 179.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 299' ' ' PHE . . . . . 0.401 ' CZ ' ' HB2' ' B' ' 39' ' ' SER . 78.0 t80 -61.57 -40.14 93.66 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 116.18 -0.464 . . . . 0.66 112.227 -179.592 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 300' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 . . . . . 0 C--N 1.325 -0.463 0 CA-C-O 120.877 0.37 . . . . 0.58 111.596 -179.567 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 . . . . . 0 CA--C 1.529 0.139 0 N-CA-C 111.317 0.118 . . . . 0.47 111.317 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 23' ' ' PHE . . . . . 0.479 ' HA ' ' SD ' ' A' ' 212' ' ' MET . 0.7 OUTLIER -55.64 -40.05 71.68 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 112.566 0.58 . . . . 0.43 112.566 -179.194 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 24' ' ' ALA . . . . . 0.429 ' N ' ' HD1' ' B' ' 23' ' ' PHE . . . -68.97 -46.16 68.83 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.969 0.414 . . . . 1.0 111.049 -179.648 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . 0.547 ' O ' ' HG2' ' B' ' 29' ' ' LYS . . . -64.05 -52.84 57.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.005 -0.543 . . . . 1.18 110.806 179.319 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -55.19 -54.65 40.67 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 115.375 -0.829 . . . . 0.5 112.102 -179.394 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 45.3 mt -63.2 -29.4 70.75 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 120.957 -0.297 . . . . 1.05 111.638 -179.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 28' ' ' ARG . . . . . . . . . . . . . 4.4 tmt_? -70.93 -57.21 4.8 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 120.896 0.379 . . . . 1.09 110.503 178.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . 0.547 ' HG2' ' O ' ' B' ' 25' ' ' ALA . 10.4 ptmt -61.79 -42.39 98.94 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 116.397 -0.365 . . . . 1.51 111.901 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 88.3 mt -64.79 -41.51 92.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.181 0 N-CA-C 109.831 -0.433 . . . . 0.93 109.831 179.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . 0.531 ' HA3' ' HG2' ' A' ' 244' ' ' ARG . . . -59.76 -49.22 80.92 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.956 -0.64 . . . . 0.29 112.017 178.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 36.9 m-20 -66.6 -34.72 78.52 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.642 0.221 . . . . 0.37 110.876 178.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 33' ' ' LYS . . . . . 0.412 ' O ' ' HE3' ' B' ' 33' ' ' LYS . 0.0 OUTLIER -65.46 -47.62 75.51 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.791 0.329 . . . . 0.84 110.128 178.169 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 42.4 t -61.37 -48.87 86.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 CA-C-O 121.067 0.461 . . . . 1.11 109.775 178.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -55.58 -38.3 69.21 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 115.63 -0.714 . . . . 1.12 109.999 178.088 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 36' ' ' CYS . . . . . . . . . . . . . 52.1 t -65.56 -46.14 80.64 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-N 116.012 -0.54 . . . . 2.07 110.996 178.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 97.0 m -62.33 -35.86 80.39 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 112.861 0.689 . . . . 1.02 112.861 -179.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 38' ' ' TRP . . . . . . . . . . . . . 96.8 m95 -86.86 -25.43 24.5 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 112.767 0.654 . . . . 0.73 112.767 -178.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 39' ' ' SER . . . . . 0.401 ' HB2' ' CZ ' ' A' ' 299' ' ' PHE . 14.7 t . . . . . 0 N--CA 1.466 0.366 0 CA-C-O 121.007 0.432 . . . . 1.1 111.286 179.079 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 . . . . . 0 CA--C 1.531 0.246 0 N-CA-C 111.536 0.198 . . . . 0.53 111.536 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -57.84 -46.53 84.63 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 121.036 0.446 . . . . 0.48 110.951 179.394 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.625 HD22 ' HB3' ' A' ' 287' ' ' LEU . 13.9 tp -62.83 -46.41 88.07 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.99 -0.55 . . . . 1.38 111.133 178.701 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 44.5 t80 -66.71 -40.6 88.52 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.167 -0.469 . . . . 0.44 111.767 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 32.4 mtm180 -59.75 -46.75 88.18 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.81 0.338 . . . . 0.61 111.416 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . 0.402 ' HA ' ' HB2' ' A' ' 183' ' ' ALA . 51.1 mt-30 -70.45 -35.81 73.55 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.756 0.312 . . . . 0.95 110.585 179.536 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 51.9 m -65.04 -45.85 83.72 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.481 -0.327 . . . . 0.33 110.138 178.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.773 ' HA ' HG23 ' A' ' 276' ' ' THR . 2.1 tm? -53.64 -55.29 27.23 Favored 'General case' 0 C--O 1.225 -0.186 0 CA-C-N 116.026 -0.534 . . . . 1.14 110.572 178.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -55.13 -43.61 74.3 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 112.271 0.471 . . . . 1.18 112.271 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . 0.491 HG21 HD23 ' A' ' 191' ' ' LEU . 90.6 mt -69.18 -53.46 25.43 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 N-CA-C 112.394 0.516 . . . . 1.07 112.394 -179.313 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.519 HD12 HG21 ' A' ' 276' ' ' THR . 68.2 mt -66.12 -47.77 83.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 N-CA-C 112.017 0.377 . . . . 1.07 112.017 -179.39 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 3.5 t -58.34 -44.55 88.76 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.644 0.259 . . . . 0.34 111.226 -179.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 21.4 ttm180 -66.69 -49.48 65.97 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 120.296 -0.562 . . . . 0.67 110.506 178.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' TYR . . . . . 0.988 ' HE1' ' HA ' ' A' ' 195' ' ' ARG . 93.5 t80 -55.41 -52.47 63.45 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 112.601 0.593 . . . . 0.42 112.601 -179.672 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 5.0 mp -60.74 -45.7 93.3 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 120.834 -0.346 . . . . 0.88 111.833 -179.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . 0.535 ' HD2' ' OE1' ' A' ' 269' ' ' GLU . 0.0 OUTLIER -65.36 -37.18 86.26 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.665 0.269 . . . . 0.47 110.924 179.679 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -58.22 -53.9 53.02 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.056 -0.52 . . . . 0.45 110.473 178.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . 0.749 ' HB3' ' HE3' ' A' ' 257' ' ' LYS . 2.2 mt-30 -67.19 -39.9 86.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.026 -0.533 . . . . 0.52 111.093 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.221 0 CA-C-O 120.833 0.349 . . . . 0.44 111.711 179.414 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . 0.639 ' O ' ' HA3' ' A' ' 187' ' ' GLY . . . . . . . . 0 CA--C 1.536 0.408 0 CA-C-O 121.096 0.474 . . . . 0.62 111.611 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -80.41 -71.54 1.27 Allowed Glycine 0 CA--C 1.527 0.808 0 C-N-CA 120.67 -0.776 . . . . 0.46 113.527 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -64.05 -55.78 19.72 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 120.992 0.425 . . . . 1.17 111.264 -179.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -65.65 -34.55 78.48 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.934 -0.576 . . . . 1.06 110.261 178.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . 0.639 ' HA3' ' O ' ' A' ' 183' ' ' ALA . . . -65.39 -47.91 74.33 Favored Glycine 0 C--O 1.217 -0.945 0 C-N-CA 121.068 -0.587 . . . . 0.47 112.723 179.702 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 4.8 tmm_? -60.37 -48.65 80.84 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-N 117.349 0.574 . . . . 0.84 111.314 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 189' ' ' ARG . . . . . 0.471 ' HG2' HG21 ' A' ' 297' ' ' VAL . 3.9 ttp180 -63.02 -46.29 88.3 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 120.763 0.316 . . . . 0.67 110.753 -179.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . 0.442 ' HA ' ' CG1' ' A' ' 297' ' ' VAL . . . -71.69 -31.15 66.45 Favored 'General case' 0 C--O 1.222 -0.367 0 N-CA-C 112.245 0.461 . . . . 0.93 112.245 -179.576 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 191' ' ' LEU . . . . . 0.551 ' HB2' ' O ' ' A' ' 187' ' ' GLY . 0.2 OUTLIER -62.2 -53.46 54.93 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 120.578 0.228 . . . . 1.36 111.056 -179.752 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -65.11 -42.1 94.29 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.461 -0.336 . . . . 1.09 111.059 179.205 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 193' ' ' THR . . . . . 0.644 HG21 ' HA ' ' A' ' 297' ' ' VAL . 39.3 m -62.57 -47.28 84.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.476 -0.329 . . . . 1.13 110.698 179.4 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 33.6 tp -67.76 -41.24 83.64 Favored 'General case' 0 C--O 1.224 -0.241 0 CA-C-N 116.526 -0.307 . . . . 1.03 111.085 179.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . 0.988 ' HA ' ' HE1' ' A' ' 166' ' ' TYR . 45.4 ttm180 -60.57 -45.33 94.35 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.783 0.325 . . . . 0.8 111.34 179.215 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 12.7 mtp180 -73.87 -49.48 24.81 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.547 0.573 . . . . 1.94 112.547 -179.086 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 86.6 t -68.86 -38.88 79.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-O 120.923 0.392 . . . . 0.98 111.161 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -65.12 -52.77 38.17 Favored Glycine 0 C--N 1.332 0.359 0 C-N-CA 121.14 -0.552 . . . . 0.32 112.895 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -63.19 -31.13 72.2 Favored 'General case' 0 CA--C 1.528 0.099 0 CA-C-N 117.114 0.457 . . . . 0.47 110.258 179.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . 0.456 ' O ' ' HB2' ' A' ' 204' ' ' ASN . . . -60.65 -53.8 42.35 Favored Glycine 0 C--N 1.336 0.554 0 C-N-CA 120.902 -0.666 . . . . 0.35 111.462 178.014 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 83.3 t -63.54 -41.35 92.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 CA-C-O 121.355 0.598 . . . . 0.94 110.471 178.153 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 202' ' ' GLN . . . . . 0.406 ' HA ' ' CE2' ' A' ' 209' ' ' PHE . 7.4 tt0 -60.73 -51.27 70.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 114.729 -1.123 . . . . 1.01 112.723 -178.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 2.8 mmp_? -74.01 -32.58 63.44 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 111.716 0.265 . . . . 0.61 111.716 -179.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 204' ' ' ASN . . . . . 0.456 ' HB2' ' O ' ' A' ' 200' ' ' GLY . 8.4 t-20 -68.68 -53.77 20.3 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.049 0.452 . . . . 1.57 110.822 179.477 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 89.0 m-70 -95.18 32.14 1.78 Allowed 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 121.184 0.516 . . . . 0.75 110.853 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . 0.457 ' HG2' HE21 ' A' ' 210' ' ' GLN . 10.0 tt0 -59.5 -38.51 81.11 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.581 -0.736 . . . . 0.52 111.675 -179.333 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 42.2 p -59.26 -49.74 76.68 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.154 0.502 . . . . 0.9 110.95 179.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -66.59 -44.54 81.91 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.682 -0.69 . . . . 0.49 110.401 178.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 209' ' ' PHE . . . . . 0.406 ' CE2' ' HA ' ' A' ' 202' ' ' GLN . 4.8 m-30 -58.46 -44.51 89.28 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.177 -0.465 . . . . 0.57 110.736 179.498 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 210' ' ' GLN . . . . . 0.491 ' HB3' ' NH2' ' A' ' 214' ' ' ARG . 59.6 mt-30 -64.02 -34.73 78.68 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.56 -0.291 . . . . 0.64 110.971 179.446 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . 0.478 ' O ' ' HB2' ' A' ' 215' ' ' LYS . . . -60.21 -44.91 96.94 Favored Glycine 0 C--N 1.334 0.454 0 N-CA-C 111.028 -0.829 . . . . 0.41 111.028 178.021 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 212' ' ' MET . . . . . 0.808 ' HG2' ' HA ' ' B' ' 23' ' ' PHE . 1.0 OUTLIER -77.29 -30.68 54.31 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 120.616 0.246 . . . . 0.95 110.581 178.457 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 16.8 tp -59.7 -44.85 93.5 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.197 -0.456 . . . . 1.15 111.026 179.208 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 214' ' ' ARG . . . . . 0.491 ' NH2' ' HB3' ' A' ' 210' ' ' GLN . 68.0 mtm-85 -81.25 -27.47 35.17 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.034 -0.53 . . . . 0.75 110.169 178.574 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 215' ' ' LYS . . . . . 0.478 ' HB2' ' O ' ' A' ' 211' ' ' GLY . 0.7 OUTLIER -66.97 -46.9 73.2 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 115.875 -0.602 . . . . 1.16 110.621 178.443 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . 0.44 HD21 ' HB ' ' A' ' 218' ' ' ILE . 4.6 tp -65.19 120.7 13.19 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 115.901 -0.59 . . . . 1.17 111.354 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -75.03 36.07 0.11 Allowed 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 112.877 0.695 . . . . 1.47 112.877 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 218' ' ' ILE . . . . . 0.932 ' HA ' ' HB3' ' A' ' 223' ' ' ASP . 1.3 tt -61.05 106.55 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-O 121.914 0.864 . . . . 1.12 111.571 -179.766 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -162.1 -50.88 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.28 -0.873 . . . . 1.09 110.462 -179.471 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -99.6 178.38 4.87 Favored 'General case' 0 C--O 1.221 -0.418 0 CA-C-N 116.189 -0.46 . . . . 1.14 111.164 179.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . 0.429 ' HA ' ' HE1' ' A' ' 267' ' ' PHE . 2.0 mm-40 -49.38 -20.74 0.73 Allowed 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 113.794 1.035 . . . . 0.86 113.794 -179.316 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -67.84 -24.51 74.27 Favored Glycine 0 CA--C 1.534 1.271 0 N-CA-C 114.643 0.617 . . . . 0.38 114.643 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 223' ' ' ASP . . . . . 0.932 ' HB3' ' HA ' ' A' ' 218' ' ' ILE . 9.9 p30 -59.16 -56.06 26.97 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 113.475 0.917 . . . . 0.57 113.475 -177.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . 0.431 HG23 HG23 ' A' ' 274' ' ' THR . 2.6 p -54.27 -39.73 44.67 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-O 120.983 0.42 . . . . 1.1 111.764 179.492 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 30.2 mttp -68.68 -42.99 77.06 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-O 120.935 0.398 . . . . 0.71 110.171 178.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 226' ' ' SER . . . . . 0.573 ' O ' HG23 ' A' ' 230' ' ' VAL . 45.3 m -62.03 -43.25 99.23 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.9 -0.591 . . . . 0.8 109.693 178.579 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 227' ' ' PHE . . . . . 0.488 ' O ' ' HG3' ' A' ' 231' ' ' MET . 16.8 t80 -55.96 -42.92 76.98 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 115.731 -0.668 . . . . 0.88 110.447 178.821 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 12.7 p -60.31 -39.56 87.42 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 120.823 0.344 . . . . 0.4 110.368 178.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 6.4 mmp_? -67.85 -35.7 79.01 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 116.24 -0.437 . . . . 0.62 110.786 179.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . 0.573 HG23 ' O ' ' A' ' 226' ' ' SER . 24.3 t -61.96 -52.4 60.95 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 N-CA-C 109.985 -0.376 . . . . 1.01 109.985 178.568 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 231' ' ' MET . . . . . 0.641 ' HE1' HG13 ' A' ' 275' ' ' ILE . 31.5 mtp -56.79 -46.3 81.62 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.726 -0.67 . . . . 0.92 110.866 179.293 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 56.1 t -62.12 -40.29 86.96 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 CA-C-N 116.167 -0.47 . . . . 1.08 110.659 178.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 64.7 t-80 -66.65 -43.62 84.1 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 116.557 -0.292 . . . . 0.71 111.203 178.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . 0.438 HG21 ' O ' ' A' ' 230' ' ' VAL . 78.1 t -60.89 -40.4 85.17 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 CA-C-O 120.66 0.267 . . . . 1.14 111.539 179.532 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -101.44 23.51 10.96 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 111.951 0.352 . . . . 0.65 111.951 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 1.9 tmtm? -70.78 -11.73 61.13 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 112.1 0.408 . . . . 1.85 112.1 -179.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -83.23 -16.86 44.78 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.662 0.268 . . . . 0.49 111.267 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 91.86 -5.78 79.35 Favored Glycine 0 CA--C 1.524 0.64 0 C-N-CA 120.827 -0.701 . . . . 0.47 113.898 179.273 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 3.1 p -98.04 114.94 36.83 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-O 121.663 0.744 . . . . 0.68 111.87 -179.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 99.4 m -94.74 109.44 21.4 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.089 -0.505 . . . . 1.07 111.739 179.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . 0.541 ' HB2' ' HD2' ' A' ' 244' ' ' ARG . 25.7 m-20 -113.61 139.45 49.01 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.296 -0.411 . . . . 0.47 110.762 179.022 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 242' ' ' TRP . . . . . 0.421 ' CZ3' ' HB2' ' A' ' 296' ' ' PHE . 40.4 m95 -54.54 -42.12 70.53 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.183 -0.462 . . . . 0.53 111.619 -179.375 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -60.16 -33.91 81.9 Favored Glycine 0 C--N 1.333 0.412 0 C-N-CA 120.937 -0.649 . . . . 0.36 112.095 178.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 244' ' ' ARG . . . . . 0.541 ' HD2' ' HB2' ' A' ' 241' ' ' ASN . 23.6 mtt180 -70.73 -44.96 65.77 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.163 0.506 . . . . 0.46 109.638 178.687 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . 0.438 ' O ' HG13 ' A' ' 249' ' ' ILE . 74.2 mt -61.84 -50.08 81.64 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 115.412 -0.813 . . . . 1.17 111.491 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 8.5 p -65.4 -32.71 59.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 120.814 -0.354 . . . . 1.08 111.36 -179.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 82.8 m -66.14 -34.47 78.12 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.467 0.651 . . . . 1.04 109.261 177.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 248' ' ' LEU . . . . . 0.455 HD21 ' HG2' ' A' ' 231' ' ' MET . 33.7 tp -73.23 -45.33 56.64 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 115.43 -0.804 . . . . 1.67 110.426 178.199 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 249' ' ' ILE . . . . . 0.438 HG13 ' O ' ' A' ' 245' ' ' ILE . 23.5 mt -63.13 -44.18 99.3 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 CA-C-N 116.506 -0.316 . . . . 1.01 110.886 179.143 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 12.6 p -61.98 -36.17 80.66 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.277 0.561 . . . . 1.0 109.572 178.096 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 251' ' ' PHE . . . . . 0.427 ' O ' HG22 ' A' ' 255' ' ' VAL . 48.8 t80 -66.27 -41.34 90.04 Favored 'General case' 0 C--O 1.227 -0.122 0 CA-C-N 115.514 -0.767 . . . . 0.58 109.411 177.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -57.85 -49.23 76.37 Favored Glycine 0 C--N 1.335 0.5 0 N-CA-C 111.203 -0.759 . . . . 0.28 111.203 178.133 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -59.13 -43.03 91.94 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 120.68 0.276 . . . . 1.04 110.692 177.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -63.01 -43.99 97.21 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 121.071 0.462 . . . . 0.93 110.787 179.011 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 255' ' ' VAL . . . . . 0.427 HG22 ' O ' ' A' ' 251' ' ' PHE . 72.7 t -62.96 -46.46 96.25 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 N-CA-C 109.383 -0.599 . . . . 1.02 109.383 177.798 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -59.13 -37.84 78.21 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.081 -0.509 . . . . 0.56 110.078 177.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 257' ' ' LYS . . . . . 0.749 ' HE3' ' HB3' ' A' ' 170' ' ' GLN . 81.0 mttt -59.04 -45.79 89.87 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 109.468 -0.567 . . . . 0.65 109.468 177.364 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 80.3 t60 -61.06 -46.32 91.15 Favored 'General case' 0 C--O 1.228 -0.033 0 CA-C-N 115.4 -0.818 . . . . 0.73 109.632 178.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . 0.827 HD12 HG12 ' A' ' 218' ' ' ILE . 8.8 mp -59.82 -42.52 93.69 Favored 'General case' 0 C--O 1.221 -0.401 0 CA-C-N 115.968 -0.56 . . . . 1.11 110.316 178.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 260' ' ' LYS . . . . . 0.47 ' HZ2' ' CD ' ' A' ' 265' ' ' GLU . 2.2 tptp -64.15 -35.91 82.31 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.992 0.425 . . . . 0.75 110.419 178.762 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 21.2 m -69.78 -31.97 70.19 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.775 -0.648 . . . . 0.59 111.094 179.355 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 33.6 m -101.03 10.56 7.66 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 CA-C-O 120.796 0.331 . . . . 1.02 111.425 179.112 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 16.4 m120 59.16 47.92 11.13 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 113.123 0.786 . . . . 0.6 113.123 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 264' ' ' GLN . . . . . 0.549 ' HB3' ' HG ' ' A' ' 259' ' ' LEU . 17.7 tt0 -106.77 36.85 2.5 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.198 0.523 . . . . 0.66 110.31 179.044 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 265' ' ' GLU . . . . . 0.506 ' HA ' HD13 ' A' ' 268' ' ' ILE . 0.0 OUTLIER -54.33 -27.7 37.64 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 115.735 -0.666 . . . . 0.51 111.556 179.814 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 26.1 p -58.45 -26.36 63.26 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 115.785 -0.643 . . . . 1.04 110.941 178.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 267' ' ' PHE . . . . . 0.429 ' HE1' ' HA ' ' A' ' 221' ' ' GLU . 70.0 m-85 -108.52 -11.4 15.14 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.197 -0.456 . . . . 0.99 110.917 178.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 268' ' ' ILE . . . . . 0.506 HD13 ' HA ' ' A' ' 265' ' ' GLU . 53.1 mt -66.62 -51.15 59.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 CA-C-O 120.776 0.322 . . . . 1.11 110.791 179.381 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 269' ' ' GLU . . . . . 0.717 ' HB2' ' HD3' ' A' ' 270' ' ' PRO . 55.2 mm-40 -58.78 -54.7 53.71 Favored Pre-proline 0 CA--C 1.541 0.629 0 CA-C-N 116.186 -0.461 . . . . 0.49 111.178 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 270' ' ' PRO . . . . . 0.717 ' HD3' ' HB2' ' A' ' 269' ' ' GLU . 32.1 Cg_exo -60.73 -32.51 93.13 Favored 'Trans proline' 0 C--N 1.359 1.108 0 C-N-CA 122.086 1.858 . . . . 0.42 112.76 178.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 271' ' ' LEU . . . . . . . . . . . . . 29.4 tp -63.2 -46.09 88.68 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 120.531 0.205 . . . . 1.25 111.394 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -61.58 -40.99 96.75 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.13 0.49 . . . . 0.45 111.248 179.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 273' ' ' GLU . . . . . 0.441 ' HG2' ' O ' ' A' ' 269' ' ' GLU . 4.4 mm-40 -72.27 -33.74 67.69 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.195 0.522 . . . . 0.42 109.822 179.103 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 274' ' ' THR . . . . . 0.431 HG23 HG23 ' A' ' 224' ' ' VAL . 87.3 m -66.84 -51.92 49.86 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.99 -0.55 . . . . 0.98 110.952 178.668 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 275' ' ' ILE . . . . . 0.641 HG13 ' HE1' ' A' ' 231' ' ' MET . 14.4 tt -59.52 -36.51 65.17 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-O 120.682 0.277 . . . . 1.03 110.621 179.447 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 276' ' ' THR . . . . . 0.773 HG23 ' HA ' ' A' ' 160' ' ' LEU . 38.2 m -67.82 -49.68 60.96 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 120.786 0.326 . . . . 0.75 110.383 178.646 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 277' ' ' ASP . . . . . 0.567 ' O ' ' HB2' ' A' ' 281' ' ' ARG . 1.4 t70 -60.41 -54.58 43.94 Favored 'General case' 0 C--O 1.216 -0.671 0 CA-C-N 116.23 -0.441 . . . . 0.34 111.19 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 61.6 t -59.37 -34.08 53.13 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 N-CA-C 112.01 0.374 . . . . 0.91 112.01 -179.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 21.4 tp -67.82 -47.58 68.64 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.685 0.279 . . . . 0.91 111.392 179.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 39.7 t -78.06 -36.22 21.29 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 CA-C-O 120.864 0.364 . . . . 0.95 111.544 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 281' ' ' ARG . . . . . 0.567 ' HB2' ' O ' ' A' ' 277' ' ' ASP . 1.1 tpp180 -61.68 -41.02 96.99 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 122.921 0.488 . . . . 0.44 112.308 -179.434 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 282' ' ' THR . . . . . . . . . . . . . 74.5 p -90.78 -1.69 57.84 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 112.823 0.675 . . . . 0.47 112.823 -179.061 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 11.0 mtmm -138.72 33.71 2.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.672 0.273 . . . . 0.74 111.409 -179.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 34.0 ttm180 -53.16 -58.17 7.95 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 112.449 0.537 . . . . 0.5 112.449 -179.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -63.33 -42.95 99.0 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 112.179 0.437 . . . . 0.57 112.179 -179.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 286' ' ' TRP . . . . . . . . . . . . . 1.5 t90 -64.35 -51.23 64.38 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 112.227 0.454 . . . . 0.59 112.227 -178.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 287' ' ' LEU . . . . . 0.625 ' HB3' HD22 ' A' ' 155' ' ' LEU . 1.5 mm? -64.61 -48.18 75.86 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.317 0.488 . . . . 1.23 112.317 -178.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 3.0 p -63.99 -29.77 48.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 N-CA-C 112.007 0.373 . . . . 1.12 112.007 -179.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 289' ' ' LYS . . . . . 0.444 ' HB2' ' HE3' ' A' ' 289' ' ' LYS . 12.3 ttmt -76.56 -44.47 34.58 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 112.371 0.508 . . . . 1.48 112.371 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -80.62 28.86 0.32 Allowed 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 113.14 0.793 . . . . 0.56 113.14 -178.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 291' ' ' ARG . . . . . 0.432 ' HB3' ' HB3' ' A' ' 294' ' ' ASP . 62.5 mtp180 62.95 9.47 3.76 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 112.522 0.564 . . . . 0.52 112.522 179.572 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 62.22 -130.27 44.07 Favored Glycine 0 CA--C 1.522 0.504 0 CA-C-O 121.307 0.393 . . . . 0.42 113.439 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 293' ' ' TRP . . . . . 0.518 ' O ' HG23 ' A' ' 297' ' ' VAL . 77.5 m95 -61.87 -27.09 68.55 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.672 -0.264 . . . . 0.65 111.475 -179.854 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 294' ' ' ASP . . . . . 0.44 ' O ' ' HB2' ' A' ' 298' ' ' GLU . 0.5 OUTLIER -58.97 -44.46 91.54 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 120.881 0.372 . . . . 0.42 110.224 178.77 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -75.64 -30.18 58.46 Favored Glycine 0 CA--C 1.522 0.485 0 C-N-CA 120.795 -0.717 . . . . 0.38 111.639 178.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 296' ' ' PHE . . . . . 0.553 ' CE1' ' HE2' ' A' ' 300' ' ' PHE . 4.3 t80 -67.02 -47.29 71.87 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 120.821 0.343 . . . . 0.51 110.993 179.274 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 297' ' ' VAL . . . . . 0.644 ' HA ' HG21 ' A' ' 193' ' ' THR . 27.1 m -71.27 -37.41 65.71 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-N 116.44 -0.345 . . . . 0.9 111.567 -179.704 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 298' ' ' GLU . . . . . 0.44 ' HB2' ' O ' ' A' ' 294' ' ' ASP . 1.2 mt-10 -69.56 -27.58 65.25 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.571 -0.286 . . . . 0.67 111.432 179.687 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 299' ' ' PHE . . . . . . . . . . . . . 69.1 t80 -62.53 -43.73 98.09 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.346 -0.388 . . . . 0.8 110.434 178.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 300' ' ' PHE . . . . . 0.553 ' HE2' ' CE1' ' A' ' 296' ' ' PHE . 44.7 m-85 . . . . . 0 CA--C 1.532 0.266 0 CA-C-O 120.827 0.346 . . . . 0.58 111.125 179.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 22' ' ' GLU . . . . . 0.436 ' HG2' ' NE2' ' B' ' 26' ' ' GLN . 1.3 tt0 . . . . . 0 C--O 1.233 0.232 0 CA-C-O 120.675 0.274 . . . . 0.82 111.259 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 23' ' ' PHE . . . . . 0.808 ' HA ' ' HG2' ' A' ' 212' ' ' MET . 3.5 p90 -62.41 -35.9 80.67 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 116.323 -0.399 . . . . 0.59 111.465 179.797 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -76.51 -45.3 31.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.792 0.329 . . . . 0.63 110.808 179.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.22 -45.8 87.02 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.244 -0.435 . . . . 0.65 110.569 178.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 26' ' ' GLN . . . . . 0.436 ' NE2' ' HG2' ' B' ' 22' ' ' GLU . 1.3 mp0 -61.32 -47.71 84.68 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 115.755 -0.657 . . . . 0.44 110.218 178.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . 0.529 ' HG ' ' HE1' ' A' ' 212' ' ' MET . 15.7 mt -58.22 -39.28 78.63 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.137 -0.483 . . . . 0.76 110.803 178.817 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 28' ' ' ARG . . . . . . . . . . . . . 1.1 ttp180 -61.32 -50.35 73.34 Favored 'General case' 0 N--CA 1.462 0.136 0 N-CA-C 109.896 -0.409 . . . . 1.35 109.896 178.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 83.6 mttt -56.26 -49.62 73.68 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 116.06 -0.518 . . . . 1.13 110.84 179.198 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 62.3 mt -62.41 -41.89 93.5 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 CA-C-N 116.297 -0.41 . . . . 1.11 110.4 179.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . 0.402 ' HA3' ' HA ' ' A' ' 244' ' ' ARG . . . -60.17 -49.56 77.26 Favored Glycine 0 CA--C 1.522 0.481 0 C-N-CA 120.768 -0.729 . . . . 0.28 112.123 179.043 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 57.9 m-20 -60.19 -44.58 94.98 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.098 0.475 . . . . 0.98 110.028 178.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 15.0 tppt? -62.01 -51.27 68.7 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 115.672 -0.695 . . . . 1.33 111.005 179.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 38.9 t -57.49 -41.66 79.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-O 120.785 0.326 . . . . 1.02 110.973 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -62.73 -43.84 97.77 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 120.984 0.421 . . . . 1.0 109.919 178.381 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 36' ' ' CYS . . . . . . . . . . . . . 55.7 m -66.13 -42.73 88.75 Favored 'General case' 0 C--O 1.224 -0.248 0 CA-C-N 116.095 -0.502 . . . . 2.22 111.248 179.094 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 98.6 m -61.78 -39.93 93.39 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 112.436 0.532 . . . . 1.22 112.436 179.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 38' ' ' TRP . . . . . . . . . . . . . 70.3 m95 -77.72 -29.03 51.04 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 112.562 0.578 . . . . 0.77 112.562 -179.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 37.1 p . . . . . 0 N--CA 1.467 0.415 0 CA-C-O 120.943 0.401 . . . . 0.5 111.437 179.504 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . 0.47 ' O ' ' HG3' ' A' ' 157' ' ' ARG . 15.4 t70 . . . . . 0 N--CA 1.469 0.487 0 N-CA-C 111.591 0.219 . . . . 0.72 111.591 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . 0.43 ' HA ' ' CZ ' ' A' ' 157' ' ' ARG . 17.8 m-20 -57.23 -49.09 77.12 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.684 0.278 . . . . 0.56 111.309 179.703 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 49.8 tp -66.22 -36.63 83.53 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 121.192 0.52 . . . . 1.41 109.911 178.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 76.4 t80 -63.78 -46.29 85.91 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.52 -0.763 . . . . 0.63 111.607 179.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . 0.47 ' HG3' ' O ' ' A' ' 153' ' ' ASP . 79.1 mtm-85 -58.0 -44.94 87.5 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.665 0.269 . . . . 0.92 110.442 179.419 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . 0.403 ' HG3' ' O ' ' A' ' 154' ' ' ASP . 38.0 mt-30 -64.62 -42.73 95.31 Favored 'General case' 0 CA--C 1.529 0.141 0 N-CA-C 109.862 -0.422 . . . . 1.68 109.862 178.243 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 50.9 m -58.54 -53.03 62.93 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.892 -0.594 . . . . 0.28 111.282 179.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 24.4 tp -61.82 -44.48 96.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.27 -0.423 . . . . 0.78 111.131 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -60.87 -53.47 56.9 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.607 0.241 . . . . 0.42 110.772 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 77.5 mt -56.85 -50.8 73.96 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 CA-C-N 116.32 -0.4 . . . . 1.08 111.162 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.665 ' O ' ' HG ' ' A' ' 167' ' ' LEU . 63.0 mt -62.23 -51.31 73.9 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-N 116.701 -0.227 . . . . 0.99 111.394 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 29.3 t -56.62 -46.12 81.14 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 120.763 0.316 . . . . 0.34 111.063 179.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . 0.713 ' O ' ' HG2' ' A' ' 169' ' ' GLU . 6.6 mmm180 -67.59 -44.09 78.98 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.615 -0.266 . . . . 0.41 111.255 179.66 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' TYR . . . . . 0.971 ' HE1' ' HA ' ' A' ' 195' ' ' ARG . 49.3 t80 -59.3 -51.21 70.94 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 111.74 0.274 . . . . 0.45 111.74 -179.76 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.665 ' HG ' ' O ' ' A' ' 163' ' ' ILE . 20.3 mt -62.79 -38.27 89.98 Favored 'General case' 0 N--CA 1.462 0.161 0 N-CA-C 109.662 -0.496 . . . . 1.09 109.662 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 16.9 ttm180 -58.57 -41.34 85.44 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.805 -0.634 . . . . 0.39 111.529 179.308 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . 0.713 ' HG2' ' O ' ' A' ' 165' ' ' ARG . 4.2 mm-40 -67.91 -53.9 22.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.577 -0.283 . . . . 0.47 110.929 179.679 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . 0.605 HE22 ' HG3' ' A' ' 195' ' ' ARG . 1.2 mp0 -59.61 -36.9 77.22 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 120.754 0.311 . . . . 0.81 111.672 179.594 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . 0.407 ' HA ' ' CD ' ' A' ' 257' ' ' LYS . . . . . . . . 0 N--CA 1.467 0.4 0 N-CA-C 112.268 0.469 . . . . 0.45 112.268 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . 0.573 ' O ' ' HA3' ' A' ' 187' ' ' GLY . . . . . . . . 0 CA--C 1.532 0.253 0 CA-C-O 121.225 0.536 . . . . 0.75 110.889 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -76.59 -70.14 1.32 Allowed Glycine 0 CA--C 1.524 0.6 0 C-N-CA 120.822 -0.704 . . . . 0.45 113.683 -179.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -66.09 -55.4 16.69 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.049 0.452 . . . . 0.57 111.95 -179.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -65.91 -39.11 90.26 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 116.134 -0.485 . . . . 0.57 110.563 179.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . 0.573 ' HA3' ' O ' ' A' ' 183' ' ' ALA . . . -66.37 -33.11 83.91 Favored Glycine 0 C--O 1.224 -0.469 0 C-N-CA 121.126 -0.559 . . . . 0.35 112.727 179.792 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 35.5 ttm180 -67.27 -50.97 58.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.768 0.318 . . . . 0.7 110.27 178.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 189' ' ' ARG . . . . . 0.721 ' HB3' HG12 ' A' ' 297' ' ' VAL . 49.9 mtm180 -64.18 -36.05 82.81 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.445 -0.343 . . . . 0.73 110.419 179.139 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . 0.401 ' HA ' HG22 ' A' ' 297' ' ' VAL . . . -70.97 -48.74 51.6 Favored 'General case' 0 C--O 1.216 -0.69 0 CA-C-N 116.093 -0.503 . . . . 0.35 111.435 179.356 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 191' ' ' LEU . . . . . 0.531 ' HB2' ' O ' ' A' ' 187' ' ' GLY . 0.2 OUTLIER -57.58 -51.57 68.93 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 120.711 0.291 . . . . 1.17 111.453 -179.899 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -59.57 -47.38 85.79 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.2 -0.455 . . . . 0.42 111.695 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 58.4 m -66.5 -48.34 70.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.869 0.366 . . . . 0.78 110.748 179.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 25.1 tp -60.63 -36.88 79.75 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.867 -0.606 . . . . 1.06 111.371 179.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . 0.971 ' HA ' ' HE1' ' A' ' 166' ' ' TYR . 35.4 ttm180 -64.69 -46.87 80.53 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.777 0.322 . . . . 0.57 110.668 178.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.76 -52.81 39.92 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.924 -0.58 . . . . 0.81 111.639 -179.774 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . 0.526 ' O ' HG21 ' A' ' 201' ' ' VAL . 55.4 t -67.15 -40.42 85.19 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 CA-C-O 120.974 0.416 . . . . 0.92 111.704 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . 0.57 ' HA3' ' HH ' ' A' ' 166' ' ' TYR . . . -66.11 -49.87 55.16 Favored Glycine 0 CA--C 1.52 0.387 0 C-N-CA 121.216 -0.516 . . . . 0.33 113.25 -179.628 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . 0.4 ' HB2' ' O ' ' A' ' 195' ' ' ARG . 0.8 OUTLIER -63.47 -34.09 76.99 Favored 'General case' 0 N--CA 1.462 0.172 0 N-CA-C 109.749 -0.463 . . . . 0.51 109.749 179.183 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -63.09 -39.77 98.41 Favored Glycine 0 C--N 1.335 0.522 0 C-N-CA 121.179 -0.534 . . . . 0.39 112.366 178.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . 0.526 HG21 ' O ' ' A' ' 197' ' ' VAL . 84.4 t -69.48 -43.13 80.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 CA-C-O 120.694 0.283 . . . . 0.58 110.857 179.078 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 202' ' ' GLN . . . . . 0.565 ' HG3' ' OG ' ' A' ' 250' ' ' SER . 34.2 mt-30 -59.12 -45.07 91.85 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.023 -0.535 . . . . 0.77 111.411 179.588 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 37.3 mtt180 -76.11 -24.68 54.97 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 116.304 -0.407 . . . . 0.77 111.817 179.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -78.12 -54.17 6.55 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.848 0.356 . . . . 0.66 111.753 179.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 33.6 m-70 -101.0 36.56 1.94 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.747 0.308 . . . . 0.85 110.465 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -55.28 -40.25 70.82 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 112.777 0.658 . . . . 0.6 112.777 -178.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 35.1 p -59.64 -53.82 53.62 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.026 0.441 . . . . 0.81 111.511 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -64.03 -42.74 96.99 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.048 -0.524 . . . . 0.66 110.56 178.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 2.3 m-30 -60.1 -48.94 79.61 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 115.963 -0.562 . . . . 0.63 110.958 179.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -57.24 -40.96 78.67 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 120.465 0.174 . . . . 0.7 111.449 179.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -57.39 -51.79 55.58 Favored Glycine 0 C--N 1.334 0.461 0 C-N-CA 120.507 -0.854 . . . . 0.42 111.513 178.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 212' ' ' MET . . . . . 0.482 ' O ' ' HB2' ' A' ' 216' ' ' LEU . 1.8 mpp? -69.76 -30.35 67.91 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 120.792 0.33 . . . . 1.16 110.669 178.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -61.45 -48.79 79.52 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.047 -0.524 . . . . 1.13 111.082 178.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 214' ' ' ARG . . . . . 0.439 HH11 ' HD3' ' A' ' 214' ' ' ARG . 27.7 mtt180 -69.64 -34.51 74.13 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.207 -0.451 . . . . 1.47 111.483 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 215' ' ' LYS . . . . . 0.417 ' HD3' ' HA ' ' A' ' 215' ' ' LYS . 72.1 mmtt -80.0 -4.26 51.83 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 120.876 0.37 . . . . 1.46 111.477 179.613 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . 0.499 ' HG ' HG13 ' A' ' 218' ' ' ILE . 1.5 tp -98.7 85.97 3.44 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.178 0.513 . . . . 1.26 111.111 179.567 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -81.82 34.57 0.4 Allowed 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 116.208 -0.451 . . . . 1.01 110.947 179.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 218' ' ' ILE . . . . . 0.741 HG12 ' HB3' ' A' ' 223' ' ' ASP . 13.7 mt -45.25 116.4 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 N-CA-C 114.021 1.119 . . . . 1.09 114.021 -178.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 9.0 ptpp? -158.61 -9.81 0.07 Allowed 'General case' 0 CA--C 1.548 0.88 0 CA-C-N 115.083 -0.962 . . . . 0.78 112.595 178.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -134.0 175.37 9.53 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 113.547 0.943 . . . . 1.01 113.547 -179.204 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . 0.549 ' O ' ' HG2' ' A' ' 225' ' ' LYS . 4.9 mm-40 -58.23 -22.99 54.32 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 114.995 -1.002 . . . . 0.77 113.573 -179.257 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -77.8 -27.08 59.36 Favored Glycine 0 CA--C 1.526 0.739 0 C-N-CA 120.677 -0.773 . . . . 0.56 113.152 179.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 223' ' ' ASP . . . . . 0.741 ' HB3' HG12 ' A' ' 218' ' ' ILE . 36.4 m-20 -69.32 -44.14 72.31 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 111.879 0.325 . . . . 0.59 111.879 -179.123 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -62.25 -28.94 45.53 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 CA-C-O 121.022 0.439 . . . . 1.1 110.087 178.433 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . 0.549 ' HG2' ' O ' ' A' ' 221' ' ' GLU . 42.3 mmtm -69.3 -35.71 76.27 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 109.511 -0.551 . . . . 0.92 109.511 177.805 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 226' ' ' SER . . . . . 0.655 ' O ' HG21 ' A' ' 230' ' ' VAL . 41.2 t -70.79 -44.62 66.25 Favored 'General case' 0 N--CA 1.463 0.18 0 N-CA-C 109.291 -0.633 . . . . 1.02 109.291 178.024 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 227' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -58.82 -44.43 90.87 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 115.848 -0.615 . . . . 0.78 110.278 178.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 5.1 p -70.63 -34.29 71.93 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.123 -0.489 . . . . 1.28 110.3 178.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 5.8 ttt180 -63.58 -42.32 98.3 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.296 0.57 . . . . 3.62 110.304 178.048 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . 0.905 HG12 ' HA ' ' B' ' 24' ' ' ALA . 43.2 t -65.11 -38.89 83.87 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 N-CA-C 109.774 -0.454 . . . . 1.04 109.774 178.327 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 231' ' ' MET . . . . . 0.782 ' HG3' ' HG ' ' A' ' 248' ' ' LEU . 34.1 ttm -62.86 -51.11 68.28 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 115.896 -0.593 . . . . 1.14 111.79 179.65 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 31.7 m -60.96 -33.08 54.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 C-N-CA 121.053 -0.259 . . . . 1.21 111.593 -179.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 233' ' ' HIS . . . . . 0.531 ' CD2' ' HB1' ' B' ' 24' ' ' ALA . 17.1 t60 -67.31 -40.27 85.97 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 109.803 -0.443 . . . . 0.57 109.803 178.139 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . 0.53 HG23 ' O ' ' A' ' 230' ' ' VAL . 59.9 t -53.6 -47.86 60.14 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 CA-C-N 116.116 -0.493 . . . . 1.08 110.523 179.483 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -96.72 23.23 7.21 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.941 -0.572 . . . . 0.76 111.948 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 3.1 tmtm? -66.89 -17.06 64.72 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.878 0.37 . . . . 1.65 111.63 -179.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -80.55 -16.16 54.87 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.447 -0.342 . . . . 0.6 111.172 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 97.82 -17.72 58.37 Favored Glycine 0 CA--C 1.522 0.524 0 C-N-CA 120.744 -0.741 . . . . 0.46 113.661 179.323 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 6.8 p -89.63 120.28 38.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-O 121.454 0.645 . . . . 1.16 111.641 -179.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 32.8 m -94.34 99.62 11.8 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.006 0.431 . . . . 1.11 111.69 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . 0.446 ' HB2' ' HD2' ' A' ' 244' ' ' ARG . 90.4 m-20 -90.3 135.71 33.51 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.591 -0.277 . . . . 0.99 110.434 178.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 242' ' ' TRP . . . . . 0.506 ' CZ3' ' HB2' ' A' ' 296' ' ' PHE . 25.9 m95 -58.21 -40.6 82.03 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.823 0.344 . . . . 0.55 111.124 179.561 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . 0.494 ' HA3' ' N ' ' B' ' 35' ' ' TYR . . . -61.03 -30.32 73.2 Favored Glycine 0 C--N 1.332 0.359 0 C-N-CA 120.771 -0.728 . . . . 0.43 111.877 178.417 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 244' ' ' ARG . . . . . 0.467 ' HA ' ' HA3' ' B' ' 31' ' ' GLY . 74.3 mtt180 -69.25 -47.9 63.36 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.816 -0.439 . . . . 0.85 109.816 178.416 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . 0.458 ' O ' HG13 ' A' ' 249' ' ' ILE . 68.7 mt -59.15 -49.95 81.52 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.12 0 CA-C-N 115.523 -0.762 . . . . 1.11 111.294 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 7.3 p -66.13 -28.41 43.66 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 C-N-CA 120.727 -0.389 . . . . 1.01 111.133 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 19.3 m -65.15 -46.08 82.36 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 109.935 -0.395 . . . . 1.08 109.935 178.293 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 248' ' ' LEU . . . . . 0.782 ' HG ' ' HG3' ' A' ' 231' ' ' MET . 3.0 mm? -62.3 -39.58 93.45 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 116.106 -0.497 . . . . 1.18 110.582 178.814 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 249' ' ' ILE . . . . . 0.458 HG13 ' O ' ' A' ' 245' ' ' ILE . 17.6 mt -70.12 -40.96 78.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-O 120.929 0.395 . . . . 1.09 110.079 178.316 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 250' ' ' SER . . . . . 0.565 ' OG ' ' HG3' ' A' ' 202' ' ' GLN . 33.7 t -61.53 -44.89 96.23 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 109.553 -0.536 . . . . 1.66 109.553 178.257 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 251' ' ' PHE . . . . . . . . . . . . . 42.4 t80 -66.23 -38.57 88.2 Favored 'General case' 0 C--O 1.231 0.128 0 N-CA-C 109.097 -0.705 . . . . 0.66 109.097 177.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -60.61 -36.29 91.18 Favored Glycine 0 C--N 1.336 0.541 0 N-CA-C 111.199 -0.761 . . . . 0.3 111.199 177.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -68.18 -38.32 81.93 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-O 120.909 0.385 . . . . 0.45 110.031 177.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -65.13 -40.82 94.99 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 109.458 -0.571 . . . . 1.57 109.458 178.33 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 70.1 t -63.59 -44.21 98.5 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 CA-C-N 115.834 -0.621 . . . . 1.08 109.495 177.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -59.39 -32.37 70.09 Favored 'General case' 0 C--O 1.226 -0.163 0 CA-C-N 116.381 -0.372 . . . . 0.35 110.137 177.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 257' ' ' LYS . . . . . 0.407 ' CD ' ' HA ' ' A' ' 171' ' ' ALA . 43.5 tptt -63.82 -49.18 73.88 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.071 -0.513 . . . . 1.25 110.433 178.332 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -71.43 -32.59 68.53 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 120.888 0.375 . . . . 0.46 110.143 179.034 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . 0.5 ' HG ' ' HB3' ' A' ' 264' ' ' GLN . 1.6 tp -67.85 -40.21 83.69 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 121.204 0.526 . . . . 0.91 109.744 177.672 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 260' ' ' LYS . . . . . 0.439 ' HA ' ' HD2' ' A' ' 260' ' ' LYS . 45.3 tptt -70.65 -27.46 64.06 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.012 -0.54 . . . . 0.48 110.51 178.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 42.1 t -57.34 -28.55 63.23 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.436 -0.347 . . . . 0.94 110.583 178.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 16.1 m -113.15 14.78 8.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 CA-C-N 116.006 -0.543 . . . . 0.8 110.168 178.263 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 40.6 t30 54.73 45.07 27.49 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 115.208 -0.906 . . . . 0.5 112.967 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 264' ' ' GLN . . . . . 0.5 ' HB3' ' HG ' ' A' ' 259' ' ' LEU . 1.6 mt-30 -83.73 37.72 0.6 Allowed 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 120.761 0.315 . . . . 0.67 111.363 179.274 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -50.93 -42.15 59.42 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 112.665 0.617 . . . . 0.38 112.665 -179.069 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 1.3 p -62.24 -13.99 33.81 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.32 -0.4 . . . . 1.19 111.615 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 267' ' ' PHE . . . . . 0.485 ' C ' ' HD2' ' A' ' 270' ' ' PRO . 18.3 t80 -110.12 -22.91 11.56 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.347 -0.388 . . . . 0.79 110.372 178.345 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 268' ' ' ILE . . . . . 0.417 HG13 ' O ' ' A' ' 264' ' ' GLN . 72.1 mt -61.51 -46.49 96.47 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-N 116.387 -0.37 . . . . 1.12 110.554 178.712 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 269' ' ' GLU . . . . . 0.699 ' HB2' ' HD3' ' A' ' 270' ' ' PRO . 29.2 mm-40 -57.9 -56.57 33.35 Favored Pre-proline 0 CA--C 1.541 0.62 0 CA-C-N 116.576 -0.284 . . . . 0.34 110.785 178.562 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 270' ' ' PRO . . . . . 0.699 ' HD3' ' HB2' ' A' ' 269' ' ' GLU . 52.4 Cg_exo -57.97 -27.46 79.22 Favored 'Trans proline' 0 C--N 1.365 1.444 0 C-N-CA 122.402 2.068 . . . . 0.4 112.336 177.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 271' ' ' LEU . . . . . . . . . . . . . 20.9 tp -68.3 -53.06 26.9 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 108.959 -0.756 . . . . 1.13 108.959 177.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -61.31 -35.75 78.21 Favored 'General case' 0 C--O 1.23 0.075 0 N-CA-C 109.064 -0.717 . . . . 1.08 109.064 177.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 273' ' ' GLU . . . . . 0.424 ' HB3' ' HA ' ' A' ' 270' ' ' PRO . 32.4 tt0 -61.88 -48.62 79.69 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 114.939 -1.028 . . . . 1.62 109.852 177.605 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 274' ' ' THR . . . . . . . . . . . . . 89.0 m -62.49 -46.49 88.23 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.964 -0.562 . . . . 0.86 110.422 178.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 275' ' ' ILE . . . . . 0.524 ' HA ' ' HE2' ' A' ' 231' ' ' MET . 95.5 mt -56.59 -54.61 26.64 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-N 116.116 -0.493 . . . . 1.13 110.572 178.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 19.2 m -57.95 -52.4 65.68 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.603 -0.726 . . . . 0.54 111.577 179.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 277' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -51.23 -54.44 25.64 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.072 -0.513 . . . . 0.4 111.482 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 87.6 t -64.41 -39.29 85.03 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-N 116.381 -0.372 . . . . 1.01 111.804 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 279' ' ' LEU . . . . . 0.458 ' O ' ' HB2' ' A' ' 283' ' ' LYS . 1.0 OUTLIER -67.65 -41.07 84.39 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 120.942 0.401 . . . . 1.68 111.364 -179.926 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 76.2 t -77.08 -46.02 29.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 112.394 0.516 . . . . 0.77 112.394 -179.245 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 67.3 mtp180 -65.6 -35.67 81.5 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 112.997 0.74 . . . . 0.95 112.997 -178.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 282' ' ' THR . . . . . . . . . . . . . 60.4 p -83.49 -15.88 47.78 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 122.13 -0.356 . . . . 1.0 111.923 179.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . 0.575 ' HB3' HD23 ' A' ' 287' ' ' LEU . 0.1 OUTLIER -123.21 39.76 3.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.746 0.307 . . . . 0.76 110.915 179.866 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 33.9 ttm180 -52.36 -61.43 2.28 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 112.666 0.617 . . . . 0.74 112.666 -179.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -64.77 -38.87 92.45 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 112.527 0.565 . . . . 0.84 112.527 -179.219 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 286' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -65.44 -41.36 93.56 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.805 0.336 . . . . 0.86 111.817 -179.23 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 287' ' ' LEU . . . . . 0.575 HD23 ' HB3' ' A' ' 283' ' ' LYS . 1.7 mm? -70.0 -41.63 74.09 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.468 0.544 . . . . 1.25 112.468 -179.174 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 20.4 m -67.02 -35.76 75.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 C-N-CA 120.799 -0.36 . . . . 1.07 111.899 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 47.4 mttp -69.99 -39.56 75.82 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 112.677 0.621 . . . . 1.64 112.677 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -89.92 20.17 4.37 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 113.405 0.891 . . . . 0.6 113.405 -178.038 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 42.9 mtm180 60.42 15.33 5.42 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 112.916 0.709 . . . . 0.56 112.916 179.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 292' ' ' GLY . . . . . 0.435 ' HA2' HD12 ' A' ' 287' ' ' LEU . . . 66.59 -124.42 24.31 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 114.274 0.47 . . . . 0.4 114.274 179.445 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 293' ' ' TRP . . . . . 0.518 ' O ' HG21 ' A' ' 297' ' ' VAL . 89.2 m95 -63.85 -30.37 71.47 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.334 0.494 . . . . 0.45 112.334 -178.809 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 294' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.88 -43.45 94.73 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.836 -0.346 . . . . 0.74 110.623 178.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -67.9 -37.89 88.53 Favored Glycine 0 C--N 1.333 0.406 0 C-N-CA 120.56 -0.828 . . . . 0.35 111.073 177.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 296' ' ' PHE . . . . . 0.506 ' HB2' ' CZ3' ' A' ' 242' ' ' TRP . 0.3 OUTLIER -62.43 -45.81 91.41 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 120.936 0.398 . . . . 0.57 110.48 178.413 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 297' ' ' VAL . . . . . 0.721 HG12 ' HB3' ' A' ' 189' ' ' ARG . 80.3 t -63.58 -49.82 80.83 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.23 0 CA-C-N 115.855 -0.611 . . . . 1.07 110.898 179.749 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 71.6 mt-10 -61.96 -45.21 94.65 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.245 -0.434 . . . . 0.59 111.777 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 299' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -60.01 -49.48 77.51 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 120.87 0.367 . . . . 0.72 111.678 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 300' ' ' PHE . . . . . 0.476 ' HB3' HG23 ' A' ' 197' ' ' VAL . 59.3 m-85 . . . . . 0 C--N 1.329 -0.321 0 CA-C-O 121.009 0.433 . . . . 0.62 111.3 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 22' ' ' GLU . . . . . 0.465 ' O ' ' HB2' ' B' ' 26' ' ' GLN . 4.8 mm-40 . . . . . 0 C--O 1.224 -0.265 0 N-CA-C 111.407 0.151 . . . . 0.75 111.407 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 23' ' ' PHE . . . . . . . . . . . . . 10.3 p90 -63.64 -35.39 80.37 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.18 0.515 . . . . 0.77 110.747 179.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 24' ' ' ALA . . . . . 0.905 ' HA ' HG12 ' A' ' 230' ' ' VAL . . . -72.11 -43.98 63.91 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.639 -0.71 . . . . 0.64 110.623 179.178 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -69.73 -37.03 76.35 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.147 -0.479 . . . . 0.58 110.532 179.108 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 26' ' ' GLN . . . . . 0.465 ' HB2' ' O ' ' B' ' 22' ' ' GLU . 0.0 OUTLIER -61.73 -54.84 37.07 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 116.481 -0.327 . . . . 0.71 111.174 179.514 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . 0.444 HD11 HG11 ' A' ' 230' ' ' VAL . 30.9 mt -58.06 -37.32 74.22 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 120.863 0.363 . . . . 1.09 110.197 178.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 28' ' ' ARG . . . . . 0.509 ' HA ' HG12 ' A' ' 234' ' ' VAL . 4.8 tmt_? -62.6 -53.69 50.81 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 109.26 -0.644 . . . . 1.55 109.26 177.55 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 21.3 mtmt -53.7 -48.95 69.06 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.858 -0.61 . . . . 0.99 110.582 178.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . 0.446 HG13 ' O ' ' B' ' 26' ' ' GLN . 75.5 mt -59.07 -42.28 85.97 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.202 0 CA-C-N 116.057 -0.52 . . . . 1.05 110.123 179.129 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . 0.467 ' HA3' ' HA ' ' A' ' 244' ' ' ARG . . . -58.76 -50.15 70.32 Favored Glycine 0 CA--C 1.521 0.421 0 C-N-CA 120.886 -0.673 . . . . 0.36 112.398 178.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 32' ' ' ASP . . . . . 0.476 ' OD2' ' HD3' ' B' ' 28' ' ' ARG . 9.1 m-20 -61.84 -40.12 94.2 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.14 0.495 . . . . 0.43 110.145 178.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 15.6 tppt? -64.0 -53.82 44.01 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 115.74 -0.663 . . . . 1.73 111.101 179.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 77.3 t -59.13 -39.03 77.58 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-O 121.067 0.461 . . . . 1.04 110.48 179.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 35' ' ' TYR . . . . . 0.494 ' N ' ' HA3' ' A' ' 243' ' ' GLY . 4.0 t80 -60.55 -50.44 73.55 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.898 -0.592 . . . . 0.93 110.467 178.479 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 36' ' ' CYS . . . . . . . . . . . . . 61.5 m -64.25 -25.82 68.23 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.009 0.433 . . . . 0.7 110.983 179.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 20.9 m -75.36 -43.14 52.05 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 116.022 -0.536 . . . . 0.9 112.259 -179.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 38' ' ' TRP . . . . . . . . . . . . . 97.2 m95 -87.9 -9.78 52.67 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 113.249 0.833 . . . . 0.76 113.249 -178.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 38.2 t . . . . . 0 N--CA 1.468 0.474 0 N-CA-C 111.731 0.271 . . . . 0.78 111.731 179.196 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 33.0 t70 . . . . . 0 CA--C 1.534 0.338 0 N-CA-C 112.454 0.538 . . . . 0.64 112.454 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.93 -55.54 33.8 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.123 0.487 . . . . 0.83 111.121 179.758 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.447 HD22 ' HB3' ' A' ' 287' ' ' LEU . 26.4 tp -58.63 -42.35 88.09 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.91 -0.587 . . . . 0.7 112.251 179.616 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 68.3 t80 -69.01 -47.04 66.48 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 112.399 0.518 . . . . 0.6 112.399 -179.219 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 60.9 mtp180 -61.21 -40.23 93.22 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 111.744 0.276 . . . . 0.8 111.744 -179.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 2.8 mm-40 -68.57 -44.29 74.76 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.891 0.377 . . . . 0.72 110.183 179.14 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 34.1 m -63.69 -49.35 73.47 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.949 -0.568 . . . . 0.36 111.346 179.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.517 ' HA ' HG21 ' A' ' 276' ' ' THR . 11.1 tp -55.68 -49.49 72.81 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 111.871 0.323 . . . . 0.68 111.871 -179.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . 0.706 ' O ' ' HG2' ' A' ' 165' ' ' ARG . 0.0 OUTLIER -58.64 -53.72 55.2 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-O 120.625 0.25 . . . . 0.54 111.152 179.806 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . 0.496 HG12 ' HA2' ' A' ' 187' ' ' GLY . 83.3 mt -58.54 -46.95 89.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-N 116.416 -0.356 . . . . 0.88 111.683 -179.711 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.475 HD12 HG22 ' A' ' 276' ' ' THR . 71.7 mt -62.74 -45.51 98.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 CA-C-N 116.446 -0.343 . . . . 1.11 110.716 179.643 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' SER . . . . . 0.535 ' O ' ' HB2' ' A' ' 168' ' ' ARG . 51.1 m -57.87 -41.38 82.36 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.482 -0.326 . . . . 0.34 110.332 178.346 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . 0.706 ' HG2' ' O ' ' A' ' 161' ' ' GLU . 13.5 mmt180 -65.11 -54.8 24.34 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.493 -0.321 . . . . 0.66 111.33 179.612 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' TYR . . . . . 0.813 ' HE1' ' HA ' ' A' ' 195' ' ' ARG . 65.2 t80 -60.93 -51.26 70.02 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 113.036 0.754 . . . . 0.57 113.036 -178.063 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.455 HD12 HG22 ' A' ' 163' ' ' ILE . 9.2 mp -60.43 -39.87 89.03 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.879 -0.329 . . . . 1.11 111.056 -179.078 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . 0.535 ' HB2' ' O ' ' A' ' 164' ' ' SER . 3.9 mmt180 -68.7 -42.8 77.25 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 120.881 0.372 . . . . 0.61 111.126 178.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . 0.559 ' CD ' HH21 ' A' ' 195' ' ' ARG . 63.5 mt-10 -65.33 -48.67 72.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.019 0.437 . . . . 0.42 111.447 178.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . 0.645 ' HB3' ' HB1' ' A' ' 253' ' ' ALA . 7.4 tp60 -65.71 -37.3 86.05 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.137 -0.483 . . . . 0.39 111.821 -179.355 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . 0.451 ' HA ' ' HA ' ' A' ' 257' ' ' LYS . . . . . . . . 0 N--CA 1.463 0.204 0 CA-C-O 120.787 0.327 . . . . 0.81 111.396 179.083 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . 0.547 ' O ' ' HA3' ' A' ' 187' ' ' GLY . . . . . . . . 0 C--O 1.224 -0.281 0 CA-C-O 120.669 0.271 . . . . 1.13 111.062 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -74.81 -71.15 1.16 Allowed Glycine 0 CA--C 1.528 0.849 0 C-N-CA 120.552 -0.832 . . . . 0.64 114.255 -179.341 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -62.31 -55.29 29.61 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-O 121.06 0.457 . . . . 0.78 111.736 -179.161 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -63.78 -40.27 96.27 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.915 -0.584 . . . . 0.98 110.672 179.172 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . 0.547 ' HA3' ' O ' ' A' ' 183' ' ' ALA . . . -64.3 -40.41 97.87 Favored Glycine 0 C--N 1.333 0.4 0 C-N-CA 121.261 -0.495 . . . . 0.39 113.592 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 62.7 ttt180 -62.89 -51.3 67.51 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 117.269 0.534 . . . . 1.71 110.759 179.198 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 48.4 mtm180 -67.54 -31.56 71.74 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 116.112 -0.494 . . . . 0.57 111.033 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . 0.509 ' HA ' ' CG1' ' A' ' 297' ' ' VAL . . . -71.29 -40.43 70.89 Favored 'General case' 0 C--O 1.222 -0.368 0 CA-C-N 116.282 -0.417 . . . . 1.06 110.943 178.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 20.0 tp -63.36 -47.15 83.31 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 111.589 0.218 . . . . 1.21 111.589 179.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 6.0 tm-20 -60.17 -45.37 93.33 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.291 0.567 . . . . 0.44 110.267 179.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 193' ' ' THR . . . . . 0.631 HG21 ' HA ' ' A' ' 297' ' ' VAL . 27.8 m -65.68 -47.19 76.3 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.762 -0.654 . . . . 0.94 110.665 179.284 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 7.0 tp -61.07 -41.75 97.22 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 116.032 -0.531 . . . . 1.02 110.678 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . 0.813 ' HA ' ' HE1' ' A' ' 166' ' ' TYR . 50.5 mtt180 -59.38 -58.44 8.6 Favored 'General case' 0 C--O 1.226 -0.136 0 CA-C-O 120.774 0.321 . . . . 0.78 110.172 178.319 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 8.5 ttm180 -57.77 -56.34 23.16 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.654 -0.703 . . . . 0.6 112.714 -179.028 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . 0.472 ' O ' HG21 ' A' ' 201' ' ' VAL . 58.6 t -62.3 -41.71 92.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-O 120.87 0.367 . . . . 0.98 111.021 -179.395 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . 0.626 ' HA3' ' HH ' ' A' ' 166' ' ' TYR . . . -63.21 -46.85 92.16 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 120.86 -0.686 . . . . 0.29 111.939 179.174 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 51.3 m-20 -55.74 -45.56 77.98 Favored 'General case' 0 N--CA 1.462 0.163 0 N-CA-C 109.509 -0.552 . . . . 0.36 109.509 178.114 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -58.69 -54.31 38.96 Favored Glycine 0 C--O 1.223 -0.573 0 CA-C-N 115.633 -0.712 . . . . 0.31 111.921 178.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . 0.472 HG21 ' O ' ' A' ' 197' ' ' VAL . 57.5 t -59.58 -42.3 87.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 CA-C-O 120.787 0.327 . . . . 0.52 111.701 179.279 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 202' ' ' GLN . . . . . 0.441 ' HG2' ' HD1' ' A' ' 254' ' ' PHE . 5.9 mt-30 -64.3 -52.47 58.39 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 112.444 0.535 . . . . 0.58 112.444 -179.389 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 203' ' ' ARG . . . . . 0.421 HH11 ' HD3' ' A' ' 203' ' ' ARG . 2.8 mmp_? -69.37 -35.18 75.58 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.743 0.306 . . . . 0.71 111.475 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -68.53 -48.27 64.75 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.995 0.426 . . . . 0.44 110.819 179.105 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 -100.69 32.95 2.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.007 0.432 . . . . 0.66 110.818 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -56.72 -46.72 81.14 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.607 -0.724 . . . . 0.42 112.148 -179.167 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 58.4 p -60.46 -45.62 93.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.994 0.426 . . . . 0.82 111.176 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -65.94 -41.88 90.74 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.844 -0.616 . . . . 0.44 110.886 179.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 7.8 m-30 -66.17 -44.34 84.33 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.521 -0.309 . . . . 0.64 110.573 179.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -64.71 -44.52 89.98 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.532 -0.303 . . . . 1.5 110.616 178.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -60.51 -44.67 97.46 Favored Glycine 0 C--N 1.336 0.549 0 C-N-CA 120.749 -0.739 . . . . 0.38 111.28 178.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 28.1 ttm -66.3 -40.87 90.28 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 121.022 0.439 . . . . 1.13 109.935 178.248 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 12.9 tp -59.36 -42.54 91.83 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.596 -0.729 . . . . 1.05 111.718 179.177 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 77.1 mtp180 -74.28 -28.71 61.33 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.401 -0.363 . . . . 1.08 111.741 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 49.4 mtmt -76.33 -34.19 58.99 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 120.823 0.344 . . . . 1.41 110.69 178.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . 0.523 ' HB3' HG12 ' A' ' 218' ' ' ILE . 81.6 mt -67.84 136.39 54.04 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 121.11 0.481 . . . . 1.22 111.795 179.499 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -101.28 30.97 3.89 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.11 -0.495 . . . . 0.71 110.485 179.31 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 218' ' ' ILE . . . . . 0.523 HG12 ' HB3' ' A' ' 216' ' ' LEU . 20.0 mm -59.17 119.86 4.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-N 115.8 -0.636 . . . . 1.19 111.316 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 19.3 mtmm -149.04 -30.99 0.24 Allowed 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 113.178 0.807 . . . . 1.49 113.178 -179.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -125.18 174.67 7.92 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.748 0.647 . . . . 0.51 112.748 -178.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . 0.464 ' O ' HG21 ' A' ' 224' ' ' VAL . 1.0 OUTLIER -62.35 -28.77 69.99 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 115.732 -0.667 . . . . 0.59 111.302 -179.949 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -61.88 -25.59 66.08 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 121.351 -0.452 . . . . 0.36 113.268 179.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 -58.43 -28.34 65.17 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 113.226 0.824 . . . . 0.36 113.226 -179.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . 0.541 ' HB ' HG22 ' A' ' 274' ' ' THR . 25.8 m -54.0 -29.78 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 N-CA-C 112.908 0.707 . . . . 1.04 112.908 -179.237 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 33.4 mtmm -64.89 -43.39 93.04 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-O 121.415 0.626 . . . . 1.14 110.075 178.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 15.5 m -70.34 -38.65 74.88 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.309 -0.86 . . . . 0.79 109.715 178.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 227' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -59.63 -38.82 82.39 Favored 'General case' 0 CA--C 1.528 0.13 0 N-CA-C 108.791 -0.818 . . . . 0.75 108.791 177.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 49.8 m -62.32 -41.19 98.33 Favored 'General case' 0 CA--C 1.528 0.101 0 CA-C-N 115.426 -0.806 . . . . 0.5 109.989 177.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.2 -40.93 78.41 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.33 -0.395 . . . . 2.47 110.371 178.592 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . 0.503 ' O ' HG23 ' A' ' 234' ' ' VAL . 13.4 t -61.97 -51.3 74.18 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-N 116.466 -0.334 . . . . 0.85 110.139 178.679 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 231' ' ' MET . . . . . 0.517 ' HE1' ' HA ' ' A' ' 275' ' ' ILE . 38.9 mtp -58.84 -47.63 84.18 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.146 -0.479 . . . . 1.03 111.116 179.41 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 75.6 t -63.92 -41.0 91.07 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 CA-C-N 116.34 -0.391 . . . . 1.29 110.907 179.19 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 31.8 t-80 -64.58 -37.56 87.97 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 116.414 -0.357 . . . . 0.79 110.975 178.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . 0.503 HG23 ' O ' ' A' ' 230' ' ' VAL . 53.1 t -63.2 -51.61 69.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-O 120.794 0.331 . . . . 0.99 111.736 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -90.37 24.56 2.53 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 112.159 0.429 . . . . 0.67 112.159 -178.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 1.8 tmtm? -66.69 -15.37 63.46 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 112.537 0.569 . . . . 1.63 112.537 -179.25 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 44.8 p30 -85.27 -16.21 40.88 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 120.767 0.318 . . . . 0.59 111.497 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 94.38 -0.84 66.22 Favored Glycine 0 CA--C 1.524 0.636 0 C-N-CA 121.088 -0.577 . . . . 0.58 113.262 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . 0.477 ' HB ' ' NH1' ' A' ' 244' ' ' ARG . 25.6 t -93.44 109.84 22.43 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-O 121.092 0.472 . . . . 1.06 111.584 -179.597 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 240' ' ' THR . . . . . 0.606 HG22 HD13 ' A' ' 245' ' ' ILE . 21.2 m -94.11 76.74 4.06 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.951 0.405 . . . . 1.38 111.582 179.718 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . 0.409 ' HB2' ' HD2' ' A' ' 244' ' ' ARG . 59.3 m-20 -77.05 140.3 40.28 Favored 'General case' 0 C--N 1.329 -0.307 0 O-C-N 122.206 -0.309 . . . . 0.87 110.943 179.194 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 242' ' ' TRP . . . . . 0.532 ' HB3' ' CE2' ' A' ' 300' ' ' PHE . 47.8 m95 -56.32 -40.95 75.24 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.813 0.34 . . . . 0.7 110.871 179.275 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . 0.408 ' HA2' HG12 ' A' ' 246' ' ' VAL . . . -62.98 -28.82 72.65 Favored Glycine 0 C--N 1.334 0.466 0 C-N-CA 121.168 -0.539 . . . . 0.27 112.028 178.49 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 244' ' ' ARG . . . . . 0.477 ' NH1' ' HB ' ' A' ' 239' ' ' VAL . 89.7 mtt180 -74.44 -42.39 59.21 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.659 -0.497 . . . . 0.61 109.659 178.779 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . 0.606 HD13 HG22 ' A' ' 240' ' ' THR . 67.8 mt -63.81 -52.71 53.63 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 CA-C-N 115.903 -0.589 . . . . 1.0 110.377 178.771 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . 0.408 HG12 ' HA2' ' A' ' 243' ' ' GLY . 6.8 p -62.63 -29.76 47.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 CA-C-N 116.287 -0.415 . . . . 1.05 110.836 179.43 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 11.1 m -65.93 -44.49 84.98 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 109.743 -0.465 . . . . 0.73 109.743 177.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -64.42 -40.65 96.18 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 109.832 -0.432 . . . . 1.08 109.832 178.035 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 249' ' ' ILE . . . . . 0.44 HG12 ' O ' ' A' ' 245' ' ' ILE . 48.7 mm -64.05 -43.06 97.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 CA-C-O 121.052 0.453 . . . . 1.13 109.868 178.162 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 56.2 m -62.32 -42.61 99.52 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 115.846 -0.615 . . . . 0.4 109.6 178.313 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 251' ' ' PHE . . . . . . . . . . . . . 18.2 t80 -62.77 -42.99 99.94 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 116.008 -0.542 . . . . 0.63 109.675 178.079 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -57.82 -46.61 92.15 Favored Glycine 0 C--N 1.335 0.521 0 N-CA-C 111.386 -0.686 . . . . 0.3 111.386 178.165 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 253' ' ' ALA . . . . . 0.645 ' HB1' ' HB3' ' A' ' 170' ' ' GLN . . . -68.19 -27.77 66.68 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 120.661 0.267 . . . . 0.8 111.483 178.261 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 254' ' ' PHE . . . . . 0.441 ' HD1' ' HG2' ' A' ' 202' ' ' GLN . 26.6 t80 -74.81 -48.51 24.91 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 120.626 0.25 . . . . 0.81 111.047 179.3 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 255' ' ' VAL . . . . . 0.526 ' O ' ' HG ' ' A' ' 259' ' ' LEU . 23.6 m -64.18 -37.75 80.69 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.129 0 C-N-CA 120.503 -0.479 . . . . 0.55 109.751 178.454 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -67.36 -32.15 72.88 Favored 'General case' 0 C--N 1.341 0.199 0 CA-C-N 116.342 -0.39 . . . . 0.36 110.497 178.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 257' ' ' LYS . . . . . 0.537 ' HE2' ' HG3' ' A' ' 170' ' ' GLN . 28.0 ttmt -61.94 -46.99 86.88 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 109.048 -0.723 . . . . 0.9 109.048 177.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 82.9 t60 -66.0 -40.47 91.15 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 115.356 -0.838 . . . . 0.73 109.445 177.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . 0.634 ' HB3' ' HB2' ' A' ' 264' ' ' GLN . 95.0 mt -62.89 -36.39 83.18 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.104 -0.498 . . . . 1.12 110.591 178.438 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -65.54 -37.36 86.52 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 110.134 -0.321 . . . . 0.46 110.134 178.47 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 15.9 p -64.2 -24.62 67.74 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.839 0.352 . . . . 0.53 110.7 178.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 7.3 p -107.09 8.15 9.62 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 CA-C-O 121.592 0.71 . . . . 1.21 110.328 178.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 6.5 t30 59.13 49.31 9.45 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 113.7 1.0 . . . . 0.66 113.7 179.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 264' ' ' GLN . . . . . 0.634 ' HB2' ' HB3' ' A' ' 259' ' ' LEU . 4.0 mm100 -92.24 35.19 1.0 Allowed 'General case' 0 N--CA 1.47 0.532 0 O-C-N 122.082 -0.386 . . . . 0.66 111.352 178.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -47.52 -43.94 25.28 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 112.594 0.591 . . . . 0.45 112.594 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 86.8 p -59.11 -18.13 32.74 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 116.326 -0.397 . . . . 0.77 111.749 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 267' ' ' PHE . . . . . 0.435 ' CE1' ' HA ' ' A' ' 221' ' ' GLU . 53.8 t80 -107.77 -28.62 9.57 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 116.653 -0.249 . . . . 0.71 111.073 178.723 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 73.9 mt -57.13 -49.97 77.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 CA-C-O 120.575 0.226 . . . . 1.07 111.474 179.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 269' ' ' GLU . . . . . 0.446 ' HB2' ' HD3' ' A' ' 270' ' ' PRO . 2.5 mp0 -58.6 -56.86 31.27 Favored Pre-proline 0 CA--C 1.543 0.707 0 C-N-CA 121.128 -0.229 . . . . 0.4 111.542 179.431 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 270' ' ' PRO . . . . . 0.446 ' HD3' ' HB2' ' A' ' 269' ' ' GLU . 45.1 Cg_exo -59.37 -29.83 91.18 Favored 'Trans proline' 0 C--N 1.361 1.198 0 C-N-CA 122.369 2.046 . . . . 0.37 112.854 178.57 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 271' ' ' LEU . . . . . . . . . . . . . 56.6 tp -67.72 -49.38 62.96 Favored 'General case' 0 N--CA 1.464 0.225 0 N-CA-C 109.914 -0.402 . . . . 1.0 109.914 178.452 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -60.17 -37.21 79.47 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.113 -0.494 . . . . 0.6 110.217 178.454 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 273' ' ' GLU . . . . . 0.442 ' O ' ' HB2' ' A' ' 277' ' ' ASP . 32.0 tt0 -67.05 -43.12 83.51 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 109.462 -0.57 . . . . 1.11 109.462 178.109 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 274' ' ' THR . . . . . 0.541 HG22 ' HB ' ' A' ' 224' ' ' VAL . 70.1 m -61.47 -49.29 77.39 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.104 -0.498 . . . . 1.09 110.348 178.216 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 275' ' ' ILE . . . . . 0.517 ' HA ' ' HE1' ' A' ' 231' ' ' MET . 96.8 mt -55.37 -54.16 28.04 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.123 0 CA-C-N 115.775 -0.648 . . . . 1.13 110.763 179.419 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 276' ' ' THR . . . . . 0.517 HG21 ' HA ' ' A' ' 160' ' ' LEU . 15.9 m -57.69 -46.75 83.89 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 120.918 0.39 . . . . 0.79 110.993 179.433 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 277' ' ' ASP . . . . . 0.442 ' HB2' ' O ' ' A' ' 273' ' ' GLU . 0.4 OUTLIER -54.65 -59.92 4.06 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 115.685 -0.689 . . . . 0.59 110.966 179.345 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 57.3 t -60.38 -39.48 81.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 CA-C-O 120.812 0.339 . . . . 0.59 111.418 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 279' ' ' LEU . . . . . 0.539 HD11 HG22 ' A' ' 245' ' ' ILE . 15.8 tp -61.32 -47.59 85.23 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.564 -0.289 . . . . 1.34 111.151 179.568 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 80.2 t -73.04 -42.89 59.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 120.928 -0.309 . . . . 1.08 111.556 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 80.6 mtt-85 -60.92 -34.48 74.77 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 112.458 0.54 . . . . 1.46 112.458 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 282' ' ' THR . . . . . . . . . . . . . 69.3 p -95.74 0.13 52.1 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 113.089 0.774 . . . . 0.89 113.089 -178.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . 0.487 ' HD2' ' O ' ' A' ' 279' ' ' LEU . 5.7 mttp -141.26 30.1 1.78 Allowed 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 111.649 0.24 . . . . 1.43 111.649 179.773 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 40.1 ttm180 -57.72 -56.12 26.07 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 112.077 0.399 . . . . 1.09 112.077 -179.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 285' ' ' ASP . . . . . 0.412 ' CG ' ' HZ3' ' A' ' 289' ' ' LYS . 24.9 t70 -61.4 -44.52 97.0 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 120.826 0.346 . . . . 0.77 111.652 -179.692 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 286' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -65.18 -49.52 69.5 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 112.36 0.504 . . . . 0.82 112.36 -179.074 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 287' ' ' LEU . . . . . 0.447 ' HB3' HD22 ' A' ' 155' ' ' LEU . 1.6 mm? -66.36 -42.61 87.8 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 113.007 0.743 . . . . 1.1 113.007 -178.502 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 5.6 p -67.75 -36.49 76.09 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 C-N-CA 120.797 -0.361 . . . . 1.0 111.962 -179.511 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 289' ' ' LYS . . . . . 0.412 ' HZ3' ' CG ' ' A' ' 285' ' ' ASP . 50.3 mttt -76.82 -33.57 57.96 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 112.38 0.511 . . . . 1.42 112.38 179.822 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 1.1 tp-100 -84.88 26.43 0.84 Allowed 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 113.002 0.741 . . . . 0.76 113.002 -178.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 32.7 mtp180 63.22 9.39 3.92 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 112.874 0.694 . . . . 0.6 112.874 178.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 62.64 -132.47 44.18 Favored Glycine 0 CA--C 1.524 0.656 0 CA-C-O 121.619 0.566 . . . . 0.4 113.954 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 293' ' ' TRP . . . . . 0.456 ' HA ' ' HB3' ' A' ' 296' ' ' PHE . 78.7 m95 -66.56 -23.45 66.21 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.392 0.516 . . . . 0.58 112.392 -178.766 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 294' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -64.52 -43.49 93.87 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 109.776 -0.453 . . . . 0.43 109.776 178.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -69.74 -32.04 70.5 Favored Glycine 0 C--N 1.334 0.459 0 N-CA-C 110.765 -0.934 . . . . 0.31 110.765 177.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 296' ' ' PHE . . . . . 0.466 ' HB2' ' CZ3' ' A' ' 242' ' ' TRP . 6.0 t80 -67.53 -48.91 65.64 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 115.553 -0.323 . . . . 0.51 111.202 178.779 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 297' ' ' VAL . . . . . 0.631 ' HA ' HG21 ' A' ' 193' ' ' THR . 21.7 m -69.14 -33.18 57.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 CA-C-N 116.63 -0.259 . . . . 0.72 111.591 -179.591 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -69.47 -42.2 75.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.9 0.381 . . . . 0.54 110.713 179.176 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 299' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -67.69 -45.73 74.32 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.005 -0.543 . . . . 0.79 111.427 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 300' ' ' PHE . . . . . 0.532 ' CE2' ' HB3' ' A' ' 242' ' ' TRP . 60.1 m-85 . . . . . 0 CA--C 1.538 0.494 0 N-CA-C 112.687 0.625 . . . . 0.61 112.687 -179.089 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 . . . . . 0 CA--C 1.534 0.327 0 N-CA-C 111.774 0.287 . . . . 0.64 111.774 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 23' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -55.93 -41.17 74.21 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 112.218 0.451 . . . . 0.51 112.218 -179.063 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -66.95 -38.98 87.1 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.882 0.372 . . . . 0.49 111.37 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.8 -35.71 81.99 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-O 121.507 0.67 . . . . 1.09 110.01 178.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -66.16 -49.77 66.25 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.246 -0.888 . . . . 0.5 109.43 178.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 82.8 mt -57.21 -36.16 70.53 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.275 -0.42 . . . . 1.15 110.678 178.291 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 28' ' ' ARG . . . . . . . . . . . . . 37.7 mtp85 -57.25 -58.21 9.25 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 116.108 -0.496 . . . . 0.59 111.299 178.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 8.6 ptpp? -64.57 -31.53 72.78 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.523 -0.308 . . . . 0.63 110.791 179.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 52.2 mt -62.82 -49.85 82.04 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 N-CA-C 109.421 -0.585 . . . . 1.11 109.421 178.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -62.18 -43.61 98.88 Favored Glycine 0 N--CA 1.448 -0.527 0 CA-C-N 115.423 -0.808 . . . . 0.31 112.012 178.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -66.95 -37.11 83.68 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 121.221 -0.191 . . . . 0.54 110.878 179.076 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 23.6 ttmm -65.08 -44.6 88.39 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 109.865 -0.42 . . . . 1.25 109.865 177.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 45.7 t -63.92 -50.79 75.9 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-N 115.969 -0.559 . . . . 1.09 110.186 178.439 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -58.0 -40.54 81.0 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.681 -0.691 . . . . 0.78 110.817 179.273 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 36' ' ' CYS . . . . . . . . . . . . . 23.6 t -69.64 -26.47 64.43 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 120.873 0.368 . . . . 1.09 111.422 179.411 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 85.7 m -76.17 -35.02 59.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.305 -0.407 . . . . 1.1 111.18 179.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 38' ' ' TRP . . . . . . . . . . . . . 97.7 m95 -88.03 -37.36 16.38 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 112.052 0.39 . . . . 0.69 112.052 -179.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 45.7 p . . . . . 0 N--CA 1.471 0.619 0 CA-C-O 120.761 0.315 . . . . 0.68 111.396 179.16 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 . . . . . 0 C--O 1.223 -0.324 0 CA-C-O 120.608 0.242 . . . . 0.45 110.846 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -55.52 -41.49 73.19 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.232 0.539 . . . . 0.43 110.242 178.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -71.66 -40.28 69.75 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 109.004 -0.739 . . . . 1.27 109.004 177.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -60.65 -46.95 88.4 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 115.966 -0.561 . . . . 0.51 110.86 179.095 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 14.2 mtp180 -60.53 -45.92 92.07 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 116.336 -0.393 . . . . 0.52 111.301 179.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -63.9 -50.46 68.64 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.062 0.458 . . . . 0.45 109.826 178.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 16.8 m -56.72 -48.47 77.67 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 115.461 -0.791 . . . . 0.31 110.925 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.487 ' HA ' HG23 ' A' ' 276' ' ' THR . 2.1 tm? -57.21 -49.54 75.69 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.551 -0.295 . . . . 0.62 110.254 178.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.2 -45.46 93.11 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.348 -0.387 . . . . 1.02 111.474 179.552 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . 0.486 HG23 HD21 ' A' ' 191' ' ' LEU . 89.9 mt -65.65 -56.56 14.55 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 CA-C-N 116.0 -0.546 . . . . 0.98 112.359 -179.252 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.514 HD13 HG21 ' A' ' 276' ' ' THR . 97.1 mt -58.49 -51.99 64.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 N-CA-C 112.71 0.633 . . . . 1.05 112.71 -178.689 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 65.9 p -56.1 -42.67 77.14 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 120.556 0.217 . . . . 0.33 111.452 -179.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.55 -52.95 48.65 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.889 0.376 . . . . 1.47 111.105 178.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' TYR . . . . . 0.785 ' HE1' ' HA ' ' A' ' 195' ' ' ARG . 59.9 t80 -57.3 -49.08 77.23 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 112.594 0.59 . . . . 0.37 112.594 -179.614 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 5.5 mp -60.71 -46.14 91.55 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 112.413 0.523 . . . . 1.15 112.413 -178.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 38.2 ttm-85 -69.14 -49.89 52.81 Favored 'General case' 0 C--O 1.239 0.545 0 N-CA-C 113.067 0.766 . . . . 0.34 113.067 -178.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -64.12 -52.08 60.85 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.171 0.434 . . . . 0.43 112.171 -178.801 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -64.29 -32.42 74.01 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 111.972 0.36 . . . . 0.51 111.972 -179.284 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . 0.462 ' O ' ' HG3' ' A' ' 257' ' ' LYS . . . . . . . . 0 C--N 1.332 -0.156 0 CA-C-O 121.04 0.448 . . . . 0.41 110.305 178.076 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . 0.461 ' O ' ' HA3' ' A' ' 187' ' ' GLY . . . . . . . . 0 CA--C 1.536 0.425 0 CA-C-O 121.261 0.553 . . . . 0.54 111.192 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . 0.693 ' HA2' ' NH2' ' A' ' 188' ' ' ARG . . . -79.84 -73.85 1.12 Allowed Glycine 0 CA--C 1.525 0.713 0 C-N-CA 120.312 -0.947 . . . . 0.69 114.079 -179.605 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -71.79 -54.72 9.29 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.065 0.46 . . . . 0.89 110.886 -179.36 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -65.14 -35.18 80.3 Favored 'General case' 0 C--O 1.221 -0.427 0 CA-C-N 115.76 -0.655 . . . . 1.14 110.601 179.277 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . 0.461 ' HA3' ' O ' ' A' ' 183' ' ' ALA . . . -64.03 -53.33 37.78 Favored Glycine 0 C--O 1.228 -0.262 0 C-N-CA 120.903 -0.665 . . . . 0.51 113.082 -179.81 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . 0.693 ' NH2' ' HA2' ' A' ' 184' ' ' GLY . 0.3 OUTLIER -59.64 -41.71 91.13 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 117.095 0.447 . . . . 2.23 111.192 -179.98 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 189' ' ' ARG . . . . . 0.833 ' HD3' HG11 ' A' ' 297' ' ' VAL . 0.2 OUTLIER -71.12 -40.3 71.51 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.509 -0.314 . . . . 0.64 111.245 179.386 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . 0.5 ' HA ' HG21 ' A' ' 297' ' ' VAL . . . -69.6 -39.4 77.27 Favored 'General case' 0 C--O 1.22 -0.481 0 CA-C-N 116.865 -0.152 . . . . 0.92 111.394 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 191' ' ' LEU . . . . . 0.562 HD13 ' HE ' ' A' ' 195' ' ' ARG . 0.3 OUTLIER -64.59 -47.52 78.37 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.603 0.24 . . . . 1.32 111.212 179.788 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -60.79 -42.85 98.37 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.265 0.555 . . . . 0.4 110.897 179.461 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 193' ' ' THR . . . . . 0.531 ' OG1' HG12 ' A' ' 297' ' ' VAL . 27.8 m -69.76 -54.06 15.44 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.757 -0.656 . . . . 0.5 110.906 179.515 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . 0.405 HD21 HG21 ' A' ' 249' ' ' ILE . 16.7 tp -55.32 -42.34 73.6 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 115.828 -0.623 . . . . 0.96 111.324 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . 0.785 ' HA ' ' HE1' ' A' ' 166' ' ' TYR . 17.9 mtm105 -63.27 -53.05 59.03 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.717 -0.22 . . . . 0.48 111.37 179.654 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.51 -49.77 76.51 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 111.888 0.329 . . . . 0.73 111.888 -179.774 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 87.2 t -63.89 -46.81 93.16 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 CA-C-O 120.877 0.37 . . . . 1.08 110.315 179.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . 0.601 ' HA3' ' OH ' ' A' ' 166' ' ' TYR . . . -58.83 -42.13 96.42 Favored Glycine 0 C--N 1.333 0.372 0 CA-C-N 115.9 -0.591 . . . . 0.26 112.222 179.017 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -56.95 -44.27 82.38 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.837 0.351 . . . . 0.49 110.31 178.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -66.96 -53.48 26.63 Favored Glycine 0 CA--C 1.523 0.568 0 C-N-CA 120.928 -0.654 . . . . 0.36 112.883 179.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 60.3 t -60.77 -42.73 93.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 N-CA-C 112.217 0.451 . . . . 1.09 112.217 -179.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 202' ' ' GLN . . . . . 0.585 ' HA ' ' HE2' ' A' ' 209' ' ' PHE . 0.2 OUTLIER -63.44 -52.71 60.32 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 112.131 0.419 . . . . 0.51 112.131 -179.392 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 30.6 mtt-85 -66.66 -33.39 75.54 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.732 0.301 . . . . 0.56 110.343 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -63.92 -52.6 59.09 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.121 -0.491 . . . . 1.04 110.311 178.379 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 80.7 m-70 -102.21 36.02 2.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.294 -0.412 . . . . 0.6 111.731 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -57.19 -46.52 82.76 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 120.931 0.396 . . . . 1.23 111.31 -179.389 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 47.5 p -64.11 -41.63 97.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.832 -0.622 . . . . 0.84 111.16 179.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -63.61 -41.21 98.32 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.914 -0.585 . . . . 0.57 110.523 179.054 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 209' ' ' PHE . . . . . 0.596 ' O ' ' HG ' ' A' ' 213' ' ' LEU . 20.6 m-30 -70.23 -46.98 63.37 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.143 -0.48 . . . . 0.69 110.138 178.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 210' ' ' GLN . . . . . 0.429 ' HA ' HD13 ' A' ' 213' ' ' LEU . 0.6 OUTLIER -58.66 -44.57 90.2 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 121.039 0.447 . . . . 1.16 110.206 178.708 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . 0.444 ' O ' ' HG3' ' A' ' 215' ' ' LYS . . . -64.33 -43.75 96.43 Favored Glycine 0 C--N 1.335 0.479 0 C-N-CA 121.016 -0.612 . . . . 0.39 111.741 178.489 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 212' ' ' MET . . . . . 0.435 ' HA ' ' HD2' ' A' ' 215' ' ' LYS . 30.8 ttm -62.2 -37.69 86.27 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 120.719 0.295 . . . . 0.53 110.276 178.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . 0.596 ' HG ' ' O ' ' A' ' 209' ' ' PHE . 97.4 mt -58.0 -43.93 86.9 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.169 -0.468 . . . . 1.15 110.068 177.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 214' ' ' ARG . . . . . 0.525 ' HD3' ' O ' ' A' ' 214' ' ' ARG . 0.0 OUTLIER -66.92 -32.01 72.98 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 115.855 -0.611 . . . . 0.89 110.401 178.755 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 215' ' ' LYS . . . . . 0.505 ' HZ3' ' CD ' ' B' ' 22' ' ' GLU . 89.7 mttt -70.32 -43.69 69.78 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 116.282 -0.417 . . . . 0.65 110.856 178.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 15.1 mt -72.8 164.23 26.89 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 121.159 0.504 . . . . 1.42 111.811 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -111.55 32.75 5.17 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 121.251 0.548 . . . . 1.04 110.999 179.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 218' ' ' ILE . . . . . 0.595 ' HA ' ' HB2' ' A' ' 223' ' ' ASP . 41.2 mm -57.15 108.38 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-N 115.746 -0.661 . . . . 1.03 111.992 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . 0.501 ' HZ2' ' HA ' ' A' ' 219' ' ' LYS . 0.4 OUTLIER -145.83 -82.6 0.14 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.843 0.354 . . . . 0.71 111.727 179.887 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 65.9 m-20 -87.49 -176.54 5.63 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.883 -0.599 . . . . 2.26 110.612 178.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . 0.511 ' O ' HG21 ' A' ' 224' ' ' VAL . 13.1 tm-20 -46.48 -31.16 2.55 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 122.975 0.51 . . . . 0.91 112.362 -179.804 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -55.12 -24.85 37.21 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 121.631 -0.319 . . . . 0.59 113.681 178.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 223' ' ' ASP . . . . . 0.595 ' HB2' ' HA ' ' A' ' 218' ' ' ILE . 0.5 OUTLIER -56.63 -36.11 69.1 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 112.741 0.645 . . . . 0.69 112.741 -179.047 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . 0.516 ' HB ' HG22 ' A' ' 274' ' ' THR . 14.2 m -61.15 -29.77 46.44 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-O 120.823 0.344 . . . . 0.64 111.808 -179.521 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 30.6 mttp -72.81 -40.54 65.74 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.143 0.497 . . . . 1.14 109.892 179.132 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 226' ' ' SER . . . . . 0.533 ' O ' HG22 ' A' ' 230' ' ' VAL . 53.4 p -70.73 -38.77 73.6 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.802 -0.635 . . . . 0.56 109.856 178.545 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 227' ' ' PHE . . . . . 0.63 ' O ' ' HG3' ' A' ' 231' ' ' MET . 10.3 t80 -65.11 -46.67 80.07 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 116.102 -0.499 . . . . 0.75 110.031 178.748 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 48.2 t -57.72 -40.12 78.87 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.373 -0.376 . . . . 0.99 110.153 178.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 3.1 ttp180 -56.88 -43.18 81.02 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.048 -0.524 . . . . 1.95 109.69 178.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . 0.533 HG22 ' O ' ' A' ' 226' ' ' SER . 29.6 t -65.67 -49.59 76.68 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 CA-C-N 115.812 -0.631 . . . . 1.06 109.895 178.076 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 231' ' ' MET . . . . . 0.63 ' HG3' ' O ' ' A' ' 227' ' ' PHE . 68.3 mtp -54.38 -51.4 64.94 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 115.784 -0.644 . . . . 1.11 111.842 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 93.2 t -60.84 -39.9 83.4 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 CA-C-N 116.512 -0.313 . . . . 0.81 111.598 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -70.65 -37.66 73.75 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 120.751 -0.38 . . . . 0.81 110.973 179.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . 0.427 HG21 ' O ' ' A' ' 230' ' ' VAL . 51.1 t -59.24 -36.03 61.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-O 121.206 0.527 . . . . 1.02 110.987 179.27 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 235' ' ' PHE . . . . . 0.464 ' HE2' HD21 ' A' ' 248' ' ' LEU . 86.2 m-85 -103.61 18.2 22.42 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.302 -0.408 . . . . 0.57 111.553 179.372 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 11.8 tptp -77.96 -9.52 59.14 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 120.941 0.4 . . . . 1.56 111.324 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 -70.23 -16.23 63.02 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.379 -0.373 . . . . 0.54 111.651 179.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 90.83 -1.86 78.91 Favored Glycine 0 CA--C 1.521 0.423 0 C-N-CA 120.748 -0.739 . . . . 0.64 112.504 -179.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 6.0 p -119.36 119.08 59.55 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 CA-C-O 121.509 0.671 . . . . 1.09 110.979 179.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 240' ' ' THR . . . . . 0.514 HG21 ' HG2' ' A' ' 283' ' ' LYS . 0.5 OUTLIER -93.71 83.38 4.43 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.152 -0.476 . . . . 1.12 112.2 -179.653 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -76.92 136.36 38.81 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.117 -0.492 . . . . 0.42 111.266 179.305 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 242' ' ' TRP . . . . . . . . . . . . . 6.0 m95 -53.93 -45.54 71.26 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.783 0.325 . . . . 0.45 111.0 179.126 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -57.39 -35.98 74.43 Favored Glycine 0 C--N 1.336 0.568 0 CA-C-N 116.068 -0.514 . . . . 0.3 112.823 179.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 84.0 mtt180 -68.25 -44.29 75.95 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 109.985 -0.376 . . . . 0.44 109.985 178.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . 0.639 HG21 HD12 ' A' ' 279' ' ' LEU . 98.5 mt -59.65 -51.36 73.69 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-N 115.954 -0.567 . . . . 1.18 110.518 178.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 59.6 t -63.07 -40.37 88.77 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 CA-C-N 116.164 -0.471 . . . . 0.73 111.07 178.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 23.5 m -60.63 -41.07 94.14 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 120.81 0.338 . . . . 0.83 110.432 179.011 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 248' ' ' LEU . . . . . 0.464 HD21 ' HE2' ' A' ' 235' ' ' PHE . 21.0 tp -64.2 -38.49 91.23 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 121.102 0.477 . . . . 0.91 109.914 178.191 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 249' ' ' ILE . . . . . 0.664 HD13 HD23 ' A' ' 279' ' ' LEU . 47.6 mm -68.2 -41.72 84.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-N 116.091 -0.504 . . . . 1.12 109.952 178.155 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 65.6 m -62.6 -43.95 97.52 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.026 -0.534 . . . . 0.55 109.653 178.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 251' ' ' PHE . . . . . 0.521 ' O ' HG21 ' A' ' 255' ' ' VAL . 29.9 t80 -62.44 -43.16 99.47 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 115.722 -0.672 . . . . 0.47 109.375 177.76 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -56.5 -47.83 80.87 Favored Glycine 0 C--N 1.338 0.666 0 N-CA-C 111.091 -0.803 . . . . 0.27 111.091 178.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -59.12 -42.2 89.99 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-O 120.573 0.225 . . . . 0.43 110.557 177.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 254' ' ' PHE . . . . . 0.409 ' CD2' HD11 ' A' ' 213' ' ' LEU . 5.8 t80 -63.81 -40.06 95.73 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.487 -0.324 . . . . 0.74 110.648 178.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 255' ' ' VAL . . . . . 0.521 HG21 ' O ' ' A' ' 251' ' ' PHE . 84.8 t -63.64 -43.8 98.27 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 N-CA-C 109.297 -0.631 . . . . 1.04 109.297 177.426 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -62.82 -34.55 77.54 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 115.81 -0.632 . . . . 0.76 109.992 178.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 257' ' ' LYS . . . . . 0.462 ' HG3' ' O ' ' A' ' 171' ' ' ALA . 30.4 tttp -66.7 -46.08 76.72 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 115.385 -0.825 . . . . 1.16 110.163 178.248 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 14.4 t60 -62.1 -42.41 99.2 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 115.827 -0.624 . . . . 0.83 109.393 178.29 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 4.7 mp -67.27 -35.5 79.63 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.012 -0.54 . . . . 1.04 110.846 178.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.71 -34.53 77.35 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.533 -0.303 . . . . 1.01 111.018 178.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 24.0 p -62.45 -20.07 64.15 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 120.684 0.278 . . . . 0.97 111.591 179.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 262' ' ' VAL . . . . . 0.449 HG22 ' HG3' ' A' ' 264' ' ' GLN . 13.8 m -117.03 18.82 7.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-O 120.92 0.39 . . . . 1.23 111.073 178.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 65.1 m-80 56.98 46.39 19.53 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 113.8 1.037 . . . . 1.92 113.8 179.171 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 264' ' ' GLN . . . . . 0.449 ' HG3' HG22 ' A' ' 262' ' ' VAL . 12.6 mt-30 -99.29 36.64 1.7 Allowed 'General case' 0 CA--C 1.536 0.423 0 O-C-N 121.884 -0.51 . . . . 0.48 111.491 179.074 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 265' ' ' GLU . . . . . 0.401 ' HA ' HD11 ' A' ' 268' ' ' ILE . 11.4 tp10 -53.9 -42.1 68.35 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 120.91 0.386 . . . . 0.41 111.653 -179.718 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 30.9 t -61.06 -14.94 27.25 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.128 -0.487 . . . . 0.48 111.729 179.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 267' ' ' PHE . . . . . 0.475 ' C ' ' HD2' ' A' ' 270' ' ' PRO . 71.7 m-85 -101.21 -21.27 14.97 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 121.15 0.5 . . . . 0.94 110.064 178.703 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 268' ' ' ILE . . . . . 0.401 HD11 ' HA ' ' A' ' 265' ' ' GLU . 76.1 mt -67.42 -37.19 78.47 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 CA-C-N 115.851 -0.613 . . . . 1.09 109.891 178.462 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 269' ' ' GLU . . . . . 0.75 ' HB2' ' HD3' ' A' ' 270' ' ' PRO . 9.1 mm-40 -56.63 -57.82 21.21 Favored Pre-proline 0 CA--C 1.548 0.876 0 CA-C-N 116.383 -0.372 . . . . 0.44 111.025 178.623 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 270' ' ' PRO . . . . . 0.75 ' HD3' ' HB2' ' A' ' 269' ' ' GLU . 35.1 Cg_exo -63.22 -30.19 74.12 Favored 'Trans proline' 0 C--N 1.365 1.403 0 C-N-CA 122.322 2.014 . . . . 0.4 112.122 178.58 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 271' ' ' LEU . . . . . . . . . . . . . 56.7 tp -67.09 -50.86 60.23 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 109.72 -0.474 . . . . 1.0 109.72 178.425 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -62.49 -36.52 82.76 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 115.948 -0.569 . . . . 0.4 110.456 178.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 273' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -63.13 -48.89 76.6 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.142 -0.481 . . . . 0.41 109.724 178.009 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 274' ' ' THR . . . . . 0.516 HG22 ' HB ' ' A' ' 224' ' ' VAL . 62.7 m -62.72 -48.54 78.77 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.863 -0.608 . . . . 0.91 110.853 178.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 275' ' ' ILE . . . . . 0.531 ' HA ' ' HE2' ' A' ' 231' ' ' MET . 92.1 mt -54.78 -51.9 47.52 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.157 0 CA-C-N 116.135 -0.484 . . . . 1.01 111.106 179.42 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 276' ' ' THR . . . . . 0.514 HG21 HD13 ' A' ' 163' ' ' ILE . 40.8 m -60.49 -51.23 70.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.277 -0.42 . . . . 0.92 111.193 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 277' ' ' ASP . . . . . 0.513 ' OD1' ' HD2' ' A' ' 281' ' ' ARG . 25.9 t0 -55.09 -58.26 8.37 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.129 -0.487 . . . . 0.9 111.61 179.807 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 95.4 t -58.41 -41.8 82.46 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 CA-C-O 120.795 0.331 . . . . 0.97 111.58 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 279' ' ' LEU . . . . . 0.664 HD23 HD13 ' A' ' 249' ' ' ILE . 12.2 tp -61.77 -47.74 83.79 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 112.219 0.452 . . . . 1.27 112.219 -179.578 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 46.5 t -79.31 -42.81 23.64 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 N-CA-C 112.612 0.597 . . . . 0.98 112.612 -178.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 281' ' ' ARG . . . . . 0.513 ' HD2' ' OD1' ' A' ' 277' ' ' ASP . 0.4 OUTLIER -58.8 -33.53 70.46 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 112.326 0.491 . . . . 1.4 112.326 -179.336 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 282' ' ' THR . . . . . . . . . . . . . 48.4 p -85.84 -1.62 57.43 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 111.772 0.286 . . . . 0.6 111.772 179.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . 0.514 ' HG2' HG21 ' A' ' 240' ' ' THR . 32.8 mttp -141.22 34.11 1.7 Allowed 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.572 -0.286 . . . . 0.59 111.391 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 48.9 mtp180 -53.83 -62.24 1.78 Allowed 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 112.573 0.582 . . . . 0.57 112.573 -178.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 285' ' ' ASP . . . . . 0.483 ' O ' ' HE2' ' A' ' 289' ' ' LYS . 8.7 p-10 -65.63 -37.65 87.19 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.168 -0.469 . . . . 0.46 110.901 -179.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 286' ' ' TRP . . . . . 0.506 ' CZ2' ' HG2' ' A' ' 290' ' ' GLN . 71.9 t90 -62.4 -40.5 96.7 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.425 -0.352 . . . . 0.44 110.912 179.653 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 287' ' ' LEU . . . . . 0.488 HD13 ' HA2' ' A' ' 292' ' ' GLY . 0.8 OUTLIER -60.71 -48.36 82.14 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 111.971 0.36 . . . . 1.11 111.971 179.749 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 9.5 p -69.35 -32.16 52.32 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 C-N-CA 120.481 -0.487 . . . . 0.7 111.453 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 289' ' ' LYS . . . . . 0.483 ' HE2' ' O ' ' A' ' 285' ' ' ASP . 39.8 mtmt -75.97 -40.3 54.21 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 112.775 0.657 . . . . 1.41 112.775 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 290' ' ' GLN . . . . . 0.506 ' HG2' ' CZ2' ' A' ' 286' ' ' TRP . 1.6 mp0 -87.82 29.87 0.88 Allowed 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 114.278 1.214 . . . . 0.7 114.278 -177.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 291' ' ' ARG . . . . . 0.581 ' HG2' ' HB2' ' A' ' 294' ' ' ASP . 1.9 ttt180 60.74 19.7 9.79 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 112.762 0.653 . . . . 0.55 112.762 178.435 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 292' ' ' GLY . . . . . 0.488 ' HA2' HD13 ' A' ' 287' ' ' LEU . . . 42.34 -135.52 3.76 Favored Glycine 0 CA--C 1.527 0.788 0 N-CA-C 115.363 0.905 . . . . 0.42 115.363 178.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 293' ' ' TRP . . . . . 0.581 ' O ' HG23 ' A' ' 297' ' ' VAL . 97.2 m95 -64.46 -37.41 87.44 Favored 'General case' 0 C--O 1.226 -0.133 0 CA-C-N 115.428 -0.386 . . . . 0.66 111.058 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 294' ' ' ASP . . . . . 0.581 ' HB2' ' HG2' ' A' ' 291' ' ' ARG . 0.9 OUTLIER -53.8 -46.91 71.22 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 121.176 0.512 . . . . 0.63 110.195 179.023 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -65.79 -39.3 95.1 Favored Glycine 0 CA--C 1.523 0.56 0 C-N-CA 120.884 -0.674 . . . . 0.32 111.835 178.324 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 296' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -64.05 -36.15 83.07 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 120.799 0.333 . . . . 0.42 110.937 179.131 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 297' ' ' VAL . . . . . 0.833 HG11 ' HD3' ' A' ' 189' ' ' ARG . 77.8 t -64.99 -54.16 32.84 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 CA-C-N 116.202 -0.454 . . . . 1.0 111.65 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -69.71 -23.16 63.38 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 112.312 0.486 . . . . 0.49 112.312 -179.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 299' ' ' PHE . . . . . . . . . . . . . 88.2 t80 -70.12 -52.68 21.74 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 111.694 0.257 . . . . 0.58 111.694 179.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 300' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 . . . . . 0 CA--C 1.535 0.378 0 CA-C-O 120.827 0.346 . . . . 0.5 111.67 -179.578 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 22' ' ' GLU . . . . . 0.505 ' CD ' ' HZ3' ' A' ' 215' ' ' LYS . 0.5 OUTLIER . . . . . 0 CA--C 1.532 0.262 0 CA-C-O 120.264 0.078 . . . . 0.68 111.096 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 23' ' ' PHE . . . . . 0.436 ' CD1' HG23 ' A' ' 230' ' ' VAL . 0.8 OUTLIER -58.29 -40.16 81.23 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.276 0.56 . . . . 0.58 110.715 179.125 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -70.52 -40.33 73.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.008 -0.542 . . . . 1.06 110.427 178.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . 0.423 ' O ' ' HB3' ' B' ' 28' ' ' ARG . . . -64.15 -37.38 87.24 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 116.133 -0.485 . . . . 0.44 110.808 178.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -62.74 -54.26 41.85 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.012 -0.54 . . . . 0.59 110.419 178.72 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 95.9 mt -58.96 -34.36 71.71 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.134 0.492 . . . . 1.05 109.833 178.167 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 28' ' ' ARG . . . . . 0.423 ' HB3' ' O ' ' B' ' 25' ' ' ALA . 1.1 ttt180 -59.84 -51.04 71.44 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 115.43 -0.805 . . . . 0.7 110.111 177.854 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -67.66 -40.14 84.53 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.304 -0.407 . . . . 1.34 111.264 179.157 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 96.5 mt -62.68 -46.9 95.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-O 120.962 0.41 . . . . 0.85 110.318 178.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.35 -48.34 86.47 Favored Glycine 0 N--CA 1.45 -0.419 0 CA-C-N 115.72 -0.673 . . . . 0.28 112.871 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -64.6 -37.87 89.06 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.917 0.359 . . . . 0.47 111.548 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 20.7 ttmm -63.72 -47.78 79.73 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-O 121.121 0.486 . . . . 1.74 110.255 178.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 55.5 t -65.06 -46.69 90.59 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 CA-C-N 115.844 -0.616 . . . . 1.11 110.532 178.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -56.08 -48.54 75.9 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 115.824 -0.625 . . . . 0.88 111.743 179.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 36' ' ' CYS . . . . . . . . . . . . . 84.2 m -64.51 -35.35 80.67 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 120.812 0.339 . . . . 0.82 111.543 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 63.1 m -67.92 -40.99 83.29 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 112.227 0.455 . . . . 0.83 112.227 -179.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 38' ' ' TRP . . . . . . . . . . . . . 97.8 m95 -87.41 -18.54 29.74 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.498 0.555 . . . . 0.8 112.498 -179.19 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 28.8 t . . . . . 0 N--CA 1.47 0.574 0 N-CA-C 112.054 0.39 . . . . 0.89 112.054 179.49 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . 0.538 ' O ' ' HG3' ' A' ' 157' ' ' ARG . 0.1 OUTLIER . . . . . 0 CA--C 1.539 0.523 0 N-CA-C 112.711 0.634 . . . . 0.54 112.711 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 -60.88 -43.66 98.13 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.185 0.517 . . . . 0.46 111.391 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.537 HD22 ' HB3' ' A' ' 287' ' ' LEU . 27.1 tp -63.89 -49.35 73.04 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.754 -0.657 . . . . 1.25 110.231 179.377 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 44.4 t80 -58.8 -43.57 90.55 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 115.885 -0.598 . . . . 0.58 111.45 179.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . 0.538 ' HG3' ' O ' ' A' ' 153' ' ' ASP . 51.5 mtm180 -60.08 -52.71 64.21 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.698 0.285 . . . . 0.46 111.13 179.556 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 29.0 mt-30 -63.05 -45.27 93.01 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.541 -0.3 . . . . 0.54 110.781 179.155 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' SER . . . . . 0.534 ' HA ' ' CZ2' ' A' ' 293' ' ' TRP . 21.1 m -58.93 -56.92 16.0 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.384 -0.371 . . . . 0.32 111.375 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.669 HD12 ' HG2' ' A' ' 273' ' ' GLU . 12.7 tp -54.55 -48.88 71.49 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.751 -0.204 . . . . 1.23 111.474 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -57.49 -54.25 48.93 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 111.85 0.315 . . . . 1.08 111.85 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 74.7 mt -62.28 -43.43 98.0 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 N-CA-C 111.871 0.323 . . . . 1.13 111.871 -179.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.631 ' O ' ' HG ' ' A' ' 167' ' ' LEU . 87.0 mt -64.43 -48.42 85.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 N-CA-C 110.225 -0.287 . . . . 1.08 110.225 179.211 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 6.8 t -58.42 -44.63 89.18 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.409 -0.36 . . . . 0.36 110.282 178.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . 0.416 HH11 ' HD2' ' A' ' 165' ' ' ARG . 2.6 mmt180 -59.12 -51.98 67.71 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.121 -0.491 . . . . 0.6 111.89 178.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' TYR . . . . . 0.703 ' CE1' ' HA ' ' A' ' 195' ' ' ARG . 51.6 t80 -60.57 -49.77 76.22 Favored 'General case' 0 CA--C 1.527 0.085 0 N-CA-C 112.399 0.518 . . . . 0.48 112.399 -179.042 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.631 ' HG ' ' O ' ' A' ' 163' ' ' ILE . 11.8 mt -67.14 -33.74 76.08 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 120.225 -0.59 . . . . 0.99 111.293 -178.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 21.5 ttp180 -69.75 -52.62 23.77 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 111.803 0.297 . . . . 0.5 111.803 179.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -61.65 -48.41 80.99 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 111.838 0.31 . . . . 0.35 111.838 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.36 -40.73 91.85 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.09 -0.505 . . . . 0.35 112.12 -179.726 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . 0.409 ' HB1' ' HB2' ' A' ' 260' ' ' LYS . . . . . . . . 0 N--CA 1.465 0.276 0 N-CA-C 112.114 0.413 . . . . 0.5 112.114 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . 0.559 ' O ' ' HA3' ' A' ' 187' ' ' GLY . . . . . . . . 0 CA--C 1.536 0.435 0 CA-C-O 121.226 0.536 . . . . 1.07 110.768 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -78.74 -71.01 1.27 Allowed Glycine 0 CA--C 1.524 0.655 0 C-N-CA 120.617 -0.801 . . . . 0.4 113.993 -179.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -70.78 -55.43 8.6 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-O 120.923 0.392 . . . . 1.11 111.189 -179.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -63.51 -35.56 80.85 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 116.064 -0.516 . . . . 0.48 110.369 178.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . 0.559 ' HA3' ' O ' ' A' ' 183' ' ' ALA . . . -64.32 -34.83 90.98 Favored Glycine 0 C--N 1.336 0.559 0 CA-C-N 116.017 -0.538 . . . . 0.34 112.648 179.464 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 1.2 mmm-85 -68.04 -57.84 5.47 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 109.589 -0.523 . . . . 0.8 109.589 178.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 189' ' ' ARG . . . . . 0.58 ' HB3' HG12 ' A' ' 297' ' ' VAL . 44.5 mtp180 -56.73 -48.34 77.97 Favored 'General case' 0 C--O 1.226 -0.176 0 CA-C-N 115.53 -0.759 . . . . 0.87 111.2 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . 0.593 ' O ' ' HB2' ' A' ' 194' ' ' LEU . . . -60.85 -37.74 83.11 Favored 'General case' 0 C--O 1.224 -0.265 0 N-CA-C 111.849 0.314 . . . . 1.05 111.849 -179.583 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 191' ' ' LEU . . . . . 0.473 ' HB2' ' O ' ' A' ' 187' ' ' GLY . 7.8 tp -66.46 -42.5 87.49 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.95 0.405 . . . . 1.18 110.385 179.199 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -66.33 -46.81 75.57 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.069 -0.514 . . . . 0.39 110.573 178.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 193' ' ' THR . . . . . 0.559 HG23 ' HA ' ' A' ' 297' ' ' VAL . 5.6 m -62.34 -43.87 97.8 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.985 0.421 . . . . 1.06 109.936 178.266 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . 0.593 ' HB2' ' O ' ' A' ' 190' ' ' ALA . 6.4 tp -62.2 -43.55 98.58 Favored 'General case' 0 C--O 1.224 -0.278 0 CA-C-N 115.585 -0.734 . . . . 1.13 110.672 178.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . 0.703 ' HA ' ' CE1' ' A' ' 166' ' ' TYR . 0.0 OUTLIER -65.01 -38.34 90.61 Favored 'General case' 0 C--O 1.224 -0.271 0 CA-C-O 121.292 0.568 . . . . 1.08 110.37 178.939 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . 0.406 HH11 ' HD3' ' A' ' 196' ' ' ARG . 0.9 OUTLIER -67.5 -60.06 2.87 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.968 -0.56 . . . . 0.44 112.076 -179.739 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 7.0 t -71.19 -45.69 69.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 111.836 0.31 . . . . 0.79 111.836 -178.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -57.21 -45.17 92.93 Favored Glycine 0 CA--C 1.522 0.514 0 C-N-CA 121.465 -0.398 . . . . 0.29 113.538 -179.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . 0.506 ' O ' ' HB2' ' A' ' 203' ' ' ARG . 2.7 m-20 -73.92 -32.58 63.59 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 117.059 0.43 . . . . 0.49 110.713 179.725 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -68.85 -48.42 48.79 Favored Glycine 0 CA--C 1.524 0.653 0 C-N-CA 120.946 -0.645 . . . . 0.31 112.677 178.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 76.7 t -61.36 -48.69 87.72 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-N 116.745 0.272 . . . . 1.09 111.123 179.413 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 202' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -62.33 -32.58 73.36 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.369 -0.378 . . . . 0.38 111.397 179.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 203' ' ' ARG . . . . . 0.506 ' HB2' ' O ' ' A' ' 199' ' ' ASP . 0.0 OUTLIER -77.46 -38.95 48.29 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 120.712 0.291 . . . . 0.72 111.027 179.532 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -71.44 -52.37 18.85 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 116.226 -0.443 . . . . 0.45 111.449 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 33.4 m-70 -97.27 36.25 1.49 Allowed 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 120.863 0.363 . . . . 0.61 110.855 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -58.16 -37.62 75.05 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 113.038 0.755 . . . . 0.72 113.038 -178.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 4.1 t -56.89 -37.28 71.16 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 120.931 0.396 . . . . 1.16 111.902 -179.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -75.06 -43.42 53.43 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 121.124 0.487 . . . . 1.15 111.001 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 209' ' ' PHE . . . . . 0.407 ' O ' ' HB2' ' A' ' 213' ' ' LEU . 56.2 m-85 -66.56 -39.18 88.37 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 115.871 -0.604 . . . . 0.54 110.943 179.748 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 210' ' ' GLN . . . . . 0.4 ' O ' ' HG2' ' A' ' 214' ' ' ARG . 0.6 OUTLIER -64.7 -45.25 87.42 Favored 'General case' 0 C--O 1.222 -0.371 0 CA-C-N 116.515 -0.311 . . . . 0.67 111.251 179.634 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -56.77 -48.43 78.05 Favored Glycine 0 CA--C 1.523 0.564 0 C-N-CA 120.251 -0.976 . . . . 0.36 111.766 178.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 212' ' ' MET . . . . . 0.542 ' O ' ' HB2' ' A' ' 216' ' ' LEU . 49.2 mtp -67.06 -34.0 76.73 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 115.637 -0.281 . . . . 1.44 111.296 178.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . 0.472 HD22 ' HB2' ' A' ' 258' ' ' HIS . 1.0 OUTLIER -75.73 -37.61 59.22 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 112.205 0.446 . . . . 1.14 112.205 -179.949 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 214' ' ' ARG . . . . . 0.4 ' HG2' ' O ' ' A' ' 210' ' ' GLN . 33.2 mmt180 -64.12 -35.14 79.78 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.89 0.376 . . . . 1.4 110.079 179.028 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 215' ' ' LYS . . . . . 0.521 ' HE2' ' HA ' ' A' ' 215' ' ' LYS . 0.0 OUTLIER -95.7 12.51 29.61 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 121.171 0.51 . . . . 0.86 110.585 177.91 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . 0.642 ' HG ' HG13 ' A' ' 218' ' ' ILE . 10.1 tp -93.84 99.22 11.63 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.211 -0.45 . . . . 1.19 110.934 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -93.94 33.25 1.35 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.261 -0.427 . . . . 0.84 110.985 179.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 218' ' ' ILE . . . . . 0.642 HG13 ' HG ' ' A' ' 216' ' ' LEU . 16.1 mt -61.86 108.52 0.52 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.495 0 CA-C-O 121.748 0.785 . . . . 1.15 111.826 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 1.6 ttpm? -161.61 17.51 0.1 Allowed 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 114.945 -1.025 . . . . 2.52 110.878 -179.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -139.04 160.75 39.03 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-O 120.864 0.364 . . . . 0.66 111.397 -179.088 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -62.51 -22.99 66.7 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.015 0.436 . . . . 0.81 111.733 179.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -74.7 -26.04 68.29 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 120.94 -0.648 . . . . 0.69 113.508 179.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 223' ' ' ASP . . . . . 0.436 ' HB3' HG12 ' A' ' 218' ' ' ILE . 71.9 m-20 -61.65 -43.97 97.84 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 113.011 0.745 . . . . 0.79 113.011 -178.795 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . 0.5 HG22 ' HD2' ' A' ' 225' ' ' LYS . 29.9 m -59.86 -28.71 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 N-CA-C 112.123 0.416 . . . . 0.85 112.123 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . 0.5 ' HD2' HG22 ' A' ' 224' ' ' VAL . 11.9 mptt -64.28 -42.05 96.62 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 121.318 0.58 . . . . 1.28 109.847 178.871 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 226' ' ' SER . . . . . 0.593 ' O ' HG23 ' A' ' 230' ' ' VAL . 3.5 m -71.0 -38.72 72.69 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.787 -0.642 . . . . 1.2 109.577 178.032 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 227' ' ' PHE . . . . . 0.483 ' HE1' HG12 ' A' ' 275' ' ' ILE . 8.8 t80 -56.02 -43.83 78.16 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 115.84 -0.618 . . . . 0.75 109.863 177.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 228' ' ' SER . . . . . 0.416 ' O ' HG23 ' A' ' 232' ' ' VAL . 39.2 m -61.59 -44.54 96.83 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.634 -0.712 . . . . 0.46 110.022 178.067 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 229' ' ' ARG . . . . . 0.471 ' NH1' ' HA ' ' A' ' 226' ' ' SER . 4.2 ttm105 -61.01 -38.86 87.55 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 115.806 -0.634 . . . . 1.1 110.935 178.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . 0.593 HG23 ' O ' ' A' ' 226' ' ' SER . 97.0 t -55.88 -52.56 47.8 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-N 116.164 -0.471 . . . . 1.11 110.587 178.683 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 231' ' ' MET . . . . . 0.615 ' HG2' HD22 ' A' ' 248' ' ' LEU . 72.3 mtm -59.98 -38.0 81.25 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.07 -0.514 . . . . 1.01 111.471 179.405 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 232' ' ' VAL . . . . . 0.416 HG23 ' O ' ' A' ' 228' ' ' SER . 84.6 t -62.76 -42.49 96.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-O 120.771 0.319 . . . . 0.99 110.812 179.151 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 233' ' ' HIS . . . . . 0.429 ' HB3' ' HB3' ' B' ' 24' ' ' ALA . 48.7 t-80 -63.44 -35.61 81.01 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 120.84 0.353 . . . . 0.56 111.164 179.166 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 97.2 t -63.16 -38.19 81.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-O 121.114 0.483 . . . . 0.54 111.42 179.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 235' ' ' PHE . . . . . 0.526 ' HE2' HD13 ' A' ' 248' ' ' LEU . 62.2 m-85 -103.54 23.89 11.93 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.271 -0.422 . . . . 0.72 111.517 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 3.9 ttpp -69.83 -1.4 9.26 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 113.297 0.851 . . . . 0.93 113.297 -178.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 6.2 p30 -102.87 -16.13 15.99 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.949 0.404 . . . . 0.4 111.038 179.377 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 94.19 -6.48 72.19 Favored Glycine 0 CA--C 1.522 0.487 0 C-N-CA 120.905 -0.664 . . . . 0.37 112.605 -179.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 7.9 t -81.01 112.01 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.139 0 CA-C-O 121.157 0.504 . . . . 0.95 111.199 -179.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 240' ' ' THR . . . . . 0.432 ' HB ' ' CE2' ' A' ' 286' ' ' TRP . 1.2 m -94.43 101.62 13.55 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 120.777 -0.369 . . . . 0.69 111.444 179.505 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -110.31 139.08 45.86 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.396 -0.366 . . . . 0.92 110.713 179.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 242' ' ' TRP . . . . . 0.573 ' HB3' ' CE2' ' A' ' 300' ' ' PHE . 16.0 m95 -57.98 -42.82 85.91 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 120.625 0.25 . . . . 0.48 111.446 179.443 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -60.26 -28.83 67.53 Favored Glycine 0 CA--C 1.522 0.514 0 C-N-CA 121.306 -0.473 . . . . 0.31 112.775 178.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 244' ' ' ARG . . . . . 0.44 ' O ' ' HG ' ' A' ' 248' ' ' LEU . 94.3 mtt180 -71.42 -46.86 59.08 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.349 -0.612 . . . . 0.56 109.349 178.422 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 74.8 mt -60.93 -45.45 98.32 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-N 115.376 -0.829 . . . . 0.72 111.074 179.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . 0.44 HG21 ' O ' ' A' ' 242' ' ' TRP . 61.3 t -62.52 -40.62 88.87 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-O 120.608 0.242 . . . . 0.87 111.015 179.269 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 55.1 m -57.67 -40.8 80.2 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.479 -0.328 . . . . 0.82 110.756 179.278 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 248' ' ' LEU . . . . . 0.615 HD22 ' HG2' ' A' ' 231' ' ' MET . 69.8 mt -61.63 -36.71 81.54 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 121.047 0.451 . . . . 1.11 110.298 178.229 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 29.5 mm -74.23 -38.98 48.99 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.133 0 CA-C-N 116.292 -0.413 . . . . 1.14 110.107 178.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 16.5 t -60.76 -42.77 98.09 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 108.921 -0.77 . . . . 0.59 108.921 178.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 251' ' ' PHE . . . . . 0.455 ' O ' HG21 ' A' ' 255' ' ' VAL . 19.7 t80 -64.85 -42.85 94.57 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 108.599 -0.889 . . . . 0.57 108.599 176.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -56.65 -40.31 87.86 Favored Glycine 0 C--N 1.337 0.616 0 N-CA-C 111.434 -0.667 . . . . 0.28 111.434 177.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -63.05 -37.48 87.36 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 120.956 0.408 . . . . 0.56 110.539 177.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -69.71 -38.9 77.1 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.066 -0.515 . . . . 1.09 109.952 178.329 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 255' ' ' VAL . . . . . 0.604 ' O ' ' HG ' ' A' ' 259' ' ' LEU . 59.8 t -67.53 -42.33 86.82 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.209 0 CA-C-N 116.079 -0.509 . . . . 1.0 109.719 178.281 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -57.96 -43.55 86.48 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 109.525 -0.546 . . . . 0.38 109.525 177.076 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 60.8 mttt -62.55 -43.45 98.78 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.7 -0.682 . . . . 1.12 109.982 177.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 258' ' ' HIS . . . . . 0.472 ' HB2' HD22 ' A' ' 213' ' ' LEU . 36.0 t60 -61.63 -44.38 97.1 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.935 -0.575 . . . . 1.04 110.465 178.534 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . 0.604 ' HG ' ' O ' ' A' ' 255' ' ' VAL . 80.3 mt -67.42 -47.21 70.9 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 115.906 -0.588 . . . . 1.01 110.917 179.475 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 260' ' ' LYS . . . . . 0.409 ' HB2' ' HB1' ' A' ' 171' ' ' ALA . 0.5 OUTLIER -61.74 -32.49 72.74 Favored 'General case' 0 CA--C 1.535 0.369 0 O-C-N 122.386 -0.196 . . . . 1.06 110.99 179.526 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 69.3 m -60.95 -31.13 70.69 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.108 0.48 . . . . 0.48 110.588 178.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 28.4 m -110.18 20.66 5.82 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 CA-C-N 115.888 -0.597 . . . . 1.25 110.907 179.195 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 55.01 51.1 14.06 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 115.609 -0.723 . . . . 1.36 112.927 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -106.93 36.15 2.76 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.489 -0.323 . . . . 0.66 111.55 179.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 265' ' ' GLU . . . . . 0.497 ' HA ' HD11 ' A' ' 268' ' ' ILE . 0.8 OUTLIER -51.42 -38.91 55.98 Favored 'General case' 0 C--O 1.242 0.659 0 CA-C-O 120.922 0.391 . . . . 0.82 111.943 179.614 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 36.0 p -64.38 -12.93 47.59 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.787 -0.642 . . . . 1.05 111.537 179.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 267' ' ' PHE . . . . . 0.46 ' C ' ' HD2' ' A' ' 270' ' ' PRO . 14.9 t80 -105.3 -25.19 12.52 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.626 -0.509 . . . . 1.06 109.626 178.327 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 268' ' ' ILE . . . . . 0.497 HD11 ' HA ' ' A' ' 265' ' ' GLU . 70.3 mt -59.8 -50.01 81.68 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-N 115.957 -0.565 . . . . 1.0 110.947 179.055 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 269' ' ' GLU . . . . . 0.699 ' HB3' ' HD3' ' A' ' 270' ' ' PRO . 1.2 tp10 -57.03 -55.63 41.94 Favored Pre-proline 0 CA--C 1.547 0.853 0 C-N-CA 120.812 -0.355 . . . . 0.81 110.487 179.109 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 270' ' ' PRO . . . . . 0.699 ' HD3' ' HB3' ' A' ' 269' ' ' GLU . 52.1 Cg_exo -58.86 -29.71 90.88 Favored 'Trans proline' 0 C--N 1.364 1.378 0 C-N-CA 122.464 2.11 . . . . 0.4 112.392 177.44 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 271' ' ' LEU . . . . . 0.439 ' O ' HG13 ' A' ' 275' ' ' ILE . 1.5 tm? -67.09 -43.38 82.7 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 108.746 -0.835 . . . . 0.99 108.746 177.775 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -64.05 -35.86 82.1 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.563 -0.744 . . . . 0.43 109.0 177.148 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 273' ' ' GLU . . . . . 0.669 ' HG2' HD12 ' A' ' 160' ' ' LEU . 52.5 mt-10 -66.06 -44.82 83.42 Favored 'General case' 0 C--O 1.222 -0.379 0 CA-C-N 115.662 -0.699 . . . . 0.76 109.217 177.27 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 274' ' ' THR . . . . . . . . . . . . . 89.9 m -55.6 -46.89 77.24 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.713 -0.676 . . . . 1.06 110.578 178.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 275' ' ' ILE . . . . . 0.5 ' HA ' ' HE2' ' A' ' 231' ' ' MET . 72.9 mt -63.04 -55.42 23.65 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.128 0 CA-C-N 115.936 -0.575 . . . . 1.09 110.853 179.316 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 5.6 m -57.38 -47.81 80.71 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.009 -0.542 . . . . 0.49 112.052 -179.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 277' ' ' ASP . . . . . 0.471 ' HB2' ' O ' ' A' ' 273' ' ' GLU . 0.1 OUTLIER -52.61 -57.17 10.88 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.488 -0.324 . . . . 0.63 111.52 -179.867 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 48.5 t -66.33 -37.11 78.95 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 N-CA-C 111.915 0.339 . . . . 1.03 111.915 -179.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 41.4 tp -64.78 -47.11 79.34 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 111.971 0.36 . . . . 1.24 111.971 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 86.7 t -73.68 -32.39 35.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 CA-C-O 121.009 0.433 . . . . 1.16 111.186 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 281' ' ' ARG . . . . . 0.434 HH11 ' HD2' ' A' ' 281' ' ' ARG . 2.0 tpm_? -71.81 -43.52 65.48 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 112.439 0.533 . . . . 0.41 112.439 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 282' ' ' THR . . . . . . . . . . . . . 3.4 m -78.29 -26.53 47.06 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 112.981 0.734 . . . . 0.77 112.981 -178.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 63.9 mmtt -129.83 41.64 3.4 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 112.257 0.465 . . . . 1.19 112.257 -179.063 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.65 -62.06 1.89 Allowed 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 113.661 0.985 . . . . 0.66 113.661 -178.664 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -64.04 -42.32 97.11 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 112.794 0.665 . . . . 0.42 112.794 -178.334 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 286' ' ' TRP . . . . . 0.499 ' HE3' HD22 ' A' ' 287' ' ' LEU . 10.0 t90 -60.41 -50.19 74.58 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.733 0.301 . . . . 0.45 111.275 -179.756 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 287' ' ' LEU . . . . . 0.537 ' HB3' HD22 ' A' ' 155' ' ' LEU . 1.6 mm? -66.88 -42.76 85.04 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.319 0.489 . . . . 1.1 112.319 -179.3 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -67.24 -35.8 74.99 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 N-CA-C 112.004 0.372 . . . . 1.78 112.004 -179.487 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 56.1 mttt -77.52 -34.41 54.01 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 112.159 0.429 . . . . 1.23 112.159 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -81.05 23.89 0.54 Allowed 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 112.457 0.54 . . . . 0.73 112.457 -179.382 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 291' ' ' ARG . . . . . 0.684 ' HB3' ' HB2' ' A' ' 294' ' ' ASP . 3.1 mmt180 60.46 16.57 6.49 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.834 0.679 . . . . 0.56 112.834 179.696 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 47.63 -112.58 1.07 Allowed Glycine 0 CA--C 1.525 0.658 0 N-CA-C 114.637 0.615 . . . . 0.34 114.637 179.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 293' ' ' TRP . . . . . 0.534 ' CZ2' ' HA ' ' A' ' 159' ' ' SER . 86.0 m95 -66.74 -30.08 70.22 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.763 0.653 . . . . 0.44 112.763 -178.595 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 294' ' ' ASP . . . . . 0.684 ' HB2' ' HB3' ' A' ' 291' ' ' ARG . 15.5 m-20 -62.01 -42.92 99.68 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 121.049 0.452 . . . . 0.37 110.042 178.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -67.82 -41.86 87.69 Favored Glycine 0 CA--C 1.521 0.414 0 C-N-CA 120.639 -0.791 . . . . 0.34 111.885 178.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 296' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -67.39 -43.34 81.58 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 120.708 0.289 . . . . 0.43 111.315 179.524 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 297' ' ' VAL . . . . . 0.58 HG12 ' HB3' ' A' ' 189' ' ' ARG . 50.3 t -65.89 -55.43 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-N 116.412 -0.358 . . . . 1.0 111.664 -179.32 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -62.56 -30.91 71.67 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 112.709 0.633 . . . . 0.78 112.709 -178.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 299' ' ' PHE . . . . . . . . . . . . . 93.1 t80 -76.54 -40.82 48.81 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 112.372 0.508 . . . . 0.57 112.372 179.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 300' ' ' PHE . . . . . 0.573 ' CE2' ' HB3' ' A' ' 242' ' ' TRP . 62.1 m-85 . . . . . 0 CA--C 1.539 0.523 0 N-CA-C 114.036 1.124 . . . . 0.46 114.036 -178.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.535 0.379 0 N-CA-C 111.851 0.315 . . . . 0.64 111.851 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 23' ' ' PHE . . . . . 0.48 ' HD1' ' N ' ' B' ' 24' ' ' ALA . 0.2 OUTLIER -59.91 -33.22 71.57 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.151 0.501 . . . . 0.8 111.077 179.317 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 24' ' ' ALA . . . . . 0.48 ' N ' ' HD1' ' B' ' 23' ' ' PHE . . . -75.83 -38.41 58.1 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.207 0.527 . . . . 0.89 110.027 179.268 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -66.78 -36.63 82.87 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.937 -0.574 . . . . 0.99 109.485 178.201 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -60.54 -51.98 67.12 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 115.822 -0.626 . . . . 0.44 110.23 177.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 94.9 mt -61.86 -30.83 71.12 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 121.052 0.453 . . . . 1.1 110.14 178.556 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 28' ' ' ARG . . . . . . . . . . . . . 34.9 ttm-85 -68.0 -51.46 46.92 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 115.534 -0.757 . . . . 0.55 110.152 178.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 59.6 mttt -57.0 -42.46 80.35 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.296 -0.411 . . . . 0.55 110.599 178.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 69.6 mt -69.45 -42.95 81.12 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 CA-C-N 116.305 -0.407 . . . . 1.09 110.157 178.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.08 -46.18 94.66 Favored Glycine 0 C--N 1.333 0.368 0 C-N-CA 121.056 -0.592 . . . . 0.28 112.299 179.039 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -64.85 -34.98 79.65 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-O 121.176 0.512 . . . . 0.76 110.375 179.114 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 14.2 tppt? -71.73 -47.66 52.33 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.057 -0.52 . . . . 1.26 111.116 179.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 55.5 t -62.68 -44.63 99.6 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-O 120.823 0.344 . . . . 1.06 111.009 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -59.35 -47.24 86.16 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.155 -0.475 . . . . 0.89 110.468 179.102 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 36' ' ' CYS . . . . . . . . . . . . . 11.8 t -70.01 -36.05 74.82 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 116.259 -0.428 . . . . 0.7 111.913 -179.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 99.0 m -64.75 -40.04 94.63 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.209 0.448 . . . . 1.04 112.209 -179.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 38' ' ' TRP . . . . . . . . . . . . . 94.0 m95 -82.78 -31.28 28.33 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 120.821 -0.352 . . . . 0.83 111.781 -179.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 82.9 p . . . . . 0 N--CA 1.467 0.421 0 CA-C-O 120.737 0.303 . . . . 1.11 111.093 178.337 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 25.6 t70 . . . . . 0 N--CA 1.465 0.29 0 CA-C-O 120.831 0.348 . . . . 0.52 110.832 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -55.22 -48.34 74.03 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.007 -0.542 . . . . 0.44 110.805 178.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.583 HD21 ' HB3' ' A' ' 287' ' ' LEU . 47.6 tp -73.17 -36.08 66.54 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.091 -0.504 . . . . 1.24 110.783 178.675 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 64.3 t80 -60.06 -40.58 89.97 Favored 'General case' 0 C--O 1.224 -0.282 0 CA-C-N 116.223 -0.444 . . . . 0.44 111.489 179.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 7.6 mtm180 -56.22 -52.32 64.85 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.772 0.32 . . . . 0.53 111.552 179.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -64.89 -45.93 83.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.126 -0.488 . . . . 0.38 110.658 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' SER . . . . . 0.434 ' HA ' ' CZ2' ' A' ' 293' ' ' TRP . 15.6 m -58.35 -50.25 74.3 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.802 -0.635 . . . . 0.29 111.207 179.46 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.417 ' HA ' HG23 ' A' ' 276' ' ' THR . 2.1 tm? -60.37 -47.57 85.5 Favored 'General case' 0 C--O 1.225 -0.219 0 CA-C-N 116.149 -0.478 . . . . 0.59 111.263 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -58.2 -50.28 74.08 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 120.633 0.254 . . . . 0.42 111.166 -179.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 84.9 mt -61.32 -50.14 81.65 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 CA-C-N 116.321 -0.4 . . . . 1.04 111.082 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.499 HD13 HG21 ' A' ' 276' ' ' THR . 68.4 mt -61.45 -46.53 96.38 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 N-CA-C 111.533 0.197 . . . . 1.07 111.533 179.389 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 2.0 t -56.28 -52.63 63.78 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.733 0.302 . . . . 0.48 110.807 178.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 40.0 ttt-85 -61.19 -41.54 96.99 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 120.768 0.318 . . . . 0.41 111.782 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' TYR . . . . . 0.494 ' HE1' ' HA ' ' A' ' 195' ' ' ARG . 80.9 t80 -68.37 -50.3 54.1 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 112.236 0.458 . . . . 0.33 112.236 -179.459 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.469 ' HG ' ' HA ' ' A' ' 253' ' ' ALA . 5.8 mp -54.57 -39.22 67.56 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.66 0.267 . . . . 1.14 111.101 -179.413 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 52.6 mtt-85 -65.32 -44.46 87.75 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.434 -0.348 . . . . 0.42 111.029 178.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -54.18 -45.1 72.04 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 121.111 0.481 . . . . 1.04 111.125 178.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . 0.74 ' HB2' ' HB3' ' A' ' 253' ' ' ALA . 12.3 mm100 -77.01 -37.36 55.17 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 116.18 -0.464 . . . . 0.38 111.951 -179.847 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . 0.426 ' O ' ' HG3' ' A' ' 257' ' ' LYS . . . . . . . . 0 C--O 1.232 0.183 0 CA-C-O 120.916 0.388 . . . . 0.4 110.715 178.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . 0.624 ' O ' ' HA3' ' A' ' 187' ' ' GLY . . . . . . . . 0 CA--C 1.533 0.301 0 CA-C-O 121.182 0.515 . . . . 0.44 111.439 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -80.09 -71.97 1.24 Allowed Glycine 0 CA--C 1.524 0.643 0 C-N-CA 120.609 -0.805 . . . . 0.39 113.356 179.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -68.17 -55.61 11.71 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-O 120.979 0.418 . . . . 0.64 111.118 -179.608 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -65.18 -39.08 92.39 Favored 'General case' 0 C--O 1.218 -0.555 0 CA-C-N 115.904 -0.589 . . . . 0.55 110.077 178.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . 0.624 ' HA3' ' O ' ' A' ' 183' ' ' ALA . . . -60.6 -50.82 63.4 Favored Glycine 0 C--O 1.219 -0.79 0 C-N-CA 121.399 -0.429 . . . . 0.35 113.135 179.641 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . 0.417 HH11 ' HD2' ' A' ' 188' ' ' ARG . 13.4 mtp180 -56.84 -47.85 79.39 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 117.547 0.673 . . . . 1.8 111.484 179.234 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 189' ' ' ARG . . . . . 0.698 ' HB3' HG13 ' A' ' 297' ' ' VAL . 48.3 mtm180 -70.29 -41.0 73.95 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 112.479 0.548 . . . . 0.52 112.479 -179.438 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . 0.513 ' HA ' HG21 ' A' ' 297' ' ' VAL . . . -74.22 -44.63 52.39 Favored 'General case' 0 C--O 1.221 -0.408 0 N-CA-C 111.873 0.323 . . . . 1.07 111.873 -178.649 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 3.4 tp -61.07 -49.32 77.83 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.679 -0.408 . . . . 1.08 110.319 179.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -61.08 -44.11 97.86 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 120.706 -0.398 . . . . 0.98 110.996 179.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 91.5 m -63.53 -46.19 87.13 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 110.026 -0.361 . . . . 0.8 110.026 178.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 59.8 tp -63.58 -37.27 86.68 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.075 -0.511 . . . . 1.04 111.184 179.196 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . 0.494 ' HA ' ' HE1' ' A' ' 166' ' ' TYR . 2.1 mtt180 -58.6 -48.34 81.28 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.819 0.342 . . . . 0.48 110.711 178.709 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 10.5 mmp_? -74.66 -45.12 46.75 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 116.149 -0.478 . . . . 0.45 111.868 -179.25 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . 0.468 ' O ' HG23 ' A' ' 201' ' ' VAL . 49.7 t -65.67 -51.55 61.18 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 CA-C-O 120.687 0.279 . . . . 1.01 111.628 179.529 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -62.31 -53.23 43.74 Favored Glycine 0 CA--C 1.521 0.435 0 CA-C-O 119.933 -0.371 . . . . 0.3 113.388 -179.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -55.18 -40.34 70.61 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 117.225 0.513 . . . . 0.4 109.763 179.011 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -60.36 -53.6 44.17 Favored Glycine 0 C--N 1.335 0.507 0 N-CA-C 111.138 -0.785 . . . . 0.36 111.138 177.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 197' ' ' VAL . 98.9 t -58.29 -38.33 68.33 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-O 120.792 0.33 . . . . 1.12 110.691 178.461 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 202' ' ' GLN . . . . . 0.49 ' HG3' ' HB3' ' A' ' 250' ' ' SER . 31.7 mt-30 -62.91 -54.2 42.23 Favored 'General case' 0 C--O 1.225 -0.228 0 CA-C-N 115.818 -0.628 . . . . 0.47 111.803 179.594 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 29.0 mtp180 -67.88 -36.34 80.07 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 121.028 -0.269 . . . . 0.64 111.434 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 10.9 m-80 -62.98 -50.95 68.73 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 121.181 0.515 . . . . 1.71 110.499 178.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 57.1 m-70 -101.85 35.89 2.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.214 -0.448 . . . . 0.62 111.233 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -53.47 -47.45 69.75 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 112.23 0.456 . . . . 0.44 112.23 -179.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -56.34 -39.51 72.95 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 112.285 0.476 . . . . 0.93 112.285 -179.78 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -64.86 -48.79 73.01 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 120.989 0.424 . . . . 1.06 110.84 -179.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 209' ' ' PHE . . . . . 0.609 ' O ' ' HB2' ' A' ' 213' ' ' LEU . 46.3 m-85 -66.76 -35.27 79.71 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.94 -0.573 . . . . 0.82 109.912 178.692 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 210' ' ' GLN . . . . . 0.559 ' O ' ' HG2' ' A' ' 214' ' ' ARG . 49.5 mt-30 -66.12 -45.78 79.92 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.481 -0.327 . . . . 0.66 111.181 179.005 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -55.7 -49.03 67.8 Favored Glycine 0 C--N 1.336 0.574 0 N-CA-C 111.14 -0.784 . . . . 0.39 111.14 178.29 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -68.54 -29.86 68.53 Favored 'General case' 0 C--O 1.221 -0.42 0 CA-C-O 120.602 0.239 . . . . 1.23 110.367 178.144 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . 0.609 ' HB2' ' O ' ' A' ' 209' ' ' PHE . 0.3 OUTLIER -69.55 -41.56 75.75 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.521 -0.309 . . . . 1.06 111.507 179.668 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 214' ' ' ARG . . . . . 0.559 ' HG2' ' O ' ' A' ' 210' ' ' GLN . 2.8 mmp_? -66.52 -40.03 88.95 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 121.185 0.517 . . . . 0.67 110.137 179.569 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 48.1 mtmt -91.87 13.15 19.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.888 -0.596 . . . . 1.03 111.94 179.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . 0.448 HD23 HG11 ' A' ' 255' ' ' VAL . 7.4 tp -79.72 106.4 11.72 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 121.422 0.629 . . . . 0.77 111.34 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -84.13 -2.14 56.26 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 115.011 -0.995 . . . . 0.55 111.708 -179.341 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 218' ' ' ILE . . . . . 0.608 HG12 ' HB3' ' A' ' 223' ' ' ASP . 46.9 mt -53.71 114.37 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 N-CA-C 112.255 0.465 . . . . 0.86 112.255 -179.75 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 26.5 mtmm -138.11 -28.4 0.86 Allowed 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 115.982 -0.553 . . . . 1.14 112.424 -179.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -125.14 -179.37 4.54 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 113.017 0.747 . . . . 0.63 113.017 -178.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . 0.553 ' O ' HG21 ' A' ' 224' ' ' VAL . 1.2 mp0 -64.3 -22.05 66.82 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.448 -0.796 . . . . 0.6 111.376 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -71.49 -26.82 72.44 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 121.021 -0.609 . . . . 0.42 112.859 179.177 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 223' ' ' ASP . . . . . 0.608 ' HB3' HG12 ' A' ' 218' ' ' ILE . 39.3 m-20 -68.37 -31.45 70.84 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 112.283 0.475 . . . . 0.37 112.283 -179.632 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . 0.553 HG21 ' O ' ' A' ' 221' ' ' GLU . 3.1 m -58.16 -27.67 32.63 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 CA-C-O 120.745 0.307 . . . . 1.11 111.73 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 6.1 mptt -65.16 -37.08 86.26 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.107 0.48 . . . . 1.37 109.9 178.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 226' ' ' SER . . . . . 0.618 ' O ' HG21 ' A' ' 230' ' ' VAL . 18.4 t -67.57 -44.13 78.93 Favored 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 109.176 -0.676 . . . . 0.42 109.176 178.214 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 227' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -59.76 -39.96 86.57 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 115.391 -0.822 . . . . 0.56 110.19 178.495 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 228' ' ' SER . . . . . 0.631 ' HA ' ' HE1' ' A' ' 231' ' ' MET . 15.9 m -63.44 -39.48 94.58 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.168 0.508 . . . . 0.41 109.883 178.441 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 28.2 mtp180 -65.88 -35.51 80.84 Favored 'General case' 0 C--O 1.225 -0.202 0 CA-C-N 115.482 -0.781 . . . . 0.84 109.766 178.237 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . 0.618 HG21 ' O ' ' A' ' 226' ' ' SER . 56.8 t -60.86 -51.18 76.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 109.879 -0.415 . . . . 1.08 109.879 177.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 231' ' ' MET . . . . . 0.631 ' HE1' ' HA ' ' A' ' 228' ' ' SER . 56.5 mtm -55.73 -53.35 57.64 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.891 -0.595 . . . . 0.62 111.788 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 35.2 m -63.87 -30.91 51.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 120.861 -0.336 . . . . 1.06 111.167 179.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 233' ' ' HIS . . . . . 0.459 ' O ' ' HB3' ' A' ' 236' ' ' LYS . 44.5 t-80 -69.82 -39.56 76.41 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 120.962 0.41 . . . . 0.6 110.321 178.51 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 69.0 t -71.8 -41.0 70.03 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 CA-C-O 120.969 0.414 . . . . 0.95 111.046 178.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -87.9 12.73 12.43 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 120.954 0.407 . . . . 0.98 111.574 179.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . 0.521 ' O ' ' HG2' ' A' ' 236' ' ' LYS . 0.0 OUTLIER -68.99 -15.32 63.45 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 115.606 -0.725 . . . . 0.71 111.267 179.221 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 237' ' ' ASP . . . . . 0.456 ' HA ' ' NZ ' ' A' ' 236' ' ' LYS . 71.8 m-20 -75.86 -7.89 55.57 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 122.085 -0.385 . . . . 0.4 111.651 179.812 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 84.92 -19.97 18.28 Favored Glycine 0 CA--C 1.519 0.291 0 C-N-CA 121.014 -0.613 . . . . 0.4 112.773 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 2.5 t -91.97 108.89 20.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.148 0.499 . . . . 1.44 111.166 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 240' ' ' THR . . . . . 0.516 HG23 HD12 ' A' ' 245' ' ' ILE . 3.4 m -89.79 68.2 7.43 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.206 -0.452 . . . . 0.75 111.131 -179.793 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . 0.462 ' HB2' ' HG3' ' A' ' 244' ' ' ARG . 11.9 m120 -66.24 141.58 57.99 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.918 0.389 . . . . 0.47 111.431 -179.771 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 242' ' ' TRP . . . . . 0.48 ' CZ3' ' HB2' ' A' ' 296' ' ' PHE . 76.1 m95 -59.69 -36.35 76.31 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.282 -0.417 . . . . 0.49 110.369 178.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . 0.432 ' HA3' ' HB2' ' B' ' 35' ' ' TYR . . . -61.14 -31.75 77.97 Favored Glycine 0 C--N 1.335 0.5 0 C-N-CA 121.082 -0.58 . . . . 0.28 112.058 178.083 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 244' ' ' ARG . . . . . 0.518 ' HG2' ' HA3' ' B' ' 31' ' ' GLY . 81.6 mtt180 -75.76 -32.74 60.08 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 121.151 0.501 . . . . 0.48 109.914 178.684 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . 0.516 HD12 HG23 ' A' ' 240' ' ' THR . 78.1 mt -72.05 -49.63 42.73 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 CA-C-N 115.78 -0.646 . . . . 1.14 110.692 179.064 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 26.9 m -67.56 -31.51 52.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 C-N-CA 121.171 -0.212 . . . . 1.02 111.324 179.333 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 247' ' ' THR . . . . . 0.423 HG22 HD22 ' B' ' 27' ' ' LEU . 30.9 m -67.53 -40.5 85.07 Favored 'General case' 0 C--O 1.232 0.157 0 N-CA-C 109.134 -0.691 . . . . 0.77 109.134 177.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.5 -42.26 98.53 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 109.047 -0.723 . . . . 1.18 109.047 177.14 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 249' ' ' ILE . . . . . 0.436 HG13 ' O ' ' A' ' 245' ' ' ILE . 49.7 mt -63.36 -44.99 99.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.404 0 CA-C-N 115.812 -0.631 . . . . 1.08 110.219 178.105 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 250' ' ' SER . . . . . 0.49 ' HB3' ' HG3' ' A' ' 202' ' ' GLN . 40.3 m -58.98 -44.22 91.56 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.062 -0.517 . . . . 0.49 110.005 178.699 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 251' ' ' PHE . . . . . . . . . . . . . 21.7 t80 -63.67 -44.28 94.21 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 115.89 -0.596 . . . . 0.46 109.495 177.369 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -56.22 -44.61 89.04 Favored Glycine 0 C--N 1.336 0.552 0 C-N-CA 121.067 -0.587 . . . . 0.28 111.705 178.462 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 253' ' ' ALA . . . . . 0.74 ' HB3' ' HB2' ' A' ' 170' ' ' GLN . . . -59.96 -43.16 95.23 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.669 0.271 . . . . 0.94 110.585 177.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 254' ' ' PHE . . . . . 0.46 ' HD1' HE21 ' A' ' 202' ' ' GLN . 0.3 OUTLIER -65.04 -40.64 95.08 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 121.233 0.539 . . . . 0.79 110.215 178.462 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 255' ' ' VAL . . . . . 0.448 HG11 HD23 ' A' ' 216' ' ' LEU . 78.4 t -66.63 -39.97 85.11 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-N 116.107 -0.497 . . . . 1.1 110.207 178.561 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -57.86 -39.42 77.72 Favored 'General case' 0 N--CA 1.461 0.097 0 CA-C-O 121.469 0.652 . . . . 0.32 109.259 178.093 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 257' ' ' LYS . . . . . 0.426 ' HG3' ' O ' ' A' ' 171' ' ' ALA . 23.1 tttp -61.65 -41.72 97.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.262 -0.881 . . . . 0.44 110.236 178.062 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 71.3 t60 -58.77 -45.58 89.48 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 116.243 -0.435 . . . . 0.58 110.719 178.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . 0.52 HD22 ' NE2' ' A' ' 264' ' ' GLN . 13.1 mt -70.86 -43.1 69.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.248 -0.433 . . . . 0.6 110.932 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 21.0 ttmm -63.1 -36.93 85.22 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.785 0.326 . . . . 0.97 111.089 179.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 54.3 m -63.15 -25.46 68.36 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 116.387 -0.369 . . . . 0.72 111.684 179.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 262' ' ' VAL . . . . . 0.503 HG23 ' HG3' ' A' ' 264' ' ' GLN . 17.9 m -108.67 21.8 4.64 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-O 120.848 0.356 . . . . 1.07 111.23 179.34 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 57.32 42.55 24.86 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 112.903 0.705 . . . . 2.28 112.903 179.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 264' ' ' GLN . . . . . 0.52 ' NE2' HD22 ' A' ' 259' ' ' LEU . 10.5 mt-30 -98.22 38.4 1.33 Allowed 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.219 0.451 . . . . 0.58 112.219 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -51.48 -37.33 48.42 Favored 'General case' 0 C--O 1.243 0.715 0 CA-C-O 120.892 0.377 . . . . 0.8 111.857 179.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 26.5 p -62.59 -16.88 58.62 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 116.101 -0.499 . . . . 1.29 111.162 178.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -110.44 -12.18 14.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.939 -0.573 . . . . 0.93 109.889 178.271 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 8.4 mm -66.41 -49.33 76.34 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 CA-C-N 115.834 -0.621 . . . . 1.02 110.303 179.06 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 269' ' ' GLU . . . . . 0.731 ' HB2' ' HD3' ' A' ' 270' ' ' PRO . 57.4 mm-40 -61.44 -54.95 47.73 Favored Pre-proline 0 CA--C 1.545 0.765 0 CA-C-N 115.841 -0.618 . . . . 0.51 111.106 179.331 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 270' ' ' PRO . . . . . 0.731 ' HD3' ' HB2' ' A' ' 269' ' ' GLU . 51.2 Cg_exo -57.0 -36.14 99.2 Favored 'Trans proline' 0 C--N 1.359 1.086 0 C-N-CA 122.244 1.963 . . . . 0.37 112.879 178.577 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 271' ' ' LEU . . . . . 0.403 ' O ' HG13 ' A' ' 275' ' ' ILE . 18.6 tp -63.84 -52.1 61.63 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.485 0.183 . . . . 0.87 111.188 179.035 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -58.16 -39.79 79.75 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.276 -0.42 . . . . 1.06 111.242 179.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 273' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -71.36 -40.48 70.61 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.247 -0.433 . . . . 0.61 110.723 178.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 274' ' ' THR . . . . . 0.532 HG21 ' HB ' ' A' ' 224' ' ' VAL . 87.3 m -63.53 -43.84 95.98 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.874 0.368 . . . . 1.09 110.679 179.309 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 275' ' ' ILE . . . . . 0.439 ' HA ' ' CE ' ' A' ' 231' ' ' MET . 88.1 mt -61.88 -54.88 28.71 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.083 0 CA-C-N 116.277 -0.42 . . . . 1.1 110.414 179.163 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 276' ' ' THR . . . . . 0.499 HG21 HD13 ' A' ' 163' ' ' ILE . 24.2 m -56.41 -51.07 69.74 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.26 -0.427 . . . . 1.04 111.533 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 277' ' ' ASP . . . . . 0.635 ' O ' ' HB2' ' A' ' 281' ' ' ARG . 29.7 t70 -52.26 -60.22 3.47 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.35 -0.386 . . . . 0.39 111.79 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 278' ' ' VAL . . . . . 0.422 ' HB ' ' HE3' ' A' ' 231' ' ' MET . 59.6 t -63.94 -42.57 96.19 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 N-CA-C 112.336 0.495 . . . . 0.96 112.336 -179.074 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 27.1 tp -60.72 -47.61 85.51 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 111.987 0.365 . . . . 1.26 111.987 -179.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 86.7 t -80.96 -46.32 20.82 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 N-CA-C 113.056 0.761 . . . . 1.03 113.056 -178.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 281' ' ' ARG . . . . . 0.635 ' HB2' ' O ' ' A' ' 277' ' ' ASP . 1.5 mpt_? -60.72 -35.59 76.7 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 113.039 0.755 . . . . 0.49 113.039 -178.32 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 282' ' ' THR . . . . . . . . . . . . . 85.0 m -65.09 -38.13 89.73 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 112.389 0.514 . . . . 1.04 112.389 -179.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 28.8 mmtp -129.67 42.1 3.34 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 112.582 0.586 . . . . 1.05 112.582 -178.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -60.35 -28.82 68.47 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 111.965 0.357 . . . . 0.98 111.965 -179.697 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 285' ' ' ASP . . . . . 0.449 ' HA ' HG22 ' A' ' 288' ' ' VAL . 3.1 t70 -62.41 -44.99 95.12 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-O 121.023 0.439 . . . . 0.71 110.383 179.201 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 286' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -61.09 -35.61 77.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.307 0.575 . . . . 0.63 110.13 178.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 287' ' ' LEU . . . . . 0.583 ' HB3' HD21 ' A' ' 155' ' ' LEU . 1.2 mm? -71.24 -54.31 11.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.517 -0.765 . . . . 1.0 111.148 179.378 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 288' ' ' VAL . . . . . 0.449 HG22 ' HA ' ' A' ' 285' ' ' ASP . 33.8 m -59.96 -30.39 45.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 N-CA-C 111.763 0.283 . . . . 1.1 111.763 -179.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 27.8 mttp -65.77 -32.43 73.96 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.861 0.363 . . . . 1.29 110.927 178.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 -108.51 28.98 7.82 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 111.873 0.323 . . . . 0.96 111.873 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 291' ' ' ARG . . . . . 0.757 ' HB3' ' HB2' ' A' ' 294' ' ' ASP . 0.8 OUTLIER 61.84 19.41 10.6 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 112.612 0.597 . . . . 0.52 112.612 178.896 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 69.11 -118.02 8.4 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 121.302 -0.475 . . . . 0.35 113.236 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 293' ' ' TRP . . . . . 0.652 ' O ' HG23 ' A' ' 297' ' ' VAL . 90.5 m95 -72.0 -21.7 61.52 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 111.683 0.253 . . . . 0.43 111.683 -179.262 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 294' ' ' ASP . . . . . 0.757 ' HB2' ' HB3' ' A' ' 291' ' ' ARG . 60.1 m-20 -57.74 -51.5 69.29 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 109.509 -0.552 . . . . 0.45 109.509 178.019 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -65.25 -41.36 96.82 Favored Glycine 0 C--N 1.335 0.52 0 N-CA-C 111.355 -0.698 . . . . 0.32 111.355 178.137 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 296' ' ' PHE . . . . . 0.48 ' HB2' ' CZ3' ' A' ' 242' ' ' TRP . 6.7 t80 -56.33 -46.04 80.09 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 120.753 0.311 . . . . 0.42 111.371 178.707 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 297' ' ' VAL . . . . . 0.698 HG13 ' HB3' ' A' ' 189' ' ' ARG . 88.9 t -58.48 -54.6 30.85 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 CA-C-O 120.96 0.409 . . . . 0.87 111.768 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -71.23 -29.86 65.65 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.948 0.721 . . . . 0.99 112.948 -178.488 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 299' ' ' PHE . . . . . 0.502 ' CZ ' ' HB2' ' B' ' 39' ' ' SER . 61.3 t80 -59.18 -46.11 89.26 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.901 0.381 . . . . 0.48 111.051 178.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 300' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 . . . . . 0 CA--C 1.534 0.349 0 CA-C-O 121.132 0.491 . . . . 0.57 111.902 -179.599 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 . . . . . 0 CA--C 1.528 0.114 0 N-CA-C 111.62 0.23 . . . . 1.19 111.62 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 23' ' ' PHE . . . . . 0.62 ' HD1' ' N ' ' B' ' 24' ' ' ALA . 0.2 OUTLIER -62.36 -33.9 75.63 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 120.788 -0.365 . . . . 0.38 111.422 -179.967 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 24' ' ' ALA . . . . . 0.62 ' N ' ' HD1' ' B' ' 23' ' ' PHE . . . -76.83 -40.22 48.63 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.855 0.36 . . . . 0.76 110.561 -179.73 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -69.94 -40.56 75.4 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.075 -0.511 . . . . 1.14 111.577 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -68.96 -50.92 44.96 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 111.909 0.337 . . . . 0.66 111.909 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . 0.423 HD22 HG22 ' A' ' 247' ' ' THR . 81.7 mt -64.8 -30.39 71.4 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 111.734 0.272 . . . . 0.75 111.734 -179.332 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 28' ' ' ARG . . . . . 0.501 ' HB2' ' O ' ' B' ' 24' ' ' ALA . 0.0 OUTLIER -70.67 -55.92 7.61 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 120.886 0.374 . . . . 0.54 110.795 178.35 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 34.9 mtmm -61.64 -53.01 61.86 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 116.463 -0.335 . . . . 0.51 111.672 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 97.4 mt -58.39 -40.02 76.7 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.077 0 CA-C-N 116.41 -0.359 . . . . 1.01 110.573 -179.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . 0.518 ' HA3' ' HG2' ' A' ' 244' ' ' ARG . . . -56.61 -50.01 65.99 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.946 -0.645 . . . . 0.27 112.45 179.388 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 32' ' ' ASP . . . . . 0.401 ' CG ' HH21 ' A' ' 244' ' ' ARG . 65.0 m-20 -72.09 -40.37 68.25 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.927 0.364 . . . . 0.73 111.43 179.602 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 33' ' ' LYS . . . . . 0.451 ' HA ' ' HD2' ' B' ' 33' ' ' LYS . 1.1 tptt -59.45 -51.68 68.85 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 120.879 0.371 . . . . 1.39 110.749 179.245 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 33.6 t -63.94 -46.42 94.11 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 CA-C-N 116.057 -0.52 . . . . 0.68 110.467 178.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 35' ' ' TYR . . . . . 0.432 ' HB2' ' HA3' ' A' ' 243' ' ' GLY . 9.0 t80 -56.56 -48.26 77.72 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 115.934 -0.575 . . . . 0.93 111.517 179.39 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 36' ' ' CYS . . . . . . . . . . . . . 80.8 m -63.98 -33.04 74.84 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.866 0.365 . . . . 0.54 111.164 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 34.5 m -69.63 -33.51 72.75 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.081 -0.509 . . . . 1.46 111.704 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 38' ' ' TRP . . . . . . . . . . . . . 80.8 m95 -87.96 -34.64 18.01 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 120.675 0.274 . . . . 0.67 111.661 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 39' ' ' SER . . . . . 0.502 ' HB2' ' CZ ' ' A' ' 299' ' ' PHE . 39.1 t . . . . . 0 N--CA 1.465 0.321 0 CA-C-O 121.016 0.436 . . . . 0.61 111.018 179.045 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 . . . . . 0 CA--C 1.537 0.473 0 N-CA-C 112.706 0.632 . . . . 1.01 112.706 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -58.86 -52.53 65.35 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.926 0.393 . . . . 0.97 111.236 179.769 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 1.4 mt -60.56 -39.51 88.25 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.167 -0.47 . . . . 1.31 110.925 178.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -66.75 -39.03 87.76 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.544 -0.298 . . . . 1.03 111.459 179.493 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 1.5 mmt180 -57.04 -51.64 68.44 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.714 0.293 . . . . 1.07 111.24 179.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 71.0 mt-30 -69.28 -42.17 75.85 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.991 -0.283 . . . . 0.63 111.095 179.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 49.4 m -59.97 -49.78 76.32 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 111.752 0.278 . . . . 0.37 111.752 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.628 HD23 ' HA ' ' A' ' 273' ' ' GLU . 1.5 tm? -58.44 -53.41 58.63 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.548 -0.296 . . . . 1.4 110.994 179.539 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -60.48 -47.43 86.17 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 112.013 0.375 . . . . 1.1 112.013 -179.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . 0.492 HG12 ' HA2' ' A' ' 187' ' ' GLY . 83.2 mt -61.99 -47.54 92.72 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-O 120.621 0.248 . . . . 1.14 111.392 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 39.6 mt -64.19 -45.54 96.04 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 CA-C-N 116.745 -0.207 . . . . 1.18 110.733 179.245 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 27.2 t -57.98 -44.71 87.3 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.944 0.402 . . . . 0.66 110.006 178.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -61.02 -44.62 97.14 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 115.658 -0.701 . . . . 0.61 111.611 179.117 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' TYR . . . . . 0.901 ' HE1' ' HA ' ' A' ' 195' ' ' ARG . 75.6 t80 -68.22 -51.18 48.33 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 111.824 0.305 . . . . 0.47 111.824 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 8.6 mp -58.85 -41.29 86.62 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.713 -0.221 . . . . 0.94 111.455 -179.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 5.4 mtt-85 -67.27 -39.67 86.08 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.009 0.433 . . . . 1.09 111.029 179.122 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -68.57 -48.19 64.87 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.159 -0.473 . . . . 0.8 111.377 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . 0.434 ' HG3' ' CZ ' ' A' ' 166' ' ' TYR . 27.6 mm-40 -65.56 -25.97 67.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.699 0.285 . . . . 0.56 111.158 178.779 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.137 0 CA-C-N 116.486 -0.325 . . . . 0.92 111.401 178.736 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . 0.486 ' O ' ' HA3' ' A' ' 187' ' ' GLY . . . . . . . . 0 CA--C 1.533 0.313 0 CA-C-O 120.933 0.397 . . . . 1.09 111.269 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -79.13 -70.51 1.32 Allowed Glycine 0 CA--C 1.524 0.634 0 C-N-CA 120.696 -0.764 . . . . 0.53 113.479 -179.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -61.83 -55.91 24.94 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 120.774 0.321 . . . . 0.77 111.253 -179.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -62.31 -37.34 85.2 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.265 -0.425 . . . . 0.87 110.452 179.083 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . 0.492 ' HA2' HG12 ' A' ' 162' ' ' ILE . . . -63.2 -42.81 99.29 Favored Glycine 0 C--N 1.334 0.464 0 C-N-CA 121.2 -0.524 . . . . 0.4 112.659 179.528 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 40.8 ttt-85 -62.55 -48.93 77.34 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 117.022 0.411 . . . . 1.21 110.907 179.24 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 189' ' ' ARG . . . . . 0.732 ' HB3' HG12 ' A' ' 297' ' ' VAL . 34.8 mtp180 -66.28 -41.28 90.05 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.218 -0.446 . . . . 0.58 111.264 179.515 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -68.91 -45.86 69.8 Favored 'General case' 0 C--O 1.219 -0.504 0 CA-C-N 116.177 -0.465 . . . . 0.46 111.836 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 191' ' ' LEU . . . . . 0.446 ' HB2' ' O ' ' A' ' 187' ' ' GLY . 0.9 OUTLIER -59.37 -45.78 90.49 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.626 0.25 . . . . 1.23 111.22 179.505 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -62.34 -49.67 74.67 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 121.101 0.477 . . . . 0.59 111.172 179.389 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 25.7 m -66.04 -51.2 60.43 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.01 -0.541 . . . . 0.96 111.7 -179.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . 0.442 HD23 HG23 ' A' ' 249' ' ' ILE . 12.6 tp -58.27 -40.4 81.76 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.222 -0.445 . . . . 1.13 111.736 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . 0.901 ' HA ' ' HE1' ' A' ' 166' ' ' TYR . 43.4 ttm180 -61.31 -53.58 54.95 Favored 'General case' 0 N--CA 1.461 0.121 0 CA-C-O 120.606 0.241 . . . . 1.1 110.705 178.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 22.9 ttm105 -60.96 -50.17 74.48 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.24 -0.437 . . . . 0.54 112.149 -179.436 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . 0.461 ' O ' HG21 ' A' ' 201' ' ' VAL . 53.3 t -65.51 -48.71 81.85 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 N-CA-C 111.996 0.369 . . . . 1.04 111.996 -179.351 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . 0.601 ' HA3' ' HH ' ' A' ' 166' ' ' TYR . . . -61.5 -42.93 99.87 Favored Glycine 0 C--N 1.334 0.432 0 C-N-CA 121.108 -0.568 . . . . 0.32 113.03 -179.598 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . 0.408 ' HB2' ' O ' ' A' ' 195' ' ' ARG . 0.8 OUTLIER -62.33 -45.11 94.7 Favored 'General case' 0 N--CA 1.46 0.074 0 N-CA-C 109.564 -0.532 . . . . 0.89 109.564 178.617 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -61.22 -42.78 99.88 Favored Glycine 0 C--N 1.337 0.605 0 C-N-CA 120.841 -0.695 . . . . 0.33 111.917 178.399 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . 0.461 HG21 ' O ' ' A' ' 197' ' ' VAL . 67.4 t -62.34 -47.69 91.88 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-O 120.593 0.235 . . . . 0.91 110.936 178.536 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 202' ' ' GLN . . . . . 0.41 ' OE1' ' HD1' ' A' ' 254' ' ' PHE . 37.6 mt-30 -65.78 -41.32 92.14 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.353 -0.385 . . . . 0.39 111.476 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.64 -37.3 85.82 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.03 0.443 . . . . 0.84 110.546 179.077 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 18.0 m-80 -78.18 -52.37 8.8 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.155 -0.475 . . . . 0.7 111.477 179.468 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 205' ' ' HIS . . . . . 0.438 ' ND1' HG12 ' B' ' 30' ' ' ILE . 75.4 m-70 -92.18 35.86 0.99 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.743 0.306 . . . . 0.9 111.306 -179.373 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -58.29 -49.68 76.28 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.424 0.527 . . . . 0.58 112.424 -179.015 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 69.2 p -60.49 -39.31 87.21 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.896 0.379 . . . . 1.08 111.722 -179.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -66.65 -50.38 63.13 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-N 115.915 -0.584 . . . . 0.63 110.78 179.561 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 209' ' ' PHE . . . . . 0.448 ' HB3' ' CD2' ' A' ' 254' ' ' PHE . 31.0 m-85 -63.17 -41.09 99.17 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.882 -0.599 . . . . 0.65 110.495 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 12.0 mt-30 -59.48 -45.44 91.66 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-N 116.103 -0.498 . . . . 0.62 111.408 179.245 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -55.77 -50.17 62.28 Favored Glycine 0 C--N 1.334 0.461 0 C-N-CA 120.644 -0.789 . . . . 0.36 111.645 179.261 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 212' ' ' MET . . . . . 0.579 ' HG2' ' HA ' ' B' ' 23' ' ' PHE . 6.6 mtp -64.65 -37.08 86.35 Favored 'General case' 0 C--O 1.225 -0.212 0 CA-C-O 120.561 0.22 . . . . 1.24 111.012 178.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 6.6 tp -67.49 -42.97 82.03 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 112.022 0.378 . . . . 1.26 112.022 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 214' ' ' ARG . . . . . 0.451 HH11 ' HD3' ' A' ' 214' ' ' ARG . 40.3 mtt180 -61.6 -40.05 93.42 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.932 0.396 . . . . 1.44 110.833 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 215' ' ' LYS . . . . . 0.527 ' HE2' ' HA ' ' A' ' 215' ' ' LYS . 0.0 OUTLIER -95.85 13.36 26.97 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.85 -0.34 . . . . 0.72 111.03 178.584 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 11.3 tp -78.34 100.04 6.59 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.891 0.377 . . . . 1.18 110.398 179.222 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.73 33.06 0.42 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.28 -0.418 . . . . 0.51 111.957 -179.365 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 218' ' ' ILE . . . . . 0.658 HG12 ' HB3' ' A' ' 223' ' ' ASP . 47.6 mt -87.53 119.08 34.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.766 0.317 . . . . 1.13 110.66 179.278 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.63 -15.32 0.73 Allowed 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 112.772 0.656 . . . . 0.62 112.772 -179.204 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -132.31 -178.37 4.88 Favored 'General case' 0 CA--C 1.541 0.613 0 O-C-N 122.002 -0.436 . . . . 0.63 112.154 -179.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . 0.568 ' O ' HG22 ' A' ' 224' ' ' VAL . 1.9 mp0 -69.59 -21.99 63.55 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 112.902 0.704 . . . . 0.73 112.902 -178.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -72.6 -26.86 70.55 Favored Glycine 0 CA--C 1.523 0.551 0 C-N-CA 120.66 -0.781 . . . . 0.53 112.685 179.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 223' ' ' ASP . . . . . 0.658 ' HB3' HG12 ' A' ' 218' ' ' ILE . 61.2 m-20 -65.52 -30.48 71.24 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 112.128 0.418 . . . . 0.56 112.128 -179.624 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . 0.568 HG22 ' O ' ' A' ' 221' ' ' GLU . 4.1 m -56.39 -28.25 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 N-CA-C 111.878 0.325 . . . . 0.56 111.878 179.612 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . 0.41 ' HD2' ' H ' ' A' ' 225' ' ' LYS . 7.7 mptt -64.67 -36.79 85.4 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.192 0.52 . . . . 1.26 110.037 178.587 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 226' ' ' SER . . . . . 0.498 ' O ' HG22 ' A' ' 230' ' ' VAL . 7.8 t -69.31 -35.02 75.56 Favored 'General case' 0 N--CA 1.462 0.148 0 N-CA-C 108.901 -0.777 . . . . 0.69 108.901 177.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 227' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -61.74 -37.63 84.96 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 115.269 -0.878 . . . . 0.55 109.601 177.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 228' ' ' SER . . . . . 0.66 ' HG ' HG21 ' A' ' 278' ' ' VAL . 69.1 m -66.37 -40.43 89.73 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.093 -0.503 . . . . 1.06 109.804 178.036 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 73.0 mtp180 -58.13 -37.66 75.03 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.031 -0.531 . . . . 1.08 110.381 178.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . 0.574 HG12 ' HA ' ' B' ' 24' ' ' ALA . 36.3 t -66.32 -46.74 86.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.946 -0.57 . . . . 1.12 110.107 178.337 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 231' ' ' MET . . . . . 0.495 ' HE2' ' HA ' ' A' ' 275' ' ' ILE . 60.3 mtm -63.94 -48.35 76.85 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.017 -0.538 . . . . 0.63 111.852 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 31.1 m -62.9 -31.24 51.75 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 C-N-CA 120.585 -0.446 . . . . 0.55 110.508 179.048 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 233' ' ' HIS . . . . . 0.661 ' CD2' ' HB3' ' B' ' 24' ' ' ALA . 8.7 t60 -67.91 -44.44 76.92 Favored 'General case' 0 CA--C 1.528 0.125 0 N-CA-C 109.126 -0.694 . . . . 0.42 109.126 177.109 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . 0.503 ' HA ' ' HG3' ' B' ' 28' ' ' ARG . 51.2 t -56.46 -42.46 75.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 CA-C-N 115.775 -0.648 . . . . 1.04 110.78 179.633 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -99.79 23.74 9.28 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.001 0.371 . . . . 0.77 112.001 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 2.6 ttpp -73.01 -13.73 61.28 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.799 0.333 . . . . 1.38 111.361 179.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -86.16 -16.21 38.57 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 120.88 0.371 . . . . 0.62 110.988 179.527 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 92.48 -19.08 52.82 Favored Glycine 0 CA--C 1.524 0.636 0 C-N-CA 121.032 -0.604 . . . . 0.4 113.84 179.179 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 6.1 p -83.9 117.25 29.19 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-O 121.625 0.726 . . . . 0.81 111.727 -179.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 10.8 m -94.9 117.3 29.91 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.057 0.456 . . . . 1.0 111.577 179.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -113.48 141.54 47.0 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.5 -0.318 . . . . 0.67 110.639 179.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 242' ' ' TRP . . . . . 0.513 ' CZ3' ' HB2' ' A' ' 296' ' ' PHE . 24.8 m95 -60.02 -42.4 94.28 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 120.721 0.296 . . . . 0.45 110.424 178.419 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . 0.422 ' HA3' ' N ' ' B' ' 35' ' ' TYR . . . -60.26 -33.31 79.81 Favored Glycine 0 C--N 1.336 0.531 0 C-N-CA 120.967 -0.635 . . . . 0.31 111.816 178.187 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 244' ' ' ARG . . . . . 0.469 ' HA ' ' HA3' ' B' ' 31' ' ' GLY . 50.1 mtt180 -69.25 -51.43 37.7 Favored 'General case' 0 C--O 1.232 0.153 0 N-CA-C 109.569 -0.53 . . . . 0.48 109.569 178.099 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . 0.512 HG22 HD22 ' A' ' 279' ' ' LEU . 83.1 mt -55.94 -48.32 78.73 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 CA-C-N 115.582 -0.735 . . . . 1.07 110.89 179.455 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 96.1 t -64.69 -32.32 57.46 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-N 116.471 -0.331 . . . . 1.22 110.984 179.46 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 247' ' ' THR . . . . . 0.454 HG22 HD22 ' B' ' 27' ' ' LEU . 20.2 m -63.35 -44.35 95.07 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.611 0.243 . . . . 1.08 110.448 178.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 248' ' ' LEU . . . . . 0.48 HD21 ' HG2' ' A' ' 231' ' ' MET . 54.2 mt -62.2 -41.2 98.15 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.396 0.617 . . . . 1.17 109.857 178.454 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 249' ' ' ILE . . . . . 0.442 HG23 HD23 ' A' ' 194' ' ' LEU . 27.8 mt -66.45 -39.98 85.38 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 CA-C-N 115.782 -0.644 . . . . 1.13 110.013 178.115 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 49.4 m -62.91 -41.77 99.56 Favored 'General case' 0 N--CA 1.461 0.115 0 N-CA-C 109.148 -0.686 . . . . 0.91 109.148 178.154 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 251' ' ' PHE . . . . . 0.495 ' CD2' HD11 ' B' ' 27' ' ' LEU . 8.7 t80 -62.14 -42.17 98.99 Favored 'General case' 0 C--O 1.226 -0.15 0 N-CA-C 108.821 -0.807 . . . . 0.51 108.821 177.518 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -57.68 -46.79 91.79 Favored Glycine 0 C--N 1.335 0.527 0 N-CA-C 111.053 -0.819 . . . . 0.27 111.053 177.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 253' ' ' ALA . . . . . 0.487 ' O ' ' HG3' ' A' ' 257' ' ' LYS . . . -64.34 -35.33 80.53 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 120.617 0.246 . . . . 0.39 111.245 177.627 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 254' ' ' PHE . . . . . 0.448 ' CD2' ' HB3' ' A' ' 209' ' ' PHE . 2.5 t80 -71.07 -43.76 67.11 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 120.617 0.246 . . . . 1.13 111.25 179.373 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 23.7 m -68.04 -34.58 67.7 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.109 0 N-CA-C 109.354 -0.61 . . . . 1.06 109.354 178.269 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -60.91 -36.72 80.0 Favored 'General case' 0 C--O 1.227 -0.127 0 N-CA-C 109.371 -0.604 . . . . 0.4 109.371 177.009 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 257' ' ' LYS . . . . . 0.487 ' HG3' ' O ' ' A' ' 253' ' ' ALA . 59.3 mttp -62.42 -45.66 92.08 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 109.608 -0.515 . . . . 0.93 109.608 177.24 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 22.2 t60 -60.76 -36.58 79.29 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.722 -0.672 . . . . 0.97 110.774 179.363 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 78.4 mt -74.95 -45.05 44.89 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.301 -0.408 . . . . 1.23 110.662 178.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 1.5 tptp -62.19 -34.82 77.18 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 120.717 0.294 . . . . 0.57 110.838 179.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 49.2 m -63.12 -24.31 67.84 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.254 -0.43 . . . . 0.54 110.946 179.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 262' ' ' VAL . . . . . 0.522 HG21 ' HG3' ' A' ' 264' ' ' GLN . 16.0 m -114.88 19.03 7.34 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-N 116.239 -0.437 . . . . 1.23 110.882 178.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 57.44 52.37 8.68 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 113.073 0.768 . . . . 1.42 113.073 179.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 264' ' ' GLN . . . . . 0.522 ' HG3' HG21 ' A' ' 262' ' ' VAL . 23.0 mt-30 -119.72 36.26 4.57 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 112.087 0.402 . . . . 0.75 112.087 179.332 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 265' ' ' GLU . . . . . 0.49 ' HA ' HD11 ' A' ' 268' ' ' ILE . 2.2 pm0 -57.74 -23.73 53.49 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-O 120.828 0.347 . . . . 0.62 111.656 179.061 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 54.4 p -61.62 -21.18 64.13 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.016 -0.538 . . . . 0.91 110.403 178.313 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 267' ' ' PHE . . . . . 0.494 ' C ' ' HD2' ' A' ' 270' ' ' PRO . 90.8 m-85 -95.3 -20.25 19.32 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 116.093 -0.503 . . . . 0.82 110.578 178.594 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 268' ' ' ILE . . . . . 0.49 HD11 ' HA ' ' A' ' 265' ' ' GLU . 78.6 mt -67.31 -41.16 86.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-N 116.26 -0.427 . . . . 1.07 110.078 178.574 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 269' ' ' GLU . . . . . 0.77 ' HB2' ' HD3' ' A' ' 270' ' ' PRO . 2.2 mm-40 -53.8 -56.4 25.75 Favored Pre-proline 0 CA--C 1.546 0.789 0 CA-C-N 116.089 -0.505 . . . . 0.76 111.122 178.591 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 270' ' ' PRO . . . . . 0.77 ' HD3' ' HB2' ' A' ' 269' ' ' GLU . 33.4 Cg_exo -62.23 -30.29 81.44 Favored 'Trans proline' 0 C--N 1.362 1.268 0 C-N-CA 122.139 1.892 . . . . 0.47 111.675 177.708 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 271' ' ' LEU . . . . . . . . . . . . . 4.3 mt -62.69 -50.41 71.24 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.286 -0.416 . . . . 1.15 110.045 177.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -56.29 -36.39 68.59 Favored 'General case' 0 N--CA 1.461 0.111 0 CA-C-N 116.147 -0.479 . . . . 0.6 110.825 179.143 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 273' ' ' GLU . . . . . 0.628 ' HA ' HD23 ' A' ' 160' ' ' LEU . 1.2 mm-40 -72.39 -50.79 23.96 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.102 -0.499 . . . . 1.39 110.658 178.381 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 274' ' ' THR . . . . . 0.462 HG21 ' HB ' ' A' ' 224' ' ' VAL . 25.3 m -58.45 -45.97 87.48 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.297 -0.41 . . . . 1.2 111.8 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 275' ' ' ILE . . . . . 0.495 ' HA ' ' HE2' ' A' ' 231' ' ' MET . 92.0 mt -63.77 -55.33 23.1 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 CA-C-N 116.558 -0.292 . . . . 1.18 111.089 179.842 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 22.0 m -58.08 -47.71 82.35 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.26 -0.427 . . . . 0.58 111.604 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 277' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -50.98 -58.64 5.53 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.385 -0.371 . . . . 0.54 111.7 179.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 278' ' ' VAL . . . . . 0.66 HG21 ' HG ' ' A' ' 228' ' ' SER . 61.4 t -64.65 -39.52 85.9 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 N-CA-C 111.816 0.302 . . . . 1.09 111.816 -179.78 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 279' ' ' LEU . . . . . 0.512 HD22 HG22 ' A' ' 245' ' ' ILE . 51.3 tp -64.59 -47.21 79.49 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 112.582 0.586 . . . . 1.27 112.582 -179.123 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 86.1 t -73.61 -46.78 47.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 N-CA-C 112.826 0.676 . . . . 1.17 112.826 -178.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 39.4 mtm105 -62.01 -43.61 98.48 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 112.533 0.568 . . . . 0.65 112.533 -178.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 282' ' ' THR . . . . . . . . . . . . . 68.6 p -69.16 -15.19 63.35 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 112.111 0.412 . . . . 0.46 112.111 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . 0.499 ' HB3' HD22 ' A' ' 287' ' ' LEU . 0.1 OUTLIER -128.23 36.53 4.28 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 111.723 0.268 . . . . 0.82 111.723 -179.566 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 36.3 ttm180 -53.17 -54.24 38.83 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 112.607 0.595 . . . . 1.34 112.607 -179.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -66.99 -33.96 76.7 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 111.862 0.319 . . . . 0.63 111.862 -178.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 286' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -70.14 -39.75 75.19 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.013 0.435 . . . . 0.84 110.489 179.647 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 287' ' ' LEU . . . . . 0.499 HD22 ' HB3' ' A' ' 283' ' ' LYS . 1.9 mm? -65.99 -46.77 76.8 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 115.878 -0.601 . . . . 1.1 111.587 179.782 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 30.8 m -65.83 -31.6 54.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 C-N-CA 121.003 -0.279 . . . . 0.96 111.41 179.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 26.2 mtmm -72.28 -32.79 66.94 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 112.384 0.513 . . . . 1.66 112.384 179.585 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 290' ' ' GLN . . . . . 0.432 HE21 ' N ' ' A' ' 290' ' ' GLN . 0.0 OUTLIER -101.73 15.45 28.91 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 112.683 0.623 . . . . 1.32 112.683 -179.231 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 291' ' ' ARG . . . . . 0.602 ' HB3' ' HB2' ' A' ' 294' ' ' ASP . 0.0 OUTLIER 59.92 24.13 13.21 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-O 121.174 0.511 . . . . 0.71 112.106 179.734 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 292' ' ' GLY . . . . . 0.465 ' HA2' HD11 ' A' ' 287' ' ' LEU . . . 58.4 -117.87 11.88 Favored Glycine 0 CA--C 1.522 0.494 0 CA-C-N 115.615 -0.721 . . . . 0.35 114.795 179.446 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 293' ' ' TRP . . . . . 0.409 ' O ' HG21 ' A' ' 297' ' ' VAL . 83.9 m95 -67.19 -33.51 75.55 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 112.808 0.67 . . . . 0.59 112.808 -178.368 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 294' ' ' ASP . . . . . 0.602 ' HB2' ' HB3' ' A' ' 291' ' ' ARG . 60.7 m-20 -53.09 -49.76 65.79 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 118.026 0.375 . . . . 0.46 111.098 179.143 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -65.02 -50.43 57.79 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.687 -0.768 . . . . 0.34 111.488 178.522 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 296' ' ' PHE . . . . . 0.513 ' HB2' ' CZ3' ' A' ' 242' ' ' TRP . 0.4 OUTLIER -53.58 -45.0 69.83 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 122.586 0.354 . . . . 0.46 111.766 179.212 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 297' ' ' VAL . . . . . 0.732 HG12 ' HB3' ' A' ' 189' ' ' ARG . 52.0 t -63.4 -53.59 43.54 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 N-CA-C 112.351 0.5 . . . . 1.01 112.351 -178.679 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.74 -26.89 63.57 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.617 -0.433 . . . . 0.49 111.911 -179.255 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 299' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -62.5 -44.16 97.06 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 109.848 -0.427 . . . . 0.64 109.848 177.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 300' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 . . . . . 0 CA--C 1.532 0.278 0 CA-C-O 121.344 0.593 . . . . 0.78 110.841 178.909 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 22' ' ' GLU . . . . . 0.49 ' O ' ' HB2' ' B' ' 26' ' ' GLN . 3.4 mm-40 . . . . . 0 CA--C 1.533 0.325 0 N-CA-C 112.02 0.378 . . . . 0.44 112.02 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 23' ' ' PHE . . . . . 0.579 ' HA ' ' HG2' ' A' ' 212' ' ' MET . 0.8 OUTLIER -68.97 -40.78 78.65 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 120.222 -0.591 . . . . 0.54 110.929 179.166 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 24' ' ' ALA . . . . . 0.661 ' HB3' ' CD2' ' A' ' 233' ' ' HIS . . . -70.5 -39.44 74.14 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.552 0.691 . . . . 0.48 109.767 179.371 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.79 -46.61 78.08 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 114.905 -1.043 . . . . 0.97 109.993 178.231 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 26' ' ' GLN . . . . . 0.49 ' HB2' ' O ' ' B' ' 22' ' ' GLU . 0.8 OUTLIER -58.83 -53.89 53.24 Favored 'General case' 0 C--O 1.224 -0.268 0 CA-C-N 116.159 -0.473 . . . . 0.36 111.323 179.504 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . 0.495 HD11 ' CD2' ' A' ' 251' ' ' PHE . 19.3 mt -54.74 -36.42 64.77 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.641 0.258 . . . . 1.1 110.938 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 28' ' ' ARG . . . . . 0.503 ' HG3' ' HA ' ' A' ' 234' ' ' VAL . 0.2 OUTLIER -70.59 -53.24 16.76 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.539 -0.3 . . . . 0.66 110.204 178.102 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 21.4 mttt -53.28 -47.76 68.89 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.251 0.548 . . . . 0.7 110.614 179.056 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . 0.438 HG12 ' ND1' ' A' ' 205' ' ' HIS . 84.8 mt -64.25 -45.22 96.83 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 CA-C-N 115.331 -0.85 . . . . 0.98 110.603 179.626 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . 0.469 ' HA3' ' HA ' ' A' ' 244' ' ' ARG . . . -57.84 -49.37 75.07 Favored Glycine 0 C--N 1.334 0.419 0 C-N-CA 120.974 -0.631 . . . . 0.29 112.749 179.736 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -62.26 -42.76 99.62 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 121.17 0.51 . . . . 0.41 110.279 179.334 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 33' ' ' LYS . . . . . 0.486 ' HA ' ' HZ3' ' B' ' 33' ' ' LYS . 0.0 OUTLIER -62.69 -57.45 10.97 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.792 -0.64 . . . . 1.59 111.784 179.646 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 71.1 t -54.53 -44.14 67.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 O-C-N 123.308 0.38 . . . . 1.09 111.268 -179.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 35' ' ' TYR . . . . . 0.422 ' N ' ' HA3' ' A' ' 243' ' ' GLY . 0.6 OUTLIER -56.77 -43.48 80.88 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 121.044 0.449 . . . . 0.87 110.477 178.699 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 36' ' ' CYS . . . . . . . . . . . . . 66.0 m -68.95 -40.97 78.62 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.352 -0.385 . . . . 0.47 111.418 179.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 8.4 m -59.13 -40.83 86.68 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 113.091 0.774 . . . . 0.62 113.091 -179.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 38' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -83.6 -36.67 23.74 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 112.42 0.526 . . . . 0.64 112.42 -178.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 65.9 p . . . . . 0 N--CA 1.467 0.402 0 CA-C-O 120.727 0.298 . . . . 0.46 110.762 179.147 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . 0.506 ' HA ' ' HB3' ' A' ' 156' ' ' TYR . 1.0 OUTLIER . . . . . 0 N--CA 1.465 0.301 0 CA-C-O 120.784 0.326 . . . . 0.0 111.189 . . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -62.78 -43.67 98.18 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.16 178.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 48.4 tp -77.56 -36.5 52.09 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 178.048 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . 0.506 ' HB3' ' HA ' ' A' ' 153' ' ' ASP . 69.7 t80 -58.54 -38.22 77.35 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 115.105 -0.952 . . . . 0.0 111.739 179.575 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . 0.521 ' HD2' ' OE2' ' A' ' 161' ' ' GLU . 0.0 OUTLIER -56.46 -53.04 62.12 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.999 0.428 . . . . 0.0 110.352 178.976 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . 0.422 ' HG2' ' HB1' ' A' ' 183' ' ' ALA . 26.9 mt-30 -68.44 -37.46 80.26 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.58 179.166 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 41.4 m -57.83 -50.69 72.43 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.367 179.266 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.527 ' HA ' HG21 ' A' ' 276' ' ' THR . 2.3 tm? -58.69 -47.43 84.56 Favored 'General case' 0 C--O 1.225 -0.232 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.451 178.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . 0.521 ' OE2' ' HD2' ' A' ' 157' ' ' ARG . 30.8 mt-10 -60.52 -51.1 70.89 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 111.949 0.352 . . . . 0.0 111.949 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . 0.499 HG12 ' HA2' ' A' ' 187' ' ' GLY . 46.2 mt -58.87 -51.68 69.37 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 CA-C-O 120.636 0.255 . . . . 0.0 111.145 179.633 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.589 ' O ' ' HG ' ' A' ' 167' ' ' LEU . 89.5 mt -62.04 -48.08 90.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-N 116.646 -0.252 . . . . 0.0 111.414 179.589 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' SER . . . . . 0.532 ' O ' ' HB2' ' A' ' 168' ' ' ARG . 1.2 t -57.7 -42.34 83.5 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 120.751 0.31 . . . . 0.0 111.322 179.452 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . 0.426 ' HA ' ' HD3' ' A' ' 165' ' ' ARG . 5.7 tpp180 -72.37 -37.0 68.87 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 121.08 -0.248 . . . . 0.0 111.225 179.758 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' TYR . . . . . 0.82 ' CE1' ' HA ' ' A' ' 195' ' ' ARG . 39.1 t80 -66.27 -52.79 44.01 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.679 -0.237 . . . . 0.0 111.622 179.768 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.589 ' HG ' ' O ' ' A' ' 163' ' ' ILE . 20.7 mt -61.95 -40.6 96.1 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.712 -0.222 . . . . 0.0 110.789 -179.728 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . 0.532 ' HB2' ' O ' ' A' ' 164' ' ' SER . 0.5 OUTLIER -62.15 -44.44 96.61 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 120.953 0.406 . . . . 0.0 110.506 179.215 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -60.83 -48.11 83.29 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.164 178.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 6.8 mm-40 -61.55 -43.49 98.76 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.149 179.126 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.265 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -179.074 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . 0.525 ' O ' ' HA3' ' A' ' 187' ' ' GLY . . . . . . . . 0 CA--C 1.533 0.323 0 CA-C-O 121.092 0.472 . . . . 0.0 111.029 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -79.89 -70.5 1.33 Allowed Glycine 0 CA--C 1.524 0.595 0 C-N-CA 121.069 -0.586 . . . . 0.0 113.961 -179.588 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -63.92 -55.51 22.1 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 111.998 0.37 . . . . 0.0 111.998 -178.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -68.0 -33.68 75.09 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.354 179.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . 0.525 ' HA3' ' O ' ' A' ' 183' ' ' ALA . . . -66.94 -41.62 93.22 Favored Glycine 0 C--O 1.225 -0.429 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.559 178.747 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 3.9 tpt180 -63.01 -53.9 46.7 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 120.615 0.245 . . . . 0.0 111.279 179.202 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 28.0 mtp180 -62.79 -44.04 97.21 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.592 -179.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -70.3 -48.77 55.15 Favored 'General case' 0 C--O 1.22 -0.468 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -179.166 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 19.3 tp -60.19 -42.83 95.9 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 118.359 0.527 . . . . 0.0 111.746 -179.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -63.69 -46.02 87.41 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 121.136 0.493 . . . . 0.0 110.934 179.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 34.3 m -68.4 -45.48 72.55 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.889 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . 0.47 HD21 HG22 ' A' ' 249' ' ' ILE . 12.3 tp -59.77 -37.43 79.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.084 -179.636 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . 0.82 ' HA ' ' CE1' ' A' ' 166' ' ' TYR . 11.5 ttp180 -70.8 -53.36 15.65 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.508 179.034 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . 0.401 ' C ' ' HD3' ' A' ' 196' ' ' ARG . 0.0 OUTLIER -59.36 -48.2 82.52 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.888 -179.935 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . 0.534 ' O ' HG21 ' A' ' 201' ' ' VAL . 73.5 t -70.89 -47.92 59.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.334 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . 0.469 ' O ' ' HG2' ' A' ' 202' ' ' GLN . . . -56.19 -43.51 89.0 Favored Glycine 0 C--N 1.338 0.645 0 N-CA-C 111.371 -0.691 . . . . 0.0 111.371 179.367 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . 0.525 ' HB2' ' O ' ' A' ' 195' ' ' ARG . 0.4 OUTLIER -58.26 -48.5 80.25 Favored 'General case' 0 C--O 1.226 -0.138 0 O-C-N 123.963 0.449 . . . . 0.0 109.83 177.951 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -62.89 -41.17 99.93 Favored Glycine 0 CA--C 1.524 0.597 0 C-N-CA 121.085 -0.579 . . . . 0.0 112.601 179.247 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . 0.692 HG11 HG21 ' B' ' 34' ' ' VAL . 70.3 t -58.06 -51.7 67.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 CA-C-O 120.786 0.327 . . . . 0.0 111.127 179.254 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 202' ' ' GLN . . . . . 0.543 ' HG3' ' CZ ' ' A' ' 203' ' ' ARG . 1.2 pt20 -72.35 -31.68 65.83 Favored 'General case' 0 C--O 1.222 -0.36 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.404 179.745 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 203' ' ' ARG . . . . . 0.543 ' CZ ' ' HG3' ' A' ' 202' ' ' GLN . 0.0 OUTLIER -66.73 -38.97 87.73 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 121.247 0.546 . . . . 0.0 109.793 177.739 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -62.3 -54.21 43.94 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.968 179.17 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 205' ' ' HIS . . . . . 0.504 ' ND1' HG12 ' B' ' 30' ' ' ILE . 31.8 m-70 -101.66 37.79 1.75 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.968 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -48.02 -47.73 33.21 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -178.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -61.97 -41.62 98.21 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -73.08 -47.33 45.45 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.901 0.382 . . . . 0.0 111.149 -179.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 209' ' ' PHE . . . . . 0.509 ' CD2' ' HA ' ' A' ' 202' ' ' GLN . 8.5 m-85 -60.62 -45.13 95.2 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.534 178.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 210' ' ' GLN . . . . . 0.679 ' O ' ' HG2' ' A' ' 214' ' ' ARG . 27.8 mt-30 -68.01 -44.0 77.55 Favored 'General case' 0 C--O 1.225 -0.199 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.021 179.216 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -55.29 -50.81 58.05 Favored Glycine 0 C--N 1.335 0.507 0 C-N-CA 120.723 -0.751 . . . . 0.0 111.953 179.343 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 212' ' ' MET . . . . . 0.443 ' HG2' ' HB3' ' B' ' 23' ' ' PHE . 0.8 OUTLIER -64.25 -29.65 70.74 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.672 0.272 . . . . 0.0 110.799 178.623 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . 0.495 HD12 HD21 ' A' ' 216' ' ' LEU . 8.4 tp -73.83 -42.33 61.03 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.488 179.334 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 214' ' ' ARG . . . . . 0.679 ' HG2' ' O ' ' A' ' 210' ' ' GLN . 16.4 mmt85 -61.39 -37.19 82.51 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.184 0.516 . . . . 0.0 109.751 178.814 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.71 12.52 31.62 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.992 178.624 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . 0.755 ' HG ' HG12 ' A' ' 218' ' ' ILE . 16.2 tp -77.52 103.69 7.6 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 121.127 0.489 . . . . 0.0 110.037 179.027 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -81.71 33.03 0.36 Allowed 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 113.032 0.753 . . . . 0.0 113.032 -178.395 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 218' ' ' ILE . . . . . 0.755 HG12 ' HG ' ' A' ' 216' ' ' LEU . 50.8 mm -81.64 107.41 13.75 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-O 120.728 0.299 . . . . 0.0 110.326 178.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.59 -19.31 0.53 Allowed 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 -178.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -112.63 179.6 3.93 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -179.088 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . 0.544 ' O ' HG21 ' A' ' 224' ' ' VAL . 15.6 tm-20 -68.59 -40.74 80.38 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.775 179.587 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -58.16 -26.43 58.66 Favored Glycine 0 CA--C 1.524 0.607 0 C-N-CA 121.297 -0.478 . . . . 0.0 113.169 179.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 223' ' ' ASP . . . . . 0.502 ' HB3' HG23 ' A' ' 218' ' ' ILE . 40.2 m-20 -59.34 -30.5 68.42 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 112.94 0.719 . . . . 0.0 112.94 -179.586 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . 0.544 HG21 ' O ' ' A' ' 221' ' ' GLU . 11.8 m -62.87 -29.17 46.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 CA-C-O 120.991 0.424 . . . . 0.0 110.828 179.444 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . 0.542 ' O ' ' HG2' ' A' ' 229' ' ' ARG . 23.5 mttp -71.32 -31.75 67.77 Favored 'General case' 0 C--O 1.232 0.15 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 179.027 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 226' ' ' SER . . . . . 0.578 ' O ' HG21 ' A' ' 230' ' ' VAL . 3.8 m -65.22 -44.96 86.61 Favored 'General case' 0 C--N 1.335 -0.062 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 177.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 227' ' ' PHE . . . . . . . . . . . . . 8.7 t80 -61.94 -36.45 81.42 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.822 178.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 13.0 t -61.9 -41.38 97.83 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.714 177.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 229' ' ' ARG . . . . . 0.542 ' HG2' ' O ' ' A' ' 225' ' ' LYS . 5.7 mmp_? -70.03 -43.8 70.55 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.439 179.035 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . 0.578 HG21 ' O ' ' A' ' 226' ' ' SER . 60.5 t -58.66 -47.72 87.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 178.523 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 231' ' ' MET . . . . . 0.929 ' HG3' ' HG ' ' A' ' 248' ' ' LEU . 36.5 ttm -53.09 -53.79 45.14 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.41 178.784 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 96.8 t -59.36 -44.85 93.38 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.755 179.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 233' ' ' HIS . . . . . 0.437 ' O ' ' HB2' ' A' ' 236' ' ' LYS . 2.0 t-80 -57.29 -33.95 68.18 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 230' ' ' VAL . 89.1 t -56.31 -32.1 34.44 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 O-C-N 121.917 -0.489 . . . . 0.0 111.623 179.683 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -103.01 25.17 9.71 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.562 -179.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . 0.437 ' HB2' ' O ' ' A' ' 233' ' ' HIS . 0.6 OUTLIER -49.65 -35.79 22.49 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 -178.804 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 237' ' ' ASP . . . . . 0.446 ' HB2' HG12 ' A' ' 239' ' ' VAL . 0.0 OUTLIER -71.88 -16.07 62.12 Favored 'General case' 0 N--CA 1.468 0.447 0 O-C-N 122.153 -0.342 . . . . 0.0 111.466 -179.689 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 98.18 -18.74 56.64 Favored Glycine 0 CA--C 1.52 0.371 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.162 -178.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . 0.446 HG12 ' HB2' ' A' ' 237' ' ' ASP . 4.0 p -79.48 115.55 22.0 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 CA-C-O 121.746 0.784 . . . . 0.0 111.017 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 240' ' ' THR . . . . . 0.487 HG22 HD12 ' A' ' 245' ' ' ILE . 4.2 m -90.14 74.67 7.12 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.738 -179.208 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -65.91 135.0 54.18 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 121.076 -0.249 . . . . 0.0 110.401 178.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 242' ' ' TRP . . . . . 0.539 ' HB3' ' CE2' ' A' ' 300' ' ' PHE . 2.1 m95 -56.09 -37.76 69.8 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.922 0.391 . . . . 0.0 111.147 179.664 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -65.1 -25.33 70.89 Favored Glycine 0 C--N 1.336 0.57 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.713 179.277 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 93.3 mtt180 -75.31 -45.29 40.6 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 178.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . 0.487 HD12 HG22 ' A' ' 240' ' ' THR . 54.0 mt -57.05 -48.35 82.0 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.847 179.333 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 10.5 p -67.23 -33.18 61.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.909 179.121 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 20.6 m -62.28 -38.46 89.45 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 121.065 -0.254 . . . . 0.0 110.458 178.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 248' ' ' LEU . . . . . 0.929 ' HG ' ' HG3' ' A' ' 231' ' ' MET . 1.0 OUTLIER -63.59 -33.51 75.76 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.141 0.496 . . . . 0.0 110.413 178.337 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 249' ' ' ILE . . . . . 0.475 HD12 HD23 ' A' ' 279' ' ' LEU . 33.7 mm -76.84 -40.7 32.03 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.737 178.386 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 23.2 t -59.94 -44.79 94.15 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 178.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 251' ' ' PHE . . . . . 0.53 ' O ' HG23 ' A' ' 255' ' ' VAL . 22.7 t80 -66.82 -44.52 80.94 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.251 177.832 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -54.98 -42.92 82.36 Favored Glycine 0 C--N 1.34 0.754 0 N-CA-C 111.078 -0.809 . . . . 0.0 111.078 177.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 253' ' ' ALA . . . . . 0.601 ' O ' ' HG3' ' A' ' 257' ' ' LYS . . . -61.78 -46.37 89.85 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 115.551 -0.324 . . . . 0.0 110.201 177.294 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -58.27 -41.6 84.66 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 120.972 0.415 . . . . 0.0 110.289 178.591 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 255' ' ' VAL . . . . . 0.53 HG23 ' O ' ' A' ' 251' ' ' PHE . 64.0 t -62.38 -44.7 99.49 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-N 116.159 -0.473 . . . . 0.0 109.897 177.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -59.38 -42.76 92.41 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-O 121.02 0.438 . . . . 0.0 109.836 177.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 257' ' ' LYS . . . . . 0.601 ' HG3' ' O ' ' A' ' 253' ' ' ALA . 20.0 mtpp -62.06 -39.97 94.18 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.928 177.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 10.9 t60 -66.22 -43.44 86.64 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.367 178.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 75.2 mt -65.4 -39.44 92.19 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.466 178.591 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -68.54 -32.0 71.63 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 120.911 0.386 . . . . 0.0 110.008 178.357 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 66.4 m -59.44 -34.23 72.25 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.449 178.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 15.7 m -101.53 15.57 4.99 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.211 179.036 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 56.23 48.15 17.87 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 112.705 0.631 . . . . 0.0 112.705 179.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -118.67 37.71 3.99 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 120.887 0.375 . . . . 0.0 111.414 179.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 265' ' ' GLU . . . . . 0.56 ' HA ' HD13 ' A' ' 268' ' ' ILE . 0.0 OUTLIER -51.9 -26.49 10.33 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 179.843 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 50.6 p -59.88 -25.54 65.15 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 120.674 0.273 . . . . 0.0 111.126 179.064 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -88.91 -20.56 24.4 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 120.93 0.395 . . . . 0.0 110.592 178.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 268' ' ' ILE . . . . . 0.56 HD13 ' HA ' ' A' ' 265' ' ' GLU . 75.9 mt -67.85 -42.72 86.13 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.021 179.468 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 269' ' ' GLU . . . . . 0.78 ' HB3' ' HD3' ' A' ' 270' ' ' PRO . 9.4 tp10 -53.72 -57.08 18.99 Favored Pre-proline 0 CA--C 1.546 0.817 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.649 179.324 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 270' ' ' PRO . . . . . 0.78 ' HD3' ' HB3' ' A' ' 269' ' ' GLU . 24.9 Cg_exo -64.76 -33.81 52.59 Favored 'Trans proline' 0 C--N 1.36 1.184 0 C-N-CA 122.086 1.857 . . . . 0.0 111.878 178.536 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 271' ' ' LEU . . . . . . . . . . . . . 27.1 tp -63.96 -42.0 97.41 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.129 178.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -59.81 -48.89 79.87 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.483 178.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 273' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -63.77 -41.17 98.02 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.409 178.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 274' ' ' THR . . . . . 0.408 HG21 ' HB ' ' A' ' 224' ' ' VAL . 91.1 m -60.21 -48.93 79.64 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.052 178.664 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 275' ' ' ILE . . . . . 0.464 ' HA ' ' HE1' ' A' ' 231' ' ' MET . 96.7 mt -61.9 -50.68 79.16 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.684 178.411 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 276' ' ' THR . . . . . 0.527 HG21 ' HA ' ' A' ' 160' ' ' LEU . 27.8 m -58.66 -53.9 53.13 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -178.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 277' ' ' ASP . . . . . 0.566 ' O ' ' HB2' ' A' ' 281' ' ' ARG . 2.3 t70 -58.16 -54.02 51.72 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 120.873 -0.331 . . . . 0.0 111.496 -178.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 95.1 t -59.38 -34.8 55.42 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 CA-C-O 120.673 0.273 . . . . 0.0 111.177 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 279' ' ' LEU . . . . . 0.475 HD23 HD12 ' A' ' 249' ' ' ILE . 5.0 tp -65.09 -48.12 74.82 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 111.742 0.275 . . . . 0.0 111.742 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 42.5 t -78.68 -36.59 19.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -179.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 281' ' ' ARG . . . . . 0.566 ' HB2' ' O ' ' A' ' 277' ' ' ASP . 0.1 OUTLIER -65.95 -36.03 82.22 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -179.493 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 282' ' ' THR . . . . . . . . . . . . . 15.4 p -73.39 -52.06 15.14 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 120.885 0.374 . . . . 0.0 111.623 179.456 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . 0.479 ' HB2' HD21 ' A' ' 287' ' ' LEU . 15.2 mttp -88.54 41.85 1.04 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.783 0.325 . . . . 0.0 110.68 179.583 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 28.9 ttm180 -48.05 -63.32 1.1 Allowed 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 -178.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -72.02 -31.51 66.26 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 121.028 -0.269 . . . . 0.0 111.625 -178.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 286' ' ' TRP . . . . . . . . . . . . . 2.3 t90 -68.37 -49.02 63.12 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.877 0.37 . . . . 0.0 111.121 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 287' ' ' LEU . . . . . 0.479 HD21 ' HB2' ' A' ' 283' ' ' LYS . 0.7 OUTLIER -63.08 -41.21 99.36 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -179.593 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 29.5 m -70.48 -37.86 71.74 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 C-N-CA 120.514 -0.474 . . . . 0.0 111.826 179.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 39.3 mttp -72.91 -32.23 65.18 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -85.46 17.3 3.25 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -179.064 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 291' ' ' ARG . . . . . 0.437 HH11 ' HD2' ' A' ' 291' ' ' ARG . 25.3 mtm105 60.09 18.6 7.87 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 179.553 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 63.16 -137.02 43.11 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 114.687 0.635 . . . . 0.0 114.687 178.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 293' ' ' TRP . . . . . . . . . . . . . 72.4 m95 -59.13 -28.39 66.5 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -178.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 294' ' ' ASP . . . . . 0.496 ' O ' ' HG3' ' A' ' 298' ' ' GLU . 0.4 OUTLIER -59.41 -48.35 81.98 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 120.782 0.325 . . . . 0.0 110.24 178.335 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -66.19 -36.48 91.86 Favored Glycine 0 CA--C 1.521 0.458 0 C-N-CA 120.53 -0.843 . . . . 0.0 111.252 178.401 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 296' ' ' PHE . . . . . 0.462 ' HB2' ' CH2' ' A' ' 242' ' ' TRP . 12.2 t80 -58.67 -48.0 82.58 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.51 -0.345 . . . . 0.0 111.015 178.616 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 297' ' ' VAL . . . . . . . . . . . . . 18.4 m -72.33 -22.68 20.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 120.934 -0.306 . . . . 0.0 111.636 -179.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 298' ' ' GLU . . . . . 0.496 ' HG3' ' O ' ' A' ' 294' ' ' ASP . 37.1 mt-10 -65.97 -50.1 65.51 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.206 0.527 . . . . 0.0 110.599 178.336 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 299' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -77.1 -25.02 51.75 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 115.912 -0.585 . . . . 0.0 112.292 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 300' ' ' PHE . . . . . 0.539 ' CE2' ' HB3' ' A' ' 242' ' ' TRP . 44.7 m-85 . . . . . 0 CA--C 1.54 0.571 0 N-CA-C 115.16 1.541 . . . . 0.0 115.16 -177.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 22' ' ' GLU . . . . . 0.401 ' O ' ' HB2' ' B' ' 26' ' ' GLN . 4.8 mm-40 . . . . . 0 CA--C 1.535 0.381 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 23' ' ' PHE . . . . . 0.579 ' HD1' ' N ' ' B' ' 24' ' ' ALA . 0.1 OUTLIER -60.22 -31.88 70.58 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 118.302 0.501 . . . . 0.0 111.886 179.812 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 24' ' ' ALA . . . . . 0.579 ' N ' ' HD1' ' B' ' 23' ' ' PHE . . . -74.7 -48.38 26.31 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.16 0.505 . . . . 0.0 110.625 -179.724 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . 0.493 ' HA ' ' HD3' ' B' ' 28' ' ' ARG . . . -64.71 -37.12 86.49 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.505 178.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 26' ' ' GLN . . . . . 0.416 ' O ' HG13 ' B' ' 30' ' ' ILE . 0.0 OUTLIER -62.92 -48.13 80.25 Favored 'General case' 0 C--O 1.226 -0.134 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.13 178.751 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . 0.559 ' HG ' ' O ' ' B' ' 23' ' ' PHE . 29.8 mt -58.96 -32.45 69.65 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 178.371 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 28' ' ' ARG . . . . . 0.493 ' HD3' ' HA ' ' B' ' 25' ' ' ALA . 56.1 mtp85 -65.43 -54.81 23.14 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 177.432 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . 0.444 ' HG3' ' O ' ' B' ' 25' ' ' ALA . 54.5 mttt -55.67 -46.37 77.57 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.008 178.501 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . 0.504 HG12 ' ND1' ' A' ' 205' ' ' HIS . 97.9 mt -60.76 -52.42 61.77 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.237 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.218 179.76 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -57.03 -43.68 93.14 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 121.301 -0.476 . . . . 0.0 113.097 179.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -68.68 -40.89 79.9 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 120.709 0.29 . . . . 0.0 111.148 179.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.93 -39.97 83.42 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 120.954 0.407 . . . . 0.0 110.077 178.277 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 34' ' ' VAL . . . . . 0.692 HG21 HG11 ' A' ' 201' ' ' VAL . 4.9 t -62.56 -52.62 57.53 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.555 179.809 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -57.35 -40.95 79.14 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 120.943 0.402 . . . . 0.0 110.337 179.236 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 36' ' ' CYS . . . . . . . . . . . . . 42.7 t -68.68 -25.98 65.07 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 120.925 0.393 . . . . 0.0 111.298 179.256 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 59.6 m -78.55 -46.37 19.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.514 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 38' ' ' TRP . . . . . 0.429 ' CD1' HG13 ' B' ' 34' ' ' VAL . 99.2 m95 -75.52 -13.79 60.38 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 -179.132 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 43.7 m . . . . . 0 N--CA 1.472 0.66 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 178.878 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 . . . . . 0 CA--C 1.526 0.058 0 CA-C-O 120.854 0.359 . . . . 0.0 110.65 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.76 -57.19 14.11 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.911 179.234 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.36 -35.99 80.84 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.03 178.716 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . 0.404 ' HE1' ' HA ' ' A' ' 277' ' ' ASP . 0.1 OUTLIER -68.86 -46.29 68.85 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.69 -0.232 . . . . 0.0 111.447 179.6 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 6.2 mtp180 -62.6 -45.87 90.87 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 121.119 -0.233 . . . . 0.0 111.14 179.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 59.3 mt-30 -58.02 -43.77 86.9 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 121.074 0.464 . . . . 0.0 110.222 178.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' SER . . . . . 0.478 ' HA ' ' CZ2' ' A' ' 293' ' ' TRP . 51.4 m -61.38 -54.35 44.78 Favored 'General case' 0 C--O 1.223 -0.313 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.788 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -58.38 -47.23 84.53 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 120.492 0.187 . . . . 0.0 111.308 179.299 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -60.75 -51.85 67.59 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . 0.474 HG23 HD21 ' A' ' 191' ' ' LEU . 60.5 mt -71.26 -48.66 53.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 -178.429 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.591 ' O ' ' HG ' ' A' ' 167' ' ' LEU . 64.4 mt -58.85 -50.83 78.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 N-CA-C 111.64 0.237 . . . . 0.0 111.64 -179.44 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 39.3 t -61.9 -41.76 98.28 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 120.959 -0.296 . . . . 0.0 110.827 179.558 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . 0.498 ' O ' ' HB2' ' A' ' 169' ' ' GLU . 6.7 tpp85 -61.07 -47.66 85.31 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 111.658 0.244 . . . . 0.0 111.658 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' TYR . . . . . 0.85 ' HE1' ' HA ' ' A' ' 195' ' ' ARG . 87.6 t80 -65.98 -50.97 62.44 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -179.358 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.591 ' HG ' ' O ' ' A' ' 163' ' ' ILE . 40.7 mt -59.11 -45.0 92.03 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 121.127 -0.229 . . . . 0.0 111.477 -178.784 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 3.7 ttt180 -70.26 -42.03 72.69 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 120.959 -0.296 . . . . 0.0 111.637 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . 0.498 ' HB2' ' O ' ' A' ' 165' ' ' ARG . 0.5 OUTLIER -59.6 -46.0 90.24 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.222 0.534 . . . . 0.0 109.645 179.081 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . 0.605 ' HB3' ' HE3' ' A' ' 257' ' ' LYS . 6.9 mm-40 -65.34 -49.75 68.22 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.87 179.058 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . 0.43 ' HA ' ' HG2' ' A' ' 257' ' ' LYS . . . . . . . . 0 N--CA 1.466 0.375 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 -178.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 0.26 0 CA-C-O 120.874 0.369 . . . . 0.0 110.949 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -73.73 -71.15 1.14 Allowed Glycine 0 CA--C 1.524 0.616 0 C-N-CA 120.631 -0.795 . . . . 0.0 113.56 -179.456 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -72.09 -44.82 62.64 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.104 0.478 . . . . 0.0 110.966 179.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -67.9 -26.94 66.24 Favored 'General case' 0 C--O 1.225 -0.204 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.213 179.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . 0.543 ' O ' ' HB2' ' A' ' 191' ' ' LEU . . . -63.82 -53.49 37.46 Favored Glycine 0 C--N 1.332 0.315 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.199 179.64 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . 0.594 ' HE ' ' HG2' ' A' ' 192' ' ' GLU . 1.4 tpm_? -63.33 -44.42 94.95 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 120.902 0.382 . . . . 0.0 110.302 178.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 189' ' ' ARG . . . . . 0.418 HH22 ' CD ' ' A' ' 298' ' ' GLU . 37.0 mtp180 -60.17 -47.41 86.06 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.096 179.618 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . 0.47 ' HA ' HG13 ' A' ' 297' ' ' VAL . . . -72.75 -40.52 65.95 Favored 'General case' 0 C--O 1.22 -0.453 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -179.679 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 191' ' ' LEU . . . . . 0.543 ' HB2' ' O ' ' A' ' 187' ' ' GLY . 0.3 OUTLIER -58.66 -45.78 88.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.798 0.333 . . . . 0.0 110.735 179.885 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 192' ' ' GLU . . . . . 0.594 ' HG2' ' HE ' ' A' ' 188' ' ' ARG . 15.2 mm-40 -76.81 -40.98 46.19 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -179.806 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 193' ' ' THR . . . . . 0.64 HG21 ' HA ' ' A' ' 297' ' ' VAL . 80.1 m -65.0 -48.55 73.53 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.813 0.34 . . . . 0.0 110.108 178.847 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 56.1 tp -64.81 -30.03 71.02 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.292 178.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . 0.85 ' HA ' ' HE1' ' A' ' 166' ' ' TYR . 56.9 ttm-85 -61.5 -49.49 76.56 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.832 0.349 . . . . 0.0 110.385 178.231 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . 0.44 HH11 ' HD2' ' A' ' 196' ' ' ARG . 0.2 OUTLIER -70.99 -55.25 8.71 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.026 -179.688 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . 0.469 ' O ' HG23 ' A' ' 201' ' ' VAL . 35.5 t -63.29 -47.65 91.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-O 120.997 0.427 . . . . 0.0 111.851 -179.341 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -60.43 -44.9 97.14 Favored Glycine 0 CA--C 1.519 0.302 0 CA-C-N 116.067 -0.515 . . . . 0.0 113.004 -179.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -73.48 -32.44 64.31 Favored 'General case' 0 C--N 1.331 -0.235 0 O-C-N 122.211 -0.582 . . . . 0.0 109.492 179.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -56.27 -48.49 74.59 Favored Glycine 0 C--N 1.337 0.621 0 N-CA-C 110.999 -0.841 . . . . 0.0 110.999 177.314 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 197' ' ' VAL . 41.3 t -65.36 -37.68 80.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 CA-C-O 120.883 0.373 . . . . 0.0 110.404 178.108 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 202' ' ' GLN . . . . . 0.44 ' HA ' ' CE2' ' A' ' 209' ' ' PHE . 24.5 mt-30 -61.69 -53.03 61.54 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.935 -0.575 . . . . 0.0 112.041 179.687 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 203' ' ' ARG . . . . . 0.403 HH11 ' HD3' ' A' ' 203' ' ' ARG . 9.2 ptt180 -72.88 -27.75 62.08 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 120.924 -0.31 . . . . 0.0 111.499 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -71.55 -53.59 13.3 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.058 0.456 . . . . 0.0 110.789 179.122 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 205' ' ' HIS . . . . . 0.424 ' HB3' ' HB2' ' A' ' 208' ' ' ALA . 94.2 m-70 -101.19 36.84 1.89 Allowed 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.897 179.5 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 11.0 tm-20 -53.83 -46.38 71.14 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.508 -179.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 49.1 p -64.66 -34.68 78.87 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.151 179.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 208' ' ' ALA . . . . . 0.424 ' HB2' ' HB3' ' A' ' 205' ' ' HIS . . . -69.22 -42.43 75.72 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 178.61 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 209' ' ' PHE . . . . . 0.479 ' O ' ' HG ' ' A' ' 213' ' ' LEU . 13.9 m-85 -70.81 -35.07 72.34 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.236 178.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -66.58 -46.9 74.46 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 177.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -62.26 -39.93 98.35 Favored Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 110.555 -1.018 . . . . 0.0 110.555 177.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 212' ' ' MET . . . . . 0.413 ' HE3' ' HB3' ' B' ' 26' ' ' GLN . 5.5 tpp -61.36 -37.0 81.78 Favored 'General case' 0 C--O 1.223 -0.293 0 N-CA-C 110.166 -0.309 . . . . 0.0 110.166 178.109 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . 0.479 ' HG ' ' O ' ' A' ' 209' ' ' PHE . 34.7 mt -60.42 -41.62 94.32 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.043 0.449 . . . . 0.0 110.568 178.366 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 83.7 mtt85 -70.6 -27.02 63.78 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.594 179.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 10.1 mmmm -91.58 -11.19 37.95 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 120.89 0.376 . . . . 0.0 111.446 179.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . 0.49 HD21 HD13 ' A' ' 218' ' ' ILE . 16.4 tp -100.11 114.3 27.56 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.38 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -90.16 24.12 2.61 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 120.996 0.427 . . . . 0.0 111.787 -179.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 218' ' ' ILE . . . . . 0.536 HG12 ' HB3' ' A' ' 223' ' ' ASP . 5.7 mt -66.69 122.85 18.49 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-O 121.094 0.473 . . . . 0.0 111.354 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 7.0 ptpp? -154.98 -16.15 0.12 Allowed 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -179.131 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -130.95 -178.95 5.04 Favored 'General case' 0 CA--C 1.536 0.413 0 O-C-N 121.688 -0.633 . . . . 0.0 112.515 -178.523 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . 0.45 ' O ' HG22 ' A' ' 224' ' ' VAL . 3.5 tp10 -61.64 -39.81 92.66 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -179.143 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . 0.404 ' O ' ' HG2' ' A' ' 225' ' ' LYS . . . -55.7 -26.07 45.47 Favored Glycine 0 CA--C 1.524 0.606 0 C-N-CA 121.399 -0.429 . . . . 0.0 113.764 -179.347 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 223' ' ' ASP . . . . . 0.536 ' HB3' HG12 ' A' ' 218' ' ' ILE . 61.4 m-20 -60.13 -28.09 67.6 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 -179.544 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . 0.45 HG22 ' O ' ' A' ' 221' ' ' GLU . 31.5 m -53.69 -31.72 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 N-CA-C 113.221 0.823 . . . . 0.0 113.221 -179.095 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . 0.404 ' HG2' ' O ' ' A' ' 222' ' ' GLY . 10.6 ptpp? -68.06 -33.61 74.88 Favored 'General case' 0 C--O 1.237 0.41 0 O-C-N 121.845 -0.535 . . . . 0.0 110.407 179.516 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 226' ' ' SER . . . . . 0.643 ' O ' HG21 ' A' ' 230' ' ' VAL . 33.3 p -69.63 -47.59 62.86 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.755 179.181 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 227' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -55.87 -37.7 69.15 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.154 0.502 . . . . 0.0 110.069 179.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 39.3 m -59.27 -48.73 80.55 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.488 177.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 229' ' ' ARG . . . . . 0.442 ' HA ' ' HD3' ' A' ' 229' ' ' ARG . 13.8 mmt180 -68.26 -34.09 75.56 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.074 179.5 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . 0.643 HG21 ' O ' ' A' ' 226' ' ' SER . 54.4 t -57.13 -54.83 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-O 120.562 0.22 . . . . 0.0 110.632 179.303 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 231' ' ' MET . . . . . 0.597 ' HG2' HD13 ' A' ' 248' ' ' LEU . 72.3 mtm -59.41 -43.35 93.02 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.334 179.374 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 79.7 t -59.07 -44.18 90.86 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-O 120.727 0.299 . . . . 0.0 110.874 178.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 65.7 t-80 -60.07 -38.62 83.41 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 120.826 0.346 . . . . 0.0 111.519 179.217 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 94.2 t -61.85 -39.62 84.14 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 CA-C-O 121.192 0.52 . . . . 0.0 111.056 178.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -99.24 24.42 7.98 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.638 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -62.24 -18.22 60.54 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -179.631 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -83.12 -16.71 45.71 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.772 0.32 . . . . 0.0 111.399 179.558 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 90.98 -10.07 76.06 Favored Glycine 0 CA--C 1.524 0.632 0 C-N-CA 120.701 -0.761 . . . . 0.0 113.747 179.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 6.2 p -93.47 118.19 38.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-O 121.571 0.701 . . . . 0.0 111.414 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 83.8 m -94.03 119.77 33.37 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.063 0.459 . . . . 0.0 111.896 -179.448 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -113.67 140.76 47.96 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.162 178.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 242' ' ' TRP . . . . . 0.488 ' HA ' ' CE3' ' A' ' 242' ' ' TRP . 1.3 m95 -56.79 -44.94 82.39 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.715 0.293 . . . . 0.0 111.014 179.601 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . 0.43 ' HA2' HG12 ' A' ' 246' ' ' VAL . . . -60.8 -29.53 70.51 Favored Glycine 0 CA--C 1.523 0.541 0 C-N-CA 121.083 -0.58 . . . . 0.0 112.384 178.671 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 244' ' ' ARG . . . . . 0.449 ' HA ' ' HA3' ' B' ' 31' ' ' GLY . 60.5 mtt180 -68.96 -47.25 66.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.112 0.482 . . . . 0.0 109.797 178.675 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . 0.456 ' O ' HG13 ' A' ' 249' ' ' ILE . 68.3 mt -62.59 -48.23 89.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.3 179.827 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . 0.43 HG12 ' HA2' ' A' ' 243' ' ' GLY . 8.7 p -65.44 -27.87 42.89 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 C-N-CA 120.849 -0.341 . . . . 0.0 111.143 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 17.5 m -65.74 -41.24 92.4 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.201 0.524 . . . . 0.0 109.718 178.041 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 248' ' ' LEU . . . . . 0.597 HD13 ' HG2' ' A' ' 231' ' ' MET . 55.0 mt -65.72 -38.29 88.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.999 178.226 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 249' ' ' ILE . . . . . 0.456 HG13 ' O ' ' A' ' 245' ' ' ILE . 14.9 mt -68.41 -43.05 84.37 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.524 178.875 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 250' ' ' SER . . . . . 0.414 ' HB2' ' HG3' ' A' ' 202' ' ' GLN . 5.2 p -66.47 -38.26 86.94 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 178.256 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 251' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -62.92 -44.15 96.85 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 176.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . 0.406 ' HA2' HG21 ' A' ' 255' ' ' VAL . . . -61.21 -42.68 99.86 Favored Glycine 0 C--N 1.336 0.579 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.359 177.845 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -62.43 -38.72 90.8 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 120.926 0.393 . . . . 0.0 110.692 178.109 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -66.73 -47.56 71.92 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.256 179.312 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 255' ' ' VAL . . . . . 0.541 ' O ' ' HG ' ' A' ' 259' ' ' LEU . 31.3 m -66.63 -33.77 65.67 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.2 178.817 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -63.25 -40.3 97.03 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.133 0.492 . . . . 0.0 109.779 177.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 257' ' ' LYS . . . . . 0.605 ' HE3' ' HB3' ' A' ' 170' ' ' GLN . 81.2 mttt -63.72 -39.18 93.67 Favored 'General case' 0 CA--C 1.528 0.1 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.582 177.541 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 66.7 t60 -65.0 -36.43 84.39 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 177.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . 0.541 ' HG ' ' O ' ' A' ' 255' ' ' VAL . 72.9 mt -70.07 -42.48 72.76 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.882 178.146 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 28.1 tptt -64.7 -33.83 76.87 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.672 179.132 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 40.7 t -59.77 -24.42 64.07 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.206 179.004 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 262' ' ' VAL . . . . . 0.502 HG22 ' HG3' ' A' ' 264' ' ' GLN . 16.7 m -117.54 18.16 7.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 CA-C-O 121.264 0.554 . . . . 0.0 110.179 178.607 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 23.3 t30 51.48 47.68 24.37 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 114.96 -1.018 . . . . 0.0 113.066 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 264' ' ' GLN . . . . . 0.502 ' HG3' HG22 ' A' ' 262' ' ' VAL . 11.6 mt-30 -91.36 39.11 0.99 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.707 0.289 . . . . 0.0 111.457 179.049 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 265' ' ' GLU . . . . . 0.494 ' HA ' HD13 ' A' ' 268' ' ' ILE . 15.6 tp10 -47.07 -36.63 8.36 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.906 179.477 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 2.5 m -55.9 -29.17 59.6 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.911 179.424 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 267' ' ' PHE . . . . . 0.406 ' C ' ' HD2' ' A' ' 270' ' ' PRO . 44.1 t80 -95.62 -21.38 18.26 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 120.925 -0.31 . . . . 0.0 111.623 179.819 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 268' ' ' ILE . . . . . 0.494 HD13 ' HA ' ' A' ' 265' ' ' GLU . 70.6 mt -63.77 -37.82 80.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 CA-C-O 121.06 0.457 . . . . 0.0 110.357 179.252 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 269' ' ' GLU . . . . . 0.575 ' HB3' ' HD3' ' A' ' 270' ' ' PRO . 2.1 tp10 -59.56 -58.27 20.69 Favored Pre-proline 0 CA--C 1.551 1.018 0 CA-C-N 115.886 -0.597 . . . . 0.0 112.113 179.236 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 270' ' ' PRO . . . . . 0.575 ' HD3' ' HB3' ' A' ' 269' ' ' GLU . 21.5 Cg_exo -67.82 -25.12 39.62 Favored 'Trans proline' 0 C--N 1.361 1.215 0 C-N-CA 122.314 2.009 . . . . 0.0 113.167 179.616 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 271' ' ' LEU . . . . . . . . . . . . . 42.6 tp -64.45 -46.22 84.09 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.622 -0.263 . . . . 0.0 110.55 179.075 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -61.17 -39.45 90.19 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.073 179.247 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 273' ' ' GLU . . . . . . . . . . . . . 49.9 mm-40 -68.48 -46.28 70.15 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.794 178.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 274' ' ' THR . . . . . . . . . . . . . 84.9 m -58.01 -49.18 77.73 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.94 179.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 275' ' ' ILE . . . . . 0.483 ' HA ' ' HE3' ' A' ' 231' ' ' MET . 95.1 mt -59.54 -54.0 40.54 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.115 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.267 178.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 78.6 m -52.5 -53.13 50.04 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.767 -0.651 . . . . 0.0 112.627 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 277' ' ' ASP . . . . . 0.404 ' HA ' ' HE1' ' A' ' 156' ' ' TYR . 38.4 t70 -59.64 -57.98 10.58 Favored 'General case' 0 C--O 1.224 -0.25 0 C-N-CA 120.849 -0.34 . . . . 0.0 111.561 -179.341 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 278' ' ' VAL . . . . . 0.455 ' HB ' ' HE3' ' A' ' 231' ' ' MET . 43.1 t -58.26 -41.34 80.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -179.295 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 19.1 tp -63.13 -47.2 83.77 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 75.7 t -77.73 -46.16 27.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -179.243 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 21.2 ptt180 -59.76 -30.16 68.67 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -179.16 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 282' ' ' THR . . . . . . . . . . . . . 12.0 m -84.71 -22.34 29.78 Favored 'General case' 0 CA--C 1.543 0.673 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . 0.619 ' HZ3' ' HB2' ' A' ' 283' ' ' LYS . 0.0 OUTLIER -139.38 42.03 2.05 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 -178.71 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 11.1 ptm180 -63.8 -47.16 81.98 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -179.21 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -61.8 -41.71 98.1 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.838 0.352 . . . . 0.0 111.207 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 286' ' ' TRP . . . . . 0.555 ' O ' ' HG2' ' A' ' 290' ' ' GLN . 7.7 t90 -64.41 -41.62 96.53 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.803 0.335 . . . . 0.0 110.261 178.74 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -66.46 -51.71 53.89 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 27.2 m -59.78 -32.55 49.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -179.304 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.98 -36.53 75.27 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 120.772 0.32 . . . . 0.0 110.797 179.336 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 290' ' ' GLN . . . . . 0.555 ' HG2' ' O ' ' A' ' 286' ' ' TRP . 40.5 mm-40 -88.83 28.74 1.11 Allowed 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 121.032 -0.267 . . . . 0.0 110.977 179.543 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 46.1 mtp85 59.68 22.33 11.08 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 112.192 0.441 . . . . 0.0 112.192 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 62.91 -130.62 42.51 Favored Glycine 0 C--O 1.239 0.433 0 CA-C-O 121.485 0.492 . . . . 0.0 113.866 179.512 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 293' ' ' TRP . . . . . 0.522 ' O ' HG12 ' A' ' 297' ' ' VAL . 90.6 m95 -65.12 -26.17 68.08 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.428 -0.386 . . . . 0.0 112.02 -179.294 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 294' ' ' ASP . . . . . 0.4 ' O ' ' HB2' ' A' ' 298' ' ' GLU . 25.5 t70 -64.64 -36.35 83.96 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 121.136 0.493 . . . . 0.0 109.995 178.579 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 295' ' ' GLY . . . . . 0.469 ' HA3' ' O ' ' A' ' 290' ' ' GLN . . . -71.37 -36.96 63.02 Favored Glycine 0 N--CA 1.45 -0.386 0 N-CA-C 110.551 -1.02 . . . . 0.0 110.551 177.598 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 296' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -63.87 -45.84 87.64 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 115.477 -0.362 . . . . 0.0 111.097 178.412 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 297' ' ' VAL . . . . . 0.64 ' HA ' HG21 ' A' ' 193' ' ' THR . 14.0 m -72.31 -28.4 28.8 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 -179.614 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 298' ' ' GLU . . . . . 0.418 ' CD ' HH22 ' A' ' 189' ' ' ARG . 2.3 tp10 -76.76 -49.74 15.22 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.582 0.229 . . . . 0.0 111.275 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 299' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -55.15 -48.72 73.33 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 120.879 0.371 . . . . 0.0 111.267 179.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 300' ' ' PHE . . . . . 0.47 ' CZ ' ' HB3' ' A' ' 242' ' ' TRP . 54.2 m-85 . . . . . 0 CA--C 1.538 0.497 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 . . . . . 0 C--O 1.236 0.37 0 CA-C-O 121.221 0.534 . . . . 0.0 110.932 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 23' ' ' PHE . . . . . 0.525 ' CE1' HG22 ' A' ' 230' ' ' VAL . 1.5 p90 -63.19 -41.57 99.22 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.478 -179.671 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.75 -36.42 83.83 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.939 0.4 . . . . 0.0 110.756 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.84 -47.37 86.65 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.798 178.241 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 26' ' ' GLN . . . . . 0.413 ' HB3' ' HE3' ' A' ' 212' ' ' MET . 5.5 mt-30 -66.01 -45.62 80.85 Favored 'General case' 0 CA--C 1.527 0.081 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.409 178.448 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 80.6 mt -56.75 -39.42 73.94 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.844 0.355 . . . . 0.0 110.378 178.386 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 28' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -62.63 -51.82 65.78 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.67 178.194 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -56.91 -42.01 79.17 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.568 178.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 87.8 mt -65.09 -43.29 95.86 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.433 178.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . 0.449 ' HA3' ' HA ' ' A' ' 244' ' ' ARG . . . -59.17 -50.08 71.63 Favored Glycine 0 C--N 1.335 0.514 0 C-N-CA 121.069 -0.586 . . . . 0.0 112.397 179.273 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -61.31 -44.62 96.91 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.091 0.472 . . . . 0.0 109.808 178.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 33' ' ' LYS . . . . . 0.452 ' HA ' ' HD2' ' B' ' 33' ' ' LYS . 0.2 OUTLIER -59.59 -55.98 27.67 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.787 179.718 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 55.7 t -59.14 -44.96 92.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-O 120.848 0.356 . . . . 0.0 110.974 179.558 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -57.09 -45.96 82.94 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.567 179.145 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 36' ' ' CYS . . . . . . . . . . . . . 73.3 m -65.77 -29.55 70.06 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.405 179.302 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 97.0 m -66.69 -45.39 78.97 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 120.645 0.259 . . . . 0.0 111.217 179.464 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 38' ' ' TRP . . . . . . . . . . . . . 99.3 m95 -75.58 -40.81 56.11 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 120.74 0.305 . . . . 0.0 111.136 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 41.7 t . . . . . 0 N--CA 1.468 0.451 0 CA-C-O 120.841 0.353 . . . . 0.0 111.66 179.511 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . 0.583 ' O ' ' HG3' ' A' ' 157' ' ' ARG . 26.5 t70 . . . . . 0 CA--C 1.536 0.419 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . 0.596 ' HA ' ' CZ ' ' A' ' 157' ' ' ARG . 2.9 m-20 -55.6 -47.41 76.55 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -178.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 47.9 tp -66.37 -37.02 84.34 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.139 0.495 . . . . 0.0 110.616 179.283 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 56.7 t80 -68.49 -43.19 77.43 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.389 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . 0.596 ' CZ ' ' HA ' ' A' ' 154' ' ' ASP . 54.4 mtm-85 -56.43 -49.77 73.58 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 27.6 tt0 -64.86 -43.93 91.39 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 120.851 0.358 . . . . 0.0 110.961 -179.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 20.0 m -63.52 -43.26 97.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.205 179.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -64.24 -47.54 79.27 Favored 'General case' 0 C--O 1.221 -0.402 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.43 178.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -54.38 -47.39 72.73 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-O 120.875 0.369 . . . . 0.0 111.461 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . 0.486 HG12 ' HA2' ' A' ' 187' ' ' GLY . 67.8 mt -63.11 -53.21 49.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-N 116.069 -0.514 . . . . 0.0 112.137 -179.783 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.481 HD11 HG21 ' A' ' 276' ' ' THR . 80.3 mt -63.12 -43.99 99.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.908 0.385 . . . . 0.0 110.935 179.725 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 2.5 t -59.16 -46.66 87.8 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.508 179.374 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . 0.533 ' HD2' ' OE2' ' A' ' 169' ' ' GLU . 2.3 mmm180 -57.19 -40.61 77.71 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 120.729 0.299 . . . . 0.0 111.075 179.024 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 70.6 t80 -71.0 -53.76 13.67 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.43 ' HG ' ' O ' ' A' ' 163' ' ' ILE . 38.9 mt -61.03 -43.42 98.92 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -178.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . 0.438 HH11 ' HD3' ' A' ' 168' ' ' ARG . 1.7 mtt-85 -67.79 -46.18 72.69 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -179.201 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . 0.533 ' OE2' ' HD2' ' A' ' 165' ' ' ARG . 17.6 mt-10 -66.3 -39.25 89.21 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 120.89 -0.324 . . . . 0.0 111.808 -179.512 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . 0.497 ' HG3' ' HE3' ' A' ' 257' ' ' LYS . 6.5 tp-100 -70.05 -26.32 63.97 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 121.234 0.54 . . . . 0.0 110.3 178.662 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . 0.524 ' O ' ' HG2' ' A' ' 260' ' ' LYS . . . . . . . . 0 CA--C 1.53 0.199 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.803 179.293 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . 0.6 ' O ' ' HA3' ' A' ' 187' ' ' GLY . . . . . . . . 0 CA--C 1.531 0.227 0 CA-C-O 120.939 0.399 . . . . 0.0 111.499 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -79.97 -71.48 1.26 Allowed Glycine 0 CA--C 1.525 0.705 0 C-N-CA 120.751 -0.737 . . . . 0.0 113.969 -179.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -70.56 -57.01 5.2 Favored 'General case' 0 C--O 1.238 0.449 0 O-C-N 122.519 -0.4 . . . . 0.0 111.823 -179.14 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -67.24 -27.75 67.49 Favored 'General case' 0 C--N 1.335 -0.061 0 CA-C-O 121.199 0.523 . . . . 0.0 109.892 179.234 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . 0.6 ' HA3' ' O ' ' A' ' 183' ' ' ALA . . . -72.64 -33.36 60.76 Favored Glycine 0 N--CA 1.447 -0.614 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.861 178.573 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -65.97 -54.51 25.3 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.797 0.332 . . . . 0.0 110.269 178.688 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 189' ' ' ARG . . . . . 0.69 ' HB3' HG12 ' A' ' 297' ' ' VAL . 16.0 mtm180 -55.12 -46.79 75.6 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 121.136 0.493 . . . . 0.0 110.818 179.17 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -71.35 -31.33 67.24 Favored 'General case' 0 C--O 1.221 -0.409 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.474 -179.474 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 191' ' ' LEU . . . . . 0.597 ' HB2' ' O ' ' A' ' 187' ' ' GLY . 0.2 OUTLIER -62.16 -53.59 53.15 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 117.893 0.315 . . . . 0.0 111.08 179.67 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -64.2 -41.41 97.08 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 120.713 0.292 . . . . 0.0 111.214 179.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 193' ' ' THR . . . . . 0.512 HG21 ' HA ' ' A' ' 297' ' ' VAL . 11.8 m -64.33 -47.76 78.18 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.81 179.109 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 14.9 tp -66.69 -35.28 79.76 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.776 0.322 . . . . 0.0 110.829 179.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . 0.422 HH11 ' HD2' ' A' ' 195' ' ' ARG . 9.2 tpp85 -67.73 -57.43 6.36 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.991 179.024 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 16.6 tpp180 -60.96 -50.8 71.91 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -178.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . 0.554 ' O ' HG23 ' A' ' 201' ' ' VAL . 97.1 t -70.1 -47.0 70.54 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -179.225 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -59.73 -48.06 87.9 Favored Glycine 0 CA--C 1.52 0.395 0 C-N-CA 121.359 -0.448 . . . . 0.0 113.229 -179.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . 0.507 ' HA ' ' HG2' ' A' ' 202' ' ' GLN . 98.2 m-20 -65.95 -36.38 83.2 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.828 0.347 . . . . 0.0 110.176 179.253 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -62.05 -37.69 94.86 Favored Glycine 0 CA--C 1.522 0.531 0 C-N-CA 120.708 -0.758 . . . . 0.0 111.97 178.48 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 201' ' ' VAL . . . . . 0.554 HG23 ' O ' ' A' ' 197' ' ' VAL . 93.4 t -67.09 -46.29 84.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 O-C-N 122.844 -0.21 . . . . 0.0 110.968 179.023 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 202' ' ' GLN . . . . . 0.507 ' HG2' ' HA ' ' A' ' 199' ' ' ASP . 8.0 pt20 -68.91 -31.68 70.76 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.443 179.593 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.35 -44.43 45.18 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 120.661 0.267 . . . . 0.0 111.152 179.012 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 27.1 m-80 -68.19 -44.89 74.87 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.844 0.354 . . . . 0.0 111.715 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 205' ' ' HIS . . . . . 0.444 ' HB2' ' CD2' ' A' ' 209' ' ' PHE . 10.2 m80 -100.65 32.82 2.96 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 120.897 0.379 . . . . 0.0 110.32 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -49.62 -51.4 37.87 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 -178.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 28.2 p -57.91 -53.43 58.29 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -179.08 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -61.93 -41.09 97.55 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.029 0.442 . . . . 0.0 110.871 179.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 209' ' ' PHE . . . . . 0.444 ' CD2' ' HB2' ' A' ' 205' ' ' HIS . 5.1 m-85 -64.04 -48.61 75.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.55 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -67.96 -33.58 74.93 Favored 'General case' 0 C--O 1.225 -0.189 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.853 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -57.69 -50.1 68.32 Favored Glycine 0 C--N 1.336 0.555 0 C-N-CA 120.52 -0.847 . . . . 0.0 111.217 178.265 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 212' ' ' MET . . . . . 0.715 ' SD ' ' HA ' ' B' ' 23' ' ' PHE . 41.6 mtm -67.84 -33.16 74.23 Favored 'General case' 0 C--O 1.224 -0.275 0 N-CA-C 110.355 -0.239 . . . . 0.0 110.355 178.474 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . 0.761 HD11 HD12 ' A' ' 216' ' ' LEU . 10.0 tp -67.97 -36.51 80.17 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.196 179.293 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 15.8 mtp180 -68.76 -34.39 75.5 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 178.441 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -86.76 -6.95 58.67 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.765 178.113 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . 0.761 HD12 HD11 ' A' ' 213' ' ' LEU . 5.9 mt -68.73 110.26 4.22 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.186 0.517 . . . . 0.0 111.916 -179.293 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -94.66 18.99 10.54 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.764 179.476 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 218' ' ' ILE . . . . . 0.651 HG13 HD22 ' A' ' 216' ' ' LEU . 34.2 mt -59.3 107.63 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 CA-C-O 121.431 0.634 . . . . 0.0 111.619 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . 0.422 ' HB2' ' HZ1' ' A' ' 219' ' ' LYS . 6.2 mtmp? -150.31 -28.68 0.23 Allowed 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 115.111 -0.949 . . . . 0.0 111.752 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -107.59 166.3 10.78 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 121.082 -0.247 . . . . 0.0 111.249 -179.393 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -54.5 -33.3 59.61 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -179.138 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -64.66 -27.76 72.38 Favored Glycine 0 CA--C 1.526 0.768 0 C-N-CA 120.989 -0.624 . . . . 0.0 113.507 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 223' ' ' ASP . . . . . 0.644 ' HB3' HG12 ' A' ' 218' ' ' ILE . 69.2 m-20 -66.94 -38.02 85.37 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 120.911 0.386 . . . . 0.0 111.5 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . 0.436 HG13 HG23 ' A' ' 274' ' ' THR . 1.1 t -63.46 -35.1 71.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-O 121.361 0.601 . . . . 0.0 110.349 179.26 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 36.0 mmtm -65.56 -30.98 71.79 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.585 178.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 226' ' ' SER . . . . . 0.673 ' O ' HG23 ' A' ' 230' ' ' VAL . 30.6 t -71.63 -37.0 70.94 Favored 'General case' 0 C--O 1.223 -0.304 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.65 178.16 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 227' ' ' PHE . . . . . 0.608 ' HE2' HD12 ' A' ' 275' ' ' ILE . 8.8 t80 -57.11 -43.78 82.62 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 178.419 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 228' ' ' SER . . . . . 0.679 ' HB3' HG22 ' A' ' 278' ' ' VAL . 0.6 OUTLIER -70.35 -32.36 70.03 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.914 177.276 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 54.5 ttp180 -64.09 -48.41 76.26 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.113 178.562 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 230' ' ' VAL . . . . . 0.718 HG12 ' HA ' ' B' ' 24' ' ' ALA . 13.6 t -61.12 -43.77 96.96 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 178.174 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 231' ' ' MET . . . . . 0.908 ' HG3' ' HG ' ' A' ' 248' ' ' LEU . 26.3 ttm -55.07 -50.24 69.64 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.245 178.238 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 72.2 t -64.63 -42.16 94.29 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 CA-C-O 120.847 0.356 . . . . 0.0 110.818 178.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 233' ' ' HIS . . . . . 0.42 ' ND1' ' HB1' ' B' ' 24' ' ' ALA . 52.7 t-80 -59.78 -39.51 85.15 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 116.278 -0.419 . . . . 0.0 112.06 179.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . 0.521 HG13 ' HA ' ' B' ' 28' ' ' ARG . 44.2 t -54.99 -43.94 71.62 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 179.7 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -90.95 25.7 2.34 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -179.316 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . 0.408 ' HA ' ' HD2' ' A' ' 236' ' ' LYS . 0.0 OUTLIER -58.11 -18.74 27.15 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 113.729 1.011 . . . . 0.0 113.729 -178.904 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -85.68 -16.17 39.98 Favored 'General case' 0 C--N 1.327 -0.384 0 O-C-N 122.093 -0.379 . . . . 0.0 111.4 179.737 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 100.28 -18.84 54.89 Favored Glycine 0 CA--C 1.522 0.522 0 C-N-CA 120.752 -0.737 . . . . 0.0 113.613 179.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 4.3 p -85.71 118.83 33.09 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-O 121.56 0.695 . . . . 0.0 111.237 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 240' ' ' THR . . . . . 0.446 HG22 ' HG2' ' A' ' 283' ' ' LYS . 53.8 m -89.95 98.26 11.67 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.807 -179.36 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -89.59 131.87 35.39 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.884 -0.326 . . . . 0.0 110.455 178.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 242' ' ' TRP . . . . . 0.465 ' CH2' ' HB2' ' A' ' 296' ' ' PHE . 17.2 m95 -55.74 -36.76 67.61 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 120.995 0.426 . . . . 0.0 110.75 179.165 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -61.56 -32.51 81.55 Favored Glycine 0 C--N 1.333 0.401 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.152 178.335 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 244' ' ' ARG . . . . . 0.492 ' HA ' ' HA3' ' B' ' 31' ' ' GLY . 99.1 mtt180 -72.01 -46.24 57.92 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 178.541 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . 0.61 HG23 HD23 ' A' ' 279' ' ' LEU . 52.2 mt -58.14 -49.25 82.24 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.154 179.022 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 8.7 p -69.05 -26.2 31.69 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-N 116.623 -0.262 . . . . 0.0 111.133 179.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 17.0 m -65.72 -37.28 85.99 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 177.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 248' ' ' LEU . . . . . 0.908 ' HG ' ' HG3' ' A' ' 231' ' ' MET . 2.6 mm? -66.62 -38.72 87.53 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 177.865 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 18.2 mm -67.63 -41.4 85.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 177.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 29.8 m -62.25 -41.62 98.6 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.79 178.603 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 251' ' ' PHE . . . . . 0.479 ' CD2' HD13 ' B' ' 27' ' ' LEU . 7.6 t80 -68.03 -40.35 82.93 Favored 'General case' 0 N--CA 1.456 -0.142 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 177.218 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -56.81 -42.26 91.65 Favored Glycine 0 C--N 1.337 0.586 0 N-CA-C 111.106 -0.798 . . . . 0.0 111.106 177.655 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -61.39 -44.45 97.13 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-O 120.937 0.399 . . . . 0.0 110.048 177.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 254' ' ' PHE . . . . . 0.547 ' HB3' HD13 ' A' ' 213' ' ' LEU . 0.2 OUTLIER -61.17 -41.0 96.0 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.271 178.475 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 255' ' ' VAL . . . . . 0.45 HG22 ' O ' ' A' ' 251' ' ' PHE . 91.5 t -62.32 -45.95 97.57 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.225 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 178.096 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 256' ' ' ALA . . . . . 0.456 ' HB2' ' HB2' ' A' ' 171' ' ' ALA . . . -58.82 -39.77 82.17 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 177.766 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 257' ' ' LYS . . . . . 0.497 ' HE3' ' HG3' ' A' ' 170' ' ' GLN . 74.5 mttt -62.89 -47.41 83.4 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.116 177.577 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 4.2 t60 -59.47 -40.97 88.66 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.428 179.081 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . 0.438 HD12 ' HB3' ' A' ' 267' ' ' PHE . 87.2 mt -68.73 -42.29 77.82 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.406 178.624 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 260' ' ' LYS . . . . . 0.524 ' HG2' ' O ' ' A' ' 171' ' ' ALA . 0.7 OUTLIER -64.98 -34.72 79.11 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 120.847 0.356 . . . . 0.0 110.596 178.667 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 32.0 t -63.06 -25.83 68.56 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.019 179.279 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 262' ' ' VAL . . . . . 0.435 HG21 ' HB2' ' A' ' 264' ' ' GLN . 27.2 m -111.62 13.87 8.49 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.19 178.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 1.6 t30 57.06 50.96 11.11 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.451 179.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 264' ' ' GLN . . . . . 0.467 ' NE2' ' HB2' ' A' ' 267' ' ' PHE . 0.0 OUTLIER -119.03 39.2 3.6 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -179.87 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 265' ' ' GLU . . . . . 0.451 ' HA ' HD13 ' A' ' 268' ' ' ILE . 0.0 OUTLIER -49.63 -27.41 4.59 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 178.933 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.21 -20.67 43.46 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.251 178.641 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 267' ' ' PHE . . . . . 0.467 ' HB2' ' NE2' ' A' ' 264' ' ' GLN . 2.2 t80 -97.67 -20.9 17.33 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.883 178.709 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 268' ' ' ILE . . . . . 0.451 HD13 ' HA ' ' A' ' 265' ' ' GLU . 76.1 mt -65.39 -43.15 94.82 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-O 120.741 0.305 . . . . 0.0 110.373 179.252 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 269' ' ' GLU . . . . . 0.435 ' HB2' ' HD3' ' A' ' 270' ' ' PRO . 0.3 OUTLIER -54.98 -56.98 21.88 Favored Pre-proline 0 CA--C 1.543 0.711 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.794 179.177 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 270' ' ' PRO . . . . . 0.447 ' HD2' ' C ' ' A' ' 267' ' ' PHE . 38.8 Cg_exo -62.89 -32.66 76.9 Favored 'Trans proline' 0 C--N 1.358 1.043 0 C-N-CA 122.055 1.837 . . . . 0.0 112.37 178.43 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 271' ' ' LEU . . . . . 0.556 ' O ' HG22 ' A' ' 275' ' ' ILE . 2.1 tm? -63.79 -50.62 68.26 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.621 179.445 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -60.33 -42.39 95.54 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.734 179.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 273' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -67.2 -43.87 81.04 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 120.945 0.402 . . . . 0.0 110.988 178.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 274' ' ' THR . . . . . 0.436 HG23 HG13 ' A' ' 224' ' ' VAL . 60.6 m -62.22 -52.68 62.8 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.682 -179.497 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 275' ' ' ILE . . . . . 0.608 HD12 ' HE2' ' A' ' 227' ' ' PHE . 6.3 tt -58.28 -47.69 86.89 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 C-N-CA 121.018 -0.273 . . . . 0.0 111.228 179.741 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 276' ' ' THR . . . . . 0.481 HG21 HD11 ' A' ' 163' ' ' ILE . 50.7 m -59.84 -53.73 54.48 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -179.679 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 277' ' ' ASP . . . . . 0.446 ' OD1' ' HD3' ' A' ' 281' ' ' ARG . 33.5 t70 -59.72 -51.16 70.97 Favored 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 120.637 -0.425 . . . . 0.0 111.092 -179.645 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 278' ' ' VAL . . . . . 0.679 HG22 ' HB3' ' A' ' 228' ' ' SER . 73.8 t -58.27 -47.65 86.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 120.747 -0.381 . . . . 0.0 111.02 179.715 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 279' ' ' LEU . . . . . 0.61 HD23 HG23 ' A' ' 245' ' ' ILE . 45.3 tp -60.58 -47.64 85.29 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 111.676 0.25 . . . . 0.0 111.676 179.782 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 55.6 t -66.86 -39.74 84.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 CA-C-O 120.75 0.31 . . . . 0.0 111.008 179.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 281' ' ' ARG . . . . . 0.446 ' HD3' ' OD1' ' A' ' 277' ' ' ASP . 0.0 OUTLIER -68.17 -47.09 68.93 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -179.883 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 282' ' ' THR . . . . . 0.78 HG22 ' HD2' ' A' ' 283' ' ' LYS . 4.7 t -63.37 -44.16 95.56 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 120.435 -0.506 . . . . 0.0 112.216 -179.676 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . 0.78 ' HD2' HG22 ' A' ' 282' ' ' THR . 0.0 OUTLIER -99.46 40.27 1.23 Allowed 'General case' 0 C--N 1.327 -0.392 0 O-C-N 121.987 -0.445 . . . . 0.0 111.463 179.77 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 284' ' ' ARG . . . . . 0.489 HH12 ' HB ' ' A' ' 288' ' ' VAL . 39.6 tpt85 -58.49 -51.12 71.19 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.941 -179.495 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 285' ' ' ASP . . . . . 0.421 ' CG ' ' HZ2' ' A' ' 289' ' ' LYS . 34.4 t70 -66.96 -43.59 82.73 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 120.994 0.426 . . . . 0.0 111.462 179.679 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 286' ' ' TRP . . . . . 0.437 ' O ' ' HB2' ' A' ' 290' ' ' GLN . 3.5 t90 -64.58 -41.37 96.31 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.933 -179.711 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 287' ' ' LEU . . . . . 0.563 HD22 ' HB3' ' A' ' 283' ' ' LYS . 2.0 mm? -69.0 -47.65 64.98 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 112.319 0.488 . . . . 0.0 112.319 -179.751 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 288' ' ' VAL . . . . . 0.489 ' HB ' HH12 ' A' ' 284' ' ' ARG . 7.3 p -60.73 -37.62 76.51 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 CA-C-O 120.634 0.254 . . . . 0.0 111.641 -179.769 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 289' ' ' LYS . . . . . 0.421 ' HZ2' ' CG ' ' A' ' 285' ' ' ASP . 79.6 mttt -75.3 -21.74 58.23 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 120.891 0.377 . . . . 0.0 111.35 178.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 290' ' ' GLN . . . . . 0.437 ' HB2' ' O ' ' A' ' 286' ' ' TRP . 0.0 OUTLIER -96.34 12.77 30.0 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 111.984 0.365 . . . . 0.0 111.984 179.969 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 291' ' ' ARG . . . . . 0.547 ' HB3' ' HB2' ' A' ' 294' ' ' ASP . 0.0 OUTLIER 62.19 19.09 10.66 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.089 0.471 . . . . 0.0 111.772 179.939 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 64.45 -122.48 25.15 Favored Glycine 0 CA--C 1.522 0.475 0 CA-C-N 115.906 -0.588 . . . . 0.0 113.964 179.207 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 293' ' ' TRP . . . . . 0.503 ' O ' HG21 ' A' ' 297' ' ' VAL . 89.4 m95 -66.57 -33.71 76.27 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.545 -0.328 . . . . 0.0 111.637 -178.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 294' ' ' ASP . . . . . 0.547 ' HB2' ' HB3' ' A' ' 291' ' ' ARG . 45.0 m-20 -54.86 -40.25 69.47 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.017 0.437 . . . . 0.0 110.251 178.354 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -72.18 -44.51 43.82 Favored Glycine 0 C--N 1.334 0.455 0 C-N-CA 120.761 -0.733 . . . . 0.0 111.727 178.394 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 296' ' ' PHE . . . . . 0.465 ' HB2' ' CH2' ' A' ' 242' ' ' TRP . 7.2 t80 -58.92 -45.06 91.29 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 120.852 0.358 . . . . 0.0 111.114 178.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 297' ' ' VAL . . . . . 0.69 HG12 ' HB3' ' A' ' 189' ' ' ARG . 81.0 t -67.57 -39.51 82.49 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.942 -179.529 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -76.15 -26.95 56.8 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 112.578 0.584 . . . . 0.0 112.578 -179.379 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 299' ' ' PHE . . . . . . . . . . . . . 87.4 t80 -60.9 -41.32 95.83 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.807 0.337 . . . . 0.0 111.372 179.446 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 300' ' ' PHE . . . . . 0.446 ' HE2' ' CD1' ' A' ' 296' ' ' PHE . 68.4 m-85 . . . . . 0 CA--C 1.535 0.372 0 CA-C-O 120.706 0.289 . . . . 0.0 111.628 -179.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 22' ' ' GLU . . . . . 0.403 ' HB2' ' NE2' ' B' ' 26' ' ' GLN . 0.5 OUTLIER . . . . . 0 CA--C 1.531 0.244 0 CA-C-O 121.001 0.429 . . . . 0.0 110.265 . . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 23' ' ' PHE . . . . . 0.715 ' HA ' ' SD ' ' A' ' 212' ' ' MET . 11.1 p90 -60.5 -35.7 76.57 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.498 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 24' ' ' ALA . . . . . 0.718 ' HA ' HG12 ' A' ' 230' ' ' VAL . . . -61.25 -47.79 84.42 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.007 0.432 . . . . 0.0 110.531 179.587 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . 0.436 ' O ' ' HG2' ' B' ' 29' ' ' LYS . . . -70.61 -44.78 66.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.599 179.163 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 26' ' ' GLN . . . . . 0.73 ' O ' HG12 ' B' ' 30' ' ' ILE . 1.7 mp0 -57.74 -56.97 15.11 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.261 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . 0.479 HD13 ' CD2' ' A' ' 251' ' ' PHE . 50.4 mt -56.31 -42.53 77.74 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 120.589 0.233 . . . . 0.0 111.274 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 28' ' ' ARG . . . . . 0.521 ' HA ' HG13 ' A' ' 234' ' ' VAL . 10.7 ttt85 -57.45 -48.01 80.31 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.523 178.471 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . 0.436 ' HG2' ' O ' ' B' ' 25' ' ' ALA . 20.1 mmmt -68.28 -39.1 82.25 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.872 179.329 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . 0.73 HG12 ' O ' ' B' ' 26' ' ' GLN . 48.8 mm -55.25 -49.95 68.42 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 177.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . 0.492 ' HA3' ' HA ' ' A' ' 244' ' ' ARG . . . -58.84 -44.96 95.64 Favored Glycine 0 N--CA 1.448 -0.559 0 CA-C-N 115.228 -0.897 . . . . 0.0 112.306 179.082 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -57.78 -44.99 86.61 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-O 120.662 0.268 . . . . 0.0 110.955 179.154 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 29.8 tttp -69.73 -52.29 26.74 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 121.017 -0.273 . . . . 0.0 111.171 179.621 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 74.2 t -52.94 -49.3 49.32 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-O 121.075 0.464 . . . . 0.0 110.761 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -57.33 -48.59 78.59 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.698 178.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 36' ' ' CYS . . . . . . . . . . . . . 36.7 t -65.5 -35.04 79.71 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.501 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 44.7 m -65.21 -37.3 86.85 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.965 -0.562 . . . . 0.0 111.615 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 38' ' ' TRP . . . . . . . . . . . . . 87.7 m95 -85.52 -35.44 21.13 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.243 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 40.9 t . . . . . 0 N--CA 1.462 0.166 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 177.916 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.303 0 CA-C-O 119.999 -0.334 . . . . 1.84 112.54 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -70.38 119.86 6.68 Favored 'Trans proline' 0 CA--C 1.532 0.419 0 C-N-CA 122.523 2.149 . . . . 1.84 112.858 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 83.6 mt -123.63 -38.42 2.53 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.171 -0.468 . . . . 2.72 111.014 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -116.64 -70.6 0.44 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.846 -0.692 . . . . 1.25 112.38 179.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 57.7 p -149.53 -70.92 0.19 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.954 0.407 . . . . 0.99 111.432 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.524 ' OE1' ' HD3' ' A' ' 284' ' ' ARG . 18.1 mp0 -121.06 42.64 3.0 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.084 0.469 . . . . 0.8 110.706 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -59.98 -42.14 93.52 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.914 -0.585 . . . . 1.37 111.987 -179.402 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -57.95 -41.49 82.93 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.291 -0.413 . . . . 1.16 111.872 179.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 44.5 tp -57.29 -43.26 83.0 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.585 -0.279 . . . . 0.77 111.722 -179.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -66.5 -48.91 68.31 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 112.075 0.398 . . . . 0.46 112.075 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.573 ' HD3' ' OE2' ' A' ' 182' ' ' GLU . 6.6 mtp180 -59.3 -52.08 67.19 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 112.409 0.522 . . . . 1.01 112.409 -179.274 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 35.9 mm-40 -57.46 -45.68 84.5 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.129 0.49 . . . . 0.53 110.719 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 20.3 m -64.18 -48.51 75.68 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.69 -0.686 . . . . 0.34 111.383 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.609 ' HA ' HG22 ' A' ' 276' ' ' THR . 17.3 tp -58.12 -48.59 79.74 Favored 'General case' 0 C--O 1.225 -0.235 0 CA-C-N 116.326 -0.397 . . . . 1.15 111.498 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . 0.656 ' HB3' HD11 ' A' ' 180' ' ' LEU . 2.0 mt-10 -55.96 -50.47 70.69 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 111.781 0.289 . . . . 1.08 111.781 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . 0.512 HG12 ' HA2' ' A' ' 187' ' ' GLY . 57.1 mt -62.56 -50.1 81.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 CA-C-N 116.331 -0.395 . . . . 1.07 111.918 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.508 HD11 HG23 ' A' ' 276' ' ' THR . 77.4 mt -62.86 -47.33 93.33 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 C-N-CA 121.297 -0.161 . . . . 1.12 111.214 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 19.4 m -58.2 -42.01 85.23 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.101 0.477 . . . . 0.37 109.989 178.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . 0.567 ' HG3' ' CD1' ' A' ' 180' ' ' LEU . 1.1 mmp_? -66.75 -48.77 68.09 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.119 -0.491 . . . . 0.48 111.308 178.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' TYR . . . . . 0.824 ' CE1' ' HA ' ' A' ' 195' ' ' ARG . 66.0 t80 -60.39 -51.99 67.15 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 112.9 0.704 . . . . 0.44 112.9 -179.206 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 10.9 mp -62.4 -45.07 94.79 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 120.961 -0.296 . . . . 1.14 111.782 -178.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 1.4 mmt85 -65.06 -40.38 94.63 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 120.551 0.215 . . . . 0.72 111.263 179.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . 0.534 ' HB2' ' O ' ' A' ' 165' ' ' ARG . 0.6 OUTLIER -60.35 -53.99 50.98 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 120.999 0.428 . . . . 0.4 111.499 179.544 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . 0.454 ' HB3' ' CE ' ' A' ' 257' ' ' LYS . 9.0 mm-40 -61.82 -32.44 72.75 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.708 -0.678 . . . . 0.76 112.348 -179.377 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . 0.561 ' O ' ' HG2' ' A' ' 260' ' ' LYS . . . -62.87 -23.46 67.33 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 112.165 0.431 . . . . 1.04 112.165 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 18.6 p -72.28 -24.27 61.32 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 112.019 0.377 . . . . 0.76 112.019 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 92.08 -7.16 78.88 Favored Glycine 0 CA--C 1.523 0.559 0 C-N-CA 120.781 -0.723 . . . . 0.88 112.831 -179.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 12.3 t -112.01 158.49 19.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.04 0.448 . . . . 1.15 111.606 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 2.0 ttpm? -84.84 60.64 6.31 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.218 0.532 . . . . 1.53 111.372 -179.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 40.9 t0 -91.42 169.6 10.65 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.772 -0.649 . . . . 0.71 110.302 179.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 1.9 t -159.42 95.08 1.21 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.419 -0.355 . . . . 0.58 110.429 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . 0.438 ' HB2' ' NE ' ' A' ' 165' ' ' ARG . 51.9 mttp -82.76 149.76 60.87 Favored Pre-proline 0 CA--C 1.534 0.33 0 CA-C-O 120.969 0.414 . . . . 0.71 111.702 -178.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.57 156.2 61.73 Favored 'Trans proline' 0 CA--C 1.533 0.429 0 C-N-CA 122.481 2.121 . . . . 1.04 113.416 -179.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.656 HD11 ' HB3' ' A' ' 161' ' ' GLU . 3.7 mm? -92.64 158.48 15.93 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.483 -0.781 . . . . 1.14 110.344 179.39 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -93.67 -28.9 10.54 Favored Glycine 0 CA--C 1.519 0.315 0 C-N-CA 120.729 -0.748 . . . . 0.61 112.205 179.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . 0.573 ' OE2' ' HD3' ' A' ' 157' ' ' ARG . 14.9 tt0 -124.06 -42.18 2.17 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.137 0.494 . . . . 0.69 110.704 179.329 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . 0.57 ' O ' ' HA3' ' A' ' 187' ' ' GLY . . . -77.25 72.15 3.78 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 121.175 0.512 . . . . 0.9 112.069 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -73.79 -69.48 1.39 Allowed Glycine 0 CA--C 1.523 0.539 0 C-N-CA 120.707 -0.758 . . . . 0.38 112.718 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -68.31 -54.94 14.05 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.654 0.264 . . . . 0.49 111.355 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -66.84 -40.92 88.12 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.382 -0.372 . . . . 1.07 111.247 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . 0.57 ' HA3' ' O ' ' A' ' 183' ' ' ALA . . . -60.39 -47.01 93.24 Favored Glycine 0 C--O 1.222 -0.601 0 C-N-CA 121.0 -0.619 . . . . 0.34 113.848 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 20.2 mtp180 -69.19 -40.79 77.85 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 117.634 0.717 . . . . 1.5 112.012 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 32.6 ttt180 -66.57 -46.1 77.16 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-O 121.364 0.602 . . . . 0.46 110.359 179.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . 0.436 ' HB1' HD13 ' A' ' 162' ' ' ILE . . . -74.88 -40.2 61.09 Favored 'General case' 0 C--O 1.221 -0.442 0 CA-C-N 115.621 -0.718 . . . . 0.74 112.598 -179.111 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 29.4 tp -63.76 -41.02 98.06 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 118.517 0.599 . . . . 1.05 111.021 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -64.81 -42.96 94.59 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 121.168 0.508 . . . . 0.42 110.508 179.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' THR . . . . . 0.477 HG22 ' HA ' ' A' ' 297' ' ' VAL . 43.4 m -71.7 -45.71 61.01 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.0 -0.546 . . . . 0.46 111.491 179.618 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 24.3 tp -60.37 -31.98 70.86 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.292 -0.413 . . . . 1.06 111.292 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . 0.824 ' HA ' ' CE1' ' A' ' 166' ' ' TYR . 6.3 ttm105 -70.74 -51.2 28.85 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.59 -0.522 . . . . 0.49 109.59 178.588 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.67 -46.18 91.34 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.507 -0.77 . . . . 0.63 111.624 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . 0.405 ' O ' HG21 ' A' ' 201' ' ' VAL . 94.2 t -72.71 -48.02 47.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.516 -0.311 . . . . 0.98 111.536 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -56.43 -40.82 87.09 Favored Glycine 0 C--N 1.335 0.522 0 CA-C-N 116.335 -0.393 . . . . 0.27 112.818 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -68.32 -47.69 66.89 Favored 'General case' 0 CA--C 1.527 0.076 0 N-CA-C 110.319 -0.252 . . . . 0.39 110.319 178.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -57.75 -42.62 94.52 Favored Glycine 0 CA--C 1.524 0.633 0 C-N-CA 120.942 -0.647 . . . . 0.28 113.006 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . 0.695 HG13 HG21 ' B' ' 34' ' ' VAL . 74.8 t -65.36 -52.0 57.34 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 N-CA-C 112.2 0.444 . . . . 0.46 112.2 179.635 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' GLN . . . . . 0.463 ' HB3' ' HB2' ' A' ' 250' ' ' SER . 10.0 pt20 -71.17 -33.13 69.71 Favored 'General case' 0 C--O 1.222 -0.369 0 N-CA-C 113.043 0.757 . . . . 0.48 113.043 -178.163 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -71.6 -37.53 70.94 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 118.377 0.535 . . . . 0.7 110.9 179.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 9.3 m-80 -66.82 -51.09 59.78 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.893 0.378 . . . . 0.67 110.827 178.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' HIS . . . . . 0.46 ' O ' ' HD2' ' A' ' 209' ' ' PHE . 50.0 m-70 -96.59 32.75 1.96 Allowed 'General case' 0 CA--C 1.537 0.446 0 O-C-N 122.331 -0.231 . . . . 0.6 110.82 179.083 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -55.75 -43.12 76.35 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 112.894 0.701 . . . . 0.48 112.894 -178.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 32.7 p -60.25 -42.2 94.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.131 0.491 . . . . 1.14 111.265 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -68.45 -42.44 78.79 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.863 -0.608 . . . . 1.1 110.253 178.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' PHE . . . . . 0.46 ' HD2' ' O ' ' A' ' 205' ' ' HIS . 18.1 m-85 -62.44 -49.08 76.85 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.034 -0.53 . . . . 1.34 110.424 179.256 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 65.0 mt-30 -61.78 -39.86 93.15 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.178 -0.465 . . . . 0.78 110.907 179.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -58.0 -46.39 92.61 Favored Glycine 0 C--N 1.335 0.503 0 N-CA-C 111.009 -0.837 . . . . 0.34 111.009 178.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' MET . . . . . 0.567 ' SD ' ' HA ' ' B' ' 23' ' ' PHE . 76.2 mtm -70.91 -35.69 72.38 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 120.759 0.314 . . . . 1.12 110.695 178.372 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 16.2 tp -60.85 -40.49 93.06 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.043 0.449 . . . . 1.16 110.754 179.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 79.4 mtp180 -77.34 -27.14 52.67 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.115 -0.493 . . . . 0.84 110.557 178.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 7.6 mmtp -75.94 -31.86 59.29 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.86 -0.609 . . . . 1.12 110.837 178.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 26.7 mt -69.08 137.21 53.33 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.047 -0.524 . . . . 1.13 112.397 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -101.78 19.88 17.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.968 -0.56 . . . . 0.49 110.392 178.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' ILE . . . . . 0.521 HG12 ' HB3' ' A' ' 223' ' ' ASP . 16.7 mt -62.73 118.88 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 N-CA-C 113.155 0.798 . . . . 1.06 113.155 -178.348 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . 0.57 ' HG2' HE22 ' A' ' 264' ' ' GLN . 3.3 ttpp -150.41 -16.76 0.24 Allowed 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 115.369 -0.832 . . . . 0.62 112.761 179.132 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -128.85 -178.9 4.8 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 112.872 0.693 . . . . 0.53 112.872 -178.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . 0.48 ' O ' HG23 ' A' ' 224' ' ' VAL . 0.8 OUTLIER -69.13 -22.43 63.96 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.643 -0.708 . . . . 0.5 111.772 -179.702 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -70.6 -26.29 74.33 Favored Glycine 0 CA--C 1.524 0.647 0 C-N-CA 120.834 -0.698 . . . . 0.34 113.313 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' ASP . . . . . 0.521 ' HB3' HG12 ' A' ' 218' ' ' ILE . 59.9 m-20 -65.17 -29.38 70.21 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 113.074 0.768 . . . . 0.39 113.074 -179.107 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . 0.551 ' HB ' HG22 ' A' ' 274' ' ' THR . 6.4 m -53.78 -27.9 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 N-CA-C 112.895 0.702 . . . . 0.86 112.895 -179.313 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . 0.417 ' O ' ' HD3' ' A' ' 229' ' ' ARG . 33.5 mtmm -60.16 -44.15 95.24 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.297 0.57 . . . . 1.06 110.334 178.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' SER . . . . . 0.43 ' HB3' HD12 ' B' ' 19' ' ' LEU . 17.6 m -72.3 -39.67 68.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.806 -0.633 . . . . 0.61 110.861 179.442 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' PHE . . . . . 0.459 ' CE1' HG12 ' A' ' 275' ' ' ILE . 17.1 t80 -60.9 -48.21 82.87 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.212 -0.449 . . . . 0.71 110.785 179.708 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' SER . . . . . 0.664 ' HB2' HG13 ' A' ' 278' ' ' VAL . 13.7 p -62.73 -39.15 93.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.205 -0.452 . . . . 0.64 110.267 178.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' ARG . . . . . 0.417 ' HD3' ' O ' ' A' ' 225' ' ' LYS . 4.1 mpt_? -64.85 -46.07 83.45 Favored 'General case' 0 C--O 1.227 -0.123 0 CA-C-N 116.103 -0.499 . . . . 0.75 110.541 178.688 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . 0.446 HG12 ' HA ' ' B' ' 24' ' ' ALA . 43.0 t -59.2 -44.88 92.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 CA-C-O 120.944 0.402 . . . . 0.91 110.321 178.168 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' MET . . . . . 0.581 ' HG2' HD23 ' A' ' 248' ' ' LEU . 30.4 mtm -57.54 -52.39 65.6 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.155 -0.475 . . . . 1.0 111.621 179.362 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' VAL . . . . . 0.506 HG11 HG21 ' A' ' 282' ' ' THR . 21.9 m -67.82 -31.84 53.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 C-N-CA 120.9 -0.32 . . . . 1.1 111.091 179.444 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 5.6 t-80 -59.82 -32.07 70.31 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.366 -0.379 . . . . 0.68 111.347 179.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . 0.517 HG13 ' HA ' ' B' ' 28' ' ' ARG . 78.8 t -58.61 -30.21 41.09 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 CA-C-O 120.79 0.328 . . . . 1.06 111.606 179.105 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' PHE . . . . . 0.472 ' CD1' ' HA ' ' A' ' 240' ' ' THR . 67.9 m-85 -102.58 23.7 11.56 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 111.882 0.327 . . . . 0.71 111.882 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 7.6 tptp -62.81 -24.8 67.94 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 113.062 0.764 . . . . 1.45 113.062 -178.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -81.73 -9.63 59.59 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.863 0.363 . . . . 0.51 111.527 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 93.23 2.55 65.95 Favored Glycine 0 CA--C 1.522 0.518 0 C-N-CA 120.822 -0.704 . . . . 0.58 113.388 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 11.9 t -96.77 95.51 4.74 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-O 120.994 0.426 . . . . 0.97 111.379 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' THR . . . . . 0.472 ' HA ' ' CD1' ' A' ' 235' ' ' PHE . 0.6 OUTLIER -82.8 70.52 9.8 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.827 0.677 . . . . 1.48 112.827 -179.781 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . 0.415 ' HB2' ' HD2' ' A' ' 244' ' ' ARG . 20.6 m-20 -83.89 140.0 32.26 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.916 0.388 . . . . 0.43 111.641 179.448 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 242' ' ' TRP . . . . . . . . . . . . . 54.1 m95 -51.09 -43.46 61.07 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.951 -0.568 . . . . 0.47 112.432 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -54.33 -35.2 55.19 Favored Glycine 0 C--N 1.339 0.708 0 C-N-CA 121.407 -0.425 . . . . 0.27 112.931 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 244' ' ' ARG . . . . . 0.415 ' HD2' ' HB2' ' A' ' 241' ' ' ASN . 24.4 mtt180 -73.99 -43.06 59.35 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.126 0.489 . . . . 0.41 109.769 178.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 48.2 mt -60.32 -50.22 81.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-N 115.709 -0.678 . . . . 0.77 111.101 179.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 31.4 m -65.86 -34.32 69.52 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 C-N-CA 121.03 -0.268 . . . . 0.9 111.497 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 40.3 m -58.06 -40.65 81.53 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.076 0.465 . . . . 1.06 110.015 178.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' LEU . . . . . 0.581 HD23 ' HG2' ' A' ' 231' ' ' MET . 80.7 mt -66.12 -32.31 73.69 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.023 -0.535 . . . . 1.07 111.102 178.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 19.3 mt -74.5 -42.62 49.22 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 CA-C-N 116.216 -0.447 . . . . 1.14 109.818 178.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 250' ' ' SER . . . . . 0.463 ' HB2' ' HB3' ' A' ' 202' ' ' GLN . 51.3 p -64.89 -30.4 71.4 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 109.502 -0.555 . . . . 0.79 109.502 177.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 251' ' ' PHE . . . . . . . . . . . . . 18.6 t80 -70.52 -43.97 68.53 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 108.584 -0.895 . . . . 0.69 108.584 177.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -59.18 -47.0 92.94 Favored Glycine 0 C--N 1.336 0.531 0 N-CA-C 110.767 -0.933 . . . . 0.29 110.767 177.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 253' ' ' ALA . . . . . 0.439 ' O ' ' HG3' ' A' ' 257' ' ' LYS . . . -59.5 -39.72 84.71 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 120.655 0.264 . . . . 0.56 110.691 177.369 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -61.94 -41.78 98.35 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 121.052 0.453 . . . . 0.82 110.55 178.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 59.5 t -72.04 -37.72 61.33 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-N 116.184 -0.462 . . . . 1.08 110.025 178.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -56.69 -42.88 79.87 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.028 0.442 . . . . 0.97 109.907 177.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 257' ' ' LYS . . . . . 0.454 ' CE ' ' HB3' ' A' ' 170' ' ' GLN . 93.0 mttt -64.7 -42.94 94.93 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 115.846 -0.616 . . . . 1.19 110.117 177.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 40.3 t60 -59.19 -42.79 91.72 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.292 -0.413 . . . . 0.8 110.66 178.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 95.7 mt -69.86 -42.62 73.3 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 116.392 -0.367 . . . . 1.15 111.149 179.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 260' ' ' LYS . . . . . 0.561 ' HG2' ' O ' ' A' ' 171' ' ' ALA . 2.1 tptp -64.94 -35.95 82.81 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.705 0.288 . . . . 0.78 111.311 179.239 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 63.0 m -59.69 -28.96 67.75 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.262 -0.427 . . . . 0.6 111.301 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 24.2 m -107.32 16.27 7.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-N 116.382 -0.372 . . . . 1.22 111.071 178.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 55.61 52.47 11.0 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 112.769 0.655 . . . . 1.17 112.769 179.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 264' ' ' GLN . . . . . 0.57 HE22 ' HG2' ' A' ' 219' ' ' LYS . 7.3 mt-30 -117.98 37.74 3.88 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 120.769 0.318 . . . . 0.67 111.462 179.413 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . 0.511 ' HA ' HD12 ' A' ' 268' ' ' ILE . 1.2 mp0 -48.06 -31.75 5.87 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 112.716 0.636 . . . . 0.59 112.716 179.39 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -55.57 -22.42 21.84 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 122.847 0.459 . . . . 1.53 111.974 179.276 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -100.43 -17.89 16.97 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 120.79 0.328 . . . . 0.65 110.986 178.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 268' ' ' ILE . . . . . 0.511 HD12 ' HA ' ' A' ' 265' ' ' GLU . 66.5 mt -67.77 -45.71 83.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-N 116.416 -0.356 . . . . 1.05 111.107 179.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 269' ' ' GLU . . . . . 0.664 ' HB2' ' HD3' ' A' ' 270' ' ' PRO . 0.5 OUTLIER -55.74 -56.58 28.41 Favored Pre-proline 0 CA--C 1.545 0.774 0 CA-C-N 116.296 -0.411 . . . . 0.37 111.21 179.332 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 270' ' ' PRO . . . . . 0.664 ' HD3' ' HB2' ' A' ' 269' ' ' GLU . 31.2 Cg_exo -61.33 -32.19 89.45 Favored 'Trans proline' 0 C--N 1.361 1.213 0 C-N-CA 122.23 1.953 . . . . 0.32 112.101 178.428 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 271' ' ' LEU . . . . . 0.422 ' O ' HG13 ' A' ' 275' ' ' ILE . 46.8 tp -66.62 -54.76 19.88 Favored 'General case' 0 C--O 1.226 -0.135 0 CA-C-N 116.406 -0.361 . . . . 1.17 110.14 178.682 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -56.98 -37.82 72.16 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 120.852 0.358 . . . . 0.4 110.628 178.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 273' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -64.26 -51.48 63.39 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.028 -0.533 . . . . 0.49 110.134 178.04 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 274' ' ' THR . . . . . 0.551 HG22 ' HB ' ' A' ' 224' ' ' VAL . 31.1 m -59.82 -42.67 94.04 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.292 -0.413 . . . . 0.99 110.595 179.173 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 275' ' ' ILE . . . . . 0.464 ' HA ' ' HE1' ' A' ' 231' ' ' MET . 96.5 mt -57.98 -54.3 33.89 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.105 0 CA-C-N 116.165 -0.471 . . . . 1.02 110.603 179.15 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 276' ' ' THR . . . . . 0.609 HG22 ' HA ' ' A' ' 160' ' ' LEU . 32.5 m -60.71 -49.88 75.71 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.253 -0.43 . . . . 1.12 111.441 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 277' ' ' ASP . . . . . 0.585 ' O ' ' HB2' ' A' ' 281' ' ' ARG . 17.0 t0 -56.28 -61.04 2.67 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.946 -0.57 . . . . 0.4 112.104 -179.425 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 278' ' ' VAL . . . . . 0.664 HG13 ' HB2' ' A' ' 228' ' ' SER . 66.4 t -61.25 -46.24 97.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 112.304 0.483 . . . . 1.07 112.304 -178.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . 0.486 HD11 ' HZ3' ' A' ' 283' ' ' LYS . 14.0 tp -54.7 -47.58 73.52 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 111.635 0.235 . . . . 0.97 111.635 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 84.0 t -77.38 -41.05 29.66 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 N-CA-C 111.803 0.297 . . . . 0.95 111.803 -179.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 281' ' ' ARG . . . . . 0.585 ' HB2' ' O ' ' A' ' 277' ' ' ASP . 2.5 ttt180 -53.7 -42.73 68.31 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 112.616 0.598 . . . . 1.03 112.616 -179.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 282' ' ' THR . . . . . 0.506 HG21 HG11 ' A' ' 232' ' ' VAL . 15.2 t -84.41 0.39 49.64 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 112.843 0.683 . . . . 1.05 112.843 -179.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . 0.488 ' HG3' HG22 ' A' ' 282' ' ' THR . 34.6 mtmm -141.02 40.76 1.8 Allowed 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 120.877 0.37 . . . . 0.71 111.546 -179.586 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 284' ' ' ARG . . . . . 0.524 ' HD3' ' OE1' ' A' ' 152' ' ' GLU . 13.2 ttm180 -63.21 -60.65 3.13 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 112.714 0.635 . . . . 0.77 112.714 -178.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 285' ' ' ASP . . . . . 0.416 ' HA ' HG12 ' A' ' 288' ' ' VAL . 35.8 t70 -58.71 -45.48 89.47 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.366 -0.379 . . . . 0.51 111.895 -179.471 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 286' ' ' TRP . . . . . . . . . . . . . 4.1 t90 -59.62 -44.95 93.27 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 120.571 0.224 . . . . 0.57 111.25 -179.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -68.84 -44.52 73.25 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 112.072 0.397 . . . . 1.0 112.072 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 288' ' ' VAL . . . . . 0.416 HG12 ' HA ' ' A' ' 285' ' ' ASP . 6.2 p -66.2 -34.5 70.63 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 O-C-N 122.207 -0.308 . . . . 0.91 111.645 -179.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 31.9 mttp -76.31 -26.87 56.26 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-O 120.766 0.317 . . . . 1.05 111.398 179.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 1.7 tp-100 -91.04 24.95 2.61 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 112.563 0.579 . . . . 0.97 112.563 -179.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 53.6 mtp180 62.99 12.65 6.05 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 112.505 0.557 . . . . 0.53 112.505 179.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 64.64 -131.86 37.67 Favored Glycine 0 CA--C 1.522 0.487 0 C-N-CA 121.235 -0.507 . . . . 0.38 113.241 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 293' ' ' TRP . . . . . 0.428 ' HB3' ' HB2' ' A' ' 190' ' ' ALA . 86.3 m95 -67.67 -21.21 65.36 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 111.903 0.334 . . . . 0.59 111.903 -179.695 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 294' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -62.85 -48.54 78.62 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 121.175 0.512 . . . . 0.47 110.098 177.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -69.78 -33.62 71.2 Favored Glycine 0 C--N 1.332 0.329 0 C-N-CA 120.657 -0.783 . . . . 0.32 111.614 178.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 296' ' ' PHE . . . . . 0.417 ' HB3' ' HA ' ' A' ' 293' ' ' TRP . 1.6 t80 -60.52 -50.94 71.53 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.674 -0.263 . . . . 0.36 111.615 179.108 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 297' ' ' VAL . . . . . 0.477 ' HA ' HG22 ' A' ' 193' ' ' THR . 28.8 m -63.94 -43.25 97.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 N-CA-C 111.836 0.31 . . . . 0.72 111.836 -178.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -58.64 -41.67 86.53 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 112.197 0.443 . . . . 0.64 112.197 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 299' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -58.69 -45.46 89.43 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 120.907 0.385 . . . . 0.56 111.875 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 300' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -83.98 3.2 35.33 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 112.556 0.576 . . . . 0.48 112.556 -179.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 301' ' ' HIS . . . . . 0.559 ' HB3' ' HG2' ' A' ' 306' ' ' GLU . 27.8 m170 -109.71 11.38 24.55 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.514 0.197 . . . . 0.59 111.154 179.596 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . 0.603 ' HA ' ' HA3' ' A' ' 307' ' ' GLY . 31.4 m -75.22 -10.78 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 N-CA-C 112.027 0.38 . . . . 1.62 112.027 -179.43 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 -61.9 -63.12 1.36 Allowed 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.377 -0.374 . . . . 1.85 110.554 179.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -170.83 61.47 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.477 0.656 . . . . 2.0 110.88 178.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 61.2 mt -141.53 -57.85 0.48 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.524 -0.762 . . . . 2.36 110.615 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 306' ' ' GLU . . . . . 0.559 ' HG2' ' HB3' ' A' ' 301' ' ' HIS . 8.4 pt-20 -151.26 46.02 0.82 Allowed 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 121.428 0.633 . . . . 0.83 110.708 179.302 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 307' ' ' GLY . . . . . 0.603 ' HA3' ' HA ' ' A' ' 302' ' ' VAL . . . -126.06 131.65 7.56 Favored Glycine 0 CA--C 1.521 0.463 0 C-N-CA 120.884 -0.674 . . . . 1.67 112.696 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.309 0 CA-C-O 118.41 -1.217 . . . . 3.86 112.77 -179.92 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.484 0 CA-C-O 120.56 0.219 . . . . 1.9 111.565 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -171.07 155.99 4.64 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.563 -0.29 . . . . 0.92 110.444 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 19' ' ' LEU . . . . . 0.452 HD22 ' HA ' ' B' ' 19' ' ' LEU . 0.1 OUTLIER -109.7 91.87 11.27 Favored Pre-proline 0 CA--C 1.533 0.291 0 N-CA-C 112.26 0.467 . . . . 0.88 112.26 -179.51 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 20' ' ' PRO . . . . . 0.409 ' HD2' ' HZ ' ' B' ' 23' ' ' PHE . 61.2 Cg_endo -76.63 115.73 4.13 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.108 1.872 . . . . 0.59 109.137 176.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 21' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -63.94 45.21 0.12 Allowed 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 122.881 2.387 . . . . 0.82 115.934 -176.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -89.83 -27.13 20.15 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.477 -0.564 . . . . 0.77 109.477 177.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 23' ' ' PHE . . . . . 0.567 ' HA ' ' SD ' ' A' ' 212' ' ' MET . 0.4 OUTLIER -61.9 -41.41 97.86 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.322 0.582 . . . . 0.45 109.848 179.019 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 24' ' ' ALA . . . . . 0.501 ' O ' ' HB2' ' B' ' 28' ' ' ARG . . . -59.09 -43.83 91.85 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.249 -0.887 . . . . 0.97 111.126 179.425 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -72.42 -46.8 53.47 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 116.191 -0.459 . . . . 0.49 110.751 179.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -58.01 -54.31 48.42 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 115.96 -0.564 . . . . 0.44 110.778 179.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 98.8 mt -59.34 -37.86 78.91 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.596 -0.275 . . . . 1.12 110.863 179.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 28' ' ' ARG . . . . . 0.517 ' HA ' HG13 ' A' ' 234' ' ' VAL . 0.9 OUTLIER -61.32 -52.72 63.52 Favored 'General case' 0 CA--C 1.528 0.106 0 N-CA-C 109.9 -0.407 . . . . 0.54 109.9 178.736 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -59.82 -43.24 94.62 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.372 -0.377 . . . . 0.7 110.654 178.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 96.1 mt -58.75 -49.31 83.21 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 CA-C-N 116.345 -0.389 . . . . 1.09 110.172 178.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -55.32 -45.38 83.39 Favored Glycine 0 CA--C 1.52 0.404 0 CA-C-N 116.306 -0.407 . . . . 0.28 112.931 179.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -59.19 -49.61 77.19 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 121.087 0.47 . . . . 0.36 110.68 179.143 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 5.4 ttmm -64.01 -45.59 88.28 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 115.927 -0.578 . . . . 1.76 110.847 179.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 34' ' ' VAL . . . . . 0.695 HG21 HG13 ' A' ' 201' ' ' VAL . 5.3 t -58.56 -49.68 81.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 CA-C-O 120.958 0.409 . . . . 1.02 110.659 179.127 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -57.95 -43.65 86.51 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.971 -0.559 . . . . 0.7 110.601 178.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 36' ' ' CYS . . . . . . . . . . . . . 74.3 m -68.22 -25.93 65.46 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 120.942 0.401 . . . . 0.44 111.175 179.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 45.8 m -80.13 -35.47 36.65 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 116.115 -0.493 . . . . 0.88 111.953 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 38' ' ' TRP . . . . . . . . . . . . . 85.0 m95 -84.83 -30.47 24.5 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.039 0.385 . . . . 0.63 112.039 -179.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 16.9 p -70.19 -35.87 74.23 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 120.767 0.318 . . . . 0.41 110.673 179.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -90.72 115.1 63.47 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.384 -0.371 . . . . 0.57 111.222 178.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -80.87 171.17 14.6 Favored 'Trans proline' 0 CA--C 1.533 0.426 0 C-N-CA 122.566 2.177 . . . . 0.97 112.692 179.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.55 63.77 0.84 Allowed 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 121.048 0.452 . . . . 0.97 111.654 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 43' ' ' MET . . . . . . . . . . . . . 26.8 ttt . . . . . 0 C--O 1.251 1.151 0 CA-C-O 118.199 -0.905 . . . . 2.65 111.224 179.835 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.468 0 CA-C-O 119.776 -0.458 . . . . 5.22 112.242 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.37 -18.97 29.46 Favored 'Trans proline' 0 CA--C 1.535 0.557 0 C-N-CA 122.442 2.095 . . . . 4.41 113.514 -179.299 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 96.0 mt -119.0 80.41 1.54 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.841 0.353 . . . . 5.29 111.664 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 179.7 -94.64 0.1 OUTLIER Glycine 0 C--N 1.333 0.375 0 C-N-CA 120.612 -0.804 . . . . 2.53 112.479 179.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 68.3 p -84.44 96.26 9.04 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.674 -0.491 . . . . 1.28 109.674 178.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 9.2 mp0 -33.16 103.07 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.898 0 O-C-N 124.164 0.915 . . . . 0.96 113.34 -179.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . 0.523 ' HA ' ' HB3' ' A' ' 156' ' ' TYR . 2.6 m-20 -55.55 -37.67 68.3 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 113.73 1.011 . . . . 0.74 113.73 -178.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . 0.425 ' HA ' ' HE ' ' A' ' 157' ' ' ARG . 11.2 t0 -52.58 -44.47 65.93 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 120.973 0.416 . . . . 0.49 111.27 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 44.4 tp -85.26 -33.36 22.19 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.142 0.496 . . . . 1.12 110.22 178.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . 0.523 ' HB3' ' HA ' ' A' ' 153' ' ' ASP . 55.6 t80 -61.21 -45.73 93.37 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 115.637 -0.71 . . . . 0.56 112.336 -179.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.624 ' HD2' ' OE1' ' A' ' 182' ' ' GLU . 20.4 ptt85 -59.4 -44.37 92.81 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 120.785 0.326 . . . . 0.63 110.993 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 10.3 mt-30 -65.17 -44.19 89.3 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-O 120.86 0.362 . . . . 0.53 110.223 178.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' SER . . . . . 0.518 ' HA ' ' CZ2' ' A' ' 293' ' ' TRP . 17.0 m -61.63 -49.43 76.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.965 -0.562 . . . . 0.43 111.129 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.59 HD22 ' HA ' ' A' ' 273' ' ' GLU . 0.2 OUTLIER -59.47 -44.12 93.09 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.349 -0.387 . . . . 1.36 110.879 179.375 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . 0.484 ' HG2' HD21 ' A' ' 180' ' ' LEU . 21.4 tt0 -66.9 -53.59 30.54 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 112.037 0.384 . . . . 0.46 112.037 -179.496 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 79.4 mt -61.22 -51.09 77.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 N-CA-C 112.28 0.474 . . . . 1.04 112.28 -179.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 59.2 mt -60.27 -51.42 73.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 N-CA-C 112.297 0.48 . . . . 0.61 112.297 -178.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 90.6 p -57.7 -35.84 71.18 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.575 0.226 . . . . 1.21 111.227 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . 0.417 HH11 ' HD2' ' A' ' 165' ' ' ARG . 0.0 OUTLIER -72.28 -51.1 22.41 Favored 'General case' 0 C--O 1.226 -0.157 0 C-N-CA 120.954 -0.298 . . . . 1.97 111.096 179.091 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' TYR . . . . . 0.784 ' HE1' ' HA ' ' A' ' 195' ' ' ARG . 60.1 t80 -59.7 -46.12 90.05 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 120.648 0.261 . . . . 0.4 111.244 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 5.2 mp -60.63 -45.47 93.94 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 116.354 -0.385 . . . . 1.07 111.175 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 12.2 ttm105 -71.99 -34.68 69.11 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 121.021 -0.272 . . . . 0.63 110.907 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -63.74 -52.63 59.6 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 120.752 0.31 . . . . 1.14 110.354 178.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . 0.4 ' O ' ' HE2' ' A' ' 257' ' ' LYS . 6.6 mm-40 -65.56 -26.51 67.9 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.902 0.382 . . . . 1.21 111.508 179.267 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -79.82 -23.98 41.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.375 -0.375 . . . . 0.56 111.955 179.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 19.1 p -102.09 -37.58 8.1 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.59 0.589 . . . . 0.64 112.59 -179.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 78.94 28.73 53.8 Favored Glycine 0 CA--C 1.521 0.45 0 C-N-CA 120.714 -0.755 . . . . 0.45 112.203 -179.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 23.0 t -112.45 175.06 5.59 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.43 0.634 . . . . 1.11 112.007 -179.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 24.0 pttt -88.2 75.46 8.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.737 -0.665 . . . . 1.61 110.496 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 39.8 t0 -65.16 156.44 31.69 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.78 -0.646 . . . . 1.08 111.734 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 14.8 m -58.57 118.25 5.43 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.238 -0.892 . . . . 1.09 111.236 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . 0.459 ' HB2' ' HD3' ' A' ' 179' ' ' PRO . 10.5 mmtm -75.89 -47.66 3.78 Favored Pre-proline 0 CA--C 1.542 0.646 0 N-CA-C 112.929 0.715 . . . . 0.66 112.929 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . 0.459 ' HD3' ' HB2' ' A' ' 178' ' ' LYS . 11.7 Cg_exo -72.12 100.52 1.11 Allowed 'Trans proline' 0 C--N 1.355 0.915 0 C-N-CA 121.773 1.649 . . . . 1.52 112.324 178.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.484 HD21 ' HG2' ' A' ' 161' ' ' GLU . 4.4 mp -76.17 -178.44 4.48 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 116.318 -0.401 . . . . 1.08 111.326 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -104.34 -54.61 0.79 Allowed Glycine 0 C--N 1.332 0.323 0 C-N-CA 120.622 -0.799 . . . . 0.45 112.565 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . 0.624 ' OE1' ' HD2' ' A' ' 157' ' ' ARG . 81.6 mm-40 -76.32 -53.24 8.48 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.234 0.54 . . . . 0.74 110.723 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . 0.453 ' O ' ' HA3' ' A' ' 187' ' ' GLY . . . -100.13 87.91 3.59 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.961 -0.563 . . . . 0.62 111.05 179.444 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -78.7 -71.73 1.22 Allowed Glycine 0 CA--C 1.522 0.512 0 C-N-CA 120.118 -1.039 . . . . 0.59 112.887 -179.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -72.1 -48.49 43.56 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 120.96 0.409 . . . . 1.09 110.731 179.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -65.11 -34.42 78.36 Favored 'General case' 0 C--O 1.224 -0.237 0 CA-C-N 115.889 -0.596 . . . . 0.94 110.27 178.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . 0.453 ' HA3' ' O ' ' A' ' 183' ' ' ALA . . . -65.71 -40.9 96.02 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.67 -0.776 . . . . 0.42 111.66 178.597 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . 0.408 HH11 ' HD2' ' A' ' 188' ' ' ARG . 11.2 mmt180 -63.98 -54.29 36.76 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.753 0.311 . . . . 1.84 110.962 179.123 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 3.0 ttp180 -60.24 -42.85 96.15 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 115.882 -0.599 . . . . 2.47 110.942 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . 0.535 ' HA ' ' CG1' ' A' ' 297' ' ' VAL . . . -64.26 -46.32 84.26 Favored 'General case' 0 C--O 1.222 -0.391 0 CA-C-N 116.391 -0.368 . . . . 0.97 110.681 179.055 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 15.7 tp -61.38 -37.36 83.1 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.722 0.296 . . . . 1.28 110.779 179.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . 0.601 ' OE2' ' HD3' ' A' ' 196' ' ' ARG . 4.0 tm-20 -63.01 -53.2 57.69 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 121.402 0.62 . . . . 1.04 110.84 178.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' THR . . . . . 0.494 HG22 ' HA ' ' A' ' 297' ' ' VAL . 98.0 m -70.21 -41.24 73.91 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.475 -0.784 . . . . 1.12 111.699 -178.578 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 11.3 tp -61.24 -42.39 98.53 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.281 -0.418 . . . . 1.08 111.433 179.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . 0.784 ' HA ' ' HE1' ' A' ' 166' ' ' TYR . 13.0 ttm-85 -65.6 -41.17 93.06 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 121.189 0.518 . . . . 1.4 109.867 178.614 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . 0.601 ' HD3' ' OE2' ' A' ' 192' ' ' GLU . 8.1 mtp-105 -63.32 -57.0 11.82 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.708 -0.678 . . . . 0.39 111.592 179.574 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 58.2 t -68.59 -40.13 81.43 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-N 116.397 -0.365 . . . . 0.92 111.962 -179.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . 0.537 ' HA3' ' OH ' ' A' ' 166' ' ' TYR . . . -59.15 -47.15 92.18 Favored Glycine 0 C--N 1.33 0.244 0 C-N-CA 121.475 -0.393 . . . . 0.26 112.751 -179.52 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -75.66 -26.35 57.6 Favored 'General case' 0 C--O 1.223 -0.316 0 N-CA-C 110.026 -0.361 . . . . 0.43 110.026 178.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -63.13 -47.02 91.86 Favored Glycine 0 C--N 1.336 0.568 0 N-CA-C 110.929 -0.868 . . . . 0.25 110.929 177.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 61.0 t -69.18 -39.57 79.45 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-O 121.017 0.437 . . . . 0.97 110.021 177.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -67.08 -41.48 86.26 Favored 'General case' 0 C--O 1.219 -0.504 0 CA-C-N 115.71 -0.677 . . . . 0.82 112.024 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.88 -46.47 84.76 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.934 0.397 . . . . 0.46 110.298 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 32.6 m-80 -68.16 -46.82 69.73 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 115.987 -0.551 . . . . 0.57 112.107 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 86.3 m-70 -102.71 30.63 4.58 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 113.556 0.947 . . . . 0.45 113.556 -178.132 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -62.53 -36.21 81.89 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 121.011 0.434 . . . . 0.42 111.216 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 32.7 p -68.86 -39.8 79.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.085 0.469 . . . . 1.76 110.521 178.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -67.05 -40.76 87.21 Favored 'General case' 0 N--CA 1.456 -0.126 0 CA-C-N 115.887 -0.597 . . . . 0.39 110.085 178.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 11.8 m-30 -65.89 -39.59 90.77 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.991 -0.55 . . . . 0.52 110.22 178.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -67.04 -47.67 70.65 Favored 'General case' 0 N--CA 1.46 0.052 0 CA-C-N 116.354 -0.385 . . . . 0.89 110.362 178.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -58.59 -42.62 96.2 Favored Glycine 0 C--N 1.337 0.595 0 N-CA-C 111.0 -0.84 . . . . 0.31 111.0 178.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 30.6 ttm -64.16 -46.04 85.78 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.688 -0.486 . . . . 1.04 109.688 178.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . 0.464 ' HA ' HD12 ' A' ' 216' ' ' LEU . 6.7 tp -59.62 -41.39 90.28 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.806 -0.634 . . . . 1.23 111.112 179.002 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' ARG . . . . . 0.536 ' HD3' ' O ' ' A' ' 214' ' ' ARG . 0.0 OUTLIER -65.0 -32.07 73.61 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.238 -0.437 . . . . 0.91 110.553 179.268 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 56.4 mtpt -89.0 -0.99 57.89 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.253 -0.43 . . . . 1.31 110.781 178.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . 0.64 ' HB3' HG22 ' A' ' 218' ' ' ILE . 10.1 mt -92.26 134.28 35.04 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 121.175 0.512 . . . . 1.4 111.226 179.598 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -99.38 29.16 4.12 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 115.824 -0.625 . . . . 0.45 110.401 178.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' ILE . . . . . 0.64 HG22 ' HB3' ' A' ' 216' ' ' LEU . 2.3 tt -66.91 114.62 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 N-CA-C 113.061 0.763 . . . . 1.1 113.061 -178.603 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 10.0 ptpp? -161.27 4.69 0.06 Allowed 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 115.474 -0.785 . . . . 0.5 112.645 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -154.29 -175.96 5.65 Favored 'General case' 0 C--O 1.218 -0.567 0 O-C-N 121.747 -0.595 . . . . 0.59 112.555 -178.249 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -61.59 -20.84 63.76 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 112.599 0.592 . . . . 0.48 112.599 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -67.71 -42.95 86.34 Favored Glycine 0 CA--C 1.531 1.04 0 N-CA-C 114.708 0.643 . . . . 0.42 114.708 -179.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' ASP . . . . . 0.474 ' OD1' HG13 ' A' ' 218' ' ' ILE . 0.1 OUTLIER -65.51 -31.86 73.15 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 117.621 0.711 . . . . 0.38 112.05 -179.098 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 12.1 t -58.37 -42.35 83.76 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 CA-C-O 121.429 0.633 . . . . 1.08 110.337 178.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 35.2 mmtm -67.91 -41.52 82.56 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.783 -0.644 . . . . 0.6 109.689 178.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' SER . . . . . 0.553 ' O ' HG21 ' A' ' 230' ' ' VAL . 20.6 t -61.19 -38.95 88.38 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.506 -0.77 . . . . 0.65 110.07 178.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' PHE . . . . . 0.419 ' HE1' ' CD2' ' A' ' 251' ' ' PHE . 49.7 t80 -59.47 -43.22 93.3 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.45 -0.795 . . . . 0.57 110.423 178.295 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' SER . . . . . 0.951 ' HB2' HG22 ' A' ' 278' ' ' VAL . 9.6 p -65.16 -31.97 73.42 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.057 -0.519 . . . . 0.49 110.074 178.127 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 22.2 ttp-105 -67.84 -36.24 79.99 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 109.561 -0.533 . . . . 0.7 109.561 178.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . 0.553 HG21 ' O ' ' A' ' 226' ' ' SER . 26.3 t -59.99 -45.41 95.4 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 N-CA-C 109.138 -0.69 . . . . 1.02 109.138 177.345 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' MET . . . . . 0.767 ' HG3' HD11 ' A' ' 248' ' ' LEU . 29.0 ttm -56.08 -53.26 59.09 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 114.822 -1.081 . . . . 1.0 111.786 179.205 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 34.2 m -66.09 -31.12 52.25 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-O 120.563 0.22 . . . . 0.51 111.419 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 44.3 t-80 -69.38 -42.27 75.4 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.987 0.423 . . . . 0.64 110.383 178.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . 0.513 HG13 ' HA ' ' B' ' 28' ' ' ARG . 44.9 t -58.17 -43.99 86.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-N 116.192 -0.458 . . . . 1.1 110.749 178.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 235' ' ' PHE . . . . . 0.481 ' CD2' ' HA ' ' A' ' 240' ' ' THR . 96.2 m-85 -94.43 23.38 5.26 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 116.088 -0.505 . . . . 0.52 112.017 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -65.14 -13.47 58.21 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 112.028 0.381 . . . . 1.32 112.028 -179.373 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -83.37 -17.09 43.5 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.641 0.258 . . . . 0.41 111.324 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 97.15 -7.69 64.51 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 120.81 -0.71 . . . . 0.46 114.034 179.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 4.5 p -97.73 116.09 39.38 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 CA-C-O 121.337 0.589 . . . . 1.19 111.576 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 240' ' ' THR . . . . . 0.481 ' HA ' ' CD2' ' A' ' 235' ' ' PHE . 25.4 m -88.39 84.63 6.81 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.048 0.452 . . . . 1.25 111.875 -179.57 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . 0.537 ' HB2' ' HD2' ' A' ' 244' ' ' ARG . 92.0 m-20 -76.04 135.45 39.94 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.205 -0.452 . . . . 0.54 111.141 179.277 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 242' ' ' TRP . . . . . 0.595 ' HB3' ' CZ ' ' A' ' 300' ' ' PHE . 5.1 m95 -60.33 -37.88 82.01 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.911 0.386 . . . . 0.53 111.282 179.342 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . 0.48 ' HA3' ' N ' ' B' ' 35' ' ' TYR . . . -64.58 -29.95 76.57 Favored Glycine 0 CA--C 1.52 0.378 0 C-N-CA 121.072 -0.585 . . . . 0.32 112.376 178.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 244' ' ' ARG . . . . . 0.54 ' HA ' ' HA3' ' B' ' 31' ' ' GLY . 79.5 mtt180 -69.28 -44.53 71.65 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.86 -0.422 . . . . 0.39 109.86 178.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . 0.507 ' O ' HG12 ' A' ' 249' ' ' ILE . 69.7 mt -61.21 -53.84 43.45 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 CA-C-N 115.542 -0.754 . . . . 0.56 111.435 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 19.0 m -60.6 -34.84 60.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 C-N-CA 120.89 -0.324 . . . . 0.87 111.335 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 53.0 m -62.36 -44.68 95.9 Favored 'General case' 0 N--CA 1.463 0.179 0 N-CA-C 109.985 -0.376 . . . . 1.0 109.985 178.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 248' ' ' LEU . . . . . 0.767 HD11 ' HG3' ' A' ' 231' ' ' MET . 91.5 mt -65.8 -39.76 91.25 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.213 -0.448 . . . . 0.82 110.561 178.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 249' ' ' ILE . . . . . 0.507 HG12 ' O ' ' A' ' 245' ' ' ILE . 26.7 mm -65.67 -43.88 93.66 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 CA-C-O 121.119 0.485 . . . . 1.01 109.837 178.144 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 35.5 t -60.46 -45.97 91.79 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.788 -0.642 . . . . 0.32 109.383 178.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 251' ' ' PHE . . . . . 0.425 ' CD2' HD12 ' B' ' 27' ' ' LEU . 22.0 t80 -63.58 -39.4 94.28 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 115.687 -0.688 . . . . 0.43 110.115 178.144 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -56.99 -42.69 93.01 Favored Glycine 0 C--N 1.335 0.503 0 N-CA-C 111.419 -0.672 . . . . 0.27 111.419 177.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -69.21 -31.33 69.84 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 120.827 0.346 . . . . 0.43 110.521 177.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -70.93 -47.58 58.27 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 116.247 -0.433 . . . . 0.66 111.378 179.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 19.1 m -64.64 -35.62 75.26 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 C-N-CA 120.725 -0.39 . . . . 0.6 110.159 178.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -66.04 -32.33 73.74 Favored 'General case' 0 N--CA 1.456 -0.146 0 N-CA-C 109.257 -0.645 . . . . 0.62 109.257 177.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 257' ' ' LYS . . . . . 0.4 ' HE2' ' O ' ' A' ' 170' ' ' GLN . 24.5 ttmt -63.66 -40.03 95.82 Favored 'General case' 0 CA--C 1.528 0.108 0 CA-C-N 115.493 -0.776 . . . . 1.54 109.085 177.615 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 75.4 t60 -66.09 -44.86 83.17 Favored 'General case' 0 C--O 1.231 0.085 0 CA-C-N 115.93 -0.577 . . . . 0.5 109.539 177.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 97.4 mt -60.14 -47.33 86.35 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 115.8 -0.636 . . . . 1.13 110.33 178.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 260' ' ' LYS . . . . . 0.429 ' HA ' ' OE1' ' A' ' 265' ' ' GLU . 0.7 OUTLIER -62.96 -33.8 76.16 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.277 -0.419 . . . . 0.64 110.742 178.998 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 72.4 m -60.23 -29.46 68.77 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 120.858 0.361 . . . . 0.51 110.836 179.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 262' ' ' VAL . . . . . 0.407 HG22 ' HG3' ' A' ' 264' ' ' GLN . 6.1 m -109.95 17.97 7.14 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-O 120.951 0.405 . . . . 1.2 110.662 178.509 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 58.05 50.33 10.28 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 115.528 -0.76 . . . . 0.66 113.036 179.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 264' ' ' GLN . . . . . 0.407 ' HG3' HG22 ' A' ' 262' ' ' VAL . 22.6 mt-30 -110.99 36.49 3.13 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 120.953 0.406 . . . . 0.44 110.931 178.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . 0.512 ' HA ' HD12 ' A' ' 268' ' ' ILE . 0.9 OUTLIER -51.36 -33.48 29.9 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 112.823 0.675 . . . . 0.53 112.823 -179.804 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 24.9 p -59.12 -20.25 51.95 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 111.793 0.294 . . . . 1.52 111.793 179.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -93.35 -23.49 18.43 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 121.063 0.459 . . . . 0.79 110.838 178.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 268' ' ' ILE . . . . . 0.512 HD12 ' HA ' ' A' ' 265' ' ' GLU . 73.0 mt -67.62 -42.17 86.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 CA-C-N 116.243 -0.435 . . . . 1.03 110.889 179.382 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 269' ' ' GLU . . . . . 0.791 ' HB2' ' HD3' ' A' ' 270' ' ' PRO . 58.2 mm-40 -54.77 -56.41 27.67 Favored Pre-proline 0 CA--C 1.544 0.74 0 CA-C-N 116.006 -0.543 . . . . 0.58 111.789 179.539 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 270' ' ' PRO . . . . . 0.791 ' HD3' ' HB2' ' A' ' 269' ' ' GLU . 22.7 Cg_exo -66.81 -28.15 43.47 Favored 'Trans proline' 0 C--N 1.358 1.068 0 C-N-CA 122.181 1.921 . . . . 0.77 111.79 178.205 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 271' ' ' LEU . . . . . 0.494 ' O ' HG22 ' A' ' 275' ' ' ILE . 32.7 tp -62.91 -50.4 71.01 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.366 -0.379 . . . . 1.06 110.278 178.686 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -60.69 -34.0 73.69 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 121.336 0.589 . . . . 0.52 110.602 178.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 273' ' ' GLU . . . . . 0.59 ' HA ' HD22 ' A' ' 160' ' ' LEU . 34.9 tt0 -71.85 -40.9 68.68 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.566 -0.743 . . . . 0.93 109.478 178.065 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 274' ' ' THR . . . . . . . . . . . . . 93.2 m -66.54 -50.62 62.57 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.792 -0.64 . . . . 0.46 111.663 179.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 275' ' ' ILE . . . . . 0.581 HG13 ' HE1' ' A' ' 231' ' ' MET . 13.6 tt -58.94 -49.67 82.31 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-N 116.816 -0.174 . . . . 1.05 111.125 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 13.2 m -62.06 -47.65 83.73 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.795 0.331 . . . . 0.44 111.037 179.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 277' ' ' ASP . . . . . 0.527 ' HB2' ' O ' ' A' ' 273' ' ' GLU . 4.4 t70 -53.31 -55.36 25.36 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 115.998 -0.546 . . . . 0.46 111.193 179.575 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 278' ' ' VAL . . . . . 0.951 HG22 ' HB2' ' A' ' 228' ' ' SER . 84.0 t -64.37 -40.53 89.38 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 CA-C-N 116.405 -0.361 . . . . 0.63 111.375 179.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 25.2 tp -62.73 -38.93 92.44 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.831 0.348 . . . . 0.88 111.644 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 91.5 t -82.73 -41.71 17.65 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 N-CA-C 112.249 0.463 . . . . 0.73 112.249 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 55.3 mtp180 -69.28 -28.02 65.93 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 112.959 0.725 . . . . 0.72 112.959 -178.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 282' ' ' THR . . . . . . . . . . . . . 82.0 p -93.67 -12.38 29.46 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 112.485 0.55 . . . . 0.68 112.485 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 4.4 mptp? -129.17 34.44 4.41 Favored 'General case' 0 C--N 1.33 -0.259 0 O-C-N 122.321 -0.237 . . . . 0.83 111.423 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 41.4 ttt180 -50.75 -53.07 34.69 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 116.291 -0.413 . . . . 1.25 111.867 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -59.27 -52.15 66.89 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 116.292 -0.413 . . . . 0.71 111.863 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 286' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -62.18 -42.74 99.56 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.492 0.553 . . . . 0.72 112.492 -179.04 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 287' ' ' LEU . . . . . 0.423 HD13 ' HA2' ' A' ' 292' ' ' GLY . 2.1 mm? -66.51 -49.77 65.45 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 111.719 0.266 . . . . 1.12 111.719 -179.516 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 5.5 p -65.56 -31.18 52.68 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-O 120.785 0.326 . . . . 0.74 111.261 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 11.8 ttmt -74.91 -30.69 61.35 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 120.79 0.328 . . . . 1.72 111.302 179.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.89 9.05 43.02 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 112.341 0.497 . . . . 0.65 112.341 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 291' ' ' ARG . . . . . 0.464 ' HB3' ' HB2' ' A' ' 294' ' ' ASP . 0.0 OUTLIER 62.57 24.87 14.82 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 112.767 0.654 . . . . 0.95 112.767 179.013 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 292' ' ' GLY . . . . . 0.423 ' HA2' HD13 ' A' ' 287' ' ' LEU . . . 56.07 -115.32 5.95 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 115.27 0.868 . . . . 0.47 115.27 178.533 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 293' ' ' TRP . . . . . 0.564 ' O ' HG23 ' A' ' 297' ' ' VAL . 88.8 m95 -65.83 -41.22 92.04 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 112.713 0.635 . . . . 0.88 112.713 -178.322 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 294' ' ' ASP . . . . . 0.464 ' HB2' ' HB3' ' A' ' 291' ' ' ARG . 27.6 m-20 -52.35 -49.67 63.86 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.086 0.47 . . . . 0.4 111.253 179.568 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -71.71 -33.74 63.21 Favored Glycine 0 CA--C 1.521 0.436 0 C-N-CA 120.84 -0.695 . . . . 0.29 112.598 179.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 296' ' ' PHE . . . . . 0.427 ' HB2' ' CH2' ' A' ' 242' ' ' TRP . 0.9 OUTLIER -66.77 -47.39 72.34 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 120.733 0.302 . . . . 0.4 111.759 179.893 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 297' ' ' VAL . . . . . 0.564 HG23 ' O ' ' A' ' 293' ' ' TRP . 23.7 m -68.06 -40.89 83.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 112.477 0.547 . . . . 1.08 112.477 -178.556 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 298' ' ' GLU . . . . . 0.436 ' HA ' ' OE1' ' A' ' 298' ' ' GLU . 0.0 OUTLIER -71.55 -30.21 65.63 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 120.538 -0.465 . . . . 0.61 112.079 -179.509 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 299' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -69.19 -41.97 76.43 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.83 0.348 . . . . 0.53 110.539 178.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 300' ' ' PHE . . . . . 0.595 ' CZ ' ' HB3' ' A' ' 242' ' ' TRP . 81.8 m-85 -90.87 30.73 1.15 Allowed 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 112.647 0.61 . . . . 0.48 112.647 -179.164 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -110.06 58.68 0.61 Allowed 'General case' 0 CA--C 1.535 0.373 0 O-C-N 121.983 -0.448 . . . . 0.46 110.82 179.114 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 5.7 t -98.48 -84.69 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 CA-C-N 116.233 -0.44 . . . . 1.17 111.835 -179.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -170.65 119.08 0.53 Allowed 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 120.63 0.252 . . . . 1.08 111.41 -179.606 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -145.96 -82.22 0.14 Allowed 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 111.81 0.3 . . . . 0.47 111.81 179.168 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 305' ' ' LEU . . . . . 0.54 HD11 ' HG2' ' A' ' 196' ' ' ARG . 68.1 mt -69.43 -28.65 66.32 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 112.244 0.461 . . . . 1.31 112.244 -179.491 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.39 -7.58 54.9 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.854 0.359 . . . . 0.77 110.984 179.625 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . -113.93 57.61 0.45 Allowed Glycine 0 CA--C 1.52 0.385 0 C-N-CA 120.96 -0.638 . . . . 1.36 112.62 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.104 0 CA-C-O 118.444 -1.198 . . . . 2.89 112.823 -179.921 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.372 0 CA-C-O 120.476 0.179 . . . . 0.86 111.069 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -82.97 153.03 25.21 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 120.934 0.397 . . . . 0.97 110.904 179.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 19' ' ' LEU . . . . . 0.485 ' HA ' HD22 ' B' ' 19' ' ' LEU . 10.7 mt -111.88 97.68 38.83 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-O 121.141 0.496 . . . . 1.1 111.265 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 20' ' ' PRO . . . . . 0.408 ' C ' ' H ' ' B' ' 22' ' ' GLU . 71.9 Cg_endo -76.21 158.67 37.37 Favored 'Trans proline' 0 CA--C 1.532 0.4 0 C-N-CA 122.924 2.416 . . . . 0.51 113.035 -179.468 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 21' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -67.57 8.91 0.37 Allowed 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 122.967 2.444 . . . . 0.6 113.393 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 22' ' ' GLU . . . . . 0.408 ' H ' ' C ' ' B' ' 20' ' ' PRO . 3.0 tt0 -61.72 -41.51 97.71 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.39 -0.368 . . . . 0.55 111.285 179.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 23' ' ' PHE . . . . . 0.552 ' CE1' HG22 ' A' ' 230' ' ' VAL . 0.2 OUTLIER -60.38 -32.93 71.76 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 121.057 0.456 . . . . 0.44 110.528 179.549 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 24' ' ' ALA . . . . . 0.535 ' N ' ' HD1' ' B' ' 23' ' ' PHE . . . -72.8 -37.49 67.54 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 115.733 -0.667 . . . . 0.82 110.252 179.362 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.3 -42.59 99.07 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 109.674 -0.491 . . . . 0.99 109.674 178.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 26' ' ' GLN . . . . . 0.41 ' O ' HG13 ' B' ' 30' ' ' ILE . 0.1 OUTLIER -64.29 -54.44 33.18 Favored 'General case' 0 C--O 1.227 -0.125 0 CA-C-N 115.692 -0.685 . . . . 0.36 110.518 178.473 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . 0.471 HD11 HG13 ' A' ' 230' ' ' VAL . 48.9 mt -57.6 -35.23 70.15 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.855 0.36 . . . . 1.07 110.746 179.102 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 28' ' ' ARG . . . . . 0.513 ' HA ' HG13 ' A' ' 234' ' ' VAL . 65.5 ttt180 -60.86 -54.41 45.47 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 109.371 -0.603 . . . . 0.76 109.371 177.59 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -61.48 -41.14 96.81 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.725 -0.671 . . . . 1.25 111.18 178.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . 0.412 ' O ' HG22 ' B' ' 34' ' ' VAL . 95.6 mt -63.7 -44.05 98.27 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 N-CA-C 110.054 -0.35 . . . . 1.01 110.054 178.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . 0.54 ' HA3' ' HA ' ' A' ' 244' ' ' ARG . . . -60.68 -46.97 93.42 Favored Glycine 0 C--N 1.333 0.372 0 C-N-CA 120.645 -0.788 . . . . 0.28 111.674 178.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 85.0 m-20 -60.4 -36.93 79.27 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 121.196 0.522 . . . . 0.69 110.133 178.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 16.2 tppt? -68.05 -50.47 55.04 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 115.752 -0.658 . . . . 1.31 110.47 178.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 34' ' ' VAL . . . . . 0.412 HG22 ' O ' ' B' ' 30' ' ' ILE . 77.0 t -59.66 -42.26 87.87 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-O 120.943 0.402 . . . . 0.76 111.067 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 35' ' ' TYR . . . . . 0.48 ' N ' ' HA3' ' A' ' 243' ' ' GLY . 0.1 OUTLIER -57.9 -45.74 85.99 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 121.258 0.552 . . . . 1.04 109.907 178.479 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 36' ' ' CYS . . . . . . . . . . . . . 5.9 t -70.69 -26.09 63.26 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 115.905 -0.589 . . . . 0.6 111.17 179.114 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 37.3 m -71.61 -40.52 69.75 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 112.755 0.65 . . . . 0.65 112.755 -179.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 38' ' ' TRP . . . . . . . . . . . . . 99.3 m95 -85.64 -35.0 21.22 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.222 0.453 . . . . 0.51 112.222 -178.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 65.4 p -67.74 -42.44 81.82 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 111.644 0.238 . . . . 1.04 111.644 179.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -89.6 115.21 63.24 Favored Pre-proline 0 CA--C 1.532 0.257 0 CA-C-O 121.097 0.475 . . . . 1.04 111.144 179.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -82.18 63.58 8.26 Favored 'Trans proline' 0 CA--C 1.534 0.498 0 C-N-CA 122.663 2.242 . . . . 1.56 113.138 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 36.2 m-20 -74.72 71.78 1.96 Allowed 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 121.245 0.545 . . . . 1.46 111.411 179.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 43' ' ' MET . . . . . . . . . . . . . 54.2 mtt . . . . . 0 C--O 1.251 1.164 0 CA-C-O 118.362 -0.828 . . . . 3.02 111.353 -179.997 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.322 0 CA-C-O 120.214 -0.215 . . . . 0.99 112.632 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_exo -72.73 52.38 2.09 Favored 'Trans proline' 0 CA--C 1.535 0.566 0 C-N-CA 123.068 2.512 . . . . 1.66 113.152 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 68.8 mt -109.57 15.94 22.55 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.449 0.642 . . . . 2.3 110.545 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 139.04 -158.17 25.14 Favored Glycine 0 N--CA 1.45 -0.409 0 CA-C-N 115.38 -0.827 . . . . 1.09 111.726 -179.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 3.1 p -83.49 69.07 10.0 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.994 0.426 . . . . 1.01 110.906 179.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.592 ' OE1' ' HD3' ' A' ' 284' ' ' ARG . 8.7 pt-20 -122.42 -33.29 3.48 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 112.39 0.515 . . . . 0.94 112.39 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 45.1 m-20 -56.78 -38.25 72.24 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 112.022 0.378 . . . . 1.15 112.022 -179.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -71.09 -45.05 64.45 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 120.892 0.377 . . . . 1.77 111.207 178.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 41.3 tp -69.92 -32.98 71.56 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-N 116.387 -0.37 . . . . 1.31 111.824 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -55.55 -50.44 70.03 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 113.174 0.805 . . . . 0.56 113.174 -179.445 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 60.0 mtp85 -54.63 -51.91 63.9 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 112.882 0.697 . . . . 0.69 112.882 -178.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . 0.49 ' HG3' ' CB ' ' A' ' 183' ' ' ALA . 4.9 tt0 -66.9 -43.84 82.33 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.082 -0.508 . . . . 0.72 111.193 -179.24 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 31.1 m -61.57 -47.57 84.88 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.856 -0.611 . . . . 0.31 111.101 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.726 HD12 ' HG3' ' A' ' 273' ' ' GLU . 27.9 tp -59.52 -47.82 84.03 Favored 'General case' 0 C--O 1.222 -0.373 0 CA-C-N 115.913 -0.585 . . . . 1.19 111.517 -179.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . 0.453 ' CD ' ' H ' ' A' ' 181' ' ' GLY . 26.8 tt0 -58.5 -50.41 73.86 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 120.601 0.239 . . . . 0.56 111.521 -179.328 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . 0.41 HD12 ' HB1' ' A' ' 190' ' ' ALA . 52.2 mt -58.05 -52.07 62.93 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-N 116.541 -0.299 . . . . 1.12 111.565 179.51 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.493 HD12 HG23 ' A' ' 276' ' ' THR . 88.2 mt -67.31 -54.86 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 N-CA-C 112.787 0.662 . . . . 0.97 112.787 -179.323 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 6.7 t -53.52 -41.23 66.15 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 120.775 0.322 . . . . 0.29 111.302 -178.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . 0.488 ' HD2' ' HA ' ' A' ' 165' ' ' ARG . 3.6 tpt180 -71.92 -45.93 59.4 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 120.344 -0.542 . . . . 0.79 110.775 179.28 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' TYR . . . . . 0.675 ' HE1' ' HA ' ' A' ' 195' ' ' ARG . 65.4 t80 -57.92 -49.33 77.13 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 111.561 0.208 . . . . 0.36 111.561 179.11 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 6.4 mp -60.82 -42.73 98.27 Favored 'General case' 0 C--O 1.226 -0.141 0 CA-C-N 116.717 -0.22 . . . . 0.97 110.566 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 1.9 ttt180 -65.28 -43.72 90.31 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 121.176 0.513 . . . . 0.7 110.457 178.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -60.44 -54.56 44.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.34 -0.846 . . . . 0.45 110.337 178.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 23.4 mm-40 -63.77 -35.8 81.79 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.09 -0.505 . . . . 0.38 111.085 179.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -57.33 -35.02 69.35 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.083 0.468 . . . . 0.59 111.496 179.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 21.8 m -94.11 -34.03 13.12 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.958 -0.564 . . . . 0.58 111.317 -179.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 89.36 12.18 63.43 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.884 -0.674 . . . . 0.5 112.131 -179.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 5.0 t -102.43 -168.61 1.55 Allowed 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 120.794 0.331 . . . . 0.64 111.079 -179.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 1.9 tppt? -137.15 116.3 12.52 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.946 0.403 . . . . 0.52 111.552 -179.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -80.68 130.81 35.31 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.95 -0.568 . . . . 0.51 110.675 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 8.7 m -70.11 -23.83 63.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.062 -0.517 . . . . 1.41 110.697 179.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.55 70.21 25.98 Favored Pre-proline 0 CA--C 1.537 0.472 0 CA-C-N 116.159 -0.473 . . . . 1.04 110.85 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -66.25 -57.52 0.22 Allowed 'Trans proline' 0 C--N 1.347 0.5 0 C-N-CA 122.648 2.232 . . . . 0.67 113.397 -179.021 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -77.44 156.62 30.99 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.356 0.598 . . . . 0.66 111.296 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . 0.453 ' H ' ' CD ' ' A' ' 161' ' ' GLU . . . -130.92 -46.11 0.15 Allowed Glycine 0 C--N 1.32 -0.327 0 CA-C-N 115.532 -0.758 . . . . 0.55 111.269 179.362 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -108.8 -29.84 8.45 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 121.148 0.499 . . . . 0.63 110.398 178.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . 0.518 ' O ' ' HA3' ' A' ' 187' ' ' GLY . . . -80.93 79.09 7.67 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 121.26 0.553 . . . . 0.43 110.642 179.486 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -78.55 -71.06 1.26 Allowed Glycine 0 CA--C 1.527 0.823 0 N-CA-C 115.16 0.824 . . . . 0.46 115.16 -178.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -68.49 -57.81 5.26 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 112.774 0.657 . . . . 0.61 112.774 -177.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . 0.481 ' HB3' ' OE1' ' A' ' 158' ' ' GLN . . . -72.08 -34.11 68.43 Favored 'General case' 0 C--O 1.221 -0.426 0 C-N-CA 120.466 -0.494 . . . . 1.09 110.265 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . 0.518 ' HA3' ' O ' ' A' ' 183' ' ' ALA . . . -62.14 -43.66 98.83 Favored Glycine 0 CA--C 1.52 0.393 0 C-N-CA 120.828 -0.701 . . . . 0.35 112.601 179.166 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 3.0 tmt_? -62.38 -53.78 49.96 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.84 0.32 . . . . 0.68 110.601 179.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . 0.491 ' O ' ' HG2' ' A' ' 192' ' ' GLU . 47.6 mtm180 -63.4 -44.22 95.3 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.233 -0.44 . . . . 0.54 111.933 -179.472 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . 0.51 ' HB2' ' HB3' ' A' ' 293' ' ' TRP . . . -68.47 -45.48 72.33 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.179 0.437 . . . . 1.05 112.179 -179.206 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . 0.449 ' CD1' ' HB2' ' A' ' 166' ' ' TYR . 27.3 tp -65.91 -38.36 88.49 Favored 'General case' 0 N--CA 1.463 0.177 0 C-N-CA 120.411 -0.516 . . . . 1.17 111.813 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . 0.491 ' HG2' ' O ' ' A' ' 189' ' ' ARG . 9.3 pt-20 -66.61 -36.73 83.31 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 120.433 -0.507 . . . . 0.72 110.549 179.52 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' THR . . . . . 0.607 HG21 ' HA ' ' A' ' 297' ' ' VAL . 20.7 m -73.73 -46.75 44.02 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.129 -0.487 . . . . 0.84 110.247 179.512 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 14.6 tp -60.74 -38.35 84.83 Favored 'General case' 0 N--CA 1.457 -0.125 0 CA-C-N 115.75 -0.659 . . . . 1.09 110.261 179.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . 0.675 ' HA ' ' HE1' ' A' ' 166' ' ' TYR . 46.2 ttm105 -61.85 -51.15 69.4 Favored 'General case' 0 C--O 1.223 -0.293 0 CA-C-N 116.072 -0.513 . . . . 0.38 111.07 178.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 7.3 tpm_? -69.16 -53.03 22.21 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 112.828 0.677 . . . . 0.57 112.828 -179.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . 0.438 HG23 ' HB3' ' A' ' 300' ' ' PHE . 46.5 t -63.72 -50.63 77.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 N-CA-C 112.028 0.381 . . . . 0.92 112.028 -178.505 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -57.78 -50.35 66.31 Favored Glycine 0 C--N 1.333 0.402 0 C-N-CA 120.976 -0.631 . . . . 0.26 111.976 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -54.28 -40.74 68.12 Favored 'General case' 0 CA--C 1.526 0.054 0 N-CA-C 109.992 -0.373 . . . . 0.41 109.992 178.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -63.2 -50.68 60.98 Favored Glycine 0 CA--C 1.522 0.525 0 C-N-CA 120.831 -0.699 . . . . 0.35 111.85 178.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 60.2 t -60.25 -42.28 89.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-O 120.837 0.351 . . . . 0.97 110.995 178.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' GLN . . . . . 0.643 ' HG3' ' HB3' ' A' ' 250' ' ' SER . 25.8 mt-30 -66.91 -42.4 85.51 Favored 'General case' 0 C--O 1.223 -0.314 0 CA-C-N 116.033 -0.53 . . . . 0.45 112.088 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' ARG . . . . . 0.496 ' HD3' ' OE1' ' A' ' 206' ' ' GLU . 0.0 OUTLIER -70.35 -37.49 74.65 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.814 0.34 . . . . 0.35 110.493 179.476 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 16.1 m-80 -67.88 -47.73 68.05 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-O 121.15 0.5 . . . . 1.13 110.489 178.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 86.9 m-70 -101.04 35.88 2.11 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.183 -0.462 . . . . 0.57 111.328 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . 0.512 ' HG3' ' CZ ' ' A' ' 254' ' ' PHE . 2.6 tt0 -57.49 -48.84 78.16 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.274 -0.421 . . . . 0.47 111.562 -179.538 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 45.9 p -64.95 -39.39 93.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.334 -0.394 . . . . 1.05 111.646 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -61.19 -43.27 99.15 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 121.138 0.494 . . . . 0.55 110.483 179.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' PHE . . . . . 0.504 ' O ' ' HG ' ' A' ' 213' ' ' LEU . 21.9 m-85 -74.52 -39.1 62.59 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.949 -0.569 . . . . 0.53 110.295 179.147 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -60.09 -46.1 90.72 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.151 -0.477 . . . . 1.12 110.277 178.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -63.69 -39.22 97.3 Favored Glycine 0 C--N 1.335 0.516 0 N-CA-C 111.031 -0.827 . . . . 0.35 111.031 177.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' MET . . . . . 0.635 ' HA ' ' HE2' ' A' ' 215' ' ' LYS . 9.9 tpp -62.12 -40.4 95.77 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 109.718 -0.475 . . . . 1.07 109.718 178.182 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . 0.504 ' HG ' ' O ' ' A' ' 209' ' ' PHE . 40.7 mt -59.09 -41.29 87.73 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.372 -0.376 . . . . 1.0 111.169 178.663 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.74 -44.6 96.47 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.086 -0.506 . . . . 1.23 110.886 179.459 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' LYS . . . . . 0.635 ' HE2' ' HA ' ' A' ' 212' ' ' MET . 32.8 mtmt -73.13 -33.59 65.61 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 116.222 -0.444 . . . . 1.07 111.798 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . 0.576 ' HA ' HD12 ' B' ' 19' ' ' LEU . 35.9 mt -65.32 143.48 57.74 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 121.254 0.55 . . . . 1.22 112.465 -179.602 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' ASP . . . . . 0.424 ' O ' ' HG3' ' A' ' 219' ' ' LYS . 0.3 OUTLIER -112.45 33.23 5.05 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.798 -0.637 . . . . 0.48 110.719 179.523 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' ILE . . . . . 0.44 HG12 ' HB3' ' A' ' 216' ' ' LEU . 27.5 mm -66.1 112.43 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 CA-C-N 116.549 -0.296 . . . . 1.16 111.29 -179.658 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . 0.424 ' HG3' ' O ' ' A' ' 217' ' ' ASP . 21.2 mtmm -134.33 -43.57 0.78 Allowed 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 112.15 0.426 . . . . 0.68 112.15 -179.426 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -128.9 -176.37 3.83 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 112.737 0.643 . . . . 0.69 112.737 -177.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . 0.562 ' O ' HG21 ' A' ' 224' ' ' VAL . 1.2 mp0 -61.37 -22.31 64.85 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 112.743 0.646 . . . . 0.72 112.743 -179.055 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -70.19 -27.25 73.13 Favored Glycine 0 CA--C 1.524 0.61 0 C-N-CA 120.402 -0.904 . . . . 0.36 112.999 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -70.12 -31.29 68.76 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 112.779 0.659 . . . . 0.4 112.779 -179.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . 0.562 HG21 ' O ' ' A' ' 221' ' ' GLU . 3.8 m -56.56 -27.37 25.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 N-CA-C 112.122 0.416 . . . . 1.07 112.122 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . 0.467 ' O ' ' HG3' ' A' ' 229' ' ' ARG . 7.9 mptt -64.93 -42.49 94.63 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.037 0.446 . . . . 1.08 110.184 178.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' SER . . . . . 0.65 ' HA ' ' HE ' ' A' ' 229' ' ' ARG . 31.6 m -70.71 -36.68 73.34 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.228 -0.442 . . . . 0.8 109.877 178.478 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' PHE . . . . . . . . . . . . . 16.5 t80 -61.94 -40.68 96.36 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.767 -0.651 . . . . 0.71 109.631 178.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 49.2 m -65.24 -38.17 89.52 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.72 -0.673 . . . . 0.51 109.954 178.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' ARG . . . . . 0.65 ' HE ' ' HA ' ' A' ' 226' ' ' SER . 61.3 mtm180 -59.65 -37.51 78.9 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.239 -0.437 . . . . 0.86 109.925 178.187 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . 0.517 HG21 ' CE1' ' B' ' 23' ' ' PHE . 44.4 t -59.42 -53.54 46.73 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.142 0 N-CA-C 109.311 -0.625 . . . . 1.0 109.311 177.433 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' MET . . . . . 0.583 ' HE3' HG22 ' A' ' 275' ' ' ILE . 1.5 ttp -56.15 -45.23 79.7 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 115.463 -0.79 . . . . 0.95 111.01 178.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 80.6 t -62.75 -42.32 95.77 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-O 120.901 0.381 . . . . 1.24 110.923 178.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 9.2 t-80 -69.85 -35.58 74.84 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 116.515 -0.311 . . . . 0.73 111.221 179.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . 0.507 HG22 ' O ' ' A' ' 230' ' ' VAL . 39.5 t -54.19 -37.01 34.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 CA-C-O 120.974 0.416 . . . . 0.98 111.48 179.351 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 235' ' ' PHE . . . . . 0.592 ' CE1' ' HA ' ' A' ' 240' ' ' THR . 72.9 m-85 -102.26 24.55 10.07 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 112.007 0.373 . . . . 0.76 112.007 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . 0.419 ' HA ' ' HD2' ' A' ' 236' ' ' LYS . 8.2 tptp -70.22 -20.63 63.08 Favored 'General case' 0 CA--C 1.537 0.462 0 O-C-N 122.241 -0.287 . . . . 1.3 111.355 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 23.8 p-10 -82.22 -8.29 59.64 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 120.789 0.328 . . . . 0.73 110.869 179.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 83.05 9.92 83.53 Favored Glycine 0 CA--C 1.522 0.475 0 C-N-CA 120.99 -0.624 . . . . 0.49 114.039 178.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 33.5 t -102.23 91.08 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.441 0.638 . . . . 1.14 111.187 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 240' ' ' THR . . . . . 0.592 ' HA ' ' CE1' ' A' ' 235' ' ' PHE . 3.1 m -80.13 73.27 6.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.875 -0.602 . . . . 1.28 111.439 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 38.3 m-20 -80.11 140.87 36.24 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.928 0.394 . . . . 0.57 111.885 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 242' ' ' TRP . . . . . 0.463 ' HB3' ' CE2' ' A' ' 300' ' ' PHE . 35.4 m95 -57.96 -40.03 79.55 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.981 -0.554 . . . . 0.59 111.367 179.538 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -61.69 -27.43 68.25 Favored Glycine 0 CA--C 1.521 0.467 0 C-N-CA 120.864 -0.684 . . . . 0.3 112.135 178.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 244' ' ' ARG . . . . . 0.54 ' HG2' ' HA3' ' B' ' 31' ' ' GLY . 71.9 mtt180 -74.81 -46.03 39.46 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 110.0 -0.37 . . . . 0.62 110.0 178.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . 0.512 HG23 HD11 ' A' ' 279' ' ' LEU . 83.7 mt -58.2 -47.33 87.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-N 115.674 -0.694 . . . . 1.02 109.899 179.046 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 83.9 t -64.82 -38.41 82.66 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-N 115.87 -0.604 . . . . 1.04 110.059 178.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 17.0 m -60.68 -41.5 95.21 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.712 0.291 . . . . 0.97 110.217 178.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 248' ' ' LEU . . . . . 0.553 HD23 HD13 ' B' ' 27' ' ' LEU . 64.3 mt -63.02 -43.89 97.47 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 121.043 0.449 . . . . 1.35 109.842 177.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 249' ' ' ILE . . . . . 0.489 HG12 ' O ' ' A' ' 245' ' ' ILE . 41.6 mm -63.01 -40.46 89.12 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 CA-C-O 121.35 0.595 . . . . 1.08 109.579 177.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 250' ' ' SER . . . . . 0.643 ' HB3' ' HG3' ' A' ' 202' ' ' GLN . 38.8 m -61.57 -47.63 84.63 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 115.243 -0.89 . . . . 0.37 109.624 178.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 251' ' ' PHE . . . . . 0.514 ' O ' HG21 ' A' ' 255' ' ' VAL . 11.1 t80 -60.81 -45.4 94.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.452 -0.795 . . . . 0.55 109.579 178.155 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -55.66 -48.07 73.65 Favored Glycine 0 C--N 1.335 0.523 0 C-N-CA 121.151 -0.547 . . . . 0.25 111.974 178.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 253' ' ' ALA . . . . . 0.54 ' O ' ' HG3' ' A' ' 257' ' ' LYS . . . -62.1 -34.69 76.8 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 120.737 0.303 . . . . 0.31 111.069 178.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 254' ' ' PHE . . . . . 0.512 ' CZ ' ' HG3' ' A' ' 206' ' ' GLU . 2.4 t80 -72.18 -41.5 66.93 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 121.08 0.467 . . . . 0.52 110.45 178.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 255' ' ' VAL . . . . . 0.514 HG21 ' O ' ' A' ' 251' ' ' PHE . 81.1 t -65.19 -36.25 77.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 N-CA-C 109.047 -0.723 . . . . 1.03 109.047 177.533 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -62.69 -36.76 83.96 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 115.544 -0.753 . . . . 0.31 109.61 178.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 257' ' ' LYS . . . . . 0.54 ' HG3' ' O ' ' A' ' 253' ' ' ALA . 54.7 mttm -60.66 -43.54 97.5 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.033 -0.531 . . . . 0.53 109.65 177.571 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 258' ' ' HIS . . . . . 0.485 ' HB2' HD12 ' A' ' 213' ' ' LEU . 34.7 t60 -57.09 -44.36 83.11 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.824 -0.626 . . . . 0.85 110.844 178.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 94.3 mt -71.04 -40.77 71.5 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 120.99 0.424 . . . . 1.23 111.404 179.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -65.85 -27.78 68.49 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 120.646 0.26 . . . . 0.6 111.481 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 51.2 m -62.84 -21.66 66.11 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 116.356 -0.384 . . . . 0.45 111.414 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 11.3 m -120.35 23.58 4.83 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-N 116.289 -0.414 . . . . 1.05 111.44 179.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 54.4 m-80 58.03 45.33 18.09 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 112.888 0.699 . . . . 1.63 112.888 179.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -109.46 37.65 2.55 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 122.176 -0.328 . . . . 0.89 111.678 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . 0.602 ' HA ' HD11 ' A' ' 268' ' ' ILE . 13.3 tt0 -58.04 -28.62 64.66 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 111.975 0.361 . . . . 0.74 111.975 -179.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 15.5 p -62.17 -18.68 61.69 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.189 -0.459 . . . . 0.87 111.212 179.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 267' ' ' PHE . . . . . 0.409 ' C ' ' HD2' ' A' ' 270' ' ' PRO . 90.1 m-85 -101.94 -19.0 15.42 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 121.05 0.453 . . . . 0.84 110.242 177.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 268' ' ' ILE . . . . . 0.602 HD11 ' HA ' ' A' ' 265' ' ' GLU . 78.9 mt -66.9 -43.86 89.18 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-N 115.767 -0.651 . . . . 1.1 110.599 179.605 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 269' ' ' GLU . . . . . 0.774 ' HB2' ' HD3' ' A' ' 270' ' ' PRO . 45.2 mt-10 -59.47 -57.3 27.96 Favored Pre-proline 0 CA--C 1.54 0.577 0 CA-C-N 116.271 -0.422 . . . . 0.52 110.54 178.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 270' ' ' PRO . . . . . 0.774 ' HD3' ' HB2' ' A' ' 269' ' ' GLU . 66.4 Cg_exo -54.0 -35.14 79.91 Favored 'Trans proline' 0 C--N 1.362 1.261 0 C-N-CA 122.137 1.891 . . . . 0.83 112.212 178.36 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 271' ' ' LEU . . . . . . . . . . . . . 51.1 tp -68.54 -54.57 15.85 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.312 -0.404 . . . . 1.05 110.073 178.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -57.6 -40.47 79.15 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 116.282 -0.417 . . . . 1.02 110.918 179.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 273' ' ' GLU . . . . . 0.726 ' HG3' HD12 ' A' ' 160' ' ' LEU . 0.7 OUTLIER -66.43 -44.19 83.57 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.119 -0.491 . . . . 0.33 110.302 178.499 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 274' ' ' THR . . . . . . . . . . . . . 67.5 m -61.46 -43.16 99.35 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-O 120.905 0.383 . . . . 0.93 110.195 178.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 275' ' ' ILE . . . . . 0.583 HG22 ' HE3' ' A' ' 231' ' ' MET . 96.7 mt -59.05 -53.98 40.45 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-N 115.973 -0.558 . . . . 1.08 110.696 178.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 276' ' ' THR . . . . . 0.521 HG22 ' HA ' ' A' ' 160' ' ' LEU . 49.9 m -56.76 -47.08 80.89 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.299 -0.41 . . . . 0.93 110.77 179.476 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 277' ' ' ASP . . . . . 0.599 ' O ' ' HB2' ' A' ' 281' ' ' ARG . 28.0 t70 -55.82 -59.21 5.2 Favored 'General case' 0 C--O 1.222 -0.358 0 CA-C-N 115.632 -0.713 . . . . 0.46 111.157 179.442 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 84.4 t -58.7 -36.98 63.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-O 120.905 0.383 . . . . 1.06 111.384 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . 0.512 HD11 HG23 ' A' ' 245' ' ' ILE . 26.3 tp -63.95 -47.19 81.45 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 116.333 -0.394 . . . . 1.32 112.024 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 60.8 t -80.89 -42.18 20.11 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 N-CA-C 112.272 0.471 . . . . 1.09 112.272 -179.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 281' ' ' ARG . . . . . 0.599 ' HB2' ' O ' ' A' ' 277' ' ' ASP . 2.7 ttt180 -56.49 -43.41 79.63 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 112.936 0.717 . . . . 1.02 112.936 -179.393 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 282' ' ' THR . . . . . . . . . . . . . 51.9 p -83.0 -23.7 33.19 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 113.143 0.794 . . . . 0.62 113.143 -179.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . 0.487 ' HZ1' ' HA ' ' A' ' 279' ' ' LEU . 1.5 mttp -118.04 39.16 3.46 Favored 'General case' 0 C--N 1.329 -0.307 0 O-C-N 122.068 -0.395 . . . . 1.03 111.905 -179.062 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 284' ' ' ARG . . . . . 0.592 ' HD3' ' OE1' ' A' ' 152' ' ' GLU . 31.0 ttp180 -58.65 -48.11 82.16 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.109 -0.496 . . . . 1.44 111.932 -179.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -68.41 -46.08 70.89 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 116.574 -0.285 . . . . 0.52 111.755 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 286' ' ' TRP . . . . . . . . . . . . . 1.8 t90 -61.65 -45.97 91.78 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 112.023 0.379 . . . . 0.6 112.023 -179.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -63.37 -52.25 62.49 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.15 0.426 . . . . 1.06 112.15 -179.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 6.8 p -61.8 -30.74 49.09 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 CA-C-O 120.784 0.326 . . . . 1.19 111.787 -179.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 10.6 ttmt -69.55 -38.78 77.61 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 120.971 0.415 . . . . 1.33 111.121 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 290' ' ' GLN . . . . . 0.445 ' HB3' ' HZ2' ' A' ' 242' ' ' TRP . 0.3 OUTLIER -91.6 22.45 4.05 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 112.231 0.456 . . . . 0.95 112.231 -179.44 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 8.7 mpt_? 61.67 17.61 8.83 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 112.391 0.515 . . . . 0.98 112.391 179.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 58.81 -120.27 21.67 Favored Glycine 0 CA--C 1.523 0.566 0 CA-C-O 121.436 0.464 . . . . 0.52 113.997 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 293' ' ' TRP . . . . . 0.51 ' HB3' ' HB2' ' A' ' 190' ' ' ALA . 84.9 m95 -65.44 -28.56 69.32 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.717 0.636 . . . . 0.57 112.717 -178.74 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 294' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.38 -45.24 91.99 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 121.075 0.464 . . . . 0.56 110.595 179.009 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -69.28 -30.89 71.44 Favored Glycine 0 CA--C 1.518 0.259 0 C-N-CA 120.472 -0.871 . . . . 0.33 111.252 178.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 296' ' ' PHE . . . . . 0.458 ' HB2' ' CZ3' ' A' ' 242' ' ' TRP . 2.5 t80 -69.62 -48.44 59.99 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 115.7 -0.25 . . . . 0.44 111.512 179.013 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 297' ' ' VAL . . . . . 0.607 ' HA ' HG21 ' A' ' 193' ' ' THR . 26.4 m -66.2 -33.83 66.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 N-CA-C 112.113 0.412 . . . . 1.1 112.113 -179.165 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -76.11 -33.08 59.47 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 120.624 0.25 . . . . 1.13 111.052 179.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 299' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -69.7 -38.23 76.88 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.025 0.441 . . . . 0.54 110.456 178.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 300' ' ' PHE . . . . . 0.463 ' CE2' ' HB3' ' A' ' 242' ' ' TRP . 91.2 m-85 -102.52 27.08 7.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.206 0.527 . . . . 0.49 110.691 179.224 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 22.7 t-80 -78.67 130.09 35.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.794 -0.639 . . . . 0.6 111.359 -179.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 20.1 m -96.6 179.46 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.777 -0.647 . . . . 0.95 111.001 179.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 303' ' ' GLN . . . . . 0.762 ' HB3' ' HB2' ' A' ' 306' ' ' GLU . 44.7 mt-30 -83.86 74.09 10.24 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.78 0.324 . . . . 0.73 110.784 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -66.03 -49.62 67.09 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 120.96 0.41 . . . . 0.62 111.813 -179.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 21.5 tp -72.02 -15.42 62.04 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 112.305 0.483 . . . . 1.92 112.305 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 306' ' ' GLU . . . . . 0.762 ' HB2' ' HB3' ' A' ' 303' ' ' GLN . 35.2 mt-10 -101.41 -44.88 5.49 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 112.254 0.464 . . . . 0.85 112.254 -179.413 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . 125.95 47.56 0.21 Allowed Glycine 0 CA--C 1.525 0.689 0 C-N-CA 120.679 -0.772 . . . . 0.78 113.719 179.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.186 0 CA-C-O 118.578 -1.123 . . . . 0.6 113.452 179.689 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.698 0 CA-C-O 121.277 0.56 . . . . 0.95 110.927 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 18' ' ' GLU . . . . . 0.579 ' O ' ' HD3' ' B' ' 20' ' ' PRO . 1.9 pm0 -71.97 81.86 0.93 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.297 -0.865 . . . . 0.59 110.724 179.418 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 19' ' ' LEU . . . . . 0.576 HD12 ' HA ' ' A' ' 216' ' ' LEU . 6.5 mp -107.14 93.12 8.78 Favored Pre-proline 0 CA--C 1.536 0.431 0 N-CA-C 112.587 0.588 . . . . 1.19 112.587 -179.344 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 20' ' ' PRO . . . . . 0.579 ' HD3' ' O ' ' B' ' 18' ' ' GLU . 87.8 Cg_endo -98.45 163.62 0.72 Allowed 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 123.764 2.976 . . . . 0.56 112.143 178.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 21' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -64.32 6.38 0.32 Allowed 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 122.674 2.25 . . . . 0.75 113.482 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 22' ' ' GLU . . . . . 0.44 ' H ' ' C ' ' B' ' 20' ' ' PRO . 4.8 tm-20 -69.78 -35.8 75.18 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.204 -0.453 . . . . 0.79 111.537 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 23' ' ' PHE . . . . . 0.517 ' CE1' HG21 ' A' ' 230' ' ' VAL . 0.2 OUTLIER -62.17 -33.21 74.09 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.763 0.316 . . . . 0.53 111.634 -179.84 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 24' ' ' ALA . . . . . 0.512 ' N ' ' HD1' ' B' ' 23' ' ' PHE . . . -75.63 -36.32 60.26 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.236 0.541 . . . . 0.54 109.872 179.274 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -69.25 -43.02 74.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.618 -0.719 . . . . 0.57 110.198 178.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -60.24 -48.72 80.55 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.074 -0.512 . . . . 0.64 110.854 179.396 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . 0.553 HD13 HD23 ' A' ' 248' ' ' LEU . 89.2 mt -64.73 -33.4 75.89 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 120.92 0.391 . . . . 1.05 110.324 178.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 28' ' ' ARG . . . . . . . . . . . . . 3.6 tmt_? -64.46 -45.73 86.18 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 121.215 0.531 . . . . 1.08 109.722 177.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 33.4 mtpt -71.27 -45.19 63.72 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 115.672 -0.695 . . . . 0.72 111.647 179.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 96.7 mt -62.52 -43.44 98.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-O 120.722 0.296 . . . . 1.09 110.324 179.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . 0.54 ' HA3' ' HG2' ' A' ' 244' ' ' ARG . . . -59.72 -50.25 69.73 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.807 -0.711 . . . . 0.31 112.582 179.437 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -65.81 -32.11 73.45 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.749 0.275 . . . . 0.56 110.754 179.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.9 -52.0 58.89 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 121.097 0.475 . . . . 1.27 109.738 178.307 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 55.2 t -63.04 -45.1 99.66 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-N 115.494 -0.775 . . . . 1.07 110.53 178.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -54.98 -47.05 75.1 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 115.607 -0.724 . . . . 0.69 111.316 179.319 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 36' ' ' CYS . . . . . . . . . . . . . 73.0 m -62.45 -45.07 94.72 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 120.663 0.268 . . . . 0.52 111.303 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 13.1 m -60.4 -37.55 81.19 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 116.316 -0.402 . . . . 1.32 112.033 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 38' ' ' TRP . . . . . . . . . . . . . 93.9 m95 -87.65 -29.47 21.15 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 112.637 0.606 . . . . 0.92 112.637 -179.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 42.2 t -67.76 -31.08 70.73 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 111.982 0.364 . . . . 0.6 111.982 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -89.53 117.57 68.28 Favored Pre-proline 0 CA--C 1.533 0.293 0 CA-C-O 120.745 0.307 . . . . 0.79 111.505 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -71.23 -24.09 23.63 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.64 2.226 . . . . 1.65 112.98 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -74.3 76.37 1.85 Allowed 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 115.999 -0.546 . . . . 1.54 111.089 179.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 43' ' ' MET . . . . . . . . . . . . . 4.5 mmm . . . . . 0 C--O 1.25 1.105 0 CA-C-O 118.307 -0.854 . . . . 2.94 111.712 179.925 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.456 0 CA-C-O 119.8 -0.444 . . . . 3.14 112.423 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -73.06 67.49 4.11 Favored 'Trans proline' 0 CA--C 1.534 0.519 0 C-N-CA 122.595 2.197 . . . . 2.17 112.645 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 90.5 mt -98.58 157.04 16.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.256 -0.429 . . . . 1.42 111.528 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -169.08 -88.29 0.07 OUTLIER Glycine 0 CA--C 1.521 0.448 0 C-N-CA 120.86 -0.686 . . . . 0.61 112.792 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 93.4 p -81.32 60.72 4.51 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.36 0.6 . . . . 1.11 111.294 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.657 ' OE2' ' HD2' ' A' ' 284' ' ' ARG . 4.4 mp0 -110.32 -60.98 1.73 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.853 -0.612 . . . . 0.37 111.753 -179.702 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -46.64 -47.73 20.06 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 113.448 0.907 . . . . 0.52 113.448 -178.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -49.35 -51.62 33.41 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 121.038 0.447 . . . . 0.48 112.142 -179.257 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.505 HD22 ' HB3' ' A' ' 287' ' ' LEU . 44.7 tp -84.47 -40.2 18.0 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.297 -0.41 . . . . 1.48 111.664 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . 0.483 ' OH ' ' HB2' ' A' ' 281' ' ' ARG . 0.3 OUTLIER -52.04 -44.16 64.1 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 112.203 0.446 . . . . 0.47 112.203 -179.766 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.645 ' HD2' ' OE2' ' A' ' 182' ' ' GLU . 21.5 mtm180 -60.56 -51.9 67.46 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 112.145 0.424 . . . . 0.63 112.145 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 1.8 mm100 -63.27 -40.13 96.53 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 121.239 0.542 . . . . 0.67 110.401 179.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 18.4 m -64.89 -50.1 67.89 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.414 -0.812 . . . . 0.34 111.534 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -55.96 -47.89 76.8 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.405 -0.361 . . . . 1.13 111.046 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . 0.607 ' O ' ' HB2' ' A' ' 165' ' ' ARG . 1.4 mm-40 -59.37 -47.26 86.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.402 -0.363 . . . . 0.55 111.294 179.349 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . 0.524 HG12 ' HA2' ' A' ' 187' ' ' GLY . 68.4 mt -66.04 -51.88 55.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 N-CA-C 113.114 0.783 . . . . 1.07 113.114 -179.01 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.498 HD11 HG22 ' A' ' 276' ' ' THR . 56.0 mt -60.18 -54.62 32.39 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 N-CA-C 112.232 0.456 . . . . 1.06 112.232 -178.612 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 70.4 p -59.33 -37.08 76.9 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.63 0.252 . . . . 0.4 111.077 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . 0.625 ' HG2' ' HG ' ' A' ' 180' ' ' LEU . 0.0 OUTLIER -68.92 -36.78 78.39 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 120.959 -0.296 . . . . 0.68 111.256 179.099 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' TYR . . . . . 0.845 ' HE1' ' HA ' ' A' ' 195' ' ' ARG . 67.5 t80 -72.32 -49.16 36.54 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 121.237 -0.185 . . . . 0.98 111.242 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.496 ' HG ' ' O ' ' A' ' 163' ' ' ILE . 38.1 mt -55.99 -41.01 74.17 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.183 0.516 . . . . 1.07 110.316 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 3.7 tpp180 -69.83 -42.99 72.91 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.554 -0.748 . . . . 0.61 110.449 178.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . 0.634 ' HA ' ' HA3' ' A' ' 173' ' ' GLY . 0.4 OUTLIER -56.85 -44.05 81.74 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 116.351 -0.386 . . . . 0.53 111.939 -179.701 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 22.5 tp60 -76.28 -32.9 59.04 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 112.034 0.383 . . . . 0.55 112.034 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . 0.845 ' HA ' ' HG2' ' A' ' 257' ' ' LYS . . . -79.2 -54.24 6.18 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 113.072 0.768 . . . . 0.91 113.072 -179.476 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' THR . . . . . 0.532 ' HB ' ' HG2' ' A' ' 260' ' ' LYS . 11.3 t -147.14 33.41 0.9 Allowed 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.264 0.554 . . . . 1.14 112.135 -177.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . 0.634 ' HA3' ' HA ' ' A' ' 169' ' ' GLU . . . -71.77 28.43 0.62 Allowed Glycine 0 CA--C 1.528 0.902 0 C-N-CA 120.978 -0.629 . . . . 0.53 114.633 -178.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 81.0 p -108.87 -22.38 12.22 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 117.261 0.531 . . . . 0.64 111.305 179.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -142.83 17.42 1.97 Allowed 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.439 -0.346 . . . . 1.27 111.801 -179.683 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . 0.42 ' HB3' ' H ' ' A' ' 177' ' ' SER . 6.2 m-20 -129.48 -159.07 0.93 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.06 0.457 . . . . 0.6 112.055 -178.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' SER . . . . . 0.42 ' H ' ' HB3' ' A' ' 176' ' ' ASP . 71.2 p -63.91 101.31 0.37 Allowed 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.957 -0.565 . . . . 0.56 111.39 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . 0.401 ' HB3' ' HD3' ' A' ' 179' ' ' PRO . 33.4 tttp -104.42 -51.01 0.12 Allowed Pre-proline 0 CA--C 1.544 0.729 0 N-CA-C 112.818 0.673 . . . . 0.62 112.818 -179.364 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . 0.401 ' HD3' ' HB3' ' A' ' 178' ' ' LYS . 89.2 Cg_endo -77.93 157.45 30.94 Favored 'Trans proline' 0 C--N 1.36 1.144 0 C-N-CA 122.037 1.824 . . . . 0.88 113.851 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.625 ' HG ' ' HG2' ' A' ' 165' ' ' ARG . 3.8 mp -95.94 171.5 8.6 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.253 -0.43 . . . . 1.21 111.617 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -119.62 -54.84 0.26 Allowed Glycine 0 CA--C 1.526 0.723 0 C-N-CA 120.553 -0.832 . . . . 0.65 113.772 -178.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . 0.645 ' OE2' ' HD2' ' A' ' 157' ' ' ARG . 5.9 tt0 -94.44 -45.27 7.51 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.238 0.542 . . . . 1.4 110.409 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . 0.669 ' O ' ' HA3' ' A' ' 187' ' ' GLY . . . -80.33 74.14 7.18 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.949 -0.568 . . . . 0.59 110.561 179.498 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -79.94 -69.76 1.38 Allowed Glycine 0 CA--C 1.522 0.496 0 C-N-CA 120.953 -0.642 . . . . 0.45 113.359 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -59.79 -56.01 27.08 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 120.653 0.263 . . . . 0.64 111.535 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -67.69 -32.92 73.91 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.949 -0.389 . . . . 1.18 109.949 179.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . 0.669 ' HA3' ' O ' ' A' ' 183' ' ' ALA . . . -62.63 -48.64 80.02 Favored Glycine 0 C--O 1.224 -0.492 0 CA-C-N 115.685 -0.688 . . . . 0.46 112.97 179.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.28 -50.75 68.88 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 117.221 0.511 . . . . 2.05 110.893 179.313 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . 0.634 ' HB3' HG23 ' A' ' 297' ' ' VAL . 4.4 mtp180 -56.31 -55.15 36.96 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-O 120.971 0.415 . . . . 0.91 111.164 179.346 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . 0.415 ' O ' ' HB2' ' A' ' 194' ' ' LEU . . . -66.98 -40.67 87.46 Favored 'General case' 0 C--O 1.219 -0.51 0 N-CA-C 113.035 0.754 . . . . 0.52 113.035 -178.767 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 14.2 tp -62.45 -44.37 96.58 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 118.475 0.579 . . . . 1.27 111.529 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -67.58 -40.11 84.84 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 121.143 0.497 . . . . 1.16 110.963 179.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' THR . . . . . 0.454 ' OG1' HG13 ' A' ' 297' ' ' VAL . 20.8 m -68.52 -47.26 67.42 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.113 -0.494 . . . . 0.98 110.204 179.035 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . 0.439 HD23 HG22 ' A' ' 249' ' ' ILE . 7.9 tp -60.12 -42.17 94.17 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 115.661 -0.7 . . . . 1.1 110.468 179.26 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . 0.845 ' HA ' ' HE1' ' A' ' 166' ' ' TYR . 0.6 OUTLIER -56.03 -54.08 49.26 Favored 'General case' 0 CA--C 1.522 -0.125 0 CA-C-O 121.243 0.545 . . . . 0.48 110.377 178.268 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 10.9 mmm180 -61.53 -54.03 48.49 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.972 -1.013 . . . . 0.99 112.36 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . 0.489 ' O ' HG22 ' A' ' 201' ' ' VAL . 99.0 t -61.36 -46.31 96.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 N-CA-C 111.899 0.333 . . . . 1.12 111.899 -179.361 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . 0.524 ' HA3' ' OH ' ' A' ' 166' ' ' TYR . . . -62.24 -50.43 65.1 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 121.244 -0.503 . . . . 0.33 112.242 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . 0.462 ' HB2' ' O ' ' A' ' 195' ' ' ARG . 0.3 OUTLIER -58.27 -43.1 87.77 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 120.856 0.36 . . . . 0.47 110.117 178.846 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -61.68 -48.36 84.81 Favored Glycine 0 CA--C 1.525 0.708 0 C-N-CA 121.021 -0.609 . . . . 0.42 112.303 178.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . 0.489 HG22 ' O ' ' A' ' 197' ' ' VAL . 71.0 t -62.37 -43.18 97.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-O 120.943 0.402 . . . . 0.81 110.607 178.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' GLN . . . . . 0.547 ' HB3' ' NH2' ' A' ' 203' ' ' ARG . 68.8 mt-30 -63.41 -55.2 26.24 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.583 -0.735 . . . . 0.74 112.098 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' ARG . . . . . 0.547 ' NH2' ' HB3' ' A' ' 202' ' ' GLN . 0.0 OUTLIER -58.15 -34.41 70.25 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 112.157 0.428 . . . . 0.48 112.157 -178.822 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 17.7 m-80 -75.34 -43.79 48.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.895 0.378 . . . . 0.8 111.489 179.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' HIS . . . . . 0.462 ' CD2' HG21 ' B' ' 30' ' ' ILE . 95.2 m-70 -100.9 35.95 2.07 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.8 0.333 . . . . 0.67 111.68 -179.598 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . 0.453 ' HG2' ' HA ' ' A' ' 203' ' ' ARG . 26.9 mm-40 -55.68 -35.64 66.25 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 112.4 0.519 . . . . 0.53 112.4 -179.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 19.4 p -63.15 -52.64 61.65 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.808 0.337 . . . . 1.17 111.6 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -63.41 -40.57 97.56 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.154 -0.475 . . . . 1.11 110.919 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' PHE . . . . . 0.425 ' CE2' ' HA ' ' A' ' 202' ' ' GLN . 25.9 m-85 -68.04 -49.49 61.09 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.094 -0.503 . . . . 0.58 111.547 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -65.31 -38.91 91.65 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 121.266 -0.174 . . . . 0.58 111.021 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -59.23 -45.71 94.95 Favored Glycine 0 C--N 1.334 0.443 0 C-N-CA 120.448 -0.882 . . . . 0.31 110.991 178.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' MET . . . . . 0.481 ' SD ' ' HA ' ' B' ' 23' ' ' PHE . 56.9 mtm -70.62 -33.78 71.39 Favored 'General case' 0 C--O 1.223 -0.324 0 N-CA-C 110.25 -0.278 . . . . 1.15 110.25 178.196 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . 0.442 HD21 ' HA ' ' A' ' 213' ' ' LEU . 0.3 OUTLIER -65.8 -43.84 87.47 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.351 -0.386 . . . . 0.84 111.302 179.506 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 71.9 mtp180 -66.11 -38.46 88.25 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.916 0.389 . . . . 1.15 110.84 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 54.9 mtmt -91.42 11.57 23.44 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.288 -0.415 . . . . 1.09 111.287 179.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . 0.477 HD23 HD12 ' A' ' 218' ' ' ILE . 6.5 tp -79.26 99.07 6.89 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.14 0.495 . . . . 1.06 111.361 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -83.25 32.07 0.45 Allowed 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.7 -0.682 . . . . 0.43 111.191 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' ILE . . . . . 0.758 HG12 ' HB3' ' A' ' 223' ' ' ASP . 36.4 mt -81.1 106.74 12.64 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-O 121.069 0.461 . . . . 0.96 110.709 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 8.2 mppt? -140.92 -24.45 0.76 Allowed 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 115.696 -0.684 . . . . 0.83 111.978 -179.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -116.28 171.1 8.04 Favored 'General case' 0 CA--C 1.533 0.296 0 O-C-N 121.875 -0.516 . . . . 1.33 111.68 -179.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -58.48 -31.45 67.85 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 120.955 0.407 . . . . 0.68 111.197 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -62.45 -26.72 68.47 Favored Glycine 0 CA--C 1.524 0.627 0 CA-C-N 115.978 -0.555 . . . . 0.51 113.117 179.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' ASP . . . . . 0.758 ' HB3' HG12 ' A' ' 218' ' ' ILE . 55.5 m-20 -68.66 -34.11 75.15 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 117.024 0.412 . . . . 0.38 111.488 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 16.4 t -62.23 -29.41 46.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-O 121.556 0.693 . . . . 0.55 110.16 178.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 32.2 mmtm -72.67 -33.48 66.58 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 115.533 -0.758 . . . . 0.61 110.441 179.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' SER . . . . . 0.442 ' O ' HG22 ' A' ' 230' ' ' VAL . 33.6 t -68.13 -38.65 82.44 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.381 0.61 . . . . 1.29 109.585 178.329 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -63.54 -38.36 90.83 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 115.211 -0.904 . . . . 0.58 109.503 178.107 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 46.8 t -62.53 -37.44 86.1 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 115.442 -0.799 . . . . 0.71 109.951 178.165 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 84.3 mtp180 -63.07 -39.67 95.4 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.013 -0.539 . . . . 0.71 109.882 178.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . 0.442 HG22 ' O ' ' A' ' 226' ' ' SER . 18.2 t -59.3 -46.14 92.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-N 116.324 -0.398 . . . . 1.0 110.5 178.143 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' MET . . . . . 0.512 ' HE1' HG21 ' A' ' 275' ' ' ILE . 7.3 tpp -55.33 -52.2 64.28 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.933 -0.576 . . . . 0.99 110.929 179.605 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 232' ' ' VAL . . . . . 0.518 ' O ' ' HB2' ' A' ' 236' ' ' LYS . 38.2 t -66.89 -36.71 77.85 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-N 116.262 -0.426 . . . . 0.56 111.362 179.511 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 54.0 t-80 -65.48 -52.55 52.06 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 112.057 0.392 . . . . 0.79 112.057 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 97.0 t -63.98 -39.09 84.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 N-CA-C 112.078 0.399 . . . . 1.03 112.078 -179.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 235' ' ' PHE . . . . . 0.555 ' HZ ' ' HA ' ' A' ' 245' ' ' ILE . 63.0 m-85 -91.84 10.94 26.52 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.412 0.523 . . . . 0.72 112.412 -179.397 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . 0.554 ' HE2' ' HA ' ' A' ' 236' ' ' LYS . 0.3 OUTLIER -76.0 -11.43 59.95 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 111.873 0.323 . . . . 0.9 111.873 -179.807 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -69.97 -16.73 63.24 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 120.855 0.359 . . . . 0.42 111.262 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 89.28 -19.83 37.2 Favored Glycine 0 CA--C 1.521 0.442 0 C-N-CA 121.168 -0.539 . . . . 0.47 111.959 -178.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 2.4 t -80.39 112.03 17.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.048 0.452 . . . . 1.52 111.093 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 1.9 m -94.47 91.32 6.58 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.37 -0.377 . . . . 0.92 111.046 179.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -101.56 135.22 43.44 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.77 0.319 . . . . 0.51 111.389 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 242' ' ' TRP . . . . . 0.646 ' HB3' ' CZ ' ' A' ' 300' ' ' PHE . 7.2 m95 -55.0 -44.01 74.14 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 116.311 -0.404 . . . . 0.49 111.761 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -59.21 -37.02 91.2 Favored Glycine 0 CA--C 1.524 0.619 0 C-N-CA 121.086 -0.578 . . . . 0.29 112.868 179.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 63.9 mtt180 -68.46 -43.45 77.0 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 109.777 -0.453 . . . . 0.47 109.777 178.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . 0.555 ' HA ' ' HZ ' ' A' ' 235' ' ' PHE . 84.7 mt -59.99 -50.67 79.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-N 115.58 -0.736 . . . . 0.92 111.569 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . 0.403 HG22 ' O ' ' A' ' 242' ' ' TRP . 16.1 m -67.04 -28.03 41.49 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 C-N-CA 120.769 -0.373 . . . . 1.05 111.411 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 23.1 m -61.79 -48.62 79.81 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 109.754 -0.461 . . . . 1.06 109.754 178.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -60.2 -42.47 95.19 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.063 -0.517 . . . . 1.18 110.312 178.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 249' ' ' ILE . . . . . 0.439 HG22 HD23 ' A' ' 194' ' ' LEU . 43.3 mm -63.99 -44.99 97.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 CA-C-N 116.238 -0.437 . . . . 1.17 110.499 178.521 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 250' ' ' SER . . . . . 0.434 ' HB2' ' HG3' ' A' ' 202' ' ' GLN . 54.4 p -62.19 -36.61 82.44 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.816 0.341 . . . . 0.65 110.17 178.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 251' ' ' PHE . . . . . 0.435 ' CD2' HD13 ' B' ' 27' ' ' LEU . 13.2 t80 -69.71 -40.33 76.35 Favored 'General case' 0 C--O 1.232 0.142 0 N-CA-C 108.704 -0.85 . . . . 0.57 108.704 177.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -57.76 -37.32 83.41 Favored Glycine 0 C--N 1.336 0.566 0 N-CA-C 110.683 -0.967 . . . . 0.28 110.683 177.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 253' ' ' ALA . . . . . 0.434 ' O ' ' HG3' ' A' ' 257' ' ' LYS . . . -68.68 -41.33 79.4 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 120.767 0.318 . . . . 0.39 110.185 177.332 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -63.29 -44.5 94.89 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 116.236 -0.438 . . . . 0.48 110.896 178.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 255' ' ' VAL . . . . . 0.448 HG22 HD22 ' A' ' 271' ' ' LEU . 16.3 m -70.91 -26.34 27.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-O 120.819 0.342 . . . . 0.81 110.472 178.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -66.72 -39.25 87.92 Favored 'General case' 0 C--N 1.339 0.12 0 N-CA-C 108.454 -0.943 . . . . 0.46 108.454 177.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 257' ' ' LYS . . . . . 0.845 ' HG2' ' HA ' ' A' ' 171' ' ' ALA . 24.2 mtpp -65.16 -36.52 84.47 Favored 'General case' 0 C--O 1.225 -0.199 0 CA-C-N 115.351 -0.84 . . . . 0.96 109.646 177.503 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 63.6 t60 -59.54 -49.03 79.35 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 109.957 -0.386 . . . . 0.52 109.957 177.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . 0.458 HD23 HG23 ' A' ' 218' ' ' ILE . 95.9 mt -68.79 -36.08 77.82 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.038 -0.528 . . . . 1.11 110.453 178.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 260' ' ' LYS . . . . . 0.532 ' HG2' ' HB ' ' A' ' 172' ' ' THR . 5.0 tptp -67.47 -36.57 81.41 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 120.774 0.321 . . . . 0.66 111.048 179.116 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 35.3 t -64.89 -25.86 68.07 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.184 -0.462 . . . . 0.62 111.325 179.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 26.8 m -107.78 11.0 9.04 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 CA-C-N 116.424 -0.353 . . . . 1.14 110.968 178.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 58.98 48.23 11.13 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 113.202 0.816 . . . . 1.95 113.202 179.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 14.7 mt-30 -114.99 36.28 3.95 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.457 -0.338 . . . . 0.82 111.064 178.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . 0.551 ' HA ' HD12 ' A' ' 268' ' ' ILE . 1.8 pm0 -52.62 -29.21 24.81 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 112.407 0.521 . . . . 0.55 112.407 179.412 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 9.3 p -59.96 -20.19 56.23 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 120.725 0.298 . . . . 0.87 111.049 178.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 267' ' ' PHE . . . . . 0.433 ' C ' ' HD2' ' A' ' 270' ' ' PRO . 41.7 m-85 -98.01 -18.87 18.36 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 121.109 0.48 . . . . 0.71 110.181 178.425 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 268' ' ' ILE . . . . . 0.551 HD12 ' HA ' ' A' ' 265' ' ' GLU . 72.4 mt -68.58 -39.57 80.67 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 CA-C-N 115.849 -0.614 . . . . 1.12 110.4 178.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 269' ' ' GLU . . . . . 0.695 ' HB2' ' HD3' ' A' ' 270' ' ' PRO . 1.5 mm-40 -56.38 -56.94 26.39 Favored Pre-proline 0 CA--C 1.543 0.686 0 CA-C-N 116.287 -0.415 . . . . 0.49 111.036 179.27 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 270' ' ' PRO . . . . . 0.695 ' HD3' ' HB2' ' A' ' 269' ' ' GLU . 34.7 Cg_exo -61.68 -34.89 82.91 Favored 'Trans proline' 0 C--N 1.361 1.233 0 C-N-CA 121.954 1.769 . . . . 0.37 111.435 177.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 271' ' ' LEU . . . . . 0.448 HD22 HG22 ' A' ' 255' ' ' VAL . 26.8 tp -62.61 -51.07 68.75 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.182 -0.463 . . . . 1.19 110.251 178.487 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -59.09 -41.12 87.3 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 116.104 -0.498 . . . . 0.53 110.12 178.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 273' ' ' GLU . . . . . . . . . . . . . 62.2 mm-40 -63.34 -45.48 91.01 Favored 'General case' 0 C--O 1.225 -0.189 0 CA-C-N 115.761 -0.654 . . . . 1.05 109.831 177.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 274' ' ' THR . . . . . . . . . . . . . 87.5 m -62.2 -44.02 97.51 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.917 -0.583 . . . . 0.92 111.179 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 275' ' ' ILE . . . . . 0.512 HG21 ' HE1' ' A' ' 231' ' ' MET . 94.4 mt -58.66 -50.48 78.98 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 CA-C-O 120.984 0.421 . . . . 1.05 110.286 179.008 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 276' ' ' THR . . . . . 0.498 HG22 HD11 ' A' ' 163' ' ' ILE . 24.1 m -63.12 -46.17 88.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.041 -0.527 . . . . 0.57 110.669 178.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 277' ' ' ASP . . . . . 0.422 ' CG ' HH12 ' A' ' 281' ' ' ARG . 36.1 t70 -51.69 -60.72 2.84 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.309 -0.86 . . . . 0.35 112.442 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 21.8 t -66.35 -37.25 79.25 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 N-CA-C 113.058 0.762 . . . . 0.53 113.058 -178.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 32.5 tp -70.67 -48.47 54.66 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 112.855 0.687 . . . . 1.24 112.855 -178.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 58.2 t -70.73 -34.82 58.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 N-CA-C 112.595 0.591 . . . . 0.66 112.595 -178.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 281' ' ' ARG . . . . . 0.483 ' HB2' ' OH ' ' A' ' 156' ' ' TYR . 21.9 ttp-105 -72.79 -51.39 19.21 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.407 0.521 . . . . 0.46 112.407 -179.684 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 282' ' ' THR . . . . . . . . . . . . . 10.1 m -60.6 -35.34 75.89 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 112.168 0.432 . . . . 0.69 112.168 -178.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 64.9 mmtt -115.96 38.78 3.23 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 122.225 -0.297 . . . . 0.7 111.611 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 284' ' ' ARG . . . . . 0.657 ' HD2' ' OE2' ' A' ' 152' ' ' GLU . 0.2 OUTLIER -62.13 -54.01 47.28 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 112.812 0.671 . . . . 0.45 112.812 -179.066 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 285' ' ' ASP . . . . . 0.544 ' H ' ' HG3' ' A' ' 284' ' ' ARG . 0.2 OUTLIER -60.27 -39.44 86.85 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 112.128 0.418 . . . . 0.52 112.128 -178.855 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 286' ' ' TRP . . . . . 0.46 ' O ' ' HB2' ' A' ' 290' ' ' GLN . 12.4 t90 -67.14 -41.58 85.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.808 0.337 . . . . 0.55 110.921 179.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 287' ' ' LEU . . . . . 0.505 ' HB3' HD22 ' A' ' 155' ' ' LEU . 2.0 mm? -70.6 -48.4 55.36 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.298 -0.41 . . . . 1.07 112.078 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 288' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 284' ' ' ARG . 26.9 m -59.88 -37.84 73.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 N-CA-C 111.901 0.334 . . . . 0.53 111.901 -179.678 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 54.1 mttp -75.52 -23.95 56.74 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-O 120.789 0.328 . . . . 0.77 111.274 179.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 290' ' ' GLN . . . . . 0.46 ' HB2' ' O ' ' A' ' 286' ' ' TRP . 1.5 tp-100 -91.06 17.58 7.84 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.604 -0.271 . . . . 0.66 111.659 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 36.0 mtp180 64.69 15.38 9.71 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 112.025 0.38 . . . . 0.57 112.025 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 63.71 -132.47 40.81 Favored Glycine 0 CA--C 1.523 0.593 0 CA-C-O 121.462 0.479 . . . . 0.42 114.01 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 293' ' ' TRP . . . . . 0.602 ' O ' HG21 ' A' ' 297' ' ' VAL . 77.4 m95 -67.05 -25.18 66.13 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.019 0.377 . . . . 0.5 112.019 -178.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 294' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -56.73 -48.38 77.89 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 109.852 -0.425 . . . . 0.78 109.852 178.324 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -68.7 -38.85 86.28 Favored Glycine 0 C--N 1.336 0.574 0 N-CA-C 111.24 -0.744 . . . . 0.37 111.24 178.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 296' ' ' PHE . . . . . 0.511 ' HB3' ' HA ' ' A' ' 293' ' ' TRP . 0.9 OUTLIER -57.74 -45.63 85.59 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 120.769 0.318 . . . . 0.5 111.064 178.498 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 297' ' ' VAL . . . . . 0.634 HG23 ' HB3' ' A' ' 189' ' ' ARG . 78.3 t -65.8 -40.41 87.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-N 116.015 -0.539 . . . . 1.14 111.269 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -66.53 -48.26 70.3 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.207 -0.451 . . . . 0.63 111.476 179.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 299' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -62.26 -51.08 69.18 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.053 0.454 . . . . 0.61 110.843 179.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 300' ' ' PHE . . . . . 0.646 ' CZ ' ' HB3' ' A' ' 242' ' ' TRP . 49.6 m-85 -80.36 33.23 0.29 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.091 -0.504 . . . . 0.68 112.316 -179.667 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 14.9 t-80 -56.62 150.74 15.06 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 109.628 -0.508 . . . . 1.02 109.628 178.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 2.0 m -66.74 74.1 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 N-CA-C 112.707 0.632 . . . . 1.71 112.707 -179.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 303' ' ' GLN . . . . . 0.711 ' HG3' ' HA2' ' A' ' 308' ' ' GLY . 0.8 OUTLIER -61.27 -22.51 64.9 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 121.395 0.617 . . . . 1.25 110.267 178.632 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -78.29 -12.93 60.03 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.496 -0.775 . . . . 1.63 111.693 179.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 96.9 mt -117.92 -25.85 6.63 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.25 0.463 . . . . 2.06 112.25 -179.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -124.95 9.99 8.19 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 112.913 0.709 . . . . 1.38 112.913 -179.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . 80.17 -62.08 4.3 Favored Glycine 0 CA--C 1.525 0.712 0 C-N-CA 120.757 -0.735 . . . . 1.66 114.141 178.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 308' ' ' GLY . . . . . 0.711 ' HA2' ' HG3' ' A' ' 303' ' ' GLN . . . . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.272 -1.294 . . . . 1.81 113.146 -179.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.507 0 N-CA-C 112.321 0.489 . . . . 0.66 112.321 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -92.67 94.42 9.01 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 121.014 0.435 . . . . 1.89 111.504 -178.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 19' ' ' LEU . . . . . 0.434 HD11 ' HA ' ' B' ' 19' ' ' LEU . 3.3 tp -104.64 122.89 42.05 Favored Pre-proline 0 CA--C 1.535 0.368 0 CA-C-O 120.894 0.378 . . . . 1.13 111.455 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 20' ' ' PRO . . . . . 0.41 ' HA ' ' HD3' ' B' ' 21' ' ' PRO . 18.5 Cg_endo -58.08 123.93 14.8 Favored 'Trans proline' 0 C--N 1.352 0.738 0 C-N-CA 123.581 2.854 . . . . 0.63 113.497 -179.22 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 21' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' B' ' 20' ' ' PRO . 24.5 Cg_exo -63.61 -0.23 2.34 Favored 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 123.442 2.761 . . . . 0.57 114.399 -178.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 22' ' ' GLU . . . . . 0.479 ' O ' ' HB2' ' B' ' 26' ' ' GLN . 1.8 mt-10 -67.93 -25.87 65.69 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.224 0.453 . . . . 1.02 112.224 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 23' ' ' PHE . . . . . 0.499 ' HD1' ' N ' ' B' ' 24' ' ' ALA . 0.1 OUTLIER -55.74 -32.17 63.17 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 112.843 0.683 . . . . 0.45 112.843 -178.924 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 24' ' ' ALA . . . . . 0.663 ' O ' ' HB2' ' B' ' 28' ' ' ARG . . . -69.95 -51.59 31.47 Favored 'General case' 0 C--N 1.322 -0.593 0 O-C-N 122.023 -0.423 . . . . 0.99 111.713 -179.019 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -74.1 -41.41 61.7 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.108 0.41 . . . . 0.68 112.108 -179.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 26' ' ' GLN . . . . . 0.479 ' HB2' ' O ' ' B' ' 22' ' ' GLU . 1.1 tp-100 -62.04 -54.92 34.75 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.326 -0.397 . . . . 0.39 111.297 -179.396 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . 0.435 HD13 ' CD2' ' A' ' 251' ' ' PHE . 70.2 mt -63.47 -37.56 87.75 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.96 -0.296 . . . . 1.01 110.58 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 28' ' ' ARG . . . . . 0.663 ' HB2' ' O ' ' B' ' 24' ' ' ALA . 0.0 OUTLIER -57.88 -57.38 13.06 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 120.694 0.283 . . . . 0.49 111.437 179.292 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 18.8 mmmt -66.48 -35.08 79.37 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.425 -0.352 . . . . 0.58 111.563 -179.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . 0.462 HG21 ' CD2' ' A' ' 205' ' ' HIS . 43.4 mt -64.15 -42.76 96.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 N-CA-C 108.946 -0.761 . . . . 1.08 108.946 177.514 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -58.88 -49.44 78.02 Favored Glycine 0 C--N 1.334 0.449 0 CA-C-N 115.961 -0.563 . . . . 0.3 112.42 178.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -55.55 -44.91 77.24 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 121.16 0.505 . . . . 0.45 110.759 178.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 33' ' ' LYS . . . . . 0.461 ' HZ2' ' HB2' ' B' ' 33' ' ' LYS . 2.2 ttmp? -65.87 -52.34 51.08 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 115.654 -0.703 . . . . 1.53 111.098 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 40.4 t -56.33 -45.37 81.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-O 121.135 0.493 . . . . 0.79 110.741 178.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -56.69 -49.66 74.44 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 115.597 -0.729 . . . . 1.12 110.447 178.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 36' ' ' CYS . . . . . . . . . . . . . 5.9 t -66.13 -34.21 77.54 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 120.825 0.345 . . . . 1.15 111.027 179.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 52.2 m -62.85 -51.79 65.65 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 112.364 0.505 . . . . 0.76 112.364 -179.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 38' ' ' TRP . . . . . . . . . . . . . 96.7 m95 -73.65 -30.38 62.9 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.345 0.498 . . . . 0.98 112.345 -179.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 23.0 t -65.33 -24.89 67.38 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 111.801 0.297 . . . . 1.03 111.801 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -90.21 117.68 68.23 Favored Pre-proline 0 CA--C 1.536 0.419 0 N-CA-C 111.98 0.363 . . . . 0.96 111.98 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -86.28 157.32 9.61 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 122.763 2.309 . . . . 1.54 113.22 179.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -86.93 77.24 9.26 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 121.022 0.439 . . . . 2.68 110.867 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 43' ' ' MET . . . . . . . . . . . . . 23.4 mmt . . . . . 0 C--O 1.251 1.164 0 CA-C-O 118.184 -0.912 . . . . 5.82 111.49 -179.62 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.351 0 CA-C-O 119.924 -0.375 . . . . 1.42 112.389 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -70.67 107.81 2.11 Favored 'Trans proline' 0 CA--C 1.532 0.42 0 C-N-CA 122.84 2.36 . . . . 1.08 112.655 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 90.1 mt -77.43 79.18 3.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.985 0.421 . . . . 1.35 111.356 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -155.79 -173.72 24.76 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 121.024 -0.608 . . . . 0.6 112.275 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 46.6 t -75.41 94.15 3.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.366 0.603 . . . . 0.55 111.53 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -142.9 -63.67 0.41 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.757 -0.656 . . . . 0.66 110.621 179.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -60.7 -36.52 78.99 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.184 -0.462 . . . . 0.59 111.278 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -57.92 -44.99 87.21 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.056 -0.52 . . . . 0.44 110.685 178.428 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 35.0 tp -76.94 -29.3 55.56 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-O 121.323 0.582 . . . . 1.13 109.955 178.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 87.8 t80 -63.89 -30.79 71.84 Favored 'General case' 0 C--O 1.223 -0.338 0 CA-C-N 115.666 -0.697 . . . . 0.43 110.369 178.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.533 ' HD3' ' OE1' ' A' ' 182' ' ' GLU . 45.0 mtt180 -60.72 -51.91 67.36 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.028 0.442 . . . . 0.81 110.261 178.431 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 32.1 mt-30 -59.66 -43.99 93.73 Favored 'General case' 0 N--CA 1.46 0.071 0 CA-C-N 115.701 -0.681 . . . . 1.13 109.515 178.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' SER . . . . . 0.562 ' HA ' ' CZ2' ' A' ' 293' ' ' TRP . 18.5 m -60.38 -58.67 7.49 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.191 -0.913 . . . . 0.49 111.531 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.554 ' HA ' HG21 ' A' ' 276' ' ' THR . 1.4 tm? -53.98 -49.67 68.28 Favored 'General case' 0 CA--C 1.529 0.139 0 O-C-N 123.203 0.315 . . . . 1.1 110.93 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . 0.677 ' HG2' HD22 ' A' ' 180' ' ' LEU . 36.5 tt0 -60.06 -53.55 56.42 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 116.488 -0.324 . . . . 0.44 111.836 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . 0.461 HD12 ' HA2' ' A' ' 187' ' ' GLY . 89.7 mt -61.82 -48.75 87.17 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 N-CA-C 112.567 0.58 . . . . 1.07 112.567 -178.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.537 ' O ' ' HG ' ' A' ' 167' ' ' LEU . 80.8 mt -63.93 -52.33 58.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 N-CA-C 112.154 0.427 . . . . 1.1 112.154 -179.038 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.87 -39.78 72.01 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 120.916 0.388 . . . . 0.36 110.534 179.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . 0.518 ' HD2' ' OE2' ' A' ' 169' ' ' GLU . 0.6 OUTLIER -65.77 -52.07 53.92 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.408 -0.36 . . . . 0.63 110.537 178.457 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' TYR . . . . . 0.822 ' HE1' ' HA ' ' A' ' 195' ' ' ARG . 81.4 t80 -55.56 -47.24 76.7 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 112.447 0.536 . . . . 0.38 112.447 -179.48 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.537 ' HG ' ' O ' ' A' ' 163' ' ' ILE . 28.0 mt -64.03 -39.1 93.34 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 120.88 -0.328 . . . . 1.1 110.641 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -66.45 -38.45 87.4 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.958 0.408 . . . . 0.47 110.301 178.297 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . 0.518 ' OE2' ' HD2' ' A' ' 165' ' ' ARG . 0.4 OUTLIER -70.26 -38.35 75.1 Favored 'General case' 0 CA--C 1.528 0.111 0 CA-C-N 116.08 -0.509 . . . . 0.62 110.767 178.58 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . 0.674 ' HG2' ' HB2' ' A' ' 253' ' ' ALA . 6.1 tp60 -68.53 -42.13 78.9 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 116.37 -0.377 . . . . 0.37 110.249 178.455 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . 0.775 ' HA ' ' HG2' ' A' ' 257' ' ' LYS . . . -59.31 -40.5 86.43 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.807 -0.633 . . . . 1.09 111.977 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 76.5 p -87.08 -27.54 23.07 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 121.121 0.486 . . . . 1.12 110.945 178.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 97.36 -20.0 52.48 Favored Glycine 0 CA--C 1.522 0.476 0 CA-C-N 115.655 -0.702 . . . . 0.43 112.501 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 40.7 t -167.5 165.52 14.68 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 122.76 0.424 . . . . 1.0 110.108 -179.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 2.6 tppp? -166.76 -68.11 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.128 0.489 . . . . 0.87 110.178 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -164.61 168.95 17.6 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.494 -0.775 . . . . 0.77 110.121 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 46.8 t -107.73 -1.17 21.25 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.017 -0.538 . . . . 1.97 110.463 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . 0.433 ' HA ' ' HD3' ' A' ' 179' ' ' PRO . 56.1 mttp -69.96 151.34 96.2 Favored Pre-proline 0 C--O 1.237 0.431 0 CA-C-N 115.514 -0.766 . . . . 1.34 111.95 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 178' ' ' LYS . 16.1 Cg_exo -68.87 -169.16 0.27 Allowed 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 123.194 2.596 . . . . 1.15 113.193 179.639 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.677 HD22 ' HG2' ' A' ' 161' ' ' GLU . 5.2 mp -98.84 -163.37 1.03 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.4 -0.364 . . . . 1.18 111.71 -178.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -102.75 -52.96 0.93 Allowed Glycine 0 C--N 1.331 0.277 0 C-N-CA 120.757 -0.735 . . . . 0.44 112.256 -179.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . 0.533 ' OE1' ' HD3' ' A' ' 157' ' ' ARG . 31.3 mt-10 -84.83 -53.08 5.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.152 0.501 . . . . 0.53 110.28 179.52 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . 0.565 ' O ' ' HA3' ' A' ' 187' ' ' GLY . . . -87.01 86.26 7.3 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.379 -0.373 . . . . 0.42 110.406 178.678 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -79.93 -71.5 1.26 Allowed Glycine 0 CA--C 1.528 0.886 0 C-N-CA 120.833 -0.699 . . . . 0.45 114.755 -179.051 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -70.79 -55.83 7.71 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 117.203 0.501 . . . . 0.71 111.646 -178.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -65.59 -35.24 80.25 Favored 'General case' 0 C--O 1.222 -0.342 0 CA-C-N 115.979 -0.555 . . . . 0.53 110.111 178.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . 0.565 ' HA3' ' O ' ' A' ' 183' ' ' ALA . . . -66.93 -49.9 51.02 Favored Glycine 0 C--O 1.225 -0.454 0 CA-C-N 115.762 -0.653 . . . . 0.42 112.845 179.237 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 4.2 tpt180 -55.26 -46.9 76.09 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 117.174 0.487 . . . . 1.05 110.113 178.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . 0.601 ' HB3' HG12 ' A' ' 297' ' ' VAL . 50.7 mtm180 -66.9 -40.24 87.68 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.92 -0.582 . . . . 0.41 110.616 179.275 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -65.27 -40.43 93.89 Favored 'General case' 0 C--O 1.223 -0.338 0 CA-C-N 116.334 -0.394 . . . . 0.84 111.511 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 13.6 tp -64.58 -41.0 96.55 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 110.247 -0.279 . . . . 1.19 110.247 178.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 15.8 tm-20 -65.68 -50.63 64.22 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 109.732 -0.47 . . . . 0.42 109.732 178.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' THR . . . . . 0.423 HG23 ' HA ' ' A' ' 297' ' ' VAL . 8.5 m -60.05 -43.22 95.54 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.905 -0.589 . . . . 1.05 110.974 179.46 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 7.4 tp -65.59 -41.92 92.27 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 116.233 -0.44 . . . . 1.15 111.829 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . 0.822 ' HA ' ' HE1' ' A' ' 166' ' ' TYR . 8.8 tpt180 -67.35 -38.71 85.24 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.093 0.473 . . . . 0.5 110.538 179.322 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 15.2 ttm180 -67.01 -56.71 8.95 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 115.78 -0.645 . . . . 0.57 111.999 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 34.7 t -71.56 -38.59 68.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 111.95 0.352 . . . . 0.43 111.95 -178.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . 0.627 ' O ' ' HB2' ' A' ' 202' ' ' GLN . . . -62.02 -54.04 38.12 Favored Glycine 0 C--N 1.331 0.275 0 C-N-CA 121.052 -0.595 . . . . 0.29 112.793 -179.576 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.81 -38.8 92.2 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 117.045 0.422 . . . . 0.37 110.675 179.211 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -59.86 -48.63 85.13 Favored Glycine 0 CA--C 1.524 0.626 0 C-N-CA 120.744 -0.741 . . . . 0.33 112.137 178.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 73.7 t -70.46 -42.29 78.34 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-O 120.862 0.363 . . . . 0.51 110.816 178.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' GLN . . . . . 0.627 ' HB2' ' O ' ' A' ' 198' ' ' GLY . 2.1 tt0 -58.87 -53.34 59.49 Favored 'General case' 0 C--O 1.224 -0.278 0 CA-C-N 115.652 -0.704 . . . . 0.49 111.807 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' ARG . . . . . 0.503 ' HA ' ' OE1' ' A' ' 206' ' ' GLU . 0.0 OUTLIER -64.4 -35.2 80.12 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-O 120.718 0.294 . . . . 0.4 110.393 179.779 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -65.94 -49.82 66.58 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 121.027 0.441 . . . . 0.86 110.765 178.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 72.1 m-70 -100.75 36.09 2.02 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.425 -0.352 . . . . 0.65 111.47 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . 0.503 ' OE1' ' HA ' ' A' ' 203' ' ' ARG . 3.7 tp10 -55.53 -49.0 73.79 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.222 -0.444 . . . . 0.4 111.212 -179.543 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 69.4 p -62.98 -42.8 99.94 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.983 -0.553 . . . . 0.89 111.52 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -61.8 -46.11 90.95 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.018 0.437 . . . . 0.56 110.306 178.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' PHE . . . . . 0.604 ' HE2' ' HA ' ' A' ' 202' ' ' GLN . 16.8 m-30 -65.43 -44.11 88.35 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.98 -0.555 . . . . 0.58 110.06 179.331 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -61.23 -44.08 97.84 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.091 -0.504 . . . . 1.03 110.594 178.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -60.07 -48.58 85.43 Favored Glycine 0 C--N 1.334 0.444 0 N-CA-C 111.205 -0.758 . . . . 0.39 111.205 178.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' MET . . . . . 0.525 ' O ' ' HG ' ' A' ' 216' ' ' LEU . 1.2 mtp -64.31 -35.03 79.53 Favored 'General case' 0 C--O 1.224 -0.253 0 CA-C-O 120.655 0.264 . . . . 1.28 110.312 178.407 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . 0.426 HD21 ' HA ' ' A' ' 213' ' ' LEU . 0.4 OUTLIER -60.61 -47.99 83.75 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.239 -0.437 . . . . 1.19 110.004 178.473 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 73.0 mtp180 -61.97 -31.71 72.09 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.122 -0.49 . . . . 1.33 111.016 179.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -84.95 -9.09 58.43 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.12 -0.491 . . . . 1.75 111.682 179.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . 0.525 ' HG ' ' O ' ' A' ' 212' ' ' MET . 20.3 mt -82.41 142.89 31.59 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.155 0.502 . . . . 1.17 112.295 -179.531 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -102.07 5.74 40.66 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.846 -0.616 . . . . 0.66 110.212 178.403 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' ILE . . . . . 0.61 HG22 ' HE2' ' A' ' 267' ' ' PHE . 21.0 mm -55.33 106.93 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 CA-C-N 115.9 -0.591 . . . . 1.16 112.319 -178.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 6.1 mtmp? -143.48 -42.19 0.29 Allowed 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 112.373 0.509 . . . . 0.81 112.373 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 18.2 m-80 -124.1 -178.91 4.22 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 113.085 0.772 . . . . 1.51 113.085 -178.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . 0.572 ' O ' HG22 ' A' ' 224' ' ' VAL . 12.2 tm-20 -51.92 -37.61 53.24 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 112.867 0.691 . . . . 0.76 112.867 -179.184 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -63.83 -26.47 70.06 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 120.816 -0.707 . . . . 0.41 113.622 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' ASP . . . . . 0.54 ' HB3' ' HA ' ' A' ' 218' ' ' ILE . 59.0 m-20 -72.34 -31.12 65.35 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 113.322 0.86 . . . . 0.44 113.322 -178.584 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . 0.572 HG22 ' O ' ' A' ' 221' ' ' GLU . 4.8 m -55.87 -29.1 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 CA-C-O 120.833 0.349 . . . . 0.83 111.469 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 10.7 mttp -66.0 -38.71 89.16 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.152 0.501 . . . . 1.51 109.908 178.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' SER . . . . . 0.583 ' HG ' HD12 ' B' ' 19' ' ' LEU . 1.8 t -68.74 -30.67 69.34 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 109.113 -0.699 . . . . 0.88 109.113 178.183 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -66.5 -36.67 83.3 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 109.004 -0.739 . . . . 0.86 109.004 178.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 7.1 t -62.03 -39.72 93.29 Favored 'General case' 0 N--CA 1.462 0.147 0 N-CA-C 108.992 -0.744 . . . . 0.77 108.992 176.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' ARG . . . . . 0.476 ' HA ' HG21 ' A' ' 232' ' ' VAL . 0.0 OUTLIER -61.07 -36.88 80.8 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-N 115.617 -0.719 . . . . 0.55 109.934 177.873 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . 0.553 HG22 ' CE1' ' B' ' 23' ' ' PHE . 29.4 t -65.99 -48.14 82.76 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-O 121.316 0.579 . . . . 1.03 109.439 177.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 231' ' ' MET . . . . . 0.515 ' SD ' HD12 ' A' ' 248' ' ' LEU . 8.1 tpp -60.34 -49.47 77.45 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 115.198 -0.91 . . . . 1.0 111.508 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 232' ' ' VAL . . . . . 0.476 HG21 ' HA ' ' A' ' 229' ' ' ARG . 33.3 m -64.66 -32.05 56.29 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 120.745 -0.382 . . . . 1.12 111.866 -179.741 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 7.3 t-80 -72.38 -47.02 52.7 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 120.899 -0.32 . . . . 0.51 110.843 178.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 70.2 t -62.32 -31.28 51.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-O 120.911 0.386 . . . . 1.04 111.571 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -97.3 4.34 50.89 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 122.224 -0.298 . . . . 0.62 111.749 179.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . 0.454 ' HB2' ' O ' ' A' ' 232' ' ' VAL . 0.3 OUTLIER -73.87 -17.83 61.0 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 112.286 0.476 . . . . 2.05 112.286 -178.989 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -70.12 -11.33 60.81 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.924 0.392 . . . . 0.43 111.244 179.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 91.1 -19.31 47.15 Favored Glycine 0 CA--C 1.519 0.33 0 C-N-CA 121.087 -0.578 . . . . 0.37 112.554 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -95.69 92.71 3.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.117 0.484 . . . . 1.13 112.109 -179.682 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 240' ' ' THR . . . . . 0.501 HG23 HD13 ' A' ' 245' ' ' ILE . 2.4 m -79.03 62.61 3.49 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.487 0.66 . . . . 0.75 110.347 178.505 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 73.2 m-20 -65.42 137.77 57.68 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.441 -0.8 . . . . 0.36 111.705 -179.059 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 242' ' ' TRP . . . . . . . . . . . . . 78.7 m95 -54.73 -38.6 67.31 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.154 -0.475 . . . . 0.49 111.188 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -58.61 -32.44 69.2 Favored Glycine 0 CA--C 1.521 0.419 0 C-N-CA 120.902 -0.666 . . . . 0.29 111.919 178.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 78.8 mtt180 -75.44 -41.95 54.58 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-O 120.943 0.401 . . . . 0.46 109.933 178.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . 0.545 ' O ' HG12 ' A' ' 249' ' ' ILE . 78.3 mt -62.14 -49.32 84.52 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-N 115.819 -0.628 . . . . 1.07 110.561 179.142 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . 0.417 HG23 ' CE2' ' A' ' 300' ' ' PHE . 48.0 t -67.48 -38.46 80.7 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 CA-C-N 116.347 -0.388 . . . . 0.89 111.047 179.317 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 19.4 m -62.2 -40.1 94.96 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 120.909 -0.316 . . . . 1.08 110.247 178.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 248' ' ' LEU . . . . . 0.515 HD12 ' SD ' ' A' ' 231' ' ' MET . 44.7 mt -65.24 -35.27 80.54 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 109.776 -0.453 . . . . 1.04 109.776 177.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 249' ' ' ILE . . . . . 0.545 HG12 ' O ' ' A' ' 245' ' ' ILE . 36.7 mm -69.41 -40.35 79.85 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 N-CA-C 109.084 -0.71 . . . . 1.19 109.084 177.442 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 14.7 m -61.67 -48.38 81.07 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.242 -0.89 . . . . 0.93 109.923 178.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 251' ' ' PHE . . . . . 0.532 ' O ' HG23 ' A' ' 255' ' ' VAL . 12.8 t80 -63.45 -45.06 92.61 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 115.648 -0.705 . . . . 0.72 109.832 178.305 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -57.79 -45.16 93.81 Favored Glycine 0 C--N 1.337 0.594 0 N-CA-C 111.181 -0.768 . . . . 0.26 111.181 178.199 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 253' ' ' ALA . . . . . 0.674 ' HB2' ' HG2' ' A' ' 170' ' ' GLN . . . -59.95 -38.56 82.82 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 122.328 0.251 . . . . 0.33 110.683 177.582 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 61.2 t80 -61.28 -40.42 94.05 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 121.147 0.499 . . . . 0.67 109.776 178.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 255' ' ' VAL . . . . . 0.532 HG23 ' O ' ' A' ' 251' ' ' PHE . 20.2 t -67.47 -40.24 84.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 CA-C-N 115.735 -0.666 . . . . 1.01 109.81 178.048 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -58.43 -41.36 84.88 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.115 0.484 . . . . 0.36 110.1 178.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 257' ' ' LYS . . . . . 0.775 ' HG2' ' HA ' ' A' ' 171' ' ' ALA . 14.4 mtpp -62.86 -45.22 93.6 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 115.76 -0.655 . . . . 1.03 110.104 177.508 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 82.6 t60 -60.6 -39.77 89.37 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 109.672 -0.492 . . . . 0.62 109.672 178.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . 0.478 HD23 ' CD2' ' A' ' 267' ' ' PHE . 4.4 mp -64.26 -50.68 67.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.856 -0.611 . . . . 1.02 110.037 178.528 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 260' ' ' LYS . . . . . 0.713 ' HG3' ' HB3' ' A' ' 171' ' ' ALA . 0.0 OUTLIER -61.57 -29.6 70.12 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.682 -0.236 . . . . 1.1 111.597 179.204 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 56.4 m -57.55 -33.05 67.71 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.041 0.448 . . . . 0.54 111.002 179.097 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 262' ' ' VAL . . . . . 0.5 HG22 ' HG3' ' A' ' 264' ' ' GLN . 26.4 m -112.12 13.63 8.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 CA-C-N 115.787 -0.642 . . . . 0.74 110.079 178.358 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 34.8 t30 58.8 47.24 12.95 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 115.079 -0.964 . . . . 0.61 113.012 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 264' ' ' GLN . . . . . 0.5 ' HG3' HG22 ' A' ' 262' ' ' VAL . 19.9 mt-30 -87.83 39.0 0.86 Allowed 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 116.523 -0.308 . . . . 1.48 111.666 179.007 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . 0.416 ' HA ' HD11 ' A' ' 268' ' ' ILE . 7.3 tp10 -49.34 -39.53 32.02 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 121.048 0.451 . . . . 0.46 112.051 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 3.2 p -59.34 -20.33 53.75 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.815 -0.63 . . . . 1.33 111.948 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 267' ' ' PHE . . . . . 0.61 ' HE2' HG22 ' A' ' 218' ' ' ILE . 15.7 t80 -103.57 -21.66 13.72 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 120.8 0.333 . . . . 0.67 111.011 179.38 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 268' ' ' ILE . . . . . 0.416 HD11 ' HA ' ' A' ' 265' ' ' GLU . 63.7 mt -65.39 -43.26 94.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.547 -0.297 . . . . 1.04 110.808 179.663 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 269' ' ' GLU . . . . . 0.629 ' HB3' ' HD3' ' A' ' 270' ' ' PRO . 1.8 tp10 -55.23 -58.13 16.62 Favored Pre-proline 0 CA--C 1.544 0.728 0 CA-C-N 116.332 -0.394 . . . . 0.55 111.01 179.061 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 270' ' ' PRO . . . . . 0.629 ' HD3' ' HB3' ' A' ' 269' ' ' GLU . 26.6 Cg_exo -63.64 -36.55 52.19 Favored 'Trans proline' 0 C--N 1.358 1.036 0 C-N-CA 121.725 1.617 . . . . 0.37 112.655 179.179 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 271' ' ' LEU . . . . . . . . . . . . . 52.6 tp -65.72 -54.81 22.2 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 121.147 -0.221 . . . . 1.18 111.49 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -58.16 -44.58 88.0 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-O 120.861 0.362 . . . . 0.89 111.445 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 273' ' ' GLU . . . . . 0.532 ' HG3' HD22 ' A' ' 160' ' ' LEU . 0.5 OUTLIER -66.51 -39.84 88.9 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 116.246 -0.434 . . . . 0.36 111.4 179.755 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 274' ' ' THR . . . . . 0.461 HG23 ' HB ' ' A' ' 224' ' ' VAL . 62.5 m -64.16 -45.34 88.88 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 120.718 0.294 . . . . 1.06 110.395 179.019 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 275' ' ' ILE . . . . . 0.434 HG21 ' HE1' ' A' ' 231' ' ' MET . 96.3 mt -54.12 -52.99 32.11 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 CA-C-N 116.093 -0.503 . . . . 1.1 110.622 179.147 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 276' ' ' THR . . . . . 0.554 HG21 ' HA ' ' A' ' 160' ' ' LEU . 56.8 m -56.38 -52.47 64.49 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.543 -0.298 . . . . 1.03 111.781 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 277' ' ' ASP . . . . . 0.588 ' OD1' ' HD2' ' A' ' 281' ' ' ARG . 0.4 OUTLIER -53.8 -51.66 62.77 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 112.127 0.418 . . . . 0.43 112.127 -179.364 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 27.3 t -70.05 -46.56 72.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 111.887 0.329 . . . . 0.88 111.887 -179.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . 0.448 HD22 HG23 ' A' ' 245' ' ' ILE . 0.4 OUTLIER -62.67 -41.24 98.98 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 113.14 0.792 . . . . 1.15 113.14 -178.757 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 280' ' ' VAL . . . . . 0.403 HG21 ' HB3' ' A' ' 159' ' ' SER . 81.4 t -87.21 -46.22 16.2 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 N-CA-C 113.768 1.025 . . . . 0.64 113.768 -178.266 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 281' ' ' ARG . . . . . 0.588 ' HD2' ' OD1' ' A' ' 277' ' ' ASP . 38.1 mtt85 -70.96 -34.9 71.89 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 114.425 1.269 . . . . 1.06 114.425 -177.122 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 282' ' ' THR . . . . . . . . . . . . . 42.0 p -61.5 -30.71 70.8 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 119.073 0.851 . . . . 1.03 111.513 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 29.9 mmtp -125.06 41.21 3.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.321 -0.399 . . . . 1.09 111.001 179.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 284' ' ' ARG . . . . . 0.516 ' HG2' ' N ' ' A' ' 285' ' ' ASP . 0.0 OUTLIER -53.34 -35.6 60.39 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 112.866 0.691 . . . . 0.54 112.866 -179.319 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 285' ' ' ASP . . . . . 0.516 ' N ' ' HG2' ' A' ' 284' ' ' ARG . 8.1 p-10 -63.04 -44.41 95.94 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-O 120.634 0.254 . . . . 0.46 111.254 -179.363 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 286' ' ' TRP . . . . . 0.76 ' HA ' ' HD2' ' A' ' 289' ' ' LYS . 0.0 OUTLIER -61.5 -34.68 75.91 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.163 0.506 . . . . 0.47 110.477 179.404 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 287' ' ' LEU . . . . . 0.437 HD13 ' HA2' ' A' ' 292' ' ' GLY . 1.7 mm? -70.13 -47.01 63.55 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.566 -0.743 . . . . 1.23 110.482 179.194 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 288' ' ' VAL . . . . . 0.501 HG22 ' O ' ' A' ' 284' ' ' ARG . 64.3 t -60.67 -33.07 53.42 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 CA-C-O 120.898 0.38 . . . . 1.5 110.858 178.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 289' ' ' LYS . . . . . 0.76 ' HD2' ' HA ' ' A' ' 286' ' ' TRP . 74.3 mttt -60.45 -42.17 95.61 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.01 -0.541 . . . . 0.71 112.213 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 290' ' ' GLN . . . . . 0.518 ' HB3' ' HA3' ' A' ' 295' ' ' GLY . 5.1 mt-30 -111.86 28.29 8.89 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 112.869 0.692 . . . . 0.52 112.869 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 291' ' ' ARG . . . . . 0.465 ' HB3' ' HB2' ' A' ' 294' ' ' ASP . 3.8 mmm180 59.09 13.91 3.18 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 112.768 0.655 . . . . 0.64 112.768 179.545 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 292' ' ' GLY . . . . . 0.437 ' HA2' HD13 ' A' ' 287' ' ' LEU . . . 75.06 -108.2 2.47 Favored Glycine 0 N--CA 1.448 -0.502 0 N-CA-C 114.361 0.504 . . . . 0.38 114.361 179.448 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 293' ' ' TRP . . . . . 0.562 ' CZ2' ' HA ' ' A' ' 159' ' ' SER . 80.5 m95 -68.42 -29.27 67.9 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.62 0.6 . . . . 0.63 112.62 -177.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 294' ' ' ASP . . . . . 0.465 ' HB2' ' HB3' ' A' ' 291' ' ' ARG . 22.0 m-20 -62.11 -44.99 95.44 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 120.57 -0.452 . . . . 0.38 109.949 178.489 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 295' ' ' GLY . . . . . 0.518 ' HA3' ' HB3' ' A' ' 290' ' ' GLN . . . -69.07 -33.85 75.04 Favored Glycine 0 C--O 1.224 -0.524 0 C-N-CA 120.809 -0.71 . . . . 0.35 111.695 178.076 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 296' ' ' PHE . . . . . 0.409 ' CD2' ' HE3' ' A' ' 293' ' ' TRP . 0.5 OUTLIER -70.51 -45.11 66.22 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 120.655 0.264 . . . . 0.44 111.232 179.111 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 297' ' ' VAL . . . . . 0.601 HG12 ' HB3' ' A' ' 189' ' ' ARG . 69.3 t -63.81 -50.65 76.77 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.117 0 CA-C-O 120.689 0.281 . . . . 0.99 110.75 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.34 -22.87 64.66 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 116.188 -0.46 . . . . 0.49 111.745 -179.605 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 299' ' ' PHE . . . . . . . . . . . . . 88.2 t80 -71.54 -36.04 70.87 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-O 120.764 0.316 . . . . 0.58 110.854 178.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 300' ' ' PHE . . . . . 0.417 ' CE2' HG23 ' A' ' 246' ' ' VAL . 79.3 m-85 -100.07 -5.41 28.01 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.79 0.329 . . . . 0.55 111.832 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 301' ' ' HIS . . . . . 0.476 ' HB2' ' O ' ' A' ' 297' ' ' VAL . 1.6 m-70 -102.37 30.37 4.62 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.556 -0.293 . . . . 1.05 110.453 178.572 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 14.1 p -58.85 -25.16 28.37 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-O 121.132 0.491 . . . . 0.89 111.448 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -87.99 -80.37 0.27 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.987 -0.551 . . . . 1.37 110.389 179.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -86.29 73.32 10.21 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 121.246 0.546 . . . . 0.66 111.624 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 305' ' ' LEU . . . . . 0.41 ' HG ' ' O ' ' A' ' 301' ' ' HIS . 14.6 mt -63.93 -30.39 71.47 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.33 -0.395 . . . . 1.77 111.921 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -82.96 -15.1 52.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.32 -0.4 . . . . 1.38 111.696 -179.438 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . -85.8 173.2 46.99 Favored Glycine 0 CA--C 1.523 0.542 0 C-N-CA 120.791 -0.719 . . . . 1.17 112.685 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.282 0 CA-C-O 118.643 -1.087 . . . . 0.86 112.949 179.93 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.424 0.154 . . . . 1.73 110.825 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.4 164.27 12.89 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.894 0.378 . . . . 0.53 110.731 179.363 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 19' ' ' LEU . . . . . 0.583 HD12 ' HG ' ' A' ' 226' ' ' SER . 7.1 mt -111.0 115.23 53.23 Favored Pre-proline 0 C--N 1.326 -0.435 0 N-CA-C 112.097 0.406 . . . . 1.17 112.097 -179.218 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 20' ' ' PRO . . . . . 0.407 ' HD2' HD23 ' B' ' 19' ' ' LEU . 69.6 Cg_endo -75.55 146.04 30.32 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.779 2.32 . . . . 0.66 112.064 179.283 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 21' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -68.99 35.55 0.19 Allowed 'Trans proline' 0 CA--C 1.542 0.918 0 C-N-CA 122.935 2.423 . . . . 0.68 114.493 -178.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -83.1 -42.02 17.89 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.039 0.447 . . . . 0.89 110.172 179.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 23' ' ' PHE . . . . . 0.553 ' CE1' HG22 ' A' ' 230' ' ' VAL . 0.7 OUTLIER -57.34 -37.79 73.11 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 115.706 -0.679 . . . . 0.46 111.394 179.377 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 24' ' ' ALA . . . . . 0.522 ' N ' ' HD1' ' B' ' 23' ' ' PHE . . . -65.57 -40.25 92.56 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.121 -0.491 . . . . 0.59 111.655 -179.151 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . 0.525 ' O ' ' HG3' ' B' ' 29' ' ' LYS . . . -66.15 -46.85 76.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.996 0.427 . . . . 0.93 110.218 179.175 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -62.32 -51.57 67.11 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 115.827 -0.624 . . . . 0.74 110.68 179.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 51.3 mt -57.65 -41.72 82.03 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.755 0.312 . . . . 1.21 110.339 178.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 28' ' ' ARG . . . . . . . . . . . . . 1.2 ttm180 -58.86 -50.81 72.58 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.164 -0.471 . . . . 0.96 110.434 178.133 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . 0.525 ' HG3' ' O ' ' B' ' 25' ' ' ALA . 85.3 mttt -57.82 -51.39 69.78 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.039 -0.528 . . . . 0.8 110.798 178.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 78.9 mt -58.87 -45.45 91.69 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 CA-C-N 115.878 -0.601 . . . . 1.12 110.983 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -58.67 -50.52 66.37 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.897 -0.668 . . . . 0.28 113.009 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 -68.17 -37.21 80.73 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.966 0.383 . . . . 0.37 111.527 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 21.8 ttmm -62.42 -50.5 71.27 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 120.912 0.387 . . . . 1.32 110.328 178.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 49.1 t -63.19 -47.43 92.35 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 116.097 -0.501 . . . . 0.94 110.593 178.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -58.04 -50.82 72.1 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 115.777 -0.647 . . . . 1.16 111.508 179.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 36' ' ' CYS . . . . . . . . . . . . . 13.0 t -63.14 -28.43 70.06 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 120.804 0.335 . . . . 1.07 111.839 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 89.1 m -77.64 -45.91 23.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.425 -0.352 . . . . 1.06 111.87 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 38' ' ' TRP . . . . . . . . . . . . . 97.1 m95 -80.12 -19.7 46.71 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 112.95 0.722 . . . . 0.63 112.95 -178.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 40.0 t -74.2 -6.49 48.08 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 112.268 0.47 . . . . 0.43 112.268 179.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -90.15 119.35 69.27 Favored Pre-proline 0 CA--C 1.533 0.313 0 N-CA-C 112.003 0.372 . . . . 0.58 112.003 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -84.13 -15.46 6.67 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.721 2.281 . . . . 1.09 112.824 179.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -78.81 89.92 4.66 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.12 -0.491 . . . . 1.22 110.993 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 43' ' ' MET . . . . . . . . . . . . . 64.5 mtt . . . . . 0 C--O 1.251 1.157 0 CA-C-O 118.249 -0.881 . . . . 1.72 111.425 179.91 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.131 0 N-CA-C 112.14 -0.384 . . . . 0.71 112.14 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -69.93 -67.77 0.03 OUTLIER 'Trans proline' 0 CA--C 1.534 0.516 0 C-N-CA 122.523 2.149 . . . . 1.2 112.5 179.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 25.3 tp -170.86 149.64 3.06 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.212 -0.449 . . . . 1.06 110.219 179.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 167.37 171.52 33.5 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.274 -0.965 . . . . 0.52 113.016 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -62.32 -30.06 70.89 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 112.228 0.455 . . . . 0.53 112.228 -179.672 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -114.77 26.89 9.82 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.295 -0.411 . . . . 0.47 111.321 -179.435 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -77.75 -27.96 50.54 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 112.478 0.548 . . . . 0.37 112.478 -178.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -55.15 -56.48 19.43 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 120.95 0.405 . . . . 0.78 111.369 -179.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.22 -37.08 77.84 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.028 0.442 . . . . 1.27 110.534 179.567 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 13.6 t80 -61.62 -40.71 95.83 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 115.906 -0.588 . . . . 0.46 111.697 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 55.0 mtt-85 -65.32 -48.3 73.53 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 111.834 0.309 . . . . 0.59 111.834 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 2.7 mm-40 -62.07 -42.48 99.24 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.203 0.525 . . . . 0.44 110.303 179.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' SER . . . . . 0.46 ' HA ' ' CZ2' ' A' ' 293' ' ' TRP . 12.3 m -66.19 -54.69 22.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.756 -0.657 . . . . 0.32 111.218 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.647 ' HA ' HG23 ' A' ' 276' ' ' THR . 2.0 tm? -54.11 -46.38 72.13 Favored 'General case' 0 N--CA 1.464 0.248 0 O-C-N 123.183 0.302 . . . . 1.4 111.08 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . 0.57 ' HG2' HD11 ' A' ' 180' ' ' LEU . 30.3 tt0 -63.57 -54.38 37.03 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 112.067 0.395 . . . . 0.4 112.067 -179.584 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . 0.465 HD11 ' HA2' ' A' ' 187' ' ' GLY . 88.1 mt -59.33 -46.68 92.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 N-CA-C 111.589 0.218 . . . . 1.04 111.589 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.498 ' O ' ' HG ' ' A' ' 167' ' ' LEU . 84.2 mt -62.84 -51.23 74.62 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 C-N-CA 121.085 -0.246 . . . . 1.02 111.462 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 55.2 p -58.78 -42.29 88.65 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.586 0.231 . . . . 0.37 111.302 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . 0.417 ' O ' ' HB2' ' A' ' 169' ' ' GLU . 2.0 tpt85 -58.02 -51.64 68.81 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.855 0.359 . . . . 0.42 110.806 179.374 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' TYR . . . . . 0.468 ' O ' ' HB2' ' A' ' 170' ' ' GLN . 66.7 t80 -64.04 -49.37 72.62 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.937 -0.574 . . . . 0.44 112.065 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.498 ' HG ' ' O ' ' A' ' 163' ' ' ILE . 21.4 mt -56.17 -45.96 79.53 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 112.024 0.379 . . . . 1.08 112.024 -178.612 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 11.8 ttm105 -70.18 -44.59 68.43 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.57 0.224 . . . . 0.39 111.133 179.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . 0.432 ' CD ' ' HZ1' ' A' ' 175' ' ' LYS . 1.9 tt0 -61.52 -36.08 79.53 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-O 121.32 0.581 . . . . 0.7 110.564 179.347 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . 0.468 ' HB2' ' O ' ' A' ' 166' ' ' TYR . 1.8 tm0? -71.98 -47.8 49.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.76 -0.654 . . . . 0.58 110.246 178.434 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -61.53 -24.51 66.67 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.094 -0.503 . . . . 1.03 112.103 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 12.0 p -95.01 -7.93 38.32 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 111.914 0.338 . . . . 0.72 111.914 179.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 58.18 28.63 61.69 Favored Glycine 0 C--N 1.336 0.58 0 CA-C-N 116.333 -0.394 . . . . 0.57 113.532 179.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 30.1 m -126.5 174.66 8.48 Favored 'General case' 0 C--N 1.329 -0.296 0 O-C-N 122.61 -0.347 . . . . 1.12 111.413 -179.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . 0.471 ' HE3' ' HB3' ' A' ' 175' ' ' LYS . 9.2 mmmt -124.12 125.66 44.86 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 111.959 0.355 . . . . 1.04 111.959 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -105.59 138.61 41.51 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 121.054 0.454 . . . . 0.49 111.045 179.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 68.8 p -94.57 -18.43 21.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.155 -0.475 . . . . 0.99 111.108 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 24.2 mttp -60.94 144.49 90.39 Favored Pre-proline 0 CA--C 1.532 0.27 0 CA-C-N 116.293 -0.412 . . . . 0.92 111.388 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -63.72 161.93 30.31 Favored 'Trans proline' 0 CA--C 1.533 0.43 0 C-N-CA 123.13 2.554 . . . . 0.65 113.784 -179.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.57 HD11 ' HG2' ' A' ' 161' ' ' GLU . 4.1 mm? -54.44 -60.51 3.25 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.769 -0.65 . . . . 0.91 111.04 179.546 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 149.99 -69.55 0.32 Allowed Glycine 0 CA--C 1.521 0.447 0 CA-C-N 115.364 -0.835 . . . . 0.72 111.347 -179.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . 0.447 ' H ' ' CD ' ' A' ' 161' ' ' GLU . 87.4 mt-10 -109.98 -36.24 5.93 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.141 0.496 . . . . 0.91 110.206 178.674 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . 0.532 ' O ' ' HA3' ' A' ' 187' ' ' GLY . . . -83.65 85.8 7.22 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 116.164 -0.471 . . . . 0.44 110.349 178.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -77.33 -71.47 1.2 Allowed Glycine 0 CA--C 1.525 0.688 0 C-N-CA 120.445 -0.884 . . . . 0.43 114.543 -178.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -63.43 -56.19 18.16 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 112.076 0.399 . . . . 0.51 112.076 -178.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -66.56 -44.44 82.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.373 -0.376 . . . . 1.07 110.702 179.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . 0.532 ' HA3' ' O ' ' A' ' 183' ' ' ALA . . . -57.48 -53.49 44.61 Favored Glycine 0 CA--C 1.522 0.507 0 C-N-CA 121.238 -0.506 . . . . 0.33 113.823 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . 0.437 HH11 ' HD2' ' A' ' 188' ' ' ARG . 1.6 mmp_? -61.17 -44.48 97.23 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 117.617 0.708 . . . . 0.59 112.245 -179.661 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . 0.63 ' HB3' HG12 ' A' ' 297' ' ' VAL . 49.9 mtm180 -66.93 -39.12 87.25 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 120.802 0.334 . . . . 0.5 110.745 179.429 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . 0.428 ' HA ' HG23 ' A' ' 297' ' ' VAL . . . -70.58 -34.79 72.57 Favored 'General case' 0 C--O 1.222 -0.349 0 CA-C-N 116.362 -0.381 . . . . 0.36 110.677 178.645 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . 0.463 HD22 ' HA ' ' A' ' 191' ' ' LEU . 0.2 OUTLIER -61.53 -45.4 94.34 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.823 -0.171 . . . . 1.05 111.142 179.202 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -66.79 -45.46 78.36 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 121.028 0.442 . . . . 0.35 111.125 179.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 1.3 p -65.21 -48.51 73.14 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.288 -0.415 . . . . 0.99 111.7 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . 0.462 HD21 HG22 ' A' ' 249' ' ' ILE . 19.1 tp -60.65 -35.49 76.35 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 116.406 -0.361 . . . . 1.08 111.112 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . 0.417 ' HA ' ' HE1' ' A' ' 166' ' ' TYR . 5.0 mmt180 -65.05 -44.49 88.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.917 0.389 . . . . 0.42 110.775 178.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.88 -52.43 24.86 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.149 0.426 . . . . 0.43 112.149 -179.43 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . 0.476 ' O ' HG23 ' A' ' 201' ' ' VAL . 48.1 t -69.61 -43.39 80.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 N-CA-C 112.572 0.582 . . . . 1.04 112.572 -178.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -67.14 -51.68 37.14 Favored Glycine 0 CA--C 1.521 0.409 0 C-N-CA 121.018 -0.611 . . . . 0.25 113.467 -178.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -63.87 -35.79 81.79 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 120.804 0.335 . . . . 0.29 110.378 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -59.94 -48.15 87.48 Favored Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 111.119 -0.792 . . . . 0.29 111.119 177.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . 0.476 HG23 ' O ' ' A' ' 197' ' ' VAL . 76.3 t -64.04 -40.93 90.83 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 122.217 0.207 . . . . 1.11 111.331 179.014 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' GLN . . . . . 0.489 ' HA ' ' HE2' ' A' ' 209' ' ' PHE . 31.7 tt0 -60.07 -48.07 83.24 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 116.587 -0.279 . . . . 0.42 111.5 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.33 -39.02 71.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.615 0.245 . . . . 1.71 111.255 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 18.2 m-80 -67.08 -52.22 44.64 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 111.969 0.359 . . . . 1.59 111.969 179.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 74.0 m-70 -101.47 34.91 2.43 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 112.427 0.529 . . . . 0.54 112.427 -178.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -62.9 -40.12 96.61 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 120.999 -0.28 . . . . 0.51 111.266 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 38.4 p -60.66 -43.11 98.01 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.061 0.458 . . . . 0.74 110.683 179.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . 0.436 ' O ' ' HG3' ' A' ' 212' ' ' MET . . . -65.99 -41.87 90.55 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.83 -0.623 . . . . 1.14 109.93 178.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' PHE . . . . . 0.489 ' HE2' ' HA ' ' A' ' 202' ' ' GLN . 14.4 m-30 -63.0 -42.58 99.88 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.893 -0.594 . . . . 0.62 110.112 178.66 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' GLN . . . . . 0.698 ' O ' ' HG2' ' A' ' 214' ' ' ARG . 31.3 mt-30 -57.79 -46.72 84.21 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.288 -0.414 . . . . 0.71 110.542 178.494 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -55.68 -46.75 81.36 Favored Glycine 0 C--N 1.339 0.711 0 C-N-CA 121.051 -0.595 . . . . 0.33 111.951 178.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' MET . . . . . 0.572 ' HE2' ' HB3' ' B' ' 26' ' ' GLN . 35.1 mtt -62.91 -42.68 99.87 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 109.515 -0.55 . . . . 1.39 109.515 177.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 12.7 tp -58.92 -44.53 91.31 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.744 -0.662 . . . . 0.78 111.11 179.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' ARG . . . . . 0.698 ' HG2' ' O ' ' A' ' 210' ' ' GLN . 22.1 mmt180 -60.65 -35.16 75.54 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 120.887 0.375 . . . . 1.35 110.945 179.439 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -94.7 12.31 28.22 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.968 0.359 . . . . 1.63 111.968 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . 0.48 ' HB3' HG12 ' A' ' 218' ' ' ILE . 12.1 mt -99.39 154.27 18.33 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.127 0.489 . . . . 1.25 111.511 179.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -105.05 17.2 24.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.9 -0.591 . . . . 1.09 111.052 179.62 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' ILE . . . . . 0.532 ' HA ' ' HB2' ' A' ' 223' ' ' ASP . 17.3 mm -59.33 105.93 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-N 116.417 -0.356 . . . . 1.01 111.441 -179.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . 0.431 ' HG3' ' O ' ' A' ' 218' ' ' ILE . 7.5 mtmp? -159.56 -65.64 0.08 Allowed 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.862 -0.608 . . . . 0.89 110.7 -179.301 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -104.3 -175.65 2.86 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 115.098 -0.955 . . . . 0.79 110.722 -179.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . 0.416 ' O ' HG23 ' A' ' 224' ' ' VAL . 0.5 OUTLIER -46.83 -22.37 0.3 Allowed 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 113.538 0.94 . . . . 0.8 113.538 -179.221 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . 0.564 ' HA2' ' HD2' ' A' ' 225' ' ' LYS . . . -65.92 -23.99 71.31 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 121.223 -0.513 . . . . 0.42 113.076 178.606 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' ASP . . . . . 0.532 ' HB2' ' HA ' ' A' ' 218' ' ' ILE . 2.9 p-10 -56.56 -45.49 81.26 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 113.478 0.918 . . . . 0.76 113.478 -178.354 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . 0.416 HG23 ' O ' ' A' ' 221' ' ' GLU . 28.9 m -59.96 -29.55 43.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-N 118.107 0.412 . . . . 0.74 111.475 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . 0.564 ' HD2' ' HA2' ' A' ' 222' ' ' GLY . 26.4 mttp -76.08 -42.76 46.34 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.549 -0.537 . . . . 1.33 109.549 178.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 94.3 p -64.5 -40.51 95.78 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.741 -0.663 . . . . 0.95 110.327 178.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -65.39 -42.63 92.44 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 109.919 -0.4 . . . . 0.65 109.919 178.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' SER . . . . . 0.544 ' HA ' ' HG2' ' A' ' 231' ' ' MET . 7.5 t -60.44 -43.79 96.47 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.086 -0.506 . . . . 1.11 110.423 178.595 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' ARG . . . . . 0.421 HH11 ' HD2' ' A' ' 229' ' ' ARG . 9.0 mmm180 -55.69 -44.36 77.3 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.243 0.544 . . . . 1.0 110.545 178.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . 0.483 ' O ' HG21 ' A' ' 234' ' ' VAL . 60.1 t -69.19 -54.32 20.69 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-N 115.877 -0.601 . . . . 1.07 111.475 179.307 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 231' ' ' MET . . . . . 0.558 ' HE3' HD21 ' A' ' 248' ' ' LEU . 10.6 ptm -59.58 -37.13 77.69 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 112.491 0.552 . . . . 1.06 112.491 -178.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 33.0 t -66.4 -41.07 88.16 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 N-CA-C 109.522 -0.547 . . . . 0.95 109.522 178.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 233' ' ' HIS . . . . . 0.488 ' HA ' ' HB2' ' A' ' 236' ' ' LYS . 2.3 t-80 -68.16 -40.18 82.4 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 116.203 -0.453 . . . . 0.55 110.44 178.473 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . 0.483 HG21 ' O ' ' A' ' 230' ' ' VAL . 69.3 t -56.99 -37.95 57.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 CA-C-O 121.057 0.456 . . . . 1.05 111.12 179.546 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 235' ' ' PHE . . . . . 0.501 ' HE2' HD23 ' A' ' 248' ' ' LEU . 93.3 m-85 -104.11 19.39 20.19 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.394 -0.366 . . . . 0.65 111.386 179.289 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . 0.488 ' HB2' ' HA ' ' A' ' 233' ' ' HIS . 1.3 tmtm? -79.81 -9.72 59.7 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 111.744 0.276 . . . . 1.81 111.744 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -70.16 -17.98 63.19 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 120.847 0.356 . . . . 0.53 111.033 179.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 96.83 -17.94 58.4 Favored Glycine 0 CA--C 1.524 0.621 0 C-N-CA 120.938 -0.649 . . . . 0.58 113.23 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 6.5 p -98.77 130.23 47.93 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-O 121.23 0.538 . . . . 1.26 111.8 -179.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 240' ' ' THR . . . . . 0.447 HG22 ' HG2' ' A' ' 283' ' ' LYS . 1.4 m -94.59 98.87 11.12 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.206 -0.452 . . . . 1.16 111.771 179.302 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -100.11 130.9 46.31 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.876 0.369 . . . . 0.57 111.208 179.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 242' ' ' TRP . . . . . . . . . . . . . 7.0 m95 -55.33 -43.76 75.22 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 116.032 -0.531 . . . . 0.62 111.146 179.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -58.01 -32.07 66.1 Favored Glycine 0 CA--C 1.519 0.329 0 CA-C-N 115.98 -0.555 . . . . 0.32 112.605 179.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 86.8 mtt180 -74.9 -36.39 62.23 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.78 -0.452 . . . . 0.46 109.78 178.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . 0.552 ' O ' HG12 ' A' ' 249' ' ' ILE . 79.1 mt -66.97 -51.36 55.46 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 CA-C-N 115.944 -0.571 . . . . 1.16 110.714 179.115 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 27.6 m -62.93 -35.9 73.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 C-N-CA 121.089 -0.244 . . . . 1.03 111.08 179.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 53.0 m -65.69 -37.77 87.39 Favored 'General case' 0 N--CA 1.463 0.187 0 N-CA-C 109.538 -0.542 . . . . 1.04 109.538 178.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 248' ' ' LEU . . . . . 0.558 HD21 ' HE3' ' A' ' 231' ' ' MET . 34.2 tp -65.32 -40.58 93.92 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 116.143 -0.481 . . . . 1.08 109.759 177.624 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 249' ' ' ILE . . . . . 0.552 HG12 ' O ' ' A' ' 245' ' ' ILE . 43.0 mm -65.9 -48.89 80.36 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 CA-C-N 116.186 -0.461 . . . . 1.09 110.101 178.533 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 31.3 t -57.07 -42.68 81.09 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.801 -0.636 . . . . 0.33 110.31 178.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 251' ' ' PHE . . . . . . . . . . . . . 32.0 t80 -64.03 -45.46 88.78 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 115.647 -0.706 . . . . 0.59 110.059 177.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -58.22 -41.28 94.76 Favored Glycine 0 C--N 1.337 0.623 0 N-CA-C 111.464 -0.655 . . . . 0.34 111.464 178.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -64.01 -42.68 97.06 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 120.773 0.32 . . . . 0.52 110.277 177.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -60.07 -40.87 91.0 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.357 0.598 . . . . 0.85 109.742 178.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 255' ' ' VAL . . . . . 0.45 ' CG1' HG23 ' A' ' 218' ' ' ILE . 79.9 t -66.54 -51.25 59.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 CA-C-N 115.682 -0.69 . . . . 1.1 109.696 177.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -54.21 -39.29 66.56 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.082 -0.508 . . . . 0.38 111.076 177.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -62.48 -42.89 99.8 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.402 -0.363 . . . . 1.26 110.667 178.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 31.3 t60 -64.61 -36.14 83.28 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.311 -0.404 . . . . 0.62 110.32 179.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 6.7 mp -74.6 -41.49 60.35 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 121.061 0.458 . . . . 0.94 110.696 178.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -62.82 -27.35 69.26 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.9 0.381 . . . . 0.57 110.666 179.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 56.4 m -59.67 -31.86 69.95 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.074 -0.512 . . . . 0.48 110.494 178.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 262' ' ' VAL . . . . . 0.417 HG22 ' HG3' ' A' ' 264' ' ' GLN . 15.7 m -110.49 16.99 7.72 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 CA-C-O 121.28 0.562 . . . . 0.81 110.192 178.29 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 25.6 t30 59.31 44.22 15.67 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 114.922 -1.035 . . . . 0.54 113.567 179.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 264' ' ' GLN . . . . . 0.417 ' HG3' HG22 ' A' ' 262' ' ' VAL . 15.0 mt-30 -91.54 36.61 0.95 Allowed 'General case' 0 N--CA 1.466 0.369 0 O-C-N 121.978 -0.452 . . . . 0.5 110.856 178.536 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . 0.423 ' HA ' HD11 ' A' ' 268' ' ' ILE . 6.4 mm-40 -57.94 -29.22 64.99 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 116.422 -0.354 . . . . 0.49 111.862 -179.418 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.37 -22.84 67.12 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.229 -0.441 . . . . 1.09 110.788 178.696 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 267' ' ' PHE . . . . . 0.42 ' C ' ' HD2' ' A' ' 270' ' ' PRO . 66.2 m-85 -100.01 -24.74 14.53 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.048 -0.524 . . . . 0.91 110.611 178.566 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 268' ' ' ILE . . . . . 0.423 HD11 ' HA ' ' A' ' 265' ' ' GLU . 89.3 mt -65.3 -40.9 90.03 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-N 116.11 -0.495 . . . . 1.12 111.477 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 269' ' ' GLU . . . . . 0.667 ' HB2' ' HD3' ' A' ' 270' ' ' PRO . 6.4 mm-40 -57.49 -56.47 33.81 Favored Pre-proline 0 CA--C 1.542 0.669 0 C-N-CA 120.979 -0.289 . . . . 0.68 111.111 178.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 270' ' ' PRO . . . . . 0.667 ' HD3' ' HB2' ' A' ' 269' ' ' GLU . 50.6 Cg_exo -58.04 -32.24 94.95 Favored 'Trans proline' 0 C--N 1.363 1.323 0 C-N-CA 121.843 1.695 . . . . 0.39 111.643 177.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 271' ' ' LEU . . . . . 0.444 ' O ' HG13 ' A' ' 275' ' ' ILE . 0.4 OUTLIER -66.06 -55.16 17.97 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.183 -0.462 . . . . 1.18 110.233 178.582 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -60.06 -39.12 84.91 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 115.846 -0.616 . . . . 0.44 110.951 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 273' ' ' GLU . . . . . 0.449 ' O ' ' HB2' ' A' ' 277' ' ' ASP . 26.4 tt0 -66.92 -43.41 83.38 Favored 'General case' 0 C--O 1.226 -0.18 0 CA-C-N 115.885 -0.598 . . . . 1.79 110.012 178.583 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 274' ' ' THR . . . . . . . . . . . . . 41.2 m -64.95 -44.35 89.71 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.605 -0.27 . . . . 0.92 110.927 179.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 275' ' ' ILE . . . . . 0.556 ' HA ' ' HE2' ' A' ' 231' ' ' MET . 96.5 mt -57.54 -54.97 24.09 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 CA-C-O 121.132 0.491 . . . . 0.98 110.157 179.09 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 276' ' ' THR . . . . . 0.647 HG23 ' HA ' ' A' ' 160' ' ' LEU . 24.4 m -59.25 -45.46 91.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.664 -0.698 . . . . 0.88 110.541 179.179 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 277' ' ' ASP . . . . . 0.449 ' HB2' ' O ' ' A' ' 273' ' ' GLU . 7.9 t70 -56.27 -58.35 8.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.315 -0.857 . . . . 0.33 111.723 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 95.3 t -57.7 -39.47 70.42 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-O 120.609 0.242 . . . . 0.65 110.953 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 22.3 tp -61.5 -47.92 83.42 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 120.669 0.271 . . . . 1.15 111.672 179.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 44.6 t -78.79 -23.28 12.97 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-O 121.052 0.453 . . . . 1.14 111.835 -179.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 281' ' ' ARG . . . . . 0.403 ' HB2' ' O ' ' A' ' 277' ' ' ASP . 19.3 ttm-85 -82.29 -25.8 33.66 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 121.824 -0.547 . . . . 0.56 111.949 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 282' ' ' THR . . . . . . . . . . . . . 37.7 p -98.69 -31.15 12.06 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 112.526 0.565 . . . . 0.42 112.526 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . 0.447 ' HG2' HG22 ' A' ' 240' ' ' THR . 3.3 mppt? -117.08 32.99 5.84 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 112.16 0.43 . . . . 1.61 112.16 -179.149 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 284' ' ' ARG . . . . . 0.479 ' H ' ' HG2' ' A' ' 284' ' ' ARG . 0.4 OUTLIER -56.81 -42.46 79.61 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 112.139 0.422 . . . . 0.54 112.139 179.817 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 285' ' ' ASP . . . . . 0.509 ' O ' ' HB2' ' A' ' 289' ' ' LYS . 26.0 t70 -62.19 -48.75 78.64 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.393 -0.367 . . . . 0.77 111.73 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 286' ' ' TRP . . . . . 0.505 ' CZ2' ' HG2' ' A' ' 290' ' ' GLN . 31.7 t90 -70.63 -41.42 72.22 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.018 0.377 . . . . 1.16 112.018 -179.201 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -61.27 -40.97 96.08 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 111.891 0.33 . . . . 1.28 111.891 -179.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 6.0 p -77.38 -29.69 16.87 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-O 120.75 0.309 . . . . 0.81 110.954 179.048 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 289' ' ' LYS . . . . . 0.509 ' HB2' ' O ' ' A' ' 285' ' ' ASP . 3.4 ttmm -75.36 -44.85 42.81 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 112.858 0.688 . . . . 1.22 112.858 -179.081 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 290' ' ' GLN . . . . . 0.505 ' HG2' ' CZ2' ' A' ' 286' ' ' TRP . 1.9 mp0 -84.83 29.88 0.6 Allowed 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 113.765 1.024 . . . . 0.78 113.765 -177.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 291' ' ' ARG . . . . . 0.592 ' HB3' ' HB3' ' A' ' 294' ' ' ASP . 21.5 mtm180 64.04 6.8 3.02 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 112.745 0.646 . . . . 0.62 112.745 179.318 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 59.07 -125.59 40.16 Favored Glycine 0 CA--C 1.521 0.421 0 CA-C-O 121.395 0.442 . . . . 0.4 113.573 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 293' ' ' TRP . . . . . 0.582 ' O ' HG22 ' A' ' 297' ' ' VAL . 83.8 m95 -64.9 -26.3 68.26 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.641 0.608 . . . . 0.58 112.641 -178.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 294' ' ' ASP . . . . . 0.592 ' HB3' ' HB3' ' A' ' 291' ' ' ARG . 20.0 t70 -64.32 -43.91 93.21 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 121.045 0.45 . . . . 0.54 109.934 178.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -68.38 -31.8 74.68 Favored Glycine 0 C--N 1.334 0.45 0 N-CA-C 110.609 -0.997 . . . . 0.37 110.609 177.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 296' ' ' PHE . . . . . 0.433 ' HB3' ' HA ' ' A' ' 293' ' ' TRP . 1.0 OUTLIER -67.7 -48.11 67.49 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 115.51 -0.345 . . . . 0.4 110.557 178.464 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 297' ' ' VAL . . . . . 0.63 HG12 ' HB3' ' A' ' 189' ' ' ARG . 86.0 t -61.14 -43.4 96.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-O 120.825 0.345 . . . . 1.02 110.615 179.306 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -64.51 -46.49 82.71 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.863 -0.608 . . . . 0.48 112.053 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 299' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -62.63 -35.2 78.81 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 112.31 0.485 . . . . 0.69 112.31 -179.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 300' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -100.76 30.98 3.72 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.284 0.476 . . . . 0.55 112.284 -179.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 13.1 t-80 -148.91 146.06 27.71 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.054 0.454 . . . . 0.58 111.834 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 5.7 m -84.97 133.22 29.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.399 -0.364 . . . . 1.03 110.284 178.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 -132.57 103.03 5.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.881 0.372 . . . . 0.9 111.063 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.05 57.7 0.47 Allowed 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.059 0.456 . . . . 1.83 111.847 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 73.1 mt -77.59 -33.16 53.93 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.88 0.372 . . . . 2.48 111.393 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -100.19 21.79 12.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.981 0.419 . . . . 2.83 111.143 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . -138.73 47.85 0.9 Allowed Glycine 0 CA--C 1.523 0.587 0 C-N-CA 120.812 -0.708 . . . . 2.23 112.936 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.309 0 CA-C-O 118.454 -1.192 . . . . 4.41 112.871 -179.829 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.45 0 CA-C-O 120.659 0.266 . . . . 1.22 110.869 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.44 -35.84 7.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.172 0.511 . . . . 0.7 111.192 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 19' ' ' LEU . . . . . 0.536 ' HG ' ' CE1' ' B' ' 23' ' ' PHE . 6.2 tp -113.8 113.56 47.28 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 116.132 -0.485 . . . . 1.26 111.179 -179.68 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -65.35 116.28 3.8 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.336 2.024 . . . . 0.67 110.261 178.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 21' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -65.14 47.23 0.17 Allowed 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 122.785 2.324 . . . . 0.88 115.806 -176.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -87.58 -57.07 3.08 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.34 -0.615 . . . . 1.0 109.34 178.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 23' ' ' PHE . . . . . 0.536 ' CE1' ' HG ' ' B' ' 19' ' ' LEU . 0.0 OUTLIER -56.55 -41.3 76.62 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.87 -0.605 . . . . 0.91 110.686 178.54 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.61 -49.01 78.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.064 -0.516 . . . . 0.85 110.735 179.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.78 -42.1 95.33 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.329 -0.396 . . . . 0.67 110.933 179.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 26' ' ' GLN . . . . . 0.572 ' HB3' ' HE2' ' A' ' 212' ' ' MET . 1.2 mt-30 -64.73 -49.53 70.45 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.128 -0.487 . . . . 1.42 111.351 179.531 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 61.6 mt -56.65 -36.03 69.06 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 120.815 0.34 . . . . 1.11 110.33 178.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 28' ' ' ARG . . . . . . . . . . . . . 19.4 mtp180 -62.89 -48.44 78.96 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.171 -0.468 . . . . 0.57 110.157 178.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . 0.514 ' HA ' ' HE3' ' B' ' 29' ' ' LYS . 0.0 OUTLIER -66.83 -41.81 86.83 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.319 -0.4 . . . . 0.73 111.96 -179.79 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . 0.405 ' O ' HG22 ' B' ' 34' ' ' VAL . 78.8 mt -61.65 -41.61 91.03 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 N-CA-C 109.142 -0.688 . . . . 1.07 109.142 178.027 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -61.85 -49.13 78.95 Favored Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 115.655 -0.702 . . . . 0.31 111.872 178.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -58.9 -44.23 91.19 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-O 121.117 0.484 . . . . 0.45 109.737 178.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 3.3 tmtt? -58.84 -52.61 64.98 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 115.434 -0.803 . . . . 0.58 111.137 178.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 34' ' ' VAL . . . . . 0.405 HG22 ' O ' ' B' ' 30' ' ' ILE . 58.7 t -58.87 -49.43 83.04 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 CA-C-O 120.749 0.309 . . . . 0.57 111.416 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -58.74 -43.96 90.39 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 116.307 -0.406 . . . . 0.85 111.972 -179.586 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 36' ' ' CYS . . . . . . . . . . . . . 17.8 p -73.39 -32.84 64.68 Favored 'General case' 0 N--CA 1.468 0.444 0 O-C-N 122.023 -0.423 . . . . 1.13 111.421 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 89.5 m -66.35 -39.82 89.42 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.526 -0.306 . . . . 1.03 111.365 179.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 38' ' ' TRP . . . . . . . . . . . . . 84.2 m95 -80.45 -25.05 39.13 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.981 -0.288 . . . . 0.65 111.201 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 69.2 m -68.08 -42.83 79.8 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 120.898 0.38 . . . . 0.48 110.71 178.139 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -88.8 127.7 55.12 Favored Pre-proline 0 CA--C 1.532 0.285 0 CA-C-N 116.216 -0.447 . . . . 0.71 111.522 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -78.14 61.27 7.69 Favored 'Trans proline' 0 CA--C 1.535 0.547 0 C-N-CA 122.58 2.187 . . . . 1.19 113.144 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 52.8 m-20 -79.0 73.01 5.56 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 120.981 0.419 . . . . 1.01 111.325 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 43' ' ' MET . . . . . . . . . . . . . 52.6 ttp . . . . . 0 C--O 1.253 1.255 0 CA-C-O 118.232 -0.889 . . . . 1.62 111.367 179.792 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.277 0 CA-C-O 119.969 -0.351 . . . . 1.55 112.705 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -74.17 89.87 1.02 Allowed 'Trans proline' 0 CA--C 1.534 0.503 0 C-N-CA 122.929 2.419 . . . . 1.19 112.775 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 84.8 mt -59.65 141.73 54.43 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 112.583 0.586 . . . . 2.12 112.583 -179.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 77.85 -36.79 1.66 Allowed Glycine 0 CA--C 1.523 0.564 0 CA-C-N 115.775 -0.648 . . . . 1.21 114.358 179.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 99.4 p -93.96 -46.52 7.13 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 113.092 0.775 . . . . 0.81 113.092 -178.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.512 ' OE2' ' HD3' ' A' ' 284' ' ' ARG . 1.4 mt-10 -138.93 -30.56 0.74 Allowed 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 114.379 1.252 . . . . 0.56 114.379 -178.132 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -62.24 -53.72 51.13 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 112.763 0.653 . . . . 0.91 112.763 -178.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -67.85 -38.7 83.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.856 0.36 . . . . 0.59 110.679 179.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.418 HD11 ' HA3' ' A' ' 292' ' ' GLY . 53.8 tp -61.56 -39.4 90.97 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.732 -0.47 . . . . 1.11 109.732 178.366 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -58.17 -51.49 69.5 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.604 -0.726 . . . . 0.52 112.02 179.179 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.511 ' HD2' ' OE1' ' A' ' 182' ' ' GLU . 20.1 mtm180 -56.77 -49.66 74.61 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 112.37 0.507 . . . . 0.71 112.37 -178.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -59.04 -50.45 74.03 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 120.903 0.382 . . . . 1.19 111.007 179.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' SER . . . . . 0.451 ' HA ' ' CZ2' ' A' ' 293' ' ' TRP . 3.3 p -63.64 -45.9 88.1 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 112.278 0.473 . . . . 0.34 112.278 -179.374 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.404 HD21 ' HA ' ' A' ' 160' ' ' LEU . 0.4 OUTLIER -53.4 -49.76 66.6 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 120.774 0.321 . . . . 1.28 111.124 179.45 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . 1.022 ' HG3' ' HA3' ' A' ' 181' ' ' GLY . 1.3 mm-40 -75.99 -43.17 45.63 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.873 0.694 . . . . 0.39 112.873 -179.365 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . 0.448 HD11 ' HB2' ' A' ' 190' ' ' ALA . 79.9 mt -62.01 -42.44 94.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 O-C-N 121.978 -0.451 . . . . 0.89 111.753 -179.292 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.676 ' O ' ' HG ' ' A' ' 167' ' ' LEU . 74.1 mt -69.06 -52.3 35.23 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 C-N-CA 121.018 -0.273 . . . . 1.1 110.768 179.043 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 54.6 p -58.03 -42.27 84.98 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 121.281 -0.167 . . . . 0.31 110.983 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . 0.423 HH11 ' HD2' ' A' ' 165' ' ' ARG . 2.0 mmt85 -55.43 -51.77 65.81 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.722 -0.217 . . . . 0.46 110.951 178.472 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' TYR . . . . . 0.836 ' CE1' ' HA ' ' A' ' 195' ' ' ARG . 72.5 t80 -60.26 -48.68 80.69 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.666 -0.243 . . . . 0.4 111.142 179.28 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.676 ' HG ' ' O ' ' A' ' 163' ' ' ILE . 18.8 mt -59.0 -44.18 91.63 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.561 -0.29 . . . . 0.86 111.484 -179.568 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . 0.52 ' HD3' ' OE2' ' A' ' 269' ' ' GLU . 25.3 mtm180 -70.47 -44.42 67.77 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 112.22 0.452 . . . . 0.55 112.22 179.671 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -62.8 -44.1 97.06 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.705 0.288 . . . . 0.48 111.168 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . 0.444 ' HG3' ' CZ ' ' A' ' 166' ' ' TYR . 6.4 mm-40 -70.48 -28.99 65.41 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.853 0.359 . . . . 0.43 110.708 178.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . 0.79 ' HA ' ' HG2' ' A' ' 257' ' ' LYS . . . -69.09 -32.82 72.51 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 112.522 0.564 . . . . 0.9 112.522 -179.695 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' THR . . . . . 0.768 ' HB ' ' HD3' ' A' ' 260' ' ' LYS . 8.8 t -106.51 -14.4 15.07 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 112.681 0.623 . . . . 1.0 112.681 -179.584 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 79.4 28.62 52.11 Favored Glycine 0 CA--C 1.523 0.549 0 C-N-CA 120.689 -0.767 . . . . 0.42 112.971 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 32.6 t -98.28 163.64 12.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.49 0.662 . . . . 0.64 111.788 -179.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 7.4 mptt -122.12 60.37 0.99 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.835 -0.621 . . . . 0.61 110.48 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -74.82 81.12 2.11 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.01 -0.541 . . . . 0.47 112.161 -179.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 9.1 t -79.38 13.59 1.88 Allowed 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 121.161 0.505 . . . . 0.79 111.277 179.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 36.2 mttt -68.49 155.29 93.04 Favored Pre-proline 0 CA--C 1.535 0.394 0 CA-C-N 116.018 -0.537 . . . . 0.7 110.309 178.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -52.9 111.89 0.77 Allowed 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 122.595 2.197 . . . . 0.56 112.574 179.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -83.45 176.03 9.38 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.343 -0.39 . . . . 1.18 111.906 -179.372 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . 1.022 ' HA3' ' HG3' ' A' ' 161' ' ' GLU . . . -54.83 130.27 46.21 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.872 -0.68 . . . . 0.39 112.514 -179.613 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . 0.511 ' OE1' ' HD2' ' A' ' 157' ' ' ARG . 84.8 mt-10 4.46 75.46 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 125.313 1.445 . . . . 1.46 114.478 -178.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . 0.495 ' O ' ' HA3' ' A' ' 187' ' ' GLY . . . -169.0 72.96 0.09 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 115.624 -0.716 . . . . 1.06 110.247 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -78.74 -71.68 1.23 Allowed Glycine 0 CA--C 1.523 0.542 0 C-N-CA 120.647 -0.787 . . . . 0.42 113.811 -178.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -71.97 -56.14 6.2 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 120.8 0.333 . . . . 0.77 111.049 -179.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -61.52 -35.03 76.58 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.116 -0.493 . . . . 0.77 110.578 179.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . 0.495 ' HA3' ' O ' ' A' ' 183' ' ' ALA . . . -65.37 -40.46 96.43 Favored Glycine 0 C--N 1.333 0.408 0 C-N-CA 121.229 -0.51 . . . . 0.4 113.201 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . 0.443 ' HD3' ' HA ' ' A' ' 188' ' ' ARG . 15.0 mmt180 -66.52 -47.02 74.26 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 117.193 0.497 . . . . 0.79 110.552 179.656 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . 0.66 ' HB3' HG13 ' A' ' 297' ' ' VAL . 23.9 mmt180 -66.97 -39.52 87.22 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.067 -0.515 . . . . 0.77 111.204 179.678 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . 0.448 ' HB2' HD11 ' A' ' 162' ' ' ILE . . . -70.09 -40.08 75.17 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.899 -0.321 . . . . 0.65 111.136 179.095 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 16.0 tp -69.27 -44.41 71.94 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 120.777 -0.369 . . . . 1.21 111.294 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . 0.543 ' HG3' ' O ' ' A' ' 189' ' ' ARG . 0.0 OUTLIER -58.43 -37.73 75.99 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 120.597 -0.441 . . . . 0.36 110.401 179.169 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' THR . . . . . 0.555 HG22 ' HA ' ' A' ' 297' ' ' VAL . 1.1 p -76.87 -47.59 20.81 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 120.953 -0.299 . . . . 1.05 111.08 178.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . 0.445 HD13 ' HA ' ' A' ' 194' ' ' LEU . 10.3 tp -58.85 -35.36 72.82 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.737 0.303 . . . . 1.01 110.977 179.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . 0.836 ' HA ' ' CE1' ' A' ' 166' ' ' TYR . 12.6 mmt180 -68.8 -58.29 4.4 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.788 0.328 . . . . 0.45 110.348 178.393 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 20.7 ttp85 -60.77 -54.02 50.24 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 112.914 0.709 . . . . 1.03 112.914 -179.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . 0.555 ' O ' HG22 ' A' ' 201' ' ' VAL . 46.8 t -68.7 -45.1 81.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 112.051 0.389 . . . . 1.05 112.051 -179.033 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -61.7 -42.41 99.75 Favored Glycine 0 CA--C 1.521 0.444 0 C-N-CA 120.996 -0.621 . . . . 0.33 113.027 -179.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -68.39 -42.39 79.15 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 109.728 -0.471 . . . . 0.49 109.728 179.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -56.54 -48.68 74.76 Favored Glycine 0 C--N 1.336 0.547 0 C-N-CA 120.797 -0.716 . . . . 0.39 111.655 178.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . 0.555 HG22 ' O ' ' A' ' 197' ' ' VAL . 60.0 t -62.92 -42.6 97.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 CA-C-O 120.702 0.287 . . . . 0.84 111.193 178.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -63.38 -48.64 77.04 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.152 -0.476 . . . . 0.39 112.028 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 31.7 mtm180 -73.5 -35.27 65.6 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.908 -0.317 . . . . 1.06 111.739 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -63.73 -49.19 74.03 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 121.117 0.484 . . . . 1.11 110.039 178.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 79.6 m-70 -101.17 33.78 2.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.157 -0.474 . . . . 0.78 110.711 179.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -53.65 -45.71 70.32 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.89 -0.596 . . . . 0.79 112.042 -179.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -59.51 -41.89 90.97 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 120.928 0.394 . . . . 1.2 111.51 179.34 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -70.62 -50.62 35.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.23 -0.441 . . . . 0.48 111.045 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -60.26 -44.09 95.59 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 116.478 -0.328 . . . . 0.82 111.024 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -64.67 -40.89 96.2 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 110.272 -0.27 . . . . 0.96 110.272 178.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -62.3 -44.81 97.14 Favored Glycine 0 C--N 1.335 0.522 0 N-CA-C 110.746 -0.942 . . . . 0.44 110.746 178.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' MET . . . . . 0.518 ' O ' ' HG ' ' A' ' 216' ' ' LEU . 8.0 mtp -64.09 -42.12 97.05 Favored 'General case' 0 C--O 1.222 -0.375 0 N-CA-C 110.076 -0.342 . . . . 0.95 110.076 178.102 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . 0.42 HD21 ' HB2' ' A' ' 258' ' ' HIS . 6.8 tp -61.85 -39.16 90.87 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 120.889 0.376 . . . . 1.22 111.245 179.136 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 10.4 tpt180 -68.66 -32.52 72.43 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 116.267 -0.424 . . . . 0.97 111.32 179.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' LYS . . . . . 0.488 ' HZ3' ' CD ' ' B' ' 22' ' ' GLU . 99.3 mttt -89.99 -15.56 31.68 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 111.899 0.333 . . . . 0.86 111.899 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . 0.524 HD13 ' CZ ' ' A' ' 251' ' ' PHE . 13.3 mt -62.92 134.18 55.8 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 113.036 0.754 . . . . 1.27 113.036 -179.288 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -100.95 17.04 23.3 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 115.511 -0.768 . . . . 1.1 110.127 178.589 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 30.7 mm -67.88 108.24 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 CA-C-N 116.073 -0.512 . . . . 1.07 111.385 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 2.9 mtmp? -135.08 -42.6 0.73 Allowed 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 112.355 0.502 . . . . 1.36 112.355 -179.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -113.87 -178.39 3.36 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 113.184 0.809 . . . . 1.27 113.184 -177.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . 0.605 ' O ' HG22 ' A' ' 224' ' ' VAL . 8.7 tm-20 -56.52 -44.53 80.88 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 115.723 -0.671 . . . . 1.34 112.244 -179.438 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -54.02 -26.99 36.42 Favored Glycine 0 CA--C 1.527 0.807 0 C-N-CA 121.112 -0.566 . . . . 0.51 113.564 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 62.7 m-20 -68.47 -31.03 70.03 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 112.71 0.633 . . . . 0.75 112.71 -179.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . 0.605 HG22 ' O ' ' A' ' 221' ' ' GLU . 4.4 m -63.22 -28.65 45.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 CA-C-O 121.156 0.503 . . . . 1.18 111.548 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . 0.409 ' HZ1' ' CD ' ' A' ' 221' ' ' GLU . 37.6 mttm -70.0 -39.36 75.93 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-O 121.334 0.587 . . . . 1.95 110.278 179.399 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' SER . . . . . 0.522 ' O ' HG23 ' A' ' 230' ' ' VAL . 11.3 t -66.34 -36.03 81.88 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.896 -0.593 . . . . 0.47 109.535 178.315 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' PHE . . . . . . . . . . . . . 33.8 t80 -60.81 -42.55 97.87 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.184 -0.916 . . . . 0.66 110.314 178.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' SER . . . . . 0.404 ' HB3' HG12 ' A' ' 278' ' ' VAL . 18.8 m -59.62 -45.61 91.45 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 115.716 -0.675 . . . . 1.25 110.634 178.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 15.8 ttm105 -55.52 -43.68 75.97 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.611 -0.722 . . . . 0.46 110.799 178.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . 0.522 HG23 ' O ' ' A' ' 226' ' ' SER . 25.4 t -58.9 -49.56 82.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 CA-C-N 116.118 -0.492 . . . . 1.11 111.679 179.328 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 231' ' ' MET . . . . . 0.535 ' HA ' HD23 ' A' ' 248' ' ' LEU . 70.5 mtm -53.11 -45.74 68.42 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.351 -0.386 . . . . 1.16 111.755 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 37.7 t -68.91 -40.45 81.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-O 120.657 0.265 . . . . 0.69 110.976 178.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 39.5 t-80 -54.89 -33.09 61.63 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.038 -0.528 . . . . 0.6 111.175 179.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . 0.557 HG11 ' HA ' ' B' ' 28' ' ' ARG . 79.0 t -61.78 -30.9 49.4 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 N-CA-C 112.405 0.52 . . . . 0.91 112.405 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -93.98 23.16 5.1 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 112.432 0.53 . . . . 0.71 112.432 -179.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.58 -23.57 17.4 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 113.399 0.889 . . . . 1.25 113.399 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . 0.456 ' HB2' HG12 ' A' ' 239' ' ' VAL . 0.1 OUTLIER -76.67 -14.64 59.95 Favored 'General case' 0 CA--C 1.533 0.321 0 O-C-N 121.932 -0.48 . . . . 0.67 111.991 -179.688 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 88.53 12.71 64.35 Favored Glycine 0 CA--C 1.522 0.516 0 C-N-CA 120.79 -0.719 . . . . 0.67 113.488 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . 0.456 HG12 ' HB2' ' A' ' 237' ' ' ASP . 3.9 p -119.48 112.21 36.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 CA-C-O 121.533 0.682 . . . . 0.92 111.569 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 240' ' ' THR . . . . . 0.732 HG22 HD13 ' A' ' 245' ' ' ILE . 4.2 m -81.33 69.93 8.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.101 -0.499 . . . . 0.65 112.235 -179.445 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 48.2 m-20 -76.89 136.21 38.85 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 120.724 0.297 . . . . 0.96 110.976 179.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 242' ' ' TRP . . . . . 0.545 ' CZ3' ' HB2' ' A' ' 296' ' ' PHE . 68.8 m95 -53.66 -36.53 62.22 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 112.972 0.73 . . . . 0.61 112.972 -179.17 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -58.09 -34.88 74.49 Favored Glycine 0 CA--C 1.521 0.46 0 C-N-CA 120.994 -0.622 . . . . 0.38 112.894 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 244' ' ' ARG . . . . . 0.609 ' O ' ' HG ' ' A' ' 248' ' ' LEU . 28.9 mtt180 -74.37 -46.45 40.43 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.917 -0.401 . . . . 1.03 109.917 179.389 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . 0.732 HD13 HG22 ' A' ' 240' ' ' THR . 58.5 mt -55.91 -47.96 79.13 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-N 115.533 -0.758 . . . . 1.17 110.778 178.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 7.6 p -70.15 -29.01 38.01 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 120.905 -0.318 . . . . 1.11 110.852 179.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 247' ' ' THR . . . . . 0.447 HG22 HD21 ' B' ' 27' ' ' LEU . 19.8 m -65.16 -39.64 93.24 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 109.603 -0.517 . . . . 1.01 109.603 177.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 248' ' ' LEU . . . . . 0.609 ' HG ' ' O ' ' A' ' 244' ' ' ARG . 51.4 mt -63.21 -38.91 93.03 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.863 -0.608 . . . . 1.11 109.784 178.204 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 249' ' ' ILE . . . . . 0.431 HG22 HD11 ' A' ' 194' ' ' LEU . 15.6 mt -70.22 -36.9 69.66 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 N-CA-C 109.55 -0.537 . . . . 1.07 109.55 177.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 20.4 m -64.08 -40.5 96.38 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 109.255 -0.646 . . . . 0.4 109.255 178.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 251' ' ' PHE . . . . . 0.525 ' CD2' HD13 ' B' ' 27' ' ' LEU . 8.0 t80 -65.83 -40.99 92.32 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 108.644 -0.873 . . . . 0.68 108.644 176.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -62.69 -39.55 98.06 Favored Glycine 0 C--N 1.336 0.53 0 CA-C-N 115.509 -0.769 . . . . 0.3 111.576 178.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -64.75 -41.44 95.92 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 120.665 0.269 . . . . 0.4 110.517 178.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -63.09 -37.9 89.03 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.042 0.449 . . . . 0.73 110.209 178.503 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 255' ' ' VAL . . . . . 0.513 HG21 ' O ' ' A' ' 251' ' ' PHE . 59.9 t -72.97 -39.42 57.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 N-CA-C 109.83 -0.433 . . . . 1.1 109.83 178.218 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 256' ' ' ALA . . . . . 0.413 ' HB3' HD12 ' A' ' 268' ' ' ILE . . . -55.64 -43.71 76.47 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.143 0.497 . . . . 1.06 109.942 178.042 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 257' ' ' LYS . . . . . 0.79 ' HG2' ' HA ' ' A' ' 171' ' ' ALA . 93.0 mttt -62.39 -47.87 82.25 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 115.507 -0.769 . . . . 0.61 110.378 178.267 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 258' ' ' HIS . . . . . 0.42 ' HB2' HD21 ' A' ' 213' ' ' LEU . 45.3 t60 -59.45 -36.43 75.91 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.3 -0.409 . . . . 0.82 111.379 179.668 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . 0.404 ' O ' ' HB2' ' A' ' 264' ' ' GLN . 88.2 mt -77.37 -51.06 11.47 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 112.023 0.379 . . . . 1.17 112.023 179.275 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 260' ' ' LYS . . . . . 0.768 ' HD3' ' HB ' ' A' ' 172' ' ' THR . 0.4 OUTLIER -60.81 -42.05 96.91 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 112.496 0.554 . . . . 1.28 112.496 -179.341 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 29.3 p -55.63 -27.98 52.73 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 112.35 0.5 . . . . 0.62 112.35 -179.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 262' ' ' VAL . . . . . 0.513 HG22 ' HG3' ' A' ' 264' ' ' GLN . 17.1 m -109.41 25.83 2.76 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-O 120.759 0.314 . . . . 1.22 111.594 179.361 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 58.4 m-80 55.63 47.44 20.68 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 113.219 0.822 . . . . 1.58 113.219 179.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 264' ' ' GLN . . . . . 0.513 ' HG3' HG22 ' A' ' 262' ' ' VAL . 37.3 mt-30 -103.94 39.8 1.56 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.005 0.431 . . . . 0.89 111.359 179.381 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . 0.791 ' HA ' HG22 ' A' ' 268' ' ' ILE . 24.2 mm-40 -50.84 -35.88 34.72 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 112.668 0.618 . . . . 0.71 112.668 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 57.1 p -67.81 -7.96 32.05 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.658 -0.246 . . . . 0.98 111.608 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -116.76 -33.45 4.8 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.525 0.194 . . . . 0.96 111.525 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 268' ' ' ILE . . . . . 0.791 HG22 ' HA ' ' A' ' 265' ' ' GLU . 6.1 tt -67.38 -43.32 87.82 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 N-CA-C 111.705 0.261 . . . . 1.11 111.705 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 269' ' ' GLU . . . . . 0.719 ' HB2' ' HD3' ' A' ' 270' ' ' PRO . 6.7 mm-40 -63.08 -56.03 31.86 Favored Pre-proline 0 CA--C 1.537 0.447 0 C-N-CA 120.851 -0.34 . . . . 0.78 110.751 179.573 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 270' ' ' PRO . . . . . 0.719 ' HD3' ' HB2' ' A' ' 269' ' ' GLU . 50.3 Cg_exo -57.0 -29.64 83.57 Favored 'Trans proline' 0 C--N 1.36 1.179 0 C-N-CA 122.0 1.8 . . . . 0.39 111.588 177.577 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 271' ' ' LEU . . . . . . . . . . . . . 19.1 tp -66.7 -51.08 60.1 Favored 'General case' 0 C--O 1.224 -0.265 0 N-CA-C 109.782 -0.451 . . . . 0.87 109.782 178.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -58.36 -34.48 70.72 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 120.942 0.401 . . . . 0.38 110.514 178.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 273' ' ' GLU . . . . . 0.595 ' OE1' ' HA ' ' A' ' 270' ' ' PRO . 68.9 mt-10 -71.21 -47.81 55.15 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 115.856 -0.611 . . . . 0.97 109.892 178.244 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 274' ' ' THR . . . . . . . . . . . . . 61.1 m -60.67 -43.11 98.05 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.889 -0.596 . . . . 1.16 110.713 179.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 275' ' ' ILE . . . . . 0.514 ' HA ' ' HE3' ' A' ' 231' ' ' MET . 96.1 mt -60.48 -54.64 32.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 115.833 -0.621 . . . . 1.0 110.386 178.589 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 26.0 m -61.17 -48.87 79.55 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.096 -0.502 . . . . 0.85 112.331 -179.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 277' ' ' ASP . . . . . 0.478 ' CG ' HH12 ' A' ' 281' ' ' ARG . 24.2 t70 -54.44 -53.26 56.58 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 120.873 0.368 . . . . 0.37 111.635 -179.676 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 278' ' ' VAL . . . . . 0.404 HG12 ' HB3' ' A' ' 228' ' ' SER . 97.8 t -68.6 -42.93 83.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.365 -0.379 . . . . 1.01 111.649 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . 0.422 HD13 HG22 ' A' ' 245' ' ' ILE . 40.6 tp -57.77 -43.08 85.25 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 120.601 0.239 . . . . 1.18 111.618 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 77.6 t -72.3 -53.33 19.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 120.824 -0.351 . . . . 1.12 110.737 179.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 281' ' ' ARG . . . . . 0.51 ' HA ' ' HG3' ' A' ' 284' ' ' ARG . 18.8 ttp-105 -56.44 -40.97 75.67 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 113.669 0.989 . . . . 0.66 113.669 -179.685 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 282' ' ' THR . . . . . 0.872 HG21 ' HD2' ' A' ' 283' ' ' LYS . 13.9 t -63.14 -21.63 66.32 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 113.269 0.84 . . . . 0.67 113.269 -178.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . 0.872 ' HD2' HG21 ' A' ' 282' ' ' THR . 0.4 OUTLIER -142.26 41.76 1.64 Allowed 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 112.4 0.519 . . . . 1.15 112.4 -179.736 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 284' ' ' ARG . . . . . 0.512 ' HD3' ' OE2' ' A' ' 152' ' ' GLU . 68.8 mtt180 -55.01 -47.84 74.14 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 113.035 0.754 . . . . 1.21 113.035 -178.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 285' ' ' ASP . . . . . 0.431 ' HA ' HG21 ' A' ' 288' ' ' VAL . 32.4 t70 -60.5 -39.6 88.32 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.043 0.449 . . . . 0.59 111.327 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 286' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -67.99 -37.99 82.13 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.201 0.524 . . . . 0.66 110.218 179.088 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -70.62 -48.93 52.55 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.639 -0.71 . . . . 1.13 111.638 179.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 288' ' ' VAL . . . . . 0.431 HG21 ' HA ' ' A' ' 285' ' ' ASP . 33.5 m -61.32 -33.76 57.98 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-O 120.627 0.251 . . . . 1.18 111.436 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 50.6 mttp -72.0 -26.14 62.11 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 120.854 0.359 . . . . 1.35 110.874 178.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -101.93 11.01 39.26 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 112.437 0.532 . . . . 0.87 112.437 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 291' ' ' ARG . . . . . 0.402 HH11 ' HD2' ' A' ' 291' ' ' ARG . 29.1 mtm180 62.54 20.29 11.85 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 120.716 0.293 . . . . 0.95 111.7 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 292' ' ' GLY . . . . . 0.418 ' HA3' HD11 ' A' ' 155' ' ' LEU . . . 65.07 -111.67 4.38 Favored Glycine 0 CA--C 1.525 0.662 0 C-N-CA 121.375 -0.441 . . . . 0.56 114.061 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 293' ' ' TRP . . . . . 0.589 ' O ' HG22 ' A' ' 297' ' ' VAL . 53.9 m95 -63.48 -45.89 88.68 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.857 0.688 . . . . 0.57 112.857 -178.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 294' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -50.21 -47.36 54.82 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 111.849 0.315 . . . . 0.52 111.849 -179.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -66.03 -41.19 95.31 Favored Glycine 0 CA--C 1.523 0.561 0 C-N-CA 120.582 -0.818 . . . . 0.33 112.258 178.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 296' ' ' PHE . . . . . 0.545 ' HB2' ' CZ3' ' A' ' 242' ' ' TRP . 1.6 t80 -62.37 -42.68 99.6 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.95 0.405 . . . . 0.5 111.116 179.076 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 297' ' ' VAL . . . . . 0.66 HG13 ' HB3' ' A' ' 189' ' ' ARG . 64.0 t -63.91 -47.18 91.77 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-N 116.004 -0.544 . . . . 1.05 111.807 -179.555 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -59.07 -46.16 88.96 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 112.128 0.418 . . . . 0.65 112.128 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 299' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -59.05 -27.35 65.41 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 120.976 0.417 . . . . 0.63 111.74 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 300' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 -108.02 22.73 15.54 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.283 0.563 . . . . 0.71 111.286 179.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -101.49 6.68 42.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.182 0.515 . . . . 1.4 111.064 179.361 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 6.1 p -81.95 134.15 27.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.765 -0.652 . . . . 1.32 111.151 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -148.7 105.61 3.59 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 120.933 0.397 . . . . 1.58 111.457 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 49.2 t0 -148.07 123.1 10.08 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.132 -0.486 . . . . 2.41 110.931 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 16.6 tp -127.37 6.63 6.36 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.52 0.676 . . . . 3.01 109.813 178.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -113.46 -32.71 6.13 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 115.464 -0.789 . . . . 2.38 111.744 -179.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . 108.85 76.95 0.96 Allowed Glycine 0 CA--C 1.522 0.481 0 C-N-CA 120.621 -0.799 . . . . 2.67 113.181 179.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.209 0 CA-C-O 118.418 -1.212 . . . . 3.02 113.249 179.661 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 121.295 0.569 . . . . 1.99 110.787 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -142.94 -74.23 0.28 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.548 -0.751 . . . . 1.24 110.986 -178.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 19' ' ' LEU . . . . . 0.416 HD23 ' HD2' ' B' ' 20' ' ' PRO . 6.4 mt -101.88 115.52 64.66 Favored Pre-proline 0 CA--C 1.531 0.225 0 CA-C-O 121.096 0.474 . . . . 1.58 111.524 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 20' ' ' PRO . . . . . 0.469 ' C ' ' H ' ' B' ' 22' ' ' GLU . 82.0 Cg_endo -78.63 154.85 27.35 Favored 'Trans proline' 0 CA--C 1.532 0.402 0 C-N-CA 122.773 2.315 . . . . 1.11 112.528 179.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 21' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -69.04 27.57 0.16 Allowed 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 123.085 2.523 . . . . 1.37 113.602 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 22' ' ' GLU . . . . . 0.488 ' CD ' ' HZ3' ' A' ' 215' ' ' LYS . 23.5 tt0 -72.91 -43.95 61.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.912 0.387 . . . . 0.81 110.406 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 23' ' ' PHE . . . . . 0.542 ' O ' ' HG ' ' B' ' 27' ' ' LEU . 4.0 p90 -63.76 -33.2 75.12 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.113 -0.494 . . . . 0.65 110.829 179.227 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -72.76 -46.47 53.21 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.256 -0.429 . . . . 1.14 111.095 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.89 -42.21 97.52 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 121.072 0.463 . . . . 0.98 110.456 179.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -59.57 -53.38 58.77 Favored 'General case' 0 N--CA 1.457 -0.105 0 CA-C-N 115.681 -0.69 . . . . 1.15 110.739 179.237 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . 0.542 ' HG ' ' O ' ' B' ' 23' ' ' PHE . 78.3 mt -56.5 -35.58 68.18 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.623 -0.262 . . . . 1.11 111.597 179.685 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 28' ' ' ARG . . . . . 0.557 ' HA ' HG11 ' A' ' 234' ' ' VAL . 0.0 OUTLIER -67.3 -47.07 71.7 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.74 0.305 . . . . 0.56 111.09 179.532 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 44.3 mtmt -67.67 -41.83 83.11 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 121.038 0.447 . . . . 1.16 110.371 178.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . 0.462 ' O ' HG21 ' B' ' 34' ' ' VAL . 97.0 mt -64.31 -40.03 87.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 CA-C-N 115.942 -0.572 . . . . 1.02 110.128 178.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -57.88 -49.95 70.07 Favored Glycine 0 C--N 1.333 0.412 0 CA-C-N 115.879 -0.6 . . . . 0.29 112.941 179.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 39.1 m-20 -68.9 -26.73 65.25 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 117.157 0.479 . . . . 0.48 110.273 178.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 33' ' ' LYS . . . . . 0.423 ' HE2' ' HA ' ' B' ' 33' ' ' LYS . 0.0 OUTLIER -67.86 -53.72 24.51 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.505 -0.316 . . . . 0.5 110.734 178.75 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 34' ' ' VAL . . . . . 0.462 HG21 ' O ' ' B' ' 30' ' ' ILE . 57.3 t -58.03 -47.24 87.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-O 121.081 0.467 . . . . 1.08 110.745 179.503 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -58.15 -46.53 85.52 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.625 -0.716 . . . . 1.13 110.138 178.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 36' ' ' CYS . . . . . . . . . . . . . 43.5 t -63.53 -46.04 87.81 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 115.881 -0.599 . . . . 0.42 111.111 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 37' ' ' THR . . . . . 0.574 ' HA ' ' HB3' ' B' ' 42' ' ' ASP . 62.3 m -61.07 -43.24 99.18 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 112.878 0.695 . . . . 0.91 112.878 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 38' ' ' TRP . . . . . . . . . . . . . 94.2 m95 -82.76 -26.3 32.01 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.696 0.628 . . . . 0.74 112.696 -178.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 8.6 t -82.29 -65.72 0.98 Allowed 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 121.019 0.437 . . . . 0.88 110.287 178.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . 0.436 ' HB1' ' HD2' ' B' ' 41' ' ' PRO . . . -92.08 162.26 30.99 Favored Pre-proline 0 CA--C 1.535 0.4 0 CA-C-N 116.091 -0.504 . . . . 0.56 110.662 178.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 41' ' ' PRO . . . . . 0.436 ' HD2' ' HB1' ' B' ' 40' ' ' ALA . 41.9 Cg_endo -69.21 65.33 1.47 Allowed 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 122.295 1.996 . . . . 1.09 112.445 178.494 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 42' ' ' ASP . . . . . 0.574 ' HB3' ' HA ' ' B' ' 37' ' ' THR . 44.7 t0 -112.39 173.46 6.36 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 115.78 -0.646 . . . . 0.71 111.304 -179.064 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 43' ' ' MET . . . . . . . . . . . . . 17.5 tpt . . . . . 0 C--O 1.25 1.094 0 CA-C-O 118.408 -0.806 . . . . 3.08 110.983 179.679 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.369 0 CA-C-O 119.858 -0.412 . . . . 2.23 112.379 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -62.7 132.31 37.06 Favored 'Trans proline' 0 CA--C 1.532 0.4 0 C-N-CA 122.776 2.317 . . . . 1.36 112.721 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 24.5 tp -97.29 -19.28 18.65 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 120.995 0.426 . . . . 2.05 111.309 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 179.61 -155.0 14.61 Favored Glycine 0 CA--C 1.519 0.317 0 C-N-CA 121.167 -0.54 . . . . 0.82 111.866 -179.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.418 ' HA ' ' OD2' ' A' ' 154' ' ' ASP . 0.9 OUTLIER -79.4 76.99 5.98 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.197 0.522 . . . . 0.72 110.928 -179.89 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -117.19 -72.76 0.67 Allowed 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 115.618 -0.719 . . . . 0.53 112.334 -178.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -67.1 -34.41 77.56 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 112.036 0.384 . . . . 0.44 112.036 -178.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . 0.418 ' OD2' ' HA ' ' A' ' 151' ' ' SER . 0.3 OUTLIER -51.98 -52.42 50.59 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 120.747 0.308 . . . . 0.71 111.157 179.544 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 47.4 tp -59.22 -46.17 89.17 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.298 -0.41 . . . . 1.12 111.136 178.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . 0.483 ' OH ' ' HG3' ' A' ' 281' ' ' ARG . 0.1 OUTLIER -60.87 -49.27 78.14 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.413 -0.358 . . . . 0.74 111.545 179.658 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 62.3 mtp180 -62.07 -48.82 78.52 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 112.146 0.424 . . . . 0.57 112.146 -179.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 54.7 mm-40 -61.05 -46.84 89.05 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.732 0.301 . . . . 0.65 110.28 179.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' SER . . . . . 0.4 ' HA ' ' CZ2' ' A' ' 293' ' ' TRP . 16.6 m -61.73 -48.86 78.83 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.217 -0.447 . . . . 0.33 111.078 179.313 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.731 ' HA ' HG22 ' A' ' 276' ' ' THR . 2.0 tm? -56.29 -47.82 77.87 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.65 0.262 . . . . 1.26 110.561 179.487 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . 0.845 ' HG3' ' HB2' ' A' ' 182' ' ' GLU . 4.5 mm-40 -64.54 -48.08 76.41 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.126 0.417 . . . . 0.64 112.126 179.669 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 78.5 mt -67.25 -51.36 53.91 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 N-CA-C 113.022 0.749 . . . . 1.04 113.022 -179.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.495 HD11 HG23 ' A' ' 276' ' ' THR . 80.2 mt -60.74 -49.35 84.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 O-C-N 122.279 -0.263 . . . . 1.08 111.528 -179.35 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' SER . . . . . 0.5 ' O ' ' HB2' ' A' ' 168' ' ' ARG . 3.1 t -57.99 -38.04 75.36 Favored 'General case' 0 N--CA 1.462 0.153 0 N-CA-C 110.249 -0.278 . . . . 0.83 110.249 178.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . 0.423 HH22 ' CG ' ' A' ' 176' ' ' ASP . 0.0 OUTLIER -58.64 -55.74 31.2 Favored 'General case' 0 C--O 1.22 -0.463 0 CA-C-N 116.563 -0.289 . . . . 0.41 110.967 179.344 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' TYR . . . . . 0.643 ' CE1' ' HA ' ' A' ' 195' ' ' ARG . 76.4 t80 -61.26 -51.94 66.81 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 112.495 0.554 . . . . 0.62 112.495 -178.8 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.487 ' HG ' ' O ' ' A' ' 163' ' ' ILE . 33.9 mt -58.76 -48.62 80.57 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 120.713 0.292 . . . . 1.14 111.761 -179.025 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . 0.5 ' HB2' ' O ' ' A' ' 164' ' ' SER . 0.7 OUTLIER -70.97 -45.05 64.77 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 112.318 0.488 . . . . 0.39 112.318 -179.689 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -60.72 -44.35 96.74 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 112.049 0.389 . . . . 0.47 112.049 -179.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -66.73 -48.42 69.26 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.935 -0.306 . . . . 1.14 111.467 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . 0.53 ' HA ' ' HG2' ' A' ' 257' ' ' LYS . . . -69.14 -35.25 76.16 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.54 0.57 . . . . 0.39 112.54 -179.223 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' THR . . . . . 0.775 HG23 ' HD2' ' A' ' 260' ' ' LYS . 0.2 OUTLIER -114.9 35.72 4.18 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.753 0.649 . . . . 0.58 112.753 -177.718 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -59.36 -11.44 13.86 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 121.304 -0.475 . . . . 0.52 113.491 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 10.8 p -96.14 -5.21 41.21 Favored 'General case' 0 CA--C 1.534 0.339 0 O-C-N 122.732 -0.275 . . . . 0.84 111.364 179.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . 0.445 ' HE3' ' HB3' ' A' ' 175' ' ' LYS . 14.6 ttpp -165.56 95.9 0.64 Allowed 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 120.765 0.317 . . . . 0.53 111.561 -179.468 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . 0.423 ' CG ' HH22 ' A' ' 165' ' ' ARG . 3.9 t0 -72.83 179.66 3.56 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-O 121.035 0.445 . . . . 0.63 111.087 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 37.3 t -162.93 -63.14 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.338 -0.392 . . . . 1.51 111.797 -179.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . 0.43 ' HE3' ' HB3' ' A' ' 178' ' ' LYS . 0.4 OUTLIER -109.14 103.29 51.96 Favored Pre-proline 0 CA--C 1.534 0.353 0 CA-C-O 120.611 0.243 . . . . 0.9 110.928 -179.473 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -74.23 -157.21 0.06 OUTLIER 'Trans proline' 0 CA--C 1.536 0.599 0 C-N-CA 123.074 2.516 . . . . 1.31 113.283 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 14.2 mt -100.72 135.36 42.28 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.958 0.409 . . . . 1.33 111.271 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -130.99 -36.27 0.35 Allowed Glycine 0 CA--C 1.526 0.771 0 C-N-CA 120.653 -0.784 . . . . 0.65 113.462 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . 0.845 ' HB2' ' HG3' ' A' ' 161' ' ' GLU . 1.4 mm-40 -98.27 -65.22 0.98 Allowed 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 117.032 0.416 . . . . 0.65 111.684 -179.615 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . 0.435 ' O ' ' HA3' ' A' ' 187' ' ' GLY . . . -74.21 69.55 1.55 Allowed 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 120.941 0.4 . . . . 0.43 111.543 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -79.13 -70.74 1.3 Allowed Glycine 0 CA--C 1.527 0.818 0 C-N-CA 120.984 -0.626 . . . . 0.38 114.396 -179.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -70.19 -57.42 4.94 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 112.48 0.548 . . . . 0.54 112.48 -178.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -62.93 -32.13 73.36 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 121.111 0.482 . . . . 1.07 110.087 179.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . 0.435 ' HA3' ' O ' ' A' ' 183' ' ' ALA . . . -72.93 -38.0 56.32 Favored Glycine 0 C--O 1.22 -0.73 0 CA-C-N 115.281 -0.872 . . . . 0.27 112.819 179.245 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 13.1 tpp180 -61.29 -46.73 89.12 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 117.532 0.666 . . . . 0.98 110.877 179.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . 0.442 ' HB3' HG12 ' A' ' 297' ' ' VAL . 49.1 mtp180 -67.13 -38.99 86.5 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.251 0.548 . . . . 0.47 110.553 178.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . 0.521 ' HA ' HG21 ' A' ' 297' ' ' VAL . . . -69.83 -38.12 76.42 Favored 'General case' 0 C--O 1.224 -0.269 0 CA-C-N 115.701 -0.681 . . . . 0.54 111.68 179.586 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 20.4 tp -65.81 -47.7 74.18 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 111.531 0.197 . . . . 1.07 111.531 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . 0.678 ' O ' ' HG2' ' A' ' 196' ' ' ARG . 5.8 tm-20 -58.62 -47.36 84.64 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 108.964 -0.754 . . . . 0.41 108.964 178.37 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 38.9 m -58.21 -52.36 65.91 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 115.755 -0.657 . . . . 0.4 110.998 178.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 26.9 tp -63.28 -38.68 92.12 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 112.916 0.71 . . . . 0.96 112.916 -179.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . 0.643 ' HA ' ' CE1' ' A' ' 166' ' ' TYR . 3.5 ttm-85 -64.97 -47.24 78.32 Favored 'General case' 0 C--N 1.333 -0.142 0 O-C-N 122.234 -0.291 . . . . 1.01 110.825 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . 0.678 ' HG2' ' O ' ' A' ' 192' ' ' GLU . 33.0 mmm-85 -66.01 -52.78 46.29 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.617 0.246 . . . . 0.56 110.836 179.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . 0.501 HG21 ' HB3' ' A' ' 300' ' ' PHE . 69.4 t -60.65 -51.77 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-N 116.464 -0.335 . . . . 1.01 111.618 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -56.54 -45.28 90.11 Favored Glycine 0 C--N 1.333 0.394 0 C-N-CA 121.389 -0.434 . . . . 0.36 113.042 -179.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . 0.414 ' HA ' ' HG2' ' A' ' 202' ' ' GLN . 33.3 m-20 -67.11 -33.69 76.01 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.658 0.266 . . . . 0.36 110.416 179.173 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -68.93 -32.88 73.9 Favored Glycine 0 CA--C 1.523 0.548 0 C-N-CA 120.72 -0.752 . . . . 0.27 112.002 178.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . 0.558 HG13 ' HA ' ' A' ' 247' ' ' THR . 92.3 t -72.82 -46.48 52.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 CA-C-O 120.687 0.28 . . . . 0.83 111.17 179.181 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' GLN . . . . . 0.414 ' HG2' ' HA ' ' A' ' 199' ' ' ASP . 11.3 pt20 -70.58 -32.5 69.91 Favored 'General case' 0 C--O 1.22 -0.48 0 CA-C-N 116.354 -0.384 . . . . 0.75 111.322 -179.697 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 23.3 ttm180 -68.95 -50.4 49.61 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.798 0.332 . . . . 3.41 110.706 178.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 18.9 m-80 -62.45 -44.46 96.35 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.269 -0.423 . . . . 0.72 111.235 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 87.9 m-70 -103.03 36.28 2.28 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 112.382 0.512 . . . . 0.55 112.382 -179.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -58.01 -42.64 85.67 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 112.613 0.597 . . . . 1.1 112.613 -179.256 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 34.0 p -61.24 -53.05 61.82 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.88 0.371 . . . . 1.19 111.709 -179.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -61.54 -43.73 98.34 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.096 -0.502 . . . . 1.11 110.61 179.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 3.3 m-30 -60.94 -52.04 66.72 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 116.107 -0.497 . . . . 0.59 111.05 179.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 20.1 mt-30 -59.97 -42.74 94.79 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 120.519 0.2 . . . . 0.89 111.249 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -61.21 -51.13 60.21 Favored Glycine 0 C--N 1.335 0.477 0 C-N-CA 120.611 -0.804 . . . . 0.37 111.993 178.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' MET . . . . . 0.644 ' HB3' ' HB3' ' B' ' 23' ' ' PHE . 71.2 mtm -66.34 -31.98 73.1 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 120.586 0.231 . . . . 1.1 110.991 179.344 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 10.3 tp -63.51 -41.95 98.49 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.958 0.408 . . . . 1.16 110.742 178.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' ARG . . . . . 0.425 HH11 ' HD3' ' A' ' 214' ' ' ARG . 39.7 mtt-85 -70.86 -31.74 68.52 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.038 -0.528 . . . . 1.19 111.04 179.414 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -72.8 -21.17 61.02 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 120.971 0.415 . . . . 1.35 111.044 178.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . 0.767 ' HB3' HG12 ' A' ' 218' ' ' ILE . 66.6 mt -72.78 135.37 45.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.02 0.438 . . . . 1.14 111.842 179.617 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -87.79 23.05 2.11 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 116.257 -0.429 . . . . 0.62 110.696 179.08 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' ILE . . . . . 0.767 HG12 ' HB3' ' A' ' 216' ' ' LEU . 50.6 mm -59.47 106.72 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-N 115.723 -0.671 . . . . 1.12 111.627 -179.682 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -154.97 -68.78 0.13 Allowed 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.957 -0.565 . . . . 0.82 111.55 -179.537 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -90.97 -176.48 4.65 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 115.793 -0.64 . . . . 0.76 112.579 -178.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -47.0 -22.45 0.33 Allowed 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 113.34 0.867 . . . . 1.44 113.34 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . 0.447 ' HA2' ' HD2' ' A' ' 225' ' ' LYS . . . -69.7 -22.53 76.81 Favored Glycine 0 CA--C 1.529 0.968 0 CA-C-N 116.522 -0.308 . . . . 0.49 113.134 178.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' ASP . . . . . 0.503 ' HB2' HG22 ' A' ' 218' ' ' ILE . 1.3 p-10 -56.31 -47.44 78.7 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 113.193 0.812 . . . . 0.8 113.193 -178.392 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 31.5 m -60.32 -32.0 49.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-O 121.001 0.429 . . . . 2.29 111.482 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . 0.447 ' HD2' ' HA2' ' A' ' 222' ' ' GLY . 36.9 mttp -76.82 -42.19 41.41 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.315 -0.624 . . . . 1.16 109.315 178.69 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' SER . . . . . 0.869 ' HB3' HD22 ' B' ' 19' ' ' LEU . 19.9 m -63.16 -42.56 99.46 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 115.321 -0.854 . . . . 0.46 110.568 178.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' PHE . . . . . 0.578 ' O ' ' HG3' ' A' ' 231' ' ' MET . 13.8 t80 -65.39 -48.78 71.67 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.936 -0.575 . . . . 0.75 110.141 179.081 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 30.3 t -56.01 -39.09 71.39 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 109.549 -0.537 . . . . 0.94 109.549 178.211 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' ARG . . . . . 0.508 ' HB3' ' O ' ' A' ' 226' ' ' SER . 19.1 ttt180 -55.95 -44.54 78.53 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 115.165 -0.925 . . . . 1.01 110.23 177.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 47.6 t -68.78 -42.73 82.98 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-N 116.292 -0.413 . . . . 0.79 110.804 178.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 231' ' ' MET . . . . . 0.578 ' HG3' ' O ' ' A' ' 227' ' ' PHE . 47.8 mtp -58.14 -53.0 63.22 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 120.84 0.352 . . . . 1.12 111.492 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 34.5 m -65.58 -30.79 51.23 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 CA-C-N 116.484 -0.326 . . . . 0.49 111.558 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 42.4 t-80 -61.47 -54.79 38.76 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 111.76 0.282 . . . . 0.49 111.76 179.198 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . 0.801 ' HB ' ' HB3' ' B' ' 28' ' ' ARG . 4.0 m -66.4 -29.44 46.6 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 N-CA-C 112.224 0.453 . . . . 1.04 112.224 -178.606 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 36.4 m-85 -100.63 22.18 12.26 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 111.999 0.37 . . . . 0.67 111.999 179.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . 0.439 ' HA ' ' HD2' ' A' ' 236' ' ' LYS . 14.9 tptp -79.75 -21.36 44.55 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.87 0.366 . . . . 1.36 111.545 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . 0.418 ' OD1' ' N ' ' A' ' 237' ' ' ASP . 0.0 OUTLIER -69.54 -15.96 63.33 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.096 -0.502 . . . . 0.5 112.085 -179.841 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 90.92 -19.25 46.88 Favored Glycine 0 CA--C 1.521 0.439 0 C-N-CA 120.929 -0.653 . . . . 0.37 113.689 179.089 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 3.3 p -86.49 113.55 24.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.34 0.591 . . . . 0.96 110.848 179.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 59.7 m -93.63 106.25 18.23 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.088 0.471 . . . . 1.0 111.807 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . 0.522 ' HB2' ' HG3' ' A' ' 244' ' ' ARG . 94.8 m-20 -95.39 129.81 42.41 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.937 -0.574 . . . . 0.47 110.43 178.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 242' ' ' TRP . . . . . 0.602 ' HB3' ' CZ ' ' A' ' 300' ' ' PHE . 1.6 m95 -53.29 -41.93 66.09 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 120.938 0.399 . . . . 0.52 111.58 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . 0.428 ' HA3' ' N ' ' B' ' 35' ' ' TYR . . . -64.28 -28.46 73.03 Favored Glycine 0 CA--C 1.521 0.463 0 C-N-CA 120.815 -0.707 . . . . 0.3 112.852 179.139 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 244' ' ' ARG . . . . . 0.522 ' HG3' ' HB2' ' A' ' 241' ' ' ASN . 63.8 mtt180 -70.69 -39.06 73.7 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 122.47 -0.429 . . . . 0.66 110.127 179.194 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 64.0 mt -63.99 -52.28 58.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 CA-C-N 115.82 -0.627 . . . . 1.14 111.229 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 16.8 m -62.38 -35.87 71.82 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 C-N-CA 120.937 -0.305 . . . . 0.6 111.293 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 247' ' ' THR . . . . . 0.558 ' HA ' HG13 ' A' ' 201' ' ' VAL . 99.6 m -64.05 -42.4 97.06 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.076 0.465 . . . . 0.73 109.996 178.159 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 18.9 tp -65.1 -43.6 91.55 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.774 -0.648 . . . . 2.58 110.304 178.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 28.9 mt -64.66 -42.49 95.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 109.757 -0.46 . . . . 1.06 109.757 178.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 45.5 t -61.03 -38.23 85.39 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.786 -0.643 . . . . 0.44 109.842 178.084 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 251' ' ' PHE . . . . . 0.474 ' O ' HG22 ' A' ' 255' ' ' VAL . 34.1 t80 -69.88 -41.37 74.86 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.545 -0.752 . . . . 0.49 109.921 177.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -58.69 -43.93 96.03 Favored Glycine 0 C--N 1.335 0.515 0 N-CA-C 111.134 -0.786 . . . . 0.34 111.134 178.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -61.24 -40.64 94.8 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-O 120.844 0.355 . . . . 0.65 110.087 177.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -60.22 -43.44 96.02 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 116.023 -0.535 . . . . 0.87 109.793 178.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 255' ' ' VAL . . . . . 0.474 HG22 ' O ' ' A' ' 251' ' ' PHE . 64.8 t -66.26 -40.76 87.71 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-N 115.736 -0.666 . . . . 1.07 110.323 178.393 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -62.48 -45.76 91.59 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.318 -0.401 . . . . 0.43 110.155 177.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 257' ' ' LYS . . . . . 0.53 ' HG2' ' HA ' ' A' ' 171' ' ' ALA . 48.0 mtmt -58.98 -45.03 91.59 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.953 -0.567 . . . . 1.06 109.964 177.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -61.63 -34.81 76.33 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.789 -0.641 . . . . 0.44 109.903 178.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . 0.763 ' HG ' ' HB3' ' A' ' 264' ' ' GLN . 2.9 tp -72.12 -32.62 67.12 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 121.251 0.548 . . . . 0.98 110.036 178.096 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 260' ' ' LYS . . . . . 0.775 ' HD2' HG23 ' A' ' 172' ' ' THR . 0.0 OUTLIER -75.4 -31.1 60.31 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 121.118 0.485 . . . . 1.24 110.4 178.069 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 26.7 t -64.07 -19.26 65.1 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.125 -0.489 . . . . 0.76 110.71 178.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 262' ' ' VAL . . . . . 0.407 HG21 ' HB2' ' A' ' 264' ' ' GLN . 31.2 m -114.14 13.81 8.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-N 116.149 -0.478 . . . . 1.14 110.613 178.311 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 6.1 t30 55.91 49.32 16.16 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 115.521 -0.763 . . . . 1.65 112.861 179.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 264' ' ' GLN . . . . . 0.763 ' HB3' ' HG ' ' A' ' 259' ' ' LEU . 4.3 tt0 -113.26 39.13 2.67 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 112.027 0.381 . . . . 1.21 112.027 -179.729 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . 0.663 ' HG3' ' HE3' ' A' ' 260' ' ' LYS . 26.4 mt-10 -48.54 -35.96 14.38 Favored 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 112.934 0.716 . . . . 0.52 112.934 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -56.54 -24.69 48.58 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 112.377 0.51 . . . . 1.44 112.377 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 267' ' ' PHE . . . . . 0.446 ' C ' ' HD2' ' A' ' 270' ' ' PRO . 23.3 m-85 -99.37 -16.74 18.31 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 120.974 0.416 . . . . 1.45 111.001 179.214 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 268' ' ' ILE . . . . . 0.57 HD11 ' HA ' ' A' ' 265' ' ' GLU . 67.3 mt -67.15 -43.22 88.68 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-N 116.209 -0.45 . . . . 1.07 110.564 179.251 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 269' ' ' GLU . . . . . 0.719 ' HB2' ' HD3' ' A' ' 270' ' ' PRO . 2.1 mm-40 -55.26 -56.66 26.14 Favored Pre-proline 0 CA--C 1.543 0.692 0 CA-C-N 116.295 -0.411 . . . . 0.4 111.14 179.361 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 270' ' ' PRO . . . . . 0.719 ' HD3' ' HB2' ' A' ' 269' ' ' GLU . 38.1 Cg_exo -59.61 -34.89 96.47 Favored 'Trans proline' 0 C--N 1.362 1.259 0 C-N-CA 122.253 1.969 . . . . 0.39 112.247 178.295 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 271' ' ' LEU . . . . . . . . . . . . . 43.2 tp -64.91 -51.14 63.51 Favored 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 110.128 -0.323 . . . . 0.68 110.128 178.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -59.02 -42.87 91.21 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 120.997 0.427 . . . . 1.13 110.458 178.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 273' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -63.45 -44.53 94.22 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 115.912 -0.585 . . . . 1.97 110.056 178.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 274' ' ' THR . . . . . . . . . . . . . 99.6 m -60.31 -48.4 81.9 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.236 -0.438 . . . . 1.11 110.381 178.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 275' ' ' ILE . . . . . 0.56 ' O ' ' HB2' ' A' ' 279' ' ' LEU . 95.9 mt -54.89 -47.67 75.28 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.096 0 CA-C-N 115.982 -0.554 . . . . 1.11 110.384 179.051 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 276' ' ' THR . . . . . 0.731 HG22 ' HA ' ' A' ' 160' ' ' LEU . 37.9 m -62.95 -52.06 64.5 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.247 -0.433 . . . . 0.93 111.203 179.374 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 277' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -51.94 -53.86 36.24 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.135 -0.484 . . . . 0.46 111.21 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 278' ' ' VAL . . . . . 0.564 ' O ' HG23 ' A' ' 282' ' ' THR . 60.7 t -63.32 -43.57 98.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-O 120.47 0.176 . . . . 0.98 110.883 179.291 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . 0.56 ' HB2' ' O ' ' A' ' 275' ' ' ILE . 0.3 OUTLIER -56.01 -47.84 77.02 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.604 -0.271 . . . . 1.2 111.313 179.967 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 57.0 t -75.38 -48.69 30.07 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 N-CA-C 111.729 0.27 . . . . 0.61 111.729 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 281' ' ' ARG . . . . . 0.483 ' HG3' ' OH ' ' A' ' 156' ' ' TYR . 31.2 mtp180 -54.69 -40.09 68.8 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 112.941 0.719 . . . . 0.64 112.941 -179.413 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 282' ' ' THR . . . . . 0.564 HG23 ' O ' ' A' ' 278' ' ' VAL . 6.9 t -91.03 4.62 51.63 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 120.191 -0.603 . . . . 0.49 112.289 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . 0.598 ' HZ3' ' HB2' ' A' ' 283' ' ' LYS . 0.0 OUTLIER -141.23 40.83 1.77 Allowed 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 120.92 0.39 . . . . 0.99 111.328 179.777 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -66.1 -62.33 1.55 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.109 0.481 . . . . 0.57 111.84 -179.274 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 285' ' ' ASP . . . . . 0.4 ' CG ' ' HZ1' ' A' ' 289' ' ' LYS . 25.2 t70 -65.32 -45.05 85.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.912 -0.585 . . . . 0.63 112.214 -179.331 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 286' ' ' TRP . . . . . 0.461 ' O ' ' HB2' ' A' ' 290' ' ' GLN . 2.2 t90 -58.12 -38.89 77.37 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 112.38 0.511 . . . . 0.69 112.38 -179.214 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 287' ' ' LEU . . . . . 0.569 HD23 ' HB3' ' A' ' 283' ' ' LYS . 1.2 mm? -70.59 -49.42 47.98 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.776 0.288 . . . . 0.91 111.776 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 9.1 p -62.83 -34.32 65.25 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-O 120.752 0.31 . . . . 1.26 111.409 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 289' ' ' LYS . . . . . 0.4 ' HZ1' ' CG ' ' A' ' 285' ' ' ASP . 43.5 mttp -75.47 -21.55 57.99 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 120.751 0.31 . . . . 1.42 111.473 178.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 290' ' ' GLN . . . . . 0.461 ' HB2' ' O ' ' A' ' 286' ' ' TRP . 0.0 OUTLIER -100.47 29.1 4.59 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 112.66 0.615 . . . . 0.79 112.66 -179.123 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 291' ' ' ARG . . . . . 0.47 ' HD2' ' HB3' ' A' ' 294' ' ' ASP . 8.1 ttm180 64.71 13.11 8.15 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 112.809 0.67 . . . . 1.07 112.809 179.076 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 65.82 -141.13 41.41 Favored Glycine 0 CA--C 1.525 0.692 0 C-N-CA 121.04 -0.6 . . . . 0.46 114.036 179.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 293' ' ' TRP . . . . . 0.621 ' O ' HG23 ' A' ' 297' ' ' VAL . 84.7 m95 -65.39 -32.22 73.74 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.29 0.478 . . . . 0.63 112.29 -179.149 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 294' ' ' ASP . . . . . 0.47 ' HB3' ' HD2' ' A' ' 291' ' ' ARG . 16.1 t70 -59.97 -37.95 81.11 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 121.102 0.477 . . . . 0.74 109.837 178.34 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -65.3 -43.2 95.56 Favored Glycine 0 C--N 1.335 0.511 0 N-CA-C 110.786 -0.926 . . . . 0.27 110.786 177.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 296' ' ' PHE . . . . . 0.494 ' HB2' ' CH2' ' A' ' 242' ' ' TRP . 0.8 OUTLIER -63.03 -46.71 86.29 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 120.88 0.371 . . . . 0.41 110.457 177.947 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 297' ' ' VAL . . . . . 0.621 HG23 ' O ' ' A' ' 293' ' ' TRP . 90.9 t -59.89 -49.27 84.56 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.395 0 CA-C-N 115.922 -0.581 . . . . 1.08 111.242 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -61.8 -46.57 88.95 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.066 0.395 . . . . 1.17 112.066 -179.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 299' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -61.84 -42.29 98.85 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 112.419 0.525 . . . . 0.6 112.419 -179.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 300' ' ' PHE . . . . . 0.602 ' CZ ' ' HB3' ' A' ' 242' ' ' TRP . 76.5 m-85 -99.73 13.62 33.03 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 113.133 0.79 . . . . 0.51 113.133 -178.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -158.38 102.89 1.76 Allowed 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.057 0.456 . . . . 0.39 111.718 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 6.6 m -71.64 136.0 26.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.111 -0.495 . . . . 1.47 111.327 179.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 303' ' ' GLN . . . . . 0.473 HE21 ' HB2' ' A' ' 303' ' ' GLN . 2.9 mt-30 -122.59 -15.08 7.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.078 -0.51 . . . . 1.39 111.626 -179.312 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.86 96.7 0.6 Allowed 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 115.832 -0.622 . . . . 1.06 111.464 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 84.8 mt -97.46 -10.74 24.83 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.264 -0.426 . . . . 1.94 111.402 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.87 -35.11 6.05 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.249 -0.432 . . . . 1.34 111.136 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . -81.27 68.73 3.4 Favored Glycine 0 CA--C 1.523 0.539 0 C-N-CA 120.744 -0.741 . . . . 1.7 113.063 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.211 0 CA-C-O 118.547 -1.14 . . . . 3.74 113.066 -179.946 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.439 0 CA-C-O 120.641 0.257 . . . . 1.49 110.917 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.21 162.59 12.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.734 0.302 . . . . 0.9 110.524 179.134 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 19' ' ' LEU . . . . . 0.869 HD22 ' HB3' ' A' ' 226' ' ' SER . 5.2 tp -104.62 99.09 16.66 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 116.48 -0.327 . . . . 1.12 111.619 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.39 132.01 19.99 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.494 2.129 . . . . 0.52 110.867 178.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 21' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -65.56 45.95 0.18 Allowed 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 122.715 2.277 . . . . 0.61 115.284 -177.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -87.27 -48.92 7.62 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 109.527 -0.545 . . . . 0.47 109.527 178.631 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 23' ' ' PHE . . . . . 0.762 ' CE1' ' HG ' ' B' ' 19' ' ' LEU . 0.0 OUTLIER -59.29 -43.84 92.53 Favored 'General case' 0 C--O 1.225 -0.198 0 CA-C-N 115.669 -0.696 . . . . 0.44 110.55 179.076 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.85 -43.35 77.0 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 115.968 -0.56 . . . . 0.49 111.515 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . 0.458 ' O ' ' HG3' ' B' ' 28' ' ' ARG . . . -61.08 -49.55 76.85 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 116.162 -0.472 . . . . 0.67 111.282 179.732 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 13.7 mt-30 -68.63 -42.25 78.33 Favored 'General case' 0 C--O 1.224 -0.255 0 CA-C-N 116.304 -0.407 . . . . 0.54 111.202 179.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 16.0 mt -55.53 -49.39 72.75 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.607 -0.27 . . . . 1.28 111.556 179.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 28' ' ' ARG . . . . . 0.801 ' HB3' ' HB ' ' A' ' 234' ' ' VAL . 0.0 OUTLIER -65.29 -37.04 85.95 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 120.473 -0.491 . . . . 0.78 110.519 179.267 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . 0.546 ' HA ' ' HE3' ' B' ' 29' ' ' LYS . 0.0 OUTLIER -65.71 -40.56 92.37 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 109.62 -0.511 . . . . 0.66 109.62 178.264 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 93.4 mt -63.68 -39.94 87.22 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 N-CA-C 108.51 -0.922 . . . . 0.98 108.51 176.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . 0.514 ' HA3' ' HG2' ' A' ' 244' ' ' ARG . . . -60.4 -49.55 77.31 Favored Glycine 0 C--N 1.334 0.445 0 N-CA-C 111.192 -0.763 . . . . 0.25 111.192 177.671 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -56.9 -38.11 72.36 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.165 0.507 . . . . 0.43 109.665 177.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.61 -58.5 5.59 Favored 'General case' 0 C--O 1.227 -0.108 0 CA-C-N 115.613 -0.721 . . . . 1.21 110.598 179.024 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 85.9 t -54.86 -39.52 48.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-O 121.185 0.517 . . . . 0.77 110.289 179.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 35' ' ' TYR . . . . . 0.428 ' N ' ' HA3' ' A' ' 243' ' ' GLY . 9.4 t80 -58.47 -52.49 65.43 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.557 -0.747 . . . . 0.86 110.804 178.487 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 36' ' ' CYS . . . . . 0.436 ' HA ' ' OG ' ' B' ' 39' ' ' SER . 19.9 p -70.03 -25.3 63.51 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.739 0.304 . . . . 0.94 111.033 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 30.6 m -63.71 -44.08 94.68 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.454 -0.339 . . . . 0.99 111.349 179.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 38' ' ' TRP . . . . . . . . . . . . . 95.4 m95 -85.68 -30.25 23.33 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 120.742 0.306 . . . . 0.59 111.632 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 39' ' ' SER . . . . . 0.436 ' OG ' ' HA ' ' B' ' 36' ' ' CYS . 54.7 p -67.87 -24.92 65.3 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 112.166 0.432 . . . . 0.66 112.166 179.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -88.52 116.24 65.68 Favored Pre-proline 0 CA--C 1.532 0.269 0 CA-C-O 120.867 0.365 . . . . 0.9 111.718 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -82.24 49.76 3.22 Favored 'Trans proline' 0 CA--C 1.534 0.481 0 C-N-CA 122.777 2.318 . . . . 1.41 112.817 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -148.09 -169.8 3.43 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 116.193 -0.458 . . . . 1.34 110.676 -179.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 43' ' ' MET . . . . . . . . . . . . . 47.9 ttm . . . . . 0 C--O 1.251 1.17 0 CA-C-O 118.28 -0.867 . . . . 2.42 111.547 -179.932 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.067 0 CA-C-O 119.971 -0.349 . . . . 0.68 112.324 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . 0.636 ' HD2' ' HB3' ' A' ' 153' ' ' ASP . 20.1 Cg_exo -66.91 -179.16 1.57 Allowed 'Trans proline' 0 CA--C 1.535 0.54 0 C-N-CA 122.75 2.3 . . . . 1.01 112.724 179.111 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 96.6 mt -97.85 71.41 2.2 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.412 -0.358 . . . . 1.95 111.14 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -111.29 -60.11 0.47 Allowed Glycine 0 CA--C 1.52 0.395 0 C-N-CA 120.75 -0.738 . . . . 0.81 112.359 179.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 28.4 t -171.5 -68.59 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 120.941 0.4 . . . . 0.9 111.965 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -120.85 31.71 6.29 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.166 0.508 . . . . 0.73 111.25 -179.378 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . 0.636 ' HB3' ' HD2' ' A' ' 148' ' ' PRO . 1.6 m-20 -58.52 -51.82 68.27 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.694 -0.684 . . . . 0.72 112.197 -179.563 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -61.38 -45.32 94.86 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.765 0.317 . . . . 0.93 111.64 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 65.3 tp -61.27 -47.05 87.77 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.318 -0.401 . . . . 1.14 110.501 179.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . 0.404 ' O ' ' HB2' ' A' ' 160' ' ' LEU . 0.2 OUTLIER -66.53 -41.34 88.93 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 116.198 -0.456 . . . . 0.53 111.53 179.792 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.24 -51.94 66.83 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 112.538 0.57 . . . . 0.67 112.538 -179.411 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . 0.43 ' HA ' ' HB3' ' A' ' 183' ' ' ALA . 64.6 mt-30 -60.7 -45.55 93.79 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 120.702 0.287 . . . . 0.42 111.153 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' SER . . . . . 0.48 ' HA ' ' CZ2' ' A' ' 293' ' ' TRP . 4.0 p -62.88 -41.9 99.57 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.392 -0.367 . . . . 0.34 111.04 179.379 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.465 HD21 ' HA ' ' A' ' 273' ' ' GLU . 0.2 OUTLIER -58.14 -47.63 82.73 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 120.839 0.352 . . . . 1.24 110.306 178.887 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -64.56 -52.33 58.2 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 112.364 0.505 . . . . 0.72 112.364 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . 0.481 HG12 ' HA2' ' A' ' 187' ' ' GLY . 90.6 mt -59.05 -46.34 91.83 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 CA-C-N 116.754 -0.203 . . . . 0.94 111.348 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 86.7 mt -67.39 -41.82 86.69 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 121.135 -0.226 . . . . 0.98 110.792 178.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 33.3 t -61.0 -44.17 97.81 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.771 0.32 . . . . 0.55 110.914 179.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . 0.476 HH21 ' CD ' ' A' ' 169' ' ' GLU . 2.7 mtp180 -69.15 -52.14 31.17 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.572 -0.285 . . . . 0.99 111.697 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' TYR . . . . . 0.684 ' HE1' ' HA ' ' A' ' 195' ' ' ARG . 64.0 t80 -56.32 -45.58 80.26 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.553 0.216 . . . . 0.47 111.508 -179.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 5.6 mp -60.47 -50.08 75.01 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 121.188 -0.205 . . . . 1.06 111.22 -179.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . 0.512 ' HD2' ' OE2' ' A' ' 269' ' ' GLU . 9.3 mtp180 -66.95 -36.65 82.7 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 112.083 0.401 . . . . 1.56 112.083 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . 0.476 ' CD ' HH21 ' A' ' 165' ' ' ARG . 0.9 OUTLIER -66.12 -51.31 59.18 Favored 'General case' 0 N--CA 1.465 0.282 0 O-C-N 122.268 -0.27 . . . . 0.65 111.391 179.436 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . 0.44 ' HB2' ' HB2' ' A' ' 253' ' ' ALA . 4.4 mm-40 -64.84 -26.22 68.24 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-O 121.014 0.435 . . . . 0.87 110.323 178.545 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -77.2 -18.33 57.83 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 115.916 -0.584 . . . . 0.94 110.714 178.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' THR . . . . . 0.422 ' OG1' ' HE2' ' A' ' 260' ' ' LYS . 25.4 m -98.1 -42.82 7.29 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.061 -0.518 . . . . 1.14 111.466 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 108.88 -0.61 31.83 Favored Glycine 0 CA--C 1.519 0.327 0 C-N-CA 120.633 -0.794 . . . . 0.56 112.723 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 29.8 t -155.69 -92.78 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.854 0.359 . . . . 0.89 111.033 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . 0.469 ' HB3' ' HZ2' ' A' ' 175' ' ' LYS . 0.0 OUTLIER -149.0 105.55 3.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.532 -0.304 . . . . 1.21 110.912 -179.809 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -75.52 177.28 6.84 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 121.28 0.562 . . . . 0.77 111.916 -179.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 46.9 t -80.15 54.96 2.06 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 116.153 -0.476 . . . . 1.93 111.977 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . 0.477 ' HD3' ' HD2' ' A' ' 179' ' ' PRO . 5.2 mmtp -123.18 119.13 27.69 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 120.82 0.343 . . . . 0.72 111.353 179.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . 0.477 ' HD2' ' HD3' ' A' ' 178' ' ' LYS . 83.1 Cg_endo -94.9 179.66 0.69 Allowed 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 123.192 2.595 . . . . 0.73 113.773 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 71.2 mt -123.3 151.67 42.18 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.021 -0.536 . . . . 1.12 110.42 179.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -127.84 -72.01 0.16 Allowed Glycine 0 CA--C 1.522 0.503 0 C-N-CA 120.577 -0.821 . . . . 0.52 113.064 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 57.1 mt-10 -91.1 -24.55 19.96 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 120.94 0.4 . . . . 0.87 111.532 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . 0.438 ' O ' ' HA3' ' A' ' 187' ' ' GLY . . . -80.83 61.57 4.52 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 121.06 0.457 . . . . 0.61 111.311 179.385 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -80.07 -70.31 1.34 Allowed Glycine 0 CA--C 1.527 0.803 0 N-CA-C 114.432 0.533 . . . . 0.42 114.432 -179.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -71.71 -55.48 7.6 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-O 121.063 0.458 . . . . 0.75 111.542 -179.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -63.51 -35.2 79.69 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.974 -0.557 . . . . 0.48 110.16 179.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . 0.61 ' O ' ' HB2' ' A' ' 191' ' ' LEU . . . -63.06 -31.8 81.94 Favored Glycine 0 C--N 1.333 0.403 0 C-N-CA 120.985 -0.626 . . . . 0.33 112.468 179.117 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 6.2 tpt180 -73.07 -57.04 4.31 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 120.635 0.255 . . . . 1.07 111.645 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . 0.54 ' HA ' ' OE1' ' A' ' 192' ' ' GLU . 0.0 OUTLIER -62.54 -41.27 98.78 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-O 121.032 0.444 . . . . 0.67 111.576 -179.266 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . 0.442 ' HB1' HD13 ' A' ' 162' ' ' ILE . . . -66.62 -37.06 84.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.362 -0.381 . . . . 0.95 110.909 179.064 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . 0.61 ' HB2' ' O ' ' A' ' 187' ' ' GLY . 0.2 OUTLIER -59.84 -41.5 91.51 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.608 0.242 . . . . 1.17 111.293 179.915 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . 0.54 ' OE1' ' HA ' ' A' ' 189' ' ' ARG . 5.3 mt-10 -67.14 -52.38 42.4 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.129 0.49 . . . . 0.51 111.422 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' THR . . . . . 0.548 HG21 ' HA ' ' A' ' 297' ' ' VAL . 4.6 m -65.12 -35.43 81.09 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.874 -0.603 . . . . 1.12 112.265 -179.059 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . 0.419 HD12 ' HA ' ' A' ' 194' ' ' LEU . 12.6 tp -69.79 -37.7 76.42 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.694 0.283 . . . . 1.14 111.048 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . 0.684 ' HA ' ' HE1' ' A' ' 166' ' ' TYR . 1.7 ttt180 -66.5 -45.47 79.49 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-O 120.979 0.419 . . . . 0.74 110.882 179.181 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 18.6 mmt85 -64.83 -56.58 12.6 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.821 -0.627 . . . . 1.18 111.959 -179.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . 0.451 ' O ' HG23 ' A' ' 201' ' ' VAL . 98.8 t -66.24 -41.65 89.54 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 CA-C-O 120.901 0.381 . . . . 1.16 111.423 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . 0.495 ' HA3' ' OH ' ' A' ' 166' ' ' TYR . . . -62.0 -52.39 50.46 Favored Glycine 0 CA--C 1.522 0.484 0 C-N-CA 121.178 -0.534 . . . . 0.31 113.494 -179.694 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -63.83 -40.14 95.88 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 117.385 0.592 . . . . 0.57 109.902 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -53.86 -44.97 71.33 Favored Glycine 0 C--N 1.337 0.599 0 C-N-CA 120.621 -0.8 . . . . 0.39 111.603 178.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . 0.547 HG13 ' HD2' ' A' ' 205' ' ' HIS . 88.9 t -72.37 -36.88 56.42 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-O 121.137 0.494 . . . . 0.51 110.949 178.582 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' GLN . . . . . 0.41 ' HA ' ' CE2' ' A' ' 209' ' ' PHE . 14.7 tt0 -64.39 -34.64 78.63 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 115.926 -0.579 . . . . 0.45 111.415 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 17.0 mmp_? -80.54 -53.75 6.29 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 112.998 0.74 . . . . 0.46 112.998 -179.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 24.1 p30 -67.33 -31.0 70.97 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 119.836 -0.745 . . . . 0.57 111.879 -179.125 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' HIS . . . . . 0.547 ' HD2' HG13 ' A' ' 201' ' ' VAL . 93.8 m-70 -102.31 26.86 7.28 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 121.023 -0.271 . . . . 0.61 111.25 178.54 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -53.21 -54.9 29.28 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 115.995 -0.548 . . . . 0.75 112.276 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 43.0 p -58.05 -47.12 84.1 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.078 -0.51 . . . . 1.25 111.882 -179.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -59.46 -44.61 92.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.249 -0.432 . . . . 0.61 110.285 179.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' PHE . . . . . 0.41 ' CE2' ' HA ' ' A' ' 202' ' ' GLN . 10.8 m-30 -63.77 -50.96 66.96 Favored 'General case' 0 C--O 1.223 -0.335 0 CA-C-N 115.973 -0.558 . . . . 0.54 110.751 179.246 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -57.41 -43.7 83.96 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 120.586 0.232 . . . . 0.9 111.553 179.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -61.21 -51.1 60.4 Favored Glycine 0 C--N 1.335 0.505 0 C-N-CA 120.821 -0.704 . . . . 0.5 112.345 179.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -68.07 -34.82 77.15 Favored 'General case' 0 CA--C 1.531 0.212 0 O-C-N 122.592 -0.358 . . . . 1.35 111.086 179.3 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 8.7 tp -59.46 -39.22 82.92 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.96 0.409 . . . . 1.25 110.709 178.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 47.6 ttp180 -71.99 -36.3 69.73 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.944 -0.571 . . . . 1.46 110.521 178.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 52.6 mtmt -73.31 -37.46 66.18 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 116.266 -0.424 . . . . 1.96 112.021 179.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . 0.709 ' HB3' HG12 ' A' ' 218' ' ' ILE . 41.0 mt -63.55 131.64 48.72 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 121.147 0.498 . . . . 1.29 112.117 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -80.4 33.69 0.3 Allowed 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.005 -0.543 . . . . 1.36 111.648 179.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' ILE . . . . . 0.709 HG12 ' HB3' ' A' ' 216' ' ' LEU . 30.7 mm -71.42 105.47 1.78 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.302 0 CA-C-O 120.929 0.395 . . . . 0.75 111.564 -179.172 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 2.6 ttmm -163.07 -53.69 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 115.881 -0.6 . . . . 2.26 111.218 179.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 52.8 m-20 -104.41 -178.5 3.67 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 115.935 -0.575 . . . . 0.89 111.391 -179.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -46.7 -29.42 1.88 Allowed 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 113.482 0.919 . . . . 1.38 113.482 -179.272 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -62.22 -23.59 64.38 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 121.487 -0.387 . . . . 0.53 113.971 179.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' ASP . . . . . 0.506 ' HB2' HG22 ' A' ' 218' ' ' ILE . 2.1 p-10 -58.61 -52.15 66.89 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 113.625 0.972 . . . . 1.11 113.625 -178.297 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 19.6 m -58.66 -38.35 70.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 N-CA-C 112.205 0.446 . . . . 1.06 112.205 -179.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 85.7 mttt -69.09 -43.58 74.25 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.059 0.457 . . . . 1.31 110.29 179.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' SER . . . . . 0.552 ' O ' HG23 ' A' ' 230' ' ' VAL . 20.9 m -65.66 -46.6 78.54 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.84 -0.618 . . . . 0.94 110.265 179.289 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' PHE . . . . . 0.613 ' O ' ' HG3' ' A' ' 231' ' ' MET . 7.2 t80 -58.23 -43.34 87.73 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.918 -0.583 . . . . 0.76 110.521 179.167 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' SER . . . . . 0.426 ' O ' HG23 ' A' ' 232' ' ' VAL . 67.3 m -56.58 -44.16 80.75 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.023 0.44 . . . . 0.45 109.983 178.462 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 69.7 mtp180 -63.18 -35.97 82.06 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 115.885 -0.598 . . . . 1.51 110.321 178.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . 0.698 HG21 ' HE1' ' B' ' 23' ' ' PHE . 28.4 t -63.14 -51.94 65.11 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 N-CA-C 109.601 -0.518 . . . . 0.88 109.601 177.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 231' ' ' MET . . . . . 0.613 ' HG3' ' O ' ' A' ' 227' ' ' PHE . 54.0 mtp -57.23 -43.98 83.38 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.517 -0.765 . . . . 0.54 111.102 179.58 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 232' ' ' VAL . . . . . 0.426 HG23 ' O ' ' A' ' 228' ' ' SER . 55.7 t -58.41 -40.91 80.02 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 N-CA-C 109.985 -0.376 . . . . 1.1 109.985 178.803 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 233' ' ' HIS . . . . . 0.549 ' HA ' ' HB2' ' A' ' 236' ' ' LYS . 54.9 t-80 -71.24 -39.96 71.34 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 116.048 -0.524 . . . . 0.81 111.039 178.725 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . 0.509 HG23 ' O ' ' A' ' 230' ' ' VAL . 74.0 t -57.09 -38.92 63.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-O 120.749 0.309 . . . . 1.08 111.003 179.262 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -104.79 23.7 13.03 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 116.406 -0.361 . . . . 1.1 111.176 178.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . 0.549 ' HB2' ' HA ' ' A' ' 233' ' ' HIS . 5.9 tptp -70.52 -29.95 66.58 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 114.571 1.322 . . . . 1.92 114.571 -177.331 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -69.92 -16.93 63.29 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 118.643 0.656 . . . . 1.24 112.301 -178.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 98.7 -19.67 53.43 Favored Glycine 0 CA--C 1.522 0.527 0 C-N-CA 120.877 -0.678 . . . . 0.48 113.631 179.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . 0.423 ' HB ' ' NH2' ' A' ' 244' ' ' ARG . 21.8 t -77.22 118.12 23.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 121.147 0.499 . . . . 1.13 110.788 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -95.07 100.07 11.95 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.097 0.406 . . . . 0.86 112.097 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . 0.492 ' HB2' ' HG3' ' A' ' 244' ' ' ARG . 14.9 m120 -103.88 134.51 47.06 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 110.391 -0.226 . . . . 0.63 110.391 178.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 242' ' ' TRP . . . . . 0.486 ' HB3' ' CE2' ' A' ' 300' ' ' PHE . 14.0 m95 -56.81 -27.48 59.99 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 112.127 0.417 . . . . 0.59 112.127 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -69.64 -29.57 71.27 Favored Glycine 0 CA--C 1.52 0.39 0 C-N-CA 121.186 -0.531 . . . . 0.35 112.9 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 244' ' ' ARG . . . . . 0.492 ' HG3' ' HB2' ' A' ' 241' ' ' ASN . 19.6 mtt180 -73.72 -37.15 65.22 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.297 0.57 . . . . 0.62 109.645 179.268 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . 0.675 HG21 HD23 ' A' ' 279' ' ' LEU . 83.0 mt -63.03 -51.8 67.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-N 115.446 -0.797 . . . . 1.11 110.998 179.197 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 17.4 m -66.71 -30.33 49.35 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 C-N-CA 120.795 -0.362 . . . . 0.73 111.322 179.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 17.4 m -64.07 -46.54 83.83 Favored 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 110.248 -0.278 . . . . 1.12 110.248 178.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 248' ' ' LEU . . . . . 0.416 HD13 ' HA ' ' A' ' 248' ' ' LEU . 2.5 mm? -60.82 -35.91 77.74 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 120.688 0.28 . . . . 1.19 110.769 178.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 249' ' ' ILE . . . . . 0.546 HG12 ' O ' ' A' ' 245' ' ' ILE . 35.5 mm -71.88 -47.08 57.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 CA-C-O 120.868 0.366 . . . . 1.13 110.436 178.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 39.6 t -59.59 -42.02 91.62 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 121.156 0.503 . . . . 0.37 109.708 178.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 251' ' ' PHE . . . . . 0.435 ' O ' HG21 ' A' ' 255' ' ' VAL . 8.9 t80 -65.72 -44.03 87.31 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 115.607 -0.724 . . . . 0.5 109.825 177.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -57.29 -41.63 93.08 Favored Glycine 0 C--N 1.338 0.653 0 N-CA-C 111.623 -0.591 . . . . 0.32 111.623 178.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 253' ' ' ALA . . . . . 0.44 ' HB2' ' HB2' ' A' ' 170' ' ' GLN . . . -63.83 -40.4 96.53 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 120.808 0.337 . . . . 0.52 110.513 177.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 21.9 t80 -67.51 -38.97 85.08 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-O 121.454 0.645 . . . . 0.7 109.944 178.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 255' ' ' VAL . . . . . 0.435 HG21 ' O ' ' A' ' 251' ' ' PHE . 63.5 t -65.0 -46.65 90.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.775 -0.648 . . . . 1.16 109.445 178.021 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -57.91 -36.62 72.71 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.306 -0.406 . . . . 0.35 110.195 178.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 257' ' ' LYS . . . . . 0.414 ' HG3' ' HZ2' ' A' ' 257' ' ' LYS . 23.3 ttmm -60.21 -45.09 94.37 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 115.663 -0.699 . . . . 2.57 111.45 178.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 258' ' ' HIS . . . . . 0.45 ' CE1' HD12 ' A' ' 259' ' ' LEU . 0.3 OUTLIER -65.95 -34.97 79.33 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 120.731 0.3 . . . . 0.47 111.132 179.538 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . 0.601 ' HG ' ' HB3' ' A' ' 264' ' ' GLN . 3.5 tp -76.83 -46.19 25.75 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 116.551 -0.295 . . . . 1.1 111.485 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 260' ' ' LYS . . . . . 0.422 ' HE2' ' OG1' ' A' ' 172' ' ' THR . 42.7 tttp -63.04 -27.23 69.26 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 120.608 0.242 . . . . 0.55 111.353 179.293 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 57.8 m -57.98 -26.74 62.73 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 121.004 0.43 . . . . 0.45 110.817 178.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 15.9 m -114.53 23.42 5.25 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 CA-C-O 121.305 0.574 . . . . 1.23 110.093 178.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 263' ' ' ASN . . . . . 0.45 ' HA ' ' OE2' ' A' ' 265' ' ' GLU . 1.7 m120 54.19 59.99 3.87 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 114.948 -1.024 . . . . 0.71 113.475 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 264' ' ' GLN . . . . . 0.601 ' HB3' ' HG ' ' A' ' 259' ' ' LEU . 5.9 mt-30 -119.86 35.61 4.79 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.238 -0.437 . . . . 0.95 110.771 178.485 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . 0.579 ' HA ' HG12 ' A' ' 268' ' ' ILE . 0.9 OUTLIER -59.9 -25.0 64.76 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 112.422 0.527 . . . . 0.84 112.422 -179.568 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 16.6 p -64.02 -16.69 62.21 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 120.586 0.231 . . . . 1.19 111.285 179.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 267' ' ' PHE . . . . . 0.515 ' O ' ' HD2' ' A' ' 270' ' ' PRO . 28.6 m-85 -98.96 -32.35 11.34 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 120.982 0.42 . . . . 1.34 111.333 179.082 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 268' ' ' ILE . . . . . 0.579 HG12 ' HA ' ' A' ' 265' ' ' GLU . 20.3 pt -68.07 -28.86 42.64 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 120.955 -0.298 . . . . 1.11 111.453 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 269' ' ' GLU . . . . . 0.84 ' HB2' ' HD3' ' A' ' 270' ' ' PRO . 39.0 mm-40 -57.27 -57.02 27.81 Favored Pre-proline 0 CA--C 1.546 0.82 0 N-CA-C 110.028 -0.36 . . . . 0.66 110.028 178.09 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 270' ' ' PRO . . . . . 0.84 ' HD3' ' HB2' ' A' ' 269' ' ' GLU . 32.0 Cg_exo -62.09 -30.51 82.67 Favored 'Trans proline' 0 C--N 1.362 1.287 0 C-N-CA 122.291 1.994 . . . . 0.52 111.605 177.07 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 271' ' ' LEU . . . . . . . . . . . . . 40.3 tp -64.93 -40.25 94.75 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.114 -0.494 . . . . 1.27 109.751 177.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -63.39 -40.31 96.88 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 109.096 -0.705 . . . . 1.14 109.096 177.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 273' ' ' GLU . . . . . 0.594 ' OE1' ' HA ' ' A' ' 270' ' ' PRO . 35.0 mt-10 -63.49 -41.94 98.54 Favored 'General case' 0 C--O 1.223 -0.332 0 N-CA-C 108.693 -0.854 . . . . 0.8 108.693 177.009 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 274' ' ' THR . . . . . . . . . . . . . 10.1 m -60.32 -53.19 60.63 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.387 -0.824 . . . . 0.71 110.905 178.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 275' ' ' ILE . . . . . 0.506 ' O ' ' HE2' ' A' ' 231' ' ' MET . 97.3 mt -58.09 -46.0 88.3 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-N 116.127 -0.488 . . . . 1.14 111.042 179.738 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 16.6 m -66.21 -49.51 67.03 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.337 -0.392 . . . . 0.64 111.539 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 277' ' ' ASP . . . . . 0.628 ' OD1' ' HD2' ' A' ' 281' ' ' ARG . 25.8 t0 -58.65 -56.34 23.44 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.335 -0.393 . . . . 0.59 111.975 -179.146 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 278' ' ' VAL . . . . . 0.5 HG12 ' HB2' ' A' ' 231' ' ' MET . 61.6 t -58.98 -37.76 69.55 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 120.924 -0.31 . . . . 1.1 111.237 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . 0.675 HD23 HG21 ' A' ' 245' ' ' ILE . 28.1 tp -65.7 -46.5 78.79 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 111.98 0.363 . . . . 1.25 111.98 179.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 66.3 t -79.62 -51.25 16.76 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 N-CA-C 112.196 0.443 . . . . 0.83 112.196 -179.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 281' ' ' ARG . . . . . 0.628 ' HD2' ' OD1' ' A' ' 277' ' ' ASP . 3.0 mtt180 -55.11 -38.43 68.15 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 113.205 0.817 . . . . 1.15 113.205 -179.184 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 282' ' ' THR . . . . . . . . . . . . . 2.7 m -82.07 -12.7 58.11 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 112.332 0.493 . . . . 1.24 112.332 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 67.8 mmtt -135.04 41.55 2.83 Favored 'General case' 0 N--CA 1.468 0.47 0 O-C-N 122.063 -0.398 . . . . 1.46 111.774 -179.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 57.3 mtp180 -55.41 -54.44 43.74 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 112.805 0.669 . . . . 0.89 112.805 -178.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 285' ' ' ASP . . . . . 0.494 ' CG ' ' HZ3' ' A' ' 289' ' ' LYS . 29.2 t70 -56.98 -46.0 82.54 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 120.924 0.392 . . . . 0.63 111.85 -179.792 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 286' ' ' TRP . . . . . 0.414 ' O ' ' HB2' ' A' ' 290' ' ' GLN . 0.8 OUTLIER -67.45 -43.1 81.91 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.029 0.381 . . . . 0.72 112.029 -179.375 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -69.13 -46.24 68.13 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 112.373 0.509 . . . . 1.14 112.373 -179.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 9.3 p -63.6 -37.11 78.75 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 121.059 -0.256 . . . . 1.21 111.588 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 289' ' ' LYS . . . . . 0.494 ' HZ3' ' CG ' ' A' ' 285' ' ' ASP . 64.9 mttt -75.03 -24.76 58.38 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 120.759 0.314 . . . . 1.38 111.301 179.236 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 290' ' ' GLN . . . . . 0.414 ' HB2' ' O ' ' A' ' 286' ' ' TRP . 0.0 OUTLIER -91.75 2.98 56.13 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 112.122 0.416 . . . . 0.59 112.122 179.907 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 291' ' ' ARG . . . . . 0.434 HH11 ' HD2' ' A' ' 291' ' ' ARG . 29.5 mtm180 64.06 17.19 10.48 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 112.493 0.553 . . . . 0.57 112.493 179.393 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 64.75 -114.58 6.91 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 114.852 0.701 . . . . 0.39 114.852 178.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 293' ' ' TRP . . . . . 0.48 ' CZ2' ' HA ' ' A' ' 159' ' ' SER . 82.2 m95 -66.26 -36.76 83.83 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 113.262 0.838 . . . . 0.59 113.262 -177.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 294' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -58.69 -47.5 84.32 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 120.826 0.346 . . . . 0.5 110.45 179.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -69.18 -27.5 73.69 Favored Glycine 0 CA--C 1.522 0.471 0 C-N-CA 120.397 -0.906 . . . . 0.31 111.481 178.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 296' ' ' PHE . . . . . 0.423 ' HB3' ' HA ' ' A' ' 293' ' ' TRP . 1.9 t80 -70.2 -48.32 57.63 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 122.561 0.345 . . . . 0.49 111.27 179.057 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 297' ' ' VAL . . . . . 0.548 ' HA ' HG21 ' A' ' 193' ' ' THR . 33.9 m -66.95 -32.62 58.81 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 CA-C-O 120.605 0.241 . . . . 0.8 111.388 -179.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -64.71 -53.54 45.67 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.791 0.329 . . . . 0.49 111.429 179.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 299' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -64.19 -33.83 76.69 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.322 -0.399 . . . . 0.75 111.952 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 300' ' ' PHE . . . . . 0.486 ' CE2' ' HB3' ' A' ' 242' ' ' TRP . 70.2 m-85 -98.47 30.01 3.4 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 112.515 0.561 . . . . 0.57 112.515 -179.246 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 301' ' ' HIS . . . . . 0.469 ' HB2' ' O ' ' A' ' 297' ' ' VAL . 48.6 t-80 -105.44 77.71 1.31 Allowed 'General case' 0 C--O 1.233 0.23 0 C-N-CA 120.536 -0.466 . . . . 2.03 111.564 179.356 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . 0.412 ' HB ' ' H ' ' A' ' 303' ' ' GLN . 8.0 m -82.68 -145.76 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 116.314 -0.403 . . . . 1.58 110.467 178.565 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 303' ' ' GLN . . . . . 0.412 ' H ' ' HB ' ' A' ' 302' ' ' VAL . 3.8 tp-100 -74.19 66.35 1.25 Allowed 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 121.446 0.641 . . . . 1.91 110.801 179.189 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -154.35 111.92 3.45 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 115.865 -0.607 . . . . 1.11 111.208 -179.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 56.3 mt -102.19 -57.48 2.06 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.251 0.548 . . . . 2.33 109.929 179.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.04 -42.84 3.48 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.429 -0.805 . . . . 1.71 110.233 179.027 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . 63.79 -121.43 23.51 Favored Glycine 0 C--N 1.338 0.686 0 CA-C-N 116.003 -0.544 . . . . 1.27 113.475 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.256 1.526 0 CA-C-O 118.863 -0.965 . . . . 1.71 112.875 179.529 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.671 0 CA-C-O 121.354 0.597 . . . . 2.84 110.862 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 18' ' ' GLU . . . . . 0.421 ' HB2' ' H ' ' B' ' 19' ' ' LEU . 1.2 pm0 -103.65 -145.39 0.37 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.291 -0.868 . . . . 1.72 111.359 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 19' ' ' LEU . . . . . 0.518 ' HG ' ' HD2' ' B' ' 20' ' ' PRO . 0.3 OUTLIER -78.77 140.21 58.6 Favored Pre-proline 0 CA--C 1.538 0.514 0 CA-C-N 116.39 -0.368 . . . . 2.03 110.447 179.398 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 20' ' ' PRO . . . . . 0.518 ' HD2' ' HG ' ' B' ' 19' ' ' LEU . 14.8 Cg_endo -54.05 151.83 26.28 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 123.608 2.872 . . . . 0.91 113.383 -179.506 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 21' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.38 29.79 0.17 Allowed 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 122.928 2.419 . . . . 0.73 113.652 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 22' ' ' GLU . . . . . 0.473 ' H ' ' C ' ' B' ' 20' ' ' PRO . 7.4 tm-20 -68.42 -41.95 79.66 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.0 -0.546 . . . . 1.46 110.596 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 23' ' ' PHE . . . . . 0.698 ' HE1' HG21 ' A' ' 230' ' ' VAL . 10.7 p90 -63.09 -35.41 80.17 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.104 0.478 . . . . 0.77 110.63 179.363 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.34 -44.62 64.74 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.986 -0.552 . . . . 1.03 109.986 178.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.05 -44.72 96.97 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.923 -0.58 . . . . 0.63 110.172 177.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 1.2 tp-100 -58.59 -48.9 79.4 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 115.548 -0.751 . . . . 1.06 110.161 178.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 45.6 mt -58.75 -40.55 84.17 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.292 -0.413 . . . . 1.22 110.637 178.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.89 -51.14 70.55 Favored 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 109.736 -0.468 . . . . 0.49 109.736 178.472 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 46.9 mtpt -55.61 -45.17 77.51 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 116.25 -0.432 . . . . 1.15 110.008 178.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . 0.497 ' O ' HG21 ' B' ' 34' ' ' VAL . 95.5 mt -59.21 -44.96 93.13 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 N-CA-C 109.719 -0.474 . . . . 1.05 109.719 178.123 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . 0.461 ' HA3' ' HG2' ' A' ' 244' ' ' ARG . . . -60.4 -49.55 77.35 Favored Glycine 0 C--N 1.336 0.534 0 CA-C-N 116.028 -0.533 . . . . 0.31 112.302 178.579 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -58.77 -38.82 79.34 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.18 0.514 . . . . 0.43 110.121 178.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -68.28 -47.67 67.03 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 115.75 -0.659 . . . . 1.43 111.353 179.247 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 34' ' ' VAL . . . . . 0.497 HG21 ' O ' ' B' ' 30' ' ' ILE . 53.9 t -56.65 -50.06 75.49 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-O 120.717 0.294 . . . . 0.75 111.422 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -61.86 -38.57 88.73 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 120.881 0.372 . . . . 1.15 110.345 178.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 36' ' ' CYS . . . . . . . . . . . . . 21.4 t -68.03 -25.4 65.36 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.205 -0.452 . . . . 0.94 111.226 179.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 20.4 m -82.78 -42.14 18.31 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.189 -0.46 . . . . 1.01 111.977 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 38' ' ' TRP . . . . . . . . . . . . . 99.2 m95 -80.78 -22.9 39.69 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 112.54 0.571 . . . . 0.79 112.54 -179.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 20.3 t -74.2 -6.06 45.58 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 112.283 0.475 . . . . 0.76 112.283 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -90.57 123.23 65.85 Favored Pre-proline 0 CA--C 1.534 0.349 0 N-CA-C 111.857 0.317 . . . . 1.34 111.857 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -75.62 131.32 13.47 Favored 'Trans proline' 0 CA--C 1.534 0.513 0 C-N-CA 122.688 2.258 . . . . 1.71 113.05 179.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -94.07 -78.84 0.43 Allowed 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 116.155 -0.475 . . . . 2.28 111.662 179.746 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 43' ' ' MET . . . . . . . . . . . . . 47.5 ttm . . . . . 0 C--O 1.255 1.346 0 CA-C-O 118.427 -0.797 . . . . 3.81 111.516 179.626 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.088 0 N-CA-C 112.339 -0.304 . . . . 0.67 112.339 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -79.01 50.58 3.54 Favored 'Trans proline' 0 CA--C 1.535 0.564 0 C-N-CA 122.698 2.265 . . . . 0.96 113.115 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 24.0 tp -90.26 -18.96 24.71 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 121.005 0.431 . . . . 1.95 111.187 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 126.1 -170.67 17.93 Favored Glycine 0 CA--C 1.52 0.353 0 C-N-CA 120.814 -0.708 . . . . 0.62 112.649 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 92.0 p -72.14 72.47 0.89 Allowed 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.563 0.697 . . . . 0.76 111.264 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -162.61 -43.18 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.216 -0.902 . . . . 0.59 110.103 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . 0.473 ' HA ' ' HB3' ' A' ' 156' ' ' TYR . 2.3 m-20 -61.25 -26.77 67.98 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.866 -0.606 . . . . 0.46 110.867 179.622 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -56.16 -37.09 69.06 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 121.368 0.604 . . . . 0.48 109.42 177.593 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 53.6 tp -83.44 -32.29 26.15 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.696 -0.684 . . . . 1.25 109.674 178.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . 0.473 ' HB3' ' HA ' ' A' ' 153' ' ' ASP . 83.3 t80 -62.18 -37.45 85.31 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 115.767 -0.651 . . . . 0.52 110.647 178.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.595 ' HD3' ' OE1' ' A' ' 182' ' ' GLU . 0.7 OUTLIER -59.25 -44.88 92.36 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.039 0.447 . . . . 0.4 110.637 178.727 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -74.32 -35.3 63.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.253 -0.43 . . . . 0.77 110.014 178.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' SER . . . . . 0.459 ' HA ' ' NE1' ' A' ' 293' ' ' TRP . 64.8 m -59.03 -57.69 11.94 Favored 'General case' 0 CA--C 1.521 -0.144 0 CA-C-N 115.854 -0.612 . . . . 0.34 110.645 178.769 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.467 HD21 ' NH2' ' A' ' 157' ' ' ARG . 46.9 tp -62.01 -36.93 83.02 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 121.077 -0.249 . . . . 0.78 110.757 179.306 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . 0.479 ' OE2' ' HB3' ' A' ' 180' ' ' LEU . 0.0 OUTLIER -59.02 -54.11 50.78 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 120.792 0.329 . . . . 0.43 110.649 179.037 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . 0.5 HG12 ' HA2' ' A' ' 187' ' ' GLY . 54.8 mt -63.77 -45.45 97.2 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-N 116.093 -0.503 . . . . 0.95 111.381 179.631 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.451 ' O ' ' HG ' ' A' ' 167' ' ' LEU . 54.8 mt -61.33 -46.73 96.01 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 CA-C-N 116.5 -0.318 . . . . 1.01 111.243 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 31.4 t -62.34 -45.38 93.44 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.876 0.369 . . . . 0.85 110.495 178.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . 0.662 ' HG2' ' HG ' ' A' ' 180' ' ' LEU . 0.0 OUTLIER -61.84 -46.13 90.8 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.2 -0.455 . . . . 0.84 111.587 -179.894 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' TYR . . . . . 0.854 ' HE1' ' HA ' ' A' ' 195' ' ' ARG . 91.6 t80 -70.36 -54.14 13.75 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 112.634 0.605 . . . . 0.99 112.634 -179.289 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.451 ' HG ' ' O ' ' A' ' 163' ' ' ILE . 29.8 mt -58.71 -49.74 76.48 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 112.516 0.561 . . . . 1.0 112.516 -177.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -66.03 -39.02 89.84 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 112.274 0.472 . . . . 1.72 112.274 -179.2 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . 0.473 ' HB2' ' O ' ' A' ' 165' ' ' ARG . 14.3 mm-40 -71.19 -47.93 54.62 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 120.56 -0.456 . . . . 0.44 111.755 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . 0.459 ' O ' ' HG3' ' A' ' 170' ' ' GLN . 0.5 OUTLIER -62.27 -28.02 69.42 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 120.918 0.39 . . . . 1.06 111.159 179.129 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . 0.418 ' HB2' ' HB2' ' A' ' 256' ' ' ALA . . . -74.26 -24.62 59.3 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 112.7 0.63 . . . . 1.04 112.7 -179.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 9.4 t -111.05 -21.23 12.08 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 112.814 0.672 . . . . 0.85 112.814 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 70.88 29.99 68.59 Favored Glycine 0 CA--C 1.525 0.686 0 C-N-CA 120.607 -0.806 . . . . 0.56 113.505 179.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' SER . . . . . 0.459 ' HB3' ' OE1' ' A' ' 169' ' ' GLU . 28.9 t -77.47 -62.05 1.79 Allowed 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.989 0.395 . . . . 0.74 111.396 -179.255 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . 0.677 ' HB3' ' HG3' ' A' ' 178' ' ' LYS . 19.8 tptt -151.83 118.9 5.86 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 121.035 0.445 . . . . 1.29 111.602 179.117 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . 0.427 ' CG ' ' HZ1' ' A' ' 175' ' ' LYS . 0.3 OUTLIER -50.6 -71.71 0.06 Allowed 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 115.23 -0.895 . . . . 0.77 112.484 179.675 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 3.6 m -88.52 79.92 7.5 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.938 -0.574 . . . . 0.78 111.174 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . 0.677 ' HG3' ' HB3' ' A' ' 175' ' ' LYS . 10.7 mttt -96.0 138.9 21.62 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-O 120.756 0.313 . . . . 1.22 110.856 179.221 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -57.03 138.17 85.15 Favored 'Trans proline' 0 CA--C 1.535 0.532 0 C-N-CA 123.172 2.581 . . . . 1.07 113.834 -179.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.662 ' HG ' ' HG2' ' A' ' 165' ' ' ARG . 5.3 mp -97.81 -165.84 1.3 Allowed 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 115.647 -0.706 . . . . 1.14 110.857 179.586 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -125.15 -41.34 0.37 Allowed Glycine 0 CA--C 1.524 0.654 0 C-N-CA 120.325 -0.94 . . . . 0.62 113.516 -179.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . 0.595 ' OE1' ' HD3' ' A' ' 157' ' ' ARG . 82.7 mt-10 -114.14 -27.18 7.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.06 0.457 . . . . 0.74 111.374 -179.545 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . 0.56 ' HB2' HD21 ' A' ' 180' ' ' LEU . . . -102.29 81.84 2.12 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 121.138 0.495 . . . . 0.47 111.542 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -80.43 -71.59 1.27 Allowed Glycine 0 CA--C 1.525 0.691 0 C-N-CA 120.88 -0.676 . . . . 0.39 113.986 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -66.83 -55.58 14.17 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 120.823 0.345 . . . . 0.52 111.808 -179.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -66.26 -37.04 84.53 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.265 -0.425 . . . . 0.47 110.235 179.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . 0.517 ' HA3' ' O ' ' A' ' 183' ' ' ALA . . . -64.85 -41.25 97.58 Favored Glycine 0 C--N 1.334 0.462 0 C-N-CA 120.909 -0.662 . . . . 0.29 112.667 179.282 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . 0.443 HH11 ' HD2' ' A' ' 188' ' ' ARG . 13.5 ttt180 -62.31 -53.47 54.63 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.621 0.248 . . . . 0.61 110.666 178.73 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . 0.754 ' HB3' HG13 ' A' ' 297' ' ' VAL . 73.7 mtt180 -59.63 -44.9 93.31 Favored 'General case' 0 C--O 1.228 -0.072 0 CA-C-N 116.24 -0.436 . . . . 0.55 110.98 179.549 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -69.45 -37.86 77.55 Favored 'General case' 0 C--O 1.218 -0.558 0 N-CA-C 112.817 0.673 . . . . 0.84 112.817 -178.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 18.6 tp -64.41 -49.15 72.68 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 118.178 0.444 . . . . 1.1 111.911 -179.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.4 -36.02 81.79 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.853 0.358 . . . . 0.4 111.044 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' THR . . . . . 0.487 HG21 ' HA ' ' A' ' 297' ' ' VAL . 48.2 m -73.05 -44.91 60.1 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.578 -0.283 . . . . 0.49 110.673 179.287 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . 0.427 HD22 HG23 ' A' ' 249' ' ' ILE . 14.7 tp -62.03 -36.46 81.64 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.41 -0.359 . . . . 1.03 110.531 179.181 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . 0.854 ' HA ' ' HE1' ' A' ' 166' ' ' TYR . 0.8 OUTLIER -63.96 -55.72 20.38 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.015 0.436 . . . . 0.41 110.683 178.449 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.33 -47.9 83.65 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.457 -0.792 . . . . 1.64 112.41 -179.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . 0.513 ' O ' HG21 ' A' ' 201' ' ' VAL . 83.0 t -72.82 -49.73 38.04 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 N-CA-C 111.97 0.359 . . . . 0.63 111.97 -179.461 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . 0.513 ' O ' ' HG2' ' A' ' 202' ' ' GLN . . . -57.61 -53.38 45.54 Favored Glycine 0 C--N 1.334 0.462 0 C-N-CA 121.187 -0.53 . . . . 0.33 112.498 -179.568 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . 0.537 ' HB2' ' O ' ' A' ' 195' ' ' ARG . 0.3 OUTLIER -59.17 -40.65 86.29 Favored 'General case' 0 C--O 1.224 -0.262 0 N-CA-C 109.841 -0.429 . . . . 0.72 109.841 178.783 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -62.4 -50.01 68.71 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 120.898 -0.668 . . . . 0.4 112.604 178.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . 0.513 HG21 ' O ' ' A' ' 197' ' ' VAL . 78.1 t -55.88 -52.63 47.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-O 120.743 0.306 . . . . 1.04 111.764 179.275 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' GLN . . . . . 0.529 ' HG3' ' CZ ' ' A' ' 203' ' ' ARG . 1.4 pt20 -69.53 -31.75 70.17 Favored 'General case' 0 C--O 1.221 -0.432 0 N-CA-C 112.091 0.404 . . . . 0.52 112.091 -179.382 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' ARG . . . . . 0.529 ' CZ ' ' HG3' ' A' ' 202' ' ' GLN . 0.0 OUTLIER -68.77 -43.43 75.77 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.955 0.407 . . . . 0.86 109.997 178.003 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 18.2 m-80 -66.35 -47.09 74.56 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 121.163 0.506 . . . . 0.6 110.604 178.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -97.76 36.26 1.55 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.028 -0.533 . . . . 0.71 110.216 179.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . 0.517 ' OE1' ' HA ' ' A' ' 203' ' ' ARG . 4.5 tp10 -49.72 -52.0 34.6 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 115.477 -0.783 . . . . 0.47 112.186 -178.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 64.7 p -65.66 -38.96 90.78 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.595 0.591 . . . . 1.17 112.595 -179.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -63.85 -45.51 89.17 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.066 0.46 . . . . 1.07 110.449 179.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -71.13 -42.34 69.34 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.976 -0.557 . . . . 0.62 110.475 179.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' GLN . . . . . 0.42 ' O ' ' HG3' ' A' ' 214' ' ' ARG . 6.7 tt0 -62.58 -45.88 90.89 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.188 -0.46 . . . . 1.01 110.852 179.243 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -59.93 -49.45 78.41 Favored Glycine 0 C--N 1.334 0.47 0 C-N-CA 120.902 -0.666 . . . . 0.34 111.82 178.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' MET . . . . . 0.479 ' SD ' ' HA ' ' B' ' 23' ' ' PHE . 2.0 ttp -60.91 -36.34 79.02 Favored 'General case' 0 C--O 1.224 -0.257 0 CA-C-O 120.884 0.374 . . . . 1.1 110.002 178.631 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 7.8 tp -68.1 -39.93 82.7 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.663 -0.699 . . . . 1.25 110.919 178.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' ARG . . . . . 0.42 ' HG3' ' O ' ' A' ' 210' ' ' GLN . 70.0 mtt-85 -57.54 -39.34 76.41 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.163 -0.471 . . . . 0.97 110.759 178.639 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' LYS . . . . . 0.425 ' HE3' ' HB2' ' A' ' 215' ' ' LYS . 47.2 mtmt -99.01 12.13 36.91 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.099 -0.5 . . . . 0.88 111.191 179.055 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . 0.549 ' HA ' HD13 ' B' ' 19' ' ' LEU . 28.0 tp -82.41 110.41 17.53 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.948 0.404 . . . . 1.08 111.14 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 35.8 m-20 -79.43 32.74 0.24 Allowed 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 112.437 0.532 . . . . 0.59 112.437 -179.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' ILE . . . . . 0.447 HG22 ' HB2' ' A' ' 223' ' ' ASP . 2.7 mt -81.18 107.68 13.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 CA-C-O 121.424 0.63 . . . . 1.09 110.634 179.155 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . 0.453 ' HG2' HE22 ' A' ' 264' ' ' GLN . 0.4 OUTLIER -161.3 -39.24 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 115.252 -0.885 . . . . 0.9 111.209 179.396 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -105.11 -177.46 3.37 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.5 -0.318 . . . . 0.78 111.853 -179.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -49.53 -21.68 1.03 Allowed 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 113.677 0.992 . . . . 0.66 113.677 -179.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -69.55 -23.81 76.45 Favored Glycine 0 CA--C 1.531 1.074 0 N-CA-C 114.265 0.466 . . . . 0.47 114.265 -179.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' ASP . . . . . 0.447 ' HB2' HG22 ' A' ' 218' ' ' ILE . 6.5 p-10 -55.48 -56.52 19.23 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 113.711 1.004 . . . . 0.89 113.711 -177.449 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . 0.513 ' HB ' HG21 ' A' ' 274' ' ' THR . 17.2 m -61.53 -33.38 56.83 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-O 121.038 0.447 . . . . 1.07 111.672 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 48.2 mttp -70.26 -39.14 75.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.085 0.469 . . . . 1.49 110.478 179.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' SER . . . . . 0.649 ' O ' HG23 ' A' ' 230' ' ' VAL . 7.3 t -74.19 -44.69 52.43 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.095 -0.502 . . . . 1.44 110.652 179.113 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -57.99 -46.62 84.91 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.969 0.414 . . . . 0.56 110.853 179.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' SER . . . . . 0.475 ' CB ' HG23 ' A' ' 278' ' ' VAL . 16.3 p -65.78 -39.37 90.91 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.735 -0.469 . . . . 0.54 109.735 178.483 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 42.6 ttp180 -60.08 -45.39 93.06 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.198 -0.456 . . . . 1.39 110.202 177.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . 0.649 HG23 ' O ' ' A' ' 226' ' ' SER . 99.8 t -59.39 -48.0 88.66 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-N 116.017 -0.538 . . . . 0.98 110.353 178.48 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 231' ' ' MET . . . . . 0.728 ' HG3' HD11 ' A' ' 248' ' ' LEU . 29.6 ttm -55.22 -41.15 71.69 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.046 -0.524 . . . . 1.09 111.553 179.606 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 232' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 228' ' ' SER . 85.2 t -66.93 -36.1 76.32 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-O 121.037 0.446 . . . . 1.0 111.079 179.287 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 44.8 t-80 -77.2 -36.36 54.98 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 116.415 -0.357 . . . . 0.67 111.636 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . 0.436 HG23 ' O ' ' A' ' 230' ' ' VAL . 52.0 t -56.58 -39.63 63.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 CA-C-O 120.867 0.365 . . . . 1.1 111.49 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 235' ' ' PHE . . . . . 0.818 ' HE2' HD13 ' A' ' 248' ' ' LEU . 75.7 m-85 -100.29 24.25 9.03 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.031 0.382 . . . . 0.48 112.031 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 3.2 ttpp -73.1 -10.91 60.29 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 120.541 0.21 . . . . 1.09 111.489 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 22.2 p-10 -89.06 -10.38 47.66 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 120.731 0.301 . . . . 0.38 111.061 179.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 91.52 -19.23 48.92 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 114.487 0.555 . . . . 0.36 114.487 178.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . 0.539 ' HB ' ' NH2' ' A' ' 244' ' ' ARG . 17.9 t -78.78 102.81 5.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 O-C-N 122.23 -0.571 . . . . 0.51 111.305 -179.67 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 240' ' ' THR . . . . . 0.477 ' HA ' ' CE1' ' A' ' 235' ' ' PHE . 24.1 m -93.25 84.03 4.72 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.112 0.482 . . . . 0.71 111.344 -179.662 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . 0.406 ' HB2' ' HG3' ' A' ' 244' ' ' ARG . 80.5 m-20 -89.09 141.03 28.85 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.316 -0.402 . . . . 0.44 111.338 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 242' ' ' TRP . . . . . . . . . . . . . 18.9 m95 -57.93 -37.89 74.91 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.759 0.314 . . . . 0.6 111.112 179.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -60.04 -30.89 71.18 Favored Glycine 0 C--N 1.335 0.503 0 C-N-CA 120.991 -0.623 . . . . 0.26 112.047 178.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 244' ' ' ARG . . . . . 0.539 ' NH2' ' HB ' ' A' ' 239' ' ' VAL . 26.1 mtt180 -75.45 -48.06 24.43 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.969 0.414 . . . . 0.5 109.959 178.526 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . 0.526 HG22 HD12 ' A' ' 279' ' ' LEU . 73.3 mt -56.5 -44.93 81.72 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-N 115.449 -0.796 . . . . 1.03 110.625 179.53 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 9.9 p -70.94 -32.38 48.37 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-N 116.322 -0.399 . . . . 0.68 110.819 178.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 15.8 m -63.09 -38.02 89.54 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 122.293 -0.254 . . . . 1.09 110.567 179.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 248' ' ' LEU . . . . . 0.818 HD13 ' HE2' ' A' ' 235' ' ' PHE . 26.3 mt -62.83 -41.89 99.51 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 121.3 0.571 . . . . 1.16 109.799 177.657 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 249' ' ' ILE . . . . . 0.427 HG23 HD22 ' A' ' 194' ' ' LEU . 32.8 mm -68.53 -36.06 73.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 CA-C-N 115.694 -0.685 . . . . 1.1 109.571 178.197 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 40.6 t -63.3 -45.06 93.12 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 109.288 -0.634 . . . . 1.04 109.288 178.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 251' ' ' PHE . . . . . 0.445 ' O ' HG22 ' A' ' 255' ' ' VAL . 10.9 t80 -64.09 -41.02 97.46 Favored 'General case' 0 N--CA 1.456 -0.165 0 N-CA-C 108.766 -0.827 . . . . 0.51 108.766 177.636 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -57.57 -44.73 93.75 Favored Glycine 0 C--N 1.337 0.588 0 N-CA-C 110.946 -0.861 . . . . 0.28 110.946 177.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 253' ' ' ALA . . . . . 0.467 ' O ' ' HG3' ' A' ' 257' ' ' LYS . . . -63.95 -32.02 73.4 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 121.0 0.428 . . . . 0.84 110.899 177.485 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -68.8 -45.05 72.27 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 121.164 0.507 . . . . 0.87 109.634 178.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 255' ' ' VAL . . . . . 0.445 HG22 ' O ' ' A' ' 251' ' ' PHE . 59.3 t -64.22 -38.36 82.3 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-N 115.783 -0.644 . . . . 1.1 109.743 178.019 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 256' ' ' ALA . . . . . 0.418 ' HB2' ' HB2' ' A' ' 171' ' ' ALA . . . -57.99 -47.45 82.96 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 115.892 -0.595 . . . . 1.07 110.067 178.316 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 257' ' ' LYS . . . . . 0.467 ' HG3' ' O ' ' A' ' 253' ' ' ALA . 49.5 mttp -59.25 -49.13 79.04 Favored 'General case' 0 N--CA 1.462 0.137 0 N-CA-C 110.066 -0.346 . . . . 0.49 110.066 178.069 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 81.4 t60 -57.59 -45.78 84.85 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 115.81 -0.632 . . . . 0.84 111.738 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 4.9 mp -69.53 -41.89 75.4 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.449 -0.341 . . . . 1.1 111.519 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 1.3 tmtm? -67.44 -32.48 73.38 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-O 120.476 0.179 . . . . 0.62 111.177 179.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 54.2 m -63.98 -27.64 69.27 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 120.893 0.378 . . . . 0.43 111.151 179.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 29.9 m -105.89 10.96 8.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-O 121.002 0.43 . . . . 1.07 110.702 178.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 61.34 36.76 17.42 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 113.231 0.826 . . . . 0.69 113.231 179.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 264' ' ' GLN . . . . . 0.453 HE22 ' HG2' ' A' ' 219' ' ' LYS . 5.4 mt-30 -105.33 37.67 2.14 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.337 0.589 . . . . 0.92 110.22 178.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -56.65 -22.72 36.46 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 113.306 0.854 . . . . 0.56 113.306 -179.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 10.7 p -61.35 -18.75 60.13 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.556 0.217 . . . . 1.05 111.271 179.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -96.22 -22.57 17.18 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 120.837 0.351 . . . . 1.16 110.772 178.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 60.1 mt -67.18 -44.79 87.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-N 116.361 -0.382 . . . . 1.02 111.093 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 269' ' ' GLU . . . . . 0.637 ' HB2' ' HD3' ' A' ' 270' ' ' PRO . 1.0 OUTLIER -53.64 -56.38 25.52 Favored Pre-proline 0 CA--C 1.547 0.847 0 CA-C-N 116.254 -0.43 . . . . 0.61 111.643 179.706 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 270' ' ' PRO . . . . . 0.637 ' HD3' ' HB2' ' A' ' 269' ' ' GLU . 27.5 Cg_exo -64.34 -28.87 63.32 Favored 'Trans proline' 0 C--N 1.36 1.161 0 C-N-CA 122.105 1.87 . . . . 0.44 112.333 178.554 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 271' ' ' LEU . . . . . . . . . . . . . 38.3 tp -65.19 -43.21 92.36 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.4 -0.364 . . . . 1.06 110.586 178.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -58.84 -46.97 86.45 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.259 -0.428 . . . . 0.56 111.246 179.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 273' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -65.44 -42.94 91.88 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.534 -0.303 . . . . 0.68 110.403 178.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 274' ' ' THR . . . . . 0.513 HG21 ' HB ' ' A' ' 224' ' ' VAL . 85.9 m -58.86 -50.35 74.33 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.235 -0.438 . . . . 0.86 110.411 179.148 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 275' ' ' ILE . . . . . 0.478 ' HA ' ' HE3' ' A' ' 231' ' ' MET . 96.9 mt -59.44 -54.41 34.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.105 -0.498 . . . . 1.07 110.351 178.463 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 21.0 m -56.61 -52.99 62.73 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 113.105 0.78 . . . . 0.45 113.105 -179.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 277' ' ' ASP . . . . . 0.471 ' O ' ' HD2' ' A' ' 281' ' ' ARG . 0.2 OUTLIER -56.41 -53.7 54.34 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.445 0.164 . . . . 0.4 111.433 -179.212 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 278' ' ' VAL . . . . . 0.475 HG23 ' CB ' ' A' ' 228' ' ' SER . 89.3 t -60.68 -38.55 78.9 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 CA-C-O 120.796 0.331 . . . . 0.88 110.804 179.363 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . 0.526 HD12 HG22 ' A' ' 245' ' ' ILE . 2.4 tp -62.0 -47.08 86.39 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 116.421 -0.354 . . . . 1.42 111.881 179.527 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 61.9 t -76.56 -40.88 34.26 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 N-CA-C 112.47 0.544 . . . . 0.96 112.47 -179.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 281' ' ' ARG . . . . . 0.471 ' HD2' ' O ' ' A' ' 277' ' ' ASP . 0.0 OUTLIER -66.31 -28.5 68.73 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 112.474 0.546 . . . . 0.42 112.474 -179.356 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 282' ' ' THR . . . . . . . . . . . . . 25.3 p -85.32 -64.15 1.2 Allowed 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.063 0.459 . . . . 0.99 112.024 179.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . 0.418 ' HZ1' ' HA ' ' A' ' 279' ' ' LEU . 22.3 mtmm -88.99 40.74 0.99 Allowed 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.24 0.459 . . . . 0.79 112.24 -178.353 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 284' ' ' ARG . . . . . 0.46 ' O ' HG21 ' A' ' 288' ' ' VAL . 2.9 ptp85 -57.66 -46.17 84.57 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 112.136 0.421 . . . . 0.57 112.136 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 285' ' ' ASP . . . . . 0.422 ' O ' ' HB2' ' A' ' 289' ' ' LYS . 8.0 t70 -62.13 -51.52 67.54 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 111.87 0.322 . . . . 0.42 111.87 -179.24 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 286' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -61.83 -33.07 73.5 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.862 0.363 . . . . 0.5 111.234 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -70.81 -52.47 20.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.228 -0.442 . . . . 0.77 110.809 178.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 288' ' ' VAL . . . . . 0.46 HG21 ' O ' ' A' ' 284' ' ' ARG . 27.6 m -64.36 -30.68 50.83 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-O 120.813 0.34 . . . . 0.5 111.821 179.724 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 289' ' ' LYS . . . . . 0.422 ' HB2' ' O ' ' A' ' 285' ' ' ASP . 0.3 OUTLIER -68.36 -40.81 81.35 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 112.294 0.479 . . . . 0.87 112.294 -179.808 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 290' ' ' GLN . . . . . 0.465 ' O ' ' HA3' ' A' ' 295' ' ' GLY . 0.8 OUTLIER -96.94 30.05 2.84 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 112.867 0.692 . . . . 0.57 112.867 -178.9 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 33.1 mtm105 58.37 23.66 10.79 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 112.14 0.422 . . . . 0.46 112.14 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 69.21 -130.32 24.05 Favored Glycine 0 CA--C 1.523 0.554 0 C-N-CA 121.21 -0.519 . . . . 0.35 114.003 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 293' ' ' TRP . . . . . 0.604 ' O ' HG21 ' A' ' 297' ' ' VAL . 76.0 m95 -71.48 -29.45 64.85 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.386 0.514 . . . . 0.54 112.386 -178.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 294' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -59.72 -42.83 93.95 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 120.637 -0.425 . . . . 0.42 110.046 179.563 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 295' ' ' GLY . . . . . 0.465 ' HA3' ' O ' ' A' ' 290' ' ' GLN . . . -70.05 -38.13 73.6 Favored Glycine 0 C--N 1.336 0.556 0 N-CA-C 111.003 -0.839 . . . . 0.28 111.003 177.596 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 296' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -59.45 -37.48 78.25 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.096 0.474 . . . . 0.49 110.352 177.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 297' ' ' VAL . . . . . 0.754 HG13 ' HB3' ' A' ' 189' ' ' ARG . 71.4 t -65.71 -50.2 72.63 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-N 115.794 -0.639 . . . . 0.94 110.925 179.236 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -57.91 -41.87 83.56 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.236 -0.438 . . . . 0.54 111.395 179.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 299' ' ' PHE . . . . . 0.401 ' CZ ' ' HB2' ' B' ' 39' ' ' SER . 78.0 t80 -61.57 -40.14 93.66 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 116.18 -0.464 . . . . 0.66 112.227 -179.592 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 300' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -93.83 23.69 4.66 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.877 0.37 . . . . 0.58 111.596 -179.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -138.91 -164.99 1.75 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.957 0.408 . . . . 0.6 111.088 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . 0.596 HG21 ' H ' ' A' ' 303' ' ' GLN . 4.0 p -164.36 175.46 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 CA-C-N 116.143 -0.48 . . . . 1.35 110.235 -179.686 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 303' ' ' GLN . . . . . 0.596 ' H ' HG21 ' A' ' 302' ' ' VAL . 15.8 mm100 -76.08 65.08 2.04 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.39 0.614 . . . . 1.61 110.675 179.608 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -74.06 122.64 22.98 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.33 -0.85 . . . . 1.09 111.833 -179.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 14.9 tp -119.06 10.14 12.04 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.867 -1.06 . . . . 2.2 110.594 178.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -126.17 -41.03 1.95 Allowed 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.444 -0.344 . . . . 2.09 111.736 -179.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . 109.59 75.82 0.87 Allowed Glycine 0 CA--C 1.521 0.454 0 C-N-CA 120.737 -0.744 . . . . 1.42 113.196 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.261 0 CA-C-O 118.473 -1.181 . . . . 1.86 113.195 179.777 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.477 0 CA-C-O 120.971 0.415 . . . . 0.76 110.65 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -135.38 9.83 3.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.296 -0.411 . . . . 0.86 111.688 -178.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 19' ' ' LEU . . . . . 0.549 HD13 ' HA ' ' A' ' 216' ' ' LEU . 30.5 tp -58.36 110.24 2.44 Favored Pre-proline 0 CA--C 1.535 0.386 0 CA-C-O 121.054 0.454 . . . . 0.97 112.168 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 20' ' ' PRO . . . . . 0.758 ' HG2' ' HG2' ' B' ' 22' ' ' GLU . 95.2 Cg_endo -91.52 151.02 3.55 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 123.176 2.584 . . . . 0.53 113.149 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 21' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -70.59 27.5 0.2 Allowed 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 123.242 2.628 . . . . 0.99 113.625 -179.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 22' ' ' GLU . . . . . 0.758 ' HG2' ' HG2' ' B' ' 20' ' ' PRO . 6.6 pt-20 -88.96 -17.17 30.04 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.608 -0.269 . . . . 0.47 111.317 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 23' ' ' PHE . . . . . 0.479 ' HA ' ' SD ' ' A' ' 212' ' ' MET . 0.7 OUTLIER -55.64 -40.05 71.68 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 112.566 0.58 . . . . 0.43 112.566 -179.194 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 24' ' ' ALA . . . . . 0.429 ' N ' ' HD1' ' B' ' 23' ' ' PHE . . . -68.97 -46.16 68.83 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.969 0.414 . . . . 1.0 111.049 -179.648 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . 0.547 ' O ' ' HG2' ' B' ' 29' ' ' LYS . . . -64.05 -52.84 57.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.005 -0.543 . . . . 1.18 110.806 179.319 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -55.19 -54.65 40.67 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 115.375 -0.829 . . . . 0.5 112.102 -179.394 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 45.3 mt -63.2 -29.4 70.75 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 120.957 -0.297 . . . . 1.05 111.638 -179.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 28' ' ' ARG . . . . . . . . . . . . . 4.4 tmt_? -70.93 -57.21 4.8 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 120.896 0.379 . . . . 1.09 110.503 178.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . 0.547 ' HG2' ' O ' ' B' ' 25' ' ' ALA . 10.4 ptmt -61.79 -42.39 98.94 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 116.397 -0.365 . . . . 1.51 111.901 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 88.3 mt -64.79 -41.51 92.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.181 0 N-CA-C 109.831 -0.433 . . . . 0.93 109.831 179.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . 0.531 ' HA3' ' HG2' ' A' ' 244' ' ' ARG . . . -59.76 -49.22 80.92 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.956 -0.64 . . . . 0.29 112.017 178.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 36.9 m-20 -66.6 -34.72 78.52 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.642 0.221 . . . . 0.37 110.876 178.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 33' ' ' LYS . . . . . 0.412 ' O ' ' HE3' ' B' ' 33' ' ' LYS . 0.0 OUTLIER -65.46 -47.62 75.51 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.791 0.329 . . . . 0.84 110.128 178.169 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 42.4 t -61.37 -48.87 86.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 CA-C-O 121.067 0.461 . . . . 1.11 109.775 178.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -55.58 -38.3 69.21 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 115.63 -0.714 . . . . 1.12 109.999 178.088 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 36' ' ' CYS . . . . . . . . . . . . . 52.1 t -65.56 -46.14 80.64 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-N 116.012 -0.54 . . . . 2.07 110.996 178.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 97.0 m -62.33 -35.86 80.39 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 112.861 0.689 . . . . 1.02 112.861 -179.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 38' ' ' TRP . . . . . . . . . . . . . 96.8 m95 -86.86 -25.43 24.5 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 112.767 0.654 . . . . 0.73 112.767 -178.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 39' ' ' SER . . . . . 0.401 ' HB2' ' CZ ' ' A' ' 299' ' ' PHE . 14.7 t -93.6 -56.36 2.94 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.007 0.432 . . . . 1.1 111.286 179.079 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -92.27 157.38 40.71 Favored Pre-proline 0 CA--C 1.538 0.493 0 CA-C-N 116.171 -0.468 . . . . 0.62 111.732 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -75.7 83.13 1.98 Allowed 'Trans proline' 0 CA--C 1.538 0.687 0 C-N-CA 122.35 2.033 . . . . 1.07 112.69 178.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -71.08 74.78 0.66 Allowed 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 116.185 -0.462 . . . . 0.95 111.797 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 43' ' ' MET . . . . . . . . . . . . . 85.1 mtp . . . . . 0 C--O 1.251 1.167 0 CA-C-O 118.327 -0.844 . . . . 3.94 111.668 179.838 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.49 ' H2 ' ' CG ' ' A' ' 154' ' ' ASP . . . . . . . . 0 N--CA 1.49 2.24 0 N-CA-C 112.611 -0.196 . . . . 0.78 112.611 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -73.04 -22.1 19.87 Favored 'Trans proline' 0 CA--C 1.532 0.42 0 C-N-CA 122.564 2.176 . . . . 1.12 113.256 179.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 93.9 mt -116.52 -54.16 2.47 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.799 0.333 . . . . 2.59 111.314 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -127.02 -131.32 3.49 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.373 -0.918 . . . . 0.63 112.281 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 56.1 p -111.33 -46.03 3.34 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.109 0.48 . . . . 0.95 111.075 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -140.15 -20.81 0.87 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.884 -0.598 . . . . 0.45 111.041 -179.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -51.77 -50.4 60.74 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.764 -0.653 . . . . 0.53 111.536 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . 0.49 ' CG ' ' H2 ' ' A' ' 147' ' ' GLY . 0.7 OUTLIER -57.84 -46.53 84.63 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 121.036 0.446 . . . . 0.48 110.951 179.394 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.625 HD22 ' HB3' ' A' ' 287' ' ' LEU . 13.9 tp -62.83 -46.41 88.07 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.99 -0.55 . . . . 1.38 111.133 178.701 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 44.5 t80 -66.71 -40.6 88.52 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.167 -0.469 . . . . 0.44 111.767 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.606 ' HD2' ' OE1' ' A' ' 182' ' ' GLU . 32.4 mtm180 -59.75 -46.75 88.18 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.81 0.338 . . . . 0.61 111.416 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . 0.402 ' HA ' ' HB2' ' A' ' 183' ' ' ALA . 51.1 mt-30 -70.45 -35.81 73.55 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.756 0.312 . . . . 0.95 110.585 179.536 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 51.9 m -65.04 -45.85 83.72 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.481 -0.327 . . . . 0.33 110.138 178.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.773 ' HA ' HG23 ' A' ' 276' ' ' THR . 2.1 tm? -53.64 -55.29 27.23 Favored 'General case' 0 C--O 1.225 -0.186 0 CA-C-N 116.026 -0.534 . . . . 1.14 110.572 178.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . 0.402 ' HB3' HD23 ' A' ' 180' ' ' LEU . 11.9 mt-10 -55.13 -43.61 74.3 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 112.271 0.471 . . . . 1.18 112.271 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . 0.491 HG21 HD23 ' A' ' 191' ' ' LEU . 90.6 mt -69.18 -53.46 25.43 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 N-CA-C 112.394 0.516 . . . . 1.07 112.394 -179.313 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.519 HD12 HG21 ' A' ' 276' ' ' THR . 68.2 mt -66.12 -47.77 83.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 N-CA-C 112.017 0.377 . . . . 1.07 112.017 -179.39 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 3.5 t -58.34 -44.55 88.76 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.644 0.259 . . . . 0.34 111.226 -179.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . 0.57 ' NH2' ' HG ' ' A' ' 180' ' ' LEU . 21.4 ttm180 -66.69 -49.48 65.97 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 120.296 -0.562 . . . . 0.67 110.506 178.575 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' TYR . . . . . 0.988 ' HE1' ' HA ' ' A' ' 195' ' ' ARG . 93.5 t80 -55.41 -52.47 63.45 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 112.601 0.593 . . . . 0.42 112.601 -179.672 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 5.0 mp -60.74 -45.7 93.3 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 120.834 -0.346 . . . . 0.88 111.833 -179.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . 0.535 ' HD2' ' OE1' ' A' ' 269' ' ' GLU . 0.0 OUTLIER -65.36 -37.18 86.26 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.665 0.269 . . . . 0.47 110.924 179.679 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . 0.749 ' HG3' ' HA ' ' A' ' 175' ' ' LYS . 19.7 tt0 -58.22 -53.9 53.02 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.056 -0.52 . . . . 0.45 110.473 178.724 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . 0.749 ' HB3' ' HE3' ' A' ' 257' ' ' LYS . 2.2 mt-30 -67.19 -39.9 86.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.026 -0.533 . . . . 0.52 111.093 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -59.46 -55.75 30.71 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.833 0.349 . . . . 0.44 111.711 179.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 44.9 p -68.0 -36.38 79.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.446 . . . . 1.16 112.11 -179.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 100.2 25.29 8.98 Favored Glycine 0 CA--C 1.519 0.313 0 C-N-CA 120.66 -0.781 . . . . 0.7 112.725 179.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 47.0 t -146.63 125.37 12.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.236 0.541 . . . . 1.42 111.404 179.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . 0.792 ' HD3' ' H ' ' A' ' 175' ' ' LYS . 0.0 OUTLIER -69.86 149.05 48.28 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 115.52 -0.764 . . . . 0.92 112.338 179.889 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -110.88 109.88 20.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.096 0.474 . . . . 0.64 111.055 178.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 82.6 p -104.07 26.13 9.14 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.921 -0.581 . . . . 1.36 111.721 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . 0.595 ' HZ2' ' HB2' ' A' ' 178' ' ' LYS . 0.0 OUTLIER -97.01 154.25 38.26 Favored Pre-proline 0 C--N 1.33 -0.252 0 O-C-N 122.33 -0.231 . . . . 1.23 110.54 179.338 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -59.62 146.59 94.88 Favored 'Trans proline' 0 CA--C 1.533 0.466 0 C-N-CA 122.404 2.069 . . . . 0.73 113.222 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.57 ' HG ' ' NH2' ' A' ' 165' ' ' ARG . 3.4 mp -95.86 177.62 5.71 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 116.059 -0.519 . . . . 1.13 110.571 179.128 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -81.24 -67.67 1.52 Allowed Glycine 0 CA--C 1.523 0.555 0 C-N-CA 120.681 -0.771 . . . . 0.63 113.176 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . 0.606 ' OE1' ' HD2' ' A' ' 157' ' ' ARG . 31.8 mt-10 -113.12 -24.37 9.48 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 120.834 0.35 . . . . 1.1 111.408 -179.539 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . 0.639 ' O ' ' HA3' ' A' ' 187' ' ' GLY . . . -87.56 59.75 5.63 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 121.096 0.474 . . . . 0.62 111.611 179.477 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -80.41 -71.54 1.27 Allowed Glycine 0 CA--C 1.527 0.808 0 C-N-CA 120.67 -0.776 . . . . 0.46 113.527 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -64.05 -55.78 19.72 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 120.992 0.425 . . . . 1.17 111.264 -179.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -65.65 -34.55 78.48 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.934 -0.576 . . . . 1.06 110.261 178.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . 0.639 ' HA3' ' O ' ' A' ' 183' ' ' ALA . . . -65.39 -47.91 74.33 Favored Glycine 0 C--O 1.217 -0.945 0 C-N-CA 121.068 -0.587 . . . . 0.47 112.723 179.702 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 4.8 tmm_? -60.37 -48.65 80.84 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-N 117.349 0.574 . . . . 0.84 111.314 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . 0.471 ' HG2' HG21 ' A' ' 297' ' ' VAL . 3.9 ttp180 -63.02 -46.29 88.3 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 120.763 0.316 . . . . 0.67 110.753 -179.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . 0.442 ' HA ' ' CG1' ' A' ' 297' ' ' VAL . . . -71.69 -31.15 66.45 Favored 'General case' 0 C--O 1.222 -0.367 0 N-CA-C 112.245 0.461 . . . . 0.93 112.245 -179.576 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . 0.551 ' HB2' ' O ' ' A' ' 187' ' ' GLY . 0.2 OUTLIER -62.2 -53.46 54.93 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 120.578 0.228 . . . . 1.36 111.056 -179.752 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -65.11 -42.1 94.29 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.461 -0.336 . . . . 1.09 111.059 179.205 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' THR . . . . . 0.644 HG21 ' HA ' ' A' ' 297' ' ' VAL . 39.3 m -62.57 -47.28 84.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.476 -0.329 . . . . 1.13 110.698 179.4 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 33.6 tp -67.76 -41.24 83.64 Favored 'General case' 0 C--O 1.224 -0.241 0 CA-C-N 116.526 -0.307 . . . . 1.03 111.085 179.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . 0.988 ' HA ' ' HE1' ' A' ' 166' ' ' TYR . 45.4 ttm180 -60.57 -45.33 94.35 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.783 0.325 . . . . 0.8 111.34 179.215 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 12.7 mtp180 -73.87 -49.48 24.81 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.547 0.573 . . . . 1.94 112.547 -179.086 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 86.6 t -68.86 -38.88 79.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-O 120.923 0.392 . . . . 0.98 111.161 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -65.12 -52.77 38.17 Favored Glycine 0 C--N 1.332 0.359 0 C-N-CA 121.14 -0.552 . . . . 0.32 112.895 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -63.19 -31.13 72.2 Favored 'General case' 0 CA--C 1.528 0.099 0 CA-C-N 117.114 0.457 . . . . 0.47 110.258 179.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . 0.456 ' O ' ' HB2' ' A' ' 204' ' ' ASN . . . -60.65 -53.8 42.35 Favored Glycine 0 C--N 1.336 0.554 0 C-N-CA 120.902 -0.666 . . . . 0.35 111.462 178.014 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 83.3 t -63.54 -41.35 92.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 CA-C-O 121.355 0.598 . . . . 0.94 110.471 178.153 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 202' ' ' GLN . . . . . 0.406 ' HA ' ' CE2' ' A' ' 209' ' ' PHE . 7.4 tt0 -60.73 -51.27 70.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 114.729 -1.123 . . . . 1.01 112.723 -178.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 2.8 mmp_? -74.01 -32.58 63.44 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 111.716 0.265 . . . . 0.61 111.716 -179.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 204' ' ' ASN . . . . . 0.456 ' HB2' ' O ' ' A' ' 200' ' ' GLY . 8.4 t-20 -68.68 -53.77 20.3 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.049 0.452 . . . . 1.57 110.822 179.477 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 89.0 m-70 -95.18 32.14 1.78 Allowed 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 121.184 0.516 . . . . 0.75 110.853 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . 0.457 ' HG2' HE21 ' A' ' 210' ' ' GLN . 10.0 tt0 -59.5 -38.51 81.11 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.581 -0.736 . . . . 0.52 111.675 -179.333 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 42.2 p -59.26 -49.74 76.68 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.154 0.502 . . . . 0.9 110.95 179.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -66.59 -44.54 81.91 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.682 -0.69 . . . . 0.49 110.401 178.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 209' ' ' PHE . . . . . 0.406 ' CE2' ' HA ' ' A' ' 202' ' ' GLN . 4.8 m-30 -58.46 -44.51 89.28 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.177 -0.465 . . . . 0.57 110.736 179.498 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 210' ' ' GLN . . . . . 0.491 ' HB3' ' NH2' ' A' ' 214' ' ' ARG . 59.6 mt-30 -64.02 -34.73 78.68 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.56 -0.291 . . . . 0.64 110.971 179.446 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . 0.478 ' O ' ' HB2' ' A' ' 215' ' ' LYS . . . -60.21 -44.91 96.94 Favored Glycine 0 C--N 1.334 0.454 0 N-CA-C 111.028 -0.829 . . . . 0.41 111.028 178.021 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 212' ' ' MET . . . . . 0.808 ' HG2' ' HA ' ' B' ' 23' ' ' PHE . 1.0 OUTLIER -77.29 -30.68 54.31 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 120.616 0.246 . . . . 0.95 110.581 178.457 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 16.8 tp -59.7 -44.85 93.5 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.197 -0.456 . . . . 1.15 111.026 179.208 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 214' ' ' ARG . . . . . 0.491 ' NH2' ' HB3' ' A' ' 210' ' ' GLN . 68.0 mtm-85 -81.25 -27.47 35.17 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.034 -0.53 . . . . 0.75 110.169 178.574 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 215' ' ' LYS . . . . . 0.478 ' HB2' ' O ' ' A' ' 211' ' ' GLY . 0.7 OUTLIER -66.97 -46.9 73.2 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 115.875 -0.602 . . . . 1.16 110.621 178.443 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . 0.44 HD21 ' HB ' ' A' ' 218' ' ' ILE . 4.6 tp -65.19 120.7 13.19 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 115.901 -0.59 . . . . 1.17 111.354 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -75.03 36.07 0.11 Allowed 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 112.877 0.695 . . . . 1.47 112.877 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 218' ' ' ILE . . . . . 0.932 ' HA ' ' HB3' ' A' ' 223' ' ' ASP . 1.3 tt -61.05 106.55 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-O 121.914 0.864 . . . . 1.12 111.571 -179.766 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -162.1 -50.88 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.28 -0.873 . . . . 1.09 110.462 -179.471 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -99.6 178.38 4.87 Favored 'General case' 0 C--O 1.221 -0.418 0 CA-C-N 116.189 -0.46 . . . . 1.14 111.164 179.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . 0.429 ' HA ' ' HE1' ' A' ' 267' ' ' PHE . 2.0 mm-40 -49.38 -20.74 0.73 Allowed 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 113.794 1.035 . . . . 0.86 113.794 -179.316 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -67.84 -24.51 74.27 Favored Glycine 0 CA--C 1.534 1.271 0 N-CA-C 114.643 0.617 . . . . 0.38 114.643 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 223' ' ' ASP . . . . . 0.932 ' HB3' ' HA ' ' A' ' 218' ' ' ILE . 9.9 p30 -59.16 -56.06 26.97 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 113.475 0.917 . . . . 0.57 113.475 -177.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . 0.431 HG23 HG23 ' A' ' 274' ' ' THR . 2.6 p -54.27 -39.73 44.67 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-O 120.983 0.42 . . . . 1.1 111.764 179.492 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 30.2 mttp -68.68 -42.99 77.06 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-O 120.935 0.398 . . . . 0.71 110.171 178.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 226' ' ' SER . . . . . 0.573 ' O ' HG23 ' A' ' 230' ' ' VAL . 45.3 m -62.03 -43.25 99.23 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.9 -0.591 . . . . 0.8 109.693 178.579 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 227' ' ' PHE . . . . . 0.488 ' O ' ' HG3' ' A' ' 231' ' ' MET . 16.8 t80 -55.96 -42.92 76.98 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 115.731 -0.668 . . . . 0.88 110.447 178.821 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 12.7 p -60.31 -39.56 87.42 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 120.823 0.344 . . . . 0.4 110.368 178.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 6.4 mmp_? -67.85 -35.7 79.01 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 116.24 -0.437 . . . . 0.62 110.786 179.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . 0.573 HG23 ' O ' ' A' ' 226' ' ' SER . 24.3 t -61.96 -52.4 60.95 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 N-CA-C 109.985 -0.376 . . . . 1.01 109.985 178.568 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 231' ' ' MET . . . . . 0.641 ' HE1' HG13 ' A' ' 275' ' ' ILE . 31.5 mtp -56.79 -46.3 81.62 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.726 -0.67 . . . . 0.92 110.866 179.293 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 56.1 t -62.12 -40.29 86.96 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 CA-C-N 116.167 -0.47 . . . . 1.08 110.659 178.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 64.7 t-80 -66.65 -43.62 84.1 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 116.557 -0.292 . . . . 0.71 111.203 178.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . 0.438 HG21 ' O ' ' A' ' 230' ' ' VAL . 78.1 t -60.89 -40.4 85.17 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 CA-C-O 120.66 0.267 . . . . 1.14 111.539 179.532 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -101.44 23.51 10.96 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 111.951 0.352 . . . . 0.65 111.951 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 1.9 tmtm? -70.78 -11.73 61.13 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 112.1 0.408 . . . . 1.85 112.1 -179.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -83.23 -16.86 44.78 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.662 0.268 . . . . 0.49 111.267 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 91.86 -5.78 79.35 Favored Glycine 0 CA--C 1.524 0.64 0 C-N-CA 120.827 -0.701 . . . . 0.47 113.898 179.273 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 3.1 p -98.04 114.94 36.83 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-O 121.663 0.744 . . . . 0.68 111.87 -179.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 99.4 m -94.74 109.44 21.4 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.089 -0.505 . . . . 1.07 111.739 179.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . 0.541 ' HB2' ' HD2' ' A' ' 244' ' ' ARG . 25.7 m-20 -113.61 139.45 49.01 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.296 -0.411 . . . . 0.47 110.762 179.022 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 242' ' ' TRP . . . . . 0.421 ' CZ3' ' HB2' ' A' ' 296' ' ' PHE . 40.4 m95 -54.54 -42.12 70.53 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.183 -0.462 . . . . 0.53 111.619 -179.375 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -60.16 -33.91 81.9 Favored Glycine 0 C--N 1.333 0.412 0 C-N-CA 120.937 -0.649 . . . . 0.36 112.095 178.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 244' ' ' ARG . . . . . 0.541 ' HD2' ' HB2' ' A' ' 241' ' ' ASN . 23.6 mtt180 -70.73 -44.96 65.77 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.163 0.506 . . . . 0.46 109.638 178.687 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . 0.438 ' O ' HG13 ' A' ' 249' ' ' ILE . 74.2 mt -61.84 -50.08 81.64 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 115.412 -0.813 . . . . 1.17 111.491 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 8.5 p -65.4 -32.71 59.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 120.814 -0.354 . . . . 1.08 111.36 -179.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 82.8 m -66.14 -34.47 78.12 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.467 0.651 . . . . 1.04 109.261 177.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 248' ' ' LEU . . . . . 0.455 HD21 ' HG2' ' A' ' 231' ' ' MET . 33.7 tp -73.23 -45.33 56.64 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 115.43 -0.804 . . . . 1.67 110.426 178.199 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 249' ' ' ILE . . . . . 0.438 HG13 ' O ' ' A' ' 245' ' ' ILE . 23.5 mt -63.13 -44.18 99.3 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 CA-C-N 116.506 -0.316 . . . . 1.01 110.886 179.143 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 12.6 p -61.98 -36.17 80.66 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.277 0.561 . . . . 1.0 109.572 178.096 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 251' ' ' PHE . . . . . 0.427 ' O ' HG22 ' A' ' 255' ' ' VAL . 48.8 t80 -66.27 -41.34 90.04 Favored 'General case' 0 C--O 1.227 -0.122 0 CA-C-N 115.514 -0.767 . . . . 0.58 109.411 177.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -57.85 -49.23 76.37 Favored Glycine 0 C--N 1.335 0.5 0 N-CA-C 111.203 -0.759 . . . . 0.28 111.203 178.133 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -59.13 -43.03 91.94 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 120.68 0.276 . . . . 1.04 110.692 177.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -63.01 -43.99 97.21 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 121.071 0.462 . . . . 0.93 110.787 179.011 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 255' ' ' VAL . . . . . 0.427 HG22 ' O ' ' A' ' 251' ' ' PHE . 72.7 t -62.96 -46.46 96.25 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 N-CA-C 109.383 -0.599 . . . . 1.02 109.383 177.798 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -59.13 -37.84 78.21 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.081 -0.509 . . . . 0.56 110.078 177.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 257' ' ' LYS . . . . . 0.749 ' HE3' ' HB3' ' A' ' 170' ' ' GLN . 81.0 mttt -59.04 -45.79 89.87 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 109.468 -0.567 . . . . 0.65 109.468 177.364 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 80.3 t60 -61.06 -46.32 91.15 Favored 'General case' 0 C--O 1.228 -0.033 0 CA-C-N 115.4 -0.818 . . . . 0.73 109.632 178.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . 0.827 HD12 HG12 ' A' ' 218' ' ' ILE . 8.8 mp -59.82 -42.52 93.69 Favored 'General case' 0 C--O 1.221 -0.401 0 CA-C-N 115.968 -0.56 . . . . 1.11 110.316 178.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 260' ' ' LYS . . . . . 0.47 ' HZ2' ' CD ' ' A' ' 265' ' ' GLU . 2.2 tptp -64.15 -35.91 82.31 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.992 0.425 . . . . 0.75 110.419 178.762 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 21.2 m -69.78 -31.97 70.19 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.775 -0.648 . . . . 0.59 111.094 179.355 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 33.6 m -101.03 10.56 7.66 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 CA-C-O 120.796 0.331 . . . . 1.02 111.425 179.112 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 16.4 m120 59.16 47.92 11.13 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 113.123 0.786 . . . . 0.6 113.123 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 264' ' ' GLN . . . . . 0.549 ' HB3' ' HG ' ' A' ' 259' ' ' LEU . 17.7 tt0 -106.77 36.85 2.5 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.198 0.523 . . . . 0.66 110.31 179.044 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . 0.506 ' HA ' HD13 ' A' ' 268' ' ' ILE . 0.0 OUTLIER -54.33 -27.7 37.64 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 115.735 -0.666 . . . . 0.51 111.556 179.814 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 26.1 p -58.45 -26.36 63.26 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 115.785 -0.643 . . . . 1.04 110.941 178.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 267' ' ' PHE . . . . . 0.429 ' HE1' ' HA ' ' A' ' 221' ' ' GLU . 70.0 m-85 -108.52 -11.4 15.14 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.197 -0.456 . . . . 0.99 110.917 178.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 268' ' ' ILE . . . . . 0.506 HD13 ' HA ' ' A' ' 265' ' ' GLU . 53.1 mt -66.62 -51.15 59.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 CA-C-O 120.776 0.322 . . . . 1.11 110.791 179.381 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 269' ' ' GLU . . . . . 0.717 ' HB2' ' HD3' ' A' ' 270' ' ' PRO . 55.2 mm-40 -58.78 -54.7 53.71 Favored Pre-proline 0 CA--C 1.541 0.629 0 CA-C-N 116.186 -0.461 . . . . 0.49 111.178 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 270' ' ' PRO . . . . . 0.717 ' HD3' ' HB2' ' A' ' 269' ' ' GLU . 32.1 Cg_exo -60.73 -32.51 93.13 Favored 'Trans proline' 0 C--N 1.359 1.108 0 C-N-CA 122.086 1.858 . . . . 0.42 112.76 178.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 271' ' ' LEU . . . . . . . . . . . . . 29.4 tp -63.2 -46.09 88.68 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 120.531 0.205 . . . . 1.25 111.394 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -61.58 -40.99 96.75 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.13 0.49 . . . . 0.45 111.248 179.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 273' ' ' GLU . . . . . 0.441 ' HG2' ' O ' ' A' ' 269' ' ' GLU . 4.4 mm-40 -72.27 -33.74 67.69 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.195 0.522 . . . . 0.42 109.822 179.103 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 274' ' ' THR . . . . . 0.431 HG23 HG23 ' A' ' 224' ' ' VAL . 87.3 m -66.84 -51.92 49.86 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.99 -0.55 . . . . 0.98 110.952 178.668 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 275' ' ' ILE . . . . . 0.641 HG13 ' HE1' ' A' ' 231' ' ' MET . 14.4 tt -59.52 -36.51 65.17 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-O 120.682 0.277 . . . . 1.03 110.621 179.447 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 276' ' ' THR . . . . . 0.773 HG23 ' HA ' ' A' ' 160' ' ' LEU . 38.2 m -67.82 -49.68 60.96 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 120.786 0.326 . . . . 0.75 110.383 178.646 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 277' ' ' ASP . . . . . 0.567 ' O ' ' HB2' ' A' ' 281' ' ' ARG . 1.4 t70 -60.41 -54.58 43.94 Favored 'General case' 0 C--O 1.216 -0.671 0 CA-C-N 116.23 -0.441 . . . . 0.34 111.19 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 61.6 t -59.37 -34.08 53.13 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 N-CA-C 112.01 0.374 . . . . 0.91 112.01 -179.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 21.4 tp -67.82 -47.58 68.64 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.685 0.279 . . . . 0.91 111.392 179.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 39.7 t -78.06 -36.22 21.29 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 CA-C-O 120.864 0.364 . . . . 0.95 111.544 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 281' ' ' ARG . . . . . 0.567 ' HB2' ' O ' ' A' ' 277' ' ' ASP . 1.1 tpp180 -61.68 -41.02 96.99 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 122.921 0.488 . . . . 0.44 112.308 -179.434 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 282' ' ' THR . . . . . . . . . . . . . 74.5 p -90.78 -1.69 57.84 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 112.823 0.675 . . . . 0.47 112.823 -179.061 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 11.0 mtmm -138.72 33.71 2.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.672 0.273 . . . . 0.74 111.409 -179.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 34.0 ttm180 -53.16 -58.17 7.95 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 112.449 0.537 . . . . 0.5 112.449 -179.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -63.33 -42.95 99.0 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 112.179 0.437 . . . . 0.57 112.179 -179.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 286' ' ' TRP . . . . . . . . . . . . . 1.5 t90 -64.35 -51.23 64.38 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 112.227 0.454 . . . . 0.59 112.227 -178.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 287' ' ' LEU . . . . . 0.625 ' HB3' HD22 ' A' ' 155' ' ' LEU . 1.5 mm? -64.61 -48.18 75.86 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.317 0.488 . . . . 1.23 112.317 -178.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 3.0 p -63.99 -29.77 48.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 N-CA-C 112.007 0.373 . . . . 1.12 112.007 -179.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 289' ' ' LYS . . . . . 0.444 ' HB2' ' HE3' ' A' ' 289' ' ' LYS . 12.3 ttmt -76.56 -44.47 34.58 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 112.371 0.508 . . . . 1.48 112.371 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -80.62 28.86 0.32 Allowed 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 113.14 0.793 . . . . 0.56 113.14 -178.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 291' ' ' ARG . . . . . 0.432 ' HB3' ' HB3' ' A' ' 294' ' ' ASP . 62.5 mtp180 62.95 9.47 3.76 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 112.522 0.564 . . . . 0.52 112.522 179.572 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 62.22 -130.27 44.07 Favored Glycine 0 CA--C 1.522 0.504 0 CA-C-O 121.307 0.393 . . . . 0.42 113.439 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 293' ' ' TRP . . . . . 0.518 ' O ' HG23 ' A' ' 297' ' ' VAL . 77.5 m95 -61.87 -27.09 68.55 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.672 -0.264 . . . . 0.65 111.475 -179.854 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 294' ' ' ASP . . . . . 0.44 ' O ' ' HB2' ' A' ' 298' ' ' GLU . 0.5 OUTLIER -58.97 -44.46 91.54 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 120.881 0.372 . . . . 0.42 110.224 178.77 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -75.64 -30.18 58.46 Favored Glycine 0 CA--C 1.522 0.485 0 C-N-CA 120.795 -0.717 . . . . 0.38 111.639 178.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 296' ' ' PHE . . . . . 0.553 ' CE1' ' HE2' ' A' ' 300' ' ' PHE . 4.3 t80 -67.02 -47.29 71.87 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 120.821 0.343 . . . . 0.51 110.993 179.274 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 297' ' ' VAL . . . . . 0.644 ' HA ' HG21 ' A' ' 193' ' ' THR . 27.1 m -71.27 -37.41 65.71 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-N 116.44 -0.345 . . . . 0.9 111.567 -179.704 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 298' ' ' GLU . . . . . 0.44 ' HB2' ' O ' ' A' ' 294' ' ' ASP . 1.2 mt-10 -69.56 -27.58 65.25 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.571 -0.286 . . . . 0.67 111.432 179.687 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 299' ' ' PHE . . . . . . . . . . . . . 69.1 t80 -62.53 -43.73 98.09 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.346 -0.388 . . . . 0.8 110.434 178.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 300' ' ' PHE . . . . . 0.553 ' HE2' ' CE1' ' A' ' 296' ' ' PHE . 44.7 m-85 -87.13 -34.8 18.96 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 120.827 0.346 . . . . 0.58 111.125 179.664 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 51.5 m80 -110.56 88.81 2.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.506 -0.315 . . . . 0.83 111.16 -179.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 1.6 m -62.24 103.64 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 CA-C-O 121.474 0.654 . . . . 1.18 111.289 179.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 11.2 mm-40 -76.79 89.25 3.42 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.808 -0.633 . . . . 1.16 111.511 -179.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 34.4 t0 -74.8 105.01 5.65 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.508 0.671 . . . . 1.9 111.066 179.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -106.4 15.2 26.33 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.475 -0.784 . . . . 3.12 110.252 178.75 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -118.55 -43.92 2.68 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.964 -0.562 . . . . 3.14 111.783 -179.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . -80.37 -71.41 1.27 Allowed Glycine 0 CA--C 1.522 0.507 0 C-N-CA 120.926 -0.654 . . . . 3.2 113.198 -179.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.168 0 CA-C-O 118.378 -1.235 . . . . 5.95 112.81 -179.913 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.814 0 CA-C-O 121.236 0.541 . . . . 1.9 111.065 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 18' ' ' GLU . . . . . 0.574 ' CD ' ' H ' ' B' ' 18' ' ' GLU . 0.0 OUTLIER -79.22 -74.3 0.29 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.238 -0.892 . . . . 1.2 111.374 179.436 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 19' ' ' LEU . . . . . 0.498 HD23 ' HD2' ' B' ' 20' ' ' PRO . 4.1 mt -93.32 117.11 67.33 Favored Pre-proline 0 CA--C 1.53 0.182 0 CA-C-O 120.99 0.424 . . . . 1.46 111.26 179.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 20' ' ' PRO . . . . . 0.502 ' C ' ' H ' ' B' ' 22' ' ' GLU . 79.5 Cg_endo -75.17 161.46 38.22 Favored 'Trans proline' 0 CA--C 1.532 0.39 0 C-N-CA 122.775 2.317 . . . . 0.85 112.08 179.348 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 21' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.63 22.87 0.2 Allowed 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 122.531 2.154 . . . . 1.01 112.954 179.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 22' ' ' GLU . . . . . 0.502 ' H ' ' C ' ' B' ' 20' ' ' PRO . 1.3 tt0 -60.64 -45.66 93.24 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 123.527 0.731 . . . . 0.82 111.259 -179.709 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 23' ' ' PHE . . . . . 0.808 ' HA ' ' HG2' ' A' ' 212' ' ' MET . 3.5 p90 -62.41 -35.9 80.67 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 116.323 -0.399 . . . . 0.59 111.465 179.797 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -76.51 -45.3 31.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.792 0.329 . . . . 0.63 110.808 179.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.22 -45.8 87.02 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.244 -0.435 . . . . 0.65 110.569 178.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 26' ' ' GLN . . . . . 0.436 ' NE2' ' HG2' ' B' ' 22' ' ' GLU . 1.3 mp0 -61.32 -47.71 84.68 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 115.755 -0.657 . . . . 0.44 110.218 178.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . 0.529 ' HG ' ' HE1' ' A' ' 212' ' ' MET . 15.7 mt -58.22 -39.28 78.63 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.137 -0.483 . . . . 0.76 110.803 178.817 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 28' ' ' ARG . . . . . . . . . . . . . 1.1 ttp180 -61.32 -50.35 73.34 Favored 'General case' 0 N--CA 1.462 0.136 0 N-CA-C 109.896 -0.409 . . . . 1.35 109.896 178.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 83.6 mttt -56.26 -49.62 73.68 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 116.06 -0.518 . . . . 1.13 110.84 179.198 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 62.3 mt -62.41 -41.89 93.5 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 CA-C-N 116.297 -0.41 . . . . 1.11 110.4 179.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . 0.402 ' HA3' ' HA ' ' A' ' 244' ' ' ARG . . . -60.17 -49.56 77.26 Favored Glycine 0 CA--C 1.522 0.481 0 C-N-CA 120.768 -0.729 . . . . 0.28 112.123 179.043 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 57.9 m-20 -60.19 -44.58 94.98 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.098 0.475 . . . . 0.98 110.028 178.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 15.0 tppt? -62.01 -51.27 68.7 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 115.672 -0.695 . . . . 1.33 111.005 179.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 38.9 t -57.49 -41.66 79.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-O 120.785 0.326 . . . . 1.02 110.973 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -62.73 -43.84 97.77 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 120.984 0.421 . . . . 1.0 109.919 178.381 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 36' ' ' CYS . . . . . . . . . . . . . 55.7 m -66.13 -42.73 88.75 Favored 'General case' 0 C--O 1.224 -0.248 0 CA-C-N 116.095 -0.502 . . . . 2.22 111.248 179.094 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 98.6 m -61.78 -39.93 93.39 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 112.436 0.532 . . . . 1.22 112.436 179.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 38' ' ' TRP . . . . . . . . . . . . . 70.3 m95 -77.72 -29.03 51.04 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 112.562 0.578 . . . . 0.77 112.562 -179.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 37.1 p -87.54 -67.66 0.81 Allowed 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 120.943 0.401 . . . . 0.5 111.437 179.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . 0.441 ' HB2' ' HD2' ' B' ' 41' ' ' PRO . . . -90.86 161.12 36.67 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 116.085 -0.507 . . . . 0.56 111.165 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 41' ' ' PRO . . . . . 0.441 ' HD2' ' HB2' ' B' ' 40' ' ' ALA . 56.9 Cg_endo -71.64 58.07 2.51 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 122.44 2.094 . . . . 1.03 112.813 179.215 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -103.02 159.23 15.7 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 116.106 -0.497 . . . . 0.65 110.962 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 43' ' ' MET . . . . . . . . . . . . . 66.7 mtt . . . . . 0 C--O 1.251 1.138 0 CA-C-O 118.404 -0.808 . . . . 2.13 110.53 179.814 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.447 0 CA-C-O 119.907 -0.385 . . . . 2.67 112.41 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -74.13 62.86 5.12 Favored 'Trans proline' 0 CA--C 1.535 0.53 0 C-N-CA 122.763 2.309 . . . . 2.65 113.041 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 73.9 mt -93.75 112.03 23.83 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.231 -0.441 . . . . 2.53 111.165 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 115.83 77.89 0.71 Allowed Glycine 0 CA--C 1.52 0.346 0 C-N-CA 120.697 -0.763 . . . . 0.8 112.839 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 35.0 t -178.17 -62.58 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.815 0.34 . . . . 1.22 110.775 -179.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -60.66 -51.61 68.63 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.2 -0.454 . . . . 0.55 111.827 -179.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . 0.47 ' O ' ' HG3' ' A' ' 157' ' ' ARG . 15.4 t70 -58.11 -48.25 80.77 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 111.591 0.219 . . . . 0.72 111.591 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . 0.43 ' HA ' ' CZ ' ' A' ' 157' ' ' ARG . 17.8 m-20 -57.23 -49.09 77.12 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.684 0.278 . . . . 0.56 111.309 179.703 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 49.8 tp -66.22 -36.63 83.53 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 121.192 0.52 . . . . 1.41 109.911 178.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 76.4 t80 -63.78 -46.29 85.91 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.52 -0.763 . . . . 0.63 111.607 179.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.47 ' HG3' ' O ' ' A' ' 153' ' ' ASP . 79.1 mtm-85 -58.0 -44.94 87.5 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.665 0.269 . . . . 0.92 110.442 179.419 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . 0.403 ' HG3' ' O ' ' A' ' 154' ' ' ASP . 38.0 mt-30 -64.62 -42.73 95.31 Favored 'General case' 0 CA--C 1.529 0.141 0 N-CA-C 109.862 -0.422 . . . . 1.68 109.862 178.243 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 50.9 m -58.54 -53.03 62.93 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.892 -0.594 . . . . 0.28 111.282 179.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 24.4 tp -61.82 -44.48 96.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.27 -0.423 . . . . 0.78 111.131 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -60.87 -53.47 56.9 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.607 0.241 . . . . 0.42 110.772 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 77.5 mt -56.85 -50.8 73.96 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 CA-C-N 116.32 -0.4 . . . . 1.08 111.162 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.665 ' O ' ' HG ' ' A' ' 167' ' ' LEU . 63.0 mt -62.23 -51.31 73.9 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-N 116.701 -0.227 . . . . 0.99 111.394 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 29.3 t -56.62 -46.12 81.14 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 120.763 0.316 . . . . 0.34 111.063 179.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . 0.713 ' O ' ' HG2' ' A' ' 169' ' ' GLU . 6.6 mmm180 -67.59 -44.09 78.98 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.615 -0.266 . . . . 0.41 111.255 179.66 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' TYR . . . . . 0.971 ' HE1' ' HA ' ' A' ' 195' ' ' ARG . 49.3 t80 -59.3 -51.21 70.94 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 111.74 0.274 . . . . 0.45 111.74 -179.76 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.665 ' HG ' ' O ' ' A' ' 163' ' ' ILE . 20.3 mt -62.79 -38.27 89.98 Favored 'General case' 0 N--CA 1.462 0.161 0 N-CA-C 109.662 -0.496 . . . . 1.09 109.662 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 16.9 ttm180 -58.57 -41.34 85.44 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.805 -0.634 . . . . 0.39 111.529 179.308 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . 0.713 ' HG2' ' O ' ' A' ' 165' ' ' ARG . 4.2 mm-40 -67.91 -53.9 22.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.577 -0.283 . . . . 0.47 110.929 179.679 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . 0.605 HE22 ' HG3' ' A' ' 195' ' ' ARG . 1.2 mp0 -59.61 -36.9 77.22 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 120.754 0.311 . . . . 0.81 111.672 179.594 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . 0.407 ' HA ' ' CD ' ' A' ' 257' ' ' LYS . . . -70.86 -44.41 66.43 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 112.268 0.469 . . . . 0.45 112.268 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 37.9 p -77.92 -40.61 39.16 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 111.808 0.299 . . . . 0.72 111.808 -179.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 128.16 3.68 5.7 Favored Glycine 0 CA--C 1.524 0.626 0 C-N-CA 120.569 -0.824 . . . . 0.71 113.354 -179.453 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' SER . . . . . 0.664 ' HB2' ' HB3' ' A' ' 169' ' ' GLU . 0.9 OUTLIER -59.96 116.43 4.14 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 117.08 0.44 . . . . 0.79 111.118 179.447 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . 0.434 ' O ' ' HD2' ' A' ' 175' ' ' LYS . 0.8 OUTLIER -76.49 -33.81 58.64 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.054 -0.521 . . . . 1.75 111.699 -179.478 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -129.98 166.07 20.83 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.128 0.49 . . . . 0.63 112.142 -178.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' SER . . . . . 0.629 ' HB2' HH22 ' A' ' 195' ' ' ARG . 0.4 OUTLIER -175.33 121.0 0.2 Allowed 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 115.283 -0.871 . . . . 0.39 110.196 179.152 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -117.39 -44.62 0.05 OUTLIER Pre-proline 0 CA--C 1.549 0.928 0 N-CA-C 113.62 0.97 . . . . 0.58 113.62 -178.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -86.86 152.94 8.57 Favored 'Trans proline' 0 C--N 1.358 1.035 0 C-N-CA 121.868 1.712 . . . . 0.79 114.546 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 1.2 mp -141.9 -173.09 3.71 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 115.954 -0.566 . . . . 1.12 110.423 179.322 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -81.98 -73.15 1.22 Allowed Glycine 0 CA--C 1.521 0.438 0 C-N-CA 120.765 -0.731 . . . . 0.56 112.447 179.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 46.1 tt0 -105.81 -33.55 7.95 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.21 0.529 . . . . 0.83 109.838 179.142 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . 0.573 ' O ' ' HA3' ' A' ' 187' ' ' GLY . . . -84.65 68.69 10.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.225 0.536 . . . . 0.75 110.889 179.554 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -76.59 -70.14 1.32 Allowed Glycine 0 CA--C 1.524 0.6 0 C-N-CA 120.822 -0.704 . . . . 0.45 113.683 -179.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -66.09 -55.4 16.69 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.049 0.452 . . . . 0.57 111.95 -179.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -65.91 -39.11 90.26 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 116.134 -0.485 . . . . 0.57 110.563 179.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . 0.573 ' HA3' ' O ' ' A' ' 183' ' ' ALA . . . -66.37 -33.11 83.91 Favored Glycine 0 C--O 1.224 -0.469 0 C-N-CA 121.126 -0.559 . . . . 0.35 112.727 179.792 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 35.5 ttm180 -67.27 -50.97 58.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.768 0.318 . . . . 0.7 110.27 178.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . 0.721 ' HB3' HG12 ' A' ' 297' ' ' VAL . 49.9 mtm180 -64.18 -36.05 82.81 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.445 -0.343 . . . . 0.73 110.419 179.139 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . 0.401 ' HA ' HG22 ' A' ' 297' ' ' VAL . . . -70.97 -48.74 51.6 Favored 'General case' 0 C--O 1.216 -0.69 0 CA-C-N 116.093 -0.503 . . . . 0.35 111.435 179.356 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . 0.531 ' HB2' ' O ' ' A' ' 187' ' ' GLY . 0.2 OUTLIER -57.58 -51.57 68.93 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 120.711 0.291 . . . . 1.17 111.453 -179.899 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -59.57 -47.38 85.79 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.2 -0.455 . . . . 0.42 111.695 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 58.4 m -66.5 -48.34 70.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.869 0.366 . . . . 0.78 110.748 179.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 25.1 tp -60.63 -36.88 79.75 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.867 -0.606 . . . . 1.06 111.371 179.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . 0.971 ' HA ' ' HE1' ' A' ' 166' ' ' TYR . 35.4 ttm180 -64.69 -46.87 80.53 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.777 0.322 . . . . 0.57 110.668 178.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.76 -52.81 39.92 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.924 -0.58 . . . . 0.81 111.639 -179.774 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . 0.526 ' O ' HG21 ' A' ' 201' ' ' VAL . 55.4 t -67.15 -40.42 85.19 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 CA-C-O 120.974 0.416 . . . . 0.92 111.704 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . 0.57 ' HA3' ' HH ' ' A' ' 166' ' ' TYR . . . -66.11 -49.87 55.16 Favored Glycine 0 CA--C 1.52 0.387 0 C-N-CA 121.216 -0.516 . . . . 0.33 113.25 -179.628 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . 0.4 ' HB2' ' O ' ' A' ' 195' ' ' ARG . 0.8 OUTLIER -63.47 -34.09 76.99 Favored 'General case' 0 N--CA 1.462 0.172 0 N-CA-C 109.749 -0.463 . . . . 0.51 109.749 179.183 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -63.09 -39.77 98.41 Favored Glycine 0 C--N 1.335 0.522 0 C-N-CA 121.179 -0.534 . . . . 0.39 112.366 178.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . 0.526 HG21 ' O ' ' A' ' 197' ' ' VAL . 84.4 t -69.48 -43.13 80.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 CA-C-O 120.694 0.283 . . . . 0.58 110.857 179.078 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 202' ' ' GLN . . . . . 0.565 ' HG3' ' OG ' ' A' ' 250' ' ' SER . 34.2 mt-30 -59.12 -45.07 91.85 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.023 -0.535 . . . . 0.77 111.411 179.588 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 37.3 mtt180 -76.11 -24.68 54.97 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 116.304 -0.407 . . . . 0.77 111.817 179.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -78.12 -54.17 6.55 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.848 0.356 . . . . 0.66 111.753 179.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 33.6 m-70 -101.0 36.56 1.94 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.747 0.308 . . . . 0.85 110.465 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -55.28 -40.25 70.82 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 112.777 0.658 . . . . 0.6 112.777 -178.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 35.1 p -59.64 -53.82 53.62 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.026 0.441 . . . . 0.81 111.511 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -64.03 -42.74 96.99 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.048 -0.524 . . . . 0.66 110.56 178.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 2.3 m-30 -60.1 -48.94 79.61 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 115.963 -0.562 . . . . 0.63 110.958 179.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -57.24 -40.96 78.67 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 120.465 0.174 . . . . 0.7 111.449 179.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -57.39 -51.79 55.58 Favored Glycine 0 C--N 1.334 0.461 0 C-N-CA 120.507 -0.854 . . . . 0.42 111.513 178.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 212' ' ' MET . . . . . 0.482 ' O ' ' HB2' ' A' ' 216' ' ' LEU . 1.8 mpp? -69.76 -30.35 67.91 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 120.792 0.33 . . . . 1.16 110.669 178.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -61.45 -48.79 79.52 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.047 -0.524 . . . . 1.13 111.082 178.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 214' ' ' ARG . . . . . 0.439 HH11 ' HD3' ' A' ' 214' ' ' ARG . 27.7 mtt180 -69.64 -34.51 74.13 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.207 -0.451 . . . . 1.47 111.483 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 215' ' ' LYS . . . . . 0.45 ' HZ1' ' CD ' ' B' ' 18' ' ' GLU . 72.1 mmtt -80.0 -4.26 51.83 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 120.876 0.37 . . . . 1.46 111.477 179.613 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . 0.499 ' HG ' HG13 ' A' ' 218' ' ' ILE . 1.5 tp -98.7 85.97 3.44 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.178 0.513 . . . . 1.26 111.111 179.567 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -81.82 34.57 0.4 Allowed 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 116.208 -0.451 . . . . 1.01 110.947 179.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 218' ' ' ILE . . . . . 0.741 HG12 ' HB3' ' A' ' 223' ' ' ASP . 13.7 mt -45.25 116.4 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 N-CA-C 114.021 1.119 . . . . 1.09 114.021 -178.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 9.0 ptpp? -158.61 -9.81 0.07 Allowed 'General case' 0 CA--C 1.548 0.88 0 CA-C-N 115.083 -0.962 . . . . 0.78 112.595 178.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -134.0 175.37 9.53 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 113.547 0.943 . . . . 1.01 113.547 -179.204 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . 0.549 ' O ' ' HG2' ' A' ' 225' ' ' LYS . 4.9 mm-40 -58.23 -22.99 54.32 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 114.995 -1.002 . . . . 0.77 113.573 -179.257 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -77.8 -27.08 59.36 Favored Glycine 0 CA--C 1.526 0.739 0 C-N-CA 120.677 -0.773 . . . . 0.56 113.152 179.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 223' ' ' ASP . . . . . 0.741 ' HB3' HG12 ' A' ' 218' ' ' ILE . 36.4 m-20 -69.32 -44.14 72.31 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 111.879 0.325 . . . . 0.59 111.879 -179.123 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -62.25 -28.94 45.53 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 CA-C-O 121.022 0.439 . . . . 1.1 110.087 178.433 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . 0.549 ' HG2' ' O ' ' A' ' 221' ' ' GLU . 42.3 mmtm -69.3 -35.71 76.27 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 109.511 -0.551 . . . . 0.92 109.511 177.805 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 226' ' ' SER . . . . . 0.655 ' O ' HG21 ' A' ' 230' ' ' VAL . 41.2 t -70.79 -44.62 66.25 Favored 'General case' 0 N--CA 1.463 0.18 0 N-CA-C 109.291 -0.633 . . . . 1.02 109.291 178.024 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 227' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -58.82 -44.43 90.87 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 115.848 -0.615 . . . . 0.78 110.278 178.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 5.1 p -70.63 -34.29 71.93 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.123 -0.489 . . . . 1.28 110.3 178.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 5.8 ttt180 -63.58 -42.32 98.3 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.296 0.57 . . . . 3.62 110.304 178.048 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . 0.905 HG12 ' HA ' ' B' ' 24' ' ' ALA . 43.2 t -65.11 -38.89 83.87 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 N-CA-C 109.774 -0.454 . . . . 1.04 109.774 178.327 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 231' ' ' MET . . . . . 0.782 ' HG3' ' HG ' ' A' ' 248' ' ' LEU . 34.1 ttm -62.86 -51.11 68.28 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 115.896 -0.593 . . . . 1.14 111.79 179.65 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 31.7 m -60.96 -33.08 54.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 C-N-CA 121.053 -0.259 . . . . 1.21 111.593 -179.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 233' ' ' HIS . . . . . 0.531 ' CD2' ' HB1' ' B' ' 24' ' ' ALA . 17.1 t60 -67.31 -40.27 85.97 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 109.803 -0.443 . . . . 0.57 109.803 178.139 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . 0.53 HG23 ' O ' ' A' ' 230' ' ' VAL . 59.9 t -53.6 -47.86 60.14 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 CA-C-N 116.116 -0.493 . . . . 1.08 110.523 179.483 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -96.72 23.23 7.21 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.941 -0.572 . . . . 0.76 111.948 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 3.1 tmtm? -66.89 -17.06 64.72 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.878 0.37 . . . . 1.65 111.63 -179.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -80.55 -16.16 54.87 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.447 -0.342 . . . . 0.6 111.172 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 97.82 -17.72 58.37 Favored Glycine 0 CA--C 1.522 0.524 0 C-N-CA 120.744 -0.741 . . . . 0.46 113.661 179.323 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 6.8 p -89.63 120.28 38.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-O 121.454 0.645 . . . . 1.16 111.641 -179.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 32.8 m -94.34 99.62 11.8 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.006 0.431 . . . . 1.11 111.69 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . 0.446 ' HB2' ' HD2' ' A' ' 244' ' ' ARG . 90.4 m-20 -90.3 135.71 33.51 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.591 -0.277 . . . . 0.99 110.434 178.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 242' ' ' TRP . . . . . 0.506 ' CZ3' ' HB2' ' A' ' 296' ' ' PHE . 25.9 m95 -58.21 -40.6 82.03 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.823 0.344 . . . . 0.55 111.124 179.561 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . 0.494 ' HA3' ' N ' ' B' ' 35' ' ' TYR . . . -61.03 -30.32 73.2 Favored Glycine 0 C--N 1.332 0.359 0 C-N-CA 120.771 -0.728 . . . . 0.43 111.877 178.417 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 244' ' ' ARG . . . . . 0.467 ' HA ' ' HA3' ' B' ' 31' ' ' GLY . 74.3 mtt180 -69.25 -47.9 63.36 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.816 -0.439 . . . . 0.85 109.816 178.416 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . 0.458 ' O ' HG13 ' A' ' 249' ' ' ILE . 68.7 mt -59.15 -49.95 81.52 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.12 0 CA-C-N 115.523 -0.762 . . . . 1.11 111.294 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 7.3 p -66.13 -28.41 43.66 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 C-N-CA 120.727 -0.389 . . . . 1.01 111.133 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 19.3 m -65.15 -46.08 82.36 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 109.935 -0.395 . . . . 1.08 109.935 178.293 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 248' ' ' LEU . . . . . 0.782 ' HG ' ' HG3' ' A' ' 231' ' ' MET . 3.0 mm? -62.3 -39.58 93.45 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 116.106 -0.497 . . . . 1.18 110.582 178.814 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 249' ' ' ILE . . . . . 0.458 HG13 ' O ' ' A' ' 245' ' ' ILE . 17.6 mt -70.12 -40.96 78.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-O 120.929 0.395 . . . . 1.09 110.079 178.316 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 250' ' ' SER . . . . . 0.565 ' OG ' ' HG3' ' A' ' 202' ' ' GLN . 33.7 t -61.53 -44.89 96.23 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 109.553 -0.536 . . . . 1.66 109.553 178.257 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 251' ' ' PHE . . . . . . . . . . . . . 42.4 t80 -66.23 -38.57 88.2 Favored 'General case' 0 C--O 1.231 0.128 0 N-CA-C 109.097 -0.705 . . . . 0.66 109.097 177.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -60.61 -36.29 91.18 Favored Glycine 0 C--N 1.336 0.541 0 N-CA-C 111.199 -0.761 . . . . 0.3 111.199 177.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -68.18 -38.32 81.93 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-O 120.909 0.385 . . . . 0.45 110.031 177.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -65.13 -40.82 94.99 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 109.458 -0.571 . . . . 1.57 109.458 178.33 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 70.1 t -63.59 -44.21 98.5 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 CA-C-N 115.834 -0.621 . . . . 1.08 109.495 177.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -59.39 -32.37 70.09 Favored 'General case' 0 C--O 1.226 -0.163 0 CA-C-N 116.381 -0.372 . . . . 0.35 110.137 177.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 257' ' ' LYS . . . . . 0.407 ' CD ' ' HA ' ' A' ' 171' ' ' ALA . 43.5 tptt -63.82 -49.18 73.88 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.071 -0.513 . . . . 1.25 110.433 178.332 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -71.43 -32.59 68.53 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 120.888 0.375 . . . . 0.46 110.143 179.034 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . 0.5 ' HG ' ' HB3' ' A' ' 264' ' ' GLN . 1.6 tp -67.85 -40.21 83.69 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 121.204 0.526 . . . . 0.91 109.744 177.672 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 260' ' ' LYS . . . . . 0.439 ' HA ' ' HD2' ' A' ' 260' ' ' LYS . 45.3 tptt -70.65 -27.46 64.06 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.012 -0.54 . . . . 0.48 110.51 178.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 42.1 t -57.34 -28.55 63.23 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.436 -0.347 . . . . 0.94 110.583 178.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 16.1 m -113.15 14.78 8.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 CA-C-N 116.006 -0.543 . . . . 0.8 110.168 178.263 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 40.6 t30 54.73 45.07 27.49 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 115.208 -0.906 . . . . 0.5 112.967 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 264' ' ' GLN . . . . . 0.5 ' HB3' ' HG ' ' A' ' 259' ' ' LEU . 1.6 mt-30 -83.73 37.72 0.6 Allowed 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 120.761 0.315 . . . . 0.67 111.363 179.274 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -50.93 -42.15 59.42 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 112.665 0.617 . . . . 0.38 112.665 -179.069 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 1.3 p -62.24 -13.99 33.81 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.32 -0.4 . . . . 1.19 111.615 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 267' ' ' PHE . . . . . 0.485 ' C ' ' HD2' ' A' ' 270' ' ' PRO . 18.3 t80 -110.12 -22.91 11.56 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.347 -0.388 . . . . 0.79 110.372 178.345 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 268' ' ' ILE . . . . . 0.417 HG13 ' O ' ' A' ' 264' ' ' GLN . 72.1 mt -61.51 -46.49 96.47 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-N 116.387 -0.37 . . . . 1.12 110.554 178.712 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 269' ' ' GLU . . . . . 0.699 ' HB2' ' HD3' ' A' ' 270' ' ' PRO . 29.2 mm-40 -57.9 -56.57 33.35 Favored Pre-proline 0 CA--C 1.541 0.62 0 CA-C-N 116.576 -0.284 . . . . 0.34 110.785 178.562 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 270' ' ' PRO . . . . . 0.699 ' HD3' ' HB2' ' A' ' 269' ' ' GLU . 52.4 Cg_exo -57.97 -27.46 79.22 Favored 'Trans proline' 0 C--N 1.365 1.444 0 C-N-CA 122.402 2.068 . . . . 0.4 112.336 177.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 271' ' ' LEU . . . . . . . . . . . . . 20.9 tp -68.3 -53.06 26.9 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 108.959 -0.756 . . . . 1.13 108.959 177.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -61.31 -35.75 78.21 Favored 'General case' 0 C--O 1.23 0.075 0 N-CA-C 109.064 -0.717 . . . . 1.08 109.064 177.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 273' ' ' GLU . . . . . 0.424 ' HB3' ' HA ' ' A' ' 270' ' ' PRO . 32.4 tt0 -61.88 -48.62 79.69 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 114.939 -1.028 . . . . 1.62 109.852 177.605 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 274' ' ' THR . . . . . . . . . . . . . 89.0 m -62.49 -46.49 88.23 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.964 -0.562 . . . . 0.86 110.422 178.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 275' ' ' ILE . . . . . 0.524 ' HA ' ' HE2' ' A' ' 231' ' ' MET . 95.5 mt -56.59 -54.61 26.64 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-N 116.116 -0.493 . . . . 1.13 110.572 178.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 19.2 m -57.95 -52.4 65.68 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.603 -0.726 . . . . 0.54 111.577 179.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 277' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -51.23 -54.44 25.64 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.072 -0.513 . . . . 0.4 111.482 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 87.6 t -64.41 -39.29 85.03 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-N 116.381 -0.372 . . . . 1.01 111.804 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . 0.458 ' O ' ' HB2' ' A' ' 283' ' ' LYS . 1.0 OUTLIER -67.65 -41.07 84.39 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 120.942 0.401 . . . . 1.68 111.364 -179.926 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 76.2 t -77.08 -46.02 29.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 112.394 0.516 . . . . 0.77 112.394 -179.245 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 67.3 mtp180 -65.6 -35.67 81.5 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 112.997 0.74 . . . . 0.95 112.997 -178.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 282' ' ' THR . . . . . . . . . . . . . 60.4 p -83.49 -15.88 47.78 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 122.13 -0.356 . . . . 1.0 111.923 179.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . 0.575 ' HB3' HD23 ' A' ' 287' ' ' LEU . 0.1 OUTLIER -123.21 39.76 3.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.746 0.307 . . . . 0.76 110.915 179.866 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 33.9 ttm180 -52.36 -61.43 2.28 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 112.666 0.617 . . . . 0.74 112.666 -179.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -64.77 -38.87 92.45 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 112.527 0.565 . . . . 0.84 112.527 -179.219 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 286' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -65.44 -41.36 93.56 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.805 0.336 . . . . 0.86 111.817 -179.23 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 287' ' ' LEU . . . . . 0.575 HD23 ' HB3' ' A' ' 283' ' ' LYS . 1.7 mm? -70.0 -41.63 74.09 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.468 0.544 . . . . 1.25 112.468 -179.174 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 20.4 m -67.02 -35.76 75.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 C-N-CA 120.799 -0.36 . . . . 1.07 111.899 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 47.4 mttp -69.99 -39.56 75.82 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 112.677 0.621 . . . . 1.64 112.677 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -89.92 20.17 4.37 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 113.405 0.891 . . . . 0.6 113.405 -178.038 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 42.9 mtm180 60.42 15.33 5.42 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 112.916 0.709 . . . . 0.56 112.916 179.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 292' ' ' GLY . . . . . 0.435 ' HA2' HD12 ' A' ' 287' ' ' LEU . . . 66.59 -124.42 24.31 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 114.274 0.47 . . . . 0.4 114.274 179.445 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 293' ' ' TRP . . . . . 0.518 ' O ' HG21 ' A' ' 297' ' ' VAL . 89.2 m95 -63.85 -30.37 71.47 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.334 0.494 . . . . 0.45 112.334 -178.809 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 294' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.88 -43.45 94.73 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.836 -0.346 . . . . 0.74 110.623 178.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -67.9 -37.89 88.53 Favored Glycine 0 C--N 1.333 0.406 0 C-N-CA 120.56 -0.828 . . . . 0.35 111.073 177.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 296' ' ' PHE . . . . . 0.506 ' HB2' ' CZ3' ' A' ' 242' ' ' TRP . 0.3 OUTLIER -62.43 -45.81 91.41 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 120.936 0.398 . . . . 0.57 110.48 178.413 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 297' ' ' VAL . . . . . 0.721 HG12 ' HB3' ' A' ' 189' ' ' ARG . 80.3 t -63.58 -49.82 80.83 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.23 0 CA-C-N 115.855 -0.611 . . . . 1.07 110.898 179.749 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 71.6 mt-10 -61.96 -45.21 94.65 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.245 -0.434 . . . . 0.59 111.777 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 299' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -60.01 -49.48 77.51 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 120.87 0.367 . . . . 0.72 111.678 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 300' ' ' PHE . . . . . 0.476 ' HB3' HG23 ' A' ' 197' ' ' VAL . 59.3 m-85 -80.3 4.86 16.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.009 0.433 . . . . 0.62 111.3 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 301' ' ' HIS . . . . . 0.699 ' HB2' ' O ' ' A' ' 297' ' ' VAL . 1.6 t-160 -99.91 39.86 1.29 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.293 -0.412 . . . . 1.15 110.692 178.609 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . 0.558 ' HB ' ' HA ' ' B' ' 41' ' ' PRO . 6.0 m -80.16 10.9 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 CA-C-N 116.361 -0.381 . . . . 1.75 111.559 179.529 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -103.48 -84.43 0.47 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.105 0.478 . . . . 1.52 111.187 -179.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -85.67 108.22 17.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.394 0.616 . . . . 0.92 111.11 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 76.9 mt -85.01 -55.1 4.23 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.709 -0.678 . . . . 2.06 111.277 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 6.6 mp0 -72.25 -34.22 68.09 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 116.398 -0.365 . . . . 3.29 111.65 179.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . 118.75 -147.93 18.42 Favored Glycine 0 CA--C 1.522 0.522 0 C-N-CA 120.777 -0.725 . . . . 3.84 113.227 179.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.432 -1.205 . . . . 4.16 113.123 -179.858 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.495 0 CA-C-O 120.444 0.164 . . . . 2.69 110.944 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 18' ' ' GLU . . . . . 0.45 ' CD ' ' HZ1' ' A' ' 215' ' ' LYS . 1.0 OUTLIER -139.99 -66.81 0.44 Allowed 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 120.942 0.401 . . . . 1.73 111.026 -179.95 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 19' ' ' LEU . . . . . 0.438 HD12 ' HG3' ' A' ' 215' ' ' LYS . 64.3 tp -100.91 109.39 57.92 Favored Pre-proline 0 CA--C 1.534 0.365 0 CA-C-O 120.929 0.395 . . . . 1.76 111.317 179.695 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 20' ' ' PRO . . . . . 0.472 ' C ' ' H ' ' B' ' 22' ' ' GLU . 97.9 Cg_endo -79.47 157.05 25.38 Favored 'Trans proline' 0 CA--C 1.534 0.519 0 C-N-CA 122.628 2.218 . . . . 0.99 112.387 179.648 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 21' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -68.8 31.66 0.16 Allowed 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 122.789 2.326 . . . . 0.87 113.482 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 22' ' ' GLU . . . . . 0.472 ' H ' ' C ' ' B' ' 20' ' ' PRO . 4.8 mm-40 -88.94 -12.57 41.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.268 -0.424 . . . . 0.75 111.407 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 23' ' ' PHE . . . . . . . . . . . . . 10.3 p90 -63.64 -35.39 80.37 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.18 0.515 . . . . 0.77 110.747 179.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 24' ' ' ALA . . . . . 0.905 ' HA ' HG12 ' A' ' 230' ' ' VAL . . . -72.11 -43.98 63.91 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.639 -0.71 . . . . 0.64 110.623 179.178 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -69.73 -37.03 76.35 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.147 -0.479 . . . . 0.58 110.532 179.108 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 26' ' ' GLN . . . . . 0.465 ' HB2' ' O ' ' B' ' 22' ' ' GLU . 0.0 OUTLIER -61.73 -54.84 37.07 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 116.481 -0.327 . . . . 0.71 111.174 179.514 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . 0.444 HD11 HG11 ' A' ' 230' ' ' VAL . 30.9 mt -58.06 -37.32 74.22 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 120.863 0.363 . . . . 1.09 110.197 178.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 28' ' ' ARG . . . . . 0.509 ' HA ' HG12 ' A' ' 234' ' ' VAL . 4.8 tmt_? -62.6 -53.69 50.81 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 109.26 -0.644 . . . . 1.55 109.26 177.55 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 21.3 mtmt -53.7 -48.95 69.06 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.858 -0.61 . . . . 0.99 110.582 178.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . 0.446 HG13 ' O ' ' B' ' 26' ' ' GLN . 75.5 mt -59.07 -42.28 85.97 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.202 0 CA-C-N 116.057 -0.52 . . . . 1.05 110.123 179.129 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . 0.467 ' HA3' ' HA ' ' A' ' 244' ' ' ARG . . . -58.76 -50.15 70.32 Favored Glycine 0 CA--C 1.521 0.421 0 C-N-CA 120.886 -0.673 . . . . 0.36 112.398 178.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 32' ' ' ASP . . . . . 0.476 ' OD2' ' HD3' ' B' ' 28' ' ' ARG . 9.1 m-20 -61.84 -40.12 94.2 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.14 0.495 . . . . 0.43 110.145 178.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 15.6 tppt? -64.0 -53.82 44.01 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 115.74 -0.663 . . . . 1.73 111.101 179.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 77.3 t -59.13 -39.03 77.58 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-O 121.067 0.461 . . . . 1.04 110.48 179.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 35' ' ' TYR . . . . . 0.494 ' N ' ' HA3' ' A' ' 243' ' ' GLY . 4.0 t80 -60.55 -50.44 73.55 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.898 -0.592 . . . . 0.93 110.467 178.479 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 36' ' ' CYS . . . . . . . . . . . . . 61.5 m -64.25 -25.82 68.23 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.009 0.433 . . . . 0.7 110.983 179.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 20.9 m -75.36 -43.14 52.05 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 116.022 -0.536 . . . . 0.9 112.259 -179.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 38' ' ' TRP . . . . . . . . . . . . . 97.2 m95 -87.9 -9.78 52.67 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 113.249 0.833 . . . . 0.76 113.249 -178.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 38.2 t -73.18 -15.84 61.44 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 111.731 0.271 . . . . 0.78 111.731 179.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -91.91 126.66 52.73 Favored Pre-proline 0 CA--C 1.534 0.346 0 CA-C-N 116.555 -0.293 . . . . 0.87 111.673 179.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 41' ' ' PRO . . . . . 0.558 ' HA ' ' HB ' ' A' ' 302' ' ' VAL . 73.3 Cg_endo -77.16 65.92 7.83 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 122.452 2.102 . . . . 1.88 112.826 179.492 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -121.37 -170.31 2.01 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 116.253 -0.43 . . . . 2.52 111.559 -179.322 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 43' ' ' MET . . . . . . . . . . . . . 61.7 mtt . . . . . 0 C--O 1.251 1.154 0 CA-C-O 118.149 -0.929 . . . . 4.44 111.939 -179.754 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.768 ' HA3' ' HA ' ' A' ' 153' ' ' ASP . . . . . . . . 0 N--CA 1.487 2.099 0 N-CA-C 112.568 -0.213 . . . . 0.95 112.568 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . 0.505 ' HD2' ' OE1' ' A' ' 152' ' ' GLU . 27.1 Cg_exo -63.44 -39.63 35.67 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 122.883 2.389 . . . . 1.64 113.556 179.666 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -97.81 151.65 19.98 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.84 0.352 . . . . 2.61 111.817 -179.256 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -58.46 -63.11 5.53 Favored Glycine 0 C--N 1.335 0.511 0 C-N-CA 121.15 -0.548 . . . . 1.34 112.288 179.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 14.7 p -77.09 52.93 0.92 Allowed 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.449 0.643 . . . . 1.34 110.365 178.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.505 ' OE1' ' HD2' ' A' ' 148' ' ' PRO . 8.6 tt0 -164.39 -34.37 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.277 -0.874 . . . . 1.29 110.935 -179.006 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . 0.768 ' HA ' ' HA3' ' A' ' 147' ' ' GLY . 33.0 t70 -46.85 -52.72 13.64 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 112.454 0.538 . . . . 0.64 112.454 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.93 -55.54 33.8 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.123 0.487 . . . . 0.83 111.121 179.758 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.447 HD22 ' HB3' ' A' ' 287' ' ' LEU . 26.4 tp -58.63 -42.35 88.09 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.91 -0.587 . . . . 0.7 112.251 179.616 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 68.3 t80 -69.01 -47.04 66.48 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 112.399 0.518 . . . . 0.6 112.399 -179.219 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 60.9 mtp180 -61.21 -40.23 93.22 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 111.744 0.276 . . . . 0.8 111.744 -179.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 2.8 mm-40 -68.57 -44.29 74.76 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.891 0.377 . . . . 0.72 110.183 179.14 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 34.1 m -63.69 -49.35 73.47 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.949 -0.568 . . . . 0.36 111.346 179.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.517 ' HA ' HG21 ' A' ' 276' ' ' THR . 11.1 tp -55.68 -49.49 72.81 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 111.871 0.323 . . . . 0.68 111.871 -179.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . 0.706 ' O ' ' HG2' ' A' ' 165' ' ' ARG . 0.0 OUTLIER -58.64 -53.72 55.2 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-O 120.625 0.25 . . . . 0.54 111.152 179.806 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . 0.496 HG12 ' HA2' ' A' ' 187' ' ' GLY . 83.3 mt -58.54 -46.95 89.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-N 116.416 -0.356 . . . . 0.88 111.683 -179.711 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.475 HD12 HG22 ' A' ' 276' ' ' THR . 71.7 mt -62.74 -45.51 98.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 CA-C-N 116.446 -0.343 . . . . 1.11 110.716 179.643 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' SER . . . . . 0.535 ' O ' ' HB2' ' A' ' 168' ' ' ARG . 51.1 m -57.87 -41.38 82.36 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.482 -0.326 . . . . 0.34 110.332 178.346 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . 0.706 ' HG2' ' O ' ' A' ' 161' ' ' GLU . 13.5 mmt180 -65.11 -54.8 24.34 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.493 -0.321 . . . . 0.66 111.33 179.612 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' TYR . . . . . 0.813 ' HE1' ' HA ' ' A' ' 195' ' ' ARG . 65.2 t80 -60.93 -51.26 70.02 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 113.036 0.754 . . . . 0.57 113.036 -178.063 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.455 HD12 HG22 ' A' ' 163' ' ' ILE . 9.2 mp -60.43 -39.87 89.03 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.879 -0.329 . . . . 1.11 111.056 -179.078 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . 0.535 ' HB2' ' O ' ' A' ' 164' ' ' SER . 3.9 mmt180 -68.7 -42.8 77.25 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 120.881 0.372 . . . . 0.61 111.126 178.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . 0.559 ' CD ' HH21 ' A' ' 195' ' ' ARG . 63.5 mt-10 -65.33 -48.67 72.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.019 0.437 . . . . 0.42 111.447 178.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . 0.645 ' HB3' ' HB1' ' A' ' 253' ' ' ALA . 7.4 tp60 -65.71 -37.3 86.05 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.137 -0.483 . . . . 0.39 111.821 -179.355 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . 0.451 ' HA ' ' HA ' ' A' ' 257' ' ' LYS . . . -65.77 -30.78 71.48 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.787 0.327 . . . . 0.81 111.396 179.083 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' THR . . . . . 0.507 HG21 ' HD3' ' A' ' 260' ' ' LYS . 16.6 p -91.97 -41.34 10.62 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.259 0.466 . . . . 0.92 112.259 -179.612 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 113.4 3.48 24.1 Favored Glycine 0 CA--C 1.524 0.623 0 C-N-CA 120.95 -0.643 . . . . 0.54 112.622 -179.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -84.86 127.58 34.22 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.889 0.376 . . . . 0.74 111.624 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . 0.408 ' HZ2' ' CG ' ' A' ' 199' ' ' ASP . 65.4 mttm -130.18 44.1 3.02 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.446 0.641 . . . . 1.15 111.227 179.789 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . 0.423 ' HB2' ' H ' ' A' ' 177' ' ' SER . 0.3 OUTLIER -90.54 -135.33 0.12 Allowed 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 115.472 -0.785 . . . . 0.68 111.386 179.815 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' SER . . . . . 0.423 ' H ' ' HB2' ' A' ' 176' ' ' ASP . 29.5 t -137.42 116.57 12.56 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.973 0.416 . . . . 1.84 111.181 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 52.1 mttp -115.78 141.96 28.29 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 116.069 -0.514 . . . . 0.99 111.407 -179.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.85 130.04 16.27 Favored 'Trans proline' 0 CA--C 1.536 0.622 0 C-N-CA 122.647 2.232 . . . . 1.38 113.243 179.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.421 ' HA ' ' NH2' ' A' ' 165' ' ' ARG . 3.1 mm? -92.34 159.26 15.67 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.049 -0.523 . . . . 1.2 110.816 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -119.46 -51.63 0.28 Allowed Glycine 0 CA--C 1.523 0.538 0 C-N-CA 120.358 -0.925 . . . . 0.71 113.355 -179.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . 0.641 ' HB2' ' HG3' ' A' ' 161' ' ' GLU . 5.0 mm-40 -85.55 -38.37 18.58 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.98 0.419 . . . . 0.69 111.476 -179.516 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . 0.547 ' O ' ' HA3' ' A' ' 187' ' ' GLY . . . -123.13 83.3 2.11 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.177 -0.465 . . . . 1.13 111.062 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -74.81 -71.15 1.16 Allowed Glycine 0 CA--C 1.528 0.849 0 C-N-CA 120.552 -0.832 . . . . 0.64 114.255 -179.341 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -62.31 -55.29 29.61 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-O 121.06 0.457 . . . . 0.78 111.736 -179.161 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -63.78 -40.27 96.27 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.915 -0.584 . . . . 0.98 110.672 179.172 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . 0.547 ' HA3' ' O ' ' A' ' 183' ' ' ALA . . . -64.3 -40.41 97.87 Favored Glycine 0 C--N 1.333 0.4 0 C-N-CA 121.261 -0.495 . . . . 0.39 113.592 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 62.7 ttt180 -62.89 -51.3 67.51 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 117.269 0.534 . . . . 1.71 110.759 179.198 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 48.4 mtm180 -67.54 -31.56 71.74 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 116.112 -0.494 . . . . 0.57 111.033 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . 0.509 ' HA ' ' CG1' ' A' ' 297' ' ' VAL . . . -71.29 -40.43 70.89 Favored 'General case' 0 C--O 1.222 -0.368 0 CA-C-N 116.282 -0.417 . . . . 1.06 110.943 178.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 20.0 tp -63.36 -47.15 83.31 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 111.589 0.218 . . . . 1.21 111.589 179.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 6.0 tm-20 -60.17 -45.37 93.33 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.291 0.567 . . . . 0.44 110.267 179.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' THR . . . . . 0.631 HG21 ' HA ' ' A' ' 297' ' ' VAL . 27.8 m -65.68 -47.19 76.3 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.762 -0.654 . . . . 0.94 110.665 179.284 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 7.0 tp -61.07 -41.75 97.22 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 116.032 -0.531 . . . . 1.02 110.678 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . 0.813 ' HA ' ' HE1' ' A' ' 166' ' ' TYR . 50.5 mtt180 -59.38 -58.44 8.6 Favored 'General case' 0 C--O 1.226 -0.136 0 CA-C-O 120.774 0.321 . . . . 0.78 110.172 178.319 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 8.5 ttm180 -57.77 -56.34 23.16 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.654 -0.703 . . . . 0.6 112.714 -179.028 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . 0.472 ' O ' HG21 ' A' ' 201' ' ' VAL . 58.6 t -62.3 -41.71 92.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-O 120.87 0.367 . . . . 0.98 111.021 -179.395 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . 0.626 ' HA3' ' HH ' ' A' ' 166' ' ' TYR . . . -63.21 -46.85 92.16 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 120.86 -0.686 . . . . 0.29 111.939 179.174 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . 0.408 ' CG ' ' HZ2' ' A' ' 175' ' ' LYS . 51.3 m-20 -55.74 -45.56 77.98 Favored 'General case' 0 N--CA 1.462 0.163 0 N-CA-C 109.509 -0.552 . . . . 0.36 109.509 178.114 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -58.69 -54.31 38.96 Favored Glycine 0 C--O 1.223 -0.573 0 CA-C-N 115.633 -0.712 . . . . 0.31 111.921 178.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . 0.472 HG21 ' O ' ' A' ' 197' ' ' VAL . 57.5 t -59.58 -42.3 87.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 CA-C-O 120.787 0.327 . . . . 0.52 111.701 179.279 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 202' ' ' GLN . . . . . 0.441 ' HG2' ' HD1' ' A' ' 254' ' ' PHE . 5.9 mt-30 -64.3 -52.47 58.39 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 112.444 0.535 . . . . 0.58 112.444 -179.389 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 203' ' ' ARG . . . . . 0.421 HH11 ' HD3' ' A' ' 203' ' ' ARG . 2.8 mmp_? -69.37 -35.18 75.58 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.743 0.306 . . . . 0.71 111.475 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -68.53 -48.27 64.75 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.995 0.426 . . . . 0.44 110.819 179.105 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 -100.69 32.95 2.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.007 0.432 . . . . 0.66 110.818 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -56.72 -46.72 81.14 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.607 -0.724 . . . . 0.42 112.148 -179.167 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 58.4 p -60.46 -45.62 93.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.994 0.426 . . . . 0.82 111.176 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -65.94 -41.88 90.74 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.844 -0.616 . . . . 0.44 110.886 179.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 7.8 m-30 -66.17 -44.34 84.33 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.521 -0.309 . . . . 0.64 110.573 179.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -64.71 -44.52 89.98 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.532 -0.303 . . . . 1.5 110.616 178.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -60.51 -44.67 97.46 Favored Glycine 0 C--N 1.336 0.549 0 C-N-CA 120.749 -0.739 . . . . 0.38 111.28 178.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 28.1 ttm -66.3 -40.87 90.28 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 121.022 0.439 . . . . 1.13 109.935 178.248 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 12.9 tp -59.36 -42.54 91.83 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.596 -0.729 . . . . 1.05 111.718 179.177 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 77.1 mtp180 -74.28 -28.71 61.33 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.401 -0.363 . . . . 1.08 111.741 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 49.4 mtmt -76.33 -34.19 58.99 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 120.823 0.344 . . . . 1.41 110.69 178.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . 0.563 ' HA ' HD11 ' B' ' 19' ' ' LEU . 81.6 mt -67.84 136.39 54.04 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 121.11 0.481 . . . . 1.22 111.795 179.499 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -101.28 30.97 3.89 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.11 -0.495 . . . . 0.71 110.485 179.31 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 218' ' ' ILE . . . . . 0.523 HG12 ' HB3' ' A' ' 216' ' ' LEU . 20.0 mm -59.17 119.86 4.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-N 115.8 -0.636 . . . . 1.19 111.316 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 19.3 mtmm -149.04 -30.99 0.24 Allowed 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 113.178 0.807 . . . . 1.49 113.178 -179.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -125.18 174.67 7.92 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.748 0.647 . . . . 0.51 112.748 -178.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . 0.464 ' O ' HG21 ' A' ' 224' ' ' VAL . 1.0 OUTLIER -62.35 -28.77 69.99 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 115.732 -0.667 . . . . 0.59 111.302 -179.949 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -61.88 -25.59 66.08 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 121.351 -0.452 . . . . 0.36 113.268 179.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 -58.43 -28.34 65.17 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 113.226 0.824 . . . . 0.36 113.226 -179.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . 0.541 ' HB ' HG22 ' A' ' 274' ' ' THR . 25.8 m -54.0 -29.78 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 N-CA-C 112.908 0.707 . . . . 1.04 112.908 -179.237 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 33.4 mtmm -64.89 -43.39 93.04 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-O 121.415 0.626 . . . . 1.14 110.075 178.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 15.5 m -70.34 -38.65 74.88 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.309 -0.86 . . . . 0.79 109.715 178.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 227' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -59.63 -38.82 82.39 Favored 'General case' 0 CA--C 1.528 0.13 0 N-CA-C 108.791 -0.818 . . . . 0.75 108.791 177.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 49.8 m -62.32 -41.19 98.33 Favored 'General case' 0 CA--C 1.528 0.101 0 CA-C-N 115.426 -0.806 . . . . 0.5 109.989 177.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.2 -40.93 78.41 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.33 -0.395 . . . . 2.47 110.371 178.592 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . 0.503 ' O ' HG23 ' A' ' 234' ' ' VAL . 13.4 t -61.97 -51.3 74.18 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-N 116.466 -0.334 . . . . 0.85 110.139 178.679 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 231' ' ' MET . . . . . 0.517 ' HE1' ' HA ' ' A' ' 275' ' ' ILE . 38.9 mtp -58.84 -47.63 84.18 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.146 -0.479 . . . . 1.03 111.116 179.41 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 75.6 t -63.92 -41.0 91.07 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 CA-C-N 116.34 -0.391 . . . . 1.29 110.907 179.19 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 31.8 t-80 -64.58 -37.56 87.97 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 116.414 -0.357 . . . . 0.79 110.975 178.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . 0.503 HG23 ' O ' ' A' ' 230' ' ' VAL . 53.1 t -63.2 -51.61 69.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-O 120.794 0.331 . . . . 0.99 111.736 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -90.37 24.56 2.53 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 112.159 0.429 . . . . 0.67 112.159 -178.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 1.8 tmtm? -66.69 -15.37 63.46 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 112.537 0.569 . . . . 1.63 112.537 -179.25 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 44.8 p30 -85.27 -16.21 40.88 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 120.767 0.318 . . . . 0.59 111.497 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 94.38 -0.84 66.22 Favored Glycine 0 CA--C 1.524 0.636 0 C-N-CA 121.088 -0.577 . . . . 0.58 113.262 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . 0.477 ' HB ' ' NH1' ' A' ' 244' ' ' ARG . 25.6 t -93.44 109.84 22.43 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-O 121.092 0.472 . . . . 1.06 111.584 -179.597 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 240' ' ' THR . . . . . 0.606 HG22 HD13 ' A' ' 245' ' ' ILE . 21.2 m -94.11 76.74 4.06 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.951 0.405 . . . . 1.38 111.582 179.718 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . 0.409 ' HB2' ' HD2' ' A' ' 244' ' ' ARG . 59.3 m-20 -77.05 140.3 40.28 Favored 'General case' 0 C--N 1.329 -0.307 0 O-C-N 122.206 -0.309 . . . . 0.87 110.943 179.194 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 242' ' ' TRP . . . . . 0.532 ' HB3' ' CE2' ' A' ' 300' ' ' PHE . 47.8 m95 -56.32 -40.95 75.24 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.813 0.34 . . . . 0.7 110.871 179.275 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . 0.408 ' HA2' HG12 ' A' ' 246' ' ' VAL . . . -62.98 -28.82 72.65 Favored Glycine 0 C--N 1.334 0.466 0 C-N-CA 121.168 -0.539 . . . . 0.27 112.028 178.49 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 244' ' ' ARG . . . . . 0.477 ' NH1' ' HB ' ' A' ' 239' ' ' VAL . 89.7 mtt180 -74.44 -42.39 59.21 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.659 -0.497 . . . . 0.61 109.659 178.779 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . 0.606 HD13 HG22 ' A' ' 240' ' ' THR . 67.8 mt -63.81 -52.71 53.63 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 CA-C-N 115.903 -0.589 . . . . 1.0 110.377 178.771 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . 0.408 HG12 ' HA2' ' A' ' 243' ' ' GLY . 6.8 p -62.63 -29.76 47.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 CA-C-N 116.287 -0.415 . . . . 1.05 110.836 179.43 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 11.1 m -65.93 -44.49 84.98 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 109.743 -0.465 . . . . 0.73 109.743 177.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -64.42 -40.65 96.18 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 109.832 -0.432 . . . . 1.08 109.832 178.035 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 249' ' ' ILE . . . . . 0.44 HG12 ' O ' ' A' ' 245' ' ' ILE . 48.7 mm -64.05 -43.06 97.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 CA-C-O 121.052 0.453 . . . . 1.13 109.868 178.162 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 56.2 m -62.32 -42.61 99.52 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 115.846 -0.615 . . . . 0.4 109.6 178.313 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 251' ' ' PHE . . . . . . . . . . . . . 18.2 t80 -62.77 -42.99 99.94 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 116.008 -0.542 . . . . 0.63 109.675 178.079 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -57.82 -46.61 92.15 Favored Glycine 0 C--N 1.335 0.521 0 N-CA-C 111.386 -0.686 . . . . 0.3 111.386 178.165 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 253' ' ' ALA . . . . . 0.645 ' HB1' ' HB3' ' A' ' 170' ' ' GLN . . . -68.19 -27.77 66.68 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 120.661 0.267 . . . . 0.8 111.483 178.261 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 254' ' ' PHE . . . . . 0.441 ' HD1' ' HG2' ' A' ' 202' ' ' GLN . 26.6 t80 -74.81 -48.51 24.91 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 120.626 0.25 . . . . 0.81 111.047 179.3 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 255' ' ' VAL . . . . . 0.526 ' O ' ' HG ' ' A' ' 259' ' ' LEU . 23.6 m -64.18 -37.75 80.69 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.129 0 C-N-CA 120.503 -0.479 . . . . 0.55 109.751 178.454 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -67.36 -32.15 72.88 Favored 'General case' 0 C--N 1.341 0.199 0 CA-C-N 116.342 -0.39 . . . . 0.36 110.497 178.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 257' ' ' LYS . . . . . 0.537 ' HE2' ' HG3' ' A' ' 170' ' ' GLN . 28.0 ttmt -61.94 -46.99 86.88 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 109.048 -0.723 . . . . 0.9 109.048 177.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 82.9 t60 -66.0 -40.47 91.15 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 115.356 -0.838 . . . . 0.73 109.445 177.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . 0.634 ' HB3' ' HB2' ' A' ' 264' ' ' GLN . 95.0 mt -62.89 -36.39 83.18 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.104 -0.498 . . . . 1.12 110.591 178.438 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 260' ' ' LYS . . . . . 0.507 ' HD3' HG21 ' A' ' 172' ' ' THR . 0.3 OUTLIER -65.54 -37.36 86.52 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 110.134 -0.321 . . . . 0.46 110.134 178.47 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 15.9 p -64.2 -24.62 67.74 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.839 0.352 . . . . 0.53 110.7 178.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 7.3 p -107.09 8.15 9.62 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 CA-C-O 121.592 0.71 . . . . 1.21 110.328 178.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 6.5 t30 59.13 49.31 9.45 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 113.7 1.0 . . . . 0.66 113.7 179.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 264' ' ' GLN . . . . . 0.634 ' HB2' ' HB3' ' A' ' 259' ' ' LEU . 4.0 mm100 -92.24 35.19 1.0 Allowed 'General case' 0 N--CA 1.47 0.532 0 O-C-N 122.082 -0.386 . . . . 0.66 111.352 178.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -47.52 -43.94 25.28 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 112.594 0.591 . . . . 0.45 112.594 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 86.8 p -59.11 -18.13 32.74 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 116.326 -0.397 . . . . 0.77 111.749 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 267' ' ' PHE . . . . . 0.435 ' CE1' ' HA ' ' A' ' 221' ' ' GLU . 53.8 t80 -107.77 -28.62 9.57 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 116.653 -0.249 . . . . 0.71 111.073 178.723 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 73.9 mt -57.13 -49.97 77.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 CA-C-O 120.575 0.226 . . . . 1.07 111.474 179.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 269' ' ' GLU . . . . . 0.446 ' HB2' ' HD3' ' A' ' 270' ' ' PRO . 2.5 mp0 -58.6 -56.86 31.27 Favored Pre-proline 0 CA--C 1.543 0.707 0 C-N-CA 121.128 -0.229 . . . . 0.4 111.542 179.431 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 270' ' ' PRO . . . . . 0.446 ' HD3' ' HB2' ' A' ' 269' ' ' GLU . 45.1 Cg_exo -59.37 -29.83 91.18 Favored 'Trans proline' 0 C--N 1.361 1.198 0 C-N-CA 122.369 2.046 . . . . 0.37 112.854 178.57 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 271' ' ' LEU . . . . . . . . . . . . . 56.6 tp -67.72 -49.38 62.96 Favored 'General case' 0 N--CA 1.464 0.225 0 N-CA-C 109.914 -0.402 . . . . 1.0 109.914 178.452 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -60.17 -37.21 79.47 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.113 -0.494 . . . . 0.6 110.217 178.454 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 273' ' ' GLU . . . . . 0.442 ' O ' ' HB2' ' A' ' 277' ' ' ASP . 32.0 tt0 -67.05 -43.12 83.51 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 109.462 -0.57 . . . . 1.11 109.462 178.109 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 274' ' ' THR . . . . . 0.541 HG22 ' HB ' ' A' ' 224' ' ' VAL . 70.1 m -61.47 -49.29 77.39 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.104 -0.498 . . . . 1.09 110.348 178.216 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 275' ' ' ILE . . . . . 0.517 ' HA ' ' HE1' ' A' ' 231' ' ' MET . 96.8 mt -55.37 -54.16 28.04 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.123 0 CA-C-N 115.775 -0.648 . . . . 1.13 110.763 179.419 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 276' ' ' THR . . . . . 0.517 HG21 ' HA ' ' A' ' 160' ' ' LEU . 15.9 m -57.69 -46.75 83.89 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 120.918 0.39 . . . . 0.79 110.993 179.433 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 277' ' ' ASP . . . . . 0.442 ' HB2' ' O ' ' A' ' 273' ' ' GLU . 0.4 OUTLIER -54.65 -59.92 4.06 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 115.685 -0.689 . . . . 0.59 110.966 179.345 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 57.3 t -60.38 -39.48 81.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 CA-C-O 120.812 0.339 . . . . 0.59 111.418 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . 0.539 HD11 HG22 ' A' ' 245' ' ' ILE . 15.8 tp -61.32 -47.59 85.23 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.564 -0.289 . . . . 1.34 111.151 179.568 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 80.2 t -73.04 -42.89 59.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 120.928 -0.309 . . . . 1.08 111.556 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 80.6 mtt-85 -60.92 -34.48 74.77 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 112.458 0.54 . . . . 1.46 112.458 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 282' ' ' THR . . . . . . . . . . . . . 69.3 p -95.74 0.13 52.1 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 113.089 0.774 . . . . 0.89 113.089 -178.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . 0.487 ' HD2' ' O ' ' A' ' 279' ' ' LEU . 5.7 mttp -141.26 30.1 1.78 Allowed 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 111.649 0.24 . . . . 1.43 111.649 179.773 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 40.1 ttm180 -57.72 -56.12 26.07 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 112.077 0.399 . . . . 1.09 112.077 -179.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 285' ' ' ASP . . . . . 0.412 ' CG ' ' HZ3' ' A' ' 289' ' ' LYS . 24.9 t70 -61.4 -44.52 97.0 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 120.826 0.346 . . . . 0.77 111.652 -179.692 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 286' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -65.18 -49.52 69.5 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 112.36 0.504 . . . . 0.82 112.36 -179.074 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 287' ' ' LEU . . . . . 0.447 ' HB3' HD22 ' A' ' 155' ' ' LEU . 1.6 mm? -66.36 -42.61 87.8 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 113.007 0.743 . . . . 1.1 113.007 -178.502 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 5.6 p -67.75 -36.49 76.09 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 C-N-CA 120.797 -0.361 . . . . 1.0 111.962 -179.511 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 289' ' ' LYS . . . . . 0.412 ' HZ3' ' CG ' ' A' ' 285' ' ' ASP . 50.3 mttt -76.82 -33.57 57.96 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 112.38 0.511 . . . . 1.42 112.38 179.822 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 1.1 tp-100 -84.88 26.43 0.84 Allowed 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 113.002 0.741 . . . . 0.76 113.002 -178.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 32.7 mtp180 63.22 9.39 3.92 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 112.874 0.694 . . . . 0.6 112.874 178.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 62.64 -132.47 44.18 Favored Glycine 0 CA--C 1.524 0.656 0 CA-C-O 121.619 0.566 . . . . 0.4 113.954 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 293' ' ' TRP . . . . . 0.456 ' HA ' ' HB3' ' A' ' 296' ' ' PHE . 78.7 m95 -66.56 -23.45 66.21 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.392 0.516 . . . . 0.58 112.392 -178.766 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 294' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -64.52 -43.49 93.87 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 109.776 -0.453 . . . . 0.43 109.776 178.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -69.74 -32.04 70.5 Favored Glycine 0 C--N 1.334 0.459 0 N-CA-C 110.765 -0.934 . . . . 0.31 110.765 177.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 296' ' ' PHE . . . . . 0.466 ' HB2' ' CZ3' ' A' ' 242' ' ' TRP . 6.0 t80 -67.53 -48.91 65.64 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 115.553 -0.323 . . . . 0.51 111.202 178.779 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 297' ' ' VAL . . . . . 0.631 ' HA ' HG21 ' A' ' 193' ' ' THR . 21.7 m -69.14 -33.18 57.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 CA-C-N 116.63 -0.259 . . . . 0.72 111.591 -179.591 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -69.47 -42.2 75.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.9 0.381 . . . . 0.54 110.713 179.176 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 299' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -67.69 -45.73 74.32 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.005 -0.543 . . . . 0.79 111.427 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 300' ' ' PHE . . . . . 0.532 ' CE2' ' HB3' ' A' ' 242' ' ' TRP . 60.1 m-85 -87.15 30.92 0.74 Allowed 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 112.687 0.625 . . . . 0.61 112.687 -179.089 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 301' ' ' HIS . . . . . 0.611 ' HB2' ' O ' ' A' ' 297' ' ' VAL . 0.1 OUTLIER -145.89 151.14 37.38 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.95 0.405 . . . . 0.43 111.373 179.628 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 2.3 p -89.99 113.02 25.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.204 0.526 . . . . 0.97 110.473 178.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -101.72 -50.62 3.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.205 -0.452 . . . . 0.78 111.628 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 64.2 t0 -146.79 123.37 11.11 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 121.003 0.43 . . . . 1.53 111.125 -179.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 42.6 mt -122.68 -2.81 8.81 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.15 0.5 . . . . 2.76 110.319 178.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -106.27 -35.32 7.2 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.83 -0.623 . . . . 3.79 111.76 -179.064 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . 103.21 84.11 1.77 Allowed Glycine 0 CA--C 1.52 0.384 0 C-N-CA 120.619 -0.801 . . . . 2.86 113.285 179.563 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.278 0 CA-C-O 118.641 -1.088 . . . . 2.49 113.261 179.401 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.685 0 CA-C-O 121.411 0.624 . . . . 1.22 111.058 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -109.8 113.69 26.65 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.642 -0.708 . . . . 1.31 111.22 -179.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 19' ' ' LEU . . . . . 0.563 HD11 ' HA ' ' A' ' 216' ' ' LEU . 9.2 mt -94.16 108.08 33.27 Favored Pre-proline 0 CA--C 1.534 0.345 0 CA-C-O 120.901 0.382 . . . . 1.2 111.701 179.791 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -80.66 160.89 21.92 Favored 'Trans proline' 0 CA--C 1.534 0.48 0 C-N-CA 122.935 2.423 . . . . 0.6 112.598 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 21' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -72.5 38.41 0.39 Allowed 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 122.918 2.412 . . . . 1.17 113.021 179.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -89.39 -39.04 13.67 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 116.093 -0.503 . . . . 0.64 111.774 -179.268 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 23' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -55.93 -41.17 74.21 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 112.218 0.451 . . . . 0.51 112.218 -179.063 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -66.95 -38.98 87.1 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.882 0.372 . . . . 0.49 111.37 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.8 -35.71 81.99 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-O 121.507 0.67 . . . . 1.09 110.01 178.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -66.16 -49.77 66.25 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.246 -0.888 . . . . 0.5 109.43 178.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 82.8 mt -57.21 -36.16 70.53 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.275 -0.42 . . . . 1.15 110.678 178.291 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 28' ' ' ARG . . . . . . . . . . . . . 37.7 mtp85 -57.25 -58.21 9.25 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 116.108 -0.496 . . . . 0.59 111.299 178.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 8.6 ptpp? -64.57 -31.53 72.78 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.523 -0.308 . . . . 0.63 110.791 179.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 52.2 mt -62.82 -49.85 82.04 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 N-CA-C 109.421 -0.585 . . . . 1.11 109.421 178.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -62.18 -43.61 98.88 Favored Glycine 0 N--CA 1.448 -0.527 0 CA-C-N 115.423 -0.808 . . . . 0.31 112.012 178.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -66.95 -37.11 83.68 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 121.221 -0.191 . . . . 0.54 110.878 179.076 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 23.6 ttmm -65.08 -44.6 88.39 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 109.865 -0.42 . . . . 1.25 109.865 177.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 45.7 t -63.92 -50.79 75.9 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-N 115.969 -0.559 . . . . 1.09 110.186 178.439 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -58.0 -40.54 81.0 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.681 -0.691 . . . . 0.78 110.817 179.273 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 36' ' ' CYS . . . . . . . . . . . . . 23.6 t -69.64 -26.47 64.43 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 120.873 0.368 . . . . 1.09 111.422 179.411 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 85.7 m -76.17 -35.02 59.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.305 -0.407 . . . . 1.1 111.18 179.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 38' ' ' TRP . . . . . . . . . . . . . 97.7 m95 -88.03 -37.36 16.38 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 112.052 0.39 . . . . 0.69 112.052 -179.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 45.7 p -65.66 -34.24 77.76 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 120.761 0.315 . . . . 0.68 111.396 179.16 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -90.33 119.07 69.21 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.444 -0.344 . . . . 0.82 110.813 179.128 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_exo -61.44 126.88 20.29 Favored 'Trans proline' 0 CA--C 1.532 0.418 0 C-N-CA 122.815 2.343 . . . . 1.67 112.93 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -78.7 -24.77 44.8 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 116.216 -0.447 . . . . 1.26 111.929 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 43' ' ' MET . . . . . . . . . . . . . 28.0 ttt . . . . . 0 C--O 1.252 1.19 0 CA-C-O 118.261 -0.875 . . . . 2.69 111.649 -179.899 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.314 0 CA-C-O 120.061 -0.3 . . . . 1.5 112.571 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -73.68 -20.84 19.77 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.502 2.135 . . . . 2.12 112.732 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 19.1 tp -152.96 133.58 13.79 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.022 -0.536 . . . . 1.67 110.07 179.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 77.52 72.26 1.15 Allowed Glycine 0 CA--C 1.522 0.482 0 C-N-CA 120.514 -0.851 . . . . 0.84 112.196 -179.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 71.1 m -167.09 -43.53 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 121.348 0.595 . . . . 0.96 110.264 -178.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -158.81 -26.96 0.07 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 114.928 -1.033 . . . . 0.53 109.494 179.346 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -58.25 -27.7 64.24 Favored 'General case' 0 C--O 1.223 -0.324 0 CA-C-N 115.203 -0.908 . . . . 0.45 110.846 178.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -55.52 -41.49 73.19 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.232 0.539 . . . . 0.43 110.242 178.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -71.66 -40.28 69.75 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 109.004 -0.739 . . . . 1.27 109.004 177.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -60.65 -46.95 88.4 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 115.966 -0.561 . . . . 0.51 110.86 179.095 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 14.2 mtp180 -60.53 -45.92 92.07 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 116.336 -0.393 . . . . 0.52 111.301 179.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -63.9 -50.46 68.64 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.062 0.458 . . . . 0.45 109.826 178.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 16.8 m -56.72 -48.47 77.67 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 115.461 -0.791 . . . . 0.31 110.925 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.487 ' HA ' HG23 ' A' ' 276' ' ' THR . 2.1 tm? -57.21 -49.54 75.69 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.551 -0.295 . . . . 0.62 110.254 178.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.2 -45.46 93.11 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.348 -0.387 . . . . 1.02 111.474 179.552 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . 0.486 HG23 HD21 ' A' ' 191' ' ' LEU . 89.9 mt -65.65 -56.56 14.55 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 CA-C-N 116.0 -0.546 . . . . 0.98 112.359 -179.252 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.514 HD13 HG21 ' A' ' 276' ' ' THR . 97.1 mt -58.49 -51.99 64.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 N-CA-C 112.71 0.633 . . . . 1.05 112.71 -178.689 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 65.9 p -56.1 -42.67 77.14 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 120.556 0.217 . . . . 0.33 111.452 -179.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . 0.411 ' NH1' HD21 ' A' ' 180' ' ' LEU . 0.0 OUTLIER -65.55 -52.95 48.65 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.889 0.376 . . . . 1.47 111.105 178.961 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' TYR . . . . . 0.785 ' HE1' ' HA ' ' A' ' 195' ' ' ARG . 59.9 t80 -57.3 -49.08 77.23 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 112.594 0.59 . . . . 0.37 112.594 -179.614 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 5.5 mp -60.71 -46.14 91.55 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 112.413 0.523 . . . . 1.15 112.413 -178.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 38.2 ttm-85 -69.14 -49.89 52.81 Favored 'General case' 0 C--O 1.239 0.545 0 N-CA-C 113.067 0.766 . . . . 0.34 113.067 -178.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -64.12 -52.08 60.85 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.171 0.434 . . . . 0.43 112.171 -178.801 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -64.29 -32.42 74.01 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 111.972 0.36 . . . . 0.51 111.972 -179.284 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . 0.462 ' O ' ' HG3' ' A' ' 257' ' ' LYS . . . -70.6 -48.22 56.23 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.04 0.448 . . . . 0.41 110.305 178.076 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 44.6 m -66.43 -41.12 89.65 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 115.869 -0.605 . . . . 1.12 111.572 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 127.03 29.01 0.89 Allowed Glycine 0 CA--C 1.526 0.724 0 C-N-CA 120.422 -0.894 . . . . 0.53 113.743 179.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 13.3 t -120.21 135.03 55.12 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.012 0.434 . . . . 0.94 111.378 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 20.8 mtpp -108.03 0.53 21.83 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.822 0.344 . . . . 1.19 111.032 179.288 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -91.36 49.74 1.65 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.359 0.599 . . . . 1.56 112.237 -179.098 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' SER . . . . . 0.409 ' O ' ' HG ' ' A' ' 191' ' ' LEU . 7.5 t -91.89 72.43 5.66 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.51 0.671 . . . . 0.74 109.274 178.82 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . 0.684 ' H ' ' HD2' ' A' ' 179' ' ' PRO . 37.7 mttt -110.54 -41.79 0.11 Allowed Pre-proline 0 CA--C 1.544 0.716 0 N-CA-C 113.64 0.978 . . . . 1.2 113.64 -178.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . 0.684 ' HD2' ' H ' ' A' ' 178' ' ' LYS . 23.3 Cg_endo -61.84 99.18 0.18 Allowed 'Trans proline' 0 C--N 1.361 1.187 0 C-N-CA 121.845 1.697 . . . . 2.34 114.034 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.548 ' HB2' ' NH2' ' A' ' 188' ' ' ARG . 1.1 mt -123.39 146.38 48.02 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.918 -0.583 . . . . 1.17 109.594 178.51 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -92.3 -53.89 1.94 Allowed Glycine 0 CA--C 1.522 0.502 0 C-N-CA 120.916 -0.659 . . . . 0.79 114.077 -178.271 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -88.8 -44.95 10.14 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.249 0.547 . . . . 0.89 110.62 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . 0.472 ' HB2' HD22 ' A' ' 180' ' ' LEU . . . -81.49 77.18 8.38 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.261 0.553 . . . . 0.54 111.192 179.648 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . 0.693 ' HA2' ' NH2' ' A' ' 188' ' ' ARG . . . -79.84 -73.85 1.12 Allowed Glycine 0 CA--C 1.525 0.713 0 C-N-CA 120.312 -0.947 . . . . 0.69 114.079 -179.605 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -71.79 -54.72 9.29 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.065 0.46 . . . . 0.89 110.886 -179.36 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -65.14 -35.18 80.3 Favored 'General case' 0 C--O 1.221 -0.427 0 CA-C-N 115.76 -0.655 . . . . 1.14 110.601 179.277 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . 0.461 ' HA3' ' O ' ' A' ' 183' ' ' ALA . . . -64.03 -53.33 37.78 Favored Glycine 0 C--O 1.228 -0.262 0 C-N-CA 120.903 -0.665 . . . . 0.51 113.082 -179.81 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . 0.693 ' NH2' ' HA2' ' A' ' 184' ' ' GLY . 0.3 OUTLIER -59.64 -41.71 91.13 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 117.095 0.447 . . . . 2.23 111.192 -179.98 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . 0.833 ' HD3' HG11 ' A' ' 297' ' ' VAL . 0.2 OUTLIER -71.12 -40.3 71.51 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.509 -0.314 . . . . 0.64 111.245 179.386 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . 0.5 ' HA ' HG21 ' A' ' 297' ' ' VAL . . . -69.6 -39.4 77.27 Favored 'General case' 0 C--O 1.22 -0.481 0 CA-C-N 116.865 -0.152 . . . . 0.92 111.394 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . 0.562 HD13 ' HE ' ' A' ' 195' ' ' ARG . 0.3 OUTLIER -64.59 -47.52 78.37 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.603 0.24 . . . . 1.32 111.212 179.788 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -60.79 -42.85 98.37 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.265 0.555 . . . . 0.4 110.897 179.461 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' THR . . . . . 0.531 ' OG1' HG12 ' A' ' 297' ' ' VAL . 27.8 m -69.76 -54.06 15.44 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.757 -0.656 . . . . 0.5 110.906 179.515 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . 0.405 HD21 HG21 ' A' ' 249' ' ' ILE . 16.7 tp -55.32 -42.34 73.6 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 115.828 -0.623 . . . . 0.96 111.324 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . 0.785 ' HA ' ' HE1' ' A' ' 166' ' ' TYR . 17.9 mtm105 -63.27 -53.05 59.03 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.717 -0.22 . . . . 0.48 111.37 179.654 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.51 -49.77 76.51 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 111.888 0.329 . . . . 0.73 111.888 -179.774 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 87.2 t -63.89 -46.81 93.16 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 CA-C-O 120.877 0.37 . . . . 1.08 110.315 179.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . 0.601 ' HA3' ' OH ' ' A' ' 166' ' ' TYR . . . -58.83 -42.13 96.42 Favored Glycine 0 C--N 1.333 0.372 0 CA-C-N 115.9 -0.591 . . . . 0.26 112.222 179.017 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -56.95 -44.27 82.38 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.837 0.351 . . . . 0.49 110.31 178.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -66.96 -53.48 26.63 Favored Glycine 0 CA--C 1.523 0.568 0 C-N-CA 120.928 -0.654 . . . . 0.36 112.883 179.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 60.3 t -60.77 -42.73 93.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 N-CA-C 112.217 0.451 . . . . 1.09 112.217 -179.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 202' ' ' GLN . . . . . 0.585 ' HA ' ' HE2' ' A' ' 209' ' ' PHE . 0.2 OUTLIER -63.44 -52.71 60.32 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 112.131 0.419 . . . . 0.51 112.131 -179.392 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 30.6 mtt-85 -66.66 -33.39 75.54 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.732 0.301 . . . . 0.56 110.343 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -63.92 -52.6 59.09 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.121 -0.491 . . . . 1.04 110.311 178.379 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 80.7 m-70 -102.21 36.02 2.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.294 -0.412 . . . . 0.6 111.731 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -57.19 -46.52 82.76 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 120.931 0.396 . . . . 1.23 111.31 -179.389 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 47.5 p -64.11 -41.63 97.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.832 -0.622 . . . . 0.84 111.16 179.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -63.61 -41.21 98.32 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.914 -0.585 . . . . 0.57 110.523 179.054 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 209' ' ' PHE . . . . . 0.596 ' O ' ' HG ' ' A' ' 213' ' ' LEU . 20.6 m-30 -70.23 -46.98 63.37 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.143 -0.48 . . . . 0.69 110.138 178.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 210' ' ' GLN . . . . . 0.429 ' HA ' HD13 ' A' ' 213' ' ' LEU . 0.6 OUTLIER -58.66 -44.57 90.2 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 121.039 0.447 . . . . 1.16 110.206 178.708 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . 0.444 ' O ' ' HG3' ' A' ' 215' ' ' LYS . . . -64.33 -43.75 96.43 Favored Glycine 0 C--N 1.335 0.479 0 C-N-CA 121.016 -0.612 . . . . 0.39 111.741 178.489 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 212' ' ' MET . . . . . 0.435 ' HA ' ' HD2' ' A' ' 215' ' ' LYS . 30.8 ttm -62.2 -37.69 86.27 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 120.719 0.295 . . . . 0.53 110.276 178.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . 0.596 ' HG ' ' O ' ' A' ' 209' ' ' PHE . 97.4 mt -58.0 -43.93 86.9 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.169 -0.468 . . . . 1.15 110.068 177.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 214' ' ' ARG . . . . . 0.525 ' HD3' ' O ' ' A' ' 214' ' ' ARG . 0.0 OUTLIER -66.92 -32.01 72.98 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 115.855 -0.611 . . . . 0.89 110.401 178.755 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 215' ' ' LYS . . . . . 0.505 ' HZ3' ' CD ' ' B' ' 22' ' ' GLU . 89.7 mttt -70.32 -43.69 69.78 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 116.282 -0.417 . . . . 0.65 110.856 178.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 15.1 mt -72.8 164.23 26.89 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 121.159 0.504 . . . . 1.42 111.811 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -111.55 32.75 5.17 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 121.251 0.548 . . . . 1.04 110.999 179.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 218' ' ' ILE . . . . . 0.595 ' HA ' ' HB2' ' A' ' 223' ' ' ASP . 41.2 mm -57.15 108.38 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-N 115.746 -0.661 . . . . 1.03 111.992 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . 0.501 ' HZ2' ' HA ' ' A' ' 219' ' ' LYS . 0.4 OUTLIER -145.83 -82.6 0.14 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.843 0.354 . . . . 0.71 111.727 179.887 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 65.9 m-20 -87.49 -176.54 5.63 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.883 -0.599 . . . . 2.26 110.612 178.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . 0.511 ' O ' HG21 ' A' ' 224' ' ' VAL . 13.1 tm-20 -46.48 -31.16 2.55 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 122.975 0.51 . . . . 0.91 112.362 -179.804 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -55.12 -24.85 37.21 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 121.631 -0.319 . . . . 0.59 113.681 178.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 223' ' ' ASP . . . . . 0.595 ' HB2' ' HA ' ' A' ' 218' ' ' ILE . 0.5 OUTLIER -56.63 -36.11 69.1 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 112.741 0.645 . . . . 0.69 112.741 -179.047 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . 0.516 ' HB ' HG22 ' A' ' 274' ' ' THR . 14.2 m -61.15 -29.77 46.44 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-O 120.823 0.344 . . . . 0.64 111.808 -179.521 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 30.6 mttp -72.81 -40.54 65.74 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.143 0.497 . . . . 1.14 109.892 179.132 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 226' ' ' SER . . . . . 0.533 ' O ' HG22 ' A' ' 230' ' ' VAL . 53.4 p -70.73 -38.77 73.6 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.802 -0.635 . . . . 0.56 109.856 178.545 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 227' ' ' PHE . . . . . 0.63 ' O ' ' HG3' ' A' ' 231' ' ' MET . 10.3 t80 -65.11 -46.67 80.07 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 116.102 -0.499 . . . . 0.75 110.031 178.748 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 48.2 t -57.72 -40.12 78.87 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.373 -0.376 . . . . 0.99 110.153 178.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 3.1 ttp180 -56.88 -43.18 81.02 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.048 -0.524 . . . . 1.95 109.69 178.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . 0.533 HG22 ' O ' ' A' ' 226' ' ' SER . 29.6 t -65.67 -49.59 76.68 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 CA-C-N 115.812 -0.631 . . . . 1.06 109.895 178.076 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 231' ' ' MET . . . . . 0.63 ' HG3' ' O ' ' A' ' 227' ' ' PHE . 68.3 mtp -54.38 -51.4 64.94 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 115.784 -0.644 . . . . 1.11 111.842 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 93.2 t -60.84 -39.9 83.4 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 CA-C-N 116.512 -0.313 . . . . 0.81 111.598 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -70.65 -37.66 73.75 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 120.751 -0.38 . . . . 0.81 110.973 179.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . 0.427 HG21 ' O ' ' A' ' 230' ' ' VAL . 51.1 t -59.24 -36.03 61.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-O 121.206 0.527 . . . . 1.02 110.987 179.27 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 235' ' ' PHE . . . . . 0.464 ' HE2' HD21 ' A' ' 248' ' ' LEU . 86.2 m-85 -103.61 18.2 22.42 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.302 -0.408 . . . . 0.57 111.553 179.372 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 11.8 tptp -77.96 -9.52 59.14 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 120.941 0.4 . . . . 1.56 111.324 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 -70.23 -16.23 63.02 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.379 -0.373 . . . . 0.54 111.651 179.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 90.83 -1.86 78.91 Favored Glycine 0 CA--C 1.521 0.423 0 C-N-CA 120.748 -0.739 . . . . 0.64 112.504 -179.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 6.0 p -119.36 119.08 59.55 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 CA-C-O 121.509 0.671 . . . . 1.09 110.979 179.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 240' ' ' THR . . . . . 0.514 HG21 ' HG2' ' A' ' 283' ' ' LYS . 0.5 OUTLIER -93.71 83.38 4.43 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.152 -0.476 . . . . 1.12 112.2 -179.653 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -76.92 136.36 38.81 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.117 -0.492 . . . . 0.42 111.266 179.305 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 242' ' ' TRP . . . . . . . . . . . . . 6.0 m95 -53.93 -45.54 71.26 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.783 0.325 . . . . 0.45 111.0 179.126 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -57.39 -35.98 74.43 Favored Glycine 0 C--N 1.336 0.568 0 CA-C-N 116.068 -0.514 . . . . 0.3 112.823 179.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 84.0 mtt180 -68.25 -44.29 75.95 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 109.985 -0.376 . . . . 0.44 109.985 178.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . 0.639 HG21 HD12 ' A' ' 279' ' ' LEU . 98.5 mt -59.65 -51.36 73.69 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-N 115.954 -0.567 . . . . 1.18 110.518 178.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 59.6 t -63.07 -40.37 88.77 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 CA-C-N 116.164 -0.471 . . . . 0.73 111.07 178.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 23.5 m -60.63 -41.07 94.14 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 120.81 0.338 . . . . 0.83 110.432 179.011 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 248' ' ' LEU . . . . . 0.464 HD21 ' HE2' ' A' ' 235' ' ' PHE . 21.0 tp -64.2 -38.49 91.23 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 121.102 0.477 . . . . 0.91 109.914 178.191 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 249' ' ' ILE . . . . . 0.664 HD13 HD23 ' A' ' 279' ' ' LEU . 47.6 mm -68.2 -41.72 84.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-N 116.091 -0.504 . . . . 1.12 109.952 178.155 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 65.6 m -62.6 -43.95 97.52 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.026 -0.534 . . . . 0.55 109.653 178.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 251' ' ' PHE . . . . . 0.521 ' O ' HG21 ' A' ' 255' ' ' VAL . 29.9 t80 -62.44 -43.16 99.47 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 115.722 -0.672 . . . . 0.47 109.375 177.76 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -56.5 -47.83 80.87 Favored Glycine 0 C--N 1.338 0.666 0 N-CA-C 111.091 -0.803 . . . . 0.27 111.091 178.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -59.12 -42.2 89.99 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-O 120.573 0.225 . . . . 0.43 110.557 177.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 254' ' ' PHE . . . . . 0.409 ' CD2' HD11 ' A' ' 213' ' ' LEU . 5.8 t80 -63.81 -40.06 95.73 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.487 -0.324 . . . . 0.74 110.648 178.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 255' ' ' VAL . . . . . 0.521 HG21 ' O ' ' A' ' 251' ' ' PHE . 84.8 t -63.64 -43.8 98.27 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 N-CA-C 109.297 -0.631 . . . . 1.04 109.297 177.426 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -62.82 -34.55 77.54 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 115.81 -0.632 . . . . 0.76 109.992 178.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 257' ' ' LYS . . . . . 0.462 ' HG3' ' O ' ' A' ' 171' ' ' ALA . 30.4 tttp -66.7 -46.08 76.72 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 115.385 -0.825 . . . . 1.16 110.163 178.248 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 14.4 t60 -62.1 -42.41 99.2 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 115.827 -0.624 . . . . 0.83 109.393 178.29 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 4.7 mp -67.27 -35.5 79.63 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.012 -0.54 . . . . 1.04 110.846 178.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.71 -34.53 77.35 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.533 -0.303 . . . . 1.01 111.018 178.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 24.0 p -62.45 -20.07 64.15 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 120.684 0.278 . . . . 0.97 111.591 179.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 262' ' ' VAL . . . . . 0.449 HG22 ' HG3' ' A' ' 264' ' ' GLN . 13.8 m -117.03 18.82 7.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-O 120.92 0.39 . . . . 1.23 111.073 178.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 65.1 m-80 56.98 46.39 19.53 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 113.8 1.037 . . . . 1.92 113.8 179.171 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 264' ' ' GLN . . . . . 0.449 ' HG3' HG22 ' A' ' 262' ' ' VAL . 12.6 mt-30 -99.29 36.64 1.7 Allowed 'General case' 0 CA--C 1.536 0.423 0 O-C-N 121.884 -0.51 . . . . 0.48 111.491 179.074 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . 0.401 ' HA ' HD11 ' A' ' 268' ' ' ILE . 11.4 tp10 -53.9 -42.1 68.35 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 120.91 0.386 . . . . 0.41 111.653 -179.718 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 30.9 t -61.06 -14.94 27.25 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.128 -0.487 . . . . 0.48 111.729 179.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 267' ' ' PHE . . . . . 0.475 ' C ' ' HD2' ' A' ' 270' ' ' PRO . 71.7 m-85 -101.21 -21.27 14.97 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 121.15 0.5 . . . . 0.94 110.064 178.703 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 268' ' ' ILE . . . . . 0.401 HD11 ' HA ' ' A' ' 265' ' ' GLU . 76.1 mt -67.42 -37.19 78.47 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 CA-C-N 115.851 -0.613 . . . . 1.09 109.891 178.462 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 269' ' ' GLU . . . . . 0.75 ' HB2' ' HD3' ' A' ' 270' ' ' PRO . 9.1 mm-40 -56.63 -57.82 21.21 Favored Pre-proline 0 CA--C 1.548 0.876 0 CA-C-N 116.383 -0.372 . . . . 0.44 111.025 178.623 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 270' ' ' PRO . . . . . 0.75 ' HD3' ' HB2' ' A' ' 269' ' ' GLU . 35.1 Cg_exo -63.22 -30.19 74.12 Favored 'Trans proline' 0 C--N 1.365 1.403 0 C-N-CA 122.322 2.014 . . . . 0.4 112.122 178.58 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 271' ' ' LEU . . . . . . . . . . . . . 56.7 tp -67.09 -50.86 60.23 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 109.72 -0.474 . . . . 1.0 109.72 178.425 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -62.49 -36.52 82.76 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 115.948 -0.569 . . . . 0.4 110.456 178.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 273' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -63.13 -48.89 76.6 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.142 -0.481 . . . . 0.41 109.724 178.009 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 274' ' ' THR . . . . . 0.516 HG22 ' HB ' ' A' ' 224' ' ' VAL . 62.7 m -62.72 -48.54 78.77 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.863 -0.608 . . . . 0.91 110.853 178.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 275' ' ' ILE . . . . . 0.531 ' HA ' ' HE2' ' A' ' 231' ' ' MET . 92.1 mt -54.78 -51.9 47.52 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.157 0 CA-C-N 116.135 -0.484 . . . . 1.01 111.106 179.42 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 276' ' ' THR . . . . . 0.514 HG21 HD13 ' A' ' 163' ' ' ILE . 40.8 m -60.49 -51.23 70.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.277 -0.42 . . . . 0.92 111.193 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 277' ' ' ASP . . . . . 0.513 ' OD1' ' HD2' ' A' ' 281' ' ' ARG . 25.9 t0 -55.09 -58.26 8.37 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.129 -0.487 . . . . 0.9 111.61 179.807 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 95.4 t -58.41 -41.8 82.46 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 CA-C-O 120.795 0.331 . . . . 0.97 111.58 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . 0.664 HD23 HD13 ' A' ' 249' ' ' ILE . 12.2 tp -61.77 -47.74 83.79 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 112.219 0.452 . . . . 1.27 112.219 -179.578 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 46.5 t -79.31 -42.81 23.64 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 N-CA-C 112.612 0.597 . . . . 0.98 112.612 -178.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 281' ' ' ARG . . . . . 0.513 ' HD2' ' OD1' ' A' ' 277' ' ' ASP . 0.4 OUTLIER -58.8 -33.53 70.46 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 112.326 0.491 . . . . 1.4 112.326 -179.336 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 282' ' ' THR . . . . . . . . . . . . . 48.4 p -85.84 -1.62 57.43 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 111.772 0.286 . . . . 0.6 111.772 179.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . 0.514 ' HG2' HG21 ' A' ' 240' ' ' THR . 32.8 mttp -141.22 34.11 1.7 Allowed 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.572 -0.286 . . . . 0.59 111.391 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 48.9 mtp180 -53.83 -62.24 1.78 Allowed 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 112.573 0.582 . . . . 0.57 112.573 -178.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 285' ' ' ASP . . . . . 0.483 ' O ' ' HE2' ' A' ' 289' ' ' LYS . 8.7 p-10 -65.63 -37.65 87.19 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.168 -0.469 . . . . 0.46 110.901 -179.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 286' ' ' TRP . . . . . 0.506 ' CZ2' ' HG2' ' A' ' 290' ' ' GLN . 71.9 t90 -62.4 -40.5 96.7 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.425 -0.352 . . . . 0.44 110.912 179.653 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 287' ' ' LEU . . . . . 0.488 HD13 ' HA2' ' A' ' 292' ' ' GLY . 0.8 OUTLIER -60.71 -48.36 82.14 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 111.971 0.36 . . . . 1.11 111.971 179.749 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 9.5 p -69.35 -32.16 52.32 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 C-N-CA 120.481 -0.487 . . . . 0.7 111.453 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 289' ' ' LYS . . . . . 0.483 ' HE2' ' O ' ' A' ' 285' ' ' ASP . 39.8 mtmt -75.97 -40.3 54.21 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 112.775 0.657 . . . . 1.41 112.775 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 290' ' ' GLN . . . . . 0.506 ' HG2' ' CZ2' ' A' ' 286' ' ' TRP . 1.6 mp0 -87.82 29.87 0.88 Allowed 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 114.278 1.214 . . . . 0.7 114.278 -177.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 291' ' ' ARG . . . . . 0.581 ' HG2' ' HB2' ' A' ' 294' ' ' ASP . 1.9 ttt180 60.74 19.7 9.79 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 112.762 0.653 . . . . 0.55 112.762 178.435 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 292' ' ' GLY . . . . . 0.488 ' HA2' HD13 ' A' ' 287' ' ' LEU . . . 42.34 -135.52 3.76 Favored Glycine 0 CA--C 1.527 0.788 0 N-CA-C 115.363 0.905 . . . . 0.42 115.363 178.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 293' ' ' TRP . . . . . 0.581 ' O ' HG23 ' A' ' 297' ' ' VAL . 97.2 m95 -64.46 -37.41 87.44 Favored 'General case' 0 C--O 1.226 -0.133 0 CA-C-N 115.428 -0.386 . . . . 0.66 111.058 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 294' ' ' ASP . . . . . 0.581 ' HB2' ' HG2' ' A' ' 291' ' ' ARG . 0.9 OUTLIER -53.8 -46.91 71.22 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 121.176 0.512 . . . . 0.63 110.195 179.023 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -65.79 -39.3 95.1 Favored Glycine 0 CA--C 1.523 0.56 0 C-N-CA 120.884 -0.674 . . . . 0.32 111.835 178.324 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 296' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -64.05 -36.15 83.07 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 120.799 0.333 . . . . 0.42 110.937 179.131 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 297' ' ' VAL . . . . . 0.833 HG11 ' HD3' ' A' ' 189' ' ' ARG . 77.8 t -64.99 -54.16 32.84 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 CA-C-N 116.202 -0.454 . . . . 1.0 111.65 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -69.71 -23.16 63.38 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 112.312 0.486 . . . . 0.49 112.312 -179.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 299' ' ' PHE . . . . . . . . . . . . . 88.2 t80 -70.12 -52.68 21.74 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 111.694 0.257 . . . . 0.58 111.694 179.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 300' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -85.08 30.18 0.61 Allowed 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 120.827 0.346 . . . . 0.5 111.67 -179.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 2.6 m170 -152.8 -169.28 3.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.246 0.546 . . . . 0.72 111.352 -179.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 5.4 p -99.87 164.65 2.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-N 115.866 -0.606 . . . . 1.16 110.343 179.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 303' ' ' GLN . . . . . 0.662 ' HB3' ' HA2' ' A' ' 307' ' ' GLY . 62.5 mt-30 -131.04 117.49 19.23 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.93 0.395 . . . . 0.61 111.532 -179.522 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -124.64 -79.26 0.61 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.055 -0.521 . . . . 0.9 109.967 179.018 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 96.1 mt -84.1 -15.33 47.73 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.414 0.626 . . . . 1.42 109.799 178.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.88 20.49 17.49 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.221 -0.9 . . . . 0.64 111.123 179.708 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 307' ' ' GLY . . . . . 0.662 ' HA2' ' HB3' ' A' ' 303' ' ' GLN . . . -75.93 57.42 3.11 Favored Glycine 0 CA--C 1.524 0.652 0 C-N-CA 120.966 -0.635 . . . . 0.67 113.507 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 308' ' ' GLY . . . . . 0.422 ' C ' HH12 ' A' ' 291' ' ' ARG . . . . . . . . 0 C--O 1.246 0.906 0 CA-C-O 118.907 -0.941 . . . . 0.95 112.715 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 121.269 0.557 . . . . 1.74 110.857 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.53 -77.68 0.23 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.539 -0.755 . . . . 1.4 111.275 -179.032 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 19' ' ' LEU . . . . . 0.525 HD21 ' HD2' ' B' ' 20' ' ' PRO . 0.8 OUTLIER -99.15 117.98 63.29 Favored Pre-proline 0 C--O 1.234 0.261 0 CA-C-N 116.52 -0.309 . . . . 1.3 111.497 -179.749 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 20' ' ' PRO . . . . . 0.525 ' HD2' HD21 ' B' ' 19' ' ' LEU . 18.8 Cg_endo -57.78 136.84 77.96 Favored 'Trans proline' 0 CA--C 1.534 0.482 0 C-N-CA 122.874 2.383 . . . . 0.88 112.258 179.087 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 21' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -71.15 40.4 0.37 Allowed 'Trans proline' 0 CA--C 1.537 0.638 0 C-N-CA 122.808 2.339 . . . . 1.58 113.683 -179.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 22' ' ' GLU . . . . . 0.505 ' CD ' ' HZ3' ' A' ' 215' ' ' LYS . 0.5 OUTLIER -87.46 -30.42 20.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.7 -0.227 . . . . 0.68 111.096 -179.963 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 23' ' ' PHE . . . . . 0.436 ' CD1' HG23 ' A' ' 230' ' ' VAL . 0.8 OUTLIER -58.29 -40.16 81.23 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.276 0.56 . . . . 0.58 110.715 179.125 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -70.52 -40.33 73.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.008 -0.542 . . . . 1.06 110.427 178.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . 0.423 ' O ' ' HB3' ' B' ' 28' ' ' ARG . . . -64.15 -37.38 87.24 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 116.133 -0.485 . . . . 0.44 110.808 178.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -62.74 -54.26 41.85 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.012 -0.54 . . . . 0.59 110.419 178.72 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 95.9 mt -58.96 -34.36 71.71 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.134 0.492 . . . . 1.05 109.833 178.167 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 28' ' ' ARG . . . . . 0.423 ' HB3' ' O ' ' B' ' 25' ' ' ALA . 1.1 ttt180 -59.84 -51.04 71.44 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 115.43 -0.805 . . . . 0.7 110.111 177.854 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -67.66 -40.14 84.53 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.304 -0.407 . . . . 1.34 111.264 179.157 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 96.5 mt -62.68 -46.9 95.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-O 120.962 0.41 . . . . 0.85 110.318 178.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.35 -48.34 86.47 Favored Glycine 0 N--CA 1.45 -0.419 0 CA-C-N 115.72 -0.673 . . . . 0.28 112.871 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -64.6 -37.87 89.06 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.917 0.359 . . . . 0.47 111.548 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 20.7 ttmm -63.72 -47.78 79.73 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-O 121.121 0.486 . . . . 1.74 110.255 178.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 55.5 t -65.06 -46.69 90.59 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 CA-C-N 115.844 -0.616 . . . . 1.11 110.532 178.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -56.08 -48.54 75.9 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 115.824 -0.625 . . . . 0.88 111.743 179.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 36' ' ' CYS . . . . . . . . . . . . . 84.2 m -64.51 -35.35 80.67 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 120.812 0.339 . . . . 0.82 111.543 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 63.1 m -67.92 -40.99 83.29 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 112.227 0.455 . . . . 0.83 112.227 -179.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 38' ' ' TRP . . . . . . . . . . . . . 97.8 m95 -87.41 -18.54 29.74 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.498 0.555 . . . . 0.8 112.498 -179.19 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 28.8 t -70.55 -18.2 62.93 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 112.054 0.39 . . . . 0.89 112.054 179.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.39 118.45 56.73 Favored Pre-proline 0 CA--C 1.533 0.307 0 CA-C-O 120.763 0.316 . . . . 1.43 111.363 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -80.36 -13.84 12.11 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.688 2.259 . . . . 2.17 113.075 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -77.02 80.04 3.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.119 -0.491 . . . . 1.67 111.026 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 43' ' ' MET . . . . . . . . . . . . . 24.3 mmt . . . . . 0 C--O 1.251 1.146 0 CA-C-O 118.345 -0.836 . . . . 2.84 111.313 -179.871 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.238 0 N-CA-C 112.535 -0.226 . . . . 0.71 112.535 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -64.55 -28.44 61.48 Favored 'Trans proline' 0 CA--C 1.536 0.61 0 C-N-CA 122.658 2.239 . . . . 1.07 113.073 179.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.416 ' HB3' ' OD1' ' A' ' 153' ' ' ASP . 43.2 tp -119.09 -69.39 0.85 Allowed 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 120.841 0.353 . . . . 1.14 110.967 179.577 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -148.78 -100.05 0.22 Allowed Glycine 0 CA--C 1.518 0.265 0 C-N-CA 120.521 -0.847 . . . . 0.69 112.55 179.387 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.546 ' HB2' HG23 ' A' ' 288' ' ' VAL . 17.6 p -126.71 -30.64 2.77 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.088 0.471 . . . . 0.81 110.957 179.432 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 52.7 tt0 -58.48 -47.41 84.17 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.816 -0.629 . . . . 0.52 111.704 179.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . 0.538 ' O ' ' HG3' ' A' ' 157' ' ' ARG . 0.1 OUTLIER -49.84 -52.03 35.59 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 115.655 -0.702 . . . . 0.54 112.711 -179.839 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 -60.88 -43.66 98.13 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.185 0.517 . . . . 0.46 111.391 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.537 HD22 ' HB3' ' A' ' 287' ' ' LEU . 27.1 tp -63.89 -49.35 73.04 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.754 -0.657 . . . . 1.25 110.231 179.377 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 44.4 t80 -58.8 -43.57 90.55 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 115.885 -0.598 . . . . 0.58 111.45 179.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.677 ' HD2' ' OE2' ' A' ' 182' ' ' GLU . 51.5 mtm180 -60.08 -52.71 64.21 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.698 0.285 . . . . 0.46 111.13 179.556 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 29.0 mt-30 -63.05 -45.27 93.01 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.541 -0.3 . . . . 0.54 110.781 179.155 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' SER . . . . . 0.534 ' HA ' ' CZ2' ' A' ' 293' ' ' TRP . 21.1 m -58.93 -56.92 16.0 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.384 -0.371 . . . . 0.32 111.375 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.669 HD12 ' HG2' ' A' ' 273' ' ' GLU . 12.7 tp -54.55 -48.88 71.49 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.751 -0.204 . . . . 1.23 111.474 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . 0.532 ' OE2' ' HB3' ' A' ' 180' ' ' LEU . 0.1 OUTLIER -57.49 -54.25 48.93 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 111.85 0.315 . . . . 1.08 111.85 179.889 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 74.7 mt -62.28 -43.43 98.0 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 N-CA-C 111.871 0.323 . . . . 1.13 111.871 -179.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.631 ' O ' ' HG ' ' A' ' 167' ' ' LEU . 87.0 mt -64.43 -48.42 85.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 N-CA-C 110.225 -0.287 . . . . 1.08 110.225 179.211 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 6.8 t -58.42 -44.63 89.18 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.409 -0.36 . . . . 0.36 110.282 178.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . 0.437 ' HG3' ' HG ' ' A' ' 180' ' ' LEU . 2.6 mmt180 -59.12 -51.98 67.71 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.121 -0.491 . . . . 0.6 111.89 178.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' TYR . . . . . 0.703 ' CE1' ' HA ' ' A' ' 195' ' ' ARG . 51.6 t80 -60.57 -49.77 76.22 Favored 'General case' 0 CA--C 1.527 0.085 0 N-CA-C 112.399 0.518 . . . . 0.48 112.399 -179.042 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.631 ' HG ' ' O ' ' A' ' 163' ' ' ILE . 11.8 mt -67.14 -33.74 76.08 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 120.225 -0.59 . . . . 0.99 111.293 -178.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 21.5 ttp180 -69.75 -52.62 23.77 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 111.803 0.297 . . . . 0.5 111.803 179.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -61.65 -48.41 80.99 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 111.838 0.31 . . . . 0.35 111.838 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.36 -40.73 91.85 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.09 -0.505 . . . . 0.35 112.12 -179.726 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . 0.409 ' HB1' ' HB2' ' A' ' 260' ' ' LYS . . . -75.76 -34.96 60.29 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 112.114 0.413 . . . . 0.5 112.114 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 83.4 m -71.15 -41.29 70.62 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 112.0 0.37 . . . . 1.09 112.0 -179.486 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 104.88 10.14 33.2 Favored Glycine 0 CA--C 1.52 0.391 0 C-N-CA 120.591 -0.814 . . . . 0.56 112.48 -179.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 32.6 t -129.36 121.05 26.63 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.985 -0.376 . . . . 0.92 109.985 179.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 4.7 tmtm? -102.09 135.54 43.5 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.238 0.542 . . . . 0.7 112.445 -178.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -108.06 143.05 37.32 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 115.734 -0.666 . . . . 0.45 110.705 179.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 4.9 t -107.0 -3.18 20.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.934 0.397 . . . . 1.36 111.917 -179.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . 0.496 ' HB3' ' HD2' ' A' ' 179' ' ' PRO . 7.0 mtmp? -79.55 162.99 61.16 Favored Pre-proline 0 CA--C 1.537 0.448 0 CA-C-O 120.709 0.29 . . . . 1.42 111.587 -179.701 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . 0.496 ' HD2' ' HB3' ' A' ' 178' ' ' LYS . 40.2 Cg_endo -67.51 170.64 13.26 Favored 'Trans proline' 0 CA--C 1.535 0.569 0 C-N-CA 122.358 2.039 . . . . 0.66 113.275 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.611 ' HB2' ' O ' ' A' ' 183' ' ' ALA . 10.5 mp -94.24 -168.69 1.9 Allowed 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 115.955 -0.566 . . . . 1.13 111.034 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -74.85 -54.25 5.95 Favored Glycine 0 C--N 1.331 0.294 0 C-N-CA 120.65 -0.786 . . . . 0.52 112.131 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . 0.677 ' OE2' ' HD2' ' A' ' 157' ' ' ARG . 31.5 mt-10 -108.05 -42.91 4.53 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.388 0.614 . . . . 0.52 109.671 179.065 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . 0.611 ' O ' ' HB2' ' A' ' 180' ' ' LEU . . . -82.62 79.21 9.1 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 115.794 -0.639 . . . . 1.07 110.768 179.128 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -78.74 -71.01 1.27 Allowed Glycine 0 CA--C 1.524 0.655 0 C-N-CA 120.617 -0.801 . . . . 0.4 113.993 -179.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -70.78 -55.43 8.6 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-O 120.923 0.392 . . . . 1.11 111.189 -179.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -63.51 -35.56 80.85 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 116.064 -0.516 . . . . 0.48 110.369 178.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . 0.559 ' HA3' ' O ' ' A' ' 183' ' ' ALA . . . -64.32 -34.83 90.98 Favored Glycine 0 C--N 1.336 0.559 0 CA-C-N 116.017 -0.538 . . . . 0.34 112.648 179.464 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 1.2 mmm-85 -68.04 -57.84 5.47 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 109.589 -0.523 . . . . 0.8 109.589 178.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . 0.58 ' HB3' HG12 ' A' ' 297' ' ' VAL . 44.5 mtp180 -56.73 -48.34 77.97 Favored 'General case' 0 C--O 1.226 -0.176 0 CA-C-N 115.53 -0.759 . . . . 0.87 111.2 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . 0.593 ' O ' ' HB2' ' A' ' 194' ' ' LEU . . . -60.85 -37.74 83.11 Favored 'General case' 0 C--O 1.224 -0.265 0 N-CA-C 111.849 0.314 . . . . 1.05 111.849 -179.583 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . 0.473 ' HB2' ' O ' ' A' ' 187' ' ' GLY . 7.8 tp -66.46 -42.5 87.49 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.95 0.405 . . . . 1.18 110.385 179.199 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -66.33 -46.81 75.57 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.069 -0.514 . . . . 0.39 110.573 178.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 193' ' ' THR . . . . . 0.559 HG23 ' HA ' ' A' ' 297' ' ' VAL . 5.6 m -62.34 -43.87 97.8 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.985 0.421 . . . . 1.06 109.936 178.266 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . 0.593 ' HB2' ' O ' ' A' ' 190' ' ' ALA . 6.4 tp -62.2 -43.55 98.58 Favored 'General case' 0 C--O 1.224 -0.278 0 CA-C-N 115.585 -0.734 . . . . 1.13 110.672 178.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . 0.703 ' HA ' ' CE1' ' A' ' 166' ' ' TYR . 0.0 OUTLIER -65.01 -38.34 90.61 Favored 'General case' 0 C--O 1.224 -0.271 0 CA-C-O 121.292 0.568 . . . . 1.08 110.37 178.939 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . 0.41 ' HG2' ' CD2' ' A' ' 301' ' ' HIS . 0.9 OUTLIER -67.5 -60.06 2.87 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.968 -0.56 . . . . 0.44 112.076 -179.739 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 7.0 t -71.19 -45.69 69.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 111.836 0.31 . . . . 0.79 111.836 -178.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -57.21 -45.17 92.93 Favored Glycine 0 CA--C 1.522 0.514 0 C-N-CA 121.465 -0.398 . . . . 0.29 113.538 -179.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . 0.506 ' O ' ' HB2' ' A' ' 203' ' ' ARG . 2.7 m-20 -73.92 -32.58 63.59 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 117.059 0.43 . . . . 0.49 110.713 179.725 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -68.85 -48.42 48.79 Favored Glycine 0 CA--C 1.524 0.653 0 C-N-CA 120.946 -0.645 . . . . 0.31 112.677 178.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 76.7 t -61.36 -48.69 87.72 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-N 116.745 0.272 . . . . 1.09 111.123 179.413 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 202' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -62.33 -32.58 73.36 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.369 -0.378 . . . . 0.38 111.397 179.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 203' ' ' ARG . . . . . 0.506 ' HB2' ' O ' ' A' ' 199' ' ' ASP . 0.0 OUTLIER -77.46 -38.95 48.29 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 120.712 0.291 . . . . 0.72 111.027 179.532 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -71.44 -52.37 18.85 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 116.226 -0.443 . . . . 0.45 111.449 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 33.4 m-70 -97.27 36.25 1.49 Allowed 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 120.863 0.363 . . . . 0.61 110.855 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -58.16 -37.62 75.05 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 113.038 0.755 . . . . 0.72 113.038 -178.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 4.1 t -56.89 -37.28 71.16 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 120.931 0.396 . . . . 1.16 111.902 -179.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -75.06 -43.42 53.43 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 121.124 0.487 . . . . 1.15 111.001 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 209' ' ' PHE . . . . . 0.407 ' O ' ' HB2' ' A' ' 213' ' ' LEU . 56.2 m-85 -66.56 -39.18 88.37 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 115.871 -0.604 . . . . 0.54 110.943 179.748 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 210' ' ' GLN . . . . . 0.4 ' O ' ' HG2' ' A' ' 214' ' ' ARG . 0.6 OUTLIER -64.7 -45.25 87.42 Favored 'General case' 0 C--O 1.222 -0.371 0 CA-C-N 116.515 -0.311 . . . . 0.67 111.251 179.634 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -56.77 -48.43 78.05 Favored Glycine 0 CA--C 1.523 0.564 0 C-N-CA 120.251 -0.976 . . . . 0.36 111.766 178.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 212' ' ' MET . . . . . 0.542 ' O ' ' HB2' ' A' ' 216' ' ' LEU . 49.2 mtp -67.06 -34.0 76.73 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 115.637 -0.281 . . . . 1.44 111.296 178.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . 0.472 HD22 ' HB2' ' A' ' 258' ' ' HIS . 1.0 OUTLIER -75.73 -37.61 59.22 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 112.205 0.446 . . . . 1.14 112.205 -179.949 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 214' ' ' ARG . . . . . 0.4 ' HG2' ' O ' ' A' ' 210' ' ' GLN . 33.2 mmt180 -64.12 -35.14 79.78 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.89 0.376 . . . . 1.4 110.079 179.028 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 215' ' ' LYS . . . . . 0.521 ' HE2' ' HA ' ' A' ' 215' ' ' LYS . 0.0 OUTLIER -95.7 12.51 29.61 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 121.171 0.51 . . . . 0.86 110.585 177.91 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . 0.642 ' HG ' HG13 ' A' ' 218' ' ' ILE . 10.1 tp -93.84 99.22 11.63 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.211 -0.45 . . . . 1.19 110.934 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -93.94 33.25 1.35 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.261 -0.427 . . . . 0.84 110.985 179.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 218' ' ' ILE . . . . . 0.642 HG13 ' HG ' ' A' ' 216' ' ' LEU . 16.1 mt -61.86 108.52 0.52 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.495 0 CA-C-O 121.748 0.785 . . . . 1.15 111.826 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 1.6 ttpm? -161.61 17.51 0.1 Allowed 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 114.945 -1.025 . . . . 2.52 110.878 -179.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -139.04 160.75 39.03 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-O 120.864 0.364 . . . . 0.66 111.397 -179.088 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -62.51 -22.99 66.7 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.015 0.436 . . . . 0.81 111.733 179.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -74.7 -26.04 68.29 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 120.94 -0.648 . . . . 0.69 113.508 179.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 223' ' ' ASP . . . . . 0.436 ' HB3' HG12 ' A' ' 218' ' ' ILE . 71.9 m-20 -61.65 -43.97 97.84 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 113.011 0.745 . . . . 0.79 113.011 -178.795 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . 0.5 HG22 ' HD2' ' A' ' 225' ' ' LYS . 29.9 m -59.86 -28.71 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 N-CA-C 112.123 0.416 . . . . 0.85 112.123 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . 0.5 ' HD2' HG22 ' A' ' 224' ' ' VAL . 11.9 mptt -64.28 -42.05 96.62 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 121.318 0.58 . . . . 1.28 109.847 178.871 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 226' ' ' SER . . . . . 0.593 ' O ' HG23 ' A' ' 230' ' ' VAL . 3.5 m -71.0 -38.72 72.69 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.787 -0.642 . . . . 1.2 109.577 178.032 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 227' ' ' PHE . . . . . 0.483 ' HE1' HG12 ' A' ' 275' ' ' ILE . 8.8 t80 -56.02 -43.83 78.16 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 115.84 -0.618 . . . . 0.75 109.863 177.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 228' ' ' SER . . . . . 0.416 ' O ' HG23 ' A' ' 232' ' ' VAL . 39.2 m -61.59 -44.54 96.83 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.634 -0.712 . . . . 0.46 110.022 178.067 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 229' ' ' ARG . . . . . 0.471 ' NH1' ' HA ' ' A' ' 226' ' ' SER . 4.2 ttm105 -61.01 -38.86 87.55 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 115.806 -0.634 . . . . 1.1 110.935 178.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . 0.593 HG23 ' O ' ' A' ' 226' ' ' SER . 97.0 t -55.88 -52.56 47.8 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-N 116.164 -0.471 . . . . 1.11 110.587 178.683 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 231' ' ' MET . . . . . 0.615 ' HG2' HD22 ' A' ' 248' ' ' LEU . 72.3 mtm -59.98 -38.0 81.25 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.07 -0.514 . . . . 1.01 111.471 179.405 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 232' ' ' VAL . . . . . 0.416 HG23 ' O ' ' A' ' 228' ' ' SER . 84.6 t -62.76 -42.49 96.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-O 120.771 0.319 . . . . 0.99 110.812 179.151 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 233' ' ' HIS . . . . . 0.429 ' HB3' ' HB3' ' B' ' 24' ' ' ALA . 48.7 t-80 -63.44 -35.61 81.01 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 120.84 0.353 . . . . 0.56 111.164 179.166 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 97.2 t -63.16 -38.19 81.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-O 121.114 0.483 . . . . 0.54 111.42 179.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 235' ' ' PHE . . . . . 0.526 ' HE2' HD13 ' A' ' 248' ' ' LEU . 62.2 m-85 -103.54 23.89 11.93 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.271 -0.422 . . . . 0.72 111.517 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 3.9 ttpp -69.83 -1.4 9.26 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 113.297 0.851 . . . . 0.93 113.297 -178.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 6.2 p30 -102.87 -16.13 15.99 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.949 0.404 . . . . 0.4 111.038 179.377 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 94.19 -6.48 72.19 Favored Glycine 0 CA--C 1.522 0.487 0 C-N-CA 120.905 -0.664 . . . . 0.37 112.605 -179.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 7.9 t -81.01 112.01 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.139 0 CA-C-O 121.157 0.504 . . . . 0.95 111.199 -179.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 240' ' ' THR . . . . . 0.432 ' HB ' ' CE2' ' A' ' 286' ' ' TRP . 1.2 m -94.43 101.62 13.55 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 120.777 -0.369 . . . . 0.69 111.444 179.505 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -110.31 139.08 45.86 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.396 -0.366 . . . . 0.92 110.713 179.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 242' ' ' TRP . . . . . 0.573 ' HB3' ' CE2' ' A' ' 300' ' ' PHE . 16.0 m95 -57.98 -42.82 85.91 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 120.625 0.25 . . . . 0.48 111.446 179.443 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -60.26 -28.83 67.53 Favored Glycine 0 CA--C 1.522 0.514 0 C-N-CA 121.306 -0.473 . . . . 0.31 112.775 178.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 244' ' ' ARG . . . . . 0.44 ' O ' ' HG ' ' A' ' 248' ' ' LEU . 94.3 mtt180 -71.42 -46.86 59.08 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.349 -0.612 . . . . 0.56 109.349 178.422 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 74.8 mt -60.93 -45.45 98.32 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-N 115.376 -0.829 . . . . 0.72 111.074 179.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . 0.44 HG21 ' O ' ' A' ' 242' ' ' TRP . 61.3 t -62.52 -40.62 88.87 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-O 120.608 0.242 . . . . 0.87 111.015 179.269 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 55.1 m -57.67 -40.8 80.2 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.479 -0.328 . . . . 0.82 110.756 179.278 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 248' ' ' LEU . . . . . 0.615 HD22 ' HG2' ' A' ' 231' ' ' MET . 69.8 mt -61.63 -36.71 81.54 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 121.047 0.451 . . . . 1.11 110.298 178.229 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 29.5 mm -74.23 -38.98 48.99 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.133 0 CA-C-N 116.292 -0.413 . . . . 1.14 110.107 178.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 16.5 t -60.76 -42.77 98.09 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 108.921 -0.77 . . . . 0.59 108.921 178.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 251' ' ' PHE . . . . . 0.455 ' O ' HG21 ' A' ' 255' ' ' VAL . 19.7 t80 -64.85 -42.85 94.57 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 108.599 -0.889 . . . . 0.57 108.599 176.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -56.65 -40.31 87.86 Favored Glycine 0 C--N 1.337 0.616 0 N-CA-C 111.434 -0.667 . . . . 0.28 111.434 177.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -63.05 -37.48 87.36 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 120.956 0.408 . . . . 0.56 110.539 177.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -69.71 -38.9 77.1 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.066 -0.515 . . . . 1.09 109.952 178.329 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 255' ' ' VAL . . . . . 0.604 ' O ' ' HG ' ' A' ' 259' ' ' LEU . 59.8 t -67.53 -42.33 86.82 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.209 0 CA-C-N 116.079 -0.509 . . . . 1.0 109.719 178.281 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -57.96 -43.55 86.48 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 109.525 -0.546 . . . . 0.38 109.525 177.076 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 60.8 mttt -62.55 -43.45 98.78 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.7 -0.682 . . . . 1.12 109.982 177.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 258' ' ' HIS . . . . . 0.472 ' HB2' HD22 ' A' ' 213' ' ' LEU . 36.0 t60 -61.63 -44.38 97.1 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.935 -0.575 . . . . 1.04 110.465 178.534 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . 0.604 ' HG ' ' O ' ' A' ' 255' ' ' VAL . 80.3 mt -67.42 -47.21 70.9 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 115.906 -0.588 . . . . 1.01 110.917 179.475 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 260' ' ' LYS . . . . . 0.409 ' HB2' ' HB1' ' A' ' 171' ' ' ALA . 0.5 OUTLIER -61.74 -32.49 72.74 Favored 'General case' 0 CA--C 1.535 0.369 0 O-C-N 122.386 -0.196 . . . . 1.06 110.99 179.526 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 69.3 m -60.95 -31.13 70.69 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.108 0.48 . . . . 0.48 110.588 178.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 28.4 m -110.18 20.66 5.82 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 CA-C-N 115.888 -0.597 . . . . 1.25 110.907 179.195 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 55.01 51.1 14.06 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 115.609 -0.723 . . . . 1.36 112.927 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -106.93 36.15 2.76 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.489 -0.323 . . . . 0.66 111.55 179.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . 0.497 ' HA ' HD11 ' A' ' 268' ' ' ILE . 0.8 OUTLIER -51.42 -38.91 55.98 Favored 'General case' 0 C--O 1.242 0.659 0 CA-C-O 120.922 0.391 . . . . 0.82 111.943 179.614 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 36.0 p -64.38 -12.93 47.59 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.787 -0.642 . . . . 1.05 111.537 179.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 267' ' ' PHE . . . . . 0.46 ' C ' ' HD2' ' A' ' 270' ' ' PRO . 14.9 t80 -105.3 -25.19 12.52 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.626 -0.509 . . . . 1.06 109.626 178.327 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 268' ' ' ILE . . . . . 0.497 HD11 ' HA ' ' A' ' 265' ' ' GLU . 70.3 mt -59.8 -50.01 81.68 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-N 115.957 -0.565 . . . . 1.0 110.947 179.055 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 269' ' ' GLU . . . . . 0.699 ' HB3' ' HD3' ' A' ' 270' ' ' PRO . 1.2 tp10 -57.03 -55.63 41.94 Favored Pre-proline 0 CA--C 1.547 0.853 0 C-N-CA 120.812 -0.355 . . . . 0.81 110.487 179.109 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 270' ' ' PRO . . . . . 0.699 ' HD3' ' HB3' ' A' ' 269' ' ' GLU . 52.1 Cg_exo -58.86 -29.71 90.88 Favored 'Trans proline' 0 C--N 1.364 1.378 0 C-N-CA 122.464 2.11 . . . . 0.4 112.392 177.44 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 271' ' ' LEU . . . . . 0.439 ' O ' HG13 ' A' ' 275' ' ' ILE . 1.5 tm? -67.09 -43.38 82.7 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 108.746 -0.835 . . . . 0.99 108.746 177.775 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -64.05 -35.86 82.1 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.563 -0.744 . . . . 0.43 109.0 177.148 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 273' ' ' GLU . . . . . 0.669 ' HG2' HD12 ' A' ' 160' ' ' LEU . 52.5 mt-10 -66.06 -44.82 83.42 Favored 'General case' 0 C--O 1.222 -0.379 0 CA-C-N 115.662 -0.699 . . . . 0.76 109.217 177.27 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 274' ' ' THR . . . . . . . . . . . . . 89.9 m -55.6 -46.89 77.24 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.713 -0.676 . . . . 1.06 110.578 178.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 275' ' ' ILE . . . . . 0.5 ' HA ' ' HE2' ' A' ' 231' ' ' MET . 72.9 mt -63.04 -55.42 23.65 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.128 0 CA-C-N 115.936 -0.575 . . . . 1.09 110.853 179.316 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 5.6 m -57.38 -47.81 80.71 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.009 -0.542 . . . . 0.49 112.052 -179.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 277' ' ' ASP . . . . . 0.471 ' HB2' ' O ' ' A' ' 273' ' ' GLU . 0.1 OUTLIER -52.61 -57.17 10.88 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.488 -0.324 . . . . 0.63 111.52 -179.867 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 48.5 t -66.33 -37.11 78.95 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 N-CA-C 111.915 0.339 . . . . 1.03 111.915 -179.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 41.4 tp -64.78 -47.11 79.34 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 111.971 0.36 . . . . 1.24 111.971 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 86.7 t -73.68 -32.39 35.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 CA-C-O 121.009 0.433 . . . . 1.16 111.186 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 281' ' ' ARG . . . . . 0.434 HH11 ' HD2' ' A' ' 281' ' ' ARG . 2.0 tpm_? -71.81 -43.52 65.48 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 112.439 0.533 . . . . 0.41 112.439 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 282' ' ' THR . . . . . . . . . . . . . 3.4 m -78.29 -26.53 47.06 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 112.981 0.734 . . . . 0.77 112.981 -178.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 63.9 mmtt -129.83 41.64 3.4 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 112.257 0.465 . . . . 1.19 112.257 -179.063 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.65 -62.06 1.89 Allowed 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 113.661 0.985 . . . . 0.66 113.661 -178.664 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -64.04 -42.32 97.11 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 112.794 0.665 . . . . 0.42 112.794 -178.334 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 286' ' ' TRP . . . . . 0.499 ' HE3' HD22 ' A' ' 287' ' ' LEU . 10.0 t90 -60.41 -50.19 74.58 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.733 0.301 . . . . 0.45 111.275 -179.756 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 287' ' ' LEU . . . . . 0.537 ' HB3' HD22 ' A' ' 155' ' ' LEU . 1.6 mm? -66.88 -42.76 85.04 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.319 0.489 . . . . 1.1 112.319 -179.3 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 288' ' ' VAL . . . . . 0.546 HG23 ' HB2' ' A' ' 151' ' ' SER . 0.3 OUTLIER -67.24 -35.8 74.99 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 N-CA-C 112.004 0.372 . . . . 1.78 112.004 -179.487 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 56.1 mttt -77.52 -34.41 54.01 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 112.159 0.429 . . . . 1.23 112.159 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -81.05 23.89 0.54 Allowed 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 112.457 0.54 . . . . 0.73 112.457 -179.382 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 291' ' ' ARG . . . . . 0.684 ' HB3' ' HB2' ' A' ' 294' ' ' ASP . 3.1 mmt180 60.46 16.57 6.49 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.834 0.679 . . . . 0.56 112.834 179.696 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 47.63 -112.58 1.07 Allowed Glycine 0 CA--C 1.525 0.658 0 N-CA-C 114.637 0.615 . . . . 0.34 114.637 179.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 293' ' ' TRP . . . . . 0.534 ' CZ2' ' HA ' ' A' ' 159' ' ' SER . 86.0 m95 -66.74 -30.08 70.22 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.763 0.653 . . . . 0.44 112.763 -178.595 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 294' ' ' ASP . . . . . 0.684 ' HB2' ' HB3' ' A' ' 291' ' ' ARG . 15.5 m-20 -62.01 -42.92 99.68 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 121.049 0.452 . . . . 0.37 110.042 178.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -67.82 -41.86 87.69 Favored Glycine 0 CA--C 1.521 0.414 0 C-N-CA 120.639 -0.791 . . . . 0.34 111.885 178.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 296' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -67.39 -43.34 81.58 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 120.708 0.289 . . . . 0.43 111.315 179.524 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 297' ' ' VAL . . . . . 0.58 HG12 ' HB3' ' A' ' 189' ' ' ARG . 50.3 t -65.89 -55.43 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-N 116.412 -0.358 . . . . 1.0 111.664 -179.32 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -62.56 -30.91 71.67 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 112.709 0.633 . . . . 0.78 112.709 -178.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 299' ' ' PHE . . . . . . . . . . . . . 93.1 t80 -76.54 -40.82 48.81 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 112.372 0.508 . . . . 0.57 112.372 179.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 300' ' ' PHE . . . . . 0.573 ' CE2' ' HB3' ' A' ' 242' ' ' TRP . 62.1 m-85 -93.99 -50.92 5.09 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 114.036 1.124 . . . . 0.46 114.036 -178.044 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 301' ' ' HIS . . . . . 0.41 ' CD2' ' HG2' ' A' ' 196' ' ' ARG . 0.1 OUTLIER -170.17 134.12 1.2 Allowed 'General case' 0 N--CA 1.468 0.432 0 O-C-N 121.88 -0.513 . . . . 0.59 112.318 -177.962 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 31.2 t -100.32 -63.91 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.143 0.497 . . . . 1.08 109.934 178.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 23.1 mm-40 -138.06 -157.71 0.8 Allowed 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.037 -0.529 . . . . 0.71 109.871 178.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -92.24 3.49 55.24 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.225 0.536 . . . . 0.65 110.956 179.152 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 29.5 tp -71.49 -22.36 61.81 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 115.814 -0.63 . . . . 0.96 111.1 179.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -84.71 -20.37 31.29 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.308 -0.405 . . . . 0.71 111.473 179.678 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . 83.64 139.49 3.89 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 121.052 -0.594 . . . . 0.73 113.6 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.005 0 CA-C-O 118.641 -1.088 . . . . 0.71 113.466 179.392 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.06 0.457 . . . . 1.14 111.409 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -68.18 157.95 34.26 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.643 -0.708 . . . . 1.39 111.3 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 20.1 mt -113.68 125.94 28.81 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-O 120.949 0.404 . . . . 1.69 111.444 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 20' ' ' PRO . . . . . 0.427 ' HA ' ' HD3' ' B' ' 21' ' ' PRO . 58.5 Cg_endo -73.56 140.37 29.68 Favored 'Trans proline' 0 CA--C 1.533 0.44 0 C-N-CA 122.28 1.987 . . . . 1.09 112.17 179.444 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 21' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' B' ' 20' ' ' PRO . 32.3 Cg_exo -59.49 0.49 0.53 Allowed 'Trans proline' 0 N--CA 1.481 0.791 0 C-N-CA 123.265 2.643 . . . . 1.02 113.735 -179.655 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 22' ' ' GLU . . . . . 0.416 ' H ' ' C ' ' B' ' 20' ' ' PRO . 0.9 OUTLIER -72.64 -13.25 61.32 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 111.851 0.315 . . . . 0.64 111.851 179.693 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 23' ' ' PHE . . . . . 0.48 ' HD1' ' N ' ' B' ' 24' ' ' ALA . 0.2 OUTLIER -59.91 -33.22 71.57 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.151 0.501 . . . . 0.8 111.077 179.317 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 24' ' ' ALA . . . . . 0.48 ' N ' ' HD1' ' B' ' 23' ' ' PHE . . . -75.83 -38.41 58.1 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.207 0.527 . . . . 0.89 110.027 179.268 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -66.78 -36.63 82.87 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.937 -0.574 . . . . 0.99 109.485 178.201 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -60.54 -51.98 67.12 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 115.822 -0.626 . . . . 0.44 110.23 177.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 94.9 mt -61.86 -30.83 71.12 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 121.052 0.453 . . . . 1.1 110.14 178.556 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 28' ' ' ARG . . . . . . . . . . . . . 34.9 ttm-85 -68.0 -51.46 46.92 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 115.534 -0.757 . . . . 0.55 110.152 178.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 59.6 mttt -57.0 -42.46 80.35 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.296 -0.411 . . . . 0.55 110.599 178.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 69.6 mt -69.45 -42.95 81.12 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 CA-C-N 116.305 -0.407 . . . . 1.09 110.157 178.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.08 -46.18 94.66 Favored Glycine 0 C--N 1.333 0.368 0 C-N-CA 121.056 -0.592 . . . . 0.28 112.299 179.039 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -64.85 -34.98 79.65 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-O 121.176 0.512 . . . . 0.76 110.375 179.114 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 14.2 tppt? -71.73 -47.66 52.33 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.057 -0.52 . . . . 1.26 111.116 179.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 55.5 t -62.68 -44.63 99.6 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-O 120.823 0.344 . . . . 1.06 111.009 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -59.35 -47.24 86.16 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.155 -0.475 . . . . 0.89 110.468 179.102 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 36' ' ' CYS . . . . . . . . . . . . . 11.8 t -70.01 -36.05 74.82 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 116.259 -0.428 . . . . 0.7 111.913 -179.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 99.0 m -64.75 -40.04 94.63 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.209 0.448 . . . . 1.04 112.209 -179.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 38' ' ' TRP . . . . . . . . . . . . . 94.0 m95 -82.78 -31.28 28.33 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 120.821 -0.352 . . . . 0.83 111.781 -179.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 82.9 p -71.67 -26.01 62.35 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 120.737 0.303 . . . . 1.11 111.093 178.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -90.13 141.2 27.62 Favored Pre-proline 0 CA--C 1.533 0.292 0 CA-C-O 120.784 0.326 . . . . 0.89 111.452 179.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -81.64 -8.62 12.42 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 122.696 2.264 . . . . 1.34 113.489 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -79.17 78.93 5.62 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 120.994 0.426 . . . . 1.54 111.348 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 43' ' ' MET . . . . . . . . . . . . . 62.2 mtt . . . . . 0 C--O 1.251 1.142 0 CA-C-O 118.315 -0.85 . . . . 1.59 111.633 -179.718 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.438 0 N-CA-C 112.306 -0.318 . . . . 1.21 112.306 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -69.28 -23.44 32.98 Favored 'Trans proline' 0 CA--C 1.533 0.47 0 C-N-CA 122.515 2.144 . . . . 1.65 112.541 179.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 5.8 tp -133.02 148.13 52.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.201 -0.454 . . . . 2.29 110.323 179.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 128.66 45.96 0.18 Allowed Glycine 0 CA--C 1.523 0.573 0 C-N-CA 120.215 -0.993 . . . . 0.6 113.666 179.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 32.1 t -174.63 28.58 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 121.456 0.646 . . . . 0.6 109.92 179.062 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.41 -50.83 0.47 Allowed 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 115.218 -0.901 . . . . 0.49 111.781 -177.403 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -64.55 -40.9 96.44 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.831 0.348 . . . . 0.52 110.832 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -55.22 -48.34 74.03 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.007 -0.542 . . . . 0.44 110.805 178.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.583 HD21 ' HB3' ' A' ' 287' ' ' LEU . 47.6 tp -73.17 -36.08 66.54 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.091 -0.504 . . . . 1.24 110.783 178.675 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 64.3 t80 -60.06 -40.58 89.97 Favored 'General case' 0 C--O 1.224 -0.282 0 CA-C-N 116.223 -0.444 . . . . 0.44 111.489 179.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.501 ' HD2' ' OE2' ' A' ' 182' ' ' GLU . 7.6 mtm180 -56.22 -52.32 64.85 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.772 0.32 . . . . 0.53 111.552 179.48 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -64.89 -45.93 83.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.126 -0.488 . . . . 0.38 110.658 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' SER . . . . . 0.434 ' HA ' ' CZ2' ' A' ' 293' ' ' TRP . 15.6 m -58.35 -50.25 74.3 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.802 -0.635 . . . . 0.29 111.207 179.46 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.417 ' HA ' HG23 ' A' ' 276' ' ' THR . 2.1 tm? -60.37 -47.57 85.5 Favored 'General case' 0 C--O 1.225 -0.219 0 CA-C-N 116.149 -0.478 . . . . 0.59 111.263 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . 0.488 ' HG2' HD23 ' A' ' 180' ' ' LEU . 44.0 tt0 -58.2 -50.28 74.08 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 120.633 0.254 . . . . 0.42 111.166 -179.708 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 84.9 mt -61.32 -50.14 81.65 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 CA-C-N 116.321 -0.4 . . . . 1.04 111.082 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.499 HD13 HG21 ' A' ' 276' ' ' THR . 68.4 mt -61.45 -46.53 96.38 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 N-CA-C 111.533 0.197 . . . . 1.07 111.533 179.389 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 2.0 t -56.28 -52.63 63.78 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.733 0.302 . . . . 0.48 110.807 178.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 40.0 ttt-85 -61.19 -41.54 96.99 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 120.768 0.318 . . . . 0.41 111.782 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' TYR . . . . . 0.494 ' HE1' ' HA ' ' A' ' 195' ' ' ARG . 80.9 t80 -68.37 -50.3 54.1 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 112.236 0.458 . . . . 0.33 112.236 -179.459 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.469 ' HG ' ' HA ' ' A' ' 253' ' ' ALA . 5.8 mp -54.57 -39.22 67.56 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.66 0.267 . . . . 1.14 111.101 -179.413 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 52.6 mtt-85 -65.32 -44.46 87.75 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.434 -0.348 . . . . 0.42 111.029 178.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -54.18 -45.1 72.04 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 121.111 0.481 . . . . 1.04 111.125 178.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . 0.74 ' HB2' ' HB3' ' A' ' 253' ' ' ALA . 12.3 mm100 -77.01 -37.36 55.17 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 116.18 -0.464 . . . . 0.38 111.951 -179.847 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . 0.426 ' O ' ' HG3' ' A' ' 257' ' ' LYS . . . -65.86 -40.62 91.85 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.916 0.388 . . . . 0.4 110.715 178.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 35.2 p -78.6 -43.89 25.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.348 -0.387 . . . . 0.56 110.938 178.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 101.94 25.16 8.13 Favored Glycine 0 CA--C 1.522 0.499 0 C-N-CA 120.445 -0.883 . . . . 0.57 113.598 179.116 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 41.6 t -145.16 142.74 29.87 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.734 0.302 . . . . 1.33 111.049 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -90.63 104.62 17.19 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.792 0.33 . . . . 0.97 110.814 179.759 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -80.69 161.54 24.57 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.103 0.478 . . . . 0.51 110.869 -179.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 46.3 m -112.8 6.72 18.18 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.253 -0.43 . . . . 0.8 111.813 -179.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 38.1 mttp -61.29 123.84 77.9 Favored Pre-proline 0 N--CA 1.468 0.475 0 CA-C-O 120.836 0.35 . . . . 0.69 111.368 178.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -73.54 156.48 49.63 Favored 'Trans proline' 0 CA--C 1.535 0.56 0 C-N-CA 123.001 2.467 . . . . 1.03 113.822 -179.562 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.488 HD23 ' HG2' ' A' ' 161' ' ' GLU . 5.2 mp -87.88 168.01 13.27 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.701 -0.681 . . . . 1.15 111.213 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -111.23 -45.31 0.87 Allowed Glycine 0 CA--C 1.522 0.478 0 C-N-CA 120.9 -0.667 . . . . 0.49 113.295 -179.401 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . 0.501 ' OE2' ' HD2' ' A' ' 157' ' ' ARG . 0.0 OUTLIER -86.67 -58.94 2.42 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 121.235 0.541 . . . . 0.55 110.702 -179.833 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . 0.624 ' O ' ' HA3' ' A' ' 187' ' ' GLY . . . -80.13 80.36 6.57 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.182 0.515 . . . . 0.44 111.439 -179.724 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -80.09 -71.97 1.24 Allowed Glycine 0 CA--C 1.524 0.643 0 C-N-CA 120.609 -0.805 . . . . 0.39 113.356 179.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -68.17 -55.61 11.71 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-O 120.979 0.418 . . . . 0.64 111.118 -179.608 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -65.18 -39.08 92.39 Favored 'General case' 0 C--O 1.218 -0.555 0 CA-C-N 115.904 -0.589 . . . . 0.55 110.077 178.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . 0.624 ' HA3' ' O ' ' A' ' 183' ' ' ALA . . . -60.6 -50.82 63.4 Favored Glycine 0 C--O 1.219 -0.79 0 C-N-CA 121.399 -0.429 . . . . 0.35 113.135 179.641 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . 0.417 HH11 ' HD2' ' A' ' 188' ' ' ARG . 13.4 mtp180 -56.84 -47.85 79.39 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 117.547 0.673 . . . . 1.8 111.484 179.234 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . 0.698 ' HB3' HG13 ' A' ' 297' ' ' VAL . 48.3 mtm180 -70.29 -41.0 73.95 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 112.479 0.548 . . . . 0.52 112.479 -179.438 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . 0.513 ' HA ' HG21 ' A' ' 297' ' ' VAL . . . -74.22 -44.63 52.39 Favored 'General case' 0 C--O 1.221 -0.408 0 N-CA-C 111.873 0.323 . . . . 1.07 111.873 -178.649 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 3.4 tp -61.07 -49.32 77.83 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.679 -0.408 . . . . 1.08 110.319 179.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -61.08 -44.11 97.86 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 120.706 -0.398 . . . . 0.98 110.996 179.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 91.5 m -63.53 -46.19 87.13 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 110.026 -0.361 . . . . 0.8 110.026 178.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 59.8 tp -63.58 -37.27 86.68 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.075 -0.511 . . . . 1.04 111.184 179.196 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . 0.494 ' HA ' ' HE1' ' A' ' 166' ' ' TYR . 2.1 mtt180 -58.6 -48.34 81.28 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.819 0.342 . . . . 0.48 110.711 178.709 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 10.5 mmp_? -74.66 -45.12 46.75 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 116.149 -0.478 . . . . 0.45 111.868 -179.25 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . 0.468 ' O ' HG23 ' A' ' 201' ' ' VAL . 49.7 t -65.67 -51.55 61.18 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 CA-C-O 120.687 0.279 . . . . 1.01 111.628 179.529 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -62.31 -53.23 43.74 Favored Glycine 0 CA--C 1.521 0.435 0 CA-C-O 119.933 -0.371 . . . . 0.3 113.388 -179.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -55.18 -40.34 70.61 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 117.225 0.513 . . . . 0.4 109.763 179.011 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -60.36 -53.6 44.17 Favored Glycine 0 C--N 1.335 0.507 0 N-CA-C 111.138 -0.785 . . . . 0.36 111.138 177.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 197' ' ' VAL . 98.9 t -58.29 -38.33 68.33 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-O 120.792 0.33 . . . . 1.12 110.691 178.461 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 202' ' ' GLN . . . . . 0.49 ' HG3' ' HB3' ' A' ' 250' ' ' SER . 31.7 mt-30 -62.91 -54.2 42.23 Favored 'General case' 0 C--O 1.225 -0.228 0 CA-C-N 115.818 -0.628 . . . . 0.47 111.803 179.594 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 29.0 mtp180 -67.88 -36.34 80.07 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 121.028 -0.269 . . . . 0.64 111.434 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 10.9 m-80 -62.98 -50.95 68.73 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 121.181 0.515 . . . . 1.71 110.499 178.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 57.1 m-70 -101.85 35.89 2.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.214 -0.448 . . . . 0.62 111.233 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -53.47 -47.45 69.75 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 112.23 0.456 . . . . 0.44 112.23 -179.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -56.34 -39.51 72.95 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 112.285 0.476 . . . . 0.93 112.285 -179.78 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -64.86 -48.79 73.01 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 120.989 0.424 . . . . 1.06 110.84 -179.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 209' ' ' PHE . . . . . 0.609 ' O ' ' HB2' ' A' ' 213' ' ' LEU . 46.3 m-85 -66.76 -35.27 79.71 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.94 -0.573 . . . . 0.82 109.912 178.692 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 210' ' ' GLN . . . . . 0.559 ' O ' ' HG2' ' A' ' 214' ' ' ARG . 49.5 mt-30 -66.12 -45.78 79.92 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.481 -0.327 . . . . 0.66 111.181 179.005 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -55.7 -49.03 67.8 Favored Glycine 0 C--N 1.336 0.574 0 N-CA-C 111.14 -0.784 . . . . 0.39 111.14 178.29 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -68.54 -29.86 68.53 Favored 'General case' 0 C--O 1.221 -0.42 0 CA-C-O 120.602 0.239 . . . . 1.23 110.367 178.144 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . 0.609 ' HB2' ' O ' ' A' ' 209' ' ' PHE . 0.3 OUTLIER -69.55 -41.56 75.75 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.521 -0.309 . . . . 1.06 111.507 179.668 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 214' ' ' ARG . . . . . 0.559 ' HG2' ' O ' ' A' ' 210' ' ' GLN . 2.8 mmp_? -66.52 -40.03 88.95 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 121.185 0.517 . . . . 0.67 110.137 179.569 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 48.1 mtmt -91.87 13.15 19.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.888 -0.596 . . . . 1.03 111.94 179.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . 0.448 HD23 HG11 ' A' ' 255' ' ' VAL . 7.4 tp -79.72 106.4 11.72 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 121.422 0.629 . . . . 0.77 111.34 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -84.13 -2.14 56.26 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 115.011 -0.995 . . . . 0.55 111.708 -179.341 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 218' ' ' ILE . . . . . 0.608 HG12 ' HB3' ' A' ' 223' ' ' ASP . 46.9 mt -53.71 114.37 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 N-CA-C 112.255 0.465 . . . . 0.86 112.255 -179.75 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 26.5 mtmm -138.11 -28.4 0.86 Allowed 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 115.982 -0.553 . . . . 1.14 112.424 -179.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -125.14 -179.37 4.54 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 113.017 0.747 . . . . 0.63 113.017 -178.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . 0.553 ' O ' HG21 ' A' ' 224' ' ' VAL . 1.2 mp0 -64.3 -22.05 66.82 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.448 -0.796 . . . . 0.6 111.376 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -71.49 -26.82 72.44 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 121.021 -0.609 . . . . 0.42 112.859 179.177 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 223' ' ' ASP . . . . . 0.608 ' HB3' HG12 ' A' ' 218' ' ' ILE . 39.3 m-20 -68.37 -31.45 70.84 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 112.283 0.475 . . . . 0.37 112.283 -179.632 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . 0.553 HG21 ' O ' ' A' ' 221' ' ' GLU . 3.1 m -58.16 -27.67 32.63 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 CA-C-O 120.745 0.307 . . . . 1.11 111.73 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 6.1 mptt -65.16 -37.08 86.26 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.107 0.48 . . . . 1.37 109.9 178.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 226' ' ' SER . . . . . 0.618 ' O ' HG21 ' A' ' 230' ' ' VAL . 18.4 t -67.57 -44.13 78.93 Favored 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 109.176 -0.676 . . . . 0.42 109.176 178.214 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 227' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -59.76 -39.96 86.57 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 115.391 -0.822 . . . . 0.56 110.19 178.495 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 228' ' ' SER . . . . . 0.631 ' HA ' ' HE1' ' A' ' 231' ' ' MET . 15.9 m -63.44 -39.48 94.58 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.168 0.508 . . . . 0.41 109.883 178.441 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 28.2 mtp180 -65.88 -35.51 80.84 Favored 'General case' 0 C--O 1.225 -0.202 0 CA-C-N 115.482 -0.781 . . . . 0.84 109.766 178.237 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . 0.618 HG21 ' O ' ' A' ' 226' ' ' SER . 56.8 t -60.86 -51.18 76.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 109.879 -0.415 . . . . 1.08 109.879 177.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 231' ' ' MET . . . . . 0.631 ' HE1' ' HA ' ' A' ' 228' ' ' SER . 56.5 mtm -55.73 -53.35 57.64 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.891 -0.595 . . . . 0.62 111.788 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 35.2 m -63.87 -30.91 51.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 120.861 -0.336 . . . . 1.06 111.167 179.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 233' ' ' HIS . . . . . 0.459 ' O ' ' HB3' ' A' ' 236' ' ' LYS . 44.5 t-80 -69.82 -39.56 76.41 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 120.962 0.41 . . . . 0.6 110.321 178.51 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 69.0 t -71.8 -41.0 70.03 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 CA-C-O 120.969 0.414 . . . . 0.95 111.046 178.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -87.9 12.73 12.43 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 120.954 0.407 . . . . 0.98 111.574 179.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . 0.521 ' O ' ' HG2' ' A' ' 236' ' ' LYS . 0.0 OUTLIER -68.99 -15.32 63.45 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 115.606 -0.725 . . . . 0.71 111.267 179.221 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . 0.456 ' HA ' ' NZ ' ' A' ' 236' ' ' LYS . 71.8 m-20 -75.86 -7.89 55.57 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 122.085 -0.385 . . . . 0.4 111.651 179.812 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 84.92 -19.97 18.28 Favored Glycine 0 CA--C 1.519 0.291 0 C-N-CA 121.014 -0.613 . . . . 0.4 112.773 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 2.5 t -91.97 108.89 20.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.148 0.499 . . . . 1.44 111.166 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 240' ' ' THR . . . . . 0.516 HG23 HD12 ' A' ' 245' ' ' ILE . 3.4 m -89.79 68.2 7.43 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.206 -0.452 . . . . 0.75 111.131 -179.793 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . 0.462 ' HB2' ' HG3' ' A' ' 244' ' ' ARG . 11.9 m120 -66.24 141.58 57.99 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.918 0.389 . . . . 0.47 111.431 -179.771 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 242' ' ' TRP . . . . . 0.48 ' CZ3' ' HB2' ' A' ' 296' ' ' PHE . 76.1 m95 -59.69 -36.35 76.31 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.282 -0.417 . . . . 0.49 110.369 178.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . 0.432 ' HA3' ' HB2' ' B' ' 35' ' ' TYR . . . -61.14 -31.75 77.97 Favored Glycine 0 C--N 1.335 0.5 0 C-N-CA 121.082 -0.58 . . . . 0.28 112.058 178.083 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 244' ' ' ARG . . . . . 0.518 ' HG2' ' HA3' ' B' ' 31' ' ' GLY . 81.6 mtt180 -75.76 -32.74 60.08 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 121.151 0.501 . . . . 0.48 109.914 178.684 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . 0.516 HD12 HG23 ' A' ' 240' ' ' THR . 78.1 mt -72.05 -49.63 42.73 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 CA-C-N 115.78 -0.646 . . . . 1.14 110.692 179.064 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 26.9 m -67.56 -31.51 52.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 C-N-CA 121.171 -0.212 . . . . 1.02 111.324 179.333 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 247' ' ' THR . . . . . 0.423 HG22 HD22 ' B' ' 27' ' ' LEU . 30.9 m -67.53 -40.5 85.07 Favored 'General case' 0 C--O 1.232 0.157 0 N-CA-C 109.134 -0.691 . . . . 0.77 109.134 177.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.5 -42.26 98.53 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 109.047 -0.723 . . . . 1.18 109.047 177.14 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 249' ' ' ILE . . . . . 0.436 HG13 ' O ' ' A' ' 245' ' ' ILE . 49.7 mt -63.36 -44.99 99.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.404 0 CA-C-N 115.812 -0.631 . . . . 1.08 110.219 178.105 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 250' ' ' SER . . . . . 0.49 ' HB3' ' HG3' ' A' ' 202' ' ' GLN . 40.3 m -58.98 -44.22 91.56 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.062 -0.517 . . . . 0.49 110.005 178.699 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 251' ' ' PHE . . . . . . . . . . . . . 21.7 t80 -63.67 -44.28 94.21 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 115.89 -0.596 . . . . 0.46 109.495 177.369 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -56.22 -44.61 89.04 Favored Glycine 0 C--N 1.336 0.552 0 C-N-CA 121.067 -0.587 . . . . 0.28 111.705 178.462 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 253' ' ' ALA . . . . . 0.74 ' HB3' ' HB2' ' A' ' 170' ' ' GLN . . . -59.96 -43.16 95.23 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.669 0.271 . . . . 0.94 110.585 177.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 254' ' ' PHE . . . . . 0.46 ' HD1' HE21 ' A' ' 202' ' ' GLN . 0.3 OUTLIER -65.04 -40.64 95.08 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 121.233 0.539 . . . . 0.79 110.215 178.462 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 255' ' ' VAL . . . . . 0.448 HG11 HD23 ' A' ' 216' ' ' LEU . 78.4 t -66.63 -39.97 85.11 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-N 116.107 -0.497 . . . . 1.1 110.207 178.561 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -57.86 -39.42 77.72 Favored 'General case' 0 N--CA 1.461 0.097 0 CA-C-O 121.469 0.652 . . . . 0.32 109.259 178.093 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 257' ' ' LYS . . . . . 0.426 ' HG3' ' O ' ' A' ' 171' ' ' ALA . 23.1 tttp -61.65 -41.72 97.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.262 -0.881 . . . . 0.44 110.236 178.062 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 71.3 t60 -58.77 -45.58 89.48 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 116.243 -0.435 . . . . 0.58 110.719 178.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . 0.52 HD22 ' NE2' ' A' ' 264' ' ' GLN . 13.1 mt -70.86 -43.1 69.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.248 -0.433 . . . . 0.6 110.932 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 21.0 ttmm -63.1 -36.93 85.22 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.785 0.326 . . . . 0.97 111.089 179.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 54.3 m -63.15 -25.46 68.36 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 116.387 -0.369 . . . . 0.72 111.684 179.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 262' ' ' VAL . . . . . 0.503 HG23 ' HG3' ' A' ' 264' ' ' GLN . 17.9 m -108.67 21.8 4.64 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-O 120.848 0.356 . . . . 1.07 111.23 179.34 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 57.32 42.55 24.86 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 112.903 0.705 . . . . 2.28 112.903 179.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 264' ' ' GLN . . . . . 0.52 ' NE2' HD22 ' A' ' 259' ' ' LEU . 10.5 mt-30 -98.22 38.4 1.33 Allowed 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.219 0.451 . . . . 0.58 112.219 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -51.48 -37.33 48.42 Favored 'General case' 0 C--O 1.243 0.715 0 CA-C-O 120.892 0.377 . . . . 0.8 111.857 179.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 26.5 p -62.59 -16.88 58.62 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 116.101 -0.499 . . . . 1.29 111.162 178.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -110.44 -12.18 14.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.939 -0.573 . . . . 0.93 109.889 178.271 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 8.4 mm -66.41 -49.33 76.34 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 CA-C-N 115.834 -0.621 . . . . 1.02 110.303 179.06 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 269' ' ' GLU . . . . . 0.731 ' HB2' ' HD3' ' A' ' 270' ' ' PRO . 57.4 mm-40 -61.44 -54.95 47.73 Favored Pre-proline 0 CA--C 1.545 0.765 0 CA-C-N 115.841 -0.618 . . . . 0.51 111.106 179.331 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 270' ' ' PRO . . . . . 0.731 ' HD3' ' HB2' ' A' ' 269' ' ' GLU . 51.2 Cg_exo -57.0 -36.14 99.2 Favored 'Trans proline' 0 C--N 1.359 1.086 0 C-N-CA 122.244 1.963 . . . . 0.37 112.879 178.577 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 271' ' ' LEU . . . . . 0.403 ' O ' HG13 ' A' ' 275' ' ' ILE . 18.6 tp -63.84 -52.1 61.63 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.485 0.183 . . . . 0.87 111.188 179.035 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -58.16 -39.79 79.75 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.276 -0.42 . . . . 1.06 111.242 179.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 273' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -71.36 -40.48 70.61 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.247 -0.433 . . . . 0.61 110.723 178.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 274' ' ' THR . . . . . 0.532 HG21 ' HB ' ' A' ' 224' ' ' VAL . 87.3 m -63.53 -43.84 95.98 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.874 0.368 . . . . 1.09 110.679 179.309 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 275' ' ' ILE . . . . . 0.439 ' HA ' ' CE ' ' A' ' 231' ' ' MET . 88.1 mt -61.88 -54.88 28.71 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.083 0 CA-C-N 116.277 -0.42 . . . . 1.1 110.414 179.163 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 276' ' ' THR . . . . . 0.499 HG21 HD13 ' A' ' 163' ' ' ILE . 24.2 m -56.41 -51.07 69.74 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.26 -0.427 . . . . 1.04 111.533 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 277' ' ' ASP . . . . . 0.635 ' O ' ' HB2' ' A' ' 281' ' ' ARG . 29.7 t70 -52.26 -60.22 3.47 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.35 -0.386 . . . . 0.39 111.79 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 278' ' ' VAL . . . . . 0.422 ' HB ' ' HE3' ' A' ' 231' ' ' MET . 59.6 t -63.94 -42.57 96.19 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 N-CA-C 112.336 0.495 . . . . 0.96 112.336 -179.074 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 27.1 tp -60.72 -47.61 85.51 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 111.987 0.365 . . . . 1.26 111.987 -179.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 86.7 t -80.96 -46.32 20.82 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 N-CA-C 113.056 0.761 . . . . 1.03 113.056 -178.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 281' ' ' ARG . . . . . 0.635 ' HB2' ' O ' ' A' ' 277' ' ' ASP . 1.5 mpt_? -60.72 -35.59 76.7 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 113.039 0.755 . . . . 0.49 113.039 -178.32 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 282' ' ' THR . . . . . . . . . . . . . 85.0 m -65.09 -38.13 89.73 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 112.389 0.514 . . . . 1.04 112.389 -179.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 28.8 mmtp -129.67 42.1 3.34 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 112.582 0.586 . . . . 1.05 112.582 -178.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -60.35 -28.82 68.47 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 111.965 0.357 . . . . 0.98 111.965 -179.697 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 285' ' ' ASP . . . . . 0.449 ' HA ' HG22 ' A' ' 288' ' ' VAL . 3.1 t70 -62.41 -44.99 95.12 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-O 121.023 0.439 . . . . 0.71 110.383 179.201 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 286' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -61.09 -35.61 77.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.307 0.575 . . . . 0.63 110.13 178.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 287' ' ' LEU . . . . . 0.583 ' HB3' HD21 ' A' ' 155' ' ' LEU . 1.2 mm? -71.24 -54.31 11.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.517 -0.765 . . . . 1.0 111.148 179.378 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 288' ' ' VAL . . . . . 0.449 HG22 ' HA ' ' A' ' 285' ' ' ASP . 33.8 m -59.96 -30.39 45.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 N-CA-C 111.763 0.283 . . . . 1.1 111.763 -179.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 27.8 mttp -65.77 -32.43 73.96 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.861 0.363 . . . . 1.29 110.927 178.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 -108.51 28.98 7.82 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 111.873 0.323 . . . . 0.96 111.873 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 291' ' ' ARG . . . . . 0.757 ' HB3' ' HB2' ' A' ' 294' ' ' ASP . 0.8 OUTLIER 61.84 19.41 10.6 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 112.612 0.597 . . . . 0.52 112.612 178.896 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 69.11 -118.02 8.4 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 121.302 -0.475 . . . . 0.35 113.236 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 293' ' ' TRP . . . . . 0.652 ' O ' HG23 ' A' ' 297' ' ' VAL . 90.5 m95 -72.0 -21.7 61.52 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 111.683 0.253 . . . . 0.43 111.683 -179.262 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 294' ' ' ASP . . . . . 0.757 ' HB2' ' HB3' ' A' ' 291' ' ' ARG . 60.1 m-20 -57.74 -51.5 69.29 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 109.509 -0.552 . . . . 0.45 109.509 178.019 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -65.25 -41.36 96.82 Favored Glycine 0 C--N 1.335 0.52 0 N-CA-C 111.355 -0.698 . . . . 0.32 111.355 178.137 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 296' ' ' PHE . . . . . 0.48 ' HB2' ' CZ3' ' A' ' 242' ' ' TRP . 6.7 t80 -56.33 -46.04 80.09 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 120.753 0.311 . . . . 0.42 111.371 178.707 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 297' ' ' VAL . . . . . 0.698 HG13 ' HB3' ' A' ' 189' ' ' ARG . 88.9 t -58.48 -54.6 30.85 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 CA-C-O 120.96 0.409 . . . . 0.87 111.768 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -71.23 -29.86 65.65 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.948 0.721 . . . . 0.99 112.948 -178.488 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 299' ' ' PHE . . . . . 0.502 ' CZ ' ' HB2' ' B' ' 39' ' ' SER . 61.3 t80 -59.18 -46.11 89.26 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.901 0.381 . . . . 0.48 111.051 178.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 300' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -86.45 25.02 1.28 Allowed 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 121.132 0.491 . . . . 0.57 111.902 -179.599 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 14.0 m170 -114.09 13.39 18.1 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.066 -0.516 . . . . 0.93 110.714 178.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 59.3 t -77.78 100.97 3.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.981 -0.554 . . . . 1.33 110.632 178.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -160.04 -151.23 0.24 Allowed 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.017 -0.538 . . . . 1.36 110.459 -179.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -75.2 80.2 2.33 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.398 0.618 . . . . 1.49 111.251 179.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 305' ' ' LEU . . . . . 0.485 ' HB2' ' HE2' ' B' ' 43' ' ' MET . 82.8 mt -83.15 -55.65 4.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.207 -0.451 . . . . 1.67 111.155 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 7.0 mp0 -97.94 -4.39 36.48 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 120.953 0.406 . . . . 1.8 111.199 179.314 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . 102.76 -95.72 1.3 Allowed Glycine 0 CA--C 1.522 0.493 0 C-N-CA 120.8 -0.714 . . . . 1.77 112.821 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.158 0 CA-C-O 118.472 -1.182 . . . . 2.68 113.108 -179.856 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.49 0 N-CA-C 111.568 0.21 . . . . 0.65 111.568 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -141.3 149.45 41.25 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 121.048 0.452 . . . . 0.64 111.312 -179.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 19' ' ' LEU . . . . . 0.508 ' HB2' ' CE2' ' B' ' 23' ' ' PHE . 0.1 OUTLIER -114.02 160.92 30.51 Favored Pre-proline 0 CA--C 1.538 0.513 0 CA-C-N 115.9 -0.591 . . . . 1.07 111.106 -179.242 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 20' ' ' PRO . . . . . 0.404 ' HA ' ' HD3' ' B' ' 21' ' ' PRO . 36.2 Cg_endo -64.84 145.13 85.47 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 122.844 2.363 . . . . 0.79 113.223 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 21' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' B' ' 20' ' ' PRO . 39.7 Cg_exo -58.34 -1.77 0.76 Allowed 'Trans proline' 0 N--CA 1.483 0.872 0 C-N-CA 123.749 2.966 . . . . 0.95 114.689 -179.093 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -64.11 -26.18 68.42 Favored 'General case' 0 C--N 1.328 -0.337 0 O-C-N 122.317 -0.239 . . . . 1.19 111.62 179.127 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 23' ' ' PHE . . . . . 0.62 ' HD1' ' N ' ' B' ' 24' ' ' ALA . 0.2 OUTLIER -62.36 -33.9 75.63 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 120.788 -0.365 . . . . 0.38 111.422 -179.967 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 24' ' ' ALA . . . . . 0.62 ' N ' ' HD1' ' B' ' 23' ' ' PHE . . . -76.83 -40.22 48.63 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.855 0.36 . . . . 0.76 110.561 -179.73 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -69.94 -40.56 75.4 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.075 -0.511 . . . . 1.14 111.577 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -68.96 -50.92 44.96 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 111.909 0.337 . . . . 0.66 111.909 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . 0.423 HD22 HG22 ' A' ' 247' ' ' THR . 81.7 mt -64.8 -30.39 71.4 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 111.734 0.272 . . . . 0.75 111.734 -179.332 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 28' ' ' ARG . . . . . 0.501 ' HB2' ' O ' ' B' ' 24' ' ' ALA . 0.0 OUTLIER -70.67 -55.92 7.61 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 120.886 0.374 . . . . 0.54 110.795 178.35 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 34.9 mtmm -61.64 -53.01 61.86 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 116.463 -0.335 . . . . 0.51 111.672 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 97.4 mt -58.39 -40.02 76.7 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.077 0 CA-C-N 116.41 -0.359 . . . . 1.01 110.573 -179.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . 0.518 ' HA3' ' HG2' ' A' ' 244' ' ' ARG . . . -56.61 -50.01 65.99 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.946 -0.645 . . . . 0.27 112.45 179.388 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 32' ' ' ASP . . . . . 0.401 ' CG ' HH21 ' A' ' 244' ' ' ARG . 65.0 m-20 -72.09 -40.37 68.25 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.927 0.364 . . . . 0.73 111.43 179.602 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 33' ' ' LYS . . . . . 0.451 ' HA ' ' HD2' ' B' ' 33' ' ' LYS . 1.1 tptt -59.45 -51.68 68.85 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 120.879 0.371 . . . . 1.39 110.749 179.245 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 33.6 t -63.94 -46.42 94.11 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 CA-C-N 116.057 -0.52 . . . . 0.68 110.467 178.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 35' ' ' TYR . . . . . 0.432 ' HB2' ' HA3' ' A' ' 243' ' ' GLY . 9.0 t80 -56.56 -48.26 77.72 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 115.934 -0.575 . . . . 0.93 111.517 179.39 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 36' ' ' CYS . . . . . . . . . . . . . 80.8 m -63.98 -33.04 74.84 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.866 0.365 . . . . 0.54 111.164 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 34.5 m -69.63 -33.51 72.75 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.081 -0.509 . . . . 1.46 111.704 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 38' ' ' TRP . . . . . . . . . . . . . 80.8 m95 -87.96 -34.64 18.01 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 120.675 0.274 . . . . 0.67 111.661 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 39' ' ' SER . . . . . 0.502 ' HB2' ' CZ ' ' A' ' 299' ' ' PHE . 39.1 t -89.66 32.53 0.87 Allowed 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.016 0.436 . . . . 0.61 111.018 179.045 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -89.76 124.59 63.5 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.351 -0.386 . . . . 1.19 111.453 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -75.78 65.67 6.72 Favored 'Trans proline' 0 CA--C 1.535 0.548 0 C-N-CA 122.593 2.195 . . . . 1.61 113.041 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -78.93 -25.08 43.63 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.394 -0.367 . . . . 1.57 111.21 179.366 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 43' ' ' MET . . . . . 0.485 ' HE2' ' HB2' ' A' ' 305' ' ' LEU . 29.6 ttp . . . . . 0 C--O 1.251 1.15 0 CA-C-O 118.38 -0.819 . . . . 1.67 110.944 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.51 ' H1 ' ' CG ' ' A' ' 154' ' ' ASP . . . . . . . . 0 N--CA 1.491 2.309 0 CA-C-O 120.18 -0.233 . . . . 4.91 112.768 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -71.61 -25.69 20.56 Favored 'Trans proline' 0 CA--C 1.534 0.519 0 C-N-CA 123.021 2.481 . . . . 5.0 113.384 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.417 ' HB2' ' HB3' ' A' ' 154' ' ' ASP . 91.3 mt -105.83 -51.79 2.93 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.877 0.37 . . . . 3.57 110.661 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -139.4 -108.01 0.76 Allowed Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.878 -0.677 . . . . 1.71 111.867 179.073 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 17.1 t -138.19 -48.84 0.55 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.281 0.562 . . . . 1.52 111.672 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -123.97 -26.83 3.99 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.386 -0.825 . . . . 0.84 110.499 -178.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -56.34 -52.51 64.27 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.727 0.811 . . . . 1.01 112.706 -179.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . 0.51 ' CG ' ' H1 ' ' A' ' 147' ' ' GLY . 0.6 OUTLIER -58.86 -52.53 65.35 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.926 0.393 . . . . 0.97 111.236 179.769 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 1.4 mt -60.56 -39.51 88.25 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.167 -0.47 . . . . 1.31 110.925 178.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -66.75 -39.03 87.76 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.544 -0.298 . . . . 1.03 111.459 179.493 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.606 ' HD2' ' OE2' ' A' ' 182' ' ' GLU . 1.5 mmt180 -57.04 -51.64 68.44 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.714 0.293 . . . . 1.07 111.24 179.772 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 71.0 mt-30 -69.28 -42.17 75.85 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.991 -0.283 . . . . 0.63 111.095 179.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 49.4 m -59.97 -49.78 76.32 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 111.752 0.278 . . . . 0.37 111.752 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.628 HD23 ' HA ' ' A' ' 273' ' ' GLU . 1.5 tm? -58.44 -53.41 58.63 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.548 -0.296 . . . . 1.4 110.994 179.539 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . 0.448 ' CD ' ' HZ2' ' A' ' 178' ' ' LYS . 6.3 mm-40 -60.48 -47.43 86.17 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 112.013 0.375 . . . . 1.1 112.013 -179.631 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . 0.492 HG12 ' HA2' ' A' ' 187' ' ' GLY . 83.2 mt -61.99 -47.54 92.72 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-O 120.621 0.248 . . . . 1.14 111.392 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 39.6 mt -64.19 -45.54 96.04 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 CA-C-N 116.745 -0.207 . . . . 1.18 110.733 179.245 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 27.2 t -57.98 -44.71 87.3 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.944 0.402 . . . . 0.66 110.006 178.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . 0.684 HH21 ' HB3' ' A' ' 176' ' ' ASP . 0.2 OUTLIER -61.02 -44.62 97.14 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 115.658 -0.701 . . . . 0.61 111.611 179.117 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' TYR . . . . . 0.901 ' HE1' ' HA ' ' A' ' 195' ' ' ARG . 75.6 t80 -68.22 -51.18 48.33 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 111.824 0.305 . . . . 0.47 111.824 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 8.6 mp -58.85 -41.29 86.62 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.713 -0.221 . . . . 0.94 111.455 -179.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . 0.417 ' HD3' ' OD1' ' A' ' 176' ' ' ASP . 5.4 mtt-85 -67.27 -39.67 86.08 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.009 0.433 . . . . 1.09 111.029 179.122 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -68.57 -48.19 64.87 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.159 -0.473 . . . . 0.8 111.377 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . 0.434 ' HG3' ' CZ ' ' A' ' 166' ' ' TYR . 27.6 mm-40 -65.56 -25.97 67.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.699 0.285 . . . . 0.56 111.158 178.779 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -79.24 -32.63 43.89 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 116.486 -0.325 . . . . 0.92 111.401 178.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 2.9 p -82.83 -23.09 33.92 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 111.88 0.326 . . . . 1.37 111.88 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 73.35 17.37 78.86 Favored Glycine 0 CA--C 1.521 0.423 0 C-N-CA 121.072 -0.585 . . . . 0.7 113.131 179.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 72.0 p -151.07 -92.67 0.06 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.865 0.364 . . . . 1.02 111.468 -179.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -145.95 127.21 14.82 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.089 0.471 . . . . 1.51 111.46 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . 0.684 ' HB3' HH21 ' A' ' 165' ' ' ARG . 0.1 OUTLIER -87.31 129.4 35.02 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.118 0.485 . . . . 0.64 110.751 179.388 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 56.6 m -85.84 70.8 10.69 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.294 -0.412 . . . . 1.21 111.859 -179.299 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . 0.513 ' HG2' ' HD2' ' A' ' 179' ' ' PRO . 6.3 ttpp -136.99 133.32 18.57 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 116.533 -0.303 . . . . 1.11 111.01 179.396 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . 0.513 ' HD2' ' HG2' ' A' ' 178' ' ' LYS . 59.6 Cg_endo -73.5 144.78 36.67 Favored 'Trans proline' 0 CA--C 1.531 0.338 0 C-N-CA 122.348 2.032 . . . . 1.04 112.317 179.192 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 11.6 mt -87.83 -19.65 27.15 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.44 -0.345 . . . . 1.22 111.922 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 55.26 -114.84 5.05 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 114.303 0.481 . . . . 0.84 114.303 179.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . 0.606 ' OE2' ' HD2' ' A' ' 157' ' ' ARG . 2.5 mp0 -70.95 -5.8 33.68 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 112.444 0.535 . . . . 1.04 112.444 -179.683 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . 0.486 ' O ' ' HA3' ' A' ' 187' ' ' GLY . . . -105.87 56.68 0.67 Allowed 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 120.933 0.397 . . . . 1.09 111.269 179.521 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -79.13 -70.51 1.32 Allowed Glycine 0 CA--C 1.524 0.634 0 C-N-CA 120.696 -0.764 . . . . 0.53 113.479 -179.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -61.83 -55.91 24.94 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 120.774 0.321 . . . . 0.77 111.253 -179.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -62.31 -37.34 85.2 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.265 -0.425 . . . . 0.87 110.452 179.083 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . 0.492 ' HA2' HG12 ' A' ' 162' ' ' ILE . . . -63.2 -42.81 99.29 Favored Glycine 0 C--N 1.334 0.464 0 C-N-CA 121.2 -0.524 . . . . 0.4 112.659 179.528 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 40.8 ttt-85 -62.55 -48.93 77.34 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 117.022 0.411 . . . . 1.21 110.907 179.24 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . 0.732 ' HB3' HG12 ' A' ' 297' ' ' VAL . 34.8 mtp180 -66.28 -41.28 90.05 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.218 -0.446 . . . . 0.58 111.264 179.515 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -68.91 -45.86 69.8 Favored 'General case' 0 C--O 1.219 -0.504 0 CA-C-N 116.177 -0.465 . . . . 0.46 111.836 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . 0.446 ' HB2' ' O ' ' A' ' 187' ' ' GLY . 0.9 OUTLIER -59.37 -45.78 90.49 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.626 0.25 . . . . 1.23 111.22 179.505 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -62.34 -49.67 74.67 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 121.101 0.477 . . . . 0.59 111.172 179.389 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 25.7 m -66.04 -51.2 60.43 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.01 -0.541 . . . . 0.96 111.7 -179.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . 0.442 HD23 HG23 ' A' ' 249' ' ' ILE . 12.6 tp -58.27 -40.4 81.76 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.222 -0.445 . . . . 1.13 111.736 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . 0.901 ' HA ' ' HE1' ' A' ' 166' ' ' TYR . 43.4 ttm180 -61.31 -53.58 54.95 Favored 'General case' 0 N--CA 1.461 0.121 0 CA-C-O 120.606 0.241 . . . . 1.1 110.705 178.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 22.9 ttm105 -60.96 -50.17 74.48 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.24 -0.437 . . . . 0.54 112.149 -179.436 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . 0.461 ' O ' HG21 ' A' ' 201' ' ' VAL . 53.3 t -65.51 -48.71 81.85 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 N-CA-C 111.996 0.369 . . . . 1.04 111.996 -179.351 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . 0.601 ' HA3' ' HH ' ' A' ' 166' ' ' TYR . . . -61.5 -42.93 99.87 Favored Glycine 0 C--N 1.334 0.432 0 C-N-CA 121.108 -0.568 . . . . 0.32 113.03 -179.598 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . 0.408 ' HB2' ' O ' ' A' ' 195' ' ' ARG . 0.8 OUTLIER -62.33 -45.11 94.7 Favored 'General case' 0 N--CA 1.46 0.074 0 N-CA-C 109.564 -0.532 . . . . 0.89 109.564 178.617 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -61.22 -42.78 99.88 Favored Glycine 0 C--N 1.337 0.605 0 C-N-CA 120.841 -0.695 . . . . 0.33 111.917 178.399 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . 0.461 HG21 ' O ' ' A' ' 197' ' ' VAL . 67.4 t -62.34 -47.69 91.88 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-O 120.593 0.235 . . . . 0.91 110.936 178.536 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 202' ' ' GLN . . . . . 0.41 ' OE1' ' HD1' ' A' ' 254' ' ' PHE . 37.6 mt-30 -65.78 -41.32 92.14 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.353 -0.385 . . . . 0.39 111.476 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.64 -37.3 85.82 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.03 0.443 . . . . 0.84 110.546 179.077 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 18.0 m-80 -78.18 -52.37 8.8 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.155 -0.475 . . . . 0.7 111.477 179.468 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 205' ' ' HIS . . . . . 0.438 ' ND1' HG12 ' B' ' 30' ' ' ILE . 75.4 m-70 -92.18 35.86 0.99 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.743 0.306 . . . . 0.9 111.306 -179.373 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -58.29 -49.68 76.28 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.424 0.527 . . . . 0.58 112.424 -179.015 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 69.2 p -60.49 -39.31 87.21 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.896 0.379 . . . . 1.08 111.722 -179.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -66.65 -50.38 63.13 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-N 115.915 -0.584 . . . . 0.63 110.78 179.561 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 209' ' ' PHE . . . . . 0.448 ' HB3' ' CD2' ' A' ' 254' ' ' PHE . 31.0 m-85 -63.17 -41.09 99.17 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.882 -0.599 . . . . 0.65 110.495 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 12.0 mt-30 -59.48 -45.44 91.66 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-N 116.103 -0.498 . . . . 0.62 111.408 179.245 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -55.77 -50.17 62.28 Favored Glycine 0 C--N 1.334 0.461 0 C-N-CA 120.644 -0.789 . . . . 0.36 111.645 179.261 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 212' ' ' MET . . . . . 0.579 ' HG2' ' HA ' ' B' ' 23' ' ' PHE . 6.6 mtp -64.65 -37.08 86.35 Favored 'General case' 0 C--O 1.225 -0.212 0 CA-C-O 120.561 0.22 . . . . 1.24 111.012 178.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 6.6 tp -67.49 -42.97 82.03 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 112.022 0.378 . . . . 1.26 112.022 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 214' ' ' ARG . . . . . 0.451 HH11 ' HD3' ' A' ' 214' ' ' ARG . 40.3 mtt180 -61.6 -40.05 93.42 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.932 0.396 . . . . 1.44 110.833 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 215' ' ' LYS . . . . . 0.527 ' HE2' ' HA ' ' A' ' 215' ' ' LYS . 0.0 OUTLIER -95.85 13.36 26.97 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.85 -0.34 . . . . 0.72 111.03 178.584 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 11.3 tp -78.34 100.04 6.59 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.891 0.377 . . . . 1.18 110.398 179.222 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 217' ' ' ASP . . . . . 0.558 ' H ' HD13 ' B' ' 19' ' ' LEU . 0.2 OUTLIER -82.73 33.06 0.42 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.28 -0.418 . . . . 0.51 111.957 -179.365 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 218' ' ' ILE . . . . . 0.658 HG12 ' HB3' ' A' ' 223' ' ' ASP . 47.6 mt -87.53 119.08 34.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.766 0.317 . . . . 1.13 110.66 179.278 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.63 -15.32 0.73 Allowed 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 112.772 0.656 . . . . 0.62 112.772 -179.204 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -132.31 -178.37 4.88 Favored 'General case' 0 CA--C 1.541 0.613 0 O-C-N 122.002 -0.436 . . . . 0.63 112.154 -179.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . 0.568 ' O ' HG22 ' A' ' 224' ' ' VAL . 1.9 mp0 -69.59 -21.99 63.55 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 112.902 0.704 . . . . 0.73 112.902 -178.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -72.6 -26.86 70.55 Favored Glycine 0 CA--C 1.523 0.551 0 C-N-CA 120.66 -0.781 . . . . 0.53 112.685 179.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 223' ' ' ASP . . . . . 0.658 ' HB3' HG12 ' A' ' 218' ' ' ILE . 61.2 m-20 -65.52 -30.48 71.24 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 112.128 0.418 . . . . 0.56 112.128 -179.624 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . 0.568 HG22 ' O ' ' A' ' 221' ' ' GLU . 4.1 m -56.39 -28.25 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 N-CA-C 111.878 0.325 . . . . 0.56 111.878 179.612 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . 0.41 ' HD2' ' H ' ' A' ' 225' ' ' LYS . 7.7 mptt -64.67 -36.79 85.4 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.192 0.52 . . . . 1.26 110.037 178.587 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 226' ' ' SER . . . . . 0.498 ' O ' HG22 ' A' ' 230' ' ' VAL . 7.8 t -69.31 -35.02 75.56 Favored 'General case' 0 N--CA 1.462 0.148 0 N-CA-C 108.901 -0.777 . . . . 0.69 108.901 177.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 227' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -61.74 -37.63 84.96 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 115.269 -0.878 . . . . 0.55 109.601 177.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 228' ' ' SER . . . . . 0.66 ' HG ' HG21 ' A' ' 278' ' ' VAL . 69.1 m -66.37 -40.43 89.73 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.093 -0.503 . . . . 1.06 109.804 178.036 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 73.0 mtp180 -58.13 -37.66 75.03 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.031 -0.531 . . . . 1.08 110.381 178.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . 0.574 HG12 ' HA ' ' B' ' 24' ' ' ALA . 36.3 t -66.32 -46.74 86.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.946 -0.57 . . . . 1.12 110.107 178.337 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 231' ' ' MET . . . . . 0.495 ' HE2' ' HA ' ' A' ' 275' ' ' ILE . 60.3 mtm -63.94 -48.35 76.85 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.017 -0.538 . . . . 0.63 111.852 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 31.1 m -62.9 -31.24 51.75 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 C-N-CA 120.585 -0.446 . . . . 0.55 110.508 179.048 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 233' ' ' HIS . . . . . 0.661 ' CD2' ' HB3' ' B' ' 24' ' ' ALA . 8.7 t60 -67.91 -44.44 76.92 Favored 'General case' 0 CA--C 1.528 0.125 0 N-CA-C 109.126 -0.694 . . . . 0.42 109.126 177.109 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . 0.503 ' HA ' ' HG3' ' B' ' 28' ' ' ARG . 51.2 t -56.46 -42.46 75.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 CA-C-N 115.775 -0.648 . . . . 1.04 110.78 179.633 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -99.79 23.74 9.28 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.001 0.371 . . . . 0.77 112.001 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 2.6 ttpp -73.01 -13.73 61.28 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.799 0.333 . . . . 1.38 111.361 179.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -86.16 -16.21 38.57 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 120.88 0.371 . . . . 0.62 110.988 179.527 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 92.48 -19.08 52.82 Favored Glycine 0 CA--C 1.524 0.636 0 C-N-CA 121.032 -0.604 . . . . 0.4 113.84 179.179 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 6.1 p -83.9 117.25 29.19 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-O 121.625 0.726 . . . . 0.81 111.727 -179.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 10.8 m -94.9 117.3 29.91 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.057 0.456 . . . . 1.0 111.577 179.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -113.48 141.54 47.0 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.5 -0.318 . . . . 0.67 110.639 179.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 242' ' ' TRP . . . . . 0.513 ' CZ3' ' HB2' ' A' ' 296' ' ' PHE . 24.8 m95 -60.02 -42.4 94.28 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 120.721 0.296 . . . . 0.45 110.424 178.419 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . 0.422 ' HA3' ' N ' ' B' ' 35' ' ' TYR . . . -60.26 -33.31 79.81 Favored Glycine 0 C--N 1.336 0.531 0 C-N-CA 120.967 -0.635 . . . . 0.31 111.816 178.187 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 244' ' ' ARG . . . . . 0.469 ' HA ' ' HA3' ' B' ' 31' ' ' GLY . 50.1 mtt180 -69.25 -51.43 37.7 Favored 'General case' 0 C--O 1.232 0.153 0 N-CA-C 109.569 -0.53 . . . . 0.48 109.569 178.099 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . 0.512 HG22 HD22 ' A' ' 279' ' ' LEU . 83.1 mt -55.94 -48.32 78.73 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 CA-C-N 115.582 -0.735 . . . . 1.07 110.89 179.455 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 96.1 t -64.69 -32.32 57.46 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-N 116.471 -0.331 . . . . 1.22 110.984 179.46 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 247' ' ' THR . . . . . 0.454 HG22 HD22 ' B' ' 27' ' ' LEU . 20.2 m -63.35 -44.35 95.07 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.611 0.243 . . . . 1.08 110.448 178.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 248' ' ' LEU . . . . . 0.48 HD21 ' HG2' ' A' ' 231' ' ' MET . 54.2 mt -62.2 -41.2 98.15 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.396 0.617 . . . . 1.17 109.857 178.454 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 249' ' ' ILE . . . . . 0.442 HG23 HD23 ' A' ' 194' ' ' LEU . 27.8 mt -66.45 -39.98 85.38 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 CA-C-N 115.782 -0.644 . . . . 1.13 110.013 178.115 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 49.4 m -62.91 -41.77 99.56 Favored 'General case' 0 N--CA 1.461 0.115 0 N-CA-C 109.148 -0.686 . . . . 0.91 109.148 178.154 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 251' ' ' PHE . . . . . 0.495 ' CD2' HD11 ' B' ' 27' ' ' LEU . 8.7 t80 -62.14 -42.17 98.99 Favored 'General case' 0 C--O 1.226 -0.15 0 N-CA-C 108.821 -0.807 . . . . 0.51 108.821 177.518 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -57.68 -46.79 91.79 Favored Glycine 0 C--N 1.335 0.527 0 N-CA-C 111.053 -0.819 . . . . 0.27 111.053 177.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 253' ' ' ALA . . . . . 0.487 ' O ' ' HG3' ' A' ' 257' ' ' LYS . . . -64.34 -35.33 80.53 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 120.617 0.246 . . . . 0.39 111.245 177.627 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 254' ' ' PHE . . . . . 0.448 ' CD2' ' HB3' ' A' ' 209' ' ' PHE . 2.5 t80 -71.07 -43.76 67.11 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 120.617 0.246 . . . . 1.13 111.25 179.373 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 23.7 m -68.04 -34.58 67.7 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.109 0 N-CA-C 109.354 -0.61 . . . . 1.06 109.354 178.269 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -60.91 -36.72 80.0 Favored 'General case' 0 C--O 1.227 -0.127 0 N-CA-C 109.371 -0.604 . . . . 0.4 109.371 177.009 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 257' ' ' LYS . . . . . 0.487 ' HG3' ' O ' ' A' ' 253' ' ' ALA . 59.3 mttp -62.42 -45.66 92.08 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 109.608 -0.515 . . . . 0.93 109.608 177.24 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 22.2 t60 -60.76 -36.58 79.29 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.722 -0.672 . . . . 0.97 110.774 179.363 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 78.4 mt -74.95 -45.05 44.89 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.301 -0.408 . . . . 1.23 110.662 178.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 1.5 tptp -62.19 -34.82 77.18 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 120.717 0.294 . . . . 0.57 110.838 179.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 49.2 m -63.12 -24.31 67.84 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.254 -0.43 . . . . 0.54 110.946 179.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 262' ' ' VAL . . . . . 0.522 HG21 ' HG3' ' A' ' 264' ' ' GLN . 16.0 m -114.88 19.03 7.34 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-N 116.239 -0.437 . . . . 1.23 110.882 178.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 57.44 52.37 8.68 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 113.073 0.768 . . . . 1.42 113.073 179.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 264' ' ' GLN . . . . . 0.522 ' HG3' HG21 ' A' ' 262' ' ' VAL . 23.0 mt-30 -119.72 36.26 4.57 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 112.087 0.402 . . . . 0.75 112.087 179.332 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . 0.49 ' HA ' HD11 ' A' ' 268' ' ' ILE . 2.2 pm0 -57.74 -23.73 53.49 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-O 120.828 0.347 . . . . 0.62 111.656 179.061 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 54.4 p -61.62 -21.18 64.13 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.016 -0.538 . . . . 0.91 110.403 178.313 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 267' ' ' PHE . . . . . 0.494 ' C ' ' HD2' ' A' ' 270' ' ' PRO . 90.8 m-85 -95.3 -20.25 19.32 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 116.093 -0.503 . . . . 0.82 110.578 178.594 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 268' ' ' ILE . . . . . 0.49 HD11 ' HA ' ' A' ' 265' ' ' GLU . 78.6 mt -67.31 -41.16 86.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-N 116.26 -0.427 . . . . 1.07 110.078 178.574 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 269' ' ' GLU . . . . . 0.77 ' HB2' ' HD3' ' A' ' 270' ' ' PRO . 2.2 mm-40 -53.8 -56.4 25.75 Favored Pre-proline 0 CA--C 1.546 0.789 0 CA-C-N 116.089 -0.505 . . . . 0.76 111.122 178.591 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 270' ' ' PRO . . . . . 0.77 ' HD3' ' HB2' ' A' ' 269' ' ' GLU . 33.4 Cg_exo -62.23 -30.29 81.44 Favored 'Trans proline' 0 C--N 1.362 1.268 0 C-N-CA 122.139 1.892 . . . . 0.47 111.675 177.708 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 271' ' ' LEU . . . . . . . . . . . . . 4.3 mt -62.69 -50.41 71.24 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.286 -0.416 . . . . 1.15 110.045 177.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -56.29 -36.39 68.59 Favored 'General case' 0 N--CA 1.461 0.111 0 CA-C-N 116.147 -0.479 . . . . 0.6 110.825 179.143 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 273' ' ' GLU . . . . . 0.628 ' HA ' HD23 ' A' ' 160' ' ' LEU . 1.2 mm-40 -72.39 -50.79 23.96 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.102 -0.499 . . . . 1.39 110.658 178.381 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 274' ' ' THR . . . . . 0.462 HG21 ' HB ' ' A' ' 224' ' ' VAL . 25.3 m -58.45 -45.97 87.48 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.297 -0.41 . . . . 1.2 111.8 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 275' ' ' ILE . . . . . 0.495 ' HA ' ' HE2' ' A' ' 231' ' ' MET . 92.0 mt -63.77 -55.33 23.1 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 CA-C-N 116.558 -0.292 . . . . 1.18 111.089 179.842 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 22.0 m -58.08 -47.71 82.35 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.26 -0.427 . . . . 0.58 111.604 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 277' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -50.98 -58.64 5.53 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.385 -0.371 . . . . 0.54 111.7 179.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 278' ' ' VAL . . . . . 0.66 HG21 ' HG ' ' A' ' 228' ' ' SER . 61.4 t -64.65 -39.52 85.9 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 N-CA-C 111.816 0.302 . . . . 1.09 111.816 -179.78 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . 0.512 HD22 HG22 ' A' ' 245' ' ' ILE . 51.3 tp -64.59 -47.21 79.49 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 112.582 0.586 . . . . 1.27 112.582 -179.123 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 86.1 t -73.61 -46.78 47.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 N-CA-C 112.826 0.676 . . . . 1.17 112.826 -178.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 39.4 mtm105 -62.01 -43.61 98.48 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 112.533 0.568 . . . . 0.65 112.533 -178.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 282' ' ' THR . . . . . . . . . . . . . 68.6 p -69.16 -15.19 63.35 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 112.111 0.412 . . . . 0.46 112.111 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . 0.499 ' HB3' HD22 ' A' ' 287' ' ' LEU . 0.1 OUTLIER -128.23 36.53 4.28 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 111.723 0.268 . . . . 0.82 111.723 -179.566 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 36.3 ttm180 -53.17 -54.24 38.83 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 112.607 0.595 . . . . 1.34 112.607 -179.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -66.99 -33.96 76.7 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 111.862 0.319 . . . . 0.63 111.862 -178.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 286' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -70.14 -39.75 75.19 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.013 0.435 . . . . 0.84 110.489 179.647 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 287' ' ' LEU . . . . . 0.499 HD22 ' HB3' ' A' ' 283' ' ' LYS . 1.9 mm? -65.99 -46.77 76.8 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 115.878 -0.601 . . . . 1.1 111.587 179.782 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 30.8 m -65.83 -31.6 54.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 C-N-CA 121.003 -0.279 . . . . 0.96 111.41 179.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 26.2 mtmm -72.28 -32.79 66.94 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 112.384 0.513 . . . . 1.66 112.384 179.585 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 290' ' ' GLN . . . . . 0.432 HE21 ' N ' ' A' ' 290' ' ' GLN . 0.0 OUTLIER -101.73 15.45 28.91 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 112.683 0.623 . . . . 1.32 112.683 -179.231 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 291' ' ' ARG . . . . . 0.602 ' HB3' ' HB2' ' A' ' 294' ' ' ASP . 0.0 OUTLIER 59.92 24.13 13.21 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-O 121.174 0.511 . . . . 0.71 112.106 179.734 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 292' ' ' GLY . . . . . 0.465 ' HA2' HD11 ' A' ' 287' ' ' LEU . . . 58.4 -117.87 11.88 Favored Glycine 0 CA--C 1.522 0.494 0 CA-C-N 115.615 -0.721 . . . . 0.35 114.795 179.446 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 293' ' ' TRP . . . . . 0.409 ' O ' HG21 ' A' ' 297' ' ' VAL . 83.9 m95 -67.19 -33.51 75.55 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 112.808 0.67 . . . . 0.59 112.808 -178.368 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 294' ' ' ASP . . . . . 0.602 ' HB2' ' HB3' ' A' ' 291' ' ' ARG . 60.7 m-20 -53.09 -49.76 65.79 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 118.026 0.375 . . . . 0.46 111.098 179.143 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -65.02 -50.43 57.79 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.687 -0.768 . . . . 0.34 111.488 178.522 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 296' ' ' PHE . . . . . 0.513 ' HB2' ' CZ3' ' A' ' 242' ' ' TRP . 0.4 OUTLIER -53.58 -45.0 69.83 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 122.586 0.354 . . . . 0.46 111.766 179.212 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 297' ' ' VAL . . . . . 0.732 HG12 ' HB3' ' A' ' 189' ' ' ARG . 52.0 t -63.4 -53.59 43.54 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 N-CA-C 112.351 0.5 . . . . 1.01 112.351 -178.679 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 298' ' ' GLU . . . . . 0.647 ' HA ' ' HB2' ' A' ' 301' ' ' HIS . 0.1 OUTLIER -70.74 -26.89 63.57 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.617 -0.433 . . . . 0.49 111.911 -179.255 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 299' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -62.5 -44.16 97.06 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 109.848 -0.427 . . . . 0.64 109.848 177.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 300' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -87.47 8.46 24.71 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 121.344 0.593 . . . . 0.78 110.841 178.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 301' ' ' HIS . . . . . 0.647 ' HB2' ' HA ' ' A' ' 298' ' ' GLU . 2.2 m170 -104.25 -44.22 5.02 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 115.774 -0.648 . . . . 0.61 109.914 177.873 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 7.4 p -136.94 136.14 47.81 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-N 116.015 -0.538 . . . . 0.83 110.489 179.047 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -76.46 64.74 2.21 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 120.72 0.295 . . . . 0.82 111.742 -179.51 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 51.2 t0 -85.32 107.81 17.51 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.283 0.564 . . . . 0.84 110.523 179.494 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 83.5 mt -107.67 -24.46 11.72 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.857 -0.61 . . . . 2.07 110.858 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -87.91 -35.04 17.93 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.03 -0.532 . . . . 2.18 112.242 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . 108.57 92.92 2.26 Favored Glycine 0 CA--C 1.522 0.502 0 C-N-CA 120.423 -0.894 . . . . 1.32 113.168 179.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.296 0 CA-C-O 118.64 -1.089 . . . . 1.73 113.425 179.597 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.428 0 CA-C-O 120.262 0.077 . . . . 0.82 110.889 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.3 162.92 24.32 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 121.014 0.435 . . . . 1.53 111.618 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 19' ' ' LEU . . . . . 0.558 HD13 ' H ' ' A' ' 217' ' ' ASP . 0.9 OUTLIER -110.52 108.64 58.3 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 116.191 -0.459 . . . . 1.1 111.325 -179.643 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 20' ' ' PRO . . . . . 0.42 ' HA ' ' HD3' ' B' ' 21' ' ' PRO . 37.8 Cg_endo -66.14 130.4 24.1 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.777 2.318 . . . . 0.96 112.984 -179.423 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 21' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' B' ' 20' ' ' PRO . 37.1 Cg_exo -61.14 3.36 0.33 Allowed 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 123.229 2.619 . . . . 0.66 114.28 -179.212 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 22' ' ' GLU . . . . . 0.49 ' O ' ' HB2' ' B' ' 26' ' ' GLN . 3.4 mm-40 -73.69 -17.09 61.18 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 112.02 0.378 . . . . 0.44 112.02 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 23' ' ' PHE . . . . . 0.579 ' HA ' ' HG2' ' A' ' 212' ' ' MET . 0.8 OUTLIER -68.97 -40.78 78.65 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 120.222 -0.591 . . . . 0.54 110.929 179.166 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 24' ' ' ALA . . . . . 0.661 ' HB3' ' CD2' ' A' ' 233' ' ' HIS . . . -70.5 -39.44 74.14 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.552 0.691 . . . . 0.48 109.767 179.371 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.79 -46.61 78.08 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 114.905 -1.043 . . . . 0.97 109.993 178.231 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 26' ' ' GLN . . . . . 0.49 ' HB2' ' O ' ' B' ' 22' ' ' GLU . 0.8 OUTLIER -58.83 -53.89 53.24 Favored 'General case' 0 C--O 1.224 -0.268 0 CA-C-N 116.159 -0.473 . . . . 0.36 111.323 179.504 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . 0.495 HD11 ' CD2' ' A' ' 251' ' ' PHE . 19.3 mt -54.74 -36.42 64.77 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.641 0.258 . . . . 1.1 110.938 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 28' ' ' ARG . . . . . 0.503 ' HG3' ' HA ' ' A' ' 234' ' ' VAL . 0.2 OUTLIER -70.59 -53.24 16.76 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.539 -0.3 . . . . 0.66 110.204 178.102 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 21.4 mttt -53.28 -47.76 68.89 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.251 0.548 . . . . 0.7 110.614 179.056 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . 0.438 HG12 ' ND1' ' A' ' 205' ' ' HIS . 84.8 mt -64.25 -45.22 96.83 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 CA-C-N 115.331 -0.85 . . . . 0.98 110.603 179.626 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . 0.469 ' HA3' ' HA ' ' A' ' 244' ' ' ARG . . . -57.84 -49.37 75.07 Favored Glycine 0 C--N 1.334 0.419 0 C-N-CA 120.974 -0.631 . . . . 0.29 112.749 179.736 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -62.26 -42.76 99.62 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 121.17 0.51 . . . . 0.41 110.279 179.334 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 33' ' ' LYS . . . . . 0.498 ' HE2' ' HG3' ' B' ' 43' ' ' MET . 0.0 OUTLIER -62.69 -57.45 10.97 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.792 -0.64 . . . . 1.59 111.784 179.646 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 71.1 t -54.53 -44.14 67.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 O-C-N 123.308 0.38 . . . . 1.09 111.268 -179.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 35' ' ' TYR . . . . . 0.422 ' N ' ' HA3' ' A' ' 243' ' ' GLY . 0.6 OUTLIER -56.77 -43.48 80.88 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 121.044 0.449 . . . . 0.87 110.477 178.699 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 36' ' ' CYS . . . . . . . . . . . . . 66.0 m -68.95 -40.97 78.62 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.352 -0.385 . . . . 0.47 111.418 179.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 8.4 m -59.13 -40.83 86.68 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 113.091 0.774 . . . . 0.62 113.091 -179.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 38' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -83.6 -36.67 23.74 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 112.42 0.526 . . . . 0.64 112.42 -178.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 65.9 p -72.45 -63.39 1.16 Allowed 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.727 0.298 . . . . 0.46 110.762 179.147 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . 0.461 ' HA ' ' HD3' ' B' ' 41' ' ' PRO . . . -90.85 136.71 27.38 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 116.404 -0.362 . . . . 1.12 111.046 179.313 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 41' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' B' ' 40' ' ' ALA . 11.9 Cg_exo -71.07 56.7 2.0 Allowed 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 122.755 2.303 . . . . 0.98 112.769 179.433 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -145.05 -152.06 0.4 Allowed 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 116.056 -0.52 . . . . 0.95 110.071 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 43' ' ' MET . . . . . 0.498 ' HG3' ' HE2' ' B' ' 33' ' ' LYS . 44.9 tpp . . . . . 0 C--O 1.25 1.113 0 CA-C-O 118.573 -0.727 . . . . 3.52 111.747 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.502 ' H2 ' ' CG ' ' A' ' 154' ' ' ASP . . . . . . . . 0 N--CA 1.49 2.234 0 CA-C-O 120.246 -0.197 . . . . 0.0 113.092 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -60.56 -40.61 54.87 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 123.126 2.551 . . . . 0.0 113.589 -179.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -86.59 -66.48 0.9 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.973 0.416 . . . . 0.0 110.695 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -154.93 -135.17 2.0 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.915 -0.66 . . . . 0.0 111.997 179.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 12.9 p -115.42 33.05 5.67 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.001 0.429 . . . . 0.0 110.99 179.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -134.12 -28.74 1.32 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.884 179.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . 0.506 ' HA ' ' HB3' ' A' ' 156' ' ' TYR . 1.0 OUTLIER -59.98 -29.04 68.18 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.784 0.326 . . . . 0.0 111.189 -179.637 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . 0.502 ' CG ' ' H2 ' ' A' ' 147' ' ' GLY . 0.6 OUTLIER -62.78 -43.67 98.18 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.16 178.972 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 48.4 tp -77.56 -36.5 52.09 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 178.048 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . 0.506 ' HB3' ' HA ' ' A' ' 153' ' ' ASP . 69.7 t80 -58.54 -38.22 77.35 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 115.105 -0.952 . . . . 0.0 111.739 179.575 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.521 ' HD2' ' OE2' ' A' ' 161' ' ' GLU . 0.0 OUTLIER -56.46 -53.04 62.12 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.999 0.428 . . . . 0.0 110.352 178.976 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . 0.422 ' HG2' ' HB1' ' A' ' 183' ' ' ALA . 26.9 mt-30 -68.44 -37.46 80.26 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.58 179.166 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 41.4 m -57.83 -50.69 72.43 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.367 179.266 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.527 ' HA ' HG21 ' A' ' 276' ' ' THR . 2.3 tm? -58.69 -47.43 84.56 Favored 'General case' 0 C--O 1.225 -0.232 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.451 178.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . 0.521 ' OE2' ' HD2' ' A' ' 157' ' ' ARG . 30.8 mt-10 -60.52 -51.1 70.89 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 111.949 0.352 . . . . 0.0 111.949 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . 0.499 HG12 ' HA2' ' A' ' 187' ' ' GLY . 46.2 mt -58.87 -51.68 69.37 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 CA-C-O 120.636 0.255 . . . . 0.0 111.145 179.633 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.589 ' O ' ' HG ' ' A' ' 167' ' ' LEU . 89.5 mt -62.04 -48.08 90.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-N 116.646 -0.252 . . . . 0.0 111.414 179.589 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' SER . . . . . 0.532 ' O ' ' HB2' ' A' ' 168' ' ' ARG . 1.2 t -57.7 -42.34 83.5 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 120.751 0.31 . . . . 0.0 111.322 179.452 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . 0.426 ' HA ' ' HD3' ' A' ' 165' ' ' ARG . 5.7 tpp180 -72.37 -37.0 68.87 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 121.08 -0.248 . . . . 0.0 111.225 179.758 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' TYR . . . . . 0.82 ' CE1' ' HA ' ' A' ' 195' ' ' ARG . 39.1 t80 -66.27 -52.79 44.01 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.679 -0.237 . . . . 0.0 111.622 179.768 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.589 ' HG ' ' O ' ' A' ' 163' ' ' ILE . 20.7 mt -61.95 -40.6 96.1 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.712 -0.222 . . . . 0.0 110.789 -179.728 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . 0.532 ' HB2' ' O ' ' A' ' 164' ' ' SER . 0.5 OUTLIER -62.15 -44.44 96.61 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 120.953 0.406 . . . . 0.0 110.506 179.215 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . 0.477 ' HG2' ' HA ' ' A' ' 175' ' ' LYS . 2.2 mt-10 -60.83 -48.11 83.29 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.164 178.613 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 6.8 mm-40 -61.55 -43.49 98.76 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.149 179.126 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -70.49 -44.24 68.07 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -179.074 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 31.8 p -67.61 -25.85 65.96 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 120.851 -0.34 . . . . 0.0 111.502 179.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 80.97 29.06 43.28 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 120.527 -0.844 . . . . 0.0 112.472 179.26 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 21.1 t -164.44 -138.09 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.631 0.253 . . . . 0.0 110.486 -179.466 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . 0.477 ' HA ' ' HG2' ' A' ' 169' ' ' GLU . 15.0 tptp -125.08 126.33 45.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.844 0.354 . . . . 0.0 111.333 179.61 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 59.7 t0 -64.92 128.03 34.06 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.241 178.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 71.8 p -75.1 -10.37 59.41 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.773 179.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.22 131.79 23.59 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 120.767 0.318 . . . . 0.0 111.221 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -61.57 154.46 59.57 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.627 2.218 . . . . 0.0 112.533 179.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.463 HD11 ' HA3' ' A' ' 187' ' ' GLY . 0.4 OUTLIER -85.27 78.05 9.87 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.299 0.571 . . . . 0.0 111.232 -179.797 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 58.38 -115.72 7.46 Favored Glycine 0 C--N 1.332 0.323 0 CA-C-N 115.019 -0.991 . . . . 0.0 113.731 179.157 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -124.66 -0.73 8.03 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.82 0.343 . . . . 0.0 110.976 -179.268 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . 0.525 ' O ' ' HA3' ' A' ' 187' ' ' GLY . . . -69.54 81.03 0.4 Allowed 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 121.092 0.472 . . . . 0.0 111.029 178.574 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -79.89 -70.5 1.33 Allowed Glycine 0 CA--C 1.524 0.595 0 C-N-CA 121.069 -0.586 . . . . 0.0 113.961 -179.588 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -63.92 -55.51 22.1 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 111.998 0.37 . . . . 0.0 111.998 -178.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -68.0 -33.68 75.09 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.354 179.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . 0.525 ' HA3' ' O ' ' A' ' 183' ' ' ALA . . . -66.94 -41.62 93.22 Favored Glycine 0 C--O 1.225 -0.429 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.559 178.747 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 3.9 tpt180 -63.01 -53.9 46.7 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 120.615 0.245 . . . . 0.0 111.279 179.202 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 28.0 mtp180 -62.79 -44.04 97.21 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.592 -179.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -70.3 -48.77 55.15 Favored 'General case' 0 C--O 1.22 -0.468 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -179.166 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 19.3 tp -60.19 -42.83 95.9 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 118.359 0.527 . . . . 0.0 111.746 -179.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -63.69 -46.02 87.41 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 121.136 0.493 . . . . 0.0 110.934 179.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 34.3 m -68.4 -45.48 72.55 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.889 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . 0.47 HD21 HG22 ' A' ' 249' ' ' ILE . 12.3 tp -59.77 -37.43 79.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.084 -179.636 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . 0.82 ' HA ' ' CE1' ' A' ' 166' ' ' TYR . 11.5 ttp180 -70.8 -53.36 15.65 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.508 179.034 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . 0.401 ' C ' ' HD3' ' A' ' 196' ' ' ARG . 0.0 OUTLIER -59.36 -48.2 82.52 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.888 -179.935 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . 0.534 ' O ' HG21 ' A' ' 201' ' ' VAL . 73.5 t -70.89 -47.92 59.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.334 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . 0.469 ' O ' ' HG2' ' A' ' 202' ' ' GLN . . . -56.19 -43.51 89.0 Favored Glycine 0 C--N 1.338 0.645 0 N-CA-C 111.371 -0.691 . . . . 0.0 111.371 179.367 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . 0.525 ' HB2' ' O ' ' A' ' 195' ' ' ARG . 0.4 OUTLIER -58.26 -48.5 80.25 Favored 'General case' 0 C--O 1.226 -0.138 0 O-C-N 123.963 0.449 . . . . 0.0 109.83 177.951 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -62.89 -41.17 99.93 Favored Glycine 0 CA--C 1.524 0.597 0 C-N-CA 121.085 -0.579 . . . . 0.0 112.601 179.247 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . 0.692 HG11 HG21 ' B' ' 34' ' ' VAL . 70.3 t -58.06 -51.7 67.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 CA-C-O 120.786 0.327 . . . . 0.0 111.127 179.254 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 202' ' ' GLN . . . . . 0.543 ' HG3' ' CZ ' ' A' ' 203' ' ' ARG . 1.2 pt20 -72.35 -31.68 65.83 Favored 'General case' 0 C--O 1.222 -0.36 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.404 179.745 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 203' ' ' ARG . . . . . 0.543 ' CZ ' ' HG3' ' A' ' 202' ' ' GLN . 0.0 OUTLIER -66.73 -38.97 87.73 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 121.247 0.546 . . . . 0.0 109.793 177.739 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -62.3 -54.21 43.94 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.968 179.17 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 205' ' ' HIS . . . . . 0.504 ' ND1' HG12 ' B' ' 30' ' ' ILE . 31.8 m-70 -101.66 37.79 1.75 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.968 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -48.02 -47.73 33.21 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -178.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -61.97 -41.62 98.21 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -73.08 -47.33 45.45 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.901 0.382 . . . . 0.0 111.149 -179.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 209' ' ' PHE . . . . . 0.509 ' CD2' ' HA ' ' A' ' 202' ' ' GLN . 8.5 m-85 -60.62 -45.13 95.2 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.534 178.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 210' ' ' GLN . . . . . 0.679 ' O ' ' HG2' ' A' ' 214' ' ' ARG . 27.8 mt-30 -68.01 -44.0 77.55 Favored 'General case' 0 C--O 1.225 -0.199 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.021 179.216 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -55.29 -50.81 58.05 Favored Glycine 0 C--N 1.335 0.507 0 C-N-CA 120.723 -0.751 . . . . 0.0 111.953 179.343 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 212' ' ' MET . . . . . 0.443 ' HG2' ' HB3' ' B' ' 23' ' ' PHE . 0.8 OUTLIER -64.25 -29.65 70.74 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.672 0.272 . . . . 0.0 110.799 178.623 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . 0.495 HD12 HD21 ' A' ' 216' ' ' LEU . 8.4 tp -73.83 -42.33 61.03 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.488 179.334 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 214' ' ' ARG . . . . . 0.679 ' HG2' ' O ' ' A' ' 210' ' ' GLN . 16.4 mmt85 -61.39 -37.19 82.51 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.184 0.516 . . . . 0.0 109.751 178.814 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.71 12.52 31.62 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.992 178.624 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . 0.755 ' HG ' HG12 ' A' ' 218' ' ' ILE . 16.2 tp -77.52 103.69 7.6 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 121.127 0.489 . . . . 0.0 110.037 179.027 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 217' ' ' ASP . . . . . 0.497 ' HB2' ' HG ' ' B' ' 19' ' ' LEU . 0.4 OUTLIER -81.71 33.03 0.36 Allowed 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 113.032 0.753 . . . . 0.0 113.032 -178.395 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 218' ' ' ILE . . . . . 0.755 HG12 ' HG ' ' A' ' 216' ' ' LEU . 50.8 mm -81.64 107.41 13.75 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-O 120.728 0.299 . . . . 0.0 110.326 178.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.59 -19.31 0.53 Allowed 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 -178.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -112.63 179.6 3.93 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -179.088 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . 0.544 ' O ' HG21 ' A' ' 224' ' ' VAL . 15.6 tm-20 -68.59 -40.74 80.38 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.775 179.587 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -58.16 -26.43 58.66 Favored Glycine 0 CA--C 1.524 0.607 0 C-N-CA 121.297 -0.478 . . . . 0.0 113.169 179.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 223' ' ' ASP . . . . . 0.502 ' HB3' HG23 ' A' ' 218' ' ' ILE . 40.2 m-20 -59.34 -30.5 68.42 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 112.94 0.719 . . . . 0.0 112.94 -179.586 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . 0.544 HG21 ' O ' ' A' ' 221' ' ' GLU . 11.8 m -62.87 -29.17 46.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 CA-C-O 120.991 0.424 . . . . 0.0 110.828 179.444 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . 0.542 ' O ' ' HG2' ' A' ' 229' ' ' ARG . 23.5 mttp -71.32 -31.75 67.77 Favored 'General case' 0 C--O 1.232 0.15 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 179.027 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 226' ' ' SER . . . . . 0.578 ' O ' HG21 ' A' ' 230' ' ' VAL . 3.8 m -65.22 -44.96 86.61 Favored 'General case' 0 C--N 1.335 -0.062 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 177.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 227' ' ' PHE . . . . . . . . . . . . . 8.7 t80 -61.94 -36.45 81.42 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.822 178.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 13.0 t -61.9 -41.38 97.83 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.714 177.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 229' ' ' ARG . . . . . 0.542 ' HG2' ' O ' ' A' ' 225' ' ' LYS . 5.7 mmp_? -70.03 -43.8 70.55 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.439 179.035 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . 0.578 HG21 ' O ' ' A' ' 226' ' ' SER . 60.5 t -58.66 -47.72 87.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 178.523 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 231' ' ' MET . . . . . 0.929 ' HG3' ' HG ' ' A' ' 248' ' ' LEU . 36.5 ttm -53.09 -53.79 45.14 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.41 178.784 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 96.8 t -59.36 -44.85 93.38 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.755 179.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 233' ' ' HIS . . . . . 0.437 ' O ' ' HB2' ' A' ' 236' ' ' LYS . 2.0 t-80 -57.29 -33.95 68.18 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 230' ' ' VAL . 89.1 t -56.31 -32.1 34.44 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 O-C-N 121.917 -0.489 . . . . 0.0 111.623 179.683 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -103.01 25.17 9.71 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.562 -179.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . 0.437 ' HB2' ' O ' ' A' ' 233' ' ' HIS . 0.6 OUTLIER -49.65 -35.79 22.49 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 -178.804 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . 0.446 ' HB2' HG12 ' A' ' 239' ' ' VAL . 0.0 OUTLIER -71.88 -16.07 62.12 Favored 'General case' 0 N--CA 1.468 0.447 0 O-C-N 122.153 -0.342 . . . . 0.0 111.466 -179.689 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 98.18 -18.74 56.64 Favored Glycine 0 CA--C 1.52 0.371 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.162 -178.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . 0.446 HG12 ' HB2' ' A' ' 237' ' ' ASP . 4.0 p -79.48 115.55 22.0 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 CA-C-O 121.746 0.784 . . . . 0.0 111.017 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 240' ' ' THR . . . . . 0.487 HG22 HD12 ' A' ' 245' ' ' ILE . 4.2 m -90.14 74.67 7.12 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.738 -179.208 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -65.91 135.0 54.18 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 121.076 -0.249 . . . . 0.0 110.401 178.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 242' ' ' TRP . . . . . 0.539 ' HB3' ' CE2' ' A' ' 300' ' ' PHE . 2.1 m95 -56.09 -37.76 69.8 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.922 0.391 . . . . 0.0 111.147 179.664 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -65.1 -25.33 70.89 Favored Glycine 0 C--N 1.336 0.57 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.713 179.277 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 93.3 mtt180 -75.31 -45.29 40.6 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 178.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . 0.487 HD12 HG22 ' A' ' 240' ' ' THR . 54.0 mt -57.05 -48.35 82.0 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.847 179.333 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 10.5 p -67.23 -33.18 61.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.909 179.121 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 20.6 m -62.28 -38.46 89.45 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 121.065 -0.254 . . . . 0.0 110.458 178.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 248' ' ' LEU . . . . . 0.929 ' HG ' ' HG3' ' A' ' 231' ' ' MET . 1.0 OUTLIER -63.59 -33.51 75.76 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.141 0.496 . . . . 0.0 110.413 178.337 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 249' ' ' ILE . . . . . 0.475 HD12 HD23 ' A' ' 279' ' ' LEU . 33.7 mm -76.84 -40.7 32.03 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.737 178.386 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 23.2 t -59.94 -44.79 94.15 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 178.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 251' ' ' PHE . . . . . 0.53 ' O ' HG23 ' A' ' 255' ' ' VAL . 22.7 t80 -66.82 -44.52 80.94 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.251 177.832 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -54.98 -42.92 82.36 Favored Glycine 0 C--N 1.34 0.754 0 N-CA-C 111.078 -0.809 . . . . 0.0 111.078 177.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 253' ' ' ALA . . . . . 0.601 ' O ' ' HG3' ' A' ' 257' ' ' LYS . . . -61.78 -46.37 89.85 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 115.551 -0.324 . . . . 0.0 110.201 177.294 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -58.27 -41.6 84.66 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 120.972 0.415 . . . . 0.0 110.289 178.591 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 255' ' ' VAL . . . . . 0.53 HG23 ' O ' ' A' ' 251' ' ' PHE . 64.0 t -62.38 -44.7 99.49 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-N 116.159 -0.473 . . . . 0.0 109.897 177.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -59.38 -42.76 92.41 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-O 121.02 0.438 . . . . 0.0 109.836 177.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 257' ' ' LYS . . . . . 0.601 ' HG3' ' O ' ' A' ' 253' ' ' ALA . 20.0 mtpp -62.06 -39.97 94.18 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.928 177.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 10.9 t60 -66.22 -43.44 86.64 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.367 178.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 75.2 mt -65.4 -39.44 92.19 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.466 178.591 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -68.54 -32.0 71.63 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 120.911 0.386 . . . . 0.0 110.008 178.357 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 66.4 m -59.44 -34.23 72.25 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.449 178.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 15.7 m -101.53 15.57 4.99 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.211 179.036 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 56.23 48.15 17.87 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 112.705 0.631 . . . . 0.0 112.705 179.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -118.67 37.71 3.99 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 120.887 0.375 . . . . 0.0 111.414 179.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . 0.56 ' HA ' HD13 ' A' ' 268' ' ' ILE . 0.0 OUTLIER -51.9 -26.49 10.33 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 179.843 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 50.6 p -59.88 -25.54 65.15 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 120.674 0.273 . . . . 0.0 111.126 179.064 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -88.91 -20.56 24.4 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 120.93 0.395 . . . . 0.0 110.592 178.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 268' ' ' ILE . . . . . 0.56 HD13 ' HA ' ' A' ' 265' ' ' GLU . 75.9 mt -67.85 -42.72 86.13 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.021 179.468 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 269' ' ' GLU . . . . . 0.78 ' HB3' ' HD3' ' A' ' 270' ' ' PRO . 9.4 tp10 -53.72 -57.08 18.99 Favored Pre-proline 0 CA--C 1.546 0.817 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.649 179.324 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 270' ' ' PRO . . . . . 0.78 ' HD3' ' HB3' ' A' ' 269' ' ' GLU . 24.9 Cg_exo -64.76 -33.81 52.59 Favored 'Trans proline' 0 C--N 1.36 1.184 0 C-N-CA 122.086 1.857 . . . . 0.0 111.878 178.536 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 271' ' ' LEU . . . . . . . . . . . . . 27.1 tp -63.96 -42.0 97.41 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.129 178.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -59.81 -48.89 79.87 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.483 178.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 273' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -63.77 -41.17 98.02 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.409 178.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 274' ' ' THR . . . . . 0.408 HG21 ' HB ' ' A' ' 224' ' ' VAL . 91.1 m -60.21 -48.93 79.64 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.052 178.664 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 275' ' ' ILE . . . . . 0.464 ' HA ' ' HE1' ' A' ' 231' ' ' MET . 96.7 mt -61.9 -50.68 79.16 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.684 178.411 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 276' ' ' THR . . . . . 0.527 HG21 ' HA ' ' A' ' 160' ' ' LEU . 27.8 m -58.66 -53.9 53.13 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -178.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 277' ' ' ASP . . . . . 0.566 ' O ' ' HB2' ' A' ' 281' ' ' ARG . 2.3 t70 -58.16 -54.02 51.72 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 120.873 -0.331 . . . . 0.0 111.496 -178.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 95.1 t -59.38 -34.8 55.42 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 CA-C-O 120.673 0.273 . . . . 0.0 111.177 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . 0.475 HD23 HD12 ' A' ' 249' ' ' ILE . 5.0 tp -65.09 -48.12 74.82 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 111.742 0.275 . . . . 0.0 111.742 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 42.5 t -78.68 -36.59 19.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -179.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 281' ' ' ARG . . . . . 0.566 ' HB2' ' O ' ' A' ' 277' ' ' ASP . 0.1 OUTLIER -65.95 -36.03 82.22 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -179.493 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 282' ' ' THR . . . . . . . . . . . . . 15.4 p -73.39 -52.06 15.14 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 120.885 0.374 . . . . 0.0 111.623 179.456 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . 0.479 ' HB2' HD21 ' A' ' 287' ' ' LEU . 15.2 mttp -88.54 41.85 1.04 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.783 0.325 . . . . 0.0 110.68 179.583 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 28.9 ttm180 -48.05 -63.32 1.1 Allowed 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 -178.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -72.02 -31.51 66.26 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 121.028 -0.269 . . . . 0.0 111.625 -178.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 286' ' ' TRP . . . . . . . . . . . . . 2.3 t90 -68.37 -49.02 63.12 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.877 0.37 . . . . 0.0 111.121 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 287' ' ' LEU . . . . . 0.479 HD21 ' HB2' ' A' ' 283' ' ' LYS . 0.7 OUTLIER -63.08 -41.21 99.36 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -179.593 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 29.5 m -70.48 -37.86 71.74 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 C-N-CA 120.514 -0.474 . . . . 0.0 111.826 179.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 39.3 mttp -72.91 -32.23 65.18 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -85.46 17.3 3.25 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -179.064 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 291' ' ' ARG . . . . . 0.437 HH11 ' HD2' ' A' ' 291' ' ' ARG . 25.3 mtm105 60.09 18.6 7.87 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 179.553 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 63.16 -137.02 43.11 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 114.687 0.635 . . . . 0.0 114.687 178.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 293' ' ' TRP . . . . . . . . . . . . . 72.4 m95 -59.13 -28.39 66.5 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -178.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 294' ' ' ASP . . . . . 0.496 ' O ' ' HG3' ' A' ' 298' ' ' GLU . 0.4 OUTLIER -59.41 -48.35 81.98 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 120.782 0.325 . . . . 0.0 110.24 178.335 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -66.19 -36.48 91.86 Favored Glycine 0 CA--C 1.521 0.458 0 C-N-CA 120.53 -0.843 . . . . 0.0 111.252 178.401 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 296' ' ' PHE . . . . . 0.462 ' HB2' ' CH2' ' A' ' 242' ' ' TRP . 12.2 t80 -58.67 -48.0 82.58 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.51 -0.345 . . . . 0.0 111.015 178.616 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 297' ' ' VAL . . . . . . . . . . . . . 18.4 m -72.33 -22.68 20.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 120.934 -0.306 . . . . 0.0 111.636 -179.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 298' ' ' GLU . . . . . 0.496 ' HG3' ' O ' ' A' ' 294' ' ' ASP . 37.1 mt-10 -65.97 -50.1 65.51 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.206 0.527 . . . . 0.0 110.599 178.336 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 299' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -77.1 -25.02 51.75 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 115.912 -0.585 . . . . 0.0 112.292 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 300' ' ' PHE . . . . . 0.539 ' CE2' ' HB3' ' A' ' 242' ' ' TRP . 44.7 m-85 -109.43 6.12 23.98 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 115.16 1.541 . . . . 0.0 115.16 -177.54 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -161.25 -59.55 0.05 Allowed 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 119.479 1.036 . . . . 0.0 112.891 -179.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 2.3 t -90.94 72.98 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 120.953 0.406 . . . . 0.0 111.014 -178.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 303' ' ' GLN . . . . . 0.485 ' OE1' ' HB3' ' B' ' 41' ' ' PRO . 90.0 mt-30 -89.58 3.5 52.32 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.961 -179.354 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -97.64 34.45 1.85 Allowed 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 121.061 0.458 . . . . 0.0 111.995 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 78.7 mt -100.81 7.17 43.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.989 0.423 . . . . 0.0 111.103 179.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -112.5 -55.24 2.54 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.172 179.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . -100.94 92.61 1.07 Allowed Glycine 0 CA--C 1.522 0.506 0 C-N-CA 120.558 -0.83 . . . . 0.0 112.864 179.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.272 0 CA-C-O 118.282 -1.288 . . . . 0.0 112.771 179.924 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.868 0 CA-C-O 121.422 0.63 . . . . 0.0 111.301 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -99.18 -36.68 9.58 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.246 -179.601 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 19' ' ' LEU . . . . . 0.497 ' HG ' ' HB2' ' A' ' 217' ' ' ASP . 4.6 mt -93.4 128.45 42.49 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.359 -179.852 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 20' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' B' ' 19' ' ' LEU . 7.3 Cg_exo -72.12 121.0 7.17 Favored 'Trans proline' 0 CA--C 1.531 0.365 0 C-N-CA 122.542 2.161 . . . . 0.0 112.277 179.399 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 21' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -60.65 -11.79 18.74 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.943 2.428 . . . . 0.0 113.475 -179.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 22' ' ' GLU . . . . . 0.401 ' O ' ' HB2' ' B' ' 26' ' ' GLN . 4.8 mm-40 -66.67 -14.2 62.18 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 23' ' ' PHE . . . . . 0.579 ' HD1' ' N ' ' B' ' 24' ' ' ALA . 0.1 OUTLIER -60.22 -31.88 70.58 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 118.302 0.501 . . . . 0.0 111.886 179.812 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 24' ' ' ALA . . . . . 0.579 ' N ' ' HD1' ' B' ' 23' ' ' PHE . . . -74.7 -48.38 26.31 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.16 0.505 . . . . 0.0 110.625 -179.724 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . 0.493 ' HA ' ' HD3' ' B' ' 28' ' ' ARG . . . -64.71 -37.12 86.49 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.505 178.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 26' ' ' GLN . . . . . 0.416 ' O ' HG13 ' B' ' 30' ' ' ILE . 0.0 OUTLIER -62.92 -48.13 80.25 Favored 'General case' 0 C--O 1.226 -0.134 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.13 178.751 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . 0.559 ' HG ' ' O ' ' B' ' 23' ' ' PHE . 29.8 mt -58.96 -32.45 69.65 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 178.371 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 28' ' ' ARG . . . . . 0.493 ' HD3' ' HA ' ' B' ' 25' ' ' ALA . 56.1 mtp85 -65.43 -54.81 23.14 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 177.432 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . 0.444 ' HG3' ' O ' ' B' ' 25' ' ' ALA . 54.5 mttt -55.67 -46.37 77.57 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.008 178.501 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . 0.504 HG12 ' ND1' ' A' ' 205' ' ' HIS . 97.9 mt -60.76 -52.42 61.77 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.237 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.218 179.76 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -57.03 -43.68 93.14 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 121.301 -0.476 . . . . 0.0 113.097 179.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -68.68 -40.89 79.9 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 120.709 0.29 . . . . 0.0 111.148 179.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.93 -39.97 83.42 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 120.954 0.407 . . . . 0.0 110.077 178.277 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 34' ' ' VAL . . . . . 0.692 HG21 HG11 ' A' ' 201' ' ' VAL . 4.9 t -62.56 -52.62 57.53 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.555 179.809 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -57.35 -40.95 79.14 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 120.943 0.402 . . . . 0.0 110.337 179.236 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 36' ' ' CYS . . . . . . . . . . . . . 42.7 t -68.68 -25.98 65.07 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 120.925 0.393 . . . . 0.0 111.298 179.256 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 59.6 m -78.55 -46.37 19.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.514 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 38' ' ' TRP . . . . . 0.429 ' CD1' HG13 ' B' ' 34' ' ' VAL . 99.2 m95 -75.52 -13.79 60.38 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 -179.132 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 43.7 m -61.17 -31.29 71.03 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 178.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -90.36 118.43 68.78 Favored Pre-proline 0 CA--C 1.531 0.243 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -179.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 41' ' ' PRO . . . . . 0.485 ' HB3' ' OE1' ' A' ' 303' ' ' GLN . 95.9 Cg_endo -86.98 -160.48 0.11 Allowed 'Trans proline' 0 CA--C 1.534 0.521 0 C-N-CA 122.845 2.363 . . . . 0.0 112.697 179.307 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -88.7 -54.13 4.3 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 120.983 0.42 . . . . 0.0 110.32 178.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 43' ' ' MET . . . . . . . . . . . . . 53.9 ttp . . . . . 0 C--O 1.25 1.087 0 CA-C-O 118.323 -0.846 . . . . 0.0 111.191 179.074 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.158 0 CA-C-O 120.261 -0.188 . . . . 0.0 112.804 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -71.18 -23.17 24.86 Favored 'Trans proline' 0 CA--C 1.534 0.492 0 C-N-CA 122.804 2.336 . . . . 0.0 113.769 -179.579 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 41.0 tp -73.56 -42.06 62.14 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 120.839 0.352 . . . . 0.0 111.648 -179.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 117.26 -67.44 0.32 Allowed Glycine 0 C--N 1.329 0.142 0 C-N-CA 120.636 -0.792 . . . . 0.0 111.677 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 37.2 t -75.26 94.81 3.05 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 178.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.428 ' CD ' HH21 ' A' ' 284' ' ' ARG . 2.6 mp0 4.61 70.01 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 125.852 1.661 . . . . 0.0 114.889 -177.649 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -71.12 -36.84 72.27 Favored 'General case' 0 C--N 1.335 -0.062 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.65 179.247 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.76 -57.19 14.11 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.911 179.234 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.36 -35.99 80.84 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.03 178.716 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . 0.404 ' HE1' ' HA ' ' A' ' 277' ' ' ASP . 0.1 OUTLIER -68.86 -46.29 68.85 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.69 -0.232 . . . . 0.0 111.447 179.6 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 6.2 mtp180 -62.6 -45.87 90.87 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 121.119 -0.233 . . . . 0.0 111.14 179.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 59.3 mt-30 -58.02 -43.77 86.9 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 121.074 0.464 . . . . 0.0 110.222 178.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' SER . . . . . 0.478 ' HA ' ' CZ2' ' A' ' 293' ' ' TRP . 51.4 m -61.38 -54.35 44.78 Favored 'General case' 0 C--O 1.223 -0.313 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.788 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -58.38 -47.23 84.53 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 120.492 0.187 . . . . 0.0 111.308 179.299 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -60.75 -51.85 67.59 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . 0.474 HG23 HD21 ' A' ' 191' ' ' LEU . 60.5 mt -71.26 -48.66 53.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 -178.429 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.591 ' O ' ' HG ' ' A' ' 167' ' ' LEU . 64.4 mt -58.85 -50.83 78.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 N-CA-C 111.64 0.237 . . . . 0.0 111.64 -179.44 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 39.3 t -61.9 -41.76 98.28 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 120.959 -0.296 . . . . 0.0 110.827 179.558 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . 0.498 ' O ' ' HB2' ' A' ' 169' ' ' GLU . 6.7 tpp85 -61.07 -47.66 85.31 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 111.658 0.244 . . . . 0.0 111.658 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' TYR . . . . . 0.85 ' HE1' ' HA ' ' A' ' 195' ' ' ARG . 87.6 t80 -65.98 -50.97 62.44 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -179.358 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.591 ' HG ' ' O ' ' A' ' 163' ' ' ILE . 40.7 mt -59.11 -45.0 92.03 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 121.127 -0.229 . . . . 0.0 111.477 -178.784 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 3.7 ttt180 -70.26 -42.03 72.69 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 120.959 -0.296 . . . . 0.0 111.637 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . 0.498 ' HB2' ' O ' ' A' ' 165' ' ' ARG . 0.5 OUTLIER -59.6 -46.0 90.24 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.222 0.534 . . . . 0.0 109.645 179.081 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . 0.605 ' HB3' ' HE3' ' A' ' 257' ' ' LYS . 6.9 mm-40 -65.34 -49.75 68.22 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.87 179.058 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . 0.43 ' HA ' ' HG2' ' A' ' 257' ' ' LYS . . . -63.69 -31.76 73.03 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 -178.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 7.4 m -84.64 -43.25 14.57 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -179.157 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 84.03 13.02 75.57 Favored Glycine 0 CA--C 1.522 0.48 0 C-N-CA 120.545 -0.836 . . . . 0.0 111.706 -178.472 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 13.7 t -100.09 -159.48 0.74 Allowed 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 115.654 -0.273 . . . . 0.0 110.636 -179.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . 0.425 ' HA ' ' HE3' ' A' ' 175' ' ' LYS . 0.0 OUTLIER -127.57 163.03 25.07 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 120.696 0.284 . . . . 0.0 111.386 -179.948 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . 0.458 ' OD2' ' HD2' ' A' ' 165' ' ' ARG . 16.3 t0 -131.21 117.47 19.07 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 120.861 0.362 . . . . 0.0 111.48 -179.359 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 59.2 p -105.7 16.9 24.62 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.321 0.582 . . . . 0.0 110.775 179.087 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . 0.853 ' HZ3' ' HB3' ' A' ' 178' ' ' LYS . 3.3 ttpm? -105.82 128.29 26.73 Favored Pre-proline 0 CA--C 1.534 0.341 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.02 -179.728 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -66.83 -177.83 1.09 Allowed 'Trans proline' 0 CA--C 1.539 0.731 0 C-N-CA 122.715 2.277 . . . . 0.0 113.381 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.483 HD13 ' HA3' ' A' ' 187' ' ' GLY . 0.9 OUTLIER -105.61 -173.17 2.24 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.073 179.625 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -110.55 -84.69 1.53 Allowed Glycine 0 CA--C 1.52 0.398 0 C-N-CA 120.343 -0.932 . . . . 0.0 113.656 -178.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -85.25 -8.75 58.39 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.093 0.473 . . . . 0.0 111.471 -179.377 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -109.76 68.76 0.68 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.949 179.303 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -73.73 -71.15 1.14 Allowed Glycine 0 CA--C 1.524 0.616 0 C-N-CA 120.631 -0.795 . . . . 0.0 113.56 -179.456 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -72.09 -44.82 62.64 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.104 0.478 . . . . 0.0 110.966 179.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -67.9 -26.94 66.24 Favored 'General case' 0 C--O 1.225 -0.204 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.213 179.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . 0.543 ' O ' ' HB2' ' A' ' 191' ' ' LEU . . . -63.82 -53.49 37.46 Favored Glycine 0 C--N 1.332 0.315 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.199 179.64 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . 0.594 ' HE ' ' HG2' ' A' ' 192' ' ' GLU . 1.4 tpm_? -63.33 -44.42 94.95 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 120.902 0.382 . . . . 0.0 110.302 178.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . 0.418 HH22 ' CD ' ' A' ' 298' ' ' GLU . 37.0 mtp180 -60.17 -47.41 86.06 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.096 179.618 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . 0.47 ' HA ' HG13 ' A' ' 297' ' ' VAL . . . -72.75 -40.52 65.95 Favored 'General case' 0 C--O 1.22 -0.453 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -179.679 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . 0.543 ' HB2' ' O ' ' A' ' 187' ' ' GLY . 0.3 OUTLIER -58.66 -45.78 88.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.798 0.333 . . . . 0.0 110.735 179.885 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . 0.594 ' HG2' ' HE ' ' A' ' 188' ' ' ARG . 15.2 mm-40 -76.81 -40.98 46.19 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -179.806 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 193' ' ' THR . . . . . 0.64 HG21 ' HA ' ' A' ' 297' ' ' VAL . 80.1 m -65.0 -48.55 73.53 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.813 0.34 . . . . 0.0 110.108 178.847 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 56.1 tp -64.81 -30.03 71.02 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.292 178.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . 0.85 ' HA ' ' HE1' ' A' ' 166' ' ' TYR . 56.9 ttm-85 -61.5 -49.49 76.56 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.832 0.349 . . . . 0.0 110.385 178.231 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . 0.44 HH11 ' HD2' ' A' ' 196' ' ' ARG . 0.2 OUTLIER -70.99 -55.25 8.71 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.026 -179.688 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . 0.469 ' O ' HG23 ' A' ' 201' ' ' VAL . 35.5 t -63.29 -47.65 91.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-O 120.997 0.427 . . . . 0.0 111.851 -179.341 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -60.43 -44.9 97.14 Favored Glycine 0 CA--C 1.519 0.302 0 CA-C-N 116.067 -0.515 . . . . 0.0 113.004 -179.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -73.48 -32.44 64.31 Favored 'General case' 0 C--N 1.331 -0.235 0 O-C-N 122.211 -0.582 . . . . 0.0 109.492 179.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -56.27 -48.49 74.59 Favored Glycine 0 C--N 1.337 0.621 0 N-CA-C 110.999 -0.841 . . . . 0.0 110.999 177.314 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 197' ' ' VAL . 41.3 t -65.36 -37.68 80.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 CA-C-O 120.883 0.373 . . . . 0.0 110.404 178.108 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 202' ' ' GLN . . . . . 0.44 ' HA ' ' CE2' ' A' ' 209' ' ' PHE . 24.5 mt-30 -61.69 -53.03 61.54 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.935 -0.575 . . . . 0.0 112.041 179.687 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 203' ' ' ARG . . . . . 0.403 HH11 ' HD3' ' A' ' 203' ' ' ARG . 9.2 ptt180 -72.88 -27.75 62.08 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 120.924 -0.31 . . . . 0.0 111.499 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -71.55 -53.59 13.3 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.058 0.456 . . . . 0.0 110.789 179.122 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 205' ' ' HIS . . . . . 0.424 ' HB3' ' HB2' ' A' ' 208' ' ' ALA . 94.2 m-70 -101.19 36.84 1.89 Allowed 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.897 179.5 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 11.0 tm-20 -53.83 -46.38 71.14 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.508 -179.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 49.1 p -64.66 -34.68 78.87 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.151 179.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . 0.424 ' HB2' ' HB3' ' A' ' 205' ' ' HIS . . . -69.22 -42.43 75.72 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 178.61 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 209' ' ' PHE . . . . . 0.479 ' O ' ' HG ' ' A' ' 213' ' ' LEU . 13.9 m-85 -70.81 -35.07 72.34 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.236 178.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -66.58 -46.9 74.46 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 177.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -62.26 -39.93 98.35 Favored Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 110.555 -1.018 . . . . 0.0 110.555 177.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 212' ' ' MET . . . . . 0.413 ' HE3' ' HB3' ' B' ' 26' ' ' GLN . 5.5 tpp -61.36 -37.0 81.78 Favored 'General case' 0 C--O 1.223 -0.293 0 N-CA-C 110.166 -0.309 . . . . 0.0 110.166 178.109 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . 0.479 ' HG ' ' O ' ' A' ' 209' ' ' PHE . 34.7 mt -60.42 -41.62 94.32 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.043 0.449 . . . . 0.0 110.568 178.366 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 83.7 mtt85 -70.6 -27.02 63.78 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.594 179.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 10.1 mmmm -91.58 -11.19 37.95 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 120.89 0.376 . . . . 0.0 111.446 179.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . 0.49 HD21 HD13 ' A' ' 218' ' ' ILE . 16.4 tp -100.11 114.3 27.56 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.38 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -90.16 24.12 2.61 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 120.996 0.427 . . . . 0.0 111.787 -179.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 218' ' ' ILE . . . . . 0.536 HG12 ' HB3' ' A' ' 223' ' ' ASP . 5.7 mt -66.69 122.85 18.49 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-O 121.094 0.473 . . . . 0.0 111.354 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 7.0 ptpp? -154.98 -16.15 0.12 Allowed 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -179.131 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -130.95 -178.95 5.04 Favored 'General case' 0 CA--C 1.536 0.413 0 O-C-N 121.688 -0.633 . . . . 0.0 112.515 -178.523 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . 0.45 ' O ' HG22 ' A' ' 224' ' ' VAL . 3.5 tp10 -61.64 -39.81 92.66 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -179.143 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . 0.404 ' O ' ' HG2' ' A' ' 225' ' ' LYS . . . -55.7 -26.07 45.47 Favored Glycine 0 CA--C 1.524 0.606 0 C-N-CA 121.399 -0.429 . . . . 0.0 113.764 -179.347 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 223' ' ' ASP . . . . . 0.536 ' HB3' HG12 ' A' ' 218' ' ' ILE . 61.4 m-20 -60.13 -28.09 67.6 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 -179.544 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . 0.45 HG22 ' O ' ' A' ' 221' ' ' GLU . 31.5 m -53.69 -31.72 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 N-CA-C 113.221 0.823 . . . . 0.0 113.221 -179.095 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . 0.404 ' HG2' ' O ' ' A' ' 222' ' ' GLY . 10.6 ptpp? -68.06 -33.61 74.88 Favored 'General case' 0 C--O 1.237 0.41 0 O-C-N 121.845 -0.535 . . . . 0.0 110.407 179.516 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 226' ' ' SER . . . . . 0.643 ' O ' HG21 ' A' ' 230' ' ' VAL . 33.3 p -69.63 -47.59 62.86 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.755 179.181 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 227' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -55.87 -37.7 69.15 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.154 0.502 . . . . 0.0 110.069 179.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 39.3 m -59.27 -48.73 80.55 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.488 177.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 229' ' ' ARG . . . . . 0.442 ' HA ' ' HD3' ' A' ' 229' ' ' ARG . 13.8 mmt180 -68.26 -34.09 75.56 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.074 179.5 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . 0.643 HG21 ' O ' ' A' ' 226' ' ' SER . 54.4 t -57.13 -54.83 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-O 120.562 0.22 . . . . 0.0 110.632 179.303 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 231' ' ' MET . . . . . 0.597 ' HG2' HD13 ' A' ' 248' ' ' LEU . 72.3 mtm -59.41 -43.35 93.02 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.334 179.374 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 79.7 t -59.07 -44.18 90.86 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-O 120.727 0.299 . . . . 0.0 110.874 178.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 65.7 t-80 -60.07 -38.62 83.41 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 120.826 0.346 . . . . 0.0 111.519 179.217 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 94.2 t -61.85 -39.62 84.14 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 CA-C-O 121.192 0.52 . . . . 0.0 111.056 178.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -99.24 24.42 7.98 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.638 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -62.24 -18.22 60.54 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -179.631 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -83.12 -16.71 45.71 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.772 0.32 . . . . 0.0 111.399 179.558 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 90.98 -10.07 76.06 Favored Glycine 0 CA--C 1.524 0.632 0 C-N-CA 120.701 -0.761 . . . . 0.0 113.747 179.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 6.2 p -93.47 118.19 38.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-O 121.571 0.701 . . . . 0.0 111.414 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 83.8 m -94.03 119.77 33.37 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.063 0.459 . . . . 0.0 111.896 -179.448 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -113.67 140.76 47.96 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.162 178.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 242' ' ' TRP . . . . . 0.488 ' HA ' ' CE3' ' A' ' 242' ' ' TRP . 1.3 m95 -56.79 -44.94 82.39 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.715 0.293 . . . . 0.0 111.014 179.601 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . 0.43 ' HA2' HG12 ' A' ' 246' ' ' VAL . . . -60.8 -29.53 70.51 Favored Glycine 0 CA--C 1.523 0.541 0 C-N-CA 121.083 -0.58 . . . . 0.0 112.384 178.671 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 244' ' ' ARG . . . . . 0.449 ' HA ' ' HA3' ' B' ' 31' ' ' GLY . 60.5 mtt180 -68.96 -47.25 66.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.112 0.482 . . . . 0.0 109.797 178.675 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . 0.456 ' O ' HG13 ' A' ' 249' ' ' ILE . 68.3 mt -62.59 -48.23 89.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.3 179.827 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . 0.43 HG12 ' HA2' ' A' ' 243' ' ' GLY . 8.7 p -65.44 -27.87 42.89 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 C-N-CA 120.849 -0.341 . . . . 0.0 111.143 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 17.5 m -65.74 -41.24 92.4 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.201 0.524 . . . . 0.0 109.718 178.041 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 248' ' ' LEU . . . . . 0.597 HD13 ' HG2' ' A' ' 231' ' ' MET . 55.0 mt -65.72 -38.29 88.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.999 178.226 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 249' ' ' ILE . . . . . 0.456 HG13 ' O ' ' A' ' 245' ' ' ILE . 14.9 mt -68.41 -43.05 84.37 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.524 178.875 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 250' ' ' SER . . . . . 0.414 ' HB2' ' HG3' ' A' ' 202' ' ' GLN . 5.2 p -66.47 -38.26 86.94 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 178.256 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 251' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -62.92 -44.15 96.85 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 176.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . 0.406 ' HA2' HG21 ' A' ' 255' ' ' VAL . . . -61.21 -42.68 99.86 Favored Glycine 0 C--N 1.336 0.579 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.359 177.845 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -62.43 -38.72 90.8 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 120.926 0.393 . . . . 0.0 110.692 178.109 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -66.73 -47.56 71.92 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.256 179.312 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 255' ' ' VAL . . . . . 0.541 ' O ' ' HG ' ' A' ' 259' ' ' LEU . 31.3 m -66.63 -33.77 65.67 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.2 178.817 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -63.25 -40.3 97.03 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.133 0.492 . . . . 0.0 109.779 177.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 257' ' ' LYS . . . . . 0.605 ' HE3' ' HB3' ' A' ' 170' ' ' GLN . 81.2 mttt -63.72 -39.18 93.67 Favored 'General case' 0 CA--C 1.528 0.1 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.582 177.541 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 66.7 t60 -65.0 -36.43 84.39 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 177.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . 0.541 ' HG ' ' O ' ' A' ' 255' ' ' VAL . 72.9 mt -70.07 -42.48 72.76 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.882 178.146 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 28.1 tptt -64.7 -33.83 76.87 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.672 179.132 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 40.7 t -59.77 -24.42 64.07 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.206 179.004 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 262' ' ' VAL . . . . . 0.502 HG22 ' HG3' ' A' ' 264' ' ' GLN . 16.7 m -117.54 18.16 7.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 CA-C-O 121.264 0.554 . . . . 0.0 110.179 178.607 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 23.3 t30 51.48 47.68 24.37 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 114.96 -1.018 . . . . 0.0 113.066 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 264' ' ' GLN . . . . . 0.502 ' HG3' HG22 ' A' ' 262' ' ' VAL . 11.6 mt-30 -91.36 39.11 0.99 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.707 0.289 . . . . 0.0 111.457 179.049 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . 0.494 ' HA ' HD13 ' A' ' 268' ' ' ILE . 15.6 tp10 -47.07 -36.63 8.36 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.906 179.477 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 2.5 m -55.9 -29.17 59.6 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.911 179.424 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 267' ' ' PHE . . . . . 0.406 ' C ' ' HD2' ' A' ' 270' ' ' PRO . 44.1 t80 -95.62 -21.38 18.26 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 120.925 -0.31 . . . . 0.0 111.623 179.819 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 268' ' ' ILE . . . . . 0.494 HD13 ' HA ' ' A' ' 265' ' ' GLU . 70.6 mt -63.77 -37.82 80.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 CA-C-O 121.06 0.457 . . . . 0.0 110.357 179.252 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 269' ' ' GLU . . . . . 0.575 ' HB3' ' HD3' ' A' ' 270' ' ' PRO . 2.1 tp10 -59.56 -58.27 20.69 Favored Pre-proline 0 CA--C 1.551 1.018 0 CA-C-N 115.886 -0.597 . . . . 0.0 112.113 179.236 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 270' ' ' PRO . . . . . 0.575 ' HD3' ' HB3' ' A' ' 269' ' ' GLU . 21.5 Cg_exo -67.82 -25.12 39.62 Favored 'Trans proline' 0 C--N 1.361 1.215 0 C-N-CA 122.314 2.009 . . . . 0.0 113.167 179.616 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 271' ' ' LEU . . . . . . . . . . . . . 42.6 tp -64.45 -46.22 84.09 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.622 -0.263 . . . . 0.0 110.55 179.075 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -61.17 -39.45 90.19 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.073 179.247 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 273' ' ' GLU . . . . . . . . . . . . . 49.9 mm-40 -68.48 -46.28 70.15 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.794 178.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 274' ' ' THR . . . . . . . . . . . . . 84.9 m -58.01 -49.18 77.73 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.94 179.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 275' ' ' ILE . . . . . 0.483 ' HA ' ' HE3' ' A' ' 231' ' ' MET . 95.1 mt -59.54 -54.0 40.54 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.115 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.267 178.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 78.6 m -52.5 -53.13 50.04 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.767 -0.651 . . . . 0.0 112.627 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 277' ' ' ASP . . . . . 0.404 ' HA ' ' HE1' ' A' ' 156' ' ' TYR . 38.4 t70 -59.64 -57.98 10.58 Favored 'General case' 0 C--O 1.224 -0.25 0 C-N-CA 120.849 -0.34 . . . . 0.0 111.561 -179.341 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 278' ' ' VAL . . . . . 0.455 ' HB ' ' HE3' ' A' ' 231' ' ' MET . 43.1 t -58.26 -41.34 80.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -179.295 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 19.1 tp -63.13 -47.2 83.77 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 75.7 t -77.73 -46.16 27.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -179.243 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 21.2 ptt180 -59.76 -30.16 68.67 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -179.16 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 282' ' ' THR . . . . . . . . . . . . . 12.0 m -84.71 -22.34 29.78 Favored 'General case' 0 CA--C 1.543 0.673 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . 0.619 ' HZ3' ' HB2' ' A' ' 283' ' ' LYS . 0.0 OUTLIER -139.38 42.03 2.05 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 -178.71 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 284' ' ' ARG . . . . . 0.428 HH21 ' CD ' ' A' ' 152' ' ' GLU . 11.1 ptm180 -63.8 -47.16 81.98 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -179.21 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -61.8 -41.71 98.1 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.838 0.352 . . . . 0.0 111.207 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 286' ' ' TRP . . . . . 0.555 ' O ' ' HG2' ' A' ' 290' ' ' GLN . 7.7 t90 -64.41 -41.62 96.53 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.803 0.335 . . . . 0.0 110.261 178.74 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -66.46 -51.71 53.89 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 27.2 m -59.78 -32.55 49.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -179.304 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.98 -36.53 75.27 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 120.772 0.32 . . . . 0.0 110.797 179.336 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 290' ' ' GLN . . . . . 0.555 ' HG2' ' O ' ' A' ' 286' ' ' TRP . 40.5 mm-40 -88.83 28.74 1.11 Allowed 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 121.032 -0.267 . . . . 0.0 110.977 179.543 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 46.1 mtp85 59.68 22.33 11.08 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 112.192 0.441 . . . . 0.0 112.192 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 62.91 -130.62 42.51 Favored Glycine 0 C--O 1.239 0.433 0 CA-C-O 121.485 0.492 . . . . 0.0 113.866 179.512 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 293' ' ' TRP . . . . . 0.522 ' O ' HG12 ' A' ' 297' ' ' VAL . 90.6 m95 -65.12 -26.17 68.08 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.428 -0.386 . . . . 0.0 112.02 -179.294 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 294' ' ' ASP . . . . . 0.4 ' O ' ' HB2' ' A' ' 298' ' ' GLU . 25.5 t70 -64.64 -36.35 83.96 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 121.136 0.493 . . . . 0.0 109.995 178.579 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 295' ' ' GLY . . . . . 0.469 ' HA3' ' O ' ' A' ' 290' ' ' GLN . . . -71.37 -36.96 63.02 Favored Glycine 0 N--CA 1.45 -0.386 0 N-CA-C 110.551 -1.02 . . . . 0.0 110.551 177.598 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 296' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -63.87 -45.84 87.64 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 115.477 -0.362 . . . . 0.0 111.097 178.412 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 297' ' ' VAL . . . . . 0.64 ' HA ' HG21 ' A' ' 193' ' ' THR . 14.0 m -72.31 -28.4 28.8 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 -179.614 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 298' ' ' GLU . . . . . 0.466 ' O ' HG22 ' A' ' 302' ' ' VAL . 2.3 tp10 -76.76 -49.74 15.22 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.582 0.229 . . . . 0.0 111.275 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 299' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -55.15 -48.72 73.33 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 120.879 0.371 . . . . 0.0 111.267 179.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 300' ' ' PHE . . . . . 0.47 ' CZ ' ' HB3' ' A' ' 242' ' ' TRP . 54.2 m-85 -80.43 31.13 0.28 Allowed 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -139.65 -46.71 0.45 Allowed 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 111.843 0.312 . . . . 0.0 111.843 179.814 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . 0.466 HG22 ' O ' ' A' ' 298' ' ' GLU . 6.1 m -71.52 65.77 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-O 121.468 0.652 . . . . 0.0 112.263 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -106.27 24.12 13.01 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -179.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -73.91 69.52 1.41 Allowed 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.098 0.475 . . . . 0.0 111.41 179.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 305' ' ' LEU . . . . . 0.413 HD12 ' HA ' ' A' ' 305' ' ' LEU . 2.7 mm? -79.05 -33.59 44.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.281 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -72.61 -30.05 64.02 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.404 179.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . -100.9 69.67 0.44 Allowed Glycine 0 CA--C 1.521 0.418 0 C-N-CA 120.879 -0.677 . . . . 0.0 113.128 -179.557 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.186 0 CA-C-O 118.476 -1.18 . . . . 0.0 113.08 -179.975 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.499 0 CA-C-O 121.02 0.438 . . . . 0.0 110.704 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -109.59 -78.37 0.59 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.174 -179.144 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 19' ' ' LEU . . . . . 0.444 HD23 ' HA ' ' A' ' 216' ' ' LEU . 9.1 tp -88.37 121.57 70.19 Favored Pre-proline 0 CA--C 1.532 0.287 0 CA-C-O 120.762 0.315 . . . . 0.0 110.874 179.459 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 20' ' ' PRO . . . . . 0.416 ' HA ' ' HD3' ' B' ' 21' ' ' PRO . 58.0 Cg_endo -70.15 139.73 39.56 Favored 'Trans proline' 0 CA--C 1.534 0.514 0 C-N-CA 122.869 2.379 . . . . 0.0 113.045 -179.743 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 21' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' B' ' 20' ' ' PRO . 8.3 Cg_exo -72.5 37.23 0.36 Allowed 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 123.105 2.537 . . . . 0.0 113.686 -179.615 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -75.54 -33.05 60.67 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 121.221 0.534 . . . . 0.0 110.932 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 23' ' ' PHE . . . . . 0.525 ' CE1' HG22 ' A' ' 230' ' ' VAL . 1.5 p90 -63.19 -41.57 99.22 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.478 -179.671 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.75 -36.42 83.83 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.939 0.4 . . . . 0.0 110.756 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.84 -47.37 86.65 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.798 178.241 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 26' ' ' GLN . . . . . 0.413 ' HB3' ' HE3' ' A' ' 212' ' ' MET . 5.5 mt-30 -66.01 -45.62 80.85 Favored 'General case' 0 CA--C 1.527 0.081 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.409 178.448 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 80.6 mt -56.75 -39.42 73.94 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.844 0.355 . . . . 0.0 110.378 178.386 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 28' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -62.63 -51.82 65.78 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.67 178.194 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -56.91 -42.01 79.17 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.568 178.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 87.8 mt -65.09 -43.29 95.86 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.433 178.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . 0.449 ' HA3' ' HA ' ' A' ' 244' ' ' ARG . . . -59.17 -50.08 71.63 Favored Glycine 0 C--N 1.335 0.514 0 C-N-CA 121.069 -0.586 . . . . 0.0 112.397 179.273 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -61.31 -44.62 96.91 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.091 0.472 . . . . 0.0 109.808 178.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 33' ' ' LYS . . . . . 0.452 ' HA ' ' HD2' ' B' ' 33' ' ' LYS . 0.2 OUTLIER -59.59 -55.98 27.67 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.787 179.718 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 55.7 t -59.14 -44.96 92.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-O 120.848 0.356 . . . . 0.0 110.974 179.558 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -57.09 -45.96 82.94 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.567 179.145 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 36' ' ' CYS . . . . . . . . . . . . . 73.3 m -65.77 -29.55 70.06 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.405 179.302 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 97.0 m -66.69 -45.39 78.97 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 120.645 0.259 . . . . 0.0 111.217 179.464 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 38' ' ' TRP . . . . . . . . . . . . . 99.3 m95 -75.58 -40.81 56.11 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 120.74 0.305 . . . . 0.0 111.136 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 41.7 t -81.29 54.47 2.3 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 120.841 0.353 . . . . 0.0 111.66 179.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -70.44 115.02 30.73 Favored Pre-proline 0 N--CA 1.466 0.356 0 CA-C-O 121.0 0.429 . . . . 0.0 111.552 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -97.08 29.8 0.17 Allowed 'Trans proline' 0 CA--C 1.535 0.572 0 C-N-CA 123.425 2.75 . . . . 0.0 114.095 -179.132 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -77.4 58.06 1.62 Allowed 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 120.913 0.387 . . . . 0.0 111.732 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 43' ' ' MET . . . . . . . . . . . . . 10.8 ptm . . . . . 0 C--O 1.252 1.185 0 CA-C-O 118.316 -0.849 . . . . 0.0 111.553 179.994 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.541 ' HA3' ' HB3' ' A' ' 153' ' ' ASP . . . . . . . . 0 N--CA 1.493 2.469 0 CA-C-O 119.853 -0.415 . . . . 0.0 112.152 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_exo -57.38 -55.18 2.69 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.74 2.293 . . . . 0.0 112.43 179.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 16.5 tp -84.63 54.4 3.02 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 121.386 0.612 . . . . 0.0 110.811 179.388 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 74.08 -110.55 3.14 Favored Glycine 0 C--O 1.228 -0.23 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.844 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 61.0 p -117.92 6.69 12.22 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.95 0.405 . . . . 0.0 110.46 178.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 45.3 mm-40 -64.95 -39.46 93.52 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.636 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . 0.583 ' O ' ' HG3' ' A' ' 157' ' ' ARG . 26.5 t70 -64.63 -49.05 72.59 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.82 179.867 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . 0.596 ' HA ' ' CZ ' ' A' ' 157' ' ' ARG . 2.9 m-20 -55.6 -47.41 76.55 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -178.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 47.9 tp -66.37 -37.02 84.34 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.139 0.495 . . . . 0.0 110.616 179.283 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 56.7 t80 -68.49 -43.19 77.43 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.389 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . 0.596 ' CZ ' ' HA ' ' A' ' 154' ' ' ASP . 54.4 mtm-85 -56.43 -49.77 73.58 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 27.6 tt0 -64.86 -43.93 91.39 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 120.851 0.358 . . . . 0.0 110.961 -179.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 20.0 m -63.52 -43.26 97.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.205 179.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -64.24 -47.54 79.27 Favored 'General case' 0 C--O 1.221 -0.402 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.43 178.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . 0.437 ' HB3' HD11 ' A' ' 180' ' ' LEU . 33.8 mt-10 -54.38 -47.39 72.73 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-O 120.875 0.369 . . . . 0.0 111.461 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . 0.486 HG12 ' HA2' ' A' ' 187' ' ' GLY . 67.8 mt -63.11 -53.21 49.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-N 116.069 -0.514 . . . . 0.0 112.137 -179.783 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.481 HD11 HG21 ' A' ' 276' ' ' THR . 80.3 mt -63.12 -43.99 99.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.908 0.385 . . . . 0.0 110.935 179.725 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 2.5 t -59.16 -46.66 87.8 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.508 179.374 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . 0.84 ' HG2' ' HD2' ' A' ' 179' ' ' PRO . 2.3 mmm180 -57.19 -40.61 77.71 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 120.729 0.299 . . . . 0.0 111.075 179.024 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 70.6 t80 -71.0 -53.76 13.67 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.43 ' HG ' ' O ' ' A' ' 163' ' ' ILE . 38.9 mt -61.03 -43.42 98.92 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -178.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . 0.555 ' HD3' ' OG ' ' A' ' 177' ' ' SER . 1.7 mtt-85 -67.79 -46.18 72.69 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -179.201 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . 0.533 ' OE2' ' HD2' ' A' ' 165' ' ' ARG . 17.6 mt-10 -66.3 -39.25 89.21 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 120.89 -0.324 . . . . 0.0 111.808 -179.512 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . 0.497 ' HG3' ' HE3' ' A' ' 257' ' ' LYS . 6.5 tp-100 -70.05 -26.32 63.97 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 121.234 0.54 . . . . 0.0 110.3 178.662 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . 0.524 ' O ' ' HG2' ' A' ' 260' ' ' LYS . . . -79.67 -48.07 14.32 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.803 179.293 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' THR . . . . . 0.481 ' HB ' ' HB2' ' A' ' 175' ' ' LYS . 64.3 p -67.65 -49.22 63.98 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 111.662 0.245 . . . . 0.0 111.662 -179.695 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 65.47 -19.32 0.14 Allowed Glycine 0 CA--C 1.532 1.104 0 N-CA-C 115.035 0.774 . . . . 0.0 115.035 179.349 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' SER . . . . . 0.438 ' H ' ' C ' ' A' ' 172' ' ' THR . 89.3 p -141.69 9.89 2.0 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 117.641 0.721 . . . . 0.0 111.952 -179.455 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . 0.481 ' HB2' ' HB ' ' A' ' 172' ' ' THR . 25.1 mmtm -127.08 124.04 38.31 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.399 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -70.92 86.35 0.7 Allowed 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 121.536 0.684 . . . . 0.0 111.464 -179.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' SER . . . . . 0.555 ' OG ' ' HD3' ' A' ' 168' ' ' ARG . 27.5 t -103.98 78.91 1.58 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.992 -179.78 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 47.2 mttp -106.79 97.33 16.98 Favored Pre-proline 0 CA--C 1.537 0.454 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -179.269 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . 0.84 ' HD2' ' HG2' ' A' ' 165' ' ' ARG . 95.0 Cg_endo -95.53 40.88 0.14 Allowed 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 123.167 2.578 . . . . 0.0 112.383 178.289 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.471 HD13 ' HG3' ' A' ' 165' ' ' ARG . 9.0 tp -90.31 137.43 32.36 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.437 -179.31 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -148.71 -54.16 0.02 OUTLIER Glycine 0 CA--C 1.52 0.373 0 C-N-CA 120.438 -0.886 . . . . 0.0 112.967 -179.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 62.3 tt0 -96.45 -30.23 13.47 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.819 0.343 . . . . 0.0 111.725 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . 0.6 ' O ' ' HA3' ' A' ' 187' ' ' GLY . . . -80.67 62.57 4.77 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.939 0.399 . . . . 0.0 111.499 -179.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -79.97 -71.48 1.26 Allowed Glycine 0 CA--C 1.525 0.705 0 C-N-CA 120.751 -0.737 . . . . 0.0 113.969 -179.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -70.56 -57.01 5.2 Favored 'General case' 0 C--O 1.238 0.449 0 O-C-N 122.519 -0.4 . . . . 0.0 111.823 -179.14 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -67.24 -27.75 67.49 Favored 'General case' 0 C--N 1.335 -0.061 0 CA-C-O 121.199 0.523 . . . . 0.0 109.892 179.234 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . 0.6 ' HA3' ' O ' ' A' ' 183' ' ' ALA . . . -72.64 -33.36 60.76 Favored Glycine 0 N--CA 1.447 -0.614 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.861 178.573 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -65.97 -54.51 25.3 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.797 0.332 . . . . 0.0 110.269 178.688 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . 0.69 ' HB3' HG12 ' A' ' 297' ' ' VAL . 16.0 mtm180 -55.12 -46.79 75.6 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 121.136 0.493 . . . . 0.0 110.818 179.17 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -71.35 -31.33 67.24 Favored 'General case' 0 C--O 1.221 -0.409 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.474 -179.474 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . 0.597 ' HB2' ' O ' ' A' ' 187' ' ' GLY . 0.2 OUTLIER -62.16 -53.59 53.15 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 117.893 0.315 . . . . 0.0 111.08 179.67 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -64.2 -41.41 97.08 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 120.713 0.292 . . . . 0.0 111.214 179.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 193' ' ' THR . . . . . 0.512 HG21 ' HA ' ' A' ' 297' ' ' VAL . 11.8 m -64.33 -47.76 78.18 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.81 179.109 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 14.9 tp -66.69 -35.28 79.76 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.776 0.322 . . . . 0.0 110.829 179.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . 0.422 HH11 ' HD2' ' A' ' 195' ' ' ARG . 9.2 tpp85 -67.73 -57.43 6.36 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.991 179.024 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 16.6 tpp180 -60.96 -50.8 71.91 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -178.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . 0.554 ' O ' HG23 ' A' ' 201' ' ' VAL . 97.1 t -70.1 -47.0 70.54 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -179.225 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -59.73 -48.06 87.9 Favored Glycine 0 CA--C 1.52 0.395 0 C-N-CA 121.359 -0.448 . . . . 0.0 113.229 -179.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . 0.507 ' HA ' ' HG2' ' A' ' 202' ' ' GLN . 98.2 m-20 -65.95 -36.38 83.2 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.828 0.347 . . . . 0.0 110.176 179.253 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -62.05 -37.69 94.86 Favored Glycine 0 CA--C 1.522 0.531 0 C-N-CA 120.708 -0.758 . . . . 0.0 111.97 178.48 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 201' ' ' VAL . . . . . 0.554 HG23 ' O ' ' A' ' 197' ' ' VAL . 93.4 t -67.09 -46.29 84.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 O-C-N 122.844 -0.21 . . . . 0.0 110.968 179.023 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 202' ' ' GLN . . . . . 0.507 ' HG2' ' HA ' ' A' ' 199' ' ' ASP . 8.0 pt20 -68.91 -31.68 70.76 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.443 179.593 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.35 -44.43 45.18 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 120.661 0.267 . . . . 0.0 111.152 179.012 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 27.1 m-80 -68.19 -44.89 74.87 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.844 0.354 . . . . 0.0 111.715 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 205' ' ' HIS . . . . . 0.444 ' HB2' ' CD2' ' A' ' 209' ' ' PHE . 10.2 m80 -100.65 32.82 2.96 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 120.897 0.379 . . . . 0.0 110.32 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -49.62 -51.4 37.87 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 -178.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 28.2 p -57.91 -53.43 58.29 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -179.08 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -61.93 -41.09 97.55 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.029 0.442 . . . . 0.0 110.871 179.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 209' ' ' PHE . . . . . 0.444 ' CD2' ' HB2' ' A' ' 205' ' ' HIS . 5.1 m-85 -64.04 -48.61 75.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.55 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -67.96 -33.58 74.93 Favored 'General case' 0 C--O 1.225 -0.189 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.853 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -57.69 -50.1 68.32 Favored Glycine 0 C--N 1.336 0.555 0 C-N-CA 120.52 -0.847 . . . . 0.0 111.217 178.265 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 212' ' ' MET . . . . . 0.715 ' SD ' ' HA ' ' B' ' 23' ' ' PHE . 41.6 mtm -67.84 -33.16 74.23 Favored 'General case' 0 C--O 1.224 -0.275 0 N-CA-C 110.355 -0.239 . . . . 0.0 110.355 178.474 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . 0.761 HD11 HD12 ' A' ' 216' ' ' LEU . 10.0 tp -67.97 -36.51 80.17 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.196 179.293 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 15.8 mtp180 -68.76 -34.39 75.5 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 178.441 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -86.76 -6.95 58.67 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.765 178.113 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . 0.761 HD12 HD11 ' A' ' 213' ' ' LEU . 5.9 mt -68.73 110.26 4.22 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.186 0.517 . . . . 0.0 111.916 -179.293 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 217' ' ' ASP . . . . . 0.46 ' H ' HD21 ' B' ' 19' ' ' LEU . 0.3 OUTLIER -94.66 18.99 10.54 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.764 179.476 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 218' ' ' ILE . . . . . 0.651 HG13 HD22 ' A' ' 216' ' ' LEU . 34.2 mt -59.3 107.63 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 CA-C-O 121.431 0.634 . . . . 0.0 111.619 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . 0.422 ' HB2' ' HZ1' ' A' ' 219' ' ' LYS . 6.2 mtmp? -150.31 -28.68 0.23 Allowed 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 115.111 -0.949 . . . . 0.0 111.752 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -107.59 166.3 10.78 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 121.082 -0.247 . . . . 0.0 111.249 -179.393 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -54.5 -33.3 59.61 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -179.138 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -64.66 -27.76 72.38 Favored Glycine 0 CA--C 1.526 0.768 0 C-N-CA 120.989 -0.624 . . . . 0.0 113.507 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 223' ' ' ASP . . . . . 0.644 ' HB3' HG12 ' A' ' 218' ' ' ILE . 69.2 m-20 -66.94 -38.02 85.37 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 120.911 0.386 . . . . 0.0 111.5 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . 0.436 HG13 HG23 ' A' ' 274' ' ' THR . 1.1 t -63.46 -35.1 71.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-O 121.361 0.601 . . . . 0.0 110.349 179.26 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 36.0 mmtm -65.56 -30.98 71.79 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.585 178.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 226' ' ' SER . . . . . 0.673 ' O ' HG23 ' A' ' 230' ' ' VAL . 30.6 t -71.63 -37.0 70.94 Favored 'General case' 0 C--O 1.223 -0.304 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.65 178.16 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 227' ' ' PHE . . . . . 0.608 ' HE2' HD12 ' A' ' 275' ' ' ILE . 8.8 t80 -57.11 -43.78 82.62 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 178.419 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 228' ' ' SER . . . . . 0.679 ' HB3' HG22 ' A' ' 278' ' ' VAL . 0.6 OUTLIER -70.35 -32.36 70.03 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.914 177.276 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 54.5 ttp180 -64.09 -48.41 76.26 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.113 178.562 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . 0.718 HG12 ' HA ' ' B' ' 24' ' ' ALA . 13.6 t -61.12 -43.77 96.96 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 178.174 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 231' ' ' MET . . . . . 0.908 ' HG3' ' HG ' ' A' ' 248' ' ' LEU . 26.3 ttm -55.07 -50.24 69.64 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.245 178.238 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 72.2 t -64.63 -42.16 94.29 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 CA-C-O 120.847 0.356 . . . . 0.0 110.818 178.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 233' ' ' HIS . . . . . 0.42 ' ND1' ' HB1' ' B' ' 24' ' ' ALA . 52.7 t-80 -59.78 -39.51 85.15 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 116.278 -0.419 . . . . 0.0 112.06 179.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . 0.521 HG13 ' HA ' ' B' ' 28' ' ' ARG . 44.2 t -54.99 -43.94 71.62 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 179.7 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -90.95 25.7 2.34 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -179.316 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . 0.408 ' HA ' ' HD2' ' A' ' 236' ' ' LYS . 0.0 OUTLIER -58.11 -18.74 27.15 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 113.729 1.011 . . . . 0.0 113.729 -178.904 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -85.68 -16.17 39.98 Favored 'General case' 0 C--N 1.327 -0.384 0 O-C-N 122.093 -0.379 . . . . 0.0 111.4 179.737 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 100.28 -18.84 54.89 Favored Glycine 0 CA--C 1.522 0.522 0 C-N-CA 120.752 -0.737 . . . . 0.0 113.613 179.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 4.3 p -85.71 118.83 33.09 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-O 121.56 0.695 . . . . 0.0 111.237 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 240' ' ' THR . . . . . 0.446 HG22 ' HG2' ' A' ' 283' ' ' LYS . 53.8 m -89.95 98.26 11.67 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.807 -179.36 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -89.59 131.87 35.39 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.884 -0.326 . . . . 0.0 110.455 178.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 242' ' ' TRP . . . . . 0.465 ' CH2' ' HB2' ' A' ' 296' ' ' PHE . 17.2 m95 -55.74 -36.76 67.61 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 120.995 0.426 . . . . 0.0 110.75 179.165 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -61.56 -32.51 81.55 Favored Glycine 0 C--N 1.333 0.401 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.152 178.335 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 244' ' ' ARG . . . . . 0.492 ' HA ' ' HA3' ' B' ' 31' ' ' GLY . 99.1 mtt180 -72.01 -46.24 57.92 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 178.541 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . 0.61 HG23 HD23 ' A' ' 279' ' ' LEU . 52.2 mt -58.14 -49.25 82.24 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.154 179.022 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 8.7 p -69.05 -26.2 31.69 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-N 116.623 -0.262 . . . . 0.0 111.133 179.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 17.0 m -65.72 -37.28 85.99 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 177.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 248' ' ' LEU . . . . . 0.908 ' HG ' ' HG3' ' A' ' 231' ' ' MET . 2.6 mm? -66.62 -38.72 87.53 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 177.865 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 18.2 mm -67.63 -41.4 85.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 177.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 29.8 m -62.25 -41.62 98.6 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.79 178.603 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 251' ' ' PHE . . . . . 0.479 ' CD2' HD13 ' B' ' 27' ' ' LEU . 7.6 t80 -68.03 -40.35 82.93 Favored 'General case' 0 N--CA 1.456 -0.142 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 177.218 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -56.81 -42.26 91.65 Favored Glycine 0 C--N 1.337 0.586 0 N-CA-C 111.106 -0.798 . . . . 0.0 111.106 177.655 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -61.39 -44.45 97.13 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-O 120.937 0.399 . . . . 0.0 110.048 177.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 254' ' ' PHE . . . . . 0.547 ' HB3' HD13 ' A' ' 213' ' ' LEU . 0.2 OUTLIER -61.17 -41.0 96.0 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.271 178.475 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 255' ' ' VAL . . . . . 0.45 HG22 ' O ' ' A' ' 251' ' ' PHE . 91.5 t -62.32 -45.95 97.57 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.225 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 178.096 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 256' ' ' ALA . . . . . 0.456 ' HB2' ' HB2' ' A' ' 171' ' ' ALA . . . -58.82 -39.77 82.17 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 177.766 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 257' ' ' LYS . . . . . 0.497 ' HE3' ' HG3' ' A' ' 170' ' ' GLN . 74.5 mttt -62.89 -47.41 83.4 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.116 177.577 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 4.2 t60 -59.47 -40.97 88.66 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.428 179.081 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . 0.438 HD12 ' HB3' ' A' ' 267' ' ' PHE . 87.2 mt -68.73 -42.29 77.82 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.406 178.624 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 260' ' ' LYS . . . . . 0.524 ' HG2' ' O ' ' A' ' 171' ' ' ALA . 0.7 OUTLIER -64.98 -34.72 79.11 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 120.847 0.356 . . . . 0.0 110.596 178.667 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 32.0 t -63.06 -25.83 68.56 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.019 179.279 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 262' ' ' VAL . . . . . 0.435 HG21 ' HB2' ' A' ' 264' ' ' GLN . 27.2 m -111.62 13.87 8.49 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.19 178.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 1.6 t30 57.06 50.96 11.11 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.451 179.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 264' ' ' GLN . . . . . 0.467 ' NE2' ' HB2' ' A' ' 267' ' ' PHE . 0.0 OUTLIER -119.03 39.2 3.6 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -179.87 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . 0.451 ' HA ' HD13 ' A' ' 268' ' ' ILE . 0.0 OUTLIER -49.63 -27.41 4.59 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 178.933 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.21 -20.67 43.46 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.251 178.641 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 267' ' ' PHE . . . . . 0.467 ' HB2' ' NE2' ' A' ' 264' ' ' GLN . 2.2 t80 -97.67 -20.9 17.33 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.883 178.709 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 268' ' ' ILE . . . . . 0.451 HD13 ' HA ' ' A' ' 265' ' ' GLU . 76.1 mt -65.39 -43.15 94.82 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-O 120.741 0.305 . . . . 0.0 110.373 179.252 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 269' ' ' GLU . . . . . 0.435 ' HB2' ' HD3' ' A' ' 270' ' ' PRO . 0.3 OUTLIER -54.98 -56.98 21.88 Favored Pre-proline 0 CA--C 1.543 0.711 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.794 179.177 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 270' ' ' PRO . . . . . 0.447 ' HD2' ' C ' ' A' ' 267' ' ' PHE . 38.8 Cg_exo -62.89 -32.66 76.9 Favored 'Trans proline' 0 C--N 1.358 1.043 0 C-N-CA 122.055 1.837 . . . . 0.0 112.37 178.43 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 271' ' ' LEU . . . . . 0.556 ' O ' HG22 ' A' ' 275' ' ' ILE . 2.1 tm? -63.79 -50.62 68.26 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.621 179.445 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -60.33 -42.39 95.54 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.734 179.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 273' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -67.2 -43.87 81.04 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 120.945 0.402 . . . . 0.0 110.988 178.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 274' ' ' THR . . . . . 0.436 HG23 HG13 ' A' ' 224' ' ' VAL . 60.6 m -62.22 -52.68 62.8 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.682 -179.497 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 275' ' ' ILE . . . . . 0.608 HD12 ' HE2' ' A' ' 227' ' ' PHE . 6.3 tt -58.28 -47.69 86.89 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 C-N-CA 121.018 -0.273 . . . . 0.0 111.228 179.741 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 276' ' ' THR . . . . . 0.481 HG21 HD11 ' A' ' 163' ' ' ILE . 50.7 m -59.84 -53.73 54.48 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -179.679 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 277' ' ' ASP . . . . . 0.446 ' OD1' ' HD3' ' A' ' 281' ' ' ARG . 33.5 t70 -59.72 -51.16 70.97 Favored 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 120.637 -0.425 . . . . 0.0 111.092 -179.645 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 278' ' ' VAL . . . . . 0.679 HG22 ' HB3' ' A' ' 228' ' ' SER . 73.8 t -58.27 -47.65 86.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 120.747 -0.381 . . . . 0.0 111.02 179.715 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . 0.61 HD23 HG23 ' A' ' 245' ' ' ILE . 45.3 tp -60.58 -47.64 85.29 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 111.676 0.25 . . . . 0.0 111.676 179.782 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 55.6 t -66.86 -39.74 84.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 CA-C-O 120.75 0.31 . . . . 0.0 111.008 179.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 281' ' ' ARG . . . . . 0.446 ' HD3' ' OD1' ' A' ' 277' ' ' ASP . 0.0 OUTLIER -68.17 -47.09 68.93 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -179.883 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 282' ' ' THR . . . . . 0.78 HG22 ' HD2' ' A' ' 283' ' ' LYS . 4.7 t -63.37 -44.16 95.56 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 120.435 -0.506 . . . . 0.0 112.216 -179.676 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . 0.78 ' HD2' HG22 ' A' ' 282' ' ' THR . 0.0 OUTLIER -99.46 40.27 1.23 Allowed 'General case' 0 C--N 1.327 -0.392 0 O-C-N 121.987 -0.445 . . . . 0.0 111.463 179.77 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 284' ' ' ARG . . . . . 0.489 HH12 ' HB ' ' A' ' 288' ' ' VAL . 39.6 tpt85 -58.49 -51.12 71.19 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.941 -179.495 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 285' ' ' ASP . . . . . 0.421 ' CG ' ' HZ2' ' A' ' 289' ' ' LYS . 34.4 t70 -66.96 -43.59 82.73 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 120.994 0.426 . . . . 0.0 111.462 179.679 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 286' ' ' TRP . . . . . 0.437 ' O ' ' HB2' ' A' ' 290' ' ' GLN . 3.5 t90 -64.58 -41.37 96.31 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.933 -179.711 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 287' ' ' LEU . . . . . 0.563 HD22 ' HB3' ' A' ' 283' ' ' LYS . 2.0 mm? -69.0 -47.65 64.98 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 112.319 0.488 . . . . 0.0 112.319 -179.751 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 288' ' ' VAL . . . . . 0.489 ' HB ' HH12 ' A' ' 284' ' ' ARG . 7.3 p -60.73 -37.62 76.51 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 CA-C-O 120.634 0.254 . . . . 0.0 111.641 -179.769 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 289' ' ' LYS . . . . . 0.421 ' HZ2' ' CG ' ' A' ' 285' ' ' ASP . 79.6 mttt -75.3 -21.74 58.23 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 120.891 0.377 . . . . 0.0 111.35 178.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 290' ' ' GLN . . . . . 0.437 ' HB2' ' O ' ' A' ' 286' ' ' TRP . 0.0 OUTLIER -96.34 12.77 30.0 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 111.984 0.365 . . . . 0.0 111.984 179.969 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 291' ' ' ARG . . . . . 0.547 ' HB3' ' HB2' ' A' ' 294' ' ' ASP . 0.0 OUTLIER 62.19 19.09 10.66 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.089 0.471 . . . . 0.0 111.772 179.939 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 64.45 -122.48 25.15 Favored Glycine 0 CA--C 1.522 0.475 0 CA-C-N 115.906 -0.588 . . . . 0.0 113.964 179.207 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 293' ' ' TRP . . . . . 0.503 ' O ' HG21 ' A' ' 297' ' ' VAL . 89.4 m95 -66.57 -33.71 76.27 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.545 -0.328 . . . . 0.0 111.637 -178.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 294' ' ' ASP . . . . . 0.547 ' HB2' ' HB3' ' A' ' 291' ' ' ARG . 45.0 m-20 -54.86 -40.25 69.47 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.017 0.437 . . . . 0.0 110.251 178.354 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -72.18 -44.51 43.82 Favored Glycine 0 C--N 1.334 0.455 0 C-N-CA 120.761 -0.733 . . . . 0.0 111.727 178.394 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 296' ' ' PHE . . . . . 0.465 ' HB2' ' CH2' ' A' ' 242' ' ' TRP . 7.2 t80 -58.92 -45.06 91.29 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 120.852 0.358 . . . . 0.0 111.114 178.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 297' ' ' VAL . . . . . 0.69 HG12 ' HB3' ' A' ' 189' ' ' ARG . 81.0 t -67.57 -39.51 82.49 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.942 -179.529 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -76.15 -26.95 56.8 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 112.578 0.584 . . . . 0.0 112.578 -179.379 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 299' ' ' PHE . . . . . . . . . . . . . 87.4 t80 -60.9 -41.32 95.83 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.807 0.337 . . . . 0.0 111.372 179.446 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 300' ' ' PHE . . . . . 0.446 ' HE2' ' CD1' ' A' ' 296' ' ' PHE . 68.4 m-85 -88.68 29.54 1.0 Allowed 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 120.706 0.289 . . . . 0.0 111.628 -179.661 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 301' ' ' HIS . . . . . 0.447 ' HB3' HD22 ' A' ' 305' ' ' LEU . 3.8 t60 -77.4 70.64 3.81 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 121.102 0.477 . . . . 0.0 111.056 -179.827 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 2.5 p -86.13 95.48 4.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-O 121.137 0.494 . . . . 0.0 110.896 179.407 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 59.2 tp60 179.71 -78.05 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.259 -179.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -111.0 30.68 6.66 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 120.958 0.409 . . . . 0.0 111.929 -179.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 305' ' ' LEU . . . . . 0.447 HD22 ' HB3' ' A' ' 301' ' ' HIS . 27.3 tp -113.74 -32.6 6.08 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 121.159 0.504 . . . . 0.0 111.36 -179.769 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -88.0 -19.38 27.26 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.574 179.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . 169.13 -116.07 0.64 Allowed Glycine 0 CA--C 1.522 0.473 0 C-N-CA 120.769 -0.729 . . . . 0.0 113.123 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.196 0 CA-C-O 118.366 -1.241 . . . . 0.0 112.947 -179.77 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.506 0 CA-C-O 121.156 0.503 . . . . 0.0 110.481 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -113.1 -166.4 1.08 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.285 -178.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 19' ' ' LEU . . . . . 0.65 ' H ' HD23 ' B' ' 19' ' ' LEU . 0.7 OUTLIER -69.59 157.69 88.88 Favored Pre-proline 0 CA--C 1.539 0.522 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.458 179.823 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 20' ' ' PRO . . . . . 0.427 ' HD2' ' HB2' ' B' ' 19' ' ' LEU . 10.2 Cg_endo -50.17 129.8 26.43 Favored 'Trans proline' 0 C--N 1.354 0.819 0 C-N-CA 123.184 2.59 . . . . 0.0 112.582 -179.841 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 21' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' B' ' 20' ' ' PRO . 24.4 Cg_exo -64.16 42.46 0.12 Allowed 'Trans proline' 0 N--CA 1.482 0.849 0 C-N-CA 123.791 2.994 . . . . 0.0 114.913 -178.735 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 22' ' ' GLU . . . . . 0.403 ' HB2' ' NE2' ' B' ' 26' ' ' GLN . 0.5 OUTLIER -85.97 -29.03 23.87 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.001 0.429 . . . . 0.0 110.265 178.887 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 23' ' ' PHE . . . . . 0.715 ' HA ' ' SD ' ' A' ' 212' ' ' MET . 11.1 p90 -60.5 -35.7 76.57 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.498 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 24' ' ' ALA . . . . . 0.718 ' HA ' HG12 ' A' ' 230' ' ' VAL . . . -61.25 -47.79 84.42 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.007 0.432 . . . . 0.0 110.531 179.587 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . 0.436 ' O ' ' HG2' ' B' ' 29' ' ' LYS . . . -70.61 -44.78 66.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.599 179.163 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 26' ' ' GLN . . . . . 0.73 ' O ' HG12 ' B' ' 30' ' ' ILE . 1.7 mp0 -57.74 -56.97 15.11 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.261 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . 0.479 HD13 ' CD2' ' A' ' 251' ' ' PHE . 50.4 mt -56.31 -42.53 77.74 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 120.589 0.233 . . . . 0.0 111.274 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 28' ' ' ARG . . . . . 0.521 ' HA ' HG13 ' A' ' 234' ' ' VAL . 10.7 ttt85 -57.45 -48.01 80.31 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.523 178.471 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . 0.436 ' HG2' ' O ' ' B' ' 25' ' ' ALA . 20.1 mmmt -68.28 -39.1 82.25 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.872 179.329 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . 0.73 HG12 ' O ' ' B' ' 26' ' ' GLN . 48.8 mm -55.25 -49.95 68.42 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 177.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . 0.492 ' HA3' ' HA ' ' A' ' 244' ' ' ARG . . . -58.84 -44.96 95.64 Favored Glycine 0 N--CA 1.448 -0.559 0 CA-C-N 115.228 -0.897 . . . . 0.0 112.306 179.082 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -57.78 -44.99 86.61 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-O 120.662 0.268 . . . . 0.0 110.955 179.154 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 29.8 tttp -69.73 -52.29 26.74 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 121.017 -0.273 . . . . 0.0 111.171 179.621 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 74.2 t -52.94 -49.3 49.32 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-O 121.075 0.464 . . . . 0.0 110.761 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -57.33 -48.59 78.59 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.698 178.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 36' ' ' CYS . . . . . . . . . . . . . 36.7 t -65.5 -35.04 79.71 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.501 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 37' ' ' THR . . . . . 0.501 ' HA ' ' HB3' ' B' ' 43' ' ' MET . 44.7 m -65.21 -37.3 86.85 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.965 -0.562 . . . . 0.0 111.615 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 38' ' ' TRP . . . . . . . . . . . . . 87.7 m95 -85.52 -35.44 21.13 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.243 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 40.9 t -67.78 -58.14 5.12 Favored 'General case' 0 N--CA 1.462 0.166 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 177.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -92.89 115.14 64.45 Favored Pre-proline 0 CA--C 1.532 0.267 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.134 177.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -68.68 -10.18 28.32 Favored 'Trans proline' 0 CA--C 1.534 0.499 0 C-N-CA 122.458 2.105 . . . . 0.0 113.184 -179.392 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -99.61 30.76 3.46 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.762 -179.721 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 43' ' ' MET . . . . . 0.501 ' HB3' ' HA ' ' B' ' 37' ' ' THR . 40.0 tpp . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.418 -0.801 . . . . 0.0 111.866 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.536 0.42 0 N-CA-C 111.987 0.366 . . . . 1.37 111.987 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -57.95 -41.49 82.93 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.291 -0.413 . . . . 1.16 111.872 179.684 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 44.5 tp -57.29 -43.26 83.0 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.585 -0.279 . . . . 0.57 111.722 -179.484 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -66.5 -48.91 68.31 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 112.075 0.398 . . . . 0.34 112.075 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 157' ' ' ARG . . . . . 0.401 ' HD3' HH11 ' A' ' 157' ' ' ARG . 6.6 mtp180 -59.3 -52.08 67.19 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 112.409 0.522 . . . . 0.89 112.409 -179.274 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 35.9 mm-40 -57.46 -45.68 84.5 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.129 0.49 . . . . 0.47 110.719 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 20.3 m -64.18 -48.51 75.68 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.69 -0.686 . . . . 0.25 111.383 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.619 ' HA ' HG21 ' A' ' 276' ' ' THR . 17.3 tp -58.12 -48.59 79.74 Favored 'General case' 0 C--O 1.225 -0.235 0 CA-C-N 116.326 -0.397 . . . . 0.38 111.498 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -55.96 -50.47 70.69 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 111.781 0.289 . . . . 0.97 111.781 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' ILE . . . . . 0.529 HG12 ' HA2' ' A' ' 187' ' ' GLY . 57.1 mt -62.56 -50.1 81.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 CA-C-N 116.331 -0.395 . . . . 0.34 111.918 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.531 HD12 HG23 ' A' ' 276' ' ' THR . 77.4 mt -62.86 -47.33 93.33 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 C-N-CA 121.297 -0.161 . . . . 0.39 111.214 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 19.4 m -58.2 -42.01 85.23 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.101 0.477 . . . . 0.33 109.989 178.769 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' ARG . . . . . 0.54 ' O ' ' HB2' ' A' ' 169' ' ' GLU . 1.1 mmp_? -66.75 -48.77 68.09 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.119 -0.491 . . . . 0.39 111.308 178.859 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 166' ' ' TYR . . . . . 0.836 ' CE1' ' HA ' ' A' ' 195' ' ' ARG . 66.0 t80 -60.39 -51.99 67.15 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 112.9 0.704 . . . . 0.42 112.9 -179.206 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 10.9 mp -62.4 -45.07 94.79 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 120.961 -0.296 . . . . 0.51 111.782 -178.575 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 1.4 mmt85 -65.06 -40.38 94.63 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 120.551 0.215 . . . . 0.57 111.263 179.128 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' GLU . . . . . 0.54 ' HB2' ' O ' ' A' ' 165' ' ' ARG . 0.6 OUTLIER -60.35 -53.99 50.98 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 120.999 0.428 . . . . 0.38 111.499 179.544 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 170' ' ' GLN . . . . . 0.46 ' HB3' ' CE ' ' A' ' 257' ' ' LYS . 9.0 mm-40 -61.82 -32.44 72.75 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.708 -0.678 . . . . 0.76 112.348 -179.377 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.569 ' O ' ' HG2' ' A' ' 260' ' ' LYS . . . . . . . . 0 CA--C 1.534 0.327 0 N-CA-C 112.165 0.431 . . . . 0.48 112.165 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.57 ' O ' ' HA3' ' A' ' 187' ' ' GLY . . . . . . . . 0 CA--C 1.536 0.433 0 CA-C-O 121.175 0.512 . . . . 0.34 112.069 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -73.79 -69.48 1.39 Allowed Glycine 0 CA--C 1.523 0.539 0 C-N-CA 120.707 -0.758 . . . . 0.36 112.718 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -68.31 -54.94 14.05 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.654 0.264 . . . . 0.38 111.355 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -66.84 -40.92 88.12 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.382 -0.372 . . . . 0.36 111.247 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 187' ' ' GLY . . . . . 0.57 ' HA3' ' O ' ' A' ' 183' ' ' ALA . . . -60.39 -47.01 93.24 Favored Glycine 0 C--O 1.222 -0.601 0 C-N-CA 121.0 -0.619 . . . . 0.32 113.848 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 20.2 mtp180 -69.19 -40.79 77.85 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 117.634 0.717 . . . . 1.04 112.012 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 32.6 ttt180 -66.57 -46.1 77.16 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-O 121.364 0.602 . . . . 0.41 110.359 179.624 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 190' ' ' ALA . . . . . 0.492 ' HB2' ' HB3' ' A' ' 293' ' ' TRP . . . -74.88 -40.2 61.09 Favored 'General case' 0 C--O 1.221 -0.442 0 CA-C-N 115.621 -0.718 . . . . 0.28 112.598 -179.111 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 29.4 tp -63.76 -41.02 98.06 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 118.517 0.599 . . . . 0.49 111.021 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -64.81 -42.96 94.59 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 121.168 0.508 . . . . 0.42 110.508 179.187 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 193' ' ' THR . . . . . 0.477 HG21 ' HA ' ' A' ' 297' ' ' VAL . 43.4 m -71.7 -45.71 61.01 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.0 -0.546 . . . . 0.28 111.491 179.618 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 194' ' ' LEU . . . . . 0.412 HD21 HG21 ' A' ' 249' ' ' ILE . 24.3 tp -60.37 -31.98 70.86 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.292 -0.413 . . . . 0.32 111.292 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 195' ' ' ARG . . . . . 0.836 ' HA ' ' CE1' ' A' ' 166' ' ' TYR . 6.3 ttm105 -70.74 -51.2 28.85 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.59 -0.522 . . . . 0.39 109.59 178.588 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.67 -46.18 91.34 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.507 -0.77 . . . . 0.51 111.624 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 197' ' ' VAL . . . . . 0.412 ' O ' HG23 ' A' ' 201' ' ' VAL . 94.2 t -72.71 -48.02 47.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.516 -0.311 . . . . 0.35 111.536 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -56.43 -40.82 87.09 Favored Glycine 0 C--N 1.335 0.522 0 CA-C-N 116.335 -0.393 . . . . 0.25 112.818 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -68.32 -47.69 66.89 Favored 'General case' 0 CA--C 1.527 0.076 0 N-CA-C 110.319 -0.252 . . . . 0.39 110.319 178.495 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -57.75 -42.62 94.52 Favored Glycine 0 CA--C 1.524 0.633 0 C-N-CA 120.942 -0.647 . . . . 0.27 113.006 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 201' ' ' VAL . . . . . 0.707 HG13 HG21 ' B' ' 34' ' ' VAL . 74.8 t -65.36 -52.0 57.34 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 N-CA-C 112.2 0.444 . . . . 0.3 112.2 179.635 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 202' ' ' GLN . . . . . 0.479 ' HB3' ' HB2' ' A' ' 250' ' ' SER . 10.0 pt20 -71.17 -33.13 69.71 Favored 'General case' 0 C--O 1.222 -0.369 0 N-CA-C 113.043 0.757 . . . . 0.48 113.043 -178.163 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -71.6 -37.53 70.94 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 118.377 0.535 . . . . 0.57 110.9 179.363 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 9.3 m-80 -66.82 -51.09 59.78 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.893 0.378 . . . . 0.67 110.827 178.637 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 205' ' ' HIS . . . . . 0.459 ' O ' ' HD2' ' A' ' 209' ' ' PHE . 50.0 m-70 -96.59 32.75 1.96 Allowed 'General case' 0 CA--C 1.537 0.446 0 O-C-N 122.331 -0.231 . . . . 0.42 110.82 179.083 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -55.75 -43.12 76.35 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 112.894 0.701 . . . . 0.48 112.894 -178.348 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 32.7 p -60.25 -42.2 94.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.131 0.491 . . . . 0.54 111.265 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -68.45 -42.44 78.79 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.863 -0.608 . . . . 0.36 110.253 178.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 209' ' ' PHE . . . . . 0.459 ' HD2' ' O ' ' A' ' 205' ' ' HIS . 18.1 m-85 -62.44 -49.08 76.85 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.034 -0.53 . . . . 0.85 110.424 179.256 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 65.0 mt-30 -61.78 -39.86 93.15 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.178 -0.465 . . . . 0.78 110.907 179.23 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -58.0 -46.39 92.61 Favored Glycine 0 C--N 1.335 0.503 0 N-CA-C 111.009 -0.837 . . . . 0.34 111.009 178.065 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 212' ' ' MET . . . . . 0.576 ' SD ' ' HA ' ' B' ' 23' ' ' PHE . 76.2 mtm -70.91 -35.69 72.38 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 120.759 0.314 . . . . 0.56 110.695 178.372 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 16.2 tp -60.85 -40.49 93.06 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.043 0.449 . . . . 0.49 110.754 179.18 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 79.4 mtp180 -77.34 -27.14 52.67 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.115 -0.493 . . . . 0.64 110.557 178.569 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 7.6 mmtp -75.94 -31.86 59.29 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.86 -0.609 . . . . 0.65 110.837 178.558 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 26.7 mt -69.08 137.21 53.33 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.047 -0.524 . . . . 0.51 112.397 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -101.78 19.88 17.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.968 -0.56 . . . . 0.49 110.392 178.322 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 218' ' ' ILE . . . . . 0.534 HG12 ' HB3' ' A' ' 223' ' ' ASP . 16.7 mt -62.73 118.88 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 N-CA-C 113.155 0.798 . . . . 0.37 113.155 -178.348 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 219' ' ' LYS . . . . . 0.609 ' HG2' HE22 ' A' ' 264' ' ' GLN . 3.3 ttpp -150.41 -16.76 0.24 Allowed 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 115.369 -0.832 . . . . 0.48 112.761 179.132 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -128.85 -178.9 4.8 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 112.872 0.693 . . . . 0.48 112.872 -178.348 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 221' ' ' GLU . . . . . 0.48 ' O ' HG22 ' A' ' 224' ' ' VAL . 0.8 OUTLIER -69.13 -22.43 63.96 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.643 -0.708 . . . . 0.5 111.772 -179.702 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -70.6 -26.29 74.33 Favored Glycine 0 CA--C 1.524 0.647 0 C-N-CA 120.834 -0.698 . . . . 0.3 113.313 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 223' ' ' ASP . . . . . 0.534 ' HB3' HG12 ' A' ' 218' ' ' ILE . 59.9 m-20 -65.17 -29.38 70.21 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 113.074 0.768 . . . . 0.39 113.074 -179.107 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.595 ' HB ' HG21 ' A' ' 274' ' ' THR . 6.4 m -53.78 -27.9 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 N-CA-C 112.895 0.702 . . . . 0.41 112.895 -179.313 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 225' ' ' LYS . . . . . 0.409 ' O ' ' HD3' ' A' ' 229' ' ' ARG . 33.5 mtmm -60.16 -44.15 95.24 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.297 0.57 . . . . 0.54 110.334 178.787 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 17.6 m -72.3 -39.67 68.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.806 -0.633 . . . . 0.35 110.861 179.442 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 227' ' ' PHE . . . . . 0.506 ' HE2' HG21 ' A' ' 255' ' ' VAL . 17.1 t80 -60.9 -48.21 82.87 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.212 -0.449 . . . . 0.53 110.785 179.708 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 228' ' ' SER . . . . . 0.692 ' HB2' HG11 ' A' ' 278' ' ' VAL . 13.7 p -62.73 -39.15 93.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.205 -0.452 . . . . 0.4 110.267 178.788 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 229' ' ' ARG . . . . . 0.409 ' HD3' ' O ' ' A' ' 225' ' ' LYS . 4.1 mpt_? -64.85 -46.07 83.45 Favored 'General case' 0 C--O 1.227 -0.123 0 CA-C-N 116.103 -0.499 . . . . 0.62 110.541 178.688 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 230' ' ' VAL . . . . . 0.433 HG13 ' HA ' ' B' ' 24' ' ' ALA . 43.0 t -59.2 -44.88 92.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 CA-C-O 120.944 0.402 . . . . 0.44 110.321 178.168 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 231' ' ' MET . . . . . 0.569 ' HG2' HD22 ' A' ' 248' ' ' LEU . 30.4 mtm -57.54 -52.39 65.6 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.155 -0.475 . . . . 0.44 111.621 179.362 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 232' ' ' VAL . . . . . 0.67 HG12 HG21 ' A' ' 282' ' ' THR . 21.9 m -67.82 -31.84 53.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 C-N-CA 120.9 -0.32 . . . . 0.4 111.091 179.444 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 5.6 t-80 -59.82 -32.07 70.31 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.366 -0.379 . . . . 0.51 111.347 179.324 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.676 HG21 HD21 ' A' ' 248' ' ' LEU . 78.8 t -58.61 -30.21 41.09 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 CA-C-O 120.79 0.328 . . . . 0.39 111.606 179.105 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 235' ' ' PHE . . . . . 0.477 ' CD1' ' HA ' ' A' ' 240' ' ' THR . 67.9 m-85 -102.58 23.7 11.56 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 111.882 0.327 . . . . 0.53 111.882 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 7.6 tptp -62.81 -24.8 67.94 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 113.062 0.764 . . . . 0.94 113.062 -178.907 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -81.73 -9.63 59.59 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.863 0.363 . . . . 0.51 111.527 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 93.23 2.55 65.95 Favored Glycine 0 CA--C 1.522 0.518 0 C-N-CA 120.822 -0.704 . . . . 0.58 113.388 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 11.9 t -96.77 95.51 4.74 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-O 120.994 0.426 . . . . 0.39 111.379 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 240' ' ' THR . . . . . 0.477 ' HA ' ' CD1' ' A' ' 235' ' ' PHE . 0.6 OUTLIER -82.8 70.52 9.8 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.827 0.677 . . . . 0.85 112.827 -179.781 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 241' ' ' ASN . . . . . 0.429 ' HB2' ' HD2' ' A' ' 244' ' ' ARG . 20.6 m-20 -83.89 140.0 32.26 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.916 0.388 . . . . 0.43 111.641 179.448 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 242' ' ' TRP . . . . . . . . . . . . . 54.1 m95 -51.09 -43.46 61.07 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.951 -0.568 . . . . 0.41 112.432 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -54.33 -35.2 55.19 Favored Glycine 0 C--N 1.339 0.708 0 C-N-CA 121.407 -0.425 . . . . 0.23 112.931 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 244' ' ' ARG . . . . . 0.429 ' HD2' ' HB2' ' A' ' 241' ' ' ASN . 24.4 mtt180 -73.99 -43.06 59.35 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.126 0.489 . . . . 0.33 109.769 178.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 48.2 mt -60.32 -50.22 81.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-N 115.709 -0.678 . . . . 0.33 111.101 179.315 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 31.4 m -65.86 -34.32 69.52 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 C-N-CA 121.03 -0.268 . . . . 0.28 111.497 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 40.3 m -58.06 -40.65 81.53 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.076 0.465 . . . . 0.39 110.015 178.215 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 248' ' ' LEU . . . . . 0.676 HD21 HG21 ' A' ' 234' ' ' VAL . 80.7 mt -66.12 -32.31 73.69 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.023 -0.535 . . . . 0.43 111.102 178.697 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 249' ' ' ILE . . . . . 0.412 HG21 HD21 ' A' ' 194' ' ' LEU . 19.3 mt -74.5 -42.62 49.22 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 CA-C-N 116.216 -0.447 . . . . 0.53 109.818 178.261 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 250' ' ' SER . . . . . 0.479 ' HB2' ' HB3' ' A' ' 202' ' ' GLN . 51.3 p -64.89 -30.4 71.4 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 109.502 -0.555 . . . . 0.34 109.502 177.784 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 251' ' ' PHE . . . . . . . . . . . . . 18.6 t80 -70.52 -43.97 68.53 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 108.584 -0.895 . . . . 0.58 108.584 177.389 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -59.18 -47.0 92.94 Favored Glycine 0 C--N 1.336 0.531 0 N-CA-C 110.767 -0.933 . . . . 0.27 110.767 177.739 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 253' ' ' ALA . . . . . 0.433 ' O ' ' HG3' ' A' ' 257' ' ' LYS . . . -59.5 -39.72 84.71 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 120.655 0.264 . . . . 0.33 110.691 177.369 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -61.94 -41.78 98.35 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 121.052 0.453 . . . . 0.59 110.55 178.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 255' ' ' VAL . . . . . 0.506 HG21 ' HE2' ' A' ' 227' ' ' PHE . 59.5 t -72.04 -37.72 61.33 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-N 116.184 -0.462 . . . . 0.36 110.025 178.414 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -56.69 -42.88 79.87 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.028 0.442 . . . . 0.28 109.907 177.734 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 257' ' ' LYS . . . . . 0.46 ' CE ' ' HB3' ' A' ' 170' ' ' GLN . 93.0 mttt -64.7 -42.94 94.93 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 115.846 -0.616 . . . . 0.66 110.117 177.899 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 40.3 t60 -59.19 -42.79 91.72 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.292 -0.413 . . . . 0.66 110.66 178.772 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 95.7 mt -69.86 -42.62 73.3 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 116.392 -0.367 . . . . 0.54 111.149 179.122 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 260' ' ' LYS . . . . . 0.569 ' HG2' ' O ' ' A' ' 171' ' ' ALA . 2.1 tptp -64.94 -35.95 82.81 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.705 0.288 . . . . 0.56 111.311 179.239 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 63.0 m -59.69 -28.96 67.75 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.262 -0.427 . . . . 0.51 111.301 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 24.2 m -107.32 16.27 7.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-N 116.382 -0.372 . . . . 0.55 111.071 178.869 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 55.61 52.47 11.0 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 112.769 0.655 . . . . 0.98 112.769 179.517 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 264' ' ' GLN . . . . . 0.609 HE22 ' HG2' ' A' ' 219' ' ' LYS . 7.3 mt-30 -117.98 37.74 3.88 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 120.769 0.318 . . . . 0.56 111.462 179.413 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 265' ' ' GLU . . . . . 0.497 ' HA ' HD12 ' A' ' 268' ' ' ILE . 1.2 mp0 -48.06 -31.75 5.87 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 112.716 0.636 . . . . 0.59 112.716 179.39 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -55.57 -22.42 21.84 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 122.847 0.459 . . . . 0.95 111.974 179.276 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 267' ' ' PHE . . . . . 0.402 ' C ' ' HD2' ' A' ' 270' ' ' PRO . 95.3 m-85 -100.43 -17.89 16.97 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 120.79 0.328 . . . . 0.48 110.986 178.859 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 268' ' ' ILE . . . . . 0.497 HD12 ' HA ' ' A' ' 265' ' ' GLU . 66.5 mt -67.77 -45.71 83.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-N 116.416 -0.356 . . . . 0.39 111.107 179.754 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 269' ' ' GLU . . . . . 0.643 ' HB2' ' HD3' ' A' ' 270' ' ' PRO . 0.5 OUTLIER -55.74 -56.58 28.41 Favored Pre-proline 0 CA--C 1.545 0.774 0 CA-C-N 116.296 -0.411 . . . . 0.37 111.21 179.332 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 270' ' ' PRO . . . . . 0.643 ' HD3' ' HB2' ' A' ' 269' ' ' GLU . 31.2 Cg_exo -61.33 -32.19 89.45 Favored 'Trans proline' 0 C--N 1.361 1.213 0 C-N-CA 122.23 1.953 . . . . 0.27 112.101 178.428 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 271' ' ' LEU . . . . . 0.414 ' O ' HG13 ' A' ' 275' ' ' ILE . 46.8 tp -66.62 -54.76 19.88 Favored 'General case' 0 C--O 1.226 -0.135 0 CA-C-N 116.406 -0.361 . . . . 0.44 110.14 178.682 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -56.98 -37.82 72.16 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 120.852 0.358 . . . . 0.29 110.628 178.825 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 273' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -64.26 -51.48 63.39 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.028 -0.533 . . . . 0.49 110.134 178.04 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 274' ' ' THR . . . . . 0.595 HG21 ' HB ' ' A' ' 224' ' ' VAL . 31.1 m -59.82 -42.67 94.04 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.292 -0.413 . . . . 0.3 110.595 179.173 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 275' ' ' ILE . . . . . 0.459 HG12 ' CE1' ' A' ' 227' ' ' PHE . 96.5 mt -57.98 -54.3 33.89 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.105 0 CA-C-N 116.165 -0.471 . . . . 0.35 110.603 179.15 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 276' ' ' THR . . . . . 0.619 HG21 ' HA ' ' A' ' 160' ' ' LEU . 32.5 m -60.71 -49.88 75.71 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.253 -0.43 . . . . 0.3 111.441 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 277' ' ' ASP . . . . . 0.595 ' O ' ' HB2' ' A' ' 281' ' ' ARG . 17.0 t0 -56.28 -61.04 2.67 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.946 -0.57 . . . . 0.4 112.104 -179.425 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 278' ' ' VAL . . . . . 0.692 HG11 ' HB2' ' A' ' 228' ' ' SER . 66.4 t -61.25 -46.24 97.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 112.304 0.483 . . . . 0.39 112.304 -178.762 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 279' ' ' LEU . . . . . 0.45 HD12 ' HZ1' ' A' ' 283' ' ' LYS . 14.0 tp -54.7 -47.58 73.52 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 111.635 0.235 . . . . 0.75 111.635 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 84.0 t -77.38 -41.05 29.66 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 N-CA-C 111.803 0.297 . . . . 0.39 111.803 -179.535 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 281' ' ' ARG . . . . . 0.595 ' HB2' ' O ' ' A' ' 277' ' ' ASP . 2.5 ttt180 -53.7 -42.73 68.31 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 112.616 0.598 . . . . 0.85 112.616 -179.753 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 282' ' ' THR . . . . . 0.67 HG21 HG12 ' A' ' 232' ' ' VAL . 15.2 t -84.41 0.39 49.64 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 112.843 0.683 . . . . 0.37 112.843 -179.656 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 283' ' ' LYS . . . . . 0.49 ' HG3' HG23 ' A' ' 282' ' ' THR . 34.6 mtmm -141.02 40.76 1.8 Allowed 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 120.877 0.37 . . . . 0.38 111.546 -179.586 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 284' ' ' ARG . . . . . 0.438 HH11 ' HD3' ' A' ' 284' ' ' ARG . 13.2 ttm180 -63.21 -60.65 3.13 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 112.714 0.635 . . . . 0.64 112.714 -178.666 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 285' ' ' ASP . . . . . 0.44 ' HA ' HG12 ' A' ' 288' ' ' VAL . 35.8 t70 -58.71 -45.48 89.47 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.366 -0.379 . . . . 0.51 111.895 -179.471 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 286' ' ' TRP . . . . . . . . . . . . . 4.1 t90 -59.62 -44.95 93.27 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 120.571 0.224 . . . . 0.49 111.25 -179.573 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -68.84 -44.52 73.25 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 112.072 0.397 . . . . 0.47 112.072 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 288' ' ' VAL . . . . . 0.44 HG12 ' HA ' ' A' ' 285' ' ' ASP . 6.2 p -66.2 -34.5 70.63 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 O-C-N 122.207 -0.308 . . . . 0.52 111.645 -179.542 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 31.9 mttp -76.31 -26.87 56.26 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-O 120.766 0.317 . . . . 0.78 111.398 179.017 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 6.0 tp60 -91.04 24.95 2.61 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 112.563 0.579 . . . . 0.97 112.563 -179.193 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 53.6 mtp180 62.99 12.65 6.05 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 112.505 0.557 . . . . 0.43 112.505 179.575 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 64.64 -131.86 37.67 Favored Glycine 0 CA--C 1.522 0.487 0 C-N-CA 121.235 -0.507 . . . . 0.33 113.241 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 293' ' ' TRP . . . . . 0.492 ' HB3' ' HB2' ' A' ' 190' ' ' ALA . 86.3 m95 -67.67 -21.21 65.36 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 111.903 0.334 . . . . 0.48 111.903 -179.695 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 294' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -62.85 -48.54 78.62 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 121.175 0.512 . . . . 0.47 110.098 177.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -69.78 -33.62 71.2 Favored Glycine 0 C--N 1.332 0.329 0 C-N-CA 120.657 -0.783 . . . . 0.32 111.614 178.616 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 296' ' ' PHE . . . . . 0.446 ' HB3' ' HA ' ' A' ' 293' ' ' TRP . 1.6 t80 -60.52 -50.94 71.53 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.674 -0.263 . . . . 0.29 111.615 179.108 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 297' ' ' VAL . . . . . 0.477 ' HA ' HG21 ' A' ' 193' ' ' THR . 28.8 m -63.94 -43.25 97.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 N-CA-C 111.836 0.31 . . . . 0.27 111.836 -178.899 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -58.64 -41.67 86.53 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 112.197 0.443 . . . . 0.42 112.197 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 299' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -58.69 -45.46 89.43 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 120.907 0.385 . . . . 0.41 111.875 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 300' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 . . . . . 0 CA--C 1.535 0.395 0 N-CA-C 112.556 0.576 . . . . 0.47 112.556 -179.145 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 . . . . . 0 N--CA 1.453 -0.312 0 N-CA-C 109.477 -0.564 . . . . 0.77 109.477 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 23' ' ' PHE . . . . . 0.576 ' HA ' ' SD ' ' A' ' 212' ' ' MET . 0.4 OUTLIER -61.9 -41.41 97.86 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.322 0.582 . . . . 0.4 109.848 179.019 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 24' ' ' ALA . . . . . 0.512 ' O ' ' HB2' ' B' ' 28' ' ' ARG . . . -59.09 -43.83 91.85 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.249 -0.887 . . . . 0.42 111.126 179.425 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -72.42 -46.8 53.47 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 116.191 -0.459 . . . . 0.37 110.751 179.315 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -58.01 -54.31 48.42 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 115.96 -0.564 . . . . 0.39 110.778 179.541 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 98.8 mt -59.34 -37.86 78.91 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.596 -0.275 . . . . 0.4 110.863 179.431 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 28' ' ' ARG . . . . . 0.561 ' HA ' HG13 ' A' ' 234' ' ' VAL . 0.9 OUTLIER -61.32 -52.72 63.52 Favored 'General case' 0 CA--C 1.528 0.106 0 N-CA-C 109.9 -0.407 . . . . 0.46 109.9 178.736 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -59.82 -43.24 94.62 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.372 -0.377 . . . . 0.51 110.654 178.821 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 96.1 mt -58.75 -49.31 83.21 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 CA-C-N 116.345 -0.389 . . . . 0.41 110.172 178.655 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -55.32 -45.38 83.39 Favored Glycine 0 CA--C 1.52 0.404 0 CA-C-N 116.306 -0.407 . . . . 0.25 112.931 179.505 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -59.19 -49.61 77.19 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 121.087 0.47 . . . . 0.36 110.68 179.143 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 5.4 ttmm -64.01 -45.59 88.28 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 115.927 -0.578 . . . . 1.22 110.847 179.353 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 34' ' ' VAL . . . . . 0.707 HG21 HG13 ' A' ' 201' ' ' VAL . 5.3 t -58.56 -49.68 81.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 CA-C-O 120.958 0.409 . . . . 0.33 110.659 179.127 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -57.95 -43.65 86.51 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.971 -0.559 . . . . 0.65 110.601 178.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 36' ' ' CYS . . . . . . . . . . . . . 74.3 m -68.22 -25.93 65.46 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 120.942 0.401 . . . . 0.36 111.175 179.28 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 45.8 m -80.13 -35.47 36.65 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 116.115 -0.493 . . . . 0.33 111.953 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 38' ' ' TRP . . . . . . . . . . . . . 85.0 m95 -84.83 -30.47 24.5 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.039 0.385 . . . . 0.54 112.039 -179.586 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 16.9 p . . . . . 0 N--CA 1.466 0.33 0 CA-C-O 120.767 0.318 . . . . 0.41 110.673 179.248 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 153' ' ' ASP . . . . . 0.578 ' HA ' ' HB3' ' A' ' 156' ' ' TYR . 2.6 m-20 . . . . . 0 CA--C 1.537 0.462 0 N-CA-C 113.73 1.011 . . . . 0.74 113.73 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' ASP . . . . . 0.474 ' HA ' ' HE ' ' A' ' 157' ' ' ARG . 11.2 t0 -52.58 -44.47 65.93 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 120.973 0.416 . . . . 0.49 111.27 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 44.4 tp -85.26 -33.36 22.19 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.142 0.496 . . . . 0.66 110.22 178.676 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' TYR . . . . . 0.578 ' HB3' ' HA ' ' A' ' 153' ' ' ASP . 55.6 t80 -61.21 -45.73 93.37 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 115.637 -0.71 . . . . 0.45 112.336 -179.737 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 157' ' ' ARG . . . . . 0.474 ' HE ' ' HA ' ' A' ' 154' ' ' ASP . 20.4 ptt85 -59.4 -44.37 92.81 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 120.785 0.326 . . . . 0.5 110.993 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 10.3 mt-30 -65.17 -44.19 89.3 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-O 120.86 0.362 . . . . 0.53 110.223 178.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' SER . . . . . 0.531 ' HA ' ' CZ2' ' A' ' 293' ' ' TRP . 17.0 m -61.63 -49.43 76.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.965 -0.562 . . . . 0.38 111.129 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.599 HD21 ' HA ' ' A' ' 273' ' ' GLU . 0.2 OUTLIER -59.47 -44.12 93.09 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.349 -0.387 . . . . 0.7 110.879 179.375 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -66.9 -53.59 30.54 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 112.037 0.384 . . . . 0.45 112.037 -179.496 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 79.4 mt -61.22 -51.09 77.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 N-CA-C 112.28 0.474 . . . . 0.34 112.28 -179.491 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.42 HG23 HD13 ' A' ' 167' ' ' LEU . 59.2 mt -60.27 -51.42 73.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 N-CA-C 112.297 0.48 . . . . 0.4 112.297 -178.801 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 90.6 p -57.7 -35.84 71.18 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.575 0.226 . . . . 0.8 111.227 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' ARG . . . . . 0.411 HH11 ' HD2' ' A' ' 165' ' ' ARG . 0.0 OUTLIER -72.28 -51.1 22.41 Favored 'General case' 0 C--O 1.226 -0.157 0 C-N-CA 120.954 -0.298 . . . . 1.51 111.096 179.091 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 166' ' ' TYR . . . . . 0.798 ' HE1' ' HA ' ' A' ' 195' ' ' ARG . 60.1 t80 -59.7 -46.12 90.05 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 120.648 0.261 . . . . 0.39 111.244 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.42 HD13 HG23 ' A' ' 163' ' ' ILE . 5.2 mp -60.63 -45.47 93.94 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 116.354 -0.385 . . . . 0.37 111.175 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 12.2 ttm105 -71.99 -34.68 69.11 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 121.021 -0.272 . . . . 0.5 110.907 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -63.74 -52.63 59.6 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 120.752 0.31 . . . . 0.72 110.354 178.541 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 170' ' ' GLN . . . . . 0.406 ' O ' ' HE2' ' A' ' 257' ' ' LYS . 6.6 mm-40 -65.56 -26.51 67.9 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.902 0.382 . . . . 1.14 111.508 179.267 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.375 -0.375 . . . . 0.35 111.955 179.344 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.452 ' O ' ' HA3' ' A' ' 187' ' ' GLY . . . . . . . . 0 N--CA 1.455 -0.208 0 CA-C-O 121.126 0.489 . . . . 0.41 111.05 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -78.7 -71.73 1.22 Allowed Glycine 0 CA--C 1.522 0.512 0 C-N-CA 120.118 -1.039 . . . . 0.51 112.887 -179.598 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -72.1 -48.49 43.56 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 120.96 0.409 . . . . 0.53 110.731 179.484 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -65.11 -34.42 78.36 Favored 'General case' 0 C--O 1.224 -0.237 0 CA-C-N 115.889 -0.596 . . . . 0.4 110.27 178.832 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 187' ' ' GLY . . . . . 0.452 ' HA3' ' O ' ' A' ' 183' ' ' ALA . . . -65.71 -40.9 96.02 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.67 -0.776 . . . . 0.37 111.66 178.597 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 188' ' ' ARG . . . . . 0.421 HH11 ' HD2' ' A' ' 188' ' ' ARG . 11.2 mmt180 -63.98 -54.29 36.76 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.753 0.311 . . . . 1.48 110.962 179.123 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 3.0 ttp180 -60.24 -42.85 96.15 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 115.882 -0.599 . . . . 2.07 110.942 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 190' ' ' ALA . . . . . 0.541 ' HA ' ' CG1' ' A' ' 297' ' ' VAL . . . -64.26 -46.32 84.26 Favored 'General case' 0 C--O 1.222 -0.391 0 CA-C-N 116.391 -0.368 . . . . 0.33 110.681 179.055 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 15.7 tp -61.38 -37.36 83.1 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.722 0.296 . . . . 0.88 110.779 179.213 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 192' ' ' GLU . . . . . 0.615 ' OE2' ' HD3' ' A' ' 196' ' ' ARG . 4.0 tm-20 -63.01 -53.2 57.69 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 121.402 0.62 . . . . 1.04 110.84 178.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 193' ' ' THR . . . . . 0.503 HG21 ' HA ' ' A' ' 297' ' ' VAL . 98.0 m -70.21 -41.24 73.91 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.475 -0.784 . . . . 0.35 111.699 -178.578 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 194' ' ' LEU . . . . . 0.487 HD11 HG21 ' A' ' 249' ' ' ILE . 11.3 tp -61.24 -42.39 98.53 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.281 -0.418 . . . . 0.37 111.433 179.531 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 195' ' ' ARG . . . . . 0.798 ' HA ' ' HE1' ' A' ' 166' ' ' TYR . 13.0 ttm-85 -65.6 -41.17 93.06 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 121.189 0.518 . . . . 0.94 109.867 178.614 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 196' ' ' ARG . . . . . 0.615 ' HD3' ' OE2' ' A' ' 192' ' ' GLU . 8.1 mtp-105 -63.32 -57.0 11.82 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.708 -0.678 . . . . 0.34 111.592 179.574 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 58.2 t -68.59 -40.13 81.43 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-N 116.397 -0.365 . . . . 0.33 111.962 -179.521 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 198' ' ' GLY . . . . . 0.544 ' HA3' ' OH ' ' A' ' 166' ' ' TYR . . . -59.15 -47.15 92.18 Favored Glycine 0 C--N 1.33 0.244 0 C-N-CA 121.475 -0.393 . . . . 0.25 112.751 -179.52 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -75.66 -26.35 57.6 Favored 'General case' 0 C--O 1.223 -0.316 0 N-CA-C 110.026 -0.361 . . . . 0.43 110.026 178.897 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -63.13 -47.02 91.86 Favored Glycine 0 C--N 1.336 0.568 0 N-CA-C 110.929 -0.868 . . . . 0.25 110.929 177.727 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 61.0 t -69.18 -39.57 79.45 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-O 121.017 0.437 . . . . 0.3 110.021 177.716 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 202' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -67.08 -41.48 86.26 Favored 'General case' 0 C--O 1.219 -0.504 0 CA-C-N 115.71 -0.677 . . . . 0.66 112.024 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 203' ' ' ARG . . . . . 0.4 ' CZ ' ' HA ' ' A' ' 203' ' ' ARG . 0.1 OUTLIER -63.88 -46.47 84.76 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.934 0.397 . . . . 0.36 110.298 179.779 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 32.6 m-80 -68.16 -46.82 69.73 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 115.987 -0.551 . . . . 0.48 112.107 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 86.3 m-70 -102.71 30.63 4.58 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 113.556 0.947 . . . . 0.34 113.556 -178.132 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -62.53 -36.21 81.89 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 121.011 0.434 . . . . 0.38 111.216 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 32.7 p -68.86 -39.8 79.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.085 0.469 . . . . 1.08 110.521 178.877 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -67.05 -40.76 87.21 Favored 'General case' 0 N--CA 1.456 -0.126 0 CA-C-N 115.887 -0.597 . . . . 0.3 110.085 178.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 11.8 m-30 -65.89 -39.59 90.77 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.991 -0.55 . . . . 0.42 110.22 178.887 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -67.04 -47.67 70.65 Favored 'General case' 0 N--CA 1.46 0.052 0 CA-C-N 116.354 -0.385 . . . . 0.89 110.362 178.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -58.59 -42.62 96.2 Favored Glycine 0 C--N 1.337 0.595 0 N-CA-C 111.0 -0.84 . . . . 0.3 111.0 178.183 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 30.6 ttm -64.16 -46.04 85.78 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.688 -0.486 . . . . 0.38 109.688 178.016 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.505 ' HA ' HD12 ' A' ' 216' ' ' LEU . 6.7 tp -59.62 -41.39 90.28 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.806 -0.634 . . . . 0.49 111.112 179.002 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 214' ' ' ARG . . . . . 0.538 ' HD3' ' O ' ' A' ' 214' ' ' ARG . 0.0 OUTLIER -65.0 -32.07 73.61 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.238 -0.437 . . . . 0.75 110.553 179.268 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 56.4 mtpt -89.0 -0.99 57.89 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.253 -0.43 . . . . 0.75 110.781 178.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 216' ' ' LEU . . . . . 0.674 ' HB3' HG22 ' A' ' 218' ' ' ILE . 10.1 mt -92.26 134.28 35.04 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 121.175 0.512 . . . . 0.72 111.226 179.598 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -99.38 29.16 4.12 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 115.824 -0.625 . . . . 0.45 110.401 178.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 218' ' ' ILE . . . . . 0.674 HG22 ' HB3' ' A' ' 216' ' ' LEU . 2.3 tt -66.91 114.62 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 N-CA-C 113.061 0.763 . . . . 0.37 113.061 -178.603 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 10.0 ptpp? -161.27 4.69 0.06 Allowed 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 115.474 -0.785 . . . . 0.4 112.645 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -154.29 -175.96 5.65 Favored 'General case' 0 C--O 1.218 -0.567 0 O-C-N 121.747 -0.595 . . . . 0.59 112.555 -178.249 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -61.59 -20.84 63.76 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 112.599 0.592 . . . . 0.48 112.599 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -67.71 -42.95 86.34 Favored Glycine 0 CA--C 1.531 1.04 0 N-CA-C 114.708 0.643 . . . . 0.39 114.708 -179.345 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 223' ' ' ASP . . . . . 0.472 ' OD1' HG13 ' A' ' 218' ' ' ILE . 0.1 OUTLIER -65.51 -31.86 73.15 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 117.621 0.711 . . . . 0.38 112.05 -179.098 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 12.1 t -58.37 -42.35 83.76 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 CA-C-O 121.429 0.633 . . . . 0.39 110.337 178.521 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 35.2 mmtm -67.91 -41.52 82.56 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.783 -0.644 . . . . 0.45 109.689 178.815 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 226' ' ' SER . . . . . 0.561 ' O ' HG23 ' A' ' 230' ' ' VAL . 20.6 t -61.19 -38.95 88.38 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.506 -0.77 . . . . 0.45 110.07 178.558 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 227' ' ' PHE . . . . . 0.417 ' HE1' ' CD2' ' A' ' 251' ' ' PHE . 49.7 t80 -59.47 -43.22 93.3 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.45 -0.795 . . . . 0.47 110.423 178.295 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 228' ' ' SER . . . . . 0.97 ' HB2' HG21 ' A' ' 278' ' ' VAL . 9.6 p -65.16 -31.97 73.42 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.057 -0.519 . . . . 0.32 110.074 178.127 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 22.2 ttp-105 -67.84 -36.24 79.99 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 109.561 -0.533 . . . . 0.57 109.561 178.275 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 230' ' ' VAL . . . . . 0.561 HG23 ' O ' ' A' ' 226' ' ' SER . 26.3 t -59.99 -45.41 95.4 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 N-CA-C 109.138 -0.69 . . . . 0.34 109.138 177.345 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 231' ' ' MET . . . . . 0.787 ' HG3' HD13 ' A' ' 248' ' ' LEU . 29.0 ttm -56.08 -53.26 59.09 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 114.822 -1.081 . . . . 0.32 111.786 179.205 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 34.2 m -66.09 -31.12 52.25 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-O 120.563 0.22 . . . . 0.4 111.419 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 44.3 t-80 -69.38 -42.27 75.4 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.987 0.423 . . . . 0.43 110.383 178.791 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.585 HG13 ' HA ' ' B' ' 28' ' ' ARG . 44.9 t -58.17 -43.99 86.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-N 116.192 -0.458 . . . . 0.33 110.749 178.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 235' ' ' PHE . . . . . 0.489 ' CD2' ' HA ' ' A' ' 240' ' ' THR . 96.2 m-85 -94.43 23.38 5.26 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 116.088 -0.505 . . . . 0.38 112.017 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -65.14 -13.47 58.21 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 112.028 0.381 . . . . 1.08 112.028 -179.373 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -83.37 -17.09 43.5 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.641 0.258 . . . . 0.41 111.324 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 97.15 -7.69 64.51 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 120.81 -0.71 . . . . 0.46 114.034 179.392 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 4.5 p -97.73 116.09 39.38 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 CA-C-O 121.337 0.589 . . . . 0.43 111.576 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 240' ' ' THR . . . . . 0.489 ' HA ' ' CD2' ' A' ' 235' ' ' PHE . 25.4 m -88.39 84.63 6.81 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.048 0.452 . . . . 0.61 111.875 -179.57 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 241' ' ' ASN . . . . . 0.521 ' HB2' ' HD2' ' A' ' 244' ' ' ARG . 92.0 m-20 -76.04 135.45 39.94 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.205 -0.452 . . . . 0.49 111.141 179.277 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 242' ' ' TRP . . . . . 0.608 ' HB3' ' CZ ' ' A' ' 300' ' ' PHE . 5.1 m95 -60.33 -37.88 82.01 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.911 0.386 . . . . 0.47 111.282 179.342 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 243' ' ' GLY . . . . . 0.493 ' HA3' ' N ' ' B' ' 35' ' ' TYR . . . -64.58 -29.95 76.57 Favored Glycine 0 CA--C 1.52 0.378 0 C-N-CA 121.072 -0.585 . . . . 0.27 112.376 178.742 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 244' ' ' ARG . . . . . 0.574 ' HA ' ' HA3' ' B' ' 31' ' ' GLY . 79.5 mtt180 -69.28 -44.53 71.65 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.86 -0.422 . . . . 0.34 109.86 178.728 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 245' ' ' ILE . . . . . 0.527 ' O ' HG12 ' A' ' 249' ' ' ILE . 69.7 mt -61.21 -53.84 43.45 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 CA-C-N 115.542 -0.754 . . . . 0.37 111.435 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 19.0 m -60.6 -34.84 60.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 C-N-CA 120.89 -0.324 . . . . 0.32 111.335 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 53.0 m -62.36 -44.68 95.9 Favored 'General case' 0 N--CA 1.463 0.179 0 N-CA-C 109.985 -0.376 . . . . 0.36 109.985 178.107 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 248' ' ' LEU . . . . . 0.787 HD13 ' HG3' ' A' ' 231' ' ' MET . 91.5 mt -65.8 -39.76 91.25 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.213 -0.448 . . . . 0.65 110.561 178.637 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 249' ' ' ILE . . . . . 0.527 HG12 ' O ' ' A' ' 245' ' ' ILE . 26.7 mm -65.67 -43.88 93.66 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 CA-C-O 121.119 0.485 . . . . 0.38 109.837 178.144 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 35.5 t -60.46 -45.97 91.79 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.788 -0.642 . . . . 0.28 109.383 178.236 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 251' ' ' PHE . . . . . 0.422 ' CD2' HD11 ' B' ' 27' ' ' LEU . 22.0 t80 -63.58 -39.4 94.28 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 115.687 -0.688 . . . . 0.34 110.115 178.144 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -56.99 -42.69 93.01 Favored Glycine 0 C--N 1.335 0.503 0 N-CA-C 111.419 -0.672 . . . . 0.25 111.419 177.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -69.21 -31.33 69.84 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 120.827 0.346 . . . . 0.28 110.521 177.454 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -70.93 -47.58 58.27 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 116.247 -0.433 . . . . 0.49 111.378 179.362 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 19.1 m -64.64 -35.62 75.26 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 C-N-CA 120.725 -0.39 . . . . 0.33 110.159 178.842 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -66.04 -32.33 73.74 Favored 'General case' 0 N--CA 1.456 -0.146 0 N-CA-C 109.257 -0.645 . . . . 0.29 109.257 177.76 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 257' ' ' LYS . . . . . 0.406 ' HE2' ' O ' ' A' ' 170' ' ' GLN . 24.5 ttmt -63.66 -40.03 95.82 Favored 'General case' 0 CA--C 1.528 0.108 0 CA-C-N 115.493 -0.776 . . . . 0.8 109.085 177.615 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 258' ' ' HIS . . . . . 0.463 ' HB2' HD21 ' A' ' 213' ' ' LEU . 75.4 t60 -66.09 -44.86 83.17 Favored 'General case' 0 C--O 1.231 0.085 0 CA-C-N 115.93 -0.577 . . . . 0.4 109.539 177.414 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 97.4 mt -60.14 -47.33 86.35 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 115.8 -0.636 . . . . 0.48 110.33 178.633 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 260' ' ' LYS . . . . . 0.44 ' HA ' ' OE1' ' A' ' 265' ' ' GLU . 0.7 OUTLIER -62.96 -33.8 76.16 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.277 -0.419 . . . . 0.53 110.742 178.998 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 72.4 m -60.23 -29.46 68.77 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 120.858 0.361 . . . . 0.51 110.836 179.179 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 262' ' ' VAL . . . . . 0.408 HG23 ' HG3' ' A' ' 264' ' ' GLN . 6.1 m -109.95 17.97 7.14 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-O 120.951 0.405 . . . . 0.49 110.662 178.509 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 58.05 50.33 10.28 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 115.528 -0.76 . . . . 0.58 113.036 179.469 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 264' ' ' GLN . . . . . 0.408 ' HG3' HG23 ' A' ' 262' ' ' VAL . 70.4 mt-30 -110.99 36.49 3.13 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 120.953 0.406 . . . . 0.44 110.931 178.729 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 265' ' ' GLU . . . . . 0.508 ' HA ' HD12 ' A' ' 268' ' ' ILE . 0.9 OUTLIER -51.36 -33.48 29.9 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 112.823 0.675 . . . . 0.53 112.823 -179.804 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 24.9 p -59.12 -20.25 51.95 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 111.793 0.294 . . . . 0.94 111.793 179.456 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 267' ' ' PHE . . . . . 0.418 ' C ' ' HD2' ' A' ' 270' ' ' PRO . 83.1 m-85 -93.35 -23.49 18.43 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 121.063 0.459 . . . . 0.6 110.838 178.868 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 268' ' ' ILE . . . . . 0.508 HD12 ' HA ' ' A' ' 265' ' ' GLU . 73.0 mt -67.62 -42.17 86.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 CA-C-N 116.243 -0.435 . . . . 0.38 110.889 179.382 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 269' ' ' GLU . . . . . 0.789 ' HB2' ' HD3' ' A' ' 270' ' ' PRO . 58.2 mm-40 -54.77 -56.41 27.67 Favored Pre-proline 0 CA--C 1.544 0.74 0 CA-C-N 116.006 -0.543 . . . . 0.58 111.789 179.539 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 270' ' ' PRO . . . . . 0.789 ' HD3' ' HB2' ' A' ' 269' ' ' GLU . 22.7 Cg_exo -66.81 -28.15 43.47 Favored 'Trans proline' 0 C--N 1.358 1.068 0 C-N-CA 122.181 1.921 . . . . 0.46 111.79 178.205 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 271' ' ' LEU . . . . . 0.5 ' O ' HG22 ' A' ' 275' ' ' ILE . 32.7 tp -62.91 -50.4 71.01 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.366 -0.379 . . . . 0.48 110.278 178.686 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 272' ' ' ALA . . . . . 0.405 ' HA ' HG22 ' A' ' 275' ' ' ILE . . . -60.69 -34.0 73.69 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 121.336 0.589 . . . . 0.36 110.602 178.769 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 273' ' ' GLU . . . . . 0.599 ' HA ' HD21 ' A' ' 160' ' ' LEU . 34.9 tt0 -71.85 -40.9 68.68 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.566 -0.743 . . . . 0.93 109.478 178.065 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 274' ' ' THR . . . . . . . . . . . . . 93.2 m -66.54 -50.62 62.57 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.792 -0.64 . . . . 0.35 111.663 179.58 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 275' ' ' ILE . . . . . 0.736 HG13 ' HE1' ' A' ' 231' ' ' MET . 13.6 tt -58.94 -49.67 82.31 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-N 116.816 -0.174 . . . . 0.34 111.125 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 13.2 m -62.06 -47.65 83.73 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.795 0.331 . . . . 0.35 111.037 179.449 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 277' ' ' ASP . . . . . 0.546 ' HB2' ' O ' ' A' ' 273' ' ' GLU . 4.4 t70 -53.31 -55.36 25.36 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 115.998 -0.546 . . . . 0.46 111.193 179.575 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 278' ' ' VAL . . . . . 0.97 HG21 ' HB2' ' A' ' 228' ' ' SER . 84.0 t -64.37 -40.53 89.38 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 CA-C-N 116.405 -0.361 . . . . 0.37 111.375 179.816 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 25.2 tp -62.73 -38.93 92.44 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.831 0.348 . . . . 0.58 111.644 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 91.5 t -82.73 -41.71 17.65 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 N-CA-C 112.249 0.463 . . . . 0.47 112.249 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 55.3 mtp180 -69.28 -28.02 65.93 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 112.959 0.725 . . . . 0.61 112.959 -178.834 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 282' ' ' THR . . . . . . . . . . . . . 82.0 p -93.67 -12.38 29.46 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 112.485 0.55 . . . . 0.68 112.485 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 4.4 mptp? -129.17 34.44 4.41 Favored 'General case' 0 C--N 1.33 -0.259 0 O-C-N 122.321 -0.237 . . . . 0.7 111.423 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 41.4 ttt180 -50.75 -53.07 34.69 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 116.291 -0.413 . . . . 0.97 111.867 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -59.27 -52.15 66.89 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 116.292 -0.413 . . . . 0.71 111.863 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 286' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -62.18 -42.74 99.56 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.492 0.553 . . . . 0.58 112.492 -179.04 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 287' ' ' LEU . . . . . 0.441 HD13 ' HA2' ' A' ' 292' ' ' GLY . 2.1 mm? -66.51 -49.77 65.45 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 111.719 0.266 . . . . 0.54 111.719 -179.516 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 5.5 p -65.56 -31.18 52.68 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-O 120.785 0.326 . . . . 0.62 111.261 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 11.8 ttmt -74.91 -30.69 61.35 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 120.79 0.328 . . . . 1.01 111.302 179.492 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -96.89 9.05 43.02 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 112.341 0.497 . . . . 0.64 112.341 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 291' ' ' ARG . . . . . 0.484 ' HB3' ' HB2' ' A' ' 294' ' ' ASP . 0.0 OUTLIER 62.57 24.87 14.82 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 112.767 0.654 . . . . 0.78 112.767 179.013 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 292' ' ' GLY . . . . . 0.441 ' HA2' HD13 ' A' ' 287' ' ' LEU . . . 56.07 -115.32 5.95 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 115.27 0.868 . . . . 0.39 115.27 178.533 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 293' ' ' TRP . . . . . 0.569 ' O ' HG22 ' A' ' 297' ' ' VAL . 88.8 m95 -65.83 -41.22 92.04 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 112.713 0.635 . . . . 0.7 112.713 -178.322 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 294' ' ' ASP . . . . . 0.484 ' HB2' ' HB3' ' A' ' 291' ' ' ARG . 27.6 m-20 -52.35 -49.67 63.86 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.086 0.47 . . . . 0.4 111.253 179.568 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -71.71 -33.74 63.21 Favored Glycine 0 CA--C 1.521 0.436 0 C-N-CA 120.84 -0.695 . . . . 0.29 112.598 179.343 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 296' ' ' PHE . . . . . 0.446 ' HB2' ' CH2' ' A' ' 242' ' ' TRP . 0.9 OUTLIER -66.77 -47.39 72.34 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 120.733 0.302 . . . . 0.32 111.759 179.893 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 297' ' ' VAL . . . . . 0.569 HG22 ' O ' ' A' ' 293' ' ' TRP . 23.7 m -68.06 -40.89 83.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 112.477 0.547 . . . . 0.35 112.477 -178.556 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 298' ' ' GLU . . . . . 0.431 ' OE1' ' HA ' ' A' ' 298' ' ' GLU . 0.0 OUTLIER -71.55 -30.21 65.63 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 120.538 -0.465 . . . . 0.45 112.079 -179.509 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 299' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -69.19 -41.97 76.43 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.83 0.348 . . . . 0.43 110.539 178.298 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 300' ' ' PHE . . . . . 0.608 ' CZ ' ' HB3' ' A' ' 242' ' ' TRP . 81.8 m-85 . . . . . 0 CA--C 1.539 0.542 0 N-CA-C 112.647 0.61 . . . . 0.35 112.647 -179.164 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 . . . . . 0 CA--C 1.53 0.199 0 CA-C-O 120.49 0.186 . . . . 0.51 111.285 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 23' ' ' PHE . . . . . 0.56 ' CE1' HG22 ' A' ' 230' ' ' VAL . 0.2 OUTLIER -60.38 -32.93 71.76 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 121.057 0.456 . . . . 0.36 110.528 179.549 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 24' ' ' ALA . . . . . 0.533 ' N ' ' HD1' ' B' ' 23' ' ' PHE . . . -72.8 -37.49 67.54 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 115.733 -0.667 . . . . 0.35 110.252 179.362 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.3 -42.59 99.07 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 109.674 -0.491 . . . . 0.36 109.674 178.443 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 26' ' ' GLN . . . . . 0.408 ' O ' HG13 ' B' ' 30' ' ' ILE . 0.1 OUTLIER -64.29 -54.44 33.18 Favored 'General case' 0 C--O 1.227 -0.125 0 CA-C-N 115.692 -0.685 . . . . 0.33 110.518 178.473 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 27' ' ' LEU . . . . . 0.537 HD12 HG11 ' A' ' 230' ' ' VAL . 48.9 mt -57.6 -35.23 70.15 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.855 0.36 . . . . 0.39 110.746 179.102 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 28' ' ' ARG . . . . . 0.585 ' HA ' HG13 ' A' ' 234' ' ' VAL . 65.5 ttt180 -60.86 -54.41 45.47 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 109.371 -0.603 . . . . 0.59 109.371 177.59 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -61.48 -41.14 96.81 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.725 -0.671 . . . . 0.83 111.18 178.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 30' ' ' ILE . . . . . 0.417 ' O ' HG23 ' B' ' 34' ' ' VAL . 95.6 mt -63.7 -44.05 98.27 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 N-CA-C 110.054 -0.35 . . . . 0.36 110.054 178.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 31' ' ' GLY . . . . . 0.574 ' HA3' ' HA ' ' A' ' 244' ' ' ARG . . . -60.68 -46.97 93.42 Favored Glycine 0 C--N 1.333 0.372 0 C-N-CA 120.645 -0.788 . . . . 0.28 111.674 178.807 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 85.0 m-20 -60.4 -36.93 79.27 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 121.196 0.522 . . . . 0.69 110.133 178.769 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 16.2 tppt? -68.05 -50.47 55.04 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 115.752 -0.658 . . . . 0.84 110.47 178.575 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 34' ' ' VAL . . . . . 0.417 HG23 ' O ' ' B' ' 30' ' ' ILE . 77.0 t -59.66 -42.26 87.87 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-O 120.943 0.402 . . . . 0.35 111.067 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 35' ' ' TYR . . . . . 0.493 ' N ' ' HA3' ' A' ' 243' ' ' GLY . 0.1 OUTLIER -57.9 -45.74 85.99 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 121.258 0.552 . . . . 0.93 109.907 178.479 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 36' ' ' CYS . . . . . . . . . . . . . 5.9 t -70.69 -26.09 63.26 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 115.905 -0.589 . . . . 0.54 111.17 179.114 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 37.3 m -71.61 -40.52 69.75 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 112.755 0.65 . . . . 0.37 112.755 -179.099 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 38' ' ' TRP . . . . . . . . . . . . . 99.3 m95 -85.64 -35.0 21.22 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.222 0.453 . . . . 0.45 112.222 -178.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 65.4 p . . . . . 0 N--CA 1.468 0.455 0 N-CA-C 111.644 0.238 . . . . 0.6 111.644 179.754 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 45.1 m-20 . . . . . 0 N--CA 1.468 0.433 0 N-CA-C 112.022 0.378 . . . . 1.15 112.022 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -71.09 -45.05 64.45 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 120.892 0.377 . . . . 1.77 111.207 178.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 41.3 tp -69.92 -32.98 71.56 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-N 116.387 -0.37 . . . . 0.66 111.824 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' TYR . . . . . 0.401 ' HE1' ' HA ' ' A' ' 277' ' ' ASP . 0.2 OUTLIER -55.55 -50.44 70.03 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 113.174 0.805 . . . . 0.45 113.174 -179.445 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 60.0 mtp85 -54.63 -51.91 63.9 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 112.882 0.697 . . . . 0.58 112.882 -178.31 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' GLN . . . . . 0.532 ' OE1' ' HB3' ' A' ' 186' ' ' ALA . 4.9 tt0 -66.9 -43.84 82.33 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.082 -0.508 . . . . 0.56 111.193 -179.24 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 31.1 m -61.57 -47.57 84.88 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.856 -0.611 . . . . 0.28 111.101 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.736 HD11 ' HG3' ' A' ' 273' ' ' GLU . 27.9 tp -59.52 -47.82 84.03 Favored 'General case' 0 C--O 1.222 -0.373 0 CA-C-N 115.913 -0.585 . . . . 0.51 111.517 -179.747 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -58.5 -50.41 73.86 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 120.601 0.239 . . . . 0.56 111.521 -179.328 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' ILE . . . . . 0.472 HD13 ' HB3' ' A' ' 190' ' ' ALA . 52.2 mt -58.05 -52.07 62.93 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-N 116.541 -0.299 . . . . 0.29 111.565 179.51 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.514 HD12 HG23 ' A' ' 276' ' ' THR . 88.2 mt -67.31 -54.86 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 N-CA-C 112.787 0.662 . . . . 0.29 112.787 -179.323 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 6.7 t -53.52 -41.23 66.15 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 120.775 0.322 . . . . 0.25 111.302 -178.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' ARG . . . . . 0.505 ' HD2' ' HA ' ' A' ' 165' ' ' ARG . 3.6 tpt180 -71.92 -45.93 59.4 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 120.344 -0.542 . . . . 0.6 110.775 179.28 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 166' ' ' TYR . . . . . 0.688 ' HE1' ' HA ' ' A' ' 195' ' ' ARG . 65.4 t80 -57.92 -49.33 77.13 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 111.561 0.208 . . . . 0.31 111.561 179.11 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 6.4 mp -60.82 -42.73 98.27 Favored 'General case' 0 C--O 1.226 -0.141 0 CA-C-N 116.717 -0.22 . . . . 0.39 110.566 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 1.9 ttt180 -65.28 -43.72 90.31 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 121.176 0.513 . . . . 0.44 110.457 178.886 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -60.44 -54.56 44.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.34 -0.846 . . . . 0.45 110.337 178.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 23.4 mm-40 -63.77 -35.8 81.79 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.09 -0.505 . . . . 0.28 111.085 179.41 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.449 ' HB2' ' HB1' ' A' ' 256' ' ' ALA . . . . . . . . 0 N--CA 1.466 0.342 0 CA-C-O 121.083 0.468 . . . . 0.31 111.496 179.186 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.516 ' O ' ' HA3' ' A' ' 187' ' ' GLY . . . . . . . . 0 CA--C 1.531 0.216 0 CA-C-O 121.26 0.553 . . . . 0.36 110.642 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -78.55 -71.06 1.26 Allowed Glycine 0 CA--C 1.527 0.823 0 N-CA-C 115.16 0.824 . . . . 0.39 115.16 -178.4 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -68.49 -57.81 5.26 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 112.774 0.657 . . . . 0.48 112.774 -177.885 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 186' ' ' ALA . . . . . 0.532 ' HB3' ' OE1' ' A' ' 158' ' ' GLN . . . -72.08 -34.11 68.43 Favored 'General case' 0 C--O 1.221 -0.426 0 C-N-CA 120.466 -0.494 . . . . 0.43 110.265 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 187' ' ' GLY . . . . . 0.516 ' HA3' ' O ' ' A' ' 183' ' ' ALA . . . -62.14 -43.66 98.83 Favored Glycine 0 CA--C 1.52 0.393 0 C-N-CA 120.828 -0.701 . . . . 0.35 112.601 179.166 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 3.0 tmt_? -62.38 -53.78 49.96 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.84 0.32 . . . . 0.58 110.601 179.018 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 189' ' ' ARG . . . . . 0.51 ' O ' ' HG2' ' A' ' 192' ' ' GLU . 47.6 mtm180 -63.4 -44.22 95.3 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.233 -0.44 . . . . 0.45 111.933 -179.472 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 190' ' ' ALA . . . . . 0.565 ' HB2' ' HB3' ' A' ' 293' ' ' TRP . . . -68.47 -45.48 72.33 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.179 0.437 . . . . 0.29 112.179 -179.206 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 191' ' ' LEU . . . . . 0.457 ' CD1' ' HB2' ' A' ' 166' ' ' TYR . 27.3 tp -65.91 -38.36 88.49 Favored 'General case' 0 N--CA 1.463 0.177 0 C-N-CA 120.411 -0.516 . . . . 0.6 111.813 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 192' ' ' GLU . . . . . 0.51 ' HG2' ' O ' ' A' ' 189' ' ' ARG . 9.3 pt-20 -66.61 -36.73 83.31 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 120.433 -0.507 . . . . 0.72 110.549 179.52 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 193' ' ' THR . . . . . 0.622 HG21 ' HA ' ' A' ' 297' ' ' VAL . 20.7 m -73.73 -46.75 44.02 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.129 -0.487 . . . . 0.31 110.247 179.512 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 194' ' ' LEU . . . . . 0.409 HD21 HG21 ' A' ' 249' ' ' ILE . 14.6 tp -60.74 -38.35 84.83 Favored 'General case' 0 N--CA 1.457 -0.125 0 CA-C-N 115.75 -0.659 . . . . 0.32 110.261 179.29 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 195' ' ' ARG . . . . . 0.688 ' HA ' ' HE1' ' A' ' 166' ' ' TYR . 46.2 ttm105 -61.85 -51.15 69.4 Favored 'General case' 0 C--O 1.223 -0.293 0 CA-C-N 116.072 -0.513 . . . . 0.32 111.07 178.886 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 7.3 tpm_? -69.16 -53.03 22.21 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 112.828 0.677 . . . . 0.45 112.828 -179.149 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 197' ' ' VAL . . . . . 0.473 HG21 ' HB3' ' A' ' 300' ' ' PHE . 46.5 t -63.72 -50.63 77.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 N-CA-C 112.028 0.381 . . . . 0.3 112.028 -178.505 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -57.78 -50.35 66.31 Favored Glycine 0 C--N 1.333 0.402 0 C-N-CA 120.976 -0.631 . . . . 0.25 111.976 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -54.28 -40.74 68.12 Favored 'General case' 0 CA--C 1.526 0.054 0 N-CA-C 109.992 -0.373 . . . . 0.41 109.992 178.554 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -63.2 -50.68 60.98 Favored Glycine 0 CA--C 1.522 0.525 0 C-N-CA 120.831 -0.699 . . . . 0.33 111.85 178.434 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 201' ' ' VAL . . . . . 0.405 HG23 ' O ' ' A' ' 197' ' ' VAL . 60.2 t -60.25 -42.28 89.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-O 120.837 0.351 . . . . 0.4 110.995 178.862 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 202' ' ' GLN . . . . . 0.659 ' HG3' ' HB3' ' A' ' 250' ' ' SER . 25.8 mt-30 -66.91 -42.4 85.51 Favored 'General case' 0 C--O 1.223 -0.314 0 CA-C-N 116.033 -0.53 . . . . 0.39 112.088 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 203' ' ' ARG . . . . . 0.513 ' HD3' ' OE1' ' A' ' 206' ' ' GLU . 0.0 OUTLIER -70.35 -37.49 74.65 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.814 0.34 . . . . 0.32 110.493 179.476 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 16.1 m-80 -67.88 -47.73 68.05 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-O 121.15 0.5 . . . . 0.84 110.489 178.42 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 86.9 m-70 -101.04 35.88 2.11 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.183 -0.462 . . . . 0.44 111.328 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 206' ' ' GLU . . . . . 0.525 ' HG3' ' CZ ' ' A' ' 254' ' ' PHE . 2.6 tt0 -57.49 -48.84 78.16 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.274 -0.421 . . . . 0.47 111.562 -179.538 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 45.9 p -64.95 -39.39 93.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.334 -0.394 . . . . 0.49 111.646 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -61.19 -43.27 99.15 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 121.138 0.494 . . . . 0.32 110.483 179.037 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 209' ' ' PHE . . . . . 0.517 ' O ' ' HG ' ' A' ' 213' ' ' LEU . 21.9 m-85 -74.52 -39.1 62.59 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.949 -0.569 . . . . 0.42 110.295 179.147 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -60.09 -46.1 90.72 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.151 -0.477 . . . . 0.76 110.277 178.8 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -63.69 -39.22 97.3 Favored Glycine 0 C--N 1.335 0.516 0 N-CA-C 111.031 -0.827 . . . . 0.3 111.031 177.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 212' ' ' MET . . . . . 0.648 ' HA ' ' HE2' ' A' ' 215' ' ' LYS . 9.9 tpp -62.12 -40.4 95.77 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 109.718 -0.475 . . . . 0.68 109.718 178.182 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.627 HD13 ' HB2' ' A' ' 258' ' ' HIS . 40.7 mt -59.09 -41.29 87.73 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.372 -0.376 . . . . 0.4 111.169 178.663 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.74 -44.6 96.47 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.086 -0.506 . . . . 0.99 110.886 179.459 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 215' ' ' LYS . . . . . 0.648 ' HE2' ' HA ' ' A' ' 212' ' ' MET . 32.8 mtmt -73.13 -33.59 65.61 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 116.222 -0.444 . . . . 0.66 111.798 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 216' ' ' LEU . . . . . 0.464 ' HB3' HG12 ' A' ' 218' ' ' ILE . 35.9 mt -65.32 143.48 57.74 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 121.254 0.55 . . . . 0.54 112.465 -179.602 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 217' ' ' ASP . . . . . 0.427 ' O ' ' HG3' ' A' ' 219' ' ' LYS . 0.3 OUTLIER -112.45 33.23 5.05 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.798 -0.637 . . . . 0.48 110.719 179.523 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 218' ' ' ILE . . . . . 0.464 HG12 ' HB3' ' A' ' 216' ' ' LEU . 27.5 mm -66.1 112.43 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 CA-C-N 116.549 -0.296 . . . . 0.51 111.29 -179.658 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 219' ' ' LYS . . . . . 0.427 ' HG3' ' O ' ' A' ' 217' ' ' ASP . 21.2 mtmm -134.33 -43.57 0.78 Allowed 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 112.15 0.426 . . . . 0.55 112.15 -179.426 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -128.9 -176.37 3.83 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 112.737 0.643 . . . . 0.58 112.737 -177.841 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 221' ' ' GLU . . . . . 0.568 ' O ' HG22 ' A' ' 224' ' ' VAL . 1.2 mp0 -61.37 -22.31 64.85 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 112.743 0.646 . . . . 0.72 112.743 -179.055 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -70.19 -27.25 73.13 Favored Glycine 0 CA--C 1.524 0.61 0 C-N-CA 120.402 -0.904 . . . . 0.34 112.999 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -70.12 -31.29 68.76 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 112.779 0.659 . . . . 0.4 112.779 -179.15 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.568 HG22 ' O ' ' A' ' 221' ' ' GLU . 3.8 m -56.56 -27.37 25.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 N-CA-C 112.122 0.416 . . . . 0.46 112.122 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 225' ' ' LYS . . . . . 0.473 ' O ' ' HG3' ' A' ' 229' ' ' ARG . 7.9 mptt -64.93 -42.49 94.63 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.037 0.446 . . . . 0.51 110.184 178.723 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 226' ' ' SER . . . . . 0.708 ' HA ' ' HE ' ' A' ' 229' ' ' ARG . 31.6 m -70.71 -36.68 73.34 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.228 -0.442 . . . . 0.59 109.877 178.478 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 227' ' ' PHE . . . . . . . . . . . . . 16.5 t80 -61.94 -40.68 96.36 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.767 -0.651 . . . . 0.55 109.631 178.388 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 49.2 m -65.24 -38.17 89.52 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.72 -0.673 . . . . 0.46 109.954 178.574 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 229' ' ' ARG . . . . . 0.708 ' HE ' ' HA ' ' A' ' 226' ' ' SER . 61.3 mtm180 -59.65 -37.51 78.9 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.239 -0.437 . . . . 0.65 109.925 178.187 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 230' ' ' VAL . . . . . 0.529 HG22 ' CE1' ' B' ' 23' ' ' PHE . 44.4 t -59.42 -53.54 46.73 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.142 0 N-CA-C 109.311 -0.625 . . . . 0.4 109.311 177.433 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 231' ' ' MET . . . . . 0.504 ' SD ' HD13 ' A' ' 248' ' ' LEU . 1.5 ttp -56.15 -45.23 79.7 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 115.463 -0.79 . . . . 0.73 111.01 178.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 80.6 t -62.75 -42.32 95.77 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-O 120.901 0.381 . . . . 0.49 110.923 178.876 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 9.2 t-80 -69.85 -35.58 74.84 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 116.515 -0.311 . . . . 0.54 111.221 179.625 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.517 HG23 ' O ' ' A' ' 230' ' ' VAL . 39.5 t -54.19 -37.01 34.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 CA-C-O 120.974 0.416 . . . . 0.43 111.48 179.351 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 235' ' ' PHE . . . . . 0.596 ' CE1' ' HA ' ' A' ' 240' ' ' THR . 72.9 m-85 -102.26 24.55 10.07 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 112.007 0.373 . . . . 0.55 112.007 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 236' ' ' LYS . . . . . 0.41 ' HA ' ' HD2' ' A' ' 236' ' ' LYS . 8.2 tptp -70.22 -20.63 63.08 Favored 'General case' 0 CA--C 1.537 0.462 0 O-C-N 122.241 -0.287 . . . . 1.17 111.355 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 23.8 p-10 -82.22 -8.29 59.64 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 120.789 0.328 . . . . 0.73 110.869 179.569 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 83.05 9.92 83.53 Favored Glycine 0 CA--C 1.522 0.475 0 C-N-CA 120.99 -0.624 . . . . 0.49 114.039 178.688 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 33.5 t -102.23 91.08 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.441 0.638 . . . . 0.53 111.187 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 240' ' ' THR . . . . . 0.596 ' HA ' ' CE1' ' A' ' 235' ' ' PHE . 3.1 m -80.13 73.27 6.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.875 -0.602 . . . . 0.71 111.439 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 38.3 m-20 -80.11 140.87 36.24 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.928 0.394 . . . . 0.51 111.885 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 242' ' ' TRP . . . . . 0.477 ' HB3' ' CE2' ' A' ' 300' ' ' PHE . 35.4 m95 -57.96 -40.03 79.55 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.981 -0.554 . . . . 0.5 111.367 179.538 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 243' ' ' GLY . . . . . 0.459 ' H ' ' HB2' ' B' ' 35' ' ' TYR . . . -61.69 -27.43 68.25 Favored Glycine 0 CA--C 1.521 0.467 0 C-N-CA 120.864 -0.684 . . . . 0.25 112.135 178.643 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 244' ' ' ARG . . . . . 0.548 ' HG2' ' HA3' ' B' ' 31' ' ' GLY . 71.9 mtt180 -74.81 -46.03 39.46 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 110.0 -0.37 . . . . 0.54 110.0 178.924 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 245' ' ' ILE . . . . . 0.525 HG23 HD11 ' A' ' 279' ' ' LEU . 83.7 mt -58.2 -47.33 87.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-N 115.674 -0.694 . . . . 0.49 109.899 179.046 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 246' ' ' VAL . . . . . 0.471 HG11 HG12 ' A' ' 197' ' ' VAL . 83.9 t -64.82 -38.41 82.66 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-N 115.87 -0.604 . . . . 0.35 110.059 178.139 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 17.0 m -60.68 -41.5 95.21 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.712 0.291 . . . . 0.32 110.217 178.423 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 248' ' ' LEU . . . . . 0.559 HD23 HD13 ' B' ' 27' ' ' LEU . 64.3 mt -63.02 -43.89 97.47 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 121.043 0.449 . . . . 0.74 109.842 177.924 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 249' ' ' ILE . . . . . 0.508 HG12 ' O ' ' A' ' 245' ' ' ILE . 41.6 mm -63.01 -40.46 89.12 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 CA-C-O 121.35 0.595 . . . . 0.41 109.579 177.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 250' ' ' SER . . . . . 0.659 ' HB3' ' HG3' ' A' ' 202' ' ' GLN . 38.8 m -61.57 -47.63 84.63 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 115.243 -0.89 . . . . 0.29 109.624 178.82 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 251' ' ' PHE . . . . . 0.527 ' O ' HG23 ' A' ' 255' ' ' VAL . 11.1 t80 -60.81 -45.4 94.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.452 -0.795 . . . . 0.43 109.579 178.155 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -55.66 -48.07 73.65 Favored Glycine 0 C--N 1.335 0.523 0 C-N-CA 121.151 -0.547 . . . . 0.22 111.974 178.479 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 253' ' ' ALA . . . . . 0.543 ' O ' ' HG3' ' A' ' 257' ' ' LYS . . . -62.1 -34.69 76.8 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 120.737 0.303 . . . . 0.25 111.069 178.826 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 254' ' ' PHE . . . . . 0.525 ' CZ ' ' HG3' ' A' ' 206' ' ' GLU . 2.4 t80 -72.18 -41.5 66.93 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 121.08 0.467 . . . . 0.4 110.45 178.762 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 255' ' ' VAL . . . . . 0.527 HG23 ' O ' ' A' ' 251' ' ' PHE . 81.1 t -65.19 -36.25 77.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 N-CA-C 109.047 -0.723 . . . . 0.31 109.047 177.533 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 256' ' ' ALA . . . . . 0.449 ' HB1' ' HB2' ' A' ' 171' ' ' ALA . . . -62.69 -36.76 83.96 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 115.544 -0.753 . . . . 0.24 109.61 178.101 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 257' ' ' LYS . . . . . 0.543 ' HG3' ' O ' ' A' ' 253' ' ' ALA . 54.7 mttm -60.66 -43.54 97.5 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.033 -0.531 . . . . 0.38 109.65 177.571 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 258' ' ' HIS . . . . . 0.627 ' HB2' HD13 ' A' ' 213' ' ' LEU . 34.7 t60 -57.09 -44.36 83.11 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.824 -0.626 . . . . 0.69 110.844 178.931 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 94.3 mt -71.04 -40.77 71.5 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 120.99 0.424 . . . . 0.61 111.404 179.327 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -65.85 -27.78 68.49 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 120.646 0.26 . . . . 0.42 111.481 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 51.2 m -62.84 -21.66 66.11 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 116.356 -0.384 . . . . 0.45 111.414 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 11.3 m -120.35 23.58 4.83 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-N 116.289 -0.414 . . . . 0.6 111.44 179.413 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 54.4 m-80 58.03 45.33 18.09 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 112.888 0.699 . . . . 1.26 112.888 179.516 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -109.46 37.65 2.55 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 122.176 -0.328 . . . . 0.89 111.678 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 265' ' ' GLU . . . . . 0.599 ' HA ' HD12 ' A' ' 268' ' ' ILE . 13.3 tt0 -58.04 -28.62 64.66 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 111.975 0.361 . . . . 0.74 111.975 -179.564 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 15.5 p -62.17 -18.68 61.69 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.189 -0.459 . . . . 0.53 111.212 179.035 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 267' ' ' PHE . . . . . 0.416 ' C ' ' HD2' ' A' ' 270' ' ' PRO . 90.1 m-85 -101.94 -19.0 15.42 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 121.05 0.453 . . . . 0.65 110.242 177.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 268' ' ' ILE . . . . . 0.599 HD12 ' HA ' ' A' ' 265' ' ' GLU . 78.9 mt -66.9 -43.86 89.18 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-N 115.767 -0.651 . . . . 0.35 110.599 179.605 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 269' ' ' GLU . . . . . 0.776 ' HB2' ' HD3' ' A' ' 270' ' ' PRO . 45.2 mt-10 -59.47 -57.3 27.96 Favored Pre-proline 0 CA--C 1.54 0.577 0 CA-C-N 116.271 -0.422 . . . . 0.42 110.54 178.823 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 270' ' ' PRO . . . . . 0.776 ' HD3' ' HB2' ' A' ' 269' ' ' GLU . 66.4 Cg_exo -54.0 -35.14 79.91 Favored 'Trans proline' 0 C--N 1.362 1.261 0 C-N-CA 122.137 1.891 . . . . 0.45 112.212 178.36 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 271' ' ' LEU . . . . . . . . . . . . . 51.1 tp -68.54 -54.57 15.85 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.312 -0.404 . . . . 0.45 110.073 178.497 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -57.6 -40.47 79.15 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 116.282 -0.417 . . . . 0.23 110.918 179.008 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 273' ' ' GLU . . . . . 0.736 ' HG3' HD11 ' A' ' 160' ' ' LEU . 0.7 OUTLIER -66.43 -44.19 83.57 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.119 -0.491 . . . . 0.33 110.302 178.499 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 274' ' ' THR . . . . . . . . . . . . . 67.5 m -61.46 -43.16 99.35 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-O 120.905 0.383 . . . . 0.28 110.195 178.667 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 96.7 mt -59.05 -53.98 40.45 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-N 115.973 -0.558 . . . . 0.31 110.696 178.878 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 276' ' ' THR . . . . . 0.53 HG21 ' HA ' ' A' ' 160' ' ' LEU . 49.9 m -56.76 -47.08 80.89 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.299 -0.41 . . . . 0.29 110.77 179.476 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 277' ' ' ASP . . . . . 0.611 ' O ' ' HB2' ' A' ' 281' ' ' ARG . 28.0 t70 -55.82 -59.21 5.2 Favored 'General case' 0 C--O 1.222 -0.358 0 CA-C-N 115.632 -0.713 . . . . 0.46 111.157 179.442 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 84.4 t -58.7 -36.98 63.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-O 120.905 0.383 . . . . 0.41 111.384 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 279' ' ' LEU . . . . . 0.525 HD11 HG23 ' A' ' 245' ' ' ILE . 26.3 tp -63.95 -47.19 81.45 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 116.333 -0.394 . . . . 0.7 112.024 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 60.8 t -80.89 -42.18 20.11 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 N-CA-C 112.272 0.471 . . . . 0.44 112.272 -179.513 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 281' ' ' ARG . . . . . 0.611 ' HB2' ' O ' ' A' ' 277' ' ' ASP . 2.7 ttt180 -56.49 -43.41 79.63 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 112.936 0.717 . . . . 0.89 112.936 -179.393 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 282' ' ' THR . . . . . . . . . . . . . 51.9 p -83.0 -23.7 33.19 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 113.143 0.794 . . . . 0.57 113.143 -179.125 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 283' ' ' LYS . . . . . 0.451 ' HD3' HG23 ' A' ' 240' ' ' THR . 1.5 mttp -118.04 39.16 3.46 Favored 'General case' 0 C--N 1.329 -0.307 0 O-C-N 122.068 -0.395 . . . . 0.77 111.905 -179.062 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 284' ' ' ARG . . . . . 0.422 HH11 ' HD3' ' A' ' 284' ' ' ARG . 31.0 ttp180 -58.65 -48.11 82.16 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.109 -0.496 . . . . 0.93 111.932 -179.734 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -68.41 -46.08 70.89 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 116.574 -0.285 . . . . 0.52 111.755 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 286' ' ' TRP . . . . . . . . . . . . . 1.8 t90 -61.65 -45.97 91.78 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 112.023 0.379 . . . . 0.51 112.023 -179.128 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -63.37 -52.25 62.49 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.15 0.426 . . . . 0.49 112.15 -179.418 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 6.8 p -61.8 -30.74 49.09 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 CA-C-O 120.784 0.326 . . . . 0.55 111.787 -179.5 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 10.6 ttmt -69.55 -38.78 77.61 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 120.971 0.415 . . . . 0.86 111.121 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 290' ' ' GLN . . . . . 0.451 ' HB3' ' HZ2' ' A' ' 242' ' ' TRP . 3.4 mp0 -91.6 22.45 4.05 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 112.231 0.456 . . . . 0.95 112.231 -179.44 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 8.7 mpt_? 61.67 17.61 8.83 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 112.391 0.515 . . . . 0.86 112.391 179.379 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 58.81 -120.27 21.67 Favored Glycine 0 CA--C 1.523 0.566 0 CA-C-O 121.436 0.464 . . . . 0.44 113.997 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 293' ' ' TRP . . . . . 0.565 ' HB3' ' HB2' ' A' ' 190' ' ' ALA . 84.9 m95 -65.44 -28.56 69.32 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.717 0.636 . . . . 0.47 112.717 -178.74 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 294' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.38 -45.24 91.99 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 121.075 0.464 . . . . 0.56 110.595 179.009 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -69.28 -30.89 71.44 Favored Glycine 0 CA--C 1.518 0.259 0 C-N-CA 120.472 -0.871 . . . . 0.29 111.252 178.355 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 296' ' ' PHE . . . . . 0.475 ' HB2' ' CZ3' ' A' ' 242' ' ' TRP . 2.5 t80 -69.62 -48.44 59.99 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 115.7 -0.25 . . . . 0.35 111.512 179.013 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 297' ' ' VAL . . . . . 0.622 ' HA ' HG21 ' A' ' 193' ' ' THR . 26.4 m -66.2 -33.83 66.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 N-CA-C 112.113 0.412 . . . . 0.31 112.113 -179.165 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -76.11 -33.08 59.47 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 120.624 0.25 . . . . 0.86 111.052 179.412 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 299' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -69.7 -38.23 76.88 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.025 0.441 . . . . 0.43 110.456 178.812 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 300' ' ' PHE . . . . . 0.477 ' CE2' ' HB3' ' A' ' 242' ' ' TRP . 91.2 m-85 . . . . . 0 C--N 1.329 -0.299 0 CA-C-O 121.206 0.527 . . . . 0.38 110.691 179.224 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 . . . . . 0 CA--C 1.533 0.311 0 N-CA-C 111.537 0.199 . . . . 0.79 111.537 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 23' ' ' PHE . . . . . 0.529 ' CE1' HG22 ' A' ' 230' ' ' VAL . 0.2 OUTLIER -62.17 -33.21 74.09 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.763 0.316 . . . . 0.47 111.634 -179.84 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 24' ' ' ALA . . . . . 0.512 ' N ' ' HD1' ' B' ' 23' ' ' PHE . . . -75.63 -36.32 60.26 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.236 0.541 . . . . 0.48 109.872 179.274 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -69.25 -43.02 74.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.618 -0.719 . . . . 0.46 110.198 178.654 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -60.24 -48.72 80.55 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.074 -0.512 . . . . 0.63 110.854 179.396 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 27' ' ' LEU . . . . . 0.559 HD13 HD23 ' A' ' 248' ' ' LEU . 89.2 mt -64.73 -33.4 75.89 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 120.92 0.391 . . . . 0.45 110.324 178.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 28' ' ' ARG . . . . . . . . . . . . . 3.6 tmt_? -64.46 -45.73 86.18 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 121.215 0.531 . . . . 0.87 109.722 177.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 33.4 mtpt -71.27 -45.19 63.72 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 115.672 -0.695 . . . . 0.59 111.647 179.617 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 96.7 mt -62.52 -43.44 98.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-O 120.722 0.296 . . . . 0.4 110.324 179.733 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 31' ' ' GLY . . . . . 0.548 ' HA3' ' HG2' ' A' ' 244' ' ' ARG . . . -59.72 -50.25 69.73 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.807 -0.711 . . . . 0.3 112.582 179.437 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -65.81 -32.11 73.45 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.749 0.275 . . . . 0.56 110.754 179.252 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.9 -52.0 58.89 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 121.097 0.475 . . . . 0.7 109.738 178.307 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 55.2 t -63.04 -45.1 99.66 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-N 115.494 -0.775 . . . . 0.38 110.53 178.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 35' ' ' TYR . . . . . 0.459 ' HB2' ' H ' ' A' ' 243' ' ' GLY . 0.7 OUTLIER -54.98 -47.05 75.1 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 115.607 -0.724 . . . . 0.63 111.316 179.319 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 36' ' ' CYS . . . . . . . . . . . . . 73.0 m -62.45 -45.07 94.72 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 120.663 0.268 . . . . 0.45 111.303 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 13.1 m -60.4 -37.55 81.19 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 116.316 -0.402 . . . . 0.61 112.033 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 38' ' ' TRP . . . . . . . . . . . . . 93.9 m95 -87.65 -29.47 21.15 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 112.637 0.606 . . . . 0.75 112.637 -179.429 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 42.2 t . . . . . 0 N--CA 1.471 0.581 0 N-CA-C 111.982 0.364 . . . . 0.6 111.982 179.675 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 2.8 t70 . . . . . 0 N--CA 1.472 0.638 0 N-CA-C 113.448 0.907 . . . . 0.52 113.448 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -49.35 -51.62 33.41 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 121.038 0.447 . . . . 0.48 112.142 -179.257 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.519 HD21 ' HB3' ' A' ' 287' ' ' LEU . 44.7 tp -84.47 -40.2 18.0 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.297 -0.41 . . . . 0.91 111.664 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 156' ' ' TYR . . . . . 0.496 ' OH ' ' HB2' ' A' ' 281' ' ' ARG . 0.3 OUTLIER -52.04 -44.16 64.1 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 112.203 0.446 . . . . 0.36 112.203 -179.766 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 21.5 mtm180 -60.56 -51.9 67.46 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 112.145 0.424 . . . . 0.53 112.145 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 1.8 mm100 -63.27 -40.13 96.53 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 121.239 0.542 . . . . 0.53 110.401 179.584 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 18.4 m -64.89 -50.1 67.89 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.414 -0.812 . . . . 0.28 111.534 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -55.96 -47.89 76.8 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.405 -0.361 . . . . 0.47 111.046 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' GLU . . . . . 0.621 ' O ' ' HB2' ' A' ' 165' ' ' ARG . 1.4 mm-40 -59.37 -47.26 86.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.402 -0.363 . . . . 0.55 111.294 179.349 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 162' ' ' ILE . . . . . 0.55 HG12 ' HA2' ' A' ' 187' ' ' GLY . 68.4 mt -66.04 -51.88 55.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 N-CA-C 113.114 0.783 . . . . 0.35 113.114 -179.01 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.539 HD12 HG23 ' A' ' 276' ' ' THR . 56.0 mt -60.18 -54.62 32.39 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 N-CA-C 112.232 0.456 . . . . 0.34 112.232 -178.612 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 70.4 p -59.33 -37.08 76.9 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.63 0.252 . . . . 0.33 111.077 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' ARG . . . . . 0.621 ' HB2' ' O ' ' A' ' 161' ' ' GLU . 0.0 OUTLIER -68.92 -36.78 78.39 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 120.959 -0.296 . . . . 0.56 111.256 179.099 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 166' ' ' TYR . . . . . 0.852 ' HE1' ' HA ' ' A' ' 195' ' ' ARG . 67.5 t80 -72.32 -49.16 36.54 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 121.237 -0.185 . . . . 0.48 111.242 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.512 ' HG ' ' O ' ' A' ' 163' ' ' ILE . 38.1 mt -55.99 -41.01 74.17 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.183 0.516 . . . . 0.34 110.316 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 3.7 tpp180 -69.83 -42.99 72.91 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.554 -0.748 . . . . 0.49 110.449 178.402 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' GLU . . . . . 0.502 ' HB2' ' O ' ' A' ' 165' ' ' ARG . 0.4 OUTLIER -56.85 -44.05 81.74 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 116.351 -0.386 . . . . 0.52 111.939 -179.701 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 22.5 tp60 -76.28 -32.9 59.04 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 112.034 0.383 . . . . 0.55 112.034 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.865 ' HA ' ' HG2' ' A' ' 257' ' ' LYS . . . . . . . . 0 CA--C 1.537 0.449 0 N-CA-C 113.072 0.768 . . . . 0.45 113.072 -179.476 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.672 ' O ' ' HA3' ' A' ' 187' ' ' GLY . . . . . . . . 0 C--O 1.224 -0.256 0 CA-C-O 121.118 0.485 . . . . 0.37 110.561 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -79.94 -69.76 1.38 Allowed Glycine 0 CA--C 1.522 0.496 0 C-N-CA 120.953 -0.642 . . . . 0.38 113.359 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -59.79 -56.01 27.08 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 120.653 0.263 . . . . 0.43 111.535 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -67.69 -32.92 73.91 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.949 -0.389 . . . . 0.46 109.949 179.224 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 187' ' ' GLY . . . . . 0.672 ' HA3' ' O ' ' A' ' 183' ' ' ALA . . . -62.63 -48.64 80.02 Favored Glycine 0 C--O 1.224 -0.492 0 CA-C-N 115.685 -0.688 . . . . 0.39 112.97 179.0 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.28 -50.75 68.88 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 117.221 0.511 . . . . 1.58 110.893 179.313 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 189' ' ' ARG . . . . . 0.649 ' HB3' HG21 ' A' ' 297' ' ' VAL . 4.4 mtp180 -56.31 -55.15 36.96 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-O 120.971 0.415 . . . . 0.73 111.164 179.346 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 190' ' ' ALA . . . . . 0.428 ' O ' ' HB2' ' A' ' 194' ' ' LEU . . . -66.98 -40.67 87.46 Favored 'General case' 0 C--O 1.219 -0.51 0 N-CA-C 113.035 0.754 . . . . 0.35 113.035 -178.767 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 14.2 tp -62.45 -44.37 96.58 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 118.475 0.579 . . . . 0.77 111.529 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -67.58 -40.11 84.84 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 121.143 0.497 . . . . 1.16 110.963 179.692 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 193' ' ' THR . . . . . 0.519 ' OG1' HG13 ' A' ' 297' ' ' VAL . 20.8 m -68.52 -47.26 67.42 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.113 -0.494 . . . . 0.46 110.204 179.035 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 194' ' ' LEU . . . . . 0.461 HD21 HG21 ' A' ' 249' ' ' ILE . 7.9 tp -60.12 -42.17 94.17 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 115.661 -0.7 . . . . 0.36 110.468 179.26 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 195' ' ' ARG . . . . . 0.852 ' HA ' ' HE1' ' A' ' 166' ' ' TYR . 0.6 OUTLIER -56.03 -54.08 49.26 Favored 'General case' 0 CA--C 1.522 -0.125 0 CA-C-O 121.243 0.545 . . . . 0.41 110.377 178.268 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 10.9 mmm180 -61.53 -54.03 48.49 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.972 -1.013 . . . . 0.9 112.36 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 197' ' ' VAL . . . . . 0.497 ' O ' HG23 ' A' ' 201' ' ' VAL . 99.0 t -61.36 -46.31 96.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 N-CA-C 111.899 0.333 . . . . 0.47 111.899 -179.361 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 198' ' ' GLY . . . . . 0.529 ' HA3' ' OH ' ' A' ' 166' ' ' TYR . . . -62.24 -50.43 65.1 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 121.244 -0.503 . . . . 0.3 112.242 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 199' ' ' ASP . . . . . 0.47 ' HB2' ' O ' ' A' ' 195' ' ' ARG . 0.3 OUTLIER -58.27 -43.1 87.77 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 120.856 0.36 . . . . 0.47 110.117 178.846 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -61.68 -48.36 84.81 Favored Glycine 0 CA--C 1.525 0.708 0 C-N-CA 121.021 -0.609 . . . . 0.42 112.303 178.641 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 201' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 197' ' ' VAL . 71.0 t -62.37 -43.18 97.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-O 120.943 0.402 . . . . 0.41 110.607 178.813 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 202' ' ' GLN . . . . . 0.562 ' HB3' ' NH2' ' A' ' 203' ' ' ARG . 68.8 mt-30 -63.41 -55.2 26.24 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.583 -0.735 . . . . 0.55 112.098 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 203' ' ' ARG . . . . . 0.562 ' NH2' ' HB3' ' A' ' 202' ' ' GLN . 0.0 OUTLIER -58.15 -34.41 70.25 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 112.157 0.428 . . . . 0.45 112.157 -178.822 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 17.7 m-80 -75.34 -43.79 48.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.895 0.378 . . . . 0.8 111.489 179.477 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 205' ' ' HIS . . . . . 0.436 ' CD2' HG23 ' B' ' 30' ' ' ILE . 95.2 m-70 -100.9 35.95 2.07 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.8 0.333 . . . . 0.52 111.68 -179.598 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 206' ' ' GLU . . . . . 0.495 ' HG2' ' HA ' ' A' ' 203' ' ' ARG . 26.9 mm-40 -55.68 -35.64 66.25 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 112.4 0.519 . . . . 0.53 112.4 -179.668 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 19.4 p -63.15 -52.64 61.65 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.808 0.337 . . . . 0.54 111.6 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -63.41 -40.57 97.56 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.154 -0.475 . . . . 0.4 110.919 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 209' ' ' PHE . . . . . 0.442 ' CE2' ' HA ' ' A' ' 202' ' ' GLN . 25.9 m-85 -68.04 -49.49 61.09 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.094 -0.503 . . . . 0.45 111.547 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -65.31 -38.91 91.65 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 121.266 -0.174 . . . . 0.51 111.021 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -59.23 -45.71 94.95 Favored Glycine 0 C--N 1.334 0.443 0 C-N-CA 120.448 -0.882 . . . . 0.28 110.991 178.15 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 212' ' ' MET . . . . . 0.487 ' SD ' ' HA ' ' B' ' 23' ' ' PHE . 56.9 mtm -70.62 -33.78 71.39 Favored 'General case' 0 C--O 1.223 -0.324 0 N-CA-C 110.25 -0.278 . . . . 0.73 110.25 178.196 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.449 HD22 ' HA ' ' A' ' 213' ' ' LEU . 0.3 OUTLIER -65.8 -43.84 87.47 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.351 -0.386 . . . . 0.33 111.302 179.506 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 71.9 mtp180 -66.11 -38.46 88.25 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.916 0.389 . . . . 0.92 110.84 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 54.9 mtmt -91.42 11.57 23.44 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.288 -0.415 . . . . 0.59 111.287 179.19 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 216' ' ' LEU . . . . . 0.509 HD21 HD12 ' A' ' 218' ' ' ILE . 6.5 tp -79.26 99.07 6.89 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.14 0.495 . . . . 0.4 111.361 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -83.25 32.07 0.45 Allowed 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.7 -0.682 . . . . 0.43 111.191 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 218' ' ' ILE . . . . . 0.765 HG12 ' HB3' ' A' ' 223' ' ' ASP . 36.4 mt -81.1 106.74 12.64 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-O 121.069 0.461 . . . . 0.4 110.709 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 8.2 mppt? -140.92 -24.45 0.76 Allowed 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 115.696 -0.684 . . . . 0.6 111.978 -179.451 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -116.28 171.1 8.04 Favored 'General case' 0 CA--C 1.533 0.296 0 O-C-N 121.875 -0.516 . . . . 1.11 111.68 -179.344 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -58.48 -31.45 67.85 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 120.955 0.407 . . . . 0.55 111.197 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -62.45 -26.72 68.47 Favored Glycine 0 CA--C 1.524 0.627 0 CA-C-N 115.978 -0.555 . . . . 0.45 113.117 179.253 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 223' ' ' ASP . . . . . 0.765 ' HB3' HG12 ' A' ' 218' ' ' ILE . 55.5 m-20 -68.66 -34.11 75.15 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 117.024 0.412 . . . . 0.36 111.488 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 16.4 t -62.23 -29.41 46.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-O 121.556 0.693 . . . . 0.38 110.16 178.39 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 32.2 mmtm -72.67 -33.48 66.58 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 115.533 -0.758 . . . . 0.5 110.441 179.458 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 226' ' ' SER . . . . . 0.453 ' O ' HG23 ' A' ' 230' ' ' VAL . 33.6 t -68.13 -38.65 82.44 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.381 0.61 . . . . 0.91 109.585 178.329 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 227' ' ' PHE . . . . . 0.448 ' HE2' HG11 ' A' ' 255' ' ' VAL . 8.5 t80 -63.54 -38.36 90.83 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 115.211 -0.904 . . . . 0.46 109.503 178.107 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 46.8 t -62.53 -37.44 86.1 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 115.442 -0.799 . . . . 0.29 109.951 178.165 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 84.3 mtp180 -63.07 -39.67 95.4 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.013 -0.539 . . . . 0.55 109.882 178.037 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 230' ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' ' 226' ' ' SER . 18.2 t -59.3 -46.14 92.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-N 116.324 -0.398 . . . . 0.35 110.5 178.143 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 231' ' ' MET . . . . . 0.474 ' HE3' ' HA ' ' A' ' 275' ' ' ILE . 7.3 tpp -55.33 -52.2 64.28 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.933 -0.576 . . . . 0.37 110.929 179.605 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 232' ' ' VAL . . . . . 0.527 ' O ' ' HB2' ' A' ' 236' ' ' LYS . 38.2 t -66.89 -36.71 77.85 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-N 116.262 -0.426 . . . . 0.37 111.362 179.511 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 54.0 t-80 -65.48 -52.55 52.06 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 112.057 0.392 . . . . 0.55 112.057 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 97.0 t -63.98 -39.09 84.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 N-CA-C 112.078 0.399 . . . . 0.41 112.078 -179.223 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 235' ' ' PHE . . . . . 0.568 ' HZ ' ' HA ' ' A' ' 245' ' ' ILE . 63.0 m-85 -91.84 10.94 26.52 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.412 0.523 . . . . 0.56 112.412 -179.397 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 236' ' ' LYS . . . . . 0.55 ' HE2' ' HA ' ' A' ' 236' ' ' LYS . 0.3 OUTLIER -76.0 -11.43 59.95 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 111.873 0.323 . . . . 0.74 111.873 -179.807 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -69.97 -16.73 63.24 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 120.855 0.359 . . . . 0.42 111.262 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 89.28 -19.83 37.2 Favored Glycine 0 CA--C 1.521 0.442 0 C-N-CA 121.168 -0.539 . . . . 0.47 111.959 -178.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 2.4 t -80.39 112.03 17.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.048 0.452 . . . . 0.86 111.093 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 240' ' ' THR . . . . . 0.41 HG22 HD11 ' A' ' 245' ' ' ILE . 1.9 m -94.47 91.32 6.58 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.37 -0.377 . . . . 0.55 111.046 179.477 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -101.56 135.22 43.44 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.77 0.319 . . . . 0.47 111.389 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 242' ' ' TRP . . . . . 0.658 ' HB3' ' CZ ' ' A' ' 300' ' ' PHE . 7.2 m95 -55.0 -44.01 74.14 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 116.311 -0.404 . . . . 0.41 111.761 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 243' ' ' GLY . . . . . 0.463 ' H ' ' HB2' ' B' ' 35' ' ' TYR . . . -59.21 -37.02 91.2 Favored Glycine 0 CA--C 1.524 0.619 0 C-N-CA 121.086 -0.578 . . . . 0.28 112.868 179.096 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 63.9 mtt180 -68.46 -43.45 77.0 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 109.777 -0.453 . . . . 0.35 109.777 178.462 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 245' ' ' ILE . . . . . 0.568 ' HA ' ' HZ ' ' A' ' 235' ' ' PHE . 84.7 mt -59.99 -50.67 79.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-N 115.58 -0.736 . . . . 0.48 111.569 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 246' ' ' VAL . . . . . 0.412 HG22 ' O ' ' A' ' 242' ' ' TRP . 16.1 m -67.04 -28.03 41.49 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 C-N-CA 120.769 -0.373 . . . . 0.35 111.411 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 23.1 m -61.79 -48.62 79.81 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 109.754 -0.461 . . . . 0.37 109.754 178.27 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -60.2 -42.47 95.19 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.063 -0.517 . . . . 0.53 110.312 178.659 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 249' ' ' ILE . . . . . 0.461 HG21 HD21 ' A' ' 194' ' ' LEU . 43.3 mm -63.99 -44.99 97.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 CA-C-N 116.238 -0.437 . . . . 0.47 110.499 178.521 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 250' ' ' SER . . . . . 0.448 ' HB2' ' HG3' ' A' ' 202' ' ' GLN . 54.4 p -62.19 -36.61 82.44 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.816 0.341 . . . . 0.33 110.17 178.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 251' ' ' PHE . . . . . 0.428 ' CD2' HD11 ' B' ' 27' ' ' LEU . 13.2 t80 -69.71 -40.33 76.35 Favored 'General case' 0 C--O 1.232 0.142 0 N-CA-C 108.704 -0.85 . . . . 0.46 108.704 177.924 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -57.76 -37.32 83.41 Favored Glycine 0 C--N 1.336 0.566 0 N-CA-C 110.683 -0.967 . . . . 0.25 110.683 177.444 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 253' ' ' ALA . . . . . 0.448 ' O ' ' HG3' ' A' ' 257' ' ' LYS . . . -68.68 -41.33 79.4 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 120.767 0.318 . . . . 0.31 110.185 177.332 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -63.29 -44.5 94.89 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 116.236 -0.438 . . . . 0.38 110.896 178.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 255' ' ' VAL . . . . . 0.472 HG23 HD21 ' A' ' 271' ' ' LEU . 16.3 m -70.91 -26.34 27.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-O 120.819 0.342 . . . . 0.27 110.472 178.729 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -66.72 -39.25 87.92 Favored 'General case' 0 C--N 1.339 0.12 0 N-CA-C 108.454 -0.943 . . . . 0.29 108.454 177.123 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 257' ' ' LYS . . . . . 0.865 ' HG2' ' HA ' ' A' ' 171' ' ' ALA . 24.2 mtpp -65.16 -36.52 84.47 Favored 'General case' 0 C--O 1.225 -0.199 0 CA-C-N 115.351 -0.84 . . . . 0.74 109.646 177.503 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 63.6 t60 -59.54 -49.03 79.35 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 109.957 -0.386 . . . . 0.43 109.957 177.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.476 HD21 HG22 ' A' ' 218' ' ' ILE . 95.9 mt -68.79 -36.08 77.82 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.038 -0.528 . . . . 0.48 110.453 178.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 5.0 tptp -67.47 -36.57 81.41 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 120.774 0.321 . . . . 0.52 111.048 179.116 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 35.3 t -64.89 -25.86 68.07 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.184 -0.462 . . . . 0.46 111.325 179.566 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 26.8 m -107.78 11.0 9.04 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 CA-C-N 116.424 -0.353 . . . . 0.46 110.968 178.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 58.98 48.23 11.13 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 113.202 0.816 . . . . 1.55 113.202 179.457 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 14.7 mt-30 -114.99 36.28 3.95 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.457 -0.338 . . . . 0.76 111.064 178.576 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 265' ' ' GLU . . . . . 0.546 ' HA ' HD12 ' A' ' 268' ' ' ILE . 1.8 pm0 -52.62 -29.21 24.81 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 112.407 0.521 . . . . 0.48 112.407 179.412 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 9.3 p -59.96 -20.19 56.23 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 120.725 0.298 . . . . 0.5 111.049 178.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 267' ' ' PHE . . . . . 0.446 ' C ' ' HD2' ' A' ' 270' ' ' PRO . 41.7 m-85 -98.01 -18.87 18.36 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 121.109 0.48 . . . . 0.53 110.181 178.425 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 268' ' ' ILE . . . . . 0.546 HD12 ' HA ' ' A' ' 265' ' ' GLU . 72.4 mt -68.58 -39.57 80.67 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 CA-C-N 115.849 -0.614 . . . . 0.41 110.4 178.651 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 269' ' ' GLU . . . . . 0.685 ' HB2' ' HD3' ' A' ' 270' ' ' PRO . 1.5 mm-40 -56.38 -56.94 26.39 Favored Pre-proline 0 CA--C 1.543 0.686 0 CA-C-N 116.287 -0.415 . . . . 0.49 111.036 179.27 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 270' ' ' PRO . . . . . 0.685 ' HD3' ' HB2' ' A' ' 269' ' ' GLU . 34.7 Cg_exo -61.68 -34.89 82.91 Favored 'Trans proline' 0 C--N 1.361 1.233 0 C-N-CA 121.954 1.769 . . . . 0.32 111.435 177.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 271' ' ' LEU . . . . . 0.472 HD21 HG23 ' A' ' 255' ' ' VAL . 26.8 tp -62.61 -51.07 68.75 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.182 -0.463 . . . . 0.45 110.251 178.487 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -59.09 -41.12 87.3 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 116.104 -0.498 . . . . 0.34 110.12 178.663 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 273' ' ' GLU . . . . . . . . . . . . . 62.2 mm-40 -63.34 -45.48 91.01 Favored 'General case' 0 C--O 1.225 -0.189 0 CA-C-N 115.761 -0.654 . . . . 1.05 109.831 177.762 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 274' ' ' THR . . . . . . . . . . . . . 87.5 m -62.2 -44.02 97.51 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.917 -0.583 . . . . 0.34 111.179 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 275' ' ' ILE . . . . . 0.474 ' HA ' ' HE3' ' A' ' 231' ' ' MET . 94.4 mt -58.66 -50.48 78.98 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 CA-C-O 120.984 0.421 . . . . 0.39 110.286 179.008 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 276' ' ' THR . . . . . 0.539 HG23 HD12 ' A' ' 163' ' ' ILE . 24.1 m -63.12 -46.17 88.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.041 -0.527 . . . . 0.3 110.669 178.845 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 277' ' ' ASP . . . . . 0.429 ' CG ' HH12 ' A' ' 281' ' ' ARG . 36.1 t70 -51.69 -60.72 2.84 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.309 -0.86 . . . . 0.35 112.442 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 21.8 t -66.35 -37.25 79.25 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 N-CA-C 113.058 0.762 . . . . 0.36 113.058 -178.345 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 32.5 tp -70.67 -48.47 54.66 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 112.855 0.687 . . . . 0.72 112.855 -178.556 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 58.2 t -70.73 -34.82 58.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 N-CA-C 112.595 0.591 . . . . 0.32 112.595 -178.421 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 281' ' ' ARG . . . . . 0.496 ' HB2' ' OH ' ' A' ' 156' ' ' TYR . 21.9 ttp-105 -72.79 -51.39 19.21 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.407 0.521 . . . . 0.38 112.407 -179.684 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 282' ' ' THR . . . . . . . . . . . . . 10.1 m -60.6 -35.34 75.89 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 112.168 0.432 . . . . 0.49 112.168 -178.89 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 64.9 mmtt -115.96 38.78 3.23 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 122.225 -0.297 . . . . 0.53 111.611 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 284' ' ' ARG . . . . . 0.522 ' HG3' ' H ' ' A' ' 285' ' ' ASP . 0.2 OUTLIER -62.13 -54.01 47.28 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 112.812 0.671 . . . . 0.39 112.812 -179.066 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 285' ' ' ASP . . . . . 0.522 ' H ' ' HG3' ' A' ' 284' ' ' ARG . 0.2 OUTLIER -60.27 -39.44 86.85 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 112.128 0.418 . . . . 0.52 112.128 -178.855 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 286' ' ' TRP . . . . . 0.47 ' O ' ' HB2' ' A' ' 290' ' ' GLN . 12.4 t90 -67.14 -41.58 85.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.808 0.337 . . . . 0.48 110.921 179.61 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 287' ' ' LEU . . . . . 0.519 ' HB3' HD21 ' A' ' 155' ' ' LEU . 2.0 mm? -70.6 -48.4 55.36 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.298 -0.41 . . . . 0.44 112.078 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 288' ' ' VAL . . . . . 0.41 HG22 ' O ' ' A' ' 284' ' ' ARG . 26.9 m -59.88 -37.84 73.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 N-CA-C 111.901 0.334 . . . . 0.33 111.901 -179.678 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 54.1 mttp -75.52 -23.95 56.74 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-O 120.789 0.328 . . . . 0.59 111.274 179.081 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 290' ' ' GLN . . . . . 0.47 ' HB2' ' O ' ' A' ' 286' ' ' TRP . 5.1 tp60 -91.06 17.58 7.84 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.604 -0.271 . . . . 0.66 111.659 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 36.0 mtp180 64.69 15.38 9.71 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 112.025 0.38 . . . . 0.47 112.025 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 63.71 -132.47 40.81 Favored Glycine 0 CA--C 1.523 0.593 0 CA-C-O 121.462 0.479 . . . . 0.38 114.01 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 293' ' ' TRP . . . . . 0.61 ' O ' HG23 ' A' ' 297' ' ' VAL . 77.4 m95 -67.05 -25.18 66.13 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.019 0.377 . . . . 0.43 112.019 -178.892 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 294' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -56.73 -48.38 77.89 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 109.852 -0.425 . . . . 0.78 109.852 178.324 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -68.7 -38.85 86.28 Favored Glycine 0 C--N 1.336 0.574 0 N-CA-C 111.24 -0.744 . . . . 0.37 111.24 178.045 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 296' ' ' PHE . . . . . 0.547 ' HB3' ' HA ' ' A' ' 293' ' ' TRP . 0.9 OUTLIER -57.74 -45.63 85.59 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 120.769 0.318 . . . . 0.4 111.064 178.498 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 297' ' ' VAL . . . . . 0.649 HG21 ' HB3' ' A' ' 189' ' ' ARG . 78.3 t -65.8 -40.41 87.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-N 116.015 -0.539 . . . . 0.39 111.269 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -66.53 -48.26 70.3 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.207 -0.451 . . . . 0.58 111.476 179.125 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 299' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -62.26 -51.08 69.18 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.053 0.454 . . . . 0.49 110.843 179.566 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 300' ' ' PHE . . . . . 0.658 ' CZ ' ' HB3' ' A' ' 242' ' ' TRP . 49.6 m-85 . . . . . 0 C--N 1.328 -0.352 0 CA-C-N 116.091 -0.504 . . . . 0.57 112.316 -179.667 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 22' ' ' GLU . . . . . 0.494 ' O ' ' HB2' ' B' ' 26' ' ' GLN . 1.8 mt-10 . . . . . 0 CA--C 1.529 0.14 0 N-CA-C 112.224 0.453 . . . . 1.02 112.224 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 23' ' ' PHE . . . . . 0.5 ' HD1' ' N ' ' B' ' 24' ' ' ALA . 0.1 OUTLIER -55.74 -32.17 63.17 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 112.843 0.683 . . . . 0.36 112.843 -178.924 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 24' ' ' ALA . . . . . 0.674 ' O ' ' HB2' ' B' ' 28' ' ' ARG . . . -69.95 -51.59 31.47 Favored 'General case' 0 C--N 1.322 -0.593 0 O-C-N 122.023 -0.423 . . . . 0.29 111.713 -179.019 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -74.1 -41.41 61.7 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.108 0.41 . . . . 0.33 112.108 -179.444 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 26' ' ' GLN . . . . . 0.494 ' HB2' ' O ' ' B' ' 22' ' ' GLU . 1.1 tp-100 -62.04 -54.92 34.75 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.326 -0.397 . . . . 0.39 111.297 -179.396 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 27' ' ' LEU . . . . . 0.428 HD11 ' CD2' ' A' ' 251' ' ' PHE . 70.2 mt -63.47 -37.56 87.75 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.96 -0.296 . . . . 0.35 110.58 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 28' ' ' ARG . . . . . 0.674 ' HB2' ' O ' ' B' ' 24' ' ' ALA . 0.0 OUTLIER -57.88 -57.38 13.06 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 120.694 0.283 . . . . 0.41 111.437 179.292 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 18.8 mmmt -66.48 -35.08 79.37 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.425 -0.352 . . . . 0.48 111.563 -179.535 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 30' ' ' ILE . . . . . 0.436 HG23 ' CD2' ' A' ' 205' ' ' HIS . 43.4 mt -64.15 -42.76 96.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 N-CA-C 108.946 -0.761 . . . . 0.39 108.946 177.514 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -58.88 -49.44 78.02 Favored Glycine 0 C--N 1.334 0.449 0 CA-C-N 115.961 -0.563 . . . . 0.29 112.42 178.866 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -55.55 -44.91 77.24 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 121.16 0.505 . . . . 0.42 110.759 178.673 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 2.2 ttmp? -65.87 -52.34 51.08 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 115.654 -0.703 . . . . 1.12 111.098 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 40.4 t -56.33 -45.37 81.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-O 121.135 0.493 . . . . 0.46 110.741 178.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 35' ' ' TYR . . . . . 0.463 ' HB2' ' H ' ' A' ' 243' ' ' GLY . 3.4 t80 -56.69 -49.66 74.44 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 115.597 -0.729 . . . . 1.01 110.447 178.604 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 36' ' ' CYS . . . . . . . . . . . . . 5.9 t -66.13 -34.21 77.54 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 120.825 0.345 . . . . 0.67 111.027 179.08 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 52.2 m -62.85 -51.79 65.65 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 112.364 0.505 . . . . 0.62 112.364 -179.638 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 38' ' ' TRP . . . . . . . . . . . . . 96.7 m95 -73.65 -30.38 62.9 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.345 0.498 . . . . 0.88 112.345 -179.0 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 23.0 t . . . . . 0 N--CA 1.467 0.407 0 N-CA-C 111.801 0.297 . . . . 0.79 111.801 -179.913 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 . . . . . 0 N--CA 1.466 0.343 0 CA-C-O 120.83 0.348 . . . . 0.59 111.278 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -57.92 -44.99 87.21 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.056 -0.52 . . . . 0.44 110.685 178.428 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 35.0 tp -76.94 -29.3 55.56 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-O 121.323 0.582 . . . . 0.55 109.955 178.456 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 87.8 t80 -63.89 -30.79 71.84 Favored 'General case' 0 C--O 1.223 -0.338 0 CA-C-N 115.666 -0.697 . . . . 0.35 110.369 178.503 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' ARG . . . . . 0.457 HH11 ' HD3' ' A' ' 157' ' ' ARG . 45.0 mtt180 -60.72 -51.91 67.36 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.028 0.442 . . . . 0.72 110.261 178.431 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 32.1 mt-30 -59.66 -43.99 93.73 Favored 'General case' 0 N--CA 1.46 0.071 0 CA-C-N 115.701 -0.681 . . . . 1.13 109.515 178.35 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' SER . . . . . 0.572 ' HA ' ' CZ2' ' A' ' 293' ' ' TRP . 18.5 m -60.38 -58.67 7.49 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.191 -0.913 . . . . 0.26 111.531 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.543 HD21 ' HG3' ' A' ' 273' ' ' GLU . 1.4 tm? -53.98 -49.67 68.28 Favored 'General case' 0 CA--C 1.529 0.139 0 O-C-N 123.203 0.315 . . . . 0.4 110.93 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -60.06 -53.55 56.42 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 116.488 -0.324 . . . . 0.39 111.836 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' ILE . . . . . 0.481 HD11 ' HA2' ' A' ' 187' ' ' GLY . 89.7 mt -61.82 -48.75 87.17 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 N-CA-C 112.567 0.58 . . . . 0.33 112.567 -178.884 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.581 HD12 HG23 ' A' ' 276' ' ' THR . 80.8 mt -63.93 -52.33 58.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 N-CA-C 112.154 0.427 . . . . 0.34 112.154 -179.038 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.87 -39.78 72.01 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 120.916 0.388 . . . . 0.32 110.534 179.617 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 165' ' ' ARG . . . . . 0.53 ' HD2' ' OE2' ' A' ' 169' ' ' GLU . 0.6 OUTLIER -65.77 -52.07 53.92 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.408 -0.36 . . . . 0.45 110.537 178.457 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 166' ' ' TYR . . . . . 0.828 ' HE1' ' HA ' ' A' ' 195' ' ' ARG . 81.4 t80 -55.56 -47.24 76.7 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 112.447 0.536 . . . . 0.35 112.447 -179.48 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.55 ' HG ' ' O ' ' A' ' 163' ' ' ILE . 28.0 mt -64.03 -39.1 93.34 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 120.88 -0.328 . . . . 0.36 110.641 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -66.45 -38.45 87.4 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.958 0.408 . . . . 0.38 110.301 178.297 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 169' ' ' GLU . . . . . 0.53 ' OE2' ' HD2' ' A' ' 165' ' ' ARG . 0.4 OUTLIER -70.26 -38.35 75.1 Favored 'General case' 0 CA--C 1.528 0.111 0 CA-C-N 116.08 -0.509 . . . . 0.62 110.767 178.58 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 170' ' ' GLN . . . . . 0.704 ' HG2' ' HB1' ' A' ' 253' ' ' ALA . 6.1 tp60 -68.53 -42.13 78.9 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 116.37 -0.377 . . . . 0.37 110.249 178.455 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.805 ' HA ' ' HG2' ' A' ' 257' ' ' LYS . . . . . . . . 0 N--CA 1.467 0.402 0 CA-C-N 115.807 -0.633 . . . . 0.46 111.977 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.565 ' O ' ' HA3' ' A' ' 187' ' ' GLY . . . . . . . . 0 CA--C 1.535 0.398 0 CA-C-O 120.86 0.362 . . . . 0.34 110.406 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -79.93 -71.5 1.26 Allowed Glycine 0 CA--C 1.528 0.886 0 C-N-CA 120.833 -0.699 . . . . 0.42 114.755 -179.051 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -70.79 -55.83 7.71 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 117.203 0.501 . . . . 0.49 111.646 -178.806 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -65.59 -35.24 80.25 Favored 'General case' 0 C--O 1.222 -0.342 0 CA-C-N 115.979 -0.555 . . . . 0.47 110.111 178.772 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 187' ' ' GLY . . . . . 0.565 ' HA3' ' O ' ' A' ' 183' ' ' ALA . . . -66.93 -49.9 51.02 Favored Glycine 0 C--O 1.225 -0.454 0 CA-C-N 115.762 -0.653 . . . . 0.36 112.845 179.237 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 4.2 tpt180 -55.26 -46.9 76.09 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 117.174 0.487 . . . . 0.85 110.113 178.718 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 189' ' ' ARG . . . . . 0.658 ' HB3' HG11 ' A' ' 297' ' ' VAL . 50.7 mtm180 -66.9 -40.24 87.68 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.92 -0.582 . . . . 0.32 110.616 179.275 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 190' ' ' ALA . . . . . 0.406 ' O ' ' HB2' ' A' ' 194' ' ' LEU . . . -65.27 -40.43 93.89 Favored 'General case' 0 C--O 1.223 -0.338 0 CA-C-N 116.334 -0.394 . . . . 0.29 111.511 179.669 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 13.6 tp -64.58 -41.0 96.55 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 110.247 -0.279 . . . . 0.7 110.247 178.837 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 15.8 tm-20 -65.68 -50.63 64.22 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 109.732 -0.47 . . . . 0.32 109.732 178.497 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 193' ' ' THR . . . . . 0.436 HG21 ' HA ' ' A' ' 297' ' ' VAL . 8.5 m -60.05 -43.22 95.54 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.905 -0.589 . . . . 0.38 110.974 179.46 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 194' ' ' LEU . . . . . 0.449 HD12 ' HA ' ' A' ' 194' ' ' LEU . 7.4 tp -65.59 -41.92 92.27 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 116.233 -0.44 . . . . 0.42 111.829 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 195' ' ' ARG . . . . . 0.828 ' HA ' ' HE1' ' A' ' 166' ' ' TYR . 8.8 tpt180 -67.35 -38.71 85.24 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.093 0.473 . . . . 0.42 110.538 179.322 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 15.2 ttm180 -67.01 -56.71 8.95 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 115.78 -0.645 . . . . 0.52 111.999 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 34.7 t -71.56 -38.59 68.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 111.95 0.352 . . . . 0.33 111.95 -178.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 198' ' ' GLY . . . . . 0.64 ' O ' ' HB2' ' A' ' 202' ' ' GLN . . . -62.02 -54.04 38.12 Favored Glycine 0 C--N 1.331 0.275 0 C-N-CA 121.052 -0.595 . . . . 0.29 112.793 -179.576 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 199' ' ' ASP . . . . . 0.401 ' HB2' ' O ' ' A' ' 195' ' ' ARG . 0.4 OUTLIER -64.81 -38.8 92.2 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 117.045 0.422 . . . . 0.37 110.675 179.211 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -59.86 -48.63 85.13 Favored Glycine 0 CA--C 1.524 0.626 0 C-N-CA 120.744 -0.741 . . . . 0.33 112.137 178.78 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 73.7 t -70.46 -42.29 78.34 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-O 120.862 0.363 . . . . 0.37 110.816 178.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 202' ' ' GLN . . . . . 0.64 ' HB2' ' O ' ' A' ' 198' ' ' GLY . 2.1 tt0 -58.87 -53.34 59.49 Favored 'General case' 0 C--O 1.224 -0.278 0 CA-C-N 115.652 -0.704 . . . . 0.42 111.807 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 203' ' ' ARG . . . . . 0.511 ' HA ' ' OE1' ' A' ' 206' ' ' GLU . 0.0 OUTLIER -64.4 -35.2 80.12 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-O 120.718 0.294 . . . . 0.4 110.393 179.779 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -65.94 -49.82 66.58 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 121.027 0.441 . . . . 0.86 110.765 178.137 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 72.1 m-70 -100.75 36.09 2.02 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.425 -0.352 . . . . 0.46 111.47 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 206' ' ' GLU . . . . . 0.511 ' OE1' ' HA ' ' A' ' 203' ' ' ARG . 3.7 tp10 -55.53 -49.0 73.79 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.222 -0.444 . . . . 0.4 111.212 -179.543 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 69.4 p -62.98 -42.8 99.94 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.983 -0.553 . . . . 0.5 111.52 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -61.8 -46.11 90.95 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.018 0.437 . . . . 0.41 110.306 178.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 209' ' ' PHE . . . . . 0.605 ' HE2' ' HA ' ' A' ' 202' ' ' GLN . 16.8 m-30 -65.43 -44.11 88.35 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.98 -0.555 . . . . 0.45 110.06 179.331 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -61.23 -44.08 97.84 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.091 -0.504 . . . . 0.8 110.594 178.759 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -60.07 -48.58 85.43 Favored Glycine 0 C--N 1.334 0.444 0 N-CA-C 111.205 -0.758 . . . . 0.34 111.205 178.323 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 212' ' ' MET . . . . . 0.533 ' O ' ' HG ' ' A' ' 216' ' ' LEU . 1.2 mtp -64.31 -35.03 79.53 Favored 'General case' 0 C--O 1.224 -0.253 0 CA-C-O 120.655 0.264 . . . . 0.72 110.312 178.407 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.445 HD22 ' HA ' ' A' ' 213' ' ' LEU . 0.4 OUTLIER -60.61 -47.99 83.75 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.239 -0.437 . . . . 0.51 110.004 178.473 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 73.0 mtp180 -61.97 -31.71 72.09 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.122 -0.49 . . . . 1.14 111.016 179.125 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -84.95 -9.09 58.43 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.12 -0.491 . . . . 1.23 111.682 179.445 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 216' ' ' LEU . . . . . 0.533 ' HG ' ' O ' ' A' ' 212' ' ' MET . 20.3 mt -82.41 142.89 31.59 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.155 0.502 . . . . 0.52 112.295 -179.531 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -102.07 5.74 40.66 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.846 -0.616 . . . . 0.66 110.212 178.403 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 218' ' ' ILE . . . . . 0.62 HG22 ' HE2' ' A' ' 267' ' ' PHE . 21.0 mm -55.33 106.93 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 CA-C-N 115.9 -0.591 . . . . 0.49 112.319 -178.826 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 6.1 mtmp? -143.48 -42.19 0.29 Allowed 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 112.373 0.509 . . . . 0.67 112.373 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 18.2 m-80 -124.1 -178.91 4.22 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 113.085 0.772 . . . . 1.24 113.085 -178.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 221' ' ' GLU . . . . . 0.576 ' O ' HG22 ' A' ' 224' ' ' VAL . 12.2 tm-20 -51.92 -37.61 53.24 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 112.867 0.691 . . . . 0.76 112.867 -179.184 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -63.83 -26.47 70.06 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 120.816 -0.707 . . . . 0.35 113.622 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 223' ' ' ASP . . . . . 0.556 ' HB3' ' HA ' ' A' ' 218' ' ' ILE . 59.0 m-20 -72.34 -31.12 65.35 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 113.322 0.86 . . . . 0.44 113.322 -178.584 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.576 HG22 ' O ' ' A' ' 221' ' ' GLU . 4.8 m -55.87 -29.1 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 CA-C-O 120.833 0.349 . . . . 0.45 111.469 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 10.7 mttp -66.0 -38.71 89.16 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.152 0.501 . . . . 0.84 109.908 178.739 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 226' ' ' SER . . . . . 0.492 ' O ' HG23 ' A' ' 230' ' ' VAL . 1.8 t -68.74 -30.67 69.34 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 109.113 -0.699 . . . . 0.46 109.113 178.183 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 227' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -66.5 -36.67 83.3 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 109.004 -0.739 . . . . 0.6 109.004 178.075 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 7.1 t -62.03 -39.72 93.29 Favored 'General case' 0 N--CA 1.462 0.147 0 N-CA-C 108.992 -0.744 . . . . 0.37 108.992 176.802 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 229' ' ' ARG . . . . . 0.476 ' HA ' HG22 ' A' ' 232' ' ' VAL . 0.0 OUTLIER -61.07 -36.88 80.8 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-N 115.617 -0.719 . . . . 0.39 109.934 177.873 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 230' ' ' VAL . . . . . 0.564 HG22 ' CE1' ' B' ' 23' ' ' PHE . 29.4 t -65.99 -48.14 82.76 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-O 121.316 0.579 . . . . 0.34 109.439 177.824 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 231' ' ' MET . . . . . 0.525 ' SD ' HD13 ' A' ' 248' ' ' LEU . 8.1 tpp -60.34 -49.47 77.45 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 115.198 -0.91 . . . . 0.46 111.508 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 232' ' ' VAL . . . . . 0.476 HG22 ' HA ' ' A' ' 229' ' ' ARG . 33.3 m -64.66 -32.05 56.29 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 120.745 -0.382 . . . . 0.44 111.866 -179.741 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 7.3 t-80 -72.38 -47.02 52.7 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 120.899 -0.32 . . . . 0.38 110.843 178.805 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 70.2 t -62.32 -31.28 51.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-O 120.911 0.386 . . . . 0.44 111.571 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -97.3 4.34 50.89 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 122.224 -0.298 . . . . 0.49 111.749 179.092 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 236' ' ' LYS . . . . . 0.463 ' HB2' ' O ' ' A' ' 232' ' ' VAL . 0.3 OUTLIER -73.87 -17.83 61.0 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 112.286 0.476 . . . . 1.58 112.286 -178.989 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -70.12 -11.33 60.81 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.924 0.392 . . . . 0.43 111.244 179.534 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 91.1 -19.31 47.15 Favored Glycine 0 CA--C 1.519 0.33 0 C-N-CA 121.087 -0.578 . . . . 0.37 112.554 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -95.69 92.71 3.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.117 0.484 . . . . 0.47 112.109 -179.682 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 240' ' ' THR . . . . . 0.521 HG22 HD11 ' A' ' 245' ' ' ILE . 2.4 m -79.03 62.61 3.49 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.487 0.66 . . . . 0.36 110.347 178.505 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 73.2 m-20 -65.42 137.77 57.68 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.441 -0.8 . . . . 0.34 111.705 -179.059 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 242' ' ' TRP . . . . . . . . . . . . . 78.7 m95 -54.73 -38.6 67.31 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.154 -0.475 . . . . 0.41 111.188 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 243' ' ' GLY . . . . . 0.481 ' H ' ' HB2' ' B' ' 35' ' ' TYR . . . -58.61 -32.44 69.2 Favored Glycine 0 CA--C 1.521 0.419 0 C-N-CA 120.902 -0.666 . . . . 0.29 111.919 178.143 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 78.8 mtt180 -75.44 -41.95 54.58 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-O 120.943 0.401 . . . . 0.3 109.933 178.679 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 245' ' ' ILE . . . . . 0.563 ' O ' HG12 ' A' ' 249' ' ' ILE . 78.3 mt -62.14 -49.32 84.52 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-N 115.819 -0.628 . . . . 0.48 110.561 179.142 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 246' ' ' VAL . . . . . 0.424 HG21 ' CE2' ' A' ' 300' ' ' PHE . 48.0 t -67.48 -38.46 80.7 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 CA-C-N 116.347 -0.388 . . . . 0.36 111.047 179.317 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 19.4 m -62.2 -40.1 94.96 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 120.909 -0.316 . . . . 0.39 110.247 178.817 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 248' ' ' LEU . . . . . 0.525 HD13 ' SD ' ' A' ' 231' ' ' MET . 44.7 mt -65.24 -35.27 80.54 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 109.776 -0.453 . . . . 0.61 109.776 177.846 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 249' ' ' ILE . . . . . 0.563 HG12 ' O ' ' A' ' 245' ' ' ILE . 36.7 mm -69.41 -40.35 79.85 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 N-CA-C 109.084 -0.71 . . . . 0.43 109.084 177.442 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 14.7 m -61.67 -48.38 81.07 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.242 -0.89 . . . . 0.32 109.923 178.688 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 251' ' ' PHE . . . . . 0.542 ' O ' HG23 ' A' ' 255' ' ' VAL . 12.8 t80 -63.45 -45.06 92.61 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 115.648 -0.705 . . . . 0.59 109.832 178.305 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -57.79 -45.16 93.81 Favored Glycine 0 C--N 1.337 0.594 0 N-CA-C 111.181 -0.768 . . . . 0.26 111.181 178.199 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 253' ' ' ALA . . . . . 0.704 ' HB1' ' HG2' ' A' ' 170' ' ' GLN . . . -59.95 -38.56 82.82 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 122.328 0.251 . . . . 0.26 110.683 177.582 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 61.2 t80 -61.28 -40.42 94.05 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 121.147 0.499 . . . . 0.49 109.776 178.403 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 255' ' ' VAL . . . . . 0.542 HG23 ' O ' ' A' ' 251' ' ' PHE . 20.2 t -67.47 -40.24 84.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 CA-C-N 115.735 -0.666 . . . . 0.29 109.81 178.048 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -58.43 -41.36 84.88 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.115 0.484 . . . . 0.28 110.1 178.345 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 257' ' ' LYS . . . . . 0.805 ' HG2' ' HA ' ' A' ' 171' ' ' ALA . 14.4 mtpp -62.86 -45.22 93.6 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 115.76 -0.655 . . . . 0.57 110.104 177.508 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 82.6 t60 -60.6 -39.77 89.37 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 109.672 -0.492 . . . . 0.51 109.672 178.278 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.482 HD21 ' CD2' ' A' ' 267' ' ' PHE . 4.4 mp -64.26 -50.68 67.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.856 -0.611 . . . . 0.52 110.037 178.528 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 260' ' ' LYS . . . . . 0.713 ' HG3' ' HB1' ' A' ' 171' ' ' ALA . 0.0 OUTLIER -61.57 -29.6 70.12 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.682 -0.236 . . . . 0.6 111.597 179.204 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 56.4 m -57.55 -33.05 67.71 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.041 0.448 . . . . 0.54 111.002 179.097 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 262' ' ' VAL . . . . . 0.531 HG23 ' HG3' ' A' ' 264' ' ' GLN . 26.4 m -112.12 13.63 8.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 CA-C-N 115.787 -0.642 . . . . 0.52 110.079 178.358 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 34.8 t30 58.8 47.24 12.95 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 115.079 -0.964 . . . . 0.55 113.012 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 264' ' ' GLN . . . . . 0.531 ' HG3' HG23 ' A' ' 262' ' ' VAL . 19.9 mt-30 -87.83 39.0 0.86 Allowed 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 116.523 -0.308 . . . . 0.97 111.666 179.007 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 265' ' ' GLU . . . . . 0.419 ' HA ' HD12 ' A' ' 268' ' ' ILE . 7.3 tp10 -49.34 -39.53 32.02 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 121.048 0.451 . . . . 0.45 112.051 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 3.2 p -59.34 -20.33 53.75 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.815 -0.63 . . . . 0.97 111.948 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 267' ' ' PHE . . . . . 0.62 ' HE2' HG22 ' A' ' 218' ' ' ILE . 15.7 t80 -103.57 -21.66 13.72 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 120.8 0.333 . . . . 0.53 111.011 179.38 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 268' ' ' ILE . . . . . 0.419 HD12 ' HA ' ' A' ' 265' ' ' GLU . 63.7 mt -65.39 -43.26 94.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.547 -0.297 . . . . 0.39 110.808 179.663 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 269' ' ' GLU . . . . . 0.642 ' HB3' ' HD3' ' A' ' 270' ' ' PRO . 1.8 tp10 -55.23 -58.13 16.62 Favored Pre-proline 0 CA--C 1.544 0.728 0 CA-C-N 116.332 -0.394 . . . . 0.43 111.01 179.061 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 270' ' ' PRO . . . . . 0.642 ' HD3' ' HB3' ' A' ' 269' ' ' GLU . 26.6 Cg_exo -63.64 -36.55 52.19 Favored 'Trans proline' 0 C--N 1.358 1.036 0 C-N-CA 121.725 1.617 . . . . 0.29 112.655 179.179 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 271' ' ' LEU . . . . . . . . . . . . . 52.6 tp -65.72 -54.81 22.2 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 121.147 -0.221 . . . . 0.5 111.49 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -58.16 -44.58 88.0 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-O 120.861 0.362 . . . . 0.29 111.445 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 273' ' ' GLU . . . . . 0.543 ' HG3' HD21 ' A' ' 160' ' ' LEU . 0.5 OUTLIER -66.51 -39.84 88.9 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 116.246 -0.434 . . . . 0.36 111.4 179.755 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 274' ' ' THR . . . . . 0.483 HG21 ' HB ' ' A' ' 224' ' ' VAL . 62.5 m -64.16 -45.34 88.88 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 120.718 0.294 . . . . 0.39 110.395 179.019 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 96.3 mt -54.12 -52.99 32.11 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 CA-C-N 116.093 -0.503 . . . . 0.42 110.622 179.147 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 276' ' ' THR . . . . . 0.581 HG23 HD12 ' A' ' 163' ' ' ILE . 56.8 m -56.38 -52.47 64.49 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.543 -0.298 . . . . 0.28 111.781 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 277' ' ' ASP . . . . . 0.59 ' OD1' ' HD2' ' A' ' 281' ' ' ARG . 0.4 OUTLIER -53.8 -51.66 62.77 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 112.127 0.418 . . . . 0.43 112.127 -179.364 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 27.3 t -70.05 -46.56 72.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 111.887 0.329 . . . . 0.38 111.887 -179.62 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 279' ' ' LEU . . . . . 0.46 HD21 HG23 ' A' ' 245' ' ' ILE . 0.4 OUTLIER -62.67 -41.24 98.98 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 113.14 0.792 . . . . 0.54 113.14 -178.757 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 280' ' ' VAL . . . . . 0.424 HG21 ' HB3' ' A' ' 159' ' ' SER . 81.4 t -87.21 -46.22 16.2 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 N-CA-C 113.768 1.025 . . . . 0.48 113.768 -178.266 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 281' ' ' ARG . . . . . 0.59 ' HD2' ' OD1' ' A' ' 277' ' ' ASP . 38.1 mtt85 -70.96 -34.9 71.89 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 114.425 1.269 . . . . 0.53 114.425 -177.122 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 282' ' ' THR . . . . . . . . . . . . . 42.0 p -61.5 -30.71 70.8 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 119.073 0.851 . . . . 0.35 111.513 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 29.9 mmtp -125.06 41.21 3.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.321 -0.399 . . . . 0.36 111.001 179.382 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 284' ' ' ARG . . . . . 0.524 ' HG2' ' N ' ' A' ' 285' ' ' ASP . 0.0 OUTLIER -53.34 -35.6 60.39 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 112.866 0.691 . . . . 0.44 112.866 -179.319 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 285' ' ' ASP . . . . . 0.524 ' N ' ' HG2' ' A' ' 284' ' ' ARG . 8.1 p-10 -63.04 -44.41 95.94 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-O 120.634 0.254 . . . . 0.46 111.254 -179.363 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 286' ' ' TRP . . . . . 0.777 ' HA ' ' HD2' ' A' ' 289' ' ' LYS . 0.0 OUTLIER -61.5 -34.68 75.91 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.163 0.506 . . . . 0.4 110.477 179.404 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 287' ' ' LEU . . . . . 0.588 HD13 ' HA2' ' A' ' 292' ' ' GLY . 1.7 mm? -70.13 -47.01 63.55 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.566 -0.743 . . . . 0.54 110.482 179.194 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 288' ' ' VAL . . . . . 0.509 HG23 ' O ' ' A' ' 284' ' ' ARG . 64.3 t -60.67 -33.07 53.42 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 CA-C-O 120.898 0.38 . . . . 0.92 110.858 178.939 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 289' ' ' LYS . . . . . 0.777 ' HD2' ' HA ' ' A' ' 286' ' ' TRP . 74.3 mttt -60.45 -42.17 95.61 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.01 -0.541 . . . . 0.47 112.213 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 290' ' ' GLN . . . . . 0.534 ' HB3' ' HA3' ' A' ' 295' ' ' GLY . 5.1 mt-30 -111.86 28.29 8.89 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 112.869 0.692 . . . . 0.45 112.869 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 291' ' ' ARG . . . . . 0.489 ' HB3' ' HB2' ' A' ' 294' ' ' ASP . 3.8 mmm180 59.09 13.91 3.18 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 112.768 0.655 . . . . 0.55 112.768 179.545 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 292' ' ' GLY . . . . . 0.588 ' HA2' HD13 ' A' ' 287' ' ' LEU . . . 75.06 -108.2 2.47 Favored Glycine 0 N--CA 1.448 -0.502 0 N-CA-C 114.361 0.504 . . . . 0.35 114.361 179.448 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 293' ' ' TRP . . . . . 0.572 ' CZ2' ' HA ' ' A' ' 159' ' ' SER . 80.5 m95 -68.42 -29.27 67.9 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.62 0.6 . . . . 0.51 112.62 -177.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 294' ' ' ASP . . . . . 0.489 ' HB2' ' HB3' ' A' ' 291' ' ' ARG . 22.0 m-20 -62.11 -44.99 95.44 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 120.57 -0.452 . . . . 0.38 109.949 178.489 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 295' ' ' GLY . . . . . 0.534 ' HA3' ' HB3' ' A' ' 290' ' ' GLN . . . -69.07 -33.85 75.04 Favored Glycine 0 C--O 1.224 -0.524 0 C-N-CA 120.809 -0.71 . . . . 0.35 111.695 178.076 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 296' ' ' PHE . . . . . 0.405 ' CD2' ' HE3' ' A' ' 293' ' ' TRP . 0.5 OUTLIER -70.51 -45.11 66.22 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 120.655 0.264 . . . . 0.35 111.232 179.111 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 297' ' ' VAL . . . . . 0.658 HG11 ' HB3' ' A' ' 189' ' ' ARG . 69.3 t -63.81 -50.65 76.77 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.117 0 CA-C-O 120.689 0.281 . . . . 0.29 110.75 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.34 -22.87 64.66 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 116.188 -0.46 . . . . 0.43 111.745 -179.605 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 299' ' ' PHE . . . . . 0.412 ' HB2' ' O ' ' A' ' 295' ' ' GLY . 88.2 t80 -71.54 -36.04 70.87 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-O 120.764 0.316 . . . . 0.46 110.854 178.319 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 300' ' ' PHE . . . . . 0.424 ' CE2' HG21 ' A' ' 246' ' ' VAL . 79.3 m-85 . . . . . 0 C--N 1.328 -0.349 0 CA-C-O 120.79 0.329 . . . . 0.53 111.832 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 . . . . . 0 C--O 1.234 0.284 0 CA-C-O 121.039 0.447 . . . . 0.89 110.172 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 23' ' ' PHE . . . . . 0.564 ' CE1' HG22 ' A' ' 230' ' ' VAL . 0.7 OUTLIER -57.34 -37.79 73.11 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 115.706 -0.679 . . . . 0.38 111.394 179.377 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 24' ' ' ALA . . . . . 0.518 ' N ' ' HD1' ' B' ' 23' ' ' PHE . . . -65.57 -40.25 92.56 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.121 -0.491 . . . . 0.4 111.655 -179.151 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 25' ' ' ALA . . . . . 0.513 ' O ' ' HG3' ' B' ' 29' ' ' LYS . . . -66.15 -46.85 76.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.996 0.427 . . . . 0.4 110.218 179.175 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -62.32 -51.57 67.11 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 115.827 -0.624 . . . . 0.61 110.68 179.129 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 51.3 mt -57.65 -41.72 82.03 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.755 0.312 . . . . 0.59 110.339 178.654 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 28' ' ' ARG . . . . . . . . . . . . . 1.2 ttm180 -58.86 -50.81 72.58 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.164 -0.471 . . . . 0.75 110.434 178.133 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 29' ' ' LYS . . . . . 0.513 ' HG3' ' O ' ' B' ' 25' ' ' ALA . 85.3 mttt -57.82 -51.39 69.78 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.039 -0.528 . . . . 0.65 110.798 178.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 78.9 mt -58.87 -45.45 91.69 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 CA-C-N 115.878 -0.601 . . . . 0.42 110.983 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -58.67 -50.52 66.37 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.897 -0.668 . . . . 0.28 113.009 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 -68.17 -37.21 80.73 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.966 0.383 . . . . 0.37 111.527 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 21.8 ttmm -62.42 -50.5 71.27 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 120.912 0.387 . . . . 0.81 110.328 178.586 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 49.1 t -63.19 -47.43 92.35 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 116.097 -0.501 . . . . 0.41 110.593 178.832 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 35' ' ' TYR . . . . . 0.481 ' HB2' ' H ' ' A' ' 243' ' ' GLY . 1.6 t80 -58.04 -50.82 72.1 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 115.777 -0.647 . . . . 0.98 111.508 179.44 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 36' ' ' CYS . . . . . . . . . . . . . 13.0 t -63.14 -28.43 70.06 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 120.804 0.335 . . . . 0.48 111.839 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 89.1 m -77.64 -45.91 23.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.425 -0.352 . . . . 0.44 111.87 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 38' ' ' TRP . . . . . . . . . . . . . 97.1 m95 -80.12 -19.7 46.71 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 112.95 0.722 . . . . 0.54 112.95 -178.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 40.0 t . . . . . 0 N--CA 1.472 0.647 0 N-CA-C 112.268 0.47 . . . . 0.43 112.268 179.545 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 12.0 t0 . . . . . 0 CA--C 1.535 0.366 0 N-CA-C 112.478 0.548 . . . . 0.37 112.478 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -55.15 -56.48 19.43 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 120.95 0.405 . . . . 0.78 111.369 -179.608 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.22 -37.08 77.84 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.028 0.442 . . . . 0.73 110.534 179.567 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 13.6 t80 -61.62 -40.71 95.83 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 115.906 -0.588 . . . . 0.41 111.697 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' ARG . . . . . 0.401 HH11 ' HD3' ' A' ' 157' ' ' ARG . 55.0 mtt-85 -65.32 -48.3 73.53 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 111.834 0.309 . . . . 0.49 111.834 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 2.7 mm-40 -62.07 -42.48 99.24 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.203 0.525 . . . . 0.39 110.303 179.492 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' SER . . . . . 0.469 ' HA ' ' CZ2' ' A' ' 293' ' ' TRP . 12.3 m -66.19 -54.69 22.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.756 -0.657 . . . . 0.25 111.218 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.614 ' HA ' HG21 ' A' ' 276' ' ' THR . 2.0 tm? -54.11 -46.38 72.13 Favored 'General case' 0 N--CA 1.464 0.248 0 O-C-N 123.183 0.302 . . . . 0.73 111.08 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -63.57 -54.38 37.03 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 112.067 0.395 . . . . 0.4 112.067 -179.584 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' ILE . . . . . 0.478 HD11 ' HA2' ' A' ' 187' ' ' GLY . 88.1 mt -59.33 -46.68 92.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 N-CA-C 111.589 0.218 . . . . 0.33 111.589 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.57 HD12 HG23 ' A' ' 276' ' ' THR . 84.2 mt -62.84 -51.23 74.62 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 C-N-CA 121.085 -0.246 . . . . 0.32 111.462 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 55.2 p -58.78 -42.29 88.65 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.586 0.231 . . . . 0.29 111.302 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' ARG . . . . . 0.432 ' O ' ' HB2' ' A' ' 169' ' ' GLU . 2.0 tpt85 -58.02 -51.64 68.81 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.855 0.359 . . . . 0.35 110.806 179.374 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 166' ' ' TYR . . . . . 0.475 ' O ' ' HB2' ' A' ' 170' ' ' GLN . 66.7 t80 -64.04 -49.37 72.62 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.937 -0.574 . . . . 0.37 112.065 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.517 ' HG ' ' O ' ' A' ' 163' ' ' ILE . 21.4 mt -56.17 -45.96 79.53 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 112.024 0.379 . . . . 0.32 112.024 -178.612 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 168' ' ' ARG . . . . . 0.41 HH11 ' HD2' ' A' ' 168' ' ' ARG . 11.8 ttm105 -70.18 -44.59 68.43 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.57 0.224 . . . . 0.34 111.133 179.431 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 169' ' ' GLU . . . . . 0.432 ' HB2' ' O ' ' A' ' 165' ' ' ARG . 1.9 tt0 -61.52 -36.08 79.53 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-O 121.32 0.581 . . . . 0.46 110.564 179.347 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 170' ' ' GLN . . . . . 0.475 ' HB2' ' O ' ' A' ' 166' ' ' TYR . 1.8 tm0? -71.98 -47.8 49.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.76 -0.654 . . . . 0.4 110.246 178.434 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.292 0 CA-C-N 116.094 -0.503 . . . . 0.36 112.103 179.743 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.531 ' O ' ' HA3' ' A' ' 187' ' ' GLY . . . . . . . . 0 CA--C 1.537 0.452 0 CA-C-O 120.784 0.326 . . . . 0.31 110.349 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -77.33 -71.47 1.2 Allowed Glycine 0 CA--C 1.525 0.688 0 C-N-CA 120.445 -0.884 . . . . 0.37 114.543 -178.642 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -63.43 -56.19 18.16 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 112.076 0.399 . . . . 0.43 112.076 -178.727 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -66.56 -44.44 82.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.373 -0.376 . . . . 0.36 110.702 179.493 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 187' ' ' GLY . . . . . 0.531 ' HA3' ' O ' ' A' ' 183' ' ' ALA . . . -57.48 -53.49 44.61 Favored Glycine 0 CA--C 1.522 0.507 0 C-N-CA 121.238 -0.506 . . . . 0.33 113.823 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 188' ' ' ARG . . . . . 0.444 HH11 ' HD2' ' A' ' 188' ' ' ARG . 1.6 mmp_? -61.17 -44.48 97.23 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 117.617 0.708 . . . . 0.5 112.245 -179.661 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 189' ' ' ARG . . . . . 0.581 ' HB3' HG11 ' A' ' 297' ' ' VAL . 49.9 mtm180 -66.93 -39.12 87.25 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 120.802 0.334 . . . . 0.43 110.745 179.429 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 190' ' ' ALA . . . . . 0.44 ' HA ' HG22 ' A' ' 297' ' ' VAL . . . -70.58 -34.79 72.57 Favored 'General case' 0 C--O 1.222 -0.349 0 CA-C-N 116.362 -0.381 . . . . 0.27 110.677 178.645 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.53 -45.4 94.34 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.823 -0.171 . . . . 0.61 111.142 179.202 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -66.79 -45.46 78.36 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 121.028 0.442 . . . . 0.35 111.125 179.558 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 1.3 p -65.21 -48.51 73.14 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.288 -0.415 . . . . 0.36 111.7 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 194' ' ' LEU . . . . . 0.483 HD21 HG21 ' A' ' 249' ' ' ILE . 19.1 tp -60.65 -35.49 76.35 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 116.406 -0.361 . . . . 0.36 111.112 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 195' ' ' ARG . . . . . 0.422 ' HA ' ' HE1' ' A' ' 166' ' ' TYR . 5.0 mmt180 -65.05 -44.49 88.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.917 0.389 . . . . 0.34 110.775 178.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.88 -52.43 24.86 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.149 0.426 . . . . 0.34 112.149 -179.43 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 197' ' ' VAL . . . . . 0.482 ' O ' HG23 ' A' ' 201' ' ' VAL . 48.1 t -69.61 -43.39 80.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 N-CA-C 112.572 0.582 . . . . 0.32 112.572 -178.785 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -67.14 -51.68 37.14 Favored Glycine 0 CA--C 1.521 0.409 0 C-N-CA 121.018 -0.611 . . . . 0.23 113.467 -178.864 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -63.87 -35.79 81.79 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 120.804 0.335 . . . . 0.29 110.378 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -59.94 -48.15 87.48 Favored Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 111.119 -0.792 . . . . 0.29 111.119 177.789 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 201' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 197' ' ' VAL . 76.3 t -64.04 -40.93 90.83 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 122.217 0.207 . . . . 0.32 111.331 179.014 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 202' ' ' GLN . . . . . 0.499 ' HA ' ' HE2' ' A' ' 209' ' ' PHE . 31.7 tt0 -60.07 -48.07 83.24 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 116.587 -0.279 . . . . 0.42 111.5 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.33 -39.02 71.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.615 0.245 . . . . 1.44 111.255 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 18.2 m-80 -67.08 -52.22 44.64 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 111.969 0.359 . . . . 1.23 111.969 179.596 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 74.0 m-70 -101.47 34.91 2.43 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 112.427 0.529 . . . . 0.42 112.427 -178.615 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -62.9 -40.12 96.61 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 120.999 -0.28 . . . . 0.44 111.266 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 38.4 p -60.66 -43.11 98.01 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.061 0.458 . . . . 0.55 110.683 179.414 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 208' ' ' ALA . . . . . 0.441 ' O ' ' HG3' ' A' ' 212' ' ' MET . . . -65.99 -41.87 90.55 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.83 -0.623 . . . . 0.37 109.93 178.678 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 209' ' ' PHE . . . . . 0.499 ' HE2' ' HA ' ' A' ' 202' ' ' GLN . 14.4 m-30 -63.0 -42.58 99.88 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.893 -0.594 . . . . 0.45 110.112 178.66 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 210' ' ' GLN . . . . . 0.698 ' O ' ' HG2' ' A' ' 214' ' ' ARG . 31.3 mt-30 -57.79 -46.72 84.21 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.288 -0.414 . . . . 0.64 110.542 178.494 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -55.68 -46.75 81.36 Favored Glycine 0 C--N 1.339 0.711 0 C-N-CA 121.051 -0.595 . . . . 0.33 111.951 178.756 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 212' ' ' MET . . . . . 0.473 ' HB3' ' HB3' ' B' ' 23' ' ' PHE . 35.1 mtt -62.91 -42.68 99.87 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 109.515 -0.55 . . . . 0.7 109.515 177.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 12.7 tp -58.92 -44.53 91.31 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.744 -0.662 . . . . 0.6 111.11 179.055 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 214' ' ' ARG . . . . . 0.698 ' HG2' ' O ' ' A' ' 210' ' ' GLN . 22.1 mmt180 -60.65 -35.16 75.54 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 120.887 0.375 . . . . 1.08 110.945 179.439 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -94.7 12.31 28.22 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.968 0.359 . . . . 1.13 111.968 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 216' ' ' LEU . . . . . 0.506 ' HB3' HG12 ' A' ' 218' ' ' ILE . 12.1 mt -99.39 154.27 18.33 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.127 0.489 . . . . 0.7 111.511 179.821 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -105.05 17.2 24.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.9 -0.591 . . . . 1.09 111.052 179.62 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 218' ' ' ILE . . . . . 0.543 ' HA ' ' HB2' ' A' ' 223' ' ' ASP . 17.3 mm -59.33 105.93 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-N 116.417 -0.356 . . . . 0.42 111.441 -179.716 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 219' ' ' LYS . . . . . 0.444 ' HG3' ' O ' ' A' ' 218' ' ' ILE . 7.5 mtmp? -159.56 -65.64 0.08 Allowed 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.862 -0.608 . . . . 0.62 110.7 -179.301 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -104.3 -175.65 2.86 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 115.098 -0.955 . . . . 0.69 110.722 -179.464 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 221' ' ' GLU . . . . . 0.425 ' O ' HG22 ' A' ' 224' ' ' VAL . 0.5 OUTLIER -46.83 -22.37 0.3 Allowed 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 113.538 0.94 . . . . 0.8 113.538 -179.221 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 222' ' ' GLY . . . . . 0.577 ' HA2' ' HD2' ' A' ' 225' ' ' LYS . . . -65.92 -23.99 71.31 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 121.223 -0.513 . . . . 0.38 113.076 178.606 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 223' ' ' ASP . . . . . 0.543 ' HB2' ' HA ' ' A' ' 218' ' ' ILE . 2.9 p-10 -56.56 -45.49 81.26 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 113.478 0.918 . . . . 0.76 113.478 -178.354 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.425 HG22 ' O ' ' A' ' 221' ' ' GLU . 28.9 m -59.96 -29.55 43.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-N 118.107 0.412 . . . . 0.5 111.475 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 225' ' ' LYS . . . . . 0.577 ' HD2' ' HA2' ' A' ' 222' ' ' GLY . 26.4 mttp -76.08 -42.76 46.34 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.549 -0.537 . . . . 0.91 109.549 178.886 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 94.3 p -64.5 -40.51 95.78 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.741 -0.663 . . . . 0.61 110.327 178.654 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 227' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -65.39 -42.63 92.44 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 109.919 -0.4 . . . . 0.51 109.919 178.831 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 228' ' ' SER . . . . . 0.539 ' HA ' ' HG2' ' A' ' 231' ' ' MET . 7.5 t -60.44 -43.79 96.47 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.086 -0.506 . . . . 0.64 110.423 178.595 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 229' ' ' ARG . . . . . 0.423 HH11 ' HD2' ' A' ' 229' ' ' ARG . 9.0 mmm180 -55.69 -44.36 77.3 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.243 0.544 . . . . 0.78 110.545 178.821 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 230' ' ' VAL . . . . . 0.499 ' O ' HG23 ' A' ' 234' ' ' VAL . 60.1 t -69.19 -54.32 20.69 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-N 115.877 -0.601 . . . . 0.33 111.475 179.307 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 231' ' ' MET . . . . . 0.539 ' HG2' ' HA ' ' A' ' 228' ' ' SER . 10.6 ptm -59.58 -37.13 77.69 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 112.491 0.552 . . . . 0.33 112.491 -178.838 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 33.0 t -66.4 -41.07 88.16 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 N-CA-C 109.522 -0.547 . . . . 0.38 109.522 178.373 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 233' ' ' HIS . . . . . 0.509 ' HA ' ' HB2' ' A' ' 236' ' ' LYS . 2.3 t-80 -68.16 -40.18 82.4 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 116.203 -0.453 . . . . 0.41 110.44 178.473 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.499 HG23 ' O ' ' A' ' 230' ' ' VAL . 69.3 t -56.99 -37.95 57.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 CA-C-O 121.057 0.456 . . . . 0.34 111.12 179.546 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 235' ' ' PHE . . . . . 0.511 ' HE2' HD22 ' A' ' 248' ' ' LEU . 93.3 m-85 -104.11 19.39 20.19 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.394 -0.366 . . . . 0.53 111.386 179.289 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 236' ' ' LYS . . . . . 0.509 ' HB2' ' HA ' ' A' ' 233' ' ' HIS . 1.3 tmtm? -79.81 -9.72 59.7 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 111.744 0.276 . . . . 1.27 111.744 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -70.16 -17.98 63.19 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 120.847 0.356 . . . . 0.53 111.033 179.685 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 96.83 -17.94 58.4 Favored Glycine 0 CA--C 1.524 0.621 0 C-N-CA 120.938 -0.649 . . . . 0.58 113.23 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 6.5 p -98.77 130.23 47.93 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-O 121.23 0.538 . . . . 0.58 111.8 -179.694 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 240' ' ' THR . . . . . 0.538 HG23 ' HG2' ' A' ' 283' ' ' LYS . 1.4 m -94.59 98.87 11.12 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.206 -0.452 . . . . 0.88 111.771 179.302 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -100.11 130.9 46.31 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.876 0.369 . . . . 0.48 111.208 179.431 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 242' ' ' TRP . . . . . . . . . . . . . 7.0 m95 -55.33 -43.76 75.22 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 116.032 -0.531 . . . . 0.54 111.146 179.326 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -58.01 -32.07 66.1 Favored Glycine 0 CA--C 1.519 0.329 0 CA-C-N 115.98 -0.555 . . . . 0.28 112.605 179.333 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 86.8 mtt180 -74.9 -36.39 62.23 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.78 -0.452 . . . . 0.34 109.78 178.786 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 245' ' ' ILE . . . . . 0.561 ' O ' HG12 ' A' ' 249' ' ' ILE . 79.1 mt -66.97 -51.36 55.46 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 CA-C-N 115.944 -0.571 . . . . 0.41 110.714 179.115 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 27.6 m -62.93 -35.9 73.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 C-N-CA 121.089 -0.244 . . . . 0.35 111.08 179.523 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 53.0 m -65.69 -37.77 87.39 Favored 'General case' 0 N--CA 1.463 0.187 0 N-CA-C 109.538 -0.542 . . . . 0.38 109.538 178.292 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 248' ' ' LEU . . . . . 0.511 HD22 ' HE2' ' A' ' 235' ' ' PHE . 34.2 tp -65.32 -40.58 93.92 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 116.143 -0.481 . . . . 0.63 109.759 177.624 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 249' ' ' ILE . . . . . 0.561 HG12 ' O ' ' A' ' 245' ' ' ILE . 43.0 mm -65.9 -48.89 80.36 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 CA-C-N 116.186 -0.461 . . . . 0.34 110.101 178.533 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 31.3 t -57.07 -42.68 81.09 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.801 -0.636 . . . . 0.28 110.31 178.709 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 251' ' ' PHE . . . . . . . . . . . . . 32.0 t80 -64.03 -45.46 88.78 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 115.647 -0.706 . . . . 0.46 110.059 177.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -58.22 -41.28 94.76 Favored Glycine 0 C--N 1.337 0.623 0 N-CA-C 111.464 -0.655 . . . . 0.32 111.464 178.632 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 253' ' ' ALA . . . . . 0.417 ' HB1' ' HB3' ' A' ' 170' ' ' GLN . . . -64.01 -42.68 97.06 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 120.773 0.32 . . . . 0.32 110.277 177.836 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -60.07 -40.87 91.0 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.357 0.598 . . . . 0.65 109.742 178.317 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 255' ' ' VAL . . . . . 0.461 ' CG1' HG21 ' A' ' 218' ' ' ILE . 79.9 t -66.54 -51.25 59.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 CA-C-N 115.682 -0.69 . . . . 0.41 109.696 177.815 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -54.21 -39.29 66.56 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.082 -0.508 . . . . 0.27 111.076 177.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -62.48 -42.89 99.8 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.402 -0.363 . . . . 0.59 110.667 178.53 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 31.3 t60 -64.61 -36.14 83.28 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.311 -0.404 . . . . 0.5 110.32 179.07 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 6.7 mp -74.6 -41.49 60.35 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 121.061 0.458 . . . . 0.51 110.696 178.479 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -62.82 -27.35 69.26 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.9 0.381 . . . . 0.4 110.666 179.079 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 56.4 m -59.67 -31.86 69.95 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.074 -0.512 . . . . 0.41 110.494 178.821 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 262' ' ' VAL . . . . . 0.419 HG23 ' HG3' ' A' ' 264' ' ' GLN . 15.7 m -110.49 16.99 7.72 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 CA-C-O 121.28 0.562 . . . . 0.4 110.192 178.29 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 25.6 t30 59.31 44.22 15.67 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 114.922 -1.035 . . . . 0.47 113.567 179.441 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 264' ' ' GLN . . . . . 0.419 ' HG3' HG23 ' A' ' 262' ' ' VAL . 15.0 mt-30 -91.54 36.61 0.95 Allowed 'General case' 0 N--CA 1.466 0.369 0 O-C-N 121.978 -0.452 . . . . 0.5 110.856 178.536 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 265' ' ' GLU . . . . . 0.427 ' HA ' HD12 ' A' ' 268' ' ' ILE . 6.4 mm-40 -57.94 -29.22 64.99 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 116.422 -0.354 . . . . 0.49 111.862 -179.418 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.37 -22.84 67.12 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.229 -0.441 . . . . 0.63 110.788 178.696 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 267' ' ' PHE . . . . . 0.428 ' C ' ' HD2' ' A' ' 270' ' ' PRO . 66.2 m-85 -100.01 -24.74 14.53 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.048 -0.524 . . . . 0.72 110.611 178.566 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 268' ' ' ILE . . . . . 0.427 HD12 ' HA ' ' A' ' 265' ' ' GLU . 89.3 mt -65.3 -40.9 90.03 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-N 116.11 -0.495 . . . . 0.37 111.477 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 269' ' ' GLU . . . . . 0.686 ' HB2' ' HD3' ' A' ' 270' ' ' PRO . 6.4 mm-40 -57.49 -56.47 33.81 Favored Pre-proline 0 CA--C 1.542 0.669 0 C-N-CA 120.979 -0.289 . . . . 0.68 111.111 178.873 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 270' ' ' PRO . . . . . 0.686 ' HD3' ' HB2' ' A' ' 269' ' ' GLU . 50.6 Cg_exo -58.04 -32.24 94.95 Favored 'Trans proline' 0 C--N 1.363 1.323 0 C-N-CA 121.843 1.695 . . . . 0.32 111.643 177.737 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 271' ' ' LEU . . . . . 0.44 ' O ' HG13 ' A' ' 275' ' ' ILE . 0.4 OUTLIER -66.06 -55.16 17.97 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.183 -0.462 . . . . 0.51 110.233 178.582 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -60.06 -39.12 84.91 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 115.846 -0.616 . . . . 0.28 110.951 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 273' ' ' GLU . . . . . 0.468 ' O ' ' HB2' ' A' ' 277' ' ' ASP . 26.4 tt0 -66.92 -43.41 83.38 Favored 'General case' 0 C--O 1.226 -0.18 0 CA-C-N 115.885 -0.598 . . . . 1.79 110.012 178.583 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 274' ' ' THR . . . . . . . . . . . . . 41.2 m -64.95 -44.35 89.71 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.605 -0.27 . . . . 0.39 110.927 179.057 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 275' ' ' ILE . . . . . 0.44 HG13 ' O ' ' A' ' 271' ' ' LEU . 96.5 mt -57.54 -54.97 24.09 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 CA-C-O 121.132 0.491 . . . . 0.4 110.157 179.09 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 276' ' ' THR . . . . . 0.614 HG21 ' HA ' ' A' ' 160' ' ' LEU . 24.4 m -59.25 -45.46 91.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.664 -0.698 . . . . 0.31 110.541 179.179 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 277' ' ' ASP . . . . . 0.468 ' HB2' ' O ' ' A' ' 273' ' ' GLU . 7.9 t70 -56.27 -58.35 8.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.315 -0.857 . . . . 0.33 111.723 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 95.3 t -57.7 -39.47 70.42 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-O 120.609 0.242 . . . . 0.4 110.953 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 22.3 tp -61.5 -47.92 83.42 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 120.669 0.271 . . . . 0.68 111.672 179.49 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 44.6 t -78.79 -23.28 12.97 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-O 121.052 0.453 . . . . 0.52 111.835 -179.699 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 281' ' ' ARG . . . . . 0.422 ' HB2' ' O ' ' A' ' 277' ' ' ASP . 19.3 ttm-85 -82.29 -25.8 33.66 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 121.824 -0.547 . . . . 0.47 111.949 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 282' ' ' THR . . . . . . . . . . . . . 37.7 p -98.69 -31.15 12.06 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 112.526 0.565 . . . . 0.4 112.526 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 283' ' ' LYS . . . . . 0.538 ' HG2' HG23 ' A' ' 240' ' ' THR . 3.3 mppt? -117.08 32.99 5.84 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 112.16 0.43 . . . . 1.01 112.16 -179.149 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 284' ' ' ARG . . . . . 0.48 ' H ' ' HG2' ' A' ' 284' ' ' ARG . 0.4 OUTLIER -56.81 -42.46 79.61 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 112.139 0.422 . . . . 0.45 112.139 179.817 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 285' ' ' ASP . . . . . 0.525 ' O ' ' HB2' ' A' ' 289' ' ' LYS . 26.0 t70 -62.19 -48.75 78.64 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.393 -0.367 . . . . 0.77 111.73 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 286' ' ' TRP . . . . . 0.513 ' CZ2' ' HG2' ' A' ' 290' ' ' GLN . 31.7 t90 -70.63 -41.42 72.22 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.018 0.377 . . . . 0.98 112.018 -179.201 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -61.27 -40.97 96.08 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 111.891 0.33 . . . . 0.55 111.891 -179.378 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 6.0 p -77.38 -29.69 16.87 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-O 120.75 0.309 . . . . 0.59 110.954 179.048 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 289' ' ' LYS . . . . . 0.525 ' HB2' ' O ' ' A' ' 285' ' ' ASP . 3.4 ttmm -75.36 -44.85 42.81 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 112.858 0.688 . . . . 0.81 112.858 -179.081 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 290' ' ' GLN . . . . . 0.513 ' HG2' ' CZ2' ' A' ' 286' ' ' TRP . 1.9 mp0 -84.83 29.88 0.6 Allowed 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 113.765 1.024 . . . . 0.78 113.765 -177.828 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 291' ' ' ARG . . . . . 0.608 ' HB3' ' HB3' ' A' ' 294' ' ' ASP . 21.5 mtm180 64.04 6.8 3.02 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 112.745 0.646 . . . . 0.42 112.745 179.318 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 59.07 -125.59 40.16 Favored Glycine 0 CA--C 1.521 0.421 0 CA-C-O 121.395 0.442 . . . . 0.32 113.573 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 293' ' ' TRP . . . . . 0.589 ' O ' HG23 ' A' ' 297' ' ' VAL . 83.8 m95 -64.9 -26.3 68.26 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.641 0.608 . . . . 0.48 112.641 -178.892 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 294' ' ' ASP . . . . . 0.608 ' HB3' ' HB3' ' A' ' 291' ' ' ARG . 20.0 t70 -64.32 -43.91 93.21 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 121.045 0.45 . . . . 0.54 109.934 178.844 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -68.38 -31.8 74.68 Favored Glycine 0 C--N 1.334 0.45 0 N-CA-C 110.609 -0.997 . . . . 0.36 110.609 177.776 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 296' ' ' PHE . . . . . 0.471 ' HB3' ' HA ' ' A' ' 293' ' ' TRP . 1.0 OUTLIER -67.7 -48.11 67.49 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 115.51 -0.345 . . . . 0.31 110.557 178.464 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 297' ' ' VAL . . . . . 0.589 HG23 ' O ' ' A' ' 293' ' ' TRP . 86.0 t -61.14 -43.4 96.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-O 120.825 0.345 . . . . 0.36 110.615 179.306 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -64.51 -46.49 82.71 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.863 -0.608 . . . . 0.48 112.053 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 299' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -62.63 -35.2 78.81 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 112.31 0.485 . . . . 0.54 112.31 -179.446 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 300' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 . . . . . 0 C--N 1.326 -0.455 0 N-CA-C 112.284 0.476 . . . . 0.51 112.284 -179.464 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 . . . . . 0 N--CA 1.456 -0.171 0 N-CA-C 109.34 -0.615 . . . . 1.0 109.34 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 23' ' ' PHE . . . . . 0.473 ' HB3' ' HB3' ' A' ' 212' ' ' MET . 0.0 OUTLIER -56.55 -41.3 76.62 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.87 -0.605 . . . . 0.72 110.686 178.54 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.61 -49.01 78.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.064 -0.516 . . . . 0.35 110.735 179.169 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 25' ' ' ALA . . . . . 0.411 ' HA ' ' HD3' ' B' ' 28' ' ' ARG . . . -64.78 -42.1 95.33 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.329 -0.396 . . . . 0.53 110.933 179.335 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -64.73 -49.53 70.45 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.128 -0.487 . . . . 1.09 111.351 179.531 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 61.6 mt -56.65 -36.03 69.06 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 120.815 0.34 . . . . 0.57 110.33 178.843 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 28' ' ' ARG . . . . . 0.411 ' HD3' ' HA ' ' B' ' 25' ' ' ALA . 19.4 mtp180 -62.89 -48.44 78.96 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.171 -0.468 . . . . 0.48 110.157 178.009 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 29' ' ' LYS . . . . . 0.504 ' HA ' ' HE3' ' B' ' 29' ' ' LYS . 0.0 OUTLIER -66.83 -41.81 86.83 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.319 -0.4 . . . . 0.53 111.96 -179.79 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 30' ' ' ILE . . . . . 0.407 ' O ' HG23 ' B' ' 34' ' ' VAL . 78.8 mt -61.65 -41.61 91.03 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 N-CA-C 109.142 -0.688 . . . . 0.39 109.142 178.027 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -61.85 -49.13 78.95 Favored Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 115.655 -0.702 . . . . 0.31 111.872 178.287 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -58.9 -44.23 91.19 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-O 121.117 0.484 . . . . 0.45 109.737 178.264 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 3.3 tmtt? -58.84 -52.61 64.98 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 115.434 -0.803 . . . . 0.41 111.137 178.667 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 34' ' ' VAL . . . . . 0.407 HG23 ' O ' ' B' ' 30' ' ' ILE . 58.7 t -58.87 -49.43 83.04 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 CA-C-O 120.749 0.309 . . . . 0.39 111.416 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -58.74 -43.96 90.39 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 116.307 -0.406 . . . . 0.62 111.972 -179.586 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 36' ' ' CYS . . . . . . . . . . . . . 17.8 p -73.39 -32.84 64.68 Favored 'General case' 0 N--CA 1.468 0.444 0 O-C-N 122.023 -0.423 . . . . 0.4 111.421 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 89.5 m -66.35 -39.82 89.42 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.526 -0.306 . . . . 0.37 111.365 179.53 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 38' ' ' TRP . . . . . . . . . . . . . 84.2 m95 -80.45 -25.05 39.13 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.981 -0.288 . . . . 0.56 111.201 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 69.2 m . . . . . 0 N--CA 1.469 0.489 0 CA-C-O 120.898 0.38 . . . . 0.48 110.71 178.139 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 15.1 t70 . . . . . 0 N--CA 1.473 0.722 0 N-CA-C 112.763 0.653 . . . . 0.91 112.763 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -67.85 -38.7 83.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.856 0.36 . . . . 0.59 110.679 179.773 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.436 HD11 ' HA3' ' A' ' 292' ' ' GLY . 53.8 tp -61.56 -39.4 90.97 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.732 -0.47 . . . . 0.63 109.732 178.366 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -58.17 -51.49 69.5 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.604 -0.726 . . . . 0.42 112.02 179.179 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 157' ' ' ARG . . . . . 0.41 HH11 ' HD2' ' A' ' 157' ' ' ARG . 20.1 mtm180 -56.77 -49.66 74.61 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 112.37 0.507 . . . . 0.5 112.37 -178.837 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -59.04 -50.45 74.03 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 120.903 0.382 . . . . 1.19 111.007 179.48 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 159' ' ' SER . . . . . 0.457 ' HA ' ' CZ2' ' A' ' 293' ' ' TRP . 3.3 p -63.64 -45.9 88.1 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 112.278 0.473 . . . . 0.29 112.278 -179.374 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.409 HD22 ' HA ' ' A' ' 160' ' ' LEU . 0.4 OUTLIER -53.4 -49.76 66.6 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 120.774 0.321 . . . . 0.8 111.124 179.45 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -75.99 -43.17 45.63 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.873 0.694 . . . . 0.39 112.873 -179.365 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' ILE . . . . . 0.466 HD13 ' HB3' ' A' ' 190' ' ' ALA . 79.9 mt -62.01 -42.44 94.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 O-C-N 121.978 -0.451 . . . . 0.31 111.753 -179.292 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.692 ' O ' ' HG ' ' A' ' 167' ' ' LEU . 74.1 mt -69.06 -52.3 35.23 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 C-N-CA 121.018 -0.273 . . . . 0.33 110.768 179.043 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 54.6 p -58.03 -42.27 84.98 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 121.281 -0.167 . . . . 0.26 110.983 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' ARG . . . . . 0.438 HH11 ' HD2' ' A' ' 165' ' ' ARG . 2.0 mmt85 -55.43 -51.77 65.81 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.722 -0.217 . . . . 0.41 110.951 178.472 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 166' ' ' TYR . . . . . 0.848 ' CE1' ' HA ' ' A' ' 195' ' ' ARG . 72.5 t80 -60.26 -48.68 80.69 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.666 -0.243 . . . . 0.31 111.142 179.28 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.692 ' HG ' ' O ' ' A' ' 163' ' ' ILE . 18.8 mt -59.0 -44.18 91.63 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.561 -0.29 . . . . 0.35 111.484 -179.568 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 168' ' ' ARG . . . . . 0.539 ' HD3' ' OE2' ' A' ' 269' ' ' GLU . 25.3 mtm180 -70.47 -44.42 67.77 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 112.22 0.452 . . . . 0.38 112.22 179.671 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -62.8 -44.1 97.06 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.705 0.288 . . . . 0.35 111.168 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 170' ' ' GLN . . . . . 0.456 ' HG3' ' CZ ' ' A' ' 166' ' ' TYR . 6.4 mm-40 -70.48 -28.99 65.41 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.853 0.359 . . . . 0.4 110.708 178.896 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.838 ' HA ' ' HG2' ' A' ' 257' ' ' LYS . . . . . . . . 0 CA--C 1.53 0.21 0 N-CA-C 112.522 0.564 . . . . 0.44 112.522 -179.695 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.496 ' O ' ' HA3' ' A' ' 187' ' ' GLY . . . . . . . . 0 CA--C 1.532 0.285 0 CA-C-O 120.884 0.373 . . . . 0.38 110.247 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -78.74 -71.68 1.23 Allowed Glycine 0 CA--C 1.523 0.542 0 C-N-CA 120.647 -0.787 . . . . 0.42 113.811 -178.586 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -71.97 -56.14 6.2 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 120.8 0.333 . . . . 0.5 111.049 -179.697 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -61.52 -35.03 76.58 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.116 -0.493 . . . . 0.45 110.578 179.036 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 187' ' ' GLY . . . . . 0.496 ' HA3' ' O ' ' A' ' 183' ' ' ALA . . . -65.37 -40.46 96.43 Favored Glycine 0 C--N 1.333 0.408 0 C-N-CA 121.229 -0.51 . . . . 0.36 113.201 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 188' ' ' ARG . . . . . 0.449 ' HD3' ' HA ' ' A' ' 188' ' ' ARG . 15.0 mmt180 -66.52 -47.02 74.26 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 117.193 0.497 . . . . 0.66 110.552 179.656 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 189' ' ' ARG . . . . . 0.685 ' HB3' HG11 ' A' ' 297' ' ' VAL . 23.9 mmt180 -66.97 -39.52 87.22 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.067 -0.515 . . . . 0.65 111.204 179.678 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 190' ' ' ALA . . . . . 0.466 ' HB3' HD13 ' A' ' 162' ' ' ILE . . . -70.09 -40.08 75.17 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.899 -0.321 . . . . 0.32 111.136 179.095 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 16.0 tp -69.27 -44.41 71.94 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 120.777 -0.369 . . . . 0.52 111.294 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 192' ' ' GLU . . . . . 0.558 ' HG3' ' O ' ' A' ' 189' ' ' ARG . 0.0 OUTLIER -58.43 -37.73 75.99 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 120.597 -0.441 . . . . 0.34 110.401 179.169 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 193' ' ' THR . . . . . 0.561 HG21 ' HA ' ' A' ' 297' ' ' VAL . 1.1 p -76.87 -47.59 20.81 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 120.953 -0.299 . . . . 0.35 111.08 178.884 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 194' ' ' LEU . . . . . 0.482 ' HA ' HD12 ' A' ' 194' ' ' LEU . 10.3 tp -58.85 -35.36 72.82 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.737 0.303 . . . . 0.4 110.977 179.704 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 195' ' ' ARG . . . . . 0.848 ' HA ' ' CE1' ' A' ' 166' ' ' TYR . 12.6 mmt180 -68.8 -58.29 4.4 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.788 0.328 . . . . 0.35 110.348 178.393 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 20.7 ttp85 -60.77 -54.02 50.24 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 112.914 0.709 . . . . 0.52 112.914 -179.183 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 197' ' ' VAL . . . . . 0.564 ' O ' HG23 ' A' ' 201' ' ' VAL . 46.8 t -68.7 -45.1 81.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 112.051 0.389 . . . . 0.36 112.051 -179.033 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -61.7 -42.41 99.75 Favored Glycine 0 CA--C 1.521 0.444 0 C-N-CA 120.996 -0.621 . . . . 0.32 113.027 -179.494 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -68.39 -42.39 79.15 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 109.728 -0.471 . . . . 0.49 109.728 179.416 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -56.54 -48.68 74.76 Favored Glycine 0 C--N 1.336 0.547 0 C-N-CA 120.797 -0.716 . . . . 0.39 111.655 178.318 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 201' ' ' VAL . . . . . 0.564 HG23 ' O ' ' A' ' 197' ' ' VAL . 60.0 t -62.92 -42.6 97.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 CA-C-O 120.702 0.287 . . . . 0.43 111.193 178.726 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 202' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -63.38 -48.64 77.04 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.152 -0.476 . . . . 0.35 112.028 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 31.7 mtm180 -73.5 -35.27 65.6 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.908 -0.317 . . . . 0.74 111.739 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -63.73 -49.19 74.03 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 121.117 0.484 . . . . 0.91 110.039 178.6 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 79.6 m-70 -101.17 33.78 2.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.157 -0.474 . . . . 0.59 110.711 179.56 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -53.65 -45.71 70.32 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.89 -0.596 . . . . 0.79 112.042 -179.42 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -59.51 -41.89 90.97 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 120.928 0.394 . . . . 0.5 111.51 179.34 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -70.62 -50.62 35.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.23 -0.441 . . . . 0.43 111.045 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -60.26 -44.09 95.59 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 116.478 -0.328 . . . . 0.6 111.024 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 -64.67 -40.89 96.2 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 110.272 -0.27 . . . . 0.96 110.272 178.558 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -62.3 -44.81 97.14 Favored Glycine 0 C--N 1.335 0.522 0 N-CA-C 110.746 -0.942 . . . . 0.39 110.746 178.104 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 212' ' ' MET . . . . . 0.527 ' O ' ' HG ' ' A' ' 216' ' ' LEU . 8.0 mtp -64.09 -42.12 97.05 Favored 'General case' 0 C--O 1.222 -0.375 0 N-CA-C 110.076 -0.342 . . . . 0.67 110.076 178.102 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.437 HD21 ' HB2' ' A' ' 258' ' ' HIS . 6.8 tp -61.85 -39.16 90.87 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 120.889 0.376 . . . . 0.51 111.245 179.136 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 10.4 tpt180 -68.66 -32.52 72.43 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 116.267 -0.424 . . . . 0.79 111.32 179.546 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -89.99 -15.56 31.68 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 111.899 0.333 . . . . 0.57 111.899 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 216' ' ' LEU . . . . . 0.535 HD11 ' CZ ' ' A' ' 251' ' ' PHE . 13.3 mt -62.92 134.18 55.8 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 113.036 0.754 . . . . 0.59 113.036 -179.288 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -100.95 17.04 23.3 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 115.511 -0.768 . . . . 1.1 110.127 178.589 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 30.7 mm -67.88 108.24 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 CA-C-N 116.073 -0.512 . . . . 0.73 111.385 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 2.9 mtmp? -135.08 -42.6 0.73 Allowed 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 112.355 0.502 . . . . 1.06 112.355 -179.522 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -113.87 -178.39 3.36 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 113.184 0.809 . . . . 1.27 113.184 -177.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 221' ' ' GLU . . . . . 0.612 ' O ' HG22 ' A' ' 224' ' ' VAL . 8.7 tm-20 -56.52 -44.53 80.88 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 115.723 -0.671 . . . . 1.34 112.244 -179.438 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -54.02 -26.99 36.42 Favored Glycine 0 CA--C 1.527 0.807 0 C-N-CA 121.112 -0.566 . . . . 0.43 113.564 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 62.7 m-20 -68.47 -31.03 70.03 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 112.71 0.633 . . . . 0.75 112.71 -179.689 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.612 HG22 ' O ' ' A' ' 221' ' ' GLU . 4.4 m -63.22 -28.65 45.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 CA-C-O 121.156 0.503 . . . . 0.54 111.548 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 37.6 mttm -70.0 -39.36 75.93 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-O 121.334 0.587 . . . . 1.28 110.278 179.399 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 226' ' ' SER . . . . . 0.533 ' O ' HG23 ' A' ' 230' ' ' VAL . 11.3 t -66.34 -36.03 81.88 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.896 -0.593 . . . . 0.35 109.535 178.315 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 227' ' ' PHE . . . . . . . . . . . . . 33.8 t80 -60.81 -42.55 97.87 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.184 -0.916 . . . . 0.53 110.314 178.604 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 228' ' ' SER . . . . . 0.417 ' HB3' HG11 ' A' ' 278' ' ' VAL . 18.8 m -59.62 -45.61 91.45 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 115.716 -0.675 . . . . 0.75 110.634 178.894 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 15.8 ttm105 -55.52 -43.68 75.97 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.611 -0.722 . . . . 0.38 110.799 178.679 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 230' ' ' VAL . . . . . 0.533 HG23 ' O ' ' A' ' 226' ' ' SER . 25.4 t -58.9 -49.56 82.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 CA-C-N 116.118 -0.492 . . . . 0.42 111.679 179.328 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 231' ' ' MET . . . . . 0.538 ' HA ' HD22 ' A' ' 248' ' ' LEU . 70.5 mtm -53.11 -45.74 68.42 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.351 -0.386 . . . . 0.53 111.755 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 37.7 t -68.91 -40.45 81.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-O 120.657 0.265 . . . . 0.54 110.976 178.798 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 39.5 t-80 -54.89 -33.09 61.63 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.038 -0.528 . . . . 0.41 111.175 179.366 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.577 HG13 ' HA ' ' B' ' 28' ' ' ARG . 79.0 t -61.78 -30.9 49.4 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 N-CA-C 112.405 0.52 . . . . 0.41 112.405 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -93.98 23.16 5.1 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 112.432 0.53 . . . . 0.52 112.432 -179.094 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.58 -23.57 17.4 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 113.399 0.889 . . . . 1.06 113.399 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 237' ' ' ASP . . . . . 0.476 ' HB2' HG12 ' A' ' 239' ' ' VAL . 0.1 OUTLIER -76.67 -14.64 59.95 Favored 'General case' 0 CA--C 1.533 0.321 0 O-C-N 121.932 -0.48 . . . . 0.67 111.991 -179.688 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 88.53 12.71 64.35 Favored Glycine 0 CA--C 1.522 0.516 0 C-N-CA 120.79 -0.719 . . . . 0.67 113.488 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 239' ' ' VAL . . . . . 0.476 HG12 ' HB2' ' A' ' 237' ' ' ASP . 3.9 p -119.48 112.21 36.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 CA-C-O 121.533 0.682 . . . . 0.55 111.569 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 240' ' ' THR . . . . . 0.75 HG22 HD11 ' A' ' 245' ' ' ILE . 4.2 m -81.33 69.93 8.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.101 -0.499 . . . . 0.58 112.235 -179.445 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 48.2 m-20 -76.89 136.21 38.85 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 120.724 0.297 . . . . 0.8 110.976 179.02 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 242' ' ' TRP . . . . . 0.558 ' CZ3' ' HB2' ' A' ' 296' ' ' PHE . 68.8 m95 -53.66 -36.53 62.22 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 112.972 0.73 . . . . 0.52 112.972 -179.17 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 243' ' ' GLY . . . . . 0.474 ' H ' ' HB2' ' B' ' 35' ' ' TYR . . . -58.09 -34.88 74.49 Favored Glycine 0 CA--C 1.521 0.46 0 C-N-CA 120.994 -0.622 . . . . 0.34 112.894 179.658 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 244' ' ' ARG . . . . . 0.617 ' O ' ' HG ' ' A' ' 248' ' ' LEU . 28.9 mtt180 -74.37 -46.45 40.43 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.917 -0.401 . . . . 0.59 109.917 179.389 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 245' ' ' ILE . . . . . 0.75 HD11 HG22 ' A' ' 240' ' ' THR . 58.5 mt -55.91 -47.96 79.13 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-N 115.533 -0.758 . . . . 0.54 110.778 178.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 7.6 p -70.15 -29.01 38.01 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 120.905 -0.318 . . . . 0.37 110.852 179.773 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 247' ' ' THR . . . . . 0.545 HG22 HD22 ' B' ' 27' ' ' LEU . 19.8 m -65.16 -39.64 93.24 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 109.603 -0.517 . . . . 0.42 109.603 177.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 248' ' ' LEU . . . . . 0.617 ' HG ' ' O ' ' A' ' 244' ' ' ARG . 51.4 mt -63.21 -38.91 93.03 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.863 -0.608 . . . . 0.43 109.784 178.204 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 249' ' ' ILE . . . . . 0.469 HG21 HD11 ' A' ' 194' ' ' LEU . 15.6 mt -70.22 -36.9 69.66 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 N-CA-C 109.55 -0.537 . . . . 0.41 109.55 177.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 20.4 m -64.08 -40.5 96.38 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 109.255 -0.646 . . . . 0.37 109.255 178.136 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 251' ' ' PHE . . . . . 0.535 ' CZ ' HD11 ' A' ' 216' ' ' LEU . 8.0 t80 -65.83 -40.99 92.32 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 108.644 -0.873 . . . . 0.56 108.644 176.788 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -62.69 -39.55 98.06 Favored Glycine 0 C--N 1.336 0.53 0 CA-C-N 115.509 -0.769 . . . . 0.28 111.576 178.051 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -64.75 -41.44 95.92 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 120.665 0.269 . . . . 0.28 110.517 178.033 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -63.09 -37.9 89.03 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.042 0.449 . . . . 0.53 110.209 178.503 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 255' ' ' VAL . . . . . 0.523 HG23 ' O ' ' A' ' 251' ' ' PHE . 59.9 t -72.97 -39.42 57.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 N-CA-C 109.83 -0.433 . . . . 0.35 109.83 178.218 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 256' ' ' ALA . . . . . 0.415 ' HB1' HD11 ' A' ' 268' ' ' ILE . . . -55.64 -43.71 76.47 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.143 0.497 . . . . 0.31 109.942 178.042 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 257' ' ' LYS . . . . . 0.838 ' HG2' ' HA ' ' A' ' 171' ' ' ALA . 93.0 mttt -62.39 -47.87 82.25 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 115.507 -0.769 . . . . 0.4 110.378 178.267 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 258' ' ' HIS . . . . . 0.437 ' HB2' HD21 ' A' ' 213' ' ' LEU . 45.3 t60 -59.45 -36.43 75.91 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.3 -0.409 . . . . 0.68 111.379 179.668 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.401 ' O ' ' HB2' ' A' ' 264' ' ' GLN . 88.2 mt -77.37 -51.06 11.47 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 112.023 0.379 . . . . 0.57 112.023 179.275 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 260' ' ' LYS . . . . . 0.506 ' HD2' ' HB3' ' A' ' 171' ' ' ALA . 0.4 OUTLIER -60.81 -42.05 96.91 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 112.496 0.554 . . . . 0.68 112.496 -179.341 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 29.3 p -55.63 -27.98 52.73 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 112.35 0.5 . . . . 0.61 112.35 -179.493 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 262' ' ' VAL . . . . . 0.609 HG23 ' HG3' ' A' ' 264' ' ' GLN . 17.1 m -109.41 25.83 2.76 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-O 120.759 0.314 . . . . 0.63 111.594 179.361 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 58.4 m-80 55.63 47.44 20.68 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 113.219 0.822 . . . . 1.2 113.219 179.121 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 264' ' ' GLN . . . . . 0.609 ' HG3' HG23 ' A' ' 262' ' ' VAL . 37.3 mt-30 -103.94 39.8 1.56 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.005 0.431 . . . . 0.75 111.359 179.381 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 265' ' ' GLU . . . . . 0.826 ' HA ' HG22 ' A' ' 268' ' ' ILE . 24.2 mm-40 -50.84 -35.88 34.72 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 112.668 0.618 . . . . 0.71 112.668 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 266' ' ' SER . . . . . 0.403 ' O ' ' HG2' ' A' ' 270' ' ' PRO . 57.1 p -67.81 -7.96 32.05 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.658 -0.246 . . . . 0.55 111.608 179.631 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -116.76 -33.45 4.8 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.525 0.194 . . . . 0.81 111.525 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 268' ' ' ILE . . . . . 0.826 HG22 ' HA ' ' A' ' 265' ' ' GLU . 6.1 tt -67.38 -43.32 87.82 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 N-CA-C 111.705 0.261 . . . . 0.44 111.705 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 269' ' ' GLU . . . . . 0.733 ' HB2' ' HD3' ' A' ' 270' ' ' PRO . 6.7 mm-40 -63.08 -56.03 31.86 Favored Pre-proline 0 CA--C 1.537 0.447 0 C-N-CA 120.851 -0.34 . . . . 0.78 110.751 179.573 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 270' ' ' PRO . . . . . 0.733 ' HD3' ' HB2' ' A' ' 269' ' ' GLU . 50.3 Cg_exo -57.0 -29.64 83.57 Favored 'Trans proline' 0 C--N 1.36 1.179 0 C-N-CA 122.0 1.8 . . . . 0.33 111.588 177.577 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 271' ' ' LEU . . . . . . . . . . . . . 19.1 tp -66.7 -51.08 60.1 Favored 'General case' 0 C--O 1.224 -0.265 0 N-CA-C 109.782 -0.451 . . . . 0.46 109.782 178.009 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -58.36 -34.48 70.72 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 120.942 0.401 . . . . 0.32 110.514 178.865 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 273' ' ' GLU . . . . . 0.583 ' OE1' ' HA ' ' A' ' 270' ' ' PRO . 68.9 mt-10 -71.21 -47.81 55.15 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 115.856 -0.611 . . . . 0.97 109.892 178.244 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 274' ' ' THR . . . . . . . . . . . . . 61.1 m -60.67 -43.11 98.05 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.889 -0.596 . . . . 0.37 110.713 179.112 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 275' ' ' ILE . . . . . 0.425 HG23 ' SD ' ' A' ' 231' ' ' MET . 96.1 mt -60.48 -54.64 32.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 115.833 -0.621 . . . . 0.32 110.386 178.589 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 26.0 m -61.17 -48.87 79.55 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.096 -0.502 . . . . 0.3 112.331 -179.382 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 277' ' ' ASP . . . . . 0.471 ' CG ' HH12 ' A' ' 281' ' ' ARG . 24.2 t70 -54.44 -53.26 56.58 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 120.873 0.368 . . . . 0.37 111.635 -179.676 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 278' ' ' VAL . . . . . 0.417 HG11 ' HB3' ' A' ' 228' ' ' SER . 97.8 t -68.6 -42.93 83.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.365 -0.379 . . . . 0.4 111.649 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 279' ' ' LEU . . . . . 0.441 HD11 HG23 ' A' ' 245' ' ' ILE . 40.6 tp -57.77 -43.08 85.25 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 120.601 0.239 . . . . 0.62 111.618 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 77.6 t -72.3 -53.33 19.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 120.824 -0.351 . . . . 0.43 110.737 179.078 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 281' ' ' ARG . . . . . 0.554 ' HA ' ' HG3' ' A' ' 284' ' ' ARG . 18.8 ttp-105 -56.44 -40.97 75.67 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 113.669 0.989 . . . . 0.53 113.669 -179.685 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 282' ' ' THR . . . . . 0.892 HG23 ' HD2' ' A' ' 283' ' ' LYS . 13.9 t -63.14 -21.63 66.32 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 113.269 0.84 . . . . 0.51 113.269 -178.777 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 283' ' ' LYS . . . . . 0.892 ' HD2' HG23 ' A' ' 282' ' ' THR . 0.4 OUTLIER -142.26 41.76 1.64 Allowed 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 112.4 0.519 . . . . 0.66 112.4 -179.736 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 284' ' ' ARG . . . . . 0.554 ' HG3' ' HA ' ' A' ' 281' ' ' ARG . 68.8 mtt180 -55.01 -47.84 74.14 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 113.035 0.754 . . . . 0.68 113.035 -178.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 285' ' ' ASP . . . . . 0.442 ' HA ' HG22 ' A' ' 288' ' ' VAL . 32.4 t70 -60.5 -39.6 88.32 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.043 0.449 . . . . 0.59 111.327 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 286' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -67.99 -37.99 82.13 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.201 0.524 . . . . 0.56 110.218 179.088 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 287' ' ' LEU . . . . . 0.406 ' CD1' ' HA2' ' A' ' 292' ' ' GLY . 2.8 mm? -70.62 -48.93 52.55 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.639 -0.71 . . . . 0.58 111.638 179.582 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 288' ' ' VAL . . . . . 0.442 HG22 ' HA ' ' A' ' 285' ' ' ASP . 33.5 m -61.32 -33.76 57.98 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-O 120.627 0.251 . . . . 0.5 111.436 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 50.6 mttp -72.0 -26.14 62.11 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 120.854 0.359 . . . . 0.93 110.874 178.648 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -101.93 11.01 39.26 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 112.437 0.532 . . . . 0.87 112.437 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 291' ' ' ARG . . . . . 0.416 HH11 ' HD2' ' A' ' 291' ' ' ARG . 29.1 mtm180 62.54 20.29 11.85 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 120.716 0.293 . . . . 0.79 111.7 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 292' ' ' GLY . . . . . 0.436 ' HA3' HD11 ' A' ' 155' ' ' LEU . . . 65.07 -111.67 4.38 Favored Glycine 0 CA--C 1.525 0.662 0 C-N-CA 121.375 -0.441 . . . . 0.47 114.061 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 293' ' ' TRP . . . . . 0.597 ' O ' HG23 ' A' ' 297' ' ' VAL . 53.9 m95 -63.48 -45.89 88.68 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.857 0.688 . . . . 0.46 112.857 -178.832 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 294' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -50.21 -47.36 54.82 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 111.849 0.315 . . . . 0.52 111.849 -179.352 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -66.03 -41.19 95.31 Favored Glycine 0 CA--C 1.523 0.561 0 C-N-CA 120.582 -0.818 . . . . 0.31 112.258 178.526 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 296' ' ' PHE . . . . . 0.558 ' HB2' ' CZ3' ' A' ' 242' ' ' TRP . 1.6 t80 -62.37 -42.68 99.6 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.95 0.405 . . . . 0.4 111.116 179.076 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 297' ' ' VAL . . . . . 0.685 HG11 ' HB3' ' A' ' 189' ' ' ARG . 64.0 t -63.91 -47.18 91.77 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-N 116.004 -0.544 . . . . 0.33 111.807 -179.555 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -59.07 -46.16 88.96 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 112.128 0.418 . . . . 0.65 112.128 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 299' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -59.05 -27.35 65.41 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 120.976 0.417 . . . . 0.51 111.74 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 300' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 . . . . . 0 C--N 1.327 -0.378 0 CA-C-O 121.283 0.563 . . . . 0.53 111.286 179.625 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 . . . . . 0 C--O 1.232 0.184 0 CA-C-O 120.912 0.387 . . . . 0.81 110.406 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 23' ' ' PHE . . . . . 0.556 ' O ' ' HG ' ' B' ' 27' ' ' LEU . 4.0 p90 -63.76 -33.2 75.12 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.113 -0.494 . . . . 0.48 110.829 179.227 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -72.76 -46.47 53.21 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.256 -0.429 . . . . 0.51 111.095 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.89 -42.21 97.52 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 121.072 0.463 . . . . 0.67 110.456 179.383 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -59.57 -53.38 58.77 Favored 'General case' 0 N--CA 1.457 -0.105 0 CA-C-N 115.681 -0.69 . . . . 0.96 110.739 179.237 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 27' ' ' LEU . . . . . 0.556 ' HG ' ' O ' ' B' ' 23' ' ' PHE . 78.3 mt -56.5 -35.58 68.18 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.623 -0.262 . . . . 0.52 111.597 179.685 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 28' ' ' ARG . . . . . 0.577 ' HA ' HG13 ' A' ' 234' ' ' VAL . 0.0 OUTLIER -67.3 -47.07 71.7 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.74 0.305 . . . . 0.51 111.09 179.532 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 44.3 mtmt -67.67 -41.83 83.11 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 121.038 0.447 . . . . 0.77 110.371 178.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 30' ' ' ILE . . . . . 0.47 ' O ' HG23 ' B' ' 34' ' ' VAL . 97.0 mt -64.31 -40.03 87.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 CA-C-N 115.942 -0.572 . . . . 0.39 110.128 178.899 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -57.88 -49.95 70.07 Favored Glycine 0 C--N 1.333 0.412 0 CA-C-N 115.879 -0.6 . . . . 0.29 112.941 179.377 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 39.1 m-20 -68.9 -26.73 65.25 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 117.157 0.479 . . . . 0.48 110.273 178.504 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 33' ' ' LYS . . . . . 0.427 ' HE2' ' HA ' ' B' ' 33' ' ' LYS . 0.0 OUTLIER -67.86 -53.72 24.51 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.505 -0.316 . . . . 0.41 110.734 178.75 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 34' ' ' VAL . . . . . 0.47 HG23 ' O ' ' B' ' 30' ' ' ILE . 57.3 t -58.03 -47.24 87.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-O 121.081 0.467 . . . . 0.37 110.745 179.503 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 35' ' ' TYR . . . . . 0.474 ' HB2' ' H ' ' A' ' 243' ' ' GLY . 2.4 t80 -58.15 -46.53 85.52 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.625 -0.716 . . . . 0.5 110.138 178.84 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 36' ' ' CYS . . . . . . . . . . . . . 43.5 t -63.53 -46.04 87.81 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 115.881 -0.599 . . . . 0.35 111.111 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 62.3 m -61.07 -43.24 99.18 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 112.878 0.695 . . . . 0.4 112.878 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 38' ' ' TRP . . . . . . . . . . . . . 94.2 m95 -82.76 -26.3 32.01 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.696 0.628 . . . . 0.62 112.696 -178.499 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 8.6 t . . . . . 0 CA--C 1.533 0.308 0 CA-C-O 121.019 0.437 . . . . 0.54 110.287 178.212 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 . . . . . 0 CA--C 1.532 0.281 0 N-CA-C 112.036 0.384 . . . . 0.44 112.036 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -51.98 -52.42 50.59 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 120.747 0.308 . . . . 0.71 111.157 179.544 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 47.4 tp -59.22 -46.17 89.17 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.298 -0.41 . . . . 0.55 111.136 178.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' TYR . . . . . 0.487 ' OH ' ' HG3' ' A' ' 281' ' ' ARG . 0.1 OUTLIER -60.87 -49.27 78.14 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.413 -0.358 . . . . 0.56 111.545 179.658 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 62.3 mtp180 -62.07 -48.82 78.52 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 112.146 0.424 . . . . 0.49 112.146 -179.154 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' GLN . . . . . 0.418 ' HA ' ' HB2' ' A' ' 183' ' ' ALA . 54.7 mm-40 -61.05 -46.84 89.05 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.732 0.301 . . . . 0.65 110.28 179.354 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' SER . . . . . 0.407 ' HA ' ' CZ2' ' A' ' 293' ' ' TRP . 16.6 m -61.73 -48.86 78.83 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.217 -0.447 . . . . 0.29 111.078 179.313 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.739 ' HA ' HG21 ' A' ' 276' ' ' THR . 2.0 tm? -56.29 -47.82 77.87 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.65 0.262 . . . . 0.65 110.561 179.487 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -64.54 -48.08 76.41 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.126 0.417 . . . . 0.64 112.126 179.669 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 78.5 mt -67.25 -51.36 53.91 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 N-CA-C 113.022 0.749 . . . . 0.33 113.022 -179.091 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.514 HD12 HG23 ' A' ' 276' ' ' THR . 80.2 mt -60.74 -49.35 84.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 O-C-N 122.279 -0.263 . . . . 0.41 111.528 -179.35 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 164' ' ' SER . . . . . 0.505 ' O ' ' HB2' ' A' ' 168' ' ' ARG . 3.1 t -57.99 -38.04 75.36 Favored 'General case' 0 N--CA 1.462 0.153 0 N-CA-C 110.249 -0.278 . . . . 0.61 110.249 178.841 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.64 -55.74 31.2 Favored 'General case' 0 C--O 1.22 -0.463 0 CA-C-N 116.563 -0.289 . . . . 0.34 110.967 179.344 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 166' ' ' TYR . . . . . 0.655 ' CE1' ' HA ' ' A' ' 195' ' ' ARG . 76.4 t80 -61.26 -51.94 66.81 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 112.495 0.554 . . . . 0.52 112.495 -178.8 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.5 ' HG ' ' O ' ' A' ' 163' ' ' ILE . 33.9 mt -58.76 -48.62 80.57 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 120.713 0.292 . . . . 0.45 111.761 -179.025 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 168' ' ' ARG . . . . . 0.505 ' HB2' ' O ' ' A' ' 164' ' ' SER . 0.7 OUTLIER -70.97 -45.05 64.77 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 112.318 0.488 . . . . 0.39 112.318 -179.689 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -60.72 -44.35 96.74 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 112.049 0.389 . . . . 0.46 112.049 -179.19 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -66.73 -48.42 69.26 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.935 -0.306 . . . . 0.93 111.467 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.543 ' HA ' ' HG2' ' A' ' 257' ' ' LYS . . . . . . . . 0 C--N 1.329 -0.304 0 N-CA-C 112.54 0.57 . . . . 0.33 112.54 -179.223 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.436 ' O ' ' HA3' ' A' ' 187' ' ' GLY . . . . . . . . 0 CA--C 1.535 0.386 0 CA-C-O 120.941 0.4 . . . . 0.34 111.543 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -79.13 -70.74 1.3 Allowed Glycine 0 CA--C 1.527 0.818 0 C-N-CA 120.984 -0.626 . . . . 0.33 114.396 -179.428 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -70.19 -57.42 4.94 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 112.48 0.548 . . . . 0.39 112.48 -178.565 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -62.93 -32.13 73.36 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 121.111 0.482 . . . . 0.32 110.087 179.241 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 187' ' ' GLY . . . . . 0.436 ' HA3' ' O ' ' A' ' 183' ' ' ALA . . . -72.93 -38.0 56.32 Favored Glycine 0 C--O 1.22 -0.73 0 CA-C-N 115.281 -0.872 . . . . 0.26 112.819 179.245 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 188' ' ' ARG . . . . . 0.402 ' HD3' ' HA ' ' A' ' 188' ' ' ARG . 13.1 tpp180 -61.29 -46.73 89.12 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 117.532 0.666 . . . . 0.8 110.877 179.435 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 189' ' ' ARG . . . . . 0.434 ' HB3' HG11 ' A' ' 297' ' ' VAL . 49.1 mtp180 -67.13 -38.99 86.5 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.251 0.548 . . . . 0.4 110.553 178.799 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 190' ' ' ALA . . . . . 0.669 ' HA ' HG22 ' A' ' 297' ' ' VAL . . . -69.83 -38.12 76.42 Favored 'General case' 0 C--O 1.224 -0.269 0 CA-C-N 115.701 -0.681 . . . . 0.26 111.68 179.586 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 20.4 tp -65.81 -47.7 74.18 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 111.531 0.197 . . . . 0.45 111.531 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 192' ' ' GLU . . . . . 0.693 ' O ' ' HG2' ' A' ' 196' ' ' ARG . 5.8 tm-20 -58.62 -47.36 84.64 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 108.964 -0.754 . . . . 0.36 108.964 178.37 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 38.9 m -58.21 -52.36 65.91 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 115.755 -0.657 . . . . 0.27 110.998 178.25 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 194' ' ' LEU . . . . . 0.422 HD21 HG21 ' A' ' 249' ' ' ILE . 26.9 tp -63.28 -38.68 92.12 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 112.916 0.71 . . . . 0.37 112.916 -179.5 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 195' ' ' ARG . . . . . 0.655 ' HA ' ' CE1' ' A' ' 166' ' ' TYR . 3.5 ttm-85 -64.97 -47.24 78.32 Favored 'General case' 0 C--N 1.333 -0.142 0 O-C-N 122.234 -0.291 . . . . 0.58 110.825 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 196' ' ' ARG . . . . . 0.693 ' HG2' ' O ' ' A' ' 192' ' ' GLU . 33.0 mmm-85 -66.01 -52.78 46.29 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.617 0.246 . . . . 0.47 110.836 179.819 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 197' ' ' VAL . . . . . 0.564 HG21 ' HB3' ' A' ' 300' ' ' PHE . 69.4 t -60.65 -51.77 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-N 116.464 -0.335 . . . . 0.33 111.618 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -56.54 -45.28 90.11 Favored Glycine 0 C--N 1.333 0.394 0 C-N-CA 121.389 -0.434 . . . . 0.32 113.042 -179.171 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 199' ' ' ASP . . . . . 0.423 ' HA ' ' HG2' ' A' ' 202' ' ' GLN . 33.3 m-20 -67.11 -33.69 76.01 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.658 0.266 . . . . 0.36 110.416 179.173 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -68.93 -32.88 73.9 Favored Glycine 0 CA--C 1.523 0.548 0 C-N-CA 120.72 -0.752 . . . . 0.25 112.002 178.385 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 201' ' ' VAL . . . . . 0.579 HG11 ' HA ' ' A' ' 247' ' ' THR . 92.3 t -72.82 -46.48 52.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 CA-C-O 120.687 0.28 . . . . 0.35 111.17 179.181 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 202' ' ' GLN . . . . . 0.423 ' HG2' ' HA ' ' A' ' 199' ' ' ASP . 11.3 pt20 -70.58 -32.5 69.91 Favored 'General case' 0 C--O 1.22 -0.48 0 CA-C-N 116.354 -0.384 . . . . 0.61 111.322 -179.697 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 23.3 ttm180 -68.95 -50.4 49.61 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.798 0.332 . . . . 2.99 110.706 178.712 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 18.9 m-80 -62.45 -44.46 96.35 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.269 -0.423 . . . . 0.62 111.235 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 87.9 m-70 -103.03 36.28 2.28 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 112.382 0.512 . . . . 0.44 112.382 -179.462 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -58.01 -42.64 85.67 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 112.613 0.597 . . . . 0.96 112.613 -179.256 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 34.0 p -61.24 -53.05 61.82 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.88 0.371 . . . . 0.53 111.709 -179.529 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -61.54 -43.73 98.34 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.096 -0.502 . . . . 0.44 110.61 179.041 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 3.3 m-30 -60.94 -52.04 66.72 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 116.107 -0.497 . . . . 0.45 111.05 179.688 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 20.1 mt-30 -59.97 -42.74 94.79 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 120.519 0.2 . . . . 0.74 111.249 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -61.21 -51.13 60.21 Favored Glycine 0 C--N 1.335 0.477 0 C-N-CA 120.611 -0.804 . . . . 0.36 111.993 178.815 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 212' ' ' MET . . . . . 0.65 ' HB3' ' HB3' ' B' ' 23' ' ' PHE . 71.2 mtm -66.34 -31.98 73.1 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 120.586 0.231 . . . . 0.73 110.991 179.344 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 10.3 tp -63.51 -41.95 98.49 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.958 0.408 . . . . 0.55 110.742 178.842 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 214' ' ' ARG . . . . . 0.427 HH11 ' HD3' ' A' ' 214' ' ' ARG . 39.7 mtt-85 -70.86 -31.74 68.52 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.038 -0.528 . . . . 0.96 111.04 179.414 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -72.8 -21.17 61.02 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 120.971 0.415 . . . . 0.78 111.044 178.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 216' ' ' LEU . . . . . 0.797 ' HB3' HG12 ' A' ' 218' ' ' ILE . 66.6 mt -72.78 135.37 45.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.02 0.438 . . . . 0.56 111.842 179.617 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -87.79 23.05 2.11 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 116.257 -0.429 . . . . 0.62 110.696 179.08 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 218' ' ' ILE . . . . . 0.797 HG12 ' HB3' ' A' ' 216' ' ' LEU . 50.6 mm -59.47 106.72 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-N 115.723 -0.671 . . . . 0.46 111.627 -179.682 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -154.97 -68.78 0.13 Allowed 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.957 -0.565 . . . . 0.62 111.55 -179.537 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -90.97 -176.48 4.65 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 115.793 -0.64 . . . . 0.63 112.579 -178.588 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -47.0 -22.45 0.33 Allowed 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 113.34 0.867 . . . . 1.44 113.34 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 222' ' ' GLY . . . . . 0.458 ' HA2' ' HD2' ' A' ' 225' ' ' LYS . . . -69.7 -22.53 76.81 Favored Glycine 0 CA--C 1.529 0.968 0 CA-C-N 116.522 -0.308 . . . . 0.44 113.134 178.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 223' ' ' ASP . . . . . 0.692 ' HB2' HG23 ' A' ' 218' ' ' ILE . 1.3 p-10 -56.31 -47.44 78.7 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 113.193 0.812 . . . . 0.8 113.193 -178.392 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 31.5 m -60.32 -32.0 49.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-O 121.001 0.429 . . . . 1.63 111.482 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 225' ' ' LYS . . . . . 0.458 ' HD2' ' HA2' ' A' ' 222' ' ' GLY . 36.9 mttp -76.82 -42.19 41.41 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.315 -0.624 . . . . 0.85 109.315 178.69 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 226' ' ' SER . . . . . 0.518 ' O ' ' HB3' ' A' ' 229' ' ' ARG . 19.9 m -63.16 -42.56 99.46 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 115.321 -0.854 . . . . 0.35 110.568 178.856 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 227' ' ' PHE . . . . . 0.582 ' O ' ' HG3' ' A' ' 231' ' ' MET . 13.8 t80 -65.39 -48.78 71.67 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.936 -0.575 . . . . 0.56 110.141 179.081 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 30.3 t -56.01 -39.09 71.39 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 109.549 -0.537 . . . . 0.42 109.549 178.211 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 229' ' ' ARG . . . . . 0.518 ' HB3' ' O ' ' A' ' 226' ' ' SER . 19.1 ttt180 -55.95 -44.54 78.53 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 115.165 -0.925 . . . . 0.78 110.23 177.795 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 47.6 t -68.78 -42.73 82.98 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-N 116.292 -0.413 . . . . 0.31 110.804 178.388 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 231' ' ' MET . . . . . 0.582 ' HG3' ' O ' ' A' ' 227' ' ' PHE . 47.8 mtp -58.14 -53.0 63.22 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 120.84 0.352 . . . . 0.37 111.492 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 34.5 m -65.58 -30.79 51.23 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 CA-C-N 116.484 -0.326 . . . . 0.34 111.558 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 42.4 t-80 -61.47 -54.79 38.76 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 111.76 0.282 . . . . 0.41 111.76 179.198 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.813 ' HB ' ' HB3' ' B' ' 28' ' ' ARG . 4.0 m -66.4 -29.44 46.6 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 N-CA-C 112.224 0.453 . . . . 0.36 112.224 -178.606 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 36.4 m-85 -100.63 22.18 12.26 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 111.999 0.37 . . . . 0.54 111.999 179.419 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 236' ' ' LYS . . . . . 0.438 ' HA ' ' HD2' ' A' ' 236' ' ' LYS . 14.9 tptp -79.75 -21.36 44.55 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.87 0.366 . . . . 0.93 111.545 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 237' ' ' ASP . . . . . 0.418 ' OD1' ' N ' ' A' ' 237' ' ' ASP . 0.0 OUTLIER -69.54 -15.96 63.33 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.096 -0.502 . . . . 0.5 112.085 -179.841 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 90.92 -19.25 46.88 Favored Glycine 0 CA--C 1.521 0.439 0 C-N-CA 120.929 -0.653 . . . . 0.37 113.689 179.089 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 239' ' ' VAL . . . . . 0.409 HG12 ' HB2' ' A' ' 237' ' ' ASP . 3.3 p -86.49 113.55 24.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.34 0.591 . . . . 0.38 110.848 179.597 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 59.7 m -93.63 106.25 18.23 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.088 0.471 . . . . 0.4 111.807 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 241' ' ' ASN . . . . . 0.533 ' HB2' ' HG3' ' A' ' 244' ' ' ARG . 94.8 m-20 -95.39 129.81 42.41 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.937 -0.574 . . . . 0.4 110.43 178.862 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 242' ' ' TRP . . . . . 0.612 ' HB3' ' CZ ' ' A' ' 300' ' ' PHE . 1.6 m95 -53.29 -41.93 66.09 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 120.938 0.399 . . . . 0.45 111.58 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 243' ' ' GLY . . . . . 0.44 ' HA3' ' N ' ' B' ' 35' ' ' TYR . . . -64.28 -28.46 73.03 Favored Glycine 0 CA--C 1.521 0.463 0 C-N-CA 120.815 -0.707 . . . . 0.24 112.852 179.139 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 244' ' ' ARG . . . . . 0.533 ' HG3' ' HB2' ' A' ' 241' ' ' ASN . 63.8 mtt180 -70.69 -39.06 73.7 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 122.47 -0.429 . . . . 0.41 110.127 179.194 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 64.0 mt -63.99 -52.28 58.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 CA-C-N 115.82 -0.627 . . . . 0.44 111.229 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 16.8 m -62.38 -35.87 71.82 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 C-N-CA 120.937 -0.305 . . . . 0.32 111.293 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 247' ' ' THR . . . . . 0.579 ' HA ' HG11 ' A' ' 201' ' ' VAL . 99.6 m -64.05 -42.4 97.06 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.076 0.465 . . . . 0.45 109.996 178.159 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 18.9 tp -65.1 -43.6 91.55 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.774 -0.648 . . . . 2.02 110.304 178.71 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 249' ' ' ILE . . . . . 0.422 HG21 HD21 ' A' ' 194' ' ' LEU . 28.9 mt -64.66 -42.49 95.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 109.757 -0.46 . . . . 0.38 109.757 178.285 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 45.5 t -61.03 -38.23 85.39 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.786 -0.643 . . . . 0.42 109.842 178.084 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 251' ' ' PHE . . . . . 0.476 ' O ' HG23 ' A' ' 255' ' ' VAL . 34.1 t80 -69.88 -41.37 74.86 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.545 -0.752 . . . . 0.38 109.921 177.945 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -58.69 -43.93 96.03 Favored Glycine 0 C--N 1.335 0.515 0 N-CA-C 111.134 -0.786 . . . . 0.32 111.134 178.165 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -61.24 -40.64 94.8 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-O 120.844 0.355 . . . . 0.4 110.087 177.593 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -60.22 -43.44 96.02 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 116.023 -0.535 . . . . 0.66 109.793 178.17 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 255' ' ' VAL . . . . . 0.476 HG23 ' O ' ' A' ' 251' ' ' PHE . 64.8 t -66.26 -40.76 87.71 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-N 115.736 -0.666 . . . . 0.33 110.323 178.393 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -62.48 -45.76 91.59 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.318 -0.401 . . . . 0.32 110.155 177.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 257' ' ' LYS . . . . . 0.543 ' HG2' ' HA ' ' A' ' 171' ' ' ALA . 48.0 mtmt -58.98 -45.03 91.59 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.953 -0.567 . . . . 0.52 109.964 177.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -61.63 -34.81 76.33 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.789 -0.641 . . . . 0.35 109.903 178.783 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.787 ' HG ' ' HB3' ' A' ' 264' ' ' GLN . 2.9 tp -72.12 -32.62 67.12 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 121.251 0.548 . . . . 0.47 110.036 178.096 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 260' ' ' LYS . . . . . 0.669 ' HE3' ' HG3' ' A' ' 265' ' ' GLU . 0.0 OUTLIER -75.4 -31.1 60.31 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 121.118 0.485 . . . . 0.68 110.4 178.069 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 26.7 t -64.07 -19.26 65.1 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.125 -0.489 . . . . 0.49 110.71 178.74 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 262' ' ' VAL . . . . . 0.427 HG23 ' HB2' ' A' ' 264' ' ' GLN . 31.2 m -114.14 13.81 8.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-N 116.149 -0.478 . . . . 0.53 110.613 178.311 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 6.1 t30 55.91 49.32 16.16 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 115.521 -0.763 . . . . 1.28 112.861 179.324 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 264' ' ' GLN . . . . . 0.787 ' HB3' ' HG ' ' A' ' 259' ' ' LEU . 4.3 tt0 -113.26 39.13 2.67 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 112.027 0.381 . . . . 1.21 112.027 -179.729 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 265' ' ' GLU . . . . . 0.669 ' HG3' ' HE3' ' A' ' 260' ' ' LYS . 26.4 mt-10 -48.54 -35.96 14.38 Favored 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 112.934 0.716 . . . . 0.38 112.934 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -56.54 -24.69 48.58 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 112.377 0.51 . . . . 1.0 112.377 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 267' ' ' PHE . . . . . 0.455 ' C ' ' HD2' ' A' ' 270' ' ' PRO . 23.3 m-85 -99.37 -16.74 18.31 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 120.974 0.416 . . . . 1.19 111.001 179.214 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 268' ' ' ILE . . . . . 0.557 HD12 ' HA ' ' A' ' 265' ' ' GLU . 67.3 mt -67.15 -43.22 88.68 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-N 116.209 -0.45 . . . . 0.39 110.564 179.251 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 269' ' ' GLU . . . . . 0.711 ' HB2' ' HD3' ' A' ' 270' ' ' PRO . 2.1 mm-40 -55.26 -56.66 26.14 Favored Pre-proline 0 CA--C 1.543 0.692 0 CA-C-N 116.295 -0.411 . . . . 0.38 111.14 179.361 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 270' ' ' PRO . . . . . 0.711 ' HD3' ' HB2' ' A' ' 269' ' ' GLU . 38.1 Cg_exo -59.61 -34.89 96.47 Favored 'Trans proline' 0 C--N 1.362 1.259 0 C-N-CA 122.253 1.969 . . . . 0.36 112.247 178.295 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 271' ' ' LEU . . . . . . . . . . . . . 43.2 tp -64.91 -51.14 63.51 Favored 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 110.128 -0.323 . . . . 0.56 110.128 178.726 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -59.02 -42.87 91.21 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 120.997 0.427 . . . . 0.38 110.458 178.471 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 273' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -63.45 -44.53 94.22 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 115.912 -0.585 . . . . 1.97 110.056 178.231 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 274' ' ' THR . . . . . . . . . . . . . 99.6 m -60.31 -48.4 81.9 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.236 -0.438 . . . . 0.49 110.381 178.556 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 275' ' ' ILE . . . . . 0.569 ' O ' ' HB2' ' A' ' 279' ' ' LEU . 95.9 mt -54.89 -47.67 75.28 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.096 0 CA-C-N 115.982 -0.554 . . . . 0.46 110.384 179.051 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 276' ' ' THR . . . . . 0.739 HG21 ' HA ' ' A' ' 160' ' ' LEU . 37.9 m -62.95 -52.06 64.5 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.247 -0.433 . . . . 0.34 111.203 179.374 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 277' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -51.94 -53.86 36.24 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.135 -0.484 . . . . 0.46 111.21 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 278' ' ' VAL . . . . . 0.574 ' O ' HG22 ' A' ' 282' ' ' THR . 60.7 t -63.32 -43.57 98.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-O 120.47 0.176 . . . . 0.38 110.883 179.291 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 279' ' ' LEU . . . . . 0.569 ' HB2' ' O ' ' A' ' 275' ' ' ILE . 0.3 OUTLIER -56.01 -47.84 77.02 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.604 -0.271 . . . . 0.84 111.313 179.967 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 57.0 t -75.38 -48.69 30.07 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 N-CA-C 111.729 0.27 . . . . 0.43 111.729 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 281' ' ' ARG . . . . . 0.487 ' HG3' ' OH ' ' A' ' 156' ' ' TYR . 31.2 mtp180 -54.69 -40.09 68.8 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 112.941 0.719 . . . . 0.55 112.941 -179.413 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 282' ' ' THR . . . . . 0.574 HG22 ' O ' ' A' ' 278' ' ' VAL . 6.9 t -91.03 4.62 51.63 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 120.191 -0.603 . . . . 0.39 112.289 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 283' ' ' LYS . . . . . 0.661 ' HZ3' ' HB2' ' A' ' 283' ' ' LYS . 0.0 OUTLIER -141.23 40.83 1.77 Allowed 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 120.92 0.39 . . . . 0.52 111.328 179.777 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -66.1 -62.33 1.55 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.109 0.481 . . . . 0.49 111.84 -179.274 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -65.32 -45.05 85.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.912 -0.585 . . . . 0.63 112.214 -179.331 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 286' ' ' TRP . . . . . 0.464 ' O ' ' HB2' ' A' ' 290' ' ' GLN . 2.2 t90 -58.12 -38.89 77.37 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 112.38 0.511 . . . . 0.59 112.38 -179.214 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 287' ' ' LEU . . . . . 0.57 HD23 ' HB3' ' A' ' 283' ' ' LYS . 1.2 mm? -70.59 -49.42 47.98 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.776 0.288 . . . . 0.46 111.776 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 9.1 p -62.83 -34.32 65.25 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-O 120.752 0.31 . . . . 0.55 111.409 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 43.5 mttp -75.47 -21.55 57.99 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 120.751 0.31 . . . . 0.87 111.473 178.785 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 290' ' ' GLN . . . . . 0.464 ' HB2' ' O ' ' A' ' 286' ' ' TRP . 0.0 OUTLIER -100.47 29.1 4.59 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 112.66 0.615 . . . . 0.79 112.66 -179.123 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 291' ' ' ARG . . . . . 0.465 ' HD2' ' HB3' ' A' ' 294' ' ' ASP . 8.1 ttm180 64.71 13.11 8.15 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 112.809 0.67 . . . . 0.84 112.809 179.076 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 65.82 -141.13 41.41 Favored Glycine 0 CA--C 1.525 0.692 0 C-N-CA 121.04 -0.6 . . . . 0.34 114.036 179.388 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 293' ' ' TRP . . . . . 0.623 ' O ' HG23 ' A' ' 297' ' ' VAL . 84.7 m95 -65.39 -32.22 73.74 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.29 0.478 . . . . 0.51 112.29 -179.149 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 294' ' ' ASP . . . . . 0.465 ' HB3' ' HD2' ' A' ' 291' ' ' ARG . 16.1 t70 -59.97 -37.95 81.11 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 121.102 0.477 . . . . 0.74 109.837 178.34 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -65.3 -43.2 95.56 Favored Glycine 0 C--N 1.335 0.511 0 N-CA-C 110.786 -0.926 . . . . 0.26 110.786 177.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 296' ' ' PHE . . . . . 0.513 ' HB2' ' CH2' ' A' ' 242' ' ' TRP . 0.8 OUTLIER -63.03 -46.71 86.29 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 120.88 0.371 . . . . 0.32 110.457 177.947 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 297' ' ' VAL . . . . . 0.669 HG22 ' HA ' ' A' ' 190' ' ' ALA . 90.9 t -59.89 -49.27 84.56 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.395 0 CA-C-N 115.922 -0.581 . . . . 0.32 111.242 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -61.8 -46.57 88.95 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.066 0.395 . . . . 0.97 112.066 -179.684 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 299' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -61.84 -42.29 98.85 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 112.419 0.525 . . . . 0.45 112.419 -179.178 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 300' ' ' PHE . . . . . 0.612 ' CZ ' ' HB3' ' A' ' 242' ' ' TRP . 76.5 m-85 . . . . . 0 CA--C 1.537 0.454 0 N-CA-C 113.133 0.79 . . . . 0.39 113.133 -178.583 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.236 0.381 0 N-CA-C 109.527 -0.545 . . . . 0.47 109.527 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 23' ' ' PHE . . . . . 0.65 ' HB3' ' HB3' ' A' ' 212' ' ' MET . 0.0 OUTLIER -59.29 -43.84 92.53 Favored 'General case' 0 C--O 1.225 -0.198 0 CA-C-N 115.669 -0.696 . . . . 0.36 110.55 179.076 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.85 -43.35 77.0 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 115.968 -0.56 . . . . 0.32 111.515 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 25' ' ' ALA . . . . . 0.478 ' O ' ' HG3' ' B' ' 28' ' ' ARG . . . -61.08 -49.55 76.85 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 116.162 -0.472 . . . . 0.28 111.282 179.732 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 13.7 mt-30 -68.63 -42.25 78.33 Favored 'General case' 0 C--O 1.224 -0.255 0 CA-C-N 116.304 -0.407 . . . . 0.54 111.202 179.785 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 16.0 mt -55.53 -49.39 72.75 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.607 -0.27 . . . . 0.59 111.556 179.777 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 28' ' ' ARG . . . . . 0.813 ' HB3' ' HB ' ' A' ' 234' ' ' VAL . 0.0 OUTLIER -65.29 -37.04 85.95 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 120.473 -0.491 . . . . 0.56 110.519 179.267 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 29' ' ' LYS . . . . . 0.566 ' HA ' ' HE3' ' B' ' 29' ' ' LYS . 0.0 OUTLIER -65.71 -40.56 92.37 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 109.62 -0.511 . . . . 0.48 109.62 178.264 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 93.4 mt -63.68 -39.94 87.22 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 N-CA-C 108.51 -0.922 . . . . 0.4 108.51 176.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 31' ' ' GLY . . . . . 0.525 ' HA3' ' HG2' ' A' ' 244' ' ' ARG . . . -60.4 -49.55 77.31 Favored Glycine 0 C--N 1.334 0.445 0 N-CA-C 111.192 -0.763 . . . . 0.23 111.192 177.671 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -56.9 -38.11 72.36 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.165 0.507 . . . . 0.43 109.665 177.813 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.61 -58.5 5.59 Favored 'General case' 0 C--O 1.227 -0.108 0 CA-C-N 115.613 -0.721 . . . . 0.61 110.598 179.024 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 85.9 t -54.86 -39.52 48.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-O 121.185 0.517 . . . . 0.37 110.289 179.174 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 35' ' ' TYR . . . . . 0.44 ' N ' ' HA3' ' A' ' 243' ' ' GLY . 9.4 t80 -58.47 -52.49 65.43 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.557 -0.747 . . . . 0.45 110.804 178.487 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 36' ' ' CYS . . . . . 0.439 ' HA ' ' OG ' ' B' ' 39' ' ' SER . 19.9 p -70.03 -25.3 63.51 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.739 0.304 . . . . 0.4 111.033 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 30.6 m -63.71 -44.08 94.68 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.454 -0.339 . . . . 0.4 111.349 179.626 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 38' ' ' TRP . . . . . . . . . . . . . 95.4 m95 -85.68 -30.25 23.33 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 120.742 0.306 . . . . 0.5 111.632 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 39' ' ' SER . . . . . 0.439 ' OG ' ' HA ' ' B' ' 36' ' ' CYS . 54.7 p . . . . . 0 N--CA 1.47 0.559 0 N-CA-C 112.166 0.432 . . . . 0.66 112.166 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 . . . . . 0 CA--C 1.535 0.375 0 N-CA-C 112.197 0.443 . . . . 0.72 112.197 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -61.38 -45.32 94.86 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.765 0.317 . . . . 0.93 111.64 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 65.3 tp -61.27 -47.05 87.77 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.318 -0.401 . . . . 0.58 110.501 179.293 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' TYR . . . . . 0.412 ' O ' ' HB2' ' A' ' 160' ' ' LEU . 0.2 OUTLIER -66.53 -41.34 88.93 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 116.198 -0.456 . . . . 0.42 111.53 179.792 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.24 -51.94 66.83 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 112.538 0.57 . . . . 0.54 112.538 -179.411 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 158' ' ' GLN . . . . . 0.463 ' HA ' ' HB2' ' A' ' 183' ' ' ALA . 64.6 mt-30 -60.7 -45.55 93.79 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 120.702 0.287 . . . . 0.4 111.153 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 159' ' ' SER . . . . . 0.492 ' HA ' ' CZ2' ' A' ' 293' ' ' TRP . 4.0 p -62.88 -41.9 99.57 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.392 -0.367 . . . . 0.29 111.04 179.379 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.49 HD21 ' HA ' ' A' ' 273' ' ' GLU . 0.2 OUTLIER -58.14 -47.63 82.73 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 120.839 0.352 . . . . 0.73 110.306 178.887 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -64.56 -52.33 58.2 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 112.364 0.505 . . . . 0.56 112.364 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' ILE . . . . . 0.489 HG12 ' HA2' ' A' ' 187' ' ' GLY . 90.6 mt -59.05 -46.34 91.83 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 CA-C-N 116.754 -0.203 . . . . 0.3 111.348 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 86.7 mt -67.39 -41.82 86.69 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 121.135 -0.226 . . . . 0.37 110.792 178.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 33.3 t -61.0 -44.17 97.81 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.771 0.32 . . . . 0.32 110.914 179.144 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 165' ' ' ARG . . . . . 0.479 HH21 ' CD ' ' A' ' 169' ' ' GLU . 2.7 mtp180 -69.15 -52.14 31.17 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.572 -0.285 . . . . 0.73 111.697 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 166' ' ' TYR . . . . . 0.692 ' HE1' ' HA ' ' A' ' 195' ' ' ARG . 64.0 t80 -56.32 -45.58 80.26 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.553 0.216 . . . . 0.35 111.508 -179.676 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 5.6 mp -60.47 -50.08 75.01 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 121.188 -0.205 . . . . 0.49 111.22 -179.623 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 168' ' ' ARG . . . . . 0.528 ' HD2' ' OE2' ' A' ' 269' ' ' GLU . 9.3 mtp180 -66.95 -36.65 82.7 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 112.083 0.401 . . . . 0.86 112.083 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 169' ' ' GLU . . . . . 0.479 ' CD ' HH21 ' A' ' 165' ' ' ARG . 0.9 OUTLIER -66.12 -51.31 59.18 Favored 'General case' 0 N--CA 1.465 0.282 0 O-C-N 122.268 -0.27 . . . . 0.65 111.391 179.436 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 170' ' ' GLN . . . . . 0.451 ' HB2' ' HB1' ' A' ' 253' ' ' ALA . 4.4 mm-40 -64.84 -26.22 68.24 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-O 121.014 0.435 . . . . 0.87 110.323 178.545 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.156 0 CA-C-N 115.916 -0.584 . . . . 0.47 110.714 178.222 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.463 ' HB2' ' HA ' ' A' ' 158' ' ' GLN . . . . . . . . 0 CA--C 1.536 0.433 0 CA-C-O 121.06 0.457 . . . . 0.32 111.311 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -80.07 -70.31 1.34 Allowed Glycine 0 CA--C 1.527 0.803 0 N-CA-C 114.432 0.533 . . . . 0.36 114.432 -179.309 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -71.71 -55.48 7.6 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-O 121.063 0.458 . . . . 0.47 111.542 -179.434 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -63.51 -35.2 79.69 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.974 -0.557 . . . . 0.35 110.16 179.404 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 187' ' ' GLY . . . . . 0.617 ' O ' ' HB2' ' A' ' 191' ' ' LEU . . . -63.06 -31.8 81.94 Favored Glycine 0 C--N 1.333 0.403 0 C-N-CA 120.985 -0.626 . . . . 0.33 112.468 179.117 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 6.2 tpt180 -73.07 -57.04 4.31 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 120.635 0.255 . . . . 0.85 111.645 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 189' ' ' ARG . . . . . 0.551 ' HA ' ' OE1' ' A' ' 192' ' ' GLU . 0.0 OUTLIER -62.54 -41.27 98.78 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-O 121.032 0.444 . . . . 0.57 111.576 -179.266 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 190' ' ' ALA . . . . . 0.478 ' HB2' ' HB3' ' A' ' 293' ' ' TRP . . . -66.62 -37.06 84.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.362 -0.381 . . . . 0.31 110.909 179.064 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 191' ' ' LEU . . . . . 0.617 ' HB2' ' O ' ' A' ' 187' ' ' GLY . 0.2 OUTLIER -59.84 -41.5 91.51 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.608 0.242 . . . . 0.6 111.293 179.915 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 192' ' ' GLU . . . . . 0.551 ' OE1' ' HA ' ' A' ' 189' ' ' ARG . 5.3 mt-10 -67.14 -52.38 42.4 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.129 0.49 . . . . 0.51 111.422 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 193' ' ' THR . . . . . 0.565 HG21 ' HA ' ' A' ' 297' ' ' VAL . 4.6 m -65.12 -35.43 81.09 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.874 -0.603 . . . . 0.42 112.265 -179.059 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 194' ' ' LEU . . . . . 0.411 HD12 ' HA ' ' A' ' 194' ' ' LEU . 12.6 tp -69.79 -37.7 76.42 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.694 0.283 . . . . 0.4 111.048 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 195' ' ' ARG . . . . . 0.692 ' HA ' ' HE1' ' A' ' 166' ' ' TYR . 1.7 ttt180 -66.5 -45.47 79.49 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-O 120.979 0.419 . . . . 0.44 110.882 179.181 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 18.6 mmt85 -64.83 -56.58 12.6 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.821 -0.627 . . . . 0.98 111.959 -179.209 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 197' ' ' VAL . . . . . 0.458 ' O ' HG23 ' A' ' 201' ' ' VAL . 98.8 t -66.24 -41.65 89.54 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 CA-C-O 120.901 0.381 . . . . 0.38 111.423 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 198' ' ' GLY . . . . . 0.503 ' HA3' ' OH ' ' A' ' 166' ' ' TYR . . . -62.0 -52.39 50.46 Favored Glycine 0 CA--C 1.522 0.484 0 C-N-CA 121.178 -0.534 . . . . 0.3 113.494 -179.694 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -63.83 -40.14 95.88 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 117.385 0.592 . . . . 0.57 109.902 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -53.86 -44.97 71.33 Favored Glycine 0 C--N 1.337 0.599 0 C-N-CA 120.621 -0.8 . . . . 0.39 111.603 178.318 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 201' ' ' VAL . . . . . 0.458 HG23 ' O ' ' A' ' 197' ' ' VAL . 88.9 t -72.37 -36.88 56.42 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-O 121.137 0.494 . . . . 0.38 110.949 178.582 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 202' ' ' GLN . . . . . 0.419 ' HA ' ' CE2' ' A' ' 209' ' ' PHE . 14.7 tt0 -64.39 -34.64 78.63 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 115.926 -0.579 . . . . 0.38 111.415 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 17.0 mmp_? -80.54 -53.75 6.29 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 112.998 0.74 . . . . 0.42 112.998 -179.358 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 24.1 p30 -67.33 -31.0 70.97 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 119.836 -0.745 . . . . 0.49 111.879 -179.125 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 42.3 m80 -102.31 26.86 7.28 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 121.023 -0.271 . . . . 0.49 111.25 178.54 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -53.21 -54.9 29.28 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 115.995 -0.548 . . . . 0.75 112.276 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 43.0 p -58.05 -47.12 84.1 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.078 -0.51 . . . . 0.64 111.882 -179.617 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -59.46 -44.61 92.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.249 -0.432 . . . . 0.43 110.285 179.088 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 209' ' ' PHE . . . . . 0.419 ' CE2' ' HA ' ' A' ' 202' ' ' GLN . 10.8 m-30 -63.77 -50.96 66.96 Favored 'General case' 0 C--O 1.223 -0.335 0 CA-C-N 115.973 -0.558 . . . . 0.44 110.751 179.246 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -57.41 -43.7 83.96 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 120.586 0.232 . . . . 0.74 111.553 179.571 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -61.21 -51.1 60.4 Favored Glycine 0 C--N 1.335 0.505 0 C-N-CA 120.821 -0.704 . . . . 0.43 112.345 179.199 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 212' ' ' MET . . . . . 0.433 ' HA ' ' HE3' ' A' ' 215' ' ' LYS . 0.7 OUTLIER -68.07 -34.82 77.15 Favored 'General case' 0 CA--C 1.531 0.212 0 O-C-N 122.592 -0.358 . . . . 0.73 111.086 179.3 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 8.7 tp -59.46 -39.22 82.92 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.96 0.409 . . . . 0.65 110.709 178.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 47.6 ttp180 -71.99 -36.3 69.73 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.944 -0.571 . . . . 1.23 110.521 178.899 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 215' ' ' LYS . . . . . 0.433 ' HE3' ' HA ' ' A' ' 212' ' ' MET . 52.6 mtmt -73.31 -37.46 66.18 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 116.266 -0.424 . . . . 1.33 112.021 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 216' ' ' LEU . . . . . 0.74 ' HB3' HG12 ' A' ' 218' ' ' ILE . 41.0 mt -63.55 131.64 48.72 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 121.147 0.498 . . . . 0.69 112.117 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -80.4 33.69 0.3 Allowed 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.005 -0.543 . . . . 1.36 111.648 179.633 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 218' ' ' ILE . . . . . 0.74 HG12 ' HB3' ' A' ' 216' ' ' LEU . 30.7 mm -71.42 105.47 1.78 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.302 0 CA-C-O 120.929 0.395 . . . . 0.49 111.564 -179.172 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 2.6 ttmm -163.07 -53.69 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 115.881 -0.6 . . . . 1.74 111.218 179.253 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 52.8 m-20 -104.41 -178.5 3.67 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 115.935 -0.575 . . . . 0.73 111.391 -179.522 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -46.7 -29.42 1.88 Allowed 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 113.482 0.919 . . . . 1.38 113.482 -179.272 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -62.22 -23.59 64.38 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 121.487 -0.387 . . . . 0.47 113.971 179.507 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 223' ' ' ASP . . . . . 0.515 ' HB2' HG23 ' A' ' 218' ' ' ILE . 2.1 p-10 -58.61 -52.15 66.89 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 113.625 0.972 . . . . 1.11 113.625 -178.297 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 19.6 m -58.66 -38.35 70.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 N-CA-C 112.205 0.446 . . . . 0.48 112.205 -179.407 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 85.7 mttt -69.09 -43.58 74.25 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.059 0.457 . . . . 0.86 110.29 179.245 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 226' ' ' SER . . . . . 0.573 ' O ' HG23 ' A' ' 230' ' ' VAL . 20.9 m -65.66 -46.6 78.54 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.84 -0.618 . . . . 0.38 110.265 179.289 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 227' ' ' PHE . . . . . 0.617 ' O ' ' HG3' ' A' ' 231' ' ' MET . 7.2 t80 -58.23 -43.34 87.73 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.918 -0.583 . . . . 0.57 110.521 179.167 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 228' ' ' SER . . . . . 0.429 ' O ' HG23 ' A' ' 232' ' ' VAL . 67.3 m -56.58 -44.16 80.75 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.023 0.44 . . . . 0.37 109.983 178.462 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 69.7 mtp180 -63.18 -35.97 82.06 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 115.885 -0.598 . . . . 1.17 110.321 178.547 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 230' ' ' VAL . . . . . 0.717 HG22 ' HE1' ' B' ' 23' ' ' PHE . 28.4 t -63.14 -51.94 65.11 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 N-CA-C 109.601 -0.518 . . . . 0.32 109.601 177.629 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 231' ' ' MET . . . . . 0.617 ' HG3' ' O ' ' A' ' 227' ' ' PHE . 54.0 mtp -57.23 -43.98 83.38 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.517 -0.765 . . . . 0.44 111.102 179.58 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 232' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 228' ' ' SER . 55.7 t -58.41 -40.91 80.02 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 N-CA-C 109.985 -0.376 . . . . 0.51 109.985 178.803 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 233' ' ' HIS . . . . . 0.571 ' HA ' ' HB2' ' A' ' 236' ' ' LYS . 54.9 t-80 -71.24 -39.96 71.34 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 116.048 -0.524 . . . . 0.58 111.039 178.725 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.519 HG23 ' O ' ' A' ' 230' ' ' VAL . 74.0 t -57.09 -38.92 63.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-O 120.749 0.309 . . . . 0.43 111.003 179.262 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -104.79 23.7 13.03 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 116.406 -0.361 . . . . 0.92 111.176 178.666 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 236' ' ' LYS . . . . . 0.571 ' HB2' ' HA ' ' A' ' 233' ' ' HIS . 5.9 tptp -70.52 -29.95 66.58 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 114.571 1.322 . . . . 1.46 114.571 -177.331 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -69.92 -16.93 63.29 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 118.643 0.656 . . . . 1.24 112.301 -178.656 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 98.7 -19.67 53.43 Favored Glycine 0 CA--C 1.522 0.527 0 C-N-CA 120.877 -0.678 . . . . 0.48 113.631 179.234 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 239' ' ' VAL . . . . . 0.432 ' HB ' ' NH2' ' A' ' 244' ' ' ARG . 21.8 t -77.22 118.12 23.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 121.147 0.499 . . . . 0.52 110.788 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -95.07 100.07 11.95 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.097 0.406 . . . . 0.76 112.097 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 241' ' ' ASN . . . . . 0.506 ' HB2' ' HG3' ' A' ' 244' ' ' ARG . 14.9 m120 -103.88 134.51 47.06 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 110.391 -0.226 . . . . 0.48 110.391 178.742 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 242' ' ' TRP . . . . . 0.502 ' HB3' ' CZ ' ' A' ' 300' ' ' PHE . 14.0 m95 -56.81 -27.48 59.99 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 112.127 0.417 . . . . 0.53 112.127 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 243' ' ' GLY . . . . . 0.412 ' H ' ' HB2' ' B' ' 35' ' ' TYR . . . -69.64 -29.57 71.27 Favored Glycine 0 CA--C 1.52 0.39 0 C-N-CA 121.186 -0.531 . . . . 0.32 112.9 179.761 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 244' ' ' ARG . . . . . 0.506 ' HG3' ' HB2' ' A' ' 241' ' ' ASN . 19.6 mtt180 -73.72 -37.15 65.22 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.297 0.57 . . . . 0.46 109.645 179.268 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 245' ' ' ILE . . . . . 0.692 HG23 HD21 ' A' ' 279' ' ' LEU . 83.0 mt -63.03 -51.8 67.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-N 115.446 -0.797 . . . . 0.46 110.998 179.197 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 17.4 m -66.71 -30.33 49.35 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 C-N-CA 120.795 -0.362 . . . . 0.36 111.322 179.502 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 17.4 m -64.07 -46.54 83.83 Favored 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 110.248 -0.278 . . . . 0.43 110.248 178.659 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 248' ' ' LEU . . . . . 0.449 HD13 ' HA ' ' A' ' 248' ' ' LEU . 2.5 mm? -60.82 -35.91 77.74 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 120.688 0.28 . . . . 0.66 110.769 178.633 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 249' ' ' ILE . . . . . 0.563 HG12 ' O ' ' A' ' 245' ' ' ILE . 35.5 mm -71.88 -47.08 57.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 CA-C-O 120.868 0.366 . . . . 0.4 110.436 178.916 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 39.6 t -59.59 -42.02 91.62 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 121.156 0.503 . . . . 0.31 109.708 178.515 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 251' ' ' PHE . . . . . 0.441 ' O ' HG23 ' A' ' 255' ' ' VAL . 8.9 t80 -65.72 -44.03 87.31 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 115.607 -0.724 . . . . 0.39 109.825 177.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -57.29 -41.63 93.08 Favored Glycine 0 C--N 1.338 0.653 0 N-CA-C 111.623 -0.591 . . . . 0.28 111.623 178.169 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 253' ' ' ALA . . . . . 0.451 ' HB1' ' HB2' ' A' ' 170' ' ' GLN . . . -63.83 -40.4 96.53 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 120.808 0.337 . . . . 0.3 110.513 177.62 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 21.9 t80 -67.51 -38.97 85.08 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-O 121.454 0.645 . . . . 0.52 109.944 178.278 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 255' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 251' ' ' PHE . 63.5 t -65.0 -46.65 90.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.775 -0.648 . . . . 0.39 109.445 178.021 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -57.91 -36.62 72.71 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.306 -0.406 . . . . 0.27 110.195 178.126 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 23.3 ttmm -60.21 -45.09 94.37 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 115.663 -0.699 . . . . 2.05 111.45 178.858 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 258' ' ' HIS . . . . . 0.434 ' CE1' HD13 ' A' ' 259' ' ' LEU . 0.3 OUTLIER -65.95 -34.97 79.33 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 120.731 0.3 . . . . 0.39 111.132 179.538 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.623 ' HG ' ' HB3' ' A' ' 264' ' ' GLN . 3.5 tp -76.83 -46.19 25.75 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 116.551 -0.295 . . . . 0.45 111.485 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 42.7 tttp -63.04 -27.23 69.26 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 120.608 0.242 . . . . 0.41 111.353 179.293 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 57.8 m -57.98 -26.74 62.73 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 121.004 0.43 . . . . 0.44 110.817 178.704 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 15.9 m -114.53 23.42 5.25 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 CA-C-O 121.305 0.574 . . . . 0.46 110.093 178.448 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 263' ' ' ASN . . . . . 0.458 ' HA ' ' OE2' ' A' ' 265' ' ' GLU . 1.7 m120 54.19 59.99 3.87 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 114.948 -1.024 . . . . 0.65 113.475 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 264' ' ' GLN . . . . . 0.623 ' HB3' ' HG ' ' A' ' 259' ' ' LEU . 5.9 mt-30 -119.86 35.61 4.79 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.238 -0.437 . . . . 0.91 110.771 178.485 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 265' ' ' GLU . . . . . 0.562 ' HA ' HG12 ' A' ' 268' ' ' ILE . 0.9 OUTLIER -59.9 -25.0 64.76 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 112.422 0.527 . . . . 0.62 112.422 -179.568 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 16.6 p -64.02 -16.69 62.21 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 120.586 0.231 . . . . 0.86 111.285 179.14 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 267' ' ' PHE . . . . . 0.506 ' O ' ' HD2' ' A' ' 270' ' ' PRO . 28.6 m-85 -98.96 -32.35 11.34 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 120.982 0.42 . . . . 1.07 111.333 179.082 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 268' ' ' ILE . . . . . 0.562 HG12 ' HA ' ' A' ' 265' ' ' GLU . 20.3 pt -68.07 -28.86 42.64 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 120.955 -0.298 . . . . 0.41 111.453 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 269' ' ' GLU . . . . . 0.844 ' HB2' ' HD3' ' A' ' 270' ' ' PRO . 39.0 mm-40 -57.27 -57.02 27.81 Favored Pre-proline 0 CA--C 1.546 0.82 0 N-CA-C 110.028 -0.36 . . . . 0.66 110.028 178.09 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 270' ' ' PRO . . . . . 0.844 ' HD3' ' HB2' ' A' ' 269' ' ' GLU . 32.0 Cg_exo -62.09 -30.51 82.67 Favored 'Trans proline' 0 C--N 1.362 1.287 0 C-N-CA 122.291 1.994 . . . . 0.44 111.605 177.07 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 271' ' ' LEU . . . . . . . . . . . . . 40.3 tp -64.93 -40.25 94.75 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.114 -0.494 . . . . 0.57 109.751 177.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -63.39 -40.31 96.88 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 109.096 -0.705 . . . . 0.43 109.096 177.623 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 273' ' ' GLU . . . . . 0.574 ' OE1' ' HA ' ' A' ' 270' ' ' PRO . 35.0 mt-10 -63.49 -41.94 98.54 Favored 'General case' 0 C--O 1.223 -0.332 0 N-CA-C 108.693 -0.854 . . . . 0.8 108.693 177.009 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 274' ' ' THR . . . . . . . . . . . . . 10.1 m -60.32 -53.19 60.63 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.387 -0.824 . . . . 0.54 110.905 178.406 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 275' ' ' ILE . . . . . 0.614 HG23 ' HE3' ' A' ' 231' ' ' MET . 97.3 mt -58.09 -46.0 88.3 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-N 116.127 -0.488 . . . . 0.48 111.042 179.738 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 16.6 m -66.21 -49.51 67.03 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.337 -0.392 . . . . 0.41 111.539 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 277' ' ' ASP . . . . . 0.633 ' OD1' ' HD2' ' A' ' 281' ' ' ARG . 25.8 t0 -58.65 -56.34 23.44 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.335 -0.393 . . . . 0.59 111.975 -179.146 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 278' ' ' VAL . . . . . 0.515 HG11 ' HB2' ' A' ' 231' ' ' MET . 61.6 t -58.98 -37.76 69.55 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 120.924 -0.31 . . . . 0.49 111.237 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 279' ' ' LEU . . . . . 0.692 HD21 HG23 ' A' ' 245' ' ' ILE . 28.1 tp -65.7 -46.5 78.79 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 111.98 0.363 . . . . 0.97 111.98 179.744 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 66.3 t -79.62 -51.25 16.76 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 N-CA-C 112.196 0.443 . . . . 0.53 112.196 -179.553 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 281' ' ' ARG . . . . . 0.633 ' HD2' ' OD1' ' A' ' 277' ' ' ASP . 3.0 mtt180 -55.11 -38.43 68.15 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 113.205 0.817 . . . . 0.92 113.205 -179.184 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 282' ' ' THR . . . . . . . . . . . . . 2.7 m -82.07 -12.7 58.11 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 112.332 0.493 . . . . 0.59 112.332 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 67.8 mmtt -135.04 41.55 2.83 Favored 'General case' 0 N--CA 1.468 0.47 0 O-C-N 122.063 -0.398 . . . . 0.95 111.774 -179.412 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 57.3 mtp180 -55.41 -54.44 43.74 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 112.805 0.669 . . . . 0.69 112.805 -178.791 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -56.98 -46.0 82.54 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 120.924 0.392 . . . . 0.63 111.85 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 286' ' ' TRP . . . . . 0.418 ' O ' ' HB2' ' A' ' 290' ' ' GLN . 0.8 OUTLIER -67.45 -43.1 81.91 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.029 0.381 . . . . 0.59 112.029 -179.375 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -69.13 -46.24 68.13 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 112.373 0.509 . . . . 0.56 112.373 -179.401 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 9.3 p -63.6 -37.11 78.75 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 121.059 -0.256 . . . . 0.57 111.588 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 64.9 mttt -75.03 -24.76 58.38 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 120.759 0.314 . . . . 0.98 111.301 179.236 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 290' ' ' GLN . . . . . 0.418 ' HB2' ' O ' ' A' ' 286' ' ' TRP . 0.0 OUTLIER -91.75 2.98 56.13 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 112.122 0.416 . . . . 0.58 112.122 179.907 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 291' ' ' ARG . . . . . 0.446 HH11 ' HD2' ' A' ' 291' ' ' ARG . 29.5 mtm180 64.06 17.19 10.48 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 112.493 0.553 . . . . 0.46 112.493 179.393 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 64.75 -114.58 6.91 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 114.852 0.701 . . . . 0.34 114.852 178.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 293' ' ' TRP . . . . . 0.492 ' CZ2' ' HA ' ' A' ' 159' ' ' SER . 82.2 m95 -66.26 -36.76 83.83 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 113.262 0.838 . . . . 0.49 113.262 -177.879 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 294' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -58.69 -47.5 84.32 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 120.826 0.346 . . . . 0.5 110.45 179.317 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -69.18 -27.5 73.69 Favored Glycine 0 CA--C 1.522 0.471 0 C-N-CA 120.397 -0.906 . . . . 0.29 111.481 178.081 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 296' ' ' PHE . . . . . 0.47 ' HB3' ' HA ' ' A' ' 293' ' ' TRP . 1.9 t80 -70.2 -48.32 57.63 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 122.561 0.345 . . . . 0.37 111.27 179.057 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 297' ' ' VAL . . . . . 0.565 ' HA ' HG21 ' A' ' 193' ' ' THR . 33.9 m -66.95 -32.62 58.81 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 CA-C-O 120.605 0.241 . . . . 0.36 111.388 -179.686 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -64.71 -53.54 45.67 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.791 0.329 . . . . 0.43 111.429 179.07 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 299' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -64.19 -33.83 76.69 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.322 -0.399 . . . . 0.6 111.952 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 300' ' ' PHE . . . . . 0.502 ' CZ ' ' HB3' ' A' ' 242' ' ' TRP . 70.2 m-85 . . . . . 0 C--N 1.325 -0.463 0 N-CA-C 112.515 0.561 . . . . 0.56 112.515 -179.246 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 7.4 tm-20 . . . . . 0 CA--C 1.531 0.22 0 CA-C-O 120.618 0.247 . . . . 1.46 110.596 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 23' ' ' PHE . . . . . 0.717 ' HE1' HG22 ' A' ' 230' ' ' VAL . 10.7 p90 -63.09 -35.41 80.17 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.104 0.478 . . . . 0.55 110.63 179.363 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.34 -44.62 64.74 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.986 -0.552 . . . . 0.36 109.986 178.831 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.05 -44.72 96.97 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.923 -0.58 . . . . 0.48 110.172 177.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 1.2 tp-100 -58.59 -48.9 79.4 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 115.548 -0.751 . . . . 0.88 110.161 178.591 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 45.6 mt -58.75 -40.55 84.17 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.292 -0.413 . . . . 0.47 110.637 178.669 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.89 -51.14 70.55 Favored 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 109.736 -0.468 . . . . 0.41 109.736 178.472 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 46.9 mtpt -55.61 -45.17 77.51 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 116.25 -0.432 . . . . 0.66 110.008 178.418 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 30' ' ' ILE . . . . . 0.514 ' O ' HG23 ' B' ' 34' ' ' VAL . 95.5 mt -59.21 -44.96 93.13 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 N-CA-C 109.719 -0.474 . . . . 0.45 109.719 178.123 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 31' ' ' GLY . . . . . 0.47 ' HA3' ' HG2' ' A' ' 244' ' ' ARG . . . -60.4 -49.55 77.35 Favored Glycine 0 C--N 1.336 0.534 0 CA-C-N 116.028 -0.533 . . . . 0.3 112.302 178.579 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -58.77 -38.82 79.34 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.18 0.514 . . . . 0.43 110.121 178.267 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -68.28 -47.67 67.03 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 115.75 -0.659 . . . . 0.98 111.353 179.247 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 34' ' ' VAL . . . . . 0.514 HG23 ' O ' ' B' ' 30' ' ' ILE . 53.9 t -56.65 -50.06 75.49 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-O 120.717 0.294 . . . . 0.34 111.422 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 35' ' ' TYR . . . . . 0.412 ' HB2' ' H ' ' A' ' 243' ' ' GLY . 0.0 OUTLIER -61.86 -38.57 88.73 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 120.881 0.372 . . . . 0.77 110.345 178.995 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 36' ' ' CYS . . . . . . . . . . . . . 21.4 t -68.03 -25.4 65.36 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.205 -0.452 . . . . 0.67 111.226 179.427 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 20.4 m -82.78 -42.14 18.31 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.189 -0.46 . . . . 0.49 111.977 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 38' ' ' TRP . . . . . . . . . . . . . 99.2 m95 -80.78 -22.9 39.69 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 112.54 0.571 . . . . 0.66 112.54 -179.198 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 20.3 t . . . . . 0 N--CA 1.468 0.472 0 N-CA-C 112.283 0.475 . . . . 0.76 112.283 179.888 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 153' ' ' ASP . . . . . 0.504 ' HA ' ' HB3' ' A' ' 156' ' ' TYR . 2.3 m-20 . . . . . 0 C--O 1.233 0.21 0 CA-C-O 120.904 0.383 . . . . 0.46 110.867 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -56.16 -37.09 69.06 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 121.368 0.604 . . . . 0.48 109.42 177.593 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 53.6 tp -83.44 -32.29 26.15 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.696 -0.684 . . . . 0.62 109.674 178.799 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' TYR . . . . . 0.504 ' HB3' ' HA ' ' A' ' 153' ' ' ASP . 83.3 t80 -62.18 -37.45 85.31 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 115.767 -0.651 . . . . 0.39 110.647 178.875 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 157' ' ' ARG . . . . . 0.475 ' NH2' HD23 ' A' ' 160' ' ' LEU . 0.7 OUTLIER -59.25 -44.88 92.36 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.039 0.447 . . . . 0.34 110.637 178.727 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -74.32 -35.3 63.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.253 -0.43 . . . . 0.66 110.014 178.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' SER . . . . . 0.467 ' HA ' ' NE1' ' A' ' 293' ' ' TRP . 64.8 m -59.03 -57.69 11.94 Favored 'General case' 0 CA--C 1.521 -0.144 0 CA-C-N 115.854 -0.612 . . . . 0.25 110.645 178.769 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.475 HD23 ' NH2' ' A' ' 157' ' ' ARG . 46.9 tp -62.01 -36.93 83.02 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 121.077 -0.249 . . . . 0.35 110.757 179.306 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.02 -54.11 50.78 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 120.792 0.329 . . . . 0.43 110.649 179.037 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 162' ' ' ILE . . . . . 0.517 HG12 ' HA2' ' A' ' 187' ' ' GLY . 54.8 mt -63.77 -45.45 97.2 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-N 116.093 -0.503 . . . . 0.28 111.381 179.631 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.466 ' O ' ' HG ' ' A' ' 167' ' ' LEU . 54.8 mt -61.33 -46.73 96.01 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 CA-C-N 116.5 -0.318 . . . . 0.33 111.243 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 31.4 t -62.34 -45.38 93.44 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.876 0.369 . . . . 0.38 110.495 178.696 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' ARG . . . . . 0.47 ' O ' ' HB2' ' A' ' 169' ' ' GLU . 0.0 OUTLIER -61.84 -46.13 90.8 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.2 -0.455 . . . . 0.66 111.587 -179.894 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 166' ' ' TYR . . . . . 0.864 ' HE1' ' HA ' ' A' ' 195' ' ' ARG . 91.6 t80 -70.36 -54.14 13.75 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 112.634 0.605 . . . . 0.4 112.634 -179.289 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.466 ' HG ' ' O ' ' A' ' 163' ' ' ILE . 29.8 mt -58.71 -49.74 76.48 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 112.516 0.561 . . . . 0.33 112.516 -177.743 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -66.03 -39.02 89.84 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 112.274 0.472 . . . . 1.09 112.274 -179.2 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 169' ' ' GLU . . . . . 0.47 ' HB2' ' O ' ' A' ' 165' ' ' ARG . 14.3 mm-40 -71.19 -47.93 54.62 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 120.56 -0.456 . . . . 0.44 111.755 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 170' ' ' GLN . . . . . 0.456 ' O ' ' HG3' ' A' ' 170' ' ' GLN . 0.5 OUTLIER -62.27 -28.02 69.42 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 120.918 0.39 . . . . 1.06 111.159 179.129 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.482 ' HB2' ' HB1' ' A' ' 256' ' ' ALA . . . . . . . . 0 N--CA 1.465 0.279 0 N-CA-C 112.7 0.63 . . . . 0.43 112.7 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.518 ' O ' ' HA3' ' A' ' 187' ' ' GLY . . . . . . . . 0 CA--C 1.536 0.416 0 CA-C-O 121.138 0.495 . . . . 0.33 111.542 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -80.43 -71.59 1.27 Allowed Glycine 0 CA--C 1.525 0.691 0 C-N-CA 120.88 -0.676 . . . . 0.34 113.986 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -66.83 -55.58 14.17 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 120.823 0.345 . . . . 0.42 111.808 -179.22 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -66.26 -37.04 84.53 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.265 -0.425 . . . . 0.36 110.235 179.192 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 187' ' ' GLY . . . . . 0.518 ' HA3' ' O ' ' A' ' 183' ' ' ALA . . . -64.85 -41.25 97.58 Favored Glycine 0 C--N 1.334 0.462 0 C-N-CA 120.909 -0.662 . . . . 0.29 112.667 179.282 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 188' ' ' ARG . . . . . 0.453 HH11 ' HD2' ' A' ' 188' ' ' ARG . 13.5 ttt180 -62.31 -53.47 54.63 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.621 0.248 . . . . 0.51 110.666 178.73 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 189' ' ' ARG . . . . . 0.757 ' HB3' HG11 ' A' ' 297' ' ' VAL . 73.7 mtt180 -59.63 -44.9 93.31 Favored 'General case' 0 C--O 1.228 -0.072 0 CA-C-N 116.24 -0.436 . . . . 0.41 110.98 179.549 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -69.45 -37.86 77.55 Favored 'General case' 0 C--O 1.218 -0.558 0 N-CA-C 112.817 0.673 . . . . 0.28 112.817 -178.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 18.6 tp -64.41 -49.15 72.68 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 118.178 0.444 . . . . 0.6 111.911 -179.383 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.4 -36.02 81.79 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.853 0.358 . . . . 0.4 111.044 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 193' ' ' THR . . . . . 0.505 HG21 ' HA ' ' A' ' 297' ' ' VAL . 48.2 m -73.05 -44.91 60.1 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.578 -0.283 . . . . 0.31 110.673 179.287 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 194' ' ' LEU . . . . . 0.474 HD21 HG21 ' A' ' 249' ' ' ILE . 14.7 tp -62.03 -36.46 81.64 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.41 -0.359 . . . . 0.39 110.531 179.181 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 195' ' ' ARG . . . . . 0.864 ' HA ' ' HE1' ' A' ' 166' ' ' TYR . 0.8 OUTLIER -63.96 -55.72 20.38 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.015 0.436 . . . . 0.35 110.683 178.449 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.33 -47.9 83.65 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.457 -0.792 . . . . 1.33 112.41 -179.71 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 197' ' ' VAL . . . . . 0.524 ' O ' HG23 ' A' ' 201' ' ' VAL . 83.0 t -72.82 -49.73 38.04 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 N-CA-C 111.97 0.359 . . . . 0.32 111.97 -179.461 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 198' ' ' GLY . . . . . 0.507 ' O ' ' HG2' ' A' ' 202' ' ' GLN . . . -57.61 -53.38 45.54 Favored Glycine 0 C--N 1.334 0.462 0 C-N-CA 121.187 -0.53 . . . . 0.33 112.498 -179.568 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 199' ' ' ASP . . . . . 0.551 ' HB2' ' O ' ' A' ' 195' ' ' ARG . 0.3 OUTLIER -59.17 -40.65 86.29 Favored 'General case' 0 C--O 1.224 -0.262 0 N-CA-C 109.841 -0.429 . . . . 0.72 109.841 178.783 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -62.4 -50.01 68.71 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 120.898 -0.668 . . . . 0.36 112.604 178.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 201' ' ' VAL . . . . . 0.524 HG23 ' O ' ' A' ' 197' ' ' VAL . 78.1 t -55.88 -52.63 47.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-O 120.743 0.306 . . . . 0.38 111.764 179.275 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 202' ' ' GLN . . . . . 0.533 ' HG3' ' CZ ' ' A' ' 203' ' ' ARG . 1.4 pt20 -69.53 -31.75 70.17 Favored 'General case' 0 C--O 1.221 -0.432 0 N-CA-C 112.091 0.404 . . . . 0.43 112.091 -179.382 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 203' ' ' ARG . . . . . 0.533 ' CZ ' ' HG3' ' A' ' 202' ' ' GLN . 0.0 OUTLIER -68.77 -43.43 75.77 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.955 0.407 . . . . 0.73 109.997 178.003 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 18.2 m-80 -66.35 -47.09 74.56 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 121.163 0.506 . . . . 0.6 110.604 178.703 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -97.76 36.26 1.55 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.028 -0.533 . . . . 0.47 110.216 179.182 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 206' ' ' GLU . . . . . 0.528 ' OE1' ' HA ' ' A' ' 203' ' ' ARG . 4.5 tp10 -49.72 -52.0 34.6 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 115.477 -0.783 . . . . 0.47 112.186 -178.804 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 64.7 p -65.66 -38.96 90.78 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.595 0.591 . . . . 0.59 112.595 -179.534 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -63.85 -45.51 89.17 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.066 0.46 . . . . 0.4 110.449 179.406 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -71.13 -42.34 69.34 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.976 -0.557 . . . . 0.48 110.475 179.57 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 210' ' ' GLN . . . . . 0.415 ' O ' ' HG3' ' A' ' 214' ' ' ARG . 6.7 tt0 -62.58 -45.88 90.89 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.188 -0.46 . . . . 0.81 110.852 179.243 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -59.93 -49.45 78.41 Favored Glycine 0 C--N 1.334 0.47 0 C-N-CA 120.902 -0.666 . . . . 0.32 111.82 178.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 212' ' ' MET . . . . . 0.488 ' SD ' ' HA ' ' B' ' 23' ' ' PHE . 2.0 ttp -60.91 -36.34 79.02 Favored 'General case' 0 C--O 1.224 -0.257 0 CA-C-O 120.884 0.374 . . . . 0.51 110.002 178.631 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.409 HD13 ' HD2' ' A' ' 254' ' ' PHE . 7.8 tp -68.1 -39.93 82.7 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.663 -0.699 . . . . 0.55 110.919 178.684 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 214' ' ' ARG . . . . . 0.415 ' HG3' ' O ' ' A' ' 210' ' ' GLN . 70.0 mtt-85 -57.54 -39.34 76.41 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.163 -0.471 . . . . 0.81 110.759 178.639 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 215' ' ' LYS . . . . . 0.428 ' HE3' ' HB2' ' A' ' 215' ' ' LYS . 47.2 mtmt -99.01 12.13 36.91 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.099 -0.5 . . . . 0.63 111.191 179.055 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 216' ' ' LEU . . . . . 0.425 HD21 HD12 ' A' ' 218' ' ' ILE . 28.0 tp -82.41 110.41 17.53 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.948 0.404 . . . . 0.45 111.14 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 35.8 m-20 -79.43 32.74 0.24 Allowed 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 112.437 0.532 . . . . 0.59 112.437 -179.531 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 218' ' ' ILE . . . . . 0.525 HG23 ' HB2' ' A' ' 223' ' ' ASP . 2.7 mt -81.18 107.68 13.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 CA-C-O 121.424 0.63 . . . . 0.42 110.634 179.155 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 219' ' ' LYS . . . . . 0.477 ' HG2' HE22 ' A' ' 264' ' ' GLN . 0.4 OUTLIER -161.3 -39.24 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 115.252 -0.885 . . . . 0.49 111.209 179.396 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -105.11 -177.46 3.37 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.5 -0.318 . . . . 0.59 111.853 -179.483 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -49.53 -21.68 1.03 Allowed 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 113.677 0.992 . . . . 0.66 113.677 -179.133 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -69.55 -23.81 76.45 Favored Glycine 0 CA--C 1.531 1.074 0 N-CA-C 114.265 0.466 . . . . 0.41 114.265 -179.515 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 223' ' ' ASP . . . . . 0.525 ' HB2' HG23 ' A' ' 218' ' ' ILE . 6.5 p-10 -55.48 -56.52 19.23 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 113.711 1.004 . . . . 0.89 113.711 -177.449 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.524 ' HB ' HG21 ' A' ' 274' ' ' THR . 17.2 m -61.53 -33.38 56.83 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-O 121.038 0.447 . . . . 0.45 111.672 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 48.2 mttp -70.26 -39.14 75.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.085 0.469 . . . . 0.91 110.478 179.314 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 226' ' ' SER . . . . . 0.658 ' O ' HG23 ' A' ' 230' ' ' VAL . 7.3 t -74.19 -44.69 52.43 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.095 -0.502 . . . . 0.89 110.652 179.113 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 227' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -57.99 -46.62 84.91 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.969 0.414 . . . . 0.46 110.853 179.681 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 228' ' ' SER . . . . . 0.486 ' CB ' HG21 ' A' ' 278' ' ' VAL . 16.3 p -65.78 -39.37 90.91 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.735 -0.469 . . . . 0.38 109.735 178.483 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 42.6 ttp180 -60.08 -45.39 93.06 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.198 -0.456 . . . . 1.08 110.202 177.833 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 230' ' ' VAL . . . . . 0.658 HG23 ' O ' ' A' ' 226' ' ' SER . 99.8 t -59.39 -48.0 88.66 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-N 116.017 -0.538 . . . . 0.35 110.353 178.48 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 231' ' ' MET . . . . . 0.745 ' HG3' HD13 ' A' ' 248' ' ' LEU . 29.6 ttm -55.22 -41.15 71.69 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.046 -0.524 . . . . 0.35 111.553 179.606 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 232' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 228' ' ' SER . 85.2 t -66.93 -36.1 76.32 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-O 121.037 0.446 . . . . 0.54 111.079 179.287 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 44.8 t-80 -77.2 -36.36 54.98 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 116.415 -0.357 . . . . 0.47 111.636 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.445 HG23 ' O ' ' A' ' 230' ' ' VAL . 52.0 t -56.58 -39.63 63.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 CA-C-O 120.867 0.365 . . . . 0.4 111.49 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 235' ' ' PHE . . . . . 0.826 ' HE2' HD11 ' A' ' 248' ' ' LEU . 75.7 m-85 -100.29 24.25 9.03 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.031 0.382 . . . . 0.36 112.031 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 3.2 ttpp -73.1 -10.91 60.29 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 120.541 0.21 . . . . 0.87 111.489 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 22.2 p-10 -89.06 -10.38 47.66 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 120.731 0.301 . . . . 0.38 111.061 179.258 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 91.52 -19.23 48.92 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 114.487 0.555 . . . . 0.35 114.487 178.436 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 239' ' ' VAL . . . . . 0.548 ' HB ' ' NH2' ' A' ' 244' ' ' ARG . 17.9 t -78.78 102.81 5.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 O-C-N 122.23 -0.571 . . . . 0.41 111.305 -179.67 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 240' ' ' THR . . . . . 0.481 ' HA ' ' CE1' ' A' ' 235' ' ' PHE . 24.1 m -93.25 84.03 4.72 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.112 0.482 . . . . 0.36 111.344 -179.662 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 241' ' ' ASN . . . . . 0.422 ' HB2' ' HG3' ' A' ' 244' ' ' ARG . 80.5 m-20 -89.09 141.03 28.85 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.316 -0.402 . . . . 0.42 111.338 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 242' ' ' TRP . . . . . 0.435 ' HE1' ' HG2' ' A' ' 290' ' ' GLN . 18.9 m95 -57.93 -37.89 74.91 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.759 0.314 . . . . 0.52 111.112 179.533 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 243' ' ' GLY . . . . . 0.468 ' H ' ' HB2' ' B' ' 35' ' ' TYR . . . -60.04 -30.89 71.18 Favored Glycine 0 C--N 1.335 0.503 0 C-N-CA 120.991 -0.623 . . . . 0.23 112.047 178.492 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 244' ' ' ARG . . . . . 0.548 ' NH2' ' HB ' ' A' ' 239' ' ' VAL . 26.1 mtt180 -75.45 -48.06 24.43 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.969 0.414 . . . . 0.34 109.959 178.526 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 245' ' ' ILE . . . . . 0.545 HG23 HD11 ' A' ' 279' ' ' LEU . 73.3 mt -56.5 -44.93 81.72 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-N 115.449 -0.796 . . . . 0.47 110.625 179.53 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 9.9 p -70.94 -32.38 48.37 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-N 116.322 -0.399 . . . . 0.33 110.819 178.784 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 15.8 m -63.09 -38.02 89.54 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 122.293 -0.254 . . . . 0.37 110.567 179.01 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 248' ' ' LEU . . . . . 0.826 HD11 ' HE2' ' A' ' 235' ' ' PHE . 26.3 mt -62.83 -41.89 99.51 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 121.3 0.571 . . . . 0.59 109.799 177.657 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 249' ' ' ILE . . . . . 0.474 HG21 HD21 ' A' ' 194' ' ' LEU . 32.8 mm -68.53 -36.06 73.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 CA-C-N 115.694 -0.685 . . . . 0.51 109.571 178.197 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 40.6 t -63.3 -45.06 93.12 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 109.288 -0.634 . . . . 0.37 109.288 178.067 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 251' ' ' PHE . . . . . 0.457 ' O ' HG23 ' A' ' 255' ' ' VAL . 10.9 t80 -64.09 -41.02 97.46 Favored 'General case' 0 N--CA 1.456 -0.165 0 N-CA-C 108.766 -0.827 . . . . 0.42 108.766 177.636 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -57.57 -44.73 93.75 Favored Glycine 0 C--N 1.337 0.588 0 N-CA-C 110.946 -0.861 . . . . 0.28 110.946 177.161 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 253' ' ' ALA . . . . . 0.471 ' O ' ' HG3' ' A' ' 257' ' ' LYS . . . -63.95 -32.02 73.4 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 121.0 0.428 . . . . 0.27 110.899 177.485 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 254' ' ' PHE . . . . . 0.409 ' HD2' HD13 ' A' ' 213' ' ' LEU . 1.1 t80 -68.8 -45.05 72.27 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 121.164 0.507 . . . . 0.64 109.634 178.176 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 255' ' ' VAL . . . . . 0.457 HG23 ' O ' ' A' ' 251' ' ' PHE . 59.3 t -64.22 -38.36 82.3 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-N 115.783 -0.644 . . . . 0.4 109.743 178.019 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 256' ' ' ALA . . . . . 0.482 ' HB1' ' HB2' ' A' ' 171' ' ' ALA . . . -57.99 -47.45 82.96 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 115.892 -0.595 . . . . 0.22 110.067 178.316 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 257' ' ' LYS . . . . . 0.471 ' HG3' ' O ' ' A' ' 253' ' ' ALA . 49.5 mttp -59.25 -49.13 79.04 Favored 'General case' 0 N--CA 1.462 0.137 0 N-CA-C 110.066 -0.346 . . . . 0.34 110.066 178.069 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 81.4 t60 -57.59 -45.78 84.85 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 115.81 -0.632 . . . . 0.68 111.738 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 4.9 mp -69.53 -41.89 75.4 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.449 -0.341 . . . . 0.49 111.519 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 1.3 tmtm? -67.44 -32.48 73.38 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-O 120.476 0.179 . . . . 0.49 111.177 179.492 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 54.2 m -63.98 -27.64 69.27 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 120.893 0.378 . . . . 0.43 111.151 179.553 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 29.9 m -105.89 10.96 8.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-O 121.002 0.43 . . . . 0.51 110.702 178.624 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 61.34 36.76 17.42 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 113.231 0.826 . . . . 0.57 113.231 179.452 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 264' ' ' GLN . . . . . 0.477 HE22 ' HG2' ' A' ' 219' ' ' LYS . 5.4 mt-30 -105.33 37.67 2.14 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.337 0.589 . . . . 0.76 110.22 178.716 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -56.65 -22.72 36.46 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 113.306 0.854 . . . . 0.46 113.306 -179.002 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 10.7 p -61.35 -18.75 60.13 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.556 0.217 . . . . 0.67 111.271 179.141 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 267' ' ' PHE . . . . . 0.402 ' C ' ' HD2' ' A' ' 270' ' ' PRO . 92.6 m-85 -96.22 -22.57 17.18 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 120.837 0.351 . . . . 0.96 110.772 178.453 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 60.1 mt -67.18 -44.79 87.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-N 116.361 -0.382 . . . . 0.35 111.093 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 269' ' ' GLU . . . . . 0.618 ' HB2' ' HD3' ' A' ' 270' ' ' PRO . 1.0 OUTLIER -53.64 -56.38 25.52 Favored Pre-proline 0 CA--C 1.547 0.847 0 CA-C-N 116.254 -0.43 . . . . 0.61 111.643 179.706 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 270' ' ' PRO . . . . . 0.618 ' HD3' ' HB2' ' A' ' 269' ' ' GLU . 27.5 Cg_exo -64.34 -28.87 63.32 Favored 'Trans proline' 0 C--N 1.36 1.161 0 C-N-CA 122.105 1.87 . . . . 0.37 112.333 178.554 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 271' ' ' LEU . . . . . . . . . . . . . 38.3 tp -65.19 -43.21 92.36 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.4 -0.364 . . . . 0.41 110.586 178.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -58.84 -46.97 86.45 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.259 -0.428 . . . . 0.37 111.246 179.5 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 273' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -65.44 -42.94 91.88 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.534 -0.303 . . . . 0.68 110.403 178.687 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 274' ' ' THR . . . . . 0.524 HG21 ' HB ' ' A' ' 224' ' ' VAL . 85.9 m -58.86 -50.35 74.33 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.235 -0.438 . . . . 0.39 110.411 179.148 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 96.9 mt -59.44 -54.41 34.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.105 -0.498 . . . . 0.36 110.351 178.463 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 21.0 m -56.61 -52.99 62.73 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 113.105 0.78 . . . . 0.33 113.105 -179.25 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 277' ' ' ASP . . . . . 0.486 ' O ' ' HD2' ' A' ' 281' ' ' ARG . 0.2 OUTLIER -56.41 -53.7 54.34 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.445 0.164 . . . . 0.4 111.433 -179.212 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 278' ' ' VAL . . . . . 0.486 HG21 ' CB ' ' A' ' 228' ' ' SER . 89.3 t -60.68 -38.55 78.9 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 CA-C-O 120.796 0.331 . . . . 0.35 110.804 179.363 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 279' ' ' LEU . . . . . 0.545 HD11 HG23 ' A' ' 245' ' ' ILE . 2.4 tp -62.0 -47.08 86.39 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 116.421 -0.354 . . . . 0.78 111.881 179.527 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 61.9 t -76.56 -40.88 34.26 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 N-CA-C 112.47 0.544 . . . . 0.36 112.47 -179.017 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 281' ' ' ARG . . . . . 0.486 ' HD2' ' O ' ' A' ' 277' ' ' ASP . 0.0 OUTLIER -66.31 -28.5 68.73 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 112.474 0.546 . . . . 0.37 112.474 -179.356 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 282' ' ' THR . . . . . . . . . . . . . 25.3 p -85.32 -64.15 1.2 Allowed 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.063 0.459 . . . . 0.42 112.024 179.626 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 22.3 mtmm -88.99 40.74 0.99 Allowed 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.24 0.459 . . . . 0.46 112.24 -178.353 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 284' ' ' ARG . . . . . 0.467 ' O ' HG22 ' A' ' 288' ' ' VAL . 2.9 ptp85 -57.66 -46.17 84.57 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 112.136 0.421 . . . . 0.48 112.136 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 285' ' ' ASP . . . . . 0.439 ' O ' ' HB2' ' A' ' 289' ' ' LYS . 8.0 t70 -62.13 -51.52 67.54 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 111.87 0.322 . . . . 0.42 111.87 -179.24 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 286' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -61.83 -33.07 73.5 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.862 0.363 . . . . 0.42 111.234 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -70.81 -52.47 20.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.228 -0.442 . . . . 0.39 110.809 178.875 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 288' ' ' VAL . . . . . 0.467 HG22 ' O ' ' A' ' 284' ' ' ARG . 27.6 m -64.36 -30.68 50.83 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-O 120.813 0.34 . . . . 0.38 111.821 179.724 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 289' ' ' LYS . . . . . 0.439 ' HB2' ' O ' ' A' ' 285' ' ' ASP . 0.3 OUTLIER -68.36 -40.81 81.35 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 112.294 0.479 . . . . 0.47 112.294 -179.808 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 290' ' ' GLN . . . . . 0.465 ' O ' ' HA3' ' A' ' 295' ' ' GLY . 6.0 mp0 -96.94 30.05 2.84 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 112.867 0.692 . . . . 0.57 112.867 -178.9 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 33.1 mtm105 58.37 23.66 10.79 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 112.14 0.422 . . . . 0.45 112.14 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 69.21 -130.32 24.05 Favored Glycine 0 CA--C 1.523 0.554 0 C-N-CA 121.21 -0.519 . . . . 0.3 114.003 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 293' ' ' TRP . . . . . 0.613 ' O ' HG23 ' A' ' 297' ' ' VAL . 76.0 m95 -71.48 -29.45 64.85 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.386 0.514 . . . . 0.44 112.386 -178.949 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 294' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -59.72 -42.83 93.95 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 120.637 -0.425 . . . . 0.42 110.046 179.563 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 295' ' ' GLY . . . . . 0.465 ' HA3' ' O ' ' A' ' 290' ' ' GLN . . . -70.05 -38.13 73.6 Favored Glycine 0 C--N 1.336 0.556 0 N-CA-C 111.003 -0.839 . . . . 0.26 111.003 177.596 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 296' ' ' PHE . . . . . 0.423 ' HB3' ' HA ' ' A' ' 293' ' ' TRP . 0.1 OUTLIER -59.45 -37.48 78.25 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.096 0.474 . . . . 0.38 110.352 177.845 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 297' ' ' VAL . . . . . 0.757 HG11 ' HB3' ' A' ' 189' ' ' ARG . 71.4 t -65.71 -50.2 72.63 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-N 115.794 -0.639 . . . . 0.29 110.925 179.236 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -57.91 -41.87 83.56 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.236 -0.438 . . . . 0.54 111.395 179.319 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 299' ' ' PHE . . . . . 0.405 ' CZ ' ' HB2' ' B' ' 39' ' ' SER . 78.0 t80 -61.57 -40.14 93.66 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 116.18 -0.464 . . . . 0.52 112.227 -179.592 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 300' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 . . . . . 0 C--N 1.325 -0.463 0 CA-C-O 120.877 0.37 . . . . 0.42 111.596 -179.567 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 . . . . . 0 CA--C 1.529 0.139 0 N-CA-C 111.317 0.118 . . . . 0.44 111.317 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 23' ' ' PHE . . . . . 0.488 ' HA ' ' SD ' ' A' ' 212' ' ' MET . 0.7 OUTLIER -55.64 -40.05 71.68 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 112.566 0.58 . . . . 0.34 112.566 -179.194 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 24' ' ' ALA . . . . . 0.428 ' N ' ' HD1' ' B' ' 23' ' ' PHE . . . -68.97 -46.16 68.83 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.969 0.414 . . . . 0.4 111.049 -179.648 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 25' ' ' ALA . . . . . 0.546 ' O ' ' HG2' ' B' ' 29' ' ' LYS . . . -64.05 -52.84 57.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.005 -0.543 . . . . 0.4 110.806 179.319 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -55.19 -54.65 40.67 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 115.375 -0.829 . . . . 0.43 112.102 -179.394 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 45.3 mt -63.2 -29.4 70.75 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 120.957 -0.297 . . . . 0.34 111.638 -179.636 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 28' ' ' ARG . . . . . . . . . . . . . 4.4 tmt_? -70.93 -57.21 4.8 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 120.896 0.379 . . . . 0.86 110.503 178.523 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 29' ' ' LYS . . . . . 0.546 ' HG2' ' O ' ' B' ' 25' ' ' ALA . 10.4 ptmt -61.79 -42.39 98.94 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 116.397 -0.365 . . . . 0.89 111.901 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 88.3 mt -64.79 -41.51 92.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.181 0 N-CA-C 109.831 -0.433 . . . . 0.4 109.831 179.358 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 31' ' ' GLY . . . . . 0.535 ' HA3' ' HG2' ' A' ' 244' ' ' ARG . . . -59.76 -49.22 80.92 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.956 -0.64 . . . . 0.28 112.017 178.93 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 36.9 m-20 -66.6 -34.72 78.52 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.642 0.221 . . . . 0.37 110.876 178.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 33' ' ' LYS . . . . . 0.417 ' O ' ' HE3' ' B' ' 33' ' ' LYS . 0.0 OUTLIER -65.46 -47.62 75.51 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.791 0.329 . . . . 0.55 110.128 178.169 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 42.4 t -61.37 -48.87 86.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 CA-C-O 121.067 0.461 . . . . 0.41 109.775 178.332 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 35' ' ' TYR . . . . . 0.468 ' HB2' ' H ' ' A' ' 243' ' ' GLY . 0.6 OUTLIER -55.58 -38.3 69.21 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 115.63 -0.714 . . . . 0.73 109.999 178.088 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 36' ' ' CYS . . . . . . . . . . . . . 52.1 t -65.56 -46.14 80.64 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-N 116.012 -0.54 . . . . 1.24 110.996 178.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 97.0 m -62.33 -35.86 80.39 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 112.861 0.689 . . . . 0.45 112.861 -179.463 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 38' ' ' TRP . . . . . . . . . . . . . 96.8 m95 -86.86 -25.43 24.5 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 112.767 0.654 . . . . 0.64 112.767 -178.736 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 39' ' ' SER . . . . . 0.405 ' HB2' ' CZ ' ' A' ' 299' ' ' PHE . 14.7 t . . . . . 0 N--CA 1.466 0.366 0 CA-C-O 121.007 0.432 . . . . 0.61 111.286 179.079 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 . . . . . 0 CA--C 1.531 0.246 0 N-CA-C 111.536 0.198 . . . . 0.53 111.536 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -57.84 -46.53 84.63 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 121.036 0.446 . . . . 0.43 110.951 179.394 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.653 HD21 ' HB3' ' A' ' 287' ' ' LEU . 13.9 tp -62.83 -46.41 88.07 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.99 -0.55 . . . . 0.85 111.133 178.701 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 44.5 t80 -66.71 -40.6 88.52 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.167 -0.469 . . . . 0.4 111.767 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 32.4 mtm180 -59.75 -46.75 88.18 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.81 0.338 . . . . 0.49 111.416 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 158' ' ' GLN . . . . . 0.43 ' HA ' ' HB2' ' A' ' 183' ' ' ALA . 51.1 mt-30 -70.45 -35.81 73.55 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.756 0.312 . . . . 0.82 110.585 179.536 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 51.9 m -65.04 -45.85 83.72 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.481 -0.327 . . . . 0.29 110.138 178.675 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.774 ' HA ' HG21 ' A' ' 276' ' ' THR . 2.1 tm? -53.64 -55.29 27.23 Favored 'General case' 0 C--O 1.225 -0.186 0 CA-C-N 116.026 -0.534 . . . . 0.45 110.572 178.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -55.13 -43.61 74.3 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 112.271 0.471 . . . . 1.18 112.271 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 162' ' ' ILE . . . . . 0.508 HG23 HD22 ' A' ' 191' ' ' LEU . 90.6 mt -69.18 -53.46 25.43 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 N-CA-C 112.394 0.516 . . . . 0.31 112.394 -179.313 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.542 HD12 HG23 ' A' ' 276' ' ' THR . 68.2 mt -66.12 -47.77 83.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 N-CA-C 112.017 0.377 . . . . 0.35 112.017 -179.39 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 3.5 t -58.34 -44.55 88.76 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.644 0.259 . . . . 0.27 111.226 -179.449 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 21.4 ttm180 -66.69 -49.48 65.97 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 120.296 -0.562 . . . . 0.55 110.506 178.575 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 166' ' ' TYR . . . . . 0.995 ' HE1' ' HA ' ' A' ' 195' ' ' ARG . 93.5 t80 -55.41 -52.47 63.45 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 112.601 0.593 . . . . 0.39 112.601 -179.672 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 5.0 mp -60.74 -45.7 93.3 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 120.834 -0.346 . . . . 0.48 111.833 -179.081 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 168' ' ' ARG . . . . . 0.538 ' HD2' ' OE1' ' A' ' 269' ' ' GLU . 0.0 OUTLIER -65.36 -37.18 86.26 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.665 0.269 . . . . 0.37 110.924 179.679 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -58.22 -53.9 53.02 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.056 -0.52 . . . . 0.44 110.473 178.724 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 170' ' ' GLN . . . . . 0.763 ' HB3' ' HE3' ' A' ' 257' ' ' LYS . 2.2 mt-30 -67.19 -39.9 86.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.026 -0.533 . . . . 0.45 111.093 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.47 ' HB2' ' HB1' ' A' ' 256' ' ' ALA . . . . . . . . 0 N--CA 1.463 0.221 0 CA-C-O 120.833 0.349 . . . . 0.37 111.711 179.414 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.643 ' O ' ' HA3' ' A' ' 187' ' ' GLY . . . . . . . . 0 CA--C 1.536 0.408 0 CA-C-O 121.096 0.474 . . . . 0.43 111.611 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -80.41 -71.54 1.27 Allowed Glycine 0 CA--C 1.527 0.808 0 C-N-CA 120.67 -0.776 . . . . 0.42 113.527 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -64.05 -55.78 19.72 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 120.992 0.425 . . . . 0.53 111.264 -179.671 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -65.65 -34.55 78.48 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.934 -0.576 . . . . 0.52 110.261 178.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 187' ' ' GLY . . . . . 0.643 ' HA3' ' O ' ' A' ' 183' ' ' ALA . . . -65.39 -47.91 74.33 Favored Glycine 0 C--O 1.217 -0.945 0 C-N-CA 121.068 -0.587 . . . . 0.41 112.723 179.702 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 4.8 tmm_? -60.37 -48.65 80.84 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-N 117.349 0.574 . . . . 0.73 111.314 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 189' ' ' ARG . . . . . 0.469 ' HG2' HG21 ' A' ' 297' ' ' VAL . 3.9 ttp180 -63.02 -46.29 88.3 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 120.763 0.316 . . . . 0.57 110.753 -179.827 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 190' ' ' ALA . . . . . 0.44 ' HA ' ' CG1' ' A' ' 297' ' ' VAL . . . -71.69 -31.15 66.45 Favored 'General case' 0 C--O 1.222 -0.367 0 N-CA-C 112.245 0.461 . . . . 0.32 112.245 -179.576 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 191' ' ' LEU . . . . . 0.552 ' HB2' ' O ' ' A' ' 187' ' ' GLY . 0.2 OUTLIER -62.2 -53.46 54.93 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 120.578 0.228 . . . . 0.6 111.056 -179.752 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -65.11 -42.1 94.29 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.461 -0.336 . . . . 0.69 111.059 179.205 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 193' ' ' THR . . . . . 0.658 HG21 ' HA ' ' A' ' 297' ' ' VAL . 39.3 m -62.57 -47.28 84.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.476 -0.329 . . . . 0.39 110.698 179.4 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 194' ' ' LEU . . . . . 0.479 HD21 HG21 ' A' ' 249' ' ' ILE . 33.6 tp -67.76 -41.24 83.64 Favored 'General case' 0 C--O 1.224 -0.241 0 CA-C-N 116.526 -0.307 . . . . 0.41 111.085 179.658 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 195' ' ' ARG . . . . . 0.995 ' HA ' ' HE1' ' A' ' 166' ' ' TYR . 45.4 ttm180 -60.57 -45.33 94.35 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.783 0.325 . . . . 0.63 111.34 179.215 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 12.7 mtp180 -73.87 -49.48 24.81 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.547 0.573 . . . . 1.59 112.547 -179.086 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 197' ' ' VAL . . . . . 0.621 HG12 HG21 ' A' ' 246' ' ' VAL . 86.6 t -68.86 -38.88 79.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-O 120.923 0.392 . . . . 0.35 111.161 -179.791 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -65.12 -52.77 38.17 Favored Glycine 0 C--N 1.332 0.359 0 C-N-CA 121.14 -0.552 . . . . 0.31 112.895 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -63.19 -31.13 72.2 Favored 'General case' 0 CA--C 1.528 0.099 0 CA-C-N 117.114 0.457 . . . . 0.47 110.258 179.364 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 200' ' ' GLY . . . . . 0.476 ' O ' ' HB2' ' A' ' 204' ' ' ASN . . . -60.65 -53.8 42.35 Favored Glycine 0 C--N 1.336 0.554 0 C-N-CA 120.902 -0.666 . . . . 0.35 111.462 178.014 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 83.3 t -63.54 -41.35 92.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 CA-C-O 121.355 0.598 . . . . 0.35 110.471 178.153 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 202' ' ' GLN . . . . . 0.41 ' HA ' ' CE2' ' A' ' 209' ' ' PHE . 7.4 tt0 -60.73 -51.27 70.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 114.729 -1.123 . . . . 0.71 112.723 -178.897 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 2.8 mmp_? -74.01 -32.58 63.44 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 111.716 0.265 . . . . 0.52 111.716 -179.466 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 204' ' ' ASN . . . . . 0.476 ' HB2' ' O ' ' A' ' 200' ' ' GLY . 8.4 t-20 -68.68 -53.77 20.3 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.049 0.452 . . . . 1.55 110.822 179.477 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 89.0 m-70 -95.18 32.14 1.78 Allowed 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 121.184 0.516 . . . . 0.53 110.853 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 206' ' ' GLU . . . . . 0.504 ' HG2' HE21 ' A' ' 210' ' ' GLN . 10.0 tt0 -59.5 -38.51 81.11 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.581 -0.736 . . . . 0.43 111.675 -179.333 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 42.2 p -59.26 -49.74 76.68 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.154 0.502 . . . . 0.54 110.95 179.409 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -66.59 -44.54 81.91 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.682 -0.69 . . . . 0.41 110.401 178.865 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 209' ' ' PHE . . . . . 0.41 ' CE2' ' HA ' ' A' ' 202' ' ' GLN . 4.8 m-30 -58.46 -44.51 89.28 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.177 -0.465 . . . . 0.45 110.736 179.498 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 210' ' ' GLN . . . . . 0.511 ' HB3' ' NH2' ' A' ' 214' ' ' ARG . 59.6 mt-30 -64.02 -34.73 78.68 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.56 -0.291 . . . . 0.6 110.971 179.446 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 211' ' ' GLY . . . . . 0.495 ' O ' ' HB2' ' A' ' 215' ' ' LYS . . . -60.21 -44.91 96.94 Favored Glycine 0 C--N 1.334 0.454 0 N-CA-C 111.028 -0.829 . . . . 0.37 111.028 178.021 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 212' ' ' MET . . . . . 0.833 ' HG2' ' HA ' ' B' ' 23' ' ' PHE . 1.0 OUTLIER -77.29 -30.68 54.31 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 120.616 0.246 . . . . 0.56 110.581 178.457 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.434 HD22 ' CE2' ' A' ' 254' ' ' PHE . 16.8 tp -59.7 -44.85 93.5 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.197 -0.456 . . . . 0.54 111.026 179.208 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 214' ' ' ARG . . . . . 0.511 ' NH2' ' HB3' ' A' ' 210' ' ' GLN . 68.0 mtm-85 -81.25 -27.47 35.17 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.034 -0.53 . . . . 0.65 110.169 178.574 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 215' ' ' LYS . . . . . 0.495 ' HB2' ' O ' ' A' ' 211' ' ' GLY . 0.7 OUTLIER -66.97 -46.9 73.2 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 115.875 -0.602 . . . . 0.8 110.621 178.443 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 216' ' ' LEU . . . . . 0.447 HD23 ' HB ' ' A' ' 218' ' ' ILE . 4.6 tp -65.19 120.7 13.19 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 115.901 -0.59 . . . . 0.48 111.354 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -75.03 36.07 0.11 Allowed 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 112.877 0.695 . . . . 1.47 112.877 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 218' ' ' ILE . . . . . 0.956 ' HA ' ' HB3' ' A' ' 223' ' ' ASP . 1.3 tt -61.05 106.55 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-O 121.914 0.864 . . . . 0.41 111.571 -179.766 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -162.1 -50.88 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.28 -0.873 . . . . 0.61 110.462 -179.471 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -99.6 178.38 4.87 Favored 'General case' 0 C--O 1.221 -0.418 0 CA-C-N 116.189 -0.46 . . . . 0.91 111.164 179.602 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 221' ' ' GLU . . . . . 0.43 ' HA ' ' HE1' ' A' ' 267' ' ' PHE . 2.0 mm-40 -49.38 -20.74 0.73 Allowed 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 113.794 1.035 . . . . 0.86 113.794 -179.316 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -67.84 -24.51 74.27 Favored Glycine 0 CA--C 1.534 1.271 0 N-CA-C 114.643 0.617 . . . . 0.34 114.643 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 223' ' ' ASP . . . . . 0.956 ' HB3' ' HA ' ' A' ' 218' ' ' ILE . 9.9 p30 -59.16 -56.06 26.97 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 113.475 0.917 . . . . 0.57 113.475 -177.937 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.454 HG23 HG21 ' A' ' 274' ' ' THR . 2.6 p -54.27 -39.73 44.67 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-O 120.983 0.42 . . . . 0.44 111.764 179.492 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 30.2 mttp -68.68 -42.99 77.06 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-O 120.935 0.398 . . . . 0.61 110.171 178.863 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 226' ' ' SER . . . . . 0.585 ' O ' HG23 ' A' ' 230' ' ' VAL . 45.3 m -62.03 -43.25 99.23 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.9 -0.591 . . . . 0.44 109.693 178.579 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 227' ' ' PHE . . . . . 0.488 ' O ' ' HG3' ' A' ' 231' ' ' MET . 16.8 t80 -55.96 -42.92 76.98 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 115.731 -0.668 . . . . 0.66 110.447 178.821 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 12.7 p -60.31 -39.56 87.42 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 120.823 0.344 . . . . 0.34 110.368 178.682 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 6.4 mmp_? -67.85 -35.7 79.01 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 116.24 -0.437 . . . . 0.51 110.786 179.455 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 230' ' ' VAL . . . . . 0.585 HG23 ' O ' ' A' ' 226' ' ' SER . 24.3 t -61.96 -52.4 60.95 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 N-CA-C 109.985 -0.376 . . . . 0.35 109.985 178.568 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 231' ' ' MET . . . . . 0.635 ' HE3' HG13 ' A' ' 275' ' ' ILE . 31.5 mtp -56.79 -46.3 81.62 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.726 -0.67 . . . . 0.43 110.866 179.293 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 56.1 t -62.12 -40.29 86.96 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 CA-C-N 116.167 -0.47 . . . . 0.46 110.659 178.87 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 64.7 t-80 -66.65 -43.62 84.1 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 116.557 -0.292 . . . . 0.51 111.203 178.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.445 HG23 ' O ' ' A' ' 230' ' ' VAL . 78.1 t -60.89 -40.4 85.17 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 CA-C-O 120.66 0.267 . . . . 0.34 111.539 179.532 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -101.44 23.51 10.96 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 111.951 0.352 . . . . 0.49 111.951 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 1.9 tmtm? -70.78 -11.73 61.13 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 112.1 0.408 . . . . 1.29 112.1 -179.38 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -83.23 -16.86 44.78 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.662 0.268 . . . . 0.49 111.267 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 91.86 -5.78 79.35 Favored Glycine 0 CA--C 1.524 0.64 0 C-N-CA 120.827 -0.701 . . . . 0.47 113.898 179.273 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 3.1 p -98.04 114.94 36.83 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-O 121.663 0.744 . . . . 0.45 111.87 -179.663 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 99.4 m -94.74 109.44 21.4 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.089 -0.505 . . . . 0.43 111.739 179.48 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 241' ' ' ASN . . . . . 0.554 ' HB2' ' HD2' ' A' ' 244' ' ' ARG . 25.7 m-20 -113.61 139.45 49.01 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.296 -0.411 . . . . 0.46 110.762 179.022 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 242' ' ' TRP . . . . . 0.433 ' CZ3' ' HB2' ' A' ' 296' ' ' PHE . 40.4 m95 -54.54 -42.12 70.53 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.183 -0.462 . . . . 0.47 111.619 -179.375 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -60.16 -33.91 81.9 Favored Glycine 0 C--N 1.333 0.412 0 C-N-CA 120.937 -0.649 . . . . 0.31 112.095 178.691 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 244' ' ' ARG . . . . . 0.554 ' HD2' ' HB2' ' A' ' 241' ' ' ASN . 23.6 mtt180 -70.73 -44.96 65.77 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.163 0.506 . . . . 0.32 109.638 178.687 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 245' ' ' ILE . . . . . 0.448 ' O ' HG13 ' A' ' 249' ' ' ILE . 74.2 mt -61.84 -50.08 81.64 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 115.412 -0.813 . . . . 0.51 111.491 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 246' ' ' VAL . . . . . 0.621 HG21 HG12 ' A' ' 197' ' ' VAL . 8.5 p -65.4 -32.71 59.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 120.814 -0.354 . . . . 0.4 111.36 -179.564 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 82.8 m -66.14 -34.47 78.12 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.467 0.651 . . . . 0.37 109.261 177.878 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 248' ' ' LEU . . . . . 0.445 HD21 ' HG2' ' A' ' 231' ' ' MET . 33.7 tp -73.23 -45.33 56.64 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 115.43 -0.804 . . . . 1.23 110.426 178.199 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 249' ' ' ILE . . . . . 0.479 HG21 HD21 ' A' ' 194' ' ' LEU . 23.5 mt -63.13 -44.18 99.3 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 CA-C-N 116.506 -0.316 . . . . 0.34 110.886 179.143 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 12.6 p -61.98 -36.17 80.66 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.277 0.561 . . . . 0.44 109.572 178.096 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 251' ' ' PHE . . . . . 0.431 ' O ' HG23 ' A' ' 255' ' ' VAL . 48.8 t80 -66.27 -41.34 90.04 Favored 'General case' 0 C--O 1.227 -0.122 0 CA-C-N 115.514 -0.767 . . . . 0.46 109.411 177.721 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -57.85 -49.23 76.37 Favored Glycine 0 C--N 1.335 0.5 0 N-CA-C 111.203 -0.759 . . . . 0.24 111.203 178.133 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -59.13 -43.03 91.94 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 120.68 0.276 . . . . 0.32 110.692 177.862 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 254' ' ' PHE . . . . . 0.434 ' CE2' HD22 ' A' ' 213' ' ' LEU . 7.1 t80 -63.01 -43.99 97.21 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 121.071 0.462 . . . . 0.7 110.787 179.011 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 255' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 251' ' ' PHE . 72.7 t -62.96 -46.46 96.25 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 N-CA-C 109.383 -0.599 . . . . 0.39 109.383 177.798 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 256' ' ' ALA . . . . . 0.47 ' HB1' ' HB2' ' A' ' 171' ' ' ALA . . . -59.13 -37.84 78.21 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.081 -0.509 . . . . 0.29 110.078 177.88 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 257' ' ' LYS . . . . . 0.763 ' HE3' ' HB3' ' A' ' 170' ' ' GLN . 81.0 mttt -59.04 -45.79 89.87 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 109.468 -0.567 . . . . 0.51 109.468 177.364 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 258' ' ' HIS . . . . . 0.429 ' HB2' HD21 ' A' ' 213' ' ' LEU . 80.3 t60 -61.06 -46.32 91.15 Favored 'General case' 0 C--O 1.228 -0.033 0 CA-C-N 115.4 -0.818 . . . . 0.59 109.632 178.38 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.83 HD11 HG12 ' A' ' 218' ' ' ILE . 8.8 mp -59.82 -42.52 93.69 Favored 'General case' 0 C--O 1.221 -0.401 0 CA-C-N 115.968 -0.56 . . . . 0.51 110.316 178.928 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 2.2 tptp -64.15 -35.91 82.31 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.992 0.425 . . . . 0.53 110.419 178.762 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 21.2 m -69.78 -31.97 70.19 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.775 -0.648 . . . . 0.55 111.094 179.355 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 33.6 m -101.03 10.56 7.66 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 CA-C-O 120.796 0.331 . . . . 0.61 111.425 179.112 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 16.4 m120 59.16 47.92 11.13 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 113.123 0.786 . . . . 0.6 113.123 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 264' ' ' GLN . . . . . 0.572 ' HB3' ' HG ' ' A' ' 259' ' ' LEU . 17.7 tt0 -106.77 36.85 2.5 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.198 0.523 . . . . 0.6 110.31 179.044 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 265' ' ' GLU . . . . . 0.511 ' HA ' HD12 ' A' ' 268' ' ' ILE . 0.0 OUTLIER -54.33 -27.7 37.64 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 115.735 -0.666 . . . . 0.48 111.556 179.814 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 26.1 p -58.45 -26.36 63.26 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 115.785 -0.643 . . . . 0.66 110.941 178.795 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 267' ' ' PHE . . . . . 0.43 ' HE1' ' HA ' ' A' ' 221' ' ' GLU . 70.0 m-85 -108.52 -11.4 15.14 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.197 -0.456 . . . . 0.75 110.917 178.859 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 268' ' ' ILE . . . . . 0.511 HD12 ' HA ' ' A' ' 265' ' ' GLU . 53.1 mt -66.62 -51.15 59.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 CA-C-O 120.776 0.322 . . . . 0.45 110.791 179.381 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 269' ' ' GLU . . . . . 0.728 ' HB2' ' HD3' ' A' ' 270' ' ' PRO . 55.2 mm-40 -58.78 -54.7 53.71 Favored Pre-proline 0 CA--C 1.541 0.629 0 CA-C-N 116.186 -0.461 . . . . 0.49 111.178 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 270' ' ' PRO . . . . . 0.728 ' HD3' ' HB2' ' A' ' 269' ' ' GLU . 32.1 Cg_exo -60.73 -32.51 93.13 Favored 'Trans proline' 0 C--N 1.359 1.108 0 C-N-CA 122.086 1.858 . . . . 0.35 112.76 178.818 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 271' ' ' LEU . . . . . . . . . . . . . 29.4 tp -63.2 -46.09 88.68 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 120.531 0.205 . . . . 0.68 111.394 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -61.58 -40.99 96.75 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.13 0.49 . . . . 0.32 111.248 179.779 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 273' ' ' GLU . . . . . 0.457 ' HG2' ' O ' ' A' ' 269' ' ' GLU . 4.4 mm-40 -72.27 -33.74 67.69 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.195 0.522 . . . . 0.42 109.822 179.103 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 274' ' ' THR . . . . . 0.454 HG21 HG23 ' A' ' 224' ' ' VAL . 87.3 m -66.84 -51.92 49.86 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.99 -0.55 . . . . 0.34 110.952 178.668 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 275' ' ' ILE . . . . . 0.635 HG13 ' HE3' ' A' ' 231' ' ' MET . 14.4 tt -59.52 -36.51 65.17 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-O 120.682 0.277 . . . . 0.42 110.621 179.447 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 276' ' ' THR . . . . . 0.774 HG21 ' HA ' ' A' ' 160' ' ' LEU . 38.2 m -67.82 -49.68 60.96 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 120.786 0.326 . . . . 0.29 110.383 178.646 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 277' ' ' ASP . . . . . 0.586 ' O ' ' HB2' ' A' ' 281' ' ' ARG . 1.4 t70 -60.41 -54.58 43.94 Favored 'General case' 0 C--O 1.216 -0.671 0 CA-C-N 116.23 -0.441 . . . . 0.34 111.19 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 61.6 t -59.37 -34.08 53.13 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 N-CA-C 112.01 0.374 . . . . 0.41 112.01 -179.621 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 21.4 tp -67.82 -47.58 68.64 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.685 0.279 . . . . 0.69 111.392 179.735 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 39.7 t -78.06 -36.22 21.29 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 CA-C-O 120.864 0.364 . . . . 0.42 111.544 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 281' ' ' ARG . . . . . 0.586 ' HB2' ' O ' ' A' ' 277' ' ' ASP . 1.1 tpp180 -61.68 -41.02 96.99 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 122.921 0.488 . . . . 0.37 112.308 -179.434 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 282' ' ' THR . . . . . . . . . . . . . 74.5 p -90.78 -1.69 57.84 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 112.823 0.675 . . . . 0.42 112.823 -179.061 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 283' ' ' LYS . . . . . 0.425 ' HB3' HD23 ' A' ' 287' ' ' LEU . 11.0 mtmm -138.72 33.71 2.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.672 0.273 . . . . 0.53 111.409 -179.61 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 34.0 ttm180 -53.16 -58.17 7.95 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 112.449 0.537 . . . . 0.42 112.449 -179.307 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 285' ' ' ASP . . . . . 0.412 ' O ' ' HB2' ' A' ' 289' ' ' LYS . 22.1 t70 -63.33 -42.95 99.0 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 112.179 0.437 . . . . 0.57 112.179 -179.042 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 286' ' ' TRP . . . . . . . . . . . . . 1.5 t90 -64.35 -51.23 64.38 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 112.227 0.454 . . . . 0.49 112.227 -178.869 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 287' ' ' LEU . . . . . 0.653 ' HB3' HD21 ' A' ' 155' ' ' LEU . 1.5 mm? -64.61 -48.18 75.86 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.317 0.488 . . . . 0.54 112.317 -178.976 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 3.0 p -63.99 -29.77 48.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 N-CA-C 112.007 0.373 . . . . 0.52 112.007 -179.623 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 289' ' ' LYS . . . . . 0.425 ' HB2' ' HE3' ' A' ' 289' ' ' LYS . 12.3 ttmt -76.56 -44.47 34.58 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 112.371 0.508 . . . . 0.8 112.371 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -80.62 28.86 0.32 Allowed 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 113.14 0.793 . . . . 0.56 113.14 -178.347 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 291' ' ' ARG . . . . . 0.472 ' HB3' ' HB3' ' A' ' 294' ' ' ASP . 62.5 mtp180 62.95 9.47 3.76 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 112.522 0.564 . . . . 0.49 112.522 179.572 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 62.22 -130.27 44.07 Favored Glycine 0 CA--C 1.522 0.504 0 CA-C-O 121.307 0.393 . . . . 0.35 113.439 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 293' ' ' TRP . . . . . 0.523 ' O ' HG22 ' A' ' 297' ' ' VAL . 77.5 m95 -61.87 -27.09 68.55 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.672 -0.264 . . . . 0.55 111.475 -179.854 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 294' ' ' ASP . . . . . 0.472 ' HB3' ' HB3' ' A' ' 291' ' ' ARG . 0.5 OUTLIER -58.97 -44.46 91.54 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 120.881 0.372 . . . . 0.42 110.224 178.77 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -75.64 -30.18 58.46 Favored Glycine 0 CA--C 1.522 0.485 0 C-N-CA 120.795 -0.717 . . . . 0.38 111.639 178.423 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 296' ' ' PHE . . . . . 0.553 ' CE1' ' HE2' ' A' ' 300' ' ' PHE . 4.3 t80 -67.02 -47.29 71.87 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 120.821 0.343 . . . . 0.41 110.993 179.274 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 297' ' ' VAL . . . . . 0.658 ' HA ' HG21 ' A' ' 193' ' ' THR . 27.1 m -71.27 -37.41 65.71 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-N 116.44 -0.345 . . . . 0.38 111.567 -179.704 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 298' ' ' GLU . . . . . 0.444 ' HB2' ' O ' ' A' ' 294' ' ' ASP . 1.2 mt-10 -69.56 -27.58 65.25 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.571 -0.286 . . . . 0.45 111.432 179.687 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 299' ' ' PHE . . . . . . . . . . . . . 69.1 t80 -62.53 -43.73 98.09 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.346 -0.388 . . . . 0.6 110.434 178.821 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 300' ' ' PHE . . . . . 0.553 ' HE2' ' CE1' ' A' ' 296' ' ' PHE . 44.7 m-85 . . . . . 0 CA--C 1.532 0.266 0 CA-C-O 120.827 0.346 . . . . 0.58 111.125 179.664 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 22' ' ' GLU . . . . . 0.444 ' HG2' ' NE2' ' B' ' 26' ' ' GLN . 1.3 tt0 . . . . . 0 C--O 1.233 0.232 0 CA-C-O 120.675 0.274 . . . . 0.7 111.259 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 23' ' ' PHE . . . . . 0.833 ' HA ' ' HG2' ' A' ' 212' ' ' MET . 3.5 p90 -62.41 -35.9 80.67 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 116.323 -0.399 . . . . 0.49 111.465 179.797 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -76.51 -45.3 31.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.792 0.329 . . . . 0.39 110.808 179.646 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.22 -45.8 87.02 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.244 -0.435 . . . . 0.35 110.569 178.579 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 26' ' ' GLN . . . . . 0.444 ' NE2' ' HG2' ' B' ' 22' ' ' GLU . 1.3 mp0 -61.32 -47.71 84.68 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 115.755 -0.657 . . . . 0.43 110.218 178.92 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 15.7 mt -58.22 -39.28 78.63 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.137 -0.483 . . . . 0.42 110.803 178.817 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 28' ' ' ARG . . . . . . . . . . . . . 1.1 ttp180 -61.32 -50.35 73.34 Favored 'General case' 0 N--CA 1.462 0.136 0 N-CA-C 109.896 -0.409 . . . . 1.02 109.896 178.625 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 83.6 mttt -56.26 -49.62 73.68 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 116.06 -0.518 . . . . 0.75 110.84 179.198 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 62.3 mt -62.41 -41.89 93.5 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 CA-C-N 116.297 -0.41 . . . . 0.45 110.4 179.377 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 31' ' ' GLY . . . . . 0.436 ' HA3' ' HA ' ' A' ' 244' ' ' ARG . . . -60.17 -49.56 77.26 Favored Glycine 0 CA--C 1.522 0.481 0 C-N-CA 120.768 -0.729 . . . . 0.27 112.123 179.043 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 57.9 m-20 -60.19 -44.58 94.98 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.098 0.475 . . . . 0.98 110.028 178.861 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 15.0 tppt? -62.01 -51.27 68.7 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 115.672 -0.695 . . . . 0.84 111.005 179.347 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 38.9 t -57.49 -41.66 79.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-O 120.785 0.326 . . . . 0.4 110.973 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -62.73 -43.84 97.77 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 120.984 0.421 . . . . 0.75 109.919 178.381 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 36' ' ' CYS . . . . . . . . . . . . . 55.7 m -66.13 -42.73 88.75 Favored 'General case' 0 C--O 1.224 -0.248 0 CA-C-N 116.095 -0.502 . . . . 1.34 111.248 179.094 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 98.6 m -61.78 -39.93 93.39 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 112.436 0.532 . . . . 0.5 112.436 179.77 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 38' ' ' TRP . . . . . . . . . . . . . 70.3 m95 -77.72 -29.03 51.04 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 112.562 0.578 . . . . 0.64 112.562 -179.29 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 37.1 p . . . . . 0 N--CA 1.467 0.415 0 CA-C-O 120.943 0.401 . . . . 0.5 111.437 179.504 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 153' ' ' ASP . . . . . 0.471 ' O ' ' HG3' ' A' ' 157' ' ' ARG . 15.4 t70 . . . . . 0 N--CA 1.469 0.487 0 N-CA-C 111.591 0.219 . . . . 0.72 111.591 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' ASP . . . . . 0.433 ' HA ' ' CZ ' ' A' ' 157' ' ' ARG . 17.8 m-20 -57.23 -49.09 77.12 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.684 0.278 . . . . 0.56 111.309 179.703 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 49.8 tp -66.22 -36.63 83.53 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 121.192 0.52 . . . . 0.88 109.911 178.458 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 76.4 t80 -63.78 -46.29 85.91 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.52 -0.763 . . . . 0.48 111.607 179.626 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 157' ' ' ARG . . . . . 0.471 ' HG3' ' O ' ' A' ' 153' ' ' ASP . 79.1 mtm-85 -58.0 -44.94 87.5 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.665 0.269 . . . . 0.6 110.442 179.419 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 158' ' ' GLN . . . . . 0.416 ' HG3' ' O ' ' A' ' 154' ' ' ASP . 38.0 mt-30 -64.62 -42.73 95.31 Favored 'General case' 0 CA--C 1.529 0.141 0 N-CA-C 109.862 -0.422 . . . . 1.25 109.862 178.243 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 50.9 m -58.54 -53.03 62.93 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.892 -0.594 . . . . 0.27 111.282 179.455 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 24.4 tp -61.82 -44.48 96.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.27 -0.423 . . . . 0.54 111.131 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -60.87 -53.47 56.9 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.607 0.241 . . . . 0.42 110.772 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 77.5 mt -56.85 -50.8 73.96 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 CA-C-N 116.32 -0.4 . . . . 0.33 111.162 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.678 ' O ' ' HG ' ' A' ' 167' ' ' LEU . 63.0 mt -62.23 -51.31 73.9 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-N 116.701 -0.227 . . . . 0.33 111.394 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 29.3 t -56.62 -46.12 81.14 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 120.763 0.316 . . . . 0.32 111.063 179.423 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 165' ' ' ARG . . . . . 0.726 ' O ' ' HG2' ' A' ' 169' ' ' GLU . 6.6 mmm180 -67.59 -44.09 78.98 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.615 -0.266 . . . . 0.34 111.255 179.66 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 166' ' ' TYR . . . . . 0.979 ' HE1' ' HA ' ' A' ' 195' ' ' ARG . 49.3 t80 -59.3 -51.21 70.94 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 111.74 0.274 . . . . 0.44 111.74 -179.76 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.678 ' HG ' ' O ' ' A' ' 163' ' ' ILE . 20.3 mt -62.79 -38.27 89.98 Favored 'General case' 0 N--CA 1.462 0.161 0 N-CA-C 109.662 -0.496 . . . . 0.34 109.662 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 16.9 ttm180 -58.57 -41.34 85.44 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.805 -0.634 . . . . 0.31 111.529 179.308 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 169' ' ' GLU . . . . . 0.726 ' HG2' ' O ' ' A' ' 165' ' ' ARG . 4.2 mm-40 -67.91 -53.9 22.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.577 -0.283 . . . . 0.44 110.929 179.679 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.61 -36.9 77.22 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 120.754 0.311 . . . . 0.56 111.672 179.594 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.442 ' HA ' ' HD2' ' A' ' 257' ' ' LYS . . . . . . . . 0 N--CA 1.467 0.4 0 N-CA-C 112.268 0.469 . . . . 0.4 112.268 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.572 ' O ' ' HA3' ' A' ' 187' ' ' GLY . . . . . . . . 0 CA--C 1.532 0.253 0 CA-C-O 121.225 0.536 . . . . 0.44 110.889 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -76.59 -70.14 1.32 Allowed Glycine 0 CA--C 1.524 0.6 0 C-N-CA 120.822 -0.704 . . . . 0.45 113.683 -179.624 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -66.09 -55.4 16.69 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.049 0.452 . . . . 0.48 111.95 -179.335 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -65.91 -39.11 90.26 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 116.134 -0.485 . . . . 0.41 110.563 179.309 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 187' ' ' GLY . . . . . 0.572 ' HA3' ' O ' ' A' ' 183' ' ' ALA . . . -66.37 -33.11 83.91 Favored Glycine 0 C--O 1.224 -0.469 0 C-N-CA 121.126 -0.559 . . . . 0.35 112.727 179.792 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 35.5 ttm180 -67.27 -50.97 58.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.768 0.318 . . . . 0.59 110.27 178.553 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 189' ' ' ARG . . . . . 0.703 ' HB3' HG11 ' A' ' 297' ' ' VAL . 49.9 mtm180 -64.18 -36.05 82.81 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.445 -0.343 . . . . 0.62 110.419 179.139 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 190' ' ' ALA . . . . . 0.413 ' HA ' HG22 ' A' ' 297' ' ' VAL . . . -70.97 -48.74 51.6 Favored 'General case' 0 C--O 1.216 -0.69 0 CA-C-N 116.093 -0.503 . . . . 0.31 111.435 179.356 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 191' ' ' LEU . . . . . 0.539 ' HB2' ' O ' ' A' ' 187' ' ' GLY . 0.2 OUTLIER -57.58 -51.57 68.93 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 120.711 0.291 . . . . 0.44 111.453 -179.899 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -59.57 -47.38 85.79 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.2 -0.455 . . . . 0.42 111.695 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 58.4 m -66.5 -48.34 70.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.869 0.366 . . . . 0.38 110.748 179.67 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 194' ' ' LEU . . . . . 0.41 HD21 HG21 ' A' ' 249' ' ' ILE . 25.1 tp -60.63 -36.88 79.75 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.867 -0.606 . . . . 0.35 111.371 179.564 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 195' ' ' ARG . . . . . 0.979 ' HA ' ' HE1' ' A' ' 166' ' ' TYR . 35.4 ttm180 -64.69 -46.87 80.53 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.777 0.322 . . . . 0.47 110.668 178.932 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.76 -52.81 39.92 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.924 -0.58 . . . . 0.58 111.639 -179.774 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 197' ' ' VAL . . . . . 0.537 ' O ' HG23 ' A' ' 201' ' ' VAL . 55.4 t -67.15 -40.42 85.19 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 CA-C-O 120.974 0.416 . . . . 0.41 111.704 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 198' ' ' GLY . . . . . 0.512 ' HA3' ' OH ' ' A' ' 166' ' ' TYR . . . -66.11 -49.87 55.16 Favored Glycine 0 CA--C 1.52 0.387 0 C-N-CA 121.216 -0.516 . . . . 0.3 113.25 -179.628 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 199' ' ' ASP . . . . . 0.419 ' HB2' ' O ' ' A' ' 195' ' ' ARG . 0.8 OUTLIER -63.47 -34.09 76.99 Favored 'General case' 0 N--CA 1.462 0.172 0 N-CA-C 109.749 -0.463 . . . . 0.51 109.749 179.183 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -63.09 -39.77 98.41 Favored Glycine 0 C--N 1.335 0.522 0 C-N-CA 121.179 -0.534 . . . . 0.38 112.366 178.712 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 201' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 197' ' ' VAL . 84.4 t -69.48 -43.13 80.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 CA-C-O 120.694 0.283 . . . . 0.37 110.857 179.078 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 202' ' ' GLN . . . . . 0.573 ' HG3' ' OG ' ' A' ' 250' ' ' SER . 34.2 mt-30 -59.12 -45.07 91.85 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.023 -0.535 . . . . 0.5 111.411 179.588 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 37.3 mtt180 -76.11 -24.68 54.97 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 116.304 -0.407 . . . . 0.62 111.817 179.512 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -78.12 -54.17 6.55 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.848 0.356 . . . . 0.66 111.753 179.362 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 33.6 m-70 -101.0 36.56 1.94 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.747 0.308 . . . . 0.64 110.465 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -55.28 -40.25 70.82 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 112.777 0.658 . . . . 0.6 112.777 -178.825 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 35.1 p -59.64 -53.82 53.62 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.026 0.441 . . . . 0.58 111.511 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -64.03 -42.74 96.99 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.048 -0.524 . . . . 0.46 110.56 178.921 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 2.3 m-30 -60.1 -48.94 79.61 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 115.963 -0.562 . . . . 0.5 110.958 179.533 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -57.24 -40.96 78.67 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 120.465 0.174 . . . . 0.7 111.449 179.629 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -57.39 -51.79 55.58 Favored Glycine 0 C--N 1.334 0.461 0 C-N-CA 120.507 -0.854 . . . . 0.4 111.513 178.725 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 212' ' ' MET . . . . . 0.486 ' O ' ' HB2' ' A' ' 216' ' ' LEU . 1.8 mpp? -69.76 -30.35 67.91 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 120.792 0.33 . . . . 0.82 110.669 178.894 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.42 HD22 ' HA ' ' A' ' 213' ' ' LEU . 1.6 tm? -61.45 -48.79 79.52 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.047 -0.524 . . . . 0.56 111.082 178.956 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 214' ' ' ARG . . . . . 0.447 HH11 ' HD3' ' A' ' 214' ' ' ARG . 27.7 mtt180 -69.64 -34.51 74.13 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.207 -0.451 . . . . 1.16 111.483 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 215' ' ' LYS . . . . . 0.419 ' HD3' ' HA ' ' A' ' 215' ' ' LYS . 72.1 mmtt -80.0 -4.26 51.83 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 120.876 0.37 . . . . 0.9 111.477 179.613 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 216' ' ' LEU . . . . . 0.512 ' HG ' HG13 ' A' ' 218' ' ' ILE . 1.5 tp -98.7 85.97 3.44 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.178 0.513 . . . . 0.73 111.111 179.567 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -81.82 34.57 0.4 Allowed 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 116.208 -0.451 . . . . 1.01 110.947 179.78 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 218' ' ' ILE . . . . . 0.754 HG12 ' HB3' ' A' ' 223' ' ' ASP . 13.7 mt -45.25 116.4 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 N-CA-C 114.021 1.119 . . . . 0.5 114.021 -178.956 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 9.0 ptpp? -158.61 -9.81 0.07 Allowed 'General case' 0 CA--C 1.548 0.88 0 CA-C-N 115.083 -0.962 . . . . 0.63 112.595 178.688 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -134.0 175.37 9.53 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 113.547 0.943 . . . . 0.96 113.547 -179.204 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 221' ' ' GLU . . . . . 0.563 ' O ' ' HG2' ' A' ' 225' ' ' LYS . 4.9 mm-40 -58.23 -22.99 54.32 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 114.995 -1.002 . . . . 0.67 113.573 -179.257 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -77.8 -27.08 59.36 Favored Glycine 0 CA--C 1.526 0.739 0 C-N-CA 120.677 -0.773 . . . . 0.49 113.152 179.771 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 223' ' ' ASP . . . . . 0.754 ' HB3' HG12 ' A' ' 218' ' ' ILE . 36.4 m-20 -69.32 -44.14 72.31 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 111.879 0.325 . . . . 0.59 111.879 -179.123 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -62.25 -28.94 45.53 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 CA-C-O 121.022 0.439 . . . . 0.54 110.087 178.433 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 225' ' ' LYS . . . . . 0.563 ' HG2' ' O ' ' A' ' 221' ' ' GLU . 42.3 mmtm -69.3 -35.71 76.27 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 109.511 -0.551 . . . . 0.76 109.511 177.805 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 226' ' ' SER . . . . . 0.666 ' O ' HG23 ' A' ' 230' ' ' VAL . 41.2 t -70.79 -44.62 66.25 Favored 'General case' 0 N--CA 1.463 0.18 0 N-CA-C 109.291 -0.633 . . . . 0.8 109.291 178.024 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 227' ' ' PHE . . . . . 0.564 ' HE2' HG21 ' A' ' 255' ' ' VAL . 10.5 t80 -58.82 -44.43 90.87 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 115.848 -0.615 . . . . 0.61 110.278 178.926 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 5.1 p -70.63 -34.29 71.93 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.123 -0.489 . . . . 0.83 110.3 178.428 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 5.8 ttt180 -63.58 -42.32 98.3 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.296 0.57 . . . . 3.18 110.304 178.048 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 230' ' ' VAL . . . . . 0.897 HG13 ' HA ' ' B' ' 24' ' ' ALA . 43.2 t -65.11 -38.89 83.87 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 N-CA-C 109.774 -0.454 . . . . 0.55 109.774 178.327 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 231' ' ' MET . . . . . 0.797 ' HG3' ' HG ' ' A' ' 248' ' ' LEU . 34.1 ttm -62.86 -51.11 68.28 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 115.896 -0.593 . . . . 0.43 111.79 179.65 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 31.7 m -60.96 -33.08 54.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 C-N-CA 121.053 -0.259 . . . . 0.44 111.593 -179.745 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 4.0 t-80 -67.31 -40.27 85.97 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 109.803 -0.443 . . . . 0.45 109.803 178.139 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.541 HG23 ' O ' ' A' ' 230' ' ' VAL . 59.9 t -53.6 -47.86 60.14 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 CA-C-N 116.116 -0.493 . . . . 0.4 110.523 179.483 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -96.72 23.23 7.21 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.941 -0.572 . . . . 0.6 111.948 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 3.1 tmtm? -66.89 -17.06 64.72 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.878 0.37 . . . . 1.04 111.63 -179.629 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -80.55 -16.16 54.87 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.447 -0.342 . . . . 0.6 111.172 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 97.82 -17.72 58.37 Favored Glycine 0 CA--C 1.522 0.524 0 C-N-CA 120.744 -0.741 . . . . 0.46 113.661 179.323 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 6.8 p -89.63 120.28 38.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-O 121.454 0.645 . . . . 0.42 111.641 -179.617 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 32.8 m -94.34 99.62 11.8 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.006 0.431 . . . . 0.57 111.69 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 241' ' ' ASN . . . . . 0.42 ' HB2' ' HD2' ' A' ' 244' ' ' ARG . 90.4 m-20 -90.3 135.71 33.51 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.591 -0.277 . . . . 0.84 110.434 178.986 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 242' ' ' TRP . . . . . 0.523 ' CZ3' ' HB2' ' A' ' 296' ' ' PHE . 25.9 m95 -58.21 -40.6 82.03 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.823 0.344 . . . . 0.49 111.124 179.561 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 243' ' ' GLY . . . . . 0.51 ' HA3' ' N ' ' B' ' 35' ' ' TYR . . . -61.03 -30.32 73.2 Favored Glycine 0 C--N 1.332 0.359 0 C-N-CA 120.771 -0.728 . . . . 0.37 111.877 178.417 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 244' ' ' ARG . . . . . 0.501 ' HA ' ' HA3' ' B' ' 31' ' ' GLY . 74.3 mtt180 -69.25 -47.9 63.36 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.816 -0.439 . . . . 0.51 109.816 178.416 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 245' ' ' ILE . . . . . 0.464 ' O ' HG13 ' A' ' 249' ' ' ILE . 68.7 mt -59.15 -49.95 81.52 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.12 0 CA-C-N 115.523 -0.762 . . . . 0.43 111.294 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 246' ' ' VAL . . . . . 0.418 HG21 ' CG1' ' A' ' 197' ' ' VAL . 7.3 p -66.13 -28.41 43.66 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 C-N-CA 120.727 -0.389 . . . . 0.42 111.133 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 19.3 m -65.15 -46.08 82.36 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 109.935 -0.395 . . . . 0.4 109.935 178.293 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 248' ' ' LEU . . . . . 0.797 ' HG ' ' HG3' ' A' ' 231' ' ' MET . 3.0 mm? -62.3 -39.58 93.45 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 116.106 -0.497 . . . . 0.51 110.582 178.814 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 249' ' ' ILE . . . . . 0.464 HG13 ' O ' ' A' ' 245' ' ' ILE . 17.6 mt -70.12 -40.96 78.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-O 120.929 0.395 . . . . 0.4 110.079 178.316 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 250' ' ' SER . . . . . 0.573 ' OG ' ' HG3' ' A' ' 202' ' ' GLN . 33.7 t -61.53 -44.89 96.23 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 109.553 -0.536 . . . . 1.04 109.553 178.257 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 251' ' ' PHE . . . . . . . . . . . . . 42.4 t80 -66.23 -38.57 88.2 Favored 'General case' 0 C--O 1.231 0.128 0 N-CA-C 109.097 -0.705 . . . . 0.5 109.097 177.42 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -60.61 -36.29 91.18 Favored Glycine 0 C--N 1.336 0.541 0 N-CA-C 111.199 -0.761 . . . . 0.3 111.199 177.619 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -68.18 -38.32 81.93 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-O 120.909 0.385 . . . . 0.33 110.031 177.708 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -65.13 -40.82 94.99 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 109.458 -0.571 . . . . 1.03 109.458 178.33 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 255' ' ' VAL . . . . . 0.564 HG21 ' HE2' ' A' ' 227' ' ' PHE . 70.1 t -63.59 -44.21 98.5 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 CA-C-N 115.834 -0.621 . . . . 0.38 109.495 177.468 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -59.39 -32.37 70.09 Favored 'General case' 0 C--O 1.226 -0.163 0 CA-C-N 116.381 -0.372 . . . . 0.29 110.137 177.938 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 257' ' ' LYS . . . . . 0.442 ' HD2' ' HA ' ' A' ' 171' ' ' ALA . 43.5 tptt -63.82 -49.18 73.88 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.071 -0.513 . . . . 0.66 110.433 178.332 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -71.43 -32.59 68.53 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 120.888 0.375 . . . . 0.36 110.143 179.034 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.521 ' HG ' ' HB3' ' A' ' 264' ' ' GLN . 1.6 tp -67.85 -40.21 83.69 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 121.204 0.526 . . . . 0.43 109.744 177.672 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 45.3 tptt -70.65 -27.46 64.06 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.012 -0.54 . . . . 0.37 110.51 178.919 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 42.1 t -57.34 -28.55 63.23 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.436 -0.347 . . . . 0.55 110.583 178.519 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 16.1 m -113.15 14.78 8.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 CA-C-N 116.006 -0.543 . . . . 0.5 110.168 178.263 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 40.6 t30 54.73 45.07 27.49 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 115.208 -0.906 . . . . 0.44 112.967 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 264' ' ' GLN . . . . . 0.521 ' HB3' ' HG ' ' A' ' 259' ' ' LEU . 1.6 mt-30 -83.73 37.72 0.6 Allowed 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 120.761 0.315 . . . . 0.5 111.363 179.274 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -50.93 -42.15 59.42 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 112.665 0.617 . . . . 0.38 112.665 -179.069 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 1.3 p -62.24 -13.99 33.81 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.32 -0.4 . . . . 0.82 111.615 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 267' ' ' PHE . . . . . 0.489 ' C ' ' HD2' ' A' ' 270' ' ' PRO . 18.3 t80 -110.12 -22.91 11.56 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.347 -0.388 . . . . 0.59 110.372 178.345 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 268' ' ' ILE . . . . . 0.426 HG13 ' O ' ' A' ' 264' ' ' GLN . 72.1 mt -61.51 -46.49 96.47 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-N 116.387 -0.37 . . . . 0.33 110.554 178.712 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 269' ' ' GLU . . . . . 0.736 ' HB2' ' HD3' ' A' ' 270' ' ' PRO . 29.2 mm-40 -57.9 -56.57 33.35 Favored Pre-proline 0 CA--C 1.541 0.62 0 CA-C-N 116.576 -0.284 . . . . 0.34 110.785 178.562 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 270' ' ' PRO . . . . . 0.736 ' HD3' ' HB2' ' A' ' 269' ' ' GLU . 52.4 Cg_exo -57.97 -27.46 79.22 Favored 'Trans proline' 0 C--N 1.365 1.444 0 C-N-CA 122.402 2.068 . . . . 0.33 112.336 177.922 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 271' ' ' LEU . . . . . . . . . . . . . 20.9 tp -68.3 -53.06 26.9 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 108.959 -0.756 . . . . 0.5 108.959 177.924 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -61.31 -35.75 78.21 Favored 'General case' 0 C--O 1.23 0.075 0 N-CA-C 109.064 -0.717 . . . . 0.3 109.064 177.75 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 273' ' ' GLU . . . . . 0.514 ' HB3' ' HA ' ' A' ' 270' ' ' PRO . 32.4 tt0 -61.88 -48.62 79.69 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 114.939 -1.028 . . . . 1.62 109.852 177.605 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 274' ' ' THR . . . . . . . . . . . . . 89.0 m -62.49 -46.49 88.23 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.964 -0.562 . . . . 0.41 110.422 178.9 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 95.5 mt -56.59 -54.61 26.64 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-N 116.116 -0.493 . . . . 0.43 110.572 178.892 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 19.2 m -57.95 -52.4 65.68 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.603 -0.726 . . . . 0.42 111.577 179.797 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 277' ' ' ASP . . . . . 0.409 ' HB2' ' O ' ' A' ' 273' ' ' GLU . 1.0 OUTLIER -51.23 -54.44 25.64 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.072 -0.513 . . . . 0.4 111.482 179.956 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 87.6 t -64.41 -39.29 85.03 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-N 116.381 -0.372 . . . . 0.45 111.804 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 279' ' ' LEU . . . . . 0.465 ' O ' ' HB2' ' A' ' 283' ' ' LYS . 1.0 OUTLIER -67.65 -41.07 84.39 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 120.942 0.401 . . . . 1.1 111.364 -179.926 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 76.2 t -77.08 -46.02 29.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 112.394 0.516 . . . . 0.46 112.394 -179.245 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 67.3 mtp180 -65.6 -35.67 81.5 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 112.997 0.74 . . . . 0.76 112.997 -178.864 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 282' ' ' THR . . . . . . . . . . . . . 60.4 p -83.49 -15.88 47.78 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 122.13 -0.356 . . . . 0.35 111.923 179.797 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 283' ' ' LYS . . . . . 0.603 ' HB3' HD23 ' A' ' 287' ' ' LEU . 0.1 OUTLIER -123.21 39.76 3.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.746 0.307 . . . . 0.63 110.915 179.866 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 33.9 ttm180 -52.36 -61.43 2.28 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 112.666 0.617 . . . . 0.61 112.666 -179.57 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -64.77 -38.87 92.45 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 112.527 0.565 . . . . 0.84 112.527 -179.219 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 286' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -65.44 -41.36 93.56 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.805 0.336 . . . . 0.73 111.817 -179.23 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 287' ' ' LEU . . . . . 0.603 HD23 ' HB3' ' A' ' 283' ' ' LYS . 1.7 mm? -70.0 -41.63 74.09 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.468 0.544 . . . . 0.59 112.468 -179.174 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 20.4 m -67.02 -35.76 75.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 C-N-CA 120.799 -0.36 . . . . 0.53 111.899 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 47.4 mttp -69.99 -39.56 75.82 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 112.677 0.621 . . . . 1.12 112.677 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -89.92 20.17 4.37 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 113.405 0.891 . . . . 0.58 113.405 -178.038 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 291' ' ' ARG . . . . . 0.414 HH11 ' HD2' ' A' ' 291' ' ' ARG . 42.9 mtm180 60.42 15.33 5.42 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 112.916 0.709 . . . . 0.46 112.916 179.441 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 292' ' ' GLY . . . . . 0.478 ' HA2' HD13 ' A' ' 287' ' ' LEU . . . 66.59 -124.42 24.31 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 114.274 0.47 . . . . 0.31 114.274 179.445 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 293' ' ' TRP . . . . . 0.525 ' O ' HG23 ' A' ' 297' ' ' VAL . 89.2 m95 -63.85 -30.37 71.47 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.334 0.494 . . . . 0.38 112.334 -178.809 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 294' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.88 -43.45 94.73 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.836 -0.346 . . . . 0.74 110.623 178.947 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -67.9 -37.89 88.53 Favored Glycine 0 C--N 1.333 0.406 0 C-N-CA 120.56 -0.828 . . . . 0.33 111.073 177.775 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 296' ' ' PHE . . . . . 0.523 ' HB2' ' CZ3' ' A' ' 242' ' ' TRP . 0.3 OUTLIER -62.43 -45.81 91.41 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 120.936 0.398 . . . . 0.46 110.48 178.413 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 297' ' ' VAL . . . . . 0.703 HG11 ' HB3' ' A' ' 189' ' ' ARG . 80.3 t -63.58 -49.82 80.83 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.23 0 CA-C-N 115.855 -0.611 . . . . 0.34 110.898 179.749 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 71.6 mt-10 -61.96 -45.21 94.65 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.245 -0.434 . . . . 0.53 111.777 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 299' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -60.01 -49.48 77.51 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 120.87 0.367 . . . . 0.55 111.678 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 300' ' ' PHE . . . . . 0.505 ' HB3' HG21 ' A' ' 197' ' ' VAL . 59.3 m-85 . . . . . 0 C--N 1.329 -0.321 0 CA-C-O 121.009 0.433 . . . . 0.56 111.3 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 22' ' ' GLU . . . . . 0.464 ' O ' ' HB2' ' B' ' 26' ' ' GLN . 4.8 mm-40 . . . . . 0 C--O 1.224 -0.265 0 N-CA-C 111.407 0.151 . . . . 0.75 111.407 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 23' ' ' PHE . . . . . . . . . . . . . 10.3 p90 -63.64 -35.39 80.37 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.18 0.515 . . . . 0.62 110.747 179.68 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 24' ' ' ALA . . . . . 0.897 ' HA ' HG13 ' A' ' 230' ' ' VAL . . . -72.11 -43.98 63.91 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.639 -0.71 . . . . 0.42 110.623 179.178 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -69.73 -37.03 76.35 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.147 -0.479 . . . . 0.42 110.532 179.108 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 26' ' ' GLN . . . . . 0.464 ' HB2' ' O ' ' B' ' 22' ' ' GLU . 0.0 OUTLIER -61.73 -54.84 37.07 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 116.481 -0.327 . . . . 0.71 111.174 179.514 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 27' ' ' LEU . . . . . 0.52 HD12 HG11 ' A' ' 230' ' ' VAL . 30.9 mt -58.06 -37.32 74.22 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 120.863 0.363 . . . . 0.63 110.197 178.962 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 28' ' ' ARG . . . . . 0.528 ' HA ' HG13 ' A' ' 234' ' ' VAL . 4.8 tmt_? -62.6 -53.69 50.81 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 109.26 -0.644 . . . . 1.24 109.26 177.55 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 21.3 mtmt -53.7 -48.95 69.06 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.858 -0.61 . . . . 0.55 110.582 178.686 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 30' ' ' ILE . . . . . 0.444 HG13 ' O ' ' B' ' 26' ' ' GLN . 75.5 mt -59.07 -42.28 85.97 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.202 0 CA-C-N 116.057 -0.52 . . . . 0.41 110.123 179.129 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 31' ' ' GLY . . . . . 0.501 ' HA3' ' HA ' ' A' ' 244' ' ' ARG . . . -58.76 -50.15 70.32 Favored Glycine 0 CA--C 1.521 0.421 0 C-N-CA 120.886 -0.673 . . . . 0.34 112.398 178.968 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 32' ' ' ASP . . . . . 0.484 ' OD2' ' HD3' ' B' ' 28' ' ' ARG . 9.1 m-20 -61.84 -40.12 94.2 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.14 0.495 . . . . 0.42 110.145 178.948 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 15.6 tppt? -64.0 -53.82 44.01 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 115.74 -0.663 . . . . 1.22 111.101 179.514 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 77.3 t -59.13 -39.03 77.58 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-O 121.067 0.461 . . . . 0.42 110.48 179.315 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 35' ' ' TYR . . . . . 0.51 ' N ' ' HA3' ' A' ' 243' ' ' GLY . 4.0 t80 -60.55 -50.44 73.55 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.898 -0.592 . . . . 0.82 110.467 178.479 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 36' ' ' CYS . . . . . . . . . . . . . 61.5 m -64.25 -25.82 68.23 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.009 0.433 . . . . 0.43 110.983 179.429 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 20.9 m -75.36 -43.14 52.05 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 116.022 -0.536 . . . . 0.44 112.259 -179.59 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 38' ' ' TRP . . . . . . . . . . . . . 97.2 m95 -87.9 -9.78 52.67 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 113.249 0.833 . . . . 0.66 113.249 -178.623 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 38.2 t . . . . . 0 N--CA 1.468 0.474 0 N-CA-C 111.731 0.271 . . . . 0.67 111.731 179.196 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 33.0 t70 . . . . . 0 CA--C 1.534 0.338 0 N-CA-C 112.454 0.538 . . . . 0.64 112.454 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.93 -55.54 33.8 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.123 0.487 . . . . 0.83 111.121 179.758 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.477 HD21 ' HB3' ' A' ' 287' ' ' LEU . 26.4 tp -58.63 -42.35 88.09 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.91 -0.587 . . . . 0.54 112.251 179.616 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 68.3 t80 -69.01 -47.04 66.48 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 112.399 0.518 . . . . 0.51 112.399 -179.219 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 60.9 mtp180 -61.21 -40.23 93.22 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 111.744 0.276 . . . . 0.64 111.744 -179.6 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 2.8 mm-40 -68.57 -44.29 74.76 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.891 0.377 . . . . 0.63 110.183 179.14 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 34.1 m -63.69 -49.35 73.47 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.949 -0.568 . . . . 0.32 111.346 179.705 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.51 ' HA ' HG21 ' A' ' 276' ' ' THR . 11.1 tp -55.68 -49.49 72.81 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 111.871 0.323 . . . . 0.47 111.871 -179.797 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 161' ' ' GLU . . . . . 0.724 ' O ' ' HG2' ' A' ' 165' ' ' ARG . 0.0 OUTLIER -58.64 -53.72 55.2 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-O 120.625 0.25 . . . . 0.54 111.152 179.806 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 162' ' ' ILE . . . . . 0.514 HG12 ' HA2' ' A' ' 187' ' ' GLY . 83.3 mt -58.54 -46.95 89.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-N 116.416 -0.356 . . . . 0.33 111.683 -179.711 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.512 HD12 HG23 ' A' ' 276' ' ' THR . 71.7 mt -62.74 -45.51 98.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 CA-C-N 116.446 -0.343 . . . . 0.32 110.716 179.643 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 164' ' ' SER . . . . . 0.536 ' O ' ' HB2' ' A' ' 168' ' ' ARG . 51.1 m -57.87 -41.38 82.36 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.482 -0.326 . . . . 0.29 110.332 178.346 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 165' ' ' ARG . . . . . 0.724 ' HG2' ' O ' ' A' ' 161' ' ' GLU . 13.5 mmt180 -65.11 -54.8 24.34 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.493 -0.321 . . . . 0.52 111.33 179.612 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 166' ' ' TYR . . . . . 0.823 ' HE1' ' HA ' ' A' ' 195' ' ' ARG . 65.2 t80 -60.93 -51.26 70.02 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 113.036 0.754 . . . . 0.39 113.036 -178.063 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.469 HD13 HG23 ' A' ' 163' ' ' ILE . 9.2 mp -60.43 -39.87 89.03 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.879 -0.329 . . . . 0.45 111.056 -179.078 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 168' ' ' ARG . . . . . 0.536 ' HB2' ' O ' ' A' ' 164' ' ' SER . 3.9 mmt180 -68.7 -42.8 77.25 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 120.881 0.372 . . . . 0.39 111.126 178.836 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 169' ' ' GLU . . . . . 0.562 ' CD ' HH21 ' A' ' 195' ' ' ARG . 63.5 mt-10 -65.33 -48.67 72.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.019 0.437 . . . . 0.37 111.447 178.875 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 170' ' ' GLN . . . . . 0.636 ' HB3' ' HB1' ' A' ' 253' ' ' ALA . 7.4 tp60 -65.71 -37.3 86.05 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.137 -0.483 . . . . 0.39 111.821 -179.355 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.458 ' HA ' ' HA ' ' A' ' 257' ' ' LYS . . . . . . . . 0 N--CA 1.463 0.204 0 CA-C-O 120.787 0.327 . . . . 0.39 111.396 179.083 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.549 ' O ' ' HA3' ' A' ' 187' ' ' GLY . . . . . . . . 0 C--O 1.224 -0.281 0 CA-C-O 120.669 0.271 . . . . 0.43 111.062 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -74.81 -71.15 1.16 Allowed Glycine 0 CA--C 1.528 0.849 0 C-N-CA 120.552 -0.832 . . . . 0.55 114.255 -179.341 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -62.31 -55.29 29.61 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-O 121.06 0.457 . . . . 0.63 111.736 -179.161 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -63.78 -40.27 96.27 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.915 -0.584 . . . . 0.42 110.672 179.172 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 187' ' ' GLY . . . . . 0.549 ' HA3' ' O ' ' A' ' 183' ' ' ALA . . . -64.3 -40.41 97.87 Favored Glycine 0 C--N 1.333 0.4 0 C-N-CA 121.261 -0.495 . . . . 0.32 113.592 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 62.7 ttt180 -62.89 -51.3 67.51 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 117.269 0.534 . . . . 1.4 110.759 179.198 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 48.4 mtm180 -67.54 -31.56 71.74 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 116.112 -0.494 . . . . 0.45 111.033 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 190' ' ' ALA . . . . . 0.518 ' HA ' ' CG1' ' A' ' 297' ' ' VAL . . . -71.29 -40.43 70.89 Favored 'General case' 0 C--O 1.222 -0.368 0 CA-C-N 116.282 -0.417 . . . . 0.27 110.943 178.888 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 20.0 tp -63.36 -47.15 83.31 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 111.589 0.218 . . . . 0.55 111.589 179.536 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 6.0 tm-20 -60.17 -45.37 93.33 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.291 0.567 . . . . 0.35 110.267 179.405 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 193' ' ' THR . . . . . 0.652 HG21 ' HA ' ' A' ' 297' ' ' VAL . 27.8 m -65.68 -47.19 76.3 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.762 -0.654 . . . . 0.31 110.665 179.284 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 194' ' ' LEU . . . . . 0.445 HD12 ' HA ' ' A' ' 194' ' ' LEU . 7.0 tp -61.07 -41.75 97.22 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 116.032 -0.531 . . . . 0.34 110.678 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 195' ' ' ARG . . . . . 0.823 ' HA ' ' HE1' ' A' ' 166' ' ' TYR . 50.5 mtt180 -59.38 -58.44 8.6 Favored 'General case' 0 C--O 1.226 -0.136 0 CA-C-O 120.774 0.321 . . . . 0.48 110.172 178.319 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 8.5 ttm180 -57.77 -56.34 23.16 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.654 -0.703 . . . . 0.45 112.714 -179.028 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 197' ' ' VAL . . . . . 0.482 ' O ' HG23 ' A' ' 201' ' ' VAL . 58.6 t -62.3 -41.71 92.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-O 120.87 0.367 . . . . 0.3 111.021 -179.395 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 198' ' ' GLY . . . . . 0.581 ' HA3' ' OH ' ' A' ' 166' ' ' TYR . . . -63.21 -46.85 92.16 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 120.86 -0.686 . . . . 0.28 111.939 179.174 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 51.3 m-20 -55.74 -45.56 77.98 Favored 'General case' 0 N--CA 1.462 0.163 0 N-CA-C 109.509 -0.552 . . . . 0.36 109.509 178.114 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -58.69 -54.31 38.96 Favored Glycine 0 C--O 1.223 -0.573 0 CA-C-N 115.633 -0.712 . . . . 0.31 111.921 178.464 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 201' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 197' ' ' VAL . 57.5 t -59.58 -42.3 87.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 CA-C-O 120.787 0.327 . . . . 0.41 111.701 179.279 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 202' ' ' GLN . . . . . 0.44 ' HG2' ' HD1' ' A' ' 254' ' ' PHE . 5.9 mt-30 -64.3 -52.47 58.39 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 112.444 0.535 . . . . 0.55 112.444 -179.389 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 203' ' ' ARG . . . . . 0.43 ' HD3' HH11 ' A' ' 203' ' ' ARG . 2.8 mmp_? -69.37 -35.18 75.58 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.743 0.306 . . . . 0.59 111.475 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -68.53 -48.27 64.75 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.995 0.426 . . . . 0.4 110.819 179.105 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 -100.69 32.95 2.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.007 0.432 . . . . 0.54 110.818 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -56.72 -46.72 81.14 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.607 -0.724 . . . . 0.42 112.148 -179.167 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 58.4 p -60.46 -45.62 93.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.994 0.426 . . . . 0.57 111.176 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -65.94 -41.88 90.74 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.844 -0.616 . . . . 0.37 110.886 179.053 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 7.8 m-30 -66.17 -44.34 84.33 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.521 -0.309 . . . . 0.48 110.573 179.281 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -64.71 -44.52 89.98 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.532 -0.303 . . . . 1.34 110.616 178.643 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -60.51 -44.67 97.46 Favored Glycine 0 C--N 1.336 0.549 0 C-N-CA 120.749 -0.739 . . . . 0.33 111.28 178.588 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 28.1 ttm -66.3 -40.87 90.28 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 121.022 0.439 . . . . 0.51 109.935 178.248 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 12.9 tp -59.36 -42.54 91.83 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.596 -0.729 . . . . 0.49 111.718 179.177 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 77.1 mtp180 -74.28 -28.71 61.33 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.401 -0.363 . . . . 0.87 111.741 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 49.4 mtmt -76.33 -34.19 58.99 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 120.823 0.344 . . . . 0.82 110.69 178.89 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 216' ' ' LEU . . . . . 0.557 ' HB3' HG12 ' A' ' 218' ' ' ILE . 81.6 mt -67.84 136.39 54.04 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 121.11 0.481 . . . . 0.57 111.795 179.499 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -101.28 30.97 3.89 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.11 -0.495 . . . . 0.71 110.485 179.31 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 218' ' ' ILE . . . . . 0.557 HG12 ' HB3' ' A' ' 216' ' ' LEU . 20.0 mm -59.17 119.86 4.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-N 115.8 -0.636 . . . . 0.5 111.316 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 19.3 mtmm -149.04 -30.99 0.24 Allowed 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 113.178 0.807 . . . . 1.1 113.178 -179.601 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -125.18 174.67 7.92 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.748 0.647 . . . . 0.46 112.748 -178.222 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 221' ' ' GLU . . . . . 0.463 ' O ' HG22 ' A' ' 224' ' ' VAL . 1.0 OUTLIER -62.35 -28.77 69.99 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 115.732 -0.667 . . . . 0.59 111.302 -179.949 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -61.88 -25.59 66.08 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 121.351 -0.452 . . . . 0.33 113.268 179.682 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 -58.43 -28.34 65.17 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 113.226 0.824 . . . . 0.36 113.226 -179.688 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.728 ' HB ' HG21 ' A' ' 274' ' ' THR . 25.8 m -54.0 -29.78 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 N-CA-C 112.908 0.707 . . . . 0.39 112.908 -179.237 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 33.4 mtmm -64.89 -43.39 93.04 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-O 121.415 0.626 . . . . 0.63 110.075 178.928 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 15.5 m -70.34 -38.65 74.88 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.309 -0.86 . . . . 0.6 109.715 178.637 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 227' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -59.63 -38.82 82.39 Favored 'General case' 0 CA--C 1.528 0.13 0 N-CA-C 108.791 -0.818 . . . . 0.61 108.791 177.867 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 49.8 m -62.32 -41.19 98.33 Favored 'General case' 0 CA--C 1.528 0.101 0 CA-C-N 115.426 -0.806 . . . . 0.48 109.989 177.529 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.2 -40.93 78.41 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.33 -0.395 . . . . 2.11 110.371 178.592 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 230' ' ' VAL . . . . . 0.51 ' O ' HG23 ' A' ' 234' ' ' VAL . 13.4 t -61.97 -51.3 74.18 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-N 116.466 -0.334 . . . . 0.3 110.139 178.679 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 231' ' ' MET . . . . . . . . . . . . . 38.9 mtp -58.84 -47.63 84.18 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.146 -0.479 . . . . 0.4 111.116 179.41 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 75.6 t -63.92 -41.0 91.07 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 CA-C-N 116.34 -0.391 . . . . 0.53 110.907 179.19 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 31.8 t-80 -64.58 -37.56 87.97 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 116.414 -0.357 . . . . 0.58 110.975 178.922 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.51 HG23 ' O ' ' A' ' 230' ' ' VAL . 53.1 t -63.2 -51.61 69.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-O 120.794 0.331 . . . . 0.43 111.736 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -90.37 24.56 2.53 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 112.159 0.429 . . . . 0.58 112.159 -178.93 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 1.8 tmtm? -66.69 -15.37 63.46 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 112.537 0.569 . . . . 1.21 112.537 -179.25 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 44.8 p30 -85.27 -16.21 40.88 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 120.767 0.318 . . . . 0.57 111.497 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 94.38 -0.84 66.22 Favored Glycine 0 CA--C 1.524 0.636 0 C-N-CA 121.088 -0.577 . . . . 0.58 113.262 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 239' ' ' VAL . . . . . 0.487 ' HB ' ' NH1' ' A' ' 244' ' ' ARG . 25.6 t -93.44 109.84 22.43 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-O 121.092 0.472 . . . . 0.48 111.584 -179.597 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 240' ' ' THR . . . . . 0.626 HG22 HD11 ' A' ' 245' ' ' ILE . 21.2 m -94.11 76.74 4.06 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.951 0.405 . . . . 0.84 111.582 179.718 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 241' ' ' ASN . . . . . 0.448 ' H ' ' HD2' ' A' ' 244' ' ' ARG . 59.3 m-20 -77.05 140.3 40.28 Favored 'General case' 0 C--N 1.329 -0.307 0 O-C-N 122.206 -0.309 . . . . 0.72 110.943 179.194 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 242' ' ' TRP . . . . . 0.546 ' HB3' ' CE2' ' A' ' 300' ' ' PHE . 47.8 m95 -56.32 -40.95 75.24 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.813 0.34 . . . . 0.6 110.871 179.275 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 243' ' ' GLY . . . . . 0.452 ' H ' ' HB2' ' B' ' 35' ' ' TYR . . . -62.98 -28.82 72.65 Favored Glycine 0 C--N 1.334 0.466 0 C-N-CA 121.168 -0.539 . . . . 0.25 112.028 178.49 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 244' ' ' ARG . . . . . 0.487 ' NH1' ' HB ' ' A' ' 239' ' ' VAL . 89.7 mtt180 -74.44 -42.39 59.21 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.659 -0.497 . . . . 0.46 109.659 178.779 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 245' ' ' ILE . . . . . 0.626 HD11 HG22 ' A' ' 240' ' ' THR . 67.8 mt -63.81 -52.71 53.63 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 CA-C-N 115.903 -0.589 . . . . 0.4 110.377 178.771 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 246' ' ' VAL . . . . . 0.405 HG12 ' HA2' ' A' ' 243' ' ' GLY . 6.8 p -62.63 -29.76 47.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 CA-C-N 116.287 -0.415 . . . . 0.35 110.836 179.43 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 11.1 m -65.93 -44.49 84.98 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 109.743 -0.465 . . . . 0.31 109.743 177.965 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 248' ' ' LEU . . . . . 0.41 HD13 ' HA ' ' A' ' 248' ' ' LEU . 2.5 mm? -64.42 -40.65 96.18 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 109.832 -0.432 . . . . 0.53 109.832 178.035 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 249' ' ' ILE . . . . . 0.459 HG12 ' O ' ' A' ' 245' ' ' ILE . 48.7 mm -64.05 -43.06 97.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 CA-C-O 121.052 0.453 . . . . 0.46 109.868 178.162 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 56.2 m -62.32 -42.61 99.52 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 115.846 -0.615 . . . . 0.3 109.6 178.313 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 251' ' ' PHE . . . . . . . . . . . . . 18.2 t80 -62.77 -42.99 99.94 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 116.008 -0.542 . . . . 0.5 109.675 178.079 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -57.82 -46.61 92.15 Favored Glycine 0 C--N 1.335 0.521 0 N-CA-C 111.386 -0.686 . . . . 0.28 111.386 178.165 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 253' ' ' ALA . . . . . 0.636 ' HB1' ' HB3' ' A' ' 170' ' ' GLN . . . -68.19 -27.77 66.68 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 120.661 0.267 . . . . 0.35 111.483 178.261 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 254' ' ' PHE . . . . . 0.44 ' HD1' ' HG2' ' A' ' 202' ' ' GLN . 26.6 t80 -74.81 -48.51 24.91 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 120.626 0.25 . . . . 0.6 111.047 179.3 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 255' ' ' VAL . . . . . 0.535 ' O ' ' HG ' ' A' ' 259' ' ' LEU . 23.6 m -64.18 -37.75 80.69 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.129 0 C-N-CA 120.503 -0.479 . . . . 0.34 109.751 178.454 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -67.36 -32.15 72.88 Favored 'General case' 0 C--N 1.341 0.199 0 CA-C-N 116.342 -0.39 . . . . 0.26 110.497 178.339 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 257' ' ' LYS . . . . . 0.562 ' HE2' ' HG3' ' A' ' 170' ' ' GLN . 28.0 ttmt -61.94 -46.99 86.88 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 109.048 -0.723 . . . . 0.44 109.048 177.907 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 82.9 t60 -66.0 -40.47 91.15 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 115.356 -0.838 . . . . 0.58 109.445 177.843 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.65 ' HB3' ' HB2' ' A' ' 264' ' ' GLN . 95.0 mt -62.89 -36.39 83.18 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.104 -0.498 . . . . 0.41 110.591 178.438 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -65.54 -37.36 86.52 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 110.134 -0.321 . . . . 0.37 110.134 178.47 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 15.9 p -64.2 -24.62 67.74 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.839 0.352 . . . . 0.53 110.7 178.877 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 7.3 p -107.09 8.15 9.62 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 CA-C-O 121.592 0.71 . . . . 0.4 110.328 178.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 6.5 t30 59.13 49.31 9.45 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 113.7 1.0 . . . . 0.59 113.7 179.187 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 264' ' ' GLN . . . . . 0.65 ' HB2' ' HB3' ' A' ' 259' ' ' LEU . 4.0 mm100 -92.24 35.19 1.0 Allowed 'General case' 0 N--CA 1.47 0.532 0 O-C-N 122.082 -0.386 . . . . 0.6 111.352 178.888 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 265' ' ' GLU . . . . . 0.408 ' HG2' ' H ' ' A' ' 265' ' ' GLU . 5.3 mm-40 -47.52 -43.94 25.28 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 112.594 0.591 . . . . 0.45 112.594 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 86.8 p -59.11 -18.13 32.74 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 116.326 -0.397 . . . . 0.47 111.749 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 267' ' ' PHE . . . . . 0.448 ' CE1' ' HA ' ' A' ' 221' ' ' GLU . 53.8 t80 -107.77 -28.62 9.57 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 116.653 -0.249 . . . . 0.53 111.073 178.723 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 73.9 mt -57.13 -49.97 77.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 CA-C-O 120.575 0.226 . . . . 0.38 111.474 179.79 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 269' ' ' GLU . . . . . 0.485 ' HB2' ' HD3' ' A' ' 270' ' ' PRO . 2.5 mp0 -58.6 -56.86 31.27 Favored Pre-proline 0 CA--C 1.543 0.707 0 C-N-CA 121.128 -0.229 . . . . 0.36 111.542 179.431 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 270' ' ' PRO . . . . . 0.485 ' HD3' ' HB2' ' A' ' 269' ' ' GLU . 45.1 Cg_exo -59.37 -29.83 91.18 Favored 'Trans proline' 0 C--N 1.361 1.198 0 C-N-CA 122.369 2.046 . . . . 0.3 112.854 178.57 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 271' ' ' LEU . . . . . . . . . . . . . 56.6 tp -67.72 -49.38 62.96 Favored 'General case' 0 N--CA 1.464 0.225 0 N-CA-C 109.914 -0.402 . . . . 0.44 109.914 178.452 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -60.17 -37.21 79.47 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.113 -0.494 . . . . 0.31 110.217 178.454 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 273' ' ' GLU . . . . . 0.451 ' O ' ' HB2' ' A' ' 277' ' ' ASP . 32.0 tt0 -67.05 -43.12 83.51 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 109.462 -0.57 . . . . 1.11 109.462 178.109 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 274' ' ' THR . . . . . 0.728 HG21 ' HB ' ' A' ' 224' ' ' VAL . 70.1 m -61.47 -49.29 77.39 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.104 -0.498 . . . . 0.4 110.348 178.216 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 96.8 mt -55.37 -54.16 28.04 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.123 0 CA-C-N 115.775 -0.648 . . . . 0.42 110.763 179.419 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 276' ' ' THR . . . . . 0.512 HG23 HD12 ' A' ' 163' ' ' ILE . 15.9 m -57.69 -46.75 83.89 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 120.918 0.39 . . . . 0.31 110.993 179.433 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 277' ' ' ASP . . . . . 0.451 ' HB2' ' O ' ' A' ' 273' ' ' GLU . 0.4 OUTLIER -54.65 -59.92 4.06 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 115.685 -0.689 . . . . 0.59 110.966 179.345 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 57.3 t -60.38 -39.48 81.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 CA-C-O 120.812 0.339 . . . . 0.42 111.418 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 279' ' ' LEU . . . . . 0.554 HD11 HG23 ' A' ' 245' ' ' ILE . 15.8 tp -61.32 -47.59 85.23 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.564 -0.289 . . . . 0.85 111.151 179.568 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 80.2 t -73.04 -42.89 59.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 120.928 -0.309 . . . . 0.49 111.556 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 80.6 mtt-85 -60.92 -34.48 74.77 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 112.458 0.54 . . . . 1.09 112.458 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 282' ' ' THR . . . . . . . . . . . . . 69.3 p -95.74 0.13 52.1 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 113.089 0.774 . . . . 0.71 113.089 -178.732 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 283' ' ' LYS . . . . . 0.502 ' HD2' ' O ' ' A' ' 279' ' ' LEU . 5.7 mttp -141.26 30.1 1.78 Allowed 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 111.649 0.24 . . . . 0.93 111.649 179.773 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 40.1 ttm180 -57.72 -56.12 26.07 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 112.077 0.399 . . . . 0.92 112.077 -179.222 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -61.4 -44.52 97.0 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 120.826 0.346 . . . . 0.77 111.652 -179.692 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 286' ' ' TRP . . . . . 0.405 ' O ' ' HB2' ' A' ' 290' ' ' GLN . 0.8 OUTLIER -65.18 -49.52 69.5 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 112.36 0.504 . . . . 0.71 112.36 -179.074 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 287' ' ' LEU . . . . . 0.477 ' HB3' HD21 ' A' ' 155' ' ' LEU . 1.6 mm? -66.36 -42.61 87.8 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 113.007 0.743 . . . . 0.51 113.007 -178.502 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 5.6 p -67.75 -36.49 76.09 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 C-N-CA 120.797 -0.361 . . . . 0.49 111.962 -179.511 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 50.3 mttt -76.82 -33.57 57.96 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 112.38 0.511 . . . . 0.95 112.38 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 290' ' ' GLN . . . . . 0.405 ' HB2' ' O ' ' A' ' 286' ' ' TRP . 1.1 tp-100 -84.88 26.43 0.84 Allowed 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 113.002 0.741 . . . . 0.76 113.002 -178.679 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 32.7 mtp180 63.22 9.39 3.92 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 112.874 0.694 . . . . 0.49 112.874 178.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 62.64 -132.47 44.18 Favored Glycine 0 CA--C 1.524 0.656 0 CA-C-O 121.619 0.566 . . . . 0.35 113.954 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 293' ' ' TRP . . . . . 0.498 ' HA ' ' HB3' ' A' ' 296' ' ' PHE . 78.7 m95 -66.56 -23.45 66.21 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.392 0.516 . . . . 0.49 112.392 -178.766 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 294' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -64.52 -43.49 93.87 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 109.776 -0.453 . . . . 0.43 109.776 178.487 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -69.74 -32.04 70.5 Favored Glycine 0 C--N 1.334 0.459 0 N-CA-C 110.765 -0.934 . . . . 0.3 110.765 177.77 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 296' ' ' PHE . . . . . 0.498 ' HB3' ' HA ' ' A' ' 293' ' ' TRP . 6.0 t80 -67.53 -48.91 65.64 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 115.553 -0.323 . . . . 0.41 111.202 178.779 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 297' ' ' VAL . . . . . 0.652 ' HA ' HG21 ' A' ' 193' ' ' THR . 21.7 m -69.14 -33.18 57.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 CA-C-N 116.63 -0.259 . . . . 0.33 111.591 -179.591 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -69.47 -42.2 75.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.9 0.381 . . . . 0.47 110.713 179.176 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 299' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -67.69 -45.73 74.32 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.005 -0.543 . . . . 0.64 111.427 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 300' ' ' PHE . . . . . 0.546 ' CE2' ' HB3' ' A' ' 242' ' ' TRP . 60.1 m-85 . . . . . 0 CA--C 1.538 0.494 0 N-CA-C 112.687 0.625 . . . . 0.46 112.687 -179.089 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 . . . . . 0 CA--C 1.534 0.327 0 N-CA-C 111.774 0.287 . . . . 0.64 111.774 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 23' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -55.93 -41.17 74.21 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 112.218 0.451 . . . . 0.41 112.218 -179.063 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -66.95 -38.98 87.1 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.882 0.372 . . . . 0.36 111.37 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.8 -35.71 81.99 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-O 121.507 0.67 . . . . 0.38 110.01 178.635 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -66.16 -49.77 66.25 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.246 -0.888 . . . . 0.5 109.43 178.053 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 82.8 mt -57.21 -36.16 70.53 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.275 -0.42 . . . . 0.48 110.678 178.291 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 28' ' ' ARG . . . . . . . . . . . . . 37.7 mtp85 -57.25 -58.21 9.25 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 116.108 -0.496 . . . . 0.5 111.299 178.607 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 8.6 ptpp? -64.57 -31.53 72.78 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.523 -0.308 . . . . 0.48 110.791 179.517 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 52.2 mt -62.82 -49.85 82.04 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 N-CA-C 109.421 -0.585 . . . . 0.43 109.421 178.073 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -62.18 -43.61 98.88 Favored Glycine 0 N--CA 1.448 -0.527 0 CA-C-N 115.423 -0.808 . . . . 0.29 112.012 178.785 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -66.95 -37.11 83.68 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 121.221 -0.191 . . . . 0.54 110.878 179.076 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 23.6 ttmm -65.08 -44.6 88.39 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 109.865 -0.42 . . . . 0.8 109.865 177.932 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 45.7 t -63.92 -50.79 75.9 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-N 115.969 -0.559 . . . . 0.35 110.186 178.439 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 35' ' ' TYR . . . . . 0.452 ' HB2' ' H ' ' A' ' 243' ' ' GLY . 0.0 OUTLIER -58.0 -40.54 81.0 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.681 -0.691 . . . . 0.73 110.817 179.273 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 36' ' ' CYS . . . . . . . . . . . . . 23.6 t -69.64 -26.47 64.43 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 120.873 0.368 . . . . 0.64 111.422 179.411 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 85.7 m -76.17 -35.02 59.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.305 -0.407 . . . . 0.46 111.18 179.579 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 38' ' ' TRP . . . . . . . . . . . . . 97.7 m95 -88.03 -37.36 16.38 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 112.052 0.39 . . . . 0.6 112.052 -179.785 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 45.7 p . . . . . 0 N--CA 1.471 0.619 0 CA-C-O 120.761 0.315 . . . . 0.68 111.396 179.16 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 153' ' ' ASP . . . . . 0.401 ' HA ' ' HB2' ' A' ' 156' ' ' TYR . 2.3 p-10 . . . . . 0 C--O 1.223 -0.324 0 CA-C-O 120.608 0.242 . . . . 0.45 110.846 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -55.52 -41.49 73.19 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.232 0.539 . . . . 0.43 110.242 178.743 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -71.66 -40.28 69.75 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 109.004 -0.739 . . . . 0.74 109.004 177.754 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 156' ' ' TYR . . . . . 0.401 ' HB2' ' HA ' ' A' ' 153' ' ' ASP . 0.1 OUTLIER -60.65 -46.95 88.4 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 115.966 -0.561 . . . . 0.35 110.86 179.095 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 14.2 mtp180 -60.53 -45.92 92.07 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 116.336 -0.393 . . . . 0.45 111.301 179.54 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 72.4 mt-30 -63.9 -50.46 68.64 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.062 0.458 . . . . 0.43 109.826 178.59 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 16.8 m -56.72 -48.47 77.67 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 115.461 -0.791 . . . . 0.25 110.925 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.473 ' HA ' HG21 ' A' ' 276' ' ' THR . 2.1 tm? -57.21 -49.54 75.69 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.551 -0.295 . . . . 0.46 110.254 178.871 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.2 -45.46 93.11 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.348 -0.387 . . . . 0.79 111.474 179.552 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 162' ' ' ILE . . . . . 0.54 HG23 HD22 ' A' ' 191' ' ' LEU . 89.9 mt -65.65 -56.56 14.55 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 CA-C-N 116.0 -0.546 . . . . 0.29 112.359 -179.252 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.542 HD12 HG23 ' A' ' 276' ' ' THR . 97.1 mt -58.49 -51.99 64.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 N-CA-C 112.71 0.633 . . . . 0.36 112.71 -178.689 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 65.9 p -56.1 -42.67 77.14 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 120.556 0.217 . . . . 0.29 111.452 -179.398 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.55 -52.95 48.65 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.889 0.376 . . . . 1.24 111.105 178.961 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 166' ' ' TYR . . . . . 0.788 ' HE1' ' HA ' ' A' ' 195' ' ' ARG . 59.9 t80 -57.3 -49.08 77.23 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 112.594 0.59 . . . . 0.32 112.594 -179.614 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 5.5 mp -60.71 -46.14 91.55 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 112.413 0.523 . . . . 0.42 112.413 -178.64 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 38.2 ttm-85 -69.14 -49.89 52.81 Favored 'General case' 0 C--O 1.239 0.545 0 N-CA-C 113.067 0.766 . . . . 0.29 113.067 -178.659 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -64.12 -52.08 60.85 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.171 0.434 . . . . 0.41 112.171 -178.801 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -64.29 -32.42 74.01 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 111.972 0.36 . . . . 0.43 111.972 -179.284 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.463 ' O ' ' HG3' ' A' ' 257' ' ' LYS . . . . . . . . 0 C--N 1.332 -0.156 0 CA-C-O 121.04 0.448 . . . . 0.37 110.305 178.076 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.468 ' HB1' ' CA ' ' A' ' 187' ' ' GLY . . . . . . . . 0 CA--C 1.536 0.425 0 CA-C-O 121.261 0.553 . . . . 0.43 111.192 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 184' ' ' GLY . . . . . 0.701 ' HA2' ' NH2' ' A' ' 188' ' ' ARG . . . -79.84 -73.85 1.12 Allowed Glycine 0 CA--C 1.525 0.713 0 C-N-CA 120.312 -0.947 . . . . 0.57 114.079 -179.605 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -71.79 -54.72 9.29 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.065 0.46 . . . . 0.74 110.886 -179.36 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -65.14 -35.18 80.3 Favored 'General case' 0 C--O 1.221 -0.427 0 CA-C-N 115.76 -0.655 . . . . 0.6 110.601 179.277 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 187' ' ' GLY . . . . . 0.468 ' CA ' ' HB1' ' A' ' 183' ' ' ALA . . . -64.03 -53.33 37.78 Favored Glycine 0 C--O 1.228 -0.262 0 C-N-CA 120.903 -0.665 . . . . 0.43 113.082 -179.81 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 188' ' ' ARG . . . . . 0.701 ' NH2' ' HA2' ' A' ' 184' ' ' GLY . 0.3 OUTLIER -59.64 -41.71 91.13 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 117.095 0.447 . . . . 1.6 111.192 -179.98 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 189' ' ' ARG . . . . . 0.9 ' HD3' HG11 ' A' ' 297' ' ' VAL . 0.2 OUTLIER -71.12 -40.3 71.51 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.509 -0.314 . . . . 0.48 111.245 179.386 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 190' ' ' ALA . . . . . 0.517 ' HA ' HG22 ' A' ' 297' ' ' VAL . . . -69.6 -39.4 77.27 Favored 'General case' 0 C--O 1.22 -0.481 0 CA-C-N 116.865 -0.152 . . . . 0.26 111.394 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 191' ' ' LEU . . . . . 0.605 HD12 ' HE ' ' A' ' 195' ' ' ARG . 0.3 OUTLIER -64.59 -47.52 78.37 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.603 0.24 . . . . 0.47 111.212 179.788 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -60.79 -42.85 98.37 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.265 0.555 . . . . 0.4 110.897 179.461 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 193' ' ' THR . . . . . 0.542 ' OG1' HG13 ' A' ' 297' ' ' VAL . 27.8 m -69.76 -54.06 15.44 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.757 -0.656 . . . . 0.32 110.906 179.515 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 194' ' ' LEU . . . . . 0.477 HD21 HG21 ' A' ' 249' ' ' ILE . 16.7 tp -55.32 -42.34 73.6 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 115.828 -0.623 . . . . 0.32 111.324 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 195' ' ' ARG . . . . . 0.788 ' HA ' ' HE1' ' A' ' 166' ' ' TYR . 17.9 mtm105 -63.27 -53.05 59.03 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.717 -0.22 . . . . 0.36 111.37 179.654 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.51 -49.77 76.51 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 111.888 0.329 . . . . 0.56 111.888 -179.774 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 87.2 t -63.89 -46.81 93.16 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 CA-C-O 120.877 0.37 . . . . 0.34 110.315 179.678 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 198' ' ' GLY . . . . . 0.612 ' HA3' ' OH ' ' A' ' 166' ' ' TYR . . . -58.83 -42.13 96.42 Favored Glycine 0 C--N 1.333 0.372 0 CA-C-N 115.9 -0.591 . . . . 0.24 112.222 179.017 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -56.95 -44.27 82.38 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.837 0.351 . . . . 0.49 110.31 178.233 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -66.96 -53.48 26.63 Favored Glycine 0 CA--C 1.523 0.568 0 C-N-CA 120.928 -0.654 . . . . 0.36 112.883 179.354 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 60.3 t -60.77 -42.73 93.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 N-CA-C 112.217 0.451 . . . . 0.36 112.217 -179.685 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 202' ' ' GLN . . . . . 0.592 ' HA ' ' HE2' ' A' ' 209' ' ' PHE . 0.2 OUTLIER -63.44 -52.71 60.32 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 112.131 0.419 . . . . 0.36 112.131 -179.392 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 30.6 mtt-85 -66.66 -33.39 75.54 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.732 0.301 . . . . 0.45 110.343 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -63.92 -52.6 59.09 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.121 -0.491 . . . . 0.88 110.311 178.379 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 205' ' ' HIS . . . . . 0.422 ' HB3' ' HB3' ' A' ' 208' ' ' ALA . 80.7 m-70 -102.21 36.02 2.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.294 -0.412 . . . . 0.48 111.731 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -57.19 -46.52 82.76 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 120.931 0.396 . . . . 1.23 111.31 -179.389 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 47.5 p -64.11 -41.63 97.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.832 -0.622 . . . . 0.62 111.16 179.686 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 208' ' ' ALA . . . . . 0.422 ' HB3' ' HB3' ' A' ' 205' ' ' HIS . . . -63.61 -41.21 98.32 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.914 -0.585 . . . . 0.37 110.523 179.054 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 209' ' ' PHE . . . . . 0.608 ' O ' ' HG ' ' A' ' 213' ' ' LEU . 20.6 m-30 -70.23 -46.98 63.37 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.143 -0.48 . . . . 0.5 110.138 178.903 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 210' ' ' GLN . . . . . 0.429 ' HA ' HD12 ' A' ' 213' ' ' LEU . 0.6 OUTLIER -58.66 -44.57 90.2 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 121.039 0.447 . . . . 1.0 110.206 178.708 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 211' ' ' GLY . . . . . 0.443 ' O ' ' HG3' ' A' ' 215' ' ' LYS . . . -64.33 -43.75 96.43 Favored Glycine 0 C--N 1.335 0.479 0 C-N-CA 121.016 -0.612 . . . . 0.38 111.741 178.489 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 212' ' ' MET . . . . . 0.438 ' HA ' ' HD2' ' A' ' 215' ' ' LYS . 30.8 ttm -62.2 -37.69 86.27 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 120.719 0.295 . . . . 0.39 110.276 178.928 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.608 ' HG ' ' O ' ' A' ' 209' ' ' PHE . 97.4 mt -58.0 -43.93 86.9 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.169 -0.468 . . . . 0.52 110.068 177.926 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 214' ' ' ARG . . . . . 0.523 ' HD3' ' O ' ' A' ' 214' ' ' ARG . 0.0 OUTLIER -66.92 -32.01 72.98 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 115.855 -0.611 . . . . 0.8 110.401 178.755 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 215' ' ' LYS . . . . . 0.443 ' HG3' ' O ' ' A' ' 211' ' ' GLY . 89.7 mttt -70.32 -43.69 69.78 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 116.282 -0.417 . . . . 0.46 110.856 178.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 15.1 mt -72.8 164.23 26.89 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 121.159 0.504 . . . . 0.77 111.811 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -111.55 32.75 5.17 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 121.251 0.548 . . . . 1.04 110.999 179.71 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 218' ' ' ILE . . . . . 0.606 ' HA ' ' HB2' ' A' ' 223' ' ' ASP . 41.2 mm -57.15 108.38 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-N 115.746 -0.661 . . . . 0.37 111.992 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 219' ' ' LYS . . . . . 0.487 ' NZ ' ' HA ' ' A' ' 219' ' ' LYS . 0.4 OUTLIER -145.83 -82.6 0.14 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.843 0.354 . . . . 0.55 111.727 179.887 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 65.9 m-20 -87.49 -176.54 5.63 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.883 -0.599 . . . . 1.97 110.612 178.854 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 221' ' ' GLU . . . . . 0.515 ' O ' HG22 ' A' ' 224' ' ' VAL . 13.1 tm-20 -46.48 -31.16 2.55 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 122.975 0.51 . . . . 0.74 112.362 -179.804 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -55.12 -24.85 37.21 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 121.631 -0.319 . . . . 0.53 113.681 178.949 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 223' ' ' ASP . . . . . 0.606 ' HB2' ' HA ' ' A' ' 218' ' ' ILE . 0.5 OUTLIER -56.63 -36.11 69.1 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 112.741 0.645 . . . . 0.69 112.741 -179.047 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.544 ' HB ' HG21 ' A' ' 274' ' ' THR . 14.2 m -61.15 -29.77 46.44 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-O 120.823 0.344 . . . . 0.48 111.808 -179.521 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 30.6 mttp -72.81 -40.54 65.74 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.143 0.497 . . . . 0.64 109.892 179.132 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 226' ' ' SER . . . . . 0.543 ' O ' HG23 ' A' ' 230' ' ' VAL . 53.4 p -70.73 -38.77 73.6 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.802 -0.635 . . . . 0.52 109.856 178.545 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 227' ' ' PHE . . . . . 0.634 ' O ' ' HG3' ' A' ' 231' ' ' MET . 10.3 t80 -65.11 -46.67 80.07 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 116.102 -0.499 . . . . 0.57 110.031 178.748 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 48.2 t -57.72 -40.12 78.87 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.373 -0.376 . . . . 0.48 110.153 178.492 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 3.1 ttp180 -56.88 -43.18 81.02 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.048 -0.524 . . . . 1.4 109.69 178.245 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 230' ' ' VAL . . . . . 0.543 HG23 ' O ' ' A' ' 226' ' ' SER . 29.6 t -65.67 -49.59 76.68 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 CA-C-N 115.812 -0.631 . . . . 0.38 109.895 178.076 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 231' ' ' MET . . . . . 0.634 ' HG3' ' O ' ' A' ' 227' ' ' PHE . 68.3 mtp -54.38 -51.4 64.94 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 115.784 -0.644 . . . . 0.43 111.842 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 93.2 t -60.84 -39.9 83.4 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 CA-C-N 116.512 -0.313 . . . . 0.39 111.598 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -70.65 -37.66 73.75 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 120.751 -0.38 . . . . 0.54 110.973 179.368 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 230' ' ' VAL . 51.1 t -59.24 -36.03 61.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-O 121.206 0.527 . . . . 0.45 110.987 179.27 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 235' ' ' PHE . . . . . 0.468 ' HE2' HD22 ' A' ' 248' ' ' LEU . 86.2 m-85 -103.61 18.2 22.42 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.302 -0.408 . . . . 0.42 111.553 179.372 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 11.8 tptp -77.96 -9.52 59.14 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 120.941 0.4 . . . . 1.08 111.324 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 -70.23 -16.23 63.02 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.379 -0.373 . . . . 0.54 111.651 179.739 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 90.83 -1.86 78.91 Favored Glycine 0 CA--C 1.521 0.423 0 C-N-CA 120.748 -0.739 . . . . 0.64 112.504 -179.571 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 6.0 p -119.36 119.08 59.55 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 CA-C-O 121.509 0.671 . . . . 0.49 110.979 179.763 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 240' ' ' THR . . . . . 0.547 HG21 ' HG2' ' A' ' 283' ' ' LYS . 0.5 OUTLIER -93.71 83.38 4.43 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.152 -0.476 . . . . 0.52 112.2 -179.653 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -76.92 136.36 38.81 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.117 -0.492 . . . . 0.36 111.266 179.305 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 242' ' ' TRP . . . . . . . . . . . . . 6.0 m95 -53.93 -45.54 71.26 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.783 0.325 . . . . 0.39 111.0 179.126 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 243' ' ' GLY . . . . . 0.454 ' H ' ' HB2' ' B' ' 35' ' ' TYR . . . -57.39 -35.98 74.43 Favored Glycine 0 C--N 1.336 0.568 0 CA-C-N 116.068 -0.514 . . . . 0.27 112.823 179.134 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 84.0 mtt180 -68.25 -44.29 75.95 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 109.985 -0.376 . . . . 0.31 109.985 178.843 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 245' ' ' ILE . . . . . 0.657 HG23 HD11 ' A' ' 279' ' ' LEU . 98.5 mt -59.65 -51.36 73.69 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-N 115.954 -0.567 . . . . 0.42 110.518 178.86 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 59.6 t -63.07 -40.37 88.77 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 CA-C-N 116.164 -0.471 . . . . 0.37 111.07 178.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 23.5 m -60.63 -41.07 94.14 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 120.81 0.338 . . . . 0.36 110.432 179.011 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 248' ' ' LEU . . . . . 0.468 HD22 ' HE2' ' A' ' 235' ' ' PHE . 21.0 tp -64.2 -38.49 91.23 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 121.102 0.477 . . . . 0.62 109.914 178.191 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 249' ' ' ILE . . . . . 0.678 HD11 HD22 ' A' ' 279' ' ' LEU . 47.6 mm -68.2 -41.72 84.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-N 116.091 -0.504 . . . . 0.45 109.952 178.155 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 65.6 m -62.6 -43.95 97.52 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.026 -0.534 . . . . 0.37 109.653 178.561 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 251' ' ' PHE . . . . . 0.527 ' O ' HG23 ' A' ' 255' ' ' VAL . 29.9 t80 -62.44 -43.16 99.47 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 115.722 -0.672 . . . . 0.37 109.375 177.76 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -56.5 -47.83 80.87 Favored Glycine 0 C--N 1.338 0.666 0 N-CA-C 111.091 -0.803 . . . . 0.26 111.091 178.226 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -59.12 -42.2 89.99 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-O 120.573 0.225 . . . . 0.29 110.557 177.772 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 254' ' ' PHE . . . . . 0.454 ' CD2' HD11 ' A' ' 213' ' ' LEU . 5.8 t80 -63.81 -40.06 95.73 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.487 -0.324 . . . . 0.53 110.648 178.934 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 255' ' ' VAL . . . . . 0.527 HG23 ' O ' ' A' ' 251' ' ' PHE . 84.8 t -63.64 -43.8 98.27 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 N-CA-C 109.297 -0.631 . . . . 0.41 109.297 177.426 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -62.82 -34.55 77.54 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 115.81 -0.632 . . . . 0.28 109.992 178.134 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 257' ' ' LYS . . . . . 0.463 ' HG3' ' O ' ' A' ' 171' ' ' ALA . 30.4 tttp -66.7 -46.08 76.72 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 115.385 -0.825 . . . . 0.62 110.163 178.248 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 14.4 t60 -62.1 -42.41 99.2 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 115.827 -0.624 . . . . 0.65 109.393 178.29 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 4.7 mp -67.27 -35.5 79.63 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.012 -0.54 . . . . 0.48 110.846 178.332 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.71 -34.53 77.35 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.533 -0.303 . . . . 0.6 111.018 178.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 24.0 p -62.45 -20.07 64.15 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 120.684 0.278 . . . . 0.74 111.591 179.517 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 262' ' ' VAL . . . . . 0.451 HG23 ' HG3' ' A' ' 264' ' ' GLN . 13.8 m -117.03 18.82 7.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-O 120.92 0.39 . . . . 0.67 111.073 178.882 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 65.1 m-80 56.98 46.39 19.53 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 113.8 1.037 . . . . 1.45 113.8 179.171 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 264' ' ' GLN . . . . . 0.451 ' HG3' HG23 ' A' ' 262' ' ' VAL . 12.6 mt-30 -99.29 36.64 1.7 Allowed 'General case' 0 CA--C 1.536 0.423 0 O-C-N 121.884 -0.51 . . . . 0.43 111.491 179.074 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 265' ' ' GLU . . . . . 0.431 ' HA ' HD12 ' A' ' 268' ' ' ILE . 11.4 tp10 -53.9 -42.1 68.35 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 120.91 0.386 . . . . 0.41 111.653 -179.718 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 30.9 t -61.06 -14.94 27.25 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.128 -0.487 . . . . 0.46 111.729 179.575 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 267' ' ' PHE . . . . . 0.487 ' C ' ' HD2' ' A' ' 270' ' ' PRO . 71.7 m-85 -101.21 -21.27 14.97 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 121.15 0.5 . . . . 0.78 110.064 178.703 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 268' ' ' ILE . . . . . 0.431 HD12 ' HA ' ' A' ' 265' ' ' GLU . 76.1 mt -67.42 -37.19 78.47 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 CA-C-N 115.851 -0.613 . . . . 0.45 109.891 178.462 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 269' ' ' GLU . . . . . 0.729 ' HB2' ' HD3' ' A' ' 270' ' ' PRO . 9.1 mm-40 -56.63 -57.82 21.21 Favored Pre-proline 0 CA--C 1.548 0.876 0 CA-C-N 116.383 -0.372 . . . . 0.44 111.025 178.623 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 270' ' ' PRO . . . . . 0.729 ' HD3' ' HB2' ' A' ' 269' ' ' GLU . 35.1 Cg_exo -63.22 -30.19 74.12 Favored 'Trans proline' 0 C--N 1.365 1.403 0 C-N-CA 122.322 2.014 . . . . 0.33 112.122 178.58 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 271' ' ' LEU . . . . . . . . . . . . . 56.7 tp -67.09 -50.86 60.23 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 109.72 -0.474 . . . . 0.46 109.72 178.425 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -62.49 -36.52 82.76 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 115.948 -0.569 . . . . 0.33 110.456 178.749 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 273' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -63.13 -48.89 76.6 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.142 -0.481 . . . . 0.4 109.724 178.009 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 274' ' ' THR . . . . . 0.544 HG21 ' HB ' ' A' ' 224' ' ' VAL . 62.7 m -62.72 -48.54 78.77 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.863 -0.608 . . . . 0.36 110.853 178.867 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 275' ' ' ILE . . . . . 0.466 ' HA ' ' HE1' ' A' ' 231' ' ' MET . 92.1 mt -54.78 -51.9 47.52 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.157 0 CA-C-N 116.135 -0.484 . . . . 0.34 111.106 179.42 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 276' ' ' THR . . . . . 0.542 HG23 HD12 ' A' ' 163' ' ' ILE . 40.8 m -60.49 -51.23 70.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.277 -0.42 . . . . 0.29 111.193 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 277' ' ' ASP . . . . . 0.526 ' OD1' ' HD2' ' A' ' 281' ' ' ARG . 25.9 t0 -55.09 -58.26 8.37 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.129 -0.487 . . . . 0.9 111.61 179.807 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 95.4 t -58.41 -41.8 82.46 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 CA-C-O 120.795 0.331 . . . . 0.36 111.58 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 279' ' ' LEU . . . . . 0.678 HD22 HD11 ' A' ' 249' ' ' ILE . 12.2 tp -61.77 -47.74 83.79 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 112.219 0.452 . . . . 0.64 112.219 -179.578 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 46.5 t -79.31 -42.81 23.64 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 N-CA-C 112.612 0.597 . . . . 0.35 112.612 -178.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 281' ' ' ARG . . . . . 0.526 ' HD2' ' OD1' ' A' ' 277' ' ' ASP . 0.4 OUTLIER -58.8 -33.53 70.46 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 112.326 0.491 . . . . 1.18 112.326 -179.336 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 282' ' ' THR . . . . . . . . . . . . . 48.4 p -85.84 -1.62 57.43 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 111.772 0.286 . . . . 0.34 111.772 179.568 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 283' ' ' LYS . . . . . 0.547 ' HG2' HG21 ' A' ' 240' ' ' THR . 32.8 mttp -141.22 34.11 1.7 Allowed 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.572 -0.286 . . . . 0.42 111.391 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 48.9 mtp180 -53.83 -62.24 1.78 Allowed 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 112.573 0.582 . . . . 0.45 112.573 -178.862 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 285' ' ' ASP . . . . . 0.494 ' O ' ' HE2' ' A' ' 289' ' ' LYS . 8.7 p-10 -65.63 -37.65 87.19 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.168 -0.469 . . . . 0.46 110.901 -179.846 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 286' ' ' TRP . . . . . 0.516 ' CZ2' ' HG2' ' A' ' 290' ' ' GLN . 71.9 t90 -62.4 -40.5 96.7 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.425 -0.352 . . . . 0.38 110.912 179.653 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 287' ' ' LEU . . . . . 0.537 HD13 ' HA2' ' A' ' 292' ' ' GLY . 0.8 OUTLIER -60.71 -48.36 82.14 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 111.971 0.36 . . . . 0.42 111.971 179.749 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 9.5 p -69.35 -32.16 52.32 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 C-N-CA 120.481 -0.487 . . . . 0.52 111.453 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 289' ' ' LYS . . . . . 0.494 ' HE2' ' O ' ' A' ' 285' ' ' ASP . 39.8 mtmt -75.97 -40.3 54.21 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 112.775 0.657 . . . . 0.73 112.775 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 290' ' ' GLN . . . . . 0.516 ' HG2' ' CZ2' ' A' ' 286' ' ' TRP . 1.6 mp0 -87.82 29.87 0.88 Allowed 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 114.278 1.214 . . . . 0.7 114.278 -177.842 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 291' ' ' ARG . . . . . 0.621 ' HG2' ' HB2' ' A' ' 294' ' ' ASP . 1.9 ttt180 60.74 19.7 9.79 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 112.762 0.653 . . . . 0.47 112.762 178.435 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 292' ' ' GLY . . . . . 0.537 ' HA2' HD13 ' A' ' 287' ' ' LEU . . . 42.34 -135.52 3.76 Favored Glycine 0 CA--C 1.527 0.788 0 N-CA-C 115.363 0.905 . . . . 0.35 115.363 178.917 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 293' ' ' TRP . . . . . 0.588 ' O ' HG23 ' A' ' 297' ' ' VAL . 97.2 m95 -64.46 -37.41 87.44 Favored 'General case' 0 C--O 1.226 -0.133 0 CA-C-N 115.428 -0.386 . . . . 0.55 111.058 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 294' ' ' ASP . . . . . 0.621 ' HB2' ' HG2' ' A' ' 291' ' ' ARG . 0.9 OUTLIER -53.8 -46.91 71.22 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 121.176 0.512 . . . . 0.63 110.195 179.023 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -65.79 -39.3 95.1 Favored Glycine 0 CA--C 1.523 0.56 0 C-N-CA 120.884 -0.674 . . . . 0.29 111.835 178.324 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 296' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -64.05 -36.15 83.07 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 120.799 0.333 . . . . 0.33 110.937 179.131 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 297' ' ' VAL . . . . . 0.9 HG11 ' HD3' ' A' ' 189' ' ' ARG . 77.8 t -64.99 -54.16 32.84 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 CA-C-N 116.202 -0.454 . . . . 0.34 111.65 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -69.71 -23.16 63.38 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 112.312 0.486 . . . . 0.42 112.312 -179.429 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 299' ' ' PHE . . . . . . . . . . . . . 88.2 t80 -70.12 -52.68 21.74 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 111.694 0.257 . . . . 0.46 111.694 179.448 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 300' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 . . . . . 0 CA--C 1.535 0.378 0 CA-C-O 120.827 0.346 . . . . 0.41 111.67 -179.578 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.532 0.262 0 CA-C-O 120.264 0.078 . . . . 0.68 111.096 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 23' ' ' PHE . . . . . 0.445 ' CD1' HG22 ' A' ' 230' ' ' VAL . 0.8 OUTLIER -58.29 -40.16 81.23 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.276 0.56 . . . . 0.48 110.715 179.125 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -70.52 -40.33 73.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.008 -0.542 . . . . 0.32 110.427 178.792 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 25' ' ' ALA . . . . . 0.433 ' O ' ' HB3' ' B' ' 28' ' ' ARG . . . -64.15 -37.38 87.24 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 116.133 -0.485 . . . . 0.33 110.808 178.942 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -62.74 -54.26 41.85 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.012 -0.54 . . . . 0.5 110.419 178.72 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 95.9 mt -58.96 -34.36 71.71 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.134 0.492 . . . . 0.35 109.833 178.167 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 28' ' ' ARG . . . . . 0.433 ' HB3' ' O ' ' B' ' 25' ' ' ALA . 1.1 ttt180 -59.84 -51.04 71.44 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 115.43 -0.805 . . . . 0.58 110.111 177.854 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -67.66 -40.14 84.53 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.304 -0.407 . . . . 0.89 111.264 179.157 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 96.5 mt -62.68 -46.9 95.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-O 120.962 0.41 . . . . 0.43 110.318 178.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.35 -48.34 86.47 Favored Glycine 0 N--CA 1.45 -0.419 0 CA-C-N 115.72 -0.673 . . . . 0.27 112.871 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -64.6 -37.87 89.06 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.917 0.359 . . . . 0.47 111.548 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 33' ' ' LYS . . . . . 0.404 ' HE2' ' HB2' ' B' ' 33' ' ' LYS . 20.7 ttmm -63.72 -47.78 79.73 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-O 121.121 0.486 . . . . 1.21 110.255 178.573 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 55.5 t -65.06 -46.69 90.59 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 CA-C-N 115.844 -0.616 . . . . 0.48 110.532 178.676 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 35' ' ' TYR . . . . . 0.454 ' HB2' ' H ' ' A' ' 243' ' ' GLY . 1.3 t80 -56.08 -48.54 75.9 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 115.824 -0.625 . . . . 0.83 111.743 179.668 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 36' ' ' CYS . . . . . . . . . . . . . 84.2 m -64.51 -35.35 80.67 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 120.812 0.339 . . . . 0.58 111.543 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 63.1 m -67.92 -40.99 83.29 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 112.227 0.455 . . . . 0.66 112.227 -179.682 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 38' ' ' TRP . . . . . . . . . . . . . 97.8 m95 -87.41 -18.54 29.74 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.498 0.555 . . . . 0.7 112.498 -179.19 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 28.8 t . . . . . 0 N--CA 1.47 0.574 0 N-CA-C 112.054 0.39 . . . . 0.89 112.054 179.49 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 153' ' ' ASP . . . . . 0.534 ' O ' ' HG3' ' A' ' 157' ' ' ARG . 0.1 OUTLIER . . . . . 0 CA--C 1.539 0.523 0 N-CA-C 112.711 0.634 . . . . 0.54 112.711 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 -60.88 -43.66 98.13 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.185 0.517 . . . . 0.46 111.391 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.558 HD21 ' HB3' ' A' ' 287' ' ' LEU . 27.1 tp -63.89 -49.35 73.04 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.754 -0.657 . . . . 0.88 110.231 179.377 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 44.4 t80 -58.8 -43.57 90.55 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 115.885 -0.598 . . . . 0.42 111.45 179.696 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 157' ' ' ARG . . . . . 0.534 ' HG3' ' O ' ' A' ' 153' ' ' ASP . 51.5 mtm180 -60.08 -52.71 64.21 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.698 0.285 . . . . 0.4 111.13 179.556 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -63.05 -45.27 93.01 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.541 -0.3 . . . . 0.54 110.781 179.155 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 159' ' ' SER . . . . . 0.543 ' HA ' ' CZ2' ' A' ' 293' ' ' TRP . 21.1 m -58.93 -56.92 16.0 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.384 -0.371 . . . . 0.27 111.375 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.695 HD11 ' HG2' ' A' ' 273' ' ' GLU . 12.7 tp -54.55 -48.88 71.49 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.751 -0.204 . . . . 0.77 111.474 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -57.49 -54.25 48.93 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 111.85 0.315 . . . . 0.74 111.85 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 74.7 mt -62.28 -43.43 98.0 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 N-CA-C 111.871 0.323 . . . . 0.33 111.871 -179.524 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.644 ' O ' ' HG ' ' A' ' 167' ' ' LEU . 87.0 mt -64.43 -48.42 85.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 N-CA-C 110.225 -0.287 . . . . 0.35 110.225 179.211 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 6.8 t -58.42 -44.63 89.18 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.409 -0.36 . . . . 0.31 110.282 178.721 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 165' ' ' ARG . . . . . 0.432 HH11 ' HD2' ' A' ' 165' ' ' ARG . 2.6 mmt180 -59.12 -51.98 67.71 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.121 -0.491 . . . . 0.38 111.89 178.942 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 166' ' ' TYR . . . . . 0.711 ' CE1' ' HA ' ' A' ' 195' ' ' ARG . 51.6 t80 -60.57 -49.77 76.22 Favored 'General case' 0 CA--C 1.527 0.085 0 N-CA-C 112.399 0.518 . . . . 0.45 112.399 -179.042 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.644 ' HG ' ' O ' ' A' ' 163' ' ' ILE . 11.8 mt -67.14 -33.74 76.08 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 120.225 -0.59 . . . . 0.36 111.293 -178.91 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 21.5 ttp180 -69.75 -52.62 23.77 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 111.803 0.297 . . . . 0.43 111.803 179.359 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -61.65 -48.41 80.99 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 111.838 0.31 . . . . 0.28 111.838 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.36 -40.73 91.85 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.09 -0.505 . . . . 0.32 112.12 -179.726 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.447 ' HB1' ' HB2' ' A' ' 260' ' ' LYS . . . . . . . . 0 N--CA 1.465 0.276 0 N-CA-C 112.114 0.413 . . . . 0.32 112.114 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.561 ' O ' ' HA3' ' A' ' 187' ' ' GLY . . . . . . . . 0 CA--C 1.536 0.435 0 CA-C-O 121.226 0.536 . . . . 0.35 110.768 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -78.74 -71.01 1.27 Allowed Glycine 0 CA--C 1.524 0.655 0 C-N-CA 120.617 -0.801 . . . . 0.35 113.993 -179.242 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -70.78 -55.43 8.6 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-O 120.923 0.392 . . . . 0.4 111.189 -179.623 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -63.51 -35.56 80.85 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 116.064 -0.516 . . . . 0.34 110.369 178.811 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 187' ' ' GLY . . . . . 0.561 ' HA3' ' O ' ' A' ' 183' ' ' ALA . . . -64.32 -34.83 90.98 Favored Glycine 0 C--N 1.336 0.559 0 CA-C-N 116.017 -0.538 . . . . 0.31 112.648 179.464 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 1.2 mmm-85 -68.04 -57.84 5.47 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 109.589 -0.523 . . . . 0.6 109.589 178.241 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 189' ' ' ARG . . . . . 0.521 ' HB3' HG11 ' A' ' 297' ' ' VAL . 44.5 mtp180 -56.73 -48.34 77.97 Favored 'General case' 0 C--O 1.226 -0.176 0 CA-C-N 115.53 -0.759 . . . . 0.7 111.2 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 190' ' ' ALA . . . . . 0.604 ' O ' ' HB2' ' A' ' 194' ' ' LEU . . . -60.85 -37.74 83.11 Favored 'General case' 0 C--O 1.224 -0.265 0 N-CA-C 111.849 0.314 . . . . 0.28 111.849 -179.583 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 191' ' ' LEU . . . . . 0.484 ' HB2' ' O ' ' A' ' 187' ' ' GLY . 7.8 tp -66.46 -42.5 87.49 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.95 0.405 . . . . 0.65 110.385 179.199 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -66.33 -46.81 75.57 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.069 -0.514 . . . . 0.32 110.573 178.742 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 193' ' ' THR . . . . . 0.581 HG21 ' HA ' ' A' ' 297' ' ' VAL . 5.6 m -62.34 -43.87 97.8 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.985 0.421 . . . . 0.27 109.936 178.266 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 194' ' ' LEU . . . . . 0.604 ' HB2' ' O ' ' A' ' 190' ' ' ALA . 6.4 tp -62.2 -43.55 98.58 Favored 'General case' 0 C--O 1.224 -0.278 0 CA-C-N 115.585 -0.734 . . . . 0.4 110.672 178.901 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 195' ' ' ARG . . . . . 0.711 ' HA ' ' CE1' ' A' ' 166' ' ' TYR . 0.0 OUTLIER -65.01 -38.34 90.61 Favored 'General case' 0 C--O 1.224 -0.271 0 CA-C-O 121.292 0.568 . . . . 0.75 110.37 178.939 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 196' ' ' ARG . . . . . 0.413 HH11 ' HD3' ' A' ' 196' ' ' ARG . 0.9 OUTLIER -67.5 -60.06 2.87 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.968 -0.56 . . . . 0.37 112.076 -179.739 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 7.0 t -71.19 -45.69 69.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 111.836 0.31 . . . . 0.36 111.836 -178.826 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -57.21 -45.17 92.93 Favored Glycine 0 CA--C 1.522 0.514 0 C-N-CA 121.465 -0.398 . . . . 0.29 113.538 -179.457 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 199' ' ' ASP . . . . . 0.515 ' O ' ' HB2' ' A' ' 203' ' ' ARG . 2.7 m-20 -73.92 -32.58 63.59 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 117.059 0.43 . . . . 0.49 110.713 179.725 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -68.85 -48.42 48.79 Favored Glycine 0 CA--C 1.524 0.653 0 C-N-CA 120.946 -0.645 . . . . 0.29 112.677 178.932 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 76.7 t -61.36 -48.69 87.72 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-N 116.745 0.272 . . . . 0.37 111.123 179.413 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 202' ' ' GLN . . . . . 0.41 ' HB2' ' CD1' ' A' ' 254' ' ' PHE . 7.2 pt20 -62.33 -32.58 73.36 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.369 -0.378 . . . . 0.38 111.397 179.727 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 203' ' ' ARG . . . . . 0.515 ' HB2' ' O ' ' A' ' 199' ' ' ASP . 0.0 OUTLIER -77.46 -38.95 48.29 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 120.712 0.291 . . . . 0.61 111.027 179.532 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -71.44 -52.37 18.85 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 116.226 -0.443 . . . . 0.39 111.449 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 33.4 m-70 -97.27 36.25 1.49 Allowed 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 120.863 0.363 . . . . 0.41 110.855 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -58.16 -37.62 75.05 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 113.038 0.755 . . . . 0.72 113.038 -178.901 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 4.1 t -56.89 -37.28 71.16 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 120.931 0.396 . . . . 0.5 111.902 -179.156 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -75.06 -43.42 53.43 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 121.124 0.487 . . . . 0.41 111.001 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 209' ' ' PHE . . . . . 0.418 ' O ' ' HB2' ' A' ' 213' ' ' LEU . 56.2 m-85 -66.56 -39.18 88.37 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 115.871 -0.604 . . . . 0.43 110.943 179.748 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 210' ' ' GLN . . . . . 0.406 ' O ' ' HG2' ' A' ' 214' ' ' ARG . 0.6 OUTLIER -64.7 -45.25 87.42 Favored 'General case' 0 C--O 1.222 -0.371 0 CA-C-N 116.515 -0.311 . . . . 0.67 111.251 179.634 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -56.77 -48.43 78.05 Favored Glycine 0 CA--C 1.523 0.564 0 C-N-CA 120.251 -0.976 . . . . 0.31 111.766 178.592 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 212' ' ' MET . . . . . 0.546 ' O ' ' HB2' ' A' ' 216' ' ' LEU . 49.2 mtp -67.06 -34.0 76.73 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 115.637 -0.281 . . . . 0.77 111.296 178.899 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.602 HD21 ' HB2' ' A' ' 258' ' ' HIS . 1.0 OUTLIER -75.73 -37.61 59.22 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 112.205 0.446 . . . . 0.41 112.205 -179.949 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 214' ' ' ARG . . . . . 0.406 ' HG2' ' O ' ' A' ' 210' ' ' GLN . 33.2 mmt180 -64.12 -35.14 79.78 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.89 0.376 . . . . 1.12 110.079 179.028 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 215' ' ' LYS . . . . . 0.52 ' HE2' ' HA ' ' A' ' 215' ' ' LYS . 0.0 OUTLIER -95.7 12.51 29.61 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 121.171 0.51 . . . . 0.66 110.585 177.91 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 216' ' ' LEU . . . . . 0.634 ' HG ' HG13 ' A' ' 218' ' ' ILE . 10.1 tp -93.84 99.22 11.63 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.211 -0.45 . . . . 0.49 110.934 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -93.94 33.25 1.35 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.261 -0.427 . . . . 0.84 110.985 179.6 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 218' ' ' ILE . . . . . 0.634 HG13 ' HG ' ' A' ' 216' ' ' LEU . 16.1 mt -61.86 108.52 0.52 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.495 0 CA-C-O 121.748 0.785 . . . . 0.49 111.826 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 1.6 ttpm? -161.61 17.51 0.1 Allowed 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 114.945 -1.025 . . . . 1.86 110.878 -179.774 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -139.04 160.75 39.03 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-O 120.864 0.364 . . . . 0.56 111.397 -179.088 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -62.51 -22.99 66.7 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.015 0.436 . . . . 0.76 111.733 179.645 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -74.7 -26.04 68.29 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 120.94 -0.648 . . . . 0.59 113.508 179.55 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 223' ' ' ASP . . . . . 0.424 ' HB3' HG12 ' A' ' 218' ' ' ILE . 71.9 m-20 -61.65 -43.97 97.84 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 113.011 0.745 . . . . 0.79 113.011 -178.795 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.522 HG23 ' HD2' ' A' ' 225' ' ' LYS . 29.9 m -59.86 -28.71 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 N-CA-C 112.123 0.416 . . . . 0.6 112.123 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 225' ' ' LYS . . . . . 0.522 ' HD2' HG23 ' A' ' 224' ' ' VAL . 11.9 mptt -64.28 -42.05 96.62 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 121.318 0.58 . . . . 0.9 109.847 178.871 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 226' ' ' SER . . . . . 0.603 ' O ' HG23 ' A' ' 230' ' ' VAL . 3.5 m -71.0 -38.72 72.69 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.787 -0.642 . . . . 0.86 109.577 178.032 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 227' ' ' PHE . . . . . 0.492 ' HE1' HG12 ' A' ' 275' ' ' ILE . 8.8 t80 -56.02 -43.83 78.16 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 115.84 -0.618 . . . . 0.57 109.863 177.935 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 228' ' ' SER . . . . . 0.417 ' O ' HG23 ' A' ' 232' ' ' VAL . 39.2 m -61.59 -44.54 96.83 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.634 -0.712 . . . . 0.37 110.022 178.067 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 229' ' ' ARG . . . . . 0.491 ' NH1' ' HA ' ' A' ' 226' ' ' SER . 4.2 ttm105 -61.01 -38.86 87.55 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 115.806 -0.634 . . . . 0.82 110.935 178.874 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 230' ' ' VAL . . . . . 0.603 HG23 ' O ' ' A' ' 226' ' ' SER . 97.0 t -55.88 -52.56 47.8 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-N 116.164 -0.471 . . . . 0.39 110.587 178.683 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 231' ' ' MET . . . . . 0.628 ' HG2' HD22 ' A' ' 248' ' ' LEU . 72.3 mtm -59.98 -38.0 81.25 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.07 -0.514 . . . . 0.41 111.471 179.405 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 232' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 228' ' ' SER . 84.6 t -62.76 -42.49 96.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-O 120.771 0.319 . . . . 0.4 110.812 179.151 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 233' ' ' HIS . . . . . 0.432 ' HB3' ' HB1' ' B' ' 24' ' ' ALA . 48.7 t-80 -63.44 -35.61 81.01 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 120.84 0.353 . . . . 0.44 111.164 179.166 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 97.2 t -63.16 -38.19 81.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-O 121.114 0.483 . . . . 0.36 111.42 179.379 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 235' ' ' PHE . . . . . 0.522 ' HE2' HD11 ' A' ' 248' ' ' LEU . 62.2 m-85 -103.54 23.89 11.93 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.271 -0.422 . . . . 0.54 111.517 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 3.9 ttpp -69.83 -1.4 9.26 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 113.297 0.851 . . . . 0.76 113.297 -178.72 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 6.2 p30 -102.87 -16.13 15.99 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.949 0.404 . . . . 0.4 111.038 179.377 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 94.19 -6.48 72.19 Favored Glycine 0 CA--C 1.522 0.487 0 C-N-CA 120.905 -0.664 . . . . 0.33 112.605 -179.363 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 7.9 t -81.01 112.01 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.139 0 CA-C-O 121.157 0.504 . . . . 0.31 111.199 -179.306 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 240' ' ' THR . . . . . 0.438 ' HB ' ' CE2' ' A' ' 286' ' ' TRP . 1.2 m -94.43 101.62 13.55 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 120.777 -0.369 . . . . 0.31 111.444 179.505 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -110.31 139.08 45.86 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.396 -0.366 . . . . 0.88 110.713 179.635 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 242' ' ' TRP . . . . . 0.588 ' HB3' ' CE2' ' A' ' 300' ' ' PHE . 16.0 m95 -57.98 -42.82 85.91 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 120.625 0.25 . . . . 0.41 111.446 179.443 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 243' ' ' GLY . . . . . 0.455 ' H ' ' HB2' ' B' ' 35' ' ' TYR . . . -60.26 -28.83 67.53 Favored Glycine 0 CA--C 1.522 0.514 0 C-N-CA 121.306 -0.473 . . . . 0.27 112.775 178.993 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 244' ' ' ARG . . . . . 0.449 ' O ' ' HG ' ' A' ' 248' ' ' LEU . 94.3 mtt180 -71.42 -46.86 59.08 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.349 -0.612 . . . . 0.36 109.349 178.422 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 74.8 mt -60.93 -45.45 98.32 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-N 115.376 -0.829 . . . . 0.42 111.074 179.365 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 246' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 242' ' ' TRP . 61.3 t -62.52 -40.62 88.87 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-O 120.608 0.242 . . . . 0.49 111.015 179.269 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 55.1 m -57.67 -40.8 80.2 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.479 -0.328 . . . . 0.33 110.756 179.278 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 248' ' ' LEU . . . . . 0.628 HD22 ' HG2' ' A' ' 231' ' ' MET . 69.8 mt -61.63 -36.71 81.54 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 121.047 0.451 . . . . 0.45 110.298 178.229 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 29.5 mm -74.23 -38.98 48.99 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.133 0 CA-C-N 116.292 -0.413 . . . . 0.37 110.107 178.692 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 16.5 t -60.76 -42.77 98.09 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 108.921 -0.77 . . . . 0.27 108.921 178.097 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 251' ' ' PHE . . . . . 0.517 ' O ' HG23 ' A' ' 255' ' ' VAL . 19.7 t80 -64.85 -42.85 94.57 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 108.599 -0.889 . . . . 0.45 108.599 176.87 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -56.65 -40.31 87.86 Favored Glycine 0 C--N 1.337 0.616 0 N-CA-C 111.434 -0.667 . . . . 0.26 111.434 177.665 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -63.05 -37.48 87.36 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 120.956 0.408 . . . . 0.29 110.539 177.764 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 254' ' ' PHE . . . . . 0.418 ' HD2' HD13 ' A' ' 213' ' ' LEU . 0.2 OUTLIER -69.71 -38.9 77.1 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.066 -0.515 . . . . 0.75 109.952 178.329 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 255' ' ' VAL . . . . . 0.615 ' O ' ' HG ' ' A' ' 259' ' ' LEU . 59.8 t -67.53 -42.33 86.82 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.209 0 CA-C-N 116.079 -0.509 . . . . 0.31 109.719 178.281 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -57.96 -43.55 86.48 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 109.525 -0.546 . . . . 0.28 109.525 177.076 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 60.8 mttt -62.55 -43.45 98.78 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.7 -0.682 . . . . 0.5 109.982 177.816 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 258' ' ' HIS . . . . . 0.602 ' HB2' HD21 ' A' ' 213' ' ' LEU . 36.0 t60 -61.63 -44.38 97.1 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.935 -0.575 . . . . 0.87 110.465 178.534 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.615 ' HG ' ' O ' ' A' ' 255' ' ' VAL . 80.3 mt -67.42 -47.21 70.9 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 115.906 -0.588 . . . . 0.49 110.917 179.475 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 260' ' ' LYS . . . . . 0.447 ' HB2' ' HB1' ' A' ' 171' ' ' ALA . 0.5 OUTLIER -61.74 -32.49 72.74 Favored 'General case' 0 CA--C 1.535 0.369 0 O-C-N 122.386 -0.196 . . . . 0.6 110.99 179.526 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 69.3 m -60.95 -31.13 70.69 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.108 0.48 . . . . 0.47 110.588 178.928 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 28.4 m -110.18 20.66 5.82 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 CA-C-N 115.888 -0.597 . . . . 0.52 110.907 179.195 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 55.01 51.1 14.06 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 115.609 -0.723 . . . . 1.1 112.927 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -106.93 36.15 2.76 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.489 -0.323 . . . . 0.57 111.55 179.639 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 265' ' ' GLU . . . . . 0.487 ' HA ' HD12 ' A' ' 268' ' ' ILE . 0.8 OUTLIER -51.42 -38.91 55.98 Favored 'General case' 0 C--O 1.242 0.659 0 CA-C-O 120.922 0.391 . . . . 0.82 111.943 179.614 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 36.0 p -64.38 -12.93 47.59 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.787 -0.642 . . . . 0.7 111.537 179.244 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 267' ' ' PHE . . . . . 0.464 ' C ' ' HD2' ' A' ' 270' ' ' PRO . 14.9 t80 -105.3 -25.19 12.52 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.626 -0.509 . . . . 0.78 109.626 178.327 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 268' ' ' ILE . . . . . 0.487 HD12 ' HA ' ' A' ' 265' ' ' GLU . 70.3 mt -59.8 -50.01 81.68 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-N 115.957 -0.565 . . . . 0.4 110.947 179.055 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 269' ' ' GLU . . . . . 0.709 ' HB3' ' HD3' ' A' ' 270' ' ' PRO . 1.2 tp10 -57.03 -55.63 41.94 Favored Pre-proline 0 CA--C 1.547 0.853 0 C-N-CA 120.812 -0.355 . . . . 0.81 110.487 179.109 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 270' ' ' PRO . . . . . 0.709 ' HD3' ' HB3' ' A' ' 269' ' ' GLU . 52.1 Cg_exo -58.86 -29.71 90.88 Favored 'Trans proline' 0 C--N 1.364 1.378 0 C-N-CA 122.464 2.11 . . . . 0.35 112.392 177.44 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 271' ' ' LEU . . . . . 0.439 ' O ' HG13 ' A' ' 275' ' ' ILE . 1.5 tm? -67.09 -43.38 82.7 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 108.746 -0.835 . . . . 0.5 108.746 177.775 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -64.05 -35.86 82.1 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.563 -0.744 . . . . 0.31 109.0 177.148 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 273' ' ' GLU . . . . . 0.695 ' HG2' HD11 ' A' ' 160' ' ' LEU . 52.5 mt-10 -66.06 -44.82 83.42 Favored 'General case' 0 C--O 1.222 -0.379 0 CA-C-N 115.662 -0.699 . . . . 0.76 109.217 177.27 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 274' ' ' THR . . . . . . . . . . . . . 89.9 m -55.6 -46.89 77.24 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.713 -0.676 . . . . 0.52 110.578 178.724 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 275' ' ' ILE . . . . . 0.578 ' HA ' ' HE1' ' A' ' 231' ' ' MET . 72.9 mt -63.04 -55.42 23.65 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.128 0 CA-C-N 115.936 -0.575 . . . . 0.41 110.853 179.316 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 5.6 m -57.38 -47.81 80.71 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.009 -0.542 . . . . 0.37 112.052 -179.41 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 277' ' ' ASP . . . . . 0.471 ' HB2' ' O ' ' A' ' 273' ' ' GLU . 0.1 OUTLIER -52.61 -57.17 10.88 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.488 -0.324 . . . . 0.63 111.52 -179.867 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 278' ' ' VAL . . . . . 0.405 ' HB ' ' CE ' ' A' ' 231' ' ' MET . 48.5 t -66.33 -37.11 78.95 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 N-CA-C 111.915 0.339 . . . . 0.42 111.915 -179.694 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 41.4 tp -64.78 -47.11 79.34 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 111.971 0.36 . . . . 0.86 111.971 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 86.7 t -73.68 -32.39 35.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 CA-C-O 121.009 0.433 . . . . 0.53 111.186 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 281' ' ' ARG . . . . . 0.449 HH11 ' HD2' ' A' ' 281' ' ' ARG . 2.0 tpm_? -71.81 -43.52 65.48 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 112.439 0.533 . . . . 0.38 112.439 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 282' ' ' THR . . . . . . . . . . . . . 3.4 m -78.29 -26.53 47.06 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 112.981 0.734 . . . . 0.47 112.981 -178.399 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 63.9 mmtt -129.83 41.64 3.4 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 112.257 0.465 . . . . 0.73 112.257 -179.063 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.65 -62.06 1.89 Allowed 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 113.661 0.985 . . . . 0.44 113.661 -178.664 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -64.04 -42.32 97.11 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 112.794 0.665 . . . . 0.42 112.794 -178.334 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 286' ' ' TRP . . . . . 0.472 ' HE3' HD22 ' A' ' 287' ' ' LEU . 10.0 t90 -60.41 -50.19 74.58 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.733 0.301 . . . . 0.38 111.275 -179.756 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 287' ' ' LEU . . . . . 0.558 ' HB3' HD21 ' A' ' 155' ' ' LEU . 1.6 mm? -66.88 -42.76 85.04 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.319 0.489 . . . . 0.47 112.319 -179.3 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -67.24 -35.8 74.99 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 N-CA-C 112.004 0.372 . . . . 1.04 112.004 -179.487 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 56.1 mttt -77.52 -34.41 54.01 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 112.159 0.429 . . . . 0.82 112.159 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 3.6 tp60 -81.05 23.89 0.54 Allowed 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 112.457 0.54 . . . . 0.73 112.457 -179.382 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 291' ' ' ARG . . . . . 0.708 ' HB3' ' HB2' ' A' ' 294' ' ' ASP . 3.1 mmt180 60.46 16.57 6.49 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.834 0.679 . . . . 0.48 112.834 179.696 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 47.63 -112.58 1.07 Allowed Glycine 0 CA--C 1.525 0.658 0 N-CA-C 114.637 0.615 . . . . 0.28 114.637 179.722 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 293' ' ' TRP . . . . . 0.543 ' CZ2' ' HA ' ' A' ' 159' ' ' SER . 86.0 m95 -66.74 -30.08 70.22 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.763 0.653 . . . . 0.36 112.763 -178.595 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 294' ' ' ASP . . . . . 0.708 ' HB2' ' HB3' ' A' ' 291' ' ' ARG . 15.5 m-20 -62.01 -42.92 99.68 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 121.049 0.452 . . . . 0.37 110.042 178.957 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -67.82 -41.86 87.69 Favored Glycine 0 CA--C 1.521 0.414 0 C-N-CA 120.639 -0.791 . . . . 0.32 111.885 178.834 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 296' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -67.39 -43.34 81.58 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 120.708 0.289 . . . . 0.34 111.315 179.524 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 297' ' ' VAL . . . . . 0.581 ' HA ' HG21 ' A' ' 193' ' ' THR . 50.3 t -65.89 -55.43 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-N 116.412 -0.358 . . . . 0.27 111.664 -179.32 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -62.56 -30.91 71.67 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 112.709 0.633 . . . . 0.73 112.709 -178.906 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 299' ' ' PHE . . . . . . . . . . . . . 93.1 t80 -76.54 -40.82 48.81 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 112.372 0.508 . . . . 0.45 112.372 179.643 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 300' ' ' PHE . . . . . 0.588 ' CE2' ' HB3' ' A' ' 242' ' ' TRP . 62.1 m-85 . . . . . 0 CA--C 1.539 0.523 0 N-CA-C 114.036 1.124 . . . . 0.39 114.036 -178.044 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.535 0.379 0 N-CA-C 111.851 0.315 . . . . 0.57 111.851 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 23' ' ' PHE . . . . . 0.479 ' HD1' ' N ' ' B' ' 24' ' ' ALA . 0.2 OUTLIER -59.91 -33.22 71.57 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.151 0.501 . . . . 0.65 111.077 179.317 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 24' ' ' ALA . . . . . 0.479 ' N ' ' HD1' ' B' ' 23' ' ' PHE . . . -75.83 -38.41 58.1 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.207 0.527 . . . . 0.33 110.027 179.268 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -66.78 -36.63 82.87 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.937 -0.574 . . . . 0.34 109.485 178.201 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -60.54 -51.98 67.12 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 115.822 -0.626 . . . . 0.41 110.23 177.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 94.9 mt -61.86 -30.83 71.12 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 121.052 0.453 . . . . 0.41 110.14 178.556 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 28' ' ' ARG . . . . . . . . . . . . . 34.9 ttm-85 -68.0 -51.46 46.92 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 115.534 -0.757 . . . . 0.46 110.152 178.604 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 59.6 mttt -57.0 -42.46 80.35 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.296 -0.411 . . . . 0.44 110.599 178.916 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 69.6 mt -69.45 -42.95 81.12 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 CA-C-N 116.305 -0.407 . . . . 0.35 110.157 178.839 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.08 -46.18 94.66 Favored Glycine 0 C--N 1.333 0.368 0 C-N-CA 121.056 -0.592 . . . . 0.26 112.299 179.039 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -64.85 -34.98 79.65 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-O 121.176 0.512 . . . . 0.76 110.375 179.114 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 14.2 tppt? -71.73 -47.66 52.33 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.057 -0.52 . . . . 0.73 111.116 179.416 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 55.5 t -62.68 -44.63 99.6 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-O 120.823 0.344 . . . . 0.35 111.009 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 35' ' ' TYR . . . . . 0.455 ' HB2' ' H ' ' A' ' 243' ' ' GLY . 0.0 OUTLIER -59.35 -47.24 86.16 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.155 -0.475 . . . . 0.77 110.468 179.102 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 36' ' ' CYS . . . . . . . . . . . . . 11.8 t -70.01 -36.05 74.82 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 116.259 -0.428 . . . . 0.57 111.913 -179.713 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 99.0 m -64.75 -40.04 94.63 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.209 0.448 . . . . 0.52 112.209 -179.784 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 38' ' ' TRP . . . . . . . . . . . . . 94.0 m95 -82.78 -31.28 28.33 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 120.821 -0.352 . . . . 0.72 111.781 -179.394 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 82.9 p . . . . . 0 N--CA 1.467 0.421 0 CA-C-O 120.737 0.303 . . . . 0.63 111.093 178.337 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 25.6 t70 . . . . . 0 N--CA 1.465 0.29 0 CA-C-O 120.831 0.348 . . . . 0.52 110.832 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -55.22 -48.34 74.03 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.007 -0.542 . . . . 0.44 110.805 178.926 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.601 HD21 ' HB3' ' A' ' 287' ' ' LEU . 47.6 tp -73.17 -36.08 66.54 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.091 -0.504 . . . . 0.73 110.783 178.675 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 64.3 t80 -60.06 -40.58 89.97 Favored 'General case' 0 C--O 1.224 -0.282 0 CA-C-N 116.223 -0.444 . . . . 0.36 111.489 179.643 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 7.6 mtm180 -56.22 -52.32 64.85 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.772 0.32 . . . . 0.35 111.552 179.48 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -64.89 -45.93 83.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.126 -0.488 . . . . 0.3 110.658 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 159' ' ' SER . . . . . 0.439 ' HA ' ' CZ2' ' A' ' 293' ' ' TRP . 15.6 m -58.35 -50.25 74.3 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.802 -0.635 . . . . 0.25 111.207 179.46 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -60.37 -47.57 85.5 Favored 'General case' 0 C--O 1.225 -0.219 0 CA-C-N 116.149 -0.478 . . . . 0.43 111.263 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -58.2 -50.28 74.08 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 120.633 0.254 . . . . 0.34 111.166 -179.708 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 84.9 mt -61.32 -50.14 81.65 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 CA-C-N 116.321 -0.4 . . . . 0.27 111.082 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.554 HD12 HG23 ' A' ' 276' ' ' THR . 68.4 mt -61.45 -46.53 96.38 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 N-CA-C 111.533 0.197 . . . . 0.38 111.533 179.389 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 2.0 t -56.28 -52.63 63.78 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.733 0.302 . . . . 0.31 110.807 178.953 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 40.0 ttt-85 -61.19 -41.54 96.99 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 120.768 0.318 . . . . 0.35 111.782 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 166' ' ' TYR . . . . . 0.495 ' HE1' ' HA ' ' A' ' 195' ' ' ARG . 80.9 t80 -68.37 -50.3 54.1 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 112.236 0.458 . . . . 0.28 112.236 -179.459 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.474 ' HG ' ' HA ' ' A' ' 253' ' ' ALA . 5.8 mp -54.57 -39.22 67.56 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.66 0.267 . . . . 0.42 111.101 -179.413 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 52.6 mtt-85 -65.32 -44.46 87.75 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.434 -0.348 . . . . 0.33 111.029 178.934 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -54.18 -45.1 72.04 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 121.111 0.481 . . . . 0.54 111.125 178.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 170' ' ' GLN . . . . . 0.759 ' HB2' ' HB1' ' A' ' 253' ' ' ALA . 12.3 mm100 -77.01 -37.36 55.17 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 116.18 -0.464 . . . . 0.38 111.951 -179.847 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.43 ' O ' ' HG3' ' A' ' 257' ' ' LYS . . . . . . . . 0 C--O 1.232 0.183 0 CA-C-O 120.916 0.388 . . . . 0.26 110.715 178.954 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.625 ' O ' ' HA3' ' A' ' 187' ' ' GLY . . . . . . . . 0 CA--C 1.533 0.301 0 CA-C-O 121.182 0.515 . . . . 0.32 111.439 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -80.09 -71.97 1.24 Allowed Glycine 0 CA--C 1.524 0.643 0 C-N-CA 120.609 -0.805 . . . . 0.38 113.356 179.483 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -68.17 -55.61 11.71 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-O 120.979 0.418 . . . . 0.46 111.118 -179.608 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -65.18 -39.08 92.39 Favored 'General case' 0 C--O 1.218 -0.555 0 CA-C-N 115.904 -0.589 . . . . 0.41 110.077 178.733 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 187' ' ' GLY . . . . . 0.625 ' HA3' ' O ' ' A' ' 183' ' ' ALA . . . -60.6 -50.82 63.4 Favored Glycine 0 C--O 1.219 -0.79 0 C-N-CA 121.399 -0.429 . . . . 0.3 113.135 179.641 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 188' ' ' ARG . . . . . 0.427 HH11 ' HD2' ' A' ' 188' ' ' ARG . 13.4 mtp180 -56.84 -47.85 79.39 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 117.547 0.673 . . . . 1.34 111.484 179.234 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 189' ' ' ARG . . . . . 0.71 ' HB3' HG11 ' A' ' 297' ' ' VAL . 48.3 mtm180 -70.29 -41.0 73.95 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 112.479 0.548 . . . . 0.48 112.479 -179.438 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 190' ' ' ALA . . . . . 0.536 ' HA ' HG22 ' A' ' 297' ' ' VAL . . . -74.22 -44.63 52.39 Favored 'General case' 0 C--O 1.221 -0.408 0 N-CA-C 111.873 0.323 . . . . 0.27 111.873 -178.649 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 3.4 tp -61.07 -49.32 77.83 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.679 -0.408 . . . . 0.45 110.319 179.645 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -61.08 -44.11 97.86 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 120.706 -0.398 . . . . 0.57 110.996 179.545 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 91.5 m -63.53 -46.19 87.13 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 110.026 -0.361 . . . . 0.32 110.026 178.769 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 59.8 tp -63.58 -37.27 86.68 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.075 -0.511 . . . . 0.39 111.184 179.196 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 195' ' ' ARG . . . . . 0.495 ' HA ' ' HE1' ' A' ' 166' ' ' TYR . 2.1 mtt180 -58.6 -48.34 81.28 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.819 0.342 . . . . 0.38 110.711 178.709 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 10.5 mmp_? -74.66 -45.12 46.75 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 116.149 -0.478 . . . . 0.4 111.868 -179.25 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 197' ' ' VAL . . . . . 0.479 ' O ' HG23 ' A' ' 201' ' ' VAL . 49.7 t -65.67 -51.55 61.18 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 CA-C-O 120.687 0.279 . . . . 0.35 111.628 179.529 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -62.31 -53.23 43.74 Favored Glycine 0 CA--C 1.521 0.435 0 CA-C-O 119.933 -0.371 . . . . 0.29 113.388 -179.456 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -55.18 -40.34 70.61 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 117.225 0.513 . . . . 0.4 109.763 179.011 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -60.36 -53.6 44.17 Favored Glycine 0 C--N 1.335 0.507 0 N-CA-C 111.138 -0.785 . . . . 0.36 111.138 177.837 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 201' ' ' VAL . . . . . 0.479 HG23 ' O ' ' A' ' 197' ' ' VAL . 98.9 t -58.29 -38.33 68.33 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-O 120.792 0.33 . . . . 0.39 110.691 178.461 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 202' ' ' GLN . . . . . 0.517 HE21 ' HD1' ' A' ' 254' ' ' PHE . 31.7 mt-30 -62.91 -54.2 42.23 Favored 'General case' 0 C--O 1.225 -0.228 0 CA-C-N 115.818 -0.628 . . . . 0.36 111.803 179.594 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 29.0 mtp180 -67.88 -36.34 80.07 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 121.028 -0.269 . . . . 0.57 111.434 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 10.9 m-80 -62.98 -50.95 68.73 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 121.181 0.515 . . . . 1.3 110.499 178.532 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 57.1 m-70 -101.85 35.89 2.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.214 -0.448 . . . . 0.47 111.233 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -53.47 -47.45 69.75 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 112.23 0.456 . . . . 0.43 112.23 -179.261 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 207' ' ' THR . . . . . 0.401 HG22 ' H ' ' A' ' 207' ' ' THR . 0.6 OUTLIER -56.34 -39.51 72.95 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 112.285 0.476 . . . . 0.47 112.285 -179.78 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -64.86 -48.79 73.01 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 120.989 0.424 . . . . 0.35 110.84 -179.802 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 209' ' ' PHE . . . . . 0.614 ' O ' ' HB2' ' A' ' 213' ' ' LEU . 46.3 m-85 -66.76 -35.27 79.71 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.94 -0.573 . . . . 0.56 109.912 178.692 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 210' ' ' GLN . . . . . 0.558 ' O ' ' HG2' ' A' ' 214' ' ' ARG . 49.5 mt-30 -66.12 -45.78 79.92 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.481 -0.327 . . . . 0.66 111.181 179.005 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -55.7 -49.03 67.8 Favored Glycine 0 C--N 1.336 0.574 0 N-CA-C 111.14 -0.784 . . . . 0.34 111.14 178.29 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -68.54 -29.86 68.53 Favored 'General case' 0 C--O 1.221 -0.42 0 CA-C-O 120.602 0.239 . . . . 0.65 110.367 178.144 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.614 ' HB2' ' O ' ' A' ' 209' ' ' PHE . 0.3 OUTLIER -69.55 -41.56 75.75 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.521 -0.309 . . . . 0.35 111.507 179.668 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 214' ' ' ARG . . . . . 0.558 ' HG2' ' O ' ' A' ' 210' ' ' GLN . 2.8 mmp_? -66.52 -40.03 88.95 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 121.185 0.517 . . . . 0.57 110.137 179.569 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 48.1 mtmt -91.87 13.15 19.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.888 -0.596 . . . . 0.58 111.94 179.711 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 216' ' ' LEU . . . . . 0.467 HD21 HG13 ' A' ' 255' ' ' VAL . 7.4 tp -79.72 106.4 11.72 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 121.422 0.629 . . . . 0.46 111.34 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -84.13 -2.14 56.26 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 115.011 -0.995 . . . . 0.55 111.708 -179.341 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 218' ' ' ILE . . . . . 0.628 HG12 ' HB3' ' A' ' 223' ' ' ASP . 46.9 mt -53.71 114.37 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 N-CA-C 112.255 0.465 . . . . 0.39 112.255 -179.75 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 26.5 mtmm -138.11 -28.4 0.86 Allowed 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 115.982 -0.553 . . . . 0.84 112.424 -179.72 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -125.14 -179.37 4.54 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 113.017 0.747 . . . . 0.55 113.017 -178.251 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 221' ' ' GLU . . . . . 0.56 ' O ' HG22 ' A' ' 224' ' ' VAL . 1.2 mp0 -64.3 -22.05 66.82 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.448 -0.796 . . . . 0.59 111.376 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -71.49 -26.82 72.44 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 121.021 -0.609 . . . . 0.38 112.859 179.177 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 223' ' ' ASP . . . . . 0.628 ' HB3' HG12 ' A' ' 218' ' ' ILE . 39.3 m-20 -68.37 -31.45 70.84 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 112.283 0.475 . . . . 0.37 112.283 -179.632 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.661 ' HB ' HG21 ' A' ' 274' ' ' THR . 3.1 m -58.16 -27.67 32.63 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 CA-C-O 120.745 0.307 . . . . 0.43 111.73 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 225' ' ' LYS . . . . . 0.419 ' HD2' ' H ' ' A' ' 225' ' ' LYS . 6.1 mptt -65.16 -37.08 86.26 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.107 0.48 . . . . 0.82 109.9 178.768 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 226' ' ' SER . . . . . 0.627 ' O ' HG23 ' A' ' 230' ' ' VAL . 18.4 t -67.57 -44.13 78.93 Favored 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 109.176 -0.676 . . . . 0.36 109.176 178.214 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 227' ' ' PHE . . . . . 0.616 ' HE2' HG21 ' A' ' 255' ' ' VAL . 2.7 t80 -59.76 -39.96 86.57 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 115.391 -0.822 . . . . 0.43 110.19 178.495 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 228' ' ' SER . . . . . 0.598 ' HA ' ' HE3' ' A' ' 231' ' ' MET . 15.9 m -63.44 -39.48 94.58 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.168 0.508 . . . . 0.35 109.883 178.441 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 28.2 mtp180 -65.88 -35.51 80.84 Favored 'General case' 0 C--O 1.225 -0.202 0 CA-C-N 115.482 -0.781 . . . . 0.62 109.766 178.237 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 230' ' ' VAL . . . . . 0.627 HG23 ' O ' ' A' ' 226' ' ' SER . 56.8 t -60.86 -51.18 76.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 109.879 -0.415 . . . . 0.36 109.879 177.969 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 231' ' ' MET . . . . . 0.613 ' HE1' ' HB ' ' A' ' 278' ' ' VAL . 56.5 mtm -55.73 -53.35 57.64 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.891 -0.595 . . . . 0.4 111.788 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 35.2 m -63.87 -30.91 51.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 120.861 -0.336 . . . . 0.4 111.167 179.388 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 233' ' ' HIS . . . . . 0.474 ' O ' ' HB3' ' A' ' 236' ' ' LYS . 44.5 t-80 -69.82 -39.56 76.41 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 120.962 0.41 . . . . 0.42 110.321 178.51 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 69.0 t -71.8 -41.0 70.03 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 CA-C-O 120.969 0.414 . . . . 0.38 111.046 178.71 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -87.9 12.73 12.43 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 120.954 0.407 . . . . 0.71 111.574 179.601 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 236' ' ' LYS . . . . . 0.51 ' O ' ' HG2' ' A' ' 236' ' ' LYS . 0.0 OUTLIER -68.99 -15.32 63.45 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 115.606 -0.725 . . . . 0.52 111.267 179.221 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 237' ' ' ASP . . . . . 0.456 ' HA ' ' NZ ' ' A' ' 236' ' ' LYS . 71.8 m-20 -75.86 -7.89 55.57 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 122.085 -0.385 . . . . 0.36 111.651 179.812 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 84.92 -19.97 18.28 Favored Glycine 0 CA--C 1.519 0.291 0 C-N-CA 121.014 -0.613 . . . . 0.4 112.773 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 2.5 t -91.97 108.89 20.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.148 0.499 . . . . 0.85 111.166 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 240' ' ' THR . . . . . 0.537 HG22 HD11 ' A' ' 245' ' ' ILE . 3.4 m -89.79 68.2 7.43 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.206 -0.452 . . . . 0.48 111.131 -179.793 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 241' ' ' ASN . . . . . 0.461 ' HB2' ' HG3' ' A' ' 244' ' ' ARG . 11.9 m120 -66.24 141.58 57.99 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.918 0.389 . . . . 0.4 111.431 -179.771 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 242' ' ' TRP . . . . . 0.491 ' CZ3' ' HB2' ' A' ' 296' ' ' PHE . 76.1 m95 -59.69 -36.35 76.31 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.282 -0.417 . . . . 0.43 110.369 178.931 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 243' ' ' GLY . . . . . 0.452 ' HA3' ' HB2' ' B' ' 35' ' ' TYR . . . -61.14 -31.75 77.97 Favored Glycine 0 C--N 1.335 0.5 0 C-N-CA 121.082 -0.58 . . . . 0.27 112.058 178.083 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 244' ' ' ARG . . . . . 0.539 ' HG2' ' HA3' ' B' ' 31' ' ' GLY . 81.6 mtt180 -75.76 -32.74 60.08 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 121.151 0.501 . . . . 0.36 109.914 178.684 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 245' ' ' ILE . . . . . 0.537 HD11 HG22 ' A' ' 240' ' ' THR . 78.1 mt -72.05 -49.63 42.73 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 CA-C-N 115.78 -0.646 . . . . 0.44 110.692 179.064 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 26.9 m -67.56 -31.51 52.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 C-N-CA 121.171 -0.212 . . . . 0.3 111.324 179.333 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 247' ' ' THR . . . . . 0.475 HG22 HD22 ' B' ' 27' ' ' LEU . 30.9 m -67.53 -40.5 85.07 Favored 'General case' 0 C--O 1.232 0.157 0 N-CA-C 109.134 -0.691 . . . . 0.37 109.134 177.863 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 248' ' ' LEU . . . . . 0.419 ' HA ' HD13 ' A' ' 248' ' ' LEU . 0.3 OUTLIER -61.5 -42.26 98.53 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 109.047 -0.723 . . . . 0.48 109.047 177.14 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 249' ' ' ILE . . . . . 0.439 HG13 ' O ' ' A' ' 245' ' ' ILE . 49.7 mt -63.36 -44.99 99.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.404 0 CA-C-N 115.812 -0.631 . . . . 0.39 110.219 178.105 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 250' ' ' SER . . . . . 0.505 ' HB3' ' HG3' ' A' ' 202' ' ' GLN . 40.3 m -58.98 -44.22 91.56 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.062 -0.517 . . . . 0.32 110.005 178.699 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 251' ' ' PHE . . . . . . . . . . . . . 21.7 t80 -63.67 -44.28 94.21 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 115.89 -0.596 . . . . 0.36 109.495 177.369 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -56.22 -44.61 89.04 Favored Glycine 0 C--N 1.336 0.552 0 C-N-CA 121.067 -0.587 . . . . 0.25 111.705 178.462 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 253' ' ' ALA . . . . . 0.759 ' HB1' ' HB2' ' A' ' 170' ' ' GLN . . . -59.96 -43.16 95.23 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.669 0.271 . . . . 0.26 110.585 177.945 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 254' ' ' PHE . . . . . 0.517 ' HD1' HE21 ' A' ' 202' ' ' GLN . 0.3 OUTLIER -65.04 -40.64 95.08 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 121.233 0.539 . . . . 0.57 110.215 178.462 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 255' ' ' VAL . . . . . 0.616 HG21 ' HE2' ' A' ' 227' ' ' PHE . 78.4 t -66.63 -39.97 85.11 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-N 116.107 -0.497 . . . . 0.3 110.207 178.561 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -57.86 -39.42 77.72 Favored 'General case' 0 N--CA 1.461 0.097 0 CA-C-O 121.469 0.652 . . . . 0.27 109.259 178.093 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 257' ' ' LYS . . . . . 0.43 ' HG3' ' O ' ' A' ' 171' ' ' ALA . 23.1 tttp -61.65 -41.72 97.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.262 -0.881 . . . . 0.33 110.236 178.062 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 71.3 t60 -58.77 -45.58 89.48 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 116.243 -0.435 . . . . 0.46 110.719 178.64 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.528 HD22 ' NE2' ' A' ' 264' ' ' GLN . 13.1 mt -70.86 -43.1 69.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.248 -0.433 . . . . 0.45 110.932 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 21.0 ttmm -63.1 -36.93 85.22 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.785 0.326 . . . . 0.68 111.089 179.445 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 54.3 m -63.15 -25.46 68.36 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 116.387 -0.369 . . . . 0.44 111.684 179.839 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 262' ' ' VAL . . . . . 0.523 HG23 ' HG3' ' A' ' 264' ' ' GLN . 17.9 m -108.67 21.8 4.64 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-O 120.848 0.356 . . . . 0.49 111.23 179.34 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 57.32 42.55 24.86 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 112.903 0.705 . . . . 1.81 112.903 179.388 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 264' ' ' GLN . . . . . 0.528 ' NE2' HD22 ' A' ' 259' ' ' LEU . 10.5 mt-30 -98.22 38.4 1.33 Allowed 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.219 0.451 . . . . 0.48 112.219 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -51.48 -37.33 48.42 Favored 'General case' 0 C--O 1.243 0.715 0 CA-C-O 120.892 0.377 . . . . 0.8 111.857 179.765 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 26.5 p -62.59 -16.88 58.62 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 116.101 -0.499 . . . . 0.97 111.162 178.794 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 267' ' ' PHE . . . . . 0.401 ' C ' ' HD2' ' A' ' 270' ' ' PRO . 73.7 m-85 -110.44 -12.18 14.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.939 -0.573 . . . . 0.67 109.889 178.271 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 8.4 mm -66.41 -49.33 76.34 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 CA-C-N 115.834 -0.621 . . . . 0.4 110.303 179.06 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 269' ' ' GLU . . . . . 0.732 ' HB2' ' HD3' ' A' ' 270' ' ' PRO . 57.4 mm-40 -61.44 -54.95 47.73 Favored Pre-proline 0 CA--C 1.545 0.765 0 CA-C-N 115.841 -0.618 . . . . 0.51 111.106 179.331 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 270' ' ' PRO . . . . . 0.732 ' HD3' ' HB2' ' A' ' 269' ' ' GLU . 51.2 Cg_exo -57.0 -36.14 99.2 Favored 'Trans proline' 0 C--N 1.359 1.086 0 C-N-CA 122.244 1.963 . . . . 0.31 112.879 178.577 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 271' ' ' LEU . . . . . . . . . . . . . 18.6 tp -63.84 -52.1 61.63 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.485 0.183 . . . . 0.5 111.188 179.035 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -58.16 -39.79 79.75 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.276 -0.42 . . . . 0.29 111.242 179.794 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 273' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -71.36 -40.48 70.61 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.247 -0.433 . . . . 0.61 110.723 178.844 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 274' ' ' THR . . . . . 0.661 HG21 ' HB ' ' A' ' 224' ' ' VAL . 87.3 m -63.53 -43.84 95.98 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.874 0.368 . . . . 0.33 110.679 179.309 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 275' ' ' ILE . . . . . 0.442 ' HA ' ' CE ' ' A' ' 231' ' ' MET . 88.1 mt -61.88 -54.88 28.71 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.083 0 CA-C-N 116.277 -0.42 . . . . 0.39 110.414 179.163 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 276' ' ' THR . . . . . 0.554 HG23 HD12 ' A' ' 163' ' ' ILE . 24.2 m -56.41 -51.07 69.74 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.26 -0.427 . . . . 0.31 111.533 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 277' ' ' ASP . . . . . 0.637 ' O ' ' HB2' ' A' ' 281' ' ' ARG . 29.7 t70 -52.26 -60.22 3.47 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.35 -0.386 . . . . 0.39 111.79 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 278' ' ' VAL . . . . . 0.613 ' HB ' ' HE1' ' A' ' 231' ' ' MET . 59.6 t -63.94 -42.57 96.19 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 N-CA-C 112.336 0.495 . . . . 0.36 112.336 -179.074 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 27.1 tp -60.72 -47.61 85.51 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 111.987 0.365 . . . . 0.66 111.987 -179.698 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 86.7 t -80.96 -46.32 20.82 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 N-CA-C 113.056 0.761 . . . . 0.47 113.056 -178.966 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 281' ' ' ARG . . . . . 0.637 ' HB2' ' O ' ' A' ' 277' ' ' ASP . 1.5 mpt_? -60.72 -35.59 76.7 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 113.039 0.755 . . . . 0.42 113.039 -178.32 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 282' ' ' THR . . . . . . . . . . . . . 85.0 m -65.09 -38.13 89.73 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 112.389 0.514 . . . . 0.47 112.389 -179.618 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 28.8 mmtp -129.67 42.1 3.34 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 112.582 0.586 . . . . 0.46 112.582 -178.639 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 284' ' ' ARG . . . . . 0.412 ' HD3' ' O ' ' A' ' 281' ' ' ARG . 0.1 OUTLIER -60.35 -28.82 68.47 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 111.965 0.357 . . . . 0.59 111.965 -179.697 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 285' ' ' ASP . . . . . 0.458 ' HA ' HG22 ' A' ' 288' ' ' VAL . 3.1 t70 -62.41 -44.99 95.12 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-O 121.023 0.439 . . . . 0.71 110.383 179.201 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 286' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -61.09 -35.61 77.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.307 0.575 . . . . 0.54 110.13 178.961 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 287' ' ' LEU . . . . . 0.601 ' HB3' HD21 ' A' ' 155' ' ' LEU . 1.2 mm? -71.24 -54.31 11.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.517 -0.765 . . . . 0.46 111.148 179.378 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 288' ' ' VAL . . . . . 0.458 HG22 ' HA ' ' A' ' 285' ' ' ASP . 33.8 m -59.96 -30.39 45.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 N-CA-C 111.763 0.283 . . . . 0.43 111.763 -179.702 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 27.8 mttp -65.77 -32.43 73.96 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.861 0.363 . . . . 0.82 110.927 178.752 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 -108.51 28.98 7.82 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 111.873 0.323 . . . . 0.67 111.873 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 291' ' ' ARG . . . . . 0.777 ' HB3' ' HB2' ' A' ' 294' ' ' ASP . 0.8 OUTLIER 61.84 19.41 10.6 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 112.612 0.597 . . . . 0.44 112.612 178.896 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 69.11 -118.02 8.4 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 121.302 -0.475 . . . . 0.32 113.236 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 293' ' ' TRP . . . . . 0.674 ' O ' HG23 ' A' ' 297' ' ' VAL . 90.5 m95 -72.0 -21.7 61.52 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 111.683 0.253 . . . . 0.35 111.683 -179.262 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 294' ' ' ASP . . . . . 0.777 ' HB2' ' HB3' ' A' ' 291' ' ' ARG . 60.1 m-20 -57.74 -51.5 69.29 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 109.509 -0.552 . . . . 0.45 109.509 178.019 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -65.25 -41.36 96.82 Favored Glycine 0 C--N 1.335 0.52 0 N-CA-C 111.355 -0.698 . . . . 0.3 111.355 178.137 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 296' ' ' PHE . . . . . 0.491 ' HB2' ' CZ3' ' A' ' 242' ' ' TRP . 6.7 t80 -56.33 -46.04 80.09 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 120.753 0.311 . . . . 0.34 111.371 178.707 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 297' ' ' VAL . . . . . 0.71 HG11 ' HB3' ' A' ' 189' ' ' ARG . 88.9 t -58.48 -54.6 30.85 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 CA-C-O 120.96 0.409 . . . . 0.35 111.768 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -71.23 -29.86 65.65 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.948 0.721 . . . . 0.71 112.948 -178.488 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 299' ' ' PHE . . . . . 0.51 ' CZ ' ' HB2' ' B' ' 39' ' ' SER . 61.3 t80 -59.18 -46.11 89.26 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.901 0.381 . . . . 0.4 111.051 178.978 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 300' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 . . . . . 0 CA--C 1.534 0.349 0 CA-C-O 121.132 0.491 . . . . 0.45 111.902 -179.599 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 . . . . . 0 CA--C 1.528 0.114 0 N-CA-C 111.62 0.23 . . . . 1.19 111.62 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 23' ' ' PHE . . . . . 0.621 ' HD1' ' N ' ' B' ' 24' ' ' ALA . 0.2 OUTLIER -62.36 -33.9 75.63 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 120.788 -0.365 . . . . 0.33 111.422 -179.967 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 24' ' ' ALA . . . . . 0.621 ' N ' ' HD1' ' B' ' 23' ' ' PHE . . . -76.83 -40.22 48.63 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.855 0.36 . . . . 0.34 110.561 -179.73 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -69.94 -40.56 75.4 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.075 -0.511 . . . . 0.42 111.577 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -68.96 -50.92 44.96 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 111.909 0.337 . . . . 0.57 111.909 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 27' ' ' LEU . . . . . 0.475 HD22 HG22 ' A' ' 247' ' ' THR . 81.7 mt -64.8 -30.39 71.4 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 111.734 0.272 . . . . 0.44 111.734 -179.332 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 28' ' ' ARG . . . . . 0.518 ' HB2' ' O ' ' B' ' 24' ' ' ALA . 0.0 OUTLIER -70.67 -55.92 7.61 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 120.886 0.374 . . . . 0.42 110.795 178.35 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 34.9 mtmm -61.64 -53.01 61.86 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 116.463 -0.335 . . . . 0.42 111.672 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 97.4 mt -58.39 -40.02 76.7 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.077 0 CA-C-N 116.41 -0.359 . . . . 0.4 110.573 -179.828 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 31' ' ' GLY . . . . . 0.539 ' HA3' ' HG2' ' A' ' 244' ' ' ARG . . . -56.61 -50.01 65.99 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.946 -0.645 . . . . 0.25 112.45 179.388 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -72.09 -40.37 68.25 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.927 0.364 . . . . 0.73 111.43 179.602 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 33' ' ' LYS . . . . . 0.479 ' HA ' ' HD2' ' B' ' 33' ' ' LYS . 1.1 tptt -59.45 -51.68 68.85 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 120.879 0.371 . . . . 1.13 110.749 179.245 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 33.6 t -63.94 -46.42 94.11 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 CA-C-N 116.057 -0.52 . . . . 0.4 110.467 178.664 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 35' ' ' TYR . . . . . 0.452 ' HB2' ' HA3' ' A' ' 243' ' ' GLY . 9.0 t80 -56.56 -48.26 77.72 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 115.934 -0.575 . . . . 0.73 111.517 179.39 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 36' ' ' CYS . . . . . . . . . . . . . 80.8 m -63.98 -33.04 74.84 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.866 0.365 . . . . 0.46 111.164 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 34.5 m -69.63 -33.51 72.75 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.081 -0.509 . . . . 0.63 111.704 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 38' ' ' TRP . . . . . . . . . . . . . 80.8 m95 -87.96 -34.64 18.01 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 120.675 0.274 . . . . 0.58 111.661 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 39' ' ' SER . . . . . 0.51 ' HB2' ' CZ ' ' A' ' 299' ' ' PHE . 39.1 t . . . . . 0 N--CA 1.465 0.321 0 CA-C-O 121.016 0.436 . . . . 0.61 111.018 179.045 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 . . . . . 0 CA--C 1.537 0.473 0 N-CA-C 112.706 0.632 . . . . 1.01 112.706 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -58.86 -52.53 65.35 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.926 0.393 . . . . 0.97 111.236 179.769 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 1.4 mt -60.56 -39.51 88.25 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.167 -0.47 . . . . 0.64 110.925 178.71 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -66.75 -39.03 87.76 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.544 -0.298 . . . . 0.9 111.459 179.493 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 1.5 mmt180 -57.04 -51.64 68.44 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.714 0.293 . . . . 0.92 111.24 179.772 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 158' ' ' GLN . . . . . 0.406 ' HA ' ' HB2' ' A' ' 183' ' ' ALA . 71.0 mt-30 -69.28 -42.17 75.85 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.991 -0.283 . . . . 0.54 111.095 179.464 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 49.4 m -59.97 -49.78 76.32 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 111.752 0.278 . . . . 0.37 111.752 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.634 HD21 ' HA ' ' A' ' 273' ' ' GLU . 1.5 tm? -58.44 -53.41 58.63 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.548 -0.296 . . . . 0.72 110.994 179.539 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -60.48 -47.43 86.17 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 112.013 0.375 . . . . 1.1 112.013 -179.631 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 162' ' ' ILE . . . . . 0.507 HG12 ' HA2' ' A' ' 187' ' ' GLY . 83.2 mt -61.99 -47.54 92.72 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-O 120.621 0.248 . . . . 0.38 111.392 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 39.6 mt -64.19 -45.54 96.04 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 CA-C-N 116.745 -0.207 . . . . 0.42 110.733 179.245 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 27.2 t -57.98 -44.71 87.3 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.944 0.402 . . . . 0.34 110.006 178.345 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -61.02 -44.62 97.14 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 115.658 -0.701 . . . . 0.49 111.611 179.117 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 166' ' ' TYR . . . . . 0.906 ' HE1' ' HA ' ' A' ' 195' ' ' ARG . 75.6 t80 -68.22 -51.18 48.33 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 111.824 0.305 . . . . 0.38 111.824 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 8.6 mp -58.85 -41.29 86.62 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.713 -0.221 . . . . 0.46 111.455 -179.396 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 5.4 mtt-85 -67.27 -39.67 86.08 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.009 0.433 . . . . 0.86 111.029 179.122 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -68.57 -48.19 64.87 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.159 -0.473 . . . . 0.73 111.377 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 170' ' ' GLN . . . . . 0.45 ' HG3' ' CZ ' ' A' ' 166' ' ' TYR . 27.6 mm-40 -65.56 -25.97 67.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.699 0.285 . . . . 0.54 111.158 178.779 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.137 0 CA-C-N 116.486 -0.325 . . . . 0.52 111.401 178.736 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.488 ' O ' ' HA3' ' A' ' 187' ' ' GLY . . . . . . . . 0 CA--C 1.533 0.313 0 CA-C-O 120.933 0.397 . . . . 0.54 111.269 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -79.13 -70.51 1.32 Allowed Glycine 0 CA--C 1.524 0.634 0 C-N-CA 120.696 -0.764 . . . . 0.48 113.479 -179.526 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -61.83 -55.91 24.94 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 120.774 0.321 . . . . 0.46 111.253 -179.657 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -62.31 -37.34 85.2 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.265 -0.425 . . . . 0.4 110.452 179.083 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 187' ' ' GLY . . . . . 0.507 ' HA2' HG12 ' A' ' 162' ' ' ILE . . . -63.2 -42.81 99.29 Favored Glycine 0 C--N 1.334 0.464 0 C-N-CA 121.2 -0.524 . . . . 0.35 112.659 179.528 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 40.8 ttt-85 -62.55 -48.93 77.34 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 117.022 0.411 . . . . 0.96 110.907 179.24 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 189' ' ' ARG . . . . . 0.749 ' HB3' HG11 ' A' ' 297' ' ' VAL . 34.8 mtp180 -66.28 -41.28 90.05 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.218 -0.446 . . . . 0.5 111.264 179.515 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -68.91 -45.86 69.8 Favored 'General case' 0 C--O 1.219 -0.504 0 CA-C-N 116.177 -0.465 . . . . 0.36 111.836 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 191' ' ' LEU . . . . . 0.447 ' HB2' ' O ' ' A' ' 187' ' ' GLY . 0.9 OUTLIER -59.37 -45.78 90.49 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.626 0.25 . . . . 0.66 111.22 179.505 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -62.34 -49.67 74.67 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 121.101 0.477 . . . . 0.59 111.172 179.389 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 193' ' ' THR . . . . . 0.42 HG21 ' HA ' ' A' ' 297' ' ' VAL . 25.7 m -66.04 -51.2 60.43 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.01 -0.541 . . . . 0.52 111.7 -179.533 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 194' ' ' LEU . . . . . 0.514 HD21 HG21 ' A' ' 249' ' ' ILE . 12.6 tp -58.27 -40.4 81.76 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.222 -0.445 . . . . 0.35 111.736 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 195' ' ' ARG . . . . . 0.906 ' HA ' ' HE1' ' A' ' 166' ' ' TYR . 43.4 ttm180 -61.31 -53.58 54.95 Favored 'General case' 0 N--CA 1.461 0.121 0 CA-C-O 120.606 0.241 . . . . 0.85 110.705 178.912 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 22.9 ttm105 -60.96 -50.17 74.48 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.24 -0.437 . . . . 0.46 112.149 -179.436 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 197' ' ' VAL . . . . . 0.518 HG12 HG11 ' A' ' 246' ' ' VAL . 53.3 t -65.51 -48.71 81.85 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 N-CA-C 111.996 0.369 . . . . 0.38 111.996 -179.351 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 198' ' ' GLY . . . . . 0.539 ' HA3' ' OH ' ' A' ' 166' ' ' TYR . . . -61.5 -42.93 99.87 Favored Glycine 0 C--N 1.334 0.432 0 C-N-CA 121.108 -0.568 . . . . 0.32 113.03 -179.598 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 199' ' ' ASP . . . . . 0.427 ' HB2' ' O ' ' A' ' 195' ' ' ARG . 0.8 OUTLIER -62.33 -45.11 94.7 Favored 'General case' 0 N--CA 1.46 0.074 0 N-CA-C 109.564 -0.532 . . . . 0.89 109.564 178.617 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -61.22 -42.78 99.88 Favored Glycine 0 C--N 1.337 0.605 0 C-N-CA 120.841 -0.695 . . . . 0.3 111.917 178.399 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 201' ' ' VAL . . . . . 0.47 HG23 ' O ' ' A' ' 197' ' ' VAL . 67.4 t -62.34 -47.69 91.88 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-O 120.593 0.235 . . . . 0.38 110.936 178.536 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 202' ' ' GLN . . . . . 0.408 ' OE1' ' HD1' ' A' ' 254' ' ' PHE . 37.6 mt-30 -65.78 -41.32 92.14 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.353 -0.385 . . . . 0.38 111.476 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.64 -37.3 85.82 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.03 0.443 . . . . 0.65 110.546 179.077 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 18.0 m-80 -78.18 -52.37 8.8 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.155 -0.475 . . . . 0.62 111.477 179.468 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 205' ' ' HIS . . . . . 0.441 ' ND1' HG12 ' B' ' 30' ' ' ILE . 75.4 m-70 -92.18 35.86 0.99 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.743 0.306 . . . . 0.68 111.306 -179.373 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -58.29 -49.68 76.28 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.424 0.527 . . . . 0.56 112.424 -179.015 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 69.2 p -60.49 -39.31 87.21 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.896 0.379 . . . . 0.5 111.722 -179.538 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -66.65 -50.38 63.13 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-N 115.915 -0.584 . . . . 0.33 110.78 179.561 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 209' ' ' PHE . . . . . 0.46 ' HB3' ' CD2' ' A' ' 254' ' ' PHE . 31.0 m-85 -63.17 -41.09 99.17 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.882 -0.599 . . . . 0.5 110.495 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 12.0 mt-30 -59.48 -45.44 91.66 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-N 116.103 -0.498 . . . . 0.54 111.408 179.245 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -55.77 -50.17 62.28 Favored Glycine 0 C--N 1.334 0.461 0 C-N-CA 120.644 -0.789 . . . . 0.33 111.645 179.261 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 212' ' ' MET . . . . . 0.603 ' HG2' ' HA ' ' B' ' 23' ' ' PHE . 6.6 mtp -64.65 -37.08 86.35 Favored 'General case' 0 C--O 1.225 -0.212 0 CA-C-O 120.561 0.22 . . . . 0.54 111.012 178.898 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.456 HD11 ' HA ' ' A' ' 255' ' ' VAL . 6.6 tp -67.49 -42.97 82.03 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 112.022 0.378 . . . . 0.61 112.022 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 214' ' ' ARG . . . . . 0.457 HH11 ' HD3' ' A' ' 214' ' ' ARG . 40.3 mtt180 -61.6 -40.05 93.42 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.932 0.396 . . . . 1.13 110.833 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 215' ' ' LYS . . . . . 0.53 ' HE2' ' HA ' ' A' ' 215' ' ' LYS . 0.0 OUTLIER -95.85 13.36 26.97 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.85 -0.34 . . . . 0.55 111.03 178.584 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 11.3 tp -78.34 100.04 6.59 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.891 0.377 . . . . 0.55 110.398 179.222 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.73 33.06 0.42 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.28 -0.418 . . . . 0.51 111.957 -179.365 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 218' ' ' ILE . . . . . 0.684 HG12 ' HB3' ' A' ' 223' ' ' ASP . 47.6 mt -87.53 119.08 34.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.766 0.317 . . . . 0.48 110.66 179.278 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.63 -15.32 0.73 Allowed 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 112.772 0.656 . . . . 0.52 112.772 -179.204 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 220' ' ' ASN . . . . . 0.41 ' HA ' ' CE1' ' A' ' 267' ' ' PHE . 7.4 p30 -132.31 -178.37 4.88 Favored 'General case' 0 CA--C 1.541 0.613 0 O-C-N 122.002 -0.436 . . . . 0.55 112.154 -179.663 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 221' ' ' GLU . . . . . 0.573 ' O ' HG22 ' A' ' 224' ' ' VAL . 1.9 mp0 -69.59 -21.99 63.55 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 112.902 0.704 . . . . 0.73 112.902 -178.952 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -72.6 -26.86 70.55 Favored Glycine 0 CA--C 1.523 0.551 0 C-N-CA 120.66 -0.781 . . . . 0.47 112.685 179.592 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 223' ' ' ASP . . . . . 0.684 ' HB3' HG12 ' A' ' 218' ' ' ILE . 61.2 m-20 -65.52 -30.48 71.24 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 112.128 0.418 . . . . 0.56 112.128 -179.624 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.573 HG22 ' O ' ' A' ' 221' ' ' GLU . 4.1 m -56.39 -28.25 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 N-CA-C 111.878 0.325 . . . . 0.47 111.878 179.612 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 225' ' ' LYS . . . . . 0.473 ' HD2' ' H ' ' A' ' 225' ' ' LYS . 7.7 mptt -64.67 -36.79 85.4 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.192 0.52 . . . . 0.73 110.037 178.587 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 226' ' ' SER . . . . . 0.509 ' O ' HG23 ' A' ' 230' ' ' VAL . 7.8 t -69.31 -35.02 75.56 Favored 'General case' 0 N--CA 1.462 0.148 0 N-CA-C 108.901 -0.777 . . . . 0.45 108.901 177.932 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 227' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -61.74 -37.63 84.96 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 115.269 -0.878 . . . . 0.44 109.601 177.844 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 228' ' ' SER . . . . . 0.4 ' O ' HG22 ' A' ' 232' ' ' VAL . 69.1 m -66.37 -40.43 89.73 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.093 -0.503 . . . . 0.45 109.804 178.036 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 73.0 mtp180 -58.13 -37.66 75.03 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.031 -0.531 . . . . 0.86 110.381 178.682 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 230' ' ' VAL . . . . . 0.582 HG13 ' HA ' ' B' ' 24' ' ' ALA . 36.3 t -66.32 -46.74 86.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.946 -0.57 . . . . 0.37 110.107 178.337 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 231' ' ' MET . . . . . 0.514 ' HE1' ' HA ' ' A' ' 275' ' ' ILE . 60.3 mtm -63.94 -48.35 76.85 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.017 -0.538 . . . . 0.46 111.852 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 232' ' ' VAL . . . . . 0.4 HG22 ' O ' ' A' ' 228' ' ' SER . 31.1 m -62.9 -31.24 51.75 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 C-N-CA 120.585 -0.446 . . . . 0.38 110.508 179.048 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 233' ' ' HIS . . . . . 0.479 ' ND1' ' HB1' ' B' ' 24' ' ' ALA . 2.0 t-80 -67.91 -44.44 76.92 Favored 'General case' 0 CA--C 1.528 0.125 0 N-CA-C 109.126 -0.694 . . . . 0.32 109.126 177.109 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.536 ' HA ' ' HG3' ' B' ' 28' ' ' ARG . 51.2 t -56.46 -42.46 75.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 CA-C-N 115.775 -0.648 . . . . 0.43 110.78 179.633 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -99.79 23.74 9.28 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.001 0.371 . . . . 0.6 112.001 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 2.6 ttpp -73.01 -13.73 61.28 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.799 0.333 . . . . 1.13 111.361 179.737 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -86.16 -16.21 38.57 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 120.88 0.371 . . . . 0.62 110.988 179.527 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 92.48 -19.08 52.82 Favored Glycine 0 CA--C 1.524 0.636 0 C-N-CA 121.032 -0.604 . . . . 0.4 113.84 179.179 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 6.1 p -83.9 117.25 29.19 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-O 121.625 0.726 . . . . 0.5 111.727 -179.462 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 240' ' ' THR . . . . . 0.411 HG21 ' HG2' ' A' ' 283' ' ' LYS . 10.8 m -94.9 117.3 29.91 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.057 0.456 . . . . 0.4 111.577 179.764 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 73.8 m-20 -113.48 141.54 47.0 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.5 -0.318 . . . . 0.58 110.639 179.157 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 242' ' ' TRP . . . . . 0.529 ' CZ3' ' HB2' ' A' ' 296' ' ' PHE . 24.8 m95 -60.02 -42.4 94.28 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 120.721 0.296 . . . . 0.38 110.424 178.419 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 243' ' ' GLY . . . . . 0.434 ' HA3' ' N ' ' B' ' 35' ' ' TYR . . . -60.26 -33.31 79.81 Favored Glycine 0 C--N 1.336 0.531 0 C-N-CA 120.967 -0.635 . . . . 0.27 111.816 178.187 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 244' ' ' ARG . . . . . 0.503 ' HA ' ' HA3' ' B' ' 31' ' ' GLY . 50.1 mtt180 -69.25 -51.43 37.7 Favored 'General case' 0 C--O 1.232 0.153 0 N-CA-C 109.569 -0.53 . . . . 0.39 109.569 178.099 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 245' ' ' ILE . . . . . 0.527 HG23 HD21 ' A' ' 279' ' ' LEU . 83.1 mt -55.94 -48.32 78.73 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 CA-C-N 115.582 -0.735 . . . . 0.44 110.89 179.455 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 246' ' ' VAL . . . . . 0.518 HG11 HG12 ' A' ' 197' ' ' VAL . 96.1 t -64.69 -32.32 57.46 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-N 116.471 -0.331 . . . . 0.59 110.984 179.46 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 247' ' ' THR . . . . . 0.497 HG22 HD22 ' B' ' 27' ' ' LEU . 20.2 m -63.35 -44.35 95.07 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.611 0.243 . . . . 0.35 110.448 178.893 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 248' ' ' LEU . . . . . 0.502 HD22 ' HG2' ' A' ' 231' ' ' MET . 54.2 mt -62.2 -41.2 98.15 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.396 0.617 . . . . 0.47 109.857 178.454 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 249' ' ' ILE . . . . . 0.514 HG21 HD21 ' A' ' 194' ' ' LEU . 27.8 mt -66.45 -39.98 85.38 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 CA-C-N 115.782 -0.644 . . . . 0.45 110.013 178.115 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 49.4 m -62.91 -41.77 99.56 Favored 'General case' 0 N--CA 1.461 0.115 0 N-CA-C 109.148 -0.686 . . . . 0.39 109.148 178.154 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 251' ' ' PHE . . . . . 0.502 ' CD2' HD11 ' B' ' 27' ' ' LEU . 8.7 t80 -62.14 -42.17 98.99 Favored 'General case' 0 C--O 1.226 -0.15 0 N-CA-C 108.821 -0.807 . . . . 0.41 108.821 177.518 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -57.68 -46.79 91.79 Favored Glycine 0 C--N 1.335 0.527 0 N-CA-C 111.053 -0.819 . . . . 0.27 111.053 177.451 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 253' ' ' ALA . . . . . 0.486 ' O ' ' HG3' ' A' ' 257' ' ' LYS . . . -64.34 -35.33 80.53 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 120.617 0.246 . . . . 0.31 111.245 177.627 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 254' ' ' PHE . . . . . 0.46 ' CD2' ' HB3' ' A' ' 209' ' ' PHE . 2.5 t80 -71.07 -43.76 67.11 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 120.617 0.246 . . . . 0.78 111.25 179.373 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 255' ' ' VAL . . . . . 0.456 ' HA ' HD11 ' A' ' 213' ' ' LEU . 23.7 m -68.04 -34.58 67.7 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.109 0 N-CA-C 109.354 -0.61 . . . . 0.36 109.354 178.269 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -60.91 -36.72 80.0 Favored 'General case' 0 C--O 1.227 -0.127 0 N-CA-C 109.371 -0.604 . . . . 0.32 109.371 177.009 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 257' ' ' LYS . . . . . 0.486 ' HG3' ' O ' ' A' ' 253' ' ' ALA . 59.3 mttp -62.42 -45.66 92.08 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 109.608 -0.515 . . . . 0.58 109.608 177.24 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 258' ' ' HIS . . . . . 0.429 ' HB2' HD11 ' A' ' 213' ' ' LEU . 22.2 t60 -60.76 -36.58 79.29 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.722 -0.672 . . . . 0.79 110.774 179.363 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 78.4 mt -74.95 -45.05 44.89 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.301 -0.408 . . . . 0.62 110.662 178.663 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 1.5 tptp -62.19 -34.82 77.18 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 120.717 0.294 . . . . 0.46 110.838 179.359 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 49.2 m -63.12 -24.31 67.84 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.254 -0.43 . . . . 0.52 110.946 179.503 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 262' ' ' VAL . . . . . 0.553 HG23 ' HG3' ' A' ' 264' ' ' GLN . 16.0 m -114.88 19.03 7.34 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-N 116.239 -0.437 . . . . 0.63 110.882 178.93 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 57.44 52.37 8.68 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 113.073 0.768 . . . . 1.15 113.073 179.417 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 264' ' ' GLN . . . . . 0.553 ' HG3' HG23 ' A' ' 262' ' ' VAL . 72.9 mt-30 -119.72 36.26 4.57 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 112.087 0.402 . . . . 0.75 112.087 179.332 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 265' ' ' GLU . . . . . 0.482 ' HA ' HD12 ' A' ' 268' ' ' ILE . 2.2 pm0 -57.74 -23.73 53.49 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-O 120.828 0.347 . . . . 0.62 111.656 179.061 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 54.4 p -61.62 -21.18 64.13 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.016 -0.538 . . . . 0.7 110.403 178.313 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 267' ' ' PHE . . . . . 0.509 ' C ' ' HD2' ' A' ' 270' ' ' PRO . 90.8 m-85 -95.3 -20.25 19.32 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 116.093 -0.503 . . . . 0.66 110.578 178.594 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 268' ' ' ILE . . . . . 0.482 HD12 ' HA ' ' A' ' 265' ' ' GLU . 78.6 mt -67.31 -41.16 86.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-N 116.26 -0.427 . . . . 0.42 110.078 178.574 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 269' ' ' GLU . . . . . 0.771 ' HB2' ' HD3' ' A' ' 270' ' ' PRO . 2.2 mm-40 -53.8 -56.4 25.75 Favored Pre-proline 0 CA--C 1.546 0.789 0 CA-C-N 116.089 -0.505 . . . . 0.76 111.122 178.591 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 270' ' ' PRO . . . . . 0.771 ' HD3' ' HB2' ' A' ' 269' ' ' GLU . 33.4 Cg_exo -62.23 -30.29 81.44 Favored 'Trans proline' 0 C--N 1.362 1.268 0 C-N-CA 122.139 1.892 . . . . 0.42 111.675 177.708 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 271' ' ' LEU . . . . . 0.404 ' HA ' HD23 ' A' ' 271' ' ' LEU . 4.3 mt -62.69 -50.41 71.24 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.286 -0.416 . . . . 0.71 110.045 177.922 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -56.29 -36.39 68.59 Favored 'General case' 0 N--CA 1.461 0.111 0 CA-C-N 116.147 -0.479 . . . . 0.45 110.825 179.143 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 273' ' ' GLU . . . . . 0.634 ' HA ' HD21 ' A' ' 160' ' ' LEU . 1.2 mm-40 -72.39 -50.79 23.96 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.102 -0.499 . . . . 1.39 110.658 178.381 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 274' ' ' THR . . . . . 0.487 HG21 ' HB ' ' A' ' 224' ' ' VAL . 25.3 m -58.45 -45.97 87.48 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.297 -0.41 . . . . 0.54 111.8 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 275' ' ' ILE . . . . . 0.514 ' HA ' ' HE1' ' A' ' 231' ' ' MET . 92.0 mt -63.77 -55.33 23.1 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 CA-C-N 116.558 -0.292 . . . . 0.49 111.089 179.842 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 22.0 m -58.08 -47.71 82.35 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.26 -0.427 . . . . 0.36 111.604 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 277' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -50.98 -58.64 5.53 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.385 -0.371 . . . . 0.54 111.7 179.747 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 61.4 t -64.65 -39.52 85.9 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 N-CA-C 111.816 0.302 . . . . 0.49 111.816 -179.78 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 279' ' ' LEU . . . . . 0.527 HD21 HG23 ' A' ' 245' ' ' ILE . 51.3 tp -64.59 -47.21 79.49 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 112.582 0.586 . . . . 0.74 112.582 -179.123 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 86.1 t -73.61 -46.78 47.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 N-CA-C 112.826 0.676 . . . . 0.49 112.826 -178.703 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 39.4 mtm105 -62.01 -43.61 98.48 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 112.533 0.568 . . . . 0.57 112.533 -178.892 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 282' ' ' THR . . . . . . . . . . . . . 68.6 p -69.16 -15.19 63.35 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 112.111 0.412 . . . . 0.33 112.111 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 283' ' ' LYS . . . . . 0.51 ' HB3' HD23 ' A' ' 287' ' ' LEU . 0.1 OUTLIER -128.23 36.53 4.28 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 111.723 0.268 . . . . 0.62 111.723 -179.566 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 36.3 ttm180 -53.17 -54.24 38.83 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 112.607 0.595 . . . . 1.07 112.607 -179.767 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -66.99 -33.96 76.7 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 111.862 0.319 . . . . 0.63 111.862 -178.923 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 286' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -70.14 -39.75 75.19 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.013 0.435 . . . . 0.72 110.489 179.647 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 287' ' ' LEU . . . . . 0.563 HD13 ' HA2' ' A' ' 292' ' ' GLY . 1.9 mm? -65.99 -46.77 76.8 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 115.878 -0.601 . . . . 0.5 111.587 179.782 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 30.8 m -65.83 -31.6 54.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 C-N-CA 121.003 -0.279 . . . . 0.44 111.41 179.821 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 26.2 mtmm -72.28 -32.79 66.94 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 112.384 0.513 . . . . 0.97 112.384 179.585 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -101.73 15.45 28.91 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 112.683 0.623 . . . . 0.96 112.683 -179.231 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 291' ' ' ARG . . . . . 0.624 ' HB3' ' HB2' ' A' ' 294' ' ' ASP . 0.0 OUTLIER 59.92 24.13 13.21 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-O 121.174 0.511 . . . . 0.64 112.106 179.734 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 292' ' ' GLY . . . . . 0.563 ' HA2' HD13 ' A' ' 287' ' ' LEU . . . 58.4 -117.87 11.88 Favored Glycine 0 CA--C 1.522 0.494 0 CA-C-N 115.615 -0.721 . . . . 0.32 114.795 179.446 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 293' ' ' TRP . . . . . 0.412 ' O ' HG23 ' A' ' 297' ' ' VAL . 83.9 m95 -67.19 -33.51 75.55 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 112.808 0.67 . . . . 0.49 112.808 -178.368 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 294' ' ' ASP . . . . . 0.624 ' HB2' ' HB3' ' A' ' 291' ' ' ARG . 60.7 m-20 -53.09 -49.76 65.79 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 118.026 0.375 . . . . 0.46 111.098 179.143 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -65.02 -50.43 57.79 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.687 -0.768 . . . . 0.33 111.488 178.522 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 296' ' ' PHE . . . . . 0.529 ' HB2' ' CZ3' ' A' ' 242' ' ' TRP . 0.4 OUTLIER -53.58 -45.0 69.83 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 122.586 0.354 . . . . 0.38 111.766 179.212 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 297' ' ' VAL . . . . . 0.749 HG11 ' HB3' ' A' ' 189' ' ' ARG . 52.0 t -63.4 -53.59 43.54 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 N-CA-C 112.351 0.5 . . . . 0.34 112.351 -178.679 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.74 -26.89 63.57 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.617 -0.433 . . . . 0.45 111.911 -179.255 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 299' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -62.5 -44.16 97.06 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 109.848 -0.427 . . . . 0.51 109.848 177.852 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 300' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 . . . . . 0 CA--C 1.532 0.278 0 CA-C-O 121.344 0.593 . . . . 0.58 110.841 178.909 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 22' ' ' GLU . . . . . 0.492 ' O ' ' HB2' ' B' ' 26' ' ' GLN . 3.4 mm-40 . . . . . 0 CA--C 1.533 0.325 0 N-CA-C 112.02 0.378 . . . . 0.41 112.02 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 23' ' ' PHE . . . . . 0.603 ' HA ' ' HG2' ' A' ' 212' ' ' MET . 0.8 OUTLIER -68.97 -40.78 78.65 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 120.222 -0.591 . . . . 0.42 110.929 179.166 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 24' ' ' ALA . . . . . 0.582 ' HA ' HG13 ' A' ' 230' ' ' VAL . . . -70.5 -39.44 74.14 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.552 0.691 . . . . 0.34 109.767 179.371 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.79 -46.61 78.08 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 114.905 -1.043 . . . . 0.31 109.993 178.231 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 26' ' ' GLN . . . . . 0.492 ' HB2' ' O ' ' B' ' 22' ' ' GLU . 0.8 OUTLIER -58.83 -53.89 53.24 Favored 'General case' 0 C--O 1.224 -0.268 0 CA-C-N 116.159 -0.473 . . . . 0.35 111.323 179.504 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 27' ' ' LEU . . . . . 0.502 HD11 ' CD2' ' A' ' 251' ' ' PHE . 19.3 mt -54.74 -36.42 64.77 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.641 0.258 . . . . 0.43 110.938 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 28' ' ' ARG . . . . . 0.536 ' HG3' ' HA ' ' A' ' 234' ' ' VAL . 0.2 OUTLIER -70.59 -53.24 16.76 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.539 -0.3 . . . . 0.52 110.204 178.102 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 21.4 mttt -53.28 -47.76 68.89 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.251 0.548 . . . . 0.44 110.614 179.056 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 30' ' ' ILE . . . . . 0.441 HG12 ' ND1' ' A' ' 205' ' ' HIS . 84.8 mt -64.25 -45.22 96.83 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 CA-C-N 115.331 -0.85 . . . . 0.39 110.603 179.626 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 31' ' ' GLY . . . . . 0.503 ' HA3' ' HA ' ' A' ' 244' ' ' ARG . . . -57.84 -49.37 75.07 Favored Glycine 0 C--N 1.334 0.419 0 C-N-CA 120.974 -0.631 . . . . 0.29 112.749 179.736 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -62.26 -42.76 99.62 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 121.17 0.51 . . . . 0.41 110.279 179.334 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.69 -57.45 10.97 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.792 -0.64 . . . . 1.15 111.784 179.646 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 71.1 t -54.53 -44.14 67.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 O-C-N 123.308 0.38 . . . . 0.43 111.268 -179.861 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 35' ' ' TYR . . . . . 0.434 ' N ' ' HA3' ' A' ' 243' ' ' GLY . 0.6 OUTLIER -56.77 -43.48 80.88 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 121.044 0.449 . . . . 0.79 110.477 178.699 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 36' ' ' CYS . . . . . . . . . . . . . 66.0 m -68.95 -40.97 78.62 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.352 -0.385 . . . . 0.39 111.418 179.6 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 8.4 m -59.13 -40.83 86.68 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 113.091 0.774 . . . . 0.44 113.091 -179.68 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 38' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -83.6 -36.67 23.74 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 112.42 0.526 . . . . 0.54 112.42 -178.812 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 65.9 p . . . . . 0 N--CA 1.467 0.402 0 CA-C-O 120.727 0.298 . . . . 0.45 110.762 179.147 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 153' ' ' ASP . . . . . 0.541 ' HA ' ' HB3' ' A' ' 156' ' ' TYR . 1.0 OUTLIER . . . . . 0 N--CA 1.465 0.301 0 CA-C-O 120.784 0.326 . . . . 0.0 111.189 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -62.78 -43.67 98.18 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.16 178.972 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 48.4 tp -77.56 -36.5 52.09 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 178.048 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 156' ' ' TYR . . . . . 0.541 ' HB3' ' HA ' ' A' ' 153' ' ' ASP . 69.7 t80 -58.54 -38.22 77.35 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 115.105 -0.952 . . . . 0.0 111.739 179.575 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 157' ' ' ARG . . . . . 0.539 ' HD2' ' OE2' ' A' ' 161' ' ' GLU . 0.0 OUTLIER -56.46 -53.04 62.12 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.999 0.428 . . . . 0.0 110.352 178.976 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 158' ' ' GLN . . . . . 0.455 ' HG2' ' HB2' ' A' ' 183' ' ' ALA . 92.2 mt-30 -68.44 -37.46 80.26 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.58 179.166 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 41.4 m -57.83 -50.69 72.43 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.367 179.266 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.516 ' HA ' HG21 ' A' ' 276' ' ' THR . 2.3 tm? -58.69 -47.43 84.56 Favored 'General case' 0 C--O 1.225 -0.232 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.451 178.968 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 161' ' ' GLU . . . . . 0.539 ' OE2' ' HD2' ' A' ' 157' ' ' ARG . 30.8 mt-10 -60.52 -51.1 70.89 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 111.949 0.352 . . . . 0.0 111.949 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 162' ' ' ILE . . . . . 0.517 HG12 ' HA2' ' A' ' 187' ' ' GLY . 46.2 mt -58.87 -51.68 69.37 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 CA-C-O 120.636 0.255 . . . . 0.0 111.145 179.633 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.603 ' O ' ' HG ' ' A' ' 167' ' ' LEU . 89.5 mt -62.04 -48.08 90.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-N 116.646 -0.252 . . . . 0.0 111.414 179.589 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 164' ' ' SER . . . . . 0.54 ' O ' ' HB2' ' A' ' 168' ' ' ARG . 1.2 t -57.7 -42.34 83.5 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 120.751 0.31 . . . . 0.0 111.322 179.452 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 165' ' ' ARG . . . . . 0.445 ' HA ' ' HD3' ' A' ' 165' ' ' ARG . 5.7 tpp180 -72.37 -37.0 68.87 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 121.08 -0.248 . . . . 0.0 111.225 179.758 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 166' ' ' TYR . . . . . 0.829 ' CE1' ' HA ' ' A' ' 195' ' ' ARG . 39.1 t80 -66.27 -52.79 44.01 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.679 -0.237 . . . . 0.0 111.622 179.768 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.603 ' HG ' ' O ' ' A' ' 163' ' ' ILE . 20.7 mt -61.95 -40.6 96.1 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.712 -0.222 . . . . 0.0 110.789 -179.728 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 168' ' ' ARG . . . . . 0.54 ' HB2' ' O ' ' A' ' 164' ' ' SER . 0.5 OUTLIER -62.15 -44.44 96.61 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 120.953 0.406 . . . . 0.0 110.506 179.215 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -60.83 -48.11 83.29 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.164 178.613 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 6.8 mm-40 -61.55 -43.49 98.76 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.149 179.126 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.265 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -179.074 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.524 ' O ' ' HA3' ' A' ' 187' ' ' GLY . . . . . . . . 0 CA--C 1.533 0.323 0 CA-C-O 121.092 0.472 . . . . 0.0 111.029 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -79.89 -70.5 1.33 Allowed Glycine 0 CA--C 1.524 0.595 0 C-N-CA 121.069 -0.586 . . . . 0.0 113.961 -179.588 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -63.92 -55.51 22.1 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 111.998 0.37 . . . . 0.0 111.998 -178.959 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -68.0 -33.68 75.09 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.354 179.581 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 187' ' ' GLY . . . . . 0.524 ' HA3' ' O ' ' A' ' 183' ' ' ALA . . . -66.94 -41.62 93.22 Favored Glycine 0 C--O 1.225 -0.429 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.559 178.747 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 3.9 tpt180 -63.01 -53.9 46.7 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 120.615 0.245 . . . . 0.0 111.279 179.202 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 189' ' ' ARG . . . . . 0.408 HH11 ' HD3' ' A' ' 189' ' ' ARG . 28.0 mtp180 -62.79 -44.04 97.21 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.592 -179.728 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -70.3 -48.77 55.15 Favored 'General case' 0 C--O 1.22 -0.468 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -179.166 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 19.3 tp -60.19 -42.83 95.9 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 118.359 0.527 . . . . 0.0 111.746 -179.659 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -63.69 -46.02 87.41 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 121.136 0.493 . . . . 0.0 110.934 179.657 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 34.3 m -68.4 -45.48 72.55 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.889 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 194' ' ' LEU . . . . . 0.526 HD21 HG21 ' A' ' 249' ' ' ILE . 12.3 tp -59.77 -37.43 79.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.084 -179.636 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 195' ' ' ARG . . . . . 0.829 ' HA ' ' CE1' ' A' ' 166' ' ' TYR . 11.5 ttp180 -70.8 -53.36 15.65 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.508 179.034 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 196' ' ' ARG . . . . . 0.4 ' C ' ' HD3' ' A' ' 196' ' ' ARG . 0.0 OUTLIER -59.36 -48.2 82.52 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.888 -179.935 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 197' ' ' VAL . . . . . 0.62 HG21 ' HB3' ' A' ' 300' ' ' PHE . 73.5 t -70.89 -47.92 59.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.334 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 198' ' ' GLY . . . . . 0.462 ' O ' ' HG2' ' A' ' 202' ' ' GLN . . . -56.19 -43.51 89.0 Favored Glycine 0 C--N 1.338 0.645 0 N-CA-C 111.371 -0.691 . . . . 0.0 111.371 179.367 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 199' ' ' ASP . . . . . 0.534 ' HB2' ' O ' ' A' ' 195' ' ' ARG . 0.4 OUTLIER -58.26 -48.5 80.25 Favored 'General case' 0 C--O 1.226 -0.138 0 O-C-N 123.963 0.449 . . . . 0.0 109.83 177.951 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -62.89 -41.17 99.93 Favored Glycine 0 CA--C 1.524 0.597 0 C-N-CA 121.085 -0.579 . . . . 0.0 112.601 179.247 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 201' ' ' VAL . . . . . 0.716 HG13 HG21 ' B' ' 34' ' ' VAL . 70.3 t -58.06 -51.7 67.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 CA-C-O 120.786 0.327 . . . . 0.0 111.127 179.254 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 202' ' ' GLN . . . . . 0.551 ' HG3' ' CZ ' ' A' ' 203' ' ' ARG . 1.2 pt20 -72.35 -31.68 65.83 Favored 'General case' 0 C--O 1.222 -0.36 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.404 179.745 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 203' ' ' ARG . . . . . 0.551 ' CZ ' ' HG3' ' A' ' 202' ' ' GLN . 0.0 OUTLIER -66.73 -38.97 87.73 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 121.247 0.546 . . . . 0.0 109.793 177.739 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -62.3 -54.21 43.94 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.968 179.17 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 205' ' ' HIS . . . . . 0.718 ' CD2' HG12 ' B' ' 30' ' ' ILE . 41.4 m80 -101.66 37.79 1.75 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.968 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 206' ' ' GLU . . . . . 0.403 ' OE1' ' HA ' ' A' ' 203' ' ' ARG . 3.3 tp10 -48.02 -47.73 33.21 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -178.883 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -61.97 -41.62 98.21 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -73.08 -47.33 45.45 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.901 0.382 . . . . 0.0 111.149 -179.806 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 209' ' ' PHE . . . . . 0.52 ' CD2' ' HA ' ' A' ' 202' ' ' GLN . 8.5 m-85 -60.62 -45.13 95.2 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.534 178.887 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 210' ' ' GLN . . . . . 0.685 ' O ' ' HG2' ' A' ' 214' ' ' ARG . 27.8 mt-30 -68.01 -44.0 77.55 Favored 'General case' 0 C--O 1.225 -0.199 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.021 179.216 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -55.29 -50.81 58.05 Favored Glycine 0 C--N 1.335 0.507 0 C-N-CA 120.723 -0.751 . . . . 0.0 111.953 179.343 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 212' ' ' MET . . . . . 0.456 ' HG2' ' HB3' ' B' ' 23' ' ' PHE . 0.8 OUTLIER -64.25 -29.65 70.74 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.672 0.272 . . . . 0.0 110.799 178.623 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.49 HD12 HD22 ' A' ' 216' ' ' LEU . 8.4 tp -73.83 -42.33 61.03 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.488 179.334 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 214' ' ' ARG . . . . . 0.685 ' HG2' ' O ' ' A' ' 210' ' ' GLN . 16.4 mmt85 -61.39 -37.19 82.51 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.184 0.516 . . . . 0.0 109.751 178.814 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.71 12.52 31.62 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.992 178.624 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 216' ' ' LEU . . . . . 0.78 ' HG ' HG12 ' A' ' 218' ' ' ILE . 16.2 tp -77.52 103.69 7.6 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 121.127 0.489 . . . . 0.0 110.037 179.027 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -81.71 33.03 0.36 Allowed 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 113.032 0.753 . . . . 0.0 113.032 -178.395 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 218' ' ' ILE . . . . . 0.78 HG12 ' HG ' ' A' ' 216' ' ' LEU . 50.8 mm -81.64 107.41 13.75 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-O 120.728 0.299 . . . . 0.0 110.326 178.894 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.59 -19.31 0.53 Allowed 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 -178.865 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -112.63 179.6 3.93 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -179.088 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 221' ' ' GLU . . . . . 0.549 ' O ' HG22 ' A' ' 224' ' ' VAL . 15.6 tm-20 -68.59 -40.74 80.38 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.775 179.587 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -58.16 -26.43 58.66 Favored Glycine 0 CA--C 1.524 0.607 0 C-N-CA 121.297 -0.478 . . . . 0.0 113.169 179.673 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 223' ' ' ASP . . . . . 0.566 ' HB3' HD12 ' A' ' 218' ' ' ILE . 40.2 m-20 -59.34 -30.5 68.42 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 112.94 0.719 . . . . 0.0 112.94 -179.586 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.549 HG22 ' O ' ' A' ' 221' ' ' GLU . 11.8 m -62.87 -29.17 46.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 CA-C-O 120.991 0.424 . . . . 0.0 110.828 179.444 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 225' ' ' LYS . . . . . 0.548 ' O ' ' HG2' ' A' ' 229' ' ' ARG . 23.5 mttp -71.32 -31.75 67.77 Favored 'General case' 0 C--O 1.232 0.15 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 179.027 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 226' ' ' SER . . . . . 0.584 ' O ' HG23 ' A' ' 230' ' ' VAL . 3.8 m -65.22 -44.96 86.61 Favored 'General case' 0 C--N 1.335 -0.062 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 177.97 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 227' ' ' PHE . . . . . 0.478 ' HE2' HG21 ' A' ' 255' ' ' VAL . 8.7 t80 -61.94 -36.45 81.42 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.822 178.607 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 13.0 t -61.9 -41.38 97.83 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.714 177.793 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 229' ' ' ARG . . . . . 0.548 ' HG2' ' O ' ' A' ' 225' ' ' LYS . 5.7 mmp_? -70.03 -43.8 70.55 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.439 179.035 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 230' ' ' VAL . . . . . 0.584 HG23 ' O ' ' A' ' 226' ' ' SER . 60.5 t -58.66 -47.72 87.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 178.523 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 231' ' ' MET . . . . . 0.953 ' HG3' ' HG ' ' A' ' 248' ' ' LEU . 36.5 ttm -53.09 -53.79 45.14 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.41 178.784 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 96.8 t -59.36 -44.85 93.38 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.755 179.711 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 233' ' ' HIS . . . . . 0.45 ' O ' ' HB2' ' A' ' 236' ' ' LYS . 2.0 t-80 -57.29 -33.95 68.18 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.512 HG23 ' O ' ' A' ' 230' ' ' VAL . 89.1 t -56.31 -32.1 34.44 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 O-C-N 121.917 -0.489 . . . . 0.0 111.623 179.683 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -103.01 25.17 9.71 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.562 -179.822 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 236' ' ' LYS . . . . . 0.45 ' HB2' ' O ' ' A' ' 233' ' ' HIS . 0.6 OUTLIER -49.65 -35.79 22.49 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 -178.804 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 237' ' ' ASP . . . . . 0.45 ' HB2' HG12 ' A' ' 239' ' ' VAL . 0.0 OUTLIER -71.88 -16.07 62.12 Favored 'General case' 0 N--CA 1.468 0.447 0 O-C-N 122.153 -0.342 . . . . 0.0 111.466 -179.689 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 98.18 -18.74 56.64 Favored Glycine 0 CA--C 1.52 0.371 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.162 -178.93 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 239' ' ' VAL . . . . . 0.45 HG12 ' HB2' ' A' ' 237' ' ' ASP . 4.0 p -79.48 115.55 22.0 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 CA-C-O 121.746 0.784 . . . . 0.0 111.017 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 240' ' ' THR . . . . . 0.5 HG22 HD11 ' A' ' 245' ' ' ILE . 4.2 m -90.14 74.67 7.12 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.738 -179.208 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -65.91 135.0 54.18 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 121.076 -0.249 . . . . 0.0 110.401 178.913 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 242' ' ' TRP . . . . . 0.547 ' HB3' ' CE2' ' A' ' 300' ' ' PHE . 2.1 m95 -56.09 -37.76 69.8 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.922 0.391 . . . . 0.0 111.147 179.664 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -65.1 -25.33 70.89 Favored Glycine 0 C--N 1.336 0.57 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.713 179.277 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 93.3 mtt180 -75.31 -45.29 40.6 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 178.934 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 245' ' ' ILE . . . . . 0.5 HD11 HG22 ' A' ' 240' ' ' THR . 54.0 mt -57.05 -48.35 82.0 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.847 179.333 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 10.5 p -67.23 -33.18 61.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.909 179.121 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 20.6 m -62.28 -38.46 89.45 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 121.065 -0.254 . . . . 0.0 110.458 178.446 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 248' ' ' LEU . . . . . 0.953 ' HG ' ' HG3' ' A' ' 231' ' ' MET . 1.0 OUTLIER -63.59 -33.51 75.76 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.141 0.496 . . . . 0.0 110.413 178.337 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 249' ' ' ILE . . . . . 0.526 HG21 HD21 ' A' ' 194' ' ' LEU . 33.7 mm -76.84 -40.7 32.03 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.737 178.386 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 23.2 t -59.94 -44.79 94.15 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 178.128 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 251' ' ' PHE . . . . . 0.54 ' O ' HG23 ' A' ' 255' ' ' VAL . 22.7 t80 -66.82 -44.52 80.94 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.251 177.832 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -54.98 -42.92 82.36 Favored Glycine 0 C--N 1.34 0.754 0 N-CA-C 111.078 -0.809 . . . . 0.0 111.078 177.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 253' ' ' ALA . . . . . 0.603 ' O ' ' HG3' ' A' ' 257' ' ' LYS . . . -61.78 -46.37 89.85 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 115.551 -0.324 . . . . 0.0 110.201 177.294 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 254' ' ' PHE . . . . . 0.414 ' HB3' HD13 ' A' ' 213' ' ' LEU . 0.1 OUTLIER -58.27 -41.6 84.66 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 120.972 0.415 . . . . 0.0 110.289 178.591 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 255' ' ' VAL . . . . . 0.54 HG23 ' O ' ' A' ' 251' ' ' PHE . 64.0 t -62.38 -44.7 99.49 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-N 116.159 -0.473 . . . . 0.0 109.897 177.92 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -59.38 -42.76 92.41 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-O 121.02 0.438 . . . . 0.0 109.836 177.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 257' ' ' LYS . . . . . 0.603 ' HG3' ' O ' ' A' ' 253' ' ' ALA . 20.0 mtpp -62.06 -39.97 94.18 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.928 177.992 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 10.9 t60 -66.22 -43.44 86.64 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.367 178.359 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 75.2 mt -65.4 -39.44 92.19 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.466 178.591 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -68.54 -32.0 71.63 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 120.911 0.386 . . . . 0.0 110.008 178.357 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 66.4 m -59.44 -34.23 72.25 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.449 178.84 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 15.7 m -101.53 15.57 4.99 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.211 179.036 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 56.23 48.15 17.87 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 112.705 0.631 . . . . 0.0 112.705 179.655 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 66.7 mt-30 -118.67 37.71 3.99 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 120.887 0.375 . . . . 0.0 111.414 179.547 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 265' ' ' GLU . . . . . 0.54 ' HA ' HD12 ' A' ' 268' ' ' ILE . 0.0 OUTLIER -51.9 -26.49 10.33 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 179.843 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 50.6 p -59.88 -25.54 65.15 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 120.674 0.273 . . . . 0.0 111.126 179.064 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -88.91 -20.56 24.4 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 120.93 0.395 . . . . 0.0 110.592 178.714 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 268' ' ' ILE . . . . . 0.54 HD12 ' HA ' ' A' ' 265' ' ' GLU . 75.9 mt -67.85 -42.72 86.13 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.021 179.468 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 269' ' ' GLU . . . . . 0.778 ' HB3' ' HD3' ' A' ' 270' ' ' PRO . 9.4 tp10 -53.72 -57.08 18.99 Favored Pre-proline 0 CA--C 1.546 0.817 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.649 179.324 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 270' ' ' PRO . . . . . 0.778 ' HD3' ' HB3' ' A' ' 269' ' ' GLU . 24.9 Cg_exo -64.76 -33.81 52.59 Favored 'Trans proline' 0 C--N 1.36 1.184 0 C-N-CA 122.086 1.857 . . . . 0.0 111.878 178.536 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 271' ' ' LEU . . . . . . . . . . . . . 27.1 tp -63.96 -42.0 97.41 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.129 178.833 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -59.81 -48.89 79.87 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.483 178.797 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 273' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -63.77 -41.17 98.02 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.409 178.728 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 274' ' ' THR . . . . . 0.436 HG21 ' HB ' ' A' ' 224' ' ' VAL . 91.1 m -60.21 -48.93 79.64 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.052 178.664 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 96.7 mt -61.9 -50.68 79.16 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.684 178.411 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 276' ' ' THR . . . . . 0.523 HG23 HD12 ' A' ' 163' ' ' ILE . 27.8 m -58.66 -53.9 53.13 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -178.906 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 277' ' ' ASP . . . . . 0.577 ' O ' ' HB2' ' A' ' 281' ' ' ARG . 2.3 t70 -58.16 -54.02 51.72 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 120.873 -0.331 . . . . 0.0 111.496 -178.973 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 95.1 t -59.38 -34.8 55.42 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 CA-C-O 120.673 0.273 . . . . 0.0 111.177 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 279' ' ' LEU . . . . . 0.49 HD22 HD11 ' A' ' 249' ' ' ILE . 5.0 tp -65.09 -48.12 74.82 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 111.742 0.275 . . . . 0.0 111.742 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 42.5 t -78.68 -36.59 19.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -179.502 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 281' ' ' ARG . . . . . 0.577 ' HB2' ' O ' ' A' ' 277' ' ' ASP . 0.1 OUTLIER -65.95 -36.03 82.22 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -179.493 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 282' ' ' THR . . . . . . . . . . . . . 15.4 p -73.39 -52.06 15.14 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 120.885 0.374 . . . . 0.0 111.623 179.456 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 283' ' ' LYS . . . . . 0.5 ' HB2' HD23 ' A' ' 287' ' ' LEU . 15.2 mttp -88.54 41.85 1.04 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.783 0.325 . . . . 0.0 110.68 179.583 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 28.9 ttm180 -48.05 -63.32 1.1 Allowed 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 -178.294 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -72.02 -31.51 66.26 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 121.028 -0.269 . . . . 0.0 111.625 -178.771 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 286' ' ' TRP . . . . . . . . . . . . . 2.3 t90 -68.37 -49.02 63.12 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.877 0.37 . . . . 0.0 111.121 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 287' ' ' LEU . . . . . 0.5 HD23 ' HB2' ' A' ' 283' ' ' LYS . 0.7 OUTLIER -63.08 -41.21 99.36 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -179.593 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 29.5 m -70.48 -37.86 71.74 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 C-N-CA 120.514 -0.474 . . . . 0.0 111.826 179.68 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 39.3 mttp -72.91 -32.23 65.18 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -85.46 17.3 3.25 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -179.064 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 291' ' ' ARG . . . . . 0.444 HH11 ' HD2' ' A' ' 291' ' ' ARG . 25.3 mtm105 60.09 18.6 7.87 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 179.553 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 63.16 -137.02 43.11 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 114.687 0.635 . . . . 0.0 114.687 178.895 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 293' ' ' TRP . . . . . 0.407 ' HA ' ' HB3' ' A' ' 296' ' ' PHE . 72.4 m95 -59.13 -28.39 66.5 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -178.829 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 294' ' ' ASP . . . . . 0.498 ' O ' ' HG3' ' A' ' 298' ' ' GLU . 0.4 OUTLIER -59.41 -48.35 81.98 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 120.782 0.325 . . . . 0.0 110.24 178.335 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -66.19 -36.48 91.86 Favored Glycine 0 CA--C 1.521 0.458 0 C-N-CA 120.53 -0.843 . . . . 0.0 111.252 178.401 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 296' ' ' PHE . . . . . 0.477 ' HB2' ' CH2' ' A' ' 242' ' ' TRP . 12.2 t80 -58.67 -48.0 82.58 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.51 -0.345 . . . . 0.0 111.015 178.616 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 297' ' ' VAL . . . . . . . . . . . . . 18.4 m -72.33 -22.68 20.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 120.934 -0.306 . . . . 0.0 111.636 -179.583 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 298' ' ' GLU . . . . . 0.498 ' HG3' ' O ' ' A' ' 294' ' ' ASP . 37.1 mt-10 -65.97 -50.1 65.51 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.206 0.527 . . . . 0.0 110.599 178.336 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 299' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -77.1 -25.02 51.75 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 115.912 -0.585 . . . . 0.0 112.292 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 300' ' ' PHE . . . . . 0.62 ' HB3' HG21 ' A' ' 197' ' ' VAL . 44.7 m-85 . . . . . 0 CA--C 1.54 0.571 0 N-CA-C 115.16 1.541 . . . . 0.0 115.16 -177.54 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 22' ' ' GLU . . . . . 0.404 ' O ' ' HB2' ' B' ' 26' ' ' GLN . 4.8 mm-40 . . . . . 0 CA--C 1.535 0.381 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 23' ' ' PHE . . . . . 0.58 ' HD1' ' N ' ' B' ' 24' ' ' ALA . 0.1 OUTLIER -60.22 -31.88 70.58 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 118.302 0.501 . . . . 0.0 111.886 179.812 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 24' ' ' ALA . . . . . 0.58 ' N ' ' HD1' ' B' ' 23' ' ' PHE . . . -74.7 -48.38 26.31 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.16 0.505 . . . . 0.0 110.625 -179.724 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 25' ' ' ALA . . . . . 0.498 ' HA ' ' HD3' ' B' ' 28' ' ' ARG . . . -64.71 -37.12 86.49 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.505 178.966 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 26' ' ' GLN . . . . . 0.412 ' O ' HG13 ' B' ' 30' ' ' ILE . 0.0 OUTLIER -62.92 -48.13 80.25 Favored 'General case' 0 C--O 1.226 -0.134 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.13 178.751 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 27' ' ' LEU . . . . . 0.574 ' HG ' ' O ' ' B' ' 23' ' ' PHE . 29.8 mt -58.96 -32.45 69.65 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 178.371 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 28' ' ' ARG . . . . . 0.498 ' HD3' ' HA ' ' B' ' 25' ' ' ALA . 56.1 mtp85 -65.43 -54.81 23.14 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 177.432 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 29' ' ' LYS . . . . . 0.442 ' HG3' ' O ' ' B' ' 25' ' ' ALA . 54.5 mttt -55.67 -46.37 77.57 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.008 178.501 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 30' ' ' ILE . . . . . 0.718 HG12 ' CD2' ' A' ' 205' ' ' HIS . 97.9 mt -60.76 -52.42 61.77 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.237 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.218 179.76 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -57.03 -43.68 93.14 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 121.301 -0.476 . . . . 0.0 113.097 179.747 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -68.68 -40.89 79.9 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 120.709 0.29 . . . . 0.0 111.148 179.737 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.93 -39.97 83.42 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 120.954 0.407 . . . . 0.0 110.077 178.277 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 34' ' ' VAL . . . . . 0.716 HG21 HG13 ' A' ' 201' ' ' VAL . 4.9 t -62.56 -52.62 57.53 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.555 179.809 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -57.35 -40.95 79.14 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 120.943 0.402 . . . . 0.0 110.337 179.236 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 36' ' ' CYS . . . . . . . . . . . . . 42.7 t -68.68 -25.98 65.07 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 120.925 0.393 . . . . 0.0 111.298 179.256 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 59.6 m -78.55 -46.37 19.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.514 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 38' ' ' TRP . . . . . 0.435 ' CD1' HG13 ' B' ' 34' ' ' VAL . 99.2 m95 -75.52 -13.79 60.38 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 -179.132 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 43.7 m . . . . . 0 N--CA 1.472 0.66 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 178.878 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 . . . . . 0 CA--C 1.526 0.058 0 CA-C-O 120.854 0.359 . . . . 0.0 110.65 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.76 -57.19 14.11 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.911 179.234 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.409 HD21 ' HA3' ' A' ' 292' ' ' GLY . 0.2 OUTLIER -62.36 -35.99 80.84 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.03 178.716 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 156' ' ' TYR . . . . . 0.42 ' HE1' ' HA ' ' A' ' 277' ' ' ASP . 0.1 OUTLIER -68.86 -46.29 68.85 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.69 -0.232 . . . . 0.0 111.447 179.6 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 6.2 mtp180 -62.6 -45.87 90.87 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 121.119 -0.233 . . . . 0.0 111.14 179.515 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 59.3 mt-30 -58.02 -43.77 86.9 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 121.074 0.464 . . . . 0.0 110.222 178.594 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 159' ' ' SER . . . . . 0.489 ' HA ' ' CZ2' ' A' ' 293' ' ' TRP . 51.4 m -61.38 -54.35 44.78 Favored 'General case' 0 C--O 1.223 -0.313 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.788 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.412 HD22 ' HA ' ' A' ' 160' ' ' LEU . 1.2 tm? -58.38 -47.23 84.53 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 120.492 0.187 . . . . 0.0 111.308 179.299 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -60.75 -51.85 67.59 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 162' ' ' ILE . . . . . 0.501 HG23 HD22 ' A' ' 191' ' ' LEU . 60.5 mt -71.26 -48.66 53.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 -178.429 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.603 ' O ' ' HG ' ' A' ' 167' ' ' LEU . 64.4 mt -58.85 -50.83 78.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 N-CA-C 111.64 0.237 . . . . 0.0 111.64 -179.44 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 39.3 t -61.9 -41.76 98.28 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 120.959 -0.296 . . . . 0.0 110.827 179.558 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 165' ' ' ARG . . . . . 0.512 ' O ' ' HB2' ' A' ' 169' ' ' GLU . 6.7 tpp85 -61.07 -47.66 85.31 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 111.658 0.244 . . . . 0.0 111.658 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 166' ' ' TYR . . . . . 0.854 ' HE1' ' HA ' ' A' ' 195' ' ' ARG . 87.6 t80 -65.98 -50.97 62.44 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -179.358 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.603 ' HG ' ' O ' ' A' ' 163' ' ' ILE . 40.7 mt -59.11 -45.0 92.03 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 121.127 -0.229 . . . . 0.0 111.477 -178.784 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 3.7 ttt180 -70.26 -42.03 72.69 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 120.959 -0.296 . . . . 0.0 111.637 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 169' ' ' GLU . . . . . 0.512 ' HB2' ' O ' ' A' ' 165' ' ' ARG . 0.5 OUTLIER -59.6 -46.0 90.24 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.222 0.534 . . . . 0.0 109.645 179.081 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 170' ' ' GLN . . . . . 0.629 ' HB3' ' HE3' ' A' ' 257' ' ' LYS . 6.9 mm-40 -65.34 -49.75 68.22 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.87 179.058 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.472 ' HA ' ' HG2' ' A' ' 257' ' ' LYS . . . . . . . . 0 N--CA 1.466 0.375 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 -178.917 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 0.26 0 CA-C-O 120.874 0.369 . . . . 0.0 110.949 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -73.73 -71.15 1.14 Allowed Glycine 0 CA--C 1.524 0.616 0 C-N-CA 120.631 -0.795 . . . . 0.0 113.56 -179.456 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -72.09 -44.82 62.64 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.104 0.478 . . . . 0.0 110.966 179.799 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -67.9 -26.94 66.24 Favored 'General case' 0 C--O 1.225 -0.204 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.213 179.49 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 187' ' ' GLY . . . . . 0.544 ' O ' ' HB2' ' A' ' 191' ' ' LEU . . . -63.82 -53.49 37.46 Favored Glycine 0 C--N 1.332 0.315 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.199 179.64 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 188' ' ' ARG . . . . . 0.661 ' HE ' ' HG2' ' A' ' 192' ' ' GLU . 1.4 tpm_? -63.33 -44.42 94.95 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 120.902 0.382 . . . . 0.0 110.302 178.877 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 189' ' ' ARG . . . . . 0.415 HH22 ' CD ' ' A' ' 298' ' ' GLU . 37.0 mtp180 -60.17 -47.41 86.06 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.096 179.618 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 190' ' ' ALA . . . . . 0.561 ' HA ' HG12 ' A' ' 297' ' ' VAL . . . -72.75 -40.52 65.95 Favored 'General case' 0 C--O 1.22 -0.453 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -179.679 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 191' ' ' LEU . . . . . 0.544 ' HB2' ' O ' ' A' ' 187' ' ' GLY . 0.3 OUTLIER -58.66 -45.78 88.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.798 0.333 . . . . 0.0 110.735 179.885 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 192' ' ' GLU . . . . . 0.661 ' HG2' ' HE ' ' A' ' 188' ' ' ARG . 15.2 mm-40 -76.81 -40.98 46.19 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -179.806 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 193' ' ' THR . . . . . 0.649 HG21 ' HA ' ' A' ' 297' ' ' VAL . 80.1 m -65.0 -48.55 73.53 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.813 0.34 . . . . 0.0 110.108 178.847 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 194' ' ' LEU . . . . . 0.507 HD21 HG21 ' A' ' 249' ' ' ILE . 56.1 tp -64.81 -30.03 71.02 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.292 178.88 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 195' ' ' ARG . . . . . 0.854 ' HA ' ' HE1' ' A' ' 166' ' ' TYR . 56.9 ttm-85 -61.5 -49.49 76.56 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.832 0.349 . . . . 0.0 110.385 178.231 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 196' ' ' ARG . . . . . 0.449 HH11 ' HD2' ' A' ' 196' ' ' ARG . 0.2 OUTLIER -70.99 -55.25 8.71 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.026 -179.688 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 197' ' ' VAL . . . . . 0.516 HG21 ' HB3' ' A' ' 300' ' ' PHE . 35.5 t -63.29 -47.65 91.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-O 120.997 0.427 . . . . 0.0 111.851 -179.341 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -60.43 -44.9 97.14 Favored Glycine 0 CA--C 1.519 0.302 0 CA-C-N 116.067 -0.515 . . . . 0.0 113.004 -179.752 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -73.48 -32.44 64.31 Favored 'General case' 0 C--N 1.331 -0.235 0 O-C-N 122.211 -0.582 . . . . 0.0 109.492 179.202 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -56.27 -48.49 74.59 Favored Glycine 0 C--N 1.337 0.621 0 N-CA-C 110.999 -0.841 . . . . 0.0 110.999 177.314 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 201' ' ' VAL . . . . . 0.48 HG23 ' O ' ' A' ' 197' ' ' VAL . 41.3 t -65.36 -37.68 80.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 CA-C-O 120.883 0.373 . . . . 0.0 110.404 178.108 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 202' ' ' GLN . . . . . 0.456 ' HA ' ' CE2' ' A' ' 209' ' ' PHE . 24.5 mt-30 -61.69 -53.03 61.54 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.935 -0.575 . . . . 0.0 112.041 179.687 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 203' ' ' ARG . . . . . 0.412 HH11 ' HD3' ' A' ' 203' ' ' ARG . 9.2 ptt180 -72.88 -27.75 62.08 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 120.924 -0.31 . . . . 0.0 111.499 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -71.55 -53.59 13.3 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.058 0.456 . . . . 0.0 110.789 179.122 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 205' ' ' HIS . . . . . 0.453 ' HB3' ' HB3' ' A' ' 208' ' ' ALA . 94.2 m-70 -101.19 36.84 1.89 Allowed 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.897 179.5 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 11.0 tm-20 -53.83 -46.38 71.14 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.508 -179.782 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 49.1 p -64.66 -34.68 78.87 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.151 179.794 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 208' ' ' ALA . . . . . 0.453 ' HB3' ' HB3' ' A' ' 205' ' ' HIS . . . -69.22 -42.43 75.72 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 178.61 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 209' ' ' PHE . . . . . 0.49 ' O ' ' HG ' ' A' ' 213' ' ' LEU . 13.9 m-85 -70.81 -35.07 72.34 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.236 178.877 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -66.58 -46.9 74.46 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 177.591 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -62.26 -39.93 98.35 Favored Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 110.555 -1.018 . . . . 0.0 110.555 177.427 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 212' ' ' MET . . . . . 0.404 ' SD ' ' HA ' ' B' ' 23' ' ' PHE . 5.5 tpp -61.36 -37.0 81.78 Favored 'General case' 0 C--O 1.223 -0.293 0 N-CA-C 110.166 -0.309 . . . . 0.0 110.166 178.109 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.49 ' HG ' ' O ' ' A' ' 209' ' ' PHE . 34.7 mt -60.42 -41.62 94.32 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.043 0.449 . . . . 0.0 110.568 178.366 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 83.7 mtt85 -70.6 -27.02 63.78 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.594 179.584 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 10.1 mmmm -91.58 -11.19 37.95 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 120.89 0.376 . . . . 0.0 111.446 179.434 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 216' ' ' LEU . . . . . 0.527 HD21 HD12 ' A' ' 218' ' ' ILE . 16.4 tp -100.11 114.3 27.56 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.38 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -90.16 24.12 2.61 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 120.996 0.427 . . . . 0.0 111.787 -179.487 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 218' ' ' ILE . . . . . 0.527 HD12 HD21 ' A' ' 216' ' ' LEU . 5.7 mt -66.69 122.85 18.49 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-O 121.094 0.473 . . . . 0.0 111.354 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 7.0 ptpp? -154.98 -16.15 0.12 Allowed 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -179.131 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -130.95 -178.95 5.04 Favored 'General case' 0 CA--C 1.536 0.413 0 O-C-N 121.688 -0.633 . . . . 0.0 112.515 -178.523 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 221' ' ' GLU . . . . . 0.454 ' O ' HG22 ' A' ' 224' ' ' VAL . 3.5 tp10 -61.64 -39.81 92.66 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -179.143 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 222' ' ' GLY . . . . . 0.405 ' O ' ' HG2' ' A' ' 225' ' ' LYS . . . -55.7 -26.07 45.47 Favored Glycine 0 CA--C 1.524 0.606 0 C-N-CA 121.399 -0.429 . . . . 0.0 113.764 -179.347 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 223' ' ' ASP . . . . . 0.516 ' HB3' HG12 ' A' ' 218' ' ' ILE . 61.4 m-20 -60.13 -28.09 67.6 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 -179.544 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.454 HG22 ' O ' ' A' ' 221' ' ' GLU . 31.5 m -53.69 -31.72 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 N-CA-C 113.221 0.823 . . . . 0.0 113.221 -179.095 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 225' ' ' LYS . . . . . 0.405 ' HG2' ' O ' ' A' ' 222' ' ' GLY . 10.6 ptpp? -68.06 -33.61 74.88 Favored 'General case' 0 C--O 1.237 0.41 0 O-C-N 121.845 -0.535 . . . . 0.0 110.407 179.516 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 226' ' ' SER . . . . . 0.661 ' O ' HG23 ' A' ' 230' ' ' VAL . 33.3 p -69.63 -47.59 62.86 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.755 179.181 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 227' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -55.87 -37.7 69.15 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.154 0.502 . . . . 0.0 110.069 179.492 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 228' ' ' SER . . . . . 0.42 ' HA ' HG21 ' A' ' 278' ' ' VAL . 39.3 m -59.27 -48.73 80.55 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.488 177.547 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 229' ' ' ARG . . . . . 0.428 ' HA ' ' HD3' ' A' ' 229' ' ' ARG . 13.8 mmt180 -68.26 -34.09 75.56 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.074 179.5 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 230' ' ' VAL . . . . . 0.661 HG23 ' O ' ' A' ' 226' ' ' SER . 54.4 t -57.13 -54.83 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-O 120.562 0.22 . . . . 0.0 110.632 179.303 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 231' ' ' MET . . . . . 0.587 ' HG2' HD13 ' A' ' 248' ' ' LEU . 72.3 mtm -59.41 -43.35 93.02 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.334 179.374 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 79.7 t -59.07 -44.18 90.86 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-O 120.727 0.299 . . . . 0.0 110.874 178.697 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 65.7 t-80 -60.07 -38.62 83.41 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 120.826 0.346 . . . . 0.0 111.519 179.217 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.404 HG13 ' HA ' ' B' ' 28' ' ' ARG . 94.2 t -61.85 -39.62 84.14 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 CA-C-O 121.192 0.52 . . . . 0.0 111.056 178.983 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -99.24 24.42 7.98 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.638 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -62.24 -18.22 60.54 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -179.631 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -83.12 -16.71 45.71 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.772 0.32 . . . . 0.0 111.399 179.558 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 90.98 -10.07 76.06 Favored Glycine 0 CA--C 1.524 0.632 0 C-N-CA 120.701 -0.761 . . . . 0.0 113.747 179.517 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 6.2 p -93.47 118.19 38.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-O 121.571 0.701 . . . . 0.0 111.414 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 83.8 m -94.03 119.77 33.37 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.063 0.459 . . . . 0.0 111.896 -179.448 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 70.1 m-20 -113.67 140.76 47.96 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.162 178.58 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 242' ' ' TRP . . . . . 0.497 ' HA ' ' CE3' ' A' ' 242' ' ' TRP . 1.3 m95 -56.79 -44.94 82.39 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.715 0.293 . . . . 0.0 111.014 179.601 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 243' ' ' GLY . . . . . 0.438 ' HA2' HG12 ' A' ' 246' ' ' VAL . . . -60.8 -29.53 70.51 Favored Glycine 0 CA--C 1.523 0.541 0 C-N-CA 121.083 -0.58 . . . . 0.0 112.384 178.671 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 244' ' ' ARG . . . . . 0.481 ' HA ' ' HA3' ' B' ' 31' ' ' GLY . 60.5 mtt180 -68.96 -47.25 66.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.112 0.482 . . . . 0.0 109.797 178.675 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 245' ' ' ILE . . . . . 0.465 ' O ' HG13 ' A' ' 249' ' ' ILE . 68.3 mt -62.59 -48.23 89.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.3 179.827 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 246' ' ' VAL . . . . . 0.454 HG21 HG12 ' A' ' 197' ' ' VAL . 8.7 p -65.44 -27.87 42.89 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 C-N-CA 120.849 -0.341 . . . . 0.0 111.143 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 17.5 m -65.74 -41.24 92.4 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.201 0.524 . . . . 0.0 109.718 178.041 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 248' ' ' LEU . . . . . 0.587 HD13 ' HG2' ' A' ' 231' ' ' MET . 55.0 mt -65.72 -38.29 88.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.999 178.226 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 249' ' ' ILE . . . . . 0.507 HG21 HD21 ' A' ' 194' ' ' LEU . 14.9 mt -68.41 -43.05 84.37 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.524 178.875 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 250' ' ' SER . . . . . 0.453 ' HB2' ' HG3' ' A' ' 202' ' ' GLN . 5.2 p -66.47 -38.26 86.94 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 178.256 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 251' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -62.92 -44.15 96.85 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 176.328 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 252' ' ' GLY . . . . . 0.403 ' HA2' HG22 ' A' ' 255' ' ' VAL . . . -61.21 -42.68 99.86 Favored Glycine 0 C--N 1.336 0.579 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.359 177.845 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -62.43 -38.72 90.8 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 120.926 0.393 . . . . 0.0 110.692 178.109 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -66.73 -47.56 71.92 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.256 179.312 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 255' ' ' VAL . . . . . 0.551 ' O ' ' HG ' ' A' ' 259' ' ' LEU . 31.3 m -66.63 -33.77 65.67 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.2 178.817 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -63.25 -40.3 97.03 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.133 0.492 . . . . 0.0 109.779 177.55 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 257' ' ' LYS . . . . . 0.629 ' HE3' ' HB3' ' A' ' 170' ' ' GLN . 81.2 mttt -63.72 -39.18 93.67 Favored 'General case' 0 CA--C 1.528 0.1 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.582 177.541 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 66.7 t60 -65.0 -36.43 84.39 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 177.697 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.551 ' HG ' ' O ' ' A' ' 255' ' ' VAL . 72.9 mt -70.07 -42.48 72.76 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.882 178.146 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 28.1 tptt -64.7 -33.83 76.87 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.672 179.132 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 40.7 t -59.77 -24.42 64.07 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.206 179.004 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 262' ' ' VAL . . . . . 0.569 HG23 ' HG3' ' A' ' 264' ' ' GLN . 16.7 m -117.54 18.16 7.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 CA-C-O 121.264 0.554 . . . . 0.0 110.179 178.607 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 23.3 t30 51.48 47.68 24.37 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 114.96 -1.018 . . . . 0.0 113.066 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 264' ' ' GLN . . . . . 0.569 ' HG3' HG23 ' A' ' 262' ' ' VAL . 11.6 mt-30 -91.36 39.11 0.99 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.707 0.289 . . . . 0.0 111.457 179.049 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 265' ' ' GLU . . . . . 0.501 ' HA ' HD12 ' A' ' 268' ' ' ILE . 15.6 tp10 -47.07 -36.63 8.36 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.906 179.477 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 2.5 m -55.9 -29.17 59.6 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.911 179.424 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 267' ' ' PHE . . . . . 0.426 ' C ' ' HD2' ' A' ' 270' ' ' PRO . 44.1 t80 -95.62 -21.38 18.26 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 120.925 -0.31 . . . . 0.0 111.623 179.819 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 268' ' ' ILE . . . . . 0.501 HD12 ' HA ' ' A' ' 265' ' ' GLU . 70.6 mt -63.77 -37.82 80.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 CA-C-O 121.06 0.457 . . . . 0.0 110.357 179.252 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 269' ' ' GLU . . . . . 0.579 ' HB3' ' HD3' ' A' ' 270' ' ' PRO . 2.1 tp10 -59.56 -58.27 20.69 Favored Pre-proline 0 CA--C 1.551 1.018 0 CA-C-N 115.886 -0.597 . . . . 0.0 112.113 179.236 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 270' ' ' PRO . . . . . 0.579 ' HD3' ' HB3' ' A' ' 269' ' ' GLU . 21.5 Cg_exo -67.82 -25.12 39.62 Favored 'Trans proline' 0 C--N 1.361 1.215 0 C-N-CA 122.314 2.009 . . . . 0.0 113.167 179.616 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 271' ' ' LEU . . . . . . . . . . . . . 42.6 tp -64.45 -46.22 84.09 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.622 -0.263 . . . . 0.0 110.55 179.075 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -61.17 -39.45 90.19 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.073 179.247 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 273' ' ' GLU . . . . . . . . . . . . . 49.9 mm-40 -68.48 -46.28 70.15 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.794 178.842 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 274' ' ' THR . . . . . . . . . . . . . 84.9 m -58.01 -49.18 77.73 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.94 179.601 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 275' ' ' ILE . . . . . 0.406 ' HA ' ' HE1' ' A' ' 231' ' ' MET . 95.1 mt -59.54 -54.0 40.54 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.115 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.267 178.891 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 78.6 m -52.5 -53.13 50.04 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.767 -0.651 . . . . 0.0 112.627 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 277' ' ' ASP . . . . . 0.42 ' HA ' ' HE1' ' A' ' 156' ' ' TYR . 38.4 t70 -59.64 -57.98 10.58 Favored 'General case' 0 C--O 1.224 -0.25 0 C-N-CA 120.849 -0.34 . . . . 0.0 111.561 -179.341 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 278' ' ' VAL . . . . . 0.559 ' HB ' ' HE1' ' A' ' 231' ' ' MET . 43.1 t -58.26 -41.34 80.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -179.295 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 19.1 tp -63.13 -47.2 83.77 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 75.7 t -77.73 -46.16 27.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -179.243 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 21.2 ptt180 -59.76 -30.16 68.67 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -179.16 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 282' ' ' THR . . . . . . . . . . . . . 12.0 m -84.71 -22.34 29.78 Favored 'General case' 0 CA--C 1.543 0.673 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 283' ' ' LYS . . . . . 0.567 ' HB2' ' NZ ' ' A' ' 283' ' ' LYS . 0.0 OUTLIER -139.38 42.03 2.05 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 -178.71 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 11.1 ptm180 -63.8 -47.16 81.98 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -179.21 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -61.8 -41.71 98.1 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.838 0.352 . . . . 0.0 111.207 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 286' ' ' TRP . . . . . 0.566 ' O ' ' HG2' ' A' ' 290' ' ' GLN . 7.7 t90 -64.41 -41.62 96.53 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.803 0.335 . . . . 0.0 110.261 178.74 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -66.46 -51.71 53.89 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 27.2 m -59.78 -32.55 49.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -179.304 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.98 -36.53 75.27 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 120.772 0.32 . . . . 0.0 110.797 179.336 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 290' ' ' GLN . . . . . 0.566 ' HG2' ' O ' ' A' ' 286' ' ' TRP . 40.5 mm-40 -88.83 28.74 1.11 Allowed 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 121.032 -0.267 . . . . 0.0 110.977 179.543 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 46.1 mtp85 59.68 22.33 11.08 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 112.192 0.441 . . . . 0.0 112.192 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 292' ' ' GLY . . . . . 0.409 ' HA3' HD21 ' A' ' 155' ' ' LEU . . . 62.91 -130.62 42.51 Favored Glycine 0 C--O 1.239 0.433 0 CA-C-O 121.485 0.492 . . . . 0.0 113.866 179.512 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 293' ' ' TRP . . . . . 0.5 ' O ' HG13 ' A' ' 297' ' ' VAL . 90.6 m95 -65.12 -26.17 68.08 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.428 -0.386 . . . . 0.0 112.02 -179.294 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 294' ' ' ASP . . . . . 0.414 ' O ' ' HB2' ' A' ' 298' ' ' GLU . 25.5 t70 -64.64 -36.35 83.96 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 121.136 0.493 . . . . 0.0 109.995 178.579 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 295' ' ' GLY . . . . . 0.479 ' HA3' ' O ' ' A' ' 290' ' ' GLN . . . -71.37 -36.96 63.02 Favored Glycine 0 N--CA 1.45 -0.386 0 N-CA-C 110.551 -1.02 . . . . 0.0 110.551 177.598 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 296' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -63.87 -45.84 87.64 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 115.477 -0.362 . . . . 0.0 111.097 178.412 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 297' ' ' VAL . . . . . 0.649 ' HA ' HG21 ' A' ' 193' ' ' THR . 14.0 m -72.31 -28.4 28.8 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 -179.614 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 298' ' ' GLU . . . . . 0.415 ' CD ' HH22 ' A' ' 189' ' ' ARG . 2.3 tp10 -76.76 -49.74 15.22 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.582 0.229 . . . . 0.0 111.275 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 299' ' ' PHE . . . . . 0.402 ' HZ ' ' HB2' ' B' ' 39' ' ' SER . 68.4 t80 -55.15 -48.72 73.33 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 120.879 0.371 . . . . 0.0 111.267 179.642 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 300' ' ' PHE . . . . . 0.516 ' HB3' HG21 ' A' ' 197' ' ' VAL . 54.2 m-85 . . . . . 0 CA--C 1.538 0.497 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 . . . . . 0 C--O 1.236 0.37 0 CA-C-O 121.221 0.534 . . . . 0.0 110.932 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 23' ' ' PHE . . . . . 0.546 ' CE1' HG22 ' A' ' 230' ' ' VAL . 1.5 p90 -63.19 -41.57 99.22 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.478 -179.671 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.75 -36.42 83.83 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.939 0.4 . . . . 0.0 110.756 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.84 -47.37 86.65 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.798 178.241 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -66.01 -45.62 80.85 Favored 'General case' 0 CA--C 1.527 0.081 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.409 178.448 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 80.6 mt -56.75 -39.42 73.94 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.844 0.355 . . . . 0.0 110.378 178.386 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 28' ' ' ARG . . . . . 0.404 ' HA ' HG13 ' A' ' 234' ' ' VAL . 0.7 OUTLIER -62.63 -51.82 65.78 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.67 178.194 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -56.91 -42.01 79.17 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.568 178.691 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 87.8 mt -65.09 -43.29 95.86 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.433 178.716 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 31' ' ' GLY . . . . . 0.481 ' HA3' ' HA ' ' A' ' 244' ' ' ARG . . . -59.17 -50.08 71.63 Favored Glycine 0 C--N 1.335 0.514 0 C-N-CA 121.069 -0.586 . . . . 0.0 112.397 179.273 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -61.31 -44.62 96.91 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.091 0.472 . . . . 0.0 109.808 178.667 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 33' ' ' LYS . . . . . 0.456 ' HA ' ' HD2' ' B' ' 33' ' ' LYS . 0.2 OUTLIER -59.59 -55.98 27.67 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.787 179.718 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 55.7 t -59.14 -44.96 92.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-O 120.848 0.356 . . . . 0.0 110.974 179.558 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 35' ' ' TYR . . . . . 0.402 ' HB2' ' HA3' ' A' ' 243' ' ' GLY . 9.7 t80 -57.09 -45.96 82.94 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.567 179.145 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 36' ' ' CYS . . . . . . . . . . . . . 73.3 m -65.77 -29.55 70.06 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.405 179.302 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 97.0 m -66.69 -45.39 78.97 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 120.645 0.259 . . . . 0.0 111.217 179.464 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 38' ' ' TRP . . . . . . . . . . . . . 99.3 m95 -75.58 -40.81 56.11 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 120.74 0.305 . . . . 0.0 111.136 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 39' ' ' SER . . . . . 0.402 ' HB2' ' HZ ' ' A' ' 299' ' ' PHE . 41.7 t . . . . . 0 N--CA 1.468 0.451 0 CA-C-O 120.841 0.353 . . . . 0.0 111.66 179.511 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 153' ' ' ASP . . . . . 0.589 ' O ' ' HG3' ' A' ' 157' ' ' ARG . 26.5 t70 . . . . . 0 CA--C 1.536 0.419 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 154' ' ' ASP . . . . . 0.588 ' HA ' ' CZ ' ' A' ' 157' ' ' ARG . 2.9 m-20 -55.6 -47.41 76.55 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -178.908 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 47.9 tp -66.37 -37.02 84.34 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.139 0.495 . . . . 0.0 110.616 179.283 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 56.7 t80 -68.49 -43.19 77.43 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.389 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 157' ' ' ARG . . . . . 0.589 ' HG3' ' O ' ' A' ' 153' ' ' ASP . 54.4 mtm-85 -56.43 -49.77 73.58 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 27.6 tt0 -64.86 -43.93 91.39 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 120.851 0.358 . . . . 0.0 110.961 -179.596 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 159' ' ' SER . . . . . 0.4 ' HA ' ' NE1' ' A' ' 293' ' ' TRP . 20.0 m -63.52 -43.26 97.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.205 179.493 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -64.24 -47.54 79.27 Favored 'General case' 0 C--O 1.221 -0.402 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.43 178.905 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -54.38 -47.39 72.73 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-O 120.875 0.369 . . . . 0.0 111.461 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 162' ' ' ILE . . . . . 0.494 HG12 ' HA2' ' A' ' 187' ' ' GLY . 67.8 mt -63.11 -53.21 49.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-N 116.069 -0.514 . . . . 0.0 112.137 -179.783 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.516 HD12 HG23 ' A' ' 276' ' ' THR . 80.3 mt -63.12 -43.99 99.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.908 0.385 . . . . 0.0 110.935 179.725 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 2.5 t -59.16 -46.66 87.8 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.508 179.374 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 165' ' ' ARG . . . . . 0.546 ' HD2' ' OE2' ' A' ' 169' ' ' GLU . 2.3 mmm180 -57.19 -40.61 77.71 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 120.729 0.299 . . . . 0.0 111.075 179.024 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 70.6 t80 -71.0 -53.76 13.67 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.442 ' HG ' ' O ' ' A' ' 163' ' ' ILE . 38.9 mt -61.03 -43.42 98.92 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -178.887 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 168' ' ' ARG . . . . . 0.437 HH11 ' HD3' ' A' ' 168' ' ' ARG . 1.7 mtt-85 -67.79 -46.18 72.69 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -179.201 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 169' ' ' GLU . . . . . 0.546 ' OE2' ' HD2' ' A' ' 165' ' ' ARG . 17.6 mt-10 -66.3 -39.25 89.21 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 120.89 -0.324 . . . . 0.0 111.808 -179.512 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 170' ' ' GLN . . . . . 0.511 ' HG3' ' HE3' ' A' ' 257' ' ' LYS . 6.5 tp-100 -70.05 -26.32 63.97 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 121.234 0.54 . . . . 0.0 110.3 178.662 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.523 ' O ' ' HG2' ' A' ' 260' ' ' LYS . . . . . . . . 0 CA--C 1.53 0.199 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.803 179.293 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.601 ' O ' ' HA3' ' A' ' 187' ' ' GLY . . . . . . . . 0 CA--C 1.531 0.227 0 CA-C-O 120.939 0.399 . . . . 0.0 111.499 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -79.97 -71.48 1.26 Allowed Glycine 0 CA--C 1.525 0.705 0 C-N-CA 120.751 -0.737 . . . . 0.0 113.969 -179.681 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -70.56 -57.01 5.2 Favored 'General case' 0 C--O 1.238 0.449 0 O-C-N 122.519 -0.4 . . . . 0.0 111.823 -179.14 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -67.24 -27.75 67.49 Favored 'General case' 0 C--N 1.335 -0.061 0 CA-C-O 121.199 0.523 . . . . 0.0 109.892 179.234 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 187' ' ' GLY . . . . . 0.601 ' HA3' ' O ' ' A' ' 183' ' ' ALA . . . -72.64 -33.36 60.76 Favored Glycine 0 N--CA 1.447 -0.614 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.861 178.573 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -65.97 -54.51 25.3 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.797 0.332 . . . . 0.0 110.269 178.688 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 189' ' ' ARG . . . . . 0.692 ' HB3' HG11 ' A' ' 297' ' ' VAL . 16.0 mtm180 -55.12 -46.79 75.6 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 121.136 0.493 . . . . 0.0 110.818 179.17 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -71.35 -31.33 67.24 Favored 'General case' 0 C--O 1.221 -0.409 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.474 -179.474 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 191' ' ' LEU . . . . . 0.601 ' HB2' ' O ' ' A' ' 187' ' ' GLY . 0.2 OUTLIER -62.16 -53.59 53.15 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 117.893 0.315 . . . . 0.0 111.08 179.67 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -64.2 -41.41 97.08 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 120.713 0.292 . . . . 0.0 111.214 179.578 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 193' ' ' THR . . . . . 0.537 HG21 ' HA ' ' A' ' 297' ' ' VAL . 11.8 m -64.33 -47.76 78.18 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.81 179.109 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 14.9 tp -66.69 -35.28 79.76 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.776 0.322 . . . . 0.0 110.829 179.483 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 195' ' ' ARG . . . . . 0.429 HH11 ' HD2' ' A' ' 195' ' ' ARG . 9.2 tpp85 -67.73 -57.43 6.36 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.991 179.024 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 16.6 tpp180 -60.96 -50.8 71.91 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -178.963 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 197' ' ' VAL . . . . . 0.565 ' O ' HG23 ' A' ' 201' ' ' VAL . 97.1 t -70.1 -47.0 70.54 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -179.225 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -59.73 -48.06 87.9 Favored Glycine 0 CA--C 1.52 0.395 0 C-N-CA 121.359 -0.448 . . . . 0.0 113.229 -179.542 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 199' ' ' ASP . . . . . 0.514 ' HA ' ' HG2' ' A' ' 202' ' ' GLN . 98.2 m-20 -65.95 -36.38 83.2 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.828 0.347 . . . . 0.0 110.176 179.253 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -62.05 -37.69 94.86 Favored Glycine 0 CA--C 1.522 0.531 0 C-N-CA 120.708 -0.758 . . . . 0.0 111.97 178.48 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 201' ' ' VAL . . . . . 0.565 HG23 ' O ' ' A' ' 197' ' ' VAL . 93.4 t -67.09 -46.29 84.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 O-C-N 122.844 -0.21 . . . . 0.0 110.968 179.023 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 202' ' ' GLN . . . . . 0.514 ' HG2' ' HA ' ' A' ' 199' ' ' ASP . 8.0 pt20 -68.91 -31.68 70.76 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.443 179.593 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.35 -44.43 45.18 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 120.661 0.267 . . . . 0.0 111.152 179.012 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 27.1 m-80 -68.19 -44.89 74.87 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.844 0.354 . . . . 0.0 111.715 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 205' ' ' HIS . . . . . 0.464 ' HB2' ' CD2' ' A' ' 209' ' ' PHE . 10.2 m80 -100.65 32.82 2.96 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 120.897 0.379 . . . . 0.0 110.32 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -49.62 -51.4 37.87 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 -178.661 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 28.2 p -57.91 -53.43 58.29 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -179.08 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -61.93 -41.09 97.55 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.029 0.442 . . . . 0.0 110.871 179.45 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 209' ' ' PHE . . . . . 0.464 ' CD2' ' HB2' ' A' ' 205' ' ' HIS . 5.1 m-85 -64.04 -48.61 75.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.55 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -67.96 -33.58 74.93 Favored 'General case' 0 C--O 1.225 -0.189 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.853 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -57.69 -50.1 68.32 Favored Glycine 0 C--N 1.336 0.555 0 C-N-CA 120.52 -0.847 . . . . 0.0 111.217 178.265 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 212' ' ' MET . . . . . 0.721 ' SD ' ' HA ' ' B' ' 23' ' ' PHE . 41.6 mtm -67.84 -33.16 74.23 Favored 'General case' 0 C--O 1.224 -0.275 0 N-CA-C 110.355 -0.239 . . . . 0.0 110.355 178.474 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.781 HD12 HD12 ' A' ' 216' ' ' LEU . 10.0 tp -67.97 -36.51 80.17 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.196 179.293 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 15.8 mtp180 -68.76 -34.39 75.5 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 178.441 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -86.76 -6.95 58.67 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.765 178.113 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 216' ' ' LEU . . . . . 0.781 HD12 HD12 ' A' ' 213' ' ' LEU . 5.9 mt -68.73 110.26 4.22 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.186 0.517 . . . . 0.0 111.916 -179.293 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -94.66 18.99 10.54 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.764 179.476 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 218' ' ' ILE . . . . . 0.662 HG13 HD22 ' A' ' 216' ' ' LEU . 34.2 mt -59.3 107.63 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 CA-C-O 121.431 0.634 . . . . 0.0 111.619 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 6.2 mtmp? -150.31 -28.68 0.23 Allowed 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 115.111 -0.949 . . . . 0.0 111.752 -179.789 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -107.59 166.3 10.78 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 121.082 -0.247 . . . . 0.0 111.249 -179.393 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -54.5 -33.3 59.61 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -179.138 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -64.66 -27.76 72.38 Favored Glycine 0 CA--C 1.526 0.768 0 C-N-CA 120.989 -0.624 . . . . 0.0 113.507 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 223' ' ' ASP . . . . . 0.65 ' HB3' HG12 ' A' ' 218' ' ' ILE . 69.2 m-20 -66.94 -38.02 85.37 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 120.911 0.386 . . . . 0.0 111.5 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.442 HG12 HG21 ' A' ' 274' ' ' THR . 1.1 t -63.46 -35.1 71.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-O 121.361 0.601 . . . . 0.0 110.349 179.26 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 36.0 mmtm -65.56 -30.98 71.79 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.585 178.666 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 226' ' ' SER . . . . . 0.682 ' O ' HG23 ' A' ' 230' ' ' VAL . 30.6 t -71.63 -37.0 70.94 Favored 'General case' 0 C--O 1.223 -0.304 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.65 178.16 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 227' ' ' PHE . . . . . 0.607 ' HE2' HD12 ' A' ' 275' ' ' ILE . 8.8 t80 -57.11 -43.78 82.62 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 178.419 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 228' ' ' SER . . . . . 0.704 ' HB3' HG21 ' A' ' 278' ' ' VAL . 0.6 OUTLIER -70.35 -32.36 70.03 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.914 177.276 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 54.5 ttp180 -64.09 -48.41 76.26 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.113 178.562 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 230' ' ' VAL . . . . . 0.721 HG13 ' HA ' ' B' ' 24' ' ' ALA . 13.6 t -61.12 -43.77 96.96 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 178.174 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 231' ' ' MET . . . . . 0.923 ' HG3' ' HG ' ' A' ' 248' ' ' LEU . 26.3 ttm -55.07 -50.24 69.64 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.245 178.238 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 72.2 t -64.63 -42.16 94.29 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 CA-C-O 120.847 0.356 . . . . 0.0 110.818 178.811 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 233' ' ' HIS . . . . . 0.44 ' ND1' ' HB1' ' B' ' 24' ' ' ALA . 52.7 t-80 -59.78 -39.51 85.15 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 116.278 -0.419 . . . . 0.0 112.06 179.839 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.622 HG13 ' HA ' ' B' ' 28' ' ' ARG . 44.2 t -54.99 -43.94 71.62 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 179.7 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -90.95 25.7 2.34 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -179.316 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.11 -18.74 27.15 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 113.729 1.011 . . . . 0.0 113.729 -178.904 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -85.68 -16.17 39.98 Favored 'General case' 0 C--N 1.327 -0.384 0 O-C-N 122.093 -0.379 . . . . 0.0 111.4 179.737 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 100.28 -18.84 54.89 Favored Glycine 0 CA--C 1.522 0.522 0 C-N-CA 120.752 -0.737 . . . . 0.0 113.613 179.405 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 4.3 p -85.71 118.83 33.09 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-O 121.56 0.695 . . . . 0.0 111.237 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 240' ' ' THR . . . . . 0.568 HG21 ' HG2' ' A' ' 283' ' ' LYS . 53.8 m -89.95 98.26 11.67 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.807 -179.36 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -89.59 131.87 35.39 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.884 -0.326 . . . . 0.0 110.455 178.875 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 242' ' ' TRP . . . . . 0.483 ' CH2' ' HB2' ' A' ' 296' ' ' PHE . 17.2 m95 -55.74 -36.76 67.61 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 120.995 0.426 . . . . 0.0 110.75 179.165 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 243' ' ' GLY . . . . . 0.486 ' H ' ' HB2' ' B' ' 35' ' ' TYR . . . -61.56 -32.51 81.55 Favored Glycine 0 C--N 1.333 0.401 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.152 178.335 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 244' ' ' ARG . . . . . 0.53 ' HA ' ' HA3' ' B' ' 31' ' ' GLY . 99.1 mtt180 -72.01 -46.24 57.92 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 178.541 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 245' ' ' ILE . . . . . 0.624 HG23 HD21 ' A' ' 279' ' ' LEU . 52.2 mt -58.14 -49.25 82.24 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.154 179.022 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 246' ' ' VAL . . . . . 0.438 HG21 HG12 ' A' ' 197' ' ' VAL . 8.7 p -69.05 -26.2 31.69 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-N 116.623 -0.262 . . . . 0.0 111.133 179.777 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 247' ' ' THR . . . . . 0.405 HG21 ' HB ' ' B' ' 30' ' ' ILE . 17.0 m -65.72 -37.28 85.99 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 177.87 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 248' ' ' LEU . . . . . 0.923 ' HG ' ' HG3' ' A' ' 231' ' ' MET . 2.6 mm? -66.62 -38.72 87.53 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 177.865 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 18.2 mm -67.63 -41.4 85.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 177.846 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 29.8 m -62.25 -41.62 98.6 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.79 178.603 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 251' ' ' PHE . . . . . 0.489 ' CD2' HD11 ' B' ' 27' ' ' LEU . 7.6 t80 -68.03 -40.35 82.93 Favored 'General case' 0 N--CA 1.456 -0.142 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 177.218 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -56.81 -42.26 91.65 Favored Glycine 0 C--N 1.337 0.586 0 N-CA-C 111.106 -0.798 . . . . 0.0 111.106 177.655 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -61.39 -44.45 97.13 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-O 120.937 0.399 . . . . 0.0 110.048 177.734 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 254' ' ' PHE . . . . . 0.566 ' HB3' HD13 ' A' ' 213' ' ' LEU . 0.2 OUTLIER -61.17 -41.0 96.0 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.271 178.475 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 255' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 251' ' ' PHE . 91.5 t -62.32 -45.95 97.57 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.225 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 178.096 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 256' ' ' ALA . . . . . 0.507 ' HB1' ' HB2' ' A' ' 171' ' ' ALA . . . -58.82 -39.77 82.17 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 177.766 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 257' ' ' LYS . . . . . 0.511 ' HE3' ' HG3' ' A' ' 170' ' ' GLN . 74.5 mttt -62.89 -47.41 83.4 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.116 177.577 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 4.2 t60 -59.47 -40.97 88.66 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.428 179.081 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.454 HD13 ' HB3' ' A' ' 267' ' ' PHE . 87.2 mt -68.73 -42.29 77.82 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.406 178.624 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 260' ' ' LYS . . . . . 0.523 ' HG2' ' O ' ' A' ' 171' ' ' ALA . 0.7 OUTLIER -64.98 -34.72 79.11 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 120.847 0.356 . . . . 0.0 110.596 178.667 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 32.0 t -63.06 -25.83 68.56 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.019 179.279 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 262' ' ' VAL . . . . . 0.45 HG23 ' HB2' ' A' ' 264' ' ' GLN . 27.2 m -111.62 13.87 8.49 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.19 178.96 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 1.6 t30 57.06 50.96 11.11 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.451 179.818 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 264' ' ' GLN . . . . . 0.472 ' NE2' ' HB2' ' A' ' 267' ' ' PHE . 0.0 OUTLIER -119.03 39.2 3.6 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -179.87 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 265' ' ' GLU . . . . . 0.453 ' HA ' HD12 ' A' ' 268' ' ' ILE . 0.0 OUTLIER -49.63 -27.41 4.59 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 178.933 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.21 -20.67 43.46 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.251 178.641 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 267' ' ' PHE . . . . . 0.472 ' HB2' ' NE2' ' A' ' 264' ' ' GLN . 2.2 t80 -97.67 -20.9 17.33 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.883 178.709 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 268' ' ' ILE . . . . . 0.453 HD12 ' HA ' ' A' ' 265' ' ' GLU . 76.1 mt -65.39 -43.15 94.82 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-O 120.741 0.305 . . . . 0.0 110.373 179.252 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 269' ' ' GLU . . . . . 0.466 ' HB2' ' HD3' ' A' ' 270' ' ' PRO . 0.3 OUTLIER -54.98 -56.98 21.88 Favored Pre-proline 0 CA--C 1.543 0.711 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.794 179.177 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 270' ' ' PRO . . . . . 0.466 ' HD3' ' HB2' ' A' ' 269' ' ' GLU . 38.8 Cg_exo -62.89 -32.66 76.9 Favored 'Trans proline' 0 C--N 1.358 1.043 0 C-N-CA 122.055 1.837 . . . . 0.0 112.37 178.43 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 271' ' ' LEU . . . . . 0.562 ' O ' HG22 ' A' ' 275' ' ' ILE . 2.1 tm? -63.79 -50.62 68.26 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.621 179.445 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -60.33 -42.39 95.54 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.734 179.745 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 273' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -67.2 -43.87 81.04 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 120.945 0.402 . . . . 0.0 110.988 178.901 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 274' ' ' THR . . . . . 0.442 HG21 HG12 ' A' ' 224' ' ' VAL . 60.6 m -62.22 -52.68 62.8 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.682 -179.497 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 275' ' ' ILE . . . . . 0.607 HD12 ' HE2' ' A' ' 227' ' ' PHE . 6.3 tt -58.28 -47.69 86.89 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 C-N-CA 121.018 -0.273 . . . . 0.0 111.228 179.741 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 276' ' ' THR . . . . . 0.516 HG23 HD12 ' A' ' 163' ' ' ILE . 50.7 m -59.84 -53.73 54.48 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -179.679 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 277' ' ' ASP . . . . . 0.466 ' OD1' ' HD3' ' A' ' 281' ' ' ARG . 33.5 t70 -59.72 -51.16 70.97 Favored 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 120.637 -0.425 . . . . 0.0 111.092 -179.645 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 278' ' ' VAL . . . . . 0.704 HG21 ' HB3' ' A' ' 228' ' ' SER . 73.8 t -58.27 -47.65 86.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 120.747 -0.381 . . . . 0.0 111.02 179.715 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 279' ' ' LEU . . . . . 0.624 HD21 HG23 ' A' ' 245' ' ' ILE . 45.3 tp -60.58 -47.64 85.29 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 111.676 0.25 . . . . 0.0 111.676 179.782 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 55.6 t -66.86 -39.74 84.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 CA-C-O 120.75 0.31 . . . . 0.0 111.008 179.648 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 281' ' ' ARG . . . . . 0.466 ' HD3' ' OD1' ' A' ' 277' ' ' ASP . 0.0 OUTLIER -68.17 -47.09 68.93 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -179.883 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 282' ' ' THR . . . . . 0.818 HG23 ' HD2' ' A' ' 283' ' ' LYS . 4.7 t -63.37 -44.16 95.56 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 120.435 -0.506 . . . . 0.0 112.216 -179.676 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 283' ' ' LYS . . . . . 0.818 ' HD2' HG23 ' A' ' 282' ' ' THR . 0.0 OUTLIER -99.46 40.27 1.23 Allowed 'General case' 0 C--N 1.327 -0.392 0 O-C-N 121.987 -0.445 . . . . 0.0 111.463 179.77 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 284' ' ' ARG . . . . . 0.492 HH12 ' HB ' ' A' ' 288' ' ' VAL . 39.6 tpt85 -58.49 -51.12 71.19 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.941 -179.495 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -66.96 -43.59 82.73 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 120.994 0.426 . . . . 0.0 111.462 179.679 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 286' ' ' TRP . . . . . 0.442 ' O ' ' HB2' ' A' ' 290' ' ' GLN . 3.5 t90 -64.58 -41.37 96.31 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.933 -179.711 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 287' ' ' LEU . . . . . 0.6 HD23 ' HB3' ' A' ' 283' ' ' LYS . 2.0 mm? -69.0 -47.65 64.98 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 112.319 0.488 . . . . 0.0 112.319 -179.751 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 288' ' ' VAL . . . . . 0.492 ' HB ' HH12 ' A' ' 284' ' ' ARG . 7.3 p -60.73 -37.62 76.51 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 CA-C-O 120.634 0.254 . . . . 0.0 111.641 -179.769 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 79.6 mttt -75.3 -21.74 58.23 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 120.891 0.377 . . . . 0.0 111.35 178.981 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 290' ' ' GLN . . . . . 0.442 ' HB2' ' O ' ' A' ' 286' ' ' TRP . 0.0 OUTLIER -96.34 12.77 30.0 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 111.984 0.365 . . . . 0.0 111.984 179.969 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 291' ' ' ARG . . . . . 0.573 ' HB3' ' HB2' ' A' ' 294' ' ' ASP . 0.0 OUTLIER 62.19 19.09 10.66 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.089 0.471 . . . . 0.0 111.772 179.939 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 64.45 -122.48 25.15 Favored Glycine 0 CA--C 1.522 0.475 0 CA-C-N 115.906 -0.588 . . . . 0.0 113.964 179.207 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 293' ' ' TRP . . . . . 0.509 ' O ' HG23 ' A' ' 297' ' ' VAL . 89.4 m95 -66.57 -33.71 76.27 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.545 -0.328 . . . . 0.0 111.637 -178.941 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 294' ' ' ASP . . . . . 0.573 ' HB2' ' HB3' ' A' ' 291' ' ' ARG . 45.0 m-20 -54.86 -40.25 69.47 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.017 0.437 . . . . 0.0 110.251 178.354 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -72.18 -44.51 43.82 Favored Glycine 0 C--N 1.334 0.455 0 C-N-CA 120.761 -0.733 . . . . 0.0 111.727 178.394 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 296' ' ' PHE . . . . . 0.483 ' HB2' ' CH2' ' A' ' 242' ' ' TRP . 7.2 t80 -58.92 -45.06 91.29 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 120.852 0.358 . . . . 0.0 111.114 178.913 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 297' ' ' VAL . . . . . 0.692 HG11 ' HB3' ' A' ' 189' ' ' ARG . 81.0 t -67.57 -39.51 82.49 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.942 -179.529 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -76.15 -26.95 56.8 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 112.578 0.584 . . . . 0.0 112.578 -179.379 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 299' ' ' PHE . . . . . . . . . . . . . 87.4 t80 -60.9 -41.32 95.83 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.807 0.337 . . . . 0.0 111.372 179.446 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 300' ' ' PHE . . . . . 0.447 ' HE2' ' CD1' ' A' ' 296' ' ' PHE . 68.4 m-85 . . . . . 0 CA--C 1.535 0.372 0 CA-C-O 120.706 0.289 . . . . 0.0 111.628 -179.661 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 22' ' ' GLU . . . . . 0.408 ' HB2' ' NE2' ' B' ' 26' ' ' GLN . 0.5 OUTLIER . . . . . 0 CA--C 1.531 0.244 0 CA-C-O 121.001 0.429 . . . . 0.0 110.265 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 23' ' ' PHE . . . . . 0.721 ' HA ' ' SD ' ' A' ' 212' ' ' MET . 11.1 p90 -60.5 -35.7 76.57 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.498 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 24' ' ' ALA . . . . . 0.721 ' HA ' HG13 ' A' ' 230' ' ' VAL . . . -61.25 -47.79 84.42 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.007 0.432 . . . . 0.0 110.531 179.587 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 25' ' ' ALA . . . . . 0.431 ' O ' ' HG2' ' B' ' 29' ' ' LYS . . . -70.61 -44.78 66.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.599 179.163 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 26' ' ' GLN . . . . . 0.738 ' O ' HG12 ' B' ' 30' ' ' ILE . 1.7 mp0 -57.74 -56.97 15.11 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.261 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 27' ' ' LEU . . . . . 0.509 HD12 HG11 ' A' ' 230' ' ' VAL . 50.4 mt -56.31 -42.53 77.74 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 120.589 0.233 . . . . 0.0 111.274 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 28' ' ' ARG . . . . . 0.622 ' HA ' HG13 ' A' ' 234' ' ' VAL . 10.7 ttt85 -57.45 -48.01 80.31 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.523 178.471 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 29' ' ' LYS . . . . . 0.431 ' HG2' ' O ' ' B' ' 25' ' ' ALA . 20.1 mmmt -68.28 -39.1 82.25 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.872 179.329 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 30' ' ' ILE . . . . . 0.738 HG12 ' O ' ' B' ' 26' ' ' GLN . 48.8 mm -55.25 -49.95 68.42 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 177.979 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 31' ' ' GLY . . . . . 0.53 ' HA3' ' HA ' ' A' ' 244' ' ' ARG . . . -58.84 -44.96 95.64 Favored Glycine 0 N--CA 1.448 -0.559 0 CA-C-N 115.228 -0.897 . . . . 0.0 112.306 179.082 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -57.78 -44.99 86.61 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-O 120.662 0.268 . . . . 0.0 110.955 179.154 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 29.8 tttp -69.73 -52.29 26.74 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 121.017 -0.273 . . . . 0.0 111.171 179.621 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 74.2 t -52.94 -49.3 49.32 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-O 121.075 0.464 . . . . 0.0 110.761 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 35' ' ' TYR . . . . . 0.486 ' HB2' ' H ' ' A' ' 243' ' ' GLY . 1.2 t80 -57.33 -48.59 78.59 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.698 178.831 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 36' ' ' CYS . . . . . . . . . . . . . 36.7 t -65.5 -35.04 79.71 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.501 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 44.7 m -65.21 -37.3 86.85 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.965 -0.562 . . . . 0.0 111.615 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 38' ' ' TRP . . . . . . . . . . . . . 87.7 m95 -85.52 -35.44 21.13 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.243 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 40.9 t . . . . . 0 N--CA 1.462 0.166 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 177.916 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.41 ' N ' ' OD1' ' A' ' 154' ' ' ASP . . . . . . . . 0 N--CA 1.491 2.303 0 CA-C-O 119.999 -0.334 . . . . 1.61 112.54 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -70.38 119.86 6.68 Favored 'Trans proline' 0 CA--C 1.532 0.419 0 C-N-CA 122.523 2.149 . . . . 1.54 112.858 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 83.6 mt -123.63 -38.42 2.53 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.171 -0.468 . . . . 2.18 111.014 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -116.64 -70.6 0.44 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.846 -0.692 . . . . 1.18 112.38 179.664 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 57.7 p -149.53 -70.92 0.19 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.954 0.407 . . . . 0.84 111.432 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.534 ' OE1' ' HD3' ' A' ' 284' ' ' ARG . 18.1 mp0 -121.06 42.64 3.0 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.084 0.469 . . . . 0.8 110.706 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -59.98 -42.14 93.52 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.914 -0.585 . . . . 1.37 111.987 -179.402 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.41 ' OD1' ' N ' ' A' ' 147' ' ' GLY . 14.7 m-20 -57.95 -41.49 82.93 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.291 -0.413 . . . . 1.16 111.872 179.684 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 44.5 tp -57.29 -43.26 83.0 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.585 -0.279 . . . . 0.57 111.722 -179.484 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -66.5 -48.91 68.31 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 112.075 0.398 . . . . 0.34 112.075 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.581 ' HD3' ' OE2' ' A' ' 182' ' ' GLU . 6.6 mtp180 -59.3 -52.08 67.19 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 112.409 0.522 . . . . 0.89 112.409 -179.274 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 35.9 mm-40 -57.46 -45.68 84.5 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.129 0.49 . . . . 0.47 110.719 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 20.3 m -64.18 -48.51 75.68 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.69 -0.686 . . . . 0.25 111.383 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.619 ' HA ' HG21 ' A' ' 276' ' ' THR . 17.3 tp -58.12 -48.59 79.74 Favored 'General case' 0 C--O 1.225 -0.235 0 CA-C-N 116.326 -0.397 . . . . 0.38 111.498 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' GLU . . . . . 0.662 ' HB3' HD12 ' A' ' 180' ' ' LEU . 2.0 mt-10 -55.96 -50.47 70.69 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 111.781 0.289 . . . . 0.97 111.781 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' ILE . . . . . 0.529 HG12 ' HA2' ' A' ' 187' ' ' GLY . 57.1 mt -62.56 -50.1 81.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 CA-C-N 116.331 -0.395 . . . . 0.34 111.918 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.531 HD12 HG23 ' A' ' 276' ' ' THR . 77.4 mt -62.86 -47.33 93.33 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 C-N-CA 121.297 -0.161 . . . . 0.39 111.214 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 19.4 m -58.2 -42.01 85.23 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.101 0.477 . . . . 0.33 109.989 178.769 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' ARG . . . . . 0.577 ' HG3' ' CD1' ' A' ' 180' ' ' LEU . 1.1 mmp_? -66.75 -48.77 68.09 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.119 -0.491 . . . . 0.39 111.308 178.859 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 166' ' ' TYR . . . . . 0.836 ' CE1' ' HA ' ' A' ' 195' ' ' ARG . 66.0 t80 -60.39 -51.99 67.15 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 112.9 0.704 . . . . 0.42 112.9 -179.206 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 10.9 mp -62.4 -45.07 94.79 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 120.961 -0.296 . . . . 0.51 111.782 -178.575 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 1.4 mmt85 -65.06 -40.38 94.63 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 120.551 0.215 . . . . 0.57 111.263 179.128 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' GLU . . . . . 0.54 ' HB2' ' O ' ' A' ' 165' ' ' ARG . 0.6 OUTLIER -60.35 -53.99 50.98 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 120.999 0.428 . . . . 0.38 111.499 179.544 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 170' ' ' GLN . . . . . 0.46 ' HB3' ' CE ' ' A' ' 257' ' ' LYS . 9.0 mm-40 -61.82 -32.44 72.75 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.708 -0.678 . . . . 0.76 112.348 -179.377 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.569 ' O ' ' HG2' ' A' ' 260' ' ' LYS . . . -62.87 -23.46 67.33 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 112.165 0.431 . . . . 0.48 112.165 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 18.6 p -72.28 -24.27 61.32 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 112.019 0.377 . . . . 0.76 112.019 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 92.08 -7.16 78.88 Favored Glycine 0 CA--C 1.523 0.559 0 C-N-CA 120.781 -0.723 . . . . 0.88 112.831 -179.599 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 12.3 t -112.01 158.49 19.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.04 0.448 . . . . 0.77 111.606 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 2.0 ttpm? -84.84 60.64 6.31 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.218 0.532 . . . . 0.96 111.372 -179.484 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 40.9 t0 -91.42 169.6 10.65 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.772 -0.649 . . . . 0.71 110.302 179.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 1.9 t -159.42 95.08 1.21 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.419 -0.355 . . . . 0.38 110.429 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' LYS . . . . . 0.448 ' HB2' ' NE ' ' A' ' 165' ' ' ARG . 51.9 mttp -82.76 149.76 60.87 Favored Pre-proline 0 CA--C 1.534 0.33 0 CA-C-O 120.969 0.414 . . . . 0.58 111.702 -178.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.57 156.2 61.73 Favored 'Trans proline' 0 CA--C 1.533 0.429 0 C-N-CA 122.481 2.121 . . . . 0.7 113.416 -179.653 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.662 HD12 ' HB3' ' A' ' 161' ' ' GLU . 3.7 mm? -92.64 158.48 15.93 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.483 -0.781 . . . . 0.5 110.344 179.39 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -93.67 -28.9 10.54 Favored Glycine 0 CA--C 1.519 0.315 0 C-N-CA 120.729 -0.748 . . . . 0.61 112.205 179.5 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' GLU . . . . . 0.581 ' OE2' ' HD3' ' A' ' 157' ' ' ARG . 14.9 tt0 -124.06 -42.18 2.17 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.137 0.494 . . . . 0.69 110.704 179.329 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.57 ' O ' ' HA3' ' A' ' 187' ' ' GLY . . . -77.25 72.15 3.78 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 121.175 0.512 . . . . 0.34 112.069 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -73.79 -69.48 1.39 Allowed Glycine 0 CA--C 1.523 0.539 0 C-N-CA 120.707 -0.758 . . . . 0.36 112.718 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -68.31 -54.94 14.05 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.654 0.264 . . . . 0.38 111.355 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -66.84 -40.92 88.12 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.382 -0.372 . . . . 0.36 111.247 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 187' ' ' GLY . . . . . 0.57 ' HA3' ' O ' ' A' ' 183' ' ' ALA . . . -60.39 -47.01 93.24 Favored Glycine 0 C--O 1.222 -0.601 0 C-N-CA 121.0 -0.619 . . . . 0.32 113.848 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 20.2 mtp180 -69.19 -40.79 77.85 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 117.634 0.717 . . . . 1.04 112.012 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 32.6 ttt180 -66.57 -46.1 77.16 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-O 121.364 0.602 . . . . 0.41 110.359 179.624 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.492 ' HB2' ' HB3' ' A' ' 293' ' ' TRP . . . -74.88 -40.2 61.09 Favored 'General case' 0 C--O 1.221 -0.442 0 CA-C-N 115.621 -0.718 . . . . 0.28 112.598 -179.111 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 29.4 tp -63.76 -41.02 98.06 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 118.517 0.599 . . . . 0.49 111.021 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -64.81 -42.96 94.59 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 121.168 0.508 . . . . 0.42 110.508 179.187 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 193' ' ' THR . . . . . 0.477 HG21 ' HA ' ' A' ' 297' ' ' VAL . 43.4 m -71.7 -45.71 61.01 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.0 -0.546 . . . . 0.28 111.491 179.618 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 0.412 HD21 HG21 ' A' ' 249' ' ' ILE . 24.3 tp -60.37 -31.98 70.86 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.292 -0.413 . . . . 0.32 111.292 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 195' ' ' ARG . . . . . 0.836 ' HA ' ' CE1' ' A' ' 166' ' ' TYR . 6.3 ttm105 -70.74 -51.2 28.85 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.59 -0.522 . . . . 0.39 109.59 178.588 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.67 -46.18 91.34 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.507 -0.77 . . . . 0.51 111.624 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 197' ' ' VAL . . . . . 0.412 ' O ' HG23 ' A' ' 201' ' ' VAL . 94.2 t -72.71 -48.02 47.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.516 -0.311 . . . . 0.35 111.536 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -56.43 -40.82 87.09 Favored Glycine 0 C--N 1.335 0.522 0 CA-C-N 116.335 -0.393 . . . . 0.25 112.818 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -68.32 -47.69 66.89 Favored 'General case' 0 CA--C 1.527 0.076 0 N-CA-C 110.319 -0.252 . . . . 0.39 110.319 178.495 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -57.75 -42.62 94.52 Favored Glycine 0 CA--C 1.524 0.633 0 C-N-CA 120.942 -0.647 . . . . 0.27 113.006 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 201' ' ' VAL . . . . . 0.707 HG13 HG21 ' B' ' 34' ' ' VAL . 74.8 t -65.36 -52.0 57.34 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 N-CA-C 112.2 0.444 . . . . 0.3 112.2 179.635 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 202' ' ' GLN . . . . . 0.479 ' HB3' ' HB2' ' A' ' 250' ' ' SER . 10.0 pt20 -71.17 -33.13 69.71 Favored 'General case' 0 C--O 1.222 -0.369 0 N-CA-C 113.043 0.757 . . . . 0.48 113.043 -178.163 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -71.6 -37.53 70.94 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 118.377 0.535 . . . . 0.57 110.9 179.363 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 9.3 m-80 -66.82 -51.09 59.78 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.893 0.378 . . . . 0.67 110.827 178.637 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 205' ' ' HIS . . . . . 0.459 ' O ' ' HD2' ' A' ' 209' ' ' PHE . 50.0 m-70 -96.59 32.75 1.96 Allowed 'General case' 0 CA--C 1.537 0.446 0 O-C-N 122.331 -0.231 . . . . 0.42 110.82 179.083 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -55.75 -43.12 76.35 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 112.894 0.701 . . . . 0.48 112.894 -178.348 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 32.7 p -60.25 -42.2 94.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.131 0.491 . . . . 0.54 111.265 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -68.45 -42.44 78.79 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.863 -0.608 . . . . 0.36 110.253 178.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 209' ' ' PHE . . . . . 0.459 ' HD2' ' O ' ' A' ' 205' ' ' HIS . 18.1 m-85 -62.44 -49.08 76.85 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.034 -0.53 . . . . 0.85 110.424 179.256 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 65.0 mt-30 -61.78 -39.86 93.15 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.178 -0.465 . . . . 0.78 110.907 179.23 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -58.0 -46.39 92.61 Favored Glycine 0 C--N 1.335 0.503 0 N-CA-C 111.009 -0.837 . . . . 0.34 111.009 178.065 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 212' ' ' MET . . . . . 0.576 ' SD ' ' HA ' ' B' ' 23' ' ' PHE . 76.2 mtm -70.91 -35.69 72.38 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 120.759 0.314 . . . . 0.56 110.695 178.372 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 16.2 tp -60.85 -40.49 93.06 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.043 0.449 . . . . 0.49 110.754 179.18 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 79.4 mtp180 -77.34 -27.14 52.67 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.115 -0.493 . . . . 0.64 110.557 178.569 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 7.6 mmtp -75.94 -31.86 59.29 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.86 -0.609 . . . . 0.65 110.837 178.558 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 26.7 mt -69.08 137.21 53.33 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.047 -0.524 . . . . 0.51 112.397 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -101.78 19.88 17.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.968 -0.56 . . . . 0.49 110.392 178.322 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 218' ' ' ILE . . . . . 0.534 HG12 ' HB3' ' A' ' 223' ' ' ASP . 16.7 mt -62.73 118.88 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 N-CA-C 113.155 0.798 . . . . 0.37 113.155 -178.348 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 219' ' ' LYS . . . . . 0.609 ' HG2' HE22 ' A' ' 264' ' ' GLN . 3.3 ttpp -150.41 -16.76 0.24 Allowed 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 115.369 -0.832 . . . . 0.48 112.761 179.132 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -128.85 -178.9 4.8 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 112.872 0.693 . . . . 0.48 112.872 -178.348 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 221' ' ' GLU . . . . . 0.48 ' O ' HG22 ' A' ' 224' ' ' VAL . 0.8 OUTLIER -69.13 -22.43 63.96 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.643 -0.708 . . . . 0.5 111.772 -179.702 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -70.6 -26.29 74.33 Favored Glycine 0 CA--C 1.524 0.647 0 C-N-CA 120.834 -0.698 . . . . 0.3 113.313 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 223' ' ' ASP . . . . . 0.534 ' HB3' HG12 ' A' ' 218' ' ' ILE . 59.9 m-20 -65.17 -29.38 70.21 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 113.074 0.768 . . . . 0.39 113.074 -179.107 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.595 ' HB ' HG21 ' A' ' 274' ' ' THR . 6.4 m -53.78 -27.9 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 N-CA-C 112.895 0.702 . . . . 0.41 112.895 -179.313 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 225' ' ' LYS . . . . . 0.409 ' O ' ' HD3' ' A' ' 229' ' ' ARG . 33.5 mtmm -60.16 -44.15 95.24 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.297 0.57 . . . . 0.54 110.334 178.787 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 17.6 m -72.3 -39.67 68.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.806 -0.633 . . . . 0.35 110.861 179.442 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 227' ' ' PHE . . . . . 0.506 ' HE2' HG21 ' A' ' 255' ' ' VAL . 17.1 t80 -60.9 -48.21 82.87 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.212 -0.449 . . . . 0.53 110.785 179.708 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 228' ' ' SER . . . . . 0.692 ' HB2' HG11 ' A' ' 278' ' ' VAL . 13.7 p -62.73 -39.15 93.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.205 -0.452 . . . . 0.4 110.267 178.788 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 229' ' ' ARG . . . . . 0.409 ' HD3' ' O ' ' A' ' 225' ' ' LYS . 4.1 mpt_? -64.85 -46.07 83.45 Favored 'General case' 0 C--O 1.227 -0.123 0 CA-C-N 116.103 -0.499 . . . . 0.62 110.541 178.688 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 0.433 HG13 ' HA ' ' B' ' 24' ' ' ALA . 43.0 t -59.2 -44.88 92.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 CA-C-O 120.944 0.402 . . . . 0.44 110.321 178.168 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 231' ' ' MET . . . . . 0.569 ' HG2' HD22 ' A' ' 248' ' ' LEU . 30.4 mtm -57.54 -52.39 65.6 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.155 -0.475 . . . . 0.44 111.621 179.362 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 232' ' ' VAL . . . . . 0.67 HG12 HG21 ' A' ' 282' ' ' THR . 21.9 m -67.82 -31.84 53.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 C-N-CA 120.9 -0.32 . . . . 0.4 111.091 179.444 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 5.6 t-80 -59.82 -32.07 70.31 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.366 -0.379 . . . . 0.51 111.347 179.324 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.676 HG21 HD21 ' A' ' 248' ' ' LEU . 78.8 t -58.61 -30.21 41.09 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 CA-C-O 120.79 0.328 . . . . 0.39 111.606 179.105 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 235' ' ' PHE . . . . . 0.477 ' CD1' ' HA ' ' A' ' 240' ' ' THR . 67.9 m-85 -102.58 23.7 11.56 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 111.882 0.327 . . . . 0.53 111.882 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 7.6 tptp -62.81 -24.8 67.94 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 113.062 0.764 . . . . 0.94 113.062 -178.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -81.73 -9.63 59.59 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.863 0.363 . . . . 0.51 111.527 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 93.23 2.55 65.95 Favored Glycine 0 CA--C 1.522 0.518 0 C-N-CA 120.822 -0.704 . . . . 0.58 113.388 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 11.9 t -96.77 95.51 4.74 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-O 120.994 0.426 . . . . 0.39 111.379 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 240' ' ' THR . . . . . 0.477 ' HA ' ' CD1' ' A' ' 235' ' ' PHE . 0.6 OUTLIER -82.8 70.52 9.8 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.827 0.677 . . . . 0.85 112.827 -179.781 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 241' ' ' ASN . . . . . 0.429 ' HB2' ' HD2' ' A' ' 244' ' ' ARG . 20.6 m-20 -83.89 140.0 32.26 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.916 0.388 . . . . 0.43 111.641 179.448 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 242' ' ' TRP . . . . . . . . . . . . . 54.1 m95 -51.09 -43.46 61.07 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.951 -0.568 . . . . 0.41 112.432 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -54.33 -35.2 55.19 Favored Glycine 0 C--N 1.339 0.708 0 C-N-CA 121.407 -0.425 . . . . 0.23 112.931 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 244' ' ' ARG . . . . . 0.429 ' HD2' ' HB2' ' A' ' 241' ' ' ASN . 24.4 mtt180 -73.99 -43.06 59.35 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.126 0.489 . . . . 0.33 109.769 178.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 48.2 mt -60.32 -50.22 81.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-N 115.709 -0.678 . . . . 0.33 111.101 179.315 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 31.4 m -65.86 -34.32 69.52 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 C-N-CA 121.03 -0.268 . . . . 0.28 111.497 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 40.3 m -58.06 -40.65 81.53 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.076 0.465 . . . . 0.39 110.015 178.215 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 248' ' ' LEU . . . . . 0.676 HD21 HG21 ' A' ' 234' ' ' VAL . 80.7 mt -66.12 -32.31 73.69 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.023 -0.535 . . . . 0.43 111.102 178.697 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 249' ' ' ILE . . . . . 0.412 HG21 HD21 ' A' ' 194' ' ' LEU . 19.3 mt -74.5 -42.62 49.22 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 CA-C-N 116.216 -0.447 . . . . 0.53 109.818 178.261 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 250' ' ' SER . . . . . 0.479 ' HB2' ' HB3' ' A' ' 202' ' ' GLN . 51.3 p -64.89 -30.4 71.4 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 109.502 -0.555 . . . . 0.34 109.502 177.784 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 251' ' ' PHE . . . . . . . . . . . . . 18.6 t80 -70.52 -43.97 68.53 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 108.584 -0.895 . . . . 0.58 108.584 177.389 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -59.18 -47.0 92.94 Favored Glycine 0 C--N 1.336 0.531 0 N-CA-C 110.767 -0.933 . . . . 0.27 110.767 177.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 253' ' ' ALA . . . . . 0.433 ' O ' ' HG3' ' A' ' 257' ' ' LYS . . . -59.5 -39.72 84.71 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 120.655 0.264 . . . . 0.33 110.691 177.369 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -61.94 -41.78 98.35 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 121.052 0.453 . . . . 0.59 110.55 178.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 255' ' ' VAL . . . . . 0.506 HG21 ' HE2' ' A' ' 227' ' ' PHE . 59.5 t -72.04 -37.72 61.33 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-N 116.184 -0.462 . . . . 0.36 110.025 178.414 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -56.69 -42.88 79.87 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.028 0.442 . . . . 0.28 109.907 177.734 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 257' ' ' LYS . . . . . 0.46 ' CE ' ' HB3' ' A' ' 170' ' ' GLN . 93.0 mttt -64.7 -42.94 94.93 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 115.846 -0.616 . . . . 0.66 110.117 177.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 40.3 t60 -59.19 -42.79 91.72 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.292 -0.413 . . . . 0.66 110.66 178.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 95.7 mt -69.86 -42.62 73.3 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 116.392 -0.367 . . . . 0.54 111.149 179.122 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 260' ' ' LYS . . . . . 0.569 ' HG2' ' O ' ' A' ' 171' ' ' ALA . 2.1 tptp -64.94 -35.95 82.81 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.705 0.288 . . . . 0.56 111.311 179.239 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 63.0 m -59.69 -28.96 67.75 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.262 -0.427 . . . . 0.51 111.301 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 24.2 m -107.32 16.27 7.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-N 116.382 -0.372 . . . . 0.55 111.071 178.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 55.61 52.47 11.0 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 112.769 0.655 . . . . 0.98 112.769 179.517 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 264' ' ' GLN . . . . . 0.609 HE22 ' HG2' ' A' ' 219' ' ' LYS . 7.3 mt-30 -117.98 37.74 3.88 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 120.769 0.318 . . . . 0.56 111.462 179.413 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 265' ' ' GLU . . . . . 0.497 ' HA ' HD12 ' A' ' 268' ' ' ILE . 1.2 mp0 -48.06 -31.75 5.87 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 112.716 0.636 . . . . 0.59 112.716 179.39 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -55.57 -22.42 21.84 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 122.847 0.459 . . . . 0.95 111.974 179.276 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 267' ' ' PHE . . . . . 0.402 ' C ' ' HD2' ' A' ' 270' ' ' PRO . 95.3 m-85 -100.43 -17.89 16.97 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 120.79 0.328 . . . . 0.48 110.986 178.859 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 268' ' ' ILE . . . . . 0.497 HD12 ' HA ' ' A' ' 265' ' ' GLU . 66.5 mt -67.77 -45.71 83.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-N 116.416 -0.356 . . . . 0.39 111.107 179.754 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 269' ' ' GLU . . . . . 0.643 ' HB2' ' HD3' ' A' ' 270' ' ' PRO . 0.5 OUTLIER -55.74 -56.58 28.41 Favored Pre-proline 0 CA--C 1.545 0.774 0 CA-C-N 116.296 -0.411 . . . . 0.37 111.21 179.332 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 270' ' ' PRO . . . . . 0.643 ' HD3' ' HB2' ' A' ' 269' ' ' GLU . 31.2 Cg_exo -61.33 -32.19 89.45 Favored 'Trans proline' 0 C--N 1.361 1.213 0 C-N-CA 122.23 1.953 . . . . 0.27 112.101 178.428 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 271' ' ' LEU . . . . . 0.414 ' O ' HG13 ' A' ' 275' ' ' ILE . 46.8 tp -66.62 -54.76 19.88 Favored 'General case' 0 C--O 1.226 -0.135 0 CA-C-N 116.406 -0.361 . . . . 0.44 110.14 178.682 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -56.98 -37.82 72.16 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 120.852 0.358 . . . . 0.29 110.628 178.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 273' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -64.26 -51.48 63.39 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.028 -0.533 . . . . 0.49 110.134 178.04 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 274' ' ' THR . . . . . 0.595 HG21 ' HB ' ' A' ' 224' ' ' VAL . 31.1 m -59.82 -42.67 94.04 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.292 -0.413 . . . . 0.3 110.595 179.173 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 275' ' ' ILE . . . . . 0.459 HG12 ' CE1' ' A' ' 227' ' ' PHE . 96.5 mt -57.98 -54.3 33.89 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.105 0 CA-C-N 116.165 -0.471 . . . . 0.35 110.603 179.15 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 276' ' ' THR . . . . . 0.619 HG21 ' HA ' ' A' ' 160' ' ' LEU . 32.5 m -60.71 -49.88 75.71 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.253 -0.43 . . . . 0.3 111.441 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 277' ' ' ASP . . . . . 0.595 ' O ' ' HB2' ' A' ' 281' ' ' ARG . 17.0 t0 -56.28 -61.04 2.67 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.946 -0.57 . . . . 0.4 112.104 -179.425 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 278' ' ' VAL . . . . . 0.692 HG11 ' HB2' ' A' ' 228' ' ' SER . 66.4 t -61.25 -46.24 97.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 112.304 0.483 . . . . 0.39 112.304 -178.762 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 279' ' ' LEU . . . . . 0.45 HD12 ' HZ1' ' A' ' 283' ' ' LYS . 14.0 tp -54.7 -47.58 73.52 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 111.635 0.235 . . . . 0.75 111.635 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 84.0 t -77.38 -41.05 29.66 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 N-CA-C 111.803 0.297 . . . . 0.39 111.803 -179.535 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 281' ' ' ARG . . . . . 0.595 ' HB2' ' O ' ' A' ' 277' ' ' ASP . 2.5 ttt180 -53.7 -42.73 68.31 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 112.616 0.598 . . . . 0.85 112.616 -179.753 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 282' ' ' THR . . . . . 0.67 HG21 HG12 ' A' ' 232' ' ' VAL . 15.2 t -84.41 0.39 49.64 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 112.843 0.683 . . . . 0.37 112.843 -179.656 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 283' ' ' LYS . . . . . 0.49 ' HG3' HG23 ' A' ' 282' ' ' THR . 34.6 mtmm -141.02 40.76 1.8 Allowed 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 120.877 0.37 . . . . 0.38 111.546 -179.586 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 284' ' ' ARG . . . . . 0.534 ' HD3' ' OE1' ' A' ' 152' ' ' GLU . 13.2 ttm180 -63.21 -60.65 3.13 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 112.714 0.635 . . . . 0.64 112.714 -178.666 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 285' ' ' ASP . . . . . 0.44 ' HA ' HG12 ' A' ' 288' ' ' VAL . 35.8 t70 -58.71 -45.48 89.47 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.366 -0.379 . . . . 0.51 111.895 -179.471 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 286' ' ' TRP . . . . . . . . . . . . . 4.1 t90 -59.62 -44.95 93.27 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 120.571 0.224 . . . . 0.49 111.25 -179.573 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -68.84 -44.52 73.25 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 112.072 0.397 . . . . 0.47 112.072 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 288' ' ' VAL . . . . . 0.44 HG12 ' HA ' ' A' ' 285' ' ' ASP . 6.2 p -66.2 -34.5 70.63 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 O-C-N 122.207 -0.308 . . . . 0.52 111.645 -179.542 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 31.9 mttp -76.31 -26.87 56.26 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-O 120.766 0.317 . . . . 0.78 111.398 179.017 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 6.0 tp60 -91.04 24.95 2.61 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 112.563 0.579 . . . . 0.97 112.563 -179.193 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 53.6 mtp180 62.99 12.65 6.05 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 112.505 0.557 . . . . 0.43 112.505 179.575 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 64.64 -131.86 37.67 Favored Glycine 0 CA--C 1.522 0.487 0 C-N-CA 121.235 -0.507 . . . . 0.33 113.241 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 293' ' ' TRP . . . . . 0.492 ' HB3' ' HB2' ' A' ' 190' ' ' ALA . 86.3 m95 -67.67 -21.21 65.36 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 111.903 0.334 . . . . 0.48 111.903 -179.695 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 294' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -62.85 -48.54 78.62 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 121.175 0.512 . . . . 0.47 110.098 177.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -69.78 -33.62 71.2 Favored Glycine 0 C--N 1.332 0.329 0 C-N-CA 120.657 -0.783 . . . . 0.32 111.614 178.616 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 296' ' ' PHE . . . . . 0.446 ' HB3' ' HA ' ' A' ' 293' ' ' TRP . 1.6 t80 -60.52 -50.94 71.53 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.674 -0.263 . . . . 0.29 111.615 179.108 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 297' ' ' VAL . . . . . 0.477 ' HA ' HG21 ' A' ' 193' ' ' THR . 28.8 m -63.94 -43.25 97.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 N-CA-C 111.836 0.31 . . . . 0.27 111.836 -178.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -58.64 -41.67 86.53 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 112.197 0.443 . . . . 0.42 112.197 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 299' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -58.69 -45.46 89.43 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 120.907 0.385 . . . . 0.41 111.875 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 300' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -83.98 3.2 35.33 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 112.556 0.576 . . . . 0.47 112.556 -179.145 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 301' ' ' HIS . . . . . 0.588 ' HB3' ' HG2' ' A' ' 306' ' ' GLU . 27.8 m170 -109.71 11.38 24.55 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.514 0.197 . . . . 0.45 111.154 179.596 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 302' ' ' VAL . . . . . 0.609 ' HA ' ' HA3' ' A' ' 307' ' ' GLY . 31.4 m -75.22 -10.78 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 N-CA-C 112.027 0.38 . . . . 1.18 112.027 -179.43 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 -61.9 -63.12 1.36 Allowed 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.377 -0.374 . . . . 1.65 110.554 179.141 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -170.83 61.47 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.477 0.656 . . . . 2.0 110.88 178.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 61.2 mt -141.53 -57.85 0.48 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.524 -0.762 . . . . 1.76 110.615 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 306' ' ' GLU . . . . . 0.588 ' HG2' ' HB3' ' A' ' 301' ' ' HIS . 8.4 pt-20 -151.26 46.02 0.82 Allowed 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 121.428 0.633 . . . . 0.83 110.708 179.302 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 307' ' ' GLY . . . . . 0.609 ' HA3' ' HA ' ' A' ' 302' ' ' VAL . . . -126.06 131.65 7.56 Favored Glycine 0 CA--C 1.521 0.463 0 C-N-CA 120.884 -0.674 . . . . 1.67 112.696 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.309 0 CA-C-O 118.41 -1.217 . . . . 3.86 112.77 -179.92 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.484 0 CA-C-O 120.56 0.219 . . . . 1.37 111.565 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -171.07 155.99 4.64 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.563 -0.29 . . . . 0.92 110.444 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 19' ' ' LEU . . . . . 0.663 HD13 ' HE2' ' B' ' 23' ' ' PHE . 0.1 OUTLIER -109.7 91.87 11.27 Favored Pre-proline 0 CA--C 1.533 0.291 0 N-CA-C 112.26 0.467 . . . . 0.6 112.26 -179.51 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -76.63 115.73 4.13 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.108 1.872 . . . . 0.52 109.137 176.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 21' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -63.94 45.21 0.12 Allowed 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 122.881 2.387 . . . . 0.72 115.934 -176.242 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -89.83 -27.13 20.15 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.477 -0.564 . . . . 0.77 109.477 177.618 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 23' ' ' PHE . . . . . 0.663 ' HE2' HD13 ' B' ' 19' ' ' LEU . 0.4 OUTLIER -61.9 -41.41 97.86 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.322 0.582 . . . . 0.4 109.848 179.019 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 24' ' ' ALA . . . . . 0.512 ' O ' ' HB2' ' B' ' 28' ' ' ARG . . . -59.09 -43.83 91.85 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.249 -0.887 . . . . 0.42 111.126 179.425 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -72.42 -46.8 53.47 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 116.191 -0.459 . . . . 0.37 110.751 179.315 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -58.01 -54.31 48.42 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 115.96 -0.564 . . . . 0.39 110.778 179.541 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 98.8 mt -59.34 -37.86 78.91 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.596 -0.275 . . . . 0.4 110.863 179.431 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 28' ' ' ARG . . . . . 0.561 ' HA ' HG13 ' A' ' 234' ' ' VAL . 0.9 OUTLIER -61.32 -52.72 63.52 Favored 'General case' 0 CA--C 1.528 0.106 0 N-CA-C 109.9 -0.407 . . . . 0.46 109.9 178.736 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -59.82 -43.24 94.62 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.372 -0.377 . . . . 0.51 110.654 178.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 96.1 mt -58.75 -49.31 83.21 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 CA-C-N 116.345 -0.389 . . . . 0.41 110.172 178.655 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -55.32 -45.38 83.39 Favored Glycine 0 CA--C 1.52 0.404 0 CA-C-N 116.306 -0.407 . . . . 0.25 112.931 179.505 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -59.19 -49.61 77.19 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 121.087 0.47 . . . . 0.36 110.68 179.143 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 5.4 ttmm -64.01 -45.59 88.28 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 115.927 -0.578 . . . . 1.22 110.847 179.353 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 34' ' ' VAL . . . . . 0.707 HG21 HG13 ' A' ' 201' ' ' VAL . 5.3 t -58.56 -49.68 81.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 CA-C-O 120.958 0.409 . . . . 0.33 110.659 179.127 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -57.95 -43.65 86.51 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.971 -0.559 . . . . 0.65 110.601 178.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 36' ' ' CYS . . . . . . . . . . . . . 74.3 m -68.22 -25.93 65.46 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 120.942 0.401 . . . . 0.36 111.175 179.28 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 45.8 m -80.13 -35.47 36.65 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 116.115 -0.493 . . . . 0.33 111.953 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 38' ' ' TRP . . . . . . . . . . . . . 85.0 m95 -84.83 -30.47 24.5 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.039 0.385 . . . . 0.54 112.039 -179.586 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 16.9 p -70.19 -35.87 74.23 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 120.767 0.318 . . . . 0.41 110.673 179.248 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -90.72 115.1 63.47 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.384 -0.371 . . . . 0.46 111.222 178.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -80.87 171.17 14.6 Favored 'Trans proline' 0 CA--C 1.533 0.426 0 C-N-CA 122.566 2.177 . . . . 0.75 112.692 179.554 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.55 63.77 0.84 Allowed 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 121.048 0.452 . . . . 0.97 111.654 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 43' ' ' MET . . . . . . . . . . . . . 26.8 ttt . . . . . 0 C--O 1.251 1.151 0 CA-C-O 118.199 -0.905 . . . . 2.03 111.224 179.835 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.468 0 CA-C-O 119.776 -0.458 . . . . 4.5 112.242 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.37 -18.97 29.46 Favored 'Trans proline' 0 CA--C 1.535 0.557 0 C-N-CA 122.442 2.095 . . . . 3.99 113.514 -179.299 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 96.0 mt -119.0 80.41 1.54 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.841 0.353 . . . . 4.8 111.664 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 179.7 -94.64 0.1 OUTLIER Glycine 0 C--N 1.333 0.375 0 C-N-CA 120.612 -0.804 . . . . 2.27 112.479 179.428 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 68.3 p -84.44 96.26 9.04 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.674 -0.491 . . . . 1.24 109.674 178.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 9.2 mp0 -33.16 103.07 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.898 0 O-C-N 124.164 0.915 . . . . 0.69 113.34 -179.57 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' ASP . . . . . 0.578 ' HA ' ' HB3' ' A' ' 156' ' ' TYR . 2.6 m-20 -55.55 -37.67 68.3 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 113.73 1.011 . . . . 0.74 113.73 -178.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.474 ' HA ' ' HE ' ' A' ' 157' ' ' ARG . 11.2 t0 -52.58 -44.47 65.93 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 120.973 0.416 . . . . 0.49 111.27 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 44.4 tp -85.26 -33.36 22.19 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.142 0.496 . . . . 0.66 110.22 178.676 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' TYR . . . . . 0.578 ' HB3' ' HA ' ' A' ' 153' ' ' ASP . 55.6 t80 -61.21 -45.73 93.37 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 115.637 -0.71 . . . . 0.45 112.336 -179.737 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.637 ' HD2' ' OE1' ' A' ' 182' ' ' GLU . 20.4 ptt85 -59.4 -44.37 92.81 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 120.785 0.326 . . . . 0.5 110.993 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 10.3 mt-30 -65.17 -44.19 89.3 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-O 120.86 0.362 . . . . 0.53 110.223 178.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' SER . . . . . 0.531 ' HA ' ' CZ2' ' A' ' 293' ' ' TRP . 17.0 m -61.63 -49.43 76.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.965 -0.562 . . . . 0.38 111.129 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.599 HD21 ' HA ' ' A' ' 273' ' ' GLU . 0.2 OUTLIER -59.47 -44.12 93.09 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.349 -0.387 . . . . 0.7 110.879 179.375 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 161' ' ' GLU . . . . . 0.493 ' HG2' HD23 ' A' ' 180' ' ' LEU . 21.4 tt0 -66.9 -53.59 30.54 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 112.037 0.384 . . . . 0.45 112.037 -179.496 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 79.4 mt -61.22 -51.09 77.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 N-CA-C 112.28 0.474 . . . . 0.34 112.28 -179.491 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.42 HG23 HD13 ' A' ' 167' ' ' LEU . 59.2 mt -60.27 -51.42 73.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 N-CA-C 112.297 0.48 . . . . 0.4 112.297 -178.801 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 90.6 p -57.7 -35.84 71.18 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.575 0.226 . . . . 0.8 111.227 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' ARG . . . . . 0.411 HH11 ' HD2' ' A' ' 165' ' ' ARG . 0.0 OUTLIER -72.28 -51.1 22.41 Favored 'General case' 0 C--O 1.226 -0.157 0 C-N-CA 120.954 -0.298 . . . . 1.51 111.096 179.091 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 166' ' ' TYR . . . . . 0.798 ' HE1' ' HA ' ' A' ' 195' ' ' ARG . 60.1 t80 -59.7 -46.12 90.05 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 120.648 0.261 . . . . 0.39 111.244 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.42 HD13 HG23 ' A' ' 163' ' ' ILE . 5.2 mp -60.63 -45.47 93.94 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 116.354 -0.385 . . . . 0.37 111.175 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 12.2 ttm105 -71.99 -34.68 69.11 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 121.021 -0.272 . . . . 0.5 110.907 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -63.74 -52.63 59.6 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 120.752 0.31 . . . . 0.72 110.354 178.541 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' GLN . . . . . 0.406 ' O ' ' HE2' ' A' ' 257' ' ' LYS . 6.6 mm-40 -65.56 -26.51 67.9 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.902 0.382 . . . . 1.14 111.508 179.267 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -79.82 -23.98 41.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.375 -0.375 . . . . 0.35 111.955 179.344 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 19.1 p -102.09 -37.58 8.1 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.59 0.589 . . . . 0.5 112.59 -179.006 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 78.94 28.73 53.8 Favored Glycine 0 CA--C 1.521 0.45 0 C-N-CA 120.714 -0.755 . . . . 0.45 112.203 -179.086 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 23.0 t -112.45 175.06 5.59 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.43 0.634 . . . . 0.7 112.007 -179.058 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 24.0 pttt -88.2 75.46 8.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.737 -0.665 . . . . 1.32 110.496 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 39.8 t0 -65.16 156.44 31.69 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.78 -0.646 . . . . 1.08 111.734 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 14.8 m -58.57 118.25 5.43 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.238 -0.892 . . . . 0.98 111.236 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' LYS . . . . . 0.464 ' HB2' ' HD3' ' A' ' 179' ' ' PRO . 10.5 mmtm -75.89 -47.66 3.78 Favored Pre-proline 0 CA--C 1.542 0.646 0 N-CA-C 112.929 0.715 . . . . 0.56 112.929 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 179' ' ' PRO . . . . . 0.464 ' HD3' ' HB2' ' A' ' 178' ' ' LYS . 11.7 Cg_exo -72.12 100.52 1.11 Allowed 'Trans proline' 0 C--N 1.355 0.915 0 C-N-CA 121.773 1.649 . . . . 1.05 112.324 178.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.493 HD23 ' HG2' ' A' ' 161' ' ' GLU . 4.4 mp -76.17 -178.44 4.48 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 116.318 -0.401 . . . . 0.49 111.326 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -104.34 -54.61 0.79 Allowed Glycine 0 C--N 1.332 0.323 0 C-N-CA 120.622 -0.799 . . . . 0.41 112.565 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 182' ' ' GLU . . . . . 0.637 ' OE1' ' HD2' ' A' ' 157' ' ' ARG . 81.6 mm-40 -76.32 -53.24 8.48 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.234 0.54 . . . . 0.74 110.723 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.452 ' O ' ' HA3' ' A' ' 187' ' ' GLY . . . -100.13 87.91 3.59 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.961 -0.563 . . . . 0.41 111.05 179.444 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -78.7 -71.73 1.22 Allowed Glycine 0 CA--C 1.522 0.512 0 C-N-CA 120.118 -1.039 . . . . 0.51 112.887 -179.598 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -72.1 -48.49 43.56 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 120.96 0.409 . . . . 0.53 110.731 179.484 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -65.11 -34.42 78.36 Favored 'General case' 0 C--O 1.224 -0.237 0 CA-C-N 115.889 -0.596 . . . . 0.4 110.27 178.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 187' ' ' GLY . . . . . 0.452 ' HA3' ' O ' ' A' ' 183' ' ' ALA . . . -65.71 -40.9 96.02 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.67 -0.776 . . . . 0.37 111.66 178.597 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 188' ' ' ARG . . . . . 0.421 HH11 ' HD2' ' A' ' 188' ' ' ARG . 11.2 mmt180 -63.98 -54.29 36.76 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.753 0.311 . . . . 1.48 110.962 179.123 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 3.0 ttp180 -60.24 -42.85 96.15 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 115.882 -0.599 . . . . 2.07 110.942 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.541 ' HA ' ' CG1' ' A' ' 297' ' ' VAL . . . -64.26 -46.32 84.26 Favored 'General case' 0 C--O 1.222 -0.391 0 CA-C-N 116.391 -0.368 . . . . 0.33 110.681 179.055 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 15.7 tp -61.38 -37.36 83.1 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.722 0.296 . . . . 0.88 110.779 179.213 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 192' ' ' GLU . . . . . 0.615 ' OE2' ' HD3' ' A' ' 196' ' ' ARG . 4.0 tm-20 -63.01 -53.2 57.69 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 121.402 0.62 . . . . 1.04 110.84 178.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 193' ' ' THR . . . . . 0.503 HG21 ' HA ' ' A' ' 297' ' ' VAL . 98.0 m -70.21 -41.24 73.91 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.475 -0.784 . . . . 0.35 111.699 -178.578 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 0.487 HD11 HG21 ' A' ' 249' ' ' ILE . 11.3 tp -61.24 -42.39 98.53 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.281 -0.418 . . . . 0.37 111.433 179.531 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 195' ' ' ARG . . . . . 0.798 ' HA ' ' HE1' ' A' ' 166' ' ' TYR . 13.0 ttm-85 -65.6 -41.17 93.06 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 121.189 0.518 . . . . 0.94 109.867 178.614 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 196' ' ' ARG . . . . . 0.615 ' HD3' ' OE2' ' A' ' 192' ' ' GLU . 8.1 mtp-105 -63.32 -57.0 11.82 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.708 -0.678 . . . . 0.34 111.592 179.574 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 58.2 t -68.59 -40.13 81.43 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-N 116.397 -0.365 . . . . 0.33 111.962 -179.521 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 198' ' ' GLY . . . . . 0.544 ' HA3' ' OH ' ' A' ' 166' ' ' TYR . . . -59.15 -47.15 92.18 Favored Glycine 0 C--N 1.33 0.244 0 C-N-CA 121.475 -0.393 . . . . 0.25 112.751 -179.52 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -75.66 -26.35 57.6 Favored 'General case' 0 C--O 1.223 -0.316 0 N-CA-C 110.026 -0.361 . . . . 0.43 110.026 178.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -63.13 -47.02 91.86 Favored Glycine 0 C--N 1.336 0.568 0 N-CA-C 110.929 -0.868 . . . . 0.25 110.929 177.727 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 61.0 t -69.18 -39.57 79.45 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-O 121.017 0.437 . . . . 0.3 110.021 177.716 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 202' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -67.08 -41.48 86.26 Favored 'General case' 0 C--O 1.219 -0.504 0 CA-C-N 115.71 -0.677 . . . . 0.66 112.024 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 203' ' ' ARG . . . . . 0.4 ' CZ ' ' HA ' ' A' ' 203' ' ' ARG . 0.1 OUTLIER -63.88 -46.47 84.76 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.934 0.397 . . . . 0.36 110.298 179.779 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 32.6 m-80 -68.16 -46.82 69.73 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 115.987 -0.551 . . . . 0.48 112.107 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 86.3 m-70 -102.71 30.63 4.58 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 113.556 0.947 . . . . 0.34 113.556 -178.132 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -62.53 -36.21 81.89 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 121.011 0.434 . . . . 0.38 111.216 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 32.7 p -68.86 -39.8 79.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.085 0.469 . . . . 1.08 110.521 178.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -67.05 -40.76 87.21 Favored 'General case' 0 N--CA 1.456 -0.126 0 CA-C-N 115.887 -0.597 . . . . 0.3 110.085 178.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 11.8 m-30 -65.89 -39.59 90.77 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.991 -0.55 . . . . 0.42 110.22 178.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -67.04 -47.67 70.65 Favored 'General case' 0 N--CA 1.46 0.052 0 CA-C-N 116.354 -0.385 . . . . 0.89 110.362 178.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -58.59 -42.62 96.2 Favored Glycine 0 C--N 1.337 0.595 0 N-CA-C 111.0 -0.84 . . . . 0.3 111.0 178.183 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 30.6 ttm -64.16 -46.04 85.78 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.688 -0.486 . . . . 0.38 109.688 178.016 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.505 ' HA ' HD12 ' A' ' 216' ' ' LEU . 6.7 tp -59.62 -41.39 90.28 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.806 -0.634 . . . . 0.49 111.112 179.002 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 214' ' ' ARG . . . . . 0.538 ' HD3' ' O ' ' A' ' 214' ' ' ARG . 0.0 OUTLIER -65.0 -32.07 73.61 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.238 -0.437 . . . . 0.75 110.553 179.268 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 56.4 mtpt -89.0 -0.99 57.89 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.253 -0.43 . . . . 0.75 110.781 178.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.674 ' HB3' HG22 ' A' ' 218' ' ' ILE . 10.1 mt -92.26 134.28 35.04 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 121.175 0.512 . . . . 0.72 111.226 179.598 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -99.38 29.16 4.12 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 115.824 -0.625 . . . . 0.45 110.401 178.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 218' ' ' ILE . . . . . 0.674 HG22 ' HB3' ' A' ' 216' ' ' LEU . 2.3 tt -66.91 114.62 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 N-CA-C 113.061 0.763 . . . . 0.37 113.061 -178.603 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 10.0 ptpp? -161.27 4.69 0.06 Allowed 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 115.474 -0.785 . . . . 0.4 112.645 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -154.29 -175.96 5.65 Favored 'General case' 0 C--O 1.218 -0.567 0 O-C-N 121.747 -0.595 . . . . 0.59 112.555 -178.249 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -61.59 -20.84 63.76 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 112.599 0.592 . . . . 0.48 112.599 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -67.71 -42.95 86.34 Favored Glycine 0 CA--C 1.531 1.04 0 N-CA-C 114.708 0.643 . . . . 0.39 114.708 -179.345 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 223' ' ' ASP . . . . . 0.472 ' OD1' HG13 ' A' ' 218' ' ' ILE . 0.1 OUTLIER -65.51 -31.86 73.15 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 117.621 0.711 . . . . 0.38 112.05 -179.098 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 12.1 t -58.37 -42.35 83.76 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 CA-C-O 121.429 0.633 . . . . 0.39 110.337 178.521 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 35.2 mmtm -67.91 -41.52 82.56 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.783 -0.644 . . . . 0.45 109.689 178.815 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 226' ' ' SER . . . . . 0.561 ' O ' HG23 ' A' ' 230' ' ' VAL . 20.6 t -61.19 -38.95 88.38 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.506 -0.77 . . . . 0.45 110.07 178.558 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 227' ' ' PHE . . . . . 0.417 ' HE1' ' CD2' ' A' ' 251' ' ' PHE . 49.7 t80 -59.47 -43.22 93.3 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.45 -0.795 . . . . 0.47 110.423 178.295 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 228' ' ' SER . . . . . 0.97 ' HB2' HG21 ' A' ' 278' ' ' VAL . 9.6 p -65.16 -31.97 73.42 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.057 -0.519 . . . . 0.32 110.074 178.127 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 22.2 ttp-105 -67.84 -36.24 79.99 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 109.561 -0.533 . . . . 0.57 109.561 178.275 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 0.561 HG23 ' O ' ' A' ' 226' ' ' SER . 26.3 t -59.99 -45.41 95.4 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 N-CA-C 109.138 -0.69 . . . . 0.34 109.138 177.345 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 231' ' ' MET . . . . . 0.787 ' HG3' HD13 ' A' ' 248' ' ' LEU . 29.0 ttm -56.08 -53.26 59.09 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 114.822 -1.081 . . . . 0.32 111.786 179.205 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 34.2 m -66.09 -31.12 52.25 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-O 120.563 0.22 . . . . 0.4 111.419 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 44.3 t-80 -69.38 -42.27 75.4 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.987 0.423 . . . . 0.43 110.383 178.791 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.585 HG13 ' HA ' ' B' ' 28' ' ' ARG . 44.9 t -58.17 -43.99 86.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-N 116.192 -0.458 . . . . 0.33 110.749 178.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 235' ' ' PHE . . . . . 0.489 ' CD2' ' HA ' ' A' ' 240' ' ' THR . 96.2 m-85 -94.43 23.38 5.26 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 116.088 -0.505 . . . . 0.38 112.017 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -65.14 -13.47 58.21 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 112.028 0.381 . . . . 1.08 112.028 -179.373 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -83.37 -17.09 43.5 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.641 0.258 . . . . 0.41 111.324 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 97.15 -7.69 64.51 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 120.81 -0.71 . . . . 0.46 114.034 179.392 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 4.5 p -97.73 116.09 39.38 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 CA-C-O 121.337 0.589 . . . . 0.43 111.576 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 240' ' ' THR . . . . . 0.489 ' HA ' ' CD2' ' A' ' 235' ' ' PHE . 25.4 m -88.39 84.63 6.81 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.048 0.452 . . . . 0.61 111.875 -179.57 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 241' ' ' ASN . . . . . 0.521 ' HB2' ' HD2' ' A' ' 244' ' ' ARG . 92.0 m-20 -76.04 135.45 39.94 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.205 -0.452 . . . . 0.49 111.141 179.277 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 242' ' ' TRP . . . . . 0.608 ' HB3' ' CZ ' ' A' ' 300' ' ' PHE . 5.1 m95 -60.33 -37.88 82.01 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.911 0.386 . . . . 0.47 111.282 179.342 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 243' ' ' GLY . . . . . 0.493 ' HA3' ' N ' ' B' ' 35' ' ' TYR . . . -64.58 -29.95 76.57 Favored Glycine 0 CA--C 1.52 0.378 0 C-N-CA 121.072 -0.585 . . . . 0.27 112.376 178.742 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 244' ' ' ARG . . . . . 0.574 ' HA ' ' HA3' ' B' ' 31' ' ' GLY . 79.5 mtt180 -69.28 -44.53 71.65 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.86 -0.422 . . . . 0.34 109.86 178.728 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 245' ' ' ILE . . . . . 0.527 ' O ' HG12 ' A' ' 249' ' ' ILE . 69.7 mt -61.21 -53.84 43.45 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 CA-C-N 115.542 -0.754 . . . . 0.37 111.435 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 19.0 m -60.6 -34.84 60.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 C-N-CA 120.89 -0.324 . . . . 0.32 111.335 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 53.0 m -62.36 -44.68 95.9 Favored 'General case' 0 N--CA 1.463 0.179 0 N-CA-C 109.985 -0.376 . . . . 0.36 109.985 178.107 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 248' ' ' LEU . . . . . 0.787 HD13 ' HG3' ' A' ' 231' ' ' MET . 91.5 mt -65.8 -39.76 91.25 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.213 -0.448 . . . . 0.65 110.561 178.637 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 249' ' ' ILE . . . . . 0.527 HG12 ' O ' ' A' ' 245' ' ' ILE . 26.7 mm -65.67 -43.88 93.66 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 CA-C-O 121.119 0.485 . . . . 0.38 109.837 178.144 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 35.5 t -60.46 -45.97 91.79 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.788 -0.642 . . . . 0.28 109.383 178.236 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 251' ' ' PHE . . . . . 0.422 ' CD2' HD11 ' B' ' 27' ' ' LEU . 22.0 t80 -63.58 -39.4 94.28 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 115.687 -0.688 . . . . 0.34 110.115 178.144 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -56.99 -42.69 93.01 Favored Glycine 0 C--N 1.335 0.503 0 N-CA-C 111.419 -0.672 . . . . 0.25 111.419 177.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -69.21 -31.33 69.84 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 120.827 0.346 . . . . 0.28 110.521 177.454 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -70.93 -47.58 58.27 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 116.247 -0.433 . . . . 0.49 111.378 179.362 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 19.1 m -64.64 -35.62 75.26 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 C-N-CA 120.725 -0.39 . . . . 0.33 110.159 178.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -66.04 -32.33 73.74 Favored 'General case' 0 N--CA 1.456 -0.146 0 N-CA-C 109.257 -0.645 . . . . 0.29 109.257 177.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 257' ' ' LYS . . . . . 0.406 ' HE2' ' O ' ' A' ' 170' ' ' GLN . 24.5 ttmt -63.66 -40.03 95.82 Favored 'General case' 0 CA--C 1.528 0.108 0 CA-C-N 115.493 -0.776 . . . . 0.8 109.085 177.615 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 258' ' ' HIS . . . . . 0.463 ' HB2' HD21 ' A' ' 213' ' ' LEU . 75.4 t60 -66.09 -44.86 83.17 Favored 'General case' 0 C--O 1.231 0.085 0 CA-C-N 115.93 -0.577 . . . . 0.4 109.539 177.414 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 97.4 mt -60.14 -47.33 86.35 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 115.8 -0.636 . . . . 0.48 110.33 178.633 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 260' ' ' LYS . . . . . 0.44 ' HA ' ' OE1' ' A' ' 265' ' ' GLU . 0.7 OUTLIER -62.96 -33.8 76.16 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.277 -0.419 . . . . 0.53 110.742 178.998 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 72.4 m -60.23 -29.46 68.77 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 120.858 0.361 . . . . 0.51 110.836 179.179 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 262' ' ' VAL . . . . . 0.408 HG23 ' HG3' ' A' ' 264' ' ' GLN . 6.1 m -109.95 17.97 7.14 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-O 120.951 0.405 . . . . 0.49 110.662 178.509 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 58.05 50.33 10.28 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 115.528 -0.76 . . . . 0.58 113.036 179.469 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 264' ' ' GLN . . . . . 0.408 ' HG3' HG23 ' A' ' 262' ' ' VAL . 70.4 mt-30 -110.99 36.49 3.13 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 120.953 0.406 . . . . 0.44 110.931 178.729 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 265' ' ' GLU . . . . . 0.508 ' HA ' HD12 ' A' ' 268' ' ' ILE . 0.9 OUTLIER -51.36 -33.48 29.9 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 112.823 0.675 . . . . 0.53 112.823 -179.804 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 24.9 p -59.12 -20.25 51.95 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 111.793 0.294 . . . . 0.94 111.793 179.456 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 267' ' ' PHE . . . . . 0.418 ' C ' ' HD2' ' A' ' 270' ' ' PRO . 83.1 m-85 -93.35 -23.49 18.43 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 121.063 0.459 . . . . 0.6 110.838 178.868 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 268' ' ' ILE . . . . . 0.508 HD12 ' HA ' ' A' ' 265' ' ' GLU . 73.0 mt -67.62 -42.17 86.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 CA-C-N 116.243 -0.435 . . . . 0.38 110.889 179.382 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 269' ' ' GLU . . . . . 0.789 ' HB2' ' HD3' ' A' ' 270' ' ' PRO . 58.2 mm-40 -54.77 -56.41 27.67 Favored Pre-proline 0 CA--C 1.544 0.74 0 CA-C-N 116.006 -0.543 . . . . 0.58 111.789 179.539 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 270' ' ' PRO . . . . . 0.789 ' HD3' ' HB2' ' A' ' 269' ' ' GLU . 22.7 Cg_exo -66.81 -28.15 43.47 Favored 'Trans proline' 0 C--N 1.358 1.068 0 C-N-CA 122.181 1.921 . . . . 0.46 111.79 178.205 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 271' ' ' LEU . . . . . 0.5 ' O ' HG22 ' A' ' 275' ' ' ILE . 32.7 tp -62.91 -50.4 71.01 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.366 -0.379 . . . . 0.48 110.278 178.686 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 272' ' ' ALA . . . . . 0.405 ' HA ' HG22 ' A' ' 275' ' ' ILE . . . -60.69 -34.0 73.69 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 121.336 0.589 . . . . 0.36 110.602 178.769 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 273' ' ' GLU . . . . . 0.599 ' HA ' HD21 ' A' ' 160' ' ' LEU . 34.9 tt0 -71.85 -40.9 68.68 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.566 -0.743 . . . . 0.93 109.478 178.065 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 274' ' ' THR . . . . . . . . . . . . . 93.2 m -66.54 -50.62 62.57 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.792 -0.64 . . . . 0.35 111.663 179.58 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 275' ' ' ILE . . . . . 0.736 HG13 ' HE1' ' A' ' 231' ' ' MET . 13.6 tt -58.94 -49.67 82.31 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-N 116.816 -0.174 . . . . 0.34 111.125 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 13.2 m -62.06 -47.65 83.73 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.795 0.331 . . . . 0.35 111.037 179.449 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 277' ' ' ASP . . . . . 0.546 ' HB2' ' O ' ' A' ' 273' ' ' GLU . 4.4 t70 -53.31 -55.36 25.36 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 115.998 -0.546 . . . . 0.46 111.193 179.575 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 278' ' ' VAL . . . . . 0.97 HG21 ' HB2' ' A' ' 228' ' ' SER . 84.0 t -64.37 -40.53 89.38 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 CA-C-N 116.405 -0.361 . . . . 0.37 111.375 179.816 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 25.2 tp -62.73 -38.93 92.44 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.831 0.348 . . . . 0.58 111.644 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 91.5 t -82.73 -41.71 17.65 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 N-CA-C 112.249 0.463 . . . . 0.47 112.249 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 55.3 mtp180 -69.28 -28.02 65.93 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 112.959 0.725 . . . . 0.61 112.959 -178.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 282' ' ' THR . . . . . . . . . . . . . 82.0 p -93.67 -12.38 29.46 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 112.485 0.55 . . . . 0.68 112.485 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 4.4 mptp? -129.17 34.44 4.41 Favored 'General case' 0 C--N 1.33 -0.259 0 O-C-N 122.321 -0.237 . . . . 0.7 111.423 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 41.4 ttt180 -50.75 -53.07 34.69 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 116.291 -0.413 . . . . 0.97 111.867 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -59.27 -52.15 66.89 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 116.292 -0.413 . . . . 0.71 111.863 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 286' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -62.18 -42.74 99.56 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.492 0.553 . . . . 0.58 112.492 -179.04 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 287' ' ' LEU . . . . . 0.441 HD13 ' HA2' ' A' ' 292' ' ' GLY . 2.1 mm? -66.51 -49.77 65.45 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 111.719 0.266 . . . . 0.54 111.719 -179.516 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 5.5 p -65.56 -31.18 52.68 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-O 120.785 0.326 . . . . 0.62 111.261 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 11.8 ttmt -74.91 -30.69 61.35 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 120.79 0.328 . . . . 1.01 111.302 179.492 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -96.89 9.05 43.02 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 112.341 0.497 . . . . 0.64 112.341 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 291' ' ' ARG . . . . . 0.484 ' HB3' ' HB2' ' A' ' 294' ' ' ASP . 0.0 OUTLIER 62.57 24.87 14.82 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 112.767 0.654 . . . . 0.78 112.767 179.013 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 292' ' ' GLY . . . . . 0.441 ' HA2' HD13 ' A' ' 287' ' ' LEU . . . 56.07 -115.32 5.95 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 115.27 0.868 . . . . 0.39 115.27 178.533 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 293' ' ' TRP . . . . . 0.569 ' O ' HG22 ' A' ' 297' ' ' VAL . 88.8 m95 -65.83 -41.22 92.04 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 112.713 0.635 . . . . 0.7 112.713 -178.322 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 294' ' ' ASP . . . . . 0.484 ' HB2' ' HB3' ' A' ' 291' ' ' ARG . 27.6 m-20 -52.35 -49.67 63.86 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.086 0.47 . . . . 0.4 111.253 179.568 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -71.71 -33.74 63.21 Favored Glycine 0 CA--C 1.521 0.436 0 C-N-CA 120.84 -0.695 . . . . 0.29 112.598 179.343 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 296' ' ' PHE . . . . . 0.446 ' HB2' ' CH2' ' A' ' 242' ' ' TRP . 0.9 OUTLIER -66.77 -47.39 72.34 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 120.733 0.302 . . . . 0.32 111.759 179.893 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 297' ' ' VAL . . . . . 0.569 HG22 ' O ' ' A' ' 293' ' ' TRP . 23.7 m -68.06 -40.89 83.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 112.477 0.547 . . . . 0.35 112.477 -178.556 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 298' ' ' GLU . . . . . 0.431 ' OE1' ' HA ' ' A' ' 298' ' ' GLU . 0.0 OUTLIER -71.55 -30.21 65.63 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 120.538 -0.465 . . . . 0.45 112.079 -179.509 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 299' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -69.19 -41.97 76.43 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.83 0.348 . . . . 0.43 110.539 178.298 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 300' ' ' PHE . . . . . 0.608 ' CZ ' ' HB3' ' A' ' 242' ' ' TRP . 81.8 m-85 -90.87 30.73 1.15 Allowed 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 112.647 0.61 . . . . 0.35 112.647 -179.164 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -110.06 58.68 0.61 Allowed 'General case' 0 CA--C 1.535 0.373 0 O-C-N 121.983 -0.448 . . . . 0.4 110.82 179.114 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 302' ' ' VAL . . . . . 0.4 ' HB ' ' H ' ' A' ' 303' ' ' GLN . 5.7 t -98.48 -84.69 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 CA-C-N 116.233 -0.44 . . . . 0.78 111.835 -179.557 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 303' ' ' GLN . . . . . 0.4 ' H ' ' HB ' ' A' ' 302' ' ' VAL . 0.2 OUTLIER -170.65 119.08 0.53 Allowed 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 120.63 0.252 . . . . 1.03 111.41 -179.606 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -145.96 -82.22 0.14 Allowed 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 111.81 0.3 . . . . 0.47 111.81 179.168 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 305' ' ' LEU . . . . . 0.556 HD12 ' HG2' ' A' ' 196' ' ' ARG . 68.1 mt -69.43 -28.65 66.32 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 112.244 0.461 . . . . 0.85 112.244 -179.491 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 306' ' ' GLU . . . . . 0.448 ' CD ' ' H ' ' A' ' 306' ' ' GLU . 0.0 OUTLIER -89.39 -7.58 54.9 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.854 0.359 . . . . 0.71 110.984 179.625 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . -113.93 57.61 0.45 Allowed Glycine 0 CA--C 1.52 0.385 0 C-N-CA 120.96 -0.638 . . . . 1.36 112.62 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.104 0 CA-C-O 118.444 -1.198 . . . . 2.89 112.823 -179.921 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.372 0 CA-C-O 120.476 0.179 . . . . 0.71 111.069 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -82.97 153.03 25.21 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 120.934 0.397 . . . . 0.97 110.904 179.667 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 19' ' ' LEU . . . . . 0.615 HD21 ' HA ' ' A' ' 216' ' ' LEU . 10.7 mt -111.88 97.68 38.83 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-O 121.141 0.496 . . . . 0.43 111.265 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 20' ' ' PRO . . . . . 0.439 ' HA ' ' HD3' ' B' ' 21' ' ' PRO . 71.9 Cg_endo -76.21 158.67 37.37 Favored 'Trans proline' 0 CA--C 1.532 0.4 0 C-N-CA 122.924 2.416 . . . . 0.45 113.035 -179.468 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 21' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' B' ' 20' ' ' PRO . 17.2 Cg_exo -67.57 8.91 0.37 Allowed 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 122.967 2.444 . . . . 0.51 113.393 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -61.72 -41.51 97.71 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.39 -0.368 . . . . 0.51 111.285 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 23' ' ' PHE . . . . . 0.56 ' CE1' HG22 ' A' ' 230' ' ' VAL . 0.2 OUTLIER -60.38 -32.93 71.76 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 121.057 0.456 . . . . 0.36 110.528 179.549 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 24' ' ' ALA . . . . . 0.533 ' N ' ' HD1' ' B' ' 23' ' ' PHE . . . -72.8 -37.49 67.54 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 115.733 -0.667 . . . . 0.35 110.252 179.362 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.3 -42.59 99.07 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 109.674 -0.491 . . . . 0.36 109.674 178.443 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 26' ' ' GLN . . . . . 0.408 ' O ' HG13 ' B' ' 30' ' ' ILE . 0.1 OUTLIER -64.29 -54.44 33.18 Favored 'General case' 0 C--O 1.227 -0.125 0 CA-C-N 115.692 -0.685 . . . . 0.33 110.518 178.473 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 27' ' ' LEU . . . . . 0.537 HD12 HG11 ' A' ' 230' ' ' VAL . 48.9 mt -57.6 -35.23 70.15 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.855 0.36 . . . . 0.39 110.746 179.102 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 28' ' ' ARG . . . . . 0.585 ' HA ' HG13 ' A' ' 234' ' ' VAL . 65.5 ttt180 -60.86 -54.41 45.47 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 109.371 -0.603 . . . . 0.59 109.371 177.59 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -61.48 -41.14 96.81 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.725 -0.671 . . . . 0.83 111.18 178.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 30' ' ' ILE . . . . . 0.417 ' O ' HG23 ' B' ' 34' ' ' VAL . 95.6 mt -63.7 -44.05 98.27 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 N-CA-C 110.054 -0.35 . . . . 0.36 110.054 178.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 31' ' ' GLY . . . . . 0.574 ' HA3' ' HA ' ' A' ' 244' ' ' ARG . . . -60.68 -46.97 93.42 Favored Glycine 0 C--N 1.333 0.372 0 C-N-CA 120.645 -0.788 . . . . 0.28 111.674 178.807 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 85.0 m-20 -60.4 -36.93 79.27 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 121.196 0.522 . . . . 0.69 110.133 178.769 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 16.2 tppt? -68.05 -50.47 55.04 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 115.752 -0.658 . . . . 0.84 110.47 178.575 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 34' ' ' VAL . . . . . 0.417 HG23 ' O ' ' B' ' 30' ' ' ILE . 77.0 t -59.66 -42.26 87.87 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-O 120.943 0.402 . . . . 0.35 111.067 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 35' ' ' TYR . . . . . 0.493 ' N ' ' HA3' ' A' ' 243' ' ' GLY . 0.1 OUTLIER -57.9 -45.74 85.99 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 121.258 0.552 . . . . 0.93 109.907 178.479 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 36' ' ' CYS . . . . . . . . . . . . . 5.9 t -70.69 -26.09 63.26 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 115.905 -0.589 . . . . 0.54 111.17 179.114 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 37.3 m -71.61 -40.52 69.75 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 112.755 0.65 . . . . 0.37 112.755 -179.099 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 38' ' ' TRP . . . . . . . . . . . . . 99.3 m95 -85.64 -35.0 21.22 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.222 0.453 . . . . 0.45 112.222 -178.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 65.4 p -67.74 -42.44 81.82 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 111.644 0.238 . . . . 0.6 111.644 179.754 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -89.6 115.21 63.24 Favored Pre-proline 0 CA--C 1.532 0.257 0 CA-C-O 121.097 0.475 . . . . 0.67 111.144 179.367 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -82.18 63.58 8.26 Favored 'Trans proline' 0 CA--C 1.534 0.498 0 C-N-CA 122.663 2.242 . . . . 1.25 113.138 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 36.2 m-20 -74.72 71.78 1.96 Allowed 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 121.245 0.545 . . . . 1.46 111.411 179.733 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 43' ' ' MET . . . . . . . . . . . . . 54.2 mtt . . . . . 0 C--O 1.251 1.164 0 CA-C-O 118.362 -0.828 . . . . 2.63 111.353 -179.997 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.403 ' N ' ' OD1' ' A' ' 153' ' ' ASP . . . . . . . . 0 N--CA 1.491 2.322 0 CA-C-O 120.214 -0.215 . . . . 0.82 112.632 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_exo -72.73 52.38 2.09 Favored 'Trans proline' 0 CA--C 1.535 0.566 0 C-N-CA 123.068 2.512 . . . . 1.58 113.152 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 68.8 mt -109.57 15.94 22.55 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.449 0.642 . . . . 2.06 110.545 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 139.04 -158.17 25.14 Favored Glycine 0 N--CA 1.45 -0.409 0 CA-C-N 115.38 -0.827 . . . . 1.02 111.726 -179.602 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 3.1 p -83.49 69.07 10.0 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.994 0.426 . . . . 0.91 110.906 179.602 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.605 ' OE1' ' HD3' ' A' ' 284' ' ' ARG . 8.7 pt-20 -122.42 -33.29 3.48 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 112.39 0.515 . . . . 0.94 112.39 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' ASP . . . . . 0.403 ' OD1' ' N ' ' A' ' 147' ' ' GLY . 45.1 m-20 -56.78 -38.25 72.24 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 112.022 0.378 . . . . 1.15 112.022 -179.43 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -71.09 -45.05 64.45 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 120.892 0.377 . . . . 1.77 111.207 178.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 41.3 tp -69.92 -32.98 71.56 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-N 116.387 -0.37 . . . . 0.66 111.824 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' TYR . . . . . 0.401 ' HE1' ' HA ' ' A' ' 277' ' ' ASP . 0.2 OUTLIER -55.55 -50.44 70.03 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 113.174 0.805 . . . . 0.45 113.174 -179.445 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 60.0 mtp85 -54.63 -51.91 63.9 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 112.882 0.697 . . . . 0.58 112.882 -178.31 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' GLN . . . . . 0.532 ' OE1' ' HB3' ' A' ' 186' ' ' ALA . 4.9 tt0 -66.9 -43.84 82.33 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.082 -0.508 . . . . 0.56 111.193 -179.24 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 31.1 m -61.57 -47.57 84.88 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.856 -0.611 . . . . 0.28 111.101 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.736 HD11 ' HG3' ' A' ' 273' ' ' GLU . 27.9 tp -59.52 -47.82 84.03 Favored 'General case' 0 C--O 1.222 -0.373 0 CA-C-N 115.913 -0.585 . . . . 0.51 111.517 -179.747 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 161' ' ' GLU . . . . . 0.489 ' CD ' ' H ' ' A' ' 181' ' ' GLY . 26.8 tt0 -58.5 -50.41 73.86 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 120.601 0.239 . . . . 0.56 111.521 -179.328 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 162' ' ' ILE . . . . . 0.472 HD13 ' HB3' ' A' ' 190' ' ' ALA . 52.2 mt -58.05 -52.07 62.93 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-N 116.541 -0.299 . . . . 0.29 111.565 179.51 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.514 HD12 HG23 ' A' ' 276' ' ' THR . 88.2 mt -67.31 -54.86 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 N-CA-C 112.787 0.662 . . . . 0.29 112.787 -179.323 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 6.7 t -53.52 -41.23 66.15 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 120.775 0.322 . . . . 0.25 111.302 -178.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' ARG . . . . . 0.505 ' HD2' ' HA ' ' A' ' 165' ' ' ARG . 3.6 tpt180 -71.92 -45.93 59.4 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 120.344 -0.542 . . . . 0.6 110.775 179.28 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 166' ' ' TYR . . . . . 0.688 ' HE1' ' HA ' ' A' ' 195' ' ' ARG . 65.4 t80 -57.92 -49.33 77.13 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 111.561 0.208 . . . . 0.31 111.561 179.11 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 6.4 mp -60.82 -42.73 98.27 Favored 'General case' 0 C--O 1.226 -0.141 0 CA-C-N 116.717 -0.22 . . . . 0.39 110.566 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 1.9 ttt180 -65.28 -43.72 90.31 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 121.176 0.513 . . . . 0.44 110.457 178.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -60.44 -54.56 44.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.34 -0.846 . . . . 0.45 110.337 178.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 23.4 mm-40 -63.77 -35.8 81.79 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.09 -0.505 . . . . 0.28 111.085 179.41 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.449 ' HB2' ' HB1' ' A' ' 256' ' ' ALA . . . -57.33 -35.02 69.35 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.083 0.468 . . . . 0.31 111.496 179.186 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 21.8 m -94.11 -34.03 13.12 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.958 -0.564 . . . . 0.44 111.317 -179.365 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 89.36 12.18 63.43 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.884 -0.674 . . . . 0.5 112.131 -179.473 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 5.0 t -102.43 -168.61 1.55 Allowed 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 120.794 0.331 . . . . 0.39 111.079 -179.609 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' LYS . . . . . 0.455 ' HD3' ' HA ' ' A' ' 175' ' ' LYS . 1.9 tppt? -137.15 116.3 12.52 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.946 0.403 . . . . 0.52 111.552 -179.474 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -80.68 130.81 35.31 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.95 -0.568 . . . . 0.51 110.675 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 8.7 m -70.11 -23.83 63.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.062 -0.517 . . . . 1.07 110.697 179.21 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.55 70.21 25.98 Favored Pre-proline 0 CA--C 1.537 0.472 0 CA-C-N 116.159 -0.473 . . . . 0.86 110.85 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -66.25 -57.52 0.22 Allowed 'Trans proline' 0 C--N 1.347 0.5 0 C-N-CA 122.648 2.232 . . . . 0.4 113.397 -179.021 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -77.44 156.62 30.99 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.356 0.598 . . . . 0.59 111.296 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 181' ' ' GLY . . . . . 0.489 ' H ' ' CD ' ' A' ' 161' ' ' GLU . . . -130.92 -46.11 0.15 Allowed Glycine 0 C--N 1.32 -0.327 0 CA-C-N 115.532 -0.758 . . . . 0.55 111.269 179.362 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -108.8 -29.84 8.45 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 121.148 0.499 . . . . 0.63 110.398 178.695 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.516 ' O ' ' HA3' ' A' ' 187' ' ' GLY . . . -80.93 79.09 7.67 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 121.26 0.553 . . . . 0.36 110.642 179.486 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -78.55 -71.06 1.26 Allowed Glycine 0 CA--C 1.527 0.823 0 N-CA-C 115.16 0.824 . . . . 0.39 115.16 -178.4 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -68.49 -57.81 5.26 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 112.774 0.657 . . . . 0.48 112.774 -177.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 186' ' ' ALA . . . . . 0.532 ' HB3' ' OE1' ' A' ' 158' ' ' GLN . . . -72.08 -34.11 68.43 Favored 'General case' 0 C--O 1.221 -0.426 0 C-N-CA 120.466 -0.494 . . . . 0.43 110.265 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 187' ' ' GLY . . . . . 0.516 ' HA3' ' O ' ' A' ' 183' ' ' ALA . . . -62.14 -43.66 98.83 Favored Glycine 0 CA--C 1.52 0.393 0 C-N-CA 120.828 -0.701 . . . . 0.35 112.601 179.166 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 3.0 tmt_? -62.38 -53.78 49.96 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.84 0.32 . . . . 0.58 110.601 179.018 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 189' ' ' ARG . . . . . 0.51 ' O ' ' HG2' ' A' ' 192' ' ' GLU . 47.6 mtm180 -63.4 -44.22 95.3 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.233 -0.44 . . . . 0.45 111.933 -179.472 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.565 ' HB2' ' HB3' ' A' ' 293' ' ' TRP . . . -68.47 -45.48 72.33 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.179 0.437 . . . . 0.29 112.179 -179.206 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 191' ' ' LEU . . . . . 0.457 ' CD1' ' HB2' ' A' ' 166' ' ' TYR . 27.3 tp -65.91 -38.36 88.49 Favored 'General case' 0 N--CA 1.463 0.177 0 C-N-CA 120.411 -0.516 . . . . 0.6 111.813 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 192' ' ' GLU . . . . . 0.51 ' HG2' ' O ' ' A' ' 189' ' ' ARG . 9.3 pt-20 -66.61 -36.73 83.31 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 120.433 -0.507 . . . . 0.72 110.549 179.52 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 193' ' ' THR . . . . . 0.622 HG21 ' HA ' ' A' ' 297' ' ' VAL . 20.7 m -73.73 -46.75 44.02 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.129 -0.487 . . . . 0.31 110.247 179.512 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 0.409 HD21 HG21 ' A' ' 249' ' ' ILE . 14.6 tp -60.74 -38.35 84.83 Favored 'General case' 0 N--CA 1.457 -0.125 0 CA-C-N 115.75 -0.659 . . . . 0.32 110.261 179.29 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 195' ' ' ARG . . . . . 0.688 ' HA ' ' HE1' ' A' ' 166' ' ' TYR . 46.2 ttm105 -61.85 -51.15 69.4 Favored 'General case' 0 C--O 1.223 -0.293 0 CA-C-N 116.072 -0.513 . . . . 0.32 111.07 178.886 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 7.3 tpm_? -69.16 -53.03 22.21 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 112.828 0.677 . . . . 0.45 112.828 -179.149 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 197' ' ' VAL . . . . . 0.473 HG21 ' HB3' ' A' ' 300' ' ' PHE . 46.5 t -63.72 -50.63 77.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 N-CA-C 112.028 0.381 . . . . 0.3 112.028 -178.505 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -57.78 -50.35 66.31 Favored Glycine 0 C--N 1.333 0.402 0 C-N-CA 120.976 -0.631 . . . . 0.25 111.976 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -54.28 -40.74 68.12 Favored 'General case' 0 CA--C 1.526 0.054 0 N-CA-C 109.992 -0.373 . . . . 0.41 109.992 178.554 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -63.2 -50.68 60.98 Favored Glycine 0 CA--C 1.522 0.525 0 C-N-CA 120.831 -0.699 . . . . 0.33 111.85 178.434 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 201' ' ' VAL . . . . . 0.405 HG23 ' O ' ' A' ' 197' ' ' VAL . 60.2 t -60.25 -42.28 89.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-O 120.837 0.351 . . . . 0.4 110.995 178.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 202' ' ' GLN . . . . . 0.659 ' HG3' ' HB3' ' A' ' 250' ' ' SER . 25.8 mt-30 -66.91 -42.4 85.51 Favored 'General case' 0 C--O 1.223 -0.314 0 CA-C-N 116.033 -0.53 . . . . 0.39 112.088 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 203' ' ' ARG . . . . . 0.513 ' HD3' ' OE1' ' A' ' 206' ' ' GLU . 0.0 OUTLIER -70.35 -37.49 74.65 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.814 0.34 . . . . 0.32 110.493 179.476 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 16.1 m-80 -67.88 -47.73 68.05 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-O 121.15 0.5 . . . . 0.84 110.489 178.42 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 86.9 m-70 -101.04 35.88 2.11 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.183 -0.462 . . . . 0.44 111.328 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 206' ' ' GLU . . . . . 0.525 ' HG3' ' CZ ' ' A' ' 254' ' ' PHE . 2.6 tt0 -57.49 -48.84 78.16 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.274 -0.421 . . . . 0.47 111.562 -179.538 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 45.9 p -64.95 -39.39 93.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.334 -0.394 . . . . 0.49 111.646 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -61.19 -43.27 99.15 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 121.138 0.494 . . . . 0.32 110.483 179.037 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 209' ' ' PHE . . . . . 0.517 ' O ' ' HG ' ' A' ' 213' ' ' LEU . 21.9 m-85 -74.52 -39.1 62.59 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.949 -0.569 . . . . 0.42 110.295 179.147 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -60.09 -46.1 90.72 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.151 -0.477 . . . . 0.76 110.277 178.8 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -63.69 -39.22 97.3 Favored Glycine 0 C--N 1.335 0.516 0 N-CA-C 111.031 -0.827 . . . . 0.3 111.031 177.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 212' ' ' MET . . . . . 0.648 ' HA ' ' HE2' ' A' ' 215' ' ' LYS . 9.9 tpp -62.12 -40.4 95.77 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 109.718 -0.475 . . . . 0.68 109.718 178.182 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.627 HD13 ' HB2' ' A' ' 258' ' ' HIS . 40.7 mt -59.09 -41.29 87.73 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.372 -0.376 . . . . 0.4 111.169 178.663 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.74 -44.6 96.47 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.086 -0.506 . . . . 0.99 110.886 179.459 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 215' ' ' LYS . . . . . 0.648 ' HE2' ' HA ' ' A' ' 212' ' ' MET . 32.8 mtmt -73.13 -33.59 65.61 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 116.222 -0.444 . . . . 0.66 111.798 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.589 ' HA ' HD11 ' B' ' 19' ' ' LEU . 35.9 mt -65.32 143.48 57.74 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 121.254 0.55 . . . . 0.54 112.465 -179.602 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 217' ' ' ASP . . . . . 0.427 ' O ' ' HG3' ' A' ' 219' ' ' LYS . 0.3 OUTLIER -112.45 33.23 5.05 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.798 -0.637 . . . . 0.48 110.719 179.523 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 218' ' ' ILE . . . . . 0.464 HG12 ' HB3' ' A' ' 216' ' ' LEU . 27.5 mm -66.1 112.43 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 CA-C-N 116.549 -0.296 . . . . 0.51 111.29 -179.658 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 219' ' ' LYS . . . . . 0.427 ' HG3' ' O ' ' A' ' 217' ' ' ASP . 21.2 mtmm -134.33 -43.57 0.78 Allowed 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 112.15 0.426 . . . . 0.55 112.15 -179.426 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -128.9 -176.37 3.83 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 112.737 0.643 . . . . 0.58 112.737 -177.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 221' ' ' GLU . . . . . 0.568 ' O ' HG22 ' A' ' 224' ' ' VAL . 1.2 mp0 -61.37 -22.31 64.85 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 112.743 0.646 . . . . 0.72 112.743 -179.055 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -70.19 -27.25 73.13 Favored Glycine 0 CA--C 1.524 0.61 0 C-N-CA 120.402 -0.904 . . . . 0.34 112.999 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -70.12 -31.29 68.76 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 112.779 0.659 . . . . 0.4 112.779 -179.15 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.568 HG22 ' O ' ' A' ' 221' ' ' GLU . 3.8 m -56.56 -27.37 25.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 N-CA-C 112.122 0.416 . . . . 0.46 112.122 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 225' ' ' LYS . . . . . 0.473 ' O ' ' HG3' ' A' ' 229' ' ' ARG . 7.9 mptt -64.93 -42.49 94.63 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.037 0.446 . . . . 0.51 110.184 178.723 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 226' ' ' SER . . . . . 0.708 ' HA ' ' HE ' ' A' ' 229' ' ' ARG . 31.6 m -70.71 -36.68 73.34 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.228 -0.442 . . . . 0.59 109.877 178.478 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 227' ' ' PHE . . . . . . . . . . . . . 16.5 t80 -61.94 -40.68 96.36 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.767 -0.651 . . . . 0.55 109.631 178.388 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 49.2 m -65.24 -38.17 89.52 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.72 -0.673 . . . . 0.46 109.954 178.574 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 229' ' ' ARG . . . . . 0.708 ' HE ' ' HA ' ' A' ' 226' ' ' SER . 61.3 mtm180 -59.65 -37.51 78.9 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.239 -0.437 . . . . 0.65 109.925 178.187 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 0.529 HG22 ' CE1' ' B' ' 23' ' ' PHE . 44.4 t -59.42 -53.54 46.73 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.142 0 N-CA-C 109.311 -0.625 . . . . 0.4 109.311 177.433 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 231' ' ' MET . . . . . 0.504 ' SD ' HD13 ' A' ' 248' ' ' LEU . 1.5 ttp -56.15 -45.23 79.7 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 115.463 -0.79 . . . . 0.73 111.01 178.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 80.6 t -62.75 -42.32 95.77 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-O 120.901 0.381 . . . . 0.49 110.923 178.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 9.2 t-80 -69.85 -35.58 74.84 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 116.515 -0.311 . . . . 0.54 111.221 179.625 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.517 HG23 ' O ' ' A' ' 230' ' ' VAL . 39.5 t -54.19 -37.01 34.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 CA-C-O 120.974 0.416 . . . . 0.43 111.48 179.351 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 235' ' ' PHE . . . . . 0.596 ' CE1' ' HA ' ' A' ' 240' ' ' THR . 72.9 m-85 -102.26 24.55 10.07 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 112.007 0.373 . . . . 0.55 112.007 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 236' ' ' LYS . . . . . 0.41 ' HA ' ' HD2' ' A' ' 236' ' ' LYS . 8.2 tptp -70.22 -20.63 63.08 Favored 'General case' 0 CA--C 1.537 0.462 0 O-C-N 122.241 -0.287 . . . . 1.17 111.355 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 23.8 p-10 -82.22 -8.29 59.64 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 120.789 0.328 . . . . 0.73 110.869 179.569 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 83.05 9.92 83.53 Favored Glycine 0 CA--C 1.522 0.475 0 C-N-CA 120.99 -0.624 . . . . 0.49 114.039 178.688 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 33.5 t -102.23 91.08 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.441 0.638 . . . . 0.53 111.187 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 240' ' ' THR . . . . . 0.596 ' HA ' ' CE1' ' A' ' 235' ' ' PHE . 3.1 m -80.13 73.27 6.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.875 -0.602 . . . . 0.71 111.439 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 38.3 m-20 -80.11 140.87 36.24 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.928 0.394 . . . . 0.51 111.885 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 242' ' ' TRP . . . . . 0.477 ' HB3' ' CE2' ' A' ' 300' ' ' PHE . 35.4 m95 -57.96 -40.03 79.55 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.981 -0.554 . . . . 0.5 111.367 179.538 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 243' ' ' GLY . . . . . 0.459 ' H ' ' HB2' ' B' ' 35' ' ' TYR . . . -61.69 -27.43 68.25 Favored Glycine 0 CA--C 1.521 0.467 0 C-N-CA 120.864 -0.684 . . . . 0.25 112.135 178.643 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 244' ' ' ARG . . . . . 0.548 ' HG2' ' HA3' ' B' ' 31' ' ' GLY . 71.9 mtt180 -74.81 -46.03 39.46 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 110.0 -0.37 . . . . 0.54 110.0 178.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 245' ' ' ILE . . . . . 0.525 HG23 HD11 ' A' ' 279' ' ' LEU . 83.7 mt -58.2 -47.33 87.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-N 115.674 -0.694 . . . . 0.49 109.899 179.046 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 246' ' ' VAL . . . . . 0.471 HG11 HG12 ' A' ' 197' ' ' VAL . 83.9 t -64.82 -38.41 82.66 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-N 115.87 -0.604 . . . . 0.35 110.059 178.139 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 17.0 m -60.68 -41.5 95.21 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.712 0.291 . . . . 0.32 110.217 178.423 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 248' ' ' LEU . . . . . 0.559 HD23 HD13 ' B' ' 27' ' ' LEU . 64.3 mt -63.02 -43.89 97.47 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 121.043 0.449 . . . . 0.74 109.842 177.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 249' ' ' ILE . . . . . 0.508 HG12 ' O ' ' A' ' 245' ' ' ILE . 41.6 mm -63.01 -40.46 89.12 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 CA-C-O 121.35 0.595 . . . . 0.41 109.579 177.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 250' ' ' SER . . . . . 0.659 ' HB3' ' HG3' ' A' ' 202' ' ' GLN . 38.8 m -61.57 -47.63 84.63 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 115.243 -0.89 . . . . 0.29 109.624 178.82 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 251' ' ' PHE . . . . . 0.527 ' O ' HG23 ' A' ' 255' ' ' VAL . 11.1 t80 -60.81 -45.4 94.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.452 -0.795 . . . . 0.43 109.579 178.155 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -55.66 -48.07 73.65 Favored Glycine 0 C--N 1.335 0.523 0 C-N-CA 121.151 -0.547 . . . . 0.22 111.974 178.479 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 253' ' ' ALA . . . . . 0.543 ' O ' ' HG3' ' A' ' 257' ' ' LYS . . . -62.1 -34.69 76.8 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 120.737 0.303 . . . . 0.25 111.069 178.826 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 254' ' ' PHE . . . . . 0.525 ' CZ ' ' HG3' ' A' ' 206' ' ' GLU . 2.4 t80 -72.18 -41.5 66.93 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 121.08 0.467 . . . . 0.4 110.45 178.762 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 255' ' ' VAL . . . . . 0.527 HG23 ' O ' ' A' ' 251' ' ' PHE . 81.1 t -65.19 -36.25 77.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 N-CA-C 109.047 -0.723 . . . . 0.31 109.047 177.533 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 256' ' ' ALA . . . . . 0.449 ' HB1' ' HB2' ' A' ' 171' ' ' ALA . . . -62.69 -36.76 83.96 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 115.544 -0.753 . . . . 0.24 109.61 178.101 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 257' ' ' LYS . . . . . 0.543 ' HG3' ' O ' ' A' ' 253' ' ' ALA . 54.7 mttm -60.66 -43.54 97.5 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.033 -0.531 . . . . 0.38 109.65 177.571 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 258' ' ' HIS . . . . . 0.627 ' HB2' HD13 ' A' ' 213' ' ' LEU . 34.7 t60 -57.09 -44.36 83.11 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.824 -0.626 . . . . 0.69 110.844 178.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 94.3 mt -71.04 -40.77 71.5 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 120.99 0.424 . . . . 0.61 111.404 179.327 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -65.85 -27.78 68.49 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 120.646 0.26 . . . . 0.42 111.481 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 51.2 m -62.84 -21.66 66.11 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 116.356 -0.384 . . . . 0.45 111.414 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 11.3 m -120.35 23.58 4.83 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-N 116.289 -0.414 . . . . 0.6 111.44 179.413 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 54.4 m-80 58.03 45.33 18.09 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 112.888 0.699 . . . . 1.26 112.888 179.516 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -109.46 37.65 2.55 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 122.176 -0.328 . . . . 0.89 111.678 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 265' ' ' GLU . . . . . 0.599 ' HA ' HD12 ' A' ' 268' ' ' ILE . 13.3 tt0 -58.04 -28.62 64.66 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 111.975 0.361 . . . . 0.74 111.975 -179.564 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 15.5 p -62.17 -18.68 61.69 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.189 -0.459 . . . . 0.53 111.212 179.035 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 267' ' ' PHE . . . . . 0.416 ' C ' ' HD2' ' A' ' 270' ' ' PRO . 90.1 m-85 -101.94 -19.0 15.42 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 121.05 0.453 . . . . 0.65 110.242 177.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 268' ' ' ILE . . . . . 0.599 HD12 ' HA ' ' A' ' 265' ' ' GLU . 78.9 mt -66.9 -43.86 89.18 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-N 115.767 -0.651 . . . . 0.35 110.599 179.605 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 269' ' ' GLU . . . . . 0.776 ' HB2' ' HD3' ' A' ' 270' ' ' PRO . 45.2 mt-10 -59.47 -57.3 27.96 Favored Pre-proline 0 CA--C 1.54 0.577 0 CA-C-N 116.271 -0.422 . . . . 0.42 110.54 178.823 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 270' ' ' PRO . . . . . 0.776 ' HD3' ' HB2' ' A' ' 269' ' ' GLU . 66.4 Cg_exo -54.0 -35.14 79.91 Favored 'Trans proline' 0 C--N 1.362 1.261 0 C-N-CA 122.137 1.891 . . . . 0.45 112.212 178.36 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 271' ' ' LEU . . . . . . . . . . . . . 51.1 tp -68.54 -54.57 15.85 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.312 -0.404 . . . . 0.45 110.073 178.497 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -57.6 -40.47 79.15 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 116.282 -0.417 . . . . 0.23 110.918 179.008 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 273' ' ' GLU . . . . . 0.736 ' HG3' HD11 ' A' ' 160' ' ' LEU . 0.7 OUTLIER -66.43 -44.19 83.57 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.119 -0.491 . . . . 0.33 110.302 178.499 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 274' ' ' THR . . . . . . . . . . . . . 67.5 m -61.46 -43.16 99.35 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-O 120.905 0.383 . . . . 0.28 110.195 178.667 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 96.7 mt -59.05 -53.98 40.45 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-N 115.973 -0.558 . . . . 0.31 110.696 178.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 276' ' ' THR . . . . . 0.53 HG21 ' HA ' ' A' ' 160' ' ' LEU . 49.9 m -56.76 -47.08 80.89 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.299 -0.41 . . . . 0.29 110.77 179.476 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 277' ' ' ASP . . . . . 0.611 ' O ' ' HB2' ' A' ' 281' ' ' ARG . 28.0 t70 -55.82 -59.21 5.2 Favored 'General case' 0 C--O 1.222 -0.358 0 CA-C-N 115.632 -0.713 . . . . 0.46 111.157 179.442 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 84.4 t -58.7 -36.98 63.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-O 120.905 0.383 . . . . 0.41 111.384 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 279' ' ' LEU . . . . . 0.525 HD11 HG23 ' A' ' 245' ' ' ILE . 26.3 tp -63.95 -47.19 81.45 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 116.333 -0.394 . . . . 0.7 112.024 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 60.8 t -80.89 -42.18 20.11 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 N-CA-C 112.272 0.471 . . . . 0.44 112.272 -179.513 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 281' ' ' ARG . . . . . 0.611 ' HB2' ' O ' ' A' ' 277' ' ' ASP . 2.7 ttt180 -56.49 -43.41 79.63 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 112.936 0.717 . . . . 0.89 112.936 -179.393 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 282' ' ' THR . . . . . . . . . . . . . 51.9 p -83.0 -23.7 33.19 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 113.143 0.794 . . . . 0.57 113.143 -179.125 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 283' ' ' LYS . . . . . 0.451 ' HD3' HG23 ' A' ' 240' ' ' THR . 1.5 mttp -118.04 39.16 3.46 Favored 'General case' 0 C--N 1.329 -0.307 0 O-C-N 122.068 -0.395 . . . . 0.77 111.905 -179.062 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 284' ' ' ARG . . . . . 0.605 ' HD3' ' OE1' ' A' ' 152' ' ' GLU . 31.0 ttp180 -58.65 -48.11 82.16 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.109 -0.496 . . . . 0.93 111.932 -179.734 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -68.41 -46.08 70.89 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 116.574 -0.285 . . . . 0.52 111.755 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 286' ' ' TRP . . . . . . . . . . . . . 1.8 t90 -61.65 -45.97 91.78 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 112.023 0.379 . . . . 0.51 112.023 -179.128 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -63.37 -52.25 62.49 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.15 0.426 . . . . 0.49 112.15 -179.418 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 6.8 p -61.8 -30.74 49.09 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 CA-C-O 120.784 0.326 . . . . 0.55 111.787 -179.5 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 10.6 ttmt -69.55 -38.78 77.61 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 120.971 0.415 . . . . 0.86 111.121 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 290' ' ' GLN . . . . . 0.451 ' HB3' ' HZ2' ' A' ' 242' ' ' TRP . 3.4 mp0 -91.6 22.45 4.05 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 112.231 0.456 . . . . 0.95 112.231 -179.44 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 8.7 mpt_? 61.67 17.61 8.83 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 112.391 0.515 . . . . 0.86 112.391 179.379 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 58.81 -120.27 21.67 Favored Glycine 0 CA--C 1.523 0.566 0 CA-C-O 121.436 0.464 . . . . 0.44 113.997 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 293' ' ' TRP . . . . . 0.565 ' HB3' ' HB2' ' A' ' 190' ' ' ALA . 84.9 m95 -65.44 -28.56 69.32 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.717 0.636 . . . . 0.47 112.717 -178.74 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 294' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.38 -45.24 91.99 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 121.075 0.464 . . . . 0.56 110.595 179.009 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -69.28 -30.89 71.44 Favored Glycine 0 CA--C 1.518 0.259 0 C-N-CA 120.472 -0.871 . . . . 0.29 111.252 178.355 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 296' ' ' PHE . . . . . 0.475 ' HB2' ' CZ3' ' A' ' 242' ' ' TRP . 2.5 t80 -69.62 -48.44 59.99 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 115.7 -0.25 . . . . 0.35 111.512 179.013 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 297' ' ' VAL . . . . . 0.622 ' HA ' HG21 ' A' ' 193' ' ' THR . 26.4 m -66.2 -33.83 66.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 N-CA-C 112.113 0.412 . . . . 0.31 112.113 -179.165 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -76.11 -33.08 59.47 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 120.624 0.25 . . . . 0.86 111.052 179.412 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 299' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -69.7 -38.23 76.88 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.025 0.441 . . . . 0.43 110.456 178.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 300' ' ' PHE . . . . . 0.477 ' CE2' ' HB3' ' A' ' 242' ' ' TRP . 91.2 m-85 -102.52 27.08 7.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.206 0.527 . . . . 0.38 110.691 179.224 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 22.7 t-80 -78.67 130.09 35.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.794 -0.639 . . . . 0.44 111.359 -179.712 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 302' ' ' VAL . . . . . 0.403 ' HB ' ' OXT' ' A' ' 308' ' ' GLY . 20.1 m -96.6 179.46 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.777 -0.647 . . . . 0.57 111.001 179.367 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 303' ' ' GLN . . . . . 0.783 ' HB3' ' HB2' ' A' ' 306' ' ' GLU . 44.7 mt-30 -83.86 74.09 10.24 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.78 0.324 . . . . 0.63 110.784 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -66.03 -49.62 67.09 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 120.96 0.41 . . . . 0.62 111.813 -179.641 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 21.5 tp -72.02 -15.42 62.04 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 112.305 0.483 . . . . 1.51 112.305 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 306' ' ' GLU . . . . . 0.783 ' HB2' ' HB3' ' A' ' 303' ' ' GLN . 35.2 mt-10 -101.41 -44.88 5.49 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 112.254 0.464 . . . . 0.85 112.254 -179.413 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . 125.95 47.56 0.21 Allowed Glycine 0 CA--C 1.525 0.689 0 C-N-CA 120.679 -0.772 . . . . 0.77 113.719 179.699 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 308' ' ' GLY . . . . . 0.403 ' OXT' ' HB ' ' A' ' 302' ' ' VAL . . . . . . . . 0 C--O 1.251 1.186 0 CA-C-O 118.578 -1.123 . . . . 0.59 113.452 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 17' ' ' ALA . . . . . 0.404 ' N ' ' OD1' ' A' ' 217' ' ' ASP . . . . . . . . 0 N--CA 1.493 1.698 0 CA-C-O 121.277 0.56 . . . . 0.62 110.927 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 18' ' ' GLU . . . . . 0.599 ' O ' ' HD3' ' B' ' 20' ' ' PRO . 1.9 pm0 -71.97 81.86 0.93 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.297 -0.865 . . . . 0.59 110.724 179.418 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 19' ' ' LEU . . . . . 0.589 HD11 ' HA ' ' A' ' 216' ' ' LEU . 6.5 mp -107.14 93.12 8.78 Favored Pre-proline 0 CA--C 1.536 0.431 0 N-CA-C 112.587 0.588 . . . . 0.52 112.587 -179.344 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 20' ' ' PRO . . . . . 0.599 ' HD3' ' O ' ' B' ' 18' ' ' GLU . 87.8 Cg_endo -98.45 163.62 0.72 Allowed 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 123.764 2.976 . . . . 0.47 112.143 178.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 21' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -64.32 6.38 0.32 Allowed 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 122.674 2.25 . . . . 0.66 113.482 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 22' ' ' GLU . . . . . 0.405 ' H ' ' C ' ' B' ' 20' ' ' PRO . 4.8 tm-20 -69.78 -35.8 75.18 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.204 -0.453 . . . . 0.79 111.537 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 23' ' ' PHE . . . . . 0.529 ' CE1' HG22 ' A' ' 230' ' ' VAL . 0.2 OUTLIER -62.17 -33.21 74.09 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.763 0.316 . . . . 0.47 111.634 -179.84 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 24' ' ' ALA . . . . . 0.512 ' N ' ' HD1' ' B' ' 23' ' ' PHE . . . -75.63 -36.32 60.26 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.236 0.541 . . . . 0.48 109.872 179.274 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -69.25 -43.02 74.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.618 -0.719 . . . . 0.46 110.198 178.654 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -60.24 -48.72 80.55 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.074 -0.512 . . . . 0.63 110.854 179.396 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 27' ' ' LEU . . . . . 0.559 HD13 HD23 ' A' ' 248' ' ' LEU . 89.2 mt -64.73 -33.4 75.89 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 120.92 0.391 . . . . 0.45 110.324 178.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 28' ' ' ARG . . . . . . . . . . . . . 3.6 tmt_? -64.46 -45.73 86.18 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 121.215 0.531 . . . . 0.87 109.722 177.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 33.4 mtpt -71.27 -45.19 63.72 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 115.672 -0.695 . . . . 0.59 111.647 179.617 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 96.7 mt -62.52 -43.44 98.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-O 120.722 0.296 . . . . 0.4 110.324 179.733 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 31' ' ' GLY . . . . . 0.548 ' HA3' ' HG2' ' A' ' 244' ' ' ARG . . . -59.72 -50.25 69.73 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.807 -0.711 . . . . 0.3 112.582 179.437 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -65.81 -32.11 73.45 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.749 0.275 . . . . 0.56 110.754 179.252 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.9 -52.0 58.89 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 121.097 0.475 . . . . 0.7 109.738 178.307 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 55.2 t -63.04 -45.1 99.66 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-N 115.494 -0.775 . . . . 0.38 110.53 178.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 35' ' ' TYR . . . . . 0.459 ' HB2' ' H ' ' A' ' 243' ' ' GLY . 0.7 OUTLIER -54.98 -47.05 75.1 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 115.607 -0.724 . . . . 0.63 111.316 179.319 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 36' ' ' CYS . . . . . . . . . . . . . 73.0 m -62.45 -45.07 94.72 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 120.663 0.268 . . . . 0.45 111.303 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 13.1 m -60.4 -37.55 81.19 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 116.316 -0.402 . . . . 0.61 112.033 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 38' ' ' TRP . . . . . . . . . . . . . 93.9 m95 -87.65 -29.47 21.15 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 112.637 0.606 . . . . 0.75 112.637 -179.429 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 42.2 t -67.76 -31.08 70.73 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 111.982 0.364 . . . . 0.6 111.982 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -89.53 117.57 68.28 Favored Pre-proline 0 CA--C 1.533 0.293 0 CA-C-O 120.745 0.307 . . . . 0.66 111.505 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -71.23 -24.09 23.63 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.64 2.226 . . . . 1.34 112.98 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -74.3 76.37 1.85 Allowed 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 115.999 -0.546 . . . . 1.54 111.089 179.634 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 43' ' ' MET . . . . . . . . . . . . . 4.5 mmm . . . . . 0 C--O 1.25 1.105 0 CA-C-O 118.307 -0.854 . . . . 2.51 111.712 179.925 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.456 0 CA-C-O 119.8 -0.444 . . . . 2.63 112.423 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -73.06 67.49 4.11 Favored 'Trans proline' 0 CA--C 1.534 0.519 0 C-N-CA 122.595 2.197 . . . . 1.84 112.645 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 90.5 mt -98.58 157.04 16.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.256 -0.429 . . . . 1.06 111.528 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -169.08 -88.29 0.07 OUTLIER Glycine 0 CA--C 1.521 0.448 0 C-N-CA 120.86 -0.686 . . . . 0.49 112.792 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 93.4 p -81.32 60.72 4.51 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.36 0.6 . . . . 0.55 111.294 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.667 ' OE2' ' HD2' ' A' ' 284' ' ' ARG . 4.4 mp0 -110.32 -60.98 1.73 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.853 -0.612 . . . . 0.37 111.753 -179.702 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -46.64 -47.73 20.06 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 113.448 0.907 . . . . 0.52 113.448 -178.527 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -49.35 -51.62 33.41 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 121.038 0.447 . . . . 0.48 112.142 -179.257 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.519 HD21 ' HB3' ' A' ' 287' ' ' LEU . 44.7 tp -84.47 -40.2 18.0 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.297 -0.41 . . . . 0.91 111.664 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' TYR . . . . . 0.496 ' OH ' ' HB2' ' A' ' 281' ' ' ARG . 0.3 OUTLIER -52.04 -44.16 64.1 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 112.203 0.446 . . . . 0.36 112.203 -179.766 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.653 ' HD2' ' OE2' ' A' ' 182' ' ' GLU . 21.5 mtm180 -60.56 -51.9 67.46 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 112.145 0.424 . . . . 0.53 112.145 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 1.8 mm100 -63.27 -40.13 96.53 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 121.239 0.542 . . . . 0.53 110.401 179.584 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 18.4 m -64.89 -50.1 67.89 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.414 -0.812 . . . . 0.28 111.534 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -55.96 -47.89 76.8 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.405 -0.361 . . . . 0.47 111.046 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' GLU . . . . . 0.621 ' O ' ' HB2' ' A' ' 165' ' ' ARG . 1.4 mm-40 -59.37 -47.26 86.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.402 -0.363 . . . . 0.55 111.294 179.349 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 162' ' ' ILE . . . . . 0.55 HG12 ' HA2' ' A' ' 187' ' ' GLY . 68.4 mt -66.04 -51.88 55.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 N-CA-C 113.114 0.783 . . . . 0.35 113.114 -179.01 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.539 HD12 HG23 ' A' ' 276' ' ' THR . 56.0 mt -60.18 -54.62 32.39 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 N-CA-C 112.232 0.456 . . . . 0.34 112.232 -178.612 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 70.4 p -59.33 -37.08 76.9 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.63 0.252 . . . . 0.33 111.077 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' ARG . . . . . 0.626 ' HG2' ' HG ' ' A' ' 180' ' ' LEU . 0.0 OUTLIER -68.92 -36.78 78.39 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 120.959 -0.296 . . . . 0.56 111.256 179.099 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 166' ' ' TYR . . . . . 0.852 ' HE1' ' HA ' ' A' ' 195' ' ' ARG . 67.5 t80 -72.32 -49.16 36.54 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 121.237 -0.185 . . . . 0.48 111.242 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.512 ' HG ' ' O ' ' A' ' 163' ' ' ILE . 38.1 mt -55.99 -41.01 74.17 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.183 0.516 . . . . 0.34 110.316 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 3.7 tpp180 -69.83 -42.99 72.91 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.554 -0.748 . . . . 0.49 110.449 178.402 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' GLU . . . . . 0.663 ' HA ' ' HA3' ' A' ' 173' ' ' GLY . 0.4 OUTLIER -56.85 -44.05 81.74 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 116.351 -0.386 . . . . 0.52 111.939 -179.701 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 22.5 tp60 -76.28 -32.9 59.04 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 112.034 0.383 . . . . 0.55 112.034 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.865 ' HA ' ' HG2' ' A' ' 257' ' ' LYS . . . -79.2 -54.24 6.18 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 113.072 0.768 . . . . 0.45 113.072 -179.476 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 172' ' ' THR . . . . . 0.547 ' HB ' ' HG2' ' A' ' 260' ' ' LYS . 11.3 t -147.14 33.41 0.9 Allowed 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.264 0.554 . . . . 0.46 112.135 -177.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 173' ' ' GLY . . . . . 0.663 ' HA3' ' HA ' ' A' ' 169' ' ' GLU . . . -71.77 28.43 0.62 Allowed Glycine 0 CA--C 1.528 0.902 0 C-N-CA 120.978 -0.629 . . . . 0.53 114.633 -178.742 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 81.0 p -108.87 -22.38 12.22 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 117.261 0.531 . . . . 0.55 111.305 179.637 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -142.83 17.42 1.97 Allowed 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.439 -0.346 . . . . 0.61 111.801 -179.683 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -129.48 -159.07 0.93 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.06 0.457 . . . . 0.6 112.055 -178.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 71.2 p -63.91 101.31 0.37 Allowed 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.957 -0.565 . . . . 0.53 111.39 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' LYS . . . . . 0.492 ' H ' ' HD2' ' A' ' 179' ' ' PRO . 33.4 tttp -104.42 -51.01 0.12 Allowed Pre-proline 0 CA--C 1.544 0.729 0 N-CA-C 112.818 0.673 . . . . 0.5 112.818 -179.364 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 179' ' ' PRO . . . . . 0.492 ' HD2' ' H ' ' A' ' 178' ' ' LYS . 89.2 Cg_endo -77.93 157.45 30.94 Favored 'Trans proline' 0 C--N 1.36 1.144 0 C-N-CA 122.037 1.824 . . . . 0.62 113.851 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.626 ' HG ' ' HG2' ' A' ' 165' ' ' ARG . 3.8 mp -95.94 171.5 8.6 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.253 -0.43 . . . . 1.07 111.617 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -119.62 -54.84 0.26 Allowed Glycine 0 CA--C 1.526 0.723 0 C-N-CA 120.553 -0.832 . . . . 0.61 113.772 -178.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 182' ' ' GLU . . . . . 0.653 ' OE2' ' HD2' ' A' ' 157' ' ' ARG . 5.9 tt0 -94.44 -45.27 7.51 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.238 0.542 . . . . 1.4 110.409 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.672 ' O ' ' HA3' ' A' ' 187' ' ' GLY . . . -80.33 74.14 7.18 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.949 -0.568 . . . . 0.37 110.561 179.498 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -79.94 -69.76 1.38 Allowed Glycine 0 CA--C 1.522 0.496 0 C-N-CA 120.953 -0.642 . . . . 0.38 113.359 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -59.79 -56.01 27.08 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 120.653 0.263 . . . . 0.43 111.535 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -67.69 -32.92 73.91 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.949 -0.389 . . . . 0.46 109.949 179.224 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 187' ' ' GLY . . . . . 0.672 ' HA3' ' O ' ' A' ' 183' ' ' ALA . . . -62.63 -48.64 80.02 Favored Glycine 0 C--O 1.224 -0.492 0 CA-C-N 115.685 -0.688 . . . . 0.39 112.97 179.0 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.28 -50.75 68.88 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 117.221 0.511 . . . . 1.58 110.893 179.313 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 189' ' ' ARG . . . . . 0.649 ' HB3' HG21 ' A' ' 297' ' ' VAL . 4.4 mtp180 -56.31 -55.15 36.96 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-O 120.971 0.415 . . . . 0.73 111.164 179.346 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.428 ' O ' ' HB2' ' A' ' 194' ' ' LEU . . . -66.98 -40.67 87.46 Favored 'General case' 0 C--O 1.219 -0.51 0 N-CA-C 113.035 0.754 . . . . 0.35 113.035 -178.767 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 14.2 tp -62.45 -44.37 96.58 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 118.475 0.579 . . . . 0.77 111.529 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -67.58 -40.11 84.84 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 121.143 0.497 . . . . 1.16 110.963 179.692 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 193' ' ' THR . . . . . 0.519 ' OG1' HG13 ' A' ' 297' ' ' VAL . 20.8 m -68.52 -47.26 67.42 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.113 -0.494 . . . . 0.46 110.204 179.035 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 0.461 HD21 HG21 ' A' ' 249' ' ' ILE . 7.9 tp -60.12 -42.17 94.17 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 115.661 -0.7 . . . . 0.36 110.468 179.26 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 195' ' ' ARG . . . . . 0.852 ' HA ' ' HE1' ' A' ' 166' ' ' TYR . 0.6 OUTLIER -56.03 -54.08 49.26 Favored 'General case' 0 CA--C 1.522 -0.125 0 CA-C-O 121.243 0.545 . . . . 0.41 110.377 178.268 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 10.9 mmm180 -61.53 -54.03 48.49 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.972 -1.013 . . . . 0.9 112.36 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 197' ' ' VAL . . . . . 0.497 ' O ' HG23 ' A' ' 201' ' ' VAL . 99.0 t -61.36 -46.31 96.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 N-CA-C 111.899 0.333 . . . . 0.47 111.899 -179.361 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 198' ' ' GLY . . . . . 0.529 ' HA3' ' OH ' ' A' ' 166' ' ' TYR . . . -62.24 -50.43 65.1 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 121.244 -0.503 . . . . 0.3 112.242 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 199' ' ' ASP . . . . . 0.47 ' HB2' ' O ' ' A' ' 195' ' ' ARG . 0.3 OUTLIER -58.27 -43.1 87.77 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 120.856 0.36 . . . . 0.47 110.117 178.846 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -61.68 -48.36 84.81 Favored Glycine 0 CA--C 1.525 0.708 0 C-N-CA 121.021 -0.609 . . . . 0.42 112.303 178.641 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 201' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 197' ' ' VAL . 71.0 t -62.37 -43.18 97.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-O 120.943 0.402 . . . . 0.41 110.607 178.813 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 202' ' ' GLN . . . . . 0.562 ' HB3' ' NH2' ' A' ' 203' ' ' ARG . 68.8 mt-30 -63.41 -55.2 26.24 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.583 -0.735 . . . . 0.55 112.098 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 203' ' ' ARG . . . . . 0.562 ' NH2' ' HB3' ' A' ' 202' ' ' GLN . 0.0 OUTLIER -58.15 -34.41 70.25 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 112.157 0.428 . . . . 0.45 112.157 -178.822 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 17.7 m-80 -75.34 -43.79 48.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.895 0.378 . . . . 0.8 111.489 179.477 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 205' ' ' HIS . . . . . 0.436 ' CD2' HG23 ' B' ' 30' ' ' ILE . 95.2 m-70 -100.9 35.95 2.07 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.8 0.333 . . . . 0.52 111.68 -179.598 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 206' ' ' GLU . . . . . 0.495 ' HG2' ' HA ' ' A' ' 203' ' ' ARG . 26.9 mm-40 -55.68 -35.64 66.25 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 112.4 0.519 . . . . 0.53 112.4 -179.668 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 19.4 p -63.15 -52.64 61.65 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.808 0.337 . . . . 0.54 111.6 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -63.41 -40.57 97.56 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.154 -0.475 . . . . 0.4 110.919 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 209' ' ' PHE . . . . . 0.442 ' CE2' ' HA ' ' A' ' 202' ' ' GLN . 25.9 m-85 -68.04 -49.49 61.09 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.094 -0.503 . . . . 0.45 111.547 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -65.31 -38.91 91.65 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 121.266 -0.174 . . . . 0.51 111.021 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -59.23 -45.71 94.95 Favored Glycine 0 C--N 1.334 0.443 0 C-N-CA 120.448 -0.882 . . . . 0.28 110.991 178.15 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 212' ' ' MET . . . . . 0.487 ' SD ' ' HA ' ' B' ' 23' ' ' PHE . 56.9 mtm -70.62 -33.78 71.39 Favored 'General case' 0 C--O 1.223 -0.324 0 N-CA-C 110.25 -0.278 . . . . 0.73 110.25 178.196 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.449 HD22 ' HA ' ' A' ' 213' ' ' LEU . 0.3 OUTLIER -65.8 -43.84 87.47 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.351 -0.386 . . . . 0.33 111.302 179.506 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 71.9 mtp180 -66.11 -38.46 88.25 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.916 0.389 . . . . 0.92 110.84 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 54.9 mtmt -91.42 11.57 23.44 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.288 -0.415 . . . . 0.59 111.287 179.19 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.509 HD21 HD12 ' A' ' 218' ' ' ILE . 6.5 tp -79.26 99.07 6.89 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.14 0.495 . . . . 0.4 111.361 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -83.25 32.07 0.45 Allowed 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.7 -0.682 . . . . 0.43 111.191 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 218' ' ' ILE . . . . . 0.765 HG12 ' HB3' ' A' ' 223' ' ' ASP . 36.4 mt -81.1 106.74 12.64 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-O 121.069 0.461 . . . . 0.4 110.709 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 8.2 mppt? -140.92 -24.45 0.76 Allowed 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 115.696 -0.684 . . . . 0.6 111.978 -179.451 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -116.28 171.1 8.04 Favored 'General case' 0 CA--C 1.533 0.296 0 O-C-N 121.875 -0.516 . . . . 1.11 111.68 -179.344 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -58.48 -31.45 67.85 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 120.955 0.407 . . . . 0.55 111.197 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -62.45 -26.72 68.47 Favored Glycine 0 CA--C 1.524 0.627 0 CA-C-N 115.978 -0.555 . . . . 0.45 113.117 179.253 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 223' ' ' ASP . . . . . 0.765 ' HB3' HG12 ' A' ' 218' ' ' ILE . 55.5 m-20 -68.66 -34.11 75.15 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 117.024 0.412 . . . . 0.36 111.488 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 16.4 t -62.23 -29.41 46.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-O 121.556 0.693 . . . . 0.38 110.16 178.39 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 32.2 mmtm -72.67 -33.48 66.58 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 115.533 -0.758 . . . . 0.5 110.441 179.458 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 226' ' ' SER . . . . . 0.453 ' O ' HG23 ' A' ' 230' ' ' VAL . 33.6 t -68.13 -38.65 82.44 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.381 0.61 . . . . 0.91 109.585 178.329 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 227' ' ' PHE . . . . . 0.448 ' HE2' HG11 ' A' ' 255' ' ' VAL . 8.5 t80 -63.54 -38.36 90.83 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 115.211 -0.904 . . . . 0.46 109.503 178.107 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 46.8 t -62.53 -37.44 86.1 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 115.442 -0.799 . . . . 0.29 109.951 178.165 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 84.3 mtp180 -63.07 -39.67 95.4 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.013 -0.539 . . . . 0.55 109.882 178.037 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' ' 226' ' ' SER . 18.2 t -59.3 -46.14 92.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-N 116.324 -0.398 . . . . 0.35 110.5 178.143 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 231' ' ' MET . . . . . 0.474 ' HE3' ' HA ' ' A' ' 275' ' ' ILE . 7.3 tpp -55.33 -52.2 64.28 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.933 -0.576 . . . . 0.37 110.929 179.605 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 232' ' ' VAL . . . . . 0.527 ' O ' ' HB2' ' A' ' 236' ' ' LYS . 38.2 t -66.89 -36.71 77.85 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-N 116.262 -0.426 . . . . 0.37 111.362 179.511 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 54.0 t-80 -65.48 -52.55 52.06 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 112.057 0.392 . . . . 0.55 112.057 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 97.0 t -63.98 -39.09 84.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 N-CA-C 112.078 0.399 . . . . 0.41 112.078 -179.223 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 235' ' ' PHE . . . . . 0.568 ' HZ ' ' HA ' ' A' ' 245' ' ' ILE . 63.0 m-85 -91.84 10.94 26.52 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.412 0.523 . . . . 0.56 112.412 -179.397 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 236' ' ' LYS . . . . . 0.55 ' HE2' ' HA ' ' A' ' 236' ' ' LYS . 0.3 OUTLIER -76.0 -11.43 59.95 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 111.873 0.323 . . . . 0.74 111.873 -179.807 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -69.97 -16.73 63.24 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 120.855 0.359 . . . . 0.42 111.262 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 89.28 -19.83 37.2 Favored Glycine 0 CA--C 1.521 0.442 0 C-N-CA 121.168 -0.539 . . . . 0.47 111.959 -178.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 2.4 t -80.39 112.03 17.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.048 0.452 . . . . 0.86 111.093 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 240' ' ' THR . . . . . 0.41 HG22 HD11 ' A' ' 245' ' ' ILE . 1.9 m -94.47 91.32 6.58 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.37 -0.377 . . . . 0.55 111.046 179.477 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -101.56 135.22 43.44 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.77 0.319 . . . . 0.47 111.389 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 242' ' ' TRP . . . . . 0.658 ' HB3' ' CZ ' ' A' ' 300' ' ' PHE . 7.2 m95 -55.0 -44.01 74.14 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 116.311 -0.404 . . . . 0.41 111.761 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 243' ' ' GLY . . . . . 0.463 ' H ' ' HB2' ' B' ' 35' ' ' TYR . . . -59.21 -37.02 91.2 Favored Glycine 0 CA--C 1.524 0.619 0 C-N-CA 121.086 -0.578 . . . . 0.28 112.868 179.096 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 63.9 mtt180 -68.46 -43.45 77.0 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 109.777 -0.453 . . . . 0.35 109.777 178.462 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 245' ' ' ILE . . . . . 0.568 ' HA ' ' HZ ' ' A' ' 235' ' ' PHE . 84.7 mt -59.99 -50.67 79.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-N 115.58 -0.736 . . . . 0.48 111.569 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 246' ' ' VAL . . . . . 0.412 HG22 ' O ' ' A' ' 242' ' ' TRP . 16.1 m -67.04 -28.03 41.49 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 C-N-CA 120.769 -0.373 . . . . 0.35 111.411 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 23.1 m -61.79 -48.62 79.81 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 109.754 -0.461 . . . . 0.37 109.754 178.27 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -60.2 -42.47 95.19 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.063 -0.517 . . . . 0.53 110.312 178.659 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 249' ' ' ILE . . . . . 0.461 HG21 HD21 ' A' ' 194' ' ' LEU . 43.3 mm -63.99 -44.99 97.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 CA-C-N 116.238 -0.437 . . . . 0.47 110.499 178.521 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 250' ' ' SER . . . . . 0.448 ' HB2' ' HG3' ' A' ' 202' ' ' GLN . 54.4 p -62.19 -36.61 82.44 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.816 0.341 . . . . 0.33 110.17 178.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 251' ' ' PHE . . . . . 0.428 ' CD2' HD11 ' B' ' 27' ' ' LEU . 13.2 t80 -69.71 -40.33 76.35 Favored 'General case' 0 C--O 1.232 0.142 0 N-CA-C 108.704 -0.85 . . . . 0.46 108.704 177.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -57.76 -37.32 83.41 Favored Glycine 0 C--N 1.336 0.566 0 N-CA-C 110.683 -0.967 . . . . 0.25 110.683 177.444 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 253' ' ' ALA . . . . . 0.448 ' O ' ' HG3' ' A' ' 257' ' ' LYS . . . -68.68 -41.33 79.4 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 120.767 0.318 . . . . 0.31 110.185 177.332 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -63.29 -44.5 94.89 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 116.236 -0.438 . . . . 0.38 110.896 178.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 255' ' ' VAL . . . . . 0.472 HG23 HD21 ' A' ' 271' ' ' LEU . 16.3 m -70.91 -26.34 27.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-O 120.819 0.342 . . . . 0.27 110.472 178.729 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -66.72 -39.25 87.92 Favored 'General case' 0 C--N 1.339 0.12 0 N-CA-C 108.454 -0.943 . . . . 0.29 108.454 177.123 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 257' ' ' LYS . . . . . 0.865 ' HG2' ' HA ' ' A' ' 171' ' ' ALA . 24.2 mtpp -65.16 -36.52 84.47 Favored 'General case' 0 C--O 1.225 -0.199 0 CA-C-N 115.351 -0.84 . . . . 0.74 109.646 177.503 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 63.6 t60 -59.54 -49.03 79.35 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 109.957 -0.386 . . . . 0.43 109.957 177.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.476 HD21 HG22 ' A' ' 218' ' ' ILE . 95.9 mt -68.79 -36.08 77.82 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.038 -0.528 . . . . 0.48 110.453 178.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 260' ' ' LYS . . . . . 0.547 ' HG2' ' HB ' ' A' ' 172' ' ' THR . 5.0 tptp -67.47 -36.57 81.41 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 120.774 0.321 . . . . 0.52 111.048 179.116 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 35.3 t -64.89 -25.86 68.07 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.184 -0.462 . . . . 0.46 111.325 179.566 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 26.8 m -107.78 11.0 9.04 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 CA-C-N 116.424 -0.353 . . . . 0.46 110.968 178.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 58.98 48.23 11.13 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 113.202 0.816 . . . . 1.55 113.202 179.457 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 14.7 mt-30 -114.99 36.28 3.95 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.457 -0.338 . . . . 0.76 111.064 178.576 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 265' ' ' GLU . . . . . 0.546 ' HA ' HD12 ' A' ' 268' ' ' ILE . 1.8 pm0 -52.62 -29.21 24.81 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 112.407 0.521 . . . . 0.48 112.407 179.412 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 9.3 p -59.96 -20.19 56.23 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 120.725 0.298 . . . . 0.5 111.049 178.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 267' ' ' PHE . . . . . 0.446 ' C ' ' HD2' ' A' ' 270' ' ' PRO . 41.7 m-85 -98.01 -18.87 18.36 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 121.109 0.48 . . . . 0.53 110.181 178.425 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 268' ' ' ILE . . . . . 0.546 HD12 ' HA ' ' A' ' 265' ' ' GLU . 72.4 mt -68.58 -39.57 80.67 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 CA-C-N 115.849 -0.614 . . . . 0.41 110.4 178.651 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 269' ' ' GLU . . . . . 0.685 ' HB2' ' HD3' ' A' ' 270' ' ' PRO . 1.5 mm-40 -56.38 -56.94 26.39 Favored Pre-proline 0 CA--C 1.543 0.686 0 CA-C-N 116.287 -0.415 . . . . 0.49 111.036 179.27 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 270' ' ' PRO . . . . . 0.685 ' HD3' ' HB2' ' A' ' 269' ' ' GLU . 34.7 Cg_exo -61.68 -34.89 82.91 Favored 'Trans proline' 0 C--N 1.361 1.233 0 C-N-CA 121.954 1.769 . . . . 0.32 111.435 177.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 271' ' ' LEU . . . . . 0.472 HD21 HG23 ' A' ' 255' ' ' VAL . 26.8 tp -62.61 -51.07 68.75 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.182 -0.463 . . . . 0.45 110.251 178.487 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -59.09 -41.12 87.3 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 116.104 -0.498 . . . . 0.34 110.12 178.663 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 273' ' ' GLU . . . . . . . . . . . . . 62.2 mm-40 -63.34 -45.48 91.01 Favored 'General case' 0 C--O 1.225 -0.189 0 CA-C-N 115.761 -0.654 . . . . 1.05 109.831 177.762 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 274' ' ' THR . . . . . . . . . . . . . 87.5 m -62.2 -44.02 97.51 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.917 -0.583 . . . . 0.34 111.179 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 275' ' ' ILE . . . . . 0.474 ' HA ' ' HE3' ' A' ' 231' ' ' MET . 94.4 mt -58.66 -50.48 78.98 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 CA-C-O 120.984 0.421 . . . . 0.39 110.286 179.008 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 276' ' ' THR . . . . . 0.539 HG23 HD12 ' A' ' 163' ' ' ILE . 24.1 m -63.12 -46.17 88.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.041 -0.527 . . . . 0.3 110.669 178.845 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 277' ' ' ASP . . . . . 0.429 ' CG ' HH12 ' A' ' 281' ' ' ARG . 36.1 t70 -51.69 -60.72 2.84 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.309 -0.86 . . . . 0.35 112.442 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 21.8 t -66.35 -37.25 79.25 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 N-CA-C 113.058 0.762 . . . . 0.36 113.058 -178.345 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 32.5 tp -70.67 -48.47 54.66 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 112.855 0.687 . . . . 0.72 112.855 -178.556 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 58.2 t -70.73 -34.82 58.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 N-CA-C 112.595 0.591 . . . . 0.32 112.595 -178.421 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 281' ' ' ARG . . . . . 0.496 ' HB2' ' OH ' ' A' ' 156' ' ' TYR . 21.9 ttp-105 -72.79 -51.39 19.21 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.407 0.521 . . . . 0.38 112.407 -179.684 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 282' ' ' THR . . . . . . . . . . . . . 10.1 m -60.6 -35.34 75.89 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 112.168 0.432 . . . . 0.49 112.168 -178.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 64.9 mmtt -115.96 38.78 3.23 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 122.225 -0.297 . . . . 0.53 111.611 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 284' ' ' ARG . . . . . 0.667 ' HD2' ' OE2' ' A' ' 152' ' ' GLU . 0.2 OUTLIER -62.13 -54.01 47.28 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 112.812 0.671 . . . . 0.39 112.812 -179.066 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 285' ' ' ASP . . . . . 0.522 ' H ' ' HG3' ' A' ' 284' ' ' ARG . 0.2 OUTLIER -60.27 -39.44 86.85 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 112.128 0.418 . . . . 0.52 112.128 -178.855 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 286' ' ' TRP . . . . . 0.47 ' O ' ' HB2' ' A' ' 290' ' ' GLN . 12.4 t90 -67.14 -41.58 85.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.808 0.337 . . . . 0.48 110.921 179.61 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 287' ' ' LEU . . . . . 0.519 ' HB3' HD21 ' A' ' 155' ' ' LEU . 2.0 mm? -70.6 -48.4 55.36 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.298 -0.41 . . . . 0.44 112.078 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 288' ' ' VAL . . . . . 0.41 HG22 ' O ' ' A' ' 284' ' ' ARG . 26.9 m -59.88 -37.84 73.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 N-CA-C 111.901 0.334 . . . . 0.33 111.901 -179.678 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 54.1 mttp -75.52 -23.95 56.74 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-O 120.789 0.328 . . . . 0.59 111.274 179.081 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 290' ' ' GLN . . . . . 0.47 ' HB2' ' O ' ' A' ' 286' ' ' TRP . 5.1 tp60 -91.06 17.58 7.84 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.604 -0.271 . . . . 0.66 111.659 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 36.0 mtp180 64.69 15.38 9.71 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 112.025 0.38 . . . . 0.47 112.025 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 63.71 -132.47 40.81 Favored Glycine 0 CA--C 1.523 0.593 0 CA-C-O 121.462 0.479 . . . . 0.38 114.01 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 293' ' ' TRP . . . . . 0.61 ' O ' HG23 ' A' ' 297' ' ' VAL . 77.4 m95 -67.05 -25.18 66.13 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.019 0.377 . . . . 0.43 112.019 -178.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 294' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -56.73 -48.38 77.89 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 109.852 -0.425 . . . . 0.78 109.852 178.324 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -68.7 -38.85 86.28 Favored Glycine 0 C--N 1.336 0.574 0 N-CA-C 111.24 -0.744 . . . . 0.37 111.24 178.045 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 296' ' ' PHE . . . . . 0.547 ' HB3' ' HA ' ' A' ' 293' ' ' TRP . 0.9 OUTLIER -57.74 -45.63 85.59 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 120.769 0.318 . . . . 0.4 111.064 178.498 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 297' ' ' VAL . . . . . 0.649 HG21 ' HB3' ' A' ' 189' ' ' ARG . 78.3 t -65.8 -40.41 87.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-N 116.015 -0.539 . . . . 0.39 111.269 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -66.53 -48.26 70.3 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.207 -0.451 . . . . 0.58 111.476 179.125 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 299' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -62.26 -51.08 69.18 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.053 0.454 . . . . 0.49 110.843 179.566 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 300' ' ' PHE . . . . . 0.658 ' CZ ' ' HB3' ' A' ' 242' ' ' TRP . 49.6 m-85 -80.36 33.23 0.29 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.091 -0.504 . . . . 0.57 112.316 -179.667 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 14.9 t-80 -56.62 150.74 15.06 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 109.628 -0.508 . . . . 0.74 109.628 178.367 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 302' ' ' VAL . . . . . 0.415 HG22 ' H ' ' A' ' 302' ' ' VAL . 2.0 m -66.74 74.1 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 N-CA-C 112.707 0.632 . . . . 1.22 112.707 -179.648 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 303' ' ' GLN . . . . . 0.726 ' HG3' ' HA2' ' A' ' 308' ' ' GLY . 0.8 OUTLIER -61.27 -22.51 64.9 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 121.395 0.617 . . . . 1.25 110.267 178.632 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -78.29 -12.93 60.03 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.496 -0.775 . . . . 1.56 111.693 179.621 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 96.9 mt -117.92 -25.85 6.63 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.25 0.463 . . . . 1.86 112.25 -179.521 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -124.95 9.99 8.19 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 112.913 0.709 . . . . 1.38 112.913 -179.194 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . 80.17 -62.08 4.3 Favored Glycine 0 CA--C 1.525 0.712 0 C-N-CA 120.757 -0.735 . . . . 1.66 114.141 178.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 308' ' ' GLY . . . . . 0.726 ' HA2' ' HG3' ' A' ' 303' ' ' GLN . . . . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.272 -1.294 . . . . 1.72 113.146 -179.658 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.507 0 N-CA-C 112.321 0.489 . . . . 0.55 112.321 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -92.67 94.42 9.01 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 121.014 0.435 . . . . 1.89 111.504 -178.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 19' ' ' LEU . . . . . 0.434 HD12 ' HA ' ' B' ' 19' ' ' LEU . 3.3 tp -104.64 122.89 42.05 Favored Pre-proline 0 CA--C 1.535 0.368 0 CA-C-O 120.894 0.378 . . . . 0.4 111.455 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 20' ' ' PRO . . . . . 0.467 ' HA ' ' HD3' ' B' ' 21' ' ' PRO . 18.5 Cg_endo -58.08 123.93 14.8 Favored 'Trans proline' 0 C--N 1.352 0.738 0 C-N-CA 123.581 2.854 . . . . 0.5 113.497 -179.22 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 21' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' B' ' 20' ' ' PRO . 24.5 Cg_exo -63.61 -0.23 2.34 Favored 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 123.442 2.761 . . . . 0.48 114.399 -178.727 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 22' ' ' GLU . . . . . 0.494 ' O ' ' HB2' ' B' ' 26' ' ' GLN . 1.8 mt-10 -67.93 -25.87 65.69 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.224 0.453 . . . . 1.02 112.224 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 23' ' ' PHE . . . . . 0.5 ' HD1' ' N ' ' B' ' 24' ' ' ALA . 0.1 OUTLIER -55.74 -32.17 63.17 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 112.843 0.683 . . . . 0.36 112.843 -178.924 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 24' ' ' ALA . . . . . 0.674 ' O ' ' HB2' ' B' ' 28' ' ' ARG . . . -69.95 -51.59 31.47 Favored 'General case' 0 C--N 1.322 -0.593 0 O-C-N 122.023 -0.423 . . . . 0.29 111.713 -179.019 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -74.1 -41.41 61.7 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.108 0.41 . . . . 0.33 112.108 -179.444 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 26' ' ' GLN . . . . . 0.494 ' HB2' ' O ' ' B' ' 22' ' ' GLU . 1.1 tp-100 -62.04 -54.92 34.75 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.326 -0.397 . . . . 0.39 111.297 -179.396 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 27' ' ' LEU . . . . . 0.428 HD11 ' CD2' ' A' ' 251' ' ' PHE . 70.2 mt -63.47 -37.56 87.75 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.96 -0.296 . . . . 0.35 110.58 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 28' ' ' ARG . . . . . 0.674 ' HB2' ' O ' ' B' ' 24' ' ' ALA . 0.0 OUTLIER -57.88 -57.38 13.06 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 120.694 0.283 . . . . 0.41 111.437 179.292 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 18.8 mmmt -66.48 -35.08 79.37 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.425 -0.352 . . . . 0.48 111.563 -179.535 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 30' ' ' ILE . . . . . 0.436 HG23 ' CD2' ' A' ' 205' ' ' HIS . 43.4 mt -64.15 -42.76 96.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 N-CA-C 108.946 -0.761 . . . . 0.39 108.946 177.514 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -58.88 -49.44 78.02 Favored Glycine 0 C--N 1.334 0.449 0 CA-C-N 115.961 -0.563 . . . . 0.29 112.42 178.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -55.55 -44.91 77.24 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 121.16 0.505 . . . . 0.42 110.759 178.673 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 2.2 ttmp? -65.87 -52.34 51.08 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 115.654 -0.703 . . . . 1.12 111.098 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 40.4 t -56.33 -45.37 81.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-O 121.135 0.493 . . . . 0.46 110.741 178.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 35' ' ' TYR . . . . . 0.463 ' HB2' ' H ' ' A' ' 243' ' ' GLY . 3.4 t80 -56.69 -49.66 74.44 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 115.597 -0.729 . . . . 1.01 110.447 178.604 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 36' ' ' CYS . . . . . . . . . . . . . 5.9 t -66.13 -34.21 77.54 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 120.825 0.345 . . . . 0.67 111.027 179.08 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 52.2 m -62.85 -51.79 65.65 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 112.364 0.505 . . . . 0.62 112.364 -179.638 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 38' ' ' TRP . . . . . . . . . . . . . 96.7 m95 -73.65 -30.38 62.9 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.345 0.498 . . . . 0.88 112.345 -179.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 23.0 t -65.33 -24.89 67.38 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 111.801 0.297 . . . . 0.79 111.801 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -90.21 117.68 68.23 Favored Pre-proline 0 CA--C 1.536 0.419 0 N-CA-C 111.98 0.363 . . . . 0.89 111.98 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -86.28 157.32 9.61 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 122.763 2.309 . . . . 1.35 113.22 179.579 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -86.93 77.24 9.26 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 121.022 0.439 . . . . 2.68 110.867 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 43' ' ' MET . . . . . . . . . . . . . 23.4 mmt . . . . . 0 C--O 1.251 1.164 0 CA-C-O 118.184 -0.912 . . . . 5.0 111.49 -179.62 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.351 0 CA-C-O 119.924 -0.375 . . . . 0.96 112.389 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -70.67 107.81 2.11 Favored 'Trans proline' 0 CA--C 1.532 0.42 0 C-N-CA 122.84 2.36 . . . . 0.73 112.655 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 90.1 mt -77.43 79.18 3.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.985 0.421 . . . . 1.03 111.356 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -155.79 -173.72 24.76 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 121.024 -0.608 . . . . 0.6 112.275 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 46.6 t -75.41 94.15 3.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.366 0.603 . . . . 0.48 111.53 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -142.9 -63.67 0.41 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.757 -0.656 . . . . 0.46 110.621 179.173 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -60.7 -36.52 78.99 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.184 -0.462 . . . . 0.59 111.278 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -57.92 -44.99 87.21 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.056 -0.52 . . . . 0.44 110.685 178.428 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 35.0 tp -76.94 -29.3 55.56 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-O 121.323 0.582 . . . . 0.55 109.955 178.456 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 87.8 t80 -63.89 -30.79 71.84 Favored 'General case' 0 C--O 1.223 -0.338 0 CA-C-N 115.666 -0.697 . . . . 0.35 110.369 178.503 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.54 ' HD3' ' OE1' ' A' ' 182' ' ' GLU . 45.0 mtt180 -60.72 -51.91 67.36 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.028 0.442 . . . . 0.72 110.261 178.431 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 32.1 mt-30 -59.66 -43.99 93.73 Favored 'General case' 0 N--CA 1.46 0.071 0 CA-C-N 115.701 -0.681 . . . . 1.13 109.515 178.35 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' SER . . . . . 0.572 ' HA ' ' CZ2' ' A' ' 293' ' ' TRP . 18.5 m -60.38 -58.67 7.49 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.191 -0.913 . . . . 0.26 111.531 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.543 HD21 ' HG3' ' A' ' 273' ' ' GLU . 1.4 tm? -53.98 -49.67 68.28 Favored 'General case' 0 CA--C 1.529 0.139 0 O-C-N 123.203 0.315 . . . . 0.4 110.93 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' GLU . . . . . 0.675 ' HG2' HD23 ' A' ' 180' ' ' LEU . 36.5 tt0 -60.06 -53.55 56.42 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 116.488 -0.324 . . . . 0.39 111.836 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 162' ' ' ILE . . . . . 0.481 HD11 ' HA2' ' A' ' 187' ' ' GLY . 89.7 mt -61.82 -48.75 87.17 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 N-CA-C 112.567 0.58 . . . . 0.33 112.567 -178.884 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.581 HD12 HG23 ' A' ' 276' ' ' THR . 80.8 mt -63.93 -52.33 58.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 N-CA-C 112.154 0.427 . . . . 0.34 112.154 -179.038 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.87 -39.78 72.01 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 120.916 0.388 . . . . 0.32 110.534 179.617 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 165' ' ' ARG . . . . . 0.53 ' HD2' ' OE2' ' A' ' 169' ' ' GLU . 0.6 OUTLIER -65.77 -52.07 53.92 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.408 -0.36 . . . . 0.45 110.537 178.457 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 166' ' ' TYR . . . . . 0.828 ' HE1' ' HA ' ' A' ' 195' ' ' ARG . 81.4 t80 -55.56 -47.24 76.7 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 112.447 0.536 . . . . 0.35 112.447 -179.48 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.55 ' HG ' ' O ' ' A' ' 163' ' ' ILE . 28.0 mt -64.03 -39.1 93.34 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 120.88 -0.328 . . . . 0.36 110.641 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -66.45 -38.45 87.4 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.958 0.408 . . . . 0.38 110.301 178.297 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 169' ' ' GLU . . . . . 0.53 ' OE2' ' HD2' ' A' ' 165' ' ' ARG . 0.4 OUTLIER -70.26 -38.35 75.1 Favored 'General case' 0 CA--C 1.528 0.111 0 CA-C-N 116.08 -0.509 . . . . 0.62 110.767 178.58 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 170' ' ' GLN . . . . . 0.704 ' HG2' ' HB1' ' A' ' 253' ' ' ALA . 6.1 tp60 -68.53 -42.13 78.9 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 116.37 -0.377 . . . . 0.37 110.249 178.455 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.805 ' HA ' ' HG2' ' A' ' 257' ' ' LYS . . . -59.31 -40.5 86.43 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.807 -0.633 . . . . 0.46 111.977 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 76.5 p -87.08 -27.54 23.07 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 121.121 0.486 . . . . 0.47 110.945 178.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 97.36 -20.0 52.48 Favored Glycine 0 CA--C 1.522 0.476 0 CA-C-N 115.655 -0.702 . . . . 0.42 112.501 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 40.7 t -167.5 165.52 14.68 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 122.76 0.424 . . . . 0.69 110.108 -179.59 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 2.6 tppp? -166.76 -68.11 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.128 0.489 . . . . 0.68 110.178 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -164.61 168.95 17.6 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.494 -0.775 . . . . 0.77 110.121 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 46.8 t -107.73 -1.17 21.25 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.017 -0.538 . . . . 1.54 110.463 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' LYS . . . . . 0.451 ' HA ' ' HD3' ' A' ' 179' ' ' PRO . 56.1 mttp -69.96 151.34 96.2 Favored Pre-proline 0 C--O 1.237 0.431 0 CA-C-N 115.514 -0.766 . . . . 0.93 111.95 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 179' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 178' ' ' LYS . 16.1 Cg_exo -68.87 -169.16 0.27 Allowed 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 123.194 2.596 . . . . 0.78 113.193 179.639 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.675 HD23 ' HG2' ' A' ' 161' ' ' GLU . 5.2 mp -98.84 -163.37 1.03 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.4 -0.364 . . . . 0.5 111.71 -178.76 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -102.75 -52.96 0.93 Allowed Glycine 0 C--N 1.331 0.277 0 C-N-CA 120.757 -0.735 . . . . 0.44 112.256 -179.746 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 182' ' ' GLU . . . . . 0.54 ' OE1' ' HD3' ' A' ' 157' ' ' ARG . 31.3 mt-10 -84.83 -53.08 5.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.152 0.501 . . . . 0.53 110.28 179.52 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.565 ' O ' ' HA3' ' A' ' 187' ' ' GLY . . . -87.01 86.26 7.3 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.379 -0.373 . . . . 0.34 110.406 178.678 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -79.93 -71.5 1.26 Allowed Glycine 0 CA--C 1.528 0.886 0 C-N-CA 120.833 -0.699 . . . . 0.42 114.755 -179.051 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -70.79 -55.83 7.71 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 117.203 0.501 . . . . 0.49 111.646 -178.806 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -65.59 -35.24 80.25 Favored 'General case' 0 C--O 1.222 -0.342 0 CA-C-N 115.979 -0.555 . . . . 0.47 110.111 178.772 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 187' ' ' GLY . . . . . 0.565 ' HA3' ' O ' ' A' ' 183' ' ' ALA . . . -66.93 -49.9 51.02 Favored Glycine 0 C--O 1.225 -0.454 0 CA-C-N 115.762 -0.653 . . . . 0.36 112.845 179.237 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 4.2 tpt180 -55.26 -46.9 76.09 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 117.174 0.487 . . . . 0.85 110.113 178.718 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 189' ' ' ARG . . . . . 0.658 ' HB3' HG11 ' A' ' 297' ' ' VAL . 50.7 mtm180 -66.9 -40.24 87.68 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.92 -0.582 . . . . 0.32 110.616 179.275 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.406 ' O ' ' HB2' ' A' ' 194' ' ' LEU . . . -65.27 -40.43 93.89 Favored 'General case' 0 C--O 1.223 -0.338 0 CA-C-N 116.334 -0.394 . . . . 0.29 111.511 179.669 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 13.6 tp -64.58 -41.0 96.55 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 110.247 -0.279 . . . . 0.7 110.247 178.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 15.8 tm-20 -65.68 -50.63 64.22 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 109.732 -0.47 . . . . 0.32 109.732 178.497 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 193' ' ' THR . . . . . 0.436 HG21 ' HA ' ' A' ' 297' ' ' VAL . 8.5 m -60.05 -43.22 95.54 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.905 -0.589 . . . . 0.38 110.974 179.46 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 0.449 HD12 ' HA ' ' A' ' 194' ' ' LEU . 7.4 tp -65.59 -41.92 92.27 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 116.233 -0.44 . . . . 0.42 111.829 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 195' ' ' ARG . . . . . 0.828 ' HA ' ' HE1' ' A' ' 166' ' ' TYR . 8.8 tpt180 -67.35 -38.71 85.24 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.093 0.473 . . . . 0.42 110.538 179.322 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 15.2 ttm180 -67.01 -56.71 8.95 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 115.78 -0.645 . . . . 0.52 111.999 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 34.7 t -71.56 -38.59 68.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 111.95 0.352 . . . . 0.33 111.95 -178.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 198' ' ' GLY . . . . . 0.64 ' O ' ' HB2' ' A' ' 202' ' ' GLN . . . -62.02 -54.04 38.12 Favored Glycine 0 C--N 1.331 0.275 0 C-N-CA 121.052 -0.595 . . . . 0.29 112.793 -179.576 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 199' ' ' ASP . . . . . 0.401 ' HB2' ' O ' ' A' ' 195' ' ' ARG . 0.4 OUTLIER -64.81 -38.8 92.2 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 117.045 0.422 . . . . 0.37 110.675 179.211 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -59.86 -48.63 85.13 Favored Glycine 0 CA--C 1.524 0.626 0 C-N-CA 120.744 -0.741 . . . . 0.33 112.137 178.78 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 73.7 t -70.46 -42.29 78.34 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-O 120.862 0.363 . . . . 0.37 110.816 178.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 202' ' ' GLN . . . . . 0.64 ' HB2' ' O ' ' A' ' 198' ' ' GLY . 2.1 tt0 -58.87 -53.34 59.49 Favored 'General case' 0 C--O 1.224 -0.278 0 CA-C-N 115.652 -0.704 . . . . 0.42 111.807 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 203' ' ' ARG . . . . . 0.511 ' HA ' ' OE1' ' A' ' 206' ' ' GLU . 0.0 OUTLIER -64.4 -35.2 80.12 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-O 120.718 0.294 . . . . 0.4 110.393 179.779 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -65.94 -49.82 66.58 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 121.027 0.441 . . . . 0.86 110.765 178.137 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 72.1 m-70 -100.75 36.09 2.02 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.425 -0.352 . . . . 0.46 111.47 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 206' ' ' GLU . . . . . 0.511 ' OE1' ' HA ' ' A' ' 203' ' ' ARG . 3.7 tp10 -55.53 -49.0 73.79 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.222 -0.444 . . . . 0.4 111.212 -179.543 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 69.4 p -62.98 -42.8 99.94 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.983 -0.553 . . . . 0.5 111.52 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -61.8 -46.11 90.95 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.018 0.437 . . . . 0.41 110.306 178.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 209' ' ' PHE . . . . . 0.605 ' HE2' ' HA ' ' A' ' 202' ' ' GLN . 16.8 m-30 -65.43 -44.11 88.35 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.98 -0.555 . . . . 0.45 110.06 179.331 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -61.23 -44.08 97.84 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.091 -0.504 . . . . 0.8 110.594 178.759 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -60.07 -48.58 85.43 Favored Glycine 0 C--N 1.334 0.444 0 N-CA-C 111.205 -0.758 . . . . 0.34 111.205 178.323 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 212' ' ' MET . . . . . 0.533 ' O ' ' HG ' ' A' ' 216' ' ' LEU . 1.2 mtp -64.31 -35.03 79.53 Favored 'General case' 0 C--O 1.224 -0.253 0 CA-C-O 120.655 0.264 . . . . 0.72 110.312 178.407 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.445 HD22 ' HA ' ' A' ' 213' ' ' LEU . 0.4 OUTLIER -60.61 -47.99 83.75 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.239 -0.437 . . . . 0.51 110.004 178.473 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 73.0 mtp180 -61.97 -31.71 72.09 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.122 -0.49 . . . . 1.14 111.016 179.125 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -84.95 -9.09 58.43 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.12 -0.491 . . . . 1.23 111.682 179.445 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.663 ' HA ' HD21 ' B' ' 19' ' ' LEU . 20.3 mt -82.41 142.89 31.59 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.155 0.502 . . . . 0.52 112.295 -179.531 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 217' ' ' ASP . . . . . 0.41 ' OD2' ' N ' ' B' ' 17' ' ' ALA . 0.4 OUTLIER -102.07 5.74 40.66 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.846 -0.616 . . . . 0.66 110.212 178.403 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 218' ' ' ILE . . . . . 0.62 HG22 ' HE2' ' A' ' 267' ' ' PHE . 21.0 mm -55.33 106.93 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 CA-C-N 115.9 -0.591 . . . . 0.49 112.319 -178.826 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 6.1 mtmp? -143.48 -42.19 0.29 Allowed 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 112.373 0.509 . . . . 0.67 112.373 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 18.2 m-80 -124.1 -178.91 4.22 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 113.085 0.772 . . . . 1.24 113.085 -178.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 221' ' ' GLU . . . . . 0.576 ' O ' HG22 ' A' ' 224' ' ' VAL . 12.2 tm-20 -51.92 -37.61 53.24 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 112.867 0.691 . . . . 0.76 112.867 -179.184 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -63.83 -26.47 70.06 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 120.816 -0.707 . . . . 0.35 113.622 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 223' ' ' ASP . . . . . 0.556 ' HB3' ' HA ' ' A' ' 218' ' ' ILE . 59.0 m-20 -72.34 -31.12 65.35 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 113.322 0.86 . . . . 0.44 113.322 -178.584 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.576 HG22 ' O ' ' A' ' 221' ' ' GLU . 4.8 m -55.87 -29.1 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 CA-C-O 120.833 0.349 . . . . 0.45 111.469 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 10.7 mttp -66.0 -38.71 89.16 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.152 0.501 . . . . 0.84 109.908 178.739 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 226' ' ' SER . . . . . 0.492 ' O ' HG23 ' A' ' 230' ' ' VAL . 1.8 t -68.74 -30.67 69.34 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 109.113 -0.699 . . . . 0.46 109.113 178.183 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 227' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -66.5 -36.67 83.3 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 109.004 -0.739 . . . . 0.6 109.004 178.075 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 7.1 t -62.03 -39.72 93.29 Favored 'General case' 0 N--CA 1.462 0.147 0 N-CA-C 108.992 -0.744 . . . . 0.37 108.992 176.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 229' ' ' ARG . . . . . 0.476 ' HA ' HG22 ' A' ' 232' ' ' VAL . 0.0 OUTLIER -61.07 -36.88 80.8 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-N 115.617 -0.719 . . . . 0.39 109.934 177.873 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 0.564 HG22 ' CE1' ' B' ' 23' ' ' PHE . 29.4 t -65.99 -48.14 82.76 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-O 121.316 0.579 . . . . 0.34 109.439 177.824 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 231' ' ' MET . . . . . 0.525 ' SD ' HD13 ' A' ' 248' ' ' LEU . 8.1 tpp -60.34 -49.47 77.45 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 115.198 -0.91 . . . . 0.46 111.508 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 232' ' ' VAL . . . . . 0.476 HG22 ' HA ' ' A' ' 229' ' ' ARG . 33.3 m -64.66 -32.05 56.29 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 120.745 -0.382 . . . . 0.44 111.866 -179.741 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 7.3 t-80 -72.38 -47.02 52.7 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 120.899 -0.32 . . . . 0.38 110.843 178.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 70.2 t -62.32 -31.28 51.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-O 120.911 0.386 . . . . 0.44 111.571 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -97.3 4.34 50.89 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 122.224 -0.298 . . . . 0.49 111.749 179.092 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 236' ' ' LYS . . . . . 0.463 ' HB2' ' O ' ' A' ' 232' ' ' VAL . 0.3 OUTLIER -73.87 -17.83 61.0 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 112.286 0.476 . . . . 1.58 112.286 -178.989 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -70.12 -11.33 60.81 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.924 0.392 . . . . 0.43 111.244 179.534 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 91.1 -19.31 47.15 Favored Glycine 0 CA--C 1.519 0.33 0 C-N-CA 121.087 -0.578 . . . . 0.37 112.554 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -95.69 92.71 3.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.117 0.484 . . . . 0.47 112.109 -179.682 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 240' ' ' THR . . . . . 0.521 HG22 HD11 ' A' ' 245' ' ' ILE . 2.4 m -79.03 62.61 3.49 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.487 0.66 . . . . 0.36 110.347 178.505 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 73.2 m-20 -65.42 137.77 57.68 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.441 -0.8 . . . . 0.34 111.705 -179.059 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 242' ' ' TRP . . . . . . . . . . . . . 78.7 m95 -54.73 -38.6 67.31 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.154 -0.475 . . . . 0.41 111.188 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 243' ' ' GLY . . . . . 0.481 ' H ' ' HB2' ' B' ' 35' ' ' TYR . . . -58.61 -32.44 69.2 Favored Glycine 0 CA--C 1.521 0.419 0 C-N-CA 120.902 -0.666 . . . . 0.29 111.919 178.143 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 78.8 mtt180 -75.44 -41.95 54.58 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-O 120.943 0.401 . . . . 0.3 109.933 178.679 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 245' ' ' ILE . . . . . 0.563 ' O ' HG12 ' A' ' 249' ' ' ILE . 78.3 mt -62.14 -49.32 84.52 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-N 115.819 -0.628 . . . . 0.48 110.561 179.142 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 246' ' ' VAL . . . . . 0.424 HG21 ' CE2' ' A' ' 300' ' ' PHE . 48.0 t -67.48 -38.46 80.7 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 CA-C-N 116.347 -0.388 . . . . 0.36 111.047 179.317 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 19.4 m -62.2 -40.1 94.96 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 120.909 -0.316 . . . . 0.39 110.247 178.817 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 248' ' ' LEU . . . . . 0.525 HD13 ' SD ' ' A' ' 231' ' ' MET . 44.7 mt -65.24 -35.27 80.54 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 109.776 -0.453 . . . . 0.61 109.776 177.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 249' ' ' ILE . . . . . 0.563 HG12 ' O ' ' A' ' 245' ' ' ILE . 36.7 mm -69.41 -40.35 79.85 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 N-CA-C 109.084 -0.71 . . . . 0.43 109.084 177.442 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 14.7 m -61.67 -48.38 81.07 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.242 -0.89 . . . . 0.32 109.923 178.688 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 251' ' ' PHE . . . . . 0.542 ' O ' HG23 ' A' ' 255' ' ' VAL . 12.8 t80 -63.45 -45.06 92.61 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 115.648 -0.705 . . . . 0.59 109.832 178.305 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -57.79 -45.16 93.81 Favored Glycine 0 C--N 1.337 0.594 0 N-CA-C 111.181 -0.768 . . . . 0.26 111.181 178.199 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 253' ' ' ALA . . . . . 0.704 ' HB1' ' HG2' ' A' ' 170' ' ' GLN . . . -59.95 -38.56 82.82 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 122.328 0.251 . . . . 0.26 110.683 177.582 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 61.2 t80 -61.28 -40.42 94.05 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 121.147 0.499 . . . . 0.49 109.776 178.403 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 255' ' ' VAL . . . . . 0.542 HG23 ' O ' ' A' ' 251' ' ' PHE . 20.2 t -67.47 -40.24 84.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 CA-C-N 115.735 -0.666 . . . . 0.29 109.81 178.048 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -58.43 -41.36 84.88 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.115 0.484 . . . . 0.28 110.1 178.345 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 257' ' ' LYS . . . . . 0.805 ' HG2' ' HA ' ' A' ' 171' ' ' ALA . 14.4 mtpp -62.86 -45.22 93.6 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 115.76 -0.655 . . . . 0.57 110.104 177.508 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 82.6 t60 -60.6 -39.77 89.37 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 109.672 -0.492 . . . . 0.51 109.672 178.278 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.482 HD21 ' CD2' ' A' ' 267' ' ' PHE . 4.4 mp -64.26 -50.68 67.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.856 -0.611 . . . . 0.52 110.037 178.528 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 260' ' ' LYS . . . . . 0.713 ' HG3' ' HB1' ' A' ' 171' ' ' ALA . 0.0 OUTLIER -61.57 -29.6 70.12 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.682 -0.236 . . . . 0.6 111.597 179.204 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 56.4 m -57.55 -33.05 67.71 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.041 0.448 . . . . 0.54 111.002 179.097 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 262' ' ' VAL . . . . . 0.531 HG23 ' HG3' ' A' ' 264' ' ' GLN . 26.4 m -112.12 13.63 8.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 CA-C-N 115.787 -0.642 . . . . 0.52 110.079 178.358 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 34.8 t30 58.8 47.24 12.95 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 115.079 -0.964 . . . . 0.55 113.012 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 264' ' ' GLN . . . . . 0.531 ' HG3' HG23 ' A' ' 262' ' ' VAL . 19.9 mt-30 -87.83 39.0 0.86 Allowed 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 116.523 -0.308 . . . . 0.97 111.666 179.007 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 265' ' ' GLU . . . . . 0.419 ' HA ' HD12 ' A' ' 268' ' ' ILE . 7.3 tp10 -49.34 -39.53 32.02 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 121.048 0.451 . . . . 0.45 112.051 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 3.2 p -59.34 -20.33 53.75 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.815 -0.63 . . . . 0.97 111.948 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 267' ' ' PHE . . . . . 0.62 ' HE2' HG22 ' A' ' 218' ' ' ILE . 15.7 t80 -103.57 -21.66 13.72 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 120.8 0.333 . . . . 0.53 111.011 179.38 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 268' ' ' ILE . . . . . 0.419 HD12 ' HA ' ' A' ' 265' ' ' GLU . 63.7 mt -65.39 -43.26 94.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.547 -0.297 . . . . 0.39 110.808 179.663 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 269' ' ' GLU . . . . . 0.642 ' HB3' ' HD3' ' A' ' 270' ' ' PRO . 1.8 tp10 -55.23 -58.13 16.62 Favored Pre-proline 0 CA--C 1.544 0.728 0 CA-C-N 116.332 -0.394 . . . . 0.43 111.01 179.061 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 270' ' ' PRO . . . . . 0.642 ' HD3' ' HB3' ' A' ' 269' ' ' GLU . 26.6 Cg_exo -63.64 -36.55 52.19 Favored 'Trans proline' 0 C--N 1.358 1.036 0 C-N-CA 121.725 1.617 . . . . 0.29 112.655 179.179 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 271' ' ' LEU . . . . . . . . . . . . . 52.6 tp -65.72 -54.81 22.2 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 121.147 -0.221 . . . . 0.5 111.49 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -58.16 -44.58 88.0 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-O 120.861 0.362 . . . . 0.29 111.445 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 273' ' ' GLU . . . . . 0.543 ' HG3' HD21 ' A' ' 160' ' ' LEU . 0.5 OUTLIER -66.51 -39.84 88.9 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 116.246 -0.434 . . . . 0.36 111.4 179.755 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 274' ' ' THR . . . . . 0.483 HG21 ' HB ' ' A' ' 224' ' ' VAL . 62.5 m -64.16 -45.34 88.88 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 120.718 0.294 . . . . 0.39 110.395 179.019 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 96.3 mt -54.12 -52.99 32.11 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 CA-C-N 116.093 -0.503 . . . . 0.42 110.622 179.147 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 276' ' ' THR . . . . . 0.581 HG23 HD12 ' A' ' 163' ' ' ILE . 56.8 m -56.38 -52.47 64.49 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.543 -0.298 . . . . 0.28 111.781 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 277' ' ' ASP . . . . . 0.59 ' OD1' ' HD2' ' A' ' 281' ' ' ARG . 0.4 OUTLIER -53.8 -51.66 62.77 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 112.127 0.418 . . . . 0.43 112.127 -179.364 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 27.3 t -70.05 -46.56 72.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 111.887 0.329 . . . . 0.38 111.887 -179.62 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 279' ' ' LEU . . . . . 0.46 HD21 HG23 ' A' ' 245' ' ' ILE . 0.4 OUTLIER -62.67 -41.24 98.98 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 113.14 0.792 . . . . 0.54 113.14 -178.757 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 280' ' ' VAL . . . . . 0.424 HG21 ' HB3' ' A' ' 159' ' ' SER . 81.4 t -87.21 -46.22 16.2 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 N-CA-C 113.768 1.025 . . . . 0.48 113.768 -178.266 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 281' ' ' ARG . . . . . 0.59 ' HD2' ' OD1' ' A' ' 277' ' ' ASP . 38.1 mtt85 -70.96 -34.9 71.89 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 114.425 1.269 . . . . 0.53 114.425 -177.122 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 282' ' ' THR . . . . . . . . . . . . . 42.0 p -61.5 -30.71 70.8 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 119.073 0.851 . . . . 0.35 111.513 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 29.9 mmtp -125.06 41.21 3.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.321 -0.399 . . . . 0.36 111.001 179.382 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 284' ' ' ARG . . . . . 0.524 ' HG2' ' N ' ' A' ' 285' ' ' ASP . 0.0 OUTLIER -53.34 -35.6 60.39 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 112.866 0.691 . . . . 0.44 112.866 -179.319 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 285' ' ' ASP . . . . . 0.524 ' N ' ' HG2' ' A' ' 284' ' ' ARG . 8.1 p-10 -63.04 -44.41 95.94 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-O 120.634 0.254 . . . . 0.46 111.254 -179.363 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 286' ' ' TRP . . . . . 0.777 ' HA ' ' HD2' ' A' ' 289' ' ' LYS . 0.0 OUTLIER -61.5 -34.68 75.91 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.163 0.506 . . . . 0.4 110.477 179.404 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 287' ' ' LEU . . . . . 0.588 HD13 ' HA2' ' A' ' 292' ' ' GLY . 1.7 mm? -70.13 -47.01 63.55 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.566 -0.743 . . . . 0.54 110.482 179.194 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 288' ' ' VAL . . . . . 0.509 HG23 ' O ' ' A' ' 284' ' ' ARG . 64.3 t -60.67 -33.07 53.42 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 CA-C-O 120.898 0.38 . . . . 0.92 110.858 178.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 289' ' ' LYS . . . . . 0.777 ' HD2' ' HA ' ' A' ' 286' ' ' TRP . 74.3 mttt -60.45 -42.17 95.61 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.01 -0.541 . . . . 0.47 112.213 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 290' ' ' GLN . . . . . 0.534 ' HB3' ' HA3' ' A' ' 295' ' ' GLY . 5.1 mt-30 -111.86 28.29 8.89 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 112.869 0.692 . . . . 0.45 112.869 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 291' ' ' ARG . . . . . 0.489 ' HB3' ' HB2' ' A' ' 294' ' ' ASP . 3.8 mmm180 59.09 13.91 3.18 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 112.768 0.655 . . . . 0.55 112.768 179.545 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 292' ' ' GLY . . . . . 0.588 ' HA2' HD13 ' A' ' 287' ' ' LEU . . . 75.06 -108.2 2.47 Favored Glycine 0 N--CA 1.448 -0.502 0 N-CA-C 114.361 0.504 . . . . 0.35 114.361 179.448 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 293' ' ' TRP . . . . . 0.572 ' CZ2' ' HA ' ' A' ' 159' ' ' SER . 80.5 m95 -68.42 -29.27 67.9 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.62 0.6 . . . . 0.51 112.62 -177.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 294' ' ' ASP . . . . . 0.489 ' HB2' ' HB3' ' A' ' 291' ' ' ARG . 22.0 m-20 -62.11 -44.99 95.44 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 120.57 -0.452 . . . . 0.38 109.949 178.489 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 295' ' ' GLY . . . . . 0.534 ' HA3' ' HB3' ' A' ' 290' ' ' GLN . . . -69.07 -33.85 75.04 Favored Glycine 0 C--O 1.224 -0.524 0 C-N-CA 120.809 -0.71 . . . . 0.35 111.695 178.076 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 296' ' ' PHE . . . . . 0.405 ' CD2' ' HE3' ' A' ' 293' ' ' TRP . 0.5 OUTLIER -70.51 -45.11 66.22 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 120.655 0.264 . . . . 0.35 111.232 179.111 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 297' ' ' VAL . . . . . 0.658 HG11 ' HB3' ' A' ' 189' ' ' ARG . 69.3 t -63.81 -50.65 76.77 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.117 0 CA-C-O 120.689 0.281 . . . . 0.29 110.75 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.34 -22.87 64.66 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 116.188 -0.46 . . . . 0.43 111.745 -179.605 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 299' ' ' PHE . . . . . 0.412 ' HB2' ' O ' ' A' ' 295' ' ' GLY . 88.2 t80 -71.54 -36.04 70.87 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-O 120.764 0.316 . . . . 0.46 110.854 178.319 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 300' ' ' PHE . . . . . 0.424 ' CE2' HG21 ' A' ' 246' ' ' VAL . 79.3 m-85 -100.07 -5.41 28.01 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.79 0.329 . . . . 0.53 111.832 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 301' ' ' HIS . . . . . 0.468 ' HB2' ' O ' ' A' ' 297' ' ' VAL . 1.6 m-70 -102.37 30.37 4.62 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.556 -0.293 . . . . 0.75 110.453 178.572 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 14.1 p -58.85 -25.16 28.37 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-O 121.132 0.491 . . . . 0.75 111.448 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -87.99 -80.37 0.27 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.987 -0.551 . . . . 1.37 110.389 179.328 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -86.29 73.32 10.21 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 121.246 0.546 . . . . 0.66 111.624 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 305' ' ' LEU . . . . . 0.418 ' HG ' ' O ' ' A' ' 301' ' ' HIS . 14.6 mt -63.93 -30.39 71.47 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.33 -0.395 . . . . 1.28 111.921 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -82.96 -15.1 52.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.32 -0.4 . . . . 1.12 111.696 -179.438 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . -85.8 173.2 46.99 Favored Glycine 0 CA--C 1.523 0.542 0 C-N-CA 120.791 -0.719 . . . . 0.98 112.685 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.282 0 CA-C-O 118.643 -1.087 . . . . 0.81 112.949 179.93 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 17' ' ' ALA . . . . . 0.41 ' N ' ' OD2' ' A' ' 217' ' ' ASP . . . . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.424 0.154 . . . . 1.04 110.825 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.4 164.27 12.89 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.894 0.378 . . . . 0.49 110.731 179.363 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 19' ' ' LEU . . . . . 0.663 HD21 ' HA ' ' A' ' 216' ' ' LEU . 7.1 mt -111.0 115.23 53.23 Favored Pre-proline 0 C--N 1.326 -0.435 0 N-CA-C 112.097 0.406 . . . . 0.46 112.097 -179.218 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -75.55 146.04 30.32 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.779 2.32 . . . . 0.54 112.064 179.283 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 21' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -68.99 35.55 0.19 Allowed 'Trans proline' 0 CA--C 1.542 0.918 0 C-N-CA 122.935 2.423 . . . . 0.54 114.493 -178.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -83.1 -42.02 17.89 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.039 0.447 . . . . 0.89 110.172 179.423 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 23' ' ' PHE . . . . . 0.584 ' HE2' HD22 ' B' ' 19' ' ' LEU . 0.7 OUTLIER -57.34 -37.79 73.11 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 115.706 -0.679 . . . . 0.38 111.394 179.377 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 24' ' ' ALA . . . . . 0.518 ' N ' ' HD1' ' B' ' 23' ' ' PHE . . . -65.57 -40.25 92.56 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.121 -0.491 . . . . 0.4 111.655 -179.151 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 25' ' ' ALA . . . . . 0.513 ' O ' ' HG3' ' B' ' 29' ' ' LYS . . . -66.15 -46.85 76.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.996 0.427 . . . . 0.4 110.218 179.175 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -62.32 -51.57 67.11 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 115.827 -0.624 . . . . 0.61 110.68 179.129 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 51.3 mt -57.65 -41.72 82.03 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.755 0.312 . . . . 0.59 110.339 178.654 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 28' ' ' ARG . . . . . . . . . . . . . 1.2 ttm180 -58.86 -50.81 72.58 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.164 -0.471 . . . . 0.75 110.434 178.133 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 29' ' ' LYS . . . . . 0.513 ' HG3' ' O ' ' B' ' 25' ' ' ALA . 85.3 mttt -57.82 -51.39 69.78 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.039 -0.528 . . . . 0.65 110.798 178.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 78.9 mt -58.87 -45.45 91.69 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 CA-C-N 115.878 -0.601 . . . . 0.42 110.983 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -58.67 -50.52 66.37 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.897 -0.668 . . . . 0.28 113.009 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 -68.17 -37.21 80.73 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.966 0.383 . . . . 0.37 111.527 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 21.8 ttmm -62.42 -50.5 71.27 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 120.912 0.387 . . . . 0.81 110.328 178.586 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 49.1 t -63.19 -47.43 92.35 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 116.097 -0.501 . . . . 0.41 110.593 178.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 35' ' ' TYR . . . . . 0.481 ' HB2' ' H ' ' A' ' 243' ' ' GLY . 1.6 t80 -58.04 -50.82 72.1 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 115.777 -0.647 . . . . 0.98 111.508 179.44 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 36' ' ' CYS . . . . . . . . . . . . . 13.0 t -63.14 -28.43 70.06 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 120.804 0.335 . . . . 0.48 111.839 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 89.1 m -77.64 -45.91 23.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.425 -0.352 . . . . 0.44 111.87 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 38' ' ' TRP . . . . . . . . . . . . . 97.1 m95 -80.12 -19.7 46.71 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 112.95 0.722 . . . . 0.54 112.95 -178.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 40.0 t -74.2 -6.49 48.08 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 112.268 0.47 . . . . 0.43 112.268 179.545 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -90.15 119.35 69.27 Favored Pre-proline 0 CA--C 1.533 0.313 0 N-CA-C 112.003 0.372 . . . . 0.51 112.003 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -84.13 -15.46 6.67 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.721 2.281 . . . . 0.97 112.824 179.27 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -78.81 89.92 4.66 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.12 -0.491 . . . . 1.22 110.993 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 43' ' ' MET . . . . . . . . . . . . . 64.5 mtt . . . . . 0 C--O 1.251 1.157 0 CA-C-O 118.249 -0.881 . . . . 1.72 111.425 179.91 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.131 0 N-CA-C 112.14 -0.384 . . . . 0.6 112.14 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -69.93 -67.77 0.03 OUTLIER 'Trans proline' 0 CA--C 1.534 0.516 0 C-N-CA 122.523 2.149 . . . . 0.94 112.5 179.442 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 25.3 tp -170.86 149.64 3.06 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.212 -0.449 . . . . 0.81 110.219 179.623 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 167.37 171.52 33.5 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.274 -0.965 . . . . 0.4 113.016 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -62.32 -30.06 70.89 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 112.228 0.455 . . . . 0.46 112.228 -179.672 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -114.77 26.89 9.82 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.295 -0.411 . . . . 0.4 111.321 -179.435 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -77.75 -27.96 50.54 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 112.478 0.548 . . . . 0.37 112.478 -178.56 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -55.15 -56.48 19.43 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 120.95 0.405 . . . . 0.78 111.369 -179.608 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.22 -37.08 77.84 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.028 0.442 . . . . 0.73 110.534 179.567 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 13.6 t80 -61.62 -40.71 95.83 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 115.906 -0.588 . . . . 0.41 111.697 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.401 HH11 ' HD3' ' A' ' 157' ' ' ARG . 55.0 mtt-85 -65.32 -48.3 73.53 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 111.834 0.309 . . . . 0.49 111.834 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 2.7 mm-40 -62.07 -42.48 99.24 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.203 0.525 . . . . 0.39 110.303 179.492 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' SER . . . . . 0.469 ' HA ' ' CZ2' ' A' ' 293' ' ' TRP . 12.3 m -66.19 -54.69 22.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.756 -0.657 . . . . 0.25 111.218 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.614 ' HA ' HG21 ' A' ' 276' ' ' THR . 2.0 tm? -54.11 -46.38 72.13 Favored 'General case' 0 N--CA 1.464 0.248 0 O-C-N 123.183 0.302 . . . . 0.73 111.08 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' GLU . . . . . 0.579 ' HG2' HD12 ' A' ' 180' ' ' LEU . 30.3 tt0 -63.57 -54.38 37.03 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 112.067 0.395 . . . . 0.4 112.067 -179.584 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' ILE . . . . . 0.478 HD11 ' HA2' ' A' ' 187' ' ' GLY . 88.1 mt -59.33 -46.68 92.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 N-CA-C 111.589 0.218 . . . . 0.33 111.589 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.57 HD12 HG23 ' A' ' 276' ' ' THR . 84.2 mt -62.84 -51.23 74.62 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 C-N-CA 121.085 -0.246 . . . . 0.32 111.462 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 55.2 p -58.78 -42.29 88.65 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.586 0.231 . . . . 0.29 111.302 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' ARG . . . . . 0.432 ' O ' ' HB2' ' A' ' 169' ' ' GLU . 2.0 tpt85 -58.02 -51.64 68.81 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.855 0.359 . . . . 0.35 110.806 179.374 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 166' ' ' TYR . . . . . 0.475 ' O ' ' HB2' ' A' ' 170' ' ' GLN . 66.7 t80 -64.04 -49.37 72.62 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.937 -0.574 . . . . 0.37 112.065 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.517 ' HG ' ' O ' ' A' ' 163' ' ' ILE . 21.4 mt -56.17 -45.96 79.53 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 112.024 0.379 . . . . 0.32 112.024 -178.612 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 168' ' ' ARG . . . . . 0.41 HH11 ' HD2' ' A' ' 168' ' ' ARG . 11.8 ttm105 -70.18 -44.59 68.43 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.57 0.224 . . . . 0.34 111.133 179.431 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 169' ' ' GLU . . . . . 0.432 ' HB2' ' O ' ' A' ' 165' ' ' ARG . 1.9 tt0 -61.52 -36.08 79.53 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-O 121.32 0.581 . . . . 0.46 110.564 179.347 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 170' ' ' GLN . . . . . 0.475 ' HB2' ' O ' ' A' ' 166' ' ' TYR . 1.8 tm0? -71.98 -47.8 49.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.76 -0.654 . . . . 0.4 110.246 178.434 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -61.53 -24.51 66.67 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.094 -0.503 . . . . 0.36 112.103 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 12.0 p -95.01 -7.93 38.32 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 111.914 0.338 . . . . 0.49 111.914 179.489 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 58.18 28.63 61.69 Favored Glycine 0 C--N 1.336 0.58 0 CA-C-N 116.333 -0.394 . . . . 0.57 113.532 179.558 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 30.1 m -126.5 174.66 8.48 Favored 'General case' 0 C--N 1.329 -0.296 0 O-C-N 122.61 -0.347 . . . . 0.54 111.413 -179.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' LYS . . . . . 0.456 ' HE3' ' HB3' ' A' ' 175' ' ' LYS . 9.2 mmmt -124.12 125.66 44.86 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 111.959 0.355 . . . . 0.62 111.959 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -105.59 138.61 41.51 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 121.054 0.454 . . . . 0.49 111.045 179.473 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 68.8 p -94.57 -18.43 21.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.155 -0.475 . . . . 0.74 111.108 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' LYS . . . . . 0.43 ' HB2' HH22 ' A' ' 165' ' ' ARG . 24.2 mttp -60.94 144.49 90.39 Favored Pre-proline 0 CA--C 1.532 0.27 0 CA-C-N 116.293 -0.412 . . . . 0.68 111.388 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 179' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 178' ' ' LYS . 24.5 Cg_exo -63.72 161.93 30.31 Favored 'Trans proline' 0 CA--C 1.533 0.43 0 C-N-CA 123.13 2.554 . . . . 0.57 113.784 -179.399 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.579 HD12 ' HG2' ' A' ' 161' ' ' GLU . 4.1 mm? -54.44 -60.51 3.25 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.769 -0.65 . . . . 0.63 111.04 179.546 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 149.99 -69.55 0.32 Allowed Glycine 0 CA--C 1.521 0.447 0 CA-C-N 115.364 -0.835 . . . . 0.72 111.347 -179.528 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 182' ' ' GLU . . . . . 0.459 ' H ' ' CD ' ' A' ' 161' ' ' GLU . 87.4 mt-10 -109.98 -36.24 5.93 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.141 0.496 . . . . 0.82 110.206 178.674 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.531 ' O ' ' HA3' ' A' ' 187' ' ' GLY . . . -83.65 85.8 7.22 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 116.164 -0.471 . . . . 0.31 110.349 178.863 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -77.33 -71.47 1.2 Allowed Glycine 0 CA--C 1.525 0.688 0 C-N-CA 120.445 -0.884 . . . . 0.37 114.543 -178.642 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -63.43 -56.19 18.16 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 112.076 0.399 . . . . 0.43 112.076 -178.727 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -66.56 -44.44 82.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.373 -0.376 . . . . 0.36 110.702 179.493 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 187' ' ' GLY . . . . . 0.531 ' HA3' ' O ' ' A' ' 183' ' ' ALA . . . -57.48 -53.49 44.61 Favored Glycine 0 CA--C 1.522 0.507 0 C-N-CA 121.238 -0.506 . . . . 0.33 113.823 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 188' ' ' ARG . . . . . 0.444 HH11 ' HD2' ' A' ' 188' ' ' ARG . 1.6 mmp_? -61.17 -44.48 97.23 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 117.617 0.708 . . . . 0.5 112.245 -179.661 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 189' ' ' ARG . . . . . 0.581 ' HB3' HG11 ' A' ' 297' ' ' VAL . 49.9 mtm180 -66.93 -39.12 87.25 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 120.802 0.334 . . . . 0.43 110.745 179.429 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.44 ' HA ' HG22 ' A' ' 297' ' ' VAL . . . -70.58 -34.79 72.57 Favored 'General case' 0 C--O 1.222 -0.349 0 CA-C-N 116.362 -0.381 . . . . 0.27 110.677 178.645 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.53 -45.4 94.34 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.823 -0.171 . . . . 0.61 111.142 179.202 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -66.79 -45.46 78.36 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 121.028 0.442 . . . . 0.35 111.125 179.558 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 1.3 p -65.21 -48.51 73.14 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.288 -0.415 . . . . 0.36 111.7 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 0.483 HD21 HG21 ' A' ' 249' ' ' ILE . 19.1 tp -60.65 -35.49 76.35 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 116.406 -0.361 . . . . 0.36 111.112 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 195' ' ' ARG . . . . . 0.422 ' HA ' ' HE1' ' A' ' 166' ' ' TYR . 5.0 mmt180 -65.05 -44.49 88.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.917 0.389 . . . . 0.34 110.775 178.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.88 -52.43 24.86 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.149 0.426 . . . . 0.34 112.149 -179.43 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 197' ' ' VAL . . . . . 0.482 ' O ' HG23 ' A' ' 201' ' ' VAL . 48.1 t -69.61 -43.39 80.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 N-CA-C 112.572 0.582 . . . . 0.32 112.572 -178.785 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -67.14 -51.68 37.14 Favored Glycine 0 CA--C 1.521 0.409 0 C-N-CA 121.018 -0.611 . . . . 0.23 113.467 -178.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -63.87 -35.79 81.79 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 120.804 0.335 . . . . 0.29 110.378 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -59.94 -48.15 87.48 Favored Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 111.119 -0.792 . . . . 0.29 111.119 177.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 201' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 197' ' ' VAL . 76.3 t -64.04 -40.93 90.83 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 122.217 0.207 . . . . 0.32 111.331 179.014 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 202' ' ' GLN . . . . . 0.499 ' HA ' ' HE2' ' A' ' 209' ' ' PHE . 31.7 tt0 -60.07 -48.07 83.24 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 116.587 -0.279 . . . . 0.42 111.5 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.33 -39.02 71.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.615 0.245 . . . . 1.44 111.255 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 18.2 m-80 -67.08 -52.22 44.64 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 111.969 0.359 . . . . 1.23 111.969 179.596 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 74.0 m-70 -101.47 34.91 2.43 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 112.427 0.529 . . . . 0.42 112.427 -178.615 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -62.9 -40.12 96.61 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 120.999 -0.28 . . . . 0.44 111.266 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 38.4 p -60.66 -43.11 98.01 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.061 0.458 . . . . 0.55 110.683 179.414 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 208' ' ' ALA . . . . . 0.441 ' O ' ' HG3' ' A' ' 212' ' ' MET . . . -65.99 -41.87 90.55 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.83 -0.623 . . . . 0.37 109.93 178.678 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 209' ' ' PHE . . . . . 0.499 ' HE2' ' HA ' ' A' ' 202' ' ' GLN . 14.4 m-30 -63.0 -42.58 99.88 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.893 -0.594 . . . . 0.45 110.112 178.66 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 210' ' ' GLN . . . . . 0.698 ' O ' ' HG2' ' A' ' 214' ' ' ARG . 31.3 mt-30 -57.79 -46.72 84.21 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.288 -0.414 . . . . 0.64 110.542 178.494 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -55.68 -46.75 81.36 Favored Glycine 0 C--N 1.339 0.711 0 C-N-CA 121.051 -0.595 . . . . 0.33 111.951 178.756 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 212' ' ' MET . . . . . 0.473 ' HB3' ' HB3' ' B' ' 23' ' ' PHE . 35.1 mtt -62.91 -42.68 99.87 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 109.515 -0.55 . . . . 0.7 109.515 177.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 12.7 tp -58.92 -44.53 91.31 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.744 -0.662 . . . . 0.6 111.11 179.055 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 214' ' ' ARG . . . . . 0.698 ' HG2' ' O ' ' A' ' 210' ' ' GLN . 22.1 mmt180 -60.65 -35.16 75.54 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 120.887 0.375 . . . . 1.08 110.945 179.439 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -94.7 12.31 28.22 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.968 0.359 . . . . 1.13 111.968 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.506 ' HB3' HG12 ' A' ' 218' ' ' ILE . 12.1 mt -99.39 154.27 18.33 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.127 0.489 . . . . 0.7 111.511 179.821 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -105.05 17.2 24.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.9 -0.591 . . . . 1.09 111.052 179.62 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 218' ' ' ILE . . . . . 0.543 ' HA ' ' HB2' ' A' ' 223' ' ' ASP . 17.3 mm -59.33 105.93 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-N 116.417 -0.356 . . . . 0.42 111.441 -179.716 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 219' ' ' LYS . . . . . 0.444 ' HG3' ' O ' ' A' ' 218' ' ' ILE . 7.5 mtmp? -159.56 -65.64 0.08 Allowed 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.862 -0.608 . . . . 0.62 110.7 -179.301 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -104.3 -175.65 2.86 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 115.098 -0.955 . . . . 0.69 110.722 -179.464 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 221' ' ' GLU . . . . . 0.425 ' O ' HG22 ' A' ' 224' ' ' VAL . 0.5 OUTLIER -46.83 -22.37 0.3 Allowed 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 113.538 0.94 . . . . 0.8 113.538 -179.221 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 222' ' ' GLY . . . . . 0.577 ' HA2' ' HD2' ' A' ' 225' ' ' LYS . . . -65.92 -23.99 71.31 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 121.223 -0.513 . . . . 0.38 113.076 178.606 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 223' ' ' ASP . . . . . 0.543 ' HB2' ' HA ' ' A' ' 218' ' ' ILE . 2.9 p-10 -56.56 -45.49 81.26 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 113.478 0.918 . . . . 0.76 113.478 -178.354 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.425 HG22 ' O ' ' A' ' 221' ' ' GLU . 28.9 m -59.96 -29.55 43.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-N 118.107 0.412 . . . . 0.5 111.475 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 225' ' ' LYS . . . . . 0.577 ' HD2' ' HA2' ' A' ' 222' ' ' GLY . 26.4 mttp -76.08 -42.76 46.34 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.549 -0.537 . . . . 0.91 109.549 178.886 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 94.3 p -64.5 -40.51 95.78 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.741 -0.663 . . . . 0.61 110.327 178.654 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 227' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -65.39 -42.63 92.44 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 109.919 -0.4 . . . . 0.51 109.919 178.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 228' ' ' SER . . . . . 0.539 ' HA ' ' HG2' ' A' ' 231' ' ' MET . 7.5 t -60.44 -43.79 96.47 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.086 -0.506 . . . . 0.64 110.423 178.595 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 229' ' ' ARG . . . . . 0.423 HH11 ' HD2' ' A' ' 229' ' ' ARG . 9.0 mmm180 -55.69 -44.36 77.3 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.243 0.544 . . . . 0.78 110.545 178.821 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 0.499 ' O ' HG23 ' A' ' 234' ' ' VAL . 60.1 t -69.19 -54.32 20.69 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-N 115.877 -0.601 . . . . 0.33 111.475 179.307 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 231' ' ' MET . . . . . 0.539 ' HG2' ' HA ' ' A' ' 228' ' ' SER . 10.6 ptm -59.58 -37.13 77.69 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 112.491 0.552 . . . . 0.33 112.491 -178.838 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 33.0 t -66.4 -41.07 88.16 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 N-CA-C 109.522 -0.547 . . . . 0.38 109.522 178.373 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 233' ' ' HIS . . . . . 0.509 ' HA ' ' HB2' ' A' ' 236' ' ' LYS . 2.3 t-80 -68.16 -40.18 82.4 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 116.203 -0.453 . . . . 0.41 110.44 178.473 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.499 HG23 ' O ' ' A' ' 230' ' ' VAL . 69.3 t -56.99 -37.95 57.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 CA-C-O 121.057 0.456 . . . . 0.34 111.12 179.546 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 235' ' ' PHE . . . . . 0.511 ' HE2' HD22 ' A' ' 248' ' ' LEU . 93.3 m-85 -104.11 19.39 20.19 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.394 -0.366 . . . . 0.53 111.386 179.289 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 236' ' ' LYS . . . . . 0.509 ' HB2' ' HA ' ' A' ' 233' ' ' HIS . 1.3 tmtm? -79.81 -9.72 59.7 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 111.744 0.276 . . . . 1.27 111.744 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -70.16 -17.98 63.19 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 120.847 0.356 . . . . 0.53 111.033 179.685 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 96.83 -17.94 58.4 Favored Glycine 0 CA--C 1.524 0.621 0 C-N-CA 120.938 -0.649 . . . . 0.58 113.23 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 6.5 p -98.77 130.23 47.93 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-O 121.23 0.538 . . . . 0.58 111.8 -179.694 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 240' ' ' THR . . . . . 0.538 HG23 ' HG2' ' A' ' 283' ' ' LYS . 1.4 m -94.59 98.87 11.12 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.206 -0.452 . . . . 0.88 111.771 179.302 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -100.11 130.9 46.31 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.876 0.369 . . . . 0.48 111.208 179.431 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 242' ' ' TRP . . . . . . . . . . . . . 7.0 m95 -55.33 -43.76 75.22 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 116.032 -0.531 . . . . 0.54 111.146 179.326 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -58.01 -32.07 66.1 Favored Glycine 0 CA--C 1.519 0.329 0 CA-C-N 115.98 -0.555 . . . . 0.28 112.605 179.333 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 86.8 mtt180 -74.9 -36.39 62.23 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.78 -0.452 . . . . 0.34 109.78 178.786 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 245' ' ' ILE . . . . . 0.561 ' O ' HG12 ' A' ' 249' ' ' ILE . 79.1 mt -66.97 -51.36 55.46 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 CA-C-N 115.944 -0.571 . . . . 0.41 110.714 179.115 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 27.6 m -62.93 -35.9 73.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 C-N-CA 121.089 -0.244 . . . . 0.35 111.08 179.523 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 53.0 m -65.69 -37.77 87.39 Favored 'General case' 0 N--CA 1.463 0.187 0 N-CA-C 109.538 -0.542 . . . . 0.38 109.538 178.292 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 248' ' ' LEU . . . . . 0.511 HD22 ' HE2' ' A' ' 235' ' ' PHE . 34.2 tp -65.32 -40.58 93.92 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 116.143 -0.481 . . . . 0.63 109.759 177.624 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 249' ' ' ILE . . . . . 0.561 HG12 ' O ' ' A' ' 245' ' ' ILE . 43.0 mm -65.9 -48.89 80.36 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 CA-C-N 116.186 -0.461 . . . . 0.34 110.101 178.533 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 31.3 t -57.07 -42.68 81.09 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.801 -0.636 . . . . 0.28 110.31 178.709 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 251' ' ' PHE . . . . . . . . . . . . . 32.0 t80 -64.03 -45.46 88.78 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 115.647 -0.706 . . . . 0.46 110.059 177.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -58.22 -41.28 94.76 Favored Glycine 0 C--N 1.337 0.623 0 N-CA-C 111.464 -0.655 . . . . 0.32 111.464 178.632 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 253' ' ' ALA . . . . . 0.417 ' HB1' ' HB3' ' A' ' 170' ' ' GLN . . . -64.01 -42.68 97.06 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 120.773 0.32 . . . . 0.32 110.277 177.836 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -60.07 -40.87 91.0 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.357 0.598 . . . . 0.65 109.742 178.317 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 255' ' ' VAL . . . . . 0.461 ' CG1' HG21 ' A' ' 218' ' ' ILE . 79.9 t -66.54 -51.25 59.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 CA-C-N 115.682 -0.69 . . . . 0.41 109.696 177.815 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -54.21 -39.29 66.56 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.082 -0.508 . . . . 0.27 111.076 177.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -62.48 -42.89 99.8 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.402 -0.363 . . . . 0.59 110.667 178.53 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 31.3 t60 -64.61 -36.14 83.28 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.311 -0.404 . . . . 0.5 110.32 179.07 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 6.7 mp -74.6 -41.49 60.35 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 121.061 0.458 . . . . 0.51 110.696 178.479 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -62.82 -27.35 69.26 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.9 0.381 . . . . 0.4 110.666 179.079 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 56.4 m -59.67 -31.86 69.95 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.074 -0.512 . . . . 0.41 110.494 178.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 262' ' ' VAL . . . . . 0.419 HG23 ' HG3' ' A' ' 264' ' ' GLN . 15.7 m -110.49 16.99 7.72 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 CA-C-O 121.28 0.562 . . . . 0.4 110.192 178.29 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 25.6 t30 59.31 44.22 15.67 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 114.922 -1.035 . . . . 0.47 113.567 179.441 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 264' ' ' GLN . . . . . 0.419 ' HG3' HG23 ' A' ' 262' ' ' VAL . 15.0 mt-30 -91.54 36.61 0.95 Allowed 'General case' 0 N--CA 1.466 0.369 0 O-C-N 121.978 -0.452 . . . . 0.5 110.856 178.536 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 265' ' ' GLU . . . . . 0.427 ' HA ' HD12 ' A' ' 268' ' ' ILE . 6.4 mm-40 -57.94 -29.22 64.99 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 116.422 -0.354 . . . . 0.49 111.862 -179.418 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.37 -22.84 67.12 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.229 -0.441 . . . . 0.63 110.788 178.696 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 267' ' ' PHE . . . . . 0.428 ' C ' ' HD2' ' A' ' 270' ' ' PRO . 66.2 m-85 -100.01 -24.74 14.53 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.048 -0.524 . . . . 0.72 110.611 178.566 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 268' ' ' ILE . . . . . 0.427 HD12 ' HA ' ' A' ' 265' ' ' GLU . 89.3 mt -65.3 -40.9 90.03 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-N 116.11 -0.495 . . . . 0.37 111.477 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 269' ' ' GLU . . . . . 0.686 ' HB2' ' HD3' ' A' ' 270' ' ' PRO . 6.4 mm-40 -57.49 -56.47 33.81 Favored Pre-proline 0 CA--C 1.542 0.669 0 C-N-CA 120.979 -0.289 . . . . 0.68 111.111 178.873 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 270' ' ' PRO . . . . . 0.686 ' HD3' ' HB2' ' A' ' 269' ' ' GLU . 50.6 Cg_exo -58.04 -32.24 94.95 Favored 'Trans proline' 0 C--N 1.363 1.323 0 C-N-CA 121.843 1.695 . . . . 0.32 111.643 177.737 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 271' ' ' LEU . . . . . 0.44 ' O ' HG13 ' A' ' 275' ' ' ILE . 0.4 OUTLIER -66.06 -55.16 17.97 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.183 -0.462 . . . . 0.51 110.233 178.582 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -60.06 -39.12 84.91 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 115.846 -0.616 . . . . 0.28 110.951 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 273' ' ' GLU . . . . . 0.468 ' O ' ' HB2' ' A' ' 277' ' ' ASP . 26.4 tt0 -66.92 -43.41 83.38 Favored 'General case' 0 C--O 1.226 -0.18 0 CA-C-N 115.885 -0.598 . . . . 1.79 110.012 178.583 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 274' ' ' THR . . . . . . . . . . . . . 41.2 m -64.95 -44.35 89.71 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.605 -0.27 . . . . 0.39 110.927 179.057 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 275' ' ' ILE . . . . . 0.44 HG13 ' O ' ' A' ' 271' ' ' LEU . 96.5 mt -57.54 -54.97 24.09 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 CA-C-O 121.132 0.491 . . . . 0.4 110.157 179.09 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 276' ' ' THR . . . . . 0.614 HG21 ' HA ' ' A' ' 160' ' ' LEU . 24.4 m -59.25 -45.46 91.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.664 -0.698 . . . . 0.31 110.541 179.179 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 277' ' ' ASP . . . . . 0.468 ' HB2' ' O ' ' A' ' 273' ' ' GLU . 7.9 t70 -56.27 -58.35 8.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.315 -0.857 . . . . 0.33 111.723 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 95.3 t -57.7 -39.47 70.42 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-O 120.609 0.242 . . . . 0.4 110.953 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 22.3 tp -61.5 -47.92 83.42 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 120.669 0.271 . . . . 0.68 111.672 179.49 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 44.6 t -78.79 -23.28 12.97 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-O 121.052 0.453 . . . . 0.52 111.835 -179.699 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 281' ' ' ARG . . . . . 0.422 ' HB2' ' O ' ' A' ' 277' ' ' ASP . 19.3 ttm-85 -82.29 -25.8 33.66 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 121.824 -0.547 . . . . 0.47 111.949 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 282' ' ' THR . . . . . . . . . . . . . 37.7 p -98.69 -31.15 12.06 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 112.526 0.565 . . . . 0.4 112.526 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 283' ' ' LYS . . . . . 0.538 ' HG2' HG23 ' A' ' 240' ' ' THR . 3.3 mppt? -117.08 32.99 5.84 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 112.16 0.43 . . . . 1.01 112.16 -179.149 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 284' ' ' ARG . . . . . 0.48 ' H ' ' HG2' ' A' ' 284' ' ' ARG . 0.4 OUTLIER -56.81 -42.46 79.61 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 112.139 0.422 . . . . 0.45 112.139 179.817 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 285' ' ' ASP . . . . . 0.525 ' O ' ' HB2' ' A' ' 289' ' ' LYS . 26.0 t70 -62.19 -48.75 78.64 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.393 -0.367 . . . . 0.77 111.73 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 286' ' ' TRP . . . . . 0.513 ' CZ2' ' HG2' ' A' ' 290' ' ' GLN . 31.7 t90 -70.63 -41.42 72.22 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.018 0.377 . . . . 0.98 112.018 -179.201 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -61.27 -40.97 96.08 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 111.891 0.33 . . . . 0.55 111.891 -179.378 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 6.0 p -77.38 -29.69 16.87 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-O 120.75 0.309 . . . . 0.59 110.954 179.048 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 289' ' ' LYS . . . . . 0.525 ' HB2' ' O ' ' A' ' 285' ' ' ASP . 3.4 ttmm -75.36 -44.85 42.81 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 112.858 0.688 . . . . 0.81 112.858 -179.081 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 290' ' ' GLN . . . . . 0.513 ' HG2' ' CZ2' ' A' ' 286' ' ' TRP . 1.9 mp0 -84.83 29.88 0.6 Allowed 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 113.765 1.024 . . . . 0.78 113.765 -177.828 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 291' ' ' ARG . . . . . 0.608 ' HB3' ' HB3' ' A' ' 294' ' ' ASP . 21.5 mtm180 64.04 6.8 3.02 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 112.745 0.646 . . . . 0.42 112.745 179.318 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 59.07 -125.59 40.16 Favored Glycine 0 CA--C 1.521 0.421 0 CA-C-O 121.395 0.442 . . . . 0.32 113.573 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 293' ' ' TRP . . . . . 0.589 ' O ' HG23 ' A' ' 297' ' ' VAL . 83.8 m95 -64.9 -26.3 68.26 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.641 0.608 . . . . 0.48 112.641 -178.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 294' ' ' ASP . . . . . 0.608 ' HB3' ' HB3' ' A' ' 291' ' ' ARG . 20.0 t70 -64.32 -43.91 93.21 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 121.045 0.45 . . . . 0.54 109.934 178.844 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -68.38 -31.8 74.68 Favored Glycine 0 C--N 1.334 0.45 0 N-CA-C 110.609 -0.997 . . . . 0.36 110.609 177.776 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 296' ' ' PHE . . . . . 0.471 ' HB3' ' HA ' ' A' ' 293' ' ' TRP . 1.0 OUTLIER -67.7 -48.11 67.49 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 115.51 -0.345 . . . . 0.31 110.557 178.464 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 297' ' ' VAL . . . . . 0.589 HG23 ' O ' ' A' ' 293' ' ' TRP . 86.0 t -61.14 -43.4 96.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-O 120.825 0.345 . . . . 0.36 110.615 179.306 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -64.51 -46.49 82.71 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.863 -0.608 . . . . 0.48 112.053 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 299' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -62.63 -35.2 78.81 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 112.31 0.485 . . . . 0.54 112.31 -179.446 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 300' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -100.76 30.98 3.72 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.284 0.476 . . . . 0.51 112.284 -179.464 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 301' ' ' HIS . . . . . 0.406 ' HB2' ' O ' ' A' ' 297' ' ' VAL . 13.1 t-80 -148.91 146.06 27.71 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.054 0.454 . . . . 0.58 111.834 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 5.7 m -84.97 133.22 29.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.399 -0.364 . . . . 0.86 110.284 178.368 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 -132.57 103.03 5.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.881 0.372 . . . . 0.9 111.063 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.05 57.7 0.47 Allowed 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.059 0.456 . . . . 1.83 111.847 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 73.1 mt -77.59 -33.16 53.93 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.88 0.372 . . . . 2.15 111.393 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -100.19 21.79 12.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.981 0.419 . . . . 2.83 111.143 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . -138.73 47.85 0.9 Allowed Glycine 0 CA--C 1.523 0.587 0 C-N-CA 120.812 -0.708 . . . . 2.23 112.936 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.309 0 CA-C-O 118.454 -1.192 . . . . 4.41 112.871 -179.829 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.45 0 CA-C-O 120.659 0.266 . . . . 1.02 110.869 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.44 -35.84 7.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.172 0.511 . . . . 0.68 111.192 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 19' ' ' LEU . . . . . 0.562 ' HG ' ' HE1' ' B' ' 23' ' ' PHE . 6.2 tp -113.8 113.56 47.28 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 116.132 -0.485 . . . . 0.59 111.179 -179.68 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 20' ' ' PRO . . . . . 0.459 ' HD2' HD12 ' B' ' 19' ' ' LEU . 34.8 Cg_endo -65.35 116.28 3.8 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.336 2.024 . . . . 0.61 110.261 178.564 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 21' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -65.14 47.23 0.17 Allowed 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 122.785 2.324 . . . . 0.74 115.806 -176.512 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -87.58 -57.07 3.08 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.34 -0.615 . . . . 1.0 109.34 178.035 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 23' ' ' PHE . . . . . 0.562 ' HE1' ' HG ' ' B' ' 19' ' ' LEU . 0.0 OUTLIER -56.55 -41.3 76.62 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.87 -0.605 . . . . 0.72 110.686 178.54 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.61 -49.01 78.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.064 -0.516 . . . . 0.35 110.735 179.169 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 25' ' ' ALA . . . . . 0.411 ' HA ' ' HD3' ' B' ' 28' ' ' ARG . . . -64.78 -42.1 95.33 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.329 -0.396 . . . . 0.53 110.933 179.335 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -64.73 -49.53 70.45 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.128 -0.487 . . . . 1.09 111.351 179.531 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 61.6 mt -56.65 -36.03 69.06 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 120.815 0.34 . . . . 0.57 110.33 178.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 28' ' ' ARG . . . . . 0.411 ' HD3' ' HA ' ' B' ' 25' ' ' ALA . 19.4 mtp180 -62.89 -48.44 78.96 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.171 -0.468 . . . . 0.48 110.157 178.009 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 29' ' ' LYS . . . . . 0.504 ' HA ' ' HE3' ' B' ' 29' ' ' LYS . 0.0 OUTLIER -66.83 -41.81 86.83 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.319 -0.4 . . . . 0.53 111.96 -179.79 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 30' ' ' ILE . . . . . 0.407 ' O ' HG23 ' B' ' 34' ' ' VAL . 78.8 mt -61.65 -41.61 91.03 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 N-CA-C 109.142 -0.688 . . . . 0.39 109.142 178.027 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -61.85 -49.13 78.95 Favored Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 115.655 -0.702 . . . . 0.31 111.872 178.287 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -58.9 -44.23 91.19 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-O 121.117 0.484 . . . . 0.45 109.737 178.264 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 3.3 tmtt? -58.84 -52.61 64.98 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 115.434 -0.803 . . . . 0.41 111.137 178.667 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 34' ' ' VAL . . . . . 0.407 HG23 ' O ' ' B' ' 30' ' ' ILE . 58.7 t -58.87 -49.43 83.04 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 CA-C-O 120.749 0.309 . . . . 0.39 111.416 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -58.74 -43.96 90.39 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 116.307 -0.406 . . . . 0.62 111.972 -179.586 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 36' ' ' CYS . . . . . . . . . . . . . 17.8 p -73.39 -32.84 64.68 Favored 'General case' 0 N--CA 1.468 0.444 0 O-C-N 122.023 -0.423 . . . . 0.4 111.421 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 89.5 m -66.35 -39.82 89.42 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.526 -0.306 . . . . 0.37 111.365 179.53 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 38' ' ' TRP . . . . . . . . . . . . . 84.2 m95 -80.45 -25.05 39.13 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.981 -0.288 . . . . 0.56 111.201 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 69.2 m -68.08 -42.83 79.8 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 120.898 0.38 . . . . 0.48 110.71 178.139 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -88.8 127.7 55.12 Favored Pre-proline 0 CA--C 1.532 0.285 0 CA-C-N 116.216 -0.447 . . . . 0.58 111.522 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -78.14 61.27 7.69 Favored 'Trans proline' 0 CA--C 1.535 0.547 0 C-N-CA 122.58 2.187 . . . . 0.89 113.144 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 52.8 m-20 -79.0 73.01 5.56 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 120.981 0.419 . . . . 1.01 111.325 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 43' ' ' MET . . . . . . . . . . . . . 52.6 ttp . . . . . 0 C--O 1.253 1.255 0 CA-C-O 118.232 -0.889 . . . . 1.45 111.367 179.792 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.423 ' N ' ' OD2' ' A' ' 153' ' ' ASP . . . . . . . . 0 N--CA 1.49 2.277 0 CA-C-O 119.969 -0.351 . . . . 1.34 112.705 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -74.17 89.87 1.02 Allowed 'Trans proline' 0 CA--C 1.534 0.503 0 C-N-CA 122.929 2.419 . . . . 0.91 112.775 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 84.8 mt -59.65 141.73 54.43 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 112.583 0.586 . . . . 1.63 112.583 -179.307 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 77.85 -36.79 1.66 Allowed Glycine 0 CA--C 1.523 0.564 0 CA-C-N 115.775 -0.648 . . . . 1.21 114.358 179.538 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 99.4 p -93.96 -46.52 7.13 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 113.092 0.775 . . . . 0.68 113.092 -178.333 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.526 ' OE2' ' HD3' ' A' ' 284' ' ' ARG . 1.4 mt-10 -138.93 -30.56 0.74 Allowed 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 114.379 1.252 . . . . 0.45 114.379 -178.132 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' ASP . . . . . 0.423 ' OD2' ' N ' ' A' ' 147' ' ' GLY . 15.1 t70 -62.24 -53.72 51.13 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 112.763 0.653 . . . . 0.91 112.763 -178.377 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -67.85 -38.7 83.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.856 0.36 . . . . 0.59 110.679 179.773 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.436 HD11 ' HA3' ' A' ' 292' ' ' GLY . 53.8 tp -61.56 -39.4 90.97 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.732 -0.47 . . . . 0.63 109.732 178.366 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -58.17 -51.49 69.5 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.604 -0.726 . . . . 0.42 112.02 179.179 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.525 ' HD2' ' OE1' ' A' ' 182' ' ' GLU . 20.1 mtm180 -56.77 -49.66 74.61 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 112.37 0.507 . . . . 0.5 112.37 -178.837 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -59.04 -50.45 74.03 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 120.903 0.382 . . . . 1.19 111.007 179.48 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' SER . . . . . 0.457 ' HA ' ' CZ2' ' A' ' 293' ' ' TRP . 3.3 p -63.64 -45.9 88.1 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 112.278 0.473 . . . . 0.29 112.278 -179.374 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.409 HD22 ' HA ' ' A' ' 160' ' ' LEU . 0.4 OUTLIER -53.4 -49.76 66.6 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 120.774 0.321 . . . . 0.8 111.124 179.45 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 161' ' ' GLU . . . . . 1.025 ' HG3' ' HA3' ' A' ' 181' ' ' GLY . 1.3 mm-40 -75.99 -43.17 45.63 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.873 0.694 . . . . 0.39 112.873 -179.365 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 162' ' ' ILE . . . . . 0.466 HD13 ' HB3' ' A' ' 190' ' ' ALA . 79.9 mt -62.01 -42.44 94.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 O-C-N 121.978 -0.451 . . . . 0.31 111.753 -179.292 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.692 ' O ' ' HG ' ' A' ' 167' ' ' LEU . 74.1 mt -69.06 -52.3 35.23 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 C-N-CA 121.018 -0.273 . . . . 0.33 110.768 179.043 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 54.6 p -58.03 -42.27 84.98 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 121.281 -0.167 . . . . 0.26 110.983 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' ARG . . . . . 0.438 HH11 ' HD2' ' A' ' 165' ' ' ARG . 2.0 mmt85 -55.43 -51.77 65.81 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.722 -0.217 . . . . 0.41 110.951 178.472 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 166' ' ' TYR . . . . . 0.848 ' CE1' ' HA ' ' A' ' 195' ' ' ARG . 72.5 t80 -60.26 -48.68 80.69 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.666 -0.243 . . . . 0.31 111.142 179.28 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.692 ' HG ' ' O ' ' A' ' 163' ' ' ILE . 18.8 mt -59.0 -44.18 91.63 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.561 -0.29 . . . . 0.35 111.484 -179.568 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 168' ' ' ARG . . . . . 0.539 ' HD3' ' OE2' ' A' ' 269' ' ' GLU . 25.3 mtm180 -70.47 -44.42 67.77 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 112.22 0.452 . . . . 0.38 112.22 179.671 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -62.8 -44.1 97.06 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.705 0.288 . . . . 0.35 111.168 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' GLN . . . . . 0.456 ' HG3' ' CZ ' ' A' ' 166' ' ' TYR . 6.4 mm-40 -70.48 -28.99 65.41 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.853 0.359 . . . . 0.4 110.708 178.896 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.838 ' HA ' ' HG2' ' A' ' 257' ' ' LYS . . . -69.09 -32.82 72.51 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 112.522 0.564 . . . . 0.44 112.522 -179.695 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 172' ' ' THR . . . . . 0.797 ' HB ' ' HD3' ' A' ' 260' ' ' LYS . 8.8 t -106.51 -14.4 15.07 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 112.681 0.623 . . . . 0.48 112.681 -179.584 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 79.4 28.62 52.11 Favored Glycine 0 CA--C 1.523 0.549 0 C-N-CA 120.689 -0.767 . . . . 0.42 112.971 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 32.6 t -98.28 163.64 12.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.49 0.662 . . . . 0.5 111.788 -179.303 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 7.4 mptt -122.12 60.37 0.99 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.835 -0.621 . . . . 0.49 110.48 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -74.82 81.12 2.11 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.01 -0.541 . . . . 0.47 112.161 -179.518 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 9.1 t -79.38 13.59 1.88 Allowed 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 121.161 0.505 . . . . 0.59 111.277 179.405 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 36.2 mttt -68.49 155.29 93.04 Favored Pre-proline 0 CA--C 1.535 0.394 0 CA-C-N 116.018 -0.537 . . . . 0.54 110.309 178.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -52.9 111.89 0.77 Allowed 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 122.595 2.197 . . . . 0.52 112.574 179.628 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.462 ' H ' HD23 ' A' ' 180' ' ' LEU . 0.7 OUTLIER -83.45 176.03 9.38 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.343 -0.39 . . . . 0.47 111.906 -179.372 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 181' ' ' GLY . . . . . 1.025 ' HA3' ' HG3' ' A' ' 161' ' ' GLU . . . -54.83 130.27 46.21 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.872 -0.68 . . . . 0.35 112.514 -179.613 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 182' ' ' GLU . . . . . 0.525 ' OE1' ' HD2' ' A' ' 157' ' ' ARG . 84.8 mt-10 4.46 75.46 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 125.313 1.445 . . . . 0.97 114.478 -178.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.496 ' O ' ' HA3' ' A' ' 187' ' ' GLY . . . -169.0 72.96 0.09 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 115.624 -0.716 . . . . 0.38 110.247 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -78.74 -71.68 1.23 Allowed Glycine 0 CA--C 1.523 0.542 0 C-N-CA 120.647 -0.787 . . . . 0.42 113.811 -178.586 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -71.97 -56.14 6.2 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 120.8 0.333 . . . . 0.5 111.049 -179.697 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -61.52 -35.03 76.58 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.116 -0.493 . . . . 0.45 110.578 179.036 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 187' ' ' GLY . . . . . 0.496 ' HA3' ' O ' ' A' ' 183' ' ' ALA . . . -65.37 -40.46 96.43 Favored Glycine 0 C--N 1.333 0.408 0 C-N-CA 121.229 -0.51 . . . . 0.36 113.201 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 188' ' ' ARG . . . . . 0.449 ' HD3' ' HA ' ' A' ' 188' ' ' ARG . 15.0 mmt180 -66.52 -47.02 74.26 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 117.193 0.497 . . . . 0.66 110.552 179.656 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 189' ' ' ARG . . . . . 0.685 ' HB3' HG11 ' A' ' 297' ' ' VAL . 23.9 mmt180 -66.97 -39.52 87.22 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.067 -0.515 . . . . 0.65 111.204 179.678 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.466 ' HB3' HD13 ' A' ' 162' ' ' ILE . . . -70.09 -40.08 75.17 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.899 -0.321 . . . . 0.32 111.136 179.095 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 16.0 tp -69.27 -44.41 71.94 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 120.777 -0.369 . . . . 0.52 111.294 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 192' ' ' GLU . . . . . 0.558 ' HG3' ' O ' ' A' ' 189' ' ' ARG . 0.0 OUTLIER -58.43 -37.73 75.99 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 120.597 -0.441 . . . . 0.34 110.401 179.169 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 193' ' ' THR . . . . . 0.561 HG21 ' HA ' ' A' ' 297' ' ' VAL . 1.1 p -76.87 -47.59 20.81 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 120.953 -0.299 . . . . 0.35 111.08 178.884 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 0.482 ' HA ' HD12 ' A' ' 194' ' ' LEU . 10.3 tp -58.85 -35.36 72.82 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.737 0.303 . . . . 0.4 110.977 179.704 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 195' ' ' ARG . . . . . 0.848 ' HA ' ' CE1' ' A' ' 166' ' ' TYR . 12.6 mmt180 -68.8 -58.29 4.4 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.788 0.328 . . . . 0.35 110.348 178.393 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 20.7 ttp85 -60.77 -54.02 50.24 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 112.914 0.709 . . . . 0.52 112.914 -179.183 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 197' ' ' VAL . . . . . 0.564 ' O ' HG23 ' A' ' 201' ' ' VAL . 46.8 t -68.7 -45.1 81.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 112.051 0.389 . . . . 0.36 112.051 -179.033 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -61.7 -42.41 99.75 Favored Glycine 0 CA--C 1.521 0.444 0 C-N-CA 120.996 -0.621 . . . . 0.32 113.027 -179.494 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -68.39 -42.39 79.15 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 109.728 -0.471 . . . . 0.49 109.728 179.416 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -56.54 -48.68 74.76 Favored Glycine 0 C--N 1.336 0.547 0 C-N-CA 120.797 -0.716 . . . . 0.39 111.655 178.318 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 201' ' ' VAL . . . . . 0.564 HG23 ' O ' ' A' ' 197' ' ' VAL . 60.0 t -62.92 -42.6 97.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 CA-C-O 120.702 0.287 . . . . 0.43 111.193 178.726 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 202' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -63.38 -48.64 77.04 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.152 -0.476 . . . . 0.35 112.028 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 31.7 mtm180 -73.5 -35.27 65.6 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.908 -0.317 . . . . 0.74 111.739 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -63.73 -49.19 74.03 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 121.117 0.484 . . . . 0.91 110.039 178.6 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 79.6 m-70 -101.17 33.78 2.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.157 -0.474 . . . . 0.59 110.711 179.56 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -53.65 -45.71 70.32 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.89 -0.596 . . . . 0.79 112.042 -179.42 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -59.51 -41.89 90.97 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 120.928 0.394 . . . . 0.5 111.51 179.34 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -70.62 -50.62 35.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.23 -0.441 . . . . 0.43 111.045 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -60.26 -44.09 95.59 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 116.478 -0.328 . . . . 0.6 111.024 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 -64.67 -40.89 96.2 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 110.272 -0.27 . . . . 0.96 110.272 178.558 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -62.3 -44.81 97.14 Favored Glycine 0 C--N 1.335 0.522 0 N-CA-C 110.746 -0.942 . . . . 0.39 110.746 178.104 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 212' ' ' MET . . . . . 0.527 ' O ' ' HG ' ' A' ' 216' ' ' LEU . 8.0 mtp -64.09 -42.12 97.05 Favored 'General case' 0 C--O 1.222 -0.375 0 N-CA-C 110.076 -0.342 . . . . 0.67 110.076 178.102 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.437 HD21 ' HB2' ' A' ' 258' ' ' HIS . 6.8 tp -61.85 -39.16 90.87 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 120.889 0.376 . . . . 0.51 111.245 179.136 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 10.4 tpt180 -68.66 -32.52 72.43 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 116.267 -0.424 . . . . 0.79 111.32 179.546 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -89.99 -15.56 31.68 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 111.899 0.333 . . . . 0.57 111.899 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.535 HD11 ' CZ ' ' A' ' 251' ' ' PHE . 13.3 mt -62.92 134.18 55.8 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 113.036 0.754 . . . . 0.59 113.036 -179.288 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -100.95 17.04 23.3 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 115.511 -0.768 . . . . 1.1 110.127 178.589 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 30.7 mm -67.88 108.24 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 CA-C-N 116.073 -0.512 . . . . 0.73 111.385 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 2.9 mtmp? -135.08 -42.6 0.73 Allowed 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 112.355 0.502 . . . . 1.06 112.355 -179.522 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -113.87 -178.39 3.36 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 113.184 0.809 . . . . 1.27 113.184 -177.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 221' ' ' GLU . . . . . 0.612 ' O ' HG22 ' A' ' 224' ' ' VAL . 8.7 tm-20 -56.52 -44.53 80.88 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 115.723 -0.671 . . . . 1.34 112.244 -179.438 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -54.02 -26.99 36.42 Favored Glycine 0 CA--C 1.527 0.807 0 C-N-CA 121.112 -0.566 . . . . 0.43 113.564 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 62.7 m-20 -68.47 -31.03 70.03 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 112.71 0.633 . . . . 0.75 112.71 -179.689 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.612 HG22 ' O ' ' A' ' 221' ' ' GLU . 4.4 m -63.22 -28.65 45.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 CA-C-O 121.156 0.503 . . . . 0.54 111.548 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 37.6 mttm -70.0 -39.36 75.93 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-O 121.334 0.587 . . . . 1.28 110.278 179.399 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 226' ' ' SER . . . . . 0.533 ' O ' HG23 ' A' ' 230' ' ' VAL . 11.3 t -66.34 -36.03 81.88 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.896 -0.593 . . . . 0.35 109.535 178.315 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 227' ' ' PHE . . . . . . . . . . . . . 33.8 t80 -60.81 -42.55 97.87 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.184 -0.916 . . . . 0.53 110.314 178.604 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 228' ' ' SER . . . . . 0.417 ' HB3' HG11 ' A' ' 278' ' ' VAL . 18.8 m -59.62 -45.61 91.45 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 115.716 -0.675 . . . . 0.75 110.634 178.894 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 15.8 ttm105 -55.52 -43.68 75.97 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.611 -0.722 . . . . 0.38 110.799 178.679 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 0.533 HG23 ' O ' ' A' ' 226' ' ' SER . 25.4 t -58.9 -49.56 82.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 CA-C-N 116.118 -0.492 . . . . 0.42 111.679 179.328 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 231' ' ' MET . . . . . 0.538 ' HA ' HD22 ' A' ' 248' ' ' LEU . 70.5 mtm -53.11 -45.74 68.42 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.351 -0.386 . . . . 0.53 111.755 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 37.7 t -68.91 -40.45 81.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-O 120.657 0.265 . . . . 0.54 110.976 178.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 39.5 t-80 -54.89 -33.09 61.63 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.038 -0.528 . . . . 0.41 111.175 179.366 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.577 HG13 ' HA ' ' B' ' 28' ' ' ARG . 79.0 t -61.78 -30.9 49.4 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 N-CA-C 112.405 0.52 . . . . 0.41 112.405 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -93.98 23.16 5.1 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 112.432 0.53 . . . . 0.52 112.432 -179.094 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.58 -23.57 17.4 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 113.399 0.889 . . . . 1.06 113.399 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 237' ' ' ASP . . . . . 0.476 ' HB2' HG12 ' A' ' 239' ' ' VAL . 0.1 OUTLIER -76.67 -14.64 59.95 Favored 'General case' 0 CA--C 1.533 0.321 0 O-C-N 121.932 -0.48 . . . . 0.67 111.991 -179.688 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 88.53 12.71 64.35 Favored Glycine 0 CA--C 1.522 0.516 0 C-N-CA 120.79 -0.719 . . . . 0.67 113.488 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 0.476 HG12 ' HB2' ' A' ' 237' ' ' ASP . 3.9 p -119.48 112.21 36.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 CA-C-O 121.533 0.682 . . . . 0.55 111.569 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 240' ' ' THR . . . . . 0.75 HG22 HD11 ' A' ' 245' ' ' ILE . 4.2 m -81.33 69.93 8.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.101 -0.499 . . . . 0.58 112.235 -179.445 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 48.2 m-20 -76.89 136.21 38.85 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 120.724 0.297 . . . . 0.8 110.976 179.02 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 242' ' ' TRP . . . . . 0.558 ' CZ3' ' HB2' ' A' ' 296' ' ' PHE . 68.8 m95 -53.66 -36.53 62.22 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 112.972 0.73 . . . . 0.52 112.972 -179.17 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 243' ' ' GLY . . . . . 0.474 ' H ' ' HB2' ' B' ' 35' ' ' TYR . . . -58.09 -34.88 74.49 Favored Glycine 0 CA--C 1.521 0.46 0 C-N-CA 120.994 -0.622 . . . . 0.34 112.894 179.658 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 244' ' ' ARG . . . . . 0.617 ' O ' ' HG ' ' A' ' 248' ' ' LEU . 28.9 mtt180 -74.37 -46.45 40.43 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.917 -0.401 . . . . 0.59 109.917 179.389 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 245' ' ' ILE . . . . . 0.75 HD11 HG22 ' A' ' 240' ' ' THR . 58.5 mt -55.91 -47.96 79.13 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-N 115.533 -0.758 . . . . 0.54 110.778 178.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 7.6 p -70.15 -29.01 38.01 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 120.905 -0.318 . . . . 0.37 110.852 179.773 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 247' ' ' THR . . . . . 0.545 HG22 HD22 ' B' ' 27' ' ' LEU . 19.8 m -65.16 -39.64 93.24 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 109.603 -0.517 . . . . 0.42 109.603 177.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 248' ' ' LEU . . . . . 0.617 ' HG ' ' O ' ' A' ' 244' ' ' ARG . 51.4 mt -63.21 -38.91 93.03 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.863 -0.608 . . . . 0.43 109.784 178.204 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 249' ' ' ILE . . . . . 0.469 HG21 HD11 ' A' ' 194' ' ' LEU . 15.6 mt -70.22 -36.9 69.66 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 N-CA-C 109.55 -0.537 . . . . 0.41 109.55 177.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 20.4 m -64.08 -40.5 96.38 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 109.255 -0.646 . . . . 0.37 109.255 178.136 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 251' ' ' PHE . . . . . 0.535 ' CZ ' HD11 ' A' ' 216' ' ' LEU . 8.0 t80 -65.83 -40.99 92.32 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 108.644 -0.873 . . . . 0.56 108.644 176.788 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -62.69 -39.55 98.06 Favored Glycine 0 C--N 1.336 0.53 0 CA-C-N 115.509 -0.769 . . . . 0.28 111.576 178.051 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -64.75 -41.44 95.92 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 120.665 0.269 . . . . 0.28 110.517 178.033 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -63.09 -37.9 89.03 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.042 0.449 . . . . 0.53 110.209 178.503 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 255' ' ' VAL . . . . . 0.523 HG23 ' O ' ' A' ' 251' ' ' PHE . 59.9 t -72.97 -39.42 57.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 N-CA-C 109.83 -0.433 . . . . 0.35 109.83 178.218 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 256' ' ' ALA . . . . . 0.415 ' HB1' HD11 ' A' ' 268' ' ' ILE . . . -55.64 -43.71 76.47 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.143 0.497 . . . . 0.31 109.942 178.042 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 257' ' ' LYS . . . . . 0.838 ' HG2' ' HA ' ' A' ' 171' ' ' ALA . 93.0 mttt -62.39 -47.87 82.25 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 115.507 -0.769 . . . . 0.4 110.378 178.267 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 258' ' ' HIS . . . . . 0.437 ' HB2' HD21 ' A' ' 213' ' ' LEU . 45.3 t60 -59.45 -36.43 75.91 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.3 -0.409 . . . . 0.68 111.379 179.668 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.401 ' O ' ' HB2' ' A' ' 264' ' ' GLN . 88.2 mt -77.37 -51.06 11.47 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 112.023 0.379 . . . . 0.57 112.023 179.275 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 260' ' ' LYS . . . . . 0.797 ' HD3' ' HB ' ' A' ' 172' ' ' THR . 0.4 OUTLIER -60.81 -42.05 96.91 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 112.496 0.554 . . . . 0.68 112.496 -179.341 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 29.3 p -55.63 -27.98 52.73 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 112.35 0.5 . . . . 0.61 112.35 -179.493 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 262' ' ' VAL . . . . . 0.609 HG23 ' HG3' ' A' ' 264' ' ' GLN . 17.1 m -109.41 25.83 2.76 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-O 120.759 0.314 . . . . 0.63 111.594 179.361 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 58.4 m-80 55.63 47.44 20.68 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 113.219 0.822 . . . . 1.2 113.219 179.121 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 264' ' ' GLN . . . . . 0.609 ' HG3' HG23 ' A' ' 262' ' ' VAL . 37.3 mt-30 -103.94 39.8 1.56 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.005 0.431 . . . . 0.75 111.359 179.381 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 265' ' ' GLU . . . . . 0.826 ' HA ' HG22 ' A' ' 268' ' ' ILE . 24.2 mm-40 -50.84 -35.88 34.72 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 112.668 0.618 . . . . 0.71 112.668 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 266' ' ' SER . . . . . 0.403 ' O ' ' HG2' ' A' ' 270' ' ' PRO . 57.1 p -67.81 -7.96 32.05 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.658 -0.246 . . . . 0.55 111.608 179.631 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -116.76 -33.45 4.8 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.525 0.194 . . . . 0.81 111.525 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 268' ' ' ILE . . . . . 0.826 HG22 ' HA ' ' A' ' 265' ' ' GLU . 6.1 tt -67.38 -43.32 87.82 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 N-CA-C 111.705 0.261 . . . . 0.44 111.705 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 269' ' ' GLU . . . . . 0.733 ' HB2' ' HD3' ' A' ' 270' ' ' PRO . 6.7 mm-40 -63.08 -56.03 31.86 Favored Pre-proline 0 CA--C 1.537 0.447 0 C-N-CA 120.851 -0.34 . . . . 0.78 110.751 179.573 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 270' ' ' PRO . . . . . 0.733 ' HD3' ' HB2' ' A' ' 269' ' ' GLU . 50.3 Cg_exo -57.0 -29.64 83.57 Favored 'Trans proline' 0 C--N 1.36 1.179 0 C-N-CA 122.0 1.8 . . . . 0.33 111.588 177.577 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 271' ' ' LEU . . . . . . . . . . . . . 19.1 tp -66.7 -51.08 60.1 Favored 'General case' 0 C--O 1.224 -0.265 0 N-CA-C 109.782 -0.451 . . . . 0.46 109.782 178.009 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -58.36 -34.48 70.72 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 120.942 0.401 . . . . 0.32 110.514 178.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 273' ' ' GLU . . . . . 0.583 ' OE1' ' HA ' ' A' ' 270' ' ' PRO . 68.9 mt-10 -71.21 -47.81 55.15 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 115.856 -0.611 . . . . 0.97 109.892 178.244 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 274' ' ' THR . . . . . . . . . . . . . 61.1 m -60.67 -43.11 98.05 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.889 -0.596 . . . . 0.37 110.713 179.112 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 275' ' ' ILE . . . . . 0.425 HG23 ' SD ' ' A' ' 231' ' ' MET . 96.1 mt -60.48 -54.64 32.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 115.833 -0.621 . . . . 0.32 110.386 178.589 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 26.0 m -61.17 -48.87 79.55 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.096 -0.502 . . . . 0.3 112.331 -179.382 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 277' ' ' ASP . . . . . 0.471 ' CG ' HH12 ' A' ' 281' ' ' ARG . 24.2 t70 -54.44 -53.26 56.58 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 120.873 0.368 . . . . 0.37 111.635 -179.676 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 278' ' ' VAL . . . . . 0.417 HG11 ' HB3' ' A' ' 228' ' ' SER . 97.8 t -68.6 -42.93 83.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.365 -0.379 . . . . 0.4 111.649 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 279' ' ' LEU . . . . . 0.441 HD11 HG23 ' A' ' 245' ' ' ILE . 40.6 tp -57.77 -43.08 85.25 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 120.601 0.239 . . . . 0.62 111.618 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 77.6 t -72.3 -53.33 19.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 120.824 -0.351 . . . . 0.43 110.737 179.078 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 281' ' ' ARG . . . . . 0.554 ' HA ' ' HG3' ' A' ' 284' ' ' ARG . 18.8 ttp-105 -56.44 -40.97 75.67 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 113.669 0.989 . . . . 0.53 113.669 -179.685 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 282' ' ' THR . . . . . 0.892 HG23 ' HD2' ' A' ' 283' ' ' LYS . 13.9 t -63.14 -21.63 66.32 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 113.269 0.84 . . . . 0.51 113.269 -178.777 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 283' ' ' LYS . . . . . 0.892 ' HD2' HG23 ' A' ' 282' ' ' THR . 0.4 OUTLIER -142.26 41.76 1.64 Allowed 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 112.4 0.519 . . . . 0.66 112.4 -179.736 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 284' ' ' ARG . . . . . 0.554 ' HG3' ' HA ' ' A' ' 281' ' ' ARG . 68.8 mtt180 -55.01 -47.84 74.14 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 113.035 0.754 . . . . 0.68 113.035 -178.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 285' ' ' ASP . . . . . 0.442 ' HA ' HG22 ' A' ' 288' ' ' VAL . 32.4 t70 -60.5 -39.6 88.32 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.043 0.449 . . . . 0.59 111.327 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 286' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -67.99 -37.99 82.13 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.201 0.524 . . . . 0.56 110.218 179.088 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 287' ' ' LEU . . . . . 0.406 ' CD1' ' HA2' ' A' ' 292' ' ' GLY . 2.8 mm? -70.62 -48.93 52.55 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.639 -0.71 . . . . 0.58 111.638 179.582 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 288' ' ' VAL . . . . . 0.442 HG22 ' HA ' ' A' ' 285' ' ' ASP . 33.5 m -61.32 -33.76 57.98 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-O 120.627 0.251 . . . . 0.5 111.436 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 50.6 mttp -72.0 -26.14 62.11 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 120.854 0.359 . . . . 0.93 110.874 178.648 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -101.93 11.01 39.26 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 112.437 0.532 . . . . 0.87 112.437 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 291' ' ' ARG . . . . . 0.416 HH11 ' HD2' ' A' ' 291' ' ' ARG . 29.1 mtm180 62.54 20.29 11.85 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 120.716 0.293 . . . . 0.79 111.7 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 292' ' ' GLY . . . . . 0.436 ' HA3' HD11 ' A' ' 155' ' ' LEU . . . 65.07 -111.67 4.38 Favored Glycine 0 CA--C 1.525 0.662 0 C-N-CA 121.375 -0.441 . . . . 0.47 114.061 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 293' ' ' TRP . . . . . 0.597 ' O ' HG23 ' A' ' 297' ' ' VAL . 53.9 m95 -63.48 -45.89 88.68 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.857 0.688 . . . . 0.46 112.857 -178.832 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 294' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -50.21 -47.36 54.82 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 111.849 0.315 . . . . 0.52 111.849 -179.352 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -66.03 -41.19 95.31 Favored Glycine 0 CA--C 1.523 0.561 0 C-N-CA 120.582 -0.818 . . . . 0.31 112.258 178.526 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 296' ' ' PHE . . . . . 0.558 ' HB2' ' CZ3' ' A' ' 242' ' ' TRP . 1.6 t80 -62.37 -42.68 99.6 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.95 0.405 . . . . 0.4 111.116 179.076 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 297' ' ' VAL . . . . . 0.685 HG11 ' HB3' ' A' ' 189' ' ' ARG . 64.0 t -63.91 -47.18 91.77 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-N 116.004 -0.544 . . . . 0.33 111.807 -179.555 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -59.07 -46.16 88.96 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 112.128 0.418 . . . . 0.65 112.128 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 299' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -59.05 -27.35 65.41 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 120.976 0.417 . . . . 0.51 111.74 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 300' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 -108.02 22.73 15.54 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.283 0.563 . . . . 0.53 111.286 179.625 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -101.49 6.68 42.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.182 0.515 . . . . 1.0 111.064 179.361 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 6.1 p -81.95 134.15 27.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.765 -0.652 . . . . 0.81 111.151 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -148.7 105.61 3.59 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 120.933 0.397 . . . . 1.41 111.457 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 49.2 t0 -148.07 123.1 10.08 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.132 -0.486 . . . . 2.41 110.931 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 16.6 tp -127.37 6.63 6.36 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.52 0.676 . . . . 2.61 109.813 178.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -113.46 -32.71 6.13 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 115.464 -0.789 . . . . 2.38 111.744 -179.143 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . 108.85 76.95 0.96 Allowed Glycine 0 CA--C 1.522 0.481 0 C-N-CA 120.621 -0.799 . . . . 2.57 113.181 179.499 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.209 0 CA-C-O 118.418 -1.212 . . . . 3.02 113.249 179.661 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 121.295 0.569 . . . . 1.81 110.787 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -142.94 -74.23 0.28 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.548 -0.751 . . . . 1.2 110.986 -178.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 19' ' ' LEU . . . . . 0.561 HD22 ' HE2' ' B' ' 23' ' ' PHE . 6.4 mt -101.88 115.52 64.66 Favored Pre-proline 0 CA--C 1.531 0.225 0 CA-C-O 121.096 0.474 . . . . 1.0 111.524 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 20' ' ' PRO . . . . . 0.423 ' C ' ' H ' ' B' ' 22' ' ' GLU . 82.0 Cg_endo -78.63 154.85 27.35 Favored 'Trans proline' 0 CA--C 1.532 0.402 0 C-N-CA 122.773 2.315 . . . . 0.94 112.528 179.733 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 21' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -69.04 27.57 0.16 Allowed 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 123.085 2.523 . . . . 0.99 113.602 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 22' ' ' GLU . . . . . 0.423 ' H ' ' C ' ' B' ' 20' ' ' PRO . 23.5 tt0 -72.91 -43.95 61.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.912 0.387 . . . . 0.81 110.406 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 23' ' ' PHE . . . . . 0.561 ' HE2' HD22 ' B' ' 19' ' ' LEU . 4.0 p90 -63.76 -33.2 75.12 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.113 -0.494 . . . . 0.48 110.829 179.227 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -72.76 -46.47 53.21 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.256 -0.429 . . . . 0.51 111.095 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.89 -42.21 97.52 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 121.072 0.463 . . . . 0.67 110.456 179.383 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -59.57 -53.38 58.77 Favored 'General case' 0 N--CA 1.457 -0.105 0 CA-C-N 115.681 -0.69 . . . . 0.96 110.739 179.237 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 27' ' ' LEU . . . . . 0.556 ' HG ' ' O ' ' B' ' 23' ' ' PHE . 78.3 mt -56.5 -35.58 68.18 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.623 -0.262 . . . . 0.52 111.597 179.685 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 28' ' ' ARG . . . . . 0.577 ' HA ' HG13 ' A' ' 234' ' ' VAL . 0.0 OUTLIER -67.3 -47.07 71.7 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.74 0.305 . . . . 0.51 111.09 179.532 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 44.3 mtmt -67.67 -41.83 83.11 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 121.038 0.447 . . . . 0.77 110.371 178.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 30' ' ' ILE . . . . . 0.47 ' O ' HG23 ' B' ' 34' ' ' VAL . 97.0 mt -64.31 -40.03 87.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 CA-C-N 115.942 -0.572 . . . . 0.39 110.128 178.899 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -57.88 -49.95 70.07 Favored Glycine 0 C--N 1.333 0.412 0 CA-C-N 115.879 -0.6 . . . . 0.29 112.941 179.377 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 39.1 m-20 -68.9 -26.73 65.25 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 117.157 0.479 . . . . 0.48 110.273 178.504 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 33' ' ' LYS . . . . . 0.427 ' HE2' ' HA ' ' B' ' 33' ' ' LYS . 0.0 OUTLIER -67.86 -53.72 24.51 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.505 -0.316 . . . . 0.41 110.734 178.75 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 34' ' ' VAL . . . . . 0.47 HG23 ' O ' ' B' ' 30' ' ' ILE . 57.3 t -58.03 -47.24 87.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-O 121.081 0.467 . . . . 0.37 110.745 179.503 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 35' ' ' TYR . . . . . 0.474 ' HB2' ' H ' ' A' ' 243' ' ' GLY . 2.4 t80 -58.15 -46.53 85.52 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.625 -0.716 . . . . 0.5 110.138 178.84 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 36' ' ' CYS . . . . . . . . . . . . . 43.5 t -63.53 -46.04 87.81 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 115.881 -0.599 . . . . 0.35 111.111 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 37' ' ' THR . . . . . 0.608 ' HA ' ' HB3' ' B' ' 42' ' ' ASP . 62.3 m -61.07 -43.24 99.18 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 112.878 0.695 . . . . 0.4 112.878 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 38' ' ' TRP . . . . . . . . . . . . . 94.2 m95 -82.76 -26.3 32.01 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.696 0.628 . . . . 0.62 112.696 -178.499 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 8.6 t -82.29 -65.72 0.98 Allowed 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 121.019 0.437 . . . . 0.54 110.287 178.212 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 40' ' ' ALA . . . . . 0.446 ' HB1' ' HD2' ' B' ' 41' ' ' PRO . . . -92.08 162.26 30.99 Favored Pre-proline 0 CA--C 1.535 0.4 0 CA-C-N 116.091 -0.504 . . . . 0.46 110.662 178.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 41' ' ' PRO . . . . . 0.446 ' HD2' ' HB1' ' B' ' 40' ' ' ALA . 41.9 Cg_endo -69.21 65.33 1.47 Allowed 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 122.295 1.996 . . . . 0.78 112.445 178.494 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 42' ' ' ASP . . . . . 0.608 ' HB3' ' HA ' ' B' ' 37' ' ' THR . 44.7 t0 -112.39 173.46 6.36 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 115.78 -0.646 . . . . 0.7 111.304 -179.064 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 43' ' ' MET . . . . . . . . . . . . . 17.5 tpt . . . . . 0 C--O 1.25 1.094 0 CA-C-O 118.408 -0.806 . . . . 2.51 110.983 179.679 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.369 0 CA-C-O 119.858 -0.412 . . . . 1.87 112.379 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -62.7 132.31 37.06 Favored 'Trans proline' 0 CA--C 1.532 0.4 0 C-N-CA 122.776 2.317 . . . . 0.99 112.721 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 24.5 tp -97.29 -19.28 18.65 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 120.995 0.426 . . . . 1.54 111.309 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 179.61 -155.0 14.61 Favored Glycine 0 CA--C 1.519 0.317 0 C-N-CA 121.167 -0.54 . . . . 0.8 111.866 -179.56 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.428 ' HA ' ' OD2' ' A' ' 154' ' ' ASP . 0.9 OUTLIER -79.4 76.99 5.98 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.197 0.522 . . . . 0.72 110.928 -179.89 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -117.19 -72.76 0.67 Allowed 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 115.618 -0.719 . . . . 0.45 112.334 -178.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -67.1 -34.41 77.56 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 112.036 0.384 . . . . 0.44 112.036 -178.64 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.428 ' OD2' ' HA ' ' A' ' 151' ' ' SER . 0.3 OUTLIER -51.98 -52.42 50.59 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 120.747 0.308 . . . . 0.71 111.157 179.544 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 47.4 tp -59.22 -46.17 89.17 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.298 -0.41 . . . . 0.55 111.136 178.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' TYR . . . . . 0.487 ' OH ' ' HG3' ' A' ' 281' ' ' ARG . 0.1 OUTLIER -60.87 -49.27 78.14 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.413 -0.358 . . . . 0.56 111.545 179.658 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 62.3 mtp180 -62.07 -48.82 78.52 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 112.146 0.424 . . . . 0.49 112.146 -179.154 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' GLN . . . . . 0.418 ' HA ' ' HB2' ' A' ' 183' ' ' ALA . 54.7 mm-40 -61.05 -46.84 89.05 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.732 0.301 . . . . 0.65 110.28 179.354 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' SER . . . . . 0.407 ' HA ' ' CZ2' ' A' ' 293' ' ' TRP . 16.6 m -61.73 -48.86 78.83 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.217 -0.447 . . . . 0.29 111.078 179.313 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.739 ' HA ' HG21 ' A' ' 276' ' ' THR . 2.0 tm? -56.29 -47.82 77.87 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.65 0.262 . . . . 0.65 110.561 179.487 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 161' ' ' GLU . . . . . 0.854 ' HG3' ' HB2' ' A' ' 182' ' ' GLU . 4.5 mm-40 -64.54 -48.08 76.41 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.126 0.417 . . . . 0.64 112.126 179.669 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 78.5 mt -67.25 -51.36 53.91 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 N-CA-C 113.022 0.749 . . . . 0.33 113.022 -179.091 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.514 HD12 HG23 ' A' ' 276' ' ' THR . 80.2 mt -60.74 -49.35 84.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 O-C-N 122.279 -0.263 . . . . 0.41 111.528 -179.35 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 164' ' ' SER . . . . . 0.505 ' O ' ' HB2' ' A' ' 168' ' ' ARG . 3.1 t -57.99 -38.04 75.36 Favored 'General case' 0 N--CA 1.462 0.153 0 N-CA-C 110.249 -0.278 . . . . 0.61 110.249 178.841 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 165' ' ' ARG . . . . . 0.425 HH22 ' CG ' ' A' ' 176' ' ' ASP . 0.0 OUTLIER -58.64 -55.74 31.2 Favored 'General case' 0 C--O 1.22 -0.463 0 CA-C-N 116.563 -0.289 . . . . 0.34 110.967 179.344 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 166' ' ' TYR . . . . . 0.655 ' CE1' ' HA ' ' A' ' 195' ' ' ARG . 76.4 t80 -61.26 -51.94 66.81 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 112.495 0.554 . . . . 0.52 112.495 -178.8 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.5 ' HG ' ' O ' ' A' ' 163' ' ' ILE . 33.9 mt -58.76 -48.62 80.57 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 120.713 0.292 . . . . 0.45 111.761 -179.025 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 168' ' ' ARG . . . . . 0.505 ' HB2' ' O ' ' A' ' 164' ' ' SER . 0.7 OUTLIER -70.97 -45.05 64.77 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 112.318 0.488 . . . . 0.39 112.318 -179.689 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -60.72 -44.35 96.74 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 112.049 0.389 . . . . 0.46 112.049 -179.19 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -66.73 -48.42 69.26 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.935 -0.306 . . . . 0.93 111.467 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.543 ' HA ' ' HG2' ' A' ' 257' ' ' LYS . . . -69.14 -35.25 76.16 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.54 0.57 . . . . 0.33 112.54 -179.223 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 172' ' ' THR . . . . . 0.784 HG23 ' HD2' ' A' ' 260' ' ' LYS . 0.2 OUTLIER -114.9 35.72 4.18 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.753 0.649 . . . . 0.37 112.753 -177.718 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -59.36 -11.44 13.86 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 121.304 -0.475 . . . . 0.52 113.491 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 10.8 p -96.14 -5.21 41.21 Favored 'General case' 0 CA--C 1.534 0.339 0 O-C-N 122.732 -0.275 . . . . 0.55 111.364 179.248 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' LYS . . . . . 0.43 ' HE3' ' HB3' ' A' ' 175' ' ' LYS . 14.6 ttpp -165.56 95.9 0.64 Allowed 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 120.765 0.317 . . . . 0.45 111.561 -179.468 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 176' ' ' ASP . . . . . 0.425 ' CG ' HH22 ' A' ' 165' ' ' ARG . 3.9 t0 -72.83 179.66 3.56 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-O 121.035 0.445 . . . . 0.63 111.087 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 37.3 t -162.93 -63.14 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.338 -0.392 . . . . 1.11 111.797 -179.33 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' LYS . . . . . 0.423 ' HE3' ' HB3' ' A' ' 178' ' ' LYS . 0.4 OUTLIER -109.14 103.29 51.96 Favored Pre-proline 0 CA--C 1.534 0.353 0 CA-C-O 120.611 0.243 . . . . 0.71 110.928 -179.473 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -74.23 -157.21 0.06 OUTLIER 'Trans proline' 0 CA--C 1.536 0.599 0 C-N-CA 123.074 2.516 . . . . 0.99 113.283 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 14.2 mt -100.72 135.36 42.28 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.958 0.409 . . . . 0.76 111.271 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -130.99 -36.27 0.35 Allowed Glycine 0 CA--C 1.526 0.771 0 C-N-CA 120.653 -0.784 . . . . 0.65 113.462 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 182' ' ' GLU . . . . . 0.854 ' HB2' ' HG3' ' A' ' 161' ' ' GLU . 1.4 mm-40 -98.27 -65.22 0.98 Allowed 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 117.032 0.416 . . . . 0.65 111.684 -179.615 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.436 ' O ' ' HA3' ' A' ' 187' ' ' GLY . . . -74.21 69.55 1.55 Allowed 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 120.941 0.4 . . . . 0.34 111.543 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -79.13 -70.74 1.3 Allowed Glycine 0 CA--C 1.527 0.818 0 C-N-CA 120.984 -0.626 . . . . 0.33 114.396 -179.428 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -70.19 -57.42 4.94 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 112.48 0.548 . . . . 0.39 112.48 -178.565 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -62.93 -32.13 73.36 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 121.111 0.482 . . . . 0.32 110.087 179.241 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 187' ' ' GLY . . . . . 0.436 ' HA3' ' O ' ' A' ' 183' ' ' ALA . . . -72.93 -38.0 56.32 Favored Glycine 0 C--O 1.22 -0.73 0 CA-C-N 115.281 -0.872 . . . . 0.26 112.819 179.245 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 188' ' ' ARG . . . . . 0.402 ' HD3' ' HA ' ' A' ' 188' ' ' ARG . 13.1 tpp180 -61.29 -46.73 89.12 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 117.532 0.666 . . . . 0.8 110.877 179.435 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 189' ' ' ARG . . . . . 0.434 ' HB3' HG11 ' A' ' 297' ' ' VAL . 49.1 mtp180 -67.13 -38.99 86.5 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.251 0.548 . . . . 0.4 110.553 178.799 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.669 ' HA ' HG22 ' A' ' 297' ' ' VAL . . . -69.83 -38.12 76.42 Favored 'General case' 0 C--O 1.224 -0.269 0 CA-C-N 115.701 -0.681 . . . . 0.26 111.68 179.586 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 20.4 tp -65.81 -47.7 74.18 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 111.531 0.197 . . . . 0.45 111.531 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 192' ' ' GLU . . . . . 0.693 ' O ' ' HG2' ' A' ' 196' ' ' ARG . 5.8 tm-20 -58.62 -47.36 84.64 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 108.964 -0.754 . . . . 0.36 108.964 178.37 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 38.9 m -58.21 -52.36 65.91 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 115.755 -0.657 . . . . 0.27 110.998 178.25 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 0.422 HD21 HG21 ' A' ' 249' ' ' ILE . 26.9 tp -63.28 -38.68 92.12 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 112.916 0.71 . . . . 0.37 112.916 -179.5 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 195' ' ' ARG . . . . . 0.655 ' HA ' ' CE1' ' A' ' 166' ' ' TYR . 3.5 ttm-85 -64.97 -47.24 78.32 Favored 'General case' 0 C--N 1.333 -0.142 0 O-C-N 122.234 -0.291 . . . . 0.58 110.825 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 196' ' ' ARG . . . . . 0.693 ' HG2' ' O ' ' A' ' 192' ' ' GLU . 33.0 mmm-85 -66.01 -52.78 46.29 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.617 0.246 . . . . 0.47 110.836 179.819 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 197' ' ' VAL . . . . . 0.564 HG21 ' HB3' ' A' ' 300' ' ' PHE . 69.4 t -60.65 -51.77 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-N 116.464 -0.335 . . . . 0.33 111.618 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -56.54 -45.28 90.11 Favored Glycine 0 C--N 1.333 0.394 0 C-N-CA 121.389 -0.434 . . . . 0.32 113.042 -179.171 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 199' ' ' ASP . . . . . 0.423 ' HA ' ' HG2' ' A' ' 202' ' ' GLN . 33.3 m-20 -67.11 -33.69 76.01 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.658 0.266 . . . . 0.36 110.416 179.173 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -68.93 -32.88 73.9 Favored Glycine 0 CA--C 1.523 0.548 0 C-N-CA 120.72 -0.752 . . . . 0.25 112.002 178.385 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 201' ' ' VAL . . . . . 0.579 HG11 ' HA ' ' A' ' 247' ' ' THR . 92.3 t -72.82 -46.48 52.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 CA-C-O 120.687 0.28 . . . . 0.35 111.17 179.181 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 202' ' ' GLN . . . . . 0.423 ' HG2' ' HA ' ' A' ' 199' ' ' ASP . 11.3 pt20 -70.58 -32.5 69.91 Favored 'General case' 0 C--O 1.22 -0.48 0 CA-C-N 116.354 -0.384 . . . . 0.61 111.322 -179.697 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 23.3 ttm180 -68.95 -50.4 49.61 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.798 0.332 . . . . 2.99 110.706 178.712 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 18.9 m-80 -62.45 -44.46 96.35 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.269 -0.423 . . . . 0.62 111.235 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 87.9 m-70 -103.03 36.28 2.28 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 112.382 0.512 . . . . 0.44 112.382 -179.462 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -58.01 -42.64 85.67 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 112.613 0.597 . . . . 0.96 112.613 -179.256 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 34.0 p -61.24 -53.05 61.82 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.88 0.371 . . . . 0.53 111.709 -179.529 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -61.54 -43.73 98.34 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.096 -0.502 . . . . 0.44 110.61 179.041 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 3.3 m-30 -60.94 -52.04 66.72 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 116.107 -0.497 . . . . 0.45 111.05 179.688 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 20.1 mt-30 -59.97 -42.74 94.79 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 120.519 0.2 . . . . 0.74 111.249 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -61.21 -51.13 60.21 Favored Glycine 0 C--N 1.335 0.477 0 C-N-CA 120.611 -0.804 . . . . 0.36 111.993 178.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 212' ' ' MET . . . . . 0.65 ' HB3' ' HB3' ' B' ' 23' ' ' PHE . 71.2 mtm -66.34 -31.98 73.1 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 120.586 0.231 . . . . 0.73 110.991 179.344 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 10.3 tp -63.51 -41.95 98.49 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.958 0.408 . . . . 0.55 110.742 178.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 214' ' ' ARG . . . . . 0.427 HH11 ' HD3' ' A' ' 214' ' ' ARG . 39.7 mtt-85 -70.86 -31.74 68.52 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.038 -0.528 . . . . 0.96 111.04 179.414 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -72.8 -21.17 61.02 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 120.971 0.415 . . . . 0.78 111.044 178.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.797 ' HB3' HG12 ' A' ' 218' ' ' ILE . 66.6 mt -72.78 135.37 45.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.02 0.438 . . . . 0.56 111.842 179.617 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 217' ' ' ASP . . . . . 0.412 ' OD2' ' N ' ' B' ' 17' ' ' ALA . 0.3 OUTLIER -87.79 23.05 2.11 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 116.257 -0.429 . . . . 0.62 110.696 179.08 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 218' ' ' ILE . . . . . 0.797 HG12 ' HB3' ' A' ' 216' ' ' LEU . 50.6 mm -59.47 106.72 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-N 115.723 -0.671 . . . . 0.46 111.627 -179.682 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -154.97 -68.78 0.13 Allowed 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.957 -0.565 . . . . 0.62 111.55 -179.537 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -90.97 -176.48 4.65 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 115.793 -0.64 . . . . 0.63 112.579 -178.588 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -47.0 -22.45 0.33 Allowed 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 113.34 0.867 . . . . 1.44 113.34 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 222' ' ' GLY . . . . . 0.458 ' HA2' ' HD2' ' A' ' 225' ' ' LYS . . . -69.7 -22.53 76.81 Favored Glycine 0 CA--C 1.529 0.968 0 CA-C-N 116.522 -0.308 . . . . 0.44 113.134 178.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 223' ' ' ASP . . . . . 0.692 ' HB2' HG23 ' A' ' 218' ' ' ILE . 1.3 p-10 -56.31 -47.44 78.7 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 113.193 0.812 . . . . 0.8 113.193 -178.392 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 31.5 m -60.32 -32.0 49.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-O 121.001 0.429 . . . . 1.63 111.482 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 225' ' ' LYS . . . . . 0.458 ' HD2' ' HA2' ' A' ' 222' ' ' GLY . 36.9 mttp -76.82 -42.19 41.41 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.315 -0.624 . . . . 0.85 109.315 178.69 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 226' ' ' SER . . . . . 0.883 ' HB3' HD22 ' B' ' 19' ' ' LEU . 19.9 m -63.16 -42.56 99.46 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 115.321 -0.854 . . . . 0.35 110.568 178.856 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 227' ' ' PHE . . . . . 0.582 ' O ' ' HG3' ' A' ' 231' ' ' MET . 13.8 t80 -65.39 -48.78 71.67 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.936 -0.575 . . . . 0.56 110.141 179.081 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 30.3 t -56.01 -39.09 71.39 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 109.549 -0.537 . . . . 0.42 109.549 178.211 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 229' ' ' ARG . . . . . 0.518 ' HB3' ' O ' ' A' ' 226' ' ' SER . 19.1 ttt180 -55.95 -44.54 78.53 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 115.165 -0.925 . . . . 0.78 110.23 177.795 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 47.6 t -68.78 -42.73 82.98 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-N 116.292 -0.413 . . . . 0.31 110.804 178.388 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 231' ' ' MET . . . . . 0.582 ' HG3' ' O ' ' A' ' 227' ' ' PHE . 47.8 mtp -58.14 -53.0 63.22 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 120.84 0.352 . . . . 0.37 111.492 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 34.5 m -65.58 -30.79 51.23 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 CA-C-N 116.484 -0.326 . . . . 0.34 111.558 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 42.4 t-80 -61.47 -54.79 38.76 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 111.76 0.282 . . . . 0.41 111.76 179.198 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.813 ' HB ' ' HB3' ' B' ' 28' ' ' ARG . 4.0 m -66.4 -29.44 46.6 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 N-CA-C 112.224 0.453 . . . . 0.36 112.224 -178.606 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 36.4 m-85 -100.63 22.18 12.26 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 111.999 0.37 . . . . 0.54 111.999 179.419 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 236' ' ' LYS . . . . . 0.438 ' HA ' ' HD2' ' A' ' 236' ' ' LYS . 14.9 tptp -79.75 -21.36 44.55 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.87 0.366 . . . . 0.93 111.545 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 237' ' ' ASP . . . . . 0.418 ' OD1' ' N ' ' A' ' 237' ' ' ASP . 0.0 OUTLIER -69.54 -15.96 63.33 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.096 -0.502 . . . . 0.5 112.085 -179.841 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 90.92 -19.25 46.88 Favored Glycine 0 CA--C 1.521 0.439 0 C-N-CA 120.929 -0.653 . . . . 0.37 113.689 179.089 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 0.409 HG12 ' HB2' ' A' ' 237' ' ' ASP . 3.3 p -86.49 113.55 24.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.34 0.591 . . . . 0.38 110.848 179.597 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 59.7 m -93.63 106.25 18.23 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.088 0.471 . . . . 0.4 111.807 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 241' ' ' ASN . . . . . 0.533 ' HB2' ' HG3' ' A' ' 244' ' ' ARG . 94.8 m-20 -95.39 129.81 42.41 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.937 -0.574 . . . . 0.4 110.43 178.862 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 242' ' ' TRP . . . . . 0.612 ' HB3' ' CZ ' ' A' ' 300' ' ' PHE . 1.6 m95 -53.29 -41.93 66.09 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 120.938 0.399 . . . . 0.45 111.58 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 243' ' ' GLY . . . . . 0.44 ' HA3' ' N ' ' B' ' 35' ' ' TYR . . . -64.28 -28.46 73.03 Favored Glycine 0 CA--C 1.521 0.463 0 C-N-CA 120.815 -0.707 . . . . 0.24 112.852 179.139 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 244' ' ' ARG . . . . . 0.533 ' HG3' ' HB2' ' A' ' 241' ' ' ASN . 63.8 mtt180 -70.69 -39.06 73.7 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 122.47 -0.429 . . . . 0.41 110.127 179.194 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 64.0 mt -63.99 -52.28 58.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 CA-C-N 115.82 -0.627 . . . . 0.44 111.229 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 16.8 m -62.38 -35.87 71.82 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 C-N-CA 120.937 -0.305 . . . . 0.32 111.293 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 247' ' ' THR . . . . . 0.579 ' HA ' HG11 ' A' ' 201' ' ' VAL . 99.6 m -64.05 -42.4 97.06 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.076 0.465 . . . . 0.45 109.996 178.159 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 18.9 tp -65.1 -43.6 91.55 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.774 -0.648 . . . . 2.02 110.304 178.71 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 249' ' ' ILE . . . . . 0.422 HG21 HD21 ' A' ' 194' ' ' LEU . 28.9 mt -64.66 -42.49 95.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 109.757 -0.46 . . . . 0.38 109.757 178.285 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 45.5 t -61.03 -38.23 85.39 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.786 -0.643 . . . . 0.42 109.842 178.084 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 251' ' ' PHE . . . . . 0.476 ' O ' HG23 ' A' ' 255' ' ' VAL . 34.1 t80 -69.88 -41.37 74.86 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.545 -0.752 . . . . 0.38 109.921 177.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -58.69 -43.93 96.03 Favored Glycine 0 C--N 1.335 0.515 0 N-CA-C 111.134 -0.786 . . . . 0.32 111.134 178.165 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -61.24 -40.64 94.8 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-O 120.844 0.355 . . . . 0.4 110.087 177.593 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -60.22 -43.44 96.02 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 116.023 -0.535 . . . . 0.66 109.793 178.17 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 255' ' ' VAL . . . . . 0.476 HG23 ' O ' ' A' ' 251' ' ' PHE . 64.8 t -66.26 -40.76 87.71 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-N 115.736 -0.666 . . . . 0.33 110.323 178.393 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -62.48 -45.76 91.59 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.318 -0.401 . . . . 0.32 110.155 177.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 257' ' ' LYS . . . . . 0.543 ' HG2' ' HA ' ' A' ' 171' ' ' ALA . 48.0 mtmt -58.98 -45.03 91.59 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.953 -0.567 . . . . 0.52 109.964 177.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -61.63 -34.81 76.33 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.789 -0.641 . . . . 0.35 109.903 178.783 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.787 ' HG ' ' HB3' ' A' ' 264' ' ' GLN . 2.9 tp -72.12 -32.62 67.12 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 121.251 0.548 . . . . 0.47 110.036 178.096 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 260' ' ' LYS . . . . . 0.784 ' HD2' HG23 ' A' ' 172' ' ' THR . 0.0 OUTLIER -75.4 -31.1 60.31 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 121.118 0.485 . . . . 0.68 110.4 178.069 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 26.7 t -64.07 -19.26 65.1 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.125 -0.489 . . . . 0.49 110.71 178.74 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 262' ' ' VAL . . . . . 0.427 HG23 ' HB2' ' A' ' 264' ' ' GLN . 31.2 m -114.14 13.81 8.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-N 116.149 -0.478 . . . . 0.53 110.613 178.311 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 6.1 t30 55.91 49.32 16.16 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 115.521 -0.763 . . . . 1.28 112.861 179.324 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 264' ' ' GLN . . . . . 0.787 ' HB3' ' HG ' ' A' ' 259' ' ' LEU . 4.3 tt0 -113.26 39.13 2.67 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 112.027 0.381 . . . . 1.21 112.027 -179.729 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 265' ' ' GLU . . . . . 0.669 ' HG3' ' HE3' ' A' ' 260' ' ' LYS . 26.4 mt-10 -48.54 -35.96 14.38 Favored 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 112.934 0.716 . . . . 0.38 112.934 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -56.54 -24.69 48.58 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 112.377 0.51 . . . . 1.0 112.377 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 267' ' ' PHE . . . . . 0.455 ' C ' ' HD2' ' A' ' 270' ' ' PRO . 23.3 m-85 -99.37 -16.74 18.31 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 120.974 0.416 . . . . 1.19 111.001 179.214 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 268' ' ' ILE . . . . . 0.557 HD12 ' HA ' ' A' ' 265' ' ' GLU . 67.3 mt -67.15 -43.22 88.68 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-N 116.209 -0.45 . . . . 0.39 110.564 179.251 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 269' ' ' GLU . . . . . 0.711 ' HB2' ' HD3' ' A' ' 270' ' ' PRO . 2.1 mm-40 -55.26 -56.66 26.14 Favored Pre-proline 0 CA--C 1.543 0.692 0 CA-C-N 116.295 -0.411 . . . . 0.38 111.14 179.361 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 270' ' ' PRO . . . . . 0.711 ' HD3' ' HB2' ' A' ' 269' ' ' GLU . 38.1 Cg_exo -59.61 -34.89 96.47 Favored 'Trans proline' 0 C--N 1.362 1.259 0 C-N-CA 122.253 1.969 . . . . 0.36 112.247 178.295 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 271' ' ' LEU . . . . . . . . . . . . . 43.2 tp -64.91 -51.14 63.51 Favored 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 110.128 -0.323 . . . . 0.56 110.128 178.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -59.02 -42.87 91.21 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 120.997 0.427 . . . . 0.38 110.458 178.471 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 273' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -63.45 -44.53 94.22 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 115.912 -0.585 . . . . 1.97 110.056 178.231 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 274' ' ' THR . . . . . . . . . . . . . 99.6 m -60.31 -48.4 81.9 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.236 -0.438 . . . . 0.49 110.381 178.556 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 275' ' ' ILE . . . . . 0.569 ' O ' ' HB2' ' A' ' 279' ' ' LEU . 95.9 mt -54.89 -47.67 75.28 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.096 0 CA-C-N 115.982 -0.554 . . . . 0.46 110.384 179.051 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 276' ' ' THR . . . . . 0.739 HG21 ' HA ' ' A' ' 160' ' ' LEU . 37.9 m -62.95 -52.06 64.5 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.247 -0.433 . . . . 0.34 111.203 179.374 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 277' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -51.94 -53.86 36.24 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.135 -0.484 . . . . 0.46 111.21 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 278' ' ' VAL . . . . . 0.574 ' O ' HG22 ' A' ' 282' ' ' THR . 60.7 t -63.32 -43.57 98.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-O 120.47 0.176 . . . . 0.38 110.883 179.291 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 279' ' ' LEU . . . . . 0.569 ' HB2' ' O ' ' A' ' 275' ' ' ILE . 0.3 OUTLIER -56.01 -47.84 77.02 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.604 -0.271 . . . . 0.84 111.313 179.967 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 57.0 t -75.38 -48.69 30.07 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 N-CA-C 111.729 0.27 . . . . 0.43 111.729 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 281' ' ' ARG . . . . . 0.487 ' HG3' ' OH ' ' A' ' 156' ' ' TYR . 31.2 mtp180 -54.69 -40.09 68.8 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 112.941 0.719 . . . . 0.55 112.941 -179.413 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 282' ' ' THR . . . . . 0.574 HG22 ' O ' ' A' ' 278' ' ' VAL . 6.9 t -91.03 4.62 51.63 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 120.191 -0.603 . . . . 0.39 112.289 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 283' ' ' LYS . . . . . 0.661 ' HZ3' ' HB2' ' A' ' 283' ' ' LYS . 0.0 OUTLIER -141.23 40.83 1.77 Allowed 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 120.92 0.39 . . . . 0.52 111.328 179.777 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -66.1 -62.33 1.55 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.109 0.481 . . . . 0.49 111.84 -179.274 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -65.32 -45.05 85.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.912 -0.585 . . . . 0.63 112.214 -179.331 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 286' ' ' TRP . . . . . 0.464 ' O ' ' HB2' ' A' ' 290' ' ' GLN . 2.2 t90 -58.12 -38.89 77.37 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 112.38 0.511 . . . . 0.59 112.38 -179.214 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 287' ' ' LEU . . . . . 0.57 HD23 ' HB3' ' A' ' 283' ' ' LYS . 1.2 mm? -70.59 -49.42 47.98 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.776 0.288 . . . . 0.46 111.776 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 9.1 p -62.83 -34.32 65.25 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-O 120.752 0.31 . . . . 0.55 111.409 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 43.5 mttp -75.47 -21.55 57.99 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 120.751 0.31 . . . . 0.87 111.473 178.785 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 290' ' ' GLN . . . . . 0.464 ' HB2' ' O ' ' A' ' 286' ' ' TRP . 0.0 OUTLIER -100.47 29.1 4.59 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 112.66 0.615 . . . . 0.79 112.66 -179.123 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 291' ' ' ARG . . . . . 0.465 ' HD2' ' HB3' ' A' ' 294' ' ' ASP . 8.1 ttm180 64.71 13.11 8.15 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 112.809 0.67 . . . . 0.84 112.809 179.076 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 65.82 -141.13 41.41 Favored Glycine 0 CA--C 1.525 0.692 0 C-N-CA 121.04 -0.6 . . . . 0.34 114.036 179.388 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 293' ' ' TRP . . . . . 0.623 ' O ' HG23 ' A' ' 297' ' ' VAL . 84.7 m95 -65.39 -32.22 73.74 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.29 0.478 . . . . 0.51 112.29 -179.149 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 294' ' ' ASP . . . . . 0.465 ' HB3' ' HD2' ' A' ' 291' ' ' ARG . 16.1 t70 -59.97 -37.95 81.11 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 121.102 0.477 . . . . 0.74 109.837 178.34 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -65.3 -43.2 95.56 Favored Glycine 0 C--N 1.335 0.511 0 N-CA-C 110.786 -0.926 . . . . 0.26 110.786 177.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 296' ' ' PHE . . . . . 0.513 ' HB2' ' CH2' ' A' ' 242' ' ' TRP . 0.8 OUTLIER -63.03 -46.71 86.29 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 120.88 0.371 . . . . 0.32 110.457 177.947 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 297' ' ' VAL . . . . . 0.669 HG22 ' HA ' ' A' ' 190' ' ' ALA . 90.9 t -59.89 -49.27 84.56 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.395 0 CA-C-N 115.922 -0.581 . . . . 0.32 111.242 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -61.8 -46.57 88.95 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.066 0.395 . . . . 0.97 112.066 -179.684 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 299' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -61.84 -42.29 98.85 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 112.419 0.525 . . . . 0.45 112.419 -179.178 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 300' ' ' PHE . . . . . 0.612 ' CZ ' ' HB3' ' A' ' 242' ' ' TRP . 76.5 m-85 -99.73 13.62 33.03 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 113.133 0.79 . . . . 0.39 113.133 -178.583 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -158.38 102.89 1.76 Allowed 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.057 0.456 . . . . 0.39 111.718 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 6.6 m -71.64 136.0 26.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.111 -0.495 . . . . 0.83 111.327 179.516 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 303' ' ' GLN . . . . . 0.455 HE21 ' HB2' ' A' ' 303' ' ' GLN . 2.9 mt-30 -122.59 -15.08 7.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.078 -0.51 . . . . 1.12 111.626 -179.312 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.86 96.7 0.6 Allowed 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 115.832 -0.622 . . . . 1.06 111.464 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 84.8 mt -97.46 -10.74 24.83 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.264 -0.426 . . . . 1.48 111.402 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.87 -35.11 6.05 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.249 -0.432 . . . . 1.34 111.136 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . -81.27 68.73 3.4 Favored Glycine 0 CA--C 1.523 0.539 0 C-N-CA 120.744 -0.741 . . . . 1.7 113.063 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.211 0 CA-C-O 118.547 -1.14 . . . . 3.74 113.066 -179.946 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 17' ' ' ALA . . . . . 0.412 ' N ' ' OD2' ' A' ' 217' ' ' ASP . . . . . . . . 0 N--CA 1.488 1.439 0 CA-C-O 120.641 0.257 . . . . 0.99 110.917 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.21 162.59 12.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.734 0.302 . . . . 0.9 110.524 179.134 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 19' ' ' LEU . . . . . 0.883 HD22 ' HB3' ' A' ' 226' ' ' SER . 5.2 tp -104.62 99.09 16.66 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 116.48 -0.327 . . . . 0.5 111.619 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.39 132.01 19.99 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.494 2.129 . . . . 0.45 110.867 178.796 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 21' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -65.56 45.95 0.18 Allowed 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 122.715 2.277 . . . . 0.53 115.284 -177.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -87.27 -48.92 7.62 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 109.527 -0.545 . . . . 0.47 109.527 178.631 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 23' ' ' PHE . . . . . 0.773 ' CE1' ' HG ' ' B' ' 19' ' ' LEU . 0.0 OUTLIER -59.29 -43.84 92.53 Favored 'General case' 0 C--O 1.225 -0.198 0 CA-C-N 115.669 -0.696 . . . . 0.36 110.55 179.076 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.85 -43.35 77.0 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 115.968 -0.56 . . . . 0.32 111.515 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 25' ' ' ALA . . . . . 0.478 ' O ' ' HG3' ' B' ' 28' ' ' ARG . . . -61.08 -49.55 76.85 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 116.162 -0.472 . . . . 0.28 111.282 179.732 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 13.7 mt-30 -68.63 -42.25 78.33 Favored 'General case' 0 C--O 1.224 -0.255 0 CA-C-N 116.304 -0.407 . . . . 0.54 111.202 179.785 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 16.0 mt -55.53 -49.39 72.75 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.607 -0.27 . . . . 0.59 111.556 179.777 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 28' ' ' ARG . . . . . 0.813 ' HB3' ' HB ' ' A' ' 234' ' ' VAL . 0.0 OUTLIER -65.29 -37.04 85.95 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 120.473 -0.491 . . . . 0.56 110.519 179.267 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 29' ' ' LYS . . . . . 0.566 ' HA ' ' HE3' ' B' ' 29' ' ' LYS . 0.0 OUTLIER -65.71 -40.56 92.37 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 109.62 -0.511 . . . . 0.48 109.62 178.264 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 93.4 mt -63.68 -39.94 87.22 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 N-CA-C 108.51 -0.922 . . . . 0.4 108.51 176.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 31' ' ' GLY . . . . . 0.525 ' HA3' ' HG2' ' A' ' 244' ' ' ARG . . . -60.4 -49.55 77.31 Favored Glycine 0 C--N 1.334 0.445 0 N-CA-C 111.192 -0.763 . . . . 0.23 111.192 177.671 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -56.9 -38.11 72.36 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.165 0.507 . . . . 0.43 109.665 177.813 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.61 -58.5 5.59 Favored 'General case' 0 C--O 1.227 -0.108 0 CA-C-N 115.613 -0.721 . . . . 0.61 110.598 179.024 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 85.9 t -54.86 -39.52 48.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-O 121.185 0.517 . . . . 0.37 110.289 179.174 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 35' ' ' TYR . . . . . 0.44 ' N ' ' HA3' ' A' ' 243' ' ' GLY . 9.4 t80 -58.47 -52.49 65.43 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.557 -0.747 . . . . 0.45 110.804 178.487 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 36' ' ' CYS . . . . . 0.439 ' HA ' ' OG ' ' B' ' 39' ' ' SER . 19.9 p -70.03 -25.3 63.51 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.739 0.304 . . . . 0.4 111.033 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 30.6 m -63.71 -44.08 94.68 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.454 -0.339 . . . . 0.4 111.349 179.626 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 38' ' ' TRP . . . . . . . . . . . . . 95.4 m95 -85.68 -30.25 23.33 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 120.742 0.306 . . . . 0.5 111.632 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 39' ' ' SER . . . . . 0.439 ' OG ' ' HA ' ' B' ' 36' ' ' CYS . 54.7 p -67.87 -24.92 65.3 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 112.166 0.432 . . . . 0.66 112.166 179.747 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -88.52 116.24 65.68 Favored Pre-proline 0 CA--C 1.532 0.269 0 CA-C-O 120.867 0.365 . . . . 0.73 111.718 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -82.24 49.76 3.22 Favored 'Trans proline' 0 CA--C 1.534 0.481 0 C-N-CA 122.777 2.318 . . . . 1.23 112.817 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -148.09 -169.8 3.43 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 116.193 -0.458 . . . . 1.34 110.676 -179.634 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 43' ' ' MET . . . . . . . . . . . . . 47.9 ttm . . . . . 0 C--O 1.251 1.17 0 CA-C-O 118.28 -0.867 . . . . 2.16 111.547 -179.932 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.41 ' N ' ' OD1' ' A' ' 154' ' ' ASP . . . . . . . . 0 N--CA 1.487 2.067 0 CA-C-O 119.971 -0.349 . . . . 0.68 112.324 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.646 ' HD2' ' HB3' ' A' ' 153' ' ' ASP . 20.1 Cg_exo -66.91 -179.16 1.57 Allowed 'Trans proline' 0 CA--C 1.535 0.54 0 C-N-CA 122.75 2.3 . . . . 0.83 112.724 179.111 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 96.6 mt -97.85 71.41 2.2 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.412 -0.358 . . . . 1.5 111.14 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -111.29 -60.11 0.47 Allowed Glycine 0 CA--C 1.52 0.395 0 C-N-CA 120.75 -0.738 . . . . 0.81 112.359 179.694 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 28.4 t -171.5 -68.59 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 120.941 0.4 . . . . 0.83 111.965 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -120.85 31.71 6.29 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.166 0.508 . . . . 0.73 111.25 -179.378 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' ASP . . . . . 0.646 ' HB3' ' HD2' ' A' ' 148' ' ' PRO . 1.6 m-20 -58.52 -51.82 68.27 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.694 -0.684 . . . . 0.72 112.197 -179.563 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.41 ' OD1' ' N ' ' A' ' 147' ' ' GLY . 44.9 m-20 -61.38 -45.32 94.86 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.765 0.317 . . . . 0.93 111.64 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 65.3 tp -61.27 -47.05 87.77 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.318 -0.401 . . . . 0.58 110.501 179.293 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' TYR . . . . . 0.412 ' O ' ' HB2' ' A' ' 160' ' ' LEU . 0.2 OUTLIER -66.53 -41.34 88.93 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 116.198 -0.456 . . . . 0.42 111.53 179.792 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.24 -51.94 66.83 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 112.538 0.57 . . . . 0.54 112.538 -179.411 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' GLN . . . . . 0.463 ' HA ' ' HB2' ' A' ' 183' ' ' ALA . 64.6 mt-30 -60.7 -45.55 93.79 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 120.702 0.287 . . . . 0.4 111.153 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' SER . . . . . 0.492 ' HA ' ' CZ2' ' A' ' 293' ' ' TRP . 4.0 p -62.88 -41.9 99.57 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.392 -0.367 . . . . 0.29 111.04 179.379 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.49 HD21 ' HA ' ' A' ' 273' ' ' GLU . 0.2 OUTLIER -58.14 -47.63 82.73 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 120.839 0.352 . . . . 0.73 110.306 178.887 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -64.56 -52.33 58.2 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 112.364 0.505 . . . . 0.56 112.364 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' ILE . . . . . 0.489 HG12 ' HA2' ' A' ' 187' ' ' GLY . 90.6 mt -59.05 -46.34 91.83 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 CA-C-N 116.754 -0.203 . . . . 0.3 111.348 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 86.7 mt -67.39 -41.82 86.69 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 121.135 -0.226 . . . . 0.37 110.792 178.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 33.3 t -61.0 -44.17 97.81 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.771 0.32 . . . . 0.32 110.914 179.144 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' ARG . . . . . 0.479 HH21 ' CD ' ' A' ' 169' ' ' GLU . 2.7 mtp180 -69.15 -52.14 31.17 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.572 -0.285 . . . . 0.73 111.697 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 166' ' ' TYR . . . . . 0.692 ' HE1' ' HA ' ' A' ' 195' ' ' ARG . 64.0 t80 -56.32 -45.58 80.26 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.553 0.216 . . . . 0.35 111.508 -179.676 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 5.6 mp -60.47 -50.08 75.01 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 121.188 -0.205 . . . . 0.49 111.22 -179.623 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' ARG . . . . . 0.528 ' HD2' ' OE2' ' A' ' 269' ' ' GLU . 9.3 mtp180 -66.95 -36.65 82.7 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 112.083 0.401 . . . . 0.86 112.083 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 169' ' ' GLU . . . . . 0.479 ' CD ' HH21 ' A' ' 165' ' ' ARG . 0.9 OUTLIER -66.12 -51.31 59.18 Favored 'General case' 0 N--CA 1.465 0.282 0 O-C-N 122.268 -0.27 . . . . 0.65 111.391 179.436 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 170' ' ' GLN . . . . . 0.451 ' HB2' ' HB1' ' A' ' 253' ' ' ALA . 4.4 mm-40 -64.84 -26.22 68.24 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-O 121.014 0.435 . . . . 0.87 110.323 178.545 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -77.2 -18.33 57.83 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 115.916 -0.584 . . . . 0.47 110.714 178.222 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' THR . . . . . 0.416 ' OG1' ' HE2' ' A' ' 260' ' ' LYS . 25.4 m -98.1 -42.82 7.29 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.061 -0.518 . . . . 0.45 111.466 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 108.88 -0.61 31.83 Favored Glycine 0 CA--C 1.519 0.327 0 C-N-CA 120.633 -0.794 . . . . 0.56 112.723 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 29.8 t -155.69 -92.78 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.854 0.359 . . . . 0.61 111.033 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' LYS . . . . . 0.451 ' HA ' ' HG2' ' A' ' 169' ' ' GLU . 0.0 OUTLIER -149.0 105.55 3.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.532 -0.304 . . . . 0.66 110.912 -179.809 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -75.52 177.28 6.84 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 121.28 0.562 . . . . 0.77 111.916 -179.42 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 46.9 t -80.15 54.96 2.06 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 116.153 -0.476 . . . . 1.44 111.977 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 178' ' ' LYS . . . . . 0.504 ' HD3' ' HD2' ' A' ' 179' ' ' PRO . 5.2 mmtp -123.18 119.13 27.69 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 120.82 0.343 . . . . 0.57 111.353 179.676 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 179' ' ' PRO . . . . . 0.504 ' HD2' ' HD3' ' A' ' 178' ' ' LYS . 83.1 Cg_endo -94.9 179.66 0.69 Allowed 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 123.192 2.595 . . . . 0.57 113.773 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 71.2 mt -123.3 151.67 42.18 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.021 -0.536 . . . . 0.49 110.42 179.488 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -127.84 -72.01 0.16 Allowed Glycine 0 CA--C 1.522 0.503 0 C-N-CA 120.577 -0.821 . . . . 0.52 113.064 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 57.1 mt-10 -91.1 -24.55 19.96 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 120.94 0.4 . . . . 0.87 111.532 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.463 ' HB2' ' HA ' ' A' ' 158' ' ' GLN . . . -80.83 61.57 4.52 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 121.06 0.457 . . . . 0.32 111.311 179.385 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -80.07 -70.31 1.34 Allowed Glycine 0 CA--C 1.527 0.803 0 N-CA-C 114.432 0.533 . . . . 0.36 114.432 -179.309 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -71.71 -55.48 7.6 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-O 121.063 0.458 . . . . 0.47 111.542 -179.434 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -63.51 -35.2 79.69 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.974 -0.557 . . . . 0.35 110.16 179.404 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 187' ' ' GLY . . . . . 0.617 ' O ' ' HB2' ' A' ' 191' ' ' LEU . . . -63.06 -31.8 81.94 Favored Glycine 0 C--N 1.333 0.403 0 C-N-CA 120.985 -0.626 . . . . 0.33 112.468 179.117 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 6.2 tpt180 -73.07 -57.04 4.31 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 120.635 0.255 . . . . 0.85 111.645 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 189' ' ' ARG . . . . . 0.551 ' HA ' ' OE1' ' A' ' 192' ' ' GLU . 0.0 OUTLIER -62.54 -41.27 98.78 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-O 121.032 0.444 . . . . 0.57 111.576 -179.266 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.478 ' HB2' ' HB3' ' A' ' 293' ' ' TRP . . . -66.62 -37.06 84.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.362 -0.381 . . . . 0.31 110.909 179.064 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 191' ' ' LEU . . . . . 0.617 ' HB2' ' O ' ' A' ' 187' ' ' GLY . 0.2 OUTLIER -59.84 -41.5 91.51 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.608 0.242 . . . . 0.6 111.293 179.915 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 192' ' ' GLU . . . . . 0.551 ' OE1' ' HA ' ' A' ' 189' ' ' ARG . 5.3 mt-10 -67.14 -52.38 42.4 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.129 0.49 . . . . 0.51 111.422 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 193' ' ' THR . . . . . 0.565 HG21 ' HA ' ' A' ' 297' ' ' VAL . 4.6 m -65.12 -35.43 81.09 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.874 -0.603 . . . . 0.42 112.265 -179.059 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 0.411 HD12 ' HA ' ' A' ' 194' ' ' LEU . 12.6 tp -69.79 -37.7 76.42 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.694 0.283 . . . . 0.4 111.048 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 195' ' ' ARG . . . . . 0.692 ' HA ' ' HE1' ' A' ' 166' ' ' TYR . 1.7 ttt180 -66.5 -45.47 79.49 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-O 120.979 0.419 . . . . 0.44 110.882 179.181 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 18.6 mmt85 -64.83 -56.58 12.6 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.821 -0.627 . . . . 0.98 111.959 -179.209 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 197' ' ' VAL . . . . . 0.458 ' O ' HG23 ' A' ' 201' ' ' VAL . 98.8 t -66.24 -41.65 89.54 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 CA-C-O 120.901 0.381 . . . . 0.38 111.423 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 198' ' ' GLY . . . . . 0.503 ' HA3' ' OH ' ' A' ' 166' ' ' TYR . . . -62.0 -52.39 50.46 Favored Glycine 0 CA--C 1.522 0.484 0 C-N-CA 121.178 -0.534 . . . . 0.3 113.494 -179.694 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -63.83 -40.14 95.88 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 117.385 0.592 . . . . 0.57 109.902 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -53.86 -44.97 71.33 Favored Glycine 0 C--N 1.337 0.599 0 C-N-CA 120.621 -0.8 . . . . 0.39 111.603 178.318 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 201' ' ' VAL . . . . . 0.458 HG23 ' O ' ' A' ' 197' ' ' VAL . 88.9 t -72.37 -36.88 56.42 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-O 121.137 0.494 . . . . 0.38 110.949 178.582 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 202' ' ' GLN . . . . . 0.419 ' HA ' ' CE2' ' A' ' 209' ' ' PHE . 14.7 tt0 -64.39 -34.64 78.63 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 115.926 -0.579 . . . . 0.38 111.415 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 17.0 mmp_? -80.54 -53.75 6.29 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 112.998 0.74 . . . . 0.42 112.998 -179.358 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 24.1 p30 -67.33 -31.0 70.97 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 119.836 -0.745 . . . . 0.49 111.879 -179.125 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 42.3 m80 -102.31 26.86 7.28 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 121.023 -0.271 . . . . 0.49 111.25 178.54 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -53.21 -54.9 29.28 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 115.995 -0.548 . . . . 0.75 112.276 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 43.0 p -58.05 -47.12 84.1 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.078 -0.51 . . . . 0.64 111.882 -179.617 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -59.46 -44.61 92.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.249 -0.432 . . . . 0.43 110.285 179.088 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 209' ' ' PHE . . . . . 0.419 ' CE2' ' HA ' ' A' ' 202' ' ' GLN . 10.8 m-30 -63.77 -50.96 66.96 Favored 'General case' 0 C--O 1.223 -0.335 0 CA-C-N 115.973 -0.558 . . . . 0.44 110.751 179.246 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -57.41 -43.7 83.96 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 120.586 0.232 . . . . 0.74 111.553 179.571 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -61.21 -51.1 60.4 Favored Glycine 0 C--N 1.335 0.505 0 C-N-CA 120.821 -0.704 . . . . 0.43 112.345 179.199 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 212' ' ' MET . . . . . 0.433 ' HA ' ' HE3' ' A' ' 215' ' ' LYS . 0.7 OUTLIER -68.07 -34.82 77.15 Favored 'General case' 0 CA--C 1.531 0.212 0 O-C-N 122.592 -0.358 . . . . 0.73 111.086 179.3 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 8.7 tp -59.46 -39.22 82.92 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.96 0.409 . . . . 0.65 110.709 178.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 47.6 ttp180 -71.99 -36.3 69.73 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.944 -0.571 . . . . 1.23 110.521 178.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 215' ' ' LYS . . . . . 0.433 ' HE3' ' HA ' ' A' ' 212' ' ' MET . 52.6 mtmt -73.31 -37.46 66.18 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 116.266 -0.424 . . . . 1.33 112.021 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.74 ' HB3' HG12 ' A' ' 218' ' ' ILE . 41.0 mt -63.55 131.64 48.72 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 121.147 0.498 . . . . 0.69 112.117 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -80.4 33.69 0.3 Allowed 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.005 -0.543 . . . . 1.36 111.648 179.633 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 218' ' ' ILE . . . . . 0.74 HG12 ' HB3' ' A' ' 216' ' ' LEU . 30.7 mm -71.42 105.47 1.78 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.302 0 CA-C-O 120.929 0.395 . . . . 0.49 111.564 -179.172 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 2.6 ttmm -163.07 -53.69 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 115.881 -0.6 . . . . 1.74 111.218 179.253 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 52.8 m-20 -104.41 -178.5 3.67 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 115.935 -0.575 . . . . 0.73 111.391 -179.522 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -46.7 -29.42 1.88 Allowed 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 113.482 0.919 . . . . 1.38 113.482 -179.272 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -62.22 -23.59 64.38 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 121.487 -0.387 . . . . 0.47 113.971 179.507 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 223' ' ' ASP . . . . . 0.515 ' HB2' HG23 ' A' ' 218' ' ' ILE . 2.1 p-10 -58.61 -52.15 66.89 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 113.625 0.972 . . . . 1.11 113.625 -178.297 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 19.6 m -58.66 -38.35 70.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 N-CA-C 112.205 0.446 . . . . 0.48 112.205 -179.407 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 85.7 mttt -69.09 -43.58 74.25 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.059 0.457 . . . . 0.86 110.29 179.245 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 226' ' ' SER . . . . . 0.573 ' O ' HG23 ' A' ' 230' ' ' VAL . 20.9 m -65.66 -46.6 78.54 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.84 -0.618 . . . . 0.38 110.265 179.289 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 227' ' ' PHE . . . . . 0.617 ' O ' ' HG3' ' A' ' 231' ' ' MET . 7.2 t80 -58.23 -43.34 87.73 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.918 -0.583 . . . . 0.57 110.521 179.167 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 228' ' ' SER . . . . . 0.429 ' O ' HG23 ' A' ' 232' ' ' VAL . 67.3 m -56.58 -44.16 80.75 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.023 0.44 . . . . 0.37 109.983 178.462 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 69.7 mtp180 -63.18 -35.97 82.06 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 115.885 -0.598 . . . . 1.17 110.321 178.547 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 0.717 HG22 ' HE1' ' B' ' 23' ' ' PHE . 28.4 t -63.14 -51.94 65.11 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 N-CA-C 109.601 -0.518 . . . . 0.32 109.601 177.629 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 231' ' ' MET . . . . . 0.617 ' HG3' ' O ' ' A' ' 227' ' ' PHE . 54.0 mtp -57.23 -43.98 83.38 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.517 -0.765 . . . . 0.44 111.102 179.58 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 232' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 228' ' ' SER . 55.7 t -58.41 -40.91 80.02 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 N-CA-C 109.985 -0.376 . . . . 0.51 109.985 178.803 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 233' ' ' HIS . . . . . 0.571 ' HA ' ' HB2' ' A' ' 236' ' ' LYS . 54.9 t-80 -71.24 -39.96 71.34 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 116.048 -0.524 . . . . 0.58 111.039 178.725 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.519 HG23 ' O ' ' A' ' 230' ' ' VAL . 74.0 t -57.09 -38.92 63.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-O 120.749 0.309 . . . . 0.43 111.003 179.262 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -104.79 23.7 13.03 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 116.406 -0.361 . . . . 0.92 111.176 178.666 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 236' ' ' LYS . . . . . 0.571 ' HB2' ' HA ' ' A' ' 233' ' ' HIS . 5.9 tptp -70.52 -29.95 66.58 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 114.571 1.322 . . . . 1.46 114.571 -177.331 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -69.92 -16.93 63.29 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 118.643 0.656 . . . . 1.24 112.301 -178.656 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 98.7 -19.67 53.43 Favored Glycine 0 CA--C 1.522 0.527 0 C-N-CA 120.877 -0.678 . . . . 0.48 113.631 179.234 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 0.432 ' HB ' ' NH2' ' A' ' 244' ' ' ARG . 21.8 t -77.22 118.12 23.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 121.147 0.499 . . . . 0.52 110.788 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -95.07 100.07 11.95 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.097 0.406 . . . . 0.76 112.097 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 241' ' ' ASN . . . . . 0.506 ' HB2' ' HG3' ' A' ' 244' ' ' ARG . 14.9 m120 -103.88 134.51 47.06 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 110.391 -0.226 . . . . 0.48 110.391 178.742 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 242' ' ' TRP . . . . . 0.502 ' HB3' ' CZ ' ' A' ' 300' ' ' PHE . 14.0 m95 -56.81 -27.48 59.99 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 112.127 0.417 . . . . 0.53 112.127 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 243' ' ' GLY . . . . . 0.412 ' H ' ' HB2' ' B' ' 35' ' ' TYR . . . -69.64 -29.57 71.27 Favored Glycine 0 CA--C 1.52 0.39 0 C-N-CA 121.186 -0.531 . . . . 0.32 112.9 179.761 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 244' ' ' ARG . . . . . 0.506 ' HG3' ' HB2' ' A' ' 241' ' ' ASN . 19.6 mtt180 -73.72 -37.15 65.22 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.297 0.57 . . . . 0.46 109.645 179.268 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 245' ' ' ILE . . . . . 0.692 HG23 HD21 ' A' ' 279' ' ' LEU . 83.0 mt -63.03 -51.8 67.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-N 115.446 -0.797 . . . . 0.46 110.998 179.197 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 17.4 m -66.71 -30.33 49.35 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 C-N-CA 120.795 -0.362 . . . . 0.36 111.322 179.502 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 17.4 m -64.07 -46.54 83.83 Favored 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 110.248 -0.278 . . . . 0.43 110.248 178.659 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 248' ' ' LEU . . . . . 0.449 HD13 ' HA ' ' A' ' 248' ' ' LEU . 2.5 mm? -60.82 -35.91 77.74 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 120.688 0.28 . . . . 0.66 110.769 178.633 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 249' ' ' ILE . . . . . 0.563 HG12 ' O ' ' A' ' 245' ' ' ILE . 35.5 mm -71.88 -47.08 57.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 CA-C-O 120.868 0.366 . . . . 0.4 110.436 178.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 39.6 t -59.59 -42.02 91.62 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 121.156 0.503 . . . . 0.31 109.708 178.515 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 251' ' ' PHE . . . . . 0.441 ' O ' HG23 ' A' ' 255' ' ' VAL . 8.9 t80 -65.72 -44.03 87.31 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 115.607 -0.724 . . . . 0.39 109.825 177.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -57.29 -41.63 93.08 Favored Glycine 0 C--N 1.338 0.653 0 N-CA-C 111.623 -0.591 . . . . 0.28 111.623 178.169 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 253' ' ' ALA . . . . . 0.451 ' HB1' ' HB2' ' A' ' 170' ' ' GLN . . . -63.83 -40.4 96.53 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 120.808 0.337 . . . . 0.3 110.513 177.62 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 21.9 t80 -67.51 -38.97 85.08 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-O 121.454 0.645 . . . . 0.52 109.944 178.278 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 255' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 251' ' ' PHE . 63.5 t -65.0 -46.65 90.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.775 -0.648 . . . . 0.39 109.445 178.021 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -57.91 -36.62 72.71 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.306 -0.406 . . . . 0.27 110.195 178.126 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 23.3 ttmm -60.21 -45.09 94.37 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 115.663 -0.699 . . . . 2.05 111.45 178.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 258' ' ' HIS . . . . . 0.434 ' CE1' HD13 ' A' ' 259' ' ' LEU . 0.3 OUTLIER -65.95 -34.97 79.33 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 120.731 0.3 . . . . 0.39 111.132 179.538 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.623 ' HG ' ' HB3' ' A' ' 264' ' ' GLN . 3.5 tp -76.83 -46.19 25.75 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 116.551 -0.295 . . . . 0.45 111.485 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 260' ' ' LYS . . . . . 0.416 ' HE2' ' OG1' ' A' ' 172' ' ' THR . 42.7 tttp -63.04 -27.23 69.26 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 120.608 0.242 . . . . 0.41 111.353 179.293 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 57.8 m -57.98 -26.74 62.73 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 121.004 0.43 . . . . 0.44 110.817 178.704 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 15.9 m -114.53 23.42 5.25 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 CA-C-O 121.305 0.574 . . . . 0.46 110.093 178.448 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 263' ' ' ASN . . . . . 0.458 ' HA ' ' OE2' ' A' ' 265' ' ' GLU . 1.7 m120 54.19 59.99 3.87 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 114.948 -1.024 . . . . 0.65 113.475 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 264' ' ' GLN . . . . . 0.623 ' HB3' ' HG ' ' A' ' 259' ' ' LEU . 5.9 mt-30 -119.86 35.61 4.79 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.238 -0.437 . . . . 0.91 110.771 178.485 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 265' ' ' GLU . . . . . 0.562 ' HA ' HG12 ' A' ' 268' ' ' ILE . 0.9 OUTLIER -59.9 -25.0 64.76 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 112.422 0.527 . . . . 0.62 112.422 -179.568 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 16.6 p -64.02 -16.69 62.21 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 120.586 0.231 . . . . 0.86 111.285 179.14 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 267' ' ' PHE . . . . . 0.506 ' O ' ' HD2' ' A' ' 270' ' ' PRO . 28.6 m-85 -98.96 -32.35 11.34 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 120.982 0.42 . . . . 1.07 111.333 179.082 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 268' ' ' ILE . . . . . 0.562 HG12 ' HA ' ' A' ' 265' ' ' GLU . 20.3 pt -68.07 -28.86 42.64 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 120.955 -0.298 . . . . 0.41 111.453 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 269' ' ' GLU . . . . . 0.844 ' HB2' ' HD3' ' A' ' 270' ' ' PRO . 39.0 mm-40 -57.27 -57.02 27.81 Favored Pre-proline 0 CA--C 1.546 0.82 0 N-CA-C 110.028 -0.36 . . . . 0.66 110.028 178.09 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 270' ' ' PRO . . . . . 0.844 ' HD3' ' HB2' ' A' ' 269' ' ' GLU . 32.0 Cg_exo -62.09 -30.51 82.67 Favored 'Trans proline' 0 C--N 1.362 1.287 0 C-N-CA 122.291 1.994 . . . . 0.44 111.605 177.07 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 271' ' ' LEU . . . . . . . . . . . . . 40.3 tp -64.93 -40.25 94.75 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.114 -0.494 . . . . 0.57 109.751 177.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -63.39 -40.31 96.88 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 109.096 -0.705 . . . . 0.43 109.096 177.623 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 273' ' ' GLU . . . . . 0.574 ' OE1' ' HA ' ' A' ' 270' ' ' PRO . 35.0 mt-10 -63.49 -41.94 98.54 Favored 'General case' 0 C--O 1.223 -0.332 0 N-CA-C 108.693 -0.854 . . . . 0.8 108.693 177.009 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 274' ' ' THR . . . . . . . . . . . . . 10.1 m -60.32 -53.19 60.63 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.387 -0.824 . . . . 0.54 110.905 178.406 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 275' ' ' ILE . . . . . 0.614 HG23 ' HE3' ' A' ' 231' ' ' MET . 97.3 mt -58.09 -46.0 88.3 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-N 116.127 -0.488 . . . . 0.48 111.042 179.738 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 16.6 m -66.21 -49.51 67.03 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.337 -0.392 . . . . 0.41 111.539 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 277' ' ' ASP . . . . . 0.633 ' OD1' ' HD2' ' A' ' 281' ' ' ARG . 25.8 t0 -58.65 -56.34 23.44 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.335 -0.393 . . . . 0.59 111.975 -179.146 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 278' ' ' VAL . . . . . 0.515 HG11 ' HB2' ' A' ' 231' ' ' MET . 61.6 t -58.98 -37.76 69.55 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 120.924 -0.31 . . . . 0.49 111.237 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 279' ' ' LEU . . . . . 0.692 HD21 HG23 ' A' ' 245' ' ' ILE . 28.1 tp -65.7 -46.5 78.79 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 111.98 0.363 . . . . 0.97 111.98 179.744 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 66.3 t -79.62 -51.25 16.76 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 N-CA-C 112.196 0.443 . . . . 0.53 112.196 -179.553 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 281' ' ' ARG . . . . . 0.633 ' HD2' ' OD1' ' A' ' 277' ' ' ASP . 3.0 mtt180 -55.11 -38.43 68.15 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 113.205 0.817 . . . . 0.92 113.205 -179.184 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 282' ' ' THR . . . . . . . . . . . . . 2.7 m -82.07 -12.7 58.11 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 112.332 0.493 . . . . 0.59 112.332 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 67.8 mmtt -135.04 41.55 2.83 Favored 'General case' 0 N--CA 1.468 0.47 0 O-C-N 122.063 -0.398 . . . . 0.95 111.774 -179.412 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 57.3 mtp180 -55.41 -54.44 43.74 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 112.805 0.669 . . . . 0.69 112.805 -178.791 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -56.98 -46.0 82.54 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 120.924 0.392 . . . . 0.63 111.85 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 286' ' ' TRP . . . . . 0.418 ' O ' ' HB2' ' A' ' 290' ' ' GLN . 0.8 OUTLIER -67.45 -43.1 81.91 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.029 0.381 . . . . 0.59 112.029 -179.375 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -69.13 -46.24 68.13 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 112.373 0.509 . . . . 0.56 112.373 -179.401 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 9.3 p -63.6 -37.11 78.75 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 121.059 -0.256 . . . . 0.57 111.588 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 64.9 mttt -75.03 -24.76 58.38 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 120.759 0.314 . . . . 0.98 111.301 179.236 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 290' ' ' GLN . . . . . 0.418 ' HB2' ' O ' ' A' ' 286' ' ' TRP . 0.0 OUTLIER -91.75 2.98 56.13 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 112.122 0.416 . . . . 0.58 112.122 179.907 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 291' ' ' ARG . . . . . 0.446 HH11 ' HD2' ' A' ' 291' ' ' ARG . 29.5 mtm180 64.06 17.19 10.48 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 112.493 0.553 . . . . 0.46 112.493 179.393 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 64.75 -114.58 6.91 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 114.852 0.701 . . . . 0.34 114.852 178.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 293' ' ' TRP . . . . . 0.492 ' CZ2' ' HA ' ' A' ' 159' ' ' SER . 82.2 m95 -66.26 -36.76 83.83 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 113.262 0.838 . . . . 0.49 113.262 -177.879 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 294' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -58.69 -47.5 84.32 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 120.826 0.346 . . . . 0.5 110.45 179.317 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -69.18 -27.5 73.69 Favored Glycine 0 CA--C 1.522 0.471 0 C-N-CA 120.397 -0.906 . . . . 0.29 111.481 178.081 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 296' ' ' PHE . . . . . 0.47 ' HB3' ' HA ' ' A' ' 293' ' ' TRP . 1.9 t80 -70.2 -48.32 57.63 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 122.561 0.345 . . . . 0.37 111.27 179.057 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 297' ' ' VAL . . . . . 0.565 ' HA ' HG21 ' A' ' 193' ' ' THR . 33.9 m -66.95 -32.62 58.81 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 CA-C-O 120.605 0.241 . . . . 0.36 111.388 -179.686 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -64.71 -53.54 45.67 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.791 0.329 . . . . 0.43 111.429 179.07 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 299' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -64.19 -33.83 76.69 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.322 -0.399 . . . . 0.6 111.952 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 300' ' ' PHE . . . . . 0.502 ' CZ ' ' HB3' ' A' ' 242' ' ' TRP . 70.2 m-85 -98.47 30.01 3.4 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 112.515 0.561 . . . . 0.56 112.515 -179.246 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 301' ' ' HIS . . . . . 0.482 ' HB2' ' O ' ' A' ' 297' ' ' VAL . 48.6 t-80 -105.44 77.71 1.31 Allowed 'General case' 0 C--O 1.233 0.23 0 C-N-CA 120.536 -0.466 . . . . 1.62 111.564 179.356 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 302' ' ' VAL . . . . . 0.471 ' HB ' ' H ' ' A' ' 303' ' ' GLN . 8.0 m -82.68 -145.76 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 116.314 -0.403 . . . . 0.97 110.467 178.565 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 303' ' ' GLN . . . . . 0.471 ' H ' ' HB ' ' A' ' 302' ' ' VAL . 3.8 tp-100 -74.19 66.35 1.25 Allowed 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 121.446 0.641 . . . . 1.61 110.801 179.189 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -154.35 111.92 3.45 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 115.865 -0.607 . . . . 1.09 111.208 -179.358 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 56.3 mt -102.19 -57.48 2.06 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.251 0.548 . . . . 1.79 109.929 179.197 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.04 -42.84 3.48 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.429 -0.805 . . . . 1.47 110.233 179.027 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . 63.79 -121.43 23.51 Favored Glycine 0 C--N 1.338 0.686 0 CA-C-N 116.003 -0.544 . . . . 1.27 113.475 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.256 1.526 0 CA-C-O 118.863 -0.965 . . . . 1.71 112.875 179.529 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.671 0 CA-C-O 121.354 0.597 . . . . 2.29 110.862 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 18' ' ' GLU . . . . . 0.401 ' HB2' ' H ' ' B' ' 19' ' ' LEU . 1.2 pm0 -103.65 -145.39 0.37 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.291 -0.868 . . . . 1.52 111.359 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 19' ' ' LEU . . . . . 0.534 ' HG ' ' HD2' ' B' ' 20' ' ' PRO . 0.3 OUTLIER -78.77 140.21 58.6 Favored Pre-proline 0 CA--C 1.538 0.514 0 CA-C-N 116.39 -0.368 . . . . 1.63 110.447 179.398 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 20' ' ' PRO . . . . . 0.534 ' HD2' ' HG ' ' B' ' 19' ' ' LEU . 14.8 Cg_endo -54.05 151.83 26.28 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 123.608 2.872 . . . . 0.76 113.383 -179.506 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 21' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.38 29.79 0.17 Allowed 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 122.928 2.419 . . . . 0.61 113.652 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 22' ' ' GLU . . . . . 0.431 ' H ' ' C ' ' B' ' 20' ' ' PRO . 7.4 tm-20 -68.42 -41.95 79.66 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.0 -0.546 . . . . 1.46 110.596 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 23' ' ' PHE . . . . . 0.717 ' HE1' HG22 ' A' ' 230' ' ' VAL . 10.7 p90 -63.09 -35.41 80.17 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.104 0.478 . . . . 0.55 110.63 179.363 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.34 -44.62 64.74 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.986 -0.552 . . . . 0.36 109.986 178.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.05 -44.72 96.97 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.923 -0.58 . . . . 0.48 110.172 177.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 1.2 tp-100 -58.59 -48.9 79.4 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 115.548 -0.751 . . . . 0.88 110.161 178.591 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 45.6 mt -58.75 -40.55 84.17 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.292 -0.413 . . . . 0.47 110.637 178.669 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.89 -51.14 70.55 Favored 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 109.736 -0.468 . . . . 0.41 109.736 178.472 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 46.9 mtpt -55.61 -45.17 77.51 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 116.25 -0.432 . . . . 0.66 110.008 178.418 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 30' ' ' ILE . . . . . 0.514 ' O ' HG23 ' B' ' 34' ' ' VAL . 95.5 mt -59.21 -44.96 93.13 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 N-CA-C 109.719 -0.474 . . . . 0.45 109.719 178.123 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 31' ' ' GLY . . . . . 0.47 ' HA3' ' HG2' ' A' ' 244' ' ' ARG . . . -60.4 -49.55 77.35 Favored Glycine 0 C--N 1.336 0.534 0 CA-C-N 116.028 -0.533 . . . . 0.3 112.302 178.579 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -58.77 -38.82 79.34 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.18 0.514 . . . . 0.43 110.121 178.267 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -68.28 -47.67 67.03 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 115.75 -0.659 . . . . 0.98 111.353 179.247 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 34' ' ' VAL . . . . . 0.514 HG23 ' O ' ' B' ' 30' ' ' ILE . 53.9 t -56.65 -50.06 75.49 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-O 120.717 0.294 . . . . 0.34 111.422 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 35' ' ' TYR . . . . . 0.412 ' HB2' ' H ' ' A' ' 243' ' ' GLY . 0.0 OUTLIER -61.86 -38.57 88.73 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 120.881 0.372 . . . . 0.77 110.345 178.995 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 36' ' ' CYS . . . . . . . . . . . . . 21.4 t -68.03 -25.4 65.36 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.205 -0.452 . . . . 0.67 111.226 179.427 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 20.4 m -82.78 -42.14 18.31 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.189 -0.46 . . . . 0.49 111.977 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 38' ' ' TRP . . . . . . . . . . . . . 99.2 m95 -80.78 -22.9 39.69 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 112.54 0.571 . . . . 0.66 112.54 -179.198 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 20.3 t -74.2 -6.06 45.58 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 112.283 0.475 . . . . 0.76 112.283 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -90.57 123.23 65.85 Favored Pre-proline 0 CA--C 1.534 0.349 0 N-CA-C 111.857 0.317 . . . . 1.05 111.857 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -75.62 131.32 13.47 Favored 'Trans proline' 0 CA--C 1.534 0.513 0 C-N-CA 122.688 2.258 . . . . 1.6 113.05 179.613 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -94.07 -78.84 0.43 Allowed 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 116.155 -0.475 . . . . 2.09 111.662 179.746 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 43' ' ' MET . . . . . . . . . . . . . 47.5 ttm . . . . . 0 C--O 1.255 1.346 0 CA-C-O 118.427 -0.797 . . . . 3.19 111.516 179.626 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.088 0 N-CA-C 112.339 -0.304 . . . . 0.54 112.339 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -79.01 50.58 3.54 Favored 'Trans proline' 0 CA--C 1.535 0.564 0 C-N-CA 122.698 2.265 . . . . 0.75 113.115 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 24.0 tp -90.26 -18.96 24.71 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 121.005 0.431 . . . . 1.39 111.187 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 126.1 -170.67 17.93 Favored Glycine 0 CA--C 1.52 0.353 0 C-N-CA 120.814 -0.708 . . . . 0.52 112.649 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 92.0 p -72.14 72.47 0.89 Allowed 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.563 0.697 . . . . 0.62 111.264 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -162.61 -43.18 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.216 -0.902 . . . . 0.53 110.103 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' ASP . . . . . 0.504 ' HA ' ' HB3' ' A' ' 156' ' ' TYR . 2.3 m-20 -61.25 -26.77 67.98 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.866 -0.606 . . . . 0.46 110.867 179.622 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -56.16 -37.09 69.06 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 121.368 0.604 . . . . 0.48 109.42 177.593 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 53.6 tp -83.44 -32.29 26.15 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.696 -0.684 . . . . 0.62 109.674 178.799 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' TYR . . . . . 0.504 ' HB3' ' HA ' ' A' ' 153' ' ' ASP . 83.3 t80 -62.18 -37.45 85.31 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 115.767 -0.651 . . . . 0.39 110.647 178.875 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.606 ' HD3' ' OE1' ' A' ' 182' ' ' GLU . 0.7 OUTLIER -59.25 -44.88 92.36 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.039 0.447 . . . . 0.34 110.637 178.727 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -74.32 -35.3 63.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.253 -0.43 . . . . 0.66 110.014 178.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' SER . . . . . 0.467 ' HA ' ' NE1' ' A' ' 293' ' ' TRP . 64.8 m -59.03 -57.69 11.94 Favored 'General case' 0 CA--C 1.521 -0.144 0 CA-C-N 115.854 -0.612 . . . . 0.25 110.645 178.769 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.475 HD23 ' NH2' ' A' ' 157' ' ' ARG . 46.9 tp -62.01 -36.93 83.02 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 121.077 -0.249 . . . . 0.35 110.757 179.306 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 161' ' ' GLU . . . . . 0.492 ' OE2' ' HB3' ' A' ' 180' ' ' LEU . 0.0 OUTLIER -59.02 -54.11 50.78 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 120.792 0.329 . . . . 0.43 110.649 179.037 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 162' ' ' ILE . . . . . 0.517 HG12 ' HA2' ' A' ' 187' ' ' GLY . 54.8 mt -63.77 -45.45 97.2 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-N 116.093 -0.503 . . . . 0.28 111.381 179.631 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.466 ' O ' ' HG ' ' A' ' 167' ' ' LEU . 54.8 mt -61.33 -46.73 96.01 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 CA-C-N 116.5 -0.318 . . . . 0.33 111.243 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 31.4 t -62.34 -45.38 93.44 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.876 0.369 . . . . 0.38 110.495 178.696 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' ARG . . . . . 0.664 ' HG2' ' HG ' ' A' ' 180' ' ' LEU . 0.0 OUTLIER -61.84 -46.13 90.8 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.2 -0.455 . . . . 0.66 111.587 -179.894 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 166' ' ' TYR . . . . . 0.864 ' HE1' ' HA ' ' A' ' 195' ' ' ARG . 91.6 t80 -70.36 -54.14 13.75 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 112.634 0.605 . . . . 0.4 112.634 -179.289 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.466 ' HG ' ' O ' ' A' ' 163' ' ' ILE . 29.8 mt -58.71 -49.74 76.48 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 112.516 0.561 . . . . 0.33 112.516 -177.743 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -66.03 -39.02 89.84 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 112.274 0.472 . . . . 1.09 112.274 -179.2 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 169' ' ' GLU . . . . . 0.47 ' HB2' ' O ' ' A' ' 165' ' ' ARG . 14.3 mm-40 -71.19 -47.93 54.62 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 120.56 -0.456 . . . . 0.44 111.755 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 170' ' ' GLN . . . . . 0.456 ' O ' ' HG3' ' A' ' 170' ' ' GLN . 0.5 OUTLIER -62.27 -28.02 69.42 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 120.918 0.39 . . . . 1.06 111.159 179.129 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.482 ' HB2' ' HB1' ' A' ' 256' ' ' ALA . . . -74.26 -24.62 59.3 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 112.7 0.63 . . . . 0.43 112.7 -179.778 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 9.4 t -111.05 -21.23 12.08 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 112.814 0.672 . . . . 0.61 112.814 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 70.88 29.99 68.59 Favored Glycine 0 CA--C 1.525 0.686 0 C-N-CA 120.607 -0.806 . . . . 0.56 113.505 179.434 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' SER . . . . . 0.462 ' HB3' ' OE1' ' A' ' 169' ' ' GLU . 28.9 t -77.47 -62.05 1.79 Allowed 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.989 0.395 . . . . 0.53 111.396 -179.255 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 175' ' ' LYS . . . . . 0.677 ' HB3' ' HG3' ' A' ' 178' ' ' LYS . 19.8 tptt -151.83 118.9 5.86 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 121.035 0.445 . . . . 0.85 111.602 179.117 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -50.6 -71.71 0.06 Allowed 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 115.23 -0.895 . . . . 0.77 112.484 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 3.6 m -88.52 79.92 7.5 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.938 -0.574 . . . . 0.61 111.174 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' LYS . . . . . 0.677 ' HG3' ' HB3' ' A' ' 175' ' ' LYS . 10.7 mttt -96.0 138.9 21.62 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-O 120.756 0.313 . . . . 0.76 110.856 179.221 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -57.03 138.17 85.15 Favored 'Trans proline' 0 CA--C 1.535 0.532 0 C-N-CA 123.172 2.581 . . . . 0.7 113.834 -179.507 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.664 ' HG ' ' HG2' ' A' ' 165' ' ' ARG . 5.3 mp -97.81 -165.84 1.3 Allowed 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 115.647 -0.706 . . . . 0.65 110.857 179.586 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -125.15 -41.34 0.37 Allowed Glycine 0 CA--C 1.524 0.654 0 C-N-CA 120.325 -0.94 . . . . 0.62 113.516 -179.607 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 182' ' ' GLU . . . . . 0.606 ' OE1' ' HD3' ' A' ' 157' ' ' ARG . 82.7 mt-10 -114.14 -27.18 7.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.06 0.457 . . . . 0.74 111.374 -179.545 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.551 ' HB3' HD22 ' A' ' 180' ' ' LEU . . . -102.29 81.84 2.12 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 121.138 0.495 . . . . 0.33 111.542 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -80.43 -71.59 1.27 Allowed Glycine 0 CA--C 1.525 0.691 0 C-N-CA 120.88 -0.676 . . . . 0.34 113.986 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -66.83 -55.58 14.17 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 120.823 0.345 . . . . 0.42 111.808 -179.22 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -66.26 -37.04 84.53 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.265 -0.425 . . . . 0.36 110.235 179.192 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 187' ' ' GLY . . . . . 0.518 ' HA3' ' O ' ' A' ' 183' ' ' ALA . . . -64.85 -41.25 97.58 Favored Glycine 0 C--N 1.334 0.462 0 C-N-CA 120.909 -0.662 . . . . 0.29 112.667 179.282 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 188' ' ' ARG . . . . . 0.453 HH11 ' HD2' ' A' ' 188' ' ' ARG . 13.5 ttt180 -62.31 -53.47 54.63 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.621 0.248 . . . . 0.51 110.666 178.73 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 189' ' ' ARG . . . . . 0.757 ' HB3' HG11 ' A' ' 297' ' ' VAL . 73.7 mtt180 -59.63 -44.9 93.31 Favored 'General case' 0 C--O 1.228 -0.072 0 CA-C-N 116.24 -0.436 . . . . 0.41 110.98 179.549 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -69.45 -37.86 77.55 Favored 'General case' 0 C--O 1.218 -0.558 0 N-CA-C 112.817 0.673 . . . . 0.28 112.817 -178.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 18.6 tp -64.41 -49.15 72.68 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 118.178 0.444 . . . . 0.6 111.911 -179.383 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 192' ' ' GLU . . . . . 0.407 ' OE2' ' NE2' ' A' ' 301' ' ' HIS . 0.0 OUTLIER -66.4 -36.02 81.79 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.853 0.358 . . . . 0.4 111.044 179.675 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 193' ' ' THR . . . . . 0.505 HG21 ' HA ' ' A' ' 297' ' ' VAL . 48.2 m -73.05 -44.91 60.1 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.578 -0.283 . . . . 0.31 110.673 179.287 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 0.474 HD21 HG21 ' A' ' 249' ' ' ILE . 14.7 tp -62.03 -36.46 81.64 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.41 -0.359 . . . . 0.39 110.531 179.181 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 195' ' ' ARG . . . . . 0.864 ' HA ' ' HE1' ' A' ' 166' ' ' TYR . 0.8 OUTLIER -63.96 -55.72 20.38 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.015 0.436 . . . . 0.35 110.683 178.449 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.33 -47.9 83.65 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.457 -0.792 . . . . 1.33 112.41 -179.71 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 197' ' ' VAL . . . . . 0.524 ' O ' HG23 ' A' ' 201' ' ' VAL . 83.0 t -72.82 -49.73 38.04 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 N-CA-C 111.97 0.359 . . . . 0.32 111.97 -179.461 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 198' ' ' GLY . . . . . 0.507 ' O ' ' HG2' ' A' ' 202' ' ' GLN . . . -57.61 -53.38 45.54 Favored Glycine 0 C--N 1.334 0.462 0 C-N-CA 121.187 -0.53 . . . . 0.33 112.498 -179.568 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 199' ' ' ASP . . . . . 0.551 ' HB2' ' O ' ' A' ' 195' ' ' ARG . 0.3 OUTLIER -59.17 -40.65 86.29 Favored 'General case' 0 C--O 1.224 -0.262 0 N-CA-C 109.841 -0.429 . . . . 0.72 109.841 178.783 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -62.4 -50.01 68.71 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 120.898 -0.668 . . . . 0.36 112.604 178.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 201' ' ' VAL . . . . . 0.524 HG23 ' O ' ' A' ' 197' ' ' VAL . 78.1 t -55.88 -52.63 47.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-O 120.743 0.306 . . . . 0.38 111.764 179.275 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 202' ' ' GLN . . . . . 0.533 ' HG3' ' CZ ' ' A' ' 203' ' ' ARG . 1.4 pt20 -69.53 -31.75 70.17 Favored 'General case' 0 C--O 1.221 -0.432 0 N-CA-C 112.091 0.404 . . . . 0.43 112.091 -179.382 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 203' ' ' ARG . . . . . 0.533 ' CZ ' ' HG3' ' A' ' 202' ' ' GLN . 0.0 OUTLIER -68.77 -43.43 75.77 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.955 0.407 . . . . 0.73 109.997 178.003 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 18.2 m-80 -66.35 -47.09 74.56 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 121.163 0.506 . . . . 0.6 110.604 178.703 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -97.76 36.26 1.55 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.028 -0.533 . . . . 0.47 110.216 179.182 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 206' ' ' GLU . . . . . 0.528 ' OE1' ' HA ' ' A' ' 203' ' ' ARG . 4.5 tp10 -49.72 -52.0 34.6 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 115.477 -0.783 . . . . 0.47 112.186 -178.804 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 64.7 p -65.66 -38.96 90.78 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.595 0.591 . . . . 0.59 112.595 -179.534 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -63.85 -45.51 89.17 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.066 0.46 . . . . 0.4 110.449 179.406 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -71.13 -42.34 69.34 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.976 -0.557 . . . . 0.48 110.475 179.57 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 210' ' ' GLN . . . . . 0.415 ' O ' ' HG3' ' A' ' 214' ' ' ARG . 6.7 tt0 -62.58 -45.88 90.89 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.188 -0.46 . . . . 0.81 110.852 179.243 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -59.93 -49.45 78.41 Favored Glycine 0 C--N 1.334 0.47 0 C-N-CA 120.902 -0.666 . . . . 0.32 111.82 178.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 212' ' ' MET . . . . . 0.488 ' SD ' ' HA ' ' B' ' 23' ' ' PHE . 2.0 ttp -60.91 -36.34 79.02 Favored 'General case' 0 C--O 1.224 -0.257 0 CA-C-O 120.884 0.374 . . . . 0.51 110.002 178.631 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.409 HD13 ' HD2' ' A' ' 254' ' ' PHE . 7.8 tp -68.1 -39.93 82.7 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.663 -0.699 . . . . 0.55 110.919 178.684 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 214' ' ' ARG . . . . . 0.415 ' HG3' ' O ' ' A' ' 210' ' ' GLN . 70.0 mtt-85 -57.54 -39.34 76.41 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.163 -0.471 . . . . 0.81 110.759 178.639 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 215' ' ' LYS . . . . . 0.428 ' HE3' ' HB2' ' A' ' 215' ' ' LYS . 47.2 mtmt -99.01 12.13 36.91 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.099 -0.5 . . . . 0.63 111.191 179.055 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.567 ' HA ' HD13 ' B' ' 19' ' ' LEU . 28.0 tp -82.41 110.41 17.53 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.948 0.404 . . . . 0.45 111.14 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 35.8 m-20 -79.43 32.74 0.24 Allowed 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 112.437 0.532 . . . . 0.59 112.437 -179.531 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 218' ' ' ILE . . . . . 0.525 HG23 ' HB2' ' A' ' 223' ' ' ASP . 2.7 mt -81.18 107.68 13.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 CA-C-O 121.424 0.63 . . . . 0.42 110.634 179.155 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 219' ' ' LYS . . . . . 0.477 ' HG2' HE22 ' A' ' 264' ' ' GLN . 0.4 OUTLIER -161.3 -39.24 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 115.252 -0.885 . . . . 0.49 111.209 179.396 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -105.11 -177.46 3.37 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.5 -0.318 . . . . 0.59 111.853 -179.483 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -49.53 -21.68 1.03 Allowed 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 113.677 0.992 . . . . 0.66 113.677 -179.133 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -69.55 -23.81 76.45 Favored Glycine 0 CA--C 1.531 1.074 0 N-CA-C 114.265 0.466 . . . . 0.41 114.265 -179.515 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 223' ' ' ASP . . . . . 0.525 ' HB2' HG23 ' A' ' 218' ' ' ILE . 6.5 p-10 -55.48 -56.52 19.23 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 113.711 1.004 . . . . 0.89 113.711 -177.449 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.524 ' HB ' HG21 ' A' ' 274' ' ' THR . 17.2 m -61.53 -33.38 56.83 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-O 121.038 0.447 . . . . 0.45 111.672 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 48.2 mttp -70.26 -39.14 75.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.085 0.469 . . . . 0.91 110.478 179.314 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 226' ' ' SER . . . . . 0.658 ' O ' HG23 ' A' ' 230' ' ' VAL . 7.3 t -74.19 -44.69 52.43 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.095 -0.502 . . . . 0.89 110.652 179.113 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 227' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -57.99 -46.62 84.91 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.969 0.414 . . . . 0.46 110.853 179.681 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 228' ' ' SER . . . . . 0.486 ' CB ' HG21 ' A' ' 278' ' ' VAL . 16.3 p -65.78 -39.37 90.91 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.735 -0.469 . . . . 0.38 109.735 178.483 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 42.6 ttp180 -60.08 -45.39 93.06 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.198 -0.456 . . . . 1.08 110.202 177.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 0.658 HG23 ' O ' ' A' ' 226' ' ' SER . 99.8 t -59.39 -48.0 88.66 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-N 116.017 -0.538 . . . . 0.35 110.353 178.48 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 231' ' ' MET . . . . . 0.745 ' HG3' HD13 ' A' ' 248' ' ' LEU . 29.6 ttm -55.22 -41.15 71.69 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.046 -0.524 . . . . 0.35 111.553 179.606 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 232' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 228' ' ' SER . 85.2 t -66.93 -36.1 76.32 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-O 121.037 0.446 . . . . 0.54 111.079 179.287 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 44.8 t-80 -77.2 -36.36 54.98 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 116.415 -0.357 . . . . 0.47 111.636 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.445 HG23 ' O ' ' A' ' 230' ' ' VAL . 52.0 t -56.58 -39.63 63.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 CA-C-O 120.867 0.365 . . . . 0.4 111.49 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 235' ' ' PHE . . . . . 0.826 ' HE2' HD11 ' A' ' 248' ' ' LEU . 75.7 m-85 -100.29 24.25 9.03 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.031 0.382 . . . . 0.36 112.031 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 3.2 ttpp -73.1 -10.91 60.29 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 120.541 0.21 . . . . 0.87 111.489 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 22.2 p-10 -89.06 -10.38 47.66 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 120.731 0.301 . . . . 0.38 111.061 179.258 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 91.52 -19.23 48.92 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 114.487 0.555 . . . . 0.35 114.487 178.436 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 0.548 ' HB ' ' NH2' ' A' ' 244' ' ' ARG . 17.9 t -78.78 102.81 5.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 O-C-N 122.23 -0.571 . . . . 0.41 111.305 -179.67 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 240' ' ' THR . . . . . 0.481 ' HA ' ' CE1' ' A' ' 235' ' ' PHE . 24.1 m -93.25 84.03 4.72 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.112 0.482 . . . . 0.36 111.344 -179.662 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 241' ' ' ASN . . . . . 0.422 ' HB2' ' HG3' ' A' ' 244' ' ' ARG . 80.5 m-20 -89.09 141.03 28.85 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.316 -0.402 . . . . 0.42 111.338 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 242' ' ' TRP . . . . . 0.435 ' HE1' ' HG2' ' A' ' 290' ' ' GLN . 18.9 m95 -57.93 -37.89 74.91 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.759 0.314 . . . . 0.52 111.112 179.533 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 243' ' ' GLY . . . . . 0.468 ' H ' ' HB2' ' B' ' 35' ' ' TYR . . . -60.04 -30.89 71.18 Favored Glycine 0 C--N 1.335 0.503 0 C-N-CA 120.991 -0.623 . . . . 0.23 112.047 178.492 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 244' ' ' ARG . . . . . 0.548 ' NH2' ' HB ' ' A' ' 239' ' ' VAL . 26.1 mtt180 -75.45 -48.06 24.43 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.969 0.414 . . . . 0.34 109.959 178.526 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 245' ' ' ILE . . . . . 0.545 HG23 HD11 ' A' ' 279' ' ' LEU . 73.3 mt -56.5 -44.93 81.72 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-N 115.449 -0.796 . . . . 0.47 110.625 179.53 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 9.9 p -70.94 -32.38 48.37 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-N 116.322 -0.399 . . . . 0.33 110.819 178.784 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 15.8 m -63.09 -38.02 89.54 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 122.293 -0.254 . . . . 0.37 110.567 179.01 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 248' ' ' LEU . . . . . 0.826 HD11 ' HE2' ' A' ' 235' ' ' PHE . 26.3 mt -62.83 -41.89 99.51 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 121.3 0.571 . . . . 0.59 109.799 177.657 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 249' ' ' ILE . . . . . 0.474 HG21 HD21 ' A' ' 194' ' ' LEU . 32.8 mm -68.53 -36.06 73.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 CA-C-N 115.694 -0.685 . . . . 0.51 109.571 178.197 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 40.6 t -63.3 -45.06 93.12 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 109.288 -0.634 . . . . 0.37 109.288 178.067 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 251' ' ' PHE . . . . . 0.457 ' O ' HG23 ' A' ' 255' ' ' VAL . 10.9 t80 -64.09 -41.02 97.46 Favored 'General case' 0 N--CA 1.456 -0.165 0 N-CA-C 108.766 -0.827 . . . . 0.42 108.766 177.636 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -57.57 -44.73 93.75 Favored Glycine 0 C--N 1.337 0.588 0 N-CA-C 110.946 -0.861 . . . . 0.28 110.946 177.161 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 253' ' ' ALA . . . . . 0.471 ' O ' ' HG3' ' A' ' 257' ' ' LYS . . . -63.95 -32.02 73.4 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 121.0 0.428 . . . . 0.27 110.899 177.485 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 254' ' ' PHE . . . . . 0.409 ' HD2' HD13 ' A' ' 213' ' ' LEU . 1.1 t80 -68.8 -45.05 72.27 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 121.164 0.507 . . . . 0.64 109.634 178.176 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 255' ' ' VAL . . . . . 0.457 HG23 ' O ' ' A' ' 251' ' ' PHE . 59.3 t -64.22 -38.36 82.3 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-N 115.783 -0.644 . . . . 0.4 109.743 178.019 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 256' ' ' ALA . . . . . 0.482 ' HB1' ' HB2' ' A' ' 171' ' ' ALA . . . -57.99 -47.45 82.96 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 115.892 -0.595 . . . . 0.22 110.067 178.316 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 257' ' ' LYS . . . . . 0.471 ' HG3' ' O ' ' A' ' 253' ' ' ALA . 49.5 mttp -59.25 -49.13 79.04 Favored 'General case' 0 N--CA 1.462 0.137 0 N-CA-C 110.066 -0.346 . . . . 0.34 110.066 178.069 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 81.4 t60 -57.59 -45.78 84.85 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 115.81 -0.632 . . . . 0.68 111.738 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 4.9 mp -69.53 -41.89 75.4 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.449 -0.341 . . . . 0.49 111.519 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 1.3 tmtm? -67.44 -32.48 73.38 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-O 120.476 0.179 . . . . 0.49 111.177 179.492 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 54.2 m -63.98 -27.64 69.27 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 120.893 0.378 . . . . 0.43 111.151 179.553 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 29.9 m -105.89 10.96 8.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-O 121.002 0.43 . . . . 0.51 110.702 178.624 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 61.34 36.76 17.42 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 113.231 0.826 . . . . 0.57 113.231 179.452 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 264' ' ' GLN . . . . . 0.477 HE22 ' HG2' ' A' ' 219' ' ' LYS . 5.4 mt-30 -105.33 37.67 2.14 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.337 0.589 . . . . 0.76 110.22 178.716 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -56.65 -22.72 36.46 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 113.306 0.854 . . . . 0.46 113.306 -179.002 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 10.7 p -61.35 -18.75 60.13 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.556 0.217 . . . . 0.67 111.271 179.141 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 267' ' ' PHE . . . . . 0.402 ' C ' ' HD2' ' A' ' 270' ' ' PRO . 92.6 m-85 -96.22 -22.57 17.18 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 120.837 0.351 . . . . 0.96 110.772 178.453 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 60.1 mt -67.18 -44.79 87.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-N 116.361 -0.382 . . . . 0.35 111.093 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 269' ' ' GLU . . . . . 0.618 ' HB2' ' HD3' ' A' ' 270' ' ' PRO . 1.0 OUTLIER -53.64 -56.38 25.52 Favored Pre-proline 0 CA--C 1.547 0.847 0 CA-C-N 116.254 -0.43 . . . . 0.61 111.643 179.706 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 270' ' ' PRO . . . . . 0.618 ' HD3' ' HB2' ' A' ' 269' ' ' GLU . 27.5 Cg_exo -64.34 -28.87 63.32 Favored 'Trans proline' 0 C--N 1.36 1.161 0 C-N-CA 122.105 1.87 . . . . 0.37 112.333 178.554 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 271' ' ' LEU . . . . . . . . . . . . . 38.3 tp -65.19 -43.21 92.36 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.4 -0.364 . . . . 0.41 110.586 178.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -58.84 -46.97 86.45 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.259 -0.428 . . . . 0.37 111.246 179.5 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 273' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -65.44 -42.94 91.88 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.534 -0.303 . . . . 0.68 110.403 178.687 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 274' ' ' THR . . . . . 0.524 HG21 ' HB ' ' A' ' 224' ' ' VAL . 85.9 m -58.86 -50.35 74.33 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.235 -0.438 . . . . 0.39 110.411 179.148 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 96.9 mt -59.44 -54.41 34.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.105 -0.498 . . . . 0.36 110.351 178.463 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 21.0 m -56.61 -52.99 62.73 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 113.105 0.78 . . . . 0.33 113.105 -179.25 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 277' ' ' ASP . . . . . 0.486 ' O ' ' HD2' ' A' ' 281' ' ' ARG . 0.2 OUTLIER -56.41 -53.7 54.34 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.445 0.164 . . . . 0.4 111.433 -179.212 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 278' ' ' VAL . . . . . 0.486 HG21 ' CB ' ' A' ' 228' ' ' SER . 89.3 t -60.68 -38.55 78.9 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 CA-C-O 120.796 0.331 . . . . 0.35 110.804 179.363 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 279' ' ' LEU . . . . . 0.545 HD11 HG23 ' A' ' 245' ' ' ILE . 2.4 tp -62.0 -47.08 86.39 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 116.421 -0.354 . . . . 0.78 111.881 179.527 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 61.9 t -76.56 -40.88 34.26 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 N-CA-C 112.47 0.544 . . . . 0.36 112.47 -179.017 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 281' ' ' ARG . . . . . 0.486 ' HD2' ' O ' ' A' ' 277' ' ' ASP . 0.0 OUTLIER -66.31 -28.5 68.73 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 112.474 0.546 . . . . 0.37 112.474 -179.356 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 282' ' ' THR . . . . . . . . . . . . . 25.3 p -85.32 -64.15 1.2 Allowed 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.063 0.459 . . . . 0.42 112.024 179.626 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 22.3 mtmm -88.99 40.74 0.99 Allowed 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.24 0.459 . . . . 0.46 112.24 -178.353 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 284' ' ' ARG . . . . . 0.467 ' O ' HG22 ' A' ' 288' ' ' VAL . 2.9 ptp85 -57.66 -46.17 84.57 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 112.136 0.421 . . . . 0.48 112.136 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 285' ' ' ASP . . . . . 0.439 ' O ' ' HB2' ' A' ' 289' ' ' LYS . 8.0 t70 -62.13 -51.52 67.54 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 111.87 0.322 . . . . 0.42 111.87 -179.24 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 286' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -61.83 -33.07 73.5 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.862 0.363 . . . . 0.42 111.234 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -70.81 -52.47 20.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.228 -0.442 . . . . 0.39 110.809 178.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 288' ' ' VAL . . . . . 0.467 HG22 ' O ' ' A' ' 284' ' ' ARG . 27.6 m -64.36 -30.68 50.83 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-O 120.813 0.34 . . . . 0.38 111.821 179.724 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 289' ' ' LYS . . . . . 0.439 ' HB2' ' O ' ' A' ' 285' ' ' ASP . 0.3 OUTLIER -68.36 -40.81 81.35 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 112.294 0.479 . . . . 0.47 112.294 -179.808 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 290' ' ' GLN . . . . . 0.465 ' O ' ' HA3' ' A' ' 295' ' ' GLY . 6.0 mp0 -96.94 30.05 2.84 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 112.867 0.692 . . . . 0.57 112.867 -178.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 33.1 mtm105 58.37 23.66 10.79 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 112.14 0.422 . . . . 0.45 112.14 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 69.21 -130.32 24.05 Favored Glycine 0 CA--C 1.523 0.554 0 C-N-CA 121.21 -0.519 . . . . 0.3 114.003 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 293' ' ' TRP . . . . . 0.613 ' O ' HG23 ' A' ' 297' ' ' VAL . 76.0 m95 -71.48 -29.45 64.85 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.386 0.514 . . . . 0.44 112.386 -178.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 294' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -59.72 -42.83 93.95 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 120.637 -0.425 . . . . 0.42 110.046 179.563 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 295' ' ' GLY . . . . . 0.465 ' HA3' ' O ' ' A' ' 290' ' ' GLN . . . -70.05 -38.13 73.6 Favored Glycine 0 C--N 1.336 0.556 0 N-CA-C 111.003 -0.839 . . . . 0.26 111.003 177.596 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 296' ' ' PHE . . . . . 0.423 ' HB3' ' HA ' ' A' ' 293' ' ' TRP . 0.1 OUTLIER -59.45 -37.48 78.25 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.096 0.474 . . . . 0.38 110.352 177.845 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 297' ' ' VAL . . . . . 0.757 HG11 ' HB3' ' A' ' 189' ' ' ARG . 71.4 t -65.71 -50.2 72.63 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-N 115.794 -0.639 . . . . 0.29 110.925 179.236 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -57.91 -41.87 83.56 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.236 -0.438 . . . . 0.54 111.395 179.319 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 299' ' ' PHE . . . . . 0.405 ' CZ ' ' HB2' ' B' ' 39' ' ' SER . 78.0 t80 -61.57 -40.14 93.66 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 116.18 -0.464 . . . . 0.52 112.227 -179.592 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 300' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -93.83 23.69 4.66 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.877 0.37 . . . . 0.42 111.596 -179.567 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 301' ' ' HIS . . . . . 0.407 ' NE2' ' OE2' ' A' ' 192' ' ' GLU . 0.1 OUTLIER -138.91 -164.99 1.75 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.957 0.408 . . . . 0.6 111.088 179.852 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 302' ' ' VAL . . . . . 0.591 HG22 ' H ' ' A' ' 303' ' ' GLN . 4.0 p -164.36 175.46 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 CA-C-N 116.143 -0.48 . . . . 1.16 110.235 -179.686 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 303' ' ' GLN . . . . . 0.591 ' H ' HG22 ' A' ' 302' ' ' VAL . 77.6 mm-40 -76.08 65.08 2.04 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.39 0.614 . . . . 1.61 110.675 179.608 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -74.06 122.64 22.98 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.33 -0.85 . . . . 1.09 111.833 -179.123 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 14.9 tp -119.06 10.14 12.04 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.867 -1.06 . . . . 2.0 110.594 178.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -126.17 -41.03 1.95 Allowed 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.444 -0.344 . . . . 2.09 111.736 -179.552 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . 109.59 75.82 0.87 Allowed Glycine 0 CA--C 1.521 0.454 0 C-N-CA 120.737 -0.744 . . . . 1.42 113.196 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.261 0 CA-C-O 118.473 -1.181 . . . . 1.86 113.195 179.777 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.477 0 CA-C-O 120.971 0.415 . . . . 0.65 110.65 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -135.38 9.83 3.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.296 -0.411 . . . . 0.86 111.688 -178.61 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 19' ' ' LEU . . . . . 0.567 HD13 ' HA ' ' A' ' 216' ' ' LEU . 30.5 tp -58.36 110.24 2.44 Favored Pre-proline 0 CA--C 1.535 0.386 0 CA-C-O 121.054 0.454 . . . . 0.7 112.168 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 20' ' ' PRO . . . . . 0.775 ' HG2' ' HG2' ' B' ' 22' ' ' GLU . 95.2 Cg_endo -91.52 151.02 3.55 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 123.176 2.584 . . . . 0.43 113.149 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 21' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' B' ' 20' ' ' PRO . 12.5 Cg_exo -70.59 27.5 0.2 Allowed 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 123.242 2.628 . . . . 0.65 113.625 -179.646 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 22' ' ' GLU . . . . . 0.775 ' HG2' ' HG2' ' B' ' 20' ' ' PRO . 6.6 pt-20 -88.96 -17.17 30.04 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.608 -0.269 . . . . 0.44 111.317 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 23' ' ' PHE . . . . . 0.488 ' HA ' ' SD ' ' A' ' 212' ' ' MET . 0.7 OUTLIER -55.64 -40.05 71.68 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 112.566 0.58 . . . . 0.34 112.566 -179.194 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 24' ' ' ALA . . . . . 0.428 ' N ' ' HD1' ' B' ' 23' ' ' PHE . . . -68.97 -46.16 68.83 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.969 0.414 . . . . 0.4 111.049 -179.648 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 25' ' ' ALA . . . . . 0.546 ' O ' ' HG2' ' B' ' 29' ' ' LYS . . . -64.05 -52.84 57.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.005 -0.543 . . . . 0.4 110.806 179.319 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -55.19 -54.65 40.67 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 115.375 -0.829 . . . . 0.43 112.102 -179.394 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 45.3 mt -63.2 -29.4 70.75 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 120.957 -0.297 . . . . 0.34 111.638 -179.636 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 28' ' ' ARG . . . . . . . . . . . . . 4.4 tmt_? -70.93 -57.21 4.8 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 120.896 0.379 . . . . 0.86 110.503 178.523 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 29' ' ' LYS . . . . . 0.546 ' HG2' ' O ' ' B' ' 25' ' ' ALA . 10.4 ptmt -61.79 -42.39 98.94 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 116.397 -0.365 . . . . 0.89 111.901 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 88.3 mt -64.79 -41.51 92.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.181 0 N-CA-C 109.831 -0.433 . . . . 0.4 109.831 179.358 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 31' ' ' GLY . . . . . 0.535 ' HA3' ' HG2' ' A' ' 244' ' ' ARG . . . -59.76 -49.22 80.92 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.956 -0.64 . . . . 0.28 112.017 178.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 36.9 m-20 -66.6 -34.72 78.52 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.642 0.221 . . . . 0.37 110.876 178.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 33' ' ' LYS . . . . . 0.417 ' O ' ' HE3' ' B' ' 33' ' ' LYS . 0.0 OUTLIER -65.46 -47.62 75.51 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.791 0.329 . . . . 0.55 110.128 178.169 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 42.4 t -61.37 -48.87 86.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 CA-C-O 121.067 0.461 . . . . 0.41 109.775 178.332 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 35' ' ' TYR . . . . . 0.468 ' HB2' ' H ' ' A' ' 243' ' ' GLY . 0.6 OUTLIER -55.58 -38.3 69.21 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 115.63 -0.714 . . . . 0.73 109.999 178.088 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 36' ' ' CYS . . . . . . . . . . . . . 52.1 t -65.56 -46.14 80.64 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-N 116.012 -0.54 . . . . 1.24 110.996 178.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 97.0 m -62.33 -35.86 80.39 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 112.861 0.689 . . . . 0.45 112.861 -179.463 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 38' ' ' TRP . . . . . . . . . . . . . 96.8 m95 -86.86 -25.43 24.5 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 112.767 0.654 . . . . 0.64 112.767 -178.736 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 39' ' ' SER . . . . . 0.405 ' HB2' ' CZ ' ' A' ' 299' ' ' PHE . 14.7 t -93.6 -56.36 2.94 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.007 0.432 . . . . 0.61 111.286 179.079 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -92.27 157.38 40.71 Favored Pre-proline 0 CA--C 1.538 0.493 0 CA-C-N 116.171 -0.468 . . . . 0.5 111.732 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -75.7 83.13 1.98 Allowed 'Trans proline' 0 CA--C 1.538 0.687 0 C-N-CA 122.35 2.033 . . . . 0.76 112.69 178.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -71.08 74.78 0.66 Allowed 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 116.185 -0.462 . . . . 0.95 111.797 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 43' ' ' MET . . . . . . . . . . . . . 85.1 mtp . . . . . 0 C--O 1.251 1.167 0 CA-C-O 118.327 -0.844 . . . . 3.23 111.668 179.838 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.24 0 N-CA-C 112.611 -0.196 . . . . 0.74 112.611 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -73.04 -22.1 19.87 Favored 'Trans proline' 0 CA--C 1.532 0.42 0 C-N-CA 122.564 2.176 . . . . 0.89 113.256 179.749 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 93.9 mt -116.52 -54.16 2.47 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.799 0.333 . . . . 1.96 111.314 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -127.02 -131.32 3.49 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.373 -0.918 . . . . 0.63 112.281 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 56.1 p -111.33 -46.03 3.34 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.109 0.48 . . . . 0.52 111.075 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -140.15 -20.81 0.87 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.884 -0.598 . . . . 0.45 111.041 -179.653 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -51.77 -50.4 60.74 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.764 -0.653 . . . . 0.53 111.536 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -57.84 -46.53 84.63 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 121.036 0.446 . . . . 0.43 110.951 179.394 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.653 HD21 ' HB3' ' A' ' 287' ' ' LEU . 13.9 tp -62.83 -46.41 88.07 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.99 -0.55 . . . . 0.85 111.133 178.701 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 44.5 t80 -66.71 -40.6 88.52 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.167 -0.469 . . . . 0.4 111.767 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.614 ' HD2' ' OE1' ' A' ' 182' ' ' GLU . 32.4 mtm180 -59.75 -46.75 88.18 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.81 0.338 . . . . 0.49 111.416 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 158' ' ' GLN . . . . . 0.43 ' HA ' ' HB2' ' A' ' 183' ' ' ALA . 51.1 mt-30 -70.45 -35.81 73.55 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.756 0.312 . . . . 0.82 110.585 179.536 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 51.9 m -65.04 -45.85 83.72 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.481 -0.327 . . . . 0.29 110.138 178.675 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.774 ' HA ' HG21 ' A' ' 276' ' ' THR . 2.1 tm? -53.64 -55.29 27.23 Favored 'General case' 0 C--O 1.225 -0.186 0 CA-C-N 116.026 -0.534 . . . . 0.45 110.572 178.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -55.13 -43.61 74.3 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 112.271 0.471 . . . . 1.18 112.271 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' ILE . . . . . 0.508 HG23 HD22 ' A' ' 191' ' ' LEU . 90.6 mt -69.18 -53.46 25.43 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 N-CA-C 112.394 0.516 . . . . 0.31 112.394 -179.313 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.542 HD12 HG23 ' A' ' 276' ' ' THR . 68.2 mt -66.12 -47.77 83.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 N-CA-C 112.017 0.377 . . . . 0.35 112.017 -179.39 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 3.5 t -58.34 -44.55 88.76 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.644 0.259 . . . . 0.27 111.226 -179.449 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' ARG . . . . . 0.576 ' NH2' ' HG ' ' A' ' 180' ' ' LEU . 21.4 ttm180 -66.69 -49.48 65.97 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 120.296 -0.562 . . . . 0.55 110.506 178.575 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 166' ' ' TYR . . . . . 0.995 ' HE1' ' HA ' ' A' ' 195' ' ' ARG . 93.5 t80 -55.41 -52.47 63.45 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 112.601 0.593 . . . . 0.39 112.601 -179.672 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 5.0 mp -60.74 -45.7 93.3 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 120.834 -0.346 . . . . 0.48 111.833 -179.081 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 168' ' ' ARG . . . . . 0.538 ' HD2' ' OE1' ' A' ' 269' ' ' GLU . 0.0 OUTLIER -65.36 -37.18 86.26 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.665 0.269 . . . . 0.37 110.924 179.679 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 169' ' ' GLU . . . . . 0.751 ' HG3' ' HA ' ' A' ' 175' ' ' LYS . 19.7 tt0 -58.22 -53.9 53.02 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.056 -0.52 . . . . 0.44 110.473 178.724 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 170' ' ' GLN . . . . . 0.763 ' HB3' ' HE3' ' A' ' 257' ' ' LYS . 2.2 mt-30 -67.19 -39.9 86.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.026 -0.533 . . . . 0.45 111.093 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.47 ' HB2' ' HB1' ' A' ' 256' ' ' ALA . . . -59.46 -55.75 30.71 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.833 0.349 . . . . 0.37 111.711 179.414 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 44.9 p -68.0 -36.38 79.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.446 . . . . 0.63 112.11 -179.411 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 100.2 25.29 8.98 Favored Glycine 0 CA--C 1.519 0.313 0 C-N-CA 120.66 -0.781 . . . . 0.7 112.725 179.721 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 47.0 t -146.63 125.37 12.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.236 0.541 . . . . 1.0 111.404 179.812 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 175' ' ' LYS . . . . . 0.852 ' HD3' ' H ' ' A' ' 175' ' ' LYS . 0.0 OUTLIER -69.86 149.05 48.28 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 115.52 -0.764 . . . . 0.77 112.338 179.889 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 176' ' ' ASP . . . . . 0.495 ' CG ' ' HZ2' ' A' ' 178' ' ' LYS . 8.6 t70 -110.88 109.88 20.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.096 0.474 . . . . 0.64 111.055 178.894 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 82.6 p -104.07 26.13 9.14 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.921 -0.581 . . . . 1.07 111.721 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 178' ' ' LYS . . . . . 0.495 ' HZ2' ' CG ' ' A' ' 176' ' ' ASP . 0.0 OUTLIER -97.01 154.25 38.26 Favored Pre-proline 0 C--N 1.33 -0.252 0 O-C-N 122.33 -0.231 . . . . 0.83 110.54 179.338 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -59.62 146.59 94.88 Favored 'Trans proline' 0 CA--C 1.533 0.466 0 C-N-CA 122.404 2.069 . . . . 0.54 113.222 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.576 ' HG ' ' NH2' ' A' ' 165' ' ' ARG . 3.4 mp -95.86 177.62 5.71 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 116.059 -0.519 . . . . 0.53 110.571 179.128 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -81.24 -67.67 1.52 Allowed Glycine 0 CA--C 1.523 0.555 0 C-N-CA 120.681 -0.771 . . . . 0.63 113.176 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 182' ' ' GLU . . . . . 0.614 ' OE1' ' HD2' ' A' ' 157' ' ' ARG . 31.8 mt-10 -113.12 -24.37 9.48 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 120.834 0.35 . . . . 1.1 111.408 -179.539 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.643 ' O ' ' HA3' ' A' ' 187' ' ' GLY . . . -87.56 59.75 5.63 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 121.096 0.474 . . . . 0.43 111.611 179.477 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -80.41 -71.54 1.27 Allowed Glycine 0 CA--C 1.527 0.808 0 C-N-CA 120.67 -0.776 . . . . 0.42 113.527 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -64.05 -55.78 19.72 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 120.992 0.425 . . . . 0.53 111.264 -179.671 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -65.65 -34.55 78.48 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.934 -0.576 . . . . 0.52 110.261 178.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 187' ' ' GLY . . . . . 0.643 ' HA3' ' O ' ' A' ' 183' ' ' ALA . . . -65.39 -47.91 74.33 Favored Glycine 0 C--O 1.217 -0.945 0 C-N-CA 121.068 -0.587 . . . . 0.41 112.723 179.702 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 4.8 tmm_? -60.37 -48.65 80.84 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-N 117.349 0.574 . . . . 0.73 111.314 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 189' ' ' ARG . . . . . 0.469 ' HG2' HG21 ' A' ' 297' ' ' VAL . 3.9 ttp180 -63.02 -46.29 88.3 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 120.763 0.316 . . . . 0.57 110.753 -179.827 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.44 ' HA ' ' CG1' ' A' ' 297' ' ' VAL . . . -71.69 -31.15 66.45 Favored 'General case' 0 C--O 1.222 -0.367 0 N-CA-C 112.245 0.461 . . . . 0.32 112.245 -179.576 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 191' ' ' LEU . . . . . 0.552 ' HB2' ' O ' ' A' ' 187' ' ' GLY . 0.2 OUTLIER -62.2 -53.46 54.93 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 120.578 0.228 . . . . 0.6 111.056 -179.752 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -65.11 -42.1 94.29 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.461 -0.336 . . . . 0.69 111.059 179.205 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 193' ' ' THR . . . . . 0.658 HG21 ' HA ' ' A' ' 297' ' ' VAL . 39.3 m -62.57 -47.28 84.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.476 -0.329 . . . . 0.39 110.698 179.4 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 0.479 HD21 HG21 ' A' ' 249' ' ' ILE . 33.6 tp -67.76 -41.24 83.64 Favored 'General case' 0 C--O 1.224 -0.241 0 CA-C-N 116.526 -0.307 . . . . 0.41 111.085 179.658 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 195' ' ' ARG . . . . . 0.995 ' HA ' ' HE1' ' A' ' 166' ' ' TYR . 45.4 ttm180 -60.57 -45.33 94.35 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.783 0.325 . . . . 0.63 111.34 179.215 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 12.7 mtp180 -73.87 -49.48 24.81 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.547 0.573 . . . . 1.59 112.547 -179.086 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 197' ' ' VAL . . . . . 0.621 HG12 HG21 ' A' ' 246' ' ' VAL . 86.6 t -68.86 -38.88 79.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-O 120.923 0.392 . . . . 0.35 111.161 -179.791 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -65.12 -52.77 38.17 Favored Glycine 0 C--N 1.332 0.359 0 C-N-CA 121.14 -0.552 . . . . 0.31 112.895 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -63.19 -31.13 72.2 Favored 'General case' 0 CA--C 1.528 0.099 0 CA-C-N 117.114 0.457 . . . . 0.47 110.258 179.364 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 200' ' ' GLY . . . . . 0.476 ' O ' ' HB2' ' A' ' 204' ' ' ASN . . . -60.65 -53.8 42.35 Favored Glycine 0 C--N 1.336 0.554 0 C-N-CA 120.902 -0.666 . . . . 0.35 111.462 178.014 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 83.3 t -63.54 -41.35 92.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 CA-C-O 121.355 0.598 . . . . 0.35 110.471 178.153 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 202' ' ' GLN . . . . . 0.41 ' HA ' ' CE2' ' A' ' 209' ' ' PHE . 7.4 tt0 -60.73 -51.27 70.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 114.729 -1.123 . . . . 0.71 112.723 -178.897 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 2.8 mmp_? -74.01 -32.58 63.44 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 111.716 0.265 . . . . 0.52 111.716 -179.466 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 204' ' ' ASN . . . . . 0.476 ' HB2' ' O ' ' A' ' 200' ' ' GLY . 8.4 t-20 -68.68 -53.77 20.3 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.049 0.452 . . . . 1.55 110.822 179.477 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 89.0 m-70 -95.18 32.14 1.78 Allowed 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 121.184 0.516 . . . . 0.53 110.853 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 206' ' ' GLU . . . . . 0.504 ' HG2' HE21 ' A' ' 210' ' ' GLN . 10.0 tt0 -59.5 -38.51 81.11 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.581 -0.736 . . . . 0.43 111.675 -179.333 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 42.2 p -59.26 -49.74 76.68 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.154 0.502 . . . . 0.54 110.95 179.409 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -66.59 -44.54 81.91 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.682 -0.69 . . . . 0.41 110.401 178.865 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 209' ' ' PHE . . . . . 0.41 ' CE2' ' HA ' ' A' ' 202' ' ' GLN . 4.8 m-30 -58.46 -44.51 89.28 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.177 -0.465 . . . . 0.45 110.736 179.498 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 210' ' ' GLN . . . . . 0.511 ' HB3' ' NH2' ' A' ' 214' ' ' ARG . 59.6 mt-30 -64.02 -34.73 78.68 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.56 -0.291 . . . . 0.6 110.971 179.446 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 211' ' ' GLY . . . . . 0.495 ' O ' ' HB2' ' A' ' 215' ' ' LYS . . . -60.21 -44.91 96.94 Favored Glycine 0 C--N 1.334 0.454 0 N-CA-C 111.028 -0.829 . . . . 0.37 111.028 178.021 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 212' ' ' MET . . . . . 0.833 ' HG2' ' HA ' ' B' ' 23' ' ' PHE . 1.0 OUTLIER -77.29 -30.68 54.31 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 120.616 0.246 . . . . 0.56 110.581 178.457 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.434 HD22 ' CE2' ' A' ' 254' ' ' PHE . 16.8 tp -59.7 -44.85 93.5 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.197 -0.456 . . . . 0.54 111.026 179.208 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 214' ' ' ARG . . . . . 0.511 ' NH2' ' HB3' ' A' ' 210' ' ' GLN . 68.0 mtm-85 -81.25 -27.47 35.17 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.034 -0.53 . . . . 0.65 110.169 178.574 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 215' ' ' LYS . . . . . 0.495 ' HB2' ' O ' ' A' ' 211' ' ' GLY . 0.7 OUTLIER -66.97 -46.9 73.2 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 115.875 -0.602 . . . . 0.8 110.621 178.443 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.447 HD23 ' HB ' ' A' ' 218' ' ' ILE . 4.6 tp -65.19 120.7 13.19 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 115.901 -0.59 . . . . 0.48 111.354 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -75.03 36.07 0.11 Allowed 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 112.877 0.695 . . . . 1.47 112.877 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 218' ' ' ILE . . . . . 0.956 ' HA ' ' HB3' ' A' ' 223' ' ' ASP . 1.3 tt -61.05 106.55 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-O 121.914 0.864 . . . . 0.41 111.571 -179.766 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -162.1 -50.88 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.28 -0.873 . . . . 0.61 110.462 -179.471 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -99.6 178.38 4.87 Favored 'General case' 0 C--O 1.221 -0.418 0 CA-C-N 116.189 -0.46 . . . . 0.91 111.164 179.602 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 221' ' ' GLU . . . . . 0.43 ' HA ' ' HE1' ' A' ' 267' ' ' PHE . 2.0 mm-40 -49.38 -20.74 0.73 Allowed 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 113.794 1.035 . . . . 0.86 113.794 -179.316 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -67.84 -24.51 74.27 Favored Glycine 0 CA--C 1.534 1.271 0 N-CA-C 114.643 0.617 . . . . 0.34 114.643 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 223' ' ' ASP . . . . . 0.956 ' HB3' ' HA ' ' A' ' 218' ' ' ILE . 9.9 p30 -59.16 -56.06 26.97 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 113.475 0.917 . . . . 0.57 113.475 -177.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.454 HG23 HG21 ' A' ' 274' ' ' THR . 2.6 p -54.27 -39.73 44.67 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-O 120.983 0.42 . . . . 0.44 111.764 179.492 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 30.2 mttp -68.68 -42.99 77.06 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-O 120.935 0.398 . . . . 0.61 110.171 178.863 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 226' ' ' SER . . . . . 0.585 ' O ' HG23 ' A' ' 230' ' ' VAL . 45.3 m -62.03 -43.25 99.23 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.9 -0.591 . . . . 0.44 109.693 178.579 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 227' ' ' PHE . . . . . 0.488 ' O ' ' HG3' ' A' ' 231' ' ' MET . 16.8 t80 -55.96 -42.92 76.98 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 115.731 -0.668 . . . . 0.66 110.447 178.821 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 12.7 p -60.31 -39.56 87.42 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 120.823 0.344 . . . . 0.34 110.368 178.682 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 6.4 mmp_? -67.85 -35.7 79.01 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 116.24 -0.437 . . . . 0.51 110.786 179.455 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 0.585 HG23 ' O ' ' A' ' 226' ' ' SER . 24.3 t -61.96 -52.4 60.95 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 N-CA-C 109.985 -0.376 . . . . 0.35 109.985 178.568 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 231' ' ' MET . . . . . 0.635 ' HE3' HG13 ' A' ' 275' ' ' ILE . 31.5 mtp -56.79 -46.3 81.62 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.726 -0.67 . . . . 0.43 110.866 179.293 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 56.1 t -62.12 -40.29 86.96 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 CA-C-N 116.167 -0.47 . . . . 0.46 110.659 178.87 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 64.7 t-80 -66.65 -43.62 84.1 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 116.557 -0.292 . . . . 0.51 111.203 178.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.445 HG23 ' O ' ' A' ' 230' ' ' VAL . 78.1 t -60.89 -40.4 85.17 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 CA-C-O 120.66 0.267 . . . . 0.34 111.539 179.532 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -101.44 23.51 10.96 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 111.951 0.352 . . . . 0.49 111.951 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 1.9 tmtm? -70.78 -11.73 61.13 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 112.1 0.408 . . . . 1.29 112.1 -179.38 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -83.23 -16.86 44.78 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.662 0.268 . . . . 0.49 111.267 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 91.86 -5.78 79.35 Favored Glycine 0 CA--C 1.524 0.64 0 C-N-CA 120.827 -0.701 . . . . 0.47 113.898 179.273 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 3.1 p -98.04 114.94 36.83 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-O 121.663 0.744 . . . . 0.45 111.87 -179.663 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 99.4 m -94.74 109.44 21.4 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.089 -0.505 . . . . 0.43 111.739 179.48 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 241' ' ' ASN . . . . . 0.554 ' HB2' ' HD2' ' A' ' 244' ' ' ARG . 25.7 m-20 -113.61 139.45 49.01 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.296 -0.411 . . . . 0.46 110.762 179.022 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 242' ' ' TRP . . . . . 0.433 ' CZ3' ' HB2' ' A' ' 296' ' ' PHE . 40.4 m95 -54.54 -42.12 70.53 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.183 -0.462 . . . . 0.47 111.619 -179.375 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -60.16 -33.91 81.9 Favored Glycine 0 C--N 1.333 0.412 0 C-N-CA 120.937 -0.649 . . . . 0.31 112.095 178.691 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 244' ' ' ARG . . . . . 0.554 ' HD2' ' HB2' ' A' ' 241' ' ' ASN . 23.6 mtt180 -70.73 -44.96 65.77 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.163 0.506 . . . . 0.32 109.638 178.687 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 245' ' ' ILE . . . . . 0.448 ' O ' HG13 ' A' ' 249' ' ' ILE . 74.2 mt -61.84 -50.08 81.64 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 115.412 -0.813 . . . . 0.51 111.491 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 246' ' ' VAL . . . . . 0.621 HG21 HG12 ' A' ' 197' ' ' VAL . 8.5 p -65.4 -32.71 59.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 120.814 -0.354 . . . . 0.4 111.36 -179.564 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 82.8 m -66.14 -34.47 78.12 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.467 0.651 . . . . 0.37 109.261 177.878 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 248' ' ' LEU . . . . . 0.445 HD21 ' HG2' ' A' ' 231' ' ' MET . 33.7 tp -73.23 -45.33 56.64 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 115.43 -0.804 . . . . 1.23 110.426 178.199 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 249' ' ' ILE . . . . . 0.479 HG21 HD21 ' A' ' 194' ' ' LEU . 23.5 mt -63.13 -44.18 99.3 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 CA-C-N 116.506 -0.316 . . . . 0.34 110.886 179.143 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 12.6 p -61.98 -36.17 80.66 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.277 0.561 . . . . 0.44 109.572 178.096 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 251' ' ' PHE . . . . . 0.431 ' O ' HG23 ' A' ' 255' ' ' VAL . 48.8 t80 -66.27 -41.34 90.04 Favored 'General case' 0 C--O 1.227 -0.122 0 CA-C-N 115.514 -0.767 . . . . 0.46 109.411 177.721 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -57.85 -49.23 76.37 Favored Glycine 0 C--N 1.335 0.5 0 N-CA-C 111.203 -0.759 . . . . 0.24 111.203 178.133 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -59.13 -43.03 91.94 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 120.68 0.276 . . . . 0.32 110.692 177.862 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 254' ' ' PHE . . . . . 0.434 ' CE2' HD22 ' A' ' 213' ' ' LEU . 7.1 t80 -63.01 -43.99 97.21 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 121.071 0.462 . . . . 0.7 110.787 179.011 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 255' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 251' ' ' PHE . 72.7 t -62.96 -46.46 96.25 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 N-CA-C 109.383 -0.599 . . . . 0.39 109.383 177.798 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 256' ' ' ALA . . . . . 0.47 ' HB1' ' HB2' ' A' ' 171' ' ' ALA . . . -59.13 -37.84 78.21 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.081 -0.509 . . . . 0.29 110.078 177.88 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 257' ' ' LYS . . . . . 0.763 ' HE3' ' HB3' ' A' ' 170' ' ' GLN . 81.0 mttt -59.04 -45.79 89.87 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 109.468 -0.567 . . . . 0.51 109.468 177.364 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 258' ' ' HIS . . . . . 0.429 ' HB2' HD21 ' A' ' 213' ' ' LEU . 80.3 t60 -61.06 -46.32 91.15 Favored 'General case' 0 C--O 1.228 -0.033 0 CA-C-N 115.4 -0.818 . . . . 0.59 109.632 178.38 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.83 HD11 HG12 ' A' ' 218' ' ' ILE . 8.8 mp -59.82 -42.52 93.69 Favored 'General case' 0 C--O 1.221 -0.401 0 CA-C-N 115.968 -0.56 . . . . 0.51 110.316 178.928 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 2.2 tptp -64.15 -35.91 82.31 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.992 0.425 . . . . 0.53 110.419 178.762 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 21.2 m -69.78 -31.97 70.19 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.775 -0.648 . . . . 0.55 111.094 179.355 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 33.6 m -101.03 10.56 7.66 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 CA-C-O 120.796 0.331 . . . . 0.61 111.425 179.112 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 16.4 m120 59.16 47.92 11.13 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 113.123 0.786 . . . . 0.6 113.123 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 264' ' ' GLN . . . . . 0.572 ' HB3' ' HG ' ' A' ' 259' ' ' LEU . 17.7 tt0 -106.77 36.85 2.5 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.198 0.523 . . . . 0.6 110.31 179.044 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 265' ' ' GLU . . . . . 0.511 ' HA ' HD12 ' A' ' 268' ' ' ILE . 0.0 OUTLIER -54.33 -27.7 37.64 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 115.735 -0.666 . . . . 0.48 111.556 179.814 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 26.1 p -58.45 -26.36 63.26 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 115.785 -0.643 . . . . 0.66 110.941 178.795 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 267' ' ' PHE . . . . . 0.43 ' HE1' ' HA ' ' A' ' 221' ' ' GLU . 70.0 m-85 -108.52 -11.4 15.14 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.197 -0.456 . . . . 0.75 110.917 178.859 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 268' ' ' ILE . . . . . 0.511 HD12 ' HA ' ' A' ' 265' ' ' GLU . 53.1 mt -66.62 -51.15 59.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 CA-C-O 120.776 0.322 . . . . 0.45 110.791 179.381 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 269' ' ' GLU . . . . . 0.728 ' HB2' ' HD3' ' A' ' 270' ' ' PRO . 55.2 mm-40 -58.78 -54.7 53.71 Favored Pre-proline 0 CA--C 1.541 0.629 0 CA-C-N 116.186 -0.461 . . . . 0.49 111.178 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 270' ' ' PRO . . . . . 0.728 ' HD3' ' HB2' ' A' ' 269' ' ' GLU . 32.1 Cg_exo -60.73 -32.51 93.13 Favored 'Trans proline' 0 C--N 1.359 1.108 0 C-N-CA 122.086 1.858 . . . . 0.35 112.76 178.818 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 271' ' ' LEU . . . . . . . . . . . . . 29.4 tp -63.2 -46.09 88.68 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 120.531 0.205 . . . . 0.68 111.394 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -61.58 -40.99 96.75 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.13 0.49 . . . . 0.32 111.248 179.779 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 273' ' ' GLU . . . . . 0.457 ' HG2' ' O ' ' A' ' 269' ' ' GLU . 4.4 mm-40 -72.27 -33.74 67.69 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.195 0.522 . . . . 0.42 109.822 179.103 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 274' ' ' THR . . . . . 0.454 HG21 HG23 ' A' ' 224' ' ' VAL . 87.3 m -66.84 -51.92 49.86 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.99 -0.55 . . . . 0.34 110.952 178.668 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 275' ' ' ILE . . . . . 0.635 HG13 ' HE3' ' A' ' 231' ' ' MET . 14.4 tt -59.52 -36.51 65.17 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-O 120.682 0.277 . . . . 0.42 110.621 179.447 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 276' ' ' THR . . . . . 0.774 HG21 ' HA ' ' A' ' 160' ' ' LEU . 38.2 m -67.82 -49.68 60.96 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 120.786 0.326 . . . . 0.29 110.383 178.646 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 277' ' ' ASP . . . . . 0.586 ' O ' ' HB2' ' A' ' 281' ' ' ARG . 1.4 t70 -60.41 -54.58 43.94 Favored 'General case' 0 C--O 1.216 -0.671 0 CA-C-N 116.23 -0.441 . . . . 0.34 111.19 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 61.6 t -59.37 -34.08 53.13 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 N-CA-C 112.01 0.374 . . . . 0.41 112.01 -179.621 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 21.4 tp -67.82 -47.58 68.64 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.685 0.279 . . . . 0.69 111.392 179.735 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 39.7 t -78.06 -36.22 21.29 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 CA-C-O 120.864 0.364 . . . . 0.42 111.544 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 281' ' ' ARG . . . . . 0.586 ' HB2' ' O ' ' A' ' 277' ' ' ASP . 1.1 tpp180 -61.68 -41.02 96.99 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 122.921 0.488 . . . . 0.37 112.308 -179.434 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 282' ' ' THR . . . . . . . . . . . . . 74.5 p -90.78 -1.69 57.84 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 112.823 0.675 . . . . 0.42 112.823 -179.061 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 283' ' ' LYS . . . . . 0.425 ' HB3' HD23 ' A' ' 287' ' ' LEU . 11.0 mtmm -138.72 33.71 2.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.672 0.273 . . . . 0.53 111.409 -179.61 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 34.0 ttm180 -53.16 -58.17 7.95 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 112.449 0.537 . . . . 0.42 112.449 -179.307 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 285' ' ' ASP . . . . . 0.412 ' O ' ' HB2' ' A' ' 289' ' ' LYS . 22.1 t70 -63.33 -42.95 99.0 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 112.179 0.437 . . . . 0.57 112.179 -179.042 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 286' ' ' TRP . . . . . . . . . . . . . 1.5 t90 -64.35 -51.23 64.38 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 112.227 0.454 . . . . 0.49 112.227 -178.869 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 287' ' ' LEU . . . . . 0.653 ' HB3' HD21 ' A' ' 155' ' ' LEU . 1.5 mm? -64.61 -48.18 75.86 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.317 0.488 . . . . 0.54 112.317 -178.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 3.0 p -63.99 -29.77 48.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 N-CA-C 112.007 0.373 . . . . 0.52 112.007 -179.623 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 289' ' ' LYS . . . . . 0.425 ' HB2' ' HE3' ' A' ' 289' ' ' LYS . 12.3 ttmt -76.56 -44.47 34.58 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 112.371 0.508 . . . . 0.8 112.371 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -80.62 28.86 0.32 Allowed 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 113.14 0.793 . . . . 0.56 113.14 -178.347 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 291' ' ' ARG . . . . . 0.472 ' HB3' ' HB3' ' A' ' 294' ' ' ASP . 62.5 mtp180 62.95 9.47 3.76 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 112.522 0.564 . . . . 0.49 112.522 179.572 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 62.22 -130.27 44.07 Favored Glycine 0 CA--C 1.522 0.504 0 CA-C-O 121.307 0.393 . . . . 0.35 113.439 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 293' ' ' TRP . . . . . 0.523 ' O ' HG22 ' A' ' 297' ' ' VAL . 77.5 m95 -61.87 -27.09 68.55 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.672 -0.264 . . . . 0.55 111.475 -179.854 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 294' ' ' ASP . . . . . 0.472 ' HB3' ' HB3' ' A' ' 291' ' ' ARG . 0.5 OUTLIER -58.97 -44.46 91.54 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 120.881 0.372 . . . . 0.42 110.224 178.77 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -75.64 -30.18 58.46 Favored Glycine 0 CA--C 1.522 0.485 0 C-N-CA 120.795 -0.717 . . . . 0.38 111.639 178.423 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 296' ' ' PHE . . . . . 0.553 ' CE1' ' HE2' ' A' ' 300' ' ' PHE . 4.3 t80 -67.02 -47.29 71.87 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 120.821 0.343 . . . . 0.41 110.993 179.274 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 297' ' ' VAL . . . . . 0.658 ' HA ' HG21 ' A' ' 193' ' ' THR . 27.1 m -71.27 -37.41 65.71 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-N 116.44 -0.345 . . . . 0.38 111.567 -179.704 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 298' ' ' GLU . . . . . 0.444 ' HB2' ' O ' ' A' ' 294' ' ' ASP . 1.2 mt-10 -69.56 -27.58 65.25 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.571 -0.286 . . . . 0.45 111.432 179.687 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 299' ' ' PHE . . . . . . . . . . . . . 69.1 t80 -62.53 -43.73 98.09 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.346 -0.388 . . . . 0.6 110.434 178.821 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 300' ' ' PHE . . . . . 0.553 ' HE2' ' CE1' ' A' ' 296' ' ' PHE . 44.7 m-85 -87.13 -34.8 18.96 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 120.827 0.346 . . . . 0.58 111.125 179.664 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 51.5 m80 -110.56 88.81 2.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.506 -0.315 . . . . 0.7 111.16 -179.773 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 1.6 m -62.24 103.64 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 CA-C-O 121.474 0.654 . . . . 1.01 111.289 179.661 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 11.2 mm-40 -76.79 89.25 3.42 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.808 -0.633 . . . . 1.07 111.511 -179.392 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 34.4 t0 -74.8 105.01 5.65 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.508 0.671 . . . . 1.9 111.066 179.658 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 305' ' ' LEU . . . . . 0.468 ' H ' ' HG ' ' A' ' 305' ' ' LEU . 0.8 OUTLIER -106.4 15.2 26.33 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.475 -0.784 . . . . 2.81 110.252 178.75 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -118.55 -43.92 2.68 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.964 -0.562 . . . . 3.14 111.783 -179.288 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . -80.37 -71.41 1.27 Allowed Glycine 0 CA--C 1.522 0.507 0 C-N-CA 120.926 -0.654 . . . . 3.2 113.198 -179.714 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.168 0 CA-C-O 118.378 -1.235 . . . . 5.95 112.81 -179.913 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.814 0 CA-C-O 121.236 0.541 . . . . 1.79 111.065 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 18' ' ' GLU . . . . . 0.657 ' CD ' ' H ' ' B' ' 18' ' ' GLU . 0.0 OUTLIER -79.22 -74.3 0.29 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.238 -0.892 . . . . 1.01 111.374 179.436 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 19' ' ' LEU . . . . . 0.508 HD23 ' HD2' ' B' ' 20' ' ' PRO . 4.1 mt -93.32 117.11 67.33 Favored Pre-proline 0 CA--C 1.53 0.182 0 CA-C-O 120.99 0.424 . . . . 0.92 111.26 179.734 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 20' ' ' PRO . . . . . 0.508 ' HD2' HD23 ' B' ' 19' ' ' LEU . 79.5 Cg_endo -75.17 161.46 38.22 Favored 'Trans proline' 0 CA--C 1.532 0.39 0 C-N-CA 122.775 2.317 . . . . 0.73 112.08 179.348 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 21' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.63 22.87 0.2 Allowed 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 122.531 2.154 . . . . 0.73 112.954 179.395 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 22' ' ' GLU . . . . . 0.469 ' H ' ' C ' ' B' ' 20' ' ' PRO . 1.3 tt0 -60.64 -45.66 93.24 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 123.527 0.731 . . . . 0.7 111.259 -179.709 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 23' ' ' PHE . . . . . 0.833 ' HA ' ' HG2' ' A' ' 212' ' ' MET . 3.5 p90 -62.41 -35.9 80.67 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 116.323 -0.399 . . . . 0.49 111.465 179.797 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -76.51 -45.3 31.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.792 0.329 . . . . 0.39 110.808 179.646 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.22 -45.8 87.02 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.244 -0.435 . . . . 0.35 110.569 178.579 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 26' ' ' GLN . . . . . 0.444 ' NE2' ' HG2' ' B' ' 22' ' ' GLU . 1.3 mp0 -61.32 -47.71 84.68 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 115.755 -0.657 . . . . 0.43 110.218 178.92 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 15.7 mt -58.22 -39.28 78.63 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.137 -0.483 . . . . 0.42 110.803 178.817 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 28' ' ' ARG . . . . . . . . . . . . . 1.1 ttp180 -61.32 -50.35 73.34 Favored 'General case' 0 N--CA 1.462 0.136 0 N-CA-C 109.896 -0.409 . . . . 1.02 109.896 178.625 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 83.6 mttt -56.26 -49.62 73.68 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 116.06 -0.518 . . . . 0.75 110.84 179.198 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 62.3 mt -62.41 -41.89 93.5 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 CA-C-N 116.297 -0.41 . . . . 0.45 110.4 179.377 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 31' ' ' GLY . . . . . 0.436 ' HA3' ' HA ' ' A' ' 244' ' ' ARG . . . -60.17 -49.56 77.26 Favored Glycine 0 CA--C 1.522 0.481 0 C-N-CA 120.768 -0.729 . . . . 0.27 112.123 179.043 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 57.9 m-20 -60.19 -44.58 94.98 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.098 0.475 . . . . 0.98 110.028 178.861 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 15.0 tppt? -62.01 -51.27 68.7 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 115.672 -0.695 . . . . 0.84 111.005 179.347 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 38.9 t -57.49 -41.66 79.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-O 120.785 0.326 . . . . 0.4 110.973 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -62.73 -43.84 97.77 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 120.984 0.421 . . . . 0.75 109.919 178.381 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 36' ' ' CYS . . . . . . . . . . . . . 55.7 m -66.13 -42.73 88.75 Favored 'General case' 0 C--O 1.224 -0.248 0 CA-C-N 116.095 -0.502 . . . . 1.34 111.248 179.094 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 98.6 m -61.78 -39.93 93.39 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 112.436 0.532 . . . . 0.5 112.436 179.77 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 38' ' ' TRP . . . . . . . . . . . . . 70.3 m95 -77.72 -29.03 51.04 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 112.562 0.578 . . . . 0.64 112.562 -179.29 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 37.1 p -87.54 -67.66 0.81 Allowed 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 120.943 0.401 . . . . 0.5 111.437 179.504 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 40' ' ' ALA . . . . . 0.448 ' HB1' ' HD2' ' B' ' 41' ' ' PRO . . . -90.86 161.12 36.67 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 116.085 -0.507 . . . . 0.5 111.165 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 41' ' ' PRO . . . . . 0.448 ' HD2' ' HB1' ' B' ' 40' ' ' ALA . 56.9 Cg_endo -71.64 58.07 2.51 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 122.44 2.094 . . . . 0.78 112.813 179.215 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -103.02 159.23 15.7 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 116.106 -0.497 . . . . 0.65 110.962 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 43' ' ' MET . . . . . . . . . . . . . 66.7 mtt . . . . . 0 C--O 1.251 1.138 0 CA-C-O 118.404 -0.808 . . . . 1.65 110.53 179.814 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.447 0 CA-C-O 119.907 -0.385 . . . . 2.33 112.41 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -74.13 62.86 5.12 Favored 'Trans proline' 0 CA--C 1.535 0.53 0 C-N-CA 122.763 2.309 . . . . 2.27 113.041 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 73.9 mt -93.75 112.03 23.83 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.231 -0.441 . . . . 2.31 111.165 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 115.83 77.89 0.71 Allowed Glycine 0 CA--C 1.52 0.346 0 C-N-CA 120.697 -0.763 . . . . 0.71 112.839 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 35.0 t -178.17 -62.58 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.815 0.34 . . . . 0.8 110.775 -179.657 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -60.66 -51.61 68.63 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.2 -0.454 . . . . 0.55 111.827 -179.429 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' ASP . . . . . 0.471 ' O ' ' HG3' ' A' ' 157' ' ' ARG . 15.4 t70 -58.11 -48.25 80.77 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 111.591 0.219 . . . . 0.72 111.591 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.433 ' HA ' ' CZ ' ' A' ' 157' ' ' ARG . 17.8 m-20 -57.23 -49.09 77.12 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.684 0.278 . . . . 0.56 111.309 179.703 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 49.8 tp -66.22 -36.63 83.53 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 121.192 0.52 . . . . 0.88 109.911 178.458 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 76.4 t80 -63.78 -46.29 85.91 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.52 -0.763 . . . . 0.48 111.607 179.626 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.471 ' HG3' ' O ' ' A' ' 153' ' ' ASP . 79.1 mtm-85 -58.0 -44.94 87.5 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.665 0.269 . . . . 0.6 110.442 179.419 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 158' ' ' GLN . . . . . 0.416 ' HG3' ' O ' ' A' ' 154' ' ' ASP . 38.0 mt-30 -64.62 -42.73 95.31 Favored 'General case' 0 CA--C 1.529 0.141 0 N-CA-C 109.862 -0.422 . . . . 1.25 109.862 178.243 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 50.9 m -58.54 -53.03 62.93 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.892 -0.594 . . . . 0.27 111.282 179.455 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 24.4 tp -61.82 -44.48 96.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.27 -0.423 . . . . 0.54 111.131 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -60.87 -53.47 56.9 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.607 0.241 . . . . 0.42 110.772 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 77.5 mt -56.85 -50.8 73.96 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 CA-C-N 116.32 -0.4 . . . . 0.33 111.162 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.678 ' O ' ' HG ' ' A' ' 167' ' ' LEU . 63.0 mt -62.23 -51.31 73.9 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-N 116.701 -0.227 . . . . 0.33 111.394 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 29.3 t -56.62 -46.12 81.14 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 120.763 0.316 . . . . 0.32 111.063 179.423 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' ARG . . . . . 0.726 ' O ' ' HG2' ' A' ' 169' ' ' GLU . 6.6 mmm180 -67.59 -44.09 78.98 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.615 -0.266 . . . . 0.34 111.255 179.66 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 166' ' ' TYR . . . . . 0.979 ' HE1' ' HA ' ' A' ' 195' ' ' ARG . 49.3 t80 -59.3 -51.21 70.94 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 111.74 0.274 . . . . 0.44 111.74 -179.76 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.678 ' HG ' ' O ' ' A' ' 163' ' ' ILE . 20.3 mt -62.79 -38.27 89.98 Favored 'General case' 0 N--CA 1.462 0.161 0 N-CA-C 109.662 -0.496 . . . . 0.34 109.662 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 16.9 ttm180 -58.57 -41.34 85.44 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.805 -0.634 . . . . 0.31 111.529 179.308 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 169' ' ' GLU . . . . . 0.726 ' HG2' ' O ' ' A' ' 165' ' ' ARG . 4.2 mm-40 -67.91 -53.9 22.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.577 -0.283 . . . . 0.44 110.929 179.679 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.61 -36.9 77.22 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 120.754 0.311 . . . . 0.56 111.672 179.594 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.442 ' HA ' ' HD2' ' A' ' 257' ' ' LYS . . . -70.86 -44.41 66.43 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 112.268 0.469 . . . . 0.4 112.268 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 37.9 p -77.92 -40.61 39.16 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 111.808 0.299 . . . . 0.52 111.808 -179.697 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 128.16 3.68 5.7 Favored Glycine 0 CA--C 1.524 0.626 0 C-N-CA 120.569 -0.824 . . . . 0.62 113.354 -179.453 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 174' ' ' SER . . . . . 0.666 ' HB2' ' HB3' ' A' ' 169' ' ' GLU . 0.9 OUTLIER -59.96 116.43 4.14 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 117.08 0.44 . . . . 0.62 111.118 179.447 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 175' ' ' LYS . . . . . 0.434 ' O ' ' HD2' ' A' ' 175' ' ' LYS . 0.8 OUTLIER -76.49 -33.81 58.64 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.054 -0.521 . . . . 1.2 111.699 -179.478 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -129.98 166.07 20.83 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.128 0.49 . . . . 0.63 112.142 -178.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 177' ' ' SER . . . . . 0.671 ' HB2' HH22 ' A' ' 195' ' ' ARG . 0.4 OUTLIER -175.33 121.0 0.2 Allowed 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 115.283 -0.871 . . . . 0.39 110.196 179.152 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 178' ' ' LYS . . . . . 0.458 ' H ' ' HD2' ' A' ' 179' ' ' PRO . 14.1 mptt -117.39 -44.62 0.05 OUTLIER Pre-proline 0 CA--C 1.549 0.928 0 N-CA-C 113.62 0.97 . . . . 0.5 113.62 -178.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 179' ' ' PRO . . . . . 0.458 ' HD2' ' H ' ' A' ' 178' ' ' LYS . 94.3 Cg_endo -86.86 152.94 8.57 Favored 'Trans proline' 0 C--N 1.358 1.035 0 C-N-CA 121.868 1.712 . . . . 0.56 114.546 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 1.2 mp -141.9 -173.09 3.71 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 115.954 -0.566 . . . . 0.49 110.423 179.322 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -81.98 -73.15 1.22 Allowed Glycine 0 CA--C 1.521 0.438 0 C-N-CA 120.765 -0.731 . . . . 0.56 112.447 179.529 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 46.1 tt0 -105.81 -33.55 7.95 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.21 0.529 . . . . 0.83 109.838 179.142 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.572 ' O ' ' HA3' ' A' ' 187' ' ' GLY . . . -84.65 68.69 10.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.225 0.536 . . . . 0.44 110.889 179.554 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -76.59 -70.14 1.32 Allowed Glycine 0 CA--C 1.524 0.6 0 C-N-CA 120.822 -0.704 . . . . 0.45 113.683 -179.624 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -66.09 -55.4 16.69 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.049 0.452 . . . . 0.48 111.95 -179.335 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -65.91 -39.11 90.26 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 116.134 -0.485 . . . . 0.41 110.563 179.309 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 187' ' ' GLY . . . . . 0.572 ' HA3' ' O ' ' A' ' 183' ' ' ALA . . . -66.37 -33.11 83.91 Favored Glycine 0 C--O 1.224 -0.469 0 C-N-CA 121.126 -0.559 . . . . 0.35 112.727 179.792 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 35.5 ttm180 -67.27 -50.97 58.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.768 0.318 . . . . 0.59 110.27 178.553 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 189' ' ' ARG . . . . . 0.703 ' HB3' HG11 ' A' ' 297' ' ' VAL . 49.9 mtm180 -64.18 -36.05 82.81 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.445 -0.343 . . . . 0.62 110.419 179.139 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.413 ' HA ' HG22 ' A' ' 297' ' ' VAL . . . -70.97 -48.74 51.6 Favored 'General case' 0 C--O 1.216 -0.69 0 CA-C-N 116.093 -0.503 . . . . 0.31 111.435 179.356 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 191' ' ' LEU . . . . . 0.539 ' HB2' ' O ' ' A' ' 187' ' ' GLY . 0.2 OUTLIER -57.58 -51.57 68.93 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 120.711 0.291 . . . . 0.44 111.453 -179.899 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -59.57 -47.38 85.79 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.2 -0.455 . . . . 0.42 111.695 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 58.4 m -66.5 -48.34 70.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.869 0.366 . . . . 0.38 110.748 179.67 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 0.41 HD21 HG21 ' A' ' 249' ' ' ILE . 25.1 tp -60.63 -36.88 79.75 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.867 -0.606 . . . . 0.35 111.371 179.564 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 195' ' ' ARG . . . . . 0.979 ' HA ' ' HE1' ' A' ' 166' ' ' TYR . 35.4 ttm180 -64.69 -46.87 80.53 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.777 0.322 . . . . 0.47 110.668 178.932 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.76 -52.81 39.92 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.924 -0.58 . . . . 0.58 111.639 -179.774 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 197' ' ' VAL . . . . . 0.537 ' O ' HG23 ' A' ' 201' ' ' VAL . 55.4 t -67.15 -40.42 85.19 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 CA-C-O 120.974 0.416 . . . . 0.41 111.704 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 198' ' ' GLY . . . . . 0.512 ' HA3' ' OH ' ' A' ' 166' ' ' TYR . . . -66.11 -49.87 55.16 Favored Glycine 0 CA--C 1.52 0.387 0 C-N-CA 121.216 -0.516 . . . . 0.3 113.25 -179.628 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 199' ' ' ASP . . . . . 0.419 ' HB2' ' O ' ' A' ' 195' ' ' ARG . 0.8 OUTLIER -63.47 -34.09 76.99 Favored 'General case' 0 N--CA 1.462 0.172 0 N-CA-C 109.749 -0.463 . . . . 0.51 109.749 179.183 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -63.09 -39.77 98.41 Favored Glycine 0 C--N 1.335 0.522 0 C-N-CA 121.179 -0.534 . . . . 0.38 112.366 178.712 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 201' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 197' ' ' VAL . 84.4 t -69.48 -43.13 80.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 CA-C-O 120.694 0.283 . . . . 0.37 110.857 179.078 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 202' ' ' GLN . . . . . 0.573 ' HG3' ' OG ' ' A' ' 250' ' ' SER . 34.2 mt-30 -59.12 -45.07 91.85 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.023 -0.535 . . . . 0.5 111.411 179.588 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 37.3 mtt180 -76.11 -24.68 54.97 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 116.304 -0.407 . . . . 0.62 111.817 179.512 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -78.12 -54.17 6.55 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.848 0.356 . . . . 0.66 111.753 179.362 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 33.6 m-70 -101.0 36.56 1.94 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.747 0.308 . . . . 0.64 110.465 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -55.28 -40.25 70.82 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 112.777 0.658 . . . . 0.6 112.777 -178.825 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 35.1 p -59.64 -53.82 53.62 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.026 0.441 . . . . 0.58 111.511 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -64.03 -42.74 96.99 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.048 -0.524 . . . . 0.46 110.56 178.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 2.3 m-30 -60.1 -48.94 79.61 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 115.963 -0.562 . . . . 0.5 110.958 179.533 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -57.24 -40.96 78.67 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 120.465 0.174 . . . . 0.7 111.449 179.629 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -57.39 -51.79 55.58 Favored Glycine 0 C--N 1.334 0.461 0 C-N-CA 120.507 -0.854 . . . . 0.4 111.513 178.725 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 212' ' ' MET . . . . . 0.486 ' O ' ' HB2' ' A' ' 216' ' ' LEU . 1.8 mpp? -69.76 -30.35 67.91 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 120.792 0.33 . . . . 0.82 110.669 178.894 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.42 HD22 ' HA ' ' A' ' 213' ' ' LEU . 1.6 tm? -61.45 -48.79 79.52 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.047 -0.524 . . . . 0.56 111.082 178.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 214' ' ' ARG . . . . . 0.447 HH11 ' HD3' ' A' ' 214' ' ' ARG . 27.7 mtt180 -69.64 -34.51 74.13 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.207 -0.451 . . . . 1.16 111.483 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 215' ' ' LYS . . . . . 0.435 ' HG3' HD13 ' B' ' 19' ' ' LEU . 72.1 mmtt -80.0 -4.26 51.83 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 120.876 0.37 . . . . 0.9 111.477 179.613 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.512 ' HG ' HG13 ' A' ' 218' ' ' ILE . 1.5 tp -98.7 85.97 3.44 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.178 0.513 . . . . 0.73 111.111 179.567 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -81.82 34.57 0.4 Allowed 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 116.208 -0.451 . . . . 1.01 110.947 179.78 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 218' ' ' ILE . . . . . 0.754 HG12 ' HB3' ' A' ' 223' ' ' ASP . 13.7 mt -45.25 116.4 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 N-CA-C 114.021 1.119 . . . . 0.5 114.021 -178.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 9.0 ptpp? -158.61 -9.81 0.07 Allowed 'General case' 0 CA--C 1.548 0.88 0 CA-C-N 115.083 -0.962 . . . . 0.63 112.595 178.688 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -134.0 175.37 9.53 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 113.547 0.943 . . . . 0.96 113.547 -179.204 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 221' ' ' GLU . . . . . 0.563 ' O ' ' HG2' ' A' ' 225' ' ' LYS . 4.9 mm-40 -58.23 -22.99 54.32 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 114.995 -1.002 . . . . 0.67 113.573 -179.257 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -77.8 -27.08 59.36 Favored Glycine 0 CA--C 1.526 0.739 0 C-N-CA 120.677 -0.773 . . . . 0.49 113.152 179.771 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 223' ' ' ASP . . . . . 0.754 ' HB3' HG12 ' A' ' 218' ' ' ILE . 36.4 m-20 -69.32 -44.14 72.31 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 111.879 0.325 . . . . 0.59 111.879 -179.123 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -62.25 -28.94 45.53 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 CA-C-O 121.022 0.439 . . . . 0.54 110.087 178.433 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 225' ' ' LYS . . . . . 0.563 ' HG2' ' O ' ' A' ' 221' ' ' GLU . 42.3 mmtm -69.3 -35.71 76.27 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 109.511 -0.551 . . . . 0.76 109.511 177.805 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 226' ' ' SER . . . . . 0.666 ' O ' HG23 ' A' ' 230' ' ' VAL . 41.2 t -70.79 -44.62 66.25 Favored 'General case' 0 N--CA 1.463 0.18 0 N-CA-C 109.291 -0.633 . . . . 0.8 109.291 178.024 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 227' ' ' PHE . . . . . 0.564 ' HE2' HG21 ' A' ' 255' ' ' VAL . 10.5 t80 -58.82 -44.43 90.87 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 115.848 -0.615 . . . . 0.61 110.278 178.926 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 5.1 p -70.63 -34.29 71.93 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.123 -0.489 . . . . 0.83 110.3 178.428 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 5.8 ttt180 -63.58 -42.32 98.3 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.296 0.57 . . . . 3.18 110.304 178.048 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 0.897 HG13 ' HA ' ' B' ' 24' ' ' ALA . 43.2 t -65.11 -38.89 83.87 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 N-CA-C 109.774 -0.454 . . . . 0.55 109.774 178.327 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 231' ' ' MET . . . . . 0.797 ' HG3' ' HG ' ' A' ' 248' ' ' LEU . 34.1 ttm -62.86 -51.11 68.28 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 115.896 -0.593 . . . . 0.43 111.79 179.65 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 31.7 m -60.96 -33.08 54.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 C-N-CA 121.053 -0.259 . . . . 0.44 111.593 -179.745 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 4.0 t-80 -67.31 -40.27 85.97 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 109.803 -0.443 . . . . 0.45 109.803 178.139 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.541 HG23 ' O ' ' A' ' 230' ' ' VAL . 59.9 t -53.6 -47.86 60.14 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 CA-C-N 116.116 -0.493 . . . . 0.4 110.523 179.483 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -96.72 23.23 7.21 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.941 -0.572 . . . . 0.6 111.948 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 3.1 tmtm? -66.89 -17.06 64.72 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.878 0.37 . . . . 1.04 111.63 -179.629 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -80.55 -16.16 54.87 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.447 -0.342 . . . . 0.6 111.172 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 97.82 -17.72 58.37 Favored Glycine 0 CA--C 1.522 0.524 0 C-N-CA 120.744 -0.741 . . . . 0.46 113.661 179.323 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 6.8 p -89.63 120.28 38.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-O 121.454 0.645 . . . . 0.42 111.641 -179.617 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 32.8 m -94.34 99.62 11.8 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.006 0.431 . . . . 0.57 111.69 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 241' ' ' ASN . . . . . 0.42 ' HB2' ' HD2' ' A' ' 244' ' ' ARG . 90.4 m-20 -90.3 135.71 33.51 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.591 -0.277 . . . . 0.84 110.434 178.986 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 242' ' ' TRP . . . . . 0.523 ' CZ3' ' HB2' ' A' ' 296' ' ' PHE . 25.9 m95 -58.21 -40.6 82.03 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.823 0.344 . . . . 0.49 111.124 179.561 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 243' ' ' GLY . . . . . 0.51 ' HA3' ' N ' ' B' ' 35' ' ' TYR . . . -61.03 -30.32 73.2 Favored Glycine 0 C--N 1.332 0.359 0 C-N-CA 120.771 -0.728 . . . . 0.37 111.877 178.417 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 244' ' ' ARG . . . . . 0.501 ' HA ' ' HA3' ' B' ' 31' ' ' GLY . 74.3 mtt180 -69.25 -47.9 63.36 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.816 -0.439 . . . . 0.51 109.816 178.416 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 245' ' ' ILE . . . . . 0.464 ' O ' HG13 ' A' ' 249' ' ' ILE . 68.7 mt -59.15 -49.95 81.52 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.12 0 CA-C-N 115.523 -0.762 . . . . 0.43 111.294 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 246' ' ' VAL . . . . . 0.418 HG21 ' CG1' ' A' ' 197' ' ' VAL . 7.3 p -66.13 -28.41 43.66 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 C-N-CA 120.727 -0.389 . . . . 0.42 111.133 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 19.3 m -65.15 -46.08 82.36 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 109.935 -0.395 . . . . 0.4 109.935 178.293 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 248' ' ' LEU . . . . . 0.797 ' HG ' ' HG3' ' A' ' 231' ' ' MET . 3.0 mm? -62.3 -39.58 93.45 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 116.106 -0.497 . . . . 0.51 110.582 178.814 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 249' ' ' ILE . . . . . 0.464 HG13 ' O ' ' A' ' 245' ' ' ILE . 17.6 mt -70.12 -40.96 78.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-O 120.929 0.395 . . . . 0.4 110.079 178.316 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 250' ' ' SER . . . . . 0.573 ' OG ' ' HG3' ' A' ' 202' ' ' GLN . 33.7 t -61.53 -44.89 96.23 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 109.553 -0.536 . . . . 1.04 109.553 178.257 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 251' ' ' PHE . . . . . . . . . . . . . 42.4 t80 -66.23 -38.57 88.2 Favored 'General case' 0 C--O 1.231 0.128 0 N-CA-C 109.097 -0.705 . . . . 0.5 109.097 177.42 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -60.61 -36.29 91.18 Favored Glycine 0 C--N 1.336 0.541 0 N-CA-C 111.199 -0.761 . . . . 0.3 111.199 177.619 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -68.18 -38.32 81.93 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-O 120.909 0.385 . . . . 0.33 110.031 177.708 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -65.13 -40.82 94.99 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 109.458 -0.571 . . . . 1.03 109.458 178.33 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 255' ' ' VAL . . . . . 0.564 HG21 ' HE2' ' A' ' 227' ' ' PHE . 70.1 t -63.59 -44.21 98.5 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 CA-C-N 115.834 -0.621 . . . . 0.38 109.495 177.468 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -59.39 -32.37 70.09 Favored 'General case' 0 C--O 1.226 -0.163 0 CA-C-N 116.381 -0.372 . . . . 0.29 110.137 177.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 257' ' ' LYS . . . . . 0.442 ' HD2' ' HA ' ' A' ' 171' ' ' ALA . 43.5 tptt -63.82 -49.18 73.88 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.071 -0.513 . . . . 0.66 110.433 178.332 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -71.43 -32.59 68.53 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 120.888 0.375 . . . . 0.36 110.143 179.034 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.521 ' HG ' ' HB3' ' A' ' 264' ' ' GLN . 1.6 tp -67.85 -40.21 83.69 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 121.204 0.526 . . . . 0.43 109.744 177.672 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 45.3 tptt -70.65 -27.46 64.06 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.012 -0.54 . . . . 0.37 110.51 178.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 42.1 t -57.34 -28.55 63.23 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.436 -0.347 . . . . 0.55 110.583 178.519 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 16.1 m -113.15 14.78 8.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 CA-C-N 116.006 -0.543 . . . . 0.5 110.168 178.263 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 40.6 t30 54.73 45.07 27.49 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 115.208 -0.906 . . . . 0.44 112.967 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 264' ' ' GLN . . . . . 0.521 ' HB3' ' HG ' ' A' ' 259' ' ' LEU . 1.6 mt-30 -83.73 37.72 0.6 Allowed 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 120.761 0.315 . . . . 0.5 111.363 179.274 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -50.93 -42.15 59.42 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 112.665 0.617 . . . . 0.38 112.665 -179.069 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 1.3 p -62.24 -13.99 33.81 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.32 -0.4 . . . . 0.82 111.615 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 267' ' ' PHE . . . . . 0.489 ' C ' ' HD2' ' A' ' 270' ' ' PRO . 18.3 t80 -110.12 -22.91 11.56 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.347 -0.388 . . . . 0.59 110.372 178.345 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 268' ' ' ILE . . . . . 0.426 HG13 ' O ' ' A' ' 264' ' ' GLN . 72.1 mt -61.51 -46.49 96.47 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-N 116.387 -0.37 . . . . 0.33 110.554 178.712 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 269' ' ' GLU . . . . . 0.736 ' HB2' ' HD3' ' A' ' 270' ' ' PRO . 29.2 mm-40 -57.9 -56.57 33.35 Favored Pre-proline 0 CA--C 1.541 0.62 0 CA-C-N 116.576 -0.284 . . . . 0.34 110.785 178.562 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 270' ' ' PRO . . . . . 0.736 ' HD3' ' HB2' ' A' ' 269' ' ' GLU . 52.4 Cg_exo -57.97 -27.46 79.22 Favored 'Trans proline' 0 C--N 1.365 1.444 0 C-N-CA 122.402 2.068 . . . . 0.33 112.336 177.922 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 271' ' ' LEU . . . . . . . . . . . . . 20.9 tp -68.3 -53.06 26.9 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 108.959 -0.756 . . . . 0.5 108.959 177.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -61.31 -35.75 78.21 Favored 'General case' 0 C--O 1.23 0.075 0 N-CA-C 109.064 -0.717 . . . . 0.3 109.064 177.75 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 273' ' ' GLU . . . . . 0.514 ' HB3' ' HA ' ' A' ' 270' ' ' PRO . 32.4 tt0 -61.88 -48.62 79.69 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 114.939 -1.028 . . . . 1.62 109.852 177.605 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 274' ' ' THR . . . . . . . . . . . . . 89.0 m -62.49 -46.49 88.23 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.964 -0.562 . . . . 0.41 110.422 178.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 95.5 mt -56.59 -54.61 26.64 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-N 116.116 -0.493 . . . . 0.43 110.572 178.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 19.2 m -57.95 -52.4 65.68 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.603 -0.726 . . . . 0.42 111.577 179.797 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 277' ' ' ASP . . . . . 0.409 ' HB2' ' O ' ' A' ' 273' ' ' GLU . 1.0 OUTLIER -51.23 -54.44 25.64 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.072 -0.513 . . . . 0.4 111.482 179.956 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 87.6 t -64.41 -39.29 85.03 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-N 116.381 -0.372 . . . . 0.45 111.804 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 279' ' ' LEU . . . . . 0.465 ' O ' ' HB2' ' A' ' 283' ' ' LYS . 1.0 OUTLIER -67.65 -41.07 84.39 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 120.942 0.401 . . . . 1.1 111.364 -179.926 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 76.2 t -77.08 -46.02 29.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 112.394 0.516 . . . . 0.46 112.394 -179.245 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 67.3 mtp180 -65.6 -35.67 81.5 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 112.997 0.74 . . . . 0.76 112.997 -178.864 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 282' ' ' THR . . . . . . . . . . . . . 60.4 p -83.49 -15.88 47.78 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 122.13 -0.356 . . . . 0.35 111.923 179.797 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 283' ' ' LYS . . . . . 0.603 ' HB3' HD23 ' A' ' 287' ' ' LEU . 0.1 OUTLIER -123.21 39.76 3.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.746 0.307 . . . . 0.63 110.915 179.866 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 33.9 ttm180 -52.36 -61.43 2.28 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 112.666 0.617 . . . . 0.61 112.666 -179.57 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -64.77 -38.87 92.45 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 112.527 0.565 . . . . 0.84 112.527 -179.219 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 286' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -65.44 -41.36 93.56 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.805 0.336 . . . . 0.73 111.817 -179.23 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 287' ' ' LEU . . . . . 0.603 HD23 ' HB3' ' A' ' 283' ' ' LYS . 1.7 mm? -70.0 -41.63 74.09 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.468 0.544 . . . . 0.59 112.468 -179.174 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 20.4 m -67.02 -35.76 75.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 C-N-CA 120.799 -0.36 . . . . 0.53 111.899 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 47.4 mttp -69.99 -39.56 75.82 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 112.677 0.621 . . . . 1.12 112.677 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -89.92 20.17 4.37 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 113.405 0.891 . . . . 0.58 113.405 -178.038 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 291' ' ' ARG . . . . . 0.414 HH11 ' HD2' ' A' ' 291' ' ' ARG . 42.9 mtm180 60.42 15.33 5.42 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 112.916 0.709 . . . . 0.46 112.916 179.441 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 292' ' ' GLY . . . . . 0.478 ' HA2' HD13 ' A' ' 287' ' ' LEU . . . 66.59 -124.42 24.31 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 114.274 0.47 . . . . 0.31 114.274 179.445 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 293' ' ' TRP . . . . . 0.525 ' O ' HG23 ' A' ' 297' ' ' VAL . 89.2 m95 -63.85 -30.37 71.47 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.334 0.494 . . . . 0.38 112.334 -178.809 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 294' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.88 -43.45 94.73 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.836 -0.346 . . . . 0.74 110.623 178.947 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -67.9 -37.89 88.53 Favored Glycine 0 C--N 1.333 0.406 0 C-N-CA 120.56 -0.828 . . . . 0.33 111.073 177.775 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 296' ' ' PHE . . . . . 0.523 ' HB2' ' CZ3' ' A' ' 242' ' ' TRP . 0.3 OUTLIER -62.43 -45.81 91.41 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 120.936 0.398 . . . . 0.46 110.48 178.413 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 297' ' ' VAL . . . . . 0.708 ' O ' ' HB2' ' A' ' 301' ' ' HIS . 80.3 t -63.58 -49.82 80.83 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.23 0 CA-C-N 115.855 -0.611 . . . . 0.34 110.898 179.749 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 71.6 mt-10 -61.96 -45.21 94.65 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.245 -0.434 . . . . 0.53 111.777 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 299' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -60.01 -49.48 77.51 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 120.87 0.367 . . . . 0.55 111.678 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 300' ' ' PHE . . . . . 0.505 ' HB3' HG21 ' A' ' 197' ' ' VAL . 59.3 m-85 -80.3 4.86 16.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.009 0.433 . . . . 0.56 111.3 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 301' ' ' HIS . . . . . 0.708 ' HB2' ' O ' ' A' ' 297' ' ' VAL . 1.6 t-160 -99.91 39.86 1.29 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.293 -0.412 . . . . 0.83 110.692 178.609 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 302' ' ' VAL . . . . . 0.571 ' HB ' ' HA ' ' B' ' 41' ' ' PRO . 6.0 m -80.16 10.9 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 CA-C-N 116.361 -0.381 . . . . 1.24 111.559 179.529 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 303' ' ' GLN . . . . . 0.409 ' HB2' ' H ' ' A' ' 304' ' ' ASP . 1.6 mm-40 -103.48 -84.43 0.47 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.105 0.478 . . . . 1.4 111.187 -179.777 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 304' ' ' ASP . . . . . 0.409 ' H ' ' HB2' ' A' ' 303' ' ' GLN . 3.3 p-10 -85.67 108.22 17.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.394 0.616 . . . . 0.92 111.11 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 76.9 mt -85.01 -55.1 4.23 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.709 -0.678 . . . . 1.66 111.277 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 6.6 mp0 -72.25 -34.22 68.09 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 116.398 -0.365 . . . . 3.29 111.65 179.647 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . 118.75 -147.93 18.42 Favored Glycine 0 CA--C 1.522 0.522 0 C-N-CA 120.777 -0.725 . . . . 3.1 113.227 179.753 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.432 -1.205 . . . . 4.16 113.123 -179.858 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.495 0 CA-C-O 120.444 0.164 . . . . 2.31 110.944 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -139.99 -66.81 0.44 Allowed 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 120.942 0.401 . . . . 1.39 111.026 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 19' ' ' LEU . . . . . 0.435 HD13 ' HG3' ' A' ' 215' ' ' LYS . 64.3 tp -100.91 109.39 57.92 Favored Pre-proline 0 CA--C 1.534 0.365 0 CA-C-O 120.929 0.395 . . . . 1.27 111.317 179.695 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 20' ' ' PRO . . . . . 0.429 ' C ' ' H ' ' B' ' 22' ' ' GLU . 97.9 Cg_endo -79.47 157.05 25.38 Favored 'Trans proline' 0 CA--C 1.534 0.519 0 C-N-CA 122.628 2.218 . . . . 0.84 112.387 179.648 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 21' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -68.8 31.66 0.16 Allowed 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 122.789 2.326 . . . . 0.74 113.482 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 22' ' ' GLU . . . . . 0.464 ' O ' ' HB2' ' B' ' 26' ' ' GLN . 4.8 mm-40 -88.94 -12.57 41.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.268 -0.424 . . . . 0.75 111.407 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 23' ' ' PHE . . . . . . . . . . . . . 10.3 p90 -63.64 -35.39 80.37 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.18 0.515 . . . . 0.62 110.747 179.68 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 24' ' ' ALA . . . . . 0.897 ' HA ' HG13 ' A' ' 230' ' ' VAL . . . -72.11 -43.98 63.91 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.639 -0.71 . . . . 0.42 110.623 179.178 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -69.73 -37.03 76.35 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.147 -0.479 . . . . 0.42 110.532 179.108 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 26' ' ' GLN . . . . . 0.464 ' HB2' ' O ' ' B' ' 22' ' ' GLU . 0.0 OUTLIER -61.73 -54.84 37.07 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 116.481 -0.327 . . . . 0.71 111.174 179.514 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 27' ' ' LEU . . . . . 0.52 HD12 HG11 ' A' ' 230' ' ' VAL . 30.9 mt -58.06 -37.32 74.22 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 120.863 0.363 . . . . 0.63 110.197 178.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 28' ' ' ARG . . . . . 0.528 ' HA ' HG13 ' A' ' 234' ' ' VAL . 4.8 tmt_? -62.6 -53.69 50.81 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 109.26 -0.644 . . . . 1.24 109.26 177.55 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 21.3 mtmt -53.7 -48.95 69.06 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.858 -0.61 . . . . 0.55 110.582 178.686 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 30' ' ' ILE . . . . . 0.444 HG13 ' O ' ' B' ' 26' ' ' GLN . 75.5 mt -59.07 -42.28 85.97 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.202 0 CA-C-N 116.057 -0.52 . . . . 0.41 110.123 179.129 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 31' ' ' GLY . . . . . 0.501 ' HA3' ' HA ' ' A' ' 244' ' ' ARG . . . -58.76 -50.15 70.32 Favored Glycine 0 CA--C 1.521 0.421 0 C-N-CA 120.886 -0.673 . . . . 0.34 112.398 178.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 32' ' ' ASP . . . . . 0.484 ' OD2' ' HD3' ' B' ' 28' ' ' ARG . 9.1 m-20 -61.84 -40.12 94.2 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.14 0.495 . . . . 0.42 110.145 178.948 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 15.6 tppt? -64.0 -53.82 44.01 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 115.74 -0.663 . . . . 1.22 111.101 179.514 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 77.3 t -59.13 -39.03 77.58 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-O 121.067 0.461 . . . . 0.42 110.48 179.315 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 35' ' ' TYR . . . . . 0.51 ' N ' ' HA3' ' A' ' 243' ' ' GLY . 4.0 t80 -60.55 -50.44 73.55 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.898 -0.592 . . . . 0.82 110.467 178.479 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 36' ' ' CYS . . . . . . . . . . . . . 61.5 m -64.25 -25.82 68.23 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.009 0.433 . . . . 0.43 110.983 179.429 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 20.9 m -75.36 -43.14 52.05 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 116.022 -0.536 . . . . 0.44 112.259 -179.59 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 38' ' ' TRP . . . . . . . . . . . . . 97.2 m95 -87.9 -9.78 52.67 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 113.249 0.833 . . . . 0.66 113.249 -178.623 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 38.2 t -73.18 -15.84 61.44 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 111.731 0.271 . . . . 0.67 111.731 179.196 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -91.91 126.66 52.73 Favored Pre-proline 0 CA--C 1.534 0.346 0 CA-C-N 116.555 -0.293 . . . . 0.87 111.673 179.567 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 41' ' ' PRO . . . . . 0.571 ' HA ' ' HB ' ' A' ' 302' ' ' VAL . 73.3 Cg_endo -77.16 65.92 7.83 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 122.452 2.102 . . . . 1.88 112.826 179.492 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -121.37 -170.31 2.01 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 116.253 -0.43 . . . . 2.52 111.559 -179.322 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 43' ' ' MET . . . . . . . . . . . . . 61.7 mtt . . . . . 0 C--O 1.251 1.154 0 CA-C-O 118.149 -0.929 . . . . 4.05 111.939 -179.754 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.773 ' HA3' ' HA ' ' A' ' 153' ' ' ASP . . . . . . . . 0 N--CA 1.487 2.099 0 N-CA-C 112.568 -0.213 . . . . 0.89 112.568 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.498 ' HD2' ' OE1' ' A' ' 152' ' ' GLU . 27.1 Cg_exo -63.44 -39.63 35.67 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 122.883 2.389 . . . . 1.41 113.556 179.666 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -97.81 151.65 19.98 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.84 0.352 . . . . 2.12 111.817 -179.256 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -58.46 -63.11 5.53 Favored Glycine 0 C--N 1.335 0.511 0 C-N-CA 121.15 -0.548 . . . . 1.13 112.288 179.521 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 14.7 p -77.09 52.93 0.92 Allowed 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.449 0.643 . . . . 1.13 110.365 178.724 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.498 ' OE1' ' HD2' ' A' ' 148' ' ' PRO . 8.6 tt0 -164.39 -34.37 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.277 -0.874 . . . . 1.29 110.935 -179.006 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' ASP . . . . . 0.773 ' HA ' ' HA3' ' A' ' 147' ' ' GLY . 33.0 t70 -46.85 -52.72 13.64 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 112.454 0.538 . . . . 0.64 112.454 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.93 -55.54 33.8 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.123 0.487 . . . . 0.83 111.121 179.758 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.477 HD21 ' HB3' ' A' ' 287' ' ' LEU . 26.4 tp -58.63 -42.35 88.09 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.91 -0.587 . . . . 0.54 112.251 179.616 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 68.3 t80 -69.01 -47.04 66.48 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 112.399 0.518 . . . . 0.51 112.399 -179.219 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 60.9 mtp180 -61.21 -40.23 93.22 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 111.744 0.276 . . . . 0.64 111.744 -179.6 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 2.8 mm-40 -68.57 -44.29 74.76 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.891 0.377 . . . . 0.63 110.183 179.14 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 34.1 m -63.69 -49.35 73.47 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.949 -0.568 . . . . 0.32 111.346 179.705 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.51 ' HA ' HG21 ' A' ' 276' ' ' THR . 11.1 tp -55.68 -49.49 72.81 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 111.871 0.323 . . . . 0.47 111.871 -179.797 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 161' ' ' GLU . . . . . 0.724 ' O ' ' HG2' ' A' ' 165' ' ' ARG . 0.0 OUTLIER -58.64 -53.72 55.2 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-O 120.625 0.25 . . . . 0.54 111.152 179.806 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 162' ' ' ILE . . . . . 0.514 HG12 ' HA2' ' A' ' 187' ' ' GLY . 83.3 mt -58.54 -46.95 89.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-N 116.416 -0.356 . . . . 0.33 111.683 -179.711 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.512 HD12 HG23 ' A' ' 276' ' ' THR . 71.7 mt -62.74 -45.51 98.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 CA-C-N 116.446 -0.343 . . . . 0.32 110.716 179.643 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 164' ' ' SER . . . . . 0.536 ' O ' ' HB2' ' A' ' 168' ' ' ARG . 51.1 m -57.87 -41.38 82.36 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.482 -0.326 . . . . 0.29 110.332 178.346 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 165' ' ' ARG . . . . . 0.724 ' HG2' ' O ' ' A' ' 161' ' ' GLU . 13.5 mmt180 -65.11 -54.8 24.34 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.493 -0.321 . . . . 0.52 111.33 179.612 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 166' ' ' TYR . . . . . 0.823 ' HE1' ' HA ' ' A' ' 195' ' ' ARG . 65.2 t80 -60.93 -51.26 70.02 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 113.036 0.754 . . . . 0.39 113.036 -178.063 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.469 HD13 HG23 ' A' ' 163' ' ' ILE . 9.2 mp -60.43 -39.87 89.03 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.879 -0.329 . . . . 0.45 111.056 -179.078 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 168' ' ' ARG . . . . . 0.536 ' HB2' ' O ' ' A' ' 164' ' ' SER . 3.9 mmt180 -68.7 -42.8 77.25 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 120.881 0.372 . . . . 0.39 111.126 178.836 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 169' ' ' GLU . . . . . 0.562 ' CD ' HH21 ' A' ' 195' ' ' ARG . 63.5 mt-10 -65.33 -48.67 72.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.019 0.437 . . . . 0.37 111.447 178.875 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 170' ' ' GLN . . . . . 0.636 ' HB3' ' HB1' ' A' ' 253' ' ' ALA . 7.4 tp60 -65.71 -37.3 86.05 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.137 -0.483 . . . . 0.39 111.821 -179.355 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.458 ' HA ' ' HA ' ' A' ' 257' ' ' LYS . . . -65.77 -30.78 71.48 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.787 0.327 . . . . 0.39 111.396 179.083 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 172' ' ' THR . . . . . 0.507 HG22 ' HD3' ' A' ' 260' ' ' LYS . 16.6 p -91.97 -41.34 10.62 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.259 0.466 . . . . 0.53 112.259 -179.612 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 113.4 3.48 24.1 Favored Glycine 0 CA--C 1.524 0.623 0 C-N-CA 120.95 -0.643 . . . . 0.54 112.622 -179.404 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -84.86 127.58 34.22 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.889 0.376 . . . . 0.55 111.624 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 65.4 mttm -130.18 44.1 3.02 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.446 0.641 . . . . 0.64 111.227 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -90.54 -135.33 0.12 Allowed 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 115.472 -0.785 . . . . 0.68 111.386 179.815 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 29.5 t -137.42 116.57 12.56 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.973 0.416 . . . . 1.48 111.181 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 52.1 mttp -115.78 141.96 28.29 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 116.069 -0.514 . . . . 0.9 111.407 -179.527 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.85 130.04 16.27 Favored 'Trans proline' 0 CA--C 1.536 0.622 0 C-N-CA 122.647 2.232 . . . . 1.11 113.243 179.779 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.433 ' HA ' ' NH2' ' A' ' 165' ' ' ARG . 3.1 mm? -92.34 159.26 15.67 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.049 -0.523 . . . . 0.68 110.816 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -119.46 -51.63 0.28 Allowed Glycine 0 CA--C 1.523 0.538 0 C-N-CA 120.358 -0.925 . . . . 0.68 113.355 -179.715 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 182' ' ' GLU . . . . . 0.64 ' HB2' ' HG3' ' A' ' 161' ' ' GLU . 5.0 mm-40 -85.55 -38.37 18.58 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.98 0.419 . . . . 0.69 111.476 -179.516 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.549 ' O ' ' HA3' ' A' ' 187' ' ' GLY . . . -123.13 83.3 2.11 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.177 -0.465 . . . . 0.43 111.062 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -74.81 -71.15 1.16 Allowed Glycine 0 CA--C 1.528 0.849 0 C-N-CA 120.552 -0.832 . . . . 0.55 114.255 -179.341 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -62.31 -55.29 29.61 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-O 121.06 0.457 . . . . 0.63 111.736 -179.161 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -63.78 -40.27 96.27 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.915 -0.584 . . . . 0.42 110.672 179.172 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 187' ' ' GLY . . . . . 0.549 ' HA3' ' O ' ' A' ' 183' ' ' ALA . . . -64.3 -40.41 97.87 Favored Glycine 0 C--N 1.333 0.4 0 C-N-CA 121.261 -0.495 . . . . 0.32 113.592 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 62.7 ttt180 -62.89 -51.3 67.51 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 117.269 0.534 . . . . 1.4 110.759 179.198 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 48.4 mtm180 -67.54 -31.56 71.74 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 116.112 -0.494 . . . . 0.45 111.033 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.518 ' HA ' ' CG1' ' A' ' 297' ' ' VAL . . . -71.29 -40.43 70.89 Favored 'General case' 0 C--O 1.222 -0.368 0 CA-C-N 116.282 -0.417 . . . . 0.27 110.943 178.888 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 20.0 tp -63.36 -47.15 83.31 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 111.589 0.218 . . . . 0.55 111.589 179.536 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 6.0 tm-20 -60.17 -45.37 93.33 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.291 0.567 . . . . 0.35 110.267 179.405 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 193' ' ' THR . . . . . 0.652 HG21 ' HA ' ' A' ' 297' ' ' VAL . 27.8 m -65.68 -47.19 76.3 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.762 -0.654 . . . . 0.31 110.665 179.284 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 0.445 HD12 ' HA ' ' A' ' 194' ' ' LEU . 7.0 tp -61.07 -41.75 97.22 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 116.032 -0.531 . . . . 0.34 110.678 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 195' ' ' ARG . . . . . 0.823 ' HA ' ' HE1' ' A' ' 166' ' ' TYR . 50.5 mtt180 -59.38 -58.44 8.6 Favored 'General case' 0 C--O 1.226 -0.136 0 CA-C-O 120.774 0.321 . . . . 0.48 110.172 178.319 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 8.5 ttm180 -57.77 -56.34 23.16 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.654 -0.703 . . . . 0.45 112.714 -179.028 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 197' ' ' VAL . . . . . 0.482 ' O ' HG23 ' A' ' 201' ' ' VAL . 58.6 t -62.3 -41.71 92.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-O 120.87 0.367 . . . . 0.3 111.021 -179.395 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 198' ' ' GLY . . . . . 0.581 ' HA3' ' OH ' ' A' ' 166' ' ' TYR . . . -63.21 -46.85 92.16 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 120.86 -0.686 . . . . 0.28 111.939 179.174 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 51.3 m-20 -55.74 -45.56 77.98 Favored 'General case' 0 N--CA 1.462 0.163 0 N-CA-C 109.509 -0.552 . . . . 0.36 109.509 178.114 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -58.69 -54.31 38.96 Favored Glycine 0 C--O 1.223 -0.573 0 CA-C-N 115.633 -0.712 . . . . 0.31 111.921 178.464 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 201' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 197' ' ' VAL . 57.5 t -59.58 -42.3 87.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 CA-C-O 120.787 0.327 . . . . 0.41 111.701 179.279 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 202' ' ' GLN . . . . . 0.44 ' HG2' ' HD1' ' A' ' 254' ' ' PHE . 5.9 mt-30 -64.3 -52.47 58.39 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 112.444 0.535 . . . . 0.55 112.444 -179.389 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 203' ' ' ARG . . . . . 0.43 ' HD3' HH11 ' A' ' 203' ' ' ARG . 2.8 mmp_? -69.37 -35.18 75.58 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.743 0.306 . . . . 0.59 111.475 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -68.53 -48.27 64.75 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.995 0.426 . . . . 0.4 110.819 179.105 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 -100.69 32.95 2.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.007 0.432 . . . . 0.54 110.818 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -56.72 -46.72 81.14 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.607 -0.724 . . . . 0.42 112.148 -179.167 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 58.4 p -60.46 -45.62 93.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.994 0.426 . . . . 0.57 111.176 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -65.94 -41.88 90.74 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.844 -0.616 . . . . 0.37 110.886 179.053 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 7.8 m-30 -66.17 -44.34 84.33 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.521 -0.309 . . . . 0.48 110.573 179.281 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -64.71 -44.52 89.98 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.532 -0.303 . . . . 1.34 110.616 178.643 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -60.51 -44.67 97.46 Favored Glycine 0 C--N 1.336 0.549 0 C-N-CA 120.749 -0.739 . . . . 0.33 111.28 178.588 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 28.1 ttm -66.3 -40.87 90.28 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 121.022 0.439 . . . . 0.51 109.935 178.248 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 12.9 tp -59.36 -42.54 91.83 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.596 -0.729 . . . . 0.49 111.718 179.177 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 77.1 mtp180 -74.28 -28.71 61.33 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.401 -0.363 . . . . 0.87 111.741 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 49.4 mtmt -76.33 -34.19 58.99 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 120.823 0.344 . . . . 0.82 110.69 178.89 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.588 ' HA ' HD11 ' B' ' 19' ' ' LEU . 81.6 mt -67.84 136.39 54.04 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 121.11 0.481 . . . . 0.57 111.795 179.499 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -101.28 30.97 3.89 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.11 -0.495 . . . . 0.71 110.485 179.31 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 218' ' ' ILE . . . . . 0.557 HG12 ' HB3' ' A' ' 216' ' ' LEU . 20.0 mm -59.17 119.86 4.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-N 115.8 -0.636 . . . . 0.5 111.316 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 19.3 mtmm -149.04 -30.99 0.24 Allowed 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 113.178 0.807 . . . . 1.1 113.178 -179.601 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -125.18 174.67 7.92 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.748 0.647 . . . . 0.46 112.748 -178.222 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 221' ' ' GLU . . . . . 0.463 ' O ' HG22 ' A' ' 224' ' ' VAL . 1.0 OUTLIER -62.35 -28.77 69.99 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 115.732 -0.667 . . . . 0.59 111.302 -179.949 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -61.88 -25.59 66.08 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 121.351 -0.452 . . . . 0.33 113.268 179.682 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 -58.43 -28.34 65.17 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 113.226 0.824 . . . . 0.36 113.226 -179.688 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.728 ' HB ' HG21 ' A' ' 274' ' ' THR . 25.8 m -54.0 -29.78 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 N-CA-C 112.908 0.707 . . . . 0.39 112.908 -179.237 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 33.4 mtmm -64.89 -43.39 93.04 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-O 121.415 0.626 . . . . 0.63 110.075 178.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 15.5 m -70.34 -38.65 74.88 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.309 -0.86 . . . . 0.6 109.715 178.637 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 227' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -59.63 -38.82 82.39 Favored 'General case' 0 CA--C 1.528 0.13 0 N-CA-C 108.791 -0.818 . . . . 0.61 108.791 177.867 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 49.8 m -62.32 -41.19 98.33 Favored 'General case' 0 CA--C 1.528 0.101 0 CA-C-N 115.426 -0.806 . . . . 0.48 109.989 177.529 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.2 -40.93 78.41 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.33 -0.395 . . . . 2.11 110.371 178.592 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 0.51 ' O ' HG23 ' A' ' 234' ' ' VAL . 13.4 t -61.97 -51.3 74.18 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-N 116.466 -0.334 . . . . 0.3 110.139 178.679 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 231' ' ' MET . . . . . . . . . . . . . 38.9 mtp -58.84 -47.63 84.18 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.146 -0.479 . . . . 0.4 111.116 179.41 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 75.6 t -63.92 -41.0 91.07 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 CA-C-N 116.34 -0.391 . . . . 0.53 110.907 179.19 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 31.8 t-80 -64.58 -37.56 87.97 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 116.414 -0.357 . . . . 0.58 110.975 178.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.51 HG23 ' O ' ' A' ' 230' ' ' VAL . 53.1 t -63.2 -51.61 69.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-O 120.794 0.331 . . . . 0.43 111.736 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -90.37 24.56 2.53 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 112.159 0.429 . . . . 0.58 112.159 -178.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 1.8 tmtm? -66.69 -15.37 63.46 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 112.537 0.569 . . . . 1.21 112.537 -179.25 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 44.8 p30 -85.27 -16.21 40.88 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 120.767 0.318 . . . . 0.57 111.497 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 94.38 -0.84 66.22 Favored Glycine 0 CA--C 1.524 0.636 0 C-N-CA 121.088 -0.577 . . . . 0.58 113.262 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 0.487 ' HB ' ' NH1' ' A' ' 244' ' ' ARG . 25.6 t -93.44 109.84 22.43 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-O 121.092 0.472 . . . . 0.48 111.584 -179.597 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 240' ' ' THR . . . . . 0.626 HG22 HD11 ' A' ' 245' ' ' ILE . 21.2 m -94.11 76.74 4.06 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.951 0.405 . . . . 0.84 111.582 179.718 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 241' ' ' ASN . . . . . 0.448 ' H ' ' HD2' ' A' ' 244' ' ' ARG . 59.3 m-20 -77.05 140.3 40.28 Favored 'General case' 0 C--N 1.329 -0.307 0 O-C-N 122.206 -0.309 . . . . 0.72 110.943 179.194 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 242' ' ' TRP . . . . . 0.546 ' HB3' ' CE2' ' A' ' 300' ' ' PHE . 47.8 m95 -56.32 -40.95 75.24 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.813 0.34 . . . . 0.6 110.871 179.275 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 243' ' ' GLY . . . . . 0.452 ' H ' ' HB2' ' B' ' 35' ' ' TYR . . . -62.98 -28.82 72.65 Favored Glycine 0 C--N 1.334 0.466 0 C-N-CA 121.168 -0.539 . . . . 0.25 112.028 178.49 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 244' ' ' ARG . . . . . 0.487 ' NH1' ' HB ' ' A' ' 239' ' ' VAL . 89.7 mtt180 -74.44 -42.39 59.21 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.659 -0.497 . . . . 0.46 109.659 178.779 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 245' ' ' ILE . . . . . 0.626 HD11 HG22 ' A' ' 240' ' ' THR . 67.8 mt -63.81 -52.71 53.63 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 CA-C-N 115.903 -0.589 . . . . 0.4 110.377 178.771 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 246' ' ' VAL . . . . . 0.405 HG12 ' HA2' ' A' ' 243' ' ' GLY . 6.8 p -62.63 -29.76 47.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 CA-C-N 116.287 -0.415 . . . . 0.35 110.836 179.43 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 11.1 m -65.93 -44.49 84.98 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 109.743 -0.465 . . . . 0.31 109.743 177.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 248' ' ' LEU . . . . . 0.41 HD13 ' HA ' ' A' ' 248' ' ' LEU . 2.5 mm? -64.42 -40.65 96.18 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 109.832 -0.432 . . . . 0.53 109.832 178.035 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 249' ' ' ILE . . . . . 0.459 HG12 ' O ' ' A' ' 245' ' ' ILE . 48.7 mm -64.05 -43.06 97.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 CA-C-O 121.052 0.453 . . . . 0.46 109.868 178.162 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 56.2 m -62.32 -42.61 99.52 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 115.846 -0.615 . . . . 0.3 109.6 178.313 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 251' ' ' PHE . . . . . . . . . . . . . 18.2 t80 -62.77 -42.99 99.94 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 116.008 -0.542 . . . . 0.5 109.675 178.079 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -57.82 -46.61 92.15 Favored Glycine 0 C--N 1.335 0.521 0 N-CA-C 111.386 -0.686 . . . . 0.28 111.386 178.165 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 253' ' ' ALA . . . . . 0.636 ' HB1' ' HB3' ' A' ' 170' ' ' GLN . . . -68.19 -27.77 66.68 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 120.661 0.267 . . . . 0.35 111.483 178.261 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 254' ' ' PHE . . . . . 0.44 ' HD1' ' HG2' ' A' ' 202' ' ' GLN . 26.6 t80 -74.81 -48.51 24.91 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 120.626 0.25 . . . . 0.6 111.047 179.3 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 255' ' ' VAL . . . . . 0.535 ' O ' ' HG ' ' A' ' 259' ' ' LEU . 23.6 m -64.18 -37.75 80.69 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.129 0 C-N-CA 120.503 -0.479 . . . . 0.34 109.751 178.454 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -67.36 -32.15 72.88 Favored 'General case' 0 C--N 1.341 0.199 0 CA-C-N 116.342 -0.39 . . . . 0.26 110.497 178.339 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 257' ' ' LYS . . . . . 0.562 ' HE2' ' HG3' ' A' ' 170' ' ' GLN . 28.0 ttmt -61.94 -46.99 86.88 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 109.048 -0.723 . . . . 0.44 109.048 177.907 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 82.9 t60 -66.0 -40.47 91.15 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 115.356 -0.838 . . . . 0.58 109.445 177.843 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.65 ' HB3' ' HB2' ' A' ' 264' ' ' GLN . 95.0 mt -62.89 -36.39 83.18 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.104 -0.498 . . . . 0.41 110.591 178.438 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 260' ' ' LYS . . . . . 0.507 ' HD3' HG22 ' A' ' 172' ' ' THR . 0.3 OUTLIER -65.54 -37.36 86.52 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 110.134 -0.321 . . . . 0.37 110.134 178.47 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 15.9 p -64.2 -24.62 67.74 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.839 0.352 . . . . 0.53 110.7 178.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 7.3 p -107.09 8.15 9.62 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 CA-C-O 121.592 0.71 . . . . 0.4 110.328 178.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 6.5 t30 59.13 49.31 9.45 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 113.7 1.0 . . . . 0.59 113.7 179.187 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 264' ' ' GLN . . . . . 0.65 ' HB2' ' HB3' ' A' ' 259' ' ' LEU . 4.0 mm100 -92.24 35.19 1.0 Allowed 'General case' 0 N--CA 1.47 0.532 0 O-C-N 122.082 -0.386 . . . . 0.6 111.352 178.888 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 265' ' ' GLU . . . . . 0.408 ' HG2' ' H ' ' A' ' 265' ' ' GLU . 5.3 mm-40 -47.52 -43.94 25.28 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 112.594 0.591 . . . . 0.45 112.594 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 86.8 p -59.11 -18.13 32.74 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 116.326 -0.397 . . . . 0.47 111.749 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 267' ' ' PHE . . . . . 0.448 ' CE1' ' HA ' ' A' ' 221' ' ' GLU . 53.8 t80 -107.77 -28.62 9.57 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 116.653 -0.249 . . . . 0.53 111.073 178.723 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 73.9 mt -57.13 -49.97 77.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 CA-C-O 120.575 0.226 . . . . 0.38 111.474 179.79 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 269' ' ' GLU . . . . . 0.485 ' HB2' ' HD3' ' A' ' 270' ' ' PRO . 2.5 mp0 -58.6 -56.86 31.27 Favored Pre-proline 0 CA--C 1.543 0.707 0 C-N-CA 121.128 -0.229 . . . . 0.36 111.542 179.431 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 270' ' ' PRO . . . . . 0.485 ' HD3' ' HB2' ' A' ' 269' ' ' GLU . 45.1 Cg_exo -59.37 -29.83 91.18 Favored 'Trans proline' 0 C--N 1.361 1.198 0 C-N-CA 122.369 2.046 . . . . 0.3 112.854 178.57 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 271' ' ' LEU . . . . . . . . . . . . . 56.6 tp -67.72 -49.38 62.96 Favored 'General case' 0 N--CA 1.464 0.225 0 N-CA-C 109.914 -0.402 . . . . 0.44 109.914 178.452 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -60.17 -37.21 79.47 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.113 -0.494 . . . . 0.31 110.217 178.454 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 273' ' ' GLU . . . . . 0.451 ' O ' ' HB2' ' A' ' 277' ' ' ASP . 32.0 tt0 -67.05 -43.12 83.51 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 109.462 -0.57 . . . . 1.11 109.462 178.109 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 274' ' ' THR . . . . . 0.728 HG21 ' HB ' ' A' ' 224' ' ' VAL . 70.1 m -61.47 -49.29 77.39 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.104 -0.498 . . . . 0.4 110.348 178.216 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 96.8 mt -55.37 -54.16 28.04 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.123 0 CA-C-N 115.775 -0.648 . . . . 0.42 110.763 179.419 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 276' ' ' THR . . . . . 0.512 HG23 HD12 ' A' ' 163' ' ' ILE . 15.9 m -57.69 -46.75 83.89 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 120.918 0.39 . . . . 0.31 110.993 179.433 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 277' ' ' ASP . . . . . 0.451 ' HB2' ' O ' ' A' ' 273' ' ' GLU . 0.4 OUTLIER -54.65 -59.92 4.06 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 115.685 -0.689 . . . . 0.59 110.966 179.345 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 57.3 t -60.38 -39.48 81.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 CA-C-O 120.812 0.339 . . . . 0.42 111.418 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 279' ' ' LEU . . . . . 0.554 HD11 HG23 ' A' ' 245' ' ' ILE . 15.8 tp -61.32 -47.59 85.23 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.564 -0.289 . . . . 0.85 111.151 179.568 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 80.2 t -73.04 -42.89 59.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 120.928 -0.309 . . . . 0.49 111.556 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 80.6 mtt-85 -60.92 -34.48 74.77 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 112.458 0.54 . . . . 1.09 112.458 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 282' ' ' THR . . . . . . . . . . . . . 69.3 p -95.74 0.13 52.1 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 113.089 0.774 . . . . 0.71 113.089 -178.732 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 283' ' ' LYS . . . . . 0.502 ' HD2' ' O ' ' A' ' 279' ' ' LEU . 5.7 mttp -141.26 30.1 1.78 Allowed 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 111.649 0.24 . . . . 0.93 111.649 179.773 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 40.1 ttm180 -57.72 -56.12 26.07 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 112.077 0.399 . . . . 0.92 112.077 -179.222 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -61.4 -44.52 97.0 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 120.826 0.346 . . . . 0.77 111.652 -179.692 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 286' ' ' TRP . . . . . 0.405 ' O ' ' HB2' ' A' ' 290' ' ' GLN . 0.8 OUTLIER -65.18 -49.52 69.5 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 112.36 0.504 . . . . 0.71 112.36 -179.074 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 287' ' ' LEU . . . . . 0.477 ' HB3' HD21 ' A' ' 155' ' ' LEU . 1.6 mm? -66.36 -42.61 87.8 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 113.007 0.743 . . . . 0.51 113.007 -178.502 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 5.6 p -67.75 -36.49 76.09 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 C-N-CA 120.797 -0.361 . . . . 0.49 111.962 -179.511 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 50.3 mttt -76.82 -33.57 57.96 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 112.38 0.511 . . . . 0.95 112.38 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 290' ' ' GLN . . . . . 0.405 ' HB2' ' O ' ' A' ' 286' ' ' TRP . 1.1 tp-100 -84.88 26.43 0.84 Allowed 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 113.002 0.741 . . . . 0.76 113.002 -178.679 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 32.7 mtp180 63.22 9.39 3.92 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 112.874 0.694 . . . . 0.49 112.874 178.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 62.64 -132.47 44.18 Favored Glycine 0 CA--C 1.524 0.656 0 CA-C-O 121.619 0.566 . . . . 0.35 113.954 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 293' ' ' TRP . . . . . 0.498 ' HA ' ' HB3' ' A' ' 296' ' ' PHE . 78.7 m95 -66.56 -23.45 66.21 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.392 0.516 . . . . 0.49 112.392 -178.766 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 294' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -64.52 -43.49 93.87 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 109.776 -0.453 . . . . 0.43 109.776 178.487 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -69.74 -32.04 70.5 Favored Glycine 0 C--N 1.334 0.459 0 N-CA-C 110.765 -0.934 . . . . 0.3 110.765 177.77 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 296' ' ' PHE . . . . . 0.498 ' HB3' ' HA ' ' A' ' 293' ' ' TRP . 6.0 t80 -67.53 -48.91 65.64 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 115.553 -0.323 . . . . 0.41 111.202 178.779 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 297' ' ' VAL . . . . . 0.652 ' HA ' HG21 ' A' ' 193' ' ' THR . 21.7 m -69.14 -33.18 57.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 CA-C-N 116.63 -0.259 . . . . 0.33 111.591 -179.591 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -69.47 -42.2 75.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.9 0.381 . . . . 0.47 110.713 179.176 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 299' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -67.69 -45.73 74.32 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.005 -0.543 . . . . 0.64 111.427 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 300' ' ' PHE . . . . . 0.546 ' CE2' ' HB3' ' A' ' 242' ' ' TRP . 60.1 m-85 -87.15 30.92 0.74 Allowed 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 112.687 0.625 . . . . 0.46 112.687 -179.089 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 301' ' ' HIS . . . . . 0.61 ' HB2' ' O ' ' A' ' 297' ' ' VAL . 0.1 OUTLIER -145.89 151.14 37.38 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.95 0.405 . . . . 0.43 111.373 179.628 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 2.3 p -89.99 113.02 25.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.204 0.526 . . . . 0.73 110.473 178.739 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 303' ' ' GLN . . . . . 0.429 HE21 ' HB2' ' A' ' 303' ' ' GLN . 0.7 OUTLIER -101.72 -50.62 3.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.205 -0.452 . . . . 0.73 111.628 179.96 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 64.2 t0 -146.79 123.37 11.11 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 121.003 0.43 . . . . 1.53 111.125 -179.558 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 42.6 mt -122.68 -2.81 8.81 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.15 0.5 . . . . 2.36 110.319 178.776 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -106.27 -35.32 7.2 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.83 -0.623 . . . . 3.79 111.76 -179.064 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . 103.21 84.11 1.77 Allowed Glycine 0 CA--C 1.52 0.384 0 C-N-CA 120.619 -0.801 . . . . 2.56 113.285 179.563 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.278 0 CA-C-O 118.641 -1.088 . . . . 2.49 113.261 179.401 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.685 0 CA-C-O 121.411 0.624 . . . . 1.03 111.058 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -109.8 113.69 26.65 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.642 -0.708 . . . . 1.31 111.22 -179.602 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 19' ' ' LEU . . . . . 0.588 HD11 ' HA ' ' A' ' 216' ' ' LEU . 9.2 mt -94.16 108.08 33.27 Favored Pre-proline 0 CA--C 1.534 0.345 0 CA-C-O 120.901 0.382 . . . . 0.76 111.701 179.791 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -80.66 160.89 21.92 Favored 'Trans proline' 0 CA--C 1.534 0.48 0 C-N-CA 122.935 2.423 . . . . 0.5 112.598 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 21' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -72.5 38.41 0.39 Allowed 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 122.918 2.412 . . . . 0.8 113.021 179.677 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -89.39 -39.04 13.67 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 116.093 -0.503 . . . . 0.64 111.774 -179.268 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 23' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -55.93 -41.17 74.21 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 112.218 0.451 . . . . 0.41 112.218 -179.063 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -66.95 -38.98 87.1 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.882 0.372 . . . . 0.36 111.37 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.8 -35.71 81.99 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-O 121.507 0.67 . . . . 0.38 110.01 178.635 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -66.16 -49.77 66.25 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.246 -0.888 . . . . 0.5 109.43 178.053 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 82.8 mt -57.21 -36.16 70.53 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.275 -0.42 . . . . 0.48 110.678 178.291 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 28' ' ' ARG . . . . . . . . . . . . . 37.7 mtp85 -57.25 -58.21 9.25 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 116.108 -0.496 . . . . 0.5 111.299 178.607 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 8.6 ptpp? -64.57 -31.53 72.78 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.523 -0.308 . . . . 0.48 110.791 179.517 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 52.2 mt -62.82 -49.85 82.04 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 N-CA-C 109.421 -0.585 . . . . 0.43 109.421 178.073 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -62.18 -43.61 98.88 Favored Glycine 0 N--CA 1.448 -0.527 0 CA-C-N 115.423 -0.808 . . . . 0.29 112.012 178.785 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -66.95 -37.11 83.68 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 121.221 -0.191 . . . . 0.54 110.878 179.076 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 23.6 ttmm -65.08 -44.6 88.39 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 109.865 -0.42 . . . . 0.8 109.865 177.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 45.7 t -63.92 -50.79 75.9 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-N 115.969 -0.559 . . . . 0.35 110.186 178.439 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 35' ' ' TYR . . . . . 0.452 ' HB2' ' H ' ' A' ' 243' ' ' GLY . 0.0 OUTLIER -58.0 -40.54 81.0 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.681 -0.691 . . . . 0.73 110.817 179.273 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 36' ' ' CYS . . . . . . . . . . . . . 23.6 t -69.64 -26.47 64.43 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 120.873 0.368 . . . . 0.64 111.422 179.411 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 85.7 m -76.17 -35.02 59.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.305 -0.407 . . . . 0.46 111.18 179.579 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 38' ' ' TRP . . . . . . . . . . . . . 97.7 m95 -88.03 -37.36 16.38 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 112.052 0.39 . . . . 0.6 112.052 -179.785 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 45.7 p -65.66 -34.24 77.76 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 120.761 0.315 . . . . 0.68 111.396 179.16 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 40' ' ' ALA . . . . . 0.404 ' HA ' ' HD3' ' B' ' 41' ' ' PRO . . . -90.33 119.07 69.21 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.444 -0.344 . . . . 0.61 110.813 179.128 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 41' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' B' ' 40' ' ' ALA . 38.5 Cg_exo -61.44 126.88 20.29 Favored 'Trans proline' 0 CA--C 1.532 0.418 0 C-N-CA 122.815 2.343 . . . . 1.3 112.93 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -78.7 -24.77 44.8 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 116.216 -0.447 . . . . 1.26 111.929 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 43' ' ' MET . . . . . . . . . . . . . 28.0 ttt . . . . . 0 C--O 1.252 1.19 0 CA-C-O 118.261 -0.875 . . . . 2.31 111.649 -179.899 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.836 ' N ' ' HG ' ' A' ' 151' ' ' SER . . . . . . . . 0 N--CA 1.491 2.314 0 CA-C-O 120.061 -0.3 . . . . 1.32 112.571 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -73.68 -20.84 19.77 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.502 2.135 . . . . 1.81 112.732 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 19.1 tp -152.96 133.58 13.79 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.022 -0.536 . . . . 1.44 110.07 179.746 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 77.52 72.26 1.15 Allowed Glycine 0 CA--C 1.522 0.482 0 C-N-CA 120.514 -0.851 . . . . 0.84 112.196 -179.618 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.836 ' HG ' ' N ' ' A' ' 147' ' ' GLY . 71.1 m -167.09 -43.53 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 121.348 0.595 . . . . 0.95 110.264 -178.862 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -158.81 -26.96 0.07 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 114.928 -1.033 . . . . 0.46 109.494 179.346 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' ASP . . . . . 0.401 ' HA ' ' HB2' ' A' ' 156' ' ' TYR . 2.3 p-10 -58.25 -27.7 64.24 Favored 'General case' 0 C--O 1.223 -0.324 0 CA-C-N 115.203 -0.908 . . . . 0.45 110.846 178.889 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -55.52 -41.49 73.19 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.232 0.539 . . . . 0.43 110.242 178.743 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -71.66 -40.28 69.75 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 109.004 -0.739 . . . . 0.74 109.004 177.754 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 156' ' ' TYR . . . . . 0.401 ' HB2' ' HA ' ' A' ' 153' ' ' ASP . 0.1 OUTLIER -60.65 -46.95 88.4 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 115.966 -0.561 . . . . 0.35 110.86 179.095 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 14.2 mtp180 -60.53 -45.92 92.07 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 116.336 -0.393 . . . . 0.45 111.301 179.54 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 72.4 mt-30 -63.9 -50.46 68.64 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.062 0.458 . . . . 0.43 109.826 178.59 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 16.8 m -56.72 -48.47 77.67 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 115.461 -0.791 . . . . 0.25 110.925 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.473 ' HA ' HG21 ' A' ' 276' ' ' THR . 2.1 tm? -57.21 -49.54 75.69 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.551 -0.295 . . . . 0.46 110.254 178.871 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.2 -45.46 93.11 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.348 -0.387 . . . . 0.79 111.474 179.552 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 162' ' ' ILE . . . . . 0.54 HG23 HD22 ' A' ' 191' ' ' LEU . 89.9 mt -65.65 -56.56 14.55 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 CA-C-N 116.0 -0.546 . . . . 0.29 112.359 -179.252 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.542 HD12 HG23 ' A' ' 276' ' ' THR . 97.1 mt -58.49 -51.99 64.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 N-CA-C 112.71 0.633 . . . . 0.36 112.71 -178.689 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 65.9 p -56.1 -42.67 77.14 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 120.556 0.217 . . . . 0.29 111.452 -179.398 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' ARG . . . . . 0.415 ' NH1' HD23 ' A' ' 180' ' ' LEU . 0.0 OUTLIER -65.55 -52.95 48.65 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.889 0.376 . . . . 1.24 111.105 178.961 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 166' ' ' TYR . . . . . 0.788 ' HE1' ' HA ' ' A' ' 195' ' ' ARG . 59.9 t80 -57.3 -49.08 77.23 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 112.594 0.59 . . . . 0.32 112.594 -179.614 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 5.5 mp -60.71 -46.14 91.55 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 112.413 0.523 . . . . 0.42 112.413 -178.64 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 38.2 ttm-85 -69.14 -49.89 52.81 Favored 'General case' 0 C--O 1.239 0.545 0 N-CA-C 113.067 0.766 . . . . 0.29 113.067 -178.659 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -64.12 -52.08 60.85 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.171 0.434 . . . . 0.41 112.171 -178.801 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -64.29 -32.42 74.01 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 111.972 0.36 . . . . 0.43 111.972 -179.284 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.463 ' O ' ' HG3' ' A' ' 257' ' ' LYS . . . -70.6 -48.22 56.23 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.04 0.448 . . . . 0.37 110.305 178.076 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 44.6 m -66.43 -41.12 89.65 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 115.869 -0.605 . . . . 0.42 111.572 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 127.03 29.01 0.89 Allowed Glycine 0 CA--C 1.526 0.724 0 C-N-CA 120.422 -0.894 . . . . 0.53 113.743 179.72 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 13.3 t -120.21 135.03 55.12 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.012 0.434 . . . . 0.5 111.378 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 20.8 mtpp -108.03 0.53 21.83 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.822 0.344 . . . . 0.88 111.032 179.288 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -91.36 49.74 1.65 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.359 0.599 . . . . 1.56 112.237 -179.098 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 177' ' ' SER . . . . . 0.422 ' O ' ' HG ' ' A' ' 191' ' ' LEU . 7.5 t -91.89 72.43 5.66 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.51 0.671 . . . . 0.64 109.274 178.82 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 178' ' ' LYS . . . . . 0.772 ' H ' ' HD2' ' A' ' 179' ' ' PRO . 37.7 mttt -110.54 -41.79 0.11 Allowed Pre-proline 0 CA--C 1.544 0.716 0 N-CA-C 113.64 0.978 . . . . 1.14 113.64 -178.869 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 179' ' ' PRO . . . . . 0.772 ' HD2' ' H ' ' A' ' 178' ' ' LYS . 23.3 Cg_endo -61.84 99.18 0.18 Allowed 'Trans proline' 0 C--N 1.361 1.187 0 C-N-CA 121.845 1.697 . . . . 1.81 114.034 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.557 ' HB2' ' NH2' ' A' ' 188' ' ' ARG . 1.1 mt -123.39 146.38 48.02 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.918 -0.583 . . . . 0.93 109.594 178.51 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -92.3 -53.89 1.94 Allowed Glycine 0 CA--C 1.522 0.502 0 C-N-CA 120.916 -0.659 . . . . 0.64 114.077 -178.271 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -88.8 -44.95 10.14 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.249 0.547 . . . . 0.84 110.62 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.477 ' HB3' HD22 ' A' ' 180' ' ' LEU . . . -81.49 77.18 8.38 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.261 0.553 . . . . 0.43 111.192 179.648 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 184' ' ' GLY . . . . . 0.701 ' HA2' ' NH2' ' A' ' 188' ' ' ARG . . . -79.84 -73.85 1.12 Allowed Glycine 0 CA--C 1.525 0.713 0 C-N-CA 120.312 -0.947 . . . . 0.57 114.079 -179.605 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -71.79 -54.72 9.29 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.065 0.46 . . . . 0.74 110.886 -179.36 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -65.14 -35.18 80.3 Favored 'General case' 0 C--O 1.221 -0.427 0 CA-C-N 115.76 -0.655 . . . . 0.6 110.601 179.277 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 187' ' ' GLY . . . . . 0.468 ' CA ' ' HB1' ' A' ' 183' ' ' ALA . . . -64.03 -53.33 37.78 Favored Glycine 0 C--O 1.228 -0.262 0 C-N-CA 120.903 -0.665 . . . . 0.43 113.082 -179.81 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 188' ' ' ARG . . . . . 0.701 ' NH2' ' HA2' ' A' ' 184' ' ' GLY . 0.3 OUTLIER -59.64 -41.71 91.13 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 117.095 0.447 . . . . 1.6 111.192 -179.98 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 189' ' ' ARG . . . . . 0.9 ' HD3' HG11 ' A' ' 297' ' ' VAL . 0.2 OUTLIER -71.12 -40.3 71.51 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.509 -0.314 . . . . 0.48 111.245 179.386 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.517 ' HA ' HG22 ' A' ' 297' ' ' VAL . . . -69.6 -39.4 77.27 Favored 'General case' 0 C--O 1.22 -0.481 0 CA-C-N 116.865 -0.152 . . . . 0.26 111.394 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 191' ' ' LEU . . . . . 0.605 HD12 ' HE ' ' A' ' 195' ' ' ARG . 0.3 OUTLIER -64.59 -47.52 78.37 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.603 0.24 . . . . 0.47 111.212 179.788 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -60.79 -42.85 98.37 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.265 0.555 . . . . 0.4 110.897 179.461 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 193' ' ' THR . . . . . 0.542 ' OG1' HG13 ' A' ' 297' ' ' VAL . 27.8 m -69.76 -54.06 15.44 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.757 -0.656 . . . . 0.32 110.906 179.515 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 0.477 HD21 HG21 ' A' ' 249' ' ' ILE . 16.7 tp -55.32 -42.34 73.6 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 115.828 -0.623 . . . . 0.32 111.324 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 195' ' ' ARG . . . . . 0.788 ' HA ' ' HE1' ' A' ' 166' ' ' TYR . 17.9 mtm105 -63.27 -53.05 59.03 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.717 -0.22 . . . . 0.36 111.37 179.654 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.51 -49.77 76.51 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 111.888 0.329 . . . . 0.56 111.888 -179.774 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 87.2 t -63.89 -46.81 93.16 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 CA-C-O 120.877 0.37 . . . . 0.34 110.315 179.678 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 198' ' ' GLY . . . . . 0.612 ' HA3' ' OH ' ' A' ' 166' ' ' TYR . . . -58.83 -42.13 96.42 Favored Glycine 0 C--N 1.333 0.372 0 CA-C-N 115.9 -0.591 . . . . 0.24 112.222 179.017 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -56.95 -44.27 82.38 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.837 0.351 . . . . 0.49 110.31 178.233 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -66.96 -53.48 26.63 Favored Glycine 0 CA--C 1.523 0.568 0 C-N-CA 120.928 -0.654 . . . . 0.36 112.883 179.354 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 60.3 t -60.77 -42.73 93.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 N-CA-C 112.217 0.451 . . . . 0.36 112.217 -179.685 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 202' ' ' GLN . . . . . 0.592 ' HA ' ' HE2' ' A' ' 209' ' ' PHE . 0.2 OUTLIER -63.44 -52.71 60.32 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 112.131 0.419 . . . . 0.36 112.131 -179.392 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 30.6 mtt-85 -66.66 -33.39 75.54 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.732 0.301 . . . . 0.45 110.343 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -63.92 -52.6 59.09 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.121 -0.491 . . . . 0.88 110.311 178.379 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 205' ' ' HIS . . . . . 0.422 ' HB3' ' HB3' ' A' ' 208' ' ' ALA . 80.7 m-70 -102.21 36.02 2.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.294 -0.412 . . . . 0.48 111.731 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -57.19 -46.52 82.76 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 120.931 0.396 . . . . 1.23 111.31 -179.389 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 47.5 p -64.11 -41.63 97.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.832 -0.622 . . . . 0.62 111.16 179.686 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 208' ' ' ALA . . . . . 0.422 ' HB3' ' HB3' ' A' ' 205' ' ' HIS . . . -63.61 -41.21 98.32 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.914 -0.585 . . . . 0.37 110.523 179.054 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 209' ' ' PHE . . . . . 0.608 ' O ' ' HG ' ' A' ' 213' ' ' LEU . 20.6 m-30 -70.23 -46.98 63.37 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.143 -0.48 . . . . 0.5 110.138 178.903 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 210' ' ' GLN . . . . . 0.429 ' HA ' HD12 ' A' ' 213' ' ' LEU . 0.6 OUTLIER -58.66 -44.57 90.2 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 121.039 0.447 . . . . 1.0 110.206 178.708 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 211' ' ' GLY . . . . . 0.443 ' O ' ' HG3' ' A' ' 215' ' ' LYS . . . -64.33 -43.75 96.43 Favored Glycine 0 C--N 1.335 0.479 0 C-N-CA 121.016 -0.612 . . . . 0.38 111.741 178.489 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 212' ' ' MET . . . . . 0.438 ' HA ' ' HD2' ' A' ' 215' ' ' LYS . 30.8 ttm -62.2 -37.69 86.27 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 120.719 0.295 . . . . 0.39 110.276 178.928 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.608 ' HG ' ' O ' ' A' ' 209' ' ' PHE . 97.4 mt -58.0 -43.93 86.9 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.169 -0.468 . . . . 0.52 110.068 177.926 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 214' ' ' ARG . . . . . 0.523 ' HD3' ' O ' ' A' ' 214' ' ' ARG . 0.0 OUTLIER -66.92 -32.01 72.98 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 115.855 -0.611 . . . . 0.8 110.401 178.755 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 215' ' ' LYS . . . . . 0.443 ' HG3' ' O ' ' A' ' 211' ' ' GLY . 89.7 mttt -70.32 -43.69 69.78 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 116.282 -0.417 . . . . 0.46 110.856 178.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 15.1 mt -72.8 164.23 26.89 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 121.159 0.504 . . . . 0.77 111.811 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -111.55 32.75 5.17 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 121.251 0.548 . . . . 1.04 110.999 179.71 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 218' ' ' ILE . . . . . 0.606 ' HA ' ' HB2' ' A' ' 223' ' ' ASP . 41.2 mm -57.15 108.38 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-N 115.746 -0.661 . . . . 0.37 111.992 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 219' ' ' LYS . . . . . 0.487 ' NZ ' ' HA ' ' A' ' 219' ' ' LYS . 0.4 OUTLIER -145.83 -82.6 0.14 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.843 0.354 . . . . 0.55 111.727 179.887 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 65.9 m-20 -87.49 -176.54 5.63 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.883 -0.599 . . . . 1.97 110.612 178.854 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 221' ' ' GLU . . . . . 0.515 ' O ' HG22 ' A' ' 224' ' ' VAL . 13.1 tm-20 -46.48 -31.16 2.55 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 122.975 0.51 . . . . 0.74 112.362 -179.804 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -55.12 -24.85 37.21 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 121.631 -0.319 . . . . 0.53 113.681 178.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 223' ' ' ASP . . . . . 0.606 ' HB2' ' HA ' ' A' ' 218' ' ' ILE . 0.5 OUTLIER -56.63 -36.11 69.1 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 112.741 0.645 . . . . 0.69 112.741 -179.047 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.544 ' HB ' HG21 ' A' ' 274' ' ' THR . 14.2 m -61.15 -29.77 46.44 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-O 120.823 0.344 . . . . 0.48 111.808 -179.521 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 30.6 mttp -72.81 -40.54 65.74 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.143 0.497 . . . . 0.64 109.892 179.132 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 226' ' ' SER . . . . . 0.543 ' O ' HG23 ' A' ' 230' ' ' VAL . 53.4 p -70.73 -38.77 73.6 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.802 -0.635 . . . . 0.52 109.856 178.545 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 227' ' ' PHE . . . . . 0.634 ' O ' ' HG3' ' A' ' 231' ' ' MET . 10.3 t80 -65.11 -46.67 80.07 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 116.102 -0.499 . . . . 0.57 110.031 178.748 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 48.2 t -57.72 -40.12 78.87 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.373 -0.376 . . . . 0.48 110.153 178.492 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 3.1 ttp180 -56.88 -43.18 81.02 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.048 -0.524 . . . . 1.4 109.69 178.245 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 0.543 HG23 ' O ' ' A' ' 226' ' ' SER . 29.6 t -65.67 -49.59 76.68 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 CA-C-N 115.812 -0.631 . . . . 0.38 109.895 178.076 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 231' ' ' MET . . . . . 0.634 ' HG3' ' O ' ' A' ' 227' ' ' PHE . 68.3 mtp -54.38 -51.4 64.94 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 115.784 -0.644 . . . . 0.43 111.842 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 93.2 t -60.84 -39.9 83.4 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 CA-C-N 116.512 -0.313 . . . . 0.39 111.598 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -70.65 -37.66 73.75 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 120.751 -0.38 . . . . 0.54 110.973 179.368 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 230' ' ' VAL . 51.1 t -59.24 -36.03 61.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-O 121.206 0.527 . . . . 0.45 110.987 179.27 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 235' ' ' PHE . . . . . 0.468 ' HE2' HD22 ' A' ' 248' ' ' LEU . 86.2 m-85 -103.61 18.2 22.42 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.302 -0.408 . . . . 0.42 111.553 179.372 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 11.8 tptp -77.96 -9.52 59.14 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 120.941 0.4 . . . . 1.08 111.324 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 -70.23 -16.23 63.02 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.379 -0.373 . . . . 0.54 111.651 179.739 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 90.83 -1.86 78.91 Favored Glycine 0 CA--C 1.521 0.423 0 C-N-CA 120.748 -0.739 . . . . 0.64 112.504 -179.571 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 6.0 p -119.36 119.08 59.55 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 CA-C-O 121.509 0.671 . . . . 0.49 110.979 179.763 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 240' ' ' THR . . . . . 0.547 HG21 ' HG2' ' A' ' 283' ' ' LYS . 0.5 OUTLIER -93.71 83.38 4.43 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.152 -0.476 . . . . 0.52 112.2 -179.653 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -76.92 136.36 38.81 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.117 -0.492 . . . . 0.36 111.266 179.305 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 242' ' ' TRP . . . . . . . . . . . . . 6.0 m95 -53.93 -45.54 71.26 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.783 0.325 . . . . 0.39 111.0 179.126 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 243' ' ' GLY . . . . . 0.454 ' H ' ' HB2' ' B' ' 35' ' ' TYR . . . -57.39 -35.98 74.43 Favored Glycine 0 C--N 1.336 0.568 0 CA-C-N 116.068 -0.514 . . . . 0.27 112.823 179.134 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 84.0 mtt180 -68.25 -44.29 75.95 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 109.985 -0.376 . . . . 0.31 109.985 178.843 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 245' ' ' ILE . . . . . 0.657 HG23 HD11 ' A' ' 279' ' ' LEU . 98.5 mt -59.65 -51.36 73.69 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-N 115.954 -0.567 . . . . 0.42 110.518 178.86 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 59.6 t -63.07 -40.37 88.77 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 CA-C-N 116.164 -0.471 . . . . 0.37 111.07 178.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 23.5 m -60.63 -41.07 94.14 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 120.81 0.338 . . . . 0.36 110.432 179.011 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 248' ' ' LEU . . . . . 0.468 HD22 ' HE2' ' A' ' 235' ' ' PHE . 21.0 tp -64.2 -38.49 91.23 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 121.102 0.477 . . . . 0.62 109.914 178.191 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 249' ' ' ILE . . . . . 0.678 HD11 HD22 ' A' ' 279' ' ' LEU . 47.6 mm -68.2 -41.72 84.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-N 116.091 -0.504 . . . . 0.45 109.952 178.155 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 65.6 m -62.6 -43.95 97.52 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.026 -0.534 . . . . 0.37 109.653 178.561 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 251' ' ' PHE . . . . . 0.527 ' O ' HG23 ' A' ' 255' ' ' VAL . 29.9 t80 -62.44 -43.16 99.47 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 115.722 -0.672 . . . . 0.37 109.375 177.76 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -56.5 -47.83 80.87 Favored Glycine 0 C--N 1.338 0.666 0 N-CA-C 111.091 -0.803 . . . . 0.26 111.091 178.226 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -59.12 -42.2 89.99 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-O 120.573 0.225 . . . . 0.29 110.557 177.772 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 254' ' ' PHE . . . . . 0.454 ' CD2' HD11 ' A' ' 213' ' ' LEU . 5.8 t80 -63.81 -40.06 95.73 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.487 -0.324 . . . . 0.53 110.648 178.934 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 255' ' ' VAL . . . . . 0.527 HG23 ' O ' ' A' ' 251' ' ' PHE . 84.8 t -63.64 -43.8 98.27 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 N-CA-C 109.297 -0.631 . . . . 0.41 109.297 177.426 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -62.82 -34.55 77.54 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 115.81 -0.632 . . . . 0.28 109.992 178.134 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 257' ' ' LYS . . . . . 0.463 ' HG3' ' O ' ' A' ' 171' ' ' ALA . 30.4 tttp -66.7 -46.08 76.72 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 115.385 -0.825 . . . . 0.62 110.163 178.248 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 14.4 t60 -62.1 -42.41 99.2 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 115.827 -0.624 . . . . 0.65 109.393 178.29 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 4.7 mp -67.27 -35.5 79.63 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.012 -0.54 . . . . 0.48 110.846 178.332 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.71 -34.53 77.35 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.533 -0.303 . . . . 0.6 111.018 178.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 24.0 p -62.45 -20.07 64.15 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 120.684 0.278 . . . . 0.74 111.591 179.517 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 262' ' ' VAL . . . . . 0.451 HG23 ' HG3' ' A' ' 264' ' ' GLN . 13.8 m -117.03 18.82 7.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-O 120.92 0.39 . . . . 0.67 111.073 178.882 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 65.1 m-80 56.98 46.39 19.53 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 113.8 1.037 . . . . 1.45 113.8 179.171 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 264' ' ' GLN . . . . . 0.451 ' HG3' HG23 ' A' ' 262' ' ' VAL . 12.6 mt-30 -99.29 36.64 1.7 Allowed 'General case' 0 CA--C 1.536 0.423 0 O-C-N 121.884 -0.51 . . . . 0.43 111.491 179.074 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 265' ' ' GLU . . . . . 0.431 ' HA ' HD12 ' A' ' 268' ' ' ILE . 11.4 tp10 -53.9 -42.1 68.35 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 120.91 0.386 . . . . 0.41 111.653 -179.718 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 30.9 t -61.06 -14.94 27.25 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.128 -0.487 . . . . 0.46 111.729 179.575 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 267' ' ' PHE . . . . . 0.487 ' C ' ' HD2' ' A' ' 270' ' ' PRO . 71.7 m-85 -101.21 -21.27 14.97 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 121.15 0.5 . . . . 0.78 110.064 178.703 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 268' ' ' ILE . . . . . 0.431 HD12 ' HA ' ' A' ' 265' ' ' GLU . 76.1 mt -67.42 -37.19 78.47 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 CA-C-N 115.851 -0.613 . . . . 0.45 109.891 178.462 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 269' ' ' GLU . . . . . 0.729 ' HB2' ' HD3' ' A' ' 270' ' ' PRO . 9.1 mm-40 -56.63 -57.82 21.21 Favored Pre-proline 0 CA--C 1.548 0.876 0 CA-C-N 116.383 -0.372 . . . . 0.44 111.025 178.623 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 270' ' ' PRO . . . . . 0.729 ' HD3' ' HB2' ' A' ' 269' ' ' GLU . 35.1 Cg_exo -63.22 -30.19 74.12 Favored 'Trans proline' 0 C--N 1.365 1.403 0 C-N-CA 122.322 2.014 . . . . 0.33 112.122 178.58 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 271' ' ' LEU . . . . . . . . . . . . . 56.7 tp -67.09 -50.86 60.23 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 109.72 -0.474 . . . . 0.46 109.72 178.425 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -62.49 -36.52 82.76 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 115.948 -0.569 . . . . 0.33 110.456 178.749 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 273' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -63.13 -48.89 76.6 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.142 -0.481 . . . . 0.4 109.724 178.009 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 274' ' ' THR . . . . . 0.544 HG21 ' HB ' ' A' ' 224' ' ' VAL . 62.7 m -62.72 -48.54 78.77 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.863 -0.608 . . . . 0.36 110.853 178.867 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 275' ' ' ILE . . . . . 0.466 ' HA ' ' HE1' ' A' ' 231' ' ' MET . 92.1 mt -54.78 -51.9 47.52 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.157 0 CA-C-N 116.135 -0.484 . . . . 0.34 111.106 179.42 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 276' ' ' THR . . . . . 0.542 HG23 HD12 ' A' ' 163' ' ' ILE . 40.8 m -60.49 -51.23 70.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.277 -0.42 . . . . 0.29 111.193 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 277' ' ' ASP . . . . . 0.526 ' OD1' ' HD2' ' A' ' 281' ' ' ARG . 25.9 t0 -55.09 -58.26 8.37 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.129 -0.487 . . . . 0.9 111.61 179.807 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 95.4 t -58.41 -41.8 82.46 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 CA-C-O 120.795 0.331 . . . . 0.36 111.58 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 279' ' ' LEU . . . . . 0.678 HD22 HD11 ' A' ' 249' ' ' ILE . 12.2 tp -61.77 -47.74 83.79 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 112.219 0.452 . . . . 0.64 112.219 -179.578 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 46.5 t -79.31 -42.81 23.64 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 N-CA-C 112.612 0.597 . . . . 0.35 112.612 -178.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 281' ' ' ARG . . . . . 0.526 ' HD2' ' OD1' ' A' ' 277' ' ' ASP . 0.4 OUTLIER -58.8 -33.53 70.46 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 112.326 0.491 . . . . 1.18 112.326 -179.336 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 282' ' ' THR . . . . . . . . . . . . . 48.4 p -85.84 -1.62 57.43 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 111.772 0.286 . . . . 0.34 111.772 179.568 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 283' ' ' LYS . . . . . 0.547 ' HG2' HG21 ' A' ' 240' ' ' THR . 32.8 mttp -141.22 34.11 1.7 Allowed 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.572 -0.286 . . . . 0.42 111.391 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 48.9 mtp180 -53.83 -62.24 1.78 Allowed 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 112.573 0.582 . . . . 0.45 112.573 -178.862 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 285' ' ' ASP . . . . . 0.494 ' O ' ' HE2' ' A' ' 289' ' ' LYS . 8.7 p-10 -65.63 -37.65 87.19 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.168 -0.469 . . . . 0.46 110.901 -179.846 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 286' ' ' TRP . . . . . 0.516 ' CZ2' ' HG2' ' A' ' 290' ' ' GLN . 71.9 t90 -62.4 -40.5 96.7 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.425 -0.352 . . . . 0.38 110.912 179.653 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 287' ' ' LEU . . . . . 0.537 HD13 ' HA2' ' A' ' 292' ' ' GLY . 0.8 OUTLIER -60.71 -48.36 82.14 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 111.971 0.36 . . . . 0.42 111.971 179.749 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 9.5 p -69.35 -32.16 52.32 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 C-N-CA 120.481 -0.487 . . . . 0.52 111.453 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 289' ' ' LYS . . . . . 0.494 ' HE2' ' O ' ' A' ' 285' ' ' ASP . 39.8 mtmt -75.97 -40.3 54.21 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 112.775 0.657 . . . . 0.73 112.775 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 290' ' ' GLN . . . . . 0.516 ' HG2' ' CZ2' ' A' ' 286' ' ' TRP . 1.6 mp0 -87.82 29.87 0.88 Allowed 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 114.278 1.214 . . . . 0.7 114.278 -177.842 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 291' ' ' ARG . . . . . 0.621 ' HG2' ' HB2' ' A' ' 294' ' ' ASP . 1.9 ttt180 60.74 19.7 9.79 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 112.762 0.653 . . . . 0.47 112.762 178.435 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 292' ' ' GLY . . . . . 0.537 ' HA2' HD13 ' A' ' 287' ' ' LEU . . . 42.34 -135.52 3.76 Favored Glycine 0 CA--C 1.527 0.788 0 N-CA-C 115.363 0.905 . . . . 0.35 115.363 178.917 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 293' ' ' TRP . . . . . 0.588 ' O ' HG23 ' A' ' 297' ' ' VAL . 97.2 m95 -64.46 -37.41 87.44 Favored 'General case' 0 C--O 1.226 -0.133 0 CA-C-N 115.428 -0.386 . . . . 0.55 111.058 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 294' ' ' ASP . . . . . 0.621 ' HB2' ' HG2' ' A' ' 291' ' ' ARG . 0.9 OUTLIER -53.8 -46.91 71.22 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 121.176 0.512 . . . . 0.63 110.195 179.023 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -65.79 -39.3 95.1 Favored Glycine 0 CA--C 1.523 0.56 0 C-N-CA 120.884 -0.674 . . . . 0.29 111.835 178.324 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 296' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -64.05 -36.15 83.07 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 120.799 0.333 . . . . 0.33 110.937 179.131 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 297' ' ' VAL . . . . . 0.9 HG11 ' HD3' ' A' ' 189' ' ' ARG . 77.8 t -64.99 -54.16 32.84 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 CA-C-N 116.202 -0.454 . . . . 0.34 111.65 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -69.71 -23.16 63.38 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 112.312 0.486 . . . . 0.42 112.312 -179.429 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 299' ' ' PHE . . . . . . . . . . . . . 88.2 t80 -70.12 -52.68 21.74 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 111.694 0.257 . . . . 0.46 111.694 179.448 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 300' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -85.08 30.18 0.61 Allowed 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 120.827 0.346 . . . . 0.41 111.67 -179.578 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 2.6 m170 -152.8 -169.28 3.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.246 0.546 . . . . 0.5 111.352 -179.325 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 5.4 p -99.87 164.65 2.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-N 115.866 -0.606 . . . . 0.59 110.343 179.474 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 303' ' ' GLN . . . . . 0.682 ' HB3' ' HA2' ' A' ' 307' ' ' GLY . 62.5 mt-30 -131.04 117.49 19.23 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.93 0.395 . . . . 0.61 111.532 -179.522 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -124.64 -79.26 0.61 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.055 -0.521 . . . . 0.9 109.967 179.018 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 96.1 mt -84.1 -15.33 47.73 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.414 0.626 . . . . 0.93 109.799 178.648 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.88 20.49 17.49 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.221 -0.9 . . . . 0.55 111.123 179.708 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 307' ' ' GLY . . . . . 0.682 ' HA2' ' HB3' ' A' ' 303' ' ' GLN . . . -75.93 57.42 3.11 Favored Glycine 0 CA--C 1.524 0.652 0 C-N-CA 120.966 -0.635 . . . . 0.67 113.507 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 308' ' ' GLY . . . . . 0.421 ' C ' HH12 ' A' ' 291' ' ' ARG . . . . . . . . 0 C--O 1.246 0.906 0 CA-C-O 118.907 -0.941 . . . . 0.95 112.715 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 121.269 0.557 . . . . 1.53 110.857 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.53 -77.68 0.23 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.539 -0.755 . . . . 1.19 111.275 -179.032 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 19' ' ' LEU . . . . . 0.57 HD23 ' HD2' ' B' ' 20' ' ' PRO . 0.8 OUTLIER -99.15 117.98 63.29 Favored Pre-proline 0 C--O 1.234 0.261 0 CA-C-N 116.52 -0.309 . . . . 0.74 111.497 -179.749 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 20' ' ' PRO . . . . . 0.57 ' HD2' HD23 ' B' ' 19' ' ' LEU . 18.8 Cg_endo -57.78 136.84 77.96 Favored 'Trans proline' 0 CA--C 1.534 0.482 0 C-N-CA 122.874 2.383 . . . . 0.78 112.258 179.087 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 21' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -71.15 40.4 0.37 Allowed 'Trans proline' 0 CA--C 1.537 0.638 0 C-N-CA 122.808 2.339 . . . . 1.12 113.683 -179.433 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -87.46 -30.42 20.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.7 -0.227 . . . . 0.68 111.096 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 23' ' ' PHE . . . . . 0.513 ' HE2' HD22 ' B' ' 19' ' ' LEU . 0.8 OUTLIER -58.29 -40.16 81.23 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.276 0.56 . . . . 0.48 110.715 179.125 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -70.52 -40.33 73.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.008 -0.542 . . . . 0.32 110.427 178.792 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 25' ' ' ALA . . . . . 0.433 ' O ' ' HB3' ' B' ' 28' ' ' ARG . . . -64.15 -37.38 87.24 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 116.133 -0.485 . . . . 0.33 110.808 178.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -62.74 -54.26 41.85 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.012 -0.54 . . . . 0.5 110.419 178.72 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 95.9 mt -58.96 -34.36 71.71 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.134 0.492 . . . . 0.35 109.833 178.167 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 28' ' ' ARG . . . . . 0.433 ' HB3' ' O ' ' B' ' 25' ' ' ALA . 1.1 ttt180 -59.84 -51.04 71.44 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 115.43 -0.805 . . . . 0.58 110.111 177.854 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -67.66 -40.14 84.53 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.304 -0.407 . . . . 0.89 111.264 179.157 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 96.5 mt -62.68 -46.9 95.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-O 120.962 0.41 . . . . 0.43 110.318 178.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.35 -48.34 86.47 Favored Glycine 0 N--CA 1.45 -0.419 0 CA-C-N 115.72 -0.673 . . . . 0.27 112.871 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -64.6 -37.87 89.06 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.917 0.359 . . . . 0.47 111.548 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 33' ' ' LYS . . . . . 0.404 ' HE2' ' HB2' ' B' ' 33' ' ' LYS . 20.7 ttmm -63.72 -47.78 79.73 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-O 121.121 0.486 . . . . 1.21 110.255 178.573 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 55.5 t -65.06 -46.69 90.59 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 CA-C-N 115.844 -0.616 . . . . 0.48 110.532 178.676 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 35' ' ' TYR . . . . . 0.454 ' HB2' ' H ' ' A' ' 243' ' ' GLY . 1.3 t80 -56.08 -48.54 75.9 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 115.824 -0.625 . . . . 0.83 111.743 179.668 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 36' ' ' CYS . . . . . . . . . . . . . 84.2 m -64.51 -35.35 80.67 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 120.812 0.339 . . . . 0.58 111.543 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 63.1 m -67.92 -40.99 83.29 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 112.227 0.455 . . . . 0.66 112.227 -179.682 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 38' ' ' TRP . . . . . . . . . . . . . 97.8 m95 -87.41 -18.54 29.74 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.498 0.555 . . . . 0.7 112.498 -179.19 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 28.8 t -70.55 -18.2 62.93 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 112.054 0.39 . . . . 0.89 112.054 179.49 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.39 118.45 56.73 Favored Pre-proline 0 CA--C 1.533 0.307 0 CA-C-O 120.763 0.316 . . . . 0.89 111.363 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -80.36 -13.84 12.11 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.688 2.259 . . . . 1.8 113.075 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -77.02 80.04 3.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.119 -0.491 . . . . 1.67 111.026 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 43' ' ' MET . . . . . . . . . . . . . 24.3 mmt . . . . . 0 C--O 1.251 1.146 0 CA-C-O 118.345 -0.836 . . . . 2.41 111.313 -179.871 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.238 0 N-CA-C 112.535 -0.226 . . . . 0.6 112.535 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -64.55 -28.44 61.48 Favored 'Trans proline' 0 CA--C 1.536 0.61 0 C-N-CA 122.658 2.239 . . . . 0.8 113.073 179.415 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.422 ' HB3' ' OD1' ' A' ' 153' ' ' ASP . 43.2 tp -119.09 -69.39 0.85 Allowed 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 120.841 0.353 . . . . 0.85 110.967 179.577 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -148.78 -100.05 0.22 Allowed Glycine 0 CA--C 1.518 0.265 0 C-N-CA 120.521 -0.847 . . . . 0.69 112.55 179.387 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.52 ' HB2' HG21 ' A' ' 288' ' ' VAL . 17.6 p -126.71 -30.64 2.77 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.088 0.471 . . . . 0.43 110.957 179.432 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 52.7 tt0 -58.48 -47.41 84.17 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.816 -0.629 . . . . 0.39 111.704 179.794 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' ASP . . . . . 0.534 ' O ' ' HG3' ' A' ' 157' ' ' ARG . 0.1 OUTLIER -49.84 -52.03 35.59 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 115.655 -0.702 . . . . 0.54 112.711 -179.839 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 -60.88 -43.66 98.13 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.185 0.517 . . . . 0.46 111.391 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.558 HD21 ' HB3' ' A' ' 287' ' ' LEU . 27.1 tp -63.89 -49.35 73.04 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.754 -0.657 . . . . 0.88 110.231 179.377 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 44.4 t80 -58.8 -43.57 90.55 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 115.885 -0.598 . . . . 0.42 111.45 179.696 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.682 ' HD2' ' OE2' ' A' ' 182' ' ' GLU . 51.5 mtm180 -60.08 -52.71 64.21 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.698 0.285 . . . . 0.4 111.13 179.556 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -63.05 -45.27 93.01 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.541 -0.3 . . . . 0.54 110.781 179.155 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' SER . . . . . 0.543 ' HA ' ' CZ2' ' A' ' 293' ' ' TRP . 21.1 m -58.93 -56.92 16.0 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.384 -0.371 . . . . 0.27 111.375 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.695 HD11 ' HG2' ' A' ' 273' ' ' GLU . 12.7 tp -54.55 -48.88 71.49 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.751 -0.204 . . . . 0.77 111.474 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 161' ' ' GLU . . . . . 0.533 ' OE2' ' HB3' ' A' ' 180' ' ' LEU . 0.1 OUTLIER -57.49 -54.25 48.93 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 111.85 0.315 . . . . 0.74 111.85 179.889 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 74.7 mt -62.28 -43.43 98.0 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 N-CA-C 111.871 0.323 . . . . 0.33 111.871 -179.524 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.644 ' O ' ' HG ' ' A' ' 167' ' ' LEU . 87.0 mt -64.43 -48.42 85.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 N-CA-C 110.225 -0.287 . . . . 0.35 110.225 179.211 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 6.8 t -58.42 -44.63 89.18 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.409 -0.36 . . . . 0.31 110.282 178.721 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 165' ' ' ARG . . . . . 0.432 HH11 ' HD2' ' A' ' 165' ' ' ARG . 2.6 mmt180 -59.12 -51.98 67.71 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.121 -0.491 . . . . 0.38 111.89 178.942 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 166' ' ' TYR . . . . . 0.711 ' CE1' ' HA ' ' A' ' 195' ' ' ARG . 51.6 t80 -60.57 -49.77 76.22 Favored 'General case' 0 CA--C 1.527 0.085 0 N-CA-C 112.399 0.518 . . . . 0.45 112.399 -179.042 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.644 ' HG ' ' O ' ' A' ' 163' ' ' ILE . 11.8 mt -67.14 -33.74 76.08 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 120.225 -0.59 . . . . 0.36 111.293 -178.91 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 21.5 ttp180 -69.75 -52.62 23.77 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 111.803 0.297 . . . . 0.43 111.803 179.359 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -61.65 -48.41 80.99 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 111.838 0.31 . . . . 0.28 111.838 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.36 -40.73 91.85 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.09 -0.505 . . . . 0.32 112.12 -179.726 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.447 ' HB1' ' HB2' ' A' ' 260' ' ' LYS . . . -75.76 -34.96 60.29 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 112.114 0.413 . . . . 0.32 112.114 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 83.4 m -71.15 -41.29 70.62 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 112.0 0.37 . . . . 0.48 112.0 -179.486 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 104.88 10.14 33.2 Favored Glycine 0 CA--C 1.52 0.391 0 C-N-CA 120.591 -0.814 . . . . 0.56 112.48 -179.571 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 32.6 t -129.36 121.05 26.63 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.985 -0.376 . . . . 0.6 109.985 179.755 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 4.7 tmtm? -102.09 135.54 43.5 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.238 0.542 . . . . 0.5 112.445 -178.571 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -108.06 143.05 37.32 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 115.734 -0.666 . . . . 0.43 110.705 179.499 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 4.9 t -107.0 -3.18 20.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.934 0.397 . . . . 0.67 111.917 -179.534 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 178' ' ' LYS . . . . . 0.481 ' HB3' ' HD2' ' A' ' 179' ' ' PRO . 7.0 mtmp? -79.55 162.99 61.16 Favored Pre-proline 0 CA--C 1.537 0.448 0 CA-C-O 120.709 0.29 . . . . 0.98 111.587 -179.701 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 179' ' ' PRO . . . . . 0.481 ' HD2' ' HB3' ' A' ' 178' ' ' LYS . 40.2 Cg_endo -67.51 170.64 13.26 Favored 'Trans proline' 0 CA--C 1.535 0.569 0 C-N-CA 122.358 2.039 . . . . 0.55 113.275 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.619 ' HB2' ' O ' ' A' ' 183' ' ' ALA . 10.5 mp -94.24 -168.69 1.9 Allowed 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 115.955 -0.566 . . . . 0.49 111.034 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -74.85 -54.25 5.95 Favored Glycine 0 C--N 1.331 0.294 0 C-N-CA 120.65 -0.786 . . . . 0.49 112.131 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 182' ' ' GLU . . . . . 0.682 ' OE2' ' HD2' ' A' ' 157' ' ' ARG . 31.5 mt-10 -108.05 -42.91 4.53 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.388 0.614 . . . . 0.42 109.671 179.065 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.619 ' O ' ' HB2' ' A' ' 180' ' ' LEU . . . -82.62 79.21 9.1 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 115.794 -0.639 . . . . 0.35 110.768 179.128 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -78.74 -71.01 1.27 Allowed Glycine 0 CA--C 1.524 0.655 0 C-N-CA 120.617 -0.801 . . . . 0.35 113.993 -179.242 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -70.78 -55.43 8.6 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-O 120.923 0.392 . . . . 0.4 111.189 -179.623 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -63.51 -35.56 80.85 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 116.064 -0.516 . . . . 0.34 110.369 178.811 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 187' ' ' GLY . . . . . 0.561 ' HA3' ' O ' ' A' ' 183' ' ' ALA . . . -64.32 -34.83 90.98 Favored Glycine 0 C--N 1.336 0.559 0 CA-C-N 116.017 -0.538 . . . . 0.31 112.648 179.464 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 1.2 mmm-85 -68.04 -57.84 5.47 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 109.589 -0.523 . . . . 0.6 109.589 178.241 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 189' ' ' ARG . . . . . 0.521 ' HB3' HG11 ' A' ' 297' ' ' VAL . 44.5 mtp180 -56.73 -48.34 77.97 Favored 'General case' 0 C--O 1.226 -0.176 0 CA-C-N 115.53 -0.759 . . . . 0.7 111.2 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.604 ' O ' ' HB2' ' A' ' 194' ' ' LEU . . . -60.85 -37.74 83.11 Favored 'General case' 0 C--O 1.224 -0.265 0 N-CA-C 111.849 0.314 . . . . 0.28 111.849 -179.583 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 191' ' ' LEU . . . . . 0.484 ' HB2' ' O ' ' A' ' 187' ' ' GLY . 7.8 tp -66.46 -42.5 87.49 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.95 0.405 . . . . 0.65 110.385 179.199 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -66.33 -46.81 75.57 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.069 -0.514 . . . . 0.32 110.573 178.742 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 193' ' ' THR . . . . . 0.581 HG21 ' HA ' ' A' ' 297' ' ' VAL . 5.6 m -62.34 -43.87 97.8 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.985 0.421 . . . . 0.27 109.936 178.266 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 0.604 ' HB2' ' O ' ' A' ' 190' ' ' ALA . 6.4 tp -62.2 -43.55 98.58 Favored 'General case' 0 C--O 1.224 -0.278 0 CA-C-N 115.585 -0.734 . . . . 0.4 110.672 178.901 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 195' ' ' ARG . . . . . 0.711 ' HA ' ' CE1' ' A' ' 166' ' ' TYR . 0.0 OUTLIER -65.01 -38.34 90.61 Favored 'General case' 0 C--O 1.224 -0.271 0 CA-C-O 121.292 0.568 . . . . 0.75 110.37 178.939 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 196' ' ' ARG . . . . . 0.43 ' HG2' ' CD2' ' A' ' 301' ' ' HIS . 0.9 OUTLIER -67.5 -60.06 2.87 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.968 -0.56 . . . . 0.37 112.076 -179.739 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 7.0 t -71.19 -45.69 69.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 111.836 0.31 . . . . 0.36 111.836 -178.826 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -57.21 -45.17 92.93 Favored Glycine 0 CA--C 1.522 0.514 0 C-N-CA 121.465 -0.398 . . . . 0.29 113.538 -179.457 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 199' ' ' ASP . . . . . 0.515 ' O ' ' HB2' ' A' ' 203' ' ' ARG . 2.7 m-20 -73.92 -32.58 63.59 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 117.059 0.43 . . . . 0.49 110.713 179.725 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -68.85 -48.42 48.79 Favored Glycine 0 CA--C 1.524 0.653 0 C-N-CA 120.946 -0.645 . . . . 0.29 112.677 178.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 76.7 t -61.36 -48.69 87.72 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-N 116.745 0.272 . . . . 0.37 111.123 179.413 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 202' ' ' GLN . . . . . 0.41 ' HB2' ' CD1' ' A' ' 254' ' ' PHE . 7.2 pt20 -62.33 -32.58 73.36 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.369 -0.378 . . . . 0.38 111.397 179.727 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 203' ' ' ARG . . . . . 0.515 ' HB2' ' O ' ' A' ' 199' ' ' ASP . 0.0 OUTLIER -77.46 -38.95 48.29 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 120.712 0.291 . . . . 0.61 111.027 179.532 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -71.44 -52.37 18.85 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 116.226 -0.443 . . . . 0.39 111.449 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 33.4 m-70 -97.27 36.25 1.49 Allowed 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 120.863 0.363 . . . . 0.41 110.855 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -58.16 -37.62 75.05 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 113.038 0.755 . . . . 0.72 113.038 -178.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 4.1 t -56.89 -37.28 71.16 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 120.931 0.396 . . . . 0.5 111.902 -179.156 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -75.06 -43.42 53.43 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 121.124 0.487 . . . . 0.41 111.001 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 209' ' ' PHE . . . . . 0.418 ' O ' ' HB2' ' A' ' 213' ' ' LEU . 56.2 m-85 -66.56 -39.18 88.37 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 115.871 -0.604 . . . . 0.43 110.943 179.748 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 210' ' ' GLN . . . . . 0.406 ' O ' ' HG2' ' A' ' 214' ' ' ARG . 0.6 OUTLIER -64.7 -45.25 87.42 Favored 'General case' 0 C--O 1.222 -0.371 0 CA-C-N 116.515 -0.311 . . . . 0.67 111.251 179.634 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -56.77 -48.43 78.05 Favored Glycine 0 CA--C 1.523 0.564 0 C-N-CA 120.251 -0.976 . . . . 0.31 111.766 178.592 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 212' ' ' MET . . . . . 0.546 ' O ' ' HB2' ' A' ' 216' ' ' LEU . 49.2 mtp -67.06 -34.0 76.73 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 115.637 -0.281 . . . . 0.77 111.296 178.899 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.602 HD21 ' HB2' ' A' ' 258' ' ' HIS . 1.0 OUTLIER -75.73 -37.61 59.22 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 112.205 0.446 . . . . 0.41 112.205 -179.949 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 214' ' ' ARG . . . . . 0.406 ' HG2' ' O ' ' A' ' 210' ' ' GLN . 33.2 mmt180 -64.12 -35.14 79.78 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.89 0.376 . . . . 1.12 110.079 179.028 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 215' ' ' LYS . . . . . 0.52 ' HE2' ' HA ' ' A' ' 215' ' ' LYS . 0.0 OUTLIER -95.7 12.51 29.61 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 121.171 0.51 . . . . 0.66 110.585 177.91 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.634 ' HG ' HG13 ' A' ' 218' ' ' ILE . 10.1 tp -93.84 99.22 11.63 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.211 -0.45 . . . . 0.49 110.934 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -93.94 33.25 1.35 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.261 -0.427 . . . . 0.84 110.985 179.6 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 218' ' ' ILE . . . . . 0.634 HG13 ' HG ' ' A' ' 216' ' ' LEU . 16.1 mt -61.86 108.52 0.52 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.495 0 CA-C-O 121.748 0.785 . . . . 0.49 111.826 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 1.6 ttpm? -161.61 17.51 0.1 Allowed 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 114.945 -1.025 . . . . 1.86 110.878 -179.774 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -139.04 160.75 39.03 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-O 120.864 0.364 . . . . 0.56 111.397 -179.088 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -62.51 -22.99 66.7 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.015 0.436 . . . . 0.76 111.733 179.645 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -74.7 -26.04 68.29 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 120.94 -0.648 . . . . 0.59 113.508 179.55 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 223' ' ' ASP . . . . . 0.424 ' HB3' HG12 ' A' ' 218' ' ' ILE . 71.9 m-20 -61.65 -43.97 97.84 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 113.011 0.745 . . . . 0.79 113.011 -178.795 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.522 HG23 ' HD2' ' A' ' 225' ' ' LYS . 29.9 m -59.86 -28.71 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 N-CA-C 112.123 0.416 . . . . 0.6 112.123 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 225' ' ' LYS . . . . . 0.522 ' HD2' HG23 ' A' ' 224' ' ' VAL . 11.9 mptt -64.28 -42.05 96.62 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 121.318 0.58 . . . . 0.9 109.847 178.871 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 226' ' ' SER . . . . . 0.603 ' O ' HG23 ' A' ' 230' ' ' VAL . 3.5 m -71.0 -38.72 72.69 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.787 -0.642 . . . . 0.86 109.577 178.032 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 227' ' ' PHE . . . . . 0.492 ' HE1' HG12 ' A' ' 275' ' ' ILE . 8.8 t80 -56.02 -43.83 78.16 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 115.84 -0.618 . . . . 0.57 109.863 177.935 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 228' ' ' SER . . . . . 0.417 ' O ' HG23 ' A' ' 232' ' ' VAL . 39.2 m -61.59 -44.54 96.83 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.634 -0.712 . . . . 0.37 110.022 178.067 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 229' ' ' ARG . . . . . 0.491 ' NH1' ' HA ' ' A' ' 226' ' ' SER . 4.2 ttm105 -61.01 -38.86 87.55 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 115.806 -0.634 . . . . 0.82 110.935 178.874 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 0.603 HG23 ' O ' ' A' ' 226' ' ' SER . 97.0 t -55.88 -52.56 47.8 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-N 116.164 -0.471 . . . . 0.39 110.587 178.683 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 231' ' ' MET . . . . . 0.628 ' HG2' HD22 ' A' ' 248' ' ' LEU . 72.3 mtm -59.98 -38.0 81.25 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.07 -0.514 . . . . 0.41 111.471 179.405 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 232' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 228' ' ' SER . 84.6 t -62.76 -42.49 96.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-O 120.771 0.319 . . . . 0.4 110.812 179.151 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 233' ' ' HIS . . . . . 0.432 ' HB3' ' HB1' ' B' ' 24' ' ' ALA . 48.7 t-80 -63.44 -35.61 81.01 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 120.84 0.353 . . . . 0.44 111.164 179.166 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 97.2 t -63.16 -38.19 81.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-O 121.114 0.483 . . . . 0.36 111.42 179.379 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 235' ' ' PHE . . . . . 0.522 ' HE2' HD11 ' A' ' 248' ' ' LEU . 62.2 m-85 -103.54 23.89 11.93 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.271 -0.422 . . . . 0.54 111.517 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 3.9 ttpp -69.83 -1.4 9.26 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 113.297 0.851 . . . . 0.76 113.297 -178.72 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 6.2 p30 -102.87 -16.13 15.99 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.949 0.404 . . . . 0.4 111.038 179.377 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 94.19 -6.48 72.19 Favored Glycine 0 CA--C 1.522 0.487 0 C-N-CA 120.905 -0.664 . . . . 0.33 112.605 -179.363 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 7.9 t -81.01 112.01 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.139 0 CA-C-O 121.157 0.504 . . . . 0.31 111.199 -179.306 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 240' ' ' THR . . . . . 0.438 ' HB ' ' CE2' ' A' ' 286' ' ' TRP . 1.2 m -94.43 101.62 13.55 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 120.777 -0.369 . . . . 0.31 111.444 179.505 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -110.31 139.08 45.86 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.396 -0.366 . . . . 0.88 110.713 179.635 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 242' ' ' TRP . . . . . 0.588 ' HB3' ' CE2' ' A' ' 300' ' ' PHE . 16.0 m95 -57.98 -42.82 85.91 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 120.625 0.25 . . . . 0.41 111.446 179.443 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 243' ' ' GLY . . . . . 0.455 ' H ' ' HB2' ' B' ' 35' ' ' TYR . . . -60.26 -28.83 67.53 Favored Glycine 0 CA--C 1.522 0.514 0 C-N-CA 121.306 -0.473 . . . . 0.27 112.775 178.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 244' ' ' ARG . . . . . 0.449 ' O ' ' HG ' ' A' ' 248' ' ' LEU . 94.3 mtt180 -71.42 -46.86 59.08 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.349 -0.612 . . . . 0.36 109.349 178.422 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 74.8 mt -60.93 -45.45 98.32 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-N 115.376 -0.829 . . . . 0.42 111.074 179.365 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 246' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 242' ' ' TRP . 61.3 t -62.52 -40.62 88.87 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-O 120.608 0.242 . . . . 0.49 111.015 179.269 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 55.1 m -57.67 -40.8 80.2 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.479 -0.328 . . . . 0.33 110.756 179.278 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 248' ' ' LEU . . . . . 0.628 HD22 ' HG2' ' A' ' 231' ' ' MET . 69.8 mt -61.63 -36.71 81.54 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 121.047 0.451 . . . . 0.45 110.298 178.229 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 29.5 mm -74.23 -38.98 48.99 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.133 0 CA-C-N 116.292 -0.413 . . . . 0.37 110.107 178.692 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 16.5 t -60.76 -42.77 98.09 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 108.921 -0.77 . . . . 0.27 108.921 178.097 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 251' ' ' PHE . . . . . 0.517 ' O ' HG23 ' A' ' 255' ' ' VAL . 19.7 t80 -64.85 -42.85 94.57 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 108.599 -0.889 . . . . 0.45 108.599 176.87 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -56.65 -40.31 87.86 Favored Glycine 0 C--N 1.337 0.616 0 N-CA-C 111.434 -0.667 . . . . 0.26 111.434 177.665 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -63.05 -37.48 87.36 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 120.956 0.408 . . . . 0.29 110.539 177.764 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 254' ' ' PHE . . . . . 0.418 ' HD2' HD13 ' A' ' 213' ' ' LEU . 0.2 OUTLIER -69.71 -38.9 77.1 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.066 -0.515 . . . . 0.75 109.952 178.329 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 255' ' ' VAL . . . . . 0.615 ' O ' ' HG ' ' A' ' 259' ' ' LEU . 59.8 t -67.53 -42.33 86.82 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.209 0 CA-C-N 116.079 -0.509 . . . . 0.31 109.719 178.281 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -57.96 -43.55 86.48 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 109.525 -0.546 . . . . 0.28 109.525 177.076 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 60.8 mttt -62.55 -43.45 98.78 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.7 -0.682 . . . . 0.5 109.982 177.816 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 258' ' ' HIS . . . . . 0.602 ' HB2' HD21 ' A' ' 213' ' ' LEU . 36.0 t60 -61.63 -44.38 97.1 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.935 -0.575 . . . . 0.87 110.465 178.534 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.615 ' HG ' ' O ' ' A' ' 255' ' ' VAL . 80.3 mt -67.42 -47.21 70.9 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 115.906 -0.588 . . . . 0.49 110.917 179.475 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 260' ' ' LYS . . . . . 0.447 ' HB2' ' HB1' ' A' ' 171' ' ' ALA . 0.5 OUTLIER -61.74 -32.49 72.74 Favored 'General case' 0 CA--C 1.535 0.369 0 O-C-N 122.386 -0.196 . . . . 0.6 110.99 179.526 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 69.3 m -60.95 -31.13 70.69 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.108 0.48 . . . . 0.47 110.588 178.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 28.4 m -110.18 20.66 5.82 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 CA-C-N 115.888 -0.597 . . . . 0.52 110.907 179.195 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 55.01 51.1 14.06 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 115.609 -0.723 . . . . 1.1 112.927 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -106.93 36.15 2.76 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.489 -0.323 . . . . 0.57 111.55 179.639 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 265' ' ' GLU . . . . . 0.487 ' HA ' HD12 ' A' ' 268' ' ' ILE . 0.8 OUTLIER -51.42 -38.91 55.98 Favored 'General case' 0 C--O 1.242 0.659 0 CA-C-O 120.922 0.391 . . . . 0.82 111.943 179.614 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 36.0 p -64.38 -12.93 47.59 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.787 -0.642 . . . . 0.7 111.537 179.244 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 267' ' ' PHE . . . . . 0.464 ' C ' ' HD2' ' A' ' 270' ' ' PRO . 14.9 t80 -105.3 -25.19 12.52 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.626 -0.509 . . . . 0.78 109.626 178.327 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 268' ' ' ILE . . . . . 0.487 HD12 ' HA ' ' A' ' 265' ' ' GLU . 70.3 mt -59.8 -50.01 81.68 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-N 115.957 -0.565 . . . . 0.4 110.947 179.055 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 269' ' ' GLU . . . . . 0.709 ' HB3' ' HD3' ' A' ' 270' ' ' PRO . 1.2 tp10 -57.03 -55.63 41.94 Favored Pre-proline 0 CA--C 1.547 0.853 0 C-N-CA 120.812 -0.355 . . . . 0.81 110.487 179.109 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 270' ' ' PRO . . . . . 0.709 ' HD3' ' HB3' ' A' ' 269' ' ' GLU . 52.1 Cg_exo -58.86 -29.71 90.88 Favored 'Trans proline' 0 C--N 1.364 1.378 0 C-N-CA 122.464 2.11 . . . . 0.35 112.392 177.44 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 271' ' ' LEU . . . . . 0.439 ' O ' HG13 ' A' ' 275' ' ' ILE . 1.5 tm? -67.09 -43.38 82.7 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 108.746 -0.835 . . . . 0.5 108.746 177.775 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -64.05 -35.86 82.1 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.563 -0.744 . . . . 0.31 109.0 177.148 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 273' ' ' GLU . . . . . 0.695 ' HG2' HD11 ' A' ' 160' ' ' LEU . 52.5 mt-10 -66.06 -44.82 83.42 Favored 'General case' 0 C--O 1.222 -0.379 0 CA-C-N 115.662 -0.699 . . . . 0.76 109.217 177.27 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 274' ' ' THR . . . . . . . . . . . . . 89.9 m -55.6 -46.89 77.24 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.713 -0.676 . . . . 0.52 110.578 178.724 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 275' ' ' ILE . . . . . 0.578 ' HA ' ' HE1' ' A' ' 231' ' ' MET . 72.9 mt -63.04 -55.42 23.65 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.128 0 CA-C-N 115.936 -0.575 . . . . 0.41 110.853 179.316 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 5.6 m -57.38 -47.81 80.71 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.009 -0.542 . . . . 0.37 112.052 -179.41 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 277' ' ' ASP . . . . . 0.471 ' HB2' ' O ' ' A' ' 273' ' ' GLU . 0.1 OUTLIER -52.61 -57.17 10.88 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.488 -0.324 . . . . 0.63 111.52 -179.867 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 278' ' ' VAL . . . . . 0.405 ' HB ' ' CE ' ' A' ' 231' ' ' MET . 48.5 t -66.33 -37.11 78.95 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 N-CA-C 111.915 0.339 . . . . 0.42 111.915 -179.694 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 41.4 tp -64.78 -47.11 79.34 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 111.971 0.36 . . . . 0.86 111.971 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 86.7 t -73.68 -32.39 35.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 CA-C-O 121.009 0.433 . . . . 0.53 111.186 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 281' ' ' ARG . . . . . 0.449 HH11 ' HD2' ' A' ' 281' ' ' ARG . 2.0 tpm_? -71.81 -43.52 65.48 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 112.439 0.533 . . . . 0.38 112.439 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 282' ' ' THR . . . . . . . . . . . . . 3.4 m -78.29 -26.53 47.06 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 112.981 0.734 . . . . 0.47 112.981 -178.399 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 63.9 mmtt -129.83 41.64 3.4 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 112.257 0.465 . . . . 0.73 112.257 -179.063 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.65 -62.06 1.89 Allowed 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 113.661 0.985 . . . . 0.44 113.661 -178.664 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -64.04 -42.32 97.11 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 112.794 0.665 . . . . 0.42 112.794 -178.334 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 286' ' ' TRP . . . . . 0.472 ' HE3' HD22 ' A' ' 287' ' ' LEU . 10.0 t90 -60.41 -50.19 74.58 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.733 0.301 . . . . 0.38 111.275 -179.756 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 287' ' ' LEU . . . . . 0.558 ' HB3' HD21 ' A' ' 155' ' ' LEU . 1.6 mm? -66.88 -42.76 85.04 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.319 0.489 . . . . 0.47 112.319 -179.3 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 288' ' ' VAL . . . . . 0.52 HG21 ' HB2' ' A' ' 151' ' ' SER . 0.3 OUTLIER -67.24 -35.8 74.99 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 N-CA-C 112.004 0.372 . . . . 1.04 112.004 -179.487 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 56.1 mttt -77.52 -34.41 54.01 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 112.159 0.429 . . . . 0.82 112.159 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 3.6 tp60 -81.05 23.89 0.54 Allowed 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 112.457 0.54 . . . . 0.73 112.457 -179.382 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 291' ' ' ARG . . . . . 0.708 ' HB3' ' HB2' ' A' ' 294' ' ' ASP . 3.1 mmt180 60.46 16.57 6.49 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.834 0.679 . . . . 0.48 112.834 179.696 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 47.63 -112.58 1.07 Allowed Glycine 0 CA--C 1.525 0.658 0 N-CA-C 114.637 0.615 . . . . 0.28 114.637 179.722 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 293' ' ' TRP . . . . . 0.543 ' CZ2' ' HA ' ' A' ' 159' ' ' SER . 86.0 m95 -66.74 -30.08 70.22 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.763 0.653 . . . . 0.36 112.763 -178.595 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 294' ' ' ASP . . . . . 0.708 ' HB2' ' HB3' ' A' ' 291' ' ' ARG . 15.5 m-20 -62.01 -42.92 99.68 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 121.049 0.452 . . . . 0.37 110.042 178.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -67.82 -41.86 87.69 Favored Glycine 0 CA--C 1.521 0.414 0 C-N-CA 120.639 -0.791 . . . . 0.32 111.885 178.834 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 296' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -67.39 -43.34 81.58 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 120.708 0.289 . . . . 0.34 111.315 179.524 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 297' ' ' VAL . . . . . 0.581 ' HA ' HG21 ' A' ' 193' ' ' THR . 50.3 t -65.89 -55.43 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-N 116.412 -0.358 . . . . 0.27 111.664 -179.32 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -62.56 -30.91 71.67 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 112.709 0.633 . . . . 0.73 112.709 -178.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 299' ' ' PHE . . . . . . . . . . . . . 93.1 t80 -76.54 -40.82 48.81 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 112.372 0.508 . . . . 0.45 112.372 179.643 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 300' ' ' PHE . . . . . 0.588 ' CE2' ' HB3' ' A' ' 242' ' ' TRP . 62.1 m-85 -93.99 -50.92 5.09 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 114.036 1.124 . . . . 0.39 114.036 -178.044 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 301' ' ' HIS . . . . . 0.43 ' CD2' ' HG2' ' A' ' 196' ' ' ARG . 0.1 OUTLIER -170.17 134.12 1.2 Allowed 'General case' 0 N--CA 1.468 0.432 0 O-C-N 121.88 -0.513 . . . . 0.47 112.318 -177.962 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 31.2 t -100.32 -63.91 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.143 0.497 . . . . 0.51 109.934 178.6 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 303' ' ' GLN . . . . . 0.427 ' HB3' ' H ' ' A' ' 304' ' ' ASP . 23.1 mm-40 -138.06 -157.71 0.8 Allowed 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.037 -0.529 . . . . 0.71 109.871 178.899 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 304' ' ' ASP . . . . . 0.427 ' H ' ' HB3' ' A' ' 303' ' ' GLN . 0.4 OUTLIER -92.24 3.49 55.24 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.225 0.536 . . . . 0.65 110.956 179.152 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 29.5 tp -71.49 -22.36 61.81 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 115.814 -0.63 . . . . 0.77 111.1 179.805 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -84.71 -20.37 31.29 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.308 -0.405 . . . . 0.71 111.473 179.678 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . 83.64 139.49 3.89 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 121.052 -0.594 . . . . 0.73 113.6 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.005 0 CA-C-O 118.641 -1.088 . . . . 0.65 113.466 179.392 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 17' ' ' ALA . . . . . 0.411 ' HA ' ' HE3' ' A' ' 215' ' ' LYS . . . . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.06 0.457 . . . . 0.92 111.409 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -68.18 157.95 34.26 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.643 -0.708 . . . . 1.39 111.3 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 20.1 mt -113.68 125.94 28.81 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-O 120.949 0.404 . . . . 1.25 111.444 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 20' ' ' PRO . . . . . 0.485 ' HA ' ' HD3' ' B' ' 21' ' ' PRO . 58.5 Cg_endo -73.56 140.37 29.68 Favored 'Trans proline' 0 CA--C 1.533 0.44 0 C-N-CA 122.28 1.987 . . . . 0.94 112.17 179.444 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 21' ' ' PRO . . . . . 0.485 ' HD3' ' HA ' ' B' ' 20' ' ' PRO . 32.3 Cg_exo -59.49 0.49 0.53 Allowed 'Trans proline' 0 N--CA 1.481 0.791 0 C-N-CA 123.265 2.643 . . . . 0.88 113.735 -179.655 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -72.64 -13.25 61.32 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 111.851 0.315 . . . . 0.57 111.851 179.693 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 23' ' ' PHE . . . . . 0.479 ' HD1' ' N ' ' B' ' 24' ' ' ALA . 0.2 OUTLIER -59.91 -33.22 71.57 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.151 0.501 . . . . 0.65 111.077 179.317 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 24' ' ' ALA . . . . . 0.479 ' N ' ' HD1' ' B' ' 23' ' ' PHE . . . -75.83 -38.41 58.1 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.207 0.527 . . . . 0.33 110.027 179.268 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -66.78 -36.63 82.87 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.937 -0.574 . . . . 0.34 109.485 178.201 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -60.54 -51.98 67.12 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 115.822 -0.626 . . . . 0.41 110.23 177.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 94.9 mt -61.86 -30.83 71.12 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 121.052 0.453 . . . . 0.41 110.14 178.556 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 28' ' ' ARG . . . . . . . . . . . . . 34.9 ttm-85 -68.0 -51.46 46.92 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 115.534 -0.757 . . . . 0.46 110.152 178.604 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 59.6 mttt -57.0 -42.46 80.35 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.296 -0.411 . . . . 0.44 110.599 178.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 69.6 mt -69.45 -42.95 81.12 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 CA-C-N 116.305 -0.407 . . . . 0.35 110.157 178.839 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.08 -46.18 94.66 Favored Glycine 0 C--N 1.333 0.368 0 C-N-CA 121.056 -0.592 . . . . 0.26 112.299 179.039 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -64.85 -34.98 79.65 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-O 121.176 0.512 . . . . 0.76 110.375 179.114 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 14.2 tppt? -71.73 -47.66 52.33 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.057 -0.52 . . . . 0.73 111.116 179.416 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 55.5 t -62.68 -44.63 99.6 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-O 120.823 0.344 . . . . 0.35 111.009 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 35' ' ' TYR . . . . . 0.455 ' HB2' ' H ' ' A' ' 243' ' ' GLY . 0.0 OUTLIER -59.35 -47.24 86.16 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.155 -0.475 . . . . 0.77 110.468 179.102 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 36' ' ' CYS . . . . . . . . . . . . . 11.8 t -70.01 -36.05 74.82 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 116.259 -0.428 . . . . 0.57 111.913 -179.713 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 99.0 m -64.75 -40.04 94.63 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.209 0.448 . . . . 0.52 112.209 -179.784 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 38' ' ' TRP . . . . . . . . . . . . . 94.0 m95 -82.78 -31.28 28.33 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 120.821 -0.352 . . . . 0.72 111.781 -179.394 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 82.9 p -71.67 -26.01 62.35 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 120.737 0.303 . . . . 0.63 111.093 178.337 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -90.13 141.2 27.62 Favored Pre-proline 0 CA--C 1.533 0.292 0 CA-C-O 120.784 0.326 . . . . 0.74 111.452 179.623 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -81.64 -8.62 12.42 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 122.696 2.264 . . . . 1.19 113.489 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -79.17 78.93 5.62 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 120.994 0.426 . . . . 1.54 111.348 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 43' ' ' MET . . . . . . . . . . . . . 62.2 mtt . . . . . 0 C--O 1.251 1.142 0 CA-C-O 118.315 -0.85 . . . . 1.59 111.633 -179.718 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.438 0 N-CA-C 112.306 -0.318 . . . . 1.02 112.306 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -69.28 -23.44 32.98 Favored 'Trans proline' 0 CA--C 1.533 0.47 0 C-N-CA 122.515 2.144 . . . . 1.43 112.541 179.666 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 5.8 tp -133.02 148.13 52.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.201 -0.454 . . . . 1.72 110.323 179.687 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 128.66 45.96 0.18 Allowed Glycine 0 CA--C 1.523 0.573 0 C-N-CA 120.215 -0.993 . . . . 0.6 113.666 179.466 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 32.1 t -174.63 28.58 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 121.456 0.646 . . . . 0.56 109.92 179.062 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.41 -50.83 0.47 Allowed 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 115.218 -0.901 . . . . 0.49 111.781 -177.403 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -64.55 -40.9 96.44 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.831 0.348 . . . . 0.52 110.832 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -55.22 -48.34 74.03 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.007 -0.542 . . . . 0.44 110.805 178.926 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.601 HD21 ' HB3' ' A' ' 287' ' ' LEU . 47.6 tp -73.17 -36.08 66.54 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.091 -0.504 . . . . 0.73 110.783 178.675 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 64.3 t80 -60.06 -40.58 89.97 Favored 'General case' 0 C--O 1.224 -0.282 0 CA-C-N 116.223 -0.444 . . . . 0.36 111.489 179.643 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.502 ' HD2' ' OE2' ' A' ' 182' ' ' GLU . 7.6 mtm180 -56.22 -52.32 64.85 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.772 0.32 . . . . 0.35 111.552 179.48 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -64.89 -45.93 83.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.126 -0.488 . . . . 0.3 110.658 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' SER . . . . . 0.439 ' HA ' ' CZ2' ' A' ' 293' ' ' TRP . 15.6 m -58.35 -50.25 74.3 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.802 -0.635 . . . . 0.25 111.207 179.46 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -60.37 -47.57 85.5 Favored 'General case' 0 C--O 1.225 -0.219 0 CA-C-N 116.149 -0.478 . . . . 0.43 111.263 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' GLU . . . . . 0.482 ' HG2' HD23 ' A' ' 180' ' ' LEU . 44.0 tt0 -58.2 -50.28 74.08 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 120.633 0.254 . . . . 0.34 111.166 -179.708 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 84.9 mt -61.32 -50.14 81.65 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 CA-C-N 116.321 -0.4 . . . . 0.27 111.082 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.554 HD12 HG23 ' A' ' 276' ' ' THR . 68.4 mt -61.45 -46.53 96.38 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 N-CA-C 111.533 0.197 . . . . 0.38 111.533 179.389 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 2.0 t -56.28 -52.63 63.78 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.733 0.302 . . . . 0.31 110.807 178.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 40.0 ttt-85 -61.19 -41.54 96.99 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 120.768 0.318 . . . . 0.35 111.782 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 166' ' ' TYR . . . . . 0.495 ' HE1' ' HA ' ' A' ' 195' ' ' ARG . 80.9 t80 -68.37 -50.3 54.1 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 112.236 0.458 . . . . 0.28 112.236 -179.459 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.474 ' HG ' ' HA ' ' A' ' 253' ' ' ALA . 5.8 mp -54.57 -39.22 67.56 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.66 0.267 . . . . 0.42 111.101 -179.413 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 52.6 mtt-85 -65.32 -44.46 87.75 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.434 -0.348 . . . . 0.33 111.029 178.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -54.18 -45.1 72.04 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 121.111 0.481 . . . . 0.54 111.125 178.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 170' ' ' GLN . . . . . 0.759 ' HB2' ' HB1' ' A' ' 253' ' ' ALA . 12.3 mm100 -77.01 -37.36 55.17 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 116.18 -0.464 . . . . 0.38 111.951 -179.847 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.43 ' O ' ' HG3' ' A' ' 257' ' ' LYS . . . -65.86 -40.62 91.85 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.916 0.388 . . . . 0.26 110.715 178.954 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 35.2 p -78.6 -43.89 25.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.348 -0.387 . . . . 0.42 110.938 178.638 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 101.94 25.16 8.13 Favored Glycine 0 CA--C 1.522 0.499 0 C-N-CA 120.445 -0.883 . . . . 0.57 113.598 179.116 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 41.6 t -145.16 142.74 29.87 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.734 0.302 . . . . 0.87 111.049 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -90.63 104.62 17.19 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.792 0.33 . . . . 0.6 110.814 179.759 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -80.69 161.54 24.57 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.103 0.478 . . . . 0.43 110.869 -179.797 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 46.3 m -112.8 6.72 18.18 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.253 -0.43 . . . . 0.48 111.813 -179.575 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 38.1 mttp -61.29 123.84 77.9 Favored Pre-proline 0 N--CA 1.468 0.475 0 CA-C-O 120.836 0.35 . . . . 0.59 111.368 178.841 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -73.54 156.48 49.63 Favored 'Trans proline' 0 CA--C 1.535 0.56 0 C-N-CA 123.001 2.467 . . . . 0.68 113.822 -179.562 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.482 HD23 ' HG2' ' A' ' 161' ' ' GLU . 5.2 mp -87.88 168.01 13.27 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.701 -0.681 . . . . 0.55 111.213 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -111.23 -45.31 0.87 Allowed Glycine 0 CA--C 1.522 0.478 0 C-N-CA 120.9 -0.667 . . . . 0.49 113.295 -179.401 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 182' ' ' GLU . . . . . 0.502 ' OE2' ' HD2' ' A' ' 157' ' ' ARG . 0.0 OUTLIER -86.67 -58.94 2.42 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 121.235 0.541 . . . . 0.46 110.702 -179.833 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.625 ' O ' ' HA3' ' A' ' 187' ' ' GLY . . . -80.13 80.36 6.57 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.182 0.515 . . . . 0.32 111.439 -179.724 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -80.09 -71.97 1.24 Allowed Glycine 0 CA--C 1.524 0.643 0 C-N-CA 120.609 -0.805 . . . . 0.38 113.356 179.483 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -68.17 -55.61 11.71 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-O 120.979 0.418 . . . . 0.46 111.118 -179.608 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -65.18 -39.08 92.39 Favored 'General case' 0 C--O 1.218 -0.555 0 CA-C-N 115.904 -0.589 . . . . 0.41 110.077 178.733 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 187' ' ' GLY . . . . . 0.625 ' HA3' ' O ' ' A' ' 183' ' ' ALA . . . -60.6 -50.82 63.4 Favored Glycine 0 C--O 1.219 -0.79 0 C-N-CA 121.399 -0.429 . . . . 0.3 113.135 179.641 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 188' ' ' ARG . . . . . 0.427 HH11 ' HD2' ' A' ' 188' ' ' ARG . 13.4 mtp180 -56.84 -47.85 79.39 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 117.547 0.673 . . . . 1.34 111.484 179.234 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 189' ' ' ARG . . . . . 0.71 ' HB3' HG11 ' A' ' 297' ' ' VAL . 48.3 mtm180 -70.29 -41.0 73.95 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 112.479 0.548 . . . . 0.48 112.479 -179.438 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.536 ' HA ' HG22 ' A' ' 297' ' ' VAL . . . -74.22 -44.63 52.39 Favored 'General case' 0 C--O 1.221 -0.408 0 N-CA-C 111.873 0.323 . . . . 0.27 111.873 -178.649 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 3.4 tp -61.07 -49.32 77.83 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.679 -0.408 . . . . 0.45 110.319 179.645 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -61.08 -44.11 97.86 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 120.706 -0.398 . . . . 0.57 110.996 179.545 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 91.5 m -63.53 -46.19 87.13 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 110.026 -0.361 . . . . 0.32 110.026 178.769 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 59.8 tp -63.58 -37.27 86.68 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.075 -0.511 . . . . 0.39 111.184 179.196 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 195' ' ' ARG . . . . . 0.495 ' HA ' ' HE1' ' A' ' 166' ' ' TYR . 2.1 mtt180 -58.6 -48.34 81.28 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.819 0.342 . . . . 0.38 110.711 178.709 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 10.5 mmp_? -74.66 -45.12 46.75 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 116.149 -0.478 . . . . 0.4 111.868 -179.25 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 197' ' ' VAL . . . . . 0.479 ' O ' HG23 ' A' ' 201' ' ' VAL . 49.7 t -65.67 -51.55 61.18 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 CA-C-O 120.687 0.279 . . . . 0.35 111.628 179.529 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -62.31 -53.23 43.74 Favored Glycine 0 CA--C 1.521 0.435 0 CA-C-O 119.933 -0.371 . . . . 0.29 113.388 -179.456 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -55.18 -40.34 70.61 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 117.225 0.513 . . . . 0.4 109.763 179.011 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -60.36 -53.6 44.17 Favored Glycine 0 C--N 1.335 0.507 0 N-CA-C 111.138 -0.785 . . . . 0.36 111.138 177.837 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 201' ' ' VAL . . . . . 0.479 HG23 ' O ' ' A' ' 197' ' ' VAL . 98.9 t -58.29 -38.33 68.33 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-O 120.792 0.33 . . . . 0.39 110.691 178.461 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 202' ' ' GLN . . . . . 0.517 HE21 ' HD1' ' A' ' 254' ' ' PHE . 31.7 mt-30 -62.91 -54.2 42.23 Favored 'General case' 0 C--O 1.225 -0.228 0 CA-C-N 115.818 -0.628 . . . . 0.36 111.803 179.594 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 29.0 mtp180 -67.88 -36.34 80.07 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 121.028 -0.269 . . . . 0.57 111.434 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 10.9 m-80 -62.98 -50.95 68.73 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 121.181 0.515 . . . . 1.3 110.499 178.532 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 57.1 m-70 -101.85 35.89 2.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.214 -0.448 . . . . 0.47 111.233 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -53.47 -47.45 69.75 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 112.23 0.456 . . . . 0.43 112.23 -179.261 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 207' ' ' THR . . . . . 0.401 HG22 ' H ' ' A' ' 207' ' ' THR . 0.6 OUTLIER -56.34 -39.51 72.95 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 112.285 0.476 . . . . 0.47 112.285 -179.78 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -64.86 -48.79 73.01 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 120.989 0.424 . . . . 0.35 110.84 -179.802 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 209' ' ' PHE . . . . . 0.614 ' O ' ' HB2' ' A' ' 213' ' ' LEU . 46.3 m-85 -66.76 -35.27 79.71 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.94 -0.573 . . . . 0.56 109.912 178.692 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 210' ' ' GLN . . . . . 0.558 ' O ' ' HG2' ' A' ' 214' ' ' ARG . 49.5 mt-30 -66.12 -45.78 79.92 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.481 -0.327 . . . . 0.66 111.181 179.005 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -55.7 -49.03 67.8 Favored Glycine 0 C--N 1.336 0.574 0 N-CA-C 111.14 -0.784 . . . . 0.34 111.14 178.29 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -68.54 -29.86 68.53 Favored 'General case' 0 C--O 1.221 -0.42 0 CA-C-O 120.602 0.239 . . . . 0.65 110.367 178.144 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.614 ' HB2' ' O ' ' A' ' 209' ' ' PHE . 0.3 OUTLIER -69.55 -41.56 75.75 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.521 -0.309 . . . . 0.35 111.507 179.668 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 214' ' ' ARG . . . . . 0.558 ' HG2' ' O ' ' A' ' 210' ' ' GLN . 2.8 mmp_? -66.52 -40.03 88.95 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 121.185 0.517 . . . . 0.57 110.137 179.569 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 48.1 mtmt -91.87 13.15 19.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.888 -0.596 . . . . 0.58 111.94 179.711 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.467 HD21 HG13 ' A' ' 255' ' ' VAL . 7.4 tp -79.72 106.4 11.72 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 121.422 0.629 . . . . 0.46 111.34 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 217' ' ' ASP . . . . . 0.4 ' OD2' ' N ' ' B' ' 17' ' ' ALA . 28.2 t70 -84.13 -2.14 56.26 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 115.011 -0.995 . . . . 0.55 111.708 -179.341 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 218' ' ' ILE . . . . . 0.628 HG12 ' HB3' ' A' ' 223' ' ' ASP . 46.9 mt -53.71 114.37 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 N-CA-C 112.255 0.465 . . . . 0.39 112.255 -179.75 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 26.5 mtmm -138.11 -28.4 0.86 Allowed 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 115.982 -0.553 . . . . 0.84 112.424 -179.72 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -125.14 -179.37 4.54 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 113.017 0.747 . . . . 0.55 113.017 -178.251 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 221' ' ' GLU . . . . . 0.56 ' O ' HG22 ' A' ' 224' ' ' VAL . 1.2 mp0 -64.3 -22.05 66.82 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.448 -0.796 . . . . 0.59 111.376 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -71.49 -26.82 72.44 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 121.021 -0.609 . . . . 0.38 112.859 179.177 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 223' ' ' ASP . . . . . 0.628 ' HB3' HG12 ' A' ' 218' ' ' ILE . 39.3 m-20 -68.37 -31.45 70.84 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 112.283 0.475 . . . . 0.37 112.283 -179.632 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.661 ' HB ' HG21 ' A' ' 274' ' ' THR . 3.1 m -58.16 -27.67 32.63 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 CA-C-O 120.745 0.307 . . . . 0.43 111.73 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 225' ' ' LYS . . . . . 0.419 ' HD2' ' H ' ' A' ' 225' ' ' LYS . 6.1 mptt -65.16 -37.08 86.26 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.107 0.48 . . . . 0.82 109.9 178.768 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 226' ' ' SER . . . . . 0.627 ' O ' HG23 ' A' ' 230' ' ' VAL . 18.4 t -67.57 -44.13 78.93 Favored 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 109.176 -0.676 . . . . 0.36 109.176 178.214 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 227' ' ' PHE . . . . . 0.616 ' HE2' HG21 ' A' ' 255' ' ' VAL . 2.7 t80 -59.76 -39.96 86.57 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 115.391 -0.822 . . . . 0.43 110.19 178.495 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 228' ' ' SER . . . . . 0.598 ' HA ' ' HE3' ' A' ' 231' ' ' MET . 15.9 m -63.44 -39.48 94.58 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.168 0.508 . . . . 0.35 109.883 178.441 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 28.2 mtp180 -65.88 -35.51 80.84 Favored 'General case' 0 C--O 1.225 -0.202 0 CA-C-N 115.482 -0.781 . . . . 0.62 109.766 178.237 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 0.627 HG23 ' O ' ' A' ' 226' ' ' SER . 56.8 t -60.86 -51.18 76.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 109.879 -0.415 . . . . 0.36 109.879 177.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 231' ' ' MET . . . . . 0.613 ' HE1' ' HB ' ' A' ' 278' ' ' VAL . 56.5 mtm -55.73 -53.35 57.64 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.891 -0.595 . . . . 0.4 111.788 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 35.2 m -63.87 -30.91 51.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 120.861 -0.336 . . . . 0.4 111.167 179.388 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 233' ' ' HIS . . . . . 0.474 ' O ' ' HB3' ' A' ' 236' ' ' LYS . 44.5 t-80 -69.82 -39.56 76.41 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 120.962 0.41 . . . . 0.42 110.321 178.51 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 69.0 t -71.8 -41.0 70.03 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 CA-C-O 120.969 0.414 . . . . 0.38 111.046 178.71 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -87.9 12.73 12.43 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 120.954 0.407 . . . . 0.71 111.574 179.601 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 236' ' ' LYS . . . . . 0.51 ' O ' ' HG2' ' A' ' 236' ' ' LYS . 0.0 OUTLIER -68.99 -15.32 63.45 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 115.606 -0.725 . . . . 0.52 111.267 179.221 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 237' ' ' ASP . . . . . 0.456 ' HA ' ' NZ ' ' A' ' 236' ' ' LYS . 71.8 m-20 -75.86 -7.89 55.57 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 122.085 -0.385 . . . . 0.36 111.651 179.812 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 84.92 -19.97 18.28 Favored Glycine 0 CA--C 1.519 0.291 0 C-N-CA 121.014 -0.613 . . . . 0.4 112.773 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 2.5 t -91.97 108.89 20.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.148 0.499 . . . . 0.85 111.166 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 240' ' ' THR . . . . . 0.537 HG22 HD11 ' A' ' 245' ' ' ILE . 3.4 m -89.79 68.2 7.43 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.206 -0.452 . . . . 0.48 111.131 -179.793 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 241' ' ' ASN . . . . . 0.461 ' HB2' ' HG3' ' A' ' 244' ' ' ARG . 11.9 m120 -66.24 141.58 57.99 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.918 0.389 . . . . 0.4 111.431 -179.771 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 242' ' ' TRP . . . . . 0.491 ' CZ3' ' HB2' ' A' ' 296' ' ' PHE . 76.1 m95 -59.69 -36.35 76.31 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.282 -0.417 . . . . 0.43 110.369 178.931 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 243' ' ' GLY . . . . . 0.452 ' HA3' ' HB2' ' B' ' 35' ' ' TYR . . . -61.14 -31.75 77.97 Favored Glycine 0 C--N 1.335 0.5 0 C-N-CA 121.082 -0.58 . . . . 0.27 112.058 178.083 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 244' ' ' ARG . . . . . 0.539 ' HG2' ' HA3' ' B' ' 31' ' ' GLY . 81.6 mtt180 -75.76 -32.74 60.08 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 121.151 0.501 . . . . 0.36 109.914 178.684 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 245' ' ' ILE . . . . . 0.537 HD11 HG22 ' A' ' 240' ' ' THR . 78.1 mt -72.05 -49.63 42.73 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 CA-C-N 115.78 -0.646 . . . . 0.44 110.692 179.064 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 26.9 m -67.56 -31.51 52.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 C-N-CA 121.171 -0.212 . . . . 0.3 111.324 179.333 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 247' ' ' THR . . . . . 0.475 HG22 HD22 ' B' ' 27' ' ' LEU . 30.9 m -67.53 -40.5 85.07 Favored 'General case' 0 C--O 1.232 0.157 0 N-CA-C 109.134 -0.691 . . . . 0.37 109.134 177.863 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 248' ' ' LEU . . . . . 0.419 ' HA ' HD13 ' A' ' 248' ' ' LEU . 0.3 OUTLIER -61.5 -42.26 98.53 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 109.047 -0.723 . . . . 0.48 109.047 177.14 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 249' ' ' ILE . . . . . 0.439 HG13 ' O ' ' A' ' 245' ' ' ILE . 49.7 mt -63.36 -44.99 99.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.404 0 CA-C-N 115.812 -0.631 . . . . 0.39 110.219 178.105 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 250' ' ' SER . . . . . 0.505 ' HB3' ' HG3' ' A' ' 202' ' ' GLN . 40.3 m -58.98 -44.22 91.56 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.062 -0.517 . . . . 0.32 110.005 178.699 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 251' ' ' PHE . . . . . . . . . . . . . 21.7 t80 -63.67 -44.28 94.21 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 115.89 -0.596 . . . . 0.36 109.495 177.369 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -56.22 -44.61 89.04 Favored Glycine 0 C--N 1.336 0.552 0 C-N-CA 121.067 -0.587 . . . . 0.25 111.705 178.462 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 253' ' ' ALA . . . . . 0.759 ' HB1' ' HB2' ' A' ' 170' ' ' GLN . . . -59.96 -43.16 95.23 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.669 0.271 . . . . 0.26 110.585 177.945 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 254' ' ' PHE . . . . . 0.517 ' HD1' HE21 ' A' ' 202' ' ' GLN . 0.3 OUTLIER -65.04 -40.64 95.08 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 121.233 0.539 . . . . 0.57 110.215 178.462 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 255' ' ' VAL . . . . . 0.616 HG21 ' HE2' ' A' ' 227' ' ' PHE . 78.4 t -66.63 -39.97 85.11 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-N 116.107 -0.497 . . . . 0.3 110.207 178.561 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -57.86 -39.42 77.72 Favored 'General case' 0 N--CA 1.461 0.097 0 CA-C-O 121.469 0.652 . . . . 0.27 109.259 178.093 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 257' ' ' LYS . . . . . 0.43 ' HG3' ' O ' ' A' ' 171' ' ' ALA . 23.1 tttp -61.65 -41.72 97.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.262 -0.881 . . . . 0.33 110.236 178.062 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 71.3 t60 -58.77 -45.58 89.48 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 116.243 -0.435 . . . . 0.46 110.719 178.64 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.528 HD22 ' NE2' ' A' ' 264' ' ' GLN . 13.1 mt -70.86 -43.1 69.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.248 -0.433 . . . . 0.45 110.932 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 21.0 ttmm -63.1 -36.93 85.22 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.785 0.326 . . . . 0.68 111.089 179.445 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 54.3 m -63.15 -25.46 68.36 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 116.387 -0.369 . . . . 0.44 111.684 179.839 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 262' ' ' VAL . . . . . 0.523 HG23 ' HG3' ' A' ' 264' ' ' GLN . 17.9 m -108.67 21.8 4.64 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-O 120.848 0.356 . . . . 0.49 111.23 179.34 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 57.32 42.55 24.86 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 112.903 0.705 . . . . 1.81 112.903 179.388 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 264' ' ' GLN . . . . . 0.528 ' NE2' HD22 ' A' ' 259' ' ' LEU . 10.5 mt-30 -98.22 38.4 1.33 Allowed 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.219 0.451 . . . . 0.48 112.219 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -51.48 -37.33 48.42 Favored 'General case' 0 C--O 1.243 0.715 0 CA-C-O 120.892 0.377 . . . . 0.8 111.857 179.765 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 26.5 p -62.59 -16.88 58.62 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 116.101 -0.499 . . . . 0.97 111.162 178.794 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 267' ' ' PHE . . . . . 0.401 ' C ' ' HD2' ' A' ' 270' ' ' PRO . 73.7 m-85 -110.44 -12.18 14.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.939 -0.573 . . . . 0.67 109.889 178.271 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 8.4 mm -66.41 -49.33 76.34 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 CA-C-N 115.834 -0.621 . . . . 0.4 110.303 179.06 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 269' ' ' GLU . . . . . 0.732 ' HB2' ' HD3' ' A' ' 270' ' ' PRO . 57.4 mm-40 -61.44 -54.95 47.73 Favored Pre-proline 0 CA--C 1.545 0.765 0 CA-C-N 115.841 -0.618 . . . . 0.51 111.106 179.331 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 270' ' ' PRO . . . . . 0.732 ' HD3' ' HB2' ' A' ' 269' ' ' GLU . 51.2 Cg_exo -57.0 -36.14 99.2 Favored 'Trans proline' 0 C--N 1.359 1.086 0 C-N-CA 122.244 1.963 . . . . 0.31 112.879 178.577 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 271' ' ' LEU . . . . . . . . . . . . . 18.6 tp -63.84 -52.1 61.63 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.485 0.183 . . . . 0.5 111.188 179.035 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -58.16 -39.79 79.75 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.276 -0.42 . . . . 0.29 111.242 179.794 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 273' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -71.36 -40.48 70.61 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.247 -0.433 . . . . 0.61 110.723 178.844 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 274' ' ' THR . . . . . 0.661 HG21 ' HB ' ' A' ' 224' ' ' VAL . 87.3 m -63.53 -43.84 95.98 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.874 0.368 . . . . 0.33 110.679 179.309 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 275' ' ' ILE . . . . . 0.442 ' HA ' ' CE ' ' A' ' 231' ' ' MET . 88.1 mt -61.88 -54.88 28.71 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.083 0 CA-C-N 116.277 -0.42 . . . . 0.39 110.414 179.163 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 276' ' ' THR . . . . . 0.554 HG23 HD12 ' A' ' 163' ' ' ILE . 24.2 m -56.41 -51.07 69.74 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.26 -0.427 . . . . 0.31 111.533 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 277' ' ' ASP . . . . . 0.637 ' O ' ' HB2' ' A' ' 281' ' ' ARG . 29.7 t70 -52.26 -60.22 3.47 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.35 -0.386 . . . . 0.39 111.79 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 278' ' ' VAL . . . . . 0.613 ' HB ' ' HE1' ' A' ' 231' ' ' MET . 59.6 t -63.94 -42.57 96.19 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 N-CA-C 112.336 0.495 . . . . 0.36 112.336 -179.074 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 27.1 tp -60.72 -47.61 85.51 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 111.987 0.365 . . . . 0.66 111.987 -179.698 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 86.7 t -80.96 -46.32 20.82 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 N-CA-C 113.056 0.761 . . . . 0.47 113.056 -178.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 281' ' ' ARG . . . . . 0.637 ' HB2' ' O ' ' A' ' 277' ' ' ASP . 1.5 mpt_? -60.72 -35.59 76.7 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 113.039 0.755 . . . . 0.42 113.039 -178.32 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 282' ' ' THR . . . . . . . . . . . . . 85.0 m -65.09 -38.13 89.73 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 112.389 0.514 . . . . 0.47 112.389 -179.618 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 28.8 mmtp -129.67 42.1 3.34 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 112.582 0.586 . . . . 0.46 112.582 -178.639 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 284' ' ' ARG . . . . . 0.412 ' HD3' ' O ' ' A' ' 281' ' ' ARG . 0.1 OUTLIER -60.35 -28.82 68.47 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 111.965 0.357 . . . . 0.59 111.965 -179.697 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 285' ' ' ASP . . . . . 0.458 ' HA ' HG22 ' A' ' 288' ' ' VAL . 3.1 t70 -62.41 -44.99 95.12 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-O 121.023 0.439 . . . . 0.71 110.383 179.201 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 286' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -61.09 -35.61 77.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.307 0.575 . . . . 0.54 110.13 178.961 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 287' ' ' LEU . . . . . 0.601 ' HB3' HD21 ' A' ' 155' ' ' LEU . 1.2 mm? -71.24 -54.31 11.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.517 -0.765 . . . . 0.46 111.148 179.378 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 288' ' ' VAL . . . . . 0.458 HG22 ' HA ' ' A' ' 285' ' ' ASP . 33.8 m -59.96 -30.39 45.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 N-CA-C 111.763 0.283 . . . . 0.43 111.763 -179.702 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 27.8 mttp -65.77 -32.43 73.96 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.861 0.363 . . . . 0.82 110.927 178.752 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 -108.51 28.98 7.82 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 111.873 0.323 . . . . 0.67 111.873 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 291' ' ' ARG . . . . . 0.777 ' HB3' ' HB2' ' A' ' 294' ' ' ASP . 0.8 OUTLIER 61.84 19.41 10.6 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 112.612 0.597 . . . . 0.44 112.612 178.896 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 69.11 -118.02 8.4 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 121.302 -0.475 . . . . 0.32 113.236 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 293' ' ' TRP . . . . . 0.674 ' O ' HG23 ' A' ' 297' ' ' VAL . 90.5 m95 -72.0 -21.7 61.52 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 111.683 0.253 . . . . 0.35 111.683 -179.262 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 294' ' ' ASP . . . . . 0.777 ' HB2' ' HB3' ' A' ' 291' ' ' ARG . 60.1 m-20 -57.74 -51.5 69.29 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 109.509 -0.552 . . . . 0.45 109.509 178.019 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -65.25 -41.36 96.82 Favored Glycine 0 C--N 1.335 0.52 0 N-CA-C 111.355 -0.698 . . . . 0.3 111.355 178.137 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 296' ' ' PHE . . . . . 0.491 ' HB2' ' CZ3' ' A' ' 242' ' ' TRP . 6.7 t80 -56.33 -46.04 80.09 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 120.753 0.311 . . . . 0.34 111.371 178.707 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 297' ' ' VAL . . . . . 0.71 HG11 ' HB3' ' A' ' 189' ' ' ARG . 88.9 t -58.48 -54.6 30.85 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 CA-C-O 120.96 0.409 . . . . 0.35 111.768 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -71.23 -29.86 65.65 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.948 0.721 . . . . 0.71 112.948 -178.488 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 299' ' ' PHE . . . . . 0.51 ' CZ ' ' HB2' ' B' ' 39' ' ' SER . 61.3 t80 -59.18 -46.11 89.26 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.901 0.381 . . . . 0.4 111.051 178.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 300' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -86.45 25.02 1.28 Allowed 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 121.132 0.491 . . . . 0.45 111.902 -179.599 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 14.0 m170 -114.09 13.39 18.1 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.066 -0.516 . . . . 0.74 110.714 178.702 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 59.3 t -77.78 100.97 3.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.981 -0.554 . . . . 0.78 110.632 178.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -160.04 -151.23 0.24 Allowed 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.017 -0.538 . . . . 1.23 110.459 -179.465 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -75.2 80.2 2.33 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.398 0.618 . . . . 1.49 111.251 179.535 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 82.8 mt -83.15 -55.65 4.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.207 -0.451 . . . . 1.39 111.155 179.808 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 7.0 mp0 -97.94 -4.39 36.48 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 120.953 0.406 . . . . 1.8 111.199 179.314 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . 102.76 -95.72 1.3 Allowed Glycine 0 CA--C 1.522 0.493 0 C-N-CA 120.8 -0.714 . . . . 1.77 112.821 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.158 0 CA-C-O 118.472 -1.182 . . . . 2.68 113.108 -179.856 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 17' ' ' ALA . . . . . 0.4 ' N ' ' OD2' ' A' ' 217' ' ' ASP . . . . . . . . 0 N--CA 1.489 1.49 0 N-CA-C 111.568 0.21 . . . . 0.54 111.568 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -141.3 149.45 41.25 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 121.048 0.452 . . . . 0.64 111.312 -179.58 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 19' ' ' LEU . . . . . 0.514 ' HB2' ' CE2' ' B' ' 23' ' ' PHE . 0.1 OUTLIER -114.02 160.92 30.51 Favored Pre-proline 0 CA--C 1.538 0.513 0 CA-C-N 115.9 -0.591 . . . . 0.5 111.106 -179.242 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 20' ' ' PRO . . . . . 0.436 ' HA ' ' HD3' ' B' ' 21' ' ' PRO . 36.2 Cg_endo -64.84 145.13 85.47 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 122.844 2.363 . . . . 0.69 113.223 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 21' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' B' ' 20' ' ' PRO . 39.7 Cg_exo -58.34 -1.77 0.76 Allowed 'Trans proline' 0 N--CA 1.483 0.872 0 C-N-CA 123.749 2.966 . . . . 0.76 114.689 -179.093 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -64.11 -26.18 68.42 Favored 'General case' 0 C--N 1.328 -0.337 0 O-C-N 122.317 -0.239 . . . . 1.19 111.62 179.127 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 23' ' ' PHE . . . . . 0.621 ' HD1' ' N ' ' B' ' 24' ' ' ALA . 0.2 OUTLIER -62.36 -33.9 75.63 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 120.788 -0.365 . . . . 0.33 111.422 -179.967 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 24' ' ' ALA . . . . . 0.621 ' N ' ' HD1' ' B' ' 23' ' ' PHE . . . -76.83 -40.22 48.63 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.855 0.36 . . . . 0.34 110.561 -179.73 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -69.94 -40.56 75.4 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.075 -0.511 . . . . 0.42 111.577 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -68.96 -50.92 44.96 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 111.909 0.337 . . . . 0.57 111.909 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 27' ' ' LEU . . . . . 0.475 HD22 HG22 ' A' ' 247' ' ' THR . 81.7 mt -64.8 -30.39 71.4 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 111.734 0.272 . . . . 0.44 111.734 -179.332 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 28' ' ' ARG . . . . . 0.518 ' HB2' ' O ' ' B' ' 24' ' ' ALA . 0.0 OUTLIER -70.67 -55.92 7.61 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 120.886 0.374 . . . . 0.42 110.795 178.35 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 34.9 mtmm -61.64 -53.01 61.86 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 116.463 -0.335 . . . . 0.42 111.672 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 97.4 mt -58.39 -40.02 76.7 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.077 0 CA-C-N 116.41 -0.359 . . . . 0.4 110.573 -179.828 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 31' ' ' GLY . . . . . 0.539 ' HA3' ' HG2' ' A' ' 244' ' ' ARG . . . -56.61 -50.01 65.99 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.946 -0.645 . . . . 0.25 112.45 179.388 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -72.09 -40.37 68.25 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.927 0.364 . . . . 0.73 111.43 179.602 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 33' ' ' LYS . . . . . 0.479 ' HA ' ' HD2' ' B' ' 33' ' ' LYS . 1.1 tptt -59.45 -51.68 68.85 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 120.879 0.371 . . . . 1.13 110.749 179.245 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 33.6 t -63.94 -46.42 94.11 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 CA-C-N 116.057 -0.52 . . . . 0.4 110.467 178.664 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 35' ' ' TYR . . . . . 0.452 ' HB2' ' HA3' ' A' ' 243' ' ' GLY . 9.0 t80 -56.56 -48.26 77.72 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 115.934 -0.575 . . . . 0.73 111.517 179.39 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 36' ' ' CYS . . . . . . . . . . . . . 80.8 m -63.98 -33.04 74.84 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.866 0.365 . . . . 0.46 111.164 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 34.5 m -69.63 -33.51 72.75 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.081 -0.509 . . . . 0.63 111.704 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 38' ' ' TRP . . . . . . . . . . . . . 80.8 m95 -87.96 -34.64 18.01 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 120.675 0.274 . . . . 0.58 111.661 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 39' ' ' SER . . . . . 0.51 ' HB2' ' CZ ' ' A' ' 299' ' ' PHE . 39.1 t -89.66 32.53 0.87 Allowed 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.016 0.436 . . . . 0.61 111.018 179.045 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -89.76 124.59 63.5 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.351 -0.386 . . . . 0.6 111.453 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -75.78 65.67 6.72 Favored 'Trans proline' 0 CA--C 1.535 0.548 0 C-N-CA 122.593 2.195 . . . . 1.31 113.041 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -78.93 -25.08 43.63 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.394 -0.367 . . . . 1.57 111.21 179.366 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 43' ' ' MET . . . . . . . . . . . . . 29.6 ttp . . . . . 0 C--O 1.251 1.15 0 CA-C-O 118.38 -0.819 . . . . 1.11 110.944 -179.993 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.401 ' HA3' ' HD3' ' A' ' 148' ' ' PRO . . . . . . . . 0 N--CA 1.491 2.309 0 CA-C-O 120.18 -0.233 . . . . 4.32 112.768 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.401 ' HD3' ' HA3' ' A' ' 147' ' ' GLY . 11.5 Cg_exo -71.61 -25.69 20.56 Favored 'Trans proline' 0 CA--C 1.534 0.519 0 C-N-CA 123.021 2.481 . . . . 4.39 113.384 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.414 ' HB2' ' HB3' ' A' ' 154' ' ' ASP . 91.3 mt -105.83 -51.79 2.93 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.877 0.37 . . . . 2.99 110.661 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -139.4 -108.01 0.76 Allowed Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.878 -0.677 . . . . 1.55 111.867 179.073 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 17.1 t -138.19 -48.84 0.55 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.281 0.562 . . . . 1.24 111.672 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -123.97 -26.83 3.99 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.386 -0.825 . . . . 0.78 110.499 -178.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -56.34 -52.51 64.27 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.727 0.811 . . . . 1.01 112.706 -179.258 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.414 ' HB3' ' HB2' ' A' ' 149' ' ' LEU . 0.6 OUTLIER -58.86 -52.53 65.35 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.926 0.393 . . . . 0.97 111.236 179.769 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 1.4 mt -60.56 -39.51 88.25 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.167 -0.47 . . . . 0.64 110.925 178.71 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -66.75 -39.03 87.76 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.544 -0.298 . . . . 0.9 111.459 179.493 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.614 ' HD2' ' OE2' ' A' ' 182' ' ' GLU . 1.5 mmt180 -57.04 -51.64 68.44 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.714 0.293 . . . . 0.92 111.24 179.772 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 158' ' ' GLN . . . . . 0.406 ' HA ' ' HB2' ' A' ' 183' ' ' ALA . 71.0 mt-30 -69.28 -42.17 75.85 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.991 -0.283 . . . . 0.54 111.095 179.464 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 49.4 m -59.97 -49.78 76.32 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 111.752 0.278 . . . . 0.37 111.752 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.634 HD21 ' HA ' ' A' ' 273' ' ' GLU . 1.5 tm? -58.44 -53.41 58.63 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.548 -0.296 . . . . 0.72 110.994 179.539 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -60.48 -47.43 86.17 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 112.013 0.375 . . . . 1.1 112.013 -179.631 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 162' ' ' ILE . . . . . 0.507 HG12 ' HA2' ' A' ' 187' ' ' GLY . 83.2 mt -61.99 -47.54 92.72 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-O 120.621 0.248 . . . . 0.38 111.392 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 39.6 mt -64.19 -45.54 96.04 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 CA-C-N 116.745 -0.207 . . . . 0.42 110.733 179.245 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 27.2 t -57.98 -44.71 87.3 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.944 0.402 . . . . 0.34 110.006 178.345 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 165' ' ' ARG . . . . . 0.689 HH21 ' HB3' ' A' ' 176' ' ' ASP . 0.2 OUTLIER -61.02 -44.62 97.14 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 115.658 -0.701 . . . . 0.49 111.611 179.117 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 166' ' ' TYR . . . . . 0.906 ' HE1' ' HA ' ' A' ' 195' ' ' ARG . 75.6 t80 -68.22 -51.18 48.33 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 111.824 0.305 . . . . 0.38 111.824 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 8.6 mp -58.85 -41.29 86.62 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.713 -0.221 . . . . 0.46 111.455 -179.396 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 168' ' ' ARG . . . . . 0.418 ' HD3' ' OD1' ' A' ' 176' ' ' ASP . 5.4 mtt-85 -67.27 -39.67 86.08 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.009 0.433 . . . . 0.86 111.029 179.122 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -68.57 -48.19 64.87 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.159 -0.473 . . . . 0.73 111.377 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 170' ' ' GLN . . . . . 0.45 ' HG3' ' CZ ' ' A' ' 166' ' ' TYR . 27.6 mm-40 -65.56 -25.97 67.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.699 0.285 . . . . 0.54 111.158 178.779 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -79.24 -32.63 43.89 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 116.486 -0.325 . . . . 0.52 111.401 178.736 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 2.9 p -82.83 -23.09 33.92 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 111.88 0.326 . . . . 0.7 111.88 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 73.35 17.37 78.86 Favored Glycine 0 CA--C 1.521 0.423 0 C-N-CA 121.072 -0.585 . . . . 0.7 113.131 179.519 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 72.0 p -151.07 -92.67 0.06 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.865 0.364 . . . . 0.94 111.468 -179.713 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -145.95 127.21 14.82 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.089 0.471 . . . . 1.36 111.46 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 176' ' ' ASP . . . . . 0.689 ' HB3' HH21 ' A' ' 165' ' ' ARG . 0.1 OUTLIER -87.31 129.4 35.02 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.118 0.485 . . . . 0.63 110.751 179.388 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 56.6 m -85.84 70.8 10.69 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.294 -0.412 . . . . 0.92 111.859 -179.299 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 178' ' ' LYS . . . . . 0.527 ' HG2' ' HD2' ' A' ' 179' ' ' PRO . 6.3 ttpp -136.99 133.32 18.57 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 116.533 -0.303 . . . . 0.56 111.01 179.396 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 179' ' ' PRO . . . . . 0.527 ' HD2' ' HG2' ' A' ' 178' ' ' LYS . 59.6 Cg_endo -73.5 144.78 36.67 Favored 'Trans proline' 0 CA--C 1.531 0.338 0 C-N-CA 122.348 2.032 . . . . 0.81 112.317 179.192 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 11.6 mt -87.83 -19.65 27.15 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.44 -0.345 . . . . 0.59 111.922 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 55.26 -114.84 5.05 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 114.303 0.481 . . . . 0.68 114.303 179.205 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 182' ' ' GLU . . . . . 0.614 ' OE2' ' HD2' ' A' ' 157' ' ' ARG . 2.5 mp0 -70.95 -5.8 33.68 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 112.444 0.535 . . . . 1.04 112.444 -179.683 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.488 ' O ' ' HA3' ' A' ' 187' ' ' GLY . . . -105.87 56.68 0.67 Allowed 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 120.933 0.397 . . . . 0.54 111.269 179.521 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -79.13 -70.51 1.32 Allowed Glycine 0 CA--C 1.524 0.634 0 C-N-CA 120.696 -0.764 . . . . 0.48 113.479 -179.526 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -61.83 -55.91 24.94 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 120.774 0.321 . . . . 0.46 111.253 -179.657 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -62.31 -37.34 85.2 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.265 -0.425 . . . . 0.4 110.452 179.083 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 187' ' ' GLY . . . . . 0.507 ' HA2' HG12 ' A' ' 162' ' ' ILE . . . -63.2 -42.81 99.29 Favored Glycine 0 C--N 1.334 0.464 0 C-N-CA 121.2 -0.524 . . . . 0.35 112.659 179.528 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 40.8 ttt-85 -62.55 -48.93 77.34 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 117.022 0.411 . . . . 0.96 110.907 179.24 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 189' ' ' ARG . . . . . 0.749 ' HB3' HG11 ' A' ' 297' ' ' VAL . 34.8 mtp180 -66.28 -41.28 90.05 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.218 -0.446 . . . . 0.5 111.264 179.515 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -68.91 -45.86 69.8 Favored 'General case' 0 C--O 1.219 -0.504 0 CA-C-N 116.177 -0.465 . . . . 0.36 111.836 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 191' ' ' LEU . . . . . 0.447 ' HB2' ' O ' ' A' ' 187' ' ' GLY . 0.9 OUTLIER -59.37 -45.78 90.49 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.626 0.25 . . . . 0.66 111.22 179.505 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -62.34 -49.67 74.67 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 121.101 0.477 . . . . 0.59 111.172 179.389 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 193' ' ' THR . . . . . 0.42 HG21 ' HA ' ' A' ' 297' ' ' VAL . 25.7 m -66.04 -51.2 60.43 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.01 -0.541 . . . . 0.52 111.7 -179.533 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 0.514 HD21 HG21 ' A' ' 249' ' ' ILE . 12.6 tp -58.27 -40.4 81.76 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.222 -0.445 . . . . 0.35 111.736 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 195' ' ' ARG . . . . . 0.906 ' HA ' ' HE1' ' A' ' 166' ' ' TYR . 43.4 ttm180 -61.31 -53.58 54.95 Favored 'General case' 0 N--CA 1.461 0.121 0 CA-C-O 120.606 0.241 . . . . 0.85 110.705 178.912 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 22.9 ttm105 -60.96 -50.17 74.48 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.24 -0.437 . . . . 0.46 112.149 -179.436 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 197' ' ' VAL . . . . . 0.518 HG12 HG11 ' A' ' 246' ' ' VAL . 53.3 t -65.51 -48.71 81.85 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 N-CA-C 111.996 0.369 . . . . 0.38 111.996 -179.351 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 198' ' ' GLY . . . . . 0.539 ' HA3' ' OH ' ' A' ' 166' ' ' TYR . . . -61.5 -42.93 99.87 Favored Glycine 0 C--N 1.334 0.432 0 C-N-CA 121.108 -0.568 . . . . 0.32 113.03 -179.598 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 199' ' ' ASP . . . . . 0.427 ' HB2' ' O ' ' A' ' 195' ' ' ARG . 0.8 OUTLIER -62.33 -45.11 94.7 Favored 'General case' 0 N--CA 1.46 0.074 0 N-CA-C 109.564 -0.532 . . . . 0.89 109.564 178.617 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -61.22 -42.78 99.88 Favored Glycine 0 C--N 1.337 0.605 0 C-N-CA 120.841 -0.695 . . . . 0.3 111.917 178.399 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 201' ' ' VAL . . . . . 0.47 HG23 ' O ' ' A' ' 197' ' ' VAL . 67.4 t -62.34 -47.69 91.88 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-O 120.593 0.235 . . . . 0.38 110.936 178.536 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 202' ' ' GLN . . . . . 0.408 ' OE1' ' HD1' ' A' ' 254' ' ' PHE . 37.6 mt-30 -65.78 -41.32 92.14 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.353 -0.385 . . . . 0.38 111.476 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.64 -37.3 85.82 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.03 0.443 . . . . 0.65 110.546 179.077 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 18.0 m-80 -78.18 -52.37 8.8 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.155 -0.475 . . . . 0.62 111.477 179.468 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 205' ' ' HIS . . . . . 0.441 ' ND1' HG12 ' B' ' 30' ' ' ILE . 75.4 m-70 -92.18 35.86 0.99 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.743 0.306 . . . . 0.68 111.306 -179.373 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -58.29 -49.68 76.28 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.424 0.527 . . . . 0.56 112.424 -179.015 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 69.2 p -60.49 -39.31 87.21 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.896 0.379 . . . . 0.5 111.722 -179.538 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -66.65 -50.38 63.13 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-N 115.915 -0.584 . . . . 0.33 110.78 179.561 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 209' ' ' PHE . . . . . 0.46 ' HB3' ' CD2' ' A' ' 254' ' ' PHE . 31.0 m-85 -63.17 -41.09 99.17 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.882 -0.599 . . . . 0.5 110.495 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 12.0 mt-30 -59.48 -45.44 91.66 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-N 116.103 -0.498 . . . . 0.54 111.408 179.245 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -55.77 -50.17 62.28 Favored Glycine 0 C--N 1.334 0.461 0 C-N-CA 120.644 -0.789 . . . . 0.33 111.645 179.261 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 212' ' ' MET . . . . . 0.603 ' HG2' ' HA ' ' B' ' 23' ' ' PHE . 6.6 mtp -64.65 -37.08 86.35 Favored 'General case' 0 C--O 1.225 -0.212 0 CA-C-O 120.561 0.22 . . . . 0.54 111.012 178.898 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.456 HD11 ' HA ' ' A' ' 255' ' ' VAL . 6.6 tp -67.49 -42.97 82.03 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 112.022 0.378 . . . . 0.61 112.022 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 214' ' ' ARG . . . . . 0.457 HH11 ' HD3' ' A' ' 214' ' ' ARG . 40.3 mtt180 -61.6 -40.05 93.42 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.932 0.396 . . . . 1.13 110.833 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 215' ' ' LYS . . . . . 0.53 ' HE2' ' HA ' ' A' ' 215' ' ' LYS . 0.0 OUTLIER -95.85 13.36 26.97 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.85 -0.34 . . . . 0.55 111.03 178.584 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 11.3 tp -78.34 100.04 6.59 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.891 0.377 . . . . 0.55 110.398 179.222 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 217' ' ' ASP . . . . . 0.638 ' H ' HD11 ' B' ' 19' ' ' LEU . 0.2 OUTLIER -82.73 33.06 0.42 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.28 -0.418 . . . . 0.51 111.957 -179.365 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 218' ' ' ILE . . . . . 0.684 HG12 ' HB3' ' A' ' 223' ' ' ASP . 47.6 mt -87.53 119.08 34.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.766 0.317 . . . . 0.48 110.66 179.278 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.63 -15.32 0.73 Allowed 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 112.772 0.656 . . . . 0.52 112.772 -179.204 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 220' ' ' ASN . . . . . 0.41 ' HA ' ' CE1' ' A' ' 267' ' ' PHE . 7.4 p30 -132.31 -178.37 4.88 Favored 'General case' 0 CA--C 1.541 0.613 0 O-C-N 122.002 -0.436 . . . . 0.55 112.154 -179.663 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 221' ' ' GLU . . . . . 0.573 ' O ' HG22 ' A' ' 224' ' ' VAL . 1.9 mp0 -69.59 -21.99 63.55 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 112.902 0.704 . . . . 0.73 112.902 -178.952 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -72.6 -26.86 70.55 Favored Glycine 0 CA--C 1.523 0.551 0 C-N-CA 120.66 -0.781 . . . . 0.47 112.685 179.592 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 223' ' ' ASP . . . . . 0.684 ' HB3' HG12 ' A' ' 218' ' ' ILE . 61.2 m-20 -65.52 -30.48 71.24 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 112.128 0.418 . . . . 0.56 112.128 -179.624 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.573 HG22 ' O ' ' A' ' 221' ' ' GLU . 4.1 m -56.39 -28.25 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 N-CA-C 111.878 0.325 . . . . 0.47 111.878 179.612 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 225' ' ' LYS . . . . . 0.473 ' HD2' ' H ' ' A' ' 225' ' ' LYS . 7.7 mptt -64.67 -36.79 85.4 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.192 0.52 . . . . 0.73 110.037 178.587 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 226' ' ' SER . . . . . 0.509 ' O ' HG23 ' A' ' 230' ' ' VAL . 7.8 t -69.31 -35.02 75.56 Favored 'General case' 0 N--CA 1.462 0.148 0 N-CA-C 108.901 -0.777 . . . . 0.45 108.901 177.932 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 227' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -61.74 -37.63 84.96 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 115.269 -0.878 . . . . 0.44 109.601 177.844 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 228' ' ' SER . . . . . 0.4 ' O ' HG22 ' A' ' 232' ' ' VAL . 69.1 m -66.37 -40.43 89.73 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.093 -0.503 . . . . 0.45 109.804 178.036 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 73.0 mtp180 -58.13 -37.66 75.03 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.031 -0.531 . . . . 0.86 110.381 178.682 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 0.582 HG13 ' HA ' ' B' ' 24' ' ' ALA . 36.3 t -66.32 -46.74 86.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.946 -0.57 . . . . 0.37 110.107 178.337 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 231' ' ' MET . . . . . 0.514 ' HE1' ' HA ' ' A' ' 275' ' ' ILE . 60.3 mtm -63.94 -48.35 76.85 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.017 -0.538 . . . . 0.46 111.852 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 232' ' ' VAL . . . . . 0.4 HG22 ' O ' ' A' ' 228' ' ' SER . 31.1 m -62.9 -31.24 51.75 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 C-N-CA 120.585 -0.446 . . . . 0.38 110.508 179.048 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 233' ' ' HIS . . . . . 0.479 ' ND1' ' HB1' ' B' ' 24' ' ' ALA . 2.0 t-80 -67.91 -44.44 76.92 Favored 'General case' 0 CA--C 1.528 0.125 0 N-CA-C 109.126 -0.694 . . . . 0.32 109.126 177.109 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.536 ' HA ' ' HG3' ' B' ' 28' ' ' ARG . 51.2 t -56.46 -42.46 75.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 CA-C-N 115.775 -0.648 . . . . 0.43 110.78 179.633 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -99.79 23.74 9.28 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.001 0.371 . . . . 0.6 112.001 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 2.6 ttpp -73.01 -13.73 61.28 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.799 0.333 . . . . 1.13 111.361 179.737 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -86.16 -16.21 38.57 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 120.88 0.371 . . . . 0.62 110.988 179.527 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 92.48 -19.08 52.82 Favored Glycine 0 CA--C 1.524 0.636 0 C-N-CA 121.032 -0.604 . . . . 0.4 113.84 179.179 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 6.1 p -83.9 117.25 29.19 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-O 121.625 0.726 . . . . 0.5 111.727 -179.462 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 240' ' ' THR . . . . . 0.411 HG21 ' HG2' ' A' ' 283' ' ' LYS . 10.8 m -94.9 117.3 29.91 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.057 0.456 . . . . 0.4 111.577 179.764 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 73.8 m-20 -113.48 141.54 47.0 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.5 -0.318 . . . . 0.58 110.639 179.157 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 242' ' ' TRP . . . . . 0.529 ' CZ3' ' HB2' ' A' ' 296' ' ' PHE . 24.8 m95 -60.02 -42.4 94.28 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 120.721 0.296 . . . . 0.38 110.424 178.419 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 243' ' ' GLY . . . . . 0.434 ' HA3' ' N ' ' B' ' 35' ' ' TYR . . . -60.26 -33.31 79.81 Favored Glycine 0 C--N 1.336 0.531 0 C-N-CA 120.967 -0.635 . . . . 0.27 111.816 178.187 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 244' ' ' ARG . . . . . 0.503 ' HA ' ' HA3' ' B' ' 31' ' ' GLY . 50.1 mtt180 -69.25 -51.43 37.7 Favored 'General case' 0 C--O 1.232 0.153 0 N-CA-C 109.569 -0.53 . . . . 0.39 109.569 178.099 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 245' ' ' ILE . . . . . 0.527 HG23 HD21 ' A' ' 279' ' ' LEU . 83.1 mt -55.94 -48.32 78.73 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 CA-C-N 115.582 -0.735 . . . . 0.44 110.89 179.455 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 246' ' ' VAL . . . . . 0.518 HG11 HG12 ' A' ' 197' ' ' VAL . 96.1 t -64.69 -32.32 57.46 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-N 116.471 -0.331 . . . . 0.59 110.984 179.46 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 247' ' ' THR . . . . . 0.497 HG22 HD22 ' B' ' 27' ' ' LEU . 20.2 m -63.35 -44.35 95.07 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.611 0.243 . . . . 0.35 110.448 178.893 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 248' ' ' LEU . . . . . 0.502 HD22 ' HG2' ' A' ' 231' ' ' MET . 54.2 mt -62.2 -41.2 98.15 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.396 0.617 . . . . 0.47 109.857 178.454 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 249' ' ' ILE . . . . . 0.514 HG21 HD21 ' A' ' 194' ' ' LEU . 27.8 mt -66.45 -39.98 85.38 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 CA-C-N 115.782 -0.644 . . . . 0.45 110.013 178.115 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 49.4 m -62.91 -41.77 99.56 Favored 'General case' 0 N--CA 1.461 0.115 0 N-CA-C 109.148 -0.686 . . . . 0.39 109.148 178.154 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 251' ' ' PHE . . . . . 0.502 ' CD2' HD11 ' B' ' 27' ' ' LEU . 8.7 t80 -62.14 -42.17 98.99 Favored 'General case' 0 C--O 1.226 -0.15 0 N-CA-C 108.821 -0.807 . . . . 0.41 108.821 177.518 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -57.68 -46.79 91.79 Favored Glycine 0 C--N 1.335 0.527 0 N-CA-C 111.053 -0.819 . . . . 0.27 111.053 177.451 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 253' ' ' ALA . . . . . 0.486 ' O ' ' HG3' ' A' ' 257' ' ' LYS . . . -64.34 -35.33 80.53 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 120.617 0.246 . . . . 0.31 111.245 177.627 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 254' ' ' PHE . . . . . 0.46 ' CD2' ' HB3' ' A' ' 209' ' ' PHE . 2.5 t80 -71.07 -43.76 67.11 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 120.617 0.246 . . . . 0.78 111.25 179.373 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 255' ' ' VAL . . . . . 0.456 ' HA ' HD11 ' A' ' 213' ' ' LEU . 23.7 m -68.04 -34.58 67.7 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.109 0 N-CA-C 109.354 -0.61 . . . . 0.36 109.354 178.269 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -60.91 -36.72 80.0 Favored 'General case' 0 C--O 1.227 -0.127 0 N-CA-C 109.371 -0.604 . . . . 0.32 109.371 177.009 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 257' ' ' LYS . . . . . 0.486 ' HG3' ' O ' ' A' ' 253' ' ' ALA . 59.3 mttp -62.42 -45.66 92.08 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 109.608 -0.515 . . . . 0.58 109.608 177.24 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 258' ' ' HIS . . . . . 0.429 ' HB2' HD11 ' A' ' 213' ' ' LEU . 22.2 t60 -60.76 -36.58 79.29 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.722 -0.672 . . . . 0.79 110.774 179.363 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 78.4 mt -74.95 -45.05 44.89 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.301 -0.408 . . . . 0.62 110.662 178.663 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 1.5 tptp -62.19 -34.82 77.18 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 120.717 0.294 . . . . 0.46 110.838 179.359 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 49.2 m -63.12 -24.31 67.84 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.254 -0.43 . . . . 0.52 110.946 179.503 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 262' ' ' VAL . . . . . 0.553 HG23 ' HG3' ' A' ' 264' ' ' GLN . 16.0 m -114.88 19.03 7.34 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-N 116.239 -0.437 . . . . 0.63 110.882 178.93 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 57.44 52.37 8.68 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 113.073 0.768 . . . . 1.15 113.073 179.417 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 264' ' ' GLN . . . . . 0.553 ' HG3' HG23 ' A' ' 262' ' ' VAL . 72.9 mt-30 -119.72 36.26 4.57 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 112.087 0.402 . . . . 0.75 112.087 179.332 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 265' ' ' GLU . . . . . 0.482 ' HA ' HD12 ' A' ' 268' ' ' ILE . 2.2 pm0 -57.74 -23.73 53.49 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-O 120.828 0.347 . . . . 0.62 111.656 179.061 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 54.4 p -61.62 -21.18 64.13 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.016 -0.538 . . . . 0.7 110.403 178.313 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 267' ' ' PHE . . . . . 0.509 ' C ' ' HD2' ' A' ' 270' ' ' PRO . 90.8 m-85 -95.3 -20.25 19.32 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 116.093 -0.503 . . . . 0.66 110.578 178.594 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 268' ' ' ILE . . . . . 0.482 HD12 ' HA ' ' A' ' 265' ' ' GLU . 78.6 mt -67.31 -41.16 86.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-N 116.26 -0.427 . . . . 0.42 110.078 178.574 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 269' ' ' GLU . . . . . 0.771 ' HB2' ' HD3' ' A' ' 270' ' ' PRO . 2.2 mm-40 -53.8 -56.4 25.75 Favored Pre-proline 0 CA--C 1.546 0.789 0 CA-C-N 116.089 -0.505 . . . . 0.76 111.122 178.591 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 270' ' ' PRO . . . . . 0.771 ' HD3' ' HB2' ' A' ' 269' ' ' GLU . 33.4 Cg_exo -62.23 -30.29 81.44 Favored 'Trans proline' 0 C--N 1.362 1.268 0 C-N-CA 122.139 1.892 . . . . 0.42 111.675 177.708 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 271' ' ' LEU . . . . . 0.404 ' HA ' HD23 ' A' ' 271' ' ' LEU . 4.3 mt -62.69 -50.41 71.24 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.286 -0.416 . . . . 0.71 110.045 177.922 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -56.29 -36.39 68.59 Favored 'General case' 0 N--CA 1.461 0.111 0 CA-C-N 116.147 -0.479 . . . . 0.45 110.825 179.143 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 273' ' ' GLU . . . . . 0.634 ' HA ' HD21 ' A' ' 160' ' ' LEU . 1.2 mm-40 -72.39 -50.79 23.96 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.102 -0.499 . . . . 1.39 110.658 178.381 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 274' ' ' THR . . . . . 0.487 HG21 ' HB ' ' A' ' 224' ' ' VAL . 25.3 m -58.45 -45.97 87.48 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.297 -0.41 . . . . 0.54 111.8 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 275' ' ' ILE . . . . . 0.514 ' HA ' ' HE1' ' A' ' 231' ' ' MET . 92.0 mt -63.77 -55.33 23.1 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 CA-C-N 116.558 -0.292 . . . . 0.49 111.089 179.842 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 22.0 m -58.08 -47.71 82.35 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.26 -0.427 . . . . 0.36 111.604 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 277' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -50.98 -58.64 5.53 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.385 -0.371 . . . . 0.54 111.7 179.747 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 61.4 t -64.65 -39.52 85.9 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 N-CA-C 111.816 0.302 . . . . 0.49 111.816 -179.78 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 279' ' ' LEU . . . . . 0.527 HD21 HG23 ' A' ' 245' ' ' ILE . 51.3 tp -64.59 -47.21 79.49 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 112.582 0.586 . . . . 0.74 112.582 -179.123 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 86.1 t -73.61 -46.78 47.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 N-CA-C 112.826 0.676 . . . . 0.49 112.826 -178.703 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 39.4 mtm105 -62.01 -43.61 98.48 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 112.533 0.568 . . . . 0.57 112.533 -178.892 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 282' ' ' THR . . . . . . . . . . . . . 68.6 p -69.16 -15.19 63.35 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 112.111 0.412 . . . . 0.33 112.111 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 283' ' ' LYS . . . . . 0.51 ' HB3' HD23 ' A' ' 287' ' ' LEU . 0.1 OUTLIER -128.23 36.53 4.28 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 111.723 0.268 . . . . 0.62 111.723 -179.566 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 36.3 ttm180 -53.17 -54.24 38.83 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 112.607 0.595 . . . . 1.07 112.607 -179.767 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -66.99 -33.96 76.7 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 111.862 0.319 . . . . 0.63 111.862 -178.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 286' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -70.14 -39.75 75.19 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.013 0.435 . . . . 0.72 110.489 179.647 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 287' ' ' LEU . . . . . 0.563 HD13 ' HA2' ' A' ' 292' ' ' GLY . 1.9 mm? -65.99 -46.77 76.8 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 115.878 -0.601 . . . . 0.5 111.587 179.782 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 30.8 m -65.83 -31.6 54.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 C-N-CA 121.003 -0.279 . . . . 0.44 111.41 179.821 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 26.2 mtmm -72.28 -32.79 66.94 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 112.384 0.513 . . . . 0.97 112.384 179.585 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -101.73 15.45 28.91 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 112.683 0.623 . . . . 0.96 112.683 -179.231 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 291' ' ' ARG . . . . . 0.624 ' HB3' ' HB2' ' A' ' 294' ' ' ASP . 0.0 OUTLIER 59.92 24.13 13.21 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-O 121.174 0.511 . . . . 0.64 112.106 179.734 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 292' ' ' GLY . . . . . 0.563 ' HA2' HD13 ' A' ' 287' ' ' LEU . . . 58.4 -117.87 11.88 Favored Glycine 0 CA--C 1.522 0.494 0 CA-C-N 115.615 -0.721 . . . . 0.32 114.795 179.446 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 293' ' ' TRP . . . . . 0.412 ' O ' HG23 ' A' ' 297' ' ' VAL . 83.9 m95 -67.19 -33.51 75.55 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 112.808 0.67 . . . . 0.49 112.808 -178.368 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 294' ' ' ASP . . . . . 0.624 ' HB2' ' HB3' ' A' ' 291' ' ' ARG . 60.7 m-20 -53.09 -49.76 65.79 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 118.026 0.375 . . . . 0.46 111.098 179.143 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -65.02 -50.43 57.79 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.687 -0.768 . . . . 0.33 111.488 178.522 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 296' ' ' PHE . . . . . 0.529 ' HB2' ' CZ3' ' A' ' 242' ' ' TRP . 0.4 OUTLIER -53.58 -45.0 69.83 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 122.586 0.354 . . . . 0.38 111.766 179.212 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 297' ' ' VAL . . . . . 0.749 HG11 ' HB3' ' A' ' 189' ' ' ARG . 52.0 t -63.4 -53.59 43.54 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 N-CA-C 112.351 0.5 . . . . 0.34 112.351 -178.679 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 298' ' ' GLU . . . . . 0.669 ' HA ' ' HB2' ' A' ' 301' ' ' HIS . 0.1 OUTLIER -70.74 -26.89 63.57 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.617 -0.433 . . . . 0.45 111.911 -179.255 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 299' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -62.5 -44.16 97.06 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 109.848 -0.427 . . . . 0.51 109.848 177.852 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 300' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -87.47 8.46 24.71 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 121.344 0.593 . . . . 0.58 110.841 178.909 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 301' ' ' HIS . . . . . 0.669 ' HB2' ' HA ' ' A' ' 298' ' ' GLU . 2.2 m170 -104.25 -44.22 5.02 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 115.774 -0.648 . . . . 0.61 109.914 177.873 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 7.4 p -136.94 136.14 47.81 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-N 116.015 -0.538 . . . . 0.7 110.489 179.047 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -76.46 64.74 2.21 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 120.72 0.295 . . . . 0.82 111.742 -179.51 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 51.2 t0 -85.32 107.81 17.51 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.283 0.564 . . . . 0.84 110.523 179.494 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 83.5 mt -107.67 -24.46 11.72 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.857 -0.61 . . . . 1.57 110.858 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -87.91 -35.04 17.93 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.03 -0.532 . . . . 2.18 112.242 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . 108.57 92.92 2.26 Favored Glycine 0 CA--C 1.522 0.502 0 C-N-CA 120.423 -0.894 . . . . 1.27 113.168 179.698 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.296 0 CA-C-O 118.64 -1.089 . . . . 1.73 113.425 179.597 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.428 0 CA-C-O 120.262 0.077 . . . . 0.68 110.889 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.3 162.92 24.32 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 121.014 0.435 . . . . 1.53 111.618 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 19' ' ' LEU . . . . . 0.638 HD11 ' H ' ' A' ' 217' ' ' ASP . 0.9 OUTLIER -110.52 108.64 58.3 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 116.191 -0.459 . . . . 0.51 111.325 -179.643 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 20' ' ' PRO . . . . . 0.476 ' HA ' ' HD3' ' B' ' 21' ' ' PRO . 37.8 Cg_endo -66.14 130.4 24.1 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.777 2.318 . . . . 0.77 112.984 -179.423 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 21' ' ' PRO . . . . . 0.476 ' HD3' ' HA ' ' B' ' 20' ' ' PRO . 37.1 Cg_exo -61.14 3.36 0.33 Allowed 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 123.229 2.619 . . . . 0.55 114.28 -179.212 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 22' ' ' GLU . . . . . 0.492 ' O ' ' HB2' ' B' ' 26' ' ' GLN . 3.4 mm-40 -73.69 -17.09 61.18 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 112.02 0.378 . . . . 0.41 112.02 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 23' ' ' PHE . . . . . 0.603 ' HA ' ' HG2' ' A' ' 212' ' ' MET . 0.8 OUTLIER -68.97 -40.78 78.65 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 120.222 -0.591 . . . . 0.42 110.929 179.166 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 24' ' ' ALA . . . . . 0.582 ' HA ' HG13 ' A' ' 230' ' ' VAL . . . -70.5 -39.44 74.14 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.552 0.691 . . . . 0.34 109.767 179.371 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.79 -46.61 78.08 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 114.905 -1.043 . . . . 0.31 109.993 178.231 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 26' ' ' GLN . . . . . 0.492 ' HB2' ' O ' ' B' ' 22' ' ' GLU . 0.8 OUTLIER -58.83 -53.89 53.24 Favored 'General case' 0 C--O 1.224 -0.268 0 CA-C-N 116.159 -0.473 . . . . 0.35 111.323 179.504 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 27' ' ' LEU . . . . . 0.502 HD11 ' CD2' ' A' ' 251' ' ' PHE . 19.3 mt -54.74 -36.42 64.77 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.641 0.258 . . . . 0.43 110.938 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 28' ' ' ARG . . . . . 0.536 ' HG3' ' HA ' ' A' ' 234' ' ' VAL . 0.2 OUTLIER -70.59 -53.24 16.76 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.539 -0.3 . . . . 0.52 110.204 178.102 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 21.4 mttt -53.28 -47.76 68.89 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.251 0.548 . . . . 0.44 110.614 179.056 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 30' ' ' ILE . . . . . 0.441 HG12 ' ND1' ' A' ' 205' ' ' HIS . 84.8 mt -64.25 -45.22 96.83 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 CA-C-N 115.331 -0.85 . . . . 0.39 110.603 179.626 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 31' ' ' GLY . . . . . 0.503 ' HA3' ' HA ' ' A' ' 244' ' ' ARG . . . -57.84 -49.37 75.07 Favored Glycine 0 C--N 1.334 0.419 0 C-N-CA 120.974 -0.631 . . . . 0.29 112.749 179.736 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -62.26 -42.76 99.62 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 121.17 0.51 . . . . 0.41 110.279 179.334 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 33' ' ' LYS . . . . . 0.516 ' HE2' ' HG3' ' B' ' 43' ' ' MET . 0.0 OUTLIER -62.69 -57.45 10.97 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.792 -0.64 . . . . 1.15 111.784 179.646 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 71.1 t -54.53 -44.14 67.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 O-C-N 123.308 0.38 . . . . 0.43 111.268 -179.861 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 35' ' ' TYR . . . . . 0.434 ' N ' ' HA3' ' A' ' 243' ' ' GLY . 0.6 OUTLIER -56.77 -43.48 80.88 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 121.044 0.449 . . . . 0.79 110.477 178.699 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 36' ' ' CYS . . . . . . . . . . . . . 66.0 m -68.95 -40.97 78.62 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.352 -0.385 . . . . 0.39 111.418 179.6 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 8.4 m -59.13 -40.83 86.68 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 113.091 0.774 . . . . 0.44 113.091 -179.68 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 38' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -83.6 -36.67 23.74 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 112.42 0.526 . . . . 0.54 112.42 -178.812 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 65.9 p -72.45 -63.39 1.16 Allowed 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.727 0.298 . . . . 0.45 110.762 179.147 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 40' ' ' ALA . . . . . 0.475 ' HA ' ' HD3' ' B' ' 41' ' ' PRO . . . -90.85 136.71 27.38 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 116.404 -0.362 . . . . 0.51 111.046 179.313 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 41' ' ' PRO . . . . . 0.475 ' HD3' ' HA ' ' B' ' 40' ' ' ALA . 11.9 Cg_exo -71.07 56.7 2.0 Allowed 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 122.755 2.303 . . . . 0.76 112.769 179.433 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -145.05 -152.06 0.4 Allowed 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 116.056 -0.52 . . . . 0.95 110.071 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 43' ' ' MET . . . . . 0.516 ' HG3' ' HE2' ' B' ' 33' ' ' LYS . 44.9 tpp . . . . . 0 C--O 1.25 1.113 0 CA-C-O 118.573 -0.727 . . . . 2.96 111.747 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.234 0 CA-C-O 120.246 -0.197 . . . . 0.0 113.092 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -60.56 -40.61 54.87 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 123.126 2.551 . . . . 0.0 113.589 -179.603 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -86.59 -66.48 0.9 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.973 0.416 . . . . 0.0 110.695 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -154.93 -135.17 2.0 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.915 -0.66 . . . . 0.0 111.997 179.463 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 12.9 p -115.42 33.05 5.67 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.001 0.429 . . . . 0.0 110.99 179.356 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -134.12 -28.74 1.32 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.884 179.755 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' ASP . . . . . 0.541 ' HA ' ' HB3' ' A' ' 156' ' ' TYR . 1.0 OUTLIER -59.98 -29.04 68.18 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.784 0.326 . . . . 0.0 111.189 -179.637 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -62.78 -43.67 98.18 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.16 178.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 48.4 tp -77.56 -36.5 52.09 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 178.048 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' TYR . . . . . 0.541 ' HB3' ' HA ' ' A' ' 153' ' ' ASP . 69.7 t80 -58.54 -38.22 77.35 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 115.105 -0.952 . . . . 0.0 111.739 179.575 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.539 ' HD2' ' OE2' ' A' ' 161' ' ' GLU . 0.0 OUTLIER -56.46 -53.04 62.12 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.999 0.428 . . . . 0.0 110.352 178.976 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 158' ' ' GLN . . . . . 0.455 ' HG2' ' HB2' ' A' ' 183' ' ' ALA . 92.2 mt-30 -68.44 -37.46 80.26 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.58 179.166 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 41.4 m -57.83 -50.69 72.43 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.367 179.266 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.516 ' HA ' HG21 ' A' ' 276' ' ' THR . 2.3 tm? -58.69 -47.43 84.56 Favored 'General case' 0 C--O 1.225 -0.232 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.451 178.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 161' ' ' GLU . . . . . 0.539 ' OE2' ' HD2' ' A' ' 157' ' ' ARG . 30.8 mt-10 -60.52 -51.1 70.89 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 111.949 0.352 . . . . 0.0 111.949 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 162' ' ' ILE . . . . . 0.517 HG12 ' HA2' ' A' ' 187' ' ' GLY . 46.2 mt -58.87 -51.68 69.37 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 CA-C-O 120.636 0.255 . . . . 0.0 111.145 179.633 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.603 ' O ' ' HG ' ' A' ' 167' ' ' LEU . 89.5 mt -62.04 -48.08 90.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-N 116.646 -0.252 . . . . 0.0 111.414 179.589 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 164' ' ' SER . . . . . 0.54 ' O ' ' HB2' ' A' ' 168' ' ' ARG . 1.2 t -57.7 -42.34 83.5 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 120.751 0.31 . . . . 0.0 111.322 179.452 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 165' ' ' ARG . . . . . 0.445 ' HA ' ' HD3' ' A' ' 165' ' ' ARG . 5.7 tpp180 -72.37 -37.0 68.87 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 121.08 -0.248 . . . . 0.0 111.225 179.758 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 166' ' ' TYR . . . . . 0.829 ' CE1' ' HA ' ' A' ' 195' ' ' ARG . 39.1 t80 -66.27 -52.79 44.01 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.679 -0.237 . . . . 0.0 111.622 179.768 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.603 ' HG ' ' O ' ' A' ' 163' ' ' ILE . 20.7 mt -61.95 -40.6 96.1 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.712 -0.222 . . . . 0.0 110.789 -179.728 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 168' ' ' ARG . . . . . 0.54 ' HB2' ' O ' ' A' ' 164' ' ' SER . 0.5 OUTLIER -62.15 -44.44 96.61 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 120.953 0.406 . . . . 0.0 110.506 179.215 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 169' ' ' GLU . . . . . 0.505 ' HG2' ' HA ' ' A' ' 175' ' ' LYS . 2.2 mt-10 -60.83 -48.11 83.29 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.164 178.613 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 6.8 mm-40 -61.55 -43.49 98.76 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.149 179.126 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -70.49 -44.24 68.07 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -179.074 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 31.8 p -67.61 -25.85 65.96 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 120.851 -0.34 . . . . 0.0 111.502 179.706 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 80.97 29.06 43.28 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 120.527 -0.844 . . . . 0.0 112.472 179.26 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 21.1 t -164.44 -138.09 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.631 0.253 . . . . 0.0 110.486 -179.466 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 175' ' ' LYS . . . . . 0.505 ' HA ' ' HG2' ' A' ' 169' ' ' GLU . 15.0 tptp -125.08 126.33 45.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.844 0.354 . . . . 0.0 111.333 179.61 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 176' ' ' ASP . . . . . 0.427 ' H ' ' HG3' ' A' ' 169' ' ' GLU . 59.7 t0 -64.92 128.03 34.06 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.241 178.78 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 71.8 p -75.1 -10.37 59.41 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.773 179.801 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.22 131.79 23.59 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 120.767 0.318 . . . . 0.0 111.221 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -61.57 154.46 59.57 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.627 2.218 . . . . 0.0 112.533 179.544 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.505 HD11 ' HA3' ' A' ' 187' ' ' GLY . 0.4 OUTLIER -85.27 78.05 9.87 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.299 0.571 . . . . 0.0 111.232 -179.797 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 58.38 -115.72 7.46 Favored Glycine 0 C--N 1.332 0.323 0 CA-C-N 115.019 -0.991 . . . . 0.0 113.731 179.157 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -124.66 -0.73 8.03 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.82 0.343 . . . . 0.0 110.976 -179.268 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.524 ' O ' ' HA3' ' A' ' 187' ' ' GLY . . . -69.54 81.03 0.4 Allowed 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 121.092 0.472 . . . . 0.0 111.029 178.574 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -79.89 -70.5 1.33 Allowed Glycine 0 CA--C 1.524 0.595 0 C-N-CA 121.069 -0.586 . . . . 0.0 113.961 -179.588 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -63.92 -55.51 22.1 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 111.998 0.37 . . . . 0.0 111.998 -178.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -68.0 -33.68 75.09 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.354 179.581 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 187' ' ' GLY . . . . . 0.524 ' HA3' ' O ' ' A' ' 183' ' ' ALA . . . -66.94 -41.62 93.22 Favored Glycine 0 C--O 1.225 -0.429 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.559 178.747 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 3.9 tpt180 -63.01 -53.9 46.7 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 120.615 0.245 . . . . 0.0 111.279 179.202 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 189' ' ' ARG . . . . . 0.408 HH11 ' HD3' ' A' ' 189' ' ' ARG . 28.0 mtp180 -62.79 -44.04 97.21 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.592 -179.728 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -70.3 -48.77 55.15 Favored 'General case' 0 C--O 1.22 -0.468 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -179.166 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 19.3 tp -60.19 -42.83 95.9 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 118.359 0.527 . . . . 0.0 111.746 -179.659 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -63.69 -46.02 87.41 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 121.136 0.493 . . . . 0.0 110.934 179.657 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 34.3 m -68.4 -45.48 72.55 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.889 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 0.526 HD21 HG21 ' A' ' 249' ' ' ILE . 12.3 tp -59.77 -37.43 79.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.084 -179.636 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 195' ' ' ARG . . . . . 0.829 ' HA ' ' CE1' ' A' ' 166' ' ' TYR . 11.5 ttp180 -70.8 -53.36 15.65 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.508 179.034 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 196' ' ' ARG . . . . . 0.4 ' C ' ' HD3' ' A' ' 196' ' ' ARG . 0.0 OUTLIER -59.36 -48.2 82.52 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.888 -179.935 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 197' ' ' VAL . . . . . 0.62 HG21 ' HB3' ' A' ' 300' ' ' PHE . 73.5 t -70.89 -47.92 59.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.334 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 198' ' ' GLY . . . . . 0.462 ' O ' ' HG2' ' A' ' 202' ' ' GLN . . . -56.19 -43.51 89.0 Favored Glycine 0 C--N 1.338 0.645 0 N-CA-C 111.371 -0.691 . . . . 0.0 111.371 179.367 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 199' ' ' ASP . . . . . 0.534 ' HB2' ' O ' ' A' ' 195' ' ' ARG . 0.4 OUTLIER -58.26 -48.5 80.25 Favored 'General case' 0 C--O 1.226 -0.138 0 O-C-N 123.963 0.449 . . . . 0.0 109.83 177.951 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -62.89 -41.17 99.93 Favored Glycine 0 CA--C 1.524 0.597 0 C-N-CA 121.085 -0.579 . . . . 0.0 112.601 179.247 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 201' ' ' VAL . . . . . 0.716 HG13 HG21 ' B' ' 34' ' ' VAL . 70.3 t -58.06 -51.7 67.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 CA-C-O 120.786 0.327 . . . . 0.0 111.127 179.254 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 202' ' ' GLN . . . . . 0.551 ' HG3' ' CZ ' ' A' ' 203' ' ' ARG . 1.2 pt20 -72.35 -31.68 65.83 Favored 'General case' 0 C--O 1.222 -0.36 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.404 179.745 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 203' ' ' ARG . . . . . 0.551 ' CZ ' ' HG3' ' A' ' 202' ' ' GLN . 0.0 OUTLIER -66.73 -38.97 87.73 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 121.247 0.546 . . . . 0.0 109.793 177.739 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -62.3 -54.21 43.94 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.968 179.17 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 205' ' ' HIS . . . . . 0.718 ' CD2' HG12 ' B' ' 30' ' ' ILE . 41.4 m80 -101.66 37.79 1.75 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.968 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 206' ' ' GLU . . . . . 0.403 ' OE1' ' HA ' ' A' ' 203' ' ' ARG . 3.3 tp10 -48.02 -47.73 33.21 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -178.883 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -61.97 -41.62 98.21 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -73.08 -47.33 45.45 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.901 0.382 . . . . 0.0 111.149 -179.806 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 209' ' ' PHE . . . . . 0.52 ' CD2' ' HA ' ' A' ' 202' ' ' GLN . 8.5 m-85 -60.62 -45.13 95.2 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.534 178.887 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 210' ' ' GLN . . . . . 0.685 ' O ' ' HG2' ' A' ' 214' ' ' ARG . 27.8 mt-30 -68.01 -44.0 77.55 Favored 'General case' 0 C--O 1.225 -0.199 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.021 179.216 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -55.29 -50.81 58.05 Favored Glycine 0 C--N 1.335 0.507 0 C-N-CA 120.723 -0.751 . . . . 0.0 111.953 179.343 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 212' ' ' MET . . . . . 0.456 ' HG2' ' HB3' ' B' ' 23' ' ' PHE . 0.8 OUTLIER -64.25 -29.65 70.74 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.672 0.272 . . . . 0.0 110.799 178.623 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.49 HD12 HD22 ' A' ' 216' ' ' LEU . 8.4 tp -73.83 -42.33 61.03 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.488 179.334 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 214' ' ' ARG . . . . . 0.685 ' HG2' ' O ' ' A' ' 210' ' ' GLN . 16.4 mmt85 -61.39 -37.19 82.51 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.184 0.516 . . . . 0.0 109.751 178.814 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.71 12.52 31.62 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.992 178.624 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.78 ' HG ' HG12 ' A' ' 218' ' ' ILE . 16.2 tp -77.52 103.69 7.6 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 121.127 0.489 . . . . 0.0 110.037 179.027 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 217' ' ' ASP . . . . . 0.507 ' HB2' ' HG ' ' B' ' 19' ' ' LEU . 0.4 OUTLIER -81.71 33.03 0.36 Allowed 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 113.032 0.753 . . . . 0.0 113.032 -178.395 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 218' ' ' ILE . . . . . 0.78 HG12 ' HG ' ' A' ' 216' ' ' LEU . 50.8 mm -81.64 107.41 13.75 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-O 120.728 0.299 . . . . 0.0 110.326 178.894 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.59 -19.31 0.53 Allowed 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 -178.865 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -112.63 179.6 3.93 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -179.088 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 221' ' ' GLU . . . . . 0.549 ' O ' HG22 ' A' ' 224' ' ' VAL . 15.6 tm-20 -68.59 -40.74 80.38 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.775 179.587 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -58.16 -26.43 58.66 Favored Glycine 0 CA--C 1.524 0.607 0 C-N-CA 121.297 -0.478 . . . . 0.0 113.169 179.673 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 223' ' ' ASP . . . . . 0.566 ' HB3' HD12 ' A' ' 218' ' ' ILE . 40.2 m-20 -59.34 -30.5 68.42 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 112.94 0.719 . . . . 0.0 112.94 -179.586 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.549 HG22 ' O ' ' A' ' 221' ' ' GLU . 11.8 m -62.87 -29.17 46.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 CA-C-O 120.991 0.424 . . . . 0.0 110.828 179.444 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 225' ' ' LYS . . . . . 0.548 ' O ' ' HG2' ' A' ' 229' ' ' ARG . 23.5 mttp -71.32 -31.75 67.77 Favored 'General case' 0 C--O 1.232 0.15 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 179.027 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 226' ' ' SER . . . . . 0.584 ' O ' HG23 ' A' ' 230' ' ' VAL . 3.8 m -65.22 -44.96 86.61 Favored 'General case' 0 C--N 1.335 -0.062 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 177.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 227' ' ' PHE . . . . . 0.478 ' HE2' HG21 ' A' ' 255' ' ' VAL . 8.7 t80 -61.94 -36.45 81.42 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.822 178.607 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 13.0 t -61.9 -41.38 97.83 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.714 177.793 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 229' ' ' ARG . . . . . 0.548 ' HG2' ' O ' ' A' ' 225' ' ' LYS . 5.7 mmp_? -70.03 -43.8 70.55 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.439 179.035 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 0.584 HG23 ' O ' ' A' ' 226' ' ' SER . 60.5 t -58.66 -47.72 87.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 178.523 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 231' ' ' MET . . . . . 0.953 ' HG3' ' HG ' ' A' ' 248' ' ' LEU . 36.5 ttm -53.09 -53.79 45.14 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.41 178.784 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 96.8 t -59.36 -44.85 93.38 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.755 179.711 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 233' ' ' HIS . . . . . 0.45 ' O ' ' HB2' ' A' ' 236' ' ' LYS . 2.0 t-80 -57.29 -33.95 68.18 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.512 HG23 ' O ' ' A' ' 230' ' ' VAL . 89.1 t -56.31 -32.1 34.44 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 O-C-N 121.917 -0.489 . . . . 0.0 111.623 179.683 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -103.01 25.17 9.71 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.562 -179.822 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 236' ' ' LYS . . . . . 0.45 ' HB2' ' O ' ' A' ' 233' ' ' HIS . 0.6 OUTLIER -49.65 -35.79 22.49 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 -178.804 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 237' ' ' ASP . . . . . 0.45 ' HB2' HG12 ' A' ' 239' ' ' VAL . 0.0 OUTLIER -71.88 -16.07 62.12 Favored 'General case' 0 N--CA 1.468 0.447 0 O-C-N 122.153 -0.342 . . . . 0.0 111.466 -179.689 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 98.18 -18.74 56.64 Favored Glycine 0 CA--C 1.52 0.371 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.162 -178.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 239' ' ' VAL . . . . . 0.45 HG12 ' HB2' ' A' ' 237' ' ' ASP . 4.0 p -79.48 115.55 22.0 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 CA-C-O 121.746 0.784 . . . . 0.0 111.017 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 240' ' ' THR . . . . . 0.5 HG22 HD11 ' A' ' 245' ' ' ILE . 4.2 m -90.14 74.67 7.12 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.738 -179.208 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -65.91 135.0 54.18 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 121.076 -0.249 . . . . 0.0 110.401 178.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 242' ' ' TRP . . . . . 0.547 ' HB3' ' CE2' ' A' ' 300' ' ' PHE . 2.1 m95 -56.09 -37.76 69.8 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.922 0.391 . . . . 0.0 111.147 179.664 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -65.1 -25.33 70.89 Favored Glycine 0 C--N 1.336 0.57 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.713 179.277 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 93.3 mtt180 -75.31 -45.29 40.6 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 178.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 245' ' ' ILE . . . . . 0.5 HD11 HG22 ' A' ' 240' ' ' THR . 54.0 mt -57.05 -48.35 82.0 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.847 179.333 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 10.5 p -67.23 -33.18 61.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.909 179.121 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 20.6 m -62.28 -38.46 89.45 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 121.065 -0.254 . . . . 0.0 110.458 178.446 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 248' ' ' LEU . . . . . 0.953 ' HG ' ' HG3' ' A' ' 231' ' ' MET . 1.0 OUTLIER -63.59 -33.51 75.76 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.141 0.496 . . . . 0.0 110.413 178.337 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 249' ' ' ILE . . . . . 0.526 HG21 HD21 ' A' ' 194' ' ' LEU . 33.7 mm -76.84 -40.7 32.03 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.737 178.386 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 23.2 t -59.94 -44.79 94.15 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 178.128 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 251' ' ' PHE . . . . . 0.54 ' O ' HG23 ' A' ' 255' ' ' VAL . 22.7 t80 -66.82 -44.52 80.94 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.251 177.832 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -54.98 -42.92 82.36 Favored Glycine 0 C--N 1.34 0.754 0 N-CA-C 111.078 -0.809 . . . . 0.0 111.078 177.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 253' ' ' ALA . . . . . 0.603 ' O ' ' HG3' ' A' ' 257' ' ' LYS . . . -61.78 -46.37 89.85 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 115.551 -0.324 . . . . 0.0 110.201 177.294 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 254' ' ' PHE . . . . . 0.414 ' HB3' HD13 ' A' ' 213' ' ' LEU . 0.1 OUTLIER -58.27 -41.6 84.66 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 120.972 0.415 . . . . 0.0 110.289 178.591 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 255' ' ' VAL . . . . . 0.54 HG23 ' O ' ' A' ' 251' ' ' PHE . 64.0 t -62.38 -44.7 99.49 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-N 116.159 -0.473 . . . . 0.0 109.897 177.92 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -59.38 -42.76 92.41 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-O 121.02 0.438 . . . . 0.0 109.836 177.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 257' ' ' LYS . . . . . 0.603 ' HG3' ' O ' ' A' ' 253' ' ' ALA . 20.0 mtpp -62.06 -39.97 94.18 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.928 177.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 10.9 t60 -66.22 -43.44 86.64 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.367 178.359 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 75.2 mt -65.4 -39.44 92.19 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.466 178.591 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -68.54 -32.0 71.63 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 120.911 0.386 . . . . 0.0 110.008 178.357 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 66.4 m -59.44 -34.23 72.25 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.449 178.84 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 15.7 m -101.53 15.57 4.99 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.211 179.036 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 56.23 48.15 17.87 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 112.705 0.631 . . . . 0.0 112.705 179.655 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 66.7 mt-30 -118.67 37.71 3.99 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 120.887 0.375 . . . . 0.0 111.414 179.547 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 265' ' ' GLU . . . . . 0.54 ' HA ' HD12 ' A' ' 268' ' ' ILE . 0.0 OUTLIER -51.9 -26.49 10.33 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 179.843 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 50.6 p -59.88 -25.54 65.15 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 120.674 0.273 . . . . 0.0 111.126 179.064 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -88.91 -20.56 24.4 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 120.93 0.395 . . . . 0.0 110.592 178.714 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 268' ' ' ILE . . . . . 0.54 HD12 ' HA ' ' A' ' 265' ' ' GLU . 75.9 mt -67.85 -42.72 86.13 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.021 179.468 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 269' ' ' GLU . . . . . 0.778 ' HB3' ' HD3' ' A' ' 270' ' ' PRO . 9.4 tp10 -53.72 -57.08 18.99 Favored Pre-proline 0 CA--C 1.546 0.817 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.649 179.324 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 270' ' ' PRO . . . . . 0.778 ' HD3' ' HB3' ' A' ' 269' ' ' GLU . 24.9 Cg_exo -64.76 -33.81 52.59 Favored 'Trans proline' 0 C--N 1.36 1.184 0 C-N-CA 122.086 1.857 . . . . 0.0 111.878 178.536 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 271' ' ' LEU . . . . . . . . . . . . . 27.1 tp -63.96 -42.0 97.41 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.129 178.833 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -59.81 -48.89 79.87 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.483 178.797 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 273' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -63.77 -41.17 98.02 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.409 178.728 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 274' ' ' THR . . . . . 0.436 HG21 ' HB ' ' A' ' 224' ' ' VAL . 91.1 m -60.21 -48.93 79.64 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.052 178.664 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 96.7 mt -61.9 -50.68 79.16 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.684 178.411 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 276' ' ' THR . . . . . 0.523 HG23 HD12 ' A' ' 163' ' ' ILE . 27.8 m -58.66 -53.9 53.13 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -178.906 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 277' ' ' ASP . . . . . 0.577 ' O ' ' HB2' ' A' ' 281' ' ' ARG . 2.3 t70 -58.16 -54.02 51.72 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 120.873 -0.331 . . . . 0.0 111.496 -178.973 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 95.1 t -59.38 -34.8 55.42 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 CA-C-O 120.673 0.273 . . . . 0.0 111.177 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 279' ' ' LEU . . . . . 0.49 HD22 HD11 ' A' ' 249' ' ' ILE . 5.0 tp -65.09 -48.12 74.82 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 111.742 0.275 . . . . 0.0 111.742 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 42.5 t -78.68 -36.59 19.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -179.502 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 281' ' ' ARG . . . . . 0.577 ' HB2' ' O ' ' A' ' 277' ' ' ASP . 0.1 OUTLIER -65.95 -36.03 82.22 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -179.493 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 282' ' ' THR . . . . . . . . . . . . . 15.4 p -73.39 -52.06 15.14 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 120.885 0.374 . . . . 0.0 111.623 179.456 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 283' ' ' LYS . . . . . 0.5 ' HB2' HD23 ' A' ' 287' ' ' LEU . 15.2 mttp -88.54 41.85 1.04 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.783 0.325 . . . . 0.0 110.68 179.583 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 28.9 ttm180 -48.05 -63.32 1.1 Allowed 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 -178.294 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -72.02 -31.51 66.26 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 121.028 -0.269 . . . . 0.0 111.625 -178.771 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 286' ' ' TRP . . . . . . . . . . . . . 2.3 t90 -68.37 -49.02 63.12 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.877 0.37 . . . . 0.0 111.121 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 287' ' ' LEU . . . . . 0.5 HD23 ' HB2' ' A' ' 283' ' ' LYS . 0.7 OUTLIER -63.08 -41.21 99.36 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -179.593 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 29.5 m -70.48 -37.86 71.74 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 C-N-CA 120.514 -0.474 . . . . 0.0 111.826 179.68 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 39.3 mttp -72.91 -32.23 65.18 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -85.46 17.3 3.25 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -179.064 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 291' ' ' ARG . . . . . 0.444 HH11 ' HD2' ' A' ' 291' ' ' ARG . 25.3 mtm105 60.09 18.6 7.87 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 179.553 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 63.16 -137.02 43.11 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 114.687 0.635 . . . . 0.0 114.687 178.895 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 293' ' ' TRP . . . . . 0.407 ' HA ' ' HB3' ' A' ' 296' ' ' PHE . 72.4 m95 -59.13 -28.39 66.5 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -178.829 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 294' ' ' ASP . . . . . 0.498 ' O ' ' HG3' ' A' ' 298' ' ' GLU . 0.4 OUTLIER -59.41 -48.35 81.98 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 120.782 0.325 . . . . 0.0 110.24 178.335 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -66.19 -36.48 91.86 Favored Glycine 0 CA--C 1.521 0.458 0 C-N-CA 120.53 -0.843 . . . . 0.0 111.252 178.401 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 296' ' ' PHE . . . . . 0.477 ' HB2' ' CH2' ' A' ' 242' ' ' TRP . 12.2 t80 -58.67 -48.0 82.58 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.51 -0.345 . . . . 0.0 111.015 178.616 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 297' ' ' VAL . . . . . . . . . . . . . 18.4 m -72.33 -22.68 20.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 120.934 -0.306 . . . . 0.0 111.636 -179.583 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 298' ' ' GLU . . . . . 0.498 ' HG3' ' O ' ' A' ' 294' ' ' ASP . 37.1 mt-10 -65.97 -50.1 65.51 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.206 0.527 . . . . 0.0 110.599 178.336 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 299' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -77.1 -25.02 51.75 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 115.912 -0.585 . . . . 0.0 112.292 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 300' ' ' PHE . . . . . 0.62 ' HB3' HG21 ' A' ' 197' ' ' VAL . 44.7 m-85 -109.43 6.12 23.98 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 115.16 1.541 . . . . 0.0 115.16 -177.54 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -161.25 -59.55 0.05 Allowed 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 119.479 1.036 . . . . 0.0 112.891 -179.584 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 2.3 t -90.94 72.98 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 120.953 0.406 . . . . 0.0 111.014 -178.708 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 303' ' ' GLN . . . . . 0.487 ' OE1' ' HB3' ' B' ' 41' ' ' PRO . 90.0 mt-30 -89.58 3.5 52.32 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.961 -179.354 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -97.64 34.45 1.85 Allowed 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 121.061 0.458 . . . . 0.0 111.995 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 78.7 mt -100.81 7.17 43.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.989 0.423 . . . . 0.0 111.103 179.547 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -112.5 -55.24 2.54 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.172 179.814 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . -100.94 92.61 1.07 Allowed Glycine 0 CA--C 1.522 0.506 0 C-N-CA 120.558 -0.83 . . . . 0.0 112.864 179.692 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.272 0 CA-C-O 118.282 -1.288 . . . . 0.0 112.771 179.924 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.868 0 CA-C-O 121.422 0.63 . . . . 0.0 111.301 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 18' ' ' GLU . . . . . 0.427 ' H ' ' CD ' ' B' ' 18' ' ' GLU . 0.7 OUTLIER -99.18 -36.68 9.58 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.246 -179.601 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 19' ' ' LEU . . . . . 0.507 ' HG ' ' HB2' ' A' ' 217' ' ' ASP . 4.6 mt -93.4 128.45 42.49 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.359 -179.852 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 20' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' B' ' 19' ' ' LEU . 7.3 Cg_exo -72.12 121.0 7.17 Favored 'Trans proline' 0 CA--C 1.531 0.365 0 C-N-CA 122.542 2.161 . . . . 0.0 112.277 179.399 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 21' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -60.65 -11.79 18.74 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.943 2.428 . . . . 0.0 113.475 -179.359 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 22' ' ' GLU . . . . . 0.404 ' O ' ' HB2' ' B' ' 26' ' ' GLN . 4.8 mm-40 -66.67 -14.2 62.18 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 23' ' ' PHE . . . . . 0.58 ' HD1' ' N ' ' B' ' 24' ' ' ALA . 0.1 OUTLIER -60.22 -31.88 70.58 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 118.302 0.501 . . . . 0.0 111.886 179.812 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 24' ' ' ALA . . . . . 0.58 ' N ' ' HD1' ' B' ' 23' ' ' PHE . . . -74.7 -48.38 26.31 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.16 0.505 . . . . 0.0 110.625 -179.724 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 25' ' ' ALA . . . . . 0.498 ' HA ' ' HD3' ' B' ' 28' ' ' ARG . . . -64.71 -37.12 86.49 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.505 178.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 26' ' ' GLN . . . . . 0.412 ' O ' HG13 ' B' ' 30' ' ' ILE . 0.0 OUTLIER -62.92 -48.13 80.25 Favored 'General case' 0 C--O 1.226 -0.134 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.13 178.751 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 27' ' ' LEU . . . . . 0.574 ' HG ' ' O ' ' B' ' 23' ' ' PHE . 29.8 mt -58.96 -32.45 69.65 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 178.371 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 28' ' ' ARG . . . . . 0.498 ' HD3' ' HA ' ' B' ' 25' ' ' ALA . 56.1 mtp85 -65.43 -54.81 23.14 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 177.432 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 29' ' ' LYS . . . . . 0.442 ' HG3' ' O ' ' B' ' 25' ' ' ALA . 54.5 mttt -55.67 -46.37 77.57 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.008 178.501 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 30' ' ' ILE . . . . . 0.718 HG12 ' CD2' ' A' ' 205' ' ' HIS . 97.9 mt -60.76 -52.42 61.77 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.237 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.218 179.76 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -57.03 -43.68 93.14 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 121.301 -0.476 . . . . 0.0 113.097 179.747 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -68.68 -40.89 79.9 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 120.709 0.29 . . . . 0.0 111.148 179.737 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.93 -39.97 83.42 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 120.954 0.407 . . . . 0.0 110.077 178.277 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 34' ' ' VAL . . . . . 0.716 HG21 HG13 ' A' ' 201' ' ' VAL . 4.9 t -62.56 -52.62 57.53 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.555 179.809 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -57.35 -40.95 79.14 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 120.943 0.402 . . . . 0.0 110.337 179.236 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 36' ' ' CYS . . . . . . . . . . . . . 42.7 t -68.68 -25.98 65.07 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 120.925 0.393 . . . . 0.0 111.298 179.256 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 59.6 m -78.55 -46.37 19.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.514 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 38' ' ' TRP . . . . . 0.435 ' CD1' HG13 ' B' ' 34' ' ' VAL . 99.2 m95 -75.52 -13.79 60.38 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 -179.132 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 43.7 m -61.17 -31.29 71.03 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 178.878 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -90.36 118.43 68.78 Favored Pre-proline 0 CA--C 1.531 0.243 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -179.653 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 41' ' ' PRO . . . . . 0.487 ' HB3' ' OE1' ' A' ' 303' ' ' GLN . 95.9 Cg_endo -86.98 -160.48 0.11 Allowed 'Trans proline' 0 CA--C 1.534 0.521 0 C-N-CA 122.845 2.363 . . . . 0.0 112.697 179.307 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -88.7 -54.13 4.3 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 120.983 0.42 . . . . 0.0 110.32 178.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 43' ' ' MET . . . . . . . . . . . . . 53.9 ttp . . . . . 0 C--O 1.25 1.087 0 CA-C-O 118.323 -0.846 . . . . 0.0 111.191 179.074 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.158 0 CA-C-O 120.261 -0.188 . . . . 0.0 112.804 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -71.18 -23.17 24.86 Favored 'Trans proline' 0 CA--C 1.534 0.492 0 C-N-CA 122.804 2.336 . . . . 0.0 113.769 -179.579 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 41.0 tp -73.56 -42.06 62.14 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 120.839 0.352 . . . . 0.0 111.648 -179.838 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 117.26 -67.44 0.32 Allowed Glycine 0 C--N 1.329 0.142 0 C-N-CA 120.636 -0.792 . . . . 0.0 111.677 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 37.2 t -75.26 94.81 3.05 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 178.467 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.43 ' CD ' HH21 ' A' ' 284' ' ' ARG . 2.6 mp0 4.61 70.01 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 125.852 1.661 . . . . 0.0 114.889 -177.649 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -71.12 -36.84 72.27 Favored 'General case' 0 C--N 1.335 -0.062 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.65 179.247 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.76 -57.19 14.11 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.911 179.234 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.409 HD21 ' HA3' ' A' ' 292' ' ' GLY . 0.2 OUTLIER -62.36 -35.99 80.84 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.03 178.716 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 156' ' ' TYR . . . . . 0.42 ' HE1' ' HA ' ' A' ' 277' ' ' ASP . 0.1 OUTLIER -68.86 -46.29 68.85 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.69 -0.232 . . . . 0.0 111.447 179.6 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 6.2 mtp180 -62.6 -45.87 90.87 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 121.119 -0.233 . . . . 0.0 111.14 179.515 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 59.3 mt-30 -58.02 -43.77 86.9 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 121.074 0.464 . . . . 0.0 110.222 178.594 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 159' ' ' SER . . . . . 0.489 ' HA ' ' CZ2' ' A' ' 293' ' ' TRP . 51.4 m -61.38 -54.35 44.78 Favored 'General case' 0 C--O 1.223 -0.313 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.788 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.412 HD22 ' HA ' ' A' ' 160' ' ' LEU . 1.2 tm? -58.38 -47.23 84.53 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 120.492 0.187 . . . . 0.0 111.308 179.299 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -60.75 -51.85 67.59 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 162' ' ' ILE . . . . . 0.501 HG23 HD22 ' A' ' 191' ' ' LEU . 60.5 mt -71.26 -48.66 53.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 -178.429 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.603 ' O ' ' HG ' ' A' ' 167' ' ' LEU . 64.4 mt -58.85 -50.83 78.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 N-CA-C 111.64 0.237 . . . . 0.0 111.64 -179.44 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 39.3 t -61.9 -41.76 98.28 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 120.959 -0.296 . . . . 0.0 110.827 179.558 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 165' ' ' ARG . . . . . 0.512 ' O ' ' HB2' ' A' ' 169' ' ' GLU . 6.7 tpp85 -61.07 -47.66 85.31 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 111.658 0.244 . . . . 0.0 111.658 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 166' ' ' TYR . . . . . 0.854 ' HE1' ' HA ' ' A' ' 195' ' ' ARG . 87.6 t80 -65.98 -50.97 62.44 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -179.358 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.603 ' HG ' ' O ' ' A' ' 163' ' ' ILE . 40.7 mt -59.11 -45.0 92.03 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 121.127 -0.229 . . . . 0.0 111.477 -178.784 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 3.7 ttt180 -70.26 -42.03 72.69 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 120.959 -0.296 . . . . 0.0 111.637 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 169' ' ' GLU . . . . . 0.512 ' HB2' ' O ' ' A' ' 165' ' ' ARG . 0.5 OUTLIER -59.6 -46.0 90.24 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.222 0.534 . . . . 0.0 109.645 179.081 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 170' ' ' GLN . . . . . 0.629 ' HB3' ' HE3' ' A' ' 257' ' ' LYS . 6.9 mm-40 -65.34 -49.75 68.22 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.87 179.058 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.472 ' HA ' ' HG2' ' A' ' 257' ' ' LYS . . . -63.69 -31.76 73.03 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 -178.917 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 7.4 m -84.64 -43.25 14.57 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -179.157 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 84.03 13.02 75.57 Favored Glycine 0 CA--C 1.522 0.48 0 C-N-CA 120.545 -0.836 . . . . 0.0 111.706 -178.472 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 13.7 t -100.09 -159.48 0.74 Allowed 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 115.654 -0.273 . . . . 0.0 110.636 -179.712 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 175' ' ' LYS . . . . . 0.414 ' HA ' ' HE3' ' A' ' 175' ' ' LYS . 0.0 OUTLIER -127.57 163.03 25.07 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 120.696 0.284 . . . . 0.0 111.386 -179.948 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 176' ' ' ASP . . . . . 0.475 ' OD2' ' HD2' ' A' ' 165' ' ' ARG . 16.3 t0 -131.21 117.47 19.07 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 120.861 0.362 . . . . 0.0 111.48 -179.359 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 59.2 p -105.7 16.9 24.62 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.321 0.582 . . . . 0.0 110.775 179.087 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 178' ' ' LYS . . . . . 0.515 ' HB3' ' NZ ' ' A' ' 178' ' ' LYS . 3.3 ttpm? -105.82 128.29 26.73 Favored Pre-proline 0 CA--C 1.534 0.341 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.02 -179.728 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -66.83 -177.83 1.09 Allowed 'Trans proline' 0 CA--C 1.539 0.731 0 C-N-CA 122.715 2.277 . . . . 0.0 113.381 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.516 HD13 ' HA3' ' A' ' 187' ' ' GLY . 0.9 OUTLIER -105.61 -173.17 2.24 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.073 179.625 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -110.55 -84.69 1.53 Allowed Glycine 0 CA--C 1.52 0.398 0 C-N-CA 120.343 -0.932 . . . . 0.0 113.656 -178.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -85.25 -8.75 58.39 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.093 0.473 . . . . 0.0 111.471 -179.377 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -109.76 68.76 0.68 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.949 179.303 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -73.73 -71.15 1.14 Allowed Glycine 0 CA--C 1.524 0.616 0 C-N-CA 120.631 -0.795 . . . . 0.0 113.56 -179.456 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -72.09 -44.82 62.64 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.104 0.478 . . . . 0.0 110.966 179.799 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -67.9 -26.94 66.24 Favored 'General case' 0 C--O 1.225 -0.204 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.213 179.49 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 187' ' ' GLY . . . . . 0.544 ' O ' ' HB2' ' A' ' 191' ' ' LEU . . . -63.82 -53.49 37.46 Favored Glycine 0 C--N 1.332 0.315 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.199 179.64 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 188' ' ' ARG . . . . . 0.661 ' HE ' ' HG2' ' A' ' 192' ' ' GLU . 1.4 tpm_? -63.33 -44.42 94.95 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 120.902 0.382 . . . . 0.0 110.302 178.877 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 189' ' ' ARG . . . . . 0.415 HH22 ' CD ' ' A' ' 298' ' ' GLU . 37.0 mtp180 -60.17 -47.41 86.06 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.096 179.618 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.561 ' HA ' HG12 ' A' ' 297' ' ' VAL . . . -72.75 -40.52 65.95 Favored 'General case' 0 C--O 1.22 -0.453 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -179.679 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 191' ' ' LEU . . . . . 0.544 ' HB2' ' O ' ' A' ' 187' ' ' GLY . 0.3 OUTLIER -58.66 -45.78 88.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.798 0.333 . . . . 0.0 110.735 179.885 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 192' ' ' GLU . . . . . 0.661 ' HG2' ' HE ' ' A' ' 188' ' ' ARG . 15.2 mm-40 -76.81 -40.98 46.19 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -179.806 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 193' ' ' THR . . . . . 0.649 HG21 ' HA ' ' A' ' 297' ' ' VAL . 80.1 m -65.0 -48.55 73.53 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.813 0.34 . . . . 0.0 110.108 178.847 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 0.507 HD21 HG21 ' A' ' 249' ' ' ILE . 56.1 tp -64.81 -30.03 71.02 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.292 178.88 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 195' ' ' ARG . . . . . 0.854 ' HA ' ' HE1' ' A' ' 166' ' ' TYR . 56.9 ttm-85 -61.5 -49.49 76.56 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.832 0.349 . . . . 0.0 110.385 178.231 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 196' ' ' ARG . . . . . 0.449 HH11 ' HD2' ' A' ' 196' ' ' ARG . 0.2 OUTLIER -70.99 -55.25 8.71 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.026 -179.688 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 197' ' ' VAL . . . . . 0.516 HG21 ' HB3' ' A' ' 300' ' ' PHE . 35.5 t -63.29 -47.65 91.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-O 120.997 0.427 . . . . 0.0 111.851 -179.341 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -60.43 -44.9 97.14 Favored Glycine 0 CA--C 1.519 0.302 0 CA-C-N 116.067 -0.515 . . . . 0.0 113.004 -179.752 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -73.48 -32.44 64.31 Favored 'General case' 0 C--N 1.331 -0.235 0 O-C-N 122.211 -0.582 . . . . 0.0 109.492 179.202 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -56.27 -48.49 74.59 Favored Glycine 0 C--N 1.337 0.621 0 N-CA-C 110.999 -0.841 . . . . 0.0 110.999 177.314 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 201' ' ' VAL . . . . . 0.48 HG23 ' O ' ' A' ' 197' ' ' VAL . 41.3 t -65.36 -37.68 80.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 CA-C-O 120.883 0.373 . . . . 0.0 110.404 178.108 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 202' ' ' GLN . . . . . 0.456 ' HA ' ' CE2' ' A' ' 209' ' ' PHE . 24.5 mt-30 -61.69 -53.03 61.54 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.935 -0.575 . . . . 0.0 112.041 179.687 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 203' ' ' ARG . . . . . 0.412 HH11 ' HD3' ' A' ' 203' ' ' ARG . 9.2 ptt180 -72.88 -27.75 62.08 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 120.924 -0.31 . . . . 0.0 111.499 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -71.55 -53.59 13.3 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.058 0.456 . . . . 0.0 110.789 179.122 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 205' ' ' HIS . . . . . 0.453 ' HB3' ' HB3' ' A' ' 208' ' ' ALA . 94.2 m-70 -101.19 36.84 1.89 Allowed 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.897 179.5 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 11.0 tm-20 -53.83 -46.38 71.14 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.508 -179.782 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 49.1 p -64.66 -34.68 78.87 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.151 179.794 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 208' ' ' ALA . . . . . 0.453 ' HB3' ' HB3' ' A' ' 205' ' ' HIS . . . -69.22 -42.43 75.72 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 178.61 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 209' ' ' PHE . . . . . 0.49 ' O ' ' HG ' ' A' ' 213' ' ' LEU . 13.9 m-85 -70.81 -35.07 72.34 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.236 178.877 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -66.58 -46.9 74.46 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 177.591 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -62.26 -39.93 98.35 Favored Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 110.555 -1.018 . . . . 0.0 110.555 177.427 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 212' ' ' MET . . . . . 0.404 ' SD ' ' HA ' ' B' ' 23' ' ' PHE . 5.5 tpp -61.36 -37.0 81.78 Favored 'General case' 0 C--O 1.223 -0.293 0 N-CA-C 110.166 -0.309 . . . . 0.0 110.166 178.109 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.49 ' HG ' ' O ' ' A' ' 209' ' ' PHE . 34.7 mt -60.42 -41.62 94.32 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.043 0.449 . . . . 0.0 110.568 178.366 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 83.7 mtt85 -70.6 -27.02 63.78 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.594 179.584 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 10.1 mmmm -91.58 -11.19 37.95 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 120.89 0.376 . . . . 0.0 111.446 179.434 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.527 HD21 HD12 ' A' ' 218' ' ' ILE . 16.4 tp -100.11 114.3 27.56 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.38 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -90.16 24.12 2.61 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 120.996 0.427 . . . . 0.0 111.787 -179.487 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 218' ' ' ILE . . . . . 0.527 HD12 HD21 ' A' ' 216' ' ' LEU . 5.7 mt -66.69 122.85 18.49 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-O 121.094 0.473 . . . . 0.0 111.354 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 7.0 ptpp? -154.98 -16.15 0.12 Allowed 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -179.131 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -130.95 -178.95 5.04 Favored 'General case' 0 CA--C 1.536 0.413 0 O-C-N 121.688 -0.633 . . . . 0.0 112.515 -178.523 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 221' ' ' GLU . . . . . 0.454 ' O ' HG22 ' A' ' 224' ' ' VAL . 3.5 tp10 -61.64 -39.81 92.66 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -179.143 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 222' ' ' GLY . . . . . 0.405 ' O ' ' HG2' ' A' ' 225' ' ' LYS . . . -55.7 -26.07 45.47 Favored Glycine 0 CA--C 1.524 0.606 0 C-N-CA 121.399 -0.429 . . . . 0.0 113.764 -179.347 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 223' ' ' ASP . . . . . 0.516 ' HB3' HG12 ' A' ' 218' ' ' ILE . 61.4 m-20 -60.13 -28.09 67.6 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 -179.544 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.454 HG22 ' O ' ' A' ' 221' ' ' GLU . 31.5 m -53.69 -31.72 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 N-CA-C 113.221 0.823 . . . . 0.0 113.221 -179.095 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 225' ' ' LYS . . . . . 0.405 ' HG2' ' O ' ' A' ' 222' ' ' GLY . 10.6 ptpp? -68.06 -33.61 74.88 Favored 'General case' 0 C--O 1.237 0.41 0 O-C-N 121.845 -0.535 . . . . 0.0 110.407 179.516 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 226' ' ' SER . . . . . 0.661 ' O ' HG23 ' A' ' 230' ' ' VAL . 33.3 p -69.63 -47.59 62.86 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.755 179.181 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 227' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -55.87 -37.7 69.15 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.154 0.502 . . . . 0.0 110.069 179.492 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 228' ' ' SER . . . . . 0.42 ' HA ' HG21 ' A' ' 278' ' ' VAL . 39.3 m -59.27 -48.73 80.55 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.488 177.547 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 229' ' ' ARG . . . . . 0.428 ' HA ' ' HD3' ' A' ' 229' ' ' ARG . 13.8 mmt180 -68.26 -34.09 75.56 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.074 179.5 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 0.661 HG23 ' O ' ' A' ' 226' ' ' SER . 54.4 t -57.13 -54.83 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-O 120.562 0.22 . . . . 0.0 110.632 179.303 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 231' ' ' MET . . . . . 0.587 ' HG2' HD13 ' A' ' 248' ' ' LEU . 72.3 mtm -59.41 -43.35 93.02 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.334 179.374 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 79.7 t -59.07 -44.18 90.86 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-O 120.727 0.299 . . . . 0.0 110.874 178.697 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 65.7 t-80 -60.07 -38.62 83.41 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 120.826 0.346 . . . . 0.0 111.519 179.217 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.404 HG13 ' HA ' ' B' ' 28' ' ' ARG . 94.2 t -61.85 -39.62 84.14 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 CA-C-O 121.192 0.52 . . . . 0.0 111.056 178.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -99.24 24.42 7.98 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.638 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -62.24 -18.22 60.54 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -179.631 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -83.12 -16.71 45.71 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.772 0.32 . . . . 0.0 111.399 179.558 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 90.98 -10.07 76.06 Favored Glycine 0 CA--C 1.524 0.632 0 C-N-CA 120.701 -0.761 . . . . 0.0 113.747 179.517 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 6.2 p -93.47 118.19 38.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-O 121.571 0.701 . . . . 0.0 111.414 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 83.8 m -94.03 119.77 33.37 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.063 0.459 . . . . 0.0 111.896 -179.448 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 70.1 m-20 -113.67 140.76 47.96 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.162 178.58 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 242' ' ' TRP . . . . . 0.497 ' HA ' ' CE3' ' A' ' 242' ' ' TRP . 1.3 m95 -56.79 -44.94 82.39 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.715 0.293 . . . . 0.0 111.014 179.601 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 243' ' ' GLY . . . . . 0.438 ' HA2' HG12 ' A' ' 246' ' ' VAL . . . -60.8 -29.53 70.51 Favored Glycine 0 CA--C 1.523 0.541 0 C-N-CA 121.083 -0.58 . . . . 0.0 112.384 178.671 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 244' ' ' ARG . . . . . 0.481 ' HA ' ' HA3' ' B' ' 31' ' ' GLY . 60.5 mtt180 -68.96 -47.25 66.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.112 0.482 . . . . 0.0 109.797 178.675 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 245' ' ' ILE . . . . . 0.465 ' O ' HG13 ' A' ' 249' ' ' ILE . 68.3 mt -62.59 -48.23 89.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.3 179.827 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 246' ' ' VAL . . . . . 0.454 HG21 HG12 ' A' ' 197' ' ' VAL . 8.7 p -65.44 -27.87 42.89 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 C-N-CA 120.849 -0.341 . . . . 0.0 111.143 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 17.5 m -65.74 -41.24 92.4 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.201 0.524 . . . . 0.0 109.718 178.041 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 248' ' ' LEU . . . . . 0.587 HD13 ' HG2' ' A' ' 231' ' ' MET . 55.0 mt -65.72 -38.29 88.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.999 178.226 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 249' ' ' ILE . . . . . 0.507 HG21 HD21 ' A' ' 194' ' ' LEU . 14.9 mt -68.41 -43.05 84.37 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.524 178.875 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 250' ' ' SER . . . . . 0.453 ' HB2' ' HG3' ' A' ' 202' ' ' GLN . 5.2 p -66.47 -38.26 86.94 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 178.256 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 251' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -62.92 -44.15 96.85 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 176.328 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 252' ' ' GLY . . . . . 0.403 ' HA2' HG22 ' A' ' 255' ' ' VAL . . . -61.21 -42.68 99.86 Favored Glycine 0 C--N 1.336 0.579 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.359 177.845 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -62.43 -38.72 90.8 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 120.926 0.393 . . . . 0.0 110.692 178.109 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -66.73 -47.56 71.92 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.256 179.312 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 255' ' ' VAL . . . . . 0.551 ' O ' ' HG ' ' A' ' 259' ' ' LEU . 31.3 m -66.63 -33.77 65.67 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.2 178.817 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -63.25 -40.3 97.03 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.133 0.492 . . . . 0.0 109.779 177.55 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 257' ' ' LYS . . . . . 0.629 ' HE3' ' HB3' ' A' ' 170' ' ' GLN . 81.2 mttt -63.72 -39.18 93.67 Favored 'General case' 0 CA--C 1.528 0.1 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.582 177.541 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 66.7 t60 -65.0 -36.43 84.39 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 177.697 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.551 ' HG ' ' O ' ' A' ' 255' ' ' VAL . 72.9 mt -70.07 -42.48 72.76 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.882 178.146 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 28.1 tptt -64.7 -33.83 76.87 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.672 179.132 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 40.7 t -59.77 -24.42 64.07 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.206 179.004 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 262' ' ' VAL . . . . . 0.569 HG23 ' HG3' ' A' ' 264' ' ' GLN . 16.7 m -117.54 18.16 7.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 CA-C-O 121.264 0.554 . . . . 0.0 110.179 178.607 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 23.3 t30 51.48 47.68 24.37 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 114.96 -1.018 . . . . 0.0 113.066 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 264' ' ' GLN . . . . . 0.569 ' HG3' HG23 ' A' ' 262' ' ' VAL . 11.6 mt-30 -91.36 39.11 0.99 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.707 0.289 . . . . 0.0 111.457 179.049 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 265' ' ' GLU . . . . . 0.501 ' HA ' HD12 ' A' ' 268' ' ' ILE . 15.6 tp10 -47.07 -36.63 8.36 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.906 179.477 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 2.5 m -55.9 -29.17 59.6 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.911 179.424 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 267' ' ' PHE . . . . . 0.426 ' C ' ' HD2' ' A' ' 270' ' ' PRO . 44.1 t80 -95.62 -21.38 18.26 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 120.925 -0.31 . . . . 0.0 111.623 179.819 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 268' ' ' ILE . . . . . 0.501 HD12 ' HA ' ' A' ' 265' ' ' GLU . 70.6 mt -63.77 -37.82 80.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 CA-C-O 121.06 0.457 . . . . 0.0 110.357 179.252 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 269' ' ' GLU . . . . . 0.579 ' HB3' ' HD3' ' A' ' 270' ' ' PRO . 2.1 tp10 -59.56 -58.27 20.69 Favored Pre-proline 0 CA--C 1.551 1.018 0 CA-C-N 115.886 -0.597 . . . . 0.0 112.113 179.236 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 270' ' ' PRO . . . . . 0.579 ' HD3' ' HB3' ' A' ' 269' ' ' GLU . 21.5 Cg_exo -67.82 -25.12 39.62 Favored 'Trans proline' 0 C--N 1.361 1.215 0 C-N-CA 122.314 2.009 . . . . 0.0 113.167 179.616 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 271' ' ' LEU . . . . . . . . . . . . . 42.6 tp -64.45 -46.22 84.09 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.622 -0.263 . . . . 0.0 110.55 179.075 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -61.17 -39.45 90.19 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.073 179.247 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 273' ' ' GLU . . . . . . . . . . . . . 49.9 mm-40 -68.48 -46.28 70.15 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.794 178.842 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 274' ' ' THR . . . . . . . . . . . . . 84.9 m -58.01 -49.18 77.73 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.94 179.601 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 275' ' ' ILE . . . . . 0.406 ' HA ' ' HE1' ' A' ' 231' ' ' MET . 95.1 mt -59.54 -54.0 40.54 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.115 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.267 178.891 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 78.6 m -52.5 -53.13 50.04 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.767 -0.651 . . . . 0.0 112.627 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 277' ' ' ASP . . . . . 0.42 ' HA ' ' HE1' ' A' ' 156' ' ' TYR . 38.4 t70 -59.64 -57.98 10.58 Favored 'General case' 0 C--O 1.224 -0.25 0 C-N-CA 120.849 -0.34 . . . . 0.0 111.561 -179.341 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 278' ' ' VAL . . . . . 0.559 ' HB ' ' HE1' ' A' ' 231' ' ' MET . 43.1 t -58.26 -41.34 80.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -179.295 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 19.1 tp -63.13 -47.2 83.77 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 75.7 t -77.73 -46.16 27.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -179.243 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 21.2 ptt180 -59.76 -30.16 68.67 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -179.16 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 282' ' ' THR . . . . . . . . . . . . . 12.0 m -84.71 -22.34 29.78 Favored 'General case' 0 CA--C 1.543 0.673 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 283' ' ' LYS . . . . . 0.567 ' HB2' ' NZ ' ' A' ' 283' ' ' LYS . 0.0 OUTLIER -139.38 42.03 2.05 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 -178.71 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 284' ' ' ARG . . . . . 0.43 HH21 ' CD ' ' A' ' 152' ' ' GLU . 11.1 ptm180 -63.8 -47.16 81.98 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -179.21 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -61.8 -41.71 98.1 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.838 0.352 . . . . 0.0 111.207 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 286' ' ' TRP . . . . . 0.566 ' O ' ' HG2' ' A' ' 290' ' ' GLN . 7.7 t90 -64.41 -41.62 96.53 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.803 0.335 . . . . 0.0 110.261 178.74 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -66.46 -51.71 53.89 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 27.2 m -59.78 -32.55 49.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -179.304 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.98 -36.53 75.27 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 120.772 0.32 . . . . 0.0 110.797 179.336 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 290' ' ' GLN . . . . . 0.566 ' HG2' ' O ' ' A' ' 286' ' ' TRP . 40.5 mm-40 -88.83 28.74 1.11 Allowed 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 121.032 -0.267 . . . . 0.0 110.977 179.543 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 46.1 mtp85 59.68 22.33 11.08 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 112.192 0.441 . . . . 0.0 112.192 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 292' ' ' GLY . . . . . 0.409 ' HA3' HD21 ' A' ' 155' ' ' LEU . . . 62.91 -130.62 42.51 Favored Glycine 0 C--O 1.239 0.433 0 CA-C-O 121.485 0.492 . . . . 0.0 113.866 179.512 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 293' ' ' TRP . . . . . 0.5 ' O ' HG13 ' A' ' 297' ' ' VAL . 90.6 m95 -65.12 -26.17 68.08 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.428 -0.386 . . . . 0.0 112.02 -179.294 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 294' ' ' ASP . . . . . 0.414 ' O ' ' HB2' ' A' ' 298' ' ' GLU . 25.5 t70 -64.64 -36.35 83.96 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 121.136 0.493 . . . . 0.0 109.995 178.579 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 295' ' ' GLY . . . . . 0.479 ' HA3' ' O ' ' A' ' 290' ' ' GLN . . . -71.37 -36.96 63.02 Favored Glycine 0 N--CA 1.45 -0.386 0 N-CA-C 110.551 -1.02 . . . . 0.0 110.551 177.598 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 296' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -63.87 -45.84 87.64 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 115.477 -0.362 . . . . 0.0 111.097 178.412 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 297' ' ' VAL . . . . . 0.649 ' HA ' HG21 ' A' ' 193' ' ' THR . 14.0 m -72.31 -28.4 28.8 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 -179.614 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 298' ' ' GLU . . . . . 0.475 ' O ' HG22 ' A' ' 302' ' ' VAL . 2.3 tp10 -76.76 -49.74 15.22 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.582 0.229 . . . . 0.0 111.275 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 299' ' ' PHE . . . . . 0.402 ' HZ ' ' HB2' ' B' ' 39' ' ' SER . 68.4 t80 -55.15 -48.72 73.33 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 120.879 0.371 . . . . 0.0 111.267 179.642 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 300' ' ' PHE . . . . . 0.516 ' HB3' HG21 ' A' ' 197' ' ' VAL . 54.2 m-85 -80.43 31.13 0.28 Allowed 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -139.65 -46.71 0.45 Allowed 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 111.843 0.312 . . . . 0.0 111.843 179.814 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 302' ' ' VAL . . . . . 0.475 HG22 ' O ' ' A' ' 298' ' ' GLU . 6.1 m -71.52 65.77 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-O 121.468 0.652 . . . . 0.0 112.263 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -106.27 24.12 13.01 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -179.732 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -73.91 69.52 1.41 Allowed 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.098 0.475 . . . . 0.0 111.41 179.614 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 305' ' ' LEU . . . . . 0.418 HD13 ' HA ' ' A' ' 305' ' ' LEU . 2.7 mm? -79.05 -33.59 44.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.281 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -72.61 -30.05 64.02 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.404 179.803 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . -100.9 69.67 0.44 Allowed Glycine 0 CA--C 1.521 0.418 0 C-N-CA 120.879 -0.677 . . . . 0.0 113.128 -179.557 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.186 0 CA-C-O 118.476 -1.18 . . . . 0.0 113.08 -179.975 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.499 0 CA-C-O 121.02 0.438 . . . . 0.0 110.704 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -109.59 -78.37 0.59 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.174 -179.144 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 19' ' ' LEU . . . . . 0.468 HD21 ' HA ' ' A' ' 216' ' ' LEU . 9.1 tp -88.37 121.57 70.19 Favored Pre-proline 0 CA--C 1.532 0.287 0 CA-C-O 120.762 0.315 . . . . 0.0 110.874 179.459 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 20' ' ' PRO . . . . . 0.504 ' HA ' ' HD3' ' B' ' 21' ' ' PRO . 58.0 Cg_endo -70.15 139.73 39.56 Favored 'Trans proline' 0 CA--C 1.534 0.514 0 C-N-CA 122.869 2.379 . . . . 0.0 113.045 -179.743 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 21' ' ' PRO . . . . . 0.504 ' HD3' ' HA ' ' B' ' 20' ' ' PRO . 8.3 Cg_exo -72.5 37.23 0.36 Allowed 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 123.105 2.537 . . . . 0.0 113.686 -179.615 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -75.54 -33.05 60.67 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 121.221 0.534 . . . . 0.0 110.932 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 23' ' ' PHE . . . . . 0.546 ' CE1' HG22 ' A' ' 230' ' ' VAL . 1.5 p90 -63.19 -41.57 99.22 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.478 -179.671 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.75 -36.42 83.83 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.939 0.4 . . . . 0.0 110.756 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.84 -47.37 86.65 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.798 178.241 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -66.01 -45.62 80.85 Favored 'General case' 0 CA--C 1.527 0.081 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.409 178.448 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 80.6 mt -56.75 -39.42 73.94 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.844 0.355 . . . . 0.0 110.378 178.386 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 28' ' ' ARG . . . . . 0.404 ' HA ' HG13 ' A' ' 234' ' ' VAL . 0.7 OUTLIER -62.63 -51.82 65.78 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.67 178.194 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -56.91 -42.01 79.17 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.568 178.691 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 87.8 mt -65.09 -43.29 95.86 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.433 178.716 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 31' ' ' GLY . . . . . 0.481 ' HA3' ' HA ' ' A' ' 244' ' ' ARG . . . -59.17 -50.08 71.63 Favored Glycine 0 C--N 1.335 0.514 0 C-N-CA 121.069 -0.586 . . . . 0.0 112.397 179.273 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -61.31 -44.62 96.91 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.091 0.472 . . . . 0.0 109.808 178.667 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 33' ' ' LYS . . . . . 0.456 ' HA ' ' HD2' ' B' ' 33' ' ' LYS . 0.2 OUTLIER -59.59 -55.98 27.67 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.787 179.718 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 55.7 t -59.14 -44.96 92.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-O 120.848 0.356 . . . . 0.0 110.974 179.558 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 35' ' ' TYR . . . . . 0.402 ' HB2' ' HA3' ' A' ' 243' ' ' GLY . 9.7 t80 -57.09 -45.96 82.94 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.567 179.145 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 36' ' ' CYS . . . . . . . . . . . . . 73.3 m -65.77 -29.55 70.06 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.405 179.302 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 97.0 m -66.69 -45.39 78.97 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 120.645 0.259 . . . . 0.0 111.217 179.464 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 38' ' ' TRP . . . . . . . . . . . . . 99.3 m95 -75.58 -40.81 56.11 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 120.74 0.305 . . . . 0.0 111.136 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 39' ' ' SER . . . . . 0.402 ' HB2' ' HZ ' ' A' ' 299' ' ' PHE . 41.7 t -81.29 54.47 2.3 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 120.841 0.353 . . . . 0.0 111.66 179.511 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -70.44 115.02 30.73 Favored Pre-proline 0 N--CA 1.466 0.356 0 CA-C-O 121.0 0.429 . . . . 0.0 111.552 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -97.08 29.8 0.17 Allowed 'Trans proline' 0 CA--C 1.535 0.572 0 C-N-CA 123.425 2.75 . . . . 0.0 114.095 -179.132 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -77.4 58.06 1.62 Allowed 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 120.913 0.387 . . . . 0.0 111.732 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 43' ' ' MET . . . . . . . . . . . . . 10.8 ptm . . . . . 0 C--O 1.252 1.185 0 CA-C-O 118.316 -0.849 . . . . 0.0 111.553 179.994 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.57 ' HA3' ' HB3' ' A' ' 153' ' ' ASP . . . . . . . . 0 N--CA 1.493 2.469 0 CA-C-O 119.853 -0.415 . . . . 0.0 112.152 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_exo -57.38 -55.18 2.69 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.74 2.293 . . . . 0.0 112.43 179.22 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 16.5 tp -84.63 54.4 3.02 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 121.386 0.612 . . . . 0.0 110.811 179.388 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 74.08 -110.55 3.14 Favored Glycine 0 C--O 1.228 -0.23 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.844 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 61.0 p -117.92 6.69 12.22 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.95 0.405 . . . . 0.0 110.46 178.541 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 45.3 mm-40 -64.95 -39.46 93.52 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.636 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' ASP . . . . . 0.589 ' O ' ' HG3' ' A' ' 157' ' ' ARG . 26.5 t70 -64.63 -49.05 72.59 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.82 179.867 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.588 ' HA ' ' CZ ' ' A' ' 157' ' ' ARG . 2.9 m-20 -55.6 -47.41 76.55 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -178.908 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 47.9 tp -66.37 -37.02 84.34 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.139 0.495 . . . . 0.0 110.616 179.283 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 56.7 t80 -68.49 -43.19 77.43 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.389 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.589 ' HG3' ' O ' ' A' ' 153' ' ' ASP . 54.4 mtm-85 -56.43 -49.77 73.58 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 27.6 tt0 -64.86 -43.93 91.39 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 120.851 0.358 . . . . 0.0 110.961 -179.596 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' SER . . . . . 0.4 ' HA ' ' NE1' ' A' ' 293' ' ' TRP . 20.0 m -63.52 -43.26 97.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.205 179.493 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -64.24 -47.54 79.27 Favored 'General case' 0 C--O 1.221 -0.402 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.43 178.905 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 161' ' ' GLU . . . . . 0.45 ' HB3' HD12 ' A' ' 180' ' ' LEU . 33.8 mt-10 -54.38 -47.39 72.73 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-O 120.875 0.369 . . . . 0.0 111.461 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 162' ' ' ILE . . . . . 0.494 HG12 ' HA2' ' A' ' 187' ' ' GLY . 67.8 mt -63.11 -53.21 49.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-N 116.069 -0.514 . . . . 0.0 112.137 -179.783 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.516 HD12 HG23 ' A' ' 276' ' ' THR . 80.3 mt -63.12 -43.99 99.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.908 0.385 . . . . 0.0 110.935 179.725 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 2.5 t -59.16 -46.66 87.8 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.508 179.374 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 165' ' ' ARG . . . . . 0.849 ' HG2' ' HD2' ' A' ' 179' ' ' PRO . 2.3 mmm180 -57.19 -40.61 77.71 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 120.729 0.299 . . . . 0.0 111.075 179.024 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 70.6 t80 -71.0 -53.76 13.67 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.442 ' HG ' ' O ' ' A' ' 163' ' ' ILE . 38.9 mt -61.03 -43.42 98.92 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -178.887 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 168' ' ' ARG . . . . . 0.568 ' HD3' ' OG ' ' A' ' 177' ' ' SER . 1.7 mtt-85 -67.79 -46.18 72.69 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -179.201 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 169' ' ' GLU . . . . . 0.546 ' OE2' ' HD2' ' A' ' 165' ' ' ARG . 17.6 mt-10 -66.3 -39.25 89.21 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 120.89 -0.324 . . . . 0.0 111.808 -179.512 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 170' ' ' GLN . . . . . 0.511 ' HG3' ' HE3' ' A' ' 257' ' ' LYS . 6.5 tp-100 -70.05 -26.32 63.97 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 121.234 0.54 . . . . 0.0 110.3 178.662 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.523 ' O ' ' HG2' ' A' ' 260' ' ' LYS . . . -79.67 -48.07 14.32 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.803 179.293 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 172' ' ' THR . . . . . 0.472 ' HB ' ' HB2' ' A' ' 175' ' ' LYS . 64.3 p -67.65 -49.22 63.98 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 111.662 0.245 . . . . 0.0 111.662 -179.695 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 65.47 -19.32 0.14 Allowed Glycine 0 CA--C 1.532 1.104 0 N-CA-C 115.035 0.774 . . . . 0.0 115.035 179.349 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 174' ' ' SER . . . . . 0.401 ' H ' ' C ' ' A' ' 172' ' ' THR . 89.3 p -141.69 9.89 2.0 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 117.641 0.721 . . . . 0.0 111.952 -179.455 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 175' ' ' LYS . . . . . 0.472 ' HB2' ' HB ' ' A' ' 172' ' ' THR . 25.1 mmtm -127.08 124.04 38.31 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.399 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -70.92 86.35 0.7 Allowed 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 121.536 0.684 . . . . 0.0 111.464 -179.764 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 177' ' ' SER . . . . . 0.568 ' OG ' ' HD3' ' A' ' 168' ' ' ARG . 27.5 t -103.98 78.91 1.58 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.992 -179.78 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 47.2 mttp -106.79 97.33 16.98 Favored Pre-proline 0 CA--C 1.537 0.454 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -179.269 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 179' ' ' PRO . . . . . 0.849 ' HD2' ' HG2' ' A' ' 165' ' ' ARG . 95.0 Cg_endo -95.53 40.88 0.14 Allowed 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 123.167 2.578 . . . . 0.0 112.383 178.289 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.479 HD13 ' HG3' ' A' ' 165' ' ' ARG . 9.0 tp -90.31 137.43 32.36 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.437 -179.31 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -148.71 -54.16 0.02 OUTLIER Glycine 0 CA--C 1.52 0.373 0 C-N-CA 120.438 -0.886 . . . . 0.0 112.967 -179.747 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 62.3 tt0 -96.45 -30.23 13.47 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.819 0.343 . . . . 0.0 111.725 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.601 ' O ' ' HA3' ' A' ' 187' ' ' GLY . . . -80.67 62.57 4.77 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.939 0.399 . . . . 0.0 111.499 -179.839 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -79.97 -71.48 1.26 Allowed Glycine 0 CA--C 1.525 0.705 0 C-N-CA 120.751 -0.737 . . . . 0.0 113.969 -179.681 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -70.56 -57.01 5.2 Favored 'General case' 0 C--O 1.238 0.449 0 O-C-N 122.519 -0.4 . . . . 0.0 111.823 -179.14 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -67.24 -27.75 67.49 Favored 'General case' 0 C--N 1.335 -0.061 0 CA-C-O 121.199 0.523 . . . . 0.0 109.892 179.234 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 187' ' ' GLY . . . . . 0.601 ' HA3' ' O ' ' A' ' 183' ' ' ALA . . . -72.64 -33.36 60.76 Favored Glycine 0 N--CA 1.447 -0.614 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.861 178.573 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -65.97 -54.51 25.3 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.797 0.332 . . . . 0.0 110.269 178.688 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 189' ' ' ARG . . . . . 0.692 ' HB3' HG11 ' A' ' 297' ' ' VAL . 16.0 mtm180 -55.12 -46.79 75.6 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 121.136 0.493 . . . . 0.0 110.818 179.17 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -71.35 -31.33 67.24 Favored 'General case' 0 C--O 1.221 -0.409 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.474 -179.474 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 191' ' ' LEU . . . . . 0.601 ' HB2' ' O ' ' A' ' 187' ' ' GLY . 0.2 OUTLIER -62.16 -53.59 53.15 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 117.893 0.315 . . . . 0.0 111.08 179.67 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -64.2 -41.41 97.08 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 120.713 0.292 . . . . 0.0 111.214 179.578 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 193' ' ' THR . . . . . 0.537 HG21 ' HA ' ' A' ' 297' ' ' VAL . 11.8 m -64.33 -47.76 78.18 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.81 179.109 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 14.9 tp -66.69 -35.28 79.76 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.776 0.322 . . . . 0.0 110.829 179.483 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 195' ' ' ARG . . . . . 0.429 HH11 ' HD2' ' A' ' 195' ' ' ARG . 9.2 tpp85 -67.73 -57.43 6.36 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.991 179.024 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 16.6 tpp180 -60.96 -50.8 71.91 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -178.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 197' ' ' VAL . . . . . 0.565 ' O ' HG23 ' A' ' 201' ' ' VAL . 97.1 t -70.1 -47.0 70.54 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -179.225 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -59.73 -48.06 87.9 Favored Glycine 0 CA--C 1.52 0.395 0 C-N-CA 121.359 -0.448 . . . . 0.0 113.229 -179.542 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 199' ' ' ASP . . . . . 0.514 ' HA ' ' HG2' ' A' ' 202' ' ' GLN . 98.2 m-20 -65.95 -36.38 83.2 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.828 0.347 . . . . 0.0 110.176 179.253 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -62.05 -37.69 94.86 Favored Glycine 0 CA--C 1.522 0.531 0 C-N-CA 120.708 -0.758 . . . . 0.0 111.97 178.48 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 201' ' ' VAL . . . . . 0.565 HG23 ' O ' ' A' ' 197' ' ' VAL . 93.4 t -67.09 -46.29 84.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 O-C-N 122.844 -0.21 . . . . 0.0 110.968 179.023 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 202' ' ' GLN . . . . . 0.514 ' HG2' ' HA ' ' A' ' 199' ' ' ASP . 8.0 pt20 -68.91 -31.68 70.76 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.443 179.593 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.35 -44.43 45.18 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 120.661 0.267 . . . . 0.0 111.152 179.012 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 27.1 m-80 -68.19 -44.89 74.87 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.844 0.354 . . . . 0.0 111.715 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 205' ' ' HIS . . . . . 0.464 ' HB2' ' CD2' ' A' ' 209' ' ' PHE . 10.2 m80 -100.65 32.82 2.96 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 120.897 0.379 . . . . 0.0 110.32 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -49.62 -51.4 37.87 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 -178.661 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 28.2 p -57.91 -53.43 58.29 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -179.08 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -61.93 -41.09 97.55 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.029 0.442 . . . . 0.0 110.871 179.45 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 209' ' ' PHE . . . . . 0.464 ' CD2' ' HB2' ' A' ' 205' ' ' HIS . 5.1 m-85 -64.04 -48.61 75.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.55 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -67.96 -33.58 74.93 Favored 'General case' 0 C--O 1.225 -0.189 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.853 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -57.69 -50.1 68.32 Favored Glycine 0 C--N 1.336 0.555 0 C-N-CA 120.52 -0.847 . . . . 0.0 111.217 178.265 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 212' ' ' MET . . . . . 0.721 ' SD ' ' HA ' ' B' ' 23' ' ' PHE . 41.6 mtm -67.84 -33.16 74.23 Favored 'General case' 0 C--O 1.224 -0.275 0 N-CA-C 110.355 -0.239 . . . . 0.0 110.355 178.474 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.781 HD12 HD12 ' A' ' 216' ' ' LEU . 10.0 tp -67.97 -36.51 80.17 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.196 179.293 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 15.8 mtp180 -68.76 -34.39 75.5 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 178.441 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -86.76 -6.95 58.67 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.765 178.113 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.781 HD12 HD12 ' A' ' 213' ' ' LEU . 5.9 mt -68.73 110.26 4.22 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.186 0.517 . . . . 0.0 111.916 -179.293 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 217' ' ' ASP . . . . . 0.485 ' H ' HD22 ' B' ' 19' ' ' LEU . 0.3 OUTLIER -94.66 18.99 10.54 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.764 179.476 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 218' ' ' ILE . . . . . 0.662 HG13 HD22 ' A' ' 216' ' ' LEU . 34.2 mt -59.3 107.63 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 CA-C-O 121.431 0.634 . . . . 0.0 111.619 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 6.2 mtmp? -150.31 -28.68 0.23 Allowed 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 115.111 -0.949 . . . . 0.0 111.752 -179.789 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -107.59 166.3 10.78 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 121.082 -0.247 . . . . 0.0 111.249 -179.393 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -54.5 -33.3 59.61 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -179.138 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -64.66 -27.76 72.38 Favored Glycine 0 CA--C 1.526 0.768 0 C-N-CA 120.989 -0.624 . . . . 0.0 113.507 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 223' ' ' ASP . . . . . 0.65 ' HB3' HG12 ' A' ' 218' ' ' ILE . 69.2 m-20 -66.94 -38.02 85.37 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 120.911 0.386 . . . . 0.0 111.5 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.442 HG12 HG21 ' A' ' 274' ' ' THR . 1.1 t -63.46 -35.1 71.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-O 121.361 0.601 . . . . 0.0 110.349 179.26 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 36.0 mmtm -65.56 -30.98 71.79 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.585 178.666 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 226' ' ' SER . . . . . 0.682 ' O ' HG23 ' A' ' 230' ' ' VAL . 30.6 t -71.63 -37.0 70.94 Favored 'General case' 0 C--O 1.223 -0.304 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.65 178.16 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 227' ' ' PHE . . . . . 0.607 ' HE2' HD12 ' A' ' 275' ' ' ILE . 8.8 t80 -57.11 -43.78 82.62 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 178.419 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 228' ' ' SER . . . . . 0.704 ' HB3' HG21 ' A' ' 278' ' ' VAL . 0.6 OUTLIER -70.35 -32.36 70.03 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.914 177.276 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 54.5 ttp180 -64.09 -48.41 76.26 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.113 178.562 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 0.721 HG13 ' HA ' ' B' ' 24' ' ' ALA . 13.6 t -61.12 -43.77 96.96 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 178.174 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 231' ' ' MET . . . . . 0.923 ' HG3' ' HG ' ' A' ' 248' ' ' LEU . 26.3 ttm -55.07 -50.24 69.64 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.245 178.238 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 72.2 t -64.63 -42.16 94.29 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 CA-C-O 120.847 0.356 . . . . 0.0 110.818 178.811 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 233' ' ' HIS . . . . . 0.44 ' ND1' ' HB1' ' B' ' 24' ' ' ALA . 52.7 t-80 -59.78 -39.51 85.15 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 116.278 -0.419 . . . . 0.0 112.06 179.839 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.622 HG13 ' HA ' ' B' ' 28' ' ' ARG . 44.2 t -54.99 -43.94 71.62 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 179.7 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -90.95 25.7 2.34 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -179.316 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.11 -18.74 27.15 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 113.729 1.011 . . . . 0.0 113.729 -178.904 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -85.68 -16.17 39.98 Favored 'General case' 0 C--N 1.327 -0.384 0 O-C-N 122.093 -0.379 . . . . 0.0 111.4 179.737 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 100.28 -18.84 54.89 Favored Glycine 0 CA--C 1.522 0.522 0 C-N-CA 120.752 -0.737 . . . . 0.0 113.613 179.405 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 4.3 p -85.71 118.83 33.09 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-O 121.56 0.695 . . . . 0.0 111.237 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 240' ' ' THR . . . . . 0.568 HG21 ' HG2' ' A' ' 283' ' ' LYS . 53.8 m -89.95 98.26 11.67 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.807 -179.36 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -89.59 131.87 35.39 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.884 -0.326 . . . . 0.0 110.455 178.875 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 242' ' ' TRP . . . . . 0.483 ' CH2' ' HB2' ' A' ' 296' ' ' PHE . 17.2 m95 -55.74 -36.76 67.61 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 120.995 0.426 . . . . 0.0 110.75 179.165 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 243' ' ' GLY . . . . . 0.486 ' H ' ' HB2' ' B' ' 35' ' ' TYR . . . -61.56 -32.51 81.55 Favored Glycine 0 C--N 1.333 0.401 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.152 178.335 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 244' ' ' ARG . . . . . 0.53 ' HA ' ' HA3' ' B' ' 31' ' ' GLY . 99.1 mtt180 -72.01 -46.24 57.92 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 178.541 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 245' ' ' ILE . . . . . 0.624 HG23 HD21 ' A' ' 279' ' ' LEU . 52.2 mt -58.14 -49.25 82.24 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.154 179.022 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 246' ' ' VAL . . . . . 0.438 HG21 HG12 ' A' ' 197' ' ' VAL . 8.7 p -69.05 -26.2 31.69 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-N 116.623 -0.262 . . . . 0.0 111.133 179.777 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 247' ' ' THR . . . . . 0.405 HG21 ' HB ' ' B' ' 30' ' ' ILE . 17.0 m -65.72 -37.28 85.99 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 177.87 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 248' ' ' LEU . . . . . 0.923 ' HG ' ' HG3' ' A' ' 231' ' ' MET . 2.6 mm? -66.62 -38.72 87.53 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 177.865 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 18.2 mm -67.63 -41.4 85.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 177.846 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 29.8 m -62.25 -41.62 98.6 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.79 178.603 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 251' ' ' PHE . . . . . 0.489 ' CD2' HD11 ' B' ' 27' ' ' LEU . 7.6 t80 -68.03 -40.35 82.93 Favored 'General case' 0 N--CA 1.456 -0.142 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 177.218 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -56.81 -42.26 91.65 Favored Glycine 0 C--N 1.337 0.586 0 N-CA-C 111.106 -0.798 . . . . 0.0 111.106 177.655 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -61.39 -44.45 97.13 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-O 120.937 0.399 . . . . 0.0 110.048 177.734 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 254' ' ' PHE . . . . . 0.566 ' HB3' HD13 ' A' ' 213' ' ' LEU . 0.2 OUTLIER -61.17 -41.0 96.0 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.271 178.475 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 255' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 251' ' ' PHE . 91.5 t -62.32 -45.95 97.57 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.225 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 178.096 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 256' ' ' ALA . . . . . 0.507 ' HB1' ' HB2' ' A' ' 171' ' ' ALA . . . -58.82 -39.77 82.17 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 177.766 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 257' ' ' LYS . . . . . 0.511 ' HE3' ' HG3' ' A' ' 170' ' ' GLN . 74.5 mttt -62.89 -47.41 83.4 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.116 177.577 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 4.2 t60 -59.47 -40.97 88.66 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.428 179.081 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.454 HD13 ' HB3' ' A' ' 267' ' ' PHE . 87.2 mt -68.73 -42.29 77.82 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.406 178.624 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 260' ' ' LYS . . . . . 0.523 ' HG2' ' O ' ' A' ' 171' ' ' ALA . 0.7 OUTLIER -64.98 -34.72 79.11 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 120.847 0.356 . . . . 0.0 110.596 178.667 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 32.0 t -63.06 -25.83 68.56 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.019 179.279 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 262' ' ' VAL . . . . . 0.45 HG23 ' HB2' ' A' ' 264' ' ' GLN . 27.2 m -111.62 13.87 8.49 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.19 178.96 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 1.6 t30 57.06 50.96 11.11 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.451 179.818 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 264' ' ' GLN . . . . . 0.472 ' NE2' ' HB2' ' A' ' 267' ' ' PHE . 0.0 OUTLIER -119.03 39.2 3.6 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -179.87 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 265' ' ' GLU . . . . . 0.453 ' HA ' HD12 ' A' ' 268' ' ' ILE . 0.0 OUTLIER -49.63 -27.41 4.59 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 178.933 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.21 -20.67 43.46 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.251 178.641 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 267' ' ' PHE . . . . . 0.472 ' HB2' ' NE2' ' A' ' 264' ' ' GLN . 2.2 t80 -97.67 -20.9 17.33 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.883 178.709 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 268' ' ' ILE . . . . . 0.453 HD12 ' HA ' ' A' ' 265' ' ' GLU . 76.1 mt -65.39 -43.15 94.82 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-O 120.741 0.305 . . . . 0.0 110.373 179.252 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 269' ' ' GLU . . . . . 0.466 ' HB2' ' HD3' ' A' ' 270' ' ' PRO . 0.3 OUTLIER -54.98 -56.98 21.88 Favored Pre-proline 0 CA--C 1.543 0.711 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.794 179.177 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 270' ' ' PRO . . . . . 0.466 ' HD3' ' HB2' ' A' ' 269' ' ' GLU . 38.8 Cg_exo -62.89 -32.66 76.9 Favored 'Trans proline' 0 C--N 1.358 1.043 0 C-N-CA 122.055 1.837 . . . . 0.0 112.37 178.43 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 271' ' ' LEU . . . . . 0.562 ' O ' HG22 ' A' ' 275' ' ' ILE . 2.1 tm? -63.79 -50.62 68.26 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.621 179.445 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -60.33 -42.39 95.54 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.734 179.745 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 273' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -67.2 -43.87 81.04 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 120.945 0.402 . . . . 0.0 110.988 178.901 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 274' ' ' THR . . . . . 0.442 HG21 HG12 ' A' ' 224' ' ' VAL . 60.6 m -62.22 -52.68 62.8 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.682 -179.497 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 275' ' ' ILE . . . . . 0.607 HD12 ' HE2' ' A' ' 227' ' ' PHE . 6.3 tt -58.28 -47.69 86.89 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 C-N-CA 121.018 -0.273 . . . . 0.0 111.228 179.741 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 276' ' ' THR . . . . . 0.516 HG23 HD12 ' A' ' 163' ' ' ILE . 50.7 m -59.84 -53.73 54.48 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -179.679 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 277' ' ' ASP . . . . . 0.466 ' OD1' ' HD3' ' A' ' 281' ' ' ARG . 33.5 t70 -59.72 -51.16 70.97 Favored 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 120.637 -0.425 . . . . 0.0 111.092 -179.645 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 278' ' ' VAL . . . . . 0.704 HG21 ' HB3' ' A' ' 228' ' ' SER . 73.8 t -58.27 -47.65 86.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 120.747 -0.381 . . . . 0.0 111.02 179.715 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 279' ' ' LEU . . . . . 0.624 HD21 HG23 ' A' ' 245' ' ' ILE . 45.3 tp -60.58 -47.64 85.29 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 111.676 0.25 . . . . 0.0 111.676 179.782 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 55.6 t -66.86 -39.74 84.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 CA-C-O 120.75 0.31 . . . . 0.0 111.008 179.648 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 281' ' ' ARG . . . . . 0.466 ' HD3' ' OD1' ' A' ' 277' ' ' ASP . 0.0 OUTLIER -68.17 -47.09 68.93 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -179.883 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 282' ' ' THR . . . . . 0.818 HG23 ' HD2' ' A' ' 283' ' ' LYS . 4.7 t -63.37 -44.16 95.56 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 120.435 -0.506 . . . . 0.0 112.216 -179.676 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 283' ' ' LYS . . . . . 0.818 ' HD2' HG23 ' A' ' 282' ' ' THR . 0.0 OUTLIER -99.46 40.27 1.23 Allowed 'General case' 0 C--N 1.327 -0.392 0 O-C-N 121.987 -0.445 . . . . 0.0 111.463 179.77 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 284' ' ' ARG . . . . . 0.492 HH12 ' HB ' ' A' ' 288' ' ' VAL . 39.6 tpt85 -58.49 -51.12 71.19 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.941 -179.495 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -66.96 -43.59 82.73 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 120.994 0.426 . . . . 0.0 111.462 179.679 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 286' ' ' TRP . . . . . 0.442 ' O ' ' HB2' ' A' ' 290' ' ' GLN . 3.5 t90 -64.58 -41.37 96.31 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.933 -179.711 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 287' ' ' LEU . . . . . 0.6 HD23 ' HB3' ' A' ' 283' ' ' LYS . 2.0 mm? -69.0 -47.65 64.98 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 112.319 0.488 . . . . 0.0 112.319 -179.751 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 288' ' ' VAL . . . . . 0.492 ' HB ' HH12 ' A' ' 284' ' ' ARG . 7.3 p -60.73 -37.62 76.51 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 CA-C-O 120.634 0.254 . . . . 0.0 111.641 -179.769 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 79.6 mttt -75.3 -21.74 58.23 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 120.891 0.377 . . . . 0.0 111.35 178.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 290' ' ' GLN . . . . . 0.442 ' HB2' ' O ' ' A' ' 286' ' ' TRP . 0.0 OUTLIER -96.34 12.77 30.0 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 111.984 0.365 . . . . 0.0 111.984 179.969 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 291' ' ' ARG . . . . . 0.573 ' HB3' ' HB2' ' A' ' 294' ' ' ASP . 0.0 OUTLIER 62.19 19.09 10.66 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.089 0.471 . . . . 0.0 111.772 179.939 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 64.45 -122.48 25.15 Favored Glycine 0 CA--C 1.522 0.475 0 CA-C-N 115.906 -0.588 . . . . 0.0 113.964 179.207 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 293' ' ' TRP . . . . . 0.509 ' O ' HG23 ' A' ' 297' ' ' VAL . 89.4 m95 -66.57 -33.71 76.27 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.545 -0.328 . . . . 0.0 111.637 -178.941 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 294' ' ' ASP . . . . . 0.573 ' HB2' ' HB3' ' A' ' 291' ' ' ARG . 45.0 m-20 -54.86 -40.25 69.47 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.017 0.437 . . . . 0.0 110.251 178.354 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -72.18 -44.51 43.82 Favored Glycine 0 C--N 1.334 0.455 0 C-N-CA 120.761 -0.733 . . . . 0.0 111.727 178.394 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 296' ' ' PHE . . . . . 0.483 ' HB2' ' CH2' ' A' ' 242' ' ' TRP . 7.2 t80 -58.92 -45.06 91.29 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 120.852 0.358 . . . . 0.0 111.114 178.913 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 297' ' ' VAL . . . . . 0.692 HG11 ' HB3' ' A' ' 189' ' ' ARG . 81.0 t -67.57 -39.51 82.49 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.942 -179.529 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -76.15 -26.95 56.8 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 112.578 0.584 . . . . 0.0 112.578 -179.379 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 299' ' ' PHE . . . . . . . . . . . . . 87.4 t80 -60.9 -41.32 95.83 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.807 0.337 . . . . 0.0 111.372 179.446 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 300' ' ' PHE . . . . . 0.447 ' HE2' ' CD1' ' A' ' 296' ' ' PHE . 68.4 m-85 -88.68 29.54 1.0 Allowed 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 120.706 0.289 . . . . 0.0 111.628 -179.661 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 301' ' ' HIS . . . . . 0.463 ' HB3' HD22 ' A' ' 305' ' ' LEU . 3.8 t60 -77.4 70.64 3.81 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 121.102 0.477 . . . . 0.0 111.056 -179.827 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 2.5 p -86.13 95.48 4.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-O 121.137 0.494 . . . . 0.0 110.896 179.407 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 59.2 tp60 179.71 -78.05 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.259 -179.44 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -111.0 30.68 6.66 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 120.958 0.409 . . . . 0.0 111.929 -179.516 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 305' ' ' LEU . . . . . 0.463 HD22 ' HB3' ' A' ' 301' ' ' HIS . 27.3 tp -113.74 -32.6 6.08 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 121.159 0.504 . . . . 0.0 111.36 -179.769 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 306' ' ' GLU . . . . . 0.404 ' H ' ' CD ' ' A' ' 306' ' ' GLU . 1.3 pm0 -88.0 -19.38 27.26 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.574 179.652 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . 169.13 -116.07 0.64 Allowed Glycine 0 CA--C 1.522 0.473 0 C-N-CA 120.769 -0.729 . . . . 0.0 113.123 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.196 0 CA-C-O 118.366 -1.241 . . . . 0.0 112.947 -179.77 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.506 0 CA-C-O 121.156 0.503 . . . . 0.0 110.481 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -113.1 -166.4 1.08 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.285 -178.897 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 19' ' ' LEU . . . . . 0.718 ' H ' HD23 ' B' ' 19' ' ' LEU . 0.7 OUTLIER -69.59 157.69 88.88 Favored Pre-proline 0 CA--C 1.539 0.522 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.458 179.823 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 20' ' ' PRO . . . . . 0.47 ' HA ' ' HD3' ' B' ' 21' ' ' PRO . 10.2 Cg_endo -50.17 129.8 26.43 Favored 'Trans proline' 0 C--N 1.354 0.819 0 C-N-CA 123.184 2.59 . . . . 0.0 112.582 -179.841 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 21' ' ' PRO . . . . . 0.47 ' HD3' ' HA ' ' B' ' 20' ' ' PRO . 24.4 Cg_exo -64.16 42.46 0.12 Allowed 'Trans proline' 0 N--CA 1.482 0.849 0 C-N-CA 123.791 2.994 . . . . 0.0 114.913 -178.735 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 22' ' ' GLU . . . . . 0.408 ' HB2' ' NE2' ' B' ' 26' ' ' GLN . 0.5 OUTLIER -85.97 -29.03 23.87 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.001 0.429 . . . . 0.0 110.265 178.887 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 23' ' ' PHE . . . . . 0.721 ' HA ' ' SD ' ' A' ' 212' ' ' MET . 11.1 p90 -60.5 -35.7 76.57 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.498 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 24' ' ' ALA . . . . . 0.721 ' HA ' HG13 ' A' ' 230' ' ' VAL . . . -61.25 -47.79 84.42 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.007 0.432 . . . . 0.0 110.531 179.587 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 25' ' ' ALA . . . . . 0.431 ' O ' ' HG2' ' B' ' 29' ' ' LYS . . . -70.61 -44.78 66.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.599 179.163 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 26' ' ' GLN . . . . . 0.738 ' O ' HG12 ' B' ' 30' ' ' ILE . 1.7 mp0 -57.74 -56.97 15.11 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.261 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 27' ' ' LEU . . . . . 0.509 HD12 HG11 ' A' ' 230' ' ' VAL . 50.4 mt -56.31 -42.53 77.74 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 120.589 0.233 . . . . 0.0 111.274 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 28' ' ' ARG . . . . . 0.622 ' HA ' HG13 ' A' ' 234' ' ' VAL . 10.7 ttt85 -57.45 -48.01 80.31 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.523 178.471 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 29' ' ' LYS . . . . . 0.431 ' HG2' ' O ' ' B' ' 25' ' ' ALA . 20.1 mmmt -68.28 -39.1 82.25 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.872 179.329 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 30' ' ' ILE . . . . . 0.738 HG12 ' O ' ' B' ' 26' ' ' GLN . 48.8 mm -55.25 -49.95 68.42 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 177.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 31' ' ' GLY . . . . . 0.53 ' HA3' ' HA ' ' A' ' 244' ' ' ARG . . . -58.84 -44.96 95.64 Favored Glycine 0 N--CA 1.448 -0.559 0 CA-C-N 115.228 -0.897 . . . . 0.0 112.306 179.082 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -57.78 -44.99 86.61 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-O 120.662 0.268 . . . . 0.0 110.955 179.154 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 29.8 tttp -69.73 -52.29 26.74 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 121.017 -0.273 . . . . 0.0 111.171 179.621 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 74.2 t -52.94 -49.3 49.32 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-O 121.075 0.464 . . . . 0.0 110.761 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 35' ' ' TYR . . . . . 0.486 ' HB2' ' H ' ' A' ' 243' ' ' GLY . 1.2 t80 -57.33 -48.59 78.59 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.698 178.831 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 36' ' ' CYS . . . . . . . . . . . . . 36.7 t -65.5 -35.04 79.71 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.501 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 37' ' ' THR . . . . . 0.519 ' HA ' ' HB3' ' B' ' 43' ' ' MET . 44.7 m -65.21 -37.3 86.85 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.965 -0.562 . . . . 0.0 111.615 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 38' ' ' TRP . . . . . . . . . . . . . 87.7 m95 -85.52 -35.44 21.13 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.243 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 40.9 t -67.78 -58.14 5.12 Favored 'General case' 0 N--CA 1.462 0.166 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 177.916 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -92.89 115.14 64.45 Favored Pre-proline 0 CA--C 1.532 0.267 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.134 177.628 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -68.68 -10.18 28.32 Favored 'Trans proline' 0 CA--C 1.534 0.499 0 C-N-CA 122.458 2.105 . . . . 0.0 113.184 -179.392 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -99.61 30.76 3.46 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.762 -179.721 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 43' ' ' MET . . . . . 0.519 ' HB3' ' HA ' ' B' ' 37' ' ' THR . 40.0 tpp . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.418 -0.801 . . . . 0.0 111.866 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.536 0.42 0 N-CA-C 111.987 0.366 . . . . 1.37 111.987 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -57.95 -41.49 82.93 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.291 -0.413 . . . . 1.16 111.872 179.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 44.5 tp -57.29 -43.26 83.0 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.585 -0.279 . . . . 0.57 111.722 -179.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -66.5 -48.91 68.31 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 112.075 0.398 . . . . 0.34 112.075 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 0.401 ' HD3' HH11 ' A' ' 157' ' ' ARG . 6.6 mtp180 -59.3 -52.08 67.19 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 112.409 0.522 . . . . 0.89 112.409 -179.274 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 35.9 mm-40 -57.46 -45.68 84.5 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.129 0.49 . . . . 0.47 110.719 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 20.3 m -64.18 -48.51 75.68 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.69 -0.686 . . . . 0.25 111.383 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.619 ' HA ' HG21 ' A' ' 276' ' ' THR . 17.3 tp -58.12 -48.59 79.74 Favored 'General case' 0 C--O 1.225 -0.235 0 CA-C-N 116.326 -0.397 . . . . 0.38 111.498 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -55.96 -50.47 70.69 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 111.781 0.289 . . . . 0.97 111.781 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . 0.529 HG12 ' HA2' ' A' ' 187' ' ' GLY . 57.1 mt -62.56 -50.1 81.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 CA-C-N 116.331 -0.395 . . . . 0.34 111.918 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.531 HD12 HG23 ' A' ' 276' ' ' THR . 77.4 mt -62.86 -47.33 93.33 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 C-N-CA 121.297 -0.161 . . . . 0.39 111.214 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 19.4 m -58.2 -42.01 85.23 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.101 0.477 . . . . 0.33 109.989 178.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . 0.54 ' O ' ' HB2' ' A' ' 169' ' ' GLU . 1.1 mmp_? -66.75 -48.77 68.09 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.119 -0.491 . . . . 0.39 111.308 178.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' TYR . . . . . 0.836 ' CE1' ' HA ' ' A' ' 195' ' ' ARG . 66.0 t80 -60.39 -51.99 67.15 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 112.9 0.704 . . . . 0.42 112.9 -179.206 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 10.9 mp -62.4 -45.07 94.79 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 120.961 -0.296 . . . . 0.51 111.782 -178.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 1.4 mmt85 -65.06 -40.38 94.63 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 120.551 0.215 . . . . 0.57 111.263 179.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . 0.54 ' HB2' ' O ' ' A' ' 165' ' ' ARG . 0.6 OUTLIER -60.35 -53.99 50.98 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 120.999 0.428 . . . . 0.38 111.499 179.544 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . 0.46 ' HB3' ' CE ' ' A' ' 257' ' ' LYS . 9.0 mm-40 -61.82 -32.44 72.75 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.708 -0.678 . . . . 0.76 112.348 -179.377 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.569 ' O ' ' HG2' ' A' ' 260' ' ' LYS . . . . . . . . 0 CA--C 1.534 0.327 0 N-CA-C 112.165 0.431 . . . . 0.48 112.165 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.57 ' O ' ' HA3' ' A' ' 187' ' ' GLY . . . . . . . . 0 CA--C 1.536 0.433 0 CA-C-O 121.175 0.512 . . . . 0.34 112.069 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -73.79 -69.48 1.39 Allowed Glycine 0 CA--C 1.523 0.539 0 C-N-CA 120.707 -0.758 . . . . 0.36 112.718 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -68.31 -54.94 14.05 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.654 0.264 . . . . 0.38 111.355 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -66.84 -40.92 88.12 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.382 -0.372 . . . . 0.36 111.247 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . 0.57 ' HA3' ' O ' ' A' ' 183' ' ' ALA . . . -60.39 -47.01 93.24 Favored Glycine 0 C--O 1.222 -0.601 0 C-N-CA 121.0 -0.619 . . . . 0.32 113.848 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 20.2 mtp180 -69.19 -40.79 77.85 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 117.634 0.717 . . . . 1.04 112.012 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 32.6 ttt180 -66.57 -46.1 77.16 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-O 121.364 0.602 . . . . 0.41 110.359 179.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . 0.492 ' HB2' ' HB3' ' A' ' 293' ' ' TRP . . . -74.88 -40.2 61.09 Favored 'General case' 0 C--O 1.221 -0.442 0 CA-C-N 115.621 -0.718 . . . . 0.28 112.598 -179.111 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 29.4 tp -63.76 -41.02 98.06 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 118.517 0.599 . . . . 0.49 111.021 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -64.81 -42.96 94.59 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 121.168 0.508 . . . . 0.42 110.508 179.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . 0.477 HG21 ' HA ' ' A' ' 297' ' ' VAL . 43.4 m -71.7 -45.71 61.01 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.0 -0.546 . . . . 0.28 111.491 179.618 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . 0.412 HD21 HG21 ' A' ' 249' ' ' ILE . 24.3 tp -60.37 -31.98 70.86 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.292 -0.413 . . . . 0.32 111.292 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . 0.836 ' HA ' ' CE1' ' A' ' 166' ' ' TYR . 6.3 ttm105 -70.74 -51.2 28.85 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.59 -0.522 . . . . 0.39 109.59 178.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.67 -46.18 91.34 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.507 -0.77 . . . . 0.51 111.624 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . 0.412 ' O ' HG23 ' A' ' 201' ' ' VAL . 94.2 t -72.71 -48.02 47.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.516 -0.311 . . . . 0.35 111.536 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -56.43 -40.82 87.09 Favored Glycine 0 C--N 1.335 0.522 0 CA-C-N 116.335 -0.393 . . . . 0.25 112.818 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -68.32 -47.69 66.89 Favored 'General case' 0 CA--C 1.527 0.076 0 N-CA-C 110.319 -0.252 . . . . 0.39 110.319 178.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -57.75 -42.62 94.52 Favored Glycine 0 CA--C 1.524 0.633 0 C-N-CA 120.942 -0.647 . . . . 0.27 113.006 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . 0.707 HG13 HG21 ' B' ' 34' ' ' VAL . 74.8 t -65.36 -52.0 57.34 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 N-CA-C 112.2 0.444 . . . . 0.3 112.2 179.635 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' GLN . . . . . 0.479 ' HB3' ' HB2' ' A' ' 250' ' ' SER . 10.0 pt20 -71.17 -33.13 69.71 Favored 'General case' 0 C--O 1.222 -0.369 0 N-CA-C 113.043 0.757 . . . . 0.48 113.043 -178.163 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -71.6 -37.53 70.94 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 118.377 0.535 . . . . 0.57 110.9 179.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 9.3 m-80 -66.82 -51.09 59.78 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.893 0.378 . . . . 0.67 110.827 178.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' HIS . . . . . 0.459 ' O ' ' HD2' ' A' ' 209' ' ' PHE . 50.0 m-70 -96.59 32.75 1.96 Allowed 'General case' 0 CA--C 1.537 0.446 0 O-C-N 122.331 -0.231 . . . . 0.42 110.82 179.083 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -55.75 -43.12 76.35 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 112.894 0.701 . . . . 0.48 112.894 -178.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 32.7 p -60.25 -42.2 94.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.131 0.491 . . . . 0.54 111.265 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -68.45 -42.44 78.79 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.863 -0.608 . . . . 0.36 110.253 178.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' PHE . . . . . 0.459 ' HD2' ' O ' ' A' ' 205' ' ' HIS . 18.1 m-85 -62.44 -49.08 76.85 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.034 -0.53 . . . . 0.85 110.424 179.256 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 65.0 mt-30 -61.78 -39.86 93.15 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.178 -0.465 . . . . 0.78 110.907 179.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -58.0 -46.39 92.61 Favored Glycine 0 C--N 1.335 0.503 0 N-CA-C 111.009 -0.837 . . . . 0.34 111.009 178.065 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 212' ' ' MET . . . . . 0.576 ' SD ' ' HA ' ' B' ' 23' ' ' PHE . 76.2 mtm -70.91 -35.69 72.38 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 120.759 0.314 . . . . 0.56 110.695 178.372 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 16.2 tp -60.85 -40.49 93.06 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.043 0.449 . . . . 0.49 110.754 179.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 79.4 mtp180 -77.34 -27.14 52.67 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.115 -0.493 . . . . 0.64 110.557 178.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 7.6 mmtp -75.94 -31.86 59.29 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.86 -0.609 . . . . 0.65 110.837 178.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 26.7 mt -69.08 137.21 53.33 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.047 -0.524 . . . . 0.51 112.397 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -101.78 19.88 17.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.968 -0.56 . . . . 0.49 110.392 178.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 218' ' ' ILE . . . . . 0.534 HG12 ' HB3' ' A' ' 223' ' ' ASP . 16.7 mt -62.73 118.88 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 N-CA-C 113.155 0.798 . . . . 0.37 113.155 -178.348 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . 0.609 ' HG2' HE22 ' A' ' 264' ' ' GLN . 3.3 ttpp -150.41 -16.76 0.24 Allowed 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 115.369 -0.832 . . . . 0.48 112.761 179.132 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -128.85 -178.9 4.8 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 112.872 0.693 . . . . 0.48 112.872 -178.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . 0.48 ' O ' HG22 ' A' ' 224' ' ' VAL . 0.8 OUTLIER -69.13 -22.43 63.96 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.643 -0.708 . . . . 0.5 111.772 -179.702 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -70.6 -26.29 74.33 Favored Glycine 0 CA--C 1.524 0.647 0 C-N-CA 120.834 -0.698 . . . . 0.3 113.313 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 223' ' ' ASP . . . . . 0.534 ' HB3' HG12 ' A' ' 218' ' ' ILE . 59.9 m-20 -65.17 -29.38 70.21 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 113.074 0.768 . . . . 0.39 113.074 -179.107 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.595 ' HB ' HG21 ' A' ' 274' ' ' THR . 6.4 m -53.78 -27.9 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 N-CA-C 112.895 0.702 . . . . 0.41 112.895 -179.313 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . 0.409 ' O ' ' HD3' ' A' ' 229' ' ' ARG . 33.5 mtmm -60.16 -44.15 95.24 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.297 0.57 . . . . 0.54 110.334 178.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 17.6 m -72.3 -39.67 68.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.806 -0.633 . . . . 0.35 110.861 179.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 227' ' ' PHE . . . . . 0.506 ' HE2' HG21 ' A' ' 255' ' ' VAL . 17.1 t80 -60.9 -48.21 82.87 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.212 -0.449 . . . . 0.53 110.785 179.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 228' ' ' SER . . . . . 0.692 ' HB2' HG11 ' A' ' 278' ' ' VAL . 13.7 p -62.73 -39.15 93.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.205 -0.452 . . . . 0.4 110.267 178.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 229' ' ' ARG . . . . . 0.409 ' HD3' ' O ' ' A' ' 225' ' ' LYS . 4.1 mpt_? -64.85 -46.07 83.45 Favored 'General case' 0 C--O 1.227 -0.123 0 CA-C-N 116.103 -0.499 . . . . 0.62 110.541 178.688 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . 0.433 HG13 ' HA ' ' B' ' 24' ' ' ALA . 43.0 t -59.2 -44.88 92.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 CA-C-O 120.944 0.402 . . . . 0.44 110.321 178.168 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 231' ' ' MET . . . . . 0.569 ' HG2' HD22 ' A' ' 248' ' ' LEU . 30.4 mtm -57.54 -52.39 65.6 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.155 -0.475 . . . . 0.44 111.621 179.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 232' ' ' VAL . . . . . 0.67 HG12 HG21 ' A' ' 282' ' ' THR . 21.9 m -67.82 -31.84 53.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 C-N-CA 120.9 -0.32 . . . . 0.4 111.091 179.444 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 5.6 t-80 -59.82 -32.07 70.31 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.366 -0.379 . . . . 0.51 111.347 179.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.676 HG21 HD21 ' A' ' 248' ' ' LEU . 78.8 t -58.61 -30.21 41.09 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 CA-C-O 120.79 0.328 . . . . 0.39 111.606 179.105 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 235' ' ' PHE . . . . . 0.477 ' CD1' ' HA ' ' A' ' 240' ' ' THR . 67.9 m-85 -102.58 23.7 11.56 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 111.882 0.327 . . . . 0.53 111.882 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 7.6 tptp -62.81 -24.8 67.94 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 113.062 0.764 . . . . 0.94 113.062 -178.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -81.73 -9.63 59.59 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.863 0.363 . . . . 0.51 111.527 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 93.23 2.55 65.95 Favored Glycine 0 CA--C 1.522 0.518 0 C-N-CA 120.822 -0.704 . . . . 0.58 113.388 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 11.9 t -96.77 95.51 4.74 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-O 120.994 0.426 . . . . 0.39 111.379 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 240' ' ' THR . . . . . 0.477 ' HA ' ' CD1' ' A' ' 235' ' ' PHE . 0.6 OUTLIER -82.8 70.52 9.8 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.827 0.677 . . . . 0.85 112.827 -179.781 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . 0.429 ' HB2' ' HD2' ' A' ' 244' ' ' ARG . 20.6 m-20 -83.89 140.0 32.26 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.916 0.388 . . . . 0.43 111.641 179.448 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 242' ' ' TRP . . . . . . . . . . . . . 54.1 m95 -51.09 -43.46 61.07 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.951 -0.568 . . . . 0.41 112.432 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -54.33 -35.2 55.19 Favored Glycine 0 C--N 1.339 0.708 0 C-N-CA 121.407 -0.425 . . . . 0.23 112.931 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 244' ' ' ARG . . . . . 0.429 ' HD2' ' HB2' ' A' ' 241' ' ' ASN . 24.4 mtt180 -73.99 -43.06 59.35 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.126 0.489 . . . . 0.33 109.769 178.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 48.2 mt -60.32 -50.22 81.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-N 115.709 -0.678 . . . . 0.33 111.101 179.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 31.4 m -65.86 -34.32 69.52 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 C-N-CA 121.03 -0.268 . . . . 0.28 111.497 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 40.3 m -58.06 -40.65 81.53 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.076 0.465 . . . . 0.39 110.015 178.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 248' ' ' LEU . . . . . 0.676 HD21 HG21 ' A' ' 234' ' ' VAL . 80.7 mt -66.12 -32.31 73.69 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.023 -0.535 . . . . 0.43 111.102 178.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 249' ' ' ILE . . . . . 0.412 HG21 HD21 ' A' ' 194' ' ' LEU . 19.3 mt -74.5 -42.62 49.22 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 CA-C-N 116.216 -0.447 . . . . 0.53 109.818 178.261 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 250' ' ' SER . . . . . 0.479 ' HB2' ' HB3' ' A' ' 202' ' ' GLN . 51.3 p -64.89 -30.4 71.4 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 109.502 -0.555 . . . . 0.34 109.502 177.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 251' ' ' PHE . . . . . . . . . . . . . 18.6 t80 -70.52 -43.97 68.53 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 108.584 -0.895 . . . . 0.58 108.584 177.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -59.18 -47.0 92.94 Favored Glycine 0 C--N 1.336 0.531 0 N-CA-C 110.767 -0.933 . . . . 0.27 110.767 177.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 253' ' ' ALA . . . . . 0.433 ' O ' ' HG3' ' A' ' 257' ' ' LYS . . . -59.5 -39.72 84.71 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 120.655 0.264 . . . . 0.33 110.691 177.369 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -61.94 -41.78 98.35 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 121.052 0.453 . . . . 0.59 110.55 178.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 255' ' ' VAL . . . . . 0.506 HG21 ' HE2' ' A' ' 227' ' ' PHE . 59.5 t -72.04 -37.72 61.33 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-N 116.184 -0.462 . . . . 0.36 110.025 178.414 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -56.69 -42.88 79.87 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.028 0.442 . . . . 0.28 109.907 177.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 257' ' ' LYS . . . . . 0.46 ' CE ' ' HB3' ' A' ' 170' ' ' GLN . 93.0 mttt -64.7 -42.94 94.93 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 115.846 -0.616 . . . . 0.66 110.117 177.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 40.3 t60 -59.19 -42.79 91.72 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.292 -0.413 . . . . 0.66 110.66 178.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 95.7 mt -69.86 -42.62 73.3 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 116.392 -0.367 . . . . 0.54 111.149 179.122 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 260' ' ' LYS . . . . . 0.569 ' HG2' ' O ' ' A' ' 171' ' ' ALA . 2.1 tptp -64.94 -35.95 82.81 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.705 0.288 . . . . 0.56 111.311 179.239 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 63.0 m -59.69 -28.96 67.75 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.262 -0.427 . . . . 0.51 111.301 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 24.2 m -107.32 16.27 7.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-N 116.382 -0.372 . . . . 0.55 111.071 178.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 55.61 52.47 11.0 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 112.769 0.655 . . . . 0.98 112.769 179.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 264' ' ' GLN . . . . . 0.609 HE22 ' HG2' ' A' ' 219' ' ' LYS . 7.3 mt-30 -117.98 37.74 3.88 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 120.769 0.318 . . . . 0.56 111.462 179.413 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 265' ' ' GLU . . . . . 0.497 ' HA ' HD12 ' A' ' 268' ' ' ILE . 1.2 mp0 -48.06 -31.75 5.87 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 112.716 0.636 . . . . 0.59 112.716 179.39 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -55.57 -22.42 21.84 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 122.847 0.459 . . . . 0.95 111.974 179.276 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 267' ' ' PHE . . . . . 0.402 ' C ' ' HD2' ' A' ' 270' ' ' PRO . 95.3 m-85 -100.43 -17.89 16.97 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 120.79 0.328 . . . . 0.48 110.986 178.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 268' ' ' ILE . . . . . 0.497 HD12 ' HA ' ' A' ' 265' ' ' GLU . 66.5 mt -67.77 -45.71 83.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-N 116.416 -0.356 . . . . 0.39 111.107 179.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 269' ' ' GLU . . . . . 0.643 ' HB2' ' HD3' ' A' ' 270' ' ' PRO . 0.5 OUTLIER -55.74 -56.58 28.41 Favored Pre-proline 0 CA--C 1.545 0.774 0 CA-C-N 116.296 -0.411 . . . . 0.37 111.21 179.332 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 270' ' ' PRO . . . . . 0.643 ' HD3' ' HB2' ' A' ' 269' ' ' GLU . 31.2 Cg_exo -61.33 -32.19 89.45 Favored 'Trans proline' 0 C--N 1.361 1.213 0 C-N-CA 122.23 1.953 . . . . 0.27 112.101 178.428 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 271' ' ' LEU . . . . . 0.414 ' O ' HG13 ' A' ' 275' ' ' ILE . 46.8 tp -66.62 -54.76 19.88 Favored 'General case' 0 C--O 1.226 -0.135 0 CA-C-N 116.406 -0.361 . . . . 0.44 110.14 178.682 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -56.98 -37.82 72.16 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 120.852 0.358 . . . . 0.29 110.628 178.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 273' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -64.26 -51.48 63.39 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.028 -0.533 . . . . 0.49 110.134 178.04 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 274' ' ' THR . . . . . 0.595 HG21 ' HB ' ' A' ' 224' ' ' VAL . 31.1 m -59.82 -42.67 94.04 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.292 -0.413 . . . . 0.3 110.595 179.173 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 275' ' ' ILE . . . . . 0.459 HG12 ' CE1' ' A' ' 227' ' ' PHE . 96.5 mt -57.98 -54.3 33.89 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.105 0 CA-C-N 116.165 -0.471 . . . . 0.35 110.603 179.15 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 276' ' ' THR . . . . . 0.619 HG21 ' HA ' ' A' ' 160' ' ' LEU . 32.5 m -60.71 -49.88 75.71 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.253 -0.43 . . . . 0.3 111.441 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 277' ' ' ASP . . . . . 0.595 ' O ' ' HB2' ' A' ' 281' ' ' ARG . 17.0 t0 -56.28 -61.04 2.67 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.946 -0.57 . . . . 0.4 112.104 -179.425 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 278' ' ' VAL . . . . . 0.692 HG11 ' HB2' ' A' ' 228' ' ' SER . 66.4 t -61.25 -46.24 97.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 112.304 0.483 . . . . 0.39 112.304 -178.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 279' ' ' LEU . . . . . 0.45 HD12 ' HZ1' ' A' ' 283' ' ' LYS . 14.0 tp -54.7 -47.58 73.52 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 111.635 0.235 . . . . 0.75 111.635 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 84.0 t -77.38 -41.05 29.66 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 N-CA-C 111.803 0.297 . . . . 0.39 111.803 -179.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 281' ' ' ARG . . . . . 0.595 ' HB2' ' O ' ' A' ' 277' ' ' ASP . 2.5 ttt180 -53.7 -42.73 68.31 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 112.616 0.598 . . . . 0.85 112.616 -179.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 282' ' ' THR . . . . . 0.67 HG21 HG12 ' A' ' 232' ' ' VAL . 15.2 t -84.41 0.39 49.64 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 112.843 0.683 . . . . 0.37 112.843 -179.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . 0.49 ' HG3' HG23 ' A' ' 282' ' ' THR . 34.6 mtmm -141.02 40.76 1.8 Allowed 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 120.877 0.37 . . . . 0.38 111.546 -179.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 284' ' ' ARG . . . . . 0.438 HH11 ' HD3' ' A' ' 284' ' ' ARG . 13.2 ttm180 -63.21 -60.65 3.13 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 112.714 0.635 . . . . 0.64 112.714 -178.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 285' ' ' ASP . . . . . 0.44 ' HA ' HG12 ' A' ' 288' ' ' VAL . 35.8 t70 -58.71 -45.48 89.47 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.366 -0.379 . . . . 0.51 111.895 -179.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 286' ' ' TRP . . . . . . . . . . . . . 4.1 t90 -59.62 -44.95 93.27 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 120.571 0.224 . . . . 0.49 111.25 -179.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -68.84 -44.52 73.25 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 112.072 0.397 . . . . 0.47 112.072 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 288' ' ' VAL . . . . . 0.44 HG12 ' HA ' ' A' ' 285' ' ' ASP . 6.2 p -66.2 -34.5 70.63 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 O-C-N 122.207 -0.308 . . . . 0.52 111.645 -179.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 31.9 mttp -76.31 -26.87 56.26 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-O 120.766 0.317 . . . . 0.78 111.398 179.017 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 1.7 tp-100 -91.04 24.95 2.61 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 112.563 0.579 . . . . 0.97 112.563 -179.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 53.6 mtp180 62.99 12.65 6.05 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 112.505 0.557 . . . . 0.43 112.505 179.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 64.64 -131.86 37.67 Favored Glycine 0 CA--C 1.522 0.487 0 C-N-CA 121.235 -0.507 . . . . 0.33 113.241 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 293' ' ' TRP . . . . . 0.492 ' HB3' ' HB2' ' A' ' 190' ' ' ALA . 86.3 m95 -67.67 -21.21 65.36 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 111.903 0.334 . . . . 0.48 111.903 -179.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 294' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -62.85 -48.54 78.62 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 121.175 0.512 . . . . 0.47 110.098 177.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -69.78 -33.62 71.2 Favored Glycine 0 C--N 1.332 0.329 0 C-N-CA 120.657 -0.783 . . . . 0.32 111.614 178.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 296' ' ' PHE . . . . . 0.446 ' HB3' ' HA ' ' A' ' 293' ' ' TRP . 1.6 t80 -60.52 -50.94 71.53 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.674 -0.263 . . . . 0.29 111.615 179.108 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 297' ' ' VAL . . . . . 0.477 ' HA ' HG21 ' A' ' 193' ' ' THR . 28.8 m -63.94 -43.25 97.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 N-CA-C 111.836 0.31 . . . . 0.27 111.836 -178.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -58.64 -41.67 86.53 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 112.197 0.443 . . . . 0.42 112.197 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 299' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -58.69 -45.46 89.43 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 120.907 0.385 . . . . 0.41 111.875 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 300' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 . . . . . 0 CA--C 1.535 0.395 0 N-CA-C 112.556 0.576 . . . . 0.47 112.556 -179.145 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 . . . . . 0 N--CA 1.453 -0.312 0 N-CA-C 109.477 -0.564 . . . . 0.77 109.477 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 23' ' ' PHE . . . . . 0.576 ' HA ' ' SD ' ' A' ' 212' ' ' MET . 0.4 OUTLIER -61.9 -41.41 97.86 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.322 0.582 . . . . 0.4 109.848 179.019 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 24' ' ' ALA . . . . . 0.512 ' O ' ' HB2' ' B' ' 28' ' ' ARG . . . -59.09 -43.83 91.85 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.249 -0.887 . . . . 0.42 111.126 179.425 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -72.42 -46.8 53.47 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 116.191 -0.459 . . . . 0.37 110.751 179.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -58.01 -54.31 48.42 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 115.96 -0.564 . . . . 0.39 110.778 179.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 98.8 mt -59.34 -37.86 78.91 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.596 -0.275 . . . . 0.4 110.863 179.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 28' ' ' ARG . . . . . 0.561 ' HA ' HG13 ' A' ' 234' ' ' VAL . 0.9 OUTLIER -61.32 -52.72 63.52 Favored 'General case' 0 CA--C 1.528 0.106 0 N-CA-C 109.9 -0.407 . . . . 0.46 109.9 178.736 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -59.82 -43.24 94.62 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.372 -0.377 . . . . 0.51 110.654 178.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 96.1 mt -58.75 -49.31 83.21 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 CA-C-N 116.345 -0.389 . . . . 0.41 110.172 178.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -55.32 -45.38 83.39 Favored Glycine 0 CA--C 1.52 0.404 0 CA-C-N 116.306 -0.407 . . . . 0.25 112.931 179.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -59.19 -49.61 77.19 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 121.087 0.47 . . . . 0.36 110.68 179.143 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 5.4 ttmm -64.01 -45.59 88.28 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 115.927 -0.578 . . . . 1.22 110.847 179.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 34' ' ' VAL . . . . . 0.707 HG21 HG13 ' A' ' 201' ' ' VAL . 5.3 t -58.56 -49.68 81.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 CA-C-O 120.958 0.409 . . . . 0.33 110.659 179.127 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -57.95 -43.65 86.51 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.971 -0.559 . . . . 0.65 110.601 178.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 36' ' ' CYS . . . . . . . . . . . . . 74.3 m -68.22 -25.93 65.46 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 120.942 0.401 . . . . 0.36 111.175 179.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 45.8 m -80.13 -35.47 36.65 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 116.115 -0.493 . . . . 0.33 111.953 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 38' ' ' TRP . . . . . . . . . . . . . 85.0 m95 -84.83 -30.47 24.5 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.039 0.385 . . . . 0.54 112.039 -179.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 16.9 p . . . . . 0 N--CA 1.466 0.33 0 CA-C-O 120.767 0.318 . . . . 0.41 110.673 179.248 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . 0.578 ' HA ' ' HB3' ' A' ' 156' ' ' TYR . 2.6 m-20 . . . . . 0 CA--C 1.537 0.462 0 N-CA-C 113.73 1.011 . . . . 0.74 113.73 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . 0.474 ' HA ' ' HE ' ' A' ' 157' ' ' ARG . 11.2 t0 -52.58 -44.47 65.93 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 120.973 0.416 . . . . 0.49 111.27 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 44.4 tp -85.26 -33.36 22.19 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.142 0.496 . . . . 0.66 110.22 178.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . 0.578 ' HB3' ' HA ' ' A' ' 153' ' ' ASP . 55.6 t80 -61.21 -45.73 93.37 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 115.637 -0.71 . . . . 0.45 112.336 -179.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 0.474 ' HE ' ' HA ' ' A' ' 154' ' ' ASP . 20.4 ptt85 -59.4 -44.37 92.81 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 120.785 0.326 . . . . 0.5 110.993 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 10.3 mt-30 -65.17 -44.19 89.3 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-O 120.86 0.362 . . . . 0.53 110.223 178.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . 0.531 ' HA ' ' CZ2' ' A' ' 293' ' ' TRP . 17.0 m -61.63 -49.43 76.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.965 -0.562 . . . . 0.38 111.129 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.599 HD21 ' HA ' ' A' ' 273' ' ' GLU . 0.2 OUTLIER -59.47 -44.12 93.09 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.349 -0.387 . . . . 0.7 110.879 179.375 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -66.9 -53.59 30.54 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 112.037 0.384 . . . . 0.45 112.037 -179.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 79.4 mt -61.22 -51.09 77.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 N-CA-C 112.28 0.474 . . . . 0.34 112.28 -179.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.42 HG23 HD13 ' A' ' 167' ' ' LEU . 59.2 mt -60.27 -51.42 73.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 N-CA-C 112.297 0.48 . . . . 0.4 112.297 -178.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 90.6 p -57.7 -35.84 71.18 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.575 0.226 . . . . 0.8 111.227 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . 0.411 HH11 ' HD2' ' A' ' 165' ' ' ARG . 0.0 OUTLIER -72.28 -51.1 22.41 Favored 'General case' 0 C--O 1.226 -0.157 0 C-N-CA 120.954 -0.298 . . . . 1.51 111.096 179.091 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' TYR . . . . . 0.798 ' HE1' ' HA ' ' A' ' 195' ' ' ARG . 60.1 t80 -59.7 -46.12 90.05 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 120.648 0.261 . . . . 0.39 111.244 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.42 HD13 HG23 ' A' ' 163' ' ' ILE . 5.2 mp -60.63 -45.47 93.94 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 116.354 -0.385 . . . . 0.37 111.175 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 12.2 ttm105 -71.99 -34.68 69.11 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 121.021 -0.272 . . . . 0.5 110.907 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -63.74 -52.63 59.6 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 120.752 0.31 . . . . 0.72 110.354 178.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . 0.406 ' O ' ' HE2' ' A' ' 257' ' ' LYS . 6.6 mm-40 -65.56 -26.51 67.9 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.902 0.382 . . . . 1.14 111.508 179.267 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.375 -0.375 . . . . 0.35 111.955 179.344 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.452 ' O ' ' HA3' ' A' ' 187' ' ' GLY . . . . . . . . 0 N--CA 1.455 -0.208 0 CA-C-O 121.126 0.489 . . . . 0.41 111.05 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -78.7 -71.73 1.22 Allowed Glycine 0 CA--C 1.522 0.512 0 C-N-CA 120.118 -1.039 . . . . 0.51 112.887 -179.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -72.1 -48.49 43.56 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 120.96 0.409 . . . . 0.53 110.731 179.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -65.11 -34.42 78.36 Favored 'General case' 0 C--O 1.224 -0.237 0 CA-C-N 115.889 -0.596 . . . . 0.4 110.27 178.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . 0.452 ' HA3' ' O ' ' A' ' 183' ' ' ALA . . . -65.71 -40.9 96.02 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.67 -0.776 . . . . 0.37 111.66 178.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . 0.421 HH11 ' HD2' ' A' ' 188' ' ' ARG . 11.2 mmt180 -63.98 -54.29 36.76 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.753 0.311 . . . . 1.48 110.962 179.123 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 3.0 ttp180 -60.24 -42.85 96.15 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 115.882 -0.599 . . . . 2.07 110.942 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . 0.541 ' HA ' ' CG1' ' A' ' 297' ' ' VAL . . . -64.26 -46.32 84.26 Favored 'General case' 0 C--O 1.222 -0.391 0 CA-C-N 116.391 -0.368 . . . . 0.33 110.681 179.055 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 15.7 tp -61.38 -37.36 83.1 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.722 0.296 . . . . 0.88 110.779 179.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' GLU . . . . . 0.615 ' OE2' ' HD3' ' A' ' 196' ' ' ARG . 4.0 tm-20 -63.01 -53.2 57.69 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 121.402 0.62 . . . . 1.04 110.84 178.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . 0.503 HG21 ' HA ' ' A' ' 297' ' ' VAL . 98.0 m -70.21 -41.24 73.91 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.475 -0.784 . . . . 0.35 111.699 -178.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . 0.487 HD11 HG21 ' A' ' 249' ' ' ILE . 11.3 tp -61.24 -42.39 98.53 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.281 -0.418 . . . . 0.37 111.433 179.531 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . 0.798 ' HA ' ' HE1' ' A' ' 166' ' ' TYR . 13.0 ttm-85 -65.6 -41.17 93.06 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 121.189 0.518 . . . . 0.94 109.867 178.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . 0.615 ' HD3' ' OE2' ' A' ' 192' ' ' GLU . 8.1 mtp-105 -63.32 -57.0 11.82 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.708 -0.678 . . . . 0.34 111.592 179.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 58.2 t -68.59 -40.13 81.43 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-N 116.397 -0.365 . . . . 0.33 111.962 -179.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . 0.544 ' HA3' ' OH ' ' A' ' 166' ' ' TYR . . . -59.15 -47.15 92.18 Favored Glycine 0 C--N 1.33 0.244 0 C-N-CA 121.475 -0.393 . . . . 0.25 112.751 -179.52 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -75.66 -26.35 57.6 Favored 'General case' 0 C--O 1.223 -0.316 0 N-CA-C 110.026 -0.361 . . . . 0.43 110.026 178.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -63.13 -47.02 91.86 Favored Glycine 0 C--N 1.336 0.568 0 N-CA-C 110.929 -0.868 . . . . 0.25 110.929 177.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 61.0 t -69.18 -39.57 79.45 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-O 121.017 0.437 . . . . 0.3 110.021 177.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -67.08 -41.48 86.26 Favored 'General case' 0 C--O 1.219 -0.504 0 CA-C-N 115.71 -0.677 . . . . 0.66 112.024 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' ARG . . . . . 0.4 ' CZ ' ' HA ' ' A' ' 203' ' ' ARG . 0.1 OUTLIER -63.88 -46.47 84.76 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.934 0.397 . . . . 0.36 110.298 179.779 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 32.6 m-80 -68.16 -46.82 69.73 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 115.987 -0.551 . . . . 0.48 112.107 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 86.3 m-70 -102.71 30.63 4.58 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 113.556 0.947 . . . . 0.34 113.556 -178.132 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -62.53 -36.21 81.89 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 121.011 0.434 . . . . 0.38 111.216 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 32.7 p -68.86 -39.8 79.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.085 0.469 . . . . 1.08 110.521 178.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -67.05 -40.76 87.21 Favored 'General case' 0 N--CA 1.456 -0.126 0 CA-C-N 115.887 -0.597 . . . . 0.3 110.085 178.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 11.8 m-30 -65.89 -39.59 90.77 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.991 -0.55 . . . . 0.42 110.22 178.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -67.04 -47.67 70.65 Favored 'General case' 0 N--CA 1.46 0.052 0 CA-C-N 116.354 -0.385 . . . . 0.89 110.362 178.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -58.59 -42.62 96.2 Favored Glycine 0 C--N 1.337 0.595 0 N-CA-C 111.0 -0.84 . . . . 0.3 111.0 178.183 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 30.6 ttm -64.16 -46.04 85.78 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.688 -0.486 . . . . 0.38 109.688 178.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.505 ' HA ' HD12 ' A' ' 216' ' ' LEU . 6.7 tp -59.62 -41.39 90.28 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.806 -0.634 . . . . 0.49 111.112 179.002 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 214' ' ' ARG . . . . . 0.538 ' HD3' ' O ' ' A' ' 214' ' ' ARG . 0.0 OUTLIER -65.0 -32.07 73.61 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.238 -0.437 . . . . 0.75 110.553 179.268 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 56.4 mtpt -89.0 -0.99 57.89 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.253 -0.43 . . . . 0.75 110.781 178.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . 0.674 ' HB3' HG22 ' A' ' 218' ' ' ILE . 10.1 mt -92.26 134.28 35.04 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 121.175 0.512 . . . . 0.72 111.226 179.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -99.38 29.16 4.12 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 115.824 -0.625 . . . . 0.45 110.401 178.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 218' ' ' ILE . . . . . 0.674 HG22 ' HB3' ' A' ' 216' ' ' LEU . 2.3 tt -66.91 114.62 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 N-CA-C 113.061 0.763 . . . . 0.37 113.061 -178.603 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 10.0 ptpp? -161.27 4.69 0.06 Allowed 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 115.474 -0.785 . . . . 0.4 112.645 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -154.29 -175.96 5.65 Favored 'General case' 0 C--O 1.218 -0.567 0 O-C-N 121.747 -0.595 . . . . 0.59 112.555 -178.249 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -61.59 -20.84 63.76 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 112.599 0.592 . . . . 0.48 112.599 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -67.71 -42.95 86.34 Favored Glycine 0 CA--C 1.531 1.04 0 N-CA-C 114.708 0.643 . . . . 0.39 114.708 -179.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 223' ' ' ASP . . . . . 0.472 ' OD1' HG13 ' A' ' 218' ' ' ILE . 0.1 OUTLIER -65.51 -31.86 73.15 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 117.621 0.711 . . . . 0.38 112.05 -179.098 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 12.1 t -58.37 -42.35 83.76 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 CA-C-O 121.429 0.633 . . . . 0.39 110.337 178.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 35.2 mmtm -67.91 -41.52 82.56 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.783 -0.644 . . . . 0.45 109.689 178.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 226' ' ' SER . . . . . 0.561 ' O ' HG23 ' A' ' 230' ' ' VAL . 20.6 t -61.19 -38.95 88.38 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.506 -0.77 . . . . 0.45 110.07 178.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 227' ' ' PHE . . . . . 0.417 ' HE1' ' CD2' ' A' ' 251' ' ' PHE . 49.7 t80 -59.47 -43.22 93.3 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.45 -0.795 . . . . 0.47 110.423 178.295 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 228' ' ' SER . . . . . 0.97 ' HB2' HG21 ' A' ' 278' ' ' VAL . 9.6 p -65.16 -31.97 73.42 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.057 -0.519 . . . . 0.32 110.074 178.127 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 22.2 ttp-105 -67.84 -36.24 79.99 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 109.561 -0.533 . . . . 0.57 109.561 178.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . 0.561 HG23 ' O ' ' A' ' 226' ' ' SER . 26.3 t -59.99 -45.41 95.4 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 N-CA-C 109.138 -0.69 . . . . 0.34 109.138 177.345 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 231' ' ' MET . . . . . 0.787 ' HG3' HD13 ' A' ' 248' ' ' LEU . 29.0 ttm -56.08 -53.26 59.09 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 114.822 -1.081 . . . . 0.32 111.786 179.205 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 34.2 m -66.09 -31.12 52.25 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-O 120.563 0.22 . . . . 0.4 111.419 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 44.3 t-80 -69.38 -42.27 75.4 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.987 0.423 . . . . 0.43 110.383 178.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.585 HG13 ' HA ' ' B' ' 28' ' ' ARG . 44.9 t -58.17 -43.99 86.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-N 116.192 -0.458 . . . . 0.33 110.749 178.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 235' ' ' PHE . . . . . 0.489 ' CD2' ' HA ' ' A' ' 240' ' ' THR . 96.2 m-85 -94.43 23.38 5.26 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 116.088 -0.505 . . . . 0.38 112.017 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -65.14 -13.47 58.21 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 112.028 0.381 . . . . 1.08 112.028 -179.373 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -83.37 -17.09 43.5 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.641 0.258 . . . . 0.41 111.324 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 97.15 -7.69 64.51 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 120.81 -0.71 . . . . 0.46 114.034 179.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 4.5 p -97.73 116.09 39.38 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 CA-C-O 121.337 0.589 . . . . 0.43 111.576 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 240' ' ' THR . . . . . 0.489 ' HA ' ' CD2' ' A' ' 235' ' ' PHE . 25.4 m -88.39 84.63 6.81 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.048 0.452 . . . . 0.61 111.875 -179.57 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . 0.521 ' HB2' ' HD2' ' A' ' 244' ' ' ARG . 92.0 m-20 -76.04 135.45 39.94 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.205 -0.452 . . . . 0.49 111.141 179.277 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 242' ' ' TRP . . . . . 0.608 ' HB3' ' CZ ' ' A' ' 300' ' ' PHE . 5.1 m95 -60.33 -37.88 82.01 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.911 0.386 . . . . 0.47 111.282 179.342 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . 0.493 ' HA3' ' N ' ' B' ' 35' ' ' TYR . . . -64.58 -29.95 76.57 Favored Glycine 0 CA--C 1.52 0.378 0 C-N-CA 121.072 -0.585 . . . . 0.27 112.376 178.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 244' ' ' ARG . . . . . 0.574 ' HA ' ' HA3' ' B' ' 31' ' ' GLY . 79.5 mtt180 -69.28 -44.53 71.65 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.86 -0.422 . . . . 0.34 109.86 178.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . 0.527 ' O ' HG12 ' A' ' 249' ' ' ILE . 69.7 mt -61.21 -53.84 43.45 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 CA-C-N 115.542 -0.754 . . . . 0.37 111.435 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 19.0 m -60.6 -34.84 60.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 C-N-CA 120.89 -0.324 . . . . 0.32 111.335 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 53.0 m -62.36 -44.68 95.9 Favored 'General case' 0 N--CA 1.463 0.179 0 N-CA-C 109.985 -0.376 . . . . 0.36 109.985 178.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 248' ' ' LEU . . . . . 0.787 HD13 ' HG3' ' A' ' 231' ' ' MET . 91.5 mt -65.8 -39.76 91.25 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.213 -0.448 . . . . 0.65 110.561 178.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 249' ' ' ILE . . . . . 0.527 HG12 ' O ' ' A' ' 245' ' ' ILE . 26.7 mm -65.67 -43.88 93.66 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 CA-C-O 121.119 0.485 . . . . 0.38 109.837 178.144 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 35.5 t -60.46 -45.97 91.79 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.788 -0.642 . . . . 0.28 109.383 178.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 251' ' ' PHE . . . . . 0.422 ' CD2' HD11 ' B' ' 27' ' ' LEU . 22.0 t80 -63.58 -39.4 94.28 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 115.687 -0.688 . . . . 0.34 110.115 178.144 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -56.99 -42.69 93.01 Favored Glycine 0 C--N 1.335 0.503 0 N-CA-C 111.419 -0.672 . . . . 0.25 111.419 177.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -69.21 -31.33 69.84 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 120.827 0.346 . . . . 0.28 110.521 177.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -70.93 -47.58 58.27 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 116.247 -0.433 . . . . 0.49 111.378 179.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 19.1 m -64.64 -35.62 75.26 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 C-N-CA 120.725 -0.39 . . . . 0.33 110.159 178.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -66.04 -32.33 73.74 Favored 'General case' 0 N--CA 1.456 -0.146 0 N-CA-C 109.257 -0.645 . . . . 0.29 109.257 177.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 257' ' ' LYS . . . . . 0.406 ' HE2' ' O ' ' A' ' 170' ' ' GLN . 24.5 ttmt -63.66 -40.03 95.82 Favored 'General case' 0 CA--C 1.528 0.108 0 CA-C-N 115.493 -0.776 . . . . 0.8 109.085 177.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 258' ' ' HIS . . . . . 0.463 ' HB2' HD21 ' A' ' 213' ' ' LEU . 75.4 t60 -66.09 -44.86 83.17 Favored 'General case' 0 C--O 1.231 0.085 0 CA-C-N 115.93 -0.577 . . . . 0.4 109.539 177.414 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 97.4 mt -60.14 -47.33 86.35 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 115.8 -0.636 . . . . 0.48 110.33 178.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 260' ' ' LYS . . . . . 0.44 ' HA ' ' OE1' ' A' ' 265' ' ' GLU . 0.7 OUTLIER -62.96 -33.8 76.16 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.277 -0.419 . . . . 0.53 110.742 178.998 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 72.4 m -60.23 -29.46 68.77 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 120.858 0.361 . . . . 0.51 110.836 179.179 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 262' ' ' VAL . . . . . 0.408 HG23 ' HG3' ' A' ' 264' ' ' GLN . 6.1 m -109.95 17.97 7.14 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-O 120.951 0.405 . . . . 0.49 110.662 178.509 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 58.05 50.33 10.28 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 115.528 -0.76 . . . . 0.58 113.036 179.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 264' ' ' GLN . . . . . 0.408 ' HG3' HG23 ' A' ' 262' ' ' VAL . 22.6 mt-30 -110.99 36.49 3.13 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 120.953 0.406 . . . . 0.44 110.931 178.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 265' ' ' GLU . . . . . 0.508 ' HA ' HD12 ' A' ' 268' ' ' ILE . 0.9 OUTLIER -51.36 -33.48 29.9 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 112.823 0.675 . . . . 0.53 112.823 -179.804 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 24.9 p -59.12 -20.25 51.95 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 111.793 0.294 . . . . 0.94 111.793 179.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 267' ' ' PHE . . . . . 0.418 ' C ' ' HD2' ' A' ' 270' ' ' PRO . 83.1 m-85 -93.35 -23.49 18.43 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 121.063 0.459 . . . . 0.6 110.838 178.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 268' ' ' ILE . . . . . 0.508 HD12 ' HA ' ' A' ' 265' ' ' GLU . 73.0 mt -67.62 -42.17 86.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 CA-C-N 116.243 -0.435 . . . . 0.38 110.889 179.382 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 269' ' ' GLU . . . . . 0.789 ' HB2' ' HD3' ' A' ' 270' ' ' PRO . 58.2 mm-40 -54.77 -56.41 27.67 Favored Pre-proline 0 CA--C 1.544 0.74 0 CA-C-N 116.006 -0.543 . . . . 0.58 111.789 179.539 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 270' ' ' PRO . . . . . 0.789 ' HD3' ' HB2' ' A' ' 269' ' ' GLU . 22.7 Cg_exo -66.81 -28.15 43.47 Favored 'Trans proline' 0 C--N 1.358 1.068 0 C-N-CA 122.181 1.921 . . . . 0.46 111.79 178.205 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 271' ' ' LEU . . . . . 0.5 ' O ' HG22 ' A' ' 275' ' ' ILE . 32.7 tp -62.91 -50.4 71.01 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.366 -0.379 . . . . 0.48 110.278 178.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 272' ' ' ALA . . . . . 0.405 ' HA ' HG22 ' A' ' 275' ' ' ILE . . . -60.69 -34.0 73.69 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 121.336 0.589 . . . . 0.36 110.602 178.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 273' ' ' GLU . . . . . 0.599 ' HA ' HD21 ' A' ' 160' ' ' LEU . 34.9 tt0 -71.85 -40.9 68.68 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.566 -0.743 . . . . 0.93 109.478 178.065 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 274' ' ' THR . . . . . . . . . . . . . 93.2 m -66.54 -50.62 62.57 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.792 -0.64 . . . . 0.35 111.663 179.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 275' ' ' ILE . . . . . 0.736 HG13 ' HE1' ' A' ' 231' ' ' MET . 13.6 tt -58.94 -49.67 82.31 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-N 116.816 -0.174 . . . . 0.34 111.125 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 13.2 m -62.06 -47.65 83.73 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.795 0.331 . . . . 0.35 111.037 179.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 277' ' ' ASP . . . . . 0.546 ' HB2' ' O ' ' A' ' 273' ' ' GLU . 4.4 t70 -53.31 -55.36 25.36 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 115.998 -0.546 . . . . 0.46 111.193 179.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 278' ' ' VAL . . . . . 0.97 HG21 ' HB2' ' A' ' 228' ' ' SER . 84.0 t -64.37 -40.53 89.38 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 CA-C-N 116.405 -0.361 . . . . 0.37 111.375 179.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 25.2 tp -62.73 -38.93 92.44 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.831 0.348 . . . . 0.58 111.644 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 91.5 t -82.73 -41.71 17.65 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 N-CA-C 112.249 0.463 . . . . 0.47 112.249 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 55.3 mtp180 -69.28 -28.02 65.93 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 112.959 0.725 . . . . 0.61 112.959 -178.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 282' ' ' THR . . . . . . . . . . . . . 82.0 p -93.67 -12.38 29.46 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 112.485 0.55 . . . . 0.68 112.485 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 4.4 mptp? -129.17 34.44 4.41 Favored 'General case' 0 C--N 1.33 -0.259 0 O-C-N 122.321 -0.237 . . . . 0.7 111.423 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 41.4 ttt180 -50.75 -53.07 34.69 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 116.291 -0.413 . . . . 0.97 111.867 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -59.27 -52.15 66.89 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 116.292 -0.413 . . . . 0.71 111.863 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 286' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -62.18 -42.74 99.56 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.492 0.553 . . . . 0.58 112.492 -179.04 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 287' ' ' LEU . . . . . 0.441 HD13 ' HA2' ' A' ' 292' ' ' GLY . 2.1 mm? -66.51 -49.77 65.45 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 111.719 0.266 . . . . 0.54 111.719 -179.516 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 5.5 p -65.56 -31.18 52.68 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-O 120.785 0.326 . . . . 0.62 111.261 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 11.8 ttmt -74.91 -30.69 61.35 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 120.79 0.328 . . . . 1.01 111.302 179.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.89 9.05 43.02 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 112.341 0.497 . . . . 0.64 112.341 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 291' ' ' ARG . . . . . 0.484 ' HB3' ' HB2' ' A' ' 294' ' ' ASP . 0.0 OUTLIER 62.57 24.87 14.82 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 112.767 0.654 . . . . 0.78 112.767 179.013 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 292' ' ' GLY . . . . . 0.441 ' HA2' HD13 ' A' ' 287' ' ' LEU . . . 56.07 -115.32 5.95 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 115.27 0.868 . . . . 0.39 115.27 178.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 293' ' ' TRP . . . . . 0.569 ' O ' HG22 ' A' ' 297' ' ' VAL . 88.8 m95 -65.83 -41.22 92.04 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 112.713 0.635 . . . . 0.7 112.713 -178.322 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 294' ' ' ASP . . . . . 0.484 ' HB2' ' HB3' ' A' ' 291' ' ' ARG . 27.6 m-20 -52.35 -49.67 63.86 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.086 0.47 . . . . 0.4 111.253 179.568 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -71.71 -33.74 63.21 Favored Glycine 0 CA--C 1.521 0.436 0 C-N-CA 120.84 -0.695 . . . . 0.29 112.598 179.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 296' ' ' PHE . . . . . 0.446 ' HB2' ' CH2' ' A' ' 242' ' ' TRP . 0.9 OUTLIER -66.77 -47.39 72.34 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 120.733 0.302 . . . . 0.32 111.759 179.893 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 297' ' ' VAL . . . . . 0.569 HG22 ' O ' ' A' ' 293' ' ' TRP . 23.7 m -68.06 -40.89 83.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 112.477 0.547 . . . . 0.35 112.477 -178.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 298' ' ' GLU . . . . . 0.431 ' OE1' ' HA ' ' A' ' 298' ' ' GLU . 0.0 OUTLIER -71.55 -30.21 65.63 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 120.538 -0.465 . . . . 0.45 112.079 -179.509 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 299' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -69.19 -41.97 76.43 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.83 0.348 . . . . 0.43 110.539 178.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 300' ' ' PHE . . . . . 0.608 ' CZ ' ' HB3' ' A' ' 242' ' ' TRP . 81.8 m-85 . . . . . 0 CA--C 1.539 0.542 0 N-CA-C 112.647 0.61 . . . . 0.35 112.647 -179.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 . . . . . 0 CA--C 1.53 0.199 0 CA-C-O 120.49 0.186 . . . . 0.51 111.285 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 23' ' ' PHE . . . . . 0.56 ' CE1' HG22 ' A' ' 230' ' ' VAL . 0.2 OUTLIER -60.38 -32.93 71.76 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 121.057 0.456 . . . . 0.36 110.528 179.549 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 24' ' ' ALA . . . . . 0.533 ' N ' ' HD1' ' B' ' 23' ' ' PHE . . . -72.8 -37.49 67.54 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 115.733 -0.667 . . . . 0.35 110.252 179.362 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.3 -42.59 99.07 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 109.674 -0.491 . . . . 0.36 109.674 178.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 26' ' ' GLN . . . . . 0.408 ' O ' HG13 ' B' ' 30' ' ' ILE . 0.1 OUTLIER -64.29 -54.44 33.18 Favored 'General case' 0 C--O 1.227 -0.125 0 CA-C-N 115.692 -0.685 . . . . 0.33 110.518 178.473 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . 0.537 HD12 HG11 ' A' ' 230' ' ' VAL . 48.9 mt -57.6 -35.23 70.15 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.855 0.36 . . . . 0.39 110.746 179.102 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 28' ' ' ARG . . . . . 0.585 ' HA ' HG13 ' A' ' 234' ' ' VAL . 65.5 ttt180 -60.86 -54.41 45.47 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 109.371 -0.603 . . . . 0.59 109.371 177.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -61.48 -41.14 96.81 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.725 -0.671 . . . . 0.83 111.18 178.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . 0.417 ' O ' HG23 ' B' ' 34' ' ' VAL . 95.6 mt -63.7 -44.05 98.27 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 N-CA-C 110.054 -0.35 . . . . 0.36 110.054 178.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . 0.574 ' HA3' ' HA ' ' A' ' 244' ' ' ARG . . . -60.68 -46.97 93.42 Favored Glycine 0 C--N 1.333 0.372 0 C-N-CA 120.645 -0.788 . . . . 0.28 111.674 178.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 85.0 m-20 -60.4 -36.93 79.27 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 121.196 0.522 . . . . 0.69 110.133 178.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 16.2 tppt? -68.05 -50.47 55.04 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 115.752 -0.658 . . . . 0.84 110.47 178.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 34' ' ' VAL . . . . . 0.417 HG23 ' O ' ' B' ' 30' ' ' ILE . 77.0 t -59.66 -42.26 87.87 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-O 120.943 0.402 . . . . 0.35 111.067 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 35' ' ' TYR . . . . . 0.493 ' N ' ' HA3' ' A' ' 243' ' ' GLY . 0.1 OUTLIER -57.9 -45.74 85.99 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 121.258 0.552 . . . . 0.93 109.907 178.479 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 36' ' ' CYS . . . . . . . . . . . . . 5.9 t -70.69 -26.09 63.26 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 115.905 -0.589 . . . . 0.54 111.17 179.114 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 37.3 m -71.61 -40.52 69.75 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 112.755 0.65 . . . . 0.37 112.755 -179.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 38' ' ' TRP . . . . . . . . . . . . . 99.3 m95 -85.64 -35.0 21.22 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.222 0.453 . . . . 0.45 112.222 -178.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 65.4 p . . . . . 0 N--CA 1.468 0.455 0 N-CA-C 111.644 0.238 . . . . 0.6 111.644 179.754 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 45.1 m-20 . . . . . 0 N--CA 1.468 0.433 0 N-CA-C 112.022 0.378 . . . . 1.15 112.022 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -71.09 -45.05 64.45 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 120.892 0.377 . . . . 1.77 111.207 178.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 41.3 tp -69.92 -32.98 71.56 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-N 116.387 -0.37 . . . . 0.66 111.824 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . 0.401 ' HE1' ' HA ' ' A' ' 277' ' ' ASP . 0.2 OUTLIER -55.55 -50.44 70.03 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 113.174 0.805 . . . . 0.45 113.174 -179.445 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 60.0 mtp85 -54.63 -51.91 63.9 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 112.882 0.697 . . . . 0.58 112.882 -178.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . 0.532 ' OE1' ' HB3' ' A' ' 186' ' ' ALA . 4.9 tt0 -66.9 -43.84 82.33 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.082 -0.508 . . . . 0.56 111.193 -179.24 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 31.1 m -61.57 -47.57 84.88 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.856 -0.611 . . . . 0.28 111.101 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.736 HD11 ' HG3' ' A' ' 273' ' ' GLU . 27.9 tp -59.52 -47.82 84.03 Favored 'General case' 0 C--O 1.222 -0.373 0 CA-C-N 115.913 -0.585 . . . . 0.51 111.517 -179.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -58.5 -50.41 73.86 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 120.601 0.239 . . . . 0.56 111.521 -179.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . 0.472 HD13 ' HB3' ' A' ' 190' ' ' ALA . 52.2 mt -58.05 -52.07 62.93 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-N 116.541 -0.299 . . . . 0.29 111.565 179.51 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.514 HD12 HG23 ' A' ' 276' ' ' THR . 88.2 mt -67.31 -54.86 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 N-CA-C 112.787 0.662 . . . . 0.29 112.787 -179.323 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 6.7 t -53.52 -41.23 66.15 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 120.775 0.322 . . . . 0.25 111.302 -178.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . 0.505 ' HD2' ' HA ' ' A' ' 165' ' ' ARG . 3.6 tpt180 -71.92 -45.93 59.4 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 120.344 -0.542 . . . . 0.6 110.775 179.28 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' TYR . . . . . 0.688 ' HE1' ' HA ' ' A' ' 195' ' ' ARG . 65.4 t80 -57.92 -49.33 77.13 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 111.561 0.208 . . . . 0.31 111.561 179.11 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 6.4 mp -60.82 -42.73 98.27 Favored 'General case' 0 C--O 1.226 -0.141 0 CA-C-N 116.717 -0.22 . . . . 0.39 110.566 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 1.9 ttt180 -65.28 -43.72 90.31 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 121.176 0.513 . . . . 0.44 110.457 178.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -60.44 -54.56 44.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.34 -0.846 . . . . 0.45 110.337 178.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 23.4 mm-40 -63.77 -35.8 81.79 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.09 -0.505 . . . . 0.28 111.085 179.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.449 ' HB2' ' HB1' ' A' ' 256' ' ' ALA . . . . . . . . 0 N--CA 1.466 0.342 0 CA-C-O 121.083 0.468 . . . . 0.31 111.496 179.186 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.516 ' O ' ' HA3' ' A' ' 187' ' ' GLY . . . . . . . . 0 CA--C 1.531 0.216 0 CA-C-O 121.26 0.553 . . . . 0.36 110.642 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -78.55 -71.06 1.26 Allowed Glycine 0 CA--C 1.527 0.823 0 N-CA-C 115.16 0.824 . . . . 0.39 115.16 -178.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -68.49 -57.81 5.26 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 112.774 0.657 . . . . 0.48 112.774 -177.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . 0.532 ' HB3' ' OE1' ' A' ' 158' ' ' GLN . . . -72.08 -34.11 68.43 Favored 'General case' 0 C--O 1.221 -0.426 0 C-N-CA 120.466 -0.494 . . . . 0.43 110.265 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . 0.516 ' HA3' ' O ' ' A' ' 183' ' ' ALA . . . -62.14 -43.66 98.83 Favored Glycine 0 CA--C 1.52 0.393 0 C-N-CA 120.828 -0.701 . . . . 0.35 112.601 179.166 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 3.0 tmt_? -62.38 -53.78 49.96 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.84 0.32 . . . . 0.58 110.601 179.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' ARG . . . . . 0.51 ' O ' ' HG2' ' A' ' 192' ' ' GLU . 47.6 mtm180 -63.4 -44.22 95.3 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.233 -0.44 . . . . 0.45 111.933 -179.472 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . 0.565 ' HB2' ' HB3' ' A' ' 293' ' ' TRP . . . -68.47 -45.48 72.33 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.179 0.437 . . . . 0.29 112.179 -179.206 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' LEU . . . . . 0.457 ' CD1' ' HB2' ' A' ' 166' ' ' TYR . 27.3 tp -65.91 -38.36 88.49 Favored 'General case' 0 N--CA 1.463 0.177 0 C-N-CA 120.411 -0.516 . . . . 0.6 111.813 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' GLU . . . . . 0.51 ' HG2' ' O ' ' A' ' 189' ' ' ARG . 9.3 pt-20 -66.61 -36.73 83.31 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 120.433 -0.507 . . . . 0.72 110.549 179.52 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . 0.622 HG21 ' HA ' ' A' ' 297' ' ' VAL . 20.7 m -73.73 -46.75 44.02 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.129 -0.487 . . . . 0.31 110.247 179.512 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . 0.409 HD21 HG21 ' A' ' 249' ' ' ILE . 14.6 tp -60.74 -38.35 84.83 Favored 'General case' 0 N--CA 1.457 -0.125 0 CA-C-N 115.75 -0.659 . . . . 0.32 110.261 179.29 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . 0.688 ' HA ' ' HE1' ' A' ' 166' ' ' TYR . 46.2 ttm105 -61.85 -51.15 69.4 Favored 'General case' 0 C--O 1.223 -0.293 0 CA-C-N 116.072 -0.513 . . . . 0.32 111.07 178.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 7.3 tpm_? -69.16 -53.03 22.21 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 112.828 0.677 . . . . 0.45 112.828 -179.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . 0.473 HG21 ' HB3' ' A' ' 300' ' ' PHE . 46.5 t -63.72 -50.63 77.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 N-CA-C 112.028 0.381 . . . . 0.3 112.028 -178.505 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -57.78 -50.35 66.31 Favored Glycine 0 C--N 1.333 0.402 0 C-N-CA 120.976 -0.631 . . . . 0.25 111.976 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -54.28 -40.74 68.12 Favored 'General case' 0 CA--C 1.526 0.054 0 N-CA-C 109.992 -0.373 . . . . 0.41 109.992 178.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -63.2 -50.68 60.98 Favored Glycine 0 CA--C 1.522 0.525 0 C-N-CA 120.831 -0.699 . . . . 0.33 111.85 178.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . 0.405 HG23 ' O ' ' A' ' 197' ' ' VAL . 60.2 t -60.25 -42.28 89.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-O 120.837 0.351 . . . . 0.4 110.995 178.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' GLN . . . . . 0.659 ' HG3' ' HB3' ' A' ' 250' ' ' SER . 25.8 mt-30 -66.91 -42.4 85.51 Favored 'General case' 0 C--O 1.223 -0.314 0 CA-C-N 116.033 -0.53 . . . . 0.39 112.088 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' ARG . . . . . 0.513 ' HD3' ' OE1' ' A' ' 206' ' ' GLU . 0.0 OUTLIER -70.35 -37.49 74.65 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.814 0.34 . . . . 0.32 110.493 179.476 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 16.1 m-80 -67.88 -47.73 68.05 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-O 121.15 0.5 . . . . 0.84 110.489 178.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 86.9 m-70 -101.04 35.88 2.11 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.183 -0.462 . . . . 0.44 111.328 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . 0.525 ' HG3' ' CZ ' ' A' ' 254' ' ' PHE . 2.6 tt0 -57.49 -48.84 78.16 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.274 -0.421 . . . . 0.47 111.562 -179.538 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 45.9 p -64.95 -39.39 93.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.334 -0.394 . . . . 0.49 111.646 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -61.19 -43.27 99.15 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 121.138 0.494 . . . . 0.32 110.483 179.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' PHE . . . . . 0.517 ' O ' ' HG ' ' A' ' 213' ' ' LEU . 21.9 m-85 -74.52 -39.1 62.59 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.949 -0.569 . . . . 0.42 110.295 179.147 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -60.09 -46.1 90.72 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.151 -0.477 . . . . 0.76 110.277 178.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -63.69 -39.22 97.3 Favored Glycine 0 C--N 1.335 0.516 0 N-CA-C 111.031 -0.827 . . . . 0.3 111.031 177.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 212' ' ' MET . . . . . 0.648 ' HA ' ' HE2' ' A' ' 215' ' ' LYS . 9.9 tpp -62.12 -40.4 95.77 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 109.718 -0.475 . . . . 0.68 109.718 178.182 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.627 HD13 ' HB2' ' A' ' 258' ' ' HIS . 40.7 mt -59.09 -41.29 87.73 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.372 -0.376 . . . . 0.4 111.169 178.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.74 -44.6 96.47 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.086 -0.506 . . . . 0.99 110.886 179.459 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 215' ' ' LYS . . . . . 0.648 ' HE2' ' HA ' ' A' ' 212' ' ' MET . 32.8 mtmt -73.13 -33.59 65.61 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 116.222 -0.444 . . . . 0.66 111.798 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . 0.464 ' HB3' HG12 ' A' ' 218' ' ' ILE . 35.9 mt -65.32 143.48 57.74 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 121.254 0.55 . . . . 0.54 112.465 -179.602 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 217' ' ' ASP . . . . . 0.427 ' O ' ' HG3' ' A' ' 219' ' ' LYS . 0.3 OUTLIER -112.45 33.23 5.05 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.798 -0.637 . . . . 0.48 110.719 179.523 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 218' ' ' ILE . . . . . 0.464 HG12 ' HB3' ' A' ' 216' ' ' LEU . 27.5 mm -66.1 112.43 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 CA-C-N 116.549 -0.296 . . . . 0.51 111.29 -179.658 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . 0.427 ' HG3' ' O ' ' A' ' 217' ' ' ASP . 21.2 mtmm -134.33 -43.57 0.78 Allowed 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 112.15 0.426 . . . . 0.55 112.15 -179.426 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -128.9 -176.37 3.83 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 112.737 0.643 . . . . 0.58 112.737 -177.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . 0.568 ' O ' HG22 ' A' ' 224' ' ' VAL . 1.2 mp0 -61.37 -22.31 64.85 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 112.743 0.646 . . . . 0.72 112.743 -179.055 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -70.19 -27.25 73.13 Favored Glycine 0 CA--C 1.524 0.61 0 C-N-CA 120.402 -0.904 . . . . 0.34 112.999 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -70.12 -31.29 68.76 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 112.779 0.659 . . . . 0.4 112.779 -179.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.568 HG22 ' O ' ' A' ' 221' ' ' GLU . 3.8 m -56.56 -27.37 25.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 N-CA-C 112.122 0.416 . . . . 0.46 112.122 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . 0.473 ' O ' ' HG3' ' A' ' 229' ' ' ARG . 7.9 mptt -64.93 -42.49 94.63 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.037 0.446 . . . . 0.51 110.184 178.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 226' ' ' SER . . . . . 0.708 ' HA ' ' HE ' ' A' ' 229' ' ' ARG . 31.6 m -70.71 -36.68 73.34 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.228 -0.442 . . . . 0.59 109.877 178.478 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 227' ' ' PHE . . . . . . . . . . . . . 16.5 t80 -61.94 -40.68 96.36 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.767 -0.651 . . . . 0.55 109.631 178.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 49.2 m -65.24 -38.17 89.52 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.72 -0.673 . . . . 0.46 109.954 178.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 229' ' ' ARG . . . . . 0.708 ' HE ' ' HA ' ' A' ' 226' ' ' SER . 61.3 mtm180 -59.65 -37.51 78.9 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.239 -0.437 . . . . 0.65 109.925 178.187 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . 0.529 HG22 ' CE1' ' B' ' 23' ' ' PHE . 44.4 t -59.42 -53.54 46.73 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.142 0 N-CA-C 109.311 -0.625 . . . . 0.4 109.311 177.433 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 231' ' ' MET . . . . . 0.504 ' SD ' HD13 ' A' ' 248' ' ' LEU . 1.5 ttp -56.15 -45.23 79.7 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 115.463 -0.79 . . . . 0.73 111.01 178.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 80.6 t -62.75 -42.32 95.77 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-O 120.901 0.381 . . . . 0.49 110.923 178.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 9.2 t-80 -69.85 -35.58 74.84 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 116.515 -0.311 . . . . 0.54 111.221 179.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.517 HG23 ' O ' ' A' ' 230' ' ' VAL . 39.5 t -54.19 -37.01 34.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 CA-C-O 120.974 0.416 . . . . 0.43 111.48 179.351 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 235' ' ' PHE . . . . . 0.596 ' CE1' ' HA ' ' A' ' 240' ' ' THR . 72.9 m-85 -102.26 24.55 10.07 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 112.007 0.373 . . . . 0.55 112.007 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . 0.41 ' HA ' ' HD2' ' A' ' 236' ' ' LYS . 8.2 tptp -70.22 -20.63 63.08 Favored 'General case' 0 CA--C 1.537 0.462 0 O-C-N 122.241 -0.287 . . . . 1.17 111.355 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 23.8 p-10 -82.22 -8.29 59.64 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 120.789 0.328 . . . . 0.73 110.869 179.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 83.05 9.92 83.53 Favored Glycine 0 CA--C 1.522 0.475 0 C-N-CA 120.99 -0.624 . . . . 0.49 114.039 178.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 33.5 t -102.23 91.08 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.441 0.638 . . . . 0.53 111.187 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 240' ' ' THR . . . . . 0.596 ' HA ' ' CE1' ' A' ' 235' ' ' PHE . 3.1 m -80.13 73.27 6.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.875 -0.602 . . . . 0.71 111.439 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 38.3 m-20 -80.11 140.87 36.24 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.928 0.394 . . . . 0.51 111.885 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 242' ' ' TRP . . . . . 0.477 ' HB3' ' CE2' ' A' ' 300' ' ' PHE . 35.4 m95 -57.96 -40.03 79.55 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.981 -0.554 . . . . 0.5 111.367 179.538 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . 0.459 ' H ' ' HB2' ' B' ' 35' ' ' TYR . . . -61.69 -27.43 68.25 Favored Glycine 0 CA--C 1.521 0.467 0 C-N-CA 120.864 -0.684 . . . . 0.25 112.135 178.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 244' ' ' ARG . . . . . 0.548 ' HG2' ' HA3' ' B' ' 31' ' ' GLY . 71.9 mtt180 -74.81 -46.03 39.46 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 110.0 -0.37 . . . . 0.54 110.0 178.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . 0.525 HG23 HD11 ' A' ' 279' ' ' LEU . 83.7 mt -58.2 -47.33 87.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-N 115.674 -0.694 . . . . 0.49 109.899 179.046 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . 0.471 HG11 HG12 ' A' ' 197' ' ' VAL . 83.9 t -64.82 -38.41 82.66 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-N 115.87 -0.604 . . . . 0.35 110.059 178.139 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 17.0 m -60.68 -41.5 95.21 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.712 0.291 . . . . 0.32 110.217 178.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 248' ' ' LEU . . . . . 0.559 HD23 HD13 ' B' ' 27' ' ' LEU . 64.3 mt -63.02 -43.89 97.47 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 121.043 0.449 . . . . 0.74 109.842 177.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 249' ' ' ILE . . . . . 0.508 HG12 ' O ' ' A' ' 245' ' ' ILE . 41.6 mm -63.01 -40.46 89.12 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 CA-C-O 121.35 0.595 . . . . 0.41 109.579 177.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 250' ' ' SER . . . . . 0.659 ' HB3' ' HG3' ' A' ' 202' ' ' GLN . 38.8 m -61.57 -47.63 84.63 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 115.243 -0.89 . . . . 0.29 109.624 178.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 251' ' ' PHE . . . . . 0.527 ' O ' HG23 ' A' ' 255' ' ' VAL . 11.1 t80 -60.81 -45.4 94.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.452 -0.795 . . . . 0.43 109.579 178.155 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -55.66 -48.07 73.65 Favored Glycine 0 C--N 1.335 0.523 0 C-N-CA 121.151 -0.547 . . . . 0.22 111.974 178.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 253' ' ' ALA . . . . . 0.543 ' O ' ' HG3' ' A' ' 257' ' ' LYS . . . -62.1 -34.69 76.8 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 120.737 0.303 . . . . 0.25 111.069 178.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 254' ' ' PHE . . . . . 0.525 ' CZ ' ' HG3' ' A' ' 206' ' ' GLU . 2.4 t80 -72.18 -41.5 66.93 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 121.08 0.467 . . . . 0.4 110.45 178.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 255' ' ' VAL . . . . . 0.527 HG23 ' O ' ' A' ' 251' ' ' PHE . 81.1 t -65.19 -36.25 77.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 N-CA-C 109.047 -0.723 . . . . 0.31 109.047 177.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 256' ' ' ALA . . . . . 0.449 ' HB1' ' HB2' ' A' ' 171' ' ' ALA . . . -62.69 -36.76 83.96 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 115.544 -0.753 . . . . 0.24 109.61 178.101 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 257' ' ' LYS . . . . . 0.543 ' HG3' ' O ' ' A' ' 253' ' ' ALA . 54.7 mttm -60.66 -43.54 97.5 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.033 -0.531 . . . . 0.38 109.65 177.571 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 258' ' ' HIS . . . . . 0.627 ' HB2' HD13 ' A' ' 213' ' ' LEU . 34.7 t60 -57.09 -44.36 83.11 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.824 -0.626 . . . . 0.69 110.844 178.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 94.3 mt -71.04 -40.77 71.5 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 120.99 0.424 . . . . 0.61 111.404 179.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -65.85 -27.78 68.49 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 120.646 0.26 . . . . 0.42 111.481 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 51.2 m -62.84 -21.66 66.11 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 116.356 -0.384 . . . . 0.45 111.414 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 11.3 m -120.35 23.58 4.83 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-N 116.289 -0.414 . . . . 0.6 111.44 179.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 54.4 m-80 58.03 45.33 18.09 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 112.888 0.699 . . . . 1.26 112.888 179.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -109.46 37.65 2.55 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 122.176 -0.328 . . . . 0.89 111.678 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 265' ' ' GLU . . . . . 0.599 ' HA ' HD12 ' A' ' 268' ' ' ILE . 13.3 tt0 -58.04 -28.62 64.66 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 111.975 0.361 . . . . 0.74 111.975 -179.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 15.5 p -62.17 -18.68 61.69 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.189 -0.459 . . . . 0.53 111.212 179.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 267' ' ' PHE . . . . . 0.416 ' C ' ' HD2' ' A' ' 270' ' ' PRO . 90.1 m-85 -101.94 -19.0 15.42 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 121.05 0.453 . . . . 0.65 110.242 177.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 268' ' ' ILE . . . . . 0.599 HD12 ' HA ' ' A' ' 265' ' ' GLU . 78.9 mt -66.9 -43.86 89.18 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-N 115.767 -0.651 . . . . 0.35 110.599 179.605 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 269' ' ' GLU . . . . . 0.776 ' HB2' ' HD3' ' A' ' 270' ' ' PRO . 45.2 mt-10 -59.47 -57.3 27.96 Favored Pre-proline 0 CA--C 1.54 0.577 0 CA-C-N 116.271 -0.422 . . . . 0.42 110.54 178.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 270' ' ' PRO . . . . . 0.776 ' HD3' ' HB2' ' A' ' 269' ' ' GLU . 66.4 Cg_exo -54.0 -35.14 79.91 Favored 'Trans proline' 0 C--N 1.362 1.261 0 C-N-CA 122.137 1.891 . . . . 0.45 112.212 178.36 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 271' ' ' LEU . . . . . . . . . . . . . 51.1 tp -68.54 -54.57 15.85 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.312 -0.404 . . . . 0.45 110.073 178.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -57.6 -40.47 79.15 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 116.282 -0.417 . . . . 0.23 110.918 179.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 273' ' ' GLU . . . . . 0.736 ' HG3' HD11 ' A' ' 160' ' ' LEU . 0.7 OUTLIER -66.43 -44.19 83.57 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.119 -0.491 . . . . 0.33 110.302 178.499 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 274' ' ' THR . . . . . . . . . . . . . 67.5 m -61.46 -43.16 99.35 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-O 120.905 0.383 . . . . 0.28 110.195 178.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 96.7 mt -59.05 -53.98 40.45 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-N 115.973 -0.558 . . . . 0.31 110.696 178.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 276' ' ' THR . . . . . 0.53 HG21 ' HA ' ' A' ' 160' ' ' LEU . 49.9 m -56.76 -47.08 80.89 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.299 -0.41 . . . . 0.29 110.77 179.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 277' ' ' ASP . . . . . 0.611 ' O ' ' HB2' ' A' ' 281' ' ' ARG . 28.0 t70 -55.82 -59.21 5.2 Favored 'General case' 0 C--O 1.222 -0.358 0 CA-C-N 115.632 -0.713 . . . . 0.46 111.157 179.442 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 84.4 t -58.7 -36.98 63.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-O 120.905 0.383 . . . . 0.41 111.384 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 279' ' ' LEU . . . . . 0.525 HD11 HG23 ' A' ' 245' ' ' ILE . 26.3 tp -63.95 -47.19 81.45 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 116.333 -0.394 . . . . 0.7 112.024 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 60.8 t -80.89 -42.18 20.11 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 N-CA-C 112.272 0.471 . . . . 0.44 112.272 -179.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 281' ' ' ARG . . . . . 0.611 ' HB2' ' O ' ' A' ' 277' ' ' ASP . 2.7 ttt180 -56.49 -43.41 79.63 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 112.936 0.717 . . . . 0.89 112.936 -179.393 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 282' ' ' THR . . . . . . . . . . . . . 51.9 p -83.0 -23.7 33.19 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 113.143 0.794 . . . . 0.57 113.143 -179.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . 0.451 ' HD3' HG23 ' A' ' 240' ' ' THR . 1.5 mttp -118.04 39.16 3.46 Favored 'General case' 0 C--N 1.329 -0.307 0 O-C-N 122.068 -0.395 . . . . 0.77 111.905 -179.062 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 284' ' ' ARG . . . . . 0.422 HH11 ' HD3' ' A' ' 284' ' ' ARG . 31.0 ttp180 -58.65 -48.11 82.16 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.109 -0.496 . . . . 0.93 111.932 -179.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -68.41 -46.08 70.89 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 116.574 -0.285 . . . . 0.52 111.755 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 286' ' ' TRP . . . . . . . . . . . . . 1.8 t90 -61.65 -45.97 91.78 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 112.023 0.379 . . . . 0.51 112.023 -179.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -63.37 -52.25 62.49 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.15 0.426 . . . . 0.49 112.15 -179.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 6.8 p -61.8 -30.74 49.09 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 CA-C-O 120.784 0.326 . . . . 0.55 111.787 -179.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 10.6 ttmt -69.55 -38.78 77.61 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 120.971 0.415 . . . . 0.86 111.121 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 290' ' ' GLN . . . . . 0.451 ' HB3' ' HZ2' ' A' ' 242' ' ' TRP . 0.3 OUTLIER -91.6 22.45 4.05 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 112.231 0.456 . . . . 0.95 112.231 -179.44 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 8.7 mpt_? 61.67 17.61 8.83 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 112.391 0.515 . . . . 0.86 112.391 179.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 58.81 -120.27 21.67 Favored Glycine 0 CA--C 1.523 0.566 0 CA-C-O 121.436 0.464 . . . . 0.44 113.997 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 293' ' ' TRP . . . . . 0.565 ' HB3' ' HB2' ' A' ' 190' ' ' ALA . 84.9 m95 -65.44 -28.56 69.32 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.717 0.636 . . . . 0.47 112.717 -178.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 294' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.38 -45.24 91.99 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 121.075 0.464 . . . . 0.56 110.595 179.009 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -69.28 -30.89 71.44 Favored Glycine 0 CA--C 1.518 0.259 0 C-N-CA 120.472 -0.871 . . . . 0.29 111.252 178.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 296' ' ' PHE . . . . . 0.475 ' HB2' ' CZ3' ' A' ' 242' ' ' TRP . 2.5 t80 -69.62 -48.44 59.99 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 115.7 -0.25 . . . . 0.35 111.512 179.013 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 297' ' ' VAL . . . . . 0.622 ' HA ' HG21 ' A' ' 193' ' ' THR . 26.4 m -66.2 -33.83 66.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 N-CA-C 112.113 0.412 . . . . 0.31 112.113 -179.165 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -76.11 -33.08 59.47 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 120.624 0.25 . . . . 0.86 111.052 179.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 299' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -69.7 -38.23 76.88 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.025 0.441 . . . . 0.43 110.456 178.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 300' ' ' PHE . . . . . 0.477 ' CE2' ' HB3' ' A' ' 242' ' ' TRP . 91.2 m-85 . . . . . 0 C--N 1.329 -0.299 0 CA-C-O 121.206 0.527 . . . . 0.38 110.691 179.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 . . . . . 0 CA--C 1.533 0.311 0 N-CA-C 111.537 0.199 . . . . 0.79 111.537 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 23' ' ' PHE . . . . . 0.529 ' CE1' HG22 ' A' ' 230' ' ' VAL . 0.2 OUTLIER -62.17 -33.21 74.09 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.763 0.316 . . . . 0.47 111.634 -179.84 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 24' ' ' ALA . . . . . 0.512 ' N ' ' HD1' ' B' ' 23' ' ' PHE . . . -75.63 -36.32 60.26 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.236 0.541 . . . . 0.48 109.872 179.274 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -69.25 -43.02 74.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.618 -0.719 . . . . 0.46 110.198 178.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -60.24 -48.72 80.55 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.074 -0.512 . . . . 0.63 110.854 179.396 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . 0.559 HD13 HD23 ' A' ' 248' ' ' LEU . 89.2 mt -64.73 -33.4 75.89 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 120.92 0.391 . . . . 0.45 110.324 178.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 28' ' ' ARG . . . . . . . . . . . . . 3.6 tmt_? -64.46 -45.73 86.18 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 121.215 0.531 . . . . 0.87 109.722 177.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 33.4 mtpt -71.27 -45.19 63.72 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 115.672 -0.695 . . . . 0.59 111.647 179.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 96.7 mt -62.52 -43.44 98.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-O 120.722 0.296 . . . . 0.4 110.324 179.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . 0.548 ' HA3' ' HG2' ' A' ' 244' ' ' ARG . . . -59.72 -50.25 69.73 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.807 -0.711 . . . . 0.3 112.582 179.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -65.81 -32.11 73.45 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.749 0.275 . . . . 0.56 110.754 179.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.9 -52.0 58.89 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 121.097 0.475 . . . . 0.7 109.738 178.307 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 55.2 t -63.04 -45.1 99.66 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-N 115.494 -0.775 . . . . 0.38 110.53 178.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 35' ' ' TYR . . . . . 0.459 ' HB2' ' H ' ' A' ' 243' ' ' GLY . 0.7 OUTLIER -54.98 -47.05 75.1 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 115.607 -0.724 . . . . 0.63 111.316 179.319 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 36' ' ' CYS . . . . . . . . . . . . . 73.0 m -62.45 -45.07 94.72 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 120.663 0.268 . . . . 0.45 111.303 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 13.1 m -60.4 -37.55 81.19 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 116.316 -0.402 . . . . 0.61 112.033 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 38' ' ' TRP . . . . . . . . . . . . . 93.9 m95 -87.65 -29.47 21.15 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 112.637 0.606 . . . . 0.75 112.637 -179.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 42.2 t . . . . . 0 N--CA 1.471 0.581 0 N-CA-C 111.982 0.364 . . . . 0.6 111.982 179.675 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 2.8 t70 . . . . . 0 N--CA 1.472 0.638 0 N-CA-C 113.448 0.907 . . . . 0.52 113.448 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -49.35 -51.62 33.41 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 121.038 0.447 . . . . 0.48 112.142 -179.257 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.519 HD21 ' HB3' ' A' ' 287' ' ' LEU . 44.7 tp -84.47 -40.2 18.0 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.297 -0.41 . . . . 0.91 111.664 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . 0.496 ' OH ' ' HB2' ' A' ' 281' ' ' ARG . 0.3 OUTLIER -52.04 -44.16 64.1 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 112.203 0.446 . . . . 0.36 112.203 -179.766 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 21.5 mtm180 -60.56 -51.9 67.46 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 112.145 0.424 . . . . 0.53 112.145 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 1.8 mm100 -63.27 -40.13 96.53 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 121.239 0.542 . . . . 0.53 110.401 179.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 18.4 m -64.89 -50.1 67.89 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.414 -0.812 . . . . 0.28 111.534 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -55.96 -47.89 76.8 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.405 -0.361 . . . . 0.47 111.046 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . 0.621 ' O ' ' HB2' ' A' ' 165' ' ' ARG . 1.4 mm-40 -59.37 -47.26 86.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.402 -0.363 . . . . 0.55 111.294 179.349 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . 0.55 HG12 ' HA2' ' A' ' 187' ' ' GLY . 68.4 mt -66.04 -51.88 55.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 N-CA-C 113.114 0.783 . . . . 0.35 113.114 -179.01 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.539 HD12 HG23 ' A' ' 276' ' ' THR . 56.0 mt -60.18 -54.62 32.39 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 N-CA-C 112.232 0.456 . . . . 0.34 112.232 -178.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 70.4 p -59.33 -37.08 76.9 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.63 0.252 . . . . 0.33 111.077 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . 0.621 ' HB2' ' O ' ' A' ' 161' ' ' GLU . 0.0 OUTLIER -68.92 -36.78 78.39 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 120.959 -0.296 . . . . 0.56 111.256 179.099 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' TYR . . . . . 0.852 ' HE1' ' HA ' ' A' ' 195' ' ' ARG . 67.5 t80 -72.32 -49.16 36.54 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 121.237 -0.185 . . . . 0.48 111.242 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.512 ' HG ' ' O ' ' A' ' 163' ' ' ILE . 38.1 mt -55.99 -41.01 74.17 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.183 0.516 . . . . 0.34 110.316 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 3.7 tpp180 -69.83 -42.99 72.91 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.554 -0.748 . . . . 0.49 110.449 178.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . 0.502 ' HB2' ' O ' ' A' ' 165' ' ' ARG . 0.4 OUTLIER -56.85 -44.05 81.74 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 116.351 -0.386 . . . . 0.52 111.939 -179.701 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 22.5 tp60 -76.28 -32.9 59.04 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 112.034 0.383 . . . . 0.55 112.034 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.865 ' HA ' ' HG2' ' A' ' 257' ' ' LYS . . . . . . . . 0 CA--C 1.537 0.449 0 N-CA-C 113.072 0.768 . . . . 0.45 113.072 -179.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.672 ' O ' ' HA3' ' A' ' 187' ' ' GLY . . . . . . . . 0 C--O 1.224 -0.256 0 CA-C-O 121.118 0.485 . . . . 0.37 110.561 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -79.94 -69.76 1.38 Allowed Glycine 0 CA--C 1.522 0.496 0 C-N-CA 120.953 -0.642 . . . . 0.38 113.359 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -59.79 -56.01 27.08 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 120.653 0.263 . . . . 0.43 111.535 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -67.69 -32.92 73.91 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.949 -0.389 . . . . 0.46 109.949 179.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . 0.672 ' HA3' ' O ' ' A' ' 183' ' ' ALA . . . -62.63 -48.64 80.02 Favored Glycine 0 C--O 1.224 -0.492 0 CA-C-N 115.685 -0.688 . . . . 0.39 112.97 179.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.28 -50.75 68.88 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 117.221 0.511 . . . . 1.58 110.893 179.313 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' ARG . . . . . 0.649 ' HB3' HG21 ' A' ' 297' ' ' VAL . 4.4 mtp180 -56.31 -55.15 36.96 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-O 120.971 0.415 . . . . 0.73 111.164 179.346 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . 0.428 ' O ' ' HB2' ' A' ' 194' ' ' LEU . . . -66.98 -40.67 87.46 Favored 'General case' 0 C--O 1.219 -0.51 0 N-CA-C 113.035 0.754 . . . . 0.35 113.035 -178.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 14.2 tp -62.45 -44.37 96.58 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 118.475 0.579 . . . . 0.77 111.529 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -67.58 -40.11 84.84 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 121.143 0.497 . . . . 1.16 110.963 179.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . 0.519 ' OG1' HG13 ' A' ' 297' ' ' VAL . 20.8 m -68.52 -47.26 67.42 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.113 -0.494 . . . . 0.46 110.204 179.035 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . 0.461 HD21 HG21 ' A' ' 249' ' ' ILE . 7.9 tp -60.12 -42.17 94.17 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 115.661 -0.7 . . . . 0.36 110.468 179.26 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . 0.852 ' HA ' ' HE1' ' A' ' 166' ' ' TYR . 0.6 OUTLIER -56.03 -54.08 49.26 Favored 'General case' 0 CA--C 1.522 -0.125 0 CA-C-O 121.243 0.545 . . . . 0.41 110.377 178.268 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 10.9 mmm180 -61.53 -54.03 48.49 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.972 -1.013 . . . . 0.9 112.36 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . 0.497 ' O ' HG23 ' A' ' 201' ' ' VAL . 99.0 t -61.36 -46.31 96.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 N-CA-C 111.899 0.333 . . . . 0.47 111.899 -179.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . 0.529 ' HA3' ' OH ' ' A' ' 166' ' ' TYR . . . -62.24 -50.43 65.1 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 121.244 -0.503 . . . . 0.3 112.242 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . 0.47 ' HB2' ' O ' ' A' ' 195' ' ' ARG . 0.3 OUTLIER -58.27 -43.1 87.77 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 120.856 0.36 . . . . 0.47 110.117 178.846 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -61.68 -48.36 84.81 Favored Glycine 0 CA--C 1.525 0.708 0 C-N-CA 121.021 -0.609 . . . . 0.42 112.303 178.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 197' ' ' VAL . 71.0 t -62.37 -43.18 97.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-O 120.943 0.402 . . . . 0.41 110.607 178.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' GLN . . . . . 0.562 ' HB3' ' NH2' ' A' ' 203' ' ' ARG . 68.8 mt-30 -63.41 -55.2 26.24 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.583 -0.735 . . . . 0.55 112.098 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' ARG . . . . . 0.562 ' NH2' ' HB3' ' A' ' 202' ' ' GLN . 0.0 OUTLIER -58.15 -34.41 70.25 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 112.157 0.428 . . . . 0.45 112.157 -178.822 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 17.7 m-80 -75.34 -43.79 48.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.895 0.378 . . . . 0.8 111.489 179.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' HIS . . . . . 0.436 ' CD2' HG23 ' B' ' 30' ' ' ILE . 95.2 m-70 -100.9 35.95 2.07 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.8 0.333 . . . . 0.52 111.68 -179.598 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . 0.495 ' HG2' ' HA ' ' A' ' 203' ' ' ARG . 26.9 mm-40 -55.68 -35.64 66.25 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 112.4 0.519 . . . . 0.53 112.4 -179.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 19.4 p -63.15 -52.64 61.65 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.808 0.337 . . . . 0.54 111.6 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -63.41 -40.57 97.56 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.154 -0.475 . . . . 0.4 110.919 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' PHE . . . . . 0.442 ' CE2' ' HA ' ' A' ' 202' ' ' GLN . 25.9 m-85 -68.04 -49.49 61.09 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.094 -0.503 . . . . 0.45 111.547 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -65.31 -38.91 91.65 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 121.266 -0.174 . . . . 0.51 111.021 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -59.23 -45.71 94.95 Favored Glycine 0 C--N 1.334 0.443 0 C-N-CA 120.448 -0.882 . . . . 0.28 110.991 178.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 212' ' ' MET . . . . . 0.487 ' SD ' ' HA ' ' B' ' 23' ' ' PHE . 56.9 mtm -70.62 -33.78 71.39 Favored 'General case' 0 C--O 1.223 -0.324 0 N-CA-C 110.25 -0.278 . . . . 0.73 110.25 178.196 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.449 HD22 ' HA ' ' A' ' 213' ' ' LEU . 0.3 OUTLIER -65.8 -43.84 87.47 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.351 -0.386 . . . . 0.33 111.302 179.506 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 71.9 mtp180 -66.11 -38.46 88.25 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.916 0.389 . . . . 0.92 110.84 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 54.9 mtmt -91.42 11.57 23.44 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.288 -0.415 . . . . 0.59 111.287 179.19 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . 0.509 HD21 HD12 ' A' ' 218' ' ' ILE . 6.5 tp -79.26 99.07 6.89 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.14 0.495 . . . . 0.4 111.361 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -83.25 32.07 0.45 Allowed 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.7 -0.682 . . . . 0.43 111.191 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 218' ' ' ILE . . . . . 0.765 HG12 ' HB3' ' A' ' 223' ' ' ASP . 36.4 mt -81.1 106.74 12.64 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-O 121.069 0.461 . . . . 0.4 110.709 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 8.2 mppt? -140.92 -24.45 0.76 Allowed 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 115.696 -0.684 . . . . 0.6 111.978 -179.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -116.28 171.1 8.04 Favored 'General case' 0 CA--C 1.533 0.296 0 O-C-N 121.875 -0.516 . . . . 1.11 111.68 -179.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -58.48 -31.45 67.85 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 120.955 0.407 . . . . 0.55 111.197 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -62.45 -26.72 68.47 Favored Glycine 0 CA--C 1.524 0.627 0 CA-C-N 115.978 -0.555 . . . . 0.45 113.117 179.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 223' ' ' ASP . . . . . 0.765 ' HB3' HG12 ' A' ' 218' ' ' ILE . 55.5 m-20 -68.66 -34.11 75.15 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 117.024 0.412 . . . . 0.36 111.488 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 16.4 t -62.23 -29.41 46.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-O 121.556 0.693 . . . . 0.38 110.16 178.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 32.2 mmtm -72.67 -33.48 66.58 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 115.533 -0.758 . . . . 0.5 110.441 179.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 226' ' ' SER . . . . . 0.453 ' O ' HG23 ' A' ' 230' ' ' VAL . 33.6 t -68.13 -38.65 82.44 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.381 0.61 . . . . 0.91 109.585 178.329 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 227' ' ' PHE . . . . . 0.448 ' HE2' HG11 ' A' ' 255' ' ' VAL . 8.5 t80 -63.54 -38.36 90.83 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 115.211 -0.904 . . . . 0.46 109.503 178.107 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 46.8 t -62.53 -37.44 86.1 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 115.442 -0.799 . . . . 0.29 109.951 178.165 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 84.3 mtp180 -63.07 -39.67 95.4 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.013 -0.539 . . . . 0.55 109.882 178.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' ' 226' ' ' SER . 18.2 t -59.3 -46.14 92.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-N 116.324 -0.398 . . . . 0.35 110.5 178.143 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 231' ' ' MET . . . . . 0.474 ' HE3' ' HA ' ' A' ' 275' ' ' ILE . 7.3 tpp -55.33 -52.2 64.28 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.933 -0.576 . . . . 0.37 110.929 179.605 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 232' ' ' VAL . . . . . 0.527 ' O ' ' HB2' ' A' ' 236' ' ' LYS . 38.2 t -66.89 -36.71 77.85 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-N 116.262 -0.426 . . . . 0.37 111.362 179.511 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 54.0 t-80 -65.48 -52.55 52.06 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 112.057 0.392 . . . . 0.55 112.057 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 97.0 t -63.98 -39.09 84.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 N-CA-C 112.078 0.399 . . . . 0.41 112.078 -179.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 235' ' ' PHE . . . . . 0.568 ' HZ ' ' HA ' ' A' ' 245' ' ' ILE . 63.0 m-85 -91.84 10.94 26.52 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.412 0.523 . . . . 0.56 112.412 -179.397 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . 0.55 ' HE2' ' HA ' ' A' ' 236' ' ' LYS . 0.3 OUTLIER -76.0 -11.43 59.95 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 111.873 0.323 . . . . 0.74 111.873 -179.807 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -69.97 -16.73 63.24 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 120.855 0.359 . . . . 0.42 111.262 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 89.28 -19.83 37.2 Favored Glycine 0 CA--C 1.521 0.442 0 C-N-CA 121.168 -0.539 . . . . 0.47 111.959 -178.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 2.4 t -80.39 112.03 17.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.048 0.452 . . . . 0.86 111.093 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 240' ' ' THR . . . . . 0.41 HG22 HD11 ' A' ' 245' ' ' ILE . 1.9 m -94.47 91.32 6.58 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.37 -0.377 . . . . 0.55 111.046 179.477 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -101.56 135.22 43.44 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.77 0.319 . . . . 0.47 111.389 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 242' ' ' TRP . . . . . 0.658 ' HB3' ' CZ ' ' A' ' 300' ' ' PHE . 7.2 m95 -55.0 -44.01 74.14 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 116.311 -0.404 . . . . 0.41 111.761 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . 0.463 ' H ' ' HB2' ' B' ' 35' ' ' TYR . . . -59.21 -37.02 91.2 Favored Glycine 0 CA--C 1.524 0.619 0 C-N-CA 121.086 -0.578 . . . . 0.28 112.868 179.096 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 63.9 mtt180 -68.46 -43.45 77.0 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 109.777 -0.453 . . . . 0.35 109.777 178.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . 0.568 ' HA ' ' HZ ' ' A' ' 235' ' ' PHE . 84.7 mt -59.99 -50.67 79.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-N 115.58 -0.736 . . . . 0.48 111.569 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . 0.412 HG22 ' O ' ' A' ' 242' ' ' TRP . 16.1 m -67.04 -28.03 41.49 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 C-N-CA 120.769 -0.373 . . . . 0.35 111.411 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 23.1 m -61.79 -48.62 79.81 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 109.754 -0.461 . . . . 0.37 109.754 178.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -60.2 -42.47 95.19 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.063 -0.517 . . . . 0.53 110.312 178.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 249' ' ' ILE . . . . . 0.461 HG21 HD21 ' A' ' 194' ' ' LEU . 43.3 mm -63.99 -44.99 97.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 CA-C-N 116.238 -0.437 . . . . 0.47 110.499 178.521 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 250' ' ' SER . . . . . 0.448 ' HB2' ' HG3' ' A' ' 202' ' ' GLN . 54.4 p -62.19 -36.61 82.44 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.816 0.341 . . . . 0.33 110.17 178.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 251' ' ' PHE . . . . . 0.428 ' CD2' HD11 ' B' ' 27' ' ' LEU . 13.2 t80 -69.71 -40.33 76.35 Favored 'General case' 0 C--O 1.232 0.142 0 N-CA-C 108.704 -0.85 . . . . 0.46 108.704 177.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -57.76 -37.32 83.41 Favored Glycine 0 C--N 1.336 0.566 0 N-CA-C 110.683 -0.967 . . . . 0.25 110.683 177.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 253' ' ' ALA . . . . . 0.448 ' O ' ' HG3' ' A' ' 257' ' ' LYS . . . -68.68 -41.33 79.4 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 120.767 0.318 . . . . 0.31 110.185 177.332 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -63.29 -44.5 94.89 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 116.236 -0.438 . . . . 0.38 110.896 178.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 255' ' ' VAL . . . . . 0.472 HG23 HD21 ' A' ' 271' ' ' LEU . 16.3 m -70.91 -26.34 27.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-O 120.819 0.342 . . . . 0.27 110.472 178.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -66.72 -39.25 87.92 Favored 'General case' 0 C--N 1.339 0.12 0 N-CA-C 108.454 -0.943 . . . . 0.29 108.454 177.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 257' ' ' LYS . . . . . 0.865 ' HG2' ' HA ' ' A' ' 171' ' ' ALA . 24.2 mtpp -65.16 -36.52 84.47 Favored 'General case' 0 C--O 1.225 -0.199 0 CA-C-N 115.351 -0.84 . . . . 0.74 109.646 177.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 63.6 t60 -59.54 -49.03 79.35 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 109.957 -0.386 . . . . 0.43 109.957 177.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.476 HD21 HG22 ' A' ' 218' ' ' ILE . 95.9 mt -68.79 -36.08 77.82 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.038 -0.528 . . . . 0.48 110.453 178.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 5.0 tptp -67.47 -36.57 81.41 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 120.774 0.321 . . . . 0.52 111.048 179.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 35.3 t -64.89 -25.86 68.07 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.184 -0.462 . . . . 0.46 111.325 179.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 26.8 m -107.78 11.0 9.04 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 CA-C-N 116.424 -0.353 . . . . 0.46 110.968 178.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 58.98 48.23 11.13 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 113.202 0.816 . . . . 1.55 113.202 179.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 14.7 mt-30 -114.99 36.28 3.95 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.457 -0.338 . . . . 0.76 111.064 178.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 265' ' ' GLU . . . . . 0.546 ' HA ' HD12 ' A' ' 268' ' ' ILE . 1.8 pm0 -52.62 -29.21 24.81 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 112.407 0.521 . . . . 0.48 112.407 179.412 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 9.3 p -59.96 -20.19 56.23 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 120.725 0.298 . . . . 0.5 111.049 178.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 267' ' ' PHE . . . . . 0.446 ' C ' ' HD2' ' A' ' 270' ' ' PRO . 41.7 m-85 -98.01 -18.87 18.36 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 121.109 0.48 . . . . 0.53 110.181 178.425 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 268' ' ' ILE . . . . . 0.546 HD12 ' HA ' ' A' ' 265' ' ' GLU . 72.4 mt -68.58 -39.57 80.67 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 CA-C-N 115.849 -0.614 . . . . 0.41 110.4 178.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 269' ' ' GLU . . . . . 0.685 ' HB2' ' HD3' ' A' ' 270' ' ' PRO . 1.5 mm-40 -56.38 -56.94 26.39 Favored Pre-proline 0 CA--C 1.543 0.686 0 CA-C-N 116.287 -0.415 . . . . 0.49 111.036 179.27 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 270' ' ' PRO . . . . . 0.685 ' HD3' ' HB2' ' A' ' 269' ' ' GLU . 34.7 Cg_exo -61.68 -34.89 82.91 Favored 'Trans proline' 0 C--N 1.361 1.233 0 C-N-CA 121.954 1.769 . . . . 0.32 111.435 177.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 271' ' ' LEU . . . . . 0.472 HD21 HG23 ' A' ' 255' ' ' VAL . 26.8 tp -62.61 -51.07 68.75 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.182 -0.463 . . . . 0.45 110.251 178.487 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -59.09 -41.12 87.3 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 116.104 -0.498 . . . . 0.34 110.12 178.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 273' ' ' GLU . . . . . . . . . . . . . 62.2 mm-40 -63.34 -45.48 91.01 Favored 'General case' 0 C--O 1.225 -0.189 0 CA-C-N 115.761 -0.654 . . . . 1.05 109.831 177.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 274' ' ' THR . . . . . . . . . . . . . 87.5 m -62.2 -44.02 97.51 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.917 -0.583 . . . . 0.34 111.179 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 275' ' ' ILE . . . . . 0.474 ' HA ' ' HE3' ' A' ' 231' ' ' MET . 94.4 mt -58.66 -50.48 78.98 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 CA-C-O 120.984 0.421 . . . . 0.39 110.286 179.008 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 276' ' ' THR . . . . . 0.539 HG23 HD12 ' A' ' 163' ' ' ILE . 24.1 m -63.12 -46.17 88.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.041 -0.527 . . . . 0.3 110.669 178.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 277' ' ' ASP . . . . . 0.429 ' CG ' HH12 ' A' ' 281' ' ' ARG . 36.1 t70 -51.69 -60.72 2.84 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.309 -0.86 . . . . 0.35 112.442 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 21.8 t -66.35 -37.25 79.25 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 N-CA-C 113.058 0.762 . . . . 0.36 113.058 -178.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 32.5 tp -70.67 -48.47 54.66 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 112.855 0.687 . . . . 0.72 112.855 -178.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 58.2 t -70.73 -34.82 58.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 N-CA-C 112.595 0.591 . . . . 0.32 112.595 -178.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 281' ' ' ARG . . . . . 0.496 ' HB2' ' OH ' ' A' ' 156' ' ' TYR . 21.9 ttp-105 -72.79 -51.39 19.21 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.407 0.521 . . . . 0.38 112.407 -179.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 282' ' ' THR . . . . . . . . . . . . . 10.1 m -60.6 -35.34 75.89 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 112.168 0.432 . . . . 0.49 112.168 -178.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 64.9 mmtt -115.96 38.78 3.23 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 122.225 -0.297 . . . . 0.53 111.611 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 284' ' ' ARG . . . . . 0.522 ' HG3' ' H ' ' A' ' 285' ' ' ASP . 0.2 OUTLIER -62.13 -54.01 47.28 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 112.812 0.671 . . . . 0.39 112.812 -179.066 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 285' ' ' ASP . . . . . 0.522 ' H ' ' HG3' ' A' ' 284' ' ' ARG . 0.2 OUTLIER -60.27 -39.44 86.85 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 112.128 0.418 . . . . 0.52 112.128 -178.855 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 286' ' ' TRP . . . . . 0.47 ' O ' ' HB2' ' A' ' 290' ' ' GLN . 12.4 t90 -67.14 -41.58 85.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.808 0.337 . . . . 0.48 110.921 179.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 287' ' ' LEU . . . . . 0.519 ' HB3' HD21 ' A' ' 155' ' ' LEU . 2.0 mm? -70.6 -48.4 55.36 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.298 -0.41 . . . . 0.44 112.078 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 288' ' ' VAL . . . . . 0.41 HG22 ' O ' ' A' ' 284' ' ' ARG . 26.9 m -59.88 -37.84 73.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 N-CA-C 111.901 0.334 . . . . 0.33 111.901 -179.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 54.1 mttp -75.52 -23.95 56.74 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-O 120.789 0.328 . . . . 0.59 111.274 179.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 290' ' ' GLN . . . . . 0.47 ' HB2' ' O ' ' A' ' 286' ' ' TRP . 1.5 tp-100 -91.06 17.58 7.84 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.604 -0.271 . . . . 0.66 111.659 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 36.0 mtp180 64.69 15.38 9.71 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 112.025 0.38 . . . . 0.47 112.025 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 63.71 -132.47 40.81 Favored Glycine 0 CA--C 1.523 0.593 0 CA-C-O 121.462 0.479 . . . . 0.38 114.01 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 293' ' ' TRP . . . . . 0.61 ' O ' HG23 ' A' ' 297' ' ' VAL . 77.4 m95 -67.05 -25.18 66.13 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.019 0.377 . . . . 0.43 112.019 -178.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 294' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -56.73 -48.38 77.89 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 109.852 -0.425 . . . . 0.78 109.852 178.324 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -68.7 -38.85 86.28 Favored Glycine 0 C--N 1.336 0.574 0 N-CA-C 111.24 -0.744 . . . . 0.37 111.24 178.045 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 296' ' ' PHE . . . . . 0.547 ' HB3' ' HA ' ' A' ' 293' ' ' TRP . 0.9 OUTLIER -57.74 -45.63 85.59 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 120.769 0.318 . . . . 0.4 111.064 178.498 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 297' ' ' VAL . . . . . 0.649 HG21 ' HB3' ' A' ' 189' ' ' ARG . 78.3 t -65.8 -40.41 87.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-N 116.015 -0.539 . . . . 0.39 111.269 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -66.53 -48.26 70.3 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.207 -0.451 . . . . 0.58 111.476 179.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 299' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -62.26 -51.08 69.18 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.053 0.454 . . . . 0.49 110.843 179.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 300' ' ' PHE . . . . . 0.658 ' CZ ' ' HB3' ' A' ' 242' ' ' TRP . 49.6 m-85 . . . . . 0 C--N 1.328 -0.352 0 CA-C-N 116.091 -0.504 . . . . 0.57 112.316 -179.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 22' ' ' GLU . . . . . 0.494 ' O ' ' HB2' ' B' ' 26' ' ' GLN . 1.8 mt-10 . . . . . 0 CA--C 1.529 0.14 0 N-CA-C 112.224 0.453 . . . . 1.02 112.224 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 23' ' ' PHE . . . . . 0.5 ' HD1' ' N ' ' B' ' 24' ' ' ALA . 0.1 OUTLIER -55.74 -32.17 63.17 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 112.843 0.683 . . . . 0.36 112.843 -178.924 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 24' ' ' ALA . . . . . 0.674 ' O ' ' HB2' ' B' ' 28' ' ' ARG . . . -69.95 -51.59 31.47 Favored 'General case' 0 C--N 1.322 -0.593 0 O-C-N 122.023 -0.423 . . . . 0.29 111.713 -179.019 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -74.1 -41.41 61.7 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.108 0.41 . . . . 0.33 112.108 -179.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 26' ' ' GLN . . . . . 0.494 ' HB2' ' O ' ' B' ' 22' ' ' GLU . 1.1 tp-100 -62.04 -54.92 34.75 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.326 -0.397 . . . . 0.39 111.297 -179.396 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . 0.428 HD11 ' CD2' ' A' ' 251' ' ' PHE . 70.2 mt -63.47 -37.56 87.75 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.96 -0.296 . . . . 0.35 110.58 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 28' ' ' ARG . . . . . 0.674 ' HB2' ' O ' ' B' ' 24' ' ' ALA . 0.0 OUTLIER -57.88 -57.38 13.06 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 120.694 0.283 . . . . 0.41 111.437 179.292 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 18.8 mmmt -66.48 -35.08 79.37 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.425 -0.352 . . . . 0.48 111.563 -179.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . 0.436 HG23 ' CD2' ' A' ' 205' ' ' HIS . 43.4 mt -64.15 -42.76 96.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 N-CA-C 108.946 -0.761 . . . . 0.39 108.946 177.514 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -58.88 -49.44 78.02 Favored Glycine 0 C--N 1.334 0.449 0 CA-C-N 115.961 -0.563 . . . . 0.29 112.42 178.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -55.55 -44.91 77.24 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 121.16 0.505 . . . . 0.42 110.759 178.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 2.2 ttmp? -65.87 -52.34 51.08 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 115.654 -0.703 . . . . 1.12 111.098 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 40.4 t -56.33 -45.37 81.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-O 121.135 0.493 . . . . 0.46 110.741 178.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 35' ' ' TYR . . . . . 0.463 ' HB2' ' H ' ' A' ' 243' ' ' GLY . 3.4 t80 -56.69 -49.66 74.44 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 115.597 -0.729 . . . . 1.01 110.447 178.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 36' ' ' CYS . . . . . . . . . . . . . 5.9 t -66.13 -34.21 77.54 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 120.825 0.345 . . . . 0.67 111.027 179.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 52.2 m -62.85 -51.79 65.65 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 112.364 0.505 . . . . 0.62 112.364 -179.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 38' ' ' TRP . . . . . . . . . . . . . 96.7 m95 -73.65 -30.38 62.9 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.345 0.498 . . . . 0.88 112.345 -179.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 23.0 t . . . . . 0 N--CA 1.467 0.407 0 N-CA-C 111.801 0.297 . . . . 0.79 111.801 -179.913 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 . . . . . 0 N--CA 1.466 0.343 0 CA-C-O 120.83 0.348 . . . . 0.59 111.278 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -57.92 -44.99 87.21 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.056 -0.52 . . . . 0.44 110.685 178.428 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 35.0 tp -76.94 -29.3 55.56 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-O 121.323 0.582 . . . . 0.55 109.955 178.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 87.8 t80 -63.89 -30.79 71.84 Favored 'General case' 0 C--O 1.223 -0.338 0 CA-C-N 115.666 -0.697 . . . . 0.35 110.369 178.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 0.457 HH11 ' HD3' ' A' ' 157' ' ' ARG . 45.0 mtt180 -60.72 -51.91 67.36 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.028 0.442 . . . . 0.72 110.261 178.431 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 32.1 mt-30 -59.66 -43.99 93.73 Favored 'General case' 0 N--CA 1.46 0.071 0 CA-C-N 115.701 -0.681 . . . . 1.13 109.515 178.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . 0.572 ' HA ' ' CZ2' ' A' ' 293' ' ' TRP . 18.5 m -60.38 -58.67 7.49 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.191 -0.913 . . . . 0.26 111.531 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.543 HD21 ' HG3' ' A' ' 273' ' ' GLU . 1.4 tm? -53.98 -49.67 68.28 Favored 'General case' 0 CA--C 1.529 0.139 0 O-C-N 123.203 0.315 . . . . 0.4 110.93 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -60.06 -53.55 56.42 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 116.488 -0.324 . . . . 0.39 111.836 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . 0.481 HD11 ' HA2' ' A' ' 187' ' ' GLY . 89.7 mt -61.82 -48.75 87.17 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 N-CA-C 112.567 0.58 . . . . 0.33 112.567 -178.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.581 HD12 HG23 ' A' ' 276' ' ' THR . 80.8 mt -63.93 -52.33 58.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 N-CA-C 112.154 0.427 . . . . 0.34 112.154 -179.038 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.87 -39.78 72.01 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 120.916 0.388 . . . . 0.32 110.534 179.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . 0.53 ' HD2' ' OE2' ' A' ' 169' ' ' GLU . 0.6 OUTLIER -65.77 -52.07 53.92 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.408 -0.36 . . . . 0.45 110.537 178.457 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' TYR . . . . . 0.828 ' HE1' ' HA ' ' A' ' 195' ' ' ARG . 81.4 t80 -55.56 -47.24 76.7 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 112.447 0.536 . . . . 0.35 112.447 -179.48 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.55 ' HG ' ' O ' ' A' ' 163' ' ' ILE . 28.0 mt -64.03 -39.1 93.34 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 120.88 -0.328 . . . . 0.36 110.641 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -66.45 -38.45 87.4 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.958 0.408 . . . . 0.38 110.301 178.297 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . 0.53 ' OE2' ' HD2' ' A' ' 165' ' ' ARG . 0.4 OUTLIER -70.26 -38.35 75.1 Favored 'General case' 0 CA--C 1.528 0.111 0 CA-C-N 116.08 -0.509 . . . . 0.62 110.767 178.58 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . 0.704 ' HG2' ' HB1' ' A' ' 253' ' ' ALA . 6.1 tp60 -68.53 -42.13 78.9 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 116.37 -0.377 . . . . 0.37 110.249 178.455 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.805 ' HA ' ' HG2' ' A' ' 257' ' ' LYS . . . . . . . . 0 N--CA 1.467 0.402 0 CA-C-N 115.807 -0.633 . . . . 0.46 111.977 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.565 ' O ' ' HA3' ' A' ' 187' ' ' GLY . . . . . . . . 0 CA--C 1.535 0.398 0 CA-C-O 120.86 0.362 . . . . 0.34 110.406 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -79.93 -71.5 1.26 Allowed Glycine 0 CA--C 1.528 0.886 0 C-N-CA 120.833 -0.699 . . . . 0.42 114.755 -179.051 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -70.79 -55.83 7.71 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 117.203 0.501 . . . . 0.49 111.646 -178.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -65.59 -35.24 80.25 Favored 'General case' 0 C--O 1.222 -0.342 0 CA-C-N 115.979 -0.555 . . . . 0.47 110.111 178.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . 0.565 ' HA3' ' O ' ' A' ' 183' ' ' ALA . . . -66.93 -49.9 51.02 Favored Glycine 0 C--O 1.225 -0.454 0 CA-C-N 115.762 -0.653 . . . . 0.36 112.845 179.237 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 4.2 tpt180 -55.26 -46.9 76.09 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 117.174 0.487 . . . . 0.85 110.113 178.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' ARG . . . . . 0.658 ' HB3' HG11 ' A' ' 297' ' ' VAL . 50.7 mtm180 -66.9 -40.24 87.68 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.92 -0.582 . . . . 0.32 110.616 179.275 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . 0.406 ' O ' ' HB2' ' A' ' 194' ' ' LEU . . . -65.27 -40.43 93.89 Favored 'General case' 0 C--O 1.223 -0.338 0 CA-C-N 116.334 -0.394 . . . . 0.29 111.511 179.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 13.6 tp -64.58 -41.0 96.55 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 110.247 -0.279 . . . . 0.7 110.247 178.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 15.8 tm-20 -65.68 -50.63 64.22 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 109.732 -0.47 . . . . 0.32 109.732 178.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . 0.436 HG21 ' HA ' ' A' ' 297' ' ' VAL . 8.5 m -60.05 -43.22 95.54 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.905 -0.589 . . . . 0.38 110.974 179.46 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . 0.449 HD12 ' HA ' ' A' ' 194' ' ' LEU . 7.4 tp -65.59 -41.92 92.27 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 116.233 -0.44 . . . . 0.42 111.829 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . 0.828 ' HA ' ' HE1' ' A' ' 166' ' ' TYR . 8.8 tpt180 -67.35 -38.71 85.24 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.093 0.473 . . . . 0.42 110.538 179.322 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 15.2 ttm180 -67.01 -56.71 8.95 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 115.78 -0.645 . . . . 0.52 111.999 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 34.7 t -71.56 -38.59 68.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 111.95 0.352 . . . . 0.33 111.95 -178.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . 0.64 ' O ' ' HB2' ' A' ' 202' ' ' GLN . . . -62.02 -54.04 38.12 Favored Glycine 0 C--N 1.331 0.275 0 C-N-CA 121.052 -0.595 . . . . 0.29 112.793 -179.576 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . 0.401 ' HB2' ' O ' ' A' ' 195' ' ' ARG . 0.4 OUTLIER -64.81 -38.8 92.2 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 117.045 0.422 . . . . 0.37 110.675 179.211 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -59.86 -48.63 85.13 Favored Glycine 0 CA--C 1.524 0.626 0 C-N-CA 120.744 -0.741 . . . . 0.33 112.137 178.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 73.7 t -70.46 -42.29 78.34 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-O 120.862 0.363 . . . . 0.37 110.816 178.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' GLN . . . . . 0.64 ' HB2' ' O ' ' A' ' 198' ' ' GLY . 2.1 tt0 -58.87 -53.34 59.49 Favored 'General case' 0 C--O 1.224 -0.278 0 CA-C-N 115.652 -0.704 . . . . 0.42 111.807 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' ARG . . . . . 0.511 ' HA ' ' OE1' ' A' ' 206' ' ' GLU . 0.0 OUTLIER -64.4 -35.2 80.12 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-O 120.718 0.294 . . . . 0.4 110.393 179.779 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -65.94 -49.82 66.58 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 121.027 0.441 . . . . 0.86 110.765 178.137 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 72.1 m-70 -100.75 36.09 2.02 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.425 -0.352 . . . . 0.46 111.47 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . 0.511 ' OE1' ' HA ' ' A' ' 203' ' ' ARG . 3.7 tp10 -55.53 -49.0 73.79 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.222 -0.444 . . . . 0.4 111.212 -179.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 69.4 p -62.98 -42.8 99.94 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.983 -0.553 . . . . 0.5 111.52 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -61.8 -46.11 90.95 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.018 0.437 . . . . 0.41 110.306 178.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 209' ' ' PHE . . . . . 0.605 ' HE2' ' HA ' ' A' ' 202' ' ' GLN . 16.8 m-30 -65.43 -44.11 88.35 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.98 -0.555 . . . . 0.45 110.06 179.331 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -61.23 -44.08 97.84 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.091 -0.504 . . . . 0.8 110.594 178.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -60.07 -48.58 85.43 Favored Glycine 0 C--N 1.334 0.444 0 N-CA-C 111.205 -0.758 . . . . 0.34 111.205 178.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 212' ' ' MET . . . . . 0.533 ' O ' ' HG ' ' A' ' 216' ' ' LEU . 1.2 mtp -64.31 -35.03 79.53 Favored 'General case' 0 C--O 1.224 -0.253 0 CA-C-O 120.655 0.264 . . . . 0.72 110.312 178.407 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.445 HD22 ' HA ' ' A' ' 213' ' ' LEU . 0.4 OUTLIER -60.61 -47.99 83.75 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.239 -0.437 . . . . 0.51 110.004 178.473 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 73.0 mtp180 -61.97 -31.71 72.09 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.122 -0.49 . . . . 1.14 111.016 179.125 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -84.95 -9.09 58.43 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.12 -0.491 . . . . 1.23 111.682 179.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . 0.533 ' HG ' ' O ' ' A' ' 212' ' ' MET . 20.3 mt -82.41 142.89 31.59 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.155 0.502 . . . . 0.52 112.295 -179.531 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -102.07 5.74 40.66 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.846 -0.616 . . . . 0.66 110.212 178.403 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 218' ' ' ILE . . . . . 0.62 HG22 ' HE2' ' A' ' 267' ' ' PHE . 21.0 mm -55.33 106.93 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 CA-C-N 115.9 -0.591 . . . . 0.49 112.319 -178.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 6.1 mtmp? -143.48 -42.19 0.29 Allowed 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 112.373 0.509 . . . . 0.67 112.373 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 18.2 m-80 -124.1 -178.91 4.22 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 113.085 0.772 . . . . 1.24 113.085 -178.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . 0.576 ' O ' HG22 ' A' ' 224' ' ' VAL . 12.2 tm-20 -51.92 -37.61 53.24 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 112.867 0.691 . . . . 0.76 112.867 -179.184 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -63.83 -26.47 70.06 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 120.816 -0.707 . . . . 0.35 113.622 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 223' ' ' ASP . . . . . 0.556 ' HB3' ' HA ' ' A' ' 218' ' ' ILE . 59.0 m-20 -72.34 -31.12 65.35 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 113.322 0.86 . . . . 0.44 113.322 -178.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.576 HG22 ' O ' ' A' ' 221' ' ' GLU . 4.8 m -55.87 -29.1 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 CA-C-O 120.833 0.349 . . . . 0.45 111.469 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 10.7 mttp -66.0 -38.71 89.16 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.152 0.501 . . . . 0.84 109.908 178.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 226' ' ' SER . . . . . 0.492 ' O ' HG23 ' A' ' 230' ' ' VAL . 1.8 t -68.74 -30.67 69.34 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 109.113 -0.699 . . . . 0.46 109.113 178.183 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 227' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -66.5 -36.67 83.3 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 109.004 -0.739 . . . . 0.6 109.004 178.075 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 7.1 t -62.03 -39.72 93.29 Favored 'General case' 0 N--CA 1.462 0.147 0 N-CA-C 108.992 -0.744 . . . . 0.37 108.992 176.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 229' ' ' ARG . . . . . 0.476 ' HA ' HG22 ' A' ' 232' ' ' VAL . 0.0 OUTLIER -61.07 -36.88 80.8 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-N 115.617 -0.719 . . . . 0.39 109.934 177.873 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . 0.564 HG22 ' CE1' ' B' ' 23' ' ' PHE . 29.4 t -65.99 -48.14 82.76 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-O 121.316 0.579 . . . . 0.34 109.439 177.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 231' ' ' MET . . . . . 0.525 ' SD ' HD13 ' A' ' 248' ' ' LEU . 8.1 tpp -60.34 -49.47 77.45 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 115.198 -0.91 . . . . 0.46 111.508 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 232' ' ' VAL . . . . . 0.476 HG22 ' HA ' ' A' ' 229' ' ' ARG . 33.3 m -64.66 -32.05 56.29 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 120.745 -0.382 . . . . 0.44 111.866 -179.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 7.3 t-80 -72.38 -47.02 52.7 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 120.899 -0.32 . . . . 0.38 110.843 178.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 70.2 t -62.32 -31.28 51.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-O 120.911 0.386 . . . . 0.44 111.571 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -97.3 4.34 50.89 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 122.224 -0.298 . . . . 0.49 111.749 179.092 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . 0.463 ' HB2' ' O ' ' A' ' 232' ' ' VAL . 0.3 OUTLIER -73.87 -17.83 61.0 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 112.286 0.476 . . . . 1.58 112.286 -178.989 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -70.12 -11.33 60.81 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.924 0.392 . . . . 0.43 111.244 179.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 91.1 -19.31 47.15 Favored Glycine 0 CA--C 1.519 0.33 0 C-N-CA 121.087 -0.578 . . . . 0.37 112.554 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -95.69 92.71 3.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.117 0.484 . . . . 0.47 112.109 -179.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 240' ' ' THR . . . . . 0.521 HG22 HD11 ' A' ' 245' ' ' ILE . 2.4 m -79.03 62.61 3.49 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.487 0.66 . . . . 0.36 110.347 178.505 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 73.2 m-20 -65.42 137.77 57.68 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.441 -0.8 . . . . 0.34 111.705 -179.059 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 242' ' ' TRP . . . . . . . . . . . . . 78.7 m95 -54.73 -38.6 67.31 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.154 -0.475 . . . . 0.41 111.188 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . 0.481 ' H ' ' HB2' ' B' ' 35' ' ' TYR . . . -58.61 -32.44 69.2 Favored Glycine 0 CA--C 1.521 0.419 0 C-N-CA 120.902 -0.666 . . . . 0.29 111.919 178.143 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 78.8 mtt180 -75.44 -41.95 54.58 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-O 120.943 0.401 . . . . 0.3 109.933 178.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . 0.563 ' O ' HG12 ' A' ' 249' ' ' ILE . 78.3 mt -62.14 -49.32 84.52 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-N 115.819 -0.628 . . . . 0.48 110.561 179.142 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . 0.424 HG21 ' CE2' ' A' ' 300' ' ' PHE . 48.0 t -67.48 -38.46 80.7 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 CA-C-N 116.347 -0.388 . . . . 0.36 111.047 179.317 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 19.4 m -62.2 -40.1 94.96 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 120.909 -0.316 . . . . 0.39 110.247 178.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 248' ' ' LEU . . . . . 0.525 HD13 ' SD ' ' A' ' 231' ' ' MET . 44.7 mt -65.24 -35.27 80.54 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 109.776 -0.453 . . . . 0.61 109.776 177.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 249' ' ' ILE . . . . . 0.563 HG12 ' O ' ' A' ' 245' ' ' ILE . 36.7 mm -69.41 -40.35 79.85 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 N-CA-C 109.084 -0.71 . . . . 0.43 109.084 177.442 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 14.7 m -61.67 -48.38 81.07 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.242 -0.89 . . . . 0.32 109.923 178.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 251' ' ' PHE . . . . . 0.542 ' O ' HG23 ' A' ' 255' ' ' VAL . 12.8 t80 -63.45 -45.06 92.61 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 115.648 -0.705 . . . . 0.59 109.832 178.305 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -57.79 -45.16 93.81 Favored Glycine 0 C--N 1.337 0.594 0 N-CA-C 111.181 -0.768 . . . . 0.26 111.181 178.199 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 253' ' ' ALA . . . . . 0.704 ' HB1' ' HG2' ' A' ' 170' ' ' GLN . . . -59.95 -38.56 82.82 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 122.328 0.251 . . . . 0.26 110.683 177.582 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 61.2 t80 -61.28 -40.42 94.05 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 121.147 0.499 . . . . 0.49 109.776 178.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 255' ' ' VAL . . . . . 0.542 HG23 ' O ' ' A' ' 251' ' ' PHE . 20.2 t -67.47 -40.24 84.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 CA-C-N 115.735 -0.666 . . . . 0.29 109.81 178.048 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -58.43 -41.36 84.88 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.115 0.484 . . . . 0.28 110.1 178.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 257' ' ' LYS . . . . . 0.805 ' HG2' ' HA ' ' A' ' 171' ' ' ALA . 14.4 mtpp -62.86 -45.22 93.6 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 115.76 -0.655 . . . . 0.57 110.104 177.508 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 82.6 t60 -60.6 -39.77 89.37 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 109.672 -0.492 . . . . 0.51 109.672 178.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.482 HD21 ' CD2' ' A' ' 267' ' ' PHE . 4.4 mp -64.26 -50.68 67.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.856 -0.611 . . . . 0.52 110.037 178.528 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 260' ' ' LYS . . . . . 0.713 ' HG3' ' HB1' ' A' ' 171' ' ' ALA . 0.0 OUTLIER -61.57 -29.6 70.12 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.682 -0.236 . . . . 0.6 111.597 179.204 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 56.4 m -57.55 -33.05 67.71 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.041 0.448 . . . . 0.54 111.002 179.097 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 262' ' ' VAL . . . . . 0.531 HG23 ' HG3' ' A' ' 264' ' ' GLN . 26.4 m -112.12 13.63 8.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 CA-C-N 115.787 -0.642 . . . . 0.52 110.079 178.358 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 34.8 t30 58.8 47.24 12.95 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 115.079 -0.964 . . . . 0.55 113.012 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 264' ' ' GLN . . . . . 0.531 ' HG3' HG23 ' A' ' 262' ' ' VAL . 19.9 mt-30 -87.83 39.0 0.86 Allowed 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 116.523 -0.308 . . . . 0.97 111.666 179.007 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 265' ' ' GLU . . . . . 0.419 ' HA ' HD12 ' A' ' 268' ' ' ILE . 7.3 tp10 -49.34 -39.53 32.02 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 121.048 0.451 . . . . 0.45 112.051 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 3.2 p -59.34 -20.33 53.75 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.815 -0.63 . . . . 0.97 111.948 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 267' ' ' PHE . . . . . 0.62 ' HE2' HG22 ' A' ' 218' ' ' ILE . 15.7 t80 -103.57 -21.66 13.72 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 120.8 0.333 . . . . 0.53 111.011 179.38 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 268' ' ' ILE . . . . . 0.419 HD12 ' HA ' ' A' ' 265' ' ' GLU . 63.7 mt -65.39 -43.26 94.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.547 -0.297 . . . . 0.39 110.808 179.663 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 269' ' ' GLU . . . . . 0.642 ' HB3' ' HD3' ' A' ' 270' ' ' PRO . 1.8 tp10 -55.23 -58.13 16.62 Favored Pre-proline 0 CA--C 1.544 0.728 0 CA-C-N 116.332 -0.394 . . . . 0.43 111.01 179.061 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 270' ' ' PRO . . . . . 0.642 ' HD3' ' HB3' ' A' ' 269' ' ' GLU . 26.6 Cg_exo -63.64 -36.55 52.19 Favored 'Trans proline' 0 C--N 1.358 1.036 0 C-N-CA 121.725 1.617 . . . . 0.29 112.655 179.179 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 271' ' ' LEU . . . . . . . . . . . . . 52.6 tp -65.72 -54.81 22.2 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 121.147 -0.221 . . . . 0.5 111.49 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -58.16 -44.58 88.0 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-O 120.861 0.362 . . . . 0.29 111.445 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 273' ' ' GLU . . . . . 0.543 ' HG3' HD21 ' A' ' 160' ' ' LEU . 0.5 OUTLIER -66.51 -39.84 88.9 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 116.246 -0.434 . . . . 0.36 111.4 179.755 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 274' ' ' THR . . . . . 0.483 HG21 ' HB ' ' A' ' 224' ' ' VAL . 62.5 m -64.16 -45.34 88.88 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 120.718 0.294 . . . . 0.39 110.395 179.019 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 96.3 mt -54.12 -52.99 32.11 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 CA-C-N 116.093 -0.503 . . . . 0.42 110.622 179.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 276' ' ' THR . . . . . 0.581 HG23 HD12 ' A' ' 163' ' ' ILE . 56.8 m -56.38 -52.47 64.49 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.543 -0.298 . . . . 0.28 111.781 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 277' ' ' ASP . . . . . 0.59 ' OD1' ' HD2' ' A' ' 281' ' ' ARG . 0.4 OUTLIER -53.8 -51.66 62.77 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 112.127 0.418 . . . . 0.43 112.127 -179.364 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 27.3 t -70.05 -46.56 72.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 111.887 0.329 . . . . 0.38 111.887 -179.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 279' ' ' LEU . . . . . 0.46 HD21 HG23 ' A' ' 245' ' ' ILE . 0.4 OUTLIER -62.67 -41.24 98.98 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 113.14 0.792 . . . . 0.54 113.14 -178.757 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 280' ' ' VAL . . . . . 0.424 HG21 ' HB3' ' A' ' 159' ' ' SER . 81.4 t -87.21 -46.22 16.2 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 N-CA-C 113.768 1.025 . . . . 0.48 113.768 -178.266 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 281' ' ' ARG . . . . . 0.59 ' HD2' ' OD1' ' A' ' 277' ' ' ASP . 38.1 mtt85 -70.96 -34.9 71.89 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 114.425 1.269 . . . . 0.53 114.425 -177.122 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 282' ' ' THR . . . . . . . . . . . . . 42.0 p -61.5 -30.71 70.8 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 119.073 0.851 . . . . 0.35 111.513 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 29.9 mmtp -125.06 41.21 3.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.321 -0.399 . . . . 0.36 111.001 179.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 284' ' ' ARG . . . . . 0.524 ' HG2' ' N ' ' A' ' 285' ' ' ASP . 0.0 OUTLIER -53.34 -35.6 60.39 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 112.866 0.691 . . . . 0.44 112.866 -179.319 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 285' ' ' ASP . . . . . 0.524 ' N ' ' HG2' ' A' ' 284' ' ' ARG . 8.1 p-10 -63.04 -44.41 95.94 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-O 120.634 0.254 . . . . 0.46 111.254 -179.363 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 286' ' ' TRP . . . . . 0.777 ' HA ' ' HD2' ' A' ' 289' ' ' LYS . 0.0 OUTLIER -61.5 -34.68 75.91 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.163 0.506 . . . . 0.4 110.477 179.404 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 287' ' ' LEU . . . . . 0.588 HD13 ' HA2' ' A' ' 292' ' ' GLY . 1.7 mm? -70.13 -47.01 63.55 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.566 -0.743 . . . . 0.54 110.482 179.194 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 288' ' ' VAL . . . . . 0.509 HG23 ' O ' ' A' ' 284' ' ' ARG . 64.3 t -60.67 -33.07 53.42 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 CA-C-O 120.898 0.38 . . . . 0.92 110.858 178.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 289' ' ' LYS . . . . . 0.777 ' HD2' ' HA ' ' A' ' 286' ' ' TRP . 74.3 mttt -60.45 -42.17 95.61 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.01 -0.541 . . . . 0.47 112.213 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 290' ' ' GLN . . . . . 0.534 ' HB3' ' HA3' ' A' ' 295' ' ' GLY . 5.1 mt-30 -111.86 28.29 8.89 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 112.869 0.692 . . . . 0.45 112.869 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 291' ' ' ARG . . . . . 0.489 ' HB3' ' HB2' ' A' ' 294' ' ' ASP . 3.8 mmm180 59.09 13.91 3.18 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 112.768 0.655 . . . . 0.55 112.768 179.545 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 292' ' ' GLY . . . . . 0.588 ' HA2' HD13 ' A' ' 287' ' ' LEU . . . 75.06 -108.2 2.47 Favored Glycine 0 N--CA 1.448 -0.502 0 N-CA-C 114.361 0.504 . . . . 0.35 114.361 179.448 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 293' ' ' TRP . . . . . 0.572 ' CZ2' ' HA ' ' A' ' 159' ' ' SER . 80.5 m95 -68.42 -29.27 67.9 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.62 0.6 . . . . 0.51 112.62 -177.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 294' ' ' ASP . . . . . 0.489 ' HB2' ' HB3' ' A' ' 291' ' ' ARG . 22.0 m-20 -62.11 -44.99 95.44 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 120.57 -0.452 . . . . 0.38 109.949 178.489 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 295' ' ' GLY . . . . . 0.534 ' HA3' ' HB3' ' A' ' 290' ' ' GLN . . . -69.07 -33.85 75.04 Favored Glycine 0 C--O 1.224 -0.524 0 C-N-CA 120.809 -0.71 . . . . 0.35 111.695 178.076 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 296' ' ' PHE . . . . . 0.405 ' CD2' ' HE3' ' A' ' 293' ' ' TRP . 0.5 OUTLIER -70.51 -45.11 66.22 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 120.655 0.264 . . . . 0.35 111.232 179.111 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 297' ' ' VAL . . . . . 0.658 HG11 ' HB3' ' A' ' 189' ' ' ARG . 69.3 t -63.81 -50.65 76.77 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.117 0 CA-C-O 120.689 0.281 . . . . 0.29 110.75 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.34 -22.87 64.66 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 116.188 -0.46 . . . . 0.43 111.745 -179.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 299' ' ' PHE . . . . . 0.412 ' HB2' ' O ' ' A' ' 295' ' ' GLY . 88.2 t80 -71.54 -36.04 70.87 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-O 120.764 0.316 . . . . 0.46 110.854 178.319 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 300' ' ' PHE . . . . . 0.424 ' CE2' HG21 ' A' ' 246' ' ' VAL . 79.3 m-85 . . . . . 0 C--N 1.328 -0.349 0 CA-C-O 120.79 0.329 . . . . 0.53 111.832 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 . . . . . 0 C--O 1.234 0.284 0 CA-C-O 121.039 0.447 . . . . 0.89 110.172 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 23' ' ' PHE . . . . . 0.564 ' CE1' HG22 ' A' ' 230' ' ' VAL . 0.7 OUTLIER -57.34 -37.79 73.11 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 115.706 -0.679 . . . . 0.38 111.394 179.377 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 24' ' ' ALA . . . . . 0.518 ' N ' ' HD1' ' B' ' 23' ' ' PHE . . . -65.57 -40.25 92.56 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.121 -0.491 . . . . 0.4 111.655 -179.151 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . 0.513 ' O ' ' HG3' ' B' ' 29' ' ' LYS . . . -66.15 -46.85 76.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.996 0.427 . . . . 0.4 110.218 179.175 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -62.32 -51.57 67.11 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 115.827 -0.624 . . . . 0.61 110.68 179.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 51.3 mt -57.65 -41.72 82.03 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.755 0.312 . . . . 0.59 110.339 178.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 28' ' ' ARG . . . . . . . . . . . . . 1.2 ttm180 -58.86 -50.81 72.58 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.164 -0.471 . . . . 0.75 110.434 178.133 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . 0.513 ' HG3' ' O ' ' B' ' 25' ' ' ALA . 85.3 mttt -57.82 -51.39 69.78 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.039 -0.528 . . . . 0.65 110.798 178.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 78.9 mt -58.87 -45.45 91.69 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 CA-C-N 115.878 -0.601 . . . . 0.42 110.983 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -58.67 -50.52 66.37 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.897 -0.668 . . . . 0.28 113.009 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 -68.17 -37.21 80.73 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.966 0.383 . . . . 0.37 111.527 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 21.8 ttmm -62.42 -50.5 71.27 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 120.912 0.387 . . . . 0.81 110.328 178.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 49.1 t -63.19 -47.43 92.35 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 116.097 -0.501 . . . . 0.41 110.593 178.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 35' ' ' TYR . . . . . 0.481 ' HB2' ' H ' ' A' ' 243' ' ' GLY . 1.6 t80 -58.04 -50.82 72.1 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 115.777 -0.647 . . . . 0.98 111.508 179.44 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 36' ' ' CYS . . . . . . . . . . . . . 13.0 t -63.14 -28.43 70.06 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 120.804 0.335 . . . . 0.48 111.839 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 89.1 m -77.64 -45.91 23.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.425 -0.352 . . . . 0.44 111.87 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 38' ' ' TRP . . . . . . . . . . . . . 97.1 m95 -80.12 -19.7 46.71 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 112.95 0.722 . . . . 0.54 112.95 -178.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 40.0 t . . . . . 0 N--CA 1.472 0.647 0 N-CA-C 112.268 0.47 . . . . 0.43 112.268 179.545 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 12.0 t0 . . . . . 0 CA--C 1.535 0.366 0 N-CA-C 112.478 0.548 . . . . 0.37 112.478 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -55.15 -56.48 19.43 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 120.95 0.405 . . . . 0.78 111.369 -179.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.22 -37.08 77.84 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.028 0.442 . . . . 0.73 110.534 179.567 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 13.6 t80 -61.62 -40.71 95.83 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 115.906 -0.588 . . . . 0.41 111.697 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 0.401 HH11 ' HD3' ' A' ' 157' ' ' ARG . 55.0 mtt-85 -65.32 -48.3 73.53 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 111.834 0.309 . . . . 0.49 111.834 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 2.7 mm-40 -62.07 -42.48 99.24 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.203 0.525 . . . . 0.39 110.303 179.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . 0.469 ' HA ' ' CZ2' ' A' ' 293' ' ' TRP . 12.3 m -66.19 -54.69 22.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.756 -0.657 . . . . 0.25 111.218 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.614 ' HA ' HG21 ' A' ' 276' ' ' THR . 2.0 tm? -54.11 -46.38 72.13 Favored 'General case' 0 N--CA 1.464 0.248 0 O-C-N 123.183 0.302 . . . . 0.73 111.08 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -63.57 -54.38 37.03 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 112.067 0.395 . . . . 0.4 112.067 -179.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . 0.478 HD11 ' HA2' ' A' ' 187' ' ' GLY . 88.1 mt -59.33 -46.68 92.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 N-CA-C 111.589 0.218 . . . . 0.33 111.589 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.57 HD12 HG23 ' A' ' 276' ' ' THR . 84.2 mt -62.84 -51.23 74.62 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 C-N-CA 121.085 -0.246 . . . . 0.32 111.462 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 55.2 p -58.78 -42.29 88.65 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.586 0.231 . . . . 0.29 111.302 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . 0.432 ' O ' ' HB2' ' A' ' 169' ' ' GLU . 2.0 tpt85 -58.02 -51.64 68.81 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.855 0.359 . . . . 0.35 110.806 179.374 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' TYR . . . . . 0.475 ' O ' ' HB2' ' A' ' 170' ' ' GLN . 66.7 t80 -64.04 -49.37 72.62 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.937 -0.574 . . . . 0.37 112.065 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.517 ' HG ' ' O ' ' A' ' 163' ' ' ILE . 21.4 mt -56.17 -45.96 79.53 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 112.024 0.379 . . . . 0.32 112.024 -178.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . 0.41 HH11 ' HD2' ' A' ' 168' ' ' ARG . 11.8 ttm105 -70.18 -44.59 68.43 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.57 0.224 . . . . 0.34 111.133 179.431 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . 0.432 ' HB2' ' O ' ' A' ' 165' ' ' ARG . 1.9 tt0 -61.52 -36.08 79.53 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-O 121.32 0.581 . . . . 0.46 110.564 179.347 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . 0.475 ' HB2' ' O ' ' A' ' 166' ' ' TYR . 1.8 tm0? -71.98 -47.8 49.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.76 -0.654 . . . . 0.4 110.246 178.434 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.292 0 CA-C-N 116.094 -0.503 . . . . 0.36 112.103 179.743 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.531 ' O ' ' HA3' ' A' ' 187' ' ' GLY . . . . . . . . 0 CA--C 1.537 0.452 0 CA-C-O 120.784 0.326 . . . . 0.31 110.349 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -77.33 -71.47 1.2 Allowed Glycine 0 CA--C 1.525 0.688 0 C-N-CA 120.445 -0.884 . . . . 0.37 114.543 -178.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -63.43 -56.19 18.16 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 112.076 0.399 . . . . 0.43 112.076 -178.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -66.56 -44.44 82.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.373 -0.376 . . . . 0.36 110.702 179.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . 0.531 ' HA3' ' O ' ' A' ' 183' ' ' ALA . . . -57.48 -53.49 44.61 Favored Glycine 0 CA--C 1.522 0.507 0 C-N-CA 121.238 -0.506 . . . . 0.33 113.823 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . 0.444 HH11 ' HD2' ' A' ' 188' ' ' ARG . 1.6 mmp_? -61.17 -44.48 97.23 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 117.617 0.708 . . . . 0.5 112.245 -179.661 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' ARG . . . . . 0.581 ' HB3' HG11 ' A' ' 297' ' ' VAL . 49.9 mtm180 -66.93 -39.12 87.25 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 120.802 0.334 . . . . 0.43 110.745 179.429 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . 0.44 ' HA ' HG22 ' A' ' 297' ' ' VAL . . . -70.58 -34.79 72.57 Favored 'General case' 0 C--O 1.222 -0.349 0 CA-C-N 116.362 -0.381 . . . . 0.27 110.677 178.645 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.53 -45.4 94.34 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.823 -0.171 . . . . 0.61 111.142 179.202 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -66.79 -45.46 78.36 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 121.028 0.442 . . . . 0.35 111.125 179.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 1.3 p -65.21 -48.51 73.14 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.288 -0.415 . . . . 0.36 111.7 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . 0.483 HD21 HG21 ' A' ' 249' ' ' ILE . 19.1 tp -60.65 -35.49 76.35 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 116.406 -0.361 . . . . 0.36 111.112 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . 0.422 ' HA ' ' HE1' ' A' ' 166' ' ' TYR . 5.0 mmt180 -65.05 -44.49 88.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.917 0.389 . . . . 0.34 110.775 178.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.88 -52.43 24.86 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.149 0.426 . . . . 0.34 112.149 -179.43 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . 0.482 ' O ' HG23 ' A' ' 201' ' ' VAL . 48.1 t -69.61 -43.39 80.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 N-CA-C 112.572 0.582 . . . . 0.32 112.572 -178.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -67.14 -51.68 37.14 Favored Glycine 0 CA--C 1.521 0.409 0 C-N-CA 121.018 -0.611 . . . . 0.23 113.467 -178.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -63.87 -35.79 81.79 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 120.804 0.335 . . . . 0.29 110.378 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -59.94 -48.15 87.48 Favored Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 111.119 -0.792 . . . . 0.29 111.119 177.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 197' ' ' VAL . 76.3 t -64.04 -40.93 90.83 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 122.217 0.207 . . . . 0.32 111.331 179.014 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' GLN . . . . . 0.499 ' HA ' ' HE2' ' A' ' 209' ' ' PHE . 31.7 tt0 -60.07 -48.07 83.24 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 116.587 -0.279 . . . . 0.42 111.5 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.33 -39.02 71.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.615 0.245 . . . . 1.44 111.255 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 18.2 m-80 -67.08 -52.22 44.64 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 111.969 0.359 . . . . 1.23 111.969 179.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 74.0 m-70 -101.47 34.91 2.43 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 112.427 0.529 . . . . 0.42 112.427 -178.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -62.9 -40.12 96.61 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 120.999 -0.28 . . . . 0.44 111.266 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 38.4 p -60.66 -43.11 98.01 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.061 0.458 . . . . 0.55 110.683 179.414 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 208' ' ' ALA . . . . . 0.441 ' O ' ' HG3' ' A' ' 212' ' ' MET . . . -65.99 -41.87 90.55 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.83 -0.623 . . . . 0.37 109.93 178.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 209' ' ' PHE . . . . . 0.499 ' HE2' ' HA ' ' A' ' 202' ' ' GLN . 14.4 m-30 -63.0 -42.58 99.88 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.893 -0.594 . . . . 0.45 110.112 178.66 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 210' ' ' GLN . . . . . 0.698 ' O ' ' HG2' ' A' ' 214' ' ' ARG . 31.3 mt-30 -57.79 -46.72 84.21 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.288 -0.414 . . . . 0.64 110.542 178.494 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -55.68 -46.75 81.36 Favored Glycine 0 C--N 1.339 0.711 0 C-N-CA 121.051 -0.595 . . . . 0.33 111.951 178.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 212' ' ' MET . . . . . 0.473 ' HB3' ' HB3' ' B' ' 23' ' ' PHE . 35.1 mtt -62.91 -42.68 99.87 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 109.515 -0.55 . . . . 0.7 109.515 177.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 12.7 tp -58.92 -44.53 91.31 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.744 -0.662 . . . . 0.6 111.11 179.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 214' ' ' ARG . . . . . 0.698 ' HG2' ' O ' ' A' ' 210' ' ' GLN . 22.1 mmt180 -60.65 -35.16 75.54 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 120.887 0.375 . . . . 1.08 110.945 179.439 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -94.7 12.31 28.22 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.968 0.359 . . . . 1.13 111.968 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . 0.506 ' HB3' HG12 ' A' ' 218' ' ' ILE . 12.1 mt -99.39 154.27 18.33 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.127 0.489 . . . . 0.7 111.511 179.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -105.05 17.2 24.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.9 -0.591 . . . . 1.09 111.052 179.62 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 218' ' ' ILE . . . . . 0.543 ' HA ' ' HB2' ' A' ' 223' ' ' ASP . 17.3 mm -59.33 105.93 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-N 116.417 -0.356 . . . . 0.42 111.441 -179.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . 0.444 ' HG3' ' O ' ' A' ' 218' ' ' ILE . 7.5 mtmp? -159.56 -65.64 0.08 Allowed 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.862 -0.608 . . . . 0.62 110.7 -179.301 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -104.3 -175.65 2.86 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 115.098 -0.955 . . . . 0.69 110.722 -179.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . 0.425 ' O ' HG22 ' A' ' 224' ' ' VAL . 0.5 OUTLIER -46.83 -22.37 0.3 Allowed 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 113.538 0.94 . . . . 0.8 113.538 -179.221 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . 0.577 ' HA2' ' HD2' ' A' ' 225' ' ' LYS . . . -65.92 -23.99 71.31 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 121.223 -0.513 . . . . 0.38 113.076 178.606 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 223' ' ' ASP . . . . . 0.543 ' HB2' ' HA ' ' A' ' 218' ' ' ILE . 2.9 p-10 -56.56 -45.49 81.26 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 113.478 0.918 . . . . 0.76 113.478 -178.354 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.425 HG22 ' O ' ' A' ' 221' ' ' GLU . 28.9 m -59.96 -29.55 43.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-N 118.107 0.412 . . . . 0.5 111.475 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . 0.577 ' HD2' ' HA2' ' A' ' 222' ' ' GLY . 26.4 mttp -76.08 -42.76 46.34 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.549 -0.537 . . . . 0.91 109.549 178.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 94.3 p -64.5 -40.51 95.78 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.741 -0.663 . . . . 0.61 110.327 178.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 227' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -65.39 -42.63 92.44 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 109.919 -0.4 . . . . 0.51 109.919 178.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 228' ' ' SER . . . . . 0.539 ' HA ' ' HG2' ' A' ' 231' ' ' MET . 7.5 t -60.44 -43.79 96.47 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.086 -0.506 . . . . 0.64 110.423 178.595 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 229' ' ' ARG . . . . . 0.423 HH11 ' HD2' ' A' ' 229' ' ' ARG . 9.0 mmm180 -55.69 -44.36 77.3 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.243 0.544 . . . . 0.78 110.545 178.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . 0.499 ' O ' HG23 ' A' ' 234' ' ' VAL . 60.1 t -69.19 -54.32 20.69 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-N 115.877 -0.601 . . . . 0.33 111.475 179.307 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 231' ' ' MET . . . . . 0.539 ' HG2' ' HA ' ' A' ' 228' ' ' SER . 10.6 ptm -59.58 -37.13 77.69 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 112.491 0.552 . . . . 0.33 112.491 -178.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 33.0 t -66.4 -41.07 88.16 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 N-CA-C 109.522 -0.547 . . . . 0.38 109.522 178.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 233' ' ' HIS . . . . . 0.509 ' HA ' ' HB2' ' A' ' 236' ' ' LYS . 2.3 t-80 -68.16 -40.18 82.4 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 116.203 -0.453 . . . . 0.41 110.44 178.473 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.499 HG23 ' O ' ' A' ' 230' ' ' VAL . 69.3 t -56.99 -37.95 57.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 CA-C-O 121.057 0.456 . . . . 0.34 111.12 179.546 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 235' ' ' PHE . . . . . 0.511 ' HE2' HD22 ' A' ' 248' ' ' LEU . 93.3 m-85 -104.11 19.39 20.19 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.394 -0.366 . . . . 0.53 111.386 179.289 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . 0.509 ' HB2' ' HA ' ' A' ' 233' ' ' HIS . 1.3 tmtm? -79.81 -9.72 59.7 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 111.744 0.276 . . . . 1.27 111.744 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -70.16 -17.98 63.19 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 120.847 0.356 . . . . 0.53 111.033 179.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 96.83 -17.94 58.4 Favored Glycine 0 CA--C 1.524 0.621 0 C-N-CA 120.938 -0.649 . . . . 0.58 113.23 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 6.5 p -98.77 130.23 47.93 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-O 121.23 0.538 . . . . 0.58 111.8 -179.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 240' ' ' THR . . . . . 0.538 HG23 ' HG2' ' A' ' 283' ' ' LYS . 1.4 m -94.59 98.87 11.12 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.206 -0.452 . . . . 0.88 111.771 179.302 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -100.11 130.9 46.31 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.876 0.369 . . . . 0.48 111.208 179.431 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 242' ' ' TRP . . . . . . . . . . . . . 7.0 m95 -55.33 -43.76 75.22 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 116.032 -0.531 . . . . 0.54 111.146 179.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -58.01 -32.07 66.1 Favored Glycine 0 CA--C 1.519 0.329 0 CA-C-N 115.98 -0.555 . . . . 0.28 112.605 179.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 86.8 mtt180 -74.9 -36.39 62.23 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.78 -0.452 . . . . 0.34 109.78 178.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . 0.561 ' O ' HG12 ' A' ' 249' ' ' ILE . 79.1 mt -66.97 -51.36 55.46 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 CA-C-N 115.944 -0.571 . . . . 0.41 110.714 179.115 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 27.6 m -62.93 -35.9 73.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 C-N-CA 121.089 -0.244 . . . . 0.35 111.08 179.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 53.0 m -65.69 -37.77 87.39 Favored 'General case' 0 N--CA 1.463 0.187 0 N-CA-C 109.538 -0.542 . . . . 0.38 109.538 178.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 248' ' ' LEU . . . . . 0.511 HD22 ' HE2' ' A' ' 235' ' ' PHE . 34.2 tp -65.32 -40.58 93.92 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 116.143 -0.481 . . . . 0.63 109.759 177.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 249' ' ' ILE . . . . . 0.561 HG12 ' O ' ' A' ' 245' ' ' ILE . 43.0 mm -65.9 -48.89 80.36 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 CA-C-N 116.186 -0.461 . . . . 0.34 110.101 178.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 31.3 t -57.07 -42.68 81.09 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.801 -0.636 . . . . 0.28 110.31 178.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 251' ' ' PHE . . . . . . . . . . . . . 32.0 t80 -64.03 -45.46 88.78 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 115.647 -0.706 . . . . 0.46 110.059 177.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -58.22 -41.28 94.76 Favored Glycine 0 C--N 1.337 0.623 0 N-CA-C 111.464 -0.655 . . . . 0.32 111.464 178.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 253' ' ' ALA . . . . . 0.417 ' HB1' ' HB3' ' A' ' 170' ' ' GLN . . . -64.01 -42.68 97.06 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 120.773 0.32 . . . . 0.32 110.277 177.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -60.07 -40.87 91.0 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.357 0.598 . . . . 0.65 109.742 178.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 255' ' ' VAL . . . . . 0.461 ' CG1' HG21 ' A' ' 218' ' ' ILE . 79.9 t -66.54 -51.25 59.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 CA-C-N 115.682 -0.69 . . . . 0.41 109.696 177.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -54.21 -39.29 66.56 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.082 -0.508 . . . . 0.27 111.076 177.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -62.48 -42.89 99.8 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.402 -0.363 . . . . 0.59 110.667 178.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 31.3 t60 -64.61 -36.14 83.28 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.311 -0.404 . . . . 0.5 110.32 179.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 6.7 mp -74.6 -41.49 60.35 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 121.061 0.458 . . . . 0.51 110.696 178.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -62.82 -27.35 69.26 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.9 0.381 . . . . 0.4 110.666 179.079 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 56.4 m -59.67 -31.86 69.95 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.074 -0.512 . . . . 0.41 110.494 178.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 262' ' ' VAL . . . . . 0.419 HG23 ' HG3' ' A' ' 264' ' ' GLN . 15.7 m -110.49 16.99 7.72 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 CA-C-O 121.28 0.562 . . . . 0.4 110.192 178.29 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 25.6 t30 59.31 44.22 15.67 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 114.922 -1.035 . . . . 0.47 113.567 179.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 264' ' ' GLN . . . . . 0.419 ' HG3' HG23 ' A' ' 262' ' ' VAL . 15.0 mt-30 -91.54 36.61 0.95 Allowed 'General case' 0 N--CA 1.466 0.369 0 O-C-N 121.978 -0.452 . . . . 0.5 110.856 178.536 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 265' ' ' GLU . . . . . 0.427 ' HA ' HD12 ' A' ' 268' ' ' ILE . 6.4 mm-40 -57.94 -29.22 64.99 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 116.422 -0.354 . . . . 0.49 111.862 -179.418 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.37 -22.84 67.12 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.229 -0.441 . . . . 0.63 110.788 178.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 267' ' ' PHE . . . . . 0.428 ' C ' ' HD2' ' A' ' 270' ' ' PRO . 66.2 m-85 -100.01 -24.74 14.53 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.048 -0.524 . . . . 0.72 110.611 178.566 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 268' ' ' ILE . . . . . 0.427 HD12 ' HA ' ' A' ' 265' ' ' GLU . 89.3 mt -65.3 -40.9 90.03 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-N 116.11 -0.495 . . . . 0.37 111.477 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 269' ' ' GLU . . . . . 0.686 ' HB2' ' HD3' ' A' ' 270' ' ' PRO . 6.4 mm-40 -57.49 -56.47 33.81 Favored Pre-proline 0 CA--C 1.542 0.669 0 C-N-CA 120.979 -0.289 . . . . 0.68 111.111 178.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 270' ' ' PRO . . . . . 0.686 ' HD3' ' HB2' ' A' ' 269' ' ' GLU . 50.6 Cg_exo -58.04 -32.24 94.95 Favored 'Trans proline' 0 C--N 1.363 1.323 0 C-N-CA 121.843 1.695 . . . . 0.32 111.643 177.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 271' ' ' LEU . . . . . 0.44 ' O ' HG13 ' A' ' 275' ' ' ILE . 0.4 OUTLIER -66.06 -55.16 17.97 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.183 -0.462 . . . . 0.51 110.233 178.582 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -60.06 -39.12 84.91 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 115.846 -0.616 . . . . 0.28 110.951 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 273' ' ' GLU . . . . . 0.468 ' O ' ' HB2' ' A' ' 277' ' ' ASP . 26.4 tt0 -66.92 -43.41 83.38 Favored 'General case' 0 C--O 1.226 -0.18 0 CA-C-N 115.885 -0.598 . . . . 1.79 110.012 178.583 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 274' ' ' THR . . . . . . . . . . . . . 41.2 m -64.95 -44.35 89.71 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.605 -0.27 . . . . 0.39 110.927 179.057 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 275' ' ' ILE . . . . . 0.44 HG13 ' O ' ' A' ' 271' ' ' LEU . 96.5 mt -57.54 -54.97 24.09 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 CA-C-O 121.132 0.491 . . . . 0.4 110.157 179.09 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 276' ' ' THR . . . . . 0.614 HG21 ' HA ' ' A' ' 160' ' ' LEU . 24.4 m -59.25 -45.46 91.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.664 -0.698 . . . . 0.31 110.541 179.179 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 277' ' ' ASP . . . . . 0.468 ' HB2' ' O ' ' A' ' 273' ' ' GLU . 7.9 t70 -56.27 -58.35 8.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.315 -0.857 . . . . 0.33 111.723 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 95.3 t -57.7 -39.47 70.42 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-O 120.609 0.242 . . . . 0.4 110.953 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 22.3 tp -61.5 -47.92 83.42 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 120.669 0.271 . . . . 0.68 111.672 179.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 44.6 t -78.79 -23.28 12.97 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-O 121.052 0.453 . . . . 0.52 111.835 -179.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 281' ' ' ARG . . . . . 0.422 ' HB2' ' O ' ' A' ' 277' ' ' ASP . 19.3 ttm-85 -82.29 -25.8 33.66 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 121.824 -0.547 . . . . 0.47 111.949 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 282' ' ' THR . . . . . . . . . . . . . 37.7 p -98.69 -31.15 12.06 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 112.526 0.565 . . . . 0.4 112.526 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . 0.538 ' HG2' HG23 ' A' ' 240' ' ' THR . 3.3 mppt? -117.08 32.99 5.84 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 112.16 0.43 . . . . 1.01 112.16 -179.149 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 284' ' ' ARG . . . . . 0.48 ' H ' ' HG2' ' A' ' 284' ' ' ARG . 0.4 OUTLIER -56.81 -42.46 79.61 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 112.139 0.422 . . . . 0.45 112.139 179.817 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 285' ' ' ASP . . . . . 0.525 ' O ' ' HB2' ' A' ' 289' ' ' LYS . 26.0 t70 -62.19 -48.75 78.64 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.393 -0.367 . . . . 0.77 111.73 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 286' ' ' TRP . . . . . 0.513 ' CZ2' ' HG2' ' A' ' 290' ' ' GLN . 31.7 t90 -70.63 -41.42 72.22 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.018 0.377 . . . . 0.98 112.018 -179.201 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -61.27 -40.97 96.08 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 111.891 0.33 . . . . 0.55 111.891 -179.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 6.0 p -77.38 -29.69 16.87 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-O 120.75 0.309 . . . . 0.59 110.954 179.048 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 289' ' ' LYS . . . . . 0.525 ' HB2' ' O ' ' A' ' 285' ' ' ASP . 3.4 ttmm -75.36 -44.85 42.81 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 112.858 0.688 . . . . 0.81 112.858 -179.081 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 290' ' ' GLN . . . . . 0.513 ' HG2' ' CZ2' ' A' ' 286' ' ' TRP . 1.9 mp0 -84.83 29.88 0.6 Allowed 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 113.765 1.024 . . . . 0.78 113.765 -177.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 291' ' ' ARG . . . . . 0.608 ' HB3' ' HB3' ' A' ' 294' ' ' ASP . 21.5 mtm180 64.04 6.8 3.02 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 112.745 0.646 . . . . 0.42 112.745 179.318 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 59.07 -125.59 40.16 Favored Glycine 0 CA--C 1.521 0.421 0 CA-C-O 121.395 0.442 . . . . 0.32 113.573 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 293' ' ' TRP . . . . . 0.589 ' O ' HG23 ' A' ' 297' ' ' VAL . 83.8 m95 -64.9 -26.3 68.26 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.641 0.608 . . . . 0.48 112.641 -178.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 294' ' ' ASP . . . . . 0.608 ' HB3' ' HB3' ' A' ' 291' ' ' ARG . 20.0 t70 -64.32 -43.91 93.21 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 121.045 0.45 . . . . 0.54 109.934 178.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -68.38 -31.8 74.68 Favored Glycine 0 C--N 1.334 0.45 0 N-CA-C 110.609 -0.997 . . . . 0.36 110.609 177.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 296' ' ' PHE . . . . . 0.471 ' HB3' ' HA ' ' A' ' 293' ' ' TRP . 1.0 OUTLIER -67.7 -48.11 67.49 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 115.51 -0.345 . . . . 0.31 110.557 178.464 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 297' ' ' VAL . . . . . 0.589 HG23 ' O ' ' A' ' 293' ' ' TRP . 86.0 t -61.14 -43.4 96.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-O 120.825 0.345 . . . . 0.36 110.615 179.306 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -64.51 -46.49 82.71 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.863 -0.608 . . . . 0.48 112.053 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 299' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -62.63 -35.2 78.81 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 112.31 0.485 . . . . 0.54 112.31 -179.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 300' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 . . . . . 0 C--N 1.326 -0.455 0 N-CA-C 112.284 0.476 . . . . 0.51 112.284 -179.464 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 . . . . . 0 N--CA 1.456 -0.171 0 N-CA-C 109.34 -0.615 . . . . 1.0 109.34 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 23' ' ' PHE . . . . . 0.473 ' HB3' ' HB3' ' A' ' 212' ' ' MET . 0.0 OUTLIER -56.55 -41.3 76.62 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.87 -0.605 . . . . 0.72 110.686 178.54 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.61 -49.01 78.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.064 -0.516 . . . . 0.35 110.735 179.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . 0.411 ' HA ' ' HD3' ' B' ' 28' ' ' ARG . . . -64.78 -42.1 95.33 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.329 -0.396 . . . . 0.53 110.933 179.335 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -64.73 -49.53 70.45 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.128 -0.487 . . . . 1.09 111.351 179.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 61.6 mt -56.65 -36.03 69.06 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 120.815 0.34 . . . . 0.57 110.33 178.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 28' ' ' ARG . . . . . 0.411 ' HD3' ' HA ' ' B' ' 25' ' ' ALA . 19.4 mtp180 -62.89 -48.44 78.96 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.171 -0.468 . . . . 0.48 110.157 178.009 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . 0.504 ' HA ' ' HE3' ' B' ' 29' ' ' LYS . 0.0 OUTLIER -66.83 -41.81 86.83 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.319 -0.4 . . . . 0.53 111.96 -179.79 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . 0.407 ' O ' HG23 ' B' ' 34' ' ' VAL . 78.8 mt -61.65 -41.61 91.03 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 N-CA-C 109.142 -0.688 . . . . 0.39 109.142 178.027 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -61.85 -49.13 78.95 Favored Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 115.655 -0.702 . . . . 0.31 111.872 178.287 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -58.9 -44.23 91.19 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-O 121.117 0.484 . . . . 0.45 109.737 178.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 3.3 tmtt? -58.84 -52.61 64.98 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 115.434 -0.803 . . . . 0.41 111.137 178.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 34' ' ' VAL . . . . . 0.407 HG23 ' O ' ' B' ' 30' ' ' ILE . 58.7 t -58.87 -49.43 83.04 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 CA-C-O 120.749 0.309 . . . . 0.39 111.416 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -58.74 -43.96 90.39 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 116.307 -0.406 . . . . 0.62 111.972 -179.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 36' ' ' CYS . . . . . . . . . . . . . 17.8 p -73.39 -32.84 64.68 Favored 'General case' 0 N--CA 1.468 0.444 0 O-C-N 122.023 -0.423 . . . . 0.4 111.421 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 89.5 m -66.35 -39.82 89.42 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.526 -0.306 . . . . 0.37 111.365 179.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 38' ' ' TRP . . . . . . . . . . . . . 84.2 m95 -80.45 -25.05 39.13 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.981 -0.288 . . . . 0.56 111.201 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 69.2 m . . . . . 0 N--CA 1.469 0.489 0 CA-C-O 120.898 0.38 . . . . 0.48 110.71 178.139 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 15.1 t70 . . . . . 0 N--CA 1.473 0.722 0 N-CA-C 112.763 0.653 . . . . 0.91 112.763 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -67.85 -38.7 83.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.856 0.36 . . . . 0.59 110.679 179.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.436 HD11 ' HA3' ' A' ' 292' ' ' GLY . 53.8 tp -61.56 -39.4 90.97 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.732 -0.47 . . . . 0.63 109.732 178.366 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -58.17 -51.49 69.5 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.604 -0.726 . . . . 0.42 112.02 179.179 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 0.41 HH11 ' HD2' ' A' ' 157' ' ' ARG . 20.1 mtm180 -56.77 -49.66 74.61 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 112.37 0.507 . . . . 0.5 112.37 -178.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -59.04 -50.45 74.03 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 120.903 0.382 . . . . 1.19 111.007 179.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . 0.457 ' HA ' ' CZ2' ' A' ' 293' ' ' TRP . 3.3 p -63.64 -45.9 88.1 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 112.278 0.473 . . . . 0.29 112.278 -179.374 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.409 HD22 ' HA ' ' A' ' 160' ' ' LEU . 0.4 OUTLIER -53.4 -49.76 66.6 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 120.774 0.321 . . . . 0.8 111.124 179.45 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -75.99 -43.17 45.63 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.873 0.694 . . . . 0.39 112.873 -179.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . 0.466 HD13 ' HB3' ' A' ' 190' ' ' ALA . 79.9 mt -62.01 -42.44 94.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 O-C-N 121.978 -0.451 . . . . 0.31 111.753 -179.292 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.692 ' O ' ' HG ' ' A' ' 167' ' ' LEU . 74.1 mt -69.06 -52.3 35.23 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 C-N-CA 121.018 -0.273 . . . . 0.33 110.768 179.043 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 54.6 p -58.03 -42.27 84.98 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 121.281 -0.167 . . . . 0.26 110.983 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . 0.438 HH11 ' HD2' ' A' ' 165' ' ' ARG . 2.0 mmt85 -55.43 -51.77 65.81 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.722 -0.217 . . . . 0.41 110.951 178.472 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' TYR . . . . . 0.848 ' CE1' ' HA ' ' A' ' 195' ' ' ARG . 72.5 t80 -60.26 -48.68 80.69 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.666 -0.243 . . . . 0.31 111.142 179.28 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.692 ' HG ' ' O ' ' A' ' 163' ' ' ILE . 18.8 mt -59.0 -44.18 91.63 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.561 -0.29 . . . . 0.35 111.484 -179.568 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . 0.539 ' HD3' ' OE2' ' A' ' 269' ' ' GLU . 25.3 mtm180 -70.47 -44.42 67.77 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 112.22 0.452 . . . . 0.38 112.22 179.671 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -62.8 -44.1 97.06 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.705 0.288 . . . . 0.35 111.168 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . 0.456 ' HG3' ' CZ ' ' A' ' 166' ' ' TYR . 6.4 mm-40 -70.48 -28.99 65.41 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.853 0.359 . . . . 0.4 110.708 178.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.838 ' HA ' ' HG2' ' A' ' 257' ' ' LYS . . . . . . . . 0 CA--C 1.53 0.21 0 N-CA-C 112.522 0.564 . . . . 0.44 112.522 -179.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.496 ' O ' ' HA3' ' A' ' 187' ' ' GLY . . . . . . . . 0 CA--C 1.532 0.285 0 CA-C-O 120.884 0.373 . . . . 0.38 110.247 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -78.74 -71.68 1.23 Allowed Glycine 0 CA--C 1.523 0.542 0 C-N-CA 120.647 -0.787 . . . . 0.42 113.811 -178.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -71.97 -56.14 6.2 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 120.8 0.333 . . . . 0.5 111.049 -179.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -61.52 -35.03 76.58 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.116 -0.493 . . . . 0.45 110.578 179.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . 0.496 ' HA3' ' O ' ' A' ' 183' ' ' ALA . . . -65.37 -40.46 96.43 Favored Glycine 0 C--N 1.333 0.408 0 C-N-CA 121.229 -0.51 . . . . 0.36 113.201 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . 0.449 ' HD3' ' HA ' ' A' ' 188' ' ' ARG . 15.0 mmt180 -66.52 -47.02 74.26 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 117.193 0.497 . . . . 0.66 110.552 179.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' ARG . . . . . 0.685 ' HB3' HG11 ' A' ' 297' ' ' VAL . 23.9 mmt180 -66.97 -39.52 87.22 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.067 -0.515 . . . . 0.65 111.204 179.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . 0.466 ' HB3' HD13 ' A' ' 162' ' ' ILE . . . -70.09 -40.08 75.17 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.899 -0.321 . . . . 0.32 111.136 179.095 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 16.0 tp -69.27 -44.41 71.94 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 120.777 -0.369 . . . . 0.52 111.294 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' GLU . . . . . 0.558 ' HG3' ' O ' ' A' ' 189' ' ' ARG . 0.0 OUTLIER -58.43 -37.73 75.99 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 120.597 -0.441 . . . . 0.34 110.401 179.169 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . 0.561 HG21 ' HA ' ' A' ' 297' ' ' VAL . 1.1 p -76.87 -47.59 20.81 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 120.953 -0.299 . . . . 0.35 111.08 178.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . 0.482 ' HA ' HD12 ' A' ' 194' ' ' LEU . 10.3 tp -58.85 -35.36 72.82 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.737 0.303 . . . . 0.4 110.977 179.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . 0.848 ' HA ' ' CE1' ' A' ' 166' ' ' TYR . 12.6 mmt180 -68.8 -58.29 4.4 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.788 0.328 . . . . 0.35 110.348 178.393 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 20.7 ttp85 -60.77 -54.02 50.24 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 112.914 0.709 . . . . 0.52 112.914 -179.183 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . 0.564 ' O ' HG23 ' A' ' 201' ' ' VAL . 46.8 t -68.7 -45.1 81.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 112.051 0.389 . . . . 0.36 112.051 -179.033 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -61.7 -42.41 99.75 Favored Glycine 0 CA--C 1.521 0.444 0 C-N-CA 120.996 -0.621 . . . . 0.32 113.027 -179.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -68.39 -42.39 79.15 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 109.728 -0.471 . . . . 0.49 109.728 179.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -56.54 -48.68 74.76 Favored Glycine 0 C--N 1.336 0.547 0 C-N-CA 120.797 -0.716 . . . . 0.39 111.655 178.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . 0.564 HG23 ' O ' ' A' ' 197' ' ' VAL . 60.0 t -62.92 -42.6 97.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 CA-C-O 120.702 0.287 . . . . 0.43 111.193 178.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -63.38 -48.64 77.04 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.152 -0.476 . . . . 0.35 112.028 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 31.7 mtm180 -73.5 -35.27 65.6 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.908 -0.317 . . . . 0.74 111.739 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -63.73 -49.19 74.03 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 121.117 0.484 . . . . 0.91 110.039 178.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 79.6 m-70 -101.17 33.78 2.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.157 -0.474 . . . . 0.59 110.711 179.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -53.65 -45.71 70.32 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.89 -0.596 . . . . 0.79 112.042 -179.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -59.51 -41.89 90.97 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 120.928 0.394 . . . . 0.5 111.51 179.34 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -70.62 -50.62 35.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.23 -0.441 . . . . 0.43 111.045 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -60.26 -44.09 95.59 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 116.478 -0.328 . . . . 0.6 111.024 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -64.67 -40.89 96.2 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 110.272 -0.27 . . . . 0.96 110.272 178.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -62.3 -44.81 97.14 Favored Glycine 0 C--N 1.335 0.522 0 N-CA-C 110.746 -0.942 . . . . 0.39 110.746 178.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 212' ' ' MET . . . . . 0.527 ' O ' ' HG ' ' A' ' 216' ' ' LEU . 8.0 mtp -64.09 -42.12 97.05 Favored 'General case' 0 C--O 1.222 -0.375 0 N-CA-C 110.076 -0.342 . . . . 0.67 110.076 178.102 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.437 HD21 ' HB2' ' A' ' 258' ' ' HIS . 6.8 tp -61.85 -39.16 90.87 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 120.889 0.376 . . . . 0.51 111.245 179.136 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 10.4 tpt180 -68.66 -32.52 72.43 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 116.267 -0.424 . . . . 0.79 111.32 179.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -89.99 -15.56 31.68 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 111.899 0.333 . . . . 0.57 111.899 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . 0.535 HD11 ' CZ ' ' A' ' 251' ' ' PHE . 13.3 mt -62.92 134.18 55.8 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 113.036 0.754 . . . . 0.59 113.036 -179.288 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -100.95 17.04 23.3 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 115.511 -0.768 . . . . 1.1 110.127 178.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 30.7 mm -67.88 108.24 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 CA-C-N 116.073 -0.512 . . . . 0.73 111.385 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 2.9 mtmp? -135.08 -42.6 0.73 Allowed 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 112.355 0.502 . . . . 1.06 112.355 -179.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -113.87 -178.39 3.36 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 113.184 0.809 . . . . 1.27 113.184 -177.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . 0.612 ' O ' HG22 ' A' ' 224' ' ' VAL . 8.7 tm-20 -56.52 -44.53 80.88 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 115.723 -0.671 . . . . 1.34 112.244 -179.438 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -54.02 -26.99 36.42 Favored Glycine 0 CA--C 1.527 0.807 0 C-N-CA 121.112 -0.566 . . . . 0.43 113.564 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 62.7 m-20 -68.47 -31.03 70.03 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 112.71 0.633 . . . . 0.75 112.71 -179.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.612 HG22 ' O ' ' A' ' 221' ' ' GLU . 4.4 m -63.22 -28.65 45.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 CA-C-O 121.156 0.503 . . . . 0.54 111.548 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 37.6 mttm -70.0 -39.36 75.93 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-O 121.334 0.587 . . . . 1.28 110.278 179.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 226' ' ' SER . . . . . 0.533 ' O ' HG23 ' A' ' 230' ' ' VAL . 11.3 t -66.34 -36.03 81.88 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.896 -0.593 . . . . 0.35 109.535 178.315 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 227' ' ' PHE . . . . . . . . . . . . . 33.8 t80 -60.81 -42.55 97.87 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.184 -0.916 . . . . 0.53 110.314 178.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 228' ' ' SER . . . . . 0.417 ' HB3' HG11 ' A' ' 278' ' ' VAL . 18.8 m -59.62 -45.61 91.45 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 115.716 -0.675 . . . . 0.75 110.634 178.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 15.8 ttm105 -55.52 -43.68 75.97 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.611 -0.722 . . . . 0.38 110.799 178.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . 0.533 HG23 ' O ' ' A' ' 226' ' ' SER . 25.4 t -58.9 -49.56 82.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 CA-C-N 116.118 -0.492 . . . . 0.42 111.679 179.328 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 231' ' ' MET . . . . . 0.538 ' HA ' HD22 ' A' ' 248' ' ' LEU . 70.5 mtm -53.11 -45.74 68.42 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.351 -0.386 . . . . 0.53 111.755 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 37.7 t -68.91 -40.45 81.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-O 120.657 0.265 . . . . 0.54 110.976 178.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 39.5 t-80 -54.89 -33.09 61.63 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.038 -0.528 . . . . 0.41 111.175 179.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.577 HG13 ' HA ' ' B' ' 28' ' ' ARG . 79.0 t -61.78 -30.9 49.4 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 N-CA-C 112.405 0.52 . . . . 0.41 112.405 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -93.98 23.16 5.1 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 112.432 0.53 . . . . 0.52 112.432 -179.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.58 -23.57 17.4 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 113.399 0.889 . . . . 1.06 113.399 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 237' ' ' ASP . . . . . 0.476 ' HB2' HG12 ' A' ' 239' ' ' VAL . 0.1 OUTLIER -76.67 -14.64 59.95 Favored 'General case' 0 CA--C 1.533 0.321 0 O-C-N 121.932 -0.48 . . . . 0.67 111.991 -179.688 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 88.53 12.71 64.35 Favored Glycine 0 CA--C 1.522 0.516 0 C-N-CA 120.79 -0.719 . . . . 0.67 113.488 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . 0.476 HG12 ' HB2' ' A' ' 237' ' ' ASP . 3.9 p -119.48 112.21 36.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 CA-C-O 121.533 0.682 . . . . 0.55 111.569 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 240' ' ' THR . . . . . 0.75 HG22 HD11 ' A' ' 245' ' ' ILE . 4.2 m -81.33 69.93 8.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.101 -0.499 . . . . 0.58 112.235 -179.445 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 48.2 m-20 -76.89 136.21 38.85 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 120.724 0.297 . . . . 0.8 110.976 179.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 242' ' ' TRP . . . . . 0.558 ' CZ3' ' HB2' ' A' ' 296' ' ' PHE . 68.8 m95 -53.66 -36.53 62.22 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 112.972 0.73 . . . . 0.52 112.972 -179.17 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . 0.474 ' H ' ' HB2' ' B' ' 35' ' ' TYR . . . -58.09 -34.88 74.49 Favored Glycine 0 CA--C 1.521 0.46 0 C-N-CA 120.994 -0.622 . . . . 0.34 112.894 179.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 244' ' ' ARG . . . . . 0.617 ' O ' ' HG ' ' A' ' 248' ' ' LEU . 28.9 mtt180 -74.37 -46.45 40.43 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.917 -0.401 . . . . 0.59 109.917 179.389 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . 0.75 HD11 HG22 ' A' ' 240' ' ' THR . 58.5 mt -55.91 -47.96 79.13 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-N 115.533 -0.758 . . . . 0.54 110.778 178.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 7.6 p -70.15 -29.01 38.01 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 120.905 -0.318 . . . . 0.37 110.852 179.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . 0.545 HG22 HD22 ' B' ' 27' ' ' LEU . 19.8 m -65.16 -39.64 93.24 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 109.603 -0.517 . . . . 0.42 109.603 177.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 248' ' ' LEU . . . . . 0.617 ' HG ' ' O ' ' A' ' 244' ' ' ARG . 51.4 mt -63.21 -38.91 93.03 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.863 -0.608 . . . . 0.43 109.784 178.204 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 249' ' ' ILE . . . . . 0.469 HG21 HD11 ' A' ' 194' ' ' LEU . 15.6 mt -70.22 -36.9 69.66 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 N-CA-C 109.55 -0.537 . . . . 0.41 109.55 177.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 20.4 m -64.08 -40.5 96.38 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 109.255 -0.646 . . . . 0.37 109.255 178.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 251' ' ' PHE . . . . . 0.535 ' CZ ' HD11 ' A' ' 216' ' ' LEU . 8.0 t80 -65.83 -40.99 92.32 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 108.644 -0.873 . . . . 0.56 108.644 176.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -62.69 -39.55 98.06 Favored Glycine 0 C--N 1.336 0.53 0 CA-C-N 115.509 -0.769 . . . . 0.28 111.576 178.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -64.75 -41.44 95.92 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 120.665 0.269 . . . . 0.28 110.517 178.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -63.09 -37.9 89.03 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.042 0.449 . . . . 0.53 110.209 178.503 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 255' ' ' VAL . . . . . 0.523 HG23 ' O ' ' A' ' 251' ' ' PHE . 59.9 t -72.97 -39.42 57.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 N-CA-C 109.83 -0.433 . . . . 0.35 109.83 178.218 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 256' ' ' ALA . . . . . 0.415 ' HB1' HD11 ' A' ' 268' ' ' ILE . . . -55.64 -43.71 76.47 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.143 0.497 . . . . 0.31 109.942 178.042 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 257' ' ' LYS . . . . . 0.838 ' HG2' ' HA ' ' A' ' 171' ' ' ALA . 93.0 mttt -62.39 -47.87 82.25 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 115.507 -0.769 . . . . 0.4 110.378 178.267 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 258' ' ' HIS . . . . . 0.437 ' HB2' HD21 ' A' ' 213' ' ' LEU . 45.3 t60 -59.45 -36.43 75.91 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.3 -0.409 . . . . 0.68 111.379 179.668 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.401 ' O ' ' HB2' ' A' ' 264' ' ' GLN . 88.2 mt -77.37 -51.06 11.47 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 112.023 0.379 . . . . 0.57 112.023 179.275 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 260' ' ' LYS . . . . . 0.506 ' HD2' ' HB3' ' A' ' 171' ' ' ALA . 0.4 OUTLIER -60.81 -42.05 96.91 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 112.496 0.554 . . . . 0.68 112.496 -179.341 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 29.3 p -55.63 -27.98 52.73 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 112.35 0.5 . . . . 0.61 112.35 -179.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 262' ' ' VAL . . . . . 0.609 HG23 ' HG3' ' A' ' 264' ' ' GLN . 17.1 m -109.41 25.83 2.76 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-O 120.759 0.314 . . . . 0.63 111.594 179.361 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 58.4 m-80 55.63 47.44 20.68 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 113.219 0.822 . . . . 1.2 113.219 179.121 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 264' ' ' GLN . . . . . 0.609 ' HG3' HG23 ' A' ' 262' ' ' VAL . 37.3 mt-30 -103.94 39.8 1.56 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.005 0.431 . . . . 0.75 111.359 179.381 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 265' ' ' GLU . . . . . 0.826 ' HA ' HG22 ' A' ' 268' ' ' ILE . 24.2 mm-40 -50.84 -35.88 34.72 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 112.668 0.618 . . . . 0.71 112.668 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 266' ' ' SER . . . . . 0.403 ' O ' ' HG2' ' A' ' 270' ' ' PRO . 57.1 p -67.81 -7.96 32.05 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.658 -0.246 . . . . 0.55 111.608 179.631 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -116.76 -33.45 4.8 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.525 0.194 . . . . 0.81 111.525 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 268' ' ' ILE . . . . . 0.826 HG22 ' HA ' ' A' ' 265' ' ' GLU . 6.1 tt -67.38 -43.32 87.82 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 N-CA-C 111.705 0.261 . . . . 0.44 111.705 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 269' ' ' GLU . . . . . 0.733 ' HB2' ' HD3' ' A' ' 270' ' ' PRO . 6.7 mm-40 -63.08 -56.03 31.86 Favored Pre-proline 0 CA--C 1.537 0.447 0 C-N-CA 120.851 -0.34 . . . . 0.78 110.751 179.573 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 270' ' ' PRO . . . . . 0.733 ' HD3' ' HB2' ' A' ' 269' ' ' GLU . 50.3 Cg_exo -57.0 -29.64 83.57 Favored 'Trans proline' 0 C--N 1.36 1.179 0 C-N-CA 122.0 1.8 . . . . 0.33 111.588 177.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 271' ' ' LEU . . . . . . . . . . . . . 19.1 tp -66.7 -51.08 60.1 Favored 'General case' 0 C--O 1.224 -0.265 0 N-CA-C 109.782 -0.451 . . . . 0.46 109.782 178.009 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -58.36 -34.48 70.72 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 120.942 0.401 . . . . 0.32 110.514 178.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 273' ' ' GLU . . . . . 0.583 ' OE1' ' HA ' ' A' ' 270' ' ' PRO . 68.9 mt-10 -71.21 -47.81 55.15 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 115.856 -0.611 . . . . 0.97 109.892 178.244 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 274' ' ' THR . . . . . . . . . . . . . 61.1 m -60.67 -43.11 98.05 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.889 -0.596 . . . . 0.37 110.713 179.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 275' ' ' ILE . . . . . 0.425 HG23 ' SD ' ' A' ' 231' ' ' MET . 96.1 mt -60.48 -54.64 32.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 115.833 -0.621 . . . . 0.32 110.386 178.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 26.0 m -61.17 -48.87 79.55 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.096 -0.502 . . . . 0.3 112.331 -179.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 277' ' ' ASP . . . . . 0.471 ' CG ' HH12 ' A' ' 281' ' ' ARG . 24.2 t70 -54.44 -53.26 56.58 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 120.873 0.368 . . . . 0.37 111.635 -179.676 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 278' ' ' VAL . . . . . 0.417 HG11 ' HB3' ' A' ' 228' ' ' SER . 97.8 t -68.6 -42.93 83.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.365 -0.379 . . . . 0.4 111.649 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 279' ' ' LEU . . . . . 0.441 HD11 HG23 ' A' ' 245' ' ' ILE . 40.6 tp -57.77 -43.08 85.25 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 120.601 0.239 . . . . 0.62 111.618 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 77.6 t -72.3 -53.33 19.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 120.824 -0.351 . . . . 0.43 110.737 179.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 281' ' ' ARG . . . . . 0.554 ' HA ' ' HG3' ' A' ' 284' ' ' ARG . 18.8 ttp-105 -56.44 -40.97 75.67 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 113.669 0.989 . . . . 0.53 113.669 -179.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 282' ' ' THR . . . . . 0.892 HG23 ' HD2' ' A' ' 283' ' ' LYS . 13.9 t -63.14 -21.63 66.32 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 113.269 0.84 . . . . 0.51 113.269 -178.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . 0.892 ' HD2' HG23 ' A' ' 282' ' ' THR . 0.4 OUTLIER -142.26 41.76 1.64 Allowed 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 112.4 0.519 . . . . 0.66 112.4 -179.736 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 284' ' ' ARG . . . . . 0.554 ' HG3' ' HA ' ' A' ' 281' ' ' ARG . 68.8 mtt180 -55.01 -47.84 74.14 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 113.035 0.754 . . . . 0.68 113.035 -178.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 285' ' ' ASP . . . . . 0.442 ' HA ' HG22 ' A' ' 288' ' ' VAL . 32.4 t70 -60.5 -39.6 88.32 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.043 0.449 . . . . 0.59 111.327 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 286' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -67.99 -37.99 82.13 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.201 0.524 . . . . 0.56 110.218 179.088 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 287' ' ' LEU . . . . . 0.406 ' CD1' ' HA2' ' A' ' 292' ' ' GLY . 2.8 mm? -70.62 -48.93 52.55 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.639 -0.71 . . . . 0.58 111.638 179.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 288' ' ' VAL . . . . . 0.442 HG22 ' HA ' ' A' ' 285' ' ' ASP . 33.5 m -61.32 -33.76 57.98 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-O 120.627 0.251 . . . . 0.5 111.436 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 50.6 mttp -72.0 -26.14 62.11 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 120.854 0.359 . . . . 0.93 110.874 178.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -101.93 11.01 39.26 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 112.437 0.532 . . . . 0.87 112.437 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 291' ' ' ARG . . . . . 0.416 HH11 ' HD2' ' A' ' 291' ' ' ARG . 29.1 mtm180 62.54 20.29 11.85 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 120.716 0.293 . . . . 0.79 111.7 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 292' ' ' GLY . . . . . 0.436 ' HA3' HD11 ' A' ' 155' ' ' LEU . . . 65.07 -111.67 4.38 Favored Glycine 0 CA--C 1.525 0.662 0 C-N-CA 121.375 -0.441 . . . . 0.47 114.061 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 293' ' ' TRP . . . . . 0.597 ' O ' HG23 ' A' ' 297' ' ' VAL . 53.9 m95 -63.48 -45.89 88.68 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.857 0.688 . . . . 0.46 112.857 -178.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 294' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -50.21 -47.36 54.82 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 111.849 0.315 . . . . 0.52 111.849 -179.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -66.03 -41.19 95.31 Favored Glycine 0 CA--C 1.523 0.561 0 C-N-CA 120.582 -0.818 . . . . 0.31 112.258 178.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 296' ' ' PHE . . . . . 0.558 ' HB2' ' CZ3' ' A' ' 242' ' ' TRP . 1.6 t80 -62.37 -42.68 99.6 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.95 0.405 . . . . 0.4 111.116 179.076 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 297' ' ' VAL . . . . . 0.685 HG11 ' HB3' ' A' ' 189' ' ' ARG . 64.0 t -63.91 -47.18 91.77 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-N 116.004 -0.544 . . . . 0.33 111.807 -179.555 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -59.07 -46.16 88.96 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 112.128 0.418 . . . . 0.65 112.128 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 299' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -59.05 -27.35 65.41 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 120.976 0.417 . . . . 0.51 111.74 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 300' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 . . . . . 0 C--N 1.327 -0.378 0 CA-C-O 121.283 0.563 . . . . 0.53 111.286 179.625 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 . . . . . 0 C--O 1.232 0.184 0 CA-C-O 120.912 0.387 . . . . 0.81 110.406 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 23' ' ' PHE . . . . . 0.556 ' O ' ' HG ' ' B' ' 27' ' ' LEU . 4.0 p90 -63.76 -33.2 75.12 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.113 -0.494 . . . . 0.48 110.829 179.227 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -72.76 -46.47 53.21 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.256 -0.429 . . . . 0.51 111.095 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.89 -42.21 97.52 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 121.072 0.463 . . . . 0.67 110.456 179.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -59.57 -53.38 58.77 Favored 'General case' 0 N--CA 1.457 -0.105 0 CA-C-N 115.681 -0.69 . . . . 0.96 110.739 179.237 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . 0.556 ' HG ' ' O ' ' B' ' 23' ' ' PHE . 78.3 mt -56.5 -35.58 68.18 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.623 -0.262 . . . . 0.52 111.597 179.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 28' ' ' ARG . . . . . 0.577 ' HA ' HG13 ' A' ' 234' ' ' VAL . 0.0 OUTLIER -67.3 -47.07 71.7 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.74 0.305 . . . . 0.51 111.09 179.532 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 44.3 mtmt -67.67 -41.83 83.11 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 121.038 0.447 . . . . 0.77 110.371 178.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . 0.47 ' O ' HG23 ' B' ' 34' ' ' VAL . 97.0 mt -64.31 -40.03 87.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 CA-C-N 115.942 -0.572 . . . . 0.39 110.128 178.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -57.88 -49.95 70.07 Favored Glycine 0 C--N 1.333 0.412 0 CA-C-N 115.879 -0.6 . . . . 0.29 112.941 179.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 39.1 m-20 -68.9 -26.73 65.25 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 117.157 0.479 . . . . 0.48 110.273 178.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 33' ' ' LYS . . . . . 0.427 ' HE2' ' HA ' ' B' ' 33' ' ' LYS . 0.0 OUTLIER -67.86 -53.72 24.51 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.505 -0.316 . . . . 0.41 110.734 178.75 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 34' ' ' VAL . . . . . 0.47 HG23 ' O ' ' B' ' 30' ' ' ILE . 57.3 t -58.03 -47.24 87.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-O 121.081 0.467 . . . . 0.37 110.745 179.503 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 35' ' ' TYR . . . . . 0.474 ' HB2' ' H ' ' A' ' 243' ' ' GLY . 2.4 t80 -58.15 -46.53 85.52 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.625 -0.716 . . . . 0.5 110.138 178.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 36' ' ' CYS . . . . . . . . . . . . . 43.5 t -63.53 -46.04 87.81 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 115.881 -0.599 . . . . 0.35 111.111 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 62.3 m -61.07 -43.24 99.18 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 112.878 0.695 . . . . 0.4 112.878 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 38' ' ' TRP . . . . . . . . . . . . . 94.2 m95 -82.76 -26.3 32.01 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.696 0.628 . . . . 0.62 112.696 -178.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 8.6 t . . . . . 0 CA--C 1.533 0.308 0 CA-C-O 121.019 0.437 . . . . 0.54 110.287 178.212 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 . . . . . 0 CA--C 1.532 0.281 0 N-CA-C 112.036 0.384 . . . . 0.44 112.036 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -51.98 -52.42 50.59 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 120.747 0.308 . . . . 0.71 111.157 179.544 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 47.4 tp -59.22 -46.17 89.17 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.298 -0.41 . . . . 0.55 111.136 178.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . 0.487 ' OH ' ' HG3' ' A' ' 281' ' ' ARG . 0.1 OUTLIER -60.87 -49.27 78.14 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.413 -0.358 . . . . 0.56 111.545 179.658 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 62.3 mtp180 -62.07 -48.82 78.52 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 112.146 0.424 . . . . 0.49 112.146 -179.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . 0.418 ' HA ' ' HB2' ' A' ' 183' ' ' ALA . 54.7 mm-40 -61.05 -46.84 89.05 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.732 0.301 . . . . 0.65 110.28 179.354 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . 0.407 ' HA ' ' CZ2' ' A' ' 293' ' ' TRP . 16.6 m -61.73 -48.86 78.83 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.217 -0.447 . . . . 0.29 111.078 179.313 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.739 ' HA ' HG21 ' A' ' 276' ' ' THR . 2.0 tm? -56.29 -47.82 77.87 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.65 0.262 . . . . 0.65 110.561 179.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -64.54 -48.08 76.41 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.126 0.417 . . . . 0.64 112.126 179.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 78.5 mt -67.25 -51.36 53.91 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 N-CA-C 113.022 0.749 . . . . 0.33 113.022 -179.091 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.514 HD12 HG23 ' A' ' 276' ' ' THR . 80.2 mt -60.74 -49.35 84.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 O-C-N 122.279 -0.263 . . . . 0.41 111.528 -179.35 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . 0.505 ' O ' ' HB2' ' A' ' 168' ' ' ARG . 3.1 t -57.99 -38.04 75.36 Favored 'General case' 0 N--CA 1.462 0.153 0 N-CA-C 110.249 -0.278 . . . . 0.61 110.249 178.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.64 -55.74 31.2 Favored 'General case' 0 C--O 1.22 -0.463 0 CA-C-N 116.563 -0.289 . . . . 0.34 110.967 179.344 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' TYR . . . . . 0.655 ' CE1' ' HA ' ' A' ' 195' ' ' ARG . 76.4 t80 -61.26 -51.94 66.81 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 112.495 0.554 . . . . 0.52 112.495 -178.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.5 ' HG ' ' O ' ' A' ' 163' ' ' ILE . 33.9 mt -58.76 -48.62 80.57 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 120.713 0.292 . . . . 0.45 111.761 -179.025 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . 0.505 ' HB2' ' O ' ' A' ' 164' ' ' SER . 0.7 OUTLIER -70.97 -45.05 64.77 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 112.318 0.488 . . . . 0.39 112.318 -179.689 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -60.72 -44.35 96.74 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 112.049 0.389 . . . . 0.46 112.049 -179.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -66.73 -48.42 69.26 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.935 -0.306 . . . . 0.93 111.467 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.543 ' HA ' ' HG2' ' A' ' 257' ' ' LYS . . . . . . . . 0 C--N 1.329 -0.304 0 N-CA-C 112.54 0.57 . . . . 0.33 112.54 -179.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.436 ' O ' ' HA3' ' A' ' 187' ' ' GLY . . . . . . . . 0 CA--C 1.535 0.386 0 CA-C-O 120.941 0.4 . . . . 0.34 111.543 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -79.13 -70.74 1.3 Allowed Glycine 0 CA--C 1.527 0.818 0 C-N-CA 120.984 -0.626 . . . . 0.33 114.396 -179.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -70.19 -57.42 4.94 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 112.48 0.548 . . . . 0.39 112.48 -178.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -62.93 -32.13 73.36 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 121.111 0.482 . . . . 0.32 110.087 179.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . 0.436 ' HA3' ' O ' ' A' ' 183' ' ' ALA . . . -72.93 -38.0 56.32 Favored Glycine 0 C--O 1.22 -0.73 0 CA-C-N 115.281 -0.872 . . . . 0.26 112.819 179.245 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . 0.402 ' HD3' ' HA ' ' A' ' 188' ' ' ARG . 13.1 tpp180 -61.29 -46.73 89.12 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 117.532 0.666 . . . . 0.8 110.877 179.435 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' ARG . . . . . 0.434 ' HB3' HG11 ' A' ' 297' ' ' VAL . 49.1 mtp180 -67.13 -38.99 86.5 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.251 0.548 . . . . 0.4 110.553 178.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . 0.669 ' HA ' HG22 ' A' ' 297' ' ' VAL . . . -69.83 -38.12 76.42 Favored 'General case' 0 C--O 1.224 -0.269 0 CA-C-N 115.701 -0.681 . . . . 0.26 111.68 179.586 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 20.4 tp -65.81 -47.7 74.18 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 111.531 0.197 . . . . 0.45 111.531 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' GLU . . . . . 0.693 ' O ' ' HG2' ' A' ' 196' ' ' ARG . 5.8 tm-20 -58.62 -47.36 84.64 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 108.964 -0.754 . . . . 0.36 108.964 178.37 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 38.9 m -58.21 -52.36 65.91 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 115.755 -0.657 . . . . 0.27 110.998 178.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . 0.422 HD21 HG21 ' A' ' 249' ' ' ILE . 26.9 tp -63.28 -38.68 92.12 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 112.916 0.71 . . . . 0.37 112.916 -179.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . 0.655 ' HA ' ' CE1' ' A' ' 166' ' ' TYR . 3.5 ttm-85 -64.97 -47.24 78.32 Favored 'General case' 0 C--N 1.333 -0.142 0 O-C-N 122.234 -0.291 . . . . 0.58 110.825 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . 0.693 ' HG2' ' O ' ' A' ' 192' ' ' GLU . 33.0 mmm-85 -66.01 -52.78 46.29 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.617 0.246 . . . . 0.47 110.836 179.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . 0.564 HG21 ' HB3' ' A' ' 300' ' ' PHE . 69.4 t -60.65 -51.77 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-N 116.464 -0.335 . . . . 0.33 111.618 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -56.54 -45.28 90.11 Favored Glycine 0 C--N 1.333 0.394 0 C-N-CA 121.389 -0.434 . . . . 0.32 113.042 -179.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . 0.423 ' HA ' ' HG2' ' A' ' 202' ' ' GLN . 33.3 m-20 -67.11 -33.69 76.01 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.658 0.266 . . . . 0.36 110.416 179.173 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -68.93 -32.88 73.9 Favored Glycine 0 CA--C 1.523 0.548 0 C-N-CA 120.72 -0.752 . . . . 0.25 112.002 178.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . 0.579 HG11 ' HA ' ' A' ' 247' ' ' THR . 92.3 t -72.82 -46.48 52.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 CA-C-O 120.687 0.28 . . . . 0.35 111.17 179.181 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' GLN . . . . . 0.423 ' HG2' ' HA ' ' A' ' 199' ' ' ASP . 11.3 pt20 -70.58 -32.5 69.91 Favored 'General case' 0 C--O 1.22 -0.48 0 CA-C-N 116.354 -0.384 . . . . 0.61 111.322 -179.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 23.3 ttm180 -68.95 -50.4 49.61 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.798 0.332 . . . . 2.99 110.706 178.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 18.9 m-80 -62.45 -44.46 96.35 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.269 -0.423 . . . . 0.62 111.235 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 87.9 m-70 -103.03 36.28 2.28 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 112.382 0.512 . . . . 0.44 112.382 -179.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -58.01 -42.64 85.67 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 112.613 0.597 . . . . 0.96 112.613 -179.256 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 34.0 p -61.24 -53.05 61.82 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.88 0.371 . . . . 0.53 111.709 -179.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -61.54 -43.73 98.34 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.096 -0.502 . . . . 0.44 110.61 179.041 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 3.3 m-30 -60.94 -52.04 66.72 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 116.107 -0.497 . . . . 0.45 111.05 179.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 20.1 mt-30 -59.97 -42.74 94.79 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 120.519 0.2 . . . . 0.74 111.249 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -61.21 -51.13 60.21 Favored Glycine 0 C--N 1.335 0.477 0 C-N-CA 120.611 -0.804 . . . . 0.36 111.993 178.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 212' ' ' MET . . . . . 0.65 ' HB3' ' HB3' ' B' ' 23' ' ' PHE . 71.2 mtm -66.34 -31.98 73.1 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 120.586 0.231 . . . . 0.73 110.991 179.344 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 10.3 tp -63.51 -41.95 98.49 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.958 0.408 . . . . 0.55 110.742 178.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 214' ' ' ARG . . . . . 0.427 HH11 ' HD3' ' A' ' 214' ' ' ARG . 39.7 mtt-85 -70.86 -31.74 68.52 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.038 -0.528 . . . . 0.96 111.04 179.414 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -72.8 -21.17 61.02 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 120.971 0.415 . . . . 0.78 111.044 178.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . 0.797 ' HB3' HG12 ' A' ' 218' ' ' ILE . 66.6 mt -72.78 135.37 45.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.02 0.438 . . . . 0.56 111.842 179.617 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -87.79 23.05 2.11 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 116.257 -0.429 . . . . 0.62 110.696 179.08 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 218' ' ' ILE . . . . . 0.797 HG12 ' HB3' ' A' ' 216' ' ' LEU . 50.6 mm -59.47 106.72 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-N 115.723 -0.671 . . . . 0.46 111.627 -179.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -154.97 -68.78 0.13 Allowed 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.957 -0.565 . . . . 0.62 111.55 -179.537 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -90.97 -176.48 4.65 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 115.793 -0.64 . . . . 0.63 112.579 -178.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -47.0 -22.45 0.33 Allowed 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 113.34 0.867 . . . . 1.44 113.34 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . 0.458 ' HA2' ' HD2' ' A' ' 225' ' ' LYS . . . -69.7 -22.53 76.81 Favored Glycine 0 CA--C 1.529 0.968 0 CA-C-N 116.522 -0.308 . . . . 0.44 113.134 178.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 223' ' ' ASP . . . . . 0.692 ' HB2' HG23 ' A' ' 218' ' ' ILE . 1.3 p-10 -56.31 -47.44 78.7 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 113.193 0.812 . . . . 0.8 113.193 -178.392 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 31.5 m -60.32 -32.0 49.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-O 121.001 0.429 . . . . 1.63 111.482 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . 0.458 ' HD2' ' HA2' ' A' ' 222' ' ' GLY . 36.9 mttp -76.82 -42.19 41.41 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.315 -0.624 . . . . 0.85 109.315 178.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 226' ' ' SER . . . . . 0.518 ' O ' ' HB3' ' A' ' 229' ' ' ARG . 19.9 m -63.16 -42.56 99.46 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 115.321 -0.854 . . . . 0.35 110.568 178.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 227' ' ' PHE . . . . . 0.582 ' O ' ' HG3' ' A' ' 231' ' ' MET . 13.8 t80 -65.39 -48.78 71.67 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.936 -0.575 . . . . 0.56 110.141 179.081 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 30.3 t -56.01 -39.09 71.39 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 109.549 -0.537 . . . . 0.42 109.549 178.211 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 229' ' ' ARG . . . . . 0.518 ' HB3' ' O ' ' A' ' 226' ' ' SER . 19.1 ttt180 -55.95 -44.54 78.53 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 115.165 -0.925 . . . . 0.78 110.23 177.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 47.6 t -68.78 -42.73 82.98 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-N 116.292 -0.413 . . . . 0.31 110.804 178.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 231' ' ' MET . . . . . 0.582 ' HG3' ' O ' ' A' ' 227' ' ' PHE . 47.8 mtp -58.14 -53.0 63.22 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 120.84 0.352 . . . . 0.37 111.492 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 34.5 m -65.58 -30.79 51.23 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 CA-C-N 116.484 -0.326 . . . . 0.34 111.558 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 42.4 t-80 -61.47 -54.79 38.76 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 111.76 0.282 . . . . 0.41 111.76 179.198 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.813 ' HB ' ' HB3' ' B' ' 28' ' ' ARG . 4.0 m -66.4 -29.44 46.6 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 N-CA-C 112.224 0.453 . . . . 0.36 112.224 -178.606 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 36.4 m-85 -100.63 22.18 12.26 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 111.999 0.37 . . . . 0.54 111.999 179.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . 0.438 ' HA ' ' HD2' ' A' ' 236' ' ' LYS . 14.9 tptp -79.75 -21.36 44.55 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.87 0.366 . . . . 0.93 111.545 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 237' ' ' ASP . . . . . 0.418 ' OD1' ' N ' ' A' ' 237' ' ' ASP . 0.0 OUTLIER -69.54 -15.96 63.33 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.096 -0.502 . . . . 0.5 112.085 -179.841 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 90.92 -19.25 46.88 Favored Glycine 0 CA--C 1.521 0.439 0 C-N-CA 120.929 -0.653 . . . . 0.37 113.689 179.089 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . 0.409 HG12 ' HB2' ' A' ' 237' ' ' ASP . 3.3 p -86.49 113.55 24.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.34 0.591 . . . . 0.38 110.848 179.597 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 59.7 m -93.63 106.25 18.23 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.088 0.471 . . . . 0.4 111.807 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . 0.533 ' HB2' ' HG3' ' A' ' 244' ' ' ARG . 94.8 m-20 -95.39 129.81 42.41 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.937 -0.574 . . . . 0.4 110.43 178.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 242' ' ' TRP . . . . . 0.612 ' HB3' ' CZ ' ' A' ' 300' ' ' PHE . 1.6 m95 -53.29 -41.93 66.09 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 120.938 0.399 . . . . 0.45 111.58 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . 0.44 ' HA3' ' N ' ' B' ' 35' ' ' TYR . . . -64.28 -28.46 73.03 Favored Glycine 0 CA--C 1.521 0.463 0 C-N-CA 120.815 -0.707 . . . . 0.24 112.852 179.139 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 244' ' ' ARG . . . . . 0.533 ' HG3' ' HB2' ' A' ' 241' ' ' ASN . 63.8 mtt180 -70.69 -39.06 73.7 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 122.47 -0.429 . . . . 0.41 110.127 179.194 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 64.0 mt -63.99 -52.28 58.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 CA-C-N 115.82 -0.627 . . . . 0.44 111.229 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 16.8 m -62.38 -35.87 71.82 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 C-N-CA 120.937 -0.305 . . . . 0.32 111.293 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . 0.579 ' HA ' HG11 ' A' ' 201' ' ' VAL . 99.6 m -64.05 -42.4 97.06 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.076 0.465 . . . . 0.45 109.996 178.159 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 18.9 tp -65.1 -43.6 91.55 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.774 -0.648 . . . . 2.02 110.304 178.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 249' ' ' ILE . . . . . 0.422 HG21 HD21 ' A' ' 194' ' ' LEU . 28.9 mt -64.66 -42.49 95.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 109.757 -0.46 . . . . 0.38 109.757 178.285 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 45.5 t -61.03 -38.23 85.39 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.786 -0.643 . . . . 0.42 109.842 178.084 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 251' ' ' PHE . . . . . 0.476 ' O ' HG23 ' A' ' 255' ' ' VAL . 34.1 t80 -69.88 -41.37 74.86 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.545 -0.752 . . . . 0.38 109.921 177.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -58.69 -43.93 96.03 Favored Glycine 0 C--N 1.335 0.515 0 N-CA-C 111.134 -0.786 . . . . 0.32 111.134 178.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -61.24 -40.64 94.8 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-O 120.844 0.355 . . . . 0.4 110.087 177.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -60.22 -43.44 96.02 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 116.023 -0.535 . . . . 0.66 109.793 178.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 255' ' ' VAL . . . . . 0.476 HG23 ' O ' ' A' ' 251' ' ' PHE . 64.8 t -66.26 -40.76 87.71 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-N 115.736 -0.666 . . . . 0.33 110.323 178.393 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -62.48 -45.76 91.59 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.318 -0.401 . . . . 0.32 110.155 177.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 257' ' ' LYS . . . . . 0.543 ' HG2' ' HA ' ' A' ' 171' ' ' ALA . 48.0 mtmt -58.98 -45.03 91.59 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.953 -0.567 . . . . 0.52 109.964 177.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -61.63 -34.81 76.33 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.789 -0.641 . . . . 0.35 109.903 178.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.787 ' HG ' ' HB3' ' A' ' 264' ' ' GLN . 2.9 tp -72.12 -32.62 67.12 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 121.251 0.548 . . . . 0.47 110.036 178.096 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 260' ' ' LYS . . . . . 0.669 ' HE3' ' HG3' ' A' ' 265' ' ' GLU . 0.0 OUTLIER -75.4 -31.1 60.31 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 121.118 0.485 . . . . 0.68 110.4 178.069 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 26.7 t -64.07 -19.26 65.1 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.125 -0.489 . . . . 0.49 110.71 178.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 262' ' ' VAL . . . . . 0.427 HG23 ' HB2' ' A' ' 264' ' ' GLN . 31.2 m -114.14 13.81 8.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-N 116.149 -0.478 . . . . 0.53 110.613 178.311 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 6.1 t30 55.91 49.32 16.16 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 115.521 -0.763 . . . . 1.28 112.861 179.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 264' ' ' GLN . . . . . 0.787 ' HB3' ' HG ' ' A' ' 259' ' ' LEU . 4.3 tt0 -113.26 39.13 2.67 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 112.027 0.381 . . . . 1.21 112.027 -179.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 265' ' ' GLU . . . . . 0.669 ' HG3' ' HE3' ' A' ' 260' ' ' LYS . 26.4 mt-10 -48.54 -35.96 14.38 Favored 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 112.934 0.716 . . . . 0.38 112.934 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -56.54 -24.69 48.58 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 112.377 0.51 . . . . 1.0 112.377 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 267' ' ' PHE . . . . . 0.455 ' C ' ' HD2' ' A' ' 270' ' ' PRO . 23.3 m-85 -99.37 -16.74 18.31 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 120.974 0.416 . . . . 1.19 111.001 179.214 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 268' ' ' ILE . . . . . 0.557 HD12 ' HA ' ' A' ' 265' ' ' GLU . 67.3 mt -67.15 -43.22 88.68 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-N 116.209 -0.45 . . . . 0.39 110.564 179.251 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 269' ' ' GLU . . . . . 0.711 ' HB2' ' HD3' ' A' ' 270' ' ' PRO . 2.1 mm-40 -55.26 -56.66 26.14 Favored Pre-proline 0 CA--C 1.543 0.692 0 CA-C-N 116.295 -0.411 . . . . 0.38 111.14 179.361 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 270' ' ' PRO . . . . . 0.711 ' HD3' ' HB2' ' A' ' 269' ' ' GLU . 38.1 Cg_exo -59.61 -34.89 96.47 Favored 'Trans proline' 0 C--N 1.362 1.259 0 C-N-CA 122.253 1.969 . . . . 0.36 112.247 178.295 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 271' ' ' LEU . . . . . . . . . . . . . 43.2 tp -64.91 -51.14 63.51 Favored 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 110.128 -0.323 . . . . 0.56 110.128 178.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -59.02 -42.87 91.21 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 120.997 0.427 . . . . 0.38 110.458 178.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 273' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -63.45 -44.53 94.22 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 115.912 -0.585 . . . . 1.97 110.056 178.231 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 274' ' ' THR . . . . . . . . . . . . . 99.6 m -60.31 -48.4 81.9 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.236 -0.438 . . . . 0.49 110.381 178.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 275' ' ' ILE . . . . . 0.569 ' O ' ' HB2' ' A' ' 279' ' ' LEU . 95.9 mt -54.89 -47.67 75.28 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.096 0 CA-C-N 115.982 -0.554 . . . . 0.46 110.384 179.051 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 276' ' ' THR . . . . . 0.739 HG21 ' HA ' ' A' ' 160' ' ' LEU . 37.9 m -62.95 -52.06 64.5 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.247 -0.433 . . . . 0.34 111.203 179.374 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 277' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -51.94 -53.86 36.24 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.135 -0.484 . . . . 0.46 111.21 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 278' ' ' VAL . . . . . 0.574 ' O ' HG22 ' A' ' 282' ' ' THR . 60.7 t -63.32 -43.57 98.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-O 120.47 0.176 . . . . 0.38 110.883 179.291 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 279' ' ' LEU . . . . . 0.569 ' HB2' ' O ' ' A' ' 275' ' ' ILE . 0.3 OUTLIER -56.01 -47.84 77.02 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.604 -0.271 . . . . 0.84 111.313 179.967 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 57.0 t -75.38 -48.69 30.07 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 N-CA-C 111.729 0.27 . . . . 0.43 111.729 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 281' ' ' ARG . . . . . 0.487 ' HG3' ' OH ' ' A' ' 156' ' ' TYR . 31.2 mtp180 -54.69 -40.09 68.8 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 112.941 0.719 . . . . 0.55 112.941 -179.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 282' ' ' THR . . . . . 0.574 HG22 ' O ' ' A' ' 278' ' ' VAL . 6.9 t -91.03 4.62 51.63 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 120.191 -0.603 . . . . 0.39 112.289 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . 0.661 ' HZ3' ' HB2' ' A' ' 283' ' ' LYS . 0.0 OUTLIER -141.23 40.83 1.77 Allowed 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 120.92 0.39 . . . . 0.52 111.328 179.777 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -66.1 -62.33 1.55 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.109 0.481 . . . . 0.49 111.84 -179.274 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -65.32 -45.05 85.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.912 -0.585 . . . . 0.63 112.214 -179.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 286' ' ' TRP . . . . . 0.464 ' O ' ' HB2' ' A' ' 290' ' ' GLN . 2.2 t90 -58.12 -38.89 77.37 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 112.38 0.511 . . . . 0.59 112.38 -179.214 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 287' ' ' LEU . . . . . 0.57 HD23 ' HB3' ' A' ' 283' ' ' LYS . 1.2 mm? -70.59 -49.42 47.98 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.776 0.288 . . . . 0.46 111.776 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 9.1 p -62.83 -34.32 65.25 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-O 120.752 0.31 . . . . 0.55 111.409 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 43.5 mttp -75.47 -21.55 57.99 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 120.751 0.31 . . . . 0.87 111.473 178.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 290' ' ' GLN . . . . . 0.464 ' HB2' ' O ' ' A' ' 286' ' ' TRP . 0.0 OUTLIER -100.47 29.1 4.59 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 112.66 0.615 . . . . 0.79 112.66 -179.123 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 291' ' ' ARG . . . . . 0.465 ' HD2' ' HB3' ' A' ' 294' ' ' ASP . 8.1 ttm180 64.71 13.11 8.15 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 112.809 0.67 . . . . 0.84 112.809 179.076 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 65.82 -141.13 41.41 Favored Glycine 0 CA--C 1.525 0.692 0 C-N-CA 121.04 -0.6 . . . . 0.34 114.036 179.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 293' ' ' TRP . . . . . 0.623 ' O ' HG23 ' A' ' 297' ' ' VAL . 84.7 m95 -65.39 -32.22 73.74 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.29 0.478 . . . . 0.51 112.29 -179.149 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 294' ' ' ASP . . . . . 0.465 ' HB3' ' HD2' ' A' ' 291' ' ' ARG . 16.1 t70 -59.97 -37.95 81.11 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 121.102 0.477 . . . . 0.74 109.837 178.34 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -65.3 -43.2 95.56 Favored Glycine 0 C--N 1.335 0.511 0 N-CA-C 110.786 -0.926 . . . . 0.26 110.786 177.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 296' ' ' PHE . . . . . 0.513 ' HB2' ' CH2' ' A' ' 242' ' ' TRP . 0.8 OUTLIER -63.03 -46.71 86.29 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 120.88 0.371 . . . . 0.32 110.457 177.947 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 297' ' ' VAL . . . . . 0.669 HG22 ' HA ' ' A' ' 190' ' ' ALA . 90.9 t -59.89 -49.27 84.56 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.395 0 CA-C-N 115.922 -0.581 . . . . 0.32 111.242 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -61.8 -46.57 88.95 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.066 0.395 . . . . 0.97 112.066 -179.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 299' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -61.84 -42.29 98.85 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 112.419 0.525 . . . . 0.45 112.419 -179.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 300' ' ' PHE . . . . . 0.612 ' CZ ' ' HB3' ' A' ' 242' ' ' TRP . 76.5 m-85 . . . . . 0 CA--C 1.537 0.454 0 N-CA-C 113.133 0.79 . . . . 0.39 113.133 -178.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.236 0.381 0 N-CA-C 109.527 -0.545 . . . . 0.47 109.527 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 23' ' ' PHE . . . . . 0.65 ' HB3' ' HB3' ' A' ' 212' ' ' MET . 0.0 OUTLIER -59.29 -43.84 92.53 Favored 'General case' 0 C--O 1.225 -0.198 0 CA-C-N 115.669 -0.696 . . . . 0.36 110.55 179.076 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.85 -43.35 77.0 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 115.968 -0.56 . . . . 0.32 111.515 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . 0.478 ' O ' ' HG3' ' B' ' 28' ' ' ARG . . . -61.08 -49.55 76.85 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 116.162 -0.472 . . . . 0.28 111.282 179.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 13.7 mt-30 -68.63 -42.25 78.33 Favored 'General case' 0 C--O 1.224 -0.255 0 CA-C-N 116.304 -0.407 . . . . 0.54 111.202 179.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 16.0 mt -55.53 -49.39 72.75 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.607 -0.27 . . . . 0.59 111.556 179.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 28' ' ' ARG . . . . . 0.813 ' HB3' ' HB ' ' A' ' 234' ' ' VAL . 0.0 OUTLIER -65.29 -37.04 85.95 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 120.473 -0.491 . . . . 0.56 110.519 179.267 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . 0.566 ' HA ' ' HE3' ' B' ' 29' ' ' LYS . 0.0 OUTLIER -65.71 -40.56 92.37 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 109.62 -0.511 . . . . 0.48 109.62 178.264 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 93.4 mt -63.68 -39.94 87.22 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 N-CA-C 108.51 -0.922 . . . . 0.4 108.51 176.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . 0.525 ' HA3' ' HG2' ' A' ' 244' ' ' ARG . . . -60.4 -49.55 77.31 Favored Glycine 0 C--N 1.334 0.445 0 N-CA-C 111.192 -0.763 . . . . 0.23 111.192 177.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -56.9 -38.11 72.36 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.165 0.507 . . . . 0.43 109.665 177.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.61 -58.5 5.59 Favored 'General case' 0 C--O 1.227 -0.108 0 CA-C-N 115.613 -0.721 . . . . 0.61 110.598 179.024 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 85.9 t -54.86 -39.52 48.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-O 121.185 0.517 . . . . 0.37 110.289 179.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 35' ' ' TYR . . . . . 0.44 ' N ' ' HA3' ' A' ' 243' ' ' GLY . 9.4 t80 -58.47 -52.49 65.43 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.557 -0.747 . . . . 0.45 110.804 178.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 36' ' ' CYS . . . . . 0.439 ' HA ' ' OG ' ' B' ' 39' ' ' SER . 19.9 p -70.03 -25.3 63.51 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.739 0.304 . . . . 0.4 111.033 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 30.6 m -63.71 -44.08 94.68 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.454 -0.339 . . . . 0.4 111.349 179.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 38' ' ' TRP . . . . . . . . . . . . . 95.4 m95 -85.68 -30.25 23.33 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 120.742 0.306 . . . . 0.5 111.632 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 39' ' ' SER . . . . . 0.439 ' OG ' ' HA ' ' B' ' 36' ' ' CYS . 54.7 p . . . . . 0 N--CA 1.47 0.559 0 N-CA-C 112.166 0.432 . . . . 0.66 112.166 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 . . . . . 0 CA--C 1.535 0.375 0 N-CA-C 112.197 0.443 . . . . 0.72 112.197 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -61.38 -45.32 94.86 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.765 0.317 . . . . 0.93 111.64 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 65.3 tp -61.27 -47.05 87.77 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.318 -0.401 . . . . 0.58 110.501 179.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . 0.412 ' O ' ' HB2' ' A' ' 160' ' ' LEU . 0.2 OUTLIER -66.53 -41.34 88.93 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 116.198 -0.456 . . . . 0.42 111.53 179.792 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.24 -51.94 66.83 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 112.538 0.57 . . . . 0.54 112.538 -179.411 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . 0.463 ' HA ' ' HB2' ' A' ' 183' ' ' ALA . 64.6 mt-30 -60.7 -45.55 93.79 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 120.702 0.287 . . . . 0.4 111.153 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . 0.492 ' HA ' ' CZ2' ' A' ' 293' ' ' TRP . 4.0 p -62.88 -41.9 99.57 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.392 -0.367 . . . . 0.29 111.04 179.379 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.49 HD21 ' HA ' ' A' ' 273' ' ' GLU . 0.2 OUTLIER -58.14 -47.63 82.73 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 120.839 0.352 . . . . 0.73 110.306 178.887 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -64.56 -52.33 58.2 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 112.364 0.505 . . . . 0.56 112.364 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . 0.489 HG12 ' HA2' ' A' ' 187' ' ' GLY . 90.6 mt -59.05 -46.34 91.83 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 CA-C-N 116.754 -0.203 . . . . 0.3 111.348 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 86.7 mt -67.39 -41.82 86.69 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 121.135 -0.226 . . . . 0.37 110.792 178.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 33.3 t -61.0 -44.17 97.81 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.771 0.32 . . . . 0.32 110.914 179.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . 0.479 HH21 ' CD ' ' A' ' 169' ' ' GLU . 2.7 mtp180 -69.15 -52.14 31.17 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.572 -0.285 . . . . 0.73 111.697 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' TYR . . . . . 0.692 ' HE1' ' HA ' ' A' ' 195' ' ' ARG . 64.0 t80 -56.32 -45.58 80.26 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.553 0.216 . . . . 0.35 111.508 -179.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 5.6 mp -60.47 -50.08 75.01 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 121.188 -0.205 . . . . 0.49 111.22 -179.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . 0.528 ' HD2' ' OE2' ' A' ' 269' ' ' GLU . 9.3 mtp180 -66.95 -36.65 82.7 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 112.083 0.401 . . . . 0.86 112.083 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . 0.479 ' CD ' HH21 ' A' ' 165' ' ' ARG . 0.9 OUTLIER -66.12 -51.31 59.18 Favored 'General case' 0 N--CA 1.465 0.282 0 O-C-N 122.268 -0.27 . . . . 0.65 111.391 179.436 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . 0.451 ' HB2' ' HB1' ' A' ' 253' ' ' ALA . 4.4 mm-40 -64.84 -26.22 68.24 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-O 121.014 0.435 . . . . 0.87 110.323 178.545 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.156 0 CA-C-N 115.916 -0.584 . . . . 0.47 110.714 178.222 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.463 ' HB2' ' HA ' ' A' ' 158' ' ' GLN . . . . . . . . 0 CA--C 1.536 0.433 0 CA-C-O 121.06 0.457 . . . . 0.32 111.311 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -80.07 -70.31 1.34 Allowed Glycine 0 CA--C 1.527 0.803 0 N-CA-C 114.432 0.533 . . . . 0.36 114.432 -179.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -71.71 -55.48 7.6 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-O 121.063 0.458 . . . . 0.47 111.542 -179.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -63.51 -35.2 79.69 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.974 -0.557 . . . . 0.35 110.16 179.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . 0.617 ' O ' ' HB2' ' A' ' 191' ' ' LEU . . . -63.06 -31.8 81.94 Favored Glycine 0 C--N 1.333 0.403 0 C-N-CA 120.985 -0.626 . . . . 0.33 112.468 179.117 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 6.2 tpt180 -73.07 -57.04 4.31 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 120.635 0.255 . . . . 0.85 111.645 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' ARG . . . . . 0.551 ' HA ' ' OE1' ' A' ' 192' ' ' GLU . 0.0 OUTLIER -62.54 -41.27 98.78 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-O 121.032 0.444 . . . . 0.57 111.576 -179.266 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . 0.478 ' HB2' ' HB3' ' A' ' 293' ' ' TRP . . . -66.62 -37.06 84.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.362 -0.381 . . . . 0.31 110.909 179.064 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' LEU . . . . . 0.617 ' HB2' ' O ' ' A' ' 187' ' ' GLY . 0.2 OUTLIER -59.84 -41.5 91.51 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.608 0.242 . . . . 0.6 111.293 179.915 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' GLU . . . . . 0.551 ' OE1' ' HA ' ' A' ' 189' ' ' ARG . 5.3 mt-10 -67.14 -52.38 42.4 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.129 0.49 . . . . 0.51 111.422 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . 0.565 HG21 ' HA ' ' A' ' 297' ' ' VAL . 4.6 m -65.12 -35.43 81.09 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.874 -0.603 . . . . 0.42 112.265 -179.059 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . 0.411 HD12 ' HA ' ' A' ' 194' ' ' LEU . 12.6 tp -69.79 -37.7 76.42 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.694 0.283 . . . . 0.4 111.048 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . 0.692 ' HA ' ' HE1' ' A' ' 166' ' ' TYR . 1.7 ttt180 -66.5 -45.47 79.49 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-O 120.979 0.419 . . . . 0.44 110.882 179.181 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 18.6 mmt85 -64.83 -56.58 12.6 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.821 -0.627 . . . . 0.98 111.959 -179.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . 0.458 ' O ' HG23 ' A' ' 201' ' ' VAL . 98.8 t -66.24 -41.65 89.54 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 CA-C-O 120.901 0.381 . . . . 0.38 111.423 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . 0.503 ' HA3' ' OH ' ' A' ' 166' ' ' TYR . . . -62.0 -52.39 50.46 Favored Glycine 0 CA--C 1.522 0.484 0 C-N-CA 121.178 -0.534 . . . . 0.3 113.494 -179.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -63.83 -40.14 95.88 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 117.385 0.592 . . . . 0.57 109.902 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -53.86 -44.97 71.33 Favored Glycine 0 C--N 1.337 0.599 0 C-N-CA 120.621 -0.8 . . . . 0.39 111.603 178.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . 0.556 HG13 ' HD2' ' A' ' 205' ' ' HIS . 88.9 t -72.37 -36.88 56.42 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-O 121.137 0.494 . . . . 0.38 110.949 178.582 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' GLN . . . . . 0.419 ' HA ' ' CE2' ' A' ' 209' ' ' PHE . 14.7 tt0 -64.39 -34.64 78.63 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 115.926 -0.579 . . . . 0.38 111.415 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 17.0 mmp_? -80.54 -53.75 6.29 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 112.998 0.74 . . . . 0.42 112.998 -179.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 24.1 p30 -67.33 -31.0 70.97 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 119.836 -0.745 . . . . 0.49 111.879 -179.125 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 205' ' ' HIS . . . . . 0.556 ' HD2' HG13 ' A' ' 201' ' ' VAL . 93.8 m-70 -102.31 26.86 7.28 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 121.023 -0.271 . . . . 0.49 111.25 178.54 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -53.21 -54.9 29.28 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 115.995 -0.548 . . . . 0.75 112.276 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 43.0 p -58.05 -47.12 84.1 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.078 -0.51 . . . . 0.64 111.882 -179.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -59.46 -44.61 92.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.249 -0.432 . . . . 0.43 110.285 179.088 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 209' ' ' PHE . . . . . 0.419 ' CE2' ' HA ' ' A' ' 202' ' ' GLN . 10.8 m-30 -63.77 -50.96 66.96 Favored 'General case' 0 C--O 1.223 -0.335 0 CA-C-N 115.973 -0.558 . . . . 0.44 110.751 179.246 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -57.41 -43.7 83.96 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 120.586 0.232 . . . . 0.74 111.553 179.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -61.21 -51.1 60.4 Favored Glycine 0 C--N 1.335 0.505 0 C-N-CA 120.821 -0.704 . . . . 0.43 112.345 179.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 212' ' ' MET . . . . . 0.433 ' HA ' ' HE3' ' A' ' 215' ' ' LYS . 0.7 OUTLIER -68.07 -34.82 77.15 Favored 'General case' 0 CA--C 1.531 0.212 0 O-C-N 122.592 -0.358 . . . . 0.73 111.086 179.3 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 8.7 tp -59.46 -39.22 82.92 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.96 0.409 . . . . 0.65 110.709 178.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 47.6 ttp180 -71.99 -36.3 69.73 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.944 -0.571 . . . . 1.23 110.521 178.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 215' ' ' LYS . . . . . 0.433 ' HE3' ' HA ' ' A' ' 212' ' ' MET . 52.6 mtmt -73.31 -37.46 66.18 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 116.266 -0.424 . . . . 1.33 112.021 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . 0.74 ' HB3' HG12 ' A' ' 218' ' ' ILE . 41.0 mt -63.55 131.64 48.72 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 121.147 0.498 . . . . 0.69 112.117 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -80.4 33.69 0.3 Allowed 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.005 -0.543 . . . . 1.36 111.648 179.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 218' ' ' ILE . . . . . 0.74 HG12 ' HB3' ' A' ' 216' ' ' LEU . 30.7 mm -71.42 105.47 1.78 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.302 0 CA-C-O 120.929 0.395 . . . . 0.49 111.564 -179.172 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 2.6 ttmm -163.07 -53.69 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 115.881 -0.6 . . . . 1.74 111.218 179.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 52.8 m-20 -104.41 -178.5 3.67 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 115.935 -0.575 . . . . 0.73 111.391 -179.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -46.7 -29.42 1.88 Allowed 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 113.482 0.919 . . . . 1.38 113.482 -179.272 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -62.22 -23.59 64.38 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 121.487 -0.387 . . . . 0.47 113.971 179.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 223' ' ' ASP . . . . . 0.515 ' HB2' HG23 ' A' ' 218' ' ' ILE . 2.1 p-10 -58.61 -52.15 66.89 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 113.625 0.972 . . . . 1.11 113.625 -178.297 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 19.6 m -58.66 -38.35 70.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 N-CA-C 112.205 0.446 . . . . 0.48 112.205 -179.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 85.7 mttt -69.09 -43.58 74.25 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.059 0.457 . . . . 0.86 110.29 179.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 226' ' ' SER . . . . . 0.573 ' O ' HG23 ' A' ' 230' ' ' VAL . 20.9 m -65.66 -46.6 78.54 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.84 -0.618 . . . . 0.38 110.265 179.289 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 227' ' ' PHE . . . . . 0.617 ' O ' ' HG3' ' A' ' 231' ' ' MET . 7.2 t80 -58.23 -43.34 87.73 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.918 -0.583 . . . . 0.57 110.521 179.167 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 228' ' ' SER . . . . . 0.429 ' O ' HG23 ' A' ' 232' ' ' VAL . 67.3 m -56.58 -44.16 80.75 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.023 0.44 . . . . 0.37 109.983 178.462 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 69.7 mtp180 -63.18 -35.97 82.06 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 115.885 -0.598 . . . . 1.17 110.321 178.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . 0.717 HG22 ' HE1' ' B' ' 23' ' ' PHE . 28.4 t -63.14 -51.94 65.11 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 N-CA-C 109.601 -0.518 . . . . 0.32 109.601 177.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 231' ' ' MET . . . . . 0.617 ' HG3' ' O ' ' A' ' 227' ' ' PHE . 54.0 mtp -57.23 -43.98 83.38 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.517 -0.765 . . . . 0.44 111.102 179.58 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 232' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 228' ' ' SER . 55.7 t -58.41 -40.91 80.02 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 N-CA-C 109.985 -0.376 . . . . 0.51 109.985 178.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 233' ' ' HIS . . . . . 0.571 ' HA ' ' HB2' ' A' ' 236' ' ' LYS . 54.9 t-80 -71.24 -39.96 71.34 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 116.048 -0.524 . . . . 0.58 111.039 178.725 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.519 HG23 ' O ' ' A' ' 230' ' ' VAL . 74.0 t -57.09 -38.92 63.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-O 120.749 0.309 . . . . 0.43 111.003 179.262 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -104.79 23.7 13.03 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 116.406 -0.361 . . . . 0.92 111.176 178.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . 0.571 ' HB2' ' HA ' ' A' ' 233' ' ' HIS . 5.9 tptp -70.52 -29.95 66.58 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 114.571 1.322 . . . . 1.46 114.571 -177.331 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -69.92 -16.93 63.29 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 118.643 0.656 . . . . 1.24 112.301 -178.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 98.7 -19.67 53.43 Favored Glycine 0 CA--C 1.522 0.527 0 C-N-CA 120.877 -0.678 . . . . 0.48 113.631 179.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . 0.432 ' HB ' ' NH2' ' A' ' 244' ' ' ARG . 21.8 t -77.22 118.12 23.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 121.147 0.499 . . . . 0.52 110.788 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -95.07 100.07 11.95 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.097 0.406 . . . . 0.76 112.097 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . 0.506 ' HB2' ' HG3' ' A' ' 244' ' ' ARG . 14.9 m120 -103.88 134.51 47.06 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 110.391 -0.226 . . . . 0.48 110.391 178.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 242' ' ' TRP . . . . . 0.502 ' HB3' ' CZ ' ' A' ' 300' ' ' PHE . 14.0 m95 -56.81 -27.48 59.99 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 112.127 0.417 . . . . 0.53 112.127 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . 0.412 ' H ' ' HB2' ' B' ' 35' ' ' TYR . . . -69.64 -29.57 71.27 Favored Glycine 0 CA--C 1.52 0.39 0 C-N-CA 121.186 -0.531 . . . . 0.32 112.9 179.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 244' ' ' ARG . . . . . 0.506 ' HG3' ' HB2' ' A' ' 241' ' ' ASN . 19.6 mtt180 -73.72 -37.15 65.22 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.297 0.57 . . . . 0.46 109.645 179.268 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . 0.692 HG23 HD21 ' A' ' 279' ' ' LEU . 83.0 mt -63.03 -51.8 67.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-N 115.446 -0.797 . . . . 0.46 110.998 179.197 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 17.4 m -66.71 -30.33 49.35 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 C-N-CA 120.795 -0.362 . . . . 0.36 111.322 179.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 17.4 m -64.07 -46.54 83.83 Favored 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 110.248 -0.278 . . . . 0.43 110.248 178.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 248' ' ' LEU . . . . . 0.449 HD13 ' HA ' ' A' ' 248' ' ' LEU . 2.5 mm? -60.82 -35.91 77.74 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 120.688 0.28 . . . . 0.66 110.769 178.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 249' ' ' ILE . . . . . 0.563 HG12 ' O ' ' A' ' 245' ' ' ILE . 35.5 mm -71.88 -47.08 57.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 CA-C-O 120.868 0.366 . . . . 0.4 110.436 178.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 39.6 t -59.59 -42.02 91.62 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 121.156 0.503 . . . . 0.31 109.708 178.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 251' ' ' PHE . . . . . 0.441 ' O ' HG23 ' A' ' 255' ' ' VAL . 8.9 t80 -65.72 -44.03 87.31 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 115.607 -0.724 . . . . 0.39 109.825 177.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -57.29 -41.63 93.08 Favored Glycine 0 C--N 1.338 0.653 0 N-CA-C 111.623 -0.591 . . . . 0.28 111.623 178.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 253' ' ' ALA . . . . . 0.451 ' HB1' ' HB2' ' A' ' 170' ' ' GLN . . . -63.83 -40.4 96.53 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 120.808 0.337 . . . . 0.3 110.513 177.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 21.9 t80 -67.51 -38.97 85.08 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-O 121.454 0.645 . . . . 0.52 109.944 178.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 255' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 251' ' ' PHE . 63.5 t -65.0 -46.65 90.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.775 -0.648 . . . . 0.39 109.445 178.021 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -57.91 -36.62 72.71 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.306 -0.406 . . . . 0.27 110.195 178.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 23.3 ttmm -60.21 -45.09 94.37 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 115.663 -0.699 . . . . 2.05 111.45 178.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 258' ' ' HIS . . . . . 0.434 ' CE1' HD13 ' A' ' 259' ' ' LEU . 0.3 OUTLIER -65.95 -34.97 79.33 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 120.731 0.3 . . . . 0.39 111.132 179.538 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.623 ' HG ' ' HB3' ' A' ' 264' ' ' GLN . 3.5 tp -76.83 -46.19 25.75 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 116.551 -0.295 . . . . 0.45 111.485 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 42.7 tttp -63.04 -27.23 69.26 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 120.608 0.242 . . . . 0.41 111.353 179.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 57.8 m -57.98 -26.74 62.73 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 121.004 0.43 . . . . 0.44 110.817 178.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 15.9 m -114.53 23.42 5.25 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 CA-C-O 121.305 0.574 . . . . 0.46 110.093 178.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 263' ' ' ASN . . . . . 0.458 ' HA ' ' OE2' ' A' ' 265' ' ' GLU . 1.7 m120 54.19 59.99 3.87 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 114.948 -1.024 . . . . 0.65 113.475 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 264' ' ' GLN . . . . . 0.623 ' HB3' ' HG ' ' A' ' 259' ' ' LEU . 5.9 mt-30 -119.86 35.61 4.79 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.238 -0.437 . . . . 0.91 110.771 178.485 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 265' ' ' GLU . . . . . 0.562 ' HA ' HG12 ' A' ' 268' ' ' ILE . 0.9 OUTLIER -59.9 -25.0 64.76 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 112.422 0.527 . . . . 0.62 112.422 -179.568 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 16.6 p -64.02 -16.69 62.21 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 120.586 0.231 . . . . 0.86 111.285 179.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 267' ' ' PHE . . . . . 0.506 ' O ' ' HD2' ' A' ' 270' ' ' PRO . 28.6 m-85 -98.96 -32.35 11.34 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 120.982 0.42 . . . . 1.07 111.333 179.082 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 268' ' ' ILE . . . . . 0.562 HG12 ' HA ' ' A' ' 265' ' ' GLU . 20.3 pt -68.07 -28.86 42.64 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 120.955 -0.298 . . . . 0.41 111.453 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 269' ' ' GLU . . . . . 0.844 ' HB2' ' HD3' ' A' ' 270' ' ' PRO . 39.0 mm-40 -57.27 -57.02 27.81 Favored Pre-proline 0 CA--C 1.546 0.82 0 N-CA-C 110.028 -0.36 . . . . 0.66 110.028 178.09 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 270' ' ' PRO . . . . . 0.844 ' HD3' ' HB2' ' A' ' 269' ' ' GLU . 32.0 Cg_exo -62.09 -30.51 82.67 Favored 'Trans proline' 0 C--N 1.362 1.287 0 C-N-CA 122.291 1.994 . . . . 0.44 111.605 177.07 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 271' ' ' LEU . . . . . . . . . . . . . 40.3 tp -64.93 -40.25 94.75 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.114 -0.494 . . . . 0.57 109.751 177.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -63.39 -40.31 96.88 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 109.096 -0.705 . . . . 0.43 109.096 177.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 273' ' ' GLU . . . . . 0.574 ' OE1' ' HA ' ' A' ' 270' ' ' PRO . 35.0 mt-10 -63.49 -41.94 98.54 Favored 'General case' 0 C--O 1.223 -0.332 0 N-CA-C 108.693 -0.854 . . . . 0.8 108.693 177.009 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 274' ' ' THR . . . . . . . . . . . . . 10.1 m -60.32 -53.19 60.63 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.387 -0.824 . . . . 0.54 110.905 178.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 275' ' ' ILE . . . . . 0.614 HG23 ' HE3' ' A' ' 231' ' ' MET . 97.3 mt -58.09 -46.0 88.3 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-N 116.127 -0.488 . . . . 0.48 111.042 179.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 16.6 m -66.21 -49.51 67.03 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.337 -0.392 . . . . 0.41 111.539 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 277' ' ' ASP . . . . . 0.633 ' OD1' ' HD2' ' A' ' 281' ' ' ARG . 25.8 t0 -58.65 -56.34 23.44 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.335 -0.393 . . . . 0.59 111.975 -179.146 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 278' ' ' VAL . . . . . 0.515 HG11 ' HB2' ' A' ' 231' ' ' MET . 61.6 t -58.98 -37.76 69.55 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 120.924 -0.31 . . . . 0.49 111.237 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 279' ' ' LEU . . . . . 0.692 HD21 HG23 ' A' ' 245' ' ' ILE . 28.1 tp -65.7 -46.5 78.79 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 111.98 0.363 . . . . 0.97 111.98 179.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 66.3 t -79.62 -51.25 16.76 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 N-CA-C 112.196 0.443 . . . . 0.53 112.196 -179.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 281' ' ' ARG . . . . . 0.633 ' HD2' ' OD1' ' A' ' 277' ' ' ASP . 3.0 mtt180 -55.11 -38.43 68.15 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 113.205 0.817 . . . . 0.92 113.205 -179.184 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 282' ' ' THR . . . . . . . . . . . . . 2.7 m -82.07 -12.7 58.11 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 112.332 0.493 . . . . 0.59 112.332 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 67.8 mmtt -135.04 41.55 2.83 Favored 'General case' 0 N--CA 1.468 0.47 0 O-C-N 122.063 -0.398 . . . . 0.95 111.774 -179.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 57.3 mtp180 -55.41 -54.44 43.74 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 112.805 0.669 . . . . 0.69 112.805 -178.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -56.98 -46.0 82.54 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 120.924 0.392 . . . . 0.63 111.85 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 286' ' ' TRP . . . . . 0.418 ' O ' ' HB2' ' A' ' 290' ' ' GLN . 0.8 OUTLIER -67.45 -43.1 81.91 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.029 0.381 . . . . 0.59 112.029 -179.375 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -69.13 -46.24 68.13 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 112.373 0.509 . . . . 0.56 112.373 -179.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 9.3 p -63.6 -37.11 78.75 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 121.059 -0.256 . . . . 0.57 111.588 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 64.9 mttt -75.03 -24.76 58.38 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 120.759 0.314 . . . . 0.98 111.301 179.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 290' ' ' GLN . . . . . 0.418 ' HB2' ' O ' ' A' ' 286' ' ' TRP . 0.0 OUTLIER -91.75 2.98 56.13 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 112.122 0.416 . . . . 0.58 112.122 179.907 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 291' ' ' ARG . . . . . 0.446 HH11 ' HD2' ' A' ' 291' ' ' ARG . 29.5 mtm180 64.06 17.19 10.48 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 112.493 0.553 . . . . 0.46 112.493 179.393 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 64.75 -114.58 6.91 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 114.852 0.701 . . . . 0.34 114.852 178.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 293' ' ' TRP . . . . . 0.492 ' CZ2' ' HA ' ' A' ' 159' ' ' SER . 82.2 m95 -66.26 -36.76 83.83 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 113.262 0.838 . . . . 0.49 113.262 -177.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 294' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -58.69 -47.5 84.32 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 120.826 0.346 . . . . 0.5 110.45 179.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -69.18 -27.5 73.69 Favored Glycine 0 CA--C 1.522 0.471 0 C-N-CA 120.397 -0.906 . . . . 0.29 111.481 178.081 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 296' ' ' PHE . . . . . 0.47 ' HB3' ' HA ' ' A' ' 293' ' ' TRP . 1.9 t80 -70.2 -48.32 57.63 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 122.561 0.345 . . . . 0.37 111.27 179.057 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 297' ' ' VAL . . . . . 0.565 ' HA ' HG21 ' A' ' 193' ' ' THR . 33.9 m -66.95 -32.62 58.81 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 CA-C-O 120.605 0.241 . . . . 0.36 111.388 -179.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -64.71 -53.54 45.67 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.791 0.329 . . . . 0.43 111.429 179.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 299' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -64.19 -33.83 76.69 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.322 -0.399 . . . . 0.6 111.952 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 300' ' ' PHE . . . . . 0.502 ' CZ ' ' HB3' ' A' ' 242' ' ' TRP . 70.2 m-85 . . . . . 0 C--N 1.325 -0.463 0 N-CA-C 112.515 0.561 . . . . 0.56 112.515 -179.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 7.4 tm-20 . . . . . 0 CA--C 1.531 0.22 0 CA-C-O 120.618 0.247 . . . . 1.46 110.596 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 23' ' ' PHE . . . . . 0.717 ' HE1' HG22 ' A' ' 230' ' ' VAL . 10.7 p90 -63.09 -35.41 80.17 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.104 0.478 . . . . 0.55 110.63 179.363 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.34 -44.62 64.74 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.986 -0.552 . . . . 0.36 109.986 178.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.05 -44.72 96.97 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.923 -0.58 . . . . 0.48 110.172 177.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 1.2 tp-100 -58.59 -48.9 79.4 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 115.548 -0.751 . . . . 0.88 110.161 178.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 45.6 mt -58.75 -40.55 84.17 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.292 -0.413 . . . . 0.47 110.637 178.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.89 -51.14 70.55 Favored 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 109.736 -0.468 . . . . 0.41 109.736 178.472 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 46.9 mtpt -55.61 -45.17 77.51 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 116.25 -0.432 . . . . 0.66 110.008 178.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . 0.514 ' O ' HG23 ' B' ' 34' ' ' VAL . 95.5 mt -59.21 -44.96 93.13 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 N-CA-C 109.719 -0.474 . . . . 0.45 109.719 178.123 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . 0.47 ' HA3' ' HG2' ' A' ' 244' ' ' ARG . . . -60.4 -49.55 77.35 Favored Glycine 0 C--N 1.336 0.534 0 CA-C-N 116.028 -0.533 . . . . 0.3 112.302 178.579 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -58.77 -38.82 79.34 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.18 0.514 . . . . 0.43 110.121 178.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -68.28 -47.67 67.03 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 115.75 -0.659 . . . . 0.98 111.353 179.247 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 34' ' ' VAL . . . . . 0.514 HG23 ' O ' ' B' ' 30' ' ' ILE . 53.9 t -56.65 -50.06 75.49 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-O 120.717 0.294 . . . . 0.34 111.422 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 35' ' ' TYR . . . . . 0.412 ' HB2' ' H ' ' A' ' 243' ' ' GLY . 0.0 OUTLIER -61.86 -38.57 88.73 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 120.881 0.372 . . . . 0.77 110.345 178.995 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 36' ' ' CYS . . . . . . . . . . . . . 21.4 t -68.03 -25.4 65.36 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.205 -0.452 . . . . 0.67 111.226 179.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 20.4 m -82.78 -42.14 18.31 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.189 -0.46 . . . . 0.49 111.977 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 38' ' ' TRP . . . . . . . . . . . . . 99.2 m95 -80.78 -22.9 39.69 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 112.54 0.571 . . . . 0.66 112.54 -179.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 20.3 t . . . . . 0 N--CA 1.468 0.472 0 N-CA-C 112.283 0.475 . . . . 0.76 112.283 179.888 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . 0.504 ' HA ' ' HB3' ' A' ' 156' ' ' TYR . 2.3 m-20 . . . . . 0 C--O 1.233 0.21 0 CA-C-O 120.904 0.383 . . . . 0.46 110.867 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -56.16 -37.09 69.06 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 121.368 0.604 . . . . 0.48 109.42 177.593 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 53.6 tp -83.44 -32.29 26.15 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.696 -0.684 . . . . 0.62 109.674 178.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . 0.504 ' HB3' ' HA ' ' A' ' 153' ' ' ASP . 83.3 t80 -62.18 -37.45 85.31 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 115.767 -0.651 . . . . 0.39 110.647 178.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 0.475 ' NH2' HD23 ' A' ' 160' ' ' LEU . 0.7 OUTLIER -59.25 -44.88 92.36 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.039 0.447 . . . . 0.34 110.637 178.727 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -74.32 -35.3 63.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.253 -0.43 . . . . 0.66 110.014 178.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . 0.467 ' HA ' ' NE1' ' A' ' 293' ' ' TRP . 64.8 m -59.03 -57.69 11.94 Favored 'General case' 0 CA--C 1.521 -0.144 0 CA-C-N 115.854 -0.612 . . . . 0.25 110.645 178.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.475 HD23 ' NH2' ' A' ' 157' ' ' ARG . 46.9 tp -62.01 -36.93 83.02 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 121.077 -0.249 . . . . 0.35 110.757 179.306 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.02 -54.11 50.78 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 120.792 0.329 . . . . 0.43 110.649 179.037 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . 0.517 HG12 ' HA2' ' A' ' 187' ' ' GLY . 54.8 mt -63.77 -45.45 97.2 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-N 116.093 -0.503 . . . . 0.28 111.381 179.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.466 ' O ' ' HG ' ' A' ' 167' ' ' LEU . 54.8 mt -61.33 -46.73 96.01 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 CA-C-N 116.5 -0.318 . . . . 0.33 111.243 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 31.4 t -62.34 -45.38 93.44 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.876 0.369 . . . . 0.38 110.495 178.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . 0.47 ' O ' ' HB2' ' A' ' 169' ' ' GLU . 0.0 OUTLIER -61.84 -46.13 90.8 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.2 -0.455 . . . . 0.66 111.587 -179.894 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' TYR . . . . . 0.864 ' HE1' ' HA ' ' A' ' 195' ' ' ARG . 91.6 t80 -70.36 -54.14 13.75 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 112.634 0.605 . . . . 0.4 112.634 -179.289 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.466 ' HG ' ' O ' ' A' ' 163' ' ' ILE . 29.8 mt -58.71 -49.74 76.48 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 112.516 0.561 . . . . 0.33 112.516 -177.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -66.03 -39.02 89.84 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 112.274 0.472 . . . . 1.09 112.274 -179.2 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . 0.47 ' HB2' ' O ' ' A' ' 165' ' ' ARG . 14.3 mm-40 -71.19 -47.93 54.62 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 120.56 -0.456 . . . . 0.44 111.755 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . 0.456 ' O ' ' HG3' ' A' ' 170' ' ' GLN . 0.5 OUTLIER -62.27 -28.02 69.42 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 120.918 0.39 . . . . 1.06 111.159 179.129 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.482 ' HB2' ' HB1' ' A' ' 256' ' ' ALA . . . . . . . . 0 N--CA 1.465 0.279 0 N-CA-C 112.7 0.63 . . . . 0.43 112.7 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.518 ' O ' ' HA3' ' A' ' 187' ' ' GLY . . . . . . . . 0 CA--C 1.536 0.416 0 CA-C-O 121.138 0.495 . . . . 0.33 111.542 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -80.43 -71.59 1.27 Allowed Glycine 0 CA--C 1.525 0.691 0 C-N-CA 120.88 -0.676 . . . . 0.34 113.986 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -66.83 -55.58 14.17 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 120.823 0.345 . . . . 0.42 111.808 -179.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -66.26 -37.04 84.53 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.265 -0.425 . . . . 0.36 110.235 179.192 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . 0.518 ' HA3' ' O ' ' A' ' 183' ' ' ALA . . . -64.85 -41.25 97.58 Favored Glycine 0 C--N 1.334 0.462 0 C-N-CA 120.909 -0.662 . . . . 0.29 112.667 179.282 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . 0.453 HH11 ' HD2' ' A' ' 188' ' ' ARG . 13.5 ttt180 -62.31 -53.47 54.63 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.621 0.248 . . . . 0.51 110.666 178.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' ARG . . . . . 0.757 ' HB3' HG11 ' A' ' 297' ' ' VAL . 73.7 mtt180 -59.63 -44.9 93.31 Favored 'General case' 0 C--O 1.228 -0.072 0 CA-C-N 116.24 -0.436 . . . . 0.41 110.98 179.549 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -69.45 -37.86 77.55 Favored 'General case' 0 C--O 1.218 -0.558 0 N-CA-C 112.817 0.673 . . . . 0.28 112.817 -178.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 18.6 tp -64.41 -49.15 72.68 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 118.178 0.444 . . . . 0.6 111.911 -179.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.4 -36.02 81.79 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.853 0.358 . . . . 0.4 111.044 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . 0.505 HG21 ' HA ' ' A' ' 297' ' ' VAL . 48.2 m -73.05 -44.91 60.1 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.578 -0.283 . . . . 0.31 110.673 179.287 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . 0.474 HD21 HG21 ' A' ' 249' ' ' ILE . 14.7 tp -62.03 -36.46 81.64 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.41 -0.359 . . . . 0.39 110.531 179.181 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . 0.864 ' HA ' ' HE1' ' A' ' 166' ' ' TYR . 0.8 OUTLIER -63.96 -55.72 20.38 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.015 0.436 . . . . 0.35 110.683 178.449 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.33 -47.9 83.65 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.457 -0.792 . . . . 1.33 112.41 -179.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . 0.524 ' O ' HG23 ' A' ' 201' ' ' VAL . 83.0 t -72.82 -49.73 38.04 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 N-CA-C 111.97 0.359 . . . . 0.32 111.97 -179.461 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . 0.507 ' O ' ' HG2' ' A' ' 202' ' ' GLN . . . -57.61 -53.38 45.54 Favored Glycine 0 C--N 1.334 0.462 0 C-N-CA 121.187 -0.53 . . . . 0.33 112.498 -179.568 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . 0.551 ' HB2' ' O ' ' A' ' 195' ' ' ARG . 0.3 OUTLIER -59.17 -40.65 86.29 Favored 'General case' 0 C--O 1.224 -0.262 0 N-CA-C 109.841 -0.429 . . . . 0.72 109.841 178.783 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -62.4 -50.01 68.71 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 120.898 -0.668 . . . . 0.36 112.604 178.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . 0.524 HG23 ' O ' ' A' ' 197' ' ' VAL . 78.1 t -55.88 -52.63 47.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-O 120.743 0.306 . . . . 0.38 111.764 179.275 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' GLN . . . . . 0.533 ' HG3' ' CZ ' ' A' ' 203' ' ' ARG . 1.4 pt20 -69.53 -31.75 70.17 Favored 'General case' 0 C--O 1.221 -0.432 0 N-CA-C 112.091 0.404 . . . . 0.43 112.091 -179.382 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' ARG . . . . . 0.533 ' CZ ' ' HG3' ' A' ' 202' ' ' GLN . 0.0 OUTLIER -68.77 -43.43 75.77 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.955 0.407 . . . . 0.73 109.997 178.003 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 18.2 m-80 -66.35 -47.09 74.56 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 121.163 0.506 . . . . 0.6 110.604 178.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -97.76 36.26 1.55 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.028 -0.533 . . . . 0.47 110.216 179.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . 0.528 ' OE1' ' HA ' ' A' ' 203' ' ' ARG . 4.5 tp10 -49.72 -52.0 34.6 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 115.477 -0.783 . . . . 0.47 112.186 -178.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 64.7 p -65.66 -38.96 90.78 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.595 0.591 . . . . 0.59 112.595 -179.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -63.85 -45.51 89.17 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.066 0.46 . . . . 0.4 110.449 179.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -71.13 -42.34 69.34 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.976 -0.557 . . . . 0.48 110.475 179.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 210' ' ' GLN . . . . . 0.415 ' O ' ' HG3' ' A' ' 214' ' ' ARG . 6.7 tt0 -62.58 -45.88 90.89 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.188 -0.46 . . . . 0.81 110.852 179.243 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -59.93 -49.45 78.41 Favored Glycine 0 C--N 1.334 0.47 0 C-N-CA 120.902 -0.666 . . . . 0.32 111.82 178.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 212' ' ' MET . . . . . 0.488 ' SD ' ' HA ' ' B' ' 23' ' ' PHE . 2.0 ttp -60.91 -36.34 79.02 Favored 'General case' 0 C--O 1.224 -0.257 0 CA-C-O 120.884 0.374 . . . . 0.51 110.002 178.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.409 HD13 ' HD2' ' A' ' 254' ' ' PHE . 7.8 tp -68.1 -39.93 82.7 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.663 -0.699 . . . . 0.55 110.919 178.684 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 214' ' ' ARG . . . . . 0.415 ' HG3' ' O ' ' A' ' 210' ' ' GLN . 70.0 mtt-85 -57.54 -39.34 76.41 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.163 -0.471 . . . . 0.81 110.759 178.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 215' ' ' LYS . . . . . 0.428 ' HE3' ' HB2' ' A' ' 215' ' ' LYS . 47.2 mtmt -99.01 12.13 36.91 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.099 -0.5 . . . . 0.63 111.191 179.055 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . 0.425 HD21 HD12 ' A' ' 218' ' ' ILE . 28.0 tp -82.41 110.41 17.53 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.948 0.404 . . . . 0.45 111.14 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 35.8 m-20 -79.43 32.74 0.24 Allowed 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 112.437 0.532 . . . . 0.59 112.437 -179.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 218' ' ' ILE . . . . . 0.525 HG23 ' HB2' ' A' ' 223' ' ' ASP . 2.7 mt -81.18 107.68 13.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 CA-C-O 121.424 0.63 . . . . 0.42 110.634 179.155 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . 0.477 ' HG2' HE22 ' A' ' 264' ' ' GLN . 0.4 OUTLIER -161.3 -39.24 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 115.252 -0.885 . . . . 0.49 111.209 179.396 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -105.11 -177.46 3.37 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.5 -0.318 . . . . 0.59 111.853 -179.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -49.53 -21.68 1.03 Allowed 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 113.677 0.992 . . . . 0.66 113.677 -179.133 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -69.55 -23.81 76.45 Favored Glycine 0 CA--C 1.531 1.074 0 N-CA-C 114.265 0.466 . . . . 0.41 114.265 -179.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 223' ' ' ASP . . . . . 0.525 ' HB2' HG23 ' A' ' 218' ' ' ILE . 6.5 p-10 -55.48 -56.52 19.23 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 113.711 1.004 . . . . 0.89 113.711 -177.449 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.524 ' HB ' HG21 ' A' ' 274' ' ' THR . 17.2 m -61.53 -33.38 56.83 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-O 121.038 0.447 . . . . 0.45 111.672 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 48.2 mttp -70.26 -39.14 75.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.085 0.469 . . . . 0.91 110.478 179.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 226' ' ' SER . . . . . 0.658 ' O ' HG23 ' A' ' 230' ' ' VAL . 7.3 t -74.19 -44.69 52.43 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.095 -0.502 . . . . 0.89 110.652 179.113 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 227' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -57.99 -46.62 84.91 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.969 0.414 . . . . 0.46 110.853 179.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 228' ' ' SER . . . . . 0.486 ' CB ' HG21 ' A' ' 278' ' ' VAL . 16.3 p -65.78 -39.37 90.91 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.735 -0.469 . . . . 0.38 109.735 178.483 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 42.6 ttp180 -60.08 -45.39 93.06 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.198 -0.456 . . . . 1.08 110.202 177.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . 0.658 HG23 ' O ' ' A' ' 226' ' ' SER . 99.8 t -59.39 -48.0 88.66 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-N 116.017 -0.538 . . . . 0.35 110.353 178.48 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 231' ' ' MET . . . . . 0.745 ' HG3' HD13 ' A' ' 248' ' ' LEU . 29.6 ttm -55.22 -41.15 71.69 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.046 -0.524 . . . . 0.35 111.553 179.606 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 232' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 228' ' ' SER . 85.2 t -66.93 -36.1 76.32 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-O 121.037 0.446 . . . . 0.54 111.079 179.287 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 44.8 t-80 -77.2 -36.36 54.98 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 116.415 -0.357 . . . . 0.47 111.636 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.445 HG23 ' O ' ' A' ' 230' ' ' VAL . 52.0 t -56.58 -39.63 63.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 CA-C-O 120.867 0.365 . . . . 0.4 111.49 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 235' ' ' PHE . . . . . 0.826 ' HE2' HD11 ' A' ' 248' ' ' LEU . 75.7 m-85 -100.29 24.25 9.03 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.031 0.382 . . . . 0.36 112.031 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 3.2 ttpp -73.1 -10.91 60.29 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 120.541 0.21 . . . . 0.87 111.489 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 22.2 p-10 -89.06 -10.38 47.66 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 120.731 0.301 . . . . 0.38 111.061 179.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 91.52 -19.23 48.92 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 114.487 0.555 . . . . 0.35 114.487 178.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . 0.548 ' HB ' ' NH2' ' A' ' 244' ' ' ARG . 17.9 t -78.78 102.81 5.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 O-C-N 122.23 -0.571 . . . . 0.41 111.305 -179.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 240' ' ' THR . . . . . 0.481 ' HA ' ' CE1' ' A' ' 235' ' ' PHE . 24.1 m -93.25 84.03 4.72 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.112 0.482 . . . . 0.36 111.344 -179.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . 0.422 ' HB2' ' HG3' ' A' ' 244' ' ' ARG . 80.5 m-20 -89.09 141.03 28.85 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.316 -0.402 . . . . 0.42 111.338 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 242' ' ' TRP . . . . . 0.435 ' HE1' ' HG2' ' A' ' 290' ' ' GLN . 18.9 m95 -57.93 -37.89 74.91 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.759 0.314 . . . . 0.52 111.112 179.533 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . 0.468 ' H ' ' HB2' ' B' ' 35' ' ' TYR . . . -60.04 -30.89 71.18 Favored Glycine 0 C--N 1.335 0.503 0 C-N-CA 120.991 -0.623 . . . . 0.23 112.047 178.492 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 244' ' ' ARG . . . . . 0.548 ' NH2' ' HB ' ' A' ' 239' ' ' VAL . 26.1 mtt180 -75.45 -48.06 24.43 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.969 0.414 . . . . 0.34 109.959 178.526 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . 0.545 HG23 HD11 ' A' ' 279' ' ' LEU . 73.3 mt -56.5 -44.93 81.72 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-N 115.449 -0.796 . . . . 0.47 110.625 179.53 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 9.9 p -70.94 -32.38 48.37 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-N 116.322 -0.399 . . . . 0.33 110.819 178.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 15.8 m -63.09 -38.02 89.54 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 122.293 -0.254 . . . . 0.37 110.567 179.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 248' ' ' LEU . . . . . 0.826 HD11 ' HE2' ' A' ' 235' ' ' PHE . 26.3 mt -62.83 -41.89 99.51 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 121.3 0.571 . . . . 0.59 109.799 177.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 249' ' ' ILE . . . . . 0.474 HG21 HD21 ' A' ' 194' ' ' LEU . 32.8 mm -68.53 -36.06 73.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 CA-C-N 115.694 -0.685 . . . . 0.51 109.571 178.197 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 40.6 t -63.3 -45.06 93.12 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 109.288 -0.634 . . . . 0.37 109.288 178.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 251' ' ' PHE . . . . . 0.457 ' O ' HG23 ' A' ' 255' ' ' VAL . 10.9 t80 -64.09 -41.02 97.46 Favored 'General case' 0 N--CA 1.456 -0.165 0 N-CA-C 108.766 -0.827 . . . . 0.42 108.766 177.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -57.57 -44.73 93.75 Favored Glycine 0 C--N 1.337 0.588 0 N-CA-C 110.946 -0.861 . . . . 0.28 110.946 177.161 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 253' ' ' ALA . . . . . 0.471 ' O ' ' HG3' ' A' ' 257' ' ' LYS . . . -63.95 -32.02 73.4 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 121.0 0.428 . . . . 0.27 110.899 177.485 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 254' ' ' PHE . . . . . 0.409 ' HD2' HD13 ' A' ' 213' ' ' LEU . 1.1 t80 -68.8 -45.05 72.27 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 121.164 0.507 . . . . 0.64 109.634 178.176 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 255' ' ' VAL . . . . . 0.457 HG23 ' O ' ' A' ' 251' ' ' PHE . 59.3 t -64.22 -38.36 82.3 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-N 115.783 -0.644 . . . . 0.4 109.743 178.019 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 256' ' ' ALA . . . . . 0.482 ' HB1' ' HB2' ' A' ' 171' ' ' ALA . . . -57.99 -47.45 82.96 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 115.892 -0.595 . . . . 0.22 110.067 178.316 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 257' ' ' LYS . . . . . 0.471 ' HG3' ' O ' ' A' ' 253' ' ' ALA . 49.5 mttp -59.25 -49.13 79.04 Favored 'General case' 0 N--CA 1.462 0.137 0 N-CA-C 110.066 -0.346 . . . . 0.34 110.066 178.069 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 81.4 t60 -57.59 -45.78 84.85 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 115.81 -0.632 . . . . 0.68 111.738 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 4.9 mp -69.53 -41.89 75.4 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.449 -0.341 . . . . 0.49 111.519 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 1.3 tmtm? -67.44 -32.48 73.38 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-O 120.476 0.179 . . . . 0.49 111.177 179.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 54.2 m -63.98 -27.64 69.27 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 120.893 0.378 . . . . 0.43 111.151 179.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 29.9 m -105.89 10.96 8.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-O 121.002 0.43 . . . . 0.51 110.702 178.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 61.34 36.76 17.42 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 113.231 0.826 . . . . 0.57 113.231 179.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 264' ' ' GLN . . . . . 0.477 HE22 ' HG2' ' A' ' 219' ' ' LYS . 5.4 mt-30 -105.33 37.67 2.14 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.337 0.589 . . . . 0.76 110.22 178.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -56.65 -22.72 36.46 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 113.306 0.854 . . . . 0.46 113.306 -179.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 10.7 p -61.35 -18.75 60.13 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.556 0.217 . . . . 0.67 111.271 179.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 267' ' ' PHE . . . . . 0.402 ' C ' ' HD2' ' A' ' 270' ' ' PRO . 92.6 m-85 -96.22 -22.57 17.18 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 120.837 0.351 . . . . 0.96 110.772 178.453 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 60.1 mt -67.18 -44.79 87.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-N 116.361 -0.382 . . . . 0.35 111.093 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 269' ' ' GLU . . . . . 0.618 ' HB2' ' HD3' ' A' ' 270' ' ' PRO . 1.0 OUTLIER -53.64 -56.38 25.52 Favored Pre-proline 0 CA--C 1.547 0.847 0 CA-C-N 116.254 -0.43 . . . . 0.61 111.643 179.706 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 270' ' ' PRO . . . . . 0.618 ' HD3' ' HB2' ' A' ' 269' ' ' GLU . 27.5 Cg_exo -64.34 -28.87 63.32 Favored 'Trans proline' 0 C--N 1.36 1.161 0 C-N-CA 122.105 1.87 . . . . 0.37 112.333 178.554 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 271' ' ' LEU . . . . . . . . . . . . . 38.3 tp -65.19 -43.21 92.36 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.4 -0.364 . . . . 0.41 110.586 178.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -58.84 -46.97 86.45 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.259 -0.428 . . . . 0.37 111.246 179.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 273' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -65.44 -42.94 91.88 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.534 -0.303 . . . . 0.68 110.403 178.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 274' ' ' THR . . . . . 0.524 HG21 ' HB ' ' A' ' 224' ' ' VAL . 85.9 m -58.86 -50.35 74.33 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.235 -0.438 . . . . 0.39 110.411 179.148 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 96.9 mt -59.44 -54.41 34.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.105 -0.498 . . . . 0.36 110.351 178.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 21.0 m -56.61 -52.99 62.73 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 113.105 0.78 . . . . 0.33 113.105 -179.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 277' ' ' ASP . . . . . 0.486 ' O ' ' HD2' ' A' ' 281' ' ' ARG . 0.2 OUTLIER -56.41 -53.7 54.34 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.445 0.164 . . . . 0.4 111.433 -179.212 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 278' ' ' VAL . . . . . 0.486 HG21 ' CB ' ' A' ' 228' ' ' SER . 89.3 t -60.68 -38.55 78.9 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 CA-C-O 120.796 0.331 . . . . 0.35 110.804 179.363 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 279' ' ' LEU . . . . . 0.545 HD11 HG23 ' A' ' 245' ' ' ILE . 2.4 tp -62.0 -47.08 86.39 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 116.421 -0.354 . . . . 0.78 111.881 179.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 61.9 t -76.56 -40.88 34.26 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 N-CA-C 112.47 0.544 . . . . 0.36 112.47 -179.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 281' ' ' ARG . . . . . 0.486 ' HD2' ' O ' ' A' ' 277' ' ' ASP . 0.0 OUTLIER -66.31 -28.5 68.73 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 112.474 0.546 . . . . 0.37 112.474 -179.356 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 282' ' ' THR . . . . . . . . . . . . . 25.3 p -85.32 -64.15 1.2 Allowed 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.063 0.459 . . . . 0.42 112.024 179.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 22.3 mtmm -88.99 40.74 0.99 Allowed 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.24 0.459 . . . . 0.46 112.24 -178.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 284' ' ' ARG . . . . . 0.467 ' O ' HG22 ' A' ' 288' ' ' VAL . 2.9 ptp85 -57.66 -46.17 84.57 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 112.136 0.421 . . . . 0.48 112.136 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 285' ' ' ASP . . . . . 0.439 ' O ' ' HB2' ' A' ' 289' ' ' LYS . 8.0 t70 -62.13 -51.52 67.54 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 111.87 0.322 . . . . 0.42 111.87 -179.24 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 286' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -61.83 -33.07 73.5 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.862 0.363 . . . . 0.42 111.234 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -70.81 -52.47 20.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.228 -0.442 . . . . 0.39 110.809 178.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 288' ' ' VAL . . . . . 0.467 HG22 ' O ' ' A' ' 284' ' ' ARG . 27.6 m -64.36 -30.68 50.83 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-O 120.813 0.34 . . . . 0.38 111.821 179.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 289' ' ' LYS . . . . . 0.439 ' HB2' ' O ' ' A' ' 285' ' ' ASP . 0.3 OUTLIER -68.36 -40.81 81.35 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 112.294 0.479 . . . . 0.47 112.294 -179.808 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 290' ' ' GLN . . . . . 0.465 ' O ' ' HA3' ' A' ' 295' ' ' GLY . 0.8 OUTLIER -96.94 30.05 2.84 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 112.867 0.692 . . . . 0.57 112.867 -178.9 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 33.1 mtm105 58.37 23.66 10.79 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 112.14 0.422 . . . . 0.45 112.14 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 69.21 -130.32 24.05 Favored Glycine 0 CA--C 1.523 0.554 0 C-N-CA 121.21 -0.519 . . . . 0.3 114.003 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 293' ' ' TRP . . . . . 0.613 ' O ' HG23 ' A' ' 297' ' ' VAL . 76.0 m95 -71.48 -29.45 64.85 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.386 0.514 . . . . 0.44 112.386 -178.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 294' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -59.72 -42.83 93.95 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 120.637 -0.425 . . . . 0.42 110.046 179.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 295' ' ' GLY . . . . . 0.465 ' HA3' ' O ' ' A' ' 290' ' ' GLN . . . -70.05 -38.13 73.6 Favored Glycine 0 C--N 1.336 0.556 0 N-CA-C 111.003 -0.839 . . . . 0.26 111.003 177.596 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 296' ' ' PHE . . . . . 0.423 ' HB3' ' HA ' ' A' ' 293' ' ' TRP . 0.1 OUTLIER -59.45 -37.48 78.25 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.096 0.474 . . . . 0.38 110.352 177.845 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 297' ' ' VAL . . . . . 0.757 HG11 ' HB3' ' A' ' 189' ' ' ARG . 71.4 t -65.71 -50.2 72.63 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-N 115.794 -0.639 . . . . 0.29 110.925 179.236 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -57.91 -41.87 83.56 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.236 -0.438 . . . . 0.54 111.395 179.319 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 299' ' ' PHE . . . . . 0.405 ' CZ ' ' HB2' ' B' ' 39' ' ' SER . 78.0 t80 -61.57 -40.14 93.66 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 116.18 -0.464 . . . . 0.52 112.227 -179.592 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 300' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 . . . . . 0 C--N 1.325 -0.463 0 CA-C-O 120.877 0.37 . . . . 0.42 111.596 -179.567 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 . . . . . 0 CA--C 1.529 0.139 0 N-CA-C 111.317 0.118 . . . . 0.44 111.317 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 23' ' ' PHE . . . . . 0.488 ' HA ' ' SD ' ' A' ' 212' ' ' MET . 0.7 OUTLIER -55.64 -40.05 71.68 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 112.566 0.58 . . . . 0.34 112.566 -179.194 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 24' ' ' ALA . . . . . 0.428 ' N ' ' HD1' ' B' ' 23' ' ' PHE . . . -68.97 -46.16 68.83 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.969 0.414 . . . . 0.4 111.049 -179.648 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . 0.546 ' O ' ' HG2' ' B' ' 29' ' ' LYS . . . -64.05 -52.84 57.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.005 -0.543 . . . . 0.4 110.806 179.319 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -55.19 -54.65 40.67 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 115.375 -0.829 . . . . 0.43 112.102 -179.394 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 45.3 mt -63.2 -29.4 70.75 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 120.957 -0.297 . . . . 0.34 111.638 -179.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 28' ' ' ARG . . . . . . . . . . . . . 4.4 tmt_? -70.93 -57.21 4.8 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 120.896 0.379 . . . . 0.86 110.503 178.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . 0.546 ' HG2' ' O ' ' B' ' 25' ' ' ALA . 10.4 ptmt -61.79 -42.39 98.94 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 116.397 -0.365 . . . . 0.89 111.901 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 88.3 mt -64.79 -41.51 92.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.181 0 N-CA-C 109.831 -0.433 . . . . 0.4 109.831 179.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . 0.535 ' HA3' ' HG2' ' A' ' 244' ' ' ARG . . . -59.76 -49.22 80.92 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.956 -0.64 . . . . 0.28 112.017 178.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 36.9 m-20 -66.6 -34.72 78.52 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.642 0.221 . . . . 0.37 110.876 178.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 33' ' ' LYS . . . . . 0.417 ' O ' ' HE3' ' B' ' 33' ' ' LYS . 0.0 OUTLIER -65.46 -47.62 75.51 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.791 0.329 . . . . 0.55 110.128 178.169 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 42.4 t -61.37 -48.87 86.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 CA-C-O 121.067 0.461 . . . . 0.41 109.775 178.332 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 35' ' ' TYR . . . . . 0.468 ' HB2' ' H ' ' A' ' 243' ' ' GLY . 0.6 OUTLIER -55.58 -38.3 69.21 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 115.63 -0.714 . . . . 0.73 109.999 178.088 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 36' ' ' CYS . . . . . . . . . . . . . 52.1 t -65.56 -46.14 80.64 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-N 116.012 -0.54 . . . . 1.24 110.996 178.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 97.0 m -62.33 -35.86 80.39 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 112.861 0.689 . . . . 0.45 112.861 -179.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 38' ' ' TRP . . . . . . . . . . . . . 96.8 m95 -86.86 -25.43 24.5 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 112.767 0.654 . . . . 0.64 112.767 -178.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 39' ' ' SER . . . . . 0.405 ' HB2' ' CZ ' ' A' ' 299' ' ' PHE . 14.7 t . . . . . 0 N--CA 1.466 0.366 0 CA-C-O 121.007 0.432 . . . . 0.61 111.286 179.079 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 . . . . . 0 CA--C 1.531 0.246 0 N-CA-C 111.536 0.198 . . . . 0.53 111.536 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -57.84 -46.53 84.63 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 121.036 0.446 . . . . 0.43 110.951 179.394 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.653 HD21 ' HB3' ' A' ' 287' ' ' LEU . 13.9 tp -62.83 -46.41 88.07 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.99 -0.55 . . . . 0.85 111.133 178.701 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 44.5 t80 -66.71 -40.6 88.52 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.167 -0.469 . . . . 0.4 111.767 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 32.4 mtm180 -59.75 -46.75 88.18 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.81 0.338 . . . . 0.49 111.416 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . 0.43 ' HA ' ' HB2' ' A' ' 183' ' ' ALA . 51.1 mt-30 -70.45 -35.81 73.55 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.756 0.312 . . . . 0.82 110.585 179.536 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 51.9 m -65.04 -45.85 83.72 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.481 -0.327 . . . . 0.29 110.138 178.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.774 ' HA ' HG21 ' A' ' 276' ' ' THR . 2.1 tm? -53.64 -55.29 27.23 Favored 'General case' 0 C--O 1.225 -0.186 0 CA-C-N 116.026 -0.534 . . . . 0.45 110.572 178.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -55.13 -43.61 74.3 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 112.271 0.471 . . . . 1.18 112.271 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . 0.508 HG23 HD22 ' A' ' 191' ' ' LEU . 90.6 mt -69.18 -53.46 25.43 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 N-CA-C 112.394 0.516 . . . . 0.31 112.394 -179.313 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.542 HD12 HG23 ' A' ' 276' ' ' THR . 68.2 mt -66.12 -47.77 83.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 N-CA-C 112.017 0.377 . . . . 0.35 112.017 -179.39 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 3.5 t -58.34 -44.55 88.76 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.644 0.259 . . . . 0.27 111.226 -179.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 21.4 ttm180 -66.69 -49.48 65.97 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 120.296 -0.562 . . . . 0.55 110.506 178.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' TYR . . . . . 0.995 ' HE1' ' HA ' ' A' ' 195' ' ' ARG . 93.5 t80 -55.41 -52.47 63.45 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 112.601 0.593 . . . . 0.39 112.601 -179.672 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 5.0 mp -60.74 -45.7 93.3 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 120.834 -0.346 . . . . 0.48 111.833 -179.081 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . 0.538 ' HD2' ' OE1' ' A' ' 269' ' ' GLU . 0.0 OUTLIER -65.36 -37.18 86.26 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.665 0.269 . . . . 0.37 110.924 179.679 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -58.22 -53.9 53.02 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.056 -0.52 . . . . 0.44 110.473 178.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . 0.763 ' HB3' ' HE3' ' A' ' 257' ' ' LYS . 2.2 mt-30 -67.19 -39.9 86.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.026 -0.533 . . . . 0.45 111.093 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.47 ' HB2' ' HB1' ' A' ' 256' ' ' ALA . . . . . . . . 0 N--CA 1.463 0.221 0 CA-C-O 120.833 0.349 . . . . 0.37 111.711 179.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.643 ' O ' ' HA3' ' A' ' 187' ' ' GLY . . . . . . . . 0 CA--C 1.536 0.408 0 CA-C-O 121.096 0.474 . . . . 0.43 111.611 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -80.41 -71.54 1.27 Allowed Glycine 0 CA--C 1.527 0.808 0 C-N-CA 120.67 -0.776 . . . . 0.42 113.527 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -64.05 -55.78 19.72 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 120.992 0.425 . . . . 0.53 111.264 -179.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -65.65 -34.55 78.48 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.934 -0.576 . . . . 0.52 110.261 178.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . 0.643 ' HA3' ' O ' ' A' ' 183' ' ' ALA . . . -65.39 -47.91 74.33 Favored Glycine 0 C--O 1.217 -0.945 0 C-N-CA 121.068 -0.587 . . . . 0.41 112.723 179.702 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 4.8 tmm_? -60.37 -48.65 80.84 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-N 117.349 0.574 . . . . 0.73 111.314 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 189' ' ' ARG . . . . . 0.469 ' HG2' HG21 ' A' ' 297' ' ' VAL . 3.9 ttp180 -63.02 -46.29 88.3 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 120.763 0.316 . . . . 0.57 110.753 -179.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . 0.44 ' HA ' ' CG1' ' A' ' 297' ' ' VAL . . . -71.69 -31.15 66.45 Favored 'General case' 0 C--O 1.222 -0.367 0 N-CA-C 112.245 0.461 . . . . 0.32 112.245 -179.576 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 191' ' ' LEU . . . . . 0.552 ' HB2' ' O ' ' A' ' 187' ' ' GLY . 0.2 OUTLIER -62.2 -53.46 54.93 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 120.578 0.228 . . . . 0.6 111.056 -179.752 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -65.11 -42.1 94.29 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.461 -0.336 . . . . 0.69 111.059 179.205 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . 0.658 HG21 ' HA ' ' A' ' 297' ' ' VAL . 39.3 m -62.57 -47.28 84.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.476 -0.329 . . . . 0.39 110.698 179.4 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . 0.479 HD21 HG21 ' A' ' 249' ' ' ILE . 33.6 tp -67.76 -41.24 83.64 Favored 'General case' 0 C--O 1.224 -0.241 0 CA-C-N 116.526 -0.307 . . . . 0.41 111.085 179.658 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . 0.995 ' HA ' ' HE1' ' A' ' 166' ' ' TYR . 45.4 ttm180 -60.57 -45.33 94.35 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.783 0.325 . . . . 0.63 111.34 179.215 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 12.7 mtp180 -73.87 -49.48 24.81 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.547 0.573 . . . . 1.59 112.547 -179.086 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . 0.621 HG12 HG21 ' A' ' 246' ' ' VAL . 86.6 t -68.86 -38.88 79.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-O 120.923 0.392 . . . . 0.35 111.161 -179.791 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -65.12 -52.77 38.17 Favored Glycine 0 C--N 1.332 0.359 0 C-N-CA 121.14 -0.552 . . . . 0.31 112.895 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -63.19 -31.13 72.2 Favored 'General case' 0 CA--C 1.528 0.099 0 CA-C-N 117.114 0.457 . . . . 0.47 110.258 179.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . 0.476 ' O ' ' HB2' ' A' ' 204' ' ' ASN . . . -60.65 -53.8 42.35 Favored Glycine 0 C--N 1.336 0.554 0 C-N-CA 120.902 -0.666 . . . . 0.35 111.462 178.014 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 83.3 t -63.54 -41.35 92.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 CA-C-O 121.355 0.598 . . . . 0.35 110.471 178.153 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 202' ' ' GLN . . . . . 0.41 ' HA ' ' CE2' ' A' ' 209' ' ' PHE . 7.4 tt0 -60.73 -51.27 70.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 114.729 -1.123 . . . . 0.71 112.723 -178.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 2.8 mmp_? -74.01 -32.58 63.44 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 111.716 0.265 . . . . 0.52 111.716 -179.466 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 204' ' ' ASN . . . . . 0.476 ' HB2' ' O ' ' A' ' 200' ' ' GLY . 8.4 t-20 -68.68 -53.77 20.3 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.049 0.452 . . . . 1.55 110.822 179.477 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 89.0 m-70 -95.18 32.14 1.78 Allowed 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 121.184 0.516 . . . . 0.53 110.853 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . 0.504 ' HG2' HE21 ' A' ' 210' ' ' GLN . 10.0 tt0 -59.5 -38.51 81.11 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.581 -0.736 . . . . 0.43 111.675 -179.333 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 42.2 p -59.26 -49.74 76.68 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.154 0.502 . . . . 0.54 110.95 179.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -66.59 -44.54 81.91 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.682 -0.69 . . . . 0.41 110.401 178.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 209' ' ' PHE . . . . . 0.41 ' CE2' ' HA ' ' A' ' 202' ' ' GLN . 4.8 m-30 -58.46 -44.51 89.28 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.177 -0.465 . . . . 0.45 110.736 179.498 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 210' ' ' GLN . . . . . 0.511 ' HB3' ' NH2' ' A' ' 214' ' ' ARG . 59.6 mt-30 -64.02 -34.73 78.68 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.56 -0.291 . . . . 0.6 110.971 179.446 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . 0.495 ' O ' ' HB2' ' A' ' 215' ' ' LYS . . . -60.21 -44.91 96.94 Favored Glycine 0 C--N 1.334 0.454 0 N-CA-C 111.028 -0.829 . . . . 0.37 111.028 178.021 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 212' ' ' MET . . . . . 0.833 ' HG2' ' HA ' ' B' ' 23' ' ' PHE . 1.0 OUTLIER -77.29 -30.68 54.31 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 120.616 0.246 . . . . 0.56 110.581 178.457 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.434 HD22 ' CE2' ' A' ' 254' ' ' PHE . 16.8 tp -59.7 -44.85 93.5 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.197 -0.456 . . . . 0.54 111.026 179.208 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 214' ' ' ARG . . . . . 0.511 ' NH2' ' HB3' ' A' ' 210' ' ' GLN . 68.0 mtm-85 -81.25 -27.47 35.17 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.034 -0.53 . . . . 0.65 110.169 178.574 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 215' ' ' LYS . . . . . 0.495 ' HB2' ' O ' ' A' ' 211' ' ' GLY . 0.7 OUTLIER -66.97 -46.9 73.2 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 115.875 -0.602 . . . . 0.8 110.621 178.443 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . 0.447 HD23 ' HB ' ' A' ' 218' ' ' ILE . 4.6 tp -65.19 120.7 13.19 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 115.901 -0.59 . . . . 0.48 111.354 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -75.03 36.07 0.11 Allowed 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 112.877 0.695 . . . . 1.47 112.877 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 218' ' ' ILE . . . . . 0.956 ' HA ' ' HB3' ' A' ' 223' ' ' ASP . 1.3 tt -61.05 106.55 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-O 121.914 0.864 . . . . 0.41 111.571 -179.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -162.1 -50.88 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.28 -0.873 . . . . 0.61 110.462 -179.471 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -99.6 178.38 4.87 Favored 'General case' 0 C--O 1.221 -0.418 0 CA-C-N 116.189 -0.46 . . . . 0.91 111.164 179.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . 0.43 ' HA ' ' HE1' ' A' ' 267' ' ' PHE . 2.0 mm-40 -49.38 -20.74 0.73 Allowed 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 113.794 1.035 . . . . 0.86 113.794 -179.316 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -67.84 -24.51 74.27 Favored Glycine 0 CA--C 1.534 1.271 0 N-CA-C 114.643 0.617 . . . . 0.34 114.643 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 223' ' ' ASP . . . . . 0.956 ' HB3' ' HA ' ' A' ' 218' ' ' ILE . 9.9 p30 -59.16 -56.06 26.97 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 113.475 0.917 . . . . 0.57 113.475 -177.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.454 HG23 HG21 ' A' ' 274' ' ' THR . 2.6 p -54.27 -39.73 44.67 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-O 120.983 0.42 . . . . 0.44 111.764 179.492 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 30.2 mttp -68.68 -42.99 77.06 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-O 120.935 0.398 . . . . 0.61 110.171 178.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 226' ' ' SER . . . . . 0.585 ' O ' HG23 ' A' ' 230' ' ' VAL . 45.3 m -62.03 -43.25 99.23 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.9 -0.591 . . . . 0.44 109.693 178.579 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 227' ' ' PHE . . . . . 0.488 ' O ' ' HG3' ' A' ' 231' ' ' MET . 16.8 t80 -55.96 -42.92 76.98 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 115.731 -0.668 . . . . 0.66 110.447 178.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 12.7 p -60.31 -39.56 87.42 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 120.823 0.344 . . . . 0.34 110.368 178.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 6.4 mmp_? -67.85 -35.7 79.01 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 116.24 -0.437 . . . . 0.51 110.786 179.455 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . 0.585 HG23 ' O ' ' A' ' 226' ' ' SER . 24.3 t -61.96 -52.4 60.95 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 N-CA-C 109.985 -0.376 . . . . 0.35 109.985 178.568 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 231' ' ' MET . . . . . 0.635 ' HE3' HG13 ' A' ' 275' ' ' ILE . 31.5 mtp -56.79 -46.3 81.62 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.726 -0.67 . . . . 0.43 110.866 179.293 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 56.1 t -62.12 -40.29 86.96 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 CA-C-N 116.167 -0.47 . . . . 0.46 110.659 178.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 64.7 t-80 -66.65 -43.62 84.1 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 116.557 -0.292 . . . . 0.51 111.203 178.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.445 HG23 ' O ' ' A' ' 230' ' ' VAL . 78.1 t -60.89 -40.4 85.17 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 CA-C-O 120.66 0.267 . . . . 0.34 111.539 179.532 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -101.44 23.51 10.96 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 111.951 0.352 . . . . 0.49 111.951 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 1.9 tmtm? -70.78 -11.73 61.13 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 112.1 0.408 . . . . 1.29 112.1 -179.38 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -83.23 -16.86 44.78 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.662 0.268 . . . . 0.49 111.267 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 91.86 -5.78 79.35 Favored Glycine 0 CA--C 1.524 0.64 0 C-N-CA 120.827 -0.701 . . . . 0.47 113.898 179.273 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 3.1 p -98.04 114.94 36.83 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-O 121.663 0.744 . . . . 0.45 111.87 -179.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 99.4 m -94.74 109.44 21.4 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.089 -0.505 . . . . 0.43 111.739 179.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . 0.554 ' HB2' ' HD2' ' A' ' 244' ' ' ARG . 25.7 m-20 -113.61 139.45 49.01 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.296 -0.411 . . . . 0.46 110.762 179.022 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 242' ' ' TRP . . . . . 0.433 ' CZ3' ' HB2' ' A' ' 296' ' ' PHE . 40.4 m95 -54.54 -42.12 70.53 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.183 -0.462 . . . . 0.47 111.619 -179.375 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -60.16 -33.91 81.9 Favored Glycine 0 C--N 1.333 0.412 0 C-N-CA 120.937 -0.649 . . . . 0.31 112.095 178.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 244' ' ' ARG . . . . . 0.554 ' HD2' ' HB2' ' A' ' 241' ' ' ASN . 23.6 mtt180 -70.73 -44.96 65.77 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.163 0.506 . . . . 0.32 109.638 178.687 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . 0.448 ' O ' HG13 ' A' ' 249' ' ' ILE . 74.2 mt -61.84 -50.08 81.64 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 115.412 -0.813 . . . . 0.51 111.491 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . 0.621 HG21 HG12 ' A' ' 197' ' ' VAL . 8.5 p -65.4 -32.71 59.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 120.814 -0.354 . . . . 0.4 111.36 -179.564 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 82.8 m -66.14 -34.47 78.12 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.467 0.651 . . . . 0.37 109.261 177.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 248' ' ' LEU . . . . . 0.445 HD21 ' HG2' ' A' ' 231' ' ' MET . 33.7 tp -73.23 -45.33 56.64 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 115.43 -0.804 . . . . 1.23 110.426 178.199 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 249' ' ' ILE . . . . . 0.479 HG21 HD21 ' A' ' 194' ' ' LEU . 23.5 mt -63.13 -44.18 99.3 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 CA-C-N 116.506 -0.316 . . . . 0.34 110.886 179.143 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 12.6 p -61.98 -36.17 80.66 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.277 0.561 . . . . 0.44 109.572 178.096 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 251' ' ' PHE . . . . . 0.431 ' O ' HG23 ' A' ' 255' ' ' VAL . 48.8 t80 -66.27 -41.34 90.04 Favored 'General case' 0 C--O 1.227 -0.122 0 CA-C-N 115.514 -0.767 . . . . 0.46 109.411 177.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -57.85 -49.23 76.37 Favored Glycine 0 C--N 1.335 0.5 0 N-CA-C 111.203 -0.759 . . . . 0.24 111.203 178.133 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -59.13 -43.03 91.94 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 120.68 0.276 . . . . 0.32 110.692 177.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 254' ' ' PHE . . . . . 0.434 ' CE2' HD22 ' A' ' 213' ' ' LEU . 7.1 t80 -63.01 -43.99 97.21 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 121.071 0.462 . . . . 0.7 110.787 179.011 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 255' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 251' ' ' PHE . 72.7 t -62.96 -46.46 96.25 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 N-CA-C 109.383 -0.599 . . . . 0.39 109.383 177.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 256' ' ' ALA . . . . . 0.47 ' HB1' ' HB2' ' A' ' 171' ' ' ALA . . . -59.13 -37.84 78.21 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.081 -0.509 . . . . 0.29 110.078 177.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 257' ' ' LYS . . . . . 0.763 ' HE3' ' HB3' ' A' ' 170' ' ' GLN . 81.0 mttt -59.04 -45.79 89.87 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 109.468 -0.567 . . . . 0.51 109.468 177.364 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 258' ' ' HIS . . . . . 0.429 ' HB2' HD21 ' A' ' 213' ' ' LEU . 80.3 t60 -61.06 -46.32 91.15 Favored 'General case' 0 C--O 1.228 -0.033 0 CA-C-N 115.4 -0.818 . . . . 0.59 109.632 178.38 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.83 HD11 HG12 ' A' ' 218' ' ' ILE . 8.8 mp -59.82 -42.52 93.69 Favored 'General case' 0 C--O 1.221 -0.401 0 CA-C-N 115.968 -0.56 . . . . 0.51 110.316 178.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 2.2 tptp -64.15 -35.91 82.31 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.992 0.425 . . . . 0.53 110.419 178.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 21.2 m -69.78 -31.97 70.19 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.775 -0.648 . . . . 0.55 111.094 179.355 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 33.6 m -101.03 10.56 7.66 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 CA-C-O 120.796 0.331 . . . . 0.61 111.425 179.112 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 16.4 m120 59.16 47.92 11.13 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 113.123 0.786 . . . . 0.6 113.123 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 264' ' ' GLN . . . . . 0.572 ' HB3' ' HG ' ' A' ' 259' ' ' LEU . 17.7 tt0 -106.77 36.85 2.5 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.198 0.523 . . . . 0.6 110.31 179.044 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 265' ' ' GLU . . . . . 0.511 ' HA ' HD12 ' A' ' 268' ' ' ILE . 0.0 OUTLIER -54.33 -27.7 37.64 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 115.735 -0.666 . . . . 0.48 111.556 179.814 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 26.1 p -58.45 -26.36 63.26 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 115.785 -0.643 . . . . 0.66 110.941 178.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 267' ' ' PHE . . . . . 0.43 ' HE1' ' HA ' ' A' ' 221' ' ' GLU . 70.0 m-85 -108.52 -11.4 15.14 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.197 -0.456 . . . . 0.75 110.917 178.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 268' ' ' ILE . . . . . 0.511 HD12 ' HA ' ' A' ' 265' ' ' GLU . 53.1 mt -66.62 -51.15 59.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 CA-C-O 120.776 0.322 . . . . 0.45 110.791 179.381 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 269' ' ' GLU . . . . . 0.728 ' HB2' ' HD3' ' A' ' 270' ' ' PRO . 55.2 mm-40 -58.78 -54.7 53.71 Favored Pre-proline 0 CA--C 1.541 0.629 0 CA-C-N 116.186 -0.461 . . . . 0.49 111.178 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 270' ' ' PRO . . . . . 0.728 ' HD3' ' HB2' ' A' ' 269' ' ' GLU . 32.1 Cg_exo -60.73 -32.51 93.13 Favored 'Trans proline' 0 C--N 1.359 1.108 0 C-N-CA 122.086 1.858 . . . . 0.35 112.76 178.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 271' ' ' LEU . . . . . . . . . . . . . 29.4 tp -63.2 -46.09 88.68 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 120.531 0.205 . . . . 0.68 111.394 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -61.58 -40.99 96.75 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.13 0.49 . . . . 0.32 111.248 179.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 273' ' ' GLU . . . . . 0.457 ' HG2' ' O ' ' A' ' 269' ' ' GLU . 4.4 mm-40 -72.27 -33.74 67.69 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.195 0.522 . . . . 0.42 109.822 179.103 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 274' ' ' THR . . . . . 0.454 HG21 HG23 ' A' ' 224' ' ' VAL . 87.3 m -66.84 -51.92 49.86 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.99 -0.55 . . . . 0.34 110.952 178.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 275' ' ' ILE . . . . . 0.635 HG13 ' HE3' ' A' ' 231' ' ' MET . 14.4 tt -59.52 -36.51 65.17 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-O 120.682 0.277 . . . . 0.42 110.621 179.447 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 276' ' ' THR . . . . . 0.774 HG21 ' HA ' ' A' ' 160' ' ' LEU . 38.2 m -67.82 -49.68 60.96 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 120.786 0.326 . . . . 0.29 110.383 178.646 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 277' ' ' ASP . . . . . 0.586 ' O ' ' HB2' ' A' ' 281' ' ' ARG . 1.4 t70 -60.41 -54.58 43.94 Favored 'General case' 0 C--O 1.216 -0.671 0 CA-C-N 116.23 -0.441 . . . . 0.34 111.19 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 61.6 t -59.37 -34.08 53.13 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 N-CA-C 112.01 0.374 . . . . 0.41 112.01 -179.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 21.4 tp -67.82 -47.58 68.64 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.685 0.279 . . . . 0.69 111.392 179.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 39.7 t -78.06 -36.22 21.29 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 CA-C-O 120.864 0.364 . . . . 0.42 111.544 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 281' ' ' ARG . . . . . 0.586 ' HB2' ' O ' ' A' ' 277' ' ' ASP . 1.1 tpp180 -61.68 -41.02 96.99 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 122.921 0.488 . . . . 0.37 112.308 -179.434 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 282' ' ' THR . . . . . . . . . . . . . 74.5 p -90.78 -1.69 57.84 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 112.823 0.675 . . . . 0.42 112.823 -179.061 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . 0.425 ' HB3' HD23 ' A' ' 287' ' ' LEU . 11.0 mtmm -138.72 33.71 2.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.672 0.273 . . . . 0.53 111.409 -179.61 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 34.0 ttm180 -53.16 -58.17 7.95 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 112.449 0.537 . . . . 0.42 112.449 -179.307 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 285' ' ' ASP . . . . . 0.412 ' O ' ' HB2' ' A' ' 289' ' ' LYS . 22.1 t70 -63.33 -42.95 99.0 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 112.179 0.437 . . . . 0.57 112.179 -179.042 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 286' ' ' TRP . . . . . . . . . . . . . 1.5 t90 -64.35 -51.23 64.38 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 112.227 0.454 . . . . 0.49 112.227 -178.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 287' ' ' LEU . . . . . 0.653 ' HB3' HD21 ' A' ' 155' ' ' LEU . 1.5 mm? -64.61 -48.18 75.86 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.317 0.488 . . . . 0.54 112.317 -178.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 3.0 p -63.99 -29.77 48.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 N-CA-C 112.007 0.373 . . . . 0.52 112.007 -179.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 289' ' ' LYS . . . . . 0.425 ' HB2' ' HE3' ' A' ' 289' ' ' LYS . 12.3 ttmt -76.56 -44.47 34.58 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 112.371 0.508 . . . . 0.8 112.371 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -80.62 28.86 0.32 Allowed 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 113.14 0.793 . . . . 0.56 113.14 -178.347 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 291' ' ' ARG . . . . . 0.472 ' HB3' ' HB3' ' A' ' 294' ' ' ASP . 62.5 mtp180 62.95 9.47 3.76 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 112.522 0.564 . . . . 0.49 112.522 179.572 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 62.22 -130.27 44.07 Favored Glycine 0 CA--C 1.522 0.504 0 CA-C-O 121.307 0.393 . . . . 0.35 113.439 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 293' ' ' TRP . . . . . 0.523 ' O ' HG22 ' A' ' 297' ' ' VAL . 77.5 m95 -61.87 -27.09 68.55 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.672 -0.264 . . . . 0.55 111.475 -179.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 294' ' ' ASP . . . . . 0.472 ' HB3' ' HB3' ' A' ' 291' ' ' ARG . 0.5 OUTLIER -58.97 -44.46 91.54 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 120.881 0.372 . . . . 0.42 110.224 178.77 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -75.64 -30.18 58.46 Favored Glycine 0 CA--C 1.522 0.485 0 C-N-CA 120.795 -0.717 . . . . 0.38 111.639 178.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 296' ' ' PHE . . . . . 0.553 ' CE1' ' HE2' ' A' ' 300' ' ' PHE . 4.3 t80 -67.02 -47.29 71.87 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 120.821 0.343 . . . . 0.41 110.993 179.274 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 297' ' ' VAL . . . . . 0.658 ' HA ' HG21 ' A' ' 193' ' ' THR . 27.1 m -71.27 -37.41 65.71 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-N 116.44 -0.345 . . . . 0.38 111.567 -179.704 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 298' ' ' GLU . . . . . 0.444 ' HB2' ' O ' ' A' ' 294' ' ' ASP . 1.2 mt-10 -69.56 -27.58 65.25 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.571 -0.286 . . . . 0.45 111.432 179.687 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 299' ' ' PHE . . . . . . . . . . . . . 69.1 t80 -62.53 -43.73 98.09 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.346 -0.388 . . . . 0.6 110.434 178.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 300' ' ' PHE . . . . . 0.553 ' HE2' ' CE1' ' A' ' 296' ' ' PHE . 44.7 m-85 . . . . . 0 CA--C 1.532 0.266 0 CA-C-O 120.827 0.346 . . . . 0.58 111.125 179.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 22' ' ' GLU . . . . . 0.444 ' HG2' ' NE2' ' B' ' 26' ' ' GLN . 1.3 tt0 . . . . . 0 C--O 1.233 0.232 0 CA-C-O 120.675 0.274 . . . . 0.7 111.259 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 23' ' ' PHE . . . . . 0.833 ' HA ' ' HG2' ' A' ' 212' ' ' MET . 3.5 p90 -62.41 -35.9 80.67 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 116.323 -0.399 . . . . 0.49 111.465 179.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -76.51 -45.3 31.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.792 0.329 . . . . 0.39 110.808 179.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.22 -45.8 87.02 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.244 -0.435 . . . . 0.35 110.569 178.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 26' ' ' GLN . . . . . 0.444 ' NE2' ' HG2' ' B' ' 22' ' ' GLU . 1.3 mp0 -61.32 -47.71 84.68 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 115.755 -0.657 . . . . 0.43 110.218 178.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 15.7 mt -58.22 -39.28 78.63 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.137 -0.483 . . . . 0.42 110.803 178.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 28' ' ' ARG . . . . . . . . . . . . . 1.1 ttp180 -61.32 -50.35 73.34 Favored 'General case' 0 N--CA 1.462 0.136 0 N-CA-C 109.896 -0.409 . . . . 1.02 109.896 178.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 83.6 mttt -56.26 -49.62 73.68 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 116.06 -0.518 . . . . 0.75 110.84 179.198 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 62.3 mt -62.41 -41.89 93.5 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 CA-C-N 116.297 -0.41 . . . . 0.45 110.4 179.377 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . 0.436 ' HA3' ' HA ' ' A' ' 244' ' ' ARG . . . -60.17 -49.56 77.26 Favored Glycine 0 CA--C 1.522 0.481 0 C-N-CA 120.768 -0.729 . . . . 0.27 112.123 179.043 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 57.9 m-20 -60.19 -44.58 94.98 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.098 0.475 . . . . 0.98 110.028 178.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 15.0 tppt? -62.01 -51.27 68.7 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 115.672 -0.695 . . . . 0.84 111.005 179.347 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 38.9 t -57.49 -41.66 79.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-O 120.785 0.326 . . . . 0.4 110.973 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -62.73 -43.84 97.77 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 120.984 0.421 . . . . 0.75 109.919 178.381 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 36' ' ' CYS . . . . . . . . . . . . . 55.7 m -66.13 -42.73 88.75 Favored 'General case' 0 C--O 1.224 -0.248 0 CA-C-N 116.095 -0.502 . . . . 1.34 111.248 179.094 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 98.6 m -61.78 -39.93 93.39 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 112.436 0.532 . . . . 0.5 112.436 179.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 38' ' ' TRP . . . . . . . . . . . . . 70.3 m95 -77.72 -29.03 51.04 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 112.562 0.578 . . . . 0.64 112.562 -179.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 37.1 p . . . . . 0 N--CA 1.467 0.415 0 CA-C-O 120.943 0.401 . . . . 0.5 111.437 179.504 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . 0.471 ' O ' ' HG3' ' A' ' 157' ' ' ARG . 15.4 t70 . . . . . 0 N--CA 1.469 0.487 0 N-CA-C 111.591 0.219 . . . . 0.72 111.591 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . 0.433 ' HA ' ' CZ ' ' A' ' 157' ' ' ARG . 17.8 m-20 -57.23 -49.09 77.12 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.684 0.278 . . . . 0.56 111.309 179.703 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 49.8 tp -66.22 -36.63 83.53 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 121.192 0.52 . . . . 0.88 109.911 178.458 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 76.4 t80 -63.78 -46.29 85.91 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.52 -0.763 . . . . 0.48 111.607 179.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 0.471 ' HG3' ' O ' ' A' ' 153' ' ' ASP . 79.1 mtm-85 -58.0 -44.94 87.5 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.665 0.269 . . . . 0.6 110.442 179.419 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . 0.416 ' HG3' ' O ' ' A' ' 154' ' ' ASP . 38.0 mt-30 -64.62 -42.73 95.31 Favored 'General case' 0 CA--C 1.529 0.141 0 N-CA-C 109.862 -0.422 . . . . 1.25 109.862 178.243 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 50.9 m -58.54 -53.03 62.93 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.892 -0.594 . . . . 0.27 111.282 179.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 24.4 tp -61.82 -44.48 96.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.27 -0.423 . . . . 0.54 111.131 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -60.87 -53.47 56.9 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.607 0.241 . . . . 0.42 110.772 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 77.5 mt -56.85 -50.8 73.96 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 CA-C-N 116.32 -0.4 . . . . 0.33 111.162 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.678 ' O ' ' HG ' ' A' ' 167' ' ' LEU . 63.0 mt -62.23 -51.31 73.9 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-N 116.701 -0.227 . . . . 0.33 111.394 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 29.3 t -56.62 -46.12 81.14 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 120.763 0.316 . . . . 0.32 111.063 179.423 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . 0.726 ' O ' ' HG2' ' A' ' 169' ' ' GLU . 6.6 mmm180 -67.59 -44.09 78.98 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.615 -0.266 . . . . 0.34 111.255 179.66 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' TYR . . . . . 0.979 ' HE1' ' HA ' ' A' ' 195' ' ' ARG . 49.3 t80 -59.3 -51.21 70.94 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 111.74 0.274 . . . . 0.44 111.74 -179.76 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.678 ' HG ' ' O ' ' A' ' 163' ' ' ILE . 20.3 mt -62.79 -38.27 89.98 Favored 'General case' 0 N--CA 1.462 0.161 0 N-CA-C 109.662 -0.496 . . . . 0.34 109.662 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 16.9 ttm180 -58.57 -41.34 85.44 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.805 -0.634 . . . . 0.31 111.529 179.308 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . 0.726 ' HG2' ' O ' ' A' ' 165' ' ' ARG . 4.2 mm-40 -67.91 -53.9 22.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.577 -0.283 . . . . 0.44 110.929 179.679 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . 0.663 HE22 ' HG3' ' A' ' 195' ' ' ARG . 1.2 mp0 -59.61 -36.9 77.22 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 120.754 0.311 . . . . 0.56 111.672 179.594 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.442 ' HA ' ' HD2' ' A' ' 257' ' ' LYS . . . . . . . . 0 N--CA 1.467 0.4 0 N-CA-C 112.268 0.469 . . . . 0.4 112.268 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.572 ' O ' ' HA3' ' A' ' 187' ' ' GLY . . . . . . . . 0 CA--C 1.532 0.253 0 CA-C-O 121.225 0.536 . . . . 0.44 110.889 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -76.59 -70.14 1.32 Allowed Glycine 0 CA--C 1.524 0.6 0 C-N-CA 120.822 -0.704 . . . . 0.45 113.683 -179.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -66.09 -55.4 16.69 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.049 0.452 . . . . 0.48 111.95 -179.335 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -65.91 -39.11 90.26 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 116.134 -0.485 . . . . 0.41 110.563 179.309 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . 0.572 ' HA3' ' O ' ' A' ' 183' ' ' ALA . . . -66.37 -33.11 83.91 Favored Glycine 0 C--O 1.224 -0.469 0 C-N-CA 121.126 -0.559 . . . . 0.35 112.727 179.792 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 35.5 ttm180 -67.27 -50.97 58.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.768 0.318 . . . . 0.59 110.27 178.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 189' ' ' ARG . . . . . 0.703 ' HB3' HG11 ' A' ' 297' ' ' VAL . 49.9 mtm180 -64.18 -36.05 82.81 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.445 -0.343 . . . . 0.62 110.419 179.139 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . 0.413 ' HA ' HG22 ' A' ' 297' ' ' VAL . . . -70.97 -48.74 51.6 Favored 'General case' 0 C--O 1.216 -0.69 0 CA-C-N 116.093 -0.503 . . . . 0.31 111.435 179.356 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 191' ' ' LEU . . . . . 0.539 ' HB2' ' O ' ' A' ' 187' ' ' GLY . 0.2 OUTLIER -57.58 -51.57 68.93 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 120.711 0.291 . . . . 0.44 111.453 -179.899 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -59.57 -47.38 85.79 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.2 -0.455 . . . . 0.42 111.695 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 58.4 m -66.5 -48.34 70.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.869 0.366 . . . . 0.38 110.748 179.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . 0.41 HD21 HG21 ' A' ' 249' ' ' ILE . 25.1 tp -60.63 -36.88 79.75 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.867 -0.606 . . . . 0.35 111.371 179.564 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . 0.979 ' HA ' ' HE1' ' A' ' 166' ' ' TYR . 35.4 ttm180 -64.69 -46.87 80.53 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.777 0.322 . . . . 0.47 110.668 178.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.76 -52.81 39.92 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.924 -0.58 . . . . 0.58 111.639 -179.774 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . 0.537 ' O ' HG23 ' A' ' 201' ' ' VAL . 55.4 t -67.15 -40.42 85.19 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 CA-C-O 120.974 0.416 . . . . 0.41 111.704 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . 0.512 ' HA3' ' OH ' ' A' ' 166' ' ' TYR . . . -66.11 -49.87 55.16 Favored Glycine 0 CA--C 1.52 0.387 0 C-N-CA 121.216 -0.516 . . . . 0.3 113.25 -179.628 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . 0.419 ' HB2' ' O ' ' A' ' 195' ' ' ARG . 0.8 OUTLIER -63.47 -34.09 76.99 Favored 'General case' 0 N--CA 1.462 0.172 0 N-CA-C 109.749 -0.463 . . . . 0.51 109.749 179.183 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -63.09 -39.77 98.41 Favored Glycine 0 C--N 1.335 0.522 0 C-N-CA 121.179 -0.534 . . . . 0.38 112.366 178.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 197' ' ' VAL . 84.4 t -69.48 -43.13 80.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 CA-C-O 120.694 0.283 . . . . 0.37 110.857 179.078 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 202' ' ' GLN . . . . . 0.573 ' HG3' ' OG ' ' A' ' 250' ' ' SER . 34.2 mt-30 -59.12 -45.07 91.85 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.023 -0.535 . . . . 0.5 111.411 179.588 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 37.3 mtt180 -76.11 -24.68 54.97 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 116.304 -0.407 . . . . 0.62 111.817 179.512 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -78.12 -54.17 6.55 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.848 0.356 . . . . 0.66 111.753 179.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 33.6 m-70 -101.0 36.56 1.94 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.747 0.308 . . . . 0.64 110.465 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -55.28 -40.25 70.82 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 112.777 0.658 . . . . 0.6 112.777 -178.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 35.1 p -59.64 -53.82 53.62 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.026 0.441 . . . . 0.58 111.511 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -64.03 -42.74 96.99 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.048 -0.524 . . . . 0.46 110.56 178.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 2.3 m-30 -60.1 -48.94 79.61 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 115.963 -0.562 . . . . 0.5 110.958 179.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -57.24 -40.96 78.67 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 120.465 0.174 . . . . 0.7 111.449 179.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -57.39 -51.79 55.58 Favored Glycine 0 C--N 1.334 0.461 0 C-N-CA 120.507 -0.854 . . . . 0.4 111.513 178.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 212' ' ' MET . . . . . 0.486 ' O ' ' HB2' ' A' ' 216' ' ' LEU . 1.8 mpp? -69.76 -30.35 67.91 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 120.792 0.33 . . . . 0.82 110.669 178.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.42 HD22 ' HA ' ' A' ' 213' ' ' LEU . 1.6 tm? -61.45 -48.79 79.52 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.047 -0.524 . . . . 0.56 111.082 178.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 214' ' ' ARG . . . . . 0.447 HH11 ' HD3' ' A' ' 214' ' ' ARG . 27.7 mtt180 -69.64 -34.51 74.13 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.207 -0.451 . . . . 1.16 111.483 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 215' ' ' LYS . . . . . 0.419 ' HD3' ' HA ' ' A' ' 215' ' ' LYS . 72.1 mmtt -80.0 -4.26 51.83 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 120.876 0.37 . . . . 0.9 111.477 179.613 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . 0.512 ' HG ' HG13 ' A' ' 218' ' ' ILE . 1.5 tp -98.7 85.97 3.44 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.178 0.513 . . . . 0.73 111.111 179.567 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -81.82 34.57 0.4 Allowed 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 116.208 -0.451 . . . . 1.01 110.947 179.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 218' ' ' ILE . . . . . 0.754 HG12 ' HB3' ' A' ' 223' ' ' ASP . 13.7 mt -45.25 116.4 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 N-CA-C 114.021 1.119 . . . . 0.5 114.021 -178.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 9.0 ptpp? -158.61 -9.81 0.07 Allowed 'General case' 0 CA--C 1.548 0.88 0 CA-C-N 115.083 -0.962 . . . . 0.63 112.595 178.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -134.0 175.37 9.53 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 113.547 0.943 . . . . 0.96 113.547 -179.204 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . 0.563 ' O ' ' HG2' ' A' ' 225' ' ' LYS . 4.9 mm-40 -58.23 -22.99 54.32 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 114.995 -1.002 . . . . 0.67 113.573 -179.257 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -77.8 -27.08 59.36 Favored Glycine 0 CA--C 1.526 0.739 0 C-N-CA 120.677 -0.773 . . . . 0.49 113.152 179.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 223' ' ' ASP . . . . . 0.754 ' HB3' HG12 ' A' ' 218' ' ' ILE . 36.4 m-20 -69.32 -44.14 72.31 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 111.879 0.325 . . . . 0.59 111.879 -179.123 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -62.25 -28.94 45.53 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 CA-C-O 121.022 0.439 . . . . 0.54 110.087 178.433 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . 0.563 ' HG2' ' O ' ' A' ' 221' ' ' GLU . 42.3 mmtm -69.3 -35.71 76.27 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 109.511 -0.551 . . . . 0.76 109.511 177.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 226' ' ' SER . . . . . 0.666 ' O ' HG23 ' A' ' 230' ' ' VAL . 41.2 t -70.79 -44.62 66.25 Favored 'General case' 0 N--CA 1.463 0.18 0 N-CA-C 109.291 -0.633 . . . . 0.8 109.291 178.024 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 227' ' ' PHE . . . . . 0.564 ' HE2' HG21 ' A' ' 255' ' ' VAL . 10.5 t80 -58.82 -44.43 90.87 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 115.848 -0.615 . . . . 0.61 110.278 178.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 5.1 p -70.63 -34.29 71.93 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.123 -0.489 . . . . 0.83 110.3 178.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 5.8 ttt180 -63.58 -42.32 98.3 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.296 0.57 . . . . 3.18 110.304 178.048 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . 0.897 HG13 ' HA ' ' B' ' 24' ' ' ALA . 43.2 t -65.11 -38.89 83.87 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 N-CA-C 109.774 -0.454 . . . . 0.55 109.774 178.327 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 231' ' ' MET . . . . . 0.797 ' HG3' ' HG ' ' A' ' 248' ' ' LEU . 34.1 ttm -62.86 -51.11 68.28 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 115.896 -0.593 . . . . 0.43 111.79 179.65 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 31.7 m -60.96 -33.08 54.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 C-N-CA 121.053 -0.259 . . . . 0.44 111.593 -179.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 233' ' ' HIS . . . . . 0.566 ' CD2' ' HB1' ' B' ' 24' ' ' ALA . 17.1 t60 -67.31 -40.27 85.97 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 109.803 -0.443 . . . . 0.45 109.803 178.139 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.541 HG23 ' O ' ' A' ' 230' ' ' VAL . 59.9 t -53.6 -47.86 60.14 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 CA-C-N 116.116 -0.493 . . . . 0.4 110.523 179.483 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -96.72 23.23 7.21 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.941 -0.572 . . . . 0.6 111.948 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 3.1 tmtm? -66.89 -17.06 64.72 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.878 0.37 . . . . 1.04 111.63 -179.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -80.55 -16.16 54.87 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.447 -0.342 . . . . 0.6 111.172 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 97.82 -17.72 58.37 Favored Glycine 0 CA--C 1.522 0.524 0 C-N-CA 120.744 -0.741 . . . . 0.46 113.661 179.323 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 6.8 p -89.63 120.28 38.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-O 121.454 0.645 . . . . 0.42 111.641 -179.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 32.8 m -94.34 99.62 11.8 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.006 0.431 . . . . 0.57 111.69 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . 0.42 ' HB2' ' HD2' ' A' ' 244' ' ' ARG . 90.4 m-20 -90.3 135.71 33.51 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.591 -0.277 . . . . 0.84 110.434 178.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 242' ' ' TRP . . . . . 0.523 ' CZ3' ' HB2' ' A' ' 296' ' ' PHE . 25.9 m95 -58.21 -40.6 82.03 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.823 0.344 . . . . 0.49 111.124 179.561 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . 0.51 ' HA3' ' N ' ' B' ' 35' ' ' TYR . . . -61.03 -30.32 73.2 Favored Glycine 0 C--N 1.332 0.359 0 C-N-CA 120.771 -0.728 . . . . 0.37 111.877 178.417 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 244' ' ' ARG . . . . . 0.501 ' HA ' ' HA3' ' B' ' 31' ' ' GLY . 74.3 mtt180 -69.25 -47.9 63.36 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.816 -0.439 . . . . 0.51 109.816 178.416 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . 0.464 ' O ' HG13 ' A' ' 249' ' ' ILE . 68.7 mt -59.15 -49.95 81.52 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.12 0 CA-C-N 115.523 -0.762 . . . . 0.43 111.294 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . 0.418 HG21 ' CG1' ' A' ' 197' ' ' VAL . 7.3 p -66.13 -28.41 43.66 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 C-N-CA 120.727 -0.389 . . . . 0.42 111.133 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 19.3 m -65.15 -46.08 82.36 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 109.935 -0.395 . . . . 0.4 109.935 178.293 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 248' ' ' LEU . . . . . 0.797 ' HG ' ' HG3' ' A' ' 231' ' ' MET . 3.0 mm? -62.3 -39.58 93.45 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 116.106 -0.497 . . . . 0.51 110.582 178.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 249' ' ' ILE . . . . . 0.464 HG13 ' O ' ' A' ' 245' ' ' ILE . 17.6 mt -70.12 -40.96 78.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-O 120.929 0.395 . . . . 0.4 110.079 178.316 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 250' ' ' SER . . . . . 0.573 ' OG ' ' HG3' ' A' ' 202' ' ' GLN . 33.7 t -61.53 -44.89 96.23 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 109.553 -0.536 . . . . 1.04 109.553 178.257 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 251' ' ' PHE . . . . . . . . . . . . . 42.4 t80 -66.23 -38.57 88.2 Favored 'General case' 0 C--O 1.231 0.128 0 N-CA-C 109.097 -0.705 . . . . 0.5 109.097 177.42 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -60.61 -36.29 91.18 Favored Glycine 0 C--N 1.336 0.541 0 N-CA-C 111.199 -0.761 . . . . 0.3 111.199 177.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -68.18 -38.32 81.93 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-O 120.909 0.385 . . . . 0.33 110.031 177.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -65.13 -40.82 94.99 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 109.458 -0.571 . . . . 1.03 109.458 178.33 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 255' ' ' VAL . . . . . 0.564 HG21 ' HE2' ' A' ' 227' ' ' PHE . 70.1 t -63.59 -44.21 98.5 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 CA-C-N 115.834 -0.621 . . . . 0.38 109.495 177.468 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -59.39 -32.37 70.09 Favored 'General case' 0 C--O 1.226 -0.163 0 CA-C-N 116.381 -0.372 . . . . 0.29 110.137 177.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 257' ' ' LYS . . . . . 0.442 ' HD2' ' HA ' ' A' ' 171' ' ' ALA . 43.5 tptt -63.82 -49.18 73.88 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.071 -0.513 . . . . 0.66 110.433 178.332 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -71.43 -32.59 68.53 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 120.888 0.375 . . . . 0.36 110.143 179.034 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.521 ' HG ' ' HB3' ' A' ' 264' ' ' GLN . 1.6 tp -67.85 -40.21 83.69 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 121.204 0.526 . . . . 0.43 109.744 177.672 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 45.3 tptt -70.65 -27.46 64.06 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.012 -0.54 . . . . 0.37 110.51 178.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 42.1 t -57.34 -28.55 63.23 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.436 -0.347 . . . . 0.55 110.583 178.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 16.1 m -113.15 14.78 8.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 CA-C-N 116.006 -0.543 . . . . 0.5 110.168 178.263 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 40.6 t30 54.73 45.07 27.49 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 115.208 -0.906 . . . . 0.44 112.967 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 264' ' ' GLN . . . . . 0.521 ' HB3' ' HG ' ' A' ' 259' ' ' LEU . 1.6 mt-30 -83.73 37.72 0.6 Allowed 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 120.761 0.315 . . . . 0.5 111.363 179.274 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -50.93 -42.15 59.42 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 112.665 0.617 . . . . 0.38 112.665 -179.069 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 1.3 p -62.24 -13.99 33.81 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.32 -0.4 . . . . 0.82 111.615 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 267' ' ' PHE . . . . . 0.489 ' C ' ' HD2' ' A' ' 270' ' ' PRO . 18.3 t80 -110.12 -22.91 11.56 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.347 -0.388 . . . . 0.59 110.372 178.345 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 268' ' ' ILE . . . . . 0.426 HG13 ' O ' ' A' ' 264' ' ' GLN . 72.1 mt -61.51 -46.49 96.47 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-N 116.387 -0.37 . . . . 0.33 110.554 178.712 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 269' ' ' GLU . . . . . 0.736 ' HB2' ' HD3' ' A' ' 270' ' ' PRO . 29.2 mm-40 -57.9 -56.57 33.35 Favored Pre-proline 0 CA--C 1.541 0.62 0 CA-C-N 116.576 -0.284 . . . . 0.34 110.785 178.562 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 270' ' ' PRO . . . . . 0.736 ' HD3' ' HB2' ' A' ' 269' ' ' GLU . 52.4 Cg_exo -57.97 -27.46 79.22 Favored 'Trans proline' 0 C--N 1.365 1.444 0 C-N-CA 122.402 2.068 . . . . 0.33 112.336 177.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 271' ' ' LEU . . . . . . . . . . . . . 20.9 tp -68.3 -53.06 26.9 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 108.959 -0.756 . . . . 0.5 108.959 177.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -61.31 -35.75 78.21 Favored 'General case' 0 C--O 1.23 0.075 0 N-CA-C 109.064 -0.717 . . . . 0.3 109.064 177.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 273' ' ' GLU . . . . . 0.514 ' HB3' ' HA ' ' A' ' 270' ' ' PRO . 32.4 tt0 -61.88 -48.62 79.69 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 114.939 -1.028 . . . . 1.62 109.852 177.605 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 274' ' ' THR . . . . . . . . . . . . . 89.0 m -62.49 -46.49 88.23 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.964 -0.562 . . . . 0.41 110.422 178.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 95.5 mt -56.59 -54.61 26.64 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-N 116.116 -0.493 . . . . 0.43 110.572 178.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 19.2 m -57.95 -52.4 65.68 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.603 -0.726 . . . . 0.42 111.577 179.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 277' ' ' ASP . . . . . 0.409 ' HB2' ' O ' ' A' ' 273' ' ' GLU . 1.0 OUTLIER -51.23 -54.44 25.64 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.072 -0.513 . . . . 0.4 111.482 179.956 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 87.6 t -64.41 -39.29 85.03 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-N 116.381 -0.372 . . . . 0.45 111.804 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 279' ' ' LEU . . . . . 0.465 ' O ' ' HB2' ' A' ' 283' ' ' LYS . 1.0 OUTLIER -67.65 -41.07 84.39 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 120.942 0.401 . . . . 1.1 111.364 -179.926 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 76.2 t -77.08 -46.02 29.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 112.394 0.516 . . . . 0.46 112.394 -179.245 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 67.3 mtp180 -65.6 -35.67 81.5 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 112.997 0.74 . . . . 0.76 112.997 -178.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 282' ' ' THR . . . . . . . . . . . . . 60.4 p -83.49 -15.88 47.78 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 122.13 -0.356 . . . . 0.35 111.923 179.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . 0.603 ' HB3' HD23 ' A' ' 287' ' ' LEU . 0.1 OUTLIER -123.21 39.76 3.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.746 0.307 . . . . 0.63 110.915 179.866 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 33.9 ttm180 -52.36 -61.43 2.28 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 112.666 0.617 . . . . 0.61 112.666 -179.57 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -64.77 -38.87 92.45 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 112.527 0.565 . . . . 0.84 112.527 -179.219 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 286' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -65.44 -41.36 93.56 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.805 0.336 . . . . 0.73 111.817 -179.23 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 287' ' ' LEU . . . . . 0.603 HD23 ' HB3' ' A' ' 283' ' ' LYS . 1.7 mm? -70.0 -41.63 74.09 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.468 0.544 . . . . 0.59 112.468 -179.174 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 20.4 m -67.02 -35.76 75.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 C-N-CA 120.799 -0.36 . . . . 0.53 111.899 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 47.4 mttp -69.99 -39.56 75.82 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 112.677 0.621 . . . . 1.12 112.677 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -89.92 20.17 4.37 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 113.405 0.891 . . . . 0.58 113.405 -178.038 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 291' ' ' ARG . . . . . 0.414 HH11 ' HD2' ' A' ' 291' ' ' ARG . 42.9 mtm180 60.42 15.33 5.42 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 112.916 0.709 . . . . 0.46 112.916 179.441 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 292' ' ' GLY . . . . . 0.478 ' HA2' HD13 ' A' ' 287' ' ' LEU . . . 66.59 -124.42 24.31 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 114.274 0.47 . . . . 0.31 114.274 179.445 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 293' ' ' TRP . . . . . 0.525 ' O ' HG23 ' A' ' 297' ' ' VAL . 89.2 m95 -63.85 -30.37 71.47 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.334 0.494 . . . . 0.38 112.334 -178.809 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 294' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.88 -43.45 94.73 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.836 -0.346 . . . . 0.74 110.623 178.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -67.9 -37.89 88.53 Favored Glycine 0 C--N 1.333 0.406 0 C-N-CA 120.56 -0.828 . . . . 0.33 111.073 177.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 296' ' ' PHE . . . . . 0.523 ' HB2' ' CZ3' ' A' ' 242' ' ' TRP . 0.3 OUTLIER -62.43 -45.81 91.41 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 120.936 0.398 . . . . 0.46 110.48 178.413 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 297' ' ' VAL . . . . . 0.703 HG11 ' HB3' ' A' ' 189' ' ' ARG . 80.3 t -63.58 -49.82 80.83 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.23 0 CA-C-N 115.855 -0.611 . . . . 0.34 110.898 179.749 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 71.6 mt-10 -61.96 -45.21 94.65 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.245 -0.434 . . . . 0.53 111.777 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 299' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -60.01 -49.48 77.51 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 120.87 0.367 . . . . 0.55 111.678 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 300' ' ' PHE . . . . . 0.505 ' HB3' HG21 ' A' ' 197' ' ' VAL . 59.3 m-85 . . . . . 0 C--N 1.329 -0.321 0 CA-C-O 121.009 0.433 . . . . 0.56 111.3 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 22' ' ' GLU . . . . . 0.464 ' O ' ' HB2' ' B' ' 26' ' ' GLN . 4.8 mm-40 . . . . . 0 C--O 1.224 -0.265 0 N-CA-C 111.407 0.151 . . . . 0.75 111.407 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 23' ' ' PHE . . . . . . . . . . . . . 10.3 p90 -63.64 -35.39 80.37 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.18 0.515 . . . . 0.62 110.747 179.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 24' ' ' ALA . . . . . 0.897 ' HA ' HG13 ' A' ' 230' ' ' VAL . . . -72.11 -43.98 63.91 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.639 -0.71 . . . . 0.42 110.623 179.178 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -69.73 -37.03 76.35 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.147 -0.479 . . . . 0.42 110.532 179.108 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 26' ' ' GLN . . . . . 0.464 ' HB2' ' O ' ' B' ' 22' ' ' GLU . 0.0 OUTLIER -61.73 -54.84 37.07 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 116.481 -0.327 . . . . 0.71 111.174 179.514 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . 0.52 HD12 HG11 ' A' ' 230' ' ' VAL . 30.9 mt -58.06 -37.32 74.22 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 120.863 0.363 . . . . 0.63 110.197 178.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 28' ' ' ARG . . . . . 0.528 ' HA ' HG13 ' A' ' 234' ' ' VAL . 4.8 tmt_? -62.6 -53.69 50.81 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 109.26 -0.644 . . . . 1.24 109.26 177.55 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 21.3 mtmt -53.7 -48.95 69.06 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.858 -0.61 . . . . 0.55 110.582 178.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . 0.444 HG13 ' O ' ' B' ' 26' ' ' GLN . 75.5 mt -59.07 -42.28 85.97 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.202 0 CA-C-N 116.057 -0.52 . . . . 0.41 110.123 179.129 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . 0.501 ' HA3' ' HA ' ' A' ' 244' ' ' ARG . . . -58.76 -50.15 70.32 Favored Glycine 0 CA--C 1.521 0.421 0 C-N-CA 120.886 -0.673 . . . . 0.34 112.398 178.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 32' ' ' ASP . . . . . 0.484 ' OD2' ' HD3' ' B' ' 28' ' ' ARG . 9.1 m-20 -61.84 -40.12 94.2 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.14 0.495 . . . . 0.42 110.145 178.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 15.6 tppt? -64.0 -53.82 44.01 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 115.74 -0.663 . . . . 1.22 111.101 179.514 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 77.3 t -59.13 -39.03 77.58 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-O 121.067 0.461 . . . . 0.42 110.48 179.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 35' ' ' TYR . . . . . 0.51 ' N ' ' HA3' ' A' ' 243' ' ' GLY . 4.0 t80 -60.55 -50.44 73.55 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.898 -0.592 . . . . 0.82 110.467 178.479 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 36' ' ' CYS . . . . . . . . . . . . . 61.5 m -64.25 -25.82 68.23 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.009 0.433 . . . . 0.43 110.983 179.429 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 20.9 m -75.36 -43.14 52.05 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 116.022 -0.536 . . . . 0.44 112.259 -179.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 38' ' ' TRP . . . . . . . . . . . . . 97.2 m95 -87.9 -9.78 52.67 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 113.249 0.833 . . . . 0.66 113.249 -178.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 38.2 t . . . . . 0 N--CA 1.468 0.474 0 N-CA-C 111.731 0.271 . . . . 0.67 111.731 179.196 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 33.0 t70 . . . . . 0 CA--C 1.534 0.338 0 N-CA-C 112.454 0.538 . . . . 0.64 112.454 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.93 -55.54 33.8 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.123 0.487 . . . . 0.83 111.121 179.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.477 HD21 ' HB3' ' A' ' 287' ' ' LEU . 26.4 tp -58.63 -42.35 88.09 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.91 -0.587 . . . . 0.54 112.251 179.616 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 68.3 t80 -69.01 -47.04 66.48 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 112.399 0.518 . . . . 0.51 112.399 -179.219 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 60.9 mtp180 -61.21 -40.23 93.22 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 111.744 0.276 . . . . 0.64 111.744 -179.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 2.8 mm-40 -68.57 -44.29 74.76 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.891 0.377 . . . . 0.63 110.183 179.14 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 34.1 m -63.69 -49.35 73.47 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.949 -0.568 . . . . 0.32 111.346 179.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.51 ' HA ' HG21 ' A' ' 276' ' ' THR . 11.1 tp -55.68 -49.49 72.81 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 111.871 0.323 . . . . 0.47 111.871 -179.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . 0.724 ' O ' ' HG2' ' A' ' 165' ' ' ARG . 0.0 OUTLIER -58.64 -53.72 55.2 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-O 120.625 0.25 . . . . 0.54 111.152 179.806 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . 0.514 HG12 ' HA2' ' A' ' 187' ' ' GLY . 83.3 mt -58.54 -46.95 89.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-N 116.416 -0.356 . . . . 0.33 111.683 -179.711 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.512 HD12 HG23 ' A' ' 276' ' ' THR . 71.7 mt -62.74 -45.51 98.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 CA-C-N 116.446 -0.343 . . . . 0.32 110.716 179.643 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . 0.536 ' O ' ' HB2' ' A' ' 168' ' ' ARG . 51.1 m -57.87 -41.38 82.36 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.482 -0.326 . . . . 0.29 110.332 178.346 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . 0.724 ' HG2' ' O ' ' A' ' 161' ' ' GLU . 13.5 mmt180 -65.11 -54.8 24.34 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.493 -0.321 . . . . 0.52 111.33 179.612 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' TYR . . . . . 0.823 ' HE1' ' HA ' ' A' ' 195' ' ' ARG . 65.2 t80 -60.93 -51.26 70.02 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 113.036 0.754 . . . . 0.39 113.036 -178.063 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.469 HD13 HG23 ' A' ' 163' ' ' ILE . 9.2 mp -60.43 -39.87 89.03 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.879 -0.329 . . . . 0.45 111.056 -179.078 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . 0.536 ' HB2' ' O ' ' A' ' 164' ' ' SER . 3.9 mmt180 -68.7 -42.8 77.25 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 120.881 0.372 . . . . 0.39 111.126 178.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . 0.562 ' CD ' HH21 ' A' ' 195' ' ' ARG . 63.5 mt-10 -65.33 -48.67 72.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.019 0.437 . . . . 0.37 111.447 178.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . 0.636 ' HB3' ' HB1' ' A' ' 253' ' ' ALA . 7.4 tp60 -65.71 -37.3 86.05 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.137 -0.483 . . . . 0.39 111.821 -179.355 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.458 ' HA ' ' HA ' ' A' ' 257' ' ' LYS . . . . . . . . 0 N--CA 1.463 0.204 0 CA-C-O 120.787 0.327 . . . . 0.39 111.396 179.083 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.549 ' O ' ' HA3' ' A' ' 187' ' ' GLY . . . . . . . . 0 C--O 1.224 -0.281 0 CA-C-O 120.669 0.271 . . . . 0.43 111.062 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -74.81 -71.15 1.16 Allowed Glycine 0 CA--C 1.528 0.849 0 C-N-CA 120.552 -0.832 . . . . 0.55 114.255 -179.341 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -62.31 -55.29 29.61 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-O 121.06 0.457 . . . . 0.63 111.736 -179.161 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -63.78 -40.27 96.27 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.915 -0.584 . . . . 0.42 110.672 179.172 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . 0.549 ' HA3' ' O ' ' A' ' 183' ' ' ALA . . . -64.3 -40.41 97.87 Favored Glycine 0 C--N 1.333 0.4 0 C-N-CA 121.261 -0.495 . . . . 0.32 113.592 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 62.7 ttt180 -62.89 -51.3 67.51 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 117.269 0.534 . . . . 1.4 110.759 179.198 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 48.4 mtm180 -67.54 -31.56 71.74 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 116.112 -0.494 . . . . 0.45 111.033 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . 0.518 ' HA ' ' CG1' ' A' ' 297' ' ' VAL . . . -71.29 -40.43 70.89 Favored 'General case' 0 C--O 1.222 -0.368 0 CA-C-N 116.282 -0.417 . . . . 0.27 110.943 178.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 20.0 tp -63.36 -47.15 83.31 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 111.589 0.218 . . . . 0.55 111.589 179.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 6.0 tm-20 -60.17 -45.37 93.33 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.291 0.567 . . . . 0.35 110.267 179.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . 0.652 HG21 ' HA ' ' A' ' 297' ' ' VAL . 27.8 m -65.68 -47.19 76.3 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.762 -0.654 . . . . 0.31 110.665 179.284 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . 0.445 HD12 ' HA ' ' A' ' 194' ' ' LEU . 7.0 tp -61.07 -41.75 97.22 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 116.032 -0.531 . . . . 0.34 110.678 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . 0.823 ' HA ' ' HE1' ' A' ' 166' ' ' TYR . 50.5 mtt180 -59.38 -58.44 8.6 Favored 'General case' 0 C--O 1.226 -0.136 0 CA-C-O 120.774 0.321 . . . . 0.48 110.172 178.319 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 8.5 ttm180 -57.77 -56.34 23.16 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.654 -0.703 . . . . 0.45 112.714 -179.028 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . 0.482 ' O ' HG23 ' A' ' 201' ' ' VAL . 58.6 t -62.3 -41.71 92.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-O 120.87 0.367 . . . . 0.3 111.021 -179.395 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . 0.581 ' HA3' ' OH ' ' A' ' 166' ' ' TYR . . . -63.21 -46.85 92.16 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 120.86 -0.686 . . . . 0.28 111.939 179.174 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 51.3 m-20 -55.74 -45.56 77.98 Favored 'General case' 0 N--CA 1.462 0.163 0 N-CA-C 109.509 -0.552 . . . . 0.36 109.509 178.114 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -58.69 -54.31 38.96 Favored Glycine 0 C--O 1.223 -0.573 0 CA-C-N 115.633 -0.712 . . . . 0.31 111.921 178.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 197' ' ' VAL . 57.5 t -59.58 -42.3 87.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 CA-C-O 120.787 0.327 . . . . 0.41 111.701 179.279 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 202' ' ' GLN . . . . . 0.44 ' HG2' ' HD1' ' A' ' 254' ' ' PHE . 5.9 mt-30 -64.3 -52.47 58.39 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 112.444 0.535 . . . . 0.55 112.444 -179.389 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 203' ' ' ARG . . . . . 0.43 ' HD3' HH11 ' A' ' 203' ' ' ARG . 2.8 mmp_? -69.37 -35.18 75.58 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.743 0.306 . . . . 0.59 111.475 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -68.53 -48.27 64.75 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.995 0.426 . . . . 0.4 110.819 179.105 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 -100.69 32.95 2.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.007 0.432 . . . . 0.54 110.818 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -56.72 -46.72 81.14 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.607 -0.724 . . . . 0.42 112.148 -179.167 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 58.4 p -60.46 -45.62 93.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.994 0.426 . . . . 0.57 111.176 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -65.94 -41.88 90.74 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.844 -0.616 . . . . 0.37 110.886 179.053 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 7.8 m-30 -66.17 -44.34 84.33 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.521 -0.309 . . . . 0.48 110.573 179.281 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -64.71 -44.52 89.98 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.532 -0.303 . . . . 1.34 110.616 178.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -60.51 -44.67 97.46 Favored Glycine 0 C--N 1.336 0.549 0 C-N-CA 120.749 -0.739 . . . . 0.33 111.28 178.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 28.1 ttm -66.3 -40.87 90.28 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 121.022 0.439 . . . . 0.51 109.935 178.248 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 12.9 tp -59.36 -42.54 91.83 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.596 -0.729 . . . . 0.49 111.718 179.177 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 77.1 mtp180 -74.28 -28.71 61.33 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.401 -0.363 . . . . 0.87 111.741 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 49.4 mtmt -76.33 -34.19 58.99 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 120.823 0.344 . . . . 0.82 110.69 178.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . 0.557 ' HB3' HG12 ' A' ' 218' ' ' ILE . 81.6 mt -67.84 136.39 54.04 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 121.11 0.481 . . . . 0.57 111.795 179.499 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -101.28 30.97 3.89 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.11 -0.495 . . . . 0.71 110.485 179.31 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 218' ' ' ILE . . . . . 0.557 HG12 ' HB3' ' A' ' 216' ' ' LEU . 20.0 mm -59.17 119.86 4.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-N 115.8 -0.636 . . . . 0.5 111.316 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 19.3 mtmm -149.04 -30.99 0.24 Allowed 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 113.178 0.807 . . . . 1.1 113.178 -179.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -125.18 174.67 7.92 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.748 0.647 . . . . 0.46 112.748 -178.222 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . 0.463 ' O ' HG22 ' A' ' 224' ' ' VAL . 1.0 OUTLIER -62.35 -28.77 69.99 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 115.732 -0.667 . . . . 0.59 111.302 -179.949 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -61.88 -25.59 66.08 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 121.351 -0.452 . . . . 0.33 113.268 179.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 -58.43 -28.34 65.17 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 113.226 0.824 . . . . 0.36 113.226 -179.688 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.728 ' HB ' HG21 ' A' ' 274' ' ' THR . 25.8 m -54.0 -29.78 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 N-CA-C 112.908 0.707 . . . . 0.39 112.908 -179.237 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 33.4 mtmm -64.89 -43.39 93.04 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-O 121.415 0.626 . . . . 0.63 110.075 178.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 15.5 m -70.34 -38.65 74.88 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.309 -0.86 . . . . 0.6 109.715 178.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 227' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -59.63 -38.82 82.39 Favored 'General case' 0 CA--C 1.528 0.13 0 N-CA-C 108.791 -0.818 . . . . 0.61 108.791 177.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 49.8 m -62.32 -41.19 98.33 Favored 'General case' 0 CA--C 1.528 0.101 0 CA-C-N 115.426 -0.806 . . . . 0.48 109.989 177.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.2 -40.93 78.41 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.33 -0.395 . . . . 2.11 110.371 178.592 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . 0.51 ' O ' HG23 ' A' ' 234' ' ' VAL . 13.4 t -61.97 -51.3 74.18 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-N 116.466 -0.334 . . . . 0.3 110.139 178.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 231' ' ' MET . . . . . . . . . . . . . 38.9 mtp -58.84 -47.63 84.18 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.146 -0.479 . . . . 0.4 111.116 179.41 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 75.6 t -63.92 -41.0 91.07 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 CA-C-N 116.34 -0.391 . . . . 0.53 110.907 179.19 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 31.8 t-80 -64.58 -37.56 87.97 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 116.414 -0.357 . . . . 0.58 110.975 178.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.51 HG23 ' O ' ' A' ' 230' ' ' VAL . 53.1 t -63.2 -51.61 69.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-O 120.794 0.331 . . . . 0.43 111.736 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -90.37 24.56 2.53 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 112.159 0.429 . . . . 0.58 112.159 -178.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 1.8 tmtm? -66.69 -15.37 63.46 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 112.537 0.569 . . . . 1.21 112.537 -179.25 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 44.8 p30 -85.27 -16.21 40.88 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 120.767 0.318 . . . . 0.57 111.497 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 94.38 -0.84 66.22 Favored Glycine 0 CA--C 1.524 0.636 0 C-N-CA 121.088 -0.577 . . . . 0.58 113.262 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . 0.487 ' HB ' ' NH1' ' A' ' 244' ' ' ARG . 25.6 t -93.44 109.84 22.43 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-O 121.092 0.472 . . . . 0.48 111.584 -179.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 240' ' ' THR . . . . . 0.626 HG22 HD11 ' A' ' 245' ' ' ILE . 21.2 m -94.11 76.74 4.06 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.951 0.405 . . . . 0.84 111.582 179.718 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . 0.448 ' H ' ' HD2' ' A' ' 244' ' ' ARG . 59.3 m-20 -77.05 140.3 40.28 Favored 'General case' 0 C--N 1.329 -0.307 0 O-C-N 122.206 -0.309 . . . . 0.72 110.943 179.194 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 242' ' ' TRP . . . . . 0.546 ' HB3' ' CE2' ' A' ' 300' ' ' PHE . 47.8 m95 -56.32 -40.95 75.24 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.813 0.34 . . . . 0.6 110.871 179.275 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . 0.452 ' H ' ' HB2' ' B' ' 35' ' ' TYR . . . -62.98 -28.82 72.65 Favored Glycine 0 C--N 1.334 0.466 0 C-N-CA 121.168 -0.539 . . . . 0.25 112.028 178.49 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 244' ' ' ARG . . . . . 0.487 ' NH1' ' HB ' ' A' ' 239' ' ' VAL . 89.7 mtt180 -74.44 -42.39 59.21 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.659 -0.497 . . . . 0.46 109.659 178.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . 0.626 HD11 HG22 ' A' ' 240' ' ' THR . 67.8 mt -63.81 -52.71 53.63 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 CA-C-N 115.903 -0.589 . . . . 0.4 110.377 178.771 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . 0.405 HG12 ' HA2' ' A' ' 243' ' ' GLY . 6.8 p -62.63 -29.76 47.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 CA-C-N 116.287 -0.415 . . . . 0.35 110.836 179.43 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 11.1 m -65.93 -44.49 84.98 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 109.743 -0.465 . . . . 0.31 109.743 177.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 248' ' ' LEU . . . . . 0.41 HD13 ' HA ' ' A' ' 248' ' ' LEU . 2.5 mm? -64.42 -40.65 96.18 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 109.832 -0.432 . . . . 0.53 109.832 178.035 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 249' ' ' ILE . . . . . 0.459 HG12 ' O ' ' A' ' 245' ' ' ILE . 48.7 mm -64.05 -43.06 97.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 CA-C-O 121.052 0.453 . . . . 0.46 109.868 178.162 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 56.2 m -62.32 -42.61 99.52 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 115.846 -0.615 . . . . 0.3 109.6 178.313 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 251' ' ' PHE . . . . . . . . . . . . . 18.2 t80 -62.77 -42.99 99.94 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 116.008 -0.542 . . . . 0.5 109.675 178.079 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -57.82 -46.61 92.15 Favored Glycine 0 C--N 1.335 0.521 0 N-CA-C 111.386 -0.686 . . . . 0.28 111.386 178.165 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 253' ' ' ALA . . . . . 0.636 ' HB1' ' HB3' ' A' ' 170' ' ' GLN . . . -68.19 -27.77 66.68 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 120.661 0.267 . . . . 0.35 111.483 178.261 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 254' ' ' PHE . . . . . 0.44 ' HD1' ' HG2' ' A' ' 202' ' ' GLN . 26.6 t80 -74.81 -48.51 24.91 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 120.626 0.25 . . . . 0.6 111.047 179.3 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 255' ' ' VAL . . . . . 0.535 ' O ' ' HG ' ' A' ' 259' ' ' LEU . 23.6 m -64.18 -37.75 80.69 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.129 0 C-N-CA 120.503 -0.479 . . . . 0.34 109.751 178.454 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -67.36 -32.15 72.88 Favored 'General case' 0 C--N 1.341 0.199 0 CA-C-N 116.342 -0.39 . . . . 0.26 110.497 178.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 257' ' ' LYS . . . . . 0.562 ' HE2' ' HG3' ' A' ' 170' ' ' GLN . 28.0 ttmt -61.94 -46.99 86.88 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 109.048 -0.723 . . . . 0.44 109.048 177.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 82.9 t60 -66.0 -40.47 91.15 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 115.356 -0.838 . . . . 0.58 109.445 177.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.65 ' HB3' ' HB2' ' A' ' 264' ' ' GLN . 95.0 mt -62.89 -36.39 83.18 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.104 -0.498 . . . . 0.41 110.591 178.438 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -65.54 -37.36 86.52 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 110.134 -0.321 . . . . 0.37 110.134 178.47 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 15.9 p -64.2 -24.62 67.74 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.839 0.352 . . . . 0.53 110.7 178.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 7.3 p -107.09 8.15 9.62 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 CA-C-O 121.592 0.71 . . . . 0.4 110.328 178.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 6.5 t30 59.13 49.31 9.45 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 113.7 1.0 . . . . 0.59 113.7 179.187 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 264' ' ' GLN . . . . . 0.65 ' HB2' ' HB3' ' A' ' 259' ' ' LEU . 4.0 mm100 -92.24 35.19 1.0 Allowed 'General case' 0 N--CA 1.47 0.532 0 O-C-N 122.082 -0.386 . . . . 0.6 111.352 178.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 265' ' ' GLU . . . . . 0.408 ' HG2' ' H ' ' A' ' 265' ' ' GLU . 5.3 mm-40 -47.52 -43.94 25.28 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 112.594 0.591 . . . . 0.45 112.594 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 86.8 p -59.11 -18.13 32.74 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 116.326 -0.397 . . . . 0.47 111.749 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 267' ' ' PHE . . . . . 0.448 ' CE1' ' HA ' ' A' ' 221' ' ' GLU . 53.8 t80 -107.77 -28.62 9.57 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 116.653 -0.249 . . . . 0.53 111.073 178.723 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 73.9 mt -57.13 -49.97 77.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 CA-C-O 120.575 0.226 . . . . 0.38 111.474 179.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 269' ' ' GLU . . . . . 0.485 ' HB2' ' HD3' ' A' ' 270' ' ' PRO . 2.5 mp0 -58.6 -56.86 31.27 Favored Pre-proline 0 CA--C 1.543 0.707 0 C-N-CA 121.128 -0.229 . . . . 0.36 111.542 179.431 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 270' ' ' PRO . . . . . 0.485 ' HD3' ' HB2' ' A' ' 269' ' ' GLU . 45.1 Cg_exo -59.37 -29.83 91.18 Favored 'Trans proline' 0 C--N 1.361 1.198 0 C-N-CA 122.369 2.046 . . . . 0.3 112.854 178.57 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 271' ' ' LEU . . . . . . . . . . . . . 56.6 tp -67.72 -49.38 62.96 Favored 'General case' 0 N--CA 1.464 0.225 0 N-CA-C 109.914 -0.402 . . . . 0.44 109.914 178.452 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -60.17 -37.21 79.47 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.113 -0.494 . . . . 0.31 110.217 178.454 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 273' ' ' GLU . . . . . 0.451 ' O ' ' HB2' ' A' ' 277' ' ' ASP . 32.0 tt0 -67.05 -43.12 83.51 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 109.462 -0.57 . . . . 1.11 109.462 178.109 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 274' ' ' THR . . . . . 0.728 HG21 ' HB ' ' A' ' 224' ' ' VAL . 70.1 m -61.47 -49.29 77.39 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.104 -0.498 . . . . 0.4 110.348 178.216 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 96.8 mt -55.37 -54.16 28.04 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.123 0 CA-C-N 115.775 -0.648 . . . . 0.42 110.763 179.419 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 276' ' ' THR . . . . . 0.512 HG23 HD12 ' A' ' 163' ' ' ILE . 15.9 m -57.69 -46.75 83.89 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 120.918 0.39 . . . . 0.31 110.993 179.433 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 277' ' ' ASP . . . . . 0.451 ' HB2' ' O ' ' A' ' 273' ' ' GLU . 0.4 OUTLIER -54.65 -59.92 4.06 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 115.685 -0.689 . . . . 0.59 110.966 179.345 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 57.3 t -60.38 -39.48 81.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 CA-C-O 120.812 0.339 . . . . 0.42 111.418 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 279' ' ' LEU . . . . . 0.554 HD11 HG23 ' A' ' 245' ' ' ILE . 15.8 tp -61.32 -47.59 85.23 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.564 -0.289 . . . . 0.85 111.151 179.568 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 80.2 t -73.04 -42.89 59.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 120.928 -0.309 . . . . 0.49 111.556 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 80.6 mtt-85 -60.92 -34.48 74.77 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 112.458 0.54 . . . . 1.09 112.458 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 282' ' ' THR . . . . . . . . . . . . . 69.3 p -95.74 0.13 52.1 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 113.089 0.774 . . . . 0.71 113.089 -178.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . 0.502 ' HD2' ' O ' ' A' ' 279' ' ' LEU . 5.7 mttp -141.26 30.1 1.78 Allowed 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 111.649 0.24 . . . . 0.93 111.649 179.773 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 40.1 ttm180 -57.72 -56.12 26.07 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 112.077 0.399 . . . . 0.92 112.077 -179.222 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -61.4 -44.52 97.0 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 120.826 0.346 . . . . 0.77 111.652 -179.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 286' ' ' TRP . . . . . 0.405 ' O ' ' HB2' ' A' ' 290' ' ' GLN . 0.8 OUTLIER -65.18 -49.52 69.5 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 112.36 0.504 . . . . 0.71 112.36 -179.074 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 287' ' ' LEU . . . . . 0.477 ' HB3' HD21 ' A' ' 155' ' ' LEU . 1.6 mm? -66.36 -42.61 87.8 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 113.007 0.743 . . . . 0.51 113.007 -178.502 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 5.6 p -67.75 -36.49 76.09 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 C-N-CA 120.797 -0.361 . . . . 0.49 111.962 -179.511 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 50.3 mttt -76.82 -33.57 57.96 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 112.38 0.511 . . . . 0.95 112.38 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 290' ' ' GLN . . . . . 0.405 ' HB2' ' O ' ' A' ' 286' ' ' TRP . 1.1 tp-100 -84.88 26.43 0.84 Allowed 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 113.002 0.741 . . . . 0.76 113.002 -178.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 32.7 mtp180 63.22 9.39 3.92 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 112.874 0.694 . . . . 0.49 112.874 178.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 62.64 -132.47 44.18 Favored Glycine 0 CA--C 1.524 0.656 0 CA-C-O 121.619 0.566 . . . . 0.35 113.954 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 293' ' ' TRP . . . . . 0.498 ' HA ' ' HB3' ' A' ' 296' ' ' PHE . 78.7 m95 -66.56 -23.45 66.21 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.392 0.516 . . . . 0.49 112.392 -178.766 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 294' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -64.52 -43.49 93.87 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 109.776 -0.453 . . . . 0.43 109.776 178.487 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -69.74 -32.04 70.5 Favored Glycine 0 C--N 1.334 0.459 0 N-CA-C 110.765 -0.934 . . . . 0.3 110.765 177.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 296' ' ' PHE . . . . . 0.498 ' HB3' ' HA ' ' A' ' 293' ' ' TRP . 6.0 t80 -67.53 -48.91 65.64 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 115.553 -0.323 . . . . 0.41 111.202 178.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 297' ' ' VAL . . . . . 0.652 ' HA ' HG21 ' A' ' 193' ' ' THR . 21.7 m -69.14 -33.18 57.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 CA-C-N 116.63 -0.259 . . . . 0.33 111.591 -179.591 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -69.47 -42.2 75.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.9 0.381 . . . . 0.47 110.713 179.176 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 299' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -67.69 -45.73 74.32 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.005 -0.543 . . . . 0.64 111.427 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 300' ' ' PHE . . . . . 0.546 ' CE2' ' HB3' ' A' ' 242' ' ' TRP . 60.1 m-85 . . . . . 0 CA--C 1.538 0.494 0 N-CA-C 112.687 0.625 . . . . 0.46 112.687 -179.089 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 . . . . . 0 CA--C 1.534 0.327 0 N-CA-C 111.774 0.287 . . . . 0.64 111.774 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 23' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -55.93 -41.17 74.21 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 112.218 0.451 . . . . 0.41 112.218 -179.063 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -66.95 -38.98 87.1 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.882 0.372 . . . . 0.36 111.37 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.8 -35.71 81.99 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-O 121.507 0.67 . . . . 0.38 110.01 178.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -66.16 -49.77 66.25 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.246 -0.888 . . . . 0.5 109.43 178.053 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 82.8 mt -57.21 -36.16 70.53 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.275 -0.42 . . . . 0.48 110.678 178.291 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 28' ' ' ARG . . . . . . . . . . . . . 37.7 mtp85 -57.25 -58.21 9.25 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 116.108 -0.496 . . . . 0.5 111.299 178.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 8.6 ptpp? -64.57 -31.53 72.78 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.523 -0.308 . . . . 0.48 110.791 179.517 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 52.2 mt -62.82 -49.85 82.04 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 N-CA-C 109.421 -0.585 . . . . 0.43 109.421 178.073 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -62.18 -43.61 98.88 Favored Glycine 0 N--CA 1.448 -0.527 0 CA-C-N 115.423 -0.808 . . . . 0.29 112.012 178.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -66.95 -37.11 83.68 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 121.221 -0.191 . . . . 0.54 110.878 179.076 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 23.6 ttmm -65.08 -44.6 88.39 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 109.865 -0.42 . . . . 0.8 109.865 177.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 45.7 t -63.92 -50.79 75.9 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-N 115.969 -0.559 . . . . 0.35 110.186 178.439 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 35' ' ' TYR . . . . . 0.452 ' HB2' ' H ' ' A' ' 243' ' ' GLY . 0.0 OUTLIER -58.0 -40.54 81.0 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.681 -0.691 . . . . 0.73 110.817 179.273 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 36' ' ' CYS . . . . . . . . . . . . . 23.6 t -69.64 -26.47 64.43 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 120.873 0.368 . . . . 0.64 111.422 179.411 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 85.7 m -76.17 -35.02 59.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.305 -0.407 . . . . 0.46 111.18 179.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 38' ' ' TRP . . . . . . . . . . . . . 97.7 m95 -88.03 -37.36 16.38 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 112.052 0.39 . . . . 0.6 112.052 -179.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 45.7 p . . . . . 0 N--CA 1.471 0.619 0 CA-C-O 120.761 0.315 . . . . 0.68 111.396 179.16 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . 0.401 ' HA ' ' HB2' ' A' ' 156' ' ' TYR . 2.3 p-10 . . . . . 0 C--O 1.223 -0.324 0 CA-C-O 120.608 0.242 . . . . 0.45 110.846 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -55.52 -41.49 73.19 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.232 0.539 . . . . 0.43 110.242 178.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -71.66 -40.28 69.75 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 109.004 -0.739 . . . . 0.74 109.004 177.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . 0.401 ' HB2' ' HA ' ' A' ' 153' ' ' ASP . 0.1 OUTLIER -60.65 -46.95 88.4 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 115.966 -0.561 . . . . 0.35 110.86 179.095 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 14.2 mtp180 -60.53 -45.92 92.07 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 116.336 -0.393 . . . . 0.45 111.301 179.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -63.9 -50.46 68.64 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.062 0.458 . . . . 0.43 109.826 178.59 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 16.8 m -56.72 -48.47 77.67 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 115.461 -0.791 . . . . 0.25 110.925 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.473 ' HA ' HG21 ' A' ' 276' ' ' THR . 2.1 tm? -57.21 -49.54 75.69 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.551 -0.295 . . . . 0.46 110.254 178.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.2 -45.46 93.11 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.348 -0.387 . . . . 0.79 111.474 179.552 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . 0.54 HG23 HD22 ' A' ' 191' ' ' LEU . 89.9 mt -65.65 -56.56 14.55 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 CA-C-N 116.0 -0.546 . . . . 0.29 112.359 -179.252 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.542 HD12 HG23 ' A' ' 276' ' ' THR . 97.1 mt -58.49 -51.99 64.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 N-CA-C 112.71 0.633 . . . . 0.36 112.71 -178.689 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 65.9 p -56.1 -42.67 77.14 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 120.556 0.217 . . . . 0.29 111.452 -179.398 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.55 -52.95 48.65 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.889 0.376 . . . . 1.24 111.105 178.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' TYR . . . . . 0.788 ' HE1' ' HA ' ' A' ' 195' ' ' ARG . 59.9 t80 -57.3 -49.08 77.23 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 112.594 0.59 . . . . 0.32 112.594 -179.614 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 5.5 mp -60.71 -46.14 91.55 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 112.413 0.523 . . . . 0.42 112.413 -178.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 38.2 ttm-85 -69.14 -49.89 52.81 Favored 'General case' 0 C--O 1.239 0.545 0 N-CA-C 113.067 0.766 . . . . 0.29 113.067 -178.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -64.12 -52.08 60.85 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.171 0.434 . . . . 0.41 112.171 -178.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -64.29 -32.42 74.01 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 111.972 0.36 . . . . 0.43 111.972 -179.284 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.463 ' O ' ' HG3' ' A' ' 257' ' ' LYS . . . . . . . . 0 C--N 1.332 -0.156 0 CA-C-O 121.04 0.448 . . . . 0.37 110.305 178.076 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.468 ' HB1' ' CA ' ' A' ' 187' ' ' GLY . . . . . . . . 0 CA--C 1.536 0.425 0 CA-C-O 121.261 0.553 . . . . 0.43 111.192 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . 0.701 ' HA2' ' NH2' ' A' ' 188' ' ' ARG . . . -79.84 -73.85 1.12 Allowed Glycine 0 CA--C 1.525 0.713 0 C-N-CA 120.312 -0.947 . . . . 0.57 114.079 -179.605 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -71.79 -54.72 9.29 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.065 0.46 . . . . 0.74 110.886 -179.36 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -65.14 -35.18 80.3 Favored 'General case' 0 C--O 1.221 -0.427 0 CA-C-N 115.76 -0.655 . . . . 0.6 110.601 179.277 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . 0.468 ' CA ' ' HB1' ' A' ' 183' ' ' ALA . . . -64.03 -53.33 37.78 Favored Glycine 0 C--O 1.228 -0.262 0 C-N-CA 120.903 -0.665 . . . . 0.43 113.082 -179.81 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . 0.701 ' NH2' ' HA2' ' A' ' 184' ' ' GLY . 0.3 OUTLIER -59.64 -41.71 91.13 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 117.095 0.447 . . . . 1.6 111.192 -179.98 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 189' ' ' ARG . . . . . 0.9 ' HD3' HG11 ' A' ' 297' ' ' VAL . 0.2 OUTLIER -71.12 -40.3 71.51 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.509 -0.314 . . . . 0.48 111.245 179.386 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . 0.517 ' HA ' HG22 ' A' ' 297' ' ' VAL . . . -69.6 -39.4 77.27 Favored 'General case' 0 C--O 1.22 -0.481 0 CA-C-N 116.865 -0.152 . . . . 0.26 111.394 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 191' ' ' LEU . . . . . 0.605 HD12 ' HE ' ' A' ' 195' ' ' ARG . 0.3 OUTLIER -64.59 -47.52 78.37 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.603 0.24 . . . . 0.47 111.212 179.788 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -60.79 -42.85 98.37 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.265 0.555 . . . . 0.4 110.897 179.461 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . 0.542 ' OG1' HG13 ' A' ' 297' ' ' VAL . 27.8 m -69.76 -54.06 15.44 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.757 -0.656 . . . . 0.32 110.906 179.515 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . 0.477 HD21 HG21 ' A' ' 249' ' ' ILE . 16.7 tp -55.32 -42.34 73.6 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 115.828 -0.623 . . . . 0.32 111.324 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . 0.788 ' HA ' ' HE1' ' A' ' 166' ' ' TYR . 17.9 mtm105 -63.27 -53.05 59.03 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.717 -0.22 . . . . 0.36 111.37 179.654 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.51 -49.77 76.51 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 111.888 0.329 . . . . 0.56 111.888 -179.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 87.2 t -63.89 -46.81 93.16 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 CA-C-O 120.877 0.37 . . . . 0.34 110.315 179.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . 0.612 ' HA3' ' OH ' ' A' ' 166' ' ' TYR . . . -58.83 -42.13 96.42 Favored Glycine 0 C--N 1.333 0.372 0 CA-C-N 115.9 -0.591 . . . . 0.24 112.222 179.017 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -56.95 -44.27 82.38 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.837 0.351 . . . . 0.49 110.31 178.233 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -66.96 -53.48 26.63 Favored Glycine 0 CA--C 1.523 0.568 0 C-N-CA 120.928 -0.654 . . . . 0.36 112.883 179.354 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 60.3 t -60.77 -42.73 93.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 N-CA-C 112.217 0.451 . . . . 0.36 112.217 -179.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 202' ' ' GLN . . . . . 0.592 ' HA ' ' HE2' ' A' ' 209' ' ' PHE . 0.2 OUTLIER -63.44 -52.71 60.32 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 112.131 0.419 . . . . 0.36 112.131 -179.392 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 30.6 mtt-85 -66.66 -33.39 75.54 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.732 0.301 . . . . 0.45 110.343 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -63.92 -52.6 59.09 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.121 -0.491 . . . . 0.88 110.311 178.379 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 205' ' ' HIS . . . . . 0.422 ' HB3' ' HB3' ' A' ' 208' ' ' ALA . 80.7 m-70 -102.21 36.02 2.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.294 -0.412 . . . . 0.48 111.731 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -57.19 -46.52 82.76 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 120.931 0.396 . . . . 1.23 111.31 -179.389 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 47.5 p -64.11 -41.63 97.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.832 -0.622 . . . . 0.62 111.16 179.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 208' ' ' ALA . . . . . 0.422 ' HB3' ' HB3' ' A' ' 205' ' ' HIS . . . -63.61 -41.21 98.32 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.914 -0.585 . . . . 0.37 110.523 179.054 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 209' ' ' PHE . . . . . 0.608 ' O ' ' HG ' ' A' ' 213' ' ' LEU . 20.6 m-30 -70.23 -46.98 63.37 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.143 -0.48 . . . . 0.5 110.138 178.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 210' ' ' GLN . . . . . 0.429 ' HA ' HD12 ' A' ' 213' ' ' LEU . 0.6 OUTLIER -58.66 -44.57 90.2 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 121.039 0.447 . . . . 1.0 110.206 178.708 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . 0.443 ' O ' ' HG3' ' A' ' 215' ' ' LYS . . . -64.33 -43.75 96.43 Favored Glycine 0 C--N 1.335 0.479 0 C-N-CA 121.016 -0.612 . . . . 0.38 111.741 178.489 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 212' ' ' MET . . . . . 0.438 ' HA ' ' HD2' ' A' ' 215' ' ' LYS . 30.8 ttm -62.2 -37.69 86.27 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 120.719 0.295 . . . . 0.39 110.276 178.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.608 ' HG ' ' O ' ' A' ' 209' ' ' PHE . 97.4 mt -58.0 -43.93 86.9 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.169 -0.468 . . . . 0.52 110.068 177.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 214' ' ' ARG . . . . . 0.523 ' HD3' ' O ' ' A' ' 214' ' ' ARG . 0.0 OUTLIER -66.92 -32.01 72.98 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 115.855 -0.611 . . . . 0.8 110.401 178.755 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 215' ' ' LYS . . . . . 0.443 ' HG3' ' O ' ' A' ' 211' ' ' GLY . 89.7 mttt -70.32 -43.69 69.78 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 116.282 -0.417 . . . . 0.46 110.856 178.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 15.1 mt -72.8 164.23 26.89 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 121.159 0.504 . . . . 0.77 111.811 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -111.55 32.75 5.17 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 121.251 0.548 . . . . 1.04 110.999 179.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 218' ' ' ILE . . . . . 0.606 ' HA ' ' HB2' ' A' ' 223' ' ' ASP . 41.2 mm -57.15 108.38 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-N 115.746 -0.661 . . . . 0.37 111.992 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . 0.487 ' NZ ' ' HA ' ' A' ' 219' ' ' LYS . 0.4 OUTLIER -145.83 -82.6 0.14 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.843 0.354 . . . . 0.55 111.727 179.887 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 65.9 m-20 -87.49 -176.54 5.63 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.883 -0.599 . . . . 1.97 110.612 178.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . 0.515 ' O ' HG22 ' A' ' 224' ' ' VAL . 13.1 tm-20 -46.48 -31.16 2.55 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 122.975 0.51 . . . . 0.74 112.362 -179.804 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -55.12 -24.85 37.21 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 121.631 -0.319 . . . . 0.53 113.681 178.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 223' ' ' ASP . . . . . 0.606 ' HB2' ' HA ' ' A' ' 218' ' ' ILE . 0.5 OUTLIER -56.63 -36.11 69.1 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 112.741 0.645 . . . . 0.69 112.741 -179.047 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.544 ' HB ' HG21 ' A' ' 274' ' ' THR . 14.2 m -61.15 -29.77 46.44 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-O 120.823 0.344 . . . . 0.48 111.808 -179.521 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 30.6 mttp -72.81 -40.54 65.74 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.143 0.497 . . . . 0.64 109.892 179.132 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 226' ' ' SER . . . . . 0.543 ' O ' HG23 ' A' ' 230' ' ' VAL . 53.4 p -70.73 -38.77 73.6 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.802 -0.635 . . . . 0.52 109.856 178.545 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 227' ' ' PHE . . . . . 0.634 ' O ' ' HG3' ' A' ' 231' ' ' MET . 10.3 t80 -65.11 -46.67 80.07 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 116.102 -0.499 . . . . 0.57 110.031 178.748 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 48.2 t -57.72 -40.12 78.87 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.373 -0.376 . . . . 0.48 110.153 178.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 3.1 ttp180 -56.88 -43.18 81.02 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.048 -0.524 . . . . 1.4 109.69 178.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . 0.543 HG23 ' O ' ' A' ' 226' ' ' SER . 29.6 t -65.67 -49.59 76.68 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 CA-C-N 115.812 -0.631 . . . . 0.38 109.895 178.076 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 231' ' ' MET . . . . . 0.634 ' HG3' ' O ' ' A' ' 227' ' ' PHE . 68.3 mtp -54.38 -51.4 64.94 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 115.784 -0.644 . . . . 0.43 111.842 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 93.2 t -60.84 -39.9 83.4 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 CA-C-N 116.512 -0.313 . . . . 0.39 111.598 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -70.65 -37.66 73.75 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 120.751 -0.38 . . . . 0.54 110.973 179.368 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 230' ' ' VAL . 51.1 t -59.24 -36.03 61.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-O 121.206 0.527 . . . . 0.45 110.987 179.27 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 235' ' ' PHE . . . . . 0.468 ' HE2' HD22 ' A' ' 248' ' ' LEU . 86.2 m-85 -103.61 18.2 22.42 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.302 -0.408 . . . . 0.42 111.553 179.372 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 11.8 tptp -77.96 -9.52 59.14 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 120.941 0.4 . . . . 1.08 111.324 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 -70.23 -16.23 63.02 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.379 -0.373 . . . . 0.54 111.651 179.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 90.83 -1.86 78.91 Favored Glycine 0 CA--C 1.521 0.423 0 C-N-CA 120.748 -0.739 . . . . 0.64 112.504 -179.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 6.0 p -119.36 119.08 59.55 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 CA-C-O 121.509 0.671 . . . . 0.49 110.979 179.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 240' ' ' THR . . . . . 0.547 HG21 ' HG2' ' A' ' 283' ' ' LYS . 0.5 OUTLIER -93.71 83.38 4.43 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.152 -0.476 . . . . 0.52 112.2 -179.653 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -76.92 136.36 38.81 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.117 -0.492 . . . . 0.36 111.266 179.305 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 242' ' ' TRP . . . . . . . . . . . . . 6.0 m95 -53.93 -45.54 71.26 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.783 0.325 . . . . 0.39 111.0 179.126 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . 0.454 ' H ' ' HB2' ' B' ' 35' ' ' TYR . . . -57.39 -35.98 74.43 Favored Glycine 0 C--N 1.336 0.568 0 CA-C-N 116.068 -0.514 . . . . 0.27 112.823 179.134 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 84.0 mtt180 -68.25 -44.29 75.95 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 109.985 -0.376 . . . . 0.31 109.985 178.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . 0.657 HG23 HD11 ' A' ' 279' ' ' LEU . 98.5 mt -59.65 -51.36 73.69 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-N 115.954 -0.567 . . . . 0.42 110.518 178.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 59.6 t -63.07 -40.37 88.77 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 CA-C-N 116.164 -0.471 . . . . 0.37 111.07 178.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 23.5 m -60.63 -41.07 94.14 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 120.81 0.338 . . . . 0.36 110.432 179.011 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 248' ' ' LEU . . . . . 0.468 HD22 ' HE2' ' A' ' 235' ' ' PHE . 21.0 tp -64.2 -38.49 91.23 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 121.102 0.477 . . . . 0.62 109.914 178.191 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 249' ' ' ILE . . . . . 0.678 HD11 HD22 ' A' ' 279' ' ' LEU . 47.6 mm -68.2 -41.72 84.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-N 116.091 -0.504 . . . . 0.45 109.952 178.155 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 65.6 m -62.6 -43.95 97.52 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.026 -0.534 . . . . 0.37 109.653 178.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 251' ' ' PHE . . . . . 0.527 ' O ' HG23 ' A' ' 255' ' ' VAL . 29.9 t80 -62.44 -43.16 99.47 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 115.722 -0.672 . . . . 0.37 109.375 177.76 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -56.5 -47.83 80.87 Favored Glycine 0 C--N 1.338 0.666 0 N-CA-C 111.091 -0.803 . . . . 0.26 111.091 178.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -59.12 -42.2 89.99 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-O 120.573 0.225 . . . . 0.29 110.557 177.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 254' ' ' PHE . . . . . 0.454 ' CD2' HD11 ' A' ' 213' ' ' LEU . 5.8 t80 -63.81 -40.06 95.73 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.487 -0.324 . . . . 0.53 110.648 178.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 255' ' ' VAL . . . . . 0.527 HG23 ' O ' ' A' ' 251' ' ' PHE . 84.8 t -63.64 -43.8 98.27 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 N-CA-C 109.297 -0.631 . . . . 0.41 109.297 177.426 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -62.82 -34.55 77.54 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 115.81 -0.632 . . . . 0.28 109.992 178.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 257' ' ' LYS . . . . . 0.463 ' HG3' ' O ' ' A' ' 171' ' ' ALA . 30.4 tttp -66.7 -46.08 76.72 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 115.385 -0.825 . . . . 0.62 110.163 178.248 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 14.4 t60 -62.1 -42.41 99.2 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 115.827 -0.624 . . . . 0.65 109.393 178.29 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 4.7 mp -67.27 -35.5 79.63 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.012 -0.54 . . . . 0.48 110.846 178.332 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.71 -34.53 77.35 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.533 -0.303 . . . . 0.6 111.018 178.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 24.0 p -62.45 -20.07 64.15 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 120.684 0.278 . . . . 0.74 111.591 179.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 262' ' ' VAL . . . . . 0.451 HG23 ' HG3' ' A' ' 264' ' ' GLN . 13.8 m -117.03 18.82 7.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-O 120.92 0.39 . . . . 0.67 111.073 178.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 65.1 m-80 56.98 46.39 19.53 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 113.8 1.037 . . . . 1.45 113.8 179.171 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 264' ' ' GLN . . . . . 0.451 ' HG3' HG23 ' A' ' 262' ' ' VAL . 12.6 mt-30 -99.29 36.64 1.7 Allowed 'General case' 0 CA--C 1.536 0.423 0 O-C-N 121.884 -0.51 . . . . 0.43 111.491 179.074 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 265' ' ' GLU . . . . . 0.431 ' HA ' HD12 ' A' ' 268' ' ' ILE . 11.4 tp10 -53.9 -42.1 68.35 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 120.91 0.386 . . . . 0.41 111.653 -179.718 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 30.9 t -61.06 -14.94 27.25 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.128 -0.487 . . . . 0.46 111.729 179.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 267' ' ' PHE . . . . . 0.487 ' C ' ' HD2' ' A' ' 270' ' ' PRO . 71.7 m-85 -101.21 -21.27 14.97 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 121.15 0.5 . . . . 0.78 110.064 178.703 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 268' ' ' ILE . . . . . 0.431 HD12 ' HA ' ' A' ' 265' ' ' GLU . 76.1 mt -67.42 -37.19 78.47 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 CA-C-N 115.851 -0.613 . . . . 0.45 109.891 178.462 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 269' ' ' GLU . . . . . 0.729 ' HB2' ' HD3' ' A' ' 270' ' ' PRO . 9.1 mm-40 -56.63 -57.82 21.21 Favored Pre-proline 0 CA--C 1.548 0.876 0 CA-C-N 116.383 -0.372 . . . . 0.44 111.025 178.623 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 270' ' ' PRO . . . . . 0.729 ' HD3' ' HB2' ' A' ' 269' ' ' GLU . 35.1 Cg_exo -63.22 -30.19 74.12 Favored 'Trans proline' 0 C--N 1.365 1.403 0 C-N-CA 122.322 2.014 . . . . 0.33 112.122 178.58 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 271' ' ' LEU . . . . . . . . . . . . . 56.7 tp -67.09 -50.86 60.23 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 109.72 -0.474 . . . . 0.46 109.72 178.425 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -62.49 -36.52 82.76 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 115.948 -0.569 . . . . 0.33 110.456 178.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 273' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -63.13 -48.89 76.6 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.142 -0.481 . . . . 0.4 109.724 178.009 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 274' ' ' THR . . . . . 0.544 HG21 ' HB ' ' A' ' 224' ' ' VAL . 62.7 m -62.72 -48.54 78.77 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.863 -0.608 . . . . 0.36 110.853 178.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 275' ' ' ILE . . . . . 0.466 ' HA ' ' HE1' ' A' ' 231' ' ' MET . 92.1 mt -54.78 -51.9 47.52 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.157 0 CA-C-N 116.135 -0.484 . . . . 0.34 111.106 179.42 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 276' ' ' THR . . . . . 0.542 HG23 HD12 ' A' ' 163' ' ' ILE . 40.8 m -60.49 -51.23 70.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.277 -0.42 . . . . 0.29 111.193 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 277' ' ' ASP . . . . . 0.526 ' OD1' ' HD2' ' A' ' 281' ' ' ARG . 25.9 t0 -55.09 -58.26 8.37 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.129 -0.487 . . . . 0.9 111.61 179.807 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 95.4 t -58.41 -41.8 82.46 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 CA-C-O 120.795 0.331 . . . . 0.36 111.58 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 279' ' ' LEU . . . . . 0.678 HD22 HD11 ' A' ' 249' ' ' ILE . 12.2 tp -61.77 -47.74 83.79 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 112.219 0.452 . . . . 0.64 112.219 -179.578 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 46.5 t -79.31 -42.81 23.64 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 N-CA-C 112.612 0.597 . . . . 0.35 112.612 -178.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 281' ' ' ARG . . . . . 0.526 ' HD2' ' OD1' ' A' ' 277' ' ' ASP . 0.4 OUTLIER -58.8 -33.53 70.46 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 112.326 0.491 . . . . 1.18 112.326 -179.336 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 282' ' ' THR . . . . . . . . . . . . . 48.4 p -85.84 -1.62 57.43 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 111.772 0.286 . . . . 0.34 111.772 179.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . 0.547 ' HG2' HG21 ' A' ' 240' ' ' THR . 32.8 mttp -141.22 34.11 1.7 Allowed 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.572 -0.286 . . . . 0.42 111.391 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 48.9 mtp180 -53.83 -62.24 1.78 Allowed 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 112.573 0.582 . . . . 0.45 112.573 -178.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 285' ' ' ASP . . . . . 0.494 ' O ' ' HE2' ' A' ' 289' ' ' LYS . 8.7 p-10 -65.63 -37.65 87.19 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.168 -0.469 . . . . 0.46 110.901 -179.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 286' ' ' TRP . . . . . 0.516 ' CZ2' ' HG2' ' A' ' 290' ' ' GLN . 71.9 t90 -62.4 -40.5 96.7 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.425 -0.352 . . . . 0.38 110.912 179.653 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 287' ' ' LEU . . . . . 0.537 HD13 ' HA2' ' A' ' 292' ' ' GLY . 0.8 OUTLIER -60.71 -48.36 82.14 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 111.971 0.36 . . . . 0.42 111.971 179.749 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 9.5 p -69.35 -32.16 52.32 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 C-N-CA 120.481 -0.487 . . . . 0.52 111.453 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 289' ' ' LYS . . . . . 0.494 ' HE2' ' O ' ' A' ' 285' ' ' ASP . 39.8 mtmt -75.97 -40.3 54.21 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 112.775 0.657 . . . . 0.73 112.775 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 290' ' ' GLN . . . . . 0.516 ' HG2' ' CZ2' ' A' ' 286' ' ' TRP . 1.6 mp0 -87.82 29.87 0.88 Allowed 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 114.278 1.214 . . . . 0.7 114.278 -177.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 291' ' ' ARG . . . . . 0.621 ' HG2' ' HB2' ' A' ' 294' ' ' ASP . 1.9 ttt180 60.74 19.7 9.79 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 112.762 0.653 . . . . 0.47 112.762 178.435 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 292' ' ' GLY . . . . . 0.537 ' HA2' HD13 ' A' ' 287' ' ' LEU . . . 42.34 -135.52 3.76 Favored Glycine 0 CA--C 1.527 0.788 0 N-CA-C 115.363 0.905 . . . . 0.35 115.363 178.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 293' ' ' TRP . . . . . 0.588 ' O ' HG23 ' A' ' 297' ' ' VAL . 97.2 m95 -64.46 -37.41 87.44 Favored 'General case' 0 C--O 1.226 -0.133 0 CA-C-N 115.428 -0.386 . . . . 0.55 111.058 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 294' ' ' ASP . . . . . 0.621 ' HB2' ' HG2' ' A' ' 291' ' ' ARG . 0.9 OUTLIER -53.8 -46.91 71.22 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 121.176 0.512 . . . . 0.63 110.195 179.023 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -65.79 -39.3 95.1 Favored Glycine 0 CA--C 1.523 0.56 0 C-N-CA 120.884 -0.674 . . . . 0.29 111.835 178.324 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 296' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -64.05 -36.15 83.07 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 120.799 0.333 . . . . 0.33 110.937 179.131 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 297' ' ' VAL . . . . . 0.9 HG11 ' HD3' ' A' ' 189' ' ' ARG . 77.8 t -64.99 -54.16 32.84 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 CA-C-N 116.202 -0.454 . . . . 0.34 111.65 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -69.71 -23.16 63.38 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 112.312 0.486 . . . . 0.42 112.312 -179.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 299' ' ' PHE . . . . . . . . . . . . . 88.2 t80 -70.12 -52.68 21.74 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 111.694 0.257 . . . . 0.46 111.694 179.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 300' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 . . . . . 0 CA--C 1.535 0.378 0 CA-C-O 120.827 0.346 . . . . 0.41 111.67 -179.578 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.532 0.262 0 CA-C-O 120.264 0.078 . . . . 0.68 111.096 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 23' ' ' PHE . . . . . 0.445 ' CD1' HG22 ' A' ' 230' ' ' VAL . 0.8 OUTLIER -58.29 -40.16 81.23 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.276 0.56 . . . . 0.48 110.715 179.125 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -70.52 -40.33 73.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.008 -0.542 . . . . 0.32 110.427 178.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . 0.433 ' O ' ' HB3' ' B' ' 28' ' ' ARG . . . -64.15 -37.38 87.24 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 116.133 -0.485 . . . . 0.33 110.808 178.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -62.74 -54.26 41.85 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.012 -0.54 . . . . 0.5 110.419 178.72 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 95.9 mt -58.96 -34.36 71.71 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.134 0.492 . . . . 0.35 109.833 178.167 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 28' ' ' ARG . . . . . 0.433 ' HB3' ' O ' ' B' ' 25' ' ' ALA . 1.1 ttt180 -59.84 -51.04 71.44 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 115.43 -0.805 . . . . 0.58 110.111 177.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -67.66 -40.14 84.53 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.304 -0.407 . . . . 0.89 111.264 179.157 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 96.5 mt -62.68 -46.9 95.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-O 120.962 0.41 . . . . 0.43 110.318 178.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.35 -48.34 86.47 Favored Glycine 0 N--CA 1.45 -0.419 0 CA-C-N 115.72 -0.673 . . . . 0.27 112.871 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -64.6 -37.87 89.06 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.917 0.359 . . . . 0.47 111.548 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 33' ' ' LYS . . . . . 0.404 ' HE2' ' HB2' ' B' ' 33' ' ' LYS . 20.7 ttmm -63.72 -47.78 79.73 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-O 121.121 0.486 . . . . 1.21 110.255 178.573 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 55.5 t -65.06 -46.69 90.59 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 CA-C-N 115.844 -0.616 . . . . 0.48 110.532 178.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 35' ' ' TYR . . . . . 0.454 ' HB2' ' H ' ' A' ' 243' ' ' GLY . 1.3 t80 -56.08 -48.54 75.9 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 115.824 -0.625 . . . . 0.83 111.743 179.668 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 36' ' ' CYS . . . . . . . . . . . . . 84.2 m -64.51 -35.35 80.67 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 120.812 0.339 . . . . 0.58 111.543 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 63.1 m -67.92 -40.99 83.29 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 112.227 0.455 . . . . 0.66 112.227 -179.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 38' ' ' TRP . . . . . . . . . . . . . 97.8 m95 -87.41 -18.54 29.74 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.498 0.555 . . . . 0.7 112.498 -179.19 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 28.8 t . . . . . 0 N--CA 1.47 0.574 0 N-CA-C 112.054 0.39 . . . . 0.89 112.054 179.49 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . 0.534 ' O ' ' HG3' ' A' ' 157' ' ' ARG . 0.1 OUTLIER . . . . . 0 CA--C 1.539 0.523 0 N-CA-C 112.711 0.634 . . . . 0.54 112.711 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 -60.88 -43.66 98.13 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.185 0.517 . . . . 0.46 111.391 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.558 HD21 ' HB3' ' A' ' 287' ' ' LEU . 27.1 tp -63.89 -49.35 73.04 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.754 -0.657 . . . . 0.88 110.231 179.377 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 44.4 t80 -58.8 -43.57 90.55 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 115.885 -0.598 . . . . 0.42 111.45 179.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 0.534 ' HG3' ' O ' ' A' ' 153' ' ' ASP . 51.5 mtm180 -60.08 -52.71 64.21 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.698 0.285 . . . . 0.4 111.13 179.556 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 29.0 mt-30 -63.05 -45.27 93.01 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.541 -0.3 . . . . 0.54 110.781 179.155 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . 0.543 ' HA ' ' CZ2' ' A' ' 293' ' ' TRP . 21.1 m -58.93 -56.92 16.0 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.384 -0.371 . . . . 0.27 111.375 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.695 HD11 ' HG2' ' A' ' 273' ' ' GLU . 12.7 tp -54.55 -48.88 71.49 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.751 -0.204 . . . . 0.77 111.474 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -57.49 -54.25 48.93 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 111.85 0.315 . . . . 0.74 111.85 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 74.7 mt -62.28 -43.43 98.0 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 N-CA-C 111.871 0.323 . . . . 0.33 111.871 -179.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.644 ' O ' ' HG ' ' A' ' 167' ' ' LEU . 87.0 mt -64.43 -48.42 85.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 N-CA-C 110.225 -0.287 . . . . 0.35 110.225 179.211 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 6.8 t -58.42 -44.63 89.18 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.409 -0.36 . . . . 0.31 110.282 178.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . 0.432 HH11 ' HD2' ' A' ' 165' ' ' ARG . 2.6 mmt180 -59.12 -51.98 67.71 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.121 -0.491 . . . . 0.38 111.89 178.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' TYR . . . . . 0.711 ' CE1' ' HA ' ' A' ' 195' ' ' ARG . 51.6 t80 -60.57 -49.77 76.22 Favored 'General case' 0 CA--C 1.527 0.085 0 N-CA-C 112.399 0.518 . . . . 0.45 112.399 -179.042 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.644 ' HG ' ' O ' ' A' ' 163' ' ' ILE . 11.8 mt -67.14 -33.74 76.08 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 120.225 -0.59 . . . . 0.36 111.293 -178.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 21.5 ttp180 -69.75 -52.62 23.77 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 111.803 0.297 . . . . 0.43 111.803 179.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -61.65 -48.41 80.99 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 111.838 0.31 . . . . 0.28 111.838 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.36 -40.73 91.85 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.09 -0.505 . . . . 0.32 112.12 -179.726 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.447 ' HB1' ' HB2' ' A' ' 260' ' ' LYS . . . . . . . . 0 N--CA 1.465 0.276 0 N-CA-C 112.114 0.413 . . . . 0.32 112.114 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.561 ' O ' ' HA3' ' A' ' 187' ' ' GLY . . . . . . . . 0 CA--C 1.536 0.435 0 CA-C-O 121.226 0.536 . . . . 0.35 110.768 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -78.74 -71.01 1.27 Allowed Glycine 0 CA--C 1.524 0.655 0 C-N-CA 120.617 -0.801 . . . . 0.35 113.993 -179.242 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -70.78 -55.43 8.6 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-O 120.923 0.392 . . . . 0.4 111.189 -179.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -63.51 -35.56 80.85 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 116.064 -0.516 . . . . 0.34 110.369 178.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . 0.561 ' HA3' ' O ' ' A' ' 183' ' ' ALA . . . -64.32 -34.83 90.98 Favored Glycine 0 C--N 1.336 0.559 0 CA-C-N 116.017 -0.538 . . . . 0.31 112.648 179.464 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 1.2 mmm-85 -68.04 -57.84 5.47 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 109.589 -0.523 . . . . 0.6 109.589 178.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 189' ' ' ARG . . . . . 0.521 ' HB3' HG11 ' A' ' 297' ' ' VAL . 44.5 mtp180 -56.73 -48.34 77.97 Favored 'General case' 0 C--O 1.226 -0.176 0 CA-C-N 115.53 -0.759 . . . . 0.7 111.2 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . 0.604 ' O ' ' HB2' ' A' ' 194' ' ' LEU . . . -60.85 -37.74 83.11 Favored 'General case' 0 C--O 1.224 -0.265 0 N-CA-C 111.849 0.314 . . . . 0.28 111.849 -179.583 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 191' ' ' LEU . . . . . 0.484 ' HB2' ' O ' ' A' ' 187' ' ' GLY . 7.8 tp -66.46 -42.5 87.49 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.95 0.405 . . . . 0.65 110.385 179.199 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -66.33 -46.81 75.57 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.069 -0.514 . . . . 0.32 110.573 178.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . 0.581 HG21 ' HA ' ' A' ' 297' ' ' VAL . 5.6 m -62.34 -43.87 97.8 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.985 0.421 . . . . 0.27 109.936 178.266 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . 0.604 ' HB2' ' O ' ' A' ' 190' ' ' ALA . 6.4 tp -62.2 -43.55 98.58 Favored 'General case' 0 C--O 1.224 -0.278 0 CA-C-N 115.585 -0.734 . . . . 0.4 110.672 178.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . 0.711 ' HA ' ' CE1' ' A' ' 166' ' ' TYR . 0.0 OUTLIER -65.01 -38.34 90.61 Favored 'General case' 0 C--O 1.224 -0.271 0 CA-C-O 121.292 0.568 . . . . 0.75 110.37 178.939 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . 0.413 HH11 ' HD3' ' A' ' 196' ' ' ARG . 0.9 OUTLIER -67.5 -60.06 2.87 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.968 -0.56 . . . . 0.37 112.076 -179.739 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 7.0 t -71.19 -45.69 69.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 111.836 0.31 . . . . 0.36 111.836 -178.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -57.21 -45.17 92.93 Favored Glycine 0 CA--C 1.522 0.514 0 C-N-CA 121.465 -0.398 . . . . 0.29 113.538 -179.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . 0.515 ' O ' ' HB2' ' A' ' 203' ' ' ARG . 2.7 m-20 -73.92 -32.58 63.59 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 117.059 0.43 . . . . 0.49 110.713 179.725 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -68.85 -48.42 48.79 Favored Glycine 0 CA--C 1.524 0.653 0 C-N-CA 120.946 -0.645 . . . . 0.29 112.677 178.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 76.7 t -61.36 -48.69 87.72 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-N 116.745 0.272 . . . . 0.37 111.123 179.413 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 202' ' ' GLN . . . . . 0.41 ' HB2' ' CD1' ' A' ' 254' ' ' PHE . 7.2 pt20 -62.33 -32.58 73.36 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.369 -0.378 . . . . 0.38 111.397 179.727 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 203' ' ' ARG . . . . . 0.515 ' HB2' ' O ' ' A' ' 199' ' ' ASP . 0.0 OUTLIER -77.46 -38.95 48.29 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 120.712 0.291 . . . . 0.61 111.027 179.532 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -71.44 -52.37 18.85 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 116.226 -0.443 . . . . 0.39 111.449 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 33.4 m-70 -97.27 36.25 1.49 Allowed 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 120.863 0.363 . . . . 0.41 110.855 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -58.16 -37.62 75.05 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 113.038 0.755 . . . . 0.72 113.038 -178.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 4.1 t -56.89 -37.28 71.16 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 120.931 0.396 . . . . 0.5 111.902 -179.156 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -75.06 -43.42 53.43 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 121.124 0.487 . . . . 0.41 111.001 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 209' ' ' PHE . . . . . 0.418 ' O ' ' HB2' ' A' ' 213' ' ' LEU . 56.2 m-85 -66.56 -39.18 88.37 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 115.871 -0.604 . . . . 0.43 110.943 179.748 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 210' ' ' GLN . . . . . 0.406 ' O ' ' HG2' ' A' ' 214' ' ' ARG . 0.6 OUTLIER -64.7 -45.25 87.42 Favored 'General case' 0 C--O 1.222 -0.371 0 CA-C-N 116.515 -0.311 . . . . 0.67 111.251 179.634 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -56.77 -48.43 78.05 Favored Glycine 0 CA--C 1.523 0.564 0 C-N-CA 120.251 -0.976 . . . . 0.31 111.766 178.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 212' ' ' MET . . . . . 0.546 ' O ' ' HB2' ' A' ' 216' ' ' LEU . 49.2 mtp -67.06 -34.0 76.73 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 115.637 -0.281 . . . . 0.77 111.296 178.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.602 HD21 ' HB2' ' A' ' 258' ' ' HIS . 1.0 OUTLIER -75.73 -37.61 59.22 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 112.205 0.446 . . . . 0.41 112.205 -179.949 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 214' ' ' ARG . . . . . 0.406 ' HG2' ' O ' ' A' ' 210' ' ' GLN . 33.2 mmt180 -64.12 -35.14 79.78 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.89 0.376 . . . . 1.12 110.079 179.028 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 215' ' ' LYS . . . . . 0.52 ' HE2' ' HA ' ' A' ' 215' ' ' LYS . 0.0 OUTLIER -95.7 12.51 29.61 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 121.171 0.51 . . . . 0.66 110.585 177.91 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . 0.634 ' HG ' HG13 ' A' ' 218' ' ' ILE . 10.1 tp -93.84 99.22 11.63 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.211 -0.45 . . . . 0.49 110.934 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -93.94 33.25 1.35 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.261 -0.427 . . . . 0.84 110.985 179.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 218' ' ' ILE . . . . . 0.634 HG13 ' HG ' ' A' ' 216' ' ' LEU . 16.1 mt -61.86 108.52 0.52 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.495 0 CA-C-O 121.748 0.785 . . . . 0.49 111.826 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 1.6 ttpm? -161.61 17.51 0.1 Allowed 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 114.945 -1.025 . . . . 1.86 110.878 -179.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -139.04 160.75 39.03 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-O 120.864 0.364 . . . . 0.56 111.397 -179.088 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -62.51 -22.99 66.7 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.015 0.436 . . . . 0.76 111.733 179.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -74.7 -26.04 68.29 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 120.94 -0.648 . . . . 0.59 113.508 179.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 223' ' ' ASP . . . . . 0.424 ' HB3' HG12 ' A' ' 218' ' ' ILE . 71.9 m-20 -61.65 -43.97 97.84 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 113.011 0.745 . . . . 0.79 113.011 -178.795 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.522 HG23 ' HD2' ' A' ' 225' ' ' LYS . 29.9 m -59.86 -28.71 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 N-CA-C 112.123 0.416 . . . . 0.6 112.123 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . 0.522 ' HD2' HG23 ' A' ' 224' ' ' VAL . 11.9 mptt -64.28 -42.05 96.62 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 121.318 0.58 . . . . 0.9 109.847 178.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 226' ' ' SER . . . . . 0.603 ' O ' HG23 ' A' ' 230' ' ' VAL . 3.5 m -71.0 -38.72 72.69 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.787 -0.642 . . . . 0.86 109.577 178.032 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 227' ' ' PHE . . . . . 0.492 ' HE1' HG12 ' A' ' 275' ' ' ILE . 8.8 t80 -56.02 -43.83 78.16 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 115.84 -0.618 . . . . 0.57 109.863 177.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 228' ' ' SER . . . . . 0.417 ' O ' HG23 ' A' ' 232' ' ' VAL . 39.2 m -61.59 -44.54 96.83 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.634 -0.712 . . . . 0.37 110.022 178.067 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 229' ' ' ARG . . . . . 0.491 ' NH1' ' HA ' ' A' ' 226' ' ' SER . 4.2 ttm105 -61.01 -38.86 87.55 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 115.806 -0.634 . . . . 0.82 110.935 178.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . 0.603 HG23 ' O ' ' A' ' 226' ' ' SER . 97.0 t -55.88 -52.56 47.8 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-N 116.164 -0.471 . . . . 0.39 110.587 178.683 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 231' ' ' MET . . . . . 0.628 ' HG2' HD22 ' A' ' 248' ' ' LEU . 72.3 mtm -59.98 -38.0 81.25 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.07 -0.514 . . . . 0.41 111.471 179.405 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 232' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 228' ' ' SER . 84.6 t -62.76 -42.49 96.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-O 120.771 0.319 . . . . 0.4 110.812 179.151 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 233' ' ' HIS . . . . . 0.432 ' HB3' ' HB1' ' B' ' 24' ' ' ALA . 48.7 t-80 -63.44 -35.61 81.01 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 120.84 0.353 . . . . 0.44 111.164 179.166 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 97.2 t -63.16 -38.19 81.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-O 121.114 0.483 . . . . 0.36 111.42 179.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 235' ' ' PHE . . . . . 0.522 ' HE2' HD11 ' A' ' 248' ' ' LEU . 62.2 m-85 -103.54 23.89 11.93 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.271 -0.422 . . . . 0.54 111.517 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 3.9 ttpp -69.83 -1.4 9.26 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 113.297 0.851 . . . . 0.76 113.297 -178.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 6.2 p30 -102.87 -16.13 15.99 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.949 0.404 . . . . 0.4 111.038 179.377 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 94.19 -6.48 72.19 Favored Glycine 0 CA--C 1.522 0.487 0 C-N-CA 120.905 -0.664 . . . . 0.33 112.605 -179.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 7.9 t -81.01 112.01 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.139 0 CA-C-O 121.157 0.504 . . . . 0.31 111.199 -179.306 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 240' ' ' THR . . . . . 0.438 ' HB ' ' CE2' ' A' ' 286' ' ' TRP . 1.2 m -94.43 101.62 13.55 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 120.777 -0.369 . . . . 0.31 111.444 179.505 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -110.31 139.08 45.86 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.396 -0.366 . . . . 0.88 110.713 179.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 242' ' ' TRP . . . . . 0.588 ' HB3' ' CE2' ' A' ' 300' ' ' PHE . 16.0 m95 -57.98 -42.82 85.91 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 120.625 0.25 . . . . 0.41 111.446 179.443 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . 0.455 ' H ' ' HB2' ' B' ' 35' ' ' TYR . . . -60.26 -28.83 67.53 Favored Glycine 0 CA--C 1.522 0.514 0 C-N-CA 121.306 -0.473 . . . . 0.27 112.775 178.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 244' ' ' ARG . . . . . 0.449 ' O ' ' HG ' ' A' ' 248' ' ' LEU . 94.3 mtt180 -71.42 -46.86 59.08 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.349 -0.612 . . . . 0.36 109.349 178.422 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 74.8 mt -60.93 -45.45 98.32 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-N 115.376 -0.829 . . . . 0.42 111.074 179.365 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 242' ' ' TRP . 61.3 t -62.52 -40.62 88.87 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-O 120.608 0.242 . . . . 0.49 111.015 179.269 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 55.1 m -57.67 -40.8 80.2 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.479 -0.328 . . . . 0.33 110.756 179.278 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 248' ' ' LEU . . . . . 0.628 HD22 ' HG2' ' A' ' 231' ' ' MET . 69.8 mt -61.63 -36.71 81.54 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 121.047 0.451 . . . . 0.45 110.298 178.229 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 29.5 mm -74.23 -38.98 48.99 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.133 0 CA-C-N 116.292 -0.413 . . . . 0.37 110.107 178.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 16.5 t -60.76 -42.77 98.09 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 108.921 -0.77 . . . . 0.27 108.921 178.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 251' ' ' PHE . . . . . 0.517 ' O ' HG23 ' A' ' 255' ' ' VAL . 19.7 t80 -64.85 -42.85 94.57 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 108.599 -0.889 . . . . 0.45 108.599 176.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -56.65 -40.31 87.86 Favored Glycine 0 C--N 1.337 0.616 0 N-CA-C 111.434 -0.667 . . . . 0.26 111.434 177.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -63.05 -37.48 87.36 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 120.956 0.408 . . . . 0.29 110.539 177.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 254' ' ' PHE . . . . . 0.418 ' HD2' HD13 ' A' ' 213' ' ' LEU . 0.2 OUTLIER -69.71 -38.9 77.1 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.066 -0.515 . . . . 0.75 109.952 178.329 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 255' ' ' VAL . . . . . 0.615 ' O ' ' HG ' ' A' ' 259' ' ' LEU . 59.8 t -67.53 -42.33 86.82 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.209 0 CA-C-N 116.079 -0.509 . . . . 0.31 109.719 178.281 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -57.96 -43.55 86.48 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 109.525 -0.546 . . . . 0.28 109.525 177.076 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 60.8 mttt -62.55 -43.45 98.78 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.7 -0.682 . . . . 0.5 109.982 177.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 258' ' ' HIS . . . . . 0.602 ' HB2' HD21 ' A' ' 213' ' ' LEU . 36.0 t60 -61.63 -44.38 97.1 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.935 -0.575 . . . . 0.87 110.465 178.534 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.615 ' HG ' ' O ' ' A' ' 255' ' ' VAL . 80.3 mt -67.42 -47.21 70.9 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 115.906 -0.588 . . . . 0.49 110.917 179.475 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 260' ' ' LYS . . . . . 0.447 ' HB2' ' HB1' ' A' ' 171' ' ' ALA . 0.5 OUTLIER -61.74 -32.49 72.74 Favored 'General case' 0 CA--C 1.535 0.369 0 O-C-N 122.386 -0.196 . . . . 0.6 110.99 179.526 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 69.3 m -60.95 -31.13 70.69 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.108 0.48 . . . . 0.47 110.588 178.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 28.4 m -110.18 20.66 5.82 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 CA-C-N 115.888 -0.597 . . . . 0.52 110.907 179.195 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 55.01 51.1 14.06 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 115.609 -0.723 . . . . 1.1 112.927 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -106.93 36.15 2.76 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.489 -0.323 . . . . 0.57 111.55 179.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 265' ' ' GLU . . . . . 0.487 ' HA ' HD12 ' A' ' 268' ' ' ILE . 0.8 OUTLIER -51.42 -38.91 55.98 Favored 'General case' 0 C--O 1.242 0.659 0 CA-C-O 120.922 0.391 . . . . 0.82 111.943 179.614 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 36.0 p -64.38 -12.93 47.59 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.787 -0.642 . . . . 0.7 111.537 179.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 267' ' ' PHE . . . . . 0.464 ' C ' ' HD2' ' A' ' 270' ' ' PRO . 14.9 t80 -105.3 -25.19 12.52 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.626 -0.509 . . . . 0.78 109.626 178.327 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 268' ' ' ILE . . . . . 0.487 HD12 ' HA ' ' A' ' 265' ' ' GLU . 70.3 mt -59.8 -50.01 81.68 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-N 115.957 -0.565 . . . . 0.4 110.947 179.055 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 269' ' ' GLU . . . . . 0.709 ' HB3' ' HD3' ' A' ' 270' ' ' PRO . 1.2 tp10 -57.03 -55.63 41.94 Favored Pre-proline 0 CA--C 1.547 0.853 0 C-N-CA 120.812 -0.355 . . . . 0.81 110.487 179.109 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 270' ' ' PRO . . . . . 0.709 ' HD3' ' HB3' ' A' ' 269' ' ' GLU . 52.1 Cg_exo -58.86 -29.71 90.88 Favored 'Trans proline' 0 C--N 1.364 1.378 0 C-N-CA 122.464 2.11 . . . . 0.35 112.392 177.44 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 271' ' ' LEU . . . . . 0.439 ' O ' HG13 ' A' ' 275' ' ' ILE . 1.5 tm? -67.09 -43.38 82.7 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 108.746 -0.835 . . . . 0.5 108.746 177.775 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -64.05 -35.86 82.1 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.563 -0.744 . . . . 0.31 109.0 177.148 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 273' ' ' GLU . . . . . 0.695 ' HG2' HD11 ' A' ' 160' ' ' LEU . 52.5 mt-10 -66.06 -44.82 83.42 Favored 'General case' 0 C--O 1.222 -0.379 0 CA-C-N 115.662 -0.699 . . . . 0.76 109.217 177.27 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 274' ' ' THR . . . . . . . . . . . . . 89.9 m -55.6 -46.89 77.24 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.713 -0.676 . . . . 0.52 110.578 178.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 275' ' ' ILE . . . . . 0.578 ' HA ' ' HE1' ' A' ' 231' ' ' MET . 72.9 mt -63.04 -55.42 23.65 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.128 0 CA-C-N 115.936 -0.575 . . . . 0.41 110.853 179.316 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 5.6 m -57.38 -47.81 80.71 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.009 -0.542 . . . . 0.37 112.052 -179.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 277' ' ' ASP . . . . . 0.471 ' HB2' ' O ' ' A' ' 273' ' ' GLU . 0.1 OUTLIER -52.61 -57.17 10.88 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.488 -0.324 . . . . 0.63 111.52 -179.867 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 278' ' ' VAL . . . . . 0.405 ' HB ' ' CE ' ' A' ' 231' ' ' MET . 48.5 t -66.33 -37.11 78.95 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 N-CA-C 111.915 0.339 . . . . 0.42 111.915 -179.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 41.4 tp -64.78 -47.11 79.34 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 111.971 0.36 . . . . 0.86 111.971 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 86.7 t -73.68 -32.39 35.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 CA-C-O 121.009 0.433 . . . . 0.53 111.186 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 281' ' ' ARG . . . . . 0.449 HH11 ' HD2' ' A' ' 281' ' ' ARG . 2.0 tpm_? -71.81 -43.52 65.48 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 112.439 0.533 . . . . 0.38 112.439 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 282' ' ' THR . . . . . . . . . . . . . 3.4 m -78.29 -26.53 47.06 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 112.981 0.734 . . . . 0.47 112.981 -178.399 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 63.9 mmtt -129.83 41.64 3.4 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 112.257 0.465 . . . . 0.73 112.257 -179.063 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.65 -62.06 1.89 Allowed 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 113.661 0.985 . . . . 0.44 113.661 -178.664 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -64.04 -42.32 97.11 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 112.794 0.665 . . . . 0.42 112.794 -178.334 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 286' ' ' TRP . . . . . 0.472 ' HE3' HD22 ' A' ' 287' ' ' LEU . 10.0 t90 -60.41 -50.19 74.58 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.733 0.301 . . . . 0.38 111.275 -179.756 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 287' ' ' LEU . . . . . 0.558 ' HB3' HD21 ' A' ' 155' ' ' LEU . 1.6 mm? -66.88 -42.76 85.04 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.319 0.489 . . . . 0.47 112.319 -179.3 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -67.24 -35.8 74.99 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 N-CA-C 112.004 0.372 . . . . 1.04 112.004 -179.487 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 56.1 mttt -77.52 -34.41 54.01 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 112.159 0.429 . . . . 0.82 112.159 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -81.05 23.89 0.54 Allowed 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 112.457 0.54 . . . . 0.73 112.457 -179.382 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 291' ' ' ARG . . . . . 0.708 ' HB3' ' HB2' ' A' ' 294' ' ' ASP . 3.1 mmt180 60.46 16.57 6.49 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.834 0.679 . . . . 0.48 112.834 179.696 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 47.63 -112.58 1.07 Allowed Glycine 0 CA--C 1.525 0.658 0 N-CA-C 114.637 0.615 . . . . 0.28 114.637 179.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 293' ' ' TRP . . . . . 0.543 ' CZ2' ' HA ' ' A' ' 159' ' ' SER . 86.0 m95 -66.74 -30.08 70.22 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.763 0.653 . . . . 0.36 112.763 -178.595 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 294' ' ' ASP . . . . . 0.708 ' HB2' ' HB3' ' A' ' 291' ' ' ARG . 15.5 m-20 -62.01 -42.92 99.68 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 121.049 0.452 . . . . 0.37 110.042 178.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -67.82 -41.86 87.69 Favored Glycine 0 CA--C 1.521 0.414 0 C-N-CA 120.639 -0.791 . . . . 0.32 111.885 178.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 296' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -67.39 -43.34 81.58 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 120.708 0.289 . . . . 0.34 111.315 179.524 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 297' ' ' VAL . . . . . 0.581 ' HA ' HG21 ' A' ' 193' ' ' THR . 50.3 t -65.89 -55.43 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-N 116.412 -0.358 . . . . 0.27 111.664 -179.32 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -62.56 -30.91 71.67 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 112.709 0.633 . . . . 0.73 112.709 -178.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 299' ' ' PHE . . . . . . . . . . . . . 93.1 t80 -76.54 -40.82 48.81 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 112.372 0.508 . . . . 0.45 112.372 179.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 300' ' ' PHE . . . . . 0.588 ' CE2' ' HB3' ' A' ' 242' ' ' TRP . 62.1 m-85 . . . . . 0 CA--C 1.539 0.523 0 N-CA-C 114.036 1.124 . . . . 0.39 114.036 -178.044 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.535 0.379 0 N-CA-C 111.851 0.315 . . . . 0.57 111.851 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 23' ' ' PHE . . . . . 0.479 ' HD1' ' N ' ' B' ' 24' ' ' ALA . 0.2 OUTLIER -59.91 -33.22 71.57 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.151 0.501 . . . . 0.65 111.077 179.317 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 24' ' ' ALA . . . . . 0.479 ' N ' ' HD1' ' B' ' 23' ' ' PHE . . . -75.83 -38.41 58.1 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.207 0.527 . . . . 0.33 110.027 179.268 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -66.78 -36.63 82.87 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.937 -0.574 . . . . 0.34 109.485 178.201 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -60.54 -51.98 67.12 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 115.822 -0.626 . . . . 0.41 110.23 177.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 94.9 mt -61.86 -30.83 71.12 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 121.052 0.453 . . . . 0.41 110.14 178.556 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 28' ' ' ARG . . . . . . . . . . . . . 34.9 ttm-85 -68.0 -51.46 46.92 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 115.534 -0.757 . . . . 0.46 110.152 178.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 59.6 mttt -57.0 -42.46 80.35 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.296 -0.411 . . . . 0.44 110.599 178.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 69.6 mt -69.45 -42.95 81.12 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 CA-C-N 116.305 -0.407 . . . . 0.35 110.157 178.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.08 -46.18 94.66 Favored Glycine 0 C--N 1.333 0.368 0 C-N-CA 121.056 -0.592 . . . . 0.26 112.299 179.039 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -64.85 -34.98 79.65 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-O 121.176 0.512 . . . . 0.76 110.375 179.114 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 14.2 tppt? -71.73 -47.66 52.33 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.057 -0.52 . . . . 0.73 111.116 179.416 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 55.5 t -62.68 -44.63 99.6 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-O 120.823 0.344 . . . . 0.35 111.009 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 35' ' ' TYR . . . . . 0.455 ' HB2' ' H ' ' A' ' 243' ' ' GLY . 0.0 OUTLIER -59.35 -47.24 86.16 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.155 -0.475 . . . . 0.77 110.468 179.102 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 36' ' ' CYS . . . . . . . . . . . . . 11.8 t -70.01 -36.05 74.82 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 116.259 -0.428 . . . . 0.57 111.913 -179.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 99.0 m -64.75 -40.04 94.63 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.209 0.448 . . . . 0.52 112.209 -179.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 38' ' ' TRP . . . . . . . . . . . . . 94.0 m95 -82.78 -31.28 28.33 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 120.821 -0.352 . . . . 0.72 111.781 -179.394 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 82.9 p . . . . . 0 N--CA 1.467 0.421 0 CA-C-O 120.737 0.303 . . . . 0.63 111.093 178.337 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 25.6 t70 . . . . . 0 N--CA 1.465 0.29 0 CA-C-O 120.831 0.348 . . . . 0.52 110.832 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -55.22 -48.34 74.03 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.007 -0.542 . . . . 0.44 110.805 178.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.601 HD21 ' HB3' ' A' ' 287' ' ' LEU . 47.6 tp -73.17 -36.08 66.54 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.091 -0.504 . . . . 0.73 110.783 178.675 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 64.3 t80 -60.06 -40.58 89.97 Favored 'General case' 0 C--O 1.224 -0.282 0 CA-C-N 116.223 -0.444 . . . . 0.36 111.489 179.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 7.6 mtm180 -56.22 -52.32 64.85 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.772 0.32 . . . . 0.35 111.552 179.48 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -64.89 -45.93 83.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.126 -0.488 . . . . 0.3 110.658 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . 0.439 ' HA ' ' CZ2' ' A' ' 293' ' ' TRP . 15.6 m -58.35 -50.25 74.3 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.802 -0.635 . . . . 0.25 111.207 179.46 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -60.37 -47.57 85.5 Favored 'General case' 0 C--O 1.225 -0.219 0 CA-C-N 116.149 -0.478 . . . . 0.43 111.263 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -58.2 -50.28 74.08 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 120.633 0.254 . . . . 0.34 111.166 -179.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 84.9 mt -61.32 -50.14 81.65 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 CA-C-N 116.321 -0.4 . . . . 0.27 111.082 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.554 HD12 HG23 ' A' ' 276' ' ' THR . 68.4 mt -61.45 -46.53 96.38 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 N-CA-C 111.533 0.197 . . . . 0.38 111.533 179.389 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 2.0 t -56.28 -52.63 63.78 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.733 0.302 . . . . 0.31 110.807 178.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 40.0 ttt-85 -61.19 -41.54 96.99 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 120.768 0.318 . . . . 0.35 111.782 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' TYR . . . . . 0.495 ' HE1' ' HA ' ' A' ' 195' ' ' ARG . 80.9 t80 -68.37 -50.3 54.1 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 112.236 0.458 . . . . 0.28 112.236 -179.459 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.474 ' HG ' ' HA ' ' A' ' 253' ' ' ALA . 5.8 mp -54.57 -39.22 67.56 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.66 0.267 . . . . 0.42 111.101 -179.413 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 52.6 mtt-85 -65.32 -44.46 87.75 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.434 -0.348 . . . . 0.33 111.029 178.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -54.18 -45.1 72.04 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 121.111 0.481 . . . . 0.54 111.125 178.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . 0.759 ' HB2' ' HB1' ' A' ' 253' ' ' ALA . 12.3 mm100 -77.01 -37.36 55.17 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 116.18 -0.464 . . . . 0.38 111.951 -179.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.43 ' O ' ' HG3' ' A' ' 257' ' ' LYS . . . . . . . . 0 C--O 1.232 0.183 0 CA-C-O 120.916 0.388 . . . . 0.26 110.715 178.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.625 ' O ' ' HA3' ' A' ' 187' ' ' GLY . . . . . . . . 0 CA--C 1.533 0.301 0 CA-C-O 121.182 0.515 . . . . 0.32 111.439 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -80.09 -71.97 1.24 Allowed Glycine 0 CA--C 1.524 0.643 0 C-N-CA 120.609 -0.805 . . . . 0.38 113.356 179.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -68.17 -55.61 11.71 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-O 120.979 0.418 . . . . 0.46 111.118 -179.608 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -65.18 -39.08 92.39 Favored 'General case' 0 C--O 1.218 -0.555 0 CA-C-N 115.904 -0.589 . . . . 0.41 110.077 178.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . 0.625 ' HA3' ' O ' ' A' ' 183' ' ' ALA . . . -60.6 -50.82 63.4 Favored Glycine 0 C--O 1.219 -0.79 0 C-N-CA 121.399 -0.429 . . . . 0.3 113.135 179.641 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . 0.427 HH11 ' HD2' ' A' ' 188' ' ' ARG . 13.4 mtp180 -56.84 -47.85 79.39 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 117.547 0.673 . . . . 1.34 111.484 179.234 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 189' ' ' ARG . . . . . 0.71 ' HB3' HG11 ' A' ' 297' ' ' VAL . 48.3 mtm180 -70.29 -41.0 73.95 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 112.479 0.548 . . . . 0.48 112.479 -179.438 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . 0.536 ' HA ' HG22 ' A' ' 297' ' ' VAL . . . -74.22 -44.63 52.39 Favored 'General case' 0 C--O 1.221 -0.408 0 N-CA-C 111.873 0.323 . . . . 0.27 111.873 -178.649 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 3.4 tp -61.07 -49.32 77.83 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.679 -0.408 . . . . 0.45 110.319 179.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -61.08 -44.11 97.86 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 120.706 -0.398 . . . . 0.57 110.996 179.545 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 91.5 m -63.53 -46.19 87.13 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 110.026 -0.361 . . . . 0.32 110.026 178.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 59.8 tp -63.58 -37.27 86.68 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.075 -0.511 . . . . 0.39 111.184 179.196 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . 0.495 ' HA ' ' HE1' ' A' ' 166' ' ' TYR . 2.1 mtt180 -58.6 -48.34 81.28 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.819 0.342 . . . . 0.38 110.711 178.709 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 10.5 mmp_? -74.66 -45.12 46.75 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 116.149 -0.478 . . . . 0.4 111.868 -179.25 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . 0.479 ' O ' HG23 ' A' ' 201' ' ' VAL . 49.7 t -65.67 -51.55 61.18 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 CA-C-O 120.687 0.279 . . . . 0.35 111.628 179.529 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -62.31 -53.23 43.74 Favored Glycine 0 CA--C 1.521 0.435 0 CA-C-O 119.933 -0.371 . . . . 0.29 113.388 -179.456 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -55.18 -40.34 70.61 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 117.225 0.513 . . . . 0.4 109.763 179.011 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -60.36 -53.6 44.17 Favored Glycine 0 C--N 1.335 0.507 0 N-CA-C 111.138 -0.785 . . . . 0.36 111.138 177.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . 0.479 HG23 ' O ' ' A' ' 197' ' ' VAL . 98.9 t -58.29 -38.33 68.33 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-O 120.792 0.33 . . . . 0.39 110.691 178.461 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 202' ' ' GLN . . . . . 0.517 HE21 ' HD1' ' A' ' 254' ' ' PHE . 31.7 mt-30 -62.91 -54.2 42.23 Favored 'General case' 0 C--O 1.225 -0.228 0 CA-C-N 115.818 -0.628 . . . . 0.36 111.803 179.594 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 29.0 mtp180 -67.88 -36.34 80.07 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 121.028 -0.269 . . . . 0.57 111.434 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 10.9 m-80 -62.98 -50.95 68.73 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 121.181 0.515 . . . . 1.3 110.499 178.532 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 57.1 m-70 -101.85 35.89 2.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.214 -0.448 . . . . 0.47 111.233 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -53.47 -47.45 69.75 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 112.23 0.456 . . . . 0.43 112.23 -179.261 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . 0.401 HG22 ' H ' ' A' ' 207' ' ' THR . 0.6 OUTLIER -56.34 -39.51 72.95 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 112.285 0.476 . . . . 0.47 112.285 -179.78 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -64.86 -48.79 73.01 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 120.989 0.424 . . . . 0.35 110.84 -179.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 209' ' ' PHE . . . . . 0.614 ' O ' ' HB2' ' A' ' 213' ' ' LEU . 46.3 m-85 -66.76 -35.27 79.71 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.94 -0.573 . . . . 0.56 109.912 178.692 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 210' ' ' GLN . . . . . 0.558 ' O ' ' HG2' ' A' ' 214' ' ' ARG . 49.5 mt-30 -66.12 -45.78 79.92 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.481 -0.327 . . . . 0.66 111.181 179.005 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -55.7 -49.03 67.8 Favored Glycine 0 C--N 1.336 0.574 0 N-CA-C 111.14 -0.784 . . . . 0.34 111.14 178.29 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -68.54 -29.86 68.53 Favored 'General case' 0 C--O 1.221 -0.42 0 CA-C-O 120.602 0.239 . . . . 0.65 110.367 178.144 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.614 ' HB2' ' O ' ' A' ' 209' ' ' PHE . 0.3 OUTLIER -69.55 -41.56 75.75 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.521 -0.309 . . . . 0.35 111.507 179.668 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 214' ' ' ARG . . . . . 0.558 ' HG2' ' O ' ' A' ' 210' ' ' GLN . 2.8 mmp_? -66.52 -40.03 88.95 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 121.185 0.517 . . . . 0.57 110.137 179.569 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 48.1 mtmt -91.87 13.15 19.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.888 -0.596 . . . . 0.58 111.94 179.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . 0.467 HD21 HG13 ' A' ' 255' ' ' VAL . 7.4 tp -79.72 106.4 11.72 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 121.422 0.629 . . . . 0.46 111.34 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -84.13 -2.14 56.26 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 115.011 -0.995 . . . . 0.55 111.708 -179.341 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 218' ' ' ILE . . . . . 0.628 HG12 ' HB3' ' A' ' 223' ' ' ASP . 46.9 mt -53.71 114.37 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 N-CA-C 112.255 0.465 . . . . 0.39 112.255 -179.75 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 26.5 mtmm -138.11 -28.4 0.86 Allowed 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 115.982 -0.553 . . . . 0.84 112.424 -179.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -125.14 -179.37 4.54 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 113.017 0.747 . . . . 0.55 113.017 -178.251 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . 0.56 ' O ' HG22 ' A' ' 224' ' ' VAL . 1.2 mp0 -64.3 -22.05 66.82 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.448 -0.796 . . . . 0.59 111.376 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -71.49 -26.82 72.44 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 121.021 -0.609 . . . . 0.38 112.859 179.177 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 223' ' ' ASP . . . . . 0.628 ' HB3' HG12 ' A' ' 218' ' ' ILE . 39.3 m-20 -68.37 -31.45 70.84 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 112.283 0.475 . . . . 0.37 112.283 -179.632 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.661 ' HB ' HG21 ' A' ' 274' ' ' THR . 3.1 m -58.16 -27.67 32.63 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 CA-C-O 120.745 0.307 . . . . 0.43 111.73 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . 0.419 ' HD2' ' H ' ' A' ' 225' ' ' LYS . 6.1 mptt -65.16 -37.08 86.26 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.107 0.48 . . . . 0.82 109.9 178.768 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 226' ' ' SER . . . . . 0.627 ' O ' HG23 ' A' ' 230' ' ' VAL . 18.4 t -67.57 -44.13 78.93 Favored 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 109.176 -0.676 . . . . 0.36 109.176 178.214 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 227' ' ' PHE . . . . . 0.616 ' HE2' HG21 ' A' ' 255' ' ' VAL . 2.7 t80 -59.76 -39.96 86.57 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 115.391 -0.822 . . . . 0.43 110.19 178.495 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 228' ' ' SER . . . . . 0.598 ' HA ' ' HE3' ' A' ' 231' ' ' MET . 15.9 m -63.44 -39.48 94.58 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.168 0.508 . . . . 0.35 109.883 178.441 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 28.2 mtp180 -65.88 -35.51 80.84 Favored 'General case' 0 C--O 1.225 -0.202 0 CA-C-N 115.482 -0.781 . . . . 0.62 109.766 178.237 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . 0.627 HG23 ' O ' ' A' ' 226' ' ' SER . 56.8 t -60.86 -51.18 76.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 109.879 -0.415 . . . . 0.36 109.879 177.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 231' ' ' MET . . . . . 0.613 ' HE1' ' HB ' ' A' ' 278' ' ' VAL . 56.5 mtm -55.73 -53.35 57.64 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.891 -0.595 . . . . 0.4 111.788 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 35.2 m -63.87 -30.91 51.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 120.861 -0.336 . . . . 0.4 111.167 179.388 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 233' ' ' HIS . . . . . 0.474 ' O ' ' HB3' ' A' ' 236' ' ' LYS . 44.5 t-80 -69.82 -39.56 76.41 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 120.962 0.41 . . . . 0.42 110.321 178.51 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 69.0 t -71.8 -41.0 70.03 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 CA-C-O 120.969 0.414 . . . . 0.38 111.046 178.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -87.9 12.73 12.43 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 120.954 0.407 . . . . 0.71 111.574 179.601 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . 0.51 ' O ' ' HG2' ' A' ' 236' ' ' LYS . 0.0 OUTLIER -68.99 -15.32 63.45 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 115.606 -0.725 . . . . 0.52 111.267 179.221 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 237' ' ' ASP . . . . . 0.456 ' HA ' ' NZ ' ' A' ' 236' ' ' LYS . 71.8 m-20 -75.86 -7.89 55.57 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 122.085 -0.385 . . . . 0.36 111.651 179.812 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 84.92 -19.97 18.28 Favored Glycine 0 CA--C 1.519 0.291 0 C-N-CA 121.014 -0.613 . . . . 0.4 112.773 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 2.5 t -91.97 108.89 20.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.148 0.499 . . . . 0.85 111.166 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 240' ' ' THR . . . . . 0.537 HG22 HD11 ' A' ' 245' ' ' ILE . 3.4 m -89.79 68.2 7.43 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.206 -0.452 . . . . 0.48 111.131 -179.793 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . 0.461 ' HB2' ' HG3' ' A' ' 244' ' ' ARG . 11.9 m120 -66.24 141.58 57.99 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.918 0.389 . . . . 0.4 111.431 -179.771 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 242' ' ' TRP . . . . . 0.491 ' CZ3' ' HB2' ' A' ' 296' ' ' PHE . 76.1 m95 -59.69 -36.35 76.31 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.282 -0.417 . . . . 0.43 110.369 178.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . 0.452 ' HA3' ' HB2' ' B' ' 35' ' ' TYR . . . -61.14 -31.75 77.97 Favored Glycine 0 C--N 1.335 0.5 0 C-N-CA 121.082 -0.58 . . . . 0.27 112.058 178.083 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 244' ' ' ARG . . . . . 0.539 ' HG2' ' HA3' ' B' ' 31' ' ' GLY . 81.6 mtt180 -75.76 -32.74 60.08 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 121.151 0.501 . . . . 0.36 109.914 178.684 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . 0.537 HD11 HG22 ' A' ' 240' ' ' THR . 78.1 mt -72.05 -49.63 42.73 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 CA-C-N 115.78 -0.646 . . . . 0.44 110.692 179.064 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 26.9 m -67.56 -31.51 52.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 C-N-CA 121.171 -0.212 . . . . 0.3 111.324 179.333 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . 0.475 HG22 HD22 ' B' ' 27' ' ' LEU . 30.9 m -67.53 -40.5 85.07 Favored 'General case' 0 C--O 1.232 0.157 0 N-CA-C 109.134 -0.691 . . . . 0.37 109.134 177.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 248' ' ' LEU . . . . . 0.419 ' HA ' HD13 ' A' ' 248' ' ' LEU . 0.3 OUTLIER -61.5 -42.26 98.53 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 109.047 -0.723 . . . . 0.48 109.047 177.14 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 249' ' ' ILE . . . . . 0.439 HG13 ' O ' ' A' ' 245' ' ' ILE . 49.7 mt -63.36 -44.99 99.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.404 0 CA-C-N 115.812 -0.631 . . . . 0.39 110.219 178.105 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 250' ' ' SER . . . . . 0.505 ' HB3' ' HG3' ' A' ' 202' ' ' GLN . 40.3 m -58.98 -44.22 91.56 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.062 -0.517 . . . . 0.32 110.005 178.699 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 251' ' ' PHE . . . . . . . . . . . . . 21.7 t80 -63.67 -44.28 94.21 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 115.89 -0.596 . . . . 0.36 109.495 177.369 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -56.22 -44.61 89.04 Favored Glycine 0 C--N 1.336 0.552 0 C-N-CA 121.067 -0.587 . . . . 0.25 111.705 178.462 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 253' ' ' ALA . . . . . 0.759 ' HB1' ' HB2' ' A' ' 170' ' ' GLN . . . -59.96 -43.16 95.23 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.669 0.271 . . . . 0.26 110.585 177.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 254' ' ' PHE . . . . . 0.517 ' HD1' HE21 ' A' ' 202' ' ' GLN . 0.3 OUTLIER -65.04 -40.64 95.08 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 121.233 0.539 . . . . 0.57 110.215 178.462 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 255' ' ' VAL . . . . . 0.616 HG21 ' HE2' ' A' ' 227' ' ' PHE . 78.4 t -66.63 -39.97 85.11 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-N 116.107 -0.497 . . . . 0.3 110.207 178.561 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -57.86 -39.42 77.72 Favored 'General case' 0 N--CA 1.461 0.097 0 CA-C-O 121.469 0.652 . . . . 0.27 109.259 178.093 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 257' ' ' LYS . . . . . 0.43 ' HG3' ' O ' ' A' ' 171' ' ' ALA . 23.1 tttp -61.65 -41.72 97.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.262 -0.881 . . . . 0.33 110.236 178.062 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 71.3 t60 -58.77 -45.58 89.48 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 116.243 -0.435 . . . . 0.46 110.719 178.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.528 HD22 ' NE2' ' A' ' 264' ' ' GLN . 13.1 mt -70.86 -43.1 69.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.248 -0.433 . . . . 0.45 110.932 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 21.0 ttmm -63.1 -36.93 85.22 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.785 0.326 . . . . 0.68 111.089 179.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 54.3 m -63.15 -25.46 68.36 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 116.387 -0.369 . . . . 0.44 111.684 179.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 262' ' ' VAL . . . . . 0.523 HG23 ' HG3' ' A' ' 264' ' ' GLN . 17.9 m -108.67 21.8 4.64 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-O 120.848 0.356 . . . . 0.49 111.23 179.34 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 57.32 42.55 24.86 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 112.903 0.705 . . . . 1.81 112.903 179.388 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 264' ' ' GLN . . . . . 0.528 ' NE2' HD22 ' A' ' 259' ' ' LEU . 10.5 mt-30 -98.22 38.4 1.33 Allowed 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.219 0.451 . . . . 0.48 112.219 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -51.48 -37.33 48.42 Favored 'General case' 0 C--O 1.243 0.715 0 CA-C-O 120.892 0.377 . . . . 0.8 111.857 179.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 26.5 p -62.59 -16.88 58.62 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 116.101 -0.499 . . . . 0.97 111.162 178.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 267' ' ' PHE . . . . . 0.401 ' C ' ' HD2' ' A' ' 270' ' ' PRO . 73.7 m-85 -110.44 -12.18 14.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.939 -0.573 . . . . 0.67 109.889 178.271 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 8.4 mm -66.41 -49.33 76.34 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 CA-C-N 115.834 -0.621 . . . . 0.4 110.303 179.06 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 269' ' ' GLU . . . . . 0.732 ' HB2' ' HD3' ' A' ' 270' ' ' PRO . 57.4 mm-40 -61.44 -54.95 47.73 Favored Pre-proline 0 CA--C 1.545 0.765 0 CA-C-N 115.841 -0.618 . . . . 0.51 111.106 179.331 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 270' ' ' PRO . . . . . 0.732 ' HD3' ' HB2' ' A' ' 269' ' ' GLU . 51.2 Cg_exo -57.0 -36.14 99.2 Favored 'Trans proline' 0 C--N 1.359 1.086 0 C-N-CA 122.244 1.963 . . . . 0.31 112.879 178.577 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 271' ' ' LEU . . . . . . . . . . . . . 18.6 tp -63.84 -52.1 61.63 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.485 0.183 . . . . 0.5 111.188 179.035 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -58.16 -39.79 79.75 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.276 -0.42 . . . . 0.29 111.242 179.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 273' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -71.36 -40.48 70.61 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.247 -0.433 . . . . 0.61 110.723 178.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 274' ' ' THR . . . . . 0.661 HG21 ' HB ' ' A' ' 224' ' ' VAL . 87.3 m -63.53 -43.84 95.98 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.874 0.368 . . . . 0.33 110.679 179.309 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 275' ' ' ILE . . . . . 0.442 ' HA ' ' CE ' ' A' ' 231' ' ' MET . 88.1 mt -61.88 -54.88 28.71 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.083 0 CA-C-N 116.277 -0.42 . . . . 0.39 110.414 179.163 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 276' ' ' THR . . . . . 0.554 HG23 HD12 ' A' ' 163' ' ' ILE . 24.2 m -56.41 -51.07 69.74 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.26 -0.427 . . . . 0.31 111.533 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 277' ' ' ASP . . . . . 0.637 ' O ' ' HB2' ' A' ' 281' ' ' ARG . 29.7 t70 -52.26 -60.22 3.47 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.35 -0.386 . . . . 0.39 111.79 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 278' ' ' VAL . . . . . 0.613 ' HB ' ' HE1' ' A' ' 231' ' ' MET . 59.6 t -63.94 -42.57 96.19 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 N-CA-C 112.336 0.495 . . . . 0.36 112.336 -179.074 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 27.1 tp -60.72 -47.61 85.51 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 111.987 0.365 . . . . 0.66 111.987 -179.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 86.7 t -80.96 -46.32 20.82 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 N-CA-C 113.056 0.761 . . . . 0.47 113.056 -178.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 281' ' ' ARG . . . . . 0.637 ' HB2' ' O ' ' A' ' 277' ' ' ASP . 1.5 mpt_? -60.72 -35.59 76.7 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 113.039 0.755 . . . . 0.42 113.039 -178.32 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 282' ' ' THR . . . . . . . . . . . . . 85.0 m -65.09 -38.13 89.73 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 112.389 0.514 . . . . 0.47 112.389 -179.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 28.8 mmtp -129.67 42.1 3.34 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 112.582 0.586 . . . . 0.46 112.582 -178.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 284' ' ' ARG . . . . . 0.412 ' HD3' ' O ' ' A' ' 281' ' ' ARG . 0.1 OUTLIER -60.35 -28.82 68.47 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 111.965 0.357 . . . . 0.59 111.965 -179.697 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 285' ' ' ASP . . . . . 0.458 ' HA ' HG22 ' A' ' 288' ' ' VAL . 3.1 t70 -62.41 -44.99 95.12 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-O 121.023 0.439 . . . . 0.71 110.383 179.201 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 286' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -61.09 -35.61 77.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.307 0.575 . . . . 0.54 110.13 178.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 287' ' ' LEU . . . . . 0.601 ' HB3' HD21 ' A' ' 155' ' ' LEU . 1.2 mm? -71.24 -54.31 11.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.517 -0.765 . . . . 0.46 111.148 179.378 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 288' ' ' VAL . . . . . 0.458 HG22 ' HA ' ' A' ' 285' ' ' ASP . 33.8 m -59.96 -30.39 45.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 N-CA-C 111.763 0.283 . . . . 0.43 111.763 -179.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 27.8 mttp -65.77 -32.43 73.96 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.861 0.363 . . . . 0.82 110.927 178.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 -108.51 28.98 7.82 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 111.873 0.323 . . . . 0.67 111.873 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 291' ' ' ARG . . . . . 0.777 ' HB3' ' HB2' ' A' ' 294' ' ' ASP . 0.8 OUTLIER 61.84 19.41 10.6 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 112.612 0.597 . . . . 0.44 112.612 178.896 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 69.11 -118.02 8.4 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 121.302 -0.475 . . . . 0.32 113.236 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 293' ' ' TRP . . . . . 0.674 ' O ' HG23 ' A' ' 297' ' ' VAL . 90.5 m95 -72.0 -21.7 61.52 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 111.683 0.253 . . . . 0.35 111.683 -179.262 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 294' ' ' ASP . . . . . 0.777 ' HB2' ' HB3' ' A' ' 291' ' ' ARG . 60.1 m-20 -57.74 -51.5 69.29 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 109.509 -0.552 . . . . 0.45 109.509 178.019 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -65.25 -41.36 96.82 Favored Glycine 0 C--N 1.335 0.52 0 N-CA-C 111.355 -0.698 . . . . 0.3 111.355 178.137 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 296' ' ' PHE . . . . . 0.491 ' HB2' ' CZ3' ' A' ' 242' ' ' TRP . 6.7 t80 -56.33 -46.04 80.09 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 120.753 0.311 . . . . 0.34 111.371 178.707 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 297' ' ' VAL . . . . . 0.71 HG11 ' HB3' ' A' ' 189' ' ' ARG . 88.9 t -58.48 -54.6 30.85 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 CA-C-O 120.96 0.409 . . . . 0.35 111.768 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -71.23 -29.86 65.65 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.948 0.721 . . . . 0.71 112.948 -178.488 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 299' ' ' PHE . . . . . 0.51 ' CZ ' ' HB2' ' B' ' 39' ' ' SER . 61.3 t80 -59.18 -46.11 89.26 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.901 0.381 . . . . 0.4 111.051 178.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 300' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 . . . . . 0 CA--C 1.534 0.349 0 CA-C-O 121.132 0.491 . . . . 0.45 111.902 -179.599 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 . . . . . 0 CA--C 1.528 0.114 0 N-CA-C 111.62 0.23 . . . . 1.19 111.62 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 23' ' ' PHE . . . . . 0.621 ' HD1' ' N ' ' B' ' 24' ' ' ALA . 0.2 OUTLIER -62.36 -33.9 75.63 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 120.788 -0.365 . . . . 0.33 111.422 -179.967 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 24' ' ' ALA . . . . . 0.621 ' N ' ' HD1' ' B' ' 23' ' ' PHE . . . -76.83 -40.22 48.63 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.855 0.36 . . . . 0.34 110.561 -179.73 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -69.94 -40.56 75.4 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.075 -0.511 . . . . 0.42 111.577 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -68.96 -50.92 44.96 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 111.909 0.337 . . . . 0.57 111.909 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . 0.475 HD22 HG22 ' A' ' 247' ' ' THR . 81.7 mt -64.8 -30.39 71.4 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 111.734 0.272 . . . . 0.44 111.734 -179.332 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 28' ' ' ARG . . . . . 0.518 ' HB2' ' O ' ' B' ' 24' ' ' ALA . 0.0 OUTLIER -70.67 -55.92 7.61 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 120.886 0.374 . . . . 0.42 110.795 178.35 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 34.9 mtmm -61.64 -53.01 61.86 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 116.463 -0.335 . . . . 0.42 111.672 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 97.4 mt -58.39 -40.02 76.7 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.077 0 CA-C-N 116.41 -0.359 . . . . 0.4 110.573 -179.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . 0.539 ' HA3' ' HG2' ' A' ' 244' ' ' ARG . . . -56.61 -50.01 65.99 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.946 -0.645 . . . . 0.25 112.45 179.388 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -72.09 -40.37 68.25 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.927 0.364 . . . . 0.73 111.43 179.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 33' ' ' LYS . . . . . 0.479 ' HA ' ' HD2' ' B' ' 33' ' ' LYS . 1.1 tptt -59.45 -51.68 68.85 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 120.879 0.371 . . . . 1.13 110.749 179.245 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 33.6 t -63.94 -46.42 94.11 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 CA-C-N 116.057 -0.52 . . . . 0.4 110.467 178.664 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 35' ' ' TYR . . . . . 0.452 ' HB2' ' HA3' ' A' ' 243' ' ' GLY . 9.0 t80 -56.56 -48.26 77.72 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 115.934 -0.575 . . . . 0.73 111.517 179.39 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 36' ' ' CYS . . . . . . . . . . . . . 80.8 m -63.98 -33.04 74.84 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.866 0.365 . . . . 0.46 111.164 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 34.5 m -69.63 -33.51 72.75 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.081 -0.509 . . . . 0.63 111.704 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 38' ' ' TRP . . . . . . . . . . . . . 80.8 m95 -87.96 -34.64 18.01 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 120.675 0.274 . . . . 0.58 111.661 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 39' ' ' SER . . . . . 0.51 ' HB2' ' CZ ' ' A' ' 299' ' ' PHE . 39.1 t . . . . . 0 N--CA 1.465 0.321 0 CA-C-O 121.016 0.436 . . . . 0.61 111.018 179.045 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 . . . . . 0 CA--C 1.537 0.473 0 N-CA-C 112.706 0.632 . . . . 1.01 112.706 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -58.86 -52.53 65.35 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.926 0.393 . . . . 0.97 111.236 179.769 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 1.4 mt -60.56 -39.51 88.25 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.167 -0.47 . . . . 0.64 110.925 178.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -66.75 -39.03 87.76 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.544 -0.298 . . . . 0.9 111.459 179.493 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 1.5 mmt180 -57.04 -51.64 68.44 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.714 0.293 . . . . 0.92 111.24 179.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . 0.406 ' HA ' ' HB2' ' A' ' 183' ' ' ALA . 71.0 mt-30 -69.28 -42.17 75.85 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.991 -0.283 . . . . 0.54 111.095 179.464 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 49.4 m -59.97 -49.78 76.32 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 111.752 0.278 . . . . 0.37 111.752 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.634 HD21 ' HA ' ' A' ' 273' ' ' GLU . 1.5 tm? -58.44 -53.41 58.63 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.548 -0.296 . . . . 0.72 110.994 179.539 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -60.48 -47.43 86.17 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 112.013 0.375 . . . . 1.1 112.013 -179.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . 0.507 HG12 ' HA2' ' A' ' 187' ' ' GLY . 83.2 mt -61.99 -47.54 92.72 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-O 120.621 0.248 . . . . 0.38 111.392 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 39.6 mt -64.19 -45.54 96.04 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 CA-C-N 116.745 -0.207 . . . . 0.42 110.733 179.245 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 27.2 t -57.98 -44.71 87.3 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.944 0.402 . . . . 0.34 110.006 178.345 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -61.02 -44.62 97.14 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 115.658 -0.701 . . . . 0.49 111.611 179.117 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' TYR . . . . . 0.906 ' HE1' ' HA ' ' A' ' 195' ' ' ARG . 75.6 t80 -68.22 -51.18 48.33 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 111.824 0.305 . . . . 0.38 111.824 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 8.6 mp -58.85 -41.29 86.62 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.713 -0.221 . . . . 0.46 111.455 -179.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 5.4 mtt-85 -67.27 -39.67 86.08 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.009 0.433 . . . . 0.86 111.029 179.122 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -68.57 -48.19 64.87 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.159 -0.473 . . . . 0.73 111.377 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . 0.45 ' HG3' ' CZ ' ' A' ' 166' ' ' TYR . 27.6 mm-40 -65.56 -25.97 67.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.699 0.285 . . . . 0.54 111.158 178.779 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.137 0 CA-C-N 116.486 -0.325 . . . . 0.52 111.401 178.736 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.488 ' O ' ' HA3' ' A' ' 187' ' ' GLY . . . . . . . . 0 CA--C 1.533 0.313 0 CA-C-O 120.933 0.397 . . . . 0.54 111.269 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -79.13 -70.51 1.32 Allowed Glycine 0 CA--C 1.524 0.634 0 C-N-CA 120.696 -0.764 . . . . 0.48 113.479 -179.526 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -61.83 -55.91 24.94 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 120.774 0.321 . . . . 0.46 111.253 -179.657 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -62.31 -37.34 85.2 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.265 -0.425 . . . . 0.4 110.452 179.083 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . 0.507 ' HA2' HG12 ' A' ' 162' ' ' ILE . . . -63.2 -42.81 99.29 Favored Glycine 0 C--N 1.334 0.464 0 C-N-CA 121.2 -0.524 . . . . 0.35 112.659 179.528 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 40.8 ttt-85 -62.55 -48.93 77.34 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 117.022 0.411 . . . . 0.96 110.907 179.24 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 189' ' ' ARG . . . . . 0.749 ' HB3' HG11 ' A' ' 297' ' ' VAL . 34.8 mtp180 -66.28 -41.28 90.05 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.218 -0.446 . . . . 0.5 111.264 179.515 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -68.91 -45.86 69.8 Favored 'General case' 0 C--O 1.219 -0.504 0 CA-C-N 116.177 -0.465 . . . . 0.36 111.836 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 191' ' ' LEU . . . . . 0.447 ' HB2' ' O ' ' A' ' 187' ' ' GLY . 0.9 OUTLIER -59.37 -45.78 90.49 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.626 0.25 . . . . 0.66 111.22 179.505 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -62.34 -49.67 74.67 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 121.101 0.477 . . . . 0.59 111.172 179.389 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . 0.42 HG21 ' HA ' ' A' ' 297' ' ' VAL . 25.7 m -66.04 -51.2 60.43 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.01 -0.541 . . . . 0.52 111.7 -179.533 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . 0.514 HD21 HG21 ' A' ' 249' ' ' ILE . 12.6 tp -58.27 -40.4 81.76 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.222 -0.445 . . . . 0.35 111.736 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . 0.906 ' HA ' ' HE1' ' A' ' 166' ' ' TYR . 43.4 ttm180 -61.31 -53.58 54.95 Favored 'General case' 0 N--CA 1.461 0.121 0 CA-C-O 120.606 0.241 . . . . 0.85 110.705 178.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 22.9 ttm105 -60.96 -50.17 74.48 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.24 -0.437 . . . . 0.46 112.149 -179.436 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . 0.518 HG12 HG11 ' A' ' 246' ' ' VAL . 53.3 t -65.51 -48.71 81.85 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 N-CA-C 111.996 0.369 . . . . 0.38 111.996 -179.351 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . 0.539 ' HA3' ' OH ' ' A' ' 166' ' ' TYR . . . -61.5 -42.93 99.87 Favored Glycine 0 C--N 1.334 0.432 0 C-N-CA 121.108 -0.568 . . . . 0.32 113.03 -179.598 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . 0.427 ' HB2' ' O ' ' A' ' 195' ' ' ARG . 0.8 OUTLIER -62.33 -45.11 94.7 Favored 'General case' 0 N--CA 1.46 0.074 0 N-CA-C 109.564 -0.532 . . . . 0.89 109.564 178.617 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -61.22 -42.78 99.88 Favored Glycine 0 C--N 1.337 0.605 0 C-N-CA 120.841 -0.695 . . . . 0.3 111.917 178.399 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . 0.47 HG23 ' O ' ' A' ' 197' ' ' VAL . 67.4 t -62.34 -47.69 91.88 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-O 120.593 0.235 . . . . 0.38 110.936 178.536 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 202' ' ' GLN . . . . . 0.408 ' OE1' ' HD1' ' A' ' 254' ' ' PHE . 37.6 mt-30 -65.78 -41.32 92.14 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.353 -0.385 . . . . 0.38 111.476 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.64 -37.3 85.82 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.03 0.443 . . . . 0.65 110.546 179.077 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 18.0 m-80 -78.18 -52.37 8.8 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.155 -0.475 . . . . 0.62 111.477 179.468 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 205' ' ' HIS . . . . . 0.441 ' ND1' HG12 ' B' ' 30' ' ' ILE . 75.4 m-70 -92.18 35.86 0.99 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.743 0.306 . . . . 0.68 111.306 -179.373 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -58.29 -49.68 76.28 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.424 0.527 . . . . 0.56 112.424 -179.015 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 69.2 p -60.49 -39.31 87.21 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.896 0.379 . . . . 0.5 111.722 -179.538 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -66.65 -50.38 63.13 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-N 115.915 -0.584 . . . . 0.33 110.78 179.561 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 209' ' ' PHE . . . . . 0.46 ' HB3' ' CD2' ' A' ' 254' ' ' PHE . 31.0 m-85 -63.17 -41.09 99.17 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.882 -0.599 . . . . 0.5 110.495 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 12.0 mt-30 -59.48 -45.44 91.66 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-N 116.103 -0.498 . . . . 0.54 111.408 179.245 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -55.77 -50.17 62.28 Favored Glycine 0 C--N 1.334 0.461 0 C-N-CA 120.644 -0.789 . . . . 0.33 111.645 179.261 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 212' ' ' MET . . . . . 0.603 ' HG2' ' HA ' ' B' ' 23' ' ' PHE . 6.6 mtp -64.65 -37.08 86.35 Favored 'General case' 0 C--O 1.225 -0.212 0 CA-C-O 120.561 0.22 . . . . 0.54 111.012 178.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.456 HD11 ' HA ' ' A' ' 255' ' ' VAL . 6.6 tp -67.49 -42.97 82.03 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 112.022 0.378 . . . . 0.61 112.022 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 214' ' ' ARG . . . . . 0.457 HH11 ' HD3' ' A' ' 214' ' ' ARG . 40.3 mtt180 -61.6 -40.05 93.42 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.932 0.396 . . . . 1.13 110.833 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 215' ' ' LYS . . . . . 0.53 ' HE2' ' HA ' ' A' ' 215' ' ' LYS . 0.0 OUTLIER -95.85 13.36 26.97 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.85 -0.34 . . . . 0.55 111.03 178.584 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 11.3 tp -78.34 100.04 6.59 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.891 0.377 . . . . 0.55 110.398 179.222 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.73 33.06 0.42 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.28 -0.418 . . . . 0.51 111.957 -179.365 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 218' ' ' ILE . . . . . 0.684 HG12 ' HB3' ' A' ' 223' ' ' ASP . 47.6 mt -87.53 119.08 34.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.766 0.317 . . . . 0.48 110.66 179.278 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.63 -15.32 0.73 Allowed 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 112.772 0.656 . . . . 0.52 112.772 -179.204 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 220' ' ' ASN . . . . . 0.41 ' HA ' ' CE1' ' A' ' 267' ' ' PHE . 7.4 p30 -132.31 -178.37 4.88 Favored 'General case' 0 CA--C 1.541 0.613 0 O-C-N 122.002 -0.436 . . . . 0.55 112.154 -179.663 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . 0.573 ' O ' HG22 ' A' ' 224' ' ' VAL . 1.9 mp0 -69.59 -21.99 63.55 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 112.902 0.704 . . . . 0.73 112.902 -178.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -72.6 -26.86 70.55 Favored Glycine 0 CA--C 1.523 0.551 0 C-N-CA 120.66 -0.781 . . . . 0.47 112.685 179.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 223' ' ' ASP . . . . . 0.684 ' HB3' HG12 ' A' ' 218' ' ' ILE . 61.2 m-20 -65.52 -30.48 71.24 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 112.128 0.418 . . . . 0.56 112.128 -179.624 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.573 HG22 ' O ' ' A' ' 221' ' ' GLU . 4.1 m -56.39 -28.25 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 N-CA-C 111.878 0.325 . . . . 0.47 111.878 179.612 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . 0.473 ' HD2' ' H ' ' A' ' 225' ' ' LYS . 7.7 mptt -64.67 -36.79 85.4 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.192 0.52 . . . . 0.73 110.037 178.587 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 226' ' ' SER . . . . . 0.509 ' O ' HG23 ' A' ' 230' ' ' VAL . 7.8 t -69.31 -35.02 75.56 Favored 'General case' 0 N--CA 1.462 0.148 0 N-CA-C 108.901 -0.777 . . . . 0.45 108.901 177.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 227' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -61.74 -37.63 84.96 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 115.269 -0.878 . . . . 0.44 109.601 177.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 228' ' ' SER . . . . . 0.4 ' O ' HG22 ' A' ' 232' ' ' VAL . 69.1 m -66.37 -40.43 89.73 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.093 -0.503 . . . . 0.45 109.804 178.036 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 73.0 mtp180 -58.13 -37.66 75.03 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.031 -0.531 . . . . 0.86 110.381 178.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . 0.582 HG13 ' HA ' ' B' ' 24' ' ' ALA . 36.3 t -66.32 -46.74 86.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.946 -0.57 . . . . 0.37 110.107 178.337 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 231' ' ' MET . . . . . 0.514 ' HE1' ' HA ' ' A' ' 275' ' ' ILE . 60.3 mtm -63.94 -48.35 76.85 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.017 -0.538 . . . . 0.46 111.852 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 232' ' ' VAL . . . . . 0.4 HG22 ' O ' ' A' ' 228' ' ' SER . 31.1 m -62.9 -31.24 51.75 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 C-N-CA 120.585 -0.446 . . . . 0.38 110.508 179.048 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 233' ' ' HIS . . . . . 0.686 ' CD2' ' HB1' ' B' ' 24' ' ' ALA . 8.7 t60 -67.91 -44.44 76.92 Favored 'General case' 0 CA--C 1.528 0.125 0 N-CA-C 109.126 -0.694 . . . . 0.32 109.126 177.109 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.536 ' HA ' ' HG3' ' B' ' 28' ' ' ARG . 51.2 t -56.46 -42.46 75.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 CA-C-N 115.775 -0.648 . . . . 0.43 110.78 179.633 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -99.79 23.74 9.28 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.001 0.371 . . . . 0.6 112.001 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 2.6 ttpp -73.01 -13.73 61.28 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.799 0.333 . . . . 1.13 111.361 179.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -86.16 -16.21 38.57 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 120.88 0.371 . . . . 0.62 110.988 179.527 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 92.48 -19.08 52.82 Favored Glycine 0 CA--C 1.524 0.636 0 C-N-CA 121.032 -0.604 . . . . 0.4 113.84 179.179 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 6.1 p -83.9 117.25 29.19 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-O 121.625 0.726 . . . . 0.5 111.727 -179.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 240' ' ' THR . . . . . 0.411 HG21 ' HG2' ' A' ' 283' ' ' LYS . 10.8 m -94.9 117.3 29.91 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.057 0.456 . . . . 0.4 111.577 179.764 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -113.48 141.54 47.0 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.5 -0.318 . . . . 0.58 110.639 179.157 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 242' ' ' TRP . . . . . 0.529 ' CZ3' ' HB2' ' A' ' 296' ' ' PHE . 24.8 m95 -60.02 -42.4 94.28 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 120.721 0.296 . . . . 0.38 110.424 178.419 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . 0.434 ' HA3' ' N ' ' B' ' 35' ' ' TYR . . . -60.26 -33.31 79.81 Favored Glycine 0 C--N 1.336 0.531 0 C-N-CA 120.967 -0.635 . . . . 0.27 111.816 178.187 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 244' ' ' ARG . . . . . 0.503 ' HA ' ' HA3' ' B' ' 31' ' ' GLY . 50.1 mtt180 -69.25 -51.43 37.7 Favored 'General case' 0 C--O 1.232 0.153 0 N-CA-C 109.569 -0.53 . . . . 0.39 109.569 178.099 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . 0.527 HG23 HD21 ' A' ' 279' ' ' LEU . 83.1 mt -55.94 -48.32 78.73 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 CA-C-N 115.582 -0.735 . . . . 0.44 110.89 179.455 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . 0.518 HG11 HG12 ' A' ' 197' ' ' VAL . 96.1 t -64.69 -32.32 57.46 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-N 116.471 -0.331 . . . . 0.59 110.984 179.46 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . 0.497 HG22 HD22 ' B' ' 27' ' ' LEU . 20.2 m -63.35 -44.35 95.07 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.611 0.243 . . . . 0.35 110.448 178.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 248' ' ' LEU . . . . . 0.502 HD22 ' HG2' ' A' ' 231' ' ' MET . 54.2 mt -62.2 -41.2 98.15 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.396 0.617 . . . . 0.47 109.857 178.454 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 249' ' ' ILE . . . . . 0.514 HG21 HD21 ' A' ' 194' ' ' LEU . 27.8 mt -66.45 -39.98 85.38 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 CA-C-N 115.782 -0.644 . . . . 0.45 110.013 178.115 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 49.4 m -62.91 -41.77 99.56 Favored 'General case' 0 N--CA 1.461 0.115 0 N-CA-C 109.148 -0.686 . . . . 0.39 109.148 178.154 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 251' ' ' PHE . . . . . 0.502 ' CD2' HD11 ' B' ' 27' ' ' LEU . 8.7 t80 -62.14 -42.17 98.99 Favored 'General case' 0 C--O 1.226 -0.15 0 N-CA-C 108.821 -0.807 . . . . 0.41 108.821 177.518 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -57.68 -46.79 91.79 Favored Glycine 0 C--N 1.335 0.527 0 N-CA-C 111.053 -0.819 . . . . 0.27 111.053 177.451 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 253' ' ' ALA . . . . . 0.486 ' O ' ' HG3' ' A' ' 257' ' ' LYS . . . -64.34 -35.33 80.53 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 120.617 0.246 . . . . 0.31 111.245 177.627 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 254' ' ' PHE . . . . . 0.46 ' CD2' ' HB3' ' A' ' 209' ' ' PHE . 2.5 t80 -71.07 -43.76 67.11 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 120.617 0.246 . . . . 0.78 111.25 179.373 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 255' ' ' VAL . . . . . 0.456 ' HA ' HD11 ' A' ' 213' ' ' LEU . 23.7 m -68.04 -34.58 67.7 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.109 0 N-CA-C 109.354 -0.61 . . . . 0.36 109.354 178.269 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -60.91 -36.72 80.0 Favored 'General case' 0 C--O 1.227 -0.127 0 N-CA-C 109.371 -0.604 . . . . 0.32 109.371 177.009 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 257' ' ' LYS . . . . . 0.486 ' HG3' ' O ' ' A' ' 253' ' ' ALA . 59.3 mttp -62.42 -45.66 92.08 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 109.608 -0.515 . . . . 0.58 109.608 177.24 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 258' ' ' HIS . . . . . 0.429 ' HB2' HD11 ' A' ' 213' ' ' LEU . 22.2 t60 -60.76 -36.58 79.29 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.722 -0.672 . . . . 0.79 110.774 179.363 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 78.4 mt -74.95 -45.05 44.89 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.301 -0.408 . . . . 0.62 110.662 178.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 1.5 tptp -62.19 -34.82 77.18 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 120.717 0.294 . . . . 0.46 110.838 179.359 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 49.2 m -63.12 -24.31 67.84 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.254 -0.43 . . . . 0.52 110.946 179.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 262' ' ' VAL . . . . . 0.553 HG23 ' HG3' ' A' ' 264' ' ' GLN . 16.0 m -114.88 19.03 7.34 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-N 116.239 -0.437 . . . . 0.63 110.882 178.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 57.44 52.37 8.68 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 113.073 0.768 . . . . 1.15 113.073 179.417 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 264' ' ' GLN . . . . . 0.553 ' HG3' HG23 ' A' ' 262' ' ' VAL . 23.0 mt-30 -119.72 36.26 4.57 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 112.087 0.402 . . . . 0.75 112.087 179.332 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 265' ' ' GLU . . . . . 0.482 ' HA ' HD12 ' A' ' 268' ' ' ILE . 2.2 pm0 -57.74 -23.73 53.49 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-O 120.828 0.347 . . . . 0.62 111.656 179.061 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 54.4 p -61.62 -21.18 64.13 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.016 -0.538 . . . . 0.7 110.403 178.313 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 267' ' ' PHE . . . . . 0.509 ' C ' ' HD2' ' A' ' 270' ' ' PRO . 90.8 m-85 -95.3 -20.25 19.32 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 116.093 -0.503 . . . . 0.66 110.578 178.594 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 268' ' ' ILE . . . . . 0.482 HD12 ' HA ' ' A' ' 265' ' ' GLU . 78.6 mt -67.31 -41.16 86.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-N 116.26 -0.427 . . . . 0.42 110.078 178.574 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 269' ' ' GLU . . . . . 0.771 ' HB2' ' HD3' ' A' ' 270' ' ' PRO . 2.2 mm-40 -53.8 -56.4 25.75 Favored Pre-proline 0 CA--C 1.546 0.789 0 CA-C-N 116.089 -0.505 . . . . 0.76 111.122 178.591 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 270' ' ' PRO . . . . . 0.771 ' HD3' ' HB2' ' A' ' 269' ' ' GLU . 33.4 Cg_exo -62.23 -30.29 81.44 Favored 'Trans proline' 0 C--N 1.362 1.268 0 C-N-CA 122.139 1.892 . . . . 0.42 111.675 177.708 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 271' ' ' LEU . . . . . 0.404 ' HA ' HD23 ' A' ' 271' ' ' LEU . 4.3 mt -62.69 -50.41 71.24 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.286 -0.416 . . . . 0.71 110.045 177.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -56.29 -36.39 68.59 Favored 'General case' 0 N--CA 1.461 0.111 0 CA-C-N 116.147 -0.479 . . . . 0.45 110.825 179.143 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 273' ' ' GLU . . . . . 0.634 ' HA ' HD21 ' A' ' 160' ' ' LEU . 1.2 mm-40 -72.39 -50.79 23.96 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.102 -0.499 . . . . 1.39 110.658 178.381 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 274' ' ' THR . . . . . 0.487 HG21 ' HB ' ' A' ' 224' ' ' VAL . 25.3 m -58.45 -45.97 87.48 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.297 -0.41 . . . . 0.54 111.8 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 275' ' ' ILE . . . . . 0.514 ' HA ' ' HE1' ' A' ' 231' ' ' MET . 92.0 mt -63.77 -55.33 23.1 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 CA-C-N 116.558 -0.292 . . . . 0.49 111.089 179.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 22.0 m -58.08 -47.71 82.35 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.26 -0.427 . . . . 0.36 111.604 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 277' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -50.98 -58.64 5.53 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.385 -0.371 . . . . 0.54 111.7 179.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 61.4 t -64.65 -39.52 85.9 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 N-CA-C 111.816 0.302 . . . . 0.49 111.816 -179.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 279' ' ' LEU . . . . . 0.527 HD21 HG23 ' A' ' 245' ' ' ILE . 51.3 tp -64.59 -47.21 79.49 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 112.582 0.586 . . . . 0.74 112.582 -179.123 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 86.1 t -73.61 -46.78 47.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 N-CA-C 112.826 0.676 . . . . 0.49 112.826 -178.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 39.4 mtm105 -62.01 -43.61 98.48 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 112.533 0.568 . . . . 0.57 112.533 -178.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 282' ' ' THR . . . . . . . . . . . . . 68.6 p -69.16 -15.19 63.35 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 112.111 0.412 . . . . 0.33 112.111 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . 0.51 ' HB3' HD23 ' A' ' 287' ' ' LEU . 0.1 OUTLIER -128.23 36.53 4.28 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 111.723 0.268 . . . . 0.62 111.723 -179.566 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 36.3 ttm180 -53.17 -54.24 38.83 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 112.607 0.595 . . . . 1.07 112.607 -179.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -66.99 -33.96 76.7 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 111.862 0.319 . . . . 0.63 111.862 -178.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 286' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -70.14 -39.75 75.19 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.013 0.435 . . . . 0.72 110.489 179.647 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 287' ' ' LEU . . . . . 0.563 HD13 ' HA2' ' A' ' 292' ' ' GLY . 1.9 mm? -65.99 -46.77 76.8 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 115.878 -0.601 . . . . 0.5 111.587 179.782 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 30.8 m -65.83 -31.6 54.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 C-N-CA 121.003 -0.279 . . . . 0.44 111.41 179.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 26.2 mtmm -72.28 -32.79 66.94 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 112.384 0.513 . . . . 0.97 112.384 179.585 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 290' ' ' GLN . . . . . 0.469 HE21 ' N ' ' A' ' 290' ' ' GLN . 0.0 OUTLIER -101.73 15.45 28.91 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 112.683 0.623 . . . . 0.96 112.683 -179.231 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 291' ' ' ARG . . . . . 0.624 ' HB3' ' HB2' ' A' ' 294' ' ' ASP . 0.0 OUTLIER 59.92 24.13 13.21 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-O 121.174 0.511 . . . . 0.64 112.106 179.734 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 292' ' ' GLY . . . . . 0.563 ' HA2' HD13 ' A' ' 287' ' ' LEU . . . 58.4 -117.87 11.88 Favored Glycine 0 CA--C 1.522 0.494 0 CA-C-N 115.615 -0.721 . . . . 0.32 114.795 179.446 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 293' ' ' TRP . . . . . 0.412 ' O ' HG23 ' A' ' 297' ' ' VAL . 83.9 m95 -67.19 -33.51 75.55 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 112.808 0.67 . . . . 0.49 112.808 -178.368 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 294' ' ' ASP . . . . . 0.624 ' HB2' ' HB3' ' A' ' 291' ' ' ARG . 60.7 m-20 -53.09 -49.76 65.79 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 118.026 0.375 . . . . 0.46 111.098 179.143 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -65.02 -50.43 57.79 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.687 -0.768 . . . . 0.33 111.488 178.522 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 296' ' ' PHE . . . . . 0.529 ' HB2' ' CZ3' ' A' ' 242' ' ' TRP . 0.4 OUTLIER -53.58 -45.0 69.83 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 122.586 0.354 . . . . 0.38 111.766 179.212 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 297' ' ' VAL . . . . . 0.749 HG11 ' HB3' ' A' ' 189' ' ' ARG . 52.0 t -63.4 -53.59 43.54 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 N-CA-C 112.351 0.5 . . . . 0.34 112.351 -178.679 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.74 -26.89 63.57 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.617 -0.433 . . . . 0.45 111.911 -179.255 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 299' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -62.5 -44.16 97.06 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 109.848 -0.427 . . . . 0.51 109.848 177.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 300' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 . . . . . 0 CA--C 1.532 0.278 0 CA-C-O 121.344 0.593 . . . . 0.58 110.841 178.909 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 22' ' ' GLU . . . . . 0.492 ' O ' ' HB2' ' B' ' 26' ' ' GLN . 3.4 mm-40 . . . . . 0 CA--C 1.533 0.325 0 N-CA-C 112.02 0.378 . . . . 0.41 112.02 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 23' ' ' PHE . . . . . 0.603 ' HA ' ' HG2' ' A' ' 212' ' ' MET . 0.8 OUTLIER -68.97 -40.78 78.65 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 120.222 -0.591 . . . . 0.42 110.929 179.166 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 24' ' ' ALA . . . . . 0.686 ' HB1' ' CD2' ' A' ' 233' ' ' HIS . . . -70.5 -39.44 74.14 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.552 0.691 . . . . 0.34 109.767 179.371 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.79 -46.61 78.08 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 114.905 -1.043 . . . . 0.31 109.993 178.231 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 26' ' ' GLN . . . . . 0.492 ' HB2' ' O ' ' B' ' 22' ' ' GLU . 0.8 OUTLIER -58.83 -53.89 53.24 Favored 'General case' 0 C--O 1.224 -0.268 0 CA-C-N 116.159 -0.473 . . . . 0.35 111.323 179.504 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . 0.502 HD11 ' CD2' ' A' ' 251' ' ' PHE . 19.3 mt -54.74 -36.42 64.77 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.641 0.258 . . . . 0.43 110.938 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 28' ' ' ARG . . . . . 0.536 ' HG3' ' HA ' ' A' ' 234' ' ' VAL . 0.2 OUTLIER -70.59 -53.24 16.76 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.539 -0.3 . . . . 0.52 110.204 178.102 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 21.4 mttt -53.28 -47.76 68.89 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.251 0.548 . . . . 0.44 110.614 179.056 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . 0.441 HG12 ' ND1' ' A' ' 205' ' ' HIS . 84.8 mt -64.25 -45.22 96.83 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 CA-C-N 115.331 -0.85 . . . . 0.39 110.603 179.626 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . 0.503 ' HA3' ' HA ' ' A' ' 244' ' ' ARG . . . -57.84 -49.37 75.07 Favored Glycine 0 C--N 1.334 0.419 0 C-N-CA 120.974 -0.631 . . . . 0.29 112.749 179.736 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -62.26 -42.76 99.62 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 121.17 0.51 . . . . 0.41 110.279 179.334 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.69 -57.45 10.97 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.792 -0.64 . . . . 1.15 111.784 179.646 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 71.1 t -54.53 -44.14 67.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 O-C-N 123.308 0.38 . . . . 0.43 111.268 -179.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 35' ' ' TYR . . . . . 0.434 ' N ' ' HA3' ' A' ' 243' ' ' GLY . 0.6 OUTLIER -56.77 -43.48 80.88 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 121.044 0.449 . . . . 0.79 110.477 178.699 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 36' ' ' CYS . . . . . . . . . . . . . 66.0 m -68.95 -40.97 78.62 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.352 -0.385 . . . . 0.39 111.418 179.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 8.4 m -59.13 -40.83 86.68 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 113.091 0.774 . . . . 0.44 113.091 -179.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 38' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -83.6 -36.67 23.74 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 112.42 0.526 . . . . 0.54 112.42 -178.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 65.9 p . . . . . 0 N--CA 1.467 0.402 0 CA-C-O 120.727 0.298 . . . . 0.45 110.762 179.147 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . 0.541 ' HA ' ' HB3' ' A' ' 156' ' ' TYR . 1.0 OUTLIER . . . . . 0 N--CA 1.465 0.301 0 CA-C-O 120.784 0.326 . . . . 0.0 111.189 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -62.78 -43.67 98.18 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.16 178.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 48.4 tp -77.56 -36.5 52.09 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 178.048 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . 0.541 ' HB3' ' HA ' ' A' ' 153' ' ' ASP . 69.7 t80 -58.54 -38.22 77.35 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 115.105 -0.952 . . . . 0.0 111.739 179.575 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 0.539 ' HD2' ' OE2' ' A' ' 161' ' ' GLU . 0.0 OUTLIER -56.46 -53.04 62.12 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.999 0.428 . . . . 0.0 110.352 178.976 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . 0.455 ' HG2' ' HB2' ' A' ' 183' ' ' ALA . 26.9 mt-30 -68.44 -37.46 80.26 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.58 179.166 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 41.4 m -57.83 -50.69 72.43 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.367 179.266 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.516 ' HA ' HG21 ' A' ' 276' ' ' THR . 2.3 tm? -58.69 -47.43 84.56 Favored 'General case' 0 C--O 1.225 -0.232 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.451 178.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . 0.539 ' OE2' ' HD2' ' A' ' 157' ' ' ARG . 30.8 mt-10 -60.52 -51.1 70.89 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 111.949 0.352 . . . . 0.0 111.949 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . 0.517 HG12 ' HA2' ' A' ' 187' ' ' GLY . 46.2 mt -58.87 -51.68 69.37 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 CA-C-O 120.636 0.255 . . . . 0.0 111.145 179.633 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.603 ' O ' ' HG ' ' A' ' 167' ' ' LEU . 89.5 mt -62.04 -48.08 90.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-N 116.646 -0.252 . . . . 0.0 111.414 179.589 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . 0.54 ' O ' ' HB2' ' A' ' 168' ' ' ARG . 1.2 t -57.7 -42.34 83.5 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 120.751 0.31 . . . . 0.0 111.322 179.452 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . 0.445 ' HA ' ' HD3' ' A' ' 165' ' ' ARG . 5.7 tpp180 -72.37 -37.0 68.87 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 121.08 -0.248 . . . . 0.0 111.225 179.758 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' TYR . . . . . 0.829 ' CE1' ' HA ' ' A' ' 195' ' ' ARG . 39.1 t80 -66.27 -52.79 44.01 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.679 -0.237 . . . . 0.0 111.622 179.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.603 ' HG ' ' O ' ' A' ' 163' ' ' ILE . 20.7 mt -61.95 -40.6 96.1 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.712 -0.222 . . . . 0.0 110.789 -179.728 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . 0.54 ' HB2' ' O ' ' A' ' 164' ' ' SER . 0.5 OUTLIER -62.15 -44.44 96.61 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 120.953 0.406 . . . . 0.0 110.506 179.215 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -60.83 -48.11 83.29 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.164 178.613 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 6.8 mm-40 -61.55 -43.49 98.76 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.149 179.126 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.265 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -179.074 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.524 ' O ' ' HA3' ' A' ' 187' ' ' GLY . . . . . . . . 0 CA--C 1.533 0.323 0 CA-C-O 121.092 0.472 . . . . 0.0 111.029 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -79.89 -70.5 1.33 Allowed Glycine 0 CA--C 1.524 0.595 0 C-N-CA 121.069 -0.586 . . . . 0.0 113.961 -179.588 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -63.92 -55.51 22.1 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 111.998 0.37 . . . . 0.0 111.998 -178.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -68.0 -33.68 75.09 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.354 179.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . 0.524 ' HA3' ' O ' ' A' ' 183' ' ' ALA . . . -66.94 -41.62 93.22 Favored Glycine 0 C--O 1.225 -0.429 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.559 178.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 3.9 tpt180 -63.01 -53.9 46.7 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 120.615 0.245 . . . . 0.0 111.279 179.202 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 189' ' ' ARG . . . . . 0.408 HH11 ' HD3' ' A' ' 189' ' ' ARG . 28.0 mtp180 -62.79 -44.04 97.21 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.592 -179.728 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -70.3 -48.77 55.15 Favored 'General case' 0 C--O 1.22 -0.468 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -179.166 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 19.3 tp -60.19 -42.83 95.9 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 118.359 0.527 . . . . 0.0 111.746 -179.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -63.69 -46.02 87.41 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 121.136 0.493 . . . . 0.0 110.934 179.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 34.3 m -68.4 -45.48 72.55 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.889 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . 0.526 HD21 HG21 ' A' ' 249' ' ' ILE . 12.3 tp -59.77 -37.43 79.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.084 -179.636 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . 0.829 ' HA ' ' CE1' ' A' ' 166' ' ' TYR . 11.5 ttp180 -70.8 -53.36 15.65 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.508 179.034 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . 0.4 ' C ' ' HD3' ' A' ' 196' ' ' ARG . 0.0 OUTLIER -59.36 -48.2 82.52 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.888 -179.935 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . 0.62 HG21 ' HB3' ' A' ' 300' ' ' PHE . 73.5 t -70.89 -47.92 59.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.334 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . 0.462 ' O ' ' HG2' ' A' ' 202' ' ' GLN . . . -56.19 -43.51 89.0 Favored Glycine 0 C--N 1.338 0.645 0 N-CA-C 111.371 -0.691 . . . . 0.0 111.371 179.367 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . 0.534 ' HB2' ' O ' ' A' ' 195' ' ' ARG . 0.4 OUTLIER -58.26 -48.5 80.25 Favored 'General case' 0 C--O 1.226 -0.138 0 O-C-N 123.963 0.449 . . . . 0.0 109.83 177.951 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -62.89 -41.17 99.93 Favored Glycine 0 CA--C 1.524 0.597 0 C-N-CA 121.085 -0.579 . . . . 0.0 112.601 179.247 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . 0.716 HG13 HG21 ' B' ' 34' ' ' VAL . 70.3 t -58.06 -51.7 67.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 CA-C-O 120.786 0.327 . . . . 0.0 111.127 179.254 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 202' ' ' GLN . . . . . 0.551 ' HG3' ' CZ ' ' A' ' 203' ' ' ARG . 1.2 pt20 -72.35 -31.68 65.83 Favored 'General case' 0 C--O 1.222 -0.36 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.404 179.745 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 203' ' ' ARG . . . . . 0.551 ' CZ ' ' HG3' ' A' ' 202' ' ' GLN . 0.0 OUTLIER -66.73 -38.97 87.73 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 121.247 0.546 . . . . 0.0 109.793 177.739 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -62.3 -54.21 43.94 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.968 179.17 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 205' ' ' HIS . . . . . 0.52 ' ND1' HG12 ' B' ' 30' ' ' ILE . 31.8 m-70 -101.66 37.79 1.75 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.968 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . 0.403 ' OE1' ' HA ' ' A' ' 203' ' ' ARG . 3.3 tp10 -48.02 -47.73 33.21 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -178.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -61.97 -41.62 98.21 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -73.08 -47.33 45.45 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.901 0.382 . . . . 0.0 111.149 -179.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 209' ' ' PHE . . . . . 0.52 ' CD2' ' HA ' ' A' ' 202' ' ' GLN . 8.5 m-85 -60.62 -45.13 95.2 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.534 178.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 210' ' ' GLN . . . . . 0.685 ' O ' ' HG2' ' A' ' 214' ' ' ARG . 27.8 mt-30 -68.01 -44.0 77.55 Favored 'General case' 0 C--O 1.225 -0.199 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.021 179.216 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -55.29 -50.81 58.05 Favored Glycine 0 C--N 1.335 0.507 0 C-N-CA 120.723 -0.751 . . . . 0.0 111.953 179.343 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 212' ' ' MET . . . . . 0.456 ' HG2' ' HB3' ' B' ' 23' ' ' PHE . 0.8 OUTLIER -64.25 -29.65 70.74 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.672 0.272 . . . . 0.0 110.799 178.623 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.49 HD12 HD22 ' A' ' 216' ' ' LEU . 8.4 tp -73.83 -42.33 61.03 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.488 179.334 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 214' ' ' ARG . . . . . 0.685 ' HG2' ' O ' ' A' ' 210' ' ' GLN . 16.4 mmt85 -61.39 -37.19 82.51 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.184 0.516 . . . . 0.0 109.751 178.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.71 12.52 31.62 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.992 178.624 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . 0.78 ' HG ' HG12 ' A' ' 218' ' ' ILE . 16.2 tp -77.52 103.69 7.6 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 121.127 0.489 . . . . 0.0 110.037 179.027 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -81.71 33.03 0.36 Allowed 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 113.032 0.753 . . . . 0.0 113.032 -178.395 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 218' ' ' ILE . . . . . 0.78 HG12 ' HG ' ' A' ' 216' ' ' LEU . 50.8 mm -81.64 107.41 13.75 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-O 120.728 0.299 . . . . 0.0 110.326 178.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.59 -19.31 0.53 Allowed 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 -178.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -112.63 179.6 3.93 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -179.088 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . 0.549 ' O ' HG22 ' A' ' 224' ' ' VAL . 15.6 tm-20 -68.59 -40.74 80.38 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.775 179.587 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -58.16 -26.43 58.66 Favored Glycine 0 CA--C 1.524 0.607 0 C-N-CA 121.297 -0.478 . . . . 0.0 113.169 179.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 223' ' ' ASP . . . . . 0.566 ' HB3' HD12 ' A' ' 218' ' ' ILE . 40.2 m-20 -59.34 -30.5 68.42 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 112.94 0.719 . . . . 0.0 112.94 -179.586 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.549 HG22 ' O ' ' A' ' 221' ' ' GLU . 11.8 m -62.87 -29.17 46.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 CA-C-O 120.991 0.424 . . . . 0.0 110.828 179.444 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . 0.548 ' O ' ' HG2' ' A' ' 229' ' ' ARG . 23.5 mttp -71.32 -31.75 67.77 Favored 'General case' 0 C--O 1.232 0.15 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 179.027 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 226' ' ' SER . . . . . 0.584 ' O ' HG23 ' A' ' 230' ' ' VAL . 3.8 m -65.22 -44.96 86.61 Favored 'General case' 0 C--N 1.335 -0.062 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 177.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 227' ' ' PHE . . . . . 0.478 ' HE2' HG21 ' A' ' 255' ' ' VAL . 8.7 t80 -61.94 -36.45 81.42 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.822 178.607 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 13.0 t -61.9 -41.38 97.83 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.714 177.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 229' ' ' ARG . . . . . 0.548 ' HG2' ' O ' ' A' ' 225' ' ' LYS . 5.7 mmp_? -70.03 -43.8 70.55 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.439 179.035 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . 0.584 HG23 ' O ' ' A' ' 226' ' ' SER . 60.5 t -58.66 -47.72 87.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 178.523 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 231' ' ' MET . . . . . 0.953 ' HG3' ' HG ' ' A' ' 248' ' ' LEU . 36.5 ttm -53.09 -53.79 45.14 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.41 178.784 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 96.8 t -59.36 -44.85 93.38 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.755 179.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 233' ' ' HIS . . . . . 0.45 ' O ' ' HB2' ' A' ' 236' ' ' LYS . 2.0 t-80 -57.29 -33.95 68.18 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.512 HG23 ' O ' ' A' ' 230' ' ' VAL . 89.1 t -56.31 -32.1 34.44 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 O-C-N 121.917 -0.489 . . . . 0.0 111.623 179.683 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -103.01 25.17 9.71 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.562 -179.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . 0.45 ' HB2' ' O ' ' A' ' 233' ' ' HIS . 0.6 OUTLIER -49.65 -35.79 22.49 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 -178.804 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 237' ' ' ASP . . . . . 0.45 ' HB2' HG12 ' A' ' 239' ' ' VAL . 0.0 OUTLIER -71.88 -16.07 62.12 Favored 'General case' 0 N--CA 1.468 0.447 0 O-C-N 122.153 -0.342 . . . . 0.0 111.466 -179.689 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 98.18 -18.74 56.64 Favored Glycine 0 CA--C 1.52 0.371 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.162 -178.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . 0.45 HG12 ' HB2' ' A' ' 237' ' ' ASP . 4.0 p -79.48 115.55 22.0 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 CA-C-O 121.746 0.784 . . . . 0.0 111.017 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 240' ' ' THR . . . . . 0.5 HG22 HD11 ' A' ' 245' ' ' ILE . 4.2 m -90.14 74.67 7.12 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.738 -179.208 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -65.91 135.0 54.18 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 121.076 -0.249 . . . . 0.0 110.401 178.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 242' ' ' TRP . . . . . 0.547 ' HB3' ' CE2' ' A' ' 300' ' ' PHE . 2.1 m95 -56.09 -37.76 69.8 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.922 0.391 . . . . 0.0 111.147 179.664 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -65.1 -25.33 70.89 Favored Glycine 0 C--N 1.336 0.57 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.713 179.277 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 93.3 mtt180 -75.31 -45.29 40.6 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 178.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . 0.5 HD11 HG22 ' A' ' 240' ' ' THR . 54.0 mt -57.05 -48.35 82.0 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.847 179.333 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 10.5 p -67.23 -33.18 61.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.909 179.121 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 20.6 m -62.28 -38.46 89.45 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 121.065 -0.254 . . . . 0.0 110.458 178.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 248' ' ' LEU . . . . . 0.953 ' HG ' ' HG3' ' A' ' 231' ' ' MET . 1.0 OUTLIER -63.59 -33.51 75.76 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.141 0.496 . . . . 0.0 110.413 178.337 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 249' ' ' ILE . . . . . 0.526 HG21 HD21 ' A' ' 194' ' ' LEU . 33.7 mm -76.84 -40.7 32.03 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.737 178.386 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 23.2 t -59.94 -44.79 94.15 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 178.128 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 251' ' ' PHE . . . . . 0.54 ' O ' HG23 ' A' ' 255' ' ' VAL . 22.7 t80 -66.82 -44.52 80.94 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.251 177.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -54.98 -42.92 82.36 Favored Glycine 0 C--N 1.34 0.754 0 N-CA-C 111.078 -0.809 . . . . 0.0 111.078 177.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 253' ' ' ALA . . . . . 0.603 ' O ' ' HG3' ' A' ' 257' ' ' LYS . . . -61.78 -46.37 89.85 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 115.551 -0.324 . . . . 0.0 110.201 177.294 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 254' ' ' PHE . . . . . 0.414 ' HB3' HD13 ' A' ' 213' ' ' LEU . 0.1 OUTLIER -58.27 -41.6 84.66 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 120.972 0.415 . . . . 0.0 110.289 178.591 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 255' ' ' VAL . . . . . 0.54 HG23 ' O ' ' A' ' 251' ' ' PHE . 64.0 t -62.38 -44.7 99.49 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-N 116.159 -0.473 . . . . 0.0 109.897 177.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -59.38 -42.76 92.41 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-O 121.02 0.438 . . . . 0.0 109.836 177.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 257' ' ' LYS . . . . . 0.603 ' HG3' ' O ' ' A' ' 253' ' ' ALA . 20.0 mtpp -62.06 -39.97 94.18 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.928 177.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 10.9 t60 -66.22 -43.44 86.64 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.367 178.359 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 75.2 mt -65.4 -39.44 92.19 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.466 178.591 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -68.54 -32.0 71.63 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 120.911 0.386 . . . . 0.0 110.008 178.357 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 66.4 m -59.44 -34.23 72.25 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.449 178.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 15.7 m -101.53 15.57 4.99 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.211 179.036 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 56.23 48.15 17.87 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 112.705 0.631 . . . . 0.0 112.705 179.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -118.67 37.71 3.99 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 120.887 0.375 . . . . 0.0 111.414 179.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 265' ' ' GLU . . . . . 0.54 ' HA ' HD12 ' A' ' 268' ' ' ILE . 0.0 OUTLIER -51.9 -26.49 10.33 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 179.843 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 50.6 p -59.88 -25.54 65.15 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 120.674 0.273 . . . . 0.0 111.126 179.064 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -88.91 -20.56 24.4 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 120.93 0.395 . . . . 0.0 110.592 178.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 268' ' ' ILE . . . . . 0.54 HD12 ' HA ' ' A' ' 265' ' ' GLU . 75.9 mt -67.85 -42.72 86.13 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.021 179.468 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 269' ' ' GLU . . . . . 0.778 ' HB3' ' HD3' ' A' ' 270' ' ' PRO . 9.4 tp10 -53.72 -57.08 18.99 Favored Pre-proline 0 CA--C 1.546 0.817 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.649 179.324 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 270' ' ' PRO . . . . . 0.778 ' HD3' ' HB3' ' A' ' 269' ' ' GLU . 24.9 Cg_exo -64.76 -33.81 52.59 Favored 'Trans proline' 0 C--N 1.36 1.184 0 C-N-CA 122.086 1.857 . . . . 0.0 111.878 178.536 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 271' ' ' LEU . . . . . . . . . . . . . 27.1 tp -63.96 -42.0 97.41 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.129 178.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -59.81 -48.89 79.87 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.483 178.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 273' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -63.77 -41.17 98.02 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.409 178.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 274' ' ' THR . . . . . 0.436 HG21 ' HB ' ' A' ' 224' ' ' VAL . 91.1 m -60.21 -48.93 79.64 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.052 178.664 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 96.7 mt -61.9 -50.68 79.16 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.684 178.411 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 276' ' ' THR . . . . . 0.523 HG23 HD12 ' A' ' 163' ' ' ILE . 27.8 m -58.66 -53.9 53.13 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -178.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 277' ' ' ASP . . . . . 0.577 ' O ' ' HB2' ' A' ' 281' ' ' ARG . 2.3 t70 -58.16 -54.02 51.72 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 120.873 -0.331 . . . . 0.0 111.496 -178.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 95.1 t -59.38 -34.8 55.42 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 CA-C-O 120.673 0.273 . . . . 0.0 111.177 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 279' ' ' LEU . . . . . 0.49 HD22 HD11 ' A' ' 249' ' ' ILE . 5.0 tp -65.09 -48.12 74.82 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 111.742 0.275 . . . . 0.0 111.742 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 42.5 t -78.68 -36.59 19.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -179.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 281' ' ' ARG . . . . . 0.577 ' HB2' ' O ' ' A' ' 277' ' ' ASP . 0.1 OUTLIER -65.95 -36.03 82.22 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -179.493 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 282' ' ' THR . . . . . . . . . . . . . 15.4 p -73.39 -52.06 15.14 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 120.885 0.374 . . . . 0.0 111.623 179.456 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . 0.5 ' HB2' HD23 ' A' ' 287' ' ' LEU . 15.2 mttp -88.54 41.85 1.04 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.783 0.325 . . . . 0.0 110.68 179.583 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 28.9 ttm180 -48.05 -63.32 1.1 Allowed 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 -178.294 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -72.02 -31.51 66.26 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 121.028 -0.269 . . . . 0.0 111.625 -178.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 286' ' ' TRP . . . . . . . . . . . . . 2.3 t90 -68.37 -49.02 63.12 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.877 0.37 . . . . 0.0 111.121 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 287' ' ' LEU . . . . . 0.5 HD23 ' HB2' ' A' ' 283' ' ' LYS . 0.7 OUTLIER -63.08 -41.21 99.36 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -179.593 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 29.5 m -70.48 -37.86 71.74 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 C-N-CA 120.514 -0.474 . . . . 0.0 111.826 179.68 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 39.3 mttp -72.91 -32.23 65.18 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -85.46 17.3 3.25 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -179.064 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 291' ' ' ARG . . . . . 0.444 HH11 ' HD2' ' A' ' 291' ' ' ARG . 25.3 mtm105 60.09 18.6 7.87 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 179.553 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 63.16 -137.02 43.11 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 114.687 0.635 . . . . 0.0 114.687 178.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 293' ' ' TRP . . . . . 0.407 ' HA ' ' HB3' ' A' ' 296' ' ' PHE . 72.4 m95 -59.13 -28.39 66.5 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -178.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 294' ' ' ASP . . . . . 0.498 ' O ' ' HG3' ' A' ' 298' ' ' GLU . 0.4 OUTLIER -59.41 -48.35 81.98 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 120.782 0.325 . . . . 0.0 110.24 178.335 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -66.19 -36.48 91.86 Favored Glycine 0 CA--C 1.521 0.458 0 C-N-CA 120.53 -0.843 . . . . 0.0 111.252 178.401 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 296' ' ' PHE . . . . . 0.477 ' HB2' ' CH2' ' A' ' 242' ' ' TRP . 12.2 t80 -58.67 -48.0 82.58 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.51 -0.345 . . . . 0.0 111.015 178.616 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 297' ' ' VAL . . . . . . . . . . . . . 18.4 m -72.33 -22.68 20.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 120.934 -0.306 . . . . 0.0 111.636 -179.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 298' ' ' GLU . . . . . 0.498 ' HG3' ' O ' ' A' ' 294' ' ' ASP . 37.1 mt-10 -65.97 -50.1 65.51 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.206 0.527 . . . . 0.0 110.599 178.336 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 299' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -77.1 -25.02 51.75 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 115.912 -0.585 . . . . 0.0 112.292 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 300' ' ' PHE . . . . . 0.62 ' HB3' HG21 ' A' ' 197' ' ' VAL . 44.7 m-85 . . . . . 0 CA--C 1.54 0.571 0 N-CA-C 115.16 1.541 . . . . 0.0 115.16 -177.54 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 22' ' ' GLU . . . . . 0.404 ' O ' ' HB2' ' B' ' 26' ' ' GLN . 4.8 mm-40 . . . . . 0 CA--C 1.535 0.381 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 23' ' ' PHE . . . . . 0.58 ' HD1' ' N ' ' B' ' 24' ' ' ALA . 0.1 OUTLIER -60.22 -31.88 70.58 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 118.302 0.501 . . . . 0.0 111.886 179.812 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 24' ' ' ALA . . . . . 0.58 ' N ' ' HD1' ' B' ' 23' ' ' PHE . . . -74.7 -48.38 26.31 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.16 0.505 . . . . 0.0 110.625 -179.724 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . 0.498 ' HA ' ' HD3' ' B' ' 28' ' ' ARG . . . -64.71 -37.12 86.49 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.505 178.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 26' ' ' GLN . . . . . 0.412 ' O ' HG13 ' B' ' 30' ' ' ILE . 0.0 OUTLIER -62.92 -48.13 80.25 Favored 'General case' 0 C--O 1.226 -0.134 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.13 178.751 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . 0.574 ' HG ' ' O ' ' B' ' 23' ' ' PHE . 29.8 mt -58.96 -32.45 69.65 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 178.371 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 28' ' ' ARG . . . . . 0.498 ' HD3' ' HA ' ' B' ' 25' ' ' ALA . 56.1 mtp85 -65.43 -54.81 23.14 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 177.432 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . 0.442 ' HG3' ' O ' ' B' ' 25' ' ' ALA . 54.5 mttt -55.67 -46.37 77.57 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.008 178.501 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . 0.52 HG12 ' ND1' ' A' ' 205' ' ' HIS . 97.9 mt -60.76 -52.42 61.77 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.237 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.218 179.76 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -57.03 -43.68 93.14 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 121.301 -0.476 . . . . 0.0 113.097 179.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -68.68 -40.89 79.9 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 120.709 0.29 . . . . 0.0 111.148 179.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.93 -39.97 83.42 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 120.954 0.407 . . . . 0.0 110.077 178.277 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 34' ' ' VAL . . . . . 0.716 HG21 HG13 ' A' ' 201' ' ' VAL . 4.9 t -62.56 -52.62 57.53 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.555 179.809 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -57.35 -40.95 79.14 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 120.943 0.402 . . . . 0.0 110.337 179.236 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 36' ' ' CYS . . . . . . . . . . . . . 42.7 t -68.68 -25.98 65.07 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 120.925 0.393 . . . . 0.0 111.298 179.256 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 59.6 m -78.55 -46.37 19.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.514 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 38' ' ' TRP . . . . . 0.435 ' CD1' HG13 ' B' ' 34' ' ' VAL . 99.2 m95 -75.52 -13.79 60.38 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 -179.132 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 43.7 m . . . . . 0 N--CA 1.472 0.66 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 178.878 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 . . . . . 0 CA--C 1.526 0.058 0 CA-C-O 120.854 0.359 . . . . 0.0 110.65 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.76 -57.19 14.11 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.911 179.234 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.409 HD21 ' HA3' ' A' ' 292' ' ' GLY . 0.2 OUTLIER -62.36 -35.99 80.84 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.03 178.716 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . 0.42 ' HE1' ' HA ' ' A' ' 277' ' ' ASP . 0.1 OUTLIER -68.86 -46.29 68.85 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.69 -0.232 . . . . 0.0 111.447 179.6 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 6.2 mtp180 -62.6 -45.87 90.87 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 121.119 -0.233 . . . . 0.0 111.14 179.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 59.3 mt-30 -58.02 -43.77 86.9 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 121.074 0.464 . . . . 0.0 110.222 178.594 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . 0.489 ' HA ' ' CZ2' ' A' ' 293' ' ' TRP . 51.4 m -61.38 -54.35 44.78 Favored 'General case' 0 C--O 1.223 -0.313 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.788 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.412 HD22 ' HA ' ' A' ' 160' ' ' LEU . 1.2 tm? -58.38 -47.23 84.53 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 120.492 0.187 . . . . 0.0 111.308 179.299 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -60.75 -51.85 67.59 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . 0.501 HG23 HD22 ' A' ' 191' ' ' LEU . 60.5 mt -71.26 -48.66 53.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 -178.429 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.603 ' O ' ' HG ' ' A' ' 167' ' ' LEU . 64.4 mt -58.85 -50.83 78.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 N-CA-C 111.64 0.237 . . . . 0.0 111.64 -179.44 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 39.3 t -61.9 -41.76 98.28 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 120.959 -0.296 . . . . 0.0 110.827 179.558 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . 0.512 ' O ' ' HB2' ' A' ' 169' ' ' GLU . 6.7 tpp85 -61.07 -47.66 85.31 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 111.658 0.244 . . . . 0.0 111.658 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' TYR . . . . . 0.854 ' HE1' ' HA ' ' A' ' 195' ' ' ARG . 87.6 t80 -65.98 -50.97 62.44 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -179.358 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.603 ' HG ' ' O ' ' A' ' 163' ' ' ILE . 40.7 mt -59.11 -45.0 92.03 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 121.127 -0.229 . . . . 0.0 111.477 -178.784 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 3.7 ttt180 -70.26 -42.03 72.69 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 120.959 -0.296 . . . . 0.0 111.637 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . 0.512 ' HB2' ' O ' ' A' ' 165' ' ' ARG . 0.5 OUTLIER -59.6 -46.0 90.24 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.222 0.534 . . . . 0.0 109.645 179.081 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . 0.629 ' HB3' ' HE3' ' A' ' 257' ' ' LYS . 6.9 mm-40 -65.34 -49.75 68.22 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.87 179.058 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.472 ' HA ' ' HG2' ' A' ' 257' ' ' LYS . . . . . . . . 0 N--CA 1.466 0.375 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 -178.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 0.26 0 CA-C-O 120.874 0.369 . . . . 0.0 110.949 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -73.73 -71.15 1.14 Allowed Glycine 0 CA--C 1.524 0.616 0 C-N-CA 120.631 -0.795 . . . . 0.0 113.56 -179.456 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -72.09 -44.82 62.64 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.104 0.478 . . . . 0.0 110.966 179.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -67.9 -26.94 66.24 Favored 'General case' 0 C--O 1.225 -0.204 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.213 179.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . 0.544 ' O ' ' HB2' ' A' ' 191' ' ' LEU . . . -63.82 -53.49 37.46 Favored Glycine 0 C--N 1.332 0.315 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.199 179.64 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . 0.661 ' HE ' ' HG2' ' A' ' 192' ' ' GLU . 1.4 tpm_? -63.33 -44.42 94.95 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 120.902 0.382 . . . . 0.0 110.302 178.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 189' ' ' ARG . . . . . 0.415 HH22 ' CD ' ' A' ' 298' ' ' GLU . 37.0 mtp180 -60.17 -47.41 86.06 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.096 179.618 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . 0.561 ' HA ' HG12 ' A' ' 297' ' ' VAL . . . -72.75 -40.52 65.95 Favored 'General case' 0 C--O 1.22 -0.453 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -179.679 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 191' ' ' LEU . . . . . 0.544 ' HB2' ' O ' ' A' ' 187' ' ' GLY . 0.3 OUTLIER -58.66 -45.78 88.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.798 0.333 . . . . 0.0 110.735 179.885 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 192' ' ' GLU . . . . . 0.661 ' HG2' ' HE ' ' A' ' 188' ' ' ARG . 15.2 mm-40 -76.81 -40.98 46.19 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -179.806 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . 0.649 HG21 ' HA ' ' A' ' 297' ' ' VAL . 80.1 m -65.0 -48.55 73.53 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.813 0.34 . . . . 0.0 110.108 178.847 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . 0.507 HD21 HG21 ' A' ' 249' ' ' ILE . 56.1 tp -64.81 -30.03 71.02 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.292 178.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . 0.854 ' HA ' ' HE1' ' A' ' 166' ' ' TYR . 56.9 ttm-85 -61.5 -49.49 76.56 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.832 0.349 . . . . 0.0 110.385 178.231 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . 0.449 HH11 ' HD2' ' A' ' 196' ' ' ARG . 0.2 OUTLIER -70.99 -55.25 8.71 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.026 -179.688 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . 0.516 HG21 ' HB3' ' A' ' 300' ' ' PHE . 35.5 t -63.29 -47.65 91.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-O 120.997 0.427 . . . . 0.0 111.851 -179.341 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -60.43 -44.9 97.14 Favored Glycine 0 CA--C 1.519 0.302 0 CA-C-N 116.067 -0.515 . . . . 0.0 113.004 -179.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -73.48 -32.44 64.31 Favored 'General case' 0 C--N 1.331 -0.235 0 O-C-N 122.211 -0.582 . . . . 0.0 109.492 179.202 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -56.27 -48.49 74.59 Favored Glycine 0 C--N 1.337 0.621 0 N-CA-C 110.999 -0.841 . . . . 0.0 110.999 177.314 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . 0.48 HG23 ' O ' ' A' ' 197' ' ' VAL . 41.3 t -65.36 -37.68 80.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 CA-C-O 120.883 0.373 . . . . 0.0 110.404 178.108 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 202' ' ' GLN . . . . . 0.456 ' HA ' ' CE2' ' A' ' 209' ' ' PHE . 24.5 mt-30 -61.69 -53.03 61.54 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.935 -0.575 . . . . 0.0 112.041 179.687 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 203' ' ' ARG . . . . . 0.412 HH11 ' HD3' ' A' ' 203' ' ' ARG . 9.2 ptt180 -72.88 -27.75 62.08 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 120.924 -0.31 . . . . 0.0 111.499 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -71.55 -53.59 13.3 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.058 0.456 . . . . 0.0 110.789 179.122 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 205' ' ' HIS . . . . . 0.453 ' HB3' ' HB3' ' A' ' 208' ' ' ALA . 94.2 m-70 -101.19 36.84 1.89 Allowed 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.897 179.5 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 11.0 tm-20 -53.83 -46.38 71.14 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.508 -179.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 49.1 p -64.66 -34.68 78.87 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.151 179.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 208' ' ' ALA . . . . . 0.453 ' HB3' ' HB3' ' A' ' 205' ' ' HIS . . . -69.22 -42.43 75.72 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 178.61 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 209' ' ' PHE . . . . . 0.49 ' O ' ' HG ' ' A' ' 213' ' ' LEU . 13.9 m-85 -70.81 -35.07 72.34 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.236 178.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -66.58 -46.9 74.46 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 177.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -62.26 -39.93 98.35 Favored Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 110.555 -1.018 . . . . 0.0 110.555 177.427 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 212' ' ' MET . . . . . 0.404 ' SD ' ' HA ' ' B' ' 23' ' ' PHE . 5.5 tpp -61.36 -37.0 81.78 Favored 'General case' 0 C--O 1.223 -0.293 0 N-CA-C 110.166 -0.309 . . . . 0.0 110.166 178.109 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.49 ' HG ' ' O ' ' A' ' 209' ' ' PHE . 34.7 mt -60.42 -41.62 94.32 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.043 0.449 . . . . 0.0 110.568 178.366 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 83.7 mtt85 -70.6 -27.02 63.78 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.594 179.584 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 10.1 mmmm -91.58 -11.19 37.95 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 120.89 0.376 . . . . 0.0 111.446 179.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . 0.527 HD21 HD12 ' A' ' 218' ' ' ILE . 16.4 tp -100.11 114.3 27.56 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.38 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -90.16 24.12 2.61 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 120.996 0.427 . . . . 0.0 111.787 -179.487 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 218' ' ' ILE . . . . . 0.527 HD12 HD21 ' A' ' 216' ' ' LEU . 5.7 mt -66.69 122.85 18.49 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-O 121.094 0.473 . . . . 0.0 111.354 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 7.0 ptpp? -154.98 -16.15 0.12 Allowed 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -179.131 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -130.95 -178.95 5.04 Favored 'General case' 0 CA--C 1.536 0.413 0 O-C-N 121.688 -0.633 . . . . 0.0 112.515 -178.523 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . 0.454 ' O ' HG22 ' A' ' 224' ' ' VAL . 3.5 tp10 -61.64 -39.81 92.66 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -179.143 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . 0.405 ' O ' ' HG2' ' A' ' 225' ' ' LYS . . . -55.7 -26.07 45.47 Favored Glycine 0 CA--C 1.524 0.606 0 C-N-CA 121.399 -0.429 . . . . 0.0 113.764 -179.347 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 223' ' ' ASP . . . . . 0.516 ' HB3' HG12 ' A' ' 218' ' ' ILE . 61.4 m-20 -60.13 -28.09 67.6 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 -179.544 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.454 HG22 ' O ' ' A' ' 221' ' ' GLU . 31.5 m -53.69 -31.72 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 N-CA-C 113.221 0.823 . . . . 0.0 113.221 -179.095 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . 0.405 ' HG2' ' O ' ' A' ' 222' ' ' GLY . 10.6 ptpp? -68.06 -33.61 74.88 Favored 'General case' 0 C--O 1.237 0.41 0 O-C-N 121.845 -0.535 . . . . 0.0 110.407 179.516 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 226' ' ' SER . . . . . 0.661 ' O ' HG23 ' A' ' 230' ' ' VAL . 33.3 p -69.63 -47.59 62.86 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.755 179.181 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 227' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -55.87 -37.7 69.15 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.154 0.502 . . . . 0.0 110.069 179.492 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 228' ' ' SER . . . . . 0.42 ' HA ' HG21 ' A' ' 278' ' ' VAL . 39.3 m -59.27 -48.73 80.55 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.488 177.547 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 229' ' ' ARG . . . . . 0.428 ' HA ' ' HD3' ' A' ' 229' ' ' ARG . 13.8 mmt180 -68.26 -34.09 75.56 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.074 179.5 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . 0.661 HG23 ' O ' ' A' ' 226' ' ' SER . 54.4 t -57.13 -54.83 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-O 120.562 0.22 . . . . 0.0 110.632 179.303 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 231' ' ' MET . . . . . 0.587 ' HG2' HD13 ' A' ' 248' ' ' LEU . 72.3 mtm -59.41 -43.35 93.02 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.334 179.374 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 79.7 t -59.07 -44.18 90.86 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-O 120.727 0.299 . . . . 0.0 110.874 178.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 65.7 t-80 -60.07 -38.62 83.41 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 120.826 0.346 . . . . 0.0 111.519 179.217 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.404 HG13 ' HA ' ' B' ' 28' ' ' ARG . 94.2 t -61.85 -39.62 84.14 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 CA-C-O 121.192 0.52 . . . . 0.0 111.056 178.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -99.24 24.42 7.98 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.638 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -62.24 -18.22 60.54 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -179.631 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -83.12 -16.71 45.71 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.772 0.32 . . . . 0.0 111.399 179.558 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 90.98 -10.07 76.06 Favored Glycine 0 CA--C 1.524 0.632 0 C-N-CA 120.701 -0.761 . . . . 0.0 113.747 179.517 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 6.2 p -93.47 118.19 38.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-O 121.571 0.701 . . . . 0.0 111.414 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 83.8 m -94.03 119.77 33.37 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.063 0.459 . . . . 0.0 111.896 -179.448 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -113.67 140.76 47.96 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.162 178.58 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 242' ' ' TRP . . . . . 0.497 ' HA ' ' CE3' ' A' ' 242' ' ' TRP . 1.3 m95 -56.79 -44.94 82.39 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.715 0.293 . . . . 0.0 111.014 179.601 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . 0.438 ' HA2' HG12 ' A' ' 246' ' ' VAL . . . -60.8 -29.53 70.51 Favored Glycine 0 CA--C 1.523 0.541 0 C-N-CA 121.083 -0.58 . . . . 0.0 112.384 178.671 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 244' ' ' ARG . . . . . 0.481 ' HA ' ' HA3' ' B' ' 31' ' ' GLY . 60.5 mtt180 -68.96 -47.25 66.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.112 0.482 . . . . 0.0 109.797 178.675 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . 0.465 ' O ' HG13 ' A' ' 249' ' ' ILE . 68.3 mt -62.59 -48.23 89.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.3 179.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . 0.454 HG21 HG12 ' A' ' 197' ' ' VAL . 8.7 p -65.44 -27.87 42.89 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 C-N-CA 120.849 -0.341 . . . . 0.0 111.143 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 17.5 m -65.74 -41.24 92.4 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.201 0.524 . . . . 0.0 109.718 178.041 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 248' ' ' LEU . . . . . 0.587 HD13 ' HG2' ' A' ' 231' ' ' MET . 55.0 mt -65.72 -38.29 88.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.999 178.226 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 249' ' ' ILE . . . . . 0.507 HG21 HD21 ' A' ' 194' ' ' LEU . 14.9 mt -68.41 -43.05 84.37 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.524 178.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 250' ' ' SER . . . . . 0.453 ' HB2' ' HG3' ' A' ' 202' ' ' GLN . 5.2 p -66.47 -38.26 86.94 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 178.256 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 251' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -62.92 -44.15 96.85 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 176.328 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . 0.403 ' HA2' HG22 ' A' ' 255' ' ' VAL . . . -61.21 -42.68 99.86 Favored Glycine 0 C--N 1.336 0.579 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.359 177.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -62.43 -38.72 90.8 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 120.926 0.393 . . . . 0.0 110.692 178.109 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -66.73 -47.56 71.92 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.256 179.312 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 255' ' ' VAL . . . . . 0.551 ' O ' ' HG ' ' A' ' 259' ' ' LEU . 31.3 m -66.63 -33.77 65.67 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.2 178.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -63.25 -40.3 97.03 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.133 0.492 . . . . 0.0 109.779 177.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 257' ' ' LYS . . . . . 0.629 ' HE3' ' HB3' ' A' ' 170' ' ' GLN . 81.2 mttt -63.72 -39.18 93.67 Favored 'General case' 0 CA--C 1.528 0.1 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.582 177.541 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 66.7 t60 -65.0 -36.43 84.39 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 177.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.551 ' HG ' ' O ' ' A' ' 255' ' ' VAL . 72.9 mt -70.07 -42.48 72.76 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.882 178.146 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 28.1 tptt -64.7 -33.83 76.87 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.672 179.132 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 40.7 t -59.77 -24.42 64.07 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.206 179.004 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 262' ' ' VAL . . . . . 0.569 HG23 ' HG3' ' A' ' 264' ' ' GLN . 16.7 m -117.54 18.16 7.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 CA-C-O 121.264 0.554 . . . . 0.0 110.179 178.607 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 23.3 t30 51.48 47.68 24.37 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 114.96 -1.018 . . . . 0.0 113.066 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 264' ' ' GLN . . . . . 0.569 ' HG3' HG23 ' A' ' 262' ' ' VAL . 11.6 mt-30 -91.36 39.11 0.99 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.707 0.289 . . . . 0.0 111.457 179.049 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 265' ' ' GLU . . . . . 0.501 ' HA ' HD12 ' A' ' 268' ' ' ILE . 15.6 tp10 -47.07 -36.63 8.36 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.906 179.477 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 2.5 m -55.9 -29.17 59.6 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.911 179.424 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 267' ' ' PHE . . . . . 0.426 ' C ' ' HD2' ' A' ' 270' ' ' PRO . 44.1 t80 -95.62 -21.38 18.26 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 120.925 -0.31 . . . . 0.0 111.623 179.819 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 268' ' ' ILE . . . . . 0.501 HD12 ' HA ' ' A' ' 265' ' ' GLU . 70.6 mt -63.77 -37.82 80.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 CA-C-O 121.06 0.457 . . . . 0.0 110.357 179.252 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 269' ' ' GLU . . . . . 0.579 ' HB3' ' HD3' ' A' ' 270' ' ' PRO . 2.1 tp10 -59.56 -58.27 20.69 Favored Pre-proline 0 CA--C 1.551 1.018 0 CA-C-N 115.886 -0.597 . . . . 0.0 112.113 179.236 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 270' ' ' PRO . . . . . 0.579 ' HD3' ' HB3' ' A' ' 269' ' ' GLU . 21.5 Cg_exo -67.82 -25.12 39.62 Favored 'Trans proline' 0 C--N 1.361 1.215 0 C-N-CA 122.314 2.009 . . . . 0.0 113.167 179.616 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 271' ' ' LEU . . . . . . . . . . . . . 42.6 tp -64.45 -46.22 84.09 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.622 -0.263 . . . . 0.0 110.55 179.075 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -61.17 -39.45 90.19 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.073 179.247 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 273' ' ' GLU . . . . . . . . . . . . . 49.9 mm-40 -68.48 -46.28 70.15 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.794 178.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 274' ' ' THR . . . . . . . . . . . . . 84.9 m -58.01 -49.18 77.73 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.94 179.601 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 275' ' ' ILE . . . . . 0.406 ' HA ' ' HE1' ' A' ' 231' ' ' MET . 95.1 mt -59.54 -54.0 40.54 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.115 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.267 178.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 78.6 m -52.5 -53.13 50.04 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.767 -0.651 . . . . 0.0 112.627 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 277' ' ' ASP . . . . . 0.42 ' HA ' ' HE1' ' A' ' 156' ' ' TYR . 38.4 t70 -59.64 -57.98 10.58 Favored 'General case' 0 C--O 1.224 -0.25 0 C-N-CA 120.849 -0.34 . . . . 0.0 111.561 -179.341 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 278' ' ' VAL . . . . . 0.559 ' HB ' ' HE1' ' A' ' 231' ' ' MET . 43.1 t -58.26 -41.34 80.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -179.295 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 19.1 tp -63.13 -47.2 83.77 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 75.7 t -77.73 -46.16 27.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -179.243 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 21.2 ptt180 -59.76 -30.16 68.67 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -179.16 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 282' ' ' THR . . . . . . . . . . . . . 12.0 m -84.71 -22.34 29.78 Favored 'General case' 0 CA--C 1.543 0.673 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . 0.567 ' HB2' ' NZ ' ' A' ' 283' ' ' LYS . 0.0 OUTLIER -139.38 42.03 2.05 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 -178.71 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 11.1 ptm180 -63.8 -47.16 81.98 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -179.21 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -61.8 -41.71 98.1 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.838 0.352 . . . . 0.0 111.207 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 286' ' ' TRP . . . . . 0.566 ' O ' ' HG2' ' A' ' 290' ' ' GLN . 7.7 t90 -64.41 -41.62 96.53 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.803 0.335 . . . . 0.0 110.261 178.74 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -66.46 -51.71 53.89 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 27.2 m -59.78 -32.55 49.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -179.304 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.98 -36.53 75.27 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 120.772 0.32 . . . . 0.0 110.797 179.336 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 290' ' ' GLN . . . . . 0.566 ' HG2' ' O ' ' A' ' 286' ' ' TRP . 40.5 mm-40 -88.83 28.74 1.11 Allowed 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 121.032 -0.267 . . . . 0.0 110.977 179.543 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 46.1 mtp85 59.68 22.33 11.08 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 112.192 0.441 . . . . 0.0 112.192 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 292' ' ' GLY . . . . . 0.409 ' HA3' HD21 ' A' ' 155' ' ' LEU . . . 62.91 -130.62 42.51 Favored Glycine 0 C--O 1.239 0.433 0 CA-C-O 121.485 0.492 . . . . 0.0 113.866 179.512 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 293' ' ' TRP . . . . . 0.5 ' O ' HG13 ' A' ' 297' ' ' VAL . 90.6 m95 -65.12 -26.17 68.08 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.428 -0.386 . . . . 0.0 112.02 -179.294 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 294' ' ' ASP . . . . . 0.414 ' O ' ' HB2' ' A' ' 298' ' ' GLU . 25.5 t70 -64.64 -36.35 83.96 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 121.136 0.493 . . . . 0.0 109.995 178.579 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 295' ' ' GLY . . . . . 0.479 ' HA3' ' O ' ' A' ' 290' ' ' GLN . . . -71.37 -36.96 63.02 Favored Glycine 0 N--CA 1.45 -0.386 0 N-CA-C 110.551 -1.02 . . . . 0.0 110.551 177.598 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 296' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -63.87 -45.84 87.64 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 115.477 -0.362 . . . . 0.0 111.097 178.412 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 297' ' ' VAL . . . . . 0.649 ' HA ' HG21 ' A' ' 193' ' ' THR . 14.0 m -72.31 -28.4 28.8 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 -179.614 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 298' ' ' GLU . . . . . 0.415 ' CD ' HH22 ' A' ' 189' ' ' ARG . 2.3 tp10 -76.76 -49.74 15.22 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.582 0.229 . . . . 0.0 111.275 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 299' ' ' PHE . . . . . 0.402 ' HZ ' ' HB2' ' B' ' 39' ' ' SER . 68.4 t80 -55.15 -48.72 73.33 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 120.879 0.371 . . . . 0.0 111.267 179.642 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 300' ' ' PHE . . . . . 0.516 ' HB3' HG21 ' A' ' 197' ' ' VAL . 54.2 m-85 . . . . . 0 CA--C 1.538 0.497 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 . . . . . 0 C--O 1.236 0.37 0 CA-C-O 121.221 0.534 . . . . 0.0 110.932 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 23' ' ' PHE . . . . . 0.546 ' CE1' HG22 ' A' ' 230' ' ' VAL . 1.5 p90 -63.19 -41.57 99.22 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.478 -179.671 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.75 -36.42 83.83 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.939 0.4 . . . . 0.0 110.756 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.84 -47.37 86.65 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.798 178.241 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -66.01 -45.62 80.85 Favored 'General case' 0 CA--C 1.527 0.081 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.409 178.448 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 80.6 mt -56.75 -39.42 73.94 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.844 0.355 . . . . 0.0 110.378 178.386 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 28' ' ' ARG . . . . . 0.404 ' HA ' HG13 ' A' ' 234' ' ' VAL . 0.7 OUTLIER -62.63 -51.82 65.78 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.67 178.194 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -56.91 -42.01 79.17 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.568 178.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 87.8 mt -65.09 -43.29 95.86 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.433 178.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . 0.481 ' HA3' ' HA ' ' A' ' 244' ' ' ARG . . . -59.17 -50.08 71.63 Favored Glycine 0 C--N 1.335 0.514 0 C-N-CA 121.069 -0.586 . . . . 0.0 112.397 179.273 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -61.31 -44.62 96.91 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.091 0.472 . . . . 0.0 109.808 178.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 33' ' ' LYS . . . . . 0.456 ' HA ' ' HD2' ' B' ' 33' ' ' LYS . 0.2 OUTLIER -59.59 -55.98 27.67 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.787 179.718 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 55.7 t -59.14 -44.96 92.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-O 120.848 0.356 . . . . 0.0 110.974 179.558 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 35' ' ' TYR . . . . . 0.402 ' HB2' ' HA3' ' A' ' 243' ' ' GLY . 9.7 t80 -57.09 -45.96 82.94 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.567 179.145 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 36' ' ' CYS . . . . . . . . . . . . . 73.3 m -65.77 -29.55 70.06 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.405 179.302 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 97.0 m -66.69 -45.39 78.97 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 120.645 0.259 . . . . 0.0 111.217 179.464 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 38' ' ' TRP . . . . . . . . . . . . . 99.3 m95 -75.58 -40.81 56.11 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 120.74 0.305 . . . . 0.0 111.136 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 39' ' ' SER . . . . . 0.402 ' HB2' ' HZ ' ' A' ' 299' ' ' PHE . 41.7 t . . . . . 0 N--CA 1.468 0.451 0 CA-C-O 120.841 0.353 . . . . 0.0 111.66 179.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . 0.589 ' O ' ' HG3' ' A' ' 157' ' ' ARG . 26.5 t70 . . . . . 0 CA--C 1.536 0.419 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . 0.588 ' HA ' ' CZ ' ' A' ' 157' ' ' ARG . 2.9 m-20 -55.6 -47.41 76.55 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -178.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 47.9 tp -66.37 -37.02 84.34 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.139 0.495 . . . . 0.0 110.616 179.283 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 56.7 t80 -68.49 -43.19 77.43 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.389 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 0.589 ' HG3' ' O ' ' A' ' 153' ' ' ASP . 54.4 mtm-85 -56.43 -49.77 73.58 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 27.6 tt0 -64.86 -43.93 91.39 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 120.851 0.358 . . . . 0.0 110.961 -179.596 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . 0.4 ' HA ' ' NE1' ' A' ' 293' ' ' TRP . 20.0 m -63.52 -43.26 97.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.205 179.493 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -64.24 -47.54 79.27 Favored 'General case' 0 C--O 1.221 -0.402 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.43 178.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -54.38 -47.39 72.73 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-O 120.875 0.369 . . . . 0.0 111.461 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . 0.494 HG12 ' HA2' ' A' ' 187' ' ' GLY . 67.8 mt -63.11 -53.21 49.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-N 116.069 -0.514 . . . . 0.0 112.137 -179.783 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.516 HD12 HG23 ' A' ' 276' ' ' THR . 80.3 mt -63.12 -43.99 99.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.908 0.385 . . . . 0.0 110.935 179.725 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 2.5 t -59.16 -46.66 87.8 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.508 179.374 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . 0.546 ' HD2' ' OE2' ' A' ' 169' ' ' GLU . 2.3 mmm180 -57.19 -40.61 77.71 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 120.729 0.299 . . . . 0.0 111.075 179.024 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 70.6 t80 -71.0 -53.76 13.67 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.442 ' HG ' ' O ' ' A' ' 163' ' ' ILE . 38.9 mt -61.03 -43.42 98.92 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -178.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . 0.437 HH11 ' HD3' ' A' ' 168' ' ' ARG . 1.7 mtt-85 -67.79 -46.18 72.69 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -179.201 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . 0.546 ' OE2' ' HD2' ' A' ' 165' ' ' ARG . 17.6 mt-10 -66.3 -39.25 89.21 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 120.89 -0.324 . . . . 0.0 111.808 -179.512 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . 0.511 ' HG3' ' HE3' ' A' ' 257' ' ' LYS . 6.5 tp-100 -70.05 -26.32 63.97 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 121.234 0.54 . . . . 0.0 110.3 178.662 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.523 ' O ' ' HG2' ' A' ' 260' ' ' LYS . . . . . . . . 0 CA--C 1.53 0.199 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.803 179.293 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.601 ' O ' ' HA3' ' A' ' 187' ' ' GLY . . . . . . . . 0 CA--C 1.531 0.227 0 CA-C-O 120.939 0.399 . . . . 0.0 111.499 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -79.97 -71.48 1.26 Allowed Glycine 0 CA--C 1.525 0.705 0 C-N-CA 120.751 -0.737 . . . . 0.0 113.969 -179.681 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -70.56 -57.01 5.2 Favored 'General case' 0 C--O 1.238 0.449 0 O-C-N 122.519 -0.4 . . . . 0.0 111.823 -179.14 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -67.24 -27.75 67.49 Favored 'General case' 0 C--N 1.335 -0.061 0 CA-C-O 121.199 0.523 . . . . 0.0 109.892 179.234 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . 0.601 ' HA3' ' O ' ' A' ' 183' ' ' ALA . . . -72.64 -33.36 60.76 Favored Glycine 0 N--CA 1.447 -0.614 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.861 178.573 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -65.97 -54.51 25.3 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.797 0.332 . . . . 0.0 110.269 178.688 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 189' ' ' ARG . . . . . 0.692 ' HB3' HG11 ' A' ' 297' ' ' VAL . 16.0 mtm180 -55.12 -46.79 75.6 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 121.136 0.493 . . . . 0.0 110.818 179.17 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -71.35 -31.33 67.24 Favored 'General case' 0 C--O 1.221 -0.409 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.474 -179.474 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 191' ' ' LEU . . . . . 0.601 ' HB2' ' O ' ' A' ' 187' ' ' GLY . 0.2 OUTLIER -62.16 -53.59 53.15 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 117.893 0.315 . . . . 0.0 111.08 179.67 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -64.2 -41.41 97.08 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 120.713 0.292 . . . . 0.0 111.214 179.578 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . 0.537 HG21 ' HA ' ' A' ' 297' ' ' VAL . 11.8 m -64.33 -47.76 78.18 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.81 179.109 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 14.9 tp -66.69 -35.28 79.76 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.776 0.322 . . . . 0.0 110.829 179.483 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . 0.429 HH11 ' HD2' ' A' ' 195' ' ' ARG . 9.2 tpp85 -67.73 -57.43 6.36 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.991 179.024 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 16.6 tpp180 -60.96 -50.8 71.91 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -178.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . 0.565 ' O ' HG23 ' A' ' 201' ' ' VAL . 97.1 t -70.1 -47.0 70.54 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -179.225 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -59.73 -48.06 87.9 Favored Glycine 0 CA--C 1.52 0.395 0 C-N-CA 121.359 -0.448 . . . . 0.0 113.229 -179.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . 0.514 ' HA ' ' HG2' ' A' ' 202' ' ' GLN . 98.2 m-20 -65.95 -36.38 83.2 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.828 0.347 . . . . 0.0 110.176 179.253 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -62.05 -37.69 94.86 Favored Glycine 0 CA--C 1.522 0.531 0 C-N-CA 120.708 -0.758 . . . . 0.0 111.97 178.48 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 201' ' ' VAL . . . . . 0.565 HG23 ' O ' ' A' ' 197' ' ' VAL . 93.4 t -67.09 -46.29 84.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 O-C-N 122.844 -0.21 . . . . 0.0 110.968 179.023 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 202' ' ' GLN . . . . . 0.514 ' HG2' ' HA ' ' A' ' 199' ' ' ASP . 8.0 pt20 -68.91 -31.68 70.76 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.443 179.593 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.35 -44.43 45.18 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 120.661 0.267 . . . . 0.0 111.152 179.012 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 27.1 m-80 -68.19 -44.89 74.87 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.844 0.354 . . . . 0.0 111.715 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 205' ' ' HIS . . . . . 0.464 ' HB2' ' CD2' ' A' ' 209' ' ' PHE . 10.2 m80 -100.65 32.82 2.96 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 120.897 0.379 . . . . 0.0 110.32 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -49.62 -51.4 37.87 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 -178.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 28.2 p -57.91 -53.43 58.29 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -179.08 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -61.93 -41.09 97.55 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.029 0.442 . . . . 0.0 110.871 179.45 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 209' ' ' PHE . . . . . 0.464 ' CD2' ' HB2' ' A' ' 205' ' ' HIS . 5.1 m-85 -64.04 -48.61 75.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.55 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -67.96 -33.58 74.93 Favored 'General case' 0 C--O 1.225 -0.189 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.853 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -57.69 -50.1 68.32 Favored Glycine 0 C--N 1.336 0.555 0 C-N-CA 120.52 -0.847 . . . . 0.0 111.217 178.265 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 212' ' ' MET . . . . . 0.721 ' SD ' ' HA ' ' B' ' 23' ' ' PHE . 41.6 mtm -67.84 -33.16 74.23 Favored 'General case' 0 C--O 1.224 -0.275 0 N-CA-C 110.355 -0.239 . . . . 0.0 110.355 178.474 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.781 HD12 HD12 ' A' ' 216' ' ' LEU . 10.0 tp -67.97 -36.51 80.17 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.196 179.293 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 15.8 mtp180 -68.76 -34.39 75.5 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 178.441 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -86.76 -6.95 58.67 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.765 178.113 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . 0.781 HD12 HD12 ' A' ' 213' ' ' LEU . 5.9 mt -68.73 110.26 4.22 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.186 0.517 . . . . 0.0 111.916 -179.293 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -94.66 18.99 10.54 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.764 179.476 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 218' ' ' ILE . . . . . 0.662 HG13 HD22 ' A' ' 216' ' ' LEU . 34.2 mt -59.3 107.63 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 CA-C-O 121.431 0.634 . . . . 0.0 111.619 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 6.2 mtmp? -150.31 -28.68 0.23 Allowed 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 115.111 -0.949 . . . . 0.0 111.752 -179.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -107.59 166.3 10.78 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 121.082 -0.247 . . . . 0.0 111.249 -179.393 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -54.5 -33.3 59.61 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -179.138 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -64.66 -27.76 72.38 Favored Glycine 0 CA--C 1.526 0.768 0 C-N-CA 120.989 -0.624 . . . . 0.0 113.507 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 223' ' ' ASP . . . . . 0.65 ' HB3' HG12 ' A' ' 218' ' ' ILE . 69.2 m-20 -66.94 -38.02 85.37 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 120.911 0.386 . . . . 0.0 111.5 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.442 HG12 HG21 ' A' ' 274' ' ' THR . 1.1 t -63.46 -35.1 71.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-O 121.361 0.601 . . . . 0.0 110.349 179.26 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 36.0 mmtm -65.56 -30.98 71.79 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.585 178.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 226' ' ' SER . . . . . 0.682 ' O ' HG23 ' A' ' 230' ' ' VAL . 30.6 t -71.63 -37.0 70.94 Favored 'General case' 0 C--O 1.223 -0.304 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.65 178.16 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 227' ' ' PHE . . . . . 0.607 ' HE2' HD12 ' A' ' 275' ' ' ILE . 8.8 t80 -57.11 -43.78 82.62 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 178.419 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 228' ' ' SER . . . . . 0.704 ' HB3' HG21 ' A' ' 278' ' ' VAL . 0.6 OUTLIER -70.35 -32.36 70.03 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.914 177.276 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 54.5 ttp180 -64.09 -48.41 76.26 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.113 178.562 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 230' ' ' VAL . . . . . 0.721 HG13 ' HA ' ' B' ' 24' ' ' ALA . 13.6 t -61.12 -43.77 96.96 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 178.174 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 231' ' ' MET . . . . . 0.923 ' HG3' ' HG ' ' A' ' 248' ' ' LEU . 26.3 ttm -55.07 -50.24 69.64 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.245 178.238 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 72.2 t -64.63 -42.16 94.29 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 CA-C-O 120.847 0.356 . . . . 0.0 110.818 178.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 233' ' ' HIS . . . . . 0.44 ' ND1' ' HB1' ' B' ' 24' ' ' ALA . 52.7 t-80 -59.78 -39.51 85.15 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 116.278 -0.419 . . . . 0.0 112.06 179.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.622 HG13 ' HA ' ' B' ' 28' ' ' ARG . 44.2 t -54.99 -43.94 71.62 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 179.7 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -90.95 25.7 2.34 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -179.316 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.11 -18.74 27.15 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 113.729 1.011 . . . . 0.0 113.729 -178.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -85.68 -16.17 39.98 Favored 'General case' 0 C--N 1.327 -0.384 0 O-C-N 122.093 -0.379 . . . . 0.0 111.4 179.737 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 100.28 -18.84 54.89 Favored Glycine 0 CA--C 1.522 0.522 0 C-N-CA 120.752 -0.737 . . . . 0.0 113.613 179.405 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 4.3 p -85.71 118.83 33.09 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-O 121.56 0.695 . . . . 0.0 111.237 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 240' ' ' THR . . . . . 0.568 HG21 ' HG2' ' A' ' 283' ' ' LYS . 53.8 m -89.95 98.26 11.67 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.807 -179.36 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -89.59 131.87 35.39 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.884 -0.326 . . . . 0.0 110.455 178.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 242' ' ' TRP . . . . . 0.483 ' CH2' ' HB2' ' A' ' 296' ' ' PHE . 17.2 m95 -55.74 -36.76 67.61 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 120.995 0.426 . . . . 0.0 110.75 179.165 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . 0.486 ' H ' ' HB2' ' B' ' 35' ' ' TYR . . . -61.56 -32.51 81.55 Favored Glycine 0 C--N 1.333 0.401 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.152 178.335 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 244' ' ' ARG . . . . . 0.53 ' HA ' ' HA3' ' B' ' 31' ' ' GLY . 99.1 mtt180 -72.01 -46.24 57.92 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 178.541 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . 0.624 HG23 HD21 ' A' ' 279' ' ' LEU . 52.2 mt -58.14 -49.25 82.24 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.154 179.022 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . 0.438 HG21 HG12 ' A' ' 197' ' ' VAL . 8.7 p -69.05 -26.2 31.69 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-N 116.623 -0.262 . . . . 0.0 111.133 179.777 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . 0.405 HG21 ' HB ' ' B' ' 30' ' ' ILE . 17.0 m -65.72 -37.28 85.99 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 177.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 248' ' ' LEU . . . . . 0.923 ' HG ' ' HG3' ' A' ' 231' ' ' MET . 2.6 mm? -66.62 -38.72 87.53 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 177.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 18.2 mm -67.63 -41.4 85.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 177.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 29.8 m -62.25 -41.62 98.6 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.79 178.603 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 251' ' ' PHE . . . . . 0.489 ' CD2' HD11 ' B' ' 27' ' ' LEU . 7.6 t80 -68.03 -40.35 82.93 Favored 'General case' 0 N--CA 1.456 -0.142 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 177.218 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -56.81 -42.26 91.65 Favored Glycine 0 C--N 1.337 0.586 0 N-CA-C 111.106 -0.798 . . . . 0.0 111.106 177.655 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -61.39 -44.45 97.13 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-O 120.937 0.399 . . . . 0.0 110.048 177.734 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 254' ' ' PHE . . . . . 0.566 ' HB3' HD13 ' A' ' 213' ' ' LEU . 0.2 OUTLIER -61.17 -41.0 96.0 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.271 178.475 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 255' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 251' ' ' PHE . 91.5 t -62.32 -45.95 97.57 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.225 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 178.096 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 256' ' ' ALA . . . . . 0.507 ' HB1' ' HB2' ' A' ' 171' ' ' ALA . . . -58.82 -39.77 82.17 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 177.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 257' ' ' LYS . . . . . 0.511 ' HE3' ' HG3' ' A' ' 170' ' ' GLN . 74.5 mttt -62.89 -47.41 83.4 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.116 177.577 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 4.2 t60 -59.47 -40.97 88.66 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.428 179.081 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.454 HD13 ' HB3' ' A' ' 267' ' ' PHE . 87.2 mt -68.73 -42.29 77.82 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.406 178.624 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 260' ' ' LYS . . . . . 0.523 ' HG2' ' O ' ' A' ' 171' ' ' ALA . 0.7 OUTLIER -64.98 -34.72 79.11 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 120.847 0.356 . . . . 0.0 110.596 178.667 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 32.0 t -63.06 -25.83 68.56 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.019 179.279 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 262' ' ' VAL . . . . . 0.45 HG23 ' HB2' ' A' ' 264' ' ' GLN . 27.2 m -111.62 13.87 8.49 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.19 178.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 1.6 t30 57.06 50.96 11.11 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.451 179.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 264' ' ' GLN . . . . . 0.472 ' NE2' ' HB2' ' A' ' 267' ' ' PHE . 0.0 OUTLIER -119.03 39.2 3.6 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -179.87 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 265' ' ' GLU . . . . . 0.453 ' HA ' HD12 ' A' ' 268' ' ' ILE . 0.0 OUTLIER -49.63 -27.41 4.59 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 178.933 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.21 -20.67 43.46 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.251 178.641 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 267' ' ' PHE . . . . . 0.472 ' HB2' ' NE2' ' A' ' 264' ' ' GLN . 2.2 t80 -97.67 -20.9 17.33 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.883 178.709 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 268' ' ' ILE . . . . . 0.453 HD12 ' HA ' ' A' ' 265' ' ' GLU . 76.1 mt -65.39 -43.15 94.82 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-O 120.741 0.305 . . . . 0.0 110.373 179.252 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 269' ' ' GLU . . . . . 0.466 ' HB2' ' HD3' ' A' ' 270' ' ' PRO . 0.3 OUTLIER -54.98 -56.98 21.88 Favored Pre-proline 0 CA--C 1.543 0.711 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.794 179.177 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 270' ' ' PRO . . . . . 0.466 ' HD3' ' HB2' ' A' ' 269' ' ' GLU . 38.8 Cg_exo -62.89 -32.66 76.9 Favored 'Trans proline' 0 C--N 1.358 1.043 0 C-N-CA 122.055 1.837 . . . . 0.0 112.37 178.43 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 271' ' ' LEU . . . . . 0.562 ' O ' HG22 ' A' ' 275' ' ' ILE . 2.1 tm? -63.79 -50.62 68.26 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.621 179.445 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -60.33 -42.39 95.54 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.734 179.745 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 273' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -67.2 -43.87 81.04 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 120.945 0.402 . . . . 0.0 110.988 178.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 274' ' ' THR . . . . . 0.442 HG21 HG12 ' A' ' 224' ' ' VAL . 60.6 m -62.22 -52.68 62.8 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.682 -179.497 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 275' ' ' ILE . . . . . 0.607 HD12 ' HE2' ' A' ' 227' ' ' PHE . 6.3 tt -58.28 -47.69 86.89 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 C-N-CA 121.018 -0.273 . . . . 0.0 111.228 179.741 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 276' ' ' THR . . . . . 0.516 HG23 HD12 ' A' ' 163' ' ' ILE . 50.7 m -59.84 -53.73 54.48 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -179.679 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 277' ' ' ASP . . . . . 0.466 ' OD1' ' HD3' ' A' ' 281' ' ' ARG . 33.5 t70 -59.72 -51.16 70.97 Favored 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 120.637 -0.425 . . . . 0.0 111.092 -179.645 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 278' ' ' VAL . . . . . 0.704 HG21 ' HB3' ' A' ' 228' ' ' SER . 73.8 t -58.27 -47.65 86.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 120.747 -0.381 . . . . 0.0 111.02 179.715 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 279' ' ' LEU . . . . . 0.624 HD21 HG23 ' A' ' 245' ' ' ILE . 45.3 tp -60.58 -47.64 85.29 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 111.676 0.25 . . . . 0.0 111.676 179.782 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 55.6 t -66.86 -39.74 84.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 CA-C-O 120.75 0.31 . . . . 0.0 111.008 179.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 281' ' ' ARG . . . . . 0.466 ' HD3' ' OD1' ' A' ' 277' ' ' ASP . 0.0 OUTLIER -68.17 -47.09 68.93 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -179.883 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 282' ' ' THR . . . . . 0.818 HG23 ' HD2' ' A' ' 283' ' ' LYS . 4.7 t -63.37 -44.16 95.56 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 120.435 -0.506 . . . . 0.0 112.216 -179.676 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . 0.818 ' HD2' HG23 ' A' ' 282' ' ' THR . 0.0 OUTLIER -99.46 40.27 1.23 Allowed 'General case' 0 C--N 1.327 -0.392 0 O-C-N 121.987 -0.445 . . . . 0.0 111.463 179.77 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 284' ' ' ARG . . . . . 0.492 HH12 ' HB ' ' A' ' 288' ' ' VAL . 39.6 tpt85 -58.49 -51.12 71.19 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.941 -179.495 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -66.96 -43.59 82.73 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 120.994 0.426 . . . . 0.0 111.462 179.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 286' ' ' TRP . . . . . 0.442 ' O ' ' HB2' ' A' ' 290' ' ' GLN . 3.5 t90 -64.58 -41.37 96.31 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.933 -179.711 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 287' ' ' LEU . . . . . 0.6 HD23 ' HB3' ' A' ' 283' ' ' LYS . 2.0 mm? -69.0 -47.65 64.98 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 112.319 0.488 . . . . 0.0 112.319 -179.751 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 288' ' ' VAL . . . . . 0.492 ' HB ' HH12 ' A' ' 284' ' ' ARG . 7.3 p -60.73 -37.62 76.51 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 CA-C-O 120.634 0.254 . . . . 0.0 111.641 -179.769 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 79.6 mttt -75.3 -21.74 58.23 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 120.891 0.377 . . . . 0.0 111.35 178.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 290' ' ' GLN . . . . . 0.442 ' HB2' ' O ' ' A' ' 286' ' ' TRP . 0.0 OUTLIER -96.34 12.77 30.0 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 111.984 0.365 . . . . 0.0 111.984 179.969 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 291' ' ' ARG . . . . . 0.573 ' HB3' ' HB2' ' A' ' 294' ' ' ASP . 0.0 OUTLIER 62.19 19.09 10.66 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.089 0.471 . . . . 0.0 111.772 179.939 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 64.45 -122.48 25.15 Favored Glycine 0 CA--C 1.522 0.475 0 CA-C-N 115.906 -0.588 . . . . 0.0 113.964 179.207 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 293' ' ' TRP . . . . . 0.509 ' O ' HG23 ' A' ' 297' ' ' VAL . 89.4 m95 -66.57 -33.71 76.27 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.545 -0.328 . . . . 0.0 111.637 -178.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 294' ' ' ASP . . . . . 0.573 ' HB2' ' HB3' ' A' ' 291' ' ' ARG . 45.0 m-20 -54.86 -40.25 69.47 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.017 0.437 . . . . 0.0 110.251 178.354 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -72.18 -44.51 43.82 Favored Glycine 0 C--N 1.334 0.455 0 C-N-CA 120.761 -0.733 . . . . 0.0 111.727 178.394 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 296' ' ' PHE . . . . . 0.483 ' HB2' ' CH2' ' A' ' 242' ' ' TRP . 7.2 t80 -58.92 -45.06 91.29 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 120.852 0.358 . . . . 0.0 111.114 178.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 297' ' ' VAL . . . . . 0.692 HG11 ' HB3' ' A' ' 189' ' ' ARG . 81.0 t -67.57 -39.51 82.49 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.942 -179.529 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -76.15 -26.95 56.8 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 112.578 0.584 . . . . 0.0 112.578 -179.379 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 299' ' ' PHE . . . . . . . . . . . . . 87.4 t80 -60.9 -41.32 95.83 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.807 0.337 . . . . 0.0 111.372 179.446 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 300' ' ' PHE . . . . . 0.447 ' HE2' ' CD1' ' A' ' 296' ' ' PHE . 68.4 m-85 . . . . . 0 CA--C 1.535 0.372 0 CA-C-O 120.706 0.289 . . . . 0.0 111.628 -179.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 22' ' ' GLU . . . . . 0.408 ' HB2' ' NE2' ' B' ' 26' ' ' GLN . 0.5 OUTLIER . . . . . 0 CA--C 1.531 0.244 0 CA-C-O 121.001 0.429 . . . . 0.0 110.265 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 23' ' ' PHE . . . . . 0.721 ' HA ' ' SD ' ' A' ' 212' ' ' MET . 11.1 p90 -60.5 -35.7 76.57 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.498 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 24' ' ' ALA . . . . . 0.721 ' HA ' HG13 ' A' ' 230' ' ' VAL . . . -61.25 -47.79 84.42 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.007 0.432 . . . . 0.0 110.531 179.587 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . 0.431 ' O ' ' HG2' ' B' ' 29' ' ' LYS . . . -70.61 -44.78 66.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.599 179.163 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 26' ' ' GLN . . . . . 0.738 ' O ' HG12 ' B' ' 30' ' ' ILE . 1.7 mp0 -57.74 -56.97 15.11 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.261 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . 0.509 HD12 HG11 ' A' ' 230' ' ' VAL . 50.4 mt -56.31 -42.53 77.74 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 120.589 0.233 . . . . 0.0 111.274 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 28' ' ' ARG . . . . . 0.622 ' HA ' HG13 ' A' ' 234' ' ' VAL . 10.7 ttt85 -57.45 -48.01 80.31 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.523 178.471 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . 0.431 ' HG2' ' O ' ' B' ' 25' ' ' ALA . 20.1 mmmt -68.28 -39.1 82.25 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.872 179.329 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . 0.738 HG12 ' O ' ' B' ' 26' ' ' GLN . 48.8 mm -55.25 -49.95 68.42 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 177.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . 0.53 ' HA3' ' HA ' ' A' ' 244' ' ' ARG . . . -58.84 -44.96 95.64 Favored Glycine 0 N--CA 1.448 -0.559 0 CA-C-N 115.228 -0.897 . . . . 0.0 112.306 179.082 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -57.78 -44.99 86.61 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-O 120.662 0.268 . . . . 0.0 110.955 179.154 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 29.8 tttp -69.73 -52.29 26.74 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 121.017 -0.273 . . . . 0.0 111.171 179.621 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 74.2 t -52.94 -49.3 49.32 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-O 121.075 0.464 . . . . 0.0 110.761 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 35' ' ' TYR . . . . . 0.486 ' HB2' ' H ' ' A' ' 243' ' ' GLY . 1.2 t80 -57.33 -48.59 78.59 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.698 178.831 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 36' ' ' CYS . . . . . . . . . . . . . 36.7 t -65.5 -35.04 79.71 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.501 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 44.7 m -65.21 -37.3 86.85 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.965 -0.562 . . . . 0.0 111.615 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 38' ' ' TRP . . . . . . . . . . . . . 87.7 m95 -85.52 -35.44 21.13 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.243 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 40.9 t . . . . . 0 N--CA 1.462 0.166 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 177.916 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.41 ' N ' ' OD1' ' A' ' 154' ' ' ASP . . . . . . . . 0 N--CA 1.491 2.303 0 CA-C-O 119.999 -0.334 . . . . 1.61 112.54 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -70.38 119.86 6.68 Favored 'Trans proline' 0 CA--C 1.532 0.419 0 C-N-CA 122.523 2.149 . . . . 1.54 112.858 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 83.6 mt -123.63 -38.42 2.53 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.171 -0.468 . . . . 2.18 111.014 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -116.64 -70.6 0.44 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.846 -0.692 . . . . 1.18 112.38 179.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 57.7 p -149.53 -70.92 0.19 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.954 0.407 . . . . 0.84 111.432 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.534 ' OE1' ' HD3' ' A' ' 284' ' ' ARG . 18.1 mp0 -121.06 42.64 3.0 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.084 0.469 . . . . 0.8 110.706 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -59.98 -42.14 93.52 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.914 -0.585 . . . . 1.37 111.987 -179.402 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.41 ' OD1' ' N ' ' A' ' 147' ' ' GLY . 14.7 m-20 -57.95 -41.49 82.93 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.291 -0.413 . . . . 1.16 111.872 179.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 44.5 tp -57.29 -43.26 83.0 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.585 -0.279 . . . . 0.57 111.722 -179.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -66.5 -48.91 68.31 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 112.075 0.398 . . . . 0.34 112.075 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.581 ' HD3' ' OE2' ' A' ' 182' ' ' GLU . 6.6 mtp180 -59.3 -52.08 67.19 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 112.409 0.522 . . . . 0.89 112.409 -179.274 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 35.9 mm-40 -57.46 -45.68 84.5 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.129 0.49 . . . . 0.47 110.719 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 20.3 m -64.18 -48.51 75.68 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.69 -0.686 . . . . 0.25 111.383 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.619 ' HA ' HG21 ' A' ' 276' ' ' THR . 17.3 tp -58.12 -48.59 79.74 Favored 'General case' 0 C--O 1.225 -0.235 0 CA-C-N 116.326 -0.397 . . . . 0.38 111.498 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . 0.662 ' HB3' HD12 ' A' ' 180' ' ' LEU . 2.0 mt-10 -55.96 -50.47 70.69 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 111.781 0.289 . . . . 0.97 111.781 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . 0.529 HG12 ' HA2' ' A' ' 187' ' ' GLY . 57.1 mt -62.56 -50.1 81.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 CA-C-N 116.331 -0.395 . . . . 0.34 111.918 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.531 HD12 HG23 ' A' ' 276' ' ' THR . 77.4 mt -62.86 -47.33 93.33 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 C-N-CA 121.297 -0.161 . . . . 0.39 111.214 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 19.4 m -58.2 -42.01 85.23 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.101 0.477 . . . . 0.33 109.989 178.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . 0.577 ' HG3' ' CD1' ' A' ' 180' ' ' LEU . 1.1 mmp_? -66.75 -48.77 68.09 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.119 -0.491 . . . . 0.39 111.308 178.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' TYR . . . . . 0.836 ' CE1' ' HA ' ' A' ' 195' ' ' ARG . 66.0 t80 -60.39 -51.99 67.15 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 112.9 0.704 . . . . 0.42 112.9 -179.206 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 10.9 mp -62.4 -45.07 94.79 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 120.961 -0.296 . . . . 0.51 111.782 -178.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 1.4 mmt85 -65.06 -40.38 94.63 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 120.551 0.215 . . . . 0.57 111.263 179.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . 0.54 ' HB2' ' O ' ' A' ' 165' ' ' ARG . 0.6 OUTLIER -60.35 -53.99 50.98 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 120.999 0.428 . . . . 0.38 111.499 179.544 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . 0.46 ' HB3' ' CE ' ' A' ' 257' ' ' LYS . 9.0 mm-40 -61.82 -32.44 72.75 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.708 -0.678 . . . . 0.76 112.348 -179.377 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.569 ' O ' ' HG2' ' A' ' 260' ' ' LYS . . . -62.87 -23.46 67.33 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 112.165 0.431 . . . . 0.48 112.165 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 18.6 p -72.28 -24.27 61.32 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 112.019 0.377 . . . . 0.76 112.019 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 92.08 -7.16 78.88 Favored Glycine 0 CA--C 1.523 0.559 0 C-N-CA 120.781 -0.723 . . . . 0.88 112.831 -179.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 12.3 t -112.01 158.49 19.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.04 0.448 . . . . 0.77 111.606 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 2.0 ttpm? -84.84 60.64 6.31 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.218 0.532 . . . . 0.96 111.372 -179.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 40.9 t0 -91.42 169.6 10.65 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.772 -0.649 . . . . 0.71 110.302 179.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 1.9 t -159.42 95.08 1.21 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.419 -0.355 . . . . 0.38 110.429 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . 0.448 ' HB2' ' NE ' ' A' ' 165' ' ' ARG . 51.9 mttp -82.76 149.76 60.87 Favored Pre-proline 0 CA--C 1.534 0.33 0 CA-C-O 120.969 0.414 . . . . 0.58 111.702 -178.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.57 156.2 61.73 Favored 'Trans proline' 0 CA--C 1.533 0.429 0 C-N-CA 122.481 2.121 . . . . 0.7 113.416 -179.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.662 HD12 ' HB3' ' A' ' 161' ' ' GLU . 3.7 mm? -92.64 158.48 15.93 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.483 -0.781 . . . . 0.5 110.344 179.39 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -93.67 -28.9 10.54 Favored Glycine 0 CA--C 1.519 0.315 0 C-N-CA 120.729 -0.748 . . . . 0.61 112.205 179.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . 0.581 ' OE2' ' HD3' ' A' ' 157' ' ' ARG . 14.9 tt0 -124.06 -42.18 2.17 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.137 0.494 . . . . 0.69 110.704 179.329 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.57 ' O ' ' HA3' ' A' ' 187' ' ' GLY . . . -77.25 72.15 3.78 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 121.175 0.512 . . . . 0.34 112.069 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -73.79 -69.48 1.39 Allowed Glycine 0 CA--C 1.523 0.539 0 C-N-CA 120.707 -0.758 . . . . 0.36 112.718 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -68.31 -54.94 14.05 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.654 0.264 . . . . 0.38 111.355 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -66.84 -40.92 88.12 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.382 -0.372 . . . . 0.36 111.247 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . 0.57 ' HA3' ' O ' ' A' ' 183' ' ' ALA . . . -60.39 -47.01 93.24 Favored Glycine 0 C--O 1.222 -0.601 0 C-N-CA 121.0 -0.619 . . . . 0.32 113.848 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 20.2 mtp180 -69.19 -40.79 77.85 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 117.634 0.717 . . . . 1.04 112.012 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 32.6 ttt180 -66.57 -46.1 77.16 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-O 121.364 0.602 . . . . 0.41 110.359 179.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.492 ' HB2' ' HB3' ' A' ' 293' ' ' TRP . . . -74.88 -40.2 61.09 Favored 'General case' 0 C--O 1.221 -0.442 0 CA-C-N 115.621 -0.718 . . . . 0.28 112.598 -179.111 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 29.4 tp -63.76 -41.02 98.06 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 118.517 0.599 . . . . 0.49 111.021 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -64.81 -42.96 94.59 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 121.168 0.508 . . . . 0.42 110.508 179.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . 0.477 HG21 ' HA ' ' A' ' 297' ' ' VAL . 43.4 m -71.7 -45.71 61.01 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.0 -0.546 . . . . 0.28 111.491 179.618 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 0.412 HD21 HG21 ' A' ' 249' ' ' ILE . 24.3 tp -60.37 -31.98 70.86 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.292 -0.413 . . . . 0.32 111.292 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . 0.836 ' HA ' ' CE1' ' A' ' 166' ' ' TYR . 6.3 ttm105 -70.74 -51.2 28.85 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.59 -0.522 . . . . 0.39 109.59 178.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.67 -46.18 91.34 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.507 -0.77 . . . . 0.51 111.624 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . 0.412 ' O ' HG23 ' A' ' 201' ' ' VAL . 94.2 t -72.71 -48.02 47.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.516 -0.311 . . . . 0.35 111.536 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -56.43 -40.82 87.09 Favored Glycine 0 C--N 1.335 0.522 0 CA-C-N 116.335 -0.393 . . . . 0.25 112.818 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -68.32 -47.69 66.89 Favored 'General case' 0 CA--C 1.527 0.076 0 N-CA-C 110.319 -0.252 . . . . 0.39 110.319 178.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -57.75 -42.62 94.52 Favored Glycine 0 CA--C 1.524 0.633 0 C-N-CA 120.942 -0.647 . . . . 0.27 113.006 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . 0.707 HG13 HG21 ' B' ' 34' ' ' VAL . 74.8 t -65.36 -52.0 57.34 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 N-CA-C 112.2 0.444 . . . . 0.3 112.2 179.635 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' GLN . . . . . 0.479 ' HB3' ' HB2' ' A' ' 250' ' ' SER . 10.0 pt20 -71.17 -33.13 69.71 Favored 'General case' 0 C--O 1.222 -0.369 0 N-CA-C 113.043 0.757 . . . . 0.48 113.043 -178.163 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -71.6 -37.53 70.94 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 118.377 0.535 . . . . 0.57 110.9 179.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 9.3 m-80 -66.82 -51.09 59.78 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.893 0.378 . . . . 0.67 110.827 178.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' HIS . . . . . 0.459 ' O ' ' HD2' ' A' ' 209' ' ' PHE . 50.0 m-70 -96.59 32.75 1.96 Allowed 'General case' 0 CA--C 1.537 0.446 0 O-C-N 122.331 -0.231 . . . . 0.42 110.82 179.083 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -55.75 -43.12 76.35 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 112.894 0.701 . . . . 0.48 112.894 -178.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 32.7 p -60.25 -42.2 94.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.131 0.491 . . . . 0.54 111.265 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -68.45 -42.44 78.79 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.863 -0.608 . . . . 0.36 110.253 178.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' PHE . . . . . 0.459 ' HD2' ' O ' ' A' ' 205' ' ' HIS . 18.1 m-85 -62.44 -49.08 76.85 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.034 -0.53 . . . . 0.85 110.424 179.256 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 65.0 mt-30 -61.78 -39.86 93.15 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.178 -0.465 . . . . 0.78 110.907 179.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -58.0 -46.39 92.61 Favored Glycine 0 C--N 1.335 0.503 0 N-CA-C 111.009 -0.837 . . . . 0.34 111.009 178.065 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' MET . . . . . 0.576 ' SD ' ' HA ' ' B' ' 23' ' ' PHE . 76.2 mtm -70.91 -35.69 72.38 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 120.759 0.314 . . . . 0.56 110.695 178.372 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 16.2 tp -60.85 -40.49 93.06 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.043 0.449 . . . . 0.49 110.754 179.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 79.4 mtp180 -77.34 -27.14 52.67 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.115 -0.493 . . . . 0.64 110.557 178.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 7.6 mmtp -75.94 -31.86 59.29 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.86 -0.609 . . . . 0.65 110.837 178.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 26.7 mt -69.08 137.21 53.33 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.047 -0.524 . . . . 0.51 112.397 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -101.78 19.88 17.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.968 -0.56 . . . . 0.49 110.392 178.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' ILE . . . . . 0.534 HG12 ' HB3' ' A' ' 223' ' ' ASP . 16.7 mt -62.73 118.88 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 N-CA-C 113.155 0.798 . . . . 0.37 113.155 -178.348 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . 0.609 ' HG2' HE22 ' A' ' 264' ' ' GLN . 3.3 ttpp -150.41 -16.76 0.24 Allowed 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 115.369 -0.832 . . . . 0.48 112.761 179.132 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -128.85 -178.9 4.8 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 112.872 0.693 . . . . 0.48 112.872 -178.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . 0.48 ' O ' HG22 ' A' ' 224' ' ' VAL . 0.8 OUTLIER -69.13 -22.43 63.96 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.643 -0.708 . . . . 0.5 111.772 -179.702 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -70.6 -26.29 74.33 Favored Glycine 0 CA--C 1.524 0.647 0 C-N-CA 120.834 -0.698 . . . . 0.3 113.313 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' ASP . . . . . 0.534 ' HB3' HG12 ' A' ' 218' ' ' ILE . 59.9 m-20 -65.17 -29.38 70.21 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 113.074 0.768 . . . . 0.39 113.074 -179.107 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.595 ' HB ' HG21 ' A' ' 274' ' ' THR . 6.4 m -53.78 -27.9 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 N-CA-C 112.895 0.702 . . . . 0.41 112.895 -179.313 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . 0.409 ' O ' ' HD3' ' A' ' 229' ' ' ARG . 33.5 mtmm -60.16 -44.15 95.24 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.297 0.57 . . . . 0.54 110.334 178.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 17.6 m -72.3 -39.67 68.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.806 -0.633 . . . . 0.35 110.861 179.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' PHE . . . . . 0.506 ' HE2' HG21 ' A' ' 255' ' ' VAL . 17.1 t80 -60.9 -48.21 82.87 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.212 -0.449 . . . . 0.53 110.785 179.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' SER . . . . . 0.692 ' HB2' HG11 ' A' ' 278' ' ' VAL . 13.7 p -62.73 -39.15 93.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.205 -0.452 . . . . 0.4 110.267 178.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' ARG . . . . . 0.409 ' HD3' ' O ' ' A' ' 225' ' ' LYS . 4.1 mpt_? -64.85 -46.07 83.45 Favored 'General case' 0 C--O 1.227 -0.123 0 CA-C-N 116.103 -0.499 . . . . 0.62 110.541 178.688 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 0.433 HG13 ' HA ' ' B' ' 24' ' ' ALA . 43.0 t -59.2 -44.88 92.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 CA-C-O 120.944 0.402 . . . . 0.44 110.321 178.168 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' MET . . . . . 0.569 ' HG2' HD22 ' A' ' 248' ' ' LEU . 30.4 mtm -57.54 -52.39 65.6 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.155 -0.475 . . . . 0.44 111.621 179.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' VAL . . . . . 0.67 HG12 HG21 ' A' ' 282' ' ' THR . 21.9 m -67.82 -31.84 53.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 C-N-CA 120.9 -0.32 . . . . 0.4 111.091 179.444 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 5.6 t-80 -59.82 -32.07 70.31 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.366 -0.379 . . . . 0.51 111.347 179.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.676 HG21 HD21 ' A' ' 248' ' ' LEU . 78.8 t -58.61 -30.21 41.09 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 CA-C-O 120.79 0.328 . . . . 0.39 111.606 179.105 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' PHE . . . . . 0.477 ' CD1' ' HA ' ' A' ' 240' ' ' THR . 67.9 m-85 -102.58 23.7 11.56 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 111.882 0.327 . . . . 0.53 111.882 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 7.6 tptp -62.81 -24.8 67.94 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 113.062 0.764 . . . . 0.94 113.062 -178.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -81.73 -9.63 59.59 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.863 0.363 . . . . 0.51 111.527 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 93.23 2.55 65.95 Favored Glycine 0 CA--C 1.522 0.518 0 C-N-CA 120.822 -0.704 . . . . 0.58 113.388 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 11.9 t -96.77 95.51 4.74 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-O 120.994 0.426 . . . . 0.39 111.379 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' THR . . . . . 0.477 ' HA ' ' CD1' ' A' ' 235' ' ' PHE . 0.6 OUTLIER -82.8 70.52 9.8 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.827 0.677 . . . . 0.85 112.827 -179.781 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . 0.429 ' HB2' ' HD2' ' A' ' 244' ' ' ARG . 20.6 m-20 -83.89 140.0 32.26 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.916 0.388 . . . . 0.43 111.641 179.448 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 242' ' ' TRP . . . . . . . . . . . . . 54.1 m95 -51.09 -43.46 61.07 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.951 -0.568 . . . . 0.41 112.432 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -54.33 -35.2 55.19 Favored Glycine 0 C--N 1.339 0.708 0 C-N-CA 121.407 -0.425 . . . . 0.23 112.931 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 244' ' ' ARG . . . . . 0.429 ' HD2' ' HB2' ' A' ' 241' ' ' ASN . 24.4 mtt180 -73.99 -43.06 59.35 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.126 0.489 . . . . 0.33 109.769 178.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 48.2 mt -60.32 -50.22 81.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-N 115.709 -0.678 . . . . 0.33 111.101 179.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 31.4 m -65.86 -34.32 69.52 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 C-N-CA 121.03 -0.268 . . . . 0.28 111.497 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 40.3 m -58.06 -40.65 81.53 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.076 0.465 . . . . 0.39 110.015 178.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' LEU . . . . . 0.676 HD21 HG21 ' A' ' 234' ' ' VAL . 80.7 mt -66.12 -32.31 73.69 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.023 -0.535 . . . . 0.43 111.102 178.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 249' ' ' ILE . . . . . 0.412 HG21 HD21 ' A' ' 194' ' ' LEU . 19.3 mt -74.5 -42.62 49.22 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 CA-C-N 116.216 -0.447 . . . . 0.53 109.818 178.261 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 250' ' ' SER . . . . . 0.479 ' HB2' ' HB3' ' A' ' 202' ' ' GLN . 51.3 p -64.89 -30.4 71.4 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 109.502 -0.555 . . . . 0.34 109.502 177.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 251' ' ' PHE . . . . . . . . . . . . . 18.6 t80 -70.52 -43.97 68.53 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 108.584 -0.895 . . . . 0.58 108.584 177.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -59.18 -47.0 92.94 Favored Glycine 0 C--N 1.336 0.531 0 N-CA-C 110.767 -0.933 . . . . 0.27 110.767 177.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 253' ' ' ALA . . . . . 0.433 ' O ' ' HG3' ' A' ' 257' ' ' LYS . . . -59.5 -39.72 84.71 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 120.655 0.264 . . . . 0.33 110.691 177.369 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -61.94 -41.78 98.35 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 121.052 0.453 . . . . 0.59 110.55 178.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 255' ' ' VAL . . . . . 0.506 HG21 ' HE2' ' A' ' 227' ' ' PHE . 59.5 t -72.04 -37.72 61.33 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-N 116.184 -0.462 . . . . 0.36 110.025 178.414 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -56.69 -42.88 79.87 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.028 0.442 . . . . 0.28 109.907 177.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 257' ' ' LYS . . . . . 0.46 ' CE ' ' HB3' ' A' ' 170' ' ' GLN . 93.0 mttt -64.7 -42.94 94.93 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 115.846 -0.616 . . . . 0.66 110.117 177.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 40.3 t60 -59.19 -42.79 91.72 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.292 -0.413 . . . . 0.66 110.66 178.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 95.7 mt -69.86 -42.62 73.3 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 116.392 -0.367 . . . . 0.54 111.149 179.122 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 260' ' ' LYS . . . . . 0.569 ' HG2' ' O ' ' A' ' 171' ' ' ALA . 2.1 tptp -64.94 -35.95 82.81 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.705 0.288 . . . . 0.56 111.311 179.239 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 63.0 m -59.69 -28.96 67.75 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.262 -0.427 . . . . 0.51 111.301 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 24.2 m -107.32 16.27 7.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-N 116.382 -0.372 . . . . 0.55 111.071 178.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 55.61 52.47 11.0 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 112.769 0.655 . . . . 0.98 112.769 179.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 264' ' ' GLN . . . . . 0.609 HE22 ' HG2' ' A' ' 219' ' ' LYS . 7.3 mt-30 -117.98 37.74 3.88 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 120.769 0.318 . . . . 0.56 111.462 179.413 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . 0.497 ' HA ' HD12 ' A' ' 268' ' ' ILE . 1.2 mp0 -48.06 -31.75 5.87 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 112.716 0.636 . . . . 0.59 112.716 179.39 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -55.57 -22.42 21.84 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 122.847 0.459 . . . . 0.95 111.974 179.276 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 267' ' ' PHE . . . . . 0.402 ' C ' ' HD2' ' A' ' 270' ' ' PRO . 95.3 m-85 -100.43 -17.89 16.97 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 120.79 0.328 . . . . 0.48 110.986 178.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 268' ' ' ILE . . . . . 0.497 HD12 ' HA ' ' A' ' 265' ' ' GLU . 66.5 mt -67.77 -45.71 83.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-N 116.416 -0.356 . . . . 0.39 111.107 179.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 269' ' ' GLU . . . . . 0.643 ' HB2' ' HD3' ' A' ' 270' ' ' PRO . 0.5 OUTLIER -55.74 -56.58 28.41 Favored Pre-proline 0 CA--C 1.545 0.774 0 CA-C-N 116.296 -0.411 . . . . 0.37 111.21 179.332 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 270' ' ' PRO . . . . . 0.643 ' HD3' ' HB2' ' A' ' 269' ' ' GLU . 31.2 Cg_exo -61.33 -32.19 89.45 Favored 'Trans proline' 0 C--N 1.361 1.213 0 C-N-CA 122.23 1.953 . . . . 0.27 112.101 178.428 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 271' ' ' LEU . . . . . 0.414 ' O ' HG13 ' A' ' 275' ' ' ILE . 46.8 tp -66.62 -54.76 19.88 Favored 'General case' 0 C--O 1.226 -0.135 0 CA-C-N 116.406 -0.361 . . . . 0.44 110.14 178.682 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -56.98 -37.82 72.16 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 120.852 0.358 . . . . 0.29 110.628 178.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 273' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -64.26 -51.48 63.39 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.028 -0.533 . . . . 0.49 110.134 178.04 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 274' ' ' THR . . . . . 0.595 HG21 ' HB ' ' A' ' 224' ' ' VAL . 31.1 m -59.82 -42.67 94.04 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.292 -0.413 . . . . 0.3 110.595 179.173 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 275' ' ' ILE . . . . . 0.459 HG12 ' CE1' ' A' ' 227' ' ' PHE . 96.5 mt -57.98 -54.3 33.89 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.105 0 CA-C-N 116.165 -0.471 . . . . 0.35 110.603 179.15 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 276' ' ' THR . . . . . 0.619 HG21 ' HA ' ' A' ' 160' ' ' LEU . 32.5 m -60.71 -49.88 75.71 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.253 -0.43 . . . . 0.3 111.441 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 277' ' ' ASP . . . . . 0.595 ' O ' ' HB2' ' A' ' 281' ' ' ARG . 17.0 t0 -56.28 -61.04 2.67 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.946 -0.57 . . . . 0.4 112.104 -179.425 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 278' ' ' VAL . . . . . 0.692 HG11 ' HB2' ' A' ' 228' ' ' SER . 66.4 t -61.25 -46.24 97.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 112.304 0.483 . . . . 0.39 112.304 -178.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . 0.45 HD12 ' HZ1' ' A' ' 283' ' ' LYS . 14.0 tp -54.7 -47.58 73.52 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 111.635 0.235 . . . . 0.75 111.635 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 84.0 t -77.38 -41.05 29.66 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 N-CA-C 111.803 0.297 . . . . 0.39 111.803 -179.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 281' ' ' ARG . . . . . 0.595 ' HB2' ' O ' ' A' ' 277' ' ' ASP . 2.5 ttt180 -53.7 -42.73 68.31 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 112.616 0.598 . . . . 0.85 112.616 -179.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 282' ' ' THR . . . . . 0.67 HG21 HG12 ' A' ' 232' ' ' VAL . 15.2 t -84.41 0.39 49.64 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 112.843 0.683 . . . . 0.37 112.843 -179.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . 0.49 ' HG3' HG23 ' A' ' 282' ' ' THR . 34.6 mtmm -141.02 40.76 1.8 Allowed 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 120.877 0.37 . . . . 0.38 111.546 -179.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 284' ' ' ARG . . . . . 0.534 ' HD3' ' OE1' ' A' ' 152' ' ' GLU . 13.2 ttm180 -63.21 -60.65 3.13 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 112.714 0.635 . . . . 0.64 112.714 -178.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 285' ' ' ASP . . . . . 0.44 ' HA ' HG12 ' A' ' 288' ' ' VAL . 35.8 t70 -58.71 -45.48 89.47 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.366 -0.379 . . . . 0.51 111.895 -179.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 286' ' ' TRP . . . . . . . . . . . . . 4.1 t90 -59.62 -44.95 93.27 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 120.571 0.224 . . . . 0.49 111.25 -179.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -68.84 -44.52 73.25 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 112.072 0.397 . . . . 0.47 112.072 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 288' ' ' VAL . . . . . 0.44 HG12 ' HA ' ' A' ' 285' ' ' ASP . 6.2 p -66.2 -34.5 70.63 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 O-C-N 122.207 -0.308 . . . . 0.52 111.645 -179.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 31.9 mttp -76.31 -26.87 56.26 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-O 120.766 0.317 . . . . 0.78 111.398 179.017 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 1.7 tp-100 -91.04 24.95 2.61 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 112.563 0.579 . . . . 0.97 112.563 -179.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 53.6 mtp180 62.99 12.65 6.05 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 112.505 0.557 . . . . 0.43 112.505 179.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 64.64 -131.86 37.67 Favored Glycine 0 CA--C 1.522 0.487 0 C-N-CA 121.235 -0.507 . . . . 0.33 113.241 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 293' ' ' TRP . . . . . 0.492 ' HB3' ' HB2' ' A' ' 190' ' ' ALA . 86.3 m95 -67.67 -21.21 65.36 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 111.903 0.334 . . . . 0.48 111.903 -179.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 294' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -62.85 -48.54 78.62 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 121.175 0.512 . . . . 0.47 110.098 177.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -69.78 -33.62 71.2 Favored Glycine 0 C--N 1.332 0.329 0 C-N-CA 120.657 -0.783 . . . . 0.32 111.614 178.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 296' ' ' PHE . . . . . 0.446 ' HB3' ' HA ' ' A' ' 293' ' ' TRP . 1.6 t80 -60.52 -50.94 71.53 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.674 -0.263 . . . . 0.29 111.615 179.108 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 297' ' ' VAL . . . . . 0.477 ' HA ' HG21 ' A' ' 193' ' ' THR . 28.8 m -63.94 -43.25 97.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 N-CA-C 111.836 0.31 . . . . 0.27 111.836 -178.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -58.64 -41.67 86.53 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 112.197 0.443 . . . . 0.42 112.197 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 299' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -58.69 -45.46 89.43 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 120.907 0.385 . . . . 0.41 111.875 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 300' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -83.98 3.2 35.33 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 112.556 0.576 . . . . 0.47 112.556 -179.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 301' ' ' HIS . . . . . 0.588 ' HB3' ' HG2' ' A' ' 306' ' ' GLU . 27.8 m170 -109.71 11.38 24.55 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.514 0.197 . . . . 0.45 111.154 179.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . 0.609 ' HA ' ' HA3' ' A' ' 307' ' ' GLY . 31.4 m -75.22 -10.78 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 N-CA-C 112.027 0.38 . . . . 1.18 112.027 -179.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 -61.9 -63.12 1.36 Allowed 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.377 -0.374 . . . . 1.65 110.554 179.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 22.4 t0 -170.83 61.47 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.477 0.656 . . . . 2.0 110.88 178.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 61.2 mt -141.53 -57.85 0.48 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.524 -0.762 . . . . 1.76 110.615 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 306' ' ' GLU . . . . . 0.588 ' HG2' ' HB3' ' A' ' 301' ' ' HIS . 8.4 pt-20 -151.26 46.02 0.82 Allowed 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 121.428 0.633 . . . . 0.83 110.708 179.302 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 307' ' ' GLY . . . . . 0.609 ' HA3' ' HA ' ' A' ' 302' ' ' VAL . . . -126.06 131.65 7.56 Favored Glycine 0 CA--C 1.521 0.463 0 C-N-CA 120.884 -0.674 . . . . 1.67 112.696 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.309 0 CA-C-O 118.41 -1.217 . . . . 3.86 112.77 -179.92 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.484 0 CA-C-O 120.56 0.219 . . . . 1.37 111.565 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -171.07 155.99 4.64 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.563 -0.29 . . . . 0.92 110.444 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 19' ' ' LEU . . . . . 0.663 HD13 ' HE2' ' B' ' 23' ' ' PHE . 0.1 OUTLIER -109.7 91.87 11.27 Favored Pre-proline 0 CA--C 1.533 0.291 0 N-CA-C 112.26 0.467 . . . . 0.6 112.26 -179.51 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -76.63 115.73 4.13 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.108 1.872 . . . . 0.52 109.137 176.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 21' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -63.94 45.21 0.12 Allowed 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 122.881 2.387 . . . . 0.72 115.934 -176.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -89.83 -27.13 20.15 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.477 -0.564 . . . . 0.77 109.477 177.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 23' ' ' PHE . . . . . 0.663 ' HE2' HD13 ' B' ' 19' ' ' LEU . 0.4 OUTLIER -61.9 -41.41 97.86 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.322 0.582 . . . . 0.4 109.848 179.019 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 24' ' ' ALA . . . . . 0.512 ' O ' ' HB2' ' B' ' 28' ' ' ARG . . . -59.09 -43.83 91.85 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.249 -0.887 . . . . 0.42 111.126 179.425 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -72.42 -46.8 53.47 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 116.191 -0.459 . . . . 0.37 110.751 179.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -58.01 -54.31 48.42 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 115.96 -0.564 . . . . 0.39 110.778 179.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 98.8 mt -59.34 -37.86 78.91 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.596 -0.275 . . . . 0.4 110.863 179.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 28' ' ' ARG . . . . . 0.561 ' HA ' HG13 ' A' ' 234' ' ' VAL . 0.9 OUTLIER -61.32 -52.72 63.52 Favored 'General case' 0 CA--C 1.528 0.106 0 N-CA-C 109.9 -0.407 . . . . 0.46 109.9 178.736 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -59.82 -43.24 94.62 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.372 -0.377 . . . . 0.51 110.654 178.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 96.1 mt -58.75 -49.31 83.21 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 CA-C-N 116.345 -0.389 . . . . 0.41 110.172 178.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -55.32 -45.38 83.39 Favored Glycine 0 CA--C 1.52 0.404 0 CA-C-N 116.306 -0.407 . . . . 0.25 112.931 179.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -59.19 -49.61 77.19 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 121.087 0.47 . . . . 0.36 110.68 179.143 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 5.4 ttmm -64.01 -45.59 88.28 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 115.927 -0.578 . . . . 1.22 110.847 179.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 34' ' ' VAL . . . . . 0.707 HG21 HG13 ' A' ' 201' ' ' VAL . 5.3 t -58.56 -49.68 81.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 CA-C-O 120.958 0.409 . . . . 0.33 110.659 179.127 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -57.95 -43.65 86.51 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.971 -0.559 . . . . 0.65 110.601 178.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 36' ' ' CYS . . . . . . . . . . . . . 74.3 m -68.22 -25.93 65.46 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 120.942 0.401 . . . . 0.36 111.175 179.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 45.8 m -80.13 -35.47 36.65 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 116.115 -0.493 . . . . 0.33 111.953 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 38' ' ' TRP . . . . . . . . . . . . . 85.0 m95 -84.83 -30.47 24.5 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.039 0.385 . . . . 0.54 112.039 -179.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 16.9 p -70.19 -35.87 74.23 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 120.767 0.318 . . . . 0.41 110.673 179.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -90.72 115.1 63.47 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.384 -0.371 . . . . 0.46 111.222 178.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -80.87 171.17 14.6 Favored 'Trans proline' 0 CA--C 1.533 0.426 0 C-N-CA 122.566 2.177 . . . . 0.75 112.692 179.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.55 63.77 0.84 Allowed 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 121.048 0.452 . . . . 0.97 111.654 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 43' ' ' MET . . . . . . . . . . . . . 26.8 ttt . . . . . 0 C--O 1.251 1.151 0 CA-C-O 118.199 -0.905 . . . . 2.03 111.224 179.835 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.468 0 CA-C-O 119.776 -0.458 . . . . 4.5 112.242 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.37 -18.97 29.46 Favored 'Trans proline' 0 CA--C 1.535 0.557 0 C-N-CA 122.442 2.095 . . . . 3.99 113.514 -179.299 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 96.0 mt -119.0 80.41 1.54 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.841 0.353 . . . . 4.8 111.664 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 179.7 -94.64 0.1 OUTLIER Glycine 0 C--N 1.333 0.375 0 C-N-CA 120.612 -0.804 . . . . 2.27 112.479 179.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 68.3 p -84.44 96.26 9.04 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.674 -0.491 . . . . 1.24 109.674 178.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 9.2 mp0 -33.16 103.07 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.898 0 O-C-N 124.164 0.915 . . . . 0.69 113.34 -179.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . 0.578 ' HA ' ' HB3' ' A' ' 156' ' ' TYR . 2.6 m-20 -55.55 -37.67 68.3 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 113.73 1.011 . . . . 0.74 113.73 -178.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.474 ' HA ' ' HE ' ' A' ' 157' ' ' ARG . 11.2 t0 -52.58 -44.47 65.93 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 120.973 0.416 . . . . 0.49 111.27 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 44.4 tp -85.26 -33.36 22.19 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.142 0.496 . . . . 0.66 110.22 178.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . 0.578 ' HB3' ' HA ' ' A' ' 153' ' ' ASP . 55.6 t80 -61.21 -45.73 93.37 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 115.637 -0.71 . . . . 0.45 112.336 -179.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.637 ' HD2' ' OE1' ' A' ' 182' ' ' GLU . 20.4 ptt85 -59.4 -44.37 92.81 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 120.785 0.326 . . . . 0.5 110.993 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 10.3 mt-30 -65.17 -44.19 89.3 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-O 120.86 0.362 . . . . 0.53 110.223 178.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . 0.531 ' HA ' ' CZ2' ' A' ' 293' ' ' TRP . 17.0 m -61.63 -49.43 76.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.965 -0.562 . . . . 0.38 111.129 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.599 HD21 ' HA ' ' A' ' 273' ' ' GLU . 0.2 OUTLIER -59.47 -44.12 93.09 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.349 -0.387 . . . . 0.7 110.879 179.375 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . 0.493 ' HG2' HD23 ' A' ' 180' ' ' LEU . 21.4 tt0 -66.9 -53.59 30.54 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 112.037 0.384 . . . . 0.45 112.037 -179.496 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 79.4 mt -61.22 -51.09 77.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 N-CA-C 112.28 0.474 . . . . 0.34 112.28 -179.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.42 HG23 HD13 ' A' ' 167' ' ' LEU . 59.2 mt -60.27 -51.42 73.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 N-CA-C 112.297 0.48 . . . . 0.4 112.297 -178.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 90.6 p -57.7 -35.84 71.18 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.575 0.226 . . . . 0.8 111.227 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . 0.411 HH11 ' HD2' ' A' ' 165' ' ' ARG . 0.0 OUTLIER -72.28 -51.1 22.41 Favored 'General case' 0 C--O 1.226 -0.157 0 C-N-CA 120.954 -0.298 . . . . 1.51 111.096 179.091 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' TYR . . . . . 0.798 ' HE1' ' HA ' ' A' ' 195' ' ' ARG . 60.1 t80 -59.7 -46.12 90.05 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 120.648 0.261 . . . . 0.39 111.244 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.42 HD13 HG23 ' A' ' 163' ' ' ILE . 5.2 mp -60.63 -45.47 93.94 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 116.354 -0.385 . . . . 0.37 111.175 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 12.2 ttm105 -71.99 -34.68 69.11 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 121.021 -0.272 . . . . 0.5 110.907 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -63.74 -52.63 59.6 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 120.752 0.31 . . . . 0.72 110.354 178.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . 0.406 ' O ' ' HE2' ' A' ' 257' ' ' LYS . 6.6 mm-40 -65.56 -26.51 67.9 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.902 0.382 . . . . 1.14 111.508 179.267 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -79.82 -23.98 41.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.375 -0.375 . . . . 0.35 111.955 179.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 19.1 p -102.09 -37.58 8.1 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.59 0.589 . . . . 0.5 112.59 -179.006 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 78.94 28.73 53.8 Favored Glycine 0 CA--C 1.521 0.45 0 C-N-CA 120.714 -0.755 . . . . 0.45 112.203 -179.086 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 23.0 t -112.45 175.06 5.59 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.43 0.634 . . . . 0.7 112.007 -179.058 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 24.0 pttt -88.2 75.46 8.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.737 -0.665 . . . . 1.32 110.496 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 39.8 t0 -65.16 156.44 31.69 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.78 -0.646 . . . . 1.08 111.734 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 14.8 m -58.57 118.25 5.43 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.238 -0.892 . . . . 0.98 111.236 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . 0.464 ' HB2' ' HD3' ' A' ' 179' ' ' PRO . 10.5 mmtm -75.89 -47.66 3.78 Favored Pre-proline 0 CA--C 1.542 0.646 0 N-CA-C 112.929 0.715 . . . . 0.56 112.929 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . 0.464 ' HD3' ' HB2' ' A' ' 178' ' ' LYS . 11.7 Cg_exo -72.12 100.52 1.11 Allowed 'Trans proline' 0 C--N 1.355 0.915 0 C-N-CA 121.773 1.649 . . . . 1.05 112.324 178.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.493 HD23 ' HG2' ' A' ' 161' ' ' GLU . 4.4 mp -76.17 -178.44 4.48 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 116.318 -0.401 . . . . 0.49 111.326 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -104.34 -54.61 0.79 Allowed Glycine 0 C--N 1.332 0.323 0 C-N-CA 120.622 -0.799 . . . . 0.41 112.565 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . 0.637 ' OE1' ' HD2' ' A' ' 157' ' ' ARG . 81.6 mm-40 -76.32 -53.24 8.48 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.234 0.54 . . . . 0.74 110.723 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.452 ' O ' ' HA3' ' A' ' 187' ' ' GLY . . . -100.13 87.91 3.59 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.961 -0.563 . . . . 0.41 111.05 179.444 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -78.7 -71.73 1.22 Allowed Glycine 0 CA--C 1.522 0.512 0 C-N-CA 120.118 -1.039 . . . . 0.51 112.887 -179.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -72.1 -48.49 43.56 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 120.96 0.409 . . . . 0.53 110.731 179.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -65.11 -34.42 78.36 Favored 'General case' 0 C--O 1.224 -0.237 0 CA-C-N 115.889 -0.596 . . . . 0.4 110.27 178.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . 0.452 ' HA3' ' O ' ' A' ' 183' ' ' ALA . . . -65.71 -40.9 96.02 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.67 -0.776 . . . . 0.37 111.66 178.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . 0.421 HH11 ' HD2' ' A' ' 188' ' ' ARG . 11.2 mmt180 -63.98 -54.29 36.76 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.753 0.311 . . . . 1.48 110.962 179.123 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 3.0 ttp180 -60.24 -42.85 96.15 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 115.882 -0.599 . . . . 2.07 110.942 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.541 ' HA ' ' CG1' ' A' ' 297' ' ' VAL . . . -64.26 -46.32 84.26 Favored 'General case' 0 C--O 1.222 -0.391 0 CA-C-N 116.391 -0.368 . . . . 0.33 110.681 179.055 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 15.7 tp -61.38 -37.36 83.1 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.722 0.296 . . . . 0.88 110.779 179.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . 0.615 ' OE2' ' HD3' ' A' ' 196' ' ' ARG . 4.0 tm-20 -63.01 -53.2 57.69 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 121.402 0.62 . . . . 1.04 110.84 178.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . 0.503 HG21 ' HA ' ' A' ' 297' ' ' VAL . 98.0 m -70.21 -41.24 73.91 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.475 -0.784 . . . . 0.35 111.699 -178.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 0.487 HD11 HG21 ' A' ' 249' ' ' ILE . 11.3 tp -61.24 -42.39 98.53 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.281 -0.418 . . . . 0.37 111.433 179.531 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . 0.798 ' HA ' ' HE1' ' A' ' 166' ' ' TYR . 13.0 ttm-85 -65.6 -41.17 93.06 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 121.189 0.518 . . . . 0.94 109.867 178.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . 0.615 ' HD3' ' OE2' ' A' ' 192' ' ' GLU . 8.1 mtp-105 -63.32 -57.0 11.82 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.708 -0.678 . . . . 0.34 111.592 179.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 58.2 t -68.59 -40.13 81.43 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-N 116.397 -0.365 . . . . 0.33 111.962 -179.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . 0.544 ' HA3' ' OH ' ' A' ' 166' ' ' TYR . . . -59.15 -47.15 92.18 Favored Glycine 0 C--N 1.33 0.244 0 C-N-CA 121.475 -0.393 . . . . 0.25 112.751 -179.52 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -75.66 -26.35 57.6 Favored 'General case' 0 C--O 1.223 -0.316 0 N-CA-C 110.026 -0.361 . . . . 0.43 110.026 178.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -63.13 -47.02 91.86 Favored Glycine 0 C--N 1.336 0.568 0 N-CA-C 110.929 -0.868 . . . . 0.25 110.929 177.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 61.0 t -69.18 -39.57 79.45 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-O 121.017 0.437 . . . . 0.3 110.021 177.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -67.08 -41.48 86.26 Favored 'General case' 0 C--O 1.219 -0.504 0 CA-C-N 115.71 -0.677 . . . . 0.66 112.024 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' ARG . . . . . 0.4 ' CZ ' ' HA ' ' A' ' 203' ' ' ARG . 0.1 OUTLIER -63.88 -46.47 84.76 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.934 0.397 . . . . 0.36 110.298 179.779 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 32.6 m-80 -68.16 -46.82 69.73 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 115.987 -0.551 . . . . 0.48 112.107 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 86.3 m-70 -102.71 30.63 4.58 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 113.556 0.947 . . . . 0.34 113.556 -178.132 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -62.53 -36.21 81.89 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 121.011 0.434 . . . . 0.38 111.216 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 32.7 p -68.86 -39.8 79.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.085 0.469 . . . . 1.08 110.521 178.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -67.05 -40.76 87.21 Favored 'General case' 0 N--CA 1.456 -0.126 0 CA-C-N 115.887 -0.597 . . . . 0.3 110.085 178.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 11.8 m-30 -65.89 -39.59 90.77 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.991 -0.55 . . . . 0.42 110.22 178.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -67.04 -47.67 70.65 Favored 'General case' 0 N--CA 1.46 0.052 0 CA-C-N 116.354 -0.385 . . . . 0.89 110.362 178.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -58.59 -42.62 96.2 Favored Glycine 0 C--N 1.337 0.595 0 N-CA-C 111.0 -0.84 . . . . 0.3 111.0 178.183 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 30.6 ttm -64.16 -46.04 85.78 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.688 -0.486 . . . . 0.38 109.688 178.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.505 ' HA ' HD12 ' A' ' 216' ' ' LEU . 6.7 tp -59.62 -41.39 90.28 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.806 -0.634 . . . . 0.49 111.112 179.002 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' ARG . . . . . 0.538 ' HD3' ' O ' ' A' ' 214' ' ' ARG . 0.0 OUTLIER -65.0 -32.07 73.61 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.238 -0.437 . . . . 0.75 110.553 179.268 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 56.4 mtpt -89.0 -0.99 57.89 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.253 -0.43 . . . . 0.75 110.781 178.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.674 ' HB3' HG22 ' A' ' 218' ' ' ILE . 10.1 mt -92.26 134.28 35.04 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 121.175 0.512 . . . . 0.72 111.226 179.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -99.38 29.16 4.12 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 115.824 -0.625 . . . . 0.45 110.401 178.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' ILE . . . . . 0.674 HG22 ' HB3' ' A' ' 216' ' ' LEU . 2.3 tt -66.91 114.62 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 N-CA-C 113.061 0.763 . . . . 0.37 113.061 -178.603 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 10.0 ptpp? -161.27 4.69 0.06 Allowed 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 115.474 -0.785 . . . . 0.4 112.645 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -154.29 -175.96 5.65 Favored 'General case' 0 C--O 1.218 -0.567 0 O-C-N 121.747 -0.595 . . . . 0.59 112.555 -178.249 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -61.59 -20.84 63.76 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 112.599 0.592 . . . . 0.48 112.599 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -67.71 -42.95 86.34 Favored Glycine 0 CA--C 1.531 1.04 0 N-CA-C 114.708 0.643 . . . . 0.39 114.708 -179.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' ASP . . . . . 0.472 ' OD1' HG13 ' A' ' 218' ' ' ILE . 0.1 OUTLIER -65.51 -31.86 73.15 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 117.621 0.711 . . . . 0.38 112.05 -179.098 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 12.1 t -58.37 -42.35 83.76 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 CA-C-O 121.429 0.633 . . . . 0.39 110.337 178.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 35.2 mmtm -67.91 -41.52 82.56 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.783 -0.644 . . . . 0.45 109.689 178.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . 0.561 ' O ' HG23 ' A' ' 230' ' ' VAL . 20.6 t -61.19 -38.95 88.38 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.506 -0.77 . . . . 0.45 110.07 178.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' PHE . . . . . 0.417 ' HE1' ' CD2' ' A' ' 251' ' ' PHE . 49.7 t80 -59.47 -43.22 93.3 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.45 -0.795 . . . . 0.47 110.423 178.295 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' SER . . . . . 0.97 ' HB2' HG21 ' A' ' 278' ' ' VAL . 9.6 p -65.16 -31.97 73.42 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.057 -0.519 . . . . 0.32 110.074 178.127 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 22.2 ttp-105 -67.84 -36.24 79.99 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 109.561 -0.533 . . . . 0.57 109.561 178.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 0.561 HG23 ' O ' ' A' ' 226' ' ' SER . 26.3 t -59.99 -45.41 95.4 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 N-CA-C 109.138 -0.69 . . . . 0.34 109.138 177.345 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' MET . . . . . 0.787 ' HG3' HD13 ' A' ' 248' ' ' LEU . 29.0 ttm -56.08 -53.26 59.09 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 114.822 -1.081 . . . . 0.32 111.786 179.205 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 34.2 m -66.09 -31.12 52.25 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-O 120.563 0.22 . . . . 0.4 111.419 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 44.3 t-80 -69.38 -42.27 75.4 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.987 0.423 . . . . 0.43 110.383 178.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.585 HG13 ' HA ' ' B' ' 28' ' ' ARG . 44.9 t -58.17 -43.99 86.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-N 116.192 -0.458 . . . . 0.33 110.749 178.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 235' ' ' PHE . . . . . 0.489 ' CD2' ' HA ' ' A' ' 240' ' ' THR . 96.2 m-85 -94.43 23.38 5.26 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 116.088 -0.505 . . . . 0.38 112.017 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -65.14 -13.47 58.21 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 112.028 0.381 . . . . 1.08 112.028 -179.373 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -83.37 -17.09 43.5 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.641 0.258 . . . . 0.41 111.324 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 97.15 -7.69 64.51 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 120.81 -0.71 . . . . 0.46 114.034 179.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 4.5 p -97.73 116.09 39.38 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 CA-C-O 121.337 0.589 . . . . 0.43 111.576 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 240' ' ' THR . . . . . 0.489 ' HA ' ' CD2' ' A' ' 235' ' ' PHE . 25.4 m -88.39 84.63 6.81 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.048 0.452 . . . . 0.61 111.875 -179.57 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . 0.521 ' HB2' ' HD2' ' A' ' 244' ' ' ARG . 92.0 m-20 -76.04 135.45 39.94 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.205 -0.452 . . . . 0.49 111.141 179.277 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 242' ' ' TRP . . . . . 0.608 ' HB3' ' CZ ' ' A' ' 300' ' ' PHE . 5.1 m95 -60.33 -37.88 82.01 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.911 0.386 . . . . 0.47 111.282 179.342 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . 0.493 ' HA3' ' N ' ' B' ' 35' ' ' TYR . . . -64.58 -29.95 76.57 Favored Glycine 0 CA--C 1.52 0.378 0 C-N-CA 121.072 -0.585 . . . . 0.27 112.376 178.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 244' ' ' ARG . . . . . 0.574 ' HA ' ' HA3' ' B' ' 31' ' ' GLY . 79.5 mtt180 -69.28 -44.53 71.65 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.86 -0.422 . . . . 0.34 109.86 178.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . 0.527 ' O ' HG12 ' A' ' 249' ' ' ILE . 69.7 mt -61.21 -53.84 43.45 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 CA-C-N 115.542 -0.754 . . . . 0.37 111.435 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 19.0 m -60.6 -34.84 60.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 C-N-CA 120.89 -0.324 . . . . 0.32 111.335 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 53.0 m -62.36 -44.68 95.9 Favored 'General case' 0 N--CA 1.463 0.179 0 N-CA-C 109.985 -0.376 . . . . 0.36 109.985 178.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 248' ' ' LEU . . . . . 0.787 HD13 ' HG3' ' A' ' 231' ' ' MET . 91.5 mt -65.8 -39.76 91.25 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.213 -0.448 . . . . 0.65 110.561 178.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 249' ' ' ILE . . . . . 0.527 HG12 ' O ' ' A' ' 245' ' ' ILE . 26.7 mm -65.67 -43.88 93.66 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 CA-C-O 121.119 0.485 . . . . 0.38 109.837 178.144 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 35.5 t -60.46 -45.97 91.79 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.788 -0.642 . . . . 0.28 109.383 178.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 251' ' ' PHE . . . . . 0.422 ' CD2' HD11 ' B' ' 27' ' ' LEU . 22.0 t80 -63.58 -39.4 94.28 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 115.687 -0.688 . . . . 0.34 110.115 178.144 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -56.99 -42.69 93.01 Favored Glycine 0 C--N 1.335 0.503 0 N-CA-C 111.419 -0.672 . . . . 0.25 111.419 177.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -69.21 -31.33 69.84 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 120.827 0.346 . . . . 0.28 110.521 177.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -70.93 -47.58 58.27 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 116.247 -0.433 . . . . 0.49 111.378 179.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 19.1 m -64.64 -35.62 75.26 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 C-N-CA 120.725 -0.39 . . . . 0.33 110.159 178.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -66.04 -32.33 73.74 Favored 'General case' 0 N--CA 1.456 -0.146 0 N-CA-C 109.257 -0.645 . . . . 0.29 109.257 177.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 257' ' ' LYS . . . . . 0.406 ' HE2' ' O ' ' A' ' 170' ' ' GLN . 24.5 ttmt -63.66 -40.03 95.82 Favored 'General case' 0 CA--C 1.528 0.108 0 CA-C-N 115.493 -0.776 . . . . 0.8 109.085 177.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 258' ' ' HIS . . . . . 0.463 ' HB2' HD21 ' A' ' 213' ' ' LEU . 75.4 t60 -66.09 -44.86 83.17 Favored 'General case' 0 C--O 1.231 0.085 0 CA-C-N 115.93 -0.577 . . . . 0.4 109.539 177.414 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 97.4 mt -60.14 -47.33 86.35 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 115.8 -0.636 . . . . 0.48 110.33 178.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 260' ' ' LYS . . . . . 0.44 ' HA ' ' OE1' ' A' ' 265' ' ' GLU . 0.7 OUTLIER -62.96 -33.8 76.16 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.277 -0.419 . . . . 0.53 110.742 178.998 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 72.4 m -60.23 -29.46 68.77 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 120.858 0.361 . . . . 0.51 110.836 179.179 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 262' ' ' VAL . . . . . 0.408 HG23 ' HG3' ' A' ' 264' ' ' GLN . 6.1 m -109.95 17.97 7.14 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-O 120.951 0.405 . . . . 0.49 110.662 178.509 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 58.05 50.33 10.28 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 115.528 -0.76 . . . . 0.58 113.036 179.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 264' ' ' GLN . . . . . 0.408 ' HG3' HG23 ' A' ' 262' ' ' VAL . 22.6 mt-30 -110.99 36.49 3.13 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 120.953 0.406 . . . . 0.44 110.931 178.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . 0.508 ' HA ' HD12 ' A' ' 268' ' ' ILE . 0.9 OUTLIER -51.36 -33.48 29.9 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 112.823 0.675 . . . . 0.53 112.823 -179.804 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 24.9 p -59.12 -20.25 51.95 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 111.793 0.294 . . . . 0.94 111.793 179.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 267' ' ' PHE . . . . . 0.418 ' C ' ' HD2' ' A' ' 270' ' ' PRO . 83.1 m-85 -93.35 -23.49 18.43 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 121.063 0.459 . . . . 0.6 110.838 178.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 268' ' ' ILE . . . . . 0.508 HD12 ' HA ' ' A' ' 265' ' ' GLU . 73.0 mt -67.62 -42.17 86.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 CA-C-N 116.243 -0.435 . . . . 0.38 110.889 179.382 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 269' ' ' GLU . . . . . 0.789 ' HB2' ' HD3' ' A' ' 270' ' ' PRO . 58.2 mm-40 -54.77 -56.41 27.67 Favored Pre-proline 0 CA--C 1.544 0.74 0 CA-C-N 116.006 -0.543 . . . . 0.58 111.789 179.539 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 270' ' ' PRO . . . . . 0.789 ' HD3' ' HB2' ' A' ' 269' ' ' GLU . 22.7 Cg_exo -66.81 -28.15 43.47 Favored 'Trans proline' 0 C--N 1.358 1.068 0 C-N-CA 122.181 1.921 . . . . 0.46 111.79 178.205 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 271' ' ' LEU . . . . . 0.5 ' O ' HG22 ' A' ' 275' ' ' ILE . 32.7 tp -62.91 -50.4 71.01 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.366 -0.379 . . . . 0.48 110.278 178.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 272' ' ' ALA . . . . . 0.405 ' HA ' HG22 ' A' ' 275' ' ' ILE . . . -60.69 -34.0 73.69 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 121.336 0.589 . . . . 0.36 110.602 178.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 273' ' ' GLU . . . . . 0.599 ' HA ' HD21 ' A' ' 160' ' ' LEU . 34.9 tt0 -71.85 -40.9 68.68 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.566 -0.743 . . . . 0.93 109.478 178.065 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 274' ' ' THR . . . . . . . . . . . . . 93.2 m -66.54 -50.62 62.57 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.792 -0.64 . . . . 0.35 111.663 179.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 275' ' ' ILE . . . . . 0.736 HG13 ' HE1' ' A' ' 231' ' ' MET . 13.6 tt -58.94 -49.67 82.31 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-N 116.816 -0.174 . . . . 0.34 111.125 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 13.2 m -62.06 -47.65 83.73 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.795 0.331 . . . . 0.35 111.037 179.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 277' ' ' ASP . . . . . 0.546 ' HB2' ' O ' ' A' ' 273' ' ' GLU . 4.4 t70 -53.31 -55.36 25.36 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 115.998 -0.546 . . . . 0.46 111.193 179.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 278' ' ' VAL . . . . . 0.97 HG21 ' HB2' ' A' ' 228' ' ' SER . 84.0 t -64.37 -40.53 89.38 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 CA-C-N 116.405 -0.361 . . . . 0.37 111.375 179.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 25.2 tp -62.73 -38.93 92.44 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.831 0.348 . . . . 0.58 111.644 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 91.5 t -82.73 -41.71 17.65 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 N-CA-C 112.249 0.463 . . . . 0.47 112.249 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 55.3 mtp180 -69.28 -28.02 65.93 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 112.959 0.725 . . . . 0.61 112.959 -178.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 282' ' ' THR . . . . . . . . . . . . . 82.0 p -93.67 -12.38 29.46 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 112.485 0.55 . . . . 0.68 112.485 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 4.4 mptp? -129.17 34.44 4.41 Favored 'General case' 0 C--N 1.33 -0.259 0 O-C-N 122.321 -0.237 . . . . 0.7 111.423 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 41.4 ttt180 -50.75 -53.07 34.69 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 116.291 -0.413 . . . . 0.97 111.867 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -59.27 -52.15 66.89 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 116.292 -0.413 . . . . 0.71 111.863 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 286' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -62.18 -42.74 99.56 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.492 0.553 . . . . 0.58 112.492 -179.04 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 287' ' ' LEU . . . . . 0.441 HD13 ' HA2' ' A' ' 292' ' ' GLY . 2.1 mm? -66.51 -49.77 65.45 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 111.719 0.266 . . . . 0.54 111.719 -179.516 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 5.5 p -65.56 -31.18 52.68 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-O 120.785 0.326 . . . . 0.62 111.261 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 11.8 ttmt -74.91 -30.69 61.35 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 120.79 0.328 . . . . 1.01 111.302 179.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.89 9.05 43.02 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 112.341 0.497 . . . . 0.64 112.341 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 291' ' ' ARG . . . . . 0.484 ' HB3' ' HB2' ' A' ' 294' ' ' ASP . 0.0 OUTLIER 62.57 24.87 14.82 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 112.767 0.654 . . . . 0.78 112.767 179.013 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 292' ' ' GLY . . . . . 0.441 ' HA2' HD13 ' A' ' 287' ' ' LEU . . . 56.07 -115.32 5.95 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 115.27 0.868 . . . . 0.39 115.27 178.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 293' ' ' TRP . . . . . 0.569 ' O ' HG22 ' A' ' 297' ' ' VAL . 88.8 m95 -65.83 -41.22 92.04 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 112.713 0.635 . . . . 0.7 112.713 -178.322 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 294' ' ' ASP . . . . . 0.484 ' HB2' ' HB3' ' A' ' 291' ' ' ARG . 27.6 m-20 -52.35 -49.67 63.86 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.086 0.47 . . . . 0.4 111.253 179.568 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -71.71 -33.74 63.21 Favored Glycine 0 CA--C 1.521 0.436 0 C-N-CA 120.84 -0.695 . . . . 0.29 112.598 179.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 296' ' ' PHE . . . . . 0.446 ' HB2' ' CH2' ' A' ' 242' ' ' TRP . 0.9 OUTLIER -66.77 -47.39 72.34 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 120.733 0.302 . . . . 0.32 111.759 179.893 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 297' ' ' VAL . . . . . 0.569 HG22 ' O ' ' A' ' 293' ' ' TRP . 23.7 m -68.06 -40.89 83.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 112.477 0.547 . . . . 0.35 112.477 -178.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 298' ' ' GLU . . . . . 0.431 ' OE1' ' HA ' ' A' ' 298' ' ' GLU . 0.0 OUTLIER -71.55 -30.21 65.63 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 120.538 -0.465 . . . . 0.45 112.079 -179.509 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 299' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -69.19 -41.97 76.43 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.83 0.348 . . . . 0.43 110.539 178.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 300' ' ' PHE . . . . . 0.608 ' CZ ' ' HB3' ' A' ' 242' ' ' TRP . 81.8 m-85 -90.87 30.73 1.15 Allowed 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 112.647 0.61 . . . . 0.35 112.647 -179.164 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -110.06 58.68 0.61 Allowed 'General case' 0 CA--C 1.535 0.373 0 O-C-N 121.983 -0.448 . . . . 0.4 110.82 179.114 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . 0.4 ' HB ' ' H ' ' A' ' 303' ' ' GLN . 5.7 t -98.48 -84.69 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 CA-C-N 116.233 -0.44 . . . . 0.78 111.835 -179.557 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 303' ' ' GLN . . . . . 0.4 ' H ' ' HB ' ' A' ' 302' ' ' VAL . 0.2 OUTLIER -170.65 119.08 0.53 Allowed 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 120.63 0.252 . . . . 1.03 111.41 -179.606 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -145.96 -82.22 0.14 Allowed 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 111.81 0.3 . . . . 0.47 111.81 179.168 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 305' ' ' LEU . . . . . 0.556 HD12 ' HG2' ' A' ' 196' ' ' ARG . 68.1 mt -69.43 -28.65 66.32 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 112.244 0.461 . . . . 0.85 112.244 -179.491 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 306' ' ' GLU . . . . . 0.448 ' CD ' ' H ' ' A' ' 306' ' ' GLU . 0.0 OUTLIER -89.39 -7.58 54.9 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.854 0.359 . . . . 0.71 110.984 179.625 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . -113.93 57.61 0.45 Allowed Glycine 0 CA--C 1.52 0.385 0 C-N-CA 120.96 -0.638 . . . . 1.36 112.62 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.104 0 CA-C-O 118.444 -1.198 . . . . 2.89 112.823 -179.921 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.372 0 CA-C-O 120.476 0.179 . . . . 0.71 111.069 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -82.97 153.03 25.21 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 120.934 0.397 . . . . 0.97 110.904 179.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 19' ' ' LEU . . . . . 0.615 HD21 ' HA ' ' A' ' 216' ' ' LEU . 10.7 mt -111.88 97.68 38.83 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-O 121.141 0.496 . . . . 0.43 111.265 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 20' ' ' PRO . . . . . 0.439 ' HA ' ' HD3' ' B' ' 21' ' ' PRO . 71.9 Cg_endo -76.21 158.67 37.37 Favored 'Trans proline' 0 CA--C 1.532 0.4 0 C-N-CA 122.924 2.416 . . . . 0.45 113.035 -179.468 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 21' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' B' ' 20' ' ' PRO . 17.2 Cg_exo -67.57 8.91 0.37 Allowed 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 122.967 2.444 . . . . 0.51 113.393 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -61.72 -41.51 97.71 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.39 -0.368 . . . . 0.51 111.285 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 23' ' ' PHE . . . . . 0.56 ' CE1' HG22 ' A' ' 230' ' ' VAL . 0.2 OUTLIER -60.38 -32.93 71.76 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 121.057 0.456 . . . . 0.36 110.528 179.549 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 24' ' ' ALA . . . . . 0.533 ' N ' ' HD1' ' B' ' 23' ' ' PHE . . . -72.8 -37.49 67.54 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 115.733 -0.667 . . . . 0.35 110.252 179.362 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.3 -42.59 99.07 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 109.674 -0.491 . . . . 0.36 109.674 178.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 26' ' ' GLN . . . . . 0.408 ' O ' HG13 ' B' ' 30' ' ' ILE . 0.1 OUTLIER -64.29 -54.44 33.18 Favored 'General case' 0 C--O 1.227 -0.125 0 CA-C-N 115.692 -0.685 . . . . 0.33 110.518 178.473 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . 0.537 HD12 HG11 ' A' ' 230' ' ' VAL . 48.9 mt -57.6 -35.23 70.15 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.855 0.36 . . . . 0.39 110.746 179.102 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 28' ' ' ARG . . . . . 0.585 ' HA ' HG13 ' A' ' 234' ' ' VAL . 65.5 ttt180 -60.86 -54.41 45.47 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 109.371 -0.603 . . . . 0.59 109.371 177.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -61.48 -41.14 96.81 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.725 -0.671 . . . . 0.83 111.18 178.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . 0.417 ' O ' HG23 ' B' ' 34' ' ' VAL . 95.6 mt -63.7 -44.05 98.27 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 N-CA-C 110.054 -0.35 . . . . 0.36 110.054 178.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . 0.574 ' HA3' ' HA ' ' A' ' 244' ' ' ARG . . . -60.68 -46.97 93.42 Favored Glycine 0 C--N 1.333 0.372 0 C-N-CA 120.645 -0.788 . . . . 0.28 111.674 178.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 85.0 m-20 -60.4 -36.93 79.27 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 121.196 0.522 . . . . 0.69 110.133 178.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 16.2 tppt? -68.05 -50.47 55.04 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 115.752 -0.658 . . . . 0.84 110.47 178.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 34' ' ' VAL . . . . . 0.417 HG23 ' O ' ' B' ' 30' ' ' ILE . 77.0 t -59.66 -42.26 87.87 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-O 120.943 0.402 . . . . 0.35 111.067 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 35' ' ' TYR . . . . . 0.493 ' N ' ' HA3' ' A' ' 243' ' ' GLY . 0.1 OUTLIER -57.9 -45.74 85.99 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 121.258 0.552 . . . . 0.93 109.907 178.479 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 36' ' ' CYS . . . . . . . . . . . . . 5.9 t -70.69 -26.09 63.26 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 115.905 -0.589 . . . . 0.54 111.17 179.114 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 37.3 m -71.61 -40.52 69.75 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 112.755 0.65 . . . . 0.37 112.755 -179.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 38' ' ' TRP . . . . . . . . . . . . . 99.3 m95 -85.64 -35.0 21.22 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.222 0.453 . . . . 0.45 112.222 -178.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 65.4 p -67.74 -42.44 81.82 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 111.644 0.238 . . . . 0.6 111.644 179.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -89.6 115.21 63.24 Favored Pre-proline 0 CA--C 1.532 0.257 0 CA-C-O 121.097 0.475 . . . . 0.67 111.144 179.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -82.18 63.58 8.26 Favored 'Trans proline' 0 CA--C 1.534 0.498 0 C-N-CA 122.663 2.242 . . . . 1.25 113.138 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 36.2 m-20 -74.72 71.78 1.96 Allowed 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 121.245 0.545 . . . . 1.46 111.411 179.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 43' ' ' MET . . . . . . . . . . . . . 54.2 mtt . . . . . 0 C--O 1.251 1.164 0 CA-C-O 118.362 -0.828 . . . . 2.63 111.353 -179.997 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.403 ' N ' ' OD1' ' A' ' 153' ' ' ASP . . . . . . . . 0 N--CA 1.491 2.322 0 CA-C-O 120.214 -0.215 . . . . 0.82 112.632 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_exo -72.73 52.38 2.09 Favored 'Trans proline' 0 CA--C 1.535 0.566 0 C-N-CA 123.068 2.512 . . . . 1.58 113.152 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 68.8 mt -109.57 15.94 22.55 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.449 0.642 . . . . 2.06 110.545 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 139.04 -158.17 25.14 Favored Glycine 0 N--CA 1.45 -0.409 0 CA-C-N 115.38 -0.827 . . . . 1.02 111.726 -179.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 3.1 p -83.49 69.07 10.0 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.994 0.426 . . . . 0.91 110.906 179.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.605 ' OE1' ' HD3' ' A' ' 284' ' ' ARG . 8.7 pt-20 -122.42 -33.29 3.48 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 112.39 0.515 . . . . 0.94 112.39 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . 0.403 ' OD1' ' N ' ' A' ' 147' ' ' GLY . 45.1 m-20 -56.78 -38.25 72.24 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 112.022 0.378 . . . . 1.15 112.022 -179.43 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -71.09 -45.05 64.45 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 120.892 0.377 . . . . 1.77 111.207 178.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 41.3 tp -69.92 -32.98 71.56 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-N 116.387 -0.37 . . . . 0.66 111.824 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . 0.401 ' HE1' ' HA ' ' A' ' 277' ' ' ASP . 0.2 OUTLIER -55.55 -50.44 70.03 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 113.174 0.805 . . . . 0.45 113.174 -179.445 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 60.0 mtp85 -54.63 -51.91 63.9 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 112.882 0.697 . . . . 0.58 112.882 -178.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . 0.532 ' OE1' ' HB3' ' A' ' 186' ' ' ALA . 4.9 tt0 -66.9 -43.84 82.33 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.082 -0.508 . . . . 0.56 111.193 -179.24 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 31.1 m -61.57 -47.57 84.88 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.856 -0.611 . . . . 0.28 111.101 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.736 HD11 ' HG3' ' A' ' 273' ' ' GLU . 27.9 tp -59.52 -47.82 84.03 Favored 'General case' 0 C--O 1.222 -0.373 0 CA-C-N 115.913 -0.585 . . . . 0.51 111.517 -179.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . 0.489 ' CD ' ' H ' ' A' ' 181' ' ' GLY . 26.8 tt0 -58.5 -50.41 73.86 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 120.601 0.239 . . . . 0.56 111.521 -179.328 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . 0.472 HD13 ' HB3' ' A' ' 190' ' ' ALA . 52.2 mt -58.05 -52.07 62.93 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-N 116.541 -0.299 . . . . 0.29 111.565 179.51 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.514 HD12 HG23 ' A' ' 276' ' ' THR . 88.2 mt -67.31 -54.86 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 N-CA-C 112.787 0.662 . . . . 0.29 112.787 -179.323 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 6.7 t -53.52 -41.23 66.15 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 120.775 0.322 . . . . 0.25 111.302 -178.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . 0.505 ' HD2' ' HA ' ' A' ' 165' ' ' ARG . 3.6 tpt180 -71.92 -45.93 59.4 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 120.344 -0.542 . . . . 0.6 110.775 179.28 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' TYR . . . . . 0.688 ' HE1' ' HA ' ' A' ' 195' ' ' ARG . 65.4 t80 -57.92 -49.33 77.13 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 111.561 0.208 . . . . 0.31 111.561 179.11 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 6.4 mp -60.82 -42.73 98.27 Favored 'General case' 0 C--O 1.226 -0.141 0 CA-C-N 116.717 -0.22 . . . . 0.39 110.566 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 1.9 ttt180 -65.28 -43.72 90.31 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 121.176 0.513 . . . . 0.44 110.457 178.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -60.44 -54.56 44.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.34 -0.846 . . . . 0.45 110.337 178.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 23.4 mm-40 -63.77 -35.8 81.79 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.09 -0.505 . . . . 0.28 111.085 179.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.449 ' HB2' ' HB1' ' A' ' 256' ' ' ALA . . . -57.33 -35.02 69.35 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.083 0.468 . . . . 0.31 111.496 179.186 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 21.8 m -94.11 -34.03 13.12 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.958 -0.564 . . . . 0.44 111.317 -179.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 89.36 12.18 63.43 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.884 -0.674 . . . . 0.5 112.131 -179.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 5.0 t -102.43 -168.61 1.55 Allowed 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 120.794 0.331 . . . . 0.39 111.079 -179.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . 0.455 ' HD3' ' HA ' ' A' ' 175' ' ' LYS . 1.9 tppt? -137.15 116.3 12.52 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.946 0.403 . . . . 0.52 111.552 -179.474 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -80.68 130.81 35.31 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.95 -0.568 . . . . 0.51 110.675 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 8.7 m -70.11 -23.83 63.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.062 -0.517 . . . . 1.07 110.697 179.21 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.55 70.21 25.98 Favored Pre-proline 0 CA--C 1.537 0.472 0 CA-C-N 116.159 -0.473 . . . . 0.86 110.85 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -66.25 -57.52 0.22 Allowed 'Trans proline' 0 C--N 1.347 0.5 0 C-N-CA 122.648 2.232 . . . . 0.4 113.397 -179.021 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -77.44 156.62 30.99 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.356 0.598 . . . . 0.59 111.296 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . 0.489 ' H ' ' CD ' ' A' ' 161' ' ' GLU . . . -130.92 -46.11 0.15 Allowed Glycine 0 C--N 1.32 -0.327 0 CA-C-N 115.532 -0.758 . . . . 0.55 111.269 179.362 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -108.8 -29.84 8.45 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 121.148 0.499 . . . . 0.63 110.398 178.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.516 ' O ' ' HA3' ' A' ' 187' ' ' GLY . . . -80.93 79.09 7.67 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 121.26 0.553 . . . . 0.36 110.642 179.486 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -78.55 -71.06 1.26 Allowed Glycine 0 CA--C 1.527 0.823 0 N-CA-C 115.16 0.824 . . . . 0.39 115.16 -178.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -68.49 -57.81 5.26 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 112.774 0.657 . . . . 0.48 112.774 -177.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . 0.532 ' HB3' ' OE1' ' A' ' 158' ' ' GLN . . . -72.08 -34.11 68.43 Favored 'General case' 0 C--O 1.221 -0.426 0 C-N-CA 120.466 -0.494 . . . . 0.43 110.265 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . 0.516 ' HA3' ' O ' ' A' ' 183' ' ' ALA . . . -62.14 -43.66 98.83 Favored Glycine 0 CA--C 1.52 0.393 0 C-N-CA 120.828 -0.701 . . . . 0.35 112.601 179.166 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 3.0 tmt_? -62.38 -53.78 49.96 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.84 0.32 . . . . 0.58 110.601 179.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . 0.51 ' O ' ' HG2' ' A' ' 192' ' ' GLU . 47.6 mtm180 -63.4 -44.22 95.3 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.233 -0.44 . . . . 0.45 111.933 -179.472 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.565 ' HB2' ' HB3' ' A' ' 293' ' ' TRP . . . -68.47 -45.48 72.33 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.179 0.437 . . . . 0.29 112.179 -179.206 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . 0.457 ' CD1' ' HB2' ' A' ' 166' ' ' TYR . 27.3 tp -65.91 -38.36 88.49 Favored 'General case' 0 N--CA 1.463 0.177 0 C-N-CA 120.411 -0.516 . . . . 0.6 111.813 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . 0.51 ' HG2' ' O ' ' A' ' 189' ' ' ARG . 9.3 pt-20 -66.61 -36.73 83.31 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 120.433 -0.507 . . . . 0.72 110.549 179.52 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . 0.622 HG21 ' HA ' ' A' ' 297' ' ' VAL . 20.7 m -73.73 -46.75 44.02 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.129 -0.487 . . . . 0.31 110.247 179.512 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 0.409 HD21 HG21 ' A' ' 249' ' ' ILE . 14.6 tp -60.74 -38.35 84.83 Favored 'General case' 0 N--CA 1.457 -0.125 0 CA-C-N 115.75 -0.659 . . . . 0.32 110.261 179.29 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . 0.688 ' HA ' ' HE1' ' A' ' 166' ' ' TYR . 46.2 ttm105 -61.85 -51.15 69.4 Favored 'General case' 0 C--O 1.223 -0.293 0 CA-C-N 116.072 -0.513 . . . . 0.32 111.07 178.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 7.3 tpm_? -69.16 -53.03 22.21 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 112.828 0.677 . . . . 0.45 112.828 -179.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . 0.473 HG21 ' HB3' ' A' ' 300' ' ' PHE . 46.5 t -63.72 -50.63 77.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 N-CA-C 112.028 0.381 . . . . 0.3 112.028 -178.505 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -57.78 -50.35 66.31 Favored Glycine 0 C--N 1.333 0.402 0 C-N-CA 120.976 -0.631 . . . . 0.25 111.976 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -54.28 -40.74 68.12 Favored 'General case' 0 CA--C 1.526 0.054 0 N-CA-C 109.992 -0.373 . . . . 0.41 109.992 178.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -63.2 -50.68 60.98 Favored Glycine 0 CA--C 1.522 0.525 0 C-N-CA 120.831 -0.699 . . . . 0.33 111.85 178.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . 0.405 HG23 ' O ' ' A' ' 197' ' ' VAL . 60.2 t -60.25 -42.28 89.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-O 120.837 0.351 . . . . 0.4 110.995 178.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' GLN . . . . . 0.659 ' HG3' ' HB3' ' A' ' 250' ' ' SER . 25.8 mt-30 -66.91 -42.4 85.51 Favored 'General case' 0 C--O 1.223 -0.314 0 CA-C-N 116.033 -0.53 . . . . 0.39 112.088 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' ARG . . . . . 0.513 ' HD3' ' OE1' ' A' ' 206' ' ' GLU . 0.0 OUTLIER -70.35 -37.49 74.65 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.814 0.34 . . . . 0.32 110.493 179.476 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 16.1 m-80 -67.88 -47.73 68.05 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-O 121.15 0.5 . . . . 0.84 110.489 178.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 86.9 m-70 -101.04 35.88 2.11 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.183 -0.462 . . . . 0.44 111.328 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . 0.525 ' HG3' ' CZ ' ' A' ' 254' ' ' PHE . 2.6 tt0 -57.49 -48.84 78.16 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.274 -0.421 . . . . 0.47 111.562 -179.538 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 45.9 p -64.95 -39.39 93.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.334 -0.394 . . . . 0.49 111.646 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -61.19 -43.27 99.15 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 121.138 0.494 . . . . 0.32 110.483 179.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' PHE . . . . . 0.517 ' O ' ' HG ' ' A' ' 213' ' ' LEU . 21.9 m-85 -74.52 -39.1 62.59 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.949 -0.569 . . . . 0.42 110.295 179.147 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -60.09 -46.1 90.72 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.151 -0.477 . . . . 0.76 110.277 178.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -63.69 -39.22 97.3 Favored Glycine 0 C--N 1.335 0.516 0 N-CA-C 111.031 -0.827 . . . . 0.3 111.031 177.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' MET . . . . . 0.648 ' HA ' ' HE2' ' A' ' 215' ' ' LYS . 9.9 tpp -62.12 -40.4 95.77 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 109.718 -0.475 . . . . 0.68 109.718 178.182 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.627 HD13 ' HB2' ' A' ' 258' ' ' HIS . 40.7 mt -59.09 -41.29 87.73 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.372 -0.376 . . . . 0.4 111.169 178.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.74 -44.6 96.47 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.086 -0.506 . . . . 0.99 110.886 179.459 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' LYS . . . . . 0.648 ' HE2' ' HA ' ' A' ' 212' ' ' MET . 32.8 mtmt -73.13 -33.59 65.61 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 116.222 -0.444 . . . . 0.66 111.798 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.589 ' HA ' HD11 ' B' ' 19' ' ' LEU . 35.9 mt -65.32 143.48 57.74 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 121.254 0.55 . . . . 0.54 112.465 -179.602 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' ASP . . . . . 0.427 ' O ' ' HG3' ' A' ' 219' ' ' LYS . 0.3 OUTLIER -112.45 33.23 5.05 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.798 -0.637 . . . . 0.48 110.719 179.523 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' ILE . . . . . 0.464 HG12 ' HB3' ' A' ' 216' ' ' LEU . 27.5 mm -66.1 112.43 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 CA-C-N 116.549 -0.296 . . . . 0.51 111.29 -179.658 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . 0.427 ' HG3' ' O ' ' A' ' 217' ' ' ASP . 21.2 mtmm -134.33 -43.57 0.78 Allowed 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 112.15 0.426 . . . . 0.55 112.15 -179.426 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -128.9 -176.37 3.83 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 112.737 0.643 . . . . 0.58 112.737 -177.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . 0.568 ' O ' HG22 ' A' ' 224' ' ' VAL . 1.2 mp0 -61.37 -22.31 64.85 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 112.743 0.646 . . . . 0.72 112.743 -179.055 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -70.19 -27.25 73.13 Favored Glycine 0 CA--C 1.524 0.61 0 C-N-CA 120.402 -0.904 . . . . 0.34 112.999 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -70.12 -31.29 68.76 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 112.779 0.659 . . . . 0.4 112.779 -179.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.568 HG22 ' O ' ' A' ' 221' ' ' GLU . 3.8 m -56.56 -27.37 25.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 N-CA-C 112.122 0.416 . . . . 0.46 112.122 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . 0.473 ' O ' ' HG3' ' A' ' 229' ' ' ARG . 7.9 mptt -64.93 -42.49 94.63 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.037 0.446 . . . . 0.51 110.184 178.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . 0.708 ' HA ' ' HE ' ' A' ' 229' ' ' ARG . 31.6 m -70.71 -36.68 73.34 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.228 -0.442 . . . . 0.59 109.877 178.478 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' PHE . . . . . . . . . . . . . 16.5 t80 -61.94 -40.68 96.36 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.767 -0.651 . . . . 0.55 109.631 178.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 49.2 m -65.24 -38.17 89.52 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.72 -0.673 . . . . 0.46 109.954 178.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' ARG . . . . . 0.708 ' HE ' ' HA ' ' A' ' 226' ' ' SER . 61.3 mtm180 -59.65 -37.51 78.9 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.239 -0.437 . . . . 0.65 109.925 178.187 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 0.529 HG22 ' CE1' ' B' ' 23' ' ' PHE . 44.4 t -59.42 -53.54 46.73 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.142 0 N-CA-C 109.311 -0.625 . . . . 0.4 109.311 177.433 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' MET . . . . . 0.504 ' SD ' HD13 ' A' ' 248' ' ' LEU . 1.5 ttp -56.15 -45.23 79.7 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 115.463 -0.79 . . . . 0.73 111.01 178.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 80.6 t -62.75 -42.32 95.77 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-O 120.901 0.381 . . . . 0.49 110.923 178.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 9.2 t-80 -69.85 -35.58 74.84 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 116.515 -0.311 . . . . 0.54 111.221 179.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.517 HG23 ' O ' ' A' ' 230' ' ' VAL . 39.5 t -54.19 -37.01 34.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 CA-C-O 120.974 0.416 . . . . 0.43 111.48 179.351 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 235' ' ' PHE . . . . . 0.596 ' CE1' ' HA ' ' A' ' 240' ' ' THR . 72.9 m-85 -102.26 24.55 10.07 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 112.007 0.373 . . . . 0.55 112.007 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . 0.41 ' HA ' ' HD2' ' A' ' 236' ' ' LYS . 8.2 tptp -70.22 -20.63 63.08 Favored 'General case' 0 CA--C 1.537 0.462 0 O-C-N 122.241 -0.287 . . . . 1.17 111.355 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 23.8 p-10 -82.22 -8.29 59.64 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 120.789 0.328 . . . . 0.73 110.869 179.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 83.05 9.92 83.53 Favored Glycine 0 CA--C 1.522 0.475 0 C-N-CA 120.99 -0.624 . . . . 0.49 114.039 178.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 33.5 t -102.23 91.08 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.441 0.638 . . . . 0.53 111.187 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 240' ' ' THR . . . . . 0.596 ' HA ' ' CE1' ' A' ' 235' ' ' PHE . 3.1 m -80.13 73.27 6.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.875 -0.602 . . . . 0.71 111.439 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 38.3 m-20 -80.11 140.87 36.24 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.928 0.394 . . . . 0.51 111.885 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 242' ' ' TRP . . . . . 0.477 ' HB3' ' CE2' ' A' ' 300' ' ' PHE . 35.4 m95 -57.96 -40.03 79.55 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.981 -0.554 . . . . 0.5 111.367 179.538 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . 0.459 ' H ' ' HB2' ' B' ' 35' ' ' TYR . . . -61.69 -27.43 68.25 Favored Glycine 0 CA--C 1.521 0.467 0 C-N-CA 120.864 -0.684 . . . . 0.25 112.135 178.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 244' ' ' ARG . . . . . 0.548 ' HG2' ' HA3' ' B' ' 31' ' ' GLY . 71.9 mtt180 -74.81 -46.03 39.46 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 110.0 -0.37 . . . . 0.54 110.0 178.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . 0.525 HG23 HD11 ' A' ' 279' ' ' LEU . 83.7 mt -58.2 -47.33 87.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-N 115.674 -0.694 . . . . 0.49 109.899 179.046 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . 0.471 HG11 HG12 ' A' ' 197' ' ' VAL . 83.9 t -64.82 -38.41 82.66 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-N 115.87 -0.604 . . . . 0.35 110.059 178.139 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 17.0 m -60.68 -41.5 95.21 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.712 0.291 . . . . 0.32 110.217 178.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 248' ' ' LEU . . . . . 0.559 HD23 HD13 ' B' ' 27' ' ' LEU . 64.3 mt -63.02 -43.89 97.47 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 121.043 0.449 . . . . 0.74 109.842 177.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 249' ' ' ILE . . . . . 0.508 HG12 ' O ' ' A' ' 245' ' ' ILE . 41.6 mm -63.01 -40.46 89.12 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 CA-C-O 121.35 0.595 . . . . 0.41 109.579 177.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 250' ' ' SER . . . . . 0.659 ' HB3' ' HG3' ' A' ' 202' ' ' GLN . 38.8 m -61.57 -47.63 84.63 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 115.243 -0.89 . . . . 0.29 109.624 178.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 251' ' ' PHE . . . . . 0.527 ' O ' HG23 ' A' ' 255' ' ' VAL . 11.1 t80 -60.81 -45.4 94.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.452 -0.795 . . . . 0.43 109.579 178.155 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -55.66 -48.07 73.65 Favored Glycine 0 C--N 1.335 0.523 0 C-N-CA 121.151 -0.547 . . . . 0.22 111.974 178.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 253' ' ' ALA . . . . . 0.543 ' O ' ' HG3' ' A' ' 257' ' ' LYS . . . -62.1 -34.69 76.8 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 120.737 0.303 . . . . 0.25 111.069 178.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 254' ' ' PHE . . . . . 0.525 ' CZ ' ' HG3' ' A' ' 206' ' ' GLU . 2.4 t80 -72.18 -41.5 66.93 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 121.08 0.467 . . . . 0.4 110.45 178.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 255' ' ' VAL . . . . . 0.527 HG23 ' O ' ' A' ' 251' ' ' PHE . 81.1 t -65.19 -36.25 77.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 N-CA-C 109.047 -0.723 . . . . 0.31 109.047 177.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 256' ' ' ALA . . . . . 0.449 ' HB1' ' HB2' ' A' ' 171' ' ' ALA . . . -62.69 -36.76 83.96 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 115.544 -0.753 . . . . 0.24 109.61 178.101 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 257' ' ' LYS . . . . . 0.543 ' HG3' ' O ' ' A' ' 253' ' ' ALA . 54.7 mttm -60.66 -43.54 97.5 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.033 -0.531 . . . . 0.38 109.65 177.571 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 258' ' ' HIS . . . . . 0.627 ' HB2' HD13 ' A' ' 213' ' ' LEU . 34.7 t60 -57.09 -44.36 83.11 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.824 -0.626 . . . . 0.69 110.844 178.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 94.3 mt -71.04 -40.77 71.5 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 120.99 0.424 . . . . 0.61 111.404 179.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -65.85 -27.78 68.49 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 120.646 0.26 . . . . 0.42 111.481 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 51.2 m -62.84 -21.66 66.11 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 116.356 -0.384 . . . . 0.45 111.414 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 11.3 m -120.35 23.58 4.83 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-N 116.289 -0.414 . . . . 0.6 111.44 179.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 54.4 m-80 58.03 45.33 18.09 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 112.888 0.699 . . . . 1.26 112.888 179.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -109.46 37.65 2.55 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 122.176 -0.328 . . . . 0.89 111.678 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . 0.599 ' HA ' HD12 ' A' ' 268' ' ' ILE . 13.3 tt0 -58.04 -28.62 64.66 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 111.975 0.361 . . . . 0.74 111.975 -179.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 15.5 p -62.17 -18.68 61.69 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.189 -0.459 . . . . 0.53 111.212 179.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 267' ' ' PHE . . . . . 0.416 ' C ' ' HD2' ' A' ' 270' ' ' PRO . 90.1 m-85 -101.94 -19.0 15.42 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 121.05 0.453 . . . . 0.65 110.242 177.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 268' ' ' ILE . . . . . 0.599 HD12 ' HA ' ' A' ' 265' ' ' GLU . 78.9 mt -66.9 -43.86 89.18 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-N 115.767 -0.651 . . . . 0.35 110.599 179.605 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 269' ' ' GLU . . . . . 0.776 ' HB2' ' HD3' ' A' ' 270' ' ' PRO . 45.2 mt-10 -59.47 -57.3 27.96 Favored Pre-proline 0 CA--C 1.54 0.577 0 CA-C-N 116.271 -0.422 . . . . 0.42 110.54 178.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 270' ' ' PRO . . . . . 0.776 ' HD3' ' HB2' ' A' ' 269' ' ' GLU . 66.4 Cg_exo -54.0 -35.14 79.91 Favored 'Trans proline' 0 C--N 1.362 1.261 0 C-N-CA 122.137 1.891 . . . . 0.45 112.212 178.36 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 271' ' ' LEU . . . . . . . . . . . . . 51.1 tp -68.54 -54.57 15.85 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.312 -0.404 . . . . 0.45 110.073 178.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -57.6 -40.47 79.15 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 116.282 -0.417 . . . . 0.23 110.918 179.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 273' ' ' GLU . . . . . 0.736 ' HG3' HD11 ' A' ' 160' ' ' LEU . 0.7 OUTLIER -66.43 -44.19 83.57 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.119 -0.491 . . . . 0.33 110.302 178.499 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 274' ' ' THR . . . . . . . . . . . . . 67.5 m -61.46 -43.16 99.35 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-O 120.905 0.383 . . . . 0.28 110.195 178.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 96.7 mt -59.05 -53.98 40.45 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-N 115.973 -0.558 . . . . 0.31 110.696 178.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 276' ' ' THR . . . . . 0.53 HG21 ' HA ' ' A' ' 160' ' ' LEU . 49.9 m -56.76 -47.08 80.89 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.299 -0.41 . . . . 0.29 110.77 179.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 277' ' ' ASP . . . . . 0.611 ' O ' ' HB2' ' A' ' 281' ' ' ARG . 28.0 t70 -55.82 -59.21 5.2 Favored 'General case' 0 C--O 1.222 -0.358 0 CA-C-N 115.632 -0.713 . . . . 0.46 111.157 179.442 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 84.4 t -58.7 -36.98 63.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-O 120.905 0.383 . . . . 0.41 111.384 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . 0.525 HD11 HG23 ' A' ' 245' ' ' ILE . 26.3 tp -63.95 -47.19 81.45 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 116.333 -0.394 . . . . 0.7 112.024 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 60.8 t -80.89 -42.18 20.11 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 N-CA-C 112.272 0.471 . . . . 0.44 112.272 -179.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 281' ' ' ARG . . . . . 0.611 ' HB2' ' O ' ' A' ' 277' ' ' ASP . 2.7 ttt180 -56.49 -43.41 79.63 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 112.936 0.717 . . . . 0.89 112.936 -179.393 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 282' ' ' THR . . . . . . . . . . . . . 51.9 p -83.0 -23.7 33.19 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 113.143 0.794 . . . . 0.57 113.143 -179.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . 0.451 ' HD3' HG23 ' A' ' 240' ' ' THR . 1.5 mttp -118.04 39.16 3.46 Favored 'General case' 0 C--N 1.329 -0.307 0 O-C-N 122.068 -0.395 . . . . 0.77 111.905 -179.062 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 284' ' ' ARG . . . . . 0.605 ' HD3' ' OE1' ' A' ' 152' ' ' GLU . 31.0 ttp180 -58.65 -48.11 82.16 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.109 -0.496 . . . . 0.93 111.932 -179.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -68.41 -46.08 70.89 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 116.574 -0.285 . . . . 0.52 111.755 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 286' ' ' TRP . . . . . . . . . . . . . 1.8 t90 -61.65 -45.97 91.78 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 112.023 0.379 . . . . 0.51 112.023 -179.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -63.37 -52.25 62.49 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.15 0.426 . . . . 0.49 112.15 -179.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 6.8 p -61.8 -30.74 49.09 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 CA-C-O 120.784 0.326 . . . . 0.55 111.787 -179.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 10.6 ttmt -69.55 -38.78 77.61 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 120.971 0.415 . . . . 0.86 111.121 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 290' ' ' GLN . . . . . 0.451 ' HB3' ' HZ2' ' A' ' 242' ' ' TRP . 0.3 OUTLIER -91.6 22.45 4.05 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 112.231 0.456 . . . . 0.95 112.231 -179.44 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 8.7 mpt_? 61.67 17.61 8.83 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 112.391 0.515 . . . . 0.86 112.391 179.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 58.81 -120.27 21.67 Favored Glycine 0 CA--C 1.523 0.566 0 CA-C-O 121.436 0.464 . . . . 0.44 113.997 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 293' ' ' TRP . . . . . 0.565 ' HB3' ' HB2' ' A' ' 190' ' ' ALA . 84.9 m95 -65.44 -28.56 69.32 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.717 0.636 . . . . 0.47 112.717 -178.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 294' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.38 -45.24 91.99 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 121.075 0.464 . . . . 0.56 110.595 179.009 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -69.28 -30.89 71.44 Favored Glycine 0 CA--C 1.518 0.259 0 C-N-CA 120.472 -0.871 . . . . 0.29 111.252 178.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 296' ' ' PHE . . . . . 0.475 ' HB2' ' CZ3' ' A' ' 242' ' ' TRP . 2.5 t80 -69.62 -48.44 59.99 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 115.7 -0.25 . . . . 0.35 111.512 179.013 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 297' ' ' VAL . . . . . 0.622 ' HA ' HG21 ' A' ' 193' ' ' THR . 26.4 m -66.2 -33.83 66.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 N-CA-C 112.113 0.412 . . . . 0.31 112.113 -179.165 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -76.11 -33.08 59.47 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 120.624 0.25 . . . . 0.86 111.052 179.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 299' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -69.7 -38.23 76.88 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.025 0.441 . . . . 0.43 110.456 178.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 300' ' ' PHE . . . . . 0.477 ' CE2' ' HB3' ' A' ' 242' ' ' TRP . 91.2 m-85 -102.52 27.08 7.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.206 0.527 . . . . 0.38 110.691 179.224 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 22.7 t-80 -78.67 130.09 35.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.794 -0.639 . . . . 0.44 111.359 -179.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . 0.403 ' HB ' ' OXT' ' A' ' 308' ' ' GLY . 20.1 m -96.6 179.46 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.777 -0.647 . . . . 0.57 111.001 179.367 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 303' ' ' GLN . . . . . 0.783 ' HB3' ' HB2' ' A' ' 306' ' ' GLU . 44.7 mt-30 -83.86 74.09 10.24 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.78 0.324 . . . . 0.63 110.784 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -66.03 -49.62 67.09 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 120.96 0.41 . . . . 0.62 111.813 -179.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 21.5 tp -72.02 -15.42 62.04 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 112.305 0.483 . . . . 1.51 112.305 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 306' ' ' GLU . . . . . 0.783 ' HB2' ' HB3' ' A' ' 303' ' ' GLN . 35.2 mt-10 -101.41 -44.88 5.49 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 112.254 0.464 . . . . 0.85 112.254 -179.413 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . 125.95 47.56 0.21 Allowed Glycine 0 CA--C 1.525 0.689 0 C-N-CA 120.679 -0.772 . . . . 0.77 113.719 179.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 308' ' ' GLY . . . . . 0.403 ' OXT' ' HB ' ' A' ' 302' ' ' VAL . . . . . . . . 0 C--O 1.251 1.186 0 CA-C-O 118.578 -1.123 . . . . 0.59 113.452 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 17' ' ' ALA . . . . . 0.404 ' N ' ' OD1' ' A' ' 217' ' ' ASP . . . . . . . . 0 N--CA 1.493 1.698 0 CA-C-O 121.277 0.56 . . . . 0.62 110.927 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 18' ' ' GLU . . . . . 0.599 ' O ' ' HD3' ' B' ' 20' ' ' PRO . 1.9 pm0 -71.97 81.86 0.93 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.297 -0.865 . . . . 0.59 110.724 179.418 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 19' ' ' LEU . . . . . 0.589 HD11 ' HA ' ' A' ' 216' ' ' LEU . 6.5 mp -107.14 93.12 8.78 Favored Pre-proline 0 CA--C 1.536 0.431 0 N-CA-C 112.587 0.588 . . . . 0.52 112.587 -179.344 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 20' ' ' PRO . . . . . 0.599 ' HD3' ' O ' ' B' ' 18' ' ' GLU . 87.8 Cg_endo -98.45 163.62 0.72 Allowed 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 123.764 2.976 . . . . 0.47 112.143 178.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 21' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -64.32 6.38 0.32 Allowed 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 122.674 2.25 . . . . 0.66 113.482 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 22' ' ' GLU . . . . . 0.405 ' H ' ' C ' ' B' ' 20' ' ' PRO . 4.8 tm-20 -69.78 -35.8 75.18 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.204 -0.453 . . . . 0.79 111.537 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 23' ' ' PHE . . . . . 0.529 ' CE1' HG22 ' A' ' 230' ' ' VAL . 0.2 OUTLIER -62.17 -33.21 74.09 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.763 0.316 . . . . 0.47 111.634 -179.84 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 24' ' ' ALA . . . . . 0.512 ' N ' ' HD1' ' B' ' 23' ' ' PHE . . . -75.63 -36.32 60.26 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.236 0.541 . . . . 0.48 109.872 179.274 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -69.25 -43.02 74.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.618 -0.719 . . . . 0.46 110.198 178.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -60.24 -48.72 80.55 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.074 -0.512 . . . . 0.63 110.854 179.396 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . 0.559 HD13 HD23 ' A' ' 248' ' ' LEU . 89.2 mt -64.73 -33.4 75.89 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 120.92 0.391 . . . . 0.45 110.324 178.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 28' ' ' ARG . . . . . . . . . . . . . 3.6 tmt_? -64.46 -45.73 86.18 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 121.215 0.531 . . . . 0.87 109.722 177.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 33.4 mtpt -71.27 -45.19 63.72 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 115.672 -0.695 . . . . 0.59 111.647 179.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 96.7 mt -62.52 -43.44 98.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-O 120.722 0.296 . . . . 0.4 110.324 179.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . 0.548 ' HA3' ' HG2' ' A' ' 244' ' ' ARG . . . -59.72 -50.25 69.73 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.807 -0.711 . . . . 0.3 112.582 179.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -65.81 -32.11 73.45 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.749 0.275 . . . . 0.56 110.754 179.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.9 -52.0 58.89 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 121.097 0.475 . . . . 0.7 109.738 178.307 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 55.2 t -63.04 -45.1 99.66 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-N 115.494 -0.775 . . . . 0.38 110.53 178.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 35' ' ' TYR . . . . . 0.459 ' HB2' ' H ' ' A' ' 243' ' ' GLY . 0.7 OUTLIER -54.98 -47.05 75.1 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 115.607 -0.724 . . . . 0.63 111.316 179.319 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 36' ' ' CYS . . . . . . . . . . . . . 73.0 m -62.45 -45.07 94.72 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 120.663 0.268 . . . . 0.45 111.303 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 13.1 m -60.4 -37.55 81.19 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 116.316 -0.402 . . . . 0.61 112.033 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 38' ' ' TRP . . . . . . . . . . . . . 93.9 m95 -87.65 -29.47 21.15 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 112.637 0.606 . . . . 0.75 112.637 -179.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 42.2 t -67.76 -31.08 70.73 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 111.982 0.364 . . . . 0.6 111.982 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -89.53 117.57 68.28 Favored Pre-proline 0 CA--C 1.533 0.293 0 CA-C-O 120.745 0.307 . . . . 0.66 111.505 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -71.23 -24.09 23.63 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.64 2.226 . . . . 1.34 112.98 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -74.3 76.37 1.85 Allowed 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 115.999 -0.546 . . . . 1.54 111.089 179.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 43' ' ' MET . . . . . . . . . . . . . 4.5 mmm . . . . . 0 C--O 1.25 1.105 0 CA-C-O 118.307 -0.854 . . . . 2.51 111.712 179.925 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.456 0 CA-C-O 119.8 -0.444 . . . . 2.63 112.423 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -73.06 67.49 4.11 Favored 'Trans proline' 0 CA--C 1.534 0.519 0 C-N-CA 122.595 2.197 . . . . 1.84 112.645 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 90.5 mt -98.58 157.04 16.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.256 -0.429 . . . . 1.06 111.528 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -169.08 -88.29 0.07 OUTLIER Glycine 0 CA--C 1.521 0.448 0 C-N-CA 120.86 -0.686 . . . . 0.49 112.792 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 93.4 p -81.32 60.72 4.51 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.36 0.6 . . . . 0.55 111.294 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.667 ' OE2' ' HD2' ' A' ' 284' ' ' ARG . 4.4 mp0 -110.32 -60.98 1.73 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.853 -0.612 . . . . 0.37 111.753 -179.702 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -46.64 -47.73 20.06 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 113.448 0.907 . . . . 0.52 113.448 -178.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -49.35 -51.62 33.41 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 121.038 0.447 . . . . 0.48 112.142 -179.257 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.519 HD21 ' HB3' ' A' ' 287' ' ' LEU . 44.7 tp -84.47 -40.2 18.0 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.297 -0.41 . . . . 0.91 111.664 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . 0.496 ' OH ' ' HB2' ' A' ' 281' ' ' ARG . 0.3 OUTLIER -52.04 -44.16 64.1 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 112.203 0.446 . . . . 0.36 112.203 -179.766 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.653 ' HD2' ' OE2' ' A' ' 182' ' ' GLU . 21.5 mtm180 -60.56 -51.9 67.46 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 112.145 0.424 . . . . 0.53 112.145 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 1.8 mm100 -63.27 -40.13 96.53 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 121.239 0.542 . . . . 0.53 110.401 179.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 18.4 m -64.89 -50.1 67.89 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.414 -0.812 . . . . 0.28 111.534 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -55.96 -47.89 76.8 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.405 -0.361 . . . . 0.47 111.046 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . 0.621 ' O ' ' HB2' ' A' ' 165' ' ' ARG . 1.4 mm-40 -59.37 -47.26 86.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.402 -0.363 . . . . 0.55 111.294 179.349 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . 0.55 HG12 ' HA2' ' A' ' 187' ' ' GLY . 68.4 mt -66.04 -51.88 55.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 N-CA-C 113.114 0.783 . . . . 0.35 113.114 -179.01 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.539 HD12 HG23 ' A' ' 276' ' ' THR . 56.0 mt -60.18 -54.62 32.39 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 N-CA-C 112.232 0.456 . . . . 0.34 112.232 -178.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 70.4 p -59.33 -37.08 76.9 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.63 0.252 . . . . 0.33 111.077 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . 0.626 ' HG2' ' HG ' ' A' ' 180' ' ' LEU . 0.0 OUTLIER -68.92 -36.78 78.39 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 120.959 -0.296 . . . . 0.56 111.256 179.099 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' TYR . . . . . 0.852 ' HE1' ' HA ' ' A' ' 195' ' ' ARG . 67.5 t80 -72.32 -49.16 36.54 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 121.237 -0.185 . . . . 0.48 111.242 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.512 ' HG ' ' O ' ' A' ' 163' ' ' ILE . 38.1 mt -55.99 -41.01 74.17 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.183 0.516 . . . . 0.34 110.316 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 3.7 tpp180 -69.83 -42.99 72.91 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.554 -0.748 . . . . 0.49 110.449 178.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . 0.663 ' HA ' ' HA3' ' A' ' 173' ' ' GLY . 0.4 OUTLIER -56.85 -44.05 81.74 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 116.351 -0.386 . . . . 0.52 111.939 -179.701 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 22.5 tp60 -76.28 -32.9 59.04 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 112.034 0.383 . . . . 0.55 112.034 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.865 ' HA ' ' HG2' ' A' ' 257' ' ' LYS . . . -79.2 -54.24 6.18 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 113.072 0.768 . . . . 0.45 113.072 -179.476 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . 0.547 ' HB ' ' HG2' ' A' ' 260' ' ' LYS . 11.3 t -147.14 33.41 0.9 Allowed 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.264 0.554 . . . . 0.46 112.135 -177.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . 0.663 ' HA3' ' HA ' ' A' ' 169' ' ' GLU . . . -71.77 28.43 0.62 Allowed Glycine 0 CA--C 1.528 0.902 0 C-N-CA 120.978 -0.629 . . . . 0.53 114.633 -178.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 81.0 p -108.87 -22.38 12.22 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 117.261 0.531 . . . . 0.55 111.305 179.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -142.83 17.42 1.97 Allowed 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.439 -0.346 . . . . 0.61 111.801 -179.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -129.48 -159.07 0.93 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.06 0.457 . . . . 0.6 112.055 -178.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 71.2 p -63.91 101.31 0.37 Allowed 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.957 -0.565 . . . . 0.53 111.39 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . 0.492 ' H ' ' HD2' ' A' ' 179' ' ' PRO . 33.4 tttp -104.42 -51.01 0.12 Allowed Pre-proline 0 CA--C 1.544 0.729 0 N-CA-C 112.818 0.673 . . . . 0.5 112.818 -179.364 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . 0.492 ' HD2' ' H ' ' A' ' 178' ' ' LYS . 89.2 Cg_endo -77.93 157.45 30.94 Favored 'Trans proline' 0 C--N 1.36 1.144 0 C-N-CA 122.037 1.824 . . . . 0.62 113.851 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.626 ' HG ' ' HG2' ' A' ' 165' ' ' ARG . 3.8 mp -95.94 171.5 8.6 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.253 -0.43 . . . . 1.07 111.617 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -119.62 -54.84 0.26 Allowed Glycine 0 CA--C 1.526 0.723 0 C-N-CA 120.553 -0.832 . . . . 0.61 113.772 -178.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . 0.653 ' OE2' ' HD2' ' A' ' 157' ' ' ARG . 5.9 tt0 -94.44 -45.27 7.51 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.238 0.542 . . . . 1.4 110.409 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.672 ' O ' ' HA3' ' A' ' 187' ' ' GLY . . . -80.33 74.14 7.18 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.949 -0.568 . . . . 0.37 110.561 179.498 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -79.94 -69.76 1.38 Allowed Glycine 0 CA--C 1.522 0.496 0 C-N-CA 120.953 -0.642 . . . . 0.38 113.359 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -59.79 -56.01 27.08 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 120.653 0.263 . . . . 0.43 111.535 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -67.69 -32.92 73.91 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.949 -0.389 . . . . 0.46 109.949 179.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . 0.672 ' HA3' ' O ' ' A' ' 183' ' ' ALA . . . -62.63 -48.64 80.02 Favored Glycine 0 C--O 1.224 -0.492 0 CA-C-N 115.685 -0.688 . . . . 0.39 112.97 179.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.28 -50.75 68.88 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 117.221 0.511 . . . . 1.58 110.893 179.313 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . 0.649 ' HB3' HG21 ' A' ' 297' ' ' VAL . 4.4 mtp180 -56.31 -55.15 36.96 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-O 120.971 0.415 . . . . 0.73 111.164 179.346 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.428 ' O ' ' HB2' ' A' ' 194' ' ' LEU . . . -66.98 -40.67 87.46 Favored 'General case' 0 C--O 1.219 -0.51 0 N-CA-C 113.035 0.754 . . . . 0.35 113.035 -178.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 14.2 tp -62.45 -44.37 96.58 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 118.475 0.579 . . . . 0.77 111.529 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -67.58 -40.11 84.84 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 121.143 0.497 . . . . 1.16 110.963 179.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . 0.519 ' OG1' HG13 ' A' ' 297' ' ' VAL . 20.8 m -68.52 -47.26 67.42 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.113 -0.494 . . . . 0.46 110.204 179.035 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 0.461 HD21 HG21 ' A' ' 249' ' ' ILE . 7.9 tp -60.12 -42.17 94.17 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 115.661 -0.7 . . . . 0.36 110.468 179.26 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . 0.852 ' HA ' ' HE1' ' A' ' 166' ' ' TYR . 0.6 OUTLIER -56.03 -54.08 49.26 Favored 'General case' 0 CA--C 1.522 -0.125 0 CA-C-O 121.243 0.545 . . . . 0.41 110.377 178.268 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 10.9 mmm180 -61.53 -54.03 48.49 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 114.972 -1.013 . . . . 0.9 112.36 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . 0.497 ' O ' HG23 ' A' ' 201' ' ' VAL . 99.0 t -61.36 -46.31 96.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 N-CA-C 111.899 0.333 . . . . 0.47 111.899 -179.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . 0.529 ' HA3' ' OH ' ' A' ' 166' ' ' TYR . . . -62.24 -50.43 65.1 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 121.244 -0.503 . . . . 0.3 112.242 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . 0.47 ' HB2' ' O ' ' A' ' 195' ' ' ARG . 0.3 OUTLIER -58.27 -43.1 87.77 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 120.856 0.36 . . . . 0.47 110.117 178.846 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -61.68 -48.36 84.81 Favored Glycine 0 CA--C 1.525 0.708 0 C-N-CA 121.021 -0.609 . . . . 0.42 112.303 178.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 197' ' ' VAL . 71.0 t -62.37 -43.18 97.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-O 120.943 0.402 . . . . 0.41 110.607 178.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' GLN . . . . . 0.562 ' HB3' ' NH2' ' A' ' 203' ' ' ARG . 68.8 mt-30 -63.41 -55.2 26.24 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.583 -0.735 . . . . 0.55 112.098 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' ARG . . . . . 0.562 ' NH2' ' HB3' ' A' ' 202' ' ' GLN . 0.0 OUTLIER -58.15 -34.41 70.25 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 112.157 0.428 . . . . 0.45 112.157 -178.822 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 17.7 m-80 -75.34 -43.79 48.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.895 0.378 . . . . 0.8 111.489 179.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' HIS . . . . . 0.436 ' CD2' HG23 ' B' ' 30' ' ' ILE . 95.2 m-70 -100.9 35.95 2.07 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.8 0.333 . . . . 0.52 111.68 -179.598 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . 0.495 ' HG2' ' HA ' ' A' ' 203' ' ' ARG . 26.9 mm-40 -55.68 -35.64 66.25 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 112.4 0.519 . . . . 0.53 112.4 -179.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 19.4 p -63.15 -52.64 61.65 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.808 0.337 . . . . 0.54 111.6 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -63.41 -40.57 97.56 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.154 -0.475 . . . . 0.4 110.919 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' PHE . . . . . 0.442 ' CE2' ' HA ' ' A' ' 202' ' ' GLN . 25.9 m-85 -68.04 -49.49 61.09 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.094 -0.503 . . . . 0.45 111.547 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -65.31 -38.91 91.65 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 121.266 -0.174 . . . . 0.51 111.021 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -59.23 -45.71 94.95 Favored Glycine 0 C--N 1.334 0.443 0 C-N-CA 120.448 -0.882 . . . . 0.28 110.991 178.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' MET . . . . . 0.487 ' SD ' ' HA ' ' B' ' 23' ' ' PHE . 56.9 mtm -70.62 -33.78 71.39 Favored 'General case' 0 C--O 1.223 -0.324 0 N-CA-C 110.25 -0.278 . . . . 0.73 110.25 178.196 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.449 HD22 ' HA ' ' A' ' 213' ' ' LEU . 0.3 OUTLIER -65.8 -43.84 87.47 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.351 -0.386 . . . . 0.33 111.302 179.506 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 71.9 mtp180 -66.11 -38.46 88.25 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.916 0.389 . . . . 0.92 110.84 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 54.9 mtmt -91.42 11.57 23.44 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.288 -0.415 . . . . 0.59 111.287 179.19 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.509 HD21 HD12 ' A' ' 218' ' ' ILE . 6.5 tp -79.26 99.07 6.89 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.14 0.495 . . . . 0.4 111.361 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -83.25 32.07 0.45 Allowed 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.7 -0.682 . . . . 0.43 111.191 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' ILE . . . . . 0.765 HG12 ' HB3' ' A' ' 223' ' ' ASP . 36.4 mt -81.1 106.74 12.64 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-O 121.069 0.461 . . . . 0.4 110.709 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 8.2 mppt? -140.92 -24.45 0.76 Allowed 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 115.696 -0.684 . . . . 0.6 111.978 -179.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -116.28 171.1 8.04 Favored 'General case' 0 CA--C 1.533 0.296 0 O-C-N 121.875 -0.516 . . . . 1.11 111.68 -179.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -58.48 -31.45 67.85 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 120.955 0.407 . . . . 0.55 111.197 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -62.45 -26.72 68.47 Favored Glycine 0 CA--C 1.524 0.627 0 CA-C-N 115.978 -0.555 . . . . 0.45 113.117 179.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' ASP . . . . . 0.765 ' HB3' HG12 ' A' ' 218' ' ' ILE . 55.5 m-20 -68.66 -34.11 75.15 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 117.024 0.412 . . . . 0.36 111.488 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 16.4 t -62.23 -29.41 46.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-O 121.556 0.693 . . . . 0.38 110.16 178.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 32.2 mmtm -72.67 -33.48 66.58 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 115.533 -0.758 . . . . 0.5 110.441 179.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . 0.453 ' O ' HG23 ' A' ' 230' ' ' VAL . 33.6 t -68.13 -38.65 82.44 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.381 0.61 . . . . 0.91 109.585 178.329 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' PHE . . . . . 0.448 ' HE2' HG11 ' A' ' 255' ' ' VAL . 8.5 t80 -63.54 -38.36 90.83 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 115.211 -0.904 . . . . 0.46 109.503 178.107 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 46.8 t -62.53 -37.44 86.1 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 115.442 -0.799 . . . . 0.29 109.951 178.165 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 84.3 mtp180 -63.07 -39.67 95.4 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.013 -0.539 . . . . 0.55 109.882 178.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' ' 226' ' ' SER . 18.2 t -59.3 -46.14 92.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-N 116.324 -0.398 . . . . 0.35 110.5 178.143 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' MET . . . . . 0.474 ' HE3' ' HA ' ' A' ' 275' ' ' ILE . 7.3 tpp -55.33 -52.2 64.28 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.933 -0.576 . . . . 0.37 110.929 179.605 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 232' ' ' VAL . . . . . 0.527 ' O ' ' HB2' ' A' ' 236' ' ' LYS . 38.2 t -66.89 -36.71 77.85 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-N 116.262 -0.426 . . . . 0.37 111.362 179.511 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 54.0 t-80 -65.48 -52.55 52.06 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 112.057 0.392 . . . . 0.55 112.057 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 97.0 t -63.98 -39.09 84.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 N-CA-C 112.078 0.399 . . . . 0.41 112.078 -179.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 235' ' ' PHE . . . . . 0.568 ' HZ ' ' HA ' ' A' ' 245' ' ' ILE . 63.0 m-85 -91.84 10.94 26.52 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.412 0.523 . . . . 0.56 112.412 -179.397 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . 0.55 ' HE2' ' HA ' ' A' ' 236' ' ' LYS . 0.3 OUTLIER -76.0 -11.43 59.95 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 111.873 0.323 . . . . 0.74 111.873 -179.807 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -69.97 -16.73 63.24 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 120.855 0.359 . . . . 0.42 111.262 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 89.28 -19.83 37.2 Favored Glycine 0 CA--C 1.521 0.442 0 C-N-CA 121.168 -0.539 . . . . 0.47 111.959 -178.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 2.4 t -80.39 112.03 17.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.048 0.452 . . . . 0.86 111.093 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 240' ' ' THR . . . . . 0.41 HG22 HD11 ' A' ' 245' ' ' ILE . 1.9 m -94.47 91.32 6.58 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.37 -0.377 . . . . 0.55 111.046 179.477 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -101.56 135.22 43.44 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.77 0.319 . . . . 0.47 111.389 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 242' ' ' TRP . . . . . 0.658 ' HB3' ' CZ ' ' A' ' 300' ' ' PHE . 7.2 m95 -55.0 -44.01 74.14 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 116.311 -0.404 . . . . 0.41 111.761 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . 0.463 ' H ' ' HB2' ' B' ' 35' ' ' TYR . . . -59.21 -37.02 91.2 Favored Glycine 0 CA--C 1.524 0.619 0 C-N-CA 121.086 -0.578 . . . . 0.28 112.868 179.096 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 63.9 mtt180 -68.46 -43.45 77.0 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 109.777 -0.453 . . . . 0.35 109.777 178.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . 0.568 ' HA ' ' HZ ' ' A' ' 235' ' ' PHE . 84.7 mt -59.99 -50.67 79.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-N 115.58 -0.736 . . . . 0.48 111.569 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . 0.412 HG22 ' O ' ' A' ' 242' ' ' TRP . 16.1 m -67.04 -28.03 41.49 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 C-N-CA 120.769 -0.373 . . . . 0.35 111.411 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 23.1 m -61.79 -48.62 79.81 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 109.754 -0.461 . . . . 0.37 109.754 178.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -60.2 -42.47 95.19 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.063 -0.517 . . . . 0.53 110.312 178.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 249' ' ' ILE . . . . . 0.461 HG21 HD21 ' A' ' 194' ' ' LEU . 43.3 mm -63.99 -44.99 97.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 CA-C-N 116.238 -0.437 . . . . 0.47 110.499 178.521 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 250' ' ' SER . . . . . 0.448 ' HB2' ' HG3' ' A' ' 202' ' ' GLN . 54.4 p -62.19 -36.61 82.44 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.816 0.341 . . . . 0.33 110.17 178.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 251' ' ' PHE . . . . . 0.428 ' CD2' HD11 ' B' ' 27' ' ' LEU . 13.2 t80 -69.71 -40.33 76.35 Favored 'General case' 0 C--O 1.232 0.142 0 N-CA-C 108.704 -0.85 . . . . 0.46 108.704 177.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -57.76 -37.32 83.41 Favored Glycine 0 C--N 1.336 0.566 0 N-CA-C 110.683 -0.967 . . . . 0.25 110.683 177.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 253' ' ' ALA . . . . . 0.448 ' O ' ' HG3' ' A' ' 257' ' ' LYS . . . -68.68 -41.33 79.4 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 120.767 0.318 . . . . 0.31 110.185 177.332 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -63.29 -44.5 94.89 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 116.236 -0.438 . . . . 0.38 110.896 178.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 255' ' ' VAL . . . . . 0.472 HG23 HD21 ' A' ' 271' ' ' LEU . 16.3 m -70.91 -26.34 27.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-O 120.819 0.342 . . . . 0.27 110.472 178.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -66.72 -39.25 87.92 Favored 'General case' 0 C--N 1.339 0.12 0 N-CA-C 108.454 -0.943 . . . . 0.29 108.454 177.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 257' ' ' LYS . . . . . 0.865 ' HG2' ' HA ' ' A' ' 171' ' ' ALA . 24.2 mtpp -65.16 -36.52 84.47 Favored 'General case' 0 C--O 1.225 -0.199 0 CA-C-N 115.351 -0.84 . . . . 0.74 109.646 177.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 63.6 t60 -59.54 -49.03 79.35 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 109.957 -0.386 . . . . 0.43 109.957 177.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.476 HD21 HG22 ' A' ' 218' ' ' ILE . 95.9 mt -68.79 -36.08 77.82 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.038 -0.528 . . . . 0.48 110.453 178.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 260' ' ' LYS . . . . . 0.547 ' HG2' ' HB ' ' A' ' 172' ' ' THR . 5.0 tptp -67.47 -36.57 81.41 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 120.774 0.321 . . . . 0.52 111.048 179.116 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 35.3 t -64.89 -25.86 68.07 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.184 -0.462 . . . . 0.46 111.325 179.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 26.8 m -107.78 11.0 9.04 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 CA-C-N 116.424 -0.353 . . . . 0.46 110.968 178.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 58.98 48.23 11.13 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 113.202 0.816 . . . . 1.55 113.202 179.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 14.7 mt-30 -114.99 36.28 3.95 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.457 -0.338 . . . . 0.76 111.064 178.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . 0.546 ' HA ' HD12 ' A' ' 268' ' ' ILE . 1.8 pm0 -52.62 -29.21 24.81 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 112.407 0.521 . . . . 0.48 112.407 179.412 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 9.3 p -59.96 -20.19 56.23 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 120.725 0.298 . . . . 0.5 111.049 178.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 267' ' ' PHE . . . . . 0.446 ' C ' ' HD2' ' A' ' 270' ' ' PRO . 41.7 m-85 -98.01 -18.87 18.36 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 121.109 0.48 . . . . 0.53 110.181 178.425 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 268' ' ' ILE . . . . . 0.546 HD12 ' HA ' ' A' ' 265' ' ' GLU . 72.4 mt -68.58 -39.57 80.67 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 CA-C-N 115.849 -0.614 . . . . 0.41 110.4 178.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 269' ' ' GLU . . . . . 0.685 ' HB2' ' HD3' ' A' ' 270' ' ' PRO . 1.5 mm-40 -56.38 -56.94 26.39 Favored Pre-proline 0 CA--C 1.543 0.686 0 CA-C-N 116.287 -0.415 . . . . 0.49 111.036 179.27 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 270' ' ' PRO . . . . . 0.685 ' HD3' ' HB2' ' A' ' 269' ' ' GLU . 34.7 Cg_exo -61.68 -34.89 82.91 Favored 'Trans proline' 0 C--N 1.361 1.233 0 C-N-CA 121.954 1.769 . . . . 0.32 111.435 177.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 271' ' ' LEU . . . . . 0.472 HD21 HG23 ' A' ' 255' ' ' VAL . 26.8 tp -62.61 -51.07 68.75 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.182 -0.463 . . . . 0.45 110.251 178.487 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -59.09 -41.12 87.3 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 116.104 -0.498 . . . . 0.34 110.12 178.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 273' ' ' GLU . . . . . . . . . . . . . 62.2 mm-40 -63.34 -45.48 91.01 Favored 'General case' 0 C--O 1.225 -0.189 0 CA-C-N 115.761 -0.654 . . . . 1.05 109.831 177.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 274' ' ' THR . . . . . . . . . . . . . 87.5 m -62.2 -44.02 97.51 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.917 -0.583 . . . . 0.34 111.179 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 275' ' ' ILE . . . . . 0.474 ' HA ' ' HE3' ' A' ' 231' ' ' MET . 94.4 mt -58.66 -50.48 78.98 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 CA-C-O 120.984 0.421 . . . . 0.39 110.286 179.008 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 276' ' ' THR . . . . . 0.539 HG23 HD12 ' A' ' 163' ' ' ILE . 24.1 m -63.12 -46.17 88.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.041 -0.527 . . . . 0.3 110.669 178.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 277' ' ' ASP . . . . . 0.429 ' CG ' HH12 ' A' ' 281' ' ' ARG . 36.1 t70 -51.69 -60.72 2.84 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.309 -0.86 . . . . 0.35 112.442 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 21.8 t -66.35 -37.25 79.25 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 N-CA-C 113.058 0.762 . . . . 0.36 113.058 -178.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 32.5 tp -70.67 -48.47 54.66 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 112.855 0.687 . . . . 0.72 112.855 -178.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 58.2 t -70.73 -34.82 58.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 N-CA-C 112.595 0.591 . . . . 0.32 112.595 -178.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 281' ' ' ARG . . . . . 0.496 ' HB2' ' OH ' ' A' ' 156' ' ' TYR . 21.9 ttp-105 -72.79 -51.39 19.21 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.407 0.521 . . . . 0.38 112.407 -179.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 282' ' ' THR . . . . . . . . . . . . . 10.1 m -60.6 -35.34 75.89 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 112.168 0.432 . . . . 0.49 112.168 -178.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 64.9 mmtt -115.96 38.78 3.23 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 122.225 -0.297 . . . . 0.53 111.611 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 284' ' ' ARG . . . . . 0.667 ' HD2' ' OE2' ' A' ' 152' ' ' GLU . 0.2 OUTLIER -62.13 -54.01 47.28 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 112.812 0.671 . . . . 0.39 112.812 -179.066 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 285' ' ' ASP . . . . . 0.522 ' H ' ' HG3' ' A' ' 284' ' ' ARG . 0.2 OUTLIER -60.27 -39.44 86.85 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 112.128 0.418 . . . . 0.52 112.128 -178.855 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 286' ' ' TRP . . . . . 0.47 ' O ' ' HB2' ' A' ' 290' ' ' GLN . 12.4 t90 -67.14 -41.58 85.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.808 0.337 . . . . 0.48 110.921 179.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 287' ' ' LEU . . . . . 0.519 ' HB3' HD21 ' A' ' 155' ' ' LEU . 2.0 mm? -70.6 -48.4 55.36 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.298 -0.41 . . . . 0.44 112.078 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 288' ' ' VAL . . . . . 0.41 HG22 ' O ' ' A' ' 284' ' ' ARG . 26.9 m -59.88 -37.84 73.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 N-CA-C 111.901 0.334 . . . . 0.33 111.901 -179.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 54.1 mttp -75.52 -23.95 56.74 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-O 120.789 0.328 . . . . 0.59 111.274 179.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 290' ' ' GLN . . . . . 0.47 ' HB2' ' O ' ' A' ' 286' ' ' TRP . 1.5 tp-100 -91.06 17.58 7.84 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.604 -0.271 . . . . 0.66 111.659 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 36.0 mtp180 64.69 15.38 9.71 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 112.025 0.38 . . . . 0.47 112.025 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 63.71 -132.47 40.81 Favored Glycine 0 CA--C 1.523 0.593 0 CA-C-O 121.462 0.479 . . . . 0.38 114.01 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 293' ' ' TRP . . . . . 0.61 ' O ' HG23 ' A' ' 297' ' ' VAL . 77.4 m95 -67.05 -25.18 66.13 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.019 0.377 . . . . 0.43 112.019 -178.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 294' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -56.73 -48.38 77.89 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 109.852 -0.425 . . . . 0.78 109.852 178.324 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -68.7 -38.85 86.28 Favored Glycine 0 C--N 1.336 0.574 0 N-CA-C 111.24 -0.744 . . . . 0.37 111.24 178.045 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 296' ' ' PHE . . . . . 0.547 ' HB3' ' HA ' ' A' ' 293' ' ' TRP . 0.9 OUTLIER -57.74 -45.63 85.59 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 120.769 0.318 . . . . 0.4 111.064 178.498 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 297' ' ' VAL . . . . . 0.649 HG21 ' HB3' ' A' ' 189' ' ' ARG . 78.3 t -65.8 -40.41 87.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-N 116.015 -0.539 . . . . 0.39 111.269 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -66.53 -48.26 70.3 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.207 -0.451 . . . . 0.58 111.476 179.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 299' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -62.26 -51.08 69.18 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.053 0.454 . . . . 0.49 110.843 179.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 300' ' ' PHE . . . . . 0.658 ' CZ ' ' HB3' ' A' ' 242' ' ' TRP . 49.6 m-85 -80.36 33.23 0.29 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.091 -0.504 . . . . 0.57 112.316 -179.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 301' ' ' HIS . . . . . 0.403 ' ND1' ' OXT' ' A' ' 308' ' ' GLY . 14.9 t-80 -56.62 150.74 15.06 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 109.628 -0.508 . . . . 0.74 109.628 178.367 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . 0.415 HG22 ' H ' ' A' ' 302' ' ' VAL . 2.0 m -66.74 74.1 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 N-CA-C 112.707 0.632 . . . . 1.22 112.707 -179.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 303' ' ' GLN . . . . . 0.726 ' HG3' ' HA2' ' A' ' 308' ' ' GLY . 0.8 OUTLIER -61.27 -22.51 64.9 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 121.395 0.617 . . . . 1.25 110.267 178.632 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -78.29 -12.93 60.03 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.496 -0.775 . . . . 1.56 111.693 179.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 96.9 mt -117.92 -25.85 6.63 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.25 0.463 . . . . 1.86 112.25 -179.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -124.95 9.99 8.19 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 112.913 0.709 . . . . 1.38 112.913 -179.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . 80.17 -62.08 4.3 Favored Glycine 0 CA--C 1.525 0.712 0 C-N-CA 120.757 -0.735 . . . . 1.66 114.141 178.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 308' ' ' GLY . . . . . 0.726 ' HA2' ' HG3' ' A' ' 303' ' ' GLN . . . . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.272 -1.294 . . . . 1.72 113.146 -179.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.507 0 N-CA-C 112.321 0.489 . . . . 0.55 112.321 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -92.67 94.42 9.01 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 121.014 0.435 . . . . 1.89 111.504 -178.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 19' ' ' LEU . . . . . 0.434 HD12 ' HA ' ' B' ' 19' ' ' LEU . 3.3 tp -104.64 122.89 42.05 Favored Pre-proline 0 CA--C 1.535 0.368 0 CA-C-O 120.894 0.378 . . . . 0.4 111.455 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 20' ' ' PRO . . . . . 0.467 ' HA ' ' HD3' ' B' ' 21' ' ' PRO . 18.5 Cg_endo -58.08 123.93 14.8 Favored 'Trans proline' 0 C--N 1.352 0.738 0 C-N-CA 123.581 2.854 . . . . 0.5 113.497 -179.22 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 21' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' B' ' 20' ' ' PRO . 24.5 Cg_exo -63.61 -0.23 2.34 Favored 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 123.442 2.761 . . . . 0.48 114.399 -178.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 22' ' ' GLU . . . . . 0.494 ' O ' ' HB2' ' B' ' 26' ' ' GLN . 1.8 mt-10 -67.93 -25.87 65.69 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.224 0.453 . . . . 1.02 112.224 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 23' ' ' PHE . . . . . 0.5 ' HD1' ' N ' ' B' ' 24' ' ' ALA . 0.1 OUTLIER -55.74 -32.17 63.17 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 112.843 0.683 . . . . 0.36 112.843 -178.924 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 24' ' ' ALA . . . . . 0.674 ' O ' ' HB2' ' B' ' 28' ' ' ARG . . . -69.95 -51.59 31.47 Favored 'General case' 0 C--N 1.322 -0.593 0 O-C-N 122.023 -0.423 . . . . 0.29 111.713 -179.019 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -74.1 -41.41 61.7 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.108 0.41 . . . . 0.33 112.108 -179.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 26' ' ' GLN . . . . . 0.494 ' HB2' ' O ' ' B' ' 22' ' ' GLU . 1.1 tp-100 -62.04 -54.92 34.75 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.326 -0.397 . . . . 0.39 111.297 -179.396 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . 0.428 HD11 ' CD2' ' A' ' 251' ' ' PHE . 70.2 mt -63.47 -37.56 87.75 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.96 -0.296 . . . . 0.35 110.58 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 28' ' ' ARG . . . . . 0.674 ' HB2' ' O ' ' B' ' 24' ' ' ALA . 0.0 OUTLIER -57.88 -57.38 13.06 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 120.694 0.283 . . . . 0.41 111.437 179.292 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 18.8 mmmt -66.48 -35.08 79.37 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.425 -0.352 . . . . 0.48 111.563 -179.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . 0.436 HG23 ' CD2' ' A' ' 205' ' ' HIS . 43.4 mt -64.15 -42.76 96.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 N-CA-C 108.946 -0.761 . . . . 0.39 108.946 177.514 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -58.88 -49.44 78.02 Favored Glycine 0 C--N 1.334 0.449 0 CA-C-N 115.961 -0.563 . . . . 0.29 112.42 178.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -55.55 -44.91 77.24 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 121.16 0.505 . . . . 0.42 110.759 178.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 2.2 ttmp? -65.87 -52.34 51.08 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 115.654 -0.703 . . . . 1.12 111.098 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 40.4 t -56.33 -45.37 81.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-O 121.135 0.493 . . . . 0.46 110.741 178.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 35' ' ' TYR . . . . . 0.463 ' HB2' ' H ' ' A' ' 243' ' ' GLY . 3.4 t80 -56.69 -49.66 74.44 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 115.597 -0.729 . . . . 1.01 110.447 178.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 36' ' ' CYS . . . . . . . . . . . . . 5.9 t -66.13 -34.21 77.54 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 120.825 0.345 . . . . 0.67 111.027 179.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 52.2 m -62.85 -51.79 65.65 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 112.364 0.505 . . . . 0.62 112.364 -179.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 38' ' ' TRP . . . . . . . . . . . . . 96.7 m95 -73.65 -30.38 62.9 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.345 0.498 . . . . 0.88 112.345 -179.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 23.0 t -65.33 -24.89 67.38 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 111.801 0.297 . . . . 0.79 111.801 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -90.21 117.68 68.23 Favored Pre-proline 0 CA--C 1.536 0.419 0 N-CA-C 111.98 0.363 . . . . 0.89 111.98 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -86.28 157.32 9.61 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 122.763 2.309 . . . . 1.35 113.22 179.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -86.93 77.24 9.26 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 121.022 0.439 . . . . 2.68 110.867 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 43' ' ' MET . . . . . . . . . . . . . 23.4 mmt . . . . . 0 C--O 1.251 1.164 0 CA-C-O 118.184 -0.912 . . . . 5.0 111.49 -179.62 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.351 0 CA-C-O 119.924 -0.375 . . . . 0.96 112.389 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -70.67 107.81 2.11 Favored 'Trans proline' 0 CA--C 1.532 0.42 0 C-N-CA 122.84 2.36 . . . . 0.73 112.655 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 90.1 mt -77.43 79.18 3.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.985 0.421 . . . . 1.03 111.356 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -155.79 -173.72 24.76 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 121.024 -0.608 . . . . 0.6 112.275 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 46.6 t -75.41 94.15 3.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.366 0.603 . . . . 0.48 111.53 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -142.9 -63.67 0.41 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.757 -0.656 . . . . 0.46 110.621 179.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -60.7 -36.52 78.99 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.184 -0.462 . . . . 0.59 111.278 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -57.92 -44.99 87.21 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.056 -0.52 . . . . 0.44 110.685 178.428 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 35.0 tp -76.94 -29.3 55.56 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-O 121.323 0.582 . . . . 0.55 109.955 178.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 87.8 t80 -63.89 -30.79 71.84 Favored 'General case' 0 C--O 1.223 -0.338 0 CA-C-N 115.666 -0.697 . . . . 0.35 110.369 178.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.54 ' HD3' ' OE1' ' A' ' 182' ' ' GLU . 45.0 mtt180 -60.72 -51.91 67.36 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.028 0.442 . . . . 0.72 110.261 178.431 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 32.1 mt-30 -59.66 -43.99 93.73 Favored 'General case' 0 N--CA 1.46 0.071 0 CA-C-N 115.701 -0.681 . . . . 1.13 109.515 178.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . 0.572 ' HA ' ' CZ2' ' A' ' 293' ' ' TRP . 18.5 m -60.38 -58.67 7.49 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.191 -0.913 . . . . 0.26 111.531 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.543 HD21 ' HG3' ' A' ' 273' ' ' GLU . 1.4 tm? -53.98 -49.67 68.28 Favored 'General case' 0 CA--C 1.529 0.139 0 O-C-N 123.203 0.315 . . . . 0.4 110.93 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . 0.675 ' HG2' HD23 ' A' ' 180' ' ' LEU . 36.5 tt0 -60.06 -53.55 56.42 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 116.488 -0.324 . . . . 0.39 111.836 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . 0.481 HD11 ' HA2' ' A' ' 187' ' ' GLY . 89.7 mt -61.82 -48.75 87.17 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 N-CA-C 112.567 0.58 . . . . 0.33 112.567 -178.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.581 HD12 HG23 ' A' ' 276' ' ' THR . 80.8 mt -63.93 -52.33 58.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 N-CA-C 112.154 0.427 . . . . 0.34 112.154 -179.038 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.87 -39.78 72.01 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 120.916 0.388 . . . . 0.32 110.534 179.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . 0.53 ' HD2' ' OE2' ' A' ' 169' ' ' GLU . 0.6 OUTLIER -65.77 -52.07 53.92 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.408 -0.36 . . . . 0.45 110.537 178.457 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' TYR . . . . . 0.828 ' HE1' ' HA ' ' A' ' 195' ' ' ARG . 81.4 t80 -55.56 -47.24 76.7 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 112.447 0.536 . . . . 0.35 112.447 -179.48 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.55 ' HG ' ' O ' ' A' ' 163' ' ' ILE . 28.0 mt -64.03 -39.1 93.34 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 120.88 -0.328 . . . . 0.36 110.641 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -66.45 -38.45 87.4 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.958 0.408 . . . . 0.38 110.301 178.297 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . 0.53 ' OE2' ' HD2' ' A' ' 165' ' ' ARG . 0.4 OUTLIER -70.26 -38.35 75.1 Favored 'General case' 0 CA--C 1.528 0.111 0 CA-C-N 116.08 -0.509 . . . . 0.62 110.767 178.58 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . 0.704 ' HG2' ' HB1' ' A' ' 253' ' ' ALA . 6.1 tp60 -68.53 -42.13 78.9 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 116.37 -0.377 . . . . 0.37 110.249 178.455 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.805 ' HA ' ' HG2' ' A' ' 257' ' ' LYS . . . -59.31 -40.5 86.43 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.807 -0.633 . . . . 0.46 111.977 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 76.5 p -87.08 -27.54 23.07 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 121.121 0.486 . . . . 0.47 110.945 178.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 97.36 -20.0 52.48 Favored Glycine 0 CA--C 1.522 0.476 0 CA-C-N 115.655 -0.702 . . . . 0.42 112.501 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 40.7 t -167.5 165.52 14.68 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 122.76 0.424 . . . . 0.69 110.108 -179.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 2.6 tppp? -166.76 -68.11 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.128 0.489 . . . . 0.68 110.178 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -164.61 168.95 17.6 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.494 -0.775 . . . . 0.77 110.121 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 46.8 t -107.73 -1.17 21.25 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.017 -0.538 . . . . 1.54 110.463 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . 0.451 ' HA ' ' HD3' ' A' ' 179' ' ' PRO . 56.1 mttp -69.96 151.34 96.2 Favored Pre-proline 0 C--O 1.237 0.431 0 CA-C-N 115.514 -0.766 . . . . 0.93 111.95 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 178' ' ' LYS . 16.1 Cg_exo -68.87 -169.16 0.27 Allowed 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 123.194 2.596 . . . . 0.78 113.193 179.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.675 HD23 ' HG2' ' A' ' 161' ' ' GLU . 5.2 mp -98.84 -163.37 1.03 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.4 -0.364 . . . . 0.5 111.71 -178.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -102.75 -52.96 0.93 Allowed Glycine 0 C--N 1.331 0.277 0 C-N-CA 120.757 -0.735 . . . . 0.44 112.256 -179.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . 0.54 ' OE1' ' HD3' ' A' ' 157' ' ' ARG . 31.3 mt-10 -84.83 -53.08 5.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.152 0.501 . . . . 0.53 110.28 179.52 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.565 ' O ' ' HA3' ' A' ' 187' ' ' GLY . . . -87.01 86.26 7.3 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.379 -0.373 . . . . 0.34 110.406 178.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -79.93 -71.5 1.26 Allowed Glycine 0 CA--C 1.528 0.886 0 C-N-CA 120.833 -0.699 . . . . 0.42 114.755 -179.051 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -70.79 -55.83 7.71 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 117.203 0.501 . . . . 0.49 111.646 -178.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -65.59 -35.24 80.25 Favored 'General case' 0 C--O 1.222 -0.342 0 CA-C-N 115.979 -0.555 . . . . 0.47 110.111 178.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . 0.565 ' HA3' ' O ' ' A' ' 183' ' ' ALA . . . -66.93 -49.9 51.02 Favored Glycine 0 C--O 1.225 -0.454 0 CA-C-N 115.762 -0.653 . . . . 0.36 112.845 179.237 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 4.2 tpt180 -55.26 -46.9 76.09 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 117.174 0.487 . . . . 0.85 110.113 178.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . 0.658 ' HB3' HG11 ' A' ' 297' ' ' VAL . 50.7 mtm180 -66.9 -40.24 87.68 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.92 -0.582 . . . . 0.32 110.616 179.275 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.406 ' O ' ' HB2' ' A' ' 194' ' ' LEU . . . -65.27 -40.43 93.89 Favored 'General case' 0 C--O 1.223 -0.338 0 CA-C-N 116.334 -0.394 . . . . 0.29 111.511 179.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 13.6 tp -64.58 -41.0 96.55 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 110.247 -0.279 . . . . 0.7 110.247 178.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 15.8 tm-20 -65.68 -50.63 64.22 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 109.732 -0.47 . . . . 0.32 109.732 178.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . 0.436 HG21 ' HA ' ' A' ' 297' ' ' VAL . 8.5 m -60.05 -43.22 95.54 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.905 -0.589 . . . . 0.38 110.974 179.46 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 0.449 HD12 ' HA ' ' A' ' 194' ' ' LEU . 7.4 tp -65.59 -41.92 92.27 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 116.233 -0.44 . . . . 0.42 111.829 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . 0.828 ' HA ' ' HE1' ' A' ' 166' ' ' TYR . 8.8 tpt180 -67.35 -38.71 85.24 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.093 0.473 . . . . 0.42 110.538 179.322 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 15.2 ttm180 -67.01 -56.71 8.95 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 115.78 -0.645 . . . . 0.52 111.999 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 34.7 t -71.56 -38.59 68.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 111.95 0.352 . . . . 0.33 111.95 -178.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . 0.64 ' O ' ' HB2' ' A' ' 202' ' ' GLN . . . -62.02 -54.04 38.12 Favored Glycine 0 C--N 1.331 0.275 0 C-N-CA 121.052 -0.595 . . . . 0.29 112.793 -179.576 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . 0.401 ' HB2' ' O ' ' A' ' 195' ' ' ARG . 0.4 OUTLIER -64.81 -38.8 92.2 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 117.045 0.422 . . . . 0.37 110.675 179.211 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -59.86 -48.63 85.13 Favored Glycine 0 CA--C 1.524 0.626 0 C-N-CA 120.744 -0.741 . . . . 0.33 112.137 178.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 73.7 t -70.46 -42.29 78.34 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-O 120.862 0.363 . . . . 0.37 110.816 178.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' GLN . . . . . 0.64 ' HB2' ' O ' ' A' ' 198' ' ' GLY . 2.1 tt0 -58.87 -53.34 59.49 Favored 'General case' 0 C--O 1.224 -0.278 0 CA-C-N 115.652 -0.704 . . . . 0.42 111.807 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' ARG . . . . . 0.511 ' HA ' ' OE1' ' A' ' 206' ' ' GLU . 0.0 OUTLIER -64.4 -35.2 80.12 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-O 120.718 0.294 . . . . 0.4 110.393 179.779 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -65.94 -49.82 66.58 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 121.027 0.441 . . . . 0.86 110.765 178.137 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 72.1 m-70 -100.75 36.09 2.02 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.425 -0.352 . . . . 0.46 111.47 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . 0.511 ' OE1' ' HA ' ' A' ' 203' ' ' ARG . 3.7 tp10 -55.53 -49.0 73.79 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.222 -0.444 . . . . 0.4 111.212 -179.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 69.4 p -62.98 -42.8 99.94 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.983 -0.553 . . . . 0.5 111.52 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -61.8 -46.11 90.95 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.018 0.437 . . . . 0.41 110.306 178.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' PHE . . . . . 0.605 ' HE2' ' HA ' ' A' ' 202' ' ' GLN . 16.8 m-30 -65.43 -44.11 88.35 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.98 -0.555 . . . . 0.45 110.06 179.331 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -61.23 -44.08 97.84 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.091 -0.504 . . . . 0.8 110.594 178.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -60.07 -48.58 85.43 Favored Glycine 0 C--N 1.334 0.444 0 N-CA-C 111.205 -0.758 . . . . 0.34 111.205 178.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' MET . . . . . 0.533 ' O ' ' HG ' ' A' ' 216' ' ' LEU . 1.2 mtp -64.31 -35.03 79.53 Favored 'General case' 0 C--O 1.224 -0.253 0 CA-C-O 120.655 0.264 . . . . 0.72 110.312 178.407 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.445 HD22 ' HA ' ' A' ' 213' ' ' LEU . 0.4 OUTLIER -60.61 -47.99 83.75 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.239 -0.437 . . . . 0.51 110.004 178.473 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 73.0 mtp180 -61.97 -31.71 72.09 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.122 -0.49 . . . . 1.14 111.016 179.125 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -84.95 -9.09 58.43 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.12 -0.491 . . . . 1.23 111.682 179.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.663 ' HA ' HD21 ' B' ' 19' ' ' LEU . 20.3 mt -82.41 142.89 31.59 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.155 0.502 . . . . 0.52 112.295 -179.531 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' ASP . . . . . 0.41 ' OD2' ' N ' ' B' ' 17' ' ' ALA . 0.4 OUTLIER -102.07 5.74 40.66 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.846 -0.616 . . . . 0.66 110.212 178.403 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' ILE . . . . . 0.62 HG22 ' HE2' ' A' ' 267' ' ' PHE . 21.0 mm -55.33 106.93 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 CA-C-N 115.9 -0.591 . . . . 0.49 112.319 -178.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 6.1 mtmp? -143.48 -42.19 0.29 Allowed 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 112.373 0.509 . . . . 0.67 112.373 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 18.2 m-80 -124.1 -178.91 4.22 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 113.085 0.772 . . . . 1.24 113.085 -178.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . 0.576 ' O ' HG22 ' A' ' 224' ' ' VAL . 12.2 tm-20 -51.92 -37.61 53.24 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 112.867 0.691 . . . . 0.76 112.867 -179.184 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -63.83 -26.47 70.06 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 120.816 -0.707 . . . . 0.35 113.622 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' ASP . . . . . 0.556 ' HB3' ' HA ' ' A' ' 218' ' ' ILE . 59.0 m-20 -72.34 -31.12 65.35 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 113.322 0.86 . . . . 0.44 113.322 -178.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.576 HG22 ' O ' ' A' ' 221' ' ' GLU . 4.8 m -55.87 -29.1 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 CA-C-O 120.833 0.349 . . . . 0.45 111.469 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 10.7 mttp -66.0 -38.71 89.16 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.152 0.501 . . . . 0.84 109.908 178.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . 0.492 ' O ' HG23 ' A' ' 230' ' ' VAL . 1.8 t -68.74 -30.67 69.34 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 109.113 -0.699 . . . . 0.46 109.113 178.183 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -66.5 -36.67 83.3 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 109.004 -0.739 . . . . 0.6 109.004 178.075 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 7.1 t -62.03 -39.72 93.29 Favored 'General case' 0 N--CA 1.462 0.147 0 N-CA-C 108.992 -0.744 . . . . 0.37 108.992 176.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' ARG . . . . . 0.476 ' HA ' HG22 ' A' ' 232' ' ' VAL . 0.0 OUTLIER -61.07 -36.88 80.8 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-N 115.617 -0.719 . . . . 0.39 109.934 177.873 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 0.564 HG22 ' CE1' ' B' ' 23' ' ' PHE . 29.4 t -65.99 -48.14 82.76 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-O 121.316 0.579 . . . . 0.34 109.439 177.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 231' ' ' MET . . . . . 0.525 ' SD ' HD13 ' A' ' 248' ' ' LEU . 8.1 tpp -60.34 -49.47 77.45 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 115.198 -0.91 . . . . 0.46 111.508 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 232' ' ' VAL . . . . . 0.476 HG22 ' HA ' ' A' ' 229' ' ' ARG . 33.3 m -64.66 -32.05 56.29 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 120.745 -0.382 . . . . 0.44 111.866 -179.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 7.3 t-80 -72.38 -47.02 52.7 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 120.899 -0.32 . . . . 0.38 110.843 178.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 70.2 t -62.32 -31.28 51.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-O 120.911 0.386 . . . . 0.44 111.571 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -97.3 4.34 50.89 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 122.224 -0.298 . . . . 0.49 111.749 179.092 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . 0.463 ' HB2' ' O ' ' A' ' 232' ' ' VAL . 0.3 OUTLIER -73.87 -17.83 61.0 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 112.286 0.476 . . . . 1.58 112.286 -178.989 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -70.12 -11.33 60.81 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.924 0.392 . . . . 0.43 111.244 179.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 91.1 -19.31 47.15 Favored Glycine 0 CA--C 1.519 0.33 0 C-N-CA 121.087 -0.578 . . . . 0.37 112.554 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -95.69 92.71 3.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.117 0.484 . . . . 0.47 112.109 -179.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 240' ' ' THR . . . . . 0.521 HG22 HD11 ' A' ' 245' ' ' ILE . 2.4 m -79.03 62.61 3.49 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.487 0.66 . . . . 0.36 110.347 178.505 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 73.2 m-20 -65.42 137.77 57.68 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.441 -0.8 . . . . 0.34 111.705 -179.059 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 242' ' ' TRP . . . . . . . . . . . . . 78.7 m95 -54.73 -38.6 67.31 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.154 -0.475 . . . . 0.41 111.188 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . 0.481 ' H ' ' HB2' ' B' ' 35' ' ' TYR . . . -58.61 -32.44 69.2 Favored Glycine 0 CA--C 1.521 0.419 0 C-N-CA 120.902 -0.666 . . . . 0.29 111.919 178.143 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 78.8 mtt180 -75.44 -41.95 54.58 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-O 120.943 0.401 . . . . 0.3 109.933 178.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . 0.563 ' O ' HG12 ' A' ' 249' ' ' ILE . 78.3 mt -62.14 -49.32 84.52 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-N 115.819 -0.628 . . . . 0.48 110.561 179.142 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . 0.424 HG21 ' CE2' ' A' ' 300' ' ' PHE . 48.0 t -67.48 -38.46 80.7 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 CA-C-N 116.347 -0.388 . . . . 0.36 111.047 179.317 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 19.4 m -62.2 -40.1 94.96 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 120.909 -0.316 . . . . 0.39 110.247 178.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 248' ' ' LEU . . . . . 0.525 HD13 ' SD ' ' A' ' 231' ' ' MET . 44.7 mt -65.24 -35.27 80.54 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 109.776 -0.453 . . . . 0.61 109.776 177.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 249' ' ' ILE . . . . . 0.563 HG12 ' O ' ' A' ' 245' ' ' ILE . 36.7 mm -69.41 -40.35 79.85 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 N-CA-C 109.084 -0.71 . . . . 0.43 109.084 177.442 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 14.7 m -61.67 -48.38 81.07 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.242 -0.89 . . . . 0.32 109.923 178.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 251' ' ' PHE . . . . . 0.542 ' O ' HG23 ' A' ' 255' ' ' VAL . 12.8 t80 -63.45 -45.06 92.61 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 115.648 -0.705 . . . . 0.59 109.832 178.305 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -57.79 -45.16 93.81 Favored Glycine 0 C--N 1.337 0.594 0 N-CA-C 111.181 -0.768 . . . . 0.26 111.181 178.199 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 253' ' ' ALA . . . . . 0.704 ' HB1' ' HG2' ' A' ' 170' ' ' GLN . . . -59.95 -38.56 82.82 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 122.328 0.251 . . . . 0.26 110.683 177.582 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 61.2 t80 -61.28 -40.42 94.05 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 121.147 0.499 . . . . 0.49 109.776 178.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 255' ' ' VAL . . . . . 0.542 HG23 ' O ' ' A' ' 251' ' ' PHE . 20.2 t -67.47 -40.24 84.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 CA-C-N 115.735 -0.666 . . . . 0.29 109.81 178.048 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -58.43 -41.36 84.88 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.115 0.484 . . . . 0.28 110.1 178.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 257' ' ' LYS . . . . . 0.805 ' HG2' ' HA ' ' A' ' 171' ' ' ALA . 14.4 mtpp -62.86 -45.22 93.6 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 115.76 -0.655 . . . . 0.57 110.104 177.508 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 82.6 t60 -60.6 -39.77 89.37 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 109.672 -0.492 . . . . 0.51 109.672 178.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.482 HD21 ' CD2' ' A' ' 267' ' ' PHE . 4.4 mp -64.26 -50.68 67.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.856 -0.611 . . . . 0.52 110.037 178.528 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 260' ' ' LYS . . . . . 0.713 ' HG3' ' HB1' ' A' ' 171' ' ' ALA . 0.0 OUTLIER -61.57 -29.6 70.12 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.682 -0.236 . . . . 0.6 111.597 179.204 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 56.4 m -57.55 -33.05 67.71 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.041 0.448 . . . . 0.54 111.002 179.097 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 262' ' ' VAL . . . . . 0.531 HG23 ' HG3' ' A' ' 264' ' ' GLN . 26.4 m -112.12 13.63 8.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 CA-C-N 115.787 -0.642 . . . . 0.52 110.079 178.358 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 34.8 t30 58.8 47.24 12.95 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 115.079 -0.964 . . . . 0.55 113.012 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 264' ' ' GLN . . . . . 0.531 ' HG3' HG23 ' A' ' 262' ' ' VAL . 19.9 mt-30 -87.83 39.0 0.86 Allowed 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 116.523 -0.308 . . . . 0.97 111.666 179.007 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . 0.419 ' HA ' HD12 ' A' ' 268' ' ' ILE . 7.3 tp10 -49.34 -39.53 32.02 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 121.048 0.451 . . . . 0.45 112.051 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 3.2 p -59.34 -20.33 53.75 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.815 -0.63 . . . . 0.97 111.948 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 267' ' ' PHE . . . . . 0.62 ' HE2' HG22 ' A' ' 218' ' ' ILE . 15.7 t80 -103.57 -21.66 13.72 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 120.8 0.333 . . . . 0.53 111.011 179.38 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 268' ' ' ILE . . . . . 0.419 HD12 ' HA ' ' A' ' 265' ' ' GLU . 63.7 mt -65.39 -43.26 94.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.547 -0.297 . . . . 0.39 110.808 179.663 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 269' ' ' GLU . . . . . 0.642 ' HB3' ' HD3' ' A' ' 270' ' ' PRO . 1.8 tp10 -55.23 -58.13 16.62 Favored Pre-proline 0 CA--C 1.544 0.728 0 CA-C-N 116.332 -0.394 . . . . 0.43 111.01 179.061 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 270' ' ' PRO . . . . . 0.642 ' HD3' ' HB3' ' A' ' 269' ' ' GLU . 26.6 Cg_exo -63.64 -36.55 52.19 Favored 'Trans proline' 0 C--N 1.358 1.036 0 C-N-CA 121.725 1.617 . . . . 0.29 112.655 179.179 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 271' ' ' LEU . . . . . . . . . . . . . 52.6 tp -65.72 -54.81 22.2 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 121.147 -0.221 . . . . 0.5 111.49 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -58.16 -44.58 88.0 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-O 120.861 0.362 . . . . 0.29 111.445 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 273' ' ' GLU . . . . . 0.543 ' HG3' HD21 ' A' ' 160' ' ' LEU . 0.5 OUTLIER -66.51 -39.84 88.9 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 116.246 -0.434 . . . . 0.36 111.4 179.755 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 274' ' ' THR . . . . . 0.483 HG21 ' HB ' ' A' ' 224' ' ' VAL . 62.5 m -64.16 -45.34 88.88 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 120.718 0.294 . . . . 0.39 110.395 179.019 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 96.3 mt -54.12 -52.99 32.11 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 CA-C-N 116.093 -0.503 . . . . 0.42 110.622 179.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 276' ' ' THR . . . . . 0.581 HG23 HD12 ' A' ' 163' ' ' ILE . 56.8 m -56.38 -52.47 64.49 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.543 -0.298 . . . . 0.28 111.781 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 277' ' ' ASP . . . . . 0.59 ' OD1' ' HD2' ' A' ' 281' ' ' ARG . 0.4 OUTLIER -53.8 -51.66 62.77 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 112.127 0.418 . . . . 0.43 112.127 -179.364 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 27.3 t -70.05 -46.56 72.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 111.887 0.329 . . . . 0.38 111.887 -179.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . 0.46 HD21 HG23 ' A' ' 245' ' ' ILE . 0.4 OUTLIER -62.67 -41.24 98.98 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 113.14 0.792 . . . . 0.54 113.14 -178.757 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 280' ' ' VAL . . . . . 0.424 HG21 ' HB3' ' A' ' 159' ' ' SER . 81.4 t -87.21 -46.22 16.2 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 N-CA-C 113.768 1.025 . . . . 0.48 113.768 -178.266 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 281' ' ' ARG . . . . . 0.59 ' HD2' ' OD1' ' A' ' 277' ' ' ASP . 38.1 mtt85 -70.96 -34.9 71.89 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 114.425 1.269 . . . . 0.53 114.425 -177.122 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 282' ' ' THR . . . . . . . . . . . . . 42.0 p -61.5 -30.71 70.8 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 119.073 0.851 . . . . 0.35 111.513 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 29.9 mmtp -125.06 41.21 3.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.321 -0.399 . . . . 0.36 111.001 179.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 284' ' ' ARG . . . . . 0.524 ' HG2' ' N ' ' A' ' 285' ' ' ASP . 0.0 OUTLIER -53.34 -35.6 60.39 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 112.866 0.691 . . . . 0.44 112.866 -179.319 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 285' ' ' ASP . . . . . 0.524 ' N ' ' HG2' ' A' ' 284' ' ' ARG . 8.1 p-10 -63.04 -44.41 95.94 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-O 120.634 0.254 . . . . 0.46 111.254 -179.363 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 286' ' ' TRP . . . . . 0.777 ' HA ' ' HD2' ' A' ' 289' ' ' LYS . 0.0 OUTLIER -61.5 -34.68 75.91 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.163 0.506 . . . . 0.4 110.477 179.404 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 287' ' ' LEU . . . . . 0.588 HD13 ' HA2' ' A' ' 292' ' ' GLY . 1.7 mm? -70.13 -47.01 63.55 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.566 -0.743 . . . . 0.54 110.482 179.194 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 288' ' ' VAL . . . . . 0.509 HG23 ' O ' ' A' ' 284' ' ' ARG . 64.3 t -60.67 -33.07 53.42 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 CA-C-O 120.898 0.38 . . . . 0.92 110.858 178.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 289' ' ' LYS . . . . . 0.777 ' HD2' ' HA ' ' A' ' 286' ' ' TRP . 74.3 mttt -60.45 -42.17 95.61 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.01 -0.541 . . . . 0.47 112.213 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 290' ' ' GLN . . . . . 0.534 ' HB3' ' HA3' ' A' ' 295' ' ' GLY . 5.1 mt-30 -111.86 28.29 8.89 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 112.869 0.692 . . . . 0.45 112.869 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 291' ' ' ARG . . . . . 0.489 ' HB3' ' HB2' ' A' ' 294' ' ' ASP . 3.8 mmm180 59.09 13.91 3.18 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 112.768 0.655 . . . . 0.55 112.768 179.545 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 292' ' ' GLY . . . . . 0.588 ' HA2' HD13 ' A' ' 287' ' ' LEU . . . 75.06 -108.2 2.47 Favored Glycine 0 N--CA 1.448 -0.502 0 N-CA-C 114.361 0.504 . . . . 0.35 114.361 179.448 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 293' ' ' TRP . . . . . 0.572 ' CZ2' ' HA ' ' A' ' 159' ' ' SER . 80.5 m95 -68.42 -29.27 67.9 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.62 0.6 . . . . 0.51 112.62 -177.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 294' ' ' ASP . . . . . 0.489 ' HB2' ' HB3' ' A' ' 291' ' ' ARG . 22.0 m-20 -62.11 -44.99 95.44 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 120.57 -0.452 . . . . 0.38 109.949 178.489 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 295' ' ' GLY . . . . . 0.534 ' HA3' ' HB3' ' A' ' 290' ' ' GLN . . . -69.07 -33.85 75.04 Favored Glycine 0 C--O 1.224 -0.524 0 C-N-CA 120.809 -0.71 . . . . 0.35 111.695 178.076 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 296' ' ' PHE . . . . . 0.405 ' CD2' ' HE3' ' A' ' 293' ' ' TRP . 0.5 OUTLIER -70.51 -45.11 66.22 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 120.655 0.264 . . . . 0.35 111.232 179.111 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 297' ' ' VAL . . . . . 0.658 HG11 ' HB3' ' A' ' 189' ' ' ARG . 69.3 t -63.81 -50.65 76.77 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.117 0 CA-C-O 120.689 0.281 . . . . 0.29 110.75 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.34 -22.87 64.66 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 116.188 -0.46 . . . . 0.43 111.745 -179.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 299' ' ' PHE . . . . . 0.412 ' HB2' ' O ' ' A' ' 295' ' ' GLY . 88.2 t80 -71.54 -36.04 70.87 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-O 120.764 0.316 . . . . 0.46 110.854 178.319 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 300' ' ' PHE . . . . . 0.424 ' CE2' HG21 ' A' ' 246' ' ' VAL . 79.3 m-85 -100.07 -5.41 28.01 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.79 0.329 . . . . 0.53 111.832 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 301' ' ' HIS . . . . . 0.468 ' HB2' ' O ' ' A' ' 297' ' ' VAL . 1.6 m-70 -102.37 30.37 4.62 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.556 -0.293 . . . . 0.75 110.453 178.572 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 14.1 p -58.85 -25.16 28.37 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-O 121.132 0.491 . . . . 0.75 111.448 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -87.99 -80.37 0.27 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.987 -0.551 . . . . 1.37 110.389 179.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -86.29 73.32 10.21 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 121.246 0.546 . . . . 0.66 111.624 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 305' ' ' LEU . . . . . 0.418 ' HG ' ' O ' ' A' ' 301' ' ' HIS . 14.6 mt -63.93 -30.39 71.47 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.33 -0.395 . . . . 1.28 111.921 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -82.96 -15.1 52.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.32 -0.4 . . . . 1.12 111.696 -179.438 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . -85.8 173.2 46.99 Favored Glycine 0 CA--C 1.523 0.542 0 C-N-CA 120.791 -0.719 . . . . 0.98 112.685 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.282 0 CA-C-O 118.643 -1.087 . . . . 0.81 112.949 179.93 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 17' ' ' ALA . . . . . 0.41 ' N ' ' OD2' ' A' ' 217' ' ' ASP . . . . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.424 0.154 . . . . 1.04 110.825 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.4 164.27 12.89 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.894 0.378 . . . . 0.49 110.731 179.363 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 19' ' ' LEU . . . . . 0.663 HD21 ' HA ' ' A' ' 216' ' ' LEU . 7.1 mt -111.0 115.23 53.23 Favored Pre-proline 0 C--N 1.326 -0.435 0 N-CA-C 112.097 0.406 . . . . 0.46 112.097 -179.218 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -75.55 146.04 30.32 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.779 2.32 . . . . 0.54 112.064 179.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 21' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -68.99 35.55 0.19 Allowed 'Trans proline' 0 CA--C 1.542 0.918 0 C-N-CA 122.935 2.423 . . . . 0.54 114.493 -178.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -83.1 -42.02 17.89 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 121.039 0.447 . . . . 0.89 110.172 179.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 23' ' ' PHE . . . . . 0.584 ' HE2' HD22 ' B' ' 19' ' ' LEU . 0.7 OUTLIER -57.34 -37.79 73.11 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 115.706 -0.679 . . . . 0.38 111.394 179.377 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 24' ' ' ALA . . . . . 0.518 ' N ' ' HD1' ' B' ' 23' ' ' PHE . . . -65.57 -40.25 92.56 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.121 -0.491 . . . . 0.4 111.655 -179.151 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . 0.513 ' O ' ' HG3' ' B' ' 29' ' ' LYS . . . -66.15 -46.85 76.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.996 0.427 . . . . 0.4 110.218 179.175 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -62.32 -51.57 67.11 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 115.827 -0.624 . . . . 0.61 110.68 179.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 51.3 mt -57.65 -41.72 82.03 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.755 0.312 . . . . 0.59 110.339 178.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 28' ' ' ARG . . . . . . . . . . . . . 1.2 ttm180 -58.86 -50.81 72.58 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.164 -0.471 . . . . 0.75 110.434 178.133 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . 0.513 ' HG3' ' O ' ' B' ' 25' ' ' ALA . 85.3 mttt -57.82 -51.39 69.78 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.039 -0.528 . . . . 0.65 110.798 178.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 78.9 mt -58.87 -45.45 91.69 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 CA-C-N 115.878 -0.601 . . . . 0.42 110.983 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -58.67 -50.52 66.37 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.897 -0.668 . . . . 0.28 113.009 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 -68.17 -37.21 80.73 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.966 0.383 . . . . 0.37 111.527 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 21.8 ttmm -62.42 -50.5 71.27 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 120.912 0.387 . . . . 0.81 110.328 178.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 49.1 t -63.19 -47.43 92.35 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 116.097 -0.501 . . . . 0.41 110.593 178.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 35' ' ' TYR . . . . . 0.481 ' HB2' ' H ' ' A' ' 243' ' ' GLY . 1.6 t80 -58.04 -50.82 72.1 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 115.777 -0.647 . . . . 0.98 111.508 179.44 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 36' ' ' CYS . . . . . . . . . . . . . 13.0 t -63.14 -28.43 70.06 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 120.804 0.335 . . . . 0.48 111.839 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 89.1 m -77.64 -45.91 23.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.425 -0.352 . . . . 0.44 111.87 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 38' ' ' TRP . . . . . . . . . . . . . 97.1 m95 -80.12 -19.7 46.71 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 112.95 0.722 . . . . 0.54 112.95 -178.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 40.0 t -74.2 -6.49 48.08 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 112.268 0.47 . . . . 0.43 112.268 179.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -90.15 119.35 69.27 Favored Pre-proline 0 CA--C 1.533 0.313 0 N-CA-C 112.003 0.372 . . . . 0.51 112.003 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -84.13 -15.46 6.67 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.721 2.281 . . . . 0.97 112.824 179.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -78.81 89.92 4.66 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.12 -0.491 . . . . 1.22 110.993 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 43' ' ' MET . . . . . . . . . . . . . 64.5 mtt . . . . . 0 C--O 1.251 1.157 0 CA-C-O 118.249 -0.881 . . . . 1.72 111.425 179.91 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.131 0 N-CA-C 112.14 -0.384 . . . . 0.6 112.14 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -69.93 -67.77 0.03 OUTLIER 'Trans proline' 0 CA--C 1.534 0.516 0 C-N-CA 122.523 2.149 . . . . 0.94 112.5 179.442 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 25.3 tp -170.86 149.64 3.06 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.212 -0.449 . . . . 0.81 110.219 179.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 167.37 171.52 33.5 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.274 -0.965 . . . . 0.4 113.016 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -62.32 -30.06 70.89 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 112.228 0.455 . . . . 0.46 112.228 -179.672 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -114.77 26.89 9.82 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.295 -0.411 . . . . 0.4 111.321 -179.435 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 12.0 t0 -77.75 -27.96 50.54 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 112.478 0.548 . . . . 0.37 112.478 -178.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -55.15 -56.48 19.43 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 120.95 0.405 . . . . 0.78 111.369 -179.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.22 -37.08 77.84 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.028 0.442 . . . . 0.73 110.534 179.567 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 13.6 t80 -61.62 -40.71 95.83 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 115.906 -0.588 . . . . 0.41 111.697 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.401 HH11 ' HD3' ' A' ' 157' ' ' ARG . 55.0 mtt-85 -65.32 -48.3 73.53 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 111.834 0.309 . . . . 0.49 111.834 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 2.7 mm-40 -62.07 -42.48 99.24 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.203 0.525 . . . . 0.39 110.303 179.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . 0.469 ' HA ' ' CZ2' ' A' ' 293' ' ' TRP . 12.3 m -66.19 -54.69 22.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.756 -0.657 . . . . 0.25 111.218 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.614 ' HA ' HG21 ' A' ' 276' ' ' THR . 2.0 tm? -54.11 -46.38 72.13 Favored 'General case' 0 N--CA 1.464 0.248 0 O-C-N 123.183 0.302 . . . . 0.73 111.08 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . 0.579 ' HG2' HD12 ' A' ' 180' ' ' LEU . 30.3 tt0 -63.57 -54.38 37.03 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 112.067 0.395 . . . . 0.4 112.067 -179.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . 0.478 HD11 ' HA2' ' A' ' 187' ' ' GLY . 88.1 mt -59.33 -46.68 92.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 N-CA-C 111.589 0.218 . . . . 0.33 111.589 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.57 HD12 HG23 ' A' ' 276' ' ' THR . 84.2 mt -62.84 -51.23 74.62 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 C-N-CA 121.085 -0.246 . . . . 0.32 111.462 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 55.2 p -58.78 -42.29 88.65 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.586 0.231 . . . . 0.29 111.302 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . 0.432 ' O ' ' HB2' ' A' ' 169' ' ' GLU . 2.0 tpt85 -58.02 -51.64 68.81 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.855 0.359 . . . . 0.35 110.806 179.374 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' TYR . . . . . 0.475 ' O ' ' HB2' ' A' ' 170' ' ' GLN . 66.7 t80 -64.04 -49.37 72.62 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.937 -0.574 . . . . 0.37 112.065 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.517 ' HG ' ' O ' ' A' ' 163' ' ' ILE . 21.4 mt -56.17 -45.96 79.53 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 112.024 0.379 . . . . 0.32 112.024 -178.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . 0.41 HH11 ' HD2' ' A' ' 168' ' ' ARG . 11.8 ttm105 -70.18 -44.59 68.43 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.57 0.224 . . . . 0.34 111.133 179.431 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . 0.432 ' HB2' ' O ' ' A' ' 165' ' ' ARG . 1.9 tt0 -61.52 -36.08 79.53 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-O 121.32 0.581 . . . . 0.46 110.564 179.347 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . 0.475 ' HB2' ' O ' ' A' ' 166' ' ' TYR . 1.8 tm0? -71.98 -47.8 49.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.76 -0.654 . . . . 0.4 110.246 178.434 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -61.53 -24.51 66.67 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.094 -0.503 . . . . 0.36 112.103 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 12.0 p -95.01 -7.93 38.32 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 111.914 0.338 . . . . 0.49 111.914 179.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 58.18 28.63 61.69 Favored Glycine 0 C--N 1.336 0.58 0 CA-C-N 116.333 -0.394 . . . . 0.57 113.532 179.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 30.1 m -126.5 174.66 8.48 Favored 'General case' 0 C--N 1.329 -0.296 0 O-C-N 122.61 -0.347 . . . . 0.54 111.413 -179.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . 0.456 ' HE3' ' HB3' ' A' ' 175' ' ' LYS . 9.2 mmmt -124.12 125.66 44.86 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 111.959 0.355 . . . . 0.62 111.959 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -105.59 138.61 41.51 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 121.054 0.454 . . . . 0.49 111.045 179.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 68.8 p -94.57 -18.43 21.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.155 -0.475 . . . . 0.74 111.108 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . 0.43 ' HB2' HH22 ' A' ' 165' ' ' ARG . 24.2 mttp -60.94 144.49 90.39 Favored Pre-proline 0 CA--C 1.532 0.27 0 CA-C-N 116.293 -0.412 . . . . 0.68 111.388 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 178' ' ' LYS . 24.5 Cg_exo -63.72 161.93 30.31 Favored 'Trans proline' 0 CA--C 1.533 0.43 0 C-N-CA 123.13 2.554 . . . . 0.57 113.784 -179.399 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.579 HD12 ' HG2' ' A' ' 161' ' ' GLU . 4.1 mm? -54.44 -60.51 3.25 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.769 -0.65 . . . . 0.63 111.04 179.546 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 149.99 -69.55 0.32 Allowed Glycine 0 CA--C 1.521 0.447 0 CA-C-N 115.364 -0.835 . . . . 0.72 111.347 -179.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . 0.459 ' H ' ' CD ' ' A' ' 161' ' ' GLU . 87.4 mt-10 -109.98 -36.24 5.93 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.141 0.496 . . . . 0.82 110.206 178.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.531 ' O ' ' HA3' ' A' ' 187' ' ' GLY . . . -83.65 85.8 7.22 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 116.164 -0.471 . . . . 0.31 110.349 178.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -77.33 -71.47 1.2 Allowed Glycine 0 CA--C 1.525 0.688 0 C-N-CA 120.445 -0.884 . . . . 0.37 114.543 -178.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -63.43 -56.19 18.16 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 112.076 0.399 . . . . 0.43 112.076 -178.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -66.56 -44.44 82.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.373 -0.376 . . . . 0.36 110.702 179.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . 0.531 ' HA3' ' O ' ' A' ' 183' ' ' ALA . . . -57.48 -53.49 44.61 Favored Glycine 0 CA--C 1.522 0.507 0 C-N-CA 121.238 -0.506 . . . . 0.33 113.823 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . 0.444 HH11 ' HD2' ' A' ' 188' ' ' ARG . 1.6 mmp_? -61.17 -44.48 97.23 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 117.617 0.708 . . . . 0.5 112.245 -179.661 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . 0.581 ' HB3' HG11 ' A' ' 297' ' ' VAL . 49.9 mtm180 -66.93 -39.12 87.25 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 120.802 0.334 . . . . 0.43 110.745 179.429 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.44 ' HA ' HG22 ' A' ' 297' ' ' VAL . . . -70.58 -34.79 72.57 Favored 'General case' 0 C--O 1.222 -0.349 0 CA-C-N 116.362 -0.381 . . . . 0.27 110.677 178.645 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.53 -45.4 94.34 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.823 -0.171 . . . . 0.61 111.142 179.202 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -66.79 -45.46 78.36 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 121.028 0.442 . . . . 0.35 111.125 179.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 1.3 p -65.21 -48.51 73.14 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.288 -0.415 . . . . 0.36 111.7 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 0.483 HD21 HG21 ' A' ' 249' ' ' ILE . 19.1 tp -60.65 -35.49 76.35 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 116.406 -0.361 . . . . 0.36 111.112 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . 0.422 ' HA ' ' HE1' ' A' ' 166' ' ' TYR . 5.0 mmt180 -65.05 -44.49 88.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.917 0.389 . . . . 0.34 110.775 178.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.88 -52.43 24.86 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.149 0.426 . . . . 0.34 112.149 -179.43 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . 0.482 ' O ' HG23 ' A' ' 201' ' ' VAL . 48.1 t -69.61 -43.39 80.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 N-CA-C 112.572 0.582 . . . . 0.32 112.572 -178.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -67.14 -51.68 37.14 Favored Glycine 0 CA--C 1.521 0.409 0 C-N-CA 121.018 -0.611 . . . . 0.23 113.467 -178.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -63.87 -35.79 81.79 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 120.804 0.335 . . . . 0.29 110.378 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -59.94 -48.15 87.48 Favored Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 111.119 -0.792 . . . . 0.29 111.119 177.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 197' ' ' VAL . 76.3 t -64.04 -40.93 90.83 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 122.217 0.207 . . . . 0.32 111.331 179.014 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' GLN . . . . . 0.499 ' HA ' ' HE2' ' A' ' 209' ' ' PHE . 31.7 tt0 -60.07 -48.07 83.24 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 116.587 -0.279 . . . . 0.42 111.5 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.33 -39.02 71.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.615 0.245 . . . . 1.44 111.255 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 18.2 m-80 -67.08 -52.22 44.64 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 111.969 0.359 . . . . 1.23 111.969 179.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 74.0 m-70 -101.47 34.91 2.43 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 112.427 0.529 . . . . 0.42 112.427 -178.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -62.9 -40.12 96.61 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 120.999 -0.28 . . . . 0.44 111.266 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 38.4 p -60.66 -43.11 98.01 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.061 0.458 . . . . 0.55 110.683 179.414 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . 0.441 ' O ' ' HG3' ' A' ' 212' ' ' MET . . . -65.99 -41.87 90.55 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.83 -0.623 . . . . 0.37 109.93 178.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' PHE . . . . . 0.499 ' HE2' ' HA ' ' A' ' 202' ' ' GLN . 14.4 m-30 -63.0 -42.58 99.88 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.893 -0.594 . . . . 0.45 110.112 178.66 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' GLN . . . . . 0.698 ' O ' ' HG2' ' A' ' 214' ' ' ARG . 31.3 mt-30 -57.79 -46.72 84.21 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.288 -0.414 . . . . 0.64 110.542 178.494 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -55.68 -46.75 81.36 Favored Glycine 0 C--N 1.339 0.711 0 C-N-CA 121.051 -0.595 . . . . 0.33 111.951 178.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' MET . . . . . 0.473 ' HB3' ' HB3' ' B' ' 23' ' ' PHE . 35.1 mtt -62.91 -42.68 99.87 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 109.515 -0.55 . . . . 0.7 109.515 177.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 12.7 tp -58.92 -44.53 91.31 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.744 -0.662 . . . . 0.6 111.11 179.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' ARG . . . . . 0.698 ' HG2' ' O ' ' A' ' 210' ' ' GLN . 22.1 mmt180 -60.65 -35.16 75.54 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 120.887 0.375 . . . . 1.08 110.945 179.439 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -94.7 12.31 28.22 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.968 0.359 . . . . 1.13 111.968 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.506 ' HB3' HG12 ' A' ' 218' ' ' ILE . 12.1 mt -99.39 154.27 18.33 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.127 0.489 . . . . 0.7 111.511 179.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -105.05 17.2 24.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.9 -0.591 . . . . 1.09 111.052 179.62 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' ILE . . . . . 0.543 ' HA ' ' HB2' ' A' ' 223' ' ' ASP . 17.3 mm -59.33 105.93 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-N 116.417 -0.356 . . . . 0.42 111.441 -179.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . 0.444 ' HG3' ' O ' ' A' ' 218' ' ' ILE . 7.5 mtmp? -159.56 -65.64 0.08 Allowed 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.862 -0.608 . . . . 0.62 110.7 -179.301 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -104.3 -175.65 2.86 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 115.098 -0.955 . . . . 0.69 110.722 -179.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . 0.425 ' O ' HG22 ' A' ' 224' ' ' VAL . 0.5 OUTLIER -46.83 -22.37 0.3 Allowed 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 113.538 0.94 . . . . 0.8 113.538 -179.221 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . 0.577 ' HA2' ' HD2' ' A' ' 225' ' ' LYS . . . -65.92 -23.99 71.31 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 121.223 -0.513 . . . . 0.38 113.076 178.606 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' ASP . . . . . 0.543 ' HB2' ' HA ' ' A' ' 218' ' ' ILE . 2.9 p-10 -56.56 -45.49 81.26 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 113.478 0.918 . . . . 0.76 113.478 -178.354 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.425 HG22 ' O ' ' A' ' 221' ' ' GLU . 28.9 m -59.96 -29.55 43.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-N 118.107 0.412 . . . . 0.5 111.475 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . 0.577 ' HD2' ' HA2' ' A' ' 222' ' ' GLY . 26.4 mttp -76.08 -42.76 46.34 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.549 -0.537 . . . . 0.91 109.549 178.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 94.3 p -64.5 -40.51 95.78 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.741 -0.663 . . . . 0.61 110.327 178.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -65.39 -42.63 92.44 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 109.919 -0.4 . . . . 0.51 109.919 178.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' SER . . . . . 0.539 ' HA ' ' HG2' ' A' ' 231' ' ' MET . 7.5 t -60.44 -43.79 96.47 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.086 -0.506 . . . . 0.64 110.423 178.595 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' ARG . . . . . 0.423 HH11 ' HD2' ' A' ' 229' ' ' ARG . 9.0 mmm180 -55.69 -44.36 77.3 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.243 0.544 . . . . 0.78 110.545 178.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 0.499 ' O ' HG23 ' A' ' 234' ' ' VAL . 60.1 t -69.19 -54.32 20.69 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-N 115.877 -0.601 . . . . 0.33 111.475 179.307 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 231' ' ' MET . . . . . 0.539 ' HG2' ' HA ' ' A' ' 228' ' ' SER . 10.6 ptm -59.58 -37.13 77.69 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 112.491 0.552 . . . . 0.33 112.491 -178.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 33.0 t -66.4 -41.07 88.16 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 N-CA-C 109.522 -0.547 . . . . 0.38 109.522 178.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 233' ' ' HIS . . . . . 0.509 ' HA ' ' HB2' ' A' ' 236' ' ' LYS . 2.3 t-80 -68.16 -40.18 82.4 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 116.203 -0.453 . . . . 0.41 110.44 178.473 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.499 HG23 ' O ' ' A' ' 230' ' ' VAL . 69.3 t -56.99 -37.95 57.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 CA-C-O 121.057 0.456 . . . . 0.34 111.12 179.546 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 235' ' ' PHE . . . . . 0.511 ' HE2' HD22 ' A' ' 248' ' ' LEU . 93.3 m-85 -104.11 19.39 20.19 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.394 -0.366 . . . . 0.53 111.386 179.289 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . 0.509 ' HB2' ' HA ' ' A' ' 233' ' ' HIS . 1.3 tmtm? -79.81 -9.72 59.7 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 111.744 0.276 . . . . 1.27 111.744 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -70.16 -17.98 63.19 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 120.847 0.356 . . . . 0.53 111.033 179.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 96.83 -17.94 58.4 Favored Glycine 0 CA--C 1.524 0.621 0 C-N-CA 120.938 -0.649 . . . . 0.58 113.23 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 6.5 p -98.77 130.23 47.93 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-O 121.23 0.538 . . . . 0.58 111.8 -179.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 240' ' ' THR . . . . . 0.538 HG23 ' HG2' ' A' ' 283' ' ' LYS . 1.4 m -94.59 98.87 11.12 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.206 -0.452 . . . . 0.88 111.771 179.302 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -100.11 130.9 46.31 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.876 0.369 . . . . 0.48 111.208 179.431 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 242' ' ' TRP . . . . . . . . . . . . . 7.0 m95 -55.33 -43.76 75.22 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 116.032 -0.531 . . . . 0.54 111.146 179.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -58.01 -32.07 66.1 Favored Glycine 0 CA--C 1.519 0.329 0 CA-C-N 115.98 -0.555 . . . . 0.28 112.605 179.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 86.8 mtt180 -74.9 -36.39 62.23 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.78 -0.452 . . . . 0.34 109.78 178.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . 0.561 ' O ' HG12 ' A' ' 249' ' ' ILE . 79.1 mt -66.97 -51.36 55.46 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 CA-C-N 115.944 -0.571 . . . . 0.41 110.714 179.115 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 27.6 m -62.93 -35.9 73.36 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 C-N-CA 121.089 -0.244 . . . . 0.35 111.08 179.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 53.0 m -65.69 -37.77 87.39 Favored 'General case' 0 N--CA 1.463 0.187 0 N-CA-C 109.538 -0.542 . . . . 0.38 109.538 178.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 248' ' ' LEU . . . . . 0.511 HD22 ' HE2' ' A' ' 235' ' ' PHE . 34.2 tp -65.32 -40.58 93.92 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 116.143 -0.481 . . . . 0.63 109.759 177.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 249' ' ' ILE . . . . . 0.561 HG12 ' O ' ' A' ' 245' ' ' ILE . 43.0 mm -65.9 -48.89 80.36 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 CA-C-N 116.186 -0.461 . . . . 0.34 110.101 178.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 31.3 t -57.07 -42.68 81.09 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.801 -0.636 . . . . 0.28 110.31 178.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 251' ' ' PHE . . . . . . . . . . . . . 32.0 t80 -64.03 -45.46 88.78 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 115.647 -0.706 . . . . 0.46 110.059 177.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -58.22 -41.28 94.76 Favored Glycine 0 C--N 1.337 0.623 0 N-CA-C 111.464 -0.655 . . . . 0.32 111.464 178.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 253' ' ' ALA . . . . . 0.417 ' HB1' ' HB3' ' A' ' 170' ' ' GLN . . . -64.01 -42.68 97.06 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 120.773 0.32 . . . . 0.32 110.277 177.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -60.07 -40.87 91.0 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.357 0.598 . . . . 0.65 109.742 178.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 255' ' ' VAL . . . . . 0.461 ' CG1' HG21 ' A' ' 218' ' ' ILE . 79.9 t -66.54 -51.25 59.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 CA-C-N 115.682 -0.69 . . . . 0.41 109.696 177.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -54.21 -39.29 66.56 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.082 -0.508 . . . . 0.27 111.076 177.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -62.48 -42.89 99.8 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.402 -0.363 . . . . 0.59 110.667 178.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 31.3 t60 -64.61 -36.14 83.28 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.311 -0.404 . . . . 0.5 110.32 179.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 6.7 mp -74.6 -41.49 60.35 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 121.061 0.458 . . . . 0.51 110.696 178.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -62.82 -27.35 69.26 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.9 0.381 . . . . 0.4 110.666 179.079 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 56.4 m -59.67 -31.86 69.95 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.074 -0.512 . . . . 0.41 110.494 178.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 262' ' ' VAL . . . . . 0.419 HG23 ' HG3' ' A' ' 264' ' ' GLN . 15.7 m -110.49 16.99 7.72 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 CA-C-O 121.28 0.562 . . . . 0.4 110.192 178.29 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 25.6 t30 59.31 44.22 15.67 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 114.922 -1.035 . . . . 0.47 113.567 179.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 264' ' ' GLN . . . . . 0.419 ' HG3' HG23 ' A' ' 262' ' ' VAL . 15.0 mt-30 -91.54 36.61 0.95 Allowed 'General case' 0 N--CA 1.466 0.369 0 O-C-N 121.978 -0.452 . . . . 0.5 110.856 178.536 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . 0.427 ' HA ' HD12 ' A' ' 268' ' ' ILE . 6.4 mm-40 -57.94 -29.22 64.99 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 116.422 -0.354 . . . . 0.49 111.862 -179.418 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.37 -22.84 67.12 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.229 -0.441 . . . . 0.63 110.788 178.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 267' ' ' PHE . . . . . 0.428 ' C ' ' HD2' ' A' ' 270' ' ' PRO . 66.2 m-85 -100.01 -24.74 14.53 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.048 -0.524 . . . . 0.72 110.611 178.566 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 268' ' ' ILE . . . . . 0.427 HD12 ' HA ' ' A' ' 265' ' ' GLU . 89.3 mt -65.3 -40.9 90.03 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-N 116.11 -0.495 . . . . 0.37 111.477 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 269' ' ' GLU . . . . . 0.686 ' HB2' ' HD3' ' A' ' 270' ' ' PRO . 6.4 mm-40 -57.49 -56.47 33.81 Favored Pre-proline 0 CA--C 1.542 0.669 0 C-N-CA 120.979 -0.289 . . . . 0.68 111.111 178.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 270' ' ' PRO . . . . . 0.686 ' HD3' ' HB2' ' A' ' 269' ' ' GLU . 50.6 Cg_exo -58.04 -32.24 94.95 Favored 'Trans proline' 0 C--N 1.363 1.323 0 C-N-CA 121.843 1.695 . . . . 0.32 111.643 177.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 271' ' ' LEU . . . . . 0.44 ' O ' HG13 ' A' ' 275' ' ' ILE . 0.4 OUTLIER -66.06 -55.16 17.97 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.183 -0.462 . . . . 0.51 110.233 178.582 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -60.06 -39.12 84.91 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 115.846 -0.616 . . . . 0.28 110.951 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 273' ' ' GLU . . . . . 0.468 ' O ' ' HB2' ' A' ' 277' ' ' ASP . 26.4 tt0 -66.92 -43.41 83.38 Favored 'General case' 0 C--O 1.226 -0.18 0 CA-C-N 115.885 -0.598 . . . . 1.79 110.012 178.583 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 274' ' ' THR . . . . . . . . . . . . . 41.2 m -64.95 -44.35 89.71 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.605 -0.27 . . . . 0.39 110.927 179.057 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 275' ' ' ILE . . . . . 0.44 HG13 ' O ' ' A' ' 271' ' ' LEU . 96.5 mt -57.54 -54.97 24.09 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 CA-C-O 121.132 0.491 . . . . 0.4 110.157 179.09 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 276' ' ' THR . . . . . 0.614 HG21 ' HA ' ' A' ' 160' ' ' LEU . 24.4 m -59.25 -45.46 91.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.664 -0.698 . . . . 0.31 110.541 179.179 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 277' ' ' ASP . . . . . 0.468 ' HB2' ' O ' ' A' ' 273' ' ' GLU . 7.9 t70 -56.27 -58.35 8.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.315 -0.857 . . . . 0.33 111.723 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 95.3 t -57.7 -39.47 70.42 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-O 120.609 0.242 . . . . 0.4 110.953 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 22.3 tp -61.5 -47.92 83.42 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 120.669 0.271 . . . . 0.68 111.672 179.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 44.6 t -78.79 -23.28 12.97 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-O 121.052 0.453 . . . . 0.52 111.835 -179.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 281' ' ' ARG . . . . . 0.422 ' HB2' ' O ' ' A' ' 277' ' ' ASP . 19.3 ttm-85 -82.29 -25.8 33.66 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 121.824 -0.547 . . . . 0.47 111.949 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 282' ' ' THR . . . . . . . . . . . . . 37.7 p -98.69 -31.15 12.06 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 112.526 0.565 . . . . 0.4 112.526 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . 0.538 ' HG2' HG23 ' A' ' 240' ' ' THR . 3.3 mppt? -117.08 32.99 5.84 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 112.16 0.43 . . . . 1.01 112.16 -179.149 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 284' ' ' ARG . . . . . 0.48 ' H ' ' HG2' ' A' ' 284' ' ' ARG . 0.4 OUTLIER -56.81 -42.46 79.61 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 112.139 0.422 . . . . 0.45 112.139 179.817 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 285' ' ' ASP . . . . . 0.525 ' O ' ' HB2' ' A' ' 289' ' ' LYS . 26.0 t70 -62.19 -48.75 78.64 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.393 -0.367 . . . . 0.77 111.73 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 286' ' ' TRP . . . . . 0.513 ' CZ2' ' HG2' ' A' ' 290' ' ' GLN . 31.7 t90 -70.63 -41.42 72.22 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.018 0.377 . . . . 0.98 112.018 -179.201 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -61.27 -40.97 96.08 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 111.891 0.33 . . . . 0.55 111.891 -179.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 6.0 p -77.38 -29.69 16.87 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-O 120.75 0.309 . . . . 0.59 110.954 179.048 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 289' ' ' LYS . . . . . 0.525 ' HB2' ' O ' ' A' ' 285' ' ' ASP . 3.4 ttmm -75.36 -44.85 42.81 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 112.858 0.688 . . . . 0.81 112.858 -179.081 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 290' ' ' GLN . . . . . 0.513 ' HG2' ' CZ2' ' A' ' 286' ' ' TRP . 1.9 mp0 -84.83 29.88 0.6 Allowed 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 113.765 1.024 . . . . 0.78 113.765 -177.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 291' ' ' ARG . . . . . 0.608 ' HB3' ' HB3' ' A' ' 294' ' ' ASP . 21.5 mtm180 64.04 6.8 3.02 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 112.745 0.646 . . . . 0.42 112.745 179.318 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 59.07 -125.59 40.16 Favored Glycine 0 CA--C 1.521 0.421 0 CA-C-O 121.395 0.442 . . . . 0.32 113.573 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 293' ' ' TRP . . . . . 0.589 ' O ' HG23 ' A' ' 297' ' ' VAL . 83.8 m95 -64.9 -26.3 68.26 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.641 0.608 . . . . 0.48 112.641 -178.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 294' ' ' ASP . . . . . 0.608 ' HB3' ' HB3' ' A' ' 291' ' ' ARG . 20.0 t70 -64.32 -43.91 93.21 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 121.045 0.45 . . . . 0.54 109.934 178.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -68.38 -31.8 74.68 Favored Glycine 0 C--N 1.334 0.45 0 N-CA-C 110.609 -0.997 . . . . 0.36 110.609 177.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 296' ' ' PHE . . . . . 0.471 ' HB3' ' HA ' ' A' ' 293' ' ' TRP . 1.0 OUTLIER -67.7 -48.11 67.49 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 115.51 -0.345 . . . . 0.31 110.557 178.464 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 297' ' ' VAL . . . . . 0.589 HG23 ' O ' ' A' ' 293' ' ' TRP . 86.0 t -61.14 -43.4 96.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-O 120.825 0.345 . . . . 0.36 110.615 179.306 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -64.51 -46.49 82.71 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.863 -0.608 . . . . 0.48 112.053 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 299' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -62.63 -35.2 78.81 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 112.31 0.485 . . . . 0.54 112.31 -179.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 300' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -100.76 30.98 3.72 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.284 0.476 . . . . 0.51 112.284 -179.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 301' ' ' HIS . . . . . 0.406 ' HB2' ' O ' ' A' ' 297' ' ' VAL . 13.1 t-80 -148.91 146.06 27.71 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.054 0.454 . . . . 0.58 111.834 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 5.7 m -84.97 133.22 29.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.399 -0.364 . . . . 0.86 110.284 178.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 -132.57 103.03 5.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.881 0.372 . . . . 0.9 111.063 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.05 57.7 0.47 Allowed 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.059 0.456 . . . . 1.83 111.847 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 73.1 mt -77.59 -33.16 53.93 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.88 0.372 . . . . 2.15 111.393 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -100.19 21.79 12.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.981 0.419 . . . . 2.83 111.143 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . -138.73 47.85 0.9 Allowed Glycine 0 CA--C 1.523 0.587 0 C-N-CA 120.812 -0.708 . . . . 2.23 112.936 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.309 0 CA-C-O 118.454 -1.192 . . . . 4.41 112.871 -179.829 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.45 0 CA-C-O 120.659 0.266 . . . . 1.02 110.869 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.44 -35.84 7.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.172 0.511 . . . . 0.68 111.192 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 19' ' ' LEU . . . . . 0.562 ' HG ' ' HE1' ' B' ' 23' ' ' PHE . 6.2 tp -113.8 113.56 47.28 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 116.132 -0.485 . . . . 0.59 111.179 -179.68 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 20' ' ' PRO . . . . . 0.459 ' HD2' HD12 ' B' ' 19' ' ' LEU . 34.8 Cg_endo -65.35 116.28 3.8 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.336 2.024 . . . . 0.61 110.261 178.564 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 21' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -65.14 47.23 0.17 Allowed 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 122.785 2.324 . . . . 0.74 115.806 -176.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -87.58 -57.07 3.08 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.34 -0.615 . . . . 1.0 109.34 178.035 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 23' ' ' PHE . . . . . 0.562 ' HE1' ' HG ' ' B' ' 19' ' ' LEU . 0.0 OUTLIER -56.55 -41.3 76.62 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.87 -0.605 . . . . 0.72 110.686 178.54 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.61 -49.01 78.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.064 -0.516 . . . . 0.35 110.735 179.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . 0.411 ' HA ' ' HD3' ' B' ' 28' ' ' ARG . . . -64.78 -42.1 95.33 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.329 -0.396 . . . . 0.53 110.933 179.335 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -64.73 -49.53 70.45 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.128 -0.487 . . . . 1.09 111.351 179.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 61.6 mt -56.65 -36.03 69.06 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 120.815 0.34 . . . . 0.57 110.33 178.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 28' ' ' ARG . . . . . 0.411 ' HD3' ' HA ' ' B' ' 25' ' ' ALA . 19.4 mtp180 -62.89 -48.44 78.96 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.171 -0.468 . . . . 0.48 110.157 178.009 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . 0.504 ' HA ' ' HE3' ' B' ' 29' ' ' LYS . 0.0 OUTLIER -66.83 -41.81 86.83 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.319 -0.4 . . . . 0.53 111.96 -179.79 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . 0.407 ' O ' HG23 ' B' ' 34' ' ' VAL . 78.8 mt -61.65 -41.61 91.03 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 N-CA-C 109.142 -0.688 . . . . 0.39 109.142 178.027 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -61.85 -49.13 78.95 Favored Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 115.655 -0.702 . . . . 0.31 111.872 178.287 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -58.9 -44.23 91.19 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-O 121.117 0.484 . . . . 0.45 109.737 178.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 3.3 tmtt? -58.84 -52.61 64.98 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 115.434 -0.803 . . . . 0.41 111.137 178.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 34' ' ' VAL . . . . . 0.407 HG23 ' O ' ' B' ' 30' ' ' ILE . 58.7 t -58.87 -49.43 83.04 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 CA-C-O 120.749 0.309 . . . . 0.39 111.416 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -58.74 -43.96 90.39 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 116.307 -0.406 . . . . 0.62 111.972 -179.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 36' ' ' CYS . . . . . . . . . . . . . 17.8 p -73.39 -32.84 64.68 Favored 'General case' 0 N--CA 1.468 0.444 0 O-C-N 122.023 -0.423 . . . . 0.4 111.421 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 89.5 m -66.35 -39.82 89.42 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.526 -0.306 . . . . 0.37 111.365 179.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 38' ' ' TRP . . . . . . . . . . . . . 84.2 m95 -80.45 -25.05 39.13 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.981 -0.288 . . . . 0.56 111.201 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 69.2 m -68.08 -42.83 79.8 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 120.898 0.38 . . . . 0.48 110.71 178.139 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -88.8 127.7 55.12 Favored Pre-proline 0 CA--C 1.532 0.285 0 CA-C-N 116.216 -0.447 . . . . 0.58 111.522 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -78.14 61.27 7.69 Favored 'Trans proline' 0 CA--C 1.535 0.547 0 C-N-CA 122.58 2.187 . . . . 0.89 113.144 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 52.8 m-20 -79.0 73.01 5.56 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 120.981 0.419 . . . . 1.01 111.325 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 43' ' ' MET . . . . . . . . . . . . . 52.6 ttp . . . . . 0 C--O 1.253 1.255 0 CA-C-O 118.232 -0.889 . . . . 1.45 111.367 179.792 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.423 ' N ' ' OD2' ' A' ' 153' ' ' ASP . . . . . . . . 0 N--CA 1.49 2.277 0 CA-C-O 119.969 -0.351 . . . . 1.34 112.705 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -74.17 89.87 1.02 Allowed 'Trans proline' 0 CA--C 1.534 0.503 0 C-N-CA 122.929 2.419 . . . . 0.91 112.775 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 84.8 mt -59.65 141.73 54.43 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 112.583 0.586 . . . . 1.63 112.583 -179.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 77.85 -36.79 1.66 Allowed Glycine 0 CA--C 1.523 0.564 0 CA-C-N 115.775 -0.648 . . . . 1.21 114.358 179.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 99.4 p -93.96 -46.52 7.13 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 113.092 0.775 . . . . 0.68 113.092 -178.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.526 ' OE2' ' HD3' ' A' ' 284' ' ' ARG . 1.4 mt-10 -138.93 -30.56 0.74 Allowed 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 114.379 1.252 . . . . 0.45 114.379 -178.132 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . 0.423 ' OD2' ' N ' ' A' ' 147' ' ' GLY . 15.1 t70 -62.24 -53.72 51.13 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 112.763 0.653 . . . . 0.91 112.763 -178.377 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -67.85 -38.7 83.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.856 0.36 . . . . 0.59 110.679 179.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.436 HD11 ' HA3' ' A' ' 292' ' ' GLY . 53.8 tp -61.56 -39.4 90.97 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.732 -0.47 . . . . 0.63 109.732 178.366 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -58.17 -51.49 69.5 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.604 -0.726 . . . . 0.42 112.02 179.179 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.525 ' HD2' ' OE1' ' A' ' 182' ' ' GLU . 20.1 mtm180 -56.77 -49.66 74.61 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 112.37 0.507 . . . . 0.5 112.37 -178.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -59.04 -50.45 74.03 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 120.903 0.382 . . . . 1.19 111.007 179.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . 0.457 ' HA ' ' CZ2' ' A' ' 293' ' ' TRP . 3.3 p -63.64 -45.9 88.1 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 112.278 0.473 . . . . 0.29 112.278 -179.374 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.409 HD22 ' HA ' ' A' ' 160' ' ' LEU . 0.4 OUTLIER -53.4 -49.76 66.6 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 120.774 0.321 . . . . 0.8 111.124 179.45 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . 1.025 ' HG3' ' HA3' ' A' ' 181' ' ' GLY . 1.3 mm-40 -75.99 -43.17 45.63 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.873 0.694 . . . . 0.39 112.873 -179.365 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . 0.466 HD13 ' HB3' ' A' ' 190' ' ' ALA . 79.9 mt -62.01 -42.44 94.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 O-C-N 121.978 -0.451 . . . . 0.31 111.753 -179.292 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.692 ' O ' ' HG ' ' A' ' 167' ' ' LEU . 74.1 mt -69.06 -52.3 35.23 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 C-N-CA 121.018 -0.273 . . . . 0.33 110.768 179.043 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 54.6 p -58.03 -42.27 84.98 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 121.281 -0.167 . . . . 0.26 110.983 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . 0.438 HH11 ' HD2' ' A' ' 165' ' ' ARG . 2.0 mmt85 -55.43 -51.77 65.81 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.722 -0.217 . . . . 0.41 110.951 178.472 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' TYR . . . . . 0.848 ' CE1' ' HA ' ' A' ' 195' ' ' ARG . 72.5 t80 -60.26 -48.68 80.69 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.666 -0.243 . . . . 0.31 111.142 179.28 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.692 ' HG ' ' O ' ' A' ' 163' ' ' ILE . 18.8 mt -59.0 -44.18 91.63 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.561 -0.29 . . . . 0.35 111.484 -179.568 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . 0.539 ' HD3' ' OE2' ' A' ' 269' ' ' GLU . 25.3 mtm180 -70.47 -44.42 67.77 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 112.22 0.452 . . . . 0.38 112.22 179.671 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -62.8 -44.1 97.06 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.705 0.288 . . . . 0.35 111.168 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . 0.456 ' HG3' ' CZ ' ' A' ' 166' ' ' TYR . 6.4 mm-40 -70.48 -28.99 65.41 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.853 0.359 . . . . 0.4 110.708 178.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.838 ' HA ' ' HG2' ' A' ' 257' ' ' LYS . . . -69.09 -32.82 72.51 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 112.522 0.564 . . . . 0.44 112.522 -179.695 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . 0.797 ' HB ' ' HD3' ' A' ' 260' ' ' LYS . 8.8 t -106.51 -14.4 15.07 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 112.681 0.623 . . . . 0.48 112.681 -179.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 79.4 28.62 52.11 Favored Glycine 0 CA--C 1.523 0.549 0 C-N-CA 120.689 -0.767 . . . . 0.42 112.971 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 32.6 t -98.28 163.64 12.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.49 0.662 . . . . 0.5 111.788 -179.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 7.4 mptt -122.12 60.37 0.99 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.835 -0.621 . . . . 0.49 110.48 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -74.82 81.12 2.11 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.01 -0.541 . . . . 0.47 112.161 -179.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 9.1 t -79.38 13.59 1.88 Allowed 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 121.161 0.505 . . . . 0.59 111.277 179.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 36.2 mttt -68.49 155.29 93.04 Favored Pre-proline 0 CA--C 1.535 0.394 0 CA-C-N 116.018 -0.537 . . . . 0.54 110.309 178.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -52.9 111.89 0.77 Allowed 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 122.595 2.197 . . . . 0.52 112.574 179.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.462 ' H ' HD23 ' A' ' 180' ' ' LEU . 0.7 OUTLIER -83.45 176.03 9.38 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.343 -0.39 . . . . 0.47 111.906 -179.372 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . 1.025 ' HA3' ' HG3' ' A' ' 161' ' ' GLU . . . -54.83 130.27 46.21 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.872 -0.68 . . . . 0.35 112.514 -179.613 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . 0.525 ' OE1' ' HD2' ' A' ' 157' ' ' ARG . 84.8 mt-10 4.46 75.46 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 125.313 1.445 . . . . 0.97 114.478 -178.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.496 ' O ' ' HA3' ' A' ' 187' ' ' GLY . . . -169.0 72.96 0.09 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 115.624 -0.716 . . . . 0.38 110.247 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -78.74 -71.68 1.23 Allowed Glycine 0 CA--C 1.523 0.542 0 C-N-CA 120.647 -0.787 . . . . 0.42 113.811 -178.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -71.97 -56.14 6.2 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 120.8 0.333 . . . . 0.5 111.049 -179.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -61.52 -35.03 76.58 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.116 -0.493 . . . . 0.45 110.578 179.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . 0.496 ' HA3' ' O ' ' A' ' 183' ' ' ALA . . . -65.37 -40.46 96.43 Favored Glycine 0 C--N 1.333 0.408 0 C-N-CA 121.229 -0.51 . . . . 0.36 113.201 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . 0.449 ' HD3' ' HA ' ' A' ' 188' ' ' ARG . 15.0 mmt180 -66.52 -47.02 74.26 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 117.193 0.497 . . . . 0.66 110.552 179.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . 0.685 ' HB3' HG11 ' A' ' 297' ' ' VAL . 23.9 mmt180 -66.97 -39.52 87.22 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.067 -0.515 . . . . 0.65 111.204 179.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.466 ' HB3' HD13 ' A' ' 162' ' ' ILE . . . -70.09 -40.08 75.17 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.899 -0.321 . . . . 0.32 111.136 179.095 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 16.0 tp -69.27 -44.41 71.94 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 120.777 -0.369 . . . . 0.52 111.294 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . 0.558 ' HG3' ' O ' ' A' ' 189' ' ' ARG . 0.0 OUTLIER -58.43 -37.73 75.99 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 120.597 -0.441 . . . . 0.34 110.401 179.169 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . 0.561 HG21 ' HA ' ' A' ' 297' ' ' VAL . 1.1 p -76.87 -47.59 20.81 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 120.953 -0.299 . . . . 0.35 111.08 178.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 0.482 ' HA ' HD12 ' A' ' 194' ' ' LEU . 10.3 tp -58.85 -35.36 72.82 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.737 0.303 . . . . 0.4 110.977 179.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . 0.848 ' HA ' ' CE1' ' A' ' 166' ' ' TYR . 12.6 mmt180 -68.8 -58.29 4.4 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.788 0.328 . . . . 0.35 110.348 178.393 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 20.7 ttp85 -60.77 -54.02 50.24 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 112.914 0.709 . . . . 0.52 112.914 -179.183 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . 0.564 ' O ' HG23 ' A' ' 201' ' ' VAL . 46.8 t -68.7 -45.1 81.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 112.051 0.389 . . . . 0.36 112.051 -179.033 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -61.7 -42.41 99.75 Favored Glycine 0 CA--C 1.521 0.444 0 C-N-CA 120.996 -0.621 . . . . 0.32 113.027 -179.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -68.39 -42.39 79.15 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 109.728 -0.471 . . . . 0.49 109.728 179.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -56.54 -48.68 74.76 Favored Glycine 0 C--N 1.336 0.547 0 C-N-CA 120.797 -0.716 . . . . 0.39 111.655 178.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . 0.564 HG23 ' O ' ' A' ' 197' ' ' VAL . 60.0 t -62.92 -42.6 97.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 CA-C-O 120.702 0.287 . . . . 0.43 111.193 178.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -63.38 -48.64 77.04 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.152 -0.476 . . . . 0.35 112.028 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 31.7 mtm180 -73.5 -35.27 65.6 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.908 -0.317 . . . . 0.74 111.739 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -63.73 -49.19 74.03 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 121.117 0.484 . . . . 0.91 110.039 178.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 79.6 m-70 -101.17 33.78 2.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.157 -0.474 . . . . 0.59 110.711 179.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -53.65 -45.71 70.32 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.89 -0.596 . . . . 0.79 112.042 -179.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -59.51 -41.89 90.97 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 120.928 0.394 . . . . 0.5 111.51 179.34 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -70.62 -50.62 35.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.23 -0.441 . . . . 0.43 111.045 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -60.26 -44.09 95.59 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 116.478 -0.328 . . . . 0.6 111.024 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -64.67 -40.89 96.2 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 110.272 -0.27 . . . . 0.96 110.272 178.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -62.3 -44.81 97.14 Favored Glycine 0 C--N 1.335 0.522 0 N-CA-C 110.746 -0.942 . . . . 0.39 110.746 178.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' MET . . . . . 0.527 ' O ' ' HG ' ' A' ' 216' ' ' LEU . 8.0 mtp -64.09 -42.12 97.05 Favored 'General case' 0 C--O 1.222 -0.375 0 N-CA-C 110.076 -0.342 . . . . 0.67 110.076 178.102 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.437 HD21 ' HB2' ' A' ' 258' ' ' HIS . 6.8 tp -61.85 -39.16 90.87 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 120.889 0.376 . . . . 0.51 111.245 179.136 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 10.4 tpt180 -68.66 -32.52 72.43 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 116.267 -0.424 . . . . 0.79 111.32 179.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -89.99 -15.56 31.68 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 111.899 0.333 . . . . 0.57 111.899 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.535 HD11 ' CZ ' ' A' ' 251' ' ' PHE . 13.3 mt -62.92 134.18 55.8 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 113.036 0.754 . . . . 0.59 113.036 -179.288 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -100.95 17.04 23.3 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 115.511 -0.768 . . . . 1.1 110.127 178.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' ILE . . . . . . . . . . . . . 30.7 mm -67.88 108.24 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 CA-C-N 116.073 -0.512 . . . . 0.73 111.385 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 2.9 mtmp? -135.08 -42.6 0.73 Allowed 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 112.355 0.502 . . . . 1.06 112.355 -179.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -113.87 -178.39 3.36 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 113.184 0.809 . . . . 1.27 113.184 -177.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . 0.612 ' O ' HG22 ' A' ' 224' ' ' VAL . 8.7 tm-20 -56.52 -44.53 80.88 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 115.723 -0.671 . . . . 1.34 112.244 -179.438 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -54.02 -26.99 36.42 Favored Glycine 0 CA--C 1.527 0.807 0 C-N-CA 121.112 -0.566 . . . . 0.43 113.564 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 62.7 m-20 -68.47 -31.03 70.03 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 112.71 0.633 . . . . 0.75 112.71 -179.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.612 HG22 ' O ' ' A' ' 221' ' ' GLU . 4.4 m -63.22 -28.65 45.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 CA-C-O 121.156 0.503 . . . . 0.54 111.548 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 37.6 mttm -70.0 -39.36 75.93 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-O 121.334 0.587 . . . . 1.28 110.278 179.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . 0.533 ' O ' HG23 ' A' ' 230' ' ' VAL . 11.3 t -66.34 -36.03 81.88 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.896 -0.593 . . . . 0.35 109.535 178.315 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' PHE . . . . . . . . . . . . . 33.8 t80 -60.81 -42.55 97.87 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.184 -0.916 . . . . 0.53 110.314 178.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' SER . . . . . 0.417 ' HB3' HG11 ' A' ' 278' ' ' VAL . 18.8 m -59.62 -45.61 91.45 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 115.716 -0.675 . . . . 0.75 110.634 178.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 15.8 ttm105 -55.52 -43.68 75.97 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.611 -0.722 . . . . 0.38 110.799 178.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 0.533 HG23 ' O ' ' A' ' 226' ' ' SER . 25.4 t -58.9 -49.56 82.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 CA-C-N 116.118 -0.492 . . . . 0.42 111.679 179.328 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 231' ' ' MET . . . . . 0.538 ' HA ' HD22 ' A' ' 248' ' ' LEU . 70.5 mtm -53.11 -45.74 68.42 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.351 -0.386 . . . . 0.53 111.755 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 37.7 t -68.91 -40.45 81.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-O 120.657 0.265 . . . . 0.54 110.976 178.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 39.5 t-80 -54.89 -33.09 61.63 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.038 -0.528 . . . . 0.41 111.175 179.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.577 HG13 ' HA ' ' B' ' 28' ' ' ARG . 79.0 t -61.78 -30.9 49.4 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 N-CA-C 112.405 0.52 . . . . 0.41 112.405 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -93.98 23.16 5.1 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 112.432 0.53 . . . . 0.52 112.432 -179.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.58 -23.57 17.4 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 113.399 0.889 . . . . 1.06 113.399 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . 0.476 ' HB2' HG12 ' A' ' 239' ' ' VAL . 0.1 OUTLIER -76.67 -14.64 59.95 Favored 'General case' 0 CA--C 1.533 0.321 0 O-C-N 121.932 -0.48 . . . . 0.67 111.991 -179.688 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 88.53 12.71 64.35 Favored Glycine 0 CA--C 1.522 0.516 0 C-N-CA 120.79 -0.719 . . . . 0.67 113.488 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 0.476 HG12 ' HB2' ' A' ' 237' ' ' ASP . 3.9 p -119.48 112.21 36.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 CA-C-O 121.533 0.682 . . . . 0.55 111.569 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 240' ' ' THR . . . . . 0.75 HG22 HD11 ' A' ' 245' ' ' ILE . 4.2 m -81.33 69.93 8.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.101 -0.499 . . . . 0.58 112.235 -179.445 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 48.2 m-20 -76.89 136.21 38.85 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 120.724 0.297 . . . . 0.8 110.976 179.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 242' ' ' TRP . . . . . 0.558 ' CZ3' ' HB2' ' A' ' 296' ' ' PHE . 68.8 m95 -53.66 -36.53 62.22 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 112.972 0.73 . . . . 0.52 112.972 -179.17 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . 0.474 ' H ' ' HB2' ' B' ' 35' ' ' TYR . . . -58.09 -34.88 74.49 Favored Glycine 0 CA--C 1.521 0.46 0 C-N-CA 120.994 -0.622 . . . . 0.34 112.894 179.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 244' ' ' ARG . . . . . 0.617 ' O ' ' HG ' ' A' ' 248' ' ' LEU . 28.9 mtt180 -74.37 -46.45 40.43 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.917 -0.401 . . . . 0.59 109.917 179.389 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . 0.75 HD11 HG22 ' A' ' 240' ' ' THR . 58.5 mt -55.91 -47.96 79.13 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-N 115.533 -0.758 . . . . 0.54 110.778 178.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 7.6 p -70.15 -29.01 38.01 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 120.905 -0.318 . . . . 0.37 110.852 179.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . 0.545 HG22 HD22 ' B' ' 27' ' ' LEU . 19.8 m -65.16 -39.64 93.24 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 109.603 -0.517 . . . . 0.42 109.603 177.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 248' ' ' LEU . . . . . 0.617 ' HG ' ' O ' ' A' ' 244' ' ' ARG . 51.4 mt -63.21 -38.91 93.03 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.863 -0.608 . . . . 0.43 109.784 178.204 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 249' ' ' ILE . . . . . 0.469 HG21 HD11 ' A' ' 194' ' ' LEU . 15.6 mt -70.22 -36.9 69.66 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 N-CA-C 109.55 -0.537 . . . . 0.41 109.55 177.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 20.4 m -64.08 -40.5 96.38 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 109.255 -0.646 . . . . 0.37 109.255 178.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 251' ' ' PHE . . . . . 0.535 ' CZ ' HD11 ' A' ' 216' ' ' LEU . 8.0 t80 -65.83 -40.99 92.32 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 108.644 -0.873 . . . . 0.56 108.644 176.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -62.69 -39.55 98.06 Favored Glycine 0 C--N 1.336 0.53 0 CA-C-N 115.509 -0.769 . . . . 0.28 111.576 178.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -64.75 -41.44 95.92 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 120.665 0.269 . . . . 0.28 110.517 178.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -63.09 -37.9 89.03 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.042 0.449 . . . . 0.53 110.209 178.503 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 255' ' ' VAL . . . . . 0.523 HG23 ' O ' ' A' ' 251' ' ' PHE . 59.9 t -72.97 -39.42 57.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 N-CA-C 109.83 -0.433 . . . . 0.35 109.83 178.218 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 256' ' ' ALA . . . . . 0.415 ' HB1' HD11 ' A' ' 268' ' ' ILE . . . -55.64 -43.71 76.47 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.143 0.497 . . . . 0.31 109.942 178.042 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 257' ' ' LYS . . . . . 0.838 ' HG2' ' HA ' ' A' ' 171' ' ' ALA . 93.0 mttt -62.39 -47.87 82.25 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 115.507 -0.769 . . . . 0.4 110.378 178.267 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 258' ' ' HIS . . . . . 0.437 ' HB2' HD21 ' A' ' 213' ' ' LEU . 45.3 t60 -59.45 -36.43 75.91 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.3 -0.409 . . . . 0.68 111.379 179.668 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.401 ' O ' ' HB2' ' A' ' 264' ' ' GLN . 88.2 mt -77.37 -51.06 11.47 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 112.023 0.379 . . . . 0.57 112.023 179.275 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 260' ' ' LYS . . . . . 0.797 ' HD3' ' HB ' ' A' ' 172' ' ' THR . 0.4 OUTLIER -60.81 -42.05 96.91 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 112.496 0.554 . . . . 0.68 112.496 -179.341 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 29.3 p -55.63 -27.98 52.73 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 112.35 0.5 . . . . 0.61 112.35 -179.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 262' ' ' VAL . . . . . 0.609 HG23 ' HG3' ' A' ' 264' ' ' GLN . 17.1 m -109.41 25.83 2.76 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-O 120.759 0.314 . . . . 0.63 111.594 179.361 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 58.4 m-80 55.63 47.44 20.68 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 113.219 0.822 . . . . 1.2 113.219 179.121 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 264' ' ' GLN . . . . . 0.609 ' HG3' HG23 ' A' ' 262' ' ' VAL . 37.3 mt-30 -103.94 39.8 1.56 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.005 0.431 . . . . 0.75 111.359 179.381 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . 0.826 ' HA ' HG22 ' A' ' 268' ' ' ILE . 24.2 mm-40 -50.84 -35.88 34.72 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 112.668 0.618 . . . . 0.71 112.668 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . 0.403 ' O ' ' HG2' ' A' ' 270' ' ' PRO . 57.1 p -67.81 -7.96 32.05 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.658 -0.246 . . . . 0.55 111.608 179.631 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -116.76 -33.45 4.8 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.525 0.194 . . . . 0.81 111.525 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 268' ' ' ILE . . . . . 0.826 HG22 ' HA ' ' A' ' 265' ' ' GLU . 6.1 tt -67.38 -43.32 87.82 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 N-CA-C 111.705 0.261 . . . . 0.44 111.705 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 269' ' ' GLU . . . . . 0.733 ' HB2' ' HD3' ' A' ' 270' ' ' PRO . 6.7 mm-40 -63.08 -56.03 31.86 Favored Pre-proline 0 CA--C 1.537 0.447 0 C-N-CA 120.851 -0.34 . . . . 0.78 110.751 179.573 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 270' ' ' PRO . . . . . 0.733 ' HD3' ' HB2' ' A' ' 269' ' ' GLU . 50.3 Cg_exo -57.0 -29.64 83.57 Favored 'Trans proline' 0 C--N 1.36 1.179 0 C-N-CA 122.0 1.8 . . . . 0.33 111.588 177.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 271' ' ' LEU . . . . . . . . . . . . . 19.1 tp -66.7 -51.08 60.1 Favored 'General case' 0 C--O 1.224 -0.265 0 N-CA-C 109.782 -0.451 . . . . 0.46 109.782 178.009 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -58.36 -34.48 70.72 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 120.942 0.401 . . . . 0.32 110.514 178.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 273' ' ' GLU . . . . . 0.583 ' OE1' ' HA ' ' A' ' 270' ' ' PRO . 68.9 mt-10 -71.21 -47.81 55.15 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 115.856 -0.611 . . . . 0.97 109.892 178.244 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 274' ' ' THR . . . . . . . . . . . . . 61.1 m -60.67 -43.11 98.05 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.889 -0.596 . . . . 0.37 110.713 179.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 275' ' ' ILE . . . . . 0.425 HG23 ' SD ' ' A' ' 231' ' ' MET . 96.1 mt -60.48 -54.64 32.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 115.833 -0.621 . . . . 0.32 110.386 178.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 26.0 m -61.17 -48.87 79.55 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.096 -0.502 . . . . 0.3 112.331 -179.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 277' ' ' ASP . . . . . 0.471 ' CG ' HH12 ' A' ' 281' ' ' ARG . 24.2 t70 -54.44 -53.26 56.58 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 120.873 0.368 . . . . 0.37 111.635 -179.676 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 278' ' ' VAL . . . . . 0.417 HG11 ' HB3' ' A' ' 228' ' ' SER . 97.8 t -68.6 -42.93 83.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.365 -0.379 . . . . 0.4 111.649 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . 0.441 HD11 HG23 ' A' ' 245' ' ' ILE . 40.6 tp -57.77 -43.08 85.25 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 120.601 0.239 . . . . 0.62 111.618 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 77.6 t -72.3 -53.33 19.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 120.824 -0.351 . . . . 0.43 110.737 179.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 281' ' ' ARG . . . . . 0.554 ' HA ' ' HG3' ' A' ' 284' ' ' ARG . 18.8 ttp-105 -56.44 -40.97 75.67 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 113.669 0.989 . . . . 0.53 113.669 -179.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 282' ' ' THR . . . . . 0.892 HG23 ' HD2' ' A' ' 283' ' ' LYS . 13.9 t -63.14 -21.63 66.32 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 113.269 0.84 . . . . 0.51 113.269 -178.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . 0.892 ' HD2' HG23 ' A' ' 282' ' ' THR . 0.4 OUTLIER -142.26 41.76 1.64 Allowed 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 112.4 0.519 . . . . 0.66 112.4 -179.736 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 284' ' ' ARG . . . . . 0.554 ' HG3' ' HA ' ' A' ' 281' ' ' ARG . 68.8 mtt180 -55.01 -47.84 74.14 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 113.035 0.754 . . . . 0.68 113.035 -178.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 285' ' ' ASP . . . . . 0.442 ' HA ' HG22 ' A' ' 288' ' ' VAL . 32.4 t70 -60.5 -39.6 88.32 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.043 0.449 . . . . 0.59 111.327 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 286' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -67.99 -37.99 82.13 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.201 0.524 . . . . 0.56 110.218 179.088 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 287' ' ' LEU . . . . . 0.406 ' CD1' ' HA2' ' A' ' 292' ' ' GLY . 2.8 mm? -70.62 -48.93 52.55 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.639 -0.71 . . . . 0.58 111.638 179.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 288' ' ' VAL . . . . . 0.442 HG22 ' HA ' ' A' ' 285' ' ' ASP . 33.5 m -61.32 -33.76 57.98 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 CA-C-O 120.627 0.251 . . . . 0.5 111.436 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 50.6 mttp -72.0 -26.14 62.11 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 120.854 0.359 . . . . 0.93 110.874 178.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -101.93 11.01 39.26 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 112.437 0.532 . . . . 0.87 112.437 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 291' ' ' ARG . . . . . 0.416 HH11 ' HD2' ' A' ' 291' ' ' ARG . 29.1 mtm180 62.54 20.29 11.85 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 120.716 0.293 . . . . 0.79 111.7 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 292' ' ' GLY . . . . . 0.436 ' HA3' HD11 ' A' ' 155' ' ' LEU . . . 65.07 -111.67 4.38 Favored Glycine 0 CA--C 1.525 0.662 0 C-N-CA 121.375 -0.441 . . . . 0.47 114.061 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 293' ' ' TRP . . . . . 0.597 ' O ' HG23 ' A' ' 297' ' ' VAL . 53.9 m95 -63.48 -45.89 88.68 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.857 0.688 . . . . 0.46 112.857 -178.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 294' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -50.21 -47.36 54.82 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 111.849 0.315 . . . . 0.52 111.849 -179.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -66.03 -41.19 95.31 Favored Glycine 0 CA--C 1.523 0.561 0 C-N-CA 120.582 -0.818 . . . . 0.31 112.258 178.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 296' ' ' PHE . . . . . 0.558 ' HB2' ' CZ3' ' A' ' 242' ' ' TRP . 1.6 t80 -62.37 -42.68 99.6 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.95 0.405 . . . . 0.4 111.116 179.076 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 297' ' ' VAL . . . . . 0.685 HG11 ' HB3' ' A' ' 189' ' ' ARG . 64.0 t -63.91 -47.18 91.77 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-N 116.004 -0.544 . . . . 0.33 111.807 -179.555 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -59.07 -46.16 88.96 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 112.128 0.418 . . . . 0.65 112.128 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 299' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -59.05 -27.35 65.41 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 120.976 0.417 . . . . 0.51 111.74 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 300' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 -108.02 22.73 15.54 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.283 0.563 . . . . 0.53 111.286 179.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -101.49 6.68 42.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.182 0.515 . . . . 1.0 111.064 179.361 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 6.1 p -81.95 134.15 27.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.765 -0.652 . . . . 0.81 111.151 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -148.7 105.61 3.59 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 120.933 0.397 . . . . 1.41 111.457 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 49.2 t0 -148.07 123.1 10.08 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.132 -0.486 . . . . 2.41 110.931 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 16.6 tp -127.37 6.63 6.36 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.52 0.676 . . . . 2.61 109.813 178.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -113.46 -32.71 6.13 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 115.464 -0.789 . . . . 2.38 111.744 -179.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . 108.85 76.95 0.96 Allowed Glycine 0 CA--C 1.522 0.481 0 C-N-CA 120.621 -0.799 . . . . 2.57 113.181 179.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.209 0 CA-C-O 118.418 -1.212 . . . . 3.02 113.249 179.661 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 121.295 0.569 . . . . 1.81 110.787 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -142.94 -74.23 0.28 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.548 -0.751 . . . . 1.2 110.986 -178.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 19' ' ' LEU . . . . . 0.561 HD22 ' HE2' ' B' ' 23' ' ' PHE . 6.4 mt -101.88 115.52 64.66 Favored Pre-proline 0 CA--C 1.531 0.225 0 CA-C-O 121.096 0.474 . . . . 1.0 111.524 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 20' ' ' PRO . . . . . 0.423 ' C ' ' H ' ' B' ' 22' ' ' GLU . 82.0 Cg_endo -78.63 154.85 27.35 Favored 'Trans proline' 0 CA--C 1.532 0.402 0 C-N-CA 122.773 2.315 . . . . 0.94 112.528 179.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 21' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -69.04 27.57 0.16 Allowed 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 123.085 2.523 . . . . 0.99 113.602 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 22' ' ' GLU . . . . . 0.423 ' H ' ' C ' ' B' ' 20' ' ' PRO . 23.5 tt0 -72.91 -43.95 61.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.912 0.387 . . . . 0.81 110.406 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 23' ' ' PHE . . . . . 0.561 ' HE2' HD22 ' B' ' 19' ' ' LEU . 4.0 p90 -63.76 -33.2 75.12 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.113 -0.494 . . . . 0.48 110.829 179.227 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -72.76 -46.47 53.21 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.256 -0.429 . . . . 0.51 111.095 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.89 -42.21 97.52 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 121.072 0.463 . . . . 0.67 110.456 179.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -59.57 -53.38 58.77 Favored 'General case' 0 N--CA 1.457 -0.105 0 CA-C-N 115.681 -0.69 . . . . 0.96 110.739 179.237 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . 0.556 ' HG ' ' O ' ' B' ' 23' ' ' PHE . 78.3 mt -56.5 -35.58 68.18 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.623 -0.262 . . . . 0.52 111.597 179.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 28' ' ' ARG . . . . . 0.577 ' HA ' HG13 ' A' ' 234' ' ' VAL . 0.0 OUTLIER -67.3 -47.07 71.7 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.74 0.305 . . . . 0.51 111.09 179.532 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 44.3 mtmt -67.67 -41.83 83.11 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 121.038 0.447 . . . . 0.77 110.371 178.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . 0.47 ' O ' HG23 ' B' ' 34' ' ' VAL . 97.0 mt -64.31 -40.03 87.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 CA-C-N 115.942 -0.572 . . . . 0.39 110.128 178.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -57.88 -49.95 70.07 Favored Glycine 0 C--N 1.333 0.412 0 CA-C-N 115.879 -0.6 . . . . 0.29 112.941 179.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 39.1 m-20 -68.9 -26.73 65.25 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 117.157 0.479 . . . . 0.48 110.273 178.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 33' ' ' LYS . . . . . 0.427 ' HE2' ' HA ' ' B' ' 33' ' ' LYS . 0.0 OUTLIER -67.86 -53.72 24.51 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.505 -0.316 . . . . 0.41 110.734 178.75 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 34' ' ' VAL . . . . . 0.47 HG23 ' O ' ' B' ' 30' ' ' ILE . 57.3 t -58.03 -47.24 87.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-O 121.081 0.467 . . . . 0.37 110.745 179.503 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 35' ' ' TYR . . . . . 0.474 ' HB2' ' H ' ' A' ' 243' ' ' GLY . 2.4 t80 -58.15 -46.53 85.52 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.625 -0.716 . . . . 0.5 110.138 178.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 36' ' ' CYS . . . . . . . . . . . . . 43.5 t -63.53 -46.04 87.81 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 115.881 -0.599 . . . . 0.35 111.111 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 37' ' ' THR . . . . . 0.608 ' HA ' ' HB3' ' B' ' 42' ' ' ASP . 62.3 m -61.07 -43.24 99.18 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 112.878 0.695 . . . . 0.4 112.878 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 38' ' ' TRP . . . . . . . . . . . . . 94.2 m95 -82.76 -26.3 32.01 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.696 0.628 . . . . 0.62 112.696 -178.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 8.6 t -82.29 -65.72 0.98 Allowed 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 121.019 0.437 . . . . 0.54 110.287 178.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . 0.446 ' HB1' ' HD2' ' B' ' 41' ' ' PRO . . . -92.08 162.26 30.99 Favored Pre-proline 0 CA--C 1.535 0.4 0 CA-C-N 116.091 -0.504 . . . . 0.46 110.662 178.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 41' ' ' PRO . . . . . 0.446 ' HD2' ' HB1' ' B' ' 40' ' ' ALA . 41.9 Cg_endo -69.21 65.33 1.47 Allowed 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 122.295 1.996 . . . . 0.78 112.445 178.494 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 42' ' ' ASP . . . . . 0.608 ' HB3' ' HA ' ' B' ' 37' ' ' THR . 44.7 t0 -112.39 173.46 6.36 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 115.78 -0.646 . . . . 0.7 111.304 -179.064 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 43' ' ' MET . . . . . . . . . . . . . 17.5 tpt . . . . . 0 C--O 1.25 1.094 0 CA-C-O 118.408 -0.806 . . . . 2.51 110.983 179.679 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.369 0 CA-C-O 119.858 -0.412 . . . . 1.87 112.379 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -62.7 132.31 37.06 Favored 'Trans proline' 0 CA--C 1.532 0.4 0 C-N-CA 122.776 2.317 . . . . 0.99 112.721 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 24.5 tp -97.29 -19.28 18.65 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 120.995 0.426 . . . . 1.54 111.309 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 179.61 -155.0 14.61 Favored Glycine 0 CA--C 1.519 0.317 0 C-N-CA 121.167 -0.54 . . . . 0.8 111.866 -179.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.428 ' HA ' ' OD2' ' A' ' 154' ' ' ASP . 0.9 OUTLIER -79.4 76.99 5.98 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.197 0.522 . . . . 0.72 110.928 -179.89 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -117.19 -72.76 0.67 Allowed 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 115.618 -0.719 . . . . 0.45 112.334 -178.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -67.1 -34.41 77.56 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 112.036 0.384 . . . . 0.44 112.036 -178.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.428 ' OD2' ' HA ' ' A' ' 151' ' ' SER . 0.3 OUTLIER -51.98 -52.42 50.59 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 120.747 0.308 . . . . 0.71 111.157 179.544 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 47.4 tp -59.22 -46.17 89.17 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.298 -0.41 . . . . 0.55 111.136 178.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . 0.487 ' OH ' ' HG3' ' A' ' 281' ' ' ARG . 0.1 OUTLIER -60.87 -49.27 78.14 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.413 -0.358 . . . . 0.56 111.545 179.658 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 62.3 mtp180 -62.07 -48.82 78.52 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 112.146 0.424 . . . . 0.49 112.146 -179.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . 0.418 ' HA ' ' HB2' ' A' ' 183' ' ' ALA . 54.7 mm-40 -61.05 -46.84 89.05 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.732 0.301 . . . . 0.65 110.28 179.354 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . 0.407 ' HA ' ' CZ2' ' A' ' 293' ' ' TRP . 16.6 m -61.73 -48.86 78.83 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.217 -0.447 . . . . 0.29 111.078 179.313 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.739 ' HA ' HG21 ' A' ' 276' ' ' THR . 2.0 tm? -56.29 -47.82 77.87 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.65 0.262 . . . . 0.65 110.561 179.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . 0.854 ' HG3' ' HB2' ' A' ' 182' ' ' GLU . 4.5 mm-40 -64.54 -48.08 76.41 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.126 0.417 . . . . 0.64 112.126 179.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 78.5 mt -67.25 -51.36 53.91 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 N-CA-C 113.022 0.749 . . . . 0.33 113.022 -179.091 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.514 HD12 HG23 ' A' ' 276' ' ' THR . 80.2 mt -60.74 -49.35 84.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 O-C-N 122.279 -0.263 . . . . 0.41 111.528 -179.35 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . 0.505 ' O ' ' HB2' ' A' ' 168' ' ' ARG . 3.1 t -57.99 -38.04 75.36 Favored 'General case' 0 N--CA 1.462 0.153 0 N-CA-C 110.249 -0.278 . . . . 0.61 110.249 178.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . 0.425 HH22 ' CG ' ' A' ' 176' ' ' ASP . 0.0 OUTLIER -58.64 -55.74 31.2 Favored 'General case' 0 C--O 1.22 -0.463 0 CA-C-N 116.563 -0.289 . . . . 0.34 110.967 179.344 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' TYR . . . . . 0.655 ' CE1' ' HA ' ' A' ' 195' ' ' ARG . 76.4 t80 -61.26 -51.94 66.81 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 112.495 0.554 . . . . 0.52 112.495 -178.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.5 ' HG ' ' O ' ' A' ' 163' ' ' ILE . 33.9 mt -58.76 -48.62 80.57 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 120.713 0.292 . . . . 0.45 111.761 -179.025 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . 0.505 ' HB2' ' O ' ' A' ' 164' ' ' SER . 0.7 OUTLIER -70.97 -45.05 64.77 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 112.318 0.488 . . . . 0.39 112.318 -179.689 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -60.72 -44.35 96.74 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 112.049 0.389 . . . . 0.46 112.049 -179.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -66.73 -48.42 69.26 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.935 -0.306 . . . . 0.93 111.467 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.543 ' HA ' ' HG2' ' A' ' 257' ' ' LYS . . . -69.14 -35.25 76.16 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.54 0.57 . . . . 0.33 112.54 -179.223 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . 0.784 HG23 ' HD2' ' A' ' 260' ' ' LYS . 0.2 OUTLIER -114.9 35.72 4.18 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.753 0.649 . . . . 0.37 112.753 -177.718 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -59.36 -11.44 13.86 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 121.304 -0.475 . . . . 0.52 113.491 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 10.8 p -96.14 -5.21 41.21 Favored 'General case' 0 CA--C 1.534 0.339 0 O-C-N 122.732 -0.275 . . . . 0.55 111.364 179.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . 0.43 ' HE3' ' HB3' ' A' ' 175' ' ' LYS . 14.6 ttpp -165.56 95.9 0.64 Allowed 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 120.765 0.317 . . . . 0.45 111.561 -179.468 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . 0.425 ' CG ' HH22 ' A' ' 165' ' ' ARG . 3.9 t0 -72.83 179.66 3.56 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-O 121.035 0.445 . . . . 0.63 111.087 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 37.3 t -162.93 -63.14 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.338 -0.392 . . . . 1.11 111.797 -179.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . 0.423 ' HE3' ' HB3' ' A' ' 178' ' ' LYS . 0.4 OUTLIER -109.14 103.29 51.96 Favored Pre-proline 0 CA--C 1.534 0.353 0 CA-C-O 120.611 0.243 . . . . 0.71 110.928 -179.473 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -74.23 -157.21 0.06 OUTLIER 'Trans proline' 0 CA--C 1.536 0.599 0 C-N-CA 123.074 2.516 . . . . 0.99 113.283 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 14.2 mt -100.72 135.36 42.28 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.958 0.409 . . . . 0.76 111.271 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -130.99 -36.27 0.35 Allowed Glycine 0 CA--C 1.526 0.771 0 C-N-CA 120.653 -0.784 . . . . 0.65 113.462 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . 0.854 ' HB2' ' HG3' ' A' ' 161' ' ' GLU . 1.4 mm-40 -98.27 -65.22 0.98 Allowed 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 117.032 0.416 . . . . 0.65 111.684 -179.615 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.436 ' O ' ' HA3' ' A' ' 187' ' ' GLY . . . -74.21 69.55 1.55 Allowed 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 120.941 0.4 . . . . 0.34 111.543 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -79.13 -70.74 1.3 Allowed Glycine 0 CA--C 1.527 0.818 0 C-N-CA 120.984 -0.626 . . . . 0.33 114.396 -179.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -70.19 -57.42 4.94 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 112.48 0.548 . . . . 0.39 112.48 -178.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -62.93 -32.13 73.36 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 121.111 0.482 . . . . 0.32 110.087 179.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . 0.436 ' HA3' ' O ' ' A' ' 183' ' ' ALA . . . -72.93 -38.0 56.32 Favored Glycine 0 C--O 1.22 -0.73 0 CA-C-N 115.281 -0.872 . . . . 0.26 112.819 179.245 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . 0.402 ' HD3' ' HA ' ' A' ' 188' ' ' ARG . 13.1 tpp180 -61.29 -46.73 89.12 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 117.532 0.666 . . . . 0.8 110.877 179.435 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . 0.434 ' HB3' HG11 ' A' ' 297' ' ' VAL . 49.1 mtp180 -67.13 -38.99 86.5 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.251 0.548 . . . . 0.4 110.553 178.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.669 ' HA ' HG22 ' A' ' 297' ' ' VAL . . . -69.83 -38.12 76.42 Favored 'General case' 0 C--O 1.224 -0.269 0 CA-C-N 115.701 -0.681 . . . . 0.26 111.68 179.586 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 20.4 tp -65.81 -47.7 74.18 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 111.531 0.197 . . . . 0.45 111.531 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . 0.693 ' O ' ' HG2' ' A' ' 196' ' ' ARG . 5.8 tm-20 -58.62 -47.36 84.64 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 108.964 -0.754 . . . . 0.36 108.964 178.37 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 38.9 m -58.21 -52.36 65.91 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 115.755 -0.657 . . . . 0.27 110.998 178.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 0.422 HD21 HG21 ' A' ' 249' ' ' ILE . 26.9 tp -63.28 -38.68 92.12 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 112.916 0.71 . . . . 0.37 112.916 -179.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . 0.655 ' HA ' ' CE1' ' A' ' 166' ' ' TYR . 3.5 ttm-85 -64.97 -47.24 78.32 Favored 'General case' 0 C--N 1.333 -0.142 0 O-C-N 122.234 -0.291 . . . . 0.58 110.825 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . 0.693 ' HG2' ' O ' ' A' ' 192' ' ' GLU . 33.0 mmm-85 -66.01 -52.78 46.29 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.617 0.246 . . . . 0.47 110.836 179.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . 0.564 HG21 ' HB3' ' A' ' 300' ' ' PHE . 69.4 t -60.65 -51.77 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-N 116.464 -0.335 . . . . 0.33 111.618 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -56.54 -45.28 90.11 Favored Glycine 0 C--N 1.333 0.394 0 C-N-CA 121.389 -0.434 . . . . 0.32 113.042 -179.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . 0.423 ' HA ' ' HG2' ' A' ' 202' ' ' GLN . 33.3 m-20 -67.11 -33.69 76.01 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.658 0.266 . . . . 0.36 110.416 179.173 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -68.93 -32.88 73.9 Favored Glycine 0 CA--C 1.523 0.548 0 C-N-CA 120.72 -0.752 . . . . 0.25 112.002 178.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . 0.579 HG11 ' HA ' ' A' ' 247' ' ' THR . 92.3 t -72.82 -46.48 52.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 CA-C-O 120.687 0.28 . . . . 0.35 111.17 179.181 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' GLN . . . . . 0.423 ' HG2' ' HA ' ' A' ' 199' ' ' ASP . 11.3 pt20 -70.58 -32.5 69.91 Favored 'General case' 0 C--O 1.22 -0.48 0 CA-C-N 116.354 -0.384 . . . . 0.61 111.322 -179.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 23.3 ttm180 -68.95 -50.4 49.61 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.798 0.332 . . . . 2.99 110.706 178.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 18.9 m-80 -62.45 -44.46 96.35 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.269 -0.423 . . . . 0.62 111.235 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 87.9 m-70 -103.03 36.28 2.28 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 112.382 0.512 . . . . 0.44 112.382 -179.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -58.01 -42.64 85.67 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 112.613 0.597 . . . . 0.96 112.613 -179.256 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 34.0 p -61.24 -53.05 61.82 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.88 0.371 . . . . 0.53 111.709 -179.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -61.54 -43.73 98.34 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.096 -0.502 . . . . 0.44 110.61 179.041 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 3.3 m-30 -60.94 -52.04 66.72 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 116.107 -0.497 . . . . 0.45 111.05 179.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 20.1 mt-30 -59.97 -42.74 94.79 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 120.519 0.2 . . . . 0.74 111.249 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -61.21 -51.13 60.21 Favored Glycine 0 C--N 1.335 0.477 0 C-N-CA 120.611 -0.804 . . . . 0.36 111.993 178.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' MET . . . . . 0.65 ' HB3' ' HB3' ' B' ' 23' ' ' PHE . 71.2 mtm -66.34 -31.98 73.1 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 120.586 0.231 . . . . 0.73 110.991 179.344 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 10.3 tp -63.51 -41.95 98.49 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.958 0.408 . . . . 0.55 110.742 178.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' ARG . . . . . 0.427 HH11 ' HD3' ' A' ' 214' ' ' ARG . 39.7 mtt-85 -70.86 -31.74 68.52 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.038 -0.528 . . . . 0.96 111.04 179.414 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -72.8 -21.17 61.02 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 120.971 0.415 . . . . 0.78 111.044 178.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.797 ' HB3' HG12 ' A' ' 218' ' ' ILE . 66.6 mt -72.78 135.37 45.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.02 0.438 . . . . 0.56 111.842 179.617 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' ASP . . . . . 0.412 ' OD2' ' N ' ' B' ' 17' ' ' ALA . 0.3 OUTLIER -87.79 23.05 2.11 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 116.257 -0.429 . . . . 0.62 110.696 179.08 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' ILE . . . . . 0.797 HG12 ' HB3' ' A' ' 216' ' ' LEU . 50.6 mm -59.47 106.72 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-N 115.723 -0.671 . . . . 0.46 111.627 -179.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -154.97 -68.78 0.13 Allowed 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.957 -0.565 . . . . 0.62 111.55 -179.537 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -90.97 -176.48 4.65 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 115.793 -0.64 . . . . 0.63 112.579 -178.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -47.0 -22.45 0.33 Allowed 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 113.34 0.867 . . . . 1.44 113.34 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . 0.458 ' HA2' ' HD2' ' A' ' 225' ' ' LYS . . . -69.7 -22.53 76.81 Favored Glycine 0 CA--C 1.529 0.968 0 CA-C-N 116.522 -0.308 . . . . 0.44 113.134 178.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' ASP . . . . . 0.692 ' HB2' HG23 ' A' ' 218' ' ' ILE . 1.3 p-10 -56.31 -47.44 78.7 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 113.193 0.812 . . . . 0.8 113.193 -178.392 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 31.5 m -60.32 -32.0 49.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-O 121.001 0.429 . . . . 1.63 111.482 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . 0.458 ' HD2' ' HA2' ' A' ' 222' ' ' GLY . 36.9 mttp -76.82 -42.19 41.41 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.315 -0.624 . . . . 0.85 109.315 178.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . 0.883 ' HB3' HD22 ' B' ' 19' ' ' LEU . 19.9 m -63.16 -42.56 99.46 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 115.321 -0.854 . . . . 0.35 110.568 178.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' PHE . . . . . 0.582 ' O ' ' HG3' ' A' ' 231' ' ' MET . 13.8 t80 -65.39 -48.78 71.67 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.936 -0.575 . . . . 0.56 110.141 179.081 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 30.3 t -56.01 -39.09 71.39 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 109.549 -0.537 . . . . 0.42 109.549 178.211 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' ARG . . . . . 0.518 ' HB3' ' O ' ' A' ' 226' ' ' SER . 19.1 ttt180 -55.95 -44.54 78.53 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 115.165 -0.925 . . . . 0.78 110.23 177.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 47.6 t -68.78 -42.73 82.98 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-N 116.292 -0.413 . . . . 0.31 110.804 178.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 231' ' ' MET . . . . . 0.582 ' HG3' ' O ' ' A' ' 227' ' ' PHE . 47.8 mtp -58.14 -53.0 63.22 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 120.84 0.352 . . . . 0.37 111.492 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 34.5 m -65.58 -30.79 51.23 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 CA-C-N 116.484 -0.326 . . . . 0.34 111.558 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 42.4 t-80 -61.47 -54.79 38.76 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 111.76 0.282 . . . . 0.41 111.76 179.198 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.813 ' HB ' ' HB3' ' B' ' 28' ' ' ARG . 4.0 m -66.4 -29.44 46.6 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 N-CA-C 112.224 0.453 . . . . 0.36 112.224 -178.606 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 36.4 m-85 -100.63 22.18 12.26 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 111.999 0.37 . . . . 0.54 111.999 179.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . 0.438 ' HA ' ' HD2' ' A' ' 236' ' ' LYS . 14.9 tptp -79.75 -21.36 44.55 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.87 0.366 . . . . 0.93 111.545 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . 0.418 ' OD1' ' N ' ' A' ' 237' ' ' ASP . 0.0 OUTLIER -69.54 -15.96 63.33 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.096 -0.502 . . . . 0.5 112.085 -179.841 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 90.92 -19.25 46.88 Favored Glycine 0 CA--C 1.521 0.439 0 C-N-CA 120.929 -0.653 . . . . 0.37 113.689 179.089 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 0.409 HG12 ' HB2' ' A' ' 237' ' ' ASP . 3.3 p -86.49 113.55 24.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.34 0.591 . . . . 0.38 110.848 179.597 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 59.7 m -93.63 106.25 18.23 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.088 0.471 . . . . 0.4 111.807 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . 0.533 ' HB2' ' HG3' ' A' ' 244' ' ' ARG . 94.8 m-20 -95.39 129.81 42.41 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.937 -0.574 . . . . 0.4 110.43 178.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 242' ' ' TRP . . . . . 0.612 ' HB3' ' CZ ' ' A' ' 300' ' ' PHE . 1.6 m95 -53.29 -41.93 66.09 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 120.938 0.399 . . . . 0.45 111.58 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . 0.44 ' HA3' ' N ' ' B' ' 35' ' ' TYR . . . -64.28 -28.46 73.03 Favored Glycine 0 CA--C 1.521 0.463 0 C-N-CA 120.815 -0.707 . . . . 0.24 112.852 179.139 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 244' ' ' ARG . . . . . 0.533 ' HG3' ' HB2' ' A' ' 241' ' ' ASN . 63.8 mtt180 -70.69 -39.06 73.7 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 122.47 -0.429 . . . . 0.41 110.127 179.194 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 64.0 mt -63.99 -52.28 58.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 CA-C-N 115.82 -0.627 . . . . 0.44 111.229 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 16.8 m -62.38 -35.87 71.82 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 C-N-CA 120.937 -0.305 . . . . 0.32 111.293 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . 0.579 ' HA ' HG11 ' A' ' 201' ' ' VAL . 99.6 m -64.05 -42.4 97.06 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.076 0.465 . . . . 0.45 109.996 178.159 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 248' ' ' LEU . . . . . . . . . . . . . 18.9 tp -65.1 -43.6 91.55 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.774 -0.648 . . . . 2.02 110.304 178.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 249' ' ' ILE . . . . . 0.422 HG21 HD21 ' A' ' 194' ' ' LEU . 28.9 mt -64.66 -42.49 95.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 109.757 -0.46 . . . . 0.38 109.757 178.285 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 45.5 t -61.03 -38.23 85.39 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.786 -0.643 . . . . 0.42 109.842 178.084 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 251' ' ' PHE . . . . . 0.476 ' O ' HG23 ' A' ' 255' ' ' VAL . 34.1 t80 -69.88 -41.37 74.86 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.545 -0.752 . . . . 0.38 109.921 177.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -58.69 -43.93 96.03 Favored Glycine 0 C--N 1.335 0.515 0 N-CA-C 111.134 -0.786 . . . . 0.32 111.134 178.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -61.24 -40.64 94.8 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-O 120.844 0.355 . . . . 0.4 110.087 177.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -60.22 -43.44 96.02 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 116.023 -0.535 . . . . 0.66 109.793 178.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 255' ' ' VAL . . . . . 0.476 HG23 ' O ' ' A' ' 251' ' ' PHE . 64.8 t -66.26 -40.76 87.71 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-N 115.736 -0.666 . . . . 0.33 110.323 178.393 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -62.48 -45.76 91.59 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.318 -0.401 . . . . 0.32 110.155 177.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 257' ' ' LYS . . . . . 0.543 ' HG2' ' HA ' ' A' ' 171' ' ' ALA . 48.0 mtmt -58.98 -45.03 91.59 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.953 -0.567 . . . . 0.52 109.964 177.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -61.63 -34.81 76.33 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.789 -0.641 . . . . 0.35 109.903 178.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.787 ' HG ' ' HB3' ' A' ' 264' ' ' GLN . 2.9 tp -72.12 -32.62 67.12 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 121.251 0.548 . . . . 0.47 110.036 178.096 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 260' ' ' LYS . . . . . 0.784 ' HD2' HG23 ' A' ' 172' ' ' THR . 0.0 OUTLIER -75.4 -31.1 60.31 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 121.118 0.485 . . . . 0.68 110.4 178.069 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 26.7 t -64.07 -19.26 65.1 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.125 -0.489 . . . . 0.49 110.71 178.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 262' ' ' VAL . . . . . 0.427 HG23 ' HB2' ' A' ' 264' ' ' GLN . 31.2 m -114.14 13.81 8.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-N 116.149 -0.478 . . . . 0.53 110.613 178.311 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 6.1 t30 55.91 49.32 16.16 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 115.521 -0.763 . . . . 1.28 112.861 179.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 264' ' ' GLN . . . . . 0.787 ' HB3' ' HG ' ' A' ' 259' ' ' LEU . 4.3 tt0 -113.26 39.13 2.67 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 112.027 0.381 . . . . 1.21 112.027 -179.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . 0.669 ' HG3' ' HE3' ' A' ' 260' ' ' LYS . 26.4 mt-10 -48.54 -35.96 14.38 Favored 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 112.934 0.716 . . . . 0.38 112.934 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -56.54 -24.69 48.58 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 112.377 0.51 . . . . 1.0 112.377 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 267' ' ' PHE . . . . . 0.455 ' C ' ' HD2' ' A' ' 270' ' ' PRO . 23.3 m-85 -99.37 -16.74 18.31 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 120.974 0.416 . . . . 1.19 111.001 179.214 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 268' ' ' ILE . . . . . 0.557 HD12 ' HA ' ' A' ' 265' ' ' GLU . 67.3 mt -67.15 -43.22 88.68 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-N 116.209 -0.45 . . . . 0.39 110.564 179.251 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 269' ' ' GLU . . . . . 0.711 ' HB2' ' HD3' ' A' ' 270' ' ' PRO . 2.1 mm-40 -55.26 -56.66 26.14 Favored Pre-proline 0 CA--C 1.543 0.692 0 CA-C-N 116.295 -0.411 . . . . 0.38 111.14 179.361 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 270' ' ' PRO . . . . . 0.711 ' HD3' ' HB2' ' A' ' 269' ' ' GLU . 38.1 Cg_exo -59.61 -34.89 96.47 Favored 'Trans proline' 0 C--N 1.362 1.259 0 C-N-CA 122.253 1.969 . . . . 0.36 112.247 178.295 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 271' ' ' LEU . . . . . . . . . . . . . 43.2 tp -64.91 -51.14 63.51 Favored 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 110.128 -0.323 . . . . 0.56 110.128 178.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -59.02 -42.87 91.21 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 120.997 0.427 . . . . 0.38 110.458 178.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 273' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -63.45 -44.53 94.22 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 115.912 -0.585 . . . . 1.97 110.056 178.231 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 274' ' ' THR . . . . . . . . . . . . . 99.6 m -60.31 -48.4 81.9 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.236 -0.438 . . . . 0.49 110.381 178.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 275' ' ' ILE . . . . . 0.569 ' O ' ' HB2' ' A' ' 279' ' ' LEU . 95.9 mt -54.89 -47.67 75.28 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.096 0 CA-C-N 115.982 -0.554 . . . . 0.46 110.384 179.051 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 276' ' ' THR . . . . . 0.739 HG21 ' HA ' ' A' ' 160' ' ' LEU . 37.9 m -62.95 -52.06 64.5 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.247 -0.433 . . . . 0.34 111.203 179.374 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 277' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -51.94 -53.86 36.24 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.135 -0.484 . . . . 0.46 111.21 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 278' ' ' VAL . . . . . 0.574 ' O ' HG22 ' A' ' 282' ' ' THR . 60.7 t -63.32 -43.57 98.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-O 120.47 0.176 . . . . 0.38 110.883 179.291 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . 0.569 ' HB2' ' O ' ' A' ' 275' ' ' ILE . 0.3 OUTLIER -56.01 -47.84 77.02 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.604 -0.271 . . . . 0.84 111.313 179.967 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 57.0 t -75.38 -48.69 30.07 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 N-CA-C 111.729 0.27 . . . . 0.43 111.729 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 281' ' ' ARG . . . . . 0.487 ' HG3' ' OH ' ' A' ' 156' ' ' TYR . 31.2 mtp180 -54.69 -40.09 68.8 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 112.941 0.719 . . . . 0.55 112.941 -179.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 282' ' ' THR . . . . . 0.574 HG22 ' O ' ' A' ' 278' ' ' VAL . 6.9 t -91.03 4.62 51.63 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 120.191 -0.603 . . . . 0.39 112.289 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . 0.661 ' HZ3' ' HB2' ' A' ' 283' ' ' LYS . 0.0 OUTLIER -141.23 40.83 1.77 Allowed 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 120.92 0.39 . . . . 0.52 111.328 179.777 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -66.1 -62.33 1.55 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.109 0.481 . . . . 0.49 111.84 -179.274 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -65.32 -45.05 85.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.912 -0.585 . . . . 0.63 112.214 -179.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 286' ' ' TRP . . . . . 0.464 ' O ' ' HB2' ' A' ' 290' ' ' GLN . 2.2 t90 -58.12 -38.89 77.37 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 112.38 0.511 . . . . 0.59 112.38 -179.214 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 287' ' ' LEU . . . . . 0.57 HD23 ' HB3' ' A' ' 283' ' ' LYS . 1.2 mm? -70.59 -49.42 47.98 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.776 0.288 . . . . 0.46 111.776 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 9.1 p -62.83 -34.32 65.25 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-O 120.752 0.31 . . . . 0.55 111.409 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 43.5 mttp -75.47 -21.55 57.99 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 120.751 0.31 . . . . 0.87 111.473 178.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 290' ' ' GLN . . . . . 0.464 ' HB2' ' O ' ' A' ' 286' ' ' TRP . 0.0 OUTLIER -100.47 29.1 4.59 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 112.66 0.615 . . . . 0.79 112.66 -179.123 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 291' ' ' ARG . . . . . 0.465 ' HD2' ' HB3' ' A' ' 294' ' ' ASP . 8.1 ttm180 64.71 13.11 8.15 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 112.809 0.67 . . . . 0.84 112.809 179.076 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 65.82 -141.13 41.41 Favored Glycine 0 CA--C 1.525 0.692 0 C-N-CA 121.04 -0.6 . . . . 0.34 114.036 179.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 293' ' ' TRP . . . . . 0.623 ' O ' HG23 ' A' ' 297' ' ' VAL . 84.7 m95 -65.39 -32.22 73.74 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.29 0.478 . . . . 0.51 112.29 -179.149 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 294' ' ' ASP . . . . . 0.465 ' HB3' ' HD2' ' A' ' 291' ' ' ARG . 16.1 t70 -59.97 -37.95 81.11 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 121.102 0.477 . . . . 0.74 109.837 178.34 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -65.3 -43.2 95.56 Favored Glycine 0 C--N 1.335 0.511 0 N-CA-C 110.786 -0.926 . . . . 0.26 110.786 177.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 296' ' ' PHE . . . . . 0.513 ' HB2' ' CH2' ' A' ' 242' ' ' TRP . 0.8 OUTLIER -63.03 -46.71 86.29 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 120.88 0.371 . . . . 0.32 110.457 177.947 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 297' ' ' VAL . . . . . 0.669 HG22 ' HA ' ' A' ' 190' ' ' ALA . 90.9 t -59.89 -49.27 84.56 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.395 0 CA-C-N 115.922 -0.581 . . . . 0.32 111.242 179.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -61.8 -46.57 88.95 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.066 0.395 . . . . 0.97 112.066 -179.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 299' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -61.84 -42.29 98.85 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 112.419 0.525 . . . . 0.45 112.419 -179.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 300' ' ' PHE . . . . . 0.612 ' CZ ' ' HB3' ' A' ' 242' ' ' TRP . 76.5 m-85 -99.73 13.62 33.03 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 113.133 0.79 . . . . 0.39 113.133 -178.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -158.38 102.89 1.76 Allowed 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.057 0.456 . . . . 0.39 111.718 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 6.6 m -71.64 136.0 26.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.111 -0.495 . . . . 0.83 111.327 179.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 303' ' ' GLN . . . . . 0.455 HE21 ' HB2' ' A' ' 303' ' ' GLN . 2.9 mt-30 -122.59 -15.08 7.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.078 -0.51 . . . . 1.12 111.626 -179.312 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.86 96.7 0.6 Allowed 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 115.832 -0.622 . . . . 1.06 111.464 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 84.8 mt -97.46 -10.74 24.83 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.264 -0.426 . . . . 1.48 111.402 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.87 -35.11 6.05 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.249 -0.432 . . . . 1.34 111.136 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . -81.27 68.73 3.4 Favored Glycine 0 CA--C 1.523 0.539 0 C-N-CA 120.744 -0.741 . . . . 1.7 113.063 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.211 0 CA-C-O 118.547 -1.14 . . . . 3.74 113.066 -179.946 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 17' ' ' ALA . . . . . 0.412 ' N ' ' OD2' ' A' ' 217' ' ' ASP . . . . . . . . 0 N--CA 1.488 1.439 0 CA-C-O 120.641 0.257 . . . . 0.99 110.917 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.21 162.59 12.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.734 0.302 . . . . 0.9 110.524 179.134 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 19' ' ' LEU . . . . . 0.883 HD22 ' HB3' ' A' ' 226' ' ' SER . 5.2 tp -104.62 99.09 16.66 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 116.48 -0.327 . . . . 0.5 111.619 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.39 132.01 19.99 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.494 2.129 . . . . 0.45 110.867 178.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 21' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -65.56 45.95 0.18 Allowed 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 122.715 2.277 . . . . 0.53 115.284 -177.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -87.27 -48.92 7.62 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 109.527 -0.545 . . . . 0.47 109.527 178.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 23' ' ' PHE . . . . . 0.773 ' CE1' ' HG ' ' B' ' 19' ' ' LEU . 0.0 OUTLIER -59.29 -43.84 92.53 Favored 'General case' 0 C--O 1.225 -0.198 0 CA-C-N 115.669 -0.696 . . . . 0.36 110.55 179.076 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.85 -43.35 77.0 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 115.968 -0.56 . . . . 0.32 111.515 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . 0.478 ' O ' ' HG3' ' B' ' 28' ' ' ARG . . . -61.08 -49.55 76.85 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 116.162 -0.472 . . . . 0.28 111.282 179.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 13.7 mt-30 -68.63 -42.25 78.33 Favored 'General case' 0 C--O 1.224 -0.255 0 CA-C-N 116.304 -0.407 . . . . 0.54 111.202 179.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 16.0 mt -55.53 -49.39 72.75 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.607 -0.27 . . . . 0.59 111.556 179.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 28' ' ' ARG . . . . . 0.813 ' HB3' ' HB ' ' A' ' 234' ' ' VAL . 0.0 OUTLIER -65.29 -37.04 85.95 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 120.473 -0.491 . . . . 0.56 110.519 179.267 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . 0.566 ' HA ' ' HE3' ' B' ' 29' ' ' LYS . 0.0 OUTLIER -65.71 -40.56 92.37 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 109.62 -0.511 . . . . 0.48 109.62 178.264 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 93.4 mt -63.68 -39.94 87.22 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 N-CA-C 108.51 -0.922 . . . . 0.4 108.51 176.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . 0.525 ' HA3' ' HG2' ' A' ' 244' ' ' ARG . . . -60.4 -49.55 77.31 Favored Glycine 0 C--N 1.334 0.445 0 N-CA-C 111.192 -0.763 . . . . 0.23 111.192 177.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -56.9 -38.11 72.36 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.165 0.507 . . . . 0.43 109.665 177.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.61 -58.5 5.59 Favored 'General case' 0 C--O 1.227 -0.108 0 CA-C-N 115.613 -0.721 . . . . 0.61 110.598 179.024 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 85.9 t -54.86 -39.52 48.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-O 121.185 0.517 . . . . 0.37 110.289 179.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 35' ' ' TYR . . . . . 0.44 ' N ' ' HA3' ' A' ' 243' ' ' GLY . 9.4 t80 -58.47 -52.49 65.43 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.557 -0.747 . . . . 0.45 110.804 178.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 36' ' ' CYS . . . . . 0.439 ' HA ' ' OG ' ' B' ' 39' ' ' SER . 19.9 p -70.03 -25.3 63.51 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.739 0.304 . . . . 0.4 111.033 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 30.6 m -63.71 -44.08 94.68 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.454 -0.339 . . . . 0.4 111.349 179.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 38' ' ' TRP . . . . . . . . . . . . . 95.4 m95 -85.68 -30.25 23.33 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 120.742 0.306 . . . . 0.5 111.632 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 39' ' ' SER . . . . . 0.439 ' OG ' ' HA ' ' B' ' 36' ' ' CYS . 54.7 p -67.87 -24.92 65.3 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 112.166 0.432 . . . . 0.66 112.166 179.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -88.52 116.24 65.68 Favored Pre-proline 0 CA--C 1.532 0.269 0 CA-C-O 120.867 0.365 . . . . 0.73 111.718 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -82.24 49.76 3.22 Favored 'Trans proline' 0 CA--C 1.534 0.481 0 C-N-CA 122.777 2.318 . . . . 1.23 112.817 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -148.09 -169.8 3.43 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 116.193 -0.458 . . . . 1.34 110.676 -179.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 43' ' ' MET . . . . . . . . . . . . . 47.9 ttm . . . . . 0 C--O 1.251 1.17 0 CA-C-O 118.28 -0.867 . . . . 2.16 111.547 -179.932 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.41 ' N ' ' OD1' ' A' ' 154' ' ' ASP . . . . . . . . 0 N--CA 1.487 2.067 0 CA-C-O 119.971 -0.349 . . . . 0.68 112.324 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.646 ' HD2' ' HB3' ' A' ' 153' ' ' ASP . 20.1 Cg_exo -66.91 -179.16 1.57 Allowed 'Trans proline' 0 CA--C 1.535 0.54 0 C-N-CA 122.75 2.3 . . . . 0.83 112.724 179.111 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 96.6 mt -97.85 71.41 2.2 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.412 -0.358 . . . . 1.5 111.14 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -111.29 -60.11 0.47 Allowed Glycine 0 CA--C 1.52 0.395 0 C-N-CA 120.75 -0.738 . . . . 0.81 112.359 179.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 28.4 t -171.5 -68.59 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 120.941 0.4 . . . . 0.83 111.965 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -120.85 31.71 6.29 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.166 0.508 . . . . 0.73 111.25 -179.378 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . 0.646 ' HB3' ' HD2' ' A' ' 148' ' ' PRO . 1.6 m-20 -58.52 -51.82 68.27 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.694 -0.684 . . . . 0.72 112.197 -179.563 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.41 ' OD1' ' N ' ' A' ' 147' ' ' GLY . 44.9 m-20 -61.38 -45.32 94.86 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.765 0.317 . . . . 0.93 111.64 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 65.3 tp -61.27 -47.05 87.77 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.318 -0.401 . . . . 0.58 110.501 179.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . 0.412 ' O ' ' HB2' ' A' ' 160' ' ' LEU . 0.2 OUTLIER -66.53 -41.34 88.93 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 116.198 -0.456 . . . . 0.42 111.53 179.792 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.24 -51.94 66.83 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 112.538 0.57 . . . . 0.54 112.538 -179.411 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . 0.463 ' HA ' ' HB2' ' A' ' 183' ' ' ALA . 64.6 mt-30 -60.7 -45.55 93.79 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 120.702 0.287 . . . . 0.4 111.153 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . 0.492 ' HA ' ' CZ2' ' A' ' 293' ' ' TRP . 4.0 p -62.88 -41.9 99.57 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.392 -0.367 . . . . 0.29 111.04 179.379 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.49 HD21 ' HA ' ' A' ' 273' ' ' GLU . 0.2 OUTLIER -58.14 -47.63 82.73 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 120.839 0.352 . . . . 0.73 110.306 178.887 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -64.56 -52.33 58.2 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 112.364 0.505 . . . . 0.56 112.364 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . 0.489 HG12 ' HA2' ' A' ' 187' ' ' GLY . 90.6 mt -59.05 -46.34 91.83 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 CA-C-N 116.754 -0.203 . . . . 0.3 111.348 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 86.7 mt -67.39 -41.82 86.69 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 121.135 -0.226 . . . . 0.37 110.792 178.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 33.3 t -61.0 -44.17 97.81 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.771 0.32 . . . . 0.32 110.914 179.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . 0.479 HH21 ' CD ' ' A' ' 169' ' ' GLU . 2.7 mtp180 -69.15 -52.14 31.17 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.572 -0.285 . . . . 0.73 111.697 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' TYR . . . . . 0.692 ' HE1' ' HA ' ' A' ' 195' ' ' ARG . 64.0 t80 -56.32 -45.58 80.26 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.553 0.216 . . . . 0.35 111.508 -179.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 5.6 mp -60.47 -50.08 75.01 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 121.188 -0.205 . . . . 0.49 111.22 -179.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . 0.528 ' HD2' ' OE2' ' A' ' 269' ' ' GLU . 9.3 mtp180 -66.95 -36.65 82.7 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 112.083 0.401 . . . . 0.86 112.083 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . 0.479 ' CD ' HH21 ' A' ' 165' ' ' ARG . 0.9 OUTLIER -66.12 -51.31 59.18 Favored 'General case' 0 N--CA 1.465 0.282 0 O-C-N 122.268 -0.27 . . . . 0.65 111.391 179.436 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . 0.451 ' HB2' ' HB1' ' A' ' 253' ' ' ALA . 4.4 mm-40 -64.84 -26.22 68.24 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-O 121.014 0.435 . . . . 0.87 110.323 178.545 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -77.2 -18.33 57.83 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 115.916 -0.584 . . . . 0.47 110.714 178.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . 0.416 ' OG1' ' HE2' ' A' ' 260' ' ' LYS . 25.4 m -98.1 -42.82 7.29 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.061 -0.518 . . . . 0.45 111.466 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 108.88 -0.61 31.83 Favored Glycine 0 CA--C 1.519 0.327 0 C-N-CA 120.633 -0.794 . . . . 0.56 112.723 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 29.8 t -155.69 -92.78 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.854 0.359 . . . . 0.61 111.033 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . 0.451 ' HA ' ' HG2' ' A' ' 169' ' ' GLU . 0.0 OUTLIER -149.0 105.55 3.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.532 -0.304 . . . . 0.66 110.912 -179.809 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -75.52 177.28 6.84 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 121.28 0.562 . . . . 0.77 111.916 -179.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 46.9 t -80.15 54.96 2.06 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 116.153 -0.476 . . . . 1.44 111.977 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . 0.504 ' HD3' ' HD2' ' A' ' 179' ' ' PRO . 5.2 mmtp -123.18 119.13 27.69 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 120.82 0.343 . . . . 0.57 111.353 179.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . 0.504 ' HD2' ' HD3' ' A' ' 178' ' ' LYS . 83.1 Cg_endo -94.9 179.66 0.69 Allowed 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 123.192 2.595 . . . . 0.57 113.773 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 71.2 mt -123.3 151.67 42.18 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.021 -0.536 . . . . 0.49 110.42 179.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -127.84 -72.01 0.16 Allowed Glycine 0 CA--C 1.522 0.503 0 C-N-CA 120.577 -0.821 . . . . 0.52 113.064 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 57.1 mt-10 -91.1 -24.55 19.96 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 120.94 0.4 . . . . 0.87 111.532 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.463 ' HB2' ' HA ' ' A' ' 158' ' ' GLN . . . -80.83 61.57 4.52 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 121.06 0.457 . . . . 0.32 111.311 179.385 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -80.07 -70.31 1.34 Allowed Glycine 0 CA--C 1.527 0.803 0 N-CA-C 114.432 0.533 . . . . 0.36 114.432 -179.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -71.71 -55.48 7.6 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-O 121.063 0.458 . . . . 0.47 111.542 -179.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -63.51 -35.2 79.69 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.974 -0.557 . . . . 0.35 110.16 179.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . 0.617 ' O ' ' HB2' ' A' ' 191' ' ' LEU . . . -63.06 -31.8 81.94 Favored Glycine 0 C--N 1.333 0.403 0 C-N-CA 120.985 -0.626 . . . . 0.33 112.468 179.117 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 6.2 tpt180 -73.07 -57.04 4.31 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 120.635 0.255 . . . . 0.85 111.645 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . 0.551 ' HA ' ' OE1' ' A' ' 192' ' ' GLU . 0.0 OUTLIER -62.54 -41.27 98.78 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-O 121.032 0.444 . . . . 0.57 111.576 -179.266 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.478 ' HB2' ' HB3' ' A' ' 293' ' ' TRP . . . -66.62 -37.06 84.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.362 -0.381 . . . . 0.31 110.909 179.064 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . 0.617 ' HB2' ' O ' ' A' ' 187' ' ' GLY . 0.2 OUTLIER -59.84 -41.5 91.51 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.608 0.242 . . . . 0.6 111.293 179.915 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . 0.551 ' OE1' ' HA ' ' A' ' 189' ' ' ARG . 5.3 mt-10 -67.14 -52.38 42.4 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.129 0.49 . . . . 0.51 111.422 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . 0.565 HG21 ' HA ' ' A' ' 297' ' ' VAL . 4.6 m -65.12 -35.43 81.09 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.874 -0.603 . . . . 0.42 112.265 -179.059 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 0.411 HD12 ' HA ' ' A' ' 194' ' ' LEU . 12.6 tp -69.79 -37.7 76.42 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.694 0.283 . . . . 0.4 111.048 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . 0.692 ' HA ' ' HE1' ' A' ' 166' ' ' TYR . 1.7 ttt180 -66.5 -45.47 79.49 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-O 120.979 0.419 . . . . 0.44 110.882 179.181 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 18.6 mmt85 -64.83 -56.58 12.6 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.821 -0.627 . . . . 0.98 111.959 -179.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . 0.458 ' O ' HG23 ' A' ' 201' ' ' VAL . 98.8 t -66.24 -41.65 89.54 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 CA-C-O 120.901 0.381 . . . . 0.38 111.423 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . 0.503 ' HA3' ' OH ' ' A' ' 166' ' ' TYR . . . -62.0 -52.39 50.46 Favored Glycine 0 CA--C 1.522 0.484 0 C-N-CA 121.178 -0.534 . . . . 0.3 113.494 -179.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -63.83 -40.14 95.88 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 117.385 0.592 . . . . 0.57 109.902 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -53.86 -44.97 71.33 Favored Glycine 0 C--N 1.337 0.599 0 C-N-CA 120.621 -0.8 . . . . 0.39 111.603 178.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . 0.556 HG13 ' HD2' ' A' ' 205' ' ' HIS . 88.9 t -72.37 -36.88 56.42 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-O 121.137 0.494 . . . . 0.38 110.949 178.582 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' GLN . . . . . 0.419 ' HA ' ' CE2' ' A' ' 209' ' ' PHE . 14.7 tt0 -64.39 -34.64 78.63 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 115.926 -0.579 . . . . 0.38 111.415 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 17.0 mmp_? -80.54 -53.75 6.29 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 112.998 0.74 . . . . 0.42 112.998 -179.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 24.1 p30 -67.33 -31.0 70.97 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 119.836 -0.745 . . . . 0.49 111.879 -179.125 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' HIS . . . . . 0.556 ' HD2' HG13 ' A' ' 201' ' ' VAL . 93.8 m-70 -102.31 26.86 7.28 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 121.023 -0.271 . . . . 0.49 111.25 178.54 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -53.21 -54.9 29.28 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 115.995 -0.548 . . . . 0.75 112.276 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 43.0 p -58.05 -47.12 84.1 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.078 -0.51 . . . . 0.64 111.882 -179.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -59.46 -44.61 92.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.249 -0.432 . . . . 0.43 110.285 179.088 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' PHE . . . . . 0.419 ' CE2' ' HA ' ' A' ' 202' ' ' GLN . 10.8 m-30 -63.77 -50.96 66.96 Favored 'General case' 0 C--O 1.223 -0.335 0 CA-C-N 115.973 -0.558 . . . . 0.44 110.751 179.246 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -57.41 -43.7 83.96 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 120.586 0.232 . . . . 0.74 111.553 179.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -61.21 -51.1 60.4 Favored Glycine 0 C--N 1.335 0.505 0 C-N-CA 120.821 -0.704 . . . . 0.43 112.345 179.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' MET . . . . . 0.433 ' HA ' ' HE3' ' A' ' 215' ' ' LYS . 0.7 OUTLIER -68.07 -34.82 77.15 Favored 'General case' 0 CA--C 1.531 0.212 0 O-C-N 122.592 -0.358 . . . . 0.73 111.086 179.3 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 8.7 tp -59.46 -39.22 82.92 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.96 0.409 . . . . 0.65 110.709 178.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 47.6 ttp180 -71.99 -36.3 69.73 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.944 -0.571 . . . . 1.23 110.521 178.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' LYS . . . . . 0.433 ' HE3' ' HA ' ' A' ' 212' ' ' MET . 52.6 mtmt -73.31 -37.46 66.18 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 116.266 -0.424 . . . . 1.33 112.021 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.74 ' HB3' HG12 ' A' ' 218' ' ' ILE . 41.0 mt -63.55 131.64 48.72 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 121.147 0.498 . . . . 0.69 112.117 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -80.4 33.69 0.3 Allowed 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.005 -0.543 . . . . 1.36 111.648 179.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' ILE . . . . . 0.74 HG12 ' HB3' ' A' ' 216' ' ' LEU . 30.7 mm -71.42 105.47 1.78 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.302 0 CA-C-O 120.929 0.395 . . . . 0.49 111.564 -179.172 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 2.6 ttmm -163.07 -53.69 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 115.881 -0.6 . . . . 1.74 111.218 179.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 52.8 m-20 -104.41 -178.5 3.67 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 115.935 -0.575 . . . . 0.73 111.391 -179.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -46.7 -29.42 1.88 Allowed 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 113.482 0.919 . . . . 1.38 113.482 -179.272 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -62.22 -23.59 64.38 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 121.487 -0.387 . . . . 0.47 113.971 179.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' ASP . . . . . 0.515 ' HB2' HG23 ' A' ' 218' ' ' ILE . 2.1 p-10 -58.61 -52.15 66.89 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 113.625 0.972 . . . . 1.11 113.625 -178.297 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 19.6 m -58.66 -38.35 70.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 N-CA-C 112.205 0.446 . . . . 0.48 112.205 -179.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 85.7 mttt -69.09 -43.58 74.25 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.059 0.457 . . . . 0.86 110.29 179.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . 0.573 ' O ' HG23 ' A' ' 230' ' ' VAL . 20.9 m -65.66 -46.6 78.54 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.84 -0.618 . . . . 0.38 110.265 179.289 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' PHE . . . . . 0.617 ' O ' ' HG3' ' A' ' 231' ' ' MET . 7.2 t80 -58.23 -43.34 87.73 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.918 -0.583 . . . . 0.57 110.521 179.167 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' SER . . . . . 0.429 ' O ' HG23 ' A' ' 232' ' ' VAL . 67.3 m -56.58 -44.16 80.75 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.023 0.44 . . . . 0.37 109.983 178.462 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 69.7 mtp180 -63.18 -35.97 82.06 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 115.885 -0.598 . . . . 1.17 110.321 178.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 0.717 HG22 ' HE1' ' B' ' 23' ' ' PHE . 28.4 t -63.14 -51.94 65.11 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 N-CA-C 109.601 -0.518 . . . . 0.32 109.601 177.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 231' ' ' MET . . . . . 0.617 ' HG3' ' O ' ' A' ' 227' ' ' PHE . 54.0 mtp -57.23 -43.98 83.38 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.517 -0.765 . . . . 0.44 111.102 179.58 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 232' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 228' ' ' SER . 55.7 t -58.41 -40.91 80.02 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 N-CA-C 109.985 -0.376 . . . . 0.51 109.985 178.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 233' ' ' HIS . . . . . 0.571 ' HA ' ' HB2' ' A' ' 236' ' ' LYS . 54.9 t-80 -71.24 -39.96 71.34 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 116.048 -0.524 . . . . 0.58 111.039 178.725 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.519 HG23 ' O ' ' A' ' 230' ' ' VAL . 74.0 t -57.09 -38.92 63.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-O 120.749 0.309 . . . . 0.43 111.003 179.262 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -104.79 23.7 13.03 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 116.406 -0.361 . . . . 0.92 111.176 178.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . 0.571 ' HB2' ' HA ' ' A' ' 233' ' ' HIS . 5.9 tptp -70.52 -29.95 66.58 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 114.571 1.322 . . . . 1.46 114.571 -177.331 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -69.92 -16.93 63.29 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 118.643 0.656 . . . . 1.24 112.301 -178.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 98.7 -19.67 53.43 Favored Glycine 0 CA--C 1.522 0.527 0 C-N-CA 120.877 -0.678 . . . . 0.48 113.631 179.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 0.432 ' HB ' ' NH2' ' A' ' 244' ' ' ARG . 21.8 t -77.22 118.12 23.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 121.147 0.499 . . . . 0.52 110.788 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -95.07 100.07 11.95 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.097 0.406 . . . . 0.76 112.097 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . 0.506 ' HB2' ' HG3' ' A' ' 244' ' ' ARG . 14.9 m120 -103.88 134.51 47.06 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 110.391 -0.226 . . . . 0.48 110.391 178.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 242' ' ' TRP . . . . . 0.502 ' HB3' ' CZ ' ' A' ' 300' ' ' PHE . 14.0 m95 -56.81 -27.48 59.99 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 112.127 0.417 . . . . 0.53 112.127 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . 0.412 ' H ' ' HB2' ' B' ' 35' ' ' TYR . . . -69.64 -29.57 71.27 Favored Glycine 0 CA--C 1.52 0.39 0 C-N-CA 121.186 -0.531 . . . . 0.32 112.9 179.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 244' ' ' ARG . . . . . 0.506 ' HG3' ' HB2' ' A' ' 241' ' ' ASN . 19.6 mtt180 -73.72 -37.15 65.22 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.297 0.57 . . . . 0.46 109.645 179.268 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . 0.692 HG23 HD21 ' A' ' 279' ' ' LEU . 83.0 mt -63.03 -51.8 67.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-N 115.446 -0.797 . . . . 0.46 110.998 179.197 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 17.4 m -66.71 -30.33 49.35 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 C-N-CA 120.795 -0.362 . . . . 0.36 111.322 179.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 17.4 m -64.07 -46.54 83.83 Favored 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 110.248 -0.278 . . . . 0.43 110.248 178.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 248' ' ' LEU . . . . . 0.449 HD13 ' HA ' ' A' ' 248' ' ' LEU . 2.5 mm? -60.82 -35.91 77.74 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 120.688 0.28 . . . . 0.66 110.769 178.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 249' ' ' ILE . . . . . 0.563 HG12 ' O ' ' A' ' 245' ' ' ILE . 35.5 mm -71.88 -47.08 57.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 CA-C-O 120.868 0.366 . . . . 0.4 110.436 178.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 39.6 t -59.59 -42.02 91.62 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 121.156 0.503 . . . . 0.31 109.708 178.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 251' ' ' PHE . . . . . 0.441 ' O ' HG23 ' A' ' 255' ' ' VAL . 8.9 t80 -65.72 -44.03 87.31 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 115.607 -0.724 . . . . 0.39 109.825 177.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -57.29 -41.63 93.08 Favored Glycine 0 C--N 1.338 0.653 0 N-CA-C 111.623 -0.591 . . . . 0.28 111.623 178.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 253' ' ' ALA . . . . . 0.451 ' HB1' ' HB2' ' A' ' 170' ' ' GLN . . . -63.83 -40.4 96.53 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 120.808 0.337 . . . . 0.3 110.513 177.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 21.9 t80 -67.51 -38.97 85.08 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-O 121.454 0.645 . . . . 0.52 109.944 178.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 255' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 251' ' ' PHE . 63.5 t -65.0 -46.65 90.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.775 -0.648 . . . . 0.39 109.445 178.021 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -57.91 -36.62 72.71 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.306 -0.406 . . . . 0.27 110.195 178.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 23.3 ttmm -60.21 -45.09 94.37 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 115.663 -0.699 . . . . 2.05 111.45 178.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 258' ' ' HIS . . . . . 0.434 ' CE1' HD13 ' A' ' 259' ' ' LEU . 0.3 OUTLIER -65.95 -34.97 79.33 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 120.731 0.3 . . . . 0.39 111.132 179.538 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.623 ' HG ' ' HB3' ' A' ' 264' ' ' GLN . 3.5 tp -76.83 -46.19 25.75 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 116.551 -0.295 . . . . 0.45 111.485 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 260' ' ' LYS . . . . . 0.416 ' HE2' ' OG1' ' A' ' 172' ' ' THR . 42.7 tttp -63.04 -27.23 69.26 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 120.608 0.242 . . . . 0.41 111.353 179.293 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 57.8 m -57.98 -26.74 62.73 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 121.004 0.43 . . . . 0.44 110.817 178.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 15.9 m -114.53 23.42 5.25 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 CA-C-O 121.305 0.574 . . . . 0.46 110.093 178.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 263' ' ' ASN . . . . . 0.458 ' HA ' ' OE2' ' A' ' 265' ' ' GLU . 1.7 m120 54.19 59.99 3.87 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 114.948 -1.024 . . . . 0.65 113.475 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 264' ' ' GLN . . . . . 0.623 ' HB3' ' HG ' ' A' ' 259' ' ' LEU . 5.9 mt-30 -119.86 35.61 4.79 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.238 -0.437 . . . . 0.91 110.771 178.485 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . 0.562 ' HA ' HG12 ' A' ' 268' ' ' ILE . 0.9 OUTLIER -59.9 -25.0 64.76 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 112.422 0.527 . . . . 0.62 112.422 -179.568 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 16.6 p -64.02 -16.69 62.21 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 120.586 0.231 . . . . 0.86 111.285 179.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 267' ' ' PHE . . . . . 0.506 ' O ' ' HD2' ' A' ' 270' ' ' PRO . 28.6 m-85 -98.96 -32.35 11.34 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 120.982 0.42 . . . . 1.07 111.333 179.082 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 268' ' ' ILE . . . . . 0.562 HG12 ' HA ' ' A' ' 265' ' ' GLU . 20.3 pt -68.07 -28.86 42.64 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 120.955 -0.298 . . . . 0.41 111.453 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 269' ' ' GLU . . . . . 0.844 ' HB2' ' HD3' ' A' ' 270' ' ' PRO . 39.0 mm-40 -57.27 -57.02 27.81 Favored Pre-proline 0 CA--C 1.546 0.82 0 N-CA-C 110.028 -0.36 . . . . 0.66 110.028 178.09 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 270' ' ' PRO . . . . . 0.844 ' HD3' ' HB2' ' A' ' 269' ' ' GLU . 32.0 Cg_exo -62.09 -30.51 82.67 Favored 'Trans proline' 0 C--N 1.362 1.287 0 C-N-CA 122.291 1.994 . . . . 0.44 111.605 177.07 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 271' ' ' LEU . . . . . . . . . . . . . 40.3 tp -64.93 -40.25 94.75 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.114 -0.494 . . . . 0.57 109.751 177.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -63.39 -40.31 96.88 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 109.096 -0.705 . . . . 0.43 109.096 177.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 273' ' ' GLU . . . . . 0.574 ' OE1' ' HA ' ' A' ' 270' ' ' PRO . 35.0 mt-10 -63.49 -41.94 98.54 Favored 'General case' 0 C--O 1.223 -0.332 0 N-CA-C 108.693 -0.854 . . . . 0.8 108.693 177.009 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 274' ' ' THR . . . . . . . . . . . . . 10.1 m -60.32 -53.19 60.63 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.387 -0.824 . . . . 0.54 110.905 178.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 275' ' ' ILE . . . . . 0.614 HG23 ' HE3' ' A' ' 231' ' ' MET . 97.3 mt -58.09 -46.0 88.3 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-N 116.127 -0.488 . . . . 0.48 111.042 179.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 16.6 m -66.21 -49.51 67.03 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.337 -0.392 . . . . 0.41 111.539 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 277' ' ' ASP . . . . . 0.633 ' OD1' ' HD2' ' A' ' 281' ' ' ARG . 25.8 t0 -58.65 -56.34 23.44 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.335 -0.393 . . . . 0.59 111.975 -179.146 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 278' ' ' VAL . . . . . 0.515 HG11 ' HB2' ' A' ' 231' ' ' MET . 61.6 t -58.98 -37.76 69.55 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 120.924 -0.31 . . . . 0.49 111.237 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . 0.692 HD21 HG23 ' A' ' 245' ' ' ILE . 28.1 tp -65.7 -46.5 78.79 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 111.98 0.363 . . . . 0.97 111.98 179.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 66.3 t -79.62 -51.25 16.76 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 N-CA-C 112.196 0.443 . . . . 0.53 112.196 -179.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 281' ' ' ARG . . . . . 0.633 ' HD2' ' OD1' ' A' ' 277' ' ' ASP . 3.0 mtt180 -55.11 -38.43 68.15 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 113.205 0.817 . . . . 0.92 113.205 -179.184 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 282' ' ' THR . . . . . . . . . . . . . 2.7 m -82.07 -12.7 58.11 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 112.332 0.493 . . . . 0.59 112.332 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 67.8 mmtt -135.04 41.55 2.83 Favored 'General case' 0 N--CA 1.468 0.47 0 O-C-N 122.063 -0.398 . . . . 0.95 111.774 -179.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 57.3 mtp180 -55.41 -54.44 43.74 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 112.805 0.669 . . . . 0.69 112.805 -178.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -56.98 -46.0 82.54 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 120.924 0.392 . . . . 0.63 111.85 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 286' ' ' TRP . . . . . 0.418 ' O ' ' HB2' ' A' ' 290' ' ' GLN . 0.8 OUTLIER -67.45 -43.1 81.91 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.029 0.381 . . . . 0.59 112.029 -179.375 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -69.13 -46.24 68.13 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 112.373 0.509 . . . . 0.56 112.373 -179.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 9.3 p -63.6 -37.11 78.75 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 C-N-CA 121.059 -0.256 . . . . 0.57 111.588 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 64.9 mttt -75.03 -24.76 58.38 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 120.759 0.314 . . . . 0.98 111.301 179.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 290' ' ' GLN . . . . . 0.418 ' HB2' ' O ' ' A' ' 286' ' ' TRP . 0.0 OUTLIER -91.75 2.98 56.13 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 112.122 0.416 . . . . 0.58 112.122 179.907 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 291' ' ' ARG . . . . . 0.446 HH11 ' HD2' ' A' ' 291' ' ' ARG . 29.5 mtm180 64.06 17.19 10.48 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 112.493 0.553 . . . . 0.46 112.493 179.393 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 64.75 -114.58 6.91 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 114.852 0.701 . . . . 0.34 114.852 178.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 293' ' ' TRP . . . . . 0.492 ' CZ2' ' HA ' ' A' ' 159' ' ' SER . 82.2 m95 -66.26 -36.76 83.83 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 113.262 0.838 . . . . 0.49 113.262 -177.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 294' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -58.69 -47.5 84.32 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 120.826 0.346 . . . . 0.5 110.45 179.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -69.18 -27.5 73.69 Favored Glycine 0 CA--C 1.522 0.471 0 C-N-CA 120.397 -0.906 . . . . 0.29 111.481 178.081 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 296' ' ' PHE . . . . . 0.47 ' HB3' ' HA ' ' A' ' 293' ' ' TRP . 1.9 t80 -70.2 -48.32 57.63 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 122.561 0.345 . . . . 0.37 111.27 179.057 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 297' ' ' VAL . . . . . 0.565 ' HA ' HG21 ' A' ' 193' ' ' THR . 33.9 m -66.95 -32.62 58.81 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 CA-C-O 120.605 0.241 . . . . 0.36 111.388 -179.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -64.71 -53.54 45.67 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.791 0.329 . . . . 0.43 111.429 179.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 299' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -64.19 -33.83 76.69 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.322 -0.399 . . . . 0.6 111.952 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 300' ' ' PHE . . . . . 0.502 ' CZ ' ' HB3' ' A' ' 242' ' ' TRP . 70.2 m-85 -98.47 30.01 3.4 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 112.515 0.561 . . . . 0.56 112.515 -179.246 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 301' ' ' HIS . . . . . 0.482 ' HB2' ' O ' ' A' ' 297' ' ' VAL . 48.6 t-80 -105.44 77.71 1.31 Allowed 'General case' 0 C--O 1.233 0.23 0 C-N-CA 120.536 -0.466 . . . . 1.62 111.564 179.356 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . 0.471 ' HB ' ' H ' ' A' ' 303' ' ' GLN . 8.0 m -82.68 -145.76 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 116.314 -0.403 . . . . 0.97 110.467 178.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 303' ' ' GLN . . . . . 0.471 ' H ' ' HB ' ' A' ' 302' ' ' VAL . 3.8 tp-100 -74.19 66.35 1.25 Allowed 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 121.446 0.641 . . . . 1.61 110.801 179.189 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -154.35 111.92 3.45 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 115.865 -0.607 . . . . 1.09 111.208 -179.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 56.3 mt -102.19 -57.48 2.06 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.251 0.548 . . . . 1.79 109.929 179.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.04 -42.84 3.48 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.429 -0.805 . . . . 1.47 110.233 179.027 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . 63.79 -121.43 23.51 Favored Glycine 0 C--N 1.338 0.686 0 CA-C-N 116.003 -0.544 . . . . 1.27 113.475 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.256 1.526 0 CA-C-O 118.863 -0.965 . . . . 1.71 112.875 179.529 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.671 0 CA-C-O 121.354 0.597 . . . . 2.29 110.862 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 18' ' ' GLU . . . . . 0.401 ' HB2' ' H ' ' B' ' 19' ' ' LEU . 1.2 pm0 -103.65 -145.39 0.37 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.291 -0.868 . . . . 1.52 111.359 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 19' ' ' LEU . . . . . 0.534 ' HG ' ' HD2' ' B' ' 20' ' ' PRO . 0.3 OUTLIER -78.77 140.21 58.6 Favored Pre-proline 0 CA--C 1.538 0.514 0 CA-C-N 116.39 -0.368 . . . . 1.63 110.447 179.398 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 20' ' ' PRO . . . . . 0.534 ' HD2' ' HG ' ' B' ' 19' ' ' LEU . 14.8 Cg_endo -54.05 151.83 26.28 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 123.608 2.872 . . . . 0.76 113.383 -179.506 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 21' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.38 29.79 0.17 Allowed 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 122.928 2.419 . . . . 0.61 113.652 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 22' ' ' GLU . . . . . 0.431 ' H ' ' C ' ' B' ' 20' ' ' PRO . 7.4 tm-20 -68.42 -41.95 79.66 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.0 -0.546 . . . . 1.46 110.596 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 23' ' ' PHE . . . . . 0.717 ' HE1' HG22 ' A' ' 230' ' ' VAL . 10.7 p90 -63.09 -35.41 80.17 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.104 0.478 . . . . 0.55 110.63 179.363 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.34 -44.62 64.74 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.986 -0.552 . . . . 0.36 109.986 178.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.05 -44.72 96.97 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.923 -0.58 . . . . 0.48 110.172 177.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 1.2 tp-100 -58.59 -48.9 79.4 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 115.548 -0.751 . . . . 0.88 110.161 178.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 45.6 mt -58.75 -40.55 84.17 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.292 -0.413 . . . . 0.47 110.637 178.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.89 -51.14 70.55 Favored 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 109.736 -0.468 . . . . 0.41 109.736 178.472 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 46.9 mtpt -55.61 -45.17 77.51 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 116.25 -0.432 . . . . 0.66 110.008 178.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . 0.514 ' O ' HG23 ' B' ' 34' ' ' VAL . 95.5 mt -59.21 -44.96 93.13 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 N-CA-C 109.719 -0.474 . . . . 0.45 109.719 178.123 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . 0.47 ' HA3' ' HG2' ' A' ' 244' ' ' ARG . . . -60.4 -49.55 77.35 Favored Glycine 0 C--N 1.336 0.534 0 CA-C-N 116.028 -0.533 . . . . 0.3 112.302 178.579 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -58.77 -38.82 79.34 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.18 0.514 . . . . 0.43 110.121 178.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -68.28 -47.67 67.03 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 115.75 -0.659 . . . . 0.98 111.353 179.247 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 34' ' ' VAL . . . . . 0.514 HG23 ' O ' ' B' ' 30' ' ' ILE . 53.9 t -56.65 -50.06 75.49 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-O 120.717 0.294 . . . . 0.34 111.422 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 35' ' ' TYR . . . . . 0.412 ' HB2' ' H ' ' A' ' 243' ' ' GLY . 0.0 OUTLIER -61.86 -38.57 88.73 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 120.881 0.372 . . . . 0.77 110.345 178.995 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 36' ' ' CYS . . . . . . . . . . . . . 21.4 t -68.03 -25.4 65.36 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.205 -0.452 . . . . 0.67 111.226 179.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 20.4 m -82.78 -42.14 18.31 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.189 -0.46 . . . . 0.49 111.977 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 38' ' ' TRP . . . . . . . . . . . . . 99.2 m95 -80.78 -22.9 39.69 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 112.54 0.571 . . . . 0.66 112.54 -179.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 20.3 t -74.2 -6.06 45.58 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 112.283 0.475 . . . . 0.76 112.283 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -90.57 123.23 65.85 Favored Pre-proline 0 CA--C 1.534 0.349 0 N-CA-C 111.857 0.317 . . . . 1.05 111.857 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -75.62 131.32 13.47 Favored 'Trans proline' 0 CA--C 1.534 0.513 0 C-N-CA 122.688 2.258 . . . . 1.6 113.05 179.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -94.07 -78.84 0.43 Allowed 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 116.155 -0.475 . . . . 2.09 111.662 179.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 43' ' ' MET . . . . . . . . . . . . . 47.5 ttm . . . . . 0 C--O 1.255 1.346 0 CA-C-O 118.427 -0.797 . . . . 3.19 111.516 179.626 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.088 0 N-CA-C 112.339 -0.304 . . . . 0.54 112.339 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -79.01 50.58 3.54 Favored 'Trans proline' 0 CA--C 1.535 0.564 0 C-N-CA 122.698 2.265 . . . . 0.75 113.115 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 24.0 tp -90.26 -18.96 24.71 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 121.005 0.431 . . . . 1.39 111.187 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 126.1 -170.67 17.93 Favored Glycine 0 CA--C 1.52 0.353 0 C-N-CA 120.814 -0.708 . . . . 0.52 112.649 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 92.0 p -72.14 72.47 0.89 Allowed 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.563 0.697 . . . . 0.62 111.264 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -162.61 -43.18 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.216 -0.902 . . . . 0.53 110.103 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . 0.504 ' HA ' ' HB3' ' A' ' 156' ' ' TYR . 2.3 m-20 -61.25 -26.77 67.98 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.866 -0.606 . . . . 0.46 110.867 179.622 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -56.16 -37.09 69.06 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 121.368 0.604 . . . . 0.48 109.42 177.593 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 53.6 tp -83.44 -32.29 26.15 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.696 -0.684 . . . . 0.62 109.674 178.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . 0.504 ' HB3' ' HA ' ' A' ' 153' ' ' ASP . 83.3 t80 -62.18 -37.45 85.31 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 115.767 -0.651 . . . . 0.39 110.647 178.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.606 ' HD3' ' OE1' ' A' ' 182' ' ' GLU . 0.7 OUTLIER -59.25 -44.88 92.36 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.039 0.447 . . . . 0.34 110.637 178.727 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -74.32 -35.3 63.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.253 -0.43 . . . . 0.66 110.014 178.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . 0.467 ' HA ' ' NE1' ' A' ' 293' ' ' TRP . 64.8 m -59.03 -57.69 11.94 Favored 'General case' 0 CA--C 1.521 -0.144 0 CA-C-N 115.854 -0.612 . . . . 0.25 110.645 178.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.475 HD23 ' NH2' ' A' ' 157' ' ' ARG . 46.9 tp -62.01 -36.93 83.02 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 121.077 -0.249 . . . . 0.35 110.757 179.306 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . 0.492 ' OE2' ' HB3' ' A' ' 180' ' ' LEU . 0.0 OUTLIER -59.02 -54.11 50.78 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 120.792 0.329 . . . . 0.43 110.649 179.037 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . 0.517 HG12 ' HA2' ' A' ' 187' ' ' GLY . 54.8 mt -63.77 -45.45 97.2 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-N 116.093 -0.503 . . . . 0.28 111.381 179.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.466 ' O ' ' HG ' ' A' ' 167' ' ' LEU . 54.8 mt -61.33 -46.73 96.01 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 CA-C-N 116.5 -0.318 . . . . 0.33 111.243 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 31.4 t -62.34 -45.38 93.44 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.876 0.369 . . . . 0.38 110.495 178.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . 0.664 ' HG2' ' HG ' ' A' ' 180' ' ' LEU . 0.0 OUTLIER -61.84 -46.13 90.8 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.2 -0.455 . . . . 0.66 111.587 -179.894 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' TYR . . . . . 0.864 ' HE1' ' HA ' ' A' ' 195' ' ' ARG . 91.6 t80 -70.36 -54.14 13.75 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 112.634 0.605 . . . . 0.4 112.634 -179.289 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.466 ' HG ' ' O ' ' A' ' 163' ' ' ILE . 29.8 mt -58.71 -49.74 76.48 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 112.516 0.561 . . . . 0.33 112.516 -177.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -66.03 -39.02 89.84 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 112.274 0.472 . . . . 1.09 112.274 -179.2 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . 0.47 ' HB2' ' O ' ' A' ' 165' ' ' ARG . 14.3 mm-40 -71.19 -47.93 54.62 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 120.56 -0.456 . . . . 0.44 111.755 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . 0.456 ' O ' ' HG3' ' A' ' 170' ' ' GLN . 0.5 OUTLIER -62.27 -28.02 69.42 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 120.918 0.39 . . . . 1.06 111.159 179.129 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.482 ' HB2' ' HB1' ' A' ' 256' ' ' ALA . . . -74.26 -24.62 59.3 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 112.7 0.63 . . . . 0.43 112.7 -179.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 9.4 t -111.05 -21.23 12.08 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 112.814 0.672 . . . . 0.61 112.814 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 70.88 29.99 68.59 Favored Glycine 0 CA--C 1.525 0.686 0 C-N-CA 120.607 -0.806 . . . . 0.56 113.505 179.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . 0.462 ' HB3' ' OE1' ' A' ' 169' ' ' GLU . 28.9 t -77.47 -62.05 1.79 Allowed 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.989 0.395 . . . . 0.53 111.396 -179.255 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . 0.677 ' HB3' ' HG3' ' A' ' 178' ' ' LYS . 19.8 tptt -151.83 118.9 5.86 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 121.035 0.445 . . . . 0.85 111.602 179.117 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -50.6 -71.71 0.06 Allowed 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 115.23 -0.895 . . . . 0.77 112.484 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 3.6 m -88.52 79.92 7.5 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.938 -0.574 . . . . 0.61 111.174 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . 0.677 ' HG3' ' HB3' ' A' ' 175' ' ' LYS . 10.7 mttt -96.0 138.9 21.62 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-O 120.756 0.313 . . . . 0.76 110.856 179.221 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -57.03 138.17 85.15 Favored 'Trans proline' 0 CA--C 1.535 0.532 0 C-N-CA 123.172 2.581 . . . . 0.7 113.834 -179.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.664 ' HG ' ' HG2' ' A' ' 165' ' ' ARG . 5.3 mp -97.81 -165.84 1.3 Allowed 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 115.647 -0.706 . . . . 0.65 110.857 179.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -125.15 -41.34 0.37 Allowed Glycine 0 CA--C 1.524 0.654 0 C-N-CA 120.325 -0.94 . . . . 0.62 113.516 -179.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . 0.606 ' OE1' ' HD3' ' A' ' 157' ' ' ARG . 82.7 mt-10 -114.14 -27.18 7.75 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.06 0.457 . . . . 0.74 111.374 -179.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.551 ' HB3' HD22 ' A' ' 180' ' ' LEU . . . -102.29 81.84 2.12 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 121.138 0.495 . . . . 0.33 111.542 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -80.43 -71.59 1.27 Allowed Glycine 0 CA--C 1.525 0.691 0 C-N-CA 120.88 -0.676 . . . . 0.34 113.986 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -66.83 -55.58 14.17 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 120.823 0.345 . . . . 0.42 111.808 -179.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -66.26 -37.04 84.53 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.265 -0.425 . . . . 0.36 110.235 179.192 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . 0.518 ' HA3' ' O ' ' A' ' 183' ' ' ALA . . . -64.85 -41.25 97.58 Favored Glycine 0 C--N 1.334 0.462 0 C-N-CA 120.909 -0.662 . . . . 0.29 112.667 179.282 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . 0.453 HH11 ' HD2' ' A' ' 188' ' ' ARG . 13.5 ttt180 -62.31 -53.47 54.63 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.621 0.248 . . . . 0.51 110.666 178.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . 0.757 ' HB3' HG11 ' A' ' 297' ' ' VAL . 73.7 mtt180 -59.63 -44.9 93.31 Favored 'General case' 0 C--O 1.228 -0.072 0 CA-C-N 116.24 -0.436 . . . . 0.41 110.98 179.549 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -69.45 -37.86 77.55 Favored 'General case' 0 C--O 1.218 -0.558 0 N-CA-C 112.817 0.673 . . . . 0.28 112.817 -178.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 18.6 tp -64.41 -49.15 72.68 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 118.178 0.444 . . . . 0.6 111.911 -179.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . 0.429 ' OE2' ' NE2' ' A' ' 301' ' ' HIS . 0.0 OUTLIER -66.4 -36.02 81.79 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.853 0.358 . . . . 0.4 111.044 179.675 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . 0.505 HG21 ' HA ' ' A' ' 297' ' ' VAL . 48.2 m -73.05 -44.91 60.1 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.578 -0.283 . . . . 0.31 110.673 179.287 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 0.474 HD21 HG21 ' A' ' 249' ' ' ILE . 14.7 tp -62.03 -36.46 81.64 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.41 -0.359 . . . . 0.39 110.531 179.181 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . 0.864 ' HA ' ' HE1' ' A' ' 166' ' ' TYR . 0.8 OUTLIER -63.96 -55.72 20.38 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.015 0.436 . . . . 0.35 110.683 178.449 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.33 -47.9 83.65 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.457 -0.792 . . . . 1.33 112.41 -179.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . 0.524 ' O ' HG23 ' A' ' 201' ' ' VAL . 83.0 t -72.82 -49.73 38.04 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 N-CA-C 111.97 0.359 . . . . 0.32 111.97 -179.461 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . 0.507 ' O ' ' HG2' ' A' ' 202' ' ' GLN . . . -57.61 -53.38 45.54 Favored Glycine 0 C--N 1.334 0.462 0 C-N-CA 121.187 -0.53 . . . . 0.33 112.498 -179.568 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . 0.551 ' HB2' ' O ' ' A' ' 195' ' ' ARG . 0.3 OUTLIER -59.17 -40.65 86.29 Favored 'General case' 0 C--O 1.224 -0.262 0 N-CA-C 109.841 -0.429 . . . . 0.72 109.841 178.783 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -62.4 -50.01 68.71 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 120.898 -0.668 . . . . 0.36 112.604 178.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . 0.524 HG23 ' O ' ' A' ' 197' ' ' VAL . 78.1 t -55.88 -52.63 47.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-O 120.743 0.306 . . . . 0.38 111.764 179.275 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' GLN . . . . . 0.533 ' HG3' ' CZ ' ' A' ' 203' ' ' ARG . 1.4 pt20 -69.53 -31.75 70.17 Favored 'General case' 0 C--O 1.221 -0.432 0 N-CA-C 112.091 0.404 . . . . 0.43 112.091 -179.382 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' ARG . . . . . 0.533 ' CZ ' ' HG3' ' A' ' 202' ' ' GLN . 0.0 OUTLIER -68.77 -43.43 75.77 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.955 0.407 . . . . 0.73 109.997 178.003 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 18.2 m-80 -66.35 -47.09 74.56 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 121.163 0.506 . . . . 0.6 110.604 178.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -97.76 36.26 1.55 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.028 -0.533 . . . . 0.47 110.216 179.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . 0.528 ' OE1' ' HA ' ' A' ' 203' ' ' ARG . 4.5 tp10 -49.72 -52.0 34.6 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 115.477 -0.783 . . . . 0.47 112.186 -178.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 64.7 p -65.66 -38.96 90.78 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.595 0.591 . . . . 0.59 112.595 -179.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -63.85 -45.51 89.17 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.066 0.46 . . . . 0.4 110.449 179.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -71.13 -42.34 69.34 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.976 -0.557 . . . . 0.48 110.475 179.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' GLN . . . . . 0.415 ' O ' ' HG3' ' A' ' 214' ' ' ARG . 6.7 tt0 -62.58 -45.88 90.89 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.188 -0.46 . . . . 0.81 110.852 179.243 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -59.93 -49.45 78.41 Favored Glycine 0 C--N 1.334 0.47 0 C-N-CA 120.902 -0.666 . . . . 0.32 111.82 178.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' MET . . . . . 0.488 ' SD ' ' HA ' ' B' ' 23' ' ' PHE . 2.0 ttp -60.91 -36.34 79.02 Favored 'General case' 0 C--O 1.224 -0.257 0 CA-C-O 120.884 0.374 . . . . 0.51 110.002 178.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.409 HD13 ' HD2' ' A' ' 254' ' ' PHE . 7.8 tp -68.1 -39.93 82.7 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.663 -0.699 . . . . 0.55 110.919 178.684 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' ARG . . . . . 0.415 ' HG3' ' O ' ' A' ' 210' ' ' GLN . 70.0 mtt-85 -57.54 -39.34 76.41 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.163 -0.471 . . . . 0.81 110.759 178.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' LYS . . . . . 0.428 ' HE3' ' HB2' ' A' ' 215' ' ' LYS . 47.2 mtmt -99.01 12.13 36.91 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.099 -0.5 . . . . 0.63 111.191 179.055 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.567 ' HA ' HD13 ' B' ' 19' ' ' LEU . 28.0 tp -82.41 110.41 17.53 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.948 0.404 . . . . 0.45 111.14 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 35.8 m-20 -79.43 32.74 0.24 Allowed 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 112.437 0.532 . . . . 0.59 112.437 -179.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' ILE . . . . . 0.525 HG23 ' HB2' ' A' ' 223' ' ' ASP . 2.7 mt -81.18 107.68 13.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 CA-C-O 121.424 0.63 . . . . 0.42 110.634 179.155 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . 0.477 ' HG2' HE22 ' A' ' 264' ' ' GLN . 0.4 OUTLIER -161.3 -39.24 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 115.252 -0.885 . . . . 0.49 111.209 179.396 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -105.11 -177.46 3.37 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.5 -0.318 . . . . 0.59 111.853 -179.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -49.53 -21.68 1.03 Allowed 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 113.677 0.992 . . . . 0.66 113.677 -179.133 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -69.55 -23.81 76.45 Favored Glycine 0 CA--C 1.531 1.074 0 N-CA-C 114.265 0.466 . . . . 0.41 114.265 -179.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' ASP . . . . . 0.525 ' HB2' HG23 ' A' ' 218' ' ' ILE . 6.5 p-10 -55.48 -56.52 19.23 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 113.711 1.004 . . . . 0.89 113.711 -177.449 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.524 ' HB ' HG21 ' A' ' 274' ' ' THR . 17.2 m -61.53 -33.38 56.83 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-O 121.038 0.447 . . . . 0.45 111.672 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 48.2 mttp -70.26 -39.14 75.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.085 0.469 . . . . 0.91 110.478 179.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . 0.658 ' O ' HG23 ' A' ' 230' ' ' VAL . 7.3 t -74.19 -44.69 52.43 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.095 -0.502 . . . . 0.89 110.652 179.113 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -57.99 -46.62 84.91 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.969 0.414 . . . . 0.46 110.853 179.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' SER . . . . . 0.486 ' CB ' HG21 ' A' ' 278' ' ' VAL . 16.3 p -65.78 -39.37 90.91 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.735 -0.469 . . . . 0.38 109.735 178.483 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 42.6 ttp180 -60.08 -45.39 93.06 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.198 -0.456 . . . . 1.08 110.202 177.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 0.658 HG23 ' O ' ' A' ' 226' ' ' SER . 99.8 t -59.39 -48.0 88.66 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-N 116.017 -0.538 . . . . 0.35 110.353 178.48 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 231' ' ' MET . . . . . 0.745 ' HG3' HD13 ' A' ' 248' ' ' LEU . 29.6 ttm -55.22 -41.15 71.69 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.046 -0.524 . . . . 0.35 111.553 179.606 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 232' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 228' ' ' SER . 85.2 t -66.93 -36.1 76.32 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-O 121.037 0.446 . . . . 0.54 111.079 179.287 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 44.8 t-80 -77.2 -36.36 54.98 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 116.415 -0.357 . . . . 0.47 111.636 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.445 HG23 ' O ' ' A' ' 230' ' ' VAL . 52.0 t -56.58 -39.63 63.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 CA-C-O 120.867 0.365 . . . . 0.4 111.49 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 235' ' ' PHE . . . . . 0.826 ' HE2' HD11 ' A' ' 248' ' ' LEU . 75.7 m-85 -100.29 24.25 9.03 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.031 0.382 . . . . 0.36 112.031 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 3.2 ttpp -73.1 -10.91 60.29 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 120.541 0.21 . . . . 0.87 111.489 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 22.2 p-10 -89.06 -10.38 47.66 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 120.731 0.301 . . . . 0.38 111.061 179.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 91.52 -19.23 48.92 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 114.487 0.555 . . . . 0.35 114.487 178.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 0.548 ' HB ' ' NH2' ' A' ' 244' ' ' ARG . 17.9 t -78.78 102.81 5.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 O-C-N 122.23 -0.571 . . . . 0.41 111.305 -179.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 240' ' ' THR . . . . . 0.481 ' HA ' ' CE1' ' A' ' 235' ' ' PHE . 24.1 m -93.25 84.03 4.72 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.112 0.482 . . . . 0.36 111.344 -179.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . 0.422 ' HB2' ' HG3' ' A' ' 244' ' ' ARG . 80.5 m-20 -89.09 141.03 28.85 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.316 -0.402 . . . . 0.42 111.338 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 242' ' ' TRP . . . . . 0.435 ' HE1' ' HG2' ' A' ' 290' ' ' GLN . 18.9 m95 -57.93 -37.89 74.91 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.759 0.314 . . . . 0.52 111.112 179.533 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . 0.468 ' H ' ' HB2' ' B' ' 35' ' ' TYR . . . -60.04 -30.89 71.18 Favored Glycine 0 C--N 1.335 0.503 0 C-N-CA 120.991 -0.623 . . . . 0.23 112.047 178.492 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 244' ' ' ARG . . . . . 0.548 ' NH2' ' HB ' ' A' ' 239' ' ' VAL . 26.1 mtt180 -75.45 -48.06 24.43 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.969 0.414 . . . . 0.34 109.959 178.526 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . 0.545 HG23 HD11 ' A' ' 279' ' ' LEU . 73.3 mt -56.5 -44.93 81.72 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-N 115.449 -0.796 . . . . 0.47 110.625 179.53 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 9.9 p -70.94 -32.38 48.37 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-N 116.322 -0.399 . . . . 0.33 110.819 178.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 15.8 m -63.09 -38.02 89.54 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 122.293 -0.254 . . . . 0.37 110.567 179.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 248' ' ' LEU . . . . . 0.826 HD11 ' HE2' ' A' ' 235' ' ' PHE . 26.3 mt -62.83 -41.89 99.51 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 121.3 0.571 . . . . 0.59 109.799 177.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 249' ' ' ILE . . . . . 0.474 HG21 HD21 ' A' ' 194' ' ' LEU . 32.8 mm -68.53 -36.06 73.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 CA-C-N 115.694 -0.685 . . . . 0.51 109.571 178.197 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 40.6 t -63.3 -45.06 93.12 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 109.288 -0.634 . . . . 0.37 109.288 178.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 251' ' ' PHE . . . . . 0.457 ' O ' HG23 ' A' ' 255' ' ' VAL . 10.9 t80 -64.09 -41.02 97.46 Favored 'General case' 0 N--CA 1.456 -0.165 0 N-CA-C 108.766 -0.827 . . . . 0.42 108.766 177.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -57.57 -44.73 93.75 Favored Glycine 0 C--N 1.337 0.588 0 N-CA-C 110.946 -0.861 . . . . 0.28 110.946 177.161 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 253' ' ' ALA . . . . . 0.471 ' O ' ' HG3' ' A' ' 257' ' ' LYS . . . -63.95 -32.02 73.4 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 121.0 0.428 . . . . 0.27 110.899 177.485 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 254' ' ' PHE . . . . . 0.409 ' HD2' HD13 ' A' ' 213' ' ' LEU . 1.1 t80 -68.8 -45.05 72.27 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 121.164 0.507 . . . . 0.64 109.634 178.176 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 255' ' ' VAL . . . . . 0.457 HG23 ' O ' ' A' ' 251' ' ' PHE . 59.3 t -64.22 -38.36 82.3 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-N 115.783 -0.644 . . . . 0.4 109.743 178.019 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 256' ' ' ALA . . . . . 0.482 ' HB1' ' HB2' ' A' ' 171' ' ' ALA . . . -57.99 -47.45 82.96 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 115.892 -0.595 . . . . 0.22 110.067 178.316 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 257' ' ' LYS . . . . . 0.471 ' HG3' ' O ' ' A' ' 253' ' ' ALA . 49.5 mttp -59.25 -49.13 79.04 Favored 'General case' 0 N--CA 1.462 0.137 0 N-CA-C 110.066 -0.346 . . . . 0.34 110.066 178.069 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 81.4 t60 -57.59 -45.78 84.85 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 115.81 -0.632 . . . . 0.68 111.738 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 4.9 mp -69.53 -41.89 75.4 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.449 -0.341 . . . . 0.49 111.519 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 1.3 tmtm? -67.44 -32.48 73.38 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-O 120.476 0.179 . . . . 0.49 111.177 179.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 54.2 m -63.98 -27.64 69.27 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 120.893 0.378 . . . . 0.43 111.151 179.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 29.9 m -105.89 10.96 8.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-O 121.002 0.43 . . . . 0.51 110.702 178.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 61.34 36.76 17.42 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 113.231 0.826 . . . . 0.57 113.231 179.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 264' ' ' GLN . . . . . 0.477 HE22 ' HG2' ' A' ' 219' ' ' LYS . 5.4 mt-30 -105.33 37.67 2.14 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.337 0.589 . . . . 0.76 110.22 178.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -56.65 -22.72 36.46 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 113.306 0.854 . . . . 0.46 113.306 -179.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 10.7 p -61.35 -18.75 60.13 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.556 0.217 . . . . 0.67 111.271 179.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 267' ' ' PHE . . . . . 0.402 ' C ' ' HD2' ' A' ' 270' ' ' PRO . 92.6 m-85 -96.22 -22.57 17.18 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 120.837 0.351 . . . . 0.96 110.772 178.453 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 60.1 mt -67.18 -44.79 87.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-N 116.361 -0.382 . . . . 0.35 111.093 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 269' ' ' GLU . . . . . 0.618 ' HB2' ' HD3' ' A' ' 270' ' ' PRO . 1.0 OUTLIER -53.64 -56.38 25.52 Favored Pre-proline 0 CA--C 1.547 0.847 0 CA-C-N 116.254 -0.43 . . . . 0.61 111.643 179.706 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 270' ' ' PRO . . . . . 0.618 ' HD3' ' HB2' ' A' ' 269' ' ' GLU . 27.5 Cg_exo -64.34 -28.87 63.32 Favored 'Trans proline' 0 C--N 1.36 1.161 0 C-N-CA 122.105 1.87 . . . . 0.37 112.333 178.554 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 271' ' ' LEU . . . . . . . . . . . . . 38.3 tp -65.19 -43.21 92.36 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.4 -0.364 . . . . 0.41 110.586 178.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -58.84 -46.97 86.45 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.259 -0.428 . . . . 0.37 111.246 179.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 273' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -65.44 -42.94 91.88 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.534 -0.303 . . . . 0.68 110.403 178.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 274' ' ' THR . . . . . 0.524 HG21 ' HB ' ' A' ' 224' ' ' VAL . 85.9 m -58.86 -50.35 74.33 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.235 -0.438 . . . . 0.39 110.411 179.148 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 96.9 mt -59.44 -54.41 34.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.105 -0.498 . . . . 0.36 110.351 178.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 21.0 m -56.61 -52.99 62.73 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 113.105 0.78 . . . . 0.33 113.105 -179.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 277' ' ' ASP . . . . . 0.486 ' O ' ' HD2' ' A' ' 281' ' ' ARG . 0.2 OUTLIER -56.41 -53.7 54.34 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.445 0.164 . . . . 0.4 111.433 -179.212 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 278' ' ' VAL . . . . . 0.486 HG21 ' CB ' ' A' ' 228' ' ' SER . 89.3 t -60.68 -38.55 78.9 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 CA-C-O 120.796 0.331 . . . . 0.35 110.804 179.363 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . 0.545 HD11 HG23 ' A' ' 245' ' ' ILE . 2.4 tp -62.0 -47.08 86.39 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 116.421 -0.354 . . . . 0.78 111.881 179.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 61.9 t -76.56 -40.88 34.26 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 N-CA-C 112.47 0.544 . . . . 0.36 112.47 -179.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 281' ' ' ARG . . . . . 0.486 ' HD2' ' O ' ' A' ' 277' ' ' ASP . 0.0 OUTLIER -66.31 -28.5 68.73 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 112.474 0.546 . . . . 0.37 112.474 -179.356 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 282' ' ' THR . . . . . . . . . . . . . 25.3 p -85.32 -64.15 1.2 Allowed 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.063 0.459 . . . . 0.42 112.024 179.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 22.3 mtmm -88.99 40.74 0.99 Allowed 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.24 0.459 . . . . 0.46 112.24 -178.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 284' ' ' ARG . . . . . 0.467 ' O ' HG22 ' A' ' 288' ' ' VAL . 2.9 ptp85 -57.66 -46.17 84.57 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 112.136 0.421 . . . . 0.48 112.136 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 285' ' ' ASP . . . . . 0.439 ' O ' ' HB2' ' A' ' 289' ' ' LYS . 8.0 t70 -62.13 -51.52 67.54 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 111.87 0.322 . . . . 0.42 111.87 -179.24 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 286' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -61.83 -33.07 73.5 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.862 0.363 . . . . 0.42 111.234 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -70.81 -52.47 20.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.228 -0.442 . . . . 0.39 110.809 178.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 288' ' ' VAL . . . . . 0.467 HG22 ' O ' ' A' ' 284' ' ' ARG . 27.6 m -64.36 -30.68 50.83 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-O 120.813 0.34 . . . . 0.38 111.821 179.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 289' ' ' LYS . . . . . 0.439 ' HB2' ' O ' ' A' ' 285' ' ' ASP . 0.3 OUTLIER -68.36 -40.81 81.35 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 112.294 0.479 . . . . 0.47 112.294 -179.808 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 290' ' ' GLN . . . . . 0.465 ' O ' ' HA3' ' A' ' 295' ' ' GLY . 0.8 OUTLIER -96.94 30.05 2.84 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 112.867 0.692 . . . . 0.57 112.867 -178.9 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 33.1 mtm105 58.37 23.66 10.79 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 112.14 0.422 . . . . 0.45 112.14 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 69.21 -130.32 24.05 Favored Glycine 0 CA--C 1.523 0.554 0 C-N-CA 121.21 -0.519 . . . . 0.3 114.003 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 293' ' ' TRP . . . . . 0.613 ' O ' HG23 ' A' ' 297' ' ' VAL . 76.0 m95 -71.48 -29.45 64.85 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.386 0.514 . . . . 0.44 112.386 -178.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 294' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -59.72 -42.83 93.95 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 120.637 -0.425 . . . . 0.42 110.046 179.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 295' ' ' GLY . . . . . 0.465 ' HA3' ' O ' ' A' ' 290' ' ' GLN . . . -70.05 -38.13 73.6 Favored Glycine 0 C--N 1.336 0.556 0 N-CA-C 111.003 -0.839 . . . . 0.26 111.003 177.596 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 296' ' ' PHE . . . . . 0.423 ' HB3' ' HA ' ' A' ' 293' ' ' TRP . 0.1 OUTLIER -59.45 -37.48 78.25 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.096 0.474 . . . . 0.38 110.352 177.845 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 297' ' ' VAL . . . . . 0.757 HG11 ' HB3' ' A' ' 189' ' ' ARG . 71.4 t -65.71 -50.2 72.63 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-N 115.794 -0.639 . . . . 0.29 110.925 179.236 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -57.91 -41.87 83.56 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.236 -0.438 . . . . 0.54 111.395 179.319 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 299' ' ' PHE . . . . . 0.405 ' CZ ' ' HB2' ' B' ' 39' ' ' SER . 78.0 t80 -61.57 -40.14 93.66 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 116.18 -0.464 . . . . 0.52 112.227 -179.592 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 300' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -93.83 23.69 4.66 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.877 0.37 . . . . 0.42 111.596 -179.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 301' ' ' HIS . . . . . 0.429 ' NE2' ' OE2' ' A' ' 192' ' ' GLU . 0.1 OUTLIER -138.91 -164.99 1.75 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.957 0.408 . . . . 0.6 111.088 179.852 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . 0.591 HG22 ' H ' ' A' ' 303' ' ' GLN . 4.0 p -164.36 175.46 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 CA-C-N 116.143 -0.48 . . . . 1.16 110.235 -179.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 303' ' ' GLN . . . . . 0.591 ' H ' HG22 ' A' ' 302' ' ' VAL . 15.8 mm100 -76.08 65.08 2.04 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.39 0.614 . . . . 1.61 110.675 179.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -74.06 122.64 22.98 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.33 -0.85 . . . . 1.09 111.833 -179.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 14.9 tp -119.06 10.14 12.04 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.867 -1.06 . . . . 2.0 110.594 178.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -126.17 -41.03 1.95 Allowed 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.444 -0.344 . . . . 2.09 111.736 -179.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . 109.59 75.82 0.87 Allowed Glycine 0 CA--C 1.521 0.454 0 C-N-CA 120.737 -0.744 . . . . 1.42 113.196 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.261 0 CA-C-O 118.473 -1.181 . . . . 1.86 113.195 179.777 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.477 0 CA-C-O 120.971 0.415 . . . . 0.65 110.65 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -135.38 9.83 3.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.296 -0.411 . . . . 0.86 111.688 -178.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 19' ' ' LEU . . . . . 0.567 HD13 ' HA ' ' A' ' 216' ' ' LEU . 30.5 tp -58.36 110.24 2.44 Favored Pre-proline 0 CA--C 1.535 0.386 0 CA-C-O 121.054 0.454 . . . . 0.7 112.168 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 20' ' ' PRO . . . . . 0.775 ' HG2' ' HG2' ' B' ' 22' ' ' GLU . 95.2 Cg_endo -91.52 151.02 3.55 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 123.176 2.584 . . . . 0.43 113.149 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 21' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' B' ' 20' ' ' PRO . 12.5 Cg_exo -70.59 27.5 0.2 Allowed 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 123.242 2.628 . . . . 0.65 113.625 -179.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 22' ' ' GLU . . . . . 0.775 ' HG2' ' HG2' ' B' ' 20' ' ' PRO . 6.6 pt-20 -88.96 -17.17 30.04 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.608 -0.269 . . . . 0.44 111.317 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 23' ' ' PHE . . . . . 0.488 ' HA ' ' SD ' ' A' ' 212' ' ' MET . 0.7 OUTLIER -55.64 -40.05 71.68 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 112.566 0.58 . . . . 0.34 112.566 -179.194 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 24' ' ' ALA . . . . . 0.428 ' N ' ' HD1' ' B' ' 23' ' ' PHE . . . -68.97 -46.16 68.83 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.969 0.414 . . . . 0.4 111.049 -179.648 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . 0.546 ' O ' ' HG2' ' B' ' 29' ' ' LYS . . . -64.05 -52.84 57.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.005 -0.543 . . . . 0.4 110.806 179.319 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -55.19 -54.65 40.67 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 115.375 -0.829 . . . . 0.43 112.102 -179.394 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 45.3 mt -63.2 -29.4 70.75 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 120.957 -0.297 . . . . 0.34 111.638 -179.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 28' ' ' ARG . . . . . . . . . . . . . 4.4 tmt_? -70.93 -57.21 4.8 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 120.896 0.379 . . . . 0.86 110.503 178.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . 0.546 ' HG2' ' O ' ' B' ' 25' ' ' ALA . 10.4 ptmt -61.79 -42.39 98.94 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 116.397 -0.365 . . . . 0.89 111.901 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 88.3 mt -64.79 -41.51 92.39 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.181 0 N-CA-C 109.831 -0.433 . . . . 0.4 109.831 179.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . 0.535 ' HA3' ' HG2' ' A' ' 244' ' ' ARG . . . -59.76 -49.22 80.92 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.956 -0.64 . . . . 0.28 112.017 178.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 36.9 m-20 -66.6 -34.72 78.52 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.642 0.221 . . . . 0.37 110.876 178.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 33' ' ' LYS . . . . . 0.417 ' O ' ' HE3' ' B' ' 33' ' ' LYS . 0.0 OUTLIER -65.46 -47.62 75.51 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.791 0.329 . . . . 0.55 110.128 178.169 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 42.4 t -61.37 -48.87 86.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 CA-C-O 121.067 0.461 . . . . 0.41 109.775 178.332 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 35' ' ' TYR . . . . . 0.468 ' HB2' ' H ' ' A' ' 243' ' ' GLY . 0.6 OUTLIER -55.58 -38.3 69.21 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 115.63 -0.714 . . . . 0.73 109.999 178.088 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 36' ' ' CYS . . . . . . . . . . . . . 52.1 t -65.56 -46.14 80.64 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-N 116.012 -0.54 . . . . 1.24 110.996 178.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 97.0 m -62.33 -35.86 80.39 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 112.861 0.689 . . . . 0.45 112.861 -179.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 38' ' ' TRP . . . . . . . . . . . . . 96.8 m95 -86.86 -25.43 24.5 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 112.767 0.654 . . . . 0.64 112.767 -178.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 39' ' ' SER . . . . . 0.405 ' HB2' ' CZ ' ' A' ' 299' ' ' PHE . 14.7 t -93.6 -56.36 2.94 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.007 0.432 . . . . 0.61 111.286 179.079 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -92.27 157.38 40.71 Favored Pre-proline 0 CA--C 1.538 0.493 0 CA-C-N 116.171 -0.468 . . . . 0.5 111.732 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -75.7 83.13 1.98 Allowed 'Trans proline' 0 CA--C 1.538 0.687 0 C-N-CA 122.35 2.033 . . . . 0.76 112.69 178.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -71.08 74.78 0.66 Allowed 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 116.185 -0.462 . . . . 0.95 111.797 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 43' ' ' MET . . . . . . . . . . . . . 85.1 mtp . . . . . 0 C--O 1.251 1.167 0 CA-C-O 118.327 -0.844 . . . . 3.23 111.668 179.838 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.24 0 N-CA-C 112.611 -0.196 . . . . 0.74 112.611 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -73.04 -22.1 19.87 Favored 'Trans proline' 0 CA--C 1.532 0.42 0 C-N-CA 122.564 2.176 . . . . 0.89 113.256 179.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 93.9 mt -116.52 -54.16 2.47 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.799 0.333 . . . . 1.96 111.314 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -127.02 -131.32 3.49 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.373 -0.918 . . . . 0.63 112.281 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 56.1 p -111.33 -46.03 3.34 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.109 0.48 . . . . 0.52 111.075 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -140.15 -20.81 0.87 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.884 -0.598 . . . . 0.45 111.041 -179.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -51.77 -50.4 60.74 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.764 -0.653 . . . . 0.53 111.536 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -57.84 -46.53 84.63 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 121.036 0.446 . . . . 0.43 110.951 179.394 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.653 HD21 ' HB3' ' A' ' 287' ' ' LEU . 13.9 tp -62.83 -46.41 88.07 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.99 -0.55 . . . . 0.85 111.133 178.701 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 44.5 t80 -66.71 -40.6 88.52 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.167 -0.469 . . . . 0.4 111.767 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.614 ' HD2' ' OE1' ' A' ' 182' ' ' GLU . 32.4 mtm180 -59.75 -46.75 88.18 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.81 0.338 . . . . 0.49 111.416 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . 0.43 ' HA ' ' HB2' ' A' ' 183' ' ' ALA . 51.1 mt-30 -70.45 -35.81 73.55 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.756 0.312 . . . . 0.82 110.585 179.536 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 51.9 m -65.04 -45.85 83.72 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.481 -0.327 . . . . 0.29 110.138 178.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.774 ' HA ' HG21 ' A' ' 276' ' ' THR . 2.1 tm? -53.64 -55.29 27.23 Favored 'General case' 0 C--O 1.225 -0.186 0 CA-C-N 116.026 -0.534 . . . . 0.45 110.572 178.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -55.13 -43.61 74.3 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 112.271 0.471 . . . . 1.18 112.271 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . 0.508 HG23 HD22 ' A' ' 191' ' ' LEU . 90.6 mt -69.18 -53.46 25.43 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 N-CA-C 112.394 0.516 . . . . 0.31 112.394 -179.313 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.542 HD12 HG23 ' A' ' 276' ' ' THR . 68.2 mt -66.12 -47.77 83.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 N-CA-C 112.017 0.377 . . . . 0.35 112.017 -179.39 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 3.5 t -58.34 -44.55 88.76 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.644 0.259 . . . . 0.27 111.226 -179.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . 0.576 ' NH2' ' HG ' ' A' ' 180' ' ' LEU . 21.4 ttm180 -66.69 -49.48 65.97 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 120.296 -0.562 . . . . 0.55 110.506 178.575 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' TYR . . . . . 0.995 ' HE1' ' HA ' ' A' ' 195' ' ' ARG . 93.5 t80 -55.41 -52.47 63.45 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 112.601 0.593 . . . . 0.39 112.601 -179.672 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 5.0 mp -60.74 -45.7 93.3 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 120.834 -0.346 . . . . 0.48 111.833 -179.081 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . 0.538 ' HD2' ' OE1' ' A' ' 269' ' ' GLU . 0.0 OUTLIER -65.36 -37.18 86.26 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.665 0.269 . . . . 0.37 110.924 179.679 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . 0.751 ' HG3' ' HA ' ' A' ' 175' ' ' LYS . 19.7 tt0 -58.22 -53.9 53.02 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.056 -0.52 . . . . 0.44 110.473 178.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . 0.763 ' HB3' ' HE3' ' A' ' 257' ' ' LYS . 2.2 mt-30 -67.19 -39.9 86.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.026 -0.533 . . . . 0.45 111.093 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.47 ' HB2' ' HB1' ' A' ' 256' ' ' ALA . . . -59.46 -55.75 30.71 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.833 0.349 . . . . 0.37 111.711 179.414 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 44.9 p -68.0 -36.38 79.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.446 . . . . 0.63 112.11 -179.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 100.2 25.29 8.98 Favored Glycine 0 CA--C 1.519 0.313 0 C-N-CA 120.66 -0.781 . . . . 0.7 112.725 179.721 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 47.0 t -146.63 125.37 12.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.236 0.541 . . . . 1.0 111.404 179.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . 0.852 ' HD3' ' H ' ' A' ' 175' ' ' LYS . 0.0 OUTLIER -69.86 149.05 48.28 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 115.52 -0.764 . . . . 0.77 112.338 179.889 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . 0.495 ' CG ' ' HZ2' ' A' ' 178' ' ' LYS . 8.6 t70 -110.88 109.88 20.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.096 0.474 . . . . 0.64 111.055 178.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 82.6 p -104.07 26.13 9.14 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.921 -0.581 . . . . 1.07 111.721 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . 0.495 ' HZ2' ' CG ' ' A' ' 176' ' ' ASP . 0.0 OUTLIER -97.01 154.25 38.26 Favored Pre-proline 0 C--N 1.33 -0.252 0 O-C-N 122.33 -0.231 . . . . 0.83 110.54 179.338 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -59.62 146.59 94.88 Favored 'Trans proline' 0 CA--C 1.533 0.466 0 C-N-CA 122.404 2.069 . . . . 0.54 113.222 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.576 ' HG ' ' NH2' ' A' ' 165' ' ' ARG . 3.4 mp -95.86 177.62 5.71 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 116.059 -0.519 . . . . 0.53 110.571 179.128 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -81.24 -67.67 1.52 Allowed Glycine 0 CA--C 1.523 0.555 0 C-N-CA 120.681 -0.771 . . . . 0.63 113.176 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . 0.614 ' OE1' ' HD2' ' A' ' 157' ' ' ARG . 31.8 mt-10 -113.12 -24.37 9.48 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 120.834 0.35 . . . . 1.1 111.408 -179.539 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.643 ' O ' ' HA3' ' A' ' 187' ' ' GLY . . . -87.56 59.75 5.63 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 121.096 0.474 . . . . 0.43 111.611 179.477 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -80.41 -71.54 1.27 Allowed Glycine 0 CA--C 1.527 0.808 0 C-N-CA 120.67 -0.776 . . . . 0.42 113.527 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -64.05 -55.78 19.72 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 120.992 0.425 . . . . 0.53 111.264 -179.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -65.65 -34.55 78.48 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.934 -0.576 . . . . 0.52 110.261 178.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . 0.643 ' HA3' ' O ' ' A' ' 183' ' ' ALA . . . -65.39 -47.91 74.33 Favored Glycine 0 C--O 1.217 -0.945 0 C-N-CA 121.068 -0.587 . . . . 0.41 112.723 179.702 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 4.8 tmm_? -60.37 -48.65 80.84 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-N 117.349 0.574 . . . . 0.73 111.314 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . 0.469 ' HG2' HG21 ' A' ' 297' ' ' VAL . 3.9 ttp180 -63.02 -46.29 88.3 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 120.763 0.316 . . . . 0.57 110.753 -179.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.44 ' HA ' ' CG1' ' A' ' 297' ' ' VAL . . . -71.69 -31.15 66.45 Favored 'General case' 0 C--O 1.222 -0.367 0 N-CA-C 112.245 0.461 . . . . 0.32 112.245 -179.576 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . 0.552 ' HB2' ' O ' ' A' ' 187' ' ' GLY . 0.2 OUTLIER -62.2 -53.46 54.93 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 120.578 0.228 . . . . 0.6 111.056 -179.752 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -65.11 -42.1 94.29 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.461 -0.336 . . . . 0.69 111.059 179.205 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . 0.658 HG21 ' HA ' ' A' ' 297' ' ' VAL . 39.3 m -62.57 -47.28 84.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.476 -0.329 . . . . 0.39 110.698 179.4 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 0.479 HD21 HG21 ' A' ' 249' ' ' ILE . 33.6 tp -67.76 -41.24 83.64 Favored 'General case' 0 C--O 1.224 -0.241 0 CA-C-N 116.526 -0.307 . . . . 0.41 111.085 179.658 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . 0.995 ' HA ' ' HE1' ' A' ' 166' ' ' TYR . 45.4 ttm180 -60.57 -45.33 94.35 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.783 0.325 . . . . 0.63 111.34 179.215 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 12.7 mtp180 -73.87 -49.48 24.81 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.547 0.573 . . . . 1.59 112.547 -179.086 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . 0.621 HG12 HG21 ' A' ' 246' ' ' VAL . 86.6 t -68.86 -38.88 79.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-O 120.923 0.392 . . . . 0.35 111.161 -179.791 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -65.12 -52.77 38.17 Favored Glycine 0 C--N 1.332 0.359 0 C-N-CA 121.14 -0.552 . . . . 0.31 112.895 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -63.19 -31.13 72.2 Favored 'General case' 0 CA--C 1.528 0.099 0 CA-C-N 117.114 0.457 . . . . 0.47 110.258 179.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . 0.476 ' O ' ' HB2' ' A' ' 204' ' ' ASN . . . -60.65 -53.8 42.35 Favored Glycine 0 C--N 1.336 0.554 0 C-N-CA 120.902 -0.666 . . . . 0.35 111.462 178.014 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 83.3 t -63.54 -41.35 92.35 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 CA-C-O 121.355 0.598 . . . . 0.35 110.471 178.153 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 202' ' ' GLN . . . . . 0.41 ' HA ' ' CE2' ' A' ' 209' ' ' PHE . 7.4 tt0 -60.73 -51.27 70.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 114.729 -1.123 . . . . 0.71 112.723 -178.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 2.8 mmp_? -74.01 -32.58 63.44 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 111.716 0.265 . . . . 0.52 111.716 -179.466 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 204' ' ' ASN . . . . . 0.476 ' HB2' ' O ' ' A' ' 200' ' ' GLY . 8.4 t-20 -68.68 -53.77 20.3 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.049 0.452 . . . . 1.55 110.822 179.477 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 89.0 m-70 -95.18 32.14 1.78 Allowed 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 121.184 0.516 . . . . 0.53 110.853 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . 0.504 ' HG2' HE21 ' A' ' 210' ' ' GLN . 10.0 tt0 -59.5 -38.51 81.11 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.581 -0.736 . . . . 0.43 111.675 -179.333 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 42.2 p -59.26 -49.74 76.68 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.154 0.502 . . . . 0.54 110.95 179.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -66.59 -44.54 81.91 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.682 -0.69 . . . . 0.41 110.401 178.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 209' ' ' PHE . . . . . 0.41 ' CE2' ' HA ' ' A' ' 202' ' ' GLN . 4.8 m-30 -58.46 -44.51 89.28 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.177 -0.465 . . . . 0.45 110.736 179.498 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 210' ' ' GLN . . . . . 0.511 ' HB3' ' NH2' ' A' ' 214' ' ' ARG . 59.6 mt-30 -64.02 -34.73 78.68 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.56 -0.291 . . . . 0.6 110.971 179.446 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . 0.495 ' O ' ' HB2' ' A' ' 215' ' ' LYS . . . -60.21 -44.91 96.94 Favored Glycine 0 C--N 1.334 0.454 0 N-CA-C 111.028 -0.829 . . . . 0.37 111.028 178.021 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 212' ' ' MET . . . . . 0.833 ' HG2' ' HA ' ' B' ' 23' ' ' PHE . 1.0 OUTLIER -77.29 -30.68 54.31 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 120.616 0.246 . . . . 0.56 110.581 178.457 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.434 HD22 ' CE2' ' A' ' 254' ' ' PHE . 16.8 tp -59.7 -44.85 93.5 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.197 -0.456 . . . . 0.54 111.026 179.208 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 214' ' ' ARG . . . . . 0.511 ' NH2' ' HB3' ' A' ' 210' ' ' GLN . 68.0 mtm-85 -81.25 -27.47 35.17 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.034 -0.53 . . . . 0.65 110.169 178.574 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 215' ' ' LYS . . . . . 0.495 ' HB2' ' O ' ' A' ' 211' ' ' GLY . 0.7 OUTLIER -66.97 -46.9 73.2 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 115.875 -0.602 . . . . 0.8 110.621 178.443 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.447 HD23 ' HB ' ' A' ' 218' ' ' ILE . 4.6 tp -65.19 120.7 13.19 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 115.901 -0.59 . . . . 0.48 111.354 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -75.03 36.07 0.11 Allowed 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 112.877 0.695 . . . . 1.47 112.877 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 218' ' ' ILE . . . . . 0.956 ' HA ' ' HB3' ' A' ' 223' ' ' ASP . 1.3 tt -61.05 106.55 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-O 121.914 0.864 . . . . 0.41 111.571 -179.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -162.1 -50.88 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.28 -0.873 . . . . 0.61 110.462 -179.471 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -99.6 178.38 4.87 Favored 'General case' 0 C--O 1.221 -0.418 0 CA-C-N 116.189 -0.46 . . . . 0.91 111.164 179.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . 0.43 ' HA ' ' HE1' ' A' ' 267' ' ' PHE . 2.0 mm-40 -49.38 -20.74 0.73 Allowed 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 113.794 1.035 . . . . 0.86 113.794 -179.316 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -67.84 -24.51 74.27 Favored Glycine 0 CA--C 1.534 1.271 0 N-CA-C 114.643 0.617 . . . . 0.34 114.643 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 223' ' ' ASP . . . . . 0.956 ' HB3' ' HA ' ' A' ' 218' ' ' ILE . 9.9 p30 -59.16 -56.06 26.97 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 113.475 0.917 . . . . 0.57 113.475 -177.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.454 HG23 HG21 ' A' ' 274' ' ' THR . 2.6 p -54.27 -39.73 44.67 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 CA-C-O 120.983 0.42 . . . . 0.44 111.764 179.492 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 30.2 mttp -68.68 -42.99 77.06 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-O 120.935 0.398 . . . . 0.61 110.171 178.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . 0.585 ' O ' HG23 ' A' ' 230' ' ' VAL . 45.3 m -62.03 -43.25 99.23 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.9 -0.591 . . . . 0.44 109.693 178.579 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 227' ' ' PHE . . . . . 0.488 ' O ' ' HG3' ' A' ' 231' ' ' MET . 16.8 t80 -55.96 -42.92 76.98 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 115.731 -0.668 . . . . 0.66 110.447 178.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 12.7 p -60.31 -39.56 87.42 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 120.823 0.344 . . . . 0.34 110.368 178.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 6.4 mmp_? -67.85 -35.7 79.01 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 116.24 -0.437 . . . . 0.51 110.786 179.455 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 0.585 HG23 ' O ' ' A' ' 226' ' ' SER . 24.3 t -61.96 -52.4 60.95 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 N-CA-C 109.985 -0.376 . . . . 0.35 109.985 178.568 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 231' ' ' MET . . . . . 0.635 ' HE3' HG13 ' A' ' 275' ' ' ILE . 31.5 mtp -56.79 -46.3 81.62 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.726 -0.67 . . . . 0.43 110.866 179.293 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 56.1 t -62.12 -40.29 86.96 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 CA-C-N 116.167 -0.47 . . . . 0.46 110.659 178.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 64.7 t-80 -66.65 -43.62 84.1 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 116.557 -0.292 . . . . 0.51 111.203 178.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.445 HG23 ' O ' ' A' ' 230' ' ' VAL . 78.1 t -60.89 -40.4 85.17 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 CA-C-O 120.66 0.267 . . . . 0.34 111.539 179.532 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -101.44 23.51 10.96 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 111.951 0.352 . . . . 0.49 111.951 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 1.9 tmtm? -70.78 -11.73 61.13 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 112.1 0.408 . . . . 1.29 112.1 -179.38 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -83.23 -16.86 44.78 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.662 0.268 . . . . 0.49 111.267 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 91.86 -5.78 79.35 Favored Glycine 0 CA--C 1.524 0.64 0 C-N-CA 120.827 -0.701 . . . . 0.47 113.898 179.273 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 3.1 p -98.04 114.94 36.83 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-O 121.663 0.744 . . . . 0.45 111.87 -179.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 99.4 m -94.74 109.44 21.4 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.089 -0.505 . . . . 0.43 111.739 179.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . 0.554 ' HB2' ' HD2' ' A' ' 244' ' ' ARG . 25.7 m-20 -113.61 139.45 49.01 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.296 -0.411 . . . . 0.46 110.762 179.022 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 242' ' ' TRP . . . . . 0.433 ' CZ3' ' HB2' ' A' ' 296' ' ' PHE . 40.4 m95 -54.54 -42.12 70.53 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 116.183 -0.462 . . . . 0.47 111.619 -179.375 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -60.16 -33.91 81.9 Favored Glycine 0 C--N 1.333 0.412 0 C-N-CA 120.937 -0.649 . . . . 0.31 112.095 178.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 244' ' ' ARG . . . . . 0.554 ' HD2' ' HB2' ' A' ' 241' ' ' ASN . 23.6 mtt180 -70.73 -44.96 65.77 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.163 0.506 . . . . 0.32 109.638 178.687 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . 0.448 ' O ' HG13 ' A' ' 249' ' ' ILE . 74.2 mt -61.84 -50.08 81.64 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 115.412 -0.813 . . . . 0.51 111.491 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . 0.621 HG21 HG12 ' A' ' 197' ' ' VAL . 8.5 p -65.4 -32.71 59.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 120.814 -0.354 . . . . 0.4 111.36 -179.564 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 82.8 m -66.14 -34.47 78.12 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.467 0.651 . . . . 0.37 109.261 177.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 248' ' ' LEU . . . . . 0.445 HD21 ' HG2' ' A' ' 231' ' ' MET . 33.7 tp -73.23 -45.33 56.64 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 115.43 -0.804 . . . . 1.23 110.426 178.199 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 249' ' ' ILE . . . . . 0.479 HG21 HD21 ' A' ' 194' ' ' LEU . 23.5 mt -63.13 -44.18 99.3 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 CA-C-N 116.506 -0.316 . . . . 0.34 110.886 179.143 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 12.6 p -61.98 -36.17 80.66 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.277 0.561 . . . . 0.44 109.572 178.096 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 251' ' ' PHE . . . . . 0.431 ' O ' HG23 ' A' ' 255' ' ' VAL . 48.8 t80 -66.27 -41.34 90.04 Favored 'General case' 0 C--O 1.227 -0.122 0 CA-C-N 115.514 -0.767 . . . . 0.46 109.411 177.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -57.85 -49.23 76.37 Favored Glycine 0 C--N 1.335 0.5 0 N-CA-C 111.203 -0.759 . . . . 0.24 111.203 178.133 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -59.13 -43.03 91.94 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 120.68 0.276 . . . . 0.32 110.692 177.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 254' ' ' PHE . . . . . 0.434 ' CE2' HD22 ' A' ' 213' ' ' LEU . 7.1 t80 -63.01 -43.99 97.21 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 121.071 0.462 . . . . 0.7 110.787 179.011 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 255' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 251' ' ' PHE . 72.7 t -62.96 -46.46 96.25 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 N-CA-C 109.383 -0.599 . . . . 0.39 109.383 177.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 256' ' ' ALA . . . . . 0.47 ' HB1' ' HB2' ' A' ' 171' ' ' ALA . . . -59.13 -37.84 78.21 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.081 -0.509 . . . . 0.29 110.078 177.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 257' ' ' LYS . . . . . 0.763 ' HE3' ' HB3' ' A' ' 170' ' ' GLN . 81.0 mttt -59.04 -45.79 89.87 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 109.468 -0.567 . . . . 0.51 109.468 177.364 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 258' ' ' HIS . . . . . 0.429 ' HB2' HD21 ' A' ' 213' ' ' LEU . 80.3 t60 -61.06 -46.32 91.15 Favored 'General case' 0 C--O 1.228 -0.033 0 CA-C-N 115.4 -0.818 . . . . 0.59 109.632 178.38 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.83 HD11 HG12 ' A' ' 218' ' ' ILE . 8.8 mp -59.82 -42.52 93.69 Favored 'General case' 0 C--O 1.221 -0.401 0 CA-C-N 115.968 -0.56 . . . . 0.51 110.316 178.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 2.2 tptp -64.15 -35.91 82.31 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.992 0.425 . . . . 0.53 110.419 178.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 21.2 m -69.78 -31.97 70.19 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.775 -0.648 . . . . 0.55 111.094 179.355 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 33.6 m -101.03 10.56 7.66 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 CA-C-O 120.796 0.331 . . . . 0.61 111.425 179.112 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 16.4 m120 59.16 47.92 11.13 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 113.123 0.786 . . . . 0.6 113.123 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 264' ' ' GLN . . . . . 0.572 ' HB3' ' HG ' ' A' ' 259' ' ' LEU . 17.7 tt0 -106.77 36.85 2.5 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.198 0.523 . . . . 0.6 110.31 179.044 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . 0.511 ' HA ' HD12 ' A' ' 268' ' ' ILE . 0.0 OUTLIER -54.33 -27.7 37.64 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 115.735 -0.666 . . . . 0.48 111.556 179.814 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 26.1 p -58.45 -26.36 63.26 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 115.785 -0.643 . . . . 0.66 110.941 178.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 267' ' ' PHE . . . . . 0.43 ' HE1' ' HA ' ' A' ' 221' ' ' GLU . 70.0 m-85 -108.52 -11.4 15.14 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.197 -0.456 . . . . 0.75 110.917 178.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 268' ' ' ILE . . . . . 0.511 HD12 ' HA ' ' A' ' 265' ' ' GLU . 53.1 mt -66.62 -51.15 59.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 CA-C-O 120.776 0.322 . . . . 0.45 110.791 179.381 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 269' ' ' GLU . . . . . 0.728 ' HB2' ' HD3' ' A' ' 270' ' ' PRO . 55.2 mm-40 -58.78 -54.7 53.71 Favored Pre-proline 0 CA--C 1.541 0.629 0 CA-C-N 116.186 -0.461 . . . . 0.49 111.178 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 270' ' ' PRO . . . . . 0.728 ' HD3' ' HB2' ' A' ' 269' ' ' GLU . 32.1 Cg_exo -60.73 -32.51 93.13 Favored 'Trans proline' 0 C--N 1.359 1.108 0 C-N-CA 122.086 1.858 . . . . 0.35 112.76 178.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 271' ' ' LEU . . . . . . . . . . . . . 29.4 tp -63.2 -46.09 88.68 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 120.531 0.205 . . . . 0.68 111.394 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -61.58 -40.99 96.75 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.13 0.49 . . . . 0.32 111.248 179.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 273' ' ' GLU . . . . . 0.457 ' HG2' ' O ' ' A' ' 269' ' ' GLU . 4.4 mm-40 -72.27 -33.74 67.69 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.195 0.522 . . . . 0.42 109.822 179.103 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 274' ' ' THR . . . . . 0.454 HG21 HG23 ' A' ' 224' ' ' VAL . 87.3 m -66.84 -51.92 49.86 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.99 -0.55 . . . . 0.34 110.952 178.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 275' ' ' ILE . . . . . 0.635 HG13 ' HE3' ' A' ' 231' ' ' MET . 14.4 tt -59.52 -36.51 65.17 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-O 120.682 0.277 . . . . 0.42 110.621 179.447 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 276' ' ' THR . . . . . 0.774 HG21 ' HA ' ' A' ' 160' ' ' LEU . 38.2 m -67.82 -49.68 60.96 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 120.786 0.326 . . . . 0.29 110.383 178.646 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 277' ' ' ASP . . . . . 0.586 ' O ' ' HB2' ' A' ' 281' ' ' ARG . 1.4 t70 -60.41 -54.58 43.94 Favored 'General case' 0 C--O 1.216 -0.671 0 CA-C-N 116.23 -0.441 . . . . 0.34 111.19 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 61.6 t -59.37 -34.08 53.13 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 N-CA-C 112.01 0.374 . . . . 0.41 112.01 -179.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 21.4 tp -67.82 -47.58 68.64 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.685 0.279 . . . . 0.69 111.392 179.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 39.7 t -78.06 -36.22 21.29 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 CA-C-O 120.864 0.364 . . . . 0.42 111.544 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 281' ' ' ARG . . . . . 0.586 ' HB2' ' O ' ' A' ' 277' ' ' ASP . 1.1 tpp180 -61.68 -41.02 96.99 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 122.921 0.488 . . . . 0.37 112.308 -179.434 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 282' ' ' THR . . . . . . . . . . . . . 74.5 p -90.78 -1.69 57.84 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 112.823 0.675 . . . . 0.42 112.823 -179.061 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . 0.425 ' HB3' HD23 ' A' ' 287' ' ' LEU . 11.0 mtmm -138.72 33.71 2.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.672 0.273 . . . . 0.53 111.409 -179.61 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 34.0 ttm180 -53.16 -58.17 7.95 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 112.449 0.537 . . . . 0.42 112.449 -179.307 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 285' ' ' ASP . . . . . 0.412 ' O ' ' HB2' ' A' ' 289' ' ' LYS . 22.1 t70 -63.33 -42.95 99.0 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 112.179 0.437 . . . . 0.57 112.179 -179.042 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 286' ' ' TRP . . . . . . . . . . . . . 1.5 t90 -64.35 -51.23 64.38 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 112.227 0.454 . . . . 0.49 112.227 -178.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 287' ' ' LEU . . . . . 0.653 ' HB3' HD21 ' A' ' 155' ' ' LEU . 1.5 mm? -64.61 -48.18 75.86 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.317 0.488 . . . . 0.54 112.317 -178.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 3.0 p -63.99 -29.77 48.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 N-CA-C 112.007 0.373 . . . . 0.52 112.007 -179.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 289' ' ' LYS . . . . . 0.425 ' HB2' ' HE3' ' A' ' 289' ' ' LYS . 12.3 ttmt -76.56 -44.47 34.58 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 112.371 0.508 . . . . 0.8 112.371 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -80.62 28.86 0.32 Allowed 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 113.14 0.793 . . . . 0.56 113.14 -178.347 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 291' ' ' ARG . . . . . 0.472 ' HB3' ' HB3' ' A' ' 294' ' ' ASP . 62.5 mtp180 62.95 9.47 3.76 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 112.522 0.564 . . . . 0.49 112.522 179.572 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 62.22 -130.27 44.07 Favored Glycine 0 CA--C 1.522 0.504 0 CA-C-O 121.307 0.393 . . . . 0.35 113.439 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 293' ' ' TRP . . . . . 0.523 ' O ' HG22 ' A' ' 297' ' ' VAL . 77.5 m95 -61.87 -27.09 68.55 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.672 -0.264 . . . . 0.55 111.475 -179.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 294' ' ' ASP . . . . . 0.472 ' HB3' ' HB3' ' A' ' 291' ' ' ARG . 0.5 OUTLIER -58.97 -44.46 91.54 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 120.881 0.372 . . . . 0.42 110.224 178.77 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -75.64 -30.18 58.46 Favored Glycine 0 CA--C 1.522 0.485 0 C-N-CA 120.795 -0.717 . . . . 0.38 111.639 178.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 296' ' ' PHE . . . . . 0.553 ' CE1' ' HE2' ' A' ' 300' ' ' PHE . 4.3 t80 -67.02 -47.29 71.87 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 120.821 0.343 . . . . 0.41 110.993 179.274 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 297' ' ' VAL . . . . . 0.658 ' HA ' HG21 ' A' ' 193' ' ' THR . 27.1 m -71.27 -37.41 65.71 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-N 116.44 -0.345 . . . . 0.38 111.567 -179.704 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 298' ' ' GLU . . . . . 0.444 ' HB2' ' O ' ' A' ' 294' ' ' ASP . 1.2 mt-10 -69.56 -27.58 65.25 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.571 -0.286 . . . . 0.45 111.432 179.687 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 299' ' ' PHE . . . . . . . . . . . . . 69.1 t80 -62.53 -43.73 98.09 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.346 -0.388 . . . . 0.6 110.434 178.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 300' ' ' PHE . . . . . 0.553 ' HE2' ' CE1' ' A' ' 296' ' ' PHE . 44.7 m-85 -87.13 -34.8 18.96 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 120.827 0.346 . . . . 0.58 111.125 179.664 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 51.5 m80 -110.56 88.81 2.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.506 -0.315 . . . . 0.7 111.16 -179.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 1.6 m -62.24 103.64 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 CA-C-O 121.474 0.654 . . . . 1.01 111.289 179.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 11.2 mm-40 -76.79 89.25 3.42 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.808 -0.633 . . . . 1.07 111.511 -179.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 34.4 t0 -74.8 105.01 5.65 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.508 0.671 . . . . 1.9 111.066 179.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 305' ' ' LEU . . . . . 0.468 ' H ' ' HG ' ' A' ' 305' ' ' LEU . 0.8 OUTLIER -106.4 15.2 26.33 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.475 -0.784 . . . . 2.81 110.252 178.75 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -118.55 -43.92 2.68 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.964 -0.562 . . . . 3.14 111.783 -179.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . -80.37 -71.41 1.27 Allowed Glycine 0 CA--C 1.522 0.507 0 C-N-CA 120.926 -0.654 . . . . 3.2 113.198 -179.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.168 0 CA-C-O 118.378 -1.235 . . . . 5.95 112.81 -179.913 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.814 0 CA-C-O 121.236 0.541 . . . . 1.79 111.065 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 18' ' ' GLU . . . . . 0.657 ' CD ' ' H ' ' B' ' 18' ' ' GLU . 0.0 OUTLIER -79.22 -74.3 0.29 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.238 -0.892 . . . . 1.01 111.374 179.436 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 19' ' ' LEU . . . . . 0.508 HD23 ' HD2' ' B' ' 20' ' ' PRO . 4.1 mt -93.32 117.11 67.33 Favored Pre-proline 0 CA--C 1.53 0.182 0 CA-C-O 120.99 0.424 . . . . 0.92 111.26 179.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 20' ' ' PRO . . . . . 0.508 ' HD2' HD23 ' B' ' 19' ' ' LEU . 79.5 Cg_endo -75.17 161.46 38.22 Favored 'Trans proline' 0 CA--C 1.532 0.39 0 C-N-CA 122.775 2.317 . . . . 0.73 112.08 179.348 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 21' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.63 22.87 0.2 Allowed 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 122.531 2.154 . . . . 0.73 112.954 179.395 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 22' ' ' GLU . . . . . 0.469 ' H ' ' C ' ' B' ' 20' ' ' PRO . 1.3 tt0 -60.64 -45.66 93.24 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 123.527 0.731 . . . . 0.7 111.259 -179.709 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 23' ' ' PHE . . . . . 0.833 ' HA ' ' HG2' ' A' ' 212' ' ' MET . 3.5 p90 -62.41 -35.9 80.67 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 116.323 -0.399 . . . . 0.49 111.465 179.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -76.51 -45.3 31.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.792 0.329 . . . . 0.39 110.808 179.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.22 -45.8 87.02 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.244 -0.435 . . . . 0.35 110.569 178.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 26' ' ' GLN . . . . . 0.444 ' NE2' ' HG2' ' B' ' 22' ' ' GLU . 1.3 mp0 -61.32 -47.71 84.68 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 115.755 -0.657 . . . . 0.43 110.218 178.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 15.7 mt -58.22 -39.28 78.63 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.137 -0.483 . . . . 0.42 110.803 178.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 28' ' ' ARG . . . . . . . . . . . . . 1.1 ttp180 -61.32 -50.35 73.34 Favored 'General case' 0 N--CA 1.462 0.136 0 N-CA-C 109.896 -0.409 . . . . 1.02 109.896 178.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 83.6 mttt -56.26 -49.62 73.68 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 116.06 -0.518 . . . . 0.75 110.84 179.198 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 62.3 mt -62.41 -41.89 93.5 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 CA-C-N 116.297 -0.41 . . . . 0.45 110.4 179.377 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . 0.436 ' HA3' ' HA ' ' A' ' 244' ' ' ARG . . . -60.17 -49.56 77.26 Favored Glycine 0 CA--C 1.522 0.481 0 C-N-CA 120.768 -0.729 . . . . 0.27 112.123 179.043 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 57.9 m-20 -60.19 -44.58 94.98 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.098 0.475 . . . . 0.98 110.028 178.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 15.0 tppt? -62.01 -51.27 68.7 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 115.672 -0.695 . . . . 0.84 111.005 179.347 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 38.9 t -57.49 -41.66 79.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-O 120.785 0.326 . . . . 0.4 110.973 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -62.73 -43.84 97.77 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 120.984 0.421 . . . . 0.75 109.919 178.381 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 36' ' ' CYS . . . . . . . . . . . . . 55.7 m -66.13 -42.73 88.75 Favored 'General case' 0 C--O 1.224 -0.248 0 CA-C-N 116.095 -0.502 . . . . 1.34 111.248 179.094 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 98.6 m -61.78 -39.93 93.39 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 112.436 0.532 . . . . 0.5 112.436 179.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 38' ' ' TRP . . . . . . . . . . . . . 70.3 m95 -77.72 -29.03 51.04 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 112.562 0.578 . . . . 0.64 112.562 -179.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 37.1 p -87.54 -67.66 0.81 Allowed 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 120.943 0.401 . . . . 0.5 111.437 179.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . 0.448 ' HB1' ' HD2' ' B' ' 41' ' ' PRO . . . -90.86 161.12 36.67 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 116.085 -0.507 . . . . 0.5 111.165 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 41' ' ' PRO . . . . . 0.448 ' HD2' ' HB1' ' B' ' 40' ' ' ALA . 56.9 Cg_endo -71.64 58.07 2.51 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 122.44 2.094 . . . . 0.78 112.813 179.215 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -103.02 159.23 15.7 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 116.106 -0.497 . . . . 0.65 110.962 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 43' ' ' MET . . . . . . . . . . . . . 66.7 mtt . . . . . 0 C--O 1.251 1.138 0 CA-C-O 118.404 -0.808 . . . . 1.65 110.53 179.814 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.447 0 CA-C-O 119.907 -0.385 . . . . 2.33 112.41 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -74.13 62.86 5.12 Favored 'Trans proline' 0 CA--C 1.535 0.53 0 C-N-CA 122.763 2.309 . . . . 2.27 113.041 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 73.9 mt -93.75 112.03 23.83 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.231 -0.441 . . . . 2.31 111.165 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 115.83 77.89 0.71 Allowed Glycine 0 CA--C 1.52 0.346 0 C-N-CA 120.697 -0.763 . . . . 0.71 112.839 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 35.0 t -178.17 -62.58 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.815 0.34 . . . . 0.8 110.775 -179.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -60.66 -51.61 68.63 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.2 -0.454 . . . . 0.55 111.827 -179.429 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . 0.471 ' O ' ' HG3' ' A' ' 157' ' ' ARG . 15.4 t70 -58.11 -48.25 80.77 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 111.591 0.219 . . . . 0.72 111.591 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.433 ' HA ' ' CZ ' ' A' ' 157' ' ' ARG . 17.8 m-20 -57.23 -49.09 77.12 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.684 0.278 . . . . 0.56 111.309 179.703 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 49.8 tp -66.22 -36.63 83.53 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 121.192 0.52 . . . . 0.88 109.911 178.458 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 76.4 t80 -63.78 -46.29 85.91 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.52 -0.763 . . . . 0.48 111.607 179.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.471 ' HG3' ' O ' ' A' ' 153' ' ' ASP . 79.1 mtm-85 -58.0 -44.94 87.5 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.665 0.269 . . . . 0.6 110.442 179.419 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . 0.416 ' HG3' ' O ' ' A' ' 154' ' ' ASP . 38.0 mt-30 -64.62 -42.73 95.31 Favored 'General case' 0 CA--C 1.529 0.141 0 N-CA-C 109.862 -0.422 . . . . 1.25 109.862 178.243 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 50.9 m -58.54 -53.03 62.93 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.892 -0.594 . . . . 0.27 111.282 179.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 24.4 tp -61.82 -44.48 96.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.27 -0.423 . . . . 0.54 111.131 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -60.87 -53.47 56.9 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.607 0.241 . . . . 0.42 110.772 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 77.5 mt -56.85 -50.8 73.96 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 CA-C-N 116.32 -0.4 . . . . 0.33 111.162 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.678 ' O ' ' HG ' ' A' ' 167' ' ' LEU . 63.0 mt -62.23 -51.31 73.9 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-N 116.701 -0.227 . . . . 0.33 111.394 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 29.3 t -56.62 -46.12 81.14 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 120.763 0.316 . . . . 0.32 111.063 179.423 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . 0.726 ' O ' ' HG2' ' A' ' 169' ' ' GLU . 6.6 mmm180 -67.59 -44.09 78.98 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.615 -0.266 . . . . 0.34 111.255 179.66 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' TYR . . . . . 0.979 ' HE1' ' HA ' ' A' ' 195' ' ' ARG . 49.3 t80 -59.3 -51.21 70.94 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 111.74 0.274 . . . . 0.44 111.74 -179.76 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.678 ' HG ' ' O ' ' A' ' 163' ' ' ILE . 20.3 mt -62.79 -38.27 89.98 Favored 'General case' 0 N--CA 1.462 0.161 0 N-CA-C 109.662 -0.496 . . . . 0.34 109.662 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 16.9 ttm180 -58.57 -41.34 85.44 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.805 -0.634 . . . . 0.31 111.529 179.308 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . 0.726 ' HG2' ' O ' ' A' ' 165' ' ' ARG . 4.2 mm-40 -67.91 -53.9 22.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.577 -0.283 . . . . 0.44 110.929 179.679 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . 0.663 HE22 ' HG3' ' A' ' 195' ' ' ARG . 1.2 mp0 -59.61 -36.9 77.22 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 120.754 0.311 . . . . 0.56 111.672 179.594 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.442 ' HA ' ' HD2' ' A' ' 257' ' ' LYS . . . -70.86 -44.41 66.43 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 112.268 0.469 . . . . 0.4 112.268 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 37.9 p -77.92 -40.61 39.16 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 111.808 0.299 . . . . 0.52 111.808 -179.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 128.16 3.68 5.7 Favored Glycine 0 CA--C 1.524 0.626 0 C-N-CA 120.569 -0.824 . . . . 0.62 113.354 -179.453 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . 0.666 ' HB2' ' HB3' ' A' ' 169' ' ' GLU . 0.9 OUTLIER -59.96 116.43 4.14 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 117.08 0.44 . . . . 0.62 111.118 179.447 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . 0.434 ' O ' ' HD2' ' A' ' 175' ' ' LYS . 0.8 OUTLIER -76.49 -33.81 58.64 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.054 -0.521 . . . . 1.2 111.699 -179.478 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -129.98 166.07 20.83 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.128 0.49 . . . . 0.63 112.142 -178.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . 0.671 ' HB2' HH22 ' A' ' 195' ' ' ARG . 0.4 OUTLIER -175.33 121.0 0.2 Allowed 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 115.283 -0.871 . . . . 0.39 110.196 179.152 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . 0.458 ' H ' ' HD2' ' A' ' 179' ' ' PRO . 14.1 mptt -117.39 -44.62 0.05 OUTLIER Pre-proline 0 CA--C 1.549 0.928 0 N-CA-C 113.62 0.97 . . . . 0.5 113.62 -178.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . 0.458 ' HD2' ' H ' ' A' ' 178' ' ' LYS . 94.3 Cg_endo -86.86 152.94 8.57 Favored 'Trans proline' 0 C--N 1.358 1.035 0 C-N-CA 121.868 1.712 . . . . 0.56 114.546 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 1.2 mp -141.9 -173.09 3.71 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 115.954 -0.566 . . . . 0.49 110.423 179.322 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -81.98 -73.15 1.22 Allowed Glycine 0 CA--C 1.521 0.438 0 C-N-CA 120.765 -0.731 . . . . 0.56 112.447 179.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 46.1 tt0 -105.81 -33.55 7.95 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.21 0.529 . . . . 0.83 109.838 179.142 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.572 ' O ' ' HA3' ' A' ' 187' ' ' GLY . . . -84.65 68.69 10.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.225 0.536 . . . . 0.44 110.889 179.554 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -76.59 -70.14 1.32 Allowed Glycine 0 CA--C 1.524 0.6 0 C-N-CA 120.822 -0.704 . . . . 0.45 113.683 -179.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -66.09 -55.4 16.69 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.049 0.452 . . . . 0.48 111.95 -179.335 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -65.91 -39.11 90.26 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 116.134 -0.485 . . . . 0.41 110.563 179.309 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . 0.572 ' HA3' ' O ' ' A' ' 183' ' ' ALA . . . -66.37 -33.11 83.91 Favored Glycine 0 C--O 1.224 -0.469 0 C-N-CA 121.126 -0.559 . . . . 0.35 112.727 179.792 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 35.5 ttm180 -67.27 -50.97 58.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.768 0.318 . . . . 0.59 110.27 178.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . 0.703 ' HB3' HG11 ' A' ' 297' ' ' VAL . 49.9 mtm180 -64.18 -36.05 82.81 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.445 -0.343 . . . . 0.62 110.419 179.139 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.413 ' HA ' HG22 ' A' ' 297' ' ' VAL . . . -70.97 -48.74 51.6 Favored 'General case' 0 C--O 1.216 -0.69 0 CA-C-N 116.093 -0.503 . . . . 0.31 111.435 179.356 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . 0.539 ' HB2' ' O ' ' A' ' 187' ' ' GLY . 0.2 OUTLIER -57.58 -51.57 68.93 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 120.711 0.291 . . . . 0.44 111.453 -179.899 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -59.57 -47.38 85.79 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.2 -0.455 . . . . 0.42 111.695 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 58.4 m -66.5 -48.34 70.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.869 0.366 . . . . 0.38 110.748 179.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 0.41 HD21 HG21 ' A' ' 249' ' ' ILE . 25.1 tp -60.63 -36.88 79.75 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.867 -0.606 . . . . 0.35 111.371 179.564 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . 0.979 ' HA ' ' HE1' ' A' ' 166' ' ' TYR . 35.4 ttm180 -64.69 -46.87 80.53 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.777 0.322 . . . . 0.47 110.668 178.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.76 -52.81 39.92 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.924 -0.58 . . . . 0.58 111.639 -179.774 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . 0.537 ' O ' HG23 ' A' ' 201' ' ' VAL . 55.4 t -67.15 -40.42 85.19 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 CA-C-O 120.974 0.416 . . . . 0.41 111.704 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . 0.512 ' HA3' ' OH ' ' A' ' 166' ' ' TYR . . . -66.11 -49.87 55.16 Favored Glycine 0 CA--C 1.52 0.387 0 C-N-CA 121.216 -0.516 . . . . 0.3 113.25 -179.628 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . 0.419 ' HB2' ' O ' ' A' ' 195' ' ' ARG . 0.8 OUTLIER -63.47 -34.09 76.99 Favored 'General case' 0 N--CA 1.462 0.172 0 N-CA-C 109.749 -0.463 . . . . 0.51 109.749 179.183 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -63.09 -39.77 98.41 Favored Glycine 0 C--N 1.335 0.522 0 C-N-CA 121.179 -0.534 . . . . 0.38 112.366 178.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 197' ' ' VAL . 84.4 t -69.48 -43.13 80.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 CA-C-O 120.694 0.283 . . . . 0.37 110.857 179.078 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 202' ' ' GLN . . . . . 0.573 ' HG3' ' OG ' ' A' ' 250' ' ' SER . 34.2 mt-30 -59.12 -45.07 91.85 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.023 -0.535 . . . . 0.5 111.411 179.588 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 37.3 mtt180 -76.11 -24.68 54.97 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 116.304 -0.407 . . . . 0.62 111.817 179.512 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -78.12 -54.17 6.55 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.848 0.356 . . . . 0.66 111.753 179.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 33.6 m-70 -101.0 36.56 1.94 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.747 0.308 . . . . 0.64 110.465 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -55.28 -40.25 70.82 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 112.777 0.658 . . . . 0.6 112.777 -178.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 35.1 p -59.64 -53.82 53.62 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.026 0.441 . . . . 0.58 111.511 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -64.03 -42.74 96.99 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.048 -0.524 . . . . 0.46 110.56 178.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 2.3 m-30 -60.1 -48.94 79.61 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 115.963 -0.562 . . . . 0.5 110.958 179.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -57.24 -40.96 78.67 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 120.465 0.174 . . . . 0.7 111.449 179.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -57.39 -51.79 55.58 Favored Glycine 0 C--N 1.334 0.461 0 C-N-CA 120.507 -0.854 . . . . 0.4 111.513 178.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 212' ' ' MET . . . . . 0.486 ' O ' ' HB2' ' A' ' 216' ' ' LEU . 1.8 mpp? -69.76 -30.35 67.91 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 120.792 0.33 . . . . 0.82 110.669 178.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.42 HD22 ' HA ' ' A' ' 213' ' ' LEU . 1.6 tm? -61.45 -48.79 79.52 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.047 -0.524 . . . . 0.56 111.082 178.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 214' ' ' ARG . . . . . 0.447 HH11 ' HD3' ' A' ' 214' ' ' ARG . 27.7 mtt180 -69.64 -34.51 74.13 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.207 -0.451 . . . . 1.16 111.483 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 215' ' ' LYS . . . . . 0.435 ' HG3' HD13 ' B' ' 19' ' ' LEU . 72.1 mmtt -80.0 -4.26 51.83 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 120.876 0.37 . . . . 0.9 111.477 179.613 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.512 ' HG ' HG13 ' A' ' 218' ' ' ILE . 1.5 tp -98.7 85.97 3.44 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.178 0.513 . . . . 0.73 111.111 179.567 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -81.82 34.57 0.4 Allowed 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 116.208 -0.451 . . . . 1.01 110.947 179.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 218' ' ' ILE . . . . . 0.754 HG12 ' HB3' ' A' ' 223' ' ' ASP . 13.7 mt -45.25 116.4 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 N-CA-C 114.021 1.119 . . . . 0.5 114.021 -178.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 9.0 ptpp? -158.61 -9.81 0.07 Allowed 'General case' 0 CA--C 1.548 0.88 0 CA-C-N 115.083 -0.962 . . . . 0.63 112.595 178.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -134.0 175.37 9.53 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 113.547 0.943 . . . . 0.96 113.547 -179.204 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . 0.563 ' O ' ' HG2' ' A' ' 225' ' ' LYS . 4.9 mm-40 -58.23 -22.99 54.32 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 114.995 -1.002 . . . . 0.67 113.573 -179.257 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -77.8 -27.08 59.36 Favored Glycine 0 CA--C 1.526 0.739 0 C-N-CA 120.677 -0.773 . . . . 0.49 113.152 179.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 223' ' ' ASP . . . . . 0.754 ' HB3' HG12 ' A' ' 218' ' ' ILE . 36.4 m-20 -69.32 -44.14 72.31 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 111.879 0.325 . . . . 0.59 111.879 -179.123 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -62.25 -28.94 45.53 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 CA-C-O 121.022 0.439 . . . . 0.54 110.087 178.433 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . 0.563 ' HG2' ' O ' ' A' ' 221' ' ' GLU . 42.3 mmtm -69.3 -35.71 76.27 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 109.511 -0.551 . . . . 0.76 109.511 177.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . 0.666 ' O ' HG23 ' A' ' 230' ' ' VAL . 41.2 t -70.79 -44.62 66.25 Favored 'General case' 0 N--CA 1.463 0.18 0 N-CA-C 109.291 -0.633 . . . . 0.8 109.291 178.024 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 227' ' ' PHE . . . . . 0.564 ' HE2' HG21 ' A' ' 255' ' ' VAL . 10.5 t80 -58.82 -44.43 90.87 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 115.848 -0.615 . . . . 0.61 110.278 178.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 5.1 p -70.63 -34.29 71.93 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.123 -0.489 . . . . 0.83 110.3 178.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 5.8 ttt180 -63.58 -42.32 98.3 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.296 0.57 . . . . 3.18 110.304 178.048 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 0.897 HG13 ' HA ' ' B' ' 24' ' ' ALA . 43.2 t -65.11 -38.89 83.87 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 N-CA-C 109.774 -0.454 . . . . 0.55 109.774 178.327 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 231' ' ' MET . . . . . 0.797 ' HG3' ' HG ' ' A' ' 248' ' ' LEU . 34.1 ttm -62.86 -51.11 68.28 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 115.896 -0.593 . . . . 0.43 111.79 179.65 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 31.7 m -60.96 -33.08 54.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 C-N-CA 121.053 -0.259 . . . . 0.44 111.593 -179.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 233' ' ' HIS . . . . . 0.566 ' CD2' ' HB1' ' B' ' 24' ' ' ALA . 17.1 t60 -67.31 -40.27 85.97 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 109.803 -0.443 . . . . 0.45 109.803 178.139 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.541 HG23 ' O ' ' A' ' 230' ' ' VAL . 59.9 t -53.6 -47.86 60.14 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 CA-C-N 116.116 -0.493 . . . . 0.4 110.523 179.483 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -96.72 23.23 7.21 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.941 -0.572 . . . . 0.6 111.948 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 3.1 tmtm? -66.89 -17.06 64.72 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.878 0.37 . . . . 1.04 111.63 -179.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -80.55 -16.16 54.87 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.447 -0.342 . . . . 0.6 111.172 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 97.82 -17.72 58.37 Favored Glycine 0 CA--C 1.522 0.524 0 C-N-CA 120.744 -0.741 . . . . 0.46 113.661 179.323 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 6.8 p -89.63 120.28 38.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-O 121.454 0.645 . . . . 0.42 111.641 -179.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 32.8 m -94.34 99.62 11.8 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.006 0.431 . . . . 0.57 111.69 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . 0.42 ' HB2' ' HD2' ' A' ' 244' ' ' ARG . 90.4 m-20 -90.3 135.71 33.51 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.591 -0.277 . . . . 0.84 110.434 178.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 242' ' ' TRP . . . . . 0.523 ' CZ3' ' HB2' ' A' ' 296' ' ' PHE . 25.9 m95 -58.21 -40.6 82.03 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.823 0.344 . . . . 0.49 111.124 179.561 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . 0.51 ' HA3' ' N ' ' B' ' 35' ' ' TYR . . . -61.03 -30.32 73.2 Favored Glycine 0 C--N 1.332 0.359 0 C-N-CA 120.771 -0.728 . . . . 0.37 111.877 178.417 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 244' ' ' ARG . . . . . 0.501 ' HA ' ' HA3' ' B' ' 31' ' ' GLY . 74.3 mtt180 -69.25 -47.9 63.36 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.816 -0.439 . . . . 0.51 109.816 178.416 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . 0.464 ' O ' HG13 ' A' ' 249' ' ' ILE . 68.7 mt -59.15 -49.95 81.52 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.12 0 CA-C-N 115.523 -0.762 . . . . 0.43 111.294 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . 0.418 HG21 ' CG1' ' A' ' 197' ' ' VAL . 7.3 p -66.13 -28.41 43.66 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 C-N-CA 120.727 -0.389 . . . . 0.42 111.133 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 19.3 m -65.15 -46.08 82.36 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 109.935 -0.395 . . . . 0.4 109.935 178.293 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 248' ' ' LEU . . . . . 0.797 ' HG ' ' HG3' ' A' ' 231' ' ' MET . 3.0 mm? -62.3 -39.58 93.45 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 116.106 -0.497 . . . . 0.51 110.582 178.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 249' ' ' ILE . . . . . 0.464 HG13 ' O ' ' A' ' 245' ' ' ILE . 17.6 mt -70.12 -40.96 78.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-O 120.929 0.395 . . . . 0.4 110.079 178.316 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 250' ' ' SER . . . . . 0.573 ' OG ' ' HG3' ' A' ' 202' ' ' GLN . 33.7 t -61.53 -44.89 96.23 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 109.553 -0.536 . . . . 1.04 109.553 178.257 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 251' ' ' PHE . . . . . . . . . . . . . 42.4 t80 -66.23 -38.57 88.2 Favored 'General case' 0 C--O 1.231 0.128 0 N-CA-C 109.097 -0.705 . . . . 0.5 109.097 177.42 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -60.61 -36.29 91.18 Favored Glycine 0 C--N 1.336 0.541 0 N-CA-C 111.199 -0.761 . . . . 0.3 111.199 177.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -68.18 -38.32 81.93 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-O 120.909 0.385 . . . . 0.33 110.031 177.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -65.13 -40.82 94.99 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 109.458 -0.571 . . . . 1.03 109.458 178.33 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 255' ' ' VAL . . . . . 0.564 HG21 ' HE2' ' A' ' 227' ' ' PHE . 70.1 t -63.59 -44.21 98.5 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 CA-C-N 115.834 -0.621 . . . . 0.38 109.495 177.468 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -59.39 -32.37 70.09 Favored 'General case' 0 C--O 1.226 -0.163 0 CA-C-N 116.381 -0.372 . . . . 0.29 110.137 177.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 257' ' ' LYS . . . . . 0.442 ' HD2' ' HA ' ' A' ' 171' ' ' ALA . 43.5 tptt -63.82 -49.18 73.88 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.071 -0.513 . . . . 0.66 110.433 178.332 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -71.43 -32.59 68.53 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 120.888 0.375 . . . . 0.36 110.143 179.034 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.521 ' HG ' ' HB3' ' A' ' 264' ' ' GLN . 1.6 tp -67.85 -40.21 83.69 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 121.204 0.526 . . . . 0.43 109.744 177.672 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 45.3 tptt -70.65 -27.46 64.06 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.012 -0.54 . . . . 0.37 110.51 178.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 42.1 t -57.34 -28.55 63.23 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.436 -0.347 . . . . 0.55 110.583 178.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 16.1 m -113.15 14.78 8.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 CA-C-N 116.006 -0.543 . . . . 0.5 110.168 178.263 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 40.6 t30 54.73 45.07 27.49 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 115.208 -0.906 . . . . 0.44 112.967 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 264' ' ' GLN . . . . . 0.521 ' HB3' ' HG ' ' A' ' 259' ' ' LEU . 1.6 mt-30 -83.73 37.72 0.6 Allowed 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 120.761 0.315 . . . . 0.5 111.363 179.274 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -50.93 -42.15 59.42 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 112.665 0.617 . . . . 0.38 112.665 -179.069 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 1.3 p -62.24 -13.99 33.81 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.32 -0.4 . . . . 0.82 111.615 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 267' ' ' PHE . . . . . 0.489 ' C ' ' HD2' ' A' ' 270' ' ' PRO . 18.3 t80 -110.12 -22.91 11.56 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.347 -0.388 . . . . 0.59 110.372 178.345 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 268' ' ' ILE . . . . . 0.426 HG13 ' O ' ' A' ' 264' ' ' GLN . 72.1 mt -61.51 -46.49 96.47 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-N 116.387 -0.37 . . . . 0.33 110.554 178.712 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 269' ' ' GLU . . . . . 0.736 ' HB2' ' HD3' ' A' ' 270' ' ' PRO . 29.2 mm-40 -57.9 -56.57 33.35 Favored Pre-proline 0 CA--C 1.541 0.62 0 CA-C-N 116.576 -0.284 . . . . 0.34 110.785 178.562 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 270' ' ' PRO . . . . . 0.736 ' HD3' ' HB2' ' A' ' 269' ' ' GLU . 52.4 Cg_exo -57.97 -27.46 79.22 Favored 'Trans proline' 0 C--N 1.365 1.444 0 C-N-CA 122.402 2.068 . . . . 0.33 112.336 177.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 271' ' ' LEU . . . . . . . . . . . . . 20.9 tp -68.3 -53.06 26.9 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 108.959 -0.756 . . . . 0.5 108.959 177.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -61.31 -35.75 78.21 Favored 'General case' 0 C--O 1.23 0.075 0 N-CA-C 109.064 -0.717 . . . . 0.3 109.064 177.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 273' ' ' GLU . . . . . 0.514 ' HB3' ' HA ' ' A' ' 270' ' ' PRO . 32.4 tt0 -61.88 -48.62 79.69 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 114.939 -1.028 . . . . 1.62 109.852 177.605 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 274' ' ' THR . . . . . . . . . . . . . 89.0 m -62.49 -46.49 88.23 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.964 -0.562 . . . . 0.41 110.422 178.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 95.5 mt -56.59 -54.61 26.64 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-N 116.116 -0.493 . . . . 0.43 110.572 178.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 19.2 m -57.95 -52.4 65.68 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.603 -0.726 . . . . 0.42 111.577 179.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 277' ' ' ASP . . . . . 0.409 ' HB2' ' O ' ' A' ' 273' ' ' GLU . 1.0 OUTLIER -51.23 -54.44 25.64 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.072 -0.513 . . . . 0.4 111.482 179.956 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 87.6 t -64.41 -39.29 85.03 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-N 116.381 -0.372 . . . . 0.45 111.804 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . 0.465 ' O ' ' HB2' ' A' ' 283' ' ' LYS . 1.0 OUTLIER -67.65 -41.07 84.39 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 120.942 0.401 . . . . 1.1 111.364 -179.926 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 76.2 t -77.08 -46.02 29.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 112.394 0.516 . . . . 0.46 112.394 -179.245 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 67.3 mtp180 -65.6 -35.67 81.5 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 112.997 0.74 . . . . 0.76 112.997 -178.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 282' ' ' THR . . . . . . . . . . . . . 60.4 p -83.49 -15.88 47.78 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 122.13 -0.356 . . . . 0.35 111.923 179.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . 0.603 ' HB3' HD23 ' A' ' 287' ' ' LEU . 0.1 OUTLIER -123.21 39.76 3.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.746 0.307 . . . . 0.63 110.915 179.866 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 33.9 ttm180 -52.36 -61.43 2.28 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 112.666 0.617 . . . . 0.61 112.666 -179.57 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -64.77 -38.87 92.45 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 112.527 0.565 . . . . 0.84 112.527 -179.219 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 286' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -65.44 -41.36 93.56 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.805 0.336 . . . . 0.73 111.817 -179.23 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 287' ' ' LEU . . . . . 0.603 HD23 ' HB3' ' A' ' 283' ' ' LYS . 1.7 mm? -70.0 -41.63 74.09 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.468 0.544 . . . . 0.59 112.468 -179.174 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 20.4 m -67.02 -35.76 75.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 C-N-CA 120.799 -0.36 . . . . 0.53 111.899 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 47.4 mttp -69.99 -39.56 75.82 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 112.677 0.621 . . . . 1.12 112.677 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -89.92 20.17 4.37 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 113.405 0.891 . . . . 0.58 113.405 -178.038 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 291' ' ' ARG . . . . . 0.414 HH11 ' HD2' ' A' ' 291' ' ' ARG . 42.9 mtm180 60.42 15.33 5.42 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 112.916 0.709 . . . . 0.46 112.916 179.441 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 292' ' ' GLY . . . . . 0.478 ' HA2' HD13 ' A' ' 287' ' ' LEU . . . 66.59 -124.42 24.31 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 114.274 0.47 . . . . 0.31 114.274 179.445 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 293' ' ' TRP . . . . . 0.525 ' O ' HG23 ' A' ' 297' ' ' VAL . 89.2 m95 -63.85 -30.37 71.47 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.334 0.494 . . . . 0.38 112.334 -178.809 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 294' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.88 -43.45 94.73 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.836 -0.346 . . . . 0.74 110.623 178.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -67.9 -37.89 88.53 Favored Glycine 0 C--N 1.333 0.406 0 C-N-CA 120.56 -0.828 . . . . 0.33 111.073 177.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 296' ' ' PHE . . . . . 0.523 ' HB2' ' CZ3' ' A' ' 242' ' ' TRP . 0.3 OUTLIER -62.43 -45.81 91.41 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 120.936 0.398 . . . . 0.46 110.48 178.413 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 297' ' ' VAL . . . . . 0.708 ' O ' ' HB2' ' A' ' 301' ' ' HIS . 80.3 t -63.58 -49.82 80.83 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.23 0 CA-C-N 115.855 -0.611 . . . . 0.34 110.898 179.749 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 71.6 mt-10 -61.96 -45.21 94.65 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.245 -0.434 . . . . 0.53 111.777 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 299' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -60.01 -49.48 77.51 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 120.87 0.367 . . . . 0.55 111.678 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 300' ' ' PHE . . . . . 0.505 ' HB3' HG21 ' A' ' 197' ' ' VAL . 59.3 m-85 -80.3 4.86 16.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.009 0.433 . . . . 0.56 111.3 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 301' ' ' HIS . . . . . 0.708 ' HB2' ' O ' ' A' ' 297' ' ' VAL . 1.6 t-160 -99.91 39.86 1.29 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.293 -0.412 . . . . 0.83 110.692 178.609 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . 0.571 ' HB ' ' HA ' ' B' ' 41' ' ' PRO . 6.0 m -80.16 10.9 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 CA-C-N 116.361 -0.381 . . . . 1.24 111.559 179.529 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 303' ' ' GLN . . . . . 0.409 ' HB2' ' H ' ' A' ' 304' ' ' ASP . 1.6 mm-40 -103.48 -84.43 0.47 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.105 0.478 . . . . 1.4 111.187 -179.777 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 304' ' ' ASP . . . . . 0.409 ' H ' ' HB2' ' A' ' 303' ' ' GLN . 3.3 p-10 -85.67 108.22 17.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.394 0.616 . . . . 0.92 111.11 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 76.9 mt -85.01 -55.1 4.23 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.709 -0.678 . . . . 1.66 111.277 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 6.6 mp0 -72.25 -34.22 68.09 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 116.398 -0.365 . . . . 3.29 111.65 179.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . 118.75 -147.93 18.42 Favored Glycine 0 CA--C 1.522 0.522 0 C-N-CA 120.777 -0.725 . . . . 3.1 113.227 179.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.432 -1.205 . . . . 4.16 113.123 -179.858 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.495 0 CA-C-O 120.444 0.164 . . . . 2.31 110.944 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -139.99 -66.81 0.44 Allowed 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 120.942 0.401 . . . . 1.39 111.026 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 19' ' ' LEU . . . . . 0.435 HD13 ' HG3' ' A' ' 215' ' ' LYS . 64.3 tp -100.91 109.39 57.92 Favored Pre-proline 0 CA--C 1.534 0.365 0 CA-C-O 120.929 0.395 . . . . 1.27 111.317 179.695 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 20' ' ' PRO . . . . . 0.429 ' C ' ' H ' ' B' ' 22' ' ' GLU . 97.9 Cg_endo -79.47 157.05 25.38 Favored 'Trans proline' 0 CA--C 1.534 0.519 0 C-N-CA 122.628 2.218 . . . . 0.84 112.387 179.648 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 21' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -68.8 31.66 0.16 Allowed 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 122.789 2.326 . . . . 0.74 113.482 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 22' ' ' GLU . . . . . 0.464 ' O ' ' HB2' ' B' ' 26' ' ' GLN . 4.8 mm-40 -88.94 -12.57 41.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.268 -0.424 . . . . 0.75 111.407 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 23' ' ' PHE . . . . . . . . . . . . . 10.3 p90 -63.64 -35.39 80.37 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.18 0.515 . . . . 0.62 110.747 179.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 24' ' ' ALA . . . . . 0.897 ' HA ' HG13 ' A' ' 230' ' ' VAL . . . -72.11 -43.98 63.91 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.639 -0.71 . . . . 0.42 110.623 179.178 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -69.73 -37.03 76.35 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.147 -0.479 . . . . 0.42 110.532 179.108 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 26' ' ' GLN . . . . . 0.464 ' HB2' ' O ' ' B' ' 22' ' ' GLU . 0.0 OUTLIER -61.73 -54.84 37.07 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 116.481 -0.327 . . . . 0.71 111.174 179.514 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . 0.52 HD12 HG11 ' A' ' 230' ' ' VAL . 30.9 mt -58.06 -37.32 74.22 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 120.863 0.363 . . . . 0.63 110.197 178.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 28' ' ' ARG . . . . . 0.528 ' HA ' HG13 ' A' ' 234' ' ' VAL . 4.8 tmt_? -62.6 -53.69 50.81 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 109.26 -0.644 . . . . 1.24 109.26 177.55 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 21.3 mtmt -53.7 -48.95 69.06 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.858 -0.61 . . . . 0.55 110.582 178.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . 0.444 HG13 ' O ' ' B' ' 26' ' ' GLN . 75.5 mt -59.07 -42.28 85.97 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.202 0 CA-C-N 116.057 -0.52 . . . . 0.41 110.123 179.129 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . 0.501 ' HA3' ' HA ' ' A' ' 244' ' ' ARG . . . -58.76 -50.15 70.32 Favored Glycine 0 CA--C 1.521 0.421 0 C-N-CA 120.886 -0.673 . . . . 0.34 112.398 178.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 32' ' ' ASP . . . . . 0.484 ' OD2' ' HD3' ' B' ' 28' ' ' ARG . 9.1 m-20 -61.84 -40.12 94.2 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.14 0.495 . . . . 0.42 110.145 178.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 15.6 tppt? -64.0 -53.82 44.01 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 115.74 -0.663 . . . . 1.22 111.101 179.514 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 77.3 t -59.13 -39.03 77.58 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-O 121.067 0.461 . . . . 0.42 110.48 179.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 35' ' ' TYR . . . . . 0.51 ' N ' ' HA3' ' A' ' 243' ' ' GLY . 4.0 t80 -60.55 -50.44 73.55 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.898 -0.592 . . . . 0.82 110.467 178.479 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 36' ' ' CYS . . . . . . . . . . . . . 61.5 m -64.25 -25.82 68.23 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.009 0.433 . . . . 0.43 110.983 179.429 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 20.9 m -75.36 -43.14 52.05 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 116.022 -0.536 . . . . 0.44 112.259 -179.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 38' ' ' TRP . . . . . . . . . . . . . 97.2 m95 -87.9 -9.78 52.67 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 113.249 0.833 . . . . 0.66 113.249 -178.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 38.2 t -73.18 -15.84 61.44 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 111.731 0.271 . . . . 0.67 111.731 179.196 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -91.91 126.66 52.73 Favored Pre-proline 0 CA--C 1.534 0.346 0 CA-C-N 116.555 -0.293 . . . . 0.87 111.673 179.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 41' ' ' PRO . . . . . 0.571 ' HA ' ' HB ' ' A' ' 302' ' ' VAL . 73.3 Cg_endo -77.16 65.92 7.83 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 122.452 2.102 . . . . 1.88 112.826 179.492 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -121.37 -170.31 2.01 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 116.253 -0.43 . . . . 2.52 111.559 -179.322 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 43' ' ' MET . . . . . . . . . . . . . 61.7 mtt . . . . . 0 C--O 1.251 1.154 0 CA-C-O 118.149 -0.929 . . . . 4.05 111.939 -179.754 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.773 ' HA3' ' HA ' ' A' ' 153' ' ' ASP . . . . . . . . 0 N--CA 1.487 2.099 0 N-CA-C 112.568 -0.213 . . . . 0.89 112.568 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.498 ' HD2' ' OE1' ' A' ' 152' ' ' GLU . 27.1 Cg_exo -63.44 -39.63 35.67 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 122.883 2.389 . . . . 1.41 113.556 179.666 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -97.81 151.65 19.98 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.84 0.352 . . . . 2.12 111.817 -179.256 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -58.46 -63.11 5.53 Favored Glycine 0 C--N 1.335 0.511 0 C-N-CA 121.15 -0.548 . . . . 1.13 112.288 179.521 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 14.7 p -77.09 52.93 0.92 Allowed 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.449 0.643 . . . . 1.13 110.365 178.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.498 ' OE1' ' HD2' ' A' ' 148' ' ' PRO . 8.6 tt0 -164.39 -34.37 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.277 -0.874 . . . . 1.29 110.935 -179.006 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . 0.773 ' HA ' ' HA3' ' A' ' 147' ' ' GLY . 33.0 t70 -46.85 -52.72 13.64 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 112.454 0.538 . . . . 0.64 112.454 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.93 -55.54 33.8 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.123 0.487 . . . . 0.83 111.121 179.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.477 HD21 ' HB3' ' A' ' 287' ' ' LEU . 26.4 tp -58.63 -42.35 88.09 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.91 -0.587 . . . . 0.54 112.251 179.616 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 68.3 t80 -69.01 -47.04 66.48 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 112.399 0.518 . . . . 0.51 112.399 -179.219 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 60.9 mtp180 -61.21 -40.23 93.22 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 111.744 0.276 . . . . 0.64 111.744 -179.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 2.8 mm-40 -68.57 -44.29 74.76 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.891 0.377 . . . . 0.63 110.183 179.14 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 34.1 m -63.69 -49.35 73.47 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.949 -0.568 . . . . 0.32 111.346 179.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.51 ' HA ' HG21 ' A' ' 276' ' ' THR . 11.1 tp -55.68 -49.49 72.81 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 111.871 0.323 . . . . 0.47 111.871 -179.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . 0.724 ' O ' ' HG2' ' A' ' 165' ' ' ARG . 0.0 OUTLIER -58.64 -53.72 55.2 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-O 120.625 0.25 . . . . 0.54 111.152 179.806 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . 0.514 HG12 ' HA2' ' A' ' 187' ' ' GLY . 83.3 mt -58.54 -46.95 89.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-N 116.416 -0.356 . . . . 0.33 111.683 -179.711 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.512 HD12 HG23 ' A' ' 276' ' ' THR . 71.7 mt -62.74 -45.51 98.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 CA-C-N 116.446 -0.343 . . . . 0.32 110.716 179.643 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . 0.536 ' O ' ' HB2' ' A' ' 168' ' ' ARG . 51.1 m -57.87 -41.38 82.36 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.482 -0.326 . . . . 0.29 110.332 178.346 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . 0.724 ' HG2' ' O ' ' A' ' 161' ' ' GLU . 13.5 mmt180 -65.11 -54.8 24.34 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.493 -0.321 . . . . 0.52 111.33 179.612 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' TYR . . . . . 0.823 ' HE1' ' HA ' ' A' ' 195' ' ' ARG . 65.2 t80 -60.93 -51.26 70.02 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 113.036 0.754 . . . . 0.39 113.036 -178.063 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.469 HD13 HG23 ' A' ' 163' ' ' ILE . 9.2 mp -60.43 -39.87 89.03 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.879 -0.329 . . . . 0.45 111.056 -179.078 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . 0.536 ' HB2' ' O ' ' A' ' 164' ' ' SER . 3.9 mmt180 -68.7 -42.8 77.25 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 120.881 0.372 . . . . 0.39 111.126 178.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . 0.562 ' CD ' HH21 ' A' ' 195' ' ' ARG . 63.5 mt-10 -65.33 -48.67 72.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.019 0.437 . . . . 0.37 111.447 178.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . 0.636 ' HB3' ' HB1' ' A' ' 253' ' ' ALA . 7.4 tp60 -65.71 -37.3 86.05 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.137 -0.483 . . . . 0.39 111.821 -179.355 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.458 ' HA ' ' HA ' ' A' ' 257' ' ' LYS . . . -65.77 -30.78 71.48 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.787 0.327 . . . . 0.39 111.396 179.083 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . 0.507 HG22 ' HD3' ' A' ' 260' ' ' LYS . 16.6 p -91.97 -41.34 10.62 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.259 0.466 . . . . 0.53 112.259 -179.612 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 113.4 3.48 24.1 Favored Glycine 0 CA--C 1.524 0.623 0 C-N-CA 120.95 -0.643 . . . . 0.54 112.622 -179.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -84.86 127.58 34.22 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.889 0.376 . . . . 0.55 111.624 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 65.4 mttm -130.18 44.1 3.02 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.446 0.641 . . . . 0.64 111.227 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -90.54 -135.33 0.12 Allowed 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 115.472 -0.785 . . . . 0.68 111.386 179.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 29.5 t -137.42 116.57 12.56 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.973 0.416 . . . . 1.48 111.181 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 52.1 mttp -115.78 141.96 28.29 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 116.069 -0.514 . . . . 0.9 111.407 -179.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.85 130.04 16.27 Favored 'Trans proline' 0 CA--C 1.536 0.622 0 C-N-CA 122.647 2.232 . . . . 1.11 113.243 179.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.433 ' HA ' ' NH2' ' A' ' 165' ' ' ARG . 3.1 mm? -92.34 159.26 15.67 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.049 -0.523 . . . . 0.68 110.816 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -119.46 -51.63 0.28 Allowed Glycine 0 CA--C 1.523 0.538 0 C-N-CA 120.358 -0.925 . . . . 0.68 113.355 -179.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . 0.64 ' HB2' ' HG3' ' A' ' 161' ' ' GLU . 5.0 mm-40 -85.55 -38.37 18.58 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.98 0.419 . . . . 0.69 111.476 -179.516 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.549 ' O ' ' HA3' ' A' ' 187' ' ' GLY . . . -123.13 83.3 2.11 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.177 -0.465 . . . . 0.43 111.062 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -74.81 -71.15 1.16 Allowed Glycine 0 CA--C 1.528 0.849 0 C-N-CA 120.552 -0.832 . . . . 0.55 114.255 -179.341 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -62.31 -55.29 29.61 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-O 121.06 0.457 . . . . 0.63 111.736 -179.161 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -63.78 -40.27 96.27 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.915 -0.584 . . . . 0.42 110.672 179.172 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . 0.549 ' HA3' ' O ' ' A' ' 183' ' ' ALA . . . -64.3 -40.41 97.87 Favored Glycine 0 C--N 1.333 0.4 0 C-N-CA 121.261 -0.495 . . . . 0.32 113.592 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 62.7 ttt180 -62.89 -51.3 67.51 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 117.269 0.534 . . . . 1.4 110.759 179.198 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 48.4 mtm180 -67.54 -31.56 71.74 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 116.112 -0.494 . . . . 0.45 111.033 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.518 ' HA ' ' CG1' ' A' ' 297' ' ' VAL . . . -71.29 -40.43 70.89 Favored 'General case' 0 C--O 1.222 -0.368 0 CA-C-N 116.282 -0.417 . . . . 0.27 110.943 178.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 20.0 tp -63.36 -47.15 83.31 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 111.589 0.218 . . . . 0.55 111.589 179.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 6.0 tm-20 -60.17 -45.37 93.33 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.291 0.567 . . . . 0.35 110.267 179.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . 0.652 HG21 ' HA ' ' A' ' 297' ' ' VAL . 27.8 m -65.68 -47.19 76.3 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.762 -0.654 . . . . 0.31 110.665 179.284 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 0.445 HD12 ' HA ' ' A' ' 194' ' ' LEU . 7.0 tp -61.07 -41.75 97.22 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 116.032 -0.531 . . . . 0.34 110.678 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . 0.823 ' HA ' ' HE1' ' A' ' 166' ' ' TYR . 50.5 mtt180 -59.38 -58.44 8.6 Favored 'General case' 0 C--O 1.226 -0.136 0 CA-C-O 120.774 0.321 . . . . 0.48 110.172 178.319 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 8.5 ttm180 -57.77 -56.34 23.16 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.654 -0.703 . . . . 0.45 112.714 -179.028 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . 0.482 ' O ' HG23 ' A' ' 201' ' ' VAL . 58.6 t -62.3 -41.71 92.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-O 120.87 0.367 . . . . 0.3 111.021 -179.395 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . 0.581 ' HA3' ' OH ' ' A' ' 166' ' ' TYR . . . -63.21 -46.85 92.16 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 120.86 -0.686 . . . . 0.28 111.939 179.174 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 51.3 m-20 -55.74 -45.56 77.98 Favored 'General case' 0 N--CA 1.462 0.163 0 N-CA-C 109.509 -0.552 . . . . 0.36 109.509 178.114 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -58.69 -54.31 38.96 Favored Glycine 0 C--O 1.223 -0.573 0 CA-C-N 115.633 -0.712 . . . . 0.31 111.921 178.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 197' ' ' VAL . 57.5 t -59.58 -42.3 87.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 CA-C-O 120.787 0.327 . . . . 0.41 111.701 179.279 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 202' ' ' GLN . . . . . 0.44 ' HG2' ' HD1' ' A' ' 254' ' ' PHE . 5.9 mt-30 -64.3 -52.47 58.39 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 112.444 0.535 . . . . 0.55 112.444 -179.389 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 203' ' ' ARG . . . . . 0.43 ' HD3' HH11 ' A' ' 203' ' ' ARG . 2.8 mmp_? -69.37 -35.18 75.58 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.743 0.306 . . . . 0.59 111.475 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -68.53 -48.27 64.75 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.995 0.426 . . . . 0.4 110.819 179.105 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 -100.69 32.95 2.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.007 0.432 . . . . 0.54 110.818 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -56.72 -46.72 81.14 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.607 -0.724 . . . . 0.42 112.148 -179.167 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 58.4 p -60.46 -45.62 93.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.994 0.426 . . . . 0.57 111.176 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -65.94 -41.88 90.74 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.844 -0.616 . . . . 0.37 110.886 179.053 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 7.8 m-30 -66.17 -44.34 84.33 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.521 -0.309 . . . . 0.48 110.573 179.281 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -64.71 -44.52 89.98 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.532 -0.303 . . . . 1.34 110.616 178.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -60.51 -44.67 97.46 Favored Glycine 0 C--N 1.336 0.549 0 C-N-CA 120.749 -0.739 . . . . 0.33 111.28 178.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 28.1 ttm -66.3 -40.87 90.28 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 121.022 0.439 . . . . 0.51 109.935 178.248 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 12.9 tp -59.36 -42.54 91.83 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.596 -0.729 . . . . 0.49 111.718 179.177 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 77.1 mtp180 -74.28 -28.71 61.33 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.401 -0.363 . . . . 0.87 111.741 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 49.4 mtmt -76.33 -34.19 58.99 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 120.823 0.344 . . . . 0.82 110.69 178.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.588 ' HA ' HD11 ' B' ' 19' ' ' LEU . 81.6 mt -67.84 136.39 54.04 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 121.11 0.481 . . . . 0.57 111.795 179.499 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -101.28 30.97 3.89 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.11 -0.495 . . . . 0.71 110.485 179.31 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 218' ' ' ILE . . . . . 0.557 HG12 ' HB3' ' A' ' 216' ' ' LEU . 20.0 mm -59.17 119.86 4.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-N 115.8 -0.636 . . . . 0.5 111.316 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 19.3 mtmm -149.04 -30.99 0.24 Allowed 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 113.178 0.807 . . . . 1.1 113.178 -179.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -125.18 174.67 7.92 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.748 0.647 . . . . 0.46 112.748 -178.222 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . 0.463 ' O ' HG22 ' A' ' 224' ' ' VAL . 1.0 OUTLIER -62.35 -28.77 69.99 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 115.732 -0.667 . . . . 0.59 111.302 -179.949 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -61.88 -25.59 66.08 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 121.351 -0.452 . . . . 0.33 113.268 179.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 -58.43 -28.34 65.17 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 113.226 0.824 . . . . 0.36 113.226 -179.688 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.728 ' HB ' HG21 ' A' ' 274' ' ' THR . 25.8 m -54.0 -29.78 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 N-CA-C 112.908 0.707 . . . . 0.39 112.908 -179.237 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 33.4 mtmm -64.89 -43.39 93.04 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-O 121.415 0.626 . . . . 0.63 110.075 178.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 15.5 m -70.34 -38.65 74.88 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.309 -0.86 . . . . 0.6 109.715 178.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 227' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -59.63 -38.82 82.39 Favored 'General case' 0 CA--C 1.528 0.13 0 N-CA-C 108.791 -0.818 . . . . 0.61 108.791 177.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 49.8 m -62.32 -41.19 98.33 Favored 'General case' 0 CA--C 1.528 0.101 0 CA-C-N 115.426 -0.806 . . . . 0.48 109.989 177.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.2 -40.93 78.41 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.33 -0.395 . . . . 2.11 110.371 178.592 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 0.51 ' O ' HG23 ' A' ' 234' ' ' VAL . 13.4 t -61.97 -51.3 74.18 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-N 116.466 -0.334 . . . . 0.3 110.139 178.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 231' ' ' MET . . . . . . . . . . . . . 38.9 mtp -58.84 -47.63 84.18 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.146 -0.479 . . . . 0.4 111.116 179.41 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 75.6 t -63.92 -41.0 91.07 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 CA-C-N 116.34 -0.391 . . . . 0.53 110.907 179.19 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 31.8 t-80 -64.58 -37.56 87.97 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 116.414 -0.357 . . . . 0.58 110.975 178.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.51 HG23 ' O ' ' A' ' 230' ' ' VAL . 53.1 t -63.2 -51.61 69.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-O 120.794 0.331 . . . . 0.43 111.736 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -90.37 24.56 2.53 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 112.159 0.429 . . . . 0.58 112.159 -178.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 1.8 tmtm? -66.69 -15.37 63.46 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 112.537 0.569 . . . . 1.21 112.537 -179.25 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 44.8 p30 -85.27 -16.21 40.88 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 120.767 0.318 . . . . 0.57 111.497 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 94.38 -0.84 66.22 Favored Glycine 0 CA--C 1.524 0.636 0 C-N-CA 121.088 -0.577 . . . . 0.58 113.262 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 0.487 ' HB ' ' NH1' ' A' ' 244' ' ' ARG . 25.6 t -93.44 109.84 22.43 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-O 121.092 0.472 . . . . 0.48 111.584 -179.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 240' ' ' THR . . . . . 0.626 HG22 HD11 ' A' ' 245' ' ' ILE . 21.2 m -94.11 76.74 4.06 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.951 0.405 . . . . 0.84 111.582 179.718 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . 0.448 ' H ' ' HD2' ' A' ' 244' ' ' ARG . 59.3 m-20 -77.05 140.3 40.28 Favored 'General case' 0 C--N 1.329 -0.307 0 O-C-N 122.206 -0.309 . . . . 0.72 110.943 179.194 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 242' ' ' TRP . . . . . 0.546 ' HB3' ' CE2' ' A' ' 300' ' ' PHE . 47.8 m95 -56.32 -40.95 75.24 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.813 0.34 . . . . 0.6 110.871 179.275 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . 0.452 ' H ' ' HB2' ' B' ' 35' ' ' TYR . . . -62.98 -28.82 72.65 Favored Glycine 0 C--N 1.334 0.466 0 C-N-CA 121.168 -0.539 . . . . 0.25 112.028 178.49 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 244' ' ' ARG . . . . . 0.487 ' NH1' ' HB ' ' A' ' 239' ' ' VAL . 89.7 mtt180 -74.44 -42.39 59.21 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.659 -0.497 . . . . 0.46 109.659 178.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . 0.626 HD11 HG22 ' A' ' 240' ' ' THR . 67.8 mt -63.81 -52.71 53.63 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 CA-C-N 115.903 -0.589 . . . . 0.4 110.377 178.771 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . 0.405 HG12 ' HA2' ' A' ' 243' ' ' GLY . 6.8 p -62.63 -29.76 47.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 CA-C-N 116.287 -0.415 . . . . 0.35 110.836 179.43 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 11.1 m -65.93 -44.49 84.98 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 109.743 -0.465 . . . . 0.31 109.743 177.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 248' ' ' LEU . . . . . 0.41 HD13 ' HA ' ' A' ' 248' ' ' LEU . 2.5 mm? -64.42 -40.65 96.18 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 109.832 -0.432 . . . . 0.53 109.832 178.035 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 249' ' ' ILE . . . . . 0.459 HG12 ' O ' ' A' ' 245' ' ' ILE . 48.7 mm -64.05 -43.06 97.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 CA-C-O 121.052 0.453 . . . . 0.46 109.868 178.162 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 56.2 m -62.32 -42.61 99.52 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 115.846 -0.615 . . . . 0.3 109.6 178.313 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 251' ' ' PHE . . . . . . . . . . . . . 18.2 t80 -62.77 -42.99 99.94 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 116.008 -0.542 . . . . 0.5 109.675 178.079 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -57.82 -46.61 92.15 Favored Glycine 0 C--N 1.335 0.521 0 N-CA-C 111.386 -0.686 . . . . 0.28 111.386 178.165 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 253' ' ' ALA . . . . . 0.636 ' HB1' ' HB3' ' A' ' 170' ' ' GLN . . . -68.19 -27.77 66.68 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 120.661 0.267 . . . . 0.35 111.483 178.261 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 254' ' ' PHE . . . . . 0.44 ' HD1' ' HG2' ' A' ' 202' ' ' GLN . 26.6 t80 -74.81 -48.51 24.91 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 120.626 0.25 . . . . 0.6 111.047 179.3 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 255' ' ' VAL . . . . . 0.535 ' O ' ' HG ' ' A' ' 259' ' ' LEU . 23.6 m -64.18 -37.75 80.69 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.129 0 C-N-CA 120.503 -0.479 . . . . 0.34 109.751 178.454 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -67.36 -32.15 72.88 Favored 'General case' 0 C--N 1.341 0.199 0 CA-C-N 116.342 -0.39 . . . . 0.26 110.497 178.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 257' ' ' LYS . . . . . 0.562 ' HE2' ' HG3' ' A' ' 170' ' ' GLN . 28.0 ttmt -61.94 -46.99 86.88 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 109.048 -0.723 . . . . 0.44 109.048 177.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 82.9 t60 -66.0 -40.47 91.15 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 115.356 -0.838 . . . . 0.58 109.445 177.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.65 ' HB3' ' HB2' ' A' ' 264' ' ' GLN . 95.0 mt -62.89 -36.39 83.18 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.104 -0.498 . . . . 0.41 110.591 178.438 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 260' ' ' LYS . . . . . 0.507 ' HD3' HG22 ' A' ' 172' ' ' THR . 0.3 OUTLIER -65.54 -37.36 86.52 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 110.134 -0.321 . . . . 0.37 110.134 178.47 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 15.9 p -64.2 -24.62 67.74 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.839 0.352 . . . . 0.53 110.7 178.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 7.3 p -107.09 8.15 9.62 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 CA-C-O 121.592 0.71 . . . . 0.4 110.328 178.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 6.5 t30 59.13 49.31 9.45 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 113.7 1.0 . . . . 0.59 113.7 179.187 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 264' ' ' GLN . . . . . 0.65 ' HB2' ' HB3' ' A' ' 259' ' ' LEU . 4.0 mm100 -92.24 35.19 1.0 Allowed 'General case' 0 N--CA 1.47 0.532 0 O-C-N 122.082 -0.386 . . . . 0.6 111.352 178.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . 0.408 ' HG2' ' H ' ' A' ' 265' ' ' GLU . 5.3 mm-40 -47.52 -43.94 25.28 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 112.594 0.591 . . . . 0.45 112.594 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 86.8 p -59.11 -18.13 32.74 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 116.326 -0.397 . . . . 0.47 111.749 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 267' ' ' PHE . . . . . 0.448 ' CE1' ' HA ' ' A' ' 221' ' ' GLU . 53.8 t80 -107.77 -28.62 9.57 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 116.653 -0.249 . . . . 0.53 111.073 178.723 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 73.9 mt -57.13 -49.97 77.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 CA-C-O 120.575 0.226 . . . . 0.38 111.474 179.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 269' ' ' GLU . . . . . 0.485 ' HB2' ' HD3' ' A' ' 270' ' ' PRO . 2.5 mp0 -58.6 -56.86 31.27 Favored Pre-proline 0 CA--C 1.543 0.707 0 C-N-CA 121.128 -0.229 . . . . 0.36 111.542 179.431 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 270' ' ' PRO . . . . . 0.485 ' HD3' ' HB2' ' A' ' 269' ' ' GLU . 45.1 Cg_exo -59.37 -29.83 91.18 Favored 'Trans proline' 0 C--N 1.361 1.198 0 C-N-CA 122.369 2.046 . . . . 0.3 112.854 178.57 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 271' ' ' LEU . . . . . . . . . . . . . 56.6 tp -67.72 -49.38 62.96 Favored 'General case' 0 N--CA 1.464 0.225 0 N-CA-C 109.914 -0.402 . . . . 0.44 109.914 178.452 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -60.17 -37.21 79.47 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.113 -0.494 . . . . 0.31 110.217 178.454 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 273' ' ' GLU . . . . . 0.451 ' O ' ' HB2' ' A' ' 277' ' ' ASP . 32.0 tt0 -67.05 -43.12 83.51 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 109.462 -0.57 . . . . 1.11 109.462 178.109 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 274' ' ' THR . . . . . 0.728 HG21 ' HB ' ' A' ' 224' ' ' VAL . 70.1 m -61.47 -49.29 77.39 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.104 -0.498 . . . . 0.4 110.348 178.216 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 96.8 mt -55.37 -54.16 28.04 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.123 0 CA-C-N 115.775 -0.648 . . . . 0.42 110.763 179.419 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 276' ' ' THR . . . . . 0.512 HG23 HD12 ' A' ' 163' ' ' ILE . 15.9 m -57.69 -46.75 83.89 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 120.918 0.39 . . . . 0.31 110.993 179.433 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 277' ' ' ASP . . . . . 0.451 ' HB2' ' O ' ' A' ' 273' ' ' GLU . 0.4 OUTLIER -54.65 -59.92 4.06 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 115.685 -0.689 . . . . 0.59 110.966 179.345 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 57.3 t -60.38 -39.48 81.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 CA-C-O 120.812 0.339 . . . . 0.42 111.418 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . 0.554 HD11 HG23 ' A' ' 245' ' ' ILE . 15.8 tp -61.32 -47.59 85.23 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.564 -0.289 . . . . 0.85 111.151 179.568 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 80.2 t -73.04 -42.89 59.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 120.928 -0.309 . . . . 0.49 111.556 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 80.6 mtt-85 -60.92 -34.48 74.77 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 112.458 0.54 . . . . 1.09 112.458 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 282' ' ' THR . . . . . . . . . . . . . 69.3 p -95.74 0.13 52.1 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 113.089 0.774 . . . . 0.71 113.089 -178.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . 0.502 ' HD2' ' O ' ' A' ' 279' ' ' LEU . 5.7 mttp -141.26 30.1 1.78 Allowed 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 111.649 0.24 . . . . 0.93 111.649 179.773 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 40.1 ttm180 -57.72 -56.12 26.07 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 112.077 0.399 . . . . 0.92 112.077 -179.222 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -61.4 -44.52 97.0 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 120.826 0.346 . . . . 0.77 111.652 -179.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 286' ' ' TRP . . . . . 0.405 ' O ' ' HB2' ' A' ' 290' ' ' GLN . 0.8 OUTLIER -65.18 -49.52 69.5 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 112.36 0.504 . . . . 0.71 112.36 -179.074 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 287' ' ' LEU . . . . . 0.477 ' HB3' HD21 ' A' ' 155' ' ' LEU . 1.6 mm? -66.36 -42.61 87.8 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 113.007 0.743 . . . . 0.51 113.007 -178.502 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 5.6 p -67.75 -36.49 76.09 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 C-N-CA 120.797 -0.361 . . . . 0.49 111.962 -179.511 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 50.3 mttt -76.82 -33.57 57.96 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 112.38 0.511 . . . . 0.95 112.38 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 290' ' ' GLN . . . . . 0.405 ' HB2' ' O ' ' A' ' 286' ' ' TRP . 1.1 tp-100 -84.88 26.43 0.84 Allowed 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 113.002 0.741 . . . . 0.76 113.002 -178.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 32.7 mtp180 63.22 9.39 3.92 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 112.874 0.694 . . . . 0.49 112.874 178.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 62.64 -132.47 44.18 Favored Glycine 0 CA--C 1.524 0.656 0 CA-C-O 121.619 0.566 . . . . 0.35 113.954 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 293' ' ' TRP . . . . . 0.498 ' HA ' ' HB3' ' A' ' 296' ' ' PHE . 78.7 m95 -66.56 -23.45 66.21 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.392 0.516 . . . . 0.49 112.392 -178.766 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 294' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -64.52 -43.49 93.87 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 109.776 -0.453 . . . . 0.43 109.776 178.487 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -69.74 -32.04 70.5 Favored Glycine 0 C--N 1.334 0.459 0 N-CA-C 110.765 -0.934 . . . . 0.3 110.765 177.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 296' ' ' PHE . . . . . 0.498 ' HB3' ' HA ' ' A' ' 293' ' ' TRP . 6.0 t80 -67.53 -48.91 65.64 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 115.553 -0.323 . . . . 0.41 111.202 178.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 297' ' ' VAL . . . . . 0.652 ' HA ' HG21 ' A' ' 193' ' ' THR . 21.7 m -69.14 -33.18 57.14 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 CA-C-N 116.63 -0.259 . . . . 0.33 111.591 -179.591 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -69.47 -42.2 75.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.9 0.381 . . . . 0.47 110.713 179.176 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 299' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -67.69 -45.73 74.32 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.005 -0.543 . . . . 0.64 111.427 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 300' ' ' PHE . . . . . 0.546 ' CE2' ' HB3' ' A' ' 242' ' ' TRP . 60.1 m-85 -87.15 30.92 0.74 Allowed 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 112.687 0.625 . . . . 0.46 112.687 -179.089 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 301' ' ' HIS . . . . . 0.61 ' HB2' ' O ' ' A' ' 297' ' ' VAL . 0.1 OUTLIER -145.89 151.14 37.38 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.95 0.405 . . . . 0.43 111.373 179.628 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 2.3 p -89.99 113.02 25.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.204 0.526 . . . . 0.73 110.473 178.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 303' ' ' GLN . . . . . 0.429 HE21 ' HB2' ' A' ' 303' ' ' GLN . 0.7 OUTLIER -101.72 -50.62 3.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.205 -0.452 . . . . 0.73 111.628 179.96 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 64.2 t0 -146.79 123.37 11.11 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 121.003 0.43 . . . . 1.53 111.125 -179.558 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 42.6 mt -122.68 -2.81 8.81 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.15 0.5 . . . . 2.36 110.319 178.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -106.27 -35.32 7.2 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.83 -0.623 . . . . 3.79 111.76 -179.064 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . 103.21 84.11 1.77 Allowed Glycine 0 CA--C 1.52 0.384 0 C-N-CA 120.619 -0.801 . . . . 2.56 113.285 179.563 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.278 0 CA-C-O 118.641 -1.088 . . . . 2.49 113.261 179.401 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.685 0 CA-C-O 121.411 0.624 . . . . 1.03 111.058 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -109.8 113.69 26.65 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.642 -0.708 . . . . 1.31 111.22 -179.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 19' ' ' LEU . . . . . 0.588 HD11 ' HA ' ' A' ' 216' ' ' LEU . 9.2 mt -94.16 108.08 33.27 Favored Pre-proline 0 CA--C 1.534 0.345 0 CA-C-O 120.901 0.382 . . . . 0.76 111.701 179.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 20' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -80.66 160.89 21.92 Favored 'Trans proline' 0 CA--C 1.534 0.48 0 C-N-CA 122.935 2.423 . . . . 0.5 112.598 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 21' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -72.5 38.41 0.39 Allowed 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 122.918 2.412 . . . . 0.8 113.021 179.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -89.39 -39.04 13.67 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 116.093 -0.503 . . . . 0.64 111.774 -179.268 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 23' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -55.93 -41.17 74.21 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 112.218 0.451 . . . . 0.41 112.218 -179.063 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -66.95 -38.98 87.1 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.882 0.372 . . . . 0.36 111.37 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.8 -35.71 81.99 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-O 121.507 0.67 . . . . 0.38 110.01 178.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -66.16 -49.77 66.25 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.246 -0.888 . . . . 0.5 109.43 178.053 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 82.8 mt -57.21 -36.16 70.53 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.275 -0.42 . . . . 0.48 110.678 178.291 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 28' ' ' ARG . . . . . . . . . . . . . 37.7 mtp85 -57.25 -58.21 9.25 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 116.108 -0.496 . . . . 0.5 111.299 178.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 8.6 ptpp? -64.57 -31.53 72.78 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.523 -0.308 . . . . 0.48 110.791 179.517 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 52.2 mt -62.82 -49.85 82.04 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 N-CA-C 109.421 -0.585 . . . . 0.43 109.421 178.073 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -62.18 -43.61 98.88 Favored Glycine 0 N--CA 1.448 -0.527 0 CA-C-N 115.423 -0.808 . . . . 0.29 112.012 178.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -66.95 -37.11 83.68 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 121.221 -0.191 . . . . 0.54 110.878 179.076 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 23.6 ttmm -65.08 -44.6 88.39 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 109.865 -0.42 . . . . 0.8 109.865 177.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 45.7 t -63.92 -50.79 75.9 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-N 115.969 -0.559 . . . . 0.35 110.186 178.439 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 35' ' ' TYR . . . . . 0.452 ' HB2' ' H ' ' A' ' 243' ' ' GLY . 0.0 OUTLIER -58.0 -40.54 81.0 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.681 -0.691 . . . . 0.73 110.817 179.273 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 36' ' ' CYS . . . . . . . . . . . . . 23.6 t -69.64 -26.47 64.43 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 120.873 0.368 . . . . 0.64 111.422 179.411 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 85.7 m -76.17 -35.02 59.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.305 -0.407 . . . . 0.46 111.18 179.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 38' ' ' TRP . . . . . . . . . . . . . 97.7 m95 -88.03 -37.36 16.38 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 112.052 0.39 . . . . 0.6 112.052 -179.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 45.7 p -65.66 -34.24 77.76 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 120.761 0.315 . . . . 0.68 111.396 179.16 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . 0.404 ' HA ' ' HD3' ' B' ' 41' ' ' PRO . . . -90.33 119.07 69.21 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.444 -0.344 . . . . 0.61 110.813 179.128 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 41' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' B' ' 40' ' ' ALA . 38.5 Cg_exo -61.44 126.88 20.29 Favored 'Trans proline' 0 CA--C 1.532 0.418 0 C-N-CA 122.815 2.343 . . . . 1.3 112.93 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -78.7 -24.77 44.8 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 116.216 -0.447 . . . . 1.26 111.929 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 43' ' ' MET . . . . . . . . . . . . . 28.0 ttt . . . . . 0 C--O 1.252 1.19 0 CA-C-O 118.261 -0.875 . . . . 2.31 111.649 -179.899 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.836 ' N ' ' HG ' ' A' ' 151' ' ' SER . . . . . . . . 0 N--CA 1.491 2.314 0 CA-C-O 120.061 -0.3 . . . . 1.32 112.571 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -73.68 -20.84 19.77 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.502 2.135 . . . . 1.81 112.732 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 19.1 tp -152.96 133.58 13.79 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.022 -0.536 . . . . 1.44 110.07 179.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 77.52 72.26 1.15 Allowed Glycine 0 CA--C 1.522 0.482 0 C-N-CA 120.514 -0.851 . . . . 0.84 112.196 -179.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.836 ' HG ' ' N ' ' A' ' 147' ' ' GLY . 71.1 m -167.09 -43.53 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 121.348 0.595 . . . . 0.95 110.264 -178.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -158.81 -26.96 0.07 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 114.928 -1.033 . . . . 0.46 109.494 179.346 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . 0.401 ' HA ' ' HB2' ' A' ' 156' ' ' TYR . 2.3 p-10 -58.25 -27.7 64.24 Favored 'General case' 0 C--O 1.223 -0.324 0 CA-C-N 115.203 -0.908 . . . . 0.45 110.846 178.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -55.52 -41.49 73.19 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.232 0.539 . . . . 0.43 110.242 178.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -71.66 -40.28 69.75 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 109.004 -0.739 . . . . 0.74 109.004 177.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . 0.401 ' HB2' ' HA ' ' A' ' 153' ' ' ASP . 0.1 OUTLIER -60.65 -46.95 88.4 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 115.966 -0.561 . . . . 0.35 110.86 179.095 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 14.2 mtp180 -60.53 -45.92 92.07 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 116.336 -0.393 . . . . 0.45 111.301 179.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -63.9 -50.46 68.64 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.062 0.458 . . . . 0.43 109.826 178.59 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 16.8 m -56.72 -48.47 77.67 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 115.461 -0.791 . . . . 0.25 110.925 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.473 ' HA ' HG21 ' A' ' 276' ' ' THR . 2.1 tm? -57.21 -49.54 75.69 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.551 -0.295 . . . . 0.46 110.254 178.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.2 -45.46 93.11 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.348 -0.387 . . . . 0.79 111.474 179.552 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . 0.54 HG23 HD22 ' A' ' 191' ' ' LEU . 89.9 mt -65.65 -56.56 14.55 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 CA-C-N 116.0 -0.546 . . . . 0.29 112.359 -179.252 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.542 HD12 HG23 ' A' ' 276' ' ' THR . 97.1 mt -58.49 -51.99 64.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 N-CA-C 112.71 0.633 . . . . 0.36 112.71 -178.689 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 65.9 p -56.1 -42.67 77.14 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 120.556 0.217 . . . . 0.29 111.452 -179.398 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . 0.415 ' NH1' HD23 ' A' ' 180' ' ' LEU . 0.0 OUTLIER -65.55 -52.95 48.65 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.889 0.376 . . . . 1.24 111.105 178.961 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' TYR . . . . . 0.788 ' HE1' ' HA ' ' A' ' 195' ' ' ARG . 59.9 t80 -57.3 -49.08 77.23 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 112.594 0.59 . . . . 0.32 112.594 -179.614 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 5.5 mp -60.71 -46.14 91.55 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 112.413 0.523 . . . . 0.42 112.413 -178.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 38.2 ttm-85 -69.14 -49.89 52.81 Favored 'General case' 0 C--O 1.239 0.545 0 N-CA-C 113.067 0.766 . . . . 0.29 113.067 -178.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -64.12 -52.08 60.85 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.171 0.434 . . . . 0.41 112.171 -178.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -64.29 -32.42 74.01 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 111.972 0.36 . . . . 0.43 111.972 -179.284 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.463 ' O ' ' HG3' ' A' ' 257' ' ' LYS . . . -70.6 -48.22 56.23 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.04 0.448 . . . . 0.37 110.305 178.076 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 44.6 m -66.43 -41.12 89.65 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 115.869 -0.605 . . . . 0.42 111.572 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 127.03 29.01 0.89 Allowed Glycine 0 CA--C 1.526 0.724 0 C-N-CA 120.422 -0.894 . . . . 0.53 113.743 179.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 13.3 t -120.21 135.03 55.12 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.012 0.434 . . . . 0.5 111.378 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 20.8 mtpp -108.03 0.53 21.83 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.822 0.344 . . . . 0.88 111.032 179.288 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -91.36 49.74 1.65 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.359 0.599 . . . . 1.56 112.237 -179.098 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . 0.422 ' O ' ' HG ' ' A' ' 191' ' ' LEU . 7.5 t -91.89 72.43 5.66 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.51 0.671 . . . . 0.64 109.274 178.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . 0.772 ' H ' ' HD2' ' A' ' 179' ' ' PRO . 37.7 mttt -110.54 -41.79 0.11 Allowed Pre-proline 0 CA--C 1.544 0.716 0 N-CA-C 113.64 0.978 . . . . 1.14 113.64 -178.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . 0.772 ' HD2' ' H ' ' A' ' 178' ' ' LYS . 23.3 Cg_endo -61.84 99.18 0.18 Allowed 'Trans proline' 0 C--N 1.361 1.187 0 C-N-CA 121.845 1.697 . . . . 1.81 114.034 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.557 ' HB2' ' NH2' ' A' ' 188' ' ' ARG . 1.1 mt -123.39 146.38 48.02 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.918 -0.583 . . . . 0.93 109.594 178.51 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -92.3 -53.89 1.94 Allowed Glycine 0 CA--C 1.522 0.502 0 C-N-CA 120.916 -0.659 . . . . 0.64 114.077 -178.271 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -88.8 -44.95 10.14 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.249 0.547 . . . . 0.84 110.62 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.477 ' HB3' HD22 ' A' ' 180' ' ' LEU . . . -81.49 77.18 8.38 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.261 0.553 . . . . 0.43 111.192 179.648 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . 0.701 ' HA2' ' NH2' ' A' ' 188' ' ' ARG . . . -79.84 -73.85 1.12 Allowed Glycine 0 CA--C 1.525 0.713 0 C-N-CA 120.312 -0.947 . . . . 0.57 114.079 -179.605 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -71.79 -54.72 9.29 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.065 0.46 . . . . 0.74 110.886 -179.36 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -65.14 -35.18 80.3 Favored 'General case' 0 C--O 1.221 -0.427 0 CA-C-N 115.76 -0.655 . . . . 0.6 110.601 179.277 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . 0.468 ' CA ' ' HB1' ' A' ' 183' ' ' ALA . . . -64.03 -53.33 37.78 Favored Glycine 0 C--O 1.228 -0.262 0 C-N-CA 120.903 -0.665 . . . . 0.43 113.082 -179.81 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . 0.701 ' NH2' ' HA2' ' A' ' 184' ' ' GLY . 0.3 OUTLIER -59.64 -41.71 91.13 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 117.095 0.447 . . . . 1.6 111.192 -179.98 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . 0.9 ' HD3' HG11 ' A' ' 297' ' ' VAL . 0.2 OUTLIER -71.12 -40.3 71.51 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.509 -0.314 . . . . 0.48 111.245 179.386 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.517 ' HA ' HG22 ' A' ' 297' ' ' VAL . . . -69.6 -39.4 77.27 Favored 'General case' 0 C--O 1.22 -0.481 0 CA-C-N 116.865 -0.152 . . . . 0.26 111.394 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . 0.605 HD12 ' HE ' ' A' ' 195' ' ' ARG . 0.3 OUTLIER -64.59 -47.52 78.37 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.603 0.24 . . . . 0.47 111.212 179.788 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -60.79 -42.85 98.37 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.265 0.555 . . . . 0.4 110.897 179.461 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . 0.542 ' OG1' HG13 ' A' ' 297' ' ' VAL . 27.8 m -69.76 -54.06 15.44 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.757 -0.656 . . . . 0.32 110.906 179.515 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 0.477 HD21 HG21 ' A' ' 249' ' ' ILE . 16.7 tp -55.32 -42.34 73.6 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 115.828 -0.623 . . . . 0.32 111.324 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . 0.788 ' HA ' ' HE1' ' A' ' 166' ' ' TYR . 17.9 mtm105 -63.27 -53.05 59.03 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.717 -0.22 . . . . 0.36 111.37 179.654 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.51 -49.77 76.51 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 111.888 0.329 . . . . 0.56 111.888 -179.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 87.2 t -63.89 -46.81 93.16 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 CA-C-O 120.877 0.37 . . . . 0.34 110.315 179.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . 0.612 ' HA3' ' OH ' ' A' ' 166' ' ' TYR . . . -58.83 -42.13 96.42 Favored Glycine 0 C--N 1.333 0.372 0 CA-C-N 115.9 -0.591 . . . . 0.24 112.222 179.017 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -56.95 -44.27 82.38 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.837 0.351 . . . . 0.49 110.31 178.233 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -66.96 -53.48 26.63 Favored Glycine 0 CA--C 1.523 0.568 0 C-N-CA 120.928 -0.654 . . . . 0.36 112.883 179.354 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 60.3 t -60.77 -42.73 93.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 N-CA-C 112.217 0.451 . . . . 0.36 112.217 -179.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 202' ' ' GLN . . . . . 0.592 ' HA ' ' HE2' ' A' ' 209' ' ' PHE . 0.2 OUTLIER -63.44 -52.71 60.32 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 112.131 0.419 . . . . 0.36 112.131 -179.392 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 30.6 mtt-85 -66.66 -33.39 75.54 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.732 0.301 . . . . 0.45 110.343 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -63.92 -52.6 59.09 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.121 -0.491 . . . . 0.88 110.311 178.379 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 205' ' ' HIS . . . . . 0.422 ' HB3' ' HB3' ' A' ' 208' ' ' ALA . 80.7 m-70 -102.21 36.02 2.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.294 -0.412 . . . . 0.48 111.731 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -57.19 -46.52 82.76 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 120.931 0.396 . . . . 1.23 111.31 -179.389 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 47.5 p -64.11 -41.63 97.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.832 -0.622 . . . . 0.62 111.16 179.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . 0.422 ' HB3' ' HB3' ' A' ' 205' ' ' HIS . . . -63.61 -41.21 98.32 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.914 -0.585 . . . . 0.37 110.523 179.054 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 209' ' ' PHE . . . . . 0.608 ' O ' ' HG ' ' A' ' 213' ' ' LEU . 20.6 m-30 -70.23 -46.98 63.37 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.143 -0.48 . . . . 0.5 110.138 178.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 210' ' ' GLN . . . . . 0.429 ' HA ' HD12 ' A' ' 213' ' ' LEU . 0.6 OUTLIER -58.66 -44.57 90.2 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 121.039 0.447 . . . . 1.0 110.206 178.708 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . 0.443 ' O ' ' HG3' ' A' ' 215' ' ' LYS . . . -64.33 -43.75 96.43 Favored Glycine 0 C--N 1.335 0.479 0 C-N-CA 121.016 -0.612 . . . . 0.38 111.741 178.489 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 212' ' ' MET . . . . . 0.438 ' HA ' ' HD2' ' A' ' 215' ' ' LYS . 30.8 ttm -62.2 -37.69 86.27 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 120.719 0.295 . . . . 0.39 110.276 178.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.608 ' HG ' ' O ' ' A' ' 209' ' ' PHE . 97.4 mt -58.0 -43.93 86.9 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.169 -0.468 . . . . 0.52 110.068 177.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 214' ' ' ARG . . . . . 0.523 ' HD3' ' O ' ' A' ' 214' ' ' ARG . 0.0 OUTLIER -66.92 -32.01 72.98 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 115.855 -0.611 . . . . 0.8 110.401 178.755 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 215' ' ' LYS . . . . . 0.443 ' HG3' ' O ' ' A' ' 211' ' ' GLY . 89.7 mttt -70.32 -43.69 69.78 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 116.282 -0.417 . . . . 0.46 110.856 178.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 15.1 mt -72.8 164.23 26.89 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 121.159 0.504 . . . . 0.77 111.811 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -111.55 32.75 5.17 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 121.251 0.548 . . . . 1.04 110.999 179.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 218' ' ' ILE . . . . . 0.606 ' HA ' ' HB2' ' A' ' 223' ' ' ASP . 41.2 mm -57.15 108.38 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-N 115.746 -0.661 . . . . 0.37 111.992 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . 0.487 ' NZ ' ' HA ' ' A' ' 219' ' ' LYS . 0.4 OUTLIER -145.83 -82.6 0.14 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.843 0.354 . . . . 0.55 111.727 179.887 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 65.9 m-20 -87.49 -176.54 5.63 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.883 -0.599 . . . . 1.97 110.612 178.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . 0.515 ' O ' HG22 ' A' ' 224' ' ' VAL . 13.1 tm-20 -46.48 -31.16 2.55 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 122.975 0.51 . . . . 0.74 112.362 -179.804 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -55.12 -24.85 37.21 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 121.631 -0.319 . . . . 0.53 113.681 178.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 223' ' ' ASP . . . . . 0.606 ' HB2' ' HA ' ' A' ' 218' ' ' ILE . 0.5 OUTLIER -56.63 -36.11 69.1 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 112.741 0.645 . . . . 0.69 112.741 -179.047 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.544 ' HB ' HG21 ' A' ' 274' ' ' THR . 14.2 m -61.15 -29.77 46.44 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-O 120.823 0.344 . . . . 0.48 111.808 -179.521 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 30.6 mttp -72.81 -40.54 65.74 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.143 0.497 . . . . 0.64 109.892 179.132 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . 0.543 ' O ' HG23 ' A' ' 230' ' ' VAL . 53.4 p -70.73 -38.77 73.6 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.802 -0.635 . . . . 0.52 109.856 178.545 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 227' ' ' PHE . . . . . 0.634 ' O ' ' HG3' ' A' ' 231' ' ' MET . 10.3 t80 -65.11 -46.67 80.07 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 116.102 -0.499 . . . . 0.57 110.031 178.748 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 48.2 t -57.72 -40.12 78.87 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.373 -0.376 . . . . 0.48 110.153 178.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 3.1 ttp180 -56.88 -43.18 81.02 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.048 -0.524 . . . . 1.4 109.69 178.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 0.543 HG23 ' O ' ' A' ' 226' ' ' SER . 29.6 t -65.67 -49.59 76.68 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 CA-C-N 115.812 -0.631 . . . . 0.38 109.895 178.076 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 231' ' ' MET . . . . . 0.634 ' HG3' ' O ' ' A' ' 227' ' ' PHE . 68.3 mtp -54.38 -51.4 64.94 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 115.784 -0.644 . . . . 0.43 111.842 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 93.2 t -60.84 -39.9 83.4 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 CA-C-N 116.512 -0.313 . . . . 0.39 111.598 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -70.65 -37.66 73.75 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 120.751 -0.38 . . . . 0.54 110.973 179.368 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 230' ' ' VAL . 51.1 t -59.24 -36.03 61.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-O 121.206 0.527 . . . . 0.45 110.987 179.27 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 235' ' ' PHE . . . . . 0.468 ' HE2' HD22 ' A' ' 248' ' ' LEU . 86.2 m-85 -103.61 18.2 22.42 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.302 -0.408 . . . . 0.42 111.553 179.372 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 11.8 tptp -77.96 -9.52 59.14 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 120.941 0.4 . . . . 1.08 111.324 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 -70.23 -16.23 63.02 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.379 -0.373 . . . . 0.54 111.651 179.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 90.83 -1.86 78.91 Favored Glycine 0 CA--C 1.521 0.423 0 C-N-CA 120.748 -0.739 . . . . 0.64 112.504 -179.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 6.0 p -119.36 119.08 59.55 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 CA-C-O 121.509 0.671 . . . . 0.49 110.979 179.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 240' ' ' THR . . . . . 0.547 HG21 ' HG2' ' A' ' 283' ' ' LYS . 0.5 OUTLIER -93.71 83.38 4.43 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.152 -0.476 . . . . 0.52 112.2 -179.653 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -76.92 136.36 38.81 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.117 -0.492 . . . . 0.36 111.266 179.305 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 242' ' ' TRP . . . . . . . . . . . . . 6.0 m95 -53.93 -45.54 71.26 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.783 0.325 . . . . 0.39 111.0 179.126 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . 0.454 ' H ' ' HB2' ' B' ' 35' ' ' TYR . . . -57.39 -35.98 74.43 Favored Glycine 0 C--N 1.336 0.568 0 CA-C-N 116.068 -0.514 . . . . 0.27 112.823 179.134 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 84.0 mtt180 -68.25 -44.29 75.95 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 109.985 -0.376 . . . . 0.31 109.985 178.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . 0.657 HG23 HD11 ' A' ' 279' ' ' LEU . 98.5 mt -59.65 -51.36 73.69 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-N 115.954 -0.567 . . . . 0.42 110.518 178.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 59.6 t -63.07 -40.37 88.77 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 CA-C-N 116.164 -0.471 . . . . 0.37 111.07 178.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 23.5 m -60.63 -41.07 94.14 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 120.81 0.338 . . . . 0.36 110.432 179.011 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 248' ' ' LEU . . . . . 0.468 HD22 ' HE2' ' A' ' 235' ' ' PHE . 21.0 tp -64.2 -38.49 91.23 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 121.102 0.477 . . . . 0.62 109.914 178.191 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 249' ' ' ILE . . . . . 0.678 HD11 HD22 ' A' ' 279' ' ' LEU . 47.6 mm -68.2 -41.72 84.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-N 116.091 -0.504 . . . . 0.45 109.952 178.155 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 65.6 m -62.6 -43.95 97.52 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.026 -0.534 . . . . 0.37 109.653 178.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 251' ' ' PHE . . . . . 0.527 ' O ' HG23 ' A' ' 255' ' ' VAL . 29.9 t80 -62.44 -43.16 99.47 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 115.722 -0.672 . . . . 0.37 109.375 177.76 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -56.5 -47.83 80.87 Favored Glycine 0 C--N 1.338 0.666 0 N-CA-C 111.091 -0.803 . . . . 0.26 111.091 178.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -59.12 -42.2 89.99 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-O 120.573 0.225 . . . . 0.29 110.557 177.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 254' ' ' PHE . . . . . 0.454 ' CD2' HD11 ' A' ' 213' ' ' LEU . 5.8 t80 -63.81 -40.06 95.73 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.487 -0.324 . . . . 0.53 110.648 178.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 255' ' ' VAL . . . . . 0.527 HG23 ' O ' ' A' ' 251' ' ' PHE . 84.8 t -63.64 -43.8 98.27 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 N-CA-C 109.297 -0.631 . . . . 0.41 109.297 177.426 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -62.82 -34.55 77.54 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 115.81 -0.632 . . . . 0.28 109.992 178.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 257' ' ' LYS . . . . . 0.463 ' HG3' ' O ' ' A' ' 171' ' ' ALA . 30.4 tttp -66.7 -46.08 76.72 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 115.385 -0.825 . . . . 0.62 110.163 178.248 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 14.4 t60 -62.1 -42.41 99.2 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 115.827 -0.624 . . . . 0.65 109.393 178.29 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 4.7 mp -67.27 -35.5 79.63 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.012 -0.54 . . . . 0.48 110.846 178.332 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.71 -34.53 77.35 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.533 -0.303 . . . . 0.6 111.018 178.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 24.0 p -62.45 -20.07 64.15 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 120.684 0.278 . . . . 0.74 111.591 179.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 262' ' ' VAL . . . . . 0.451 HG23 ' HG3' ' A' ' 264' ' ' GLN . 13.8 m -117.03 18.82 7.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-O 120.92 0.39 . . . . 0.67 111.073 178.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 65.1 m-80 56.98 46.39 19.53 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 113.8 1.037 . . . . 1.45 113.8 179.171 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 264' ' ' GLN . . . . . 0.451 ' HG3' HG23 ' A' ' 262' ' ' VAL . 12.6 mt-30 -99.29 36.64 1.7 Allowed 'General case' 0 CA--C 1.536 0.423 0 O-C-N 121.884 -0.51 . . . . 0.43 111.491 179.074 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . 0.431 ' HA ' HD12 ' A' ' 268' ' ' ILE . 11.4 tp10 -53.9 -42.1 68.35 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 120.91 0.386 . . . . 0.41 111.653 -179.718 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 30.9 t -61.06 -14.94 27.25 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.128 -0.487 . . . . 0.46 111.729 179.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 267' ' ' PHE . . . . . 0.487 ' C ' ' HD2' ' A' ' 270' ' ' PRO . 71.7 m-85 -101.21 -21.27 14.97 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 121.15 0.5 . . . . 0.78 110.064 178.703 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 268' ' ' ILE . . . . . 0.431 HD12 ' HA ' ' A' ' 265' ' ' GLU . 76.1 mt -67.42 -37.19 78.47 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 CA-C-N 115.851 -0.613 . . . . 0.45 109.891 178.462 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 269' ' ' GLU . . . . . 0.729 ' HB2' ' HD3' ' A' ' 270' ' ' PRO . 9.1 mm-40 -56.63 -57.82 21.21 Favored Pre-proline 0 CA--C 1.548 0.876 0 CA-C-N 116.383 -0.372 . . . . 0.44 111.025 178.623 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 270' ' ' PRO . . . . . 0.729 ' HD3' ' HB2' ' A' ' 269' ' ' GLU . 35.1 Cg_exo -63.22 -30.19 74.12 Favored 'Trans proline' 0 C--N 1.365 1.403 0 C-N-CA 122.322 2.014 . . . . 0.33 112.122 178.58 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 271' ' ' LEU . . . . . . . . . . . . . 56.7 tp -67.09 -50.86 60.23 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 109.72 -0.474 . . . . 0.46 109.72 178.425 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -62.49 -36.52 82.76 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 115.948 -0.569 . . . . 0.33 110.456 178.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 273' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -63.13 -48.89 76.6 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.142 -0.481 . . . . 0.4 109.724 178.009 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 274' ' ' THR . . . . . 0.544 HG21 ' HB ' ' A' ' 224' ' ' VAL . 62.7 m -62.72 -48.54 78.77 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.863 -0.608 . . . . 0.36 110.853 178.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 275' ' ' ILE . . . . . 0.466 ' HA ' ' HE1' ' A' ' 231' ' ' MET . 92.1 mt -54.78 -51.9 47.52 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.157 0 CA-C-N 116.135 -0.484 . . . . 0.34 111.106 179.42 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 276' ' ' THR . . . . . 0.542 HG23 HD12 ' A' ' 163' ' ' ILE . 40.8 m -60.49 -51.23 70.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.277 -0.42 . . . . 0.29 111.193 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 277' ' ' ASP . . . . . 0.526 ' OD1' ' HD2' ' A' ' 281' ' ' ARG . 25.9 t0 -55.09 -58.26 8.37 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.129 -0.487 . . . . 0.9 111.61 179.807 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 95.4 t -58.41 -41.8 82.46 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 CA-C-O 120.795 0.331 . . . . 0.36 111.58 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . 0.678 HD22 HD11 ' A' ' 249' ' ' ILE . 12.2 tp -61.77 -47.74 83.79 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 112.219 0.452 . . . . 0.64 112.219 -179.578 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 46.5 t -79.31 -42.81 23.64 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 N-CA-C 112.612 0.597 . . . . 0.35 112.612 -178.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 281' ' ' ARG . . . . . 0.526 ' HD2' ' OD1' ' A' ' 277' ' ' ASP . 0.4 OUTLIER -58.8 -33.53 70.46 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 112.326 0.491 . . . . 1.18 112.326 -179.336 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 282' ' ' THR . . . . . . . . . . . . . 48.4 p -85.84 -1.62 57.43 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 111.772 0.286 . . . . 0.34 111.772 179.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . 0.547 ' HG2' HG21 ' A' ' 240' ' ' THR . 32.8 mttp -141.22 34.11 1.7 Allowed 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.572 -0.286 . . . . 0.42 111.391 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 48.9 mtp180 -53.83 -62.24 1.78 Allowed 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 112.573 0.582 . . . . 0.45 112.573 -178.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 285' ' ' ASP . . . . . 0.494 ' O ' ' HE2' ' A' ' 289' ' ' LYS . 8.7 p-10 -65.63 -37.65 87.19 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.168 -0.469 . . . . 0.46 110.901 -179.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 286' ' ' TRP . . . . . 0.516 ' CZ2' ' HG2' ' A' ' 290' ' ' GLN . 71.9 t90 -62.4 -40.5 96.7 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.425 -0.352 . . . . 0.38 110.912 179.653 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 287' ' ' LEU . . . . . 0.537 HD13 ' HA2' ' A' ' 292' ' ' GLY . 0.8 OUTLIER -60.71 -48.36 82.14 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 111.971 0.36 . . . . 0.42 111.971 179.749 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 9.5 p -69.35 -32.16 52.32 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 C-N-CA 120.481 -0.487 . . . . 0.52 111.453 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 289' ' ' LYS . . . . . 0.494 ' HE2' ' O ' ' A' ' 285' ' ' ASP . 39.8 mtmt -75.97 -40.3 54.21 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 112.775 0.657 . . . . 0.73 112.775 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 290' ' ' GLN . . . . . 0.516 ' HG2' ' CZ2' ' A' ' 286' ' ' TRP . 1.6 mp0 -87.82 29.87 0.88 Allowed 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 114.278 1.214 . . . . 0.7 114.278 -177.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 291' ' ' ARG . . . . . 0.621 ' HG2' ' HB2' ' A' ' 294' ' ' ASP . 1.9 ttt180 60.74 19.7 9.79 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 112.762 0.653 . . . . 0.47 112.762 178.435 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 292' ' ' GLY . . . . . 0.537 ' HA2' HD13 ' A' ' 287' ' ' LEU . . . 42.34 -135.52 3.76 Favored Glycine 0 CA--C 1.527 0.788 0 N-CA-C 115.363 0.905 . . . . 0.35 115.363 178.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 293' ' ' TRP . . . . . 0.588 ' O ' HG23 ' A' ' 297' ' ' VAL . 97.2 m95 -64.46 -37.41 87.44 Favored 'General case' 0 C--O 1.226 -0.133 0 CA-C-N 115.428 -0.386 . . . . 0.55 111.058 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 294' ' ' ASP . . . . . 0.621 ' HB2' ' HG2' ' A' ' 291' ' ' ARG . 0.9 OUTLIER -53.8 -46.91 71.22 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 121.176 0.512 . . . . 0.63 110.195 179.023 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -65.79 -39.3 95.1 Favored Glycine 0 CA--C 1.523 0.56 0 C-N-CA 120.884 -0.674 . . . . 0.29 111.835 178.324 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 296' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -64.05 -36.15 83.07 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 120.799 0.333 . . . . 0.33 110.937 179.131 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 297' ' ' VAL . . . . . 0.9 HG11 ' HD3' ' A' ' 189' ' ' ARG . 77.8 t -64.99 -54.16 32.84 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 CA-C-N 116.202 -0.454 . . . . 0.34 111.65 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -69.71 -23.16 63.38 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 112.312 0.486 . . . . 0.42 112.312 -179.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 299' ' ' PHE . . . . . . . . . . . . . 88.2 t80 -70.12 -52.68 21.74 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 111.694 0.257 . . . . 0.46 111.694 179.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 300' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -85.08 30.18 0.61 Allowed 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 120.827 0.346 . . . . 0.41 111.67 -179.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 2.6 m170 -152.8 -169.28 3.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.246 0.546 . . . . 0.5 111.352 -179.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 5.4 p -99.87 164.65 2.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-N 115.866 -0.606 . . . . 0.59 110.343 179.474 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 303' ' ' GLN . . . . . 0.682 ' HB3' ' HA2' ' A' ' 307' ' ' GLY . 62.5 mt-30 -131.04 117.49 19.23 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.93 0.395 . . . . 0.61 111.532 -179.522 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -124.64 -79.26 0.61 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.055 -0.521 . . . . 0.9 109.967 179.018 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 96.1 mt -84.1 -15.33 47.73 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.414 0.626 . . . . 0.93 109.799 178.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.88 20.49 17.49 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.221 -0.9 . . . . 0.55 111.123 179.708 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 307' ' ' GLY . . . . . 0.682 ' HA2' ' HB3' ' A' ' 303' ' ' GLN . . . -75.93 57.42 3.11 Favored Glycine 0 CA--C 1.524 0.652 0 C-N-CA 120.966 -0.635 . . . . 0.67 113.507 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 308' ' ' GLY . . . . . 0.421 ' C ' HH12 ' A' ' 291' ' ' ARG . . . . . . . . 0 C--O 1.246 0.906 0 CA-C-O 118.907 -0.941 . . . . 0.95 112.715 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 121.269 0.557 . . . . 1.53 110.857 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.53 -77.68 0.23 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.539 -0.755 . . . . 1.19 111.275 -179.032 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 19' ' ' LEU . . . . . 0.57 HD23 ' HD2' ' B' ' 20' ' ' PRO . 0.8 OUTLIER -99.15 117.98 63.29 Favored Pre-proline 0 C--O 1.234 0.261 0 CA-C-N 116.52 -0.309 . . . . 0.74 111.497 -179.749 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 20' ' ' PRO . . . . . 0.57 ' HD2' HD23 ' B' ' 19' ' ' LEU . 18.8 Cg_endo -57.78 136.84 77.96 Favored 'Trans proline' 0 CA--C 1.534 0.482 0 C-N-CA 122.874 2.383 . . . . 0.78 112.258 179.087 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 21' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -71.15 40.4 0.37 Allowed 'Trans proline' 0 CA--C 1.537 0.638 0 C-N-CA 122.808 2.339 . . . . 1.12 113.683 -179.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -87.46 -30.42 20.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.7 -0.227 . . . . 0.68 111.096 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 23' ' ' PHE . . . . . 0.513 ' HE2' HD22 ' B' ' 19' ' ' LEU . 0.8 OUTLIER -58.29 -40.16 81.23 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.276 0.56 . . . . 0.48 110.715 179.125 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -70.52 -40.33 73.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.008 -0.542 . . . . 0.32 110.427 178.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . 0.433 ' O ' ' HB3' ' B' ' 28' ' ' ARG . . . -64.15 -37.38 87.24 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 116.133 -0.485 . . . . 0.33 110.808 178.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -62.74 -54.26 41.85 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.012 -0.54 . . . . 0.5 110.419 178.72 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 95.9 mt -58.96 -34.36 71.71 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.134 0.492 . . . . 0.35 109.833 178.167 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 28' ' ' ARG . . . . . 0.433 ' HB3' ' O ' ' B' ' 25' ' ' ALA . 1.1 ttt180 -59.84 -51.04 71.44 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 115.43 -0.805 . . . . 0.58 110.111 177.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -67.66 -40.14 84.53 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.304 -0.407 . . . . 0.89 111.264 179.157 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 96.5 mt -62.68 -46.9 95.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-O 120.962 0.41 . . . . 0.43 110.318 178.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.35 -48.34 86.47 Favored Glycine 0 N--CA 1.45 -0.419 0 CA-C-N 115.72 -0.673 . . . . 0.27 112.871 179.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -64.6 -37.87 89.06 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.917 0.359 . . . . 0.47 111.548 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 33' ' ' LYS . . . . . 0.404 ' HE2' ' HB2' ' B' ' 33' ' ' LYS . 20.7 ttmm -63.72 -47.78 79.73 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-O 121.121 0.486 . . . . 1.21 110.255 178.573 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 55.5 t -65.06 -46.69 90.59 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 CA-C-N 115.844 -0.616 . . . . 0.48 110.532 178.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 35' ' ' TYR . . . . . 0.454 ' HB2' ' H ' ' A' ' 243' ' ' GLY . 1.3 t80 -56.08 -48.54 75.9 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 115.824 -0.625 . . . . 0.83 111.743 179.668 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 36' ' ' CYS . . . . . . . . . . . . . 84.2 m -64.51 -35.35 80.67 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 120.812 0.339 . . . . 0.58 111.543 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 63.1 m -67.92 -40.99 83.29 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 112.227 0.455 . . . . 0.66 112.227 -179.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 38' ' ' TRP . . . . . . . . . . . . . 97.8 m95 -87.41 -18.54 29.74 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.498 0.555 . . . . 0.7 112.498 -179.19 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 28.8 t -70.55 -18.2 62.93 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 112.054 0.39 . . . . 0.89 112.054 179.49 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.39 118.45 56.73 Favored Pre-proline 0 CA--C 1.533 0.307 0 CA-C-O 120.763 0.316 . . . . 0.89 111.363 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -80.36 -13.84 12.11 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.688 2.259 . . . . 1.8 113.075 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -77.02 80.04 3.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.119 -0.491 . . . . 1.67 111.026 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 43' ' ' MET . . . . . . . . . . . . . 24.3 mmt . . . . . 0 C--O 1.251 1.146 0 CA-C-O 118.345 -0.836 . . . . 2.41 111.313 -179.871 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.238 0 N-CA-C 112.535 -0.226 . . . . 0.6 112.535 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -64.55 -28.44 61.48 Favored 'Trans proline' 0 CA--C 1.536 0.61 0 C-N-CA 122.658 2.239 . . . . 0.8 113.073 179.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.422 ' HB3' ' OD1' ' A' ' 153' ' ' ASP . 43.2 tp -119.09 -69.39 0.85 Allowed 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 120.841 0.353 . . . . 0.85 110.967 179.577 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -148.78 -100.05 0.22 Allowed Glycine 0 CA--C 1.518 0.265 0 C-N-CA 120.521 -0.847 . . . . 0.69 112.55 179.387 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.52 ' HB2' HG21 ' A' ' 288' ' ' VAL . 17.6 p -126.71 -30.64 2.77 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.088 0.471 . . . . 0.43 110.957 179.432 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 52.7 tt0 -58.48 -47.41 84.17 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.816 -0.629 . . . . 0.39 111.704 179.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . 0.534 ' O ' ' HG3' ' A' ' 157' ' ' ARG . 0.1 OUTLIER -49.84 -52.03 35.59 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 115.655 -0.702 . . . . 0.54 112.711 -179.839 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 -60.88 -43.66 98.13 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.185 0.517 . . . . 0.46 111.391 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.558 HD21 ' HB3' ' A' ' 287' ' ' LEU . 27.1 tp -63.89 -49.35 73.04 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.754 -0.657 . . . . 0.88 110.231 179.377 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 44.4 t80 -58.8 -43.57 90.55 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 115.885 -0.598 . . . . 0.42 111.45 179.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.682 ' HD2' ' OE2' ' A' ' 182' ' ' GLU . 51.5 mtm180 -60.08 -52.71 64.21 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.698 0.285 . . . . 0.4 111.13 179.556 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 29.0 mt-30 -63.05 -45.27 93.01 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.541 -0.3 . . . . 0.54 110.781 179.155 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . 0.543 ' HA ' ' CZ2' ' A' ' 293' ' ' TRP . 21.1 m -58.93 -56.92 16.0 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.384 -0.371 . . . . 0.27 111.375 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.695 HD11 ' HG2' ' A' ' 273' ' ' GLU . 12.7 tp -54.55 -48.88 71.49 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.751 -0.204 . . . . 0.77 111.474 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . 0.533 ' OE2' ' HB3' ' A' ' 180' ' ' LEU . 0.1 OUTLIER -57.49 -54.25 48.93 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 111.85 0.315 . . . . 0.74 111.85 179.889 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 74.7 mt -62.28 -43.43 98.0 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 N-CA-C 111.871 0.323 . . . . 0.33 111.871 -179.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.644 ' O ' ' HG ' ' A' ' 167' ' ' LEU . 87.0 mt -64.43 -48.42 85.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 N-CA-C 110.225 -0.287 . . . . 0.35 110.225 179.211 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 6.8 t -58.42 -44.63 89.18 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.409 -0.36 . . . . 0.31 110.282 178.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . 0.432 HH11 ' HD2' ' A' ' 165' ' ' ARG . 2.6 mmt180 -59.12 -51.98 67.71 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.121 -0.491 . . . . 0.38 111.89 178.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' TYR . . . . . 0.711 ' CE1' ' HA ' ' A' ' 195' ' ' ARG . 51.6 t80 -60.57 -49.77 76.22 Favored 'General case' 0 CA--C 1.527 0.085 0 N-CA-C 112.399 0.518 . . . . 0.45 112.399 -179.042 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.644 ' HG ' ' O ' ' A' ' 163' ' ' ILE . 11.8 mt -67.14 -33.74 76.08 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 120.225 -0.59 . . . . 0.36 111.293 -178.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 21.5 ttp180 -69.75 -52.62 23.77 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 111.803 0.297 . . . . 0.43 111.803 179.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -61.65 -48.41 80.99 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 111.838 0.31 . . . . 0.28 111.838 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.36 -40.73 91.85 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.09 -0.505 . . . . 0.32 112.12 -179.726 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.447 ' HB1' ' HB2' ' A' ' 260' ' ' LYS . . . -75.76 -34.96 60.29 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 112.114 0.413 . . . . 0.32 112.114 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 83.4 m -71.15 -41.29 70.62 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 112.0 0.37 . . . . 0.48 112.0 -179.486 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 104.88 10.14 33.2 Favored Glycine 0 CA--C 1.52 0.391 0 C-N-CA 120.591 -0.814 . . . . 0.56 112.48 -179.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 32.6 t -129.36 121.05 26.63 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.985 -0.376 . . . . 0.6 109.985 179.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 4.7 tmtm? -102.09 135.54 43.5 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.238 0.542 . . . . 0.5 112.445 -178.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -108.06 143.05 37.32 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 115.734 -0.666 . . . . 0.43 110.705 179.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 4.9 t -107.0 -3.18 20.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.934 0.397 . . . . 0.67 111.917 -179.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . 0.481 ' HB3' ' HD2' ' A' ' 179' ' ' PRO . 7.0 mtmp? -79.55 162.99 61.16 Favored Pre-proline 0 CA--C 1.537 0.448 0 CA-C-O 120.709 0.29 . . . . 0.98 111.587 -179.701 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . 0.481 ' HD2' ' HB3' ' A' ' 178' ' ' LYS . 40.2 Cg_endo -67.51 170.64 13.26 Favored 'Trans proline' 0 CA--C 1.535 0.569 0 C-N-CA 122.358 2.039 . . . . 0.55 113.275 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.619 ' HB2' ' O ' ' A' ' 183' ' ' ALA . 10.5 mp -94.24 -168.69 1.9 Allowed 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 115.955 -0.566 . . . . 0.49 111.034 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -74.85 -54.25 5.95 Favored Glycine 0 C--N 1.331 0.294 0 C-N-CA 120.65 -0.786 . . . . 0.49 112.131 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . 0.682 ' OE2' ' HD2' ' A' ' 157' ' ' ARG . 31.5 mt-10 -108.05 -42.91 4.53 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.388 0.614 . . . . 0.42 109.671 179.065 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.619 ' O ' ' HB2' ' A' ' 180' ' ' LEU . . . -82.62 79.21 9.1 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 115.794 -0.639 . . . . 0.35 110.768 179.128 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -78.74 -71.01 1.27 Allowed Glycine 0 CA--C 1.524 0.655 0 C-N-CA 120.617 -0.801 . . . . 0.35 113.993 -179.242 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -70.78 -55.43 8.6 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-O 120.923 0.392 . . . . 0.4 111.189 -179.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -63.51 -35.56 80.85 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 116.064 -0.516 . . . . 0.34 110.369 178.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . 0.561 ' HA3' ' O ' ' A' ' 183' ' ' ALA . . . -64.32 -34.83 90.98 Favored Glycine 0 C--N 1.336 0.559 0 CA-C-N 116.017 -0.538 . . . . 0.31 112.648 179.464 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 1.2 mmm-85 -68.04 -57.84 5.47 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 109.589 -0.523 . . . . 0.6 109.589 178.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . 0.521 ' HB3' HG11 ' A' ' 297' ' ' VAL . 44.5 mtp180 -56.73 -48.34 77.97 Favored 'General case' 0 C--O 1.226 -0.176 0 CA-C-N 115.53 -0.759 . . . . 0.7 111.2 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.604 ' O ' ' HB2' ' A' ' 194' ' ' LEU . . . -60.85 -37.74 83.11 Favored 'General case' 0 C--O 1.224 -0.265 0 N-CA-C 111.849 0.314 . . . . 0.28 111.849 -179.583 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . 0.484 ' HB2' ' O ' ' A' ' 187' ' ' GLY . 7.8 tp -66.46 -42.5 87.49 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.95 0.405 . . . . 0.65 110.385 179.199 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -66.33 -46.81 75.57 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.069 -0.514 . . . . 0.32 110.573 178.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . 0.581 HG21 ' HA ' ' A' ' 297' ' ' VAL . 5.6 m -62.34 -43.87 97.8 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.985 0.421 . . . . 0.27 109.936 178.266 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 0.604 ' HB2' ' O ' ' A' ' 190' ' ' ALA . 6.4 tp -62.2 -43.55 98.58 Favored 'General case' 0 C--O 1.224 -0.278 0 CA-C-N 115.585 -0.734 . . . . 0.4 110.672 178.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . 0.711 ' HA ' ' CE1' ' A' ' 166' ' ' TYR . 0.0 OUTLIER -65.01 -38.34 90.61 Favored 'General case' 0 C--O 1.224 -0.271 0 CA-C-O 121.292 0.568 . . . . 0.75 110.37 178.939 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . 0.43 ' HG2' ' CD2' ' A' ' 301' ' ' HIS . 0.9 OUTLIER -67.5 -60.06 2.87 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.968 -0.56 . . . . 0.37 112.076 -179.739 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 7.0 t -71.19 -45.69 69.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 111.836 0.31 . . . . 0.36 111.836 -178.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -57.21 -45.17 92.93 Favored Glycine 0 CA--C 1.522 0.514 0 C-N-CA 121.465 -0.398 . . . . 0.29 113.538 -179.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . 0.515 ' O ' ' HB2' ' A' ' 203' ' ' ARG . 2.7 m-20 -73.92 -32.58 63.59 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 117.059 0.43 . . . . 0.49 110.713 179.725 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -68.85 -48.42 48.79 Favored Glycine 0 CA--C 1.524 0.653 0 C-N-CA 120.946 -0.645 . . . . 0.29 112.677 178.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . . . . . . . . . 76.7 t -61.36 -48.69 87.72 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-N 116.745 0.272 . . . . 0.37 111.123 179.413 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 202' ' ' GLN . . . . . 0.41 ' HB2' ' CD1' ' A' ' 254' ' ' PHE . 7.2 pt20 -62.33 -32.58 73.36 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.369 -0.378 . . . . 0.38 111.397 179.727 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 203' ' ' ARG . . . . . 0.515 ' HB2' ' O ' ' A' ' 199' ' ' ASP . 0.0 OUTLIER -77.46 -38.95 48.29 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-O 120.712 0.291 . . . . 0.61 111.027 179.532 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -71.44 -52.37 18.85 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 116.226 -0.443 . . . . 0.39 111.449 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 33.4 m-70 -97.27 36.25 1.49 Allowed 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 120.863 0.363 . . . . 0.41 110.855 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -58.16 -37.62 75.05 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 113.038 0.755 . . . . 0.72 113.038 -178.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 4.1 t -56.89 -37.28 71.16 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 120.931 0.396 . . . . 0.5 111.902 -179.156 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -75.06 -43.42 53.43 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 121.124 0.487 . . . . 0.41 111.001 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 209' ' ' PHE . . . . . 0.418 ' O ' ' HB2' ' A' ' 213' ' ' LEU . 56.2 m-85 -66.56 -39.18 88.37 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 115.871 -0.604 . . . . 0.43 110.943 179.748 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 210' ' ' GLN . . . . . 0.406 ' O ' ' HG2' ' A' ' 214' ' ' ARG . 0.6 OUTLIER -64.7 -45.25 87.42 Favored 'General case' 0 C--O 1.222 -0.371 0 CA-C-N 116.515 -0.311 . . . . 0.67 111.251 179.634 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -56.77 -48.43 78.05 Favored Glycine 0 CA--C 1.523 0.564 0 C-N-CA 120.251 -0.976 . . . . 0.31 111.766 178.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 212' ' ' MET . . . . . 0.546 ' O ' ' HB2' ' A' ' 216' ' ' LEU . 49.2 mtp -67.06 -34.0 76.73 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 115.637 -0.281 . . . . 0.77 111.296 178.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.602 HD21 ' HB2' ' A' ' 258' ' ' HIS . 1.0 OUTLIER -75.73 -37.61 59.22 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 112.205 0.446 . . . . 0.41 112.205 -179.949 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 214' ' ' ARG . . . . . 0.406 ' HG2' ' O ' ' A' ' 210' ' ' GLN . 33.2 mmt180 -64.12 -35.14 79.78 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.89 0.376 . . . . 1.12 110.079 179.028 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 215' ' ' LYS . . . . . 0.52 ' HE2' ' HA ' ' A' ' 215' ' ' LYS . 0.0 OUTLIER -95.7 12.51 29.61 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 121.171 0.51 . . . . 0.66 110.585 177.91 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.634 ' HG ' HG13 ' A' ' 218' ' ' ILE . 10.1 tp -93.84 99.22 11.63 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.211 -0.45 . . . . 0.49 110.934 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -93.94 33.25 1.35 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.261 -0.427 . . . . 0.84 110.985 179.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 218' ' ' ILE . . . . . 0.634 HG13 ' HG ' ' A' ' 216' ' ' LEU . 16.1 mt -61.86 108.52 0.52 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.495 0 CA-C-O 121.748 0.785 . . . . 0.49 111.826 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 1.6 ttpm? -161.61 17.51 0.1 Allowed 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 114.945 -1.025 . . . . 1.86 110.878 -179.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -139.04 160.75 39.03 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-O 120.864 0.364 . . . . 0.56 111.397 -179.088 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -62.51 -22.99 66.7 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.015 0.436 . . . . 0.76 111.733 179.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -74.7 -26.04 68.29 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 120.94 -0.648 . . . . 0.59 113.508 179.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 223' ' ' ASP . . . . . 0.424 ' HB3' HG12 ' A' ' 218' ' ' ILE . 71.9 m-20 -61.65 -43.97 97.84 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 113.011 0.745 . . . . 0.79 113.011 -178.795 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.522 HG23 ' HD2' ' A' ' 225' ' ' LYS . 29.9 m -59.86 -28.71 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 N-CA-C 112.123 0.416 . . . . 0.6 112.123 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . 0.522 ' HD2' HG23 ' A' ' 224' ' ' VAL . 11.9 mptt -64.28 -42.05 96.62 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 121.318 0.58 . . . . 0.9 109.847 178.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . 0.603 ' O ' HG23 ' A' ' 230' ' ' VAL . 3.5 m -71.0 -38.72 72.69 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.787 -0.642 . . . . 0.86 109.577 178.032 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 227' ' ' PHE . . . . . 0.492 ' HE1' HG12 ' A' ' 275' ' ' ILE . 8.8 t80 -56.02 -43.83 78.16 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 115.84 -0.618 . . . . 0.57 109.863 177.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 228' ' ' SER . . . . . 0.417 ' O ' HG23 ' A' ' 232' ' ' VAL . 39.2 m -61.59 -44.54 96.83 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.634 -0.712 . . . . 0.37 110.022 178.067 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 229' ' ' ARG . . . . . 0.491 ' NH1' ' HA ' ' A' ' 226' ' ' SER . 4.2 ttm105 -61.01 -38.86 87.55 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 115.806 -0.634 . . . . 0.82 110.935 178.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 0.603 HG23 ' O ' ' A' ' 226' ' ' SER . 97.0 t -55.88 -52.56 47.8 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-N 116.164 -0.471 . . . . 0.39 110.587 178.683 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 231' ' ' MET . . . . . 0.628 ' HG2' HD22 ' A' ' 248' ' ' LEU . 72.3 mtm -59.98 -38.0 81.25 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.07 -0.514 . . . . 0.41 111.471 179.405 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 232' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 228' ' ' SER . 84.6 t -62.76 -42.49 96.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-O 120.771 0.319 . . . . 0.4 110.812 179.151 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 233' ' ' HIS . . . . . 0.432 ' HB3' ' HB1' ' B' ' 24' ' ' ALA . 48.7 t-80 -63.44 -35.61 81.01 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 120.84 0.353 . . . . 0.44 111.164 179.166 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 97.2 t -63.16 -38.19 81.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-O 121.114 0.483 . . . . 0.36 111.42 179.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 235' ' ' PHE . . . . . 0.522 ' HE2' HD11 ' A' ' 248' ' ' LEU . 62.2 m-85 -103.54 23.89 11.93 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.271 -0.422 . . . . 0.54 111.517 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 3.9 ttpp -69.83 -1.4 9.26 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 113.297 0.851 . . . . 0.76 113.297 -178.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 6.2 p30 -102.87 -16.13 15.99 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.949 0.404 . . . . 0.4 111.038 179.377 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 94.19 -6.48 72.19 Favored Glycine 0 CA--C 1.522 0.487 0 C-N-CA 120.905 -0.664 . . . . 0.33 112.605 -179.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 7.9 t -81.01 112.01 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.139 0 CA-C-O 121.157 0.504 . . . . 0.31 111.199 -179.306 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 240' ' ' THR . . . . . 0.438 ' HB ' ' CE2' ' A' ' 286' ' ' TRP . 1.2 m -94.43 101.62 13.55 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 120.777 -0.369 . . . . 0.31 111.444 179.505 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -110.31 139.08 45.86 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.396 -0.366 . . . . 0.88 110.713 179.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 242' ' ' TRP . . . . . 0.588 ' HB3' ' CE2' ' A' ' 300' ' ' PHE . 16.0 m95 -57.98 -42.82 85.91 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 120.625 0.25 . . . . 0.41 111.446 179.443 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . 0.455 ' H ' ' HB2' ' B' ' 35' ' ' TYR . . . -60.26 -28.83 67.53 Favored Glycine 0 CA--C 1.522 0.514 0 C-N-CA 121.306 -0.473 . . . . 0.27 112.775 178.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 244' ' ' ARG . . . . . 0.449 ' O ' ' HG ' ' A' ' 248' ' ' LEU . 94.3 mtt180 -71.42 -46.86 59.08 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.349 -0.612 . . . . 0.36 109.349 178.422 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 74.8 mt -60.93 -45.45 98.32 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-N 115.376 -0.829 . . . . 0.42 111.074 179.365 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 242' ' ' TRP . 61.3 t -62.52 -40.62 88.87 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-O 120.608 0.242 . . . . 0.49 111.015 179.269 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 55.1 m -57.67 -40.8 80.2 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.479 -0.328 . . . . 0.33 110.756 179.278 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 248' ' ' LEU . . . . . 0.628 HD22 ' HG2' ' A' ' 231' ' ' MET . 69.8 mt -61.63 -36.71 81.54 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 121.047 0.451 . . . . 0.45 110.298 178.229 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 29.5 mm -74.23 -38.98 48.99 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.133 0 CA-C-N 116.292 -0.413 . . . . 0.37 110.107 178.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 16.5 t -60.76 -42.77 98.09 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 108.921 -0.77 . . . . 0.27 108.921 178.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 251' ' ' PHE . . . . . 0.517 ' O ' HG23 ' A' ' 255' ' ' VAL . 19.7 t80 -64.85 -42.85 94.57 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 108.599 -0.889 . . . . 0.45 108.599 176.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -56.65 -40.31 87.86 Favored Glycine 0 C--N 1.337 0.616 0 N-CA-C 111.434 -0.667 . . . . 0.26 111.434 177.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -63.05 -37.48 87.36 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 120.956 0.408 . . . . 0.29 110.539 177.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 254' ' ' PHE . . . . . 0.418 ' HD2' HD13 ' A' ' 213' ' ' LEU . 0.2 OUTLIER -69.71 -38.9 77.1 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.066 -0.515 . . . . 0.75 109.952 178.329 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 255' ' ' VAL . . . . . 0.615 ' O ' ' HG ' ' A' ' 259' ' ' LEU . 59.8 t -67.53 -42.33 86.82 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.209 0 CA-C-N 116.079 -0.509 . . . . 0.31 109.719 178.281 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -57.96 -43.55 86.48 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 109.525 -0.546 . . . . 0.28 109.525 177.076 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 60.8 mttt -62.55 -43.45 98.78 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.7 -0.682 . . . . 0.5 109.982 177.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 258' ' ' HIS . . . . . 0.602 ' HB2' HD21 ' A' ' 213' ' ' LEU . 36.0 t60 -61.63 -44.38 97.1 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.935 -0.575 . . . . 0.87 110.465 178.534 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.615 ' HG ' ' O ' ' A' ' 255' ' ' VAL . 80.3 mt -67.42 -47.21 70.9 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 115.906 -0.588 . . . . 0.49 110.917 179.475 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 260' ' ' LYS . . . . . 0.447 ' HB2' ' HB1' ' A' ' 171' ' ' ALA . 0.5 OUTLIER -61.74 -32.49 72.74 Favored 'General case' 0 CA--C 1.535 0.369 0 O-C-N 122.386 -0.196 . . . . 0.6 110.99 179.526 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 69.3 m -60.95 -31.13 70.69 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.108 0.48 . . . . 0.47 110.588 178.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 28.4 m -110.18 20.66 5.82 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 CA-C-N 115.888 -0.597 . . . . 0.52 110.907 179.195 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 55.01 51.1 14.06 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 115.609 -0.723 . . . . 1.1 112.927 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -106.93 36.15 2.76 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.489 -0.323 . . . . 0.57 111.55 179.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . 0.487 ' HA ' HD12 ' A' ' 268' ' ' ILE . 0.8 OUTLIER -51.42 -38.91 55.98 Favored 'General case' 0 C--O 1.242 0.659 0 CA-C-O 120.922 0.391 . . . . 0.82 111.943 179.614 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 36.0 p -64.38 -12.93 47.59 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.787 -0.642 . . . . 0.7 111.537 179.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 267' ' ' PHE . . . . . 0.464 ' C ' ' HD2' ' A' ' 270' ' ' PRO . 14.9 t80 -105.3 -25.19 12.52 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.626 -0.509 . . . . 0.78 109.626 178.327 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 268' ' ' ILE . . . . . 0.487 HD12 ' HA ' ' A' ' 265' ' ' GLU . 70.3 mt -59.8 -50.01 81.68 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-N 115.957 -0.565 . . . . 0.4 110.947 179.055 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 269' ' ' GLU . . . . . 0.709 ' HB3' ' HD3' ' A' ' 270' ' ' PRO . 1.2 tp10 -57.03 -55.63 41.94 Favored Pre-proline 0 CA--C 1.547 0.853 0 C-N-CA 120.812 -0.355 . . . . 0.81 110.487 179.109 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 270' ' ' PRO . . . . . 0.709 ' HD3' ' HB3' ' A' ' 269' ' ' GLU . 52.1 Cg_exo -58.86 -29.71 90.88 Favored 'Trans proline' 0 C--N 1.364 1.378 0 C-N-CA 122.464 2.11 . . . . 0.35 112.392 177.44 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 271' ' ' LEU . . . . . 0.439 ' O ' HG13 ' A' ' 275' ' ' ILE . 1.5 tm? -67.09 -43.38 82.7 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 108.746 -0.835 . . . . 0.5 108.746 177.775 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -64.05 -35.86 82.1 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.563 -0.744 . . . . 0.31 109.0 177.148 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 273' ' ' GLU . . . . . 0.695 ' HG2' HD11 ' A' ' 160' ' ' LEU . 52.5 mt-10 -66.06 -44.82 83.42 Favored 'General case' 0 C--O 1.222 -0.379 0 CA-C-N 115.662 -0.699 . . . . 0.76 109.217 177.27 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 274' ' ' THR . . . . . . . . . . . . . 89.9 m -55.6 -46.89 77.24 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.713 -0.676 . . . . 0.52 110.578 178.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 275' ' ' ILE . . . . . 0.578 ' HA ' ' HE1' ' A' ' 231' ' ' MET . 72.9 mt -63.04 -55.42 23.65 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.128 0 CA-C-N 115.936 -0.575 . . . . 0.41 110.853 179.316 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 5.6 m -57.38 -47.81 80.71 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.009 -0.542 . . . . 0.37 112.052 -179.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 277' ' ' ASP . . . . . 0.471 ' HB2' ' O ' ' A' ' 273' ' ' GLU . 0.1 OUTLIER -52.61 -57.17 10.88 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.488 -0.324 . . . . 0.63 111.52 -179.867 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 278' ' ' VAL . . . . . 0.405 ' HB ' ' CE ' ' A' ' 231' ' ' MET . 48.5 t -66.33 -37.11 78.95 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 N-CA-C 111.915 0.339 . . . . 0.42 111.915 -179.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 41.4 tp -64.78 -47.11 79.34 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 111.971 0.36 . . . . 0.86 111.971 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 86.7 t -73.68 -32.39 35.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 CA-C-O 121.009 0.433 . . . . 0.53 111.186 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 281' ' ' ARG . . . . . 0.449 HH11 ' HD2' ' A' ' 281' ' ' ARG . 2.0 tpm_? -71.81 -43.52 65.48 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 112.439 0.533 . . . . 0.38 112.439 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 282' ' ' THR . . . . . . . . . . . . . 3.4 m -78.29 -26.53 47.06 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 112.981 0.734 . . . . 0.47 112.981 -178.399 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 63.9 mmtt -129.83 41.64 3.4 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 112.257 0.465 . . . . 0.73 112.257 -179.063 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.65 -62.06 1.89 Allowed 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 113.661 0.985 . . . . 0.44 113.661 -178.664 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -64.04 -42.32 97.11 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 112.794 0.665 . . . . 0.42 112.794 -178.334 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 286' ' ' TRP . . . . . 0.472 ' HE3' HD22 ' A' ' 287' ' ' LEU . 10.0 t90 -60.41 -50.19 74.58 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.733 0.301 . . . . 0.38 111.275 -179.756 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 287' ' ' LEU . . . . . 0.558 ' HB3' HD21 ' A' ' 155' ' ' LEU . 1.6 mm? -66.88 -42.76 85.04 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.319 0.489 . . . . 0.47 112.319 -179.3 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 288' ' ' VAL . . . . . 0.52 HG21 ' HB2' ' A' ' 151' ' ' SER . 0.3 OUTLIER -67.24 -35.8 74.99 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 N-CA-C 112.004 0.372 . . . . 1.04 112.004 -179.487 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 56.1 mttt -77.52 -34.41 54.01 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 112.159 0.429 . . . . 0.82 112.159 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -81.05 23.89 0.54 Allowed 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 112.457 0.54 . . . . 0.73 112.457 -179.382 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 291' ' ' ARG . . . . . 0.708 ' HB3' ' HB2' ' A' ' 294' ' ' ASP . 3.1 mmt180 60.46 16.57 6.49 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.834 0.679 . . . . 0.48 112.834 179.696 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 47.63 -112.58 1.07 Allowed Glycine 0 CA--C 1.525 0.658 0 N-CA-C 114.637 0.615 . . . . 0.28 114.637 179.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 293' ' ' TRP . . . . . 0.543 ' CZ2' ' HA ' ' A' ' 159' ' ' SER . 86.0 m95 -66.74 -30.08 70.22 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.763 0.653 . . . . 0.36 112.763 -178.595 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 294' ' ' ASP . . . . . 0.708 ' HB2' ' HB3' ' A' ' 291' ' ' ARG . 15.5 m-20 -62.01 -42.92 99.68 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 121.049 0.452 . . . . 0.37 110.042 178.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -67.82 -41.86 87.69 Favored Glycine 0 CA--C 1.521 0.414 0 C-N-CA 120.639 -0.791 . . . . 0.32 111.885 178.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 296' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -67.39 -43.34 81.58 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 120.708 0.289 . . . . 0.34 111.315 179.524 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 297' ' ' VAL . . . . . 0.581 ' HA ' HG21 ' A' ' 193' ' ' THR . 50.3 t -65.89 -55.43 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-N 116.412 -0.358 . . . . 0.27 111.664 -179.32 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -62.56 -30.91 71.67 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 112.709 0.633 . . . . 0.73 112.709 -178.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 299' ' ' PHE . . . . . . . . . . . . . 93.1 t80 -76.54 -40.82 48.81 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 112.372 0.508 . . . . 0.45 112.372 179.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 300' ' ' PHE . . . . . 0.588 ' CE2' ' HB3' ' A' ' 242' ' ' TRP . 62.1 m-85 -93.99 -50.92 5.09 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 114.036 1.124 . . . . 0.39 114.036 -178.044 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 301' ' ' HIS . . . . . 0.43 ' CD2' ' HG2' ' A' ' 196' ' ' ARG . 0.1 OUTLIER -170.17 134.12 1.2 Allowed 'General case' 0 N--CA 1.468 0.432 0 O-C-N 121.88 -0.513 . . . . 0.47 112.318 -177.962 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 31.2 t -100.32 -63.91 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.143 0.497 . . . . 0.51 109.934 178.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 303' ' ' GLN . . . . . 0.427 ' HB3' ' H ' ' A' ' 304' ' ' ASP . 23.1 mm-40 -138.06 -157.71 0.8 Allowed 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.037 -0.529 . . . . 0.71 109.871 178.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 304' ' ' ASP . . . . . 0.427 ' H ' ' HB3' ' A' ' 303' ' ' GLN . 0.4 OUTLIER -92.24 3.49 55.24 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.225 0.536 . . . . 0.65 110.956 179.152 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 29.5 tp -71.49 -22.36 61.81 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 115.814 -0.63 . . . . 0.77 111.1 179.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 306' ' ' GLU . . . . . 0.424 ' OE1' ' ND1' ' A' ' 301' ' ' HIS . 0.7 OUTLIER -84.71 -20.37 31.29 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.308 -0.405 . . . . 0.71 111.473 179.678 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . 83.64 139.49 3.89 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 121.052 -0.594 . . . . 0.73 113.6 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.005 0 CA-C-O 118.641 -1.088 . . . . 0.65 113.466 179.392 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 17' ' ' ALA . . . . . 0.411 ' HA ' ' HE3' ' A' ' 215' ' ' LYS . . . . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.06 0.457 . . . . 0.92 111.409 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -68.18 157.95 34.26 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.643 -0.708 . . . . 1.39 111.3 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 20.1 mt -113.68 125.94 28.81 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-O 120.949 0.404 . . . . 1.25 111.444 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 20' ' ' PRO . . . . . 0.485 ' HA ' ' HD3' ' B' ' 21' ' ' PRO . 58.5 Cg_endo -73.56 140.37 29.68 Favored 'Trans proline' 0 CA--C 1.533 0.44 0 C-N-CA 122.28 1.987 . . . . 0.94 112.17 179.444 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 21' ' ' PRO . . . . . 0.485 ' HD3' ' HA ' ' B' ' 20' ' ' PRO . 32.3 Cg_exo -59.49 0.49 0.53 Allowed 'Trans proline' 0 N--CA 1.481 0.791 0 C-N-CA 123.265 2.643 . . . . 0.88 113.735 -179.655 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -72.64 -13.25 61.32 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 111.851 0.315 . . . . 0.57 111.851 179.693 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 23' ' ' PHE . . . . . 0.479 ' HD1' ' N ' ' B' ' 24' ' ' ALA . 0.2 OUTLIER -59.91 -33.22 71.57 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.151 0.501 . . . . 0.65 111.077 179.317 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 24' ' ' ALA . . . . . 0.479 ' N ' ' HD1' ' B' ' 23' ' ' PHE . . . -75.83 -38.41 58.1 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.207 0.527 . . . . 0.33 110.027 179.268 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -66.78 -36.63 82.87 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.937 -0.574 . . . . 0.34 109.485 178.201 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -60.54 -51.98 67.12 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 115.822 -0.626 . . . . 0.41 110.23 177.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 94.9 mt -61.86 -30.83 71.12 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 121.052 0.453 . . . . 0.41 110.14 178.556 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 28' ' ' ARG . . . . . . . . . . . . . 34.9 ttm-85 -68.0 -51.46 46.92 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 115.534 -0.757 . . . . 0.46 110.152 178.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 59.6 mttt -57.0 -42.46 80.35 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.296 -0.411 . . . . 0.44 110.599 178.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 69.6 mt -69.45 -42.95 81.12 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 CA-C-N 116.305 -0.407 . . . . 0.35 110.157 178.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -60.08 -46.18 94.66 Favored Glycine 0 C--N 1.333 0.368 0 C-N-CA 121.056 -0.592 . . . . 0.26 112.299 179.039 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -64.85 -34.98 79.65 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-O 121.176 0.512 . . . . 0.76 110.375 179.114 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 14.2 tppt? -71.73 -47.66 52.33 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.057 -0.52 . . . . 0.73 111.116 179.416 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 55.5 t -62.68 -44.63 99.6 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-O 120.823 0.344 . . . . 0.35 111.009 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 35' ' ' TYR . . . . . 0.455 ' HB2' ' H ' ' A' ' 243' ' ' GLY . 0.0 OUTLIER -59.35 -47.24 86.16 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.155 -0.475 . . . . 0.77 110.468 179.102 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 36' ' ' CYS . . . . . . . . . . . . . 11.8 t -70.01 -36.05 74.82 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 116.259 -0.428 . . . . 0.57 111.913 -179.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 99.0 m -64.75 -40.04 94.63 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.209 0.448 . . . . 0.52 112.209 -179.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 38' ' ' TRP . . . . . . . . . . . . . 94.0 m95 -82.78 -31.28 28.33 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 120.821 -0.352 . . . . 0.72 111.781 -179.394 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 82.9 p -71.67 -26.01 62.35 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 120.737 0.303 . . . . 0.63 111.093 178.337 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -90.13 141.2 27.62 Favored Pre-proline 0 CA--C 1.533 0.292 0 CA-C-O 120.784 0.326 . . . . 0.74 111.452 179.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -81.64 -8.62 12.42 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 122.696 2.264 . . . . 1.19 113.489 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -79.17 78.93 5.62 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 120.994 0.426 . . . . 1.54 111.348 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 43' ' ' MET . . . . . . . . . . . . . 62.2 mtt . . . . . 0 C--O 1.251 1.142 0 CA-C-O 118.315 -0.85 . . . . 1.59 111.633 -179.718 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.438 0 N-CA-C 112.306 -0.318 . . . . 1.02 112.306 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -69.28 -23.44 32.98 Favored 'Trans proline' 0 CA--C 1.533 0.47 0 C-N-CA 122.515 2.144 . . . . 1.43 112.541 179.666 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 5.8 tp -133.02 148.13 52.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.201 -0.454 . . . . 1.72 110.323 179.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 128.66 45.96 0.18 Allowed Glycine 0 CA--C 1.523 0.573 0 C-N-CA 120.215 -0.993 . . . . 0.6 113.666 179.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 32.1 t -174.63 28.58 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 121.456 0.646 . . . . 0.56 109.92 179.062 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.41 -50.83 0.47 Allowed 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 115.218 -0.901 . . . . 0.49 111.781 -177.403 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -64.55 -40.9 96.44 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.831 0.348 . . . . 0.52 110.832 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -55.22 -48.34 74.03 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.007 -0.542 . . . . 0.44 110.805 178.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.601 HD21 ' HB3' ' A' ' 287' ' ' LEU . 47.6 tp -73.17 -36.08 66.54 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.091 -0.504 . . . . 0.73 110.783 178.675 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 64.3 t80 -60.06 -40.58 89.97 Favored 'General case' 0 C--O 1.224 -0.282 0 CA-C-N 116.223 -0.444 . . . . 0.36 111.489 179.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.502 ' HD2' ' OE2' ' A' ' 182' ' ' GLU . 7.6 mtm180 -56.22 -52.32 64.85 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.772 0.32 . . . . 0.35 111.552 179.48 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -64.89 -45.93 83.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.126 -0.488 . . . . 0.3 110.658 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . 0.439 ' HA ' ' CZ2' ' A' ' 293' ' ' TRP . 15.6 m -58.35 -50.25 74.3 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.802 -0.635 . . . . 0.25 111.207 179.46 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -60.37 -47.57 85.5 Favored 'General case' 0 C--O 1.225 -0.219 0 CA-C-N 116.149 -0.478 . . . . 0.43 111.263 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . 0.482 ' HG2' HD23 ' A' ' 180' ' ' LEU . 44.0 tt0 -58.2 -50.28 74.08 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 120.633 0.254 . . . . 0.34 111.166 -179.708 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 84.9 mt -61.32 -50.14 81.65 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 CA-C-N 116.321 -0.4 . . . . 0.27 111.082 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.554 HD12 HG23 ' A' ' 276' ' ' THR . 68.4 mt -61.45 -46.53 96.38 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 N-CA-C 111.533 0.197 . . . . 0.38 111.533 179.389 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 2.0 t -56.28 -52.63 63.78 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.733 0.302 . . . . 0.31 110.807 178.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 40.0 ttt-85 -61.19 -41.54 96.99 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 120.768 0.318 . . . . 0.35 111.782 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' TYR . . . . . 0.495 ' HE1' ' HA ' ' A' ' 195' ' ' ARG . 80.9 t80 -68.37 -50.3 54.1 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 112.236 0.458 . . . . 0.28 112.236 -179.459 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.474 ' HG ' ' HA ' ' A' ' 253' ' ' ALA . 5.8 mp -54.57 -39.22 67.56 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.66 0.267 . . . . 0.42 111.101 -179.413 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 52.6 mtt-85 -65.32 -44.46 87.75 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.434 -0.348 . . . . 0.33 111.029 178.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -54.18 -45.1 72.04 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 121.111 0.481 . . . . 0.54 111.125 178.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . 0.759 ' HB2' ' HB1' ' A' ' 253' ' ' ALA . 12.3 mm100 -77.01 -37.36 55.17 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 116.18 -0.464 . . . . 0.38 111.951 -179.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.43 ' O ' ' HG3' ' A' ' 257' ' ' LYS . . . -65.86 -40.62 91.85 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.916 0.388 . . . . 0.26 110.715 178.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 35.2 p -78.6 -43.89 25.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.348 -0.387 . . . . 0.42 110.938 178.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 101.94 25.16 8.13 Favored Glycine 0 CA--C 1.522 0.499 0 C-N-CA 120.445 -0.883 . . . . 0.57 113.598 179.116 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 41.6 t -145.16 142.74 29.87 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.734 0.302 . . . . 0.87 111.049 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -90.63 104.62 17.19 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.792 0.33 . . . . 0.6 110.814 179.759 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -80.69 161.54 24.57 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.103 0.478 . . . . 0.43 110.869 -179.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 46.3 m -112.8 6.72 18.18 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.253 -0.43 . . . . 0.48 111.813 -179.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 38.1 mttp -61.29 123.84 77.9 Favored Pre-proline 0 N--CA 1.468 0.475 0 CA-C-O 120.836 0.35 . . . . 0.59 111.368 178.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -73.54 156.48 49.63 Favored 'Trans proline' 0 CA--C 1.535 0.56 0 C-N-CA 123.001 2.467 . . . . 0.68 113.822 -179.562 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.482 HD23 ' HG2' ' A' ' 161' ' ' GLU . 5.2 mp -87.88 168.01 13.27 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.701 -0.681 . . . . 0.55 111.213 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -111.23 -45.31 0.87 Allowed Glycine 0 CA--C 1.522 0.478 0 C-N-CA 120.9 -0.667 . . . . 0.49 113.295 -179.401 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . 0.502 ' OE2' ' HD2' ' A' ' 157' ' ' ARG . 0.0 OUTLIER -86.67 -58.94 2.42 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 121.235 0.541 . . . . 0.46 110.702 -179.833 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.625 ' O ' ' HA3' ' A' ' 187' ' ' GLY . . . -80.13 80.36 6.57 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.182 0.515 . . . . 0.32 111.439 -179.724 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -80.09 -71.97 1.24 Allowed Glycine 0 CA--C 1.524 0.643 0 C-N-CA 120.609 -0.805 . . . . 0.38 113.356 179.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -68.17 -55.61 11.71 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-O 120.979 0.418 . . . . 0.46 111.118 -179.608 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -65.18 -39.08 92.39 Favored 'General case' 0 C--O 1.218 -0.555 0 CA-C-N 115.904 -0.589 . . . . 0.41 110.077 178.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . 0.625 ' HA3' ' O ' ' A' ' 183' ' ' ALA . . . -60.6 -50.82 63.4 Favored Glycine 0 C--O 1.219 -0.79 0 C-N-CA 121.399 -0.429 . . . . 0.3 113.135 179.641 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . 0.427 HH11 ' HD2' ' A' ' 188' ' ' ARG . 13.4 mtp180 -56.84 -47.85 79.39 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 117.547 0.673 . . . . 1.34 111.484 179.234 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . 0.71 ' HB3' HG11 ' A' ' 297' ' ' VAL . 48.3 mtm180 -70.29 -41.0 73.95 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 112.479 0.548 . . . . 0.48 112.479 -179.438 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.536 ' HA ' HG22 ' A' ' 297' ' ' VAL . . . -74.22 -44.63 52.39 Favored 'General case' 0 C--O 1.221 -0.408 0 N-CA-C 111.873 0.323 . . . . 0.27 111.873 -178.649 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 3.4 tp -61.07 -49.32 77.83 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.679 -0.408 . . . . 0.45 110.319 179.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -61.08 -44.11 97.86 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 120.706 -0.398 . . . . 0.57 110.996 179.545 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 91.5 m -63.53 -46.19 87.13 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 110.026 -0.361 . . . . 0.32 110.026 178.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 59.8 tp -63.58 -37.27 86.68 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.075 -0.511 . . . . 0.39 111.184 179.196 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . 0.495 ' HA ' ' HE1' ' A' ' 166' ' ' TYR . 2.1 mtt180 -58.6 -48.34 81.28 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.819 0.342 . . . . 0.38 110.711 178.709 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 10.5 mmp_? -74.66 -45.12 46.75 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 116.149 -0.478 . . . . 0.4 111.868 -179.25 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . 0.479 ' O ' HG23 ' A' ' 201' ' ' VAL . 49.7 t -65.67 -51.55 61.18 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 CA-C-O 120.687 0.279 . . . . 0.35 111.628 179.529 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -62.31 -53.23 43.74 Favored Glycine 0 CA--C 1.521 0.435 0 CA-C-O 119.933 -0.371 . . . . 0.29 113.388 -179.456 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -55.18 -40.34 70.61 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 117.225 0.513 . . . . 0.4 109.763 179.011 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -60.36 -53.6 44.17 Favored Glycine 0 C--N 1.335 0.507 0 N-CA-C 111.138 -0.785 . . . . 0.36 111.138 177.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . 0.479 HG23 ' O ' ' A' ' 197' ' ' VAL . 98.9 t -58.29 -38.33 68.33 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-O 120.792 0.33 . . . . 0.39 110.691 178.461 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 202' ' ' GLN . . . . . 0.517 HE21 ' HD1' ' A' ' 254' ' ' PHE . 31.7 mt-30 -62.91 -54.2 42.23 Favored 'General case' 0 C--O 1.225 -0.228 0 CA-C-N 115.818 -0.628 . . . . 0.36 111.803 179.594 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 29.0 mtp180 -67.88 -36.34 80.07 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 121.028 -0.269 . . . . 0.57 111.434 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 10.9 m-80 -62.98 -50.95 68.73 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 121.181 0.515 . . . . 1.3 110.499 178.532 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 57.1 m-70 -101.85 35.89 2.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.214 -0.448 . . . . 0.47 111.233 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -53.47 -47.45 69.75 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 112.23 0.456 . . . . 0.43 112.23 -179.261 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . 0.401 HG22 ' H ' ' A' ' 207' ' ' THR . 0.6 OUTLIER -56.34 -39.51 72.95 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 112.285 0.476 . . . . 0.47 112.285 -179.78 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -64.86 -48.79 73.01 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 120.989 0.424 . . . . 0.35 110.84 -179.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 209' ' ' PHE . . . . . 0.614 ' O ' ' HB2' ' A' ' 213' ' ' LEU . 46.3 m-85 -66.76 -35.27 79.71 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.94 -0.573 . . . . 0.56 109.912 178.692 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 210' ' ' GLN . . . . . 0.558 ' O ' ' HG2' ' A' ' 214' ' ' ARG . 49.5 mt-30 -66.12 -45.78 79.92 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.481 -0.327 . . . . 0.66 111.181 179.005 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -55.7 -49.03 67.8 Favored Glycine 0 C--N 1.336 0.574 0 N-CA-C 111.14 -0.784 . . . . 0.34 111.14 178.29 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 212' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -68.54 -29.86 68.53 Favored 'General case' 0 C--O 1.221 -0.42 0 CA-C-O 120.602 0.239 . . . . 0.65 110.367 178.144 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.614 ' HB2' ' O ' ' A' ' 209' ' ' PHE . 0.3 OUTLIER -69.55 -41.56 75.75 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.521 -0.309 . . . . 0.35 111.507 179.668 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 214' ' ' ARG . . . . . 0.558 ' HG2' ' O ' ' A' ' 210' ' ' GLN . 2.8 mmp_? -66.52 -40.03 88.95 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 121.185 0.517 . . . . 0.57 110.137 179.569 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 48.1 mtmt -91.87 13.15 19.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.888 -0.596 . . . . 0.58 111.94 179.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.467 HD21 HG13 ' A' ' 255' ' ' VAL . 7.4 tp -79.72 106.4 11.72 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 121.422 0.629 . . . . 0.46 111.34 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 217' ' ' ASP . . . . . 0.4 ' OD2' ' N ' ' B' ' 17' ' ' ALA . 28.2 t70 -84.13 -2.14 56.26 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 115.011 -0.995 . . . . 0.55 111.708 -179.341 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 218' ' ' ILE . . . . . 0.628 HG12 ' HB3' ' A' ' 223' ' ' ASP . 46.9 mt -53.71 114.37 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 N-CA-C 112.255 0.465 . . . . 0.39 112.255 -179.75 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 26.5 mtmm -138.11 -28.4 0.86 Allowed 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 115.982 -0.553 . . . . 0.84 112.424 -179.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -125.14 -179.37 4.54 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 113.017 0.747 . . . . 0.55 113.017 -178.251 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . 0.56 ' O ' HG22 ' A' ' 224' ' ' VAL . 1.2 mp0 -64.3 -22.05 66.82 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.448 -0.796 . . . . 0.59 111.376 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -71.49 -26.82 72.44 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 121.021 -0.609 . . . . 0.38 112.859 179.177 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 223' ' ' ASP . . . . . 0.628 ' HB3' HG12 ' A' ' 218' ' ' ILE . 39.3 m-20 -68.37 -31.45 70.84 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 112.283 0.475 . . . . 0.37 112.283 -179.632 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.661 ' HB ' HG21 ' A' ' 274' ' ' THR . 3.1 m -58.16 -27.67 32.63 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 CA-C-O 120.745 0.307 . . . . 0.43 111.73 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . 0.419 ' HD2' ' H ' ' A' ' 225' ' ' LYS . 6.1 mptt -65.16 -37.08 86.26 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.107 0.48 . . . . 0.82 109.9 178.768 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . 0.627 ' O ' HG23 ' A' ' 230' ' ' VAL . 18.4 t -67.57 -44.13 78.93 Favored 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 109.176 -0.676 . . . . 0.36 109.176 178.214 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 227' ' ' PHE . . . . . 0.616 ' HE2' HG21 ' A' ' 255' ' ' VAL . 2.7 t80 -59.76 -39.96 86.57 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 115.391 -0.822 . . . . 0.43 110.19 178.495 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 228' ' ' SER . . . . . 0.598 ' HA ' ' HE3' ' A' ' 231' ' ' MET . 15.9 m -63.44 -39.48 94.58 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.168 0.508 . . . . 0.35 109.883 178.441 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 28.2 mtp180 -65.88 -35.51 80.84 Favored 'General case' 0 C--O 1.225 -0.202 0 CA-C-N 115.482 -0.781 . . . . 0.62 109.766 178.237 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 0.627 HG23 ' O ' ' A' ' 226' ' ' SER . 56.8 t -60.86 -51.18 76.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 109.879 -0.415 . . . . 0.36 109.879 177.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 231' ' ' MET . . . . . 0.613 ' HE1' ' HB ' ' A' ' 278' ' ' VAL . 56.5 mtm -55.73 -53.35 57.64 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.891 -0.595 . . . . 0.4 111.788 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 35.2 m -63.87 -30.91 51.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 120.861 -0.336 . . . . 0.4 111.167 179.388 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 233' ' ' HIS . . . . . 0.474 ' O ' ' HB3' ' A' ' 236' ' ' LYS . 44.5 t-80 -69.82 -39.56 76.41 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 120.962 0.41 . . . . 0.42 110.321 178.51 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 69.0 t -71.8 -41.0 70.03 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 CA-C-O 120.969 0.414 . . . . 0.38 111.046 178.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -87.9 12.73 12.43 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 120.954 0.407 . . . . 0.71 111.574 179.601 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . 0.51 ' O ' ' HG2' ' A' ' 236' ' ' LYS . 0.0 OUTLIER -68.99 -15.32 63.45 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 115.606 -0.725 . . . . 0.52 111.267 179.221 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . 0.456 ' HA ' ' NZ ' ' A' ' 236' ' ' LYS . 71.8 m-20 -75.86 -7.89 55.57 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 122.085 -0.385 . . . . 0.36 111.651 179.812 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 84.92 -19.97 18.28 Favored Glycine 0 CA--C 1.519 0.291 0 C-N-CA 121.014 -0.613 . . . . 0.4 112.773 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 2.5 t -91.97 108.89 20.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.148 0.499 . . . . 0.85 111.166 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 240' ' ' THR . . . . . 0.537 HG22 HD11 ' A' ' 245' ' ' ILE . 3.4 m -89.79 68.2 7.43 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.206 -0.452 . . . . 0.48 111.131 -179.793 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . 0.461 ' HB2' ' HG3' ' A' ' 244' ' ' ARG . 11.9 m120 -66.24 141.58 57.99 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.918 0.389 . . . . 0.4 111.431 -179.771 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 242' ' ' TRP . . . . . 0.491 ' CZ3' ' HB2' ' A' ' 296' ' ' PHE . 76.1 m95 -59.69 -36.35 76.31 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.282 -0.417 . . . . 0.43 110.369 178.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . 0.452 ' HA3' ' HB2' ' B' ' 35' ' ' TYR . . . -61.14 -31.75 77.97 Favored Glycine 0 C--N 1.335 0.5 0 C-N-CA 121.082 -0.58 . . . . 0.27 112.058 178.083 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 244' ' ' ARG . . . . . 0.539 ' HG2' ' HA3' ' B' ' 31' ' ' GLY . 81.6 mtt180 -75.76 -32.74 60.08 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 121.151 0.501 . . . . 0.36 109.914 178.684 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . 0.537 HD11 HG22 ' A' ' 240' ' ' THR . 78.1 mt -72.05 -49.63 42.73 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 CA-C-N 115.78 -0.646 . . . . 0.44 110.692 179.064 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 26.9 m -67.56 -31.51 52.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 C-N-CA 121.171 -0.212 . . . . 0.3 111.324 179.333 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . 0.475 HG22 HD22 ' B' ' 27' ' ' LEU . 30.9 m -67.53 -40.5 85.07 Favored 'General case' 0 C--O 1.232 0.157 0 N-CA-C 109.134 -0.691 . . . . 0.37 109.134 177.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 248' ' ' LEU . . . . . 0.419 ' HA ' HD13 ' A' ' 248' ' ' LEU . 0.3 OUTLIER -61.5 -42.26 98.53 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 109.047 -0.723 . . . . 0.48 109.047 177.14 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 249' ' ' ILE . . . . . 0.439 HG13 ' O ' ' A' ' 245' ' ' ILE . 49.7 mt -63.36 -44.99 99.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.404 0 CA-C-N 115.812 -0.631 . . . . 0.39 110.219 178.105 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 250' ' ' SER . . . . . 0.505 ' HB3' ' HG3' ' A' ' 202' ' ' GLN . 40.3 m -58.98 -44.22 91.56 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.062 -0.517 . . . . 0.32 110.005 178.699 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 251' ' ' PHE . . . . . . . . . . . . . 21.7 t80 -63.67 -44.28 94.21 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 115.89 -0.596 . . . . 0.36 109.495 177.369 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -56.22 -44.61 89.04 Favored Glycine 0 C--N 1.336 0.552 0 C-N-CA 121.067 -0.587 . . . . 0.25 111.705 178.462 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 253' ' ' ALA . . . . . 0.759 ' HB1' ' HB2' ' A' ' 170' ' ' GLN . . . -59.96 -43.16 95.23 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.669 0.271 . . . . 0.26 110.585 177.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 254' ' ' PHE . . . . . 0.517 ' HD1' HE21 ' A' ' 202' ' ' GLN . 0.3 OUTLIER -65.04 -40.64 95.08 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 121.233 0.539 . . . . 0.57 110.215 178.462 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 255' ' ' VAL . . . . . 0.616 HG21 ' HE2' ' A' ' 227' ' ' PHE . 78.4 t -66.63 -39.97 85.11 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-N 116.107 -0.497 . . . . 0.3 110.207 178.561 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -57.86 -39.42 77.72 Favored 'General case' 0 N--CA 1.461 0.097 0 CA-C-O 121.469 0.652 . . . . 0.27 109.259 178.093 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 257' ' ' LYS . . . . . 0.43 ' HG3' ' O ' ' A' ' 171' ' ' ALA . 23.1 tttp -61.65 -41.72 97.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.262 -0.881 . . . . 0.33 110.236 178.062 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 71.3 t60 -58.77 -45.58 89.48 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 116.243 -0.435 . . . . 0.46 110.719 178.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.528 HD22 ' NE2' ' A' ' 264' ' ' GLN . 13.1 mt -70.86 -43.1 69.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.248 -0.433 . . . . 0.45 110.932 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 21.0 ttmm -63.1 -36.93 85.22 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.785 0.326 . . . . 0.68 111.089 179.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 54.3 m -63.15 -25.46 68.36 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 116.387 -0.369 . . . . 0.44 111.684 179.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 262' ' ' VAL . . . . . 0.523 HG23 ' HG3' ' A' ' 264' ' ' GLN . 17.9 m -108.67 21.8 4.64 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-O 120.848 0.356 . . . . 0.49 111.23 179.34 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 57.32 42.55 24.86 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 112.903 0.705 . . . . 1.81 112.903 179.388 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 264' ' ' GLN . . . . . 0.528 ' NE2' HD22 ' A' ' 259' ' ' LEU . 10.5 mt-30 -98.22 38.4 1.33 Allowed 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.219 0.451 . . . . 0.48 112.219 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -51.48 -37.33 48.42 Favored 'General case' 0 C--O 1.243 0.715 0 CA-C-O 120.892 0.377 . . . . 0.8 111.857 179.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 26.5 p -62.59 -16.88 58.62 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 116.101 -0.499 . . . . 0.97 111.162 178.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 267' ' ' PHE . . . . . 0.401 ' C ' ' HD2' ' A' ' 270' ' ' PRO . 73.7 m-85 -110.44 -12.18 14.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.939 -0.573 . . . . 0.67 109.889 178.271 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 8.4 mm -66.41 -49.33 76.34 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 CA-C-N 115.834 -0.621 . . . . 0.4 110.303 179.06 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 269' ' ' GLU . . . . . 0.732 ' HB2' ' HD3' ' A' ' 270' ' ' PRO . 57.4 mm-40 -61.44 -54.95 47.73 Favored Pre-proline 0 CA--C 1.545 0.765 0 CA-C-N 115.841 -0.618 . . . . 0.51 111.106 179.331 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 270' ' ' PRO . . . . . 0.732 ' HD3' ' HB2' ' A' ' 269' ' ' GLU . 51.2 Cg_exo -57.0 -36.14 99.2 Favored 'Trans proline' 0 C--N 1.359 1.086 0 C-N-CA 122.244 1.963 . . . . 0.31 112.879 178.577 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 271' ' ' LEU . . . . . . . . . . . . . 18.6 tp -63.84 -52.1 61.63 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.485 0.183 . . . . 0.5 111.188 179.035 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -58.16 -39.79 79.75 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.276 -0.42 . . . . 0.29 111.242 179.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 273' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -71.36 -40.48 70.61 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.247 -0.433 . . . . 0.61 110.723 178.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 274' ' ' THR . . . . . 0.661 HG21 ' HB ' ' A' ' 224' ' ' VAL . 87.3 m -63.53 -43.84 95.98 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.874 0.368 . . . . 0.33 110.679 179.309 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 275' ' ' ILE . . . . . 0.442 ' HA ' ' CE ' ' A' ' 231' ' ' MET . 88.1 mt -61.88 -54.88 28.71 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.083 0 CA-C-N 116.277 -0.42 . . . . 0.39 110.414 179.163 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 276' ' ' THR . . . . . 0.554 HG23 HD12 ' A' ' 163' ' ' ILE . 24.2 m -56.41 -51.07 69.74 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.26 -0.427 . . . . 0.31 111.533 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 277' ' ' ASP . . . . . 0.637 ' O ' ' HB2' ' A' ' 281' ' ' ARG . 29.7 t70 -52.26 -60.22 3.47 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.35 -0.386 . . . . 0.39 111.79 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 278' ' ' VAL . . . . . 0.613 ' HB ' ' HE1' ' A' ' 231' ' ' MET . 59.6 t -63.94 -42.57 96.19 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 N-CA-C 112.336 0.495 . . . . 0.36 112.336 -179.074 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 27.1 tp -60.72 -47.61 85.51 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 111.987 0.365 . . . . 0.66 111.987 -179.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 86.7 t -80.96 -46.32 20.82 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 N-CA-C 113.056 0.761 . . . . 0.47 113.056 -178.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 281' ' ' ARG . . . . . 0.637 ' HB2' ' O ' ' A' ' 277' ' ' ASP . 1.5 mpt_? -60.72 -35.59 76.7 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 113.039 0.755 . . . . 0.42 113.039 -178.32 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 282' ' ' THR . . . . . . . . . . . . . 85.0 m -65.09 -38.13 89.73 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 112.389 0.514 . . . . 0.47 112.389 -179.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 28.8 mmtp -129.67 42.1 3.34 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 112.582 0.586 . . . . 0.46 112.582 -178.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 284' ' ' ARG . . . . . 0.412 ' HD3' ' O ' ' A' ' 281' ' ' ARG . 0.1 OUTLIER -60.35 -28.82 68.47 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 111.965 0.357 . . . . 0.59 111.965 -179.697 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 285' ' ' ASP . . . . . 0.458 ' HA ' HG22 ' A' ' 288' ' ' VAL . 3.1 t70 -62.41 -44.99 95.12 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-O 121.023 0.439 . . . . 0.71 110.383 179.201 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 286' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -61.09 -35.61 77.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.307 0.575 . . . . 0.54 110.13 178.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 287' ' ' LEU . . . . . 0.601 ' HB3' HD21 ' A' ' 155' ' ' LEU . 1.2 mm? -71.24 -54.31 11.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.517 -0.765 . . . . 0.46 111.148 179.378 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 288' ' ' VAL . . . . . 0.458 HG22 ' HA ' ' A' ' 285' ' ' ASP . 33.8 m -59.96 -30.39 45.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 N-CA-C 111.763 0.283 . . . . 0.43 111.763 -179.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 27.8 mttp -65.77 -32.43 73.96 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.861 0.363 . . . . 0.82 110.927 178.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 -108.51 28.98 7.82 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 111.873 0.323 . . . . 0.67 111.873 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 291' ' ' ARG . . . . . 0.777 ' HB3' ' HB2' ' A' ' 294' ' ' ASP . 0.8 OUTLIER 61.84 19.41 10.6 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 112.612 0.597 . . . . 0.44 112.612 178.896 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 69.11 -118.02 8.4 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 121.302 -0.475 . . . . 0.32 113.236 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 293' ' ' TRP . . . . . 0.674 ' O ' HG23 ' A' ' 297' ' ' VAL . 90.5 m95 -72.0 -21.7 61.52 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 111.683 0.253 . . . . 0.35 111.683 -179.262 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 294' ' ' ASP . . . . . 0.777 ' HB2' ' HB3' ' A' ' 291' ' ' ARG . 60.1 m-20 -57.74 -51.5 69.29 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 109.509 -0.552 . . . . 0.45 109.509 178.019 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -65.25 -41.36 96.82 Favored Glycine 0 C--N 1.335 0.52 0 N-CA-C 111.355 -0.698 . . . . 0.3 111.355 178.137 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 296' ' ' PHE . . . . . 0.491 ' HB2' ' CZ3' ' A' ' 242' ' ' TRP . 6.7 t80 -56.33 -46.04 80.09 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 120.753 0.311 . . . . 0.34 111.371 178.707 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 297' ' ' VAL . . . . . 0.71 HG11 ' HB3' ' A' ' 189' ' ' ARG . 88.9 t -58.48 -54.6 30.85 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 CA-C-O 120.96 0.409 . . . . 0.35 111.768 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -71.23 -29.86 65.65 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.948 0.721 . . . . 0.71 112.948 -178.488 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 299' ' ' PHE . . . . . 0.51 ' CZ ' ' HB2' ' B' ' 39' ' ' SER . 61.3 t80 -59.18 -46.11 89.26 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.901 0.381 . . . . 0.4 111.051 178.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 300' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -86.45 25.02 1.28 Allowed 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 121.132 0.491 . . . . 0.45 111.902 -179.599 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 14.0 m170 -114.09 13.39 18.1 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.066 -0.516 . . . . 0.74 110.714 178.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 59.3 t -77.78 100.97 3.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.981 -0.554 . . . . 0.78 110.632 178.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -160.04 -151.23 0.24 Allowed 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.017 -0.538 . . . . 1.23 110.459 -179.465 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -75.2 80.2 2.33 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.398 0.618 . . . . 1.49 111.251 179.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 82.8 mt -83.15 -55.65 4.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.207 -0.451 . . . . 1.39 111.155 179.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 7.0 mp0 -97.94 -4.39 36.48 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 120.953 0.406 . . . . 1.8 111.199 179.314 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . 102.76 -95.72 1.3 Allowed Glycine 0 CA--C 1.522 0.493 0 C-N-CA 120.8 -0.714 . . . . 1.77 112.821 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.158 0 CA-C-O 118.472 -1.182 . . . . 2.68 113.108 -179.856 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 17' ' ' ALA . . . . . 0.4 ' N ' ' OD2' ' A' ' 217' ' ' ASP . . . . . . . . 0 N--CA 1.489 1.49 0 N-CA-C 111.568 0.21 . . . . 0.54 111.568 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -141.3 149.45 41.25 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 121.048 0.452 . . . . 0.64 111.312 -179.58 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 19' ' ' LEU . . . . . 0.514 ' HB2' ' CE2' ' B' ' 23' ' ' PHE . 0.1 OUTLIER -114.02 160.92 30.51 Favored Pre-proline 0 CA--C 1.538 0.513 0 CA-C-N 115.9 -0.591 . . . . 0.5 111.106 -179.242 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 20' ' ' PRO . . . . . 0.436 ' HA ' ' HD3' ' B' ' 21' ' ' PRO . 36.2 Cg_endo -64.84 145.13 85.47 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 122.844 2.363 . . . . 0.69 113.223 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 21' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' B' ' 20' ' ' PRO . 39.7 Cg_exo -58.34 -1.77 0.76 Allowed 'Trans proline' 0 N--CA 1.483 0.872 0 C-N-CA 123.749 2.966 . . . . 0.76 114.689 -179.093 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -64.11 -26.18 68.42 Favored 'General case' 0 C--N 1.328 -0.337 0 O-C-N 122.317 -0.239 . . . . 1.19 111.62 179.127 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 23' ' ' PHE . . . . . 0.621 ' HD1' ' N ' ' B' ' 24' ' ' ALA . 0.2 OUTLIER -62.36 -33.9 75.63 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 120.788 -0.365 . . . . 0.33 111.422 -179.967 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 24' ' ' ALA . . . . . 0.621 ' N ' ' HD1' ' B' ' 23' ' ' PHE . . . -76.83 -40.22 48.63 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.855 0.36 . . . . 0.34 110.561 -179.73 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -69.94 -40.56 75.4 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.075 -0.511 . . . . 0.42 111.577 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -68.96 -50.92 44.96 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 111.909 0.337 . . . . 0.57 111.909 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . 0.475 HD22 HG22 ' A' ' 247' ' ' THR . 81.7 mt -64.8 -30.39 71.4 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 111.734 0.272 . . . . 0.44 111.734 -179.332 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 28' ' ' ARG . . . . . 0.518 ' HB2' ' O ' ' B' ' 24' ' ' ALA . 0.0 OUTLIER -70.67 -55.92 7.61 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 120.886 0.374 . . . . 0.42 110.795 178.35 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 34.9 mtmm -61.64 -53.01 61.86 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 116.463 -0.335 . . . . 0.42 111.672 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 97.4 mt -58.39 -40.02 76.7 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.077 0 CA-C-N 116.41 -0.359 . . . . 0.4 110.573 -179.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . 0.539 ' HA3' ' HG2' ' A' ' 244' ' ' ARG . . . -56.61 -50.01 65.99 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.946 -0.645 . . . . 0.25 112.45 179.388 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -72.09 -40.37 68.25 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.927 0.364 . . . . 0.73 111.43 179.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 33' ' ' LYS . . . . . 0.479 ' HA ' ' HD2' ' B' ' 33' ' ' LYS . 1.1 tptt -59.45 -51.68 68.85 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 120.879 0.371 . . . . 1.13 110.749 179.245 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 33.6 t -63.94 -46.42 94.11 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 CA-C-N 116.057 -0.52 . . . . 0.4 110.467 178.664 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 35' ' ' TYR . . . . . 0.452 ' HB2' ' HA3' ' A' ' 243' ' ' GLY . 9.0 t80 -56.56 -48.26 77.72 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 115.934 -0.575 . . . . 0.73 111.517 179.39 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 36' ' ' CYS . . . . . . . . . . . . . 80.8 m -63.98 -33.04 74.84 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.866 0.365 . . . . 0.46 111.164 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 34.5 m -69.63 -33.51 72.75 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.081 -0.509 . . . . 0.63 111.704 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 38' ' ' TRP . . . . . . . . . . . . . 80.8 m95 -87.96 -34.64 18.01 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 120.675 0.274 . . . . 0.58 111.661 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 39' ' ' SER . . . . . 0.51 ' HB2' ' CZ ' ' A' ' 299' ' ' PHE . 39.1 t -89.66 32.53 0.87 Allowed 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.016 0.436 . . . . 0.61 111.018 179.045 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -89.76 124.59 63.5 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.351 -0.386 . . . . 0.6 111.453 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -75.78 65.67 6.72 Favored 'Trans proline' 0 CA--C 1.535 0.548 0 C-N-CA 122.593 2.195 . . . . 1.31 113.041 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -78.93 -25.08 43.63 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.394 -0.367 . . . . 1.57 111.21 179.366 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 43' ' ' MET . . . . . . . . . . . . . 29.6 ttp . . . . . 0 C--O 1.251 1.15 0 CA-C-O 118.38 -0.819 . . . . 1.11 110.944 -179.993 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.401 ' HA3' ' HD3' ' A' ' 148' ' ' PRO . . . . . . . . 0 N--CA 1.491 2.309 0 CA-C-O 120.18 -0.233 . . . . 4.32 112.768 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.401 ' HD3' ' HA3' ' A' ' 147' ' ' GLY . 11.5 Cg_exo -71.61 -25.69 20.56 Favored 'Trans proline' 0 CA--C 1.534 0.519 0 C-N-CA 123.021 2.481 . . . . 4.39 113.384 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.414 ' HB2' ' HB3' ' A' ' 154' ' ' ASP . 91.3 mt -105.83 -51.79 2.93 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.877 0.37 . . . . 2.99 110.661 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -139.4 -108.01 0.76 Allowed Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.878 -0.677 . . . . 1.55 111.867 179.073 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 17.1 t -138.19 -48.84 0.55 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.281 0.562 . . . . 1.24 111.672 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -123.97 -26.83 3.99 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.386 -0.825 . . . . 0.78 110.499 -178.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -56.34 -52.51 64.27 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.727 0.811 . . . . 1.01 112.706 -179.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.414 ' HB3' ' HB2' ' A' ' 149' ' ' LEU . 0.6 OUTLIER -58.86 -52.53 65.35 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.926 0.393 . . . . 0.97 111.236 179.769 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 1.4 mt -60.56 -39.51 88.25 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.167 -0.47 . . . . 0.64 110.925 178.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -66.75 -39.03 87.76 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.544 -0.298 . . . . 0.9 111.459 179.493 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.614 ' HD2' ' OE2' ' A' ' 182' ' ' GLU . 1.5 mmt180 -57.04 -51.64 68.44 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.714 0.293 . . . . 0.92 111.24 179.772 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . 0.406 ' HA ' ' HB2' ' A' ' 183' ' ' ALA . 71.0 mt-30 -69.28 -42.17 75.85 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.991 -0.283 . . . . 0.54 111.095 179.464 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 49.4 m -59.97 -49.78 76.32 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 111.752 0.278 . . . . 0.37 111.752 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.634 HD21 ' HA ' ' A' ' 273' ' ' GLU . 1.5 tm? -58.44 -53.41 58.63 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.548 -0.296 . . . . 0.72 110.994 179.539 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -60.48 -47.43 86.17 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 112.013 0.375 . . . . 1.1 112.013 -179.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . 0.507 HG12 ' HA2' ' A' ' 187' ' ' GLY . 83.2 mt -61.99 -47.54 92.72 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-O 120.621 0.248 . . . . 0.38 111.392 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . . . . . . . . . 39.6 mt -64.19 -45.54 96.04 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 CA-C-N 116.745 -0.207 . . . . 0.42 110.733 179.245 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 27.2 t -57.98 -44.71 87.3 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.944 0.402 . . . . 0.34 110.006 178.345 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . 0.689 HH21 ' HB3' ' A' ' 176' ' ' ASP . 0.2 OUTLIER -61.02 -44.62 97.14 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 115.658 -0.701 . . . . 0.49 111.611 179.117 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' TYR . . . . . 0.906 ' HE1' ' HA ' ' A' ' 195' ' ' ARG . 75.6 t80 -68.22 -51.18 48.33 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 111.824 0.305 . . . . 0.38 111.824 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 8.6 mp -58.85 -41.29 86.62 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.713 -0.221 . . . . 0.46 111.455 -179.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . 0.418 ' HD3' ' OD1' ' A' ' 176' ' ' ASP . 5.4 mtt-85 -67.27 -39.67 86.08 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.009 0.433 . . . . 0.86 111.029 179.122 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -68.57 -48.19 64.87 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.159 -0.473 . . . . 0.73 111.377 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . 0.45 ' HG3' ' CZ ' ' A' ' 166' ' ' TYR . 27.6 mm-40 -65.56 -25.97 67.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.699 0.285 . . . . 0.54 111.158 178.779 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -79.24 -32.63 43.89 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 116.486 -0.325 . . . . 0.52 111.401 178.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 2.9 p -82.83 -23.09 33.92 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 111.88 0.326 . . . . 0.7 111.88 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 73.35 17.37 78.86 Favored Glycine 0 CA--C 1.521 0.423 0 C-N-CA 121.072 -0.585 . . . . 0.7 113.131 179.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 72.0 p -151.07 -92.67 0.06 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.865 0.364 . . . . 0.94 111.468 -179.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -145.95 127.21 14.82 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.089 0.471 . . . . 1.36 111.46 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . 0.689 ' HB3' HH21 ' A' ' 165' ' ' ARG . 0.1 OUTLIER -87.31 129.4 35.02 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.118 0.485 . . . . 0.63 110.751 179.388 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 56.6 m -85.84 70.8 10.69 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.294 -0.412 . . . . 0.92 111.859 -179.299 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . 0.527 ' HG2' ' HD2' ' A' ' 179' ' ' PRO . 6.3 ttpp -136.99 133.32 18.57 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 116.533 -0.303 . . . . 0.56 111.01 179.396 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . 0.527 ' HD2' ' HG2' ' A' ' 178' ' ' LYS . 59.6 Cg_endo -73.5 144.78 36.67 Favored 'Trans proline' 0 CA--C 1.531 0.338 0 C-N-CA 122.348 2.032 . . . . 0.81 112.317 179.192 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 11.6 mt -87.83 -19.65 27.15 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.44 -0.345 . . . . 0.59 111.922 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 55.26 -114.84 5.05 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 114.303 0.481 . . . . 0.68 114.303 179.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . 0.614 ' OE2' ' HD2' ' A' ' 157' ' ' ARG . 2.5 mp0 -70.95 -5.8 33.68 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 112.444 0.535 . . . . 1.04 112.444 -179.683 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.488 ' O ' ' HA3' ' A' ' 187' ' ' GLY . . . -105.87 56.68 0.67 Allowed 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 120.933 0.397 . . . . 0.54 111.269 179.521 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -79.13 -70.51 1.32 Allowed Glycine 0 CA--C 1.524 0.634 0 C-N-CA 120.696 -0.764 . . . . 0.48 113.479 -179.526 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -61.83 -55.91 24.94 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 120.774 0.321 . . . . 0.46 111.253 -179.657 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -62.31 -37.34 85.2 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.265 -0.425 . . . . 0.4 110.452 179.083 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . 0.507 ' HA2' HG12 ' A' ' 162' ' ' ILE . . . -63.2 -42.81 99.29 Favored Glycine 0 C--N 1.334 0.464 0 C-N-CA 121.2 -0.524 . . . . 0.35 112.659 179.528 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 40.8 ttt-85 -62.55 -48.93 77.34 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 117.022 0.411 . . . . 0.96 110.907 179.24 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . 0.749 ' HB3' HG11 ' A' ' 297' ' ' VAL . 34.8 mtp180 -66.28 -41.28 90.05 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.218 -0.446 . . . . 0.5 111.264 179.515 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -68.91 -45.86 69.8 Favored 'General case' 0 C--O 1.219 -0.504 0 CA-C-N 116.177 -0.465 . . . . 0.36 111.836 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . 0.447 ' HB2' ' O ' ' A' ' 187' ' ' GLY . 0.9 OUTLIER -59.37 -45.78 90.49 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.626 0.25 . . . . 0.66 111.22 179.505 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -62.34 -49.67 74.67 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 121.101 0.477 . . . . 0.59 111.172 179.389 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . 0.42 HG21 ' HA ' ' A' ' 297' ' ' VAL . 25.7 m -66.04 -51.2 60.43 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.01 -0.541 . . . . 0.52 111.7 -179.533 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 0.514 HD21 HG21 ' A' ' 249' ' ' ILE . 12.6 tp -58.27 -40.4 81.76 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.222 -0.445 . . . . 0.35 111.736 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . 0.906 ' HA ' ' HE1' ' A' ' 166' ' ' TYR . 43.4 ttm180 -61.31 -53.58 54.95 Favored 'General case' 0 N--CA 1.461 0.121 0 CA-C-O 120.606 0.241 . . . . 0.85 110.705 178.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 22.9 ttm105 -60.96 -50.17 74.48 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.24 -0.437 . . . . 0.46 112.149 -179.436 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . 0.518 HG12 HG11 ' A' ' 246' ' ' VAL . 53.3 t -65.51 -48.71 81.85 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 N-CA-C 111.996 0.369 . . . . 0.38 111.996 -179.351 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . 0.539 ' HA3' ' OH ' ' A' ' 166' ' ' TYR . . . -61.5 -42.93 99.87 Favored Glycine 0 C--N 1.334 0.432 0 C-N-CA 121.108 -0.568 . . . . 0.32 113.03 -179.598 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . 0.427 ' HB2' ' O ' ' A' ' 195' ' ' ARG . 0.8 OUTLIER -62.33 -45.11 94.7 Favored 'General case' 0 N--CA 1.46 0.074 0 N-CA-C 109.564 -0.532 . . . . 0.89 109.564 178.617 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -61.22 -42.78 99.88 Favored Glycine 0 C--N 1.337 0.605 0 C-N-CA 120.841 -0.695 . . . . 0.3 111.917 178.399 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . 0.47 HG23 ' O ' ' A' ' 197' ' ' VAL . 67.4 t -62.34 -47.69 91.88 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-O 120.593 0.235 . . . . 0.38 110.936 178.536 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 202' ' ' GLN . . . . . 0.408 ' OE1' ' HD1' ' A' ' 254' ' ' PHE . 37.6 mt-30 -65.78 -41.32 92.14 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.353 -0.385 . . . . 0.38 111.476 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.64 -37.3 85.82 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.03 0.443 . . . . 0.65 110.546 179.077 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 18.0 m-80 -78.18 -52.37 8.8 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.155 -0.475 . . . . 0.62 111.477 179.468 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 205' ' ' HIS . . . . . 0.441 ' ND1' HG12 ' B' ' 30' ' ' ILE . 75.4 m-70 -92.18 35.86 0.99 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.743 0.306 . . . . 0.68 111.306 -179.373 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -58.29 -49.68 76.28 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.424 0.527 . . . . 0.56 112.424 -179.015 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 69.2 p -60.49 -39.31 87.21 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.896 0.379 . . . . 0.5 111.722 -179.538 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -66.65 -50.38 63.13 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-N 115.915 -0.584 . . . . 0.33 110.78 179.561 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 209' ' ' PHE . . . . . 0.46 ' HB3' ' CD2' ' A' ' 254' ' ' PHE . 31.0 m-85 -63.17 -41.09 99.17 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.882 -0.599 . . . . 0.5 110.495 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 12.0 mt-30 -59.48 -45.44 91.66 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-N 116.103 -0.498 . . . . 0.54 111.408 179.245 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -55.77 -50.17 62.28 Favored Glycine 0 C--N 1.334 0.461 0 C-N-CA 120.644 -0.789 . . . . 0.33 111.645 179.261 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 212' ' ' MET . . . . . 0.603 ' HG2' ' HA ' ' B' ' 23' ' ' PHE . 6.6 mtp -64.65 -37.08 86.35 Favored 'General case' 0 C--O 1.225 -0.212 0 CA-C-O 120.561 0.22 . . . . 0.54 111.012 178.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.456 HD11 ' HA ' ' A' ' 255' ' ' VAL . 6.6 tp -67.49 -42.97 82.03 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 112.022 0.378 . . . . 0.61 112.022 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 214' ' ' ARG . . . . . 0.457 HH11 ' HD3' ' A' ' 214' ' ' ARG . 40.3 mtt180 -61.6 -40.05 93.42 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.932 0.396 . . . . 1.13 110.833 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 215' ' ' LYS . . . . . 0.53 ' HE2' ' HA ' ' A' ' 215' ' ' LYS . 0.0 OUTLIER -95.85 13.36 26.97 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.85 -0.34 . . . . 0.55 111.03 178.584 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 11.3 tp -78.34 100.04 6.59 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.891 0.377 . . . . 0.55 110.398 179.222 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 217' ' ' ASP . . . . . 0.638 ' H ' HD11 ' B' ' 19' ' ' LEU . 0.2 OUTLIER -82.73 33.06 0.42 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.28 -0.418 . . . . 0.51 111.957 -179.365 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 218' ' ' ILE . . . . . 0.684 HG12 ' HB3' ' A' ' 223' ' ' ASP . 47.6 mt -87.53 119.08 34.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.766 0.317 . . . . 0.48 110.66 179.278 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.63 -15.32 0.73 Allowed 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 112.772 0.656 . . . . 0.52 112.772 -179.204 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . 0.41 ' HA ' ' CE1' ' A' ' 267' ' ' PHE . 7.4 p30 -132.31 -178.37 4.88 Favored 'General case' 0 CA--C 1.541 0.613 0 O-C-N 122.002 -0.436 . . . . 0.55 112.154 -179.663 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . 0.573 ' O ' HG22 ' A' ' 224' ' ' VAL . 1.9 mp0 -69.59 -21.99 63.55 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 112.902 0.704 . . . . 0.73 112.902 -178.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -72.6 -26.86 70.55 Favored Glycine 0 CA--C 1.523 0.551 0 C-N-CA 120.66 -0.781 . . . . 0.47 112.685 179.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 223' ' ' ASP . . . . . 0.684 ' HB3' HG12 ' A' ' 218' ' ' ILE . 61.2 m-20 -65.52 -30.48 71.24 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 112.128 0.418 . . . . 0.56 112.128 -179.624 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.573 HG22 ' O ' ' A' ' 221' ' ' GLU . 4.1 m -56.39 -28.25 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 N-CA-C 111.878 0.325 . . . . 0.47 111.878 179.612 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . 0.473 ' HD2' ' H ' ' A' ' 225' ' ' LYS . 7.7 mptt -64.67 -36.79 85.4 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.192 0.52 . . . . 0.73 110.037 178.587 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . 0.509 ' O ' HG23 ' A' ' 230' ' ' VAL . 7.8 t -69.31 -35.02 75.56 Favored 'General case' 0 N--CA 1.462 0.148 0 N-CA-C 108.901 -0.777 . . . . 0.45 108.901 177.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 227' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -61.74 -37.63 84.96 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 115.269 -0.878 . . . . 0.44 109.601 177.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 228' ' ' SER . . . . . 0.4 ' O ' HG22 ' A' ' 232' ' ' VAL . 69.1 m -66.37 -40.43 89.73 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.093 -0.503 . . . . 0.45 109.804 178.036 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 73.0 mtp180 -58.13 -37.66 75.03 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.031 -0.531 . . . . 0.86 110.381 178.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 0.582 HG13 ' HA ' ' B' ' 24' ' ' ALA . 36.3 t -66.32 -46.74 86.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.946 -0.57 . . . . 0.37 110.107 178.337 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 231' ' ' MET . . . . . 0.514 ' HE1' ' HA ' ' A' ' 275' ' ' ILE . 60.3 mtm -63.94 -48.35 76.85 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.017 -0.538 . . . . 0.46 111.852 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 232' ' ' VAL . . . . . 0.4 HG22 ' O ' ' A' ' 228' ' ' SER . 31.1 m -62.9 -31.24 51.75 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 C-N-CA 120.585 -0.446 . . . . 0.38 110.508 179.048 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 233' ' ' HIS . . . . . 0.686 ' CD2' ' HB1' ' B' ' 24' ' ' ALA . 8.7 t60 -67.91 -44.44 76.92 Favored 'General case' 0 CA--C 1.528 0.125 0 N-CA-C 109.126 -0.694 . . . . 0.32 109.126 177.109 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.536 ' HA ' ' HG3' ' B' ' 28' ' ' ARG . 51.2 t -56.46 -42.46 75.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 CA-C-N 115.775 -0.648 . . . . 0.43 110.78 179.633 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -99.79 23.74 9.28 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.001 0.371 . . . . 0.6 112.001 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 2.6 ttpp -73.01 -13.73 61.28 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.799 0.333 . . . . 1.13 111.361 179.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -86.16 -16.21 38.57 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 120.88 0.371 . . . . 0.62 110.988 179.527 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 92.48 -19.08 52.82 Favored Glycine 0 CA--C 1.524 0.636 0 C-N-CA 121.032 -0.604 . . . . 0.4 113.84 179.179 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 6.1 p -83.9 117.25 29.19 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-O 121.625 0.726 . . . . 0.5 111.727 -179.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 240' ' ' THR . . . . . 0.411 HG21 ' HG2' ' A' ' 283' ' ' LYS . 10.8 m -94.9 117.3 29.91 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.057 0.456 . . . . 0.4 111.577 179.764 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -113.48 141.54 47.0 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.5 -0.318 . . . . 0.58 110.639 179.157 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 242' ' ' TRP . . . . . 0.529 ' CZ3' ' HB2' ' A' ' 296' ' ' PHE . 24.8 m95 -60.02 -42.4 94.28 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 120.721 0.296 . . . . 0.38 110.424 178.419 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . 0.434 ' HA3' ' N ' ' B' ' 35' ' ' TYR . . . -60.26 -33.31 79.81 Favored Glycine 0 C--N 1.336 0.531 0 C-N-CA 120.967 -0.635 . . . . 0.27 111.816 178.187 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 244' ' ' ARG . . . . . 0.503 ' HA ' ' HA3' ' B' ' 31' ' ' GLY . 50.1 mtt180 -69.25 -51.43 37.7 Favored 'General case' 0 C--O 1.232 0.153 0 N-CA-C 109.569 -0.53 . . . . 0.39 109.569 178.099 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . 0.527 HG23 HD21 ' A' ' 279' ' ' LEU . 83.1 mt -55.94 -48.32 78.73 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 CA-C-N 115.582 -0.735 . . . . 0.44 110.89 179.455 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . 0.518 HG11 HG12 ' A' ' 197' ' ' VAL . 96.1 t -64.69 -32.32 57.46 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-N 116.471 -0.331 . . . . 0.59 110.984 179.46 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . 0.497 HG22 HD22 ' B' ' 27' ' ' LEU . 20.2 m -63.35 -44.35 95.07 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.611 0.243 . . . . 0.35 110.448 178.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 248' ' ' LEU . . . . . 0.502 HD22 ' HG2' ' A' ' 231' ' ' MET . 54.2 mt -62.2 -41.2 98.15 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.396 0.617 . . . . 0.47 109.857 178.454 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 249' ' ' ILE . . . . . 0.514 HG21 HD21 ' A' ' 194' ' ' LEU . 27.8 mt -66.45 -39.98 85.38 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 CA-C-N 115.782 -0.644 . . . . 0.45 110.013 178.115 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 49.4 m -62.91 -41.77 99.56 Favored 'General case' 0 N--CA 1.461 0.115 0 N-CA-C 109.148 -0.686 . . . . 0.39 109.148 178.154 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 251' ' ' PHE . . . . . 0.502 ' CD2' HD11 ' B' ' 27' ' ' LEU . 8.7 t80 -62.14 -42.17 98.99 Favored 'General case' 0 C--O 1.226 -0.15 0 N-CA-C 108.821 -0.807 . . . . 0.41 108.821 177.518 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -57.68 -46.79 91.79 Favored Glycine 0 C--N 1.335 0.527 0 N-CA-C 111.053 -0.819 . . . . 0.27 111.053 177.451 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 253' ' ' ALA . . . . . 0.486 ' O ' ' HG3' ' A' ' 257' ' ' LYS . . . -64.34 -35.33 80.53 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 120.617 0.246 . . . . 0.31 111.245 177.627 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 254' ' ' PHE . . . . . 0.46 ' CD2' ' HB3' ' A' ' 209' ' ' PHE . 2.5 t80 -71.07 -43.76 67.11 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 120.617 0.246 . . . . 0.78 111.25 179.373 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 255' ' ' VAL . . . . . 0.456 ' HA ' HD11 ' A' ' 213' ' ' LEU . 23.7 m -68.04 -34.58 67.7 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.109 0 N-CA-C 109.354 -0.61 . . . . 0.36 109.354 178.269 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -60.91 -36.72 80.0 Favored 'General case' 0 C--O 1.227 -0.127 0 N-CA-C 109.371 -0.604 . . . . 0.32 109.371 177.009 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 257' ' ' LYS . . . . . 0.486 ' HG3' ' O ' ' A' ' 253' ' ' ALA . 59.3 mttp -62.42 -45.66 92.08 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 109.608 -0.515 . . . . 0.58 109.608 177.24 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 258' ' ' HIS . . . . . 0.429 ' HB2' HD11 ' A' ' 213' ' ' LEU . 22.2 t60 -60.76 -36.58 79.29 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.722 -0.672 . . . . 0.79 110.774 179.363 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 78.4 mt -74.95 -45.05 44.89 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.301 -0.408 . . . . 0.62 110.662 178.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 1.5 tptp -62.19 -34.82 77.18 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 120.717 0.294 . . . . 0.46 110.838 179.359 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 49.2 m -63.12 -24.31 67.84 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.254 -0.43 . . . . 0.52 110.946 179.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 262' ' ' VAL . . . . . 0.553 HG23 ' HG3' ' A' ' 264' ' ' GLN . 16.0 m -114.88 19.03 7.34 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-N 116.239 -0.437 . . . . 0.63 110.882 178.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 57.44 52.37 8.68 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 113.073 0.768 . . . . 1.15 113.073 179.417 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 264' ' ' GLN . . . . . 0.553 ' HG3' HG23 ' A' ' 262' ' ' VAL . 23.0 mt-30 -119.72 36.26 4.57 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 112.087 0.402 . . . . 0.75 112.087 179.332 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . 0.482 ' HA ' HD12 ' A' ' 268' ' ' ILE . 2.2 pm0 -57.74 -23.73 53.49 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-O 120.828 0.347 . . . . 0.62 111.656 179.061 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 54.4 p -61.62 -21.18 64.13 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.016 -0.538 . . . . 0.7 110.403 178.313 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 267' ' ' PHE . . . . . 0.509 ' C ' ' HD2' ' A' ' 270' ' ' PRO . 90.8 m-85 -95.3 -20.25 19.32 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 116.093 -0.503 . . . . 0.66 110.578 178.594 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 268' ' ' ILE . . . . . 0.482 HD12 ' HA ' ' A' ' 265' ' ' GLU . 78.6 mt -67.31 -41.16 86.17 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-N 116.26 -0.427 . . . . 0.42 110.078 178.574 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 269' ' ' GLU . . . . . 0.771 ' HB2' ' HD3' ' A' ' 270' ' ' PRO . 2.2 mm-40 -53.8 -56.4 25.75 Favored Pre-proline 0 CA--C 1.546 0.789 0 CA-C-N 116.089 -0.505 . . . . 0.76 111.122 178.591 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 270' ' ' PRO . . . . . 0.771 ' HD3' ' HB2' ' A' ' 269' ' ' GLU . 33.4 Cg_exo -62.23 -30.29 81.44 Favored 'Trans proline' 0 C--N 1.362 1.268 0 C-N-CA 122.139 1.892 . . . . 0.42 111.675 177.708 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 271' ' ' LEU . . . . . 0.404 ' HA ' HD23 ' A' ' 271' ' ' LEU . 4.3 mt -62.69 -50.41 71.24 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.286 -0.416 . . . . 0.71 110.045 177.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -56.29 -36.39 68.59 Favored 'General case' 0 N--CA 1.461 0.111 0 CA-C-N 116.147 -0.479 . . . . 0.45 110.825 179.143 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 273' ' ' GLU . . . . . 0.634 ' HA ' HD21 ' A' ' 160' ' ' LEU . 1.2 mm-40 -72.39 -50.79 23.96 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.102 -0.499 . . . . 1.39 110.658 178.381 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 274' ' ' THR . . . . . 0.487 HG21 ' HB ' ' A' ' 224' ' ' VAL . 25.3 m -58.45 -45.97 87.48 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.297 -0.41 . . . . 0.54 111.8 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 275' ' ' ILE . . . . . 0.514 ' HA ' ' HE1' ' A' ' 231' ' ' MET . 92.0 mt -63.77 -55.33 23.1 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 CA-C-N 116.558 -0.292 . . . . 0.49 111.089 179.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 22.0 m -58.08 -47.71 82.35 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.26 -0.427 . . . . 0.36 111.604 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 277' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -50.98 -58.64 5.53 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.385 -0.371 . . . . 0.54 111.7 179.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 61.4 t -64.65 -39.52 85.9 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 N-CA-C 111.816 0.302 . . . . 0.49 111.816 -179.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . 0.527 HD21 HG23 ' A' ' 245' ' ' ILE . 51.3 tp -64.59 -47.21 79.49 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 112.582 0.586 . . . . 0.74 112.582 -179.123 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 86.1 t -73.61 -46.78 47.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 N-CA-C 112.826 0.676 . . . . 0.49 112.826 -178.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 39.4 mtm105 -62.01 -43.61 98.48 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 112.533 0.568 . . . . 0.57 112.533 -178.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 282' ' ' THR . . . . . . . . . . . . . 68.6 p -69.16 -15.19 63.35 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 112.111 0.412 . . . . 0.33 112.111 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . 0.51 ' HB3' HD23 ' A' ' 287' ' ' LEU . 0.1 OUTLIER -128.23 36.53 4.28 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 111.723 0.268 . . . . 0.62 111.723 -179.566 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 36.3 ttm180 -53.17 -54.24 38.83 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 112.607 0.595 . . . . 1.07 112.607 -179.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -66.99 -33.96 76.7 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 111.862 0.319 . . . . 0.63 111.862 -178.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 286' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -70.14 -39.75 75.19 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.013 0.435 . . . . 0.72 110.489 179.647 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 287' ' ' LEU . . . . . 0.563 HD13 ' HA2' ' A' ' 292' ' ' GLY . 1.9 mm? -65.99 -46.77 76.8 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 115.878 -0.601 . . . . 0.5 111.587 179.782 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 30.8 m -65.83 -31.6 54.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 C-N-CA 121.003 -0.279 . . . . 0.44 111.41 179.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 26.2 mtmm -72.28 -32.79 66.94 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 112.384 0.513 . . . . 0.97 112.384 179.585 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 290' ' ' GLN . . . . . 0.469 HE21 ' N ' ' A' ' 290' ' ' GLN . 0.0 OUTLIER -101.73 15.45 28.91 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 112.683 0.623 . . . . 0.96 112.683 -179.231 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 291' ' ' ARG . . . . . 0.624 ' HB3' ' HB2' ' A' ' 294' ' ' ASP . 0.0 OUTLIER 59.92 24.13 13.21 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-O 121.174 0.511 . . . . 0.64 112.106 179.734 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 292' ' ' GLY . . . . . 0.563 ' HA2' HD13 ' A' ' 287' ' ' LEU . . . 58.4 -117.87 11.88 Favored Glycine 0 CA--C 1.522 0.494 0 CA-C-N 115.615 -0.721 . . . . 0.32 114.795 179.446 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 293' ' ' TRP . . . . . 0.412 ' O ' HG23 ' A' ' 297' ' ' VAL . 83.9 m95 -67.19 -33.51 75.55 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 112.808 0.67 . . . . 0.49 112.808 -178.368 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 294' ' ' ASP . . . . . 0.624 ' HB2' ' HB3' ' A' ' 291' ' ' ARG . 60.7 m-20 -53.09 -49.76 65.79 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 118.026 0.375 . . . . 0.46 111.098 179.143 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -65.02 -50.43 57.79 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.687 -0.768 . . . . 0.33 111.488 178.522 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 296' ' ' PHE . . . . . 0.529 ' HB2' ' CZ3' ' A' ' 242' ' ' TRP . 0.4 OUTLIER -53.58 -45.0 69.83 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 122.586 0.354 . . . . 0.38 111.766 179.212 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 297' ' ' VAL . . . . . 0.749 HG11 ' HB3' ' A' ' 189' ' ' ARG . 52.0 t -63.4 -53.59 43.54 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 N-CA-C 112.351 0.5 . . . . 0.34 112.351 -178.679 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 298' ' ' GLU . . . . . 0.669 ' HA ' ' HB2' ' A' ' 301' ' ' HIS . 0.1 OUTLIER -70.74 -26.89 63.57 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.617 -0.433 . . . . 0.45 111.911 -179.255 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 299' ' ' PHE . . . . . . . . . . . . . 90.9 t80 -62.5 -44.16 97.06 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 109.848 -0.427 . . . . 0.51 109.848 177.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 300' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -87.47 8.46 24.71 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 121.344 0.593 . . . . 0.58 110.841 178.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 301' ' ' HIS . . . . . 0.669 ' HB2' ' HA ' ' A' ' 298' ' ' GLU . 2.2 m170 -104.25 -44.22 5.02 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 115.774 -0.648 . . . . 0.61 109.914 177.873 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 7.4 p -136.94 136.14 47.81 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-N 116.015 -0.538 . . . . 0.7 110.489 179.047 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -76.46 64.74 2.21 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 120.72 0.295 . . . . 0.82 111.742 -179.51 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 51.2 t0 -85.32 107.81 17.51 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.283 0.564 . . . . 0.84 110.523 179.494 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 83.5 mt -107.67 -24.46 11.72 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.857 -0.61 . . . . 1.57 110.858 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -87.91 -35.04 17.93 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.03 -0.532 . . . . 2.18 112.242 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . 108.57 92.92 2.26 Favored Glycine 0 CA--C 1.522 0.502 0 C-N-CA 120.423 -0.894 . . . . 1.27 113.168 179.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.296 0 CA-C-O 118.64 -1.089 . . . . 1.73 113.425 179.597 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.428 0 CA-C-O 120.262 0.077 . . . . 0.68 110.889 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.3 162.92 24.32 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 121.014 0.435 . . . . 1.53 111.618 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 19' ' ' LEU . . . . . 0.638 HD11 ' H ' ' A' ' 217' ' ' ASP . 0.9 OUTLIER -110.52 108.64 58.3 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 116.191 -0.459 . . . . 0.51 111.325 -179.643 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 20' ' ' PRO . . . . . 0.476 ' HA ' ' HD3' ' B' ' 21' ' ' PRO . 37.8 Cg_endo -66.14 130.4 24.1 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.777 2.318 . . . . 0.77 112.984 -179.423 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 21' ' ' PRO . . . . . 0.476 ' HD3' ' HA ' ' B' ' 20' ' ' PRO . 37.1 Cg_exo -61.14 3.36 0.33 Allowed 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 123.229 2.619 . . . . 0.55 114.28 -179.212 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 22' ' ' GLU . . . . . 0.492 ' O ' ' HB2' ' B' ' 26' ' ' GLN . 3.4 mm-40 -73.69 -17.09 61.18 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 112.02 0.378 . . . . 0.41 112.02 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 23' ' ' PHE . . . . . 0.603 ' HA ' ' HG2' ' A' ' 212' ' ' MET . 0.8 OUTLIER -68.97 -40.78 78.65 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 120.222 -0.591 . . . . 0.42 110.929 179.166 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 24' ' ' ALA . . . . . 0.686 ' HB1' ' CD2' ' A' ' 233' ' ' HIS . . . -70.5 -39.44 74.14 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.552 0.691 . . . . 0.34 109.767 179.371 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -65.79 -46.61 78.08 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 114.905 -1.043 . . . . 0.31 109.993 178.231 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 26' ' ' GLN . . . . . 0.492 ' HB2' ' O ' ' B' ' 22' ' ' GLU . 0.8 OUTLIER -58.83 -53.89 53.24 Favored 'General case' 0 C--O 1.224 -0.268 0 CA-C-N 116.159 -0.473 . . . . 0.35 111.323 179.504 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . 0.502 HD11 ' CD2' ' A' ' 251' ' ' PHE . 19.3 mt -54.74 -36.42 64.77 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.641 0.258 . . . . 0.43 110.938 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 28' ' ' ARG . . . . . 0.536 ' HG3' ' HA ' ' A' ' 234' ' ' VAL . 0.2 OUTLIER -70.59 -53.24 16.76 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.539 -0.3 . . . . 0.52 110.204 178.102 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 21.4 mttt -53.28 -47.76 68.89 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.251 0.548 . . . . 0.44 110.614 179.056 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . 0.441 HG12 ' ND1' ' A' ' 205' ' ' HIS . 84.8 mt -64.25 -45.22 96.83 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 CA-C-N 115.331 -0.85 . . . . 0.39 110.603 179.626 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . 0.503 ' HA3' ' HA ' ' A' ' 244' ' ' ARG . . . -57.84 -49.37 75.07 Favored Glycine 0 C--N 1.334 0.419 0 C-N-CA 120.974 -0.631 . . . . 0.29 112.749 179.736 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -62.26 -42.76 99.62 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 121.17 0.51 . . . . 0.41 110.279 179.334 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 33' ' ' LYS . . . . . 0.516 ' HE2' ' HG3' ' B' ' 43' ' ' MET . 0.0 OUTLIER -62.69 -57.45 10.97 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.792 -0.64 . . . . 1.15 111.784 179.646 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 71.1 t -54.53 -44.14 67.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 O-C-N 123.308 0.38 . . . . 0.43 111.268 -179.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 35' ' ' TYR . . . . . 0.434 ' N ' ' HA3' ' A' ' 243' ' ' GLY . 0.6 OUTLIER -56.77 -43.48 80.88 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 121.044 0.449 . . . . 0.79 110.477 178.699 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 36' ' ' CYS . . . . . . . . . . . . . 66.0 m -68.95 -40.97 78.62 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.352 -0.385 . . . . 0.39 111.418 179.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 8.4 m -59.13 -40.83 86.68 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 113.091 0.774 . . . . 0.44 113.091 -179.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 38' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -83.6 -36.67 23.74 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 112.42 0.526 . . . . 0.54 112.42 -178.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 65.9 p -72.45 -63.39 1.16 Allowed 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.727 0.298 . . . . 0.45 110.762 179.147 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . 0.475 ' HA ' ' HD3' ' B' ' 41' ' ' PRO . . . -90.85 136.71 27.38 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 116.404 -0.362 . . . . 0.51 111.046 179.313 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 41' ' ' PRO . . . . . 0.475 ' HD3' ' HA ' ' B' ' 40' ' ' ALA . 11.9 Cg_exo -71.07 56.7 2.0 Allowed 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 122.755 2.303 . . . . 0.76 112.769 179.433 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -145.05 -152.06 0.4 Allowed 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 116.056 -0.52 . . . . 0.95 110.071 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 43' ' ' MET . . . . . 0.516 ' HG3' ' HE2' ' B' ' 33' ' ' LYS . 44.9 tpp . . . . . 0 C--O 1.25 1.113 0 CA-C-O 118.573 -0.727 . . . . 2.96 111.747 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.234 0 CA-C-O 120.246 -0.197 . . . . 0.0 113.092 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -60.56 -40.61 54.87 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 123.126 2.551 . . . . 0.0 113.589 -179.603 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -86.59 -66.48 0.9 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.973 0.416 . . . . 0.0 110.695 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -154.93 -135.17 2.0 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.915 -0.66 . . . . 0.0 111.997 179.463 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 12.9 p -115.42 33.05 5.67 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.001 0.429 . . . . 0.0 110.99 179.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -134.12 -28.74 1.32 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.884 179.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . 0.541 ' HA ' ' HB3' ' A' ' 156' ' ' TYR . 1.0 OUTLIER -59.98 -29.04 68.18 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.784 0.326 . . . . 0.0 111.189 -179.637 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -62.78 -43.67 98.18 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.16 178.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 48.4 tp -77.56 -36.5 52.09 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 178.048 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . 0.541 ' HB3' ' HA ' ' A' ' 153' ' ' ASP . 69.7 t80 -58.54 -38.22 77.35 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 115.105 -0.952 . . . . 0.0 111.739 179.575 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.539 ' HD2' ' OE2' ' A' ' 161' ' ' GLU . 0.0 OUTLIER -56.46 -53.04 62.12 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.999 0.428 . . . . 0.0 110.352 178.976 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . 0.455 ' HG2' ' HB2' ' A' ' 183' ' ' ALA . 26.9 mt-30 -68.44 -37.46 80.26 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.58 179.166 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 41.4 m -57.83 -50.69 72.43 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.367 179.266 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.516 ' HA ' HG21 ' A' ' 276' ' ' THR . 2.3 tm? -58.69 -47.43 84.56 Favored 'General case' 0 C--O 1.225 -0.232 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.451 178.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . 0.539 ' OE2' ' HD2' ' A' ' 157' ' ' ARG . 30.8 mt-10 -60.52 -51.1 70.89 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 111.949 0.352 . . . . 0.0 111.949 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . 0.517 HG12 ' HA2' ' A' ' 187' ' ' GLY . 46.2 mt -58.87 -51.68 69.37 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 CA-C-O 120.636 0.255 . . . . 0.0 111.145 179.633 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.603 ' O ' ' HG ' ' A' ' 167' ' ' LEU . 89.5 mt -62.04 -48.08 90.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-N 116.646 -0.252 . . . . 0.0 111.414 179.589 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . 0.54 ' O ' ' HB2' ' A' ' 168' ' ' ARG . 1.2 t -57.7 -42.34 83.5 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 120.751 0.31 . . . . 0.0 111.322 179.452 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . 0.445 ' HA ' ' HD3' ' A' ' 165' ' ' ARG . 5.7 tpp180 -72.37 -37.0 68.87 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 121.08 -0.248 . . . . 0.0 111.225 179.758 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' TYR . . . . . 0.829 ' CE1' ' HA ' ' A' ' 195' ' ' ARG . 39.1 t80 -66.27 -52.79 44.01 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.679 -0.237 . . . . 0.0 111.622 179.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.603 ' HG ' ' O ' ' A' ' 163' ' ' ILE . 20.7 mt -61.95 -40.6 96.1 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.712 -0.222 . . . . 0.0 110.789 -179.728 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . 0.54 ' HB2' ' O ' ' A' ' 164' ' ' SER . 0.5 OUTLIER -62.15 -44.44 96.61 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 120.953 0.406 . . . . 0.0 110.506 179.215 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . 0.505 ' HG2' ' HA ' ' A' ' 175' ' ' LYS . 2.2 mt-10 -60.83 -48.11 83.29 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.164 178.613 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 6.8 mm-40 -61.55 -43.49 98.76 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.149 179.126 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -70.49 -44.24 68.07 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -179.074 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 31.8 p -67.61 -25.85 65.96 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 120.851 -0.34 . . . . 0.0 111.502 179.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 80.97 29.06 43.28 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 120.527 -0.844 . . . . 0.0 112.472 179.26 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 21.1 t -164.44 -138.09 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.631 0.253 . . . . 0.0 110.486 -179.466 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . 0.505 ' HA ' ' HG2' ' A' ' 169' ' ' GLU . 15.0 tptp -125.08 126.33 45.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.844 0.354 . . . . 0.0 111.333 179.61 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . 0.427 ' H ' ' HG3' ' A' ' 169' ' ' GLU . 59.7 t0 -64.92 128.03 34.06 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.241 178.78 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 71.8 p -75.1 -10.37 59.41 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.773 179.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.22 131.79 23.59 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 120.767 0.318 . . . . 0.0 111.221 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -61.57 154.46 59.57 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.627 2.218 . . . . 0.0 112.533 179.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.505 HD11 ' HA3' ' A' ' 187' ' ' GLY . 0.4 OUTLIER -85.27 78.05 9.87 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.299 0.571 . . . . 0.0 111.232 -179.797 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 58.38 -115.72 7.46 Favored Glycine 0 C--N 1.332 0.323 0 CA-C-N 115.019 -0.991 . . . . 0.0 113.731 179.157 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -124.66 -0.73 8.03 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.82 0.343 . . . . 0.0 110.976 -179.268 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.524 ' O ' ' HA3' ' A' ' 187' ' ' GLY . . . -69.54 81.03 0.4 Allowed 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 121.092 0.472 . . . . 0.0 111.029 178.574 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -79.89 -70.5 1.33 Allowed Glycine 0 CA--C 1.524 0.595 0 C-N-CA 121.069 -0.586 . . . . 0.0 113.961 -179.588 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -63.92 -55.51 22.1 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 111.998 0.37 . . . . 0.0 111.998 -178.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -68.0 -33.68 75.09 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.354 179.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . 0.524 ' HA3' ' O ' ' A' ' 183' ' ' ALA . . . -66.94 -41.62 93.22 Favored Glycine 0 C--O 1.225 -0.429 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.559 178.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 3.9 tpt180 -63.01 -53.9 46.7 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 120.615 0.245 . . . . 0.0 111.279 179.202 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . 0.408 HH11 ' HD3' ' A' ' 189' ' ' ARG . 28.0 mtp180 -62.79 -44.04 97.21 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.592 -179.728 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -70.3 -48.77 55.15 Favored 'General case' 0 C--O 1.22 -0.468 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -179.166 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 19.3 tp -60.19 -42.83 95.9 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 118.359 0.527 . . . . 0.0 111.746 -179.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -63.69 -46.02 87.41 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 121.136 0.493 . . . . 0.0 110.934 179.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 34.3 m -68.4 -45.48 72.55 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.889 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 0.526 HD21 HG21 ' A' ' 249' ' ' ILE . 12.3 tp -59.77 -37.43 79.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.084 -179.636 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . 0.829 ' HA ' ' CE1' ' A' ' 166' ' ' TYR . 11.5 ttp180 -70.8 -53.36 15.65 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.508 179.034 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . 0.4 ' C ' ' HD3' ' A' ' 196' ' ' ARG . 0.0 OUTLIER -59.36 -48.2 82.52 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.888 -179.935 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . 0.62 HG21 ' HB3' ' A' ' 300' ' ' PHE . 73.5 t -70.89 -47.92 59.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.334 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . 0.462 ' O ' ' HG2' ' A' ' 202' ' ' GLN . . . -56.19 -43.51 89.0 Favored Glycine 0 C--N 1.338 0.645 0 N-CA-C 111.371 -0.691 . . . . 0.0 111.371 179.367 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . 0.534 ' HB2' ' O ' ' A' ' 195' ' ' ARG . 0.4 OUTLIER -58.26 -48.5 80.25 Favored 'General case' 0 C--O 1.226 -0.138 0 O-C-N 123.963 0.449 . . . . 0.0 109.83 177.951 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -62.89 -41.17 99.93 Favored Glycine 0 CA--C 1.524 0.597 0 C-N-CA 121.085 -0.579 . . . . 0.0 112.601 179.247 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . 0.716 HG13 HG21 ' B' ' 34' ' ' VAL . 70.3 t -58.06 -51.7 67.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 CA-C-O 120.786 0.327 . . . . 0.0 111.127 179.254 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 202' ' ' GLN . . . . . 0.551 ' HG3' ' CZ ' ' A' ' 203' ' ' ARG . 1.2 pt20 -72.35 -31.68 65.83 Favored 'General case' 0 C--O 1.222 -0.36 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.404 179.745 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 203' ' ' ARG . . . . . 0.551 ' CZ ' ' HG3' ' A' ' 202' ' ' GLN . 0.0 OUTLIER -66.73 -38.97 87.73 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 121.247 0.546 . . . . 0.0 109.793 177.739 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -62.3 -54.21 43.94 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.968 179.17 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 205' ' ' HIS . . . . . 0.52 ' ND1' HG12 ' B' ' 30' ' ' ILE . 31.8 m-70 -101.66 37.79 1.75 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.968 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . 0.403 ' OE1' ' HA ' ' A' ' 203' ' ' ARG . 3.3 tp10 -48.02 -47.73 33.21 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -178.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -61.97 -41.62 98.21 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -73.08 -47.33 45.45 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.901 0.382 . . . . 0.0 111.149 -179.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 209' ' ' PHE . . . . . 0.52 ' CD2' ' HA ' ' A' ' 202' ' ' GLN . 8.5 m-85 -60.62 -45.13 95.2 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.534 178.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 210' ' ' GLN . . . . . 0.685 ' O ' ' HG2' ' A' ' 214' ' ' ARG . 27.8 mt-30 -68.01 -44.0 77.55 Favored 'General case' 0 C--O 1.225 -0.199 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.021 179.216 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -55.29 -50.81 58.05 Favored Glycine 0 C--N 1.335 0.507 0 C-N-CA 120.723 -0.751 . . . . 0.0 111.953 179.343 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 212' ' ' MET . . . . . 0.456 ' HG2' ' HB3' ' B' ' 23' ' ' PHE . 0.8 OUTLIER -64.25 -29.65 70.74 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.672 0.272 . . . . 0.0 110.799 178.623 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.49 HD12 HD22 ' A' ' 216' ' ' LEU . 8.4 tp -73.83 -42.33 61.03 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.488 179.334 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 214' ' ' ARG . . . . . 0.685 ' HG2' ' O ' ' A' ' 210' ' ' GLN . 16.4 mmt85 -61.39 -37.19 82.51 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.184 0.516 . . . . 0.0 109.751 178.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.71 12.52 31.62 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.992 178.624 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.78 ' HG ' HG12 ' A' ' 218' ' ' ILE . 16.2 tp -77.52 103.69 7.6 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 121.127 0.489 . . . . 0.0 110.037 179.027 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 217' ' ' ASP . . . . . 0.507 ' HB2' ' HG ' ' B' ' 19' ' ' LEU . 0.4 OUTLIER -81.71 33.03 0.36 Allowed 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 113.032 0.753 . . . . 0.0 113.032 -178.395 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 218' ' ' ILE . . . . . 0.78 HG12 ' HG ' ' A' ' 216' ' ' LEU . 50.8 mm -81.64 107.41 13.75 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-O 120.728 0.299 . . . . 0.0 110.326 178.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.59 -19.31 0.53 Allowed 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 -178.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -112.63 179.6 3.93 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -179.088 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . 0.549 ' O ' HG22 ' A' ' 224' ' ' VAL . 15.6 tm-20 -68.59 -40.74 80.38 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.775 179.587 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -58.16 -26.43 58.66 Favored Glycine 0 CA--C 1.524 0.607 0 C-N-CA 121.297 -0.478 . . . . 0.0 113.169 179.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 223' ' ' ASP . . . . . 0.566 ' HB3' HD12 ' A' ' 218' ' ' ILE . 40.2 m-20 -59.34 -30.5 68.42 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 112.94 0.719 . . . . 0.0 112.94 -179.586 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.549 HG22 ' O ' ' A' ' 221' ' ' GLU . 11.8 m -62.87 -29.17 46.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 CA-C-O 120.991 0.424 . . . . 0.0 110.828 179.444 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . 0.548 ' O ' ' HG2' ' A' ' 229' ' ' ARG . 23.5 mttp -71.32 -31.75 67.77 Favored 'General case' 0 C--O 1.232 0.15 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 179.027 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . 0.584 ' O ' HG23 ' A' ' 230' ' ' VAL . 3.8 m -65.22 -44.96 86.61 Favored 'General case' 0 C--N 1.335 -0.062 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 177.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 227' ' ' PHE . . . . . 0.478 ' HE2' HG21 ' A' ' 255' ' ' VAL . 8.7 t80 -61.94 -36.45 81.42 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.822 178.607 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 228' ' ' SER . . . . . . . . . . . . . 13.0 t -61.9 -41.38 97.83 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.714 177.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 229' ' ' ARG . . . . . 0.548 ' HG2' ' O ' ' A' ' 225' ' ' LYS . 5.7 mmp_? -70.03 -43.8 70.55 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.439 179.035 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 0.584 HG23 ' O ' ' A' ' 226' ' ' SER . 60.5 t -58.66 -47.72 87.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 178.523 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 231' ' ' MET . . . . . 0.953 ' HG3' ' HG ' ' A' ' 248' ' ' LEU . 36.5 ttm -53.09 -53.79 45.14 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.41 178.784 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 96.8 t -59.36 -44.85 93.38 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.755 179.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 233' ' ' HIS . . . . . 0.45 ' O ' ' HB2' ' A' ' 236' ' ' LYS . 2.0 t-80 -57.29 -33.95 68.18 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.512 HG23 ' O ' ' A' ' 230' ' ' VAL . 89.1 t -56.31 -32.1 34.44 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 O-C-N 121.917 -0.489 . . . . 0.0 111.623 179.683 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -103.01 25.17 9.71 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.562 -179.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . 0.45 ' HB2' ' O ' ' A' ' 233' ' ' HIS . 0.6 OUTLIER -49.65 -35.79 22.49 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 -178.804 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . 0.45 ' HB2' HG12 ' A' ' 239' ' ' VAL . 0.0 OUTLIER -71.88 -16.07 62.12 Favored 'General case' 0 N--CA 1.468 0.447 0 O-C-N 122.153 -0.342 . . . . 0.0 111.466 -179.689 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 98.18 -18.74 56.64 Favored Glycine 0 CA--C 1.52 0.371 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.162 -178.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . 0.45 HG12 ' HB2' ' A' ' 237' ' ' ASP . 4.0 p -79.48 115.55 22.0 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 CA-C-O 121.746 0.784 . . . . 0.0 111.017 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 240' ' ' THR . . . . . 0.5 HG22 HD11 ' A' ' 245' ' ' ILE . 4.2 m -90.14 74.67 7.12 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.738 -179.208 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -65.91 135.0 54.18 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 121.076 -0.249 . . . . 0.0 110.401 178.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 242' ' ' TRP . . . . . 0.547 ' HB3' ' CE2' ' A' ' 300' ' ' PHE . 2.1 m95 -56.09 -37.76 69.8 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.922 0.391 . . . . 0.0 111.147 179.664 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -65.1 -25.33 70.89 Favored Glycine 0 C--N 1.336 0.57 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.713 179.277 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 93.3 mtt180 -75.31 -45.29 40.6 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 178.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . 0.5 HD11 HG22 ' A' ' 240' ' ' THR . 54.0 mt -57.05 -48.35 82.0 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.847 179.333 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 10.5 p -67.23 -33.18 61.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.909 179.121 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 20.6 m -62.28 -38.46 89.45 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 121.065 -0.254 . . . . 0.0 110.458 178.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 248' ' ' LEU . . . . . 0.953 ' HG ' ' HG3' ' A' ' 231' ' ' MET . 1.0 OUTLIER -63.59 -33.51 75.76 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.141 0.496 . . . . 0.0 110.413 178.337 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 249' ' ' ILE . . . . . 0.526 HG21 HD21 ' A' ' 194' ' ' LEU . 33.7 mm -76.84 -40.7 32.03 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.737 178.386 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 23.2 t -59.94 -44.79 94.15 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 178.128 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 251' ' ' PHE . . . . . 0.54 ' O ' HG23 ' A' ' 255' ' ' VAL . 22.7 t80 -66.82 -44.52 80.94 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.251 177.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -54.98 -42.92 82.36 Favored Glycine 0 C--N 1.34 0.754 0 N-CA-C 111.078 -0.809 . . . . 0.0 111.078 177.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 253' ' ' ALA . . . . . 0.603 ' O ' ' HG3' ' A' ' 257' ' ' LYS . . . -61.78 -46.37 89.85 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 115.551 -0.324 . . . . 0.0 110.201 177.294 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 254' ' ' PHE . . . . . 0.414 ' HB3' HD13 ' A' ' 213' ' ' LEU . 0.1 OUTLIER -58.27 -41.6 84.66 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 120.972 0.415 . . . . 0.0 110.289 178.591 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 255' ' ' VAL . . . . . 0.54 HG23 ' O ' ' A' ' 251' ' ' PHE . 64.0 t -62.38 -44.7 99.49 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-N 116.159 -0.473 . . . . 0.0 109.897 177.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -59.38 -42.76 92.41 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-O 121.02 0.438 . . . . 0.0 109.836 177.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 257' ' ' LYS . . . . . 0.603 ' HG3' ' O ' ' A' ' 253' ' ' ALA . 20.0 mtpp -62.06 -39.97 94.18 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.928 177.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 10.9 t60 -66.22 -43.44 86.64 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.367 178.359 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 75.2 mt -65.4 -39.44 92.19 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.466 178.591 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -68.54 -32.0 71.63 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 120.911 0.386 . . . . 0.0 110.008 178.357 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 66.4 m -59.44 -34.23 72.25 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.449 178.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 15.7 m -101.53 15.57 4.99 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.211 179.036 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 56.23 48.15 17.87 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 112.705 0.631 . . . . 0.0 112.705 179.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -118.67 37.71 3.99 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 120.887 0.375 . . . . 0.0 111.414 179.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . 0.54 ' HA ' HD12 ' A' ' 268' ' ' ILE . 0.0 OUTLIER -51.9 -26.49 10.33 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 179.843 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 50.6 p -59.88 -25.54 65.15 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 120.674 0.273 . . . . 0.0 111.126 179.064 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 267' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -88.91 -20.56 24.4 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 120.93 0.395 . . . . 0.0 110.592 178.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 268' ' ' ILE . . . . . 0.54 HD12 ' HA ' ' A' ' 265' ' ' GLU . 75.9 mt -67.85 -42.72 86.13 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.021 179.468 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 269' ' ' GLU . . . . . 0.778 ' HB3' ' HD3' ' A' ' 270' ' ' PRO . 9.4 tp10 -53.72 -57.08 18.99 Favored Pre-proline 0 CA--C 1.546 0.817 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.649 179.324 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 270' ' ' PRO . . . . . 0.778 ' HD3' ' HB3' ' A' ' 269' ' ' GLU . 24.9 Cg_exo -64.76 -33.81 52.59 Favored 'Trans proline' 0 C--N 1.36 1.184 0 C-N-CA 122.086 1.857 . . . . 0.0 111.878 178.536 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 271' ' ' LEU . . . . . . . . . . . . . 27.1 tp -63.96 -42.0 97.41 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.129 178.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -59.81 -48.89 79.87 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.483 178.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 273' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -63.77 -41.17 98.02 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.409 178.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 274' ' ' THR . . . . . 0.436 HG21 ' HB ' ' A' ' 224' ' ' VAL . 91.1 m -60.21 -48.93 79.64 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.052 178.664 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 275' ' ' ILE . . . . . . . . . . . . . 96.7 mt -61.9 -50.68 79.16 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.684 178.411 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 276' ' ' THR . . . . . 0.523 HG23 HD12 ' A' ' 163' ' ' ILE . 27.8 m -58.66 -53.9 53.13 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -178.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 277' ' ' ASP . . . . . 0.577 ' O ' ' HB2' ' A' ' 281' ' ' ARG . 2.3 t70 -58.16 -54.02 51.72 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 120.873 -0.331 . . . . 0.0 111.496 -178.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 95.1 t -59.38 -34.8 55.42 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 CA-C-O 120.673 0.273 . . . . 0.0 111.177 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . 0.49 HD22 HD11 ' A' ' 249' ' ' ILE . 5.0 tp -65.09 -48.12 74.82 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 111.742 0.275 . . . . 0.0 111.742 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 42.5 t -78.68 -36.59 19.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -179.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 281' ' ' ARG . . . . . 0.577 ' HB2' ' O ' ' A' ' 277' ' ' ASP . 0.1 OUTLIER -65.95 -36.03 82.22 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -179.493 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 282' ' ' THR . . . . . . . . . . . . . 15.4 p -73.39 -52.06 15.14 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 120.885 0.374 . . . . 0.0 111.623 179.456 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . 0.5 ' HB2' HD23 ' A' ' 287' ' ' LEU . 15.2 mttp -88.54 41.85 1.04 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.783 0.325 . . . . 0.0 110.68 179.583 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 28.9 ttm180 -48.05 -63.32 1.1 Allowed 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 -178.294 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -72.02 -31.51 66.26 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 121.028 -0.269 . . . . 0.0 111.625 -178.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 286' ' ' TRP . . . . . . . . . . . . . 2.3 t90 -68.37 -49.02 63.12 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.877 0.37 . . . . 0.0 111.121 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 287' ' ' LEU . . . . . 0.5 HD23 ' HB2' ' A' ' 283' ' ' LYS . 0.7 OUTLIER -63.08 -41.21 99.36 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -179.593 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 29.5 m -70.48 -37.86 71.74 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 C-N-CA 120.514 -0.474 . . . . 0.0 111.826 179.68 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 39.3 mttp -72.91 -32.23 65.18 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 290' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -85.46 17.3 3.25 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -179.064 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 291' ' ' ARG . . . . . 0.444 HH11 ' HD2' ' A' ' 291' ' ' ARG . 25.3 mtm105 60.09 18.6 7.87 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 179.553 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 63.16 -137.02 43.11 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 114.687 0.635 . . . . 0.0 114.687 178.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 293' ' ' TRP . . . . . 0.407 ' HA ' ' HB3' ' A' ' 296' ' ' PHE . 72.4 m95 -59.13 -28.39 66.5 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -178.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 294' ' ' ASP . . . . . 0.498 ' O ' ' HG3' ' A' ' 298' ' ' GLU . 0.4 OUTLIER -59.41 -48.35 81.98 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 120.782 0.325 . . . . 0.0 110.24 178.335 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -66.19 -36.48 91.86 Favored Glycine 0 CA--C 1.521 0.458 0 C-N-CA 120.53 -0.843 . . . . 0.0 111.252 178.401 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 296' ' ' PHE . . . . . 0.477 ' HB2' ' CH2' ' A' ' 242' ' ' TRP . 12.2 t80 -58.67 -48.0 82.58 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.51 -0.345 . . . . 0.0 111.015 178.616 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 297' ' ' VAL . . . . . . . . . . . . . 18.4 m -72.33 -22.68 20.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 120.934 -0.306 . . . . 0.0 111.636 -179.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 298' ' ' GLU . . . . . 0.498 ' HG3' ' O ' ' A' ' 294' ' ' ASP . 37.1 mt-10 -65.97 -50.1 65.51 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.206 0.527 . . . . 0.0 110.599 178.336 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 299' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -77.1 -25.02 51.75 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 115.912 -0.585 . . . . 0.0 112.292 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 300' ' ' PHE . . . . . 0.62 ' HB3' HG21 ' A' ' 197' ' ' VAL . 44.7 m-85 -109.43 6.12 23.98 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 115.16 1.541 . . . . 0.0 115.16 -177.54 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -161.25 -59.55 0.05 Allowed 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 119.479 1.036 . . . . 0.0 112.891 -179.584 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 2.3 t -90.94 72.98 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 120.953 0.406 . . . . 0.0 111.014 -178.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 303' ' ' GLN . . . . . 0.487 ' OE1' ' HB3' ' B' ' 41' ' ' PRO . 90.0 mt-30 -89.58 3.5 52.32 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.961 -179.354 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -97.64 34.45 1.85 Allowed 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 121.061 0.458 . . . . 0.0 111.995 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 78.7 mt -100.81 7.17 43.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.989 0.423 . . . . 0.0 111.103 179.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -112.5 -55.24 2.54 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.172 179.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . -100.94 92.61 1.07 Allowed Glycine 0 CA--C 1.522 0.506 0 C-N-CA 120.558 -0.83 . . . . 0.0 112.864 179.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.272 0 CA-C-O 118.282 -1.288 . . . . 0.0 112.771 179.924 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.868 0 CA-C-O 121.422 0.63 . . . . 0.0 111.301 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 18' ' ' GLU . . . . . 0.427 ' H ' ' CD ' ' B' ' 18' ' ' GLU . 0.7 OUTLIER -99.18 -36.68 9.58 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.246 -179.601 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 19' ' ' LEU . . . . . 0.507 ' HG ' ' HB2' ' A' ' 217' ' ' ASP . 4.6 mt -93.4 128.45 42.49 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.359 -179.852 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 20' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' B' ' 19' ' ' LEU . 7.3 Cg_exo -72.12 121.0 7.17 Favored 'Trans proline' 0 CA--C 1.531 0.365 0 C-N-CA 122.542 2.161 . . . . 0.0 112.277 179.399 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 21' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -60.65 -11.79 18.74 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.943 2.428 . . . . 0.0 113.475 -179.359 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 22' ' ' GLU . . . . . 0.404 ' O ' ' HB2' ' B' ' 26' ' ' GLN . 4.8 mm-40 -66.67 -14.2 62.18 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 23' ' ' PHE . . . . . 0.58 ' HD1' ' N ' ' B' ' 24' ' ' ALA . 0.1 OUTLIER -60.22 -31.88 70.58 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 118.302 0.501 . . . . 0.0 111.886 179.812 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 24' ' ' ALA . . . . . 0.58 ' N ' ' HD1' ' B' ' 23' ' ' PHE . . . -74.7 -48.38 26.31 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.16 0.505 . . . . 0.0 110.625 -179.724 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . 0.498 ' HA ' ' HD3' ' B' ' 28' ' ' ARG . . . -64.71 -37.12 86.49 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.505 178.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 26' ' ' GLN . . . . . 0.412 ' O ' HG13 ' B' ' 30' ' ' ILE . 0.0 OUTLIER -62.92 -48.13 80.25 Favored 'General case' 0 C--O 1.226 -0.134 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.13 178.751 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . 0.574 ' HG ' ' O ' ' B' ' 23' ' ' PHE . 29.8 mt -58.96 -32.45 69.65 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 178.371 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 28' ' ' ARG . . . . . 0.498 ' HD3' ' HA ' ' B' ' 25' ' ' ALA . 56.1 mtp85 -65.43 -54.81 23.14 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 177.432 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . 0.442 ' HG3' ' O ' ' B' ' 25' ' ' ALA . 54.5 mttt -55.67 -46.37 77.57 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.008 178.501 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . 0.52 HG12 ' ND1' ' A' ' 205' ' ' HIS . 97.9 mt -60.76 -52.42 61.77 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.237 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.218 179.76 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -57.03 -43.68 93.14 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 121.301 -0.476 . . . . 0.0 113.097 179.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -68.68 -40.89 79.9 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 120.709 0.29 . . . . 0.0 111.148 179.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.93 -39.97 83.42 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 120.954 0.407 . . . . 0.0 110.077 178.277 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 34' ' ' VAL . . . . . 0.716 HG21 HG13 ' A' ' 201' ' ' VAL . 4.9 t -62.56 -52.62 57.53 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.555 179.809 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -57.35 -40.95 79.14 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 120.943 0.402 . . . . 0.0 110.337 179.236 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 36' ' ' CYS . . . . . . . . . . . . . 42.7 t -68.68 -25.98 65.07 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 120.925 0.393 . . . . 0.0 111.298 179.256 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 59.6 m -78.55 -46.37 19.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.514 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 38' ' ' TRP . . . . . 0.435 ' CD1' HG13 ' B' ' 34' ' ' VAL . 99.2 m95 -75.52 -13.79 60.38 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 -179.132 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 43.7 m -61.17 -31.29 71.03 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 178.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -90.36 118.43 68.78 Favored Pre-proline 0 CA--C 1.531 0.243 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -179.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 41' ' ' PRO . . . . . 0.487 ' HB3' ' OE1' ' A' ' 303' ' ' GLN . 95.9 Cg_endo -86.98 -160.48 0.11 Allowed 'Trans proline' 0 CA--C 1.534 0.521 0 C-N-CA 122.845 2.363 . . . . 0.0 112.697 179.307 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -88.7 -54.13 4.3 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 120.983 0.42 . . . . 0.0 110.32 178.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 43' ' ' MET . . . . . . . . . . . . . 53.9 ttp . . . . . 0 C--O 1.25 1.087 0 CA-C-O 118.323 -0.846 . . . . 0.0 111.191 179.074 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.158 0 CA-C-O 120.261 -0.188 . . . . 0.0 112.804 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -71.18 -23.17 24.86 Favored 'Trans proline' 0 CA--C 1.534 0.492 0 C-N-CA 122.804 2.336 . . . . 0.0 113.769 -179.579 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 41.0 tp -73.56 -42.06 62.14 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 120.839 0.352 . . . . 0.0 111.648 -179.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 117.26 -67.44 0.32 Allowed Glycine 0 C--N 1.329 0.142 0 C-N-CA 120.636 -0.792 . . . . 0.0 111.677 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 37.2 t -75.26 94.81 3.05 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 178.467 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.43 ' CD ' HH21 ' A' ' 284' ' ' ARG . 2.6 mp0 4.61 70.01 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 125.852 1.661 . . . . 0.0 114.889 -177.649 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -71.12 -36.84 72.27 Favored 'General case' 0 C--N 1.335 -0.062 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.65 179.247 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.76 -57.19 14.11 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.911 179.234 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.409 HD21 ' HA3' ' A' ' 292' ' ' GLY . 0.2 OUTLIER -62.36 -35.99 80.84 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.03 178.716 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . 0.42 ' HE1' ' HA ' ' A' ' 277' ' ' ASP . 0.1 OUTLIER -68.86 -46.29 68.85 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.69 -0.232 . . . . 0.0 111.447 179.6 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 6.2 mtp180 -62.6 -45.87 90.87 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 121.119 -0.233 . . . . 0.0 111.14 179.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 59.3 mt-30 -58.02 -43.77 86.9 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 121.074 0.464 . . . . 0.0 110.222 178.594 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . 0.489 ' HA ' ' CZ2' ' A' ' 293' ' ' TRP . 51.4 m -61.38 -54.35 44.78 Favored 'General case' 0 C--O 1.223 -0.313 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.788 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.412 HD22 ' HA ' ' A' ' 160' ' ' LEU . 1.2 tm? -58.38 -47.23 84.53 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 120.492 0.187 . . . . 0.0 111.308 179.299 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -60.75 -51.85 67.59 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . 0.501 HG23 HD22 ' A' ' 191' ' ' LEU . 60.5 mt -71.26 -48.66 53.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 -178.429 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.603 ' O ' ' HG ' ' A' ' 167' ' ' LEU . 64.4 mt -58.85 -50.83 78.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 N-CA-C 111.64 0.237 . . . . 0.0 111.64 -179.44 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 39.3 t -61.9 -41.76 98.28 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 120.959 -0.296 . . . . 0.0 110.827 179.558 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . 0.512 ' O ' ' HB2' ' A' ' 169' ' ' GLU . 6.7 tpp85 -61.07 -47.66 85.31 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 111.658 0.244 . . . . 0.0 111.658 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' TYR . . . . . 0.854 ' HE1' ' HA ' ' A' ' 195' ' ' ARG . 87.6 t80 -65.98 -50.97 62.44 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -179.358 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.603 ' HG ' ' O ' ' A' ' 163' ' ' ILE . 40.7 mt -59.11 -45.0 92.03 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 121.127 -0.229 . . . . 0.0 111.477 -178.784 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 3.7 ttt180 -70.26 -42.03 72.69 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 120.959 -0.296 . . . . 0.0 111.637 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . 0.512 ' HB2' ' O ' ' A' ' 165' ' ' ARG . 0.5 OUTLIER -59.6 -46.0 90.24 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.222 0.534 . . . . 0.0 109.645 179.081 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . 0.629 ' HB3' ' HE3' ' A' ' 257' ' ' LYS . 6.9 mm-40 -65.34 -49.75 68.22 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.87 179.058 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.472 ' HA ' ' HG2' ' A' ' 257' ' ' LYS . . . -63.69 -31.76 73.03 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 -178.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 7.4 m -84.64 -43.25 14.57 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -179.157 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 84.03 13.02 75.57 Favored Glycine 0 CA--C 1.522 0.48 0 C-N-CA 120.545 -0.836 . . . . 0.0 111.706 -178.472 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 13.7 t -100.09 -159.48 0.74 Allowed 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 115.654 -0.273 . . . . 0.0 110.636 -179.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . 0.414 ' HA ' ' HE3' ' A' ' 175' ' ' LYS . 0.0 OUTLIER -127.57 163.03 25.07 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 120.696 0.284 . . . . 0.0 111.386 -179.948 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . 0.475 ' OD2' ' HD2' ' A' ' 165' ' ' ARG . 16.3 t0 -131.21 117.47 19.07 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 120.861 0.362 . . . . 0.0 111.48 -179.359 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . . . . . . . . . 59.2 p -105.7 16.9 24.62 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.321 0.582 . . . . 0.0 110.775 179.087 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . 0.515 ' HB3' ' NZ ' ' A' ' 178' ' ' LYS . 3.3 ttpm? -105.82 128.29 26.73 Favored Pre-proline 0 CA--C 1.534 0.341 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.02 -179.728 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -66.83 -177.83 1.09 Allowed 'Trans proline' 0 CA--C 1.539 0.731 0 C-N-CA 122.715 2.277 . . . . 0.0 113.381 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.516 HD13 ' HA3' ' A' ' 187' ' ' GLY . 0.9 OUTLIER -105.61 -173.17 2.24 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.073 179.625 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -110.55 -84.69 1.53 Allowed Glycine 0 CA--C 1.52 0.398 0 C-N-CA 120.343 -0.932 . . . . 0.0 113.656 -178.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -85.25 -8.75 58.39 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.093 0.473 . . . . 0.0 111.471 -179.377 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -109.76 68.76 0.68 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.949 179.303 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -73.73 -71.15 1.14 Allowed Glycine 0 CA--C 1.524 0.616 0 C-N-CA 120.631 -0.795 . . . . 0.0 113.56 -179.456 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -72.09 -44.82 62.64 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.104 0.478 . . . . 0.0 110.966 179.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -67.9 -26.94 66.24 Favored 'General case' 0 C--O 1.225 -0.204 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.213 179.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . 0.544 ' O ' ' HB2' ' A' ' 191' ' ' LEU . . . -63.82 -53.49 37.46 Favored Glycine 0 C--N 1.332 0.315 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.199 179.64 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . 0.661 ' HE ' ' HG2' ' A' ' 192' ' ' GLU . 1.4 tpm_? -63.33 -44.42 94.95 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 120.902 0.382 . . . . 0.0 110.302 178.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . 0.415 HH22 ' CD ' ' A' ' 298' ' ' GLU . 37.0 mtp180 -60.17 -47.41 86.06 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.096 179.618 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.561 ' HA ' HG12 ' A' ' 297' ' ' VAL . . . -72.75 -40.52 65.95 Favored 'General case' 0 C--O 1.22 -0.453 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -179.679 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . 0.544 ' HB2' ' O ' ' A' ' 187' ' ' GLY . 0.3 OUTLIER -58.66 -45.78 88.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.798 0.333 . . . . 0.0 110.735 179.885 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . 0.661 ' HG2' ' HE ' ' A' ' 188' ' ' ARG . 15.2 mm-40 -76.81 -40.98 46.19 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -179.806 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . 0.649 HG21 ' HA ' ' A' ' 297' ' ' VAL . 80.1 m -65.0 -48.55 73.53 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.813 0.34 . . . . 0.0 110.108 178.847 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 0.507 HD21 HG21 ' A' ' 249' ' ' ILE . 56.1 tp -64.81 -30.03 71.02 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.292 178.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . 0.854 ' HA ' ' HE1' ' A' ' 166' ' ' TYR . 56.9 ttm-85 -61.5 -49.49 76.56 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.832 0.349 . . . . 0.0 110.385 178.231 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . 0.449 HH11 ' HD2' ' A' ' 196' ' ' ARG . 0.2 OUTLIER -70.99 -55.25 8.71 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.026 -179.688 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . 0.516 HG21 ' HB3' ' A' ' 300' ' ' PHE . 35.5 t -63.29 -47.65 91.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-O 120.997 0.427 . . . . 0.0 111.851 -179.341 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -60.43 -44.9 97.14 Favored Glycine 0 CA--C 1.519 0.302 0 CA-C-N 116.067 -0.515 . . . . 0.0 113.004 -179.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -73.48 -32.44 64.31 Favored 'General case' 0 C--N 1.331 -0.235 0 O-C-N 122.211 -0.582 . . . . 0.0 109.492 179.202 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -56.27 -48.49 74.59 Favored Glycine 0 C--N 1.337 0.621 0 N-CA-C 110.999 -0.841 . . . . 0.0 110.999 177.314 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . 0.48 HG23 ' O ' ' A' ' 197' ' ' VAL . 41.3 t -65.36 -37.68 80.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 CA-C-O 120.883 0.373 . . . . 0.0 110.404 178.108 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 202' ' ' GLN . . . . . 0.456 ' HA ' ' CE2' ' A' ' 209' ' ' PHE . 24.5 mt-30 -61.69 -53.03 61.54 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.935 -0.575 . . . . 0.0 112.041 179.687 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 203' ' ' ARG . . . . . 0.412 HH11 ' HD3' ' A' ' 203' ' ' ARG . 9.2 ptt180 -72.88 -27.75 62.08 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 120.924 -0.31 . . . . 0.0 111.499 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -71.55 -53.59 13.3 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.058 0.456 . . . . 0.0 110.789 179.122 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 205' ' ' HIS . . . . . 0.453 ' HB3' ' HB3' ' A' ' 208' ' ' ALA . 94.2 m-70 -101.19 36.84 1.89 Allowed 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.897 179.5 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 11.0 tm-20 -53.83 -46.38 71.14 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.508 -179.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 49.1 p -64.66 -34.68 78.87 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.151 179.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . 0.453 ' HB3' ' HB3' ' A' ' 205' ' ' HIS . . . -69.22 -42.43 75.72 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 178.61 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 209' ' ' PHE . . . . . 0.49 ' O ' ' HG ' ' A' ' 213' ' ' LEU . 13.9 m-85 -70.81 -35.07 72.34 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.236 178.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -66.58 -46.9 74.46 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 177.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -62.26 -39.93 98.35 Favored Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 110.555 -1.018 . . . . 0.0 110.555 177.427 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 212' ' ' MET . . . . . 0.404 ' SD ' ' HA ' ' B' ' 23' ' ' PHE . 5.5 tpp -61.36 -37.0 81.78 Favored 'General case' 0 C--O 1.223 -0.293 0 N-CA-C 110.166 -0.309 . . . . 0.0 110.166 178.109 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.49 ' HG ' ' O ' ' A' ' 209' ' ' PHE . 34.7 mt -60.42 -41.62 94.32 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.043 0.449 . . . . 0.0 110.568 178.366 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 83.7 mtt85 -70.6 -27.02 63.78 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.594 179.584 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 10.1 mmmm -91.58 -11.19 37.95 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 120.89 0.376 . . . . 0.0 111.446 179.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.527 HD21 HD12 ' A' ' 218' ' ' ILE . 16.4 tp -100.11 114.3 27.56 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.38 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -90.16 24.12 2.61 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 120.996 0.427 . . . . 0.0 111.787 -179.487 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 218' ' ' ILE . . . . . 0.527 HD12 HD21 ' A' ' 216' ' ' LEU . 5.7 mt -66.69 122.85 18.49 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-O 121.094 0.473 . . . . 0.0 111.354 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 7.0 ptpp? -154.98 -16.15 0.12 Allowed 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -179.131 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -130.95 -178.95 5.04 Favored 'General case' 0 CA--C 1.536 0.413 0 O-C-N 121.688 -0.633 . . . . 0.0 112.515 -178.523 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . 0.454 ' O ' HG22 ' A' ' 224' ' ' VAL . 3.5 tp10 -61.64 -39.81 92.66 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -179.143 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . 0.405 ' O ' ' HG2' ' A' ' 225' ' ' LYS . . . -55.7 -26.07 45.47 Favored Glycine 0 CA--C 1.524 0.606 0 C-N-CA 121.399 -0.429 . . . . 0.0 113.764 -179.347 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 223' ' ' ASP . . . . . 0.516 ' HB3' HG12 ' A' ' 218' ' ' ILE . 61.4 m-20 -60.13 -28.09 67.6 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 -179.544 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.454 HG22 ' O ' ' A' ' 221' ' ' GLU . 31.5 m -53.69 -31.72 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 N-CA-C 113.221 0.823 . . . . 0.0 113.221 -179.095 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . 0.405 ' HG2' ' O ' ' A' ' 222' ' ' GLY . 10.6 ptpp? -68.06 -33.61 74.88 Favored 'General case' 0 C--O 1.237 0.41 0 O-C-N 121.845 -0.535 . . . . 0.0 110.407 179.516 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . 0.661 ' O ' HG23 ' A' ' 230' ' ' VAL . 33.3 p -69.63 -47.59 62.86 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.755 179.181 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 227' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -55.87 -37.7 69.15 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.154 0.502 . . . . 0.0 110.069 179.492 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 228' ' ' SER . . . . . 0.42 ' HA ' HG21 ' A' ' 278' ' ' VAL . 39.3 m -59.27 -48.73 80.55 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.488 177.547 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 229' ' ' ARG . . . . . 0.428 ' HA ' ' HD3' ' A' ' 229' ' ' ARG . 13.8 mmt180 -68.26 -34.09 75.56 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.074 179.5 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 0.661 HG23 ' O ' ' A' ' 226' ' ' SER . 54.4 t -57.13 -54.83 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-O 120.562 0.22 . . . . 0.0 110.632 179.303 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 231' ' ' MET . . . . . 0.587 ' HG2' HD13 ' A' ' 248' ' ' LEU . 72.3 mtm -59.41 -43.35 93.02 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.334 179.374 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 79.7 t -59.07 -44.18 90.86 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-O 120.727 0.299 . . . . 0.0 110.874 178.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 65.7 t-80 -60.07 -38.62 83.41 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 120.826 0.346 . . . . 0.0 111.519 179.217 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.404 HG13 ' HA ' ' B' ' 28' ' ' ARG . 94.2 t -61.85 -39.62 84.14 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 CA-C-O 121.192 0.52 . . . . 0.0 111.056 178.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -99.24 24.42 7.98 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.638 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -62.24 -18.22 60.54 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -179.631 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -83.12 -16.71 45.71 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.772 0.32 . . . . 0.0 111.399 179.558 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 90.98 -10.07 76.06 Favored Glycine 0 CA--C 1.524 0.632 0 C-N-CA 120.701 -0.761 . . . . 0.0 113.747 179.517 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 6.2 p -93.47 118.19 38.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-O 121.571 0.701 . . . . 0.0 111.414 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 83.8 m -94.03 119.77 33.37 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.063 0.459 . . . . 0.0 111.896 -179.448 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -113.67 140.76 47.96 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.162 178.58 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 242' ' ' TRP . . . . . 0.497 ' HA ' ' CE3' ' A' ' 242' ' ' TRP . 1.3 m95 -56.79 -44.94 82.39 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.715 0.293 . . . . 0.0 111.014 179.601 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . 0.438 ' HA2' HG12 ' A' ' 246' ' ' VAL . . . -60.8 -29.53 70.51 Favored Glycine 0 CA--C 1.523 0.541 0 C-N-CA 121.083 -0.58 . . . . 0.0 112.384 178.671 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 244' ' ' ARG . . . . . 0.481 ' HA ' ' HA3' ' B' ' 31' ' ' GLY . 60.5 mtt180 -68.96 -47.25 66.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.112 0.482 . . . . 0.0 109.797 178.675 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . 0.465 ' O ' HG13 ' A' ' 249' ' ' ILE . 68.3 mt -62.59 -48.23 89.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.3 179.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . 0.454 HG21 HG12 ' A' ' 197' ' ' VAL . 8.7 p -65.44 -27.87 42.89 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 C-N-CA 120.849 -0.341 . . . . 0.0 111.143 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 17.5 m -65.74 -41.24 92.4 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.201 0.524 . . . . 0.0 109.718 178.041 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 248' ' ' LEU . . . . . 0.587 HD13 ' HG2' ' A' ' 231' ' ' MET . 55.0 mt -65.72 -38.29 88.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.999 178.226 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 249' ' ' ILE . . . . . 0.507 HG21 HD21 ' A' ' 194' ' ' LEU . 14.9 mt -68.41 -43.05 84.37 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.524 178.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 250' ' ' SER . . . . . 0.453 ' HB2' ' HG3' ' A' ' 202' ' ' GLN . 5.2 p -66.47 -38.26 86.94 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 178.256 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 251' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -62.92 -44.15 96.85 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 176.328 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . 0.403 ' HA2' HG22 ' A' ' 255' ' ' VAL . . . -61.21 -42.68 99.86 Favored Glycine 0 C--N 1.336 0.579 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.359 177.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -62.43 -38.72 90.8 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 120.926 0.393 . . . . 0.0 110.692 178.109 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -66.73 -47.56 71.92 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.256 179.312 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 255' ' ' VAL . . . . . 0.551 ' O ' ' HG ' ' A' ' 259' ' ' LEU . 31.3 m -66.63 -33.77 65.67 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.2 178.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 256' ' ' ALA . . . . . . . . . . . . . . . -63.25 -40.3 97.03 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.133 0.492 . . . . 0.0 109.779 177.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 257' ' ' LYS . . . . . 0.629 ' HE3' ' HB3' ' A' ' 170' ' ' GLN . 81.2 mttt -63.72 -39.18 93.67 Favored 'General case' 0 CA--C 1.528 0.1 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.582 177.541 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 66.7 t60 -65.0 -36.43 84.39 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 177.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.551 ' HG ' ' O ' ' A' ' 255' ' ' VAL . 72.9 mt -70.07 -42.48 72.76 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.882 178.146 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 260' ' ' LYS . . . . . . . . . . . . . 28.1 tptt -64.7 -33.83 76.87 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.672 179.132 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 40.7 t -59.77 -24.42 64.07 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.206 179.004 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 262' ' ' VAL . . . . . 0.569 HG23 ' HG3' ' A' ' 264' ' ' GLN . 16.7 m -117.54 18.16 7.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 CA-C-O 121.264 0.554 . . . . 0.0 110.179 178.607 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 23.3 t30 51.48 47.68 24.37 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 114.96 -1.018 . . . . 0.0 113.066 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 264' ' ' GLN . . . . . 0.569 ' HG3' HG23 ' A' ' 262' ' ' VAL . 11.6 mt-30 -91.36 39.11 0.99 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.707 0.289 . . . . 0.0 111.457 179.049 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . 0.501 ' HA ' HD12 ' A' ' 268' ' ' ILE . 15.6 tp10 -47.07 -36.63 8.36 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.906 179.477 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 2.5 m -55.9 -29.17 59.6 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.911 179.424 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 267' ' ' PHE . . . . . 0.426 ' C ' ' HD2' ' A' ' 270' ' ' PRO . 44.1 t80 -95.62 -21.38 18.26 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 120.925 -0.31 . . . . 0.0 111.623 179.819 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 268' ' ' ILE . . . . . 0.501 HD12 ' HA ' ' A' ' 265' ' ' GLU . 70.6 mt -63.77 -37.82 80.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 CA-C-O 121.06 0.457 . . . . 0.0 110.357 179.252 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 269' ' ' GLU . . . . . 0.579 ' HB3' ' HD3' ' A' ' 270' ' ' PRO . 2.1 tp10 -59.56 -58.27 20.69 Favored Pre-proline 0 CA--C 1.551 1.018 0 CA-C-N 115.886 -0.597 . . . . 0.0 112.113 179.236 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 270' ' ' PRO . . . . . 0.579 ' HD3' ' HB3' ' A' ' 269' ' ' GLU . 21.5 Cg_exo -67.82 -25.12 39.62 Favored 'Trans proline' 0 C--N 1.361 1.215 0 C-N-CA 122.314 2.009 . . . . 0.0 113.167 179.616 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 271' ' ' LEU . . . . . . . . . . . . . 42.6 tp -64.45 -46.22 84.09 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.622 -0.263 . . . . 0.0 110.55 179.075 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -61.17 -39.45 90.19 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.073 179.247 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 273' ' ' GLU . . . . . . . . . . . . . 49.9 mm-40 -68.48 -46.28 70.15 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.794 178.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 274' ' ' THR . . . . . . . . . . . . . 84.9 m -58.01 -49.18 77.73 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.94 179.601 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 275' ' ' ILE . . . . . 0.406 ' HA ' ' HE1' ' A' ' 231' ' ' MET . 95.1 mt -59.54 -54.0 40.54 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.115 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.267 178.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 276' ' ' THR . . . . . . . . . . . . . 78.6 m -52.5 -53.13 50.04 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.767 -0.651 . . . . 0.0 112.627 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 277' ' ' ASP . . . . . 0.42 ' HA ' ' HE1' ' A' ' 156' ' ' TYR . 38.4 t70 -59.64 -57.98 10.58 Favored 'General case' 0 C--O 1.224 -0.25 0 C-N-CA 120.849 -0.34 . . . . 0.0 111.561 -179.341 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 278' ' ' VAL . . . . . 0.559 ' HB ' ' HE1' ' A' ' 231' ' ' MET . 43.1 t -58.26 -41.34 80.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -179.295 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . . . . . . . . . 19.1 tp -63.13 -47.2 83.77 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 75.7 t -77.73 -46.16 27.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -179.243 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 21.2 ptt180 -59.76 -30.16 68.67 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -179.16 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 282' ' ' THR . . . . . . . . . . . . . 12.0 m -84.71 -22.34 29.78 Favored 'General case' 0 CA--C 1.543 0.673 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . 0.567 ' HB2' ' NZ ' ' A' ' 283' ' ' LYS . 0.0 OUTLIER -139.38 42.03 2.05 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 -178.71 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 284' ' ' ARG . . . . . 0.43 HH21 ' CD ' ' A' ' 152' ' ' GLU . 11.1 ptm180 -63.8 -47.16 81.98 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -179.21 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -61.8 -41.71 98.1 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.838 0.352 . . . . 0.0 111.207 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 286' ' ' TRP . . . . . 0.566 ' O ' ' HG2' ' A' ' 290' ' ' GLN . 7.7 t90 -64.41 -41.62 96.53 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.803 0.335 . . . . 0.0 110.261 178.74 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 287' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -66.46 -51.71 53.89 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 288' ' ' VAL . . . . . . . . . . . . . 27.2 m -59.78 -32.55 49.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -179.304 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.98 -36.53 75.27 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 120.772 0.32 . . . . 0.0 110.797 179.336 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 290' ' ' GLN . . . . . 0.566 ' HG2' ' O ' ' A' ' 286' ' ' TRP . 40.5 mm-40 -88.83 28.74 1.11 Allowed 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 121.032 -0.267 . . . . 0.0 110.977 179.543 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 291' ' ' ARG . . . . . . . . . . . . . 46.1 mtp85 59.68 22.33 11.08 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 112.192 0.441 . . . . 0.0 112.192 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 292' ' ' GLY . . . . . 0.409 ' HA3' HD21 ' A' ' 155' ' ' LEU . . . 62.91 -130.62 42.51 Favored Glycine 0 C--O 1.239 0.433 0 CA-C-O 121.485 0.492 . . . . 0.0 113.866 179.512 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 293' ' ' TRP . . . . . 0.5 ' O ' HG13 ' A' ' 297' ' ' VAL . 90.6 m95 -65.12 -26.17 68.08 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.428 -0.386 . . . . 0.0 112.02 -179.294 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 294' ' ' ASP . . . . . 0.414 ' O ' ' HB2' ' A' ' 298' ' ' GLU . 25.5 t70 -64.64 -36.35 83.96 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 121.136 0.493 . . . . 0.0 109.995 178.579 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 295' ' ' GLY . . . . . 0.479 ' HA3' ' O ' ' A' ' 290' ' ' GLN . . . -71.37 -36.96 63.02 Favored Glycine 0 N--CA 1.45 -0.386 0 N-CA-C 110.551 -1.02 . . . . 0.0 110.551 177.598 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 296' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -63.87 -45.84 87.64 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 115.477 -0.362 . . . . 0.0 111.097 178.412 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 297' ' ' VAL . . . . . 0.649 ' HA ' HG21 ' A' ' 193' ' ' THR . 14.0 m -72.31 -28.4 28.8 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 -179.614 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 298' ' ' GLU . . . . . 0.475 ' O ' HG22 ' A' ' 302' ' ' VAL . 2.3 tp10 -76.76 -49.74 15.22 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.582 0.229 . . . . 0.0 111.275 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 299' ' ' PHE . . . . . 0.402 ' HZ ' ' HB2' ' B' ' 39' ' ' SER . 68.4 t80 -55.15 -48.72 73.33 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 120.879 0.371 . . . . 0.0 111.267 179.642 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 300' ' ' PHE . . . . . 0.516 ' HB3' HG21 ' A' ' 197' ' ' VAL . 54.2 m-85 -80.43 31.13 0.28 Allowed 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 301' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -139.65 -46.71 0.45 Allowed 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 111.843 0.312 . . . . 0.0 111.843 179.814 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . 0.475 HG22 ' O ' ' A' ' 298' ' ' GLU . 6.1 m -71.52 65.77 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-O 121.468 0.652 . . . . 0.0 112.263 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -106.27 24.12 13.01 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -179.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -73.91 69.52 1.41 Allowed 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.098 0.475 . . . . 0.0 111.41 179.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 305' ' ' LEU . . . . . 0.418 HD13 ' HA ' ' A' ' 305' ' ' LEU . 2.7 mm? -79.05 -33.59 44.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.281 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 306' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -72.61 -30.05 64.02 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.404 179.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . -100.9 69.67 0.44 Allowed Glycine 0 CA--C 1.521 0.418 0 C-N-CA 120.879 -0.677 . . . . 0.0 113.128 -179.557 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.186 0 CA-C-O 118.476 -1.18 . . . . 0.0 113.08 -179.975 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.499 0 CA-C-O 121.02 0.438 . . . . 0.0 110.704 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -109.59 -78.37 0.59 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.174 -179.144 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 19' ' ' LEU . . . . . 0.468 HD21 ' HA ' ' A' ' 216' ' ' LEU . 9.1 tp -88.37 121.57 70.19 Favored Pre-proline 0 CA--C 1.532 0.287 0 CA-C-O 120.762 0.315 . . . . 0.0 110.874 179.459 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 20' ' ' PRO . . . . . 0.504 ' HA ' ' HD3' ' B' ' 21' ' ' PRO . 58.0 Cg_endo -70.15 139.73 39.56 Favored 'Trans proline' 0 CA--C 1.534 0.514 0 C-N-CA 122.869 2.379 . . . . 0.0 113.045 -179.743 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 21' ' ' PRO . . . . . 0.504 ' HD3' ' HA ' ' B' ' 20' ' ' PRO . 8.3 Cg_exo -72.5 37.23 0.36 Allowed 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 123.105 2.537 . . . . 0.0 113.686 -179.615 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 22' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -75.54 -33.05 60.67 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 121.221 0.534 . . . . 0.0 110.932 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 23' ' ' PHE . . . . . 0.546 ' CE1' HG22 ' A' ' 230' ' ' VAL . 1.5 p90 -63.19 -41.57 99.22 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.478 -179.671 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.75 -36.42 83.83 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.939 0.4 . . . . 0.0 110.756 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -60.84 -47.37 86.65 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.798 178.241 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 26' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -66.01 -45.62 80.85 Favored 'General case' 0 CA--C 1.527 0.081 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.409 178.448 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 80.6 mt -56.75 -39.42 73.94 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.844 0.355 . . . . 0.0 110.378 178.386 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 28' ' ' ARG . . . . . 0.404 ' HA ' HG13 ' A' ' 234' ' ' VAL . 0.7 OUTLIER -62.63 -51.82 65.78 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.67 178.194 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -56.91 -42.01 79.17 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.568 178.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 87.8 mt -65.09 -43.29 95.86 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.433 178.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . 0.481 ' HA3' ' HA ' ' A' ' 244' ' ' ARG . . . -59.17 -50.08 71.63 Favored Glycine 0 C--N 1.335 0.514 0 C-N-CA 121.069 -0.586 . . . . 0.0 112.397 179.273 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -61.31 -44.62 96.91 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.091 0.472 . . . . 0.0 109.808 178.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 33' ' ' LYS . . . . . 0.456 ' HA ' ' HD2' ' B' ' 33' ' ' LYS . 0.2 OUTLIER -59.59 -55.98 27.67 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.787 179.718 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 55.7 t -59.14 -44.96 92.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-O 120.848 0.356 . . . . 0.0 110.974 179.558 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 35' ' ' TYR . . . . . 0.402 ' HB2' ' HA3' ' A' ' 243' ' ' GLY . 9.7 t80 -57.09 -45.96 82.94 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.567 179.145 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 36' ' ' CYS . . . . . . . . . . . . . 73.3 m -65.77 -29.55 70.06 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.405 179.302 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 97.0 m -66.69 -45.39 78.97 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 120.645 0.259 . . . . 0.0 111.217 179.464 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 38' ' ' TRP . . . . . . . . . . . . . 99.3 m95 -75.58 -40.81 56.11 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 120.74 0.305 . . . . 0.0 111.136 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 39' ' ' SER . . . . . 0.402 ' HB2' ' HZ ' ' A' ' 299' ' ' PHE . 41.7 t -81.29 54.47 2.3 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 120.841 0.353 . . . . 0.0 111.66 179.511 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -70.44 115.02 30.73 Favored Pre-proline 0 N--CA 1.466 0.356 0 CA-C-O 121.0 0.429 . . . . 0.0 111.552 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -97.08 29.8 0.17 Allowed 'Trans proline' 0 CA--C 1.535 0.572 0 C-N-CA 123.425 2.75 . . . . 0.0 114.095 -179.132 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -77.4 58.06 1.62 Allowed 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 120.913 0.387 . . . . 0.0 111.732 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 43' ' ' MET . . . . . . . . . . . . . 10.8 ptm . . . . . 0 C--O 1.252 1.185 0 CA-C-O 118.316 -0.849 . . . . 0.0 111.553 179.994 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.57 ' HA3' ' HB3' ' A' ' 153' ' ' ASP . . . . . . . . 0 N--CA 1.493 2.469 0 CA-C-O 119.853 -0.415 . . . . 0.0 112.152 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_exo -57.38 -55.18 2.69 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.74 2.293 . . . . 0.0 112.43 179.22 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 16.5 tp -84.63 54.4 3.02 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 121.386 0.612 . . . . 0.0 110.811 179.388 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 74.08 -110.55 3.14 Favored Glycine 0 C--O 1.228 -0.23 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.844 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 61.0 p -117.92 6.69 12.22 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.95 0.405 . . . . 0.0 110.46 178.541 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 45.3 mm-40 -64.95 -39.46 93.52 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.636 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . 0.589 ' O ' ' HG3' ' A' ' 157' ' ' ARG . 26.5 t70 -64.63 -49.05 72.59 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.82 179.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.588 ' HA ' ' CZ ' ' A' ' 157' ' ' ARG . 2.9 m-20 -55.6 -47.41 76.55 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -178.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 47.9 tp -66.37 -37.02 84.34 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.139 0.495 . . . . 0.0 110.616 179.283 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 56.7 t80 -68.49 -43.19 77.43 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.389 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.589 ' HG3' ' O ' ' A' ' 153' ' ' ASP . 54.4 mtm-85 -56.43 -49.77 73.58 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 179.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 27.6 tt0 -64.86 -43.93 91.39 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 120.851 0.358 . . . . 0.0 110.961 -179.596 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . 0.4 ' HA ' ' NE1' ' A' ' 293' ' ' TRP . 20.0 m -63.52 -43.26 97.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.205 179.493 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -64.24 -47.54 79.27 Favored 'General case' 0 C--O 1.221 -0.402 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.43 178.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . 0.45 ' HB3' HD12 ' A' ' 180' ' ' LEU . 33.8 mt-10 -54.38 -47.39 72.73 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-O 120.875 0.369 . . . . 0.0 111.461 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . 0.494 HG12 ' HA2' ' A' ' 187' ' ' GLY . 67.8 mt -63.11 -53.21 49.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-N 116.069 -0.514 . . . . 0.0 112.137 -179.783 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.516 HD12 HG23 ' A' ' 276' ' ' THR . 80.3 mt -63.12 -43.99 99.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.908 0.385 . . . . 0.0 110.935 179.725 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 2.5 t -59.16 -46.66 87.8 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.508 179.374 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . 0.849 ' HG2' ' HD2' ' A' ' 179' ' ' PRO . 2.3 mmm180 -57.19 -40.61 77.71 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 120.729 0.299 . . . . 0.0 111.075 179.024 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 70.6 t80 -71.0 -53.76 13.67 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.442 ' HG ' ' O ' ' A' ' 163' ' ' ILE . 38.9 mt -61.03 -43.42 98.92 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -178.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . 0.568 ' HD3' ' OG ' ' A' ' 177' ' ' SER . 1.7 mtt-85 -67.79 -46.18 72.69 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -179.201 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . 0.546 ' OE2' ' HD2' ' A' ' 165' ' ' ARG . 17.6 mt-10 -66.3 -39.25 89.21 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 120.89 -0.324 . . . . 0.0 111.808 -179.512 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . 0.511 ' HG3' ' HE3' ' A' ' 257' ' ' LYS . 6.5 tp-100 -70.05 -26.32 63.97 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 121.234 0.54 . . . . 0.0 110.3 178.662 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.523 ' O ' ' HG2' ' A' ' 260' ' ' LYS . . . -79.67 -48.07 14.32 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.803 179.293 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . 0.472 ' HB ' ' HB2' ' A' ' 175' ' ' LYS . 64.3 p -67.65 -49.22 63.98 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 111.662 0.245 . . . . 0.0 111.662 -179.695 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 65.47 -19.32 0.14 Allowed Glycine 0 CA--C 1.532 1.104 0 N-CA-C 115.035 0.774 . . . . 0.0 115.035 179.349 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . 0.401 ' H ' ' C ' ' A' ' 172' ' ' THR . 89.3 p -141.69 9.89 2.0 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 117.641 0.721 . . . . 0.0 111.952 -179.455 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . 0.472 ' HB2' ' HB ' ' A' ' 172' ' ' THR . 25.1 mmtm -127.08 124.04 38.31 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.399 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -70.92 86.35 0.7 Allowed 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 121.536 0.684 . . . . 0.0 111.464 -179.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' SER . . . . . 0.568 ' OG ' ' HD3' ' A' ' 168' ' ' ARG . 27.5 t -103.98 78.91 1.58 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.992 -179.78 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 47.2 mttp -106.79 97.33 16.98 Favored Pre-proline 0 CA--C 1.537 0.454 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -179.269 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . 0.849 ' HD2' ' HG2' ' A' ' 165' ' ' ARG . 95.0 Cg_endo -95.53 40.88 0.14 Allowed 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 123.167 2.578 . . . . 0.0 112.383 178.289 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.479 HD13 ' HG3' ' A' ' 165' ' ' ARG . 9.0 tp -90.31 137.43 32.36 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.437 -179.31 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -148.71 -54.16 0.02 OUTLIER Glycine 0 CA--C 1.52 0.373 0 C-N-CA 120.438 -0.886 . . . . 0.0 112.967 -179.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 62.3 tt0 -96.45 -30.23 13.47 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.819 0.343 . . . . 0.0 111.725 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.601 ' O ' ' HA3' ' A' ' 187' ' ' GLY . . . -80.67 62.57 4.77 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.939 0.399 . . . . 0.0 111.499 -179.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -79.97 -71.48 1.26 Allowed Glycine 0 CA--C 1.525 0.705 0 C-N-CA 120.751 -0.737 . . . . 0.0 113.969 -179.681 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -70.56 -57.01 5.2 Favored 'General case' 0 C--O 1.238 0.449 0 O-C-N 122.519 -0.4 . . . . 0.0 111.823 -179.14 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -67.24 -27.75 67.49 Favored 'General case' 0 C--N 1.335 -0.061 0 CA-C-O 121.199 0.523 . . . . 0.0 109.892 179.234 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . 0.601 ' HA3' ' O ' ' A' ' 183' ' ' ALA . . . -72.64 -33.36 60.76 Favored Glycine 0 N--CA 1.447 -0.614 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.861 178.573 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -65.97 -54.51 25.3 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.797 0.332 . . . . 0.0 110.269 178.688 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . 0.692 ' HB3' HG11 ' A' ' 297' ' ' VAL . 16.0 mtm180 -55.12 -46.79 75.6 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 121.136 0.493 . . . . 0.0 110.818 179.17 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -71.35 -31.33 67.24 Favored 'General case' 0 C--O 1.221 -0.409 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.474 -179.474 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . 0.601 ' HB2' ' O ' ' A' ' 187' ' ' GLY . 0.2 OUTLIER -62.16 -53.59 53.15 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 117.893 0.315 . . . . 0.0 111.08 179.67 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -64.2 -41.41 97.08 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 120.713 0.292 . . . . 0.0 111.214 179.578 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . 0.537 HG21 ' HA ' ' A' ' 297' ' ' VAL . 11.8 m -64.33 -47.76 78.18 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.81 179.109 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 14.9 tp -66.69 -35.28 79.76 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.776 0.322 . . . . 0.0 110.829 179.483 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . 0.429 HH11 ' HD2' ' A' ' 195' ' ' ARG . 9.2 tpp85 -67.73 -57.43 6.36 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.517 -0.31 . . . . 0.0 110.991 179.024 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 16.6 tpp180 -60.96 -50.8 71.91 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -178.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . 0.565 ' O ' HG23 ' A' ' 201' ' ' VAL . 97.1 t -70.1 -47.0 70.54 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -179.225 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -59.73 -48.06 87.9 Favored Glycine 0 CA--C 1.52 0.395 0 C-N-CA 121.359 -0.448 . . . . 0.0 113.229 -179.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . 0.514 ' HA ' ' HG2' ' A' ' 202' ' ' GLN . 98.2 m-20 -65.95 -36.38 83.2 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.828 0.347 . . . . 0.0 110.176 179.253 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -62.05 -37.69 94.86 Favored Glycine 0 CA--C 1.522 0.531 0 C-N-CA 120.708 -0.758 . . . . 0.0 111.97 178.48 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 201' ' ' VAL . . . . . 0.565 HG23 ' O ' ' A' ' 197' ' ' VAL . 93.4 t -67.09 -46.29 84.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 O-C-N 122.844 -0.21 . . . . 0.0 110.968 179.023 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 202' ' ' GLN . . . . . 0.514 ' HG2' ' HA ' ' A' ' 199' ' ' ASP . 8.0 pt20 -68.91 -31.68 70.76 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.443 179.593 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.35 -44.43 45.18 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 120.661 0.267 . . . . 0.0 111.152 179.012 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 204' ' ' ASN . . . . . . . . . . . . . 27.1 m-80 -68.19 -44.89 74.87 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.844 0.354 . . . . 0.0 111.715 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 205' ' ' HIS . . . . . 0.464 ' HB2' ' CD2' ' A' ' 209' ' ' PHE . 10.2 m80 -100.65 32.82 2.96 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 120.897 0.379 . . . . 0.0 110.32 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -49.62 -51.4 37.87 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 -178.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 28.2 p -57.91 -53.43 58.29 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -179.08 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -61.93 -41.09 97.55 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.029 0.442 . . . . 0.0 110.871 179.45 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 209' ' ' PHE . . . . . 0.464 ' CD2' ' HB2' ' A' ' 205' ' ' HIS . 5.1 m-85 -64.04 -48.61 75.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.55 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 210' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -67.96 -33.58 74.93 Favored 'General case' 0 C--O 1.225 -0.189 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.853 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -57.69 -50.1 68.32 Favored Glycine 0 C--N 1.336 0.555 0 C-N-CA 120.52 -0.847 . . . . 0.0 111.217 178.265 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 212' ' ' MET . . . . . 0.721 ' SD ' ' HA ' ' B' ' 23' ' ' PHE . 41.6 mtm -67.84 -33.16 74.23 Favored 'General case' 0 C--O 1.224 -0.275 0 N-CA-C 110.355 -0.239 . . . . 0.0 110.355 178.474 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.781 HD12 HD12 ' A' ' 216' ' ' LEU . 10.0 tp -67.97 -36.51 80.17 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.196 179.293 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 15.8 mtp180 -68.76 -34.39 75.5 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 178.441 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -86.76 -6.95 58.67 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.765 178.113 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.781 HD12 HD12 ' A' ' 213' ' ' LEU . 5.9 mt -68.73 110.26 4.22 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.186 0.517 . . . . 0.0 111.916 -179.293 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 217' ' ' ASP . . . . . 0.485 ' H ' HD22 ' B' ' 19' ' ' LEU . 0.3 OUTLIER -94.66 18.99 10.54 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.764 179.476 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 218' ' ' ILE . . . . . 0.662 HG13 HD22 ' A' ' 216' ' ' LEU . 34.2 mt -59.3 107.63 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 CA-C-O 121.431 0.634 . . . . 0.0 111.619 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 6.2 mtmp? -150.31 -28.68 0.23 Allowed 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 115.111 -0.949 . . . . 0.0 111.752 -179.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 220' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -107.59 166.3 10.78 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 121.082 -0.247 . . . . 0.0 111.249 -179.393 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -54.5 -33.3 59.61 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -179.138 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -64.66 -27.76 72.38 Favored Glycine 0 CA--C 1.526 0.768 0 C-N-CA 120.989 -0.624 . . . . 0.0 113.507 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 223' ' ' ASP . . . . . 0.65 ' HB3' HG12 ' A' ' 218' ' ' ILE . 69.2 m-20 -66.94 -38.02 85.37 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 120.911 0.386 . . . . 0.0 111.5 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.442 HG12 HG21 ' A' ' 274' ' ' THR . 1.1 t -63.46 -35.1 71.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-O 121.361 0.601 . . . . 0.0 110.349 179.26 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 36.0 mmtm -65.56 -30.98 71.79 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.585 178.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . 0.682 ' O ' HG23 ' A' ' 230' ' ' VAL . 30.6 t -71.63 -37.0 70.94 Favored 'General case' 0 C--O 1.223 -0.304 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.65 178.16 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 227' ' ' PHE . . . . . 0.607 ' HE2' HD12 ' A' ' 275' ' ' ILE . 8.8 t80 -57.11 -43.78 82.62 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 178.419 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 228' ' ' SER . . . . . 0.704 ' HB3' HG21 ' A' ' 278' ' ' VAL . 0.6 OUTLIER -70.35 -32.36 70.03 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.914 177.276 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 229' ' ' ARG . . . . . . . . . . . . . 54.5 ttp180 -64.09 -48.41 76.26 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.113 178.562 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 0.721 HG13 ' HA ' ' B' ' 24' ' ' ALA . 13.6 t -61.12 -43.77 96.96 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 178.174 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 231' ' ' MET . . . . . 0.923 ' HG3' ' HG ' ' A' ' 248' ' ' LEU . 26.3 ttm -55.07 -50.24 69.64 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.245 178.238 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 72.2 t -64.63 -42.16 94.29 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 CA-C-O 120.847 0.356 . . . . 0.0 110.818 178.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 233' ' ' HIS . . . . . 0.44 ' ND1' ' HB1' ' B' ' 24' ' ' ALA . 52.7 t-80 -59.78 -39.51 85.15 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 116.278 -0.419 . . . . 0.0 112.06 179.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.622 HG13 ' HA ' ' B' ' 28' ' ' ARG . 44.2 t -54.99 -43.94 71.62 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 179.7 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -90.95 25.7 2.34 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -179.316 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.11 -18.74 27.15 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 113.729 1.011 . . . . 0.0 113.729 -178.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -85.68 -16.17 39.98 Favored 'General case' 0 C--N 1.327 -0.384 0 O-C-N 122.093 -0.379 . . . . 0.0 111.4 179.737 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . 100.28 -18.84 54.89 Favored Glycine 0 CA--C 1.522 0.522 0 C-N-CA 120.752 -0.737 . . . . 0.0 113.613 179.405 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 239' ' ' VAL . . . . . . . . . . . . . 4.3 p -85.71 118.83 33.09 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-O 121.56 0.695 . . . . 0.0 111.237 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 240' ' ' THR . . . . . 0.568 HG21 ' HG2' ' A' ' 283' ' ' LYS . 53.8 m -89.95 98.26 11.67 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.807 -179.36 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -89.59 131.87 35.39 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.884 -0.326 . . . . 0.0 110.455 178.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 242' ' ' TRP . . . . . 0.483 ' CH2' ' HB2' ' A' ' 296' ' ' PHE . 17.2 m95 -55.74 -36.76 67.61 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 120.995 0.426 . . . . 0.0 110.75 179.165 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . 0.486 ' H ' ' HB2' ' B' ' 35' ' ' TYR . . . -61.56 -32.51 81.55 Favored Glycine 0 C--N 1.333 0.401 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.152 178.335 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 244' ' ' ARG . . . . . 0.53 ' HA ' ' HA3' ' B' ' 31' ' ' GLY . 99.1 mtt180 -72.01 -46.24 57.92 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 178.541 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . 0.624 HG23 HD21 ' A' ' 279' ' ' LEU . 52.2 mt -58.14 -49.25 82.24 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.154 179.022 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . 0.438 HG21 HG12 ' A' ' 197' ' ' VAL . 8.7 p -69.05 -26.2 31.69 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-N 116.623 -0.262 . . . . 0.0 111.133 179.777 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . 0.405 HG21 ' HB ' ' B' ' 30' ' ' ILE . 17.0 m -65.72 -37.28 85.99 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 177.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 248' ' ' LEU . . . . . 0.923 ' HG ' ' HG3' ' A' ' 231' ' ' MET . 2.6 mm? -66.62 -38.72 87.53 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 177.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 18.2 mm -67.63 -41.4 85.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 177.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 29.8 m -62.25 -41.62 98.6 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.79 178.603 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 251' ' ' PHE . . . . . 0.489 ' CD2' HD11 ' B' ' 27' ' ' LEU . 7.6 t80 -68.03 -40.35 82.93 Favored 'General case' 0 N--CA 1.456 -0.142 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 177.218 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . -56.81 -42.26 91.65 Favored Glycine 0 C--N 1.337 0.586 0 N-CA-C 111.106 -0.798 . . . . 0.0 111.106 177.655 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 253' ' ' ALA . . . . . . . . . . . . . . . -61.39 -44.45 97.13 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-O 120.937 0.399 . . . . 0.0 110.048 177.734 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 254' ' ' PHE . . . . . 0.566 ' HB3' HD13 ' A' ' 213' ' ' LEU . 0.2 OUTLIER -61.17 -41.0 96.0 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.271 178.475 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 255' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 251' ' ' PHE . 91.5 t -62.32 -45.95 97.57 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.225 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 178.096 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 256' ' ' ALA . . . . . 0.507 ' HB1' ' HB2' ' A' ' 171' ' ' ALA . . . -58.82 -39.77 82.17 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 177.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 257' ' ' LYS . . . . . 0.511 ' HE3' ' HG3' ' A' ' 170' ' ' GLN . 74.5 mttt -62.89 -47.41 83.4 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.116 177.577 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 4.2 t60 -59.47 -40.97 88.66 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.428 179.081 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.454 HD13 ' HB3' ' A' ' 267' ' ' PHE . 87.2 mt -68.73 -42.29 77.82 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.406 178.624 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 260' ' ' LYS . . . . . 0.523 ' HG2' ' O ' ' A' ' 171' ' ' ALA . 0.7 OUTLIER -64.98 -34.72 79.11 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 120.847 0.356 . . . . 0.0 110.596 178.667 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 261' ' ' SER . . . . . . . . . . . . . 32.0 t -63.06 -25.83 68.56 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.019 179.279 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 262' ' ' VAL . . . . . 0.45 HG23 ' HB2' ' A' ' 264' ' ' GLN . 27.2 m -111.62 13.87 8.49 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.19 178.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 263' ' ' ASN . . . . . . . . . . . . . 1.6 t30 57.06 50.96 11.11 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.451 179.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 264' ' ' GLN . . . . . 0.472 ' NE2' ' HB2' ' A' ' 267' ' ' PHE . 0.0 OUTLIER -119.03 39.2 3.6 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -179.87 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . 0.453 ' HA ' HD12 ' A' ' 268' ' ' ILE . 0.0 OUTLIER -49.63 -27.41 4.59 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 178.933 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.21 -20.67 43.46 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.251 178.641 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 267' ' ' PHE . . . . . 0.472 ' HB2' ' NE2' ' A' ' 264' ' ' GLN . 2.2 t80 -97.67 -20.9 17.33 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.883 178.709 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 268' ' ' ILE . . . . . 0.453 HD12 ' HA ' ' A' ' 265' ' ' GLU . 76.1 mt -65.39 -43.15 94.82 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-O 120.741 0.305 . . . . 0.0 110.373 179.252 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 269' ' ' GLU . . . . . 0.466 ' HB2' ' HD3' ' A' ' 270' ' ' PRO . 0.3 OUTLIER -54.98 -56.98 21.88 Favored Pre-proline 0 CA--C 1.543 0.711 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.794 179.177 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 270' ' ' PRO . . . . . 0.466 ' HD3' ' HB2' ' A' ' 269' ' ' GLU . 38.8 Cg_exo -62.89 -32.66 76.9 Favored 'Trans proline' 0 C--N 1.358 1.043 0 C-N-CA 122.055 1.837 . . . . 0.0 112.37 178.43 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 271' ' ' LEU . . . . . 0.562 ' O ' HG22 ' A' ' 275' ' ' ILE . 2.1 tm? -63.79 -50.62 68.26 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.621 179.445 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -60.33 -42.39 95.54 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.734 179.745 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 273' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -67.2 -43.87 81.04 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 120.945 0.402 . . . . 0.0 110.988 178.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 274' ' ' THR . . . . . 0.442 HG21 HG12 ' A' ' 224' ' ' VAL . 60.6 m -62.22 -52.68 62.8 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.682 -179.497 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 275' ' ' ILE . . . . . 0.607 HD12 ' HE2' ' A' ' 227' ' ' PHE . 6.3 tt -58.28 -47.69 86.89 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 C-N-CA 121.018 -0.273 . . . . 0.0 111.228 179.741 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 276' ' ' THR . . . . . 0.516 HG23 HD12 ' A' ' 163' ' ' ILE . 50.7 m -59.84 -53.73 54.48 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -179.679 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 277' ' ' ASP . . . . . 0.466 ' OD1' ' HD3' ' A' ' 281' ' ' ARG . 33.5 t70 -59.72 -51.16 70.97 Favored 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 120.637 -0.425 . . . . 0.0 111.092 -179.645 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 278' ' ' VAL . . . . . 0.704 HG21 ' HB3' ' A' ' 228' ' ' SER . 73.8 t -58.27 -47.65 86.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 120.747 -0.381 . . . . 0.0 111.02 179.715 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . 0.624 HD21 HG23 ' A' ' 245' ' ' ILE . 45.3 tp -60.58 -47.64 85.29 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 111.676 0.25 . . . . 0.0 111.676 179.782 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 280' ' ' VAL . . . . . . . . . . . . . 55.6 t -66.86 -39.74 84.24 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 CA-C-O 120.75 0.31 . . . . 0.0 111.008 179.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 281' ' ' ARG . . . . . 0.466 ' HD3' ' OD1' ' A' ' 277' ' ' ASP . 0.0 OUTLIER -68.17 -47.09 68.93 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -179.883 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 282' ' ' THR . . . . . 0.818 HG23 ' HD2' ' A' ' 283' ' ' LYS . 4.7 t -63.37 -44.16 95.56 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 120.435 -0.506 . . . . 0.0 112.216 -179.676 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . 0.818 ' HD2' HG23 ' A' ' 282' ' ' THR . 0.0 OUTLIER -99.46 40.27 1.23 Allowed 'General case' 0 C--N 1.327 -0.392 0 O-C-N 121.987 -0.445 . . . . 0.0 111.463 179.77 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 284' ' ' ARG . . . . . 0.492 HH12 ' HB ' ' A' ' 288' ' ' VAL . 39.6 tpt85 -58.49 -51.12 71.19 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.941 -179.495 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -66.96 -43.59 82.73 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 120.994 0.426 . . . . 0.0 111.462 179.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 286' ' ' TRP . . . . . 0.442 ' O ' ' HB2' ' A' ' 290' ' ' GLN . 3.5 t90 -64.58 -41.37 96.31 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.933 -179.711 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 287' ' ' LEU . . . . . 0.6 HD23 ' HB3' ' A' ' 283' ' ' LYS . 2.0 mm? -69.0 -47.65 64.98 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 112.319 0.488 . . . . 0.0 112.319 -179.751 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 288' ' ' VAL . . . . . 0.492 ' HB ' HH12 ' A' ' 284' ' ' ARG . 7.3 p -60.73 -37.62 76.51 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 CA-C-O 120.634 0.254 . . . . 0.0 111.641 -179.769 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 79.6 mttt -75.3 -21.74 58.23 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 120.891 0.377 . . . . 0.0 111.35 178.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 290' ' ' GLN . . . . . 0.442 ' HB2' ' O ' ' A' ' 286' ' ' TRP . 0.0 OUTLIER -96.34 12.77 30.0 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 111.984 0.365 . . . . 0.0 111.984 179.969 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 291' ' ' ARG . . . . . 0.573 ' HB3' ' HB2' ' A' ' 294' ' ' ASP . 0.0 OUTLIER 62.19 19.09 10.66 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.089 0.471 . . . . 0.0 111.772 179.939 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 292' ' ' GLY . . . . . . . . . . . . . . . 64.45 -122.48 25.15 Favored Glycine 0 CA--C 1.522 0.475 0 CA-C-N 115.906 -0.588 . . . . 0.0 113.964 179.207 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 293' ' ' TRP . . . . . 0.509 ' O ' HG23 ' A' ' 297' ' ' VAL . 89.4 m95 -66.57 -33.71 76.27 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.545 -0.328 . . . . 0.0 111.637 -178.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 294' ' ' ASP . . . . . 0.573 ' HB2' ' HB3' ' A' ' 291' ' ' ARG . 45.0 m-20 -54.86 -40.25 69.47 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.017 0.437 . . . . 0.0 110.251 178.354 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -72.18 -44.51 43.82 Favored Glycine 0 C--N 1.334 0.455 0 C-N-CA 120.761 -0.733 . . . . 0.0 111.727 178.394 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 296' ' ' PHE . . . . . 0.483 ' HB2' ' CH2' ' A' ' 242' ' ' TRP . 7.2 t80 -58.92 -45.06 91.29 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 120.852 0.358 . . . . 0.0 111.114 178.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 297' ' ' VAL . . . . . 0.692 HG11 ' HB3' ' A' ' 189' ' ' ARG . 81.0 t -67.57 -39.51 82.49 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.942 -179.529 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -76.15 -26.95 56.8 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 112.578 0.584 . . . . 0.0 112.578 -179.379 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 299' ' ' PHE . . . . . . . . . . . . . 87.4 t80 -60.9 -41.32 95.83 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.807 0.337 . . . . 0.0 111.372 179.446 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 300' ' ' PHE . . . . . 0.447 ' HE2' ' CD1' ' A' ' 296' ' ' PHE . 68.4 m-85 -88.68 29.54 1.0 Allowed 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 120.706 0.289 . . . . 0.0 111.628 -179.661 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 301' ' ' HIS . . . . . 0.463 ' HB3' HD22 ' A' ' 305' ' ' LEU . 3.8 t60 -77.4 70.64 3.81 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 121.102 0.477 . . . . 0.0 111.056 -179.827 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 2.5 p -86.13 95.48 4.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-O 121.137 0.494 . . . . 0.0 110.896 179.407 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 59.2 tp60 179.71 -78.05 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.259 -179.44 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 304' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -111.0 30.68 6.66 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 120.958 0.409 . . . . 0.0 111.929 -179.516 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 305' ' ' LEU . . . . . 0.463 HD22 ' HB3' ' A' ' 301' ' ' HIS . 27.3 tp -113.74 -32.6 6.08 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 121.159 0.504 . . . . 0.0 111.36 -179.769 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 306' ' ' GLU . . . . . 0.404 ' H ' ' CD ' ' A' ' 306' ' ' GLU . 1.3 pm0 -88.0 -19.38 27.26 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.574 179.652 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 307' ' ' GLY . . . . . . . . . . . . . . . 169.13 -116.07 0.64 Allowed Glycine 0 CA--C 1.522 0.473 0 C-N-CA 120.769 -0.729 . . . . 0.0 113.123 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.196 0 CA-C-O 118.366 -1.241 . . . . 0.0 112.947 -179.77 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.506 0 CA-C-O 121.156 0.503 . . . . 0.0 110.481 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 18' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -113.1 -166.4 1.08 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.285 -178.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 19' ' ' LEU . . . . . 0.718 ' H ' HD23 ' B' ' 19' ' ' LEU . 0.7 OUTLIER -69.59 157.69 88.88 Favored Pre-proline 0 CA--C 1.539 0.522 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.458 179.823 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 20' ' ' PRO . . . . . 0.47 ' HA ' ' HD3' ' B' ' 21' ' ' PRO . 10.2 Cg_endo -50.17 129.8 26.43 Favored 'Trans proline' 0 C--N 1.354 0.819 0 C-N-CA 123.184 2.59 . . . . 0.0 112.582 -179.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 21' ' ' PRO . . . . . 0.47 ' HD3' ' HA ' ' B' ' 20' ' ' PRO . 24.4 Cg_exo -64.16 42.46 0.12 Allowed 'Trans proline' 0 N--CA 1.482 0.849 0 C-N-CA 123.791 2.994 . . . . 0.0 114.913 -178.735 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 22' ' ' GLU . . . . . 0.408 ' HB2' ' NE2' ' B' ' 26' ' ' GLN . 0.5 OUTLIER -85.97 -29.03 23.87 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.001 0.429 . . . . 0.0 110.265 178.887 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 23' ' ' PHE . . . . . 0.721 ' HA ' ' SD ' ' A' ' 212' ' ' MET . 11.1 p90 -60.5 -35.7 76.57 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.498 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 24' ' ' ALA . . . . . 0.721 ' HA ' HG13 ' A' ' 230' ' ' VAL . . . -61.25 -47.79 84.42 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.007 0.432 . . . . 0.0 110.531 179.587 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . 0.431 ' O ' ' HG2' ' B' ' 29' ' ' LYS . . . -70.61 -44.78 66.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.599 179.163 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 26' ' ' GLN . . . . . 0.738 ' O ' HG12 ' B' ' 30' ' ' ILE . 1.7 mp0 -57.74 -56.97 15.11 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.261 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . 0.509 HD12 HG11 ' A' ' 230' ' ' VAL . 50.4 mt -56.31 -42.53 77.74 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 120.589 0.233 . . . . 0.0 111.274 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 28' ' ' ARG . . . . . 0.622 ' HA ' HG13 ' A' ' 234' ' ' VAL . 10.7 ttt85 -57.45 -48.01 80.31 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.523 178.471 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . 0.431 ' HG2' ' O ' ' B' ' 25' ' ' ALA . 20.1 mmmt -68.28 -39.1 82.25 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.872 179.329 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . 0.738 HG12 ' O ' ' B' ' 26' ' ' GLN . 48.8 mm -55.25 -49.95 68.42 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 177.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . 0.53 ' HA3' ' HA ' ' A' ' 244' ' ' ARG . . . -58.84 -44.96 95.64 Favored Glycine 0 N--CA 1.448 -0.559 0 CA-C-N 115.228 -0.897 . . . . 0.0 112.306 179.082 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -57.78 -44.99 86.61 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-O 120.662 0.268 . . . . 0.0 110.955 179.154 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 29.8 tttp -69.73 -52.29 26.74 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 121.017 -0.273 . . . . 0.0 111.171 179.621 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 34' ' ' VAL . . . . . . . . . . . . . 74.2 t -52.94 -49.3 49.32 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-O 121.075 0.464 . . . . 0.0 110.761 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 35' ' ' TYR . . . . . 0.486 ' HB2' ' H ' ' A' ' 243' ' ' GLY . 1.2 t80 -57.33 -48.59 78.59 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.698 178.831 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 36' ' ' CYS . . . . . . . . . . . . . 36.7 t -65.5 -35.04 79.71 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.501 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 37' ' ' THR . . . . . 0.519 ' HA ' ' HB3' ' B' ' 43' ' ' MET . 44.7 m -65.21 -37.3 86.85 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.965 -0.562 . . . . 0.0 111.615 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 38' ' ' TRP . . . . . . . . . . . . . 87.7 m95 -85.52 -35.44 21.13 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.243 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 39' ' ' SER . . . . . . . . . . . . . 40.9 t -67.78 -58.14 5.12 Favored 'General case' 0 N--CA 1.462 0.166 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 177.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -92.89 115.14 64.45 Favored Pre-proline 0 CA--C 1.532 0.267 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.134 177.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 41' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -68.68 -10.18 28.32 Favored 'Trans proline' 0 CA--C 1.534 0.499 0 C-N-CA 122.458 2.105 . . . . 0.0 113.184 -179.392 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -99.61 30.76 3.46 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.762 -179.721 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 43' ' ' MET . . . . . 0.519 ' HB3' ' HA ' ' B' ' 37' ' ' THR . 40.0 tpp . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.418 -0.801 . . . . 0.0 111.866 -179.815 . . . . . . . . 1 1 . 1 stop_ save_